PSI-HHS-000008257443-45 attachment - all COVID-AEs

This spreadsheet is large; only the first 1,000 rows of each sheet are shown. Download the full file for complete data.

Plain text view

Sheet: data
Vaccine Type + Manufacturer | Event: PT_plus_SMQ | N | E | ER05 | ERAM | ER95 | EB05 | EBGM | EB95 | RR | PRR | PRR_CHISQ
COVID19 (Custom Term) | Bell's palsy | 6 | 5.841 | 3.66 | 8.162 | 14.11 | 0.537 | 0.956 | 1.598 | 1.027 | 129.076 | 49.148
COVID19 (Custom Term) | Paraesthesia ear | 5 | 3.371 | 2.84 | 6.879 | 12.345 | 0.624 | 1.151 | 1.984 | 1.483 | 109.219 | 39.319
COVID19 (Custom Term) | Bradykinesia | 7 | 7.871 | 3.079 | 6.37 | 10.621 | 0.507 | 0.874 | 1.425 | 0.889 | 23.168 | 37.526
COVID19 (Custom Term) | Product substitution | 4 | 3.956 | 2.295 | 6.306 | 11.928 | 0.482 | 0.929 | 1.657 | 1.011 | 89.361 | 29.54
COVID19 (Custom Term) | Sinus rhythm | 7 | 6.321 | 2.984 | 6.215 | 10.398 | 0.586 | 1.01 | 1.648 | 1.107 | 69.505 | 50.031
COVID19 (Custom Term) | COVID-19 immunisation | 6 | 5.95 | 2.65 | 5.881 | 10.143 | 0.531 | 0.945 | 1.58 | 1.008 | 129.076 | 49.148
COVID19 (Custom Term) | Mean cell volume abnormal | 3 | 2.485 | 1.728 | 5.871 | 12.007 | 0.486 | 0.99 | 1.842 | 1.207 | 69.503 | 19.861
COVID19 (Custom Term) | Cardiac telemetry abnormal | 3 | 2.912 | 1.728 | 5.871 | 12.007 | 0.454 | 0.925 | 1.721 | 1.03 | 69.503 | 19.861
COVID19 (Custom Term) | AST/ALT ratio abnormal | 3 | 2.97 | 1.728 | 5.871 | 12.007 | 0.45 | 0.917 | 1.705 | 1.01 | 69.503 | 19.861
COVID19 (Custom Term) | Diaphragmatic spasm | 3 | 2.977 | 1.728 | 5.871 | 12.007 | 0.449 | 0.916 | 1.703 | 1.008 | 69.503 | 19.861
COVID19 (Custom Term) | Mastoid disorder | 3 | 2.986 | 1.728 | 5.871 | 12.007 | 0.449 | 0.914 | 1.701 | 1.005 | 69.503 | 19.861
COVID19 (Custom Term) | Cholecystitis acute | 4 | 3.968 | 2.144 | 5.834 | 10.992 | 0.481 | 0.928 | 1.654 | 1.008 | 89.361 | 29.54
COVID19 (Custom Term) | Blood pressure systolic | 8 | 6.364 | 2.949 | 5.817 | 9.469 | 0.658 | 1.106 | 1.767 | 1.257 | 168.792 | 68.882
COVID19 (Custom Term) | Ejection fraction | 8 | 7.818 | 2.963 | 5.807 | 9.421 | 0.575 | 0.965 | 1.542 | 1.023 | 79.434 | 59.585
COVID19 (Custom Term) | SARS-CoV-1 test | 4 | 3.82 | 2.068 | 5.595 | 10.517 | 0.491 | 0.946 | 1.687 | 1.047 | 89.361 | 29.54
COVID19 (Custom Term) | Cardiac failure chronic | 4 | 3.89 | 2.068 | 5.595 | 10.517 | 0.486 | 0.937 | 1.671 | 1.028 | 89.361 | 29.54
COVID19 (Custom Term) | Acute left ventricular failure | 5 | 4.995 | 2.278 | 5.555 | 9.999 | 0.506 | 0.933 | 1.607 | 1.001 | 12.412 | 18.068
COVID19 (Custom Term) | Agonal rhythm | 4 | 3.964 | 2.032 | 5.485 | 10.3 | 0.482 | 0.928 | 1.655 | 1.009 | 89.361 | 29.54
COVID19 (Custom Term) | Hypomagnesaemia | 6 | 6.008 | 2.469 | 5.423 | 9.309 | 0.528 | 0.939 | 1.57 | 0.999 | 19.858 | 29.233
COVID19 (Custom Term) | Pulmonary infarction | 7 | 6.949 | 2.593 | 5.36 | 8.935 | 0.551 | 0.95 | 1.55 | 1.007 | 69.505 | 50.031
COVID19 (Custom Term) | Cerebral artery occlusion | 5 | 4.945 | 2.227 | 5.348 | 9.56 | 0.509 | 0.939 | 1.616 | 1.011 | 24.823 | 25.6
COVID19 (Custom Term) | Diastolic dysfunction | 5 | 4.949 | 2.126 | 5.241 | 9.477 | 0.509 | 0.938 | 1.615 | 1.01 | 7.092 | 11.603
COVID19 (Custom Term) | Cardiac telemetry normal | 7 | 5.708 | 2.504 | 5.159 | 8.586 | 0.624 | 1.077 | 1.757 | 1.226 | 34.752 | 43.072
COVID19 (Custom Term) | Aortic stenosis | 5 | 4.938 | 2.141 | 5.112 | 9.116 | 0.509 | 0.94 | 1.618 | 1.013 | 24.823 | 25.6
COVID19 (Custom Term) | Sudden cardiac death | 6 | 5.869 | 2.258 | 4.903 | 8.37 | 0.536 | 0.953 | 1.593 | 1.022 | 19.858 | 29.233
COVID19 (Custom Term) | Uterine spasm | 3 | 2.494 | 1.42 | 4.768 | 9.712 | 0.485 | 0.988 | 1.84 | 1.203 | 29.788 | 13.696
COVID19 (Custom Term) | Hypertensive emergency | 6 | 4.972 | 2.168 | 4.758 | 8.163 | 0.592 | 1.052 | 1.76 | 1.207 | 59.575 | 40.585
COVID19 (Custom Term) | May-Thurner syndrome | 5 | 4.966 | 1.974 | 4.746 | 8.488 | 0.508 | 0.936 | 1.612 | 1.007 | 109.219 | 39.319
COVID19 (Custom Term) | Infusion | 4 | 3.894 | 1.774 | 4.745 | 8.878 | 0.486 | 0.937 | 1.67 | 1.027 | 39.717 | 22.272
COVID19 (Custom Term) | Adult failure to thrive | 3 | 2.964 | 1.445 | 4.708 | 9.491 | 0.45 | 0.917 | 1.707 | 1.012 | 69.503 | 19.861
COVID19 (Custom Term) | Plasminogen activator inhibitor | 3 | 2.971 | 1.445 | 4.708 | 9.491 | 0.45 | 0.916 | 1.705 | 1.01 | 69.503 | 19.861
COVID19 (Custom Term) | Blood creatine phosphokinase MB decreased | 3 | 2.97 | 1.445 | 4.708 | 9.491 | 0.45 | 0.917 | 1.705 | 1.01 | 69.503 | 19.861
COVID19 (Custom Term) | Implantable defibrillator insertion | 3 | 2.97 | 1.445 | 4.708 | 9.491 | 0.45 | 0.917 | 1.705 | 1.01 | 69.503 | 19.861
COVID19 (Custom Term) | NIH stroke scale score increased | 3 | 2.976 | 1.445 | 4.708 | 9.491 | 0.449 | 0.916 | 1.704 | 1.008 | 69.503 | 19.861
COVID19 (Custom Term) | Oral blood blister | 3 | 2.979 | 1.445 | 4.708 | 9.491 | 0.449 | 0.915 | 1.703 | 1.007 | 69.503 | 19.861
COVID19 (Custom Term) | Aortic aneurysm rupture | 4 | 3.951 | 1.76 | 4.7 | 8.787 | 0.482 | 0.93 | 1.658 | 1.012 | 39.717 | 22.272
COVID19 (Custom Term) | Thalamic infarction | 4 | 3.96 | 1.756 | 4.689 | 8.765 | 0.482 | 0.929 | 1.656 | 1.01 | 39.717 | 22.272
COVID19 (Custom Term) | Drainage | 7 | 4.87 | 2.263 | 4.657 | 7.747 | 0.686 | 1.183 | 1.932 | 1.437 | 34.752 | 43.072
COVID19 (Custom Term) | Prohormone brain natriuretic peptide | 3 | 2.487 | 1.424 | 4.623 | 9.306 | 0.486 | 0.99 | 1.842 | 1.206 | 69.503 | 19.861
COVID19 (Custom Term) | Cardiac death | 3 | 2.805 | 1.424 | 4.623 | 9.306 | 0.461 | 0.94 | 1.749 | 1.069 | 69.503 | 19.861
COVID19 (Custom Term) | Abdominal wall haematoma | 3 | 2.962 | 1.424 | 4.623 | 9.306 | 0.45 | 0.918 | 1.707 | 1.013 | 69.503 | 19.861
COVID19 (Custom Term) | Biliary dilatation | 3 | 2.967 | 1.424 | 4.623 | 9.306 | 0.45 | 0.917 | 1.706 | 1.011 | 69.503 | 19.861
COVID19 (Custom Term) | Complicated appendicitis | 3 | 2.984 | 1.424 | 4.623 | 9.306 | 0.449 | 0.915 | 1.702 | 1.005 | 69.503 | 19.861
COVID19 (Custom Term) | Sensation of blood flow | 4 | 3.481 | 1.731 | 4.606 | 8.599 | 0.515 | 0.992 | 1.768 | 1.149 | 39.717 | 22.272
COVID19 (Custom Term) | Percutaneous coronary intervention | 4 | 3.966 | 1.722 | 4.576 | 8.54 | 0.481 | 0.928 | 1.654 | 1.009 | 39.717 | 22.272
COVID19 (Custom Term) | Basal ganglia stroke | 6 | 6.055 | 2.061 | 4.451 | 7.579 | 0.525 | 0.934 | 1.563 | 0.991 | 14.894 | 25.291
COVID19 (Custom Term) | Perfusion brain scan normal | 4 | 3.966 | 1.607 | 4.412 | 8.342 | 0.481 | 0.928 | 1.654 | 1.009 | 89.361 | 29.54
COVID19 (Custom Term) | Cerebral mass effect | 3 | 2.962 | 1.323 | 4.352 | 8.801 | 0.45 | 0.918 | 1.707 | 1.013 | 29.788 | 13.696
COVID19 (Custom Term) | Carotid arteriosclerosis | 4 | 3.952 | 1.645 | 4.331 | 8.05 | 0.482 | 0.93 | 1.657 | 1.012 | 39.717 | 22.272
COVID19 (Custom Term) | Bone swelling | 4 | 2.604 | 1.577 | 4.262 | 8.009 | 0.587 | 1.132 | 2.022 | 1.536 | 19.858 | 17.461
COVID19 (Custom Term) | Coronary artery stenosis | 4 | 3.957 | 1.574 | 4.255 | 7.993 | 0.482 | 0.929 | 1.656 | 1.011 | 19.858 | 17.461
COVID19 (Custom Term) | Dental paraesthesia | 3 | 2.376 | 1.291 | 4.212 | 8.495 | 0.495 | 1.008 | 1.876 | 1.263 | 29.788 | 13.696
COVID19 (Custom Term) | NIH stroke scale abnormal | 3 | 3.026 | 1.291 | 4.212 | 8.495 | 0.446 | 0.909 | 1.691 | 0.991 | 29.788 | 13.696
COVID19 (Custom Term) | Embolic stroke | 6 | 5.938 | 1.881 | 4.146 | 7.128 | 0.532 | 0.946 | 1.582 | 1.01 | 29.788 | 34.187
COVID19 (Custom Term) | Cardiac assistance device user | 6 | 5.457 | 1.861 | 4.068 | 6.966 | 0.56 | 0.996 | 1.666 | 1.099 | 19.858 | 29.233
COVID19 (Custom Term) | Suppressed lactation | 4 | 3.489 | 1.469 | 4.023 | 7.6 | 0.514 | 0.991 | 1.766 | 1.146 | 39.717 | 22.272
COVID19 (Custom Term) | Electrocardiogram PR segment depression | 3 | 3.354 | 1.231 | 3.954 | 7.93 | 0.425 | 0.866 | 1.611 | 0.894 | 29.788 | 13.696
COVID19 (Custom Term) | Hypercoagulation | 3 | 2.914 | 1.231 | 3.953 | 7.927 | 0.454 | 0.925 | 1.72 | 1.03 | 29.788 | 13.696
COVID19 (Custom Term) | Coagulation factor V level | 3 | 2.35 | 1.221 | 3.909 | 7.831 | 0.497 | 1.013 | 1.885 | 1.277 | 29.788 | 13.696
COVID19 (Custom Term) | Sedative therapy | 3 | 2.962 | 1.22 | 3.905 | 7.822 | 0.45 | 0.918 | 1.707 | 1.013 | 29.788 | 13.696
COVID19 (Custom Term) | Renal tubular necrosis | 3 | 2.97 | 1.217 | 3.894 | 7.798 | 0.45 | 0.917 | 1.705 | 1.01 | 29.788 | 13.696
COVID19 (Custom Term) | Ultrasound foetal | 4 | 3.981 | 1.443 | 3.894 | 7.311 | 0.48 | 0.926 | 1.651 | 1.005 | 13.239 | 14.053
COVID19 (Custom Term) | Blood urea nitrogen/creatinine ratio increased | 4 | 3.961 | 1.466 | 3.888 | 7.251 | 0.482 | 0.929 | 1.656 | 1.01 | 19.858 | 17.461
COVID19 (Custom Term) | Urinary occult blood positive | 3 | 3.966 | 1.213 | 3.876 | 7.76 | 0.39 | 0.796 | 1.48 | 0.757 | 29.788 | 13.696
COVID19 (Custom Term) | Lack of spontaneous speech | 5 | 4.461 | 1.624 | 3.871 | 6.899 | 0.54 | 0.995 | 1.714 | 1.121 | 24.823 | 25.6
COVID19 (Custom Term) | Pain assessment | 3 | 2.976 | 1.179 | 3.868 | 7.818 | 0.449 | 0.916 | 1.704 | 1.008 | 14.894 | 10.038
COVID19 (Custom Term) | Arteriosclerosis coronary artery | 5 | 4.098 | 1.641 | 3.863 | 6.846 | 0.565 | 1.042 | 1.795 | 1.22 | 9.929 | 15.462
COVID19 (Custom Term) | Cerebral artery stenosis | 4 | 3.964 | 1.455 | 3.853 | 7.179 | 0.482 | 0.928 | 1.655 | 1.009 | 19.858 | 17.461
COVID19 (Custom Term) | Viral pericarditis | 3 | 2.933 | 1.205 | 3.84 | 7.681 | 0.452 | 0.922 | 1.715 | 1.023 | 29.788 | 13.696
COVID19 (Custom Term) | Absence of immediate treatment response | 3 | 2.976 | 1.204 | 3.837 | 7.672 | 0.449 | 0.916 | 1.703 | 1.008 | 29.788 | 13.696
COVID19 (Custom Term) | Foetal monitoring | 3 | 2.997 | 1.202 | 3.826 | 7.648 | 0.448 | 0.913 | 1.698 | 1.001 | 29.788 | 13.696
COVID19 (Custom Term) | Dependence on respirator | 3 | 3.033 | 1.165 | 3.807 | 7.683 | 0.445 | 0.908 | 1.689 | 0.989 | 14.894 | 10.038
COVID19 (Custom Term) | Nipple pain | 4 | 1.758 | 1.479 | 3.794 | 6.978 | 0.681 | 1.315 | 2.36 | 2.275 | 4.413 | 4.94
COVID19 (Custom Term) | Haemoperitoneum | 3 | 3.036 | 1.19 | 3.777 | 7.541 | 0.445 | 0.907 | 1.688 | 0.988 | 29.788 | 13.696
COVID19 (Custom Term) | Immunisation anxiety related reaction | 3 | 2.002 | 1.187 | 3.762 | 7.51 | 0.528 | 1.076 | 2.004 | 1.499 | 29.788 | 13.696
COVID19 (Custom Term) | Protein S | 3 | 2.356 | 1.175 | 3.708 | 7.389 | 0.496 | 1.011 | 1.883 | 1.273 | 29.788 | 13.696
COVID19 (Custom Term) | N-terminal prohormone brain natriuretic peptide | 3 | 2.962 | 1.175 | 3.707 | 7.388 | 0.45 | 0.918 | 1.707 | 1.013 | 29.788 | 13.696
COVID19 (Custom Term) | Autoscopy | 5 | 3.864 | 1.597 | 3.689 | 6.481 | 0.583 | 1.075 | 1.851 | 1.294 | 12.412 | 18.068
COVID19 (Custom Term) | Suprapubic pain | 2 | 1.498 | 0.842 | 3.686 | 8.168 | 0.45 | 0.986 | 1.938 | 1.335 | 49.645 | 10.433
COVID19 (Custom Term) | Product monitoring error | 2 | 1.912 | 0.842 | 3.686 | 8.168 | 0.416 | 0.911 | 1.79 | 1.046 | 49.645 | 10.433
COVID19 (Custom Term) | Cranial nerve injury | 2 | 1.974 | 0.842 | 3.686 | 8.168 | 0.411 | 0.901 | 1.77 | 1.013 | 49.645 | 10.433
COVID19 (Custom Term) | Hyperdynamic left ventricle | 2 | 1.975 | 0.842 | 3.686 | 8.168 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Embolic cerebral infarction | 2 | 1.975 | 0.842 | 3.686 | 8.168 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Bladder hypertrophy | 2 | 1.982 | 0.842 | 3.686 | 8.168 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Labia enlarged | 2 | 1.982 | 0.842 | 3.686 | 8.168 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Coagulation time | 2 | 1.984 | 0.842 | 3.686 | 8.168 | 0.41 | 0.899 | 1.767 | 1.008 | 49.645 | 10.433
COVID19 (Custom Term) | Serum serotonin | 2 | 1.991 | 0.842 | 3.686 | 8.168 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | Cast application | 5 | 4.952 | 1.576 | 3.674 | 6.484 | 0.509 | 0.938 | 1.615 | 1.01 | 9.929 | 15.462
COVID19 (Custom Term) | Embolism | 3 | 2.967 | 1.161 | 3.646 | 7.254 | 0.45 | 0.917 | 1.706 | 1.011 | 29.788 | 13.696
COVID19 (Custom Term) | Optical coherence tomography | 4 | 3.964 | 1.363 | 3.617 | 6.746 | 0.482 | 0.928 | 1.655 | 1.009 | 13.239 | 14.053
COVID19 (Custom Term) | Troponin T | 5 | 4.971 | 1.552 | 3.605 | 6.35 | 0.507 | 0.936 | 1.611 | 1.006 | 9.929 | 15.462
COVID19 (Custom Term) | Nipple swelling | 2 | 0.137 | 0.823 | 3.549 | 7.83 | 0.627 | 1.527 | 5.807 | 14.57 | 49.645 | 10.433
COVID19 (Custom Term) | Periorbital discomfort | 2 | 1.006 | 0.823 | 3.549 | 7.83 | 0.499 | 1.093 | 2.158 | 1.988 | 49.645 | 10.433
COVID19 (Custom Term) | White coat hypertension | 2 | 1.006 | 0.823 | 3.549 | 7.83 | 0.499 | 1.093 | 2.158 | 1.988 | 49.645 | 10.433
COVID19 (Custom Term) | Non-tobacco user | 2 | 1.496 | 0.823 | 3.549 | 7.83 | 0.45 | 0.986 | 1.939 | 1.337 | 49.645 | 10.433
COVID19 (Custom Term) | Right ventricular dilatation | 2 | 1.948 | 0.823 | 3.549 | 7.83 | 0.413 | 0.905 | 1.778 | 1.026 | 49.645 | 10.433
COVID19 (Custom Term) | Red blood cell count abnormal | 2 | 1.977 | 0.823 | 3.549 | 7.83 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Blood pressure diastolic | 2 | 1.977 | 0.823 | 3.549 | 7.83 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Arterial rupture | 2 | 1.982 | 0.823 | 3.549 | 7.83 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Airway secretion clearance therapy | 2 | 1.982 | 0.823 | 3.549 | 7.83 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Tracheal aspirate culture | 2 | 1.984 | 0.823 | 3.549 | 7.83 | 0.41 | 0.899 | 1.767 | 1.008 | 49.645 | 10.433
COVID19 (Custom Term) | Balance test | 2 | 1.987 | 0.823 | 3.549 | 7.83 | 0.41 | 0.899 | 1.766 | 1.007 | 49.645 | 10.433
COVID19 (Custom Term) | Pharyngeal mass | 2 | 1.991 | 0.823 | 3.549 | 7.83 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | Staphylococcal sepsis | 4 | 4.01 | 1.305 | 3.494 | 6.54 | 0.479 | 0.923 | 1.645 | 0.998 | 9.929 | 11.522
COVID19 (Custom Term) | Oedema mouth | 5 | 3.011 | 1.5 | 3.456 | 6.065 | 0.658 | 1.214 | 2.094 | 1.661 | 9.929 | 15.462
COVID19 (Custom Term) | Electrocardiogram ST-T segment abnormal | 3 | 3.018 | 1.116 | 3.448 | 6.819 | 0.446 | 0.91 | 1.693 | 0.994 | 29.788 | 13.696
COVID19 (Custom Term) | Gingival pruritus | 3 | 1.509 | 1.082 | 3.428 | 6.841 | 0.579 | 1.181 | 2.208 | 1.988 | 14.894 | 10.038
COVID19 (Custom Term) | Withdrawal of life support | 4 | 3.966 | 1.284 | 3.42 | 6.386 | 0.481 | 0.928 | 1.654 | 1.009 | 9.929 | 11.522
COVID19 (Custom Term) | Hip surgery | 4 | 4.006 | 1.246 | 3.363 | 6.315 | 0.479 | 0.923 | 1.646 | 0.998 | 7.943 | 9.576
COVID19 (Custom Term) | Quarantine | 4 | 4.783 | 1.288 | 3.354 | 6.207 | 0.434 | 0.838 | 1.493 | 0.836 | 13.239 | 14.053
COVID19 (Custom Term) | Hemiplegic migraine | 3 | 2.986 | 0.996 | 3.305 | 6.704 | 0.449 | 0.914 | 1.701 | 1.005 | 7.447 | 5.943
COVID19 (Custom Term) | Right ventricular hypertrophy | 3 | 2.969 | 1.082 | 3.299 | 6.493 | 0.45 | 0.917 | 1.706 | 1.011 | 29.788 | 13.696
COVID19 (Custom Term) | Ultrasound foetal abnormal | 3 | 2.986 | 1.054 | 3.299 | 6.555 | 0.449 | 0.914 | 1.701 | 1.005 | 14.894 | 10.038
COVID19 (Custom Term) | Foetal non-stress test | 3 | 2.986 | 1.052 | 3.29 | 6.535 | 0.449 | 0.914 | 1.701 | 1.005 | 14.894 | 10.038
COVID19 (Custom Term) | Arteriospasm coronary | 2 | 2.363 | 0.705 | 3.285 | 7.411 | 0.384 | 0.841 | 1.653 | 0.846 | 9.929 | 3.868
COVID19 (Custom Term) | Dysgeusia | 337 | 240.171 | 2.988 | 3.275 | 3.573 | 1.275 | 1.395 | 1.524 | 1.403 | 8.005 | 1142.008
COVID19 (Custom Term) | Vaccination site haemorrhage | 7 | 6.4 | 1.578 | 3.264 | 5.442 | 0.581 | 1.002 | 1.635 | 1.094 | 1.782 | 1.373
COVID19 (Custom Term) | Thrombolysis | 3 | 2.976 | 1.046 | 3.262 | 6.473 | 0.449 | 0.916 | 1.704 | 1.008 | 14.894 | 10.038
COVID19 (Custom Term) | Lung hyperinflation | 4 | 3.038 | 1.232 | 3.232 | 5.999 | 0.549 | 1.058 | 1.887 | 1.317 | 9.929 | 11.522
COVID19 (Custom Term) | Cholecystitis infective | 3 | 2.979 | 1.011 | 3.228 | 6.46 | 0.449 | 0.915 | 1.703 | 1.007 | 9.929 | 7.632
COVID19 (Custom Term) | Hypernatraemia | 5 | 5.016 | 1.417 | 3.213 | 5.597 | 0.505 | 0.931 | 1.603 | 0.997 | 9.929 | 15.462
COVID19 (Custom Term) | Bundle branch block left | 4 | 3.896 | 1.222 | 3.196 | 5.924 | 0.486 | 0.937 | 1.67 | 1.027 | 9.929 | 11.522
COVID19 (Custom Term) | Intestinal perforation | 5 | 4.875 | 1.331 | 3.189 | 5.695 | 0.513 | 0.947 | 1.63 | 1.026 | 3.546 | 4.829
COVID19 (Custom Term) | Diverticulum | 4 | 3.951 | 1.197 | 3.182 | 5.939 | 0.482 | 0.93 | 1.658 | 1.012 | 7.943 | 9.576
COVID19 (Custom Term) | Time perception altered | 3 | 3.352 | 1.028 | 3.175 | 6.279 | 0.425 | 0.866 | 1.611 | 0.895 | 14.894 | 10.038
COVID19 (Custom Term) | Portal hypertension | 3 | 2.982 | 1.025 | 3.161 | 6.248 | 0.449 | 0.915 | 1.702 | 1.006 | 14.894 | 10.038
COVID19 (Custom Term) | Aortic arteriosclerosis | 6 | 6.016 | 1.468 | 3.159 | 5.368 | 0.528 | 0.938 | 1.569 | 0.997 | 14.894 | 25.291
COVID19 (Custom Term) | Ventilation/perfusion scan | 3 | 2.976 | 0.992 | 3.136 | 6.255 | 0.449 | 0.916 | 1.704 | 1.008 | 9.929 | 7.632
COVID19 (Custom Term) | Blood pressure systolic abnormal | 3 | 2.473 | 0.992 | 3.135 | 6.252 | 0.487 | 0.992 | 1.846 | 1.213 | 9.929 | 7.632
COVID19 (Custom Term) | Ventricular drainage | 4 | 3.97 | 1.204 | 3.129 | 5.787 | 0.481 | 0.928 | 1.653 | 1.007 | 9.929 | 11.522
COVID19 (Custom Term) | Nucleic acid test | 3 | 3.985 | 1.011 | 3.097 | 6.105 | 0.389 | 0.794 | 1.476 | 0.753 | 14.894 | 10.038
COVID19 (Custom Term) | Aneurysm | 4 | 3.963 | 1.172 | 3.089 | 5.743 | 0.482 | 0.929 | 1.655 | 1.009 | 7.943 | 9.576
COVID19 (Custom Term) | Physical examination abnormal | 4 | 3.98 | 1.17 | 3.082 | 5.729 | 0.481 | 0.926 | 1.651 | 1.005 | 7.943 | 9.576
COVID19 (Custom Term) | Perfusion brain scan | 2 | 1.98 | 0.721 | 3.074 | 6.761 | 0.41 | 0.9 | 1.768 | 1.01 | 19.858 | 6.023
COVID19 (Custom Term) | Neck injury | 4 | 3.968 | 1.137 | 3.034 | 5.672 | 0.481 | 0.928 | 1.654 | 1.008 | 6.619 | 8.039
COVID19 (Custom Term) | Hypophosphataemia | 3 | 2.492 | 0.941 | 3.022 | 6.061 | 0.485 | 0.989 | 1.84 | 1.204 | 7.447 | 5.943
COVID19 (Custom Term) | Peritonitis bacterial | 2 | 1.975 | 0.715 | 3.022 | 6.629 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Catecholamines urine | 2 | 1.991 | 0.714 | 3.015 | 6.611 | 0.41 | 0.898 | 1.764 | 1.005 | 19.858 | 6.023
COVID19 (Custom Term) | End stage renal disease | 4 | 3.954 | 1.152 | 3.014 | 5.588 | 0.482 | 0.93 | 1.657 | 1.012 | 7.943 | 9.576
COVID19 (Custom Term) | Norovirus test | 1 | 0.552 | 0.225 | 3.006 | 8.497 | 0.399 | 0.969 | 2.06 | 1.812 | 0.284 | 1.076
COVID19 (Custom Term) | Basal ganglia haemorrhage | 3 | 2.07 | 0.964 | 2.998 | 5.943 | 0.522 | 1.063 | 1.98 | 1.449 | 9.929 | 7.632
COVID19 (Custom Term) | Intracardiac thrombus | 2 | 1.878 | 0.71 | 2.985 | 6.536 | 0.418 | 0.917 | 1.801 | 1.065 | 19.858 | 6.023
COVID19 (Custom Term) | Thromboembolectomy | 2 | 1.98 | 0.71 | 2.981 | 6.526 | 0.41 | 0.9 | 1.768 | 1.01 | 19.858 | 6.023
COVID19 (Custom Term) | Oropharyngeal spasm | 2 | 1.496 | 0.709 | 2.973 | 6.506 | 0.45 | 0.986 | 1.939 | 1.337 | 19.858 | 6.023
COVID19 (Custom Term) | Electrocardiogram QRS complex abnormal | 3 | 3.343 | 0.984 | 2.968 | 5.819 | 0.425 | 0.867 | 1.613 | 0.897 | 14.894 | 10.038
COVID19 (Custom Term) | Intentional product use issue | 3 | 2.894 | 0.957 | 2.965 | 5.869 | 0.455 | 0.927 | 1.725 | 1.037 | 9.929 | 7.632
COVID19 (Custom Term) | Product packaging quantity issue | 2 | 1.952 | 0.67 | 2.963 | 6.586 | 0.413 | 0.904 | 1.777 | 1.025 | 1.805 | 0.089
COVID19 (Custom Term) | Perfusion brain scan abnormal | 2 | 1.982 | 0.707 | 2.959 | 6.471 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Ischaemic cardiomyopathy | 2 | 1.975 | 0.704 | 2.935 | 6.41 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Radial pulse abnormal | 2 | 1.984 | 0.704 | 2.935 | 6.41 | 0.41 | 0.899 | 1.767 | 1.008 | 19.858 | 6.023
COVID19 (Custom Term) | Vascular dementia | 2 | 2.9 | 0.704 | 2.935 | 6.41 | 0.351 | 0.771 | 1.516 | 0.69 | 19.858 | 6.023
COVID19 (Custom Term) | Hemianopia | 3 | 2.976 | 0.867 | 2.934 | 5.993 | 0.449 | 0.916 | 1.704 | 1.008 | 4.965 | 3.757
COVID19 (Custom Term) | Urinary system x-ray abnormal | 2 | 1.989 | 0.703 | 2.926 | 6.388 | 0.41 | 0.898 | 1.765 | 1.006 | 19.858 | 6.023
COVID19 (Custom Term) | Albumin globulin ratio decreased | 2 | 1.989 | 0.703 | 2.926 | 6.388 | 0.41 | 0.898 | 1.765 | 1.006 | 19.858 | 6.023
COVID19 (Custom Term) | Appendicolith | 2 | 1.984 | 0.702 | 2.913 | 6.354 | 0.41 | 0.899 | 1.767 | 1.008 | 19.858 | 6.023
COVID19 (Custom Term) | Peripheral nerve injury | 2 | 1.989 | 0.702 | 2.912 | 6.351 | 0.41 | 0.898 | 1.765 | 1.006 | 19.858 | 6.023
COVID19 (Custom Term) | Oversensing | 2 | 1.496 | 0.7 | 2.902 | 6.326 | 0.45 | 0.986 | 1.939 | 1.337 | 19.858 | 6.023
COVID19 (Custom Term) | Pulmonary vascular disorder | 2 | 2.044 | 0.699 | 2.894 | 6.308 | 0.406 | 0.889 | 1.748 | 0.978 | 19.858 | 6.023
COVID19 (Custom Term) | Ventricular arrhythmia | 3 | 2.361 | 0.968 | 2.891 | 5.647 | 0.496 | 1.011 | 1.881 | 1.271 | 14.894 | 10.038
COVID19 (Custom Term) | Chronic respiratory failure | 3 | 3.021 | 0.942 | 2.89 | 5.7 | 0.446 | 0.91 | 1.692 | 0.993 | 9.929 | 7.632
COVID19 (Custom Term) | Blood pressure orthostatic abnormal | 2 | 1.496 | 0.698 | 2.885 | 6.284 | 0.45 | 0.986 | 1.939 | 1.337 | 19.858 | 6.023
COVID19 (Custom Term) | Eyelid sensory disorder | 2 | 1.006 | 0.698 | 2.879 | 6.268 | 0.499 | 1.093 | 2.158 | 1.988 | 19.858 | 6.023
COVID19 (Custom Term) | Large intestine perforation | 3 | 3.925 | 0.858 | 2.877 | 5.859 | 0.392 | 0.8 | 1.488 | 0.764 | 4.965 | 3.757
COVID19 (Custom Term) | Post procedural haemorrhage | 2 | 1.984 | 0.694 | 2.848 | 6.191 | 0.41 | 0.899 | 1.767 | 1.008 | 19.858 | 6.023
COVID19 (Custom Term) | Infusion site extravasation | 2 | 2.358 | 0.694 | 2.848 | 6.191 | 0.384 | 0.842 | 1.655 | 0.848 | 19.858 | 6.023
COVID19 (Custom Term) | Spinal compression fracture | 3 | 3.407 | 0.907 | 2.844 | 5.656 | 0.421 | 0.859 | 1.598 | 0.88 | 7.447 | 5.943
COVID19 (Custom Term) | Dental discomfort | 2 | 1.982 | 0.693 | 2.84 | 6.171 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Cerebral artery embolism | 2 | 2.006 | 0.693 | 2.84 | 6.171 | 0.409 | 0.895 | 1.76 | 0.997 | 19.858 | 6.023
COVID19 (Custom Term) | Body mass index | 2 | 1.984 | 0.692 | 2.833 | 6.152 | 0.41 | 0.899 | 1.767 | 1.008 | 19.858 | 6.023
COVID19 (Custom Term) | Right atrial dilatation | 2 | 1.982 | 0.692 | 2.829 | 6.142 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Alanine aminotransferase decreased | 3 | 2.972 | 0.848 | 2.819 | 5.724 | 0.45 | 0.916 | 1.705 | 1.009 | 4.965 | 3.757
COVID19 (Custom Term) | Visual acuity tests | 3 | 2.984 | 0.927 | 2.813 | 5.526 | 0.449 | 0.915 | 1.702 | 1.005 | 9.929 | 7.632
COVID19 (Custom Term) | Ischaemic hepatitis | 2 | 1.975 | 0.69 | 2.812 | 6.1 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Axonal and demyelinating polyneuropathy | 2 | 2.046 | 0.687 | 2.789 | 6.043 | 0.406 | 0.889 | 1.747 | 0.978 | 19.858 | 6.023
COVID19 (Custom Term) | Ultrasound pelvis | 3 | 2.986 | 0.89 | 2.784 | 5.53 | 0.449 | 0.914 | 1.701 | 1.005 | 1.986 | 0.486
COVID19 (Custom Term) | Angina unstable | 3 | 2.479 | 0.896 | 2.783 | 5.515 | 0.486 | 0.991 | 1.844 | 1.21 | 7.447 | 5.943
COVID19 (Custom Term) | Haemorrhage in pregnancy | 4 | 4.442 | 1.069 | 2.769 | 5.114 | 0.453 | 0.873 | 1.556 | 0.9 | 6.619 | 8.039
COVID19 (Custom Term) | Hyperkalaemia | 6 | 5.091 | 1.243 | 2.75 | 4.737 | 0.584 | 1.038 | 1.736 | 1.178 | 2.482 | 3.044
COVID19 (Custom Term) | Circumoral swelling | 3 | 1.577 | 0.889 | 2.749 | 5.437 | 0.572 | 1.166 | 2.177 | 1.902 | 7.447 | 5.943
COVID19 (Custom Term) | Ovarian malignant tumours (SMQ) [broad] | 3 | 3.027 | 0.929 | 2.73 | 5.299 | 0.446 | 0.909 | 1.69 | 0.991 | 2.482 | 1.02
COVID19 (Custom Term) | Basal ganglia infarction | 3 | 3.039 | 0.933 | 2.723 | 5.271 | 0.445 | 0.907 | 1.687 | 0.987 | 14.894 | 10.038
COVID19 (Custom Term) | Red blood cells urine | 3 | 3.037 | 0.905 | 2.701 | 5.273 | 0.445 | 0.907 | 1.688 | 0.988 | 9.929 | 7.632
COVID19 (Custom Term) | Diverticulum intestinal haemorrhagic | 2 | 1.982 | 0.677 | 2.698 | 5.812 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Left ventricular end-diastolic pressure increased | 2 | 1.049 | 0.71 | 2.693 | 5.714 | 0.494 | 1.083 | 2.136 | 1.907 | 49.645 | 10.433
COVID19 (Custom Term) | Gastrointestinal pathogen panel | 2 | 1.496 | 0.71 | 2.693 | 5.714 | 0.45 | 0.986 | 1.939 | 1.337 | 49.645 | 10.433
COVID19 (Custom Term) | Galactostasis | 2 | 1.498 | 0.71 | 2.693 | 5.714 | 0.45 | 0.986 | 1.938 | 1.335 | 49.645 | 10.433
COVID19 (Custom Term) | Herpes simplex reactivation | 2 | 1.498 | 0.71 | 2.693 | 5.714 | 0.45 | 0.986 | 1.938 | 1.335 | 49.645 | 10.433
COVID19 (Custom Term) | Ultrasound eye | 2 | 1.974 | 0.71 | 2.693 | 5.714 | 0.411 | 0.901 | 1.77 | 1.013 | 49.645 | 10.433
COVID19 (Custom Term) | Hypertensive encephalopathy | 2 | 1.975 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Neurologic neglect syndrome | 2 | 1.975 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Femoral neck fracture | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Internal capsule infarction | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Vertebral artery occlusion | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Patient elopement | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Systolic hypertension | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Chronic left ventricular failure | 2 | 1.977 | 0.71 | 2.693 | 5.714 | 0.411 | 0.9 | 1.769 | 1.012 | 49.645 | 10.433
COVID19 (Custom Term) | Chillblains | 2 | 1.98 | 0.71 | 2.693 | 5.714 | 0.41 | 0.9 | 1.768 | 1.01 | 49.645 | 10.433
COVID19 (Custom Term) | Retinal artery thrombosis | 2 | 1.982 | 0.71 | 2.693 | 5.714 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Water pollution | 2 | 1.982 | 0.71 | 2.693 | 5.714 | 0.41 | 0.899 | 1.767 | 1.009 | 49.645 | 10.433
COVID19 (Custom Term) | Thrombotic stroke | 2 | 1.984 | 0.71 | 2.693 | 5.714 | 0.41 | 0.899 | 1.767 | 1.008 | 49.645 | 10.433
COVID19 (Custom Term) | Pelvic haemorrhage | 2 | 1.984 | 0.71 | 2.693 | 5.714 | 0.41 | 0.899 | 1.767 | 1.008 | 49.645 | 10.433
COVID19 (Custom Term) | Pelvic fluid collection | 2 | 1.984 | 0.71 | 2.693 | 5.714 | 0.41 | 0.899 | 1.767 | 1.008 | 49.645 | 10.433
COVID19 (Custom Term) | NIH stroke scale | 2 | 1.989 | 0.71 | 2.693 | 5.714 | 0.41 | 0.898 | 1.765 | 1.006 | 49.645 | 10.433
COVID19 (Custom Term) | General physical condition normal | 2 | 1.991 | 0.71 | 2.693 | 5.714 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | Hypertrophy of tongue papillae | 2 | 1.991 | 0.71 | 2.693 | 5.714 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | Phrenic nerve injury | 2 | 1.991 | 0.71 | 2.693 | 5.714 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | Ultrasound scan vagina abnormal | 2 | 1.991 | 0.71 | 2.693 | 5.714 | 0.41 | 0.898 | 1.764 | 1.005 | 49.645 | 10.433
COVID19 (Custom Term) | CSF monocyte count | 1 | 0.987 | 0.205 | 2.692 | 7.588 | 0.359 | 0.874 | 1.853 | 1.013 | 0.903 | 0.162
COVID19 (Custom Term) | Palatal oedema | 4 | 2.612 | 1.044 | 2.671 | 4.907 | 0.587 | 1.131 | 2.019 | 1.531 | 6.619 | 8.039
COVID19 (Custom Term) | Histamine level | 2 | 1.991 | 0.674 | 2.671 | 5.744 | 0.41 | 0.898 | 1.764 | 1.005 | 19.858 | 6.023
COVID19 (Custom Term) | Chest injury | 3 | 2.964 | 0.895 | 2.651 | 5.161 | 0.45 | 0.917 | 1.707 | 1.012 | 9.929 | 7.632
COVID19 (Custom Term) | Gallbladder enlargement | 2 | 1.984 | 0.636 | 2.638 | 5.752 | 0.41 | 0.899 | 1.767 | 1.008 | 9.929 | 3.868
COVID19 (Custom Term) | Splenic infarction | 2 | 1.984 | 0.636 | 2.629 | 5.73 | 0.41 | 0.899 | 1.767 | 1.008 | 9.929 | 3.868
COVID19 (Custom Term) | Psychogenic seizure | 2 | 1.071 | 0.518 | 2.613 | 6.024 | 0.492 | 1.078 | 2.125 | 1.868 | 0.794 | 0
COVID19 (Custom Term) | Vasopressive therapy | 2 | 1.982 | 0.633 | 2.606 | 5.669 | 0.41 | 0.899 | 1.767 | 1.009 | 9.929 | 3.868
COVID19 (Custom Term) | Blood catecholamines | 2 | 2.494 | 0.633 | 2.6 | 5.653 | 0.375 | 0.823 | 1.618 | 0.802 | 9.929 | 3.868
COVID19 (Custom Term) | Vertebral foraminal stenosis | 4 | 4.06 | 1.026 | 2.599 | 4.754 | 0.476 | 0.917 | 1.634 | 0.985 | 6.619 | 8.039
COVID19 (Custom Term) | Sensory overload | 2 | 1.006 | 0.564 | 2.593 | 5.828 | 0.499 | 1.093 | 2.158 | 1.988 | 4.965 | 1.813
COVID19 (Custom Term) | Blood sodium increased | 9 | 8.411 | 1.389 | 2.591 | 4.096 | 0.61 | 1.001 | 1.569 | 1.07 | 7.447 | 24.793
COVID19 (Custom Term) | Multimorbidity | 2 | 1.974 | 0.664 | 2.577 | 5.506 | 0.411 | 0.901 | 1.77 | 1.013 | 19.858 | 6.023
COVID19 (Custom Term) | Right ventricular dysfunction | 2 | 1.942 | 0.63 | 2.573 | 5.584 | 0.413 | 0.906 | 1.78 | 1.03 | 9.929 | 3.868
COVID19 (Custom Term) | Pelvic venous thrombosis | 4 | 3.938 | 0.939 | 2.566 | 4.842 | 0.483 | 0.932 | 1.661 | 1.016 | 19.858 | 17.461
COVID19 (Custom Term) | Breast oedema | 2 | 1.006 | 0.663 | 2.565 | 5.475 | 0.499 | 1.093 | 2.158 | 1.988 | 19.858 | 6.023
COVID19 (Custom Term) | Retinal vein occlusion | 4 | 3.46 | 1.017 | 2.564 | 4.681 | 0.516 | 0.995 | 1.773 | 1.156 | 6.619 | 8.039
COVID19 (Custom Term) | Lower respiratory tract congestion | 3 | 1.884 | 0.813 | 2.561 | 5.1 | 0.539 | 1.099 | 2.049 | 1.592 | 1.986 | 0.486
COVID19 (Custom Term) | Behaviour disorder | 2 | 1.993 | 0.592 | 2.556 | 5.643 | 0.41 | 0.898 | 1.764 | 1.004 | 0.863 | 0.022
COVID19 (Custom Term) | Respiratory tract irritation | 3 | 0.61 | 0.804 | 2.554 | 5.101 | 0.707 | 1.478 | 2.927 | 4.915 | 4.965 | 3.757
COVID19 (Custom Term) | Ruptured cerebral aneurysm | 2 | 1.984 | 0.628 | 2.55 | 5.526 | 0.41 | 0.899 | 1.767 | 1.008 | 9.929 | 3.868
COVID19 (Custom Term) | Magnetic resonance imaging heart | 15 | 15.63 | 1.573 | 2.532 | 3.677 | 0.627 | 0.937 | 1.358 | 0.96 | 5.728 | 33.903
COVID19 (Custom Term) | Magnetic resonance imaging abdominal abnormal | 3 | 2.977 | 0.872 | 2.527 | 4.88 | 0.449 | 0.916 | 1.703 | 1.008 | 9.929 | 7.632
COVID19 (Custom Term) | Intraocular pressure test | 4 | 3.452 | 1.007 | 2.523 | 4.593 | 0.517 | 0.996 | 1.776 | 1.159 | 6.619 | 8.039
COVID19 (Custom Term) | Atrial enlargement | 2 | 1.042 | 0.626 | 2.522 | 5.453 | 0.495 | 1.085 | 2.139 | 1.919 | 9.929 | 3.868
COVID19 (Custom Term) | Crystal urine present | 2 | 1.989 | 0.59 | 2.51 | 5.514 | 0.41 | 0.898 | 1.765 | 1.006 | 6.619 | 2.615
COVID19 (Custom Term) | Staphylococcal bacteraemia | 3 | 2.969 | 0.82 | 2.499 | 4.917 | 0.45 | 0.917 | 1.706 | 1.011 | 5.958 | 4.701
COVID19 (Custom Term) | Metastases to liver | 2 | 1.984 | 0.589 | 2.497 | 5.481 | 0.41 | 0.899 | 1.767 | 1.008 | 6.619 | 2.615
COVID19 (Custom Term) | Wrong technique in device usage process | 3 | 2.972 | 0.818 | 2.489 | 4.895 | 0.45 | 0.916 | 1.705 | 1.01 | 5.958 | 4.701
COVID19 (Custom Term) | Vaccination site hypoaesthesia | 2 | 2.485 | 0.622 | 2.484 | 5.356 | 0.376 | 0.824 | 1.62 | 0.805 | 9.929 | 3.868
COVID19 (Custom Term) | Diverticulum intestinal | 3 | 2.964 | 0.863 | 2.48 | 4.775 | 0.45 | 0.917 | 1.707 | 1.012 | 9.929 | 7.632
COVID19 (Custom Term) | Pupillary light reflex tests abnormal | 3 | 2.49 | 0.746 | 2.478 | 5.029 | 0.485 | 0.989 | 1.841 | 1.205 | 1.418 | 0.046
COVID19 (Custom Term) | Atrial flutter | 8 | 8.299 | 1.289 | 2.461 | 3.938 | 0.551 | 0.926 | 1.479 | 0.964 | 6.619 | 19.339
COVID19 (Custom Term) | Gene mutation identification test | 3 | 2.373 | 0.842 | 2.452 | 4.745 | 0.495 | 1.009 | 1.877 | 1.264 | 2.291 | 0.807
COVID19 (Custom Term) | Vaccination site discharge | 3 | 2.876 | 0.763 | 2.451 | 4.917 | 0.456 | 0.93 | 1.73 | 1.043 | 4.255 | 3.022
COVID19 (Custom Term) | Kidney infection | 9 | 8.674 | 1.327 | 2.451 | 3.854 | 0.597 | 0.979 | 1.535 | 1.038 | 3.437 | 9.647
COVID19 (Custom Term) | Methylmalonic aciduria | 2 | 1.977 | 0.618 | 2.438 | 5.237 | 0.411 | 0.9 | 1.769 | 1.012 | 9.929 | 3.868
COVID19 (Custom Term) | Electrocardiogram T wave peaked | 2 | 1.438 | 0.549 | 2.427 | 5.394 | 0.455 | 0.997 | 1.962 | 1.39 | 4.965 | 1.813
COVID19 (Custom Term) | Carotid pulse abnormal | 2 | 1.498 | 0.615 | 2.398 | 5.132 | 0.45 | 0.986 | 1.938 | 1.335 | 9.929 | 3.868
COVID19 (Custom Term) | Dyspnoea at rest | 2 | 1.982 | 0.646 | 2.396 | 5.047 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Antithrombin III | 4 | 3.345 | 0.888 | 2.393 | 4.49 | 0.525 | 1.011 | 1.803 | 1.196 | 3.972 | 4.231
COVID19 (Custom Term) | Completed suicide | 3 | 3.73 | 0.751 | 2.39 | 4.78 | 0.403 | 0.821 | 1.528 | 0.804 | 2.128 | 0.631
COVID19 (Custom Term) | Drug screen positive | 3 | 2.493 | 0.756 | 2.387 | 4.758 | 0.485 | 0.989 | 1.84 | 1.203 | 3.31 | 1.971
COVID19 (Custom Term) | Coronary artery bypass | 4 | 4.004 | 0.962 | 2.385 | 4.324 | 0.479 | 0.923 | 1.646 | 0.999 | 5.674 | 6.8
COVID19 (Custom Term) | Amyloidosis | 2 | 1.974 | 0.644 | 2.384 | 5.016 | 0.411 | 0.901 | 1.77 | 1.013 | 19.858 | 6.023
COVID19 (Custom Term) | Pancreatic enlargement | 2 | 1.984 | 0.613 | 2.374 | 5.071 | 0.41 | 0.899 | 1.767 | 1.008 | 9.929 | 3.868
COVID19 (Custom Term) | Pressure of speech | 2 | 1.987 | 0.612 | 2.372 | 5.064 | 0.41 | 0.899 | 1.766 | 1.007 | 9.929 | 3.868
COVID19 (Custom Term) | Biopsy oesophagus normal | 2 | 1.991 | 0.643 | 2.367 | 4.973 | 0.41 | 0.898 | 1.764 | 1.005 | 19.858 | 6.023
COVID19 (Custom Term) | Electrolyte imbalance | 3 | 2.982 | 0.705 | 2.357 | 4.794 | 0.449 | 0.915 | 1.702 | 1.006 | 1.064 | 0.044
COVID19 (Custom Term) | Decompressive craniectomy | 2 | 1.984 | 0.611 | 2.356 | 5.024 | 0.41 | 0.899 | 1.767 | 1.008 | 9.929 | 3.868
COVID19 (Custom Term) | Cardioactive drug level | 2 | 1.041 | 0.642 | 2.355 | 4.943 | 0.495 | 1.085 | 2.14 | 1.922 | 19.858 | 6.023
COVID19 (Custom Term) | Menstruation delayed | 3 | 3.008 | 0.737 | 2.355 | 4.716 | 0.447 | 0.911 | 1.695 | 0.997 | 1.027 | 0.069
COVID19 (Custom Term) | Left ventricular failure | 3 | 3.019 | 0.796 | 2.355 | 4.584 | 0.446 | 0.91 | 1.692 | 0.994 | 5.958 | 4.701
COVID19 (Custom Term) | Atrial tachycardia | 3 | 2.494 | 0.773 | 2.352 | 4.626 | 0.485 | 0.988 | 1.84 | 1.203 | 4.965 | 3.757
COVID19 (Custom Term) | Nasal cavity packing | 2 | 1.977 | 0.641 | 2.344 | 4.913 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Vaccination site lymphadenopathy | 2 | 1.991 | 0.641 | 2.344 | 4.913 | 0.41 | 0.898 | 1.764 | 1.005 | 19.858 | 6.023
COVID19 (Custom Term) | Anticonvulsant drug level decreased | 2 | 2.935 | 0.61 | 2.34 | 4.982 | 0.349 | 0.767 | 1.508 | 0.681 | 9.929 | 3.868
COVID19 (Custom Term) | Urine electrolytes normal | 2 | 1.987 | 0.639 | 2.329 | 4.877 | 0.41 | 0.899 | 1.766 | 1.007 | 19.858 | 6.023
COVID19 (Custom Term) | Anaemia macrocytic | 2 | 1.975 | 0.639 | 2.327 | 4.873 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Escherichia bacteraemia | 2 | 1.975 | 0.638 | 2.318 | 4.848 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Acute leukaemia | 2 | 1.997 | 0.607 | 2.309 | 4.902 | 0.409 | 0.897 | 1.762 | 1.001 | 9.929 | 3.868
COVID19 (Custom Term) | Belligerence | 2 | 1.977 | 0.637 | 2.304 | 4.812 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Human chorionic gonadotropin positive | 2 | 1.991 | 0.479 | 2.3 | 5.231 | 0.41 | 0.898 | 1.764 | 1.005 | 0.641 | 0.098
COVID19 (Custom Term) | Intestinal ischaemia | 3 | 2.971 | 0.787 | 2.297 | 4.448 | 0.45 | 0.916 | 1.705 | 1.01 | 5.958 | 4.701
COVID19 (Custom Term) | Cytokine release syndrome | 2 | 1.974 | 0.636 | 2.296 | 4.792 | 0.411 | 0.901 | 1.77 | 1.013 | 19.858 | 6.023
COVID19 (Custom Term) | Vestibular migraine | 2 | 1.982 | 0.575 | 2.296 | 4.952 | 0.41 | 0.899 | 1.767 | 1.009 | 6.619 | 2.615
COVID19 (Custom Term) | Dependence on oxygen therapy | 2 | 1.977 | 0.605 | 2.287 | 4.844 | 0.411 | 0.9 | 1.769 | 1.012 | 9.929 | 3.868
COVID19 (Custom Term) | Vaccination site joint erythema | 2 | 2.072 | 0.509 | 2.287 | 5.106 | 0.404 | 0.885 | 1.739 | 0.965 | 1.324 | 0.002
COVID19 (Custom Term) | External ear pain | 3 | 3.039 | 0.806 | 2.28 | 4.362 | 0.445 | 0.907 | 1.687 | 0.987 | 7.447 | 5.943
COVID19 (Custom Term) | Urinary casts | 3 | 3.037 | 0.805 | 2.275 | 4.351 | 0.445 | 0.907 | 1.688 | 0.988 | 7.447 | 5.943
COVID19 (Custom Term) | Protein S normal | 3 | 2.975 | 0.782 | 2.269 | 4.381 | 0.449 | 0.916 | 1.704 | 1.008 | 5.958 | 4.701
COVID19 (Custom Term) | Adrenocortical insufficiency acute | 4 | 4.026 | 0.802 | 2.268 | 4.339 | 0.478 | 0.921 | 1.641 | 0.994 | 3.972 | 4.231
COVID19 (Custom Term) | Vitreous detachment | 4 | 5.114 | 0.872 | 2.264 | 4.183 | 0.418 | 0.806 | 1.436 | 0.782 | 2.648 | 1.965
COVID19 (Custom Term) | Urethritis | 2 | 1.764 | 0.603 | 2.261 | 4.777 | 0.427 | 0.936 | 1.84 | 1.134 | 9.929 | 3.868
COVID19 (Custom Term) | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [narrow] | 6 | 6.103 | 1.048 | 2.254 | 3.829 | 0.523 | 0.93 | 1.555 | 0.983 | 1.385 | 0.254
COVID19 (Custom Term) | Hidradenitis | 2 | 1.423 | 0.504 | 2.249 | 5.012 | 0.457 | 1 | 1.968 | 1.405 | 3.972 | 1.27
COVID19 (Custom Term) | Subdural haematoma | 9 | 9.077 | 1.199 | 2.242 | 3.548 | 0.578 | 0.948 | 1.486 | 0.991 | 3.192 | 8.506
COVID19 (Custom Term) | Pregnancy test negative | 13 | 9.549 | 1.345 | 2.23 | 3.296 | 0.795 | 1.218 | 1.804 | 1.361 | 3.227 | 13.288
COVID19 (Custom Term) | Catheterisation venous | 2 | 1.975 | 0.63 | 2.229 | 4.623 | 0.411 | 0.9 | 1.769 | 1.012 | 19.858 | 6.023
COVID19 (Custom Term) | Blood pressure diastolic increased | 3 | 2.002 | 0.796 | 2.222 | 4.229 | 0.528 | 1.076 | 2.004 | 1.499 | 7.447 | 5.943
COVID19 (Custom Term) | Intraosseous access placement | 2 | 1.98 | 0.63 | 2.222 | 4.605 | 0.41 | 0.9 | 1.768 | 1.01 | 19.858 | 6.023
COVID19 (Custom Term) | Vaccination site paraesthesia | 2 | 1.948 | 0.57 | 2.219 | 4.748 | 0.413 | 0.905 | 1.778 | 1.026 | 6.619 | 2.615
COVID19 (Custom Term) | Biliary colic | 3 | 3.472 | 0.793 | 2.207 | 4.194 | 0.417 | 0.851 | 1.584 | 0.864 | 7.447 | 5.943
COVID19 (Custom Term) | Gynaecological examination abnormal | 2 | 2.002 | 0.568 | 2.198 | 4.692 | 0.409 | 0.896 | 1.761 | 0.999 | 6.619 | 2.615
COVID19 (Custom Term) | Hand fracture | 3 | 2.973 | 0.77 | 2.189 | 4.196 | 0.45 | 0.916 | 1.704 | 1.009 | 5.958 | 4.701
COVID19 (Custom Term) | Hyperbilirubinaemia | 3 | 3.068 | 0.691 | 2.188 | 4.367 | 0.443 | 0.903 | 1.68 | 0.978 | 1.103 | 0.024
COVID19 (Custom Term) | Blood gases abnormal | 9 | 8.975 | 1.164 | 2.181 | 3.456 | 0.582 | 0.956 | 1.498 | 1.003 | 4.062 | 12.449
COVID19 (Custom Term) | Aneurysm ruptured | 2 | 1.98 | 0.626 | 2.179 | 4.493 | 0.41 | 0.9 | 1.768 | 1.01 | 19.858 | 6.023
COVID19 (Custom Term) | Therapeutic embolisation | 2 | 1.984 | 0.626 | 2.179 | 4.493 | 0.41 | 0.899 | 1.767 | 1.008 | 19.858 | 6.023
COVID19 (Custom Term) | Lacunar stroke | 2 | 2.051 | 0.626 | 2.179 | 4.493 | 0.405 | 0.888 | 1.745 | 0.975 | 19.858 | 6.023
COVID19 (Custom Term) | Myocardial strain | 2 | 2.356 | 0.626 | 2.179 | 4.493 | 0.384 | 0.842 | 1.655 | 0.849 | 19.858 | 6.023
COVID19 (Custom Term) | Iridocyclitis | 4 | 3.103 | 0.813 | 2.175 | 4.069 | 0.544 | 1.048 | 1.869 | 1.289 | 1.589 | 0.297
COVID19 (Custom Term) | Penile rash | 2 | 0.771 | 0.597 | 2.172 | 4.545 | 0.526 | 1.156 | 2.291 | 2.595 | 9.929 | 3.868
COVID19 (Custom Term) | Erectile dysfunction | 7 | 6.743 | 1.071 | 2.172 | 3.585 | 0.562 | 0.969 | 1.581 | 1.038 | 2.574 | 4.064
COVID19 (Custom Term) | Saliva altered | 3 | 2.002 | 0.767 | 2.169 | 4.149 | 0.528 | 1.076 | 2.004 | 1.499 | 5.958 | 4.701
COVID19 (Custom Term) | Brain natriuretic peptide increased | 45 | 42.977 | 1.671 | 2.169 | 2.72 | 0.809 | 1.031 | 1.299 | 1.047 | 12.766 | 207.922
COVID19 (Custom Term) | Ischaemic stroke | 23 | 23.214 | 1.496 | 2.161 | 2.927 | 0.696 | 0.97 | 1.324 | 0.991 | 7.612 | 70.726
COVID19 (Custom Term) | Tonsillar erythema | 2 | 1.006 | 0.544 | 2.152 | 4.626 | 0.499 | 1.093 | 2.158 | 1.988 | 1.418 | 0.001
COVID19 (Custom Term) | Spinal operation | 3 | 2.991 | 0.687 | 2.146 | 4.263 | 0.448 | 0.914 | 1.7 | 1.003 | 2.482 | 1.02
COVID19 (Custom Term) | Coronary artery disease | 11 | 10.37 | 1.228 | 2.139 | 3.255 | 0.635 | 1.004 | 1.524 | 1.061 | 5.461 | 22.793
COVID19 (Custom Term) | Brachial plexus injury | 2 | 2.866 | 0.434 | 2.134 | 4.887 | 0.353 | 0.775 | 1.524 | 0.698 | 1.241 | 0.014
COVID19 (Custom Term) | Tilt table test | 1 | 0.503 | 0.198 | 2.131 | 5.805 | 0.404 | 0.981 | 2.088 | 1.988 | 0.153 | 3.756
COVID19 (Custom Term) | Hypercapnia | 2 | 1.989 | 0.594 | 2.126 | 4.426 | 0.41 | 0.898 | 1.765 | 1.006 | 9.929 | 3.868
COVID19 (Custom Term) | Facial bones fracture | 4 | 3.172 | 0.852 | 2.125 | 3.862 | 0.538 | 1.037 | 1.85 | 1.261 | 2.336 | 1.428
COVID19 (Custom Term) | Colitis ischaemic | 3 | 2.972 | 0.78 | 2.125 | 4.005 | 0.45 | 0.916 | 1.705 | 1.009 | 7.447 | 5.943
COVID19 (Custom Term) | Superficial vein prominence | 2 | 1.94 | 0.564 | 2.121 | 4.488 | 0.413 | 0.906 | 1.781 | 1.031 | 6.619 | 2.615
COVID19 (Custom Term) | COVID-19 pneumonia | 73 | 69.802 | 1.73 | 2.12 | 2.544 | 0.855 | 1.036 | 1.246 | 1.046 | 55.757 | 584.467
COVID19 (Custom Term) | Pupillary disorder | 2 | 1.991 | 0.533 | 2.115 | 4.552 | 0.41 | 0.898 | 1.764 | 1.005 | 4.965 | 1.813
COVID19 (Custom Term) | Trigeminal nerve disorder | 3 | 3.532 | 0.759 | 2.113 | 4.018 | 0.414 | 0.844 | 1.57 | 0.849 | 5.958 | 4.701
COVID19 (Custom Term) | Breakthrough pain | 2 | 1.496 | 0.62 | 2.111 | 4.32 | 0.45 | 0.986 | 1.939 | 1.337 | 19.858 | 6.023
COVID19 (Custom Term) | Vein discolouration | 3 | 2.357 | 0.778 | 2.11 | 3.97 | 0.496 | 1.011 | 1.882 | 1.273 | 7.447 | 5.943
COVID19 (Custom Term) | Menstruation irregular | 3 | 2.627 | 0.607 | 2.109 | 4.346 | 0.475 | 0.967 | 1.8 | 1.142 | 0.143 | 14.35
COVID19 (Custom Term) | Pyuria | 2 | 2.011 | 0.592 | 2.102 | 4.363 | 0.408 | 0.895 | 1.758 | 0.995 | 9.929 | 3.868
COVID19 (Custom Term) | Blood parathyroid hormone increased | 2 | 1.496 | 0.592 | 2.101 | 4.36 | 0.45 | 0.986 | 1.939 | 1.337 | 9.929 | 3.868
COVID19 (Custom Term) | Urinary tract infection bacterial | 2 | 2.037 | 0.563 | 2.098 | 4.425 | 0.406 | 0.89 | 1.75 | 0.982 | 6.619 | 2.615
COVID19 (Custom Term) | Pulmonary granuloma | 2 | 2.48 | 0.563 | 2.095 | 4.418 | 0.376 | 0.825 | 1.621 | 0.806 | 6.619 | 2.615
COVID19 (Custom Term) | Stress echocardiogram normal | 2 | 1.991 | 0.592 | 2.091 | 4.335 | 0.41 | 0.898 | 1.764 | 1.005 | 9.929 | 3.868
COVID19 (Custom Term) | pH body fluid | 2 | 1.991 | 0.478 | 2.089 | 4.627 | 0.41 | 0.898 | 1.764 | 1.005 | 3.31 | 0.887
COVID19 (Custom Term) | Intraventricular haemorrhage | 2 | 2.086 | 0.465 | 2.083 | 4.647 | 0.403 | 0.883 | 1.735 | 0.959 | 3.31 | 0.887
COVID19 (Custom Term) | Dementia | 21 | 21.525 | 1.414 | 2.08 | 2.851 | 0.676 | 0.956 | 1.321 | 0.976 | 6.95 | 59.145
COVID19 (Custom Term) | Vasogenic cerebral oedema | 2 | 1.982 | 0.618 | 2.078 | 4.236 | 0.41 | 0.899 | 1.767 | 1.009 | 19.858 | 6.023
COVID19 (Custom Term) | Scrotal dermatitis | 2 | 1.123 | 0.59 | 2.072 | 4.286 | 0.486 | 1.065 | 2.1 | 1.78 | 9.929 | 3.868
COVID19 (Custom Term) | Aortic aneurysm | 4 | 4.362 | 0.811 | 2.07 | 3.8 | 0.457 | 0.882 | 1.572 | 0.917 | 4.965 | 5.784
COVID19 (Custom Term) | Haemorrhage urinary tract | 3 | 2.907 | 0.629 | 2.067 | 4.181 | 0.454 | 0.926 | 1.722 | 1.032 | 2.979 | 1.589
COVID19 (Custom Term) | Aortic valve incompetence | 3 | 3.021 | 0.711 | 2.066 | 3.993 | 0.446 | 0.91 | 1.692 | 0.993 | 4.255 | 3.022
COVID19 (Custom Term) | Lung abscess | 2 | 1.975 | 0.499 | 2.058 | 4.482 | 0.411 | 0.9 | 1.769 | 1.012 | 3.972 | 1.27
COVID19 (Custom Term) | Nail discolouration | 3 | 2.545 | 0.664 | 2.055 | 4.067 | 0.481 | 0.98 | 1.824 | 1.179 | 1.489 | 0.082
COVID19 (Custom Term) | Blood creatine phosphokinase MB | 9 | 9.293 | 1.088 | 2.05 | 3.257 | 0.568 | 0.932 | 1.461 | 0.968 | 3.31 | 9.058
COVID19 (Custom Term) | Blood creatine | 3 | 3.009 | 0.709 | 2.049 | 3.952 | 0.447 | 0.911 | 1.695 | 0.997 | 4.255 | 3.022
COVID19 (Custom Term) | Acute myocardial infarction | 63 | 62.189 | 1.639 | 2.04 | 2.477 | 0.816 | 1.003 | 1.223 | 1.013 | 26.064 | 411.416
COVID19 (Custom Term) | Adjusted calcium | 2 | 1.042 | 0.499 | 2.035 | 4.418 | 0.495 | 1.085 | 2.139 | 1.919 | 3.972 | 1.27
COVID19 (Custom Term) | Implantable cardiac monitor insertion | 2 | 2 | 0.56 | 2.035 | 4.259 | 0.409 | 0.896 | 1.762 | 1 | 6.619 | 2.615
COVID19 (Custom Term) | Atrioventricular block complete | 3 | 3.016 | 0.728 | 2.034 | 3.873 | 0.447 | 0.91 | 1.693 | 0.995 | 4.965 | 3.757
COVID19 (Custom Term) | Cardiac tamponade | 4 | 3.92 | 0.768 | 2.033 | 3.789 | 0.484 | 0.934 | 1.664 | 1.02 | 4.413 | 4.94
COVID19 (Custom Term) | Fungal test | 2 | 2.041 | 0.475 | 2.032 | 4.471 | 0.406 | 0.89 | 1.749 | 0.98 | 0.764 | 0.002
COVID19 (Custom Term) | Craniotomy | 3 | 3.029 | 0.727 | 2.027 | 3.855 | 0.446 | 0.908 | 1.69 | 0.99 | 4.965 | 3.757
COVID19 (Custom Term) | Carotid artery occlusion | 3 | 3.139 | 0.746 | 2.027 | 3.815 | 0.438 | 0.893 | 1.662 | 0.956 | 5.958 | 4.701
COVID19 (Custom Term) | Biopsy bone marrow | 8 | 9.742 | 1.088 | 2.023 | 3.194 | 0.492 | 0.826 | 1.319 | 0.821 | 2.648 | 5.124
COVID19 (Custom Term) | Electrocardiogram ST-T change | 2 | 2.034 | 0.53 | 2.018 | 4.286 | 0.406 | 0.891 | 1.751 | 0.983 | 4.965 | 1.813
COVID19 (Custom Term) | Cerebellar infarction | 2 | 1.975 | 0.53 | 2.016 | 4.28 | 0.411 | 0.9 | 1.769 | 1.012 | 4.965 | 1.813
COVID19 (Custom Term) | Haemoconcentration | 1 | 1.496 | 0.172 | 2.015 | 5.57 | 0.321 | 0.784 | 1.664 | 0.668 | 3.31 | 0.054
COVID19 (Custom Term) | Fibrosis | 2 | 1.94 | 0.587 | 2.012 | 4.128 | 0.413 | 0.906 | 1.781 | 1.031 | 9.929 | 3.868
COVID19 (Custom Term) | Haemodynamic test normal | 2 | 1.05 | 0.587 | 2.007 | 4.114 | 0.494 | 1.083 | 2.135 | 1.905 | 9.929 | 3.868
COVID19 (Custom Term) | Acute pulmonary oedema | 6 | 5.922 | 0.918 | 2.007 | 3.437 | 0.533 | 0.947 | 1.585 | 1.013 | 9.929 | 19.427
COVID19 (Custom Term) | Pneumonia aspiration | 19 | 20.782 | 1.33 | 2.006 | 2.795 | 0.629 | 0.903 | 1.265 | 0.914 | 5.099 | 38.442
COVID19 (Custom Term) | Patient isolation | 3 | 2.564 | 0.651 | 2.002 | 3.952 | 0.48 | 0.977 | 1.818 | 1.17 | 1.489 | 0.082
COVID19 (Custom Term) | Blood methaemoglobin | 2 | 1.978 | 0.529 | 2.002 | 4.243 | 0.411 | 0.9 | 1.768 | 1.011 | 4.965 | 1.813
COVID19 (Custom Term) | Orbital oedema | 2 | 1.948 | 0.529 | 1.999 | 4.234 | 0.413 | 0.905 | 1.778 | 1.026 | 4.965 | 1.813
COVID19 (Custom Term) | Crystal urine absent | 2 | 1.991 | 0.586 | 1.994 | 4.08 | 0.41 | 0.898 | 1.764 | 1.005 | 9.929 | 3.868
COVID19 (Custom Term) | Mean cell haemoglobin concentration | 5 | 5.011 | 0.84 | 1.993 | 3.544 | 0.505 | 0.932 | 1.604 | 0.998 | 2.364 | 2.082
COVID19 (Custom Term) | Prothrombin level | 3 | 2.976 | 0.722 | 1.99 | 3.768 | 0.449 | 0.916 | 1.704 | 1.008 | 4.965 | 3.757
COVID19 (Custom Term) | Cardiac telemetry | 11 | 8.839 | 1.157 | 1.989 | 3.004 | 0.713 | 1.127 | 1.712 | 1.244 | 15.603 | 52.384
COVID19 (Custom Term) | Acute cardiac event | 2 | 2.091 | 0.558 | 1.988 | 4.131 | 0.402 | 0.882 | 1.733 | 0.956 | 6.619 | 2.615
COVID19 (Custom Term) | Blood osmolarity increased | 2 | 1.397 | 0.585 | 1.982 | 4.05 | 0.459 | 1.006 | 1.979 | 1.432 | 9.929 | 3.868
COVID19 (Custom Term) | Gallbladder operation | 2 | 1.989 | 0.585 | 1.976 | 4.034 | 0.41 | 0.898 | 1.765 | 1.006 | 9.929 | 3.868
COVID19 (Custom Term) | Cardiac imaging procedure abnormal | 2 | 1.98 | 0.585 | 1.973 | 4.026 | 0.41 | 0.9 | 1.768 | 1.01 | 9.929 | 3.868
COVID19 (Custom Term) | Normocytic anaemia | 3 | 2.964 | 0.7 | 1.972 | 3.768 | 0.45 | 0.917 | 1.707 | 1.012 | 4.255 | 3.022
COVID19 (Custom Term) | Carotid artery stenosis | 3 | 3.079 | 0.72 | 1.972 | 3.725 | 0.442 | 0.902 | 1.677 | 0.974 | 4.965 | 3.757
COVID19 (Custom Term) | Sialoadenitis | 2 | 1.498 | 0.602 | 1.971 | 3.982 | 0.45 | 0.986 | 1.938 | 1.335 | 1.805 | 0.089
COVID19 (Custom Term) | Depersonalisation/derealisation disorder | 3 | 2.357 | 0.699 | 1.964 | 3.747 | 0.496 | 1.011 | 1.882 | 1.273 | 4.255 | 3.022
COVID19 (Custom Term) | Brain stem infarction | 2 | 1.984 | 0.528 | 1.964 | 4.14 | 0.41 | 0.899 | 1.767 | 1.008 | 4.965 | 1.813
COVID19 (Custom Term) | Electrocardiogram ST segment elevation | 30 | 31.455 | 1.417 | 1.964 | 2.585 | 0.702 | 0.942 | 1.243 | 0.954 | 8.511 | 102.687
COVID19 (Custom Term) | Accidental overdose | 12 | 11.374 | 1.157 | 1.963 | 2.943 | 0.645 | 1.003 | 1.503 | 1.055 | 4.766 | 21.411
COVID19 (Custom Term) | Slow response to stimuli | 6 | 3.659 | 0.953 | 1.957 | 3.251 | 0.699 | 1.243 | 2.082 | 1.64 | 0.827 | 0.063
COVID19 (Custom Term) | Vaccination site discolouration | 5 | 4.941 | 0.842 | 1.956 | 3.445 | 0.509 | 0.939 | 1.617 | 1.012 | 0.856 | 0.013
COVID19 (Custom Term) | Intracranial mass | 2 | 2.54 | 0.584 | 1.955 | 3.978 | 0.372 | 0.817 | 1.605 | 0.787 | 9.929 | 3.868
COVID19 (Custom Term) | Corrective lens user | 2 | 1.498 | 0.561 | 1.954 | 4.03 | 0.45 | 0.986 | 1.938 | 1.335 | 0.903 | 0.046
COVID19 (Custom Term) | Viral cardiomyopathy | 2 | 1.984 | 0.557 | 1.952 | 4.035 | 0.41 | 0.899 | 1.767 | 1.008 | 6.619 | 2.615
COVID19 (Custom Term) | Tongue spasm | 2 | 1.994 | 0.557 | 1.945 | 4.015 | 0.409 | 0.897 | 1.763 | 1.003 | 6.619 | 2.615
COVID19 (Custom Term) | Left atrial dilatation | 2 | 1.982 | 0.584 | 1.944 | 3.95 | 0.41 | 0.899 | 1.767 | 1.009 | 9.929 | 3.868
COVID19 (Custom Term) | Bilirubin urine present | 3 | 2.964 | 0.697 | 1.943 | 3.698 | 0.45 | 0.917 | 1.707 | 1.012 | 4.255 | 3.022
COVID19 (Custom Term) | Hepatic enzyme | 3 | 2.907 | 0.685 | 1.942 | 3.719 | 0.454 | 0.925 | 1.722 | 1.032 | 2.128 | 0.631
COVID19 (Custom Term) | Product administered to patient of inappropriate age | 106 | 163.609 | 1.643 | 1.942 | 2.261 | 0.556 | 0.652 | 0.761 | 0.648 | 0.181 | 393.336
COVID19 (Custom Term) | Bilevel positive airway pressure | 26 | 26.087 | 1.365 | 1.939 | 2.595 | 0.714 | 0.977 | 1.313 | 0.997 | 7.376 | 78.259
COVID19 (Custom Term) | Hemiparaesthesia | 2 | 1.512 | 0.528 | 1.937 | 4.066 | 0.449 | 0.983 | 1.933 | 1.323 | 4.965 | 1.813
COVID19 (Custom Term) | PCO2 increased | 9 | 8.847 | 1.044 | 1.936 | 3.051 | 0.588 | 0.966 | 1.514 | 1.017 | 2.291 | 4.23
COVID19 (Custom Term) | Cardiac failure congestive | 45 | 47.981 | 1.492 | 1.936 | 2.427 | 0.73 | 0.931 | 1.173 | 0.938 | 7.839 | 145.905
COVID19 (Custom Term) | Opiates negative | 2 | 1.496 | 0.583 | 1.934 | 3.924 | 0.45 | 0.986 | 1.939 | 1.337 | 9.929 | 3.868
COVID19 (Custom Term) | Sputum increased | 2 | 2.178 | 0.421 | 1.933 | 4.344 | 0.396 | 0.869 | 1.707 | 0.918 | 1.241 | 0.014
COVID19 (Custom Term) | Viral titre | 2 | 1.074 | 0.455 | 1.929 | 4.235 | 0.491 | 1.077 | 2.124 | 1.862 | 1.168 | 0.036
COVID19 (Custom Term) | Lumbar radiculopathy | 2 | 1.989 | 0.528 | 1.927 | 4.038 | 0.41 | 0.898 | 1.765 | 1.006 | 4.965 | 1.813
COVID19 (Custom Term) | Accidental underdose | 7 | 7.861 | 0.92 | 1.923 | 3.223 | 0.507 | 0.874 | 1.427 | 0.89 | 1.58 | 0.793
COVID19 (Custom Term) | Injection site coldness | 3 | 1.434 | 0.694 | 1.922 | 3.645 | 0.588 | 1.2 | 2.243 | 2.092 | 4.255 | 3.022
COVID19 (Custom Term) | Gastrointestinal wall thickening | 3 | 2.357 | 0.596 | 1.916 | 3.843 | 0.496 | 1.011 | 1.882 | 1.273 | 1.489 | 0.082
COVID19 (Custom Term) | Hormone level abnormal | 2 | 3.557 | 0.397 | 1.916 | 4.365 | 0.317 | 0.7 | 1.377 | 0.562 | 0.523 | 0.405
COVID19 (Custom Term) | Cerebral ventricle dilatation | 2 | 1.975 | 0.556 | 1.912 | 3.927 | 0.411 | 0.9 | 1.769 | 1.012 | 6.619 | 2.615
COVID19 (Custom Term) | Ear, nose and throat examination normal | 2 | 2.063 | 0.474 | 1.91 | 4.128 | 0.404 | 0.886 | 1.742 | 0.97 | 0.685 | 0.044
COVID19 (Custom Term) | Metamyelocyte percentage | 2 | 1.987 | 0.527 | 1.908 | 3.987 | 0.41 | 0.899 | 1.766 | 1.007 | 4.965 | 1.813
COVID19 (Custom Term) | Human chorionic gonadotropin abnormal | 2 | 1.948 | 0.556 | 1.907 | 3.915 | 0.413 | 0.905 | 1.778 | 1.026 | 6.619 | 2.615
COVID19 (Custom Term) | Overdose | 5 | 7.747 | 0.785 | 1.906 | 3.424 | 0.383 | 0.707 | 1.217 | 0.645 | 0.213 | 13.4
COVID19 (Custom Term) | Extradural abscess | 2 | 2.007 | 0.555 | 1.903 | 3.903 | 0.408 | 0.895 | 1.759 | 0.996 | 6.619 | 2.615
COVID19 (Custom Term) | Vitamin B12 decreased | 4 | 3.991 | 0.705 | 1.901 | 3.568 | 0.48 | 0.925 | 1.649 | 1.002 | 1.528 | 0.229
COVID19 (Custom Term) | Pulmonary thrombosis | 2 | 1.946 | 0.457 | 1.893 | 4.125 | 0.413 | 0.905 | 1.779 | 1.028 | 2.837 | 0.612
COVID19 (Custom Term) | Hypochromic anaemia | 2 | 1.982 | 0.555 | 1.89 | 3.869 | 0.41 | 0.899 | 1.767 | 1.009 | 6.619 | 2.615
COVID19 (Custom Term) | Intestinal obstruction | 7 | 6.496 | 0.927 | 1.886 | 3.119 | 0.576 | 0.993 | 1.62 | 1.078 | 1.053 | 0.005
COVID19 (Custom Term) | Terminal state | 2 | 2.004 | 0.555 | 1.881 | 3.845 | 0.409 | 0.896 | 1.76 | 0.998 | 6.619 | 2.615
COVID19 (Custom Term) | Noninfective gingivitis | 2 | 1.948 | 0.533 | 1.88 | 3.895 | 0.413 | 0.905 | 1.778 | 1.026 | 1.805 | 0.089
COVID19 (Custom Term) | Critical illness | 2 | 2.88 | 0.498 | 1.88 | 3.983 | 0.352 | 0.774 | 1.521 | 0.695 | 3.972 | 1.27
COVID19 (Custom Term) | Decubitus ulcer | 2 | 2.049 | 0.527 | 1.879 | 3.906 | 0.405 | 0.889 | 1.746 | 0.976 | 4.965 | 1.813
COVID19 (Custom Term) | Human chorionic gonadotropin negative | 20 | 16.483 | 1.25 | 1.872 | 2.597 | 0.804 | 1.146 | 1.594 | 1.213 | 11.681 | 84.44
COVID19 (Custom Term) | Protein C | 5 | 4.349 | 0.825 | 1.872 | 3.263 | 0.547 | 1.009 | 1.738 | 1.15 | 6.206 | 10.142
COVID19 (Custom Term) | Irregular breathing | 4 | 3.842 | 0.767 | 1.871 | 3.368 | 0.489 | 0.944 | 1.682 | 1.041 | 1.045 | 0.034
COVID19 (Custom Term) | Steroid therapy | 2 | 2.492 | 0.433 | 1.871 | 4.128 | 0.375 | 0.823 | 1.618 | 0.803 | 2.837 | 0.612
COVID19 (Custom Term) | Hyposmia | 8 | 5.816 | 0.95 | 1.868 | 3.035 | 0.697 | 1.17 | 1.87 | 1.376 | 5.296 | 15.228
COVID19 (Custom Term) | Anal erythema | 1 | 0.988 | 0.19 | 1.867 | 5.002 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Procalcitonin decreased | 2 | 1.98 | 0.555 | 1.865 | 3.8 | 0.41 | 0.9 | 1.768 | 1.01 | 6.619 | 2.615
COVID19 (Custom Term) | Coagulopathy | 9 | 9.42 | 1.021 | 1.865 | 2.915 | 0.562 | 0.923 | 1.447 | 0.955 | 2.078 | 3.24
COVID19 (Custom Term) | Craniocerebral injury | 3 | 3.027 | 0.617 | 1.86 | 3.645 | 0.446 | 0.909 | 1.69 | 0.991 | 1.655 | 0.192
COVID19 (Custom Term) | Respiratory syncytial virus test | 3 | 2.908 | 0.638 | 1.852 | 3.579 | 0.454 | 0.925 | 1.722 | 1.032 | 0.961 | 0.054
COVID19 (Custom Term) | Angiogram retina | 5 | 5.031 | 0.834 | 1.852 | 3.196 | 0.504 | 0.929 | 1.6 | 0.994 | 5.516 | 8.904
COVID19 (Custom Term) | Acute respiratory failure | 29 | 30.194 | 1.336 | 1.852 | 2.438 | 0.703 | 0.947 | 1.255 | 0.96 | 4.965 | 58.35
COVID19 (Custom Term) | Left atrial enlargement | 2 | 1.977 | 0.527 | 1.85 | 3.827 | 0.411 | 0.9 | 1.769 | 1.012 | 4.965 | 1.813
COVID19 (Custom Term) | Atrioventricular block second degree | 2 | 1.975 | 0.498 | 1.848 | 3.893 | 0.411 | 0.9 | 1.769 | 1.012 | 3.972 | 1.27
COVID19 (Custom Term) | Angiogram abnormal | 14 | 13.152 | 1.14 | 1.847 | 2.694 | 0.672 | 1.016 | 1.487 | 1.064 | 3.861 | 19.168
COVID19 (Custom Term) | Chronic obstructive pulmonary disease | 20 | 20.271 | 1.227 | 1.846 | 2.567 | 0.677 | 0.964 | 1.341 | 0.987 | 1.103 | 0.087
COVID19 (Custom Term) | Periorbital pain | 3 | 1.809 | 0.687 | 1.844 | 3.455 | 0.547 | 1.115 | 2.078 | 1.659 | 4.255 | 3.022
COVID19 (Custom Term) | Aspartate aminotransferase decreased | 2 | 1.984 | 0.527 | 1.842 | 3.805 | 0.41 | 0.899 | 1.767 | 1.008 | 4.965 | 1.813
COVID19 (Custom Term) | Haemoglobin abnormal | 2 | 2.48 | 0.527 | 1.842 | 3.805 | 0.376 | 0.825 | 1.621 | 0.806 | 4.965 | 1.813
COVID19 (Custom Term) | HIV antibody negative | 2 | 1.069 | 0.366 | 1.835 | 4.221 | 0.492 | 1.078 | 2.126 | 1.871 | 0.221 | 4.58
COVID19 (Custom Term) | Arterial disorder | 2 | 1.975 | 0.554 | 1.835 | 3.72 | 0.411 | 0.9 | 1.769 | 1.012 | 6.619 | 2.615
COVID19 (Custom Term) | Restless legs syndrome | 5 | 5.166 | 0.761 | 1.827 | 3.267 | 0.496 | 0.915 | 1.575 | 0.968 | 0.814 | 0.053
COVID19 (Custom Term) | Haemodialysis | 6 | 7.914 | 0.815 | 1.827 | 3.164 | 0.44 | 0.784 | 1.311 | 0.758 | 2.59 | 3.362
COVID19 (Custom Term) | Alcohol use | 2 | 1.022 | 0.498 | 1.826 | 3.83 | 0.497 | 1.089 | 2.149 | 1.957 | 3.972 | 1.27
COVID19 (Custom Term) | Oesophageal pain | 2 | 1.993 | 0.554 | 1.825 | 3.694 | 0.409 | 0.898 | 1.764 | 1.003 | 6.619 | 2.615
COVID19 (Custom Term) | Compression fracture | 2 | 2.032 | 0.527 | 1.825 | 3.758 | 0.407 | 0.891 | 1.751 | 0.984 | 4.965 | 1.813
COVID19 (Custom Term) | Sinus bradycardia | 4 | 3.247 | 0.69 | 1.822 | 3.39 | 0.532 | 1.026 | 1.829 | 1.232 | 1.655 | 0.378
COVID19 (Custom Term) | Blood urea | 7 | 6.411 | 0.92 | 1.817 | 2.96 | 0.581 | 1.001 | 1.633 | 1.092 | 1.931 | 1.842
COVID19 (Custom Term) | C-reactive protein decreased | 2 | 1.127 | 0.439 | 1.816 | 3.957 | 0.486 | 1.065 | 2.098 | 1.775 | 1.241 | 0.014
COVID19 (Custom Term) | Monocyte count | 4 | 3.496 | 0.693 | 1.816 | 3.369 | 0.513 | 0.99 | 1.765 | 1.144 | 1.241 | 0.014
COVID19 (Custom Term) | Metabolic acidosis | 5 | 5.032 | 0.791 | 1.815 | 3.179 | 0.504 | 0.929 | 1.6 | 0.994 | 0.636 | 0.636
COVID19 (Custom Term) | Bacterial sepsis | 2 | 2.034 | 0.436 | 1.814 | 3.959 | 0.406 | 0.891 | 1.751 | 0.983 | 2.837 | 0.612
COVID19 (Custom Term) | Electrocardiogram ambulatory normal | 2 | 2.102 | 0.428 | 1.811 | 3.972 | 0.402 | 0.88 | 1.73 | 0.952 | 0.567 | 0.255
COVID19 (Custom Term) | Gingival blister | 2 | 2.387 | 0.469 | 1.808 | 3.856 | 0.382 | 0.838 | 1.647 | 0.838 | 3.31 | 0.887
COVID19 (Custom Term) | Ventricular tachycardia | 14 | 14.151 | 1.11 | 1.807 | 2.644 | 0.634 | 0.959 | 1.404 | 0.989 | 6.319 | 34.812
COVID19 (Custom Term) | Appendicitis perforated | 9 | 8.999 | 0.974 | 1.806 | 2.846 | 0.581 | 0.954 | 1.495 | 1 | 8.936 | 28.949
COVID19 (Custom Term) | Adverse event | 47 | 48.344 | 1.398 | 1.803 | 2.251 | 0.759 | 0.963 | 1.208 | 0.972 | 0.505 | 21.238
COVID19 (Custom Term) | Rales | 15 | 13.889 | 1.124 | 1.801 | 2.609 | 0.689 | 1.03 | 1.493 | 1.08 | 2.66 | 10.856
COVID19 (Custom Term) | Blood fibrinogen | 6 | 5.936 | 0.847 | 1.799 | 3.039 | 0.532 | 0.946 | 1.582 | 1.011 | 3.972 | 7.336
COVID19 (Custom Term) | Gastrointestinal oedema | 3 | 2.965 | 0.553 | 1.799 | 3.623 | 0.45 | 0.917 | 1.706 | 1.012 | 1.862 | 0.367
COVID19 (Custom Term) | Chronic kidney disease | 7 | 6.578 | 0.901 | 1.798 | 2.944 | 0.571 | 0.985 | 1.607 | 1.064 | 4.634 | 11.01
COVID19 (Custom Term) | Vein rupture | 2 | 1.948 | 0.554 | 1.796 | 3.615 | 0.413 | 0.905 | 1.778 | 1.026 | 6.619 | 2.615
COVID19 (Custom Term) | Gastric ulcer | 2 | 1.984 | 0.491 | 1.795 | 3.764 | 0.41 | 0.899 | 1.767 | 1.008 | 2.206 | 0.266
COVID19 (Custom Term) | Apnoeic attack | 3 | 2.999 | 0.621 | 1.793 | 3.458 | 0.448 | 0.913 | 1.698 | 1 | 0.727 | 0.076
COVID19 (Custom Term) | Increased insulin requirement | 2 | 2.962 | 0.554 | 1.791 | 3.602 | 0.347 | 0.764 | 1.502 | 0.675 | 6.619 | 2.615
COVID19 (Custom Term) | Upper gastrointestinal haemorrhage | 2 | 2.032 | 0.527 | 1.79 | 3.661 | 0.407 | 0.891 | 1.751 | 0.984 | 4.965 | 1.813
COVID19 (Custom Term) | Acute respiratory distress syndrome | 10 | 11.062 | 0.993 | 1.789 | 2.775 | 0.552 | 0.888 | 1.369 | 0.904 | 1.439 | 0.786
COVID19 (Custom Term) | Dementia (SMQ) [narrow] | 24 | 26.825 | 1.24 | 1.784 | 2.408 | 0.641 | 0.888 | 1.205 | 0.895 | 5.296 | 51.509
COVID19 (Custom Term) | X-ray with contrast | 2 | 1.98 | 0.554 | 1.783 | 3.579 | 0.41 | 0.9 | 1.768 | 1.01 | 6.619 | 2.615
COVID19 (Custom Term) | Posterior reversible encephalopathy syndrome | 2 | 1.982 | 0.47 | 1.783 | 3.783 | 0.41 | 0.899 | 1.767 | 1.009 | 3.31 | 0.887
COVID19 (Custom Term) | Product preparation error | 18 | 15.71 | 1.159 | 1.782 | 2.515 | 0.751 | 1.088 | 1.536 | 1.146 | 0.27 | 33.973
COVID19 (Custom Term) | Magnetic resonance imaging thoracic | 2 | 1.989 | 0.483 | 1.782 | 3.747 | 0.41 | 0.898 | 1.765 | 1.006 | 1.324 | 0.002
COVID19 (Custom Term) | Monocytosis | 2 | 2.009 | 0.499 | 1.782 | 3.705 | 0.408 | 0.895 | 1.759 | 0.995 | 3.972 | 1.27
COVID19 (Custom Term) | Reaction to previous exposure to any vaccine | 4 | 3.475 | 0.774 | 1.778 | 3.116 | 0.515 | 0.993 | 1.77 | 1.151 | 5.674 | 6.8
COVID19 (Custom Term) | Capillary fragility | 1 | 0.995 | 0.197 | 1.776 | 4.679 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Contraindicated product administered | 3 | 1.721 | 0.61 | 1.775 | 3.434 | 0.556 | 1.133 | 2.114 | 1.743 | 1.655 | 0.192
COVID19 (Custom Term) | PO2 normal | 4 | 3.929 | 0.776 | 1.771 | 3.093 | 0.484 | 0.933 | 1.663 | 1.018 | 2.648 | 1.965
COVID19 (Custom Term) | Coagulation factor XII level | 1 | 0.374 | 0.332 | 1.769 | 4.139 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Dystonic tremor | 1 | 0.374 | 0.332 | 1.769 | 4.139 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Infusion site joint movement impairment | 1 | 0.503 | 0.332 | 1.769 | 4.139 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Barbiturates positive | 1 | 0.503 | 0.332 | 1.769 | 4.139 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Blood pressure systolic normal | 1 | 0.503 | 0.332 | 1.769 | 4.139 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Heat therapy | 1 | 0.503 | 0.332 | 1.769 | 4.139 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Therapeutic response delayed | 1 | 0.925 | 0.332 | 1.769 | 4.139 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Femoral nerve injury | 1 | 0.953 | 0.332 | 1.769 | 4.139 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Product dispensing issue | 1 | 0.953 | 0.332 | 1.769 | 4.139 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Hemidysaesthesia | 1 | 0.953 | 0.332 | 1.769 | 4.139 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Symptom recurrence | 1 | 0.953 | 0.332 | 1.769 | 4.139 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Venous oxygen partial pressure | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Renal artery arteriosclerosis | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Venous oxygen saturation normal | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Arteriovenous fistula | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | C1 esterase inhibitor test | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Microvascular coronary artery disease | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Crossmatch | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Foreign body ingestion | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Vertebrobasilar stroke | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Methaemoglobin urine absent | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Monocyte percentage abnormal | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Deposit eye | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Renal embolism | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Blood creatine abnormal | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Allen's test | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Withdrawal hypertension | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Pericardial drainage test normal | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Imaging procedure artifact | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Discouragement | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Endoscopic swallowing evaluation | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Blood urea abnormal | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | CSF electrophoresis | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Dermatillomania | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Accelerated hypertension | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Acute monocytic leukaemia | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Hepatic embolisation | 1 | 0.987 | 0.332 | 1.769 | 4.139 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Vertebroplasty | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Vascular cauterisation | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Model for end stage liver disease score | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Pericardial drainage test | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Malignant ascites | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Vitamin K decreased | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Pacemaker generated rhythm | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Piriformis syndrome | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Factor II mutation | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Colloid brain cyst | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Abdominal rebound tenderness | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Right ventricular systolic pressure | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Bladder catheter replacement | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Musculoskeletal foreign body | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Intraductal papillary mucinous neoplasm | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Electrocardiogram P wave biphasic | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | SCORTEN score | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Bile culture negative | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Abdominal wall oedema | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Hypocapnia | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Cubital tunnel syndrome | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Pulmonary hilum mass | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Vitamin K | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Catheter site haemorrhage | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Continuous glucose monitoring | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Anti factor Xa assay normal | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiac pacemaker adjustment | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Abdominal wall mass | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Agonal death struggle | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Bladder cancer stage IV | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Bladder injury | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Blood beta-D-glucan normal | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Anaemia of chronic disease | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Retroperitoneal oedema | 1 | 0.988 | 0.332 | 1.769 | 4.139 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Normetanephrine urine increased | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Laryngeal mask airway insertion | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Multisystem inflammatory syndrome in children | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Hepatic vein thrombosis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Administration site joint movement impairment | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Endoscopy gastrointestinal normal | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Terminal ileitis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Pericardial cyst | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiac perfusion defect | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Pudendal canal syndrome | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Abscess intestinal | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Spinal retrolisthesis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Accessory muscle | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Pericardial fibrosis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Laryngotracheobronchoscopy | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Gastrointestinal disorder prophylaxis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Electrocardiogram ST-T segment elevation | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Blood urea nitrogen/creatinine ratio decreased | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Carcinoid syndrome | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Computerised tomogram coronary artery | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Splenic granuloma | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Splenic haemorrhage | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Traumatic haemorrhage | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Oropharyngeal stenosis | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Phaeochromocytoma | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Renal cyst haemorrhage | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Retroperitoneal effusion | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Oscillopsia | 1 | 0.993 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Injection | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pericoronitis | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Haemorrhage subepidermal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Electric shock sensation | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Adrenal adenoma | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vascular operation | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vocal cord thickening | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Venous stent insertion | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Blood calcitonin normal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Foetal heart rate normal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Skin lesion inflammation | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Omental necrosis | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Placental calcification | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Apolipoprotein | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Amniotic membrane rupture test negative | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiac ventriculogram left normal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Biopsy small intestine normal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Histamine abnormal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Cholestasis of pregnancy | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Peritoneal lavage | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Endoscopic retrograde cholangiopancreatography | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Mast cell degranulation test | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Oropharyngeal oedema | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Abdomen crushing | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Smear vaginal normal | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Reduction of increased intracranial pressure | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Device dispensing error | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Fear of eating | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Amniotic fluid index decreased | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Tendon dislocation | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vena cava filter insertion | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vitamin B6 increased | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pregnancy-related hepatic disorders (SMQ) [broad] | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pregnancy-related hepatic disorders (SMQ) [narrow] | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Procedure aborted | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Rebound effect | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Laryngeal tremor | 1 | 0.995 | 0.332 | 1.769 | 4.139 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Haemorrhage intracranial | 5 | 4.155 | 0.791 | 1.768 | 3.058 | 0.561 | 1.034 | 1.781 | 1.203 | 4.137 | 6.136
COVID19 (Custom Term) | Chronic spontaneous urticaria | 1 | 1.026 | 0.318 | 1.763 | 4.167 | 0.356 | 0.866 | 1.837 | 0.975 | 0.993 | 0.266
COVID19 (Custom Term) | Upper respiratory tract irritation | 1 | 0.057 | 0.333 | 1.762 | 4.114 | 0.458 | 1.146 | 2.548 | 17.641 | 29.787 | 2.007
COVID19 (Custom Term) | Vasodilation procedure | 1 | 0.057 | 0.333 | 1.762 | 4.114 | 0.458 | 1.146 | 2.548 | 17.641 | 29.787 | 2.007
COVID19 (Custom Term) | Instillation site pain | 1 | 0.057 | 0.333 | 1.762 | 4.114 | 0.458 | 1.146 | 2.548 | 17.641 | 29.787 | 2.007
COVID19 (Custom Term) | SARS-CoV-2 test false positive | 1 | 0.069 | 0.333 | 1.762 | 4.114 | 0.456 | 1.137 | 2.514 | 14.57 | 29.787 | 2.007
COVID19 (Custom Term) | Internal injury | 1 | 0.069 | 0.333 | 1.762 | 4.114 | 0.456 | 1.137 | 2.514 | 14.57 | 29.787 | 2.007
COVID19 (Custom Term) | Urinary assistance device user | 1 | 0.069 | 0.333 | 1.762 | 4.114 | 0.456 | 1.137 | 2.514 | 14.57 | 29.787 | 2.007
COVID19 (Custom Term) | Endothelial dysfunction | 1 | 0.374 | 0.333 | 1.762 | 4.114 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Therapeutic response shortened | 1 | 0.374 | 0.333 | 1.762 | 4.114 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Intercepted product preparation error | 1 | 0.374 | 0.333 | 1.762 | 4.114 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Product design issue | 1 | 0.374 | 0.333 | 1.762 | 4.114 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Scalloped tongue | 1 | 0.374 | 0.333 | 1.762 | 4.114 | 0.418 | 1.016 | 2.168 | 2.671 | 29.787 | 2.007
COVID19 (Custom Term) | Holmes-Adie pupil | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Insulin resistant diabetes | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Jaw clicking | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Iodine uptake normal | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Antipsychotic drug level | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Blood insulin increased | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | SARS-CoV-2 test false negative | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Splenic lesion | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Transcutaneous pacing | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Breast milk discolouration | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Urinary stone analysis | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Product delivery mechanism issue | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Product dose omission in error | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Diplacusis | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Eye paraesthesia | 1 | 0.503 | 0.333 | 1.762 | 4.114 | 0.404 | 0.981 | 2.088 | 1.988 | 29.787 | 2.007
COVID19 (Custom Term) | Streptobacillus infection | 1 | 0.892 | 0.333 | 1.762 | 4.114 | 0.367 | 0.893 | 1.893 | 1.121 | 29.787 | 2.007
COVID19 (Custom Term) | Fluid balance assessment | 1 | 0.925 | 0.333 | 1.762 | 4.114 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Diabetic wound | 1 | 0.925 | 0.333 | 1.762 | 4.114 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Paraganglion neoplasm | 1 | 0.925 | 0.333 | 1.762 | 4.114 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Chronic myeloid leukaemia recurrent | 1 | 0.925 | 0.333 | 1.762 | 4.114 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Blue toe syndrome | 1 | 0.925 | 0.333 | 1.762 | 4.114 | 0.365 | 0.886 | 1.879 | 1.081 | 29.787 | 2.007
COVID19 (Custom Term) | Living in residential institution | 1 | 0.953 | 0.333 | 1.762 | 4.114 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Diabetic foot infection | 1 | 0.953 | 0.333 | 1.762 | 4.114 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Microembolism | 1 | 0.953 | 0.333 | 1.762 | 4.114 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Lung carcinoma cell type unspecified stage I | 1 | 0.953 | 0.333 | 1.762 | 4.114 | 0.362 | 0.88 | 1.867 | 1.049 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiovascular function test | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Aortic thrombosis | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Abdominal wall haemorrhage | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Biopsy vagina | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Urinary nitrogen increased | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Venous recanalisation | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Urine retinol binding protein increased | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Pulmonary amyloidosis | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Mean arterial pressure decreased | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | LDL/HDL ratio decreased | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Injection site muscle atrophy | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Crystal urine | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Hypertensive cerebrovascular disease | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Gastritis bacterial | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Chondritis | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Cor pulmonale acute | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Gastrointestinal stoma complication | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Eosinophilic pneumonia acute | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Intranasal paraesthesia | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Vena cava embolism | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Bone density abnormal | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiac pacemaker replacement | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Paracentesis | 2 | 1.977 | 0.528 | 1.762 | 3.583 | 0.411 | 0.9 | 1.769 | 1.012 | 4.965 | 1.813
COVID19 (Custom Term) | Paranoid personality disorder | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Computerised tomogram aorta | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Haemorrhagic varicella syndrome | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Migraine prophylaxis | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Post-traumatic neuralgia | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | General physical condition | 1 | 0.987 | 0.333 | 1.762 | 4.114 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Dementia with Lewy bodies | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Acoustic neuritis | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Acute undifferentiated leukaemia | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Albumin globulin ratio abnormal | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Rash maculovesicular | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Product substitution issue | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Progressive bulbar palsy | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Urethral meatus stenosis | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Pneumonitis chemical | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Prothrombin time ratio abnormal | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Peripheral vein occlusion | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Platelet aggregation decreased | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Insulin therapy | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Ischaemic skin ulcer | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Basilar artery occlusion | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Right ventricular systolic pressure decreased | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Alveolar lung disease | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Protein albumin ratio increased | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Stoma site haemorrhage | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Dermatophagia | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Free thyroxine index | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Hunt and Hess scale | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Lung hypoinflation | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Carotid artery stent insertion | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | EGFR gene mutation | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Coronary artery thrombosis | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Retroperitoneal haemorrhage | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Arteriovenous fistula aneurysm | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Incarcerated hernia | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Central cord syndrome | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Arterial catheterisation | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Silent myocardial infarction | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Cystic lung disease | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Red blood cell microcytes | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Posthaemorrhagic hydrocephalus | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Renal atrophy | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Blood beta-D-glucan positive | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Burkitt's lymphoma | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Intracerebral haematoma evacuation | 1 | 0.988 | 0.333 | 1.762 | 4.114 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Craniectomy | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Thrombin-antithrombin III complex normal | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Bullous haemorrhagic dermatosis | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Application site haemorrhage | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Creatine urine increased | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Urinary lipids present | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Computerised tomogram pancreas normal | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Abstains from alcohol | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Myelocyte percentage | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Wall motion score index abnormal | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Russell's viper venom time normal | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Tidal volume decreased | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Cardiac ventriculogram left | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Good syndrome | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Diverticulitis intestinal perforated | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Endoscopic ultrasound | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Brain natriuretic peptide decreased | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Hereditary spherocytosis | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Retinal operation | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Ophthalmic artery thrombosis | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Electrocardiogram PR segment elevation | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Breath sounds absent | 1 | 0.993 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.85 | 1.007 | 29.787 | 2.007
COVID19 (Custom Term) | Assisted reproductive technology | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Porphyria acute | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Forced expiratory flow | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Urine amphetamine positive | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Sleep disorder due to general medical condition, insomnia type | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Uterine cervical pain | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pelvic haematoma | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Uterine tenderness | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Coma acidotic | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Implant site pruritus | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Cautery to nose | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Sulphur dioxide test | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Transplant evaluation | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Splenic artery aneurysm | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Splenic varices | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Ultrasound uterus abnormal | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Portal hypertensive gastropathy | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Injection site recall reaction | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pelvic abscess | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Ocular rosacea | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Oocyte harvest | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Malignant hypertension | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vertebral lateral recess stenosis | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Waist circumference increased | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pulmonary hilar enlargement | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Cerebellar haemorrhage | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Epstein-Barr virus infection reactivation | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Hypnopompic hallucination | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Allergy to surgical sutures | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Focal peritonitis | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Urine porphobilinogen increased | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Gastric varices | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Directional Doppler flow tests | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Binge drinking | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Blood pressure diastolic abnormal | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Gestational age test abnormal | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Euglycaemic diabetic ketoacidosis | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Blood pressure management | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Hysterosalpingo-oophorectomy | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Mucosa vesicle | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Omentectomy | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Paraproteinaemia | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Itching scar | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Peripheral artery stent insertion | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Iliac vein occlusion | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Otoacoustic emissions test | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Oral viral infection | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Vanishing twin syndrome | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Mallampati score | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Fibronectin normal | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Locked-in syndrome | 1 | 0.995 | 0.333 | 1.762 | 4.114 | 0.359 | 0.872 | 1.849 | 1.005 | 29.787 | 2.007
COVID19 (Custom Term) | Pancreatic duct dilatation | 1 | 0.987 | 0.333 | 1.76 | 4.11 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Endoscopy upper gastrointestinal tract normal | 2 | 1.977 | 0.439 | 1.76 | 3.797 | 0.411 | 0.9 | 1.769 | 1.012 | 2.837 | 0.612
COVID19 (Custom Term) | Energy increased | 2 | 1.567 | 0.471 | 1.759 | 3.715 | 0.444 | 0.972 | 1.912 | 1.276 | 3.31 | 0.887
COVID19 (Custom Term) | CSF myelin basic protein normal | 1 | 0.987 | 0.247 | 1.759 | 4.411 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Tongue dry | 7 | 5.453 | 0.88 | 1.758 | 2.88 | 0.642 | 1.107 | 1.807 | 1.284 | 7.723 | 19.07
COVID19 (Custom Term) | Asymptomatic COVID-19 | 19 | 16.005 | 1.155 | 1.758 | 2.464 | 0.782 | 1.123 | 1.573 | 1.187 | 387.229 | 177.895
COVID19 (Custom Term) | Embolism venous | 1 | 0.987 | 0.154 | 1.757 | 4.835 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Myoglobin blood increased | 2 | 2.356 | 0.393 | 1.757 | 3.915 | 0.384 | 0.842 | 1.655 | 0.849 | 1.528 | 0.013
COVID19 (Custom Term) | Transient global amnesia | 7 | 6.48 | 0.906 | 1.756 | 2.834 | 0.577 | 0.994 | 1.622 | 1.08 | 4.344 | 10.106
COVID19 (Custom Term) | Nasal pruritus | 6 | 5.523 | 0.778 | 1.754 | 3.048 | 0.556 | 0.989 | 1.654 | 1.086 | 2.383 | 2.753
COVID19 (Custom Term) | Polychondritis | 1 | 0.987 | 0.247 | 1.753 | 4.391 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Cerebral arteriosclerosis | 1 | 0.987 | 0.334 | 1.753 | 4.086 | 0.359 | 0.874 | 1.853 | 1.013 | 29.787 | 2.007
COVID19 (Custom Term) | Small intestinal haemorrhage | 1 | 0.988 | 0.334 | 1.753 | 4.086 | 0.359 | 0.873 | 1.852 | 1.012 | 29.787 | 2.007
COVID19 (Custom Term) | Hypoglycaemia | 21 | 17.788 | 1.198 | 1.75 | 2.388 | 0.794 | 1.123 | 1.551 | 1.181 | 2.195 | 10.14
COVID19 (Custom Term) | Decerebrate posture | 2 | 1.496 | 0.528 | 1.749 | 3.545 | 0.45 | 0.986 | 1.939 | 1.337 | 4.965 | 1.813
COVID19 (Custom Term) | Thirst decreased | 2 | 2.013 | 0.446 | 1.747 | 3.743 | 0.408 | 0.894 | 1.757 | 0.993 | 1.241 | 0.014
COVID19 (Custom Term) | Osteitis | 1 | 1.052 | 0.303 | 1.747 | 4.169 | 0.354 | 0.861 | 1.826 | 0.951 | 0.993 | 0.266
COVID19 (Custom Term) | Intranasal hypoaesthesia | 2 | 1.381 | 0.501 | 1.746 | 3.604 | 0.461 | 1.009 | 1.986 | 1.449 | 3.972 | 1.27
COVID19 (Custom Term) | Beta-2 glycoprotein antibody negative | 2 | 1.982 | 0.501 | 1.746 | 3.602 | 0.41 | 0.899 | 1.767 | 1.009 | 3.972 | 1.27
COVID19 (Custom Term) | Cardiomegaly | 15 | 14.388 | 1.101 | 1.745 | 2.511 | 0.67 | 1.002 | 1.451 | 1.043 | 3.819 | 20.36
COVID19 (Custom Term) | Myocardial ischaemia | 5 | 5.035 | 0.772 | 1.745 | 3.035 | 0.504 | 0.929 | 1.6 | 0.993 | 7.092 | 11.603
COVID19 (Custom Term) | Ultrasound spleen | 2 | 2.097 | 0.554 | 1.745 | 3.476 | 0.402 | 0.881 | 1.731 | 0.954 | 6.619 | 2.615
COVID19 (Custom Term) | Weight | 18 | 17.211 | 1.129 | 1.743 | 2.465 | 0.697 | 1.01 | 1.425 | 1.046 | 178.726 | 157.301
COVID19 (Custom Term) | Ventricular hypokinesia | 7 | 6.006 | 0.874 | 1.739 | 2.844 | 0.605 | 1.043 | 1.702 | 1.166 | 7.723 | 19.07
COVID19 (Custom Term) | Body height | 15 | 14.855 | 1.079 | 1.739 | 2.528 | 0.653 | 0.976 | 1.415 | 1.01 | 307.798 | 138.216
COVID19 (Custom Term) | Mammogram abnormal | 1 | 1.552 | 0.246 | 1.739 | 4.356 | 0.317 | 0.775 | 1.646 | 0.644 | 0.903 | 0.162
COVID19 (Custom Term) | Illusion | 4 | 2.878 | 0.621 | 1.738 | 3.311 | 0.563 | 1.084 | 1.934 | 1.39 | 0.662 | 0.346
COVID19 (Custom Term) | Cardio-respiratory arrest | 60 | 60.354 | 1.389 | 1.737 | 2.117 | 0.798 | 0.985 | 1.207 | 0.994 | 6.406 | 162.857
COVID19 (Custom Term) | Hyperglycaemia | 23 | 18.765 | 1.208 | 1.734 | 2.337 | 0.834 | 1.163 | 1.588 | 1.226 | 4.478 | 40.229
COVID19 (Custom Term) | Bundle branch block right | 6 | 5.469 | 0.849 | 1.734 | 2.872 | 0.559 | 0.995 | 1.664 | 1.097 | 2.979 | 4.507
COVID19 (Custom Term) | Paroxysmal nocturnal haemoglobinuria | 2 | 2.094 | 0.502 | 1.734 | 3.567 | 0.402 | 0.881 | 1.732 | 0.955 | 2.206 | 0.266
COVID19 (Custom Term) | Procalcitonin | 13 | 13.055 | 1.035 | 1.728 | 2.566 | 0.628 | 0.962 | 1.424 | 0.996 | 2.582 | 8.665
COVID19 (Custom Term) | Lacunar infarction | 7 | 6.997 | 0.884 | 1.727 | 2.798 | 0.548 | 0.946 | 1.543 | 1 | 17.376 | 33.006
COVID19 (Custom Term) | Peau d'orange | 1 | 1.139 | 0.277 | 1.727 | 4.199 | 0.347 | 0.845 | 1.791 | 0.878 | 0.993 | 0.266
COVID19 (Custom Term) | Transient ischaemic attack | 41 | 40.398 | 1.311 | 1.72 | 2.174 | 0.776 | 1 | 1.273 | 1.015 | 5.357 | 91.308
COVID19 (Custom Term) | Catatonia | 2 | 1.564 | 0.534 | 1.715 | 3.44 | 0.444 | 0.973 | 1.913 | 1.279 | 0.863 | 0.022
COVID19 (Custom Term) | Proctitis | 2 | 1.989 | 0.529 | 1.715 | 3.453 | 0.41 | 0.898 | 1.765 | 1.006 | 4.965 | 1.813
COVID19 (Custom Term) | N-terminal prohormone brain natriuretic peptide increased | 8 | 8.453 | 0.9 | 1.711 | 2.732 | 0.544 | 0.914 | 1.46 | 0.946 | 6.619 | 19.339
COVID19 (Custom Term) | Hypercalcaemia | 5 | 7.797 | 0.734 | 1.709 | 3.014 | 0.381 | 0.704 | 1.212 | 0.641 | 4.513 | 6.931
COVID19 (Custom Term) | Ketoacidosis | 2 | 1.982 | 0.366 | 1.708 | 3.857 | 0.41 | 0.899 | 1.767 | 1.009 | 1.528 | 0.013
COVID19 (Custom Term) | Vaginal infection | 1 | 0.517 | 0.177 | 1.705 | 4.551 | 0.403 | 0.978 | 2.08 | 1.935 | 0.764 | 0.041
COVID19 (Custom Term) | Cerebral haemorrhage | 41 | 40.584 | 1.295 | 1.705 | 2.161 | 0.773 | 0.996 | 1.268 | 1.01 | 5.734 | 98.334
COVID19 (Custom Term) | Spinal cord injury | 2 | 1.998 | 0.443 | 1.705 | 3.634 | 0.409 | 0.897 | 1.762 | 1.001 | 2.837 | 0.612
COVID19 (Custom Term) | Food poisoning | 2 | 2.062 | 0.529 | 1.704 | 3.422 | 0.404 | 0.887 | 1.742 | 0.97 | 4.965 | 1.813
COVID19 (Custom Term) | Hysterectomy | 1 | 1.106 | 0.141 | 1.703 | 4.731 | 0.35 | 0.851 | 1.805 | 0.904 | 0.764 | 0.041
COVID19 (Custom Term) | Red blood cell schistocytes | 1 | 1.049 | 0.255 | 1.701 | 4.202 | 0.354 | 0.862 | 1.827 | 0.953 | 4.965 | 0.204
COVID19 (Custom Term) | Vaccination site joint pain | 2 | 1.888 | 0.444 | 1.699 | 3.614 | 0.417 | 0.915 | 1.798 | 1.059 | 2.837 | 0.612
COVID19 (Custom Term) | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [broad] | 1 | 1.133 | 0.133 | 1.696 | 4.762 | 0.347 | 0.846 | 1.794 | 0.883 | 0.231 | 1.745
COVID19 (Custom Term) | Cystitis | 8 | 8.975 | 0.869 | 1.696 | 2.746 | 0.522 | 0.877 | 1.4 | 0.891 | 1.073 | 0
COVID19 (Custom Term) | Granulocyte count decreased | 2 | 1.982 | 0.444 | 1.695 | 3.604 | 0.41 | 0.899 | 1.767 | 1.009 | 2.837 | 0.612
COVID19 (Custom Term) | Cytokine storm | 2 | 3.032 | 0.529 | 1.693 | 3.392 | 0.344 | 0.756 | 1.486 | 0.66 | 4.965 | 1.813
COVID19 (Custom Term) | Gastrointestinal haemorrhage | 23 | 21.824 | 1.163 | 1.689 | 2.295 | 0.734 | 1.023 | 1.397 | 1.054 | 5.856 | 54.951
COVID19 (Custom Term) | Anisocytosis | 2 | 1.991 | 0.503 | 1.689 | 3.44 | 0.41 | 0.898 | 1.764 | 1.004 | 3.972 | 1.27
COVID19 (Custom Term) | Pericardial drainage | 4 | 3.951 | 0.639 | 1.688 | 3.143 | 0.482 | 0.93 | 1.658 | 1.012 | 2.336 | 1.428
COVID19 (Custom Term) | Ear disorder | 3 | 2.561 | 0.543 | 1.686 | 3.341 | 0.48 | 0.978 | 1.819 | 1.171 | 1.027 | 0.069
COVID19 (Custom Term) | Hypertriglyceridaemia | 1 | 0.993 | 0.257 | 1.686 | 4.148 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Coma scale abnormal | 5 | 4.487 | 0.731 | 1.685 | 2.957 | 0.538 | 0.992 | 1.708 | 1.114 | 1.601 | 0.486
COVID19 (Custom Term) | Helicobacter test negative | 2 | 1.984 | 0.532 | 1.684 | 3.36 | 0.41 | 0.899 | 1.767 | 1.008 | 0.509 | 0.46
COVID19 (Custom Term) | Undifferentiated connective tissue disease | 2 | 1.991 | 0.503 | 1.683 | 3.423 | 0.41 | 0.898 | 1.764 | 1.005 | 3.972 | 1.27
COVID19 (Custom Term) | Status asthmaticus | 2 | 1.498 | 0.503 | 1.682 | 3.42 | 0.45 | 0.986 | 1.938 | 1.335 | 3.972 | 1.27
COVID19 (Custom Term) | Bilirubin conjugated | 4 | 3.964 | 0.628 | 1.682 | 3.148 | 0.482 | 0.928 | 1.655 | 1.009 | 2.336 | 1.428
COVID19 (Custom Term) | Food refusal | 8 | 7.967 | 0.877 | 1.682 | 2.699 | 0.567 | 0.953 | 1.522 | 1.004 | 2.206 | 3.3
COVID19 (Custom Term) | Adverse event following immunisation | 3 | 3 | 0.567 | 1.681 | 3.275 | 0.448 | 0.912 | 1.697 | 1 | 1.418 | 0.046
COVID19 (Custom Term) | Carboxyhaemoglobin decreased | 1 | 0.99 | 0.217 | 1.678 | 4.284 | 0.359 | 0.873 | 1.852 | 1.01 | 3.31 | 0.054
COVID19 (Custom Term) | Vaccination site discomfort | 11 | 10.903 | 0.959 | 1.675 | 2.553 | 0.612 | 0.967 | 1.468 | 1.009 | 3.523 | 12.695
COVID19 (Custom Term) | Thyroid hormones increased | 2 | 1.498 | 0.504 | 1.674 | 3.397 | 0.45 | 0.986 | 1.938 | 1.335 | 3.972 | 1.27
COVID19 (Custom Term) | Vaccination site irritation | 4 | 3.105 | 0.629 | 1.672 | 3.119 | 0.543 | 1.047 | 1.868 | 1.288 | 1.727 | 0.472
COVID19 (Custom Term) | Left ventricular hypertrophy | 8 | 7.923 | 0.9 | 1.671 | 2.634 | 0.569 | 0.956 | 1.528 | 1.01 | 15.887 | 36.853
COVID19 (Custom Term) | Coxsackie virus test negative | 1 | 0.995 | 0.298 | 1.671 | 3.96 | 0.359 | 0.872 | 1.849 | 1.005 | 0.903 | 0.162
COVID19 (Custom Term) | Transverse sinus thrombosis | 1 | 0.995 | 0.26 | 1.67 | 4.092 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Nasoendoscopy | 2 | 1.498 | 0.504 | 1.668 | 3.381 | 0.45 | 0.986 | 1.938 | 1.335 | 3.972 | 1.27
COVID19 (Custom Term) | Blood parathyroid hormone decreased | 1 | 2.893 | 0.26 | 1.668 | 4.083 | 0.243 | 0.607 | 1.304 | 0.346 | 4.965 | 0.204
COVID19 (Custom Term) | Breast feeding | 2 | 1.501 | 0.504 | 1.664 | 3.369 | 0.45 | 0.985 | 1.937 | 1.332 | 3.972 | 1.27
COVID19 (Custom Term) | Anaphylactoid reaction | 12 | 9.417 | 1.005 | 1.663 | 2.457 | 0.742 | 1.154 | 1.729 | 1.274 | 4.255 | 18.488
COVID19 (Custom Term) | Spinal fusion surgery | 2 | 2.034 | 0.447 | 1.663 | 3.507 | 0.406 | 0.891 | 1.751 | 0.983 | 2.837 | 0.612
COVID19 (Custom Term) | Product leakage | 2 | 2.323 | 0.458 | 1.66 | 3.469 | 0.386 | 0.847 | 1.665 | 0.861 | 1.986 | 0.162
COVID19 (Custom Term) | Ascites | 10 | 9.913 | 0.941 | 1.658 | 2.54 | 0.599 | 0.964 | 1.485 | 1.009 | 2.546 | 6.179
COVID19 (Custom Term) | Organising pneumonia | 2 | 1.977 | 0.447 | 1.657 | 3.489 | 0.411 | 0.9 | 1.769 | 1.012 | 2.837 | 0.612
COVID19 (Custom Term) | Deja vu | 1 | 0.374 | 0.263 | 1.654 | 4.031 | 0.418 | 1.016 | 2.168 | 2.671 | 4.965 | 0.204
COVID19 (Custom Term) | Torsade de pointes/QT prolongation (SMQ) [narrow] | 23 | 21.491 | 1.138 | 1.654 | 2.249 | 0.744 | 1.037 | 1.415 | 1.07 | 4.567 | 41.256
COVID19 (Custom Term) | Scleral disorders (SMQ) [narrow] | 3 | 2.601 | 0.665 | 1.652 | 2.997 | 0.477 | 0.971 | 1.807 | 1.153 | 0.876 | 0.004
COVID19 (Custom Term) | Scleral disorders (SMQ) [broad] | 3 | 2.601 | 0.665 | 1.652 | 2.997 | 0.477 | 0.971 | 1.807 | 1.153 | 0.876 | 0.004
COVID19 (Custom Term) | Phobia | 2 | 2.493 | 0.406 | 1.651 | 3.578 | 0.375 | 0.823 | 1.618 | 0.802 | 1.324 | 0.002
COVID19 (Custom Term) | Radial nerve injury | 1 | 0.993 | 0.263 | 1.65 | 4.017 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Arteriogram coronary abnormal | 2 | 1.982 | 0.478 | 1.649 | 3.391 | 0.41 | 0.899 | 1.767 | 1.009 | 3.31 | 0.887
COVID19 (Custom Term) | Infrequent bowel movements | 1 | 0.987 | 0.228 | 1.647 | 4.142 | 0.359 | 0.874 | 1.853 | 1.013 | 0.827 | 0.089
COVID19 (Custom Term) | Mean cell volume increased | 12 | 10.279 | 0.997 | 1.645 | 2.426 | 0.696 | 1.082 | 1.622 | 1.167 | 4.413 | 19.408
COVID19 (Custom Term) | Anion gap increased | 7 | 6.834 | 0.817 | 1.645 | 2.707 | 0.557 | 0.96 | 1.567 | 1.024 | 4.634 | 11.01
COVID19 (Custom Term) | Lung consolidation | 12 | 12.847 | 0.966 | 1.645 | 2.469 | 0.587 | 0.913 | 1.369 | 0.934 | 3.611 | 14.572
COVID19 (Custom Term) | Nuchal rigidity | 4 | 4.172 | 0.624 | 1.639 | 3.043 | 0.469 | 0.903 | 1.61 | 0.959 | 1.103 | 0.008
COVID19 (Custom Term) | Sudden death | 43 | 44.272 | 1.254 | 1.638 | 2.063 | 0.75 | 0.961 | 1.217 | 0.971 | 5.144 | 91.616
COVID19 (Custom Term) | Intermenstrual bleeding | 9 | 6.61 | 0.881 | 1.636 | 2.579 | 0.717 | 1.177 | 1.846 | 1.361 | 5.958 | 19.922
COVID19 (Custom Term) | Blood bilirubin decreased | 7 | 6.395 | 0.847 | 1.635 | 2.633 | 0.581 | 1.003 | 1.636 | 1.095 | 1.448 | 0.471
COVID19 (Custom Term) | Lactic acidosis | 8 | 7.907 | 0.881 | 1.632 | 2.57 | 0.57 | 0.958 | 1.53 | 1.012 | 6.619 | 19.339
COVID19 (Custom Term) | Acute motor-sensory axonal neuropathy | 2 | 1.989 | 0.45 | 1.631 | 3.408 | 0.41 | 0.898 | 1.765 | 1.006 | 2.837 | 0.612
COVID19 (Custom Term) | Lung infiltration | 43 | 43.675 | 1.25 | 1.631 | 2.054 | 0.759 | 0.973 | 1.233 | 0.985 | 6.777 | 122.145
COVID19 (Custom Term) | Electrocardiogram ST segment abnormal | 7 | 7.44 | 0.797 | 1.63 | 2.702 | 0.526 | 0.908 | 1.481 | 0.941 | 6.319 | 15.741
COVID19 (Custom Term) | Peritoneal fluid analysis abnormal | 1 | 0.988 | 0.31 | 1.628 | 3.792 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Dyspnoea paroxysmal nocturnal | 1 | 0.995 | 0.31 | 1.628 | 3.793 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Optical coherence tomography normal | 1 | 0.374 | 0.311 | 1.627 | 3.788 | 0.418 | 1.016 | 2.168 | 2.671 | 9.929 | 0.604
COVID19 (Custom Term) | Hypermagnesaemia | 1 | 0.988 | 0.31 | 1.627 | 3.789 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Dupuytren's contracture | 1 | 0.988 | 0.311 | 1.627 | 3.788 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Electrocardiogram PR shortened | 1 | 0.993 | 0.311 | 1.627 | 3.789 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Activated protein C resistance test positive | 1 | 0.995 | 0.31 | 1.627 | 3.79 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Lysozyme | 1 | 0.374 | 0.311 | 1.626 | 3.786 | 0.418 | 1.016 | 2.168 | 2.671 | 9.929 | 0.604
COVID19 (Custom Term) | Oesophageal disorder | 2 | 1.984 | 0.45 | 1.626 | 3.395 | 0.41 | 0.899 | 1.767 | 1.008 | 2.837 | 0.612
COVID19 (Custom Term) | Bilirubin conjugated increased | 6 | 6.056 | 0.755 | 1.626 | 2.767 | 0.525 | 0.934 | 1.563 | 0.991 | 1.216 | 0.048
COVID19 (Custom Term) | Hepatorenal syndrome | 1 | 1.015 | 0.311 | 1.626 | 3.786 | 0.357 | 0.868 | 1.841 | 0.985 | 9.929 | 0.604
COVID19 (Custom Term) | Pregnancy test urine positive | 1 | 2.08 | 0.167 | 1.626 | 4.349 | 0.284 | 0.7 | 1.492 | 0.481 | 0.138 | 4.422
COVID19 (Custom Term) | Mean cell haemoglobin increased | 8 | 6.45 | 0.84 | 1.625 | 2.618 | 0.653 | 1.096 | 1.752 | 1.24 | 2.147 | 3.059
COVID19 (Custom Term) | Dysentery | 4 | 4.037 | 0.607 | 1.625 | 3.04 | 0.477 | 0.92 | 1.639 | 0.991 | 1.018 | 0.053
COVID19 (Custom Term) | Foreign body in throat | 1 | 1.022 | 0.311 | 1.625 | 3.781 | 0.356 | 0.867 | 1.838 | 0.978 | 9.929 | 0.604
COVID19 (Custom Term) | Abdominal adhesions | 1 | 1.052 | 0.311 | 1.625 | 3.781 | 0.354 | 0.861 | 1.826 | 0.951 | 9.929 | 0.604
COVID19 (Custom Term) | Exercise test | 1 | 0.987 | 0.311 | 1.624 | 3.78 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Histamine release test | 1 | 0.995 | 0.311 | 1.624 | 3.78 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary hypertension (SMQ) [narrow] | 17 | 17.643 | 1.055 | 1.623 | 2.29 | 0.644 | 0.942 | 1.341 | 0.964 | 3.376 | 19.311
COVID19 (Custom Term) | Forced expiratory volume decreased | 2 | 2.115 | 0.301 | 1.623 | 3.809 | 0.401 | 0.878 | 1.726 | 0.946 | 0.331 | 1.954
COVID19 (Custom Term) | Renal failure | 30 | 31.65 | 1.184 | 1.623 | 2.118 | 0.698 | 0.937 | 1.236 | 0.948 | 3.071 | 30.293
COVID19 (Custom Term) | Arteritis coronary | 1 | 0.987 | 0.311 | 1.622 | 3.77 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Anosognosia | 1 | 0.988 | 0.311 | 1.622 | 3.77 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Wound complication | 2 | 2.005 | 0.507 | 1.622 | 3.247 | 0.409 | 0.896 | 1.76 | 0.997 | 3.972 | 1.27
COVID19 (Custom Term) | Macrophages increased | 1 | 1.014 | 0.311 | 1.622 | 3.77 | 0.357 | 0.868 | 1.842 | 0.986 | 9.929 | 0.604
COVID19 (Custom Term) | Hydrocholecystis | 1 | 0.995 | 0.311 | 1.621 | 3.77 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Viral labyrinthitis | 1 | 0.995 | 0.312 | 1.621 | 3.767 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Electrocardiogram ST segment normal | 1 | 0.374 | 0.174 | 1.62 | 4.294 | 0.418 | 1.016 | 2.168 | 2.671 | 2.482 | 0.004
COVID19 (Custom Term) | Device malfunction | 2 | 1.419 | 0.48 | 1.62 | 3.305 | 0.457 | 1.001 | 1.97 | 1.41 | 3.31 | 0.887
COVID19 (Custom Term) | Thunderclap headache | 1 | 1.496 | 0.312 | 1.62 | 3.763 | 0.321 | 0.784 | 1.664 | 0.668 | 9.929 | 0.604
COVID19 (Custom Term) | Antidepressant drug level | 1 | 0.503 | 0.312 | 1.619 | 3.762 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Wound closure | 2 | 1.871 | 0.507 | 1.619 | 3.239 | 0.419 | 0.918 | 1.804 | 1.069 | 3.972 | 1.27
COVID19 (Custom Term) | Priapism | 1 | 0.993 | 0.312 | 1.618 | 3.756 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Non-high-density lipoprotein cholesterol increased | 1 | 0.988 | 0.312 | 1.617 | 3.754 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Total cholesterol/HDL ratio normal | 1 | 0.988 | 0.312 | 1.617 | 3.754 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Hepatitis A antigen negative | 1 | 0.993 | 0.312 | 1.617 | 3.755 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Ultrasound biliary tract abnormal | 1 | 0.995 | 0.312 | 1.617 | 3.755 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Upper motor neurone lesion | 1 | 0.995 | 0.312 | 1.617 | 3.753 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Aortic dissection | 1 | 1.361 | 0.312 | 1.617 | 3.755 | 0.33 | 0.806 | 1.71 | 0.735 | 9.929 | 0.604
COVID19 (Custom Term) | Cholecystitis chronic | 1 | 0.988 | 0.312 | 1.616 | 3.751 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Haematospermia | 1 | 0.993 | 0.312 | 1.616 | 3.752 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Ureterolithiasis | 1 | 0.995 | 0.312 | 1.616 | 3.749 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Atrial septal defect repair | 1 | 1.37 | 0.312 | 1.616 | 3.751 | 0.33 | 0.804 | 1.707 | 0.73 | 9.929 | 0.604
COVID19 (Custom Term) | Atrioventricular block first degree | 1 | 1.498 | 0.312 | 1.616 | 3.749 | 0.321 | 0.783 | 1.663 | 0.667 | 9.929 | 0.604
COVID19 (Custom Term) | Aerophagia | 1 | 0.987 | 0.313 | 1.615 | 3.745 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Intestinal angioedema | 1 | 0.987 | 0.313 | 1.615 | 3.748 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Defect conduction intraventricular | 1 | 0.987 | 0.313 | 1.615 | 3.747 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Klebsiella infection | 1 | 0.988 | 0.313 | 1.615 | 3.748 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Thermometry | 1 | 0.991 | 0.313 | 1.615 | 3.748 | 0.359 | 0.873 | 1.851 | 1.009 | 9.929 | 0.604
COVID19 (Custom Term) | Foetal monitoring normal | 1 | 0.995 | 0.313 | 1.615 | 3.749 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Sleep disorder due to a general medical condition | 1 | 0.995 | 0.313 | 1.615 | 3.746 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Oral contusion | 3 | 2.539 | 0.575 | 1.614 | 3.077 | 0.482 | 0.981 | 1.826 | 1.182 | 2.979 | 1.589
COVID19 (Custom Term) | Blood sodium abnormal | 1 | 0.988 | 0.313 | 1.614 | 3.743 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | CSF lactate dehydrogenase normal | 1 | 1.498 | 0.313 | 1.614 | 3.744 | 0.321 | 0.783 | 1.663 | 0.667 | 9.929 | 0.604
COVID19 (Custom Term) | Iodine uptake decreased | 1 | 0.993 | 0.313 | 1.613 | 3.739 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Splenic rupture | 1 | 1.05 | 0.313 | 1.613 | 3.741 | 0.354 | 0.861 | 1.827 | 0.952 | 9.929 | 0.604
COVID19 (Custom Term) | Prothrombin time abnormal | 1 | 0.988 | 0.313 | 1.612 | 3.738 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Sinonasal obstruction | 1 | 0.995 | 0.313 | 1.612 | 3.737 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Tinel's sign | 1 | 0.995 | 0.313 | 1.612 | 3.738 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Open reduction of fracture | 1 | 0.995 | 0.313 | 1.612 | 3.737 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Distributive shock | 1 | 1.045 | 0.313 | 1.612 | 3.737 | 0.354 | 0.862 | 1.829 | 0.957 | 9.929 | 0.604
COVID19 (Custom Term) | Hydrops foetalis | 1 | 0.503 | 0.313 | 1.611 | 3.733 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Exposure to extreme temperature | 1 | 0.525 | 0.313 | 1.611 | 3.734 | 0.402 | 0.976 | 2.075 | 1.905 | 9.929 | 0.604
COVID19 (Custom Term) | Hypoaesthesia teeth | 1 | 0.987 | 0.313 | 1.611 | 3.731 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Ejection fraction abnormal | 1 | 0.988 | 0.313 | 1.611 | 3.733 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Spinal cord injury cervical | 1 | 0.988 | 0.313 | 1.611 | 3.734 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Bradycardia foetal | 1 | 0.995 | 0.313 | 1.611 | 3.733 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Angiogram pulmonary | 1 | 0.995 | 0.313 | 1.611 | 3.733 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Hearing disability | 1 | 0.995 | 0.313 | 1.611 | 3.734 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Alcohol interaction | 1 | 0.995 | 0.313 | 1.611 | 3.734 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Biopsy thyroid gland normal | 1 | 0.995 | 0.313 | 1.611 | 3.734 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Respirovirus test | 2 | 1.361 | 0.452 | 1.61 | 3.346 | 0.463 | 1.013 | 1.994 | 1.469 | 2.837 | 0.612
COVID19 (Custom Term) | Eyeglasses therapy | 1 | 0.993 | 0.314 | 1.61 | 3.729 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Computerised tomogram coronary artery normal | 1 | 0.503 | 0.314 | 1.609 | 3.726 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Neutrophil function test abnormal | 1 | 0.503 | 0.314 | 1.609 | 3.728 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Allergy to synthetic fabric | 1 | 0.054 | 0.314 | 1.608 | 3.722 | 0.458 | 1.148 | 2.557 | 18.64 | 9.929 | 0.604
COVID19 (Custom Term) | Joint contracture | 4 | 3.491 | 0.693 | 1.608 | 2.83 | 0.514 | 0.99 | 1.766 | 1.146 | 1.891 | 0.708
COVID19 (Custom Term) | Intercepted product dispensing error | 1 | 1 | 0.314 | 1.608 | 3.724 | 0.358 | 0.871 | 1.847 | 1 | 9.929 | 0.604
COVID19 (Custom Term) | Palatal disorder | 4 | 4.465 | 0.683 | 1.608 | 2.848 | 0.451 | 0.871 | 1.552 | 0.896 | 4.413 | 4.94
COVID19 (Custom Term) | Allergic respiratory symptom | 2 | 1.52 | 0.508 | 1.607 | 3.204 | 0.448 | 0.981 | 1.93 | 1.315 | 3.972 | 1.27
COVID19 (Custom Term) | Vascular occlusion | 1 | 0.988 | 0.314 | 1.607 | 3.718 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Endoscopic ultrasound abnormal | 1 | 0.988 | 0.314 | 1.607 | 3.717 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Nodal rhythm | 1 | 0.988 | 0.314 | 1.607 | 3.72 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Bone fragmentation | 1 | 0.995 | 0.314 | 1.607 | 3.718 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Osteonecrosis of jaw | 1 | 0.995 | 0.314 | 1.607 | 3.718 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Diaphragmatic paralysis | 2 | 2.357 | 0.508 | 1.607 | 3.206 | 0.384 | 0.842 | 1.655 | 0.849 | 3.972 | 1.27
COVID19 (Custom Term) | Anaesthesia oral | 1 | 0.503 | 0.314 | 1.605 | 3.713 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Pseudomonal bacteraemia | 1 | 0.995 | 0.314 | 1.605 | 3.713 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Instillation site paraesthesia | 1 | 0.995 | 0.314 | 1.605 | 3.713 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Abdominal symptom | 1 | 1.009 | 0.314 | 1.605 | 3.711 | 0.357 | 0.869 | 1.844 | 0.991 | 9.929 | 0.604
COVID19 (Custom Term) | Haemodynamic instability | 2 | 2.116 | 0.422 | 1.605 | 3.409 | 0.401 | 0.878 | 1.725 | 0.945 | 2.482 | 0.412
COVID19 (Custom Term) | Gastric volvulus | 1 | 0.953 | 0.272 | 1.604 | 3.849 | 0.362 | 0.88 | 1.867 | 1.049 | 4.965 | 0.204
COVID19 (Custom Term) | Intermittent claudication | 1 | 0.987 | 0.176 | 1.604 | 4.235 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Cystatin C increased | 1 | 0.991 | 0.314 | 1.604 | 3.71 | 0.359 | 0.873 | 1.851 | 1.009 | 9.929 | 0.604
COVID19 (Custom Term) | Nasal septum deviation | 1 | 0.503 | 0.315 | 1.603 | 3.705 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | High density lipoprotein decreased | 4 | 3.106 | 0.624 | 1.603 | 2.949 | 0.543 | 1.047 | 1.868 | 1.288 | 2.206 | 1.209
COVID19 (Custom Term) | Angioplasty | 5 | 5.329 | 0.757 | 1.603 | 2.703 | 0.487 | 0.898 | 1.547 | 0.938 | 8.274 | 13.348
COVID19 (Custom Term) | Halo vision | 2 | 1.646 | 0.509 | 1.602 | 3.191 | 0.437 | 0.958 | 1.882 | 1.215 | 3.972 | 1.27
COVID19 (Custom Term) | Mediastinitis | 1 | 0.993 | 0.315 | 1.602 | 3.701 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Venogram abnormal | 1 | 0.995 | 0.315 | 1.602 | 3.701 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Superior sagittal sinus thrombosis | 1 | 0.995 | 0.315 | 1.602 | 3.701 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Uterine contractions abnormal | 1 | 0.995 | 0.315 | 1.602 | 3.703 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Anterograde amnesia | 1 | 0.503 | 0.315 | 1.601 | 3.699 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Contrast media allergy | 1 | 0.995 | 0.315 | 1.601 | 3.698 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Oesophageal stenosis | 1 | 0.995 | 0.315 | 1.601 | 3.699 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Blood pressure orthostatic | 1 | 0.057 | 0.273 | 1.599 | 3.83 | 0.458 | 1.146 | 2.548 | 17.641 | 4.965 | 0.204
COVID19 (Custom Term) | Breath sounds | 1 | 0.503 | 0.316 | 1.598 | 3.686 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Pneumonia klebsiella | 1 | 0.987 | 0.316 | 1.598 | 3.686 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary calcification | 1 | 0.988 | 0.316 | 1.598 | 3.686 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Biliary catheter insertion | 1 | 0.988 | 0.316 | 1.598 | 3.686 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Haemarthrosis | 1 | 0.988 | 0.316 | 1.598 | 3.686 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Sputum abnormal | 2 | 1.982 | 0.534 | 1.598 | 3.122 | 0.41 | 0.899 | 1.767 | 1.009 | 4.965 | 1.813
COVID19 (Custom Term) | Electrocardiogram Q wave abnormal | 1 | 0.993 | 0.316 | 1.598 | 3.686 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Retinal infarction | 1 | 0.993 | 0.316 | 1.598 | 3.686 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Intra-abdominal haemorrhage | 1 | 0.999 | 0.316 | 1.598 | 3.686 | 0.358 | 0.871 | 1.848 | 1.001 | 9.929 | 0.604
COVID19 (Custom Term) | Rash pustular | 9 | 9.137 | 0.86 | 1.598 | 2.522 | 0.575 | 0.944 | 1.479 | 0.985 | 0.272 | 16.356
COVID19 (Custom Term) | Otic examination normal | 1 | 1.49 | 0.316 | 1.598 | 3.686 | 0.321 | 0.785 | 1.666 | 0.671 | 9.929 | 0.604
COVID19 (Custom Term) | Paroxysmal sympathetic hyperactivity | 1 | 1.855 | 0.316 | 1.598 | 3.686 | 0.297 | 0.73 | 1.554 | 0.539 | 9.929 | 0.604
COVID19 (Custom Term) | Blood potassium increased | 19 | 18.173 | 1.062 | 1.596 | 2.218 | 0.704 | 1.011 | 1.416 | 1.046 | 1.485 | 2.179
COVID19 (Custom Term) | Skin maceration | 1 | 0.953 | 0.316 | 1.596 | 3.681 | 0.362 | 0.88 | 1.867 | 1.049 | 9.929 | 0.604
COVID19 (Custom Term) | Blood insulin | 1 | 0.988 | 0.316 | 1.596 | 3.681 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Visual snow syndrome | 1 | 0.995 | 0.316 | 1.596 | 3.681 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Intervertebral disc operation | 1 | 1.049 | 0.316 | 1.596 | 3.68 | 0.354 | 0.862 | 1.827 | 0.953 | 9.929 | 0.604
COVID19 (Custom Term) | Peptostreptococcus infection | 1 | 0.988 | 0.316 | 1.595 | 3.678 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Blood pressure orthostatic increased | 1 | 0.503 | 0.316 | 1.594 | 3.674 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Interleukin level | 3 | 2.824 | 0.469 | 1.594 | 3.26 | 0.46 | 0.938 | 1.744 | 1.062 | 0.961 | 0.054
COVID19 (Custom Term) | Illiteracy | 1 | 0.987 | 0.316 | 1.594 | 3.674 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Masticatory pain | 1 | 0.987 | 0.316 | 1.594 | 3.674 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Irregular sleep phase | 1 | 0.988 | 0.316 | 1.594 | 3.674 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Progesterone | 1 | 0.995 | 0.316 | 1.594 | 3.674 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Neonatal exposures via breast milk (SMQ) [broad] | 19 | 15.644 | 1.049 | 1.593 | 2.228 | 0.796 | 1.144 | 1.603 | 1.215 | 3.699 | 25.147
COVID19 (Custom Term) | Neonatal exposures via breast milk (SMQ) [narrow] | 19 | 15.644 | 1.049 | 1.593 | 2.228 | 0.796 | 1.144 | 1.603 | 1.215 | 3.699 | 25.147
COVID19 (Custom Term) | Complement factor C4 decreased | 1 | 1.064 | 0.172 | 1.593 | 4.218 | 0.353 | 0.859 | 1.821 | 0.94 | 0.414 | 0.298
COVID19 (Custom Term) | Lumbar spinal stenosis | 2 | 2.117 | 0.483 | 1.593 | 3.225 | 0.4 | 0.878 | 1.725 | 0.945 | 3.31 | 0.887
COVID19 (Custom Term) | Protein albumin ratio normal | 1 | 0.988 | 0.317 | 1.592 | 3.668 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Intra-aortic balloon placement | 1 | 0.993 | 0.317 | 1.592 | 3.667 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Right ventricular ejection fraction decreased | 1 | 0.993 | 0.317 | 1.592 | 3.668 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Procalcitonin normal | 6 | 6.527 | 0.737 | 1.592 | 2.711 | 0.501 | 0.891 | 1.49 | 0.919 | 1.295 | 0.127
COVID19 (Custom Term) | Gout | 10 | 9.487 | 0.902 | 1.591 | 2.437 | 0.618 | 0.995 | 1.534 | 1.054 | 1.805 | 2.336
COVID19 (Custom Term) | Legionella test | 6 | 5.934 | 0.752 | 1.591 | 2.681 | 0.532 | 0.946 | 1.583 | 1.011 | 3.504 | 6.031
COVID19 (Custom Term) | Herpes zoster reactivation | 1 | 0.993 | 0.317 | 1.589 | 3.657 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Self-medication | 1 | 0.995 | 0.317 | 1.589 | 3.656 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Overgrowth fungal | 1 | 0.995 | 0.317 | 1.589 | 3.657 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Surgical procedure repeated | 1 | 1.049 | 0.317 | 1.589 | 3.656 | 0.354 | 0.862 | 1.827 | 0.953 | 9.929 | 0.604
COVID19 (Custom Term) | Cor pulmonale | 1 | 1.056 | 0.317 | 1.589 | 3.656 | 0.354 | 0.86 | 1.825 | 0.947 | 9.929 | 0.604
COVID19 (Custom Term) | Ultrasound thyroid | 2 | 2.547 | 0.455 | 1.589 | 3.281 | 0.372 | 0.816 | 1.604 | 0.785 | 2.837 | 0.612
COVID19 (Custom Term) | Retinal deposits | 1 | 0.987 | 0.318 | 1.588 | 3.653 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Bladder transitional cell carcinoma | 1 | 0.988 | 0.318 | 1.588 | 3.653 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Cardiac failure | 27 | 27.348 | 1.13 | 1.588 | 2.111 | 0.712 | 0.97 | 1.297 | 0.987 | 2.883 | 24.157
COVID19 (Custom Term) | Aortitis | 1 | 1.49 | 0.318 | 1.588 | 3.653 | 0.321 | 0.785 | 1.666 | 0.671 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary sarcoidosis | 1 | 0.027 | 0.318 | 1.587 | 3.648 | 0.463 | 1.174 | 2.666 | 37.25 | 9.929 | 0.604
COVID19 (Custom Term) | Tachycardia foetal | 1 | 0.892 | 0.318 | 1.587 | 3.651 | 0.367 | 0.893 | 1.893 | 1.121 | 9.929 | 0.604
COVID19 (Custom Term) | Shortened cervix | 1 | 0.995 | 0.318 | 1.587 | 3.65 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Fat tissue increased | 1 | 1.014 | 0.318 | 1.587 | 3.65 | 0.357 | 0.868 | 1.842 | 0.986 | 9.929 | 0.604
COVID19 (Custom Term) | Coronary artery occlusion | 9 | 8.271 | 0.89 | 1.586 | 2.445 | 0.617 | 1.013 | 1.587 | 1.088 | 22.341 | 49.458
COVID19 (Custom Term) | Body fluid analysis | 2 | 1.977 | 0.484 | 1.586 | 3.205 | 0.411 | 0.9 | 1.769 | 1.012 | 3.31 | 0.887
COVID19 (Custom Term) | Dental examination normal | 2 | 1.498 | 0.51 | 1.585 | 3.14 | 0.45 | 0.986 | 1.938 | 1.335 | 3.972 | 1.27
COVID19 (Custom Term) | Magnetic resonance imaging thoracic abnormal | 5 | 5.006 | 0.732 | 1.585 | 2.701 | 0.505 | 0.932 | 1.605 | 0.999 | 3.103 | 3.809
COVID19 (Custom Term) | Intervertebral disc degeneration | 5 | 4.174 | 0.669 | 1.583 | 2.81 | 0.56 | 1.032 | 1.777 | 1.198 | 1.211 | 0.022
COVID19 (Custom Term) | Orthostatic hypotension | 23 | 18.583 | 1.088 | 1.582 | 2.152 | 0.841 | 1.173 | 1.601 | 1.238 | 3.31 | 25.938
COVID19 (Custom Term) | Heart valve incompetence | 1 | 0.995 | 0.276 | 1.582 | 3.771 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Blood bilirubin normal | 36 | 33.325 | 1.18 | 1.581 | 2.029 | 0.807 | 1.057 | 1.365 | 1.08 | 2.008 | 14.256
COVID19 (Custom Term) | Sports injury | 1 | 0.993 | 0.319 | 1.581 | 3.626 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Spinal nerve stimulator implantation | 1 | 0.953 | 0.319 | 1.58 | 3.624 | 0.362 | 0.88 | 1.867 | 1.049 | 9.929 | 0.604
COVID19 (Custom Term) | Aortic valve stenosis | 1 | 0.988 | 0.319 | 1.58 | 3.624 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | VIIIth nerve injury | 1 | 0.993 | 0.319 | 1.58 | 3.624 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary resection | 1 | 0.995 | 0.319 | 1.58 | 3.624 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Band sensation | 1 | 0.995 | 0.319 | 1.58 | 3.623 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Ovarian neoplasms, malignant and unspecified (SMQ) [broad] | 3 | 3.027 | 0.548 | 1.58 | 3.046 | 0.446 | 0.909 | 1.69 | 0.991 | 1.489 | 0.082
COVID19 (Custom Term) | Cardiac ablation | 2 | 2.358 | 0.511 | 1.579 | 3.124 | 0.384 | 0.842 | 1.655 | 0.848 | 3.972 | 1.27
COVID19 (Custom Term) | Plantar erythema | 1 | 0.987 | 0.32 | 1.578 | 3.616 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Aortic valve calcification | 1 | 0.11 | 0.32 | 1.577 | 3.615 | 0.45 | 1.112 | 2.427 | 9.063 | 9.929 | 0.604
COVID19 (Custom Term) | Amphetamines positive | 1 | 0.503 | 0.32 | 1.577 | 3.613 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Blood grouping | 1 | 0.987 | 0.32 | 1.577 | 3.615 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Fungal disease carrier | 1 | 0.988 | 0.32 | 1.577 | 3.615 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Cardiac septal hypertrophy | 1 | 0.988 | 0.32 | 1.577 | 3.613 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Full blood count decreased | 1 | 0.993 | 0.32 | 1.577 | 3.615 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Atypical mycobacterial infection | 1 | 0.993 | 0.32 | 1.577 | 3.613 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Creatinine renal clearance normal | 1 | 0.993 | 0.32 | 1.577 | 3.615 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Panophthalmitis | 1 | 0.995 | 0.32 | 1.577 | 3.615 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Patient uncooperative | 1 | 0.995 | 0.32 | 1.577 | 3.613 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Prostate cancer metastatic | 1 | 1.015 | 0.32 | 1.577 | 3.615 | 0.357 | 0.868 | 1.841 | 0.985 | 9.929 | 0.604
COVID19 (Custom Term) | Increased viscosity of upper respiratory secretion | 3 | 1.736 | 0.572 | 1.576 | 2.984 | 0.555 | 1.13 | 2.108 | 1.728 | 2.291 | 0.807
COVID19 (Custom Term) | Hypokalaemia | 23 | 20.99 | 1.09 | 1.576 | 2.135 | 0.759 | 1.058 | 1.444 | 1.096 | 4.392 | 39.232
COVID19 (Custom Term) | Auscultation | 1 | 0.995 | 0.32 | 1.576 | 3.611 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Vocal cord disorder | 4 | 3.871 | 0.613 | 1.575 | 2.898 | 0.488 | 0.94 | 1.676 | 1.033 | 4.965 | 5.784
COVID19 (Custom Term) | Comminuted fracture | 1 | 0.054 | 0.32 | 1.574 | 3.604 | 0.458 | 1.148 | 2.557 | 18.64 | 9.929 | 0.604
COVID19 (Custom Term) | Ovarian necrosis | 1 | 0.995 | 0.32 | 1.574 | 3.602 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Infusion site warmth | 1 | 0.503 | 0.32 | 1.573 | 3.6 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Arteriovenous fistula operation | 1 | 0.988 | 0.321 | 1.573 | 3.599 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Multipathogen PCR test | 1 | 0.995 | 0.32 | 1.573 | 3.6 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Ischaemic colitis (SMQ) [narrow] | 8 | 8.91 | 0.82 | 1.571 | 2.52 | 0.524 | 0.881 | 1.407 | 0.898 | 1.37 | 0.389
COVID19 (Custom Term) | Cranial nerve paralysis | 2 | 2.49 | 0.457 | 1.571 | 3.226 | 0.375 | 0.824 | 1.619 | 0.803 | 2.837 | 0.612
COVID19 (Custom Term) | Septic encephalopathy | 1 | 0.987 | 0.279 | 1.57 | 3.725 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Biliary neoplasms malignant and unspecified (SMQ) [narrow] | 1 | 0.988 | 0.279 | 1.57 | 3.725 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Biliary neoplasms malignant and unspecified (SMQ) [broad] | 1 | 0.988 | 0.279 | 1.57 | 3.725 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Lung carcinoma cell type unspecified stage IV | 1 | 1.014 | 0.321 | 1.57 | 3.588 | 0.357 | 0.868 | 1.842 | 0.986 | 9.929 | 0.604
COVID19 (Custom Term) | Cardiopulmonary failure | 2 | 1.022 | 0.403 | 1.569 | 3.356 | 0.497 | 1.09 | 2.15 | 1.958 | 1.655 | 0.041
COVID19 (Custom Term) | Wheelchair user | 22 | 18.609 | 1.071 | 1.569 | 2.146 | 0.802 | 1.126 | 1.546 | 1.182 | 0.809 | 0.733
COVID19 (Custom Term) | Functional lactation disorders (SMQ) [broad] | 14 | 12.585 | 0.97 | 1.569 | 2.286 | 0.695 | 1.051 | 1.539 | 1.112 | 6.619 | 36.451
COVID19 (Custom Term) | Functional lactation disorders (SMQ) [narrow] | 14 | 12.585 | 0.97 | 1.569 | 2.286 | 0.695 | 1.051 | 1.539 | 1.112 | 6.619 | 36.451
COVID19 (Custom Term) | Urine osmolarity normal | 1 | 0.987 | 0.321 | 1.569 | 3.587 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Stenotrophomonas infection | 1 | 0.988 | 0.321 | 1.569 | 3.585 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Cholangiocarcinoma | 1 | 0.988 | 0.321 | 1.569 | 3.587 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Biliary malignant tumours (SMQ) [narrow] | 1 | 0.988 | 0.321 | 1.569 | 3.587 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Cerebral microhaemorrhage | 1 | 0.988 | 0.321 | 1.569 | 3.587 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Blood bilirubin unconjugated | 1 | 0.988 | 0.321 | 1.569 | 3.587 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Biliary malignant tumours (SMQ) [broad] | 1 | 0.988 | 0.321 | 1.569 | 3.587 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Thrombophlebitis superficial | 1 | 0.995 | 0.321 | 1.569 | 3.587 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Analgesic drug level decreased | 1 | 0.995 | 0.321 | 1.569 | 3.585 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Coccidioidomycosis | 1 | 1.007 | 0.321 | 1.569 | 3.587 | 0.358 | 0.87 | 1.844 | 0.993 | 9.929 | 0.604
COVID19 (Custom Term) | Lower urinary tract symptoms | 1 | 1.015 | 0.321 | 1.569 | 3.585 | 0.357 | 0.868 | 1.841 | 0.985 | 9.929 | 0.604
COVID19 (Custom Term) | Therapy change | 1 | 0.503 | 0.279 | 1.568 | 3.719 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Blood creatine phosphokinase decreased | 1 | 0.503 | 0.194 | 1.568 | 4.037 | 0.404 | 0.981 | 2.088 | 1.988 | 0.414 | 0.298
COVID19 (Custom Term) | Reaction to excipient | 2 | 2.172 | 0.317 | 1.568 | 3.596 | 0.397 | 0.869 | 1.708 | 0.921 | 0.146 | 8.943
COVID19 (Custom Term) | Spinal cord lipoma | 1 | 0.988 | 0.322 | 1.567 | 3.578 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Mediastinal disorder | 1 | 0.988 | 0.322 | 1.566 | 3.576 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Angiopathy | 1 | 0.563 | 0.199 | 1.565 | 4.01 | 0.398 | 0.967 | 2.054 | 1.777 | 0.292 | 0.996
COVID19 (Custom Term) | Biopsy heart abnormal | 1 | 0.987 | 0.322 | 1.565 | 3.573 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Diabetic complication | 1 | 0.925 | 0.322 | 1.564 | 3.567 | 0.365 | 0.886 | 1.879 | 1.081 | 9.929 | 0.604
COVID19 (Custom Term) | Red blood cell count decreased | 39 | 36.044 | 1.18 | 1.563 | 1.991 | 0.817 | 1.06 | 1.356 | 1.082 | 1.936 | 13.934
COVID19 (Custom Term) | Caffeine consumption | 1 | 0.993 | 0.323 | 1.563 | 3.564 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Sickle cell anaemia with crisis | 2 | 2.066 | 0.388 | 1.563 | 3.378 | 0.404 | 0.886 | 1.741 | 0.968 | 1.805 | 0.089
COVID19 (Custom Term) | Breast mass | 5 | 4.477 | 0.66 | 1.562 | 2.774 | 0.539 | 0.993 | 1.71 | 1.117 | 2.92 | 3.383
COVID19 (Custom Term) | Urinary tract disorder | 1 | 0.892 | 0.245 | 1.562 | 3.819 | 0.367 | 0.893 | 1.893 | 1.121 | 0.473 | 0.144
COVID19 (Custom Term) | Hepatitis A antibody | 1 | 0.995 | 0.234 | 1.562 | 3.859 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Diarrhoea haemorrhagic | 22 | 22.135 | 1.068 | 1.562 | 2.133 | 0.692 | 0.972 | 1.335 | 0.994 | 0.95 | 0.015
COVID19 (Custom Term) | Facet joint syndrome | 2 | 2.045 | 0.512 | 1.562 | 3.074 | 0.406 | 0.889 | 1.747 | 0.978 | 3.972 | 1.27
COVID19 (Custom Term) | Gastrointestinal scan | 1 | 0.987 | 0.323 | 1.56 | 3.554 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Anembryonic gestation | 1 | 0.995 | 0.185 | 1.56 | 4.054 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Cardiac fibrillation | 2 | 1.92 | 0.513 | 1.559 | 3.065 | 0.415 | 0.909 | 1.787 | 1.041 | 3.972 | 1.27
COVID19 (Custom Term) | Subdural haematoma evacuation | 1 | 0.988 | 0.323 | 1.559 | 3.551 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Rectal tenesmus | 1 | 0.998 | 0.178 | 1.559 | 4.083 | 0.358 | 0.871 | 1.848 | 1.002 | 1.986 | 0.005
COVID19 (Custom Term) | Hyperaesthesia teeth | 3 | 2.562 | 0.504 | 1.558 | 3.081 | 0.48 | 0.977 | 1.819 | 1.171 | 2.482 | 1.02
COVID19 (Custom Term) | Hepatic enzyme abnormal | 2 | 2.419 | 0.459 | 1.558 | 3.187 | 0.38 | 0.834 | 1.638 | 0.827 | 2.837 | 0.612
COVID19 (Custom Term) | Nitrite urine | 1 | 0.993 | 0.324 | 1.557 | 3.544 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Ejection fraction decreased | 23 | 22.479 | 1.072 | 1.556 | 2.114 | 0.715 | 0.998 | 1.362 | 1.023 | 5.075 | 46.887
COVID19 (Custom Term) | Audiogram normal | 2 | 1.987 | 0.487 | 1.556 | 3.116 | 0.41 | 0.899 | 1.766 | 1.007 | 3.31 | 0.887
COVID19 (Custom Term) | Von Willebrand's factor antigen increased | 1 | 0.995 | 0.324 | 1.556 | 3.539 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Troponin T increased | 3 | 3.423 | 0.474 | 1.556 | 3.144 | 0.42 | 0.857 | 1.595 | 0.876 | 1.241 | 0
COVID19 (Custom Term) | Pleurodesis | 1 | 0.995 | 0.324 | 1.555 | 3.538 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Fasciitis | 3 | 2.839 | 0.608 | 1.554 | 2.852 | 0.459 | 0.935 | 1.74 | 1.057 | 1.752 | 0.27
COVID19 (Custom Term) | Ear, nose and throat examination abnormal | 1 | 0.995 | 0.32 | 1.554 | 3.545 | 0.359 | 0.872 | 1.849 | 1.005 | 0.903 | 0.162
COVID19 (Custom Term) | Radius fracture | 1 | 0.987 | 0.325 | 1.553 | 3.53 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Intestinal infarction | 1 | 0.99 | 0.325 | 1.553 | 3.528 | 0.359 | 0.873 | 1.852 | 1.01 | 9.929 | 0.604
COVID19 (Custom Term) | Anal hypoaesthesia | 1 | 0.995 | 0.325 | 1.553 | 3.53 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary contusion | 1 | 0.995 | 0.325 | 1.553 | 3.53 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Ventricular enlargement | 1 | 0.996 | 0.325 | 1.553 | 3.528 | 0.359 | 0.872 | 1.849 | 1.004 | 9.929 | 0.604
COVID19 (Custom Term) | Sweating fever | 1 | 0.995 | 0.325 | 1.553 | 3.53 | 0.359 | 0.872 | 1.849 | 1.005 | 9.929 | 0.604
COVID19 (Custom Term) | Embolic cerebellar infarction | 1 | 1.044 | 0.325 | 1.553 | 3.53 | 0.355 | 0.863 | 1.829 | 0.958 | 9.929 | 0.604
COVID19 (Custom Term) | Internal haemorrhage | 5 | 5.344 | 0.682 | 1.553 | 2.711 | 0.486 | 0.897 | 1.544 | 0.936 | 7.092 | 11.603
COVID19 (Custom Term) | Polychromasia | 2 | 2.041 | 0.487 | 1.552 | 3.102 | 0.406 | 0.89 | 1.749 | 0.98 | 3.31 | 0.887
COVID19 (Custom Term) | Adjusted calcium increased | 1 | 0.988 | 0.325 | 1.551 | 3.522 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Vulvovaginal rash | 2 | 1.982 | 0.46 | 1.55 | 3.161 | 0.41 | 0.899 | 1.767 | 1.009 | 2.837 | 0.612
COVID19 (Custom Term) | Withdrawal syndrome | 1 | 0.987 | 0.325 | 1.549 | 3.514 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Blood heavy metal abnormal | 1 | 0.988 | 0.283 | 1.549 | 3.646 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Intra-uterine contraceptive device removal | 1 | 1.498 | 0.325 | 1.549 | 3.514 | 0.321 | 0.783 | 1.663 | 0.667 | 9.929 | 0.604
COVID19 (Custom Term) | Vaccination site urticaria | 2 | 1.948 | 0.459 | 1.548 | 3.156 | 0.413 | 0.905 | 1.778 | 1.026 | 1.655 | 0.041
COVID19 (Custom Term) | Serum ferritin increased | 17 | 16.808 | 1.002 | 1.548 | 2.191 | 0.67 | 0.981 | 1.396 | 1.011 | 3.31 | 18.693
COVID19 (Custom Term) | Lipoprotein (a) | 1 | 0.993 | 0.326 | 1.547 | 3.507 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Dyslipidaemia | 2 | 2.989 | 0.46 | 1.547 | 3.151 | 0.346 | 0.761 | 1.496 | 0.669 | 2.837 | 0.612
COVID19 (Custom Term) | Hypervigilance | 1 | 0.503 | 0.326 | 1.546 | 3.505 | 0.404 | 0.981 | 2.088 | 1.988 | 9.929 | 0.604
COVID19 (Custom Term) | Computerised tomogram pancreas abnormal | 1 | 0.878 | 0.326 | 1.546 | 3.505 | 0.369 | 0.896 | 1.9 | 1.14 | 9.929 | 0.604
COVID19 (Custom Term) | Pelvic girdle pain | 1 | 0.878 | 0.326 | 1.546 | 3.505 | 0.369 | 0.896 | 1.9 | 1.14 | 9.929 | 0.604
COVID19 (Custom Term) | Thoracic vertebral fracture | 1 | 0.987 | 0.326 | 1.546 | 3.505 | 0.359 | 0.874 | 1.853 | 1.013 | 9.929 | 0.604
COVID19 (Custom Term) | Blast cell crisis | 1 | 0.988 | 0.326 | 1.546 | 3.503 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Vascular graft | 1 | 0.988 | 0.326 | 1.546 | 3.505 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Pulmonary imaging procedure abnormal | 1 | 0.988 | 0.326 | 1.546 | 3.505 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Coxsackie virus test | 2 | 1.987 | 0.488 | 1.546 | 3.084 | 0.41 | 0.899 | 1.766 | 1.007 | 3.31 | 0.887
COVID19 (Custom Term) | Abortion missed | 2 | 1.991 | 0.46 | 1.546 | 3.151 | 0.41 | 0.898 | 1.764 | 1.005 | 2.837 | 0.612
COVID19 (Custom Term) | Glycosylated haemoglobin increased | 8 | 8.01 | 0.826 | 1.546 | 2.449 | 0.565 | 0.949 | 1.516 | 0.999 | 1.765 | 1.595
COVID19 (Custom Term) | Large intestinal obstruction | 1 | 1.041 | 0.326 | 1.546 | 3.505 | 0.355 | 0.863 | 1.831 | 0.961 | 9.929 | 0.604
COVID19 (Custom Term) | Peripheral embolism | 1 | 1.056 | 0.326 | 1.546 | 3.505 | 0.354 | 0.86 | 1.825 | 0.947 | 9.929 | 0.604
COVID19 (Custom Term) | Impaired self-care | 1 | 0.988 | 0.326 | 1.545 | 3.501 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Synovial fluid analysis | 1 | 0.988 | 0.326 | 1.545 | 3.5 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Overweight | 2 | 1.991 | 0.488 | 1.545 | 3.082 | 0.41 | 0.898 | 1.764 | 1.005 | 3.31 | 0.887
COVID19 (Custom Term) | Biopsy stomach | 1 | 0.995 | 0.239 | 1.542 | 3.779 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Meningioma | 2 | 2.051 | 0.514 | 1.542 | 3.015 | 0.405 | 0.888 | 1.745 | 0.975 | 3.972 | 1.27
COVID19 (Custom Term) | Nail bed disorder | 1 | 0.572 | 0.327 | 1.541 | 3.487 | 0.397 | 0.964 | 2.049 | 1.749 | 9.929 | 0.604
COVID19 (Custom Term) | Manufacturing product shipping issue | 2 | 1.964 | 0.431 | 1.541 | 3.207 | 0.412 | 0.902 | 1.773 | 1.018 | 2.482 | 0.412
COVID19 (Custom Term) | Neutrophil toxic granulation present | 1 | 0.988 | 0.328 | 1.537 | 3.473 | 0.359 | 0.873 | 1.852 | 1.012 | 9.929 | 0.604
COVID19 (Custom Term) | Red blood cell burr cells present | 1 | 0.991 | 0.328 | 1.537 | 3.473 | 0.359 | 0.873 | 1.851 | 1.009 | 9.929 | 0.604
COVID19 (Custom Term) | Vulvovaginal candidiasis | 1 | 1.498 | 0.24 | 1.537 | 3.76 | 0.321 | 0.783 | 1.663 | 0.667 | 3.31 | 0.054
COVID19 (Custom Term) | Coccydynia | 2 | 1.927 | 0.524 | 1.536 | 2.98 | 0.415 | 0.908 | 1.785 | 1.038 | 1.418 | 0.001
COVID19 (Custom Term) | Bile duct stone | 1 | 0.993 | 0.328 | 1.536 | 3.47 | 0.359 | 0.872 | 1.85 | 1.007 | 9.929 | 0.604
COVID19 (Custom Term) | Autoimmune demyelinating disease | 1 | 0.995 | 0.087 | 1.536 | 4.535 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Blast cells present | 2 | 1.984 | 0.462 | 1.535 | 3.116 | 0.41 | 0.899 | 1.767 | 1.008 | 2.837 | 0.612
COVID19 (Custom Term) | Scan abdomen abnormal | 1 | 0.953 | 0.191 | 1.534 | 3.946 | 0.362 | 0.88 | 1.867 | 1.049 | 2.482 | 0.004
COVID19 (Custom Term) | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [narrow] | 30 | 24.74 | 1.108 | 1.533 | 2.014 | 0.868 | 1.165 | 1.537 | 1.213 | 4.195 | 48.899
COVID19 (Custom Term) | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [broad] | 30 | 24.74 | 1.108 | 1.533 | 2.014 | 0.868 | 1.165 | 1.537 | 1.213 | 4.195 | 48.899
COVID19 (Custom Term) | Neisseria test | 2 | 1.379 | 0.462 | 1.532 | 3.108 | 0.461 | 1.01 | 1.986 | 1.451 | 2.837 | 0.612
COVID19 (Custom Term) | Bronchoscopy abnormal | 2 | 2.067 | 0.449 | 1.532 | 3.137 | 0.404 | 0.886 | 1.74 | 0.967 | 1.168 | 0.036
COVID19 (Custom Term) | Pericardial effusion | 26 | 29.12 | 1.08 | 1.529 | 2.041 | 0.648 | 0.887 | 1.191 | 0.893 | 3.268 | 28.947
COVID19 (Custom Term) | Computerised tomogram thorax abnormal | 58 | 57.867 | 1.217 | 1.528 | 1.869 | 0.801 | 0.993 | 1.219 | 1.002 | 3.865 | 86.463
COVID19 (Custom Term) | Basophil count decreased | 9 | 8.903 | 0.818 | 1.527 | 2.414 | 0.586 | 0.961 | 1.507 | 1.011 | 0.662 | 1.129
COVID19 (Custom Term) | Insulin resistance | 1 | 0.993 | 0.126 | 1.525 | 4.241 | 0.359 | 0.872 | 1.85 | 1.007 | 1.655 | 0.034
COVID19 (Custom Term) | T-lymphocyte count | 1 | 1.022 | 0.128 | 1.525 | 4.228 | 0.356 | 0.867 | 1.838 | 0.978 | 0.414 | 0.298
COVID19 (Custom Term) | Respiratory tract oedema | 1 | 0.503 | 0.259 | 1.524 | 3.655 | 0.404 | 0.981 | 2.088 | 1.988 | 0.827 | 0.089
COVID19 (Custom Term) | Blood lactic acid decreased | 10 | 7.17 | 0.848 | 1.524 | 2.361 | 0.751 | 1.209 | 1.864 | 1.395 | 11.032 | 38.144
COVID19 (Custom Term) | Prohormone brain natriuretic peptide increased | 1 | 0.993 | 0.289 | 1.524 | 3.554 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Type V hyperlipidaemia | 1 | 1.127 | 0.194 | 1.524 | 3.905 | 0.348 | 0.847 | 1.796 | 0.887 | 2.482 | 0.004
COVID19 (Custom Term) | Hepatic lesion | 1 | 0.993 | 0.148 | 1.523 | 4.117 | 0.359 | 0.872 | 1.85 | 1.007 | 1.986 | 0.005
COVID19 (Custom Term) | Confabulation | 1 | 0.988 | 0.29 | 1.522 | 3.546 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Specific gravity urine increased | 2 | 1.984 | 0.491 | 1.522 | 3.014 | 0.41 | 0.899 | 1.767 | 1.008 | 3.31 | 0.887
COVID19 (Custom Term) | Drug abuse | 1 | 0.993 | 0.29 | 1.522 | 3.548 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Cauda equina syndrome | 1 | 0.995 | 0.29 | 1.521 | 3.543 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Infantile spitting up | 2 | 1.139 | 0.403 | 1.52 | 3.219 | 0.485 | 1.062 | 2.092 | 1.756 | 0.193 | 5.789
COVID19 (Custom Term) | Angina pectoris | 31 | 27.428 | 1.108 | 1.519 | 1.984 | 0.82 | 1.096 | 1.441 | 1.13 | 4.217 | 50.951
COVID19 (Custom Term) | Orthostatic hypertension | 1 | 0.987 | 0.195 | 1.519 | 3.881 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Claustrophobia | 2 | 1.492 | 0.435 | 1.518 | 3.133 | 0.451 | 0.987 | 1.941 | 1.341 | 2.482 | 0.412
COVID19 (Custom Term) | Migraine with aura | 15 | 12.745 | 0.952 | 1.518 | 2.191 | 0.738 | 1.102 | 1.597 | 1.177 | 3.04 | 14.048
COVID19 (Custom Term) | Ventricular tachyarrhythmias (SMQ) [broad] | 79 | 73.133 | 1.25 | 1.518 | 1.808 | 0.888 | 1.069 | 1.277 | 1.08 | 9.121 | 293.231
COVID19 (Custom Term) | Ventricular tachyarrhythmias (SMQ) [narrow] | 79 | 73.133 | 1.25 | 1.518 | 1.808 | 0.888 | 1.069 | 1.277 | 1.08 | 9.121 | 293.231
COVID19 (Custom Term) | Urinary bladder haemorrhage | 1 | 0.988 | 0.291 | 1.518 | 3.533 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Cerebral microangiopathy | 1 | 1.045 | 0.291 | 1.518 | 3.533 | 0.354 | 0.862 | 1.829 | 0.957 | 4.965 | 0.204
COVID19 (Custom Term) | Culture tissue specimen | 1 | 0.987 | 0.291 | 1.517 | 3.527 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Enteritis | 4 | 4.258 | 0.591 | 1.516 | 2.787 | 0.463 | 0.894 | 1.593 | 0.939 | 0.764 | 0.084
COVID19 (Custom Term) | Calculus urinary | 1 | 1.37 | 0.291 | 1.516 | 3.524 | 0.33 | 0.804 | 1.707 | 0.73 | 4.965 | 0.204
COVID19 (Custom Term) | Conduction defects (SMQ) [narrow] | 38 | 36.477 | 1.142 | 1.515 | 1.932 | 0.787 | 1.023 | 1.314 | 1.042 | 4.439 | 67.396
COVID19 (Custom Term) | Conduction defects (SMQ) [broad] | 38 | 36.477 | 1.142 | 1.515 | 1.932 | 0.787 | 1.023 | 1.314 | 1.042 | 4.439 | 67.396
COVID19 (Custom Term) | Biopsy small intestine | 1 | 0.993 | 0.292 | 1.515 | 3.519 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Amniotic fluid volume decreased | 1 | 0.995 | 0.292 | 1.515 | 3.519 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Acidosis | 7 | 6.901 | 0.785 | 1.514 | 2.435 | 0.553 | 0.954 | 1.557 | 1.014 | 3.022 | 5.655
COVID19 (Custom Term) | Mycobacterium tuberculosis complex test | 2 | 1.94 | 0.388 | 1.512 | 3.235 | 0.413 | 0.906 | 1.781 | 1.031 | 1.324 | 0.002
COVID19 (Custom Term) | Treatment noncompliance | 2 | 1.365 | 0.436 | 1.51 | 3.107 | 0.462 | 1.012 | 1.992 | 1.465 | 2.482 | 0.412
COVID19 (Custom Term) | Hypothermia | 15 | 14.411 | 0.945 | 1.51 | 2.183 | 0.669 | 1 | 1.45 | 1.041 | 1.12 | 0.075
COVID19 (Custom Term) | Fracture | 2 | 2.006 | 0.466 | 1.51 | 3.04 | 0.409 | 0.895 | 1.76 | 0.997 | 2.837 | 0.612
COVID19 (Custom Term) | Glucose tolerance test abnormal | 1 | 1.498 | 0.198 | 1.51 | 3.844 | 0.321 | 0.783 | 1.663 | 0.667 | 2.482 | 0.004
COVID19 (Custom Term) | Visceral pain | 1 | 0.995 | 0.293 | 1.509 | 3.497 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Congenital anomaly | 1 | 1.044 | 0.123 | 1.507 | 4.2 | 0.355 | 0.862 | 1.829 | 0.958 | 0.171 | 3.099
COVID19 (Custom Term) | Drug interaction | 2 | 3.629 | 0.327 | 1.507 | 3.389 | 0.314 | 0.693 | 1.363 | 0.551 | 0.348 | 1.713
COVID19 (Custom Term) | Carbon dioxide normal | 30 | 27.863 | 1.098 | 1.506 | 1.967 | 0.782 | 1.049 | 1.385 | 1.077 | 2.979 | 28.693
COVID19 (Custom Term) | Blood ketone body | 2 | 1.985 | 0.467 | 1.504 | 3.019 | 0.41 | 0.899 | 1.766 | 1.007 | 2.837 | 0.612
COVID19 (Custom Term) | Hypertensive urgency | 10 | 7.608 | 0.828 | 1.503 | 2.341 | 0.722 | 1.162 | 1.791 | 1.314 | 99.292 | 78.897
COVID19 (Custom Term) | Progesterone decreased | 1 | 0.995 | 0.173 | 1.503 | 3.926 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Glucose-6-phosphate dehydrogenase abnormal | 1 | 0.995 | 0.295 | 1.503 | 3.475 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Aspergillus test | 1 | 1.914 | 0.294 | 1.503 | 3.476 | 0.294 | 0.722 | 1.537 | 0.523 | 4.965 | 0.204
COVID19 (Custom Term) | CSF culture positive | 1 | 1.022 | 0.145 | 1.502 | 4.061 | 0.356 | 0.867 | 1.838 | 0.978 | 0.195 | 2.456
COVID19 (Custom Term) | Hypervolaemia | 1 | 1.042 | 0.249 | 1.502 | 3.622 | 0.355 | 0.863 | 1.83 | 0.96 | 3.31 | 0.054
COVID19 (Custom Term) | Amniorrhoea | 1 | 0.995 | 0.295 | 1.501 | 3.468 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Coronavirus infection | 3 | 4.346 | 0.513 | 1.501 | 2.907 | 0.371 | 0.757 | 1.409 | 0.69 | 2.482 | 1.02
COVID19 (Custom Term) | Circumoral oedema | 2 | 1.948 | 0.438 | 1.5 | 3.076 | 0.413 | 0.905 | 1.778 | 1.026 | 2.482 | 0.412
COVID19 (Custom Term) | Culture wound positive | 2 | 1.98 | 0.467 | 1.5 | 3.007 | 0.41 | 0.9 | 1.768 | 1.01 | 2.837 | 0.612
COVID19 (Custom Term) | Extubation | 1 | 0.988 | 0.295 | 1.5 | 3.466 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Hepatic encephalopathy | 1 | 0.995 | 0.295 | 1.5 | 3.465 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Pulmonary physical examination | 1 | 0.987 | 0.295 | 1.499 | 3.462 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Anti factor VIII antibody increased | 1 | 0.995 | 0.296 | 1.499 | 3.461 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Pupillary light reflex tests | 1 | 0.995 | 0.296 | 1.498 | 3.457 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Pulse absent | 73 | 73.839 | 1.228 | 1.498 | 1.791 | 0.81 | 0.982 | 1.181 | 0.989 | 9.06 | 269.211
COVID19 (Custom Term) | Retinal vascular occlusion | 1 | 1.98 | 0.296 | 1.497 | 3.454 | 0.29 | 0.713 | 1.519 | 0.505 | 4.965 | 0.204
COVID19 (Custom Term) | Refusal of treatment by relative | 1 | 0.988 | 0.296 | 1.496 | 3.449 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Chronic hepatitis C | 1 | 1.014 | 0.296 | 1.496 | 3.451 | 0.357 | 0.868 | 1.842 | 0.986 | 4.965 | 0.204
COVID19 (Custom Term) | Complement factor C4 increased | 1 | 0.987 | 0.251 | 1.495 | 3.597 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Hyperuricaemia | 1 | 0.988 | 0.297 | 1.495 | 3.447 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Mineral supplementation | 1 | 0.503 | 0.297 | 1.494 | 3.444 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Tongue discolouration | 3 | 2.569 | 0.666 | 1.494 | 2.591 | 0.479 | 0.976 | 1.817 | 1.168 | 0.993 | 0.084
COVID19 (Custom Term) | Ultrasound eye normal | 1 | 0.988 | 0.297 | 1.493 | 3.437 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Hepatic cyst | 2 | 1.98 | 0.44 | 1.493 | 3.054 | 0.41 | 0.9 | 1.768 | 1.01 | 2.482 | 0.412
COVID19 (Custom Term) | Paraneoplastic syndrome | 1 | 0.993 | 0.297 | 1.493 | 3.439 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Lymphocyte count abnormal | 1 | 0.996 | 0.252 | 1.493 | 3.587 | 0.359 | 0.872 | 1.849 | 1.004 | 3.31 | 0.054
COVID19 (Custom Term) | Creatinine renal clearance decreased | 1 | 0.125 | 0.252 | 1.492 | 3.583 | 0.448 | 1.104 | 2.403 | 7.979 | 3.31 | 0.054
COVID19 (Custom Term) | Device breakage | 1 | 0.995 | 0.297 | 1.492 | 3.433 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Superinfection | 2 | 2.011 | 0.496 | 1.492 | 2.922 | 0.408 | 0.895 | 1.758 | 0.995 | 3.31 | 0.887
COVID19 (Custom Term) | Renal replacement therapy | 1 | 1.02 | 0.297 | 1.492 | 3.433 | 0.357 | 0.867 | 1.839 | 0.98 | 4.965 | 0.204
COVID19 (Custom Term) | Near death experience | 5 | 6.853 | 0.632 | 1.492 | 2.648 | 0.416 | 0.767 | 1.321 | 0.73 | 1.342 | 0.124
COVID19 (Custom Term) | Dyshidrotic eczema | 1 | 0.993 | 0.298 | 1.491 | 3.431 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Amniotic membrane rupture test positive | 1 | 0.995 | 0.298 | 1.491 | 3.43 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Psychotherapy | 1 | 1.136 | 0.298 | 1.491 | 3.431 | 0.347 | 0.845 | 1.793 | 0.88 | 4.965 | 0.204
COVID19 (Custom Term) | Laparoscopic surgery | 13 | 12.381 | 0.903 | 1.49 | 2.196 | 0.654 | 1.002 | 1.484 | 1.05 | 6.147 | 31.194
COVID19 (Custom Term) | Pulmonary hypertension | 6 | 5.934 | 0.728 | 1.49 | 2.472 | 0.532 | 0.946 | 1.583 | 1.011 | 3.31 | 5.472
COVID19 (Custom Term) | Thyroxine free abnormal | 1 | 0.995 | 0.298 | 1.49 | 3.428 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Joint vibration | 1 | 0.995 | 0.298 | 1.49 | 3.427 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Enzyme abnormality | 1 | 1.015 | 0.298 | 1.49 | 3.428 | 0.357 | 0.868 | 1.841 | 0.985 | 4.965 | 0.204
COVID19 (Custom Term) | Birth mark | 1 | 0.987 | 0.298 | 1.489 | 3.422 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Pancytopenia | 17 | 17.367 | 0.973 | 1.489 | 2.095 | 0.653 | 0.955 | 1.359 | 0.979 | 4.823 | 31.902
COVID19 (Custom Term) | Retinal ischaemia | 1 | 0.987 | 0.299 | 1.488 | 3.419 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Tumour lysis syndrome (SMQ) [algorithm] | 32 | 31.791 | 1.09 | 1.488 | 1.938 | 0.744 | 0.989 | 1.295 | 1.007 | 3.492 | 40.104
COVID19 (Custom Term) | Vaccination site dysaesthesia | 1 | 0.993 | 0.298 | 1.488 | 3.421 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Orthosis user | 2 | 1.499 | 0.503 | 1.487 | 2.894 | 0.45 | 0.985 | 1.938 | 1.334 | 0.621 | 0.132
COVID19 (Custom Term) | Abscess neck | 1 | 0.995 | 0.299 | 1.487 | 3.415 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Interchange of vaccine products | 21 | 23.036 | 1 | 1.487 | 2.054 | 0.638 | 0.902 | 1.246 | 0.912 | 0.387 | 19.03
COVID19 (Custom Term) | Fasting | 1 | 0.503 | 0.299 | 1.486 | 3.413 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Migraine without aura | 1 | 0.503 | 0.299 | 1.486 | 3.412 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Carbon dioxide | 3 | 2.485 | 0.607 | 1.486 | 2.677 | 0.486 | 0.99 | 1.842 | 1.207 | 3.723 | 2.44
COVID19 (Custom Term) | Freezing phenomenon | 1 | 0.995 | 0.299 | 1.486 | 3.412 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Uterine inflammation | 1 | 0.995 | 0.299 | 1.486 | 3.412 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Foetal non-stress test abnormal | 1 | 0.995 | 0.299 | 1.486 | 3.411 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Arrhythmia supraventricular | 1 | 1.388 | 0.299 | 1.486 | 3.411 | 0.328 | 0.801 | 1.701 | 0.72 | 4.965 | 0.204
COVID19 (Custom Term) | Mixed anxiety and depressive disorder | 1 | 1.637 | 0.299 | 1.486 | 3.411 | 0.311 | 0.762 | 1.619 | 0.611 | 4.965 | 0.204
COVID19 (Custom Term) | Dermatitis psoriasiform | 2 | 1.492 | 0.354 | 1.485 | 3.25 | 0.451 | 0.987 | 1.941 | 1.341 | 1.528 | 0.013
COVID19 (Custom Term) | Brain herniation | 2 | 2.002 | 0.497 | 1.485 | 2.901 | 0.409 | 0.896 | 1.761 | 0.999 | 3.31 | 0.887
COVID19 (Custom Term) | Polymenorrhoea | 1 | 1.052 | 0.136 | 1.485 | 4.057 | 0.354 | 0.861 | 1.826 | 0.951 | 1.655 | 0.034
COVID19 (Custom Term) | Hypoglycaemia (SMQ) [narrow] | 46 | 40.835 | 1.153 | 1.484 | 1.849 | 0.867 | 1.103 | 1.387 | 1.126 | 1.743 | 11.726
COVID19 (Custom Term) | Blood urea increased | 74 | 71.042 | 1.215 | 1.484 | 1.776 | 0.852 | 1.032 | 1.24 | 1.042 | 5.286 | 164.862
COVID19 (Custom Term) | Biliary obstruction | 1 | 0.987 | 0.3 | 1.484 | 3.403 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Ceruloplasmin normal | 1 | 0.995 | 0.254 | 1.484 | 3.552 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Retroperitoneal lymphadenopathy | 1 | 1.05 | 0.3 | 1.484 | 3.405 | 0.354 | 0.861 | 1.827 | 0.952 | 4.965 | 0.204
COVID19 (Custom Term) | Fibrin D dimer normal | 29 | 24.511 | 1.068 | 1.483 | 1.954 | 0.845 | 1.139 | 1.509 | 1.183 | 8.998 | 103.607
COVID19 (Custom Term) | Nasal odour | 1 | 0.987 | 0.3 | 1.482 | 3.396 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Tri-iodothyronine free | 1 | 1.049 | 0.238 | 1.482 | 3.603 | 0.354 | 0.862 | 1.827 | 0.953 | 0.827 | 0.089
COVID19 (Custom Term) | Gastrointestinal sounds abnormal | 4 | 3.06 | 0.597 | 1.481 | 2.684 | 0.547 | 1.055 | 1.881 | 1.307 | 1.135 | 0.001
COVID19 (Custom Term) | Libido decreased | 1 | 0.987 | 0.255 | 1.481 | 3.538 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Bronchial secretion retention | 1 | 0.995 | 0.3 | 1.481 | 3.394 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Hand dermatitis | 1 | 0.503 | 0.301 | 1.48 | 3.391 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Sputum normal | 1 | 0.988 | 0.301 | 1.48 | 3.389 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Tri-iodothyronine free abnormal | 1 | 0.995 | 0.301 | 1.48 | 3.391 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Scan bone marrow normal | 1 | 1.02 | 0.301 | 1.48 | 3.391 | 0.357 | 0.867 | 1.839 | 0.98 | 4.965 | 0.204
COVID19 (Custom Term) | Chorioretinopathy | 1 | 1.02 | 0.301 | 1.48 | 3.39 | 0.357 | 0.867 | 1.839 | 0.98 | 4.965 | 0.204
COVID19 (Custom Term) | Cerebral thrombosis | 1 | 0.987 | 0.301 | 1.479 | 3.387 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Axillary vein thrombosis | 1 | 0.988 | 0.301 | 1.479 | 3.386 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Varices oesophageal | 1 | 0.993 | 0.301 | 1.479 | 3.386 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Lactation disorder | 1 | 1.006 | 0.256 | 1.479 | 3.532 | 0.358 | 0.87 | 1.845 | 0.994 | 3.31 | 0.054
COVID19 (Custom Term) | Histamine level increased | 1 | 0.503 | 0.301 | 1.478 | 3.383 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Haemangioma of skin | 1 | 0.993 | 0.301 | 1.478 | 3.381 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | White blood cell morphology abnormal | 1 | 0.995 | 0.301 | 1.478 | 3.382 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Skin oedema | 1 | 0.616 | 0.258 | 1.477 | 3.518 | 0.393 | 0.954 | 2.025 | 1.623 | 0.473 | 0.144
COVID19 (Custom Term) | Pulmonary embolism | 120 | 118.734 | 1.264 | 1.477 | 1.705 | 0.865 | 1.006 | 1.164 | 1.011 | 20.195 | 715.059
COVID19 (Custom Term) | Total bile acids | 1 | 0.995 | 0.2 | 1.477 | 3.733 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Injection site lymphadenopathy | 12 | 9.354 | 0.867 | 1.476 | 2.216 | 0.745 | 1.159 | 1.737 | 1.283 | 23.83 | 69.985
COVID19 (Custom Term) | Hypoxia | 134 | 131.241 | 1.275 | 1.476 | 1.689 | 0.881 | 1.016 | 1.167 | 1.021 | 13.717 | 657.964
COVID19 (Custom Term) | Pneumococcal sepsis | 1 | 1.093 | 0.119 | 1.476 | 4.123 | 0.351 | 0.853 | 1.81 | 0.915 | 0.191 | 2.547
COVID19 (Custom Term) | Nephropathy | 2 | 2.866 | 0.472 | 1.476 | 2.932 | 0.353 | 0.775 | 1.524 | 0.698 | 2.837 | 0.612
COVID19 (Custom Term) | Unevaluable event | 211 | 157.435 | 1.314 | 1.475 | 1.645 | 1.186 | 1.329 | 1.485 | 1.34 | 2.038 | 91.945
COVID19 (Custom Term) | Phalen's test positive | 1 | 0.995 | 0.302 | 1.475 | 3.369 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Blood bilirubin | 6 | 5.992 | 0.687 | 1.475 | 2.506 | 0.529 | 0.941 | 1.573 | 1.001 | 1.655 | 0.787
COVID19 (Custom Term) | Microbiology test | 2 | 2.351 | 0.498 | 1.475 | 2.87 | 0.384 | 0.843 | 1.657 | 0.851 | 3.31 | 0.887
COVID19 (Custom Term) | Troponin I normal | 10 | 8.716 | 0.827 | 1.474 | 2.272 | 0.657 | 1.057 | 1.63 | 1.147 | 4.513 | 16.239
COVID19 (Custom Term) | Heart sounds abnormal | 2 | 1.993 | 0.461 | 1.474 | 2.952 | 0.409 | 0.898 | 1.764 | 1.003 | 1.168 | 0.036
COVID19 (Custom Term) | Mesenteric vein thrombosis | 1 | 1.05 | 0.302 | 1.474 | 3.368 | 0.354 | 0.861 | 1.827 | 0.952 | 4.965 | 0.204
COVID19 (Custom Term) | Pharyngeal erythema | 16 | 13.99 | 0.942 | 1.473 | 2.102 | 0.731 | 1.081 | 1.552 | 1.144 | 0.662 | 2.254
COVID19 (Custom Term) | Tonsillar haemorrhage | 1 | 0.995 | 0.303 | 1.473 | 3.362 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Slow speech | 5 | 3.443 | 0.646 | 1.472 | 2.57 | 0.618 | 1.139 | 1.963 | 1.452 | 1.601 | 0.486
COVID19 (Custom Term) | Eosinophil count increased | 12 | 11.831 | 0.873 | 1.472 | 2.199 | 0.626 | 0.973 | 1.459 | 1.014 | 0.985 | 0.01
COVID19 (Custom Term) | Megacolon | 1 | 0.992 | 0.303 | 1.472 | 3.361 | 0.359 | 0.873 | 1.85 | 1.008 | 4.965 | 0.204
COVID19 (Custom Term) | Haematoma evacuation | 1 | 0.987 | 0.303 | 1.471 | 3.356 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Menstruation normal | 1 | 0.503 | 0.304 | 1.47 | 3.35 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Nightmare | 20 | 17.842 | 0.995 | 1.47 | 2.021 | 0.753 | 1.073 | 1.493 | 1.121 | 1.551 | 2.887
COVID19 (Custom Term) | Gonorrhoea | 1 | 1.004 | 0.304 | 1.47 | 3.351 | 0.358 | 0.87 | 1.846 | 0.996 | 4.965 | 0.204
COVID19 (Custom Term) | Arterial stenosis | 1 | 0.987 | 0.304 | 1.469 | 3.346 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Renal haemorrhage | 1 | 0.988 | 0.304 | 1.469 | 3.35 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Blood premalignant disorders (SMQ) [narrow] | 3 | 3.368 | 0.565 | 1.469 | 2.717 | 0.424 | 0.864 | 1.607 | 0.891 | 1.354 | 0.022
COVID19 (Custom Term) | Blood premalignant disorders (SMQ) [broad] | 3 | 3.368 | 0.565 | 1.469 | 2.717 | 0.424 | 0.864 | 1.607 | 0.891 | 1.354 | 0.022
COVID19 (Custom Term) | Iris adhesions | 1 | 0.503 | 0.304 | 1.468 | 3.344 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Ankle fracture | 2 | 2.41 | 0.473 | 1.468 | 2.908 | 0.38 | 0.835 | 1.64 | 0.83 | 2.837 | 0.612
COVID19 (Custom Term) | Haematemesis | 16 | 15.259 | 0.947 | 1.467 | 2.079 | 0.682 | 1.008 | 1.448 | 1.049 | 1.805 | 4.144
COVID19 (Custom Term) | Bronchial wall thickening | 1 | 0.988 | 0.232 | 1.467 | 3.582 | 0.359 | 0.873 | 1.852 | 1.012 | 0.764 | 0.041
COVID19 (Custom Term) | Troponin | 105 | 96.48 | 1.24 | 1.466 | 1.708 | 0.919 | 1.079 | 1.261 | 1.088 | 14.089 | 522.165
COVID19 (Custom Term) | Mastocytosis | 1 | 0.925 | 0.21 | 1.466 | 3.66 | 0.365 | 0.886 | 1.879 | 1.081 | 2.482 | 0.004
COVID19 (Custom Term) | Electrocardiogram ambulatory | 25 | 23.033 | 1.031 | 1.465 | 1.962 | 0.764 | 1.052 | 1.42 | 1.085 | 4.004 | 37.837
COVID19 (Custom Term) | Xanthopsia | 1 | 0.953 | 0.305 | 1.465 | 3.333 | 0.362 | 0.88 | 1.867 | 1.049 | 4.965 | 0.204
COVID19 (Custom Term) | International normalised ratio decreased | 6 | 5.931 | 0.703 | 1.465 | 2.451 | 0.532 | 0.947 | 1.583 | 1.012 | 8.511 | 17.195
COVID19 (Custom Term) | Hypertrophic cardiomyopathy | 1 | 0.995 | 0.157 | 1.465 | 3.886 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Akathisia | 1 | 0.533 | 0.109 | 1.464 | 4.14 | 0.401 | 0.974 | 2.071 | 1.877 | 1.655 | 0.034
COVID19 (Custom Term) | Akathisia (SMQ) [narrow] | 1 | 0.533 | 0.109 | 1.464 | 4.14 | 0.401 | 0.974 | 2.071 | 1.877 | 1.655 | 0.034
COVID19 (Custom Term) | Gastric ulcer haemorrhage | 1 | 0.988 | 0.306 | 1.463 | 3.325 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Cognitive linguistic deficit | 1 | 0.995 | 0.306 | 1.463 | 3.324 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Explorative laparotomy | 1 | 0.995 | 0.146 | 1.463 | 3.934 | 0.359 | 0.872 | 1.849 | 1.005 | 0.523 | 0.065
COVID19 (Custom Term) | Biopsy colon | 1 | 0.995 | 0.305 | 1.463 | 3.326 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Pituitary-dependent Cushing's syndrome | 1 | 0.995 | 0.261 | 1.463 | 3.467 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Band neutrophil percentage increased | 2 | 2.072 | 0.46 | 1.463 | 2.924 | 0.404 | 0.885 | 1.739 | 0.965 | 1.168 | 0.036
COVID19 (Custom Term) | Platelet count abnormal | 2 | 2.413 | 0.5 | 1.463 | 2.834 | 0.38 | 0.834 | 1.639 | 0.829 | 3.31 | 0.887
COVID19 (Custom Term) | Osteopenia | 2 | 1.975 | 0.446 | 1.462 | 2.954 | 0.411 | 0.9 | 1.769 | 1.012 | 2.482 | 0.412
COVID19 (Custom Term) | Pancreatic enzymes normal | 1 | 0.995 | 0.306 | 1.462 | 3.321 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Clostridium difficile colitis | 2 | 2.09 | 0.446 | 1.462 | 2.952 | 0.402 | 0.882 | 1.733 | 0.957 | 2.482 | 0.412
COVID19 (Custom Term) | Oxygen saturation normal | 29 | 18.458 | 1.06 | 1.461 | 1.915 | 1.076 | 1.451 | 1.923 | 1.571 | 6.696 | 80.241
COVID19 (Custom Term) | Ileus | 3 | 2.969 | 0.461 | 1.461 | 2.917 | 0.45 | 0.917 | 1.706 | 1.011 | 1.655 | 0.192
COVID19 (Custom Term) | Inflammatory pain | 1 | 0.987 | 0.306 | 1.461 | 3.318 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Substance use | 1 | 1.428 | 0.306 | 1.461 | 3.318 | 0.325 | 0.795 | 1.687 | 0.7 | 4.965 | 0.204
COVID19 (Custom Term) | Hysteroscopy | 1 | 0.503 | 0.306 | 1.46 | 3.314 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Glucose urine present | 2 | 1.975 | 0.511 | 1.46 | 2.804 | 0.411 | 0.9 | 1.769 | 1.012 | 0.764 | 0.002
COVID19 (Custom Term) | Ulnar neuritis | 1 | 0.993 | 0.306 | 1.46 | 3.313 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Urge incontinence | 1 | 0.995 | 0.306 | 1.46 | 3.315 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Product container issue | 1 | 0.638 | 0.12 | 1.459 | 4.061 | 0.391 | 0.948 | 2.014 | 1.566 | 0.171 | 3.099
COVID19 (Custom Term) | Spleen disorder | 2 | 1.989 | 0.501 | 1.459 | 2.821 | 0.41 | 0.898 | 1.765 | 1.006 | 3.31 | 0.887
COVID19 (Custom Term) | Biopsy bone marrow abnormal | 10 | 12.355 | 0.825 | 1.459 | 2.239 | 0.507 | 0.816 | 1.258 | 0.809 | 2.069 | 3.647
COVID19 (Custom Term) | Abdominal injury | 1 | 0.988 | 0.307 | 1.458 | 3.308 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Blood testosterone | 1 | 0.993 | 0.307 | 1.458 | 3.308 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Lipids increased | 1 | 1.02 | 0.307 | 1.458 | 3.308 | 0.357 | 0.867 | 1.839 | 0.98 | 4.965 | 0.204
COVID19 (Custom Term) | Salivary gland pain | 1 | 0.878 | 0.16 | 1.455 | 3.839 | 0.369 | 0.896 | 1.9 | 1.14 | 0.903 | 0.162
COVID19 (Custom Term) | Blood heavy metal test | 2 | 2.651 | 0.368 | 1.455 | 3.125 | 0.365 | 0.802 | 1.577 | 0.755 | 0.993 | 0.13
COVID19 (Custom Term) | Phonophobia | 2 | 1.496 | 0.492 | 1.454 | 2.827 | 0.45 | 0.986 | 1.939 | 1.337 | 0.993 | 0.13
COVID19 (Custom Term) | Postoperative wound infection | 1 | 0.988 | 0.308 | 1.454 | 3.291 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Conjunctivitis allergic | 2 | 1.456 | 0.393 | 1.453 | 3.058 | 0.454 | 0.994 | 1.955 | 1.373 | 1.655 | 0.041
COVID19 (Custom Term) | Laryngoscopy | 2 | 1.987 | 0.502 | 1.453 | 2.805 | 0.41 | 0.899 | 1.766 | 1.007 | 3.31 | 0.887
COVID19 (Custom Term) | Bacteraemia | 5 | 5.061 | 0.587 | 1.453 | 2.63 | 0.502 | 0.926 | 1.595 | 0.988 | 0.482 | 2.139
COVID19 (Custom Term) | Ejection fraction normal | 10 | 10.371 | 0.806 | 1.452 | 2.252 | 0.579 | 0.932 | 1.437 | 0.964 | 3.677 | 12.157
COVID19 (Custom Term) | Asthenopia | 23 | 18.477 | 1.002 | 1.451 | 1.97 | 0.845 | 1.178 | 1.608 | 1.245 | 5.311 | 49.4
COVID19 (Custom Term) | Therapeutic response unexpected | 6 | 5.321 | 0.66 | 1.451 | 2.492 | 0.569 | 1.011 | 1.692 | 1.128 | 0.709 | 0.402
COVID19 (Custom Term) | Appendicectomy | 42 | 40.625 | 1.108 | 1.451 | 1.833 | 0.792 | 1.018 | 1.292 | 1.034 | 6.95 | 122.074
COVID19 (Custom Term) | Haematoma muscle | 1 | 0.557 | 0.309 | 1.45 | 3.276 | 0.399 | 0.968 | 2.057 | 1.796 | 4.965 | 0.204
COVID19 (Custom Term) | Tongue coated | 2 | 0.931 | 0.485 | 1.449 | 2.829 | 0.507 | 1.112 | 2.197 | 2.148 | 1.986 | 0.162
COVID19 (Custom Term) | Sudden visual loss | 3 | 2.408 | 0.565 | 1.449 | 2.664 | 0.492 | 1.003 | 1.866 | 1.246 | 3.31 | 1.971
COVID19 (Custom Term) | Trichoglossia | 1 | 0.11 | 0.31 | 1.448 | 3.27 | 0.45 | 1.112 | 2.427 | 9.063 | 4.965 | 0.204
COVID19 (Custom Term) | Appendicitis (narrow) (Custom Term) | 62 | 60.222 | 1.161 | 1.448 | 1.76 | 0.827 | 1.019 | 1.244 | 1.03 | 10.8 | 259.043
COVID19 (Custom Term) | Urinary casts absent | 1 | 0.995 | 0.31 | 1.448 | 3.268 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Body height decreased | 8 | 8.094 | 0.743 | 1.448 | 2.342 | 0.561 | 0.942 | 1.505 | 0.988 | 11.348 | 30.114
COVID19 (Custom Term) | Cerebellar atrophy | 1 | 1.056 | 0.31 | 1.448 | 3.269 | 0.354 | 0.86 | 1.825 | 0.947 | 4.965 | 0.204
COVID19 (Custom Term) | Blood urea normal | 43 | 36.562 | 1.111 | 1.447 | 1.819 | 0.894 | 1.146 | 1.451 | 1.176 | 1.438 | 4.595
COVID19 (Custom Term) | Chromosomal analysis | 1 | 1.006 | 0.31 | 1.447 | 3.264 | 0.358 | 0.87 | 1.845 | 0.994 | 4.965 | 0.204
COVID19 (Custom Term) | Neutrophil count | 10 | 9.466 | 0.815 | 1.446 | 2.223 | 0.619 | 0.996 | 1.536 | 1.056 | 1.947 | 3.029
COVID19 (Custom Term) | Uterine contractions during pregnancy | 3 | 2.986 | 0.423 | 1.446 | 2.964 | 0.449 | 0.914 | 1.701 | 1.005 | 1.568 | 0.13
COVID19 (Custom Term) | Brain stem haemorrhage | 1 | 0.995 | 0.31 | 1.446 | 3.263 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Device dependence | 1 | 1.099 | 0.311 | 1.446 | 3.262 | 0.35 | 0.852 | 1.807 | 0.91 | 4.965 | 0.204
COVID19 (Custom Term) | Pneumothorax | 4 | 5.894 | 0.626 | 1.446 | 2.541 | 0.383 | 0.739 | 1.318 | 0.679 | 0.969 | 0.039
COVID19 (Custom Term) | Herpes simplex encephalitis | 4 | 4.151 | 0.611 | 1.445 | 2.566 | 0.47 | 0.906 | 1.615 | 0.964 | 3.31 | 3.117
COVID19 (Custom Term) | Brain natriuretic peptide normal | 20 | 18.441 | 0.975 | 1.444 | 1.989 | 0.733 | 1.044 | 1.452 | 1.085 | 7.638 | 61.157
COVID19 (Custom Term) | Fungal infection | 4 | 4.898 | 0.606 | 1.444 | 2.572 | 0.428 | 0.826 | 1.473 | 0.817 | 0.611 | 0.573
COVID19 (Custom Term) | Polyuria | 9 | 8.041 | 0.816 | 1.443 | 2.215 | 0.629 | 1.033 | 1.618 | 1.119 | 2.352 | 4.515
COVID19 (Custom Term) | Platelet transfusion | 24 | 22.109 | 1.004 | 1.443 | 1.947 | 0.758 | 1.051 | 1.426 | 1.086 | 4.413 | 41.305
COVID19 (Custom Term) | Diabetes mellitus | 16 | 16.215 | 0.928 | 1.443 | 2.052 | 0.649 | 0.96 | 1.378 | 0.987 | 1.785 | 3.98
COVID19 (Custom Term) | Troponin I increased | 21 | 21.381 | 0.969 | 1.443 | 1.994 | 0.68 | 0.961 | 1.328 | 0.982 | 2.78 | 17.206
COVID19 (Custom Term) | Pelvic fracture | 1 | 1.042 | 0.267 | 1.443 | 3.388 | 0.355 | 0.863 | 1.83 | 0.96 | 3.31 | 0.054
COVID19 (Custom Term) | Gastrointestinal perforation (SMQ) [broad] | 22 | 22.903 | 0.986 | 1.442 | 1.97 | 0.672 | 0.944 | 1.296 | 0.961 | 3.641 | 28.75
COVID19 (Custom Term) | Gastrointestinal perforation (SMQ) [narrow] | 22 | 22.903 | 0.986 | 1.442 | 1.97 | 0.672 | 0.944 | 1.296 | 0.961 | 3.641 | 28.75
COVID19 (Custom Term) | Hyponatraemia/SIADH (SMQ) [narrow] | 59 | 57.519 | 1.151 | 1.441 | 1.756 | 0.82 | 1.015 | 1.244 | 1.026 | 2.421 | 38.341
COVID19 (Custom Term) | Imaging procedure abnormal | 6 | 5.943 | 0.698 | 1.441 | 2.4 | 0.532 | 0.945 | 1.581 | 1.01 | 3.136 | 4.967
COVID19 (Custom Term) | Lumbosacral radiculopathy | 1 | 0.987 | 0.312 | 1.441 | 3.242 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Mastitis | 8 | 8.079 | 0.755 | 1.441 | 2.307 | 0.562 | 0.944 | 1.507 | 0.99 | 4.673 | 13.075
COVID19 (Custom Term) | Nodular rash | 1 | 0.401 | 0.312 | 1.44 | 3.239 | 0.415 | 1.009 | 2.15 | 2.492 | 4.965 | 0.204
COVID19 (Custom Term) | Hilar lymphadenopathy | 1 | 0.993 | 0.313 | 1.439 | 3.234 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | CSF polymorphonuclear cell count increased | 1 | 0.996 | 0.313 | 1.439 | 3.235 | 0.359 | 0.872 | 1.849 | 1.004 | 4.965 | 0.204
COVID19 (Custom Term) | N-terminal prohormone brain natriuretic peptide normal | 1 | 0.503 | 0.313 | 1.438 | 3.23 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Bradycardia | 45 | 41.665 | 1.111 | 1.438 | 1.801 | 0.832 | 1.061 | 1.337 | 1.08 | 1.375 | 3.689
COVID19 (Custom Term) | Poor quality product administered | 3 | 2.923 | 0.483 | 1.438 | 2.806 | 0.453 | 0.923 | 1.717 | 1.026 | 0.677 | 0.164
COVID19 (Custom Term) | Blood chloride decreased | 17 | 17.279 | 0.945 | 1.438 | 2.015 | 0.655 | 0.959 | 1.364 | 0.984 | 4.689 | 30.814
COVID19 (Custom Term) | Globulins increased | 4 | 3.467 | 0.594 | 1.437 | 2.577 | 0.516 | 0.994 | 1.772 | 1.154 | 4.965 | 5.784
COVID19 (Custom Term) | Intestinal mass | 1 | 0.987 | 0.269 | 1.437 | 3.363 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Vaccination site coldness | 1 | 0.988 | 0.313 | 1.437 | 3.228 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Bacteriuria | 1 | 0.988 | 0.269 | 1.437 | 3.365 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | CSF neutrophil count increased | 3 | 3.993 | 0.504 | 1.437 | 2.757 | 0.388 | 0.793 | 1.475 | 0.751 | 1.027 | 0.069
COVID19 (Custom Term) | Oesophageal varices haemorrhage | 1 | 0.987 | 0.085 | 1.436 | 4.212 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Brain operation | 3 | 2.977 | 0.479 | 1.436 | 2.81 | 0.449 | 0.916 | 1.703 | 1.008 | 3.31 | 1.971
COVID19 (Custom Term) | X-ray with contrast upper gastrointestinal tract normal | 1 | 0.988 | 0.314 | 1.435 | 3.22 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Urobilinogen urine | 4 | 3.574 | 0.647 | 1.434 | 2.471 | 0.508 | 0.979 | 1.745 | 1.119 | 1.281 | 0.03
COVID19 (Custom Term) | Scan myocardial perfusion normal | 1 | 1.062 | 0.314 | 1.434 | 3.216 | 0.353 | 0.859 | 1.822 | 0.942 | 4.965 | 0.204
COVID19 (Custom Term) | Facial asymmetry | 15 | 12.707 | 0.922 | 1.433 | 2.037 | 0.739 | 1.105 | 1.601 | 1.18 | 4.255 | 23.704
COVID19 (Custom Term) | Blood alkaline phosphatase decreased | 1 | 0.988 | 0.315 | 1.433 | 3.212 | 0.359 | 0.873 | 1.852 | 1.012 | 4.965 | 0.204
COVID19 (Custom Term) | Blood lactic acid increased | 44 | 44.41 | 1.105 | 1.433 | 1.796 | 0.766 | 0.979 | 1.237 | 0.991 | 4.122 | 71.134
COVID19 (Custom Term) | Saliva discolouration | 1 | 0.953 | 0.315 | 1.432 | 3.208 | 0.362 | 0.88 | 1.867 | 1.049 | 4.965 | 0.204
COVID19 (Custom Term) | Acute kidney injury | 69 | 67.035 | 1.163 | 1.432 | 1.725 | 0.837 | 1.02 | 1.233 | 1.029 | 4.478 | 125.911
COVID19 (Custom Term) | Ultrasound bladder | 1 | 0.995 | 0.221 | 1.432 | 3.513 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Urine sodium normal | 1 | 0.987 | 0.086 | 1.431 | 4.19 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Defaecation urgency | 8 | 5.764 | 0.789 | 1.43 | 2.226 | 0.701 | 1.177 | 1.881 | 1.388 | 2.206 | 3.3
COVID19 (Custom Term) | Genital burning sensation | 1 | 0.987 | 0.316 | 1.43 | 3.199 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Facial discomfort | 21 | 15.829 | 0.978 | 1.429 | 1.95 | 0.874 | 1.236 | 1.708 | 1.327 | 104.257 | 177.007
COVID19 (Custom Term) | Fluid overload | 5 | 4.093 | 0.662 | 1.429 | 2.431 | 0.565 | 1.043 | 1.796 | 1.222 | 6.206 | 10.142
COVID19 (Custom Term) | Capillary nail refill test | 1 | 1.498 | 0.336 | 1.429 | 3.139 | 0.321 | 0.783 | 1.663 | 0.667 | 0.32 | 0.767
COVID19 (Custom Term) | Blood chloride normal | 43 | 36.739 | 1.097 | 1.428 | 1.795 | 0.89 | 1.141 | 1.444 | 1.17 | 1.617 | 8.144
COVID19 (Custom Term) | Eosinophil count normal | 21 | 16.658 | 0.973 | 1.427 | 1.952 | 0.838 | 1.185 | 1.638 | 1.261 | 1.381 | 1.587
COVID19 (Custom Term) | Mesenteritis | 1 | 0.993 | 0.317 | 1.426 | 3.187 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Blood cholesterol | 6 | 5.228 | 0.696 | 1.425 | 2.365 | 0.575 | 1.022 | 1.709 | 1.148 | 4.965 | 9.923
COVID19 (Custom Term) | Carbon dioxide increased | 8 | 7.672 | 0.789 | 1.425 | 2.211 | 0.582 | 0.978 | 1.562 | 1.043 | 4.413 | 12.135
COVID19 (Custom Term) | Haptoglobin | 1 | 0.993 | 0.317 | 1.425 | 3.18 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Coronary artery dissection | 1 | 0.993 | 0.273 | 1.425 | 3.314 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Blood cholesterol decreased | 2 | 2.031 | 0.482 | 1.425 | 2.772 | 0.407 | 0.892 | 1.752 | 0.985 | 2.837 | 0.612
COVID19 (Custom Term) | Troponin normal | 85 | 72.492 | 1.183 | 1.424 | 1.684 | 0.968 | 1.157 | 1.374 | 1.173 | 11.561 | 373.717
COVID19 (Custom Term) | Tension headache | 17 | 14.947 | 0.922 | 1.424 | 2.015 | 0.738 | 1.079 | 1.536 | 1.137 | 2.558 | 11.498
COVID19 (Custom Term) | Prothrombin level increased | 1 | 0.995 | 0.318 | 1.424 | 3.176 | 0.359 | 0.872 | 1.849 | 1.005 | 4.965 | 0.204
COVID19 (Custom Term) | Gastrointestinal haemorrhage (SMQ) [narrow] | 103 | 103.408 | 1.203 | 1.424 | 1.66 | 0.842 | 0.991 | 1.159 | 0.996 | 0.645 | 18.591
COVID19 (Custom Term) | Gastrointestinal haemorrhage (SMQ) [broad] | 103 | 103.408 | 1.203 | 1.424 | 1.66 | 0.842 | 0.991 | 1.159 | 0.996 | 0.645 | 18.591
COVID19 (Custom Term) | Pharyngeal hypoaesthesia | 49 | 37.158 | 1.112 | 1.423 | 1.767 | 1.011 | 1.276 | 1.594 | 1.319 | 14.743 | 246.64
COVID19 (Custom Term) | Basophil percentage decreased | 10 | 7.841 | 0.812 | 1.423 | 2.173 | 0.707 | 1.138 | 1.754 | 1.275 | 0.964 | 0.003
COVID19 (Custom Term) | Pleuritic pain | 21 | 18.645 | 0.965 | 1.423 | 1.954 | 0.763 | 1.08 | 1.492 | 1.126 | 5.636 | 47.886
COVID19 (Custom Term) | CSF lymphocyte count abnormal | 1 | 0.995 | 0.352 | 1.423 | 3.081 | 0.359 | 0.872 | 1.849 | 1.005 | 0.903 | 0.162
COVID19 (Custom Term) | Cardiac discomfort | 7 | 4.017 | 0.742 | 1.422 | 2.28 | 0.763 | 1.316 | 2.152 | 1.742 | 4.089 | 9.286
COVID19 (Custom Term) | Bronchoalveolar lavage normal | 1 | 0.993 | 0.274 | 1.422 | 3.305 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Liquid product physical issue | 1 | 1 | 0.113 | 1.422 | 3.983 | 0.358 | 0.871 | 1.847 | 1 | 0.242 | 1.572
COVID19 (Custom Term) | Magnetic resonance imaging joint | 1 | 1.873 | 0.318 | 1.422 | 3.169 | 0.296 | 0.728 | 1.548 | 0.534 | 4.965 | 0.204
COVID19 (Custom Term) | Lymphocyte count | 8 | 7.515 | 0.767 | 1.421 | 2.238 | 0.59 | 0.992 | 1.584 | 1.065 | 1.558 | 0.901
COVID19 (Custom Term) | Computerised tomogram abdomen abnormal | 56 | 53.67 | 1.126 | 1.421 | 1.743 | 0.828 | 1.03 | 1.27 | 1.043 | 5.56 | 131.126
COVID19 (Custom Term) | Acute abdomen | 1 | 0.993 | 0.225 | 1.421 | 3.468 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Mandibular mass | 1 | 0.503 | 0.319 | 1.42 | 3.163 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Cardiac electrophysiologic study | 1 | 0.993 | 0.225 | 1.42 | 3.464 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Calcium ionised normal | 2 | 1.539 | 0.544 | 1.419 | 2.626 | 0.446 | 0.978 | 1.922 | 1.299 | 1.418 | 0.001
COVID19 (Custom Term) | Scratch | 11 | 10.088 | 0.811 | 1.419 | 2.166 | 0.648 | 1.024 | 1.556 | 1.09 | 0.503 | 4.627
COVID19 (Custom Term) | Tracheal inflammation | 1 | 0.953 | 0.275 | 1.419 | 3.29 | 0.362 | 0.88 | 1.867 | 1.049 | 3.31 | 0.054
COVID19 (Custom Term) | Paranasal sinus hyposecretion | 1 | 1.056 | 0.319 | 1.419 | 3.159 | 0.354 | 0.86 | 1.825 | 0.947 | 4.965 | 0.204
COVID19 (Custom Term) | Acute psychosis | 1 | 0.995 | 0.275 | 1.418 | 3.287 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Glycosylated haemoglobin decreased | 1 | 0.374 | 0.32 | 1.417 | 3.152 | 0.418 | 1.016 | 2.168 | 2.671 | 4.965 | 0.204
COVID19 (Custom Term) | Dry mouth | 158 | 123.434 | 1.237 | 1.416 | 1.605 | 1.112 | 1.267 | 1.44 | 1.28 | 4.521 | 295.502
COVID19 (Custom Term) | Rash morbilliform | 5 | 4.875 | 0.593 | 1.415 | 2.522 | 0.513 | 0.947 | 1.63 | 1.026 | 0.123 | 29.812
COVID19 (Custom Term) | Tricuspid valve incompetence | 8 | 7.937 | 0.758 | 1.413 | 2.233 | 0.569 | 0.955 | 1.526 | 1.008 | 4.965 | 14.103
COVID19 (Custom Term) | Thrombosis | 68 | 69.443 | 1.146 | 1.413 | 1.702 | 0.797 | 0.972 | 1.177 | 0.979 | 7.26 | 208.161
COVID19 (Custom Term) | Bartonella test | 1 | 1.072 | 0.174 | 1.413 | 3.645 | 0.352 | 0.857 | 1.818 | 0.933 | 1.986 | 0.005
COVID19 (Custom Term) | Jaw disorder | 7 | 5.482 | 0.741 | 1.412 | 2.259 | 0.64 | 1.103 | 1.801 | 1.277 | 7.723 | 19.07
COVID19 (Custom Term) | Thrombotic thrombocytopenic purpura | 6 | 5.341 | 0.654 | 1.412 | 2.404 | 0.567 | 1.009 | 1.688 | 1.123 | 3.972 | 7.336
COVID19 (Custom Term) | Agnosia | 1 | 0.993 | 0.277 | 1.412 | 3.264 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Vaccination site pruritus | 23 | 24.096 | 0.971 | 1.412 | 1.92 | 0.674 | 0.939 | 1.282 | 0.955 | 2.625 | 16.917
COVID19 (Custom Term) | Insulin C-peptide decreased | 1 | 0.988 | 0.278 | 1.411 | 3.258 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Arterial occlusive disease | 1 | 0.993 | 0.322 | 1.411 | 3.127 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Myasthenia gravis crisis | 1 | 1.014 | 0.322 | 1.41 | 3.123 | 0.357 | 0.868 | 1.842 | 0.986 | 4.965 | 0.204
COVID19 (Custom Term) | Gastrointestinal premalignant disorders (SMQ) [broad] | 9 | 11.679 | 0.761 | 1.41 | 2.221 | 0.479 | 0.787 | 1.233 | 0.771 | 0.784 | 0.301
COVID19 (Custom Term) | Gastrointestinal premalignant disorders (SMQ) [narrow] | 9 | 11.679 | 0.761 | 1.41 | 2.221 | 0.479 | 0.787 | 1.233 | 0.771 | 0.784 | 0.301
COVID19 (Custom Term) | Drug eruption | 3 | 2.612 | 0.492 | 1.409 | 2.708 | 0.476 | 0.97 | 1.804 | 1.148 | 0.805 | 0.008
COVID19 (Custom Term) | Antineutrophil cytoplasmic antibody increased | 1 | 0.988 | 0.278 | 1.409 | 3.253 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Pulmonary pneumatocele | 1 | 0.988 | 0.279 | 1.409 | 3.251 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Mean platelet volume | 2 | 2.041 | 0.459 | 1.409 | 2.781 | 0.406 | 0.89 | 1.749 | 0.98 | 2.482 | 0.412
COVID19 (Custom Term) | Gastrointestinal obstruction (SMQ) [broad] | 29 | 30.168 | 1.012 | 1.409 | 1.86 | 0.703 | 0.948 | 1.256 | 0.961 | 0.304 | 44.297
COVID19 (Custom Term) | Gastrointestinal obstruction (SMQ) [narrow] | 29 | 30.168 | 1.012 | 1.409 | 1.86 | 0.703 | 0.948 | 1.256 | 0.961 | 0.304 | 44.297
COVID19 (Custom Term) | Spinal fracture | 2 | 1.975 | 0.486 | 1.408 | 2.718 | 0.411 | 0.9 | 1.769 | 1.012 | 2.837 | 0.612
COVID19 (Custom Term) | Arteriovenous malformation | 1 | 0.993 | 0.323 | 1.408 | 3.117 | 0.359 | 0.872 | 1.85 | 1.007 | 4.965 | 0.204
COVID19 (Custom Term) | Blood glucose decreased | 31 | 27.113 | 1.034 | 1.407 | 1.826 | 0.829 | 1.108 | 1.456 | 1.143 | 1.603 | 5.502
COVID19 (Custom Term) | Culture wound | 1 | 1.006 | 0.261 | 1.407 | 3.301 | 0.358 | 0.87 | 1.845 | 0.994 | 0.764 | 0.041
COVID19 (Custom Term) | Raynaud's phenomenon | 5 | 3.896 | 0.591 | 1.406 | 2.504 | 0.58 | 1.07 | 1.843 | 1.283 | 0.752 | 0.168
COVID19 (Custom Term) | White blood cell count | 24 | 24.928 | 0.984 | 1.406 | 1.89 | 0.684 | 0.947 | 1.285 | 0.963 | 1.462 | 2.628
COVID19 (Custom Term) | Retinal migraine | 1 | 1.496 | 0.324 | 1.406 | 3.107 | 0.321 | 0.784 | 1.664 | 0.668 | 4.965 | 0.204
COVID19 (Custom Term) | Anion gap normal | 7 | 4.544 | 0.72 | 1.405 | 2.276 | 0.713 | 1.231 | 2.01 | 1.54 | 2.896 | 5.209
COVID19 (Custom Term) | Blood pressure immeasurable | 6 | 5.276 | 0.715 | 1.405 | 2.281 | 0.572 | 1.016 | 1.7 | 1.137 | 1.986 | 1.626
COVID19 (Custom Term) | Venous oxygen saturation decreased | 1 | 0.987 | 0.324 | 1.405 | 3.105 | 0.359 | 0.874 | 1.853 | 1.013 | 4.965 | 0.204
COVID19 (Custom Term) | Hyponatraemia | 18 | 18.968 | 0.923 | 1.405 | 1.97 | 0.643 | 0.931 | 1.315 | 0.949 | 2.668 | 13.382
COVID19 (Custom Term) | Prealbumin | 1 | 0.987 | 0.231 | 1.404 | 3.392 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Sinus arrest | 1 | 0.988 | 0.28 | 1.404 | 3.232 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Herpes zoster cutaneous disseminated | 2 | 1.828 | 0.364 | 1.403 | 2.993 | 0.422 | 0.925 | 1.818 | 1.094 | 1.418 | 0.001
COVID19 (Custom Term) | Troponin increased | 145 | 142.414 | 1.218 | 1.403 | 1.6 | 0.884 | 1.014 | 1.158 | 1.018 | 16.938 | 797.722
COVID19 (Custom Term) | Submaxillary gland enlargement | 1 | 0.503 | 0.326 | 1.401 | 3.089 | 0.404 | 0.981 | 2.088 | 1.988 | 4.965 | 0.204
COVID19 (Custom Term) | Portal vein thrombosis | 1 | 0.988 | 0.281 | 1.401 | 3.218 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Reversible cerebral vasoconstriction syndrome | 1 | 0.993 | 0.282 | 1.401 | 3.217 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Non-alcoholic steatohepatitis | 1 | 1.017 | 0.325 | 1.401 | 3.09 | 0.357 | 0.868 | 1.84 | 0.983 | 4.965 | 0.204
COVID19 (Custom Term) | Use of accessory respiratory muscles | 3 | 3.059 | 0.512 | 1.401 | 2.646 | 0.444 | 0.904 | 1.682 | 0.981 | 0.584 | 0.463
COVID19 (Custom Term) | White matter lesion | 6 | 6.652 | 0.662 | 1.401 | 2.363 | 0.495 | 0.88 | 1.472 | 0.902 | 0.961 | 0.014
COVID19 (Custom Term) | Tongue erythema | 8 | 7.487 | 0.786 | 1.4 | 2.158 | 0.592 | 0.994 | 1.588 | 1.069 | 4.673 | 13.075
COVID19 (Custom Term) | Coronavirus test negative | 2 | 3.38 | 0.488 | 1.4 | 2.695 | 0.326 | 0.718 | 1.412 | 0.592 | 2.837 | 0.612
COVID19 (Custom Term) | Angiogram | 83 | 82.017 | 1.159 | 1.399 | 1.658 | 0.839 | 1.005 | 1.195 | 1.012 | 7.849 | 272.994
COVID19 (Custom Term) | Vaccination site macule | 1 | 0.995 | 0.282 | 1.399 | 3.212 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Cerebral small vessel ischaemic disease | 9 | 9.448 | 0.79 | 1.399 | 2.148 | 0.561 | 0.921 | 1.444 | 0.953 | 29.788 | 54.929
COVID19 (Custom Term) | Tissue injury | 1 | 1.126 | 0.282 | 1.399 | 3.21 | 0.348 | 0.847 | 1.797 | 0.888 | 3.31 | 0.054
COVID19 (Custom Term) | Corneal infiltrates | 1 | 0.993 | 0.282 | 1.398 | 3.208 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Premenstrual syndrome | 1 | 0.995 | 0.283 | 1.398 | 3.206 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Inner ear disorder | 2 | 2.013 | 0.471 | 1.398 | 2.723 | 0.408 | 0.894 | 1.757 | 0.993 | 1.986 | 0.162
COVID19 (Custom Term) | Coxsackie virus test positive | 2 | 1.424 | 0.341 | 1.397 | 3.035 | 0.457 | 1 | 1.968 | 1.404 | 2.206 | 0.266
COVID19 (Custom Term) | Blood iron decreased | 5 | 5.569 | 0.614 | 1.397 | 2.436 | 0.474 | 0.875 | 1.506 | 0.898 | 0.764 | 0.141
COVID19 (Custom Term) | Glaucoma | 2 | 3.592 | 0.405 | 1.397 | 2.871 | 0.316 | 0.696 | 1.37 | 0.557 | 1.103 | 0.065
COVID19 (Custom Term) | Conjunctival haemorrhage | 9 | 6.75 | 0.754 | 1.396 | 2.198 | 0.707 | 1.161 | 1.821 | 1.333 | 2.979 | 7.503
COVID19 (Custom Term) | Blood copper normal | 1 | 0.995 | 0.283 | 1.396 | 3.198 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Coronary arterial stent insertion | 11 | 11.198 | 0.822 | 1.396 | 2.094 | 0.6 | 0.947 | 1.439 | 0.982 | 10.922 | 42.16
COVID19 (Custom Term) | Mycobacterium tuberculosis complex test negative | 3 | 2.538 | 0.462 | 1.395 | 2.735 | 0.482 | 0.981 | 1.826 | 1.182 | 0.851 | 0
COVID19 (Custom Term) | Dysacusis | 2 | 1.978 | 0.489 | 1.395 | 2.676 | 0.411 | 0.9 | 1.768 | 1.011 | 2.837 | 0.612
COVID19 (Custom Term) | Ketosis | 1 | 0.993 | 0.284 | 1.395 | 3.195 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Quadrantanopia | 1 | 1.022 | 0.284 | 1.395 | 3.192 | 0.356 | 0.867 | 1.838 | 0.978 | 3.31 | 0.054
COVID19 (Custom Term) | Small intestinal resection | 1 | 0.998 | 0.235 | 1.394 | 3.349 | 0.358 | 0.871 | 1.848 | 1.002 | 2.482 | 0.004
COVID19 (Custom Term) | Labile blood pressure | 1 | 0.995 | 0.181 | 1.393 | 3.551 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Ophthalmic scan | 1 | 0.995 | 0.284 | 1.393 | 3.187 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Mucous stools | 3 | 3.097 | 0.469 | 1.393 | 2.715 | 0.441 | 0.899 | 1.673 | 0.969 | 0.105 | 21.731
COVID19 (Custom Term) | Chronic kidney disease (SMQ) [narrow] | 56 | 60.367 | 1.106 | 1.393 | 1.707 | 0.741 | 0.923 | 1.137 | 0.928 | 3.177 | 61.54
COVID19 (Custom Term) | Mean cell haemoglobin concentration decreased | 12 | 10.795 | 0.848 | 1.392 | 2.046 | 0.671 | 1.043 | 1.563 | 1.112 | 2.648 | 8.337
COVID19 (Custom Term) | Blood bilirubin increased | 28 | 25.83 | 0.995 | 1.391 | 1.841 | 0.778 | 1.054 | 1.402 | 1.084 | 1.536 | 4.042
COVID19 (Custom Term) | Angiogram pulmonary abnormal | 25 | 24.768 | 0.978 | 1.391 | 1.863 | 0.717 | 0.988 | 1.333 | 1.009 | 248.231 | 226.431
COVID19 (Custom Term) | Blood creatinine | 8 | 7.947 | 0.738 | 1.391 | 2.21 | 0.568 | 0.954 | 1.524 | 1.007 | 1.103 | 0.005
COVID19 (Custom Term) | Renal disorder | 7 | 7.791 | 0.727 | 1.391 | 2.228 | 0.51 | 0.88 | 1.435 | 0.898 | 1.39 | 0.348
COVID19 (Custom Term) | Mammogram normal | 1 | 1.597 | 0.211 | 1.391 | 3.428 | 0.314 | 0.768 | 1.631 | 0.626 | 1.655 | 0.034
COVID19 (Custom Term) | Mouth injury | 3 | 2.368 | 0.554 | 1.39 | 2.533 | 0.495 | 1.009 | 1.879 | 1.267 | 2.708 | 1.277
COVID19 (Custom Term) | Antimitochondrial antibody normal | 1 | 1.134 | 0.286 | 1.39 | 3.175 | 0.347 | 0.846 | 1.793 | 0.882 | 3.31 | 0.054
COVID19 (Custom Term) | Albumin CSF normal | 1 | 0.987 | 0.286 | 1.389 | 3.171 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Alanine aminotransferase | 4 | 4.08 | 0.575 | 1.389 | 2.491 | 0.474 | 0.914 | 1.63 | 0.98 | 0.863 | 0.001
COVID19 (Custom Term) | Rectal examination abnormal | 1 | 1.056 | 0.237 | 1.389 | 3.329 | 0.354 | 0.86 | 1.824 | 0.947 | 2.482 | 0.004
COVID19 (Custom Term) | Tonsillitis | 3 | 3.336 | 0.466 | 1.389 | 2.711 | 0.426 | 0.868 | 1.615 | 0.899 | 0.165 | 11.633
COVID19 (Custom Term) | Brain contusion | 1 | 0.993 | 0.183 | 1.388 | 3.528 | 0.359 | 0.872 | 1.85 | 1.007 | 1.986 | 0.005
COVID19 (Custom Term) | Uterine haemorrhage | 3 | 3.546 | 0.463 | 1.388 | 2.714 | 0.413 | 0.843 | 1.567 | 0.846 | 3.723 | 2.44
COVID19 (Custom Term) | Electrocardiogram PR prolongation | 1 | 0.987 | 0.287 | 1.387 | 3.161 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Clostridium difficile infection | 2 | 2.48 | 0.505 | 1.387 | 2.623 | 0.376 | 0.825 | 1.621 | 0.806 | 1.986 | 0.162
COVID19 (Custom Term) | Enzyme level test | 1 | 0.995 | 0.287 | 1.386 | 3.158 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Cardiomyopathy | 7 | 7.134 | 0.683 | 1.386 | 2.29 | 0.541 | 0.934 | 1.523 | 0.981 | 1.616 | 0.892
COVID19 (Custom Term) | Lip ulceration | 2 | 2.38 | 0.465 | 1.386 | 2.707 | 0.382 | 0.839 | 1.649 | 0.84 | 2.482 | 0.412
COVID19 (Custom Term) | Hot flush | 253 | 194.048 | 1.246 | 1.385 | 1.53 | 1.168 | 1.295 | 1.434 | 1.304 | 6.576 | 717.284
COVID19 (Custom Term) | Similar reaction on previous exposure to drug | 2 | 2.014 | 0.52 | 1.385 | 2.586 | 0.408 | 0.894 | 1.757 | 0.993 | 1.324 | 0.002
COVID19 (Custom Term) | Genital blister | 1 | 1.049 | 0.288 | 1.385 | 3.152 | 0.354 | 0.862 | 1.827 | 0.953 | 3.31 | 0.054
COVID19 (Custom Term) | Leukocytosis | 31 | 33.109 | 1.011 | 1.385 | 1.807 | 0.694 | 0.927 | 1.218 | 0.936 | 1.166 | 0.502
COVID19 (Custom Term) | Osteoporosis/osteopenia (SMQ) [broad] | 43 | 46.407 | 1.064 | 1.385 | 1.74 | 0.718 | 0.92 | 1.165 | 0.927 | 3.05 | 43.632
COVID19 (Custom Term) | Dyslexia | 1 | 0.431 | 0.288 | 1.384 | 3.15 | 0.412 | 1 | 2.131 | 2.32 | 3.31 | 0.054
COVID19 (Custom Term) | Parkinson's disease | 4 | 4.011 | 0.593 | 1.384 | 2.442 | 0.479 | 0.923 | 1.645 | 0.997 | 1.418 | 0.123
COVID19 (Custom Term) | Blood culture positive | 10 | 10.657 | 0.761 | 1.384 | 2.158 | 0.568 | 0.913 | 1.408 | 0.938 | 0.552 | 3.003
COVID19 (Custom Term) | Hypogeusia | 12 | 9.689 | 0.83 | 1.383 | 2.052 | 0.727 | 1.13 | 1.694 | 1.238 | 9.929 | 43.394
COVID19 (Custom Term) | Hepatobiliary scan abnormal | 1 | 0.999 | 0.288 | 1.383 | 3.145 | 0.358 | 0.871 | 1.848 | 1.001 | 3.31 | 0.054
COVID19 (Custom Term) | Aura | 12 | 8.368 | 0.84 | 1.382 | 2.033 | 0.807 | 1.255 | 1.881 | 1.434 | 7.447 | 34.326
COVID19 (Custom Term) | Tachyarrhythmia | 2 | 1.498 | 0.466 | 1.382 | 2.692 | 0.45 | 0.986 | 1.938 | 1.335 | 2.482 | 0.412
COVID19 (Custom Term) | Lactic acidosis (SMQ) [narrow] | 50 | 50.335 | 1.082 | 1.382 | 1.711 | 0.78 | 0.983 | 1.225 | 0.993 | 4.317 | 86.334
COVID19 (Custom Term) | Feeding tube user | 2 | 2.101 | 0.453 | 1.382 | 2.72 | 0.402 | 0.88 | 1.73 | 0.952 | 1.103 | 0.065
COVID19 (Custom Term) | Paranasal cyst | 1 | 0.503 | 0.289 | 1.381 | 3.138 | 0.404 | 0.981 | 2.088 | 1.988 | 3.31 | 0.054
COVID19 (Custom Term) | Other ischaemic heart disease (SMQ) [narrow] | 85 | 80.089 | 1.145 | 1.381 | 1.634 | 0.88 | 1.052 | 1.249 | 1.061 | 6.028 | 218.549
COVID19 (Custom Term) | Parosmia | 34 | 27.835 | 1.017 | 1.38 | 1.788 | 0.892 | 1.177 | 1.531 | 1.221 | 5.359 | 75.225
COVID19 (Custom Term) | Lymphocyte count normal | 17 | 15.416 | 0.906 | 1.38 | 1.935 | 0.719 | 1.053 | 1.498 | 1.103 | 1.133 | 0.125
COVID19 (Custom Term) | Haematopoietic erythropenia (SMQ) [narrow] | 43 | 40.208 | 1.056 | 1.379 | 1.738 | 0.819 | 1.05 | 1.33 | 1.069 | 1.856 | 13.539
COVID19 (Custom Term) | Nucleated red cells | 7 | 6.928 | 0.739 | 1.379 | 2.18 | 0.552 | 0.952 | 1.553 | 1.01 | 7.723 | 19.07
COVID19 (Custom Term) | Intellectual disability | 2 | 2 | 0.344 | 1.379 | 2.976 | 0.409 | 0.896 | 1.761 | 1 | 0.451 | 0.764
COVID19 (Custom Term) | Urodynamics measurement | 1 | 1.368 | 0.29 | 1.379 | 3.13 | 0.33 | 0.805 | 1.708 | 0.731 | 3.31 | 0.054
COVID19 (Custom Term) | High risk pregnancy | 1 | 1.555 | 0.241 | 1.379 | 3.285 | 0.317 | 0.774 | 1.645 | 0.643 | 2.482 | 0.004
COVID19 (Custom Term) | Cystoscopy abnormal | 1 | 0.988 | 0.291 | 1.377 | 3.121 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Menopause | 1 | 0.995 | 0.242 | 1.377 | 3.277 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Morning sickness | 1 | 1.017 | 0.242 | 1.377 | 3.276 | 0.357 | 0.868 | 1.84 | 0.983 | 2.482 | 0.004
COVID19 (Custom Term) | Nasal discomfort | 16 | 12.735 | 0.877 | 1.376 | 1.967 | 0.788 | 1.164 | 1.671 | 1.256 | 3.53 | 19.405
COVID19 (Custom Term) | Pernicious anaemia | 1 | 0.503 | 0.188 | 1.374 | 3.465 | 0.404 | 0.981 | 2.088 | 1.988 | 1.986 | 0.005
COVID19 (Custom Term) | Red cell distribution width increased | 14 | 12.428 | 0.851 | 1.374 | 1.999 | 0.702 | 1.062 | 1.554 | 1.126 | 2.139 | 5.991
COVID19 (Custom Term) | Cardiovascular symptom | 1 | 0.953 | 0.292 | 1.374 | 3.108 | 0.362 | 0.88 | 1.867 | 1.049 | 3.31 | 0.054
COVID19 (Custom Term) | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [narrow] | 45 | 43.574 | 1.06 | 1.373 | 1.719 | 0.798 | 1.018 | 1.283 | 1.033 | 3.633 | 60.786
COVID19 (Custom Term) | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [broad] | 45 | 43.574 | 1.06 | 1.373 | 1.719 | 0.798 | 1.018 | 1.283 | 1.033 | 3.633 | 60.786
COVID19 (Custom Term) | Labour complication | 1 | 1.498 | 0.292 | 1.373 | 3.106 | 0.321 | 0.783 | 1.663 | 0.667 | 3.31 | 0.054
COVID19 (Custom Term) | Refusal of vaccination | 1 | 1.087 | 0.244 | 1.372 | 3.254 | 0.351 | 0.854 | 1.812 | 0.92 | 2.482 | 0.004
COVID19 (Custom Term) | Genital ulceration | 1 | 0.374 | 0.293 | 1.371 | 3.095 | 0.418 | 1.016 | 2.168 | 2.671 | 3.31 | 0.054
COVID19 (Custom Term) | Rosacea | 2 | 1.628 | 0.55 | 1.371 | 2.491 | 0.439 | 0.961 | 1.889 | 1.229 | 0.863 | 0.022
COVID19 (Custom Term) | Myocardial necrosis marker normal | 18 | 14.399 | 0.905 | 1.37 | 1.914 | 0.806 | 1.168 | 1.648 | 1.25 | 4.062 | 27.146
COVID19 (Custom Term) | Basophil count normal | 14 | 11.354 | 0.87 | 1.37 | 1.963 | 0.752 | 1.138 | 1.666 | 1.233 | 1.511 | 1.64
COVID19 (Custom Term) | Hypochromasia | 1 | 0.988 | 0.294 | 1.37 | 3.092 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Serratia infection | 1 | 1.045 | 0.337 | 1.37 | 2.967 | 0.354 | 0.862 | 1.829 | 0.957 | 4.965 | 0.204
COVID19 (Custom Term) | Pulmonary mass | 5 | 6.013 | 0.619 | 1.37 | 2.358 | 0.452 | 0.835 | 1.437 | 0.832 | 1.773 | 0.799
COVID19 (Custom Term) | Blister infected | 1 | 1.496 | 0.245 | 1.37 | 3.244 | 0.321 | 0.784 | 1.664 | 0.668 | 2.482 | 0.004
COVID19 (Custom Term) | Central vision loss | 1 | 1.548 | 0.293 | 1.37 | 3.093 | 0.317 | 0.775 | 1.647 | 0.646 | 3.31 | 0.054
COVID19 (Custom Term) | Supraventricular extrasystoles | 5 | 3.359 | 0.676 | 1.369 | 2.259 | 0.625 | 1.153 | 1.987 | 1.489 | 2.92 | 3.383
COVID19 (Custom Term) | Serum ferritin | 5 | 5.317 | 0.649 | 1.369 | 2.304 | 0.488 | 0.9 | 1.549 | 0.94 | 3.546 | 4.829
COVID19 (Custom Term) | Lyme disease | 1 | 1.132 | 0.196 | 1.369 | 3.416 | 0.348 | 0.846 | 1.794 | 0.884 | 0.177 | 2.914
COVID19 (Custom Term) | Hospice care | 7 | 6.077 | 0.725 | 1.368 | 2.177 | 0.601 | 1.036 | 1.69 | 1.152 | 8.688 | 21.087
COVID19 (Custom Term) | Smear cervix normal | 1 | 0.987 | 0.12 | 1.368 | 3.767 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Stress echocardiogram | 1 | 0.995 | 0.246 | 1.368 | 3.236 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Feeling of relaxation | 1 | 0.385 | 0.295 | 1.367 | 3.081 | 0.417 | 1.013 | 2.161 | 2.595 | 3.31 | 0.054
COVID19 (Custom Term) | Blood sodium decreased | 45 | 42.588 | 1.056 | 1.367 | 1.711 | 0.815 | 1.04 | 1.31 | 1.057 | 2.212 | 23.376
COVID19 (Custom Term) | X-ray with contrast lower gastrointestinal tract | 1 | 0.987 | 0.295 | 1.366 | 3.077 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Sputum culture positive | 1 | 1.106 | 0.302 | 1.366 | 3.057 | 0.35 | 0.851 | 1.805 | 0.904 | 0.473 | 0.144
COVID19 (Custom Term) | Abdominal pain lower | 43 | 35.835 | 1.047 | 1.365 | 1.716 | 0.91 | 1.167 | 1.477 | 1.2 | 3.139 | 45.883
COVID19 (Custom Term) | Hospitalisation | 8 | 7.77 | 0.727 | 1.365 | 2.165 | 0.577 | 0.969 | 1.548 | 1.03 | 11.348 | 30.114
COVID19 (Custom Term) | Antibody test abnormal | 2 | 1.614 | 0.314 | 1.364 | 3.017 | 0.44 | 0.963 | 1.894 | 1.239 | 0.326 | 2.035
COVID19 (Custom Term) | Shock haemorrhagic | 1 | 0.987 | 0.296 | 1.364 | 3.067 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Phantom limb syndrome | 1 | 1.361 | 0.163 | 1.364 | 3.537 | 0.33 | 0.806 | 1.71 | 0.735 | 1.241 | 0.14
COVID19 (Custom Term) | Atrioventricular block | 7 | 6.943 | 0.716 | 1.363 | 2.177 | 0.551 | 0.951 | 1.551 | 1.008 | 9.929 | 23.406
COVID19 (Custom Term) | Eye infection bacterial | 1 | 0.995 | 0.297 | 1.363 | 3.063 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Red cell distribution width decreased | 1 | 1.006 | 0.297 | 1.363 | 3.063 | 0.358 | 0.87 | 1.845 | 0.994 | 3.31 | 0.054
COVID19 (Custom Term) | Trichomoniasis | 1 | 2.496 | 0.133 | 1.362 | 3.674 | 0.262 | 0.65 | 1.389 | 0.401 | 1.655 | 0.034
COVID19 (Custom Term) | Keratitis | 2 | 2.137 | 0.331 | 1.361 | 2.96 | 0.399 | 0.875 | 1.719 | 0.936 | 0.794 | 0
COVID19 (Custom Term) | Eye oedema | 3 | 3.558 | 0.601 | 1.361 | 2.369 | 0.412 | 0.841 | 1.565 | 0.843 | 1.418 | 0.046
COVID19 (Custom Term) | Angiocardiogram | 3 | 2.967 | 0.451 | 1.36 | 2.664 | 0.45 | 0.917 | 1.706 | 1.011 | 3.723 | 2.44
COVID19 (Custom Term) | Colitis | 9 | 9.488 | 0.742 | 1.36 | 2.129 | 0.559 | 0.918 | 1.44 | 0.949 | 1.295 | 0.287
COVID19 (Custom Term) | Breast discomfort | 1 | 0.995 | 0.25 | 1.359 | 3.196 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Essential hypertension | 5 | 4.992 | 0.622 | 1.358 | 2.326 | 0.506 | 0.934 | 1.607 | 1.002 | 5.516 | 8.904
COVID19 (Custom Term) | Spinal osteoarthritis | 4 | 4.753 | 0.534 | 1.358 | 2.488 | 0.436 | 0.841 | 1.498 | 0.842 | 1.324 | 0.054
COVID19 (Custom Term) | Ultrasound biliary tract normal | 1 | 0.995 | 0.299 | 1.357 | 3.039 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Increased viscosity of bronchial secretion | 1 | 0.995 | 0.251 | 1.357 | 3.186 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Lack of efficacy/effect (SMQ) [narrow] | 143 | 183.331 | 1.176 | 1.357 | 1.548 | 0.68 | 0.781 | 0.893 | 0.78 | 0.278 | 263.447
COVID19 (Custom Term) | Lack of efficacy/effect (SMQ) [broad] | 143 | 183.331 | 1.176 | 1.357 | 1.548 | 0.68 | 0.781 | 0.893 | 0.78 | 0.278 | 263.447
COVID19 (Custom Term) | Tracheomalacia | 1 | 0.503 | 0.251 | 1.356 | 3.183 | 0.404 | 0.981 | 2.088 | 1.988 | 2.482 | 0.004
COVID19 (Custom Term) | Pulmonary congestion | 28 | 27.116 | 0.975 | 1.356 | 1.79 | 0.745 | 1.01 | 1.344 | 1.033 | 4.712 | 52.807
COVID19 (Custom Term) | Panic attack | 38 | 29.525 | 1.022 | 1.355 | 1.726 | 0.951 | 1.238 | 1.589 | 1.287 | 1.925 | 13.318
COVID19 (Custom Term) | Gastrointestinal examination | 1 | 0.988 | 0.251 | 1.355 | 3.18 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Prurigo | 1 | 1.92 | 0.251 | 1.355 | 3.178 | 0.294 | 0.721 | 1.535 | 0.521 | 2.482 | 0.004
COVID19 (Custom Term) | Herpes virus test | 2 | 1.371 | 0.385 | 1.354 | 2.803 | 0.462 | 1.011 | 1.99 | 1.459 | 0.903 | 0.046
COVID19 (Custom Term) | Radicular pain | 3 | 2.569 | 0.525 | 1.354 | 2.495 | 0.479 | 0.976 | 1.817 | 1.168 | 3.723 | 2.44
COVID19 (Custom Term) | CD4 lymphocyte percentage decreased | 1 | 0.995 | 0.3 | 1.354 | 3.026 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Haematological malignancy | 1 | 1.015 | 0.3 | 1.354 | 3.028 | 0.357 | 0.868 | 1.841 | 0.985 | 3.31 | 0.054
COVID19 (Custom Term) | Epidermal necrosis | 1 | 1.052 | 0.279 | 1.354 | 3.089 | 0.354 | 0.861 | 1.826 | 0.951 | 0.827 | 0.089
COVID19 (Custom Term) | Pleural effusion | 53 | 52.011 | 1.064 | 1.353 | 1.67 | 0.805 | 1.007 | 1.248 | 1.019 | 3.957 | 81.469
COVID19 (Custom Term) | Gynaecological examination | 1 | 0.987 | 0.167 | 1.353 | 3.487 | 0.359 | 0.874 | 1.853 | 1.013 | 0.993 | 0.266
COVID19 (Custom Term) | Rhonchi | 4 | 3.963 | 0.581 | 1.353 | 2.387 | 0.482 | 0.929 | 1.655 | 1.009 | 4.965 | 5.784
COVID19 (Custom Term) | Karyotype analysis normal | 1 | 1.045 | 0.301 | 1.353 | 3.021 | 0.354 | 0.862 | 1.829 | 0.957 | 3.31 | 0.054
COVID19 (Custom Term) | Lymphocyte count increased | 10 | 9.631 | 0.754 | 1.352 | 2.092 | 0.612 | 0.984 | 1.517 | 1.038 | 0.428 | 6.743
COVID19 (Custom Term) | Protein total | 8 | 8.699 | 0.691 | 1.352 | 2.192 | 0.533 | 0.896 | 1.431 | 0.92 | 1.937 | 2.234
COVID19 (Custom Term) | Gastritis erosive | 1 | 0.988 | 0.302 | 1.351 | 3.014 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Glucose urine absent | 6 | 6.018 | 0.672 | 1.351 | 2.219 | 0.527 | 0.938 | 1.569 | 0.997 | 0.784 | 0.148
COVID19 (Custom Term) | Arrhythmia | 43 | 44.095 | 1.035 | 1.351 | 1.703 | 0.753 | 0.965 | 1.222 | 0.975 | 2.295 | 24.406
COVID19 (Custom Term) | Electrocardiogram QRS complex prolonged | 1 | 0.987 | 0.302 | 1.35 | 3.008 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Liver abscess | 1 | 0.993 | 0.254 | 1.35 | 3.155 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Blood albumin | 8 | 8.695 | 0.69 | 1.35 | 2.188 | 0.534 | 0.896 | 1.432 | 0.92 | 1.986 | 2.421
COVID19 (Custom Term) | Vaccination site cellulitis | 5 | 5.534 | 0.588 | 1.35 | 2.365 | 0.476 | 0.878 | 1.512 | 0.903 | 0.414 | 3.394
COVID19 (Custom Term) | Blood creatine phosphokinase abnormal | 1 | 1.397 | 0.302 | 1.35 | 3.007 | 0.328 | 0.8 | 1.698 | 0.716 | 3.31 | 0.054
COVID19 (Custom Term) | Haemoptysis | 20 | 19.198 | 0.909 | 1.349 | 1.859 | 0.709 | 1.01 | 1.404 | 1.042 | 2.546 | 13.623
COVID19 (Custom Term) | Computerised tomogram intestine | 1 | 1.014 | 0.303 | 1.349 | 3.004 | 0.357 | 0.868 | 1.842 | 0.986 | 3.31 | 0.054
COVID19 (Custom Term) | Reflux laryngitis | 1 | 0.56 | 0.303 | 1.348 | 2.999 | 0.398 | 0.967 | 2.056 | 1.786 | 3.31 | 0.054
COVID19 (Custom Term) | Lower respiratory tract infection | 6 | 5.744 | 0.61 | 1.348 | 2.32 | 0.543 | 0.966 | 1.615 | 1.045 | 0.301 | 8.733
COVID19 (Custom Term) | Blood alkaline phosphatase increased | 46 | 45.197 | 1.043 | 1.348 | 1.685 | 0.79 | 1.005 | 1.263 | 1.018 | 2.58 | 33.998
COVID19 (Custom Term) | Cerebral artery thrombosis | 1 | 1.057 | 0.303 | 1.347 | 2.998 | 0.354 | 0.86 | 1.824 | 0.946 | 3.31 | 0.054
COVID19 (Custom Term) | Scrotal pain | 2 | 0.749 | 0.386 | 1.346 | 2.777 | 0.529 | 1.162 | 2.305 | 2.671 | 1.986 | 0.162
COVID19 (Custom Term) | PO2 decreased | 6 | 5.21 | 0.641 | 1.346 | 2.261 | 0.576 | 1.024 | 1.713 | 1.152 | 0.993 | 0.039
COVID19 (Custom Term) | Cardiac monitoring | 56 | 49.271 | 1.069 | 1.346 | 1.648 | 0.897 | 1.116 | 1.376 | 1.137 | 6.044 | 143.162
COVID19 (Custom Term) | Blood urine | 1 | 0.988 | 0.304 | 1.346 | 2.992 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Spinal deformity | 1 | 0.993 | 0.256 | 1.346 | 3.137 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Cardiac arrest | 167 | 166.81 | 1.181 | 1.346 | 1.52 | 0.878 | 0.998 | 1.13 | 1.001 | 9.812 | 660.508
COVID19 (Custom Term) | Gastric dilatation | 2 | 2.148 | 0.411 | 1.346 | 2.718 | 0.398 | 0.873 | 1.716 | 0.931 | 1.103 | 0.065
COVID19 (Custom Term) | Myocardial necrosis marker | 16 | 13.837 | 0.856 | 1.345 | 1.923 | 0.738 | 1.091 | 1.566 | 1.156 | 8.361 | 51.985
COVID19 (Custom Term) | Blood pressure inadequately controlled | 1 | 0.987 | 0.256 | 1.345 | 3.136 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | PO2 abnormal | 1 | 0.988 | 0.305 | 1.345 | 2.987 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Thyroid cancer | 1 | 1.038 | 0.256 | 1.345 | 3.132 | 0.355 | 0.864 | 1.831 | 0.963 | 2.482 | 0.004
COVID19 (Custom Term) | Stridor | 29 | 25.744 | 0.971 | 1.344 | 1.768 | 0.809 | 1.091 | 1.446 | 1.126 | 3.388 | 34.466
COVID19 (Custom Term) | Target skin lesion | 1 | 0.993 | 0.305 | 1.344 | 2.983 | 0.359 | 0.872 | 1.85 | 1.007 | 3.31 | 0.054
COVID19 (Custom Term) | Amino acid level | 1 | 1.084 | 0.324 | 1.344 | 2.932 | 0.351 | 0.855 | 1.813 | 0.922 | 0.473 | 0.144
COVID19 (Custom Term) | Meningitis aseptic | 4 | 4.635 | 0.514 | 1.344 | 2.492 | 0.442 | 0.853 | 1.52 | 0.863 | 0.467 | 1.795
COVID19 (Custom Term) | Injection site muscle weakness | 8 | 9.298 | 0.701 | 1.344 | 2.155 | 0.509 | 0.855 | 1.365 | 0.86 | 9.929 | 27.395
COVID19 (Custom Term) | Tendon discomfort | 1 | 1.496 | 0.256 | 1.344 | 3.129 | 0.321 | 0.784 | 1.664 | 0.668 | 2.482 | 0.004
COVID19 (Custom Term) | Blood creatinine normal | 63 | 55.198 | 1.081 | 1.343 | 1.628 | 0.913 | 1.123 | 1.369 | 1.141 | 1.664 | 13.685
COVID19 (Custom Term) | Lymphocyte percentage decreased | 23 | 20.823 | 0.931 | 1.343 | 1.818 | 0.764 | 1.065 | 1.454 | 1.105 | 1.136 | 0.216
COVID19 (Custom Term) | Lacrimation decreased | 1 | 1.106 | 0.305 | 1.343 | 2.98 | 0.35 | 0.851 | 1.805 | 0.904 | 3.31 | 0.054
COVID19 (Custom Term) | Orthopnoea | 3 | 2.976 | 0.45 | 1.342 | 2.619 | 0.449 | 0.916 | 1.704 | 1.008 | 2.291 | 0.807
COVID19 (Custom Term) | Systemic scleroderma | 1 | 0.995 | 0.306 | 1.342 | 2.976 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Haematuria | 17 | 17.636 | 0.872 | 1.342 | 1.895 | 0.644 | 0.943 | 1.341 | 0.964 | 1.443 | 1.614
COVID19 (Custom Term) | Cerumen removal | 1 | 1.49 | 0.306 | 1.342 | 2.977 | 0.321 | 0.785 | 1.666 | 0.671 | 3.31 | 0.054
COVID19 (Custom Term) | Blood osmolarity | 1 | 0.925 | 0.306 | 1.341 | 2.972 | 0.365 | 0.886 | 1.879 | 1.081 | 3.31 | 0.054
COVID19 (Custom Term) | EGFR status assay | 1 | 0.988 | 0.306 | 1.341 | 2.973 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Faecaloma | 2 | 2.013 | 0.475 | 1.341 | 2.564 | 0.408 | 0.894 | 1.757 | 0.994 | 2.206 | 0.266
COVID19 (Custom Term) | Ultrasound scan vagina | 4 | 4.442 | 0.536 | 1.341 | 2.439 | 0.453 | 0.873 | 1.556 | 0.9 | 4.965 | 5.784
COVID19 (Custom Term) | Facial nerve disorder | 3 | 3.179 | 0.531 | 1.34 | 2.448 | 0.436 | 0.888 | 1.652 | 0.944 | 1.986 | 0.486
COVID19 (Custom Term) | Necrotising fasciitis | 1 | 1.103 | 0.247 | 1.339 | 3.146 | 0.35 | 0.851 | 1.806 | 0.907 | 0.709 | 0.013
COVID19 (Custom Term) | Antibiotic therapy | 1 | 1.37 | 0.307 | 1.339 | 2.961 | 0.33 | 0.804 | 1.707 | 0.73 | 3.31 | 0.054
COVID19 (Custom Term) | Seborrhoea | 1 | 0.953 | 0.259 | 1.338 | 3.101 | 0.362 | 0.88 | 1.867 | 1.049 | 2.482 | 0.004
COVID19 (Custom Term) | Neurological symptom | 52 | 52.896 | 1.055 | 1.338 | 1.649 | 0.776 | 0.974 | 1.209 | 0.983 | 2.413 | 33.391
COVID19 (Custom Term) | Cardiac disorder | 27 | 28.956 | 0.957 | 1.338 | 1.772 | 0.677 | 0.922 | 1.233 | 0.932 | 2.18 | 13.095
COVID19 (Custom Term) | Wound infection | 1 | 0.525 | 0.178 | 1.337 | 3.391 | 0.402 | 0.976 | 2.075 | 1.905 | 0.621 | 0.002
COVID19 (Custom Term) | Septic screen | 2 | 2.481 | 0.283 | 1.337 | 3.029 | 0.376 | 0.825 | 1.621 | 0.806 | 0.602 | 0.17
COVID19 (Custom Term) | Gun shot wound | 1 | 1.303 | 0.308 | 1.337 | 2.954 | 0.334 | 0.815 | 1.73 | 0.767 | 3.31 | 0.054
COVID19 (Custom Term) | Hypoaesthesia eye | 15 | 10.651 | 0.85 | 1.336 | 1.911 | 0.846 | 1.264 | 1.832 | 1.408 | 14.894 | 71.774
COVID19 (Custom Term) | Infant irritability | 1 | 0.827 | 0.309 | 1.336 | 2.952 | 0.373 | 0.906 | 1.922 | 1.209 | 3.31 | 0.054
COVID19 (Custom Term) | Dialysis | 12 | 12.3 | 0.819 | 1.336 | 1.956 | 0.607 | 0.945 | 1.416 | 0.976 | 5.18 | 23.667
COVID19 (Custom Term) | X-ray of pelvis and hip abnormal | 2 | 2.223 | 0.485 | 1.336 | 2.53 | 0.393 | 0.862 | 1.693 | 0.9 | 1.241 | 0.014
COVID19 (Custom Term) | Lid sulcus deepened | 1 | 1.022 | 0.301 | 1.335 | 2.97 | 0.356 | 0.867 | 1.838 | 0.978 | 0.764 | 0.041
COVID19 (Custom Term) | Pigmentation disorder | 1 | 1.501 | 0.207 | 1.335 | 3.275 | 0.32 | 0.783 | 1.662 | 0.666 | 0.301 | 0.918
COVID19 (Custom Term) | Viral test | 13 | 12.432 | 0.828 | 1.334 | 1.938 | 0.652 | 0.999 | 1.479 | 1.046 | 1.033 | 0.001
COVID19 (Custom Term) | Blood calcium | 8 | 6.537 | 0.785 | 1.333 | 1.998 | 0.647 | 1.087 | 1.736 | 1.224 | 3.611 | 9.068
COVID19 (Custom Term) | Scintillating scotoma | 1 | 0.988 | 0.31 | 1.333 | 2.938 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Hyperammonaemia | 1 | 0.993 | 0.262 | 1.333 | 3.08 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | International normalised ratio normal | 25 | 20.683 | 0.939 | 1.332 | 1.781 | 0.838 | 1.154 | 1.558 | 1.209 | 2.277 | 13.454
COVID19 (Custom Term) | Lip oedema | 7 | 6.39 | 0.699 | 1.332 | 2.13 | 0.582 | 1.003 | 1.637 | 1.095 | 1.655 | 0.999
COVID19 (Custom Term) | Haematochezia | 31 | 32.395 | 0.97 | 1.332 | 1.74 | 0.707 | 0.945 | 1.242 | 0.957 | 0.282 | 54.565
COVID19 (Custom Term) | Eyelid contusion | 1 | 0.503 | 0.311 | 1.331 | 2.928 | 0.404 | 0.981 | 2.088 | 1.988 | 3.31 | 0.054
COVID19 (Custom Term) | Generalised oedema | 4 | 3.562 | 0.577 | 1.331 | 2.337 | 0.509 | 0.981 | 1.748 | 1.123 | 1.135 | 0.001
COVID19 (Custom Term) | Ulna fracture | 1 | 0.987 | 0.311 | 1.331 | 2.928 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Interstitial lung disease | 4 | 5.65 | 0.503 | 1.331 | 2.478 | 0.393 | 0.759 | 1.353 | 0.708 | 0.496 | 1.454
COVID19 (Custom Term) | Drug screen | 8 | 7.91 | 0.742 | 1.33 | 2.056 | 0.57 | 0.958 | 1.529 | 1.011 | 2.407 | 4.124
COVID19 (Custom Term) | Choreoathetosis | 1 | 0.995 | 0.312 | 1.33 | 2.924 | 0.359 | 0.872 | 1.849 | 1.005 | 3.31 | 0.054
COVID19 (Custom Term) | Skin wound | 1 | 1.389 | 0.114 | 1.33 | 3.677 | 0.328 | 0.801 | 1.7 | 0.72 | 0.211 | 2.096
COVID19 (Custom Term) | Neutrophil count normal | 22 | 19.177 | 0.91 | 1.329 | 1.812 | 0.782 | 1.098 | 1.508 | 1.147 | 1.168 | 0.325
COVID19 (Custom Term) | Vaginal haemorrhage | 34 | 33.711 | 0.984 | 1.329 | 1.717 | 0.752 | 0.992 | 1.29 | 1.009 | 4.442 | 60.083
COVID19 (Custom Term) | Base excess increased | 3 | 2.975 | 0.472 | 1.329 | 2.538 | 0.449 | 0.916 | 1.704 | 1.009 | 2.291 | 0.807
COVID19 (Custom Term) | Mean cell volume | 2 | 2.041 | 0.472 | 1.329 | 2.537 | 0.406 | 0.89 | 1.749 | 0.98 | 1.103 | 0.065
COVID19 (Custom Term) | Breast inflammation | 1 | 2.002 | 0.312 | 1.329 | 2.923 | 0.289 | 0.71 | 1.513 | 0.5 | 3.31 | 0.054
COVID19 (Custom Term) | Anxiety | 435 | 355.004 | 1.225 | 1.328 | 1.434 | 1.128 | 1.221 | 1.32 | 1.225 | 2.827 | 400.467
COVID19 (Custom Term) | Ultrasound pelvis normal | 1 | 0.525 | 0.324 | 1.327 | 2.881 | 0.402 | 0.976 | 2.075 | 1.905 | 0.827 | 0.089
COVID19 (Custom Term) | Roseola | 1 | 0.99 | 0.424 | 1.327 | 2.635 | 0.359 | 0.873 | 1.852 | 1.01 | 0.451 | 0.191
COVID19 (Custom Term) | Spirometry | 1 | 1.052 | 0.173 | 1.327 | 3.381 | 0.354 | 0.861 | 1.826 | 0.951 | 0.662 | 0.001
COVID19 (Custom Term) | Livedo reticularis | 30 | 24.394 | 0.963 | 1.325 | 1.733 | 0.879 | 1.179 | 1.556 | 1.23 | 2.422 | 18.901
COVID19 (Custom Term) | Dyspnoea exertional | 64 | 61.653 | 1.067 | 1.325 | 1.608 | 0.837 | 1.027 | 1.25 | 1.038 | 7.943 | 211.662
COVID19 (Custom Term) | Pancreatic enzymes increased | 1 | 0.987 | 0.314 | 1.324 | 2.902 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Prostatic specific antigen | 1 | 0.988 | 0.314 | 1.324 | 2.901 | 0.359 | 0.873 | 1.852 | 1.012 | 3.31 | 0.054
COVID19 (Custom Term) | Coating in mouth | 1 | 1.049 | 0.314 | 1.324 | 2.902 | 0.354 | 0.862 | 1.827 | 0.953 | 3.31 | 0.054
COVID19 (Custom Term) | Haemorrhagic stroke | 11 | 11.444 | 0.784 | 1.324 | 1.979 | 0.59 | 0.932 | 1.415 | 0.961 | 9.929 | 39.39
COVID19 (Custom Term) | Scleral disorder | 1 | 0.503 | 0.315 | 1.323 | 2.894 | 0.404 | 0.981 | 2.088 | 1.988 | 3.31 | 0.054
COVID19 (Custom Term) | Protrusion tongue | 2 | 1.504 | 0.544 | 1.323 | 2.377 | 0.449 | 0.984 | 1.936 | 1.33 | 0.794 | 0
COVID19 (Custom Term) | Multiple organ dysfunction syndrome | 12 | 12.131 | 0.789 | 1.323 | 1.968 | 0.614 | 0.955 | 1.431 | 0.989 | 1.528 | 1.425
COVID19 (Custom Term) | Temperature regulation disorder | 3 | 2.993 | 0.385 | 1.322 | 2.713 | 0.448 | 0.913 | 1.699 | 1.002 | 0.327 | 3.331
COVID19 (Custom Term) | Colon cancer | 1 | 1.014 | 0.267 | 1.322 | 3.031 | 0.357 | 0.868 | 1.842 | 0.986 | 2.482 | 0.004
COVID19 (Custom Term) | Maternal exposure before pregnancy | 1 | 2.205 | 0.129 | 1.322 | 3.568 | 0.277 | 0.684 | 1.459 | 0.454 | 0.078 | 9.804
COVID19 (Custom Term) | Nasal discharge discolouration | 1 | 0.503 | 0.254 | 1.321 | 3.07 | 0.404 | 0.981 | 2.088 | 1.988 | 0.709 | 0.013
COVID19 (Custom Term) | Blood electrolytes normal | 13 | 11.207 | 0.806 | 1.321 | 1.939 | 0.706 | 1.082 | 1.601 | 1.16 | 0.687 | 1.433
COVID19 (Custom Term) | Gingival discolouration | 1 | 0.993 | 0.268 | 1.321 | 3.027 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Abdominal lymphadenopathy | 1 | 1.052 | 0.308 | 1.321 | 2.912 | 0.354 | 0.861 | 1.826 | 0.951 | 0.827 | 0.089
COVID19 (Custom Term) | Cardiac flutter | 29 | 23.727 | 0.961 | 1.32 | 1.726 | 0.869 | 1.172 | 1.552 | 1.222 | 7.999 | 94.152
COVID19 (Custom Term) | Blood alkaline phosphatase normal | 29 | 25.363 | 0.955 | 1.32 | 1.734 | 0.82 | 1.105 | 1.465 | 1.143 | 1.756 | 7.33
COVID19 (Custom Term) | Haematocrit decreased | 44 | 41.748 | 1.014 | 1.32 | 1.659 | 0.811 | 1.037 | 1.31 | 1.054 | 1.522 | 6.353
COVID19 (Custom Term) | Food aversion | 1 | 1.055 | 0.209 | 1.32 | 3.22 | 0.354 | 0.86 | 1.825 | 0.948 | 0.226 | 1.832
COVID19 (Custom Term) | Tachyarrhythmia terms, nonspecific (SMQ) [narrow] | 48 | 38.954 | 1.036 | 1.319 | 1.632 | 0.947 | 1.199 | 1.5 | 1.232 | 5.607 | 112.951
COVID19 (Custom Term) | Tachyarrhythmia terms, nonspecific (SMQ) [broad] | 48 | 38.954 | 1.036 | 1.319 | 1.632 | 0.947 | 1.199 | 1.5 | 1.232 | 5.607 | 112.951
COVID19 (Custom Term) | Peritonitis | 3 | 2.977 | 0.424 | 1.319 | 2.615 | 0.449 | 0.916 | 1.703 | 1.008 | 2.482 | 1.02
COVID19 (Custom Term) | Blood urea nitrogen/creatinine ratio | 12 | 10.328 | 0.813 | 1.318 | 1.922 | 0.693 | 1.078 | 1.616 | 1.162 | 5.416 | 24.903
COVID19 (Custom Term) | Computerised tomogram thorax normal | 34 | 32.786 | 0.977 | 1.318 | 1.701 | 0.771 | 1.017 | 1.322 | 1.037 | 5.039 | 70.115
COVID19 (Custom Term) | Corneal graft rejection | 1 | 0.993 | 0.269 | 1.318 | 3.014 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Cryoglobulins | 1 | 0.374 | 0.27 | 1.317 | 3.008 | 0.418 | 1.016 | 2.168 | 2.671 | 2.482 | 0.004
COVID19 (Custom Term) | Dysphonia | 162 | 131.255 | 1.153 | 1.317 | 1.491 | 1.075 | 1.224 | 1.388 | 1.234 | 2.935 | 158.234
COVID19 (Custom Term) | Red blood cell count normal | 26 | 23.824 | 0.934 | 1.317 | 1.755 | 0.773 | 1.058 | 1.421 | 1.091 | 0.637 | 4.676
COVID19 (Custom Term) | Clostridium test negative | 4 | 4.141 | 0.524 | 1.317 | 2.403 | 0.47 | 0.907 | 1.617 | 0.966 | 1.018 | 0.053
COVID19 (Custom Term) | Pericarditis | 47 | 47.373 | 1.018 | 1.316 | 1.645 | 0.774 | 0.981 | 1.231 | 0.992 | 3.333 | 55.598
COVID19 (Custom Term) | Respiratory viral panel | 33 | 31.339 | 0.977 | 1.315 | 1.694 | 0.778 | 1.031 | 1.345 | 1.053 | 3.091 | 33.881
COVID19 (Custom Term) | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [narrow] | 3 | 3.017 | 0.473 | 1.315 | 2.497 | 0.447 | 0.91 | 1.693 | 0.994 | 1.752 | 0.27
COVID19 (Custom Term) | Upper respiratory tract congestion | 7 | 6.536 | 0.661 | 1.314 | 2.148 | 0.573 | 0.989 | 1.613 | 1.071 | 1.545 | 0.702
COVID19 (Custom Term) | Oesophagogastroduodenoscopy abnormal | 2 | 1.984 | 0.466 | 1.314 | 2.511 | 0.41 | 0.899 | 1.767 | 1.008 | 1.986 | 0.162
COVID19 (Custom Term) | Laryngoscopy normal | 1 | 0.995 | 0.271 | 1.314 | 2.997 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Haematology test normal | 3 | 2.542 | 0.478 | 1.313 | 2.484 | 0.481 | 0.981 | 1.825 | 1.18 | 0.931 | 0.03
COVID19 (Custom Term) | Blood bicarbonate normal | 9 | 7.955 | 0.714 | 1.312 | 2.057 | 0.634 | 1.04 | 1.631 | 1.131 | 0.687 | 0.897
COVID19 (Custom Term) | Neutrophil percentage increased | 26 | 24.818 | 0.928 | 1.311 | 1.748 | 0.746 | 1.021 | 1.372 | 1.048 | 1.054 | 0.022
COVID19 (Custom Term) | Tonsillar ulcer | 1 | 0.953 | 0.321 | 1.311 | 2.847 | 0.362 | 0.88 | 1.867 | 1.049 | 3.31 | 0.054
COVID19 (Custom Term) | International normalised ratio increased | 32 | 31.237 | 0.964 | 1.311 | 1.701 | 0.756 | 1.005 | 1.316 | 1.024 | 3.345 | 37.45
COVID19 (Custom Term) | Autoimmune hepatitis | 2 | 2.581 | 0.293 | 1.311 | 2.922 | 0.37 | 0.811 | 1.595 | 0.775 | 0.462 | 0.699
COVID19 (Custom Term) | Pleural thickening | 1 | 0.988 | 0.219 | 1.31 | 3.155 | 0.359 | 0.873 | 1.852 | 1.012 | 1.986 | 0.005
COVID19 (Custom Term) | Lymph gland infection | 1 | 0.995 | 0.388 | 1.31 | 2.676 | 0.359 | 0.872 | 1.849 | 1.005 | 0.903 | 0.162
COVID19 (Custom Term) | Endoscopy normal | 4 | 4.026 | 0.522 | 1.31 | 2.389 | 0.478 | 0.921 | 1.641 | 0.994 | 1.528 | 0.229
COVID19 (Custom Term) | Blood ethanol normal | 1 | 1.02 | 0.273 | 1.31 | 2.979 | 0.357 | 0.867 | 1.839 | 0.98 | 2.482 | 0.004
COVID19 (Custom Term) | Prostatomegaly | 1 | 0.137 | 0.274 | 1.309 | 2.976 | 0.446 | 1.099 | 2.385 | 7.285 | 2.482 | 0.004
COVID19 (Custom Term) | Amblyopia | 1 | 0.995 | 0.354 | 1.309 | 2.756 | 0.359 | 0.872 | 1.849 | 1.005 | 0.827 | 0.089
COVID19 (Custom Term) | Blood triglycerides normal | 6 | 4.582 | 0.638 | 1.308 | 2.17 | 0.62 | 1.103 | 1.845 | 1.309 | 2.383 | 2.753
COVID19 (Custom Term) | Other ischaemic heart disease (SMQ) [broad] | 114 | 108.807 | 1.114 | 1.308 | 1.515 | 0.892 | 1.041 | 1.209 | 1.048 | 6.086 | 297.191
COVID19 (Custom Term) | Neutrophil count abnormal | 1 | 0.987 | 0.323 | 1.308 | 2.832 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Hypermetabolism | 1 | 0.993 | 0.275 | 1.308 | 2.968 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Bacterial test positive | 10 | 10.042 | 0.751 | 1.308 | 1.99 | 0.593 | 0.954 | 1.471 | 0.996 | 0.946 | 0
COVID19 (Custom Term) | Influenza virus test positive | 5 | 6.87 | 0.534 | 1.308 | 2.357 | 0.415 | 0.766 | 1.319 | 0.728 | 0.316 | 6.457
COVID19 (Custom Term) | Heart rate irregular | 67 | 60.834 | 1.06 | 1.307 | 1.576 | 0.889 | 1.087 | 1.317 | 1.101 | 4.377 | 118.658
COVID19 (Custom Term) | Plicated tongue | 1 | 0.995 | 0.275 | 1.307 | 2.963 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Nasal mucosal discolouration | 1 | 0.503 | 0.276 | 1.306 | 2.959 | 0.404 | 0.981 | 2.088 | 1.988 | 2.482 | 0.004
COVID19 (Custom Term) | Wound drainage | 1 | 0.987 | 0.324 | 1.306 | 2.826 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Visual tracking test abnormal | 1 | 0.374 | 0.222 | 1.305 | 3.13 | 0.418 | 1.016 | 2.168 | 2.671 | 1.986 | 0.005
COVID19 (Custom Term) | Echovirus test negative | 1 | 0.993 | 0.276 | 1.305 | 2.955 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Incorrect dose administered | 113 | 118.822 | 1.111 | 1.305 | 1.513 | 0.812 | 0.948 | 1.101 | 0.951 | 1.038 | 0.107
COVID19 (Custom Term) | Urosepsis | 3 | 3.344 | 0.434 | 1.305 | 2.555 | 0.425 | 0.867 | 1.613 | 0.897 | 2.708 | 1.277
COVID19 (Custom Term) | Ultrasound breast abnormal | 1 | 1.498 | 0.276 | 1.305 | 2.956 | 0.321 | 0.783 | 1.663 | 0.667 | 2.482 | 0.004
COVID19 (Custom Term) | Oral discomfort | 44 | 33.773 | 1.02 | 1.304 | 1.617 | 0.984 | 1.258 | 1.589 | 1.303 | 4.551 | 80.969
COVID19 (Custom Term) | Blood creatinine increased | 116 | 114.311 | 1.112 | 1.304 | 1.508 | 0.866 | 1.009 | 1.171 | 1.015 | 4.499 | 214.841
COVID19 (Custom Term) | Hypoalbuminaemia | 1 | 0.995 | 0.387 | 1.304 | 2.661 | 0.359 | 0.872 | 1.849 | 1.005 | 0.473 | 0.144
COVID19 (Custom Term) | Hypovolaemia | 5 | 4.995 | 0.648 | 1.304 | 2.146 | 0.506 | 0.933 | 1.607 | 1.001 | 6.206 | 10.142
COVID19 (Custom Term) | Central nervous system vasculitis | 1 | 1.206 | 0.35 | 1.304 | 2.752 | 0.342 | 0.833 | 1.766 | 0.83 | 0.903 | 0.162
COVID19 (Custom Term) | Dry throat | 79 | 58.987 | 1.079 | 1.303 | 1.544 | 1.089 | 1.31 | 1.566 | 1.339 | 9.805 | 309.583
COVID19 (Custom Term) | Maternal exposure during breast feeding | 13 | 10.762 | 0.78 | 1.303 | 1.936 | 0.728 | 1.115 | 1.651 | 1.208 | 3.002 | 11.69
COVID19 (Custom Term) | Disseminated intravascular coagulation | 7 | 7.006 | 0.655 | 1.303 | 2.129 | 0.548 | 0.945 | 1.542 | 0.999 | 2.574 | 4.064
COVID19 (Custom Term) | Antinuclear antibody increased | 1 | 1.188 | 0.348 | 1.303 | 2.751 | 0.343 | 0.836 | 1.773 | 0.842 | 0.473 | 0.144
COVID19 (Custom Term) | Spinal disorder | 1 | 0.167 | 0.194 | 1.302 | 3.223 | 0.443 | 1.086 | 2.346 | 5.987 | 0.414 | 0.298
COVID19 (Custom Term) | Stress at work | 1 | 0.503 | 0.278 | 1.302 | 2.943 | 0.404 | 0.981 | 2.088 | 1.988 | 2.482 | 0.004
COVID19 (Custom Term) | Peak expiratory flow rate | 1 | 0.987 | 0.278 | 1.302 | 2.942 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Wrong technique in product usage process | 17 | 22.403 | 0.835 | 1.302 | 1.853 | 0.526 | 0.77 | 1.096 | 0.759 | 0.224 | 44.098
COVID19 (Custom Term) | Pregnancy test | 6 | 5.02 | 0.628 | 1.301 | 2.171 | 0.589 | 1.047 | 1.751 | 1.195 | 2.383 | 2.753
COVID19 (Custom Term) | Red blood cell analysis | 1 | 0.988 | 0.278 | 1.301 | 2.939 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Food craving | 1 | 1.06 | 0.224 | 1.301 | 3.113 | 0.353 | 0.859 | 1.823 | 0.943 | 1.986 | 0.005
COVID19 (Custom Term) | Echocardiogram abnormal | 41 | 42.185 | 0.989 | 1.3 | 1.646 | 0.746 | 0.961 | 1.224 | 0.972 | 2.249 | 22.098
COVID19 (Custom Term) | Haematocrit abnormal | 1 | 1.866 | 0.327 | 1.3 | 2.8 | 0.297 | 0.729 | 1.55 | 0.536 | 3.31 | 0.054
COVID19 (Custom Term) | Lip blister | 16 | 14.075 | 0.843 | 1.299 | 1.836 | 0.728 | 1.076 | 1.544 | 1.137 | 1.785 | 3.98
COVID19 (Custom Term) | Frustration tolerance decreased | 5 | 4.502 | 0.628 | 1.299 | 2.166 | 0.537 | 0.99 | 1.705 | 1.111 | 0.955 | 0.017
COVID19 (Custom Term) | Myelodysplastic syndrome | 1 | 1.01 | 0.225 | 1.299 | 3.1 | 0.357 | 0.869 | 1.843 | 0.99 | 1.986 | 0.005
COVID19 (Custom Term) | Increased tendency to bruise | 3 | 3.551 | 0.463 | 1.299 | 2.478 | 0.413 | 0.842 | 1.566 | 0.845 | 0.465 | 1.243
COVID19 (Custom Term) | Diagnostic aspiration | 1 | 1.498 | 0.358 | 1.299 | 2.716 | 0.321 | 0.783 | 1.663 | 0.667 | 0.827 | 0.089
COVID19 (Custom Term) | Vascular test | 1 | 1.873 | 0.28 | 1.299 | 2.927 | 0.296 | 0.728 | 1.548 | 0.534 | 2.482 | 0.004
COVID19 (Custom Term) | Tracheal aspiration procedure | 1 | 0.995 | 0.163 | 1.298 | 3.335 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Arthropod bite | 2 | 1.248 | 0.357 | 1.297 | 2.715 | 0.473 | 1.037 | 2.042 | 1.602 | 0.342 | 1.793
COVID19 (Custom Term) | Cryptococcus test | 5 | 5.028 | 0.672 | 1.297 | 2.088 | 0.504 | 0.93 | 1.601 | 0.995 | 2.159 | 1.614
COVID19 (Custom Term) | Ultrasound Doppler | 56 | 60.136 | 1.028 | 1.297 | 1.591 | 0.744 | 0.926 | 1.141 | 0.931 | 5.197 | 121.628
COVID19 (Custom Term) | Deafness neurosensory | 20 | 22.54 | 0.87 | 1.297 | 1.795 | 0.618 | 0.881 | 1.225 | 0.887 | 1.856 | 5.884
COVID19 (Custom Term) | Blood creatine increased | 7 | 6.013 | 0.674 | 1.296 | 2.083 | 0.605 | 1.042 | 1.701 | 1.164 | 7.723 | 19.07
COVID19 (Custom Term) | Hemiplegia | 24 | 24.421 | 0.903 | 1.296 | 1.748 | 0.696 | 0.964 | 1.309 | 0.983 | 2.59 | 17.227
COVID19 (Custom Term) | Rectal haemorrhage | 14 | 14.29 | 0.799 | 1.296 | 1.89 | 0.629 | 0.951 | 1.393 | 0.98 | 1.655 | 2.523
COVID19 (Custom Term) | Speech sound disorder | 1 | 0.503 | 0.282 | 1.295 | 2.91 | 0.404 | 0.981 | 2.088 | 1.988 | 2.482 | 0.004
COVID19 (Custom Term) | Mean cell haemoglobin decreased | 8 | 7.953 | 0.68 | 1.295 | 2.069 | 0.568 | 0.954 | 1.524 | 1.006 | 0.567 | 2.067
COVID19 (Custom Term) | CSF cell count | 2 | 2.818 | 0.31 | 1.295 | 2.831 | 0.356 | 0.781 | 1.536 | 0.71 | 0.685 | 0.044
COVID19 (Custom Term) | Occupational exposure to SARS-CoV-2 | 22 | 17.015 | 0.879 | 1.294 | 1.773 | 0.864 | 1.213 | 1.666 | 1.293 | 446.803 | 207.664
COVID19 (Custom Term) | Blood albumin normal | 31 | 28.919 | 0.948 | 1.294 | 1.684 | 0.783 | 1.046 | 1.375 | 1.072 | 2.247 | 16.397
COVID19 (Custom Term) | Extraocular muscle paresis | 6 | 5.617 | 0.636 | 1.294 | 2.14 | 0.55 | 0.979 | 1.637 | 1.068 | 6.619 | 13.664
COVID19 (Custom Term) | Laziness | 1 | 0.995 | 0.283 | 1.294 | 2.903 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Activated partial thromboplastin time shortened | 9 | 7.448 | 0.741 | 1.293 | 1.969 | 0.663 | 1.088 | 1.705 | 1.208 | 2.078 | 3.24
COVID19 (Custom Term) | Culture tissue specimen negative | 1 | 0.995 | 0.166 | 1.293 | 3.305 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Genital swelling | 1 | 0.374 | 0.405 | 1.292 | 2.584 | 0.418 | 1.016 | 2.168 | 2.671 | 0.903 | 0.162
COVID19 (Custom Term) | Aspartate aminotransferase normal | 31 | 28.879 | 0.943 | 1.292 | 1.687 | 0.784 | 1.047 | 1.376 | 1.073 | 1.019 | 0
COVID19 (Custom Term) | PO2 increased | 3 | 2.964 | 0.456 | 1.292 | 2.471 | 0.45 | 0.917 | 1.707 | 1.012 | 1.986 | 0.486
COVID19 (Custom Term) | Influenza virus test | 36 | 31.255 | 0.967 | 1.291 | 1.655 | 0.854 | 1.119 | 1.446 | 1.152 | 2.668 | 28.166
COVID19 (Custom Term) | Cranial nerve disorder | 2 | 1.689 | 0.443 | 1.291 | 2.497 | 0.433 | 0.95 | 1.866 | 1.184 | 1.103 | 0.065
COVID19 (Custom Term) | Diverticulitis | 16 | 15.646 | 0.839 | 1.291 | 1.822 | 0.669 | 0.988 | 1.418 | 1.023 | 6.619 | 42.166
COVID19 (Custom Term) | Colostomy | 1 | 0.995 | 0.143 | 1.291 | 3.404 | 0.359 | 0.872 | 1.849 | 1.005 | 1.418 | 0.081
COVID19 (Custom Term) | Discoloured vomit | 4 | 4.039 | 0.527 | 1.291 | 2.33 | 0.477 | 0.919 | 1.639 | 0.99 | 3.055 | 2.676
COVID19 (Custom Term) | Motor neurone disease | 1 | 1.091 | 0.327 | 1.291 | 2.774 | 0.351 | 0.854 | 1.81 | 0.917 | 0.827 | 0.089
COVID19 (Custom Term) | Analgesic drug level therapeutic | 1 | 1.033 | 0.299 | 1.29 | 2.847 | 0.355 | 0.865 | 1.834 | 0.968 | 0.764 | 0.041
COVID19 (Custom Term) | Renovascular disorders (SMQ) [broad] | 11 | 11.829 | 0.745 | 1.29 | 1.956 | 0.575 | 0.909 | 1.38 | 0.93 | 1.734 | 2.261
COVID19 (Custom Term) | Toxic epidermal necrolysis | 1 | 1.143 | 0.18 | 1.29 | 3.241 | 0.347 | 0.844 | 1.79 | 0.875 | 0.709 | 0.013
COVID19 (Custom Term) | Blood cholesterol normal | 5 | 4.205 | 0.641 | 1.289 | 2.118 | 0.557 | 1.028 | 1.77 | 1.189 | 1.379 | 0.164
COVID19 (Custom Term) | Congestive cardiomyopathy | 1 | 0.987 | 0.32 | 1.289 | 2.787 | 0.359 | 0.874 | 1.853 | 1.013 | 0.764 | 0.041
COVID19 (Custom Term) | Human chorionic gonadotropin decreased | 8 | 8.466 | 0.698 | 1.289 | 2.027 | 0.544 | 0.913 | 1.459 | 0.945 | 15.887 | 36.853
COVID19 (Custom Term) | Ischaemic colitis (SMQ) [broad] | 114 | 120.421 | 1.098 | 1.289 | 1.493 | 0.809 | 0.944 | 1.096 | 0.947 | 0.651 | 19.779
COVID19 (Custom Term) | Electrocardiogram abnormal | 154 | 140.685 | 1.123 | 1.288 | 1.463 | 0.953 | 1.088 | 1.239 | 1.095 | 4.854 | 314.126
COVID19 (Custom Term) | Staphylococcus test negative | 6 | 5.46 | 0.687 | 1.288 | 2.042 | 0.56 | 0.996 | 1.665 | 1.099 | 2.837 | 4.09
COVID19 (Custom Term) | Alanine aminotransferase normal | 33 | 31.381 | 0.947 | 1.288 | 1.671 | 0.777 | 1.03 | 1.343 | 1.052 | 0.886 | 0.34
COVID19 (Custom Term) | Osteonecrosis (SMQ) [narrow] | 1 | 1.076 | 0.365 | 1.288 | 2.667 | 0.352 | 0.856 | 1.816 | 0.929 | 0.903 | 0.162
COVID19 (Custom Term) | Upper-airway cough syndrome | 36 | 28.454 | 0.966 | 1.287 | 1.644 | 0.929 | 1.217 | 1.572 | 1.265 | 4.062 | 56.623
COVID19 (Custom Term) | Exposure via breast milk | 6 | 4.882 | 0.611 | 1.287 | 2.166 | 0.598 | 1.064 | 1.779 | 1.229 | 7.447 | 15.296
COVID19 (Custom Term) | Blood gases normal | 3 | 2.521 | 0.518 | 1.287 | 2.334 | 0.483 | 0.984 | 1.831 | 1.19 | 0.876 | 0.004
COVID19 (Custom Term) | Resuscitation | 129 | 132.679 | 1.109 | 1.287 | 1.477 | 0.838 | 0.969 | 1.115 | 0.972 | 4.372 | 230.619
COVID19 (Custom Term) | Pregnancy test urine | 5 | 3.992 | 0.576 | 1.286 | 2.225 | 0.573 | 1.057 | 1.82 | 1.252 | 4.965 | 7.845
COVID19 (Custom Term) | Gastric haemorrhage | 1 | 0.925 | 0.287 | 1.286 | 2.866 | 0.365 | 0.886 | 1.879 | 1.081 | 2.482 | 0.004
COVID19 (Custom Term) | Cardio-respiratory distress | 1 | 0.987 | 0.287 | 1.286 | 2.868 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Prothrombin time shortened | 3 | 3.004 | 0.46 | 1.286 | 2.448 | 0.447 | 0.912 | 1.696 | 0.999 | 1.241 | 0
COVID19 (Custom Term) | Conduction disorder | 1 | 1.015 | 0.287 | 1.286 | 2.866 | 0.357 | 0.868 | 1.841 | 0.985 | 2.482 | 0.004
COVID19 (Custom Term) | Apparent life threatening event | 6 | 6.603 | 0.609 | 1.286 | 2.168 | 0.497 | 0.884 | 1.479 | 0.909 | 0.505 | 2.279
COVID19 (Custom Term) | Peripheral sensorimotor neuropathy | 1 | 1.156 | 0.339 | 1.286 | 2.726 | 0.346 | 0.841 | 1.785 | 0.865 | 0.903 | 0.162
COVID19 (Custom Term) | Throat clearing | 62 | 47.904 | 1.032 | 1.285 | 1.562 | 1.025 | 1.262 | 1.541 | 1.294 | 32.401 | 434.606
COVID19 (Custom Term) | Tongue ulceration | 5 | 4.572 | 0.65 | 1.285 | 2.094 | 0.532 | 0.982 | 1.69 | 1.094 | 1.379 | 0.164
COVID19 (Custom Term) | Mycoplasma test negative | 5 | 4.652 | 0.577 | 1.284 | 2.218 | 0.527 | 0.972 | 1.674 | 1.075 | 0.709 | 0.298
COVID19 (Custom Term) | Monocyte count decreased | 10 | 9.446 | 0.739 | 1.284 | 1.95 | 0.62 | 0.998 | 1.538 | 1.059 | 4.965 | 18.3
COVID19 (Custom Term) | Autoantibody test | 1 | 0.987 | 0.288 | 1.284 | 2.859 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Heart rate abnormal | 13 | 10.511 | 0.805 | 1.283 | 1.851 | 0.741 | 1.135 | 1.68 | 1.237 | 3.31 | 13.869
COVID19 (Custom Term) | Hiccups | 4 | 3.379 | 0.6 | 1.283 | 2.174 | 0.522 | 1.006 | 1.794 | 1.184 | 1.241 | 0.014
COVID19 (Custom Term) | Mean platelet volume normal | 22 | 19.422 | 0.887 | 1.283 | 1.739 | 0.774 | 1.087 | 1.492 | 1.133 | 2.163 | 10.271
COVID19 (Custom Term) | Chest wall mass | 1 | 0.987 | 0.337 | 1.283 | 2.726 | 0.359 | 0.874 | 1.853 | 1.013 | 3.31 | 0.054
COVID19 (Custom Term) | Protein urine absent | 5 | 5.125 | 0.602 | 1.283 | 2.172 | 0.498 | 0.919 | 1.583 | 0.976 | 0.709 | 0.298
COVID19 (Custom Term) | CSF white blood cell count | 1 | 1.951 | 0.289 | 1.283 | 2.853 | 0.292 | 0.717 | 1.527 | 0.513 | 2.482 | 0.004
COVID19 (Custom Term) | PCO2 normal | 2 | 2.104 | 0.341 | 1.282 | 2.714 | 0.401 | 0.88 | 1.729 | 0.951 | 0.423 | 0.966
COVID19 (Custom Term) | CSF culture | 4 | 4.373 | 0.517 | 1.282 | 2.323 | 0.457 | 0.881 | 1.57 | 0.915 | 0.883 | 0
COVID19 (Custom Term) | Hepatitis C test negative | 5 | 6.461 | 0.541 | 1.282 | 2.278 | 0.432 | 0.797 | 1.373 | 0.774 | 0.407 | 3.549
COVID19 (Custom Term) | Prothrombin time prolonged | 18 | 17.585 | 0.846 | 1.28 | 1.787 | 0.685 | 0.992 | 1.4 | 1.024 | 2.415 | 10.789
COVID19 (Custom Term) | Reactogenicity event | 1 | 1.022 | 0.122 | 1.279 | 3.464 | 0.356 | 0.867 | 1.838 | 0.978 | 1.103 | 0.207
COVID19 (Custom Term) | Continuous positive airway pressure | 4 | 4.885 | 0.515 | 1.279 | 2.319 | 0.429 | 0.828 | 1.475 | 0.819 | 0.651 | 0.388
COVID19 (Custom Term) | Parasite stool test | 1 | 0.995 | 0.237 | 1.278 | 2.997 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [narrow] | 1 | 1.022 | 0.105 | 1.278 | 3.56 | 0.356 | 0.867 | 1.838 | 0.978 | 1.418 | 0.081
COVID19 (Custom Term) | Anti-muscle specific kinase antibody | 1 | 1.042 | 0.292 | 1.278 | 2.831 | 0.355 | 0.863 | 1.83 | 0.96 | 2.482 | 0.004
COVID19 (Custom Term) | Urinary tract inflammation | 1 | 1.05 | 0.238 | 1.278 | 2.995 | 0.354 | 0.861 | 1.827 | 0.952 | 1.986 | 0.005
COVID19 (Custom Term) | Syringe issue | 28 | 33.308 | 0.911 | 1.278 | 1.695 | 0.62 | 0.84 | 1.118 | 0.841 | 0.505 | 12.398
COVID19 (Custom Term) | Genital lesion | 1 | 1.49 | 0.238 | 1.278 | 2.997 | 0.321 | 0.785 | 1.666 | 0.671 | 1.986 | 0.005
COVID19 (Custom Term) | Initial insomnia | 8 | 6.528 | 0.653 | 1.277 | 2.07 | 0.648 | 1.088 | 1.738 | 1.226 | 0.935 | 0
COVID19 (Custom Term) | Toxicologic test abnormal | 1 | 0.987 | 0.293 | 1.277 | 2.828 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Coombs direct test negative | 1 | 1.022 | 0.308 | 1.277 | 2.782 | 0.356 | 0.867 | 1.838 | 0.978 | 0.764 | 0.041
COVID19 (Custom Term) | X-ray dental | 1 | 1.044 | 0.293 | 1.277 | 2.826 | 0.355 | 0.863 | 1.829 | 0.958 | 2.482 | 0.004
COVID19 (Custom Term) | Duodenitis | 1 | 0.988 | 0.293 | 1.276 | 2.822 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Dysuria | 19 | 19.139 | 0.848 | 1.276 | 1.775 | 0.674 | 0.968 | 1.356 | 0.993 | 0.78 | 0.885
COVID19 (Custom Term) | Retinogram abnormal | 1 | 0.993 | 0.294 | 1.275 | 2.817 | 0.359 | 0.872 | 1.85 | 1.007 | 2.482 | 0.004
COVID19 (Custom Term) | Bladder cancer | 1 | 1.02 | 0.294 | 1.275 | 2.817 | 0.357 | 0.867 | 1.839 | 0.98 | 2.482 | 0.004
COVID19 (Custom Term) | Urine output decreased | 7 | 6.99 | 0.675 | 1.274 | 2.026 | 0.549 | 0.946 | 1.544 | 1.001 | 0.662 | 0.811
COVID19 (Custom Term) | X-ray abnormal | 13 | 14.073 | 0.781 | 1.273 | 1.864 | 0.591 | 0.907 | 1.342 | 0.924 | 0.705 | 1.207
COVID19 (Custom Term) | Mouth ulceration | 8 | 7.045 | 0.692 | 1.271 | 1.993 | 0.616 | 1.035 | 1.654 | 1.136 | 0.742 | 0.428
COVID19 (Custom Term) | Hypertensive crisis | 5 | 4.542 | 0.615 | 1.271 | 2.119 | 0.534 | 0.985 | 1.696 | 1.101 | 2.159 | 1.614
COVID19 (Custom Term) | Oesophageal discomfort | 1 | 0.503 | 0.297 | 1.27 | 2.794 | 0.404 | 0.981 | 2.088 | 1.988 | 2.482 | 0.004
COVID19 (Custom Term) | Liver-related coagulation and bleeding disturbances (SMQ) [narrow] | 40 | 39.664 | 0.964 | 1.27 | 1.609 | 0.769 | 0.994 | 1.269 | 1.008 | 2.296 | 22.631
COVID19 (Custom Term) | Liver-related coagulation and bleeding disturbances (SMQ) [broad] | 40 | 39.664 | 0.964 | 1.27 | 1.609 | 0.769 | 0.994 | 1.269 | 1.008 | 2.296 | 22.631
COVID19 (Custom Term) | Cerebral disorder | 2 | 2.066 | 0.378 | 1.269 | 2.585 | 0.404 | 0.886 | 1.741 | 0.968 | 0.315 | 2.2
COVID19 (Custom Term) | Malnutrition | 2 | 2.551 | 0.315 | 1.269 | 2.744 | 0.371 | 0.815 | 1.603 | 0.784 | 0.794 | 0
COVID19 (Custom Term) | Blood HIV RNA below assay limit | 1 | 1.92 | 0.298 | 1.268 | 2.787 | 0.294 | 0.721 | 1.535 | 0.521 | 2.482 | 0.004
COVID19 (Custom Term) | Blood sodium normal | 56 | 53.097 | 1.006 | 1.267 | 1.552 | 0.836 | 1.041 | 1.283 | 1.055 | 1.598 | 10.242
COVID19 (Custom Term) | IL-2 receptor assay | 1 | 0.988 | 0.299 | 1.267 | 2.78 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Haemolysis | 3 | 4.13 | 0.415 | 1.267 | 2.496 | 0.381 | 0.779 | 1.449 | 0.726 | 0.784 | 0.019
COVID19 (Custom Term) | Nervousness | 105 | 88.715 | 1.071 | 1.266 | 1.475 | 0.996 | 1.17 | 1.367 | 1.184 | 2.639 | 83.17
COVID19 (Custom Term) | Ear injury | 1 | 0.987 | 0.3 | 1.266 | 2.774 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Urine leukocyte esterase | 7 | 7.397 | 0.703 | 1.266 | 1.963 | 0.528 | 0.911 | 1.487 | 0.946 | 2.242 | 2.894
COVID19 (Custom Term) | Scleritis | 1 | 1.103 | 0.332 | 1.266 | 2.688 | 0.35 | 0.851 | 1.806 | 0.907 | 0.827 | 0.089
COVID19 (Custom Term) | Increased upper airway secretion | 10 | 7.903 | 0.745 | 1.265 | 1.898 | 0.703 | 1.132 | 1.745 | 1.265 | 1.601 | 1.417
COVID19 (Custom Term) | Oropharyngeal discomfort | 107 | 86.431 | 1.073 | 1.265 | 1.47 | 1.042 | 1.222 | 1.426 | 1.238 | 16.345 | 576.458
COVID19 (Custom Term) | Rhinorrhoea | 315 | 265.476 | 1.15 | 1.265 | 1.384 | 1.077 | 1.182 | 1.295 | 1.187 | 1.761 | 87.834
COVID19 (Custom Term) | Eosinophil percentage | 21 | 18.884 | 0.864 | 1.265 | 1.728 | 0.755 | 1.068 | 1.476 | 1.112 | 1.219 | 0.539
COVID19 (Custom Term) | Left ventricular dysfunction | 7 | 6.876 | 0.657 | 1.265 | 2.034 | 0.555 | 0.957 | 1.561 | 1.018 | 9.929 | 23.406
COVID19 (Custom Term) | Metabolic function test abnormal | 10 | 10.315 | 0.716 | 1.265 | 1.94 | 0.582 | 0.936 | 1.442 | 0.969 | 3.203 | 9.697
COVID19 (Custom Term) | Eustachian tube obstruction | 1 | 1.047 | 0.3 | 1.265 | 2.772 | 0.354 | 0.862 | 1.828 | 0.955 | 2.482 | 0.004
COVID19 (Custom Term) | Antineutrophil cytoplasmic antibody positive | 1 | 0.988 | 0.181 | 1.264 | 3.156 | 0.359 | 0.873 | 1.852 | 1.012 | 0.451 | 0.191
COVID19 (Custom Term) | Functional, inflammatory and gallstone related biliary disorders (SMQ) [narrow] | 70 | 69.586 | 1.028 | 1.264 | 1.52 | 0.82 | 0.998 | 1.205 | 1.006 | 1.796 | 20.204
COVID19 (Custom Term) | Vitamin B6 | 1 | 0.996 | 0.246 | 1.264 | 2.928 | 0.359 | 0.872 | 1.849 | 1.004 | 1.986 | 0.005
COVID19 (Custom Term) | Poisoning | 1 | 1.022 | 0.263 | 1.264 | 2.875 | 0.356 | 0.867 | 1.838 | 0.978 | 0.709 | 0.013
COVID19 (Custom Term) | Paresis | 2 | 2.545 | 0.288 | 1.264 | 2.803 | 0.372 | 0.816 | 1.604 | 0.786 | 0.292 | 2.621
COVID19 (Custom Term) | Systemic inflammatory response syndrome | 14 | 14.43 | 0.772 | 1.263 | 1.853 | 0.624 | 0.944 | 1.382 | 0.97 | 2.044 | 5.278
COVID19 (Custom Term) | C-reactive protein increased | 91 | 96.43 | 1.055 | 1.263 | 1.486 | 0.791 | 0.94 | 1.11 | 0.944 | 0.581 | 25.656
COVID19 (Custom Term) | Hepatitis C antibody negative | 4 | 4.423 | 0.457 | 1.263 | 2.393 | 0.454 | 0.875 | 1.56 | 0.904 | 0.328 | 4.633
COVID19 (Custom Term) | Taste disorder | 95 | 79.434 | 1.059 | 1.262 | 1.48 | 0.997 | 1.18 | 1.39 | 1.196 | 24.823 | 613.349
COVID19 (Custom Term) | Body temperature abnormal | 14 | 12.851 | 0.775 | 1.262 | 1.844 | 0.684 | 1.034 | 1.514 | 1.089 | 4.344 | 22.579
COVID19 (Custom Term) | Hypoperfusion | 1 | 0.993 | 0.141 | 1.262 | 3.317 | 0.359 | 0.872 | 1.85 | 1.007 | 1.418 | 0.081
COVID19 (Custom Term) | Hypermetropia | 1 | 1.025 | 0.365 | 1.262 | 2.598 | 0.356 | 0.866 | 1.837 | 0.976 | 0.827 | 0.089
COVID19 (Custom Term) | Vaccination site streaking | 1 | 1.064 | 0.248 | 1.262 | 2.916 | 0.353 | 0.859 | 1.821 | 0.94 | 1.986 | 0.005
COVID19 (Custom Term) | Protein total decreased | 7 | 7.648 | 0.625 | 1.262 | 2.078 | 0.517 | 0.891 | 1.454 | 0.915 | 0.688 | 0.632
COVID19 (Custom Term) | Brain hypoxia | 1 | 0.987 | 0.248 | 1.261 | 2.913 | 0.359 | 0.874 | 1.853 | 1.013 | 1.986 | 0.005
COVID19 (Custom Term) | Penile haemorrhage | 1 | 0.988 | 0.303 | 1.261 | 2.755 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Breath sounds normal | 1 | 0.998 | 0.303 | 1.261 | 2.751 | 0.358 | 0.871 | 1.848 | 1.002 | 2.482 | 0.004
COVID19 (Custom Term) | Anticonvulsant drug level | 1 | 0.374 | 0.303 | 1.26 | 2.75 | 0.418 | 1.016 | 2.168 | 2.671 | 2.482 | 0.004
COVID19 (Custom Term) | Feeling jittery | 59 | 45.894 | 1.013 | 1.26 | 1.53 | 1.012 | 1.253 | 1.537 | 1.286 | 6.974 | 173.59
COVID19 (Custom Term) | SARS-CoV-2 antibody test positive | 27 | 23.77 | 0.903 | 1.26 | 1.666 | 0.805 | 1.097 | 1.466 | 1.136 | 546.093 | 257.292
COVID19 (Custom Term) | Hernia repair | 1 | 0.988 | 0.303 | 1.26 | 2.75 | 0.359 | 0.873 | 1.852 | 1.012 | 2.482 | 0.004
COVID19 (Custom Term) | Gaze palsy | 17 | 17.09 | 0.825 | 1.26 | 1.771 | 0.661 | 0.968 | 1.377 | 0.995 | 0.482 | 8.484
COVID19 (Custom Term) | Cervical spinal stenosis | 2 | 2.029 | 0.429 | 1.26 | 2.445 | 0.407 | 0.892 | 1.752 | 0.986 | 2.206 | 0.266
COVID19 (Custom Term) | Autopsy | 30 | 32.17 | 0.913 | 1.259 | 1.651 | 0.688 | 0.923 | 1.218 | 0.933 | 0.983 | 0
COVID19 (Custom Term) | Mycobacterium test | 1 | 1.492 | 0.156 | 1.259 | 3.243 | 0.321 | 0.784 | 1.666 | 0.67 | 0.621 | 0.002
COVID19 (Custom Term) | Mean cell haemoglobin concentration normal | 26 | 24.31 | 0.891 | 1.258 | 1.678 | 0.759 | 1.04 | 1.396 | 1.07 | 1.024 | 0
COVID19 (Custom Term) | Blood corticotrophin | 1 | 0.995 | 0.305 | 1.258 | 2.738 | 0.359 | 0.872 | 1.849 | 1.005 | 2.482 | 0.004
COVID19 (Custom Term) | Renal mass | 1 | 1.02 | 0.305 | 1.258 | 2.74 | 0.357 | 0.867 | 1.839 | 0.98 | 2.482 | 0.004
COVID19 (Custom Term) | Rhabdomyolysis | 17 | 17.75 | 0.813 | 1.258 | 1.784 | 0.641 | 0.938 | 1.334 | 0.958 | 1.655 | 3.185
COVID19 (Custom Term) | Cachexia | 1 | 1.015 | 0.251 | 1.257 | 2.892 | 0.357 | 0.868 | 1.841 | 0.985 | 1.986 | 0.005
COVID19 (Custom Term) | Ophthalmic herpes simplex | 1 | 1.261 | 0.109 | 1.257 | 3.464 | 0.338 | 0.823 | 1.746 | 0.793 | 0.552 | 0.036
COVID19 (Custom Term) | Frequent bowel movements | 13 | 11.982 | 0.764 | 1.256 | 1.846 | 0.671 | 1.028 | 1.522 | 1.085 | 0.903 | 0.046
COVID19 (Custom Term) | Pulmonary haemorrhage | 1 | 1.022 | 0.388 | 1.256 | 2.524 | 0.356 | 0.867 | 1.838 | 0.978 | 0.827 | 0.089
COVID19 (Custom Term) | Red blood cell sedimentation rate abnormal | 1 | 1.049 | 0.307 | 1.256 | 2.728 | 0.354 | 0.862 | 1.827 | 0.953 | 2.482 | 0.004
COVID19 (Custom Term) | Herpes simplex | 8 | 11.194 | 0.656 | 1.256 | 2.014 | 0.443 | 0.745 | 1.19 | 0.715 | 1.005 | 0.029
COVID19 (Custom Term) | Hypertension | 425 | 355.545 | 1.157 | 1.255 | 1.356 | 1.1 | 1.192 | 1.289 | 1.195 | 7.617 | 1382.379
COVID19 (Custom Term) | Metabolic encephalopathy | 7 | 7.322 | 0.664 | 1.255 | 1.997 | 0.532 | 0.918 | 1.497 | 0.956 | 8.688 | 21.087
COVID19 (Custom Term) | Oral herpes | 46 | 48.842 | 0.971 | 1.255 | 1.57 | 0.735 | 0.935 | 1.175 | 0.942 | 1.202 | 1.203
COVID19 (Custom Term) | Band neutrophil percentage decreased | 1 | 0.988 | 0.19 | 1.254 | 3.091 | 0.359 | 0.873 | 1.852 | 1.012 | 1.655 | 0.034
COVID19 (Custom Term) | Microcytic anaemia | 1 | 1.079 | 0.375 | 1.254 | 2.553 | 0.352 | 0.856 | 1.815 | 0.927 | 0.903 | 0.162
COVID19 (Custom Term) | Herpangina | 1 | 0.374 | 0.234 | 1.253 | 2.933 | 0.418 | 1.016 | 2.168 | 2.671 | 0.662 | 0.001
COVID19 (Custom Term) | Eosinophil percentage decreased | 9 | 8.116 | 0.679 | 1.253 | 1.969 | 0.625 | 1.026 | 1.608 | 1.109 | 0.894 | 0.025
COVID19 (Custom Term) | Presyncope | 192 | 163.71 | 1.108 | 1.252 | 1.403 | 1.035 | 1.166 | 1.309 | 1.173 | 1.783 | 55.485
COVID19 (Custom Term) | Device connection issue | 30 | 27.808 | 0.905 | 1.252 | 1.646 | 0.783 | 1.051 | 1.387 | 1.079 | 18.617 | 167.302
COVID19 (Custom Term) | Blood potassium normal | 57 | 54.046 | 0.997 | 1.252 | 1.531 | 0.838 | 1.041 | 1.281 | 1.055 | 1.726 | 14.157
COVID19 (Custom Term) | Monocyte count normal | 19 | 15.316 | 0.839 | 1.251 | 1.73 | 0.81 | 1.164 | 1.63 | 1.241 | 1.85 | 5.489
COVID19 (Custom Term) | Lip pruritus | 32 | 25.961 | 0.926 | 1.251 | 1.616 | 0.89 | 1.184 | 1.551 | 1.233 | 6.23 | 82.85
COVID19 (Custom Term) | Paranasal sinus discomfort | 34 | 27.582 | 0.934 | 1.251 | 1.606 | 0.899 | 1.187 | 1.543 | 1.233 | 7.033 | 99.176
COVID19 (Custom Term) | Fluid retention | 9 | 9.342 | 0.694 | 1.251 | 1.941 | 0.566 | 0.929 | 1.456 | 0.963 | 1.161 | 0.056
COVID19 (Custom Term) | Beta-2 glycoprotein antibody | 1 | 1.553 | 0.192 | 1.251 | 3.073 | 0.317 | 0.775 | 1.645 | 0.644 | 1.655 | 0.034
COVID19 (Custom Term) | Protein total increased | 8 | 6.889 | 0.669 | 1.25 | 1.979 | 0.626 | 1.051 | 1.678 | 1.161 | 1.765 | 1.595
COVID19 (Custom Term) | Pharyngeal swelling | 290 | 253.09 | 1.133 | 1.25 | 1.373 | 1.036 | 1.142 | 1.255 | 1.146 | 12.798 | 1374.374
COVID19 (Custom Term) | Biliary system related investigations, signs and symptoms (SMQ) [narrow] | 42 | 40.725 | 0.954 | 1.25 | 1.579 | 0.79 | 1.016 | 1.289 | 1.031 | 1.372 | 3.371
COVID19 (Custom Term) | Procalcitonin increased | 21 | 20.416 | 0.844 | 1.25 | 1.721 | 0.707 | 1 | 1.382 | 1.029 | 1.5 | 2.583
COVID19 (Custom Term) | Behcet's syndrome | 1 | 1.014 | 0.181 | 1.25 | 3.113 | 0.357 | 0.868 | 1.842 | 0.986 | 0.993 | 0.266
COVID19 (Custom Term) | Blood albumin decreased | 21 | 22.487 | 0.852 | 1.25 | 1.71 | 0.651 | 0.921 | 1.272 | 0.934 | 1.372 | 1.518
COVID19 (Custom Term) | Blood pressure systolic increased | 11 | 8.805 | 0.771 | 1.249 | 1.821 | 0.715 | 1.13 | 1.717 | 1.249 | 5.749 | 24.119
COVID19 (Custom Term) | Haematocrit increased | 4 | 3.934 | 0.589 | 1.249 | 2.106 | 0.483 | 0.932 | 1.661 | 1.017 | 1.168 | 0
COVID19 (Custom Term) | Aspiration joint | 3 | 3.14 | 0.538 | 1.249 | 2.2 | 0.438 | 0.893 | 1.662 | 0.956 | 1.655 | 0.192
COVID19 (Custom Term) | Hyperreflexia | 6 | 7.379 | 0.596 | 1.249 | 2.095 | 0.462 | 0.822 | 1.374 | 0.813 | 0.839 | 0.046
COVID19 (Custom Term) | Uveitis | 3 | 2.635 | 0.393 | 1.248 | 2.491 | 0.474 | 0.966 | 1.797 | 1.139 | 0.298 | 4.1
COVID19 (Custom Term) | Disease recurrence | 13 | 12.781 | 0.75 | 1.248 | 1.848 | 0.638 | 0.978 | 1.448 | 1.017 | 32.27 | 84.768
COVID19 (Custom Term) | Splint application | 1 | 0.987 | 0.312 | 1.248 | 2.693 | 0.359 | 0.874 | 1.853 | 1.013 | 2.482 | 0.004
COVID19 (Custom Term) | Oral pruritus | 55 | 44.313 | 0.993 | 1.247 | 1.525 | 0.971 | 1.211 | 1.495 | 1.241 | 8.808 | 197.275
COVID19 (Custom Term) | Coma scale normal | 2 | 1.557 | 0.331 | 1.247 | 2.64 | 0.445 | 0.974 | 1.916 | 1.285 | 0.552 | 0.302
COVID19 (Custom Term) | Drug reaction with eosinophilia and systemic symptoms | 3 | 2.96 | 0.424 | 1.247 | 2.423 | 0.45 | 0.918 | 1.708 | 1.013 | 2.708 | 1.277
COVID19 (Custom Term) | Haemorrhage laboratory terms (SMQ) [narrow] | 40 | 40.821 | 0.949 | 1.247 | 1.578 | 0.749 | 0.968 | 1.236 | 0.98 | 1.408 | 3.768
COVID19 (Custom Term) | Radiculopathy | 4 | 4.331 | 0.525 | 1.245 | 2.212 | 0.459 | 0.885 | 1.578 | 0.924 | 0.516 | 1.259
COVID19 (Custom Term) | Ultrasound Doppler abnormal | 16 | 16.601 | 0.799 | 1.244 | 1.769 | 0.637 | 0.942 | 1.351 | 0.964 | 3.177 | 16.319
COVID19 (Custom Term) | Exposure via skin contact | 27 | 29.958 | 0.881 | 1.244 | 1.658 | 0.657 | 0.895 | 1.196 | 0.901 | 0.986 | 0.001
COVID19 (Custom Term) | Ventricular extrasystoles | 39 | 33.289 | 0.942 | 1.243 | 1.577 | 0.878 | 1.139 | 1.458 | 1.172 | 9.006 | 140.994
COVID19 (Custom Term) | Butterfly rash | 3 | 2.553 | 0.458 | 1.243 | 2.339 | 0.48 | 0.979 | 1.822 | 1.175 | 1.146 | 0.01
COVID19 (Custom Term) | Hypokalaemia (SMQ) [narrow] | 91 | 86.066 | 1.04 | 1.243 | 1.461 | 0.882 | 1.049 | 1.238 | 1.057 | 5.134 | 196.836
COVID19 (Custom Term) | Biliary disorders (SMQ) [narrow] | 72 | 71.73 | 1.014 | 1.243 | 1.492 | 0.821 | 0.996 | 1.199 | 1.004 | 1.706 | 17.328
COVID19 (Custom Term) | Cyclic vomiting syndrome | 1 | 1.049 | 0.173 | 1.243 | 3.124 | 0.354 | 0.862 | 1.827 | 0.953 | 1.418 | 0.081
COVID19 (Custom Term) | Mitral valve incompetence | 5 | 5.943 | 0.564 | 1.243 | 2.137 | 0.456 | 0.841 | 1.447 | 0.841 | 2.257 | 1.835
COVID19 (Custom Term) | Ceruloplasmin | 1 | 0.993 | 0.262 | 1.242 | 2.817 | 0.359 | 0.872 | 1.85 | 1.007 | 1.986 | 0.005
COVID19 (Custom Term) | Colonoscopy abnormal | 4 | 4.622 | 0.5 | 1.242 | 2.254 | 0.443 | 0.854 | 1.522 | 0.866 | 0.993 | 0.061
COVID19 (Custom Term) | Oral mucosal blistering | 17 | 14.716 | 0.813 | 1.241 | 1.743 | 0.747 | 1.093 | 1.555 | 1.155 | 1.298 | 0.762
COVID19 (Custom Term) | Anti-GAD antibody | 1 | 0.987 | 0.263 | 1.241 | 2.809 | 0.359 | 0.874 | 1.853 | 1.013 | 1.986 | 0.005
COVID19 (Custom Term) | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [narrow] | 115 | 115.424 | 1.058 | 1.241 | 1.435 | 0.85 | 0.992 | 1.151 | 0.996 | 3.58 | 155.245
COVID19 (Custom Term) | Progesterone normal | 1 | 1.525 | 0.263 | 1.241 | 2.809 | 0.319 | 0.779 | 1.654 | 0.656 | 1.986 | 0.005
COVID19 (Custom Term) | Product dispensing error | 1 | 0.507 | 0.263 | 1.24 | 2.806 | 0.404 | 0.981 | 2.085 | 1.973 | 1.986 | 0.005
COVID19 (Custom Term) | Pharyngeal paraesthesia | 111 | 75.814 | 1.054 | 1.24 | 1.437 | 1.228 | 1.436 | 1.67 | 1.464 | 17.494 | 618.772
COVID19 (Custom Term) | Respiratory syncytial virus test negative | 19 | 15.658 | 0.84 | 1.24 | 1.704 | 0.796 | 1.143 | 1.601 | 1.213 | 1.172 | 0.276
COVID19 (Custom Term) | Cardiac failure (SMQ) [narrow] | 139 | 142.213 | 1.073 | 1.24 | 1.417 | 0.847 | 0.974 | 1.116 | 0.977 | 4.929 | 288.401
COVID19 (Custom Term) | Eye haemorrhage | 24 | 19.655 | 0.884 | 1.239 | 1.643 | 0.838 | 1.162 | 1.577 | 1.221 | 8.217 | 78.966
COVID19 (Custom Term) | Embolic and thrombotic events, venous (SMQ) [narrow] | 170 | 170.403 | 1.088 | 1.239 | 1.398 | 0.876 | 0.994 | 1.125 | 0.998 | 9.124 | 636.865
COVID19 (Custom Term) | Embolic and thrombotic events, venous (SMQ) [broad] | 170 | 170.403 | 1.088 | 1.239 | 1.398 | 0.876 | 0.994 | 1.125 | 0.998 | 9.124 | 636.865
COVID19 (Custom Term) | Prostatic specific antigen increased | 1 | 1.39 | 0.251 | 1.239 | 2.842 | 0.328 | 0.801 | 1.7 | 0.72 | 0.662 | 0.001
COVID19 (Custom Term) | Palindromic rheumatism | 1 | 0.503 | 0.128 | 1.238 | 3.305 | 0.404 | 0.981 | 2.088 | 1.988 | 1.418 | 0.081
COVID19 (Custom Term) | Tachypnoea | 55 | 48.323 | 0.981 | 1.238 | 1.52 | 0.896 | 1.117 | 1.38 | 1.138 | 3.617 | 74.27
COVID19 (Custom Term) | Transaminases increased | 6 | 6.692 | 0.577 | 1.238 | 2.101 | 0.493 | 0.877 | 1.466 | 0.897 | 0.735 | 0.295
COVID19 (Custom Term) | Emergency care | 1 | 0.991 | 0.32 | 1.237 | 2.638 | 0.359 | 0.873 | 1.851 | 1.009 | 2.482 | 0.004
COVID19 (Custom Term) | Exploratory operation | 1 | 0.995 | 0.266 | 1.237 | 2.791 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Right ventricular failure | 1 | 1.363 | 0.203 | 1.237 | 2.992 | 0.33 | 0.805 | 1.709 | 0.734 | 1.655 | 0.034
COVID19 (Custom Term) | Dysphagia | 341 | 283.778 | 1.129 | 1.236 | 1.348 | 1.095 | 1.197 | 1.307 | 1.202 | 3.721 | 493.135
COVID19 (Custom Term) | Communication disorder | 15 | 15.847 | 0.785 | 1.236 | 1.77 | 0.62 | 0.927 | 1.343 | 0.947 | 2.364 | 8.364
COVID19 (Custom Term) | Spinal X-ray normal | 2 | 2.14 | 0.472 | 1.236 | 2.292 | 0.399 | 0.874 | 1.718 | 0.934 | 0.423 | 0.966
COVID19 (Custom Term) | Self esteem decreased | 1 | 0.469 | 0.13 | 1.235 | 3.285 | 0.408 | 0.99 | 2.108 | 2.133 | 1.418 | 0.081
COVID19 (Custom Term) | Mouth breathing | 3 | 2.511 | 0.54 | 1.235 | 2.16 | 0.484 | 0.986 | 1.834 | 1.195 | 1.655 | 0.192
COVID19 (Custom Term) | Glossitis | 4 | 3.374 | 0.537 | 1.235 | 2.166 | 0.522 | 1.007 | 1.796 | 1.186 | 2.482 | 1.678
COVID19 (Custom Term) | Lip disorder | 6 | 5.3 | 0.639 | 1.235 | 1.989 | 0.57 | 1.014 | 1.695 | 1.132 | 7.447 | 15.296
COVID19 (Custom Term) | Angioedema | 105 | 100.458 | 1.045 | 1.235 | 1.437 | 0.884 | 1.038 | 1.213 | 1.045 | 2.364 | 65.65
COVID19 (Custom Term) | Thyroiditis | 1 | 1.052 | 0.35 | 1.235 | 2.559 | 0.354 | 0.861 | 1.826 | 0.951 | 0.764 | 0.041
COVID19 (Custom Term) | Reticulocyte count increased | 2 | 2.041 | 0.374 | 1.234 | 2.497 | 0.406 | 0.89 | 1.749 | 0.98 | 1.655 | 0.041
COVID19 (Custom Term) | Heavy menstrual bleeding | 12 | 10.502 | 0.72 | 1.233 | 1.858 | 0.685 | 1.065 | 1.596 | 1.143 | 1.054 | 0
COVID19 (Custom Term) | Uterine leiomyoma | 1 | 1.555 | 0.123 | 1.233 | 3.315 | 0.317 | 0.774 | 1.645 | 0.643 | 1.241 | 0.14
COVID19 (Custom Term) | Albumin urine present | 1 | 1.555 | 0.309 | 1.233 | 2.657 | 0.317 | 0.774 | 1.645 | 0.643 | 0.764 | 0.041
COVID19 (Custom Term) | Mean platelet volume decreased | 2 | 1.384 | 0.433 | 1.232 | 2.361 | 0.46 | 1.008 | 1.984 | 1.445 | 0.863 | 0.022
COVID19 (Custom Term) | Dystonia | 3 | 2.982 | 0.543 | 1.232 | 2.148 | 0.449 | 0.915 | 1.702 | 1.006 | 0.451 | 1.38
COVID19 (Custom Term) | Dysmenorrhoea | 5 | 5.101 | 0.494 | 1.232 | 2.239 | 0.5 | 0.922 | 1.587 | 0.98 | 0.279 | 8.316
COVID19 (Custom Term) | Increased bronchial secretion | 2 | 2.136 | 0.345 | 1.232 | 2.563 | 0.399 | 0.875 | 1.719 | 0.936 | 1.418 | 0.001
COVID19 (Custom Term) | Panic reaction | 20 | 15.517 | 0.841 | 1.231 | 1.681 | 0.845 | 1.204 | 1.674 | 1.289 | 3.203 | 21.121
COVID19 (Custom Term) | SARS-CoV-2 antibody test | 42 | 38.016 | 0.939 | 1.231 | 1.556 | 0.842 | 1.082 | 1.373 | 1.105 | 208.514 | 383.999
COVID19 (Custom Term) | Electrocardiogram ST segment depression | 9 | 8.805 | 0.681 | 1.231 | 1.913 | 0.59 | 0.969 | 1.519 | 1.022 | 14.894 | 40.745
COVID19 (Custom Term) | Haemoglobin | 13 | 12.874 | 0.761 | 1.231 | 1.792 | 0.634 | 0.972 | 1.439 | 1.01 | 1.844 | 3.489
COVID19 (Custom Term) | Myeloid leukaemia | 1 | 0.987 | 0.207 | 1.231 | 2.96 | 0.359 | 0.874 | 1.853 | 1.013 | 1.655 | 0.034
COVID19 (Custom Term) | Metastases to bone | 1 | 0.988 | 0.207 | 1.231 | 2.961 | 0.359 | 0.873 | 1.852 | 1.012 | 1.655 | 0.034
COVID19 (Custom Term) | Sepsis | 68 | 71.666 | 0.998 | 1.231 | 1.483 | 0.773 | 0.944 | 1.142 | 0.949 | 1.471 | 8.499
COVID19 (Custom Term) | Sinusitis | 20 | 21.36 | 0.833 | 1.231 | 1.692 | 0.647 | 0.922 | 1.283 | 0.936 | 0.722 | 1.72
COVID19 (Custom Term) | Oxygen saturation decreased | 181 | 176.343 | 1.085 | 1.23 | 1.383 | 0.905 | 1.023 | 1.153 | 1.026 | 4.831 | 367.686
COVID19 (Custom Term) | Lower limb fracture | 1 | 1.041 | 0.271 | 1.23 | 2.754 | 0.355 | 0.863 | 1.831 | 0.961 | 1.986 | 0.005
COVID19 (Custom Term) | Thrombocytosis | 1 | 1.223 | 0.316 | 1.23 | 2.63 | 0.341 | 0.83 | 1.76 | 0.818 | 0.31 | 0.842
COVID19 (Custom Term) | Chlamydia test | 2 | 2.877 | 0.33 | 1.23 | 2.595 | 0.352 | 0.774 | 1.522 | 0.695 | 1.418 | 0.001
COVID19 (Custom Term) | Painful respiration | 46 | 39.624 | 0.952 | 1.229 | 1.536 | 0.892 | 1.134 | 1.426 | 1.161 | 3.972 | 70.773
COVID19 (Custom Term) | Anticoagulant therapy | 6 | 6.027 | 0.571 | 1.229 | 2.09 | 0.527 | 0.937 | 1.567 | 0.995 | 3.723 | 6.649
COVID19 (Custom Term) | Renal cyst | 3 | 3.024 | 0.499 | 1.229 | 2.221 | 0.446 | 0.909 | 1.691 | 0.992 | 2.128 | 0.631
COVID19 (Custom Term) | Aptyalism | 1 | 1.022 | 0.272 | 1.229 | 2.75 | 0.356 | 0.867 | 1.838 | 0.978 | 1.986 | 0.005
COVID19 (Custom Term) | Tryptase | 30 | 23.006 | 0.902 | 1.228 | 1.596 | 0.924 | 1.241 | 1.637 | 1.304 | 9.309 | 110.178
COVID19 (Custom Term) | Respiratory acidosis | 2 | 1.496 | 0.292 | 1.228 | 2.69 | 0.45 | 0.986 | 1.939 | 1.337 | 1.655 | 0.041
COVID19 (Custom Term) | Throat tightness | 567 | 471.384 | 1.145 | 1.228 | 1.314 | 1.12 | 1.2 | 1.285 | 1.203 | 6.041 | 1485.923
COVID19 (Custom Term) | Vaccination site scar | 1 | 1.061 | 0.108 | 1.228 | 3.378 | 0.353 | 0.859 | 1.822 | 0.943 | 0.523 | 0.065
COVID19 (Custom Term) | Derealisation | 1 | 1.063 | 0.127 | 1.228 | 3.276 | 0.353 | 0.859 | 1.822 | 0.941 | 1.241 | 0.14
COVID19 (Custom Term) | Specific gravity urine normal | 8 | 8.402 | 0.654 | 1.228 | 1.947 | 0.547 | 0.918 | 1.467 | 0.952 | 0.685 | 0.786
COVID19 (Custom Term) | Bladder pain | 2 | 2.484 | 0.378 | 1.228 | 2.475 | 0.376 | 0.825 | 1.62 | 0.805 | 1.528 | 0.013
COVID19 (Custom Term) | Dissociation | 4 | 2.612 | 0.476 | 1.227 | 2.26 | 0.587 | 1.131 | 2.019 | 1.531 | 2.482 | 1.678
COVID19 (Custom Term) | Amylase | 3 | 2.988 | 0.526 | 1.227 | 2.165 | 0.448 | 0.914 | 1.7 | 1.004 | 2.708 | 1.277
COVID19 (Custom Term) | Low density lipoprotein normal | 4 | 4.096 | 0.589 | 1.227 | 2.053 | 0.473 | 0.912 | 1.626 | 0.976 | 1.655 | 0.378
COVID19 (Custom Term) | Haemorrhage | 60 | 63.83 | 0.981 | 1.226 | 1.493 | 0.756 | 0.935 | 1.144 | 0.94 | 1.446 | 6.792
COVID19 (Custom Term) | Hallucination, auditory | 5 | 5.947 | 0.542 | 1.226 | 2.136 | 0.455 | 0.84 | 1.447 | 0.841 | 1.013 | 0.043
COVID19 (Custom Term) | Flat affect | 1 | 0.999 | 0.357 | 1.225 | 2.514 | 0.358 | 0.871 | 1.848 | 1.001 | 0.432 | 0.243
COVID19 (Custom Term) | Acute hepatic failure | 2 | 2.028 | 0.324 | 1.225 | 2.597 | 0.407 | 0.892 | 1.753 | 0.986 | 1.418 | 0.001
COVID19 (Custom Term) | Oesophageal spasm | 6 | 5.041 | 0.636 | 1.224 | 1.968 | 0.587 | 1.044 | 1.746 | 1.19 | 11.915 | 22.083
COVID19 (Custom Term) | Mean platelet volume increased | 7 | 5.988 | 0.609 | 1.224 | 2.012 | 0.606 | 1.045 | 1.706 | 1.169 | 2.242 | 2.894
COVID19 (Custom Term) | Emotional distress | 30 | 27.136 | 0.892 | 1.224 | 1.598 | 0.8 | 1.074 | 1.417 | 1.106 | 0.533 | 11.195
COVID19 (Custom Term) | Abdominal pain | 353 | 320.371 | 1.119 | 1.224 | 1.333 | 1.006 | 1.099 | 1.198 | 1.102 | 1.373 | 31.396
COVID19 (Custom Term) | Congenital and neonatal arrhythmias (SMQ) [broad] | 2 | 2.923 | 0.275 | 1.224 | 2.726 | 0.35 | 0.768 | 1.511 | 0.684 | 0.993 | 0.13
COVID19 (Custom Term) | Posturing | 7 | 6.863 | 0.623 | 1.223 | 1.986 | 0.555 | 0.958 | 1.563 | 1.02 | 1.695 | 1.114
COVID19 (Custom Term) | Supraventricular tachycardia | 47 | 37.829 | 0.955 | 1.222 | 1.516 | 0.952 | 1.207 | 1.514 | 1.242 | 8.046 | 155.988
COVID19 (Custom Term) | Periorbital swelling | 65 | 53.712 | 0.989 | 1.222 | 1.475 | 0.968 | 1.187 | 1.442 | 1.21 | 7.776 | 211.165
COVID19 (Custom Term) | Blood glucose normal | 149 | 124.975 | 1.064 | 1.222 | 1.389 | 1.033 | 1.182 | 1.348 | 1.192 | 1.704 | 36.475
COVID19 (Custom Term) | Monocyte percentage | 20 | 16.927 | 0.827 | 1.222 | 1.68 | 0.787 | 1.121 | 1.559 | 1.182 | 1.073 | 0.032
COVID19 (Custom Term) | Cardiac arrhythmia terms, nonspecific (SMQ) [narrow] | 136 | 131.696 | 1.055 | 1.221 | 1.397 | 0.892 | 1.027 | 1.179 | 1.033 | 3.96 | 213.092
COVID19 (Custom Term) | Cardiac arrhythmia terms, nonspecific (SMQ) [broad] | 136 | 131.696 | 1.055 | 1.221 | 1.397 | 0.892 | 1.027 | 1.179 | 1.033 | 3.96 | 213.092
COVID19 (Custom Term) | Complication associated with device | 3 | 2.964 | 0.495 | 1.221 | 2.209 | 0.45 | 0.917 | 1.707 | 1.012 | 2.979 | 1.589
COVID19 (Custom Term) | Blood count | 2 | 2.443 | 0.339 | 1.221 | 2.549 | 0.378 | 0.83 | 1.631 | 0.819 | 0.451 | 0.764
COVID19 (Custom Term) | Spinal myelogram normal | 1 | 0.988 | 0.279 | 1.22 | 2.702 | 0.359 | 0.873 | 1.852 | 1.012 | 1.986 | 0.005
COVID19 (Custom Term) | Penile pain | 1 | 0.988 | 0.28 | 1.22 | 2.701 | 0.359 | 0.873 | 1.852 | 1.012 | 1.986 | 0.005
COVID19 (Custom Term) | Cognitive disorder | 23 | 23.264 | 0.838 | 1.22 | 1.661 | 0.695 | 0.969 | 1.322 | 0.989 | 0.448 | 14.433
COVID19 (Custom Term) | Intervertebral disc disorder | 3 | 3.923 | 0.497 | 1.22 | 2.203 | 0.392 | 0.8 | 1.489 | 0.765 | 1.752 | 0.27
COVID19 (Custom Term) | Pneumonia bacterial | 5 | 6.62 | 0.522 | 1.22 | 2.156 | 0.425 | 0.785 | 1.351 | 0.755 | 1.46 | 0.268
COVID19 (Custom Term) | Platelet count normal | 71 | 64.707 | 0.995 | 1.219 | 1.462 | 0.892 | 1.084 | 1.307 | 1.097 | 1.098 | 0.468
COVID19 (Custom Term) | Reduced facial expression | 1 | 0.987 | 0.281 | 1.219 | 2.693 | 0.359 | 0.874 | 1.853 | 1.013 | 1.986 | 0.005
COVID19 (Custom Term) | Tongue paralysis | 1 | 0.998 | 0.316 | 1.219 | 2.599 | 0.358 | 0.871 | 1.848 | 1.002 | 0.709 | 0.013
COVID19 (Custom Term) | Parasite blood test | 1 | 1.494 | 0.281 | 1.219 | 2.694 | 0.321 | 0.784 | 1.665 | 0.669 | 1.986 | 0.005
COVID19 (Custom Term) | Tongue disorder | 45 | 36.763 | 0.955 | 1.218 | 1.508 | 0.933 | 1.19 | 1.499 | 1.224 | 5.803 | 109.628
COVID19 (Custom Term) | Cardiomyopathy (SMQ) [narrow] | 40 | 39.62 | 0.924 | 1.218 | 1.545 | 0.77 | 0.995 | 1.27 | 1.01 | 3.484 | 50.458
COVID19 (Custom Term) | Haemolytic disorders (SMQ) [narrow] | 16 | 18.906 | 0.782 | 1.218 | 1.732 | 0.572 | 0.845 | 1.213 | 0.846 | 0.868 | 0.176
COVID19 (Custom Term) | Blood culture negative | 53 | 56.247 | 0.959 | 1.217 | 1.5 | 0.748 | 0.936 | 1.16 | 0.942 | 0.821 | 1.737
COVID19 (Custom Term) | Product label issue | 1 | 0.418 | 0.219 | 1.216 | 2.876 | 0.413 | 1.004 | 2.139 | 2.391 | 1.655 | 0.034
COVID19 (Custom Term) | Respiratory arrest | 70 | 72.308 | 0.992 | 1.216 | 1.46 | 0.791 | 0.962 | 1.161 | 0.968 | 1.844 | 22.043
COVID19 (Custom Term) | Vaccination site rash | 32 | 33.792 | 0.895 | 1.216 | 1.578 | 0.704 | 0.937 | 1.226 | 0.947 | 1.425 | 3.15
COVID19 (Custom Term) | Cardiac monitoring abnormal | 12 | 10.343 | 0.734 | 1.215 | 1.795 | 0.693 | 1.077 | 1.614 | 1.16 | 9.165 | 40.843
COVID19 (Custom Term) | Ear discomfort | 95 | 82.8 | 1.024 | 1.215 | 1.42 | 0.958 | 1.134 | 1.335 | 1.147 | 4.837 | 191.786
COVID19 (Custom Term) | Pupillary reflex impaired | 4 | 3.621 | 0.517 | 1.215 | 2.153 | 0.504 | 0.972 | 1.734 | 1.105 | 0.883 | 0
COVID19 (Custom Term) | Coronavirus test positive | 17 | 16.059 | 0.802 | 1.215 | 1.698 | 0.696 | 1.018 | 1.449 | 1.059 | 10.55 | 66.254
COVID19 (Custom Term) | Occipital neuralgia | 1 | 1.022 | 0.289 | 1.215 | 2.661 | 0.356 | 0.867 | 1.838 | 0.978 | 0.709 | 0.013
COVID19 (Custom Term) | Dyslipidaemia (SMQ) [broad] | 29 | 31.547 | 0.88 | 1.215 | 1.594 | 0.676 | 0.911 | 1.207 | 0.919 | 1.946 | 10.296
COVID19 (Custom Term) | Dyslipidaemia (SMQ) [narrow] | 29 | 31.547 | 0.88 | 1.215 | 1.594 | 0.676 | 0.911 | 1.207 | 0.919 | 1.946 | 10.296
COVID19 (Custom Term) | Pericardial excision | 1 | 1.49 | 0.128 | 1.215 | 3.231 | 0.321 | 0.785 | 1.666 | 0.671 | 1.241 | 0.14
COVID19 (Custom Term) | Chest discomfort | 863 | 731.714 | 1.147 | 1.214 | 1.283 | 1.113 | 1.178 | 1.245 | 1.179 | 5.992 | 2250.213
COVID19 (Custom Term) | Metabolic function test normal | 142 | 125.408 | 1.054 | 1.214 | 1.384 | 0.979 | 1.124 | 1.286 | 1.132 | 2.545 | 104.882
COVID19 (Custom Term) | Fraction of inspired oxygen | 1 | 1.018 | 0.339 | 1.214 | 2.527 | 0.357 | 0.868 | 1.84 | 0.983 | 2.482 | 0.004
COVID19 (Custom Term) | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [narrow] | 161 | 165.511 | 1.062 | 1.214 | 1.375 | 0.852 | 0.97 | 1.101 | 0.973 | 0.667 | 24.995
COVID19 (Custom Term) | Hepatitis | 6 | 6.472 | 0.598 | 1.214 | 2.006 | 0.504 | 0.896 | 1.498 | 0.927 | 0.754 | 0.231
COVID19 (Custom Term) | Refusal of treatment by patient | 13 | 10.971 | 0.748 | 1.213 | 1.77 | 0.717 | 1.099 | 1.627 | 1.185 | 21.513 | 73.33
COVID19 (Custom Term) | Head discomfort | 121 | 104.354 | 1.042 | 1.213 | 1.396 | 0.989 | 1.149 | 1.328 | 1.16 | 4.245 | 208.035
COVID19 (Custom Term) | Gingival disorders (SMQ) [narrow] | 30 | 28.617 | 0.888 | 1.213 | 1.58 | 0.764 | 1.025 | 1.352 | 1.048 | 1.909 | 10.081
COVID19 (Custom Term) | Gingival disorders (SMQ) [broad] | 30 | 28.617 | 0.888 | 1.213 | 1.58 | 0.764 | 1.025 | 1.352 | 1.048 | 1.909 | 10.081
COVID19 (Custom Term) | Interstitial lung disease (SMQ) [narrow] | 100 | 106.102 | 1.022 | 1.213 | 1.417 | 0.796 | 0.939 | 1.101 | 0.942 | 2.434 | 66.668
COVID19 (Custom Term) | Thyroxine | 4 | 4.358 | 0.567 | 1.212 | 2.054 | 0.458 | 0.882 | 1.573 | 0.918 | 1.655 | 0.378
COVID19 (Custom Term) | Myocarditis | 45 | 49.611 | 0.933 | 1.212 | 1.522 | 0.708 | 0.902 | 1.137 | 0.907 | 2.628 | 34.513
COVID19 (Custom Term) | Renal impairment | 8 | 10.188 | 0.664 | 1.212 | 1.895 | 0.476 | 0.799 | 1.277 | 0.785 | 0.802 | 0.187
COVID19 (Custom Term) | Cough | 1066 | 922.208 | 1.151 | 1.211 | 1.273 | 1.098 | 1.155 | 1.214 | 1.156 | 1.977 | 436.543
COVID19 (Custom Term) | Sneezing | 61 | 53.89 | 0.971 | 1.211 | 1.473 | 0.903 | 1.113 | 1.361 | 1.132 | 1.422 | 6.286
COVID19 (Custom Term) | Basophil percentage | 16 | 14.977 | 0.797 | 1.211 | 1.694 | 0.693 | 1.024 | 1.469 | 1.068 | 1.589 | 2.477
COVID19 (Custom Term) | Iron deficiency anaemia | 4 | 4.028 | 0.474 | 1.211 | 2.224 | 0.477 | 0.921 | 1.641 | 0.993 | 1.805 | 0.582
COVID19 (Custom Term) | Respiratory failure | 60 | 64.241 | 0.969 | 1.211 | 1.475 | 0.752 | 0.929 | 1.137 | 0.934 | 2.472 | 40.858
COVID19 (Custom Term) | Feeling drunk | 18 | 14.739 | 0.804 | 1.21 | 1.685 | 0.791 | 1.146 | 1.617 | 1.221 | 3.136 | 18.155
COVID19 (Custom Term) | Electrocardiogram T wave inversion | 9 | 7.966 | 0.685 | 1.21 | 1.856 | 0.633 | 1.039 | 1.629 | 1.13 | 11.17 | 34.129
COVID19 (Custom Term) | Hydronephrosis | 1 | 0.987 | 0.288 | 1.21 | 2.65 | 0.359 | 0.874 | 1.853 | 1.013 | 1.986 | 0.005
COVID19 (Custom Term) | Mycoplasma test positive | 1 | 1.017 | 0.145 | 1.21 | 3.138 | 0.357 | 0.868 | 1.84 | 0.983 | 0.168 | 3.192
COVID19 (Custom Term) | Staphylococcus test | 1 | 1.053 | 0.322 | 1.21 | 2.56 | 0.354 | 0.861 | 1.826 | 0.95 | 0.709 | 0.013
COVID19 (Custom Term) | Psychotic disorder | 7 | 7.363 | 0.597 | 1.21 | 1.996 | 0.53 | 0.914 | 1.491 | 0.951 | 1.511 | 0.619
COVID19 (Custom Term) | Tri-iodothyronine | 1 | 1.492 | 0.138 | 1.21 | 3.172 | 0.321 | 0.784 | 1.666 | 0.67 | 1.241 | 0.14
COVID19 (Custom Term) | Clonic convulsion | 1 | 0.401 | 0.212 | 1.209 | 2.877 | 0.415 | 1.009 | 2.15 | 2.492 | 0.397 | 0.357
COVID19 (Custom Term) | Ear, nose and throat examination | 2 | 1.982 | 0.43 | 1.209 | 2.308 | 0.41 | 0.899 | 1.767 | 1.009 | 0.903 | 0.046
COVID19 (Custom Term) | Lumbar puncture normal | 15 | 15.403 | 0.788 | 1.209 | 1.704 | 0.634 | 0.948 | 1.374 | 0.974 | 0.507 | 6.357
COVID19 (Custom Term) | Haemoglobin decreased | 109 | 105.501 | 1.026 | 1.208 | 1.403 | 0.877 | 1.027 | 1.196 | 1.033 | 2.081 | 49.736
COVID19 (Custom Term) | Agranulocytosis (SMQ) [narrow] | 17 | 17.507 | 0.798 | 1.208 | 1.686 | 0.648 | 0.949 | 1.35 | 0.971 | 1.897 | 5.251
COVID19 (Custom Term) | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [narrow] | 377 | 336.918 | 1.107 | 1.207 | 1.311 | 1.025 | 1.116 | 1.213 | 1.119 | 7.427 | 1198.611
COVID19 (Custom Term) | Ischaemic heart disease (SMQ) [narrow] | 355 | 347.023 | 1.103 | 1.207 | 1.314 | 0.935 | 1.021 | 1.113 | 1.023 | 7.452 | 1131.598
COVID19 (Custom Term) | Blood homocysteine | 1 | 0.995 | 0.227 | 1.207 | 2.823 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Visual field tests | 6 | 6.015 | 0.607 | 1.207 | 1.972 | 0.528 | 0.938 | 1.569 | 0.998 | 4.965 | 9.923
COVID19 (Custom Term) | Anorectal discomfort | 1 | 1.014 | 0.291 | 1.207 | 2.63 | 0.357 | 0.868 | 1.842 | 0.986 | 1.986 | 0.005
COVID19 (Custom Term) | Euphoric mood | 8 | 5.865 | 0.649 | 1.206 | 1.903 | 0.693 | 1.164 | 1.86 | 1.364 | 7.221 | 21.019
COVID19 (Custom Term) | Extrasystoles | 15 | 11.808 | 0.778 | 1.206 | 1.711 | 0.782 | 1.169 | 1.694 | 1.27 | 4.137 | 22.813
COVID19 (Custom Term) | Blood lactate dehydrogenase | 7 | 6.285 | 0.674 | 1.206 | 1.865 | 0.588 | 1.014 | 1.654 | 1.114 | 2.172 | 2.651
COVID19 (Custom Term) | Product label confusion | 42 | 41.644 | 0.919 | 1.206 | 1.525 | 0.774 | 0.995 | 1.263 | 1.009 | 10.693 | 172.625
COVID19 (Custom Term) | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [broad] | 377 | 337.293 | 1.105 | 1.205 | 1.308 | 1.024 | 1.115 | 1.212 | 1.118 | 7.383 | 1192.339
COVID19 (Custom Term) | Miliaria | 4 | 3.914 | 0.571 | 1.205 | 2.028 | 0.485 | 0.935 | 1.666 | 1.022 | 0.863 | 0.001
COVID19 (Custom Term) | Cerebral haematoma | 1 | 0.995 | 0.293 | 1.205 | 2.621 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Multiple sclerosis relapse | 4 | 4.657 | 0.479 | 1.205 | 2.199 | 0.441 | 0.85 | 1.516 | 0.859 | 0.811 | 0.028
COVID19 (Custom Term) | Muscle strength abnormal | 1 | 1.31 | 0.229 | 1.205 | 2.812 | 0.334 | 0.814 | 1.728 | 0.763 | 1.655 | 0.034
COVID19 (Custom Term) | Electrocardiogram normal | 319 | 278.197 | 1.096 | 1.204 | 1.316 | 1.042 | 1.143 | 1.251 | 1.147 | 3.37 | 396.41
COVID19 (Custom Term) | Eosinophil count decreased | 12 | 11.542 | 0.71 | 1.204 | 1.802 | 0.638 | 0.992 | 1.486 | 1.04 | 1.228 | 0.257
COVID19 (Custom Term) | Neutrophil count increased | 19 | 20.101 | 0.8 | 1.204 | 1.677 | 0.647 | 0.929 | 1.301 | 0.945 | 0.619 | 3.825
COVID19 (Custom Term) | Ultrasound pelvis abnormal | 2 | 2.494 | 0.287 | 1.204 | 2.634 | 0.375 | 0.823 | 1.618 | 0.802 | 1.986 | 0.162
COVID19 (Custom Term) | Sluggishness | 34 | 28.96 | 0.901 | 1.203 | 1.54 | 0.861 | 1.137 | 1.478 | 1.174 | 2.192 | 17.007
COVID19 (Custom Term) | Injection site pallor | 2 | 2.034 | 0.355 | 1.203 | 2.458 | 0.406 | 0.891 | 1.751 | 0.983 | 1.324 | 0.002
COVID19 (Custom Term) | Anal incontinence | 16 | 14.919 | 0.786 | 1.202 | 1.69 | 0.695 | 1.027 | 1.474 | 1.072 | 1.335 | 0.883
COVID19 (Custom Term) | Nitrite urine absent | 12 | 11.502 | 0.743 | 1.202 | 1.752 | 0.64 | 0.995 | 1.49 | 1.043 | 1.471 | 1.157
COVID19 (Custom Term) | General physical health deterioration | 56 | 58.584 | 0.953 | 1.202 | 1.475 | 0.763 | 0.949 | 1.17 | 0.956 | 1.39 | 5.014
COVID19 (Custom Term) | Urine bilirubin decreased | 1 | 0.904 | 0.339 | 1.201 | 2.492 | 0.366 | 0.89 | 1.888 | 1.106 | 0.331 | 0.693
COVID19 (Custom Term) | Echocardiogram | 163 | 161.747 | 1.051 | 1.201 | 1.359 | 0.882 | 1.004 | 1.139 | 1.008 | 6.347 | 444.88
COVID19 (Custom Term) | Blood glucose increased | 135 | 126.743 | 1.038 | 1.2 | 1.371 | 0.919 | 1.059 | 1.215 | 1.065 | 2.846 | 124.279
COVID19 (Custom Term) | Dysarthria | 123 | 118.159 | 1.031 | 1.2 | 1.381 | 0.892 | 1.035 | 1.195 | 1.041 | 3.328 | 148.306
COVID19 (Custom Term) | Inguinal hernia repair | 1 | 1.015 | 0.298 | 1.2 | 2.593 | 0.357 | 0.868 | 1.841 | 0.985 | 1.986 | 0.005
COVID19 (Custom Term) | Asthma | 67 | 60.991 | 0.971 | 1.199 | 1.448 | 0.887 | 1.084 | 1.314 | 1.099 | 1.002 | 0.002
COVID19 (Custom Term) | Breast cancer | 1 | 0.975 | 0.235 | 1.199 | 2.771 | 0.36 | 0.876 | 1.858 | 1.026 | 1.655 | 0.034
COVID19 (Custom Term) | Occult blood positive | 3 | 3.217 | 0.393 | 1.199 | 2.36 | 0.433 | 0.883 | 1.643 | 0.932 | 0.268 | 5.071
COVID19 (Custom Term) | Reflexes abnormal | 2 | 2.486 | 0.422 | 1.199 | 2.298 | 0.376 | 0.824 | 1.62 | 0.804 | 1.805 | 0.089
COVID19 (Custom Term) | Injection site dermatitis | 1 | 0.503 | 0.33 | 1.198 | 2.506 | 0.404 | 0.981 | 2.088 | 1.988 | 0.709 | 0.013
COVID19 (Custom Term) | Thyroiditis subacute | 1 | 1.047 | 0.105 | 1.198 | 3.297 | 0.354 | 0.862 | 1.828 | 0.955 | 0.903 | 0.162
COVID19 (Custom Term) | Alpha 1 globulin normal | 1 | 0.503 | 0.3 | 1.197 | 2.581 | 0.404 | 0.981 | 2.088 | 1.988 | 1.986 | 0.005
COVID19 (Custom Term) | Bronchospasm | 15 | 14.299 | 0.76 | 1.197 | 1.714 | 0.674 | 1.007 | 1.459 | 1.049 | 1.273 | 0.535
COVID19 (Custom Term) | Burns second degree | 1 | 0.995 | 0.3 | 1.197 | 2.58 | 0.359 | 0.872 | 1.849 | 1.005 | 1.986 | 0.005
COVID19 (Custom Term) | Abnormal dreams | 13 | 13.501 | 0.718 | 1.197 | 1.776 | 0.611 | 0.937 | 1.387 | 0.963 | 1.721 | 2.706
COVID19 (Custom Term) | Eye infection | 3 | 3.577 | 0.419 | 1.197 | 2.299 | 0.411 | 0.839 | 1.561 | 0.839 | 0.709 | 0.102
COVID19 (Custom Term) | Swollen tongue | 333 | 279.528 | 1.091 | 1.195 | 1.304 | 1.084 | 1.187 | 1.297 | 1.191 | 5.207 | 741.583
COVID19 (Custom Term) | Peripheral coldness | 144 | 125.378 | 1.037 | 1.195 | 1.362 | 0.993 | 1.14 | 1.303 | 1.149 | 2.44 | 97.172
COVID19 (Custom Term) | Tic | 4 | 4.887 | 0.586 | 1.195 | 1.978 | 0.429 | 0.827 | 1.475 | 0.818 | 0.153 | 17.618
COVID19 (Custom Term) | Blood fibrinogen increased | 2 | 2.018 | 0.278 | 1.194 | 2.629 | 0.408 | 0.893 | 1.756 | 0.991 | 0.709 | 0.024
COVID19 (Custom Term) | Tachycardia | 780 | 586.254 | 1.123 | 1.193 | 1.264 | 1.251 | 1.327 | 1.407 | 1.33 | 8.995 | 2917.739
COVID19 (Custom Term) | White blood cell count normal | 86 | 81.44 | 0.992 | 1.193 | 1.409 | 0.877 | 1.047 | 1.242 | 1.056 | 0.993 | 0
COVID19 (Custom Term) | Hypovolaemic shock | 1 | 0.995 | 0.113 | 1.193 | 3.237 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Suspected COVID-19 | 7 | 7.382 | 0.594 | 1.193 | 1.959 | 0.529 | 0.913 | 1.489 | 0.948 | 17.376 | 33.006
COVID19 (Custom Term) | Ear haemorrhage | 2 | 1.111 | 0.42 | 1.192 | 2.283 | 0.488 | 1.068 | 2.106 | 1.801 | 1.528 | 0.013
COVID19 (Custom Term) | Sensation of foreign body | 152 | 116.508 | 1.039 | 1.192 | 1.354 | 1.129 | 1.291 | 1.47 | 1.305 | 6.86 | 446.682
COVID19 (Custom Term) | Tongue pruritus | 53 | 43.37 | 0.94 | 1.192 | 1.469 | 0.953 | 1.193 | 1.478 | 1.222 | 14.223 | 261.976
COVID19 (Custom Term) | Abdominal distension | 57 | 57.108 | 0.948 | 1.192 | 1.46 | 0.796 | 0.989 | 1.216 | 0.998 | 1.241 | 2.147
COVID19 (Custom Term) | Pulseless electrical activity | 28 | 28.745 | 0.858 | 1.192 | 1.571 | 0.708 | 0.959 | 1.276 | 0.974 | 34.752 | 195.82
COVID19 (Custom Term) | Psychomotor skills impaired | 1 | 1.079 | 0.182 | 1.192 | 2.936 | 0.352 | 0.856 | 1.815 | 0.927 | 0.191 | 2.547
COVID19 (Custom Term) | Allergy to arthropod sting | 1 | 1.63 | 0.305 | 1.192 | 2.552 | 0.312 | 0.763 | 1.621 | 0.613 | 1.986 | 0.005
COVID19 (Custom Term) | Tongue discomfort | 44 | 32.964 | 0.917 | 1.191 | 1.494 | 1.006 | 1.286 | 1.624 | 1.335 | 11.497 | 190.148
COVID19 (Custom Term) | Interstitial lung disease (SMQ) [broad] | 106 | 113.895 | 1.009 | 1.191 | 1.386 | 0.791 | 0.928 | 1.083 | 0.931 | 1.967 | 41.271
COVID19 (Custom Term) | Myocardial infarction (SMQ) [narrow] | 309 | 305.069 | 1.081 | 1.19 | 1.304 | 0.92 | 1.011 | 1.108 | 1.013 | 8.523 | 1101.794
COVID19 (Custom Term) | Romberg test | 1 | 0.987 | 0.166 | 1.19 | 2.988 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Prothrombin level normal | 3 | 2.978 | 0.476 | 1.19 | 2.164 | 0.449 | 0.915 | 1.703 | 1.007 | 2.979 | 1.589
COVID19 (Custom Term) | Injection site plaque | 1 | 0.998 | 0.359 | 1.19 | 2.414 | 0.358 | 0.871 | 1.848 | 1.002 | 0.301 | 0.918
COVID19 (Custom Term) | Urinary retention | 20 | 21.215 | 0.799 | 1.19 | 1.643 | 0.651 | 0.928 | 1.29 | 0.943 | 1.398 | 1.625
COVID19 (Custom Term) | Constipation | 36 | 38.931 | 0.889 | 1.19 | 1.528 | 0.7 | 0.917 | 1.185 | 0.925 | 0.513 | 15.368
COVID19 (Custom Term) | Culture throat positive | 1 | 1.235 | 0.17 | 1.19 | 2.973 | 0.34 | 0.827 | 1.755 | 0.81 | 0.32 | 0.767
COVID19 (Custom Term) | Aphonia | 28 | 26.876 | 0.864 | 1.189 | 1.557 | 0.751 | 1.018 | 1.354 | 1.042 | 2.753 | 22.986
COVID19 (Custom Term) | Nasopharyngitis | 76 | 74.856 | 0.977 | 1.189 | 1.418 | 0.834 | 1.007 | 1.207 | 1.015 | 0.691 | 9.532
COVID19 (Custom Term) | Myelodysplastic syndrome (SMQ) [broad] | 39 | 38.956 | 0.904 | 1.189 | 1.507 | 0.761 | 0.987 | 1.264 | 1.001 | 1.744 | 9.858
COVID19 (Custom Term) | Cardiac pacemaker evaluation | 1 | 1.096 | 0.308 | 1.189 | 2.537 | 0.35 | 0.853 | 1.809 | 0.913 | 1.986 | 0.005
COVID19 (Custom Term) | Dehydration (SMQ) [broad] | 2538 | 2162.808 | 1.149 | 1.188 | 1.227 | 1.135 | 1.173 | 1.212 | 1.173 | 3.571 | 3554.283
COVID19 (Custom Term) | Culture stool negative | 7 | 6.8 | 0.601 | 1.188 | 1.936 | 0.559 | 0.964 | 1.572 | 1.029 | 0.476 | 3.323
COVID19 (Custom Term) | Blood blister | 3 | 3.11 | 0.529 | 1.188 | 2.061 | 0.44 | 0.897 | 1.669 | 0.965 | 1.568 | 0.13
COVID19 (Custom Term) | Lymphopenia | 2 | 2.423 | 0.264 | 1.188 | 2.652 | 0.38 | 0.833 | 1.637 | 0.826 | 0.405 | 1.107
COVID19 (Custom Term) | Blood pressure measurement | 120 | 115.259 | 1.015 | 1.187 | 1.369 | 0.89 | 1.035 | 1.198 | 1.041 | 59.575 | 978.51
COVID19 (Custom Term) | Physical examination | 11 | 10.723 | 0.71 | 1.187 | 1.764 | 0.619 | 0.979 | 1.487 | 1.026 | 15.603 | 52.384
COVID19 (Custom Term) | Mental impairment | 36 | 36.285 | 0.884 | 1.187 | 1.526 | 0.747 | 0.978 | 1.263 | 0.992 | 1.761 | 9.36
COVID19 (Custom Term) | Retinal tear | 4 | 5.456 | 0.472 | 1.187 | 2.165 | 0.402 | 0.775 | 1.382 | 0.733 | 4.965 | 5.784
COVID19 (Custom Term) | Skin indentation | 1 | 1.552 | 0.344 | 1.187 | 2.441 | 0.317 | 0.775 | 1.646 | 0.644 | 0.764 | 0.041
COVID19 (Custom Term) | Ketonuria | 1 | 0.995 | 0.17 | 1.186 | 2.96 | 0.359 | 0.872 | 1.849 | 1.005 | 1.418 | 0.081
COVID19 (Custom Term) | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [broad] | 409 | 433.763 | 1.091 | 1.186 | 1.284 | 0.868 | 0.942 | 1.021 | 0.943 | 0.887 | 5.362
COVID19 (Custom Term) | Suicidal ideation | 3 | 4.22 | 0.425 | 1.186 | 2.256 | 0.377 | 0.77 | 1.432 | 0.711 | 0.32 | 3.499
COVID19 (Custom Term) | Lymphocyte percentage | 12 | 11.927 | 0.728 | 1.185 | 1.733 | 0.622 | 0.967 | 1.449 | 1.006 | 0.673 | 1.463
COVID19 (Custom Term) | Neutrophil percentage decreased | 9 | 9.102 | 0.649 | 1.185 | 1.853 | 0.577 | 0.946 | 1.483 | 0.989 | 0.296 | 13.912
COVID19 (Custom Term) | Spinal cord compression | 1 | 1.017 | 0.312 | 1.185 | 2.514 | 0.357 | 0.868 | 1.84 | 0.983 | 1.986 | 0.005
COVID19 (Custom Term) | Biopsy colon abnormal | 1 | 1.02 | 0.146 | 1.185 | 3.055 | 0.357 | 0.867 | 1.839 | 0.98 | 1.241 | 0.14
COVID19 (Custom Term) | Stress | 21 | 22.582 | 0.798 | 1.185 | 1.634 | 0.649 | 0.917 | 1.267 | 0.93 | 0.97 | 0
COVID19 (Custom Term) | Pelvic pain | 11 | 11.97 | 0.68 | 1.185 | 1.803 | 0.57 | 0.901 | 1.368 | 0.919 | 1.986 | 3.628
COVID19 (Custom Term) | Cytology normal | 1 | 1.49 | 0.228 | 1.185 | 2.755 | 0.321 | 0.785 | 1.666 | 0.671 | 0.621 | 0.002
COVID19 (Custom Term) | Noninfectious meningitis (SMQ) [narrow] | 105 | 102.323 | 1.002 | 1.184 | 1.379 | 0.868 | 1.02 | 1.191 | 1.026 | 0.796 | 4.871
COVID19 (Custom Term) | Osteoarthritis | 12 | 13.295 | 0.708 | 1.184 | 1.761 | 0.572 | 0.889 | 1.332 | 0.903 | 1.354 | 0.665
COVID19 (Custom Term) | Dizziness postural | 47 | 43.37 | 0.916 | 1.183 | 1.478 | 0.839 | 1.065 | 1.336 | 1.084 | 1.92 | 16.55
COVID19 (Custom Term) | Asthma exercise induced | 1 | 1.1 | 0.174 | 1.183 | 2.936 | 0.35 | 0.852 | 1.807 | 0.909 | 1.418 | 0.081
COVID19 (Custom Term) | Guttate psoriasis | 1 | 1.498 | 0.251 | 1.183 | 2.678 | 0.321 | 0.783 | 1.663 | 0.667 | 1.655 | 0.034
COVID19 (Custom Term) | Ovarian cancer | 1 | 0.987 | 0.174 | 1.182 | 2.93 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Pulmonary function test abnormal | 1 | 0.993 | 0.197 | 1.182 | 2.85 | 0.359 | 0.872 | 1.85 | 1.007 | 0.473 | 0.144
COVID19 (Custom Term) | Cardiogenic shock | 7 | 7.04 | 0.592 | 1.182 | 1.936 | 0.546 | 0.942 | 1.537 | 0.994 | 5.347 | 13.119
COVID19 (Custom Term) | Blood calcium normal | 32 | 32.336 | 0.872 | 1.182 | 1.53 | 0.732 | 0.974 | 1.276 | 0.99 | 1.513 | 4.356
COVID19 (Custom Term) | Nasal dryness | 3 | 1.809 | 0.506 | 1.181 | 2.085 | 0.547 | 1.115 | 2.078 | 1.659 | 3.723 | 2.44
COVID19 (Custom Term) | Enlarged uvula | 14 | 10.782 | 0.761 | 1.181 | 1.677 | 0.782 | 1.183 | 1.732 | 1.299 | 5.347 | 29.124
COVID19 (Custom Term) | Oropharyngeal allergic conditions (SMQ) [broad] | 478 | 420.473 | 1.094 | 1.181 | 1.271 | 1.052 | 1.134 | 1.222 | 1.137 | 2.691 | 400.681
COVID19 (Custom Term) | Oropharyngeal allergic conditions (SMQ) [narrow] | 478 | 420.473 | 1.094 | 1.181 | 1.271 | 1.052 | 1.134 | 1.222 | 1.137 | 2.691 | 400.681
COVID19 (Custom Term) | Breast swelling | 10 | 9.554 | 0.679 | 1.181 | 1.795 | 0.615 | 0.99 | 1.526 | 1.047 | 2.069 | 3.647
COVID19 (Custom Term) | Granulocyte percentage | 5 | 4.929 | 0.584 | 1.181 | 1.947 | 0.51 | 0.941 | 1.619 | 1.014 | 1.155 | 0.003
COVID19 (Custom Term) | Malignancy related conditions (SMQ) [broad] | 3 | 3.088 | 0.388 | 1.181 | 2.323 | 0.442 | 0.9 | 1.675 | 0.971 | 0.584 | 0.463
COVID19 (Custom Term) | Malignancy related conditions (SMQ) [narrow] | 3 | 3.088 | 0.388 | 1.181 | 2.323 | 0.442 | 0.9 | 1.675 | 0.971 | 0.584 | 0.463
COVID19 (Custom Term) | Vertigo positional | 13 | 14.751 | 0.74 | 1.181 | 1.704 | 0.57 | 0.873 | 1.292 | 0.881 | 4.164 | 19.636
COVID19 (Custom Term) | Eyelids pruritus | 15 | 12.521 | 0.759 | 1.18 | 1.677 | 0.748 | 1.118 | 1.619 | 1.198 | 6.206 | 36.865
COVID19 (Custom Term) | Muscle tightness | 124 | 109.949 | 1.013 | 1.18 | 1.357 | 0.965 | 1.119 | 1.291 | 1.128 | 2.565 | 92.901
COVID19 (Custom Term) | Culture urine | 26 | 24.365 | 0.844 | 1.18 | 1.561 | 0.758 | 1.038 | 1.394 | 1.067 | 1.565 | 4.057
COVID19 (Custom Term) | Lactic acidosis (SMQ) [broad] | 87 | 86.054 | 0.982 | 1.18 | 1.393 | 0.842 | 1.004 | 1.19 | 1.011 | 2.751 | 74.517
COVID19 (Custom Term) | Spleen scan normal | 1 | 0.993 | 0.317 | 1.18 | 2.487 | 0.359 | 0.872 | 1.85 | 1.007 | 1.986 | 0.005
COVID19 (Custom Term) | Thyroid function test abnormal | 1 | 1.022 | 0.206 | 1.18 | 2.812 | 0.356 | 0.867 | 1.838 | 0.978 | 0.552 | 0.036
COVID19 (Custom Term) | Salmonella test positive | 1 | 1.045 | 0.091 | 1.18 | 3.318 | 0.354 | 0.862 | 1.829 | 0.957 | 0.451 | 0.191
COVID19 (Custom Term) | Atopy | 1 | 0.878 | 0.255 | 1.179 | 2.655 | 0.369 | 0.896 | 1.9 | 1.14 | 1.655 | 0.034
COVID19 (Custom Term) | C-reactive protein abnormal | 1 | 1.179 | 0.279 | 1.179 | 2.586 | 0.344 | 0.837 | 1.776 | 0.848 | 0.709 | 0.013
COVID19 (Custom Term) | Scan thyroid gland | 1 | 1.552 | 0.318 | 1.179 | 2.482 | 0.317 | 0.775 | 1.646 | 0.644 | 1.986 | 0.005
COVID19 (Custom Term) | Red cell distribution width normal | 26 | 24.29 | 0.84 | 1.178 | 1.563 | 0.76 | 1.04 | 1.398 | 1.07 | 1.857 | 7.894
COVID19 (Custom Term) | Dyspepsia | 67 | 62.888 | 0.955 | 1.178 | 1.42 | 0.862 | 1.053 | 1.276 | 1.065 | 2.402 | 42.943
COVID19 (Custom Term) | Sputum discoloured | 8 | 7.751 | 0.622 | 1.178 | 1.879 | 0.578 | 0.971 | 1.551 | 1.032 | 1.032 | 0.011
COVID19 (Custom Term) | Myocardial necrosis marker increased | 10 | 9.95 | 0.666 | 1.178 | 1.808 | 0.597 | 0.961 | 1.481 | 1.005 | 3.677 | 12.157
COVID19 (Custom Term) | Blood glucose abnormal | 5 | 4.987 | 0.576 | 1.178 | 1.951 | 0.507 | 0.934 | 1.608 | 1.003 | 1.551 | 0.404
COVID19 (Custom Term) | Meningitis viral | 8 | 9.368 | 0.612 | 1.178 | 1.892 | 0.506 | 0.85 | 1.357 | 0.854 | 0.819 | 0.141
COVID19 (Custom Term) | Carpal tunnel syndrome | 3 | 5.067 | 0.424 | 1.178 | 2.238 | 0.339 | 0.694 | 1.292 | 0.592 | 0.764 | 0.034
COVID19 (Custom Term) | Petechiae | 66 | 65.232 | 0.953 | 1.177 | 1.42 | 0.819 | 1.003 | 1.217 | 1.012 | 0.962 | 0.055
COVID19 (Custom Term) | Hepatitis, non-infectious (SMQ) [narrow] | 12 | 13.565 | 0.696 | 1.177 | 1.76 | 0.563 | 0.875 | 1.311 | 0.885 | 0.754 | 0.661
COVID19 (Custom Term) | Hepatitis, non-infectious (SMQ) [broad] | 12 | 13.565 | 0.696 | 1.177 | 1.76 | 0.563 | 0.875 | 1.311 | 0.885 | 0.754 | 0.661
COVID19 (Custom Term) | Prostate tumours of unspecified malignancy (SMQ) [narrow] | 1 | 1.39 | 0.238 | 1.177 | 2.701 | 0.328 | 0.801 | 1.7 | 0.72 | 0.621 | 0.002
COVID19 (Custom Term) | Prostate tumours of unspecified malignancy (SMQ) [broad] | 1 | 1.39 | 0.238 | 1.177 | 2.701 | 0.328 | 0.801 | 1.7 | 0.72 | 0.621 | 0.002
COVID19 (Custom Term) | Capillary nail refill test abnormal | 3 | 2.028 | 0.455 | 1.176 | 2.169 | 0.526 | 1.071 | 1.995 | 1.479 | 1.489 | 0.082
COVID19 (Custom Term) | Temperature intolerance | 8 | 6.965 | 0.626 | 1.176 | 1.866 | 0.621 | 1.043 | 1.666 | 1.149 | 0.883 | 0.027
COVID19 (Custom Term) | Intervertebral discitis | 1 | 0.987 | 0.181 | 1.176 | 2.887 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Sciatica | 17 | 17.369 | 0.775 | 1.176 | 1.645 | 0.652 | 0.955 | 1.358 | 0.979 | 2.723 | 13.093
COVID19 (Custom Term) | Inappropriate antidiuretic hormone secretion | 1 | 1.045 | 0.322 | 1.176 | 2.464 | 0.354 | 0.862 | 1.829 | 0.957 | 1.986 | 0.005
COVID19 (Custom Term) | Endoscopy | 4 | 6.283 | 0.446 | 1.176 | 2.187 | 0.368 | 0.71 | 1.267 | 0.637 | 0.709 | 0.196
COVID19 (Custom Term) | Base excess decreased | 2 | 1.606 | 0.351 | 1.175 | 2.392 | 0.44 | 0.965 | 1.897 | 1.245 | 0.348 | 1.713
COVID19 (Custom Term) | Haemoglobin normal | 59 | 52.966 | 0.939 | 1.175 | 1.433 | 0.886 | 1.096 | 1.345 | 1.114 | 0.707 | 6.425
COVID19 (Custom Term) | Faeces discoloured | 15 | 14.087 | 0.74 | 1.175 | 1.691 | 0.682 | 1.019 | 1.476 | 1.065 | 0.453 | 8.934
COVID19 (Custom Term) | Mean cell haemoglobin normal | 27 | 26.757 | 0.838 | 1.175 | 1.56 | 0.726 | 0.989 | 1.322 | 1.009 | 1.411 | 2.449
COVID19 (Custom Term) | Mechanical urticaria | 2 | 2.247 | 0.331 | 1.175 | 2.44 | 0.391 | 0.858 | 1.686 | 0.89 | 1.168 | 0.036
COVID19 (Custom Term) | Allergy to animal | 1 | 1.61 | 0.148 | 1.175 | 3.017 | 0.313 | 0.766 | 1.627 | 0.621 | 0.382 | 0.42
COVID19 (Custom Term) | Diagnostic procedure | 3 | 1.746 | 0.545 | 1.173 | 1.994 | 0.553 | 1.128 | 2.104 | 1.719 | 0.805 | 0.008
COVID19 (Custom Term) | Choking sensation | 10 | 8.993 | 0.673 | 1.173 | 1.786 | 0.643 | 1.034 | 1.594 | 1.112 | 2.613 | 6.54
COVID19 (Custom Term) | Arthritis infective | 1 | 1.02 | 0.347 | 1.173 | 2.395 | 0.357 | 0.867 | 1.839 | 0.98 | 0.709 | 0.013
COVID19 (Custom Term) | Product colour issue | 1 | 1.293 | 0.172 | 1.173 | 2.915 | 0.335 | 0.817 | 1.734 | 0.773 | 0.621 | 0.002
COVID19 (Custom Term) | Dizziness | 3797 | 3271.022 | 1.141 | 1.172 | 1.204 | 1.13 | 1.16 | 1.192 | 1.161 | 2.942 | 3946.66
COVID19 (Custom Term) | Epistaxis | 81 | 76.024 | 0.969 | 1.172 | 1.392 | 0.879 | 1.055 | 1.258 | 1.065 | 2.021 | 33.824
COVID19 (Custom Term) | Echocardiogram normal | 78 | 81.401 | 0.964 | 1.172 | 1.396 | 0.791 | 0.953 | 1.14 | 0.958 | 2.727 | 65.517
COVID19 (Custom Term) | Sepsis (SMQ) [narrow] | 87 | 93.453 | 0.975 | 1.172 | 1.385 | 0.778 | 0.928 | 1.099 | 0.931 | 1.261 | 3.931
COVID19 (Custom Term) | Thirst | 51 | 48.592 | 0.927 | 1.171 | 1.438 | 0.823 | 1.035 | 1.287 | 1.05 | 2.084 | 22.809
COVID19 (Custom Term) | Sinus disorder | 16 | 18.202 | 0.745 | 1.171 | 1.676 | 0.59 | 0.872 | 1.252 | 0.879 | 1.986 | 5.654
COVID19 (Custom Term) | Liver function test normal | 15 | 14.355 | 0.737 | 1.17 | 1.684 | 0.671 | 1.004 | 1.454 | 1.045 | 0.662 | 2.093
COVID19 (Custom Term) | Dehydration (SMQ) [narrow] | 140 | 139.038 | 1.013 | 1.17 | 1.335 | 0.872 | 1.003 | 1.148 | 1.007 | 1.551 | 23.281
COVID19 (Custom Term) | Amylase normal | 3 | 2.976 | 0.56 | 1.17 | 1.959 | 0.449 | 0.916 | 1.704 | 1.008 | 0.993 | 0.084
COVID19 (Custom Term) | Blood iron | 3 | 3.004 | 0.463 | 1.17 | 2.138 | 0.447 | 0.912 | 1.696 | 0.999 | 1.241 | 0
COVID19 (Custom Term) | Paraesthesia oral | 692 | 519.149 | 1.097 | 1.169 | 1.243 | 1.249 | 1.33 | 1.415 | 1.333 | 11.452 | 3071.835
COVID19 (Custom Term) | Electrocardiogram | 497 | 442.794 | 1.084 | 1.169 | 1.256 | 1.04 | 1.12 | 1.205 | 1.122 | 5.206 | 1109.513
COVID19 (Custom Term) | Bandaemia | 1 | 0.988 | 0.33 | 1.169 | 2.425 | 0.359 | 0.873 | 1.852 | 1.012 | 1.986 | 0.005
COVID19 (Custom Term) | Thyroxine free decreased | 1 | 0.993 | 0.266 | 1.169 | 2.593 | 0.359 | 0.872 | 1.85 | 1.007 | 1.655 | 0.034
COVID19 (Custom Term) | Peripheral nerve palsy | 1 | 0.993 | 0.266 | 1.169 | 2.594 | 0.359 | 0.872 | 1.85 | 1.007 | 1.655 | 0.034
COVID19 (Custom Term) | Magnetic resonance imaging neck | 22 | 23.361 | 0.818 | 1.169 | 1.571 | 0.661 | 0.928 | 1.274 | 0.942 | 13.653 | 102.846
COVID19 (Custom Term) | Complement factor | 3 | 2.112 | 0.396 | 1.168 | 2.27 | 0.518 | 1.055 | 1.965 | 1.42 | 2.291 | 0.807
COVID19 (Custom Term) | PCO2 decreased | 9 | 8.043 | 0.633 | 1.168 | 1.836 | 0.629 | 1.032 | 1.618 | 1.119 | 1.752 | 1.817
COVID19 (Custom Term) | Chest X-ray abnormal | 154 | 151.289 | 1.019 | 1.168 | 1.326 | 0.888 | 1.014 | 1.154 | 1.018 | 2.869 | 144.157
COVID19 (Custom Term) | Laryngospasm | 1 | 1.022 | 0.335 | 1.168 | 2.41 | 0.356 | 0.867 | 1.838 | 0.978 | 0.414 | 0.298
COVID19 (Custom Term) | Cytokine test | 1 | 1.052 | 0.189 | 1.168 | 2.833 | 0.354 | 0.861 | 1.826 | 0.951 | 1.418 | 0.081
COVID19 (Custom Term) | Culture negative | 15 | 16.631 | 0.742 | 1.168 | 1.673 | 0.596 | 0.891 | 1.291 | 0.902 | 0.776 | 0.688
COVID19 (Custom Term) | Hyperglycaemia/new onset diabetes mellitus (SMQ) [narrow] | 185 | 183.589 | 1.031 | 1.167 | 1.311 | 0.89 | 1.004 | 1.131 | 1.008 | 2.036 | 80.296
COVID19 (Custom Term) | Apnoea | 8 | 8.746 | 0.613 | 1.167 | 1.865 | 0.531 | 0.893 | 1.426 | 0.915 | 0.14 | 40.68
COVID19 (Custom Term) | Oral disorder | 6 | 4.084 | 0.637 | 1.166 | 1.824 | 0.66 | 1.174 | 1.966 | 1.469 | 1.146 | 0.008
COVID19 (Custom Term) | Fatigue | 4619 | 4233.011 | 1.138 | 1.166 | 1.194 | 1.065 | 1.091 | 1.118 | 1.091 | 2.751 | 4299.707
COVID19 (Custom Term) | Psoriatic arthropathy | 3 | 2.754 | 0.395 | 1.166 | 2.268 | 0.465 | 0.948 | 1.763 | 1.089 | 0.961 | 0.054
COVID19 (Custom Term) | Cerebrovascular accident | 226 | 234.15 | 1.042 | 1.166 | 1.295 | 0.863 | 0.963 | 1.072 | 0.965 | 7.262 | 701.979
COVID19 (Custom Term) | Flushing | 959 | 703.079 | 1.104 | 1.165 | 1.228 | 1.291 | 1.361 | 1.435 | 1.364 | 7.37 | 3046.731
COVID19 (Custom Term) | Specialist consultation | 3 | 2.483 | 0.478 | 1.165 | 2.095 | 0.486 | 0.99 | 1.843 | 1.208 | 0.961 | 0.054
COVID19 (Custom Term) | Vitamin B12 increased | 2 | 1.975 | 0.346 | 1.165 | 2.374 | 0.411 | 0.9 | 1.769 | 1.012 | 2.206 | 0.266
COVID19 (Custom Term) | Oesophagogastroduodenoscopy normal | 2 | 2.038 | 0.366 | 1.165 | 2.33 | 0.406 | 0.89 | 1.749 | 0.981 | 2.206 | 0.266
COVID19 (Custom Term) | Blood ethanol | 1 | 1.496 | 0.334 | 1.165 | 2.405 | 0.321 | 0.784 | 1.664 | 0.668 | 1.986 | 0.005
COVID19 (Custom Term) | Exposure to SARS-CoV-2 | 106 | 92.105 | 0.985 | 1.164 | 1.356 | 0.971 | 1.139 | 1.33 | 1.151 | 1052.5 | 1030.219
COVID19 (Custom Term) | Albumin globulin ratio | 4 | 3.985 | 0.461 | 1.164 | 2.127 | 0.48 | 0.926 | 1.65 | 1.004 | 1.986 | 0.852
COVID19 (Custom Term) | Cardiac function test | 3 | 3.024 | 0.463 | 1.164 | 2.123 | 0.446 | 0.909 | 1.691 | 0.992 | 0.851 | 0
COVID19 (Custom Term) | Blood count abnormal | 5 | 5.058 | 0.567 | 1.164 | 1.934 | 0.502 | 0.927 | 1.595 | 0.989 | 1.986 | 1.235
COVID19 (Custom Term) | Acute myeloid leukaemia | 9 | 9.236 | 0.677 | 1.164 | 1.758 | 0.57 | 0.937 | 1.468 | 0.974 | 7.447 | 24.793
COVID19 (Custom Term) | Haemolytic disorders (SMQ) [broad] | 17 | 19.955 | 0.761 | 1.164 | 1.637 | 0.581 | 0.85 | 1.209 | 0.852 | 0.861 | 0.224
COVID19 (Custom Term) | Feeling hot | 724 | 621.27 | 1.094 | 1.163 | 1.235 | 1.094 | 1.163 | 1.236 | 1.165 | 3.167 | 819.266
COVID19 (Custom Term) | Full blood count normal | 209 | 188.341 | 1.035 | 1.163 | 1.297 | 0.985 | 1.105 | 1.235 | 1.11 | 1.888 | 72.839
COVID19 (Custom Term) | Appetite disorder | 4 | 4.301 | 0.529 | 1.163 | 1.995 | 0.461 | 0.889 | 1.584 | 0.93 | 0.827 | 0.015
COVID19 (Custom Term) | Tympanic membrane perforation | 1 | 1.108 | 0.367 | 1.163 | 2.322 | 0.349 | 0.85 | 1.804 | 0.902 | 0.432 | 0.243
COVID19 (Custom Term) | Skin odour abnormal | 1 | 1.368 | 0.149 | 1.163 | 2.972 | 0.33 | 0.805 | 1.708 | 0.731 | 0.584 | 0.014
COVID19 (Custom Term) | Gastric emptying study | 1 | 2.002 | 0.253 | 1.163 | 2.613 | 0.289 | 0.71 | 1.513 | 0.5 | 0.621 | 0.002
COVID19 (Custom Term) | Post vaccination syndrome | 1 | 0.514 | 0.095 | 1.162 | 3.235 | 0.403 | 0.979 | 2.081 | 1.945 | 0.066 | 12.19
COVID19 (Custom Term) | Gallbladder disorder | 5 | 4.543 | 0.552 | 1.162 | 1.954 | 0.534 | 0.985 | 1.696 | 1.101 | 5.516 | 8.904
COVID19 (Custom Term) | Embolic and thrombotic events, arterial (SMQ) [broad] | 288 | 288.543 | 1.051 | 1.162 | 1.276 | 0.904 | 0.996 | 1.096 | 0.998 | 5.8 | 720.581
COVID19 (Custom Term) | Embolic and thrombotic events, arterial (SMQ) [narrow] | 288 | 288.543 | 1.051 | 1.162 | 1.276 | 0.904 | 0.996 | 1.096 | 0.998 | 5.8 | 720.581
COVID19 (Custom Term) | Humerus fracture | 1 | 1.042 | 0.275 | 1.162 | 2.546 | 0.355 | 0.863 | 1.83 | 0.96 | 1.655 | 0.034
COVID19 (Custom Term) | Agitation | 38 | 39.825 | 0.879 | 1.162 | 1.477 | 0.726 | 0.945 | 1.212 | 0.954 | 1.13 | 0.388
COVID19 (Custom Term) | Hepatic disorders (SMQ) [narrow] | 198 | 208.602 | 1.03 | 1.162 | 1.3 | 0.842 | 0.947 | 1.062 | 0.949 | 0.844 | 5.133
COVID19 (Custom Term) | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [broad] | 32 | 35.184 | 0.854 | 1.162 | 1.508 | 0.679 | 0.903 | 1.182 | 0.909 | 1.816 | 9.174
COVID19 (Custom Term) | Vestibular disorders (SMQ) [broad] | 4019 | 3503.983 | 1.131 | 1.161 | 1.191 | 1.117 | 1.147 | 1.177 | 1.147 | 2.801 | 3834.176
COVID19 (Custom Term) | Lacrimation increased | 71 | 63.347 | 0.948 | 1.161 | 1.391 | 0.91 | 1.106 | 1.333 | 1.121 | 1.911 | 25.036
COVID19 (Custom Term) | Prothrombin time normal | 15 | 13.673 | 0.755 | 1.161 | 1.639 | 0.698 | 1.043 | 1.512 | 1.097 | 1.773 | 3.599
COVID19 (Custom Term) | Anal haemorrhage | 1 | 0.987 | 0.276 | 1.161 | 2.544 | 0.359 | 0.874 | 1.853 | 1.013 | 1.655 | 0.034
COVID19 (Custom Term) | Blood phosphorus increased | 3 | 2.972 | 0.433 | 1.161 | 2.173 | 0.45 | 0.916 | 1.705 | 1.009 | 1.295 | 0.007
COVID19 (Custom Term) | Generalised anxiety disorder | 1 | 1.022 | 0.197 | 1.161 | 2.786 | 0.356 | 0.867 | 1.838 | 0.978 | 1.418 | 0.081
COVID19 (Custom Term) | CSF mononuclear cell count increased | 1 | 0.993 | 0.277 | 1.16 | 2.539 | 0.359 | 0.872 | 1.85 | 1.007 | 1.655 | 0.034
COVID19 (Custom Term) | Blindness unilateral | 14 | 18.04 | 0.741 | 1.16 | 1.655 | 0.52 | 0.787 | 1.152 | 0.776 | 1.168 | 0.16
COVID19 (Custom Term) | Biopsy peripheral nerve | 1 | 0.995 | 0.2 | 1.159 | 2.769 | 0.359 | 0.872 | 1.849 | 1.005 | 1.418 | 0.081
COVID19 (Custom Term) | Lymphangitis | 4 | 4.99 | 0.446 | 1.159 | 2.144 | 0.424 | 0.817 | 1.457 | 0.802 | 0.662 | 0.346
COVID19 (Custom Term) | Tongue oedema | 5 | 4.373 | 0.557 | 1.158 | 1.937 | 0.546 | 1.006 | 1.732 | 1.143 | 3.31 | 4.288
COVID19 (Custom Term) | Binocular eye movement disorder | 1 | 0.503 | 0.202 | 1.157 | 2.755 | 0.404 | 0.981 | 2.088 | 1.988 | 1.418 | 0.081
COVID19 (Custom Term) | Tenosynovitis | 5 | 4.697 | 0.561 | 1.157 | 1.926 | 0.524 | 0.967 | 1.665 | 1.065 | 2.257 | 1.835
COVID19 (Custom Term) | Disorganised speech | 7 | 6.908 | 0.64 | 1.157 | 1.798 | 0.553 | 0.954 | 1.556 | 1.013 | 6.319 | 15.741
COVID19 (Custom Term) | Arteriogram carotid | 16 | 15.899 | 0.762 | 1.157 | 1.62 | 0.66 | 0.975 | 1.4 | 1.006 | 31.774 | 105.628
COVID19 (Custom Term) | Ischaemia | 5 | 5.015 | 0.514 | 1.157 | 2.008 | 0.505 | 0.931 | 1.603 | 0.997 | 3.819 | 5.44
COVID19 (Custom Term) | Carboxyhaemoglobin normal | 1 | 1.015 | 0.344 | 1.157 | 2.36 | 0.357 | 0.868 | 1.841 | 0.985 | 1.986 | 0.005
COVID19 (Custom Term) | Acute renal failure (SMQ) [narrow] | 120 | 126.1 | 0.99 | 1.157 | 1.334 | 0.816 | 0.948 | 1.097 | 0.952 | 2.906 | 114.62
COVID19 (Custom Term) | Throat irritation | 554 | 425.014 | 1.077 | 1.156 | 1.238 | 1.211 | 1.3 | 1.393 | 1.303 | 6.396 | 1536.769
COVID19 (Custom Term) | Blood mercury abnormal | 1 | 0.988 | 0.203 | 1.156 | 2.749 | 0.359 | 0.873 | 1.852 | 1.012 | 1.418 | 0.081
COVID19 (Custom Term) | Autoantibody positive | 1 | 0.993 | 0.262 | 1.156 | 2.565 | 0.359 | 0.872 | 1.85 | 1.007 | 0.621 | 0.002
COVID19 (Custom Term) | Vulvovaginal discomfort | 1 | 0.995 | 0.204 | 1.156 | 2.746 | 0.359 | 0.872 | 1.849 | 1.005 | 1.418 | 0.081
COVID19 (Custom Term) | Pneumonia | 186 | 205.563 | 1.021 | 1.156 | 1.299 | 0.801 | 0.904 | 1.017 | 0.905 | 0.924 | 0.998
COVID19 (Custom Term) | Monocyte count increased | 10 | 12.886 | 0.645 | 1.156 | 1.788 | 0.491 | 0.79 | 1.218 | 0.776 | 0.43 | 6.665
COVID19 (Custom Term) | Anaphylactic reaction | 255 | 246.387 | 1.039 | 1.155 | 1.276 | 0.931 | 1.032 | 1.142 | 1.035 | 2.737 | 219.666
COVID19 (Custom Term) | Biliary system related investigations, signs and symptoms (SMQ) [broad] | 82 | 80.356 | 0.956 | 1.155 | 1.37 | 0.845 | 1.013 | 1.206 | 1.02 | 1.19 | 2.05
COVID19 (Custom Term) | Myocardial infarction (SMQ) [broad] | 347 | 345.628 | 1.055 | 1.155 | 1.258 | 0.917 | 1.002 | 1.093 | 1.004 | 5.575 | 833.491
COVID19 (Custom Term) | Thrombocytopenia | 59 | 59.239 | 0.923 | 1.155 | 1.409 | 0.797 | 0.987 | 1.21 | 0.996 | 1.369 | 4.808
COVID19 (Custom Term) | Magnetic resonance imaging head abnormal | 80 | 87.922 | 0.953 | 1.155 | 1.374 | 0.755 | 0.907 | 1.083 | 0.91 | 1.496 | 10.981
COVID19 (Custom Term) | Gliosis | 1 | 1.363 | 0.284 | 1.155 | 2.504 | 0.33 | 0.805 | 1.709 | 0.734 | 1.655 | 0.034
COVID19 (Custom Term) | Injection site joint discomfort | 1 | 1.567 | 0.283 | 1.155 | 2.506 | 0.316 | 0.772 | 1.641 | 0.638 | 1.655 | 0.034
COVID19 (Custom Term) | Pregnancy test urine negative | 3 | 2.516 | 0.418 | 1.154 | 2.188 | 0.483 | 0.985 | 1.833 | 1.192 | 1.655 | 0.192
COVID19 (Custom Term) | Granulocyte count | 5 | 4.466 | 0.567 | 1.154 | 1.908 | 0.539 | 0.994 | 1.712 | 1.119 | 2.159 | 1.614
COVID19 (Custom Term) | Headache | 6382 | 5817.402 | 1.13 | 1.154 | 1.178 | 1.075 | 1.097 | 1.12 | 1.097 | 2.793 | 6269.801
COVID19 (Custom Term) | Activated partial thromboplastin time prolonged | 9 | 9.085 | 0.625 | 1.154 | 1.813 | 0.577 | 0.948 | 1.485 | 0.991 | 2.078 | 3.24
COVID19 (Custom Term) | Ecchymosis | 9 | 9.712 | 0.65 | 1.154 | 1.775 | 0.55 | 0.903 | 1.415 | 0.927 | 0.727 | 0.606
COVID19 (Custom Term) | Fear of injection | 4 | 4.433 | 0.509 | 1.154 | 2.009 | 0.453 | 0.874 | 1.558 | 0.902 | 1.281 | 0.03
COVID19 (Custom Term) | Blood immunoglobulin E normal | 1 | 1.456 | 0.225 | 1.154 | 2.672 | 0.324 | 0.79 | 1.677 | 0.687 | 0.32 | 0.767
COVID19 (Custom Term) | Cold sweat | 206 | 177.962 | 1.026 | 1.153 | 1.286 | 1.026 | 1.151 | 1.288 | 1.158 | 1.883 | 71.209
COVID19 (Custom Term) | Body temperature increased | 500 | 444.31 | 1.07 | 1.153 | 1.238 | 1.043 | 1.123 | 1.208 | 1.125 | 1.707 | 125.433
COVID19 (Custom Term) | Feeling abnormal | 916 | 844.387 | 1.091 | 1.153 | 1.216 | 1.026 | 1.084 | 1.144 | 1.085 | 2.44 | 632.46
COVID19 (Custom Term) | Idiopathic intracranial hypertension | 1 | 0.995 | 0.169 | 1.153 | 2.863 | 0.359 | 0.872 | 1.849 | 1.005 | 0.552 | 0.036
COVID19 (Custom Term) | Suffocation feeling | 1 | 1.045 | 0.286 | 1.153 | 2.496 | 0.354 | 0.862 | 1.829 | 0.957 | 1.655 | 0.034
COVID19 (Custom Term) | Nephrolithiasis | 9 | 9.411 | 0.649 | 1.153 | 1.775 | 0.563 | 0.924 | 1.448 | 0.956 | 1.862 | 2.277
COVID19 (Custom Term) | Whole body scan | 1 | 1.361 | 0.207 | 1.153 | 2.729 | 0.33 | 0.806 | 1.71 | 0.735 | 1.418 | 0.081
COVID19 (Custom Term) | Shift to the left | 3 | 2.997 | 0.399 | 1.152 | 2.219 | 0.448 | 0.913 | 1.698 | 1.001 | 0.931 | 0.03
COVID19 (Custom Term) | Angiogram retina abnormal | 1 | 0.401 | 0.21 | 1.151 | 2.709 | 0.415 | 1.009 | 2.15 | 2.492 | 1.418 | 0.081
COVID19 (Custom Term) | Human chorionic gonadotropin | 15 | 13.497 | 0.728 | 1.151 | 1.653 | 0.705 | 1.054 | 1.527 | 1.111 | 7.447 | 43.874
COVID19 (Custom Term) | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [broad] | 520 | 476.609 | 1.07 | 1.151 | 1.235 | 1.013 | 1.089 | 1.17 | 1.091 | 5.724 | 1288.122
COVID19 (Custom Term) | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [narrow] | 520 | 476.609 | 1.07 | 1.151 | 1.236 | 1.013 | 1.089 | 1.17 | 1.091 | 5.731 | 1289.63
COVID19 (Custom Term) | Gastrooesophageal reflux disease | 26 | 25.287 | 0.819 | 1.151 | 1.53 | 0.734 | 1.005 | 1.349 | 1.028 | 0.982 | 0
COVID19 (Custom Term) | Globulin | 7 | 6.852 | 0.587 | 1.151 | 1.869 | 0.556 | 0.959 | 1.564 | 1.022 | 2.242 | 2.894
COVID19 (Custom Term) | Noninfectious encephalopathy/delirium (SMQ) [narrow] | 64 | 71.118 | 0.927 | 1.151 | 1.394 | 0.731 | 0.897 | 1.092 | 0.9 | 1.229 | 2.217
COVID19 (Custom Term) | Periorbital oedema | 12 | 9.226 | 0.689 | 1.15 | 1.707 | 0.753 | 1.171 | 1.755 | 1.301 | 2.432 | 6.91
COVID19 (Custom Term) | Skin culture | 1 | 0.925 | 0.211 | 1.15 | 2.708 | 0.365 | 0.886 | 1.879 | 1.081 | 1.418 | 0.081
COVID19 (Custom Term) | Electrocardiogram change | 6 | 5.845 | 0.586 | 1.15 | 1.867 | 0.537 | 0.955 | 1.597 | 1.026 | 11.915 | 22.083
COVID19 (Custom Term) | Protein total normal | 31 | 30.651 | 0.842 | 1.15 | 1.498 | 0.743 | 0.993 | 1.305 | 1.011 | 1.973 | 11.54
COVID19 (Custom Term) | Cytology | 1 | 1.361 | 0.29 | 1.15 | 2.472 | 0.33 | 0.806 | 1.71 | 0.735 | 1.655 | 0.034
COVID19 (Custom Term) | Lymphoedema | 14 | 10.96 | 0.74 | 1.149 | 1.631 | 0.773 | 1.169 | 1.711 | 1.277 | 4.212 | 21.665
COVID19 (Custom Term) | Sinus operation | 9 | 7.514 | 0.67 | 1.149 | 1.733 | 0.659 | 1.081 | 1.695 | 1.198 | 11.17 | 34.129
COVID19 (Custom Term) | Lip erythema | 10 | 8.744 | 0.653 | 1.149 | 1.76 | 0.656 | 1.055 | 1.626 | 1.144 | 2.113 | 3.875
COVID19 (Custom Term) | Pain in jaw | 110 | 101.34 | 0.979 | 1.149 | 1.332 | 0.92 | 1.077 | 1.254 | 1.085 | 2.71 | 91.922
COVID19 (Custom Term) | Noninfectious diarrhoea (SMQ) [narrow] | 1144 | 1072.607 | 1.094 | 1.149 | 1.205 | 1.015 | 1.066 | 1.119 | 1.067 | 1.538 | 190.649
COVID19 (Custom Term) | Productive cough | 54 | 54.27 | 0.91 | 1.149 | 1.41 | 0.789 | 0.985 | 1.219 | 0.995 | 1.099 | 0.34
COVID19 (Custom Term) | Biliary neoplasms (SMQ) [broad] | 1 | 1.045 | 0.292 | 1.149 | 2.466 | 0.354 | 0.862 | 1.829 | 0.957 | 1.655 | 0.034
COVID19 (Custom Term) | Biliary neoplasms (SMQ) [narrow] | 1 | 1.045 | 0.292 | 1.149 | 2.466 | 0.354 | 0.862 | 1.829 | 0.957 | 1.655 | 0.034
COVID19 (Custom Term) | Arrhythmia related investigations, signs and symptoms (SMQ) [narrow] | 6 | 6.244 | 0.594 | 1.149 | 1.851 | 0.515 | 0.917 | 1.533 | 0.961 | 8.511 | 17.195
COVID19 (Custom Term) | Polyneuropathy | 5 | 4.467 | 0.5 | 1.148 | 2.013 | 0.539 | 0.994 | 1.712 | 1.119 | 0.523 | 1.603
COVID19 (Custom Term) | Vein disorder | 4 | 3.972 | 0.495 | 1.148 | 2.02 | 0.481 | 0.927 | 1.653 | 1.007 | 3.31 | 3.117
COVID19 (Custom Term) | Cerebral ischaemia | 3 | 3.043 | 0.472 | 1.148 | 2.065 | 0.445 | 0.907 | 1.686 | 0.986 | 1.862 | 0.367
COVID19 (Custom Term) | Ultrasound joint | 2 | 2.163 | 0.347 | 1.148 | 2.327 | 0.397 | 0.871 | 1.711 | 0.925 | 0.863 | 0.022
COVID19 (Custom Term) | Infective pneumonia (SMQ) [narrow] | 265 | 286.542 | 1.034 | 1.148 | 1.266 | 0.835 | 0.924 | 1.02 | 0.925 | 1.093 | 1.818
COVID19 (Custom Term) | Cardiac arrhythmias (SMQ) [narrow] | 526 | 482.478 | 1.066 | 1.147 | 1.23 | 1.013 | 1.088 | 1.168 | 1.09 | 5.752 | 1309.752
COVID19 (Custom Term) | IIIrd nerve paresis | 1 | 0.987 | 0.216 | 1.147 | 2.681 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Blood folate | 5 | 4.959 | 0.541 | 1.147 | 1.936 | 0.508 | 0.937 | 1.614 | 1.008 | 3.819 | 5.44
COVID19 (Custom Term) | Subdural haemorrhage | 5 | 4.976 | 0.509 | 1.147 | 1.992 | 0.507 | 0.935 | 1.61 | 1.005 | 6.206 | 10.142
COVID19 (Custom Term) | Blood disorder | 1 | 1.073 | 0.308 | 1.147 | 2.418 | 0.352 | 0.857 | 1.817 | 0.932 | 0.662 | 0.001
COVID19 (Custom Term) | Tracheobronchitis | 1 | 1.127 | 0.122 | 1.147 | 3.046 | 0.348 | 0.847 | 1.796 | 0.887 | 1.241 | 0.14
COVID19 (Custom Term) | Rhabdomyolysis/myopathy (SMQ) [narrow] | 19 | 21.722 | 0.762 | 1.147 | 1.597 | 0.605 | 0.87 | 1.218 | 0.875 | 1.283 | 0.795
COVID19 (Custom Term) | Blood pressure increased | 615 | 486.478 | 1.072 | 1.146 | 1.223 | 1.18 | 1.261 | 1.347 | 1.264 | 7.819 | 2050.282
COVID19 (Custom Term) | Eye pruritus | 94 | 88.288 | 0.961 | 1.146 | 1.344 | 0.891 | 1.056 | 1.244 | 1.065 | 2.293 | 54.622
COVID19 (Custom Term) | Hiatus hernia | 4 | 3.957 | 0.485 | 1.146 | 2.036 | 0.482 | 0.929 | 1.656 | 1.011 | 5.674 | 6.8
COVID19 (Custom Term) | Laryngeal oedema | 4 | 3.992 | 0.424 | 1.146 | 2.153 | 0.48 | 0.925 | 1.649 | 1.002 | 1.324 | 0.054
COVID19 (Custom Term) | Renal function test abnormal | 3 | 3.105 | 0.451 | 1.146 | 2.1 | 0.441 | 0.898 | 1.671 | 0.966 | 1.418 | 0.046
COVID19 (Custom Term) | Alanine aminotransferase increased | 64 | 66.286 | 0.924 | 1.146 | 1.388 | 0.781 | 0.959 | 1.167 | 0.966 | 1.428 | 6.783
COVID19 (Custom Term) | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [broad] | 265 | 285.755 | 1.033 | 1.146 | 1.263 | 0.837 | 0.926 | 1.023 | 0.927 | 1.101 | 2.125
COVID19 (Custom Term) | Endotracheal intubation complication | 1 | 1.638 | 0.295 | 1.146 | 2.45 | 0.311 | 0.762 | 1.618 | 0.61 | 1.655 | 0.034
COVID19 (Custom Term) | Mean cell volume normal | 30 | 29.378 | 0.832 | 1.145 | 1.5 | 0.746 | 1.001 | 1.321 | 1.021 | 1.268 | 1.254
COVID19 (Custom Term) | Staring | 17 | 18.261 | 0.767 | 1.145 | 1.586 | 0.626 | 0.916 | 1.303 | 0.931 | 0.315 | 23.87
COVID19 (Custom Term) | Bladder scan | 1 | 0.988 | 0.298 | 1.144 | 2.438 | 0.359 | 0.873 | 1.852 | 1.012 | 1.655 | 0.034
COVID19 (Custom Term) | Respiratory rate increased | 47 | 41.476 | 0.894 | 1.143 | 1.417 | 0.875 | 1.11 | 1.392 | 1.133 | 1.969 | 17.842
COVID19 (Custom Term) | Tunnel vision | 36 | 31.955 | 0.861 | 1.143 | 1.459 | 0.838 | 1.097 | 1.417 | 1.127 | 6.271 | 94.26
COVID19 (Custom Term) | Red blood cell schistocytes present | 1 | 1.015 | 0.187 | 1.143 | 2.767 | 0.357 | 0.868 | 1.841 | 0.985 | 1.241 | 0.14
COVID19 (Custom Term) | Sinus pain | 10 | 10.347 | 0.648 | 1.143 | 1.752 | 0.58 | 0.934 | 1.439 | 0.966 | 1.628 | 1.529
COVID19 (Custom Term) | Encephalopathy | 20 | 22.498 | 0.768 | 1.143 | 1.579 | 0.619 | 0.882 | 1.227 | 0.889 | 0.879 | 0.197
COVID19 (Custom Term) | HIV test positive | 1 | 0.374 | 0.301 | 1.142 | 2.424 | 0.418 | 1.016 | 2.168 | 2.671 | 1.655 | 0.034
COVID19 (Custom Term) | Paraesthesia | 1498 | 1320.385 | 1.094 | 1.142 | 1.191 | 1.086 | 1.134 | 1.183 | 1.135 | 2.918 | 1486.473
COVID19 (Custom Term) | Monocyte percentage decreased | 5 | 4.491 | 0.546 | 1.142 | 1.915 | 0.538 | 0.991 | 1.707 | 1.113 | 2.758 | 3.002
COVID19 (Custom Term) | Blood creatinine decreased | 2 | 2.039 | 0.312 | 1.142 | 2.394 | 0.406 | 0.89 | 1.749 | 0.981 | 0.292 | 2.621
COVID19 (Custom Term) | Genital rash | 2 | 2.279 | 0.438 | 1.142 | 2.115 | 0.389 | 0.854 | 1.677 | 0.878 | 0.375 | 1.403
COVID19 (Custom Term) | Heart rate normal | 1 | 1.509 | 0.382 | 1.142 | 2.232 | 0.32 | 0.781 | 1.66 | 0.663 | 0.414 | 0.298
COVID19 (Custom Term) | Macular degeneration | 1 | 1.562 | 0.222 | 1.142 | 2.648 | 0.316 | 0.773 | 1.643 | 0.64 | 1.418 | 0.081
COVID19 (Custom Term) | Device leakage | 1 | 1.072 | 0.075 | 1.141 | 3.296 | 0.352 | 0.857 | 1.818 | 0.933 | 0.221 | 1.919
COVID19 (Custom Term) | Pyelonephritis | 2 | 2.539 | 0.325 | 1.141 | 2.36 | 0.372 | 0.817 | 1.606 | 0.788 | 0.567 | 0.255
COVID19 (Custom Term) | Blood pressure systolic decreased | 4 | 2.134 | 0.522 | 1.14 | 1.952 | 0.636 | 1.227 | 2.194 | 1.875 | 4.965 | 5.784
COVID19 (Custom Term) | Sleep paralysis | 1 | 0.503 | 0.113 | 1.14 | 3.066 | 0.404 | 0.981 | 2.088 | 1.988 | 0.584 | 0.014
COVID19 (Custom Term) | Vascular injury | 1 | 0.995 | 0.313 | 1.14 | 2.387 | 0.359 | 0.872 | 1.849 | 1.005 | 0.662 | 0.001
COVID19 (Custom Term) | Anal pruritus | 1 | 1.041 | 0.303 | 1.14 | 2.412 | 0.355 | 0.863 | 1.831 | 0.961 | 1.655 | 0.034
COVID19 (Custom Term) | Red blood cell count | 3 | 3.223 | 0.368 | 1.14 | 2.258 | 0.433 | 0.883 | 1.642 | 0.931 | 0.784 | 0.019
COVID19 (Custom Term) | Skin weeping | 2 | 3.386 | 0.414 | 1.14 | 2.158 | 0.326 | 0.717 | 1.411 | 0.591 | 1.241 | 0.014
COVID19 (Custom Term) | Oral pustule | 1 | 2.476 | 0.303 | 1.14 | 2.412 | 0.263 | 0.652 | 1.394 | 0.404 | 1.655 | 0.034
COVID19 (Custom Term) | Plasma cell myeloma | 2 | 4.909 | 0.259 | 1.14 | 2.528 | 0.264 | 0.586 | 1.158 | 0.407 | 1.418 | 0.001
COVID19 (Custom Term) | Dehydration | 134 | 133.037 | 0.984 | 1.139 | 1.304 | 0.87 | 1.003 | 1.152 | 1.007 | 1.533 | 21.059
COVID19 (Custom Term) | Computerised tomogram abnormal | 92 | 94.516 | 0.953 | 1.139 | 1.338 | 0.816 | 0.968 | 1.143 | 0.973 | 4.685 | 178.558
COVID19 (Custom Term) | Thoracic operation | 1 | 1.106 | 0.226 | 1.139 | 2.626 | 0.35 | 0.851 | 1.805 | 0.904 | 1.418 | 0.081
COVID19 (Custom Term) | Skin burning sensation | 50 | 44.649 | 0.897 | 1.138 | 1.403 | 0.872 | 1.099 | 1.37 | 1.12 | 2.187 | 25.361
COVID19 (Custom Term) | Catheterisation cardiac normal | 21 | 19.235 | 0.794 | 1.138 | 1.533 | 0.744 | 1.052 | 1.453 | 1.092 | 13.032 | 95.245
COVID19 (Custom Term) | Vital functions abnormal | 12 | 11.397 | 0.684 | 1.138 | 1.684 | 0.644 | 1.001 | 1.501 | 1.053 | 29.788 | 75.734
COVID19 (Custom Term) | Chills | 4548 | 4332.689 | 1.111 | 1.138 | 1.166 | 1.024 | 1.05 | 1.075 | 1.05 | 2.72 | 4140.262
COVID19 (Custom Term) | Computerised tomogram head normal | 130 | 123.884 | 0.981 | 1.138 | 1.304 | 0.903 | 1.043 | 1.201 | 1.049 | 2.144 | 64.384
COVID19 (Custom Term) | Oxygen saturation | 38 | 36.933 | 0.867 | 1.138 | 1.44 | 0.778 | 1.012 | 1.299 | 1.029 | 17.151 | 205.478
COVID19 (Custom Term) | Aspiration pleural cavity | 5 | 5.072 | 0.519 | 1.138 | 1.951 | 0.502 | 0.925 | 1.593 | 0.986 | 2.482 | 2.356
COVID19 (Custom Term) | Cortisol normal | 2 | 2.485 | 0.416 | 1.138 | 2.148 | 0.376 | 0.824 | 1.62 | 0.805 | 1.805 | 0.089
COVID19 (Custom Term) | Coma scale | 1 | 1.368 | 0.228 | 1.138 | 2.616 | 0.33 | 0.805 | 1.708 | 0.731 | 1.418 | 0.081
COVID19 (Custom Term) | Influenza B virus test | 41 | 37.069 | 0.865 | 1.137 | 1.439 | 0.84 | 1.082 | 1.377 | 1.106 | 1.893 | 13.714
COVID19 (Custom Term) | Parkinson-like events (SMQ) [narrow] | 31 | 34.426 | 0.83 | 1.137 | 1.483 | 0.67 | 0.895 | 1.176 | 0.9 | 0.551 | 10.325
COVID19 (Custom Term) | Hyperlipidaemia | 5 | 6.293 | 0.539 | 1.137 | 1.914 | 0.439 | 0.811 | 1.396 | 0.795 | 3.103 | 3.809
COVID19 (Custom Term) | Dyschromatopsia | 1 | 1.37 | 0.258 | 1.137 | 2.523 | 0.33 | 0.804 | 1.707 | 0.73 | 0.621 | 0.002
COVID19 (Custom Term) | Peripheral circulatory failure | 1 | 0.509 | 0.129 | 1.136 | 2.977 | 0.404 | 0.98 | 2.084 | 1.966 | 1.241 | 0.14
COVID19 (Custom Term) | Lymphocyte count decreased | 18 | 16.047 | 0.752 | 1.136 | 1.585 | 0.738 | 1.07 | 1.51 | 1.122 | 1.64 | 3.276
COVID19 (Custom Term) | Anaphylactic reaction (SMQ) [algorithm] | 1483 | 1347.846 | 1.088 | 1.136 | 1.185 | 1.053 | 1.1 | 1.147 | 1.1 | 2.478 | 1068.027
COVID19 (Custom Term) | Asthma/bronchospasm (SMQ) [narrow] | 85 | 77.901 | 0.943 | 1.136 | 1.344 | 0.903 | 1.08 | 1.283 | 1.091 | 1.039 | 0.079
COVID19 (Custom Term) | Obstructive airways disorder | 17 | 15.853 | 0.741 | 1.136 | 1.602 | 0.703 | 1.029 | 1.464 | 1.072 | 3.31 | 18.693
COVID19 (Custom Term) | Aspiration bursa | 1 | 0.993 | 0.311 | 1.136 | 2.38 | 0.359 | 0.872 | 1.85 | 1.007 | 1.655 | 0.034
COVID19 (Custom Term) | Helicobacter test | 1 | 1.498 | 0.31 | 1.136 | 2.384 | 0.321 | 0.783 | 1.663 | 0.667 | 1.655 | 0.034
COVID19 (Custom Term) | Bone marrow disorder | 1 | 0.995 | 0.312 | 1.135 | 2.375 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Toxic encephalopathy | 1 | 0.995 | 0.233 | 1.135 | 2.593 | 0.359 | 0.872 | 1.849 | 1.005 | 1.418 | 0.081
COVID19 (Custom Term) | Injection site exfoliation | 1 | 1.049 | 0.368 | 1.135 | 2.244 | 0.354 | 0.862 | 1.827 | 0.953 | 0.414 | 0.298
COVID19 (Custom Term) | Hepatic cirrhosis | 6 | 6.862 | 0.59 | 1.135 | 1.824 | 0.485 | 0.862 | 1.442 | 0.874 | 5.958 | 12.248
COVID19 (Custom Term) | Dreamy state | 1 | 1.381 | 0.233 | 1.135 | 2.591 | 0.329 | 0.802 | 1.703 | 0.724 | 1.418 | 0.081
COVID19 (Custom Term) | Cystoscopy | 1 | 1.492 | 0.131 | 1.135 | 2.963 | 0.321 | 0.784 | 1.666 | 0.67 | 1.241 | 0.14
COVID19 (Custom Term) | Dark circles under eyes | 2 | 1.693 | 0.552 | 1.134 | 1.884 | 0.433 | 0.949 | 1.865 | 1.181 | 0.484 | 0.576
COVID19 (Custom Term) | Haemorrhage laboratory terms (SMQ) [broad] | 271 | 263.634 | 1.024 | 1.134 | 1.25 | 0.927 | 1.025 | 1.131 | 1.028 | 2.277 | 157.328
COVID19 (Custom Term) | Platelet disorder | 1 | 0.995 | 0.313 | 1.134 | 2.369 | 0.359 | 0.872 | 1.849 | 1.005 | 1.655 | 0.034
COVID19 (Custom Term) | Sepsis (SMQ) [broad] | 134 | 142.094 | 0.978 | 1.134 | 1.299 | 0.816 | 0.94 | 1.08 | 0.943 | 0.903 | 1.199
COVID19 (Custom Term) | Motor dysfunction | 16 | 17.185 | 0.727 | 1.134 | 1.616 | 0.619 | 0.915 | 1.313 | 0.931 | 0.845 | 0.277
COVID19 (Custom Term) | Back injury | 3 | 3.564 | 0.507 | 1.134 | 1.963 | 0.412 | 0.84 | 1.563 | 0.842 | 1.986 | 0.486
COVID19 (Custom Term) | Repetitive speech | 3 | 3.924 | 0.446 | 1.134 | 2.077 | 0.392 | 0.8 | 1.489 | 0.765 | 2.979 | 1.589
COVID19 (Custom Term) | Crohn's disease | 6 | 8.091 | 0.523 | 1.134 | 1.934 | 0.434 | 0.772 | 1.291 | 0.742 | 0.648 | 0.747
COVID19 (Custom Term) | Palpitations | 906 | 715.664 | 1.071 | 1.133 | 1.195 | 1.196 | 1.264 | 1.334 | 1.266 | 6.217 | 2452.555
COVID19 (Custom Term) | X-ray of pelvis and hip | 7 | 6.909 | 0.662 | 1.133 | 1.706 | 0.553 | 0.954 | 1.556 | 1.013 | 3.022 | 5.655
COVID19 (Custom Term) | Oral fungal infection | 1 | 0.988 | 0.314 | 1.133 | 2.365 | 0.359 | 0.873 | 1.852 | 1.012 | 1.655 | 0.034
COVID19 (Custom Term) | Epinephrine | 12 | 11.946 | 0.7 | 1.133 | 1.652 | 0.621 | 0.966 | 1.448 | 1.005 | 39.717 | 82.262
COVID19 (Custom Term) | Hypovitaminosis | 1 | 1.015 | 0.21 | 1.133 | 2.659 | 0.357 | 0.868 | 1.841 | 0.985 | 0.584 | 0.014
COVID19 (Custom Term) | Pulse abnormal | 33 | 27.026 | 0.855 | 1.132 | 1.442 | 0.887 | 1.176 | 1.534 | 1.221 | 2.979 | 31.727
COVID19 (Custom Term) | Haematocrit normal | 47 | 41.828 | 0.881 | 1.132 | 1.41 | 0.868 | 1.101 | 1.381 | 1.124 | 1.241 | 1.731
COVID19 (Custom Term) | Diarrhoea | 1113 | 1044.184 | 1.076 | 1.132 | 1.188 | 1.014 | 1.065 | 1.119 | 1.066 | 1.554 | 194.428
COVID19 (Custom Term) | Hyponatraemia/SIADH (SMQ) [broad] | 69 | 68.639 | 0.922 | 1.132 | 1.361 | 0.818 | 0.997 | 1.205 | 1.005 | 2.015 | 28.442
COVID19 (Custom Term) | Computerised tomogram pelvis abnormal | 12 | 12.511 | 0.69 | 1.132 | 1.665 | 0.599 | 0.932 | 1.397 | 0.959 | 11.915 | 49.219
COVID19 (Custom Term) | Delusion | 7 | 6.282 | 0.67 | 1.131 | 1.689 | 0.588 | 1.014 | 1.655 | 1.114 | 2.317 | 3.154
COVID19 (Custom Term) | Haemorrhagic central nervous system vascular conditions (SMQ) [broad] | 313 | 320.259 | 1.029 | 1.131 | 1.238 | 0.889 | 0.976 | 1.069 | 0.977 | 6.515 | 880.755
COVID19 (Custom Term) | Haemorrhagic central nervous system vascular conditions (SMQ) [narrow] | 313 | 320.259 | 1.029 | 1.131 | 1.238 | 0.889 | 0.976 | 1.069 | 0.977 | 6.515 | 880.755
COVID19 (Custom Term) | Polypectomy | 1 | 1.05 | 0.238 | 1.131 | 2.565 | 0.354 | 0.861 | 1.827 | 0.952 | 1.418 | 0.081
COVID19 (Custom Term) | Slit-lamp tests abnormal | 1 | 1.109 | 0.12 | 1.131 | 3.003 | 0.349 | 0.85 | 1.803 | 0.902 | 1.103 | 0.207
COVID19 (Custom Term) | Drug related hepatic disorders - severe events only (SMQ) [broad] | 44 | 48.754 | 0.87 | 1.131 | 1.421 | 0.703 | 0.898 | 1.134 | 0.902 | 0.984 | 0.001
COVID19 (Custom Term) | Oral mucosal erythema | 4 | 3.552 | 0.486 | 1.13 | 1.992 | 0.509 | 0.982 | 1.751 | 1.126 | 0.946 | 0.022
COVID19 (Custom Term) | Muscle enzyme increased | 1 | 0.993 | 0.241 | 1.13 | 2.554 | 0.359 | 0.872 | 1.85 | 1.007 | 1.418 | 0.081
COVID19 (Custom Term) | Respiration abnormal | 19 | 19.755 | 0.758 | 1.13 | 1.562 | 0.656 | 0.943 | 1.321 | 0.962 | 1.078 | 0.035
COVID19 (Custom Term) | Sleep deficit | 1 | 1.503 | 0.318 | 1.13 | 2.347 | 0.32 | 0.783 | 1.662 | 0.666 | 1.655 | 0.034
COVID19 (Custom Term) | Hypoaesthesia oral | 423 | 322.85 | 1.04 | 1.129 | 1.22 | 1.204 | 1.305 | 1.412 | 1.31 | 10.345 | 1748.032
COVID19 (Custom Term) | Arrhythmia related investigations, signs and symptoms (SMQ) [broad] | 3342 | 3015.623 | 1.097 | 1.129 | 1.161 | 1.077 | 1.108 | 1.14 | 1.108 | 2.408 | 2330.084
COVID19 (Custom Term) | Condition aggravated | 602 | 571.171 | 1.055 | 1.129 | 1.206 | 0.984 | 1.053 | 1.125 | 1.054 | 2.467 | 423.098
COVID19 (Custom Term) | Immunosuppression | 2 | 2.062 | 0.423 | 1.129 | 2.111 | 0.404 | 0.886 | 1.742 | 0.97 | 0.764 | 0.002
COVID19 (Custom Term) | Ear pruritus | 28 | 23.846 | 0.842 | 1.128 | 1.448 | 0.834 | 1.13 | 1.504 | 1.174 | 4.965 | 56.24
COVID19 (Custom Term) | Acute coronary syndrome | 4 | 3.539 | 0.474 | 1.128 | 2.008 | 0.51 | 0.984 | 1.754 | 1.13 | 5.674 | 6.8
COVID19 (Custom Term) | Pseudomembranous colitis (SMQ) [broad] | 1145 | 1078.194 | 1.074 | 1.128 | 1.184 | 1.011 | 1.061 | 1.114 | 1.062 | 1.518 | 179.563
COVID19 (Custom Term) | Oxygen saturation abnormal | 5 | 4.923 | 0.531 | 1.128 | 1.905 | 0.51 | 0.941 | 1.62 | 1.016 | 5.516 | 8.904
COVID19 (Custom Term) | Toxoplasmosis | 1 | 0.988 | 0.243 | 1.128 | 2.542 | 0.359 | 0.873 | 1.852 | 1.012 | 1.418 | 0.081
COVID19 (Custom Term) | Abnormal behaviour | 32 | 32.858 | 0.836 | 1.128 | 1.456 | 0.722 | 0.961 | 1.258 | 0.974 | 0.402 | 26.762
COVID19 (Custom Term) | Adenovirus infection | 1 | 1.097 | 0.187 | 1.128 | 2.723 | 0.35 | 0.853 | 1.808 | 0.912 | 0.368 | 0.485
COVID19 (Custom Term) | Mucosal disorder | 2 | 1.864 | 0.373 | 1.127 | 2.209 | 0.419 | 0.919 | 1.806 | 1.073 | 1.986 | 0.162
COVID19 (Custom Term) | Small intestinal obstruction | 13 | 12.343 | 0.71 | 1.127 | 1.622 | 0.656 | 1.005 | 1.487 | 1.053 | 14.342 | 60.142
COVID19 (Custom Term) | Biliary disorders (SMQ) [broad] | 108 | 107.313 | 0.956 | 1.127 | 1.309 | 0.854 | 1.001 | 1.167 | 1.006 | 1.351 | 8.337
COVID19 (Custom Term) | Stool analysis | 3 | 3.27 | 0.383 | 1.127 | 2.191 | 0.43 | 0.876 | 1.63 | 0.917 | 0.226 | 6.986
COVID19 (Custom Term) | Drug related hepatic disorders - severe events only (SMQ) [narrow] | 44 | 48.754 | 0.867 | 1.127 | 1.416 | 0.703 | 0.898 | 1.134 | 0.902 | 0.986 | 0
COVID19 (Custom Term) | Cholestasis and jaundice of hepatic origin (SMQ) [narrow] | 19 | 21.454 | 0.747 | 1.127 | 1.571 | 0.612 | 0.879 | 1.231 | 0.886 | 0.89 | 0.139
COVID19 (Custom Term) | Anosmia | 179 | 146.813 | 0.992 | 1.126 | 1.268 | 1.07 | 1.21 | 1.365 | 1.219 | 41.333 | 1356.874
COVID19 (Custom Term) | Dyspnoea | 2022 | 1830.483 | 1.086 | 1.126 | 1.168 | 1.064 | 1.104 | 1.145 | 1.105 | 3.244 | 2423.051
COVID19 (Custom Term) | Autoantibody negative | 1 | 0.995 | 0.185 | 1.126 | 2.722 | 0.359 | 0.872 | 1.849 | 1.005 | 0.584 | 0.014
COVID19 (Custom Term) | Faeces soft | 2 | 2.011 | 0.262 | 1.126 | 2.48 | 0.408 | 0.895 | 1.758 | 0.995 | 0.375 | 1.403
COVID19 (Custom Term) | Torsade de pointes, shock-associated conditions (SMQ) [broad] | 225 | 231.05 | 1.006 | 1.126 | 1.252 | 0.87 | 0.972 | 1.082 | 0.974 | 2.339 | 138.928
COVID19 (Custom Term) | Hearing and vestibular disorders (SMQ) [broad] | 4581 | 4088.442 | 1.098 | 1.125 | 1.153 | 1.093 | 1.12 | 1.148 | 1.12 | 2.729 | 4198.629
COVID19 (Custom Term) | Myoglobin blood | 1 | 1.417 | 0.249 | 1.125 | 2.514 | 0.326 | 0.796 | 1.691 | 0.706 | 1.418 | 0.081
COVID19 (Custom Term) | Tearfulness | 9 | 8.08 | 0.613 | 1.124 | 1.76 | 0.627 | 1.029 | 1.613 | 1.114 | 0.667 | 1.081
COVID19 (Custom Term) | Tonsillar hypertrophy | 12 | 11.487 | 0.665 | 1.124 | 1.68 | 0.64 | 0.996 | 1.492 | 1.045 | 0.851 | 0.157
COVID19 (Custom Term) | Intensive care | 194 | 197.083 | 0.996 | 1.124 | 1.259 | 0.872 | 0.982 | 1.102 | 0.984 | 1.978 | 77.564
COVID19 (Custom Term) | Skin lesion | 25 | 32.903 | 0.792 | 1.124 | 1.504 | 0.557 | 0.768 | 1.036 | 0.76 | 0.261 | 50.319
COVID19 (Custom Term) | Mononucleosis heterophile test | 1 | 1.517 | 0.422 | 1.124 | 2.099 | 0.319 | 0.78 | 1.657 | 0.659 | 0.168 | 3.192
COVID19 (Custom Term) | Eyelid rash | 7 | 7.168 | 0.585 | 1.123 | 1.803 | 0.54 | 0.931 | 1.518 | 0.977 | 0.858 | 0.042
COVID19 (Custom Term) | Taste and smell disorders (SMQ) [narrow] | 683 | 529.683 | 1.052 | 1.122 | 1.193 | 1.208 | 1.286 | 1.369 | 1.289 | 10.596 | 2877.525
COVID19 (Custom Term) | Taste and smell disorders (SMQ) [broad] | 683 | 529.683 | 1.052 | 1.122 | 1.193 | 1.208 | 1.286 | 1.369 | 1.289 | 10.596 | 2877.525
COVID19 (Custom Term) | Hypoglycaemic and neurogenic shock conditions (SMQ) [broad] | 212 | 222.763 | 0.999 | 1.122 | 1.251 | 0.848 | 0.95 | 1.061 | 0.952 | 1.99 | 86.349
COVID19 (Custom Term) | Trigeminal neuralgia | 6 | 6.542 | 0.524 | 1.122 | 1.903 | 0.5 | 0.89 | 1.488 | 0.917 | 0.745 | 0.262
COVID19 (Custom Term) | Vitamin B12 | 8 | 9.025 | 0.625 | 1.122 | 1.737 | 0.52 | 0.873 | 1.394 | 0.886 | 2.147 | 3.059
COVID19 (Custom Term) | Visual field defect | 16 | 18.088 | 0.717 | 1.122 | 1.601 | 0.593 | 0.877 | 1.259 | 0.885 | 1.358 | 1.004
COVID19 (Custom Term) | Septic shock | 11 | 12.78 | 0.654 | 1.122 | 1.693 | 0.542 | 0.856 | 1.3 | 0.861 | 1.2 | 0.161
COVID19 (Custom Term) | Supraventricular tachyarrhythmias (SMQ) [narrow] | 263 | 236.647 | 1.01 | 1.121 | 1.236 | 1 | 1.107 | 1.223 | 1.111 | 7.335 | 825.129
COVID19 (Custom Term) | Metabolic function test | 336 | 314.932 | 1.023 | 1.121 | 1.223 | 0.973 | 1.064 | 1.163 | 1.067 | 4.099 | 556.6
COVID19 (Custom Term) | Asthma/bronchospasm (SMQ) [broad] | 519 | 490.586 | 1.041 | 1.121 | 1.203 | 0.982 | 1.056 | 1.135 | 1.058 | 2.054 | 233.687
COVID19 (Custom Term) | Haematopoietic leukopenia (SMQ) [narrow] | 84 | 84.994 | 0.93 | 1.121 | 1.327 | 0.821 | 0.982 | 1.168 | 0.988 | 0.874 | 1.275
COVID19 (Custom Term) | Hepatomegaly | 2 | 2.075 | 0.277 | 1.121 | 2.426 | 0.403 | 0.884 | 1.738 | 0.964 | 0.361 | 1.556
COVID19 (Custom Term) | Interleukin level increased | 1 | 1.05 | 0.105 | 1.121 | 3.047 | 0.354 | 0.861 | 1.827 | 0.952 | 0.523 | 0.065
COVID19 (Custom Term) | White blood cell count increased | 178 | 187.136 | 0.987 | 1.121 | 1.262 | 0.839 | 0.949 | 1.071 | 0.951 | 1.136 | 2.476
COVID19 (Custom Term) | Jaundice | 15 | 16.403 | 0.703 | 1.121 | 1.618 | 0.603 | 0.901 | 1.305 | 0.914 | 1.034 | 0
COVID19 (Custom Term) | Abdominal discomfort | 223 | 244.103 | 1.001 | 1.121 | 1.246 | 0.817 | 0.912 | 1.017 | 0.914 | 1.261 | 10.493
COVID19 (Custom Term) | Smear test | 1 | 1.744 | 0.292 | 1.121 | 2.386 | 0.304 | 0.746 | 1.586 | 0.573 | 0.993 | 0.266
COVID19 (Custom Term) | Ageusia | 203 | 170.243 | 0.994 | 1.12 | 1.252 | 1.055 | 1.185 | 1.327 | 1.192 | 18.324 | 1162.855
COVID19 (Custom Term) | Supraventricular tachyarrhythmias (SMQ) [broad] | 263 | 237.021 | 1.009 | 1.12 | 1.235 | 0.998 | 1.106 | 1.221 | 1.11 | 7.274 | 818.969
COVID19 (Custom Term) | Cardiac arrhythmias (SMQ) [broad] | 3576 | 3232.939 | 1.09 | 1.12 | 1.151 | 1.076 | 1.106 | 1.137 | 1.106 | 2.491 | 2692.115
COVID19 (Custom Term) | Pulmonary hypertension (SMQ) [broad] | 2180 | 1985.254 | 1.081 | 1.12 | 1.16 | 1.06 | 1.098 | 1.137 | 1.098 | 3.351 | 2756.933
COVID19 (Custom Term) | Gastrointestinal nonspecific dysfunction (SMQ) [narrow] | 89 | 84.676 | 0.935 | 1.12 | 1.32 | 0.876 | 1.042 | 1.233 | 1.051 | 1.671 | 19.913
COVID19 (Custom Term) | Heart rate | 116 | 114.252 | 0.955 | 1.12 | 1.296 | 0.867 | 1.01 | 1.171 | 1.015 | 143.974 | 1052.823
COVID19 (Custom Term) | Bulbar palsy | 1 | 0.988 | 0.152 | 1.12 | 2.83 | 0.359 | 0.873 | 1.852 | 1.012 | 1.241 | 0.14
COVID19 (Custom Term) | Vaccination site reaction | 13 | 15.652 | 0.678 | 1.12 | 1.652 | 0.543 | 0.832 | 1.232 | 0.831 | 0.344 | 15.025
COVID19 (Custom Term) | Joint fluid drainage | 2 | 2.608 | 0.44 | 1.12 | 2.054 | 0.368 | 0.808 | 1.588 | 0.767 | 1.418 | 0.001
COVID19 (Custom Term) | Aphasia | 126 | 126.477 | 0.962 | 1.119 | 1.287 | 0.856 | 0.992 | 1.144 | 0.996 | 2.623 | 98.847
COVID19 (Custom Term) | Intestinal dilatation | 1 | 1.014 | 0.154 | 1.119 | 2.816 | 0.357 | 0.868 | 1.842 | 0.986 | 1.241 | 0.14
COVID19 (Custom Term) | Peripheral venous disease | 1 | 1.426 | 0.259 | 1.119 | 2.469 | 0.326 | 0.795 | 1.687 | 0.701 | 1.418 | 0.081
COVID19 (Custom Term) | Vaccination site joint movement impairment | 1 | 0.892 | 0.156 | 1.118 | 2.806 | 0.367 | 0.893 | 1.893 | 1.121 | 1.241 | 0.14
COVID19 (Custom Term) | Delirium febrile | 1 | 0.987 | 0.155 | 1.118 | 2.812 | 0.359 | 0.874 | 1.853 | 1.013 | 1.241 | 0.14
COVID19 (Custom Term) | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [narrow] | 353 | 351.982 | 1.022 | 1.118 | 1.218 | 0.917 | 1.001 | 1.092 | 1.003 | 4.517 | 663.91
COVID19 (Custom Term) | Liver related investigations, signs and symptoms (SMQ) [narrow] | 143 | 146.491 | 0.97 | 1.118 | 1.275 | 0.847 | 0.973 | 1.112 | 0.976 | 1.265 | 6.833
COVID19 (Custom Term) | Life support | 9 | 11.06 | 0.628 | 1.118 | 1.722 | 0.499 | 0.82 | 1.285 | 0.814 | 3.081 | 7.989
COVID19 (Custom Term) | Urine odour abnormal | 1 | 1.467 | 0.413 | 1.118 | 2.101 | 0.323 | 0.788 | 1.674 | 0.682 | 0.496 | 0.102
COVID19 (Custom Term) | Skin papilloma | 1 | 0.704 | 0.125 | 1.117 | 2.936 | 0.384 | 0.933 | 1.98 | 1.419 | 0.158 | 3.567
COVID19 (Custom Term) | Atelectasis | 32 | 28.816 | 0.83 | 1.117 | 1.438 | 0.812 | 1.08 | 1.414 | 1.111 | 9.078 | 115.586
COVID19 (Custom Term) | Abnormal sensation in eye | 13 | 11.783 | 0.711 | 1.117 | 1.597 | 0.679 | 1.041 | 1.541 | 1.103 | 4.781 | 23.505
COVID19 (Custom Term) | Blood pressure abnormal | 39 | 36.081 | 0.865 | 1.117 | 1.395 | 0.816 | 1.059 | 1.355 | 1.081 | 6.348 | 103.661
COVID19 (Custom Term) | Muscle swelling | 15 | 15.888 | 0.714 | 1.117 | 1.593 | 0.619 | 0.925 | 1.34 | 0.944 | 1.692 | 3.01
COVID19 (Custom Term) | Retinogram | 1 | 1.498 | 0.261 | 1.117 | 2.46 | 0.321 | 0.783 | 1.663 | 0.667 | 1.418 | 0.081
COVID19 (Custom Term) | Sinus tachycardia | 54 | 42.594 | 0.883 | 1.116 | 1.373 | 0.988 | 1.234 | 1.527 | 1.268 | 7.885 | 176.81
COVID19 (Custom Term) | Facial pain | 66 | 64.95 | 0.904 | 1.116 | 1.345 | 0.823 | 1.007 | 1.222 | 1.016 | 2.142 | 32.047
COVID19 (Custom Term) | Arteriogram carotid abnormal | 9 | 9.025 | 0.647 | 1.116 | 1.689 | 0.58 | 0.952 | 1.492 | 0.997 | 44.682 | 61.413
COVID19 (Custom Term) | Lymphadenopathy | 806 | 741.687 | 1.052 | 1.115 | 1.181 | 1.024 | 1.086 | 1.15 | 1.087 | 3.607 | 1121.695
COVID19 (Custom Term) | Gastrointestinal nonspecific dysfunction (SMQ) [broad] | 96 | 93.712 | 0.937 | 1.115 | 1.306 | 0.86 | 1.018 | 1.197 | 1.024 | 1.35 | 7.356
COVID19 (Custom Term) | Bicytopenia | 1 | 0.988 | 0.266 | 1.115 | 2.439 | 0.359 | 0.873 | 1.852 | 1.012 | 1.418 | 0.081
COVID19 (Custom Term) | CSF immunoglobulin G index | 1 | 0.988 | 0.19 | 1.115 | 2.673 | 0.359 | 0.873 | 1.852 | 1.012 | 0.584 | 0.014
COVID19 (Custom Term) | Renal function test | 7 | 7.042 | 0.625 | 1.115 | 1.721 | 0.546 | 0.942 | 1.536 | 0.994 | 2.896 | 5.209
COVID19 (Custom Term) | Platelet count decreased | 141 | 142.345 | 0.966 | 1.115 | 1.272 | 0.859 | 0.987 | 1.129 | 0.991 | 1.542 | 22.799
COVID19 (Custom Term) | Immune system disorder | 7 | 9.908 | 0.565 | 1.115 | 1.816 | 0.43 | 0.742 | 1.211 | 0.707 | 0.277 | 12.105
COVID19 (Custom Term) | Confusional state | 262 | 251.054 | 1.004 | 1.114 | 1.229 | 0.94 | 1.041 | 1.15 | 1.044 | 2.568 | 198.686
COVID19 (Custom Term) | Gastrointestinal hypomotility | 1 | 0.988 | 0.267 | 1.114 | 2.434 | 0.359 | 0.873 | 1.852 | 1.012 | 1.418 | 0.081
COVID19 (Custom Term) | Injury | 6 | 8.037 | 0.547 | 1.114 | 1.844 | 0.436 | 0.775 | 1.297 | 0.747 | 0.426 | 3.878
COVID19 (Custom Term) | Gastrointestinal pain | 11 | 10.009 | 0.66 | 1.113 | 1.664 | 0.652 | 1.03 | 1.565 | 1.099 | 1.05 | 0
COVID19 (Custom Term) | Blood pH increased | 8 | 7.455 | 0.605 | 1.113 | 1.746 | 0.594 | 0.997 | 1.592 | 1.073 | 4.673 | 13.075
COVID19 (Custom Term) | Ischaemic heart disease (SMQ) [broad] | 409 | 403.134 | 1.024 | 1.113 | 1.205 | 0.934 | 1.013 | 1.098 | 1.015 | 5.322 | 934.834
COVID19 (Custom Term) | Episcleritis | 1 | 0.995 | 0.164 | 1.113 | 2.76 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Abnormal loss of weight | 3 | 3.042 | 0.353 | 1.113 | 2.218 | 0.445 | 0.907 | 1.687 | 0.986 | 0.621 | 0.321
COVID19 (Custom Term) | Aspartate aminotransferase increased | 70 | 71.319 | 0.906 | 1.113 | 1.337 | 0.801 | 0.975 | 1.177 | 0.982 | 1.687 | 16.123
COVID19 (Custom Term) | Coombs direct test | 1 | 1.106 | 0.269 | 1.113 | 2.428 | 0.35 | 0.851 | 1.805 | 0.904 | 1.418 | 0.081
COVID19 (Custom Term) | Retinal disorders (SMQ) [narrow] | 85 | 91.51 | 0.925 | 1.113 | 1.316 | 0.774 | 0.925 | 1.099 | 0.929 | 1.884 | 28.862
COVID19 (Custom Term) | Chest pain | 724 | 671.841 | 1.045 | 1.112 | 1.181 | 1.012 | 1.076 | 1.144 | 1.078 | 3.378 | 910.105
COVID19 (Custom Term) | IVth nerve paralysis | 1 | 0.99 | 0.272 | 1.112 | 2.414 | 0.359 | 0.873 | 1.852 | 1.01 | 1.418 | 0.081
COVID19 (Custom Term) | Respiratory distress | 63 | 62.635 | 0.894 | 1.112 | 1.35 | 0.811 | 0.997 | 1.215 | 1.006 | 1.465 | 7.673
COVID19 (Custom Term) | Tryptase increased | 1 | 0.997 | 0.149 | 1.112 | 2.817 | 0.358 | 0.872 | 1.849 | 1.003 | 1.103 | 0.207
COVID19 (Custom Term) | Bronchoalveolar lavage abnormal | 1 | 1.238 | 0.166 | 1.112 | 2.751 | 0.339 | 0.827 | 1.754 | 0.808 | 0.355 | 0.552
COVID19 (Custom Term) | Vaccination site nodule | 3 | 4.041 | 0.421 | 1.112 | 2.072 | 0.386 | 0.788 | 1.466 | 0.742 | 0.292 | 4.275
COVID19 (Custom Term) | Epigastric discomfort | 1 | 0.724 | 0.22 | 1.111 | 2.563 | 0.382 | 0.929 | 1.971 | 1.381 | 0.621 | 0.002
COVID19 (Custom Term) | Hyperacusis | 25 | 23.246 | 0.778 | 1.111 | 1.492 | 0.758 | 1.044 | 1.409 | 1.075 | 0.737 | 1.933
COVID19 (Custom Term) | Ventricular fibrillation | 23 | 22.78 | 0.771 | 1.111 | 1.502 | 0.707 | 0.986 | 1.346 | 1.01 | 16.312 | 118.806
COVID19 (Custom Term) | Drug abuse and dependence (SMQ) [narrow] | 1 | 0.993 | 0.096 | 1.111 | 3.062 | 0.359 | 0.872 | 1.85 | 1.007 | 0.584 | 0.014
COVID19 (Custom Term) | Malaise | 1169 | 1163.982 | 1.058 | 1.111 | 1.165 | 0.956 | 1.004 | 1.053 | 1.004 | 1.212 | 39.595
COVID19 (Custom Term) | Sensory processing disorder | 1 | 0.999 | 0.309 | 1.111 | 2.316 | 0.358 | 0.871 | 1.847 | 1.001 | 0.261 | 1.32
COVID19 (Custom Term) | Speech disorder | 137 | 137.329 | 0.962 | 1.111 | 1.27 | 0.863 | 0.994 | 1.139 | 0.998 | 1.841 | 43.716
COVID19 (Custom Term) | Haematocrit | 5 | 5.027 | 0.502 | 1.111 | 1.912 | 0.504 | 0.93 | 1.601 | 0.995 | 1.909 | 1.074
COVID19 (Custom Term) | Hypovolaemic shock conditions (SMQ) [broad] | 212 | 222.713 | 0.989 | 1.111 | 1.238 | 0.848 | 0.95 | 1.061 | 0.952 | 2.007 | 88.472
COVID19 (Custom Term) | Eye irrigation | 1 | 1.426 | 0.184 | 1.11 | 2.68 | 0.326 | 0.795 | 1.687 | 0.701 | 0.226 | 1.832
COVID19 (Custom Term) | Acute central respiratory depression (SMQ) [broad] | 2613 | 2425.852 | 1.073 | 1.109 | 1.144 | 1.043 | 1.077 | 1.112 | 1.077 | 2.583 | 2088.765
COVID19 (Custom Term) | Breath sounds abnormal | 20 | 19.378 | 0.746 | 1.109 | 1.531 | 0.703 | 1.002 | 1.393 | 1.032 | 1.097 | 0.074
COVID19 (Custom Term) | Palatal swelling | 4 | 3.885 | 0.525 | 1.109 | 1.869 | 0.487 | 0.938 | 1.672 | 1.029 | 3.31 | 3.117
COVID19 (Custom Term) | Functional, inflammatory and gallstone related biliary disorders (SMQ) [broad] | 106 | 105.196 | 0.939 | 1.109 | 1.29 | 0.854 | 1.002 | 1.17 | 1.008 | 1.378 | 9.297
COVID19 (Custom Term) | Acute pancreatitis (SMQ) [algorithm] | 41 | 42.837 | 0.846 | 1.109 | 1.401 | 0.735 | 0.948 | 1.206 | 0.957 | 2.262 | 22.4
COVID19 (Custom Term) | Epiglottitis | 1 | 2.907 | 0.112 | 1.108 | 2.973 | 0.242 | 0.606 | 1.301 | 0.344 | 0.903 | 0.162
COVID19 (Custom Term) | Influenza A virus test negative | 38 | 34.499 | 0.833 | 1.107 | 1.413 | 0.827 | 1.077 | 1.382 | 1.101 | 1.85 | 11.733
COVID19 (Custom Term) | Hyperhidrosis | 921 | 844.408 | 1.048 | 1.107 | 1.167 | 1.032 | 1.09 | 1.15 | 1.091 | 2.315 | 564.563
COVID19 (Custom Term) | Migraine | 295 | 275.26 | 1.003 | 1.107 | 1.214 | 0.971 | 1.069 | 1.174 | 1.072 | 2.604 | 230.417
COVID19 (Custom Term) | Hypokalaemia (SMQ) [broad] | 488 | 467.793 | 1.027 | 1.107 | 1.191 | 0.967 | 1.042 | 1.121 | 1.043 | 2.609 | 384.82
COVID19 (Custom Term) | Acute renal failure (SMQ) [broad] | 245 | 249.309 | 0.994 | 1.107 | 1.225 | 0.882 | 0.981 | 1.087 | 0.983 | 2.7 | 205.395
COVID19 (Custom Term) | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [narrow] | 19 | 19.432 | 0.752 | 1.107 | 1.517 | 0.665 | 0.956 | 1.339 | 0.978 | 2.419 | 11.492
COVID19 (Custom Term) | Electrocardiogram QRS complex normal | 1 | 0.374 | 0.283 | 1.106 | 2.369 | 0.418 | 1.016 | 2.168 | 2.671 | 1.418 | 0.081
COVID19 (Custom Term) | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [broad] | 3450 | 2813.93 | 1.076 | 1.106 | 1.138 | 1.192 | 1.226 | 1.26 | 1.226 | 4.03 | 5792.141
COVID19 (Custom Term) | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [narrow] | 3450 | 2813.93 | 1.076 | 1.106 | 1.138 | 1.192 | 1.226 | 1.26 | 1.226 | 4.03 | 5792.141
COVID19 (Custom Term) | Blood fibrinogen decreased | 1 | 1.218 | 0.278 | 1.106 | 2.382 | 0.341 | 0.83 | 1.762 | 0.821 | 0.621 | 0.002
COVID19 (Custom Term) | Discharge | 1 | 1.873 | 0.283 | 1.106 | 2.366 | 0.296 | 0.728 | 1.548 | 0.534 | 1.418 | 0.081
COVID19 (Custom Term) | Hypertension (SMQ) [narrow] | 1052 | 864.195 | 1.05 | 1.105 | 1.162 | 1.155 | 1.216 | 1.279 | 1.217 | 7.32 | 3324.581
COVID19 (Custom Term) | White blood cells urine negative | 3 | 2.647 | 0.415 | 1.105 | 2.065 | 0.473 | 0.964 | 1.794 | 1.133 | 0.426 | 1.666
COVID19 (Custom Term) | Noninfectious diarrhoea (SMQ) [broad] | 1187 | 1121.481 | 1.053 | 1.105 | 1.158 | 1.008 | 1.058 | 1.109 | 1.058 | 1.406 | 125.001
COVID19 (Custom Term) | Basophil count increased | 3 | 3.031 | 0.372 | 1.105 | 2.152 | 0.446 | 0.908 | 1.689 | 0.99 | 0.851 | 0
COVID19 (Custom Term) | Ischaemic cerebral infarction | 1 | 1.05 | 0.285 | 1.105 | 2.362 | 0.354 | 0.861 | 1.827 | 0.952 | 1.418 | 0.081
COVID19 (Custom Term) | Corneal abrasion | 1 | 1.062 | 0.179 | 1.105 | 2.68 | 0.353 | 0.859 | 1.822 | 0.942 | 1.241 | 0.14
COVID19 (Custom Term) | Vertigo | 260 | 251.156 | 0.994 | 1.104 | 1.218 | 0.932 | 1.032 | 1.141 | 1.035 | 2.424 | 174.251
COVID19 (Custom Term) | Mouth swelling | 36 | 35.197 | 0.828 | 1.104 | 1.413 | 0.768 | 1.006 | 1.299 | 1.023 | 2.054 | 15.203
COVID19 (Custom Term) | Blood bicarbonate increased | 5 | 4.95 | 0.512 | 1.104 | 1.878 | 0.509 | 0.938 | 1.615 | 1.01 | 2.482 | 2.356
COVID19 (Custom Term) | Anaphylactic reaction (SMQ) [narrow] | 312 | 315.433 | 1.004 | 1.104 | 1.209 | 0.899 | 0.987 | 1.082 | 0.989 | 2.039 | 136.916
COVID19 (Custom Term) | Chorea | 1 | 1.07 | 0.342 | 1.104 | 2.217 | 0.352 | 0.857 | 1.819 | 0.934 | 0.621 | 0.002
COVID19 (Custom Term) | Colonoscopy | 7 | 10.31 | 0.558 | 1.104 | 1.799 | 0.417 | 0.721 | 1.176 | 0.679 | 0.993 | 0.032
COVID19 (Custom Term) | Hypertension (SMQ) [broad] | 1111 | 918.17 | 1.049 | 1.103 | 1.157 | 1.15 | 1.209 | 1.269 | 1.21 | 7.094 | 3415.314
COVID19 (Custom Term) | Fibrin D dimer | 52 | 47.497 | 0.869 | 1.103 | 1.36 | 0.858 | 1.077 | 1.337 | 1.095 | 10.986 | 218.948
COVID19 (Custom Term) | Lip swelling | 315 | 292.8 | 1.004 | 1.103 | 1.206 | 0.978 | 1.073 | 1.175 | 1.076 | 2.551 | 236.073
COVID19 (Custom Term) | Middle ear effusion | 9 | 8.422 | 0.634 | 1.103 | 1.678 | 0.609 | 1 | 1.567 | 1.069 | 2.793 | 6.617
COVID19 (Custom Term) | Neck mass | 7 | 6.618 | 0.642 | 1.103 | 1.666 | 0.569 | 0.981 | 1.6 | 1.058 | 1.479 | 0.542
COVID19 (Custom Term) | Hallucination | 48 | 49.064 | 0.864 | 1.103 | 1.367 | 0.765 | 0.969 | 1.213 | 0.978 | 1.922 | 16.956
COVID19 (Custom Term) | Postural orthostatic tachycardia syndrome | 6 | 8.732 | 0.493 | 1.103 | 1.909 | 0.411 | 0.732 | 1.224 | 0.687 | 0.152 | 26.985
COVID19 (Custom Term) | Oropharyngeal disorders (SMQ) [broad] | 3604 | 2972.875 | 1.072 | 1.102 | 1.132 | 1.179 | 1.212 | 1.245 | 1.212 | 3.454 | 4859.332
COVID19 (Custom Term) | Oropharyngeal disorders (SMQ) [narrow] | 3604 | 2972.875 | 1.072 | 1.102 | 1.132 | 1.179 | 1.212 | 1.245 | 1.212 | 3.454 | 4859.332
COVID19 (Custom Term) | Sinus congestion | 42 | 37.983 | 0.851 | 1.102 | 1.379 | 0.842 | 1.083 | 1.374 | 1.106 | 3 | 41.359
COVID19 (Custom Term) | Palliative care | 1 | 0.953 | 0.29 | 1.102 | 2.339 | 0.362 | 0.88 | 1.867 | 1.049 | 1.418 | 0.081
COVID19 (Custom Term) | Blood creatine normal | 3 | 2.973 | 0.426 | 1.102 | 2.033 | 0.45 | 0.916 | 1.704 | 1.009 | 3.723 | 2.44
COVID19 (Custom Term) | Oesophagitis | 1 | 1.055 | 0.157 | 1.102 | 2.755 | 0.354 | 0.86 | 1.825 | 0.948 | 1.103 | 0.207
COVID19 (Custom Term) | Impaired gastric emptying | 1 | 2.08 | 0.114 | 1.102 | 2.946 | 0.284 | 0.7 | 1.492 | 0.481 | 0.255 | 1.403
COVID19 (Custom Term) | Toothache | 46 | 42.56 | 0.854 | 1.101 | 1.375 | 0.835 | 1.062 | 1.335 | 1.081 | 2.891 | 42.489
COVID19 (Custom Term) | Lacrimal disorders (SMQ) [narrow] | 95 | 88.739 | 0.925 | 1.101 | 1.291 | 0.897 | 1.061 | 1.25 | 1.071 | 1.585 | 17.188
COVID19 (Custom Term) | Lacrimal disorders (SMQ) [broad] | 95 | 88.739 | 0.925 | 1.101 | 1.291 | 0.897 | 1.061 | 1.25 | 1.071 | 1.585 | 17.188
COVID19 (Custom Term) | Night sweats | 138 | 131.274 | 0.953 | 1.101 | 1.258 | 0.909 | 1.046 | 1.198 | 1.051 | 2.796 | 122.947
COVID19 (Custom Term) | Lip dry | 5 | 4.8 | 0.534 | 1.101 | 1.834 | 0.518 | 0.955 | 1.644 | 1.042 | 0.827 | 0.037
COVID19 (Custom Term) | Anti-NMDA antibody negative | 1 | 0.995 | 0.147 | 1.101 | 2.79 | 0.359 | 0.872 | 1.849 | 1.005 | 1.103 | 0.207
COVID19 (Custom Term) | Ammonia normal | 1 | 0.995 | 0.318 | 1.101 | 2.267 | 0.359 | 0.872 | 1.849 | 1.005 | 0.382 | 0.42
COVID19 (Custom Term) | Toxic-septic shock conditions (SMQ) [broad] | 222 | 233.912 | 0.982 | 1.101 | 1.224 | 0.848 | 0.947 | 1.056 | 0.949 | 1.988 | 90.225
COVID19 (Custom Term) | Illness | 70 | 83.101 | 0.894 | 1.101 | 1.326 | 0.692 | 0.842 | 1.017 | 0.842 | 1.687 | 16.123
COVID19 (Custom Term) | Lung disorder | 7 | 9.343 | 0.555 | 1.101 | 1.798 | 0.449 | 0.774 | 1.263 | 0.749 | 0.764 | 0.264
COVID19 (Custom Term) | Gram stain negative | 2 | 3.183 | 0.394 | 1.101 | 2.097 | 0.336 | 0.739 | 1.453 | 0.628 | 0.348 | 1.713
COVID19 (Custom Term) | Heart rate increased | 889 | 739.272 | 1.04 | 1.1 | 1.161 | 1.136 | 1.201 | 1.268 | 1.203 | 5.363 | 2061.008
COVID19 (Custom Term) | Coagulation test | 11 | 9.817 | 0.668 | 1.1 | 1.619 | 0.661 | 1.045 | 1.587 | 1.121 | 5.461 | 22.793
COVID19 (Custom Term) | Axillary mass | 32 | 29.17 | 0.817 | 1.1 | 1.418 | 0.803 | 1.069 | 1.399 | 1.097 | 2.648 | 24.505
COVID19 (Custom Term) | Photophobia | 98 | 92.94 | 0.924 | 1.1 | 1.287 | 0.886 | 1.046 | 1.229 | 1.054 | 1.107 | 0.812
COVID19 (Custom Term) | Altered visual depth perception | 1 | 0.995 | 0.189 | 1.1 | 2.63 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Streptococcus test | 20 | 17.13 | 0.752 | 1.099 | 1.499 | 0.779 | 1.11 | 1.544 | 1.168 | 1.298 | 0.938
COVID19 (Custom Term) | Injection site haematoma | 15 | 13.599 | 0.721 | 1.099 | 1.541 | 0.701 | 1.048 | 1.518 | 1.103 | 1.049 | 0.001
COVID19 (Custom Term) | Ear pain | 139 | 132.283 | 0.952 | 1.099 | 1.255 | 0.909 | 1.045 | 1.197 | 1.051 | 2.054 | 61.467
COVID19 (Custom Term) | Investigation | 48 | 46.467 | 0.853 | 1.099 | 1.371 | 0.805 | 1.019 | 1.275 | 1.033 | 5.478 | 110.129
COVID19 (Custom Term) | Myalgia | 2284 | 2261.722 | 1.062 | 1.099 | 1.137 | 0.975 | 1.01 | 1.045 | 1.01 | 2.151 | 1200.298
COVID19 (Custom Term) | Lymphadenopathy mediastinal | 1 | 1.02 | 0.298 | 1.099 | 2.31 | 0.357 | 0.867 | 1.839 | 0.98 | 1.418 | 0.081
COVID19 (Custom Term) | Drug related hepatic disorders - comprehensive search (SMQ) [narrow] | 195 | 200.719 | 0.974 | 1.099 | 1.231 | 0.861 | 0.969 | 1.088 | 0.972 | 1.246 | 8.215
COVID19 (Custom Term) | Haematopoietic leukopenia (SMQ) [broad] | 121 | 121.714 | 0.94 | 1.098 | 1.265 | 0.852 | 0.99 | 1.144 | 0.994 | 0.856 | 2.577
COVID19 (Custom Term) | Audiogram | 8 | 8.452 | 0.64 | 1.098 | 1.655 | 0.544 | 0.914 | 1.46 | 0.946 | 3.611 | 9.068
COVID19 (Custom Term) | Macule | 3 | 3.908 | 0.475 | 1.098 | 1.929 | 0.393 | 0.802 | 1.492 | 0.768 | 0.342 | 2.997
COVID19 (Custom Term) | Micturition disorder | 1 | 1.525 | 0.312 | 1.098 | 2.274 | 0.319 | 0.779 | 1.654 | 0.656 | 0.621 | 0.002
COVID19 (Custom Term) | Amylase increased | 1 | 1.548 | 0.13 | 1.098 | 2.851 | 0.317 | 0.775 | 1.647 | 0.646 | 0.552 | 0.036
COVID19 (Custom Term) | Anaphylactic/anaphylactoid shock conditions (SMQ) [narrow] | 313 | 316.471 | 0.998 | 1.097 | 1.201 | 0.899 | 0.987 | 1.082 | 0.989 | 2.065 | 142.116
COVID19 (Custom Term) | Herpes zoster oticus | 2 | 3.725 | 0.24 | 1.097 | 2.463 | 0.31 | 0.683 | 1.345 | 0.537 | 0.242 | 3.852
COVID19 (Custom Term) | Nausea | 3893 | 3576.716 | 1.068 | 1.096 | 1.126 | 1.06 | 1.088 | 1.117 | 1.088 | 2.616 | 3252.039
COVID19 (Custom Term) | Scan with contrast | 51 | 49.489 | 0.868 | 1.096 | 1.346 | 0.809 | 1.017 | 1.266 | 1.031 | 6.176 | 132.947
COVID19 (Custom Term) | Procedural pain | 1 | 0.987 | 0.304 | 1.096 | 2.288 | 0.359 | 0.874 | 1.853 | 1.013 | 1.418 | 0.081
COVID19 (Custom Term) | Drug related hepatic disorders - comprehensive search (SMQ) [broad] | 210 | 216.023 | 0.975 | 1.096 | 1.223 | 0.865 | 0.97 | 1.084 | 0.972 | 1.216 | 6.997
COVID19 (Custom Term) | Torsade de pointes, shock-associated conditions (SMQ) [narrow] | 32 | 33.405 | 0.802 | 1.096 | 1.428 | 0.711 | 0.946 | 1.239 | 0.958 | 1.181 | 0.627
COVID19 (Custom Term) | Vaccination site swelling | 94 | 99.772 | 0.919 | 1.096 | 1.286 | 0.792 | 0.939 | 1.106 | 0.942 | 0.797 | 4.308
COVID19 (Custom Term) | Micturition urgency | 6 | 6.837 | 0.545 | 1.096 | 1.803 | 0.486 | 0.864 | 1.446 | 0.878 | 1.027 | 0.024
COVID19 (Custom Term) | Stress cardiomyopathy | 7 | 6.108 | 0.585 | 1.095 | 1.733 | 0.599 | 1.032 | 1.684 | 1.146 | 9.929 | 23.406
COVID19 (Custom Term) | Abortion spontaneous | 55 | 58.754 | 0.866 | 1.095 | 1.347 | 0.746 | 0.93 | 1.149 | 0.936 | 2.936 | 52.597
COVID19 (Custom Term) | High density lipoprotein normal | 1 | 1.146 | 0.256 | 1.095 | 2.409 | 0.346 | 0.843 | 1.789 | 0.873 | 0.496 | 0.102
COVID19 (Custom Term) | Splenomegaly | 9 | 10.125 | 0.595 | 1.095 | 1.718 | 0.534 | 0.876 | 1.373 | 0.889 | 1.295 | 0.287
COVID19 (Custom Term) | Pleurisy | 11 | 10.187 | 0.658 | 1.094 | 1.62 | 0.643 | 1.017 | 1.544 | 1.08 | 3.034 | 9.839
COVID19 (Custom Term) | Acute sinusitis | 1 | 0.911 | 0.308 | 1.094 | 2.273 | 0.366 | 0.889 | 1.885 | 1.097 | 1.418 | 0.081
COVID19 (Custom Term) | Immune complex assay | 1 | 1.498 | 0.262 | 1.094 | 2.391 | 0.321 | 0.783 | 1.663 | 0.667 | 0.584 | 0.014
COVID19 (Custom Term) | Hypoaesthesia | 1172 | 1092.325 | 1.041 | 1.093 | 1.146 | 1.022 | 1.072 | 1.125 | 1.073 | 2.395 | 780.164
COVID19 (Custom Term) | Chest X-ray normal | 206 | 197.583 | 0.972 | 1.093 | 1.22 | 0.926 | 1.039 | 1.162 | 1.043 | 2.406 | 135.468
COVID19 (Custom Term) | Red blood cell anisocytes present | 1 | 1.015 | 0.311 | 1.093 | 2.261 | 0.357 | 0.868 | 1.841 | 0.985 | 1.418 | 0.081
COVID19 (Custom Term) | Respiratory failure (SMQ) [narrow] | 295 | 303.016 | 0.991 | 1.093 | 1.2 | 0.883 | 0.972 | 1.068 | 0.974 | 1.28 | 15.876
COVID19 (Custom Term) | Angiogram normal | 12 | 13.002 | 0.673 | 1.093 | 1.595 | 0.582 | 0.905 | 1.356 | 0.923 | 2.09 | 4.691
COVID19 (Custom Term) | Failure to thrive | 4 | 4.378 | 0.44 | 1.093 | 1.984 | 0.456 | 0.88 | 1.569 | 0.914 | 0.749 | 0.108
COVID19 (Custom Term) | Coagulation test normal | 4 | 4.754 | 0.437 | 1.093 | 1.99 | 0.436 | 0.841 | 1.498 | 0.841 | 0.462 | 1.865
COVID19 (Custom Term) | Retinal exudates | 1 | 0.806 | 0.244 | 1.092 | 2.437 | 0.375 | 0.911 | 1.932 | 1.241 | 0.903 | 0.162
COVID19 (Custom Term) | Troponin I | 14 | 13.8 | 0.693 | 1.092 | 1.565 | 0.647 | 0.978 | 1.432 | 1.014 | 5.56 | 30.429
COVID19 (Custom Term) | Electrocardiogram QT prolonged | 9 | 7.34 | 0.61 | 1.091 | 1.684 | 0.669 | 1.099 | 1.722 | 1.226 | 3.723 | 10.951
COVID19 (Custom Term) | Disorders of sinus node function (SMQ) [narrow] | 9 | 8.643 | 0.594 | 1.091 | 1.709 | 0.598 | 0.982 | 1.539 | 1.041 | 2.128 | 3.467
COVID19 (Custom Term) | Disorders of sinus node function (SMQ) [broad] | 9 | 8.643 | 0.594 | 1.091 | 1.709 | 0.598 | 0.982 | 1.539 | 1.041 | 2.128 | 3.467
COVID19 (Custom Term) | Vestibular disorders (SMQ) [narrow] | 271 | 264.026 | 0.985 | 1.091 | 1.202 | 0.926 | 1.024 | 1.13 | 1.026 | 2.367 | 172.199
COVID19 (Custom Term) | Haematopoietic erythropenia (SMQ) [broad] | 148 | 153.965 | 0.949 | 1.091 | 1.242 | 0.837 | 0.958 | 1.094 | 0.961 | 1.49 | 20.365
COVID19 (Custom Term) | Cardiomyopathy (SMQ) [broad] | 4176 | 3872.658 | 1.063 | 1.09 | 1.118 | 1.051 | 1.078 | 1.106 | 1.078 | 2.48 | 3143.912
COVID19 (Custom Term) | Sedation | 16 | 15.635 | 0.734 | 1.09 | 1.504 | 0.669 | 0.989 | 1.419 | 1.023 | 6.355 | 40.505
COVID19 (Custom Term) | Thoracic cavity drainage | 1 | 0.988 | 0.096 | 1.09 | 2.997 | 0.359 | 0.873 | 1.852 | 1.012 | 0.764 | 0.041
COVID19 (Custom Term) | Blood pH normal | 4 | 4.101 | 0.44 | 1.09 | 1.974 | 0.473 | 0.912 | 1.625 | 0.975 | 0.593 | 0.675
COVID19 (Custom Term) | Ischaemic central nervous system vascular conditions (SMQ) [narrow] | 344 | 353.788 | 0.995 | 1.09 | 1.188 | 0.888 | 0.971 | 1.06 | 0.972 | 6.165 | 917.346
COVID19 (Custom Term) | Ischaemic central nervous system vascular conditions (SMQ) [broad] | 344 | 353.788 | 0.995 | 1.09 | 1.188 | 0.888 | 0.971 | 1.06 | 0.972 | 6.165 | 917.346
COVID19 (Custom Term) | Tremor | 639 | 601.309 | 1.02 | 1.089 | 1.161 | 0.994 | 1.061 | 1.132 | 1.063 | 1.473 | 85.447
COVID19 (Custom Term) | Disturbance in attention | 74 | 71.728 | 0.89 | 1.089 | 1.303 | 0.845 | 1.022 | 1.228 | 1.032 | 0.821 | 2.497
COVID19 (Custom Term) | Disorientation | 107 | 105.542 | 0.925 | 1.089 | 1.265 | 0.86 | 1.008 | 1.176 | 1.014 | 1.711 | 26.35
COVID19 (Custom Term) | Nasal disorder | 1 | 0.988 | 0.321 | 1.089 | 2.227 | 0.359 | 0.873 | 1.852 | 1.012 | 1.418 | 0.081
COVID19 (Custom Term) | Blood urine absent | 3 | 2.975 | 0.484 | 1.089 | 1.891 | 0.449 | 0.916 | 1.704 | 1.008 | 0.827 | 0.001
COVID19 (Custom Term) | Blood gases | 15 | 15.282 | 0.697 | 1.089 | 1.552 | 0.638 | 0.954 | 1.383 | 0.982 | 3.238 | 15.69
COVID19 (Custom Term) | Pneumonitis | 8 | 9.26 | 0.579 | 1.089 | 1.729 | 0.51 | 0.857 | 1.369 | 0.864 | 1.302 | 0.246
COVID19 (Custom Term) | Breath odour | 1 | 0.956 | 0.179 | 1.088 | 2.631 | 0.362 | 0.88 | 1.866 | 1.046 | 0.662 | 0.001
COVID19 (Custom Term) | Blood urine present | 35 | 34.627 | 0.82 | 1.088 | 1.387 | 0.756 | 0.995 | 1.288 | 1.011 | 2.056 | 14.795
COVID19 (Custom Term) | Hypersomnia | 111 | 111.454 | 0.925 | 1.088 | 1.262 | 0.848 | 0.991 | 1.153 | 0.996 | 1.12 | 1.172
COVID19 (Custom Term) | Full blood count abnormal | 18 | 18.25 | 0.741 | 1.088 | 1.49 | 0.664 | 0.962 | 1.358 | 0.986 | 1.752 | 4.264
COVID19 (Custom Term) | Corneal disorders (SMQ) [narrow] | 11 | 14.394 | 0.635 | 1.088 | 1.639 | 0.493 | 0.779 | 1.184 | 0.764 | 0.993 | 0.018
COVID19 (Custom Term) | Electromyogram normal | 6 | 8.151 | 0.51 | 1.088 | 1.84 | 0.431 | 0.768 | 1.284 | 0.736 | 0.518 | 2.078
COVID19 (Custom Term) | Subcutaneous haematoma | 1 | 0.557 | 0.201 | 1.087 | 2.553 | 0.399 | 0.968 | 2.057 | 1.796 | 1.103 | 0.207
COVID19 (Custom Term) | Glycosylated haemoglobin | 20 | 18.148 | 0.758 | 1.087 | 1.464 | 0.743 | 1.058 | 1.472 | 1.102 | 6.206 | 50.286
COVID19 (Custom Term) | Metamorphopsia | 5 | 4.997 | 0.568 | 1.087 | 1.74 | 0.506 | 0.933 | 1.606 | 1.001 | 2.92 | 3.383
COVID19 (Custom Term) | Inappropriate affect | 1 | 0.999 | 0.399 | 1.087 | 2.049 | 0.358 | 0.871 | 1.848 | 1.001 | 0.276 | 1.156
COVID19 (Custom Term) | T-lymphocyte count increased | 1 | 1.048 | 0.137 | 1.087 | 2.79 | 0.354 | 0.862 | 1.828 | 0.954 | 0.993 | 0.266
COVID19 (Custom Term) | Eye disorder | 14 | 14.512 | 0.68 | 1.087 | 1.573 | 0.621 | 0.94 | 1.376 | 0.965 | 1.078 | 0.015
COVID19 (Custom Term) | Gram stain positive | 3 | 2.455 | 0.443 | 1.086 | 1.96 | 0.488 | 0.995 | 1.851 | 1.222 | 1.295 | 0.007
COVID19 (Custom Term) | Feeling of body temperature change | 74 | 64.346 | 0.892 | 1.086 | 1.296 | 0.936 | 1.133 | 1.362 | 1.15 | 2.752 | 63.185
COVID19 (Custom Term) | Stomatitis | 28 | 25.59 | 0.785 | 1.086 | 1.429 | 0.784 | 1.063 | 1.414 | 1.094 | 1.471 | 3.242
COVID19 (Custom Term) | COVID-19 | 865 | 807.91 | 1.026 | 1.086 | 1.147 | 1.011 | 1.07 | 1.131 | 1.071 | 114.517 | 7777.649
COVID19 (Custom Term) | Pyrexia | 4796 | 4889.348 | 1.06 | 1.086 | 1.111 | 0.958 | 0.981 | 1.004 | 0.981 | 1.232 | 213.696
COVID19 (Custom Term) | Retroperitoneal fibrosis (SMQ) [narrow] | 1 | 1.041 | 0.205 | 1.086 | 2.535 | 0.355 | 0.863 | 1.831 | 0.961 | 0.584 | 0.014
COVID19 (Custom Term) | White blood cells urine | 1 | 1.044 | 0.219 | 1.086 | 2.493 | 0.355 | 0.863 | 1.829 | 0.958 | 1.241 | 0.14
COVID19 (Custom Term) | Disability | 7 | 7.362 | 0.537 | 1.086 | 1.791 | 0.53 | 0.914 | 1.492 | 0.951 | 0.286 | 11.383
COVID19 (Custom Term) | Escherichia test positive | 3 | 3.176 | 0.401 | 1.086 | 2.04 | 0.436 | 0.889 | 1.653 | 0.945 | 0.451 | 1.38
COVID19 (Custom Term) | Hepatic disorders (SMQ) [broad] | 213 | 224.1 | 0.967 | 1.086 | 1.211 | 0.847 | 0.949 | 1.06 | 0.95 | 0.831 | 6.666
COVID19 (Custom Term) | Helicobacter test positive | 1 | 1.37 | 0.219 | 1.086 | 2.494 | 0.33 | 0.804 | 1.707 | 0.73 | 1.241 | 0.14
COVID19 (Custom Term) | Sensory disturbance | 60 | 55.691 | 0.867 | 1.085 | 1.324 | 0.86 | 1.063 | 1.301 | 1.077 | 1.137 | 0.759
COVID19 (Custom Term) | Back disorder | 1 | 1.423 | 0.262 | 1.085 | 2.364 | 0.326 | 0.795 | 1.689 | 0.703 | 0.764 | 0.041
COVID19 (Custom Term) | Tonic clonic movements | 3 | 2.394 | 0.419 | 1.084 | 2.001 | 0.493 | 1.005 | 1.871 | 1.253 | 0.175 | 10.576
COVID19 (Custom Term) | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [broad] | 6293 | 5886.612 | 1.062 | 1.084 | 1.106 | 1.047 | 1.069 | 1.091 | 1.069 | 1.887 | 2492.842
COVID19 (Custom Term) | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [broad] | 6349 | 5944.448 | 1.061 | 1.084 | 1.106 | 1.046 | 1.068 | 1.09 | 1.068 | 1.88 | 2488.575
COVID19 (Custom Term) | Wheezing | 209 | 200.754 | 0.965 | 1.084 | 1.209 | 0.925 | 1.037 | 1.16 | 1.041 | 1.92 | 76.616
COVID19 (Custom Term) | Corneal disorders (SMQ) [broad] | 246 | 238.296 | 0.973 | 1.084 | 1.2 | 0.927 | 1.029 | 1.141 | 1.032 | 1.393 | 23.72
COVID19 (Custom Term) | Formication | 12 | 11.82 | 0.7 | 1.084 | 1.536 | 0.626 | 0.974 | 1.46 | 1.015 | 0.977 | 0.005
COVID19 (Custom Term) | Vitrectomy | 1 | 0.993 | 0.225 | 1.084 | 2.467 | 0.359 | 0.872 | 1.85 | 1.007 | 1.241 | 0.14
COVID19 (Custom Term) | Atypical pneumonia | 1 | 1.096 | 0.226 | 1.084 | 2.465 | 0.35 | 0.853 | 1.809 | 0.913 | 0.368 | 0.485
COVID19 (Custom Term) | Biliary tract disorders (SMQ) [broad] | 24 | 25.989 | 0.754 | 1.084 | 1.464 | 0.659 | 0.913 | 1.239 | 0.923 | 1.146 | 0.268
COVID19 (Custom Term) | Biliary tract disorders (SMQ) [narrow] | 24 | 25.989 | 0.754 | 1.084 | 1.464 | 0.659 | 0.913 | 1.239 | 0.923 | 1.146 | 0.268
COVID19 (Custom Term) | Hepatitis viral test negative | 5 | 5.848 | 0.476 | 1.084 | 1.893 | 0.46 | 0.849 | 1.462 | 0.855 | 0.605 | 0.837
COVID19 (Custom Term) | Suicide/self-injury (SMQ) [broad] | 7 | 8.966 | 0.54 | 1.084 | 1.78 | 0.462 | 0.798 | 1.301 | 0.781 | 0.319 | 9.163
COVID19 (Custom Term) | Suicide/self-injury (SMQ) [narrow] | 7 | 8.966 | 0.54 | 1.084 | 1.78 | 0.462 | 0.798 | 1.301 | 0.781 | 0.319 | 9.163
COVID19 (Custom Term) | Peripheral sensory neuropathy | 1 | 1.726 | 0.283 | 1.084 | 2.305 | 0.306 | 0.748 | 1.591 | 0.579 | 0.382 | 0.42
COVID19 (Custom Term) | Glassy eyes | 8 | 6.422 | 0.668 | 1.083 | 1.58 | 0.655 | 1.1 | 1.756 | 1.246 | 1.168 | 0.047
COVID19 (Custom Term) | Vitamin B6 normal | 1 | 0.992 | 0.226 | 1.083 | 2.462 | 0.359 | 0.873 | 1.85 | 1.008 | 1.241 | 0.14
COVID19 (Custom Term) | Facial paresis | 47 | 47.317 | 0.844 | 1.083 | 1.348 | 0.774 | 0.982 | 1.232 | 0.993 | 2.828 | 41.708
COVID19 (Custom Term) | C-reactive protein | 45 | 49.026 | 0.839 | 1.083 | 1.352 | 0.716 | 0.912 | 1.15 | 0.918 | 1.009 | 0.001
COVID19 (Custom Term) | Oropharyngeal infections (SMQ) [narrow] | 71 | 79.331 | 0.884 | 1.083 | 1.299 | 0.735 | 0.893 | 1.076 | 0.895 | 0.567 | 21.888
COVID19 (Custom Term) | Oropharyngeal infections (SMQ) [broad] | 71 | 79.331 | 0.884 | 1.083 | 1.299 | 0.735 | 0.893 | 1.076 | 0.895 | 0.567 | 21.888
COVID19 (Custom Term) | Retching | 102 | 94.015 | 0.918 | 1.082 | 1.256 | 0.914 | 1.076 | 1.26 | 1.085 | 2.624 | 79.784
COVID19 (Custom Term) | Dry eye | 22 | 21.895 | 0.738 | 1.082 | 1.48 | 0.699 | 0.981 | 1.347 | 1.005 | 1.391 | 1.764
COVID19 (Custom Term) | Feeling cold | 295 | 300.304 | 0.981 | 1.082 | 1.187 | 0.891 | 0.981 | 1.078 | 0.982 | 1.796 | 87.875
COVID19 (Custom Term) | Hallucination, visual | 11 | 11.353 | 0.667 | 1.082 | 1.577 | 0.593 | 0.938 | 1.424 | 0.969 | 1.517 | 1.224
COVID19 (Custom Term) | Vaccination site pain | 267 | 275.885 | 0.976 | 1.082 | 1.192 | 0.873 | 0.966 | 1.067 | 0.968 | 2.243 | 149.535
COVID19 (Custom Term) | Rhinalgia | 1 | 0.698 | 0.13 | 1.081 | 2.803 | 0.385 | 0.935 | 1.984 | 1.433 | 0.261 | 1.32
COVID19 (Custom Term) | Full blood count | 395 | 379.317 | 0.994 | 1.081 | 1.171 | 0.957 | 1.039 | 1.128 | 1.041 | 2.606 | 310.007
COVID19 (Custom Term) | Laboratory test | 391 | 377.268 | 0.993 | 1.081 | 1.171 | 0.952 | 1.035 | 1.123 | 1.036 | 2.215 | 213.238
COVID19 (Custom Term) | Lung neoplasm malignant | 4 | 3.988 | 0.486 | 1.081 | 1.867 | 0.48 | 0.925 | 1.65 | 1.003 | 2.837 | 2.295
COVID19 (Custom Term) | Liver related investigations, signs and symptoms (SMQ) [broad] | 160 | 163.545 | 0.945 | 1.081 | 1.224 | 0.856 | 0.975 | 1.107 | 0.978 | 1.294 | 9.193
COVID19 (Custom Term) | Mental disorder | 8 | 8.718 | 0.566 | 1.081 | 1.73 | 0.533 | 0.895 | 1.429 | 0.918 | 0.516 | 2.97
COVID19 (Custom Term) | Hypovolaemic shock conditions (SMQ) [narrow] | 22 | 27.056 | 0.74 | 1.081 | 1.473 | 0.581 | 0.816 | 1.121 | 0.813 | 0.576 | 6.048
COVID19 (Custom Term) | Sudden hearing loss | 14 | 18.52 | 0.666 | 1.081 | 1.577 | 0.509 | 0.77 | 1.127 | 0.756 | 1.418 | 1.136
COVID19 (Custom Term) | Premature baby | 3 | 6.373 | 0.304 | 1.081 | 2.244 | 0.293 | 0.602 | 1.123 | 0.471 | 0.177 | 10.384
COVID19 (Custom Term) | Blood urea decreased | 7 | 6.611 | 0.538 | 1.08 | 1.774 | 0.569 | 0.981 | 1.601 | 1.059 | 1.363 | 0.295
COVID19 (Custom Term) | Impaired work ability | 370 | 351.005 | 0.99 | 1.08 | 1.174 | 0.965 | 1.052 | 1.145 | 1.054 | 3.009 | 380.931
COVID19 (Custom Term) | Vision blurred | 239 | 233.432 | 0.969 | 1.08 | 1.197 | 0.918 | 1.021 | 1.134 | 1.024 | 1.741 | 63.75
COVID19 (Custom Term) | Anaphylactic/anaphylactoid shock conditions (SMQ) [broad] | 500 | 509.156 | 1.002 | 1.08 | 1.16 | 0.911 | 0.981 | 1.055 | 0.982 | 2.29 | 296.409
COVID19 (Custom Term) | Stiff person syndrome | 1 | 1.881 | 0.097 | 1.08 | 2.958 | 0.296 | 0.726 | 1.546 | 0.532 | 1.103 | 0.207
COVID19 (Custom Term) | Immunoglobulins decreased | 1 | 1.921 | 0.234 | 1.08 | 2.43 | 0.294 | 0.721 | 1.535 | 0.521 | 1.241 | 0.14
COVID19 (Custom Term) | Nasal congestion | 238 | 194.501 | 0.967 | 1.079 | 1.196 | 1.093 | 1.217 | 1.351 | 1.224 | 3.03 | 246.994
COVID19 (Custom Term) | Infective pneumonia (SMQ) [broad] | 2358 | 2273.531 | 1.043 | 1.079 | 1.116 | 1.002 | 1.037 | 1.072 | 1.037 | 2.661 | 1992.773
COVID19 (Custom Term) | Chronic kidney disease (SMQ) [broad] | 348 | 355.235 | 0.986 | 1.079 | 1.176 | 0.895 | 0.978 | 1.067 | 0.98 | 1.971 | 138.89
COVID19 (Custom Term) | Large intestine polyp | 1 | 1.074 | 0.238 | 1.079 | 2.415 | 0.352 | 0.857 | 1.817 | 0.931 | 1.241 | 0.14
COVID19 (Custom Term) | Nerve block | 1 | 1.498 | 0.162 | 1.079 | 2.668 | 0.321 | 0.783 | 1.663 | 0.667 | 0.552 | 0.036
COVID19 (Custom Term) | Lymphoma | 2 | 2.134 | 0.361 | 1.078 | 2.105 | 0.399 | 0.875 | 1.72 | 0.937 | 0.552 | 0.302
COVID19 (Custom Term) | Groin pain | 14 | 15.46 | 0.681 | 1.078 | 1.548 | 0.59 | 0.893 | 1.307 | 0.906 | 1.178 | 0.184
COVID19 (Custom Term) | Wrong patient received product | 3 | 3.508 | 0.518 | 1.078 | 1.803 | 0.415 | 0.847 | 1.576 | 0.855 | 0.514 | 0.854
COVID19 (Custom Term) | Ultrasound biliary tract | 2 | 2.384 | 0.351 | 1.078 | 2.129 | 0.382 | 0.838 | 1.648 | 0.839 | 1.324 | 0.002
COVID19 (Custom Term) | Hypotension | 231 | 227.768 | 0.964 | 1.077 | 1.196 | 0.907 | 1.011 | 1.125 | 1.014 | 2.377 | 147.955
COVID19 (Custom Term) | Psychosis and psychotic disorders (SMQ) [narrow] | 90 | 90.339 | 0.899 | 1.077 | 1.269 | 0.833 | 0.99 | 1.171 | 0.996 | 1.582 | 16.089
COVID19 (Custom Term) | Blood culture | 40 | 40.219 | 0.825 | 1.077 | 1.357 | 0.759 | 0.982 | 1.253 | 0.995 | 1.277 | 1.871
COVID19 (Custom Term) | Ophthalmological examination | 14 | 13.114 | 0.682 | 1.076 | 1.544 | 0.673 | 1.018 | 1.491 | 1.068 | 1.655 | 2.523
COVID19 (Custom Term) | Dyschezia | 1 | 1.039 | 0.165 | 1.076 | 2.643 | 0.355 | 0.863 | 1.831 | 0.963 | 0.355 | 0.552
COVID19 (Custom Term) | Endotracheal intubation | 114 | 117.814 | 0.917 | 1.076 | 1.245 | 0.826 | 0.964 | 1.119 | 0.968 | 2.979 | 113.766
COVID19 (Custom Term) | Physical deconditioning | 1 | 1.099 | 0.246 | 1.076 | 2.382 | 0.35 | 0.852 | 1.807 | 0.91 | 1.241 | 0.14
COVID19 (Custom Term) | Blood lactate dehydrogenase normal | 3 | 3.575 | 0.399 | 1.076 | 2.019 | 0.411 | 0.839 | 1.561 | 0.839 | 0.542 | 0.677
COVID19 (Custom Term) | Sjogren's syndrome | 2 | 2.691 | 0.254 | 1.076 | 2.361 | 0.363 | 0.797 | 1.567 | 0.743 | 0.326 | 2.035
COVID19 (Custom Term) | Swelling face | 379 | 356.026 | 0.987 | 1.075 | 1.167 | 0.976 | 1.062 | 1.155 | 1.065 | 2.023 | 163.067
COVID19 (Custom Term) | Angiogram cerebral abnormal | 12 | 11.426 | 0.67 | 1.075 | 1.558 | 0.643 | 1 | 1.498 | 1.05 | 11.915 | 49.219
COVID19 (Custom Term) | Tongue eruption | 7 | 5.544 | 0.604 | 1.074 | 1.653 | 0.635 | 1.096 | 1.788 | 1.263 | 4.634 | 11.01
COVID19 (Custom Term) | Immunosuppressant drug therapy | 1 | 1.122 | 0.29 | 1.074 | 2.26 | 0.348 | 0.848 | 1.798 | 0.891 | 0.584 | 0.014
COVID19 (Custom Term) | Drug hypersensitivity | 8 | 9.915 | 0.574 | 1.074 | 1.699 | 0.485 | 0.816 | 1.303 | 0.807 | 0.403 | 6.178
COVID19 (Custom Term) | SARS-CoV-2 test | 563 | 504.483 | 1 | 1.073 | 1.149 | 1.039 | 1.114 | 1.193 | 1.116 | 68.173 | 4736.977
COVID19 (Custom Term) | Thrombophlebitis | 1 | 0.988 | 0.255 | 1.073 | 2.35 | 0.359 | 0.873 | 1.852 | 1.012 | 1.241 | 0.14
COVID19 (Custom Term) | Shock (SMQ) [narrow] | 666 | 662.12 | 1.006 | 1.073 | 1.142 | 0.943 | 1.005 | 1.07 | 1.006 | 3.264 | 791.522
COVID19 (Custom Term) | Corneal opacity | 1 | 0.996 | 0.255 | 1.073 | 2.35 | 0.359 | 0.872 | 1.849 | 1.004 | 1.241 | 0.14
COVID19 (Custom Term) | Embolic and thrombotic events (SMQ) [broad] | 814 | 831.623 | 1.012 | 1.073 | 1.135 | 0.923 | 0.978 | 1.036 | 0.979 | 3.466 | 1066.442
COVID19 (Custom Term) | Embolic and thrombotic events (SMQ) [narrow] | 814 | 831.623 | 1.012 | 1.073 | 1.135 | 0.923 | 0.978 | 1.036 | 0.979 | 3.466 | 1066.442
COVID19 (Custom Term) | Acute central respiratory depression (SMQ) [narrow] | 231 | 240.411 | 0.96 | 1.073 | 1.191 | 0.86 | 0.959 | 1.067 | 0.961 | 1.257 | 10.573
COVID19 (Custom Term) | Mononucleosis heterophile test negative | 6 | 6.398 | 0.566 | 1.073 | 1.711 | 0.507 | 0.902 | 1.509 | 0.938 | 0.567 | 1.449
COVID19 (Custom Term) | Uterine dilation and curettage | 4 | 4.538 | 0.502 | 1.073 | 1.818 | 0.447 | 0.863 | 1.538 | 0.881 | 3.611 | 3.63
COVID19 (Custom Term) | Urinary tract infection | 100 | 116.128 | 0.904 | 1.073 | 1.253 | 0.73 | 0.86 | 1.009 | 0.861 | 2.416 | 65.593
COVID19 (Custom Term) | Eosinophilic pneumonia (SMQ) [algorithm] | 16 | 18.651 | 0.689 | 1.073 | 1.528 | 0.578 | 0.855 | 1.227 | 0.858 | 1.528 | 2.049
COVID19 (Custom Term) | Meniere's disease | 1 | 1.496 | 0.322 | 1.073 | 2.181 | 0.321 | 0.784 | 1.664 | 0.668 | 0.584 | 0.014
COVID19 (Custom Term) | Sensitive skin | 28 | 37.779 | 0.768 | 1.073 | 1.42 | 0.553 | 0.75 | 0.998 | 0.741 | 2.418 | 17.49
COVID19 (Custom Term) | Glomerular filtration rate decreased | 33 | 30.226 | 0.799 | 1.072 | 1.377 | 0.804 | 1.065 | 1.389 | 1.092 | 9.362 | 122.189
COVID19 (Custom Term) | Injection site hypersensitivity | 10 | 9.166 | 0.631 | 1.072 | 1.608 | 0.634 | 1.02 | 1.572 | 1.091 | 0.694 | 0.963
COVID19 (Custom Term) | International normalised ratio | 32 | 30.384 | 0.79 | 1.072 | 1.39 | 0.774 | 1.03 | 1.349 | 1.053 | 10.25 | 126.495
COVID19 (Custom Term) | Thrombectomy | 11 | 11.226 | 0.647 | 1.072 | 1.583 | 0.598 | 0.946 | 1.436 | 0.98 | 54.611 | 80.221
COVID19 (Custom Term) | Blood cholesterol increased | 10 | 10.434 | 0.62 | 1.072 | 1.626 | 0.577 | 0.928 | 1.43 | 0.958 | 1.712 | 1.902
COVID19 (Custom Term) | Forced expiratory volume | 1 | 1.216 | 0.092 | 1.072 | 2.961 | 0.341 | 0.831 | 1.763 | 0.823 | 1.103 | 0.207
COVID19 (Custom Term) | Angiogram cerebral normal | 29 | 25.864 | 0.781 | 1.071 | 1.398 | 0.806 | 1.087 | 1.44 | 1.121 | 28.795 | 191.756
COVID19 (Custom Term) | Respiratory rate | 9 | 8.41 | 0.627 | 1.071 | 1.611 | 0.61 | 1.001 | 1.569 | 1.07 | 11.17 | 34.129
COVID19 (Custom Term) | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [narrow] | 5416 | 5106.264 | 1.047 | 1.071 | 1.095 | 1.037 | 1.061 | 1.084 | 1.061 | 1.77 | 1719.253
COVID19 (Custom Term) | Angioedema (SMQ) [narrow] | 2393 | 2270.489 | 1.035 | 1.071 | 1.107 | 1.019 | 1.054 | 1.089 | 1.054 | 1.765 | 706.14
COVID19 (Custom Term) | Anion gap | 23 | 21.87 | 0.756 | 1.071 | 1.43 | 0.733 | 1.022 | 1.394 | 1.052 | 4.078 | 35.523
COVID19 (Custom Term) | Appendicitis | 58 | 56.189 | 0.852 | 1.071 | 1.311 | 0.823 | 1.021 | 1.254 | 1.032 | 11.753 | 255.995
COVID19 (Custom Term) | Trigger finger | 1 | 0.995 | 0.26 | 1.071 | 2.332 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Liver function test increased | 23 | 23.56 | 0.751 | 1.071 | 1.437 | 0.687 | 0.958 | 1.307 | 0.976 | 2.819 | 19.507
COVID19 (Custom Term) | Muscle rupture | 1 | 1.121 | 0.26 | 1.071 | 2.33 | 0.348 | 0.848 | 1.799 | 0.892 | 1.241 | 0.14
COVID19 (Custom Term) | Vitamin D decreased | 3 | 3.919 | 0.37 | 1.071 | 2.066 | 0.392 | 0.801 | 1.489 | 0.765 | 0.397 | 2.04
COVID19 (Custom Term) | Guillain-Barre syndrome (SMQ) [broad] | 5751 | 5455.065 | 1.047 | 1.07 | 1.094 | 1.031 | 1.054 | 1.077 | 1.054 | 1.919 | 2368.86
COVID19 (Custom Term) | Oedema peripheral | 130 | 127.373 | 0.922 | 1.07 | 1.227 | 0.879 | 1.016 | 1.169 | 1.021 | 1.932 | 48.211
COVID19 (Custom Term) | Shock (SMQ) [broad] | 832 | 833.28 | 1.009 | 1.07 | 1.131 | 0.942 | 0.998 | 1.056 | 0.998 | 3.154 | 936.739
COVID19 (Custom Term) | Red blood cell sedimentation rate increased | 50 | 53.216 | 0.839 | 1.07 | 1.324 | 0.741 | 0.933 | 1.163 | 0.94 | 1.015 | 0.001
COVID19 (Custom Term) | Viral test negative | 25 | 27.041 | 0.754 | 1.07 | 1.432 | 0.664 | 0.914 | 1.235 | 0.925 | 0.536 | 9.054
COVID19 (Custom Term) | CSF cell count normal | 4 | 4.844 | 0.418 | 1.07 | 1.964 | 0.431 | 0.832 | 1.482 | 0.826 | 0.537 | 1.073
COVID19 (Custom Term) | Anti-cyclic citrullinated peptide antibody | 4 | 4.857 | 0.495 | 1.07 | 1.823 | 0.43 | 0.83 | 1.48 | 0.824 | 4.413 | 4.94
COVID19 (Custom Term) | Thermal burn | 4 | 3.651 | 0.512 | 1.069 | 1.791 | 0.502 | 0.968 | 1.726 | 1.096 | 2.336 | 1.428
COVID19 (Custom Term) | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [narrow] | 5460 | 5151.696 | 1.045 | 1.069 | 1.093 | 1.036 | 1.06 | 1.083 | 1.06 | 1.763 | 1713.922
COVID19 (Custom Term) | Aggression | 11 | 10.459 | 0.648 | 1.069 | 1.576 | 0.631 | 0.997 | 1.514 | 1.052 | 0.494 | 4.91
COVID19 (Custom Term) | Lymph node pain | 212 | 204.093 | 0.952 | 1.069 | 1.192 | 0.924 | 1.035 | 1.157 | 1.039 | 4.253 | 367.509
COVID19 (Custom Term) | Atrial fibrillation | 159 | 154.099 | 0.934 | 1.069 | 1.212 | 0.901 | 1.027 | 1.167 | 1.032 | 7.854 | 527.388
COVID19 (Custom Term) | Blood ketone body increased | 1 | 1.05 | 0.268 | 1.069 | 2.305 | 0.354 | 0.861 | 1.827 | 0.952 | 1.241 | 0.14
COVID19 (Custom Term) | Vaccination site necrosis | 1 | 1.05 | 0.172 | 1.069 | 2.6 | 0.354 | 0.861 | 1.827 | 0.952 | 0.903 | 0.162
COVID19 (Custom Term) | Gastrointestinal tube insertion | 6 | 6.495 | 0.52 | 1.069 | 1.775 | 0.502 | 0.894 | 1.495 | 0.924 | 0.685 | 0.522
COVID19 (Custom Term) | Prostate neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 1.581 | 0.309 | 1.069 | 2.202 | 0.315 | 0.77 | 1.637 | 0.633 | 0.397 | 0.357
COVID19 (Custom Term) | Lagophthalmos | 1 | 1.883 | 0.267 | 1.069 | 2.308 | 0.296 | 0.726 | 1.546 | 0.531 | 1.241 | 0.14
COVID19 (Custom Term) | Ligament rupture | 1 | 0.428 | 0.272 | 1.068 | 2.29 | 0.412 | 1.001 | 2.133 | 2.336 | 1.241 | 0.14
COVID19 (Custom Term) | Cardioversion | 33 | 30.473 | 0.799 | 1.068 | 1.369 | 0.798 | 1.057 | 1.379 | 1.083 | 12.603 | 149.789
COVID19 (Custom Term) | Influenza virus test negative | 120 | 113.014 | 0.913 | 1.068 | 1.233 | 0.908 | 1.055 | 1.221 | 1.062 | 0.883 | 1.611
COVID19 (Custom Term) | Neurological examination | 18 | 18.217 | 0.711 | 1.068 | 1.484 | 0.665 | 0.963 | 1.36 | 0.988 | 1.027 | 0
COVID19 (Custom Term) | Rash maculo-papular | 23 | 23.637 | 0.75 | 1.068 | 1.432 | 0.685 | 0.955 | 1.304 | 0.973 | 0.428 | 16.318
COVID19 (Custom Term) | Barium swallow | 1 | 1.49 | 0.243 | 1.068 | 2.37 | 0.321 | 0.785 | 1.666 | 0.671 | 0.993 | 0.266
COVID19 (Custom Term) | Hyperthyroidism (SMQ) [narrow] | 5 | 7.472 | 0.467 | 1.068 | 1.869 | 0.392 | 0.724 | 1.248 | 0.669 | 0.501 | 1.866
COVID19 (Custom Term) | Faeces pale | 2 | 1.451 | 0.29 | 1.067 | 2.243 | 0.454 | 0.995 | 1.957 | 1.378 | 0.405 | 1.107
COVID19 (Custom Term) | Blepharospasm | 24 | 20.269 | 0.758 | 1.067 | 1.419 | 0.817 | 1.132 | 1.536 | 1.184 | 2.407 | 14.672
COVID19 (Custom Term) | Carbon dioxide decreased | 31 | 26.835 | 0.783 | 1.067 | 1.387 | 0.836 | 1.118 | 1.469 | 1.155 | 5.4 | 68.906
COVID19 (Custom Term) | Subarachnoid haemorrhage | 11 | 10.499 | 0.641 | 1.067 | 1.581 | 0.629 | 0.994 | 1.51 | 1.048 | 9.102 | 36.869
COVID19 (Custom Term) | Cerebellar stroke | 7 | 6.935 | 0.566 | 1.067 | 1.695 | 0.552 | 0.951 | 1.552 | 1.009 | 13.901 | 29.256
COVID19 (Custom Term) | Antiacetylcholine receptor antibody positive | 1 | 0.988 | 0.13 | 1.067 | 2.757 | 0.359 | 0.873 | 1.852 | 1.012 | 1.103 | 0.207
COVID19 (Custom Term) | Retinitis | 1 | 1.555 | 0.274 | 1.067 | 2.283 | 0.317 | 0.774 | 1.645 | 0.643 | 1.241 | 0.14
COVID19 (Custom Term) | Foetal hypokinesia | 1 | 1.612 | 0.093 | 1.067 | 2.938 | 0.313 | 0.766 | 1.627 | 0.62 | 0.331 | 0.693
COVID19 (Custom Term) | Unresponsive to stimuli | 311 | 310.057 | 0.969 | 1.066 | 1.167 | 0.912 | 1.001 | 1.097 | 1.003 | 1.91 | 112.834
COVID19 (Custom Term) | Angiogram pulmonary normal | 11 | 11.046 | 0.643 | 1.066 | 1.576 | 0.606 | 0.957 | 1.454 | 0.996 | 36.407 | 73.034
COVID19 (Custom Term) | Synovitis | 4 | 4.031 | 0.449 | 1.066 | 1.896 | 0.477 | 0.92 | 1.64 | 0.992 | 0.446 | 2.08
COVID19 (Custom Term) | Streptococcus test negative | 34 | 34.85 | 0.797 | 1.066 | 1.368 | 0.729 | 0.963 | 1.252 | 0.976 | 0.6 | 8.175
COVID19 (Custom Term) | Scan brain | 6 | 6.867 | 0.55 | 1.066 | 1.72 | 0.485 | 0.862 | 1.442 | 0.874 | 1.489 | 0.436
COVID19 (Custom Term) | Benign prostatic hyperplasia | 1 | 1.458 | 0.279 | 1.066 | 2.266 | 0.323 | 0.79 | 1.677 | 0.686 | 1.241 | 0.14
COVID19 (Custom Term) | Protein urine present | 10 | 13.822 | 0.62 | 1.066 | 1.611 | 0.464 | 0.747 | 1.152 | 0.724 | 0.776 | 0.394
COVID19 (Custom Term) | Occult blood | 4 | 3.6 | 0.445 | 1.065 | 1.899 | 0.506 | 0.975 | 1.739 | 1.111 | 1.281 | 0.03
COVID19 (Custom Term) | Hyperventilation | 28 | 26.605 | 0.761 | 1.065 | 1.411 | 0.758 | 1.027 | 1.367 | 1.052 | 0.982 | 0
COVID19 (Custom Term) | Ear congestion | 7 | 6.702 | 0.61 | 1.065 | 1.623 | 0.564 | 0.973 | 1.587 | 1.045 | 1.069 | 0.001
COVID19 (Custom Term) | Mammogram | 1 | 0.953 | 0.299 | 1.065 | 2.214 | 0.362 | 0.88 | 1.867 | 1.049 | 0.709 | 0.013
COVID19 (Custom Term) | Dermatologic examination | 1 | 0.987 | 0.281 | 1.065 | 2.258 | 0.359 | 0.874 | 1.853 | 1.013 | 1.241 | 0.14
COVID19 (Custom Term) | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [narrow] | 453 | 470.497 | 0.985 | 1.065 | 1.149 | 0.89 | 0.962 | 1.038 | 0.963 | 2.544 | 338.807
COVID19 (Custom Term) | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [broad] | 453 | 470.497 | 0.985 | 1.065 | 1.149 | 0.89 | 0.962 | 1.038 | 0.963 | 2.544 | 338.807
COVID19 (Custom Term) | White blood cell count decreased | 42 | 44.65 | 0.816 | 1.065 | 1.342 | 0.726 | 0.933 | 1.184 | 0.941 | 0.95 | 0.057
COVID19 (Custom Term) | Laboratory test normal | 153 | 144.813 | 0.928 | 1.064 | 1.207 | 0.92 | 1.051 | 1.197 | 1.057 | 1.32 | 10.2
COVID19 (Custom Term) | Infarction | 1 | 0.988 | 0.29 | 1.064 | 2.232 | 0.359 | 0.873 | 1.852 | 1.012 | 0.993 | 0.266
COVID19 (Custom Term) | Red blood cell abnormality | 1 | 0.995 | 0.284 | 1.064 | 2.248 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Haematopoietic cytopenias (SMQ) [narrow] | 252 | 252.582 | 0.957 | 1.064 | 1.176 | 0.897 | 0.995 | 1.102 | 0.998 | 1.273 | 12.873
COVID19 (Custom Term) | Central nervous system vascular disorders (SMQ) [narrow] | 483 | 492.336 | 0.986 | 1.064 | 1.145 | 0.909 | 0.98 | 1.055 | 0.981 | 4.762 | 971.767
COVID19 (Custom Term) | Ultrasound Doppler normal | 14 | 14.493 | 0.677 | 1.064 | 1.522 | 0.622 | 0.941 | 1.377 | 0.966 | 1.986 | 4.843
COVID19 (Custom Term) | Conjunctival disorders (SMQ) [broad] | 51 | 53.288 | 0.835 | 1.064 | 1.315 | 0.755 | 0.95 | 1.181 | 0.957 | 0.706 | 5.531
COVID19 (Custom Term) | Conjunctival disorders (SMQ) [narrow] | 51 | 53.288 | 0.835 | 1.064 | 1.315 | 0.755 | 0.95 | 1.181 | 0.957 | 0.706 | 5.531
COVID19 (Custom Term) | Rash pruritic | 313 | 330.816 | 0.968 | 1.064 | 1.164 | 0.861 | 0.945 | 1.036 | 0.946 | 1.192 | 8.538
COVID19 (Custom Term) | Vaccination site erythema | 66 | 71.193 | 0.861 | 1.064 | 1.285 | 0.754 | 0.923 | 1.12 | 0.927 | 1.34 | 4.704
COVID19 (Custom Term) | Cardiac pacemaker insertion | 7 | 8.465 | 0.577 | 1.064 | 1.672 | 0.482 | 0.831 | 1.355 | 0.827 | 2.896 | 5.209
COVID19 (Custom Term) | SARS-CoV-2 test positive | 1338 | 1206.207 | 1.016 | 1.063 | 1.111 | 1.06 | 1.108 | 1.159 | 1.109 | 603.879 | 13068.761
COVID19 (Custom Term) | Telangiectasia | 1 | 1.037 | 0.29 | 1.063 | 2.23 | 0.355 | 0.864 | 1.832 | 0.965 | 1.241 | 0.14
COVID19 (Custom Term) | Facial neuralgia | 1 | 1.044 | 0.274 | 1.063 | 2.271 | 0.355 | 0.862 | 1.829 | 0.958 | 0.584 | 0.014
COVID19 (Custom Term) | Polymerase chain reaction | 21 | 22.074 | 0.717 | 1.063 | 1.464 | 0.662 | 0.936 | 1.292 | 0.951 | 0.14 | 108.813
COVID19 (Custom Term) | Soft tissue injury | 1 | 0.993 | 0.292 | 1.062 | 2.223 | 0.359 | 0.872 | 1.85 | 1.007 | 1.241 | 0.14
COVID19 (Custom Term) | Vasoconstriction | 1 | 0.995 | 0.292 | 1.062 | 2.221 | 0.359 | 0.872 | 1.849 | 1.005 | 1.241 | 0.14
COVID19 (Custom Term) | Blood uric acid | 2 | 2.001 | 0.448 | 1.062 | 1.886 | 0.409 | 0.896 | 1.761 | 1 | 0.827 | 0.007
COVID19 (Custom Term) | Tubulointerstitial diseases (SMQ) [broad] | 63 | 70.256 | 0.856 | 1.062 | 1.288 | 0.727 | 0.894 | 1.09 | 0.897 | 1.303 | 3.645
COVID19 (Custom Term) | COVID-19 (SMQ) [narrow] | 1710 | 1552.238 | 1.019 | 1.061 | 1.103 | 1.058 | 1.101 | 1.145 | 1.102 | 134.754 | 15654.462
COVID19 (Custom Term) | Melaena | 5 | 4.874 | 0.465 | 1.061 | 1.854 | 0.513 | 0.947 | 1.63 | 1.026 | 0.69 | 0.373
COVID19 (Custom Term) | Lymphatic disorder | 1 | 1.022 | 0.294 | 1.061 | 2.214 | 0.356 | 0.867 | 1.838 | 0.978 | 1.241 | 0.14
COVID19 (Custom Term) | Mechanical ventilation | 57 | 58.852 | 0.844 | 1.061 | 1.299 | 0.774 | 0.961 | 1.183 | 0.969 | 1.85 | 17.99
COVID19 (Custom Term) | Iritis | 1 | 1.155 | 0.145 | 1.061 | 2.675 | 0.346 | 0.842 | 1.785 | 0.866 | 0.414 | 0.298
COVID19 (Custom Term) | Respiratory failure (SMQ) [broad] | 907 | 901.074 | 1.003 | 1.06 | 1.118 | 0.952 | 1.006 | 1.062 | 1.007 | 2.355 | 578.457
COVID19 (Custom Term) | Aphthous ulcer | 7 | 7.082 | 0.542 | 1.06 | 1.72 | 0.544 | 0.938 | 1.531 | 0.988 | 0.837 | 0.072
COVID19 (Custom Term) | Retinal disorders (SMQ) [broad] | 586 | 593.192 | 0.989 | 1.06 | 1.133 | 0.922 | 0.987 | 1.056 | 0.988 | 1.39 | 56.75
COVID19 (Custom Term) | Blood pressure fluctuation | 22 | 20.607 | 0.75 | 1.059 | 1.411 | 0.736 | 1.033 | 1.419 | 1.068 | 3.467 | 26.658
COVID19 (Custom Term) | Musculoskeletal chest pain | 45 | 43.82 | 0.823 | 1.059 | 1.319 | 0.794 | 1.013 | 1.276 | 1.027 | 1.831 | 13.584
COVID19 (Custom Term) | Oesophagogastroduodenoscopy | 7 | 6.961 | 0.564 | 1.059 | 1.679 | 0.55 | 0.949 | 1.548 | 1.006 | 8.688 | 21.087
COVID19 (Custom Term) | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [narrow] | 480 | 489.15 | 0.981 | 1.059 | 1.139 | 0.909 | 0.98 | 1.056 | 0.981 | 5.049 | 1034.536
COVID19 (Custom Term) | Spinal stenosis | 3 | 3.084 | 0.434 | 1.059 | 1.905 | 0.442 | 0.901 | 1.676 | 0.973 | 2.708 | 1.277
COVID19 (Custom Term) | Angiogram cerebral | 21 | 21.844 | 0.731 | 1.059 | 1.436 | 0.668 | 0.944 | 1.304 | 0.961 | 23.168 | 126.423
COVID19 (Custom Term) | Pain of skin | 78 | 88.96 | 0.875 | 1.059 | 1.257 | 0.727 | 0.875 | 1.047 | 0.877 | 1.961 | 29.827
COVID19 (Custom Term) | Complement factor C4 | 5 | 7.139 | 0.466 | 1.059 | 1.847 | 0.405 | 0.747 | 1.286 | 0.7 | 0.613 | 0.785
COVID19 (Custom Term) | Focal dyscognitive seizures | 1 | 0.995 | 0.267 | 1.058 | 2.276 | 0.359 | 0.872 | 1.849 | 1.005 | 0.552 | 0.036
COVID19 (Custom Term) | Memory impairment | 56 | 55.898 | 0.838 | 1.058 | 1.299 | 0.797 | 0.992 | 1.223 | 1.002 | 0.791 | 2.663
COVID19 (Custom Term) | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [broad] | 524 | 528.223 | 0.983 | 1.058 | 1.135 | 0.922 | 0.991 | 1.064 | 0.992 | 3.695 | 752.85
COVID19 (Custom Term) | Myositis | 7 | 8.324 | 0.575 | 1.058 | 1.66 | 0.487 | 0.84 | 1.371 | 0.841 | 0.46 | 3.686
COVID19 (Custom Term) | Tongue movement disturbance | 7 | 6.982 | 0.535 | 1.057 | 1.722 | 0.549 | 0.947 | 1.545 | 1.003 | 2.673 | 4.417
COVID19 (Custom Term) | Computerised tomogram spine | 18 | 18.431 | 0.714 | 1.057 | 1.455 | 0.658 | 0.954 | 1.347 | 0.977 | 11.17 | 73.265
COVID19 (Custom Term) | Hepatic enzyme increased | 17 | 20.588 | 0.699 | 1.057 | 1.476 | 0.566 | 0.828 | 1.178 | 0.826 | 1.241 | 0.492
COVID19 (Custom Term) | Infection | 15 | 21.571 | 0.678 | 1.057 | 1.504 | 0.479 | 0.716 | 1.038 | 0.695 | 0.231 | 36.893
COVID19 (Custom Term) | Odynophagia | 21 | 19.838 | 0.726 | 1.056 | 1.437 | 0.725 | 1.025 | 1.416 | 1.059 | 2.512 | 13.961
COVID19 (Custom Term) | Vomiting | 1546 | 1492.067 | 1.013 | 1.056 | 1.101 | 0.993 | 1.036 | 1.08 | 1.036 | 1.388 | 152.688
COVID19 (Custom Term) | Nystagmus | 10 | 9.643 | 0.6 | 1.056 | 1.615 | 0.611 | 0.983 | 1.516 | 1.037 | 0.871 | 0.069
COVID19 (Custom Term) | Protein urine | 2 | 2.054 | 0.389 | 1.056 | 1.987 | 0.405 | 0.888 | 1.744 | 0.974 | 0.735 | 0.01
COVID19 (Custom Term) | Grunting | 3 | 3.625 | 0.475 | 1.056 | 1.822 | 0.409 | 0.833 | 1.55 | 0.828 | 0.397 | 2.04
COVID19 (Custom Term) | Hostility/aggression (SMQ) [broad] | 162 | 177.154 | 0.925 | 1.055 | 1.193 | 0.802 | 0.913 | 1.036 | 0.914 | 0.294 | 269.996
COVID19 (Custom Term) | Cardiac stress test normal | 11 | 12.884 | 0.676 | 1.055 | 1.501 | 0.538 | 0.851 | 1.292 | 0.854 | 2.142 | 4.522
COVID19 (Custom Term) | White blood cell count abnormal | 3 | 3.816 | 0.459 | 1.055 | 1.849 | 0.398 | 0.812 | 1.51 | 0.786 | 1.568 | 0.13
COVID19 (Custom Term) | Blood glucose | 50 | 48.431 | 0.832 | 1.054 | 1.298 | 0.809 | 1.019 | 1.27 | 1.032 | 2.599 | 37.637
COVID19 (Custom Term) | Parkinsonism | 1 | 1.045 | 0.323 | 1.054 | 2.124 | 0.354 | 0.862 | 1.829 | 0.957 | 1.241 | 0.14
COVID19 (Custom Term) | Enthesopathy | 1 | 1.066 | 0.172 | 1.054 | 2.555 | 0.353 | 0.858 | 1.821 | 0.938 | 1.103 | 0.207
COVID19 (Custom Term) | Abdominal X-ray | 4 | 4.912 | 0.42 | 1.054 | 1.921 | 0.428 | 0.825 | 1.47 | 0.814 | 0.235 | 8.93
COVID19 (Custom Term) | Herpes simplex test | 1 | 1.426 | 0.327 | 1.054 | 2.118 | 0.326 | 0.795 | 1.687 | 0.701 | 0.368 | 0.485
COVID19 (Custom Term) | Arteriogram carotid normal | 25 | 21.47 | 0.748 | 1.053 | 1.401 | 0.811 | 1.118 | 1.509 | 1.164 | 22.566 | 150.289
COVID19 (Custom Term) | Diabetic ketoacidosis | 13 | 12.66 | 0.672 | 1.053 | 1.502 | 0.643 | 0.985 | 1.458 | 1.027 | 9.22 | 44.823
COVID19 (Custom Term) | Deafness transitory | 2 | 2.039 | 0.32 | 1.053 | 2.13 | 0.406 | 0.89 | 1.749 | 0.981 | 1.324 | 0.002
COVID19 (Custom Term) | Anti-aquaporin-4 antibody | 1 | 1.096 | 0.328 | 1.053 | 2.109 | 0.35 | 0.853 | 1.809 | 0.913 | 1.241 | 0.14
COVID19 (Custom Term) | Walking aid user | 30 | 36.473 | 0.766 | 1.053 | 1.377 | 0.614 | 0.824 | 1.087 | 0.823 | 0.876 | 0.366
COVID19 (Custom Term) | Blood potassium decreased | 75 | 70.157 | 0.865 | 1.052 | 1.254 | 0.875 | 1.058 | 1.269 | 1.069 | 5.436 | 172.402
COVID19 (Custom Term) | Monocyte percentage increased | 5 | 4.835 | 0.491 | 1.052 | 1.784 | 0.516 | 0.951 | 1.637 | 1.034 | 0.235 | 11.338
COVID19 (Custom Term) | Red blood cell nucleated morphology present | 1 | 0.988 | 0.154 | 1.052 | 2.613 | 0.359 | 0.873 | 1.852 | 1.012 | 1.103 | 0.207
COVID19 (Custom Term) | Haematopoietic thrombocytopenia (SMQ) [narrow] | 166 | 168.536 | 0.922 | 1.052 | 1.188 | 0.864 | 0.982 | 1.112 | 0.985 | 1.498 | 23.525
COVID19 (Custom Term) | Gallbladder related disorders (SMQ) [narrow] | 32 | 32.731 | 0.775 | 1.052 | 1.362 | 0.724 | 0.964 | 1.262 | 0.978 | 4.965 | 64.683
COVID19 (Custom Term) | Gallbladder related disorders (SMQ) [broad] | 32 | 32.731 | 0.775 | 1.052 | 1.362 | 0.724 | 0.964 | 1.262 | 0.978 | 4.965 | 64.683
COVID19 (Custom Term) | Limb injury | 9 | 10.183 | 0.647 | 1.052 | 1.538 | 0.531 | 0.872 | 1.367 | 0.884 | 0.588 | 2.046
COVID19 (Custom Term) | Varicella zoster virus infection | 1 | 1.553 | 0.104 | 1.052 | 2.83 | 0.317 | 0.775 | 1.645 | 0.644 | 0.174 | 3.006
COVID19 (Custom Term) | SARS-CoV-2 test negative | 924 | 822.205 | 0.995 | 1.051 | 1.108 | 1.063 | 1.123 | 1.184 | 1.124 | 38.228 | 6922.175
COVID19 (Custom Term) | Catheterisation cardiac abnormal | 11 | 10.293 | 0.634 | 1.051 | 1.555 | 0.639 | 1.009 | 1.533 | 1.069 | 9.929 | 39.39
COVID19 (Custom Term) | Cardiac failure acute | 13 | 12.849 | 0.644 | 1.051 | 1.539 | 0.635 | 0.974 | 1.442 | 1.012 | 11.735 | 53.223
COVID19 (Custom Term) | Lymph node abscess | 1 | 1.044 | 0.155 | 1.051 | 2.608 | 0.355 | 0.862 | 1.829 | 0.958 | 1.103 | 0.207
COVID19 (Custom Term) | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [broad] | 373 | 386.73 | 0.964 | 1.051 | 1.142 | 0.884 | 0.963 | 1.048 | 0.964 | 1.358 | 30.849
COVID19 (Custom Term) | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [broad] | 32 | 35.638 | 0.771 | 1.051 | 1.367 | 0.671 | 0.893 | 1.169 | 0.898 | 1.081 | 0.103
COVID19 (Custom Term) | Pruritus | 1776 | 1703.569 | 1.009 | 1.05 | 1.091 | 1.002 | 1.042 | 1.083 | 1.043 | 1.659 | 413.031
COVID19 (Custom Term) | Intracranial aneurysm | 8 | 7.922 | 0.586 | 1.05 | 1.624 | 0.569 | 0.957 | 1.528 | 1.01 | 26.478 | 46.115
COVID19 (Custom Term) | Anion gap decreased | 5 | 4.963 | 0.546 | 1.05 | 1.688 | 0.508 | 0.937 | 1.613 | 1.007 | 5.516 | 8.904
COVID19 (Custom Term) | Psychosis and psychotic disorders (SMQ) [broad] | 313 | 319.909 | 0.954 | 1.05 | 1.149 | 0.89 | 0.977 | 1.071 | 0.978 | 1.145 | 5.036
COVID19 (Custom Term) | Tinnitus | 177 | 183.719 | 0.925 | 1.05 | 1.182 | 0.849 | 0.961 | 1.085 | 0.963 | 1.793 | 52.057
COVID19 (Custom Term) | Hyporeflexia | 3 | 3.4 | 0.392 | 1.05 | 1.964 | 0.422 | 0.86 | 1.6 | 0.882 | 0.355 | 2.752
COVID19 (Custom Term) | Piloerection | 8 | 7.143 | 0.597 | 1.049 | 1.604 | 0.611 | 1.026 | 1.638 | 1.12 | 2.648 | 5.124
COVID19 (Custom Term) | Facial paralysis | 367 | 366.61 | 0.961 | 1.049 | 1.14 | 0.917 | 0.999 | 1.088 | 1.001 | 3.615 | 508.911
COVID19 (Custom Term) | Inability to crawl | 1 | 1.046 | 0.2 | 1.049 | 2.443 | 0.354 | 0.862 | 1.828 | 0.956 | 0.236 | 1.658
COVID19 (Custom Term) | Periorbital cellulitis | 1 | 1.052 | 0.164 | 1.049 | 2.566 | 0.354 | 0.861 | 1.826 | 0.951 | 1.103 | 0.207
COVID19 (Custom Term) | Induced labour | 3 | 3.489 | 0.369 | 1.049 | 2.012 | 0.416 | 0.849 | 1.58 | 0.86 | 2.979 | 1.589
COVID19 (Custom Term) | Human herpes virus 6 serology negative | 1 | 1.496 | 0.289 | 1.049 | 2.194 | 0.321 | 0.784 | 1.664 | 0.668 | 0.552 | 0.036
COVID19 (Custom Term) | Thyroid mass | 1 | 1.605 | 0.323 | 1.049 | 2.112 | 0.313 | 0.767 | 1.629 | 0.623 | 0.903 | 0.162
COVID19 (Custom Term) | Peripheral neuropathy (SMQ) [broad] | 2973 | 2861.708 | 1.017 | 1.048 | 1.08 | 1.008 | 1.039 | 1.07 | 1.039 | 1.6 | 614.511
COVID19 (Custom Term) | Retroperitoneal fibrosis (SMQ) [broad] | 1111 | 1084.892 | 0.997 | 1.048 | 1.1 | 0.974 | 1.023 | 1.075 | 1.024 | 1.626 | 234.722
COVID19 (Custom Term) | Lipase | 12 | 12.322 | 0.68 | 1.048 | 1.481 | 0.607 | 0.943 | 1.414 | 0.974 | 4.109 | 17.619
COVID19 (Custom Term) | Pharyngitis streptococcal | 2 | 2.078 | 0.378 | 1.048 | 1.989 | 0.403 | 0.884 | 1.737 | 0.963 | 0.32 | 2.117
COVID19 (Custom Term) | Photopsia | 11 | 12.594 | 0.629 | 1.048 | 1.553 | 0.548 | 0.866 | 1.315 | 0.873 | 1.4 | 0.751
COVID19 (Custom Term) | Mental status changes | 92 | 87.72 | 0.881 | 1.047 | 1.224 | 0.876 | 1.04 | 1.228 | 1.049 | 4.5 | 169.844
COVID19 (Custom Term) | Fibrin D dimer increased | 85 | 81.149 | 0.87 | 1.047 | 1.238 | 0.869 | 1.039 | 1.233 | 1.047 | 14.305 | 425.169
COVID19 (Custom Term) | Fundoscopy | 1 | 0.992 | 0.172 | 1.047 | 2.533 | 0.359 | 0.873 | 1.85 | 1.008 | 1.103 | 0.207
COVID19 (Custom Term) | Intestinal resection | 1 | 0.998 | 0.122 | 1.047 | 2.73 | 0.358 | 0.871 | 1.848 | 1.002 | 0.331 | 0.693
COVID19 (Custom Term) | Death | 1289 | 1301.78 | 0.999 | 1.047 | 1.095 | 0.945 | 0.99 | 1.036 | 0.99 | 5.097 | 2833.801
COVID19 (Custom Term) | COVID-19 (SMQ) [broad] | 3048 | 2739.992 | 1.015 | 1.046 | 1.077 | 1.079 | 1.112 | 1.146 | 1.112 | 58.766 | 25272.177
COVID19 (Custom Term) | Periorbital and eyelid disorders (SMQ) [broad] | 228 | 213.585 | 0.937 | 1.046 | 1.16 | 0.953 | 1.064 | 1.184 | 1.067 | 1.743 | 60.982
COVID19 (Custom Term) | Periorbital and eyelid disorders (SMQ) [narrow] | 228 | 213.585 | 0.937 | 1.046 | 1.16 | 0.953 | 1.064 | 1.184 | 1.067 | 1.743 | 60.982
COVID19 (Custom Term) | Catheter placement | 3 | 2.975 | 0.415 | 1.046 | 1.908 | 0.449 | 0.916 | 1.704 | 1.008 | 1.986 | 0.486
COVID19 (Custom Term) | Seizure cluster | 1 | 0.996 | 0.18 | 1.046 | 2.5 | 0.359 | 0.872 | 1.849 | 1.004 | 1.103 | 0.207
COVID19 (Custom Term) | Seizure like phenomena | 38 | 38.95 | 0.792 | 1.046 | 1.328 | 0.741 | 0.964 | 1.237 | 0.976 | 0.799 | 1.574
COVID19 (Custom Term) | Ophthalmoplegia | 4 | 5.467 | 0.468 | 1.046 | 1.81 | 0.401 | 0.774 | 1.38 | 0.732 | 0.883 | 0
COVID19 (Custom Term) | Sleep terror | 1 | 1.001 | 0.339 | 1.045 | 2.066 | 0.358 | 0.871 | 1.847 | 0.999 | 0.211 | 2.096
COVID19 (Custom Term) | Circulatory collapse | 9 | 11.914 | 0.562 | 1.045 | 1.648 | 0.472 | 0.775 | 1.215 | 0.755 | 0.408 | 6.815
COVID19 (Custom Term) | Treponema test negative | 6 | 8.105 | 0.492 | 1.045 | 1.764 | 0.433 | 0.771 | 1.289 | 0.74 | 0.441 | 3.497
COVID19 (Custom Term) | Transfusion | 24 | 24.274 | 0.747 | 1.044 | 1.382 | 0.7 | 0.969 | 1.316 | 0.989 | 1.805 | 6.568
COVID19 (Custom Term) | Haematopoietic cytopenias (SMQ) [broad] | 361 | 372.896 | 0.956 | 1.044 | 1.136 | 0.886 | 0.967 | 1.053 | 0.968 | 1.242 | 15.087
COVID19 (Custom Term) | General symptom | 2 | 1.918 | 0.362 | 1.043 | 2.01 | 0.415 | 0.91 | 1.788 | 1.043 | 0.827 | 0.007
COVID19 (Custom Term) | Volvulus | 1 | 0.987 | 0.191 | 1.043 | 2.455 | 0.359 | 0.874 | 1.853 | 1.013 | 1.103 | 0.207
COVID19 (Custom Term) | Gallstone related disorders (SMQ) [narrow] | 14 | 14.393 | 0.669 | 1.043 | 1.484 | 0.625 | 0.946 | 1.385 | 0.973 | 6.044 | 33.266
COVID19 (Custom Term) | Gallstone related disorders (SMQ) [broad] | 14 | 14.393 | 0.669 | 1.043 | 1.484 | 0.625 | 0.946 | 1.385 | 0.973 | 6.044 | 33.266
COVID19 (Custom Term) | Salivary hypersecretion | 12 | 12.71 | 0.623 | 1.043 | 1.552 | 0.592 | 0.921 | 1.38 | 0.944 | 0.961 | 0
COVID19 (Custom Term) | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [algorithm] | 105 | 111.3 | 0.883 | 1.043 | 1.215 | 0.801 | 0.94 | 1.098 | 0.943 | 0.846 | 2.585
COVID19 (Custom Term) | White blood cells urine positive | 10 | 11.5 | 0.59 | 1.043 | 1.602 | 0.536 | 0.862 | 1.329 | 0.87 | 0.72 | 0.752
COVID19 (Custom Term) | Weight increased | 9 | 11.462 | 0.569 | 1.043 | 1.633 | 0.486 | 0.798 | 1.251 | 0.785 | 0.52 | 3.316
COVID19 (Custom Term) | Foetal exposure during pregnancy | 6 | 11.623 | 0.464 | 1.043 | 1.81 | 0.332 | 0.592 | 0.991 | 0.516 | 0.113 | 40.388
COVID19 (Custom Term) | Prothrombin time | 35 | 32.836 | 0.786 | 1.042 | 1.327 | 0.794 | 1.043 | 1.352 | 1.066 | 5.697 | 82.895
COVID19 (Custom Term) | Chest X-ray | 313 | 299.427 | 0.949 | 1.042 | 1.138 | 0.95 | 1.043 | 1.143 | 1.045 | 4.341 | 559.073
COVID19 (Custom Term) | Blood calcium decreased | 27 | 25.916 | 0.758 | 1.042 | 1.363 | 0.747 | 1.017 | 1.36 | 1.042 | 3.23 | 29.551
COVID19 (Custom Term) | Computerised tomogram normal | 119 | 117.65 | 0.895 | 1.042 | 1.199 | 0.865 | 1.006 | 1.165 | 1.011 | 2.051 | 52.295
COVID19 (Custom Term) | Hip fracture | 13 | 12.849 | 0.66 | 1.042 | 1.494 | 0.635 | 0.974 | 1.442 | 1.012 | 9.22 | 44.823
COVID19 (Custom Term) | Vaginal ulceration | 1 | 1.006 | 0.196 | 1.042 | 2.435 | 0.358 | 0.87 | 1.845 | 0.994 | 1.103 | 0.207
COVID19 (Custom Term) | Toxicity to various agents | 1 | 1.042 | 0.277 | 1.042 | 2.203 | 0.355 | 0.863 | 1.83 | 0.96 | 0.827 | 0.089
COVID19 (Custom Term) | Stillbirth | 4 | 5.088 | 0.371 | 1.042 | 1.99 | 0.419 | 0.808 | 1.441 | 0.786 | 0.641 | 0.432
COVID19 (Custom Term) | Cardiolipin antibody | 1 | 1.548 | 0.199 | 1.042 | 2.427 | 0.317 | 0.775 | 1.647 | 0.646 | 1.103 | 0.207
COVID19 (Custom Term) | Biopsy kidney | 2 | 1.982 | 0.338 | 1.041 | 2.057 | 0.41 | 0.899 | 1.767 | 1.009 | 1.986 | 0.162
COVID19 (Custom Term) | Myelodysplastic syndrome (SMQ) [narrow] | 1 | 1.01 | 0.201 | 1.041 | 2.418 | 0.357 | 0.869 | 1.843 | 0.99 | 1.103 | 0.207
COVID19 (Custom Term) | Electroencephalogram normal | 30 | 30.602 | 0.761 | 1.041 | 1.358 | 0.719 | 0.965 | 1.274 | 0.98 | 0.398 | 25.736
COVID19 (Custom Term) | Gastrointestinal nonspecific inflammation (SMQ) [broad] | 49 | 55.049 | 0.813 | 1.041 | 1.293 | 0.702 | 0.887 | 1.108 | 0.89 | 1.181 | 1.044
COVID19 (Custom Term) | Acute generalised exanthematous pustulosis | 2 | 1.408 | 0.346 | 1.04 | 2.035 | 0.458 | 1.004 | 1.975 | 1.421 | 2.206 | 0.266
COVID19 (Custom Term) | Incoherent | 24 | 23.966 | 0.759 | 1.04 | 1.358 | 0.707 | 0.98 | 1.33 | 1.001 | 2.227 | 12.179
COVID19 (Custom Term) | Haematopoietic thrombocytopenia (SMQ) [broad] | 168 | 170.902 | 0.912 | 1.04 | 1.174 | 0.863 | 0.98 | 1.109 | 0.983 | 1.506 | 24.373
COVID19 (Custom Term) | Foreign travel | 1 | 1.052 | 0.272 | 1.04 | 2.211 | 0.354 | 0.861 | 1.826 | 0.951 | 0.552 | 0.036
COVID19 (Custom Term) | Restlessness | 57 | 61.355 | 0.827 | 1.04 | 1.273 | 0.744 | 0.924 | 1.137 | 0.929 | 0.907 | 0.41
COVID19 (Custom Term) | Endocarditis | 1 | 1.127 | 0.211 | 1.04 | 2.382 | 0.348 | 0.847 | 1.796 | 0.887 | 1.103 | 0.207
COVID19 (Custom Term) | Snoring | 3 | 3.422 | 0.401 | 1.04 | 1.921 | 0.42 | 0.857 | 1.595 | 0.877 | 0.505 | 0.916
COVID19 (Custom Term) | Panic disorder | 2 | 2.487 | 0.303 | 1.04 | 2.135 | 0.375 | 0.824 | 1.62 | 0.804 | 1.241 | 0.014
COVID19 (Custom Term) | Hypoglycaemic and neurogenic shock conditions (SMQ) [narrow] | 21 | 26.119 | 0.705 | 1.04 | 1.428 | 0.572 | 0.808 | 1.117 | 0.804 | 0.542 | 7.264
COVID19 (Custom Term) | Cutaneous lupus erythematosus | 1 | 1.483 | 0.209 | 1.04 | 2.387 | 0.322 | 0.786 | 1.668 | 0.674 | 1.103 | 0.207
COVID19 (Custom Term) | Heart rate decreased | 60 | 56.594 | 0.838 | 1.039 | 1.258 | 0.847 | 1.047 | 1.282 | 1.06 | 2.514 | 42.361
COVID19 (Custom Term) | Blood pressure decreased | 87 | 88.664 | 0.865 | 1.039 | 1.226 | 0.818 | 0.976 | 1.157 | 0.981 | 1.907 | 30.698
COVID19 (Custom Term) | Surgery | 21 | 24.764 | 0.708 | 1.039 | 1.421 | 0.599 | 0.847 | 1.17 | 0.848 | 0.722 | 1.83
COVID19 (Custom Term) | Injection site ulcer | 2 | 3.467 | 0.465 | 1.039 | 1.796 | 0.322 | 0.709 | 1.394 | 0.577 | 0.375 | 1.403
COVID19 (Custom Term) | Oropharyngeal pain | 576 | 490.351 | 0.968 | 1.038 | 1.11 | 1.094 | 1.172 | 1.254 | 1.175 | 2.272 | 335.817
COVID19 (Custom Term) | Rash macular | 216 | 210.215 | 0.928 | 1.038 | 1.154 | 0.915 | 1.024 | 1.143 | 1.028 | 1.242 | 8.86
COVID19 (Custom Term) | Peripheral motor neuropathy | 1 | 1.567 | 0.221 | 1.038 | 2.348 | 0.316 | 0.772 | 1.641 | 0.638 | 1.103 | 0.207
COVID19 (Custom Term) | Metabolic disorder | 3 | 2.97 | 0.32 | 1.037 | 2.087 | 0.45 | 0.917 | 1.705 | 1.01 | 1.241 | 0
COVID19 (Custom Term) | Multi-organ disorder | 1 | 0.993 | 0.224 | 1.037 | 2.336 | 0.359 | 0.872 | 1.85 | 1.007 | 1.103 | 0.207
COVID19 (Custom Term) | Optic neuritis | 8 | 14.21 | 0.539 | 1.037 | 1.668 | 0.368 | 0.619 | 0.989 | 0.563 | 0.351 | 8.575
COVID19 (Custom Term) | Apraxia | 2 | 1.989 | 0.403 | 1.036 | 1.908 | 0.41 | 0.898 | 1.765 | 1.006 | 1.418 | 0.001
COVID19 (Custom Term) | Pulmonary oedema | 39 | 38.96 | 0.784 | 1.036 | 1.318 | 0.761 | 0.987 | 1.263 | 1.001 | 7.447 | 120.392
COVID19 (Custom Term) | Cardiac operation | 1 | 1.014 | 0.234 | 1.036 | 2.302 | 0.357 | 0.868 | 1.842 | 0.986 | 1.103 | 0.207
COVID19 (Custom Term) | Fatal outcome (Custom Term) | 1524 | 1538.393 | 0.993 | 1.036 | 1.08 | 0.949 | 0.99 | 1.033 | 0.991 | 5.393 | 3576.34
COVID19 (Custom Term) | Lens disorders (SMQ) [broad] | 359 | 364.025 | 0.948 | 1.036 | 1.128 | 0.903 | 0.985 | 1.073 | 0.986 | 1.328 | 25.576
COVID19 (Custom Term) | Blood lactate dehydrogenase increased | 15 | 16.257 | 0.649 | 1.036 | 1.495 | 0.607 | 0.908 | 1.315 | 0.923 | 0.648 | 2.351
COVID19 (Custom Term) | Gait inability | 124 | 138.672 | 0.889 | 1.036 | 1.192 | 0.77 | 0.893 | 1.031 | 0.894 | 1.036 | 0.11
COVID19 (Custom Term) | Vulvovaginal swelling | 1 | 1.373 | 0.23 | 1.036 | 2.314 | 0.329 | 0.804 | 1.706 | 0.729 | 1.103 | 0.207
COVID19 (Custom Term) | Flow cytometry | 4 | 5.194 | 0.463 | 1.036 | 1.793 | 0.414 | 0.798 | 1.423 | 0.77 | 0.845 | 0.007
COVID19 (Custom Term) | Biopsy skin | 7 | 9.891 | 0.511 | 1.036 | 1.71 | 0.43 | 0.743 | 1.212 | 0.708 | 0.466 | 3.54
COVID19 (Custom Term) | Dysphoria | 1 | 0.953 | 0.241 | 1.035 | 2.28 | 0.362 | 0.88 | 1.867 | 1.049 | 1.103 | 0.207
COVID19 (Custom Term) | Epstein-Barr virus antigen positive | 1 | 1.05 | 0.239 | 1.035 | 2.287 | 0.354 | 0.861 | 1.827 | 0.952 | 1.103 | 0.207
COVID19 (Custom Term) | CSF monocyte count decreased | 1 | 1.112 | 0.365 | 1.035 | 1.981 | 0.349 | 0.85 | 1.802 | 0.899 | 0.552 | 0.036
COVID19 (Custom Term) | Sensory loss | 41 | 44.416 | 0.791 | 1.035 | 1.306 | 0.711 | 0.917 | 1.167 | 0.923 | 1.276 | 1.912
COVID19 (Custom Term) | Oedema | 29 | 37.064 | 0.759 | 1.035 | 1.347 | 0.584 | 0.787 | 1.043 | 0.782 | 0.524 | 11.471
COVID19 (Custom Term) | Drug ineffective | 136 | 131.187 | 0.893 | 1.034 | 1.183 | 0.895 | 1.031 | 1.183 | 1.037 | 5.923 | 345.531
COVID19 (Custom Term) | Choking | 13 | 14.808 | 0.634 | 1.034 | 1.514 | 0.568 | 0.87 | 1.288 | 0.878 | 0.561 | 3.779
COVID19 (Custom Term) | CSF red blood cell count | 1 | 1.391 | 0.29 | 1.034 | 2.149 | 0.328 | 0.801 | 1.7 | 0.719 | 0.355 | 0.552
COVID19 (Custom Term) | Tonsillar disorder | 1 | 0.56 | 0.253 | 1.033 | 2.241 | 0.398 | 0.967 | 2.056 | 1.786 | 1.103 | 0.207
COVID19 (Custom Term) | Tooth abscess | 1 | 0.995 | 0.255 | 1.033 | 2.237 | 0.359 | 0.872 | 1.849 | 1.005 | 1.103 | 0.207
COVID19 (Custom Term) | Tympanic membrane disorder | 1 | 1.006 | 0.25 | 1.033 | 2.252 | 0.358 | 0.87 | 1.845 | 0.994 | 1.103 | 0.207
COVID19 (Custom Term) | Hypopnoea | 28 | 28.297 | 0.749 | 1.033 | 1.356 | 0.718 | 0.972 | 1.294 | 0.99 | 1.553 | 4.261
COVID19 (Custom Term) | Orthopaedic examination abnormal | 1 | 1.047 | 0.25 | 1.033 | 2.25 | 0.354 | 0.862 | 1.828 | 0.955 | 1.103 | 0.207
COVID19 (Custom Term) | Central nervous system vascular disorders (SMQ) [broad] | 676 | 698.756 | 0.968 | 1.033 | 1.099 | 0.907 | 0.967 | 1.029 | 0.967 | 2.013 | 288.861
COVID19 (Custom Term) | Joint instability | 6 | 6.329 | 0.531 | 1.033 | 1.67 | 0.511 | 0.909 | 1.52 | 0.948 | 5.958 | 12.248
COVID19 (Custom Term) | Vomiting projectile | 12 | 13.029 | 0.623 | 1.033 | 1.527 | 0.581 | 0.903 | 1.354 | 0.921 | 0.46 | 6.717
COVID19 (Custom Term) | Fertility disorders (SMQ) [narrow] | 12 | 15.492 | 0.603 | 1.033 | 1.556 | 0.506 | 0.787 | 1.179 | 0.775 | 0.617 | 2.299
COVID19 (Custom Term) | Seasonal allergy | 1 | 2.257 | 0.178 | 1.033 | 2.471 | 0.274 | 0.678 | 1.446 | 0.443 | 0.14 | 4.326
COVID19 (Custom Term) | Breast tenderness | 8 | 6.486 | 0.59 | 1.032 | 1.573 | 0.651 | 1.093 | 1.745 | 1.233 | 3.972 | 10.477
COVID19 (Custom Term) | Blood phosphorus | 6 | 5.343 | 0.562 | 1.032 | 1.617 | 0.567 | 1.009 | 1.687 | 1.123 | 2.837 | 4.09
COVID19 (Custom Term) | Blood magnesium | 32 | 29.653 | 0.768 | 1.032 | 1.328 | 0.791 | 1.053 | 1.379 | 1.079 | 5.209 | 68.392
COVID19 (Custom Term) | Bone pain | 66 | 66.808 | 0.838 | 1.032 | 1.243 | 0.801 | 0.98 | 1.19 | 0.988 | 1.316 | 4.125
COVID19 (Custom Term) | Venogram normal | 1 | 1.121 | 0.258 | 1.032 | 2.228 | 0.348 | 0.848 | 1.799 | 0.892 | 1.103 | 0.207
COVID19 (Custom Term) | Neurological examination normal | 16 | 17.342 | 0.669 | 1.032 | 1.46 | 0.614 | 0.908 | 1.304 | 0.923 | 0.36 | 16.892
COVID19 (Custom Term) | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [narrow] | 32 | 35.638 | 0.757 | 1.032 | 1.342 | 0.671 | 0.893 | 1.169 | 0.898 | 1.084 | 0.115
COVID19 (Custom Term) | Tongue biting | 4 | 4.536 | 0.478 | 1.032 | 1.757 | 0.447 | 0.863 | 1.538 | 0.882 | 0.946 | 0.022
COVID19 (Custom Term) | Gastrointestinal nonspecific inflammation (SMQ) [narrow] | 21 | 24.399 | 0.703 | 1.032 | 1.413 | 0.607 | 0.858 | 1.185 | 0.861 | 0.827 | 0.534
COVID19 (Custom Term) | Prostate neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 1.581 | 0.298 | 1.032 | 2.124 | 0.315 | 0.77 | 1.637 | 0.633 | 0.382 | 0.42
COVID19 (Custom Term) | Premalignant disorders (SMQ) [broad] | 12 | 17.237 | 0.604 | 1.032 | 1.552 | 0.463 | 0.721 | 1.08 | 0.696 | 0.398 | 9.857
COVID19 (Custom Term) | Premalignant disorders (SMQ) [narrow] | 12 | 17.237 | 0.604 | 1.032 | 1.552 | 0.463 | 0.721 | 1.08 | 0.696 | 0.398 | 9.857
COVID19 (Custom Term) | Myocardial infarction | 98 | 97.232 | 0.868 | 1.031 | 1.206 | 0.848 | 1.002 | 1.177 | 1.008 | 8.461 | 343.929
COVID19 (Custom Term) | Drain placement | 1 | 1.022 | 0.265 | 1.031 | 2.205 | 0.356 | 0.867 | 1.838 | 0.978 | 1.103 | 0.207
COVID19 (Custom Term) | Immature granulocyte count increased | 7 | 7.963 | 0.539 | 1.031 | 1.652 | 0.503 | 0.867 | 1.414 | 0.879 | 17.376 | 33.006
COVID19 (Custom Term) | Immunoglobulins normal | 1 | 0.658 | 0.194 | 1.03 | 2.406 | 0.389 | 0.944 | 2.004 | 1.52 | 0.211 | 2.096
COVID19 (Custom Term) | Loose tooth | 1 | 0.988 | 0.276 | 1.03 | 2.172 | 0.359 | 0.873 | 1.852 | 1.012 | 1.103 | 0.207
COVID19 (Custom Term) | Glaucoma (SMQ) [broad] | 709 | 727.561 | 0.967 | 1.03 | 1.094 | 0.915 | 0.974 | 1.035 | 0.974 | 1.318 | 48.6
COVID19 (Custom Term) | Oral mucosal exfoliation | 2 | 2.104 | 0.383 | 1.03 | 1.931 | 0.401 | 0.88 | 1.729 | 0.951 | 2.206 | 0.266
COVID19 (Custom Term) | Wound haemorrhage | 1 | 1.106 | 0.273 | 1.03 | 2.181 | 0.35 | 0.851 | 1.805 | 0.904 | 1.103 | 0.207
COVID19 (Custom Term) | Uterine and fallopian tube tumours of unspecified malignancy (SMQ) [broad] | 1 | 1.184 | 0.07 | 1.03 | 2.956 | 0.343 | 0.836 | 1.774 | 0.844 | 0.242 | 1.572
COVID19 (Custom Term) | Gastrointestinal disorder | 22 | 23.681 | 0.706 | 1.029 | 1.401 | 0.653 | 0.917 | 1.259 | 0.929 | 0.535 | 7.948
COVID19 (Custom Term) | Lipase normal | 10 | 11.43 | 0.62 | 1.029 | 1.522 | 0.538 | 0.866 | 1.335 | 0.875 | 2.159 | 4.115
COVID19 (Custom Term) | Pain management | 1 | 0.953 | 0.289 | 1.028 | 2.135 | 0.362 | 0.88 | 1.867 | 1.049 | 1.103 | 0.207
COVID19 (Custom Term) | Bowel movement irregularity | 5 | 5.081 | 0.485 | 1.028 | 1.734 | 0.501 | 0.924 | 1.591 | 0.984 | 1.013 | 0.043
COVID19 (Custom Term) | Band neutrophil count | 1 | 1.045 | 0.27 | 1.027 | 2.178 | 0.354 | 0.862 | 1.829 | 0.957 | 0.993 | 0.266
COVID19 (Custom Term) | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [broad] | 673 | 695.682 | 0.962 | 1.027 | 1.092 | 0.907 | 0.967 | 1.029 | 0.967 | 2.044 | 299.952
COVID19 (Custom Term) | Rhabdomyolysis/myopathy (SMQ) [broad] | 2937 | 3047.296 | 0.996 | 1.027 | 1.058 | 0.935 | 0.964 | 0.993 | 0.964 | 1.562 | 546.899
COVID19 (Custom Term) | Magnetic resonance imaging head | 92 | 99.765 | 0.862 | 1.027 | 1.205 | 0.774 | 0.919 | 1.085 | 0.922 | 2.727 | 77.544
COVID19 (Custom Term) | Vaccination site bruising | 10 | 11.049 | 0.598 | 1.027 | 1.55 | 0.552 | 0.889 | 1.37 | 0.905 | 1.013 | 0.016
COVID19 (Custom Term) | Blood creatine phosphokinase increased | 29 | 32.626 | 0.742 | 1.027 | 1.351 | 0.655 | 0.884 | 1.171 | 0.889 | 1.066 | 0.053
COVID19 (Custom Term) | Basophil percentage increased | 1 | 1.426 | 0.195 | 1.027 | 2.394 | 0.326 | 0.795 | 1.687 | 0.701 | 0.301 | 0.918
COVID19 (Custom Term) | Blood thyroid stimulating hormone increased | 3 | 2.567 | 0.394 | 1.026 | 1.899 | 0.479 | 0.977 | 1.817 | 1.169 | 0.727 | 0.076
COVID19 (Custom Term) | Ocular discomfort | 28 | 26.869 | 0.755 | 1.026 | 1.33 | 0.751 | 1.018 | 1.355 | 1.042 | 3.31 | 31.98
COVID19 (Custom Term) | CSF culture negative | 9 | 10.799 | 0.554 | 1.026 | 1.616 | 0.509 | 0.835 | 1.309 | 0.833 | 0.353 | 9.624
COVID19 (Custom Term) | Immune-mediated adverse reaction | 2 | 2.489 | 0.368 | 1.026 | 1.952 | 0.375 | 0.824 | 1.619 | 0.804 | 1.528 | 0.013
COVID19 (Custom Term) | Mean cell haemoglobin | 4 | 3.564 | 0.421 | 1.025 | 1.844 | 0.509 | 0.98 | 1.748 | 1.122 | 2.837 | 2.295
COVID19 (Custom Term) | Eye pain | 127 | 128.567 | 0.881 | 1.025 | 1.177 | 0.85 | 0.984 | 1.134 | 0.988 | 1.545 | 20.692
COVID19 (Custom Term) | Genital pain | 1 | 1.025 | 0.09 | 1.025 | 2.818 | 0.356 | 0.866 | 1.837 | 0.976 | 0.496 | 0.102
COVID19 (Custom Term) | Pityriasis rosea | 1 | 1.03 | 0.345 | 1.025 | 1.997 | 0.356 | 0.865 | 1.835 | 0.971 | 0.242 | 1.572
COVID19 (Custom Term) | Respiratory depression | 15 | 15.343 | 0.673 | 1.025 | 1.437 | 0.636 | 0.951 | 1.378 | 0.978 | 7.092 | 41.968
COVID19 (Custom Term) | Epididymitis | 1 | 1.089 | 0.319 | 1.025 | 2.056 | 0.351 | 0.854 | 1.811 | 0.918 | 1.103 | 0.207
COVID19 (Custom Term) | Blood test abnormal | 19 | 21.496 | 0.693 | 1.025 | 1.409 | 0.611 | 0.877 | 1.229 | 0.884 | 0.671 | 2.536
COVID19 (Custom Term) | Tachyphrenia | 2 | 2.993 | 0.44 | 1.025 | 1.81 | 0.346 | 0.76 | 1.495 | 0.668 | 1.241 | 0.014
COVID19 (Custom Term) | Myosclerosis | 4 | 3.685 | 0.464 | 1.024 | 1.762 | 0.5 | 0.964 | 1.719 | 1.086 | 0.969 | 0.039
COVID19 (Custom Term) | Product preparation issue | 84 | 80.954 | 0.848 | 1.024 | 1.214 | 0.86 | 1.029 | 1.223 | 1.038 | 1.607 | 16.037
COVID19 (Custom Term) | Arthralgia | 1727 | 1703.115 | 0.984 | 1.024 | 1.065 | 0.974 | 1.014 | 1.054 | 1.014 | 2.087 | 831.679
COVID19 (Custom Term) | Hypoglycaemia (SMQ) [broad] | 4517 | 4481.115 | 0.999 | 1.024 | 1.049 | 0.983 | 1.008 | 1.033 | 1.008 | 1.238 | 208.075
COVID19 (Custom Term) | SARS-CoV-2 antibody test negative | 28 | 27.97 | 0.748 | 1.024 | 1.334 | 0.725 | 0.983 | 1.307 | 1.001 | 39.717 | 202.94
COVID19 (Custom Term) | Red blood cell count increased | 6 | 6.079 | 0.514 | 1.024 | 1.674 | 0.524 | 0.932 | 1.559 | 0.987 | 1.61 | 0.686
COVID19 (Custom Term) | Lip exfoliation | 1 | 1.052 | 0.344 | 1.024 | 1.999 | 0.354 | 0.861 | 1.826 | 0.951 | 0.552 | 0.036
COVID19 (Custom Term) | Dysstasia | 118 | 122.178 | 0.876 | 1.024 | 1.182 | 0.827 | 0.962 | 1.115 | 0.966 | 1.571 | 20.633
COVID19 (Custom Term) | Polymyalgia rheumatica | 8 | 11.55 | 0.533 | 1.024 | 1.643 | 0.433 | 0.728 | 1.162 | 0.693 | 0.496 | 3.383
COVID19 (Custom Term) | Deep vein thrombosis | 59 | 58.86 | 0.817 | 1.023 | 1.249 | 0.802 | 0.993 | 1.218 | 1.002 | 15.416 | 305.501
COVID19 (Custom Term) | Lung opacity | 55 | 55.432 | 0.812 | 1.023 | 1.255 | 0.788 | 0.983 | 1.213 | 0.992 | 45.509 | 420.166
COVID19 (Custom Term) | Anticholinergic syndrome (SMQ) [algorithm] | 51 | 51.873 | 0.805 | 1.023 | 1.264 | 0.775 | 0.974 | 1.211 | 0.983 | 1.253 | 2.082
COVID19 (Custom Term) | Bedridden | 20 | 29.887 | 0.686 | 1.023 | 1.416 | 0.482 | 0.688 | 0.956 | 0.669 | 0.535 | 7.188
COVID19 (Custom Term) | Paranasal sinus hypersecretion | 12 | 11.887 | 0.633 | 1.022 | 1.486 | 0.624 | 0.97 | 1.453 | 1.01 | 3.136 | 11.54
COVID19 (Custom Term) | Axillary pain | 224 | 230.357 | 0.913 | 1.022 | 1.135 | 0.869 | 0.97 | 1.081 | 0.972 | 3.168 | 250.871
COVID19 (Custom Term) | Coagulation test abnormal | 1 | 1.042 | 0.218 | 1.022 | 2.311 | 0.355 | 0.863 | 1.83 | 0.96 | 0.993 | 0.266
COVID19 (Custom Term) | Oral mucosal eruption | 11 | 10.447 | 0.65 | 1.021 | 1.459 | 0.632 | 0.998 | 1.516 | 1.053 | 1.162 | 0.091
COVID19 (Custom Term) | Cholecystitis | 5 | 4.953 | 0.466 | 1.021 | 1.751 | 0.509 | 0.938 | 1.615 | 1.009 | 5.516 | 8.904
COVID19 (Custom Term) | Dementia (SMQ) [broad] | 2037 | 2036.899 | 0.984 | 1.021 | 1.058 | 0.964 | 1 | 1.037 | 1 | 1.366 | 184.675
COVID19 (Custom Term) | Vitamin B12 normal | 13 | 15.434 | 0.632 | 1.021 | 1.486 | 0.549 | 0.842 | 1.246 | 0.842 | 1.359 | 0.764
COVID19 (Custom Term) | HIV test | 9 | 12.216 | 0.548 | 1.021 | 1.613 | 0.463 | 0.76 | 1.192 | 0.737 | 2.352 | 4.515
COVID19 (Custom Term) | Glomerular filtration rate normal | 12 | 9.925 | 0.638 | 1.02 | 1.476 | 0.714 | 1.11 | 1.664 | 1.209 | 2.771 | 9.151
COVID19 (Custom Term) | Osteonecrosis (SMQ) [broad] | 203 | 203.735 | 0.907 | 1.02 | 1.139 | 0.885 | 0.994 | 1.113 | 0.996 | 1.524 | 31.305
COVID19 (Custom Term) | Lip pain | 6 | 6.235 | 0.498 | 1.02 | 1.693 | 0.516 | 0.917 | 1.534 | 0.962 | 1.385 | 0.254
COVID19 (Custom Term) | Lipodystrophy (SMQ) [broad] | 72 | 80.955 | 0.834 | 1.02 | 1.221 | 0.731 | 0.887 | 1.069 | 0.889 | 1.991 | 28.733
COVID19 (Custom Term) | Human metapneumovirus test | 2 | 2.052 | 0.301 | 1.019 | 2.08 | 0.405 | 0.888 | 1.745 | 0.974 | 0.827 | 0.007
COVID19 (Custom Term) | Seizure | 149 | 178.823 | 0.886 | 1.019 | 1.159 | 0.728 | 0.833 | 0.95 | 0.833 | 0.355 | 169.668
COVID19 (Custom Term) | Postictal state | 9 | 7.949 | 0.623 | 1.018 | 1.491 | 0.634 | 1.041 | 1.631 | 1.132 | 0.608 | 1.758
COVID19 (Custom Term) | Pupil fixed | 8 | 7.44 | 0.562 | 1.018 | 1.583 | 0.594 | 0.998 | 1.594 | 1.075 | 2.562 | 4.769
COVID19 (Custom Term) | Cardiovascular evaluation | 18 | 16.901 | 0.689 | 1.018 | 1.4 | 0.707 | 1.025 | 1.447 | 1.065 | 8.124 | 57.615
COVID19 (Custom Term) | Body temperature decreased | 23 | 21.934 | 0.733 | 1.018 | 1.342 | 0.731 | 1.019 | 1.391 | 1.049 | 1.305 | 1.168
COVID19 (Custom Term) | Vitreous floaters | 12 | 12.347 | 0.637 | 1.018 | 1.473 | 0.606 | 0.942 | 1.411 | 0.972 | 1.778 | 2.779
COVID19 (Custom Term) | Computerised tomogram | 317 | 330.592 | 0.927 | 1.018 | 1.112 | 0.873 | 0.958 | 1.049 | 0.959 | 3.77 | 466.919
COVID19 (Custom Term) | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [broad] | 6 | 6.394 | 0.455 | 1.018 | 1.763 | 0.508 | 0.903 | 1.51 | 0.938 | 0.709 | 0.402
COVID19 (Custom Term) | Central venous catheterisation | 5 | 6.111 | 0.505 | 1.018 | 1.676 | 0.448 | 0.826 | 1.422 | 0.818 | 1.273 | 0.061
COVID19 (Custom Term) | Respiratory tract congestion | 192 | 160.398 | 0.9 | 1.017 | 1.139 | 1.056 | 1.189 | 1.336 | 1.197 | 2.791 | 171.181
COVID19 (Custom Term) | Rhinitis | 6 | 5.415 | 0.477 | 1.017 | 1.72 | 0.563 | 1.001 | 1.674 | 1.108 | 0.27 | 10.799
COVID19 (Custom Term) | Limb discomfort | 282 | 278.727 | 0.921 | 1.017 | 1.117 | 0.915 | 1.01 | 1.112 | 1.012 | 2.428 | 189.931
COVID19 (Custom Term) | Lymphocyte percentage increased | 6 | 6.121 | 0.483 | 1.017 | 1.711 | 0.522 | 0.928 | 1.552 | 0.98 | 0.226 | 14.777
COVID19 (Custom Term) | Extrapyramidal syndrome (SMQ) [narrow] | 105 | 115.25 | 0.861 | 1.017 | 1.184 | 0.774 | 0.909 | 1.062 | 0.911 | 0.469 | 60.06
COVID19 (Custom Term) | Blood magnesium normal | 32 | 29.332 | 0.765 | 1.016 | 1.298 | 0.799 | 1.063 | 1.392 | 1.091 | 3.875 | 46.86
COVID19 (Custom Term) | Cyanosis | 44 | 44.247 | 0.785 | 1.016 | 1.272 | 0.769 | 0.983 | 1.241 | 0.994 | 0.349 | 51.137
COVID19 (Custom Term) | Rash papular | 136 | 142.008 | 0.878 | 1.016 | 1.161 | 0.829 | 0.955 | 1.095 | 0.958 | 1.543 | 22.063
COVID19 (Custom Term) | Eosinophil percentage increased | 4 | 4.381 | 0.451 | 1.016 | 1.763 | 0.456 | 0.88 | 1.568 | 0.913 | 0.371 | 3.468
COVID19 (Custom Term) | Neuroleptic malignant syndrome (SMQ) [algorithm] | 6 | 6.748 | 0.495 | 1.016 | 1.686 | 0.49 | 0.872 | 1.458 | 0.889 | 0.261 | 11.437
COVID19 (Custom Term) | Computerised tomogram thorax | 73 | 72.638 | 0.838 | 1.015 | 1.207 | 0.823 | 0.997 | 1.199 | 1.005 | 11.691 | 322.51
COVID19 (Custom Term) | Off label use | 36 | 37.883 | 0.756 | 1.015 | 1.306 | 0.718 | 0.941 | 1.215 | 0.95 | 3.055 | 36.365
COVID19 (Custom Term) | Yawning | 2 | 2.097 | 0.366 | 1.014 | 1.925 | 0.402 | 0.881 | 1.731 | 0.954 | 0.685 | 0.044
COVID19 (Custom Term) | Mastication disorder | 12 | 12.789 | 0.652 | 1.014 | 1.441 | 0.589 | 0.917 | 1.373 | 0.938 | 3.723 | 15.275
COVID19 (Custom Term) | Injection site erosion | 1 | 1.498 | 0.274 | 1.014 | 2.134 | 0.321 | 0.783 | 1.663 | 0.667 | 0.523 | 0.065
COVID19 (Custom Term) | Injection site paraesthesia | 52 | 50.417 | 0.806 | 1.013 | 1.239 | 0.812 | 1.019 | 1.265 | 1.031 | 1.682 | 11.671
COVID19 (Custom Term) | Tongue blistering | 7 | 6.843 | 0.545 | 1.013 | 1.599 | 0.556 | 0.96 | 1.566 | 1.023 | 2.574 | 4.064
COVID19 (Custom Term) | Bilirubin conjugated normal | 1 | 1.037 | 0.18 | 1.013 | 2.404 | 0.355 | 0.864 | 1.832 | 0.964 | 0.242 | 1.572
COVID19 (Custom Term) | White blood cell disorder | 3 | 2.957 | 0.456 | 1.012 | 1.745 | 0.451 | 0.918 | 1.709 | 1.014 | 2.979 | 1.589
COVID19 (Custom Term) | Balance disorder | 153 | 161.246 | 0.883 | 1.012 | 1.148 | 0.828 | 0.946 | 1.078 | 0.949 | 1.573 | 27.089
COVID19 (Custom Term) | pH urine normal | 9 | 9.844 | 0.584 | 1.012 | 1.535 | 0.545 | 0.894 | 1.402 | 0.914 | 0.941 | 0
COVID19 (Custom Term) | Sputum culture | 3 | 3.996 | 0.426 | 1.012 | 1.801 | 0.388 | 0.792 | 1.474 | 0.751 | 2.708 | 1.277
COVID19 (Custom Term) | Haematological malignant tumours (SMQ) [narrow] | 20 | 25.972 | 0.689 | 1.012 | 1.385 | 0.546 | 0.779 | 1.083 | 0.77 | 0.955 | 0.007
COVID19 (Custom Term) | Haematological malignant tumours (SMQ) [broad] | 20 | 25.972 | 0.689 | 1.012 | 1.385 | 0.546 | 0.779 | 1.083 | 0.77 | 0.955 | 0.007
COVID19 (Custom Term) | CSF glucose normal | 7 | 9.416 | 0.521 | 1.012 | 1.634 | 0.446 | 0.77 | 1.256 | 0.743 | 0.393 | 5.701
COVID19 (Custom Term) | Suicide attempt | 1 | 0.953 | 0.085 | 1.011 | 2.805 | 0.362 | 0.88 | 1.867 | 1.049 | 0.255 | 1.403
COVID19 (Custom Term) | Culture wound negative | 1 | 0.988 | 0.156 | 1.011 | 2.48 | 0.359 | 0.873 | 1.852 | 1.012 | 0.523 | 0.065
COVID19 (Custom Term) | Hostility/aggression (SMQ) [narrow] | 23 | 23.091 | 0.711 | 1.011 | 1.354 | 0.699 | 0.975 | 1.33 | 0.996 | 0.645 | 3.862
COVID19 (Custom Term) | Somnolence | 210 | 212.628 | 0.9 | 1.011 | 1.128 | 0.879 | 0.985 | 1.101 | 0.988 | 0.779 | 12.135
COVID19 (Custom Term) | Hearing and vestibular disorders (SMQ) [narrow] | 547 | 564.455 | 0.942 | 1.011 | 1.083 | 0.902 | 0.968 | 1.038 | 0.969 | 1.711 | 138.605
COVID19 (Custom Term) | Allergy test | 7 | 7.338 | 0.607 | 1.011 | 1.499 | 0.531 | 0.916 | 1.495 | 0.954 | 0.479 | 3.251
COVID19 (Custom Term) | Mycobacterium test negative | 1 | 1.072 | 0.194 | 1.011 | 2.351 | 0.352 | 0.857 | 1.818 | 0.933 | 0.523 | 0.065
COVID19 (Custom Term) | Aspiration | 13 | 13.701 | 0.646 | 1.011 | 1.443 | 0.604 | 0.926 | 1.371 | 0.949 | 2.531 | 8.299
COVID19 (Custom Term) | Magnetic resonance imaging head normal | 69 | 74.604 | 0.822 | 1.011 | 1.217 | 0.756 | 0.921 | 1.113 | 0.925 | 0.99 | 0
COVID19 (Custom Term) | Vibratory sense increased | 3 | 3.489 | 0.426 | 1.011 | 1.798 | 0.416 | 0.849 | 1.58 | 0.86 | 2.291 | 0.807
COVID19 (Custom Term) | Areflexia | 5 | 7.103 | 0.444 | 1.011 | 1.764 | 0.406 | 0.749 | 1.29 | 0.704 | 0.252 | 10.044
COVID19 (Custom Term) | Eye irritation | 56 | 54.194 | 0.81 | 1.01 | 1.227 | 0.821 | 1.021 | 1.259 | 1.033 | 1.749 | 14.582
COVID19 (Custom Term) | X-ray of pelvis and hip normal | 1 | 0.998 | 0.3 | 1.01 | 2.059 | 0.358 | 0.871 | 1.848 | 1.002 | 0.261 | 1.32
COVID19 (Custom Term) | Peroneal nerve palsy | 4 | 4.883 | 0.484 | 1.01 | 1.692 | 0.429 | 0.828 | 1.475 | 0.819 | 0.764 | 0.084
COVID19 (Custom Term) | Escherichia urinary tract infection | 2 | 2.961 | 0.368 | 1.01 | 1.909 | 0.348 | 0.764 | 1.502 | 0.675 | 1.805 | 0.089
COVID19 (Custom Term) | Proteinuria (SMQ) [narrow] | 15 | 21.277 | 0.646 | 1.01 | 1.439 | 0.485 | 0.724 | 1.05 | 0.705 | 0.734 | 1.092
COVID19 (Custom Term) | Scan | 5 | 5.021 | 0.453 | 1.009 | 1.744 | 0.504 | 0.93 | 1.602 | 0.996 | 0.68 | 0.413
COVID19 (Custom Term) | Catheterisation cardiac | 31 | 31.852 | 0.749 | 1.009 | 1.3 | 0.718 | 0.96 | 1.261 | 0.973 | 14.657 | 153.326
COVID19 (Custom Term) | Bordetella test negative | 1 | 1.057 | 0.276 | 1.009 | 2.117 | 0.354 | 0.86 | 1.824 | 0.946 | 0.523 | 0.065
COVID19 (Custom Term) | Hypotonia | 18 | 20.139 | 0.667 | 1.009 | 1.409 | 0.611 | 0.886 | 1.25 | 0.894 | 0.115 | 120.173
COVID19 (Custom Term) | Bruxism | 5 | 5.89 | 0.5 | 1.009 | 1.662 | 0.458 | 0.845 | 1.455 | 0.849 | 0.788 | 0.092
COVID19 (Custom Term) | Hyperthyroidism | 4 | 4.766 | 0.41 | 1.009 | 1.823 | 0.435 | 0.839 | 1.496 | 0.839 | 0.903 | 0.003
COVID19 (Custom Term) | Visual acuity tests normal | 1 | 1.496 | 0.283 | 1.009 | 2.098 | 0.321 | 0.784 | 1.664 | 0.668 | 0.827 | 0.089
COVID19 (Custom Term) | Liver function test | 25 | 24.346 | 0.724 | 1.008 | 1.332 | 0.728 | 1.003 | 1.353 | 1.027 | 2.789 | 20.895
COVID19 (Custom Term) | Urticaria | 1164 | 1172.143 | 0.961 | 1.008 | 1.057 | 0.946 | 0.993 | 1.041 | 0.993 | 1.311 | 77.645
COVID19 (Custom Term) | Body temperature | 186 | 180.268 | 0.889 | 1.007 | 1.131 | 0.911 | 1.028 | 1.157 | 1.032 | 12.15 | 851.239
COVID19 (Custom Term) | Product use issue | 34 | 33.69 | 0.742 | 1.007 | 1.306 | 0.752 | 0.993 | 1.29 | 1.009 | 1.951 | 12.328
COVID19 (Custom Term) | Stent placement | 20 | 20.324 | 0.692 | 1.007 | 1.37 | 0.675 | 0.962 | 1.338 | 0.984 | 22.065 | 117.741
COVID19 (Custom Term) | Flatulence | 30 | 31.09 | 0.73 | 1.007 | 1.321 | 0.709 | 0.952 | 1.256 | 0.965 | 0.905 | 0.185
COVID19 (Custom Term) | Pain | 4129 | 4293.928 | 0.982 | 1.007 | 1.033 | 0.937 | 0.961 | 0.986 | 0.962 | 1.519 | 699.502
COVID19 (Custom Term) | Monoplegia | 7 | 9.83 | 0.5 | 1.007 | 1.658 | 0.432 | 0.746 | 1.218 | 0.712 | 0.284 | 11.563
COVID19 (Custom Term) | Gingival bleeding | 11 | 10.595 | 0.605 | 1.006 | 1.489 | 0.625 | 0.988 | 1.5 | 1.038 | 1.734 | 2.261
COVID19 (Custom Term) | Yellow skin | 6 | 6.135 | 0.522 | 1.006 | 1.618 | 0.521 | 0.927 | 1.55 | 0.978 | 0.669 | 0.609
COVID19 (Custom Term) | Gastrointestinal inflammation | 4 | 4.402 | 0.433 | 1.006 | 1.773 | 0.455 | 0.877 | 1.564 | 0.909 | 0.924 | 0.01
COVID19 (Custom Term) | Pseudomembranous colitis (SMQ) [narrow] | 6 | 7.119 | 0.545 | 1.006 | 1.581 | 0.473 | 0.842 | 1.408 | 0.843 | 1.418 | 0.308
COVID19 (Custom Term) | Foaming at mouth | 11 | 10.468 | 0.622 | 1.005 | 1.463 | 0.631 | 0.997 | 1.514 | 1.051 | 0.775 | 0.459
COVID19 (Custom Term) | Ear swelling | 31 | 29.755 | 0.746 | 1.005 | 1.296 | 0.763 | 1.02 | 1.34 | 1.042 | 2.23 | 16.103
COVID19 (Custom Term) | Thyroid function test | 12 | 11.965 | 0.653 | 1.005 | 1.42 | 0.621 | 0.965 | 1.446 | 1.003 | 2.054 | 4.462
COVID19 (Custom Term) | Thrombophlebitis (SMQ) [broad] | 125 | 128.331 | 0.863 | 1.005 | 1.155 | 0.837 | 0.97 | 1.12 | 0.974 | 7.174 | 381.999
COVID19 (Custom Term) | Hearing impairment (SMQ) [broad] | 661 | 687.681 | 0.942 | 1.005 | 1.07 | 0.901 | 0.961 | 1.023 | 0.961 | 2.075 | 306.975
COVID19 (Custom Term) | Colonoscopy normal | 2 | 2.104 | 0.391 | 1.005 | 1.849 | 0.401 | 0.88 | 1.729 | 0.951 | 0.863 | 0.022
COVID19 (Custom Term) | Glomerular filtration rate | 19 | 20.09 | 0.701 | 1.005 | 1.354 | 0.647 | 0.929 | 1.302 | 0.946 | 3.699 | 25.147
COVID19 (Custom Term) | Laboratory test abnormal | 26 | 30.476 | 0.717 | 1.005 | 1.333 | 0.622 | 0.852 | 1.144 | 0.853 | 0.775 | 1.352
COVID19 (Custom Term) | Blood albumin increased | 3 | 2.568 | 0.379 | 1.004 | 1.87 | 0.479 | 0.977 | 1.817 | 1.168 | 2.482 | 1.02
COVID19 (Custom Term) | Blood magnesium increased | 6 | 5.339 | 0.531 | 1.004 | 1.599 | 0.568 | 1.009 | 1.688 | 1.124 | 2.383 | 2.753
COVID19 (Custom Term) | Red blood cells urine negative | 1 | 1.111 | 0.267 | 1.004 | 2.123 | 0.349 | 0.85 | 1.803 | 0.9 | 0.268 | 1.237
COVID19 (Custom Term) | Immune thrombocytopenia | 40 | 43.833 | 0.763 | 1.004 | 1.273 | 0.701 | 0.907 | 1.157 | 0.913 | 0.865 | 0.642
COVID19 (Custom Term) | Hip arthroplasty | 3 | 3.559 | 0.376 | 1.004 | 1.877 | 0.412 | 0.841 | 1.564 | 0.843 | 2.482 | 1.02
COVID19 (Custom Term) | Complement factor C3 | 6 | 8.335 | 0.478 | 1.004 | 1.686 | 0.425 | 0.756 | 1.264 | 0.72 | 0.584 | 1.274
COVID19 (Custom Term) | Blood pressure normal | 4 | 2.703 | 0.442 | 1.003 | 1.748 | 0.578 | 1.115 | 1.989 | 1.48 | 1.418 | 0.123
COVID19 (Custom Term) | Bronchoscopy | 1 | 0.993 | 0.207 | 1.003 | 2.288 | 0.359 | 0.872 | 1.85 | 1.007 | 0.496 | 0.102
COVID19 (Custom Term) | Back pain | 507 | 520.498 | 0.931 | 1.003 | 1.077 | 0.904 | 0.973 | 1.046 | 0.974 | 1.574 | 92.103
COVID19 (Custom Term) | Exercise tolerance decreased | 7 | 7.728 | 0.494 | 1.003 | 1.656 | 0.513 | 0.885 | 1.443 | 0.906 | 0.552 | 1.973
COVID19 (Custom Term) | Allodynia | 4 | 4.447 | 0.382 | 1.003 | 1.862 | 0.452 | 0.873 | 1.555 | 0.899 | 0.883 | 0
COVID19 (Custom Term) | Retinal haemorrhage | 2 | 2.969 | 0.291 | 1.003 | 2.062 | 0.347 | 0.763 | 1.5 | 0.674 | 0.621 | 0.132
COVID19 (Custom Term) | Eyelid oedema | 4 | 3.929 | 0.566 | 1.002 | 1.54 | 0.484 | 0.933 | 1.662 | 1.018 | 0.107 | 28.443
COVID19 (Custom Term) | Flank pain | 44 | 44.269 | 0.787 | 1.002 | 1.239 | 0.768 | 0.982 | 1.241 | 0.994 | 2.468 | 29.518
COVID19 (Custom Term) | Stool analysis normal | 2 | 2.194 | 0.281 | 1.002 | 2.085 | 0.395 | 0.866 | 1.702 | 0.912 | 0.146 | 8.943
COVID19 (Custom Term) | Ataxia | 13 | 14.314 | 0.616 | 1.002 | 1.465 | 0.583 | 0.894 | 1.324 | 0.908 | 0.561 | 3.779
COVID19 (Custom Term) | Troponin T normal | 5 | 5.369 | 0.429 | 1.001 | 1.767 | 0.485 | 0.894 | 1.54 | 0.931 | 3.103 | 3.809
COVID19 (Custom Term) | Shock | 8 | 10.031 | 0.537 | 1.001 | 1.582 | 0.481 | 0.809 | 1.292 | 0.798 | 0.593 | 1.711
COVID19 (Custom Term) | Computerised tomogram pelvis | 17 | 16.317 | 0.658 | 1 | 1.4 | 0.687 | 1.005 | 1.43 | 1.042 | 2.482 | 10.771
COVID19 (Custom Term) | Human rhinovirus test | 2 | 2.052 | 0.359 | 1 | 1.902 | 0.405 | 0.888 | 1.745 | 0.974 | 1.103 | 0.065
COVID19 (Custom Term) | Dystonia (SMQ) [narrow] | 17 | 18.033 | 0.657 | 1 | 1.403 | 0.632 | 0.925 | 1.317 | 0.943 | 0.398 | 14.262
COVID19 (Custom Term) | Blood thyroid stimulating hormone normal | 26 | 27.712 | 0.711 | 1 | 1.329 | 0.677 | 0.927 | 1.245 | 0.938 | 1.253 | 0.947
COVID19 (Custom Term) | Akathisia (SMQ) [broad] | 102 | 114.74 | 0.844 | 1 | 1.167 | 0.754 | 0.887 | 1.039 | 0.889 | 0.791 | 5.048
COVID19 (Custom Term) | Skin disorder | 8 | 9.333 | 0.539 | 1 | 1.576 | 0.507 | 0.852 | 1.361 | 0.857 | 0.368 | 7.733
COVID19 (Custom Term) | Toxic-septic shock conditions (SMQ) [narrow] | 32 | 38.396 | 0.734 | 1 | 1.299 | 0.627 | 0.834 | 1.092 | 0.833 | 0.685 | 4.031
COVID19 (Custom Term) | Scan myocardial perfusion | 4 | 3.361 | 0.475 | 0.998 | 1.677 | 0.523 | 1.009 | 1.799 | 1.19 | 4.413 | 4.94
COVID19 (Custom Term) | Gingival pain | 11 | 10.928 | 0.601 | 0.998 | 1.478 | 0.611 | 0.965 | 1.466 | 1.007 | 2.142 | 4.522
COVID19 (Custom Term) | Decreased appetite | 482 | 490.963 | 0.924 | 0.998 | 1.073 | 0.91 | 0.981 | 1.056 | 0.982 | 1.108 | 4.531
COVID19 (Custom Term) | Hypoacusis | 47 | 50.15 | 0.779 | 0.998 | 1.239 | 0.734 | 0.931 | 1.167 | 0.937 | 1.52 | 6.773
COVID19 (Custom Term) | Posture abnormal | 41 | 45.974 | 0.764 | 0.998 | 1.258 | 0.689 | 0.888 | 1.13 | 0.892 | 0.678 | 5.53
COVID19 (Custom Term) | Injection site oedema | 29 | 32.645 | 0.721 | 0.998 | 1.312 | 0.655 | 0.883 | 1.171 | 0.888 | 0.325 | 38.667
COVID19 (Custom Term) | Brain natriuretic peptide | 25 | 25.339 | 0.716 | 0.997 | 1.316 | 0.703 | 0.968 | 1.307 | 0.987 | 17.731 | 135.162
COVID19 (Custom Term) | Ocular motility disorders (SMQ) [narrow] | 133 | 140.405 | 0.861 | 0.997 | 1.141 | 0.819 | 0.945 | 1.085 | 0.947 | 0.595 | 34.443
COVID19 (Custom Term) | Hypocalcaemia | 4 | 3.975 | 0.442 | 0.996 | 1.731 | 0.481 | 0.927 | 1.653 | 1.006 | 4.413 | 4.94
COVID19 (Custom Term) | Immunoglobulins | 3 | 3.037 | 0.422 | 0.996 | 1.765 | 0.445 | 0.907 | 1.688 | 0.988 | 1.064 | 0.044
COVID19 (Custom Term) | Pruritus genital | 3 | 3.058 | 0.416 | 0.996 | 1.78 | 0.444 | 0.904 | 1.682 | 0.981 | 2.291 | 0.807
COVID19 (Custom Term) | Neutrophil percentage | 10 | 10.43 | 0.571 | 0.996 | 1.517 | 0.577 | 0.928 | 1.431 | 0.959 | 0.649 | 1.439
COVID19 (Custom Term) | Depression (excl suicide and self injury) (SMQ) [broad] | 377 | 410.824 | 0.913 | 0.996 | 1.081 | 0.842 | 0.917 | 0.997 | 0.918 | 0.428 | 282.455
COVID19 (Custom Term) | Dyskinesia (SMQ) [narrow] | 61 | 66.751 | 0.8 | 0.996 | 1.21 | 0.738 | 0.91 | 1.113 | 0.914 | 0.44 | 41.253
COVID19 (Custom Term) | Blood phosphorus normal | 4 | 4.67 | 0.48 | 0.996 | 1.662 | 0.44 | 0.849 | 1.513 | 0.857 | 0.503 | 1.388
COVID19 (Custom Term) | Transaminases | 2 | 1.98 | 0.299 | 0.995 | 2.022 | 0.41 | 0.9 | 1.768 | 1.01 | 0.903 | 0.046
COVID19 (Custom Term) | Pallor | 232 | 231.705 | 0.891 | 0.995 | 1.104 | 0.896 | 0.999 | 1.11 | 1.001 | 0.579 | 67.534
COVID19 (Custom Term) | Eyelid function disorder | 31 | 30.96 | 0.742 | 0.995 | 1.278 | 0.737 | 0.984 | 1.294 | 1.001 | 2.502 | 21.044
COVID19 (Custom Term) | Noninfectious encephalitis (SMQ) [broad] | 3300 | 3419.263 | 0.967 | 0.995 | 1.024 | 0.938 | 0.965 | 0.993 | 0.965 | 1.049 | 7.672
COVID19 (Custom Term) | Ultrasound skull | 3 | 3.149 | 0.303 | 0.995 | 2.013 | 0.438 | 0.892 | 1.66 | 0.953 | 0.745 | 0.053
COVID19 (Custom Term) | Joint stiffness | 42 | 44.817 | 0.763 | 0.995 | 1.254 | 0.723 | 0.93 | 1.18 | 0.937 | 0.981 | 0.001
COVID19 (Custom Term) | Muscle fatigue | 24 | 26.026 | 0.701 | 0.995 | 1.331 | 0.658 | 0.912 | 1.238 | 0.922 | 1.891 | 7.667
COVID19 (Custom Term) | Immature granulocyte percentage increased | 6 | 5.342 | 0.51 | 0.994 | 1.609 | 0.567 | 1.009 | 1.687 | 1.123 | 11.915 | 22.083
COVID19 (Custom Term) | Fear | 45 | 43.18 | 0.776 | 0.994 | 1.235 | 0.805 | 1.026 | 1.293 | 1.042 | 2.901 | 41.813
COVID19 (Custom Term) | Drooling | 17 | 16.426 | 0.703 | 0.994 | 1.326 | 0.683 | 1 | 1.422 | 1.035 | 0.97 | 0
COVID19 (Custom Term) | Infectious biliary disorders (SMQ) [narrow] | 9 | 8.948 | 0.542 | 0.993 | 1.554 | 0.584 | 0.958 | 1.502 | 1.006 | 4.468 | 14.181
COVID19 (Custom Term) | Infectious biliary disorders (SMQ) [broad] | 9 | 8.948 | 0.542 | 0.993 | 1.554 | 0.584 | 0.958 | 1.502 | 1.006 | 4.468 | 14.181
COVID19 (Custom Term) | Cardiovascular examination | 3 | 3.105 | 0.318 | 0.993 | 1.971 | 0.441 | 0.898 | 1.671 | 0.966 | 0.764 | 0.034
COVID19 (Custom Term) | Culture | 11 | 12.22 | 0.598 | 0.993 | 1.469 | 0.561 | 0.886 | 1.346 | 0.9 | 0.569 | 2.967
COVID19 (Custom Term) | Localised oedema | 7 | 8.509 | 0.531 | 0.993 | 1.573 | 0.48 | 0.828 | 1.35 | 0.823 | 0.632 | 1.057
COVID19 (Custom Term) | CSF lymphocyte count normal | 2 | 2.575 | 0.437 | 0.993 | 1.731 | 0.37 | 0.812 | 1.596 | 0.777 | 0.946 | 0.082
COVID19 (Custom Term) | Hernia | 1 | 2.049 | 0.187 | 0.993 | 2.322 | 0.286 | 0.704 | 1.5 | 0.488 | 0.584 | 0.014
COVID19 (Custom Term) | Antiphospholipid antibodies | 5 | 4.406 | 0.452 | 0.992 | 1.702 | 0.543 | 1.002 | 1.725 | 1.135 | 3.546 | 4.829
COVID19 (Custom Term) | Blood lactic acid normal | 15 | 14.465 | 0.642 | 0.992 | 1.404 | 0.667 | 0.997 | 1.445 | 1.037 | 1.96 | 5.04
COVID19 (Custom Term) | Pulmonary pain | 14 | 14.559 | 0.652 | 0.992 | 1.39 | 0.62 | 0.937 | 1.372 | 0.962 | 3.564 | 16.988
COVID19 (Custom Term) | Affect lability | 1 | 1.395 | 0.203 | 0.992 | 2.268 | 0.328 | 0.8 | 1.698 | 0.717 | 0.248 | 1.487
COVID19 (Custom Term) | Thinking abnormal | 15 | 14.361 | 0.669 | 0.991 | 1.364 | 0.671 | 1.003 | 1.454 | 1.045 | 1.909 | 4.644
COVID19 (Custom Term) | Glossodynia | 29 | 29.197 | 0.736 | 0.991 | 1.277 | 0.724 | 0.976 | 1.294 | 0.993 | 3.388 | 34.466
COVID19 (Custom Term) | Aplastic anaemia | 2 | 2.097 | 0.351 | 0.991 | 1.894 | 0.402 | 0.881 | 1.731 | 0.954 | 1.241 | 0.014
COVID19 (Custom Term) | Muscle rigidity | 16 | 18.683 | 0.649 | 0.991 | 1.393 | 0.577 | 0.854 | 1.225 | 0.856 | 0.55 | 5.137
COVID19 (Custom Term) | Base excess | 3 | 2.485 | 0.35 | 0.99 | 1.894 | 0.486 | 0.99 | 1.842 | 1.207 | 2.482 | 1.02
COVID19 (Custom Term) | Swelling of eyelid | 47 | 45.869 | 0.79 | 0.99 | 1.208 | 0.797 | 1.011 | 1.268 | 1.025 | 2.418 | 30.208
COVID19 (Custom Term) | Wrong product administered | 49 | 106.39 | 0.772 | 0.99 | 1.231 | 0.374 | 0.473 | 0.591 | 0.461 | 0.13 | 283.572
COVID19 (Custom Term) | Candida infection | 5 | 4.91 | 0.444 | 0.989 | 1.709 | 0.511 | 0.943 | 1.623 | 1.018 | 0.827 | 0.037
COVID19 (Custom Term) | Hemiparesis | 81 | 81.615 | 0.818 | 0.989 | 1.174 | 0.821 | 0.986 | 1.176 | 0.992 | 3.689 | 113.725
COVID19 (Custom Term) | Conversion disorder | 3 | 3.051 | 0.348 | 0.989 | 1.897 | 0.444 | 0.905 | 1.684 | 0.983 | 0.532 | 0.735
COVID19 (Custom Term) | Angioedema (SMQ) [broad] | 4174 | 4301.176 | 0.964 | 0.989 | 1.015 | 0.946 | 0.97 | 0.995 | 0.97 | 1.124 | 58.511
COVID19 (Custom Term) | Imaging procedure | 11 | 11.525 | 0.605 | 0.989 | 1.45 | 0.587 | 0.927 | 1.408 | 0.954 | 1.383 | 0.686
COVID19 (Custom Term) | Blood thyroid stimulating hormone | 43 | 42.896 | 0.771 | 0.988 | 1.228 | 0.772 | 0.99 | 1.253 | 1.002 | 2.904 | 39.961
COVID19 (Custom Term) | Hypersensitivity (SMQ) [broad] | 7874 | 8028.091 | 0.97 | 0.988 | 1.007 | 0.963 | 0.981 | 0.999 | 0.981 | 1.044 | 17.592
COVID19 (Custom Term) | Cholestasis and jaundice of hepatic origin (SMQ) [broad] | 21 | 23.574 | 0.672 | 0.988 | 1.355 | 0.625 | 0.884 | 1.221 | 0.891 | 0.747 | 1.421
COVID19 (Custom Term) | Bladder catheterisation | 5 | 5.9 | 0.487 | 0.988 | 1.632 | 0.458 | 0.844 | 1.454 | 0.847 | 0.887 | 0.001
COVID19 (Custom Term) | Eyelid pain | 4 | 3.6 | 0.452 | 0.987 | 1.691 | 0.506 | 0.975 | 1.739 | 1.111 | 1.073 | 0.019
COVID19 (Custom Term) | Ulcer | 3 | 3.389 | 0.448 | 0.987 | 1.696 | 0.423 | 0.861 | 1.603 | 0.885 | 0.764 | 0.034
COVID19 (Custom Term) | Complement factor normal | 3 | 3.911 | 0.331 | 0.987 | 1.925 | 0.393 | 0.801 | 1.491 | 0.767 | 0.363 | 2.59
COVID19 (Custom Term) | Amnesia | 37 | 47.621 | 0.74 | 0.987 | 1.264 | 0.598 | 0.781 | 1.006 | 0.777 | 1.05 | 0.037
COVID19 (Custom Term) | Oculogyric crisis | 1 | 0.991 | 0.124 | 0.986 | 2.529 | 0.359 | 0.873 | 1.851 | 1.009 | 0.432 | 0.243
COVID19 (Custom Term) | Emphysema | 3 | 2.991 | 0.342 | 0.986 | 1.899 | 0.448 | 0.914 | 1.7 | 1.003 | 2.128 | 0.631
COVID19 (Custom Term) | Arteriogram coronary normal | 6 | 6.052 | 0.503 | 0.986 | 1.599 | 0.526 | 0.935 | 1.563 | 0.991 | 6.619 | 13.664
COVID19 (Custom Term) | Asthenia | 1322 | 1357.717 | 0.942 | 0.986 | 1.031 | 0.93 | 0.973 | 1.018 | 0.974 | 1.621 | 277.165
COVID19 (Custom Term) | Oral pain | 23 | 24.49 | 0.705 | 0.986 | 1.305 | 0.664 | 0.926 | 1.264 | 0.939 | 1.608 | 3.998
COVID19 (Custom Term) | Sarcoidosis | 1 | 1.107 | 0.175 | 0.986 | 2.338 | 0.35 | 0.851 | 1.804 | 0.904 | 0.451 | 0.191
COVID19 (Custom Term) | Feeding disorder | 57 | 61.823 | 0.788 | 0.986 | 1.202 | 0.739 | 0.917 | 1.129 | 0.922 | 1.67 | 12.493
COVID19 (Custom Term) | Hearing impairment (SMQ) [narrow] | 292 | 320.331 | 0.893 | 0.986 | 1.082 | 0.827 | 0.911 | 1.001 | 0.912 | 1.34 | 22.004
COVID19 (Custom Term) | Abdominal pain upper | 256 | 300.389 | 0.887 | 0.986 | 1.089 | 0.768 | 0.852 | 0.943 | 0.852 | 1.055 | 0.618
COVID19 (Custom Term) | Tendon pain | 2 | 2.486 | 0.391 | 0.986 | 1.798 | 0.376 | 0.824 | 1.62 | 0.805 | 0.405 | 1.107
COVID19 (Custom Term) | Anaemia | 30 | 39.745 | 0.717 | 0.986 | 1.292 | 0.568 | 0.762 | 1.005 | 0.755 | 0.897 | 0.229
COVID19 (Custom Term) | Blood creatine phosphokinase | 24 | 23.606 | 0.708 | 0.985 | 1.299 | 0.717 | 0.993 | 1.348 | 1.017 | 2.147 | 11.079
COVID19 (Custom Term) | Noninfectious encephalopathy/delirium (SMQ) [broad] | 3499 | 3592.153 | 0.958 | 0.985 | 1.013 | 0.947 | 0.974 | 1.001 | 0.974 | 1.051 | 8.798
COVID19 (Custom Term) | Upper limb fracture | 3 | 3.495 | 0.402 | 0.985 | 1.777 | 0.416 | 0.849 | 1.579 | 0.858 | 2.708 | 1.277
COVID19 (Custom Term) | Ultrasound abdomen normal | 5 | 6.05 | 0.453 | 0.985 | 1.682 | 0.451 | 0.831 | 1.431 | 0.826 | 0.191 | 15.967
COVID19 (Custom Term) | Gastroenteritis viral | 3 | 4.666 | 0.487 | 0.985 | 1.626 | 0.356 | 0.728 | 1.355 | 0.643 | 0.403 | 1.964
COVID19 (Custom Term) | Biopsy kidney abnormal | 1 | 0.995 | 0.121 | 0.984 | 2.541 | 0.359 | 0.872 | 1.849 | 1.005 | 0.191 | 2.547
COVID19 (Custom Term) | Magnetic resonance imaging normal | 65 | 71.646 | 0.796 | 0.984 | 1.189 | 0.738 | 0.904 | 1.099 | 0.907 | 0.915 | 0.384
COVID19 (Custom Term) | Lip injury | 3 | 4.092 | 0.52 | 0.984 | 1.568 | 0.383 | 0.783 | 1.456 | 0.733 | 0.426 | 1.666
COVID19 (Custom Term) | Reaction to preservatives | 8 | 8.188 | 0.535 | 0.983 | 1.543 | 0.557 | 0.935 | 1.493 | 0.977 | 2.942 | 6.349
COVID19 (Custom Term) | Pollakiuria | 24 | 28.381 | 0.692 | 0.983 | 1.317 | 0.61 | 0.845 | 1.147 | 0.846 | 1.078 | 0.058
COVID19 (Custom Term) | Sleep talking | 2 | 2.539 | 0.284 | 0.983 | 2.023 | 0.372 | 0.817 | 1.606 | 0.788 | 1.986 | 0.162
COVID19 (Custom Term) | Herpes simplex test negative | 6 | 8.141 | 0.477 | 0.983 | 1.638 | 0.432 | 0.768 | 1.285 | 0.737 | 0.227 | 14.684
COVID19 (Custom Term) | Antineutrophil cytoplasmic antibody negative | 3 | 4.439 | 0.336 | 0.983 | 1.904 | 0.366 | 0.749 | 1.393 | 0.676 | 0.292 | 4.275
COVID19 (Custom Term) | Motion sickness | 10 | 9.057 | 0.545 | 0.982 | 1.523 | 0.639 | 1.029 | 1.586 | 1.104 | 1.986 | 3.225
COVID19 (Custom Term) | Urine leukocyte esterase positive | 9 | 8.44 | 0.578 | 0.982 | 1.473 | 0.608 | 0.998 | 1.565 | 1.066 | 5.585 | 18.574
COVID19 (Custom Term) | Activated partial thromboplastin time | 32 | 31.031 | 0.732 | 0.982 | 1.263 | 0.76 | 1.011 | 1.324 | 1.031 | 6.907 | 91.567
COVID19 (Custom Term) | Culture urine negative | 26 | 29.614 | 0.694 | 0.982 | 1.311 | 0.638 | 0.874 | 1.174 | 0.878 | 0.74 | 1.96
COVID19 (Custom Term) | Vitamin D deficiency | 2 | 2.691 | 0.235 | 0.982 | 2.147 | 0.363 | 0.797 | 1.567 | 0.743 | 0.31 | 2.283
COVID19 (Custom Term) | Stevens-Johnson syndrome | 3 | 3.976 | 0.44 | 0.982 | 1.697 | 0.389 | 0.795 | 1.478 | 0.755 | 0.488 | 1.043
COVID19 (Custom Term) | Arteriosclerosis | 9 | 9.436 | 0.546 | 0.981 | 1.519 | 0.562 | 0.922 | 1.445 | 0.954 | 9.929 | 31.389
COVID19 (Custom Term) | Neutrophil count decreased | 16 | 17.967 | 0.635 | 0.981 | 1.387 | 0.597 | 0.882 | 1.266 | 0.891 | 0.676 | 2.005
COVID19 (Custom Term) | Weight decreased | 40 | 47.599 | 0.746 | 0.981 | 1.242 | 0.65 | 0.84 | 1.072 | 0.84 | 0.505 | 18.035
COVID19 (Custom Term) | Renovascular disorders (SMQ) [narrow] | 2 | 3.491 | 0.284 | 0.981 | 2.017 | 0.32 | 0.706 | 1.39 | 0.573 | 1.655 | 0.041
COVID19 (Custom Term) | Differential white blood cell count | 53 | 52.641 | 0.781 | 0.98 | 1.197 | 0.796 | 0.996 | 1.234 | 1.007 | 1.766 | 14.256
COVID19 (Custom Term) | Computerised tomogram head | 153 | 156.246 | 0.858 | 0.98 | 1.108 | 0.854 | 0.976 | 1.111 | 0.979 | 4.162 | 256.943
COVID19 (Custom Term) | Vaccination site mass | 9 | 10.138 | 0.541 | 0.98 | 1.523 | 0.533 | 0.875 | 1.372 | 0.888 | 0.941 | 0
COVID19 (Custom Term) | Tooth disorder | 1 | 1.895 | 0.212 | 0.98 | 2.206 | 0.295 | 0.725 | 1.542 | 0.528 | 0.764 | 0.041
COVID19 (Custom Term) | Language disorder | 2 | 1.863 | 0.255 | 0.979 | 2.085 | 0.419 | 0.919 | 1.806 | 1.074 | 0.251 | 3.583
COVID19 (Custom Term) | Urine ketone body present | 6 | 5.909 | 0.549 | 0.979 | 1.509 | 0.534 | 0.949 | 1.587 | 1.015 | 0.784 | 0.148
COVID19 (Custom Term) | Lumbar puncture abnormal | 11 | 13.352 | 0.589 | 0.979 | 1.449 | 0.523 | 0.827 | 1.256 | 0.824 | 0.646 | 1.651
COVID19 (Custom Term) | CSF virus no organisms observed | 1 | 0.993 | 0.116 | 0.978 | 2.542 | 0.359 | 0.872 | 1.85 | 1.007 | 0.301 | 0.918
COVID19 (Custom Term) | Acute pancreatitis (SMQ) [narrow] | 28 | 28.862 | 0.709 | 0.978 | 1.283 | 0.705 | 0.956 | 1.272 | 0.97 | 3.757 | 38.938
COVID19 (Custom Term) | Incontinence | 14 | 14.557 | 0.648 | 0.978 | 1.364 | 0.62 | 0.937 | 1.372 | 0.962 | 1.463 | 1.373
COVID19 (Custom Term) | Neurological decompensation | 1 | 2.603 | 0.117 | 0.978 | 2.538 | 0.257 | 0.638 | 1.365 | 0.384 | 0.523 | 0.065
COVID19 (Custom Term) | Blood thyroid stimulating hormone decreased | 8 | 8.005 | 0.534 | 0.977 | 1.527 | 0.565 | 0.95 | 1.517 | 0.999 | 1.394 | 0.446
COVID19 (Custom Term) | Intervertebral disc protrusion | 9 | 9.979 | 0.536 | 0.977 | 1.525 | 0.539 | 0.885 | 1.388 | 0.902 | 1.625 | 1.314
COVID19 (Custom Term) | Skin hypertrophy | 2 | 2.441 | 0.225 | 0.977 | 2.16 | 0.378 | 0.83 | 1.632 | 0.819 | 0.567 | 0.255
COVID19 (Custom Term) | Type IV hypersensitivity reaction | 7 | 8.577 | 0.521 | 0.977 | 1.549 | 0.477 | 0.823 | 1.343 | 0.816 | 2.397 | 3.435
COVID19 (Custom Term) | Skin laceration | 20 | 25.239 | 0.667 | 0.977 | 1.336 | 0.56 | 0.798 | 1.11 | 0.792 | 0.879 | 0.197
COVID19 (Custom Term) | Tendon rupture | 2 | 3.132 | 0.338 | 0.977 | 1.883 | 0.338 | 0.744 | 1.464 | 0.639 | 0.509 | 0.46
COVID19 (Custom Term) | Culture throat negative | 1 | 1.052 | 0.441 | 0.976 | 1.682 | 0.354 | 0.861 | 1.826 | 0.951 | 0.134 | 4.613
COVID19 (Custom Term) | Inflammatory marker increased | 6 | 7.466 | 0.501 | 0.976 | 1.579 | 0.458 | 0.815 | 1.364 | 0.804 | 0.382 | 5.146
COVID19 (Custom Term) | Nerve conduction studies normal | 1 | 2.115 | 0.186 | 0.976 | 2.272 | 0.282 | 0.695 | 1.482 | 0.473 | 0.155 | 3.661
COVID19 (Custom Term) | Ocular infections (SMQ) [narrow] | 16 | 32.639 | 0.62 | 0.976 | 1.398 | 0.355 | 0.525 | 0.754 | 0.49 | 0.231 | 39.217
COVID19 (Custom Term) | Chromaturia | 25 | 25.896 | 0.695 | 0.975 | 1.293 | 0.69 | 0.95 | 1.282 | 0.965 | 1.486 | 3.013
COVID19 (Custom Term) | Neck pain | 491 | 509.878 | 0.904 | 0.975 | 1.048 | 0.893 | 0.962 | 1.035 | 0.963 | 1.514 | 74.573
COVID19 (Custom Term) | Blood test | 432 | 456.276 | 0.9 | 0.975 | 1.053 | 0.874 | 0.946 | 1.023 | 0.947 | 1.866 | 146.479
COVID19 (Custom Term) | Magnetic resonance cholangiopancreatography | 5 | 5.844 | 0.49 | 0.975 | 1.594 | 0.46 | 0.849 | 1.462 | 0.856 | 6.206 | 10.142
COVID19 (Custom Term) | Ultrasound abdomen abnormal | 11 | 13.065 | 0.561 | 0.975 | 1.48 | 0.532 | 0.841 | 1.278 | 0.842 | 0.292 | 17.61
COVID19 (Custom Term) | Influenza like illness | 290 | 416.408 | 0.883 | 0.975 | 1.071 | 0.633 | 0.698 | 0.767 | 0.696 | 0.518 | 124.918
COVID19 (Custom Term) | Injection site hypoaesthesia | 45 | 46.734 | 0.76 | 0.974 | 1.21 | 0.748 | 0.954 | 1.202 | 0.963 | 1.322 | 2.812
COVID19 (Custom Term) | Noninfectious meningitis (SMQ) [broad] | 2889 | 3004.93 | 0.944 | 0.974 | 1.004 | 0.932 | 0.961 | 0.991 | 0.961 | 1.032 | 2.775
COVID19 (Custom Term) | Depression and suicide/self-injury (SMQ) [broad] | 383 | 417.976 | 0.894 | 0.974 | 1.057 | 0.842 | 0.916 | 0.995 | 0.916 | 0.431 | 283.428
COVID19 (Custom Term) | Noninfectious encephalitis (SMQ) [narrow] | 22 | 28.649 | 0.669 | 0.974 | 1.326 | 0.553 | 0.776 | 1.065 | 0.768 | 0.311 | 31.864
COVID19 (Custom Term) | Foot deformity | 2 | 2.002 | 0.371 | 0.973 | 1.806 | 0.409 | 0.896 | 1.761 | 0.999 | 0.946 | 0.082
COVID19 (Custom Term) | Hypersensitivity (SMQ) [narrow] | 5192 | 5399.483 | 0.951 | 0.973 | 0.996 | 0.94 | 0.961 | 0.984 | 0.962 | 1.006 | 0.224
COVID19 (Custom Term) | Brain injury | 5 | 5.371 | 0.492 | 0.973 | 1.586 | 0.485 | 0.894 | 1.539 | 0.931 | 0.482 | 2.139
COVID19 (Custom Term) | Lens disorders (SMQ) [narrow] | 3 | 5.899 | 0.343 | 0.973 | 1.863 | 0.309 | 0.633 | 1.179 | 0.509 | 0.562 | 0.567
COVID19 (Custom Term) | Infectious mononucleosis | 2 | 2.428 | 0.245 | 0.972 | 2.09 | 0.379 | 0.832 | 1.636 | 0.824 | 0.211 | 4.949
COVID19 (Custom Term) | Respiratory symptom | 9 | 8.397 | 0.58 | 0.971 | 1.445 | 0.61 | 1.002 | 1.57 | 1.072 | 0.876 | 0.047
COVID19 (Custom Term) | Ammonia increased | 5 | 4.953 | 0.51 | 0.971 | 1.552 | 0.509 | 0.938 | 1.615 | 1.01 | 2.364 | 2.082
COVID19 (Custom Term) | Vital signs measurement | 10 | 9.915 | 0.557 | 0.971 | 1.477 | 0.599 | 0.963 | 1.485 | 1.009 | 11.032 | 38.144
COVID19 (Custom Term) | Photosensitivity reaction | 8 | 8.193 | 0.499 | 0.971 | 1.57 | 0.556 | 0.935 | 1.493 | 0.976 | 0.509 | 3.106
COVID19 (Custom Term) | Sleep disorder | 281 | 297.141 | 0.878 | 0.971 | 1.068 | 0.856 | 0.944 | 1.04 | 0.946 | 1.521 | 43.193
COVID19 (Custom Term) | Major depression | 1 | 1.37 | 0.201 | 0.971 | 2.213 | 0.33 | 0.804 | 1.707 | 0.73 | 0.827 | 0.089
COVID19 (Custom Term) | Small fibre neuropathy | 1 | 1.403 | 0.148 | 0.971 | 2.388 | 0.327 | 0.799 | 1.696 | 0.713 | 0.342 | 0.622
COVID19 (Custom Term) | Band neutrophil percentage | 3 | 2.964 | 0.397 | 0.97 | 1.748 | 0.45 | 0.917 | 1.707 | 1.012 | 1.418 | 0.046
COVID19 (Custom Term) | Hyporesponsive to stimuli | 12 | 12.707 | 0.587 | 0.97 | 1.432 | 0.592 | 0.921 | 1.38 | 0.944 | 0.432 | 8.021
COVID19 (Custom Term) | Cholecystectomy | 12 | 12.405 | 0.593 | 0.969 | 1.42 | 0.603 | 0.938 | 1.406 | 0.967 | 5.674 | 26.221
COVID19 (Custom Term) | Cerebral infarction | 20 | 22.492 | 0.662 | 0.969 | 1.325 | 0.619 | 0.882 | 1.227 | 0.889 | 4.053 | 30.323
COVID19 (Custom Term) | Hunger | 6 | 6.876 | 0.458 | 0.969 | 1.634 | 0.484 | 0.861 | 1.44 | 0.873 | 1.268 | 0.096
COVID19 (Custom Term) | Generalised convulsive seizures following immunisation (SMQ) [narrow] | 180 | 215.854 | 0.854 | 0.969 | 1.09 | 0.737 | 0.834 | 0.94 | 0.834 | 0.271 | 349.038
COVID19 (Custom Term) | Cardiolipin antibody negative | 2 | 2.568 | 0.231 | 0.969 | 2.12 | 0.37 | 0.813 | 1.598 | 0.779 | 0.662 | 0.069
COVID19 (Custom Term) | Premature labour | 8 | 10.054 | 0.494 | 0.969 | 1.574 | 0.48 | 0.807 | 1.289 | 0.796 | 1.847 | 1.894
COVID19 (Custom Term) | Cholelithiasis | 14 | 14.393 | 0.624 | 0.968 | 1.374 | 0.625 | 0.946 | 1.385 | 0.973 | 6.319 | 34.812
COVID19 (Custom Term) | Dermatitis allergic | 13 | 14.91 | 0.589 | 0.968 | 1.422 | 0.565 | 0.866 | 1.281 | 0.872 | 0.833 | 0.251
COVID19 (Custom Term) | Abdominal tenderness | 7 | 8.52 | 0.512 | 0.968 | 1.542 | 0.479 | 0.827 | 1.349 | 0.822 | 1.037 | 0.012
COVID19 (Custom Term) | Urobilinogen urine decreased | 1 | 1.456 | 0.259 | 0.968 | 2.043 | 0.324 | 0.79 | 1.677 | 0.687 | 0.414 | 0.298
COVID19 (Custom Term) | Testicular swelling | 2 | 0.844 | 0.294 | 0.967 | 1.956 | 0.517 | 1.135 | 2.246 | 2.369 | 0.863 | 0.022
COVID19 (Custom Term) | Computerised tomogram head abnormal | 56 | 56.558 | 0.77 | 0.967 | 1.183 | 0.788 | 0.981 | 1.209 | 0.99 | 3.682 | 77.727
COVID19 (Custom Term) | Lymphadenitis | 28 | 30.988 | 0.699 | 0.967 | 1.272 | 0.662 | 0.897 | 1.193 | 0.904 | 1.376 | 2.181
COVID19 (Custom Term) | Malignant lymphomas (SMQ) [narrow] | 3 | 3.819 | 0.368 | 0.967 | 1.796 | 0.398 | 0.811 | 1.51 | 0.786 | 0.368 | 2.51
COVID19 (Custom Term) | Blood immunoglobulin E | 2 | 1.991 | 0.307 | 0.966 | 1.922 | 0.41 | 0.898 | 1.764 | 1.005 | 0.662 | 0.069
COVID19 (Custom Term) | Mean cell volume decreased | 3 | 3.045 | 0.332 | 0.966 | 1.866 | 0.445 | 0.906 | 1.686 | 0.985 | 0.159 | 12.213
COVID19 (Custom Term) | Deafness | 44 | 55.549 | 0.745 | 0.966 | 1.212 | 0.622 | 0.795 | 1.004 | 0.792 | 1.281 | 2.141
COVID19 (Custom Term) | Leukopenia | 4 | 4.211 | 0.378 | 0.965 | 1.77 | 0.466 | 0.899 | 1.602 | 0.95 | 0.378 | 3.307
COVID19 (Custom Term) | Muscle spasms | 219 | 232.056 | 0.861 | 0.965 | 1.074 | 0.843 | 0.942 | 1.051 | 0.944 | 1.12 | 2.44
COVID19 (Custom Term) | Urine analysis normal | 68 | 72.425 | 0.789 | 0.965 | 1.156 | 0.766 | 0.934 | 1.131 | 0.939 | 0.786 | 3.465
COVID19 (Custom Term) | Lethargy | 264 | 292.996 | 0.871 | 0.965 | 1.064 | 0.813 | 0.9 | 0.995 | 0.901 | 0.873 | 4.428
COVID19 (Custom Term) | Syncope | 421 | 513.4 | 0.889 | 0.965 | 1.044 | 0.757 | 0.82 | 0.888 | 0.82 | 0.691 | 55.044
COVID19 (Custom Term) | Subcutaneous abscess | 1 | 1.582 | 0.349 | 0.965 | 1.83 | 0.315 | 0.77 | 1.636 | 0.632 | 0.236 | 1.658
COVID19 (Custom Term) | Antiphospholipid syndrome | 1 | 1.055 | 0.087 | 0.964 | 2.641 | 0.354 | 0.86 | 1.825 | 0.948 | 0.662 | 0.001
COVID19 (Custom Term) | Rash | 1609 | 1702.475 | 0.925 | 0.964 | 1.003 | 0.907 | 0.945 | 0.984 | 0.945 | 0.881 | 25.29
COVID19 (Custom Term) | Breast pain | 43 | 46.472 | 0.752 | 0.964 | 1.198 | 0.717 | 0.919 | 1.164 | 0.925 | 2.603 | 32.278
COVID19 (Custom Term) | Gastrointestinal ulceration (SMQ) [broad] | 10 | 12.986 | 0.55 | 0.964 | 1.473 | 0.488 | 0.785 | 1.21 | 0.77 | 0.591 | 2.264
COVID19 (Custom Term) | Gastrointestinal ulceration (SMQ) [narrow] | 10 | 12.986 | 0.55 | 0.964 | 1.473 | 0.488 | 0.785 | 1.21 | 0.77 | 0.591 | 2.264
COVID19 (Custom Term) | Pregnancy test positive | 8 | 11.344 | 0.493 | 0.964 | 1.563 | 0.439 | 0.738 | 1.178 | 0.705 | 0.559 | 2.19
COVID19 (Custom Term) | Computerised tomogram abdomen normal | 14 | 14.461 | 0.616 | 0.963 | 1.372 | 0.623 | 0.942 | 1.379 | 0.968 | 2.206 | 6.511
COVID19 (Custom Term) | Pancreatitis | 13 | 13.897 | 0.622 | 0.963 | 1.365 | 0.597 | 0.916 | 1.355 | 0.935 | 2.934 | 11.202
COVID19 (Custom Term) | Torticollis | 1 | 1.168 | 0.317 | 0.963 | 1.893 | 0.345 | 0.839 | 1.78 | 0.856 | 0.248 | 1.487
COVID19 (Custom Term) | Goitre | 3 | 4.106 | 0.322 | 0.963 | 1.883 | 0.383 | 0.781 | 1.453 | 0.731 | 1.295 | 0.007
COVID19 (Custom Term) | Lipids | 20 | 19.806 | 0.672 | 0.962 | 1.295 | 0.69 | 0.983 | 1.368 | 1.01 | 4.225 | 32.101
COVID19 (Custom Term) | Packed red blood cell transfusion | 9 | 9.092 | 0.545 | 0.962 | 1.475 | 0.577 | 0.947 | 1.485 | 0.99 | 1.986 | 2.822
COVID19 (Custom Term) | Arthritis (SMQ) [broad] | 2460 | 2574.903 | 0.93 | 0.962 | 0.994 | 0.924 | 0.955 | 0.987 | 0.955 | 1.451 | 318.323
COVID19 (Custom Term) | Muscle twitching | 70 | 74.221 | 0.786 | 0.962 | 1.153 | 0.771 | 0.938 | 1.133 | 0.943 | 0.905 | 0.549
COVID19 (Custom Term) | Visual impairment | 132 | 140.925 | 0.83 | 0.962 | 1.103 | 0.809 | 0.934 | 1.074 | 0.937 | 1.002 | 0.001
COVID19 (Custom Term) | Injection site mass | 151 | 162.282 | 0.838 | 0.962 | 1.093 | 0.812 | 0.928 | 1.058 | 0.93 | 0.812 | 5.907
COVID19 (Custom Term) | Dyskinesia | 57 | 62.074 | 0.766 | 0.962 | 1.177 | 0.736 | 0.914 | 1.125 | 0.918 | 0.443 | 37.811
COVID19 (Custom Term) | Influenza A virus test | 8 | 8.295 | 0.54 | 0.961 | 1.481 | 0.552 | 0.927 | 1.48 | 0.964 | 2.037 | 2.621
COVID19 (Custom Term) | Haematology test | 7 | 7.507 | 0.504 | 0.961 | 1.537 | 0.523 | 0.902 | 1.472 | 0.932 | 2.673 | 4.417
COVID19 (Custom Term) | Purpura | 12 | 15.68 | 0.59 | 0.961 | 1.407 | 0.501 | 0.779 | 1.168 | 0.765 | 0.43 | 8.099
COVID19 (Custom Term) | Thyroid dysfunction (SMQ) [broad] | 28 | 38.105 | 0.689 | 0.961 | 1.272 | 0.549 | 0.744 | 0.99 | 0.735 | 0.545 | 9.62
COVID19 (Custom Term) | Radioallergosorbent test | 0 | 0.098 | 0.21 | 0.961 | 2.156 |  |  |  |  |  | 
COVID19 (Custom Term) | Ehrlichia test | 0 | 0.099 | 0.217 | 0.961 | 2.139 |  |  |  |  |  | 
COVID19 (Custom Term) | Diaphragmalgia | 3 | 2.562 | 0.399 | 0.96 | 1.717 | 0.48 | 0.977 | 1.819 | 1.171 | 2.482 | 1.02
COVID19 (Custom Term) | Affective disorder | 1 | 0.987 | 0.263 | 0.96 | 2.012 | 0.359 | 0.874 | 1.853 | 1.013 | 0.301 | 0.918
COVID19 (Custom Term) | Dermatologic examination abnormal | 1 | 0.987 | 0.229 | 0.96 | 2.099 | 0.359 | 0.874 | 1.853 | 1.013 | 0.993 | 0.266
COVID19 (Custom Term) | Pancreatitis acute | 15 | 14.939 | 0.617 | 0.96 | 1.365 | 0.65 | 0.972 | 1.408 | 1.004 | 5.136 | 29.999
COVID19 (Custom Term) | Pregnancy | 17 | 17.435 | 0.633 | 0.96 | 1.342 | 0.65 | 0.952 | 1.354 | 0.975 | 14.066 | 79.54
COVID19 (Custom Term) | Respiratory syncytial virus test positive | 1 | 1.094 | 0.194 | 0.96 | 2.201 | 0.351 | 0.853 | 1.809 | 0.914 | 0.177 | 2.914
COVID19 (Custom Term) | Extrapyramidal disorder | 0 | 0.101 | 0.217 | 0.96 | 2.136 |  |  |  |  |  | 
COVID19 (Custom Term) | Chlamydia test negative | 1 | 1.111 | 0.277 | 0.959 | 1.975 | 0.349 | 0.85 | 1.803 | 0.9 | 0.331 | 0.693
COVID19 (Custom Term) | Dystonia (SMQ) [broad] | 886 | 952.713 | 0.907 | 0.959 | 1.013 | 0.879 | 0.93 | 0.982 | 0.93 | 0.991 | 0.06
COVID19 (Custom Term) | Hyperthyroidism (SMQ) [broad] | 22 | 28.073 | 0.656 | 0.959 | 1.309 | 0.563 | 0.79 | 1.085 | 0.784 | 0.492 | 10.483
COVID19 (Custom Term) | Opportunistic infections (SMQ) [broad] | 2046 | 2209.918 | 0.923 | 0.958 | 0.993 | 0.893 | 0.926 | 0.96 | 0.926 | 1.018 | 0.63
COVID19 (Custom Term) | Hyperglycaemia/new onset diabetes mellitus (SMQ) [broad] | 1161 | 1260.235 | 0.912 | 0.958 | 1.005 | 0.877 | 0.921 | 0.966 | 0.921 | 1.147 | 20.14
COVID19 (Custom Term) | Staphylococcus test positive | 4 | 5.018 | 0.515 | 0.958 | 1.511 | 0.422 | 0.815 | 1.452 | 0.797 | 0.397 | 2.911
COVID19 (Custom Term) | Vitamin B1 | 0 | 0.101 | 0.203 | 0.958 | 2.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lactic acid | 56 | 57.458 | 0.762 | 0.957 | 1.171 | 0.777 | 0.967 | 1.191 | 0.975 | 6.044 | 143.162
COVID19 (Custom Term) | Basophil count | 1 | 1.048 | 0.247 | 0.957 | 2.043 | 0.354 | 0.862 | 1.828 | 0.954 | 0.827 | 0.089
COVID19 (Custom Term) | Impaired driving ability | 48 | 49.62 | 0.751 | 0.957 | 1.184 | 0.757 | 0.959 | 1.2 | 0.967 | 1.485 | 6.159
COVID19 (Custom Term) | Generalised tonic-clonic seizure | 22 | 23.762 | 0.67 | 0.957 | 1.285 | 0.651 | 0.914 | 1.255 | 0.926 | 0.379 | 20.915
COVID19 (Custom Term) | Clostridium test positive | 2 | 2.549 | 0.333 | 0.957 | 1.843 | 0.372 | 0.816 | 1.603 | 0.785 | 0.794 | 0
COVID19 (Custom Term) | Madarosis | 1 | 1.72 | 0.161 | 0.957 | 2.3 | 0.306 | 0.749 | 1.593 | 0.581 | 0.432 | 0.243
COVID19 (Custom Term) | Urine analysis | 146 | 153.023 | 0.834 | 0.956 | 1.084 | 0.83 | 0.951 | 1.087 | 0.954 | 1.842 | 46.752
COVID19 (Custom Term) | Trismus | 10 | 10.638 | 0.545 | 0.956 | 1.461 | 0.568 | 0.915 | 1.41 | 0.94 | 1.013 | 0.016
COVID19 (Custom Term) | Skin discolouration | 78 | 86.298 | 0.792 | 0.956 | 1.132 | 0.748 | 0.901 | 1.078 | 0.904 | 0.687 | 10.153
COVID19 (Custom Term) | Hypersensitivity | 211 | 235.161 | 0.852 | 0.956 | 1.066 | 0.8 | 0.896 | 1.002 | 0.897 | 0.772 | 13.032
COVID19 (Custom Term) | Dysphemia | 6 | 6.95 | 0.448 | 0.956 | 1.617 | 0.481 | 0.855 | 1.43 | 0.863 | 0.669 | 0.609
COVID19 (Custom Term) | Increased appetite | 3 | 2.548 | 0.309 | 0.955 | 1.89 | 0.481 | 0.98 | 1.823 | 1.177 | 1.862 | 0.367
COVID19 (Custom Term) | Emotional disorder | 1 | 0.789 | 0.273 | 0.954 | 1.972 | 0.377 | 0.914 | 1.94 | 1.268 | 0.091 | 8.025
COVID19 (Custom Term) | Dermatitis exfoliative generalised | 3 | 2.547 | 0.361 | 0.954 | 1.777 | 0.481 | 0.98 | 1.823 | 1.178 | 3.723 | 2.44
COVID19 (Custom Term) | Eosinophilic pneumonia (SMQ) [narrow] | 10 | 12.23 | 0.544 | 0.954 | 1.458 | 0.511 | 0.823 | 1.268 | 0.818 | 1.379 | 0.585
COVID19 (Custom Term) | Bronchiectasis | 1 | 1.321 | 0.112 | 0.954 | 2.485 | 0.333 | 0.812 | 1.724 | 0.757 | 0.331 | 0.693
COVID19 (Custom Term) | Impetigo | 0 | 0.132 | 0.24 | 0.954 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Effusion | 0 | 0.105 | 0.187 | 0.954 | 2.206 |  |  |  |  |  | 
COVID19 (Custom Term) | Chapped lips | 6 | 5.955 | 0.499 | 0.953 | 1.527 | 0.531 | 0.944 | 1.579 | 1.008 | 1.027 | 0.024
COVID19 (Custom Term) | Glucose tolerance impaired | 1 | 1.05 | 0.157 | 0.953 | 2.304 | 0.354 | 0.861 | 1.827 | 0.952 | 0.764 | 0.041
COVID19 (Custom Term) | Mydriasis | 16 | 16.961 | 0.62 | 0.953 | 1.343 | 0.626 | 0.925 | 1.328 | 0.943 | 0.94 | 0.012
COVID19 (Custom Term) | Burning sensation | 275 | 293.969 | 0.862 | 0.953 | 1.049 | 0.846 | 0.934 | 1.03 | 0.935 | 1.487 | 37.947
COVID19 (Custom Term) | Injection site urticaria | 132 | 141.98 | 0.822 | 0.953 | 1.092 | 0.803 | 0.927 | 1.066 | 0.93 | 0.905 | 1.114
COVID19 (Custom Term) | Differential white blood cell count abnormal | 3 | 3.372 | 0.364 | 0.953 | 1.768 | 0.424 | 0.864 | 1.606 | 0.89 | 0.851 | 0
COVID19 (Custom Term) | Rheumatoid arthritis | 13 | 21.313 | 0.574 | 0.953 | 1.411 | 0.419 | 0.643 | 0.952 | 0.61 | 0.445 | 8.04
COVID19 (Custom Term) | Rash erythematous | 427 | 462.789 | 0.878 | 0.952 | 1.028 | 0.851 | 0.922 | 0.997 | 0.923 | 0.908 | 3.635
COVID19 (Custom Term) | Electroencephalogram | 35 | 39.411 | 0.715 | 0.952 | 1.217 | 0.672 | 0.884 | 1.145 | 0.888 | 0.596 | 8.637
COVID19 (Custom Term) | Crying | 30 | 36.019 | 0.696 | 0.952 | 1.24 | 0.621 | 0.833 | 1.1 | 0.833 | 0.077 | 334.568
COVID19 (Custom Term) | Testicular pain | 6 | 5.811 | 0.505 | 0.951 | 1.512 | 0.539 | 0.959 | 1.603 | 1.033 | 1.805 | 1.151
COVID19 (Custom Term) | Dermatitis | 14 | 14.135 | 0.609 | 0.95 | 1.352 | 0.634 | 0.96 | 1.405 | 0.99 | 0.672 | 1.783
COVID19 (Custom Term) | Musculoskeletal discomfort | 45 | 47.509 | 0.743 | 0.95 | 1.179 | 0.737 | 0.94 | 1.184 | 0.947 | 1.759 | 11.833
COVID19 (Custom Term) | Optic nerve disorders (SMQ) [broad] | 256 | 286.777 | 0.855 | 0.95 | 1.049 | 0.805 | 0.892 | 0.987 | 0.893 | 0.919 | 1.622
COVID19 (Custom Term) | Dermatitis bullous | 2 | 2.385 | 0.316 | 0.95 | 1.86 | 0.382 | 0.838 | 1.647 | 0.839 | 0.201 | 5.414
COVID19 (Custom Term) | Injection site nerve damage | 2 | 2.581 | 0.314 | 0.95 | 1.864 | 0.37 | 0.812 | 1.595 | 0.775 | 0.473 | 0.637
COVID19 (Custom Term) | Wound secretion | 2 | 2.023 | 0.32 | 0.949 | 1.848 | 0.407 | 0.893 | 1.754 | 0.988 | 0.523 | 0.405
COVID19 (Custom Term) | Extrapyramidal syndrome (SMQ) [broad] | 2209 | 2363.535 | 0.916 | 0.949 | 0.982 | 0.902 | 0.934 | 0.968 | 0.935 | 1.02 | 0.822
COVID19 (Custom Term) | Joint swelling | 92 | 99.712 | 0.797 | 0.949 | 1.111 | 0.775 | 0.92 | 1.085 | 0.923 | 0.959 | 0.112
COVID19 (Custom Term) | CSF white blood cell count increased | 3 | 3.725 | 0.327 | 0.949 | 1.833 | 0.403 | 0.822 | 1.529 | 0.805 | 0.173 | 10.767
COVID19 (Custom Term) | Hypothyroidism (SMQ) [broad] | 26 | 34.353 | 0.671 | 0.949 | 1.267 | 0.558 | 0.765 | 1.027 | 0.757 | 0.585 | 6.794
COVID19 (Custom Term) | Congenital, familial and genetic disorders (SMQ) [broad] | 15 | 20.755 | 0.6 | 0.949 | 1.365 | 0.495 | 0.74 | 1.072 | 0.723 | 0.253 | 31.456
COVID19 (Custom Term) | Congenital, familial and genetic disorders (SMQ) [narrow] | 15 | 20.755 | 0.6 | 0.949 | 1.365 | 0.495 | 0.74 | 1.072 | 0.723 | 0.253 | 31.456
COVID19 (Custom Term) | Muscle disorder | 6 | 8.445 | 0.473 | 0.949 | 1.558 | 0.421 | 0.749 | 1.253 | 0.71 | 0.578 | 1.332
COVID19 (Custom Term) | Culture stool | 5 | 5.171 | 0.425 | 0.948 | 1.64 | 0.496 | 0.915 | 1.575 | 0.967 | 0.856 | 0.013
COVID19 (Custom Term) | Cytomegalovirus test | 4 | 4.38 | 0.423 | 0.948 | 1.642 | 0.456 | 0.88 | 1.568 | 0.913 | 0.946 | 0.022
COVID19 (Custom Term) | Eating disorder | 10 | 10.978 | 0.591 | 0.948 | 1.373 | 0.555 | 0.893 | 1.377 | 0.911 | 0.675 | 1.145
COVID19 (Custom Term) | Blood test normal | 114 | 126.974 | 0.809 | 0.948 | 1.097 | 0.768 | 0.896 | 1.041 | 0.898 | 0.876 | 1.719
COVID19 (Custom Term) | Scar | 6 | 8.619 | 0.472 | 0.948 | 1.558 | 0.415 | 0.738 | 1.235 | 0.696 | 0.314 | 8.028
COVID19 (Custom Term) | Diabetes mellitus inadequate control | 4 | 3.937 | 0.427 | 0.947 | 1.633 | 0.483 | 0.932 | 1.661 | 1.016 | 4.965 | 5.784
COVID19 (Custom Term) | Ultrasound kidney | 3 | 2.971 | 0.446 | 0.947 | 1.6 | 0.45 | 0.916 | 1.705 | 1.01 | 1.489 | 0.082
COVID19 (Custom Term) | Scan with contrast abnormal | 25 | 24.897 | 0.673 | 0.947 | 1.259 | 0.714 | 0.983 | 1.327 | 1.004 | 4.355 | 42.395
COVID19 (Custom Term) | Fine motor skill dysfunction | 9 | 9.528 | 0.578 | 0.947 | 1.391 | 0.558 | 0.916 | 1.435 | 0.945 | 1.465 | 0.755
COVID19 (Custom Term) | Haemorrhages (SMQ) [broad] | 1005 | 1071.653 | 0.899 | 0.947 | 0.997 | 0.89 | 0.937 | 0.987 | 0.938 | 1.021 | 0.403
COVID19 (Custom Term) | Serology test | 2 | 2.222 | 0.248 | 0.947 | 2.015 | 0.393 | 0.862 | 1.694 | 0.9 | 0.261 | 3.317
COVID19 (Custom Term) | Neurological examination abnormal | 13 | 15.976 | 0.577 | 0.947 | 1.392 | 0.534 | 0.818 | 1.212 | 0.814 | 0.603 | 2.803
COVID19 (Custom Term) | Drug screen negative | 9 | 8.524 | 0.569 | 0.946 | 1.4 | 0.604 | 0.991 | 1.554 | 1.056 | 1.354 | 0.43
COVID19 (Custom Term) | Epstein-Barr virus antibody negative | 3 | 3.117 | 0.379 | 0.946 | 1.721 | 0.44 | 0.896 | 1.668 | 0.963 | 0.523 | 0.794
COVID19 (Custom Term) | Diplopia | 41 | 50.52 | 0.72 | 0.946 | 1.197 | 0.631 | 0.813 | 1.035 | 0.812 | 1.215 | 1.191
COVID19 (Custom Term) | Labyrinthitis | 2 | 3.32 | 0.296 | 0.946 | 1.895 | 0.329 | 0.724 | 1.424 | 0.602 | 0.484 | 0.576
COVID19 (Custom Term) | Red blood cell nucleated morphology | 9 | 7.406 | 0.552 | 0.945 | 1.423 | 0.665 | 1.092 | 1.712 | 1.215 | 7.447 | 24.793
COVID19 (Custom Term) | Depressed level of consciousness | 36 | 39.206 | 0.71 | 0.945 | 1.208 | 0.696 | 0.912 | 1.177 | 0.918 | 0.751 | 2.519
COVID19 (Custom Term) | Coma | 6 | 6.935 | 0.487 | 0.945 | 1.525 | 0.481 | 0.856 | 1.432 | 0.865 | 0.514 | 2.145
COVID19 (Custom Term) | Hepatic pain | 3 | 2.986 | 0.322 | 0.944 | 1.829 | 0.449 | 0.914 | 1.701 | 1.005 | 1.986 | 0.486
COVID19 (Custom Term) | Pharyngeal oedema | 6 | 6.041 | 0.53 | 0.944 | 1.456 | 0.526 | 0.936 | 1.565 | 0.993 | 0.1 | 47.447
COVID19 (Custom Term) | Platelet count | 22 | 22.815 | 0.665 | 0.944 | 1.263 | 0.675 | 0.947 | 1.3 | 0.964 | 2.299 | 11.985
COVID19 (Custom Term) | Gait disturbance | 237 | 257.663 | 0.846 | 0.944 | 1.046 | 0.825 | 0.919 | 1.02 | 0.92 | 0.914 | 1.69
COVID19 (Custom Term) | Muscle discomfort | 6 | 7.14 | 0.491 | 0.944 | 1.516 | 0.472 | 0.84 | 1.405 | 0.84 | 3.31 | 5.472
COVID19 (Custom Term) | Urine output increased | 1 | 1.044 | 0.293 | 0.943 | 1.891 | 0.355 | 0.863 | 1.829 | 0.958 | 0.903 | 0.162
COVID19 (Custom Term) | Needle issue | 12 | 14.044 | 0.563 | 0.943 | 1.401 | 0.547 | 0.851 | 1.276 | 0.854 | 0.745 | 0.733
COVID19 (Custom Term) | Debridement | 1 | 2.022 | 0.167 | 0.943 | 2.24 | 0.288 | 0.707 | 1.507 | 0.495 | 0.382 | 0.42
COVID19 (Custom Term) | Blood sodium | 4 | 4.005 | 0.445 | 0.942 | 1.588 | 0.479 | 0.923 | 1.646 | 0.999 | 2.206 | 1.209
COVID19 (Custom Term) | Agranulocytosis (SMQ) [broad] | 58 | 62.166 | 0.752 | 0.942 | 1.15 | 0.748 | 0.928 | 1.14 | 0.933 | 0.49 | 28.964
COVID19 (Custom Term) | Varicella virus test negative | 3 | 3.749 | 0.351 | 0.942 | 1.765 | 0.402 | 0.819 | 1.524 | 0.8 | 0.211 | 7.824
COVID19 (Custom Term) | Urine analysis abnormal | 25 | 26.722 | 0.667 | 0.941 | 1.253 | 0.671 | 0.924 | 1.248 | 0.936 | 2.002 | 9.538
COVID19 (Custom Term) | Parkinson-like events (SMQ) [broad] | 1640 | 1775.445 | 0.903 | 0.941 | 0.979 | 0.887 | 0.924 | 0.962 | 0.924 | 1.018 | 0.505
COVID19 (Custom Term) | Injection site pain | 2772 | 3004.631 | 0.912 | 0.941 | 0.97 | 0.894 | 0.922 | 0.952 | 0.923 | 0.986 | 0.565
COVID19 (Custom Term) | Irritability | 28 | 29.129 | 0.683 | 0.94 | 1.229 | 0.699 | 0.948 | 1.261 | 0.961 | 0.102 | 220.559
COVID19 (Custom Term) | Ocular motility disorders (SMQ) [broad] | 169 | 184.61 | 0.826 | 0.94 | 1.061 | 0.805 | 0.914 | 1.034 | 0.915 | 0.671 | 25.355
COVID19 (Custom Term) | Termination of pregnancy and risk of abortion (SMQ) [narrow] | 66 | 73.217 | 0.759 | 0.94 | 1.137 | 0.734 | 0.898 | 1.091 | 0.901 | 1.894 | 22.598
COVID19 (Custom Term) | Termination of pregnancy and risk of abortion (SMQ) [broad] | 66 | 73.217 | 0.759 | 0.94 | 1.137 | 0.734 | 0.898 | 1.091 | 0.901 | 1.894 | 22.598
COVID19 (Custom Term) | Severe cutaneous adverse reactions (SMQ) [narrow] | 42 | 47.947 | 0.725 | 0.94 | 1.179 | 0.679 | 0.873 | 1.109 | 0.876 | 0.613 | 9.269
COVID19 (Custom Term) | Face oedema | 10 | 9.691 | 0.55 | 0.939 | 1.413 | 0.609 | 0.98 | 1.51 | 1.032 | 0.856 | 0.101
COVID19 (Custom Term) | Viral test positive | 6 | 6.028 | 0.478 | 0.939 | 1.526 | 0.527 | 0.937 | 1.567 | 0.995 | 0.784 | 0.148
COVID19 (Custom Term) | Haemorrhages (SMQ) [narrow] | 823 | 896.871 | 0.886 | 0.939 | 0.993 | 0.866 | 0.917 | 0.971 | 0.918 | 0.897 | 9.013
COVID19 (Custom Term) | Haemorrhage terms (excl laboratory terms) (SMQ) [broad] | 822 | 895.826 | 0.886 | 0.939 | 0.993 | 0.866 | 0.917 | 0.971 | 0.918 | 0.898 | 8.818
COVID19 (Custom Term) | Haemorrhage terms (excl laboratory terms) (SMQ) [narrow] | 822 | 895.826 | 0.886 | 0.939 | 0.993 | 0.866 | 0.917 | 0.971 | 0.918 | 0.898 | 8.818
COVID19 (Custom Term) | Crepitations | 4 | 4.424 | 0.372 | 0.939 | 1.715 | 0.454 | 0.875 | 1.56 | 0.904 | 1.37 | 0.084
COVID19 (Custom Term) | Viral pharyngitis | 0 | 0.1 | 0.114 | 0.939 | 2.429 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluid intake reduced | 20 | 21.038 | 0.654 | 0.938 | 1.263 | 0.656 | 0.934 | 1.299 | 0.951 | 1.822 | 5.527
COVID19 (Custom Term) | Fall | 278 | 313.95 | 0.848 | 0.938 | 1.031 | 0.801 | 0.885 | 0.975 | 0.885 | 1.207 | 8.66
COVID19 (Custom Term) | Biopsy | 8 | 9.352 | 0.523 | 0.938 | 1.451 | 0.507 | 0.851 | 1.359 | 0.855 | 0.873 | 0.038
COVID19 (Custom Term) | Blood folate normal | 4 | 4.827 | 0.371 | 0.938 | 1.713 | 0.432 | 0.833 | 1.485 | 0.829 | 0.993 | 0.061
COVID19 (Custom Term) | Leukoencephalopathy | 0 | 0.105 | 0.12 | 0.938 | 2.401 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lymphocyte count | 0 | 0.099 | 0.111 | 0.938 | 2.44 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bicarbonate | 0 | 0.106 | 0.124 | 0.938 | 2.383 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin test negative | 1 | 1 | 0.237 | 0.937 | 2.015 | 0.358 | 0.871 | 1.847 | 1 | 0.216 | 2.008
COVID19 (Custom Term) | Computerised tomogram abdomen | 61 | 63.576 | 0.757 | 0.937 | 1.133 | 0.773 | 0.953 | 1.165 | 0.959 | 8.076 | 204.362
COVID19 (Custom Term) | Suture insertion | 9 | 9.442 | 0.568 | 0.937 | 1.382 | 0.561 | 0.922 | 1.445 | 0.953 | 1.396 | 0.546
COVID19 (Custom Term) | Urine ketone body absent | 5 | 5.567 | 0.447 | 0.937 | 1.571 | 0.474 | 0.875 | 1.507 | 0.898 | 0.752 | 0.168
COVID19 (Custom Term) | Torsade de pointes/QT prolongation (SMQ) [broad] | 969 | 1124.467 | 0.888 | 0.937 | 0.987 | 0.817 | 0.862 | 0.908 | 0.862 | 0.971 | 0.783
COVID19 (Custom Term) | Injection site movement impairment | 11 | 12.905 | 0.55 | 0.937 | 1.407 | 0.538 | 0.85 | 1.29 | 0.852 | 0.658 | 1.499
COVID19 (Custom Term) | Proteinuria (SMQ) [broad] | 20 | 25.925 | 0.636 | 0.937 | 1.286 | 0.547 | 0.78 | 1.084 | 0.771 | 0.704 | 2.028
COVID19 (Custom Term) | Demyelinating polyneuropathy | 3 | 5.905 | 0.308 | 0.937 | 1.844 | 0.308 | 0.632 | 1.178 | 0.508 | 0.621 | 0.321
COVID19 (Custom Term) | Neoplasm skin | 0 | 0.104 | 0.115 | 0.937 | 2.419 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.104 | 0.115 | 0.937 | 2.419 |  |  |  |  |  | 
COVID19 (Custom Term) | Epstein-Barr virus antibody positive | 6 | 6.62 | 0.473 | 0.936 | 1.526 | 0.496 | 0.883 | 1.476 | 0.906 | 0.993 | 0.039
COVID19 (Custom Term) | Respiratory rate decreased | 5 | 5.74 | 0.46 | 0.936 | 1.546 | 0.466 | 0.859 | 1.479 | 0.871 | 1.079 | 0.007
COVID19 (Custom Term) | Preterm premature rupture of membranes | 2 | 5.066 | 0.193 | 0.936 | 2.136 | 0.258 | 0.575 | 1.137 | 0.395 | 1.324 | 0.002
COVID19 (Custom Term) | Mutism | 0 | 0.1 | 0.107 | 0.936 | 2.453 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypophagia | 29 | 30.043 | 0.687 | 0.935 | 1.213 | 0.706 | 0.952 | 1.261 | 0.965 | 0.966 | 0.006
COVID19 (Custom Term) | Grip strength decreased | 39 | 42.565 | 0.712 | 0.935 | 1.183 | 0.702 | 0.91 | 1.165 | 0.916 | 1.132 | 0.419
COVID19 (Custom Term) | Immediate post-injection reaction | 381 | 423.692 | 0.858 | 0.935 | 1.014 | 0.826 | 0.899 | 0.977 | 0.899 | 0.942 | 1.18
COVID19 (Custom Term) | Folliculitis | 4 | 4.608 | 0.439 | 0.935 | 1.581 | 0.444 | 0.855 | 1.525 | 0.868 | 1.727 | 0.472
COVID19 (Custom Term) | Magnetic resonance imaging spinal | 23 | 27.69 | 0.651 | 0.935 | 1.261 | 0.596 | 0.832 | 1.135 | 0.831 | 1.455 | 2.432
COVID19 (Custom Term) | Necrosis | 1 | 2.038 | 0.184 | 0.935 | 2.16 | 0.287 | 0.705 | 1.503 | 0.491 | 0.292 | 0.996
COVID19 (Custom Term) | Psychomotor hyperactivity | 3 | 3.151 | 0.344 | 0.934 | 1.758 | 0.438 | 0.892 | 1.659 | 0.952 | 0.214 | 7.637
COVID19 (Custom Term) | Anuria | 2 | 3.047 | 0.225 | 0.934 | 2.038 | 0.343 | 0.754 | 1.483 | 0.656 | 1.103 | 0.065
COVID19 (Custom Term) | Blood phosphorus decreased | 5 | 4.528 | 0.451 | 0.933 | 1.557 | 0.535 | 0.987 | 1.699 | 1.104 | 1.909 | 1.074
COVID19 (Custom Term) | Blood potassium | 10 | 10.466 | 0.548 | 0.933 | 1.401 | 0.575 | 0.926 | 1.427 | 0.955 | 3.972 | 13.633
COVID19 (Custom Term) | Injection site scab | 8 | 9.41 | 0.495 | 0.933 | 1.483 | 0.504 | 0.847 | 1.353 | 0.85 | 0.537 | 2.572
COVID19 (Custom Term) | Electromyogram | 8 | 13.863 | 0.526 | 0.933 | 1.434 | 0.375 | 0.631 | 1.008 | 0.577 | 0.378 | 7.235
COVID19 (Custom Term) | Blood triglycerides increased | 4 | 3.595 | 0.408 | 0.932 | 1.628 | 0.506 | 0.976 | 1.74 | 1.113 | 1.168 | 0
COVID19 (Custom Term) | General physical condition abnormal | 6 | 6.007 | 0.451 | 0.932 | 1.552 | 0.528 | 0.939 | 1.571 | 0.999 | 2.206 | 2.243
COVID19 (Custom Term) | Injection site dryness | 2 | 2.101 | 0.355 | 0.932 | 1.731 | 0.402 | 0.88 | 1.73 | 0.952 | 0.602 | 0.17
COVID19 (Custom Term) | Skin reaction | 35 | 37.928 | 0.71 | 0.932 | 1.18 | 0.696 | 0.916 | 1.186 | 0.923 | 0.882 | 0.395
COVID19 (Custom Term) | CSF lymphocyte count increased | 2 | 2.222 | 0.249 | 0.932 | 1.967 | 0.393 | 0.862 | 1.694 | 0.9 | 0.432 | 0.897
COVID19 (Custom Term) | Deafness bilateral | 3 | 3.371 | 0.327 | 0.932 | 1.789 | 0.424 | 0.864 | 1.607 | 0.89 | 0.805 | 0.008
COVID19 (Custom Term) | Liver disorder | 2 | 2.409 | 0.224 | 0.932 | 2.032 | 0.38 | 0.835 | 1.641 | 0.83 | 0.423 | 0.966
COVID19 (Custom Term) | Culture throat | 2 | 2.127 | 0.345 | 0.931 | 1.749 | 0.4 | 0.876 | 1.722 | 0.94 | 0.284 | 2.793
COVID19 (Custom Term) | Ocular hyperaemia | 65 | 75.272 | 0.753 | 0.931 | 1.125 | 0.704 | 0.862 | 1.048 | 0.864 | 0.877 | 0.913
COVID19 (Custom Term) | Magnetic resonance imaging | 205 | 238.056 | 0.828 | 0.931 | 1.039 | 0.767 | 0.861 | 0.963 | 0.861 | 1.423 | 22.285
COVID19 (Custom Term) | Skin tightness | 30 | 34.383 | 0.683 | 0.93 | 1.209 | 0.648 | 0.869 | 1.147 | 0.873 | 1.034 | 0.006
COVID19 (Custom Term) | Convulsions (SMQ) [broad] | 240 | 276.584 | 0.834 | 0.93 | 1.031 | 0.78 | 0.867 | 0.963 | 0.868 | 0.314 | 356.584
COVID19 (Custom Term) | Blood calcium increased | 3 | 5.382 | 0.345 | 0.93 | 1.745 | 0.327 | 0.669 | 1.247 | 0.557 | 0.634 | 0.278
COVID19 (Custom Term) | Optic nerve disorders (SMQ) [narrow] | 10 | 18.485 | 0.523 | 0.93 | 1.432 | 0.366 | 0.59 | 0.909 | 0.541 | 0.279 | 17.388
COVID19 (Custom Term) | Biopsy lymph gland abnormal | 0 | 0.101 | 0.091 | 0.93 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Papilloedema | 1 | 1.161 | 0.286 | 0.929 | 1.869 | 0.345 | 0.841 | 1.783 | 0.861 | 0.168 | 3.192
COVID19 (Custom Term) | Skin texture abnormal | 2 | 2.082 | 0.299 | 0.928 | 1.841 | 0.403 | 0.883 | 1.736 | 0.961 | 1.655 | 0.041
COVID19 (Custom Term) | Positron emission tomogram abnormal | 1 | 1.68 | 0.149 | 0.928 | 2.254 | 0.308 | 0.755 | 1.605 | 0.595 | 0.342 | 0.622
COVID19 (Custom Term) | Viral load decreased | 0 | 0.092 | 0.069 | 0.928 | 2.626 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood prolactin increased | 0 | 0.102 | 0.086 | 0.928 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis viral test | 1 | 0.993 | 0.302 | 0.927 | 1.83 | 0.359 | 0.872 | 1.85 | 1.007 | 0.764 | 0.041
COVID19 (Custom Term) | Antibody test | 8 | 9.004 | 0.481 | 0.927 | 1.49 | 0.521 | 0.874 | 1.397 | 0.889 | 0.802 | 0.187
COVID19 (Custom Term) | Delirium | 31 | 35.922 | 0.685 | 0.927 | 1.2 | 0.644 | 0.861 | 1.131 | 0.863 | 1.759 | 7.933
COVID19 (Custom Term) | Auditory neuropathy spectrum disorder | 0 | 0.092 | 0.066 | 0.927 | 2.639 |  |  |  |  |  | 
COVID19 (Custom Term) | Penicillium test negative | 0 | 0.092 | 0.067 | 0.927 | 2.638 |  |  |  |  |  | 
COVID19 (Custom Term) | Philadelphia chromosome positive | 0 | 0.092 | 0.068 | 0.927 | 2.63 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendinopathies and ligament disorders (SMQ) [broad] | 5048 | 5469.949 | 0.905 | 0.926 | 0.948 | 0.902 | 0.923 | 0.944 | 0.923 | 1.286 | 325.865
COVID19 (Custom Term) | Wrong schedule | 0 | 0.092 | 0.066 | 0.926 | 2.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Shift to the right | 0 | 0.092 | 0.066 | 0.926 | 2.641 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell morphology | 0 | 0.092 | 0.066 | 0.926 | 2.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Salivary gland calculus | 0 | 0.092 | 0.064 | 0.926 | 2.65 |  |  |  |  |  | 
COVID19 (Custom Term) | Rasmussen encephalitis | 0 | 0.092 | 0.064 | 0.926 | 2.649 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye swelling | 149 | 165.572 | 0.807 | 0.925 | 1.05 | 0.785 | 0.899 | 1.025 | 0.9 | 1.468 | 18.967
COVID19 (Custom Term) | Glaucoma (SMQ) [narrow] | 10 | 12.951 | 0.525 | 0.925 | 1.418 | 0.489 | 0.787 | 1.213 | 0.772 | 0.694 | 0.963
COVID19 (Custom Term) | Anti-GAD antibody positive | 1 | 1.939 | 0.168 | 0.925 | 2.182 | 0.292 | 0.719 | 1.53 | 0.516 | 0.451 | 0.191
COVID19 (Custom Term) | Gianotti-Crosti syndrome | 0 | 0.2 | 0.21 | 0.925 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac murmur | 3 | 3.172 | 0.369 | 0.924 | 1.684 | 0.436 | 0.889 | 1.654 | 0.946 | 0.542 | 0.677
COVID19 (Custom Term) | Incision site rash | 0 | 0.092 | 0.061 | 0.924 | 2.665 |  |  |  |  |  | 
COVID19 (Custom Term) | Postmenopausal haemorrhage | 0 | 0.092 | 0.061 | 0.924 | 2.665 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood calcium abnormal | 0 | 0.092 | 0.061 | 0.924 | 2.667 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine phosphokinase MB increased | 5 | 6.105 | 0.384 | 0.923 | 1.651 | 0.448 | 0.827 | 1.423 | 0.819 | 0.814 | 0.053
COVID19 (Custom Term) | Arthritis bacterial | 2 | 2.783 | 0.34 | 0.923 | 1.737 | 0.358 | 0.786 | 1.544 | 0.719 | 0.484 | 0.576
COVID19 (Custom Term) | Myocarditis infectious | 0 | 0.092 | 0.06 | 0.923 | 2.672 |  |  |  |  |  | 
COVID19 (Custom Term) | Aldosterone urine | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Ewing's sarcoma | 0 | 0.092 | 0.059 | 0.923 | 2.675 |  |  |  |  |  | 
COVID19 (Custom Term) | Positive expiratory pressure therapy | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Victim of child abuse | 0 | 0.092 | 0.058 | 0.923 | 2.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood albumin abnormal | 0 | 0.092 | 0.058 | 0.923 | 2.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Left ventricular dilatation | 0 | 0.092 | 0.058 | 0.923 | 2.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Chromosomal deletion | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumoperitoneum | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound evisceration | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic enzyme decreased | 0 | 0.092 | 0.058 | 0.923 | 2.679 |  |  |  |  |  | 
COVID19 (Custom Term) | Serial transverse enteroplasty | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural intestinal perforation | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Lens extraction | 0 | 0.092 | 0.059 | 0.923 | 2.679 |  |  |  |  |  | 
COVID19 (Custom Term) | Small intestinal anastomosis | 0 | 0.092 | 0.059 | 0.923 | 2.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileocolectomy | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Human herpesvirus 6 encephalitis | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis mumps | 0 | 0.092 | 0.059 | 0.923 | 2.674 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile blister | 0 | 0.092 | 0.059 | 0.923 | 2.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Renin | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Poikilocytosis | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver transplant rejection | 0 | 0.092 | 0.058 | 0.923 | 2.682 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pyruvic acid normal | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Postoperative adhesion | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Femoral nerve palsy | 0 | 0.092 | 0.058 | 0.923 | 2.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Large intestinal polypectomy | 0 | 0.092 | 0.058 | 0.923 | 2.682 |  |  |  |  |  | 
COVID19 (Custom Term) | Fear of death | 2 | 2.089 | 0.262 | 0.922 | 1.911 | 0.402 | 0.882 | 1.734 | 0.957 | 1.805 | 0.089
COVID19 (Custom Term) | Positron emission tomogram normal | 1 | 1.064 | 0.151 | 0.922 | 2.23 | 0.353 | 0.859 | 1.821 | 0.94 | 0.331 | 0.693
COVID19 (Custom Term) | Burns third degree | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasminogen decreased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile ulceration | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Dissociative amnesia | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Bicuspid aortic valve | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymph node rupture | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Salmonella bacteraemia | 0 | 0.092 | 0.057 | 0.922 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbohydrate antigen 19-9 increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Visceral congestion | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Tenosynovitis stenosans | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VIII level decreased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant nipple neoplasm female | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal cancer stage IV | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Nipple disorder | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Electroglottography | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary tract disorder | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcoholic hangover | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroglobulin increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudocyst | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal neovascularisation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian cancer stage IV | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Cor pulmonale chronic | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis neonatal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Diastolic hypertension | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Colonic fistula | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreal cells | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cancer stage I | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Ischaemic limb pain | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine uric acid decreased | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter site infection | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine albumin/creatinine ratio increased | 0 | 0.092 | 0.058 | 0.922 | 2.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical device site joint pain | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic pain | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Leptospira test | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperarousal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | SUNCT syndrome | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve sheath haemorrhage | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Analgesic therapy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Diffuse cutaneous mastocytosis | 0 | 0.092 | 0.057 | 0.922 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal artery stenosis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging breast normal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastasis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | BRCA2 gene mutation assay | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Exploding head syndrome | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint adhesion | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle neoplasm | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Urticaria pressure | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte morphology | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphoblast count | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesenteric arterial occlusion | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Contraindication to medical treatment | 0 | 0.092 | 0.056 | 0.922 | 2.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Anastomotic ulcer | 0 | 0.092 | 0.056 | 0.922 | 2.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Blast cell proliferation | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural haemorrhage | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteoarthropathy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperparathyroidism primary | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Carnett's sign positive | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Small intestine operation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Epidural lipomatosis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pressure difference of extremities | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VII level increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal neoplasm | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Myalgia intercostal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail injury | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | 5'nucleotidase increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac contusion | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipase abnormal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural haematoma | 0 | 0.092 | 0.057 | 0.922 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune-mediated lung disease | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune blistering disease | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteosclerosis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body in ear | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site odour | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site irritation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Stomach lesion excision | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatic dysfunction | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Brachioradial pruritus | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Barbiturates negative | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Roseolovirus test | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood thromboplastin normal | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Paracentesis eye | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Telangiectasia congenital | 0 | 0.092 | 0.056 | 0.922 | 2.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Saliva analysis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Anisochromia | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Citrobacter infection | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Glutamate dehydrogenase increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Small intestine adenocarcinoma | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatitis viral | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Body mass index increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | BRCA1 gene mutation assay | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood loss anaemia | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal malrotation repair | 0 | 0.092 | 0.057 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Rinne tuning fork test abnormal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophil count abnormal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint surgery | 0 | 0.092 | 0.058 | 0.922 | 2.682 |  |  |  |  |  | 
COVID19 (Custom Term) | Pubic pain | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Vasomotor rhinitis | 0 | 0.092 | 0.058 | 0.922 | 2.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy eyelid | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic operation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Elephantiasis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster pharyngitis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Diffuse large B-cell lymphoma | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosal ulcer | 0 | 0.092 | 0.057 | 0.922 | 2.685 |  |  |  |  |  | 
COVID19 (Custom Term) | Long thoracic nerve palsy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Parathyroid tumour | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichen planopilaris | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal dystrophy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site haemorrhage | 0 | 0.092 | 0.057 | 0.922 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileocaecal resection | 0 | 0.092 | 0.057 | 0.922 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Colorectal cancer metastatic | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Food interaction | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Foot fracture | 0 | 0.163 | 0.155 | 0.922 | 2.215 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine phosphorus | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast ulceration | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Pigmentation lip | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood 1,25-dihydroxycholecalciferol increased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective mutism | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes oesophagitis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac septal defect | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrogastrogram | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular pseudohole | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye complication associated with device | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant splenic neoplasm | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Periorbital inflammation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular dystrophy congenital | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy mucosa normal | 0 | 0.092 | 0.057 | 0.922 | 2.686 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular cyst | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Amimia | 0 | 0.092 | 0.056 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Infusion site swelling | 0 | 0.092 | 0.057 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Plastic surgery to the face | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs positive haemolytic anaemia | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Ototoxicity | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal dilatation | 0 | 0.092 | 0.056 | 0.922 | 2.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral myelitis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Potassium hydroxide preparation negative | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Iliotibial band syndrome | 0 | 0.092 | 0.057 | 0.922 | 2.687 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental implantation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Echoencephalogram abnormal | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Maternal drugs affecting foetus | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cells stool | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular rupture | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual agnosia | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue thrust | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocution | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocytic lymphoma | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Stem cell therapy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Antemortem blood drug level | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial fibrosis | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Insurance issue | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Follicle centre lymphoma diffuse small cell lymphoma | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperkeratosis lenticularis perstans | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired diaphragmatic eventration | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperchromic anaemia | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Swollen tear duct | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Early satiety | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Incorrect disposal of product | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrolyte depletion | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural constipation | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Ulnar nerve palsy | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymph nodes scan abnormal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid boil | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyskinesia oesophageal | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Loose body in joint | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheostomy tube removal | 0 | 0.092 | 0.057 | 0.922 | 2.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrohepatorenal syndrome | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Meibomian gland dysfunction | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood triglycerides decreased | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial fluid crystal present | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Opticokinetic nystagmus tests | 0 | 0.092 | 0.057 | 0.922 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Cooling therapy | 0 | 0.092 | 0.056 | 0.922 | 2.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Inguinal hernia | 1 | 0.991 | 0.233 | 0.921 | 1.979 | 0.359 | 0.873 | 1.851 | 1.009 | 0.827 | 0.089
COVID19 (Custom Term) | Lipase increased | 11 | 11.431 | 0.559 | 0.921 | 1.355 | 0.59 | 0.933 | 1.417 | 0.962 | 5.201 | 21.557
COVID19 (Custom Term) | Prostate malignant tumours (SMQ) [narrow] | 1 | 1.179 | 0.275 | 0.921 | 1.875 | 0.344 | 0.837 | 1.776 | 0.848 | 0.993 | 0.266
COVID19 (Custom Term) | Lymphocytosis | 3 | 3.554 | 0.366 | 0.921 | 1.681 | 0.413 | 0.842 | 1.566 | 0.844 | 0.903 | 0.014
COVID19 (Custom Term) | Streptococcus test positive | 9 | 12.278 | 0.489 | 0.921 | 1.463 | 0.461 | 0.757 | 1.187 | 0.733 | 0.141 | 45.521
COVID19 (Custom Term) | T-lymphocyte count abnormal | 0 | 0.092 | 0.056 | 0.921 | 2.695 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain tumour operation | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Inborn error of lipid metabolism | 0 | 0.092 | 0.054 | 0.921 | 2.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia moraxella | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperoxia | 0 | 0.092 | 0.054 | 0.921 | 2.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pregnenolone increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasmin inhibitor | 0 | 0.092 | 0.054 | 0.921 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Leptin level increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenalectomy | 0 | 0.092 | 0.055 | 0.921 | 2.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy rectum normal | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Sigmoidoscopy abnormal | 0 | 0.092 | 0.054 | 0.921 | 2.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Parechovirus infection | 0 | 0.092 | 0.055 | 0.921 | 2.697 |  |  |  |  |  | 
COVID19 (Custom Term) | Dihydrotestosterone decreased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis echo viral | 0 | 0.092 | 0.056 | 0.921 | 2.695 |  |  |  |  |  | 
COVID19 (Custom Term) | Jaundice acholuric | 0 | 0.092 | 0.054 | 0.921 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | T-cell receptor gene rearrangement test | 0 | 0.092 | 0.055 | 0.921 | 2.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Mastoid effusion | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal transit time increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Hernial eventration | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site joint infection | 0 | 0.092 | 0.055 | 0.921 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombin-antithrombin III complex increased | 0 | 0.092 | 0.054 | 0.921 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Temperature perception test decreased | 0 | 0.092 | 0.056 | 0.921 | 2.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Exocrine pancreatic function test normal | 0 | 0.092 | 0.055 | 0.921 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Alveolar oxygen partial pressure decreased | 0 | 0.092 | 0.054 | 0.921 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal inflammation | 0 | 0.092 | 0.055 | 0.921 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperadrenalism | 0 | 0.092 | 0.055 | 0.921 | 2.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasite urine test negative | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic hypertrophy | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Melanaemia | 0 | 0.092 | 0.054 | 0.921 | 2.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchogram abnormal | 0 | 0.092 | 0.055 | 0.921 | 2.697 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephrocalcinosis | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Drain of cerebral subdural space | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Diverticulectomy | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphoblast count increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Capnogram abnormal | 0 | 0.092 | 0.056 | 0.921 | 2.694 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterococcal sepsis | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiotensin II increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | PCO2 abnormal | 0 | 0.092 | 0.055 | 0.921 | 2.697 |  |  |  |  |  | 
COVID19 (Custom Term) | Purpura neonatal | 0 | 0.092 | 0.056 | 0.921 | 2.695 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal fissure | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VIII level increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Lack of injection site rotation | 0 | 0.092 | 0.055 | 0.921 | 2.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin-like growth factor increased | 0 | 0.092 | 0.056 | 0.921 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Velo-cardio-facial syndrome | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Occupational therapy | 0 | 0.092 | 0.055 | 0.921 | 2.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Von Willebrand's factor multimers test | 0 | 0.092 | 0.055 | 0.921 | 2.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound contamination | 0 | 0.092 | 0.055 | 0.921 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyper IgD syndrome | 0 | 0.092 | 0.055 | 0.921 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Chest tube insertion | 3 | 3.089 | 0.39 | 0.92 | 1.632 | 0.442 | 0.9 | 1.675 | 0.971 | 2.482 | 1.02
COVID19 (Custom Term) | Antinuclear antibody positive | 6 | 8.642 | 0.445 | 0.92 | 1.534 | 0.414 | 0.737 | 1.233 | 0.694 | 0.368 | 5.639
COVID19 (Custom Term) | Splenectomy | 1 | 1.78 | 0.122 | 0.92 | 2.338 | 0.302 | 0.741 | 1.575 | 0.562 | 0.276 | 1.156
COVID19 (Custom Term) | Embolia cutis medicamentosa | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrospinal fluid reservoir placement | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaemia postoperative | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Peak expiratory flow rate abnormal | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF polymorphonuclear cell count decreased | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac output | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular detachment | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Vital dye staining cornea absent | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic hypothermia | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperinsulinism | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor IX level normal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Dwarfism | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Mentally late developer | 0 | 0.092 | 0.054 | 0.92 | 2.704 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchopulmonary disease | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary thrombocytosis | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Ecouvillonage | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobinaemia | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary alveolar haemorrhage | 0 | 0.092 | 0.053 | 0.92 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Stool heavy metal positive | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrosarcoma | 0 | 0.092 | 0.054 | 0.92 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Inhibiting antibodies positive | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Alloimmunisation | 0 | 0.092 | 0.054 | 0.92 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor XI level normal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Head circumference | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Inflammation scan | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Perthes disease | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Escharotomy | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenomegaly | 0 | 0.092 | 0.053 | 0.92 | 2.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitogen stimulation test abnormal | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration tracheal normal | 0 | 0.092 | 0.054 | 0.92 | 2.704 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood mercury normal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberous sclerosis complex | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Primary hyperaldosteronism | 0 | 0.092 | 0.054 | 0.92 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Large intestine infection | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast injury | 0 | 0.092 | 0.053 | 0.92 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal tube insertion | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Hydrogen breath test | 0 | 0.092 | 0.053 | 0.92 | 2.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor X level decreased | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine zinc | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory fatigue | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Precocious puberty | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral ventricle collapse | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Staphylococcal osteomyelitis | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine arsenic increased | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac index | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrotal erythema | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site dermatitis | 0 | 0.092 | 0.053 | 0.92 | 2.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardio-respiratory arrest neonatal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin A decreased | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet anisocytosis | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune-mediated dermatitis | 0 | 0.092 | 0.053 | 0.92 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Sickle cell disease | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood arsenic increased | 0 | 0.092 | 0.054 | 0.92 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site wound | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart sounds normal | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Phimosis | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvi-ureteric obstruction | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Porcelain gallbladder | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine aluminium increased | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Myocardial fibrosis | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-erythrocyte antibody negative | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypersplenism | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal polyp | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary adrenocortical insufficiency | 0 | 0.092 | 0.054 | 0.92 | 2.704 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular failure | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Intentional underdose | 0 | 0.092 | 0.054 | 0.92 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypotonia neonatal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast milk substitute intolerance | 0 | 0.092 | 0.053 | 0.92 | 2.712 |  |  |  |  |  | 
COVID19 (Custom Term) | Sitophobia | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Confluent and reticulate papillomatosis | 0 | 0.092 | 0.054 | 0.92 | 2.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal mass | 0 | 0.092 | 0.054 | 0.92 | 2.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Genetic counselling | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal clotting factor | 0 | 0.092 | 0.053 | 0.92 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperchromasia | 0 | 0.092 | 0.053 | 0.92 | 2.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal mucosal necrosis | 0 | 0.092 | 0.054 | 0.92 | 2.703 |  |  |  |  |  | 
COVID19 (Custom Term) | Vanillyl mandelic acid urine increased | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Childhood asthma | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Amino acid level abnormal | 0 | 0.092 | 0.053 | 0.92 | 2.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet count increased | 17 | 17.576 | 0.596 | 0.919 | 1.3 | 0.646 | 0.945 | 1.345 | 0.967 | 0.603 | 3.795
COVID19 (Custom Term) | Conjunctivitis | 11 | 12.538 | 0.534 | 0.919 | 1.389 | 0.55 | 0.869 | 1.32 | 0.877 | 0.381 | 10.044
COVID19 (Custom Term) | CSF red blood cell count positive | 6 | 8.261 | 0.422 | 0.919 | 1.571 | 0.427 | 0.761 | 1.272 | 0.726 | 0.37 | 5.556
COVID19 (Custom Term) | Chronic tic disorder | 0 | 0.092 | 0.052 | 0.919 | 2.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermabrasion | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal hydrocele | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Peritoneal tuberculosis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular graft complication | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bronchus normal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaplastic large-cell lymphoma | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF glucose abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Peak nasal inspiratory flow abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroglobulin absent | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Urobilinogen faeces normal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Post concussion syndrome | 0 | 0.092 | 0.051 | 0.919 | 2.722 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian prolapse | 0 | 0.092 | 0.053 | 0.919 | 2.712 |  |  |  |  |  | 
COVID19 (Custom Term) | Multiple system atrophy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral calcification | 0 | 0.092 | 0.053 | 0.919 | 2.712 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiospasm | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast engorgement | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain empyema | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal irritation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic vascular disorder | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant neoplasm progression | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal operation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Coxiella test positive | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site movement impairment | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Spermatic cord disorder | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system mass | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Elbow operation | 0 | 0.092 | 0.052 | 0.919 | 2.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal gland cancer metastatic | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood thromboplastin increased | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Inguinal hernia, obstructive | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile size reduced | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Investigation noncompliance | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Latent tuberculosis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic dysplasia | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital HIV infection | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue sarcoma | 0 | 0.092 | 0.052 | 0.919 | 2.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystitis haemorrhagic | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid bleeding | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Schistosomiasis | 0 | 0.092 | 0.051 | 0.919 | 2.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral artery occlusion | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin D abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair growth rate abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin C-peptide abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid haematoma | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint prosthesis user | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal light reflex test abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Genitourinary tract infection | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound decomposition | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood corticotrophin abnormal | 0 | 0.092 | 0.051 | 0.919 | 2.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Cellulitis of male external genital organ | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Neoplasm prostate | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Chest tube removal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site mass | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver scan | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid lung | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Residual urine volume increased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Progesterone abnormal | 0 | 0.092 | 0.051 | 0.919 | 2.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Caecum operation | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | CD8 lymphocytes abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic immune activation | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Intraductal proliferative breast lesion | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophils urine | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal dilation procedure | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Stoma site reaction | 0 | 0.092 | 0.052 | 0.919 | 2.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung induration | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrub typhus | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray therapy to joint | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal operation | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone abscess | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site swelling | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid factor decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Xanthogranuloma | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholelithotomy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Metanephrine urine | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem glioma | 0 | 0.092 | 0.051 | 0.919 | 2.722 |  |  |  |  |  | 
COVID19 (Custom Term) | Pinguecula | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial wall hypertrophy | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobin blood present | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Ergotherapy | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryptococcal cutaneous infection | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Complications of transplanted heart | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Alveolar oxygen partial pressure increased | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Musculoskeletal injury | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulval haemorrhage | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary immunodeficiency | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal herpes | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast neoplasm | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Right hemisphere deficit syndrome | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Iliac artery disease | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | End stage AIDS | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug physiologic incompatibility | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Dandy-Walker syndrome | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatobiliary sphincterotomy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging abdominal normal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenosine deaminase decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet adhesiveness | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal adhesion lysis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid gland abscess | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia cytomegaloviral | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Candida pneumonia | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Phytotherapy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypothenar hammer syndrome | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Lysozyme increased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival follicles | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site discharge | 0 | 0.092 | 0.052 | 0.919 | 2.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic cancer | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudocellulitis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Jaundice hepatocellular | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal anuria | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | B-cell lymphoma recurrent | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung carcinoma cell type unspecified recurrent | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Deltaretrovirus test positive | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood acid phosphatase | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal septum disorder | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Peak expiratory flow rate normal | 0 | 0.092 | 0.051 | 0.919 | 2.72 |  |  |  |  |  | 
COVID19 (Custom Term) | IVth nerve paresis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet morphology | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal odour | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute lung injury | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapy partial responder | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoiditis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site telangiectasia | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site haematoma | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Apolipoprotein A-I | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet-large cell ratio increased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune-mediated neuropathy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site movement impairment | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnesium deficiency | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine albumin/creatinine ratio | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophil/lymphocyte ratio increased | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesangioproliferative glomerulonephritis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Lower respiratory tract infection fungal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet function test | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta-N-acetyl-D-glucosaminidase | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric bypass | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear lobe infection | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal operation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site laceration | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign soft tissue neoplasm | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal oedema | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopic retrograde cholangiopancreatography abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic leukaemia | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngitis bacterial | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QRS complex shortened | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Norepinephrine | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperoxaluria | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalocele repair | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Tick-borne fever | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site infection | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroglobulin present | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Foot operation | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Septic embolus | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Androgen deficiency | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac ventricular disorder | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononuclear cell count | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Bleeding time abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Apolipoprotein B increased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet aggregation normal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Oculocephalogyric reflex absent | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid factor quantitative | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Postsplenectomy syndrome | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperchloraemia | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic aspiration | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint arthroplasty | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue neoplasm | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell scan | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin implant | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Colon cancer metastatic | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold exposure injury | 0 | 0.092 | 0.051 | 0.919 | 2.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Inborn error of metabolism | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspartate aminotransferase abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Obsessive-compulsive personality disorder | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Stoma site erythema | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrophage activation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug ineffective for unapproved indication | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophil morphology normal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Clot retraction | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Leucine aminopeptidase | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Sarcopenia | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Perichondritis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystatin C abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Paranasal sinus haemorrhage | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrotising ulcerative gingivostomatitis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Gardnerella test positive | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholangitis infective | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin discharge | 0 | 0.092 | 0.051 | 0.919 | 2.718 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrophages decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast reconstruction | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic abscess | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis haemorrhagic | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrectomy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaplastic lymphoma kinase gene mutation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Double ureter | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system necrosis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Bence Jones protein urine present | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginitis gardnerella | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Skeletal muscle enzymes | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular imaging | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic specific antigen decreased | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Excessive skin | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary neoplasm | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Purpura non-thrombocytopenic | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic nephropathy | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Fungal sepsis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Dopamine transporter scintigraphy abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Intravascular haemolysis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhesus antibodies positive | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature ejaculation | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous stenosis | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site cellulitis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiogram peripheral abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Alanine aminotransferase abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Cavernous sinus thrombosis | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasma viscosity abnormal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbon dioxide combining power decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin B12 absorption test | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Apolipoprotein B | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Stiff leg syndrome | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Ductal adenocarcinoma of pancreas | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood calcitonin increased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell hypochromic morphology present | 0 | 0.092 | 0.052 | 0.919 | 2.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia cryptococcal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone cancer metastatic | 0 | 0.092 | 0.052 | 0.919 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Trigeminal palsy | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic operation | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile haemangioma | 0 | 0.092 | 0.052 | 0.919 | 2.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Product sterility lacking | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Mini mental status examination normal | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Cell marker decreased | 0 | 0.092 | 0.052 | 0.919 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxicologic test | 5 | 4.959 | 0.468 | 0.918 | 1.491 | 0.508 | 0.937 | 1.614 | 1.008 | 1.712 | 0.683
COVID19 (Custom Term) | Device difficult to use | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestriol normal | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteogenesis imperfecta | 0 | 0.092 | 0.049 | 0.918 | 2.731 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal graft infection | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Product quality control issue | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Amblyopia strabismic | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Interferon gamma normal | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin-like growth factor decreased | 0 | 0.092 | 0.049 | 0.918 | 2.732 |  |  |  |  |  | 
COVID19 (Custom Term) | Human anaplasmosis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin B1 decreased | 0 | 0.092 | 0.051 | 0.918 | 2.723 |  |  |  |  |  | 
COVID19 (Custom Term) | Postoperative wound complication | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctivochalasis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | VIIth nerve injury | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratitis viral | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Middle ear disorder | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral vasculitis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Blepharochalasis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Infection reactivation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Corticobasal degeneration | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Natural killer cell activity normal | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Cancer pain | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Brow ptosis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleurisy viral | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye opacity | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival erosion | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroprosthesis implantation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Canthoplasty | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Product commingling | 0 | 0.092 | 0.051 | 0.918 | 2.723 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster meningomyelitis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticonvulsant drug level below therapeutic | 0 | 0.092 | 0.05 | 0.918 | 2.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Vth nerve injury | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cancer metastatic | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood growth hormone abnormal | 0 | 0.092 | 0.051 | 0.918 | 2.724 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood triglycerides abnormal | 0 | 0.092 | 0.05 | 0.918 | 2.724 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes sepsis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreoretinal traction syndrome | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuromuscular toxicity | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreous degeneration | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella keratitis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinoschisis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure keratitis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Sterile pyuria | 0 | 0.092 | 0.05 | 0.918 | 2.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Traumatic lumbar puncture | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue atrophy | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Ptosis repair | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital thrombocyte disorder | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal scan abnormal | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Weber tuning fork test abnormal | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Single component of a two-component product administered | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site reaction | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet aggregation abnormal | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Painful erection | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Leser-Trelat sign | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Normal pressure hydrocephalus | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic haematoma | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Pearly penile papules | 0 | 0.092 | 0.049 | 0.918 | 2.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary function challenge test | 0 | 0.092 | 0.05 | 0.918 | 2.726 |  |  |  |  |  | 
COVID19 (Custom Term) | Shunt malfunction | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve operation | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Satoyoshi syndrome | 0 | 0.092 | 0.049 | 0.918 | 2.732 |  |  |  |  |  | 
COVID19 (Custom Term) | Capillaritis | 0 | 0.092 | 0.05 | 0.918 | 2.724 |  |  |  |  |  | 
COVID19 (Custom Term) | Septic rash | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral keratouveitis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephrectomy | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Total complement activity increased | 0 | 0.092 | 0.049 | 0.918 | 2.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypergammaglobulinaemia benign monoclonal | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular pigmentation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute promyelocytic leukaemia | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Acoustic neuroma | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood growth hormone decreased | 0 | 0.092 | 0.049 | 0.918 | 2.732 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal cancer metastatic | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Cranial nerve infection | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Single functional kidney | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Instillation site vesicles | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitogen stimulation test | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to spine | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Amnestic disorder | 0 | 0.092 | 0.05 | 0.918 | 2.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin C-peptide normal | 0 | 0.092 | 0.049 | 0.918 | 2.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder operation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Glossopharyngeal nerve disorder | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4 lymphocytes abnormal | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Hernia pain | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract stoma complication | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Intracranial hypotension | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal operation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratitis interstitial | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Ophthalmic vein thrombosis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital syphilitic osteochondritis | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Reaction to colouring | 0 | 0.092 | 0.049 | 0.918 | 2.731 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 microglobulin | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Post-traumatic pain | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Larynx irritation | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Poverty of speech | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic ulcer | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaemia of pregnancy | 0 | 0.092 | 0.05 | 0.918 | 2.726 |  |  |  |  |  | 
COVID19 (Custom Term) | Basosquamous carcinoma | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratopathy | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Trabeculectomy | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhegmatogenous retinal detachment | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Orbital apex syndrome | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Inhibin B | 0 | 0.092 | 0.05 | 0.918 | 2.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreous opacities | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Transplantation complication | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Mineral deficiency | 0 | 0.092 | 0.051 | 0.918 | 2.724 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion late | 0 | 0.092 | 0.05 | 0.918 | 2.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Removal of foreign body from rectum | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Infected bite | 0 | 0.092 | 0.05 | 0.918 | 2.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophil count | 2 | 2.47 | 0.313 | 0.917 | 1.778 | 0.377 | 0.826 | 1.624 | 0.81 | 0.863 | 0.022
COVID19 (Custom Term) | Nerve root injury cervical | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell analysis abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperamylasaemia | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Intrinsic factor antibody | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic pustular folliculitis | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiogram peripheral normal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Needle fatigue | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Generalised onset non-motor seizure | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Testis cancer | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic elongation | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Smear buccal | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasma cell mastitis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Macroglossia | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaplastic astrocytoma | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal erosion | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Incorrect dosage administered | 0 | 0.092 | 0.048 | 0.917 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Forced vital capacity normal | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bladder normal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood product transfusion dependent | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerular vascular disorder | 0 | 0.092 | 0.049 | 0.917 | 2.732 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-HLA antibody test positive | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Alien limb syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix injury | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin C-peptide increased | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Enlarged cerebral perivascular spaces | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypotony of eye | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | AIDS related complication | 0 | 0.092 | 0.048 | 0.917 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Fulguration | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | CSWS syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcoholism | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Total lung capacity | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular pseudoaneurysm | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Radiotherapy to breast | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Laboratory test interference | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Tenotomy | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Lenticular opacities | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron metabolism disorder | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestrogen therapy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Buttock injury | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral ataxia | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute haemorrhagic conjunctivitis | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Right atrial enlargement | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant renal hypertension | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood prolactin decreased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood insulin normal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Enzyme activity normal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral spasm | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Atypical mycobacterium test positive | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhoids thrombosed | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal meningeal cyst | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy tonsil | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract discomfort | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophil hypersegmented morphology present | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Product contamination chemical | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Product administration interrupted | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Culture cervix | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Hostility | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan spleen | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal sympathetic nerve ablation | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Porphyrins urine | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular retrobulbar haemorrhage | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor VII deficiency | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail picking | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | ACTH stimulation test | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Trigeminal nerve paresis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic enzymes decreased | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosal roughening | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Astringent therapy | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Latent tetany | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Gallbladder rupture | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Accidental exposure to product by child | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Substance abuse | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Suspiciousness | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal hypertension | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudopapilloedema | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site erythema | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Superficial injury of eye | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrotal ulcer | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Gallbladder obstruction | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral toxoplasmosis | 0 | 0.092 | 0.048 | 0.917 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal sleep-related event | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunosuppressant drug level increased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypobarism | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Reactive attachment disorder of infancy or early childhood | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral injury | 0 | 0.092 | 0.048 | 0.917 | 2.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Fallopian tube disorder | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site pruritus | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Thoracic outlet syndrome | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Functional endoscopic sinus surgery | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes simplex meningitis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosa biopsy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cirrhosis alcoholic | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal artery embolism | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculous pleurisy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy foetal abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic granulomatous disease | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostate examination normal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral artery thrombosis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Multinucleate cell angiohistiocytoma | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic coma | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Incision site pain | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Parathyroid scan normal | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Coronavirus test | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | C1 esterase inhibitor test normal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine potassium increased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Post streptococcal glomerulonephritis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapy naive | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration bursa abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Post infection glomerulonephritis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperkinetic heart syndrome | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Jugular vein thrombosis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy lung normal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial catheterisation normal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesenteric cyst | 0 | 0.092 | 0.048 | 0.917 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Echinococciasis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy vagina abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuro-ophthalmological test | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Agglutination test | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Amputation stump pain | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal stroke | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostate cancer stage IV | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy large bowel abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal abscess | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac pharmacologic stress test | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Frontal lobe epilepsy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital hiatus hernia | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephrological examination | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Charles Bonnet syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy anus abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural headache | 0 | 0.092 | 0.048 | 0.917 | 2.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric perforation | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell agglutination present | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Follicular mucinosis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord operation | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram pacemaker spike | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Infective exacerbation of bronchiectasis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural dizziness | 0 | 0.092 | 0.048 | 0.917 | 2.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypopyon | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Embedded device | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychogenic respiratory distress | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pilonidal cyst | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Klebsiella sepsis | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendon calcification | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Change in sustained attention | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelosuppression | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Inspiratory capacity normal | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital ureterovesical junction anomaly | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cleft lip and palate | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal aneurysm | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral allergy syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF white blood cell count decreased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF neutrophil count positive | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy pharynx abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound uterus | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicitis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign neoplasm | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulse pressure increased | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Complications of transplanted lung | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy tongue | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicogenic vertigo | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Familial amyotrophic lateral sclerosis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Symphysiolysis | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti factor VIII antibody test | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site deformation | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal failure neonatal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericardial drainage test abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site hypoaesthesia | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Autotransfusion | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Dilatation ventricular | 0 | 0.092 | 0.048 | 0.917 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Pterygium | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Lateral medullary syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Ulnar tunnel syndrome | 0 | 0.092 | 0.049 | 0.917 | 2.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Short stature | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Paranasal sinus inflammation | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Peptostreptococcus test positive | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian cyst torsion | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthognathic surgery | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Aicardi's syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal suppression | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary cyst | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine operation | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumbosacral plexus lesion | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertrophic anal papilla | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Subcutaneous biopsy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy vocal cord abnormal | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour pain | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethritis noninfective | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Reflux nephropathy | 0 | 0.092 | 0.048 | 0.917 | 2.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal cancer | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical diathermy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Transplant | 0 | 0.092 | 0.049 | 0.917 | 2.732 |  |  |  |  |  | 
COVID19 (Custom Term) | Antisynthetase syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Left-handedness | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system stimulation | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Goodpasture's syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Anorectal swelling | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte adoptive therapy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicogenic headache | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Oxygen consumption decreased | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendon sheath incision | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Stasis dermatitis | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute zonal occult outer retinopathy | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Osmophobia | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Iodine uptake increased | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital tract inflammation | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine injury | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic discomfort | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic infection | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune complex level increased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Inspiratory capacity | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Proctoscopy | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Amplified musculoskeletal pain syndrome | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Provisional tic disorder | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutralising antibodies negative | 0 | 0.092 | 0.048 | 0.917 | 2.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcoholic liver disease | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniotic fluid volume increased | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Humidity intolerance | 0 | 0.092 | 0.049 | 0.917 | 2.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocochleogram | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic transformation stroke | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Hysterosalpingogram | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Compulsive lip biting | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine cannabinoids increased | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Germ cell neoplasm | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | B precursor type acute leukaemia | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Argon plasma coagulation | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Periorbital haematoma | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | JC polyomavirus test | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Bowen's disease | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy urethra normal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Urticaria contact | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Duodenogastric reflux | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyoderma | 0 | 0.092 | 0.048 | 0.917 | 2.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Meigs' syndrome | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood oestrogen abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumboperitoneal shunt | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial tracheitis | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Moyamoya disease | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Chest wall abscess | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Marburg's variant multiple sclerosis | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Carotid artery disease | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound bladder abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased gait velocity | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal lesion | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticonvulsant drug level abnormal | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Fistulogram | 0 | 0.092 | 0.049 | 0.917 | 2.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Leiomyosarcoma | 0 | 0.092 | 0.048 | 0.917 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid disorder | 7 | 6.534 | 0.52 | 0.916 | 1.403 | 0.573 | 0.989 | 1.614 | 1.071 | 3.861 | 8.54
COVID19 (Custom Term) | Streptococcal infection | 1 | 1.101 | 0.191 | 0.916 | 2.082 | 0.35 | 0.852 | 1.807 | 0.908 | 0.168 | 3.192
COVID19 (Custom Term) | Urinary incontinence | 29 | 36.173 | 0.675 | 0.916 | 1.188 | 0.597 | 0.805 | 1.067 | 0.802 | 0.654 | 4.621
COVID19 (Custom Term) | Cytomegalovirus test negative | 5 | 6.404 | 0.401 | 0.916 | 1.6 | 0.435 | 0.802 | 1.381 | 0.781 | 0.203 | 14.442
COVID19 (Custom Term) | Pemphigoid | 3 | 5.263 | 0.312 | 0.916 | 1.777 | 0.332 | 0.679 | 1.264 | 0.57 | 0.432 | 1.593
COVID19 (Custom Term) | Ovarian adenoma | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Sinobronchitis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Micrognathia | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Product contamination with body fluid | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine mass | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Ciliary body disorder | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutropenic sepsis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival cyst | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Macula thickness measurement | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | H2N2 influenza | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal stromal tumour | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis herpes | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via partner | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone debridement | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian granulosa cell tumour | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Listeria test positive | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast discharge infected | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Yersinia infection | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via body fluid | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Renin increased | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyloromyotomy | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal respiratory depression | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Antidiuretic hormone abnormality | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Thiopurine methyltransferase decreased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperandrogenism | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Detrusor sphincter dyssynergia | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cortisol abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve operation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis allergic | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal thickening | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Prosthesis user | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte morphology normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal malformation | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Coital bleeding | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Primitive reflex test | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Interferon alpha level decreased | 0 | 0.092 | 0.047 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular autonomic function test abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Sweat gland infection | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Pregnancy with contraceptive device | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic sinusitis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine aluminium | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic injury | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythroblast count normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-saccharomyces cerevisiae antibody | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature ageing | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal exploration | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Cellulitis streptococcal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Dislocation of vertebra | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Kleihauer-Betke test positive | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine abscess | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Forced expiratory volume increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract procedural complication | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem stroke | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Silent thyroiditis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | HTLV-1 test | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve root injury thoracic | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin B2 | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Base excess positive | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Acrophobia | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucocutaneous rash | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Guthrie test | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Dumping syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Convulsive threshold lowered | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous bruit | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipoprotein (a) abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan adrenal gland normal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy pharynx normal | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatitis mumps | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Maternal distress during labour | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Cutis laxa | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Periorbital disorder | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail discomfort | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningococcal carditis | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid hormones decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Residual urine volume | 0 | 0.092 | 0.047 | 0.916 | 2.747 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic mass | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Heparin-induced thrombocytopenia test positive | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Montreal cognitive assessment | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute graft versus host disease in skin | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Contact lens intolerance | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial irritation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lead abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Strongyloidiasis | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone decalcification | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasite tissue specimen test negative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian germ cell tumour | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Delayed puberty | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine sodium decreased | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukostasis syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Kidney small | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhesus antigen negative | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Suicide threat | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bronchus abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatochalasis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Adductor vocal cord weakness | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendon laxity | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Peroneal nerve injury | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal megacystis | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Expanded disability status scale | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Nodal osteoarthritis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF mononuclear cell count decreased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous ligation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Huntington's disease | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Superior mesenteric artery syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic ovarian cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Phenylalanine screen positive | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperlactacidaemia | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle hypoxia | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-neuronal antibody positive | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Temperature perception test abnormal | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor VIII inhibition | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Tissue discolouration | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Resting tremor | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypercreatinaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone lesion | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Physical breast examination | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Disability assessment scale score decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine potassium normal | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Patella fracture | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth socket haemorrhage | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratoconus | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal neoplasm | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Flavivirus test | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Choroid plexus papilloma | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac arrest neonatal | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrobiosis lipoidica diabeticorum | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Carcinogenicity | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver scan abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacille Calmette-Guerin scar reactivation | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Ballismus | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Low cardiac output syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophil function disorder | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord ischaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonic plague | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal papilloma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital neoplasm malignant female | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Milk-alkali syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Ischaemic contracture of the left ventricle | 0 | 0.092 | 0.047 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin S increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Snapping hip syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic exenteration | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermometry normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Mutagenic effect | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulocytes maturation arrest | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Fallopian tube cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononuclear cell count increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic valve disease | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Exercise electrocardiogram abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Artificial rupture of membranes | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract pain | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vision correction operation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculosis of central nervous system | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis chemical | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Histoplasmosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Duodenal polyp | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxin binding globulin increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Septic arthritis streptococcal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Patient dissatisfaction with device | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Deep brain stimulation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Ebola disease | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaesthetic complication | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Venolymphatic malformation | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Anoxia | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Bile output increased | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan bone marrow | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Precursor T-lymphoblastic lymphoma/leukaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Paroxysmal extreme pain disorder | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngotracheal oedema | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary casts present | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurotic disorder of childhood | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic retinopathy | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Air embolism | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Phospholipidosis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholangiogram | 0 | 0.092 | 0.047 | 0.916 | 2.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue neoplasm malignant stage unspecified | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour haemorrhage | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Noninfective myringitis | 0 | 0.092 | 0.047 | 0.916 | 2.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucocutaneous haemorrhage | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Collagen-vascular disease | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy placenta | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy lip abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-zinc transporter 8 antibody positive | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma recurrent | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral haemorrhage foetal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Accident at work | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy intestine normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor XIII deficiency | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Type IIa hyperlipidaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectocele | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertensive nephropathy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Female sex hormone level | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Forearm fracture | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial aspiration procedure | 0 | 0.092 | 0.046 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Mast cell degranulation present | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Decompression sickness | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram U wave present | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Dialysis efficacy test | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatostatin receptor scan abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Convalescent | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Aldolase | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis proliferative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Poisoning deliberate | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesenteric artery aneurysm | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Lasegue's test negative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Interferon alpha level | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic erosive gastritis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Small intestine polyp | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital cerebellar agenesis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Boredom | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Autophobia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine haematoma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Reye's syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Spondyloarthropathy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Hormone refractory breast cancer | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic allograft nephropathy | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac output decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Interferon gamma release assay positive | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vital capacity | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-thrombin antibody | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood 1,25-dihydroxycholecalciferol decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensory ganglionitis | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign ovarian tumour | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail pitting | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema nummular | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphatic obstruction | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary cerebellar degeneration | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal hypoplasia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerular filtration rate abnormal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Wernicke-Korsakoff syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema toxicum neonatorum | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatobiliary disease | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral congestion | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Large granular lymphocytosis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Electric shock | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain neoplasm malignant | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal neoplasm | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Trisomy 12 | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine osmolarity decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Reynold's syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystitis escherichia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemofiltration | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha-2 macroglobulin increased | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoosmolar state | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone formation increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy intestine | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute interstitial pneumonitis | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Gardnerella infection | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Nitrituria | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Genotype drug resistance test | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | JC virus CSF test positive | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoviral meningitis | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Syndactyly | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Stoma care | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | CD8 lymphocyte percentage decreased | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Lobular breast carcinoma in situ | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Naturopathy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulval cancer stage 0 | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Suicide of relative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthostatic heart rate response increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Laparoscopy abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Intervertebral disc displacement | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulinoma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal atrophy | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal mucosal atrophy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood thromboplastin abnormal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Analgesic drug level increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Radiation pneumonitis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Manifest refraction normal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Iris injury | 0 | 0.092 | 0.047 | 0.916 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix cautery | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine hypertonus | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital cytomegalovirus infection | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural hypotension | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Parathyroid hormone-related protein | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Methaemoglobinaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix operation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin ulcer haemorrhage | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal tubular injury | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E antibody positive | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Activated partial thromboplastin time ratio increased | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Metabolic surgery | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Large intestinal ulcer haemorrhage | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-IA2 antibody | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermoanaesthesia | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Tangentiality | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum serotonin decreased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory gas exchange disorder | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein albumin ratio abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Double hit lymphoma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Breathing-related sleep disorder | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour rupture | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Intra-uterine contraceptive device insertion | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthrolysis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | SeHCAT test | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Paraneoplastic neurological syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Portal shunt procedure | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Evacuation of retained products of conception | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitochondrial toxicity | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical observation normal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | HTLV test | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystic fibrosis related diabetes | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Suture related complication | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Retrograde ejaculation | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic pouch procedure | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine malposition | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular ischaemic syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatitis herpetiformis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Performance fear | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Female orgasmic disorder | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Teratoma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Injury to brachial plexus due to birth trauma | 0 | 0.092 | 0.046 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Dexamethasone suppression test | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholangiogram normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortogram abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Preictal state | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertebral artery hypoplasia | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Turbinectomy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Perseveration | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital teratoma | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical laser therapy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective abortion | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cell marker increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Acne varioliformis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Lip infection | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital laryngeal stridor | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site atrophy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Needle biopsy site unspecified normal | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body in respiratory tract | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Poor personal hygiene | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal infection | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood chromium decreased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Idiopathic partial epilepsy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Colour vision tests abnormal red-green | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Device infusion issue | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bile acid malabsorption | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis chronic | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral pain | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Ichthyosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | CHARGE syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium double contrast abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial ligation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary function challenge test normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvitis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyneuropathy in malignant disease | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Norepinephrine increased | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | HTLV-2 test | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Essential thrombocythaemia | 0 | 0.092 | 0.047 | 0.916 | 2.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Postictal psychosis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VIII level | 0 | 0.092 | 0.047 | 0.916 | 2.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-JC virus antibody index | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosal hypertrophy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Duodenal ulcer | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | ADAMTS13 inhibitor screen assay | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular stent insertion | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumefactive multiple sclerosis | 0 | 0.092 | 0.046 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Sucrose intolerance | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Non-consummation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipohypertrophy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood insulin decreased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder hydrodistension | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin urine normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain lobectomy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Neoplasm progression | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroborreliosis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-glycyl-tRNA synthetase antibody negative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal ultrasound normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-insulin antibody | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell vacuolisation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal wall cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal asphyxia | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Median nerve injury | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site thrombosis | 0 | 0.092 | 0.046 | 0.916 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Compulsions | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicitis human papilloma virus | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter culture positive | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Blindness congenital | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Automatism epileptic | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal metaplasia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychological trauma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant respiratory tract neoplasm | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Traction | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | BK polyomavirus test negative | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Sepsis syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine chloride increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrooesophageal sphincter insufficiency | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal pap smear abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Surfactant protein increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Animal scratch | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Altered pitch perception | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Myxoedema | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Family stress | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Sternal injury | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid stimulating immunoglobulin increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Trousseau's sign | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphadenitis viral | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Bush-Francis catatonia rating scale | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital renal disorder | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericardial operation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Deafness congenital | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Antipsychotic drug level decreased | 0 | 0.092 | 0.047 | 0.916 | 2.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Retention cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal intestinal perforation | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Impaired fasting glucose | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal transit time | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Relapsing multiple sclerosis | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Megakaryocytes abnormal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune-mediated encephalitis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Adnexa uteri cyst | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Deformity of orbit | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | African trypanosomiasis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Exchange blood transfusion | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Janus kinase 2 mutation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoreactive trypsinogen increased | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Oropharyngeal scar | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Non-24-hour sleep-wake disorder | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis cytomegalovirus | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Progesterone increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophil cationic protein increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Acanthosis nigricans | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine calcium/creatinine ratio | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural vomiting | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet dysfunction | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenergic syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic infection | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Brief psychotic disorder with marked stressors | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal ulcer | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Device alarm issue | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure to contaminated air | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Vena cava thrombosis | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Obstructive defaecation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | International normalised ratio fluctuation | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacillus infection | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anamnestic reaction | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Reflexology | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood viscosity increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermogram abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Opticokinetic nystagmus tests normal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal hypomotility | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine polyp | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Parkinsonian gait | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood chloride abnormal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site pallor | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Recall phenomenon | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair injury | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyomavirus-associated nephropathy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial fluid cell count | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical device implantation | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital bladder anomaly | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic discs blurred | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Intrauterine infection | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Murphy's sign test | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | VIIIth nerve lesion | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Paranasal sinus mucosal hypertrophy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell hyperchromic morphology present | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha tumour necrosis factor | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal uterine bleeding | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Antral follicle count | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniotic fluid volume | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Long QT syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipectomy | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaphylactoid syndrome of pregnancy | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Alveolar proteinosis | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis staphylococcal | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein amniotic fluid normal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired Von Willebrand's disease | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Oligodendroglioma | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Hereditary disorder | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Ectopic kidney | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Gradenigo's syndrome | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperchylomicronaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Female genital tract fistula | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular access complication | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Pathological doubt | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Verbigeration | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyogenic granuloma | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Truncus coeliacus thrombosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Single photon emission computerised tomogram | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell analysis abnormal | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Product selection error | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Mediastinal mass | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulomatous lymphadenitis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone deformity | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobinaemia | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Free thyroxine index increased | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypothyroidic goitre | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site abscess | 0 | 0.092 | 0.047 | 0.916 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Periphlebitis | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF monocyte count increased | 0 | 0.1 | 0.058 | 0.916 | 2.657 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective IgG subclass deficiency | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Ruptured ectopic pregnancy | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrobiosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic adenoma | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gitelman's syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound dehiscence | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Von Willebrand's disease | 0 | 0.092 | 0.046 | 0.916 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal necrosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve destruction | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Irlen syndrome | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Oedematous kidney | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric pH increased | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Anterior chamber fibrin | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E antigen negative | 0 | 0.092 | 0.046 | 0.916 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiopathic neuropathy | 0 | 0.092 | 0.046 | 0.916 | 2.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophagogastric fundoplasty | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Umbilical cord prolapse | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema impetiginous | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Counterfeit product administered | 0 | 0.092 | 0.047 | 0.916 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Colour blindness acquired | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Exertional headache | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site pallor | 0 | 0.092 | 0.047 | 0.916 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy large bowel | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Caffeine allergy | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Superior vena cava stenosis | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Retirement | 0 | 0.092 | 0.047 | 0.916 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthritis enteropathic | 0 | 0.092 | 0.047 | 0.916 | 2.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Clumsiness | 4 | 3.429 | 0.381 | 0.915 | 1.635 | 0.518 | 0.999 | 1.781 | 1.166 | 0.673 | 0.305
COVID19 (Custom Term) | Poor peripheral circulation | 5 | 4.479 | 0.417 | 0.915 | 1.569 | 0.538 | 0.993 | 1.71 | 1.116 | 1.342 | 0.124
COVID19 (Custom Term) | Retinal artery occlusion | 3 | 3.14 | 0.353 | 0.915 | 1.688 | 0.438 | 0.893 | 1.662 | 0.955 | 2.708 | 1.277
COVID19 (Custom Term) | Dyskinesia (SMQ) [broad] | 185 | 203.426 | 0.808 | 0.915 | 1.028 | 0.804 | 0.908 | 1.022 | 0.909 | 0.638 | 35.758
COVID19 (Custom Term) | Discomfort | 196 | 216.627 | 0.812 | 0.915 | 1.023 | 0.803 | 0.904 | 1.014 | 0.905 | 1.02 | 0.051
COVID19 (Custom Term) | Muscle strain | 13 | 14.962 | 0.586 | 0.915 | 1.304 | 0.563 | 0.863 | 1.278 | 0.869 | 1.655 | 2.303
COVID19 (Custom Term) | Deafness unilateral | 43 | 50.516 | 0.706 | 0.915 | 1.146 | 0.663 | 0.85 | 1.077 | 0.851 | 1.786 | 11.904
COVID19 (Custom Term) | Acute graft versus host disease in intestine | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Cows milk free diet | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Shunt occlusion | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve infection | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Implant site infection | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug-disease interaction | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac septal defect residual shunt | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood acid phosphatase decreased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac ventriculogram normal | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | CDKL5 deficiency disorder | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Foot and mouth disease | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial vulvovaginitis | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Yersinia test | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensory level normal | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Inferior vena cava stenosis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenine phosphoribosyl transferase deficiency | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal diameter increased | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Urogram abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Graft versus host disease in skin | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Right aortic arch | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Noonan syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal ischaemia | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal drusen | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Group B streptococcus neonatal sepsis | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug resistance | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Paracentesis ear | 0 | 0.092 | 0.046 | 0.915 | 2.752 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary artery atresia | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy pericardium abnormal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous pressure jugular increased | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Elective surgery | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical incompetence | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear infection fungal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytomegalovirus hepatitis | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin C increased | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericarditis tuberculous | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Myeloblast percentage | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Hooded prepuce | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Transmission of an infectious agent via transplant | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Right ventricular enlargement | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal dysplasia | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Anomaly of external ear congenital | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood galactose | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatoglyphic anomaly | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic aneurysm repair | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Adactyly | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal gastrointestinal disorder | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal cancer | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Omenn syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukoplakia oral | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Dilated pores | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelocyte percentage decreased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lactate abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Sexual transmission of infection | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue atrophy | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart transplant | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Duodenal ulcer perforation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermoid cyst | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesenteric vascular insufficiency | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic therapy | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Thymus hypoplasia | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary valve stenosis congenital | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF measles antibody positive | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired syringomyelia | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy tendon abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniotic fluid index | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Ilium fracture | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital pulmonary valve disorder | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Congestive hepatopathy | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | CD25 antigen positive | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Infective exacerbation of chronic obstructive airways disease | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Umbilical cord around neck | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Chordee | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder catheter temporary | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin K deficiency | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular encephalopathy | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal valve collapse | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver dialysis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Prolapse | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticonvulsant drug level above therapeutic | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha-1 anti-trypsin increased | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Chromosome banding normal | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Punctate basophilia | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor C2 | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Urea renal clearance | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Karyotype analysis abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood beta-D-glucan increased | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Personality disorder of childhood | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Accidental exposure to product packaging | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Nodular fasciitis | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | American trypanosomiasis | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Metaphyseal dysplasia | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Lice infestation | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipids abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | IgM nephropathy | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | External hydrocephalus | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Compulsive handwashing | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Micropenis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to central nervous system | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Medial tibial stress syndrome | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Urogenital disorder | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Placental insufficiency | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Large cell lung cancer | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Perinatal brain damage | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyponatriuria | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic cancer metastatic | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia measles | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac malposition | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to the mediastinum | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical spinal cord paralysis | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic cyst | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Microencephaly | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Transcranial magnetic stimulation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal stoma output increased | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteric dilatation | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Postural tremor | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine calcium | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteric obstruction | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Tensilon test normal | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Seroconversion test positive | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Iatrogenic infection | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital genital malformation | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Product substitution error | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Ependymitis | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cellulitis | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging hepatobiliary abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray with contrast lower gastrointestinal tract normal | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Stenotrophomonas sepsis | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium swallow abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Acid-base balance disorder mixed | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal transit time abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Product closure removal difficult | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Marcus Gunn syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Peritoneal mesothelial hyperplasia | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrovascular arteriovenous malformation | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Microangiopathy | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Iodine uptake abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometrial cancer | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Lenticulostriatal vasculopathy | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug withdrawal convulsions | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Brown-Sequard syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell elliptocytes present | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal congestion | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Hairy cell leukaemia | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Twin reversed arterial perfusion sequence malformation | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual brightness | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Prophylaxis against HIV infection | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral discharge | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Oculomotor study normal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperglobulinaemia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema vaccinatum | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Thoracotomy | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhesus antigen | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryopyrin associated periodic syndrome | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein amniotic fluid | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Stomatococcal infection | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal calprotectin decreased | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Acid base balance | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Iris neovascularisation | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Chylothorax | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood thrombin | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine phosphokinase MM decreased | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypofibrinogenaemia | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal calprotectin abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Exomphalos | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperglycinaemia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial rupture | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Speech rehabilitation | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasma cells increased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Infusion site haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Flour sensitivity | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine mercury abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteric stenosis | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Paradoxical drug reaction | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to meninges | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Manipulation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Clumsy child syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site nerve damage | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail matrix biopsy | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine repair | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroglobulin decreased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine inversion | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Porphyrins urine increased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Moraxella test positive | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune endocrine disorder | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin distribution width increased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventricular flutter | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombosis in device | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasmodium ovale infection | 0 | 0.092 | 0.046 | 0.915 | 2.752 |  |  |  |  |  | 
COVID19 (Custom Term) | Gamma-glutamyltransferase abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal therapeutic procedure | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival disorder | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Barotitis media | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental gangrene | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Tandem gait test normal | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Nicotinamide | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Neovascularisation | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Engraft failure | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Induced abortion failed | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C core antibody positive | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine albumin/creatinine ratio normal | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Peristalsis visible | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystic lymphangioma | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | End-tidal CO2 | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Reactive gastropathy | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung neoplasm surgery | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Constricted affect | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal shock | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Progressive relapsing multiple sclerosis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal hypertrophy | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrin degradation products normal | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine phosphorus increased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid calcification | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Thymol turbidity test | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary artery stenosis congenital | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbuncle | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter site phlebitis | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Vessel puncture site haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Micturition frequency decreased | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal malposition | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product effect delayed | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C core antibody negative | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumbar hernia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous occlusion | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteral stent insertion | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aluminium abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Artificial crown procedure | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Intentional device misuse | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenoleukodystrophy | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pressure ambulatory | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural stroke | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Enanthema | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniotic band syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal pain | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Glycocholic acid increased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Bleeding time normal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity unsaturated decreased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Stomatococcus test positive | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroma | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Glossopharyngeal nerve paralysis | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Salmonella sepsis | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Manual lymphatic drainage | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Perineurial cyst | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Choluria | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Large intestinal ulcer | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalopathy neonatal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspergillus test positive | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Intracardiac mass | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Phenylalanine screen | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyeball avulsion | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Perineal erythema | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Scleral oedema | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Epileptic aura | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelocyte percentage increased | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital pneumonia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalocele | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs indirect test negative | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Burn oesophageal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pressure orthostatic decreased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve decompression | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal biophysical profile score normal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Leiomyoma | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Apgar score | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Graft complication | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine leiomyoma embolisation | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Lasegue's test | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral rhinitis | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Helminthic infection | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis california | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Trendelenburg position | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Stomach scan | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Argininosuccinate lyase deficiency | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine dehiscence | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid vasculitis | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor I deficiency | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Camptodactyly acquired | 0 | 0.092 | 0.046 | 0.915 | 2.752 |  |  |  |  |  | 
COVID19 (Custom Term) | Oligoarthritis | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Cisternogram | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Tyrosinaemia | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Eustachian tube disorder | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Peritoneal dialysis complication | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Hydromyelia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Product dosage form confusion | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary tract infection fungal | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue pigmentation | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin cyst excision | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Enzyme activity assay | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood magnesium abnormal | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Primary progressive multiple sclerosis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Myocarditis bacterial | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Bile culture positive | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Palisaded neutrophilic granulomatous dermatitis | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital thrombocytopenia | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood alkaline phosphatase abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Barrel chest | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Transillumination | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Urogenital infection fungal | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Young's syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Atelectasis neonatal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye muscle operation | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis post transfusion | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Placenta praevia haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Disorder of orbit | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Arrhythmia neonatal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreas infection | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Extraskeletal ossification | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine dilation and evacuation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic mycosis | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral vasoconstriction | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Parietal cell antibody positive | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosal scab | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail ridging | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid ptosis congenital | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythropenia | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Diaphragm muscle weakness | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Velopharyngeal incompetence | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B antigen | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Parotid abscess | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Ankyloglossia acquired | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal wall disorder | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic disorder | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site bruise | 0 | 0.159 | 0.131 | 0.915 | 2.284 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis D RNA negative | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute lymphocytic leukaemia recurrent | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute graft versus host disease in liver | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Alice in wonderland syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Missed labour | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Floating patella | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Carcinoid tumour | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | ABO incompatibility | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Axial spondyloarthritis | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor IX level increased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal hypotension | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal movement disorder | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | End-tidal CO2 increased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Kinematic imbalances due to suboccipital strain | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Kidney malrotation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein amniotic fluid increased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Promyelocyte count decreased | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Persecutory delusion | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital thymus absence | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute oesophageal mucosal lesion | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Septum pellucidum agenesis | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural fistula | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Conductive deafness | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovectomy | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal function test normal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Oropharyngeal surgery | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal inflammation | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Venoocclusive disease | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VII level | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular operation | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic foetopathy | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical observation | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Brow presentation | 0 | 0.092 | 0.046 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine infection | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Heterosexuality | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory depth decreased | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Paraesthesia mucosal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Enteropathic spondylitis | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Prophylaxis against Rh isoimmunisation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Abscess of salivary gland | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Palatal palsy | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Myeloproliferative neoplasm | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear infection staphylococcal | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Normochromic anaemia | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic stent insertion | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Arteriovenous fistula occlusion | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin urine | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbohydrate deficient transferrin test | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Otoplasty | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Homosexuality | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Diastasis recti abdominis | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic viral infection | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Wrong dose | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Vessel puncture site erythema | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Subretinal fibrosis | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Aplasia cutis congenita | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Blunted affect | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual pathway disorder | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Device defective | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lactate dehydrogenase abnormal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | DiGeorge's syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital vesicoureteric reflux | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Lysinuric protein intolerance | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired tracheo-oesophageal fistula | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal oedema | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein C deficiency | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic injury | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis chronic active | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Calcific deposits removal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Term birth | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal ulceration | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Autosomal chromosome anomaly | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal cord insertion | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Scaphoid abdomen | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin C deficiency | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter site pain | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Post-traumatic epilepsy | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Appendix cancer | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine uptake | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Fistula repair | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum procollagen type III N-terminal propeptide | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Urea urine decreased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatic heart disease | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Orbital infection | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic cancer stage IV | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Anotia | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Schizoid personality disorder | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal haemoglobin | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Pregnancy with young maternal age | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal biophysical profile score abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal heart rate disorder | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Hookworm infection | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Colonic lavage | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Mean platelet volume abnormal | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Pregnancy with advanced maternal age | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Intra-cerebral aneurysm operation | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucormycosis | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Influenza C virus test | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Dennie-Morgan fold | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral haemorrhage | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Salivary duct inflammation | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Porphyria non-acute | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Phakomatosis | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Meconium abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Bile duct stent insertion | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulomatous liver disease | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 2 globulin increased | 0 | 0.092 | 0.045 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal rupture | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatopulmonary syndrome | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Fallot's tetralogy | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensory integration therapy | 0 | 0.092 | 0.046 | 0.915 | 2.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Chikungunya virus infection | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Stress echocardiogram abnormal | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Severe acute respiratory syndrome | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Prolonged rupture of membranes | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram Q waves | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bladder | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal perforation | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular neoplasm | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol use disorder | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin electrophoresis | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose tolerance increased | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Epidermoid cyst excision | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Apolipoprotein A-I normal | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Aorta hypoplasia | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy anus normal | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary necrosis | 0 | 0.092 | 0.044 | 0.915 | 2.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin receptor assay | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Foster care | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Orchidectomy | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacillus bacteraemia | 0 | 0.092 | 0.045 | 0.915 | 2.757 |  |  |  |  |  | 
COVID19 (Custom Term) | Porphyria screen | 0 | 0.092 | 0.045 | 0.915 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertensive cardiomegaly | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychotic symptom | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Directional Doppler flow tests abnormal | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticoagulation drug level below therapeutic | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Orbital decompression | 0 | 0.092 | 0.045 | 0.915 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema marginatum | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal wall neoplasm malignant | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Ebstein's anomaly | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Acrodermatitis enteropathica | 0 | 0.092 | 0.046 | 0.915 | 2.753 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4/CD8 ratio increased | 0 | 0.092 | 0.046 | 0.915 | 2.752 |  |  |  |  |  | 
COVID19 (Custom Term) | Glaucoma traumatic | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Creatinine urine decreased | 0 | 0.092 | 0.045 | 0.915 | 2.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Transposition of the great vessels | 0 | 0.092 | 0.045 | 0.915 | 2.755 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature baby death | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Fractured coccyx | 0 | 0.092 | 0.045 | 0.915 | 2.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial hyperreactivity | 2 | 2.109 | 0.366 | 0.914 | 1.661 | 0.401 | 0.879 | 1.727 | 0.948 | 0.863 | 0.022
COVID19 (Custom Term) | Laryngitis | 4 | 4.638 | 0.389 | 0.914 | 1.619 | 0.442 | 0.852 | 1.519 | 0.862 | 0.386 | 3.148
COVID19 (Custom Term) | Vaccination site warmth | 48 | 56.503 | 0.713 | 0.914 | 1.137 | 0.671 | 0.849 | 1.063 | 0.85 | 0.728 | 4.293
COVID19 (Custom Term) | Depression | 13 | 23.19 | 0.55 | 0.914 | 1.352 | 0.39 | 0.598 | 0.885 | 0.561 | 0.263 | 25.428
COVID19 (Custom Term) | Secondary progressive multiple sclerosis | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrocardiac syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiopulmonary exercise test abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Rinne tuning fork test | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Sinoscopy | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergy to chemicals | 0 | 0.108 | 0.065 | 0.914 | 2.607 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericarditis meningococcal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin S normal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy small intestine normal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal perforation | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Menstrual cycle management | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular somatic symptom disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull malformation | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Noninfective oophoritis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune colitis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Rickets | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Bleeding anovulatory | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal alloimmune thrombocytopenia | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood catecholamines increased | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival oedema | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucosal pigmentation | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Noctiphobia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Implant site swelling | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononucleosis syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart block congenital | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Fulminant type 1 diabetes mellitus | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular germ cell tumour | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin A2 | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Amoebic dysentery | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Product barcode issue | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Tattoo | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Past-pointing | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Infective tenosynovitis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic recurrent multifocal osteomyelitis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Radical prostatectomy | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillar atrophy | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-IA2 antibody negative | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Atonic urinary bladder | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Lead urine increased | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatofibrosarcoma protuberans | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute post asthmatic amyotrophy | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Bipolar II disorder | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Hashimoto's encephalopathy | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | T-cell lymphoma | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb fracture | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Brucella test positive | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital rubella infection | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood prolactin abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound abscess | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Human polyomavirus infection | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometrial ablation | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurologic somatic symptom disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Transcranial electrical motor evoked potential monitoring abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurosyphilis | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertrophic scar | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal examination abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial parotitis | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Physical thyroid examination abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-complement antibody | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiosarcoma | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign lung neoplasm | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Anomalous pulmonary venous connection | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Burkholderia test positive | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Spotted fever rickettsia test positive | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Selenium deficiency | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyposomnia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin saturation increased | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Perineal ulceration | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Capillary fragility increased | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical device site joint infection | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian injury | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Fallopian tube cancer metastatic | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign neoplasm of skin | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial stent insertion | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail hypertrophy | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Medication overuse headache | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Fallopian tube cancer | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound ovary abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal discomfort | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Waldenstrom's macroglobulinaemia | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Intelligence test | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Orchidopexy | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis tuberculous | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Device inappropriate shock delivery | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Murphy's sign positive | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Subretinal hyperreflective exudation | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Prader-Willi syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow myelogram normal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Primary adrenal insufficiency | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune enteropathy | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal fistula repair | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Complications of transplanted kidney | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Burnout syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Product residue present | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Epilepsy congenital | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobin blood absent | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to kidney | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint deposit | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Natural killer T cell count | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood catecholamines decreased | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | BK virus infection | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Umbilical hernia repair | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | PUVA | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic disc hyperaemia | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion spontaneous incomplete | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood beryllium increased | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Gait apraxia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Euthyroid sick syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Blastocystis infection | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast haemorrhage | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Friedreich's ataxia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal tachypnoea | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhinoplasty | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Sulcus vocalis | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Glossoptosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Staphylococcal toxaemia | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Atypical mycobacterium pericarditis | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteomyelitis acute | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Jugular vein distension | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Radiation injury | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Giardia test positive | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrotal disorder | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Latent syphilis | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal damage | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Palmoplantar keratoderma | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometrial disorder | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Device function test | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Lewis-Sumner syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal anastomosis | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Clinical death | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Lithotripsy | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulva cyst | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatic hallucination | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukaemoid reaction | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood copper increased | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Carnitine abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Postmortem blood drug level increased | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product effect increased | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypopituitarism | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Kluver-Bucy syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypereosinophilic syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood catecholamines normal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Opportunistic infection | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholera | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Autonomic seizure | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Personality change due to a general medical condition | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle graft | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Product intolerance | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperthermia therapy | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QT shortened | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aldosterone decreased | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Salpingo-oophorectomy unilateral | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal abscess | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Mini mental status examination abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Mechanical ventilation complication | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudobulbar palsy | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Sex hormone binding globulin | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-HLA antibody test | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Adjustment disorder with anxiety | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary straining | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs indirect test | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrospinal fluid drainage | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal cortical necrosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial therapeutic procedure | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Poliovirus test | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Oedema blister | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to pelvis | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Lupus enteritis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysplastic naevus | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Unemployment | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Adjustment disorder with mixed anxiety and depressed mood | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral arterial occlusive disease | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermohypoaesthesia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Ambidexterity | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug abuser | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Risus sardonicus | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Early onset familial Alzheimer's disease | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatopathic lymphadenopathy | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Instillation site reaction | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Intra-abdominal haematoma | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal injury | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleural rub | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stent insertion | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillar cyst | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Pasteurella test positive | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Patent ductus arteriosus repair | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Onycholysis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasma cells present | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy vagina normal | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimicrobial susceptibility test intermediate | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Infected cyst | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue tie operation | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix cancer metastatic | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail pigmentation | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhinotracheitis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor V Leiden mutation | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Proctitis ulcerative | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Taciturnity | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Saliva analysis normal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin-like growth factor | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy spinal cord abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Clotting factor transfusion | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Hydrogen breath test abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic stomatitis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Water deprivation test | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal growth abnormality | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Disseminated cytomegaloviral infection | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Microangiopathic haemolytic anaemia | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol test positive | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericarditis rheumatic | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Tear break up time test | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutralising antibodies positive | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug withdrawal headache | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Cutaneous sarcoidosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluorescent in situ hybridisation negative | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Lack of vaccination site rotation | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Aldolase decreased | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone giant cell tumour | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Borderline glaucoma | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Alagille syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital skin disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to heart | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Brucellosis | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Hallucination, tactile | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant neoplasm of unknown primary site | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | VIth nerve paresis | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood testosterone increased | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter site discharge | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal hypertrophy | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs negative haemolytic anaemia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxin binding globulin | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxic leukoencephalopathy | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile septic granulomatosis | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system abscess | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypogonadism | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Normal tension glaucoma | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoidal disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Sympathicotonia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Nikolsky's sign | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Implant site discolouration | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial thrombosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic ketosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Metatarsalgia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral cavity fistula | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Periodic limb movement disorder | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Intention tremor | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal examination normal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb reduction defect | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Modified Rankin score decreased | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Device power source issue | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Violence-related symptom | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Macroprolactinaemia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet function test normal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteral disorder | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic organ injury | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Left-to-right cardiac shunt | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Carotid aneurysm rupture | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign muscle neoplasm | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine phosphokinase BB | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung squamous cell carcinoma stage IV | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Accelerated idioventricular rhythm | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric mucosa erythema | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinogram normal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Progressive multiple sclerosis | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Spermatorrhoea | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural site reaction | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival erosion | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal vein thrombosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Locomotive syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyomavirus test positive | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Alveolar rhabdomyosarcoma | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Acalculia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine phosphokinase MM normal | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein S deficiency | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleural disorder | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Palmoplantar pustulosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system neoplasm | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Xanthoma | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Pre-existing disease | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Food contamination | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocardial fibrosis | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Treponema test false positive | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site anaesthesia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Partner stress | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix enlargement | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian dysplasia | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Spasmodic dysphonia | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophagostomy | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis Japanese B | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular function test abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Factitious disorder | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Thymoma | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensory level | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Rickettsiosis | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural nausea | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Otitis media chronic | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Chorioretinal scar | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Removal of foreign body from nose | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Incarcerated umbilical hernia | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin A deficiency | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Kounis syndrome | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Flail chest | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Pituitary enlargement | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Plague | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurofibroma | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrocystic breast disease | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Brachytherapy | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Histamine normal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Shigella test positive | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Paracentesis eye normal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimitochondrial antibody positive | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival suffusion | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestradiol abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.762 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF granulocyte count normal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Palpatory finding abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaemia neonatal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Scleral haemorrhage | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin A normal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid thickening | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Eustachian tube patulous | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival ulcer | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site extravasation | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema asteatotic | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site papules | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Glaucoma drainage device placement | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Denture wearer | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual acuity reduced transiently | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Primary hyperthyroidism | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Cross sensitivity reaction | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic myelomonocytic leukaemia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Uvulitis | 0 | 0.092 | 0.044 | 0.914 | 2.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Intravascular papillary endothelial hyperplasia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Focal nodular hyperplasia | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethritis gonococcal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal degeneration | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin adhesion | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual perseveration | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric fluid analysis | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-vimentin antibody positive | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | High risk sexual behaviour | 0 | 0.092 | 0.044 | 0.914 | 2.765 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF myelin basic protein abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Ejaculation disorder | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophagogastroscopy abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Lentigo | 0 | 0.092 | 0.044 | 0.914 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Female sex hormone level abnormal | 0 | 0.092 | 0.044 | 0.914 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Activated partial thromboplastin time normal | 15 | 14.41 | 0.596 | 0.913 | 1.286 | 0.669 | 1.001 | 1.45 | 1.041 | 1.712 | 3.15
COVID19 (Custom Term) | Blood smear test abnormal | 4 | 4.058 | 0.363 | 0.913 | 1.665 | 0.476 | 0.917 | 1.634 | 0.986 | 1.528 | 0.229
COVID19 (Custom Term) | Pain in extremity | 2693 | 2991.948 | 0.884 | 0.913 | 0.942 | 0.872 | 0.9 | 0.929 | 0.9 | 1.144 | 47.274
COVID19 (Custom Term) | Foetal heart rate abnormal | 10 | 12.444 | 0.506 | 0.913 | 1.417 | 0.504 | 0.812 | 1.251 | 0.804 | 3.972 | 13.633
COVID19 (Custom Term) | HIV test negative | 7 | 9.421 | 0.463 | 0.913 | 1.485 | 0.446 | 0.77 | 1.256 | 0.743 | 0.285 | 11.473
COVID19 (Custom Term) | Gastritis | 5 | 7.364 | 0.409 | 0.913 | 1.58 | 0.396 | 0.732 | 1.26 | 0.679 | 0.709 | 0.298
COVID19 (Custom Term) | CSF protein decreased | 0 | 0.294 | 0.256 | 0.913 | 1.898 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal disorder | 0 | 0.111 | 0.067 | 0.913 | 2.59 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombophlebitis (SMQ) [narrow] | 6 | 5.922 | 0.438 | 0.912 | 1.525 | 0.533 | 0.947 | 1.585 | 1.013 | 5.416 | 11.011
COVID19 (Custom Term) | Sensory level abnormal | 1 | 1.014 | 0.202 | 0.912 | 2.037 | 0.357 | 0.868 | 1.842 | 0.986 | 0.827 | 0.089
COVID19 (Custom Term) | Hypertonia | 3 | 3.139 | 0.303 | 0.912 | 1.787 | 0.438 | 0.893 | 1.662 | 0.956 | 0.129 | 16.503
COVID19 (Custom Term) | Dermatitis diaper | 1 | 1.174 | 0.409 | 0.912 | 1.577 | 0.344 | 0.838 | 1.778 | 0.852 | 0.108 | 6.357
COVID19 (Custom Term) | Ultrasound abdomen | 9 | 10.172 | 0.497 | 0.912 | 1.429 | 0.532 | 0.873 | 1.368 | 0.885 | 0.562 | 2.47
COVID19 (Custom Term) | Vaccination site induration | 20 | 23.135 | 0.622 | 0.912 | 1.249 | 0.604 | 0.861 | 1.198 | 0.864 | 0.63 | 3.704
COVID19 (Custom Term) | Brain oedema | 6 | 7.076 | 0.438 | 0.912 | 1.524 | 0.475 | 0.845 | 1.413 | 0.848 | 0.677 | 0.565
COVID19 (Custom Term) | Acoustic stimulation tests | 11 | 13.497 | 0.55 | 0.912 | 1.35 | 0.519 | 0.82 | 1.246 | 0.815 | 1.883 | 3.057
COVID19 (Custom Term) | Blister rupture | 3 | 4.279 | 0.443 | 0.912 | 1.517 | 0.374 | 0.764 | 1.421 | 0.701 | 0.993 | 0.084
COVID19 (Custom Term) | Eyelid irritation | 2 | 1.117 | 0.312 | 0.911 | 1.764 | 0.487 | 1.067 | 2.103 | 1.791 | 1.324 | 0.002
COVID19 (Custom Term) | Medical induction of coma | 2 | 2.083 | 0.289 | 0.911 | 1.815 | 0.403 | 0.883 | 1.735 | 0.96 | 0.993 | 0.13
COVID19 (Custom Term) | Romberg test positive | 1 | 1.599 | 0.152 | 0.911 | 2.197 | 0.314 | 0.767 | 1.631 | 0.625 | 0.397 | 0.357
COVID19 (Custom Term) | Biopsy muscle normal | 0 | 0.122 | 0.078 | 0.911 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF oligoclonal band | 1 | 0.988 | 0.269 | 0.91 | 1.859 | 0.359 | 0.873 | 1.852 | 1.012 | 0.709 | 0.013
COVID19 (Custom Term) | Pustule | 11 | 16.108 | 0.56 | 0.91 | 1.328 | 0.45 | 0.712 | 1.081 | 0.683 | 1.82 | 2.717
COVID19 (Custom Term) | Renal pain | 16 | 16.801 | 0.592 | 0.909 | 1.28 | 0.631 | 0.932 | 1.338 | 0.952 | 2.037 | 6.093
COVID19 (Custom Term) | Escherichia infection | 3 | 3.453 | 0.32 | 0.909 | 1.743 | 0.419 | 0.854 | 1.588 | 0.869 | 0.827 | 0.001
COVID19 (Custom Term) | Poor quality sleep | 42 | 49.887 | 0.703 | 0.909 | 1.137 | 0.655 | 0.842 | 1.068 | 0.842 | 0.813 | 1.489
COVID19 (Custom Term) | Dry skin | 23 | 30.383 | 0.635 | 0.909 | 1.223 | 0.549 | 0.766 | 1.045 | 0.757 | 0.619 | 4.699
COVID19 (Custom Term) | Radioallergosorbent test negative | 1 | 1.492 | 0.225 | 0.909 | 1.968 | 0.321 | 0.784 | 1.666 | 0.67 | 0.903 | 0.162
COVID19 (Custom Term) | Arthropathy | 6 | 8.27 | 0.455 | 0.909 | 1.49 | 0.427 | 0.76 | 1.271 | 0.726 | 0.411 | 4.266
COVID19 (Custom Term) | Neuropathy peripheral | 43 | 58.523 | 0.695 | 0.909 | 1.146 | 0.578 | 0.741 | 0.938 | 0.735 | 0.886 | 0.472
COVID19 (Custom Term) | Movement disorder | 26 | 33.556 | 0.641 | 0.908 | 1.214 | 0.57 | 0.781 | 1.049 | 0.775 | 0.794 | 1.082
COVID19 (Custom Term) | Extremity contracture | 2 | 1.983 | 0.306 | 0.907 | 1.767 | 0.41 | 0.899 | 1.767 | 1.008 | 0.993 | 0.13
COVID19 (Custom Term) | Diet refusal | 14 | 13.913 | 0.572 | 0.907 | 1.304 | 0.642 | 0.972 | 1.423 | 1.006 | 0.434 | 9.299
COVID19 (Custom Term) | Acoustic stimulation tests abnormal | 18 | 19.638 | 0.599 | 0.907 | 1.267 | 0.624 | 0.905 | 1.277 | 0.917 | 3.31 | 19.9
COVID19 (Custom Term) | Blood creatine phosphokinase normal | 17 | 20.12 | 0.593 | 0.907 | 1.276 | 0.577 | 0.844 | 1.201 | 0.845 | 0.792 | 0.658
COVID19 (Custom Term) | Tubulointerstitial diseases (SMQ) [narrow] | 1 | 1.574 | 0.156 | 0.907 | 2.166 | 0.315 | 0.771 | 1.639 | 0.635 | 0.276 | 1.156
COVID19 (Custom Term) | CSF protein increased | 13 | 19.035 | 0.554 | 0.907 | 1.33 | 0.462 | 0.708 | 1.048 | 0.683 | 0.363 | 13.4
COVID19 (Custom Term) | Hyperphagia | 1 | 0.987 | 0.105 | 0.906 | 2.368 | 0.359 | 0.874 | 1.853 | 1.013 | 0.709 | 0.013
COVID19 (Custom Term) | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [narrow] | 4 | 4.336 | 0.32 | 0.906 | 1.732 | 0.459 | 0.885 | 1.577 | 0.923 | 0.509 | 1.323
COVID19 (Custom Term) | Pharyngitis | 10 | 11.043 | 0.514 | 0.906 | 1.388 | 0.553 | 0.889 | 1.371 | 0.906 | 0.375 | 9.412
COVID19 (Custom Term) | Malignant lymphomas (SMQ) [broad] | 15 | 18.893 | 0.574 | 0.906 | 1.299 | 0.536 | 0.801 | 1.161 | 0.794 | 0.601 | 3.357
COVID19 (Custom Term) | Blood electrolytes | 12 | 11.313 | 0.556 | 0.905 | 1.324 | 0.648 | 1.007 | 1.509 | 1.061 | 2.291 | 5.989
COVID19 (Custom Term) | Cardiac stress test abnormal | 2 | 2.616 | 0.342 | 0.905 | 1.688 | 0.367 | 0.807 | 1.586 | 0.764 | 2.206 | 0.266
COVID19 (Custom Term) | Ophthalmological examination abnormal | 10 | 12.656 | 0.512 | 0.904 | 1.385 | 0.498 | 0.801 | 1.235 | 0.79 | 1.068 | 0.001
COVID19 (Custom Term) | Anal fissure | 0 | 0.195 | 0.144 | 0.904 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligament sprain | 0 | 0.34 | 0.26 | 0.904 | 1.863 |  |  |  |  |  | 
COVID19 (Custom Term) | Pathology test | 6 | 6.657 | 0.454 | 0.903 | 1.476 | 0.495 | 0.88 | 1.471 | 0.901 | 0.993 | 0.039
COVID19 (Custom Term) | Oropharyngeal blistering | 2 | 2.403 | 0.317 | 0.903 | 1.732 | 0.381 | 0.836 | 1.642 | 0.832 | 0.946 | 0.082
COVID19 (Custom Term) | Abscess limb | 1 | 1.523 | 0.257 | 0.903 | 1.868 | 0.319 | 0.779 | 1.655 | 0.656 | 0.284 | 1.076
COVID19 (Custom Term) | Hypogammaglobulinaemia | 0 | 0.171 | 0.116 | 0.903 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Physical examination normal | 5 | 3.5 | 0.403 | 0.902 | 1.562 | 0.613 | 1.13 | 1.947 | 1.429 | 4.965 | 7.845
COVID19 (Custom Term) | Inflammatory marker test | 3 | 2.853 | 0.372 | 0.902 | 1.62 | 0.458 | 0.933 | 1.736 | 1.052 | 0.32 | 3.499
COVID19 (Custom Term) | Blood chloride increased | 17 | 17.324 | 0.601 | 0.902 | 1.252 | 0.654 | 0.957 | 1.361 | 0.981 | 3.67 | 22.012
COVID19 (Custom Term) | Injection site pruritus | 1030 | 1050.952 | 0.857 | 0.902 | 0.949 | 0.93 | 0.98 | 1.031 | 0.98 | 1.62 | 214.307
COVID19 (Custom Term) | Underdose | 70 | 86.652 | 0.733 | 0.902 | 1.085 | 0.665 | 0.809 | 0.977 | 0.808 | 0.53 | 27.36
COVID19 (Custom Term) | Spirometry normal | 0 | 0.102 | 0.039 | 0.902 | 2.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchoscopy normal | 1 | 0.988 | 0.213 | 0.901 | 1.977 | 0.359 | 0.873 | 1.852 | 1.012 | 0.764 | 0.041
COVID19 (Custom Term) | Sinus headache | 9 | 9.048 | 0.5 | 0.901 | 1.397 | 0.579 | 0.95 | 1.49 | 0.995 | 1.568 | 1.104
COVID19 (Custom Term) | Eye contusion | 4 | 4.098 | 0.423 | 0.901 | 1.523 | 0.473 | 0.912 | 1.626 | 0.976 | 1.655 | 0.378
COVID19 (Custom Term) | Functional gastrointestinal disorder | 1 | 1.196 | 0.325 | 0.901 | 1.711 | 0.343 | 0.834 | 1.77 | 0.836 | 0.226 | 1.832
COVID19 (Custom Term) | Bronchitis | 14 | 19.785 | 0.563 | 0.901 | 1.304 | 0.481 | 0.728 | 1.066 | 0.708 | 0.292 | 22.623
COVID19 (Custom Term) | Vaccination site inflammation | 4 | 7.39 | 0.372 | 0.901 | 1.616 | 0.33 | 0.638 | 1.139 | 0.541 | 0.241 | 8.56
COVID19 (Custom Term) | Cytogenetic analysis | 2 | 3.9 | 0.432 | 0.901 | 1.508 | 0.302 | 0.667 | 1.314 | 0.513 | 0.337 | 1.873
COVID19 (Custom Term) | Blepharitis | 0 | 0.245 | 0.182 | 0.901 | 2.065 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan with contrast normal | 19 | 19.703 | 0.632 | 0.9 | 1.208 | 0.658 | 0.945 | 1.324 | 0.964 | 2.419 | 11.492
COVID19 (Custom Term) | Liver function test abnormal | 11 | 12.793 | 0.533 | 0.9 | 1.345 | 0.541 | 0.855 | 1.299 | 0.86 | 1.187 | 0.135
COVID19 (Custom Term) | Mucosal discolouration | 1 | 1.255 | 0.333 | 0.9 | 1.691 | 0.338 | 0.824 | 1.748 | 0.797 | 0.662 | 0.001
COVID19 (Custom Term) | Glycosylated haemoglobin normal | 5 | 6.145 | 0.474 | 0.9 | 1.437 | 0.446 | 0.823 | 1.417 | 0.814 | 1.056 | 0.015
COVID19 (Custom Term) | Gingival swelling | 9 | 11.37 | 0.505 | 0.9 | 1.388 | 0.489 | 0.803 | 1.259 | 0.792 | 2.031 | 3.025
COVID19 (Custom Term) | Adverse reaction | 14 | 23.096 | 0.563 | 0.9 | 1.301 | 0.421 | 0.638 | 0.934 | 0.606 | 0.241 | 32.029
COVID19 (Custom Term) | Biopsy site unspecified abnormal | 0 | 0.133 | 0.069 | 0.9 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatitis acneiform | 4 | 4.112 | 0.444 | 0.899 | 1.484 | 0.472 | 0.91 | 1.623 | 0.973 | 1.891 | 0.708
COVID19 (Custom Term) | Heart injury | 2 | 2.089 | 0.249 | 0.899 | 1.877 | 0.402 | 0.882 | 1.734 | 0.957 | 2.206 | 0.266
COVID19 (Custom Term) | Haemoglobin increased | 5 | 5.461 | 0.433 | 0.899 | 1.5 | 0.48 | 0.885 | 1.524 | 0.916 | 1.504 | 0.331
COVID19 (Custom Term) | Loss of consciousness | 348 | 438.082 | 0.821 | 0.899 | 0.979 | 0.727 | 0.795 | 0.867 | 0.794 | 0.756 | 25.481
COVID19 (Custom Term) | Nerve compression | 7 | 8.921 | 0.477 | 0.898 | 1.427 | 0.464 | 0.8 | 1.306 | 0.785 | 1.448 | 0.471
COVID19 (Custom Term) | Thyroid function test normal | 8 | 10.419 | 0.469 | 0.898 | 1.44 | 0.468 | 0.786 | 1.256 | 0.768 | 0.58 | 1.886
COVID19 (Custom Term) | Bone scan normal | 0 | 0.204 | 0.138 | 0.898 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia viral | 6 | 6.133 | 0.488 | 0.897 | 1.406 | 0.521 | 0.927 | 1.55 | 0.978 | 2.708 | 3.709
COVID19 (Custom Term) | Toxicologic test normal | 4 | 4.358 | 0.439 | 0.897 | 1.485 | 0.458 | 0.882 | 1.573 | 0.918 | 1.103 | 0.008
COVID19 (Custom Term) | Strawberry tongue | 1 | 1.01 | 0.206 | 0.896 | 1.983 | 0.357 | 0.869 | 1.843 | 0.99 | 0.662 | 0.001
COVID19 (Custom Term) | Computerised tomogram neck | 24 | 26.541 | 0.633 | 0.896 | 1.197 | 0.647 | 0.896 | 1.217 | 0.904 | 19.858 | 136.45
COVID19 (Custom Term) | Staphylococcal infection | 5 | 6.651 | 0.503 | 0.896 | 1.381 | 0.424 | 0.783 | 1.347 | 0.752 | 0.368 | 4.593
COVID19 (Custom Term) | Borrelia test | 2 | 3.112 | 0.416 | 0.896 | 1.524 | 0.339 | 0.747 | 1.468 | 0.643 | 0.153 | 8.363
COVID19 (Custom Term) | Blood fibrinogen normal | 1 | 1.923 | 0.117 | 0.896 | 2.282 | 0.293 | 0.721 | 1.534 | 0.52 | 0.211 | 2.096
COVID19 (Custom Term) | Histamine intolerance | 2 | 1.498 | 0.339 | 0.895 | 1.665 | 0.45 | 0.986 | 1.938 | 1.335 | 1.986 | 0.162
COVID19 (Custom Term) | Oxygen therapy | 23 | 22.745 | 0.622 | 0.895 | 1.209 | 0.708 | 0.988 | 1.348 | 1.011 | 4.859 | 44.529
COVID19 (Custom Term) | Neutropenia | 7 | 6.996 | 0.463 | 0.895 | 1.441 | 0.548 | 0.946 | 1.543 | 1.001 | 0.424 | 4.671
COVID19 (Custom Term) | Differential white blood cell count normal | 23 | 23.838 | 0.636 | 0.895 | 1.19 | 0.68 | 0.948 | 1.294 | 0.965 | 1.62 | 4.122
COVID19 (Custom Term) | Extravasation events (injections, infusions and implants) (SMQ) [broad] | 4835 | 5553.044 | 0.874 | 0.895 | 0.917 | 0.85 | 0.871 | 0.891 | 0.871 | 0.739 | 519.677
COVID19 (Custom Term) | Audiogram abnormal | 12 | 13.885 | 0.568 | 0.895 | 1.283 | 0.552 | 0.859 | 1.287 | 0.864 | 3.404 | 13.269
COVID19 (Custom Term) | Immune-mediated/autoimmune disorders (SMQ) [broad] | 807 | 947.248 | 0.844 | 0.895 | 0.948 | 0.804 | 0.852 | 0.902 | 0.852 | 0.741 | 70.221
COVID19 (Custom Term) | Blood homocysteine normal | 0 | 0.199 | 0.128 | 0.895 | 2.237 |  |  |  |  |  | 
COVID19 (Custom Term) | Occult blood negative | 1 | 1.051 | 0.16 | 0.894 | 2.118 | 0.354 | 0.861 | 1.826 | 0.952 | 0.276 | 1.156
COVID19 (Custom Term) | Antinuclear antibody negative | 7 | 11.633 | 0.459 | 0.894 | 1.447 | 0.381 | 0.658 | 1.074 | 0.602 | 0.228 | 17.096
COVID19 (Custom Term) | Eructation | 10 | 10.765 | 0.536 | 0.893 | 1.325 | 0.563 | 0.906 | 1.397 | 0.929 | 1.628 | 1.529
COVID19 (Custom Term) | Generalised convulsive seizures following immunisation (SMQ) [algorithm] | 186 | 222.03 | 0.788 | 0.893 | 1.002 | 0.742 | 0.838 | 0.943 | 0.838 | 0.27 | 363.841
COVID19 (Custom Term) | Hair metal test abnormal | 0 | 0.292 | 0.2 | 0.893 | 1.991 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram ambulatory abnormal | 2 | 2.306 | 0.25 | 0.892 | 1.854 | 0.387 | 0.85 | 1.669 | 0.867 | 0.903 | 0.046
COVID19 (Custom Term) | Ultrasound scan abnormal | 35 | 40.924 | 0.665 | 0.892 | 1.147 | 0.649 | 0.854 | 1.106 | 0.855 | 0.867 | 0.533
COVID19 (Custom Term) | Muscular weakness | 335 | 395.562 | 0.813 | 0.891 | 0.973 | 0.774 | 0.847 | 0.925 | 0.847 | 0.889 | 4.208
COVID19 (Custom Term) | Iron deficiency | 1 | 1.55 | 0.137 | 0.891 | 2.186 | 0.317 | 0.775 | 1.647 | 0.645 | 0.414 | 0.298
COVID19 (Custom Term) | Myelitis | 3 | 5.152 | 0.29 | 0.891 | 1.76 | 0.336 | 0.687 | 1.28 | 0.582 | 0.252 | 5.701
COVID19 (Custom Term) | Lip discolouration | 1 | 2.098 | 0.33 | 0.891 | 1.671 | 0.283 | 0.698 | 1.487 | 0.477 | 0.15 | 3.85
COVID19 (Custom Term) | Hodgkin's disease | 0 | 0.231 | 0.147 | 0.891 | 2.152 |  |  |  |  |  | 
COVID19 (Custom Term) | Investigation abnormal | 0 | 0.202 | 0.121 | 0.891 | 2.25 |  |  |  |  |  | 
COVID19 (Custom Term) | Cheilitis | 11 | 12.056 | 0.538 | 0.89 | 1.313 | 0.567 | 0.896 | 1.36 | 0.912 | 1.103 | 0.021
COVID19 (Custom Term) | Psoriasis | 3 | 3.416 | 0.344 | 0.89 | 1.643 | 0.421 | 0.858 | 1.596 | 0.878 | 0.248 | 5.883
COVID19 (Custom Term) | Sleep study normal | 0 | 0.293 | 0.192 | 0.89 | 2.004 |  |  |  |  |  | 
COVID19 (Custom Term) | Globulins decreased | 3 | 3.004 | 0.363 | 0.889 | 1.604 | 0.447 | 0.912 | 1.696 | 0.999 | 2.128 | 0.631
COVID19 (Custom Term) | Osteoporosis/osteopenia (SMQ) [narrow] | 2 | 2.081 | 0.317 | 0.889 | 1.695 | 0.403 | 0.884 | 1.736 | 0.961 | 0.794 | 0
COVID19 (Custom Term) | Injection site indentation | 3 | 3.77 | 0.454 | 0.889 | 1.44 | 0.4 | 0.817 | 1.52 | 0.796 | 0.903 | 0.014
COVID19 (Custom Term) | Nocturia | 1 | 1.614 | 0.241 | 0.889 | 1.869 | 0.313 | 0.765 | 1.626 | 0.62 | 0.301 | 0.918
COVID19 (Custom Term) | Depressed mood | 6 | 7.801 | 0.432 | 0.888 | 1.475 | 0.445 | 0.791 | 1.324 | 0.769 | 0.286 | 9.624
COVID19 (Custom Term) | Blood count normal | 2 | 2.107 | 0.273 | 0.887 | 1.788 | 0.401 | 0.879 | 1.728 | 0.949 | 0.211 | 4.949
COVID19 (Custom Term) | Atrial septal defect | 3 | 3.415 | 0.304 | 0.887 | 1.717 | 0.421 | 0.858 | 1.597 | 0.878 | 1.027 | 0.069
COVID19 (Custom Term) | Injection site nodule | 70 | 81.37 | 0.723 | 0.887 | 1.065 | 0.706 | 0.859 | 1.038 | 0.86 | 0.538 | 26.043
COVID19 (Custom Term) | Injury associated with device | 2 | 2.652 | 0.224 | 0.887 | 1.906 | 0.365 | 0.802 | 1.577 | 0.754 | 0.245 | 3.762
COVID19 (Custom Term) | Antiphospholipid antibodies negative | 1 | 1.548 | 0.12 | 0.887 | 2.241 | 0.317 | 0.775 | 1.647 | 0.646 | 0.32 | 0.767
COVID19 (Custom Term) | Phlebitis | 2 | 3.042 | 0.243 | 0.887 | 1.858 | 0.343 | 0.755 | 1.484 | 0.658 | 0.863 | 0.022
COVID19 (Custom Term) | Urine abnormality | 5 | 5.59 | 0.433 | 0.886 | 1.469 | 0.473 | 0.873 | 1.503 | 0.894 | 1.273 | 0.061
COVID19 (Custom Term) | Skin test | 2 | 2.42 | 0.326 | 0.886 | 1.669 | 0.38 | 0.833 | 1.638 | 0.826 | 0.496 | 0.517
COVID19 (Custom Term) | Skin irritation | 18 | 21.34 | 0.592 | 0.886 | 1.228 | 0.581 | 0.843 | 1.19 | 0.843 | 0.588 | 4.494
COVID19 (Custom Term) | Colitis ulcerative | 3 | 5.017 | 0.295 | 0.886 | 1.734 | 0.341 | 0.698 | 1.3 | 0.598 | 0.382 | 2.273
COVID19 (Custom Term) | Haptoglobin decreased | 1 | 1.268 | 0.14 | 0.885 | 2.159 | 0.337 | 0.822 | 1.743 | 0.789 | 0.496 | 0.102
COVID19 (Custom Term) | Skin swelling | 22 | 26.28 | 0.619 | 0.885 | 1.19 | 0.596 | 0.837 | 1.15 | 0.837 | 2.206 | 10.817
COVID19 (Custom Term) | Pulmonary function test decreased | 0 | 0.117 | 0.034 | 0.885 | 2.754 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site atrophy | 0 | 0.565 | 0.32 | 0.885 | 1.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Induration | 112 | 131.798 | 0.753 | 0.884 | 1.024 | 0.727 | 0.85 | 0.988 | 0.85 | 0.597 | 28.503
COVID19 (Custom Term) | Magnetic resonance imaging spinal abnormal | 22 | 27.451 | 0.608 | 0.884 | 1.203 | 0.574 | 0.806 | 1.106 | 0.801 | 0.761 | 1.299
COVID19 (Custom Term) | Systemic lupus erythematosus | 7 | 10.54 | 0.431 | 0.884 | 1.468 | 0.411 | 0.709 | 1.157 | 0.664 | 0.355 | 7.272
COVID19 (Custom Term) | Cataract operation | 2 | 2.218 | 0.326 | 0.883 | 1.66 | 0.393 | 0.863 | 1.695 | 0.902 | 1.324 | 0.002
COVID19 (Custom Term) | Drug withdrawal (SMQ) [broad] | 2 | 2.569 | 0.321 | 0.883 | 1.671 | 0.37 | 0.813 | 1.598 | 0.779 | 2.206 | 0.266
COVID19 (Custom Term) | Anaphylactic shock | 26 | 36 | 0.624 | 0.883 | 1.178 | 0.535 | 0.733 | 0.984 | 0.722 | 1.259 | 0.992
COVID19 (Custom Term) | Road traffic accident | 5 | 7.221 | 0.469 | 0.883 | 1.402 | 0.401 | 0.741 | 1.276 | 0.692 | 0.788 | 0.092
COVID19 (Custom Term) | Dermatitis contact | 5 | 7.522 | 0.508 | 0.883 | 1.342 | 0.391 | 0.721 | 1.242 | 0.665 | 0.455 | 2.566
COVID19 (Custom Term) | Allergic reaction to excipient | 0 | 0.179 | 0.086 | 0.883 | 2.383 |  |  |  |  |  | 
COVID19 (Custom Term) | Epstein-Barr virus test negative | 2 | 3.29 | 0.277 | 0.881 | 1.761 | 0.33 | 0.727 | 1.43 | 0.608 | 0.116 | 12.361
COVID19 (Custom Term) | CSF virus identified | 0 | 0.2 | 0.102 | 0.881 | 2.303 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal X-ray | 9 | 12.072 | 0.534 | 0.88 | 1.296 | 0.467 | 0.767 | 1.203 | 0.746 | 1.719 | 1.68
COVID19 (Custom Term) | Vitamin D | 4 | 6.077 | 0.452 | 0.88 | 1.423 | 0.376 | 0.725 | 1.293 | 0.658 | 0.621 | 0.525
COVID19 (Custom Term) | Sick relative | 0 | 0.098 | 0.017 | 0.88 | 2.964 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin hyperpigmentation | 5 | 4.498 | 0.458 | 0.879 | 1.41 | 0.537 | 0.991 | 1.706 | 1.112 | 1.056 | 0.015
COVID19 (Custom Term) | Radioisotope scan abnormal | 0 | 0.101 | 0.018 | 0.879 | 2.945 |  |  |  |  |  | 
COVID19 (Custom Term) | Secretion discharge | 11 | 13.632 | 0.538 | 0.878 | 1.286 | 0.515 | 0.814 | 1.236 | 0.807 | 0.433 | 7.226
COVID19 (Custom Term) | Screaming | 10 | 13.473 | 0.512 | 0.878 | 1.325 | 0.474 | 0.763 | 1.176 | 0.742 | 0.087 | 93.976
COVID19 (Custom Term) | Dysgraphia | 4 | 5.63 | 0.353 | 0.878 | 1.593 | 0.394 | 0.761 | 1.356 | 0.71 | 0.641 | 0.432
COVID19 (Custom Term) | End-tidal CO2 decreased | 0 | 0.183 | 0.082 | 0.878 | 2.388 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycoplasma test | 1 | 1.05 | 0.297 | 0.877 | 1.706 | 0.354 | 0.861 | 1.827 | 0.952 | 0.276 | 1.156
COVID19 (Custom Term) | Viral rash | 1 | 1.098 | 0.241 | 0.877 | 1.837 | 0.35 | 0.852 | 1.808 | 0.911 | 0.098 | 7.238
COVID19 (Custom Term) | Cardiac failure (SMQ) [broad] | 912 | 1107.77 | 0.83 | 0.877 | 0.925 | 0.78 | 0.823 | 0.869 | 0.823 | 0.704 | 110.61
COVID19 (Custom Term) | Passive smoking | 0 | 0.183 | 0.08 | 0.877 | 2.395 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound scan normal | 22 | 30.229 | 0.61 | 0.876 | 1.182 | 0.527 | 0.74 | 1.016 | 0.728 | 0.546 | 7.41
COVID19 (Custom Term) | Bacterial infection | 4 | 7.114 | 0.386 | 0.876 | 1.525 | 0.339 | 0.655 | 1.168 | 0.562 | 0.203 | 11.461
COVID19 (Custom Term) | Injection site injury | 1 | 2.07 | 0.173 | 0.876 | 2.021 | 0.285 | 0.701 | 1.494 | 0.483 | 0.171 | 3.099
COVID19 (Custom Term) | Sexual dysfunction | 0 | 0.19 | 0.085 | 0.876 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | West Nile virus test | 0 | 0.218 | 0.108 | 0.876 | 2.26 |  |  |  |  |  | 
COVID19 (Custom Term) | Convulsions (SMQ) [narrow] | 222 | 262.662 | 0.781 | 0.875 | 0.974 | 0.756 | 0.845 | 0.942 | 0.845 | 0.299 | 360.94
COVID19 (Custom Term) | Respiratory disorder | 9 | 10.845 | 0.493 | 0.875 | 1.345 | 0.507 | 0.832 | 1.304 | 0.83 | 0.406 | 6.895
COVID19 (Custom Term) | Injection site irritation | 14 | 19.023 | 0.568 | 0.875 | 1.238 | 0.497 | 0.752 | 1.102 | 0.736 | 0.408 | 10.969
COVID19 (Custom Term) | Limb asymmetry | 0 | 0.183 | 0.077 | 0.875 | 2.405 |  |  |  |  |  | 
COVID19 (Custom Term) | Basal ganglia haematoma | 0 | 0.183 | 0.077 | 0.875 | 2.405 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia fungal | 0 | 0.183 | 0.077 | 0.875 | 2.406 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pH decreased | 10 | 10.025 | 0.505 | 0.874 | 1.325 | 0.594 | 0.956 | 1.473 | 0.997 | 1.418 | 0.715
COVID19 (Custom Term) | Spinal cord disorder | 1 | 1.02 | 0.181 | 0.874 | 1.989 | 0.357 | 0.867 | 1.839 | 0.98 | 0.903 | 0.162
COVID19 (Custom Term) | Tumours of unspecified malignancy (SMQ) [broad] | 3 | 3.783 | 0.305 | 0.874 | 1.68 | 0.4 | 0.815 | 1.517 | 0.793 | 0.32 | 3.499
COVID19 (Custom Term) | Tumours of unspecified malignancy (SMQ) [narrow] | 3 | 3.783 | 0.305 | 0.874 | 1.68 | 0.4 | 0.815 | 1.517 | 0.793 | 0.32 | 3.499
COVID19 (Custom Term) | CSF protein normal | 4 | 5.197 | 0.351 | 0.874 | 1.588 | 0.414 | 0.798 | 1.423 | 0.77 | 0.318 | 4.976
COVID19 (Custom Term) | Serum sickness | 4 | 5.559 | 0.468 | 0.874 | 1.381 | 0.397 | 0.766 | 1.367 | 0.72 | 0.552 | 0.953
COVID19 (Custom Term) | Bursa injury | 1 | 1.736 | 0.177 | 0.874 | 2.003 | 0.305 | 0.747 | 1.589 | 0.576 | 0.451 | 0.191
COVID19 (Custom Term) | Patient restraint | 0 | 0.183 | 0.075 | 0.874 | 2.411 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal column injury | 0 | 0.183 | 0.076 | 0.874 | 2.411 |  |  |  |  |  | 
COVID19 (Custom Term) | Anger | 11 | 11.643 | 0.526 | 0.873 | 1.291 | 0.582 | 0.92 | 1.397 | 0.945 | 0.791 | 0.368
COVID19 (Custom Term) | Head titubation | 5 | 5.652 | 0.445 | 0.873 | 1.417 | 0.47 | 0.867 | 1.493 | 0.885 | 1.034 | 0.028
COVID19 (Custom Term) | X-ray normal | 28 | 34.901 | 0.64 | 0.873 | 1.136 | 0.595 | 0.806 | 1.072 | 0.802 | 0.732 | 2.302
COVID19 (Custom Term) | Legionella infection | 0 | 0.183 | 0.074 | 0.873 | 2.416 |  |  |  |  |  | 
COVID19 (Custom Term) | Developmental hip dysplasia | 0 | 0.21 | 0.095 | 0.873 | 2.307 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site papule | 0 | 0.417 | 0.228 | 0.873 | 1.857 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal oedema | 4 | 3.701 | 0.391 | 0.872 | 1.507 | 0.499 | 0.962 | 1.715 | 1.081 | 3.055 | 2.676
COVID19 (Custom Term) | Partial seizures | 2 | 2.406 | 0.345 | 0.872 | 1.594 | 0.381 | 0.835 | 1.641 | 0.831 | 0.152 | 8.46
COVID19 (Custom Term) | Jaw fracture | 1 | 2.176 | 0.261 | 0.872 | 1.773 | 0.279 | 0.688 | 1.467 | 0.46 | 0.709 | 0.013
COVID19 (Custom Term) | Large intestine anastomosis | 0 | 0.183 | 0.073 | 0.872 | 2.42 |  |  |  |  |  | 
COVID19 (Custom Term) | West Nile virus test negative | 0 | 0.335 | 0.179 | 0.871 | 1.989 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrinous bronchitis | 0 | 0.183 | 0.071 | 0.871 | 2.425 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray with contrast upper gastrointestinal tract abnormal | 0 | 0.183 | 0.072 | 0.871 | 2.423 |  |  |  |  |  | 
COVID19 (Custom Term) | T-cell type acute leukaemia | 0 | 0.183 | 0.071 | 0.871 | 2.425 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth injury | 0 | 0.099 | 0.013 | 0.871 | 3.011 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system function test | 0 | 0.183 | 0.071 | 0.871 | 2.425 |  |  |  |  |  | 
COVID19 (Custom Term) | Culture urine positive | 6 | 6.213 | 0.438 | 0.87 | 1.421 | 0.517 | 0.919 | 1.538 | 0.966 | 1.083 | 0.001
COVID19 (Custom Term) | Parvovirus B19 test | 1 | 1.11 | 0.254 | 0.87 | 1.784 | 0.349 | 0.85 | 1.803 | 0.901 | 0.827 | 0.089
COVID19 (Custom Term) | Wrist fracture | 1 | 1.121 | 0.193 | 0.87 | 1.942 | 0.348 | 0.848 | 1.799 | 0.892 | 0.903 | 0.162
COVID19 (Custom Term) | Osteoporosis | 0 | 0.317 | 0.167 | 0.87 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Perioral dermatitis | 0 | 0.183 | 0.07 | 0.87 | 2.43 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendinous contracture | 0 | 0.183 | 0.07 | 0.87 | 2.43 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular hole | 0 | 0.183 | 0.071 | 0.87 | 2.427 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site vesicles | 0 | 0.183 | 0.071 | 0.87 | 2.426 |  |  |  |  |  | 
COVID19 (Custom Term) | Intracranial pressure increased | 2 | 2.048 | 0.3 | 0.869 | 1.678 | 0.405 | 0.889 | 1.746 | 0.977 | 0.567 | 0.255
COVID19 (Custom Term) | Giant cell arteritis | 1 | 1.235 | 0.127 | 0.869 | 2.162 | 0.34 | 0.827 | 1.755 | 0.81 | 0.355 | 0.552
COVID19 (Custom Term) | Blood uric acid increased | 3 | 3.812 | 0.384 | 0.869 | 1.514 | 0.398 | 0.812 | 1.511 | 0.787 | 0.805 | 0.008
COVID19 (Custom Term) | Contraindication to vaccination | 5 | 7.224 | 0.367 | 0.869 | 1.544 | 0.401 | 0.741 | 1.276 | 0.692 | 0.268 | 8.948
COVID19 (Custom Term) | Gram stain | 3 | 4.948 | 0.335 | 0.869 | 1.605 | 0.344 | 0.704 | 1.31 | 0.606 | 0.677 | 0.164
COVID19 (Custom Term) | Pneumocystis test negative | 0 | 0.183 | 0.069 | 0.869 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripancreatic fluid collection | 0 | 0.183 | 0.069 | 0.869 | 2.432 |  |  |  |  |  | 
COVID19 (Custom Term) | Medical device pain | 0 | 0.183 | 0.069 | 0.869 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuromyotonia | 0 | 0.183 | 0.069 | 0.869 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric cancer | 0 | 0.183 | 0.069 | 0.869 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Grimacing | 0 | 0.417 | 0.219 | 0.869 | 1.868 |  |  |  |  |  | 
COVID19 (Custom Term) | Prescription drug used without a prescription | 0 | 0.183 | 0.069 | 0.869 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Face and mouth X-ray normal | 0 | 0.183 | 0.069 | 0.869 | 2.434 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular vascular disorder | 0 | 0.183 | 0.069 | 0.869 | 2.434 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal examination | 0 | 0.183 | 0.069 | 0.869 | 2.434 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucosal hypertrophy | 0 | 0.183 | 0.069 | 0.869 | 2.434 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF cell count increased | 1 | 1.168 | 0.1 | 0.868 | 2.272 | 0.345 | 0.839 | 1.78 | 0.856 | 0.117 | 5.675
COVID19 (Custom Term) | Eyelid ptosis | 15 | 18.289 | 0.59 | 0.868 | 1.189 | 0.551 | 0.823 | 1.193 | 0.82 | 1.027 | 0.001
COVID19 (Custom Term) | Vibrio test positive | 0 | 0.183 | 0.068 | 0.868 | 2.437 |  |  |  |  |  | 
COVID19 (Custom Term) | Antineutrophil cytoplasmic antibody | 5 | 4.72 | 0.415 | 0.867 | 1.454 | 0.523 | 0.964 | 1.66 | 1.059 | 2.92 | 3.383
COVID19 (Custom Term) | Blood bicarbonate decreased | 10 | 9.994 | 0.515 | 0.867 | 1.294 | 0.595 | 0.958 | 1.476 | 1.001 | 1.601 | 1.417
COVID19 (Custom Term) | Scan normal | 2 | 2.595 | 0.282 | 0.867 | 1.712 | 0.369 | 0.81 | 1.591 | 0.771 | 0.473 | 0.637
COVID19 (Custom Term) | Ultrasound scan | 59 | 73.86 | 0.695 | 0.867 | 1.054 | 0.647 | 0.801 | 0.982 | 0.799 | 1.042 | 0.055
COVID19 (Custom Term) | Herpes virus infection | 4 | 6.968 | 0.34 | 0.867 | 1.589 | 0.343 | 0.664 | 1.184 | 0.574 | 0.371 | 3.468
COVID19 (Custom Term) | Mood altered | 3 | 5.45 | 0.312 | 0.867 | 1.646 | 0.325 | 0.664 | 1.237 | 0.55 | 0.132 | 16.013
COVID19 (Custom Term) | Erythroblast count increased | 0 | 0.183 | 0.066 | 0.867 | 2.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac imaging procedure | 0 | 0.183 | 0.066 | 0.867 | 2.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Infusion site pain | 0 | 0.183 | 0.066 | 0.867 | 2.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Fungal test negative | 2 | 2.114 | 0.339 | 0.866 | 1.589 | 0.401 | 0.878 | 1.726 | 0.946 | 0.552 | 0.302
COVID19 (Custom Term) | CSF glucose increased | 2 | 2.119 | 0.243 | 0.866 | 1.8 | 0.4 | 0.878 | 1.724 | 0.944 | 0.509 | 0.46
COVID19 (Custom Term) | Acute chest syndrome | 0 | 0.183 | 0.065 | 0.866 | 2.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal erosion | 0 | 0.183 | 0.065 | 0.866 | 2.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurotransmitter level altered | 0 | 0.183 | 0.065 | 0.866 | 2.448 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid infection | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye infection viral | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth repair | 0 | 0.183 | 0.066 | 0.866 | 2.445 |  |  |  |  |  | 
COVID19 (Custom Term) | Carotid artery thrombosis | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Malformation venous | 0 | 0.183 | 0.066 | 0.866 | 2.445 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cancer recurrent | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertebral column mass | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Neovascular age-related macular degeneration | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve infarction | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Calcium ionised | 0 | 0.183 | 0.066 | 0.866 | 2.445 |  |  |  |  |  | 
COVID19 (Custom Term) | Colon operation | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Mastectomy | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Computerised tomogram liver | 0 | 0.183 | 0.065 | 0.866 | 2.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostate examination | 0 | 0.183 | 0.065 | 0.866 | 2.446 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiolipin antibody positive | 0 | 0.101 | 0.011 | 0.866 | 3.025 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint swelling | 2 | 2.047 | 0.322 | 0.865 | 1.619 | 0.405 | 0.889 | 1.746 | 0.977 | 0.946 | 0.082
COVID19 (Custom Term) | Strabismus | 2 | 2.712 | 0.319 | 0.865 | 1.628 | 0.362 | 0.794 | 1.561 | 0.737 | 0.119 | 11.968
COVID19 (Custom Term) | Excessive cerumen production | 0 | 0.291 | 0.141 | 0.865 | 2.096 |  |  |  |  |  | 
COVID19 (Custom Term) | B-lymphocyte abnormalities | 0 | 0.183 | 0.064 | 0.865 | 2.452 |  |  |  |  |  | 
COVID19 (Custom Term) | Tarsal tunnel syndrome | 0 | 0.183 | 0.063 | 0.865 | 2.453 |  |  |  |  |  | 
COVID19 (Custom Term) | Severe invasive streptococcal infection | 0 | 0.183 | 0.063 | 0.865 | 2.452 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatological examination | 0 | 0.183 | 0.064 | 0.865 | 2.451 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypomania | 0 | 0.183 | 0.064 | 0.865 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Post thrombotic syndrome | 0 | 0.183 | 0.064 | 0.865 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Mass excision | 0 | 0.226 | 0.096 | 0.865 | 2.278 |  |  |  |  |  | 
COVID19 (Custom Term) | Musculoskeletal stiffness | 249 | 291.108 | 0.778 | 0.864 | 0.954 | 0.77 | 0.855 | 0.947 | 0.855 | 0.793 | 12.38
COVID19 (Custom Term) | Haemophagocytic lymphohistiocytosis | 2 | 3.019 | 0.244 | 0.864 | 1.792 | 0.344 | 0.757 | 1.489 | 0.662 | 0.484 | 0.576
COVID19 (Custom Term) | Morbid thoughts | 0 | 0.183 | 0.063 | 0.864 | 2.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Tobacco abuse | 0 | 0.183 | 0.062 | 0.864 | 2.457 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast induration | 0 | 0.183 | 0.063 | 0.864 | 2.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood potassium abnormal | 0 | 0.183 | 0.062 | 0.864 | 2.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Haematoma infection | 0 | 0.183 | 0.063 | 0.864 | 2.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine amphetamine negative | 0 | 0.183 | 0.063 | 0.864 | 2.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Creutzfeldt-Jakob disease | 0 | 0.183 | 0.063 | 0.864 | 2.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipase decreased | 0 | 0.183 | 0.063 | 0.864 | 2.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometrial thickening | 0 | 0.183 | 0.063 | 0.864 | 2.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Smooth muscle antibody | 0 | 0.183 | 0.062 | 0.864 | 2.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Invasive ductal breast carcinoma | 0 | 0.183 | 0.063 | 0.864 | 2.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile oedema | 0 | 0.183 | 0.063 | 0.864 | 2.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Paraplegia | 2 | 2.691 | 0.226 | 0.863 | 1.836 | 0.363 | 0.797 | 1.567 | 0.743 | 0.509 | 0.46
COVID19 (Custom Term) | Vasodilatation | 1 | 1.49 | 0.328 | 0.863 | 1.603 | 0.321 | 0.785 | 1.666 | 0.671 | 0.382 | 0.42
COVID19 (Custom Term) | Injection site extravasation | 9 | 12.912 | 0.477 | 0.863 | 1.341 | 0.443 | 0.728 | 1.141 | 0.697 | 0.604 | 1.814
COVID19 (Custom Term) | Perineal pain | 0 | 0.183 | 0.062 | 0.863 | 2.457 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbohydrate antigen 125 normal | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Mammoplasty | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial cyst removal | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast disorder female | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Orbital myositis | 0 | 0.183 | 0.061 | 0.863 | 2.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermal cyst | 0 | 0.225 | 0.093 | 0.863 | 2.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Deafness permanent | 0 | 0.183 | 0.062 | 0.863 | 2.457 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemangioma of liver | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Disease prodromal stage | 0 | 0.183 | 0.061 | 0.863 | 2.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Cell-mediated immune deficiency | 0 | 0.183 | 0.062 | 0.863 | 2.458 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal disorder | 0 | 0.183 | 0.061 | 0.863 | 2.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging breast abnormal | 0 | 0.183 | 0.061 | 0.863 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Miosis | 4 | 3.998 | 0.394 | 0.862 | 1.477 | 0.479 | 0.924 | 1.647 | 1.001 | 1.805 | 0.582
COVID19 (Custom Term) | Accidents and injuries (SMQ) [narrow] | 511 | 616.608 | 0.801 | 0.862 | 0.925 | 0.77 | 0.829 | 0.891 | 0.829 | 0.845 | 13.476
COVID19 (Custom Term) | Blindness transient | 8 | 10.965 | 0.457 | 0.862 | 1.372 | 0.45 | 0.757 | 1.209 | 0.73 | 0.935 | 0
COVID19 (Custom Term) | Eosinophilia | 3 | 5.503 | 0.296 | 0.862 | 1.669 | 0.323 | 0.66 | 1.23 | 0.545 | 0.426 | 1.666
COVID19 (Custom Term) | Intermittent positive pressure breathing | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | AST/ALT ratio | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Prealbumin increased | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic bacterial infection | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy prostate | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lead normal | 0 | 0.183 | 0.061 | 0.862 | 2.463 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal deviation | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Type II hypersensitivity | 0 | 0.183 | 0.06 | 0.862 | 2.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibromuscular dysplasia | 0 | 0.183 | 0.06 | 0.862 | 2.464 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis cryptococcal | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Antiribosomal P antibody | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Swollen joint count | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal obstruction | 0 | 0.183 | 0.06 | 0.862 | 2.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebellar tumour | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Tenoplasty | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Tender joint count | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine electrophoresis abnormal | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital labial adhesions | 0 | 0.183 | 0.06 | 0.862 | 2.464 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial fluid crystal | 0 | 0.183 | 0.06 | 0.862 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunosuppressant drug level | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint effusion | 0 | 0.412 | 0.203 | 0.862 | 1.892 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site phlebitis | 0 | 0.183 | 0.061 | 0.862 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Lip haemorrhage | 3 | 3.104 | 0.38 | 0.861 | 1.5 | 0.441 | 0.898 | 1.671 | 0.966 | 1.568 | 0.13
COVID19 (Custom Term) | Visual field tests abnormal | 1 | 2 | 0.213 | 0.861 | 1.863 | 0.289 | 0.71 | 1.513 | 0.5 | 0.382 | 0.42
COVID19 (Custom Term) | Otitis media | 2 | 4.022 | 0.255 | 0.861 | 1.756 | 0.297 | 0.656 | 1.293 | 0.497 | 0.083 | 19.193
COVID19 (Custom Term) | Gouty arthritis | 0 | 0.183 | 0.059 | 0.861 | 2.468 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrin normal | 0 | 0.183 | 0.06 | 0.861 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Chondrocalcinosis | 0 | 0.183 | 0.059 | 0.861 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor XIII level decreased | 0 | 0.183 | 0.059 | 0.861 | 2.47 |  |  |  |  |  | 
COVID19 (Custom Term) | Activated partial thromboplastin time ratio normal | 0 | 0.183 | 0.059 | 0.861 | 2.47 |  |  |  |  |  | 
COVID19 (Custom Term) | Crystalluria | 0 | 0.183 | 0.06 | 0.861 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Spleen palpable | 0 | 0.183 | 0.059 | 0.861 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Sinus node dysfunction | 0 | 0.183 | 0.059 | 0.861 | 2.47 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF electrophoresis normal | 0 | 0.183 | 0.059 | 0.861 | 2.468 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes simplex meningoencephalitis | 0 | 0.183 | 0.059 | 0.861 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood osmolarity decreased | 3 | 3.048 | 0.343 | 0.86 | 1.566 | 0.444 | 0.906 | 1.685 | 0.984 | 2.291 | 0.807
COVID19 (Custom Term) | Foetal death | 8 | 11.263 | 0.437 | 0.86 | 1.398 | 0.441 | 0.742 | 1.185 | 0.71 | 1.059 | 0.001
COVID19 (Custom Term) | Ultrasound uterus normal | 0 | 0.183 | 0.058 | 0.86 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Karyotype analysis | 0 | 0.183 | 0.058 | 0.86 | 2.472 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood homocysteine increased | 0 | 0.183 | 0.058 | 0.86 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Product physical consistency issue | 0 | 0.183 | 0.058 | 0.86 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Volvulus of small bowel | 0 | 0.183 | 0.058 | 0.86 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyruvate kinase | 0 | 0.183 | 0.058 | 0.86 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-insulin antibody decreased | 0 | 0.183 | 0.058 | 0.86 | 2.473 |  |  |  |  |  | 
COVID19 (Custom Term) | Polymorphic light eruption | 0 | 0.183 | 0.058 | 0.86 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Internal fixation of fracture | 0 | 0.183 | 0.058 | 0.86 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Oromandibular dystonia | 0 | 0.183 | 0.058 | 0.86 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Solar lentigo | 0 | 0.183 | 0.058 | 0.86 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Listeriosis | 0 | 0.183 | 0.058 | 0.86 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin CSF increased | 1 | 0.987 | 0.106 | 0.859 | 2.216 | 0.359 | 0.874 | 1.853 | 1.013 | 0.414 | 0.298
COVID19 (Custom Term) | Cerebral atrophy | 5 | 5.073 | 0.393 | 0.859 | 1.471 | 0.502 | 0.925 | 1.592 | 0.986 | 2.364 | 2.082
COVID19 (Custom Term) | Red blood cell sedimentation rate | 27 | 31.099 | 0.628 | 0.859 | 1.12 | 0.635 | 0.865 | 1.157 | 0.868 | 1.108 | 0.159
COVID19 (Custom Term) | Ear infection | 9 | 10.652 | 0.485 | 0.859 | 1.319 | 0.514 | 0.844 | 1.322 | 0.845 | 0.226 | 22.583
COVID19 (Custom Term) | Accidents and injuries (SMQ) [broad] | 557 | 673.284 | 0.8 | 0.859 | 0.92 | 0.771 | 0.827 | 0.886 | 0.827 | 0.839 | 16.074
COVID19 (Custom Term) | IIIrd nerve paralysis | 1 | 1.492 | 0.234 | 0.859 | 1.803 | 0.321 | 0.784 | 1.666 | 0.67 | 0.397 | 0.357
COVID19 (Custom Term) | Neuralgia | 69 | 98.024 | 0.698 | 0.859 | 1.035 | 0.582 | 0.709 | 0.857 | 0.704 | 0.655 | 11.448
COVID19 (Custom Term) | Parvovirus B19 test negative | 2 | 3.613 | 0.242 | 0.859 | 1.782 | 0.315 | 0.694 | 1.366 | 0.554 | 0.301 | 2.451
COVID19 (Custom Term) | Myelofibrosis | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemophilia | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Porokeratosis | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Post polio syndrome | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Familial mediterranean fever | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticoagulation drug level | 0 | 0.183 | 0.057 | 0.859 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital hypoaesthesia | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital infection fungal | 0 | 0.183 | 0.056 | 0.859 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenocarcinoma of colon | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Eustachian tube operation | 0 | 0.183 | 0.056 | 0.859 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy rectum abnormal | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphangiopathy | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental care | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastritis haemorrhagic | 0 | 0.183 | 0.057 | 0.859 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet distribution width decreased | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin E | 0 | 0.183 | 0.057 | 0.859 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Red man syndrome | 0 | 0.183 | 0.057 | 0.859 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Thumb sucking | 0 | 0.183 | 0.057 | 0.859 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Sexually transmitted disease test | 0 | 0.183 | 0.057 | 0.859 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Posterior capsule opacification | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Postmenopause | 0 | 0.183 | 0.057 | 0.859 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival ulceration | 0 | 0.183 | 0.057 | 0.859 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal decompression | 0 | 0.183 | 0.057 | 0.859 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Mouth haemorrhage | 11 | 11.859 | 0.527 | 0.858 | 1.255 | 0.574 | 0.907 | 1.377 | 0.928 | 1.496 | 1.134
COVID19 (Custom Term) | Ultrasound chest | 2 | 2.547 | 0.327 | 0.858 | 1.592 | 0.372 | 0.816 | 1.604 | 0.785 | 1.045 | 0.102
COVID19 (Custom Term) | Non-haematological tumours of unspecified malignancy (SMQ) [broad] | 2 | 2.662 | 0.245 | 0.858 | 1.772 | 0.365 | 0.801 | 1.574 | 0.751 | 0.261 | 3.317
COVID19 (Custom Term) | Non-haematological tumours of unspecified malignancy (SMQ) [narrow] | 2 | 2.662 | 0.245 | 0.858 | 1.772 | 0.365 | 0.801 | 1.574 | 0.751 | 0.261 | 3.317
COVID19 (Custom Term) | Gastric disorder | 8 | 10.321 | 0.471 | 0.858 | 1.339 | 0.471 | 0.792 | 1.265 | 0.775 | 0.722 | 0.538
COVID19 (Custom Term) | Cytogenetic analysis normal | 2 | 3.106 | 0.34 | 0.858 | 1.567 | 0.34 | 0.747 | 1.47 | 0.644 | 0.32 | 2.117
COVID19 (Custom Term) | Intraocular pressure test abnormal | 0 | 0.183 | 0.056 | 0.858 | 2.481 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy thyroid gland | 0 | 0.183 | 0.056 | 0.858 | 2.481 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal disorder | 0 | 0.183 | 0.056 | 0.858 | 2.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Activated partial thromboplastin time abnormal | 0 | 0.183 | 0.056 | 0.858 | 2.481 |  |  |  |  |  | 
COVID19 (Custom Term) | Kaposi's sarcoma | 0 | 0.183 | 0.055 | 0.858 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Familial tremor | 0 | 0.183 | 0.055 | 0.858 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Basophil degranulation test | 0 | 0.183 | 0.056 | 0.858 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-transglutaminase antibody increased | 0 | 0.183 | 0.055 | 0.858 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Mallory-Weiss syndrome | 0 | 0.183 | 0.056 | 0.858 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Infected skin ulcer | 0 | 0.183 | 0.056 | 0.858 | 2.481 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull X-ray | 1 | 1.009 | 0.288 | 0.857 | 1.671 | 0.357 | 0.869 | 1.844 | 0.991 | 0.764 | 0.041
COVID19 (Custom Term) | Blood alkaline phosphatase | 1 | 1.521 | 0.206 | 0.857 | 1.87 | 0.319 | 0.78 | 1.656 | 0.657 | 0.662 | 0.001
COVID19 (Custom Term) | Urine mercury | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Sweat test | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Salivary gland neoplasm | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal infarct | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal thinning | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Malaria antibody test | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Citrobacter test positive | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Body mass index decreased | 0 | 0.183 | 0.054 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal oedema | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucocutaneous candidiasis | 0 | 0.183 | 0.055 | 0.857 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Arteritis | 0 | 0.183 | 0.055 | 0.857 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Procalcitonin abnormal | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement fixation test positive | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine copper increased | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood cholinesterase | 0 | 0.183 | 0.054 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Prinzmetal angina | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Solar dermatitis | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood methaemoglobin absent | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligamentitis | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail infection | 0 | 0.183 | 0.055 | 0.857 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropsychological test | 0 | 0.162 | 0.04 | 0.857 | 2.598 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival injury | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal polyp | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Instillation site erythema | 0 | 0.183 | 0.055 | 0.857 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbon dioxide abnormal | 0 | 0.183 | 0.055 | 0.857 | 2.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Merycism | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephritic syndrome | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QRS complex | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Epidural analgesia | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Otosalpingitis | 0 | 0.183 | 0.054 | 0.857 | 2.487 |  |  |  |  |  | 
COVID19 (Custom Term) | pH urine increased | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Chondrocalcinosis pyrophosphate | 0 | 0.183 | 0.055 | 0.857 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival pallor | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Product impurity | 0 | 0.183 | 0.055 | 0.857 | 2.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta globulin normal | 0 | 0.183 | 0.055 | 0.857 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF cell count decreased | 0 | 0.183 | 0.055 | 0.857 | 2.486 |  |  |  |  |  | 
COVID19 (Custom Term) | Cogan's syndrome | 0 | 0.183 | 0.055 | 0.857 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Type 1 diabetes mellitus | 3 | 2.635 | 0.285 | 0.856 | 1.677 | 0.474 | 0.966 | 1.798 | 1.139 | 0.193 | 9.05
COVID19 (Custom Term) | Blood smear test normal | 3 | 3.064 | 0.322 | 0.856 | 1.598 | 0.443 | 0.904 | 1.681 | 0.979 | 1.568 | 0.13
COVID19 (Custom Term) | Blood smear test | 6 | 6.902 | 0.418 | 0.856 | 1.42 | 0.483 | 0.859 | 1.437 | 0.869 | 5.958 | 12.248
COVID19 (Custom Term) | Skin haemorrhage | 2 | 3.209 | 0.313 | 0.856 | 1.615 | 0.334 | 0.736 | 1.447 | 0.623 | 0.315 | 2.2
COVID19 (Custom Term) | Skin plaque | 2 | 3.355 | 0.319 | 0.856 | 1.602 | 0.327 | 0.72 | 1.417 | 0.596 | 0.165 | 7.402
COVID19 (Custom Term) | Autoimmune thyroiditis | 3 | 5.059 | 0.269 | 0.856 | 1.71 | 0.34 | 0.695 | 1.293 | 0.593 | 0.24 | 6.248
COVID19 (Custom Term) | Furuncle | 1 | 2.667 | 0.386 | 0.856 | 1.476 | 0.254 | 0.631 | 1.351 | 0.375 | 0.187 | 2.638
COVID19 (Custom Term) | Leukaemia in remission | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Athetosis | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic neoplasm | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Tympanometry normal | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug monitoring procedure not performed | 0 | 0.183 | 0.054 | 0.856 | 2.489 |  |  |  |  |  | 
COVID19 (Custom Term) | Lasegue's test positive | 0 | 0.183 | 0.054 | 0.856 | 2.489 |  |  |  |  |  | 
COVID19 (Custom Term) | Traumatic haematoma | 0 | 0.183 | 0.054 | 0.856 | 2.488 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac resynchronisation therapy | 0 | 0.183 | 0.054 | 0.856 | 2.488 |  |  |  |  |  | 
COVID19 (Custom Term) | Micrographic skin surgery | 0 | 0.183 | 0.054 | 0.856 | 2.488 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimitochondrial antibody | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine output | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Photopheresis | 0 | 0.183 | 0.053 | 0.856 | 2.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenovirus test | 3 | 3.165 | 0.282 | 0.855 | 1.679 | 0.437 | 0.89 | 1.656 | 0.948 | 0.15 | 13.279
COVID19 (Custom Term) | Malignancy related therapeutic and diagnostic procedures (SMQ) [broad] | 91 | 119.513 | 0.715 | 0.855 | 1.006 | 0.643 | 0.764 | 0.902 | 0.761 | 0.592 | 23.822
COVID19 (Custom Term) | Malignancy related therapeutic and diagnostic procedures (SMQ) [narrow] | 91 | 119.513 | 0.715 | 0.855 | 1.006 | 0.643 | 0.764 | 0.902 | 0.761 | 0.592 | 23.822
COVID19 (Custom Term) | Hepatitis C virus test | 1 | 2.267 | 0.168 | 0.855 | 1.974 | 0.274 | 0.676 | 1.444 | 0.441 | 0.496 | 0.102
COVID19 (Custom Term) | Heat illness | 0 | 0.183 | 0.053 | 0.855 | 2.492 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood chromium | 0 | 0.183 | 0.053 | 0.855 | 2.494 |  |  |  |  |  | 
COVID19 (Custom Term) | Parietal cell antibody negative | 0 | 0.183 | 0.053 | 0.855 | 2.492 |  |  |  |  |  | 
COVID19 (Custom Term) | Acid base balance abnormal | 0 | 0.183 | 0.053 | 0.855 | 2.492 |  |  |  |  |  | 
COVID19 (Custom Term) | Otoacoustic emissions test abnormal | 0 | 0.183 | 0.052 | 0.855 | 2.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Periorbital haemorrhage | 0 | 0.183 | 0.053 | 0.855 | 2.492 |  |  |  |  |  | 
COVID19 (Custom Term) | Pedal pulse decreased | 0 | 0.183 | 0.053 | 0.855 | 2.493 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell sedimentation rate decreased | 0 | 0.183 | 0.052 | 0.855 | 2.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Hippocampal sclerosis | 0 | 0.183 | 0.052 | 0.855 | 2.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyposplenism | 0 | 0.183 | 0.053 | 0.855 | 2.494 |  |  |  |  |  | 
COVID19 (Custom Term) | Bursa removal | 0 | 0.183 | 0.052 | 0.855 | 2.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal reflex decreased | 6 | 6.521 | 0.442 | 0.854 | 1.375 | 0.501 | 0.891 | 1.491 | 0.92 | 5.416 | 11.011
COVID19 (Custom Term) | X-ray | 87 | 113.503 | 0.712 | 0.854 | 1.008 | 0.644 | 0.769 | 0.911 | 0.767 | 0.917 | 0.519
COVID19 (Custom Term) | Sciatic nerve neuropathy | 0 | 0.183 | 0.052 | 0.854 | 2.497 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipoatrophy | 0 | 0.183 | 0.051 | 0.854 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Product packaging issue | 0 | 0.242 | 0.091 | 0.854 | 2.268 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluorescent in situ hybridisation positive | 0 | 0.183 | 0.051 | 0.854 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site calcification | 0 | 0.183 | 0.051 | 0.854 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Cancer surgery | 0 | 0.204 | 0.065 | 0.854 | 2.407 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumothorax spontaneous | 0 | 0.183 | 0.051 | 0.854 | 2.499 |  |  |  |  |  | 
COVID19 (Custom Term) | Head circumference normal | 0 | 0.183 | 0.051 | 0.854 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site haematoma | 0 | 0.183 | 0.052 | 0.854 | 2.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Glioblastoma | 0 | 0.183 | 0.052 | 0.854 | 2.497 |  |  |  |  |  | 
COVID19 (Custom Term) | Coronary angioplasty | 0 | 0.183 | 0.052 | 0.854 | 2.497 |  |  |  |  |  | 
COVID19 (Custom Term) | Carcinoembryonic antigen increased | 0 | 0.183 | 0.052 | 0.854 | 2.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia legionella | 0 | 0.183 | 0.052 | 0.854 | 2.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site cyst | 0 | 0.183 | 0.051 | 0.854 | 2.498 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericardial rub | 0 | 0.183 | 0.051 | 0.854 | 2.498 |  |  |  |  |  | 
COVID19 (Custom Term) | Bilirubin urine | 5 | 5.042 | 0.415 | 0.853 | 1.418 | 0.503 | 0.928 | 1.598 | 0.992 | 2.159 | 1.614
COVID19 (Custom Term) | Erythema multiforme | 26 | 30.133 | 0.613 | 0.853 | 1.126 | 0.628 | 0.86 | 1.156 | 0.863 | 0.687 | 3.167
COVID19 (Custom Term) | Encephalitis | 13 | 16.824 | 0.522 | 0.853 | 1.249 | 0.512 | 0.785 | 1.161 | 0.773 | 0.344 | 15.025
COVID19 (Custom Term) | Hypokinesia | 11 | 14.385 | 0.501 | 0.853 | 1.279 | 0.493 | 0.78 | 1.184 | 0.765 | 0.666 | 1.4
COVID19 (Custom Term) | Aortic valve replacement | 0 | 0.183 | 0.051 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell analysis normal | 0 | 0.183 | 0.051 | 0.853 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VIII level normal | 0 | 0.183 | 0.051 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis shigella | 0 | 0.183 | 0.051 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Wrist deformity | 0 | 0.183 | 0.05 | 0.853 | 2.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic pigmented purpura | 0 | 0.183 | 0.051 | 0.853 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular function test normal | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood luteinising hormone | 0 | 0.183 | 0.051 | 0.853 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine iodine increased | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | Echoencephalogram normal | 0 | 0.183 | 0.05 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue geographic | 0 | 0.183 | 0.05 | 0.853 | 2.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis lethargica | 0 | 0.183 | 0.051 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound pancreas normal | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin electrophoresis normal | 0 | 0.183 | 0.051 | 0.853 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Periventricular leukomalacia | 0 | 0.183 | 0.05 | 0.853 | 2.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Diffuse alveolar damage | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell analysis | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | Acetonaemia | 0 | 0.183 | 0.051 | 0.853 | 2.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Hoffmann's sign | 0 | 0.183 | 0.051 | 0.853 | 2.501 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet aggregation test | 0 | 0.183 | 0.051 | 0.853 | 2.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cells urine positive | 5 | 6.432 | 0.367 | 0.852 | 1.499 | 0.433 | 0.8 | 1.377 | 0.777 | 0.443 | 2.787
COVID19 (Custom Term) | Blindness | 30 | 42.341 | 0.621 | 0.852 | 1.113 | 0.536 | 0.719 | 0.948 | 0.709 | 0.812 | 1.029
COVID19 (Custom Term) | Total bile acids increased | 0 | 0.183 | 0.05 | 0.852 | 2.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte percentage | 0 | 0.183 | 0.049 | 0.852 | 2.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Deficiency anaemia | 0 | 0.183 | 0.049 | 0.852 | 2.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Chorioretinal atrophy | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitochondrial encephalomyopathy | 0 | 0.183 | 0.05 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Mannose-binding lectin deficiency | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Heterophoria | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenosis | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Periodontitis | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Lactate pyruvate ratio | 0 | 0.183 | 0.05 | 0.852 | 2.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary valve stenosis | 0 | 0.183 | 0.049 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Invasive lobular breast carcinoma | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal transit time decreased | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Circulating anticoagulant | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Somnolence neonatal | 0 | 0.183 | 0.049 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein C decreased | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via mucosa | 0 | 0.183 | 0.05 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Accessory spleen | 0 | 0.183 | 0.05 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine lactic acid increased | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Toe amputation | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system injury | 0 | 0.183 | 0.049 | 0.852 | 2.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertebrobasilar insufficiency | 0 | 0.183 | 0.05 | 0.852 | 2.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Meige's syndrome | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Ketogenic diet | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract infection pseudomonal | 0 | 0.183 | 0.05 | 0.852 | 2.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal abscess | 0 | 0.183 | 0.049 | 0.852 | 2.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal respiratory distress | 0 | 0.183 | 0.049 | 0.852 | 2.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair metal test normal | 0 | 0.183 | 0.05 | 0.852 | 2.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemolytic anaemia | 8 | 7.853 | 0.474 | 0.851 | 1.317 | 0.573 | 0.962 | 1.537 | 1.019 | 2.482 | 4.435
COVID19 (Custom Term) | Type III immune complex mediated reaction | 3 | 4.026 | 0.303 | 0.851 | 1.623 | 0.387 | 0.789 | 1.468 | 0.745 | 0.222 | 7.171
COVID19 (Custom Term) | Pulmonary fibrosis | 2 | 3.271 | 0.212 | 0.851 | 1.836 | 0.331 | 0.729 | 1.434 | 0.611 | 0.662 | 0.069
COVID19 (Custom Term) | Coagulation time shortened | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Intercostal neuralgia | 0 | 0.183 | 0.048 | 0.851 | 2.511 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute graft versus host disease | 0 | 0.183 | 0.048 | 0.851 | 2.511 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic disorders specifically reported as alcohol-related (SMQ) [narrow] | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Vestibular ataxia | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Granuloma annulare | 0 | 0.31 | 0.129 | 0.851 | 2.097 |  |  |  |  |  | 
COVID19 (Custom Term) | Apheresis | 0 | 0.183 | 0.048 | 0.851 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Sputum retention | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Ureteritis | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Developmental coordination disorder | 0 | 0.183 | 0.049 | 0.851 | 2.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Device use issue | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic disorders specifically reported as alcohol-related (SMQ) [broad] | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Spherocytic anaemia | 0 | 0.183 | 0.048 | 0.851 | 2.511 |  |  |  |  |  | 
COVID19 (Custom Term) | Coarctation of the aorta | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypophonesis | 0 | 0.183 | 0.048 | 0.851 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Nocardiosis | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobin blood decreased | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Human ehrlichiosis | 0 | 0.183 | 0.049 | 0.851 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac hypertrophy | 0 | 0.183 | 0.049 | 0.851 | 2.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Splinter haemorrhages | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Human herpes virus 6 serology positive | 0 | 0.183 | 0.048 | 0.851 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Antigliadin antibody positive | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalopathy allergic | 0 | 0.183 | 0.048 | 0.851 | 2.511 |  |  |  |  |  | 
COVID19 (Custom Term) | Scleroedema | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian germ cell teratoma | 0 | 0.183 | 0.048 | 0.851 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Skeletal survey | 0 | 0.183 | 0.049 | 0.851 | 2.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostate malignant tumours (SMQ) [broad] | 1 | 1.179 | 0.221 | 0.85 | 1.81 | 0.344 | 0.837 | 1.776 | 0.848 | 0.903 | 0.162
COVID19 (Custom Term) | Product administration error | 13 | 21.301 | 0.506 | 0.85 | 1.266 | 0.42 | 0.643 | 0.953 | 0.61 | 0.42 | 9.369
COVID19 (Custom Term) | Liver tenderness | 0 | 0.183 | 0.048 | 0.85 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte stimulation test negative | 0 | 0.183 | 0.047 | 0.85 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound infection staphylococcal | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell poikilocytes present | 0 | 0.183 | 0.047 | 0.85 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymph node tuberculosis | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve transposition | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cancer in situ | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial fistula | 0 | 0.183 | 0.048 | 0.85 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Specific gravity urine abnormal | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Benzodiazepine drug level | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine decreased | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestrogen deficiency | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Bartonellosis | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Gallbladder hypofunction | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Prenatal care | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyomavirus test negative | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Extremity necrosis | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin normal | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Computerised tomogram coronary artery abnormal | 0 | 0.183 | 0.048 | 0.85 | 2.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood cadmium increased | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatotropin stimulation test | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Tolosa-Hunt syndrome | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder dysfunction | 0 | 0.282 | 0.11 | 0.85 | 2.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipoma excision | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Xanthelasma | 0 | 0.183 | 0.047 | 0.85 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Agoraphobia | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphangioma | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Rehabilitation therapy | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Tubulointerstitial nephritis and uveitis syndrome | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma stage I | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pressure orthostatic normal | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrovascular stenosis | 0 | 0.183 | 0.048 | 0.85 | 2.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood selenium | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | ADAMTS13 activity increased | 0 | 0.183 | 0.048 | 0.85 | 2.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid operation | 0 | 0.183 | 0.047 | 0.85 | 2.515 |  |  |  |  |  | 
COVID19 (Custom Term) | Reactive airways dysfunction syndrome | 0 | 0.183 | 0.047 | 0.85 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint dislocation | 4 | 4.252 | 0.372 | 0.849 | 1.484 | 0.464 | 0.894 | 1.594 | 0.941 | 1.045 | 0.034
COVID19 (Custom Term) | Injection site abscess | 6 | 6.462 | 0.416 | 0.849 | 1.407 | 0.504 | 0.897 | 1.5 | 0.929 | 0.23 | 14.309
COVID19 (Custom Term) | Central nervous system lesion | 5 | 8.449 | 0.389 | 0.849 | 1.454 | 0.36 | 0.666 | 1.146 | 0.592 | 0.477 | 2.209
COVID19 (Custom Term) | Enamel anomaly | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | ACTH stimulation test normal | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy prostate abnormal | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Suicidal behaviour | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Otoscopy | 0 | 0.183 | 0.047 | 0.849 | 2.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperresponsive to stimuli | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Prealbumin decreased | 0 | 0.183 | 0.046 | 0.849 | 2.519 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia pseudomonal | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid hormone replacement therapy | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital syphilis | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Obstruction gastric | 0 | 0.183 | 0.047 | 0.849 | 2.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginitis | 0 | 0.183 | 0.047 | 0.849 | 2.519 |  |  |  |  |  | 
COVID19 (Custom Term) | Astrocytoma | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenosine deaminase | 0 | 0.183 | 0.047 | 0.849 | 2.519 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve hypoplasia | 0 | 0.183 | 0.047 | 0.849 | 2.519 |  |  |  |  |  | 
COVID19 (Custom Term) | Anterior interosseous syndrome | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiomyolipoma | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone loss | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood HIV RNA decreased | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytokine abnormal | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bone | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol test | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileocolostomy | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Erosive oesophagitis | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Lennox-Gastaut syndrome | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Crystal arthropathy | 0 | 0.183 | 0.047 | 0.849 | 2.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood electrolytes increased | 0 | 0.183 | 0.047 | 0.849 | 2.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Ejaculation failure | 0 | 0.183 | 0.047 | 0.849 | 2.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site necrosis | 0 | 0.183 | 0.046 | 0.849 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal enanthema | 0 | 0.183 | 0.046 | 0.848 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumoconiosis | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Failed induction of labour | 0 | 0.183 | 0.045 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticonvulsant drug level increased | 0 | 0.183 | 0.045 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Disease risk factor | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile discharge | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Burning sensation mucosal | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Transient hypogammaglobulinaemia of infancy | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal aplasia | 0 | 0.183 | 0.045 | 0.848 | 2.524 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs test | 0 | 0.183 | 0.046 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Claudication of jaw muscles | 0 | 0.183 | 0.045 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral arteritis | 0 | 0.183 | 0.046 | 0.848 | 2.521 |  |  |  |  |  | 
COVID19 (Custom Term) | PCO2 | 0 | 0.297 | 0.117 | 0.848 | 2.136 |  |  |  |  |  | 
COVID19 (Custom Term) | Avulsion fracture | 0 | 0.183 | 0.046 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular myasthenia | 0 | 0.183 | 0.046 | 0.848 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Subclavian vein thrombosis | 0 | 0.183 | 0.045 | 0.848 | 2.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal cyst | 0 | 0.183 | 0.046 | 0.848 | 2.521 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic cyst | 0 | 0.183 | 0.046 | 0.848 | 2.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Epidural injection | 0 | 0.183 | 0.046 | 0.848 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Vesicoureteral reflux surgery | 0 | 0.183 | 0.046 | 0.848 | 2.521 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema | 1113 | 1381.603 | 0.806 | 0.847 | 0.889 | 0.767 | 0.806 | 0.846 | 0.806 | 0.541 | 437.356
COVID19 (Custom Term) | Eczema | 11 | 14.048 | 0.495 | 0.847 | 1.276 | 0.503 | 0.795 | 1.207 | 0.783 | 0.185 | 37.926
COVID19 (Custom Term) | Oropharyngeal neoplasms (SMQ) [narrow] | 2 | 2.952 | 0.251 | 0.847 | 1.729 | 0.348 | 0.765 | 1.504 | 0.678 | 0.993 | 0.13
COVID19 (Custom Term) | Oropharyngeal neoplasms (SMQ) [broad] | 2 | 2.952 | 0.251 | 0.847 | 1.729 | 0.348 | 0.765 | 1.504 | 0.678 | 0.993 | 0.13
COVID19 (Custom Term) | Cardiovascular disorder | 4 | 7.65 | 0.314 | 0.847 | 1.589 | 0.322 | 0.623 | 1.113 | 0.523 | 0.523 | 1.196
COVID19 (Custom Term) | Blood group B | 0 | 0.183 | 0.045 | 0.847 | 2.524 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis membranoproliferative | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Ehrlichia test positive | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-glomerular basement membrane antibody positive | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb amputation | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye infection staphylococcal | 0 | 0.183 | 0.045 | 0.847 | 2.525 |  |  |  |  |  | 
COVID19 (Custom Term) | Chorioretinal disorder | 0 | 0.183 | 0.045 | 0.847 | 2.527 |  |  |  |  |  | 
COVID19 (Custom Term) | Histiocytic necrotising lymphadenitis | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Body height below normal | 0 | 0.183 | 0.045 | 0.847 | 2.524 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysbiosis | 0 | 0.238 | 0.079 | 0.847 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital pyelocaliectasis | 0 | 0.183 | 0.045 | 0.847 | 2.527 |  |  |  |  |  | 
COVID19 (Custom Term) | Sinusitis bacterial | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Shoulder operation | 0 | 0.397 | 0.168 | 0.847 | 1.951 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy blood vessel abnormal | 0 | 0.183 | 0.045 | 0.847 | 2.525 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem ischaemia | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular insufficiency | 0 | 0.251 | 0.087 | 0.847 | 2.266 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin C | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy oesophagus abnormal | 0 | 0.183 | 0.045 | 0.847 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal injury | 1 | 0.987 | 0.237 | 0.846 | 1.76 | 0.359 | 0.874 | 1.853 | 1.013 | 0.827 | 0.089
COVID19 (Custom Term) | Urinary system X-ray | 1 | 0.996 | 0.241 | 0.846 | 1.748 | 0.359 | 0.872 | 1.849 | 1.004 | 0.451 | 0.191
COVID19 (Custom Term) | Face injury | 7 | 9.773 | 0.454 | 0.846 | 1.338 | 0.434 | 0.749 | 1.223 | 0.716 | 0.473 | 3.395
COVID19 (Custom Term) | Extravasation events (injections, infusions and implants) (SMQ) [narrow] | 11 | 15.297 | 0.494 | 0.846 | 1.276 | 0.469 | 0.742 | 1.127 | 0.719 | 0.723 | 0.82
COVID19 (Custom Term) | Drug abuse, dependence and withdrawal (SMQ) [narrow] | 1 | 1.58 | 0.102 | 0.846 | 2.193 | 0.315 | 0.77 | 1.637 | 0.633 | 0.397 | 0.357
COVID19 (Custom Term) | Lymphocytic hypophysitis | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone graft | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Steatorrhoea | 0 | 0.183 | 0.044 | 0.846 | 2.531 |  |  |  |  |  | 
COVID19 (Custom Term) | Koebner phenomenon | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal tubular disorder | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroleptic malignant syndrome (SMQ) [narrow] | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Heparin-induced thrombocytopenia | 0 | 0.183 | 0.044 | 0.846 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Trisomy 18 | 0 | 0.183 | 0.044 | 0.846 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemangioma | 0 | 0.39 | 0.164 | 0.846 | 1.963 |  |  |  |  |  | 
COVID19 (Custom Term) | Trisomy 13 | 0 | 0.183 | 0.044 | 0.846 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemostasis | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Colectomy total | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Massage | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Kidney fibrosis | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle operation | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Creatinine renal clearance | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal deposits | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Encapsulation reaction | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal carcinoma | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood acid phosphatase normal | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance elastography | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal leukoplakia | 0 | 0.183 | 0.044 | 0.846 | 2.529 |  |  |  |  |  | 
COVID19 (Custom Term) | External ear cellulitis | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Monomelic amyotrophy | 0 | 0.183 | 0.044 | 0.846 | 2.529 |  |  |  |  |  | 
COVID19 (Custom Term) | Burn oral cavity | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood methaemoglobin present | 0 | 0.274 | 0.1 | 0.846 | 2.2 |  |  |  |  |  | 
COVID19 (Custom Term) | Dependence | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Human anti-human antibody test | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Rapid eye movement sleep behaviour disorder | 0 | 0.183 | 0.044 | 0.846 | 2.531 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system function test normal | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Serotonin syndrome | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin dystrophy | 0 | 0.183 | 0.044 | 0.846 | 2.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Urticaria pigmentosa | 0 | 0.183 | 0.044 | 0.846 | 2.531 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear irrigation | 0 | 0.183 | 0.044 | 0.846 | 2.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye inflammation | 5 | 4.889 | 0.421 | 0.845 | 1.386 | 0.512 | 0.945 | 1.627 | 1.023 | 0.814 | 0.053
COVID19 (Custom Term) | Ocular icterus | 3 | 3.981 | 0.284 | 0.845 | 1.646 | 0.389 | 0.794 | 1.477 | 0.754 | 0.961 | 0.054
COVID19 (Custom Term) | Red blood cell sedimentation rate normal | 30 | 39.102 | 0.615 | 0.845 | 1.105 | 0.576 | 0.773 | 1.02 | 0.767 | 0.821 | 0.913
COVID19 (Custom Term) | Vitamin B12 deficiency | 1 | 2.756 | 0.08 | 0.845 | 2.296 | 0.249 | 0.621 | 1.332 | 0.363 | 0.355 | 0.552
COVID19 (Custom Term) | Fibrin | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratoplasty | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Tinea infection | 0 | 0.304 | 0.116 | 0.845 | 2.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital hand malformation | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Alphavirus test | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurological infection | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | Acne conglobata | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Vein collapse | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Gilbert's syndrome | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytomegalovirus chorioretinitis | 0 | 0.183 | 0.043 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Vital dye staining cornea present | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy kidney normal | 0 | 0.183 | 0.043 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Disinhibition | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes virus test abnormal | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aldosterone increased | 0 | 0.183 | 0.044 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Olfactory nerve disorder | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Environmental exposure | 0 | 0.183 | 0.043 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal inflammation | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumbosacral plexopathy | 0 | 0.183 | 0.043 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratouveitis | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | False negative investigation result | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV antibody positive | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholinergic syndrome | 0 | 0.183 | 0.043 | 0.845 | 2.533 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV antigen positive | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheo-oesophageal fistula | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac dysfunction | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Reversible airways obstruction | 0 | 0.183 | 0.043 | 0.845 | 2.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertensive heart disease | 0 | 0.183 | 0.043 | 0.845 | 2.532 |  |  |  |  |  | 
COVID19 (Custom Term) | Parvovirus B19 infection | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | Non-high-density lipoprotein cholesterol | 0 | 0.183 | 0.043 | 0.845 | 2.535 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF glucose decreased | 1 | 1.392 | 0.221 | 0.844 | 1.794 | 0.328 | 0.8 | 1.699 | 0.718 | 0.231 | 1.745
COVID19 (Custom Term) | Eye colour change | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Yellow nail syndrome | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile swelling | 0 | 0.395 | 0.162 | 0.844 | 1.961 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensitisation | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune tolerance induction | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac murmur functional | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhesus antibodies negative | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Molluscum contagiosum | 0 | 0.286 | 0.104 | 0.844 | 2.175 |  |  |  |  |  | 
COVID19 (Custom Term) | Eccentric fixation | 0 | 0.183 | 0.042 | 0.844 | 2.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyelonephritis acute | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Blast cell count increased | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Hemianopia homonymous | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Divorced | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic bronchitis | 0 | 0.183 | 0.043 | 0.844 | 2.536 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin decreased | 0 | 0.183 | 0.043 | 0.844 | 2.536 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-islet cell antibody negative | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bone abnormal | 0 | 0.183 | 0.042 | 0.844 | 2.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract obstruction | 0 | 0.183 | 0.042 | 0.844 | 2.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Vocal cord paresis | 0 | 0.183 | 0.043 | 0.844 | 2.536 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral diarrhoea | 0 | 0.183 | 0.042 | 0.844 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymph node palpable | 7 | 5.511 | 0.426 | 0.843 | 1.375 | 0.638 | 1.1 | 1.795 | 1.27 | 3.022 | 5.655
COVID19 (Custom Term) | Aspartate aminotransferase | 5 | 5.099 | 0.399 | 0.843 | 1.42 | 0.5 | 0.922 | 1.588 | 0.981 | 1.342 | 0.124
COVID19 (Custom Term) | Muscle contracture | 2 | 2.383 | 0.326 | 0.843 | 1.554 | 0.382 | 0.839 | 1.648 | 0.839 | 0.537 | 0.352
COVID19 (Custom Term) | Haemodynamic oedema, effusions and fluid overload (SMQ) [broad] | 2661 | 3310.969 | 0.817 | 0.843 | 0.87 | 0.778 | 0.804 | 0.83 | 0.804 | 0.585 | 862.37
COVID19 (Custom Term) | Haemodynamic oedema, effusions and fluid overload (SMQ) [narrow] | 2661 | 3310.969 | 0.817 | 0.843 | 0.87 | 0.778 | 0.804 | 0.83 | 0.804 | 0.585 | 862.37
COVID19 (Custom Term) | Smear buccal abnormal | 0 | 0.183 | 0.041 | 0.843 | 2.542 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti factor V antibody | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Quantitative sudomotor axon reflex test | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid skin dryness | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal labour affecting foetus | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital hydrocephalus | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Vibration test normal | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood oestrogen | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Computerised tomogram kidney normal | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy mucosa abnormal | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Bloch-Sulzberger syndrome | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood 25-hydroxycholecalciferol decreased | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral tonsillitis | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Dacryostenosis acquired | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Premenstrual headache | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Electroconvulsive therapy | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug provocation test | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia respiratory syncytial viral | 0 | 0.183 | 0.042 | 0.843 | 2.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurodevelopment test | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Histone antibody | 0 | 0.183 | 0.041 | 0.843 | 2.542 |  |  |  |  |  | 
COVID19 (Custom Term) | Night blindness | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic disc drusen | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric fluid analysis abnormal | 0 | 0.183 | 0.042 | 0.843 | 2.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue exfoliation | 0 | 0.183 | 0.041 | 0.843 | 2.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Sweat gland disorder | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Hand-foot-and-mouth disease | 0 | 0.288 | 0.104 | 0.843 | 2.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Cleft palate | 0 | 0.183 | 0.041 | 0.843 | 2.542 |  |  |  |  |  | 
COVID19 (Custom Term) | Cord blood transplant therapy | 0 | 0.183 | 0.042 | 0.843 | 2.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal dilation procedure | 0 | 0.183 | 0.042 | 0.843 | 2.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Epstein-Barr viraemia | 0 | 0.183 | 0.041 | 0.843 | 2.542 |  |  |  |  |  | 
COVID19 (Custom Term) | Complication of delivery | 0 | 0.183 | 0.042 | 0.843 | 2.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Stenotrophomonas test positive | 0 | 0.183 | 0.041 | 0.843 | 2.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site discomfort | 58 | 67.551 | 0.676 | 0.842 | 1.025 | 0.692 | 0.858 | 1.054 | 0.859 | 0.877 | 0.808
COVID19 (Custom Term) | Pulmonary function test normal | 1 | 2.002 | 0.202 | 0.842 | 1.839 | 0.289 | 0.71 | 1.513 | 0.5 | 0.31 | 0.842
COVID19 (Custom Term) | Aortic dilatation | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha-1 anti-trypsin normal | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Precipitate labour | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Angioscopy | 0 | 0.183 | 0.04 | 0.842 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal manometry | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan gallium abnormal | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bilirubin abnormal | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatitis | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral myositis | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Walking distance test abnormal | 0 | 0.183 | 0.04 | 0.842 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Diet noncompliance | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosal erosion | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngoscopy | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Adhesion | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site nodule | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Heterotaxia | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Pain threshold decreased | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Ciliary hyperaemia | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor level normal | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasitic test | 0 | 0.212 | 0.057 | 0.842 | 2.416 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood corticotrophin normal | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint laxity | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Waterhouse-Friderichsen syndrome | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic neoplasm | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Sitting disability | 0 | 0.274 | 0.094 | 0.842 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine cytology | 0 | 0.183 | 0.04 | 0.842 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Idiopathic angioedema | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous haemorrhage | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Sexually active | 0 | 0.183 | 0.04 | 0.842 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Culture tissue specimen positive | 0 | 0.183 | 0.04 | 0.842 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary hypogonadism | 0 | 0.183 | 0.041 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity total increased | 0 | 0.183 | 0.04 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic calcification | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal migraine | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF monocyte count negative | 0 | 0.183 | 0.04 | 0.842 | 2.546 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign breast neoplasm | 0 | 0.183 | 0.04 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum ferritin abnormal | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial haemorrhage | 0 | 0.183 | 0.041 | 0.842 | 2.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Myringitis | 0 | 0.183 | 0.04 | 0.842 | 2.545 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumbar puncture | 48 | 63.188 | 0.661 | 0.841 | 1.04 | 0.604 | 0.764 | 0.956 | 0.76 | 0.811 | 1.78
COVID19 (Custom Term) | Eye discharge | 12 | 16.576 | 0.502 | 0.841 | 1.251 | 0.479 | 0.745 | 1.116 | 0.724 | 0.593 | 2.76
COVID19 (Custom Term) | Vitamin B12 absorption test normal | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Ectropion of cervix | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Starvation | 0 | 0.183 | 0.04 | 0.841 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral sinusitis | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy stomach normal | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaemia vitamin B12 deficiency | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bone normal | 0 | 0.183 | 0.039 | 0.841 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Thought blocking | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Sigmoidoscopy normal | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF cell count abnormal | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via unknown route | 0 | 0.183 | 0.04 | 0.841 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Anorexia nervosa | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Free thyroxine index normal | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Automatism | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Economic problem | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypocomplementaemia | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibroadenoma of breast | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Transplant failure | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Biofeedback therapy | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Spontaneous haematoma | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood luteinising hormone normal | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile wart | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Hodgkin's disease recurrent | 0 | 0.183 | 0.039 | 0.841 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrin D dimer decreased | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Perineal abscess | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastatic neoplasm | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropsychiatric lupus | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Ophthalmia neonatorum | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid retraction | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Waxy flexibility | 0 | 0.183 | 0.04 | 0.841 | 2.547 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic colitis | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Paresis cranial nerve | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal vomiting | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal fungal infection | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Haptoglobin abnormal | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthrogram abnormal | 0 | 0.183 | 0.04 | 0.841 | 2.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Unintended pregnancy | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant melanoma in situ | 0 | 0.183 | 0.04 | 0.841 | 2.549 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung neoplasm | 0 | 0.183 | 0.039 | 0.841 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood androstenedione | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychotic behaviour | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired epidermolysis bullosa | 0 | 0.183 | 0.039 | 0.841 | 2.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingivitis | 1 | 1.044 | 0.194 | 0.84 | 1.857 | 0.355 | 0.863 | 1.829 | 0.958 | 0.764 | 0.041
COVID19 (Custom Term) | Eye movement disorder | 24 | 27.587 | 0.596 | 0.84 | 1.119 | 0.625 | 0.866 | 1.176 | 0.87 | 0.223 | 62.763
COVID19 (Custom Term) | Product dose omission issue | 3 | 5.839 | 0.248 | 0.84 | 1.718 | 0.311 | 0.637 | 1.187 | 0.514 | 0.284 | 4.538
COVID19 (Custom Term) | Breast malignant tumours (SMQ) [broad] | 2 | 5.367 | 0.298 | 0.84 | 1.605 | 0.249 | 0.555 | 1.099 | 0.373 | 0.382 | 1.327
COVID19 (Custom Term) | Breast neoplasms, malignant and unspecified (SMQ) [broad] | 2 | 5.367 | 0.298 | 0.84 | 1.605 | 0.249 | 0.555 | 1.099 | 0.373 | 0.382 | 1.327
COVID19 (Custom Term) | Threatened labour | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal pain | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoglycaemic coma | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory syncytial virus bronchitis | 0 | 0.183 | 0.039 | 0.84 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxic neuropathy | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Aeromonas test positive | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood acid phosphatase increased | 0 | 0.183 | 0.039 | 0.84 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheal stenosis | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Ulnar nerve injury | 0 | 0.183 | 0.039 | 0.84 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Female reproductive tract disorder | 0 | 0.183 | 0.039 | 0.84 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepcidin test | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatofibroma removal | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Barrett's oesophagus | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis influenzal | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Antigliadin antibody | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cells stool positive | 0 | 0.097 | 0.004 | 0.84 | 3.202 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid neoplasm | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Choroidal effusion | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear tube insertion | 0 | 0.428 | 0.172 | 0.84 | 1.921 |  |  |  |  |  | 
COVID19 (Custom Term) | Copper deficiency | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy thyroid gland abnormal | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryptococcosis | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary arterial hypertension | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Nutritional condition abnormal | 0 | 0.183 | 0.039 | 0.84 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital skin dimples | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic ketoacidotic hyperglycaemic coma | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine free normal | 0 | 0.199 | 0.048 | 0.84 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Testis discomfort | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord infarction | 0 | 0.183 | 0.039 | 0.84 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Blastic plasmacytoid dendritic cell neoplasia | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Aeromonas infection | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis rapidly progressive | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Purulence | 0 | 0.418 | 0.168 | 0.84 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | POEMS syndrome | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF volume increased | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart valve operation | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulosclerosis | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Extradural haematoma | 0 | 0.183 | 0.039 | 0.84 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Lumbar vertebral fracture | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy thymus gland abnormal | 0 | 0.183 | 0.039 | 0.84 | 2.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral atrophy congenital | 0 | 0.183 | 0.039 | 0.84 | 2.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Subcorneal pustular dermatosis | 0 | 0.183 | 0.039 | 0.84 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleocytosis | 1 | 1.149 | 0.095 | 0.839 | 2.2 | 0.346 | 0.843 | 1.788 | 0.87 | 0.107 | 6.455
COVID19 (Custom Term) | Injection site rash | 429 | 498.561 | 0.774 | 0.839 | 0.907 | 0.794 | 0.86 | 0.931 | 0.86 | 0.905 | 3.922
COVID19 (Custom Term) | Atrophy | 2 | 2.582 | 0.271 | 0.839 | 1.66 | 0.37 | 0.811 | 1.595 | 0.775 | 0.794 | 0
COVID19 (Custom Term) | Cellulitis | 101 | 163.288 | 0.708 | 0.839 | 0.98 | 0.529 | 0.623 | 0.73 | 0.619 | 0.271 | 193.58
COVID19 (Custom Term) | Toxoplasma serology positive | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteopetrosis | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic foot | 0 | 0.183 | 0.038 | 0.839 | 2.556 |  |  |  |  |  | 
COVID19 (Custom Term) | Acantholysis | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion incomplete | 0 | 0.183 | 0.038 | 0.839 | 2.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosal hypertrophy | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Rash neonatal | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Retained placenta or membranes | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngitis allergic | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Prolonged expiration | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Specific gravity body fluid | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Neck surgery | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Capillary fragility test | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Primary hypothyroidism | 0 | 0.183 | 0.038 | 0.839 | 2.556 |  |  |  |  |  | 
COVID19 (Custom Term) | Factor VIII deficiency | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Vasculitis necrotising | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Limbic encephalitis | 0 | 0.183 | 0.038 | 0.839 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Product container seal issue | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin B complex deficiency | 0 | 0.183 | 0.038 | 0.839 | 2.554 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood zinc increased | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyphaema | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin A abnormal | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryptorchism | 0 | 0.183 | 0.038 | 0.839 | 2.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood oestrogen normal | 0 | 0.183 | 0.038 | 0.839 | 2.556 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood electrolytes abnormal | 0 | 0.183 | 0.038 | 0.839 | 2.557 |  |  |  |  |  | 
COVID19 (Custom Term) | Palmar erythema | 1 | 0.396 | 0.228 | 0.838 | 1.758 | 0.415 | 1.01 | 2.153 | 2.523 | 0.552 | 0.036
COVID19 (Custom Term) | Myasthenia gravis | 5 | 6.455 | 0.411 | 0.838 | 1.389 | 0.432 | 0.798 | 1.374 | 0.775 | 1.056 | 0.015
COVID19 (Custom Term) | Basophilia | 0 | 0.183 | 0.037 | 0.838 | 2.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid nodule | 0 | 0.183 | 0.038 | 0.838 | 2.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin normal | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan bone marrow abnormal | 0 | 0.183 | 0.037 | 0.838 | 2.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QT interval abnormal | 0 | 0.183 | 0.037 | 0.838 | 2.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Monoclonal immunoglobulin present | 0 | 0.183 | 0.038 | 0.838 | 2.559 |  |  |  |  |  | 
COVID19 (Custom Term) | Hand amputation | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine rupture | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint infection | 0 | 0.183 | 0.037 | 0.838 | 2.559 |  |  |  |  |  | 
COVID19 (Custom Term) | Rash papulosquamous | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal heart rate deceleration abnormality | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail dystrophy | 0 | 0.183 | 0.037 | 0.838 | 2.559 |  |  |  |  |  | 
COVID19 (Custom Term) | Omphalitis | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Inadequate diet | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Metamyelocyte percentage increased | 0 | 0.183 | 0.037 | 0.838 | 2.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood cholesterol abnormal | 0 | 0.274 | 0.09 | 0.838 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound scan vagina normal | 0 | 0.183 | 0.037 | 0.838 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperintensity in brain deep nuclei | 0 | 0.183 | 0.038 | 0.838 | 2.559 |  |  |  |  |  | 
COVID19 (Custom Term) | Radioactive iodine therapy | 0 | 0.183 | 0.037 | 0.838 | 2.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Rash follicular | 0 | 0.274 | 0.089 | 0.838 | 2.225 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyarthritis | 3 | 4.027 | 0.294 | 0.837 | 1.605 | 0.387 | 0.789 | 1.468 | 0.745 | 0.346 | 2.915
COVID19 (Custom Term) | Injection site infection | 5 | 9.256 | 0.408 | 0.837 | 1.391 | 0.337 | 0.624 | 1.075 | 0.54 | 0.162 | 20.403
COVID19 (Custom Term) | ADAMTS13 activity normal | 0 | 0.183 | 0.037 | 0.837 | 2.563 |  |  |  |  |  | 
COVID19 (Custom Term) | Incorrect product administration duration | 0 | 0.183 | 0.037 | 0.837 | 2.562 |  |  |  |  |  | 
COVID19 (Custom Term) | Tachycardia paroxysmal | 0 | 0.183 | 0.037 | 0.837 | 2.563 |  |  |  |  |  | 
COVID19 (Custom Term) | UV light therapy | 0 | 0.183 | 0.036 | 0.837 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Perinatal HBV infection | 0 | 0.183 | 0.037 | 0.837 | 2.562 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac function test abnormal | 0 | 0.183 | 0.036 | 0.837 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyneuropathy idiopathic progressive | 0 | 0.183 | 0.037 | 0.837 | 2.563 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular retraction | 0 | 0.183 | 0.037 | 0.837 | 2.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Catheter site erythema | 0 | 0.183 | 0.037 | 0.837 | 2.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Urethral stenosis | 0 | 0.183 | 0.037 | 0.837 | 2.562 |  |  |  |  |  | 
COVID19 (Custom Term) | Needle track marks | 0 | 0.183 | 0.036 | 0.837 | 2.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal pap smear | 0 | 0.183 | 0.037 | 0.837 | 2.563 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthritis viral | 0 | 0.183 | 0.036 | 0.837 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Complication of device insertion | 0 | 0.183 | 0.036 | 0.837 | 2.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Opiates positive | 0 | 0.183 | 0.036 | 0.837 | 2.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterovirus test negative | 1 | 1.024 | 0.171 | 0.836 | 1.91 | 0.356 | 0.866 | 1.837 | 0.977 | 0.074 | 10.499
COVID19 (Custom Term) | Injection site induration | 331 | 358.499 | 0.762 | 0.836 | 0.913 | 0.842 | 0.922 | 1.008 | 0.923 | 0.786 | 17.84
COVID19 (Custom Term) | Blood immunoglobulin G | 6 | 9.325 | 0.399 | 0.836 | 1.404 | 0.392 | 0.698 | 1.168 | 0.643 | 0.709 | 0.402
COVID19 (Custom Term) | Premature separation of placenta | 2 | 5.513 | 0.178 | 0.836 | 1.889 | 0.244 | 0.546 | 1.081 | 0.363 | 1.168 | 0.036
COVID19 (Custom Term) | Corynebacterium bacteraemia | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF electrophoresis abnormal | 0 | 0.183 | 0.036 | 0.836 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Malaria antibody test positive | 0 | 0.183 | 0.036 | 0.836 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal injury | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Seizure anoxic | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Multiple epiphyseal dysplasia | 0 | 0.183 | 0.036 | 0.836 | 2.568 |  |  |  |  |  | 
COVID19 (Custom Term) | Zinc deficiency | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood parathyroid hormone | 0 | 0.274 | 0.087 | 0.836 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal pneumonia | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Amoeba test positive | 0 | 0.183 | 0.036 | 0.836 | 2.568 |  |  |  |  |  | 
COVID19 (Custom Term) | Torsade de pointes | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary hypoplasia | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Autologous haematopoietic stem cell transplant | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal elastase concentration decreased | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E antigen positive | 0 | 0.183 | 0.036 | 0.836 | 2.565 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory disorder neonatal | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatitis necrotising | 0 | 0.183 | 0.036 | 0.836 | 2.568 |  |  |  |  |  | 
COVID19 (Custom Term) | Interleukin therapy | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular insufficiency | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoidal hypertrophy | 0 | 0.232 | 0.064 | 0.836 | 2.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Typical aura without headache | 0 | 0.183 | 0.036 | 0.836 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Normochromic normocytic anaemia | 0 | 0.125 | 0.01 | 0.836 | 2.941 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitochondrial myopathy | 0 | 0.183 | 0.036 | 0.836 | 2.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Arteriogram | 0 | 0.274 | 0.088 | 0.836 | 2.228 |  |  |  |  |  | 
COVID19 (Custom Term) | Antiphospholipid antibodies positive | 1 | 1.496 | 0.226 | 0.835 | 1.757 | 0.321 | 0.784 | 1.664 | 0.668 | 0.662 | 0.001
COVID19 (Custom Term) | Acoustic stimulation tests normal | 1 | 1.934 | 0.143 | 0.835 | 1.999 | 0.293 | 0.719 | 1.531 | 0.517 | 0.292 | 0.996
COVID19 (Custom Term) | Enterocolitis infectious | 0 | 0.183 | 0.035 | 0.835 | 2.571 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue cyst | 0 | 0.183 | 0.035 | 0.835 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-islet cell antibody | 0 | 0.183 | 0.035 | 0.835 | 2.569 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic oedema | 0 | 0.183 | 0.035 | 0.835 | 2.571 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic haemorrhage | 0 | 0.183 | 0.035 | 0.835 | 2.57 |  |  |  |  |  | 
COVID19 (Custom Term) | Exercise test normal | 0 | 0.183 | 0.035 | 0.835 | 2.569 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue operation | 0 | 0.183 | 0.035 | 0.835 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual field tests normal | 0 | 0.183 | 0.035 | 0.835 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site inflammation | 0 | 0.183 | 0.035 | 0.835 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Cleft lip | 0 | 0.183 | 0.035 | 0.835 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia influenzal | 0 | 0.183 | 0.035 | 0.835 | 2.571 |  |  |  |  |  | 
COVID19 (Custom Term) | Base excess abnormal | 0 | 0.183 | 0.035 | 0.835 | 2.569 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign neoplasm of thyroid gland | 0 | 0.183 | 0.035 | 0.835 | 2.57 |  |  |  |  |  | 
COVID19 (Custom Term) | Hangover | 4 | 4.939 | 0.362 | 0.834 | 1.464 | 0.426 | 0.822 | 1.466 | 0.81 | 3.972 | 4.231
COVID19 (Custom Term) | Spinal pain | 24 | 29.752 | 0.597 | 0.834 | 1.105 | 0.585 | 0.81 | 1.1 | 0.807 | 1.119 | 0.167
COVID19 (Custom Term) | Vasculitis | 5 | 6.843 | 0.417 | 0.834 | 1.367 | 0.416 | 0.768 | 1.323 | 0.731 | 0.316 | 6.457
COVID19 (Custom Term) | Malignancies (SMQ) [broad] | 127 | 172.202 | 0.717 | 0.834 | 0.959 | 0.639 | 0.74 | 0.852 | 0.738 | 0.58 | 36.23
COVID19 (Custom Term) | Malignancies (SMQ) [narrow] | 127 | 172.202 | 0.717 | 0.834 | 0.959 | 0.639 | 0.74 | 0.852 | 0.738 | 0.58 | 36.23
COVID19 (Custom Term) | Inappropriate schedule of product administration | 127 | 183.139 | 0.716 | 0.834 | 0.959 | 0.601 | 0.696 | 0.803 | 0.693 | 0.291 | 215.726
COVID19 (Custom Term) | Clostridium test | 0 | 0.447 | 0.17 | 0.834 | 1.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-VGKC antibody positive | 0 | 0.183 | 0.034 | 0.834 | 2.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic pneumonia | 0 | 0.183 | 0.034 | 0.834 | 2.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy heart | 0 | 0.183 | 0.034 | 0.834 | 2.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin urine increased | 0 | 0.183 | 0.035 | 0.834 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Self-induced vomiting | 0 | 0.183 | 0.034 | 0.834 | 2.574 |  |  |  |  |  | 
COVID19 (Custom Term) | Sickle cell trait | 0 | 0.183 | 0.035 | 0.834 | 2.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Schistosoma test negative | 0 | 0.183 | 0.034 | 0.834 | 2.574 |  |  |  |  |  | 
COVID19 (Custom Term) | Bulimia nervosa | 0 | 0.183 | 0.034 | 0.834 | 2.574 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood copper decreased | 0 | 0.183 | 0.035 | 0.834 | 2.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Typhus rickettsia test positive | 0 | 0.183 | 0.035 | 0.834 | 2.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Venipuncture | 0 | 0.183 | 0.035 | 0.834 | 2.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine uric acid normal | 0 | 0.183 | 0.034 | 0.834 | 2.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune retinopathy | 0 | 0.183 | 0.034 | 0.834 | 2.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin E increased | 1 | 1.11 | 0.137 | 0.833 | 2.015 | 0.349 | 0.85 | 1.803 | 0.901 | 0.163 | 3.379
COVID19 (Custom Term) | Hyperaesthesia | 34 | 41.286 | 0.62 | 0.833 | 1.073 | 0.625 | 0.825 | 1.072 | 0.824 | 0.639 | 6.14
COVID19 (Custom Term) | Anal fistula | 0 | 0.183 | 0.033 | 0.833 | 2.578 |  |  |  |  |  | 
COVID19 (Custom Term) | Encopresis | 0 | 0.183 | 0.034 | 0.833 | 2.578 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood corticotrophin decreased | 0 | 0.183 | 0.034 | 0.833 | 2.576 |  |  |  |  |  | 
COVID19 (Custom Term) | Kidney enlargement | 0 | 0.274 | 0.084 | 0.833 | 2.237 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal volume increased | 0 | 0.191 | 0.038 | 0.833 | 2.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Shock hypoglycaemic | 0 | 0.183 | 0.034 | 0.833 | 2.578 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune pancreatitis | 0 | 0.183 | 0.034 | 0.833 | 2.577 |  |  |  |  |  | 
COVID19 (Custom Term) | Hereditary ataxia | 0 | 0.183 | 0.034 | 0.833 | 2.577 |  |  |  |  |  | 
COVID19 (Custom Term) | Murine typhus | 0 | 0.183 | 0.034 | 0.833 | 2.576 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver injury | 7 | 7.024 | 0.442 | 0.832 | 1.321 | 0.547 | 0.943 | 1.539 | 0.997 | 2.482 | 3.738
COVID19 (Custom Term) | Vocal cord paralysis | 1 | 1.201 | 0.23 | 0.832 | 1.736 | 0.342 | 0.833 | 1.768 | 0.833 | 0.827 | 0.089
COVID19 (Custom Term) | Haemangioma-thrombocytopenia syndrome | 0 | 0.183 | 0.033 | 0.832 | 2.581 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour marker decreased | 0 | 0.183 | 0.033 | 0.832 | 2.58 |  |  |  |  |  | 
COVID19 (Custom Term) | Microvillous inclusion disease | 0 | 0.183 | 0.033 | 0.832 | 2.58 |  |  |  |  |  | 
COVID19 (Custom Term) | Acquired immunodeficiency syndrome | 0 | 0.183 | 0.033 | 0.832 | 2.58 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal ulcer | 0 | 0.183 | 0.033 | 0.832 | 2.58 |  |  |  |  |  | 
COVID19 (Custom Term) | Giardiasis | 0 | 0.183 | 0.033 | 0.832 | 2.581 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin CSF abnormal | 0 | 0.183 | 0.033 | 0.832 | 2.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal vascular disorder | 0 | 0.183 | 0.033 | 0.832 | 2.581 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [broad] | 2 | 1.98 | 0.294 | 0.831 | 1.59 | 0.41 | 0.9 | 1.768 | 1.01 | 1.655 | 0.041
COVID19 (Custom Term) | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [narrow] | 2 | 1.98 | 0.294 | 0.831 | 1.59 | 0.41 | 0.9 | 1.768 | 1.01 | 1.655 | 0.041
COVID19 (Custom Term) | Mucosal inflammation | 2 | 2.059 | 0.293 | 0.831 | 1.591 | 0.405 | 0.887 | 1.743 | 0.971 | 1.324 | 0.002
COVID19 (Custom Term) | Arthritis (SMQ) [narrow] | 78 | 111.393 | 0.683 | 0.831 | 0.99 | 0.585 | 0.705 | 0.843 | 0.7 | 0.441 | 52.6
COVID19 (Custom Term) | Sleep study | 2 | 3.091 | 0.269 | 0.831 | 1.644 | 0.341 | 0.749 | 1.473 | 0.647 | 0.389 | 1.253
COVID19 (Custom Term) | Blood alcohol increased | 0 | 0.183 | 0.033 | 0.831 | 2.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Teeth brittle | 0 | 0.183 | 0.032 | 0.831 | 2.585 |  |  |  |  |  | 
COVID19 (Custom Term) | Saliva analysis abnormal | 0 | 0.183 | 0.032 | 0.831 | 2.586 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholangitis sclerosing | 0 | 0.183 | 0.032 | 0.831 | 2.584 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulocytopenia | 1 | 1.015 | 0.152 | 0.83 | 1.953 | 0.357 | 0.868 | 1.841 | 0.985 | 0.827 | 0.089
COVID19 (Custom Term) | Multiple allergies | 3 | 3.099 | 0.282 | 0.83 | 1.613 | 0.441 | 0.899 | 1.672 | 0.968 | 0.931 | 0.03
COVID19 (Custom Term) | Vestibular neuronitis | 5 | 6.475 | 0.425 | 0.83 | 1.344 | 0.431 | 0.796 | 1.371 | 0.772 | 1.551 | 0.404
COVID19 (Custom Term) | Echo virus infection | 0 | 0.274 | 0.08 | 0.83 | 2.247 |  |  |  |  |  | 
COVID19 (Custom Term) | Auricular swelling | 0 | 0.274 | 0.077 | 0.828 | 2.252 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosal blistering | 0 | 0.183 | 0.03 | 0.828 | 2.594 |  |  |  |  |  | 
COVID19 (Custom Term) | Device failure | 0 | 0.274 | 0.078 | 0.828 | 2.251 |  |  |  |  |  | 
COVID19 (Custom Term) | Metabolic syndrome | 0 | 0.274 | 0.078 | 0.828 | 2.251 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelopathy | 2 | 2.116 | 0.235 | 0.827 | 1.711 | 0.4 | 0.878 | 1.725 | 0.945 | 1.045 | 0.102
COVID19 (Custom Term) | Cardiac function test normal | 8 | 8.943 | 0.486 | 0.827 | 1.242 | 0.523 | 0.879 | 1.403 | 0.895 | 1.937 | 2.234
COVID19 (Custom Term) | Skin warm | 417 | 549.7 | 0.762 | 0.827 | 0.895 | 0.7 | 0.759 | 0.822 | 0.759 | 0.504 | 198.515
COVID19 (Custom Term) | Exposure to contaminated device | 0 | 0.274 | 0.077 | 0.827 | 2.253 |  |  |  |  |  | 
COVID19 (Custom Term) | Arachnoiditis | 0 | 0.183 | 0.029 | 0.827 | 2.599 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleuropericarditis | 0 | 0.274 | 0.076 | 0.826 | 2.256 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune dermatitis | 0 | 0.274 | 0.076 | 0.826 | 2.256 |  |  |  |  |  | 
COVID19 (Custom Term) | Tenderness | 239 | 306.042 | 0.74 | 0.825 | 0.913 | 0.702 | 0.782 | 0.868 | 0.781 | 0.75 | 18.526
COVID19 (Custom Term) | C-reactive protein normal | 32 | 42.132 | 0.606 | 0.825 | 1.073 | 0.576 | 0.766 | 1.003 | 0.76 | 0.435 | 21.921
COVID19 (Custom Term) | Autoimmune haemolytic anaemia | 2 | 3.299 | 0.252 | 0.825 | 1.665 | 0.33 | 0.726 | 1.428 | 0.606 | 0.441 | 0.83
COVID19 (Custom Term) | Limb mass | 12 | 19.253 | 0.521 | 0.825 | 1.187 | 0.422 | 0.657 | 0.985 | 0.623 | 0.446 | 7.324
COVID19 (Custom Term) | Serology normal | 1 | 1.177 | 0.197 | 0.824 | 1.801 | 0.344 | 0.838 | 1.777 | 0.85 | 0.451 | 0.191
COVID19 (Custom Term) | Incorrect product formulation administered | 4 | 5.096 | 0.292 | 0.824 | 1.576 | 0.418 | 0.807 | 1.439 | 0.785 | 0.079 | 41.398
COVID19 (Custom Term) | Injection site reaction | 228 | 289.973 | 0.737 | 0.824 | 0.914 | 0.705 | 0.787 | 0.876 | 0.786 | 0.5 | 109.639
COVID19 (Custom Term) | Herpes ophthalmic | 1 | 2.39 | 0.08 | 0.824 | 2.226 | 0.267 | 0.662 | 1.414 | 0.418 | 0.268 | 1.237
COVID19 (Custom Term) | Barium enema abnormal | 0 | 0.191 | 0.031 | 0.824 | 2.57 |  |  |  |  |  | 
COVID19 (Custom Term) | Pityriasis | 0 | 0.274 | 0.073 | 0.824 | 2.262 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine alcohol test negative | 0 | 0.183 | 0.028 | 0.824 | 2.609 |  |  |  |  |  | 
COVID19 (Custom Term) | Subperiosteal abscess | 0 | 0.274 | 0.073 | 0.823 | 2.263 |  |  |  |  |  | 
COVID19 (Custom Term) | Product confusion | 0 | 0.274 | 0.073 | 0.823 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Tardive dyskinesia | 0 | 0.501 | 0.175 | 0.823 | 1.861 |  |  |  |  |  | 
COVID19 (Custom Term) | Chalazion | 0 | 0.274 | 0.072 | 0.823 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Milk soy protein intolerance | 0 | 0.274 | 0.071 | 0.822 | 2.267 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuromuscular pain | 0 | 0.274 | 0.071 | 0.822 | 2.267 |  |  |  |  |  | 
COVID19 (Custom Term) | Lip and/or oral cavity cancer | 0 | 0.274 | 0.071 | 0.822 | 2.268 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram T wave abnormal | 4 | 3.947 | 0.379 | 0.821 | 1.401 | 0.483 | 0.931 | 1.659 | 1.014 | 2.09 | 1.019
COVID19 (Custom Term) | Decorticate posture | 0 | 0.274 | 0.071 | 0.821 | 2.269 |  |  |  |  |  | 
COVID19 (Custom Term) | Onychoclasis | 0 | 0.225 | 0.046 | 0.821 | 2.43 |  |  |  |  |  | 
COVID19 (Custom Term) | Head banging | 0 | 0.683 | 0.232 | 0.821 | 1.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian malignant tumours (SMQ) [narrow] | 1 | 1.044 | 0.195 | 0.82 | 1.793 | 0.355 | 0.863 | 1.829 | 0.958 | 0.993 | 0.266
COVID19 (Custom Term) | Peripheral swelling | 568 | 762.574 | 0.764 | 0.82 | 0.877 | 0.695 | 0.745 | 0.798 | 0.745 | 0.495 | 289.093
COVID19 (Custom Term) | Allergy test positive | 1 | 2.526 | 0.372 | 0.82 | 1.409 | 0.26 | 0.646 | 1.382 | 0.396 | 0.083 | 9.012
COVID19 (Custom Term) | Intraocular lens implant | 0 | 0.366 | 0.114 | 0.82 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site macule | 0 | 0.694 | 0.234 | 0.82 | 1.695 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal carcinoma | 0 | 0.274 | 0.069 | 0.82 | 2.272 |  |  |  |  |  | 
COVID19 (Custom Term) | Oxygen saturation increased | 0 | 0.274 | 0.069 | 0.82 | 2.272 |  |  |  |  |  | 
COVID19 (Custom Term) | Squamous cell carcinoma of skin | 0 | 0.274 | 0.069 | 0.82 | 2.272 |  |  |  |  |  | 
COVID19 (Custom Term) | Delayed fontanelle closure | 0 | 0.274 | 0.069 | 0.82 | 2.273 |  |  |  |  |  | 
COVID19 (Custom Term) | General anaesthesia | 0 | 0.274 | 0.07 | 0.82 | 2.271 |  |  |  |  |  | 
COVID19 (Custom Term) | Moaning | 6 | 8.753 | 0.409 | 0.819 | 1.344 | 0.41 | 0.73 | 1.222 | 0.685 | 0.355 | 6.139
COVID19 (Custom Term) | Head lag | 0 | 0.274 | 0.068 | 0.819 | 2.275 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram P wave abnormal | 0 | 0.274 | 0.068 | 0.819 | 2.276 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular test normal | 0 | 0.274 | 0.068 | 0.819 | 2.275 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrin degradation products | 0 | 0.274 | 0.068 | 0.819 | 2.276 |  |  |  |  |  | 
COVID19 (Custom Term) | Intertrigo | 0 | 0.274 | 0.068 | 0.819 | 2.276 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurosurgery | 0 | 0.274 | 0.068 | 0.819 | 2.274 |  |  |  |  |  | 
COVID19 (Custom Term) | Ingrown hair | 0 | 0.274 | 0.068 | 0.819 | 2.274 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemophilus test | 0 | 0.274 | 0.069 | 0.819 | 2.274 |  |  |  |  |  | 
COVID19 (Custom Term) | Creatinine urine increased | 0 | 0.274 | 0.068 | 0.819 | 2.274 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site cellulitis | 36 | 51.266 | 0.614 | 0.818 | 1.045 | 0.543 | 0.711 | 0.918 | 0.702 | 0.27 | 68.769
COVID19 (Custom Term) | Enterostomy | 0 | 0.274 | 0.067 | 0.818 | 2.277 |  |  |  |  |  | 
COVID19 (Custom Term) | Costochondritis | 0 | 0.331 | 0.094 | 0.818 | 2.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Oxygen consumption increased | 0 | 0.274 | 0.067 | 0.818 | 2.277 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine ketone body | 0 | 0.274 | 0.067 | 0.818 | 2.278 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute disseminated encephalomyelitis | 5 | 6.793 | 0.362 | 0.817 | 1.421 | 0.418 | 0.772 | 1.329 | 0.736 | 0.26 | 9.494
COVID19 (Custom Term) | Diplegia | 2 | 4.276 | 0.226 | 0.817 | 1.705 | 0.287 | 0.635 | 1.251 | 0.468 | 0.155 | 8.171
COVID19 (Custom Term) | Rash vesicular | 33 | 64.786 | 0.601 | 0.817 | 1.061 | 0.397 | 0.527 | 0.687 | 0.509 | 0.084 | 330.012
COVID19 (Custom Term) | Immunisation reaction | 0 | 0.442 | 0.143 | 0.817 | 1.946 |  |  |  |  |  | 
COVID19 (Custom Term) | Chlamydia test positive | 0 | 0.102 | 0.002 | 0.817 | 3.24 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystogram | 0 | 0.274 | 0.067 | 0.817 | 2.279 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyramidal tract syndrome | 0 | 0.103 | 0.002 | 0.817 | 3.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Contusion | 102 | 127.6 | 0.692 | 0.816 | 0.949 | 0.68 | 0.8 | 0.937 | 0.799 | 0.555 | 34.277
COVID19 (Custom Term) | Cryptococcus test positive | 0 | 0.274 | 0.065 | 0.816 | 2.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug level therapeutic | 0 | 0.274 | 0.065 | 0.816 | 2.283 |  |  |  |  |  | 
COVID19 (Custom Term) | Glossopharyngeal neuralgia | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Sciatic nerve injury | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site erythema | 0 | 0.274 | 0.065 | 0.816 | 2.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy lymph gland normal | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial cyst | 0 | 0.656 | 0.216 | 0.816 | 1.728 |  |  |  |  |  | 
COVID19 (Custom Term) | Onychalgia | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Diverticular perforation | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lead | 0 | 0.227 | 0.043 | 0.816 | 2.439 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug administered in wrong device | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Social fear | 0 | 0.274 | 0.065 | 0.816 | 2.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy abdominal wall abnormal | 0 | 0.183 | 0.023 | 0.816 | 2.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood calcitonin | 0 | 0.274 | 0.065 | 0.816 | 2.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site papule | 2 | 4.851 | 0.313 | 0.815 | 1.509 | 0.266 | 0.59 | 1.166 | 0.412 | 0.201 | 5.414
COVID19 (Custom Term) | Eye symptom | 0 | 0.274 | 0.064 | 0.815 | 2.285 |  |  |  |  |  | 
COVID19 (Custom Term) | Product lot number issue | 0 | 0.113 | 0.003 | 0.815 | 3.136 |  |  |  |  |  | 
COVID19 (Custom Term) | Personality change | 3 | 4.193 | 0.31 | 0.814 | 1.51 | 0.378 | 0.772 | 1.437 | 0.715 | 0.216 | 7.544
COVID19 (Custom Term) | X-ray limb normal | 10 | 15.307 | 0.491 | 0.814 | 1.204 | 0.428 | 0.689 | 1.062 | 0.653 | 0.378 | 9.245
COVID19 (Custom Term) | Flashback | 0 | 0.274 | 0.064 | 0.814 | 2.286 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth extraction | 0 | 0.374 | 0.11 | 0.814 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal transplant | 0 | 0.274 | 0.064 | 0.814 | 2.286 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxine free | 2 | 1.628 | 0.342 | 0.813 | 1.445 | 0.439 | 0.961 | 1.889 | 1.229 | 0.621 | 0.132
COVID19 (Custom Term) | Benign breast lump removal | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Asplenia | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal epithelium defect | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Naevus flammeus | 0 | 0.274 | 0.062 | 0.813 | 2.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Mastocytoma | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Anterior chamber cell | 0 | 0.274 | 0.062 | 0.813 | 2.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood group A | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Giardia test negative | 0 | 0.157 | 0.013 | 0.813 | 2.791 |  |  |  |  |  | 
COVID19 (Custom Term) | Head circumference abnormal | 0 | 0.274 | 0.062 | 0.813 | 2.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site induration | 0 | 0.274 | 0.062 | 0.813 | 2.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood zinc normal | 0 | 0.274 | 0.062 | 0.813 | 2.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Antinuclear antibody | 12 | 14.456 | 0.509 | 0.812 | 1.174 | 0.535 | 0.832 | 1.247 | 0.83 | 0.953 | 0
COVID19 (Custom Term) | Ileal perforation | 0 | 0.183 | 0.021 | 0.812 | 2.645 |  |  |  |  |  | 
COVID19 (Custom Term) | Meralgia paraesthetica | 0 | 0.274 | 0.061 | 0.812 | 2.293 |  |  |  |  |  | 
COVID19 (Custom Term) | Streptococcal abscess | 0 | 0.183 | 0.021 | 0.812 | 2.646 |  |  |  |  |  | 
COVID19 (Custom Term) | Vestibular function test abnormal | 0 | 0.274 | 0.061 | 0.812 | 2.292 |  |  |  |  |  | 
COVID19 (Custom Term) | Self-injurious ideation | 0 | 0.274 | 0.061 | 0.812 | 2.292 |  |  |  |  |  | 
COVID19 (Custom Term) | Groin infection | 0 | 0.274 | 0.062 | 0.812 | 2.291 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin M abnormal | 0 | 0.274 | 0.061 | 0.812 | 2.292 |  |  |  |  |  | 
COVID19 (Custom Term) | Gravitational oedema | 0 | 0.274 | 0.062 | 0.812 | 2.291 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic oesophagitis | 0 | 0.274 | 0.062 | 0.812 | 2.292 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-NMDA antibody | 0 | 0.274 | 0.061 | 0.812 | 2.292 |  |  |  |  |  | 
COVID19 (Custom Term) | Mini mental status examination | 0 | 0.274 | 0.061 | 0.812 | 2.293 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood chloride | 1 | 1.052 | 0.085 | 0.811 | 2.157 | 0.354 | 0.861 | 1.826 | 0.951 | 0.382 | 0.42
COVID19 (Custom Term) | Haematological tumours of unspecified malignancy (SMQ) [broad] | 1 | 1.121 | 0.143 | 0.811 | 1.929 | 0.348 | 0.848 | 1.799 | 0.892 | 0.584 | 0.014
COVID19 (Custom Term) | Haematological tumours of unspecified malignancy (SMQ) [narrow] | 1 | 1.121 | 0.143 | 0.811 | 1.929 | 0.348 | 0.848 | 1.799 | 0.892 | 0.584 | 0.014
COVID19 (Custom Term) | Hand-eye coordination impaired | 3 | 3.472 | 0.31 | 0.811 | 1.503 | 0.417 | 0.851 | 1.584 | 0.864 | 3.723 | 2.44
COVID19 (Custom Term) | Tooth fracture | 2 | 2.861 | 0.311 | 0.811 | 1.504 | 0.353 | 0.776 | 1.525 | 0.699 | 0.451 | 0.764
COVID19 (Custom Term) | Oral papule | 0 | 0.274 | 0.061 | 0.811 | 2.293 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial fluid analysis abnormal | 0 | 0.274 | 0.061 | 0.811 | 2.293 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuritis cranial | 0 | 0.274 | 0.06 | 0.811 | 2.295 |  |  |  |  |  | 
COVID19 (Custom Term) | Gallbladder polyp | 0 | 0.274 | 0.06 | 0.811 | 2.294 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic metabolic decompensation | 0 | 0.274 | 0.061 | 0.811 | 2.294 |  |  |  |  |  | 
COVID19 (Custom Term) | Head injury | 43 | 60.005 | 0.625 | 0.81 | 1.013 | 0.564 | 0.724 | 0.916 | 0.717 | 0.522 | 17.434
COVID19 (Custom Term) | Helicobacter infection | 2 | 3.065 | 0.298 | 0.81 | 1.525 | 0.342 | 0.752 | 1.479 | 0.653 | 1.324 | 0.002
COVID19 (Custom Term) | Plasmapheresis | 6 | 10.371 | 0.381 | 0.81 | 1.371 | 0.362 | 0.646 | 1.08 | 0.579 | 0.333 | 7.074
COVID19 (Custom Term) | Neonatal disorders (SMQ) [broad] | 18 | 31.431 | 0.531 | 0.81 | 1.136 | 0.414 | 0.6 | 0.847 | 0.573 | 0.12 | 114.486
COVID19 (Custom Term) | Toxic shock syndrome | 0 | 0.274 | 0.06 | 0.81 | 2.297 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aluminium normal | 0 | 0.274 | 0.06 | 0.81 | 2.296 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site discolouration | 0 | 0.274 | 0.06 | 0.81 | 2.296 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic enzymes | 0 | 0.274 | 0.06 | 0.81 | 2.296 |  |  |  |  |  | 
COVID19 (Custom Term) | Urobilinogen urine increased | 1 | 0.988 | 0.241 | 0.809 | 1.648 | 0.359 | 0.873 | 1.852 | 1.012 | 0.764 | 0.041
COVID19 (Custom Term) | Foreign body sensation in eyes | 2 | 2.312 | 0.314 | 0.809 | 1.49 | 0.387 | 0.849 | 1.668 | 0.865 | 0.794 | 0
COVID19 (Custom Term) | Optic disc haemorrhage | 0 | 0.274 | 0.059 | 0.809 | 2.298 |  |  |  |  |  | 
COVID19 (Custom Term) | Ephelides | 0 | 0.274 | 0.059 | 0.809 | 2.298 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4/CD8 ratio decreased | 0 | 0.274 | 0.059 | 0.809 | 2.299 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal tract irritation | 0 | 0.274 | 0.059 | 0.809 | 2.299 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased interest | 0 | 0.655 | 0.205 | 0.809 | 1.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein S decreased | 0 | 0.274 | 0.059 | 0.809 | 2.299 |  |  |  |  |  | 
COVID19 (Custom Term) | Free fatty acids | 0 | 0.274 | 0.059 | 0.809 | 2.299 |  |  |  |  |  | 
COVID19 (Custom Term) | Microbiology test normal | 1 | 1.139 | 0.185 | 0.808 | 1.79 | 0.347 | 0.845 | 1.792 | 0.878 | 0.432 | 0.243
COVID19 (Custom Term) | Mania | 2 | 2.492 | 0.271 | 0.808 | 1.577 | 0.375 | 0.823 | 1.618 | 0.803 | 2.206 | 0.266
COVID19 (Custom Term) | Concussion | 5 | 7.141 | 0.387 | 0.808 | 1.354 | 0.404 | 0.747 | 1.286 | 0.7 | 0.517 | 1.668
COVID19 (Custom Term) | Adverse drug reaction | 3 | 6.541 | 0.28 | 0.808 | 1.557 | 0.288 | 0.592 | 1.104 | 0.459 | 0.145 | 13.96
COVID19 (Custom Term) | Pityriasis rubra pilaris | 0 | 0.274 | 0.058 | 0.808 | 2.301 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord abscess | 0 | 0.274 | 0.058 | 0.808 | 2.3 |  |  |  |  |  | 
COVID19 (Custom Term) | Throat cancer | 0 | 0.274 | 0.057 | 0.808 | 2.302 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatinine abnormal | 0 | 0.274 | 0.058 | 0.808 | 2.301 |  |  |  |  |  | 
COVID19 (Custom Term) | Noninfective encephalitis | 5 | 5.11 | 0.393 | 0.807 | 1.34 | 0.499 | 0.921 | 1.586 | 0.978 | 0.973 | 0.03
COVID19 (Custom Term) | Anti-cyclic citrullinated peptide antibody negative | 1 | 2.339 | 0.186 | 0.807 | 1.784 | 0.27 | 0.668 | 1.426 | 0.428 | 0.255 | 1.403
COVID19 (Custom Term) | Abscess rupture | 0 | 0.274 | 0.057 | 0.807 | 2.303 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic prolapse | 0 | 0.274 | 0.057 | 0.807 | 2.303 |  |  |  |  |  | 
COVID19 (Custom Term) | Candida nappy rash | 0 | 0.274 | 0.057 | 0.807 | 2.303 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood uric acid decreased | 0 | 0.274 | 0.057 | 0.807 | 2.302 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site streaking | 11 | 15.561 | 0.479 | 0.806 | 1.201 | 0.463 | 0.732 | 1.112 | 0.707 | 0.775 | 0.459
COVID19 (Custom Term) | Immunodeficiency | 5 | 8.241 | 0.368 | 0.806 | 1.382 | 0.367 | 0.677 | 1.167 | 0.607 | 0.391 | 3.945
COVID19 (Custom Term) | Lung diffusion test decreased | 0 | 0.274 | 0.056 | 0.806 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Meniscus operation | 0 | 0.274 | 0.056 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrocytosis | 0 | 0.274 | 0.056 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Genitourinary symptom | 0 | 0.274 | 0.056 | 0.806 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor XII level normal | 0 | 0.183 | 0.019 | 0.806 | 2.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site nerve damage | 0 | 0.274 | 0.056 | 0.806 | 2.307 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal perivascular sheathing | 0 | 0.274 | 0.057 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Ophthalmic fluid-air exchange procedure | 0 | 0.274 | 0.057 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiopulmonary exercise test normal | 0 | 0.183 | 0.019 | 0.806 | 2.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic carcinoma | 0 | 0.366 | 0.097 | 0.806 | 2.09 |  |  |  |  |  | 
COVID19 (Custom Term) | Sphincter of Oddi dysfunction | 0 | 0.274 | 0.056 | 0.806 | 2.307 |  |  |  |  |  | 
COVID19 (Custom Term) | High density lipoprotein increased | 0 | 0.274 | 0.056 | 0.806 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord neoplasm | 0 | 0.274 | 0.056 | 0.806 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic graft versus host disease | 0 | 0.274 | 0.057 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital discomfort | 0 | 0.274 | 0.056 | 0.806 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site infection | 0 | 0.183 | 0.019 | 0.806 | 2.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterococcus test | 0 | 0.274 | 0.056 | 0.806 | 2.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Facial spasm | 4 | 3.793 | 0.344 | 0.805 | 1.422 | 0.493 | 0.95 | 1.693 | 1.054 | 2.206 | 1.209
COVID19 (Custom Term) | Eyelid margin crusting | 5 | 6.462 | 0.406 | 0.805 | 1.314 | 0.432 | 0.797 | 1.373 | 0.774 | 1.211 | 0.022
COVID19 (Custom Term) | Vaccination site movement impairment | 9 | 12.489 | 0.452 | 0.805 | 1.241 | 0.455 | 0.747 | 1.171 | 0.721 | 2.628 | 5.832
COVID19 (Custom Term) | Skeletal survey abnormal | 0 | 0.274 | 0.055 | 0.805 | 2.309 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibula fracture | 0 | 0.274 | 0.055 | 0.805 | 2.309 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid operation | 0 | 0.274 | 0.056 | 0.805 | 2.307 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal dryness | 0 | 0.366 | 0.096 | 0.805 | 2.091 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitamin D increased | 0 | 0.274 | 0.055 | 0.805 | 2.308 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell analysis normal | 0 | 0.183 | 0.018 | 0.805 | 2.665 |  |  |  |  |  | 
COVID19 (Custom Term) | Pus in stool | 0 | 0.274 | 0.056 | 0.805 | 2.307 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin mass | 5 | 7.248 | 0.398 | 0.804 | 1.324 | 0.4 | 0.739 | 1.273 | 0.69 | 0.417 | 3.316
COVID19 (Custom Term) | Congenital megacolon | 0 | 0.274 | 0.055 | 0.804 | 2.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal achalasia | 0 | 0.274 | 0.055 | 0.804 | 2.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngitis viral | 0 | 0.183 | 0.018 | 0.804 | 2.669 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF white blood cell differential | 0 | 0.295 | 0.064 | 0.804 | 2.253 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhinovirus infection | 0 | 0.304 | 0.068 | 0.804 | 2.23 |  |  |  |  |  | 
COVID19 (Custom Term) | Actinic keratosis | 0 | 0.274 | 0.054 | 0.804 | 2.311 |  |  |  |  |  | 
COVID19 (Custom Term) | Opticokinetic nystagmus tests abnormal | 0 | 0.274 | 0.055 | 0.804 | 2.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Sweat test normal | 0 | 0.274 | 0.055 | 0.804 | 2.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Gait spastic | 0 | 0.274 | 0.055 | 0.804 | 2.309 |  |  |  |  |  | 
COVID19 (Custom Term) | Asymptomatic bacteriuria | 0 | 0.274 | 0.054 | 0.804 | 2.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Rib fracture | 2 | 3.19 | 0.298 | 0.803 | 1.508 | 0.335 | 0.738 | 1.451 | 0.627 | 0.993 | 0.13
COVID19 (Custom Term) | Delayed myelination | 0 | 0.274 | 0.053 | 0.803 | 2.313 |  |  |  |  |  | 
COVID19 (Custom Term) | Seronegative arthritis | 0 | 0.274 | 0.053 | 0.803 | 2.313 |  |  |  |  |  | 
COVID19 (Custom Term) | Oligodipsia | 0 | 0.274 | 0.054 | 0.803 | 2.312 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary sepsis | 0 | 0.274 | 0.054 | 0.803 | 2.312 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerumen impaction | 0 | 0.274 | 0.054 | 0.803 | 2.312 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve neurostimulation | 0 | 0.274 | 0.054 | 0.803 | 2.311 |  |  |  |  |  | 
COVID19 (Custom Term) | Typhus rickettsia test | 0 | 0.482 | 0.14 | 0.803 | 1.915 |  |  |  |  |  | 
COVID19 (Custom Term) | Carbohydrate antigen 125 increased | 0 | 0.183 | 0.017 | 0.802 | 2.675 |  |  |  |  |  | 
COVID19 (Custom Term) | Impaired reasoning | 0 | 0.274 | 0.053 | 0.802 | 2.314 |  |  |  |  |  | 
COVID19 (Custom Term) | Subdural effusion | 0 | 0.274 | 0.053 | 0.802 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurosarcoidosis | 0 | 0.274 | 0.053 | 0.802 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Creatinine renal clearance increased | 0 | 0.274 | 0.053 | 0.802 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Product availability issue | 0 | 0.127 | 0.004 | 0.802 | 3.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergy to arthropod bite | 0 | 0.366 | 0.092 | 0.802 | 2.097 |  |  |  |  |  | 
COVID19 (Custom Term) | Paralysis | 25 | 35.703 | 0.561 | 0.801 | 1.077 | 0.518 | 0.713 | 0.963 | 0.7 | 0.4 | 20.991
COVID19 (Custom Term) | Gamma-glutamyltransferase increased | 1 | 1.658 | 0.119 | 0.801 | 1.981 | 0.31 | 0.759 | 1.612 | 0.603 | 0.081 | 9.309
COVID19 (Custom Term) | Skin hypopigmentation | 0 | 0.299 | 0.062 | 0.801 | 2.249 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site rash | 0 | 0.274 | 0.052 | 0.801 | 2.318 |  |  |  |  |  | 
COVID19 (Custom Term) | Organ failure | 0 | 0.616 | 0.181 | 0.801 | 1.778 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site abscess | 0 | 0.274 | 0.052 | 0.801 | 2.317 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood carbon monoxide increased | 0 | 0.274 | 0.052 | 0.801 | 2.316 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial toxaemia | 0 | 0.274 | 0.052 | 0.801 | 2.317 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxic shock syndrome streptococcal | 0 | 0.274 | 0.052 | 0.801 | 2.317 |  |  |  |  |  | 
COVID19 (Custom Term) | Russell's viper venom time | 0 | 0.274 | 0.052 | 0.801 | 2.317 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychiatric evaluation normal | 0 | 0.101 | 0.001 | 0.8 | 3.312 |  |  |  |  |  | 
COVID19 (Custom Term) | Excessive eye blinking | 0 | 1.139 | 0.298 | 0.8 | 1.499 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet function test abnormal | 0 | 0.274 | 0.051 | 0.8 | 2.319 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C antibody | 0 | 0.274 | 0.051 | 0.8 | 2.32 |  |  |  |  |  | 
COVID19 (Custom Term) | Wrist surgery | 0 | 0.274 | 0.051 | 0.8 | 2.319 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV antigen | 0 | 0.274 | 0.052 | 0.8 | 2.318 |  |  |  |  |  | 
COVID19 (Custom Term) | Nocturnal dyspnoea | 0 | 0.274 | 0.051 | 0.8 | 2.318 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail growth abnormal | 0 | 0.274 | 0.051 | 0.8 | 2.319 |  |  |  |  |  | 
COVID19 (Custom Term) | Proteus test positive | 0 | 0.183 | 0.016 | 0.8 | 2.679 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral neuropathy (SMQ) [narrow] | 260 | 339.926 | 0.719 | 0.799 | 0.881 | 0.691 | 0.766 | 0.846 | 0.765 | 0.673 | 38.716
COVID19 (Custom Term) | Muscle spasticity | 1 | 2.529 | 0.12 | 0.799 | 1.971 | 0.26 | 0.646 | 1.382 | 0.395 | 0.184 | 2.73
COVID19 (Custom Term) | Blood pH | 0 | 0.274 | 0.051 | 0.799 | 2.32 |  |  |  |  |  | 
COVID19 (Custom Term) | Arm amputation | 0 | 0.274 | 0.051 | 0.799 | 2.321 |  |  |  |  |  | 
COVID19 (Custom Term) | Intentional overdose | 0 | 0.274 | 0.05 | 0.799 | 2.322 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone disorder | 0 | 0.327 | 0.073 | 0.799 | 2.185 |  |  |  |  |  | 
COVID19 (Custom Term) | Victim of crime | 0 | 0.274 | 0.051 | 0.799 | 2.32 |  |  |  |  |  | 
COVID19 (Custom Term) | Knee deformity | 0 | 0.274 | 0.051 | 0.799 | 2.321 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes pharyngitis | 0 | 0.274 | 0.05 | 0.799 | 2.322 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoxic-ischaemic encephalopathy | 1 | 1.158 | 0.151 | 0.798 | 1.862 | 0.345 | 0.841 | 1.784 | 0.863 | 0.473 | 0.144
COVID19 (Custom Term) | Epstein-Barr virus test | 4 | 4.834 | 0.376 | 0.798 | 1.346 | 0.432 | 0.832 | 1.484 | 0.827 | 0.863 | 0.001
COVID19 (Custom Term) | Skin induration | 6 | 8.582 | 0.441 | 0.798 | 1.241 | 0.416 | 0.741 | 1.239 | 0.699 | 1.064 | 0.006
COVID19 (Custom Term) | Nerve conduction studies abnormal | 3 | 6.507 | 0.26 | 0.798 | 1.576 | 0.289 | 0.594 | 1.108 | 0.461 | 0.192 | 9.145
COVID19 (Custom Term) | Hepatitis B core antibody negative | 2 | 4.57 | 0.153 | 0.798 | 1.856 | 0.276 | 0.611 | 1.206 | 0.438 | 0.105 | 14.233
COVID19 (Custom Term) | Xerophthalmia | 0 | 0.274 | 0.05 | 0.798 | 2.323 |  |  |  |  |  | 
COVID19 (Custom Term) | Echoencephalogram | 0 | 0.183 | 0.016 | 0.798 | 2.685 |  |  |  |  |  | 
COVID19 (Custom Term) | Product use complaint | 0 | 0.274 | 0.049 | 0.798 | 2.324 |  |  |  |  |  | 
COVID19 (Custom Term) | Metapneumovirus infection | 0 | 0.101 | 0.001 | 0.798 | 3.321 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug trough level | 0 | 0.183 | 0.016 | 0.798 | 2.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal myelogram abnormal | 0 | 0.274 | 0.049 | 0.798 | 2.324 |  |  |  |  |  | 
COVID19 (Custom Term) | Carditis | 0 | 0.274 | 0.05 | 0.798 | 2.322 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased nasolabial fold | 0 | 0.183 | 0.016 | 0.798 | 2.685 |  |  |  |  |  | 
COVID19 (Custom Term) | Tissue infiltration | 0 | 0.274 | 0.05 | 0.798 | 2.323 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoma benign | 0 | 0.274 | 0.05 | 0.798 | 2.323 |  |  |  |  |  | 
COVID19 (Custom Term) | Band neutrophil count increased | 0 | 0.494 | 0.137 | 0.798 | 1.907 |  |  |  |  |  | 
COVID19 (Custom Term) | Interleukin-2 receptor assay | 0 | 0.274 | 0.05 | 0.798 | 2.324 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood magnesium decreased | 10 | 9.933 | 0.468 | 0.797 | 1.196 | 0.598 | 0.962 | 1.483 | 1.007 | 4.137 | 14.445
COVID19 (Custom Term) | Autoimmune disorder | 11 | 15.474 | 0.459 | 0.797 | 1.21 | 0.465 | 0.735 | 1.117 | 0.711 | 0.341 | 12.839
COVID19 (Custom Term) | Musculoskeletal disorder | 20 | 30.222 | 0.55 | 0.797 | 1.082 | 0.478 | 0.681 | 0.947 | 0.662 | 0.437 | 13.293
COVID19 (Custom Term) | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [broad] | 2 | 4.581 | 0.15 | 0.797 | 1.865 | 0.275 | 0.61 | 1.204 | 0.437 | 0.076 | 21.286
COVID19 (Custom Term) | Antiendomysial antibody test | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Upper respiratory tract endoscopy | 0 | 0.183 | 0.015 | 0.797 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Candida test negative | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint ankylosis | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Plagiocephaly | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Iontophoresis | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudoparalysis | 0 | 0.274 | 0.049 | 0.797 | 2.327 |  |  |  |  |  | 
COVID19 (Custom Term) | Plateletcrit increased | 0 | 0.274 | 0.049 | 0.797 | 2.325 |  |  |  |  |  | 
COVID19 (Custom Term) | Helicobacter gastritis | 0 | 0.274 | 0.049 | 0.797 | 2.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint warmth | 0 | 0.274 | 0.049 | 0.796 | 2.327 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillar inflammation | 2 | 1.033 | 0.257 | 0.795 | 1.574 | 0.496 | 1.087 | 2.144 | 1.936 | 1.805 | 0.089
COVID19 (Custom Term) | Bradypnoea | 0 | 0.183 | 0.014 | 0.795 | 2.693 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemothorax | 0 | 0.183 | 0.014 | 0.795 | 2.694 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell agglutination present | 0 | 0.274 | 0.048 | 0.795 | 2.329 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pyruvic acid increased | 0 | 0.183 | 0.014 | 0.795 | 2.694 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold type haemolytic anaemia | 0 | 0.366 | 0.084 | 0.795 | 2.11 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung cancer metastatic | 0 | 0.274 | 0.047 | 0.795 | 2.33 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug dependence | 0 | 0.274 | 0.048 | 0.795 | 2.329 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C virus test positive | 0 | 0.366 | 0.085 | 0.795 | 2.11 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal scan | 0 | 0.274 | 0.048 | 0.795 | 2.329 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B test negative | 4 | 5.055 | 0.31 | 0.794 | 1.461 | 0.42 | 0.811 | 1.446 | 0.791 | 0.401 | 2.833
COVID19 (Custom Term) | Systemic lupus erythematosus (SMQ) [algorithm] | 16 | 24.031 | 0.506 | 0.794 | 1.135 | 0.466 | 0.688 | 0.988 | 0.666 | 0.415 | 12.083
COVID19 (Custom Term) | Nasal obstruction | 0 | 0.307 | 0.06 | 0.794 | 2.243 |  |  |  |  |  | 
COVID19 (Custom Term) | Product origin unknown | 0 | 0.274 | 0.047 | 0.794 | 2.332 |  |  |  |  |  | 
COVID19 (Custom Term) | Angina bullosa haemorrhagica | 0 | 0.274 | 0.046 | 0.794 | 2.333 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site joint effusion | 0 | 0.274 | 0.047 | 0.794 | 2.332 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging abdominal | 0 | 0.476 | 0.126 | 0.794 | 1.935 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitral valve repair | 0 | 0.274 | 0.046 | 0.794 | 2.332 |  |  |  |  |  | 
COVID19 (Custom Term) | Capillary disorder | 0 | 0.274 | 0.046 | 0.794 | 2.332 |  |  |  |  |  | 
COVID19 (Custom Term) | Epidural blood patch | 0 | 0.274 | 0.047 | 0.794 | 2.332 |  |  |  |  |  | 
COVID19 (Custom Term) | VIth nerve paralysis | 4 | 5.568 | 0.379 | 0.793 | 1.33 | 0.397 | 0.766 | 1.365 | 0.718 | 0.779 | 0.062
COVID19 (Custom Term) | Vaccination complication | 53 | 76.573 | 0.632 | 0.793 | 0.969 | 0.558 | 0.699 | 0.866 | 0.692 | 0.296 | 85.715
COVID19 (Custom Term) | Ocular infections (SMQ) [broad] | 42 | 66.74 | 0.607 | 0.793 | 1.001 | 0.498 | 0.64 | 0.813 | 0.629 | 0.302 | 65.478
COVID19 (Custom Term) | Growth hormone deficiency | 0 | 0.274 | 0.046 | 0.793 | 2.334 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular examination abnormal | 0 | 0.274 | 0.046 | 0.793 | 2.334 |  |  |  |  |  | 
COVID19 (Custom Term) | Fistula | 0 | 0.274 | 0.046 | 0.793 | 2.334 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood brain barrier defect | 0 | 0.274 | 0.046 | 0.793 | 2.333 |  |  |  |  |  | 
COVID19 (Custom Term) | Venogram | 4 | 4.005 | 0.365 | 0.792 | 1.352 | 0.479 | 0.923 | 1.646 | 0.999 | 3.31 | 3.117
COVID19 (Custom Term) | Injection site warmth | 862 | 1024.919 | 0.748 | 0.792 | 0.837 | 0.795 | 0.841 | 0.889 | 0.841 | 0.671 | 135.028
COVID19 (Custom Term) | Hepatic steatosis | 3 | 3.816 | 0.237 | 0.792 | 1.61 | 0.398 | 0.812 | 1.51 | 0.786 | 1.146 | 0.01
COVID19 (Custom Term) | Coordination abnormal | 13 | 16.427 | 0.508 | 0.792 | 1.128 | 0.522 | 0.8 | 1.184 | 0.791 | 0.75 | 0.764
COVID19 (Custom Term) | Malignant tumours (SMQ) [broad] | 37 | 57.125 | 0.594 | 0.792 | 1.014 | 0.505 | 0.659 | 0.849 | 0.648 | 0.542 | 13.144
COVID19 (Custom Term) | Malignant tumours (SMQ) [narrow] | 37 | 57.125 | 0.594 | 0.792 | 1.014 | 0.505 | 0.659 | 0.849 | 0.648 | 0.542 | 13.144
COVID19 (Custom Term) | Breast malignant tumours (SMQ) [narrow] | 2 | 5.367 | 0.272 | 0.792 | 1.532 | 0.249 | 0.555 | 1.099 | 0.373 | 0.405 | 1.107
COVID19 (Custom Term) | Breast neoplasms, malignant and unspecified (SMQ) [narrow] | 2 | 5.367 | 0.272 | 0.792 | 1.532 | 0.249 | 0.555 | 1.099 | 0.373 | 0.405 | 1.107
COVID19 (Custom Term) | Adenosine deaminase normal | 0 | 0.274 | 0.045 | 0.792 | 2.335 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell macrocytes present | 0 | 0.183 | 0.014 | 0.792 | 2.699 |  |  |  |  |  | 
COVID19 (Custom Term) | Intra-ocular injection | 0 | 0.274 | 0.046 | 0.792 | 2.335 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein total abnormal | 0 | 0.274 | 0.045 | 0.792 | 2.337 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventricular dysfunction | 0 | 0.274 | 0.045 | 0.792 | 2.336 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood uric acid normal | 3 | 3.545 | 0.313 | 0.791 | 1.446 | 0.413 | 0.843 | 1.568 | 0.846 | 0.634 | 0.278
COVID19 (Custom Term) | Severe cutaneous adverse reactions (SMQ) [broad] | 193 | 259.297 | 0.701 | 0.791 | 0.887 | 0.662 | 0.746 | 0.837 | 0.744 | 0.397 | 172.291
COVID19 (Custom Term) | Bullous impetigo | 0 | 0.366 | 0.081 | 0.791 | 2.116 |  |  |  |  |  | 
COVID19 (Custom Term) | Dependent rubor | 0 | 0.366 | 0.081 | 0.791 | 2.117 |  |  |  |  |  | 
COVID19 (Custom Term) | Recurrent cancer | 0 | 0.274 | 0.045 | 0.791 | 2.337 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal myelogram | 0 | 0.366 | 0.081 | 0.791 | 2.116 |  |  |  |  |  | 
COVID19 (Custom Term) | Poor weight gain neonatal | 0 | 0.274 | 0.045 | 0.791 | 2.338 |  |  |  |  |  | 
COVID19 (Custom Term) | CNS ventriculitis | 0 | 0.183 | 0.013 | 0.791 | 2.704 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood selenium normal | 0 | 0.274 | 0.045 | 0.791 | 2.338 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging abnormal | 43 | 63.233 | 0.609 | 0.79 | 0.991 | 0.537 | 0.689 | 0.872 | 0.68 | 0.656 | 6.947
COVID19 (Custom Term) | Bladder disorder | 1 | 1.736 | 0.138 | 0.79 | 1.883 | 0.305 | 0.747 | 1.589 | 0.576 | 0.432 | 0.243
COVID19 (Custom Term) | Gastroenteritis eosinophilic | 0 | 0.274 | 0.044 | 0.79 | 2.341 |  |  |  |  |  | 
COVID19 (Custom Term) | pH urine decreased | 0 | 0.274 | 0.044 | 0.79 | 2.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Trichorrhexis | 0 | 0.274 | 0.044 | 0.79 | 2.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration pleural cavity abnormal | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell scan | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration related reaction | 0 | 0.274 | 0.044 | 0.79 | 2.341 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenocortical steroid therapy | 0 | 0.274 | 0.044 | 0.79 | 2.341 |  |  |  |  |  | 
COVID19 (Custom Term) | Aortic wall hypertrophy | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasite blood test positive | 0 | 0.274 | 0.044 | 0.79 | 2.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchitis bacterial | 0 | 0.274 | 0.044 | 0.79 | 2.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrinolysis | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleural fibrosis | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood uric acid abnormal | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system lupus | 0 | 0.183 | 0.013 | 0.79 | 2.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural infection | 0 | 0.183 | 0.013 | 0.789 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Extravasation blood | 0 | 0.274 | 0.043 | 0.789 | 2.343 |  |  |  |  |  | 
COVID19 (Custom Term) | IIIrd nerve disorder | 0 | 0.274 | 0.043 | 0.789 | 2.342 |  |  |  |  |  | 
COVID19 (Custom Term) | Dairy intolerance | 0 | 0.507 | 0.132 | 0.789 | 1.903 |  |  |  |  |  | 
COVID19 (Custom Term) | Trance | 0 | 0.274 | 0.043 | 0.789 | 2.341 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular disorder | 0 | 0.274 | 0.043 | 0.789 | 2.342 |  |  |  |  |  | 
COVID19 (Custom Term) | Diffuse alopecia | 0 | 0.274 | 0.043 | 0.789 | 2.342 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin temperature | 0 | 0.183 | 0.013 | 0.789 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic cough | 0 | 0.274 | 0.043 | 0.789 | 2.343 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood 1,25-dihydroxycholecalciferol | 0 | 0.183 | 0.013 | 0.789 | 2.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic vasculitis | 0 | 0.274 | 0.043 | 0.789 | 2.341 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenosine deaminase increased | 0 | 0.183 | 0.013 | 0.789 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Poor quality device used | 0 | 0.183 | 0.013 | 0.789 | 2.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Azotaemia | 3 | 2.962 | 0.31 | 0.788 | 1.443 | 0.45 | 0.918 | 1.707 | 1.013 | 2.708 | 1.277
COVID19 (Custom Term) | Albumin globulin ratio normal | 3 | 3.418 | 0.343 | 0.788 | 1.38 | 0.421 | 0.858 | 1.596 | 0.878 | 1.655 | 0.192
COVID19 (Custom Term) | Bacterial test negative | 4 | 6.537 | 0.342 | 0.788 | 1.383 | 0.358 | 0.692 | 1.235 | 0.612 | 0.123 | 23.696
COVID19 (Custom Term) | Convulsion in childhood | 0 | 0.274 | 0.043 | 0.788 | 2.344 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycobacterium test positive | 0 | 0.349 | 0.071 | 0.788 | 2.158 |  |  |  |  |  | 
COVID19 (Custom Term) | Promyelocyte count | 0 | 0.274 | 0.042 | 0.787 | 2.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy liver normal | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Cartilage injury | 0 | 0.251 | 0.033 | 0.787 | 2.422 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal turbinate hypertrophy | 0 | 0.274 | 0.042 | 0.787 | 2.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Bundle branch block | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Schizotypal personality disorder | 0 | 0.274 | 0.042 | 0.787 | 2.347 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningoradiculitis | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Simple partial seizures | 0 | 0.274 | 0.042 | 0.787 | 2.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Supportive care | 0 | 0.366 | 0.077 | 0.787 | 2.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoglobulin G4 related disease | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign lymph node neoplasm | 0 | 0.366 | 0.077 | 0.787 | 2.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine nitrogen | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulocytes abnormal | 0 | 0.274 | 0.042 | 0.787 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site nodule | 0 | 0.366 | 0.077 | 0.787 | 2.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic disc disorder | 0 | 0.274 | 0.042 | 0.787 | 2.347 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site discolouration | 30 | 40.696 | 0.577 | 0.786 | 1.02 | 0.555 | 0.746 | 0.984 | 0.737 | 0.379 | 28.822
COVID19 (Custom Term) | Myelitis transverse | 14 | 20.013 | 0.498 | 0.786 | 1.127 | 0.476 | 0.721 | 1.055 | 0.7 | 0.635 | 2.402
COVID19 (Custom Term) | Pharyngeal disorder | 0 | 0.963 | 0.245 | 0.786 | 1.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Cutaneous symptom | 0 | 0.274 | 0.041 | 0.786 | 2.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Monocyte count abnormal | 0 | 0.274 | 0.041 | 0.786 | 2.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudomonas infection | 0 | 0.366 | 0.076 | 0.786 | 2.125 |  |  |  |  |  | 
COVID19 (Custom Term) | Haptoglobin increased | 0 | 0.274 | 0.041 | 0.786 | 2.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy small intestine abnormal | 0 | 0.274 | 0.041 | 0.786 | 2.347 |  |  |  |  |  | 
COVID19 (Custom Term) | Aversion | 0 | 0.274 | 0.041 | 0.786 | 2.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Intervertebral disc space narrowing | 0 | 0.274 | 0.041 | 0.786 | 2.349 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast enlargement | 0 | 0.274 | 0.041 | 0.786 | 2.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Swelling | 447 | 586.062 | 0.725 | 0.785 | 0.847 | 0.706 | 0.763 | 0.824 | 0.763 | 0.515 | 199.107
COVID19 (Custom Term) | Liver palpable | 0 | 0.274 | 0.04 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Weight abnormal | 0 | 0.274 | 0.041 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-VGCC antibody | 0 | 0.274 | 0.041 | 0.785 | 2.349 |  |  |  |  |  | 
COVID19 (Custom Term) | Circumstance or information capable of leading to device use error | 0 | 0.274 | 0.04 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestradiol | 0 | 0.366 | 0.075 | 0.785 | 2.126 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterocolitis viral | 0 | 0.183 | 0.011 | 0.785 | 2.718 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection related reaction | 0 | 0.274 | 0.04 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Carotid artery dissection | 0 | 0.274 | 0.041 | 0.785 | 2.349 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-platelet antibody | 0 | 0.274 | 0.04 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin neoplasm excision | 0 | 0.189 | 0.013 | 0.785 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis enteroviral | 0 | 0.183 | 0.011 | 0.785 | 2.718 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvar dysplasia | 0 | 0.274 | 0.04 | 0.785 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Incisional drainage | 2 | 2.773 | 0.291 | 0.784 | 1.473 | 0.358 | 0.787 | 1.546 | 0.721 | 0.207 | 5.135
COVID19 (Custom Term) | Glutathione decreased | 0 | 0.183 | 0.011 | 0.784 | 2.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Anogenital dysplasia | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic response changed | 0 | 0.183 | 0.011 | 0.784 | 2.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to lung | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Menstrual discomfort | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiovascular autonomic function test normal | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Leptospirosis | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear infection bacterial | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestradiol increased | 0 | 0.183 | 0.011 | 0.784 | 2.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol test negative | 0 | 0.183 | 0.011 | 0.784 | 2.72 |  |  |  |  |  | 
COVID19 (Custom Term) | Onychomycosis | 0 | 0.366 | 0.074 | 0.784 | 2.128 |  |  |  |  |  | 
COVID19 (Custom Term) | Premenstrual dysphoric disorder | 0 | 0.274 | 0.04 | 0.784 | 2.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy soft tissue | 0 | 0.183 | 0.011 | 0.784 | 2.72 |  |  |  |  |  | 
COVID19 (Custom Term) | Coronary artery dilatation | 0 | 0.573 | 0.145 | 0.783 | 1.838 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy brain normal | 0 | 0.274 | 0.039 | 0.783 | 2.353 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal anaesthesia | 0 | 0.183 | 0.011 | 0.783 | 2.723 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuro-ophthalmological test normal | 0 | 0.274 | 0.039 | 0.783 | 2.354 |  |  |  |  |  | 
COVID19 (Custom Term) | Surgical failure | 0 | 0.183 | 0.011 | 0.783 | 2.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour excision | 0 | 0.366 | 0.074 | 0.783 | 2.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy gastrointestinal abnormal | 0 | 0.274 | 0.039 | 0.783 | 2.353 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalomalacia | 0 | 0.549 | 0.137 | 0.783 | 1.863 |  |  |  |  |  | 
COVID19 (Custom Term) | Dust allergy | 0 | 0.274 | 0.039 | 0.783 | 2.353 |  |  |  |  |  | 
COVID19 (Custom Term) | Anticonvulsant drug level therapeutic | 0 | 0.366 | 0.073 | 0.783 | 2.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal hernia | 0 | 0.274 | 0.039 | 0.783 | 2.353 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound breast | 0 | 0.366 | 0.073 | 0.783 | 2.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Adnexa uteri mass | 0 | 0.183 | 0.011 | 0.783 | 2.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site erythema | 1706 | 2094.327 | 0.751 | 0.782 | 0.813 | 0.783 | 0.815 | 0.848 | 0.815 | 0.556 | 630.226
COVID19 (Custom Term) | Alpha 1 globulin increased | 0 | 0.366 | 0.072 | 0.782 | 2.131 |  |  |  |  |  | 
COVID19 (Custom Term) | Legal problem | 0 | 0.274 | 0.039 | 0.782 | 2.355 |  |  |  |  |  | 
COVID19 (Custom Term) | Meniscus injury | 0 | 0.457 | 0.105 | 0.782 | 1.978 |  |  |  |  |  | 
COVID19 (Custom Term) | Mental disability | 0 | 0.274 | 0.039 | 0.782 | 2.355 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune reconstitution inflammatory syndrome | 0 | 0.274 | 0.038 | 0.782 | 2.356 |  |  |  |  |  | 
COVID19 (Custom Term) | Cluster headache | 4 | 4.41 | 0.356 | 0.781 | 1.34 | 0.455 | 0.877 | 1.562 | 0.907 | 2.648 | 1.965
COVID19 (Custom Term) | Soft tissue swelling | 3 | 3.478 | 0.298 | 0.781 | 1.449 | 0.417 | 0.851 | 1.582 | 0.863 | 0.764 | 0.034
COVID19 (Custom Term) | Abscess | 3 | 3.777 | 0.272 | 0.781 | 1.503 | 0.4 | 0.816 | 1.518 | 0.794 | 0.191 | 9.239
COVID19 (Custom Term) | Blood immunoglobulin A | 1 | 1.489 | 0.179 | 0.781 | 1.728 | 0.321 | 0.785 | 1.666 | 0.671 | 0.226 | 1.832
COVID19 (Custom Term) | Widal test | 0 | 0.274 | 0.038 | 0.781 | 2.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Cranial nerve palsies multiple | 0 | 0.274 | 0.038 | 0.781 | 2.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary tuberculosis | 0 | 0.274 | 0.038 | 0.781 | 2.357 |  |  |  |  |  | 
COVID19 (Custom Term) | Tinea cruris | 0 | 0.274 | 0.038 | 0.781 | 2.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Vagus nerve disorder | 0 | 0.274 | 0.038 | 0.78 | 2.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical dilatation | 0 | 0.274 | 0.037 | 0.78 | 2.359 |  |  |  |  |  | 
COVID19 (Custom Term) | External ear inflammation | 0 | 0.366 | 0.07 | 0.78 | 2.134 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental operation | 0 | 0.274 | 0.037 | 0.78 | 2.359 |  |  |  |  |  | 
COVID19 (Custom Term) | Positron emission tomography-magnetic resonance imaging | 0 | 0.366 | 0.071 | 0.78 | 2.134 |  |  |  |  |  | 
COVID19 (Custom Term) | Terminal insomnia | 0 | 0.366 | 0.071 | 0.78 | 2.134 |  |  |  |  |  | 
COVID19 (Custom Term) | B-lymphocyte count increased | 0 | 0.274 | 0.037 | 0.78 | 2.359 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukaemia | 2 | 3.855 | 0.257 | 0.779 | 1.53 | 0.304 | 0.671 | 1.322 | 0.519 | 0.423 | 0.966
COVID19 (Custom Term) | Patellofemoral pain syndrome | 0 | 0.366 | 0.07 | 0.779 | 2.135 |  |  |  |  |  | 
COVID19 (Custom Term) | Computerised tomogram liver abnormal | 0 | 0.274 | 0.037 | 0.779 | 2.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung transplant | 0 | 0.274 | 0.037 | 0.779 | 2.361 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound kidney abnormal | 0 | 0.478 | 0.11 | 0.779 | 1.953 |  |  |  |  |  | 
COVID19 (Custom Term) | Non-cardiac chest pain | 1 | 1.006 | 0.23 | 0.778 | 1.589 | 0.358 | 0.87 | 1.845 | 0.994 | 0.764 | 0.041
COVID19 (Custom Term) | Hepatobiliary scan | 3 | 3.055 | 0.317 | 0.778 | 1.405 | 0.444 | 0.905 | 1.683 | 0.982 | 2.482 | 1.02
COVID19 (Custom Term) | Sunburn | 1 | 1.987 | 0.209 | 0.778 | 1.639 | 0.29 | 0.712 | 1.517 | 0.503 | 0.268 | 1.237
COVID19 (Custom Term) | Epstein-Barr virus antibody | 1 | 2.005 | 0.227 | 0.778 | 1.597 | 0.289 | 0.71 | 1.512 | 0.499 | 0.473 | 0.144
COVID19 (Custom Term) | Blood follicle stimulating hormone normal | 0 | 0.274 | 0.036 | 0.778 | 2.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Jaw operation | 0 | 0.366 | 0.069 | 0.778 | 2.137 |  |  |  |  |  | 
COVID19 (Custom Term) | Product taste abnormal | 0 | 0.274 | 0.036 | 0.778 | 2.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Gallbladder oedema | 0 | 0.274 | 0.036 | 0.778 | 2.363 |  |  |  |  |  | 
COVID19 (Custom Term) | Subacute inflammatory demyelinating polyneuropathy | 0 | 0.274 | 0.036 | 0.778 | 2.363 |  |  |  |  |  | 
COVID19 (Custom Term) | Knee operation | 0 | 0.366 | 0.069 | 0.778 | 2.137 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrolyte substitution therapy | 0 | 0.274 | 0.036 | 0.778 | 2.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha tumour necrosis factor increased | 0 | 0.274 | 0.036 | 0.778 | 2.363 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary arterial pressure increased | 0 | 0.274 | 0.036 | 0.778 | 2.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0.366 | 0.068 | 0.777 | 2.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0.366 | 0.068 | 0.777 | 2.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull fractured base | 0 | 0.274 | 0.035 | 0.777 | 2.365 |  |  |  |  |  | 
COVID19 (Custom Term) | Amoeba test negative | 0 | 0.274 | 0.035 | 0.777 | 2.365 |  |  |  |  |  | 
COVID19 (Custom Term) | Stomach mass | 0 | 0.274 | 0.036 | 0.777 | 2.364 |  |  |  |  |  | 
COVID19 (Custom Term) | Vasospasm | 0 | 0.274 | 0.036 | 0.777 | 2.365 |  |  |  |  |  | 
COVID19 (Custom Term) | Relapsing fever | 0 | 0.274 | 0.036 | 0.777 | 2.365 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF immunoglobulin | 1 | 1.547 | 0.16 | 0.776 | 1.77 | 0.317 | 0.776 | 1.647 | 0.647 | 0.764 | 0.041
COVID19 (Custom Term) | Regurgitation | 1 | 1.764 | 0.111 | 0.776 | 1.937 | 0.303 | 0.743 | 1.58 | 0.567 | 0.117 | 5.675
COVID19 (Custom Term) | Breast abscess | 0 | 0.274 | 0.035 | 0.776 | 2.366 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid cyst | 0 | 0.366 | 0.067 | 0.776 | 2.14 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroschisis | 0 | 0.274 | 0.035 | 0.776 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | Acidosis hyperchloraemic | 0 | 0.274 | 0.035 | 0.776 | 2.366 |  |  |  |  |  | 
COVID19 (Custom Term) | Device issue | 0 | 0.274 | 0.035 | 0.776 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal monitoring abnormal | 0 | 0.274 | 0.035 | 0.776 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | Finger amputation | 0 | 0.366 | 0.067 | 0.776 | 2.14 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhabdomyosarcoma | 0 | 0.274 | 0.035 | 0.776 | 2.366 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerular filtration rate increased | 0 | 0.274 | 0.035 | 0.776 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve degeneration | 0 | 0.274 | 0.035 | 0.776 | 2.366 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchopulmonary aspergillosis | 0 | 0.366 | 0.067 | 0.776 | 2.14 |  |  |  |  |  | 
COVID19 (Custom Term) | Regressive behaviour | 0 | 0.579 | 0.138 | 0.776 | 1.839 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 1.044 | 0.183 | 0.775 | 1.7 | 0.355 | 0.863 | 1.829 | 0.958 | 0.827 | 0.089
COVID19 (Custom Term) | Speech disorder developmental | 1 | 1.362 | 0.135 | 0.775 | 1.846 | 0.33 | 0.805 | 1.71 | 0.734 | 0.054 | 15.384
COVID19 (Custom Term) | Electroencephalogram abnormal | 6 | 8.11 | 0.391 | 0.775 | 1.265 | 0.433 | 0.77 | 1.289 | 0.74 | 0.159 | 25.327
COVID19 (Custom Term) | Lower motor neurone lesion | 0 | 0.183 | 0.009 | 0.775 | 2.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor VII level decreased | 0 | 0.274 | 0.034 | 0.775 | 2.368 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal degeneration | 0 | 0.366 | 0.066 | 0.775 | 2.142 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastritis viral | 0 | 0.366 | 0.067 | 0.775 | 2.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal polyps | 0 | 0.366 | 0.067 | 0.775 | 2.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchopneumopathy | 0 | 0.366 | 0.067 | 0.775 | 2.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine copper | 0 | 0.274 | 0.035 | 0.775 | 2.368 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythromelalgia | 0 | 0.274 | 0.035 | 0.775 | 2.368 |  |  |  |  |  | 
COVID19 (Custom Term) | Thymectomy | 0 | 0.274 | 0.035 | 0.775 | 2.367 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin necrosis | 1 | 1.189 | 0.161 | 0.774 | 1.763 | 0.343 | 0.836 | 1.773 | 0.841 | 0.331 | 0.693
COVID19 (Custom Term) | Inflammatory marker decreased | 0 | 0.269 | 0.032 | 0.774 | 2.387 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal injury | 0 | 0.183 | 0.009 | 0.774 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebellar ataxia | 0 | 0.395 | 0.076 | 0.774 | 2.087 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor increased | 0 | 0.366 | 0.066 | 0.774 | 2.143 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular fibrosis | 0 | 0.183 | 0.009 | 0.774 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal irrigation | 0 | 0.183 | 0.009 | 0.774 | 2.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Pituitary tumour | 0 | 0.274 | 0.034 | 0.774 | 2.371 |  |  |  |  |  | 
COVID19 (Custom Term) | Canalith repositioning procedure | 0 | 0.366 | 0.066 | 0.774 | 2.142 |  |  |  |  |  | 
COVID19 (Custom Term) | Oedematous pancreatitis | 0 | 0.274 | 0.034 | 0.774 | 2.371 |  |  |  |  |  | 
COVID19 (Custom Term) | Calcium ionised increased | 0 | 0.457 | 0.097 | 0.774 | 1.987 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin culture positive | 0 | 0.366 | 0.065 | 0.774 | 2.143 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal endotheliitis | 0 | 0.183 | 0.009 | 0.774 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Drop attacks | 0 | 0.366 | 0.066 | 0.774 | 2.143 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster necrotising retinopathy | 0 | 0.183 | 0.009 | 0.774 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Culture positive | 1 | 1.503 | 0.116 | 0.773 | 1.907 | 0.32 | 0.783 | 1.662 | 0.666 | 0.276 | 1.156
COVID19 (Custom Term) | Mobility decreased | 377 | 517.696 | 0.709 | 0.773 | 0.839 | 0.67 | 0.729 | 0.793 | 0.728 | 0.699 | 46.207
COVID19 (Custom Term) | Nerve stimulation test abnormal | 0 | 0.366 | 0.065 | 0.773 | 2.145 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal depigmentation | 0 | 0.274 | 0.033 | 0.773 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol abuse | 0 | 0.274 | 0.033 | 0.773 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Arterial injury | 0 | 0.366 | 0.065 | 0.773 | 2.144 |  |  |  |  |  | 
COVID19 (Custom Term) | Idiosyncratic drug reaction | 0 | 0.274 | 0.033 | 0.773 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood iron abnormal | 0 | 0.274 | 0.033 | 0.773 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal vasculitis | 0 | 0.366 | 0.065 | 0.773 | 2.144 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute stress disorder | 0 | 0.274 | 0.033 | 0.773 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-thyroid antibody positive | 1 | 1.507 | 0.091 | 0.772 | 2.009 | 0.32 | 0.782 | 1.66 | 0.663 | 0.276 | 1.156
COVID19 (Custom Term) | Product storage error | 68 | 157.529 | 0.626 | 0.772 | 0.932 | 0.361 | 0.441 | 0.534 | 0.432 | 0.016 | 4700.906
COVID19 (Custom Term) | Meconium in amniotic fluid | 0 | 0.274 | 0.033 | 0.772 | 2.373 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear canal erythema | 0 | 0.366 | 0.064 | 0.772 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood HIV RNA increased | 0 | 0.366 | 0.064 | 0.772 | 2.145 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumatosis | 0 | 0.183 | 0.008 | 0.772 | 2.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulpitis dental | 0 | 0.366 | 0.064 | 0.772 | 2.145 |  |  |  |  |  | 
COVID19 (Custom Term) | Auditory nerve disorder | 0 | 0.366 | 0.064 | 0.772 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging hepatobiliary | 0 | 0.274 | 0.033 | 0.772 | 2.373 |  |  |  |  |  | 
COVID19 (Custom Term) | Morphoea | 0 | 0.366 | 0.064 | 0.772 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertebral osteophyte | 0 | 0.366 | 0.064 | 0.772 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Red cell distribution width | 4 | 4.024 | 0.328 | 0.771 | 1.366 | 0.478 | 0.921 | 1.642 | 0.994 | 2.09 | 1.019
COVID19 (Custom Term) | Skin exfoliation | 24 | 33.978 | 0.553 | 0.771 | 1.018 | 0.519 | 0.719 | 0.976 | 0.706 | 0.497 | 11.096
COVID19 (Custom Term) | Systemic lupus erythematosus (SMQ) [narrow] | 15 | 23.036 | 0.484 | 0.771 | 1.113 | 0.453 | 0.677 | 0.981 | 0.651 | 0.397 | 12.581
COVID19 (Custom Term) | Haemorrhoids | 1 | 2.085 | 0.207 | 0.771 | 1.627 | 0.284 | 0.699 | 1.49 | 0.48 | 0.451 | 0.191
COVID19 (Custom Term) | Galactorrhoea | 0 | 0.274 | 0.032 | 0.771 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluorescence angiogram | 0 | 0.366 | 0.063 | 0.771 | 2.147 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial biopsy abnormal | 0 | 0.274 | 0.032 | 0.771 | 2.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Human herpes virus 8 test | 0 | 0.274 | 0.032 | 0.771 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Myocardial oedema | 0 | 0.274 | 0.032 | 0.771 | 2.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Excessive granulation tissue | 0 | 0.366 | 0.064 | 0.771 | 2.147 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair metal test | 0 | 0.274 | 0.032 | 0.771 | 2.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Reproductive tract disorder | 0 | 0.274 | 0.032 | 0.771 | 2.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Sexually transmitted disease | 0 | 0.274 | 0.032 | 0.771 | 2.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Exfoliative rash | 0 | 1.042 | 0.24 | 0.771 | 1.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Iodine allergy | 0 | 0.274 | 0.032 | 0.771 | 2.374 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal discharge | 1 | 2.013 | 0.104 | 0.77 | 1.947 | 0.288 | 0.709 | 1.51 | 0.497 | 0.764 | 0.041
COVID19 (Custom Term) | Creatinine urine normal | 0 | 0.274 | 0.032 | 0.77 | 2.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Graft versus host disease in gastrointestinal tract | 0 | 0.274 | 0.032 | 0.77 | 2.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body in gastrointestinal tract | 0 | 0.274 | 0.031 | 0.77 | 2.378 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestradiol normal | 0 | 0.274 | 0.032 | 0.77 | 2.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Lower gastrointestinal haemorrhage | 0 | 0.274 | 0.032 | 0.77 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal crusting | 0 | 0.274 | 0.032 | 0.77 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth avulsion | 0 | 0.183 | 0.008 | 0.77 | 2.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Plasma viscosity normal | 0 | 0.274 | 0.032 | 0.77 | 2.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased activity | 2 | 2.382 | 0.292 | 0.769 | 1.43 | 0.382 | 0.839 | 1.648 | 0.84 | 0.099 | 15.222
COVID19 (Custom Term) | CSF test abnormal | 4 | 5.154 | 0.297 | 0.769 | 1.421 | 0.416 | 0.802 | 1.43 | 0.776 | 0.236 | 8.837
COVID19 (Custom Term) | Insomnia | 200 | 267.722 | 0.683 | 0.769 | 0.86 | 0.666 | 0.748 | 0.839 | 0.747 | 0.605 | 48.806
COVID19 (Custom Term) | Skin bacterial infection | 1 | 1.518 | 0.134 | 0.769 | 1.833 | 0.319 | 0.78 | 1.657 | 0.659 | 0.764 | 0.041
COVID19 (Custom Term) | Temporomandibular joint syndrome | 2 | 2.944 | 0.232 | 0.769 | 1.561 | 0.348 | 0.766 | 1.506 | 0.679 | 0.523 | 0.405
COVID19 (Custom Term) | Medication error | 1 | 1.569 | 0.239 | 0.769 | 1.545 | 0.316 | 0.772 | 1.64 | 0.638 | 0.095 | 7.631
COVID19 (Custom Term) | Robust take following exposure to vaccinia virus | 1 | 1.736 | 0.051 | 0.769 | 2.218 | 0.305 | 0.747 | 1.589 | 0.576 | 0.827 | 0.089
COVID19 (Custom Term) | Scab | 17 | 32.613 | 0.5 | 0.769 | 1.086 | 0.378 | 0.553 | 0.787 | 0.521 | 0.326 | 22.278
COVID19 (Custom Term) | Chemical burn | 0 | 0.274 | 0.031 | 0.769 | 2.378 |  |  |  |  |  | 
COVID19 (Custom Term) | Bickerstaff's encephalitis | 0 | 0.366 | 0.062 | 0.769 | 2.149 |  |  |  |  |  | 
COVID19 (Custom Term) | Bed sharing | 0 | 0.478 | 0.099 | 0.769 | 1.965 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster meningoencephalitis | 0 | 0.144 | 0.002 | 0.769 | 2.997 |  |  |  |  |  | 
COVID19 (Custom Term) | Frostbite | 0 | 0.274 | 0.031 | 0.769 | 2.378 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyloric stenosis | 0 | 0.366 | 0.062 | 0.769 | 2.15 |  |  |  |  |  | 
COVID19 (Custom Term) | Intra-abdominal fluid collection | 0 | 0.366 | 0.061 | 0.769 | 2.151 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin increased | 0 | 0.274 | 0.031 | 0.769 | 2.378 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site swelling | 1317 | 1646.473 | 0.734 | 0.768 | 0.804 | 0.764 | 0.8 | 0.837 | 0.8 | 0.563 | 456.424
COVID19 (Custom Term) | Endoscopy abnormal | 1 | 3.187 | 0.084 | 0.768 | 2.029 | 0.23 | 0.579 | 1.247 | 0.314 | 0.261 | 1.32
COVID19 (Custom Term) | CSF volume | 0 | 0.274 | 0.031 | 0.768 | 2.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid myoclonus | 0 | 0.274 | 0.031 | 0.768 | 2.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Gulf war syndrome | 0 | 0.274 | 0.03 | 0.768 | 2.381 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombin time | 0 | 0.457 | 0.092 | 0.768 | 1.994 |  |  |  |  |  | 
COVID19 (Custom Term) | Borderline personality disorder | 0 | 0.274 | 0.031 | 0.768 | 2.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Sydenham's chorea | 0 | 0.366 | 0.061 | 0.768 | 2.152 |  |  |  |  |  | 
COVID19 (Custom Term) | Adjustment disorder with depressed mood | 0 | 0.274 | 0.031 | 0.768 | 2.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute febrile neutrophilic dermatosis | 2 | 1.991 | 0.16 | 0.767 | 1.743 | 0.41 | 0.898 | 1.764 | 1.005 | 1.324 | 0.002
COVID19 (Custom Term) | Consciousness fluctuating | 5 | 6.652 | 0.392 | 0.767 | 1.244 | 0.424 | 0.782 | 1.347 | 0.752 | 1.128 | 0
COVID19 (Custom Term) | Erythema of eyelid | 7 | 9.505 | 0.458 | 0.767 | 1.141 | 0.443 | 0.765 | 1.248 | 0.736 | 0.827 | 0.09
COVID19 (Custom Term) | Hepatitis E virus test positive | 0 | 0.274 | 0.03 | 0.767 | 2.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Borrelia infection | 0 | 0.274 | 0.03 | 0.767 | 2.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound testes normal | 0 | 0.274 | 0.03 | 0.767 | 2.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Loss of libido | 0 | 0.274 | 0.03 | 0.767 | 2.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Sarcoma | 0 | 0.366 | 0.06 | 0.767 | 2.153 |  |  |  |  |  | 
COVID19 (Custom Term) | Colour vision tests abnormal | 0 | 0.274 | 0.03 | 0.767 | 2.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibromyalgia | 5 | 8.625 | 0.319 | 0.766 | 1.369 | 0.355 | 0.656 | 1.13 | 0.58 | 0.171 | 18.949
COVID19 (Custom Term) | Anal cancer | 0 | 0.274 | 0.03 | 0.766 | 2.383 |  |  |  |  |  | 
COVID19 (Custom Term) | New daily persistent headache | 0 | 0.163 | 0.004 | 0.766 | 2.876 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood HIV RNA | 0 | 0.274 | 0.03 | 0.766 | 2.384 |  |  |  |  |  | 
COVID19 (Custom Term) | Perinatal depression | 0 | 0.274 | 0.03 | 0.766 | 2.383 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterovirus test | 0 | 0.623 | 0.14 | 0.766 | 1.805 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin CSF decreased | 0 | 0.366 | 0.059 | 0.765 | 2.155 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine uric acid increased | 0 | 0.274 | 0.029 | 0.765 | 2.386 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram repolarisation abnormality | 0 | 0.274 | 0.029 | 0.765 | 2.386 |  |  |  |  |  | 
COVID19 (Custom Term) | Panniculitis | 0 | 0.414 | 0.075 | 0.765 | 2.065 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 globulin | 0 | 0.274 | 0.029 | 0.765 | 2.386 |  |  |  |  |  | 
COVID19 (Custom Term) | Analgesic drug level | 0 | 0.457 | 0.089 | 0.765 | 1.997 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoglobulin therapy | 52 | 72.211 | 0.601 | 0.764 | 0.944 | 0.579 | 0.726 | 0.901 | 0.72 | 0.542 | 18.621
COVID19 (Custom Term) | Myoclonus | 3 | 5.506 | 0.312 | 0.764 | 1.377 | 0.323 | 0.66 | 1.23 | 0.545 | 0.203 | 8.388
COVID19 (Custom Term) | Fluorescence angiogram abnormal | 0 | 0.274 | 0.029 | 0.764 | 2.387 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 microglobulin increased | 0 | 0.274 | 0.029 | 0.764 | 2.387 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair follicle tumour benign | 0 | 0.274 | 0.028 | 0.764 | 2.387 |  |  |  |  |  | 
COVID19 (Custom Term) | Scleral discolouration | 0 | 0.366 | 0.058 | 0.764 | 2.157 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytology abnormal | 0 | 0.225 | 0.015 | 0.764 | 2.563 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood electrolytes decreased | 0 | 0.274 | 0.029 | 0.764 | 2.386 |  |  |  |  |  | 
COVID19 (Custom Term) | Febrile infection-related epilepsy syndrome | 0 | 0.274 | 0.029 | 0.764 | 2.386 |  |  |  |  |  | 
COVID19 (Custom Term) | Immune-mediated/autoimmune disorders (SMQ) [narrow] | 230 | 333 | 0.682 | 0.763 | 0.847 | 0.621 | 0.692 | 0.77 | 0.691 | 0.365 | 248.654
COVID19 (Custom Term) | Depression and suicide/self-injury (SMQ) [narrow] | 28 | 42.917 | 0.547 | 0.763 | 1.008 | 0.492 | 0.667 | 0.888 | 0.652 | 0.307 | 41.902
COVID19 (Custom Term) | Food intolerance | 1 | 2.623 | 0.147 | 0.763 | 1.773 | 0.256 | 0.635 | 1.361 | 0.381 | 0.1 | 7.042
COVID19 (Custom Term) | Tympanic membrane hyperaemia | 0 | 0.252 | 0.022 | 0.763 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Oropharyngeal candidiasis | 0 | 0.274 | 0.028 | 0.763 | 2.389 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan adrenal gland | 0 | 0.366 | 0.057 | 0.763 | 2.158 |  |  |  |  |  | 
COVID19 (Custom Term) | Gene mutation identification test positive | 0 | 0.528 | 0.109 | 0.763 | 1.907 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal discharge | 0 | 0.183 | 0.007 | 0.763 | 2.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal motility disorder | 0 | 0.366 | 0.057 | 0.763 | 2.158 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic myocarditis | 0 | 0.274 | 0.028 | 0.763 | 2.389 |  |  |  |  |  | 
COVID19 (Custom Term) | Phenylketonuria | 0 | 0.274 | 0.028 | 0.763 | 2.389 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin sensitisation | 4 | 4.065 | 0.351 | 0.762 | 1.301 | 0.475 | 0.916 | 1.633 | 0.984 | 2.09 | 1.019
COVID19 (Custom Term) | Altered state of consciousness | 15 | 24.884 | 0.486 | 0.762 | 1.088 | 0.423 | 0.633 | 0.917 | 0.603 | 0.302 | 22.763
COVID19 (Custom Term) | Immobile | 5 | 9.178 | 0.368 | 0.762 | 1.271 | 0.339 | 0.627 | 1.081 | 0.545 | 0.558 | 1.231
COVID19 (Custom Term) | Thyroid gland scan abnormal | 0 | 0.274 | 0.028 | 0.762 | 2.389 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital central nervous system anomaly | 0 | 0.366 | 0.057 | 0.762 | 2.159 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia chlamydial | 0 | 0.366 | 0.056 | 0.762 | 2.16 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligament laxity | 0 | 0.274 | 0.028 | 0.762 | 2.39 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral papilloma | 0 | 0.183 | 0.006 | 0.762 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Second primary malignancy | 0 | 0.183 | 0.006 | 0.762 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Traumatic tooth displacement | 0 | 0.183 | 0.006 | 0.762 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Palatal ulcer | 0 | 0.274 | 0.028 | 0.762 | 2.39 |  |  |  |  |  | 
COVID19 (Custom Term) | Weight decrease neonatal | 0 | 0.183 | 0.006 | 0.762 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product effective for unapproved indication | 0 | 0.183 | 0.006 | 0.762 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet morphology abnormal | 0 | 0.366 | 0.056 | 0.762 | 2.159 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging thoracic normal | 1 | 2.022 | 0.17 | 0.761 | 1.695 | 0.288 | 0.707 | 1.507 | 0.495 | 0.584 | 0.014
COVID19 (Custom Term) | Administration site joint pain | 0 | 0.274 | 0.027 | 0.761 | 2.392 |  |  |  |  |  | 
COVID19 (Custom Term) | Dandruff | 0 | 0.274 | 0.027 | 0.761 | 2.392 |  |  |  |  |  | 
COVID19 (Custom Term) | Cutaneous T-cell lymphoma | 0 | 0.366 | 0.056 | 0.761 | 2.16 |  |  |  |  |  | 
COVID19 (Custom Term) | Booster dose missed | 0 | 0.274 | 0.027 | 0.761 | 2.391 |  |  |  |  |  | 
COVID19 (Custom Term) | Growth disorder | 0 | 0.366 | 0.056 | 0.761 | 2.16 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical vertebral fracture | 0 | 0.366 | 0.055 | 0.761 | 2.161 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal malformation | 0 | 0.274 | 0.027 | 0.761 | 2.391 |  |  |  |  |  | 
COVID19 (Custom Term) | Histology abnormal | 0 | 0.385 | 0.062 | 0.761 | 2.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac stress test | 9 | 10.838 | 0.423 | 0.76 | 1.176 | 0.507 | 0.833 | 1.305 | 0.83 | 1.625 | 1.314
COVID19 (Custom Term) | Skin discomfort | 4 | 5.037 | 0.327 | 0.76 | 1.341 | 0.421 | 0.813 | 1.449 | 0.794 | 1.727 | 0.472
COVID19 (Custom Term) | Muscle atrophy | 5 | 6.947 | 0.334 | 0.76 | 1.327 | 0.412 | 0.761 | 1.31 | 0.72 | 0.417 | 3.316
COVID19 (Custom Term) | Maternal exposure timing unspecified | 0 | 0.274 | 0.027 | 0.76 | 2.392 |  |  |  |  |  | 
COVID19 (Custom Term) | Social (pragmatic) communication disorder | 0 | 0.274 | 0.027 | 0.76 | 2.394 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood folate increased | 0 | 0.366 | 0.055 | 0.76 | 2.162 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid stimulating immunoglobulin | 0 | 0.366 | 0.055 | 0.76 | 2.162 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue necrosis | 0 | 0.457 | 0.084 | 0.76 | 2.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin G decreased | 2 | 4.344 | 0.202 | 0.759 | 1.606 | 0.284 | 0.629 | 1.24 | 0.46 | 0.248 | 3.673
COVID19 (Custom Term) | Inappropriate release of product for distribution | 0 | 0.183 | 0.006 | 0.759 | 2.771 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobin urine absent | 0 | 0.457 | 0.083 | 0.759 | 2.004 |  |  |  |  |  | 
COVID19 (Custom Term) | Wolff-Parkinson-White syndrome | 0 | 0.366 | 0.054 | 0.759 | 2.163 |  |  |  |  |  | 
COVID19 (Custom Term) | Forceps delivery | 0 | 0.274 | 0.026 | 0.759 | 2.394 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypothermia neonatal | 0 | 0.274 | 0.026 | 0.759 | 2.394 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint hyperextension | 0 | 0.706 | 0.153 | 0.759 | 1.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal bacterial overgrowth | 0 | 0.366 | 0.054 | 0.759 | 2.163 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctival oedema | 0 | 0.64 | 0.136 | 0.759 | 1.796 |  |  |  |  |  | 
COVID19 (Custom Term) | Thymus enlargement | 0 | 0.366 | 0.054 | 0.759 | 2.163 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow myelogram abnormal | 0 | 0.366 | 0.054 | 0.759 | 2.164 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy artery | 0 | 0.366 | 0.054 | 0.759 | 2.163 |  |  |  |  |  | 
COVID19 (Custom Term) | Carpal tunnel decompression | 0 | 0.457 | 0.083 | 0.759 | 2.004 |  |  |  |  |  | 
COVID19 (Custom Term) | Acne infantile | 0 | 0.274 | 0.026 | 0.759 | 2.394 |  |  |  |  |  | 
COVID19 (Custom Term) | Social avoidant behaviour | 1 | 1.021 | 0.182 | 0.758 | 1.656 | 0.356 | 0.867 | 1.838 | 0.979 | 0.086 | 8.716
COVID19 (Custom Term) | Skin ulcer | 7 | 10.697 | 0.416 | 0.758 | 1.184 | 0.406 | 0.701 | 1.144 | 0.654 | 0.406 | 5.22
COVID19 (Custom Term) | Product package associated injury | 0 | 0.366 | 0.053 | 0.758 | 2.164 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital and neonatal arrhythmias (SMQ) [narrow] | 0 | 0.274 | 0.026 | 0.758 | 2.396 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterobacter infection | 0 | 0.366 | 0.053 | 0.758 | 2.165 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone densitometry | 0 | 0.219 | 0.012 | 0.758 | 2.601 |  |  |  |  |  | 
COVID19 (Custom Term) | Oesophageal candidiasis | 0 | 0.366 | 0.053 | 0.758 | 2.164 |  |  |  |  |  | 
COVID19 (Custom Term) | Nonreassuring foetal heart rate pattern | 0 | 0.274 | 0.026 | 0.758 | 2.396 |  |  |  |  |  | 
COVID19 (Custom Term) | Pustular psoriasis | 0 | 0.274 | 0.026 | 0.758 | 2.396 |  |  |  |  |  | 
COVID19 (Custom Term) | Local reaction | 43 | 66.653 | 0.585 | 0.757 | 0.949 | 0.511 | 0.655 | 0.83 | 0.645 | 0.197 | 138.399
COVID19 (Custom Term) | Non-haematological malignant tumours (SMQ) [broad] | 17 | 32.16 | 0.487 | 0.757 | 1.075 | 0.382 | 0.56 | 0.797 | 0.529 | 0.346 | 19.66
COVID19 (Custom Term) | Non-haematological malignant tumours (SMQ) [narrow] | 17 | 32.16 | 0.487 | 0.757 | 1.075 | 0.382 | 0.56 | 0.797 | 0.529 | 0.346 | 19.66
COVID19 (Custom Term) | Allogenic stem cell transplantation | 0 | 0.274 | 0.025 | 0.757 | 2.398 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral uveitis | 0 | 0.274 | 0.025 | 0.757 | 2.398 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye abscess | 0 | 0.274 | 0.026 | 0.757 | 2.397 |  |  |  |  |  | 
COVID19 (Custom Term) | Cephalo-pelvic disproportion | 0 | 0.183 | 0.006 | 0.757 | 2.775 |  |  |  |  |  | 
COVID19 (Custom Term) | JC polyomavirus test positive | 0 | 0.274 | 0.025 | 0.757 | 2.398 |  |  |  |  |  | 
COVID19 (Custom Term) | In vitro fertilisation | 0 | 0.366 | 0.053 | 0.757 | 2.165 |  |  |  |  |  | 
COVID19 (Custom Term) | Thalassaemia | 0 | 0.183 | 0.006 | 0.757 | 2.775 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytopenia | 0 | 0.287 | 0.029 | 0.757 | 2.359 |  |  |  |  |  | 
COVID19 (Custom Term) | Myotonia | 0 | 0.366 | 0.053 | 0.757 | 2.166 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukocyturia | 0 | 0.389 | 0.06 | 0.757 | 2.121 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal lesion | 0 | 0.274 | 0.025 | 0.757 | 2.398 |  |  |  |  |  | 
COVID19 (Custom Term) | Prothrombin level decreased | 0 | 0.222 | 0.013 | 0.757 | 2.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Progressive multifocal leukoencephalopathy | 0 | 0.183 | 0.006 | 0.757 | 2.775 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune arthritis | 0 | 0.274 | 0.025 | 0.757 | 2.397 |  |  |  |  |  | 
COVID19 (Custom Term) | Bradyphrenia | 7 | 7.724 | 0.384 | 0.756 | 1.229 | 0.513 | 0.885 | 1.444 | 0.906 | 2.673 | 4.417
COVID19 (Custom Term) | Liver function test decreased | 0 | 0.366 | 0.052 | 0.756 | 2.167 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic pneumonia | 0 | 0.274 | 0.025 | 0.756 | 2.399 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum sickness-like reaction | 0 | 0.441 | 0.076 | 0.756 | 2.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Stenosis | 0 | 0.274 | 0.025 | 0.756 | 2.399 |  |  |  |  |  | 
COVID19 (Custom Term) | Vestibular function test | 0 | 0.366 | 0.052 | 0.756 | 2.167 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal flattening | 0 | 0.274 | 0.025 | 0.756 | 2.399 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy liver abnormal | 1 | 1.509 | 0.089 | 0.755 | 1.965 | 0.32 | 0.781 | 1.66 | 0.663 | 0.31 | 0.842
COVID19 (Custom Term) | Bacterial test | 5 | 7.425 | 0.339 | 0.755 | 1.306 | 0.394 | 0.727 | 1.253 | 0.673 | 0.54 | 1.413
COVID19 (Custom Term) | Malignant or unspecified tumours (SMQ) [narrow] | 39 | 59.983 | 0.571 | 0.755 | 0.961 | 0.51 | 0.661 | 0.846 | 0.65 | 0.51 | 16.973
COVID19 (Custom Term) | Malignant or unspecified tumours (SMQ) [broad] | 39 | 59.983 | 0.571 | 0.755 | 0.961 | 0.51 | 0.661 | 0.846 | 0.65 | 0.51 | 16.973
COVID19 (Custom Term) | Administration site odour | 0 | 0.274 | 0.024 | 0.755 | 2.401 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertebral lesion | 0 | 0.366 | 0.051 | 0.755 | 2.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye haematoma | 0 | 0.274 | 0.025 | 0.755 | 2.4 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoparathyroidism | 0 | 0.274 | 0.024 | 0.755 | 2.401 |  |  |  |  |  | 
COVID19 (Custom Term) | Groin abscess | 0 | 0.366 | 0.051 | 0.754 | 2.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective IgA immunodeficiency | 0 | 0.457 | 0.079 | 0.754 | 2.009 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose-6-phosphate dehydrogenase deficiency | 0 | 0.366 | 0.051 | 0.754 | 2.17 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis D virus test | 0 | 0.366 | 0.05 | 0.754 | 2.17 |  |  |  |  |  | 
COVID19 (Custom Term) | Adrenal insufficiency | 0 | 0.316 | 0.036 | 0.754 | 2.284 |  |  |  |  |  | 
COVID19 (Custom Term) | Investigation normal | 0 | 0.19 | 0.006 | 0.754 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoglobulins abnormal | 0 | 0.366 | 0.051 | 0.754 | 2.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Oropharyngeal swelling | 0 | 0.274 | 0.024 | 0.754 | 2.402 |  |  |  |  |  | 
COVID19 (Custom Term) | Scar pain | 0 | 0.274 | 0.024 | 0.754 | 2.402 |  |  |  |  |  | 
COVID19 (Custom Term) | Maculopathy | 0 | 0.457 | 0.079 | 0.754 | 2.009 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta 2 microglobulin | 0 | 0.366 | 0.051 | 0.754 | 2.17 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site swelling | 0 | 0.457 | 0.079 | 0.754 | 2.009 |  |  |  |  |  | 
COVID19 (Custom Term) | Removal of foreign body | 0 | 0.366 | 0.05 | 0.753 | 2.17 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental examination | 0 | 0.366 | 0.05 | 0.753 | 2.171 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol poisoning | 0 | 0.366 | 0.05 | 0.753 | 2.171 |  |  |  |  |  | 
COVID19 (Custom Term) | Presbyopia | 0 | 0.274 | 0.024 | 0.753 | 2.404 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurosensory hypoacusis | 0 | 0.183 | 0.005 | 0.753 | 2.782 |  |  |  |  |  | 
COVID19 (Custom Term) | Disease complication | 0 | 0.274 | 0.023 | 0.753 | 2.404 |  |  |  |  |  | 
COVID19 (Custom Term) | Warm type haemolytic anaemia | 0 | 0.366 | 0.05 | 0.753 | 2.17 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasomnia | 0 | 0.274 | 0.024 | 0.753 | 2.404 |  |  |  |  |  | 
COVID19 (Custom Term) | Chondropathy | 0 | 0.366 | 0.05 | 0.753 | 2.171 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF pressure increased | 2 | 1.989 | 0.25 | 0.752 | 1.472 | 0.41 | 0.898 | 1.765 | 1.006 | 1.045 | 0.102
COVID19 (Custom Term) | Neurodevelopmental disorder | 0 | 0.366 | 0.049 | 0.752 | 2.172 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective eating disorder | 0 | 0.393 | 0.058 | 0.752 | 2.119 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve paresis | 0 | 0.366 | 0.049 | 0.752 | 2.172 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint stabilisation | 0 | 0.366 | 0.049 | 0.752 | 2.172 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral surgery | 0 | 0.366 | 0.049 | 0.752 | 2.172 |  |  |  |  |  | 
COVID19 (Custom Term) | Polydipsia | 1 | 0.992 | 0.172 | 0.751 | 1.665 | 0.359 | 0.873 | 1.85 | 1.008 | 0.382 | 0.42
COVID19 (Custom Term) | Uterine disorder | 0 | 0.366 | 0.048 | 0.751 | 2.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Prothrombin time ratio decreased | 0 | 0.366 | 0.049 | 0.751 | 2.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoglycaemia neonatal | 0 | 0.274 | 0.023 | 0.751 | 2.406 |  |  |  |  |  | 
COVID19 (Custom Term) | Libido disorder | 0 | 0.274 | 0.023 | 0.751 | 2.407 |  |  |  |  |  | 
COVID19 (Custom Term) | Growth failure | 0 | 0.366 | 0.049 | 0.751 | 2.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Transcranial electrical motor evoked potential monitoring | 0 | 0.274 | 0.023 | 0.751 | 2.406 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body reaction | 0 | 0.457 | 0.076 | 0.751 | 2.012 |  |  |  |  |  | 
COVID19 (Custom Term) | Low density lipoprotein | 0 | 0.457 | 0.077 | 0.751 | 2.012 |  |  |  |  |  | 
COVID19 (Custom Term) | Type 2 diabetes mellitus | 5 | 6.974 | 0.334 | 0.75 | 1.301 | 0.411 | 0.759 | 1.306 | 0.717 | 1.418 | 0.212
COVID19 (Custom Term) | Tension | 4 | 7.373 | 0.339 | 0.75 | 1.292 | 0.33 | 0.639 | 1.141 | 0.543 | 0.315 | 5.062
COVID19 (Custom Term) | Neonatal infection | 0 | 0.274 | 0.022 | 0.75 | 2.408 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal mucosal blistering | 0 | 0.457 | 0.075 | 0.75 | 2.014 |  |  |  |  |  | 
COVID19 (Custom Term) | Astigmatism | 0 | 0.182 | 0.005 | 0.75 | 2.794 |  |  |  |  |  | 
COVID19 (Custom Term) | Xerosis | 0 | 0.366 | 0.048 | 0.75 | 2.174 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug withdrawal syndrome | 0 | 0.366 | 0.048 | 0.75 | 2.175 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum ferritin normal | 4 | 5.395 | 0.34 | 0.749 | 1.286 | 0.404 | 0.781 | 1.391 | 0.741 | 0.685 | 0.267
COVID19 (Custom Term) | Status epilepticus | 4 | 5.398 | 0.326 | 0.749 | 1.314 | 0.404 | 0.78 | 1.391 | 0.741 | 0.268 | 7.008
COVID19 (Custom Term) | Gastric atony | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteosarcoma | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Positive end-expiratory pressure | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocervical curettage | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma stage III | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Persistent depressive disorder | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocytic leukaemia | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Proctitis haemorrhagic | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Urogram | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Lactose tolerance test normal | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Arteriosclerotic retinopathy | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Androgenetic alopecia | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-IA2 antibody positive | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-glycyl-tRNA synthetase antibody positive | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital abscess | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchoalveolar lavage | 0 | 0.457 | 0.075 | 0.749 | 2.014 |  |  |  |  |  | 
COVID19 (Custom Term) | Partial seizures with secondary generalisation | 0 | 0.366 | 0.048 | 0.749 | 2.175 |  |  |  |  |  | 
COVID19 (Custom Term) | Male reproductive tract disorder | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast conserving surgery | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Squamous cell carcinoma of the oral cavity | 0 | 0.183 | 0.005 | 0.749 | 2.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site haemorrhage | 26 | 39.062 | 0.533 | 0.748 | 0.992 | 0.497 | 0.68 | 0.914 | 0.666 | 0.432 | 17.999
COVID19 (Custom Term) | Herpes dermatitis | 0 | 0.366 | 0.047 | 0.748 | 2.176 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial diarrhoea | 0 | 0.183 | 0.005 | 0.748 | 2.789 |  |  |  |  |  | 
COVID19 (Custom Term) | Separation anxiety disorder | 0 | 0.457 | 0.073 | 0.748 | 2.015 |  |  |  |  |  | 
COVID19 (Custom Term) | Learning disability | 0 | 0.217 | 0.01 | 0.748 | 2.623 |  |  |  |  |  | 
COVID19 (Custom Term) | Von Willebrand's factor activity increased | 0 | 0.274 | 0.021 | 0.747 | 2.412 |  |  |  |  |  | 
COVID19 (Custom Term) | Agraphia | 0 | 0.274 | 0.021 | 0.747 | 2.412 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity total normal | 0 | 0.523 | 0.092 | 0.747 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Upper respiratory tract inflammation | 0 | 0.39 | 0.053 | 0.747 | 2.13 |  |  |  |  |  | 
COVID19 (Custom Term) | Otitis externa | 0 | 0.541 | 0.097 | 0.747 | 1.906 |  |  |  |  |  | 
COVID19 (Custom Term) | Low density lipoprotein decreased | 0 | 0.366 | 0.046 | 0.747 | 2.178 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichenification | 0 | 0.366 | 0.046 | 0.747 | 2.177 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthritis | 19 | 28.795 | 0.496 | 0.746 | 1.039 | 0.473 | 0.68 | 0.952 | 0.66 | 0.351 | 21.331
COVID19 (Custom Term) | Genital herpes | 3 | 6.233 | 0.267 | 0.746 | 1.42 | 0.298 | 0.611 | 1.139 | 0.481 | 0.727 | 0.076
COVID19 (Custom Term) | Muscle electrostimulation therapy | 0 | 0.366 | 0.045 | 0.746 | 2.179 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-transglutaminase antibody negative | 0 | 0.179 | 0.004 | 0.746 | 2.812 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular hypertension | 0 | 0.366 | 0.046 | 0.746 | 2.179 |  |  |  |  |  | 
COVID19 (Custom Term) | Transmission of an infectious agent via product | 0 | 0.366 | 0.045 | 0.746 | 2.179 |  |  |  |  |  | 
COVID19 (Custom Term) | H1N1 influenza | 1 | 1.379 | 0.05 | 0.745 | 2.143 | 0.329 | 0.803 | 1.704 | 0.725 | 0.144 | 4.135
COVID19 (Custom Term) | Lipids normal | 5 | 6.781 | 0.349 | 0.745 | 1.261 | 0.419 | 0.773 | 1.33 | 0.737 | 1.986 | 1.235
COVID19 (Custom Term) | Depression (excl suicide and self injury) (SMQ) [narrow] | 22 | 35.763 | 0.511 | 0.745 | 1.016 | 0.453 | 0.636 | 0.873 | 0.615 | 0.286 | 37.463
COVID19 (Custom Term) | Ammonia decreased | 0 | 0.366 | 0.045 | 0.745 | 2.18 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy spinal cord | 0 | 0.366 | 0.045 | 0.745 | 2.179 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinitis viral | 0 | 0.457 | 0.072 | 0.745 | 2.017 |  |  |  |  |  | 
COVID19 (Custom Term) | Weight gain poor | 0 | 0.478 | 0.077 | 0.745 | 1.987 |  |  |  |  |  | 
COVID19 (Custom Term) | Antithrombin III decreased | 0 | 0.274 | 0.02 | 0.745 | 2.415 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal injury | 0 | 0.457 | 0.072 | 0.745 | 2.018 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic necrosis | 0 | 0.549 | 0.097 | 0.745 | 1.898 |  |  |  |  |  | 
COVID19 (Custom Term) | Angle closure glaucoma | 0 | 0.366 | 0.044 | 0.744 | 2.181 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluctuance | 0 | 0.366 | 0.044 | 0.744 | 2.181 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperleukocytosis | 0 | 0.457 | 0.07 | 0.744 | 2.019 |  |  |  |  |  | 
COVID19 (Custom Term) | Microscopy | 0 | 0.862 | 0.171 | 0.744 | 1.646 |  |  |  |  |  | 
COVID19 (Custom Term) | Myokymia | 0 | 0.274 | 0.02 | 0.744 | 2.416 |  |  |  |  |  | 
COVID19 (Custom Term) | Mean arterial pressure | 0 | 0.183 | 0.004 | 0.744 | 2.795 |  |  |  |  |  | 
COVID19 (Custom Term) | Histone antibody negative | 0 | 0.366 | 0.044 | 0.744 | 2.181 |  |  |  |  |  | 
COVID19 (Custom Term) | Anhedonia | 0 | 0.366 | 0.044 | 0.743 | 2.182 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperchlorhydria | 0 | 0.366 | 0.044 | 0.743 | 2.182 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity total decreased | 0 | 0.366 | 0.044 | 0.743 | 2.182 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastases to abdominal cavity | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-glomerular basement membrane antibody | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Avian influenza | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood chromogranin A increased | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Cell marker | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell rouleaux formation present | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Phagocytosis | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | B-cell lymphoma | 0 | 0.457 | 0.069 | 0.742 | 2.021 |  |  |  |  |  | 
COVID19 (Custom Term) | Surfactant protein | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital erosion | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow infiltration | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-muscle specific kinase antibody negative | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Purulent pericarditis | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Parathyroid hormone-related protein increased | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Polydactyly | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatobiliary scan normal | 0 | 0.457 | 0.069 | 0.742 | 2.021 |  |  |  |  |  | 
COVID19 (Custom Term) | Cheyne-Stokes respiration | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal erosion | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Penoscrotal fusion | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart alternation | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | 5-hydroxyindolacetic acid in urine decreased | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Rouleaux formation | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-VGCC antibody negative | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Marginal zone lymphoma | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Waist circumference decreased | 0 | 0.183 | 0.004 | 0.742 | 2.798 |  |  |  |  |  | 
COVID19 (Custom Term) | No reaction on previous exposure to drug | 2 | 4.167 | 0.256 | 0.741 | 1.429 | 0.291 | 0.644 | 1.269 | 0.48 | 1.241 | 0.014
COVID19 (Custom Term) | Sickle cell anaemia | 0 | 0.274 | 0.019 | 0.741 | 2.42 |  |  |  |  |  | 
COVID19 (Custom Term) | Balanoposthitis | 0 | 0.366 | 0.042 | 0.741 | 2.185 |  |  |  |  |  | 
COVID19 (Custom Term) | LE cells | 0 | 0.457 | 0.069 | 0.741 | 2.021 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival erythema | 2 | 2.475 | 0.242 | 0.74 | 1.458 | 0.376 | 0.826 | 1.623 | 0.808 | 1.418 | 0.001
COVID19 (Custom Term) | Injection site bruising | 83 | 116.476 | 0.614 | 0.74 | 0.875 | 0.598 | 0.716 | 0.852 | 0.713 | 0.454 | 51.893
COVID19 (Custom Term) | Hypothyroidism | 6 | 10.592 | 0.345 | 0.74 | 1.256 | 0.357 | 0.635 | 1.063 | 0.566 | 0.685 | 0.522
COVID19 (Custom Term) | Allergy to plants | 0 | 0.274 | 0.019 | 0.74 | 2.421 |  |  |  |  |  | 
COVID19 (Custom Term) | Oedema genital | 0 | 0.366 | 0.042 | 0.74 | 2.185 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy breast normal | 0 | 0.366 | 0.042 | 0.74 | 2.186 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system viral infection | 0 | 0.457 | 0.068 | 0.74 | 2.022 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthroscopic surgery | 0 | 0.457 | 0.068 | 0.74 | 2.022 |  |  |  |  |  | 
COVID19 (Custom Term) | Paranoia | 1 | 1.408 | 0.267 | 0.739 | 1.402 | 0.327 | 0.798 | 1.694 | 0.71 | 0.414 | 0.298
COVID19 (Custom Term) | Skin infection | 1 | 2.124 | 0.241 | 0.739 | 1.458 | 0.282 | 0.694 | 1.48 | 0.471 | 0.079 | 9.705
COVID19 (Custom Term) | Onychomadesis | 0 | 0.64 | 0.115 | 0.739 | 1.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Methylenetetrahydrofolate reductase gene mutation | 0 | 0.758 | 0.143 | 0.739 | 1.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Bartonella test negative | 0 | 0.825 | 0.158 | 0.739 | 1.67 |  |  |  |  |  | 
COVID19 (Custom Term) | Chorioretinitis | 0 | 0.457 | 0.067 | 0.739 | 2.023 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye laser surgery | 0 | 0.274 | 0.018 | 0.739 | 2.423 |  |  |  |  |  | 
COVID19 (Custom Term) | Pupil dilation procedure | 0 | 0.457 | 0.066 | 0.738 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Oculomucocutaneous syndrome | 0 | 0.366 | 0.041 | 0.738 | 2.188 |  |  |  |  |  | 
COVID19 (Custom Term) | Hemihypertrophy | 0 | 0.366 | 0.041 | 0.738 | 2.187 |  |  |  |  |  | 
COVID19 (Custom Term) | Fructose intolerance | 0 | 0.457 | 0.066 | 0.738 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | VIth nerve disorder | 0 | 0.366 | 0.041 | 0.738 | 2.187 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin depigmentation | 0 | 0.175 | 0.003 | 0.738 | 2.85 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin E decreased | 0 | 0.64 | 0.114 | 0.738 | 1.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Urticaria papular | 0 | 0.64 | 0.114 | 0.738 | 1.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Nosocomial infection | 0 | 0.457 | 0.066 | 0.737 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint inflammation | 0 | 0.727 | 0.134 | 0.737 | 1.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic infection | 0 | 0.274 | 0.018 | 0.737 | 2.425 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipodystrophy acquired | 0 | 0.457 | 0.065 | 0.737 | 2.025 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimicrobial susceptibility test sensitive | 0 | 0.123 | 0 | 0.737 | 3.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose tolerance test | 0 | 0.457 | 0.066 | 0.737 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Appendix disorder | 0 | 0.274 | 0.018 | 0.737 | 2.424 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor C3 increased | 0 | 0.292 | 0.022 | 0.737 | 2.372 |  |  |  |  |  | 
COVID19 (Custom Term) | Total cholesterol/HDL ratio | 0 | 0.366 | 0.04 | 0.737 | 2.188 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain death | 3 | 3.071 | 0.265 | 0.736 | 1.4 | 0.443 | 0.903 | 1.679 | 0.977 | 1.655 | 0.192
COVID19 (Custom Term) | Gastrostomy | 2 | 2.154 | 0.186 | 0.736 | 1.584 | 0.398 | 0.872 | 1.714 | 0.928 | 0.552 | 0.302
COVID19 (Custom Term) | Encephalitis viral | 1 | 1.134 | 0.183 | 0.736 | 1.589 | 0.347 | 0.846 | 1.794 | 0.882 | 0.177 | 2.914
COVID19 (Custom Term) | Myringotomy | 0 | 0.457 | 0.064 | 0.736 | 2.026 |  |  |  |  |  | 
COVID19 (Custom Term) | Escherichia sepsis | 0 | 0.457 | 0.064 | 0.736 | 2.026 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurone-specific enolase | 0 | 0.366 | 0.04 | 0.736 | 2.189 |  |  |  |  |  | 
COVID19 (Custom Term) | High density lipoprotein | 0 | 0.457 | 0.064 | 0.736 | 2.026 |  |  |  |  |  | 
COVID19 (Custom Term) | Mental fatigue | 3 | 3.487 | 0.281 | 0.735 | 1.362 | 0.417 | 0.85 | 1.58 | 0.86 | 1.986 | 0.486
COVID19 (Custom Term) | Pregnancy and neonatal topics (SMQ) [broad] | 282 | 416.986 | 0.665 | 0.735 | 0.809 | 0.614 | 0.678 | 0.746 | 0.676 | 0.558 | 94.289
COVID19 (Custom Term) | Hyperbilirubinaemia neonatal | 0 | 0.366 | 0.039 | 0.735 | 2.191 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal bacterial infection | 0 | 0.366 | 0.039 | 0.735 | 2.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal haemorrhage | 0 | 0.366 | 0.039 | 0.735 | 2.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Keloid scar | 0 | 0.366 | 0.039 | 0.735 | 2.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Subcutaneous emphysema | 0 | 0.274 | 0.017 | 0.735 | 2.427 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrotal swelling | 0 | 0.286 | 0.02 | 0.735 | 2.391 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder discomfort | 0 | 0.366 | 0.039 | 0.735 | 2.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bicarbonate abnormal | 0 | 0.274 | 0.017 | 0.735 | 2.427 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal lesion | 0 | 0.457 | 0.063 | 0.734 | 2.027 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal cancer | 0 | 0.366 | 0.039 | 0.734 | 2.191 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema annulare | 0 | 0.549 | 0.087 | 0.734 | 1.906 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphoid hyperplasia of intestine | 0 | 0.366 | 0.038 | 0.734 | 2.191 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal compartment syndrome | 0 | 0.366 | 0.039 | 0.734 | 2.191 |  |  |  |  |  | 
COVID19 (Custom Term) | LDL/HDL ratio | 0 | 0.274 | 0.017 | 0.734 | 2.429 |  |  |  |  |  | 
COVID19 (Custom Term) | Tetany | 3 | 3.001 | 0.285 | 0.733 | 1.351 | 0.448 | 0.912 | 1.697 | 1 | 2.708 | 1.277
COVID19 (Custom Term) | Joint injury | 3 | 5.587 | 0.364 | 0.733 | 1.206 | 0.32 | 0.654 | 1.219 | 0.537 | 0.451 | 1.38
COVID19 (Custom Term) | Tocolysis | 0 | 0.183 | 0.003 | 0.733 | 2.811 |  |  |  |  |  | 
COVID19 (Custom Term) | Venous injury | 0 | 0.366 | 0.038 | 0.733 | 2.192 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphoproliferative disorder | 0 | 0.274 | 0.016 | 0.733 | 2.43 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric pH decreased | 0 | 0.274 | 0.017 | 0.733 | 2.429 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal rigidity | 2 | 2.27 | 0.23 | 0.732 | 1.464 | 0.39 | 0.855 | 1.68 | 0.881 | 0.685 | 0.044
COVID19 (Custom Term) | Hyperaemia | 1 | 1.551 | 0.139 | 0.732 | 1.707 | 0.317 | 0.775 | 1.646 | 0.645 | 0.134 | 4.613
COVID19 (Custom Term) | Oral discharge | 0 | 0.366 | 0.037 | 0.732 | 2.193 |  |  |  |  |  | 
COVID19 (Custom Term) | Apolipoprotein A-I decreased | 0 | 0.183 | 0.003 | 0.732 | 2.813 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychomotor disadaptation syndrome | 0 | 0.366 | 0.037 | 0.732 | 2.193 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis toxic | 0 | 0.183 | 0.003 | 0.732 | 2.812 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cells stool negative | 0 | 0.457 | 0.062 | 0.732 | 2.029 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell morphology abnormal | 0 | 0.457 | 0.061 | 0.732 | 2.029 |  |  |  |  |  | 
COVID19 (Custom Term) | Henoch-Schonlein purpura nephritis | 0 | 0.549 | 0.086 | 0.732 | 1.907 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosa haematoma | 0 | 0.366 | 0.037 | 0.731 | 2.194 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral paralysis | 0 | 0.366 | 0.037 | 0.731 | 2.194 |  |  |  |  |  | 
COVID19 (Custom Term) | Volume blood decreased | 0 | 0.366 | 0.037 | 0.731 | 2.194 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial disease carrier | 0 | 0.457 | 0.061 | 0.731 | 2.029 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic disorder | 0 | 0.457 | 0.061 | 0.731 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysmetropsia | 0 | 0.183 | 0.003 | 0.731 | 2.814 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aluminium increased | 0 | 0.181 | 0.003 | 0.731 | 2.822 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphadenectomy | 0 | 0.486 | 0.068 | 0.731 | 1.988 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningocele acquired | 0 | 0.183 | 0.003 | 0.731 | 2.814 |  |  |  |  |  | 
COVID19 (Custom Term) | Post-traumatic neck syndrome | 0 | 0.457 | 0.061 | 0.731 | 2.029 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal faeces | 2 | 3.385 | 0.241 | 0.73 | 1.431 | 0.326 | 0.717 | 1.411 | 0.591 | 0.104 | 14.332
COVID19 (Custom Term) | Drug abuse, dependence and withdrawal (SMQ) [broad] | 136 | 216.91 | 0.631 | 0.73 | 0.835 | 0.547 | 0.63 | 0.723 | 0.627 | 0.382 | 131.618
COVID19 (Custom Term) | Breast cancer female | 1 | 3.292 | 0.182 | 0.73 | 1.576 | 0.225 | 0.569 | 1.228 | 0.304 | 0.284 | 1.076
COVID19 (Custom Term) | Cerebrovascular disorder | 0 | 0.59 | 0.094 | 0.73 | 1.863 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial fluid white blood cells positive | 0 | 0.457 | 0.06 | 0.73 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital cystic kidney disease | 0 | 0.366 | 0.036 | 0.73 | 2.195 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site hypersensitivity | 0 | 0.457 | 0.061 | 0.73 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal injury | 2 | 2.448 | 0.175 | 0.729 | 1.594 | 0.378 | 0.829 | 1.63 | 0.817 | 1.168 | 0.036
COVID19 (Custom Term) | Allergy test negative | 0 | 1.351 | 0.232 | 0.729 | 1.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Teething | 0 | 0.56 | 0.086 | 0.729 | 1.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta globulin | 0 | 0.457 | 0.059 | 0.729 | 2.031 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lactate dehydrogenase decreased | 0 | 0.457 | 0.06 | 0.729 | 2.031 |  |  |  |  |  | 
COVID19 (Custom Term) | Product administered at inappropriate site | 67 | 114.49 | 0.59 | 0.728 | 0.879 | 0.485 | 0.593 | 0.719 | 0.585 | 0.497 | 32.123
COVID19 (Custom Term) | Primary biliary cholangitis | 0 | 0.366 | 0.035 | 0.728 | 2.197 |  |  |  |  |  | 
COVID19 (Custom Term) | Noninfective sialoadenitis | 0 | 0.457 | 0.059 | 0.728 | 2.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site pruritus | 0 | 0.274 | 0.015 | 0.728 | 2.435 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival disorder | 0 | 0.457 | 0.059 | 0.728 | 2.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Punctate keratitis | 0 | 0.366 | 0.036 | 0.728 | 2.196 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune neutropenia | 0 | 0.196 | 0.004 | 0.728 | 2.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreous haze | 0 | 0.274 | 0.015 | 0.727 | 2.437 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventriculo-peritoneal shunt | 0 | 0.372 | 0.037 | 0.727 | 2.186 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypoventilation | 0 | 0.295 | 0.019 | 0.727 | 2.373 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold agglutinins negative | 0 | 0.274 | 0.015 | 0.727 | 2.436 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia mycoplasmal | 0 | 0.168 | 0.002 | 0.727 | 2.906 |  |  |  |  |  | 
COVID19 (Custom Term) | Electronystagmogram abnormal | 0 | 0.457 | 0.058 | 0.727 | 2.033 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging renal | 0 | 0.366 | 0.035 | 0.727 | 2.197 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood alcohol normal | 0 | 0.457 | 0.058 | 0.727 | 2.033 |  |  |  |  |  | 
COVID19 (Custom Term) | Intercepted product prescribing error | 0 | 0.366 | 0.035 | 0.726 | 2.198 |  |  |  |  |  | 
COVID19 (Custom Term) | Dizziness exertional | 0 | 0.366 | 0.034 | 0.726 | 2.199 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningoencephalitis bacterial | 0 | 0.274 | 0.014 | 0.726 | 2.438 |  |  |  |  |  | 
COVID19 (Custom Term) | Bipolar I disorder | 0 | 0.366 | 0.035 | 0.726 | 2.198 |  |  |  |  |  | 
COVID19 (Custom Term) | Total complement activity test | 0 | 0.251 | 0.01 | 0.726 | 2.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug abuse and dependence (SMQ) [broad] | 134 | 214.341 | 0.627 | 0.725 | 0.83 | 0.545 | 0.629 | 0.722 | 0.625 | 0.377 | 133.329
COVID19 (Custom Term) | Blood glucose fluctuation | 1 | 2.348 | 0.208 | 0.725 | 1.494 | 0.27 | 0.667 | 1.424 | 0.426 | 0.709 | 0.013
COVID19 (Custom Term) | Clavicle fracture | 0 | 0.457 | 0.057 | 0.725 | 2.034 |  |  |  |  |  | 
COVID19 (Custom Term) | Exophthalmos | 0 | 0.308 | 0.021 | 0.725 | 2.338 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary physical examination abnormal | 0 | 0.274 | 0.014 | 0.725 | 2.439 |  |  |  |  |  | 
COVID19 (Custom Term) | Bleeding varicose vein | 0 | 0.183 | 0.002 | 0.725 | 2.821 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium swallow normal | 0 | 0.457 | 0.057 | 0.725 | 2.034 |  |  |  |  |  | 
COVID19 (Custom Term) | Abscess soft tissue | 0 | 0.366 | 0.034 | 0.725 | 2.2 |  |  |  |  |  | 
COVID19 (Custom Term) | Abscess drainage | 1 | 1.603 | 0.144 | 0.724 | 1.669 | 0.314 | 0.767 | 1.63 | 0.624 | 0.177 | 2.914
COVID19 (Custom Term) | Weight bearing difficulty | 16 | 24.686 | 0.476 | 0.724 | 1.015 | 0.455 | 0.673 | 0.965 | 0.648 | 0.409 | 12.486
COVID19 (Custom Term) | CSF myelin basic protein | 0 | 0.274 | 0.014 | 0.724 | 2.439 |  |  |  |  |  | 
COVID19 (Custom Term) | Oligomenorrhoea | 0 | 0.204 | 0.004 | 0.724 | 2.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchitis viral | 0 | 0.457 | 0.056 | 0.724 | 2.035 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal X-ray abnormal | 1 | 1.637 | 0.171 | 0.723 | 1.586 | 0.311 | 0.762 | 1.619 | 0.611 | 0.276 | 1.156
COVID19 (Custom Term) | Very low density lipoprotein normal | 0 | 0.366 | 0.033 | 0.723 | 2.202 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein-losing gastroenteropathy | 0 | 0.183 | 0.002 | 0.723 | 2.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Panencephalitis | 0 | 0.183 | 0.002 | 0.723 | 2.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterocolitis bacterial | 0 | 0.274 | 0.014 | 0.723 | 2.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Impatience | 0 | 0.366 | 0.033 | 0.723 | 2.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic gastroenteritis | 0 | 0.183 | 0.002 | 0.723 | 2.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventricular hypertrophy | 0 | 0.183 | 0.002 | 0.723 | 2.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Rapid eye movements sleep abnormal | 0 | 0.457 | 0.055 | 0.723 | 2.036 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic hepatitis | 0 | 0.183 | 0.002 | 0.723 | 2.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Clonus | 1 | 1.532 | 0.13 | 0.722 | 1.71 | 0.318 | 0.778 | 1.652 | 0.653 | 0.107 | 6.455
COVID19 (Custom Term) | Oral candidiasis | 1 | 1.663 | 0.189 | 0.722 | 1.533 | 0.31 | 0.758 | 1.611 | 0.601 | 0.242 | 1.572
COVID19 (Custom Term) | Skin abrasion | 4 | 6.866 | 0.362 | 0.722 | 1.182 | 0.347 | 0.67 | 1.196 | 0.583 | 0.339 | 4.295
COVID19 (Custom Term) | Saccadic eye movement | 0 | 0.274 | 0.013 | 0.722 | 2.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug withdrawal syndrome neonatal | 0 | 0.183 | 0.002 | 0.722 | 2.824 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone cyst | 0 | 0.366 | 0.032 | 0.722 | 2.202 |  |  |  |  |  | 
COVID19 (Custom Term) | Intercepted product administration error | 0 | 0.457 | 0.055 | 0.722 | 2.036 |  |  |  |  |  | 
COVID19 (Custom Term) | Pregnancy and neonatal topics (SMQ) [narrow] | 270 | 403.99 | 0.651 | 0.721 | 0.794 | 0.606 | 0.67 | 0.739 | 0.668 | 0.555 | 91.991
COVID19 (Custom Term) | Peptic ulcer | 0 | 0.366 | 0.032 | 0.721 | 2.203 |  |  |  |  |  | 
COVID19 (Custom Term) | Winged scapula | 0 | 0.5 | 0.065 | 0.721 | 1.976 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinopexy | 0 | 0.457 | 0.054 | 0.721 | 2.037 |  |  |  |  |  | 
COVID19 (Custom Term) | Tinea pedis | 0 | 0.457 | 0.054 | 0.721 | 2.037 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound therapy | 0 | 0.457 | 0.054 | 0.721 | 2.037 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononucleosis heterophile test positive | 0 | 0.548 | 0.077 | 0.721 | 1.915 |  |  |  |  |  | 
COVID19 (Custom Term) | Staphylococcal abscess | 0 | 0.274 | 0.013 | 0.721 | 2.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculin test positive | 0 | 0.306 | 0.019 | 0.721 | 2.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillitis streptococcal | 0 | 0.366 | 0.032 | 0.721 | 2.203 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal burning sensation | 0 | 0.64 | 0.098 | 0.721 | 1.818 |  |  |  |  |  | 
COVID19 (Custom Term) | Intraocular pressure increased | 1 | 1.442 | 0.154 | 0.72 | 1.628 | 0.325 | 0.792 | 1.682 | 0.694 | 0.342 | 0.622
COVID19 (Custom Term) | Sleep apnoea syndrome | 2 | 2.983 | 0.187 | 0.72 | 1.533 | 0.346 | 0.761 | 1.497 | 0.671 | 0.251 | 3.583
COVID19 (Custom Term) | Hepatitis A antibody negative | 1 | 1.624 | 0.064 | 0.72 | 1.978 | 0.312 | 0.764 | 1.623 | 0.616 | 0.199 | 2.365
COVID19 (Custom Term) | Biopsy breast abnormal | 0 | 0.366 | 0.031 | 0.72 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold agglutinins positive | 0 | 0.274 | 0.013 | 0.72 | 2.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal mycotic infection | 0 | 0.457 | 0.054 | 0.72 | 2.038 |  |  |  |  |  | 
COVID19 (Custom Term) | Tobacco user | 0 | 0.274 | 0.013 | 0.72 | 2.444 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic disorder | 0 | 0.457 | 0.054 | 0.72 | 2.037 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligament disorder | 0 | 0.366 | 0.031 | 0.72 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | DNA antibody | 0 | 0.549 | 0.075 | 0.719 | 1.915 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone density decreased | 0 | 0.366 | 0.031 | 0.719 | 2.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Vasculitic rash | 0 | 0.788 | 0.129 | 0.719 | 1.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Bell's phenomenon | 0 | 0.366 | 0.031 | 0.719 | 2.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute flaccid myelitis | 0 | 0.366 | 0.031 | 0.719 | 2.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoinflammatory disease | 0 | 0.457 | 0.052 | 0.718 | 2.039 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site dysaesthesia | 0 | 0.457 | 0.052 | 0.718 | 2.039 |  |  |  |  |  | 
COVID19 (Custom Term) | Subdural abscess | 0 | 0.366 | 0.031 | 0.718 | 2.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Swallow study abnormal | 0 | 0.549 | 0.074 | 0.718 | 1.916 |  |  |  |  |  | 
COVID19 (Custom Term) | Body tinea | 0 | 0.457 | 0.052 | 0.718 | 2.039 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleural fluid analysis | 0 | 0.097 | 0 | 0.718 | 3.49 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle contractions involuntary | 7 | 12.889 | 0.404 | 0.717 | 1.103 | 0.352 | 0.608 | 0.992 | 0.543 | 0.368 | 6.685
COVID19 (Custom Term) | Medical diet | 0 | 0.366 | 0.03 | 0.717 | 2.206 |  |  |  |  |  | 
COVID19 (Custom Term) | Scleral hyperaemia | 0 | 0.457 | 0.051 | 0.717 | 2.04 |  |  |  |  |  | 
COVID19 (Custom Term) | Reaction to food additive | 0 | 0.366 | 0.03 | 0.717 | 2.206 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid factor | 4 | 6.015 | 0.324 | 0.716 | 1.232 | 0.378 | 0.73 | 1.302 | 0.665 | 0.641 | 0.432
COVID19 (Custom Term) | Injection site joint pain | 14 | 21.441 | 0.475 | 0.716 | 0.996 | 0.449 | 0.68 | 0.995 | 0.653 | 0.662 | 1.932
COVID19 (Custom Term) | Nervous system disorder | 7 | 11.006 | 0.356 | 0.716 | 1.176 | 0.397 | 0.686 | 1.12 | 0.636 | 0.217 | 18.604
COVID19 (Custom Term) | Hand deformity | 0 | 0.457 | 0.051 | 0.716 | 2.04 |  |  |  |  |  | 
COVID19 (Custom Term) | Lacrimal disorder | 0 | 0.457 | 0.051 | 0.716 | 2.04 |  |  |  |  |  | 
COVID19 (Custom Term) | Oxygen saturation immeasurable | 0 | 0.274 | 0.012 | 0.716 | 2.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventilation/perfusion scan normal | 0 | 0.549 | 0.073 | 0.716 | 1.916 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral infection | 0 | 0.457 | 0.051 | 0.716 | 2.04 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile colic | 0 | 0.187 | 0.002 | 0.716 | 2.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythrosis | 0 | 0.366 | 0.03 | 0.716 | 2.207 |  |  |  |  |  | 
COVID19 (Custom Term) | Multi-vitamin deficiency | 0 | 0.274 | 0.012 | 0.716 | 2.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.457 | 0.051 | 0.716 | 2.04 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb immobilisation | 1 | 1.114 | 0.092 | 0.715 | 1.828 | 0.349 | 0.849 | 1.802 | 0.898 | 0.451 | 0.191
COVID19 (Custom Term) | Blood immunoglobulin G normal | 5 | 8.36 | 0.324 | 0.715 | 1.23 | 0.363 | 0.67 | 1.155 | 0.598 | 0.36 | 4.841
COVID19 (Custom Term) | Oesophagram | 0 | 0.457 | 0.051 | 0.715 | 2.041 |  |  |  |  |  | 
COVID19 (Custom Term) | Valsalva maneuver | 0 | 0.366 | 0.029 | 0.715 | 2.208 |  |  |  |  |  | 
COVID19 (Custom Term) | Vocal cord dysfunction | 0 | 0.457 | 0.05 | 0.715 | 2.041 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug intolerance | 0 | 0.668 | 0.1 | 0.715 | 1.795 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin urine absent | 0 | 0.366 | 0.03 | 0.715 | 2.207 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia haemophilus | 0 | 0.274 | 0.012 | 0.715 | 2.448 |  |  |  |  |  | 
COVID19 (Custom Term) | Reflux gastritis | 0 | 0.366 | 0.029 | 0.715 | 2.208 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung lobectomy | 0 | 0.274 | 0.012 | 0.715 | 2.448 |  |  |  |  |  | 
COVID19 (Custom Term) | Sputum purulent | 0 | 0.366 | 0.029 | 0.715 | 2.208 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyper IgE syndrome | 0 | 0.183 | 0.002 | 0.714 | 2.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Chromosome analysis abnormal | 0 | 0.366 | 0.029 | 0.714 | 2.208 |  |  |  |  |  | 
COVID19 (Custom Term) | Inadequate aseptic technique in use of product | 0 | 0.907 | 0.147 | 0.714 | 1.629 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull X-ray normal | 0 | 0.732 | 0.113 | 0.714 | 1.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration bone marrow | 0 | 0.764 | 0.12 | 0.714 | 1.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Traumatic lung injury | 0 | 0.366 | 0.029 | 0.714 | 2.208 |  |  |  |  |  | 
COVID19 (Custom Term) | Haematoma | 8 | 12.679 | 0.393 | 0.713 | 1.111 | 0.403 | 0.677 | 1.082 | 0.631 | 0.378 | 7.235
COVID19 (Custom Term) | Rheumatoid factor negative | 4 | 7.3 | 0.28 | 0.713 | 1.307 | 0.333 | 0.644 | 1.148 | 0.548 | 0.208 | 10.988
COVID19 (Custom Term) | Guillain-Barre syndrome | 44 | 81.889 | 0.547 | 0.713 | 0.896 | 0.43 | 0.55 | 0.695 | 0.537 | 0.307 | 66.397
COVID19 (Custom Term) | Nervous system injury | 0 | 0.457 | 0.05 | 0.713 | 2.042 |  |  |  |  |  | 
COVID19 (Custom Term) | Panniculitis lobular | 0 | 0.366 | 0.028 | 0.713 | 2.21 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreous disorder | 0 | 0.274 | 0.011 | 0.713 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Metastatic malignant melanoma | 0 | 0.274 | 0.011 | 0.713 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Gomori methenamine silver stain | 0 | 0.183 | 0.002 | 0.713 | 2.833 |  |  |  |  |  | 
COVID19 (Custom Term) | Jaundice cholestatic | 0 | 0.366 | 0.029 | 0.713 | 2.209 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic respiratory disease | 0 | 0.274 | 0.011 | 0.713 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product ineffective | 0 | 0.366 | 0.028 | 0.712 | 2.21 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood 25-hydroxycholecalciferol | 0 | 0.798 | 0.124 | 0.712 | 1.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug dispensed to wrong patient | 0 | 0.755 | 0.116 | 0.712 | 1.726 |  |  |  |  |  | 
COVID19 (Custom Term) | Multipathogen PCR test positive | 0 | 0.274 | 0.011 | 0.712 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 2 globulin normal | 0 | 0.457 | 0.048 | 0.712 | 2.043 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrocephaly | 0 | 0.457 | 0.048 | 0.712 | 2.043 |  |  |  |  |  | 
COVID19 (Custom Term) | Femur fracture | 0 | 0.64 | 0.09 | 0.711 | 1.822 |  |  |  |  |  | 
COVID19 (Custom Term) | Syphilis | 0 | 0.366 | 0.028 | 0.711 | 2.211 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrosis ischaemic | 0 | 0.274 | 0.011 | 0.711 | 2.452 |  |  |  |  |  | 
COVID19 (Custom Term) | Electronystagmogram normal | 0 | 0.183 | 0.002 | 0.711 | 2.835 |  |  |  |  |  | 
COVID19 (Custom Term) | Choroidal neovascularisation | 0 | 0.366 | 0.028 | 0.711 | 2.211 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephrotic syndrome | 0 | 0.533 | 0.066 | 0.711 | 1.938 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal cardiac disorder | 0 | 0.366 | 0.028 | 0.711 | 2.211 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood ketone body present | 0 | 0.64 | 0.09 | 0.711 | 1.822 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging spinal normal | 9 | 14.168 | 0.404 | 0.71 | 1.086 | 0.412 | 0.677 | 1.061 | 0.635 | 0.529 | 3.114
COVID19 (Custom Term) | Osteomyelitis | 1 | 2.163 | 0.195 | 0.71 | 1.486 | 0.28 | 0.689 | 1.47 | 0.462 | 0.181 | 2.822
COVID19 (Custom Term) | Hydrocephalus | 0 | 0.999 | 0.159 | 0.71 | 1.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Continuous haemodiafiltration | 0 | 0.549 | 0.069 | 0.71 | 1.919 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site eschar | 0 | 0.201 | 0.003 | 0.71 | 2.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Babinski reflex test | 0 | 0.327 | 0.02 | 0.71 | 2.302 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion early | 0 | 0.183 | 0.001 | 0.71 | 2.836 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis mumps | 0 | 0.183 | 0.001 | 0.71 | 2.836 |  |  |  |  |  | 
COVID19 (Custom Term) | Rathke's cleft cyst | 0 | 0.183 | 0.002 | 0.71 | 2.835 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniocentesis abnormal | 0 | 0.183 | 0.001 | 0.71 | 2.836 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypothyroidism (SMQ) [narrow] | 6 | 10.592 | 0.327 | 0.709 | 1.209 | 0.357 | 0.635 | 1.063 | 0.566 | 0.621 | 0.947
COVID19 (Custom Term) | Anorectal disorder | 0 | 0.457 | 0.047 | 0.709 | 2.044 |  |  |  |  |  | 
COVID19 (Custom Term) | Human bocavirus infection | 0 | 0.366 | 0.027 | 0.709 | 2.212 |  |  |  |  |  | 
COVID19 (Custom Term) | False positive investigation result | 0 | 0.549 | 0.068 | 0.709 | 1.92 |  |  |  |  |  | 
COVID19 (Custom Term) | Fungal skin infection | 0 | 0.386 | 0.031 | 0.709 | 2.171 |  |  |  |  |  | 
COVID19 (Custom Term) | Streptococcal sepsis | 0 | 0.549 | 0.068 | 0.709 | 1.92 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin urine absent | 0 | 0.64 | 0.088 | 0.708 | 1.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-islet cell antibody positive | 0 | 0.457 | 0.047 | 0.708 | 2.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-thyroid antibody | 0 | 0.831 | 0.127 | 0.708 | 1.675 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypergammaglobulinaemia | 0 | 0.366 | 0.027 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic mass | 0 | 0.366 | 0.027 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Leg amputation | 0 | 0.457 | 0.047 | 0.708 | 2.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocrine ophthalmopathy | 0 | 0.366 | 0.026 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Stress urinary incontinence | 0 | 0.366 | 0.026 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertrichosis | 0 | 0.366 | 0.027 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Lower respiratory tract infection viral | 0 | 0.366 | 0.027 | 0.708 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypersensitivity vasculitis | 2 | 3.232 | 0.198 | 0.707 | 1.471 | 0.333 | 0.733 | 1.442 | 0.619 | 0.284 | 2.793
COVID19 (Custom Term) | Ovarian operation | 0 | 0.366 | 0.026 | 0.707 | 2.214 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy stomach abnormal | 0 | 0.549 | 0.067 | 0.707 | 1.921 |  |  |  |  |  | 
COVID19 (Custom Term) | Pineal gland cyst | 0 | 0.366 | 0.026 | 0.707 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Feeding intolerance | 0 | 0.457 | 0.046 | 0.707 | 2.046 |  |  |  |  |  | 
COVID19 (Custom Term) | Ankyloglossia congenital | 0 | 0.366 | 0.026 | 0.707 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthritis allergic | 0 | 0.457 | 0.046 | 0.707 | 2.046 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal erythema | 0 | 0.732 | 0.107 | 0.707 | 1.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary sediment abnormal | 0 | 0.549 | 0.066 | 0.707 | 1.921 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site hypertrophy | 0 | 0.366 | 0.026 | 0.707 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Sinus arrhythmia | 5 | 5.396 | 0.344 | 0.706 | 1.173 | 0.483 | 0.892 | 1.535 | 0.927 | 3.103 | 3.809
COVID19 (Custom Term) | Steatohepatitis | 0 | 0.183 | 0.001 | 0.706 | 2.839 |  |  |  |  |  | 
COVID19 (Custom Term) | Cellulitis staphylococcal | 0 | 0.457 | 0.045 | 0.706 | 2.046 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis D | 0 | 0.183 | 0.001 | 0.706 | 2.839 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral load | 0 | 0.183 | 0.001 | 0.706 | 2.839 |  |  |  |  |  | 
COVID19 (Custom Term) | Proteinuria | 3 | 7.866 | 0.225 | 0.705 | 1.402 | 0.253 | 0.522 | 0.977 | 0.381 | 0.458 | 1.311
COVID19 (Custom Term) | Anti-neuronal antibody | 0 | 0.549 | 0.065 | 0.705 | 1.922 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscular dystrophy | 0 | 0.64 | 0.086 | 0.705 | 1.824 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalomyelitis | 0 | 0.452 | 0.043 | 0.705 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint abscess | 0 | 0.366 | 0.025 | 0.705 | 2.215 |  |  |  |  |  | 
COVID19 (Custom Term) | Pleural decortication | 0 | 0.366 | 0.025 | 0.705 | 2.215 |  |  |  |  |  | 
COVID19 (Custom Term) | Fibrous histiocytoma | 0 | 0.457 | 0.045 | 0.705 | 2.047 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxine normal | 3 | 4.387 | 0.302 | 0.704 | 1.241 | 0.369 | 0.753 | 1.402 | 0.684 | 1.103 | 0.024
COVID19 (Custom Term) | Cardiac electrophysiologic study abnormal | 0 | 0.366 | 0.025 | 0.704 | 2.216 |  |  |  |  |  | 
COVID19 (Custom Term) | Perivascular dermatitis | 0 | 0.457 | 0.044 | 0.704 | 2.047 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood zinc | 0 | 0.366 | 0.025 | 0.704 | 2.216 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site inflammation | 45 | 69.005 | 0.547 | 0.703 | 0.876 | 0.519 | 0.661 | 0.833 | 0.652 | 0.337 | 56.217
COVID19 (Custom Term) | Medication errors (SMQ) [broad] | 867 | 1336.803 | 0.664 | 0.703 | 0.743 | 0.614 | 0.649 | 0.686 | 0.649 | 0.114 | 7570.539
COVID19 (Custom Term) | CSF shunt operation | 0 | 0.366 | 0.024 | 0.703 | 2.216 |  |  |  |  |  | 
COVID19 (Custom Term) | Smear site unspecified abnormal | 0 | 0.732 | 0.103 | 0.703 | 1.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Echolalia | 0 | 0.457 | 0.043 | 0.703 | 2.048 |  |  |  |  |  | 
COVID19 (Custom Term) | Polycythaemia | 0 | 0.457 | 0.044 | 0.703 | 2.048 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrotising soft tissue infection | 0 | 0.274 | 0.009 | 0.703 | 2.458 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligament injury | 0 | 0.549 | 0.064 | 0.703 | 1.922 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthopaedic examination | 0 | 0.64 | 0.084 | 0.703 | 1.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhinitis allergic | 1 | 1.577 | 0.163 | 0.702 | 1.549 | 0.315 | 0.771 | 1.638 | 0.634 | 0.342 | 0.622
COVID19 (Custom Term) | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [broad] | 202 | 333.124 | 0.623 | 0.702 | 0.785 | 0.542 | 0.609 | 0.682 | 0.606 | 0.599 | 51.423
COVID19 (Custom Term) | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [narrow] | 200 | 331.076 | 0.623 | 0.702 | 0.786 | 0.54 | 0.607 | 0.68 | 0.604 | 0.596 | 51.854
COVID19 (Custom Term) | Pulmonary function test | 2 | 3.91 | 0.188 | 0.702 | 1.481 | 0.302 | 0.666 | 1.312 | 0.511 | 0.414 | 1.036
COVID19 (Custom Term) | Hypoproteinaemia | 0 | 0.549 | 0.063 | 0.702 | 1.923 |  |  |  |  |  | 
COVID19 (Custom Term) | Intercepted medication error | 0 | 0.366 | 0.024 | 0.702 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Gangrene | 0 | 0.366 | 0.024 | 0.702 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity unsaturated | 0 | 0.366 | 0.024 | 0.702 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood parathyroid hormone normal | 0 | 0.732 | 0.102 | 0.702 | 1.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Synovial disorder | 0 | 0.457 | 0.043 | 0.702 | 2.048 |  |  |  |  |  | 
COVID19 (Custom Term) | Protein albumin ratio | 0 | 0.366 | 0.024 | 0.702 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy cervix normal | 0 | 0.366 | 0.024 | 0.702 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Mass | 26 | 40.085 | 0.514 | 0.701 | 0.911 | 0.485 | 0.664 | 0.892 | 0.649 | 0.488 | 12.8
COVID19 (Custom Term) | Amyotrophy | 0 | 0.366 | 0.024 | 0.701 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine free increased | 0 | 0.366 | 0.024 | 0.701 | 2.217 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte count decreased | 0 | 0.457 | 0.043 | 0.701 | 2.049 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic mastocytosis | 0 | 0.457 | 0.042 | 0.701 | 2.049 |  |  |  |  |  | 
COVID19 (Custom Term) | Stereotypy | 1 | 1.049 | 0.128 | 0.7 | 1.647 | 0.354 | 0.861 | 1.827 | 0.953 | 0.14 | 4.326
COVID19 (Custom Term) | Lymphatic system neoplasm | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovulation disorder | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic disease | 0 | 0.366 | 0.023 | 0.7 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti factor VIII antibody negative | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Abulia | 0 | 0.366 | 0.023 | 0.7 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Precancerous condition | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Babesiosis | 0 | 0.274 | 0.009 | 0.7 | 2.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Cephalhaematoma | 0 | 0.274 | 0.009 | 0.7 | 2.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Retroviral infection | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudomononucleosis | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Idiopathic generalised epilepsy | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Temperature difference of extremities | 0 | 0.366 | 0.023 | 0.7 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory tract haemorrhage | 0 | 0.183 | 0.001 | 0.7 | 2.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull X-ray abnormal | 0 | 0.457 | 0.042 | 0.7 | 2.05 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal pruritus | 3 | 4.541 | 0.267 | 0.699 | 1.295 | 0.362 | 0.739 | 1.376 | 0.661 | 1.752 | 0.27
COVID19 (Custom Term) | Viral titre increased | 1 | 1.948 | 0.116 | 0.699 | 1.685 | 0.292 | 0.717 | 1.527 | 0.513 | 0.993 | 0.266
COVID19 (Custom Term) | Myopia | 0 | 0.339 | 0.018 | 0.699 | 2.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune thyroid disorder | 0 | 0.366 | 0.023 | 0.699 | 2.219 |  |  |  |  |  | 
COVID19 (Custom Term) | Circumstance or information capable of leading to medication error | 5 | 6.019 | 0.319 | 0.698 | 1.197 | 0.452 | 0.834 | 1.436 | 0.831 | 0.218 | 12.929
COVID19 (Custom Term) | Mood swings | 3 | 3.806 | 0.225 | 0.698 | 1.383 | 0.398 | 0.813 | 1.512 | 0.788 | 0.324 | 3.415
COVID19 (Custom Term) | Vulval ulceration | 0 | 0.457 | 0.041 | 0.698 | 2.05 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal dystrophy | 0 | 0.274 | 0.008 | 0.698 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 globulin | 0 | 0.457 | 0.041 | 0.698 | 2.05 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin graft | 0 | 0.64 | 0.08 | 0.698 | 1.826 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic ischaemic neuropathy | 1 | 1.069 | 0.107 | 0.697 | 1.712 | 0.353 | 0.858 | 1.819 | 0.935 | 0.584 | 0.014
COVID19 (Custom Term) | Auditory disorder | 4 | 5.236 | 0.3 | 0.697 | 1.226 | 0.412 | 0.795 | 1.416 | 0.764 | 1.986 | 0.852
COVID19 (Custom Term) | Blood mercury | 0 | 0.549 | 0.06 | 0.697 | 1.925 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve stimulation test | 0 | 0.732 | 0.098 | 0.697 | 1.747 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericarditis lupus | 0 | 0.183 | 0.001 | 0.697 | 2.845 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal scar | 0 | 0.274 | 0.008 | 0.697 | 2.463 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermohyperaesthesia | 0 | 0.183 | 0.001 | 0.697 | 2.845 |  |  |  |  |  | 
COVID19 (Custom Term) | Febrile neutropenia | 0 | 0.64 | 0.079 | 0.697 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint debridement | 0 | 0.366 | 0.022 | 0.697 | 2.22 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal respiratory distress syndrome | 0 | 0.274 | 0.008 | 0.697 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychogenic visual disorder | 0 | 0.183 | 0.001 | 0.697 | 2.845 |  |  |  |  |  | 
COVID19 (Custom Term) | Dehydroepiandrosterone test | 0 | 0.366 | 0.022 | 0.697 | 2.22 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis | 3 | 4.507 | 0.244 | 0.696 | 1.335 | 0.363 | 0.742 | 1.381 | 0.666 | 0.108 | 21.038
COVID19 (Custom Term) | FEV1/FVC ratio | 0 | 0.366 | 0.022 | 0.696 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypochloraemia | 0 | 0.549 | 0.059 | 0.696 | 1.925 |  |  |  |  |  | 
COVID19 (Custom Term) | Spondylitis | 0 | 0.502 | 0.049 | 0.696 | 1.986 |  |  |  |  |  | 
COVID19 (Custom Term) | Breath holding | 0 | 0.843 | 0.118 | 0.696 | 1.67 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital choroid plexus cyst | 0 | 0.366 | 0.022 | 0.696 | 2.22 |  |  |  |  |  | 
COVID19 (Custom Term) | Knee arthroplasty | 0 | 0.62 | 0.074 | 0.696 | 1.847 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray limb | 18 | 28.727 | 0.471 | 0.695 | 0.956 | 0.449 | 0.65 | 0.918 | 0.627 | 0.65 | 2.837
COVID19 (Custom Term) | Syringomyelia | 0 | 0.366 | 0.022 | 0.695 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E | 0 | 0.183 | 0.001 | 0.695 | 2.846 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin urine | 0 | 0.64 | 0.078 | 0.695 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis viral test positive | 0 | 0.183 | 0.001 | 0.695 | 2.846 |  |  |  |  |  | 
COVID19 (Custom Term) | Antiacetylcholine receptor antibody | 0 | 0.497 | 0.048 | 0.695 | 1.992 |  |  |  |  |  | 
COVID19 (Custom Term) | Proctalgia | 0 | 0.506 | 0.049 | 0.695 | 1.981 |  |  |  |  |  | 
COVID19 (Custom Term) | Nitrite urine present | 3 | 2.984 | 0.259 | 0.694 | 1.299 | 0.449 | 0.915 | 1.702 | 1.005 | 2.708 | 1.277
COVID19 (Custom Term) | Hair disorder | 0 | 0.215 | 0.002 | 0.694 | 2.689 |  |  |  |  |  | 
COVID19 (Custom Term) | Typhus | 0 | 0.183 | 0.001 | 0.694 | 2.847 |  |  |  |  |  | 
COVID19 (Custom Term) | Product contamination | 0 | 0.549 | 0.058 | 0.694 | 1.926 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-ganglioside antibody | 0 | 0.457 | 0.039 | 0.694 | 2.052 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye operation | 0 | 0.697 | 0.089 | 0.694 | 1.777 |  |  |  |  |  | 
COVID19 (Custom Term) | Granuloma skin | 0 | 0.366 | 0.021 | 0.694 | 2.222 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal heart rate decreased | 0 | 0.366 | 0.021 | 0.694 | 2.222 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema weeping | 0 | 0.457 | 0.039 | 0.693 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine bilirubin increased | 0 | 0.64 | 0.077 | 0.693 | 1.828 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound liver normal | 0 | 0.911 | 0.127 | 0.693 | 1.629 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis astroviral | 0 | 0.183 | 0.001 | 0.693 | 2.848 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram T wave amplitude decreased | 0 | 0.183 | 0.001 | 0.693 | 2.848 |  |  |  |  |  | 
COVID19 (Custom Term) | Seborrhoeic dermatitis | 0 | 0.673 | 0.083 | 0.693 | 1.797 |  |  |  |  |  | 
COVID19 (Custom Term) | Autonomic nervous system imbalance | 2 | 2.728 | 0.152 | 0.692 | 1.552 | 0.361 | 0.792 | 1.558 | 0.733 | 0.089 | 17.403
COVID19 (Custom Term) | Nodule | 33 | 50.574 | 0.513 | 0.692 | 0.894 | 0.502 | 0.665 | 0.867 | 0.653 | 0.443 | 21.618
COVID19 (Custom Term) | Dysmorphism | 0 | 0.366 | 0.021 | 0.692 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal erythema | 0 | 0.183 | 0.001 | 0.692 | 2.848 |  |  |  |  |  | 
COVID19 (Custom Term) | Epiglottic erythema | 0 | 0.183 | 0.001 | 0.692 | 2.848 |  |  |  |  |  | 
COVID19 (Custom Term) | Myasthenic syndrome | 0 | 0.274 | 0.007 | 0.692 | 2.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.274 | 0.007 | 0.692 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperkeratosis | 0 | 0.821 | 0.111 | 0.692 | 1.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis bacterial | 0 | 0.366 | 0.021 | 0.692 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Lesion excision | 0 | 0.366 | 0.021 | 0.692 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal warts | 0 | 0.274 | 0.007 | 0.692 | 2.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antigen negative | 2 | 3.611 | 0.136 | 0.691 | 1.596 | 0.315 | 0.694 | 1.366 | 0.554 | 0.071 | 23.083
COVID19 (Custom Term) | Demyelination (SMQ) [narrow] | 82 | 141.433 | 0.571 | 0.691 | 0.82 | 0.489 | 0.586 | 0.698 | 0.58 | 0.316 | 117.533
COVID19 (Custom Term) | Ovarian cystectomy | 0 | 0.366 | 0.02 | 0.691 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Tympanometry | 0 | 0.64 | 0.075 | 0.691 | 1.828 |  |  |  |  |  | 
COVID19 (Custom Term) | Disease susceptibility | 0 | 0.457 | 0.038 | 0.691 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Upper airway obstruction | 0 | 0.64 | 0.075 | 0.691 | 1.828 |  |  |  |  |  | 
COVID19 (Custom Term) | Poliovirus test negative | 0 | 0.366 | 0.02 | 0.691 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Incarcerated inguinal hernia | 0 | 0.366 | 0.02 | 0.691 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue inflammation | 0 | 0.434 | 0.033 | 0.691 | 2.093 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal ulceration | 1 | 1.01 | 0.23 | 0.69 | 1.35 | 0.357 | 0.869 | 1.843 | 0.99 | 0.764 | 0.041
COVID19 (Custom Term) | Meningism | 1 | 1.154 | 0.112 | 0.69 | 1.674 | 0.346 | 0.842 | 1.786 | 0.867 | 0.155 | 3.661
COVID19 (Custom Term) | Necrotising enterocolitis neonatal | 0 | 0.274 | 0.007 | 0.69 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram T wave normal | 0 | 0.457 | 0.037 | 0.69 | 2.054 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystoscopy normal | 0 | 0.366 | 0.02 | 0.69 | 2.224 |  |  |  |  |  | 
COVID19 (Custom Term) | Fasciotomy | 0 | 0.366 | 0.02 | 0.69 | 2.224 |  |  |  |  |  | 
COVID19 (Custom Term) | Extensor plantar response | 1 | 0.987 | 0.083 | 0.689 | 1.784 | 0.359 | 0.874 | 1.853 | 1.013 | 0.368 | 0.485
COVID19 (Custom Term) | Otorrhoea | 2 | 2.28 | 0.21 | 0.689 | 1.392 | 0.389 | 0.853 | 1.677 | 0.877 | 0.584 | 0.211
COVID19 (Custom Term) | Injection site vesicles | 19 | 33.731 | 0.464 | 0.689 | 0.951 | 0.41 | 0.59 | 0.826 | 0.563 | 0.215 | 52.746
COVID19 (Custom Term) | Glucose urine | 0 | 0.274 | 0.007 | 0.689 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Antisocial behaviour | 0 | 0.457 | 0.036 | 0.689 | 2.054 |  |  |  |  |  | 
COVID19 (Custom Term) | Giardia test | 0 | 0.366 | 0.02 | 0.689 | 2.224 |  |  |  |  |  | 
COVID19 (Custom Term) | Cushingoid | 0 | 0.366 | 0.02 | 0.689 | 2.224 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin CSF | 0 | 0.299 | 0.01 | 0.689 | 2.392 |  |  |  |  |  | 
COVID19 (Custom Term) | Hordeolum | 5 | 6.16 | 0.333 | 0.688 | 1.147 | 0.445 | 0.822 | 1.415 | 0.812 | 2.482 | 2.356
COVID19 (Custom Term) | CSF test normal | 5 | 9.057 | 0.31 | 0.688 | 1.187 | 0.343 | 0.633 | 1.091 | 0.552 | 0.197 | 15.203
COVID19 (Custom Term) | Abscess oral | 0 | 0.457 | 0.036 | 0.688 | 2.055 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthopox virus infection | 0 | 0.183 | 0.001 | 0.688 | 2.85 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast cyst | 0 | 0.274 | 0.007 | 0.688 | 2.468 |  |  |  |  |  | 
COVID19 (Custom Term) | Basedow's disease | 1 | 2.124 | 0.108 | 0.687 | 1.681 | 0.282 | 0.694 | 1.48 | 0.471 | 0.248 | 1.487
COVID19 (Custom Term) | Rhesus antigen positive | 0 | 0.549 | 0.054 | 0.687 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipoma | 0 | 0.772 | 0.097 | 0.687 | 1.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Aldolase normal | 0 | 0.585 | 0.061 | 0.687 | 1.886 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye patch application | 0 | 0.549 | 0.054 | 0.687 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve injury | 0 | 0.269 | 0.006 | 0.687 | 2.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Sense of oppression | 0 | 0.457 | 0.036 | 0.687 | 2.055 |  |  |  |  |  | 
COVID19 (Custom Term) | Demyelination (SMQ) [broad] | 88 | 147.975 | 0.571 | 0.686 | 0.81 | 0.504 | 0.601 | 0.711 | 0.595 | 0.329 | 116.632
COVID19 (Custom Term) | CSF white blood cell count negative | 2 | 4.131 | 0.216 | 0.686 | 1.369 | 0.292 | 0.647 | 1.275 | 0.484 | 0.154 | 8.267
COVID19 (Custom Term) | Loss of control of legs | 1 | 2.349 | 0.153 | 0.686 | 1.53 | 0.27 | 0.667 | 1.424 | 0.426 | 0.163 | 3.379
COVID19 (Custom Term) | Familial periodic paralysis | 0 | 0.274 | 0.006 | 0.686 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF pressure | 0 | 0.274 | 0.006 | 0.686 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body aspiration | 0 | 0.366 | 0.019 | 0.686 | 2.226 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperbaric oxygen therapy | 0 | 0.457 | 0.035 | 0.686 | 2.055 |  |  |  |  |  | 
COVID19 (Custom Term) | Mucosal erosion | 0 | 0.366 | 0.019 | 0.686 | 2.226 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye allergy | 0 | 0.457 | 0.035 | 0.685 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Detoxification | 0 | 0.518 | 0.047 | 0.685 | 1.968 |  |  |  |  |  | 
COVID19 (Custom Term) | Foot amputation | 0 | 0.366 | 0.018 | 0.685 | 2.226 |  |  |  |  |  | 
COVID19 (Custom Term) | Extrapulmonary tuberculosis | 0 | 0.183 | 0.001 | 0.685 | 2.851 |  |  |  |  |  | 
COVID19 (Custom Term) | Fat necrosis | 0 | 0.732 | 0.089 | 0.685 | 1.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Guillain-Barre syndrome (SMQ) [narrow] | 47 | 87.76 | 0.53 | 0.684 | 0.854 | 0.432 | 0.548 | 0.687 | 0.536 | 0.306 | 71.53
COVID19 (Custom Term) | Neurotoxicity | 0 | 0.457 | 0.034 | 0.684 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Dengue virus test positive | 0 | 0.183 | 0.001 | 0.684 | 2.852 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid pain | 0 | 0.549 | 0.052 | 0.684 | 1.929 |  |  |  |  |  | 
COVID19 (Custom Term) | Vibration test abnormal | 0 | 0.366 | 0.018 | 0.684 | 2.227 |  |  |  |  |  | 
COVID19 (Custom Term) | Indifference | 0 | 0.457 | 0.034 | 0.684 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Maternal exposure during pregnancy | 3 | 2.939 | 0.255 | 0.683 | 1.278 | 0.452 | 0.921 | 1.713 | 1.021 | 2.482 | 1.02
COVID19 (Custom Term) | Enteroclysis | 0 | 0.274 | 0.006 | 0.683 | 2.47 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac aneurysm | 0 | 0.366 | 0.018 | 0.683 | 2.227 |  |  |  |  |  | 
COVID19 (Custom Term) | Injected limb mobility decreased | 173 | 290.024 | 0.599 | 0.682 | 0.769 | 0.529 | 0.599 | 0.677 | 0.597 | 0.4 | 151.41
COVID19 (Custom Term) | Tumour markers (SMQ) [narrow] | 3 | 5.483 | 0.225 | 0.682 | 1.339 | 0.323 | 0.662 | 1.233 | 0.547 | 0.408 | 1.889
COVID19 (Custom Term) | Tumour markers (SMQ) [broad] | 3 | 5.483 | 0.225 | 0.682 | 1.339 | 0.323 | 0.662 | 1.233 | 0.547 | 0.408 | 1.889
COVID19 (Custom Term) | Chronic myeloid leukaemia | 0 | 0.457 | 0.033 | 0.682 | 2.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone cancer | 0 | 0.274 | 0.006 | 0.682 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal calprotectin | 0 | 0.366 | 0.018 | 0.682 | 2.227 |  |  |  |  |  | 
COVID19 (Custom Term) | Total lung capacity decreased | 0 | 0.206 | 0.001 | 0.682 | 2.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte haemoglobin equivalent | 0 | 0.366 | 0.018 | 0.682 | 2.227 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic function abnormal | 1 | 1.104 | 0.091 | 0.681 | 1.727 | 0.35 | 0.851 | 1.805 | 0.906 | 0.118 | 5.578
COVID19 (Custom Term) | Immune-mediated myositis | 0 | 0.366 | 0.017 | 0.681 | 2.228 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain abscess | 0 | 0.457 | 0.033 | 0.681 | 2.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin G increased | 2 | 3.078 | 0.191 | 0.68 | 1.413 | 0.341 | 0.75 | 1.476 | 0.65 | 0.236 | 4.033
COVID19 (Custom Term) | Vasculitis (SMQ) [narrow] | 20 | 32.081 | 0.461 | 0.68 | 0.934 | 0.453 | 0.645 | 0.897 | 0.623 | 0.196 | 64.189
COVID19 (Custom Term) | Influenza B virus test positive | 1 | 2.592 | 0.062 | 0.68 | 1.859 | 0.257 | 0.639 | 1.368 | 0.386 | 0.062 | 13.187
COVID19 (Custom Term) | Uterine cancer | 0 | 0.366 | 0.017 | 0.68 | 2.228 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood prolactin | 0 | 0.366 | 0.017 | 0.68 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocauterisation | 0 | 0.457 | 0.033 | 0.68 | 2.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin A decreased | 1 | 1.511 | 0.093 | 0.679 | 1.711 | 0.32 | 0.781 | 1.659 | 0.662 | 0.216 | 2.008
COVID19 (Custom Term) | Cerebral palsy | 0 | 0.821 | 0.1 | 0.679 | 1.685 |  |  |  |  |  | 
COVID19 (Custom Term) | Papilloma | 0 | 0.274 | 0.005 | 0.679 | 2.472 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropsychiatric symptoms | 0 | 0.457 | 0.032 | 0.679 | 2.058 |  |  |  |  |  | 
COVID19 (Custom Term) | Upper respiratory tract infection bacterial | 0 | 0.457 | 0.032 | 0.679 | 2.058 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site vesicles | 0 | 0.274 | 0.005 | 0.679 | 2.473 |  |  |  |  |  | 
COVID19 (Custom Term) | Cutaneous vasculitis | 0 | 0.457 | 0.032 | 0.679 | 2.058 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid dysfunction (SMQ) [narrow] | 11 | 18.064 | 0.391 | 0.678 | 1.03 | 0.409 | 0.647 | 0.983 | 0.609 | 0.566 | 3.03
COVID19 (Custom Term) | Post transfusion purpura | 0 | 0.183 | 0.001 | 0.678 | 2.853 |  |  |  |  |  | 
COVID19 (Custom Term) | Colour blindness | 0 | 0.26 | 0.004 | 0.678 | 2.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site pain | 0 | 0.366 | 0.017 | 0.678 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Gross motor delay | 0 | 0.377 | 0.018 | 0.678 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail bed bleeding | 0 | 0.366 | 0.017 | 0.678 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrophoresis normal | 0 | 0.457 | 0.032 | 0.678 | 2.058 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric infection | 0 | 0.366 | 0.017 | 0.678 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Testicular torsion | 0 | 0.274 | 0.005 | 0.677 | 2.473 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdomen scan | 0 | 0.457 | 0.031 | 0.677 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthropod sting | 0 | 0.915 | 0.114 | 0.677 | 1.627 |  |  |  |  |  | 
COVID19 (Custom Term) | Pancreatic failure | 0 | 0.457 | 0.031 | 0.677 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Peritoneal dialysis | 0 | 0.457 | 0.031 | 0.676 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye ulcer | 0 | 0.274 | 0.005 | 0.676 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal abscess | 0 | 0.457 | 0.031 | 0.676 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Transient acantholytic dermatosis | 0 | 0.274 | 0.005 | 0.676 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Feelings of worthlessness | 0 | 0.274 | 0.005 | 0.676 | 2.474 |  |  |  |  |  | 
COVID19 (Custom Term) | Essential tremor | 0 | 0.517 | 0.041 | 0.676 | 1.972 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis viral | 0 | 0.457 | 0.031 | 0.676 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Product used for unknown indication | 0 | 0.549 | 0.047 | 0.676 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Live birth | 1 | 2.505 | 0.069 | 0.675 | 1.808 | 0.262 | 0.649 | 1.387 | 0.399 | 0.903 | 0.162
COVID19 (Custom Term) | Aspiration joint normal | 0 | 0.823 | 0.097 | 0.675 | 1.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonic convulsion | 1 | 1.682 | 0.142 | 0.674 | 1.529 | 0.308 | 0.755 | 1.605 | 0.595 | 0.112 | 6.064
COVID19 (Custom Term) | Neuralgic amyotrophy | 6 | 9.507 | 0.328 | 0.674 | 1.12 | 0.387 | 0.688 | 1.151 | 0.631 | 0.523 | 2.013
COVID19 (Custom Term) | Loss of personal independence in daily activities | 129 | 198.947 | 0.58 | 0.674 | 0.773 | 0.564 | 0.652 | 0.75 | 0.648 | 0.429 | 94.023
COVID19 (Custom Term) | CSF white blood cell count positive | 0 | 0.64 | 0.064 | 0.674 | 1.831 |  |  |  |  |  | 
COVID19 (Custom Term) | Obsessive-compulsive symptom | 0 | 0.366 | 0.015 | 0.674 | 2.231 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pressure diastolic decreased | 0 | 0.457 | 0.03 | 0.674 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Senile dementia | 0 | 0.183 | 0 | 0.674 | 2.854 |  |  |  |  |  | 
COVID19 (Custom Term) | Alopecia universalis | 0 | 0.457 | 0.03 | 0.674 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Vital capacity decreased | 0 | 0.274 | 0.005 | 0.674 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Chelation therapy | 0 | 0.549 | 0.046 | 0.674 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure during pregnancy | 183 | 307.516 | 0.594 | 0.673 | 0.757 | 0.529 | 0.598 | 0.673 | 0.595 | 0.686 | 24.445
COVID19 (Custom Term) | Laryngomalacia | 0 | 0.64 | 0.063 | 0.673 | 1.831 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration joint abnormal | 0 | 0.549 | 0.046 | 0.673 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Acid base balance normal | 0 | 0.366 | 0.015 | 0.673 | 2.231 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchopulmonary dysplasia | 0 | 0.274 | 0.005 | 0.673 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-thyroid antibody negative | 0 | 0.488 | 0.035 | 0.673 | 2.014 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue haemorrhage | 0 | 0.64 | 0.063 | 0.673 | 1.831 |  |  |  |  |  | 
COVID19 (Custom Term) | Basilar migraine | 0 | 0.274 | 0.005 | 0.673 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective polysaccharide antibody deficiency | 0 | 0.457 | 0.03 | 0.673 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Oedema mucosal | 0 | 0.915 | 0.111 | 0.673 | 1.627 |  |  |  |  |  | 
COVID19 (Custom Term) | Antibody test negative | 4 | 8.2 | 0.252 | 0.672 | 1.256 | 0.307 | 0.594 | 1.061 | 0.488 | 0.079 | 41.398
COVID19 (Custom Term) | Borrelia test negative | 5 | 10.18 | 0.332 | 0.672 | 1.109 | 0.314 | 0.581 | 1.002 | 0.491 | 0.169 | 19.142
COVID19 (Custom Term) | Chronic tonsillitis | 0 | 0.274 | 0.005 | 0.672 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell morphology normal | 0 | 0.915 | 0.11 | 0.672 | 1.627 |  |  |  |  |  | 
COVID19 (Custom Term) | Tourette's disorder | 0 | 0.484 | 0.034 | 0.672 | 2.019 |  |  |  |  |  | 
COVID19 (Custom Term) | Product prescribing issue | 0 | 0.274 | 0.005 | 0.672 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bilirubin unconjugated decreased | 0 | 0.549 | 0.045 | 0.672 | 1.932 |  |  |  |  |  | 
COVID19 (Custom Term) | White blood cell morphology normal | 0 | 0.366 | 0.015 | 0.672 | 2.231 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral venous sinus thrombosis | 2 | 2.018 | 0.165 | 0.671 | 1.455 | 0.408 | 0.894 | 1.756 | 0.991 | 2.206 | 0.266
COVID19 (Custom Term) | Hypocoagulable state | 0 | 0.274 | 0.005 | 0.671 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Gynaecological examination normal | 0 | 0.366 | 0.014 | 0.67 | 2.232 |  |  |  |  |  | 
COVID19 (Custom Term) | Idiopathic pulmonary fibrosis | 0 | 0.457 | 0.028 | 0.67 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood testosterone normal | 0 | 0.457 | 0.028 | 0.67 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Underweight | 0 | 0.226 | 0.002 | 0.67 | 2.654 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint range of motion decreased | 78 | 141.454 | 0.551 | 0.669 | 0.798 | 0.464 | 0.559 | 0.668 | 0.551 | 0.589 | 20.846
COVID19 (Custom Term) | Otitis media acute | 0 | 0.45 | 0.027 | 0.669 | 2.073 |  |  |  |  |  | 
COVID19 (Custom Term) | Bite | 0 | 0.457 | 0.028 | 0.669 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystic fibrosis | 0 | 0.274 | 0.004 | 0.669 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Parakeratosis | 0 | 0.457 | 0.028 | 0.669 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray dental normal | 1 | 1.434 | 0.143 | 0.668 | 1.507 | 0.325 | 0.793 | 1.685 | 0.697 | 0.827 | 0.089
COVID19 (Custom Term) | Pneumomediastinum | 0 | 0.457 | 0.027 | 0.668 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Fluid replacement | 0 | 0.549 | 0.043 | 0.668 | 1.932 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperprolactinaemia | 0 | 0.274 | 0.004 | 0.668 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular headache | 0 | 0.366 | 0.014 | 0.668 | 2.232 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site haemorrhage | 0 | 0.457 | 0.028 | 0.668 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Multifocal motor neuropathy | 0 | 0.64 | 0.06 | 0.668 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint movement impairment | 3 | 5.991 | 0.26 | 0.667 | 1.226 | 0.306 | 0.627 | 1.168 | 0.501 | 0.408 | 1.889
COVID19 (Custom Term) | Ill-defined disorder | 3 | 6.95 | 0.246 | 0.667 | 1.256 | 0.277 | 0.569 | 1.062 | 0.432 | 0.195 | 8.955
COVID19 (Custom Term) | Urinary hesitation | 0 | 0.64 | 0.059 | 0.667 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephritis | 0 | 0.326 | 0.009 | 0.667 | 2.329 |  |  |  |  |  | 
COVID19 (Custom Term) | Borrelia test positive | 0 | 0.437 | 0.024 | 0.667 | 2.095 |  |  |  |  |  | 
COVID19 (Custom Term) | Interleukin-2 receptor increased | 0 | 0.457 | 0.027 | 0.667 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Medication errors (SMQ) [narrow] | 718 | 1160.885 | 0.626 | 0.666 | 0.708 | 0.582 | 0.619 | 0.658 | 0.618 | 0.098 | 7514.981
COVID19 (Custom Term) | Treponema test | 7 | 14.711 | 0.318 | 0.666 | 1.119 | 0.316 | 0.547 | 0.893 | 0.476 | 1.58 | 0.793
COVID19 (Custom Term) | Horner's syndrome | 0 | 0.549 | 0.042 | 0.666 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Personal relationship issue | 0 | 0.457 | 0.027 | 0.666 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Megakaryocytes | 0 | 0.366 | 0.013 | 0.666 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycobacterial infection | 0 | 0.366 | 0.013 | 0.666 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella virus test | 0 | 0.458 | 0.027 | 0.666 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual acuity tests abnormal | 1 | 2.043 | 0.069 | 0.665 | 1.777 | 0.286 | 0.705 | 1.502 | 0.489 | 0.242 | 1.572
COVID19 (Custom Term) | Tympanometry abnormal | 0 | 0.457 | 0.026 | 0.665 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Alveolitis | 0 | 0.274 | 0.004 | 0.665 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Serous retinal detachment | 0 | 0.366 | 0.013 | 0.665 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | pH body fluid normal | 0 | 0.316 | 0.008 | 0.665 | 2.355 |  |  |  |  |  | 
COVID19 (Custom Term) | Opsoclonus myoclonus | 0 | 0.366 | 0.013 | 0.665 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Natural killer cell count decreased | 0 | 0.366 | 0.013 | 0.665 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Bed rest | 4 | 7.017 | 0.304 | 0.664 | 1.136 | 0.342 | 0.661 | 1.179 | 0.57 | 0.423 | 2.45
COVID19 (Custom Term) | Hypertransaminasaemia | 0 | 0.674 | 0.063 | 0.664 | 1.8 |  |  |  |  |  | 
COVID19 (Custom Term) | Selective IgM immunodeficiency | 0 | 0.274 | 0.004 | 0.664 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningoencephalitis viral | 0 | 0.381 | 0.015 | 0.664 | 2.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyomyositis | 0 | 0.274 | 0.004 | 0.664 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy gastrointestinal | 0 | 0.549 | 0.041 | 0.664 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia necrotising | 0 | 0.274 | 0.004 | 0.664 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Penis disorder | 0 | 0.457 | 0.026 | 0.664 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | HLA marker study positive | 1 | 1.102 | 0.049 | 0.663 | 1.875 | 0.35 | 0.852 | 1.806 | 0.908 | 0.195 | 2.456
COVID19 (Custom Term) | CSF test | 3 | 6.668 | 0.233 | 0.663 | 1.272 | 0.285 | 0.585 | 1.091 | 0.45 | 0.224 | 7.078
COVID19 (Custom Term) | Enterobacter test positive | 0 | 0.366 | 0.013 | 0.663 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Fracture treatment | 0 | 0.274 | 0.004 | 0.663 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Parainfluenzae virus infection | 0 | 0.663 | 0.061 | 0.663 | 1.811 |  |  |  |  |  | 
COVID19 (Custom Term) | Myocardial reperfusion injury | 0 | 0.64 | 0.057 | 0.663 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypospadias | 0 | 0.457 | 0.026 | 0.663 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound treatment | 0 | 0.871 | 0.096 | 0.663 | 1.653 |  |  |  |  |  | 
COVID19 (Custom Term) | Negativism | 0 | 0.549 | 0.041 | 0.663 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 2 globulin | 0 | 0.457 | 0.025 | 0.662 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Pulmonary physical examination normal | 0 | 0.549 | 0.041 | 0.662 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan myocardial perfusion abnormal | 0 | 0.274 | 0.004 | 0.662 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Choroiditis | 0 | 0.549 | 0.04 | 0.662 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Pituitary tumour benign | 0 | 0.366 | 0.013 | 0.662 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF neutrophil count | 0 | 0.366 | 0.012 | 0.662 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Device related infection | 0 | 0.732 | 0.071 | 0.661 | 1.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site ulcer | 0 | 0.549 | 0.04 | 0.66 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropathic muscular atrophy | 0 | 0.549 | 0.039 | 0.66 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-GAD antibody negative | 0 | 0.457 | 0.025 | 0.66 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrophoresis protein normal | 1 | 1.395 | 0.088 | 0.659 | 1.671 | 0.328 | 0.8 | 1.698 | 0.717 | 0.276 | 1.156
COVID19 (Custom Term) | Electrophoresis protein | 1 | 3.493 | 0.194 | 0.659 | 1.348 | 0.217 | 0.552 | 1.193 | 0.286 | 0.473 | 0.144
COVID19 (Custom Term) | Gastrointestinal obstruction | 0 | 0.457 | 0.024 | 0.659 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Bursitis infective | 0 | 0.274 | 0.004 | 0.659 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Human herpesvirus 6 infection | 0 | 0.366 | 0.012 | 0.659 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Human rhinovirus test positive | 0 | 0.828 | 0.086 | 0.659 | 1.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipaemic index score | 0 | 0.274 | 0.004 | 0.659 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | High-pitched crying | 0 | 0.464 | 0.025 | 0.659 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth loss | 0 | 0.622 | 0.051 | 0.659 | 1.851 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum amyloid A protein increased | 0 | 0.366 | 0.012 | 0.659 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystitis noninfective | 0 | 0.549 | 0.039 | 0.659 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Pituitary cyst | 0 | 0.274 | 0.003 | 0.658 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary sediment | 0 | 0.274 | 0.003 | 0.658 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema eyelids | 0 | 0.274 | 0.003 | 0.658 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute lymphocytic leukaemia | 0 | 0.844 | 0.087 | 0.658 | 1.669 |  |  |  |  |  | 
COVID19 (Custom Term) | Haematology test abnormal | 0 | 0.64 | 0.053 | 0.657 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichen striatus | 0 | 0.274 | 0.003 | 0.657 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Bleeding time prolonged | 0 | 0.366 | 0.011 | 0.657 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Post vaccination challenge strain shedding | 0 | 0.274 | 0.003 | 0.657 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdomen scan normal | 0 | 0.201 | 0.001 | 0.657 | 2.766 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray gastrointestinal tract normal | 0 | 0.253 | 0.002 | 0.657 | 2.553 |  |  |  |  |  | 
COVID19 (Custom Term) | Corneal oedema | 1 | 1.528 | 0.105 | 0.656 | 1.596 | 0.319 | 0.778 | 1.653 | 0.654 | 0.764 | 0.041
COVID19 (Custom Term) | Conjunctival hyperaemia | 1 | 2.024 | 0.189 | 0.656 | 1.353 | 0.287 | 0.707 | 1.507 | 0.494 | 0.155 | 3.661
COVID19 (Custom Term) | Injection site discharge | 1 | 3.79 | 0.203 | 0.656 | 1.317 | 0.205 | 0.527 | 1.145 | 0.264 | 0.074 | 10.598
COVID19 (Custom Term) | Sweat test abnormal | 0 | 0.366 | 0.011 | 0.656 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine flow decreased | 0 | 0.64 | 0.053 | 0.656 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair texture abnormal | 0 | 0.161 | 0 | 0.656 | 2.981 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulomatosis with polyangiitis | 0 | 0.549 | 0.038 | 0.656 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs test positive | 0 | 0.549 | 0.038 | 0.656 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Calcinosis | 0 | 0.64 | 0.053 | 0.656 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Langerhans' cell histiocytosis | 0 | 0.366 | 0.011 | 0.656 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Aldolase increased | 0 | 0.457 | 0.023 | 0.656 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Foreign body | 0 | 0.457 | 0.023 | 0.656 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Seborrhoeic keratosis | 0 | 0.549 | 0.037 | 0.656 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenotonsillectomy | 0 | 0.549 | 0.037 | 0.655 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxine free increased | 0 | 0.457 | 0.023 | 0.655 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute haemorrhagic leukoencephalitis | 0 | 0.274 | 0.003 | 0.655 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Reflex test normal | 0 | 0.421 | 0.018 | 0.655 | 2.125 |  |  |  |  |  | 
COVID19 (Custom Term) | Fontanelle bulging | 0 | 0.526 | 0.033 | 0.655 | 1.963 |  |  |  |  |  | 
COVID19 (Custom Term) | Shoulder arthroplasty | 0 | 0.457 | 0.023 | 0.654 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Matrix metalloproteinase-3 increased | 0 | 0.274 | 0.003 | 0.654 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetic neuropathy | 0 | 0.64 | 0.052 | 0.654 | 1.833 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin saturation | 0 | 0.64 | 0.052 | 0.654 | 1.833 |  |  |  |  |  | 
COVID19 (Custom Term) | Somnambulism | 0 | 0.778 | 0.074 | 0.654 | 1.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema nodosum | 2 | 2.153 | 0.178 | 0.653 | 1.37 | 0.398 | 0.872 | 1.714 | 0.929 | 0.414 | 1.036
COVID19 (Custom Term) | Alpha 1 foetoprotein abnormal | 0 | 0.366 | 0.011 | 0.653 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | JC polyomavirus test negative | 0 | 0.366 | 0.011 | 0.653 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Squamous cell carcinoma of the cervix | 0 | 0.274 | 0.003 | 0.653 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Ear infection viral | 0 | 0.732 | 0.066 | 0.653 | 1.751 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryoglobulinaemia | 0 | 0.182 | 0 | 0.652 | 2.858 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site reaction | 0 | 1.03 | 0.111 | 0.652 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Bartonella test positive | 0 | 0.274 | 0.003 | 0.652 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood oestrogen increased | 0 | 0.274 | 0.003 | 0.652 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma stage II | 0 | 0.274 | 0.003 | 0.652 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood oestrogen decreased | 0 | 0.274 | 0.003 | 0.652 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Androgens increased | 0 | 0.274 | 0.003 | 0.652 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Body temperature normal | 3 | 2.986 | 0.249 | 0.651 | 1.206 | 0.449 | 0.914 | 1.701 | 1.005 | 2.708 | 1.277
COVID19 (Custom Term) | Cataract | 2 | 3.757 | 0.183 | 0.651 | 1.354 | 0.308 | 0.68 | 1.339 | 0.532 | 0.552 | 0.302
COVID19 (Custom Term) | Parenteral nutrition | 0 | 0.27 | 0.003 | 0.651 | 2.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B virus test | 0 | 0.609 | 0.045 | 0.651 | 1.865 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood selenium decreased | 0 | 0.457 | 0.022 | 0.651 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder sphincter atony | 0 | 0.366 | 0.01 | 0.651 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Anorectal manometry | 0 | 0.366 | 0.01 | 0.651 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis acute | 1 | 1.427 | 0.101 | 0.65 | 1.593 | 0.326 | 0.795 | 1.687 | 0.701 | 0.368 | 0.485
COVID19 (Custom Term) | Ultrasound breast normal | 0 | 0.366 | 0.01 | 0.65 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Sandifer's syndrome | 0 | 0.366 | 0.01 | 0.65 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal ulcer | 0 | 0.64 | 0.049 | 0.649 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertrophy | 0 | 0.64 | 0.049 | 0.649 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Candida test | 0 | 0.274 | 0.003 | 0.649 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Suspected transmission of an infectious agent via product | 0 | 0.732 | 0.064 | 0.649 | 1.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Low density lipoprotein increased | 4 | 4.482 | 0.263 | 0.648 | 1.172 | 0.45 | 0.869 | 1.549 | 0.892 | 2.206 | 1.209
COVID19 (Custom Term) | Still's disease | 0 | 0.62 | 0.045 | 0.648 | 1.853 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubber sensitivity | 0 | 1.01 | 0.105 | 0.648 | 1.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteomyelitis chronic | 0 | 0.274 | 0.003 | 0.648 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle contusion | 0 | 0.457 | 0.021 | 0.648 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord infection | 0 | 0.549 | 0.034 | 0.648 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Retrograde amnesia | 0 | 0.549 | 0.034 | 0.648 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocytic infiltration | 0 | 0.481 | 0.024 | 0.647 | 2.026 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound thyroid normal | 0 | 0.732 | 0.062 | 0.647 | 1.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Adhesiolysis | 0 | 0.274 | 0.003 | 0.647 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Metamyelocyte count | 0 | 0.457 | 0.02 | 0.647 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Face presentation | 0 | 0.274 | 0.003 | 0.647 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral venous thrombosis | 0 | 0.457 | 0.02 | 0.647 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Monoparesis | 1 | 2.05 | 0.068 | 0.646 | 1.719 | 0.286 | 0.704 | 1.5 | 0.488 | 0.15 | 3.85
COVID19 (Custom Term) | Antithrombin III increased | 0 | 0.366 | 0.009 | 0.646 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal pseudo-obstruction | 0 | 0.274 | 0.003 | 0.646 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound ovary | 0 | 0.366 | 0.009 | 0.646 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Cancer in remission | 0 | 0.64 | 0.048 | 0.646 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyrotoxic crisis | 0 | 0.457 | 0.02 | 0.646 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Eustachian tube dysfunction | 0 | 0.549 | 0.033 | 0.646 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Tibia fracture | 0 | 0.549 | 0.033 | 0.646 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Multiple sclerosis | 3 | 6.707 | 0.196 | 0.645 | 1.305 | 0.283 | 0.582 | 1.087 | 0.447 | 0.091 | 26.002
COVID19 (Custom Term) | No adverse event | 178 | 372.067 | 0.568 | 0.645 | 0.727 | 0.426 | 0.482 | 0.544 | 0.478 | 0.031 | 6370.989
COVID19 (Custom Term) | Ear operation | 0 | 0.457 | 0.02 | 0.645 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Insulin C-peptide | 0 | 0.457 | 0.02 | 0.645 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital herpes simplex | 0 | 0.457 | 0.02 | 0.645 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint irrigation | 0 | 0.471 | 0.022 | 0.645 | 2.043 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein | 0 | 0.457 | 0.02 | 0.645 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningeal disorder | 0 | 0.461 | 0.02 | 0.645 | 2.058 |  |  |  |  |  | 
COVID19 (Custom Term) | Paracentesis eye abnormal | 0 | 0.457 | 0.02 | 0.645 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Menopausal symptoms | 0 | 0.366 | 0.009 | 0.645 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Purulent discharge | 1 | 1.808 | 0.157 | 0.644 | 1.4 | 0.3 | 0.737 | 1.567 | 0.553 | 0.092 | 7.926
COVID19 (Custom Term) | Blister | 59 | 112.338 | 0.514 | 0.644 | 0.785 | 0.432 | 0.535 | 0.656 | 0.525 | 0.196 | 191.095
COVID19 (Custom Term) | Non-small cell lung cancer | 0 | 0.274 | 0.002 | 0.644 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Mevalonate kinase deficiency | 0 | 0.274 | 0.002 | 0.644 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | DNA antibody positive | 0 | 0.457 | 0.02 | 0.644 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Agranulocytosis | 0 | 0.2 | 0 | 0.644 | 2.771 |  |  |  |  |  | 
COVID19 (Custom Term) | Donor specific antibody present | 0 | 0.274 | 0.002 | 0.644 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical radiculopathy | 1 | 2.034 | 0.174 | 0.643 | 1.351 | 0.287 | 0.706 | 1.504 | 0.492 | 0.451 | 0.191
COVID19 (Custom Term) | Parophthalmia | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Serositis | 0 | 0.457 | 0.019 | 0.643 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypothalamo-pituitary disorder | 0 | 0.457 | 0.019 | 0.643 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Squamous cell carcinoma of lung | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold-stimulus headache | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Atypical haemolytic uraemic syndrome | 0 | 0.64 | 0.046 | 0.643 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Light chain analysis increased | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthroscopy abnormal | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal vasculitis | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatic disorder | 0 | 0.758 | 0.064 | 0.643 | 1.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute vestibular syndrome | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchomalacia | 0 | 0.274 | 0.002 | 0.643 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual analogue scale | 0 | 0.549 | 0.032 | 0.642 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal abscess | 0 | 0.823 | 0.073 | 0.642 | 1.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bilirubin unconjugated increased | 0 | 0.23 | 0.001 | 0.642 | 2.638 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic colitis | 0 | 0.274 | 0.002 | 0.641 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte percentage normal | 0 | 0.549 | 0.031 | 0.641 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin operation | 0 | 0.64 | 0.045 | 0.641 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine increased | 0 | 0.549 | 0.031 | 0.641 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary tract infection neonatal | 0 | 0.274 | 0.002 | 0.641 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site induration | 0 | 0.699 | 0.054 | 0.641 | 1.778 |  |  |  |  |  | 
COVID19 (Custom Term) | Defaecation disorder | 0 | 0.64 | 0.045 | 0.641 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood alcohol | 0 | 0.732 | 0.059 | 0.641 | 1.749 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood group O | 0 | 0.549 | 0.031 | 0.641 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Otoscopy abnormal | 0 | 0.549 | 0.031 | 0.641 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Inflammation | 68 | 113.016 | 0.522 | 0.64 | 0.768 | 0.499 | 0.609 | 0.737 | 0.602 | 0.403 | 57.424
COVID19 (Custom Term) | Injection site laceration | 0 | 0.274 | 0.002 | 0.64 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctivitis bacterial | 0 | 0.64 | 0.044 | 0.64 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Radioallergosorbent test positive | 0 | 0.457 | 0.019 | 0.64 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation time prolonged | 0 | 0.549 | 0.031 | 0.64 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Shock symptom | 3 | 3.129 | 0.239 | 0.639 | 1.195 | 0.439 | 0.895 | 1.665 | 0.959 | 1.192 | 0.002
COVID19 (Custom Term) | Obsessive-compulsive disorder | 1 | 2.402 | 0.168 | 0.639 | 1.358 | 0.267 | 0.66 | 1.411 | 0.416 | 0.155 | 3.661
COVID19 (Custom Term) | Cholestasis | 0 | 0.426 | 0.014 | 0.639 | 2.117 |  |  |  |  |  | 
COVID19 (Custom Term) | Microcytosis | 0 | 0.549 | 0.03 | 0.639 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropsychological test abnormal | 0 | 0.549 | 0.031 | 0.639 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood triglycerides | 0 | 0.549 | 0.03 | 0.638 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytomegalovirus viraemia | 0 | 0.366 | 0.008 | 0.638 | 2.237 |  |  |  |  |  | 
COVID19 (Custom Term) | Eating disorder symptom | 0 | 0.274 | 0.002 | 0.638 | 2.48 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site joint erythema | 0 | 0.457 | 0.018 | 0.638 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Post-tussive vomiting | 0 | 0.543 | 0.029 | 0.638 | 1.942 |  |  |  |  |  | 
COVID19 (Custom Term) | Throat lesion | 0 | 0.549 | 0.03 | 0.638 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Ligament pain | 1 | 1.552 | 0.112 | 0.637 | 1.516 | 0.317 | 0.775 | 1.646 | 0.644 | 0.903 | 0.162
COVID19 (Custom Term) | Acne | 4 | 8.418 | 0.261 | 0.637 | 1.147 | 0.301 | 0.583 | 1.042 | 0.475 | 0.14 | 19.864
COVID19 (Custom Term) | Skin fragility | 0 | 0.366 | 0.008 | 0.637 | 2.237 |  |  |  |  |  | 
COVID19 (Custom Term) | Extravasation | 0 | 0.183 | 0 | 0.637 | 2.85 |  |  |  |  |  | 
COVID19 (Custom Term) | Ophthalmic herpes zoster | 3 | 14.917 | 0.184 | 0.636 | 1.309 | 0.143 | 0.315 | 0.602 | 0.201 | 0.062 | 41.504
COVID19 (Custom Term) | Trisomy 21 | 0 | 0.549 | 0.029 | 0.636 | 1.934 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lactate | 0 | 0.296 | 0.003 | 0.636 | 2.413 |  |  |  |  |  | 
COVID19 (Custom Term) | Focal segmental glomerulosclerosis | 0 | 0.457 | 0.017 | 0.636 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Streptococcal bacteraemia | 0 | 0.2 | 0 | 0.635 | 2.768 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF immunoglobulin increased | 1 | 1.127 | 0.083 | 0.634 | 1.612 | 0.348 | 0.847 | 1.796 | 0.887 | 0.621 | 0.002
COVID19 (Custom Term) | Human metapneumovirus test positive | 0 | 0.375 | 0.008 | 0.634 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Laparotomy | 0 | 0.249 | 0.001 | 0.634 | 2.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Granular cell tumour | 0 | 0.274 | 0.002 | 0.634 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal vein compression | 0 | 0.183 | 0 | 0.634 | 2.849 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF oligoclonal band absent | 0 | 0.579 | 0.033 | 0.634 | 1.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin M | 5 | 7.935 | 0.306 | 0.633 | 1.056 | 0.376 | 0.695 | 1.198 | 0.63 | 0.973 | 0.03
COVID19 (Custom Term) | Cutaneous tuberculosis | 0 | 0.366 | 0.007 | 0.633 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Computerised tomogram kidney abnormal | 0 | 0.549 | 0.028 | 0.633 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Food allergy | 5 | 9.888 | 0.296 | 0.632 | 1.071 | 0.321 | 0.594 | 1.024 | 0.506 | 0.171 | 18.852
COVID19 (Custom Term) | Product packaging confusion | 0 | 0.344 | 0.006 | 0.632 | 2.286 |  |  |  |  |  | 
COVID19 (Custom Term) | Escherichia pyelonephritis | 0 | 0.274 | 0.002 | 0.632 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system inflammation | 0 | 0.814 | 0.066 | 0.632 | 1.686 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipodystrophy (SMQ) [narrow] | 0 | 0.732 | 0.054 | 0.632 | 1.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis membranous | 0 | 0.274 | 0.002 | 0.632 | 2.479 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculin test negative | 0 | 0.371 | 0.007 | 0.631 | 2.225 |  |  |  |  |  | 
COVID19 (Custom Term) | CD8 lymphocytes increased | 0 | 0.64 | 0.04 | 0.631 | 1.831 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypohidrosis | 0 | 0.732 | 0.053 | 0.631 | 1.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Dissociative disorder | 3 | 3.489 | 0.241 | 0.63 | 1.168 | 0.416 | 0.849 | 1.58 | 0.86 | 2.291 | 0.807
COVID19 (Custom Term) | Takayasu's arteritis | 0 | 0.549 | 0.027 | 0.63 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Systemic lupus erythematosus rash | 0 | 0.366 | 0.007 | 0.63 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy upper gastrointestinal tract abnormal | 0 | 0.973 | 0.086 | 0.63 | 1.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Emotional poverty | 0 | 0.442 | 0.014 | 0.63 | 2.089 |  |  |  |  |  | 
COVID19 (Custom Term) | Alopecia | 10 | 18.561 | 0.354 | 0.629 | 0.968 | 0.365 | 0.587 | 0.906 | 0.539 | 0.225 | 25.375
COVID19 (Custom Term) | Endocrine test abnormal | 0 | 0.366 | 0.007 | 0.629 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin G abnormal | 0 | 0.457 | 0.016 | 0.629 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Disease progression | 0 | 0.366 | 0.007 | 0.629 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Salmonellosis | 0 | 0.215 | 0 | 0.629 | 2.698 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-neuronal antibody negative | 0 | 0.64 | 0.039 | 0.629 | 1.83 |  |  |  |  |  | 
COVID19 (Custom Term) | Carcinoma in situ | 0 | 0.366 | 0.007 | 0.629 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-Muellerian hormone level decreased | 0 | 0.366 | 0.007 | 0.628 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Gene mutation | 0 | 0.687 | 0.046 | 0.628 | 1.786 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor C3 decreased | 0 | 0.333 | 0.004 | 0.628 | 2.313 |  |  |  |  |  | 
COVID19 (Custom Term) | Labour induction | 0 | 0.457 | 0.015 | 0.628 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Cyst aspiration | 0 | 0.366 | 0.007 | 0.627 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Kinesitherapy | 0 | 0.366 | 0.007 | 0.627 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site injury | 0 | 0.823 | 0.064 | 0.627 | 1.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Campylobacter test positive | 0 | 0.309 | 0.003 | 0.626 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Superinfection bacterial | 0 | 0.732 | 0.051 | 0.626 | 1.747 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergic respiratory disease | 0 | 0.366 | 0.006 | 0.626 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Helplessness | 0 | 0.366 | 0.006 | 0.626 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray dental abnormal | 0 | 0.549 | 0.026 | 0.626 | 1.932 |  |  |  |  |  | 
COVID19 (Custom Term) | Acinetobacter test positive | 0 | 0.457 | 0.015 | 0.625 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral skin infection | 0 | 0.366 | 0.006 | 0.625 | 2.236 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobin urine present | 0 | 0.732 | 0.05 | 0.625 | 1.747 |  |  |  |  |  | 
COVID19 (Custom Term) | Electromyogram abnormal | 8 | 15.365 | 0.323 | 0.624 | 1.006 | 0.345 | 0.581 | 0.928 | 0.521 | 0.314 | 10.912
COVID19 (Custom Term) | Vitamin C normal | 0 | 0.274 | 0.001 | 0.624 | 2.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound bladder normal | 0 | 0.366 | 0.006 | 0.624 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Inner ear inflammation | 0 | 0.457 | 0.014 | 0.624 | 2.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Radiculitis brachial | 4 | 7.369 | 0.247 | 0.623 | 1.138 | 0.331 | 0.64 | 1.141 | 0.543 | 0.63 | 0.477
COVID19 (Custom Term) | Foetal disorders (SMQ) [narrow] | 24 | 46.824 | 0.431 | 0.623 | 0.844 | 0.387 | 0.536 | 0.727 | 0.513 | 0.747 | 1.664
COVID19 (Custom Term) | Temporal lobe epilepsy | 0 | 0.64 | 0.037 | 0.623 | 1.829 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperemesis gravidarum | 0 | 0.366 | 0.006 | 0.623 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Toe walking | 0 | 0.393 | 0.008 | 0.623 | 2.178 |  |  |  |  |  | 
COVID19 (Custom Term) | Walking disability | 1 | 1.496 | 0.087 | 0.622 | 1.562 | 0.321 | 0.784 | 1.664 | 0.668 | 0.584 | 0.014
COVID19 (Custom Term) | Blood iron normal | 1 | 3.028 | 0.192 | 0.622 | 1.251 | 0.237 | 0.594 | 1.277 | 0.33 | 0.284 | 1.076
COVID19 (Custom Term) | Blindness cortical | 0 | 0.457 | 0.014 | 0.622 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Intracranial infection | 0 | 0.274 | 0.001 | 0.622 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Gamma-glutamyltransferase normal | 0 | 0.808 | 0.059 | 0.622 | 1.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain scan abnormal | 0 | 0.615 | 0.033 | 0.622 | 1.855 |  |  |  |  |  | 
COVID19 (Custom Term) | Alopecia areata | 0 | 0.881 | 0.069 | 0.622 | 1.639 |  |  |  |  |  | 
COVID19 (Custom Term) | Oropharyngeal plaque | 0 | 0.549 | 0.024 | 0.622 | 1.932 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral parotitis | 0 | 0.274 | 0.001 | 0.621 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lactate decreased | 0 | 0.274 | 0.001 | 0.621 | 2.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral infection | 6 | 10.038 | 0.342 | 0.62 | 0.966 | 0.371 | 0.661 | 1.107 | 0.598 | 0.101 | 46.351
COVID19 (Custom Term) | Vestibular function test normal | 0 | 0.366 | 0.006 | 0.62 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Lordosis | 0 | 0.64 | 0.035 | 0.62 | 1.829 |  |  |  |  |  | 
COVID19 (Custom Term) | Soliloquy | 0 | 0.366 | 0.006 | 0.62 | 2.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Fixed eruption | 0 | 0.64 | 0.035 | 0.619 | 1.829 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema herpeticum | 0 | 0.549 | 0.024 | 0.619 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QT interval normal | 0 | 0.549 | 0.024 | 0.619 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuritis | 2 | 4.971 | 0.178 | 0.618 | 1.272 | 0.262 | 0.582 | 1.149 | 0.402 | 0.248 | 3.673
COVID19 (Custom Term) | Hepatitis B antibody abnormal | 0 | 0.274 | 0.001 | 0.618 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Tongue injury | 0 | 0.64 | 0.034 | 0.618 | 1.828 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone scan abnormal | 0 | 0.904 | 0.069 | 0.618 | 1.623 |  |  |  |  |  | 
COVID19 (Custom Term) | Infertility male | 0 | 0.366 | 0.005 | 0.618 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site erythema | 0 | 0.592 | 0.029 | 0.618 | 1.88 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV infection | 0 | 0.732 | 0.047 | 0.618 | 1.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombocytopenia neonatal | 0 | 0.274 | 0.001 | 0.617 | 2.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin injury | 0 | 0.482 | 0.015 | 0.617 | 2.023 |  |  |  |  |  | 
COVID19 (Custom Term) | Laparoscopy | 0 | 0.366 | 0.005 | 0.617 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteochondritis | 0 | 0.366 | 0.005 | 0.617 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site warmth | 0 | 1.235 | 0.108 | 0.616 | 1.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy liver | 0 | 0.457 | 0.013 | 0.616 | 2.061 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood pyruvic acid | 0 | 0.549 | 0.023 | 0.616 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Spondylolisthesis | 0 | 0.732 | 0.046 | 0.616 | 1.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Campylobacter gastroenteritis | 0 | 0.64 | 0.033 | 0.615 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Portal tract inflammation | 0 | 0.274 | 0.001 | 0.615 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroidectomy | 0 | 0.549 | 0.022 | 0.615 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Plantar fasciitis | 0 | 0.64 | 0.033 | 0.615 | 1.828 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E virus test | 0 | 0.549 | 0.022 | 0.615 | 1.93 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray limb abnormal | 4 | 8.379 | 0.291 | 0.614 | 1.034 | 0.302 | 0.585 | 1.045 | 0.477 | 0.26 | 7.461
COVID19 (Custom Term) | Keratosis pilaris | 0 | 0.823 | 0.057 | 0.614 | 1.674 |  |  |  |  |  | 
COVID19 (Custom Term) | Chest crushing | 0 | 0.366 | 0.005 | 0.614 | 2.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Maternal condition affecting foetus | 0 | 0.274 | 0.001 | 0.614 | 2.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyspraxia | 0 | 0.672 | 0.037 | 0.614 | 1.797 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha haemolytic streptococcal infection | 0 | 0.366 | 0.005 | 0.614 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Pemphigus | 0 | 0.587 | 0.027 | 0.614 | 1.885 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosal discolouration | 0 | 0.64 | 0.033 | 0.613 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Palmar-plantar erythrodysaesthesia syndrome | 0 | 0.64 | 0.033 | 0.613 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic disorder | 0 | 0.366 | 0.005 | 0.613 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Fundus autofluorescence | 0 | 0.549 | 0.022 | 0.613 | 1.93 |  |  |  |  |  | 
COVID19 (Custom Term) | Urinary system x-ray normal | 0 | 0.64 | 0.032 | 0.613 | 1.827 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin test positive | 1 | 1.165 | 0.078 | 0.612 | 1.569 | 0.345 | 0.84 | 1.782 | 0.859 | 0.079 | 9.705
COVID19 (Custom Term) | Mucosal dryness | 0 | 0.703 | 0.04 | 0.612 | 1.768 |  |  |  |  |  | 
COVID19 (Custom Term) | Iron binding capacity total | 0 | 0.732 | 0.044 | 0.612 | 1.743 |  |  |  |  |  | 
COVID19 (Custom Term) | PFAPA syndrome | 0 | 0.457 | 0.012 | 0.611 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Fertility disorders (SMQ) [broad] | 18 | 23.256 | 0.397 | 0.61 | 0.86 | 0.54 | 0.783 | 1.105 | 0.774 | 0.342 | 21.317
COVID19 (Custom Term) | Histology normal | 0 | 0.274 | 0.001 | 0.61 | 2.473 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis autoimmune | 0 | 0.351 | 0.004 | 0.61 | 2.267 |  |  |  |  |  | 
COVID19 (Custom Term) | Dropped head syndrome | 0 | 0.549 | 0.021 | 0.61 | 1.929 |  |  |  |  |  | 
COVID19 (Custom Term) | Scrotal oedema | 0 | 0.366 | 0.005 | 0.61 | 2.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Radioisotope scan | 0 | 0.422 | 0.008 | 0.61 | 2.121 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteochondrosis | 0 | 0.549 | 0.021 | 0.61 | 1.929 |  |  |  |  |  | 
COVID19 (Custom Term) | Matrix metalloproteinase-3 | 0 | 0.274 | 0.001 | 0.61 | 2.473 |  |  |  |  |  | 
COVID19 (Custom Term) | Histone antibody positive | 0 | 0.366 | 0.005 | 0.609 | 2.232 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteonecrosis | 0 | 0.823 | 0.054 | 0.609 | 1.673 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site cyst | 0 | 1.865 | 0.161 | 0.609 | 1.29 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononeuropathy multiplex | 0 | 0.457 | 0.011 | 0.609 | 2.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Localised infection | 3 | 7.188 | 0.222 | 0.608 | 1.149 | 0.27 | 0.556 | 1.038 | 0.417 | 0.286 | 4.45
COVID19 (Custom Term) | Bone scan | 0 | 0.909 | 0.064 | 0.608 | 1.617 |  |  |  |  |  | 
COVID19 (Custom Term) | pH body fluid decreased | 0 | 0.172 | 0 | 0.608 | 2.884 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound liver | 0 | 0.915 | 0.065 | 0.608 | 1.614 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature rupture of membranes | 2 | 3.511 | 0.135 | 0.607 | 1.354 | 0.32 | 0.704 | 1.386 | 0.57 | 1.045 | 0.102
COVID19 (Custom Term) | Foetal disorders (SMQ) [broad] | 24 | 46.846 | 0.42 | 0.607 | 0.823 | 0.386 | 0.536 | 0.727 | 0.512 | 0.733 | 1.906
COVID19 (Custom Term) | Pseudolymphoma | 0 | 0.549 | 0.02 | 0.607 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemangioma of bone | 0 | 0.64 | 0.03 | 0.607 | 1.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiotensin converting enzyme increased | 0 | 0.732 | 0.041 | 0.607 | 1.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Escherichia test | 0 | 0.64 | 0.03 | 0.607 | 1.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal renal imaging abnormal | 0 | 0.274 | 0.001 | 0.607 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Acne cystic | 0 | 0.457 | 0.011 | 0.606 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombotic microangiopathy | 0 | 0.823 | 0.052 | 0.606 | 1.672 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune nephritis | 0 | 0.274 | 0.001 | 0.606 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue disorder | 0 | 0.823 | 0.052 | 0.606 | 1.672 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve injury | 9 | 19.357 | 0.35 | 0.605 | 0.916 | 0.318 | 0.523 | 0.821 | 0.465 | 0.401 | 7.136
COVID19 (Custom Term) | Allergy to vaccine | 9 | 20.237 | 0.322 | 0.605 | 0.96 | 0.306 | 0.504 | 0.791 | 0.445 | 0.183 | 31.468
COVID19 (Custom Term) | Nasal flaring | 0 | 0.64 | 0.03 | 0.605 | 1.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal examination normal | 0 | 0.64 | 0.03 | 0.605 | 1.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphoid tissue hyperplasia | 0 | 0.366 | 0.004 | 0.605 | 2.231 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycobacterium avium complex infection | 0 | 0.274 | 0.001 | 0.605 | 2.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood lead increased | 0 | 0.457 | 0.011 | 0.605 | 2.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint effusion | 2 | 4.606 | 0.221 | 0.604 | 1.138 | 0.274 | 0.609 | 1.201 | 0.434 | 0.248 | 3.673
COVID19 (Custom Term) | Seroma | 0 | 0.64 | 0.029 | 0.604 | 1.824 |  |  |  |  |  | 
COVID19 (Custom Term) | Prothrombin time ratio increased | 0 | 0.274 | 0.001 | 0.604 | 2.47 |  |  |  |  |  | 
COVID19 (Custom Term) | Sudden onset of sleep | 0 | 0.475 | 0.012 | 0.604 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | Epiglottic oedema | 0 | 0.549 | 0.019 | 0.604 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Swallow study | 2 | 1.991 | 0.188 | 0.603 | 1.208 | 0.41 | 0.898 | 1.764 | 1.005 | 1.324 | 0.002
COVID19 (Custom Term) | Listless | 2 | 3.88 | 0.175 | 0.603 | 1.24 | 0.303 | 0.669 | 1.317 | 0.516 | 0.071 | 23.283
COVID19 (Custom Term) | Logorrhoea | 0 | 0.549 | 0.019 | 0.603 | 1.927 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood ketone body absent | 0 | 0.732 | 0.04 | 0.603 | 1.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-insulin antibody positive | 0 | 0.183 | 0 | 0.603 | 2.826 |  |  |  |  |  | 
COVID19 (Custom Term) | Restrictive pulmonary disease | 0 | 0.366 | 0.004 | 0.602 | 2.23 |  |  |  |  |  | 
COVID19 (Custom Term) | Otitis media bacterial | 0 | 0.274 | 0.001 | 0.602 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Asterixis | 0 | 0.479 | 0.012 | 0.602 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site pruritus | 0 | 0.274 | 0.001 | 0.602 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Albumin globulin ratio increased | 0 | 0.366 | 0.004 | 0.602 | 2.23 |  |  |  |  |  | 
COVID19 (Custom Term) | Pathogen resistance | 0 | 0.274 | 0.001 | 0.602 | 2.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Bloody discharge | 0 | 0.64 | 0.029 | 0.602 | 1.824 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound antenatal screen abnormal | 9 | 17.934 | 0.319 | 0.601 | 0.955 | 0.339 | 0.558 | 0.875 | 0.502 | 0.941 | 0
COVID19 (Custom Term) | Chemotherapy | 3 | 6.937 | 0.226 | 0.601 | 1.122 | 0.277 | 0.569 | 1.063 | 0.432 | 0.224 | 7.078
COVID19 (Custom Term) | Oesophageal pH | 0 | 0.366 | 0.004 | 0.601 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal viral infection | 0 | 0.915 | 0.061 | 0.601 | 1.611 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocytosis | 0 | 0.366 | 0.004 | 0.601 | 2.23 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatitis exfoliative | 0 | 0.366 | 0.004 | 0.601 | 2.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophilia | 2 | 2.73 | 0.136 | 0.6 | 1.333 | 0.361 | 0.792 | 1.557 | 0.733 | 0.382 | 1.327
COVID19 (Custom Term) | Opisthotonus | 1 | 1.879 | 0.14 | 0.6 | 1.322 | 0.296 | 0.727 | 1.547 | 0.532 | 0.049 | 17.286
COVID19 (Custom Term) | Sensitivity to weather change | 0 | 0.457 | 0.01 | 0.6 | 2.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Perfume sensitivity | 0 | 0.549 | 0.018 | 0.6 | 1.926 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillar exudate | 0 | 0.64 | 0.027 | 0.599 | 1.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic granulomatosis with polyangiitis | 0 | 0.732 | 0.038 | 0.599 | 1.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Anaesthesia | 0 | 0.823 | 0.049 | 0.599 | 1.669 |  |  |  |  |  | 
COVID19 (Custom Term) | Albuminuria | 0 | 0.457 | 0.01 | 0.599 | 2.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Accidental exposure to product | 2 | 3.424 | 0.158 | 0.598 | 1.267 | 0.324 | 0.713 | 1.403 | 0.584 | 0.078 | 20.588
COVID19 (Custom Term) | Vasculitis (SMQ) [broad] | 23 | 37.626 | 0.417 | 0.598 | 0.806 | 0.453 | 0.631 | 0.862 | 0.611 | 0.184 | 81.125
COVID19 (Custom Term) | CD4/CD8 ratio | 1 | 2.002 | 0.127 | 0.598 | 1.353 | 0.289 | 0.71 | 1.513 | 0.5 | 0.993 | 0.266
COVID19 (Custom Term) | Tonic posturing | 0 | 0.823 | 0.048 | 0.598 | 1.669 |  |  |  |  |  | 
COVID19 (Custom Term) | Microphthalmos | 0 | 0.274 | 0.001 | 0.598 | 2.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal muscular atrophy | 0 | 0.457 | 0.009 | 0.598 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Exostosis | 0 | 0.761 | 0.041 | 0.598 | 1.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital pulmonary hypertension | 0 | 0.183 | 0 | 0.597 | 2.819 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychiatric symptom | 0 | 0.771 | 0.042 | 0.597 | 1.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle injury | 0 | 1.43 | 0.114 | 0.597 | 1.391 |  |  |  |  |  | 
COVID19 (Custom Term) | Juvenile myoclonic epilepsy | 0 | 0.163 | 0 | 0.597 | 2.917 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythrodermic psoriasis | 0 | 0.457 | 0.009 | 0.597 | 2.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Axonal neuropathy | 0 | 0.631 | 0.026 | 0.597 | 1.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site swelling | 0 | 0.581 | 0.02 | 0.596 | 1.886 |  |  |  |  |  | 
COVID19 (Custom Term) | Heat stroke | 0 | 0.549 | 0.017 | 0.596 | 1.925 |  |  |  |  |  | 
COVID19 (Custom Term) | Gynaecomastia | 0 | 0.366 | 0.003 | 0.596 | 2.228 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatosplenomegaly | 0 | 0.786 | 0.043 | 0.596 | 1.695 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual evoked potentials | 0 | 0.732 | 0.036 | 0.595 | 1.737 |  |  |  |  |  | 
COVID19 (Custom Term) | Breech delivery | 0 | 0.274 | 0.001 | 0.595 | 2.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow oedema | 0 | 0.811 | 0.046 | 0.595 | 1.676 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound kidney normal | 0 | 1.054 | 0.073 | 0.595 | 1.534 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol withdrawal syndrome | 0 | 0.274 | 0.001 | 0.595 | 2.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration bone marrow normal | 0 | 0.64 | 0.026 | 0.595 | 1.821 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchitis chronic | 0 | 0.431 | 0.007 | 0.594 | 2.1 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem syndrome | 2 | 2.636 | 0.178 | 0.593 | 1.206 | 0.366 | 0.804 | 1.581 | 0.759 | 2.206 | 0.266
COVID19 (Custom Term) | Anti-cyclic citrullinated peptide antibody positive | 0 | 0.501 | 0.012 | 0.593 | 1.987 |  |  |  |  |  | 
COVID19 (Custom Term) | Squamous cell carcinoma | 0 | 0.571 | 0.018 | 0.593 | 1.896 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyoderma gangrenosum | 0 | 0.143 | 0 | 0.593 | 3.02 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunology test normal | 0 | 1.451 | 0.113 | 0.593 | 1.382 |  |  |  |  |  | 
COVID19 (Custom Term) | Prolonged pregnancy | 0 | 0.457 | 0.009 | 0.593 | 2.055 |  |  |  |  |  | 
COVID19 (Custom Term) | Lupus-like syndrome | 0 | 0.549 | 0.016 | 0.592 | 1.923 |  |  |  |  |  | 
COVID19 (Custom Term) | Cholangitis | 0 | 0.549 | 0.016 | 0.592 | 1.923 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensorimotor disorder | 0 | 0.223 | 0 | 0.592 | 2.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Internal hernia | 0 | 0.183 | 0 | 0.592 | 2.814 |  |  |  |  |  | 
COVID19 (Custom Term) | Band neutrophil count decreased | 0 | 0.732 | 0.035 | 0.591 | 1.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Cortisol decreased | 0 | 0.64 | 0.025 | 0.591 | 1.82 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyelocaliectasis | 0 | 0.484 | 0.01 | 0.591 | 2.012 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy lymph gland | 0 | 0.732 | 0.035 | 0.591 | 1.736 |  |  |  |  |  | 
COVID19 (Custom Term) | Tri-iodothyronine normal | 1 | 2 | 0.144 | 0.59 | 1.283 | 0.289 | 0.71 | 1.513 | 0.5 | 0.764 | 0.041
COVID19 (Custom Term) | Extra dose administered | 40 | 73.535 | 0.449 | 0.59 | 0.748 | 0.431 | 0.558 | 0.712 | 0.544 | 0.113 | 278.743
COVID19 (Custom Term) | Bursitis | 17 | 37.878 | 0.38 | 0.59 | 0.836 | 0.329 | 0.483 | 0.687 | 0.449 | 0.356 | 18.455
COVID19 (Custom Term) | Lymphocyte stimulation test | 0 | 0.183 | 0 | 0.59 | 2.812 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombin time normal | 0 | 0.274 | 0.001 | 0.59 | 2.462 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythroblast count | 0 | 0.64 | 0.025 | 0.59 | 1.82 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte percentage increased | 0 | 0.426 | 0.006 | 0.59 | 2.106 |  |  |  |  |  | 
COVID19 (Custom Term) | Radiotherapy | 1 | 2.209 | 0.121 | 0.589 | 1.346 | 0.277 | 0.684 | 1.458 | 0.453 | 0.301 | 0.918
COVID19 (Custom Term) | Physiotherapy | 0 | 0.457 | 0.008 | 0.589 | 2.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Rhinoscleroma | 0 | 0.366 | 0.003 | 0.588 | 2.224 |  |  |  |  |  | 
COVID19 (Custom Term) | Angular cheilitis | 0 | 0.549 | 0.015 | 0.588 | 1.922 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow failure | 0 | 0.518 | 0.012 | 0.588 | 1.963 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculin test | 1 | 2.247 | 0.107 | 0.587 | 1.383 | 0.275 | 0.679 | 1.449 | 0.445 | 0.226 | 1.832
COVID19 (Custom Term) | Incorrect route of product administration | 37 | 69.976 | 0.441 | 0.587 | 0.751 | 0.417 | 0.544 | 0.7 | 0.529 | 0.204 | 112.175
COVID19 (Custom Term) | Joint noise | 3 | 6.828 | 0.259 | 0.587 | 1.022 | 0.28 | 0.576 | 1.074 | 0.439 | 0.31 | 3.755
COVID19 (Custom Term) | Idiopathic urticaria | 0 | 0.64 | 0.023 | 0.587 | 1.818 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood iron increased | 0 | 0.732 | 0.033 | 0.587 | 1.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Smooth muscle antibody positive | 0 | 0.366 | 0.003 | 0.586 | 2.223 |  |  |  |  |  | 
COVID19 (Custom Term) | Exercise electrocardiogram | 0 | 0.823 | 0.043 | 0.586 | 1.664 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermal burns of eye | 0 | 0.823 | 0.043 | 0.586 | 1.663 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral vascular disorder | 1 | 2.233 | 0.076 | 0.585 | 1.493 | 0.276 | 0.681 | 1.452 | 0.448 | 0.191 | 2.547
COVID19 (Custom Term) | Immunology test | 3 | 6.996 | 0.201 | 0.585 | 1.131 | 0.275 | 0.566 | 1.057 | 0.429 | 0.11 | 20.543
COVID19 (Custom Term) | Treponema test positive | 0 | 0.915 | 0.053 | 0.585 | 1.604 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte transformation test | 0 | 0.274 | 0 | 0.585 | 2.459 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis Escherichia coli | 0 | 0.366 | 0.003 | 0.585 | 2.222 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal calprotectin normal | 0 | 0.64 | 0.023 | 0.585 | 1.817 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin wrinkling | 0 | 0.823 | 0.042 | 0.584 | 1.663 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte count normal | 0 | 0.915 | 0.052 | 0.584 | 1.603 |  |  |  |  |  | 
COVID19 (Custom Term) | Loss of proprioception | 2 | 2.494 | 0.132 | 0.583 | 1.295 | 0.375 | 0.823 | 1.618 | 0.802 | 1.324 | 0.002
COVID19 (Custom Term) | Acupuncture | 1 | 3.098 | 0.128 | 0.583 | 1.305 | 0.233 | 0.587 | 1.264 | 0.323 | 0.123 | 5.288
COVID19 (Custom Term) | Injection site hypertrophy | 0 | 0.366 | 0.003 | 0.583 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation time normal | 0 | 0.366 | 0.003 | 0.583 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Non-Hodgkin's lymphoma | 0 | 0.425 | 0.005 | 0.583 | 2.105 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF protein abnormal | 0 | 0.549 | 0.014 | 0.583 | 1.92 |  |  |  |  |  | 
COVID19 (Custom Term) | Stress fracture | 0 | 0.915 | 0.051 | 0.583 | 1.603 |  |  |  |  |  | 
COVID19 (Custom Term) | Petit mal epilepsy | 1 | 2.071 | 0.135 | 0.582 | 1.284 | 0.285 | 0.701 | 1.494 | 0.483 | 0.059 | 13.985
COVID19 (Custom Term) | Systolic dysfunction | 0 | 0.457 | 0.007 | 0.582 | 2.05 |  |  |  |  |  | 
COVID19 (Custom Term) | Suspected product contamination | 0 | 0.366 | 0.003 | 0.582 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Paronychia | 0 | 0.457 | 0.007 | 0.582 | 2.049 |  |  |  |  |  | 
COVID19 (Custom Term) | Myopathy | 0 | 0.672 | 0.025 | 0.582 | 1.785 |  |  |  |  |  | 
COVID19 (Custom Term) | Klebsiella test positive | 0 | 0.64 | 0.022 | 0.582 | 1.816 |  |  |  |  |  | 
COVID19 (Custom Term) | Demyelination | 3 | 5.494 | 0.19 | 0.581 | 1.145 | 0.323 | 0.661 | 1.232 | 0.546 | 0.21 | 7.918
COVID19 (Custom Term) | Upper respiratory tract infection | 7 | 14.65 | 0.304 | 0.581 | 0.931 | 0.317 | 0.549 | 0.896 | 0.478 | 0.134 | 37.809
COVID19 (Custom Term) | Epstein-Barr virus test positive | 0 | 0.942 | 0.053 | 0.581 | 1.586 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypersomnia-bulimia syndrome | 0 | 0.366 | 0.002 | 0.581 | 2.22 |  |  |  |  |  | 
COVID19 (Custom Term) | Urticaria chronic | 0 | 0.939 | 0.053 | 0.581 | 1.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Emotional disorder of childhood | 0 | 0.366 | 0.002 | 0.58 | 2.219 |  |  |  |  |  | 
COVID19 (Custom Term) | DNA test for fragile X | 0 | 0.823 | 0.04 | 0.58 | 1.661 |  |  |  |  |  | 
COVID19 (Custom Term) | Specific gravity urine | 0 | 0.366 | 0.002 | 0.579 | 2.219 |  |  |  |  |  | 
COVID19 (Custom Term) | Cyanosis central | 0 | 0.502 | 0.01 | 0.579 | 1.981 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site oedema | 0 | 0.64 | 0.021 | 0.579 | 1.815 |  |  |  |  |  | 
COVID19 (Custom Term) | Narcolepsy | 1 | 1.113 | 0.046 | 0.578 | 1.62 | 0.349 | 0.849 | 1.802 | 0.898 | 0.068 | 11.692
COVID19 (Custom Term) | Urinary sediment present | 3 | 4.454 | 0.228 | 0.578 | 1.058 | 0.366 | 0.747 | 1.39 | 0.674 | 0.727 | 0.076
COVID19 (Custom Term) | Obsessive thoughts | 0 | 0.366 | 0.002 | 0.578 | 2.219 |  |  |  |  |  | 
COVID19 (Custom Term) | Asocial behaviour | 0 | 0.29 | 0.001 | 0.578 | 2.407 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral mucosa erosion | 0 | 0.366 | 0.002 | 0.578 | 2.219 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute phase reaction | 0 | 0.366 | 0.002 | 0.578 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxine free normal | 0 | 1.119 | 0.07 | 0.578 | 1.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Anal sphincter atony | 0 | 0.549 | 0.013 | 0.577 | 1.917 |  |  |  |  |  | 
COVID19 (Custom Term) | Infusion related reaction | 0 | 0.366 | 0.002 | 0.577 | 2.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicose vein | 0 | 0.511 | 0.01 | 0.577 | 1.966 |  |  |  |  |  | 
COVID19 (Custom Term) | Eyelid injury | 0 | 0.64 | 0.02 | 0.577 | 1.813 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichenoid keratosis | 0 | 0.902 | 0.047 | 0.576 | 1.607 |  |  |  |  |  | 
COVID19 (Custom Term) | Post procedural complication | 0 | 0.549 | 0.012 | 0.575 | 1.916 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal mucosal disorder | 0 | 0.549 | 0.012 | 0.575 | 1.916 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia staphylococcal | 0 | 0.64 | 0.02 | 0.575 | 1.813 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine and fallopian tube malignant tumours (SMQ) [broad] | 1 | 3.465 | 0.036 | 0.574 | 1.67 | 0.218 | 0.554 | 1.198 | 0.289 | 0.04 | 22
COVID19 (Custom Term) | Gastroenteritis sapovirus | 0 | 0.274 | 0 | 0.574 | 2.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Ocular dysmetria | 0 | 0.183 | 0 | 0.574 | 2.789 |  |  |  |  |  | 
COVID19 (Custom Term) | Post-traumatic stress disorder | 0 | 0.567 | 0.013 | 0.574 | 1.893 |  |  |  |  |  | 
COVID19 (Custom Term) | Mesenteric panniculitis | 0 | 0.457 | 0.006 | 0.573 | 2.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Staphylococcal skin infection | 0 | 0.457 | 0.006 | 0.573 | 2.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Axillary nerve injury | 0 | 0.915 | 0.046 | 0.572 | 1.597 |  |  |  |  |  | 
COVID19 (Custom Term) | Pupils unequal | 0 | 0.966 | 0.051 | 0.572 | 1.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenoidectomy | 0 | 0.549 | 0.012 | 0.572 | 1.914 |  |  |  |  |  | 
COVID19 (Custom Term) | Oophoritis | 0 | 0.366 | 0.002 | 0.572 | 2.214 |  |  |  |  |  | 
COVID19 (Custom Term) | Febrile infection | 0 | 0.776 | 0.032 | 0.571 | 1.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile spasms | 0 | 0.982 | 0.052 | 0.571 | 1.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Impaired healing | 0 | 1.059 | 0.06 | 0.571 | 1.519 |  |  |  |  |  | 
COVID19 (Custom Term) | Keratic precipitates | 0 | 0.549 | 0.012 | 0.571 | 1.914 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve conduction studies | 2 | 5.796 | 0.196 | 0.57 | 1.102 | 0.236 | 0.529 | 1.048 | 0.345 | 0.154 | 8.267
COVID19 (Custom Term) | Developmental regression | 0 | 0.867 | 0.04 | 0.57 | 1.626 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion induced | 0 | 0.547 | 0.011 | 0.57 | 1.915 |  |  |  |  |  | 
COVID19 (Custom Term) | Epiphyses delayed fusion | 0 | 0.457 | 0.006 | 0.57 | 2.043 |  |  |  |  |  | 
COVID19 (Custom Term) | Serology abnormal | 0 | 0.307 | 0.001 | 0.57 | 2.353 |  |  |  |  |  | 
COVID19 (Custom Term) | Motor developmental delay | 0 | 0.454 | 0.005 | 0.569 | 2.049 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site pain | 2 | 4.067 | 0.222 | 0.568 | 1.043 | 0.295 | 0.652 | 1.285 | 0.492 | 0.276 | 2.966
COVID19 (Custom Term) | Opportunistic infections (SMQ) [narrow] | 17 | 39.823 | 0.366 | 0.568 | 0.807 | 0.315 | 0.461 | 0.656 | 0.427 | 0.169 | 67.725
COVID19 (Custom Term) | Deformity | 0 | 0.732 | 0.026 | 0.568 | 1.725 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinopathy | 0 | 0.64 | 0.018 | 0.568 | 1.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Ophthalmological examination normal | 1 | 2.337 | 0.113 | 0.567 | 1.305 | 0.27 | 0.668 | 1.427 | 0.428 | 0.112 | 6.064
COVID19 (Custom Term) | Change of bowel habit | 0 | 0.64 | 0.018 | 0.567 | 1.808 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperpathia | 0 | 0.274 | 0 | 0.567 | 2.444 |  |  |  |  |  | 
COVID19 (Custom Term) | Pityriasis lichenoides et varioliformis acuta | 0 | 0.32 | 0.001 | 0.567 | 2.319 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroblastoma | 0 | 0.457 | 0.005 | 0.566 | 2.041 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural complication | 0 | 0.366 | 0.002 | 0.566 | 2.21 |  |  |  |  |  | 
COVID19 (Custom Term) | B-lymphocyte count | 0 | 0.248 | 0 | 0.566 | 2.526 |  |  |  |  |  | 
COVID19 (Custom Term) | Periostitis | 0 | 0.457 | 0.005 | 0.566 | 2.041 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrotising retinitis | 0 | 0.269 | 0 | 0.566 | 2.459 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytogenetic analysis abnormal | 0 | 0.958 | 0.048 | 0.566 | 1.569 |  |  |  |  |  | 
COVID19 (Custom Term) | Infective myositis | 0 | 0.549 | 0.01 | 0.565 | 1.91 |  |  |  |  |  | 
COVID19 (Custom Term) | Chromosome analysis normal | 1 | 4.051 | 0.072 | 0.564 | 1.444 | 0.196 | 0.507 | 1.105 | 0.247 | 0.552 | 0.036
COVID19 (Custom Term) | Venous thrombosis | 0 | 0.549 | 0.01 | 0.564 | 1.91 |  |  |  |  |  | 
COVID19 (Custom Term) | Subretinal fluid | 0 | 0.366 | 0.002 | 0.564 | 2.209 |  |  |  |  |  | 
COVID19 (Custom Term) | Finger deformity | 0 | 0.366 | 0.002 | 0.564 | 2.209 |  |  |  |  |  | 
COVID19 (Custom Term) | Stool analysis abnormal | 1 | 2.065 | 0.05 | 0.563 | 1.549 | 0.285 | 0.702 | 1.496 | 0.484 | 0.101 | 6.944
COVID19 (Custom Term) | Blood immunoglobulin A normal | 1 | 2.339 | 0.108 | 0.563 | 1.311 | 0.27 | 0.668 | 1.426 | 0.428 | 0.095 | 7.533
COVID19 (Custom Term) | Fontanelle depressed | 0 | 0.253 | 0 | 0.563 | 2.509 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune neuropathy | 0 | 0.549 | 0.01 | 0.563 | 1.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Specific gravity urine decreased | 0 | 0.64 | 0.017 | 0.563 | 1.806 |  |  |  |  |  | 
COVID19 (Custom Term) | Enteritis infectious | 0 | 0.549 | 0.01 | 0.562 | 1.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Cyanosis neonatal | 0 | 0.549 | 0.01 | 0.562 | 1.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory paralysis | 0 | 0.457 | 0.005 | 0.562 | 2.038 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory tract inflammation | 0 | 0.64 | 0.016 | 0.561 | 1.805 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug withdrawal (SMQ) [narrow] | 0 | 0.732 | 0.024 | 0.561 | 1.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Arachnoid cyst | 0 | 0.366 | 0.002 | 0.561 | 2.207 |  |  |  |  |  | 
COVID19 (Custom Term) | Fungal test positive | 0 | 0.915 | 0.041 | 0.561 | 1.591 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb operation | 0 | 0.549 | 0.01 | 0.56 | 1.908 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray gastrointestinal tract | 0 | 0.366 | 0.001 | 0.559 | 2.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site abscess sterile | 0 | 0.767 | 0.027 | 0.559 | 1.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthritis reactive | 0 | 1.221 | 0.069 | 0.559 | 1.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitral valve prolapse | 0 | 0.549 | 0.009 | 0.558 | 1.906 |  |  |  |  |  | 
COVID19 (Custom Term) | Apallic syndrome | 0 | 0.286 | 0 | 0.558 | 2.4 |  |  |  |  |  | 
COVID19 (Custom Term) | Conjunctivitis viral | 0 | 0.732 | 0.023 | 0.558 | 1.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal transplant | 0 | 0.628 | 0.015 | 0.557 | 1.815 |  |  |  |  |  | 
COVID19 (Custom Term) | QRS axis abnormal | 0 | 0.366 | 0.001 | 0.557 | 2.203 |  |  |  |  |  | 
COVID19 (Custom Term) | Subdural hygroma | 0 | 0.264 | 0 | 0.557 | 2.464 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-Muellerian hormone level | 0 | 0.457 | 0.004 | 0.557 | 2.035 |  |  |  |  |  | 
COVID19 (Custom Term) | Exercise electrocardiogram normal | 0 | 0.64 | 0.015 | 0.556 | 1.802 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood prolactin normal | 0 | 0.823 | 0.031 | 0.556 | 1.648 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site inflammation | 0 | 0.915 | 0.039 | 0.556 | 1.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aldosterone normal | 0 | 0.274 | 0 | 0.556 | 2.433 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound testes | 0 | 0.366 | 0.001 | 0.556 | 2.203 |  |  |  |  |  | 
COVID19 (Custom Term) | Akinesia | 0 | 0.549 | 0.009 | 0.556 | 1.905 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy artery abnormal | 0 | 0.64 | 0.015 | 0.556 | 1.802 |  |  |  |  |  | 
COVID19 (Custom Term) | Post inflammatory pigmentation change | 0 | 0.334 | 0.001 | 0.555 | 2.274 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthopaedic examination normal | 0 | 0.549 | 0.009 | 0.555 | 1.904 |  |  |  |  |  | 
COVID19 (Custom Term) | Sick building syndrome | 0 | 0.183 | 0 | 0.555 | 2.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Placental disorder | 2 | 8.028 | 0.113 | 0.554 | 1.267 | 0.183 | 0.422 | 0.846 | 0.249 | 0.709 | 0.024
COVID19 (Custom Term) | Rheumatic fever | 0 | 0.64 | 0.015 | 0.554 | 1.8 |  |  |  |  |  | 
COVID19 (Custom Term) | Multiple chemical sensitivity | 0 | 0.915 | 0.038 | 0.553 | 1.586 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileus paralytic | 0 | 0.732 | 0.022 | 0.553 | 1.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Sputum test | 0 | 0.366 | 0.001 | 0.553 | 2.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Myoglobinuria | 0 | 0.366 | 0.001 | 0.553 | 2.2 |  |  |  |  |  | 
COVID19 (Custom Term) | Wisdom teeth removal | 0 | 0.457 | 0.004 | 0.553 | 2.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal inflammation | 1 | 1.566 | 0.133 | 0.552 | 1.203 | 0.316 | 0.773 | 1.641 | 0.639 | 0.432 | 0.243
COVID19 (Custom Term) | Laryngoscopy abnormal | 0 | 0.915 | 0.037 | 0.551 | 1.585 |  |  |  |  |  | 
COVID19 (Custom Term) | Diarrhoea infectious | 0 | 0.366 | 0.001 | 0.551 | 2.199 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulocyte count increased | 0 | 0.823 | 0.029 | 0.551 | 1.645 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterocolitis | 0 | 0.409 | 0.002 | 0.55 | 2.112 |  |  |  |  |  | 
COVID19 (Custom Term) | Tensilon test abnormal | 0 | 0.457 | 0.004 | 0.55 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF myelin basic protein increased | 0 | 0.457 | 0.004 | 0.55 | 2.03 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood cholinesterase increased | 0 | 0.823 | 0.028 | 0.549 | 1.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Central nervous system infection | 0 | 0.476 | 0.004 | 0.549 | 1.999 |  |  |  |  |  | 
COVID19 (Custom Term) | PO2 | 0 | 0.915 | 0.036 | 0.549 | 1.584 |  |  |  |  |  | 
COVID19 (Custom Term) | T-lymphocyte count normal | 0 | 0.731 | 0.021 | 0.549 | 1.714 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin M normal | 1 | 3.133 | 0.111 | 0.548 | 1.256 | 0.232 | 0.584 | 1.257 | 0.319 | 0.095 | 7.533
COVID19 (Custom Term) | Cyst removal | 0 | 0.823 | 0.028 | 0.548 | 1.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Heart disease congenital | 0 | 0.549 | 0.008 | 0.548 | 1.899 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumonia escherichia | 0 | 0.183 | 0 | 0.547 | 2.744 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycobacterium tuberculosis complex test positive | 0 | 0.448 | 0.003 | 0.547 | 2.042 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyslalia | 0 | 0.549 | 0.008 | 0.547 | 1.899 |  |  |  |  |  | 
COVID19 (Custom Term) | Product deposit | 0 | 0.366 | 0.001 | 0.546 | 2.194 |  |  |  |  |  | 
COVID19 (Custom Term) | Megakaryocytes increased | 0 | 0.549 | 0.008 | 0.546 | 1.898 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumocystis jirovecii pneumonia | 0 | 0.191 | 0 | 0.546 | 2.709 |  |  |  |  |  | 
COVID19 (Custom Term) | Suspected counterfeit product | 0 | 0.549 | 0.008 | 0.546 | 1.898 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial disorder | 0 | 0.566 | 0.008 | 0.545 | 1.877 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug level | 0 | 0.549 | 0.007 | 0.545 | 1.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Yersinia test negative | 0 | 0.421 | 0.002 | 0.545 | 2.088 |  |  |  |  |  | 
COVID19 (Custom Term) | Defiant behaviour | 0 | 0.64 | 0.013 | 0.545 | 1.795 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray with contrast upper gastrointestinal tract | 0 | 0.651 | 0.014 | 0.545 | 1.784 |  |  |  |  |  | 
COVID19 (Custom Term) | Palpable purpura | 0 | 0.514 | 0.006 | 0.544 | 1.942 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicobrachial syndrome | 0 | 0.457 | 0.003 | 0.544 | 2.025 |  |  |  |  |  | 
COVID19 (Custom Term) | Slit-lamp examination | 0 | 0.64 | 0.013 | 0.544 | 1.794 |  |  |  |  |  | 
COVID19 (Custom Term) | Small for dates baby | 0 | 0.239 | 0 | 0.543 | 2.529 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis fulminant | 0 | 0.457 | 0.003 | 0.543 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Bursa disorder | 0 | 0.928 | 0.035 | 0.543 | 1.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypermobility syndrome | 0 | 0.284 | 0 | 0.543 | 2.39 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF immunoglobulin decreased | 0 | 0.64 | 0.012 | 0.542 | 1.793 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononuclear cell percentage | 0 | 0.457 | 0.003 | 0.542 | 2.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone marrow transplant | 0 | 0.3 | 0 | 0.541 | 2.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Dengue virus test negative | 0 | 0.64 | 0.012 | 0.541 | 1.792 |  |  |  |  |  | 
COVID19 (Custom Term) | Ventricular septal defect | 0 | 0.732 | 0.019 | 0.541 | 1.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Face and mouth X-ray abnormal | 0 | 0.732 | 0.019 | 0.541 | 1.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Nasal inflammation | 0 | 0.732 | 0.019 | 0.541 | 1.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile apnoea | 0 | 0.825 | 0.026 | 0.541 | 1.637 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacillus test positive | 0 | 0.366 | 0.001 | 0.541 | 2.189 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle oedema | 1 | 2.883 | 0.073 | 0.54 | 1.364 | 0.243 | 0.608 | 1.306 | 0.347 | 0.451 | 0.191
COVID19 (Custom Term) | Sacroiliitis | 0 | 0.732 | 0.018 | 0.54 | 1.708 |  |  |  |  |  | 
COVID19 (Custom Term) | Daydreaming | 0 | 0.563 | 0.008 | 0.54 | 1.877 |  |  |  |  |  | 
COVID19 (Custom Term) | Lipoedema | 0 | 0.549 | 0.007 | 0.54 | 1.894 |  |  |  |  |  | 
COVID19 (Custom Term) | Accident | 0 | 0.732 | 0.018 | 0.54 | 1.707 |  |  |  |  |  | 
COVID19 (Custom Term) | CD8 lymphocytes decreased | 0 | 0.256 | 0 | 0.539 | 2.468 |  |  |  |  |  | 
COVID19 (Custom Term) | Anxiety disorder | 0 | 0.478 | 0.004 | 0.539 | 1.989 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostatic specific antigen normal | 0 | 0.732 | 0.018 | 0.539 | 1.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Housebound | 0 | 0.549 | 0.007 | 0.539 | 1.893 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac imaging procedure normal | 0 | 0.64 | 0.012 | 0.539 | 1.791 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased vibratory sense | 0 | 0.455 | 0.003 | 0.538 | 2.025 |  |  |  |  |  | 
COVID19 (Custom Term) | Negative thoughts | 0 | 0.457 | 0.003 | 0.538 | 2.02 |  |  |  |  |  | 
COVID19 (Custom Term) | Nail disorder | 0 | 0.64 | 0.012 | 0.538 | 1.789 |  |  |  |  |  | 
COVID19 (Custom Term) | Angiotensin converting enzyme decreased | 0 | 0.581 | 0.008 | 0.538 | 1.855 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site induration | 0 | 0.457 | 0.003 | 0.538 | 2.02 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic neuropathy | 0 | 0.56 | 0.007 | 0.537 | 1.878 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal tubular acidosis | 0 | 0.366 | 0.001 | 0.536 | 2.184 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunology test abnormal | 0 | 0.615 | 0.01 | 0.536 | 1.815 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet distribution width | 0 | 0.487 | 0.004 | 0.534 | 1.973 |  |  |  |  |  | 
COVID19 (Custom Term) | Concentric sclerosis | 0 | 0.183 | 0 | 0.534 | 2.717 |  |  |  |  |  | 
COVID19 (Custom Term) | Wound | 1 | 2.687 | 0.082 | 0.533 | 1.31 | 0.253 | 0.629 | 1.347 | 0.372 | 0.071 | 11.095
COVID19 (Custom Term) | Biopsy lung | 0 | 0.549 | 0.006 | 0.533 | 1.889 |  |  |  |  |  | 
COVID19 (Custom Term) | Roseolovirus test positive | 0 | 0.835 | 0.024 | 0.533 | 1.624 |  |  |  |  |  | 
COVID19 (Custom Term) | Hearing aid user | 0 | 0.527 | 0.005 | 0.533 | 1.917 |  |  |  |  |  | 
COVID19 (Custom Term) | Tinea capitis | 0 | 0.366 | 0.001 | 0.533 | 2.182 |  |  |  |  |  | 
COVID19 (Custom Term) | Prostate cancer | 0 | 0.732 | 0.016 | 0.532 | 1.701 |  |  |  |  |  | 
COVID19 (Custom Term) | Gamma-glutamyltransferase decreased | 0 | 0.366 | 0.001 | 0.532 | 2.18 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion threatened | 0 | 0.823 | 0.023 | 0.531 | 1.631 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxic skin eruption | 0 | 0.585 | 0.007 | 0.53 | 1.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperferritinaemia | 0 | 0.549 | 0.006 | 0.53 | 1.886 |  |  |  |  |  | 
COVID19 (Custom Term) | Minimum inhibitory concentration | 0 | 0.457 | 0.002 | 0.53 | 2.013 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal laminectomy | 0 | 0.64 | 0.01 | 0.529 | 1.783 |  |  |  |  |  | 
COVID19 (Custom Term) | Exaggerated startle response | 0 | 0.702 | 0.014 | 0.529 | 1.725 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulvovaginal pain | 0 | 0.502 | 0.004 | 0.529 | 1.946 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyserositis | 0 | 0.64 | 0.01 | 0.529 | 1.783 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatologic examination normal | 0 | 0.64 | 0.01 | 0.529 | 1.783 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain scan normal | 0 | 0.88 | 0.026 | 0.528 | 1.591 |  |  |  |  |  | 
COVID19 (Custom Term) | Adverse food reaction | 0 | 0.366 | 0.001 | 0.528 | 2.176 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug-induced liver injury | 0 | 0.649 | 0.01 | 0.528 | 1.773 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteomyelitis bacterial | 0 | 0.457 | 0.002 | 0.527 | 2.011 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral load undetectable | 0 | 0.366 | 0.001 | 0.527 | 2.175 |  |  |  |  |  | 
COVID19 (Custom Term) | Cochlea implant | 0 | 0.476 | 0.003 | 0.527 | 1.982 |  |  |  |  |  | 
COVID19 (Custom Term) | Legionella test positive | 0 | 0.457 | 0.002 | 0.527 | 2.01 |  |  |  |  |  | 
COVID19 (Custom Term) | Dementia Alzheimer's type | 0 | 0.64 | 0.01 | 0.527 | 1.781 |  |  |  |  |  | 
COVID19 (Custom Term) | Bilirubin conjugated decreased | 0 | 0.915 | 0.028 | 0.527 | 1.568 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal dysplasia | 0 | 0.457 | 0.002 | 0.526 | 2.009 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site scar | 0 | 2.045 | 0.108 | 0.526 | 1.199 |  |  |  |  |  | 
COVID19 (Custom Term) | Amino acid level normal | 0 | 0.579 | 0.006 | 0.525 | 1.846 |  |  |  |  |  | 
COVID19 (Custom Term) | Folate deficiency | 0 | 0.366 | 0.001 | 0.525 | 2.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem auditory evoked response abnormal | 0 | 0.64 | 0.009 | 0.525 | 1.779 |  |  |  |  |  | 
COVID19 (Custom Term) | Lhermitte's sign | 0 | 0.915 | 0.027 | 0.524 | 1.566 |  |  |  |  |  | 
COVID19 (Custom Term) | Electronystagmogram | 0 | 0.457 | 0.002 | 0.524 | 2.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypersensitivity pneumonitis | 0 | 0.64 | 0.009 | 0.524 | 1.779 |  |  |  |  |  | 
COVID19 (Custom Term) | Benign rolandic epilepsy | 0 | 0.64 | 0.009 | 0.524 | 1.779 |  |  |  |  |  | 
COVID19 (Custom Term) | Endodontic procedure | 0 | 0.64 | 0.009 | 0.524 | 1.779 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood zinc decreased | 0 | 0.549 | 0.005 | 0.523 | 1.88 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheitis | 1 | 1.612 | 0.059 | 0.522 | 1.371 | 0.313 | 0.766 | 1.627 | 0.62 | 0.496 | 0.102
COVID19 (Custom Term) | Tendonitis | 6 | 13.499 | 0.249 | 0.522 | 0.876 | 0.295 | 0.527 | 0.883 | 0.444 | 0.264 | 11.255
COVID19 (Custom Term) | Hypnagogic hallucination | 0 | 0.192 | 0 | 0.521 | 2.655 |  |  |  |  |  | 
COVID19 (Custom Term) | Neoplasm | 0 | 0.671 | 0.01 | 0.521 | 1.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac asthma | 0 | 0.183 | 0 | 0.521 | 2.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital tricuspid valve incompetence | 0 | 0.274 | 0 | 0.521 | 2.388 |  |  |  |  |  | 
COVID19 (Custom Term) | Eye injury | 0 | 0.661 | 0.01 | 0.52 | 1.756 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound urinary system | 0 | 0.823 | 0.02 | 0.52 | 1.623 |  |  |  |  |  | 
COVID19 (Custom Term) | Anterior chamber inflammation | 0 | 0.366 | 0.001 | 0.52 | 2.168 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin urine present | 0 | 0.64 | 0.009 | 0.52 | 1.776 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood follicle stimulating hormone | 0 | 0.274 | 0 | 0.519 | 2.384 |  |  |  |  |  | 
COVID19 (Custom Term) | Puncture site oedema | 0 | 0.457 | 0.002 | 0.519 | 2.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Prerenal failure | 0 | 0.457 | 0.002 | 0.519 | 2.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Umbilical cord abnormality | 0 | 0.457 | 0.002 | 0.518 | 2.002 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterococcus test positive | 0 | 0.732 | 0.013 | 0.517 | 1.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site warmth | 0 | 0.491 | 0.003 | 0.517 | 1.951 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitreous haemorrhage | 0 | 0.366 | 0 | 0.517 | 2.164 |  |  |  |  |  | 
COVID19 (Custom Term) | Skeletal injury | 0 | 1.007 | 0.032 | 0.517 | 1.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy muscle | 0 | 0.885 | 0.023 | 0.517 | 1.579 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle haemorrhage | 0 | 0.915 | 0.025 | 0.516 | 1.56 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4 lymphocytes normal | 0 | 0.56 | 0.005 | 0.516 | 1.86 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B antibody | 0 | 0.298 | 0 | 0.516 | 2.317 |  |  |  |  |  | 
COVID19 (Custom Term) | Disseminated Bacillus Calmette-Guerin infection | 0 | 0.549 | 0.004 | 0.515 | 1.873 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic procedure | 0 | 0.706 | 0.011 | 0.515 | 1.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital naevus | 0 | 0.366 | 0 | 0.515 | 2.161 |  |  |  |  |  | 
COVID19 (Custom Term) | Menarche | 0 | 0.274 | 0 | 0.514 | 2.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Death neonatal | 0 | 0.187 | 0 | 0.514 | 2.654 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral cyst | 0 | 0.366 | 0 | 0.512 | 2.157 |  |  |  |  |  | 
COVID19 (Custom Term) | Faeces hard | 0 | 0.781 | 0.015 | 0.512 | 1.646 |  |  |  |  |  | 
COVID19 (Custom Term) | Candida test positive | 0 | 0.823 | 0.017 | 0.511 | 1.615 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site oedema | 2 | 4.872 | 0.133 | 0.51 | 1.085 | 0.265 | 0.589 | 1.163 | 0.411 | 0.112 | 12.951
COVID19 (Custom Term) | Neonatal disorders (SMQ) [narrow] | 8 | 20.393 | 0.265 | 0.51 | 0.82 | 0.272 | 0.459 | 0.734 | 0.392 | 0.06 | 115.84
COVID19 (Custom Term) | Staphylococcal scalded skin syndrome | 0 | 0.732 | 0.012 | 0.51 | 1.684 |  |  |  |  |  | 
COVID19 (Custom Term) | Treatment failure | 0 | 0.366 | 0 | 0.51 | 2.155 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal volume decreased | 0 | 0.64 | 0.007 | 0.51 | 1.767 |  |  |  |  |  | 
COVID19 (Custom Term) | Feeling of despair | 0 | 0.994 | 0.028 | 0.509 | 1.509 |  |  |  |  |  | 
COVID19 (Custom Term) | HELLP syndrome | 0 | 0.549 | 0.004 | 0.509 | 1.867 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory muscle weakness | 0 | 0.187 | 0 | 0.509 | 2.644 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrophoresis protein abnormal | 0 | 0.71 | 0.01 | 0.508 | 1.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Stupor | 0 | 0.653 | 0.008 | 0.508 | 1.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspergillus test negative | 0 | 0.732 | 0.011 | 0.507 | 1.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin saturation decreased | 0 | 0.915 | 0.022 | 0.507 | 1.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Product contamination physical | 0 | 0.549 | 0.004 | 0.507 | 1.865 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal haemorrhage | 0 | 0.376 | 0 | 0.507 | 2.132 |  |  |  |  |  | 
COVID19 (Custom Term) | Apparent death | 0 | 0.995 | 0.028 | 0.507 | 1.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Papule | 3 | 7.271 | 0.186 | 0.506 | 0.952 | 0.268 | 0.552 | 1.03 | 0.413 | 0.089 | 26.898
COVID19 (Custom Term) | Platelet-large cell ratio | 0 | 0.342 | 0 | 0.506 | 2.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Reticulocyte count | 0 | 0.82 | 0.016 | 0.506 | 1.613 |  |  |  |  |  | 
COVID19 (Custom Term) | Botulism | 0 | 0.274 | 0 | 0.506 | 2.364 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin fissures | 1 | 2.882 | 0.103 | 0.505 | 1.156 | 0.243 | 0.608 | 1.306 | 0.347 | 0.301 | 0.918
COVID19 (Custom Term) | Pericardial haemorrhage | 0 | 0.732 | 0.011 | 0.504 | 1.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Chromatopsia | 0 | 0.549 | 0.003 | 0.504 | 1.861 |  |  |  |  |  | 
COVID19 (Custom Term) | Developmental delay | 0 | 1.13 | 0.036 | 0.504 | 1.438 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy peripheral nerve abnormal | 0 | 0.732 | 0.011 | 0.504 | 1.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal oedema | 0 | 0.64 | 0.007 | 0.503 | 1.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal pigment epitheliopathy | 0 | 0.281 | 0 | 0.503 | 2.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Subileus | 0 | 0.366 | 0 | 0.503 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Pica | 0 | 0.64 | 0.007 | 0.503 | 1.76 |  |  |  |  |  | 
COVID19 (Custom Term) | Oestradiol decreased | 0 | 0.457 | 0.001 | 0.502 | 1.984 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin premalignant disorders (SMQ) [narrow] | 0 | 0.672 | 0.008 | 0.502 | 1.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Lividity | 0 | 0.581 | 0.004 | 0.502 | 1.822 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycoplasma infection | 0 | 0.769 | 0.012 | 0.502 | 1.647 |  |  |  |  |  | 
COVID19 (Custom Term) | Adnexal torsion | 0 | 0.366 | 0 | 0.502 | 2.145 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin premalignant disorders (SMQ) [broad] | 0 | 0.672 | 0.008 | 0.502 | 1.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint manipulation | 0 | 0.457 | 0.001 | 0.501 | 1.983 |  |  |  |  |  | 
COVID19 (Custom Term) | IgA nephropathy | 1 | 1.052 | 0.08 | 0.5 | 1.215 | 0.354 | 0.861 | 1.826 | 0.951 | 0.993 | 0.266
COVID19 (Custom Term) | Vulval disorder | 0 | 0.457 | 0.001 | 0.5 | 1.982 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site abscess sterile | 0 | 0.366 | 0 | 0.5 | 2.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein increased | 0 | 0.366 | 0 | 0.5 | 2.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site haematoma | 0 | 0.731 | 0.01 | 0.499 | 1.675 |  |  |  |  |  | 
COVID19 (Custom Term) | Calcium ionised decreased | 0 | 0.389 | 0 | 0.499 | 2.096 |  |  |  |  |  | 
COVID19 (Custom Term) | Eschar | 0 | 0.915 | 0.02 | 0.497 | 1.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood bilirubin unconjugated normal | 0 | 0.492 | 0.002 | 0.496 | 1.927 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumocystis jirovecii infection | 0 | 0.366 | 0 | 0.496 | 2.136 |  |  |  |  |  | 
COVID19 (Custom Term) | Light chain analysis normal | 0 | 0.457 | 0.001 | 0.496 | 1.977 |  |  |  |  |  | 
COVID19 (Custom Term) | Injury corneal | 0 | 0.422 | 0.001 | 0.495 | 2.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic fibrosis | 0 | 0.457 | 0.001 | 0.495 | 1.977 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance imaging whole body | 0 | 0.64 | 0.006 | 0.495 | 1.752 |  |  |  |  |  | 
COVID19 (Custom Term) | Stertor | 0 | 0.366 | 0 | 0.494 | 2.133 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal colic | 0 | 0.457 | 0.001 | 0.494 | 1.976 |  |  |  |  |  | 
COVID19 (Custom Term) | Influenza | 32 | 83.088 | 0.36 | 0.493 | 0.643 | 0.303 | 0.404 | 0.529 | 0.385 | 0.121 | 201.51
COVID19 (Custom Term) | Spirometry abnormal | 0 | 0.2 | 0 | 0.493 | 2.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug level increased | 0 | 0.274 | 0 | 0.492 | 2.339 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral nerve lesion | 0 | 0.823 | 0.013 | 0.491 | 1.596 |  |  |  |  |  | 
COVID19 (Custom Term) | Light chain analysis abnormal | 0 | 0.366 | 0 | 0.491 | 2.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroid disorder | 0 | 1.025 | 0.024 | 0.491 | 1.477 |  |  |  |  |  | 
COVID19 (Custom Term) | Skull fracture | 0 | 0.717 | 0.008 | 0.491 | 1.678 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis A virus test | 1 | 1.802 | 0.068 | 0.49 | 1.23 | 0.301 | 0.738 | 1.569 | 0.555 | 0.397 | 0.357
COVID19 (Custom Term) | Electrocardiogram PR interval | 0 | 0.915 | 0.018 | 0.49 | 1.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood heavy metal increased | 0 | 0.787 | 0.011 | 0.49 | 1.622 |  |  |  |  |  | 
COVID19 (Custom Term) | Poliovirus test positive | 0 | 0.366 | 0 | 0.49 | 2.127 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin atrophy | 0 | 0.915 | 0.018 | 0.49 | 1.536 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B DNA decreased | 0 | 0.457 | 0.001 | 0.49 | 1.97 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital erythema | 0 | 0.64 | 0.005 | 0.49 | 1.747 |  |  |  |  |  | 
COVID19 (Custom Term) | Lacrimation disorder | 0 | 0.823 | 0.013 | 0.49 | 1.596 |  |  |  |  |  | 
COVID19 (Custom Term) | Haptoglobin normal | 0 | 0.823 | 0.013 | 0.49 | 1.596 |  |  |  |  |  | 
COVID19 (Custom Term) | Fundoscopy abnormal | 0 | 0.699 | 0.007 | 0.49 | 1.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold agglutinins | 0 | 0.366 | 0 | 0.49 | 2.127 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual acuity reduced | 1 | 2.109 | 0.07 | 0.489 | 1.221 | 0.283 | 0.696 | 1.484 | 0.474 | 0.064 | 12.489
COVID19 (Custom Term) | Impaired quality of life | 0 | 0.527 | 0.002 | 0.489 | 1.873 |  |  |  |  |  | 
COVID19 (Custom Term) | Floppy infant | 0 | 0.521 | 0.002 | 0.489 | 1.88 |  |  |  |  |  | 
COVID19 (Custom Term) | Ankylosing spondylitis | 0 | 0.364 | 0 | 0.489 | 2.13 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood osmolarity normal | 0 | 0.549 | 0.002 | 0.489 | 1.846 |  |  |  |  |  | 
COVID19 (Custom Term) | Exercise lack of | 0 | 0.366 | 0 | 0.488 | 2.124 |  |  |  |  |  | 
COVID19 (Custom Term) | Diabetes insipidus | 0 | 0.523 | 0.002 | 0.488 | 1.876 |  |  |  |  |  | 
COVID19 (Custom Term) | Spinal cord oedema | 0 | 0.56 | 0.003 | 0.488 | 1.831 |  |  |  |  |  | 
COVID19 (Custom Term) | Gamma-glutamyltransferase | 0 | 0.622 | 0.004 | 0.487 | 1.762 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema infantile | 0 | 0.47 | 0.001 | 0.487 | 1.948 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononeuropathy | 1 | 2.532 | 0.104 | 0.486 | 1.097 | 0.26 | 0.646 | 1.381 | 0.395 | 0.621 | 0.002
COVID19 (Custom Term) | Renal function test normal | 2 | 5.859 | 0.125 | 0.486 | 1.038 | 0.234 | 0.525 | 1.041 | 0.341 | 0.126 | 10.988
COVID19 (Custom Term) | Muscle abscess | 0 | 0.64 | 0.005 | 0.486 | 1.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Pseudomonas test positive | 0 | 0.393 | 0 | 0.486 | 2.072 |  |  |  |  |  | 
COVID19 (Custom Term) | HLA-B*27 positive | 0 | 0.823 | 0.012 | 0.486 | 1.592 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatic failure | 0 | 1.366 | 0.044 | 0.486 | 1.332 |  |  |  |  |  | 
COVID19 (Custom Term) | Acarodermatitis | 1 | 2.047 | 0.089 | 0.485 | 1.141 | 0.286 | 0.704 | 1.5 | 0.489 | 0.993 | 0.266
COVID19 (Custom Term) | Tendinopathies and ligament disorders (SMQ) [narrow] | 21 | 53.036 | 0.332 | 0.485 | 0.662 | 0.299 | 0.424 | 0.586 | 0.396 | 0.272 | 39.179
COVID19 (Custom Term) | CSF protein | 1 | 3.646 | 0.051 | 0.485 | 1.292 | 0.211 | 0.539 | 1.167 | 0.274 | 0.106 | 6.552
COVID19 (Custom Term) | Melanocytic naevus | 0 | 0.64 | 0.005 | 0.485 | 1.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Intrusive thoughts | 0 | 0.64 | 0.005 | 0.485 | 1.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Cold urticaria | 0 | 0.915 | 0.017 | 0.485 | 1.531 |  |  |  |  |  | 
COVID19 (Custom Term) | Amyotrophic lateral sclerosis | 0 | 0.352 | 0 | 0.484 | 2.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha hydroxybutyrate dehydrogenase increased | 0 | 0.549 | 0.002 | 0.484 | 1.839 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebellar syndrome | 0 | 0.165 | 0 | 0.484 | 2.647 |  |  |  |  |  | 
COVID19 (Custom Term) | Myofascial pain syndrome | 0 | 0.915 | 0.016 | 0.483 | 1.53 |  |  |  |  |  | 
COVID19 (Custom Term) | Limb deformity | 0 | 0.64 | 0.004 | 0.483 | 1.74 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site eczema | 0 | 0.646 | 0.005 | 0.483 | 1.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood thyroid stimulating hormone abnormal | 0 | 0.457 | 0.001 | 0.483 | 1.961 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory tract infection | 4 | 5.553 | 0.176 | 0.482 | 0.911 | 0.397 | 0.767 | 1.368 | 0.72 | 0.039 | 94.451
COVID19 (Custom Term) | Enterococcal infection | 0 | 0.549 | 0.002 | 0.482 | 1.838 |  |  |  |  |  | 
COVID19 (Custom Term) | Rectal prolapse | 0 | 0.574 | 0.003 | 0.482 | 1.809 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory syncytial virus infection | 0 | 0.817 | 0.011 | 0.482 | 1.593 |  |  |  |  |  | 
COVID19 (Custom Term) | Incomplete course of vaccination | 10 | 36.834 | 0.264 | 0.481 | 0.75 | 0.197 | 0.32 | 0.496 | 0.271 | 0.131 | 56.086
COVID19 (Custom Term) | Oesophageal papilloma | 0 | 0.274 | 0 | 0.481 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovulation pain | 0 | 0.274 | 0 | 0.481 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocrine disorder | 0 | 0.549 | 0.002 | 0.481 | 1.836 |  |  |  |  |  | 
COVID19 (Custom Term) | Hormone replacement therapy | 0 | 0.274 | 0 | 0.481 | 2.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Escherichia test negative | 0 | 0.72 | 0.007 | 0.48 | 1.665 |  |  |  |  |  | 
COVID19 (Custom Term) | Growth retardation | 0 | 0.922 | 0.016 | 0.48 | 1.523 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy bone marrow normal | 0 | 0.821 | 0.011 | 0.48 | 1.587 |  |  |  |  |  | 
COVID19 (Custom Term) | Transferrin | 0 | 0.457 | 0.001 | 0.48 | 1.957 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin cancer | 0 | 0.814 | 0.011 | 0.48 | 1.592 |  |  |  |  |  | 
COVID19 (Custom Term) | Gingival discomfort | 0 | 0.732 | 0.007 | 0.479 | 1.653 |  |  |  |  |  | 
COVID19 (Custom Term) | Sigmoidoscopy | 0 | 0.366 | 0 | 0.479 | 2.11 |  |  |  |  |  | 
COVID19 (Custom Term) | Executive dysfunction | 0 | 0.457 | 0.001 | 0.479 | 1.955 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose tolerance test normal | 0 | 0.823 | 0.011 | 0.478 | 1.584 |  |  |  |  |  | 
COVID19 (Custom Term) | Parapsoriasis | 0 | 0.732 | 0.007 | 0.478 | 1.653 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral lichen planus | 0 | 0.64 | 0.004 | 0.478 | 1.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site infection | 0 | 0.775 | 0.009 | 0.477 | 1.618 |  |  |  |  |  | 
COVID19 (Custom Term) | Relapsing-remitting multiple sclerosis | 0 | 0.515 | 0.001 | 0.477 | 1.874 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet morphology normal | 0 | 0.64 | 0.004 | 0.477 | 1.733 |  |  |  |  |  | 
COVID19 (Custom Term) | Mononeuritis | 0 | 0.732 | 0.007 | 0.477 | 1.652 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4 lymphocytes decreased | 0 | 0.636 | 0.004 | 0.477 | 1.738 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoelectrophoresis | 0 | 0.915 | 0.015 | 0.477 | 1.524 |  |  |  |  |  | 
COVID19 (Custom Term) | Overlap syndrome | 0 | 0.366 | 0 | 0.477 | 2.107 |  |  |  |  |  | 
COVID19 (Custom Term) | Burning mouth syndrome | 0 | 0.35 | 0 | 0.476 | 2.136 |  |  |  |  |  | 
COVID19 (Custom Term) | FEV1/FVC ratio decreased | 0 | 0.274 | 0 | 0.476 | 2.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Plateletcrit | 0 | 0.479 | 0.001 | 0.476 | 1.921 |  |  |  |  |  | 
COVID19 (Custom Term) | Learning disorder | 0 | 0.427 | 0 | 0.476 | 2 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuromyopathy | 0 | 0.915 | 0.014 | 0.475 | 1.522 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood creatine phosphokinase MB normal | 0 | 0.64 | 0.004 | 0.475 | 1.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem auditory evoked response | 0 | 0.823 | 0.01 | 0.475 | 1.58 |  |  |  |  |  | 
COVID19 (Custom Term) | Apathy | 2 | 4.008 | 0.116 | 0.474 | 1.031 | 0.298 | 0.657 | 1.295 | 0.499 | 0.071 | 23.183
COVID19 (Custom Term) | Mucosal haemorrhage | 0 | 0.436 | 0 | 0.474 | 1.981 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure to toxic agent | 0 | 0.64 | 0.004 | 0.474 | 1.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Organic acid analysis | 0 | 0.457 | 0.001 | 0.474 | 1.949 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyssomnia | 0 | 0.457 | 0.001 | 0.474 | 1.949 |  |  |  |  |  | 
COVID19 (Custom Term) | Human chorionic gonadotropin increased | 0 | 0.732 | 0.007 | 0.474 | 1.648 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray with contrast lower gastrointestinal tract abnormal | 0 | 0.274 | 0 | 0.474 | 2.301 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchial obstruction | 0 | 0.732 | 0.006 | 0.473 | 1.647 |  |  |  |  |  | 
COVID19 (Custom Term) | Capsule endoscopy | 0 | 0.457 | 0.001 | 0.473 | 1.948 |  |  |  |  |  | 
COVID19 (Custom Term) | Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 0 | 0.934 | 0.015 | 0.473 | 1.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain neoplasm | 0 | 0.79 | 0.009 | 0.473 | 1.603 |  |  |  |  |  | 
COVID19 (Custom Term) | Bladder irritation | 0 | 0.366 | 0 | 0.472 | 2.099 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella zoster pneumonia | 0 | 0.179 | 0 | 0.471 | 2.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Otoscopy normal | 0 | 0.915 | 0.014 | 0.471 | 1.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Histology | 0 | 0.64 | 0.004 | 0.471 | 1.726 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site reaction | 0 | 0.494 | 0.001 | 0.471 | 1.893 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose-6-phosphate dehydrogenase | 0 | 0.366 | 0 | 0.471 | 2.098 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac electrophysiologic study normal | 0 | 0.549 | 0.002 | 0.47 | 1.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Smooth muscle antibody negative | 1 | 1.049 | 0.076 | 0.468 | 1.134 | 0.354 | 0.862 | 1.827 | 0.953 | 0.993 | 0.266
COVID19 (Custom Term) | Respiratory syncytial virus bronchiolitis | 0 | 0.47 | 0.001 | 0.468 | 1.922 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site necrosis | 0 | 0.875 | 0.011 | 0.468 | 1.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Red blood cell microcytes present | 0 | 0.732 | 0.006 | 0.468 | 1.642 |  |  |  |  |  | 
COVID19 (Custom Term) | Personality disorder | 0 | 0.678 | 0.004 | 0.468 | 1.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurodegenerative disorder | 0 | 0.549 | 0.002 | 0.468 | 1.821 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian cyst | 0 | 0.451 | 0 | 0.468 | 1.95 |  |  |  |  |  | 
COVID19 (Custom Term) | Pupillary light reflex tests normal | 0 | 0.915 | 0.013 | 0.467 | 1.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor X level normal | 0 | 0.31 | 0 | 0.467 | 2.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Obliterative bronchiolitis | 0 | 0.549 | 0.001 | 0.467 | 1.818 |  |  |  |  |  | 
COVID19 (Custom Term) | Product contamination microbial | 0 | 0.366 | 0 | 0.467 | 2.09 |  |  |  |  |  | 
COVID19 (Custom Term) | Eczema infected | 0 | 0.64 | 0.003 | 0.467 | 1.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema infectiosum | 0 | 0.732 | 0.006 | 0.467 | 1.641 |  |  |  |  |  | 
COVID19 (Custom Term) | Product appearance confusion | 0 | 0.675 | 0.004 | 0.466 | 1.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac valve disease | 0 | 0.732 | 0.006 | 0.466 | 1.639 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin striae | 0 | 0.792 | 0.008 | 0.466 | 1.593 |  |  |  |  |  | 
COVID19 (Custom Term) | Periarthritis | 7 | 19.874 | 0.234 | 0.465 | 0.76 | 0.245 | 0.426 | 0.696 | 0.352 | 0.2 | 21.171
COVID19 (Custom Term) | Normal pregnancy conditions and outcomes (SMQ) [narrow] | 30 | 87.882 | 0.336 | 0.465 | 0.612 | 0.268 | 0.361 | 0.476 | 0.341 | 0.48 | 15.566
COVID19 (Custom Term) | Educational problem | 0 | 0.304 | 0 | 0.465 | 2.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenovirus test positive | 0 | 0.987 | 0.016 | 0.465 | 1.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumocystis test positive | 0 | 0.366 | 0 | 0.464 | 2.085 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site oedema | 0 | 0.397 | 0 | 0.464 | 2.029 |  |  |  |  |  | 
COVID19 (Custom Term) | Ex-tobacco user | 0 | 0.274 | 0 | 0.464 | 2.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Obesity | 1 | 2.758 | 0.068 | 0.463 | 1.151 | 0.249 | 0.621 | 1.332 | 0.363 | 0.382 | 0.42
COVID19 (Custom Term) | Henoch-Schonlein purpura | 1 | 3.354 | 0.134 | 0.463 | 0.953 | 0.223 | 0.564 | 1.217 | 0.298 | 0.045 | 19.391
COVID19 (Custom Term) | Intestinal operation | 0 | 0.446 | 0 | 0.463 | 1.95 |  |  |  |  |  | 
COVID19 (Custom Term) | Cushing's syndrome | 0 | 0.366 | 0 | 0.463 | 2.084 |  |  |  |  |  | 
COVID19 (Custom Term) | Peritonsillar abscess | 0 | 0.64 | 0.003 | 0.463 | 1.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccine breakthrough infection | 0 | 1.135 | 0.022 | 0.463 | 1.398 |  |  |  |  |  | 
COVID19 (Custom Term) | Cellulitis orbital | 0 | 0.61 | 0.002 | 0.462 | 1.745 |  |  |  |  |  | 
COVID19 (Custom Term) | Cafe au lait spots | 0 | 0.47 | 0 | 0.461 | 1.913 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin erosion | 0 | 2.909 | 0.105 | 0.461 | 1.022 |  |  |  |  |  | 
COVID19 (Custom Term) | Male sexual dysfunction | 0 | 0.457 | 0 | 0.46 | 1.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Sepsis neonatal | 0 | 0.823 | 0.008 | 0.46 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Poor feeding infant | 0 | 1.233 | 0.027 | 0.46 | 1.354 |  |  |  |  |  | 
COVID19 (Custom Term) | Enteral nutrition | 0 | 0.549 | 0.001 | 0.46 | 1.81 |  |  |  |  |  | 
COVID19 (Custom Term) | Epstein-Barr virus infection | 0 | 1.663 | 0.049 | 0.46 | 1.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Addison's disease | 0 | 0.823 | 0.008 | 0.46 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood folate decreased | 0 | 0.823 | 0.008 | 0.46 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Sudden infant death syndrome | 0 | 1.206 | 0.025 | 0.46 | 1.365 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryoglobulins absent | 0 | 0.832 | 0.008 | 0.459 | 1.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain malformation | 0 | 0.457 | 0 | 0.459 | 1.927 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site pain | 0 | 0.619 | 0.002 | 0.459 | 1.733 |  |  |  |  |  | 
COVID19 (Custom Term) | Forced vital capacity | 0 | 0.366 | 0 | 0.459 | 2.076 |  |  |  |  |  | 
COVID19 (Custom Term) | Breast discharge | 0 | 0.452 | 0 | 0.458 | 1.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis minimal lesion | 0 | 0.915 | 0.011 | 0.457 | 1.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurilemmoma benign | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Type 2 lepra reaction | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Bipolar disorder | 0 | 1.07 | 0.018 | 0.457 | 1.421 |  |  |  |  |  | 
COVID19 (Custom Term) | Intraocular pressure decreased | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuroendocrine tumour | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Lack of satiety | 0 | 0.457 | 0 | 0.457 | 1.924 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurogenic bowel | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Retroperitoneal mass | 0 | 0.274 | 0 | 0.457 | 2.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Talipes | 0 | 0.732 | 0.005 | 0.456 | 1.628 |  |  |  |  |  | 
COVID19 (Custom Term) | Acanthosis | 0 | 0.549 | 0.001 | 0.456 | 1.803 |  |  |  |  |  | 
COVID19 (Custom Term) | Type I hypersensitivity | 0 | 0.402 | 0 | 0.456 | 2.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Laryngeal disorder | 0 | 0.483 | 0 | 0.455 | 1.885 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspiration bone marrow abnormal | 0 | 0.588 | 0.002 | 0.455 | 1.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin M increased | 0 | 0.773 | 0.006 | 0.455 | 1.595 |  |  |  |  |  | 
COVID19 (Custom Term) | Milk allergy | 0 | 1.436 | 0.035 | 0.455 | 1.279 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy intestine abnormal | 0 | 0.64 | 0.002 | 0.454 | 1.705 |  |  |  |  |  | 
COVID19 (Custom Term) | Faecal calprotectin increased | 0 | 0.526 | 0.001 | 0.454 | 1.829 |  |  |  |  |  | 
COVID19 (Custom Term) | Oculorespiratory syndrome | 0 | 0.5 | 0.001 | 0.454 | 1.861 |  |  |  |  |  | 
COVID19 (Custom Term) | Serology negative | 0 | 0.897 | 0.01 | 0.453 | 1.509 |  |  |  |  |  | 
COVID19 (Custom Term) | DNA antibody negative | 0 | 0.465 | 0 | 0.452 | 1.906 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid factor increased | 0 | 2.196 | 0.07 | 0.452 | 1.107 |  |  |  |  |  | 
COVID19 (Custom Term) | Product name confusion | 0 | 0.989 | 0.013 | 0.452 | 1.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Alopecia totalis | 0 | 0.549 | 0.001 | 0.452 | 1.798 |  |  |  |  |  | 
COVID19 (Custom Term) | Oppositional defiant disorder | 0 | 0.549 | 0.001 | 0.451 | 1.797 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure to communicable disease | 0 | 1.522 | 0.038 | 0.451 | 1.25 |  |  |  |  |  | 
COVID19 (Custom Term) | Respirovirus test positive | 0 | 0.744 | 0.005 | 0.45 | 1.611 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C | 0 | 0.64 | 0.002 | 0.449 | 1.699 |  |  |  |  |  | 
COVID19 (Custom Term) | Smallpox | 0 | 0.64 | 0.002 | 0.449 | 1.699 |  |  |  |  |  | 
COVID19 (Custom Term) | Nerve stimulation test normal | 0 | 0.549 | 0.001 | 0.449 | 1.794 |  |  |  |  |  | 
COVID19 (Custom Term) | Magnetic resonance neurography | 0 | 0.64 | 0.002 | 0.448 | 1.697 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site scab | 0 | 0.637 | 0.002 | 0.448 | 1.7 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung assist device therapy | 0 | 0.536 | 0.001 | 0.448 | 1.807 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella virus test positive | 1 | 3.728 | 0.056 | 0.447 | 1.149 | 0.208 | 0.532 | 1.154 | 0.268 | 0.036 | 25.015
COVID19 (Custom Term) | Scleroderma | 0 | 0.833 | 0.007 | 0.447 | 1.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatitis infected | 0 | 0.64 | 0.002 | 0.447 | 1.697 |  |  |  |  |  | 
COVID19 (Custom Term) | Light chain analysis | 0 | 0.457 | 0 | 0.447 | 1.908 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site cellulitis | 0 | 0.709 | 0.003 | 0.447 | 1.635 |  |  |  |  |  | 
COVID19 (Custom Term) | Amputation | 0 | 0.27 | 0 | 0.447 | 2.251 |  |  |  |  |  | 
COVID19 (Custom Term) | Erythema induratum | 0 | 0.915 | 0.009 | 0.446 | 1.491 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperplasia | 0 | 0.549 | 0.001 | 0.446 | 1.79 |  |  |  |  |  | 
COVID19 (Custom Term) | Amaurosis | 0 | 0.549 | 0.001 | 0.446 | 1.789 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral upper respiratory tract infection | 0 | 1.492 | 0.034 | 0.445 | 1.253 |  |  |  |  |  | 
COVID19 (Custom Term) | Performance status decreased | 0 | 0.817 | 0.006 | 0.445 | 1.552 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site abscess | 0 | 0.833 | 0.007 | 0.445 | 1.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased eye contact | 0 | 2.017 | 0.058 | 0.443 | 1.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Light chain analysis decreased | 0 | 0.366 | 0 | 0.443 | 2.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Kyphosis | 0 | 0.64 | 0.002 | 0.443 | 1.69 |  |  |  |  |  | 
COVID19 (Custom Term) | Occupational exposure to product | 1 | 3.922 | 0.063 | 0.442 | 1.106 | 0.2 | 0.517 | 1.124 | 0.255 | 0.144 | 4.135
COVID19 (Custom Term) | Cardiac monitoring normal | 1 | 3.95 | 0.127 | 0.442 | 0.912 | 0.199 | 0.515 | 1.12 | 0.253 | 0.276 | 1.156
COVID19 (Custom Term) | Thyroxine decreased | 0 | 0.823 | 0.006 | 0.442 | 1.543 |  |  |  |  |  | 
COVID19 (Custom Term) | Tubulointerstitial nephritis | 0 | 1.011 | 0.012 | 0.442 | 1.433 |  |  |  |  |  | 
COVID19 (Custom Term) | Tenodesis | 0 | 0.457 | 0 | 0.441 | 1.898 |  |  |  |  |  | 
COVID19 (Custom Term) | Papillitis | 0 | 0.64 | 0.002 | 0.441 | 1.687 |  |  |  |  |  | 
COVID19 (Custom Term) | Nephropathy toxic | 0 | 0.366 | 0 | 0.441 | 2.042 |  |  |  |  |  | 
COVID19 (Custom Term) | Central auditory processing disorder | 0 | 0.274 | 0 | 0.44 | 2.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Quadriparesis | 0 | 0.706 | 0.003 | 0.44 | 1.629 |  |  |  |  |  | 
COVID19 (Custom Term) | Patent ductus arteriosus | 0 | 0.457 | 0 | 0.44 | 1.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti factor VIII antibody positive | 0 | 0.183 | 0 | 0.439 | 2.437 |  |  |  |  |  | 
COVID19 (Custom Term) | Carnitine | 0 | 0.549 | 0.001 | 0.439 | 1.779 |  |  |  |  |  | 
COVID19 (Custom Term) | Lactose intolerance | 0 | 1.01 | 0.012 | 0.439 | 1.43 |  |  |  |  |  | 
COVID19 (Custom Term) | Parvovirus B19 test positive | 0 | 0.869 | 0.007 | 0.439 | 1.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Urogram normal | 0 | 0.457 | 0 | 0.439 | 1.894 |  |  |  |  |  | 
COVID19 (Custom Term) | Brachial plexopathy | 0 | 1.031 | 0.012 | 0.438 | 1.418 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotavirus test | 0 | 0.6 | 0.001 | 0.437 | 1.721 |  |  |  |  |  | 
COVID19 (Custom Term) | Concomitant disease aggravated | 0 | 0.555 | 0.001 | 0.437 | 1.769 |  |  |  |  |  | 
COVID19 (Custom Term) | Obstruction | 0 | 0.691 | 0.002 | 0.437 | 1.638 |  |  |  |  |  | 
COVID19 (Custom Term) | West Nile viral infection | 0 | 0.456 | 0 | 0.437 | 1.893 |  |  |  |  |  | 
COVID19 (Custom Term) | Juvenile idiopathic arthritis | 0 | 0.723 | 0.003 | 0.436 | 1.609 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lactate increased | 0 | 0.64 | 0.002 | 0.436 | 1.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebrospinal fluid leakage | 0 | 0.47 | 0 | 0.436 | 1.872 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometritis | 0 | 0.549 | 0.001 | 0.435 | 1.772 |  |  |  |  |  | 
COVID19 (Custom Term) | Coxsackie viral infection | 0 | 0.732 | 0.003 | 0.435 | 1.601 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via direct contact | 0 | 0.503 | 0 | 0.434 | 1.826 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site cellulitis | 0 | 0.47 | 0 | 0.434 | 1.869 |  |  |  |  |  | 
COVID19 (Custom Term) | pH body fluid increased | 0 | 0.549 | 0.001 | 0.433 | 1.77 |  |  |  |  |  | 
COVID19 (Custom Term) | Parotid gland enlargement | 0 | 0.656 | 0.002 | 0.433 | 1.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Repetitive strain injury | 0 | 0.549 | 0.001 | 0.432 | 1.768 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-SRP antibody positive | 0 | 0.366 | 0 | 0.431 | 2.021 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumovirus test positive | 0 | 0.64 | 0.001 | 0.431 | 1.674 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis adenovirus | 0 | 0.343 | 0 | 0.431 | 2.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Lower respiratory tract infection bacterial | 0 | 0.64 | 0.001 | 0.431 | 1.673 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypotonic-hyporesponsive episode (SMQ) [algorithm] | 2 | 3.846 | 0.119 | 0.43 | 0.897 | 0.304 | 0.672 | 1.323 | 0.52 | 0.02 | 93.137
COVID19 (Custom Term) | Complex regional pain syndrome | 1 | 2.753 | 0.045 | 0.43 | 1.146 | 0.249 | 0.622 | 1.333 | 0.363 | 0.105 | 6.65
COVID19 (Custom Term) | Product prescribing error | 0 | 2.624 | 0.076 | 0.43 | 1.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-platelet antibody negative | 0 | 0.732 | 0.003 | 0.43 | 1.594 |  |  |  |  |  | 
COVID19 (Custom Term) | Weight fluctuation | 0 | 0.331 | 0 | 0.429 | 2.079 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobin distribution width | 0 | 0.274 | 0 | 0.429 | 2.194 |  |  |  |  |  | 
COVID19 (Custom Term) | Scan abnormal | 0 | 1.053 | 0.011 | 0.429 | 1.397 |  |  |  |  |  | 
COVID19 (Custom Term) | Intentional self-injury | 0 | 0.814 | 0.004 | 0.429 | 1.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Head deformity | 0 | 0.274 | 0 | 0.429 | 2.192 |  |  |  |  |  | 
COVID19 (Custom Term) | Serum ferritin decreased | 0 | 0.887 | 0.006 | 0.429 | 1.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Normal pregnancy conditions and outcomes (SMQ) [broad] | 30 | 87.926 | 0.309 | 0.428 | 0.563 | 0.268 | 0.36 | 0.476 | 0.341 | 0.468 | 16.767
COVID19 (Custom Term) | Disturbance in social behaviour | 0 | 0.911 | 0.007 | 0.428 | 1.471 |  |  |  |  |  | 
COVID19 (Custom Term) | Antibody test normal | 0 | 0.64 | 0.001 | 0.428 | 1.67 |  |  |  |  |  | 
COVID19 (Custom Term) | Quality of life decreased | 1 | 3.395 | 0.054 | 0.427 | 1.095 | 0.221 | 0.56 | 1.21 | 0.295 | 0.044 | 19.692
COVID19 (Custom Term) | Myoclonic epilepsy | 0 | 0.801 | 0.004 | 0.427 | 1.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint lock | 1 | 2.989 | 0.075 | 0.426 | 1.012 | 0.239 | 0.598 | 1.285 | 0.335 | 0.242 | 1.572
COVID19 (Custom Term) | Bordetella infection | 0 | 0.457 | 0 | 0.426 | 1.871 |  |  |  |  |  | 
COVID19 (Custom Term) | Adenocarcinoma | 0 | 0.457 | 0 | 0.426 | 1.872 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site plaque | 0 | 0.549 | 0 | 0.426 | 1.758 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal malrotation | 0 | 0.673 | 0.002 | 0.426 | 1.637 |  |  |  |  |  | 
COVID19 (Custom Term) | T-lymphocyte count decreased | 0 | 0.543 | 0 | 0.425 | 1.764 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal disorder | 0 | 0.915 | 0.006 | 0.424 | 1.464 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchopulmonary aspergillosis allergic | 0 | 0.183 | 0 | 0.424 | 2.379 |  |  |  |  |  | 
COVID19 (Custom Term) | Salpingitis | 0 | 0.366 | 0 | 0.423 | 2.004 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site hyperaesthesia | 0 | 0.915 | 0.006 | 0.422 | 1.461 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatosis | 0 | 0.732 | 0.002 | 0.422 | 1.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Apgar score normal | 1 | 4.597 | 0.031 | 0.421 | 1.194 | 0.176 | 0.468 | 1.03 | 0.218 | 0.051 | 16.585
COVID19 (Custom Term) | Corynebacterium infection | 0 | 0.633 | 0.001 | 0.421 | 1.664 |  |  |  |  |  | 
COVID19 (Custom Term) | Child abuse | 0 | 0.366 | 0 | 0.42 | 1.996 |  |  |  |  |  | 
COVID19 (Custom Term) | Convulsions local | 0 | 0.823 | 0.004 | 0.42 | 1.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Schizoaffective disorder | 0 | 0.366 | 0 | 0.419 | 1.996 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF lactate normal | 0 | 0.549 | 0 | 0.418 | 1.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuropsychiatric syndrome | 0 | 0.823 | 0.004 | 0.417 | 1.51 |  |  |  |  |  | 
COVID19 (Custom Term) | HLA-B*27 assay | 0 | 0.767 | 0.003 | 0.417 | 1.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Marrow hyperplasia | 0 | 0.64 | 0.001 | 0.417 | 1.652 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotavirus test negative | 0 | 0.81 | 0.003 | 0.416 | 1.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Schizophrenia | 0 | 0.435 | 0 | 0.416 | 1.882 |  |  |  |  |  | 
COVID19 (Custom Term) | Circadian rhythm sleep disorder | 0 | 0.504 | 0 | 0.416 | 1.793 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic nerve disorder | 0 | 0.812 | 0.003 | 0.415 | 1.516 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood copper | 0 | 0.732 | 0.002 | 0.415 | 1.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Disseminated varicella zoster virus infection | 0 | 0.568 | 0 | 0.415 | 1.719 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxoplasma serology negative | 0 | 1.118 | 0.011 | 0.415 | 1.351 |  |  |  |  |  | 
COVID19 (Custom Term) | Salivary gland enlargement | 0 | 0.788 | 0.003 | 0.415 | 1.531 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute haemorrhagic oedema of infancy | 0 | 0.606 | 0.001 | 0.415 | 1.681 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichen sclerosus | 0 | 0.732 | 0.002 | 0.415 | 1.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital herpes zoster | 0 | 0.32 | 0 | 0.414 | 2.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyp | 0 | 0.549 | 0 | 0.414 | 1.739 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine potassium | 0 | 0.168 | 0 | 0.413 | 2.36 |  |  |  |  |  | 
COVID19 (Custom Term) | Malignant melanoma | 0 | 0.915 | 0.005 | 0.413 | 1.449 |  |  |  |  |  | 
COVID19 (Custom Term) | Human herpes virus 6 serology | 0 | 0.823 | 0.003 | 0.412 | 1.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Amino acid level increased | 0 | 0.823 | 0.003 | 0.412 | 1.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-transglutaminase antibody | 0 | 0.64 | 0.001 | 0.411 | 1.642 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site pustule | 0 | 1.857 | 0.037 | 0.411 | 1.125 |  |  |  |  |  | 
COVID19 (Custom Term) | Shoulder deformity | 0 | 0.457 | 0 | 0.411 | 1.842 |  |  |  |  |  | 
COVID19 (Custom Term) | Histiocytosis | 0 | 0.457 | 0 | 0.411 | 1.842 |  |  |  |  |  | 
COVID19 (Custom Term) | Polymyositis | 0 | 0.694 | 0.001 | 0.411 | 1.597 |  |  |  |  |  | 
COVID19 (Custom Term) | Parvovirus infection | 0 | 0.549 | 0 | 0.41 | 1.731 |  |  |  |  |  | 
COVID19 (Custom Term) | Mite allergy | 0 | 0.594 | 0.001 | 0.41 | 1.685 |  |  |  |  |  | 
COVID19 (Custom Term) | Smear site unspecified normal | 0 | 0.823 | 0.003 | 0.41 | 1.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Parotitis | 0 | 0.514 | 0 | 0.41 | 1.771 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal gastrointestinal tract imaging abnormal | 0 | 0.366 | 0 | 0.41 | 1.974 |  |  |  |  |  | 
COVID19 (Custom Term) | Precancerous mucosal lesion | 0 | 0.366 | 0 | 0.41 | 1.974 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute polyneuropathy | 0 | 0.823 | 0.003 | 0.409 | 1.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasite stool test negative | 0 | 0.773 | 0.002 | 0.409 | 1.533 |  |  |  |  |  | 
COVID19 (Custom Term) | Base excess negative | 0 | 0.949 | 0.006 | 0.409 | 1.424 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal operation | 0 | 0.711 | 0.001 | 0.409 | 1.579 |  |  |  |  |  | 
COVID19 (Custom Term) | Endometriosis | 0 | 0.411 | 0 | 0.408 | 1.902 |  |  |  |  |  | 
COVID19 (Custom Term) | Labelled drug-disease interaction medication error | 0 | 0.549 | 0 | 0.408 | 1.729 |  |  |  |  |  | 
COVID19 (Custom Term) | Fear of falling | 0 | 0.457 | 0 | 0.408 | 1.838 |  |  |  |  |  | 
COVID19 (Custom Term) | Physical disability | 0 | 0.415 | 0 | 0.408 | 1.894 |  |  |  |  |  | 
COVID19 (Custom Term) | Tuberculosis | 0 | 1.08 | 0.009 | 0.408 | 1.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinol binding protein | 0 | 0.47 | 0 | 0.407 | 1.818 |  |  |  |  |  | 
COVID19 (Custom Term) | Postictal paralysis | 0 | 0.915 | 0.005 | 0.407 | 1.44 |  |  |  |  |  | 
COVID19 (Custom Term) | Exanthema subitum | 0 | 0.95 | 0.005 | 0.407 | 1.421 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster infection neurological | 0 | 0.484 | 0 | 0.406 | 1.8 |  |  |  |  |  | 
COVID19 (Custom Term) | Face and mouth X-ray | 0 | 0.579 | 0 | 0.405 | 1.691 |  |  |  |  |  | 
COVID19 (Custom Term) | Peak expiratory flow rate decreased | 0 | 0.64 | 0.001 | 0.405 | 1.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Precancerous cells present | 0 | 0.588 | 0 | 0.404 | 1.682 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubulavirus test positive | 0 | 0.265 | 0 | 0.404 | 2.139 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimicrobial susceptibility test resistant | 0 | 0.64 | 0.001 | 0.404 | 1.631 |  |  |  |  |  | 
COVID19 (Custom Term) | Combined immunodeficiency | 0 | 0.575 | 0 | 0.404 | 1.694 |  |  |  |  |  | 
COVID19 (Custom Term) | Retinal detachment | 0 | 0.979 | 0.006 | 0.404 | 1.401 |  |  |  |  |  | 
COVID19 (Custom Term) | Double stranded DNA antibody | 0 | 0.936 | 0.005 | 0.404 | 1.425 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C RNA decreased | 0 | 0.366 | 0 | 0.403 | 1.958 |  |  |  |  |  | 
COVID19 (Custom Term) | Mixed connective tissue disease | 0 | 0.457 | 0 | 0.403 | 1.826 |  |  |  |  |  | 
COVID19 (Custom Term) | Interferon gamma release assay | 0 | 0.457 | 0 | 0.403 | 1.826 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal motility disorder | 0 | 0.622 | 0.001 | 0.402 | 1.645 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal necrosis | 0 | 0.532 | 0 | 0.402 | 1.735 |  |  |  |  |  | 
COVID19 (Custom Term) | Abscess sterile | 0 | 0.873 | 0.003 | 0.401 | 1.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Bronchiolitis | 0 | 1.692 | 0.028 | 0.401 | 1.15 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site vesicles | 0 | 1.035 | 0.007 | 0.401 | 1.37 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site rash | 0 | 2.036 | 0.04 | 0.401 | 1.079 |  |  |  |  |  | 
COVID19 (Custom Term) | Lichen planus | 0 | 0.703 | 0.001 | 0.4 | 1.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium enema | 0 | 0.689 | 0.001 | 0.399 | 1.581 |  |  |  |  |  | 
COVID19 (Custom Term) | Mastoiditis | 0 | 0.795 | 0.002 | 0.399 | 1.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Growing pains | 0 | 0.549 | 0 | 0.399 | 1.711 |  |  |  |  |  | 
COVID19 (Custom Term) | Fundoscopy normal | 0 | 0.932 | 0.004 | 0.399 | 1.42 |  |  |  |  |  | 
COVID19 (Custom Term) | Post lumbar puncture syndrome | 0 | 0.823 | 0.002 | 0.399 | 1.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Asphyxia | 0 | 1.153 | 0.009 | 0.399 | 1.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Graft versus host disease | 0 | 0.915 | 0.004 | 0.398 | 1.427 |  |  |  |  |  | 
COVID19 (Custom Term) | Macular oedema | 0 | 0.64 | 0.001 | 0.398 | 1.621 |  |  |  |  |  | 
COVID19 (Custom Term) | Electroneuromyography | 0 | 0.658 | 0.001 | 0.398 | 1.606 |  |  |  |  |  | 
COVID19 (Custom Term) | Evans syndrome | 0 | 0.549 | 0 | 0.398 | 1.71 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocrine test normal | 0 | 0.823 | 0.002 | 0.398 | 1.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic sinusitis | 0 | 0.815 | 0.002 | 0.398 | 1.489 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrosomia | 0 | 0.457 | 0 | 0.398 | 1.816 |  |  |  |  |  | 
COVID19 (Custom Term) | Shoulder injury related to vaccine administration | 5 | 20.174 | 0.169 | 0.396 | 0.7 | 0.176 | 0.333 | 0.58 | 0.248 | 0.373 | 4.429
COVID19 (Custom Term) | Urticarial vasculitis | 0 | 0.676 | 0.001 | 0.396 | 1.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystoid macular oedema | 0 | 0.366 | 0 | 0.395 | 1.938 |  |  |  |  |  | 
COVID19 (Custom Term) | Amoebiasis | 0 | 0.265 | 0 | 0.395 | 2.109 |  |  |  |  |  | 
COVID19 (Custom Term) | Salt craving | 0 | 0.366 | 0 | 0.395 | 1.937 |  |  |  |  |  | 
COVID19 (Custom Term) | Epicondylitis | 0 | 1.898 | 0.032 | 0.394 | 1.096 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine organic acid test | 0 | 0.915 | 0.004 | 0.394 | 1.423 |  |  |  |  |  | 
COVID19 (Custom Term) | Steroid dependence | 0 | 0.274 | 0 | 0.394 | 2.089 |  |  |  |  |  | 
COVID19 (Custom Term) | Thyroxine increased | 0 | 0.915 | 0.004 | 0.394 | 1.423 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunoglobulins increased | 0 | 0.915 | 0.004 | 0.394 | 1.422 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychiatric evaluation | 0 | 0.76 | 0.001 | 0.393 | 1.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site swelling | 0 | 3.255 | 0.074 | 0.393 | 0.916 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site pustule | 0 | 0.364 | 0 | 0.393 | 1.936 |  |  |  |  |  | 
COVID19 (Custom Term) | Hydrocele | 0 | 0.732 | 0.001 | 0.392 | 1.538 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitello-intestinal duct remnant | 0 | 0.523 | 0 | 0.392 | 1.725 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis cholestatic | 0 | 0.274 | 0 | 0.392 | 2.082 |  |  |  |  |  | 
COVID19 (Custom Term) | Weaning failure | 0 | 0.457 | 0 | 0.392 | 1.803 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelocyte count | 0 | 0.246 | 0 | 0.392 | 2.131 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C RNA negative | 0 | 0.457 | 0 | 0.392 | 1.802 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product effect decreased | 0 | 0.733 | 0.001 | 0.392 | 1.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Product quality issue | 1 | 1.267 | 0.06 | 0.391 | 0.963 | 0.337 | 0.822 | 1.744 | 0.789 | 0.032 | 28.233
COVID19 (Custom Term) | Urine protein/creatinine ratio | 0 | 0.64 | 0 | 0.39 | 1.607 |  |  |  |  |  | 
COVID19 (Custom Term) | Quadriplegia | 0 | 0.695 | 0.001 | 0.39 | 1.562 |  |  |  |  |  | 
COVID19 (Custom Term) | Rheumatoid factor positive | 0 | 0.752 | 0.001 | 0.389 | 1.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis meningococcal | 0 | 0.366 | 0 | 0.389 | 1.922 |  |  |  |  |  | 
COVID19 (Custom Term) | Postpartum haemorrhage | 0 | 0.457 | 0 | 0.389 | 1.797 |  |  |  |  |  | 
COVID19 (Custom Term) | Ulcer haemorrhage | 0 | 0.366 | 0 | 0.388 | 1.92 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurogenic shock | 0 | 0.284 | 0 | 0.388 | 2.054 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular malformation | 0 | 0.31 | 0 | 0.388 | 2.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Cyst | 0 | 1.741 | 0.024 | 0.386 | 1.12 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatocellular injury | 0 | 0.408 | 0 | 0.385 | 1.853 |  |  |  |  |  | 
COVID19 (Custom Term) | Gluten free diet | 0 | 0.457 | 0 | 0.385 | 1.788 |  |  |  |  |  | 
COVID19 (Custom Term) | Skeletal survey normal | 0 | 0.57 | 0 | 0.385 | 1.664 |  |  |  |  |  | 
COVID19 (Custom Term) | Brucella test negative | 0 | 0.66 | 0.001 | 0.385 | 1.582 |  |  |  |  |  | 
COVID19 (Custom Term) | Croup infectious | 0 | 1.157 | 0.008 | 0.385 | 1.294 |  |  |  |  |  | 
COVID19 (Custom Term) | Poor sucking reflex | 0 | 0.709 | 0.001 | 0.384 | 1.541 |  |  |  |  |  | 
COVID19 (Custom Term) | Oliguria | 0 | 0.445 | 0 | 0.384 | 1.801 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory papilloma | 0 | 0.419 | 0 | 0.384 | 1.835 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound thyroid abnormal | 0 | 0.695 | 0.001 | 0.383 | 1.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle mass | 0 | 0.915 | 0.003 | 0.383 | 1.406 |  |  |  |  |  | 
COVID19 (Custom Term) | Metal poisoning | 0 | 0.814 | 0.002 | 0.383 | 1.466 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperpyrexia | 2 | 4.932 | 0.082 | 0.382 | 0.861 | 0.263 | 0.585 | 1.155 | 0.406 | 0.023 | 81.605
COVID19 (Custom Term) | Somatosensory evoked potentials abnormal | 0 | 0.663 | 0 | 0.382 | 1.573 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual evoked potentials abnormal | 0 | 0.385 | 0 | 0.382 | 1.874 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin candida | 0 | 0.64 | 0 | 0.382 | 1.593 |  |  |  |  |  | 
COVID19 (Custom Term) | Listeria test | 0 | 0.732 | 0.001 | 0.382 | 1.521 |  |  |  |  |  | 
COVID19 (Custom Term) | Nonspecific reaction | 0 | 1.49 | 0.016 | 0.381 | 1.177 |  |  |  |  |  | 
COVID19 (Custom Term) | Impulsive behaviour | 0 | 0.823 | 0.002 | 0.38 | 1.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes simplex test positive | 0 | 1.569 | 0.018 | 0.38 | 1.154 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitritis | 0 | 0.823 | 0.002 | 0.38 | 1.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Gestational hypertension | 1 | 6.027 | 0.028 | 0.379 | 1.075 | 0.131 | 0.385 | 0.874 | 0.166 | 0.451 | 0.191
COVID19 (Custom Term) | Stem cell transplant | 0 | 1.093 | 0.005 | 0.379 | 1.312 |  |  |  |  |  | 
COVID19 (Custom Term) | Salmonella test negative | 0 | 0.925 | 0.003 | 0.378 | 1.393 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone contusion | 0 | 0.549 | 0 | 0.378 | 1.671 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasitic blood test negative | 0 | 0.823 | 0.001 | 0.378 | 1.452 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood aluminium | 0 | 0.732 | 0.001 | 0.378 | 1.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood testosterone decreased | 0 | 0.732 | 0.001 | 0.377 | 1.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Trichotillomania | 0 | 0.64 | 0 | 0.377 | 1.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Urea urine normal | 0 | 0.267 | 0 | 0.376 | 2.042 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-neutrophil cytoplasmic antibody positive vasculitis | 0 | 0.577 | 0 | 0.376 | 1.638 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatosensory evoked potentials | 0 | 0.51 | 0 | 0.376 | 1.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis | 0 | 0.549 | 0 | 0.375 | 1.665 |  |  |  |  |  | 
COVID19 (Custom Term) | Hallucinations, mixed | 0 | 0.915 | 0.002 | 0.375 | 1.393 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatotoxicity | 0 | 0.457 | 0 | 0.374 | 1.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Eosinophilic cellulitis | 0 | 0.607 | 0 | 0.374 | 1.607 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound eye abnormal | 0 | 0.549 | 0 | 0.374 | 1.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytogenetic abnormality | 0 | 0.823 | 0.001 | 0.373 | 1.443 |  |  |  |  |  | 
COVID19 (Custom Term) | Leukodystrophy | 0 | 0.64 | 0 | 0.373 | 1.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair colour changes | 0 | 0.732 | 0.001 | 0.373 | 1.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicocele | 0 | 0.366 | 0 | 0.373 | 1.878 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis post immunisation | 0 | 0.596 | 0 | 0.372 | 1.613 |  |  |  |  |  | 
COVID19 (Custom Term) | Gluten sensitivity | 0 | 1.168 | 0.006 | 0.372 | 1.272 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin lesion removal | 0 | 0.823 | 0.001 | 0.372 | 1.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Sleep study abnormal | 0 | 0.857 | 0.002 | 0.372 | 1.42 |  |  |  |  |  | 
COVID19 (Custom Term) | Irritable bowel syndrome | 2 | 6.903 | 0.089 | 0.371 | 0.811 | 0.208 | 0.471 | 0.937 | 0.29 | 0.17 | 7.116
COVID19 (Custom Term) | Corynebacterium test positive | 0 | 0.436 | 0 | 0.371 | 1.781 |  |  |  |  |  | 
COVID19 (Custom Term) | Chest scan | 0 | 0.732 | 0.001 | 0.371 | 1.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy site unspecified normal | 0 | 0.327 | 0 | 0.371 | 1.931 |  |  |  |  |  | 
COVID19 (Custom Term) | Amaurosis fugax | 0 | 0.631 | 0 | 0.369 | 1.575 |  |  |  |  |  | 
COVID19 (Custom Term) | Endoscopy upper gastrointestinal tract | 0 | 0.763 | 0.001 | 0.369 | 1.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Attention deficit hyperactivity disorder | 0 | 1.385 | 0.01 | 0.367 | 1.189 |  |  |  |  |  | 
COVID19 (Custom Term) | Microbiology test abnormal | 0 | 0.64 | 0 | 0.367 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal infection | 0 | 1.76 | 0.019 | 0.366 | 1.09 |  |  |  |  |  | 
COVID19 (Custom Term) | Kawasaki's disease | 0 | 1.477 | 0.012 | 0.366 | 1.161 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaginal disorder | 0 | 0.457 | 0 | 0.366 | 1.743 |  |  |  |  |  | 
COVID19 (Custom Term) | Cortisol increased | 0 | 0.915 | 0.002 | 0.366 | 1.378 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillectomy | 0 | 0.915 | 0.002 | 0.365 | 1.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatomyositis | 0 | 0.654 | 0 | 0.365 | 1.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Penile erythema | 0 | 0.357 | 0 | 0.364 | 1.864 |  |  |  |  |  | 
COVID19 (Custom Term) | Small intestinal intussusception reduction | 0 | 0.389 | 0 | 0.364 | 1.823 |  |  |  |  |  | 
COVID19 (Custom Term) | Glomerulonephritis acute | 0 | 0.549 | 0 | 0.362 | 1.637 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound skull abnormal | 0 | 0.634 | 0 | 0.361 | 1.558 |  |  |  |  |  | 
COVID19 (Custom Term) | Osteolysis | 0 | 0.732 | 0 | 0.361 | 1.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Adjustment disorder | 0 | 0.823 | 0.001 | 0.361 | 1.423 |  |  |  |  |  | 
COVID19 (Custom Term) | Bursal fluid accumulation | 0 | 1.821 | 0.02 | 0.361 | 1.071 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatocellular carcinoma | 0 | 0.359 | 0 | 0.361 | 1.853 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendon disorder | 1 | 6.257 | 0.07 | 0.36 | 0.834 | 0.125 | 0.374 | 0.853 | 0.16 | 0.158 | 3.567
COVID19 (Custom Term) | Fibrin degradation products increased | 0 | 0.457 | 0 | 0.36 | 1.727 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth infection | 0 | 2.762 | 0.045 | 0.36 | 0.927 |  |  |  |  |  | 
COVID19 (Custom Term) | Coeliac disease | 0 | 1.47 | 0.011 | 0.36 | 1.153 |  |  |  |  |  | 
COVID19 (Custom Term) | Distractibility | 0 | 0.64 | 0 | 0.359 | 1.548 |  |  |  |  |  | 
COVID19 (Custom Term) | Dental caries | 0 | 0.323 | 0 | 0.359 | 1.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Mycotic allergy | 0 | 0.732 | 0 | 0.358 | 1.478 |  |  |  |  |  | 
COVID19 (Custom Term) | Tracheostomy | 0 | 0.723 | 0 | 0.358 | 1.483 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy salivary gland normal | 0 | 0.549 | 0 | 0.358 | 1.626 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement deficiency disease | 0 | 0.366 | 0 | 0.357 | 1.833 |  |  |  |  |  | 
COVID19 (Custom Term) | Culture stool positive | 0 | 0.431 | 0 | 0.356 | 1.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Papilloma excision | 0 | 0.577 | 0 | 0.355 | 1.594 |  |  |  |  |  | 
COVID19 (Custom Term) | Glycosuria | 0 | 0.915 | 0.001 | 0.355 | 1.361 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular pain | 0 | 0.758 | 0 | 0.355 | 1.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Antimicrobial susceptibility test | 0 | 0.915 | 0.001 | 0.354 | 1.358 |  |  |  |  |  | 
COVID19 (Custom Term) | Human chorionic gonadotropin normal | 0 | 0.732 | 0 | 0.354 | 1.469 |  |  |  |  |  | 
COVID19 (Custom Term) | Adnexa uteri pain | 0 | 0.503 | 0 | 0.353 | 1.661 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychiatric evaluation abnormal | 0 | 0.549 | 0 | 0.353 | 1.616 |  |  |  |  |  | 
COVID19 (Custom Term) | Enema administration | 0 | 1.237 | 0.005 | 0.353 | 1.218 |  |  |  |  |  | 
COVID19 (Custom Term) | Irritability postvaccinal | 0 | 0.538 | 0 | 0.352 | 1.623 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium double contrast | 0 | 0.495 | 0 | 0.352 | 1.668 |  |  |  |  |  | 
COVID19 (Custom Term) | Compartment syndrome | 0 | 0.915 | 0.001 | 0.351 | 1.354 |  |  |  |  |  | 
COVID19 (Custom Term) | Schellong test | 0 | 0.263 | 0 | 0.35 | 1.949 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile back arching | 0 | 0.725 | 0 | 0.35 | 1.467 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood heavy metal normal | 0 | 2.229 | 0.027 | 0.35 | 0.984 |  |  |  |  |  | 
COVID19 (Custom Term) | Social anxiety disorder | 0 | 0.526 | 0 | 0.349 | 1.629 |  |  |  |  |  | 
COVID19 (Custom Term) | Scarlet fever | 0 | 0.793 | 0.001 | 0.349 | 1.421 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubella | 0 | 0.313 | 0 | 0.348 | 1.873 |  |  |  |  |  | 
COVID19 (Custom Term) | Colitis microscopic | 0 | 0.915 | 0.001 | 0.348 | 1.348 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningococcal bacteraemia | 0 | 0.355 | 0 | 0.347 | 1.816 |  |  |  |  |  | 
COVID19 (Custom Term) | Positron emission tomogram | 1 | 3.602 | 0.064 | 0.346 | 0.81 | 0.213 | 0.542 | 1.175 | 0.278 | 0.342 | 0.622
COVID19 (Custom Term) | Cervix disorder | 0 | 0.377 | 0 | 0.346 | 1.785 |  |  |  |  |  | 
COVID19 (Custom Term) | Apoptosis | 0 | 0.454 | 0 | 0.345 | 1.692 |  |  |  |  |  | 
COVID19 (Custom Term) | Depression suicidal | 0 | 0.419 | 0 | 0.345 | 1.73 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervicectomy | 0 | 0.457 | 0 | 0.345 | 1.687 |  |  |  |  |  | 
COVID19 (Custom Term) | Brain stem auditory evoked response normal | 0 | 0.876 | 0.001 | 0.344 | 1.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune hypothyroidism | 0 | 0.457 | 0 | 0.344 | 1.686 |  |  |  |  |  | 
COVID19 (Custom Term) | Secondary transmission | 0 | 0.63 | 0 | 0.344 | 1.525 |  |  |  |  |  | 
COVID19 (Custom Term) | Necrotising colitis | 0 | 0.76 | 0 | 0.344 | 1.432 |  |  |  |  |  | 
COVID19 (Custom Term) | Scoliosis | 0 | 0.895 | 0.001 | 0.344 | 1.352 |  |  |  |  |  | 
COVID19 (Custom Term) | Glucose-6-phosphate dehydrogenase normal | 0 | 0.196 | 0 | 0.342 | 1.984 |  |  |  |  |  | 
COVID19 (Custom Term) | Cytomegalovirus test positive | 0 | 1.875 | 0.016 | 0.341 | 1.032 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthrogram | 0 | 0.457 | 0 | 0.341 | 1.677 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster meningitis | 0 | 0.345 | 0 | 0.34 | 1.804 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystatin C | 0 | 0.64 | 0 | 0.34 | 1.508 |  |  |  |  |  | 
COVID19 (Custom Term) | Pyelitis | 0 | 0.732 | 0 | 0.34 | 1.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Asthmatic crisis | 0 | 0.672 | 0 | 0.339 | 1.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Documented hypersensitivity to administered product | 0 | 2.093 | 0.021 | 0.339 | 0.991 |  |  |  |  |  | 
COVID19 (Custom Term) | Q fever | 0 | 0.541 | 0 | 0.338 | 1.587 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral myocarditis | 0 | 0.915 | 0.001 | 0.338 | 1.331 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound liver abnormal | 0 | 0.823 | 0 | 0.338 | 1.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Herpes zoster | 120 | 309.319 | 0.288 | 0.337 | 0.389 | 0.338 | 0.393 | 0.455 | 0.388 | 0.116 | 826.055
COVID19 (Custom Term) | Neurosis | 0 | 0.452 | 0 | 0.337 | 1.671 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood follicle stimulating hormone increased | 0 | 0.568 | 0 | 0.337 | 1.559 |  |  |  |  |  | 
COVID19 (Custom Term) | Precancerous skin lesion | 0 | 0.419 | 0 | 0.337 | 1.707 |  |  |  |  |  | 
COVID19 (Custom Term) | Presbyacusis | 0 | 0.358 | 0 | 0.337 | 1.778 |  |  |  |  |  | 
COVID19 (Custom Term) | Miller Fisher syndrome | 0 | 1.625 | 0.01 | 0.337 | 1.08 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs indirect test positive | 0 | 0.457 | 0 | 0.336 | 1.662 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal hypoxia | 0 | 0.478 | 0 | 0.336 | 1.642 |  |  |  |  |  | 
COVID19 (Custom Term) | Ammonia | 0 | 0.64 | 0 | 0.335 | 1.497 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site hypertrichosis | 0 | 0.366 | 0 | 0.334 | 1.759 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryotherapy | 0 | 0.844 | 0.001 | 0.334 | 1.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Clinically isolated syndrome | 0 | 0.256 | 0 | 0.334 | 1.89 |  |  |  |  |  | 
COVID19 (Custom Term) | Excessive ocular convergence | 0 | 0.183 | 0 | 0.334 | 1.943 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor V level decreased | 0 | 0.271 | 0 | 0.334 | 1.872 |  |  |  |  |  | 
COVID19 (Custom Term) | Malabsorption | 0 | 0.857 | 0.001 | 0.332 | 1.35 |  |  |  |  |  | 
COVID19 (Custom Term) | Influenza A virus test positive | 3 | 8.114 | 0.095 | 0.331 | 0.681 | 0.247 | 0.511 | 0.956 | 0.37 | 0.064 | 39.598
COVID19 (Custom Term) | Pancreatitis chronic | 0 | 0.457 | 0 | 0.331 | 1.649 |  |  |  |  |  | 
COVID19 (Custom Term) | Single photon emission computerised tomogram normal | 0 | 0.17 | 0 | 0.33 | 1.921 |  |  |  |  |  | 
COVID19 (Custom Term) | Sensory integrative dysfunction | 0 | 0.617 | 0 | 0.33 | 1.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Chiropractic | 0 | 2.979 | 0.037 | 0.33 | 0.866 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF oligoclonal band present | 0 | 1.091 | 0.002 | 0.329 | 1.233 |  |  |  |  |  | 
COVID19 (Custom Term) | Vesicoureteric reflux | 0 | 0.549 | 0 | 0.329 | 1.557 |  |  |  |  |  | 
COVID19 (Custom Term) | CD8 lymphocytes | 0 | 0.63 | 0 | 0.328 | 1.49 |  |  |  |  |  | 
COVID19 (Custom Term) | Intestinal anastomosis | 0 | 0.549 | 0 | 0.328 | 1.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Immobilisation syndrome | 0 | 0.362 | 0 | 0.328 | 1.741 |  |  |  |  |  | 
COVID19 (Custom Term) | Gene mutation identification test negative | 1 | 3.588 | 0.031 | 0.327 | 0.888 | 0.213 | 0.544 | 1.177 | 0.279 | 0.261 | 1.32
COVID19 (Custom Term) | Prothrombin time ratio | 0 | 0.529 | 0 | 0.327 | 1.571 |  |  |  |  |  | 
COVID19 (Custom Term) | Catarrh | 0 | 1.029 | 0.001 | 0.327 | 1.257 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs direct test positive | 0 | 0.915 | 0.001 | 0.327 | 1.309 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrocardiogram QT interval | 0 | 0.915 | 0.001 | 0.326 | 1.308 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C antibody positive | 0 | 0.549 | 0 | 0.326 | 1.55 |  |  |  |  |  | 
COVID19 (Custom Term) | Natural killer cell count | 0 | 0.788 | 0 | 0.325 | 1.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterovirus test positive | 0 | 1.309 | 0.004 | 0.324 | 1.147 |  |  |  |  |  | 
COVID19 (Custom Term) | Cystitis interstitial | 0 | 0.744 | 0 | 0.324 | 1.4 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antibody positive | 1 | 3.285 | 0.022 | 0.323 | 0.927 | 0.225 | 0.57 | 1.229 | 0.304 | 0.035 | 25.517
COVID19 (Custom Term) | Hyperthermia | 0 | 1.226 | 0.003 | 0.323 | 1.173 |  |  |  |  |  | 
COVID19 (Custom Term) | Activated partial thromboplastin time ratio | 0 | 0.721 | 0 | 0.323 | 1.412 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular purpura | 0 | 0.823 | 0 | 0.322 | 1.349 |  |  |  |  |  | 
COVID19 (Custom Term) | Tumour marker test | 0 | 0.549 | 0 | 0.322 | 1.54 |  |  |  |  |  | 
COVID19 (Custom Term) | Measles antibody | 0 | 0.939 | 0.001 | 0.322 | 1.288 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral circulatory failure | 0 | 0.457 | 0 | 0.321 | 1.62 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunophenotyping | 0 | 0.839 | 0 | 0.321 | 1.338 |  |  |  |  |  | 
COVID19 (Custom Term) | Colposcopy abnormal | 0 | 0.237 | 0 | 0.321 | 1.846 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral titre decreased | 0 | 0.426 | 0 | 0.321 | 1.65 |  |  |  |  |  | 
COVID19 (Custom Term) | Cryoglobulins present | 0 | 0.594 | 0 | 0.32 | 1.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningoencephalitis herpetic | 0 | 0.915 | 0.001 | 0.32 | 1.297 |  |  |  |  |  | 
COVID19 (Custom Term) | Vascular endothelial growth factor assay | 0 | 0.17 | 0 | 0.32 | 1.86 |  |  |  |  |  | 
COVID19 (Custom Term) | Emergency care examination | 0 | 0.362 | 0 | 0.319 | 1.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis enteroviral | 0 | 0.361 | 0 | 0.319 | 1.713 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B core antigen | 0 | 0.193 | 0 | 0.319 | 1.859 |  |  |  |  |  | 
COVID19 (Custom Term) | Loss of employment | 0 | 0.915 | 0.001 | 0.319 | 1.293 |  |  |  |  |  | 
COVID19 (Custom Term) | Abnormal weight gain | 0 | 0.562 | 0 | 0.318 | 1.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine sodium | 0 | 0.64 | 0 | 0.318 | 1.458 |  |  |  |  |  | 
COVID19 (Custom Term) | Monoclonal gammopathy | 0 | 0.549 | 0 | 0.318 | 1.529 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal heart rate increased | 0 | 0.274 | 0 | 0.317 | 1.796 |  |  |  |  |  | 
COVID19 (Custom Term) | Homeopathy | 0 | 0.64 | 0 | 0.317 | 1.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Optic atrophy | 0 | 0.866 | 0 | 0.317 | 1.315 |  |  |  |  |  | 
COVID19 (Custom Term) | Product temperature excursion issue | 0 | 0.507 | 0 | 0.317 | 1.561 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory tract infection bacterial | 0 | 0.549 | 0 | 0.317 | 1.525 |  |  |  |  |  | 
COVID19 (Custom Term) | Epilepsy | 2 | 6.401 | 0.077 | 0.316 | 0.686 | 0.22 | 0.496 | 0.984 | 0.312 | 0.028 | 66.853
COVID19 (Custom Term) | Beta-2 glycoprotein antibody positive | 0 | 0.823 | 0 | 0.315 | 1.334 |  |  |  |  |  | 
COVID19 (Custom Term) | Abortion | 0 | 0.524 | 0 | 0.314 | 1.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Beta haemolytic streptococcal infection | 1 | 6.076 | 0.034 | 0.313 | 0.829 | 0.13 | 0.383 | 0.87 | 0.165 | 0.284 | 1.076
COVID19 (Custom Term) | Joint warmth | 0 | 2.714 | 0.025 | 0.312 | 0.869 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin turgor decreased | 0 | 0.732 | 0 | 0.312 | 1.38 |  |  |  |  |  | 
COVID19 (Custom Term) | Cortical dysplasia | 0 | 0.259 | 0 | 0.312 | 1.787 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature delivery | 8 | 37.828 | 0.157 | 0.311 | 0.508 | 0.152 | 0.262 | 0.423 | 0.211 | 0.606 | 1.541
COVID19 (Custom Term) | Chronic lymphocytic leukaemia | 0 | 0.915 | 0 | 0.311 | 1.278 |  |  |  |  |  | 
COVID19 (Custom Term) | Metabolic alkalosis | 0 | 0.366 | 0 | 0.311 | 1.677 |  |  |  |  |  | 
COVID19 (Custom Term) | Coombs test negative | 0 | 0.915 | 0 | 0.31 | 1.276 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis C RNA increased | 0 | 0.549 | 0 | 0.31 | 1.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Hirsutism | 0 | 0.672 | 0 | 0.31 | 1.416 |  |  |  |  |  | 
COVID19 (Custom Term) | Febrile convulsion | 1 | 4.379 | 0.072 | 0.309 | 0.679 | 0.184 | 0.483 | 1.059 | 0.228 | 0.006 | 152.707
COVID19 (Custom Term) | Connective tissue disorder | 0 | 1.545 | 0.005 | 0.309 | 1.056 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin A increased | 0 | 2.377 | 0.018 | 0.309 | 0.907 |  |  |  |  |  | 
COVID19 (Custom Term) | Colectomy | 0 | 0.823 | 0 | 0.309 | 1.322 |  |  |  |  |  | 
COVID19 (Custom Term) | Phototherapy | 0 | 0.619 | 0 | 0.309 | 1.449 |  |  |  |  |  | 
COVID19 (Custom Term) | Radial nerve palsy | 0 | 1.123 | 0.001 | 0.308 | 1.184 |  |  |  |  |  | 
COVID19 (Custom Term) | Optical coherence tomography abnormal | 0 | 0.931 | 0 | 0.308 | 1.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Cell death | 0 | 0.549 | 0 | 0.307 | 1.497 |  |  |  |  |  | 
COVID19 (Custom Term) | Product reconstitution quality issue | 0 | 0.555 | 0 | 0.306 | 1.49 |  |  |  |  |  | 
COVID19 (Custom Term) | Human papilloma virus test negative | 0 | 0.505 | 0 | 0.305 | 1.528 |  |  |  |  |  | 
COVID19 (Custom Term) | Breech presentation | 0 | 0.605 | 0 | 0.305 | 1.45 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutrophilic dermatosis | 0 | 0.424 | 0 | 0.305 | 1.6 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 1.749 | 0.007 | 0.304 | 1.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory tract infection viral | 0 | 1.05 | 0.001 | 0.304 | 1.205 |  |  |  |  |  | 
COVID19 (Custom Term) | Coagulation factor V level normal | 0 | 0.64 | 0 | 0.303 | 1.42 |  |  |  |  |  | 
COVID19 (Custom Term) | Prenatal screening test abnormal | 0 | 0.457 | 0 | 0.303 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin tumours of unspecified malignancy (SMQ) [broad] | 1 | 9.202 | 0.078 | 0.302 | 0.645 | 0.052 | 0.256 | 0.649 | 0.109 | 0.03 | 29.944
COVID19 (Custom Term) | Gastric hypomotility | 0 | 0.356 | 0 | 0.302 | 1.655 |  |  |  |  |  | 
COVID19 (Custom Term) | Fine motor delay | 0 | 0.549 | 0 | 0.302 | 1.484 |  |  |  |  |  | 
COVID19 (Custom Term) | Anogenital warts | 0 | 0.34 | 0 | 0.302 | 1.669 |  |  |  |  |  | 
COVID19 (Custom Term) | X-ray gastrointestinal tract abnormal | 0 | 0.808 | 0 | 0.302 | 1.313 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileostomy | 0 | 0.872 | 0 | 0.302 | 1.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal infection | 0 | 0.549 | 0 | 0.301 | 1.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Measles antibody positive | 0 | 0.8 | 0 | 0.3 | 1.314 |  |  |  |  |  | 
COVID19 (Custom Term) | Barium enema normal | 0 | 0.504 | 0 | 0.3 | 1.514 |  |  |  |  |  | 
COVID19 (Custom Term) | Concomitant disease progression | 0 | 0.721 | 0 | 0.3 | 1.36 |  |  |  |  |  | 
COVID19 (Custom Term) | Microscopic polyangiitis | 0 | 0.732 | 0 | 0.298 | 1.349 |  |  |  |  |  | 
COVID19 (Custom Term) | Colour vision tests normal | 0 | 0.509 | 0 | 0.298 | 1.505 |  |  |  |  |  | 
COVID19 (Custom Term) | Drowning | 0 | 0.732 | 0 | 0.297 | 1.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Prophylaxis | 1 | 2.225 | 0.026 | 0.296 | 0.813 | 0.276 | 0.682 | 1.454 | 0.45 | 0.903 | 0.162
COVID19 (Custom Term) | Liver infections (SMQ) [narrow] | 3 | 10.152 | 0.086 | 0.296 | 0.608 | 0.207 | 0.433 | 0.813 | 0.296 | 0.033 | 82.816
COVID19 (Custom Term) | Rubella antibody test | 0 | 0.61 | 0 | 0.296 | 1.421 |  |  |  |  |  | 
COVID19 (Custom Term) | Humoral immune defect | 0 | 0.359 | 0 | 0.296 | 1.629 |  |  |  |  |  | 
COVID19 (Custom Term) | Coxiella test | 0 | 0.725 | 0 | 0.295 | 1.344 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy muscle abnormal | 0 | 0.476 | 0 | 0.295 | 1.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Vestibular disorder | 0 | 1.807 | 0.007 | 0.294 | 0.976 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue mass | 0 | 0.549 | 0 | 0.294 | 1.46 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site eczema | 0 | 0.478 | 0 | 0.294 | 1.517 |  |  |  |  |  | 
COVID19 (Custom Term) | Organic brain syndrome | 0 | 0.732 | 0 | 0.293 | 1.335 |  |  |  |  |  | 
COVID19 (Custom Term) | Microsomia | 0 | 0.339 | 0 | 0.293 | 1.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Slit-lamp tests normal | 0 | 0.339 | 0 | 0.293 | 1.633 |  |  |  |  |  | 
COVID19 (Custom Term) | ADAMTS13 activity decreased | 0 | 0.339 | 0 | 0.293 | 1.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy skin normal | 0 | 1.2 | 0.001 | 0.293 | 1.128 |  |  |  |  |  | 
COVID19 (Custom Term) | Forced vital capacity decreased | 0 | 0.34 | 0 | 0.293 | 1.631 |  |  |  |  |  | 
COVID19 (Custom Term) | FEV1/FVC ratio abnormal | 0 | 0.339 | 0 | 0.293 | 1.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Expired product administered | 13 | 67.476 | 0.176 | 0.292 | 0.432 | 0.142 | 0.222 | 0.332 | 0.193 | 0.02 | 636.507
COVID19 (Custom Term) | Oesophageal variceal ligation | 0 | 0.27 | 0 | 0.292 | 1.68 |  |  |  |  |  | 
COVID19 (Custom Term) | Mitochondrial cytopathy | 0 | 0.823 | 0 | 0.292 | 1.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Pre-eclampsia | 2 | 11.607 | 0.062 | 0.291 | 0.656 | 0.123 | 0.311 | 0.643 | 0.172 | 0.382 | 1.327
COVID19 (Custom Term) | Mast cell activation syndrome | 0 | 0.909 | 0 | 0.291 | 1.238 |  |  |  |  |  | 
COVID19 (Custom Term) | Oophorectomy | 0 | 0.562 | 0 | 0.291 | 1.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Vacuum extractor delivery | 0 | 0.549 | 0 | 0.29 | 1.449 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B antibody negative | 1 | 3.06 | 0.018 | 0.289 | 0.84 | 0.235 | 0.591 | 1.271 | 0.327 | 0.042 | 20.997
COVID19 (Custom Term) | Cytomegalovirus infection | 0 | 1.208 | 0.001 | 0.289 | 1.117 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood beryllium | 0 | 0.549 | 0 | 0.289 | 1.447 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic product effect incomplete | 0 | 0.352 | 0 | 0.288 | 1.601 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypometabolism | 0 | 0.672 | 0 | 0.288 | 1.359 |  |  |  |  |  | 
COVID19 (Custom Term) | Myelocyte present | 0 | 0.366 | 0 | 0.288 | 1.59 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunodeficiency common variable | 0 | 0.732 | 0 | 0.287 | 1.321 |  |  |  |  |  | 
COVID19 (Custom Term) | Renin normal | 0 | 0.36 | 0 | 0.287 | 1.592 |  |  |  |  |  | 
COVID19 (Custom Term) | Middle insomnia | 2 | 11.846 | 0.109 | 0.286 | 0.532 | 0.12 | 0.305 | 0.633 | 0.169 | 0.035 | 52.727
COVID19 (Custom Term) | Umbilical hernia | 0 | 0.732 | 0 | 0.286 | 1.318 |  |  |  |  |  | 
COVID19 (Custom Term) | Radioisotope scan normal | 0 | 0.589 | 0 | 0.285 | 1.404 |  |  |  |  |  | 
COVID19 (Custom Term) | Natural killer cell count increased | 0 | 0.635 | 0 | 0.285 | 1.375 |  |  |  |  |  | 
COVID19 (Custom Term) | Soft tissue infection | 0 | 0.843 | 0 | 0.284 | 1.253 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver infections (SMQ) [broad] | 3 | 10.238 | 0.083 | 0.283 | 0.581 | 0.206 | 0.43 | 0.808 | 0.293 | 0.032 | 86.049
COVID19 (Custom Term) | Angiotensin converting enzyme | 1 | 6.004 | 0.031 | 0.283 | 0.746 | 0.132 | 0.386 | 0.877 | 0.167 | 0.231 | 1.745
COVID19 (Custom Term) | Ectopic pregnancy | 0 | 0.732 | 0 | 0.283 | 1.311 |  |  |  |  |  | 
COVID19 (Custom Term) | Abdominal mass | 0 | 0.697 | 0 | 0.283 | 1.331 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral sepsis | 0 | 0.342 | 0 | 0.283 | 1.587 |  |  |  |  |  | 
COVID19 (Custom Term) | Premalignant disorders, general conditions and other site specific disorders (SMQ) [narrow] | 0 | 0.498 | 0 | 0.283 | 1.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Administration site abscess sterile | 0 | 0.183 | 0 | 0.283 | 1.636 |  |  |  |  |  | 
COVID19 (Custom Term) | Subacute sclerosing panencephalitis | 0 | 0.549 | 0 | 0.283 | 1.428 |  |  |  |  |  | 
COVID19 (Custom Term) | Premalignant disorders, general conditions and other site specific disorders (SMQ) [broad] | 0 | 0.498 | 0 | 0.283 | 1.465 |  |  |  |  |  | 
COVID19 (Custom Term) | Dehydroepiandrosterone decreased | 0 | 0.535 | 0 | 0.282 | 1.436 |  |  |  |  |  | 
COVID19 (Custom Term) | Reflex test abnormal | 0 | 0.64 | 0 | 0.282 | 1.363 |  |  |  |  |  | 
COVID19 (Custom Term) | West Nile virus test positive | 0 | 0.365 | 0 | 0.282 | 1.567 |  |  |  |  |  | 
COVID19 (Custom Term) | Severe myoclonic epilepsy of infancy | 0 | 0.454 | 0 | 0.282 | 1.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Intraventricular haemorrhage neonatal | 0 | 0.366 | 0 | 0.282 | 1.564 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-platelet antibody positive | 0 | 0.732 | 0 | 0.282 | 1.307 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital neurological disorder | 0 | 0.273 | 0 | 0.281 | 1.623 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypercholesterolaemia | 0 | 0.811 | 0 | 0.28 | 1.259 |  |  |  |  |  | 
COVID19 (Custom Term) | Aspergillus infection | 0 | 0.366 | 0 | 0.28 | 1.555 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysaesthesia | 1 | 4.776 | 0.032 | 0.278 | 0.726 | 0.17 | 0.457 | 1.008 | 0.209 | 0.132 | 4.709
COVID19 (Custom Term) | Lymphadenitis bacterial | 0 | 0.555 | 0 | 0.278 | 1.407 |  |  |  |  |  | 
COVID19 (Custom Term) | Body temperature fluctuation | 0 | 2.374 | 0.011 | 0.278 | 0.86 |  |  |  |  |  | 
COVID19 (Custom Term) | Prolonged labour | 0 | 0.915 | 0 | 0.277 | 1.204 |  |  |  |  |  | 
COVID19 (Custom Term) | Infantile vomiting | 0 | 0.671 | 0 | 0.277 | 1.33 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurogenic bladder | 0 | 0.807 | 0 | 0.276 | 1.252 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine protein/creatinine ratio increased | 0 | 0.594 | 0 | 0.276 | 1.376 |  |  |  |  |  | 
COVID19 (Custom Term) | Immunisation | 1 | 5.289 | 0.054 | 0.275 | 0.638 | 0.154 | 0.425 | 0.949 | 0.189 | 0.068 | 11.692
COVID19 (Custom Term) | Liver neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.732 | 0 | 0.275 | 1.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine pain | 0 | 0.673 | 0 | 0.275 | 1.322 |  |  |  |  |  | 
COVID19 (Custom Term) | Procedural failure | 0 | 0.549 | 0 | 0.275 | 1.401 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.732 | 0 | 0.275 | 1.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood luteinising hormone increased | 0 | 0.672 | 0 | 0.275 | 1.325 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic gastritis | 0 | 0.732 | 0 | 0.274 | 1.287 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site joint swelling | 0 | 0.69 | 0 | 0.273 | 1.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Psychomotor retardation | 0 | 0.874 | 0 | 0.273 | 1.213 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysplasia | 0 | 0.745 | 0 | 0.273 | 1.277 |  |  |  |  |  | 
COVID19 (Custom Term) | Intelligence test abnormal | 0 | 0.542 | 0 | 0.27 | 1.389 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood immunoglobulin M decreased | 0 | 1.94 | 0.005 | 0.269 | 0.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Brudzinski's sign | 0 | 0.726 | 0 | 0.269 | 1.277 |  |  |  |  |  | 
COVID19 (Custom Term) | Electroneurography | 0 | 0.67 | 0 | 0.268 | 1.305 |  |  |  |  |  | 
COVID19 (Custom Term) | Musculoskeletal pain | 20 | 85.369 | 0.18 | 0.266 | 0.366 | 0.179 | 0.257 | 0.359 | 0.234 | 0.055 | 326.76
COVID19 (Custom Term) | Double stranded DNA antibody positive | 0 | 0.913 | 0 | 0.266 | 1.178 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurodermatitis | 0 | 0.918 | 0 | 0.266 | 1.176 |  |  |  |  |  | 
COVID19 (Custom Term) | Coronary artery aneurysm | 0 | 0.751 | 0 | 0.266 | 1.254 |  |  |  |  |  | 
COVID19 (Custom Term) | Central pain syndrome | 0 | 0.452 | 0 | 0.266 | 1.438 |  |  |  |  |  | 
COVID19 (Custom Term) | Vogt-Koyanagi-Harada disease | 0 | 0.509 | 0 | 0.265 | 1.395 |  |  |  |  |  | 
COVID19 (Custom Term) | Visual evoked potentials normal | 0 | 0.656 | 0 | 0.264 | 1.3 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis enteroviral | 0 | 0.272 | 0 | 0.264 | 1.537 |  |  |  |  |  | 
COVID19 (Custom Term) | Ehlers-Danlos syndrome | 0 | 0.553 | 0 | 0.264 | 1.364 |  |  |  |  |  | 
COVID19 (Custom Term) | Arnold-Chiari malformation | 0 | 0.819 | 0 | 0.264 | 1.215 |  |  |  |  |  | 
COVID19 (Custom Term) | Tandem gait test abnormal | 0 | 0.765 | 0 | 0.263 | 1.24 |  |  |  |  |  | 
COVID19 (Custom Term) | Orchitis | 0 | 0.423 | 0 | 0.262 | 1.441 |  |  |  |  |  | 
COVID19 (Custom Term) | Granuloma | 0 | 0.842 | 0 | 0.262 | 1.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Cardiac massage | 0 | 0.64 | 0 | 0.262 | 1.304 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastrointestinal hypermotility | 0 | 0.61 | 0 | 0.261 | 1.319 |  |  |  |  |  | 
COVID19 (Custom Term) | Creatinine urine | 0 | 0.345 | 0 | 0.261 | 1.485 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis meningococcal | 0 | 0.515 | 0 | 0.261 | 1.377 |  |  |  |  |  | 
COVID19 (Custom Term) | Autonomic neuropathy | 0 | 0.565 | 0 | 0.261 | 1.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy skin abnormal | 1 | 9.133 | 0.066 | 0.26 | 0.56 | 0.053 | 0.258 | 0.652 | 0.109 | 0.032 | 28.535
COVID19 (Custom Term) | Adenocarcinoma of the cervix | 0 | 0.503 | 0 | 0.26 | 1.383 |  |  |  |  |  | 
COVID19 (Custom Term) | Tonsillitis bacterial | 0 | 0.767 | 0 | 0.26 | 1.231 |  |  |  |  |  | 
COVID19 (Custom Term) | Macrophage count | 0 | 0.252 | 0 | 0.26 | 1.512 |  |  |  |  |  | 
COVID19 (Custom Term) | Astrovirus test positive | 0 | 0.454 | 0 | 0.26 | 1.414 |  |  |  |  |  | 
COVID19 (Custom Term) | Bone erosion | 0 | 0.823 | 0 | 0.259 | 1.201 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure via eye contact | 0 | 1.351 | 0.001 | 0.259 | 1.015 |  |  |  |  |  | 
COVID19 (Custom Term) | Kidney transplant rejection | 0 | 0.765 | 0 | 0.259 | 1.229 |  |  |  |  |  | 
COVID19 (Custom Term) | Chlamydial infection | 0 | 0.584 | 0 | 0.258 | 1.325 |  |  |  |  |  | 
COVID19 (Custom Term) | Phrenic nerve paralysis | 0 | 0.509 | 0 | 0.258 | 1.369 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis E antibody negative | 0 | 0.79 | 0 | 0.258 | 1.214 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin malignant tumours (SMQ) [broad] | 0 | 1.642 | 0.002 | 0.257 | 0.944 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis | 1 | 1.872 | 0.035 | 0.256 | 0.646 | 0.296 | 0.728 | 1.549 | 0.534 | 0.023 | 41.025
COVID19 (Custom Term) | Product use in unapproved indication | 0 | 0.924 | 0 | 0.256 | 1.149 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemoglobinuria | 0 | 0.517 | 0 | 0.255 | 1.356 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4 lymphocytes | 0 | 0.848 | 0 | 0.255 | 1.179 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver malignant tumours (SMQ) [broad] | 0 | 0.539 | 0 | 0.255 | 1.343 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver malignant tumours (SMQ) [narrow] | 0 | 0.539 | 0 | 0.255 | 1.343 |  |  |  |  |  | 
COVID19 (Custom Term) | Oligohydramnios | 0 | 0.535 | 0 | 0.254 | 1.341 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle tone disorder | 0 | 0.874 | 0 | 0.254 | 1.164 |  |  |  |  |  | 
COVID19 (Custom Term) | Gestational diabetes | 1 | 8.061 | 0.022 | 0.252 | 0.695 | 0.075 | 0.296 | 0.716 | 0.124 | 0.242 | 1.572
COVID19 (Custom Term) | Dermo-hypodermitis | 0 | 0.808 | 0 | 0.252 | 1.188 |  |  |  |  |  | 
COVID19 (Custom Term) | Child maltreatment syndrome | 0 | 0.359 | 0 | 0.252 | 1.438 |  |  |  |  |  | 
COVID19 (Custom Term) | Ulcerative keratitis | 0 | 0.547 | 0 | 0.252 | 1.326 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin malignant tumours (SMQ) [narrow] | 0 | 1.34 | 0.001 | 0.252 | 1.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Flavivirus test negative | 0 | 0.839 | 0 | 0.251 | 1.172 |  |  |  |  |  | 
COVID19 (Custom Term) | Single umbilical artery | 0 | 0.549 | 0 | 0.251 | 1.32 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyhydramnios | 0 | 0.65 | 0 | 0.25 | 1.261 |  |  |  |  |  | 
COVID19 (Custom Term) | Peripheral ischaemia | 0 | 0.915 | 0 | 0.25 | 1.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngotonsillitis | 0 | 0.9 | 0 | 0.249 | 1.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic inflammatory demyelinating polyradiculoneuropathy | 0 | 2.394 | 0.007 | 0.249 | 0.811 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubella antibody positive | 0 | 0.719 | 0 | 0.248 | 1.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Recalled product administered | 0 | 0.53 | 0 | 0.247 | 1.318 |  |  |  |  |  | 
COVID19 (Custom Term) | CD4 lymphocytes increased | 0 | 0.687 | 0 | 0.246 | 1.228 |  |  |  |  |  | 
COVID19 (Custom Term) | Infertility | 0 | 0.675 | 0 | 0.246 | 1.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Cat scratch disease | 0 | 0.492 | 0 | 0.246 | 1.337 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital absence of bile ducts | 0 | 0.449 | 0 | 0.245 | 1.356 |  |  |  |  |  | 
COVID19 (Custom Term) | Pelvic inflammatory disease | 0 | 0.495 | 0 | 0.245 | 1.33 |  |  |  |  |  | 
COVID19 (Custom Term) | Depressive symptom | 0 | 0.351 | 0 | 0.244 | 1.403 |  |  |  |  |  | 
COVID19 (Custom Term) | ACTH stimulation test abnormal | 0 | 0.446 | 0 | 0.244 | 1.355 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte morphology abnormal | 0 | 1.08 | 0 | 0.244 | 1.062 |  |  |  |  |  | 
COVID19 (Custom Term) | Respiratory alkalosis | 0 | 0.594 | 0 | 0.244 | 1.272 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood cortisol | 0 | 2.153 | 0.004 | 0.244 | 0.832 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy cervix | 0 | 0.588 | 0 | 0.244 | 1.273 |  |  |  |  |  | 
COVID19 (Custom Term) | Liver transplant | 0 | 0.915 | 0 | 0.243 | 1.12 |  |  |  |  |  | 
COVID19 (Custom Term) | Complement factor decreased | 0 | 0.64 | 0 | 0.242 | 1.239 |  |  |  |  |  | 
COVID19 (Custom Term) | Infectious pleural effusion | 0 | 0.67 | 0 | 0.242 | 1.226 |  |  |  |  |  | 
COVID19 (Custom Term) | Antibody test positive | 0 | 2.855 | 0.01 | 0.242 | 0.75 |  |  |  |  |  | 
COVID19 (Custom Term) | Skin neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 9.881 | 0.059 | 0.241 | 0.524 | 0.041 | 0.235 | 0.613 | 0.101 | 0.026 | 34.676
COVID19 (Custom Term) | Joint range of motion measurement | 0 | 1.975 | 0.003 | 0.241 | 0.854 |  |  |  |  |  | 
COVID19 (Custom Term) | Laser therapy | 0 | 0.844 | 0 | 0.24 | 1.139 |  |  |  |  |  | 
COVID19 (Custom Term) | Extraocular muscle disorder | 0 | 0.549 | 0 | 0.24 | 1.281 |  |  |  |  |  | 
COVID19 (Custom Term) | Sapovirus test positive | 0 | 0.363 | 0 | 0.239 | 1.37 |  |  |  |  |  | 
COVID19 (Custom Term) | Pharyngeal haematoma | 0 | 0.274 | 0 | 0.239 | 1.394 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma stage 0 | 0 | 0.467 | 0 | 0.239 | 1.323 |  |  |  |  |  | 
COVID19 (Custom Term) | Encephalitis brain stem | 0 | 0.457 | 0 | 0.239 | 1.327 |  |  |  |  |  | 
COVID19 (Custom Term) | B-lymphocyte count decreased | 0 | 0.915 | 0 | 0.239 | 1.108 |  |  |  |  |  | 
COVID19 (Custom Term) | Hemianaesthesia | 0 | 0.823 | 0 | 0.237 | 1.141 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF glucose | 0 | 0.984 | 0 | 0.237 | 1.078 |  |  |  |  |  | 
COVID19 (Custom Term) | Cortical visual impairment | 0 | 0.366 | 0 | 0.237 | 1.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Empyema | 0 | 0.376 | 0 | 0.235 | 1.345 |  |  |  |  |  | 
COVID19 (Custom Term) | Kernig's sign | 0 | 0.915 | 0 | 0.235 | 1.099 |  |  |  |  |  | 
COVID19 (Custom Term) | Subglottic laryngitis | 0 | 0.518 | 0 | 0.235 | 1.278 |  |  |  |  |  | 
COVID19 (Custom Term) | Basal cell carcinoma | 0 | 0.796 | 0 | 0.235 | 1.144 |  |  |  |  |  | 
COVID19 (Custom Term) | Mumps antibody test positive | 0 | 0.72 | 0 | 0.232 | 1.169 |  |  |  |  |  | 
COVID19 (Custom Term) | School refusal | 0 | 0.34 | 0 | 0.232 | 1.346 |  |  |  |  |  | 
COVID19 (Custom Term) | Bradycardia neonatal | 0 | 0.515 | 0 | 0.231 | 1.264 |  |  |  |  |  | 
COVID19 (Custom Term) | Hair growth abnormal | 0 | 0.848 | 0 | 0.23 | 1.11 |  |  |  |  |  | 
COVID19 (Custom Term) | Heat oedema | 0 | 0.562 | 0 | 0.23 | 1.235 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy lung abnormal | 0 | 0.872 | 0 | 0.229 | 1.096 |  |  |  |  |  | 
COVID19 (Custom Term) | Enuresis | 0 | 2.519 | 0.005 | 0.229 | 0.761 |  |  |  |  |  | 
COVID19 (Custom Term) | Apgar score abnormal | 0 | 0.59 | 0 | 0.229 | 1.22 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemophilus infection | 0 | 0.489 | 0 | 0.228 | 1.266 |  |  |  |  |  | 
COVID19 (Custom Term) | Ileectomy | 0 | 0.61 | 0 | 0.228 | 1.206 |  |  |  |  |  | 
COVID19 (Custom Term) | Bordetella test | 0 | 0.755 | 0 | 0.227 | 1.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Atonic seizures | 0 | 0.886 | 0 | 0.226 | 1.082 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhage subcutaneous | 0 | 1.794 | 0.001 | 0.226 | 0.853 |  |  |  |  |  | 
COVID19 (Custom Term) | Hyperkinesia | 0 | 0.633 | 0 | 0.225 | 1.185 |  |  |  |  |  | 
COVID19 (Custom Term) | Intraocular pressure test normal | 0 | 1.396 | 0 | 0.225 | 0.93 |  |  |  |  |  | 
COVID19 (Custom Term) | Dermatitis atopic | 0 | 2.252 | 0.003 | 0.224 | 0.783 |  |  |  |  |  | 
COVID19 (Custom Term) | Measles | 0 | 1.472 | 0 | 0.224 | 0.912 |  |  |  |  |  | 
COVID19 (Custom Term) | Microcephaly | 0 | 0.732 | 0 | 0.224 | 1.138 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-NMDA antibody positive | 0 | 0.915 | 0 | 0.223 | 1.064 |  |  |  |  |  | 
COVID19 (Custom Term) | Application site erythema | 0 | 0.701 | 0 | 0.223 | 1.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Middle ear inflammation | 0 | 0.86 | 0 | 0.222 | 1.08 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterovirus infection | 0 | 1.124 | 0 | 0.222 | 0.994 |  |  |  |  |  | 
COVID19 (Custom Term) | Granulomatous dermatitis | 0 | 0.497 | 0 | 0.222 | 1.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.773 | 0 | 0.221 | 1.11 |  |  |  |  |  | 
COVID19 (Custom Term) | Expanded disability status scale score increased | 0 | 0.224 | 0 | 0.22 | 1.249 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site granuloma | 0 | 0.494 | 0 | 0.219 | 1.222 |  |  |  |  |  | 
COVID19 (Custom Term) | Cataplexy | 0 | 0.706 | 0 | 0.217 | 1.126 |  |  |  |  |  | 
COVID19 (Custom Term) | Injection site granuloma | 0 | 0.898 | 0 | 0.217 | 1.053 |  |  |  |  |  | 
COVID19 (Custom Term) | Mean cell haemoglobin concentration increased | 0 | 0.639 | 0 | 0.217 | 1.152 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypotonic-hyporesponsive episode | 0 | 2.831 | 0.005 | 0.215 | 0.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Epileptic encephalopathy | 0 | 0.715 | 0 | 0.215 | 1.113 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypotonic-hyporesponsive episode (SMQ) [narrow] | 0 | 2.831 | 0.005 | 0.215 | 0.706 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital biliary disorders (SMQ) [narrow] | 0 | 0.426 | 0 | 0.213 | 1.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Congenital biliary disorders (SMQ) [broad] | 0 | 0.426 | 0 | 0.213 | 1.221 |  |  |  |  |  | 
COVID19 (Custom Term) | Cataract nuclear | 0 | 0.744 | 0 | 0.212 | 1.092 |  |  |  |  |  | 
COVID19 (Custom Term) | Dengue fever | 0 | 0.366 | 0 | 0.212 | 1.234 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypertonic bladder | 0 | 0.812 | 0 | 0.211 | 1.063 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-ganglioside antibody positive | 0 | 0.723 | 0 | 0.211 | 1.095 |  |  |  |  |  | 
COVID19 (Custom Term) | Joint injection | 0 | 3.68 | 0.01 | 0.211 | 0.636 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis salmonella | 0 | 0.602 | 0 | 0.21 | 1.142 |  |  |  |  |  | 
COVID19 (Custom Term) | Seroconversion test negative | 0 | 0.716 | 0 | 0.21 | 1.095 |  |  |  |  |  | 
COVID19 (Custom Term) | Lymphocyte stimulation test positive | 0 | 0.623 | 0 | 0.208 | 1.125 |  |  |  |  |  | 
COVID19 (Custom Term) | Product expiration date issue | 0 | 0.891 | 0 | 0.207 | 1.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Endocrine test | 0 | 0.562 | 0 | 0.207 | 1.145 |  |  |  |  |  | 
COVID19 (Custom Term) | Inflammatory bowel disease | 0 | 1.087 | 0 | 0.207 | 0.963 |  |  |  |  |  | 
COVID19 (Custom Term) | Thrombocytopenic purpura | 0 | 1.8 | 0.001 | 0.207 | 0.814 |  |  |  |  |  | 
COVID19 (Custom Term) | Decreased immune responsiveness | 0 | 1.926 | 0.001 | 0.206 | 0.791 |  |  |  |  |  | 
COVID19 (Custom Term) | Rash rubelliform | 0 | 0.84 | 0 | 0.206 | 1.036 |  |  |  |  |  | 
COVID19 (Custom Term) | Irregular sleep wake rhythm disorder | 0 | 0.721 | 0 | 0.204 | 1.073 |  |  |  |  |  | 
COVID19 (Custom Term) | Viral load increased | 0 | 0.702 | 0 | 0.204 | 1.078 |  |  |  |  |  | 
COVID19 (Custom Term) | Tilt table test positive | 0 | 0.69 | 0 | 0.204 | 1.083 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF neutrophil count negative | 0 | 0.716 | 0 | 0.204 | 1.074 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B antibody positive | 0 | 0.863 | 0 | 0.203 | 1.021 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute macular outer retinopathy | 0 | 0.416 | 0 | 0.202 | 1.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumatosis intestinalis | 0 | 0.64 | 0 | 0.202 | 1.095 |  |  |  |  |  | 
COVID19 (Custom Term) | Arthroscopy | 0 | 1.725 | 0 | 0.201 | 0.812 |  |  |  |  |  | 
COVID19 (Custom Term) | Reading disorder | 0 | 1.713 | 0 | 0.201 | 0.814 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapeutic response decreased | 0 | 1.391 | 0 | 0.199 | 0.87 |  |  |  |  |  | 
COVID19 (Custom Term) | Sleep attacks | 0 | 0.904 | 0 | 0.199 | 0.994 |  |  |  |  |  | 
COVID19 (Custom Term) | Morbillivirus test positive | 0 | 0.897 | 0 | 0.198 | 0.992 |  |  |  |  |  | 
COVID19 (Custom Term) | Hypomenorrhoea | 0 | 0.723 | 0 | 0.197 | 1.045 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound testes abnormal | 0 | 0.499 | 0 | 0.197 | 1.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterobiasis | 0 | 0.384 | 0 | 0.196 | 1.143 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine chloride | 0 | 0.335 | 0 | 0.194 | 1.129 |  |  |  |  |  | 
COVID19 (Custom Term) | Viraemia | 0 | 0.391 | 0 | 0.194 | 1.128 |  |  |  |  |  | 
COVID19 (Custom Term) | Dysmetria | 0 | 0.811 | 0 | 0.193 | 1.003 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound antenatal screen | 1 | 9.592 | 0.019 | 0.192 | 0.516 | 0.045 | 0.244 | 0.628 | 0.104 | 0.129 | 4.902
COVID19 (Custom Term) | Anti-ganglioside antibody negative | 0 | 0.963 | 0 | 0.191 | 0.952 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy artery normal | 0 | 0.817 | 0 | 0.191 | 0.995 |  |  |  |  |  | 
COVID19 (Custom Term) | Expanded disability status scale score decreased | 0 | 0.293 | 0 | 0.189 | 1.081 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubivirus test positive | 0 | 0.531 | 0 | 0.189 | 1.075 |  |  |  |  |  | 
COVID19 (Custom Term) | CSF pressure normal | 0 | 0.732 | 0 | 0.188 | 1.007 |  |  |  |  |  | 
COVID19 (Custom Term) | Disseminated varicella zoster vaccine virus infection | 0 | 0.827 | 0 | 0.188 | 0.978 |  |  |  |  |  | 
COVID19 (Custom Term) | Tendon injury | 0 | 3.882 | 0.007 | 0.187 | 0.583 |  |  |  |  |  | 
COVID19 (Custom Term) | Prenatal screening test | 1 | 15.663 | 0.013 | 0.186 | 0.53 | 0.01 | 0.112 | 0.406 | 0.064 | 0.075 | 10.399
COVID19 (Custom Term) | Immunohistochemistry | 0 | 0.851 | 0 | 0.186 | 0.964 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccine positive rechallenge | 4 | 30.109 | 0.07 | 0.185 | 0.344 | 0.083 | 0.19 | 0.364 | 0.133 | 0.062 | 55.034
COVID19 (Custom Term) | Acute motor axonal neuropathy | 0 | 0.736 | 0 | 0.185 | 0.994 |  |  |  |  |  | 
COVID19 (Custom Term) | Campylobacter infection | 0 | 0.335 | 0 | 0.184 | 1.065 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site hypertrichosis | 0 | 0.458 | 0 | 0.183 | 1.059 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound skull normal | 0 | 1.017 | 0 | 0.183 | 0.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Alcohol intolerance | 0 | 0.658 | 0 | 0.182 | 1.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Labelled drug-drug interaction medication error | 0 | 1.048 | 0 | 0.182 | 0.9 |  |  |  |  |  | 
COVID19 (Custom Term) | Loop electrosurgical excision procedure | 0 | 0.42 | 0 | 0.182 | 1.06 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy brain abnormal | 0 | 1.165 | 0 | 0.181 | 0.867 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrophoresis abnormal | 0 | 0.6 | 0 | 0.181 | 1.017 |  |  |  |  |  | 
COVID19 (Custom Term) | Generalised vaccinia | 0 | 0.266 | 0 | 0.181 | 1.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella | 1 | 9.897 | 0.018 | 0.179 | 0.481 | 0.041 | 0.234 | 0.613 | 0.101 | 0.031 | 29.541
COVID19 (Custom Term) | Pneumonia streptococcal | 0 | 0.785 | 0 | 0.178 | 0.956 |  |  |  |  |  | 
COVID19 (Custom Term) | Premature menopause | 0 | 0.519 | 0 | 0.177 | 1.02 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian cyst ruptured | 0 | 0.758 | 0 | 0.176 | 0.955 |  |  |  |  |  | 
COVID19 (Custom Term) | Intussusception | 0 | 2.082 | 0 | 0.176 | 0.704 |  |  |  |  |  | 
COVID19 (Custom Term) | Product complaint | 0 | 1.032 | 0 | 0.175 | 0.879 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-aquaporin-4 antibody positive | 0 | 0.513 | 0 | 0.175 | 1.011 |  |  |  |  |  | 
COVID19 (Custom Term) | Hereditary neuropathy with liability to pressure palsies | 0 | 0.358 | 0 | 0.174 | 1.008 |  |  |  |  |  | 
COVID19 (Custom Term) | Vitiligo | 0 | 1.881 | 0 | 0.174 | 0.725 |  |  |  |  |  | 
COVID19 (Custom Term) | Genital haemorrhage | 0 | 0.54 | 0 | 0.174 | 0.999 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemorrhagic diathesis | 0 | 0.802 | 0 | 0.174 | 0.934 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotator cuff repair | 0 | 1.934 | 0 | 0.173 | 0.716 |  |  |  |  |  | 
COVID19 (Custom Term) | Transplant rejection | 0 | 0.765 | 0 | 0.173 | 0.939 |  |  |  |  |  | 
COVID19 (Custom Term) | Allergy to metals | 0 | 1.114 | 0 | 0.173 | 0.856 |  |  |  |  |  | 
COVID19 (Custom Term) | Polymerase chain reaction positive | 1 | 7.59 | 0.023 | 0.171 | 0.433 | 0.087 | 0.314 | 0.748 | 0.132 | 0.009 | 102.992
COVID19 (Custom Term) | Haemolytic uraemic syndrome | 0 | 0.572 | 0 | 0.171 | 0.977 |  |  |  |  |  | 
COVID19 (Custom Term) | Rash scarlatiniform | 0 | 0.848 | 0 | 0.171 | 0.909 |  |  |  |  |  | 
COVID19 (Custom Term) | Myofascitis | 0 | 0.789 | 0 | 0.17 | 0.92 |  |  |  |  |  | 
COVID19 (Custom Term) | Subchorionic haematoma | 0 | 0.732 | 0 | 0.169 | 0.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Post viral fatigue syndrome | 0 | 1.299 | 0 | 0.169 | 0.804 |  |  |  |  |  | 
COVID19 (Custom Term) | Large intestinal obstruction reduction | 0 | 0.659 | 0 | 0.167 | 0.94 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy brain | 0 | 0.518 | 0 | 0.165 | 0.955 |  |  |  |  |  | 
COVID19 (Custom Term) | Product supply issue | 0 | 0.541 | 0 | 0.165 | 0.955 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis A virus test positive | 0 | 0.608 | 0 | 0.165 | 0.942 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal distress syndrome | 0 | 0.533 | 0 | 0.164 | 0.948 |  |  |  |  |  | 
COVID19 (Custom Term) | Extensive swelling of vaccinated limb | 1 | 10.196 | 0.022 | 0.163 | 0.413 | 0.037 | 0.226 | 0.598 | 0.098 | 0.021 | 44.958
COVID19 (Custom Term) | Tetanus | 0 | 0.563 | 0 | 0.162 | 0.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Product odour abnormal | 0 | 0.357 | 0 | 0.162 | 0.933 |  |  |  |  |  | 
COVID19 (Custom Term) | Twin pregnancy | 0 | 0.604 | 0 | 0.162 | 0.927 |  |  |  |  |  | 
COVID19 (Custom Term) | Parasite stool test positive | 0 | 0.253 | 0 | 0.162 | 0.85 |  |  |  |  |  | 
COVID19 (Custom Term) | Drug effective for unapproved indication | 0 | 0.658 | 0 | 0.162 | 0.915 |  |  |  |  |  | 
COVID19 (Custom Term) | Product physical issue | 0 | 0.711 | 0 | 0.161 | 0.901 |  |  |  |  |  | 
COVID19 (Custom Term) | Enterocolitis haemorrhagic | 0 | 0.861 | 0 | 0.161 | 0.869 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-aquaporin-4 antibody negative | 0 | 1.002 | 0 | 0.16 | 0.834 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle necrosis | 0 | 0.547 | 0 | 0.16 | 0.928 |  |  |  |  |  | 
COVID19 (Custom Term) | Purpura fulminans | 0 | 0.915 | 0 | 0.16 | 0.854 |  |  |  |  |  | 
COVID19 (Custom Term) | Acute hepatitis B | 0 | 0.2 | 0 | 0.16 | 0.742 |  |  |  |  |  | 
COVID19 (Custom Term) | Post herpetic neuralgia | 1 | 17.615 | 0.011 | 0.159 | 0.46 | 0.007 | 0.089 | 0.359 | 0.057 | 0.02 | 48.086
COVID19 (Custom Term) | Morose | 0 | 0.717 | 0 | 0.159 | 0.891 |  |  |  |  |  | 
COVID19 (Custom Term) | Arrested labour | 0 | 0.679 | 0 | 0.159 | 0.897 |  |  |  |  |  | 
COVID19 (Custom Term) | Smear cervix | 0 | 1.689 | 0 | 0.159 | 0.712 |  |  |  |  |  | 
COVID19 (Custom Term) | Subchorionic haemorrhage | 0 | 0.701 | 0 | 0.158 | 0.891 |  |  |  |  |  | 
COVID19 (Custom Term) | Infection transmission via personal contact | 0 | 0.546 | 0 | 0.157 | 0.912 |  |  |  |  |  | 
COVID19 (Custom Term) | Autism spectrum disorder | 0 | 4.56 | 0.005 | 0.155 | 0.495 |  |  |  |  |  | 
COVID19 (Custom Term) | Sopor | 0 | 0.879 | 0 | 0.154 | 0.837 |  |  |  |  |  | 
COVID19 (Custom Term) | Lung adenocarcinoma | 0 | 0.75 | 0 | 0.154 | 0.86 |  |  |  |  |  | 
COVID19 (Custom Term) | Muscle enzyme | 0 | 0.823 | 0 | 0.151 | 0.836 |  |  |  |  |  | 
COVID19 (Custom Term) | HLA marker study | 0 | 0.767 | 0 | 0.151 | 0.843 |  |  |  |  |  | 
COVID19 (Custom Term) | Biopsy cervix abnormal | 0 | 0.505 | 0 | 0.15 | 0.872 |  |  |  |  |  | 
COVID19 (Custom Term) | Yellow fever | 0 | 0.363 | 0 | 0.149 | 0.848 |  |  |  |  |  | 
COVID19 (Custom Term) | Neuromyelitis optica spectrum disorder | 0 | 1.615 | 0 | 0.149 | 0.694 |  |  |  |  |  | 
COVID19 (Custom Term) | Epiglottitis haemophilus | 0 | 0.544 | 0 | 0.149 | 0.868 |  |  |  |  |  | 
COVID19 (Custom Term) | Mumps antibody test negative | 0 | 0.794 | 0 | 0.148 | 0.825 |  |  |  |  |  | 
COVID19 (Custom Term) | Exposure to vaccinated person | 0 | 0.981 | 0 | 0.148 | 0.794 |  |  |  |  |  | 
COVID19 (Custom Term) | Vulval cancer | 0 | 0.45 | 0 | 0.147 | 0.854 |  |  |  |  |  | 
COVID19 (Custom Term) | Apgar score low | 0 | 0.301 | 0 | 0.146 | 0.782 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenitis | 0 | 0.539 | 0 | 0.146 | 0.85 |  |  |  |  |  | 
COVID19 (Custom Term) | Polycystic ovaries | 0 | 0.926 | 0 | 0.145 | 0.79 |  |  |  |  |  | 
COVID19 (Custom Term) | Infection susceptibility increased | 0 | 1.765 | 0 | 0.144 | 0.661 |  |  |  |  |  | 
COVID19 (Custom Term) | Blood corticotrophin increased | 0 | 0.446 | 0 | 0.142 | 0.818 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis bacterial | 0 | 1.287 | 0 | 0.141 | 0.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Corynebacterium test negative | 0 | 0.722 | 0 | 0.141 | 0.806 |  |  |  |  |  | 
COVID19 (Custom Term) | Paraparesis | 0 | 0.946 | 0 | 0.14 | 0.767 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination site dryness | 0 | 0.581 | 0 | 0.139 | 0.808 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniocentesis normal | 0 | 0.789 | 0 | 0.137 | 0.776 |  |  |  |  |  | 
COVID19 (Custom Term) | Shoulder dystocia | 0 | 0.789 | 0 | 0.137 | 0.775 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-glomerular basement membrane antibody negative | 0 | 0.915 | 0 | 0.136 | 0.753 |  |  |  |  |  | 
COVID19 (Custom Term) | Rubella antibody negative | 0 | 1.288 | 0 | 0.136 | 0.699 |  |  |  |  |  | 
COVID19 (Custom Term) | Infective pulmonary exacerbation of cystic fibrosis | 0 | 0.641 | 0 | 0.135 | 0.785 |  |  |  |  |  | 
COVID19 (Custom Term) | Erysipelas | 0 | 2.313 | 0 | 0.134 | 0.579 |  |  |  |  |  | 
COVID19 (Custom Term) | Total complement activity decreased | 0 | 0.915 | 0 | 0.134 | 0.746 |  |  |  |  |  | 
COVID19 (Custom Term) | Urine potassium decreased | 0 | 0.435 | 0 | 0.134 | 0.77 |  |  |  |  |  | 
COVID19 (Custom Term) | Collagen disorder | 0 | 0.915 | 0 | 0.134 | 0.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis pneumococcal | 0 | 0.999 | 0 | 0.134 | 0.734 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyspareunia | 0 | 0.55 | 0 | 0.132 | 0.766 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination error | 0 | 3.178 | 0 | 0.132 | 0.513 |  |  |  |  |  | 
COVID19 (Custom Term) | Eclampsia | 0 | 1.479 | 0 | 0.132 | 0.66 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccine associated paralytic poliomyelitis | 0 | 0.546 | 0 | 0.131 | 0.763 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthostatic intolerance | 0 | 0.77 | 0 | 0.131 | 0.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Varicella post vaccine | 0 | 1.692 | 0 | 0.13 | 0.628 |  |  |  |  |  | 
COVID19 (Custom Term) | Yellow fever vaccine-associated viscerotropic disease | 0 | 0.281 | 0 | 0.13 | 0.637 |  |  |  |  |  | 
COVID19 (Custom Term) | Mumps | 0 | 0.858 | 0 | 0.129 | 0.733 |  |  |  |  |  | 
COVID19 (Custom Term) | Tilt table test normal | 0 | 0.656 | 0 | 0.129 | 0.748 |  |  |  |  |  | 
COVID19 (Custom Term) | Community acquired infection | 0 | 0.288 | 0 | 0.129 | 0.643 |  |  |  |  |  | 
COVID19 (Custom Term) | Lupus nephritis | 0 | 1.621 | 0 | 0.128 | 0.63 |  |  |  |  |  | 
COVID19 (Custom Term) | Product closure issue | 0 | 0.23 | 0 | 0.128 | 0.544 |  |  |  |  |  | 
COVID19 (Custom Term) | Poliomyelitis | 0 | 0.834 | 0 | 0.127 | 0.725 |  |  |  |  |  | 
COVID19 (Custom Term) | Malaria | 0 | 0.823 | 0 | 0.127 | 0.726 |  |  |  |  |  | 
COVID19 (Custom Term) | Polyarteritis nodosa | 0 | 0.891 | 0 | 0.127 | 0.715 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antigen | 1 | 10.476 | 0.007 | 0.125 | 0.37 | 0.034 | 0.218 | 0.585 | 0.095 | 0.211 | 2.096
COVID19 (Custom Term) | Product distribution issue | 0 | 0.623 | 0 | 0.124 | 0.724 |  |  |  |  |  | 
COVID19 (Custom Term) | Multiple use of single-use product | 0 | 0.225 | 0 | 0.124 | 0.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Single photon emission computerised tomogram abnormal | 0 | 0.377 | 0 | 0.124 | 0.676 |  |  |  |  |  | 
COVID19 (Custom Term) | Infection parasitic | 0 | 0.811 | 0 | 0.121 | 0.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Thermometry abnormal | 0 | 0.812 | 0 | 0.121 | 0.696 |  |  |  |  |  | 
COVID19 (Custom Term) | Infertility female | 0 | 0.668 | 0 | 0.12 | 0.702 |  |  |  |  |  | 
COVID19 (Custom Term) | Neoplasm malignant | 0 | 4.965 | 0.002 | 0.119 | 0.411 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian failure | 0 | 0.718 | 0 | 0.118 | 0.688 |  |  |  |  |  | 
COVID19 (Custom Term) | Malaria antibody test negative | 0 | 0.909 | 0 | 0.117 | 0.669 |  |  |  |  |  | 
COVID19 (Custom Term) | Salmonella test | 0 | 0.755 | 0 | 0.117 | 0.682 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis A antibody positive | 0 | 1.444 | 0 | 0.117 | 0.611 |  |  |  |  |  | 
COVID19 (Custom Term) | Mumps antibody test | 0 | 1.651 | 0 | 0.117 | 0.588 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemophilus test positive | 0 | 1.099 | 0 | 0.116 | 0.645 |  |  |  |  |  | 
COVID19 (Custom Term) | Neisseria test positive | 0 | 0.982 | 0 | 0.115 | 0.652 |  |  |  |  |  | 
COVID19 (Custom Term) | Amylase decreased | 0 | 0.861 | 0 | 0.114 | 0.657 |  |  |  |  |  | 
COVID19 (Custom Term) | Labelled drug-food interaction medication error | 0 | 0.365 | 0 | 0.114 | 0.592 |  |  |  |  |  | 
COVID19 (Custom Term) | Glare | 0 | 0.895 | 0 | 0.113 | 0.651 |  |  |  |  |  | 
COVID19 (Custom Term) | Arteriogram abnormal | 0 | 0.532 | 0 | 0.113 | 0.645 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B DNA assay | 0 | 0.614 | 0 | 0.112 | 0.648 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV antigen negative | 0 | 0.68 | 0 | 0.112 | 0.652 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha hydroxybutyrate dehydrogenase | 0 | 0.835 | 0 | 0.111 | 0.641 |  |  |  |  |  | 
COVID19 (Custom Term) | Serology positive | 0 | 0.639 | 0 | 0.11 | 0.64 |  |  |  |  |  | 
COVID19 (Custom Term) | Ovarian disorder | 0 | 0.807 | 0 | 0.109 | 0.633 |  |  |  |  |  | 
COVID19 (Custom Term) | Linear IgA disease | 0 | 0.798 | 0 | 0.108 | 0.628 |  |  |  |  |  | 
COVID19 (Custom Term) | Autoimmune encephalopathy | 0 | 0.513 | 0 | 0.107 | 0.605 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningococcal sepsis | 0 | 0.834 | 0 | 0.106 | 0.614 |  |  |  |  |  | 
COVID19 (Custom Term) | Dyscalculia | 0 | 0.789 | 0 | 0.106 | 0.617 |  |  |  |  |  | 
COVID19 (Custom Term) | Social problem | 0 | 1.518 | 0 | 0.104 | 0.551 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic varices haemorrhage | 0 | 0.351 | 0 | 0.103 | 0.5 |  |  |  |  |  | 
COVID19 (Custom Term) | Prosopagnosia | 0 | 0.513 | 0 | 0.103 | 0.572 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccine virus shedding | 0 | 0.371 | 0 | 0.102 | 0.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic fatigue syndrome | 0 | 2.321 | 0 | 0.101 | 0.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Gene sequencing | 0 | 1.48 | 0 | 0.1 | 0.539 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastric variceal ligation | 0 | 0.434 | 0 | 0.099 | 0.52 |  |  |  |  |  | 
COVID19 (Custom Term) | Jaundice neonatal | 0 | 0.879 | 0 | 0.098 | 0.57 |  |  |  |  |  | 
COVID19 (Custom Term) | Renal transplant failure | 0 | 0.499 | 0 | 0.096 | 0.518 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumococcal infection | 0 | 0.815 | 0 | 0.096 | 0.56 |  |  |  |  |  | 
COVID19 (Custom Term) | Post vaccination autoinoculation | 0 | 0.475 | 0 | 0.095 | 0.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Amenorrhoea | 0 | 2.393 | 0 | 0.091 | 0.445 |  |  |  |  |  | 
COVID19 (Custom Term) | Measles post vaccine | 0 | 1.557 | 0 | 0.091 | 0.496 |  |  |  |  |  | 
COVID19 (Custom Term) | Indirect infection transmission | 0 | 0.607 | 0 | 0.09 | 0.506 |  |  |  |  |  | 
COVID19 (Custom Term) | Somatic symptom disorder | 0 | 1.626 | 0 | 0.09 | 0.487 |  |  |  |  |  | 
COVID19 (Custom Term) | Diphtheria | 0 | 0.594 | 0 | 0.09 | 0.504 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B antigen positive | 0 | 0.59 | 0 | 0.09 | 0.502 |  |  |  |  |  | 
COVID19 (Custom Term) | Placenta praevia | 0 | 2.11 | 0 | 0.09 | 0.457 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis D antibody negative | 0 | 0.679 | 0 | 0.089 | 0.51 |  |  |  |  |  | 
COVID19 (Custom Term) | Haemophilus sepsis | 0 | 0.726 | 0 | 0.088 | 0.503 |  |  |  |  |  | 
COVID19 (Custom Term) | Animal bite | 0 | 0.723 | 0 | 0.088 | 0.507 |  |  |  |  |  | 
COVID19 (Custom Term) | Oral administration complication | 0 | 1.968 | 0 | 0.087 | 0.457 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccinia virus infection | 0 | 0.407 | 0 | 0.087 | 0.408 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningitis haemophilus | 0 | 0.588 | 0 | 0.087 | 0.476 |  |  |  |  |  | 
COVID19 (Custom Term) | Intentional product misuse | 0 | 0.624 | 0 | 0.086 | 0.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Measles antibody negative | 0 | 1.861 | 0 | 0.085 | 0.454 |  |  |  |  |  | 
COVID19 (Custom Term) | Tooth discolouration | 0 | 0.635 | 0 | 0.085 | 0.473 |  |  |  |  |  | 
COVID19 (Custom Term) | H3N2 influenza | 0 | 0.46 | 0 | 0.084 | 0.418 |  |  |  |  |  | 
COVID19 (Custom Term) | Cerebral hypoperfusion | 0 | 0.979 | 0 | 0.083 | 0.482 |  |  |  |  |  | 
COVID19 (Custom Term) | Menstrual disorder | 0 | 1.116 | 0 | 0.082 | 0.475 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B core antigen positive | 0 | 0.697 | 0 | 0.081 | 0.458 |  |  |  |  |  | 
COVID19 (Custom Term) | Neonatal disorder | 0 | 3.488 | 0 | 0.081 | 0.369 |  |  |  |  |  | 
COVID19 (Custom Term) | Olfactory test abnormal | 0 | 0.695 | 0 | 0.081 | 0.455 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotavirus infection | 0 | 2.279 | 0 | 0.079 | 0.408 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical conisation | 0 | 0.712 | 0 | 0.079 | 0.444 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B DNA assay negative | 0 | 0.798 | 0 | 0.079 | 0.456 |  |  |  |  |  | 
COVID19 (Custom Term) | Colposcopy | 0 | 0.75 | 0 | 0.077 | 0.433 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antigen negative | 0 | 0.851 | 0 | 0.076 | 0.438 |  |  |  |  |  | 
COVID19 (Custom Term) | Periodic acid Schiff stain | 0 | 0.785 | 0 | 0.075 | 0.427 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis A | 0 | 0.795 | 0 | 0.074 | 0.419 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis norovirus | 0 | 1.167 | 0 | 0.074 | 0.432 |  |  |  |  |  | 
COVID19 (Custom Term) | Urea urine | 0 | 0.782 | 0 | 0.074 | 0.417 |  |  |  |  |  | 
COVID19 (Custom Term) | Smear cervix abnormal | 0 | 0.768 | 0 | 0.074 | 0.417 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B core antibody | 0 | 0.409 | 0 | 0.073 | 0.297 |  |  |  |  |  | 
COVID19 (Custom Term) | Judgement impaired | 0 | 0.802 | 0 | 0.071 | 0.403 |  |  |  |  |  | 
COVID19 (Custom Term) | Lyssavirus test positive | 0 | 0.201 | 0 | 0.07 | 0.091 |  |  |  |  |  | 
COVID19 (Custom Term) | Plethysmography | 0 | 0.627 | 0 | 0.07 | 0.362 |  |  |  |  |  | 
COVID19 (Custom Term) | Electrophoresis | 0 | 0.808 | 0 | 0.07 | 0.393 |  |  |  |  |  | 
COVID19 (Custom Term) | Pericardial disease | 0 | 0.432 | 0 | 0.069 | 0.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Typhoid fever | 0 | 0.989 | 0 | 0.069 | 0.399 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antibody | 0 | 0.79 | 0 | 0.068 | 0.381 |  |  |  |  |  | 
COVID19 (Custom Term) | Caesarean section | 1 | 33.321 | 0.004 | 0.064 | 0.183 | 0.002 | 0.024 | 0.152 | 0.03 | 0.033 | 27.026
COVID19 (Custom Term) | Yellow fever vaccine-associated neurotropic disease | 0 | 0.705 | 0 | 0.064 | 0.337 |  |  |  |  |  | 
COVID19 (Custom Term) | Amniotic cavity infection | 0 | 1.913 | 0 | 0.063 | 0.355 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervix carcinoma | 0 | 0.854 | 0 | 0.062 | 0.34 |  |  |  |  |  | 
COVID19 (Custom Term) | Large for dates baby | 0 | 0.752 | 0 | 0.061 | 0.319 |  |  |  |  |  | 
COVID19 (Custom Term) | Low birth weight baby | 0 | 1.067 | 0 | 0.06 | 0.347 |  |  |  |  |  | 
COVID19 (Custom Term) | Ultrasound antenatal screen normal | 1 | 40.339 | 0.006 | 0.059 | 0.16 | 0.002 | 0.017 | 0.109 | 0.025 | 0.042 | 20.796
COVID19 (Custom Term) | Mucosal hyperaemia | 0 | 0.743 | 0 | 0.059 | 0.306 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal non-stress test normal | 0 | 1.613 | 0 | 0.059 | 0.344 |  |  |  |  |  | 
COVID19 (Custom Term) | Delivery | 1 | 25.27 | 0.005 | 0.058 | 0.161 | 0.003 | 0.041 | 0.231 | 0.04 | 0.063 | 12.788
COVID19 (Custom Term) | Neonatal seizure | 0 | 0.842 | 0 | 0.058 | 0.31 |  |  |  |  |  | 
COVID19 (Custom Term) | Norovirus test positive | 0 | 1.009 | 0 | 0.058 | 0.324 |  |  |  |  |  | 
COVID19 (Custom Term) | Fever neonatal | 0 | 0.705 | 0 | 0.057 | 0.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Neurone-specific enolase decreased | 0 | 0.793 | 0 | 0.057 | 0.295 |  |  |  |  |  | 
COVID19 (Custom Term) | Pneumococcal bacteraemia | 0 | 0.693 | 0 | 0.057 | 0.279 |  |  |  |  |  | 
COVID19 (Custom Term) | Microagglutination test | 0 | 0.787 | 0 | 0.056 | 0.291 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antibody | 0 | 0.446 | 0 | 0.056 | 0.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Anti-myelin-associated glycoprotein antibodies positive | 0 | 0.911 | 0 | 0.054 | 0.289 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotator cuff syndrome | 0 | 13.466 | 0.001 | 0.054 | 0.178 |  |  |  |  |  | 
COVID19 (Custom Term) | Splenic artery embolisation | 0 | 0.742 | 0 | 0.053 | 0.263 |  |  |  |  |  | 
COVID19 (Custom Term) | Human papilloma virus test positive | 0 | 1.869 | 0 | 0.053 | 0.309 |  |  |  |  |  | 
COVID19 (Custom Term) | Vaccination failure | 2 | 42.741 | 0.012 | 0.052 | 0.115 | 0.01 | 0.049 | 0.167 | 0.047 | 0.004 | 458.489
COVID19 (Custom Term) | Pneumonia pneumococcal | 0 | 1.025 | 0 | 0.051 | 0.282 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B virus test positive | 0 | 1.126 | 0 | 0.05 | 0.279 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 1.336 | 0 | 0.05 | 0.287 |  |  |  |  |  | 
COVID19 (Custom Term) | Uterine and fallopian tube malignant tumours (SMQ) [narrow] | 0 | 1.336 | 0 | 0.05 | 0.287 |  |  |  |  |  | 
COVID19 (Custom Term) | Bacterial vaginosis | 0 | 2.431 | 0 | 0.047 | 0.267 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B DNA increased | 0 | 0.704 | 0 | 0.044 | 0.186 |  |  |  |  |  | 
COVID19 (Custom Term) | HBV-DNA polymerase increased | 0 | 0.691 | 0 | 0.044 | 0.18 |  |  |  |  |  | 
COVID19 (Custom Term) | Papilloma viral infection | 0 | 1.576 | 0 | 0.042 | 0.24 |  |  |  |  |  | 
COVID19 (Custom Term) | Chronic hepatitis B | 0 | 0.749 | 0 | 0.041 | 0.168 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antigen positive | 0 | 0.762 | 0 | 0.041 | 0.169 |  |  |  |  |  | 
COVID19 (Custom Term) | Therapy non-responder | 0 | 2.928 | 0 | 0.039 | 0.225 |  |  |  |  |  | 
COVID19 (Custom Term) | Infection via vaccinee | 0 | 1.059 | 0 | 0.039 | 0.197 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal growth restriction | 0 | 2.676 | 0 | 0.037 | 0.216 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antibody positive | 0 | 0.721 | 0 | 0.037 | 0.133 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antibody negative | 0 | 1.076 | 0 | 0.034 | 0.154 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B e antigen | 0 | 1.003 | 0 | 0.033 | 0.146 |  |  |  |  |  | 
COVID19 (Custom Term) | Bordetella test positive | 0 | 3.04 | 0 | 0.033 | 0.19 |  |  |  |  |  | 
COVID19 (Custom Term) | Rotavirus test positive | 0 | 4.677 | 0 | 0.032 | 0.177 |  |  |  |  |  | 
COVID19 (Custom Term) | Cervical dysplasia | 0 | 1.583 | 0 | 0.03 | 0.158 |  |  |  |  |  | 
COVID19 (Custom Term) | Flavivirus test positive | 0 | 0.72 | 0 | 0.03 | 0.082 |  |  |  |  |  | 
COVID19 (Custom Term) | Reproductive premalignant disorders (SMQ) [narrow] | 0 | 1.718 | 0 | 0.03 | 0.162 |  |  |  |  |  | 
COVID19 (Custom Term) | Reproductive premalignant disorders (SMQ) [broad] | 0 | 1.718 | 0 | 0.03 | 0.162 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B core antibody positive | 0 | 2.386 | 0 | 0.028 | 0.16 |  |  |  |  |  | 
COVID19 (Custom Term) | Foetal disorder | 0 | 12.462 | 0 | 0.028 | 0.121 |  |  |  |  |  | 
COVID19 (Custom Term) | Gastroenteritis rotavirus | 0 | 5.322 | 0 | 0.028 | 0.154 |  |  |  |  |  | 
COVID19 (Custom Term) | Meningococcal infection | 0 | 1.659 | 0 | 0.025 | 0.123 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antibody negative | 0 | 3.756 | 0 | 0.024 | 0.141 |  |  |  |  |  | 
COVID19 (Custom Term) | Pertussis | 0 | 5.887 | 0 | 0.024 | 0.134 |  |  |  |  |  | 
COVID19 (Custom Term) | Alpha 1 foetoprotein normal | 0 | 7.644 | 0 | 0.024 | 0.126 |  |  |  |  |  | 
COVID19 (Custom Term) | Orthopoxvirus test positive | 0 | 0.631 | 0 | 0.022 | 0.026 |  |  |  |  |  | 
COVID19 (Custom Term) | Complication of pregnancy | 0 | 4.031 | 0 | 0.022 | 0.127 |  |  |  |  |  | 
COVID19 (Custom Term) | Aerophobia | 0 | 0.724 | 0 | 0.02 | 0.024 |  |  |  |  |  | 
COVID19 (Custom Term) | Platelet-derived growth factor receptor assay | 0 | 1.436 | 0 | 0.019 | 0.067 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B surface antigen positive | 0 | 2.722 | 0 | 0.018 | 0.094 |  |  |  |  |  | 
COVID19 (Custom Term) | Neutralising antibodies | 0 | 0.634 | 0 | 0.016 | 0.006 |  |  |  |  |  | 
COVID19 (Custom Term) | HIV antibody | 0 | 3.074 | 0 | 0.013 | 0.066 |  |  |  |  |  | 
COVID19 (Custom Term) | Toxoplasma serology | 0 | 4.868 | 0 | 0.013 | 0.074 |  |  |  |  |  | 
COVID19 (Custom Term) | Vertical infection transmission | 0 | 2.097 | 0 | 0.011 | 0.033 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B | 0 | 5.008 | 0 | 0.011 | 0.057 |  |  |  |  |  | 
COVID19 (Custom Term) | Hydrophobia | 0 | 0.81 | 0 | 0.01 | 0.001 |  |  |  |  |  | 
COVID19 (Custom Term) | Rabies | 0 | 1.552 | 0 | 0.01 | 0.013 |  |  |  |  |  | 
COVID19 (Custom Term) | Hepatitis B DNA assay positive | 0 | 3.214 | 0 | 0.01 | 0.045 |  |  |  |  |  | 
COVID19_JANSSEN | Paraesthesia oral | 1 | 0.032 | 0.436 | 1.37 | 2.726 | 0.462 | 1.168 | 2.638 | 30.78 | 131.552 | 31.992
COVID19_JANSSEN | Unevaluable event | 1 | 0.005 | 0.46 | 1.318 | 2.536 | 0.467 | 1.203 | 2.826 | 213.251 | 137.184 | 33.398
COVID19_JANSSEN | Hot flush | 1 | 0.014 | 0.461 | 1.309 | 2.509 | 0.465 | 1.19 | 2.747 | 72.239 | 267.877 | 65.992
COVID19_JANSSEN | Hypoaesthesia oral | 1 | 0.023 | 0.5 | 1.231 | 2.225 | 0.464 | 1.178 | 2.689 | 44.067 | 205.114 | 50.345
COVID19_JANSSEN | Headache | 1 | 0.466 | 0.393 | 1.156 | 2.244 | 0.408 | 0.991 | 2.109 | 2.144 | 5.843 | 0.691
COVID19_JANSSEN | Guillain-Barre syndrome (SMQ) [broad] | 1 | 0.349 | 0.451 | 1.151 | 2.112 | 0.421 | 1.024 | 2.185 | 2.862 | 4.784 | 0.452
COVID19_JANSSEN | Fatigue | 1 | 0.326 | 0.472 | 1.142 | 2.048 | 0.423 | 1.031 | 2.203 | 3.07 | 7.978 | 1.195
COVID19_JANSSEN | Oropharyngeal disorders (SMQ) [narrow] | 1 | 0.197 | 0.551 | 1.123 | 1.857 | 0.439 | 1.074 | 2.314 | 5.075 | 12.162 | 2.214
COVID19_JANSSEN | Oropharyngeal disorders (SMQ) [broad] | 1 | 0.197 | 0.551 | 1.123 | 1.857 | 0.439 | 1.074 | 2.314 | 5.075 | 12.162 | 2.214
COVID19_JANSSEN | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [broad] | 1 | 0.187 | 0.559 | 1.118 | 1.832 | 0.44 | 1.077 | 2.324 | 5.343 | 14.213 | 2.719
COVID19_JANSSEN | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [narrow] | 1 | 0.187 | 0.559 | 1.118 | 1.832 | 0.44 | 1.077 | 2.324 | 5.343 | 14.213 | 2.719
COVID19_JANSSEN | Feeling hot | 1 | 0.039 | 0.636 | 1.081 | 1.622 | 0.461 | 1.162 | 2.612 | 25.938 | 56.744 | 13.316
COVID19_JANSSEN | Stomach lesion excision | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Poisoning deliberate | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Patient dissatisfaction with device | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | External hydrocephalus | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Directional Doppler flow tests | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Chylothorax | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Occult blood positive | 0 | 0 | 0.025 | 1 | 3.274 |  |  |  |  |  | 
COVID19_JANSSEN | Food intolerance | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional self-injury | 0 | 0 | 0.01 | 1 | 3.572 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 | 0 | 0.001 | 0.255 | 1 | 2.143 |  |  |  |  |  | 
COVID19_JANSSEN | Temporomandibular joint syndrome | 0 | 0 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_JANSSEN | Intracranial pressure increased | 0 | 0 | 0.185 | 1 | 2.349 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuse, dependence and withdrawal (SMQ) [narrow] | 0 | 0 | 0.005 | 1 | 3.775 |  |  |  |  |  | 
COVID19_JANSSEN | Flavivirus test negative | 0 | 0 | 0 | 1 | 4.668 |  |  |  |  |  | 
COVID19_JANSSEN | Scleritis | 0 | 0 | 0.164 | 1 | 2.42 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune neutropenia | 0 | 0 | 0.005 | 1 | 3.777 |  |  |  |  |  | 
COVID19_JANSSEN | New daily persistent headache | 0 | 0 | 0.005 | 1 | 3.752 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B6 normal | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Blood prolactin normal | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QRS complex normal | 0 | 0 | 0.154 | 1 | 2.455 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular failure | 0 | 0 | 0.036 | 1 | 3.136 |  |  |  |  |  | 
COVID19_JANSSEN | Blood group O | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Periostitis | 0 | 0 | 0.009 | 1 | 3.606 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival pruritus | 0 | 0 | 0.009 | 1 | 3.621 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum purulent | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase abnormal | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | Lung cancer metastatic | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Light chain analysis increased | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Culture tissue specimen | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Complicated appendicitis | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Cerumen impaction | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Trisomy 13 | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Typhus rickettsia test positive | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal enanthema | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Non-high-density lipoprotein cholesterol increased | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-IA2 antibody positive | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary artery stenosis congenital | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Performance fear | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder rupture | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Exertional headache | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema toxicum neonatorum | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Rash pustular | 0 | 0 | 0.024 | 1 | 3.287 |  |  |  |  |  | 
COVID19_JANSSEN | Speech disorder developmental | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep study | 0 | 0 | 0.144 | 1 | 2.493 |  |  |  |  |  | 
COVID19_JANSSEN | Lip exfoliation | 0 | 0 | 0.264 | 1 | 2.12 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate malignant tumours (SMQ) [narrow] | 0 | 0 | 0.214 | 1 | 2.258 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney transplant rejection | 0 | 0 | 0 | 1 | 4.741 |  |  |  |  |  | 
COVID19_JANSSEN | IVth nerve paralysis | 0 | 0 | 0.139 | 1 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | Henoch-Schonlein purpura nephritis | 0 | 0 | 0.117 | 1 | 2.606 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 2 globulin normal | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | Reflux laryngitis | 0 | 0 | 0.112 | 1 | 2.63 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural complication | 0 | 0 | 0.003 | 1 | 3.907 |  |  |  |  |  | 
COVID19_JANSSEN | Knee operation | 0 | 0 | 0.089 | 1 | 2.746 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 globulin increased | 0 | 0 | 0.093 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Acute psychosis | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic oesophagitis | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Blood uric acid decreased | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Self-induced vomiting | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoatrophy | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac function test abnormal | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_JANSSEN | Bursa removal | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary malignant tumours (SMQ) [broad] | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Acne conglobata | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebrobasilar stroke | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell vacuolisation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Peak expiratory flow rate normal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Orthognathic surgery | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic contracture of the left ventricle | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Implant site swelling | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperchromasia | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Hallucination, tactile | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cor pulmonale acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor XI level normal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix operation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial stent insertion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Androgen deficiency | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Weight bearing difficulty | 0 | 0.001 | 0.294 | 1 | 2.046 |  |  |  |  |  | 
COVID19_JANSSEN | Macule | 0 | 0 | 0.266 | 1 | 2.115 |  |  |  |  |  | 
COVID19_JANSSEN | Poor peripheral circulation | 0 | 0 | 0.128 | 1 | 2.557 |  |  |  |  |  | 
COVID19_JANSSEN | Drug eruption | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Ear tube insertion | 0 | 0 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Purulence | 0 | 0 | 0.2 | 1 | 2.301 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated adverse reaction | 0 | 0 | 0.209 | 1 | 2.273 |  |  |  |  |  | 
COVID19_JANSSEN | Eschar | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Skeletal survey normal | 0 | 0 | 0 | 1 | 4.32 |  |  |  |  |  | 
COVID19_JANSSEN | Cyclic vomiting syndrome | 0 | 0 | 0.015 | 1 | 3.451 |  |  |  |  |  | 
COVID19_JANSSEN | Adjusted calcium | 0 | 0 | 0.015 | 1 | 3.453 |  |  |  |  |  | 
COVID19_JANSSEN | Progesterone normal | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis | 0 | 0 | 0 | 1 | 4.435 |  |  |  |  |  | 
COVID19_JANSSEN | Low density lipoprotein | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Hypospadias | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | Erythrodermic psoriasis | 0 | 0 | 0.015 | 1 | 3.445 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to arthropod bite | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic syndrome | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_JANSSEN | B-lymphocyte count increased | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Urogram | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Photopheresis | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Vision correction operation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine uptake | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Symptom recurrence | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Meige's syndrome | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Lung carcinoma cell type unspecified stage IV | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Klebsiella infection | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy kidney normal | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin C deficiency | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Ulnar tunnel syndrome | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Paracentesis eye | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian granulosa cell tumour | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to spine | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic surgery | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Meningococcal carditis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric pH increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Coronavirus test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune colitis | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalopathy | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchiolitis | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Slow response to stimuli | 0 | 0 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory rate decreased | 0 | 0 | 0.255 | 1 | 2.143 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac function test normal | 0 | 0.001 | 0.381 | 1 | 1.856 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral disorders (SMQ) [broad] | 0 | 0 | 0.198 | 1 | 2.305 |  |  |  |  |  | 
COVID19_JANSSEN | Blood gases normal | 0 | 0 | 0.199 | 1 | 2.304 |  |  |  |  |  | 
COVID19_JANSSEN | Functional lactation disorders (SMQ) [broad] | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Adenovirus infection | 0 | 0 | 0.038 | 1 | 3.115 |  |  |  |  |  | 
COVID19_JANSSEN | Placenta praevia | 0 | 0 | 0 | 1 | 5.101 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration joint | 0 | 0 | 0.262 | 1 | 2.125 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory rate | 0 | 0.001 | 0.313 | 1 | 2.001 |  |  |  |  |  | 
COVID19_JANSSEN | Increased viscosity of upper respiratory secretion | 0 | 0 | 0.101 | 1 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ketone body absent | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Enterobiasis | 0 | 0 | 0 | 1 | 5.819 |  |  |  |  |  | 
COVID19_JANSSEN | Legionella test positive | 0 | 0 | 0.004 | 1 | 3.818 |  |  |  |  |  | 
COVID19_JANSSEN | Forced vital capacity | 0 | 0 | 0 | 1 | 4.525 |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding time prolonged | 0 | 0 | 0.017 | 1 | 3.403 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular test normal | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Ulnar neuritis | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic metabolic decompensation | 0 | 0 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_JANSSEN | Encopresis | 0 | 0 | 0.04 | 1 | 3.095 |  |  |  |  |  | 
COVID19_JANSSEN | Carbohydrate antigen 125 increased | 0 | 0 | 0.021 | 1 | 3.337 |  |  |  |  |  | 
COVID19_JANSSEN | Alphavirus test | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Von Willebrand's factor multimers test | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral artery hypoplasia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract discomfort | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Phenylalanine screen | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Locomotive syndrome | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site muscle atrophy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Foot and mouth disease | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal growth abnormality | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Ear infection fungal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Cholelithotomy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy eyelid | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Opisthotonus | 0 | 0 | 0.123 | 1 | 2.579 |  |  |  |  |  | 
COVID19_JANSSEN | Mouth ulceration | 0 | 0 | 0.188 | 1 | 2.337 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound antenatal screen | 0 | 0 | 0.001 | 1 | 4.286 |  |  |  |  |  | 
COVID19_JANSSEN | Atelectasis | 0 | 0.002 | 0.362 | 1 | 1.895 |  |  |  |  |  | 
COVID19_JANSSEN | Infectious biliary disorders (SMQ) [narrow] | 0 | 0.001 | 0.075 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcus test negative | 0 | 0 | 0.313 | 1 | 2.003 |  |  |  |  |  | 
COVID19_JANSSEN | Post-tussive vomiting | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy rectum normal | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Complex regional pain syndrome | 0 | 0 | 0.001 | 1 | 4.132 |  |  |  |  |  | 
COVID19_JANSSEN | Mass excision | 0 | 0 | 0.111 | 1 | 2.632 |  |  |  |  |  | 
COVID19_JANSSEN | Hysterectomy | 0 | 0 | 0 | 1 | 4.895 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site bruise | 0 | 0 | 0.143 | 1 | 2.497 |  |  |  |  |  | 
COVID19_JANSSEN | Depersonalisation/derealisation disorder | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_JANSSEN | Hypophosphataemia | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal myelogram normal | 0 | 0 | 0.117 | 1 | 2.606 |  |  |  |  |  | 
COVID19_JANSSEN | Liver malignant tumours (SMQ) [narrow] | 0 | 0 | 0 | 1 | 5.255 |  |  |  |  |  | 
COVID19_JANSSEN | Choroiditis | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Vulval ulceration | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Impatience | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Cerumen removal | 0 | 0 | 0.116 | 1 | 2.613 |  |  |  |  |  | 
COVID19_JANSSEN | Antibiotic therapy | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary physical examination abnormal | 0 | 0 | 0.02 | 1 | 3.364 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery dissection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Blood parathyroid hormone decreased | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic oedema | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Visual agnosia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site atrophy | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine polyp | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord operation | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Scan spleen | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Joint arthroplasty | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Culture cervix | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical laser therapy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Emotional disorder | 0 | 0 | 0.196 | 1 | 2.313 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster pharyngitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal disorder prophylaxis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Evacuation of retained products of conception | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctivochalasis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Colour blindness acquired | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma recurrent | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Brief psychotic disorder with marked stressors | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tract disorder | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-JC virus antibody index | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Post vaccination syndrome | 0 | 0 | 0 | 1 | 4.945 |  |  |  |  |  | 
COVID19_JANSSEN | Mononucleosis heterophile test negative | 0 | 0.001 | 0.293 | 1 | 2.049 |  |  |  |  |  | 
COVID19_JANSSEN | Product packaging confusion | 0 | 0 | 0.009 | 1 | 3.617 |  |  |  |  |  | 
COVID19_JANSSEN | Asphyxia | 0 | 0 | 0.024 | 1 | 3.295 |  |  |  |  |  | 
COVID19_JANSSEN | Reaction to preservatives | 0 | 0.001 | 0.184 | 1 | 2.35 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinovirus infection | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Chlamydia test negative | 0 | 0 | 0.2 | 1 | 2.299 |  |  |  |  |  | 
COVID19_JANSSEN | Iridocyclitis | 0 | 0 | 0.008 | 1 | 3.63 |  |  |  |  |  | 
COVID19_JANSSEN | Learning disability | 0 | 0 | 0.013 | 1 | 3.506 |  |  |  |  |  | 
COVID19_JANSSEN | Daydreaming | 0 | 0 | 0.014 | 1 | 3.476 |  |  |  |  |  | 
COVID19_JANSSEN | Product package associated injury | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia chlamydial | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Angle closure glaucoma | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Spherocytic anaemia | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Pupillary disorder | 0 | 0 | 0.022 | 1 | 3.317 |  |  |  |  |  | 
COVID19_JANSSEN | Disseminated Bacillus Calmette-Guerin infection | 0 | 0 | 0.008 | 1 | 3.636 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging joint | 0 | 0 | 0.11 | 1 | 2.638 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid volume decreased | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Somatotropin stimulation test | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Hemianopia homonymous | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine cervical pain | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Thymus hypoplasia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Thermoanaesthesia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Renal abscess | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination with body fluid | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Parathyroid hormone-related protein | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Opticokinetic nystagmus tests | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Leptin level increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site haemorrhage | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin S increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin electrophoresis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Flour sensitivity | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin degradation products normal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Constricted affect | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram pancreas normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Bullous haemorrhagic dermatosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lead abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial ligation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Aplasia cutis congenita | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia of pregnancy | 0 | 0 | 0.055 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Acute post asthmatic amyotrophy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site injury | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Breast swelling | 0 | 0 | 0.161 | 1 | 2.429 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal detachment | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess negative | 0 | 0 | 0.014 | 1 | 3.482 |  |  |  |  |  | 
COVID19_JANSSEN | Serum ferritin decreased | 0 | 0 | 0.014 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound biliary tract | 0 | 0 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster cutaneous disseminated | 0 | 0 | 0.031 | 1 | 3.191 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic spontaneous urticaria | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Acute motor-sensory axonal neuropathy | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Toxoplasmosis | 0 | 0 | 0.099 | 1 | 2.693 |  |  |  |  |  | 
COVID19_JANSSEN | Audiogram normal | 0 | 0 | 0.123 | 1 | 2.578 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate increased | 0 | 0 | 0.004 | 1 | 3.857 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic respiratory failure | 0 | 0 | 0.022 | 1 | 3.323 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea nitrogen/creatinine ratio increased | 0 | 0 | 0.013 | 1 | 3.504 |  |  |  |  |  | 
COVID19_JANSSEN | Basal ganglia haemorrhage | 0 | 0 | 0.015 | 1 | 3.443 |  |  |  |  |  | 
COVID19_JANSSEN | Blister infected | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Growth failure | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous T-cell lymphoma | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Calculus urinary | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy colon | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Toe amputation | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Prinzmetal angina | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Internal fixation of fracture | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Comminuted fracture | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Antidepressant drug level | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic bronchitis | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site haematoma | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Thiopurine methyltransferase decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon laxity | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Stoma site erythema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal drusen | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Progressive bulbar palsy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Heparin-induced thrombocytopenia test positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital ureterovesical junction anomaly | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary sepsis | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Androgens increased | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy thymus gland abnormal | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous opacities | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell elliptocytes present | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfective myringitis | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Neurologic somatic symptom disorder | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Limb fracture | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Implant site pruritus | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Forearm fracture | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Eye opacity | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram pacemaker spike | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Breast milk substitute intolerance | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Beta-N-acetyl-D-glucosaminidase | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Acid base balance | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis pneumococcal | 0 | 0 | 0 | 1 | 5.467 |  |  |  |  |  | 
COVID19_JANSSEN | Contraindication to vaccination | 0 | 0 | 0.014 | 1 | 3.482 |  |  |  |  |  | 
COVID19_JANSSEN | Peroneal nerve palsy | 0 | 0.001 | 0.298 | 1 | 2.036 |  |  |  |  |  | 
COVID19_JANSSEN | Piloerection | 0 | 0 | 0.31 | 1 | 2.009 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal neoplasms (SMQ) [broad] | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Breast mass | 0 | 0 | 0.015 | 1 | 3.456 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging thoracic abnormal | 0 | 0 | 0.151 | 1 | 2.465 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium tuberculosis complex test | 0 | 0 | 0.028 | 1 | 3.235 |  |  |  |  |  | 
COVID19_JANSSEN | Dysphoria | 0 | 0 | 0.123 | 1 | 2.582 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal scalded skin syndrome | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersensitivity pneumonitis | 0 | 0 | 0.018 | 1 | 3.397 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-neuronal antibody negative | 0 | 0 | 0.063 | 1 | 2.909 |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical cord abnormality | 0 | 0 | 0.004 | 1 | 3.865 |  |  |  |  |  | 
COVID19_JANSSEN | Liver function test decreased | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Cold agglutinins negative | 0 | 0 | 0.02 | 1 | 3.348 |  |  |  |  |  | 
COVID19_JANSSEN | Divorced | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Reflexology | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Neurosyphilis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Immunosuppressant drug level increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopic ultrasound | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | DiGeorge's syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital thrombocytopenia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Conductive deafness | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid oedema | 0 | 0 | 0.476 | 1 | 1.679 |  |  |  |  |  | 
COVID19_JANSSEN | Paraplegia | 0 | 0 | 0.035 | 1 | 3.151 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculin test negative | 0 | 0 | 0.012 | 1 | 3.527 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac pacemaker insertion | 0 | 0 | 0.271 | 1 | 2.102 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria chronic | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis abnormal | 0 | 0 | 0 | 1 | 5.625 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray dental normal | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_JANSSEN | Expanded disability status scale score decreased | 0 | 0 | 0 | 1 | 5.731 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound pelvis abnormal | 0 | 0 | 0.01 | 1 | 3.592 |  |  |  |  |  | 
COVID19_JANSSEN | Rhonchi | 0 | 0 | 0.158 | 1 | 2.44 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial ischaemia | 0 | 0 | 0.077 | 1 | 2.814 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiolipin antibody | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Lagophthalmos | 0 | 0 | 0.145 | 1 | 2.488 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy anus normal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Polymyositis | 0 | 0 | 0.003 | 1 | 3.886 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular headache | 0 | 0 | 0.021 | 1 | 3.34 |  |  |  |  |  | 
COVID19_JANSSEN | Adjusted calcium increased | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site swelling | 0 | 0 | 0.189 | 1 | 2.335 |  |  |  |  |  | 
COVID19_JANSSEN | Amoeba test negative | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Decerebrate posture | 0 | 0 | 0.103 | 1 | 2.673 |  |  |  |  |  | 
COVID19_JANSSEN | Urobilinogen urine increased | 0 | 0 | 0.213 | 1 | 2.261 |  |  |  |  |  | 
COVID19_JANSSEN | Bradyphrenia | 0 | 0.001 | 0.108 | 1 | 2.645 |  |  |  |  |  | 
COVID19_JANSSEN | Relapsing multiple sclerosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Meigs' syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Polyserositis | 0 | 0 | 0.019 | 1 | 3.372 |  |  |  |  |  | 
COVID19_JANSSEN | Xanthogranuloma | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | CSF cell count normal | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperadrenalism | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal oedema | 0 | 0 | 0.216 | 1 | 2.253 |  |  |  |  |  | 
COVID19_JANSSEN | Eye haemorrhage | 0 | 0.002 | 0.373 | 1 | 1.871 |  |  |  |  |  | 
COVID19_JANSSEN | Nail bed bleeding | 0 | 0 | 0.024 | 1 | 3.285 |  |  |  |  |  | 
COVID19_JANSSEN | Application site papules | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine free decreased | 0 | 0 | 0.115 | 1 | 2.614 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal disorder | 0 | 0 | 0 | 1 | 4.529 |  |  |  |  |  | 
COVID19_JANSSEN | Gamma-glutamyltransferase decreased | 0 | 0 | 0.001 | 1 | 4.101 |  |  |  |  |  | 
COVID19_JANSSEN | Dihydrotestosterone decreased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Renal graft infection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix cautery | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Device issue | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Ammonia increased | 0 | 0 | 0.351 | 1 | 1.917 |  |  |  |  |  | 
COVID19_JANSSEN | Lactate pyruvate ratio | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Injury to brachial plexus due to birth trauma | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Synovitis | 0 | 0 | 0.134 | 1 | 2.534 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal lesion | 0 | 0 | 0.034 | 1 | 3.167 |  |  |  |  |  | 
COVID19_JANSSEN | Hypermetropia | 0 | 0 | 0.201 | 1 | 2.298 |  |  |  |  |  | 
COVID19_JANSSEN | Thunderclap headache | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Protein total abnormal | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Radiation injury | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Phytotherapy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Periphlebitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Paraproteinaemia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Oligoarthritis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Convulsive threshold lowered | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal rebound tenderness | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil percentage decreased | 0 | 0.001 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_JANSSEN | Culture throat | 0 | 0 | 0.231 | 1 | 2.21 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site abscess | 0 | 0 | 0.015 | 1 | 3.46 |  |  |  |  |  | 
COVID19_JANSSEN | Growth retardation | 0 | 0 | 0.033 | 1 | 3.17 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular evaluation | 0 | 0.002 | 0.335 | 1 | 1.951 |  |  |  |  |  | 
COVID19_JANSSEN | Exophthalmos | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus antibody | 0 | 0 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Contraindicated product administered | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis exfoliative generalised | 0 | 0 | 0.139 | 1 | 2.513 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary casts | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | CSF protein abnormal | 0 | 0 | 0.024 | 1 | 3.291 |  |  |  |  |  | 
COVID19_JANSSEN | Mononeuropathy multiplex | 0 | 0 | 0.018 | 1 | 3.384 |  |  |  |  |  | 
COVID19_JANSSEN | Cystoid macular oedema | 0 | 0 | 0 | 1 | 4.903 |  |  |  |  |  | 
COVID19_JANSSEN | Seronegative arthritis | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Prolapse | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Shock | 0 | 0.001 | 0.14 | 1 | 2.509 |  |  |  |  |  | 
COVID19_JANSSEN | Cat scratch disease | 0 | 0 | 0 | 1 | 5.426 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired syringomyelia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal fibrosis (SMQ) [narrow] | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Joint surgery | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary infarction | 0 | 0 | 0.003 | 1 | 3.874 |  |  |  |  |  | 
COVID19_JANSSEN | Drug trough level | 0 | 0 | 0.02 | 1 | 3.362 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal neovascularisation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Papilloma excision | 0 | 0 | 0 | 1 | 4.492 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobinaemia | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Capsule endoscopy | 0 | 0 | 0.001 | 1 | 4.117 |  |  |  |  |  | 
COVID19_JANSSEN | Head circumference normal | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Parapsoriasis | 0 | 0 | 0.015 | 1 | 3.458 |  |  |  |  |  | 
COVID19_JANSSEN | Blood follicle stimulating hormone increased | 0 | 0 | 0 | 1 | 4.633 |  |  |  |  |  | 
COVID19_JANSSEN | Endometriosis | 0 | 0 | 0 | 1 | 4.657 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory fatigue | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Postoperative adhesion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Vein collapse | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal stenosis | 0 | 0 | 0.216 | 1 | 2.253 |  |  |  |  |  | 
COVID19_JANSSEN | Urine iodine increased | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue injury | 0 | 0 | 0.18 | 1 | 2.363 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac stress test normal | 0 | 0.001 | 0.451 | 1 | 1.723 |  |  |  |  |  | 
COVID19_JANSSEN | Papule | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Orthostatic hypertension | 0 | 0 | 0.009 | 1 | 3.623 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin D deficiency | 0 | 0 | 0.01 | 1 | 3.572 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic aneurysm rupture | 0 | 0 | 0.009 | 1 | 3.604 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial vaginosis | 0 | 0 | 0 | 1 | 5.71 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic myocarditis | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_JANSSEN | Urea urine decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Agranulocytosis | 0 | 0 | 0 | 1 | 4.303 |  |  |  |  |  | 
COVID19_JANSSEN | Amniorrhoea | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac electrophysiologic study abnormal | 0 | 0 | 0.035 | 1 | 3.147 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperchromic anaemia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Device inappropriate shock delivery | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal oedema | 0 | 0 | 0.004 | 1 | 3.816 |  |  |  |  |  | 
COVID19_JANSSEN | Polyhydramnios | 0 | 0 | 0 | 1 | 5.041 |  |  |  |  |  | 
COVID19_JANSSEN | Turbinectomy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrops foetalis | 0 | 0 | 0.072 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Blood prolactin abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound ovary | 0 | 0 | 0.015 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | Arthrogram abnormal | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_JANSSEN | Chlamydial infection | 0 | 0 | 0 | 1 | 5.129 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic cancer | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level decreased | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumocystis test positive | 0 | 0 | 0 | 1 | 4.496 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis tuberculous | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site hypoaesthesia | 0 | 0 | 0.021 | 1 | 3.345 |  |  |  |  |  | 
COVID19_JANSSEN | Human bocavirus infection | 0 | 0 | 0.038 | 1 | 3.121 |  |  |  |  |  | 
COVID19_JANSSEN | Child maltreatment syndrome | 0 | 0 | 0 | 1 | 5.698 |  |  |  |  |  | 
COVID19_JANSSEN | Osteoarthropathy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alkaline phosphatase decreased | 0 | 0 | 0.104 | 1 | 2.665 |  |  |  |  |  | 
COVID19_JANSSEN | Paracentesis | 0 | 0 | 0.098 | 1 | 2.696 |  |  |  |  |  | 
COVID19_JANSSEN | Meconium abnormal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothermia neonatal | 0 | 0 | 0.035 | 1 | 3.154 |  |  |  |  |  | 
COVID19_JANSSEN | Seroconversion test positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Tolosa-Hunt syndrome | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Neovascular age-related macular degeneration | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal artery thrombosis | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Diagnostic procedure | 0 | 0 | 0.333 | 1 | 1.958 |  |  |  |  |  | 
COVID19_JANSSEN | Wall motion score index abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Drug screen | 0 | 0.001 | 0.26 | 1 | 2.13 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis membranoproliferative | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrovascular stenosis | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_JANSSEN | Human anti-human antibody test | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrocephalus | 0 | 0 | 0.224 | 1 | 2.23 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal growth restriction | 0 | 0 | 0 | 1 | 5.788 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth repair | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Fructose intolerance | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic haematoma | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Dissociation | 0 | 0 | 0.036 | 1 | 3.14 |  |  |  |  |  | 
COVID19_JANSSEN | Charles Bonnet syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Cheyne-Stokes respiration | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site infection | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess oral | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Thoracic operation | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of spontaneous speech | 0 | 0 | 0.008 | 1 | 3.63 |  |  |  |  |  | 
COVID19_JANSSEN | Full blood count abnormal | 0 | 0.002 | 0.372 | 1 | 1.873 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatopathic lymphadenopathy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Ventriculo-peritoneal shunt | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Femoral nerve injury | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Clumsiness | 0 | 0 | 0.12 | 1 | 2.592 |  |  |  |  |  | 
COVID19_JANSSEN | Dialysis | 0 | 0.001 | 0.246 | 1 | 2.167 |  |  |  |  |  | 
COVID19_JANSSEN | Accidental exposure to product packaging | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Porphyrins urine | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Oligodipsia | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Living in residential institution | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell analysis normal | 0 | 0 | 0.023 | 1 | 3.308 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural fibrosis | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperthyroidism | 0 | 0 | 0.087 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Body tinea | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Graft versus host disease in skin | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Quarantine | 0 | 0 | 0.026 | 1 | 3.263 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic viral infection | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pulpitis dental | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site scar | 0 | 0 | 0.206 | 1 | 2.281 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperdynamic left ventricle | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Unintended pregnancy | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulum intestinal haemorrhagic | 0 | 0 | 0.021 | 1 | 3.333 |  |  |  |  |  | 
COVID19_JANSSEN | Echovirus test negative | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_JANSSEN | Nodal rhythm | 0 | 0 | 0.073 | 1 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Necrobiosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Skin discharge | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body reaction | 0 | 0 | 0.102 | 1 | 2.68 |  |  |  |  |  | 
COVID19_JANSSEN | PO2 normal | 0 | 0 | 0.186 | 1 | 2.344 |  |  |  |  |  | 
COVID19_JANSSEN | Colour vision tests abnormal | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngotracheal oedema | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Factor XIII deficiency | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Smooth muscle antibody negative | 0 | 0 | 0.035 | 1 | 3.146 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C4 decreased | 0 | 0 | 0.002 | 1 | 4.05 |  |  |  |  |  | 
COVID19_JANSSEN | Oculomotor study normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Corticobasal degeneration | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to extreme temperature | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Hilar lymphadenopathy | 0 | 0 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_JANSSEN | Amoebiasis | 0 | 0 | 0 | 1 | 5.336 |  |  |  |  |  | 
COVID19_JANSSEN | Urine output | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil percentage | 0 | 0.001 | 0.174 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Pyloric stenosis | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Chemical burn | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Tumefactive multiple sclerosis | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell analysis normal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive cardiomegaly | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell microcytes present | 0 | 0 | 0.013 | 1 | 3.508 |  |  |  |  |  | 
COVID19_JANSSEN | Parkinsonism | 0 | 0 | 0.225 | 1 | 2.225 |  |  |  |  |  | 
COVID19_JANSSEN | Blast cell crisis | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillitis | 0 | 0 | 0.038 | 1 | 3.115 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid ptosis congenital | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle hypoxia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Listeriosis | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary malignant tumours (SMQ) [narrow] | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Double ureter | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal stoma output increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Blood premalignant disorders (SMQ) [narrow] | 0 | 0 | 0.155 | 1 | 2.452 |  |  |  |  |  | 
COVID19_JANSSEN | Osteomyelitis acute | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Stem cell transplant | 0 | 0 | 0.014 | 1 | 3.465 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobinuria | 0 | 0 | 0 | 1 | 5.308 |  |  |  |  |  | 
COVID19_JANSSEN | Venogram abnormal | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Haemofiltration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Helminthic infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Concentric sclerosis | 0 | 0 | 0 | 1 | 5.088 |  |  |  |  |  | 
COVID19_JANSSEN | Culture tissue specimen positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Oral pain | 0 | 0.001 | 0.435 | 1 | 1.753 |  |  |  |  |  | 
COVID19_JANSSEN | Antiphospholipid antibodies negative | 0 | 0 | 0.013 | 1 | 3.505 |  |  |  |  |  | 
COVID19_JANSSEN | Scrub typhus | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal ultrasound normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract procedural complication | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lentigo | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Antibody test normal | 0 | 0 | 0.003 | 1 | 3.897 |  |  |  |  |  | 
COVID19_JANSSEN | Labile blood pressure | 0 | 0 | 0.009 | 1 | 3.599 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal stenosis | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal diameter increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Diet noncompliance | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Iodine uptake decreased | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia infection | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_JANSSEN | Inhibin B | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary tumour benign | 0 | 0 | 0.019 | 1 | 3.373 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration pleural cavity abnormal | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary scan abnormal | 0 | 0 | 0.09 | 1 | 2.742 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic colitis | 0 | 0 | 0.004 | 1 | 3.866 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein A-I decreased | 0 | 0 | 0.004 | 1 | 3.844 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric haemorrhage | 0 | 0 | 0.11 | 1 | 2.639 |  |  |  |  |  | 
COVID19_JANSSEN | Phakomatosis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Haemangioma-thrombocytopenia syndrome | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site cyst | 0 | 0 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_JANSSEN | Nail discolouration | 0 | 0 | 0.018 | 1 | 3.396 |  |  |  |  |  | 
COVID19_JANSSEN | Chlamydia test positive | 0 | 0 | 0.002 | 1 | 3.965 |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding anovulatory | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Young's syndrome | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholesterol increased | 0 | 0 | 0.184 | 1 | 2.352 |  |  |  |  |  | 
COVID19_JANSSEN | Delirium febrile | 0 | 0 | 0.015 | 1 | 3.46 |  |  |  |  |  | 
COVID19_JANSSEN | Parainfluenzae virus infection | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal dilatation | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal syndrome | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_JANSSEN | Hypobarism | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive nephropathy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis chronic active | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal flaring | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Oligodendroglioma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic fluid-air exchange procedure | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid cell count | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Disseminated intravascular coagulation | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Brain natriuretic peptide normal | 0 | 0.001 | 0.142 | 1 | 2.501 |  |  |  |  |  | 
COVID19_JANSSEN | Pleocytosis | 0 | 0 | 0.003 | 1 | 3.928 |  |  |  |  |  | 
COVID19_JANSSEN | Venous oxygen partial pressure | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Ascites | 0 | 0.001 | 0.104 | 1 | 2.666 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-glomerular basement membrane antibody | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal vasculitis | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_JANSSEN | Repetitive speech | 0 | 0 | 0.176 | 1 | 2.379 |  |  |  |  |  | 
COVID19_JANSSEN | Prophylaxis against Rh isoimmunisation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | 5-hydroxyindolacetic acid in urine decreased | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal ischaemia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophils urine | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilus test | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_JANSSEN | Rash maculo-papular | 0 | 0.001 | 0.3 | 1 | 2.031 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudocellulitis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic fluid collection | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Induced abortion failed | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Epiphyses delayed fusion | 0 | 0 | 0.01 | 1 | 3.582 |  |  |  |  |  | 
COVID19_JANSSEN | Product container seal issue | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-cerebral aneurysm operation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray of pelvis and hip abnormal | 0 | 0 | 0.217 | 1 | 2.248 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular examination abnormal | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Retirement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Graft versus host disease in gastrointestinal tract | 0 | 0 | 0.041 | 1 | 3.089 |  |  |  |  |  | 
COVID19_JANSSEN | Dystonia | 0 | 0 | 0.283 | 1 | 2.073 |  |  |  |  |  | 
COVID19_JANSSEN | Gestational hypertension | 0 | 0 | 0 | 1 | 5.335 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cells increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood prolactin decreased | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound foetal abnormal | 0 | 0 | 0.013 | 1 | 3.499 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site calcification | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery dissection | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Mean platelet volume normal | 0 | 0.001 | 0.214 | 1 | 2.257 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic response delayed | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema infected | 0 | 0 | 0.007 | 1 | 3.687 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration bone marrow normal | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Anion gap increased | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical cord around neck | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Parasomnia | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Inguinal hernia, obstructive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Lip ulceration | 0 | 0 | 0.165 | 1 | 2.414 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpes virus 8 test | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal dysplasia | 0 | 0 | 0.004 | 1 | 3.823 |  |  |  |  |  | 
COVID19_JANSSEN | Dyshidrotic eczema | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocyte percentage decreased | 0 | 0 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal pH | 0 | 0 | 0.006 | 1 | 3.71 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema genital | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Stomach mass | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VII level decreased | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Ileocolostomy | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema impetiginous | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Early onset familial Alzheimer's disease | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Perinatal depression | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrinous bronchitis | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin CSF decreased | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery thrombosis | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid cyst | 0 | 0 | 0.087 | 1 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Neurilemmoma benign | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular retraction | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-insulin antibody decreased | 0 | 0 | 0.067 | 1 | 2.875 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal inflammation | 0 | 0 | 0.034 | 1 | 3.158 |  |  |  |  |  | 
COVID19_JANSSEN | Renal mass | 0 | 0 | 0.135 | 1 | 2.527 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal transplant | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral disorder | 0 | 0 | 0.095 | 1 | 2.711 |  |  |  |  |  | 
COVID19_JANSSEN | Contraindication to medical treatment | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Typical aura without headache | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Factor VIII deficiency | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Coxsackie virus test | 0 | 0 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_JANSSEN | Horner's syndrome | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Exomphalos | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood sodium abnormal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac ventriculogram left normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Lupus enteritis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotonic-hyporesponsive episode (SMQ) [algorithm] | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular vascular disorder | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal disorder | 0 | 0.001 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_JANSSEN | Separation anxiety disorder | 0 | 0 | 0.098 | 1 | 2.696 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperaemia | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_JANSSEN | C1 esterase inhibitor test | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinalgia | 0 | 0 | 0.005 | 1 | 3.788 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site discharge | 0 | 0 | 0.005 | 1 | 3.783 |  |  |  |  |  | 
COVID19_JANSSEN | Reflux nephropathy | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Calcium ionised decreased | 0 | 0 | 0.001 | 1 | 4.197 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic stomatitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hunger | 0 | 0.001 | 0.066 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Breast discomfort | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatofibrosarcoma protuberans | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid cancer | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve root injury cervical | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Microbiology test | 0 | 0 | 0.171 | 1 | 2.395 |  |  |  |  |  | 
COVID19_JANSSEN | Sinusitis bacterial | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | ABO incompatibility | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Phenylketonuria | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin concentration increased | 0 | 0 | 0 | 1 | 5.308 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor decreased | 0 | 0 | 0 | 1 | 5.124 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lip abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood smear test normal | 0 | 0 | 0.133 | 1 | 2.536 |  |  |  |  |  | 
COVID19_JANSSEN | Infection | 0 | 0.001 | 0.226 | 1 | 2.222 |  |  |  |  |  | 
COVID19_JANSSEN | Brown-Sequard syndrome | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Extradural haematoma | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_JANSSEN | Basosquamous carcinoma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Disseminated varicella zoster virus infection | 0 | 0 | 0.001 | 1 | 4.146 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time shortened | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Von Willebrand's disease | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Vocal cord thickening | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Renal atrophy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Protein S deficiency | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Osmophobia | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging abdominal normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Fistula repair | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Brain neoplasm malignant | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Bile output increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Ballismus | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia neonatal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Air embolism | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Lip dry | 0 | 0 | 0.232 | 1 | 2.207 |  |  |  |  |  | 
COVID19_JANSSEN | Skin malignant tumours (SMQ) [narrow] | 0 | 0 | 0.002 | 1 | 3.985 |  |  |  |  |  | 
COVID19_JANSSEN | Sunburn | 0 | 0 | 0.173 | 1 | 2.389 |  |  |  |  |  | 
COVID19_JANSSEN | Blood iron normal | 0 | 0 | 0.228 | 1 | 2.216 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue blistering | 0 | 0.001 | 0.252 | 1 | 2.15 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary nail refill test abnormal | 0 | 0 | 0.161 | 1 | 2.43 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system infection | 0 | 0 | 0.008 | 1 | 3.644 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site necrosis | 0 | 0 | 0.033 | 1 | 3.173 |  |  |  |  |  | 
COVID19_JANSSEN | Dreamy state | 0 | 0 | 0.086 | 1 | 2.764 |  |  |  |  |  | 
COVID19_JANSSEN | Facet joint syndrome | 0 | 0 | 0.152 | 1 | 2.463 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament injury | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Tinea pedis | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema weeping | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin G abnormal | 0 | 0 | 0.025 | 1 | 3.278 |  |  |  |  |  | 
COVID19_JANSSEN | Intracranial mass | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_JANSSEN | FEV1/FVC ratio abnormal | 0 | 0 | 0 | 1 | 5.568 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate decreased | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral cyst | 0 | 0 | 0.001 | 1 | 4.216 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha haemolytic streptococcal infection | 0 | 0 | 0.008 | 1 | 3.639 |  |  |  |  |  | 
COVID19_JANSSEN | Xanthopsia | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_JANSSEN | Dental discomfort | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy oesophagus normal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Asymptomatic bacteriuria | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland neoplasm | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Perinatal HBV infection | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin normal | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral microhaemorrhage | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast lower gastrointestinal tract normal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Renal embolism | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Prolonged rupture of membranes | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagogastric fundoplasty | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosa vesicle | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic adenoma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Enzyme activity normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor XII level | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Anticoagulation drug level below therapeutic | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test urine positive | 0 | 0 | 0.001 | 1 | 4.198 |  |  |  |  |  | 
COVID19_JANSSEN | Pemphigoid | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Alanine aminotransferase | 0 | 0 | 0.11 | 1 | 2.638 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation test | 0 | 0.001 | 0.292 | 1 | 2.051 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth infection | 0 | 0 | 0.124 | 1 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural fluid analysis | 0 | 0 | 0 | 1 | 4.857 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocyte count increased | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin urine absent | 0 | 0 | 0.124 | 1 | 2.574 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon discomfort | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell morphology abnormal | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thyroid stimulating hormone abnormal | 0 | 0 | 0.002 | 1 | 4.059 |  |  |  |  |  | 
COVID19_JANSSEN | SCORTEN score | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy with advanced maternal age | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic exenteration | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular dilatation | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Eyeball avulsion | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Escharotomy | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Deltaretrovirus test positive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs negative haemolytic anaemia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor X level decreased | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial thrombosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Staring | 0 | 0 | 0.335 | 1 | 1.952 |  |  |  |  |  | 
COVID19_JANSSEN | Skin irritation | 0 | 0.001 | 0.25 | 1 | 2.156 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil count | 0 | 0 | 0.178 | 1 | 2.37 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropsychological test | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Blood homocysteine normal | 0 | 0 | 0.143 | 1 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Liver neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0 | 1 | 4.688 |  |  |  |  |  | 
COVID19_JANSSEN | Bradycardia neonatal | 0 | 0 | 0 | 1 | 5.468 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic inflammatory disease | 0 | 0 | 0 | 1 | 5.426 |  |  |  |  |  | 
COVID19_JANSSEN | Scan abdomen abnormal | 0 | 0 | 0.007 | 1 | 3.693 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ethanol normal | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Ulcer haemorrhage | 0 | 0 | 0 | 1 | 4.945 |  |  |  |  |  | 
COVID19_JANSSEN | Positron emission tomography-magnetic resonance imaging | 0 | 0 | 0.091 | 1 | 2.736 |  |  |  |  |  | 
COVID19_JANSSEN | Penile rash | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Blood zinc | 0 | 0 | 0.035 | 1 | 3.146 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium avium complex infection | 0 | 0 | 0.001 | 1 | 4.083 |  |  |  |  |  | 
COVID19_JANSSEN | Nail bed disorder | 0 | 0 | 0.095 | 1 | 2.715 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function challenge test | 0 | 0 | 0.055 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Postoperative wound complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via partner | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal perforation | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy small intestine normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Angiotensin II increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammatory marker increased | 0 | 0 | 0.241 | 1 | 2.182 |  |  |  |  |  | 
COVID19_JANSSEN | Ill-defined disorder | 0 | 0 | 0.115 | 1 | 2.616 |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter test negative | 0 | 0 | 0.13 | 1 | 2.552 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine normal | 0 | 0.001 | 0.259 | 1 | 2.134 |  |  |  |  |  | 
COVID19_JANSSEN | Thirst decreased | 0 | 0 | 0.027 | 1 | 3.253 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma stage 0 | 0 | 0 | 0 | 1 | 5.525 |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystitis | 0 | 0 | 0.128 | 1 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Slit-lamp tests abnormal | 0 | 0 | 0.001 | 1 | 4.096 |  |  |  |  |  | 
COVID19_JANSSEN | B-lymphocyte count decreased | 0 | 0 | 0 | 1 | 4.636 |  |  |  |  |  | 
COVID19_JANSSEN | Intranasal hypoaesthesia | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Osteochondrosis | 0 | 0 | 0.034 | 1 | 3.165 |  |  |  |  |  | 
COVID19_JANSSEN | CD4/CD8 ratio decreased | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Vocal cord paresis | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine decreased | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Tocolysis | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Smear buccal abnormal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Coccidioidomycosis | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Delusion | 0 | 0 | 0.439 | 1 | 1.745 |  |  |  |  |  | 
COVID19_JANSSEN | Blood uric acid | 0 | 0 | 0.32 | 1 | 1.986 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyphrenia | 0 | 0 | 0.331 | 1 | 1.962 |  |  |  |  |  | 
COVID19_JANSSEN | Lung neoplasm malignant | 0 | 0 | 0.218 | 1 | 2.245 |  |  |  |  |  | 
COVID19_JANSSEN | Autoantibody positive | 0 | 0 | 0.114 | 1 | 2.618 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimation disorder | 0 | 0 | 0.026 | 1 | 3.256 |  |  |  |  |  | 
COVID19_JANSSEN | Lipodystrophy (SMQ) [narrow] | 0 | 0 | 0.086 | 1 | 2.764 |  |  |  |  |  | 
COVID19_JANSSEN | CSF pressure normal | 0 | 0 | 0 | 1 | 5.367 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy peripheral nerve | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Thymus enlargement | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Panniculitis lobular | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy breast abnormal | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_JANSSEN | Meningoradiculitis | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Testis discomfort | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Merycism | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Eyeglasses therapy | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestine polyp | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Skin adhesion | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Removal of foreign body from nose | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Palmoplantar keratoderma | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mallampati score | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Manual lymphatic drainage | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant hypertension | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lobular breast carcinoma in situ | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngotracheobronchoscopy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Laparoscopy abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hyposomnia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatopulmonary syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin S normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal mucosal necrosis | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicogenic vertigo | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow myelogram normal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal adenoma | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil percentage decreased | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased eye contact | 0 | 0 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis diaper | 0 | 0 | 0.41 | 1 | 1.8 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfective encephalitis | 0 | 0.001 | 0.239 | 1 | 2.184 |  |  |  |  |  | 
COVID19_JANSSEN | Double stranded DNA antibody | 0 | 0 | 0.012 | 1 | 3.525 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function test | 0 | 0 | 0.045 | 1 | 3.051 |  |  |  |  |  | 
COVID19_JANSSEN | Renal function test | 0 | 0 | 0.339 | 1 | 1.943 |  |  |  |  |  | 
COVID19_JANSSEN | Joint fluid drainage | 0 | 0 | 0.27 | 1 | 2.104 |  |  |  |  |  | 
COVID19_JANSSEN | Dysbiosis | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal swelling | 0 | 0 | 0.108 | 1 | 2.647 |  |  |  |  |  | 
COVID19_JANSSEN | Dementia Alzheimer's type | 0 | 0 | 0.019 | 1 | 3.381 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomonas infection | 0 | 0 | 0.097 | 1 | 2.704 |  |  |  |  |  | 
COVID19_JANSSEN | Type 2 lepra reaction | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Mastoid disorder | 0 | 0 | 0 | 1 | 4.649 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-VGCC antibody | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcal abscess | 0 | 0 | 0.026 | 1 | 3.259 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance elastography | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal inflammation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Inappropriate release of product for distribution | 0 | 0 | 0.008 | 1 | 3.651 |  |  |  |  |  | 
COVID19_JANSSEN | Blood HIV RNA decreased | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Amphetamines positive | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal oedema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Skin lesion inflammation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Sarcopenia | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A antibody positive | 0 | 0 | 0 | 1 | 5.205 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus bradycardia | 0 | 0 | 0.016 | 1 | 3.428 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-ganglioside antibody positive | 0 | 0 | 0 | 1 | 5.198 |  |  |  |  |  | 
COVID19_JANSSEN | Visual field tests abnormal | 0 | 0 | 0.143 | 1 | 2.499 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bicarbonate increased | 0 | 0.001 | 0.159 | 1 | 2.437 |  |  |  |  |  | 
COVID19_JANSSEN | Acute myeloid leukaemia | 0 | 0 | 0.297 | 1 | 2.04 |  |  |  |  |  | 
COVID19_JANSSEN | CSF monocyte count decreased | 0 | 0 | 0.287 | 1 | 2.062 |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric evaluation | 0 | 0 | 0.004 | 1 | 3.864 |  |  |  |  |  | 
COVID19_JANSSEN | Spondylitis | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Hypovolaemia | 0 | 0 | 0.27 | 1 | 2.106 |  |  |  |  |  | 
COVID19_JANSSEN | Hypnagogic hallucination | 0 | 0 | 0 | 1 | 5.094 |  |  |  |  |  | 
COVID19_JANSSEN | Cryoglobulinaemia | 0 | 0 | 0 | 1 | 4.386 |  |  |  |  |  | 
COVID19_JANSSEN | Antimicrobial susceptibility test sensitive | 0 | 0 | 0 | 1 | 4.369 |  |  |  |  |  | 
COVID19_JANSSEN | Palindromic rheumatism | 0 | 0 | 0.001 | 1 | 4.175 |  |  |  |  |  | 
COVID19_JANSSEN | Defaecation disorder | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms (SMQ) [broad] | 0 | 0 | 0.152 | 1 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Mitral valve prolapse | 0 | 0 | 0.017 | 1 | 3.414 |  |  |  |  |  | 
COVID19_JANSSEN | Hypochloraemia | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | High risk pregnancy | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Therapy change | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Protein S decreased | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine level increased | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Cystogram | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital tricuspid valve incompetence | 0 | 0 | 0 | 1 | 4.578 |  |  |  |  |  | 
COVID19_JANSSEN | Central auditory processing disorder | 0 | 0 | 0 | 1 | 5.052 |  |  |  |  |  | 
COVID19_JANSSEN | Ovulation disorder | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological infection | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Illiteracy | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Bradycardia foetal | 0 | 0 | 0.072 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion incomplete | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Viral myelitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine operation | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Reduction of increased intracranial pressure | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Preictal state | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal distress during labour | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Laboratory test interference | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin A2 | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid aneurysm rupture | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Acute graft versus host disease in intestine | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin M normal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth fracture | 0 | 0 | 0.253 | 1 | 2.149 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ambulatory normal | 0 | 0 | 0.008 | 1 | 3.645 |  |  |  |  |  | 
COVID19_JANSSEN | General physical condition abnormal | 0 | 0.001 | 0.118 | 1 | 2.6 |  |  |  |  |  | 
COVID19_JANSSEN | Blood smear test abnormal | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Disease recurrence | 0 | 0 | 0.019 | 1 | 3.367 |  |  |  |  |  | 
COVID19_JANSSEN | Application site warmth | 0 | 0 | 0.005 | 1 | 3.775 |  |  |  |  |  | 
COVID19_JANSSEN | Gingivitis | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Drug screen positive | 0 | 0 | 0.01 | 1 | 3.588 |  |  |  |  |  | 
COVID19_JANSSEN | Anal fissure | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine | 0 | 0 | 0.003 | 1 | 3.917 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal laminectomy | 0 | 0 | 0.019 | 1 | 3.37 |  |  |  |  |  | 
COVID19_JANSSEN | Halo vision | 0 | 0 | 0.132 | 1 | 2.541 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac pacemaker evaluation | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Psychomotor disadaptation syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Affect lability | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urine absent | 0 | 0 | 0.291 | 1 | 2.054 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder discomfort | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin CSF normal | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudoparalysis | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder polyp | 0 | 0 | 0.075 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid operation | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_JANSSEN | Neck surgery | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric cancer | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate dehydrogenase normal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Fractured coccyx | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Double hit lymphoma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte percentage increased | 0 | 0 | 0.168 | 1 | 2.406 |  |  |  |  |  | 
COVID19_JANSSEN | Culture | 0 | 0.001 | 0.256 | 1 | 2.14 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus test positive | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic inflammatory demyelinating polyradiculoneuropathy | 0 | 0 | 0.027 | 1 | 3.25 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling drunk | 0 | 0.001 | 0.199 | 1 | 2.301 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus infection | 0 | 0 | 0.023 | 1 | 3.304 |  |  |  |  |  | 
COVID19_JANSSEN | Cytogenetic analysis abnormal | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_JANSSEN | Blood fibrinogen increased | 0 | 0 | 0.006 | 1 | 3.725 |  |  |  |  |  | 
COVID19_JANSSEN | pH body fluid normal | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle oedema | 0 | 0 | 0.013 | 1 | 3.505 |  |  |  |  |  | 
COVID19_JANSSEN | Optic atrophy | 0 | 0 | 0.001 | 1 | 4.149 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth loss | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site urticaria | 0 | 0 | 0.094 | 1 | 2.721 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomonas test positive | 0 | 0 | 0.001 | 1 | 4.26 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal pigment epitheliopathy | 0 | 0 | 0 | 1 | 4.651 |  |  |  |  |  | 
COVID19_JANSSEN | Barium swallow | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Drain placement | 0 | 0 | 0.156 | 1 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopaedic examination | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Marrow hyperplasia | 0 | 0 | 0.002 | 1 | 3.964 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte percentage normal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin C-peptide | 0 | 0 | 0.031 | 1 | 3.201 |  |  |  |  |  | 
COVID19_JANSSEN | Protein S | 0 | 0 | 0.01 | 1 | 3.584 |  |  |  |  |  | 
COVID19_JANSSEN | Product deposit | 0 | 0 | 0.002 | 1 | 4.018 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging renal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | N-terminal prohormone brain natriuretic peptide normal | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Blood follicle stimulating hormone | 0 | 0 | 0 | 1 | 4.593 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation time | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valve calcification | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion early | 0 | 0 | 0.002 | 1 | 3.996 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreoretinal traction syndrome | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular operation | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Shigella test positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Schizoid personality disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Rinne tuning fork test | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Radiation pneumonitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate examination normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Neovascularisation | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Myocarditis infectious | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Meibomian gland dysfunction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Kounis syndrome | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of injection site rotation | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster meningomyelitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Cystitis escherichia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial vulvovaginitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | American trypanosomiasis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Limb mass | 0 | 0.001 | 0.361 | 1 | 1.896 |  |  |  |  |  | 
COVID19_JANSSEN | Plateletcrit increased | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antigen | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood selenium normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Aeromonas test positive | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Victim of child abuse | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Tick-borne fever | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombin-antithrombin III complex increased | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Sulphur dioxide test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural nausea | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Pearly penile papules | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal anastomosis | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Mastoid effusion | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Incarcerated hernia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoosmolar state | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hooded prepuce | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer metastatic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Anal ulcer | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MB increased | 0 | 0 | 0.004 | 1 | 3.85 |  |  |  |  |  | 
COVID19_JANSSEN | Cytogenetic analysis normal | 0 | 0 | 0.276 | 1 | 2.09 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal X-ray | 0 | 0 | 0.404 | 1 | 1.812 |  |  |  |  |  | 
COVID19_JANSSEN | Viral titre decreased | 0 | 0 | 0 | 1 | 5.145 |  |  |  |  |  | 
COVID19_JANSSEN | Antineutrophil cytoplasmic antibody | 0 | 0 | 0.209 | 1 | 2.271 |  |  |  |  |  | 
COVID19_JANSSEN | Meniere's disease | 0 | 0 | 0.216 | 1 | 2.252 |  |  |  |  |  | 
COVID19_JANSSEN | Aplastic anaemia | 0 | 0 | 0.201 | 1 | 2.298 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal dryness | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Complication associated with device | 0 | 0 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Sexual dysfunction | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_JANSSEN | Kernig's sign | 0 | 0 | 0 | 1 | 4.666 |  |  |  |  |  | 
COVID19_JANSSEN | Physical deconditioning | 0 | 0 | 0.117 | 1 | 2.605 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac assistance device user | 0 | 0 | 0.012 | 1 | 3.534 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival discomfort | 0 | 0 | 0.015 | 1 | 3.454 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose tolerance test abnormal | 0 | 0 | 0.01 | 1 | 3.583 |  |  |  |  |  | 
COVID19_JANSSEN | Gynaecomastia | 0 | 0 | 0.006 | 1 | 3.735 |  |  |  |  |  | 
COVID19_JANSSEN | Disease progression | 0 | 0 | 0.011 | 1 | 3.554 |  |  |  |  |  | 
COVID19_JANSSEN | Anogenital dysplasia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Tobacco abuse | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_JANSSEN | Blood homocysteine increased | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorder of childhood | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvi-ureteric obstruction | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperparathyroidism primary | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiospasm | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Argininosuccinate lyase deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Accessory muscle | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Antibody test negative | 0 | 0 | 0.01 | 1 | 3.593 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal infection | 0 | 0 | 0.437 | 1 | 1.75 |  |  |  |  |  | 
COVID19_JANSSEN | Renal impairment | 0 | 0 | 0.205 | 1 | 2.285 |  |  |  |  |  | 
COVID19_JANSSEN | Tilt table test normal | 0 | 0 | 0 | 1 | 5.811 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary pain | 0 | 0.001 | 0.409 | 1 | 1.801 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema nodosum | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocyte percentage | 0 | 0 | 0.264 | 1 | 2.121 |  |  |  |  |  | 
COVID19_JANSSEN | Acoustic stimulation tests normal | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Urobilinogen urine decreased | 0 | 0 | 0.171 | 1 | 2.396 |  |  |  |  |  | 
COVID19_JANSSEN | Red cell distribution width | 0 | 0 | 0.147 | 1 | 2.483 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic aneurysm | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site eschar | 0 | 0 | 0.004 | 1 | 3.861 |  |  |  |  |  | 
COVID19_JANSSEN | Neisseria test | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_JANSSEN | Superinfection bacterial | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Colitis ischaemic | 0 | 0 | 0.112 | 1 | 2.631 |  |  |  |  |  | 
COVID19_JANSSEN | Phrenic nerve paralysis | 0 | 0 | 0 | 1 | 5.314 |  |  |  |  |  | 
COVID19_JANSSEN | Inner ear inflammation | 0 | 0 | 0.023 | 1 | 3.304 |  |  |  |  |  | 
COVID19_JANSSEN | Male reproductive tract disorder | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint effusion | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Schistosoma test negative | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic cyst | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Labelled drug-disease interaction medication error | 0 | 0 | 0.001 | 1 | 4.233 |  |  |  |  |  | 
COVID19_JANSSEN | Blood oestrogen increased | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Emergency care | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound testes normal | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic infection | 0 | 0 | 0.053 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopaedic examination normal | 0 | 0 | 0.016 | 1 | 3.433 |  |  |  |  |  | 
COVID19_JANSSEN | Primitive reflex test | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Polychromasia | 0 | 0 | 0.126 | 1 | 2.567 |  |  |  |  |  | 
COVID19_JANSSEN | CSF mononuclear cell count increased | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site macule | 0 | 0 | 0.285 | 1 | 2.068 |  |  |  |  |  | 
COVID19_JANSSEN | Aversion | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Skin induration | 0 | 0.001 | 0.371 | 1 | 1.876 |  |  |  |  |  | 
COVID19_JANSSEN | Hypovolaemic shock | 0 | 0 | 0 | 1 | 4.433 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus infection reactivation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose decreased | 0 | 0.001 | 0.262 | 1 | 2.125 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic abscess | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising fasciitis | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic disorder | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alcohol | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Tension | 0 | 0 | 0.224 | 1 | 2.228 |  |  |  |  |  | 
COVID19_JANSSEN | Nodular rash | 0 | 0 | 0.101 | 1 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess soft tissue | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pyruvic acid | 0 | 0 | 0.037 | 1 | 3.134 |  |  |  |  |  | 
COVID19_JANSSEN | Electromyogram | 0 | 0.001 | 0.286 | 1 | 2.065 |  |  |  |  |  | 
COVID19_JANSSEN | Antiphospholipid antibodies | 0 | 0 | 0.127 | 1 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Otoplasty | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis influenzal | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic pigmented purpura | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated myositis | 0 | 0 | 0.026 | 1 | 3.269 |  |  |  |  |  | 
COVID19_JANSSEN | Angiosarcoma | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cafe au lait spots | 0 | 0 | 0.001 | 1 | 4.147 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antigen positive | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder cancer stage IV | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Childhood asthma | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune arthritis | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Macular pseudohole | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus pain | 0 | 0.001 | 0.099 | 1 | 2.691 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid margin crusting | 0 | 0.001 | 0.293 | 1 | 2.049 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid pain | 0 | 0 | 0.241 | 1 | 2.18 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelids pruritus | 0 | 0.001 | 0.244 | 1 | 2.172 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocytes | 0 | 0 | 0 | 1 | 4.621 |  |  |  |  |  | 
COVID19_JANSSEN | Multi-organ disorder | 0 | 0 | 0.1 | 1 | 2.689 |  |  |  |  |  | 
COVID19_JANSSEN | Thermometry abnormal | 0 | 0 | 0 | 1 | 5.751 |  |  |  |  |  | 
COVID19_JANSSEN | Nephropathy | 0 | 0 | 0.136 | 1 | 2.524 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulum | 0 | 0 | 0.012 | 1 | 3.531 |  |  |  |  |  | 
COVID19_JANSSEN | Acute motor axonal neuropathy | 0 | 0 | 0 | 1 | 5.383 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema herpeticum | 0 | 0 | 0.038 | 1 | 3.118 |  |  |  |  |  | 
COVID19_JANSSEN | Weaning failure | 0 | 0 | 0 | 1 | 4.598 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte count decreased | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Fear of falling | 0 | 0 | 0 | 1 | 4.498 |  |  |  |  |  | 
COVID19_JANSSEN | Cryoglobulins | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | Onychomycosis | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_JANSSEN | Chest crushing | 0 | 0 | 0.008 | 1 | 3.635 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestine infection | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Logorrhoea | 0 | 0 | 0.031 | 1 | 3.196 |  |  |  |  |  | 
COVID19_JANSSEN | Large granular lymphocytosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Electric shock | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothermia | 0 | 0 | 0.036 | 1 | 3.144 |  |  |  |  |  | 
COVID19_JANSSEN | Fluorescent in situ hybridisation negative | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | pH body fluid decreased | 0 | 0 | 0 | 1 | 4.743 |  |  |  |  |  | 
COVID19_JANSSEN | Stress echocardiogram abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Tensilon test abnormal | 0 | 0 | 0.007 | 1 | 3.688 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 globulin | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatic fever | 0 | 0 | 0.027 | 1 | 3.252 |  |  |  |  |  | 
COVID19_JANSSEN | Genital pain | 0 | 0 | 0 | 1 | 4.687 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic abscess | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Microcytic anaemia | 0 | 0 | 0.214 | 1 | 2.258 |  |  |  |  |  | 
COVID19_JANSSEN | Anaesthesia oral | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphatic disorder | 0 | 0 | 0.184 | 1 | 2.349 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal muscular atrophy | 0 | 0 | 0.016 | 1 | 3.44 |  |  |  |  |  | 
COVID19_JANSSEN | Paroxysmal nocturnal haemoglobinuria | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve conduction studies normal | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Respirovirus test | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular insufficiency | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_JANSSEN | Procalcitonin abnormal | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatitis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory gas exchange disorder | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging breast abnormal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiopulmonary failure | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium test negative | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Lung squamous cell carcinoma stage IV | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoma | 0 | 0 | 0.142 | 1 | 2.502 |  |  |  |  |  | 
COVID19_JANSSEN | Fracture treatment | 0 | 0 | 0.006 | 1 | 3.734 |  |  |  |  |  | 
COVID19_JANSSEN | Metamyelocyte percentage increased | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep terror | 0 | 0 | 0.249 | 1 | 2.158 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic cellulitis | 0 | 0 | 0.001 | 1 | 4.299 |  |  |  |  |  | 
COVID19_JANSSEN | Transillumination | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin distribution width increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Aortitis | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric hypomotility | 0 | 0 | 0 | 1 | 5.472 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial infection | 0 | 0 | 0.195 | 1 | 2.317 |  |  |  |  |  | 
COVID19_JANSSEN | Oedematous kidney | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 absorption test | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin A decreased | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Executive dysfunction | 0 | 0 | 0.001 | 1 | 4.085 |  |  |  |  |  | 
COVID19_JANSSEN | Vital functions abnormal | 0 | 0 | 0.151 | 1 | 2.467 |  |  |  |  |  | 
COVID19_JANSSEN | NIH stroke scale abnormal | 0 | 0 | 0.002 | 1 | 3.975 |  |  |  |  |  | 
COVID19_JANSSEN | Cephalhaematoma | 0 | 0 | 0.012 | 1 | 3.515 |  |  |  |  |  | 
COVID19_JANSSEN | Septic screen | 0 | 0 | 0 | 1 | 4.49 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal disorder | 0 | 0 | 0.312 | 1 | 2.004 |  |  |  |  |  | 
COVID19_JANSSEN | Somatosensory evoked potentials | 0 | 0 | 0 | 1 | 4.54 |  |  |  |  |  | 
COVID19_JANSSEN | Sinobronchitis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Application site mass | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella test negative | 0 | 0 | 0.007 | 1 | 3.684 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body in ear | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Urine potassium | 0 | 0 | 0 | 1 | 5.717 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary calcification | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Viraemia | 0 | 0 | 0 | 1 | 5.819 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised anxiety disorder | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram aorta | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Back injury | 0 | 0 | 0.297 | 1 | 2.039 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex meningitis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal polyps | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Norepinephrine increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure inadequately controlled | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Swollen tear duct | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint movement impairment | 0 | 0 | 0.169 | 1 | 2.401 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pH normal | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus headache | 0 | 0 | 0.136 | 1 | 2.524 |  |  |  |  |  | 
COVID19_JANSSEN | Labia enlarged | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary incontinence | 0 | 0.001 | 0.41 | 1 | 1.799 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiopulmonary exercise test normal | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Blood copper decreased | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_JANSSEN | Mononeuritis | 0 | 0 | 0.015 | 1 | 3.462 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammatory marker test | 0 | 0 | 0.222 | 1 | 2.235 |  |  |  |  |  | 
COVID19_JANSSEN | Trisomy 21 | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular dysfunction | 0 | 0 | 0.015 | 1 | 3.452 |  |  |  |  |  | 
COVID19_JANSSEN | Cardio-respiratory distress | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal hypertrophy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Psychogenic visual disorder | 0 | 0 | 0.001 | 1 | 4.081 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal exploration | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia moraxella | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral venous disease | 0 | 0 | 0.121 | 1 | 2.589 |  |  |  |  |  | 
COVID19_JANSSEN | Resting tremor | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Fistulogram | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Primary hyperthyroidism | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Anal abscess | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_JANSSEN | Metastatic neoplasm | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site phlebitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary obstruction | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Mitral valve incompetence | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Urine lactic acid increased | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell nucleated morphology | 0 | 0.001 | 0.308 | 1 | 2.014 |  |  |  |  |  | 
COVID19_JANSSEN | Conversion disorder | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Disorganised speech | 0 | 0 | 0.315 | 1 | 1.998 |  |  |  |  |  | 
COVID19_JANSSEN | Antipsychotic drug level decreased | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Deficiency anaemia | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Poliovirus test | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Coronavirus test positive | 0 | 0 | 0.246 | 1 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Urethritis | 0 | 0 | 0.043 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Viral sepsis | 0 | 0 | 0 | 1 | 5.608 |  |  |  |  |  | 
COVID19_JANSSEN | Early satiety | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Vena cava thrombosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-transglutaminase antibody increased | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Neurofibroma | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site extravasation | 0 | 0 | 0.014 | 1 | 3.478 |  |  |  |  |  | 
COVID19_JANSSEN | Palatal ulcer | 0 | 0 | 0.036 | 1 | 3.138 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal deposits | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Single functional kidney | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Acute left ventricular failure | 0 | 0 | 0 | 1 | 4.308 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal condition affecting foetus | 0 | 0 | 0.002 | 1 | 4.028 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac massage | 0 | 0 | 0 | 1 | 4.974 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuse and dependence (SMQ) [narrow] | 0 | 0 | 0 | 1 | 4.732 |  |  |  |  |  | 
COVID19_JANSSEN | Boredom | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site ulcer | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Mononuclear cell percentage | 0 | 0 | 0.006 | 1 | 3.732 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocytes abnormal | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal disorder | 0 | 0 | 0 | 1 | 4.758 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular imaging | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | HLA-B*27 positive | 0 | 0 | 0.025 | 1 | 3.274 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-insulin antibody | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Device difficult to use | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular autonomic function test normal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Nitrite urine present | 0 | 0 | 0.128 | 1 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Skin depigmentation | 0 | 0 | 0.004 | 1 | 3.862 |  |  |  |  |  | 
COVID19_JANSSEN | Acinetobacter test positive | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Haematoma | 0 | 0 | 0.225 | 1 | 2.225 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin CSF abnormal | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Placental calcification | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pyruvate kinase | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Treponema test positive | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Reactive attachment disorder of infancy or early childhood | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Fibronectin normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Renal necrosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatillomania | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Gaze palsy | 0 | 0.001 | 0.174 | 1 | 2.385 |  |  |  |  |  | 
COVID19_JANSSEN | Radioisotope scan | 0 | 0 | 0.014 | 1 | 3.477 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema induratum | 0 | 0 | 0.021 | 1 | 3.339 |  |  |  |  |  | 
COVID19_JANSSEN | Eye infection viral | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal mucosal atrophy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral arteriosclerosis | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobinuria | 0 | 0 | 0.002 | 1 | 3.981 |  |  |  |  |  | 
COVID19_JANSSEN | Scan abnormal | 0 | 0 | 0.026 | 1 | 3.257 |  |  |  |  |  | 
COVID19_JANSSEN | Aspergillus infection | 0 | 0 | 0 | 1 | 5.559 |  |  |  |  |  | 
COVID19_JANSSEN | CD4/CD8 ratio | 0 | 0 | 0.094 | 1 | 2.715 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccine associated paralytic poliomyelitis | 0 | 0 | 0 | 1 | 5.819 |  |  |  |  |  | 
COVID19_JANSSEN | Faeces hard | 0 | 0 | 0.029 | 1 | 3.217 |  |  |  |  |  | 
COVID19_JANSSEN | Application site oedema | 0 | 0 | 0 | 1 | 4.376 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal osteomyelitis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Full blood count decreased | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperchloraemia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Cogan's syndrome | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_JANSSEN | Omental necrosis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Emotional poverty | 0 | 0 | 0.022 | 1 | 3.315 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-Muellerian hormone level decreased | 0 | 0 | 0.011 | 1 | 3.559 |  |  |  |  |  | 
COVID19_JANSSEN | Factor II mutation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Developmental regression | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary casts absent | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_JANSSEN | Enteral nutrition | 0 | 0 | 0.003 | 1 | 3.931 |  |  |  |  |  | 
COVID19_JANSSEN | Urine albumin/creatinine ratio normal | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Recall phenomenon | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery stenosis | 0 | 0 | 0.004 | 1 | 3.81 |  |  |  |  |  | 
COVID19_JANSSEN | Postmenopausal haemorrhage | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | B precursor type acute leukaemia | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Urine output decreased | 0 | 0 | 0.219 | 1 | 2.243 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid nodule | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bronchus abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic foot | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Blood brain barrier defect | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine abnormal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Gestational diabetes | 0 | 0 | 0 | 1 | 4.76 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional device misuse | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Scoliosis | 0 | 0 | 0.003 | 1 | 3.926 |  |  |  |  |  | 
COVID19_JANSSEN | Renin normal | 0 | 0 | 0 | 1 | 5.539 |  |  |  |  |  | 
COVID19_JANSSEN | Massage | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperbilirubinaemia | 0 | 0 | 0.009 | 1 | 3.621 |  |  |  |  |  | 
COVID19_JANSSEN | Urine retinol binding protein increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin conjugated decreased | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Tender joint count | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Asterixis | 0 | 0 | 0.02 | 1 | 3.359 |  |  |  |  |  | 
COVID19_JANSSEN | Micrognathia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Polychondritis | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_JANSSEN | Portal shunt procedure | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Dandruff | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal dysplasia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular systolic pressure | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia viral | 0 | 0.001 | 0.346 | 1 | 1.928 |  |  |  |  |  | 
COVID19_JANSSEN | Papillitis | 0 | 0 | 0.004 | 1 | 3.829 |  |  |  |  |  | 
COVID19_JANSSEN | Pleurisy viral | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic lesion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood phosphorus decreased | 0 | 0.001 | 0.226 | 1 | 2.222 |  |  |  |  |  | 
COVID19_JANSSEN | Glaucoma drainage device placement | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Seroma | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Transplant failure | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Post-traumatic pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Glioblastoma | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | African trypanosomiasis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Macroglossia | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Fluorescence angiogram abnormal | 0 | 0 | 0.037 | 1 | 3.125 |  |  |  |  |  | 
COVID19_JANSSEN | Total bile acids increased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Elbow operation | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Iris neovascularisation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity urine | 0 | 0 | 0.004 | 1 | 3.833 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculosis | 0 | 0 | 0.022 | 1 | 3.33 |  |  |  |  |  | 
COVID19_JANSSEN | Diet refusal | 0 | 0 | 0.215 | 1 | 2.255 |  |  |  |  |  | 
COVID19_JANSSEN | Ear injury | 0 | 0 | 0.128 | 1 | 2.557 |  |  |  |  |  | 
COVID19_JANSSEN | Galactorrhoea | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_JANSSEN | Mycoplasma test positive | 0 | 0 | 0.005 | 1 | 3.783 |  |  |  |  |  | 
COVID19_JANSSEN | Methaemoglobin urine absent | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal distress syndrome | 0 | 0 | 0 | 1 | 5.786 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QT prolonged | 0 | 0 | 0.169 | 1 | 2.401 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation immeasurable | 0 | 0 | 0.017 | 1 | 3.42 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A antibody | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Anorexia nervosa | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia cryptococcal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal (SMQ) [narrow] | 0 | 0 | 0.043 | 1 | 3.069 |  |  |  |  |  | 
COVID19_JANSSEN | Canalith repositioning procedure | 0 | 0 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_JANSSEN | Actinic keratosis | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_JANSSEN | Serology negative | 0 | 0 | 0.021 | 1 | 3.333 |  |  |  |  |  | 
COVID19_JANSSEN | Histone antibody negative | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Post-traumatic stress disorder | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperferritinaemia | 0 | 0 | 0.011 | 1 | 3.559 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery stent insertion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord compression | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Glycosylated haemoglobin | 0 | 0.001 | 0.414 | 1 | 1.791 |  |  |  |  |  | 
COVID19_JANSSEN | Intercepted product preparation error | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Scleroedema | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral sensorimotor neuropathy | 0 | 0 | 0.166 | 1 | 2.413 |  |  |  |  |  | 
COVID19_JANSSEN | Burnout syndrome | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Nephrectomy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Haptoglobin abnormal | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Completed suicide | 0 | 0 | 0.007 | 1 | 3.679 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 microglobulin increased | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_JANSSEN | Withdrawal syndrome | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular graft | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Renal aplasia | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Hyposplenism | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Heart valve operation | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Femoral neck fracture | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-islet cell antibody | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_JANSSEN | T-lymphocyte count abnormal | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | Selective abortion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional underdose | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Drug resistance | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic tic disorder | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangiogram | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein A-I normal | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis | 0 | 0.001 | 0.307 | 1 | 2.015 |  |  |  |  |  | 
COVID19_JANSSEN | Enterovirus test negative | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Formication | 0 | 0.001 | 0.432 | 1 | 1.757 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal tube insertion | 0 | 0.001 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_JANSSEN | Urine ketone body present | 0 | 0.001 | 0.394 | 1 | 1.83 |  |  |  |  |  | 
COVID19_JANSSEN | Physical examination | 0 | 0.001 | 0.228 | 1 | 2.217 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness transitory | 0 | 0 | 0.107 | 1 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Dissociative disorder | 0 | 0.001 | 0.149 | 1 | 2.475 |  |  |  |  |  | 
COVID19_JANSSEN | Oligomenorrhoea | 0 | 0 | 0.006 | 1 | 3.75 |  |  |  |  |  | 
COVID19_JANSSEN | Total complement activity test | 0 | 0 | 0.014 | 1 | 3.47 |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasm skin | 0 | 0 | 0.122 | 1 | 2.582 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose-6-phosphate dehydrogenase normal | 0 | 0 | 0 | 1 | 5.797 |  |  |  |  |  | 
COVID19_JANSSEN | Ileectomy | 0 | 0 | 0 | 1 | 5.287 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal graft rejection | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_JANSSEN | Transmission of an infectious agent via product | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic lupus erythematosus rash | 0 | 0 | 0.011 | 1 | 3.549 |  |  |  |  |  | 
COVID19_JANSSEN | Cold type haemolytic anaemia | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell scan | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound eye | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Smooth muscle antibody | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Sciatic nerve injury | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Heart alternation | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic artery aneurysm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal surgery | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Nicotinamide | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Modified Rankin score decreased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Medial tibial stress syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Liver scan abnormal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Lice infestation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Denture wearer | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord abscess | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Anal incontinence | 0 | 0.001 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_JANSSEN | Bile culture negative | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Primary biliary cholangitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Chest wall mass | 0 | 0 | 0.163 | 1 | 2.421 |  |  |  |  |  | 
COVID19_JANSSEN | Retention cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lipase normal | 0 | 0.001 | 0.332 | 1 | 1.959 |  |  |  |  |  | 
COVID19_JANSSEN | Dysmorphism | 0 | 0 | 0.03 | 1 | 3.213 |  |  |  |  |  | 
COVID19_JANSSEN | Dyskinesia oesophageal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity urine decreased | 0 | 0 | 0.03 | 1 | 3.206 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian necrosis | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac flutter | 0 | 0.001 | 0.27 | 1 | 2.104 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis viral | 0 | 0 | 0.144 | 1 | 2.491 |  |  |  |  |  | 
COVID19_JANSSEN | Myosclerosis | 0 | 0 | 0.229 | 1 | 2.214 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac function test | 0 | 0 | 0.187 | 1 | 2.341 |  |  |  |  |  | 
COVID19_JANSSEN | Extensor plantar response | 0 | 0 | 0.005 | 1 | 3.766 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngotonsillitis | 0 | 0 | 0 | 1 | 4.582 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenectomy | 0 | 0 | 0.094 | 1 | 2.72 |  |  |  |  |  | 
COVID19_JANSSEN | Urosepsis | 0 | 0 | 0.034 | 1 | 3.168 |  |  |  |  |  | 
COVID19_JANSSEN | Osteitis | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound thyroid | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatologic examination | 0 | 0 | 0.166 | 1 | 2.412 |  |  |  |  |  | 
COVID19_JANSSEN | Lower respiratory tract infection bacterial | 0 | 0 | 0.003 | 1 | 3.883 |  |  |  |  |  | 
COVID19_JANSSEN | Haematology test abnormal | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Joint debridement | 0 | 0 | 0.032 | 1 | 3.185 |  |  |  |  |  | 
COVID19_JANSSEN | Intracardiac thrombus | 0 | 0 | 0.009 | 1 | 3.61 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal monitoring abnormal | 0 | 0 | 0.045 | 1 | 3.051 |  |  |  |  |  | 
COVID19_JANSSEN | Urine osmolarity normal | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral embolism | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal fungal infection | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol test | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia vitamin B12 deficiency | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Acute chest syndrome | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time ratio normal | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | AST/ALT ratio | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Wernicke-Korsakoff syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal ulceration | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin K | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumoperitoneum | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_JANSSEN | Persecutory delusion | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Iodine uptake increased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Hysterosalpingo-oophorectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Endocardial fibrosis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Duodenal ulcer | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Breast reconstruction | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Blindness congenital | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Anterior chamber fibrin | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Anal fistula repair | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema | 0 | 0.002 | 0.356 | 1 | 1.907 |  |  |  |  |  | 
COVID19_JANSSEN | Lower respiratory tract infection | 0 | 0 | 0.003 | 1 | 3.896 |  |  |  |  |  | 
COVID19_JANSSEN | Protein total increased | 0 | 0 | 0.133 | 1 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Toxoplasma serology negative | 0 | 0 | 0.027 | 1 | 3.252 |  |  |  |  |  | 
COVID19_JANSSEN | Cryptococcus test | 0 | 0.001 | 0.332 | 1 | 1.959 |  |  |  |  |  | 
COVID19_JANSSEN | Bartonella test negative | 0 | 0 | 0.214 | 1 | 2.259 |  |  |  |  |  | 
COVID19_JANSSEN | Sarcoidosis | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Poisoning | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_JANSSEN | School refusal | 0 | 0 | 0 | 1 | 5.793 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine urine | 0 | 0 | 0 | 1 | 5.697 |  |  |  |  |  | 
COVID19_JANSSEN | Viral load increased | 0 | 0 | 0 | 1 | 5.292 |  |  |  |  |  | 
COVID19_JANSSEN | Skin culture | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Macular oedema | 0 | 0 | 0.001 | 1 | 4.075 |  |  |  |  |  | 
COVID19_JANSSEN | Nucleic acid test | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Treatment failure | 0 | 0 | 0.001 | 1 | 4.224 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet morphology abnormal | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor V level | 0 | 0 | 0.006 | 1 | 3.738 |  |  |  |  |  | 
COVID19_JANSSEN | Papilloma | 0 | 0 | 0.008 | 1 | 3.643 |  |  |  |  |  | 
COVID19_JANSSEN | Cryptococcus test positive | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia respiratory syncytial viral | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival ulceration | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise test | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Excessive ocular convergence | 0 | 0 | 0 | 1 | 5.824 |  |  |  |  |  | 
COVID19_JANSSEN | Transcranial magnetic stimulation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Rhesus antigen negative | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma viscosity abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis mumps | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Leptospira test | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Eye muscle operation | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Epidural lipomatosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic pustular folliculitis | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Dysplastic naevus | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral ventricle collapse | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Skin infection | 0 | 0 | 0.252 | 1 | 2.152 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Skin erosion | 0 | 0 | 0.228 | 1 | 2.217 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatocellular injury | 0 | 0 | 0 | 1 | 4.808 |  |  |  |  |  | 
COVID19_JANSSEN | Brain death | 0 | 0.001 | 0.092 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray gastrointestinal tract abnormal | 0 | 0 | 0 | 1 | 4.352 |  |  |  |  |  | 
COVID19_JANSSEN | Dermo-hypodermitis | 0 | 0 | 0 | 1 | 4.717 |  |  |  |  |  | 
COVID19_JANSSEN | Skin odour abnormal | 0 | 0 | 0.009 | 1 | 3.625 |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmalgia | 0 | 0 | 0.229 | 1 | 2.214 |  |  |  |  |  | 
COVID19_JANSSEN | Mammogram abnormal | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_JANSSEN | Angiocardiogram | 0 | 0 | 0.032 | 1 | 3.187 |  |  |  |  |  | 
COVID19_JANSSEN | Hallucinations, mixed | 0 | 0 | 0.006 | 1 | 3.714 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal dilatation | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Infection parasitic | 0 | 0 | 0 | 1 | 5.752 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin normal | 0 | 0 | 0.001 | 1 | 4.153 |  |  |  |  |  | 
COVID19_JANSSEN | Humerus fracture | 0 | 0 | 0.128 | 1 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise electrocardiogram normal | 0 | 0 | 0.028 | 1 | 3.241 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural failure | 0 | 0 | 0 | 1 | 5.099 |  |  |  |  |  | 
COVID19_JANSSEN | Trance | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_JANSSEN | Hair follicle tumour benign | 0 | 0 | 0.037 | 1 | 3.127 |  |  |  |  |  | 
COVID19_JANSSEN | Genital burning sensation | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Senile dementia | 0 | 0 | 0.001 | 1 | 4.233 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival injury | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic cerebral infarction | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-islet cell antibody negative | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Stenotrophomonas sepsis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Spasmodic dysphonia | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral artery occlusion | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis viral | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lipectomy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Lichen planopilaris | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Elective surgery | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Bipolar II disorder | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotonic-hyporesponsive episode (SMQ) [narrow] | 0 | 0 | 0.025 | 1 | 3.277 |  |  |  |  |  | 
COVID19_JANSSEN | Caesarean section | 0 | 0 | 0 | 1 | 5.575 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site hypersensitivity | 0 | 0.001 | 0.254 | 1 | 2.146 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden infant death syndrome | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Colonoscopy | 0 | 0.001 | 0.093 | 1 | 2.721 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion induced | 0 | 0 | 0.02 | 1 | 3.358 |  |  |  |  |  | 
COVID19_JANSSEN | Phlebitis | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve disorder | 0 | 0 | 0.181 | 1 | 2.362 |  |  |  |  |  | 
COVID19_JANSSEN | Renal cyst | 0 | 0 | 0.206 | 1 | 2.283 |  |  |  |  |  | 
COVID19_JANSSEN | Radioallergosorbent test negative | 0 | 0 | 0.142 | 1 | 2.501 |  |  |  |  |  | 
COVID19_JANSSEN | IgA nephropathy | 0 | 0 | 0.033 | 1 | 3.168 |  |  |  |  |  | 
COVID19_JANSSEN | Investigation normal | 0 | 0 | 0.008 | 1 | 3.638 |  |  |  |  |  | 
COVID19_JANSSEN | Penis disorder | 0 | 0 | 0.039 | 1 | 3.103 |  |  |  |  |  | 
COVID19_JANSSEN | Blood HIV RNA below assay limit | 0 | 0 | 0.126 | 1 | 2.569 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar ulcer | 0 | 0 | 0.139 | 1 | 2.514 |  |  |  |  |  | 
COVID19_JANSSEN | Pressure of speech | 0 | 0 | 0.03 | 1 | 3.208 |  |  |  |  |  | 
COVID19_JANSSEN | Methylmalonic aciduria | 0 | 0 | 0.024 | 1 | 3.289 |  |  |  |  |  | 
COVID19_JANSSEN | Cyst aspiration | 0 | 0 | 0.01 | 1 | 3.568 |  |  |  |  |  | 
COVID19_JANSSEN | Neuromuscular pain | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Ex-tobacco user | 0 | 0 | 0 | 1 | 4.911 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical dilatation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | CNS ventriculitis | 0 | 0 | 0.017 | 1 | 3.42 |  |  |  |  |  | 
COVID19_JANSSEN | Bone graft | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Tenosynovitis stenosans | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella sepsis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy-related hepatic disorders (SMQ) [broad] | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney malrotation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumothorax spontaneous | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Post concussion syndrome | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Pericarditis meningococcal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Leiomyosarcoma | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | LDL/HDL ratio decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hypnopompic hallucination | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hypocapnia | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic haematoma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Exploding head syndrome | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Crystal urine | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital genital malformation | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | CSF granulocyte count normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Auditory neuropathy spectrum disorder | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Product label confusion | 0 | 0 | 0.013 | 1 | 3.508 |  |  |  |  |  | 
COVID19_JANSSEN | Attention deficit hyperactivity disorder | 0 | 0 | 0.028 | 1 | 3.238 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella zoster virus infection | 0 | 0 | 0.001 | 1 | 4.297 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue infection | 0 | 0 | 0 | 1 | 4.418 |  |  |  |  |  | 
COVID19_JANSSEN | Poor sucking reflex | 0 | 0 | 0.002 | 1 | 4.014 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal injury | 0 | 0 | 0.01 | 1 | 3.572 |  |  |  |  |  | 
COVID19_JANSSEN | Toxicity to various agents | 0 | 0 | 0.169 | 1 | 2.401 |  |  |  |  |  | 
COVID19_JANSSEN | Clostridium difficile infection | 0 | 0 | 0.219 | 1 | 2.242 |  |  |  |  |  | 
COVID19_JANSSEN | Cast application | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_JANSSEN | Cystoscopy | 0 | 0 | 0.003 | 1 | 3.872 |  |  |  |  |  | 
COVID19_JANSSEN | Overweight | 0 | 0 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_JANSSEN | Blood homocysteine | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Ventilation/perfusion scan | 0 | 0 | 0.009 | 1 | 3.602 |  |  |  |  |  | 
COVID19_JANSSEN | Q fever | 0 | 0 | 0 | 1 | 4.695 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrophic cardiomyopathy | 0 | 0 | 0.001 | 1 | 4.081 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST-T change | 0 | 0 | 0.036 | 1 | 3.139 |  |  |  |  |  | 
COVID19_JANSSEN | Aspartate aminotransferase decreased | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound spleen | 0 | 0 | 0.132 | 1 | 2.543 |  |  |  |  |  | 
COVID19_JANSSEN | Growth disorder | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Intertrigo | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder oedema | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte percentage | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin globulin ratio increased | 0 | 0 | 0.007 | 1 | 3.701 |  |  |  |  |  | 
COVID19_JANSSEN | Viral parotitis | 0 | 0 | 0.002 | 1 | 3.986 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis sapovirus | 0 | 0 | 0.001 | 1 | 4.27 |  |  |  |  |  | 
COVID19_JANSSEN | Adhesiolysis | 0 | 0 | 0.004 | 1 | 3.832 |  |  |  |  |  | 
COVID19_JANSSEN | Wrist deformity | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Tendinous contracture | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary hypogonadism | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary contusion | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Hyphaema | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram Q wave abnormal | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic complication | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess abnormal | 0 | 0 | 0.042 | 1 | 3.076 |  |  |  |  |  | 
COVID19_JANSSEN | Transcutaneous pacing | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Thermogram abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Syndactyly | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Pre-existing disease | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Perineal ulceration | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroprosthesis implantation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroborreliosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lithotripsy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Hypopyon | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination failure | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Eructation | 0 | 0 | 0.318 | 1 | 1.99 |  |  |  |  |  | 
COVID19_JANSSEN | Sjogren's syndrome | 0 | 0 | 0.008 | 1 | 3.651 |  |  |  |  |  | 
COVID19_JANSSEN | Polycystic ovaries | 0 | 0 | 0 | 1 | 5.454 |  |  |  |  |  | 
COVID19_JANSSEN | Shift to the left | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_JANSSEN | Liver injury | 0 | 0.001 | 0.225 | 1 | 2.226 |  |  |  |  |  | 
COVID19_JANSSEN | Electroneurography | 0 | 0 | 0 | 1 | 4.865 |  |  |  |  |  | 
COVID19_JANSSEN | Rubulavirus test positive | 0 | 0 | 0 | 1 | 5.293 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lymphocyte count normal | 0 | 0 | 0.349 | 1 | 1.922 |  |  |  |  |  | 
COVID19_JANSSEN | Bordetella test negative | 0 | 0 | 0.178 | 1 | 2.369 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord oedema | 0 | 0 | 0.005 | 1 | 3.753 |  |  |  |  |  | 
COVID19_JANSSEN | Circadian rhythm sleep disorder | 0 | 0 | 0 | 1 | 4.309 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint effusion | 0 | 0 | 0.236 | 1 | 2.195 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil count | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid hormones increased | 0 | 0 | 0.101 | 1 | 2.681 |  |  |  |  |  | 
COVID19_JANSSEN | Interferon gamma release assay | 0 | 0 | 0 | 1 | 4.532 |  |  |  |  |  | 
COVID19_JANSSEN | Valsalva maneuver | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound eye normal | 0 | 0 | 0.077 | 1 | 2.812 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine free abnormal | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Ephelides | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_JANSSEN | Birth mark | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Vesicoureteral reflux surgery | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Colon operation | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Septum pellucidum agenesis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Retrograde ejaculation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Liver scan | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Keratitis interstitial | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic skin ulcer | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E antibody positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Genital neoplasm malignant female | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cavernous sinus thrombosis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Bacillus infection | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic band syndrome | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Alice in wonderland syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Pulse pressure increased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Psychotic symptom | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Norepinephrine | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Leukostasis syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Inspiratory capacity | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Functional endoscopic sinus surgery | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Cortisol abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Breast injury | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration bursa abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-neuronal antibody positive | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Skin plaque | 0 | 0 | 0.236 | 1 | 2.194 |  |  |  |  |  | 
COVID19_JANSSEN | Bruxism | 0 | 0 | 0.267 | 1 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Psychogenic seizure | 0 | 0 | 0 | 1 | 5.223 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram T wave inversion | 0 | 0 | 0.21 | 1 | 2.269 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing aid user | 0 | 0 | 0.01 | 1 | 3.595 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle rupture | 0 | 0 | 0.137 | 1 | 2.522 |  |  |  |  |  | 
COVID19_JANSSEN | Guttate psoriasis | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Venous thrombosis | 0 | 0 | 0.018 | 1 | 3.387 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells stool negative | 0 | 0 | 0.084 | 1 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Intermittent claudication | 0 | 0 | 0.002 | 1 | 4.016 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle electrostimulation therapy | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary system x-ray abnormal | 0 | 0 | 0.011 | 1 | 3.553 |  |  |  |  |  | 
COVID19_JANSSEN | Renal replacement therapy | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time ratio increased | 0 | 0 | 0.001 | 1 | 4.089 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal respiratory distress syndrome | 0 | 0 | 0.012 | 1 | 3.533 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin M abnormal | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Renal vein compression | 0 | 0 | 0 | 1 | 4.495 |  |  |  |  |  | 
COVID19_JANSSEN | Endometrial thickening | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria contact | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic response shortened | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Sinoscopy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Severe acute respiratory syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Murphy's sign positive | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Metaphyseal dysplasia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperamylasaemia | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Bone density abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Barrel chest | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-zinc transporter 8 antibody positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Mass | 0 | 0.002 | 0.48 | 1 | 1.672 |  |  |  |  |  | 
COVID19_JANSSEN | Mental status changes | 0 | 0.004 | 0.505 | 1 | 1.63 |  |  |  |  |  | 
COVID19_JANSSEN | Viral upper respiratory tract infection | 0 | 0 | 0.077 | 1 | 2.812 |  |  |  |  |  | 
COVID19_JANSSEN | Amenorrhoea | 0 | 0 | 0 | 1 | 4.904 |  |  |  |  |  | 
COVID19_JANSSEN | Yellow skin | 0 | 0 | 0.263 | 1 | 2.122 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising colitis | 0 | 0 | 0.001 | 1 | 4.158 |  |  |  |  |  | 
COVID19_JANSSEN | CSF immunoglobulin | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Palatal disorder | 0 | 0 | 0.145 | 1 | 2.489 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural hygroma | 0 | 0 | 0 | 1 | 4.422 |  |  |  |  |  | 
COVID19_JANSSEN | Lichen sclerosus | 0 | 0 | 0.005 | 1 | 3.789 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic cerebral infarction | 0 | 0 | 0.157 | 1 | 2.446 |  |  |  |  |  | 
COVID19_JANSSEN | Total bile acids | 0 | 0 | 0.012 | 1 | 3.513 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal tenesmus | 0 | 0 | 0.003 | 1 | 3.909 |  |  |  |  |  | 
COVID19_JANSSEN | Bell's palsy | 0 | 0 | 0 | 1 | 4.304 |  |  |  |  |  | 
COVID19_JANSSEN | Urogram normal | 0 | 0 | 0 | 1 | 4.317 |  |  |  |  |  | 
COVID19_JANSSEN | Prurigo | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoalveolar lavage normal | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal infection | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Choluria | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial irritation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Brain natriuretic peptide decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis viral | 0 | 0 | 0.387 | 1 | 1.844 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiomegaly | 0 | 0.001 | 0.095 | 1 | 2.711 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test | 0 | 0 | 0.11 | 1 | 2.639 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal neoplasms (SMQ) [narrow] | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Arachnoid cyst | 0 | 0 | 0.003 | 1 | 3.931 |  |  |  |  |  | 
COVID19_JANSSEN | Venous oxygen saturation decreased | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Sitting disability | 0 | 0 | 0.112 | 1 | 2.63 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchopulmonary dysplasia | 0 | 0 | 0.007 | 1 | 3.678 |  |  |  |  |  | 
COVID19_JANSSEN | Zinc deficiency | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_JANSSEN | VIIIth nerve injury | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Oestrogen deficiency | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular vascular disorder | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Lennox-Gastaut syndrome | 0 | 0 | 0.055 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Genital hypoaesthesia | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchopulmonary aspergillosis allergic | 0 | 0 | 0 | 1 | 5.61 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural constipation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to the mediastinum | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site erythema | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Hostility | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Hashimoto's encephalopathy | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Candida pneumonia | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Benign neoplasm | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha-2 macroglobulin increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Alagille syndrome | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Areflexia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Road traffic accident | 0 | 0 | 0.366 | 1 | 1.887 |  |  |  |  |  | 
COVID19_JANSSEN | Exfoliative rash | 0 | 0 | 0.311 | 1 | 2.007 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis reactive | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_JANSSEN | Food aversion | 0 | 0 | 0.031 | 1 | 3.199 |  |  |  |  |  | 
COVID19_JANSSEN | Chromosome analysis normal | 0 | 0 | 0.008 | 1 | 3.638 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-cyclic citrullinated peptide antibody positive | 0 | 0 | 0.02 | 1 | 3.354 |  |  |  |  |  | 
COVID19_JANSSEN | Skin texture abnormal | 0 | 0 | 0.14 | 1 | 2.509 |  |  |  |  |  | 
COVID19_JANSSEN | Tinea infection | 0 | 0 | 0.137 | 1 | 2.52 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic reaction to excipient | 0 | 0 | 0.097 | 1 | 2.7 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery stenosis | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-aquaporin-4 antibody | 0 | 0 | 0.232 | 1 | 2.205 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy artery abnormal | 0 | 0 | 0.028 | 1 | 3.24 |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine disorder | 0 | 0 | 0.004 | 1 | 3.818 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ethanol | 0 | 0 | 0.197 | 1 | 2.308 |  |  |  |  |  | 
COVID19_JANSSEN | Pain assessment | 0 | 0 | 0.002 | 1 | 4.055 |  |  |  |  |  | 
COVID19_JANSSEN | Volume blood decreased | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Squamous cell carcinoma of skin | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Subcutaneous emphysema | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_JANSSEN | Promyelocyte count | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Confabulation | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoma benign | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumocystis test negative | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram pulmonary | 0 | 0 | 0.072 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal symptom | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Xanthoma | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product effect increased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet aggregation test | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Mastectomy | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Legionella infection | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrinolysis | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Blood 25-hydroxycholecalciferol decreased | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy abdominal wall abnormal | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Avian influenza | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Antigliadin antibody positive | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Acute graft versus host disease | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time abnormal | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreal cells | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal meningeal cyst | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus haemorrhage | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin C-peptide increased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site telangiectasia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated lung disease | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes oesophagitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Chordee | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Brachioradial pruritus | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Barbiturates positive | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 microglobulin | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenoleukodystrophy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site vesicles | 0 | 0.001 | 0.221 | 1 | 2.235 |  |  |  |  |  | 
COVID19_JANSSEN | Needle issue | 0 | 0.001 | 0.113 | 1 | 2.625 |  |  |  |  |  | 
COVID19_JANSSEN | Incoherent | 0 | 0.001 | 0.506 | 1 | 1.628 |  |  |  |  |  | 
COVID19_JANSSEN | Hordeolum | 0 | 0.001 | 0.228 | 1 | 2.218 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal reflex decreased | 0 | 0.001 | 0.258 | 1 | 2.136 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis minimal lesion | 0 | 0 | 0.024 | 1 | 3.29 |  |  |  |  |  | 
COVID19_JANSSEN | Candida test positive | 0 | 0 | 0.034 | 1 | 3.161 |  |  |  |  |  | 
COVID19_JANSSEN | Withdrawal of life support | 0 | 0 | 0.011 | 1 | 3.558 |  |  |  |  |  | 
COVID19_JANSSEN | Spleen disorder | 0 | 0 | 0.181 | 1 | 2.36 |  |  |  |  |  | 
COVID19_JANSSEN | Cytokine storm | 0 | 0 | 0.123 | 1 | 2.58 |  |  |  |  |  | 
COVID19_JANSSEN | Brain hypoxia | 0 | 0 | 0.075 | 1 | 2.829 |  |  |  |  |  | 
COVID19_JANSSEN | Selective IgA immunodeficiency | 0 | 0 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune hypothyroidism | 0 | 0 | 0 | 1 | 4.898 |  |  |  |  |  | 
COVID19_JANSSEN | Acne cystic | 0 | 0 | 0.018 | 1 | 3.398 |  |  |  |  |  | 
COVID19_JANSSEN | Child abuse | 0 | 0 | 0 | 1 | 4.758 |  |  |  |  |  | 
COVID19_JANSSEN | Iodine allergy | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmatic spasm | 0 | 0 | 0 | 1 | 4.649 |  |  |  |  |  | 
COVID19_JANSSEN | Arm amputation | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolitis | 0 | 0 | 0.006 | 1 | 3.728 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum retention | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Retained placenta or membranes | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Psychotic behaviour | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia legionella | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphangiopathy | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Hand amputation | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_JANSSEN | Balance test | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site anaesthesia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral injury | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Thermohypoaesthesia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Telangiectasia congenital | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal pigmentation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Glycocholic acid increased | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Dennie-Morgan fold | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Anisochromia | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Scar | 0 | 0 | 0.18 | 1 | 2.365 |  |  |  |  |  | 
COVID19_JANSSEN | Joint injury | 0 | 0 | 0.391 | 1 | 1.836 |  |  |  |  |  | 
COVID19_JANSSEN | Coma scale normal | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_JANSSEN | Tardive dyskinesia | 0 | 0 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal blistering | 0 | 0 | 0.195 | 1 | 2.315 |  |  |  |  |  | 
COVID19_JANSSEN | Blood sodium | 0 | 0 | 0.28 | 1 | 2.079 |  |  |  |  |  | 
COVID19_JANSSEN | Product physical issue | 0 | 0 | 0 | 1 | 5.598 |  |  |  |  |  | 
COVID19_JANSSEN | Hip arthroplasty | 0 | 0 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep study normal | 0 | 0 | 0.216 | 1 | 2.252 |  |  |  |  |  | 
COVID19_JANSSEN | Total complement activity decreased | 0 | 0 | 0 | 1 | 5.561 |  |  |  |  |  | 
COVID19_JANSSEN | Cortisol increased | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_JANSSEN | Aneurysm | 0 | 0 | 0.017 | 1 | 3.408 |  |  |  |  |  | 
COVID19_JANSSEN | Throat lesion | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal disorder | 0 | 0 | 0.001 | 1 | 4.146 |  |  |  |  |  | 
COVID19_JANSSEN | Exploratory operation | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac electrophysiologic study | 0 | 0 | 0.031 | 1 | 3.197 |  |  |  |  |  | 
COVID19_JANSSEN | Blindness cortical | 0 | 0 | 0.023 | 1 | 3.313 |  |  |  |  |  | 
COVID19_JANSSEN | Soliloquy | 0 | 0 | 0.009 | 1 | 3.606 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic fracture | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis Escherichia coli | 0 | 0 | 0.005 | 1 | 3.797 |  |  |  |  |  | 
COVID19_JANSSEN | Pyomyositis | 0 | 0 | 0.006 | 1 | 3.728 |  |  |  |  |  | 
COVID19_JANSSEN | Myokymia | 0 | 0 | 0.027 | 1 | 3.246 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis viral test positive | 0 | 0 | 0.001 | 1 | 4.094 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram PR shortened | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to synthetic fabric | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong schedule | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin receptor assay | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian germ cell tumour | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Needle biopsy site unspecified normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric arterial occlusion | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site thrombosis | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site cellulitis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Histoplasmosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Genitourinary tract infection | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulectomy | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Cooling therapy | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral haemorrhage foetal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tract infection fungal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level above therapeutic | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha-1 anti-trypsin increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Acalculia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Skin exfoliation | 0 | 0.001 | 0.412 | 1 | 1.795 |  |  |  |  |  | 
COVID19_JANSSEN | Infectious mononucleosis | 0 | 0 | 0.023 | 1 | 3.306 |  |  |  |  |  | 
COVID19_JANSSEN | Blood electrolytes | 0 | 0 | 0.254 | 1 | 2.145 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site ulcer | 0 | 0 | 0.361 | 1 | 1.897 |  |  |  |  |  | 
COVID19_JANSSEN | Neck mass | 0 | 0 | 0.408 | 1 | 1.803 |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemia | 0 | 0 | 0.156 | 1 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocyte count | 0 | 0 | 0.254 | 1 | 2.147 |  |  |  |  |  | 
COVID19_JANSSEN | Mononeuropathy | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | Epinephrine | 0 | 0.001 | 0.278 | 1 | 2.084 |  |  |  |  |  | 
COVID19_JANSSEN | Skin bacterial infection | 0 | 0 | 0.047 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoidal hypertrophy | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic gastritis | 0 | 0 | 0 | 1 | 4.694 |  |  |  |  |  | 
COVID19_JANSSEN | Akinesia | 0 | 0 | 0.016 | 1 | 3.425 |  |  |  |  |  | 
COVID19_JANSSEN | Leg amputation | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Saliva discolouration | 0 | 0 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_JANSSEN | Skin dystrophy | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Blood triglycerides increased | 0 | 0.001 | 0.186 | 1 | 2.343 |  |  |  |  |  | 
COVID19_JANSSEN | Varices oesophageal | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell sedimentation rate decreased | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Blood oestrogen abnormal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Parvovirus B19 test positive | 0 | 0 | 0.016 | 1 | 3.44 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumatosis intestinalis | 0 | 0 | 0 | 1 | 5.414 |  |  |  |  |  | 
COVID19_JANSSEN | Dermal cyst | 0 | 0 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | Necrosis | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_JANSSEN | Amnestic disorder | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Stevens-Johnson syndrome | 0 | 0 | 0.3 | 1 | 2.032 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinitis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival erythema | 0 | 0 | 0.151 | 1 | 2.466 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulins decreased | 0 | 0 | 0.101 | 1 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor | 0 | 0.001 | 0.227 | 1 | 2.218 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure orthostatic decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Electrolyte depletion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic hypertrophy | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Montreal cognitive assessment | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Uvulitis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic aneurysm repair | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C core antibody negative | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site exfoliation | 0 | 0 | 0.249 | 1 | 2.16 |  |  |  |  |  | 
COVID19_JANSSEN | Posturing | 0 | 0.001 | 0.113 | 1 | 2.621 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased immune responsiveness | 0 | 0 | 0.004 | 1 | 3.844 |  |  |  |  |  | 
COVID19_JANSSEN | Serum sickness | 0 | 0 | 0.423 | 1 | 1.775 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 deficiency | 0 | 0 | 0 | 1 | 4.454 |  |  |  |  |  | 
COVID19_JANSSEN | Eye contusion | 0 | 0.001 | 0.274 | 1 | 2.094 |  |  |  |  |  | 
COVID19_JANSSEN | Panic disorder | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular malformation | 0 | 0 | 0 | 1 | 5.177 |  |  |  |  |  | 
COVID19_JANSSEN | Renal injury | 0 | 0 | 0.188 | 1 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Amblyopia | 0 | 0 | 0.174 | 1 | 2.384 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagogastroduodenoscopy normal | 0 | 0 | 0.126 | 1 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | Tonic posturing | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Derealisation | 0 | 0 | 0.001 | 1 | 4.17 |  |  |  |  |  | 
COVID19_JANSSEN | Hirsutism | 0 | 0 | 0 | 1 | 4.56 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac valve disease | 0 | 0 | 0.012 | 1 | 3.52 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumovirus test positive | 0 | 0 | 0.003 | 1 | 3.881 |  |  |  |  |  | 
COVID19_JANSSEN | Time perception altered | 0 | 0 | 0.018 | 1 | 3.384 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QRS complex abnormal | 0 | 0 | 0.031 | 1 | 3.195 |  |  |  |  |  | 
COVID19_JANSSEN | Neurodevelopmental disorder | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_JANSSEN | Libido decreased | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Decompressive craniectomy | 0 | 0 | 0.032 | 1 | 3.189 |  |  |  |  |  | 
COVID19_JANSSEN | Anterior chamber inflammation | 0 | 0 | 0.001 | 1 | 4.165 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin C normal | 0 | 0 | 0.002 | 1 | 3.967 |  |  |  |  |  | 
COVID19_JANSSEN | Septic encephalopathy | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary dilatation | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Antithrombin III decreased | 0 | 0 | 0.027 | 1 | 3.243 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic girdle pain | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac murmur functional | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pyruvic acid increased | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chromogranin A increased | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Waldenstrom's macroglobulinaemia | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B2 | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Schistosomiasis | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural headache | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Granulomatous lymphadenitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood corticotrophin abnormal | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial tachycardia | 0 | 0 | 0.026 | 1 | 3.264 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-uterine contraceptive device removal | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve conduction studies abnormal | 0 | 0 | 0.021 | 1 | 3.338 |  |  |  |  |  | 
COVID19_JANSSEN | Borderline personality disorder | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_JANSSEN | Application site movement impairment | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Cellulitis streptococcal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Juvenile myoclonic epilepsy | 0 | 0 | 0 | 1 | 4.888 |  |  |  |  |  | 
COVID19_JANSSEN | Neuromyotonia | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Tricuspid valve incompetence | 0 | 0 | 0.142 | 1 | 2.502 |  |  |  |  |  | 
COVID19_JANSSEN | Phonophobia | 0 | 0 | 0.172 | 1 | 2.39 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal hypertrophy | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Urine potassium normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Benign prostatic hyperplasia | 0 | 0 | 0.163 | 1 | 2.424 |  |  |  |  |  | 
COVID19_JANSSEN | Hypereosinophilic syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Squamous cell carcinoma | 0 | 0 | 0.031 | 1 | 3.197 |  |  |  |  |  | 
COVID19_JANSSEN | Temperature perception test abnormal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular operation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate cancer | 0 | 0 | 0.031 | 1 | 3.2 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite stool test | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet aggregation normal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Infertility female | 0 | 0 | 0 | 1 | 5.822 |  |  |  |  |  | 
COVID19_JANSSEN | Mucormycosis | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Flow cytometry | 0 | 0 | 0.212 | 1 | 2.263 |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter infection | 0 | 0 | 0.227 | 1 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Viral skin infection | 0 | 0 | 0.01 | 1 | 3.576 |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical cord prolapse | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin E increased | 0 | 0 | 0.037 | 1 | 3.134 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity total normal | 0 | 0 | 0.123 | 1 | 2.581 |  |  |  |  |  | 
COVID19_JANSSEN | Blindness unilateral | 0 | 0.001 | 0.284 | 1 | 2.069 |  |  |  |  |  | 
COVID19_JANSSEN | Encapsulation reaction | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide | 0 | 0 | 0.213 | 1 | 2.261 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site joint movement impairment | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculosis of central nervous system | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Floating patella | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystectomy | 0 | 0.001 | 0.239 | 1 | 2.184 |  |  |  |  |  | 
COVID19_JANSSEN | Primary adrenal insufficiency | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram pancreas abnormal | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle strength abnormal | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagram | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Coarctation of the aorta | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive emergency | 0 | 0 | 0.008 | 1 | 3.654 |  |  |  |  |  | 
COVID19_JANSSEN | Suicide of relative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis meningococcal | 0 | 0 | 0 | 1 | 4.94 |  |  |  |  |  | 
COVID19_JANSSEN | Intercepted product administration error | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell sedimentation rate abnormal | 0 | 0 | 0.138 | 1 | 2.517 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular systolic pressure decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bronchus normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem auditory evoked response abnormal | 0 | 0 | 0.018 | 1 | 3.392 |  |  |  |  |  | 
COVID19_JANSSEN | CSF test | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve transposition | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal degeneration | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis lethargica | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteritis | 0 | 0 | 0.108 | 1 | 2.649 |  |  |  |  |  | 
COVID19_JANSSEN | Electroconvulsive therapy | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Immunisation anxiety related reaction | 0 | 0 | 0.009 | 1 | 3.626 |  |  |  |  |  | 
COVID19_JANSSEN | Type II hypersensitivity | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal swelling | 0 | 0 | 0.027 | 1 | 3.252 |  |  |  |  |  | 
COVID19_JANSSEN | Functional gastrointestinal disorder | 0 | 0 | 0.298 | 1 | 2.037 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle injury | 0 | 0 | 0.191 | 1 | 2.329 |  |  |  |  |  | 
COVID19_JANSSEN | Ebstein's anomaly | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Skin reaction | 0 | 0.002 | 0.48 | 1 | 1.672 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac murmur | 0 | 0 | 0.189 | 1 | 2.335 |  |  |  |  |  | 
COVID19_JANSSEN | Eye irrigation | 0 | 0 | 0.038 | 1 | 3.118 |  |  |  |  |  | 
COVID19_JANSSEN | Angiopathy | 0 | 0 | 0.008 | 1 | 3.65 |  |  |  |  |  | 
COVID19_JANSSEN | Hip fracture | 0 | 0 | 0.32 | 1 | 1.987 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound joint | 0 | 0 | 0.103 | 1 | 2.671 |  |  |  |  |  | 
COVID19_JANSSEN | Costochondritis | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Epigastric discomfort | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration bone marrow abnormal | 0 | 0 | 0.004 | 1 | 3.867 |  |  |  |  |  | 
COVID19_JANSSEN | Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Antidiuretic hormone abnormality | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Renal failure | 0 | 0 | 0.221 | 1 | 2.236 |  |  |  |  |  | 
COVID19_JANSSEN | Economic problem | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Lung hypoinflation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Xerosis | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Mean platelet volume decreased | 0 | 0 | 0.197 | 1 | 2.31 |  |  |  |  |  | 
COVID19_JANSSEN | Anotia | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor increased | 0 | 0 | 0.156 | 1 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin conjugated increased | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_JANSSEN | Chapped lips | 0 | 0.001 | 0.278 | 1 | 2.085 |  |  |  |  |  | 
COVID19_JANSSEN | Immobile | 0 | 0 | 0.225 | 1 | 2.225 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament sprain | 0 | 0 | 0.288 | 1 | 2.06 |  |  |  |  |  | 
COVID19_JANSSEN | Selenium deficiency | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous detachment | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder scan | 0 | 0 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract congestion | 0 | 0 | 0.079 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Cryoglobulins absent | 0 | 0 | 0.018 | 1 | 3.392 |  |  |  |  |  | 
COVID19_JANSSEN | Inborn error of lipid metabolism | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue eruption | 0 | 0 | 0.347 | 1 | 1.926 |  |  |  |  |  | 
COVID19_JANSSEN | Suicide/self-injury (SMQ) [broad] | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Holmes-Adie pupil | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland enlargement | 0 | 0 | 0.007 | 1 | 3.692 |  |  |  |  |  | 
COVID19_JANSSEN | Epiglottic erythema | 0 | 0 | 0.001 | 1 | 4.112 |  |  |  |  |  | 
COVID19_JANSSEN | Yellow nail syndrome | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Dependence on oxygen therapy | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Reye's syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperlipidaemia | 0 | 0 | 0.195 | 1 | 2.317 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac pacemaker adjustment | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Acute graft versus host disease in liver | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Atrioventricular block | 0 | 0.001 | 0.196 | 1 | 2.31 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal haemorrhage | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour markers (SMQ) [narrow] | 0 | 0 | 0.029 | 1 | 3.221 |  |  |  |  |  | 
COVID19_JANSSEN | Liver abscess | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral stenosis | 0 | 0 | 0.044 | 1 | 3.059 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-abdominal haemorrhage | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Drain of cerebral subdural space | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Fluid balance assessment | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha hydroxybutyrate dehydrogenase increased | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_JANSSEN | Smooth muscle antibody positive | 0 | 0 | 0.005 | 1 | 3.795 |  |  |  |  |  | 
COVID19_JANSSEN | Dysmetria | 0 | 0 | 0 | 1 | 5.19 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngitis streptococcal | 0 | 0 | 0.214 | 1 | 2.258 |  |  |  |  |  | 
COVID19_JANSSEN | Vagus nerve disorder | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram coronary artery abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Occupational therapy | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Device defective | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy blood vessel abnormal | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Breast malignant tumours (SMQ) [broad] | 0 | 0 | 0.202 | 1 | 2.295 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal cardiac disorder | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | West Nile virus test negative | 0 | 0 | 0.205 | 1 | 2.284 |  |  |  |  |  | 
COVID19_JANSSEN | Right hemisphere deficit syndrome | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Enterovirus infection | 0 | 0 | 0 | 1 | 4.474 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine normal | 0 | 0 | 0.137 | 1 | 2.521 |  |  |  |  |  | 
COVID19_JANSSEN | Epidermal necrosis | 0 | 0 | 0.087 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal fusion surgery | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary thrombosis | 0 | 0 | 0.012 | 1 | 3.527 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy cervix | 0 | 0 | 0 | 1 | 5.224 |  |  |  |  |  | 
COVID19_JANSSEN | Dyslalia | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Sapovirus test positive | 0 | 0 | 0 | 1 | 5.741 |  |  |  |  |  | 
COVID19_JANSSEN | Renal tubular acidosis | 0 | 0 | 0.001 | 1 | 4.076 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal haemorrhage | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow myelogram abnormal | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Bartonella test positive | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Sexually active | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Enterocolitis viral | 0 | 0 | 0.014 | 1 | 3.465 |  |  |  |  |  | 
COVID19_JANSSEN | Yersinia infection | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal cancer | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Urine sodium decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Testis cancer | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 test false positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal artery embolism | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy intestine | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site hypoaesthesia | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall mass | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Product use in unapproved indication | 0 | 0 | 0 | 1 | 4.49 |  |  |  |  |  | 
COVID19_JANSSEN | Enterovirus test positive | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Anogenital warts | 0 | 0 | 0 | 1 | 5.523 |  |  |  |  |  | 
COVID19_JANSSEN | Oral candidiasis | 0 | 0.001 | 0.163 | 1 | 2.42 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging thoracic | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic epidermal necrolysis | 0 | 0 | 0.015 | 1 | 3.449 |  |  |  |  |  | 
COVID19_JANSSEN | Enthesopathy | 0 | 0 | 0.035 | 1 | 3.148 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord injury | 0 | 0 | 0.032 | 1 | 3.18 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve lesion | 0 | 0 | 0.027 | 1 | 3.254 |  |  |  |  |  | 
COVID19_JANSSEN | Haptoglobin normal | 0 | 0 | 0.027 | 1 | 3.255 |  |  |  |  |  | 
COVID19_JANSSEN | Subchorionic haemorrhage | 0 | 0 | 0 | 1 | 5.629 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cells urine | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatotoxicity | 0 | 0 | 0 | 1 | 4.712 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum test | 0 | 0 | 0.002 | 1 | 3.977 |  |  |  |  |  | 
COVID19_JANSSEN | Erythrosis | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal papilloma | 0 | 0 | 0 | 1 | 4.818 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial secretion retention | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Urine electrophoresis abnormal | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia klebsiella | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Hoffmann's sign | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin A abnormal | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valve replacement | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Radical prostatectomy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Peptostreptococcus test positive | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Multinucleate cell angiohistiocytoma | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Female genital tract fistula | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Directional Doppler flow tests abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasm | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune enteropathy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Abstains from alcohol | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy skin abnormal | 0 | 0 | 0.149 | 1 | 2.474 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil toxic granulation present | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal scan | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Ehrlichia test positive | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy stomach normal | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue atrophy | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Tidal volume decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Sympathicotonia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Somatic dysfunction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Smear buccal | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Physical breast examination | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder obstruction | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Focal peritonitis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrocystic breast disease | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pregnenolone increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Alien limb syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte percentage increased | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site granuloma | 0 | 0 | 0 | 1 | 5.585 |  |  |  |  |  | 
COVID19_JANSSEN | Myofascitis | 0 | 0 | 0 | 1 | 5.422 |  |  |  |  |  | 
COVID19_JANSSEN | Papilloedema | 0 | 0 | 0.227 | 1 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | Glossitis | 0 | 0 | 0.175 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Neurogenic bladder | 0 | 0 | 0 | 1 | 4.538 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy peripheral nerve abnormal | 0 | 0 | 0.021 | 1 | 3.331 |  |  |  |  |  | 
COVID19_JANSSEN | Ulcerative keratitis | 0 | 0 | 0 | 1 | 5.259 |  |  |  |  |  | 
COVID19_JANSSEN | Metamyelocyte percentage | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Osteomyelitis bacterial | 0 | 0 | 0.004 | 1 | 3.813 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropsychiatric symptoms | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperleukocytosis | 0 | 0 | 0.095 | 1 | 2.715 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure diastolic decreased | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_JANSSEN | Autoantibody test | 0 | 0 | 0.111 | 1 | 2.632 |  |  |  |  |  | 
COVID19_JANSSEN | Subileus | 0 | 0 | 0.001 | 1 | 4.264 |  |  |  |  |  | 
COVID19_JANSSEN | PO2 abnormal | 0 | 0 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_JANSSEN | CSF neutrophil count | 0 | 0 | 0.019 | 1 | 3.377 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchopneumopathy | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder sphincter atony | 0 | 0 | 0.016 | 1 | 3.434 |  |  |  |  |  | 
COVID19_JANSSEN | Idiosyncratic drug reaction | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis membranous | 0 | 0 | 0.003 | 1 | 3.922 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site cyst | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | Panophthalmitis | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Paresis cranial nerve | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle operation | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Joint laxity | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Invasive lobular breast carcinoma | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic hepatitis | 0 | 0 | 0.003 | 1 | 3.902 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone normal | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Urethritis noninfective | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Transcranial electrical motor evoked potential monitoring abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle graft | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin-like growth factor increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic vein thrombosis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Heat therapy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix injury | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Analgesic drug level increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis | 0 | 0 | 0.013 | 1 | 3.506 |  |  |  |  |  | 
COVID19_JANSSEN | Blood count normal | 0 | 0 | 0.113 | 1 | 2.624 |  |  |  |  |  | 
COVID19_JANSSEN | Pathology test | 0 | 0 | 0.201 | 1 | 2.296 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong patient received product | 0 | 0 | 0.362 | 1 | 1.895 |  |  |  |  |  | 
COVID19_JANSSEN | Product temperature excursion issue | 0 | 0 | 0 | 1 | 4.928 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal discomfort | 0 | 0.002 | 0.448 | 1 | 1.728 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cells urine positive | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_JANSSEN | Cataplexy | 0 | 0 | 0 | 1 | 5.177 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy muscle abnormal | 0 | 0 | 0 | 1 | 5.16 |  |  |  |  |  | 
COVID19_JANSSEN | Miliaria | 0 | 0 | 0.285 | 1 | 2.067 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory depression | 0 | 0.002 | 0.357 | 1 | 1.905 |  |  |  |  |  | 
COVID19_JANSSEN | Gamma-glutamyltransferase | 0 | 0 | 0.009 | 1 | 3.619 |  |  |  |  |  | 
COVID19_JANSSEN | Serum ferritin | 0 | 0 | 0.194 | 1 | 2.317 |  |  |  |  |  | 
COVID19_JANSSEN | Dental caries | 0 | 0 | 0 | 1 | 5.286 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary hesitation | 0 | 0 | 0.088 | 1 | 2.748 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular function test | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinoscleroma | 0 | 0 | 0.005 | 1 | 3.781 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterial infection | 0 | 0 | 0.02 | 1 | 3.353 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic mass | 0 | 0 | 0.038 | 1 | 3.124 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise lack of | 0 | 0 | 0 | 1 | 4.355 |  |  |  |  |  | 
COVID19_JANSSEN | Megacolon | 0 | 0 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperpathia | 0 | 0 | 0 | 1 | 4.309 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor VIII antibody increased | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_JANSSEN | Echoencephalogram | 0 | 0 | 0.02 | 1 | 3.364 |  |  |  |  |  | 
COVID19_JANSSEN | Creutzfeldt-Jakob disease | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site erythema | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Urine calcium | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Perineal erythema | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Patent ductus arteriosus repair | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | JC polyomavirus test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram U wave present | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram coronary artery | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | CSF measles antibody positive | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy foetal abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Epilepsy | 0 | 0 | 0.015 | 1 | 3.454 |  |  |  |  |  | 
COVID19_JANSSEN | Scan with contrast normal | 0 | 0.003 | 0.475 | 1 | 1.681 |  |  |  |  |  | 
COVID19_JANSSEN | Consciousness fluctuating | 0 | 0 | 0.312 | 1 | 2.004 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thyroid stimulating hormone increased | 0 | 0 | 0.152 | 1 | 2.461 |  |  |  |  |  | 
COVID19_JANSSEN | Labyrinthitis | 0 | 0 | 0.123 | 1 | 2.581 |  |  |  |  |  | 
COVID19_JANSSEN | Pigmentation disorder | 0 | 0 | 0.027 | 1 | 3.242 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis acute | 0 | 0 | 0.028 | 1 | 3.238 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pH increased | 0 | 0.001 | 0.183 | 1 | 2.354 |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric symptom | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic herpes simplex | 0 | 0 | 0 | 1 | 4.731 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alkaline phosphatase | 0 | 0 | 0.133 | 1 | 2.537 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal oedema | 0 | 0 | 0.033 | 1 | 3.174 |  |  |  |  |  | 
COVID19_JANSSEN | Forced expiratory volume | 0 | 0 | 0 | 1 | 4.769 |  |  |  |  |  | 
COVID19_JANSSEN | Cellulitis orbital | 0 | 0 | 0.005 | 1 | 3.778 |  |  |  |  |  | 
COVID19_JANSSEN | Urine flow decreased | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropathic muscular atrophy | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Myringotomy | 0 | 0 | 0.087 | 1 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Hypergammaglobulinaemia | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary cyst | 0 | 0 | 0.005 | 1 | 3.766 |  |  |  |  |  | 
COVID19_JANSSEN | Application site abscess | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | JC polyomavirus test negative | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_JANSSEN | Familial periodic paralysis | 0 | 0 | 0.009 | 1 | 3.602 |  |  |  |  |  | 
COVID19_JANSSEN | Application site vesicles | 0 | 0 | 0.008 | 1 | 3.643 |  |  |  |  |  | 
COVID19_JANSSEN | Weight decrease neonatal | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Limb asymmetry | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric atony | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem ischaemia | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Blood androstenedione | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Tenotomy | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal operation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral calcification | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Autosomal chromosome anomaly | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Autism spectrum disorder | 0 | 0 | 0.031 | 1 | 3.193 |  |  |  |  |  | 
COVID19_JANSSEN | Anion gap | 0 | 0.002 | 0.344 | 1 | 1.933 |  |  |  |  |  | 
COVID19_JANSSEN | Joint lock | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin increased | 0 | 0.001 | 0.223 | 1 | 2.23 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil percentage | 0 | 0 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Patient isolation | 0 | 0 | 0.021 | 1 | 3.344 |  |  |  |  |  | 
COVID19_JANSSEN | Febrile infection | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Pyelocaliectasis | 0 | 0 | 0.017 | 1 | 3.406 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal discharge discolouration | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-thyroid antibody negative | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal ulceration | 0 | 0 | 0.262 | 1 | 2.126 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs direct test negative | 0 | 0 | 0.135 | 1 | 2.531 |  |  |  |  |  | 
COVID19_JANSSEN | Induced labour | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar syndrome | 0 | 0 | 0 | 1 | 5.471 |  |  |  |  |  | 
COVID19_JANSSEN | Smear cervix normal | 0 | 0 | 0 | 1 | 4.712 |  |  |  |  |  | 
COVID19_JANSSEN | Angina unstable | 0 | 0 | 0.016 | 1 | 3.434 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal discomfort | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_JANSSEN | Minimum inhibitory concentration | 0 | 0 | 0.005 | 1 | 3.799 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal degeneration | 0 | 0 | 0.085 | 1 | 2.765 |  |  |  |  |  | 
COVID19_JANSSEN | Blood osmolarity | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic respiratory disease | 0 | 0 | 0.01 | 1 | 3.571 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen consumption increased | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall haematoma | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Stenotrophomonas test positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity urine abnormal | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Hypophonesis | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Hypomania | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular cauterisation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Superficial injury of eye | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell analysis abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Reaction to colouring | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Pyogenic granuloma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet dysfunction | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve operation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve infection | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Natural killer cell activity normal | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial fibrosis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Medical observation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Kleihauer-Betke test positive | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperoxia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Cell marker increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Poor feeding infant | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Hallucination, visual | 0 | 0 | 0.345 | 1 | 1.932 |  |  |  |  |  | 
COVID19_JANSSEN | Panic reaction | 0 | 0.001 | 0.27 | 1 | 2.105 |  |  |  |  |  | 
COVID19_JANSSEN | Nail injury | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | JC virus CSF test positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Benign muscle neoplasm | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Barium double contrast abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Immunology test | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory symptom | 0 | 0.001 | 0.365 | 1 | 1.889 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration | 0 | 0 | 0.353 | 1 | 1.915 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine free normal | 0 | 0 | 0.121 | 1 | 2.586 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose abnormal | 0 | 0 | 0.247 | 1 | 2.164 |  |  |  |  |  | 
COVID19_JANSSEN | Lip haemorrhage | 0 | 0 | 0.285 | 1 | 2.067 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulins increased | 0 | 0 | 0.009 | 1 | 3.608 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria papular | 0 | 0 | 0.155 | 1 | 2.453 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal ulcer | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial disorder | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle contusion | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic disorder | 0 | 0 | 0.075 | 1 | 2.829 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal dermatitis | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral paralysis | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Von Willebrand's factor activity increased | 0 | 0 | 0.028 | 1 | 3.231 |  |  |  |  |  | 
COVID19_JANSSEN | Knee deformity | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid hormone replacement therapy | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Extremity necrosis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Chillblains | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Biofeedback therapy | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal disorder | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginitis gardnerella | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Sterile pyuria | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Promyelocyte count decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Progesterone increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoblast count | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Genital tract inflammation | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal megacystis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival erosion | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic allograft nephropathy | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicitis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea nitrogen/creatinine ratio decreased | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Accidental exposure to product | 0 | 0 | 0.04 | 1 | 3.102 |  |  |  |  |  | 
COVID19_JANSSEN | Irritable bowel syndrome | 0 | 0 | 0.011 | 1 | 3.56 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal eruption | 0 | 0.001 | 0.435 | 1 | 1.753 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphangitis | 0 | 0 | 0.027 | 1 | 3.243 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic stroke | 0 | 0 | 0.107 | 1 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Irregular breathing | 0 | 0 | 0.099 | 1 | 2.693 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 decreased | 0 | 0 | 0.005 | 1 | 3.762 |  |  |  |  |  | 
COVID19_JANSSEN | Phototherapy | 0 | 0 | 0 | 1 | 4.696 |  |  |  |  |  | 
COVID19_JANSSEN | Product closure issue | 0 | 0 | 0 | 1 | 4.261 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal ulceration | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Beta-2 glycoprotein antibody positive | 0 | 0 | 0.001 | 1 | 4.232 |  |  |  |  |  | 
COVID19_JANSSEN | Altered visual depth perception | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Spondylolisthesis | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Product appearance confusion | 0 | 0 | 0.009 | 1 | 3.622 |  |  |  |  |  | 
COVID19_JANSSEN | Mycotic allergy | 0 | 0 | 0.001 | 1 | 4.124 |  |  |  |  |  | 
COVID19_JANSSEN | Genital erythema | 0 | 0 | 0.011 | 1 | 3.564 |  |  |  |  |  | 
COVID19_JANSSEN | Renal cancer | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet distribution width decreased | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Penile wart | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Fibromuscular dysplasia | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Enterococcal sepsis | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Carbohydrate antigen 19-9 increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Autotransfusion | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Injury | 0 | 0 | 0.147 | 1 | 2.479 |  |  |  |  |  | 
COVID19_JANSSEN | Neuralgic amyotrophy | 0 | 0.001 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal disorder | 0 | 0 | 0 | 1 | 4.31 |  |  |  |  |  | 
COVID19_JANSSEN | Cystitis | 0 | 0 | 0.009 | 1 | 3.618 |  |  |  |  |  | 
COVID19_JANSSEN | Fine motor skill dysfunction | 0 | 0.001 | 0.413 | 1 | 1.794 |  |  |  |  |  | 
COVID19_JANSSEN | Tryptase | 0 | 0.002 | 0.321 | 1 | 1.984 |  |  |  |  |  | 
COVID19_JANSSEN | Pre-eclampsia | 0 | 0 | 0 | 1 | 4.343 |  |  |  |  |  | 
COVID19_JANSSEN | Blood magnesium increased | 0 | 0 | 0.296 | 1 | 2.04 |  |  |  |  |  | 
COVID19_JANSSEN | Catatonia | 0 | 0 | 0.121 | 1 | 2.589 |  |  |  |  |  | 
COVID19_JANSSEN | Reflex test normal | 0 | 0 | 0.028 | 1 | 3.241 |  |  |  |  |  | 
COVID19_JANSSEN | High density lipoprotein decreased | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | Serum sickness-like reaction | 0 | 0 | 0.1 | 1 | 2.687 |  |  |  |  |  | 
COVID19_JANSSEN | PO2 | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin urine | 0 | 0 | 0.112 | 1 | 2.63 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal anastomosis | 0 | 0 | 0 | 1 | 4.738 |  |  |  |  |  | 
COVID19_JANSSEN | Drug level | 0 | 0 | 0.014 | 1 | 3.483 |  |  |  |  |  | 
COVID19_JANSSEN | Paracentesis eye abnormal | 0 | 0 | 0.031 | 1 | 3.198 |  |  |  |  |  | 
COVID19_JANSSEN | Visceral pain | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Nonreassuring foetal heart rate pattern | 0 | 0 | 0.034 | 1 | 3.162 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte transformation test | 0 | 0 | 0.001 | 1 | 4.203 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol withdrawal syndrome | 0 | 0 | 0.001 | 1 | 4.145 |  |  |  |  |  | 
COVID19_JANSSEN | Protein albumin ratio normal | 0 | 0 | 0.077 | 1 | 2.814 |  |  |  |  |  | 
COVID19_JANSSEN | Eccentric fixation | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Viral keratouveitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestine adenocarcinoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid lung | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Renal scan abnormal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Placental insufficiency | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Melanaemia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site rash | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperglobulinaemia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Diplegia | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Fontanelle bulging | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Hormone level abnormal | 0 | 0 | 0 | 1 | 4.699 |  |  |  |  |  | 
COVID19_JANSSEN | CSF glucose increased | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_JANSSEN | Bundle branch block right | 0 | 0 | 0.144 | 1 | 2.493 |  |  |  |  |  | 
COVID19_JANSSEN | Smear cervix | 0 | 0 | 0 | 1 | 4.487 |  |  |  |  |  | 
COVID19_JANSSEN | Sialoadenitis | 0 | 0 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcal bacteraemia | 0 | 0 | 0 | 1 | 4.362 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema mouth | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem auditory evoked response | 0 | 0 | 0.022 | 1 | 3.33 |  |  |  |  |  | 
COVID19_JANSSEN | Seborrhoea | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary scan normal | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Focal segmental glomerulosclerosis | 0 | 0 | 0.027 | 1 | 3.244 |  |  |  |  |  | 
COVID19_JANSSEN | Genital blister | 0 | 0 | 0.089 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Trisomy 18 | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant melanoma in situ | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Dysmetropsia | 0 | 0 | 0.004 | 1 | 3.849 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram coronary artery normal | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal ulcer | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal cancer stage IV | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-ganglioside antibody negative | 0 | 0 | 0 | 1 | 4.972 |  |  |  |  |  | 
COVID19_JANSSEN | Small fibre neuropathy | 0 | 0 | 0.026 | 1 | 3.265 |  |  |  |  |  | 
COVID19_JANSSEN | Vasodilatation | 0 | 0 | 0.323 | 1 | 1.978 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-aquaporin-4 antibody positive | 0 | 0 | 0 | 1 | 5.765 |  |  |  |  |  | 
COVID19_JANSSEN | Blood folate | 0 | 0 | 0.187 | 1 | 2.342 |  |  |  |  |  | 
COVID19_JANSSEN | Typhus rickettsia test | 0 | 0 | 0.174 | 1 | 2.384 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site dermatitis | 0 | 0 | 0.181 | 1 | 2.36 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculin test positive | 0 | 0 | 0.026 | 1 | 3.262 |  |  |  |  |  | 
COVID19_JANSSEN | Major depression | 0 | 0 | 0.088 | 1 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Yellow fever vaccine-associated viscerotropic disease | 0 | 0 | 0 | 1 | 4.916 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple chemical sensitivity | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | pH body fluid | 0 | 0 | 0.004 | 1 | 3.845 |  |  |  |  |  | 
COVID19_JANSSEN | Lower limb fracture | 0 | 0 | 0.106 | 1 | 2.66 |  |  |  |  |  | 
COVID19_JANSSEN | Peak expiratory flow rate | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Basal ganglia infarction | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous disorder | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_JANSSEN | Erythromelalgia | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital neurological disorder | 0 | 0 | 0 | 1 | 5.777 |  |  |  |  |  | 
COVID19_JANSSEN | Sports injury | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Nutritional condition abnormal | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Drug monitoring procedure not performed | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Crystal arthropathy | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B1 decreased | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine hypertonus | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Septic arthritis streptococcal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Prosthesis user | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cell mastitis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Omenn syndrome | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant splenic neoplasm | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Joint deposit | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Interferon gamma release assay positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hookworm infection | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal calprotectin abnormal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Dental gangrene | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangiogram normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Brain empyema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy tongue | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess positive | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Acoustic neuritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Flank pain | 0 | 0.003 | 0.521 | 1 | 1.605 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site granuloma | 0 | 0 | 0 | 1 | 4.842 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep study abnormal | 0 | 0 | 0.004 | 1 | 3.822 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue biting | 0 | 0 | 0.257 | 1 | 2.139 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary mass | 0 | 0 | 0.114 | 1 | 2.619 |  |  |  |  |  | 
COVID19_JANSSEN | Infectious biliary disorders (SMQ) [broad] | 0 | 0.001 | 0.075 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Facial spasm | 0 | 0 | 0.154 | 1 | 2.454 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antibody positive | 0 | 0 | 0 | 1 | 5.019 |  |  |  |  |  | 
COVID19_JANSSEN | Product packaging quantity issue | 0 | 0 | 0.003 | 1 | 3.931 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate | 0 | 0 | 0.005 | 1 | 3.795 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth abscess | 0 | 0 | 0.141 | 1 | 2.504 |  |  |  |  |  | 
COVID19_JANSSEN | Lung hyperinflation | 0 | 0 | 0.02 | 1 | 3.349 |  |  |  |  |  | 
COVID19_JANSSEN | Granulomatous dermatitis | 0 | 0 | 0 | 1 | 5.561 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin urine absent | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_JANSSEN | Obsessive thoughts | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to contaminated device | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_JANSSEN | Acute haemorrhagic leukoencephalitis | 0 | 0 | 0.005 | 1 | 3.784 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine pain | 0 | 0 | 0 | 1 | 4.81 |  |  |  |  |  | 
COVID19_JANSSEN | Dengue virus test negative | 0 | 0 | 0.023 | 1 | 3.31 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B6 | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Conduction disorder | 0 | 0 | 0.11 | 1 | 2.639 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital absence of bile ducts | 0 | 0 | 0 | 1 | 5.534 |  |  |  |  |  | 
COVID19_JANSSEN | Light chain analysis decreased | 0 | 0 | 0 | 1 | 4.621 |  |  |  |  |  | 
COVID19_JANSSEN | Haemodynamic test normal | 0 | 0 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_JANSSEN | Fluctuance | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy stomach | 0 | 0 | 0.028 | 1 | 3.238 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-SRP antibody positive | 0 | 0 | 0 | 1 | 4.69 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal spasm | 0 | 0 | 0.009 | 1 | 3.598 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic cardiomyopathy | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chromium | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic operation | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Diffuse large B-cell lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Carnett's sign positive | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor Xa assay normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcus test positive | 0 | 0 | 0.427 | 1 | 1.767 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon rupture | 0 | 0 | 0.187 | 1 | 2.341 |  |  |  |  |  | 
COVID19_JANSSEN | Wound secretion | 0 | 0 | 0.17 | 1 | 2.398 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoma | 0 | 0 | 0.165 | 1 | 2.414 |  |  |  |  |  | 
COVID19_JANSSEN | Culture stool positive | 0 | 0 | 0 | 1 | 4.911 |  |  |  |  |  | 
COVID19_JANSSEN | Foot deformity | 0 | 0 | 0.25 | 1 | 2.156 |  |  |  |  |  | 
COVID19_JANSSEN | Fasciitis | 0 | 0 | 0.171 | 1 | 2.393 |  |  |  |  |  | 
COVID19_JANSSEN | CSF oligoclonal band | 0 | 0 | 0.209 | 1 | 2.271 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site haematoma | 0 | 0 | 0.02 | 1 | 3.354 |  |  |  |  |  | 
COVID19_JANSSEN | Gynaecological examination | 0 | 0 | 0.006 | 1 | 3.714 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lymph gland abnormal | 0 | 0 | 0.098 | 1 | 2.7 |  |  |  |  |  | 
COVID19_JANSSEN | Bradykinesia | 0 | 0 | 0.003 | 1 | 3.908 |  |  |  |  |  | 
COVID19_JANSSEN | Talipes | 0 | 0 | 0.01 | 1 | 3.569 |  |  |  |  |  | 
COVID19_JANSSEN | Hidradenitis | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary sediment abnormal | 0 | 0 | 0.094 | 1 | 2.718 |  |  |  |  |  | 
COVID19_JANSSEN | Inguinal hernia repair | 0 | 0 | 0.144 | 1 | 2.494 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site paraesthesia | 0 | 0 | 0.028 | 1 | 3.233 |  |  |  |  |  | 
COVID19_JANSSEN | Patellofemoral pain syndrome | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Blood folate increased | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular filtration rate increased | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Malaria antibody test positive | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder hypofunction | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Corynebacterium bacteraemia | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation time shortened | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lead normal | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Superior vena cava stenosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Oscillopsia | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal scar | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Manifest refraction normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Head circumference | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Giardia test positive | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopic retrograde cholangiopancreatography | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic wound | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Breast ulceration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Breast tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Blood mercury normal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site irritation | 0 | 0.001 | 0.355 | 1 | 1.91 |  |  |  |  |  | 
COVID19_JANSSEN | Excessive eye blinking | 0 | 0 | 0.373 | 1 | 1.873 |  |  |  |  |  | 
COVID19_JANSSEN | Neurodermatitis | 0 | 0 | 0 | 1 | 4.425 |  |  |  |  |  | 
COVID19_JANSSEN | Joint warmth | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_JANSSEN | Blood 25-hydroxycholecalciferol | 0 | 0 | 0.175 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Blood fibrinogen decreased | 0 | 0 | 0.148 | 1 | 2.478 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging abdominal | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium tuberculosis complex test positive | 0 | 0 | 0.006 | 1 | 3.736 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-cyclic citrullinated peptide antibody | 0 | 0 | 0.255 | 1 | 2.144 |  |  |  |  |  | 
COVID19_JANSSEN | CSF monocyte count | 0 | 0 | 0 | 1 | 5.218 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem syndrome | 0 | 0.001 | 0.099 | 1 | 2.692 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valve incompetence | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Sepsis neonatal | 0 | 0 | 0.017 | 1 | 3.401 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspareunia | 0 | 0 | 0 | 1 | 5.821 |  |  |  |  |  | 
COVID19_JANSSEN | Chest injury | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Blood methaemoglobin | 0 | 0 | 0.039 | 1 | 3.111 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory paralysis | 0 | 0 | 0.009 | 1 | 3.628 |  |  |  |  |  | 
COVID19_JANSSEN | Portal vein thrombosis | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_JANSSEN | Multipathogen PCR test positive | 0 | 0 | 0.016 | 1 | 3.44 |  |  |  |  |  | 
COVID19_JANSSEN | Meconium in amniotic fluid | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Application site rash | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue operation | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Product impurity | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Otoscopy | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal hypertrophy | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Multipathogen PCR test | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Meningocele acquired | 0 | 0 | 0.004 | 1 | 3.849 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint infection | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Glutathione decreased | 0 | 0 | 0.014 | 1 | 3.468 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic colitis | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial fistula | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Benign neoplasm of thyroid gland | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_JANSSEN | ADAMTS13 activity normal | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral lateral recess stenosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural rub | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet-large cell ratio increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Paracentesis ear | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Myocarditis bacterial | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Megakaryocytes abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal transit time | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect dosage administered | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Ilium fracture | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Hyponatriuria | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Enteropathic spondylitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic myeloid leukaemia recurrent | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase BB | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy mucosa normal | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_JANSSEN | Anaplastic large-cell lymphoma | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil count increased | 0 | 0.001 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Limb injury | 0 | 0 | 0.429 | 1 | 1.764 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via eye contact | 0 | 0 | 0.003 | 1 | 3.92 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothyroidism | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile apnoea | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Fundoscopy abnormal | 0 | 0 | 0.015 | 1 | 3.454 |  |  |  |  |  | 
COVID19_JANSSEN | Urine leukocyte esterase | 0 | 0 | 0.321 | 1 | 1.983 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal disorder | 0 | 0 | 0.022 | 1 | 3.317 |  |  |  |  |  | 
COVID19_JANSSEN | Joint contracture | 0 | 0 | 0.165 | 1 | 2.417 |  |  |  |  |  | 
COVID19_JANSSEN | Eye operation | 0 | 0 | 0.128 | 1 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspraxia | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_JANSSEN | Spirometry | 0 | 0 | 0.01 | 1 | 3.591 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal volume increased | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Total lung capacity decreased | 0 | 0 | 0.002 | 1 | 4.013 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac operation | 0 | 0 | 0.113 | 1 | 2.623 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal swelling | 0 | 0 | 0.032 | 1 | 3.185 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell count abnormal | 0 | 0 | 0.272 | 1 | 2.1 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin saturation | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal achalasia | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage intracranial | 0 | 0 | 0.096 | 1 | 2.709 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile spasms | 0 | 0 | 0.092 | 1 | 2.729 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess rupture | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Epiglottitis | 0 | 0 | 0.001 | 1 | 4.245 |  |  |  |  |  | 
COVID19_JANSSEN | Carnitine | 0 | 0 | 0.002 | 1 | 4.054 |  |  |  |  |  | 
COVID19_JANSSEN | Leukocyturia | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_JANSSEN | Weight fluctuation | 0 | 0 | 0 | 1 | 4.851 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonellosis | 0 | 0 | 0.001 | 1 | 4.287 |  |  |  |  |  | 
COVID19_JANSSEN | Hair disorder | 0 | 0 | 0.003 | 1 | 3.876 |  |  |  |  |  | 
COVID19_JANSSEN | Venogram normal | 0 | 0 | 0.145 | 1 | 2.488 |  |  |  |  |  | 
COVID19_JANSSEN | Meningoencephalitis herpetic | 0 | 0 | 0.002 | 1 | 4.046 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal fracture | 0 | 0 | 0.184 | 1 | 2.35 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropsychiatric syndrome | 0 | 0 | 0.009 | 1 | 3.624 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia staphylococcal | 0 | 0 | 0.035 | 1 | 3.152 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulum intestinal | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament disorder | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_JANSSEN | Cushing's syndrome | 0 | 0 | 0 | 1 | 4.498 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial biopsy abnormal | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Sickle cell anaemia | 0 | 0 | 0.026 | 1 | 3.268 |  |  |  |  |  | 
COVID19_JANSSEN | Oedematous pancreatitis | 0 | 0 | 0.044 | 1 | 3.064 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine contractions abnormal | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Squamous cell carcinoma of the oral cavity | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal column injury | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar vertebral fracture | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Inadequate diet | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis enteroviral | 0 | 0 | 0.015 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | B-lymphocyte abnormalities | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Wound contamination | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Venous recanalisation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Urine phosphorus increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Tear break up time test | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal fissure | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate cancer stage IV | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Plasminogen decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Intracerebral haematoma evacuation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal biophysical profile score abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise electrocardiogram abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cold exposure injury | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular function test abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Carcinoid tumour | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood insulin normal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Blood copper increased | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Snoring | 0 | 0 | 0.156 | 1 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate abnormal | 0 | 0 | 0.276 | 1 | 2.091 |  |  |  |  |  | 
COVID19_JANSSEN | Goitre | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate normal | 0 | 0 | 0.263 | 1 | 2.123 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue oedema | 0 | 0 | 0.218 | 1 | 2.246 |  |  |  |  |  | 
COVID19_JANSSEN | Anal pap smear abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Saliva analysis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein amniotic fluid normal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrospinal fluid reservoir placement | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral artery occlusion | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous floaters | 0 | 0.001 | 0.33 | 1 | 1.963 |  |  |  |  |  | 
COVID19_JANSSEN | Pleurisy | 0 | 0.001 | 0.252 | 1 | 2.151 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet anisocytosis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac dysfunction | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Scan normal | 0 | 0 | 0.147 | 1 | 2.483 |  |  |  |  |  | 
COVID19_JANSSEN | Flavivirus test | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Barium swallow abnormal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Telangiectasia | 0 | 0 | 0.178 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Wound drainage | 0 | 0 | 0.143 | 1 | 2.497 |  |  |  |  |  | 
COVID19_JANSSEN | Lipaemic index score | 0 | 0 | 0.005 | 1 | 3.759 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal mass | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy thyroid gland | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_JANSSEN | Hypochromasia | 0 | 0 | 0.097 | 1 | 2.701 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 2 globulin | 0 | 0 | 0.038 | 1 | 3.116 |  |  |  |  |  | 
COVID19_JANSSEN | Hemiplegic migraine | 0 | 0 | 0.001 | 1 | 4.216 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder pain | 0 | 0 | 0.113 | 1 | 2.622 |  |  |  |  |  | 
COVID19_JANSSEN | Skeletal survey | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Reflexes abnormal | 0 | 0 | 0.196 | 1 | 2.31 |  |  |  |  |  | 
COVID19_JANSSEN | Protein albumin ratio | 0 | 0 | 0.035 | 1 | 3.156 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alcohol increased | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | Inguinal hernia | 0 | 0 | 0.15 | 1 | 2.471 |  |  |  |  |  | 
COVID19_JANSSEN | Trichorrhexis | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Eye haematoma | 0 | 0 | 0.033 | 1 | 3.177 |  |  |  |  |  | 
COVID19_JANSSEN | Normetanephrine urine increased | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Subretinal fibrosis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian failure | 0 | 0 | 0 | 1 | 5.813 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar cyst | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Blood acid phosphatase normal | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Cor pulmonale | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary transmission | 0 | 0 | 0 | 1 | 4.431 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral pain | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin level decreased | 0 | 0 | 0.017 | 1 | 3.417 |  |  |  |  |  | 
COVID19_JANSSEN | Abulia | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | JC polyomavirus test positive | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | Intrauterine infection | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Penoscrotal fusion | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Sexually transmitted disease test | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Shoulder arthroplasty | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_JANSSEN | Bile duct stent insertion | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Sweat test abnormal | 0 | 0 | 0.017 | 1 | 3.405 |  |  |  |  |  | 
COVID19_JANSSEN | Dementia (SMQ) [narrow] | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic varices | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular pressure test normal | 0 | 0 | 0.001 | 1 | 4.137 |  |  |  |  |  | 
COVID19_JANSSEN | Trichotillomania | 0 | 0 | 0.001 | 1 | 4.2 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicectomy | 0 | 0 | 0 | 1 | 4.895 |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product effect incomplete | 0 | 0 | 0 | 1 | 5.557 |  |  |  |  |  | 
COVID19_JANSSEN | Drug provocation test | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Product reconstitution quality issue | 0 | 0 | 0 | 1 | 4.874 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-NMDA antibody | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | CSF immunoglobulin increased | 0 | 0 | 0.01 | 1 | 3.575 |  |  |  |  |  | 
COVID19_JANSSEN | Increased bronchial secretion | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic lymphocytic leukaemia | 0 | 0 | 0.001 | 1 | 4.108 |  |  |  |  |  | 
COVID19_JANSSEN | Vitrectomy | 0 | 0 | 0.089 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Phantom limb syndrome | 0 | 0 | 0.005 | 1 | 3.79 |  |  |  |  |  | 
COVID19_JANSSEN | Oral fungal infection | 0 | 0 | 0.184 | 1 | 2.35 |  |  |  |  |  | 
COVID19_JANSSEN | External ear pain | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Takayasu's arteritis | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Enterococcal infection | 0 | 0 | 0.004 | 1 | 3.811 |  |  |  |  |  | 
COVID19_JANSSEN | Neurotoxicity | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Throat cancer | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic shock syndrome | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal migraine | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Hair metal test | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia pyelonephritis | 0 | 0 | 0.003 | 1 | 3.924 |  |  |  |  |  | 
COVID19_JANSSEN | Posterior capsule opacification | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Pedal pulse decreased | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Optical coherence tomography normal | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Dental care | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Vasomotor rhinitis | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_JANSSEN | Renal tubular injury | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Paraneoplastic neurological syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal irritation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Lewis-Sumner syndrome | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Duodenal polyp | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle necrosis | 0 | 0 | 0 | 1 | 5.786 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal therapeutic procedure | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Supportive care | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract infection bacterial | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix cancer metastatic | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Axial spondyloarthritis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Depression | 0 | 0 | 0.029 | 1 | 3.225 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy tonsil | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal tear | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Middle insomnia | 0 | 0 | 0.247 | 1 | 2.166 |  |  |  |  |  | 
COVID19_JANSSEN | Parietal cell antibody negative | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Limb reduction defect | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral spasm | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil morphology normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Ileostomy | 0 | 0 | 0.001 | 1 | 4.236 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema annulare | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Cirrhosis alcoholic | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Skin malignant tumours (SMQ) [broad] | 0 | 0 | 0.007 | 1 | 3.667 |  |  |  |  |  | 
COVID19_JANSSEN | Polydipsia | 0 | 0 | 0.116 | 1 | 2.61 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess of salivary gland | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Olfactory nerve disorder | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Adenocarcinoma of the cervix | 0 | 0 | 0 | 1 | 5.31 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site abscess sterile | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Pathogen resistance | 0 | 0 | 0.001 | 1 | 4.099 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperoxaluria | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Ataxia | 0 | 0 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Ductal adenocarcinoma of pancreas | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hypocalcaemia | 0 | 0 | 0.202 | 1 | 2.292 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal mesothelial hyperplasia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram P wave biphasic | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Schizophrenia | 0 | 0 | 0 | 1 | 4.528 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteritis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid calcification | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | CSF monocyte count negative | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Suture insertion | 0 | 0 | 0.399 | 1 | 1.822 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular ejection fraction decreased | 0 | 0 | 0.077 | 1 | 2.814 |  |  |  |  |  | 
COVID19_JANSSEN | Dependence | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue neoplasm | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal operation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Renin increased | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Positive expiratory pressure therapy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Leser-Trelat sign | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Iris injury | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Internal injury | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis post transfusion | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide combining power decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Burkitt's lymphoma | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Brain tumour operation | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MM normal | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Blood beryllium increased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia | 0 | 0.001 | 0.133 | 1 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Rotavirus test negative | 0 | 0 | 0.008 | 1 | 3.651 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase | 0 | 0.002 | 0.429 | 1 | 1.764 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric disorder | 0 | 0 | 0.214 | 1 | 2.259 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccine breakthrough infection | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Occult blood | 0 | 0 | 0.124 | 1 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Breast tenderness | 0 | 0.001 | 0.322 | 1 | 1.98 |  |  |  |  |  | 
COVID19_JANSSEN | Joint hyperextension | 0 | 0 | 0.201 | 1 | 2.295 |  |  |  |  |  | 
COVID19_JANSSEN | Hyposmia | 0 | 0 | 0.002 | 1 | 4.005 |  |  |  |  |  | 
COVID19_JANSSEN | Apgar score low | 0 | 0 | 0 | 1 | 5.368 |  |  |  |  |  | 
COVID19_JANSSEN | Axonal neuropathy | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Depressive symptom | 0 | 0 | 0 | 1 | 5.742 |  |  |  |  |  | 
COVID19_JANSSEN | Self esteem decreased | 0 | 0 | 0.001 | 1 | 4.121 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial reperfusion injury | 0 | 0 | 0.086 | 1 | 2.764 |  |  |  |  |  | 
COVID19_JANSSEN | Cachexia | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Vibration test abnormal | 0 | 0 | 0.027 | 1 | 3.255 |  |  |  |  |  | 
COVID19_JANSSEN | Incarcerated inguinal hernia | 0 | 0 | 0.029 | 1 | 3.216 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body aspiration | 0 | 0 | 0.027 | 1 | 3.246 |  |  |  |  |  | 
COVID19_JANSSEN | Central vision loss | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_JANSSEN | Sexually transmitted disease | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary arterial pressure increased | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia necrotising | 0 | 0 | 0.006 | 1 | 3.733 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body in gastrointestinal tract | 0 | 0 | 0.041 | 1 | 3.089 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular hypertrophy | 0 | 0 | 0.003 | 1 | 3.905 |  |  |  |  |  | 
COVID19_JANSSEN | Osteopetrosis | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Non-high-density lipoprotein cholesterol | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic left ventricular failure | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract pain | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Skull malformation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Serum procollagen type III N-terminal propeptide | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Inspiratory capacity normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Immune complex level increased | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Gradenigo's syndrome | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Blast cell proliferation | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Groin pain | 0 | 0 | 0.228 | 1 | 2.216 |  |  |  |  |  | 
COVID19_JANSSEN | Hair growth abnormal | 0 | 0 | 0 | 1 | 4.817 |  |  |  |  |  | 
COVID19_JANSSEN | Quadriparesis | 0 | 0 | 0.007 | 1 | 3.699 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-thyroid antibody | 0 | 0 | 0.179 | 1 | 2.368 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal inflammation | 0 | 0 | 0.134 | 1 | 2.532 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle discomfort | 0 | 0 | 0.268 | 1 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Audiogram abnormal | 0 | 0.002 | 0.38 | 1 | 1.858 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin conjugated normal | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Otorrhoea | 0 | 0 | 0.108 | 1 | 2.645 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration pleural cavity | 0 | 0 | 0.128 | 1 | 2.559 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound pelvis | 0 | 0 | 0.013 | 1 | 3.495 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antigen positive | 0 | 0 | 0 | 1 | 5.567 |  |  |  |  |  | 
COVID19_JANSSEN | Skin turgor decreased | 0 | 0 | 0 | 1 | 4.428 |  |  |  |  |  | 
COVID19_JANSSEN | Blood luteinising hormone increased | 0 | 0 | 0 | 1 | 4.807 |  |  |  |  |  | 
COVID19_JANSSEN | Face and mouth X-ray | 0 | 0 | 0.001 | 1 | 4.178 |  |  |  |  |  | 
COVID19_JANSSEN | Fluid replacement | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_JANSSEN | Cystitis noninfective | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Vulval cancer | 0 | 0 | 0 | 1 | 5.804 |  |  |  |  |  | 
COVID19_JANSSEN | Echolalia | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product ineffective | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Poliovirus test negative | 0 | 0 | 0.029 | 1 | 3.217 |  |  |  |  |  | 
COVID19_JANSSEN | N-terminal prohormone brain natriuretic peptide | 0 | 0 | 0.01 | 1 | 3.583 |  |  |  |  |  | 
COVID19_JANSSEN | Transcranial electrical motor evoked potential monitoring | 0 | 0 | 0.031 | 1 | 3.203 |  |  |  |  |  | 
COVID19_JANSSEN | Ankle fracture | 0 | 0 | 0.141 | 1 | 2.504 |  |  |  |  |  | 
COVID19_JANSSEN | Sydenham's chorea | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Skin culture positive | 0 | 0 | 0.084 | 1 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Perfusion brain scan normal | 0 | 0 | 0.001 | 1 | 4.151 |  |  |  |  |  | 
COVID19_JANSSEN | Mevalonate kinase deficiency | 0 | 0 | 0.004 | 1 | 3.852 |  |  |  |  |  | 
COVID19_JANSSEN | Bursitis infective | 0 | 0 | 0.005 | 1 | 3.758 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cyst | 0 | 0 | 0.01 | 1 | 3.585 |  |  |  |  |  | 
COVID19_JANSSEN | Skin temperature | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_JANSSEN | Nephritic syndrome | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Heterotaxia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Genital erosion | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital hydrocephalus | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Tyrosinaemia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Truncus coeliacus thrombosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal oedema | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis california | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Electrogastrogram | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Dislocation of vertebra | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Cleft lip and palate | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell count decreased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate abnormal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis enteropathic | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Acid-base balance disorder mixed | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Type III immune complex mediated reaction | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Psoriasis | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Nitrite urine absent | 0 | 0 | 0.282 | 1 | 2.074 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue swelling | 0 | 0 | 0.146 | 1 | 2.484 |  |  |  |  |  | 
COVID19_JANSSEN | Liquid product physical issue | 0 | 0 | 0 | 1 | 5.073 |  |  |  |  |  | 
COVID19_JANSSEN | Application site pain | 0 | 0 | 0.005 | 1 | 3.774 |  |  |  |  |  | 
COVID19_JANSSEN | Eye injury | 0 | 0 | 0.019 | 1 | 3.377 |  |  |  |  |  | 
COVID19_JANSSEN | Wrist fracture | 0 | 0 | 0.108 | 1 | 2.648 |  |  |  |  |  | 
COVID19_JANSSEN | Sick relative | 0 | 0 | 0.019 | 1 | 3.367 |  |  |  |  |  | 
COVID19_JANSSEN | Retinitis viral | 0 | 0 | 0.096 | 1 | 2.706 |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system injury | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Scintillating scotoma | 0 | 0 | 0.122 | 1 | 2.583 |  |  |  |  |  | 
COVID19_JANSSEN | Ketosis | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy breast normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site dysaesthesia | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Febrile infection-related epilepsy syndrome | 0 | 0 | 0.038 | 1 | 3.121 |  |  |  |  |  | 
COVID19_JANSSEN | Enteroclysis | 0 | 0 | 0.009 | 1 | 3.615 |  |  |  |  |  | 
COVID19_JANSSEN | Drowning | 0 | 0 | 0 | 1 | 4.531 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal calprotectin normal | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound testes abnormal | 0 | 0 | 0 | 1 | 5.689 |  |  |  |  |  | 
COVID19_JANSSEN | Fraction of inspired oxygen | 0 | 0 | 0.187 | 1 | 2.342 |  |  |  |  |  | 
COVID19_JANSSEN | Astrovirus test positive | 0 | 0 | 0 | 1 | 5.434 |  |  |  |  |  | 
COVID19_JANSSEN | Terminal insomnia | 0 | 0 | 0.091 | 1 | 2.736 |  |  |  |  |  | 
COVID19_JANSSEN | Gynaecological examination normal | 0 | 0 | 0.022 | 1 | 3.329 |  |  |  |  |  | 
COVID19_JANSSEN | Excessive granulation tissue | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Bone cyst | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Spotted fever rickettsia test positive | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Palmoplantar pustulosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic granulomatous disease | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac malposition | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder operation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial therapeutic procedure | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein amniotic fluid | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Mucous stools | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_JANSSEN | Strabismus | 0 | 0 | 0.227 | 1 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | Frequent bowel movements | 0 | 0 | 0.097 | 1 | 2.701 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactic acid normal | 0 | 0.001 | 0.283 | 1 | 2.072 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic acidosis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Subcutaneous abscess | 0 | 0 | 0.299 | 1 | 2.034 |  |  |  |  |  | 
COVID19_JANSSEN | Acidosis | 0 | 0 | 0.161 | 1 | 2.428 |  |  |  |  |  | 
COVID19_JANSSEN | Scarlet fever | 0 | 0 | 0.002 | 1 | 4.066 |  |  |  |  |  | 
COVID19_JANSSEN | Mast cell activation syndrome | 0 | 0 | 0.001 | 1 | 4.255 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral palsy | 0 | 0 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_JANSSEN | Personality disorder | 0 | 0 | 0.009 | 1 | 3.607 |  |  |  |  |  | 
COVID19_JANSSEN | Lung assist device therapy | 0 | 0 | 0.002 | 1 | 4.037 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antibody | 0 | 0 | 0 | 1 | 4.493 |  |  |  |  |  | 
COVID19_JANSSEN | Hodgkin's disease | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Neck injury | 0 | 0 | 0.01 | 1 | 3.595 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal aspiration procedure | 0 | 0 | 0.007 | 1 | 3.678 |  |  |  |  |  | 
COVID19_JANSSEN | Onychomadesis | 0 | 0 | 0.156 | 1 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Skull X-ray abnormal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-Muellerian hormone level | 0 | 0 | 0.008 | 1 | 3.654 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral osteophyte | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Ulna fracture | 0 | 0 | 0.124 | 1 | 2.576 |  |  |  |  |  | 
COVID19_JANSSEN | Sigmoidoscopy | 0 | 0 | 0 | 1 | 4.407 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine renal clearance decreased | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus hyposecretion | 0 | 0 | 0.112 | 1 | 2.631 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus bronchitis | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia fungal | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Genital abscess | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Device use issue | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma stage III | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Blood luteinising hormone normal | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | ACTH stimulation test normal | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Trisomy 12 | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Reynold's syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell agglutination present | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic operation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal herpes | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin blood present | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperglycinaemia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Family stress | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Dermabrasion | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Dental implantation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Cows milk free diet | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure management | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial parotitis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiolipin antibody positive | 0 | 0 | 0.013 | 1 | 3.493 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella test | 0 | 0 | 0 | 1 | 5.8 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival blister | 0 | 0 | 0.032 | 1 | 3.191 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid pulse abnormal | 0 | 0 | 0.028 | 1 | 3.239 |  |  |  |  |  | 
COVID19_JANSSEN | Urine uric acid increased | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_JANSSEN | Radial pulse abnormal | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal injury | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hypoplasia | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_JANSSEN | Vulval haemorrhage | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular stent insertion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Thoracic outlet syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Term birth | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Silent myocardial infarction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Mutagenic effect | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to kidney | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST-T segment elevation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Dialysis efficacy test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood 1,25-dihydroxycholecalciferol decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Anorectal swelling | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Kawasaki's disease | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil count decreased | 0 | 0.001 | 0.198 | 1 | 2.304 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival pain | 0 | 0.001 | 0.253 | 1 | 2.149 |  |  |  |  |  | 
COVID19_JANSSEN | Myopathy | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney infection | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Amylase increased | 0 | 0 | 0.004 | 1 | 3.808 |  |  |  |  |  | 
COVID19_JANSSEN | Disseminated varicella zoster vaccine virus infection | 0 | 0 | 0 | 1 | 5.211 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic specific antigen increased | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia urinary tract infection | 0 | 0 | 0.22 | 1 | 2.239 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy upper gastrointestinal tract normal | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Enterococcus test positive | 0 | 0 | 0.026 | 1 | 3.267 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lymph gland | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Vein discolouration | 0 | 0 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination physical | 0 | 0 | 0.007 | 1 | 3.678 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram kidney abnormal | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site hypersensitivity | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Hand deformity | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Myelocyte present | 0 | 0 | 0 | 1 | 5.516 |  |  |  |  |  | 
COVID19_JANSSEN | ADAMTS13 activity decreased | 0 | 0 | 0 | 1 | 5.568 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell agglutination present | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic enzymes normal | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_JANSSEN | IIIrd nerve disorder | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Vena cava filter insertion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic granuloma | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Skin ulcer haemorrhage | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Posthaemorrhagic hydrocephalus | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Plastic surgery to the face | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lenticulostriatal vasculopathy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal malposition | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac index | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-saccharomyces cerevisiae antibody | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Plasmapheresis | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site inflammation | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_JANSSEN | Food refusal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Rubella | 0 | 0 | 0 | 1 | 5.382 |  |  |  |  |  | 
COVID19_JANSSEN | Palpable purpura | 0 | 0 | 0.01 | 1 | 3.572 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial wall thickening | 0 | 0 | 0.03 | 1 | 3.205 |  |  |  |  |  | 
COVID19_JANSSEN | Astigmatism | 0 | 0 | 0.006 | 1 | 3.723 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell abnormality | 0 | 0 | 0.17 | 1 | 2.399 |  |  |  |  |  | 
COVID19_JANSSEN | Intracranial infection | 0 | 0 | 0.002 | 1 | 3.98 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint warmth | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Hormone replacement therapy | 0 | 0 | 0 | 1 | 4.818 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroschisis | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose urine | 0 | 0 | 0.01 | 1 | 3.583 |  |  |  |  |  | 
COVID19_JANSSEN | Monomelic amyotrophy | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing disability | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Athetosis | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Viral load decreased | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site laceration | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Urethritis gonococcal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal thickening | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural haemorrhage | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Parathyroid tumour | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Myelocyte percentage increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Missed labour | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Dermoid cyst | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac ventriculogram normal | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Argon plasma coagulation | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial test negative | 0 | 0 | 0.173 | 1 | 2.388 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin urine | 0 | 0.001 | 0.237 | 1 | 2.192 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella zoster pneumonia | 0 | 0 | 0 | 1 | 5.434 |  |  |  |  |  | 
COVID19_JANSSEN | Subarachnoid haemorrhage | 0 | 0.001 | 0.245 | 1 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial drainage | 0 | 0 | 0.015 | 1 | 3.454 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholesterol | 0 | 0 | 0.136 | 1 | 2.525 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.128 | 1 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic granulomatosis with polyangiitis | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray dental abnormal | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Swallow study abnormal | 0 | 0 | 0.104 | 1 | 2.67 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropsychological test abnormal | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Embolism venous | 0 | 0 | 0 | 1 | 4.704 |  |  |  |  |  | 
COVID19_JANSSEN | Pleuropericarditis | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_JANSSEN | Menstrual discomfort | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Otosalpingitis | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic angioedema | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Fat tissue increased | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Complement fixation test positive | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Renal cortical necrosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal examination normal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Marcus Gunn syndrome | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant respiratory tract neoplasm | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Jaundice hepatocellular | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Intravascular papillary endothelial hyperplasia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | HTLV-1 test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix enlargement | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Breast neoplasm | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | B-cell lymphoma recurrent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor VIII antibody test | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrooesophageal reflux disease | 0 | 0.001 | 0.192 | 1 | 2.324 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle strain | 0 | 0 | 0.359 | 1 | 1.901 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophagocytic lymphohistiocytosis | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Skeletal injury | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocytes increased | 0 | 0 | 0 | 1 | 4.997 |  |  |  |  |  | 
COVID19_JANSSEN | Sensorimotor disorder | 0 | 0 | 0 | 1 | 4.468 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural vomiting | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant renal hypertension | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pyruvic acid normal | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal faeces | 0 | 0 | 0.158 | 1 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmological examination normal | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis | 0 | 0.001 | 0.096 | 1 | 2.704 |  |  |  |  |  | 
COVID19_JANSSEN | Lyme disease | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose urine present | 0 | 0 | 0.194 | 1 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Brucella test negative | 0 | 0 | 0.001 | 1 | 4.105 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal burning sensation | 0 | 0 | 0.137 | 1 | 2.522 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar exudate | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Optical coherence tomography | 0 | 0 | 0.013 | 1 | 3.509 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia test | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_JANSSEN | Male sexual dysfunction | 0 | 0 | 0.001 | 1 | 4.195 |  |  |  |  |  | 
COVID19_JANSSEN | Anorectal disorder | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time ratio decreased | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulins abnormal | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal exposure timing unspecified | 0 | 0 | 0.035 | 1 | 3.146 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C antibody | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Renal infarct | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Blood oestrogen | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic dissection | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Wound decomposition | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 test false negative | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal hypertrophy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple system atrophy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to central nervous system | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric artery aneurysm | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Keratitis viral | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Instillation site reaction | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Convalescent | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrovascular arteriovenous malformation | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Blood triglycerides decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thromboplastin abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 2 globulin increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood gases | 0 | 0.001 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Motor developmental delay | 0 | 0 | 0.009 | 1 | 3.601 |  |  |  |  |  | 
COVID19_JANSSEN | Lipase | 0 | 0.001 | 0.445 | 1 | 1.734 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal osteoarthritis | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Pupillary light reflex tests abnormal | 0 | 0 | 0.001 | 1 | 4.243 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic intracranial hypertension | 0 | 0 | 0.021 | 1 | 3.343 |  |  |  |  |  | 
COVID19_JANSSEN | Extraocular muscle paresis | 0 | 0 | 0.151 | 1 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site pustule | 0 | 0 | 0 | 1 | 4.921 |  |  |  |  |  | 
COVID19_JANSSEN | Infrequent bowel movements | 0 | 0 | 0.015 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | Deformity | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site scab | 0 | 0 | 0.005 | 1 | 3.795 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint discomfort | 0 | 0 | 0.14 | 1 | 2.511 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound eye abnormal | 0 | 0 | 0 | 1 | 4.444 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal pain | 0 | 0 | 0.106 | 1 | 2.658 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-abdominal fluid collection | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_JANSSEN | Haematocrit abnormal | 0 | 0 | 0.148 | 1 | 2.478 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet function test abnormal | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_JANSSEN | Leptospirosis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure abnormal | 0 | 0.002 | 0.52 | 1 | 1.607 |  |  |  |  |  | 
COVID19_JANSSEN | Juvenile idiopathic arthritis | 0 | 0 | 0.007 | 1 | 3.691 |  |  |  |  |  | 
COVID19_JANSSEN | Monoparesis | 0 | 0 | 0.001 | 1 | 4.135 |  |  |  |  |  | 
COVID19_JANSSEN | Atypical pneumonia | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Blood iron | 0 | 0 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_JANSSEN | Subglottic laryngitis | 0 | 0 | 0 | 1 | 5.436 |  |  |  |  |  | 
COVID19_JANSSEN | Concomitant disease aggravated | 0 | 0 | 0.002 | 1 | 4.049 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy kidney | 0 | 0 | 0.145 | 1 | 2.488 |  |  |  |  |  | 
COVID19_JANSSEN | Volvulus | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Erythroblast count | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_JANSSEN | Seborrhoeic keratosis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Shoulder deformity | 0 | 0 | 0 | 1 | 4.485 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose tolerance test | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Viral pericarditis | 0 | 0 | 0.007 | 1 | 3.685 |  |  |  |  |  | 
COVID19_JANSSEN | Hereditary neuropathy with liability to pressure palsies | 0 | 0 | 0 | 1 | 5.792 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder enlargement | 0 | 0 | 0.012 | 1 | 3.532 |  |  |  |  |  | 
COVID19_JANSSEN | Lichen striatus | 0 | 0 | 0.005 | 1 | 3.775 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid neoplasm | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic response changed | 0 | 0 | 0.014 | 1 | 3.468 |  |  |  |  |  | 
COVID19_JANSSEN | Rapid eye movement sleep behaviour disorder | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Precancerous condition | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Hypermagnesaemia | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased nasolabial fold | 0 | 0 | 0.02 | 1 | 3.364 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital hand malformation | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Chondrocalcinosis | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary catheter insertion | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Stomatococcal infection | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenitis viral | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Janus kinase 2 mutation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal transit time increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | HTLV-2 test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-HLA antibody test positive | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Acute haemorrhagic conjunctivitis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Acanthosis nigricans | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte count increased | 0 | 0 | 0.029 | 1 | 3.221 |  |  |  |  |  | 
COVID19_JANSSEN | Narcolepsy | 0 | 0 | 0 | 1 | 5.085 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle atrophy | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular pressure increased | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Colectomy | 0 | 0 | 0.001 | 1 | 4.273 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral ischaemia | 0 | 0 | 0.218 | 1 | 2.247 |  |  |  |  |  | 
COVID19_JANSSEN | Loop electrosurgical excision procedure | 0 | 0 | 0 | 1 | 5.82 |  |  |  |  |  | 
COVID19_JANSSEN | Bursa disorder | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_JANSSEN | Product expiration date issue | 0 | 0 | 0 | 1 | 4.941 |  |  |  |  |  | 
COVID19_JANSSEN | Wound complication | 0 | 0 | 0.123 | 1 | 2.579 |  |  |  |  |  | 
COVID19_JANSSEN | Change of bowel habit | 0 | 0 | 0.032 | 1 | 3.189 |  |  |  |  |  | 
COVID19_JANSSEN | Application site cellulitis | 0 | 0 | 0 | 1 | 4.303 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid white blood cells positive | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary bladder haemorrhage | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocytes abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatinine abnormal | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Venipuncture | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_JANSSEN | Tarsal tunnel syndrome | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Starvation | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell count abnormal | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc operation | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site pain | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoaesthesia teeth | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol interaction | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site vesicles | 0 | 0 | 0.082 | 1 | 2.787 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular neoplasm | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid hormones decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired epidermolysis bullosa | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Trigeminal nerve paresis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Subretinal hyperreflective exudation | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Orthostatic heart rate response increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal transit time abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin resistant diabetes | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital pneumonia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system stimulation | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Carbohydrate deficient transferrin test | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Bacille Calmette-Guerin scar reactivation | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoiditis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccine positive rechallenge | 0 | 0 | 0.018 | 1 | 3.384 |  |  |  |  |  | 
COVID19_JANSSEN | Adverse reaction | 0 | 0.001 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_JANSSEN | Acne | 0 | 0 | 0.097 | 1 | 2.701 |  |  |  |  |  | 
COVID19_JANSSEN | Circumstance or information capable of leading to medication error | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy skin | 0 | 0 | 0.031 | 1 | 3.202 |  |  |  |  |  | 
COVID19_JANSSEN | Product supply issue | 0 | 0 | 0 | 1 | 5.774 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis | 0 | 0.001 | 0.156 | 1 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Glycosylated haemoglobin normal | 0 | 0 | 0.354 | 1 | 1.912 |  |  |  |  |  | 
COVID19_JANSSEN | Mastication disorder | 0 | 0.001 | 0.421 | 1 | 1.779 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal sensation in eye | 0 | 0.001 | 0.337 | 1 | 1.947 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital biliary disorders (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.733 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinitis allergic | 0 | 0 | 0.122 | 1 | 2.585 |  |  |  |  |  | 
COVID19_JANSSEN | Detoxification | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid disorder | 0 | 0.001 | 0.365 | 1 | 1.89 |  |  |  |  |  | 
COVID19_JANSSEN | Micturition disorder | 0 | 0 | 0.193 | 1 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopnoea | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells stool positive | 0 | 0 | 0.004 | 1 | 3.81 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to chemicals | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal hypomotility | 0 | 0 | 0.132 | 1 | 2.542 |  |  |  |  |  | 
COVID19_JANSSEN | Face and mouth X-ray abnormal | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival oedema | 0 | 0 | 0.179 | 1 | 2.368 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema infantile | 0 | 0 | 0.002 | 1 | 4 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal lesion | 0 | 0 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal resection | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Blood corticotrophin | 0 | 0 | 0.136 | 1 | 2.526 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-ganglioside antibody | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Very low density lipoprotein normal | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Skin fragility | 0 | 0 | 0.012 | 1 | 3.514 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral discolouration | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Oestradiol normal | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_JANSSEN | Neurosarcoidosis | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Echo virus infection | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine urine normal | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic hepatitis C | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropsychiatric lupus | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Blood insulin | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal effusion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal injury | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Instillation site pain | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Fallot's tetralogy | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Essential thrombocythaemia | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Brucella test positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site abscess | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Acute oesophageal mucosal lesion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal erosion | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_JANSSEN | Persistent depressive disorder | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Product dispensing error | 0 | 0 | 0.095 | 1 | 2.714 |  |  |  |  |  | 
COVID19_JANSSEN | Visual evoked potentials abnormal | 0 | 0 | 0 | 1 | 4.912 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis Japanese B | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Lung transplant | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Mouth injury | 0 | 0 | 0.188 | 1 | 2.337 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes pharyngitis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Candida infection | 0 | 0 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_JANSSEN | Genital haemorrhage | 0 | 0 | 0 | 1 | 5.74 |  |  |  |  |  | 
COVID19_JANSSEN | Chlamydia test | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_JANSSEN | Rhesus antigen positive | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal flattening | 0 | 0 | 0.033 | 1 | 3.175 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-islet cell antibody positive | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Upper gastrointestinal haemorrhage | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal insufficiency | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive urgency | 0 | 0 | 0.002 | 1 | 4.043 |  |  |  |  |  | 
COVID19_JANSSEN | Chorioretinal scar | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Urogram abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Device function test | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Steatorrhoea | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess neck | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic ketosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast upper gastrointestinal tract abnormal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Iatrogenic infection | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatobiliary sphincterotomy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body in respiratory tract | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Multimorbidity | 0 | 0 | 0.03 | 1 | 3.216 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system lesion | 0 | 0 | 0.134 | 1 | 2.531 |  |  |  |  |  | 
COVID19_JANSSEN | Perineurial cyst | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Myelitis transverse | 0 | 0.001 | 0.244 | 1 | 2.172 |  |  |  |  |  | 
COVID19_JANSSEN | Retinoschisis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Plantar fasciitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Amniocentesis normal | 0 | 0 | 0 | 1 | 5.673 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary amyloidosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cytology | 0 | 0 | 0.15 | 1 | 2.472 |  |  |  |  |  | 
COVID19_JANSSEN | Female orgasmic disorder | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis chronic | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site pain | 0 | 0 | 0.267 | 1 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Suture related complication | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Citrobacter test positive | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral infarction | 0 | 0.001 | 0.259 | 1 | 2.132 |  |  |  |  |  | 
COVID19_JANSSEN | Pupil fixed | 0 | 0 | 0.23 | 1 | 2.212 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngitis | 0 | 0 | 0.148 | 1 | 2.476 |  |  |  |  |  | 
COVID19_JANSSEN | Iliac artery disease | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Systolic dysfunction | 0 | 0 | 0.012 | 1 | 3.521 |  |  |  |  |  | 
COVID19_JANSSEN | Passive smoking | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrohepatorenal syndrome | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Confluent and reticulate papillomatosis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Haematological tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Atonic seizures | 0 | 0 | 0 | 1 | 4.793 |  |  |  |  |  | 
COVID19_JANSSEN | Hemihypertrophy | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombophlebitis | 0 | 0 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral meatus stenosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomononucleosis | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | CSF cell count decreased | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_JANSSEN | Poor personal hygiene | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte stimulation test | 0 | 0 | 0 | 1 | 4.764 |  |  |  |  |  | 
COVID19_JANSSEN | Trabeculectomy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Sigmoidoscopy abnormal | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Selective IgG subclass deficiency | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosa biopsy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Lasegue's test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | International normalised ratio fluctuation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothenar hammer syndrome | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrectomy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Forced expiratory flow | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Chromosome banding normal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | CSF myelin basic protein abnormal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy vocal cord abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertransaminasaemia | 0 | 0 | 0.095 | 1 | 2.712 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomembranous colitis (SMQ) [narrow] | 0 | 0 | 0.34 | 1 | 1.942 |  |  |  |  |  | 
COVID19_JANSSEN | Bordetella infection | 0 | 0 | 0 | 1 | 4.395 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy soft tissue | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue neoplasm malignant stage unspecified | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Venous ligation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal bacterial overgrowth | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Posterior reversible encephalopathy syndrome | 0 | 0 | 0.037 | 1 | 3.125 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoventilation | 0 | 0 | 0.026 | 1 | 3.263 |  |  |  |  |  | 
COVID19_JANSSEN | Penile discharge | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_JANSSEN | Lung neoplasm surgery | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral mass effect | 0 | 0 | 0.001 | 1 | 4.085 |  |  |  |  |  | 
COVID19_JANSSEN | Colectomy total | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Urine potassium decreased | 0 | 0 | 0 | 1 | 5.722 |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube patulous | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Sexual transmission of infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Risus sardonicus | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site cellulitis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Aggression | 0 | 0 | 0.284 | 1 | 2.071 |  |  |  |  |  | 
COVID19_JANSSEN | Ear infection staphylococcal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcium abnormal | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Osteogenesis imperfecta | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral haemorrhage | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic diathesis | 0 | 0 | 0 | 1 | 5.367 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoperitoneum | 0 | 0 | 0.008 | 1 | 3.636 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal viral infection | 0 | 0 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_JANSSEN | Orbital infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Sweating fever | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast | 0 | 0 | 0.119 | 1 | 2.598 |  |  |  |  |  | 
COVID19_JANSSEN | Stasis dermatitis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding time abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | CDKL5 deficiency disorder | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Negative thoughts | 0 | 0 | 0.005 | 1 | 3.758 |  |  |  |  |  | 
COVID19_JANSSEN | Radiculopathy | 0 | 0 | 0.136 | 1 | 2.526 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis | 0 | 0.001 | 0.393 | 1 | 1.833 |  |  |  |  |  | 
COVID19_JANSSEN | Disseminated cytomegaloviral infection | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Preterm premature rupture of membranes | 0 | 0 | 0 | 1 | 4.743 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle tone disorder | 0 | 0 | 0 | 1 | 4.588 |  |  |  |  |  | 
COVID19_JANSSEN | Incisional drainage | 0 | 0 | 0.231 | 1 | 2.209 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site papule | 0 | 0 | 0.254 | 1 | 2.146 |  |  |  |  |  | 
COVID19_JANSSEN | Renin | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital haemorrhage | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Somatosensory evoked potentials abnormal | 0 | 0 | 0.001 | 1 | 4.119 |  |  |  |  |  | 
COVID19_JANSSEN | Cystitis haemorrhagic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Electrolyte imbalance | 0 | 0 | 0 | 1 | 4.341 |  |  |  |  |  | 
COVID19_JANSSEN | Intracardiac mass | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital vesicoureteric reflux | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound urinary system | 0 | 0 | 0.038 | 1 | 3.118 |  |  |  |  |  | 
COVID19_JANSSEN | Natural killer cell count decreased | 0 | 0 | 0.02 | 1 | 3.357 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall oedema | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Bedridden | 0 | 0 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_JANSSEN | Antineutrophil cytoplasmic antibody negative | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Frustration tolerance decreased | 0 | 0 | 0.227 | 1 | 2.22 |  |  |  |  |  | 
COVID19_JANSSEN | Gross motor delay | 0 | 0 | 0.027 | 1 | 3.25 |  |  |  |  |  | 
COVID19_JANSSEN | Renal transplant | 0 | 0 | 0.026 | 1 | 3.26 |  |  |  |  |  | 
COVID19_JANSSEN | Underweight | 0 | 0 | 0.002 | 1 | 3.958 |  |  |  |  |  | 
COVID19_JANSSEN | Radicular pain | 0 | 0 | 0.162 | 1 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Antimicrobial susceptibility test | 0 | 0 | 0.004 | 1 | 3.838 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve stimulation test normal | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic necrosis | 0 | 0 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem infarction | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Vasospasm | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Joint ankylosis | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Sigmoidoscopy normal | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-muscle specific kinase antibody negative | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Angioscopy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Wound abscess | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Unemployment | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Transposition of the great vessels | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Porphyria non-acute | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Nitrituria | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal haemoglobin | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Detrusor sphincter dyssynergia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour markers (SMQ) [broad] | 0 | 0 | 0.029 | 1 | 3.221 |  |  |  |  |  | 
COVID19_JANSSEN | DNA antibody negative | 0 | 0 | 0.001 | 1 | 4.214 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatomyositis | 0 | 0 | 0.001 | 1 | 4.245 |  |  |  |  |  | 
COVID19_JANSSEN | Wound treatment | 0 | 0 | 0.144 | 1 | 2.492 |  |  |  |  |  | 
COVID19_JANSSEN | Asocial behaviour | 0 | 0 | 0.001 | 1 | 4.166 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B core antigen | 0 | 0 | 0 | 1 | 5.825 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin blood | 0 | 0 | 0.107 | 1 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Wound closure | 0 | 0 | 0.124 | 1 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar radiculopathy | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Mastocytosis | 0 | 0 | 0.018 | 1 | 3.392 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound testes | 0 | 0 | 0.002 | 1 | 3.959 |  |  |  |  |  | 
COVID19_JANSSEN | Adnexal torsion | 0 | 0 | 0.001 | 1 | 4.27 |  |  |  |  |  | 
COVID19_JANSSEN | Tissue infiltration | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal perivascular sheathing | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney enlargement | 0 | 0 | 0.101 | 1 | 2.684 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound uterus normal | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Systolic hypertension | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Quantitative sudomotor axon reflex test | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Monoclonal immunoglobulin present | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_JANSSEN | Koebner phenomenon | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Diffuse alveolar damage | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Arachnoiditis | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Vital dye staining cornea absent | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine leiomyoma embolisation | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Romberg test | 0 | 0 | 0.015 | 1 | 3.445 |  |  |  |  |  | 
COVID19_JANSSEN | Epiglottic oedema | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystitis infective | 0 | 0 | 0.006 | 1 | 3.709 |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination microbial | 0 | 0 | 0 | 1 | 4.478 |  |  |  |  |  | 
COVID19_JANSSEN | Embolism | 0 | 0 | 0.012 | 1 | 3.536 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular dementia | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_JANSSEN | Paraneoplastic syndrome | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral column mass | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Ulnar nerve injury | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_JANSSEN | Dupuytren's contracture | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Angiomyolipoma | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Type IIa hyperlipidaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Rash maculovesicular | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Proctitis ulcerative | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Jugular vein distension | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid thickening | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Endometrial ablation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic foetopathy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Mental disorder | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_JANSSEN | Acupuncture | 0 | 0 | 0.105 | 1 | 2.662 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue discolouration | 0 | 0 | 0.294 | 1 | 2.046 |  |  |  |  |  | 
COVID19_JANSSEN | Blood heavy metal test | 0 | 0 | 0.024 | 1 | 3.293 |  |  |  |  |  | 
COVID19_JANSSEN | Campylobacter test positive | 0 | 0 | 0.005 | 1 | 3.792 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological decompensation | 0 | 0 | 0.005 | 1 | 3.791 |  |  |  |  |  | 
COVID19_JANSSEN | Radial nerve palsy | 0 | 0 | 0.004 | 1 | 3.84 |  |  |  |  |  | 
COVID19_JANSSEN | Wound infection | 0 | 0 | 0.011 | 1 | 3.545 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperaesthesia teeth | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammatory marker decreased | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanic membrane disorder | 0 | 0 | 0.134 | 1 | 2.531 |  |  |  |  |  | 
COVID19_JANSSEN | Alanine aminotransferase decreased | 0 | 0 | 0.001 | 1 | 4.256 |  |  |  |  |  | 
COVID19_JANSSEN | Body fluid analysis | 0 | 0 | 0.108 | 1 | 2.646 |  |  |  |  |  | 
COVID19_JANSSEN | Plicated tongue | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Antisocial behaviour | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure chronic | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Blood copper normal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary vascular disorder | 0 | 0 | 0.012 | 1 | 3.523 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site odour | 0 | 0 | 0.032 | 1 | 3.182 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal aspirate culture | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep disorder due to a general medical condition | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Peptostreptococcus infection | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Mediastinal disorder | 0 | 0 | 0.086 | 1 | 2.764 |  |  |  |  |  | 
COVID19_JANSSEN | Histiocytic necrotising lymphadenitis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex reactivation | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | CSF electrophoresis abnormal | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Superior mesenteric artery syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Sucrose intolerance | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid vasculitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic dysplasia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cells present | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | PUVA | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | PCO2 abnormal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Manipulation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Jaundice acholuric | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Human anaplasmosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema asteatotic | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital thrombocyte disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | CD25 antigen positive | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Blue toe syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Blood albumin abnormal | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenomegaly | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Tendonitis | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Glaucoma (SMQ) [narrow] | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus discomfort | 0 | 0.002 | 0.294 | 1 | 2.046 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep apnoea syndrome | 0 | 0 | 0.033 | 1 | 3.172 |  |  |  |  |  | 
COVID19_JANSSEN | Cyst | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Blood count | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Blood potassium | 0 | 0.001 | 0.246 | 1 | 2.167 |  |  |  |  |  | 
COVID19_JANSSEN | Iron deficiency anaemia | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus arrhythmia | 0 | 0.001 | 0.241 | 1 | 2.181 |  |  |  |  |  | 
COVID19_JANSSEN | Skin premalignant disorders (SMQ) [broad] | 0 | 0 | 0.015 | 1 | 3.446 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetes insipidus | 0 | 0 | 0.004 | 1 | 3.846 |  |  |  |  |  | 
COVID19_JANSSEN | Hangover | 0 | 0 | 0.174 | 1 | 2.383 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin saturation decreased | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion missed | 0 | 0 | 0.095 | 1 | 2.713 |  |  |  |  |  | 
COVID19_JANSSEN | Endodontic procedure | 0 | 0 | 0.018 | 1 | 3.396 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy intestine abnormal | 0 | 0 | 0.005 | 1 | 3.755 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic venous thrombosis | 0 | 0 | 0.002 | 1 | 4.043 |  |  |  |  |  | 
COVID19_JANSSEN | Monoclonal gammopathy | 0 | 0 | 0 | 1 | 4.804 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular migraine | 0 | 0 | 0.02 | 1 | 3.348 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal intussusception reduction | 0 | 0 | 0 | 1 | 5.002 |  |  |  |  |  | 
COVID19_JANSSEN | Light chain analysis normal | 0 | 0 | 0.002 | 1 | 3.988 |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube obstruction | 0 | 0 | 0.129 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Labour complication | 0 | 0 | 0.095 | 1 | 2.712 |  |  |  |  |  | 
COVID19_JANSSEN | Antithrombin III increased | 0 | 0 | 0.015 | 1 | 3.461 |  |  |  |  |  | 
COVID19_JANSSEN | NIH stroke scale score increased | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal pseudo-obstruction | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Frostbite | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia bacteraemia | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | CSF pressure | 0 | 0 | 0.009 | 1 | 3.602 |  |  |  |  |  | 
COVID19_JANSSEN | Acne infantile | 0 | 0 | 0.035 | 1 | 3.154 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 absorption test normal | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Purulent pericarditis | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Polydactyly | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-VGKC antibody positive | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvitis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid stimulating immunoglobulin increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Thoracotomy | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Nikolsky's sign | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mitogen stimulation test | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Infective tenosynovitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hypergammaglobulinaemia benign monoclonal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Expanded disability status scale | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatophagia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | CSF neutrophil count positive | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Acute graft versus host disease in skin | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Extrasystoles | 0 | 0.001 | 0.263 | 1 | 2.123 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin A increased | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Plateletcrit | 0 | 0 | 0.002 | 1 | 4.034 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow transplant | 0 | 0 | 0 | 1 | 4.332 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopaedic examination abnormal | 0 | 0 | 0.135 | 1 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Craniotomy | 0 | 0 | 0.091 | 1 | 2.736 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue spasm | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal skin infection | 0 | 0 | 0.01 | 1 | 3.569 |  |  |  |  |  | 
COVID19_JANSSEN | Blood testosterone normal | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_JANSSEN | Reversible cerebral vasoconstriction syndrome | 0 | 0 | 0.08 | 1 | 2.797 |  |  |  |  |  | 
COVID19_JANSSEN | Reaction to food additive | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_JANSSEN | Anal erythema | 0 | 0 | 0.001 | 1 | 4.228 |  |  |  |  |  | 
COVID19_JANSSEN | Urine nitrogen | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic cyst | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic calcification | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrophy of tongue papillae | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis rapidly progressive | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valve stenosis | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Analgesic drug level decreased | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Aerophagia | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells stool | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint infection | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteral stent insertion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Sternal injury | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal discomfort | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin C-peptide normal | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QRS complex shortened | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Cholestasis of pregnancy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Blood acid phosphatase decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Artificial rupture of membranes | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Application site pallor | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Viral rash | 0 | 0 | 0.18 | 1 | 2.364 |  |  |  |  |  | 
COVID19_JANSSEN | Lip erythema | 0 | 0 | 0.107 | 1 | 2.654 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal test negative | 0 | 0 | 0.269 | 1 | 2.108 |  |  |  |  |  | 
COVID19_JANSSEN | Immunosuppression | 0 | 0 | 0.238 | 1 | 2.189 |  |  |  |  |  | 
COVID19_JANSSEN | Epicondylitis | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Behcet's syndrome | 0 | 0 | 0.019 | 1 | 3.369 |  |  |  |  |  | 
COVID19_JANSSEN | Tryptase increased | 0 | 0 | 0.012 | 1 | 3.53 |  |  |  |  |  | 
COVID19_JANSSEN | Tandem gait test abnormal | 0 | 0 | 0 | 1 | 4.711 |  |  |  |  |  | 
COVID19_JANSSEN | Parasitic blood test negative | 0 | 0 | 0.004 | 1 | 3.839 |  |  |  |  |  | 
COVID19_JANSSEN | Hypohidrosis | 0 | 0 | 0.084 | 1 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance neurography | 0 | 0 | 0.005 | 1 | 3.788 |  |  |  |  |  | 
COVID19_JANSSEN | Bandaemia | 0 | 0 | 0.191 | 1 | 2.328 |  |  |  |  |  | 
COVID19_JANSSEN | Arthrogram | 0 | 0 | 0 | 1 | 4.918 |  |  |  |  |  | 
COVID19_JANSSEN | Adenocarcinoma | 0 | 0 | 0 | 1 | 4.391 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Acute vestibular syndrome | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Progressive multifocal leukoencephalopathy | 0 | 0 | 0.007 | 1 | 3.666 |  |  |  |  |  | 
COVID19_JANSSEN | Internal capsule infarction | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic disorders specifically reported as alcohol-related (SMQ) [broad] | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor VIII antibody negative | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Sulcus vocalis | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Peroneal nerve injury | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Neuromuscular toxicity | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Nail ridging | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Goodpasture's syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal damage | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Erythropenia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | End stage AIDS | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VIII level | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Clotting factor transfusion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial tracheitis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Amimia | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol test positive | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Scan bone marrow normal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Legal problem | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Face presentation | 0 | 0 | 0.004 | 1 | 3.833 |  |  |  |  |  | 
COVID19_JANSSEN | Body mass index | 0 | 0 | 0.014 | 1 | 3.464 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord injury cervical | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Osteonecrosis of jaw | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngitis allergic | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E antigen positive | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Haemothorax | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Giardiasis | 0 | 0 | 0.04 | 1 | 3.102 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram kidney normal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Urine aluminium | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Rhesus antibodies positive | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil hypersegmented morphology present | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary disease | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Altered state of consciousness | 0 | 0 | 0.187 | 1 | 2.341 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic enzyme increased | 0 | 0.001 | 0.254 | 1 | 2.145 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune thyroiditis | 0 | 0 | 0.007 | 1 | 3.674 |  |  |  |  |  | 
COVID19_JANSSEN | Injury associated with device | 0 | 0 | 0.024 | 1 | 3.299 |  |  |  |  |  | 
COVID19_JANSSEN | Clostridium test negative | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Toxicologic test normal | 0 | 0.001 | 0.324 | 1 | 1.977 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound skull abnormal | 0 | 0 | 0 | 1 | 4.313 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine | 0 | 0 | 0.268 | 1 | 2.109 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine decreased | 0 | 0 | 0.013 | 1 | 3.492 |  |  |  |  |  | 
COVID19_JANSSEN | Blast cells present | 0 | 0 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis infected | 0 | 0 | 0.005 | 1 | 3.791 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor V level normal | 0 | 0 | 0 | 1 | 4.681 |  |  |  |  |  | 
COVID19_JANSSEN | Increased viscosity of bronchial secretion | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin abnormal | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Intraventricular haemorrhage neonatal | 0 | 0 | 0 | 1 | 5.549 |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine ophthalmopathy | 0 | 0 | 0.037 | 1 | 3.126 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C4 increased | 0 | 0 | 0.041 | 1 | 3.093 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy artery | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_JANSSEN | Bacteriuria | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Renal vasculitis | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Perfusion brain scan abnormal | 0 | 0 | 0.01 | 1 | 3.585 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-platelet antibody | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid operation | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal cyst | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic gastroenteritis | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Venous bruit | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Terminal ileitis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Psychogenic respiratory distress | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Imaging procedure artifact | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Dystonic tremor | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular autonomic function test abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy vagina abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenergic syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Prenatal screening test | 0 | 0 | 0 | 1 | 5.455 |  |  |  |  |  | 
COVID19_JANSSEN | HLA marker study | 0 | 0 | 0 | 1 | 5.601 |  |  |  |  |  | 
COVID19_JANSSEN | Tubulointerstitial nephritis | 0 | 0 | 0.027 | 1 | 3.244 |  |  |  |  |  | 
COVID19_JANSSEN | Rubber sensitivity | 0 | 0 | 0.161 | 1 | 2.429 |  |  |  |  |  | 
COVID19_JANSSEN | Otitis externa | 0 | 0 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | Occipital neuralgia | 0 | 0 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_JANSSEN | Osteoporosis | 0 | 0 | 0.192 | 1 | 2.327 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site inflammation | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy stomach abnormal | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Haematological malignant tumours (SMQ) [broad] | 0 | 0 | 0.242 | 1 | 2.179 |  |  |  |  |  | 
COVID19_JANSSEN | Circulatory collapse | 0 | 0 | 0.025 | 1 | 3.273 |  |  |  |  |  | 
COVID19_JANSSEN | Breast pain | 0 | 0.003 | 0.484 | 1 | 1.666 |  |  |  |  |  | 
COVID19_JANSSEN | Nuchal rigidity | 0 | 0 | 0.019 | 1 | 3.367 |  |  |  |  |  | 
COVID19_JANSSEN | Suicide attempt | 0 | 0 | 0 | 1 | 4.852 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia streptococcal | 0 | 0 | 0 | 1 | 5.356 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body sensation in eyes | 0 | 0 | 0.263 | 1 | 2.123 |  |  |  |  |  | 
COVID19_JANSSEN | Pupils unequal | 0 | 0 | 0.09 | 1 | 2.742 |  |  |  |  |  | 
COVID19_JANSSEN | Pemphigus | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Lid sulcus deepened | 0 | 0 | 0.112 | 1 | 2.627 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function test decreased | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_JANSSEN | Extrapyramidal disorder | 0 | 0 | 0.226 | 1 | 2.224 |  |  |  |  |  | 
COVID19_JANSSEN | Angioplasty | 0 | 0 | 0.189 | 1 | 2.335 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar disorder | 0 | 0 | 0.139 | 1 | 2.511 |  |  |  |  |  | 
COVID19_JANSSEN | Postictal paralysis | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Atrioventricular block complete | 0 | 0 | 0.089 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy artery normal | 0 | 0 | 0 | 1 | 5.197 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural pain | 0 | 0 | 0.184 | 1 | 2.351 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory alkalosis | 0 | 0 | 0 | 1 | 5.206 |  |  |  |  |  | 
COVID19_JANSSEN | Cyanosis neonatal | 0 | 0 | 0.018 | 1 | 3.394 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac electrophysiologic study normal | 0 | 0 | 0.003 | 1 | 3.876 |  |  |  |  |  | 
COVID19_JANSSEN | West Nile viral infection | 0 | 0 | 0 | 1 | 4.332 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body | 0 | 0 | 0.035 | 1 | 3.146 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial strain | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Fasting | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin increased | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram | 0 | 0 | 0.105 | 1 | 2.664 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy prostate abnormal | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Benign breast neoplasm | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary assistance device user | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary artery atresia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy with young maternal age | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Phimosis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic vein thrombosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Mentally late developer | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric perforation | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Compulsive handwashing | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure systolic normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Blood loss anaemia | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | BK polyomavirus test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-IA2 antibody negative | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal disorders (SMQ) [broad] | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella virus test positive | 0 | 0 | 0.007 | 1 | 3.691 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic response unexpected | 0 | 0 | 0.007 | 1 | 3.7 |  |  |  |  |  | 
COVID19_JANSSEN | Trigeminal neuralgia | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Mononucleosis heterophile test | 0 | 0 | 0.318 | 1 | 1.991 |  |  |  |  |  | 
COVID19_JANSSEN | Varicose vein | 0 | 0 | 0.017 | 1 | 3.41 |  |  |  |  |  | 
COVID19_JANSSEN | Upper limb fracture | 0 | 0 | 0.211 | 1 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Lupus nephritis | 0 | 0 | 0 | 1 | 4.906 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal operation | 0 | 0 | 0.004 | 1 | 3.866 |  |  |  |  |  | 
COVID19_JANSSEN | Arnold-Chiari malformation | 0 | 0 | 0 | 1 | 4.607 |  |  |  |  |  | 
COVID19_JANSSEN | Osteolysis | 0 | 0 | 0.001 | 1 | 4.106 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil count abnormal | 0 | 0 | 0.142 | 1 | 2.502 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum normal | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic artery thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site reaction | 0 | 0 | 0.17 | 1 | 2.398 |  |  |  |  |  | 
COVID19_JANSSEN | Mean arterial pressure decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Suicidal behaviour | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy pericardium abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time ratio | 0 | 0 | 0 | 1 | 4.797 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site erosion | 0 | 0 | 0.174 | 1 | 2.384 |  |  |  |  |  | 
COVID19_JANSSEN | Embolia cutis medicamentosa | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [narrow] | 0 | 0 | 0 | 1 | 4.948 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchitis viral | 0 | 0 | 0.077 | 1 | 2.812 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament rupture | 0 | 0 | 0.153 | 1 | 2.461 |  |  |  |  |  | 
COVID19_JANSSEN | Iritis | 0 | 0 | 0.013 | 1 | 3.487 |  |  |  |  |  | 
COVID19_JANSSEN | Ingrown hair | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell analysis | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Epiglottitis haemophilus | 0 | 0 | 0 | 1 | 5.815 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-aquaporin-4 antibody negative | 0 | 0 | 0 | 1 | 5.214 |  |  |  |  |  | 
COVID19_JANSSEN | Lipase decreased | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired healing | 0 | 0 | 0.105 | 1 | 2.662 |  |  |  |  |  | 
COVID19_JANSSEN | Patient elopement | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid irritation | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Expanded disability status scale score increased | 0 | 0 | 0 | 1 | 5.663 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet-large cell ratio | 0 | 0 | 0 | 1 | 4.346 |  |  |  |  |  | 
COVID19_JANSSEN | Left-handedness | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | IVth nerve paresis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal pain | 0 | 0 | 0.007 | 1 | 3.679 |  |  |  |  |  | 
COVID19_JANSSEN | Live birth | 0 | 0 | 0.001 | 1 | 4.216 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular dilatation | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Milk allergy | 0 | 0 | 0.078 | 1 | 2.811 |  |  |  |  |  | 
COVID19_JANSSEN | Liver malignant tumours (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.255 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein A-I | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcus test | 0 | 0 | 0.168 | 1 | 2.404 |  |  |  |  |  | 
COVID19_JANSSEN | Depression suicidal | 0 | 0 | 0 | 1 | 5.019 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation | 0 | 0.002 | 0.361 | 1 | 1.897 |  |  |  |  |  | 
COVID19_JANSSEN | Apnoeic attack | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Gene mutation identification test positive | 0 | 0 | 0.142 | 1 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Audiogram | 0 | 0.001 | 0.365 | 1 | 1.888 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lung abnormal | 0 | 0 | 0 | 1 | 4.791 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial disorder | 0 | 0 | 0.016 | 1 | 3.441 |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve paralysis | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-transglutaminase antibody | 0 | 0 | 0.002 | 1 | 4 |  |  |  |  |  | 
COVID19_JANSSEN | Stress at work | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | IL-2 receptor assay | 0 | 0 | 0.127 | 1 | 2.562 |  |  |  |  |  | 
COVID19_JANSSEN | Disease susceptibility | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Enterobacter infection | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Subacute inflammatory demyelinating polyneuropathy | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract haemorrhage | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Myelofibrosis | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E | 0 | 0 | 0.001 | 1 | 4.094 |  |  |  |  |  | 
COVID19_JANSSEN | Familial mediterranean fever | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Cleft lip | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Stiff leg syndrome | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial fibrosis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Instillation site vesicles | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperlactacidaemia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Genotype drug resistance test | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Exocrine pancreatic function test normal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Breathing-related sleep disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site irritation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenalectomy | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet count | 0 | 0.002 | 0.38 | 1 | 1.858 |  |  |  |  |  | 
COVID19_JANSSEN | Localised infection | 0 | 0 | 0.105 | 1 | 2.661 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte morphology abnormal | 0 | 0 | 0 | 1 | 4.354 |  |  |  |  |  | 
COVID19_JANSSEN | Life support | 0 | 0.001 | 0.185 | 1 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatic disorder | 0 | 0 | 0.099 | 1 | 2.69 |  |  |  |  |  | 
COVID19_JANSSEN | Amyotrophic lateral sclerosis | 0 | 0 | 0 | 1 | 4.435 |  |  |  |  |  | 
COVID19_JANSSEN | Protein urine | 0 | 0 | 0.227 | 1 | 2.22 |  |  |  |  |  | 
COVID19_JANSSEN | Psychomotor retardation | 0 | 0 | 0 | 1 | 4.443 |  |  |  |  |  | 
COVID19_JANSSEN | Empyema | 0 | 0 | 0 | 1 | 5.732 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy upper gastrointestinal tract abnormal | 0 | 0 | 0.137 | 1 | 2.521 |  |  |  |  |  | 
COVID19_JANSSEN | Brachial plexus injury | 0 | 0 | 0 | 1 | 4.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial operation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperandrogenism | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular flutter | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Burns third degree | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetes mellitus inadequate control | 0 | 0.001 | 0.223 | 1 | 2.231 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve injury | 0 | 0.001 | 0.282 | 1 | 2.074 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimation decreased | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Hypocomplementaemia | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Extradural abscess | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Anaplastic astrocytoma | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal infection | 0 | 0 | 0.001 | 1 | 4.174 |  |  |  |  |  | 
COVID19_JANSSEN | Nocturia | 0 | 0 | 0.176 | 1 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Electroglottography | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersomnia-bulimia syndrome | 0 | 0 | 0.004 | 1 | 3.82 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis echo viral | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_JANSSEN | Hypophagia | 0 | 0 | 0.392 | 1 | 1.834 |  |  |  |  |  | 
COVID19_JANSSEN | Hypomagnesaemia | 0 | 0 | 0.007 | 1 | 3.685 |  |  |  |  |  | 
COVID19_JANSSEN | Product contamination chemical | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberous sclerosis complex | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Temperature intolerance | 0 | 0.001 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_JANSSEN | Barrett's oesophagus | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombophlebitis superficial | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Alopecia areata | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin C increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestine polyp | 0 | 0 | 0.106 | 1 | 2.659 |  |  |  |  |  | 
COVID19_JANSSEN | Premenstrual dysphoric disorder | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Cystitis interstitial | 0 | 0 | 0 | 1 | 4.322 |  |  |  |  |  | 
COVID19_JANSSEN | Labelled drug-food interaction medication error | 0 | 0 | 0 | 1 | 5.19 |  |  |  |  |  | 
COVID19_JANSSEN | Periodontitis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Oculocephalogyric reflex absent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Mast cell degranulation test | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal syndrome neonatal | 0 | 0 | 0.003 | 1 | 3.911 |  |  |  |  |  | 
COVID19_JANSSEN | Corynebacterium test positive | 0 | 0 | 0 | 1 | 4.8 |  |  |  |  |  | 
COVID19_JANSSEN | Pustule | 0 | 0 | 0.339 | 1 | 1.944 |  |  |  |  |  | 
COVID19_JANSSEN | Acute interstitial pneumonitis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Retinopexy | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Stoma site reaction | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue disorder | 0 | 0.002 | 0.477 | 1 | 1.678 |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve palsies multiple | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Non-alcoholic steatohepatitis | 0 | 0 | 0.122 | 1 | 2.586 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriovenous fistula aneurysm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric dilatation | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_JANSSEN | Polyomavirus-associated nephropathy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperchylomicronaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Adult failure to thrive | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial fibrosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral sensory neuropathy | 0 | 0 | 0.162 | 1 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Documented hypersensitivity to administered product | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Exanthema subitum | 0 | 0 | 0.013 | 1 | 3.491 |  |  |  |  |  | 
COVID19_JANSSEN | Osteonecrosis (SMQ) [narrow] | 0 | 0 | 0.193 | 1 | 2.322 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte count normal | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound thyroid normal | 0 | 0 | 0.097 | 1 | 2.705 |  |  |  |  |  | 
COVID19_JANSSEN | Macrosomia | 0 | 0 | 0 | 1 | 4.563 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site hypertrophy | 0 | 0 | 0.004 | 1 | 3.807 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal monitoring | 0 | 0 | 0.007 | 1 | 3.674 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital naevus | 0 | 0 | 0.001 | 1 | 4.198 |  |  |  |  |  | 
COVID19_JANSSEN | Renal scan | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Thoracic vertebral fracture | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time abnormal | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Polyneuropathy idiopathic progressive | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Gouty arthritis | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Spondyloarthropathy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothyroidic goitre | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Exchange blood transfusion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Crossmatch | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Complications of transplanted kidney | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Clot retraction | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Bone deformity | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcitonin increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Ambidexterity | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Borrelia test negative | 0 | 0.001 | 0.26 | 1 | 2.13 |  |  |  |  |  | 
COVID19_JANSSEN | Tearfulness | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | CSF red blood cell count | 0 | 0 | 0.189 | 1 | 2.335 |  |  |  |  |  | 
COVID19_JANSSEN | Sopor | 0 | 0 | 0 | 1 | 5.428 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-GAD antibody positive | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Dyschromatopsia | 0 | 0 | 0.115 | 1 | 2.617 |  |  |  |  |  | 
COVID19_JANSSEN | Panniculitis | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell differential | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_JANSSEN | Normochromic normocytic anaemia | 0 | 0 | 0.012 | 1 | 3.518 |  |  |  |  |  | 
COVID19_JANSSEN | Status asthmaticus | 0 | 0 | 0.098 | 1 | 2.697 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis acute | 0 | 0 | 0 | 1 | 4.517 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular test | 0 | 0 | 0.099 | 1 | 2.694 |  |  |  |  |  | 
COVID19_JANSSEN | Neurosis | 0 | 0 | 0 | 1 | 4.962 |  |  |  |  |  | 
COVID19_JANSSEN | Myotonia | 0 | 0 | 0.069 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Tachycardia foetal | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Seizure anoxic | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive heart disease | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Erythroblast count increased | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular encephalopathy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | VIIIth nerve lesion | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid gland abscess | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Somatostatin receptor scan abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Spermatic cord disorder | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Porphyrins urine increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen consumption decreased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Obsessive-compulsive personality disorder | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive cerebrovascular disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Diffuse cutaneous mastocytosis | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Cross sensitivity reaction | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Blunted affect | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood beta-D-glucan normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Agglutination test | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal atrophy | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia haemophilus | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_JANSSEN | Mental disability | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Intraosseous access placement | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram liver abnormal | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Catecholamines urine | 0 | 0 | 0.008 | 1 | 3.638 |  |  |  |  |  | 
COVID19_JANSSEN | Adjustment disorder with depressed mood | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_JANSSEN | Hypervigilance | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal vomiting | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular rupture | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic mycosis | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Parkinsonian gait | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Neutralising antibodies positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal adhesion lysis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Intelligence test | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hairy cell leukaemia | 0 | 0 | 0.05 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic coma | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Coital bleeding | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical spinal cord paralysis | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Seasonal allergy | 0 | 0 | 0.045 | 1 | 3.051 |  |  |  |  |  | 
COVID19_JANSSEN | Parvovirus B19 test negative | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic colitis (SMQ) [narrow] | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Ankylosing spondylitis | 0 | 0 | 0 | 1 | 4.36 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal X-ray abnormal | 0 | 0 | 0.128 | 1 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Hiccups | 0 | 0 | 0.269 | 1 | 2.108 |  |  |  |  |  | 
COVID19_JANSSEN | Giant cell arteritis | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Immunohistochemistry | 0 | 0 | 0 | 1 | 5.191 |  |  |  |  |  | 
COVID19_JANSSEN | Haematological tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocytes normal | 0 | 0 | 0.009 | 1 | 3.606 |  |  |  |  |  | 
COVID19_JANSSEN | Tetanus | 0 | 0 | 0 | 1 | 5.767 |  |  |  |  |  | 
COVID19_JANSSEN | Radioallergosorbent test | 0 | 0 | 0.218 | 1 | 2.245 |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine test normal | 0 | 0 | 0.006 | 1 | 3.723 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to bone | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Vogt-Koyanagi-Harada disease | 0 | 0 | 0 | 1 | 5.265 |  |  |  |  |  | 
COVID19_JANSSEN | Vein rupture | 0 | 0 | 0.115 | 1 | 2.616 |  |  |  |  |  | 
COVID19_JANSSEN | Nephropathy toxic | 0 | 0 | 0 | 1 | 4.631 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpesvirus 6 infection | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar haemorrhage | 0 | 0 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_JANSSEN | Refusal of treatment by relative | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Vibration test normal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Second primary malignancy | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Androgenetic alopecia | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Renal hydrocele | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular rosacea | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal congestion | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated dermatitis | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired fasting glucose | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperkeratosis lenticularis perstans | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpesvirus 6 encephalitis | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Canthoplasty | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Carbuncle | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Breast engorgement | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder catheter replacement | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal clotting factor | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Screaming | 0 | 0.001 | 0.216 | 1 | 2.251 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve conduction studies | 0 | 0.001 | 0.181 | 1 | 2.359 |  |  |  |  |  | 
COVID19_JANSSEN | Restless legs syndrome | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory processing disorder | 0 | 0 | 0.185 | 1 | 2.346 |  |  |  |  |  | 
COVID19_JANSSEN | Splenectomy | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_JANSSEN | Autonomic seizure | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia postoperative | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Adjustment disorder with mixed anxiety and depressed mood | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Adjustment disorder with anxiety | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Oral discomfort | 0 | 0.001 | 0.478 | 1 | 1.676 |  |  |  |  |  | 
COVID19_JANSSEN | Ecchymosis | 0 | 0 | 0.194 | 1 | 2.318 |  |  |  |  |  | 
COVID19_JANSSEN | Clonus | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Tonic convulsion | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Increased upper airway secretion | 0 | 0 | 0.256 | 1 | 2.14 |  |  |  |  |  | 
COVID19_JANSSEN | Human rhinovirus test positive | 0 | 0 | 0.13 | 1 | 2.55 |  |  |  |  |  | 
COVID19_JANSSEN | Cataract | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_JANSSEN | Slow speech | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | Measles antibody | 0 | 0 | 0.002 | 1 | 4.001 |  |  |  |  |  | 
COVID19_JANSSEN | Flat affect | 0 | 0 | 0.204 | 1 | 2.289 |  |  |  |  |  | 
COVID19_JANSSEN | Autoantibody negative | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell morphology normal | 0 | 0 | 0.164 | 1 | 2.42 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal abscess | 0 | 0 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_JANSSEN | Macular degeneration | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep deficit | 0 | 0 | 0.19 | 1 | 2.33 |  |  |  |  |  | 
COVID19_JANSSEN | Compression fracture | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C virus test positive | 0 | 0 | 0.107 | 1 | 2.654 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin distribution width | 0 | 0 | 0 | 1 | 5.109 |  |  |  |  |  | 
COVID19_JANSSEN | Feelings of worthlessness | 0 | 0 | 0.008 | 1 | 3.661 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine renal clearance increased | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial occlusive disease | 0 | 0 | 0.116 | 1 | 2.61 |  |  |  |  |  | 
COVID19_JANSSEN | Extravasation | 0 | 0 | 0 | 1 | 4.474 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system injury | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site infection | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombosis in device | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian prolapse | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Mononuclear cell count increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Follicular mucinosis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Aicardi's syndrome | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Tic | 0 | 0 | 0.325 | 1 | 1.975 |  |  |  |  |  | 
COVID19_JANSSEN | Breath sounds abnormal | 0 | 0.001 | 0.095 | 1 | 2.714 |  |  |  |  |  | 
COVID19_JANSSEN | Arthropathy | 0 | 0.001 | 0.19 | 1 | 2.331 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothyroidism (SMQ) [narrow] | 0 | 0 | 0.023 | 1 | 3.303 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging neck | 0 | 0.001 | 0.335 | 1 | 1.953 |  |  |  |  |  | 
COVID19_JANSSEN | Immunisation reaction | 0 | 0 | 0.175 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Blister rupture | 0 | 0 | 0.373 | 1 | 1.872 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test urine negative | 0 | 0 | 0.098 | 1 | 2.696 |  |  |  |  |  | 
COVID19_JANSSEN | Refusal of treatment by patient | 0 | 0.001 | 0.18 | 1 | 2.365 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin decreased | 0 | 0.001 | 0.17 | 1 | 2.396 |  |  |  |  |  | 
COVID19_JANSSEN | Diastolic dysfunction | 0 | 0 | 0 | 1 | 4.795 |  |  |  |  |  | 
COVID19_JANSSEN | Dyslipidaemia | 0 | 0 | 0.095 | 1 | 2.713 |  |  |  |  |  | 
COVID19_JANSSEN | CSF immunoglobulin decreased | 0 | 0 | 0.023 | 1 | 3.306 |  |  |  |  |  | 
COVID19_JANSSEN | Antimicrobial susceptibility test resistant | 0 | 0 | 0.002 | 1 | 4.039 |  |  |  |  |  | 
COVID19_JANSSEN | Enteritis infectious | 0 | 0 | 0.018 | 1 | 3.397 |  |  |  |  |  | 
COVID19_JANSSEN | Blood mercury | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_JANSSEN | Thyrotoxic crisis | 0 | 0 | 0.031 | 1 | 3.194 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level | 0 | 0 | 0.133 | 1 | 2.536 |  |  |  |  |  | 
COVID19_JANSSEN | ACTH stimulation test abnormal | 0 | 0 | 0 | 1 | 5.545 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast lower gastrointestinal tract abnormal | 0 | 0 | 0 | 1 | 4.856 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital skin disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VIII level increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Breast haemorrhage | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Antemortem blood drug level | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy | 0 | 0 | 0.257 | 1 | 2.137 |  |  |  |  |  | 
COVID19_JANSSEN | Colitis ulcerative | 0 | 0 | 0.034 | 1 | 3.16 |  |  |  |  |  | 
COVID19_JANSSEN | Middle ear effusion | 0 | 0.001 | 0.26 | 1 | 2.129 |  |  |  |  |  | 
COVID19_JANSSEN | CSF neutrophil count increased | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract disorder | 0 | 0 | 0.03 | 1 | 3.214 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis protein | 0 | 0 | 0.208 | 1 | 2.276 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal pruritus | 0 | 0 | 0.15 | 1 | 2.47 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling of despair | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Pyoderma gangrenosum | 0 | 0 | 0 | 1 | 5.093 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal disorder | 0 | 0 | 0.074 | 1 | 2.836 |  |  |  |  |  | 
COVID19_JANSSEN | Culture tissue specimen negative | 0 | 0 | 0.009 | 1 | 3.627 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine free increased | 0 | 0 | 0.035 | 1 | 3.151 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral disorder | 0 | 0 | 0.13 | 1 | 2.55 |  |  |  |  |  | 
COVID19_JANSSEN | Rash follicular | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | Macrocytosis | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Dental operation | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Delayed fontanelle closure | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Nipple swelling | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital syphilis | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac septal hypertrophy | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Acantholysis | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging breast normal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lipase abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hypogonadism | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Drug physiologic incompatibility | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Device alarm issue | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Arthrolysis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Adenine phosphoribosyl transferase deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Ear infection | 0 | 0.001 | 0.204 | 1 | 2.286 |  |  |  |  |  | 
COVID19_JANSSEN | Face oedema | 0 | 0.001 | 0.239 | 1 | 2.187 |  |  |  |  |  | 
COVID19_JANSSEN | Antibody test abnormal | 0 | 0 | 0.004 | 1 | 3.813 |  |  |  |  |  | 
COVID19_JANSSEN | Quadriplegia | 0 | 0 | 0.002 | 1 | 4.008 |  |  |  |  |  | 
COVID19_JANSSEN | Skin test negative | 0 | 0 | 0.15 | 1 | 2.47 |  |  |  |  |  | 
COVID19_JANSSEN | Amylase normal | 0 | 0 | 0.36 | 1 | 1.899 |  |  |  |  |  | 
COVID19_JANSSEN | Positron emission tomogram normal | 0 | 0 | 0.036 | 1 | 3.134 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus operation | 0 | 0.001 | 0.304 | 1 | 2.021 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract oedema | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Barium enema abnormal | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Acute generalised exanthematous pustulosis | 0 | 0 | 0.161 | 1 | 2.428 |  |  |  |  |  | 
COVID19_JANSSEN | Hand fracture | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue injury | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Polymenorrhoea | 0 | 0 | 0 | 1 | 4.56 |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary-dependent Cushing's syndrome | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Agonal rhythm | 0 | 0 | 0.005 | 1 | 3.786 |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary tumour | 0 | 0 | 0.043 | 1 | 3.064 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital skin dimples | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin unconjugated | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal anastomosis | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Mitogen stimulation test abnormal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Lens extraction | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Leiomyoma | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Infective exacerbation of bronchiectasis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocytes maturation arrest | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy small intestine normal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | C1 esterase inhibitor test normal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Bone densitometry | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_JANSSEN | Amino acid level increased | 0 | 0 | 0.008 | 1 | 3.65 |  |  |  |  |  | 
COVID19_JANSSEN | Acute polyneuropathy | 0 | 0 | 0.008 | 1 | 3.663 |  |  |  |  |  | 
COVID19_JANSSEN | Asthma exercise induced | 0 | 0 | 0.021 | 1 | 3.344 |  |  |  |  |  | 
COVID19_JANSSEN | Femur fracture | 0 | 0 | 0.127 | 1 | 2.562 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis viral | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST segment normal | 0 | 0 | 0.002 | 1 | 4.073 |  |  |  |  |  | 
COVID19_JANSSEN | Lower respiratory tract infection viral | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_JANSSEN | Candida test | 0 | 0 | 0.004 | 1 | 3.823 |  |  |  |  |  | 
COVID19_JANSSEN | Urine uric acid normal | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal stenosis | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticular perforation | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Vulval cancer stage 0 | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Trousseau's sign | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell microcytes | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pyloromyotomy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Product commingling | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial drainage test | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Micropenis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph nodes scan abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoprotein (a) abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hypercreatinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Genetic counselling | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Eye complication associated with device | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Cystatin C abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VII level | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | CSF glucose abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy anus abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Listless | 0 | 0 | 0.081 | 1 | 2.792 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile spitting up | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersensitivity vasculitis | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_JANSSEN | Toxicologic test | 0 | 0.001 | 0.308 | 1 | 2.013 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcium | 0 | 0.001 | 0.386 | 1 | 1.846 |  |  |  |  |  | 
COVID19_JANSSEN | Blood blister | 0 | 0 | 0.293 | 1 | 2.049 |  |  |  |  |  | 
COVID19_JANSSEN | Premalignant disorders, general conditions and other site specific disorders (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.175 |  |  |  |  |  | 
COVID19_JANSSEN | Skin hypopigmentation | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph node abscess | 0 | 0 | 0.021 | 1 | 3.336 |  |  |  |  |  | 
COVID19_JANSSEN | Drug effective for unapproved indication | 0 | 0 | 0 | 1 | 5.663 |  |  |  |  |  | 
COVID19_JANSSEN | Slit-lamp examination | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_JANSSEN | Splint application | 0 | 0 | 0.146 | 1 | 2.486 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary granuloma | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_JANSSEN | Post-traumatic neck syndrome | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic myeloid leukaemia | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-GAD antibody negative | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal vascular occlusion | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin level increased | 0 | 0 | 0.109 | 1 | 2.642 |  |  |  |  |  | 
COVID19_JANSSEN | Breast abscess | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Sweat gland disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Splenosis | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Orbital myositis | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Karyotype analysis | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Body mass index decreased | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Blood 1,25-dihydroxycholecalciferol | 0 | 0 | 0.016 | 1 | 3.429 |  |  |  |  |  | 
COVID19_JANSSEN | Suspiciousness | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal toxaemia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hilar enlargement | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve root injury thoracic | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Moraxella test positive | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Jugular vein thrombosis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Intranasal paraesthesia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus hepatitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Choroidal effusion | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Violence-related symptom | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine repair | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Plague | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis herpes | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Medical device site joint infection | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Infection reactivation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Iliotibial band syndrome | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis D RNA negative | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric mucosa erythema | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Duodenogastric reflux | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Colloid brain cyst | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical incompetence | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Vomiting projectile | 0 | 0.001 | 0.163 | 1 | 2.422 |  |  |  |  |  | 
COVID19_JANSSEN | Secretion discharge | 0 | 0 | 0.321 | 1 | 1.983 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatinine | 0 | 0 | 0.107 | 1 | 2.652 |  |  |  |  |  | 
COVID19_JANSSEN | Lactose intolerance | 0 | 0 | 0.026 | 1 | 3.259 |  |  |  |  |  | 
COVID19_JANSSEN | Pupillary reflex impaired | 0 | 0 | 0.146 | 1 | 2.485 |  |  |  |  |  | 
COVID19_JANSSEN | Orthosis user | 0 | 0 | 0.171 | 1 | 2.394 |  |  |  |  |  | 
COVID19_JANSSEN | General symptom | 0 | 0 | 0.187 | 1 | 2.339 |  |  |  |  |  | 
COVID19_JANSSEN | Brain neoplasm | 0 | 0 | 0.018 | 1 | 3.387 |  |  |  |  |  | 
COVID19_JANSSEN | Pruritus genital | 0 | 0 | 0.232 | 1 | 2.204 |  |  |  |  |  | 
COVID19_JANSSEN | Cochlea implant | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder disorder | 0 | 0.001 | 0.199 | 1 | 2.303 |  |  |  |  |  | 
COVID19_JANSSEN | Spirometry normal | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Small for dates baby | 0 | 0 | 0 | 1 | 4.657 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical spinal stenosis | 0 | 0 | 0.175 | 1 | 2.38 |  |  |  |  |  | 
COVID19_JANSSEN | Graft versus host disease | 0 | 0 | 0.01 | 1 | 3.589 |  |  |  |  |  | 
COVID19_JANSSEN | Chelation therapy | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Bone contusion | 0 | 0 | 0 | 1 | 4.416 |  |  |  |  |  | 
COVID19_JANSSEN | Barium enema normal | 0 | 0 | 0 | 1 | 5.049 |  |  |  |  |  | 
COVID19_JANSSEN | Brain malformation | 0 | 0 | 0.001 | 1 | 4.198 |  |  |  |  |  | 
COVID19_JANSSEN | B-cell lymphoma | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-muscle specific kinase antibody | 0 | 0 | 0.117 | 1 | 2.608 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine free abnormal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord neoplasm | 0 | 0 | 0.069 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric ulcer haemorrhage | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac death | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary sarcoidosis | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Prenatal care | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Morbid thoughts | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Mallory-Weiss syndrome | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Macular fibrosis | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal odour | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteric dilatation | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Short stature | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Proctoscopy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Free thyroxine index | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-HLA antibody test | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Optic neuritis | 0 | 0 | 0.038 | 1 | 3.116 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray abnormal | 0 | 0 | 0.143 | 1 | 2.496 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle disorder | 0 | 0.001 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal sounds abnormal | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.2 | 1 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis acneiform | 0 | 0 | 0.332 | 1 | 1.959 |  |  |  |  |  | 
COVID19_JANSSEN | Roseola | 0 | 0 | 0.243 | 1 | 2.176 |  |  |  |  |  | 
COVID19_JANSSEN | Onychoclasis | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Binge drinking | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Breast enlargement | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinoplasty | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site rash | 0 | 0 | 0.099 | 1 | 2.69 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic myelomonocytic leukaemia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Rinne tuning fork test abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Cubital tunnel syndrome | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital cerebellar agenesis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Rebound effect | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Demyelination | 0 | 0 | 0.023 | 1 | 3.305 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin G | 0 | 0.001 | 0.084 | 1 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial haemorrhage | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes sepsis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Thermal burn | 0 | 0 | 0.296 | 1 | 2.041 |  |  |  |  |  | 
COVID19_JANSSEN | Morning sickness | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Anhedonia | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep talking | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Polymorphic light eruption | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose tolerance increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Oral cavity fistula | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine haemorrhage | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Urine odour abnormal | 0 | 0 | 0.31 | 1 | 2.009 |  |  |  |  |  | 
COVID19_JANSSEN | Lung induration | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B virus test | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-abdominal haematoma | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Bone lesion | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Needle fatigue | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Heat oedema | 0 | 0 | 0 | 1 | 5.377 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram intestine | 0 | 0 | 0.111 | 1 | 2.634 |  |  |  |  |  | 
COVID19_JANSSEN | Lower urinary tract symptoms | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound breast normal | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_JANSSEN | Blood parathyroid hormone normal | 0 | 0 | 0.146 | 1 | 2.487 |  |  |  |  |  | 
COVID19_JANSSEN | Victim of crime | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Onycholysis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Squamous cell carcinoma of the cervix | 0 | 0 | 0.005 | 1 | 3.796 |  |  |  |  |  | 
COVID19_JANSSEN | Dementia | 0 | 0 | 0.107 | 1 | 2.655 |  |  |  |  |  | 
COVID19_JANSSEN | Amaurosis fugax | 0 | 0 | 0.001 | 1 | 4.273 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrostomy | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Renal colic | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve infection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Coxiella test positive | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray limb | 0 | 0.001 | 0.339 | 1 | 1.944 |  |  |  |  |  | 
COVID19_JANSSEN | Blastic plasmacytoid dendritic cell neoplasia | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte count | 0 | 0 | 0.162 | 1 | 2.425 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin | 0 | 0.001 | 0.199 | 1 | 2.302 |  |  |  |  |  | 
COVID19_JANSSEN | Craniocerebral injury | 0 | 0 | 0.031 | 1 | 3.191 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal dilation procedure | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperchlorhydria | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Visual brightness | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | No reaction on previous exposure to drug | 0 | 0 | 0.185 | 1 | 2.346 |  |  |  |  |  | 
COVID19_JANSSEN | Choreoathetosis | 0 | 0 | 0.125 | 1 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Circumstance or information capable of leading to device use error | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Axillary vein thrombosis | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal pneumonia | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Myringitis | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Lactose tolerance test normal | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Assisted reproductive technology | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Anoxia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Failure to thrive | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Skin wound | 0 | 0 | 0 | 1 | 4.788 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombocytosis | 0 | 0 | 0.156 | 1 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Osteoporosis/osteopenia (SMQ) [narrow] | 0 | 0 | 0.205 | 1 | 2.285 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid function test abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Chorea | 0 | 0 | 0.23 | 1 | 2.212 |  |  |  |  |  | 
COVID19_JANSSEN | Bursal fluid accumulation | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin unconjugated normal | 0 | 0 | 0.003 | 1 | 3.888 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis viral test | 0 | 0 | 0.251 | 1 | 2.154 |  |  |  |  |  | 
COVID19_JANSSEN | Visual acuity tests normal | 0 | 0 | 0.188 | 1 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint inflammation | 0 | 0 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_JANSSEN | Pain management | 0 | 0 | 0.19 | 1 | 2.332 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocyte count decreased | 0 | 0 | 0.035 | 1 | 3.15 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic stroke | 0 | 0 | 0.005 | 1 | 3.797 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil count decreased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Limb deformity | 0 | 0 | 0.009 | 1 | 3.602 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil percentage decreased | 0 | 0 | 0.025 | 1 | 3.282 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound breast abnormal | 0 | 0 | 0.094 | 1 | 2.72 |  |  |  |  |  | 
COVID19_JANSSEN | Duodenitis | 0 | 0 | 0.118 | 1 | 2.6 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral ventricle dilatation | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_JANSSEN | Megakaryocytes | 0 | 0 | 0.02 | 1 | 3.355 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac imaging procedure abnormal | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Anal cancer | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital discomfort | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Blood iron increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Water pollution | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex test positive | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Asthmatic crisis | 0 | 0 | 0 | 1 | 4.369 |  |  |  |  |  | 
COVID19_JANSSEN | Serum amyloid A protein increased | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal sleep-related event | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal myelogram abnormal | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C RNA negative | 0 | 0 | 0 | 1 | 4.602 |  |  |  |  |  | 
COVID19_JANSSEN | Injection | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin urine increased | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile back arching | 0 | 0 | 0.001 | 1 | 4.187 |  |  |  |  |  | 
COVID19_JANSSEN | Circumoral oedema | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Food poisoning | 0 | 0 | 0.119 | 1 | 2.598 |  |  |  |  |  | 
COVID19_JANSSEN | Chorioretinitis | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin globulin ratio | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Ectopic pregnancy | 0 | 0 | 0 | 1 | 4.626 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial septal defect | 0 | 0.001 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_JANSSEN | Tobacco user | 0 | 0 | 0.018 | 1 | 3.395 |  |  |  |  |  | 
COVID19_JANSSEN | Device failure | 0 | 0 | 0.094 | 1 | 2.718 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric fluid analysis abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Contrast media allergy | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Candida nappy rash | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral atrophy congenital | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoxic-ischaemic encephalopathy | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperphagia | 0 | 0 | 0.003 | 1 | 3.88 |  |  |  |  |  | 
COVID19_JANSSEN | Burning sensation mucosal | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord disorder | 0 | 0 | 0.088 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell volume increased | 0 | 0.001 | 0.19 | 1 | 2.332 |  |  |  |  |  | 
COVID19_JANSSEN | Parenteral nutrition | 0 | 0 | 0.004 | 1 | 3.831 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal inflammation | 0 | 0 | 0.199 | 1 | 2.303 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QT interval | 0 | 0 | 0.002 | 1 | 4.01 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-platelet antibody positive | 0 | 0 | 0 | 1 | 4.639 |  |  |  |  |  | 
COVID19_JANSSEN | Oral lichen planus | 0 | 0 | 0.008 | 1 | 3.63 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac ablation | 0 | 0 | 0.143 | 1 | 2.496 |  |  |  |  |  | 
COVID19_JANSSEN | Carpal tunnel decompression | 0 | 0 | 0.11 | 1 | 2.639 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian operation | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_JANSSEN | Menopausal symptoms | 0 | 0 | 0.014 | 1 | 3.469 |  |  |  |  |  | 
COVID19_JANSSEN | Dengue fever | 0 | 0 | 0 | 1 | 5.807 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular symptom | 0 | 0 | 0.095 | 1 | 2.713 |  |  |  |  |  | 
COVID19_JANSSEN | Blood catecholamines | 0 | 0 | 0.014 | 1 | 3.485 |  |  |  |  |  | 
COVID19_JANSSEN | Plasminogen activator inhibitor | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Solar dermatitis | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Red man syndrome | 0 | 0 | 0.067 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Pericarditis lupus | 0 | 0 | 0.001 | 1 | 4.081 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal carcinoma | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangitis sclerosing | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_JANSSEN | Anal erosion | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Transplant | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Pterygium | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian dysplasia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal tremor | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Device dispensing error | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac ventriculogram left | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Carcinogenicity | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blepharochalasis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Leukopenia | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Purulent discharge | 0 | 0 | 0.137 | 1 | 2.52 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema of eyelid | 0 | 0 | 0.451 | 1 | 1.724 |  |  |  |  |  | 
COVID19_JANSSEN | Radiculitis brachial | 0 | 0 | 0.057 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheostomy | 0 | 0 | 0.001 | 1 | 4.146 |  |  |  |  |  | 
COVID19_JANSSEN | Blood count abnormal | 0 | 0 | 0.239 | 1 | 2.187 |  |  |  |  |  | 
COVID19_JANSSEN | Shock symptom | 0 | 0 | 0.128 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Transaminases | 0 | 0 | 0.1 | 1 | 2.686 |  |  |  |  |  | 
COVID19_JANSSEN | Scan myocardial perfusion | 0 | 0 | 0.29 | 1 | 2.057 |  |  |  |  |  | 
COVID19_JANSSEN | Smallpox | 0 | 0 | 0.005 | 1 | 3.78 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngomalacia | 0 | 0 | 0.094 | 1 | 2.72 |  |  |  |  |  | 
COVID19_JANSSEN | Parvovirus infection | 0 | 0 | 0.001 | 1 | 4.224 |  |  |  |  |  | 
COVID19_JANSSEN | Urine ketone body | 0 | 0 | 0.082 | 1 | 2.787 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal candidiasis | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac telemetry abnormal | 0 | 0 | 0 | 1 | 4.649 |  |  |  |  |  | 
COVID19_JANSSEN | Agraphia | 0 | 0 | 0.029 | 1 | 3.228 |  |  |  |  |  | 
COVID19_JANSSEN | Traumatic haematoma | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia pseudomonal | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal fluid analysis abnormal | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Keratouveitis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site warmth | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic generalised epilepsy | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalopathy allergic | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Bone fragmentation | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site abscess sterile | 0 | 0 | 0 | 1 | 5.772 |  |  |  |  |  | 
COVID19_JANSSEN | Vth nerve injury | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary cerebellar degeneration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated encephalitis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric bypass | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac pacemaker replacement | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cancer pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha-1 anti-trypsin normal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Aeromonas infection | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Tangentiality | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue atrophy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Large cell lung cancer | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrogen breath test abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrooesophageal sphincter insufficiency | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragm muscle weakness | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Blood magnesium abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Blood test abnormal | 0 | 0.001 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site streaking | 0 | 0 | 0.205 | 1 | 2.284 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster oticus | 0 | 0 | 0.001 | 1 | 4.194 |  |  |  |  |  | 
COVID19_JANSSEN | Demyelinating polyneuropathy | 0 | 0 | 0.026 | 1 | 3.262 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary sediment present | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic procedure | 0 | 0 | 0.022 | 1 | 3.322 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden onset of sleep | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Rib fracture | 0 | 0 | 0.231 | 1 | 2.209 |  |  |  |  |  | 
COVID19_JANSSEN | Blood sodium increased | 0 | 0 | 0.015 | 1 | 3.452 |  |  |  |  |  | 
COVID19_JANSSEN | Viral titre | 0 | 0 | 0.008 | 1 | 3.656 |  |  |  |  |  | 
COVID19_JANSSEN | PO2 increased | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Essential hypertension | 0 | 0 | 0.134 | 1 | 2.534 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C3 increased | 0 | 0 | 0.029 | 1 | 3.218 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine free normal | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Dysacusis | 0 | 0 | 0.195 | 1 | 2.316 |  |  |  |  |  | 
COVID19_JANSSEN | Suffocation feeling | 0 | 0 | 0.143 | 1 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation time prolonged | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-neuronal antibody | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic infarction | 0 | 0 | 0.012 | 1 | 3.522 |  |  |  |  |  | 
COVID19_JANSSEN | Sedative therapy | 0 | 0 | 0.006 | 1 | 3.735 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal depigmentation | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Migraine without aura | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan vagina normal | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombotic stroke | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Mean arterial pressure | 0 | 0 | 0.005 | 1 | 3.755 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal thinning | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | CSF volume increased | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid crystal present | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil/lymphocyte ratio increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal septum disorder | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Macula thickness measurement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Macrophage activation | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal cancer | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antigen | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C core antibody positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrosarcoma | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_JANSSEN | Drug-disease interaction | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Dilatation ventricular | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis herpetiformis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stent insertion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Basilar artery occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial wall hypertrophy | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Visual acuity reduced | 0 | 0 | 0.018 | 1 | 3.401 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial test | 0 | 0 | 0.099 | 1 | 2.694 |  |  |  |  |  | 
COVID19_JANSSEN | Wisdom teeth removal | 0 | 0 | 0.007 | 1 | 3.677 |  |  |  |  |  | 
COVID19_JANSSEN | Gun shot wound | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Gangrene | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary fragility | 0 | 0 | 0.002 | 1 | 3.985 |  |  |  |  |  | 
COVID19_JANSSEN | Scar pain | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_JANSSEN | Drug dependence | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Ureterolithiasis | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanometry normal | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Punctate basophilia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Postsplenectomy syndrome | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte morphology normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Long QT syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Listeria test positive | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Kinematic imbalances due to suboccipital strain | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocochleogram | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Ectopic kidney | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood growth hormone abnormal | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Autophobia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-glycyl-tRNA synthetase antibody negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex test negative | 0 | 0 | 0.12 | 1 | 2.592 |  |  |  |  |  | 
COVID19_JANSSEN | Lung disorder | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time | 0 | 0.002 | 0.389 | 1 | 1.84 |  |  |  |  |  | 
COVID19_JANSSEN | Interstitial lung disease | 0 | 0 | 0.015 | 1 | 3.457 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal infection | 0 | 0 | 0.13 | 1 | 2.551 |  |  |  |  |  | 
COVID19_JANSSEN | Obsessive-compulsive disorder | 0 | 0 | 0.163 | 1 | 2.421 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chloride increased | 0 | 0.002 | 0.31 | 1 | 2.007 |  |  |  |  |  | 
COVID19_JANSSEN | Serum ferritin normal | 0 | 0.001 | 0.233 | 1 | 2.202 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus antibody negative | 0 | 0.001 | 0.192 | 1 | 2.323 |  |  |  |  |  | 
COVID19_JANSSEN | Nephrolithiasis | 0 | 0.001 | 0.188 | 1 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Urine abnormality | 0 | 0 | 0.245 | 1 | 2.171 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin | 0 | 0.001 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Rash scarlatiniform | 0 | 0 | 0 | 1 | 5.328 |  |  |  |  |  | 
COVID19_JANSSEN | Palmar erythema | 0 | 0 | 0.178 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site pallor | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | PCO2 | 0 | 0 | 0.138 | 1 | 2.518 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site hyperaesthesia | 0 | 0 | 0.015 | 1 | 3.462 |  |  |  |  |  | 
COVID19_JANSSEN | Skin wrinkling | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Physical examination abnormal | 0 | 0 | 0.018 | 1 | 3.399 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E antibody negative | 0 | 0 | 0 | 1 | 4.701 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose tolerance test normal | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic sinusitis | 0 | 0 | 0.006 | 1 | 3.74 |  |  |  |  |  | 
COVID19_JANSSEN | Liver neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0 | 1 | 4.688 |  |  |  |  |  | 
COVID19_JANSSEN | Corynebacterium test negative | 0 | 0 | 0 | 1 | 5.713 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure diastolic increased | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic respiratory symptom | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Blood triglycerides | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of satiety | 0 | 0 | 0.001 | 1 | 4.209 |  |  |  |  |  | 
COVID19_JANSSEN | High density lipoprotein | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal injury | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Traumatic lung injury | 0 | 0 | 0.041 | 1 | 3.092 |  |  |  |  |  | 
COVID19_JANSSEN | Light chain analysis abnormal | 0 | 0 | 0 | 1 | 4.333 |  |  |  |  |  | 
COVID19_JANSSEN | Fasciotomy | 0 | 0 | 0.029 | 1 | 3.224 |  |  |  |  |  | 
COVID19_JANSSEN | Meralgia paraesthetica | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_JANSSEN | Blood group A | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular ataxia | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Saliva analysis abnormal | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_JANSSEN | Band sensation | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_JANSSEN | Arteritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated neuropathy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric fluid analysis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Fulminant type 1 diabetes mellitus | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital cytomegalovirus infection | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral toxoplasmosis | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac septal defect | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune endocrine disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Status epilepticus | 0 | 0 | 0.175 | 1 | 2.38 |  |  |  |  |  | 
COVID19_JANSSEN | Parotid gland enlargement | 0 | 0 | 0.004 | 1 | 3.839 |  |  |  |  |  | 
COVID19_JANSSEN | Enterocolitis | 0 | 0 | 0.004 | 1 | 3.84 |  |  |  |  |  | 
COVID19_JANSSEN | Basedow's disease | 0 | 0 | 0.029 | 1 | 3.218 |  |  |  |  |  | 
COVID19_JANSSEN | Butterfly rash | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoalbuminaemia | 0 | 0 | 0.211 | 1 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Cluster headache | 0 | 0.001 | 0.237 | 1 | 2.191 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperkeratosis | 0 | 0 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Facial nerve disorder | 0 | 0 | 0.183 | 1 | 2.353 |  |  |  |  |  | 
COVID19_JANSSEN | Gene mutation identification test | 0 | 0 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_JANSSEN | Breech presentation | 0 | 0 | 0 | 1 | 4.754 |  |  |  |  |  | 
COVID19_JANSSEN | Viral pharyngitis | 0 | 0 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriosclerosis coronary artery | 0 | 0 | 0.019 | 1 | 3.371 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin E decreased | 0 | 0 | 0.155 | 1 | 2.452 |  |  |  |  |  | 
COVID19_JANSSEN | Hemiparaesthesia | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoidectomy | 0 | 0 | 0.021 | 1 | 3.346 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial toxaemia | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Post transfusion purpura | 0 | 0 | 0.001 | 1 | 4.207 |  |  |  |  |  | 
COVID19_JANSSEN | Lysozyme | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired self-care | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic disorders specifically reported as alcohol-related (SMQ) [narrow] | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | False negative investigation result | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Visual perseveration | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Visual pathway disorder | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Urine osmolarity decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic aspiration | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Smear vaginal normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Snapping hip syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pacemaker generated rhythm | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Iodine uptake abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Factor I deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QT shortened | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema nummular | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Disorder of orbit | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Citrobacter infection | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac output decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray limb normal | 0 | 0 | 0.333 | 1 | 1.956 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure congestive | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Product container issue | 0 | 0 | 0 | 1 | 4.935 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin positive | 0 | 0 | 0 | 1 | 4.64 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery dilatation | 0 | 0 | 0.185 | 1 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster meningoencephalitis | 0 | 0 | 0.003 | 1 | 3.895 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal disorder | 0 | 0 | 0.015 | 1 | 3.449 |  |  |  |  |  | 
COVID19_JANSSEN | Hospice care | 0 | 0 | 0.217 | 1 | 2.249 |  |  |  |  |  | 
COVID19_JANSSEN | Microscopic polyangiitis | 0 | 0 | 0 | 1 | 4.52 |  |  |  |  |  | 
COVID19_JANSSEN | Angiotensin converting enzyme increased | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Keratic precipitates | 0 | 0 | 0.02 | 1 | 3.352 |  |  |  |  |  | 
COVID19_JANSSEN | Adenotonsillectomy | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Serology test | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin decreased | 0 | 0.001 | 0.158 | 1 | 2.44 |  |  |  |  |  | 
COVID19_JANSSEN | Liver disorder | 0 | 0 | 0.011 | 1 | 3.539 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell count | 0 | 0 | 0.017 | 1 | 3.405 |  |  |  |  |  | 
COVID19_JANSSEN | Disturbance in social behaviour | 0 | 0 | 0.016 | 1 | 3.434 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site erythema | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Vocal cord disorder | 0 | 0 | 0.038 | 1 | 3.115 |  |  |  |  |  | 
COVID19_JANSSEN | Babinski reflex test | 0 | 0 | 0.028 | 1 | 3.241 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral haematoma | 0 | 0 | 0.137 | 1 | 2.522 |  |  |  |  |  | 
COVID19_JANSSEN | Carboxyhaemoglobin normal | 0 | 0 | 0.212 | 1 | 2.265 |  |  |  |  |  | 
COVID19_JANSSEN | Tinea capitis | 0 | 0 | 0.001 | 1 | 4.092 |  |  |  |  |  | 
COVID19_JANSSEN | Sarcoma | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte haemoglobin equivalent | 0 | 0 | 0.026 | 1 | 3.264 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumocystis jirovecii infection | 0 | 0 | 0 | 1 | 4.305 |  |  |  |  |  | 
COVID19_JANSSEN | EGFR status assay | 0 | 0 | 0.116 | 1 | 2.61 |  |  |  |  |  | 
COVID19_JANSSEN | Anorectal manometry | 0 | 0 | 0.016 | 1 | 3.437 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein increased | 0 | 0 | 0.001 | 1 | 4.284 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast upper gastrointestinal tract normal | 0 | 0 | 0.103 | 1 | 2.671 |  |  |  |  |  | 
COVID19_JANSSEN | Optic disc haemorrhage | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract obstruction | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Oral papilloma | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Blood potassium abnormal | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroglobulin decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin blood absent | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant nipple neoplasm female | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hair injury | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Deep brain stimulation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion late | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Measles | 0 | 0 | 0.002 | 1 | 4.065 |  |  |  |  |  | 
COVID19_JANSSEN | Reaction to excipient | 0 | 0 | 0 | 1 | 4.973 |  |  |  |  |  | 
COVID19_JANSSEN | Fluid intake reduced | 0 | 0.001 | 0.41 | 1 | 1.799 |  |  |  |  |  | 
COVID19_JANSSEN | Blepharospasm | 0 | 0.001 | 0.34 | 1 | 1.941 |  |  |  |  |  | 
COVID19_JANSSEN | Joint noise | 0 | 0 | 0.285 | 1 | 2.067 |  |  |  |  |  | 
COVID19_JANSSEN | Procalcitonin normal | 0 | 0 | 0.027 | 1 | 3.243 |  |  |  |  |  | 
COVID19_JANSSEN | Defaecation urgency | 0 | 0.001 | 0.226 | 1 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Inappropriate affect | 0 | 0 | 0.306 | 1 | 2.017 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte count | 0 | 0 | 0.021 | 1 | 3.338 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulins | 0 | 0 | 0.248 | 1 | 2.162 |  |  |  |  |  | 
COVID19_JANSSEN | Immunosuppressant drug therapy | 0 | 0 | 0.174 | 1 | 2.383 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance cholangiopancreatography | 0 | 0.001 | 0.288 | 1 | 2.06 |  |  |  |  |  | 
COVID19_JANSSEN | Joint range of motion measurement | 0 | 0 | 0.011 | 1 | 3.537 |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter test positive | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis salmonella | 0 | 0 | 0 | 1 | 5.428 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite blood test | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal infection | 0 | 0 | 0 | 1 | 4.919 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary occult blood positive | 0 | 0 | 0.006 | 1 | 3.713 |  |  |  |  |  | 
COVID19_JANSSEN | Intercepted medication error | 0 | 0 | 0.034 | 1 | 3.159 |  |  |  |  |  | 
COVID19_JANSSEN | CSF shunt operation | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcitonin | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Benign breast lump removal | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan vagina abnormal | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Rash papulosquamous | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Poor quality device used | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_JANSSEN | Nitrite urine | 0 | 0 | 0.089 | 1 | 2.746 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal obstruction | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | Heterophoria | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Carcinoembryonic antigen increased | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell analysis abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Serum serotonin decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Metastasis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle contracture | 0 | 0 | 0.26 | 1 | 2.13 |  |  |  |  |  | 
COVID19_JANSSEN | Malnutrition | 0 | 0 | 0.018 | 1 | 3.387 |  |  |  |  |  | 
COVID19_JANSSEN | Urine leukocyte esterase positive | 0 | 0.001 | 0.33 | 1 | 1.963 |  |  |  |  |  | 
COVID19_JANSSEN | Bursa injury | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell volume | 0 | 0 | 0.203 | 1 | 2.291 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster meningitis | 0 | 0 | 0 | 1 | 5.308 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal rash | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product effect decreased | 0 | 0 | 0.003 | 1 | 3.918 |  |  |  |  |  | 
COVID19_JANSSEN | Natural killer cell count increased | 0 | 0 | 0 | 1 | 4.82 |  |  |  |  |  | 
COVID19_JANSSEN | CD8 lymphocytes increased | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimal disorder | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Pineal gland cyst | 0 | 0 | 0.037 | 1 | 3.129 |  |  |  |  |  | 
COVID19_JANSSEN | Blood HIV RNA increased | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site nerve damage | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal infection | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_JANSSEN | Cold agglutinins positive | 0 | 0 | 0.018 | 1 | 3.393 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Viral myositis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Basal ganglia haematoma | 0 | 0 | 0.088 | 1 | 2.748 |  |  |  |  |  | 
COVID19_JANSSEN | Weber tuning fork test abnormal | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Rectocele | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal polypectomy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Ciliary body disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein normal | 0 | 0 | 0 | 1 | 5.223 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [narrow] | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilus infection | 0 | 0 | 0 | 1 | 5.54 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune haemolytic anaemia | 0 | 0 | 0.11 | 1 | 2.637 |  |  |  |  |  | 
COVID19_JANSSEN | Eye infection | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Motor neurone disease | 0 | 0 | 0.15 | 1 | 2.469 |  |  |  |  |  | 
COVID19_JANSSEN | Glycosuria | 0 | 0 | 0.004 | 1 | 3.83 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial excision | 0 | 0 | 0.001 | 1 | 4.117 |  |  |  |  |  | 
COVID19_JANSSEN | Organising pneumonia | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic encephalopathy | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal malrotation | 0 | 0 | 0.004 | 1 | 3.842 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral artery stenosis | 0 | 0 | 0.014 | 1 | 3.475 |  |  |  |  |  | 
COVID19_JANSSEN | Acanthosis | 0 | 0 | 0.002 | 1 | 3.958 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngoscopy normal | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Breath sounds normal | 0 | 0 | 0.133 | 1 | 2.537 |  |  |  |  |  | 
COVID19_JANSSEN | Reflux gastritis | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST-T segment abnormal | 0 | 0 | 0.018 | 1 | 3.386 |  |  |  |  |  | 
COVID19_JANSSEN | Psychotherapy | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Eating disorder symptom | 0 | 0 | 0.003 | 1 | 3.889 |  |  |  |  |  | 
COVID19_JANSSEN | Thermohyperaesthesia | 0 | 0 | 0.001 | 1 | 4.081 |  |  |  |  |  | 
COVID19_JANSSEN | Scan gallium abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Haemangioma of liver | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral arteritis | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Bloch-Sulzberger syndrome | 0 | 0 | 0.05 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal pain | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Reactive gastropathy | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile haemangioma | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Bush-Francis catatonia rating scale | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blastocystis infection | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Proteinuria (SMQ) [narrow] | 0 | 0.001 | 0.209 | 1 | 2.27 |  |  |  |  |  | 
COVID19_JANSSEN | Myelitis | 0 | 0 | 0.021 | 1 | 3.344 |  |  |  |  |  | 
COVID19_JANSSEN | Adactyly | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Precocious puberty | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Hydronephrosis | 0 | 0 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_JANSSEN | Heat illness | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_JANSSEN | Breast oedema | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_JANSSEN | Foot amputation | 0 | 0 | 0.027 | 1 | 3.251 |  |  |  |  |  | 
COVID19_JANSSEN | Obstructive defaecation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Haematological malignant tumours (SMQ) [narrow] | 0 | 0 | 0.242 | 1 | 2.179 |  |  |  |  |  | 
COVID19_JANSSEN | FEV1/FVC ratio decreased | 0 | 0 | 0 | 1 | 4.845 |  |  |  |  |  | 
COVID19_JANSSEN | Device infusion issue | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Coma scale abnormal | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Endocarditis | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_JANSSEN | Meningioma | 0 | 0 | 0.163 | 1 | 2.423 |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive tract disorder | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Latent tetany | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Interferon gamma normal | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac stress test | 0 | 0 | 0.15 | 1 | 2.471 |  |  |  |  |  | 
COVID19_JANSSEN | Intelligence test abnormal | 0 | 0 | 0 | 1 | 5.149 |  |  |  |  |  | 
COVID19_JANSSEN | Venogram | 0 | 0 | 0.25 | 1 | 2.156 |  |  |  |  |  | 
COVID19_JANSSEN | Burning mouth syndrome | 0 | 0 | 0 | 1 | 4.488 |  |  |  |  |  | 
COVID19_JANSSEN | Facial asymmetry | 0 | 0.001 | 0.241 | 1 | 2.179 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal discolouration | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulosclerosis | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Overdose | 0 | 0 | 0.001 | 1 | 4.14 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagogastroduodenoscopy | 0 | 0.001 | 0.231 | 1 | 2.207 |  |  |  |  |  | 
COVID19_JANSSEN | Hysterosalpingogram | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Upper airway obstruction | 0 | 0 | 0.109 | 1 | 2.644 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic elongation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Rhesus antigen | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Suprapubic pain | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Urine calcium/creatinine ratio | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy muscle normal | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | Blood acid phosphatase increased | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor XIII level decreased | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Total cholesterol/HDL ratio normal | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | LDL/HDL ratio | 0 | 0 | 0.023 | 1 | 3.311 |  |  |  |  |  | 
COVID19_JANSSEN | Liver dialysis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Osteosclerosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulitis intestinal perforated | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary straining | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Ileal perforation | 0 | 0 | 0.026 | 1 | 3.257 |  |  |  |  |  | 
COVID19_JANSSEN | Administration related reaction | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_JANSSEN | Yawning | 0 | 0 | 0.213 | 1 | 2.261 |  |  |  |  |  | 
COVID19_JANSSEN | Mean platelet volume abnormal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Rouleaux formation | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex test | 0 | 0 | 0.229 | 1 | 2.213 |  |  |  |  |  | 
COVID19_JANSSEN | Bordetella test | 0 | 0 | 0 | 1 | 5.01 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal disease carrier | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired reasoning | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | Face and mouth X-ray normal | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Aphonia | 0 | 0.001 | 0.315 | 1 | 1.996 |  |  |  |  |  | 
COVID19_JANSSEN | Waist circumference increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test negative | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar ataxia | 0 | 0 | 0.098 | 1 | 2.695 |  |  |  |  |  | 
COVID19_JANSSEN | Haematocrit | 0 | 0 | 0.114 | 1 | 2.621 |  |  |  |  |  | 
COVID19_JANSSEN | Haemolysis | 0 | 0 | 0.024 | 1 | 3.289 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrophic scar | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Nail pigmentation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Bowen's disease | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular lens implant | 0 | 0 | 0.138 | 1 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | DNA antibody | 0 | 0 | 0.105 | 1 | 2.664 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal non-stress test abnormal | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone marrow abnormal | 0 | 0 | 0.087 | 1 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric evaluation abnormal | 0 | 0 | 0 | 1 | 4.576 |  |  |  |  |  | 
COVID19_JANSSEN | Huntington's disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | End-tidal CO2 increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Airway secretion clearance therapy | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Hallucination, auditory | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin urine present | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal bacterial infection | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Social avoidant behaviour | 0 | 0 | 0.132 | 1 | 2.541 |  |  |  |  |  | 
COVID19_JANSSEN | Roseolovirus test | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Satoyoshi syndrome | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Rhesus antibodies negative | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous haze | 0 | 0 | 0.02 | 1 | 3.353 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon disorder | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte percentage increased | 0 | 0 | 0.01 | 1 | 3.57 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis protein abnormal | 0 | 0 | 0.021 | 1 | 3.346 |  |  |  |  |  | 
COVID19_JANSSEN | Teratoma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal malformation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell nucleated morphology present | 0 | 0 | 0.02 | 1 | 3.351 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal pain | 0 | 0.001 | 0.391 | 1 | 1.836 |  |  |  |  |  | 
COVID19_JANSSEN | Epidural injection | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Brain injury | 0 | 0 | 0.298 | 1 | 2.038 |  |  |  |  |  | 
COVID19_JANSSEN | Overgrowth fungal | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal haematoma | 0 | 0 | 0 | 1 | 5.825 |  |  |  |  |  | 
COVID19_JANSSEN | Barbiturates negative | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hostility/aggression (SMQ) [narrow] | 0 | 0.001 | 0.306 | 1 | 2.016 |  |  |  |  |  | 
COVID19_JANSSEN | Growth hormone deficiency | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Urine output increased | 0 | 0 | 0.231 | 1 | 2.208 |  |  |  |  |  | 
COVID19_JANSSEN | Bone swelling | 0 | 0 | 0.004 | 1 | 3.817 |  |  |  |  |  | 
COVID19_JANSSEN | Electromyogram normal | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal spasm | 0 | 0 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_JANSSEN | Sinusitis | 0 | 0.001 | 0.176 | 1 | 2.376 |  |  |  |  |  | 
COVID19_JANSSEN | Speech sound disorder | 0 | 0 | 0.102 | 1 | 2.678 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray of pelvis and hip normal | 0 | 0 | 0.212 | 1 | 2.264 |  |  |  |  |  | 
COVID19_JANSSEN | CD8 lymphocytes abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Gianotti-Crosti syndrome | 0 | 0 | 0.227 | 1 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | International normalised ratio decreased | 0 | 0 | 0.099 | 1 | 2.691 |  |  |  |  |  | 
COVID19_JANSSEN | Natural killer cell count | 0 | 0 | 0.001 | 1 | 4.229 |  |  |  |  |  | 
COVID19_JANSSEN | Oral administration complication | 0 | 0 | 0 | 1 | 5.228 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreas infection | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Vein disorder | 0 | 0 | 0.165 | 1 | 2.417 |  |  |  |  |  | 
COVID19_JANSSEN | Supraventricular extrasystoles | 0 | 0 | 0.261 | 1 | 2.128 |  |  |  |  |  | 
COVID19_JANSSEN | Salt craving | 0 | 0 | 0 | 1 | 4.905 |  |  |  |  |  | 
COVID19_JANSSEN | Positive end-expiratory pressure | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital choroid plexus cyst | 0 | 0 | 0.032 | 1 | 3.189 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular pressure test | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising soft tissue infection | 0 | 0 | 0.013 | 1 | 3.494 |  |  |  |  |  | 
COVID19_JANSSEN | Complement deficiency disease | 0 | 0 | 0 | 1 | 5.128 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness bilateral | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Keratoplasty | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotonic-hyporesponsive episode | 0 | 0 | 0.025 | 1 | 3.277 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy cervix abnormal | 0 | 0 | 0 | 1 | 5.825 |  |  |  |  |  | 
COVID19_JANSSEN | Coma acidotic | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Paroxysmal extreme pain disorder | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholesterol abnormal | 0 | 0 | 0.107 | 1 | 2.652 |  |  |  |  |  | 
COVID19_JANSSEN | Percutaneous coronary intervention | 0 | 0 | 0.012 | 1 | 3.533 |  |  |  |  |  | 
COVID19_JANSSEN | Gene sequencing | 0 | 0 | 0 | 1 | 5.402 |  |  |  |  |  | 
COVID19_JANSSEN | Oral contusion | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | Thought blocking | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Precancerous cells present | 0 | 0 | 0.001 | 1 | 4.158 |  |  |  |  |  | 
COVID19_JANSSEN | Chorioretinopathy | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_JANSSEN | Oligohydramnios | 0 | 0 | 0 | 1 | 5.271 |  |  |  |  |  | 
COVID19_JANSSEN | Facial bones fracture | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site warmth | 0 | 0 | 0.175 | 1 | 2.38 |  |  |  |  |  | 
COVID19_JANSSEN | Electronystagmogram abnormal | 0 | 0 | 0.08 | 1 | 2.797 |  |  |  |  |  | 
COVID19_JANSSEN | Macular cyst | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anterograde amnesia | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Selective eating disorder | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Joint injection | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac contusion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Fracture | 0 | 0 | 0.115 | 1 | 2.616 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalomyelitis | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Right atrial dilatation | 0 | 0 | 0.015 | 1 | 3.46 |  |  |  |  |  | 
COVID19_JANSSEN | Keratoconus | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Otoscopy normal | 0 | 0 | 0.029 | 1 | 3.224 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland calculus | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic membrane rupture test negative | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Repetitive strain injury | 0 | 0 | 0.001 | 1 | 4.094 |  |  |  |  |  | 
COVID19_JANSSEN | Sitophobia | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactoid reaction | 0 | 0 | 0.172 | 1 | 2.39 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery occlusion | 0 | 0 | 0.114 | 1 | 2.618 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis staphylococcal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine inversion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Histiocytosis | 0 | 0 | 0 | 1 | 4.484 |  |  |  |  |  | 
COVID19_JANSSEN | VIth nerve paralysis | 0 | 0.001 | 0.294 | 1 | 2.044 |  |  |  |  |  | 
COVID19_JANSSEN | Claustrophobia | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Myelocyte count | 0 | 0 | 0 | 1 | 5.442 |  |  |  |  |  | 
COVID19_JANSSEN | Acrodermatitis enteropathica | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs indirect test positive | 0 | 0 | 0 | 1 | 4.952 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin urine present | 0 | 0 | 0.147 | 1 | 2.48 |  |  |  |  |  | 
COVID19_JANSSEN | Continuous glucose monitoring | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia influenzal | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_JANSSEN | Weight | 0 | 0 | 0 | 1 | 5.248 |  |  |  |  |  | 
COVID19_JANSSEN | Macular hole | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site haematoma | 0 | 0 | 0.353 | 1 | 1.914 |  |  |  |  |  | 
COVID19_JANSSEN | Epileptic encephalopathy | 0 | 0 | 0 | 1 | 5.183 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicogenic headache | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Metastatic malignant melanoma | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudolymphoma | 0 | 0 | 0.033 | 1 | 3.178 |  |  |  |  |  | 
COVID19_JANSSEN | Gamma-glutamyltransferase normal | 0 | 0 | 0.095 | 1 | 2.712 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram peripheral abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Melaena | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Drug dispensed to wrong patient | 0 | 0 | 0.162 | 1 | 2.425 |  |  |  |  |  | 
COVID19_JANSSEN | Phenylalanine screen positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Placental disorder | 0 | 0 | 0 | 1 | 4.895 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspnoea at rest | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal ulcer haemorrhage | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Endometrial disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle contractions involuntary | 0 | 0 | 0.35 | 1 | 1.921 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cancer | 0 | 0 | 0.021 | 1 | 3.332 |  |  |  |  |  | 
COVID19_JANSSEN | Acarodermatitis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital anomaly | 0 | 0 | 0 | 1 | 4.959 |  |  |  |  |  | 
COVID19_JANSSEN | Endocervical curettage | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | HELLP syndrome | 0 | 0 | 0.007 | 1 | 3.667 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar tumour | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | HTLV test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Smear site unspecified normal | 0 | 0 | 0.008 | 1 | 3.658 |  |  |  |  |  | 
COVID19_JANSSEN | Antineutrophil cytoplasmic antibody positive | 0 | 0 | 0.018 | 1 | 3.393 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired immunodeficiency syndrome | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_JANSSEN | Psoriatic arthropathy | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal calprotectin increased | 0 | 0 | 0.002 | 1 | 4.028 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve destruction | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary disorder | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal weight gain | 0 | 0 | 0 | 1 | 4.771 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary fragility increased | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal erythema | 0 | 0 | 0.001 | 1 | 4.112 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis eosinophilic | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urine present | 0 | 0.001 | 0.379 | 1 | 1.859 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoma excision | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Blood follicle stimulating hormone normal | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal erosion | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cystic lung disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Colour blindness | 0 | 0 | 0.006 | 1 | 3.722 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure systolic decreased | 0 | 0 | 0.242 | 1 | 2.178 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue cyst | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Heart sounds abnormal | 0 | 0 | 0.123 | 1 | 2.581 |  |  |  |  |  | 
COVID19_JANSSEN | Culture wound positive | 0 | 0 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin E | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes virus infection | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperinsulinism | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Angiotensin converting enzyme decreased | 0 | 0 | 0.015 | 1 | 3.444 |  |  |  |  |  | 
COVID19_JANSSEN | Hodgkin's disease recurrent | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system inflammation | 0 | 0 | 0.104 | 1 | 2.666 |  |  |  |  |  | 
COVID19_JANSSEN | Heart sounds normal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder hydrodistension | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blood triglycerides abnormal | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Autonomic neuropathy | 0 | 0 | 0 | 1 | 5.155 |  |  |  |  |  | 
COVID19_JANSSEN | Urine mercury abnormal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Graft complication | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Enzyme abnormality | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial injury | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Product packaging issue | 0 | 0 | 0.107 | 1 | 2.655 |  |  |  |  |  | 
COVID19_JANSSEN | Mucocutaneous haemorrhage | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Dental paraesthesia | 0 | 0 | 0.002 | 1 | 3.975 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis allergic | 0 | 0.001 | 0.099 | 1 | 2.689 |  |  |  |  |  | 
COVID19_JANSSEN | Basal cell carcinoma | 0 | 0 | 0 | 1 | 4.871 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol abuse | 0 | 0 | 0.043 | 1 | 3.069 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden cardiac death | 0 | 0 | 0.019 | 1 | 3.365 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperuricaemia | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | High density lipoprotein normal | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram cerebral abnormal | 0 | 0.001 | 0.316 | 1 | 1.995 |  |  |  |  |  | 
COVID19_JANSSEN | Haematoma muscle | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | Self-injurious ideation | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Low cardiac output syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hyporesponsive to stimuli | 0 | 0 | 0.182 | 1 | 2.357 |  |  |  |  |  | 
COVID19_JANSSEN | Cellulitis staphylococcal | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngitis bacterial | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via mucosa | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial drainage test normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Thermometry normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Marburg's variant multiple sclerosis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal mass | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Product quality control issue | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Breast inflammation | 0 | 0 | 0.125 | 1 | 2.571 |  |  |  |  |  | 
COVID19_JANSSEN | Penile erythema | 0 | 0 | 0 | 1 | 5.127 |  |  |  |  |  | 
COVID19_JANSSEN | Joint instability | 0 | 0.001 | 0.245 | 1 | 2.171 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired Von Willebrand's disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy tendon abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Selective IgM immunodeficiency | 0 | 0 | 0.006 | 1 | 3.733 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin degradation products | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Protein urine absent | 0 | 0 | 0.176 | 1 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Histone antibody positive | 0 | 0 | 0.007 | 1 | 3.668 |  |  |  |  |  | 
COVID19_JANSSEN | Iontophoresis | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Liver palpable | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram carotid abnormal | 0 | 0.001 | 0.287 | 1 | 2.063 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site dryness | 0 | 0 | 0.25 | 1 | 2.158 |  |  |  |  |  | 
COVID19_JANSSEN | Radiotherapy | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound bladder abnormal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to animal | 0 | 0 | 0.007 | 1 | 3.676 |  |  |  |  |  | 
COVID19_JANSSEN | Infertility | 0 | 0 | 0 | 1 | 5.022 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor IX level increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic cancer metastatic | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Ebola disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Vena cava embolism | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Neuromyelitis optica spectrum disorder | 0 | 0 | 0 | 1 | 4.662 |  |  |  |  |  | 
COVID19_JANSSEN | Suspected counterfeit product | 0 | 0 | 0.014 | 1 | 3.475 |  |  |  |  |  | 
COVID19_JANSSEN | Breast malignant tumours (SMQ) [narrow] | 0 | 0 | 0.181 | 1 | 2.362 |  |  |  |  |  | 
COVID19_JANSSEN | Blood magnesium normal | 0 | 0.002 | 0.472 | 1 | 1.686 |  |  |  |  |  | 
COVID19_JANSSEN | Sensitivity to weather change | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Anal hypoaesthesia | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Lung abscess | 0 | 0 | 0.013 | 1 | 3.507 |  |  |  |  |  | 
COVID19_JANSSEN | Skin haemorrhage | 0 | 0 | 0.222 | 1 | 2.234 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy large bowel | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Premature baby | 0 | 0 | 0 | 1 | 5.726 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatologic examination normal | 0 | 0 | 0.019 | 1 | 3.372 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular drainage | 0 | 0 | 0.028 | 1 | 3.24 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital rubella infection | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine test abnormal | 0 | 0 | 0.011 | 1 | 3.554 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal mucosal blistering | 0 | 0 | 0.1 | 1 | 2.686 |  |  |  |  |  | 
COVID19_JANSSEN | Immobilisation syndrome | 0 | 0 | 0 | 1 | 5.316 |  |  |  |  |  | 
COVID19_JANSSEN | Progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Antinuclear antibody increased | 0 | 0 | 0.17 | 1 | 2.397 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aldosterone increased | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram carotid | 0 | 0.001 | 0.309 | 1 | 2.011 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lymphocyte count | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_JANSSEN | External ear cellulitis | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersplenism | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory muscle weakness | 0 | 0 | 0 | 1 | 5.197 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic ketoacidosis | 0 | 0.001 | 0.352 | 1 | 1.916 |  |  |  |  |  | 
COVID19_JANSSEN | Blood iron decreased | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal lesion | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis cytomegalovirus | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Cryopyrin associated periodic syndrome | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Compulsive lip biting | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system neoplasm | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level abnormal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | CSF glucose normal | 0 | 0.001 | 0.143 | 1 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site oedema | 0 | 0 | 0.033 | 1 | 3.17 |  |  |  |  |  | 
COVID19_JANSSEN | Delivery | 0 | 0 | 0 | 1 | 5.038 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin M | 0 | 0.001 | 0.226 | 1 | 2.222 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal erythema | 0 | 0 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_JANSSEN | Analgesic drug level therapeutic | 0 | 0 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_JANSSEN | Anion gap decreased | 0 | 0 | 0.336 | 1 | 1.951 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation test abnormal | 0 | 0 | 0.096 | 1 | 2.71 |  |  |  |  |  | 
COVID19_JANSSEN | Myofascial pain syndrome | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | Bone erosion | 0 | 0 | 0 | 1 | 4.633 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint swelling | 0 | 0 | 0 | 1 | 4.791 |  |  |  |  |  | 
COVID19_JANSSEN | Prerenal failure | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Bell's phenomenon | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_JANSSEN | Sweat test normal | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite blood test positive | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital megacolon | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | CSF volume | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_JANSSEN | Solar lentigo | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Sick building syndrome | 0 | 0 | 0 | 1 | 4.971 |  |  |  |  |  | 
COVID19_JANSSEN | Rathke's cleft cyst | 0 | 0 | 0.002 | 1 | 3.993 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular myasthenia | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Limb amputation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding varicose vein | 0 | 0 | 0.003 | 1 | 3.89 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic haemorrhage | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Single photon emission computerised tomogram | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hernial eventration | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival erosion | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Cryptococcal cutaneous infection | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Antiendomysial antibody test | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | VIth nerve paresis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic hepatitis | 0 | 0 | 0.015 | 1 | 3.444 |  |  |  |  |  | 
COVID19_JANSSEN | Organ failure | 0 | 0 | 0.227 | 1 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Ovulation pain | 0 | 0 | 0 | 1 | 4.818 |  |  |  |  |  | 
COVID19_JANSSEN | Mononuclear cell count | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Amino acid level abnormal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Enamel anomaly | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Nephrocalcinosis | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Eye infection staphylococcal | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Injection related reaction | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Bone decalcification | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Moyamoya disease | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level therapeutic | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_JANSSEN | Groin abscess | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Lip oedema | 0 | 0 | 0.193 | 1 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Patella fracture | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity body fluid | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal infection | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Amyloidosis | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Brain scan normal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular hypertrophy | 0 | 0 | 0.025 | 1 | 3.274 |  |  |  |  |  | 
COVID19_JANSSEN | Neurodevelopment test | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid retraction | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Cryptococcosis | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Caffeine consumption | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Blood corticotrophin normal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy thyroid gland normal | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Urine porphobilinogen increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Plasmin inhibitor | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Peristalsis visible | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Milk-alkali syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Homosexuality | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body ingestion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs indirect test negative | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic recurrent multifocal osteomyelitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Benign ovarian tumour | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid volume increased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site reaction | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal X-ray | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_JANSSEN | Oral disorder | 0 | 0 | 0.353 | 1 | 1.914 |  |  |  |  |  | 
COVID19_JANSSEN | Renal disorder | 0 | 0 | 0.183 | 1 | 2.353 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chloride decreased | 0 | 0.001 | 0.212 | 1 | 2.262 |  |  |  |  |  | 
COVID19_JANSSEN | Chiropractic | 0 | 0 | 0.113 | 1 | 2.626 |  |  |  |  |  | 
COVID19_JANSSEN | Blood osmolarity decreased | 0 | 0 | 0.189 | 1 | 2.334 |  |  |  |  |  | 
COVID19_JANSSEN | Ketoacidosis | 0 | 0 | 0 | 1 | 4.368 |  |  |  |  |  | 
COVID19_JANSSEN | Aldolase normal | 0 | 0 | 0.089 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Nephritis | 0 | 0 | 0.013 | 1 | 3.494 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial sepsis | 0 | 0 | 0.011 | 1 | 3.551 |  |  |  |  |  | 
COVID19_JANSSEN | Gliosis | 0 | 0 | 0.14 | 1 | 2.508 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal mycotic infection | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B DNA decreased | 0 | 0 | 0.002 | 1 | 4.021 |  |  |  |  |  | 
COVID19_JANSSEN | DNA antibody positive | 0 | 0 | 0.031 | 1 | 3.203 |  |  |  |  |  | 
COVID19_JANSSEN | Sandifer's syndrome | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_JANSSEN | Langerhans' cell histiocytosis | 0 | 0 | 0.017 | 1 | 3.406 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid contusion | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal compartment syndrome | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Lower gastrointestinal haemorrhage | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma stage II | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Spleen palpable | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Serum serotonin | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomonal bacteraemia | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial rub | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | Open reduction of fracture | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperintensity in brain deep nuclei | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal monitoring normal | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Failed induction of labour | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Disinhibition | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Twin reversed arterial perfusion sequence malformation | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Right aortic arch | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Nodal osteoarthritis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Insulinoma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Implant site discolouration | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Glossoptosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Euthyroid sick syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic pneumonia | 0 | 0 | 0.041 | 1 | 3.089 |  |  |  |  |  | 
COVID19_JANSSEN | Haematoma infection | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy heart abnormal | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Acid base balance abnormal | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Urine albumin/creatinine ratio increased | 0 | 0 | 0.063 | 1 | 2.91 |  |  |  |  |  | 
COVID19_JANSSEN | Stomach scan | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Radiotherapy to breast | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Pilonidal cyst | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Perichondritis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus inflammation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal stenosis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Mucocutaneous rash | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Metanephrine urine | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site swelling | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperthermia therapy | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiopulmonary exercise test abnormal | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray limb abnormal | 0 | 0 | 0.284 | 1 | 2.069 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid function test | 0 | 0.001 | 0.447 | 1 | 1.73 |  |  |  |  |  | 
COVID19_JANSSEN | Accidental underdose | 0 | 0 | 0 | 1 | 4.553 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery disease | 0 | 0 | 0.028 | 1 | 3.241 |  |  |  |  |  | 
COVID19_JANSSEN | Imaging procedure abnormal | 0 | 0.001 | 0.12 | 1 | 2.593 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aluminium increased | 0 | 0 | 0.004 | 1 | 3.862 |  |  |  |  |  | 
COVID19_JANSSEN | Phobia | 0 | 0 | 0.016 | 1 | 3.428 |  |  |  |  |  | 
COVID19_JANSSEN | Cartilage injury | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_JANSSEN | Corynebacterium infection | 0 | 0 | 0.002 | 1 | 3.957 |  |  |  |  |  | 
COVID19_JANSSEN | Dependence on respirator | 0 | 0 | 0.002 | 1 | 3.993 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial disease carrier | 0 | 0 | 0.084 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation time normal | 0 | 0 | 0.004 | 1 | 3.807 |  |  |  |  |  | 
COVID19_JANSSEN | Agnosia | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Penile oedema | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal endotheliitis | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray therapy to joint | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract stoma complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Long thoracic nerve palsy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Forced expiratory volume increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival suffusion | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Cellulitis of male external genital organ | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Application site haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar puncture abnormal | 0 | 0.001 | 0.255 | 1 | 2.142 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy test positive | 0 | 0 | 0.417 | 1 | 1.786 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy test negative | 0 | 0 | 0.318 | 1 | 1.99 |  |  |  |  |  | 
COVID19_JANSSEN | PO2 decreased | 0 | 0.001 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheitis | 0 | 0 | 0.003 | 1 | 3.943 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile vomiting | 0 | 0 | 0 | 1 | 4.798 |  |  |  |  |  | 
COVID19_JANSSEN | Parasitic test | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin T | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_JANSSEN | Vitritis | 0 | 0 | 0.004 | 1 | 3.831 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aluminium | 0 | 0 | 0.002 | 1 | 4.005 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombin time | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactate dehydrogenase decreased | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal odour | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial oedema | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Gonorrhoea | 0 | 0 | 0.087 | 1 | 2.756 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid analysis | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil count | 0 | 0 | 0.158 | 1 | 2.441 |  |  |  |  |  | 
COVID19_JANSSEN | Intracranial aneurysm | 0 | 0.001 | 0.259 | 1 | 2.133 |  |  |  |  |  | 
COVID19_JANSSEN | Death neonatal | 0 | 0 | 0 | 1 | 5.167 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal abrasion | 0 | 0 | 0.035 | 1 | 3.156 |  |  |  |  |  | 
COVID19_JANSSEN | Anaesthesia | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus rhythm | 0 | 0 | 0 | 1 | 4.303 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue haemorrhage | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Anal pruritus | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_JANSSEN | Megakaryocytes increased | 0 | 0 | 0.014 | 1 | 3.476 |  |  |  |  |  | 
COVID19_JANSSEN | Toxicologic test abnormal | 0 | 0 | 0.117 | 1 | 2.605 |  |  |  |  |  | 
COVID19_JANSSEN | Hypermetabolism | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system viral infection | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_JANSSEN | Hypervolaemia | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein abnormal | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertriglyceridaemia | 0 | 0 | 0.026 | 1 | 3.268 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriovenous malformation | 0 | 0 | 0.118 | 1 | 2.604 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia macrocytic | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Tinel's sign | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal discharge | 0 | 0 | 0.009 | 1 | 3.621 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal pathogen panel | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram liver | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy prostate | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour rupture | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | T-cell receptor gene rearrangement test | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagostomy | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Rickets | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site infection | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural site reaction | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic pouch procedure | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Macrophages decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival cyst | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal haemorrhage | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Acute monocytic leukaemia | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitis | 0 | 0 | 0.28 | 1 | 2.08 |  |  |  |  |  | 
COVID19_JANSSEN | Culture stool negative | 0 | 0 | 0.095 | 1 | 2.712 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumococcal sepsis | 0 | 0 | 0 | 1 | 5.011 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus hypersecretion | 0 | 0.001 | 0.295 | 1 | 2.043 |  |  |  |  |  | 
COVID19_JANSSEN | CD8 lymphocytes | 0 | 0 | 0 | 1 | 4.535 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyarrhythmia | 0 | 0 | 0.169 | 1 | 2.4 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-NMDA antibody negative | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve stimulation test | 0 | 0 | 0.141 | 1 | 2.505 |  |  |  |  |  | 
COVID19_JANSSEN | Immunodeficiency common variable | 0 | 0 | 0 | 1 | 4.599 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract inflammation | 0 | 0 | 0.029 | 1 | 3.218 |  |  |  |  |  | 
COVID19_JANSSEN | Leukodystrophy | 0 | 0 | 0.001 | 1 | 4.226 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Single umbilical artery | 0 | 0 | 0 | 1 | 5.263 |  |  |  |  |  | 
COVID19_JANSSEN | Chromatopsia | 0 | 0 | 0.007 | 1 | 3.695 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial disorder | 0 | 0 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary pneumatocele | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Product confusion | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Lip and/or oral cavity cancer | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_JANSSEN | Cardioactive drug level | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular enlargement | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_JANSSEN | Renal tubular disorder | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocytic leukaemia | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Instillation site paraesthesia | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Chest tube removal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-vimentin antibody positive | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to surgical sutures | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation abnormal | 0 | 0 | 0.184 | 1 | 2.352 |  |  |  |  |  | 
COVID19_JANSSEN | Eclampsia | 0 | 0 | 0 | 1 | 4.988 |  |  |  |  |  | 
COVID19_JANSSEN | Superinfection | 0 | 0 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_JANSSEN | Obliterative bronchiolitis | 0 | 0 | 0.003 | 1 | 3.896 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney fibrosis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Bile duct stone | 0 | 0 | 0.096 | 1 | 2.705 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal oedema | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal stroke | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Silent thyroiditis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudocyst | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural intestinal perforation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral artery stent insertion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal lavage | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Pathological doubt | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal intestinal perforation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Epidermoid cyst excision | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Electric shock sensation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Disability assessment scale score decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood galactose | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Accidental exposure to product by child | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Extensive swelling of vaccinated limb | 0 | 0 | 0.012 | 1 | 3.519 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal disorder | 0 | 0.001 | 0.343 | 1 | 1.934 |  |  |  |  |  | 
COVID19_JANSSEN | Fibromyalgia | 0 | 0 | 0.004 | 1 | 3.816 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis contact | 0 | 0 | 0.465 | 1 | 1.699 |  |  |  |  |  | 
COVID19_JANSSEN | Dairy intolerance | 0 | 0 | 0.167 | 1 | 2.41 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular examination | 0 | 0 | 0.014 | 1 | 3.479 |  |  |  |  |  | 
COVID19_JANSSEN | Sedation | 0 | 0.002 | 0.414 | 1 | 1.792 |  |  |  |  |  | 
COVID19_JANSSEN | Skin injury | 0 | 0 | 0.025 | 1 | 3.277 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium test | 0 | 0 | 0.006 | 1 | 3.711 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow failure | 0 | 0 | 0.021 | 1 | 3.335 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal erythema | 0 | 0 | 0.151 | 1 | 2.467 |  |  |  |  |  | 
COVID19_JANSSEN | Penile pain | 0 | 0 | 0.117 | 1 | 2.604 |  |  |  |  |  | 
COVID19_JANSSEN | Granuloma skin | 0 | 0 | 0.031 | 1 | 3.201 |  |  |  |  |  | 
COVID19_JANSSEN | Radial nerve injury | 0 | 0 | 0.032 | 1 | 3.185 |  |  |  |  |  | 
COVID19_JANSSEN | Lacunar stroke | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Groin infection | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Malaria antibody test | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_JANSSEN | Enterocolitis infectious | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Venous occlusion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Shunt malfunction | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Procedure aborted | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site swelling | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Anamnestic reaction | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Viral infection | 0 | 0.001 | 0.367 | 1 | 1.885 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal exposure before pregnancy | 0 | 0 | 0 | 1 | 4.343 |  |  |  |  |  | 
COVID19_JANSSEN | Stupor | 0 | 0 | 0.015 | 1 | 3.447 |  |  |  |  |  | 
COVID19_JANSSEN | Congestive cardiomyopathy | 0 | 0 | 0.144 | 1 | 2.495 |  |  |  |  |  | 
COVID19_JANSSEN | Robust take following exposure to vaccinia virus | 0 | 0 | 0 | 1 | 5.749 |  |  |  |  |  | 
COVID19_JANSSEN | CSF protein decreased | 0 | 0 | 0.281 | 1 | 2.078 |  |  |  |  |  | 
COVID19_JANSSEN | Skin papilloma | 0 | 0 | 0.002 | 1 | 3.958 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea | 0 | 0 | 0.096 | 1 | 2.704 |  |  |  |  |  | 
COVID19_JANSSEN | Product name confusion | 0 | 0 | 0.029 | 1 | 3.223 |  |  |  |  |  | 
COVID19_JANSSEN | Metamorphopsia | 0 | 0 | 0.346 | 1 | 1.93 |  |  |  |  |  | 
COVID19_JANSSEN | Metapneumovirus infection | 0 | 0 | 0.001 | 1 | 4.164 |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasm | 0 | 0 | 0.02 | 1 | 3.355 |  |  |  |  |  | 
COVID19_JANSSEN | Laser therapy | 0 | 0 | 0 | 1 | 4.746 |  |  |  |  |  | 
COVID19_JANSSEN | Cataract nuclear | 0 | 0 | 0 | 1 | 5.151 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic lesion | 0 | 0 | 0 | 1 | 4.372 |  |  |  |  |  | 
COVID19_JANSSEN | Menopause | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia sepsis | 0 | 0 | 0.088 | 1 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Breast tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast lower gastrointestinal tract | 0 | 0 | 0.099 | 1 | 2.69 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral artery thrombosis | 0 | 0 | 0.112 | 1 | 2.629 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchopulmonary aspergillosis | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammatory pain | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_JANSSEN | Blood group B | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Atypical mycobacterial infection | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor V antibody | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Pyoderma | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagogastroscopy abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal papilloma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Excessive skin | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Embedded device | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Colonic lavage | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site nerve damage | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Apnoea | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bicarbonate normal | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_JANSSEN | Granuloma | 0 | 0 | 0 | 1 | 4.576 |  |  |  |  |  | 
COVID19_JANSSEN | Gout | 0 | 0 | 0.102 | 1 | 2.674 |  |  |  |  |  | 
COVID19_JANSSEN | Use of accessory respiratory muscles | 0 | 0 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea nitrogen/creatinine ratio | 0 | 0 | 0.276 | 1 | 2.089 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal rigidity | 0 | 0 | 0.125 | 1 | 2.572 |  |  |  |  |  | 
COVID19_JANSSEN | Exaggerated startle response | 0 | 0 | 0.026 | 1 | 3.262 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal perforation | 0 | 0 | 0.006 | 1 | 3.751 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum increased | 0 | 0 | 0.001 | 1 | 4.225 |  |  |  |  |  | 
COVID19_JANSSEN | Performance status decreased | 0 | 0 | 0.014 | 1 | 3.484 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal necrosis | 0 | 0 | 0 | 1 | 4.32 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal operation | 0 | 0 | 0.013 | 1 | 3.487 |  |  |  |  |  | 
COVID19_JANSSEN | Bipolar disorder | 0 | 0 | 0.039 | 1 | 3.111 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose tolerance impaired | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_JANSSEN | Clostridium difficile colitis | 0 | 0 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_JANSSEN | Patent ductus arteriosus | 0 | 0 | 0 | 1 | 4.307 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal gastrointestinal tract imaging abnormal | 0 | 0 | 0 | 1 | 4.816 |  |  |  |  |  | 
COVID19_JANSSEN | Bipolar I disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell morphology abnormal | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoproliferative disorder | 0 | 0 | 0.022 | 1 | 3.317 |  |  |  |  |  | 
COVID19_JANSSEN | Visual field tests normal | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_JANSSEN | Torsade de pointes | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Proteus test positive | 0 | 0 | 0.02 | 1 | 3.347 |  |  |  |  |  | 
COVID19_JANSSEN | Amoeba test positive | 0 | 0 | 0.043 | 1 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Septic embolus | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal aneurysm | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Myxoedema | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lower respiratory tract infection fungal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Joint adhesion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site pruritus | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopic swallowing evaluation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Counterfeit product administered | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus arrest | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C RNA decreased | 0 | 0 | 0 | 1 | 4.855 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis cholestatic | 0 | 0 | 0 | 1 | 5.311 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal turbinate hypertrophy | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Orbital decompression | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Lower respiratory tract congestion | 0 | 0 | 0.011 | 1 | 3.559 |  |  |  |  |  | 
COVID19_JANSSEN | Ewing's sarcoma | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Chikungunya virus infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral artery thrombosis | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Erysipelas | 0 | 0 | 0 | 1 | 4.313 |  |  |  |  |  | 
COVID19_JANSSEN | Glossopharyngeal nerve disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestinal obstruction | 0 | 0.001 | 0.292 | 1 | 2.051 |  |  |  |  |  | 
COVID19_JANSSEN | Volvulus of small bowel | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery bypass | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin A normal | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion threatened | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Urine electrolytes normal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Convulsion in childhood | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram coronary abnormal | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Serology abnormal | 0 | 0 | 0.001 | 1 | 4.128 |  |  |  |  |  | 
COVID19_JANSSEN | Post streptococcal glomerulonephritis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Radioisotope scan abnormal | 0 | 0 | 0.02 | 1 | 3.351 |  |  |  |  |  | 
COVID19_JANSSEN | Dysgraphia | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Intercostal neuralgia | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells urine negative | 0 | 0 | 0.131 | 1 | 2.544 |  |  |  |  |  | 
COVID19_JANSSEN | Folate deficiency | 0 | 0 | 0.001 | 1 | 4.139 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal volume decreased | 0 | 0 | 0.015 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | Dyssomnia | 0 | 0 | 0.001 | 1 | 4.111 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous vasculitis | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic scan | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QRS complex prolonged | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | Weight abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular dysfunction | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Social fear | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic encephalopathy | 0 | 0 | 0.075 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Glycosylated haemoglobin decreased | 0 | 0 | 0.113 | 1 | 2.626 |  |  |  |  |  | 
COVID19_JANSSEN | Borrelia infection | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_JANSSEN | Application site induration | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Prolonged expiration | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Patient restraint | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Hair metal test normal | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Urine potassium increased | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep disorder due to general medical condition, insomnia type | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinotracheitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Renal hypoplasia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural hypotension | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Potassium hydroxide preparation negative | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Microembolism | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lateral medullary syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site deformation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Inborn error of metabolism | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal neoplasm | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric varices | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Colon cancer metastatic | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Adverse drug reaction | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Pulse abnormal | 0 | 0.002 | 0.472 | 1 | 1.687 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid rash | 0 | 0 | 0.175 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotony of eye | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | VIIth nerve injury | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Anger | 0 | 0.001 | 0.26 | 1 | 2.13 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder irritation | 0 | 0 | 0 | 1 | 4.448 |  |  |  |  |  | 
COVID19_JANSSEN | Mouth haemorrhage | 0 | 0.001 | 0.329 | 1 | 1.966 |  |  |  |  |  | 
COVID19_JANSSEN | Intracranial hypotension | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Mitochondrial myopathy | 0 | 0 | 0.043 | 1 | 3.069 |  |  |  |  |  | 
COVID19_JANSSEN | Pain threshold decreased | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Palatal swelling | 0 | 0 | 0.283 | 1 | 2.073 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal discomfort | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Scan thyroid gland | 0 | 0 | 0.174 | 1 | 2.384 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal crusting | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_JANSSEN | Interferon alpha level | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular disorder | 0 | 0 | 0.023 | 1 | 3.314 |  |  |  |  |  | 
COVID19_JANSSEN | Acute undifferentiated leukaemia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Bile acid malabsorption | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Vesicoureteric reflux | 0 | 0 | 0 | 1 | 4.734 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital pyelocaliectasis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperprolactinaemia | 0 | 0 | 0.007 | 1 | 3.705 |  |  |  |  |  | 
COVID19_JANSSEN | Left-to-right cardiac shunt | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival discolouration | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Eye disorder | 0 | 0.001 | 0.151 | 1 | 2.463 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep attacks | 0 | 0 | 0 | 1 | 4.992 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to contaminated air | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Keratosis pilaris | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve operation | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Blood electrolytes normal | 0 | 0.001 | 0.111 | 1 | 2.631 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin A deficiency | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactic acid decreased | 0 | 0 | 0.021 | 1 | 3.341 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder hypertrophy | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin decreased | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Gallstone related disorders (SMQ) [narrow] | 0 | 0.001 | 0.309 | 1 | 2.009 |  |  |  |  |  | 
COVID19_JANSSEN | Carnitine abnormal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Epilepsy congenital | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Breath holding | 0 | 0 | 0.17 | 1 | 2.399 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral hyperaemia | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Distributive shock | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Nonspecific reaction | 0 | 0 | 0.041 | 1 | 3.089 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal tube insertion | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis chemical | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Jaw disorder | 0 | 0 | 0.191 | 1 | 2.326 |  |  |  |  |  | 
COVID19_JANSSEN | CD4/CD8 ratio increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Venous stenosis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint erythema | 0 | 0 | 0.002 | 1 | 4.042 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid skin dryness | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery occlusion | 0 | 0.001 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid injury | 0 | 0 | 0.036 | 1 | 3.145 |  |  |  |  |  | 
COVID19_JANSSEN | Neuromyopathy | 0 | 0 | 0.03 | 1 | 3.205 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve disorder | 0 | 0 | 0.008 | 1 | 3.65 |  |  |  |  |  | 
COVID19_JANSSEN | Monoplegia | 0 | 0 | 0.043 | 1 | 3.064 |  |  |  |  |  | 
COVID19_JANSSEN | Steroid dependence | 0 | 0 | 0 | 1 | 5.3 |  |  |  |  |  | 
COVID19_JANSSEN | Polyneuropathy in malignant disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Food interaction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Urine phosphorus | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Sweat gland infection | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intention tremor | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic therapy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Brucellosis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Mydriasis | 0 | 0.001 | 0.235 | 1 | 2.196 |  |  |  |  |  | 
COVID19_JANSSEN | Gamma-glutamyltransferase increased | 0 | 0 | 0.023 | 1 | 3.313 |  |  |  |  |  | 
COVID19_JANSSEN | Personality change due to a general medical condition | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Protein C | 0 | 0 | 0.069 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue exfoliation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary stone analysis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulin G4 related disease | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound breast | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_JANSSEN | Skull X-ray | 0 | 0 | 0.265 | 1 | 2.117 |  |  |  |  |  | 
COVID19_JANSSEN | Medical observation normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bicarbonate | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antibody abnormal | 0 | 0 | 0.002 | 1 | 4.008 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal suppression | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Hippocampal sclerosis | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Anxiety disorder | 0 | 0 | 0.007 | 1 | 3.692 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric infection | 0 | 0 | 0.024 | 1 | 3.287 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord infection | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal polyp | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Keratitis | 0 | 0 | 0.013 | 1 | 3.493 |  |  |  |  |  | 
COVID19_JANSSEN | Hyper IgD syndrome | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Akathisia | 0 | 0 | 0 | 1 | 5.302 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells urine | 0 | 0 | 0.081 | 1 | 2.792 |  |  |  |  |  | 
COVID19_JANSSEN | Cauda equina syndrome | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial enlargement | 0 | 0 | 0.018 | 1 | 3.39 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cells urine negative | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_JANSSEN | Reading disorder | 0 | 0 | 0.002 | 1 | 4.048 |  |  |  |  |  | 
COVID19_JANSSEN | Superior sagittal sinus thrombosis | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram T wave amplitude decreased | 0 | 0 | 0.001 | 1 | 4.112 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy small intestine | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Mitral valve repair | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Anisocytosis | 0 | 0 | 0.095 | 1 | 2.711 |  |  |  |  |  | 
COVID19_JANSSEN | Reduced facial expression | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Chondritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Labour induction | 0 | 0 | 0.025 | 1 | 3.283 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound kidney normal | 0 | 0 | 0.123 | 1 | 2.579 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant ascites | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric volvulus | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_JANSSEN | Cystic fibrosis related diabetes | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Skeletal muscle enzymes | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Antithrombin III | 0 | 0 | 0.005 | 1 | 3.756 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic organ injury | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary colic | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular swelling | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Drug hypersensitivity | 0 | 0 | 0.132 | 1 | 2.542 |  |  |  |  |  | 
COVID19_JANSSEN | Immune reconstitution inflammatory syndrome | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin globulin ratio normal | 0 | 0 | 0.273 | 1 | 2.098 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram repolarisation abnormality | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site pallor | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheobronchitis | 0 | 0 | 0.001 | 1 | 4.093 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis toxic | 0 | 0 | 0.004 | 1 | 3.84 |  |  |  |  |  | 
COVID19_JANSSEN | Food craving | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic limb pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Mucocutaneous candidiasis | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_JANSSEN | Whole body scan | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Haptoglobin | 0 | 0 | 0.109 | 1 | 2.645 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site cellulitis | 0 | 0 | 0.008 | 1 | 3.655 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy brain abnormal | 0 | 0 | 0 | 1 | 4.801 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle enzyme | 0 | 0 | 0 | 1 | 5.525 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise tolerance decreased | 0 | 0 | 0.029 | 1 | 3.223 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular disorder | 0 | 0 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_JANSSEN | Traction | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Culture positive | 0 | 0 | 0.024 | 1 | 3.293 |  |  |  |  |  | 
COVID19_JANSSEN | Karyotype analysis normal | 0 | 0 | 0.108 | 1 | 2.646 |  |  |  |  |  | 
COVID19_JANSSEN | Developmental coordination disorder | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer recurrent | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Analgesic drug level | 0 | 0 | 0.116 | 1 | 2.611 |  |  |  |  |  | 
COVID19_JANSSEN | Blood disorder | 0 | 0 | 0.172 | 1 | 2.391 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillitis streptococcal | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Oculorespiratory syndrome | 0 | 0 | 0.001 | 1 | 4.1 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound uterus abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia test negative | 0 | 0 | 0.014 | 1 | 3.467 |  |  |  |  |  | 
COVID19_JANSSEN | Retinitis | 0 | 0 | 0.155 | 1 | 2.451 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular dysmetria | 0 | 0 | 0 | 1 | 4.863 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function challenge test normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Familial tremor | 0 | 0 | 0.065 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival ulcer | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac telemetry | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs test negative | 0 | 0 | 0.001 | 1 | 4.115 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time | 0 | 0.001 | 0.384 | 1 | 1.85 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve injury | 0 | 0 | 0.009 | 1 | 3.616 |  |  |  |  |  | 
COVID19_JANSSEN | Hiatus hernia | 0 | 0 | 0.138 | 1 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | Marginal zone lymphoma | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine spasm | 0 | 0 | 0 | 1 | 4.421 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine dehiscence | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum culture | 0 | 0 | 0.24 | 1 | 2.184 |  |  |  |  |  | 
COVID19_JANSSEN | Mechanical urticaria | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Infective myositis | 0 | 0 | 0.018 | 1 | 3.383 |  |  |  |  |  | 
COVID19_JANSSEN | Haemarthrosis | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Cystic fibrosis | 0 | 0 | 0.007 | 1 | 3.704 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging thoracic normal | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | White matter lesion | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_JANSSEN | Cytogenetic abnormality | 0 | 0 | 0.004 | 1 | 3.87 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess | 0 | 0.001 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Blood insulin decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Genital infection fungal | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal discolouration | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Skin lesion removal | 0 | 0 | 0.003 | 1 | 3.877 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary fragility test | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Palpatory finding abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms (SMQ) [narrow] | 0 | 0 | 0.152 | 1 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpes virus 6 serology negative | 0 | 0 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster infection neurological | 0 | 0 | 0 | 1 | 4.43 |  |  |  |  |  | 
COVID19_JANSSEN | Ear operation | 0 | 0 | 0.031 | 1 | 3.198 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin A normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Calcinosis | 0 | 0 | 0.081 | 1 | 2.792 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil count increased | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary adrenocortical insufficiency | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholinesterase | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Leukoplakia oral | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Prolonged labour | 0 | 0 | 0 | 1 | 4.346 |  |  |  |  |  | 
COVID19_JANSSEN | Vulva cyst | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic cyst | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | HIV test positive | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Inhibiting antibodies positive | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Infected skin ulcer | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial stenosis | 0 | 0 | 0.088 | 1 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Transfusion | 0 | 0.001 | 0.396 | 1 | 1.827 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine haematoma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Menstruation delayed | 0 | 0 | 0.006 | 1 | 3.715 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital thymus absence | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Nail infection | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Winged scapula | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Magnesium deficiency | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Tubulointerstitial diseases (SMQ) [narrow] | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Hydromyelia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Subperiosteal abscess | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_JANSSEN | Treatment noncompliance | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal dilation procedure | 0 | 0 | 0.05 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Breath odour | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_JANSSEN | Transverse sinus thrombosis | 0 | 0 | 0.028 | 1 | 3.233 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site haemorrhage | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Chalazion | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure diastolic | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar spinal stenosis | 0 | 0 | 0.105 | 1 | 2.661 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal dialysis complication | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination error | 0 | 0 | 0.003 | 1 | 3.887 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of vaccination site rotation | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar hernia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Cleft palate | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-ocular injection | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular hypertension | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lead | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Locked-in syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E virus test positive | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Skin disorder | 0 | 0 | 0.156 | 1 | 2.449 |  |  |  |  |  | 
COVID19_JANSSEN | Cortisol decreased | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Murphy's sign test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Shortened cervix | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound thyroid abnormal | 0 | 0 | 0.002 | 1 | 4.047 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza C virus test | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Basophilia | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_JANSSEN | CSF immunoglobulin G index | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin C-peptide decreased | 0 | 0 | 0.075 | 1 | 2.829 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfective sialoadenitis | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Collagen-vascular disease | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site abscess | 0 | 0.001 | 0.145 | 1 | 2.489 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MB decreased | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via breast milk | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculin test | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Apheresis | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site vesicles | 0 | 0 | 0.017 | 1 | 3.417 |  |  |  |  |  | 
COVID19_JANSSEN | Morbillivirus test positive | 0 | 0 | 0 | 1 | 5.013 |  |  |  |  |  | 
COVID19_JANSSEN | Ventilation/perfusion scan normal | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_JANSSEN | Language disorder | 0 | 0 | 0.033 | 1 | 3.171 |  |  |  |  |  | 
COVID19_JANSSEN | Paracentesis eye normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite tissue specimen test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Compulsions | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Haematospermia | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte percentage | 0 | 0.001 | 0.255 | 1 | 2.143 |  |  |  |  |  | 
COVID19_JANSSEN | Shoulder dystocia | 0 | 0 | 0 | 1 | 5.674 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium test positive | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Bone formation increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcal sepsis | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroidectomy | 0 | 0 | 0.036 | 1 | 3.138 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangitis infective | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pityriasis | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Post-traumatic neuralgia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic disease | 0 | 0 | 0.033 | 1 | 3.17 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system mass | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin G increased | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Haematology test normal | 0 | 0 | 0.103 | 1 | 2.671 |  |  |  |  |  | 
COVID19_JANSSEN | Postmortem blood drug level increased | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Babesiosis | 0 | 0 | 0.012 | 1 | 3.516 |  |  |  |  |  | 
COVID19_JANSSEN | Poor quality product administered | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | Antineutrophil cytoplasmic antibody increased | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroiditis | 0 | 0 | 0.193 | 1 | 2.323 |  |  |  |  |  | 
COVID19_JANSSEN | Weight increased | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Cell-mediated immune deficiency | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alcohol normal | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Neurogenic bowel | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus test negative | 0 | 0 | 0.126 | 1 | 2.565 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil count increased | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Human rhinovirus test | 0 | 0 | 0.21 | 1 | 2.269 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram retina abnormal | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Perineal abscess | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_JANSSEN | Prophylaxis | 0 | 0 | 0 | 1 | 4.671 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis fulminant | 0 | 0 | 0.006 | 1 | 3.729 |  |  |  |  |  | 
COVID19_JANSSEN | Oral blood blister | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Waist circumference decreased | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocytosis | 0 | 0 | 0.006 | 1 | 3.708 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex encephalitis | 0 | 0.001 | 0.139 | 1 | 2.512 |  |  |  |  |  | 
COVID19_JANSSEN | Oculomucocutaneous syndrome | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Breast induration | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal operation | 0 | 0 | 0.001 | 1 | 4.208 |  |  |  |  |  | 
COVID19_JANSSEN | Scleroderma | 0 | 0 | 0.015 | 1 | 3.449 |  |  |  |  |  | 
COVID19_JANSSEN | Premature ejaculation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic transformation stroke | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Investigation abnormal | 0 | 0 | 0.136 | 1 | 2.526 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary cyst | 0 | 0 | 0.053 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Gestational age test abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal mass | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Nephrological examination | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrovascular disorder | 0 | 0 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic membrane rupture test positive | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | ADAMTS13 inhibitor screen assay | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Hemidysaesthesia | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bladder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory disorder | 0 | 0.001 | 0.196 | 1 | 2.311 |  |  |  |  |  | 
COVID19_JANSSEN | Stool analysis | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperreflexia | 0 | 0 | 0.087 | 1 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antigen negative | 0 | 0 | 0 | 1 | 5.75 |  |  |  |  |  | 
COVID19_JANSSEN | Blood uric acid normal | 0 | 0 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site nerve damage | 0 | 0 | 0.157 | 1 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Explorative laparotomy | 0 | 0 | 0.001 | 1 | 4.281 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal exposure during pregnancy | 0 | 0 | 0.126 | 1 | 2.564 |  |  |  |  |  | 
COVID19_JANSSEN | Post inflammatory pigmentation change | 0 | 0 | 0.001 | 1 | 4.1 |  |  |  |  |  | 
COVID19_JANSSEN | Globulins increased | 0 | 0 | 0.109 | 1 | 2.642 |  |  |  |  |  | 
COVID19_JANSSEN | Tibia fracture | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate normal | 0 | 0 | 0.001 | 1 | 4.173 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal examination abnormal | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lead increased | 0 | 0 | 0.018 | 1 | 3.401 |  |  |  |  |  | 
COVID19_JANSSEN | Vasopressive therapy | 0 | 0 | 0.013 | 1 | 3.493 |  |  |  |  |  | 
COVID19_JANSSEN | Medical diet | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_JANSSEN | Basilar migraine | 0 | 0 | 0.007 | 1 | 3.677 |  |  |  |  |  | 
COVID19_JANSSEN | Vital dye staining cornea present | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Surfactant protein | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Perineal pain | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Murine typhus | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder transitional cell carcinoma | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Adnexa uteri mass | 0 | 0 | 0.014 | 1 | 3.474 |  |  |  |  |  | 
COVID19_JANSSEN | Accessory spleen | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell hypochromic morphology present | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Product dose omission in error | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Investigation noncompliance | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic erosive gastritis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Colonic fistula | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cardio-respiratory arrest neonatal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer stage I | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Bone abscess | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactate dehydrogenase abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage subcutaneous | 0 | 0 | 0.005 | 1 | 3.781 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis aseptic | 0 | 0 | 0.022 | 1 | 3.318 |  |  |  |  |  | 
COVID19_JANSSEN | Central venous catheterisation | 0 | 0 | 0.268 | 1 | 2.109 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholesterol normal | 0 | 0 | 0.273 | 1 | 2.097 |  |  |  |  |  | 
COVID19_JANSSEN | Mumps antibody test | 0 | 0 | 0 | 1 | 5.032 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte count | 0 | 0 | 0.032 | 1 | 3.187 |  |  |  |  |  | 
COVID19_JANSSEN | Dyschezia | 0 | 0 | 0.027 | 1 | 3.254 |  |  |  |  |  | 
COVID19_JANSSEN | Colonoscopy normal | 0 | 0 | 0.264 | 1 | 2.119 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hypertension | 0 | 0 | 0.139 | 1 | 2.513 |  |  |  |  |  | 
COVID19_JANSSEN | Culture wound | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue inflammation | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B1 | 0 | 0 | 0.212 | 1 | 2.263 |  |  |  |  |  | 
COVID19_JANSSEN | Product lot number issue | 0 | 0 | 0.004 | 1 | 3.849 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alkaline phosphatase abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Enema administration | 0 | 0 | 0.015 | 1 | 3.448 |  |  |  |  |  | 
COVID19_JANSSEN | Nodular fasciitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Colitis | 0 | 0.001 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Complications of transplanted lung | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol poisoning | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | Acute leukaemia | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell volume abnormal | 0 | 0 | 0 | 1 | 4.649 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular pressure decreased | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal malformation | 0 | 0 | 0.036 | 1 | 3.141 |  |  |  |  |  | 
COVID19_JANSSEN | Arthroscopy abnormal | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Arrhythmia supraventricular | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil function test abnormal | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | NIH stroke scale | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Free thyroxine index normal | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system function test normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Anti factor VIII antibody positive | 0 | 0 | 0 | 1 | 5.552 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroglobulin increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Thymoma | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | SUNCT syndrome | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Rickettsiosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital inflammation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Delayed puberty | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital pulmonary valve disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Aldolase | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Food allergy | 0 | 0.001 | 0.174 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Quality of life decreased | 0 | 0 | 0.008 | 1 | 3.644 |  |  |  |  |  | 
COVID19_JANSSEN | Suicidal ideation | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin D decreased | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram abdomen normal | 0 | 0.001 | 0.297 | 1 | 2.039 |  |  |  |  |  | 
COVID19_JANSSEN | Lipase increased | 0 | 0.001 | 0.292 | 1 | 2.051 |  |  |  |  |  | 
COVID19_JANSSEN | Parkinson's disease | 0 | 0 | 0.156 | 1 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte count decreased | 0 | 0.001 | 0.168 | 1 | 2.404 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic kidney disease | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Amino acid level normal | 0 | 0 | 0.012 | 1 | 3.515 |  |  |  |  |  | 
COVID19_JANSSEN | Acute hepatic failure | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue paralysis | 0 | 0 | 0.159 | 1 | 2.436 |  |  |  |  |  | 
COVID19_JANSSEN | Nipple pain | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_JANSSEN | Human metapneumovirus test positive | 0 | 0 | 0.013 | 1 | 3.498 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile colic | 0 | 0 | 0.003 | 1 | 3.922 |  |  |  |  |  | 
COVID19_JANSSEN | Stiff person syndrome | 0 | 0 | 0 | 1 | 4.602 |  |  |  |  |  | 
COVID19_JANSSEN | Polyarteritis nodosa | 0 | 0 | 0 | 1 | 5.646 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngoscopy abnormal | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical hernia | 0 | 0 | 0 | 1 | 4.608 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle enzyme increased | 0 | 0 | 0.096 | 1 | 2.71 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract infection bacterial | 0 | 0 | 0 | 1 | 4.815 |  |  |  |  |  | 
COVID19_JANSSEN | Beta globulin | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoid hyperplasia of intestine | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus viraemia | 0 | 0 | 0.013 | 1 | 3.507 |  |  |  |  |  | 
COVID19_JANSSEN | Pupillary light reflex tests | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Auricular swelling | 0 | 0 | 0.093 | 1 | 2.721 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B complex deficiency | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_JANSSEN | Urine cytology | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Sciatic nerve neuropathy | 0 | 0 | 0.061 | 1 | 2.924 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes simplex meningoencephalitis | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign body in throat | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure orthostatic normal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Vanishing twin syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Transplantation complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Phaeochromocytoma | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian adenoma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Neutropenia | 0 | 0 | 0.156 | 1 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Acoustic stimulation tests | 0 | 0.001 | 0.259 | 1 | 2.133 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis autoimmune | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_JANSSEN | Middle ear inflammation | 0 | 0 | 0 | 1 | 4.866 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal haemorrhage | 0 | 0 | 0.001 | 1 | 4.206 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal artery occlusion | 0 | 0.001 | 0.159 | 1 | 2.437 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal skin infection | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_JANSSEN | Inner ear disorder | 0 | 0 | 0.169 | 1 | 2.4 |  |  |  |  |  | 
COVID19_JANSSEN | Urine organic acid test | 0 | 0 | 0.009 | 1 | 3.607 |  |  |  |  |  | 
COVID19_JANSSEN | Collagen disorder | 0 | 0 | 0 | 1 | 5.557 |  |  |  |  |  | 
COVID19_JANSSEN | Energy increased | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_JANSSEN | Melanocytic naevus | 0 | 0 | 0.01 | 1 | 3.589 |  |  |  |  |  | 
COVID19_JANSSEN | Penile haemorrhage | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_JANSSEN | Oral infection | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Metamyelocyte count | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Pyuria | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion related reaction | 0 | 0 | 0.004 | 1 | 3.843 |  |  |  |  |  | 
COVID19_JANSSEN | Stenosis | 0 | 0 | 0.033 | 1 | 3.173 |  |  |  |  |  | 
COVID19_JANSSEN | Recurrent cancer | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal epithelium defect | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine urine increased | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue geographic | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Retroviral infection | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Pleurodesis | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestine anastomosis | 0 | 0 | 0.084 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Interleukin therapy | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Immune tolerance induction | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Hereditary ataxia | 0 | 0 | 0.041 | 1 | 3.092 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac resynchronisation therapy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriovenous fistula operation | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Visual acuity reduced transiently | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Renal sympathetic nerve ablation | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Product substitution issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pituitary enlargement | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Placenta praevia haemorrhage | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to meninges | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Infantile septic granulomatosis | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Hypopituitarism | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Fulguration | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Dumping syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Dopamine transporter scintigraphy abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs positive haemolytic anaemia | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Rotator cuff syndrome | 0 | 0 | 0.024 | 1 | 3.286 |  |  |  |  |  | 
COVID19_JANSSEN | Communication disorder | 0 | 0 | 0.152 | 1 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site discolouration | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_JANSSEN | Ear, nose and throat examination normal | 0 | 0 | 0.018 | 1 | 3.383 |  |  |  |  |  | 
COVID19_JANSSEN | Low density lipoprotein normal | 0 | 0 | 0.3 | 1 | 2.032 |  |  |  |  |  | 
COVID19_JANSSEN | Immune complex assay | 0 | 0 | 0.131 | 1 | 2.545 |  |  |  |  |  | 
COVID19_JANSSEN | Skin premalignant disorders (SMQ) [narrow] | 0 | 0 | 0.015 | 1 | 3.446 |  |  |  |  |  | 
COVID19_JANSSEN | Product colour issue | 0 | 0 | 0.02 | 1 | 3.351 |  |  |  |  |  | 
COVID19_JANSSEN | Ileus paralytic | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_JANSSEN | Acute sinusitis | 0 | 0 | 0.19 | 1 | 2.332 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C | 0 | 0 | 0.005 | 1 | 3.782 |  |  |  |  |  | 
COVID19_JANSSEN | Breast feeding | 0 | 0 | 0.105 | 1 | 2.662 |  |  |  |  |  | 
COVID19_JANSSEN | Implantable cardiac monitor insertion | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Brain abscess | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Scan adrenal gland | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Plagiocephaly | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Electrolyte substitution therapy | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lactate decreased | 0 | 0 | 0.002 | 1 | 3.99 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia escherichia | 0 | 0 | 0 | 1 | 5.014 |  |  |  |  |  | 
COVID19_JANSSEN | Ectropion of cervix | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol test negative | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord ischaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Shunt occlusion | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudobulbar palsy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Post infection glomerulonephritis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema blister | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Liver transplant rejection | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Intravascular haemolysis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic ovarian cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Duodenal ulcer perforation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cellulitis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Alcoholism | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired diaphragmatic eventration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella post vaccine | 0 | 0 | 0 | 1 | 4.82 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lymphocyte count increased | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_JANSSEN | Enuresis | 0 | 0 | 0.022 | 1 | 3.323 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin E normal | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoscopy | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve block | 0 | 0 | 0.023 | 1 | 3.305 |  |  |  |  |  | 
COVID19_JANSSEN | Glossodynia | 0 | 0.002 | 0.468 | 1 | 1.694 |  |  |  |  |  | 
COVID19_JANSSEN | Myoclonic epilepsy | 0 | 0 | 0.009 | 1 | 3.603 |  |  |  |  |  | 
COVID19_JANSSEN | Hypogammaglobulinaemia | 0 | 0 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_JANSSEN | Granuloma annulare | 0 | 0 | 0.152 | 1 | 2.463 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin unconjugated increased | 0 | 0 | 0.001 | 1 | 4.108 |  |  |  |  |  | 
COVID19_JANSSEN | Lacunar infarction | 0 | 0 | 0.126 | 1 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal disorder | 0 | 0 | 0.208 | 1 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Lordosis | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Brain contusion | 0 | 0 | 0.01 | 1 | 3.567 |  |  |  |  |  | 
COVID19_JANSSEN | Alopecia totalis | 0 | 0 | 0.002 | 1 | 3.979 |  |  |  |  |  | 
COVID19_JANSSEN | Hypochromic anaemia | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Emotional disorder of childhood | 0 | 0 | 0.004 | 1 | 3.829 |  |  |  |  |  | 
COVID19_JANSSEN | Poor weight gain neonatal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Osteomyelitis chronic | 0 | 0 | 0.004 | 1 | 3.827 |  |  |  |  |  | 
COVID19_JANSSEN | Meniscus operation | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Prescription drug used without a prescription | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Omphalitis | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_JANSSEN | Liver tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine renal clearance normal | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Antigliadin antibody | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_JANSSEN | Urea renal clearance | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic leukoencephalopathy | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Pinguecula | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Peak expiratory flow rate abnormal | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic discomfort | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Paraganglion neoplasm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Nail pitting | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal headache | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Drug ineffective for unapproved indication | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival disorder | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Crying | 0 | 0.001 | 0.264 | 1 | 2.119 |  |  |  |  |  | 
COVID19_JANSSEN | Febrile convulsion | 0 | 0 | 0.124 | 1 | 2.574 |  |  |  |  |  | 
COVID19_JANSSEN | Ileocaecal resection | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Glossopharyngeal nerve paralysis | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic pneumonia acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Dementia with Lewy bodies | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Calcific deposits removal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site nodule | 0 | 0 | 0.139 | 1 | 2.514 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcal infection | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Drug interaction | 0 | 0 | 0.001 | 1 | 4.241 |  |  |  |  |  | 
COVID19_JANSSEN | Social problem | 0 | 0 | 0 | 1 | 5.321 |  |  |  |  |  | 
COVID19_JANSSEN | Glycosylated haemoglobin increased | 0 | 0.001 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | CSF culture | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound liver normal | 0 | 0 | 0.184 | 1 | 2.352 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar stroke | 0 | 0.001 | 0.222 | 1 | 2.234 |  |  |  |  |  | 
COVID19_JANSSEN | Blood folate decreased | 0 | 0 | 0.017 | 1 | 3.403 |  |  |  |  |  | 
COVID19_JANSSEN | Pernicious anaemia | 0 | 0 | 0.014 | 1 | 3.485 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar infarction | 0 | 0 | 0.036 | 1 | 3.135 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin unconjugated decreased | 0 | 0 | 0.067 | 1 | 2.875 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory papilloma | 0 | 0 | 0 | 1 | 4.775 |  |  |  |  |  | 
COVID19_JANSSEN | Colon cancer | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal inflammation | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural decortication | 0 | 0 | 0.036 | 1 | 3.142 |  |  |  |  |  | 
COVID19_JANSSEN | Obsessive-compulsive symptom | 0 | 0 | 0.023 | 1 | 3.308 |  |  |  |  |  | 
COVID19_JANSSEN | Helplessness | 0 | 0 | 0.01 | 1 | 3.571 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac aneurysm | 0 | 0 | 0.026 | 1 | 3.26 |  |  |  |  |  | 
COVID19_JANSSEN | Blood prolactin | 0 | 0 | 0.025 | 1 | 3.279 |  |  |  |  |  | 
COVID19_JANSSEN | Absence of immediate treatment response | 0 | 0 | 0.007 | 1 | 3.683 |  |  |  |  |  | 
COVID19_JANSSEN | Myasthenia gravis crisis | 0 | 0 | 0.117 | 1 | 2.607 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric vein thrombosis | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_JANSSEN | Diffuse alopecia | 0 | 0 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_JANSSEN | Blood HIV RNA | 0 | 0 | 0.039 | 1 | 3.113 |  |  |  |  |  | 
COVID19_JANSSEN | Postmenopause | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal injury | 0 | 0 | 0.043 | 1 | 3.069 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus chorioretinitis | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor XII level normal | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_JANSSEN | Residual urine volume increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Multisystem inflammatory syndrome in children | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Latent tuberculosis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal operation | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertonia | 0 | 0 | 0.032 | 1 | 3.182 |  |  |  |  |  | 
COVID19_JANSSEN | Orthostatic intolerance | 0 | 0 | 0 | 1 | 5.729 |  |  |  |  |  | 
COVID19_JANSSEN | Gram stain | 0 | 0.001 | 0.157 | 1 | 2.443 |  |  |  |  |  | 
COVID19_JANSSEN | Type 2 diabetes mellitus | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperkalaemia | 0 | 0 | 0.003 | 1 | 3.937 |  |  |  |  |  | 
COVID19_JANSSEN | Rosacea | 0 | 0 | 0.285 | 1 | 2.069 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanic membrane perforation | 0 | 0 | 0.237 | 1 | 2.192 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin | 0 | 0.001 | 0.101 | 1 | 2.678 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-neutrophil cytoplasmic antibody positive vasculitis | 0 | 0 | 0 | 1 | 4.361 |  |  |  |  |  | 
COVID19_JANSSEN | Physical examination normal | 0 | 0 | 0.092 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature normal | 0 | 0.001 | 0.15 | 1 | 2.47 |  |  |  |  |  | 
COVID19_JANSSEN | Internal haemorrhage | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | CSF virus identified | 0 | 0 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_JANSSEN | IIIrd nerve paresis | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatosis | 0 | 0 | 0.006 | 1 | 3.749 |  |  |  |  |  | 
COVID19_JANSSEN | Vocal cord dysfunction | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Stress urinary incontinence | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_JANSSEN | Acid base balance normal | 0 | 0 | 0.022 | 1 | 3.315 |  |  |  |  |  | 
COVID19_JANSSEN | Medical induction of coma | 0 | 0 | 0.131 | 1 | 2.544 |  |  |  |  |  | 
COVID19_JANSSEN | Type I hypersensitivity | 0 | 0 | 0 | 1 | 4.407 |  |  |  |  |  | 
COVID19_JANSSEN | Roseolovirus test positive | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Myelodysplastic syndrome (SMQ) [narrow] | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular failure | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet morphology normal | 0 | 0 | 0.008 | 1 | 3.634 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour marker test | 0 | 0 | 0 | 1 | 4.777 |  |  |  |  |  | 
COVID19_JANSSEN | Retinol binding protein | 0 | 0 | 0 | 1 | 4.466 |  |  |  |  |  | 
COVID19_JANSSEN | Blood osmolarity normal | 0 | 0 | 0.005 | 1 | 3.774 |  |  |  |  |  | 
COVID19_JANSSEN | Aptyalism | 0 | 0 | 0.106 | 1 | 2.655 |  |  |  |  |  | 
COVID19_JANSSEN | Oestradiol | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | Humoral immune defect | 0 | 0 | 0 | 1 | 5.493 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary sediment | 0 | 0 | 0.005 | 1 | 3.769 |  |  |  |  |  | 
COVID19_JANSSEN | Haptoglobin increased | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Fistula | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria pigmentosa | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal respiratory distress | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Intraocular pressure test abnormal | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_JANSSEN | Septic rash | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral haemorrhage | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Palatal palsy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Myelocyte percentage decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphatic obstruction | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised onset non-motor seizure | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal biophysical profile score normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoviral meningitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell count increased | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Rubella antibody negative | 0 | 0 | 0 | 1 | 5.131 |  |  |  |  |  | 
COVID19_JANSSEN | Lens disorders (SMQ) [narrow] | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Haematology test | 0 | 0 | 0.19 | 1 | 2.33 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal hypokinesia | 0 | 0 | 0 | 1 | 4.712 |  |  |  |  |  | 
COVID19_JANSSEN | Positron emission tomogram abnormal | 0 | 0 | 0.034 | 1 | 3.167 |  |  |  |  |  | 
COVID19_JANSSEN | Gram stain positive | 0 | 0 | 0.21 | 1 | 2.268 |  |  |  |  |  | 
COVID19_JANSSEN | Urine chloride | 0 | 0 | 0 | 1 | 5.816 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy site unspecified normal | 0 | 0 | 0 | 1 | 5.2 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph gland infection | 0 | 0 | 0.21 | 1 | 2.27 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral motor neuropathy | 0 | 0 | 0.095 | 1 | 2.714 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral circulatory failure | 0 | 0 | 0.003 | 1 | 3.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrocele | 0 | 0 | 0.003 | 1 | 3.918 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary system x-ray normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Kinesitherapy | 0 | 0 | 0.011 | 1 | 3.563 |  |  |  |  |  | 
COVID19_JANSSEN | Laparoscopy | 0 | 0 | 0.009 | 1 | 3.618 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperbilirubinaemia neonatal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis viral | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Carcinoma in situ | 0 | 0 | 0.011 | 1 | 3.554 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombin time normal | 0 | 0 | 0.001 | 1 | 4.173 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve neurostimulation | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Neurosurgery | 0 | 0 | 0.084 | 1 | 2.776 |  |  |  |  |  | 
COVID19_JANSSEN | Allogenic stem cell transplantation | 0 | 0 | 0.034 | 1 | 3.167 |  |  |  |  |  | 
COVID19_JANSSEN | Parathyroid hormone-related protein increased | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect product administration duration | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_JANSSEN | Haemostasis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Epidural analgesia | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal labour affecting foetus | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin D abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site dermatitis | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroglobulin present | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue haemorrhage | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Sepsis syndrome | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Progressive relapsing multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Mononucleosis syndrome | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic enzyme decreased | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_JANSSEN | EGFR gene mutation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Decompression sickness | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein B increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site bruising | 0 | 0.001 | 0.214 | 1 | 2.256 |  |  |  |  |  | 
COVID19_JANSSEN | CSF culture positive | 0 | 0 | 0 | 1 | 4.379 |  |  |  |  |  | 
COVID19_JANSSEN | Inability to crawl | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac monitoring normal | 0 | 0 | 0.198 | 1 | 2.305 |  |  |  |  |  | 
COVID19_JANSSEN | Miosis | 0 | 0 | 0.24 | 1 | 2.183 |  |  |  |  |  | 
COVID19_JANSSEN | Hernia | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar erythema | 0 | 0 | 0.024 | 1 | 3.299 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma cell myeloma | 0 | 0 | 0.003 | 1 | 3.883 |  |  |  |  |  | 
COVID19_JANSSEN | Application site reaction | 0 | 0 | 0.002 | 1 | 4.022 |  |  |  |  |  | 
COVID19_JANSSEN | Fear of death | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal exudates | 0 | 0 | 0.109 | 1 | 2.642 |  |  |  |  |  | 
COVID19_JANSSEN | Coxsackie virus test negative | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Reaction to previous exposure to any vaccine | 0 | 0 | 0.178 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoelectrophoresis | 0 | 0 | 0.031 | 1 | 3.196 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal opacity | 0 | 0 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site dryness | 0 | 0 | 0 | 1 | 5.819 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin increased | 0 | 0 | 0.014 | 1 | 3.479 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural complication | 0 | 0 | 0.021 | 1 | 3.332 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site haemorrhage | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Postpartum haemorrhage | 0 | 0 | 0 | 1 | 4.617 |  |  |  |  |  | 
COVID19_JANSSEN | Urodynamics measurement | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose-6-phosphate dehydrogenase deficiency | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Parophthalmia | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Non-small cell lung cancer | 0 | 0 | 0.004 | 1 | 3.851 |  |  |  |  |  | 
COVID19_JANSSEN | Waterhouse-Friderichsen syndrome | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal infarction | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Neurologic neglect syndrome | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngitis viral | 0 | 0 | 0.022 | 1 | 3.32 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QRS complex | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic ketoacidotic hyperglycaemic coma | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cadmium increased | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis viral | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_JANSSEN | Acetonaemia | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Withdrawal hypertension | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic specific antigen decreased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Product intolerance | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Product design issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Portal hypertensive gastropathy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbosacral plexus lesion | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Intrinsic factor antibody | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Bence Jones protein urine present | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Application site haematoma | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-thrombin antibody | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal neoplasm | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid ptosis | 0 | 0.001 | 0.481 | 1 | 1.672 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte count normal | 0 | 0.001 | 0.19 | 1 | 2.329 |  |  |  |  |  | 
COVID19_JANSSEN | Proteinuria | 0 | 0 | 0.012 | 1 | 3.524 |  |  |  |  |  | 
COVID19_JANSSEN | Floppy infant | 0 | 0 | 0.004 | 1 | 3.847 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilus test positive | 0 | 0 | 0 | 1 | 5.539 |  |  |  |  |  | 
COVID19_JANSSEN | Mumps antibody test positive | 0 | 0 | 0 | 1 | 5.038 |  |  |  |  |  | 
COVID19_JANSSEN | Anal polyp | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis post immunisation | 0 | 0 | 0 | 1 | 4.335 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal movement disorder | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site macule | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal irrigation | 0 | 0 | 0.011 | 1 | 3.546 |  |  |  |  |  | 
COVID19_JANSSEN | Anastomotic ulcer | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal respiratory depression | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Toe walking | 0 | 0 | 0.013 | 1 | 3.497 |  |  |  |  |  | 
COVID19_JANSSEN | Osteochondritis | 0 | 0 | 0.009 | 1 | 3.618 |  |  |  |  |  | 
COVID19_JANSSEN | Total lung capacity | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product effect delayed | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Borrelia test | 0 | 0 | 0.386 | 1 | 1.847 |  |  |  |  |  | 
COVID19_JANSSEN | Noctiphobia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Moaning | 0 | 0 | 0.185 | 1 | 2.347 |  |  |  |  |  | 
COVID19_JANSSEN | Alanine aminotransferase abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Granulomatous liver disease | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Swallow study | 0 | 0 | 0.122 | 1 | 2.582 |  |  |  |  |  | 
COVID19_JANSSEN | Axillary nerve injury | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Organic acid analysis | 0 | 0 | 0.001 | 1 | 4.109 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral venous thrombosis | 0 | 0 | 0.032 | 1 | 3.191 |  |  |  |  |  | 
COVID19_JANSSEN | Foot operation | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pyelitis | 0 | 0 | 0.001 | 1 | 4.241 |  |  |  |  |  | 
COVID19_JANSSEN | Skin oedema | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Product distribution issue | 0 | 0 | 0 | 1 | 5.825 |  |  |  |  |  | 
COVID19_JANSSEN | Iron metabolism disorder | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary angioplasty | 0 | 0 | 0.061 | 1 | 2.924 |  |  |  |  |  | 
COVID19_JANSSEN | Submaxillary gland enlargement | 0 | 0 | 0.122 | 1 | 2.585 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine abscess | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural haematoma | 0 | 0 | 0.01 | 1 | 3.581 |  |  |  |  |  | 
COVID19_JANSSEN | Ceruloplasmin normal | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint swelling | 0 | 0 | 0.235 | 1 | 2.196 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital and neonatal arrhythmias (SMQ) [broad] | 0 | 0 | 0.002 | 1 | 3.981 |  |  |  |  |  | 
COVID19_JANSSEN | Educational problem | 0 | 0 | 0 | 1 | 4.763 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage in pregnancy | 0 | 0 | 0.031 | 1 | 3.203 |  |  |  |  |  | 
COVID19_JANSSEN | Parotid abscess | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Visual tracking test abnormal | 0 | 0 | 0.043 | 1 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Compartment syndrome | 0 | 0 | 0.004 | 1 | 3.853 |  |  |  |  |  | 
COVID19_JANSSEN | Verbigeration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital syphilitic osteochondritis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | DNA test for fragile X | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic specific antigen | 0 | 0 | 0.129 | 1 | 2.555 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to metals | 0 | 0 | 0 | 1 | 4.936 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrosis | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to vaccinated person | 0 | 0 | 0 | 1 | 5.353 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site pain | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Streptobacillus infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | HIV infection | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Dissociative amnesia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Skin mass | 0 | 0.001 | 0.265 | 1 | 2.116 |  |  |  |  |  | 
COVID19_JANSSEN | Substance abuse | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural haematoma evacuation | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal anaesthesia | 0 | 0 | 0.014 | 1 | 3.479 |  |  |  |  |  | 
COVID19_JANSSEN | Intercepted product dispensing error | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site discharge | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Female sex hormone level abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Negativism | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Borrelia test positive | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage urinary tract | 0 | 0 | 0.001 | 1 | 4.081 |  |  |  |  |  | 
COVID19_JANSSEN | Chorioretinal atrophy | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic infection | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Serum ferritin abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Premenstrual syndrome | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_JANSSEN | Decubitus ulcer | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Apgar score abnormal | 0 | 0 | 0 | 1 | 5.322 |  |  |  |  |  | 
COVID19_JANSSEN | Breast neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.202 | 1 | 2.295 |  |  |  |  |  | 
COVID19_JANSSEN | Enterostomy | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Apraxia | 0 | 0.001 | 0.264 | 1 | 2.121 |  |  |  |  |  | 
COVID19_JANSSEN | Acidosis hyperchloraemic | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound skull normal | 0 | 0 | 0 | 1 | 4.975 |  |  |  |  |  | 
COVID19_JANSSEN | Kluver-Bucy syndrome | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Incarcerated umbilical hernia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Palatal oedema | 0 | 0 | 0.043 | 1 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Atonic urinary bladder | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis mumps | 0 | 0 | 0.002 | 1 | 3.996 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular occlusion | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic haemorrhage | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_JANSSEN | Appendix cancer | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes virus test | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Orbital oedema | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity unsaturated | 0 | 0 | 0.034 | 1 | 3.158 |  |  |  |  |  | 
COVID19_JANSSEN | Rubivirus test positive | 0 | 0 | 0 | 1 | 5.68 |  |  |  |  |  | 
COVID19_JANSSEN | Micturition frequency decreased | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Therapy naive | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Anterior interosseous syndrome | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Suppressed lactation | 0 | 0 | 0.001 | 1 | 4.099 |  |  |  |  |  | 
COVID19_JANSSEN | Hair growth rate abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VIII level decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemia neonatal | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-insulin antibody positive | 0 | 0 | 0 | 1 | 4.684 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament pain | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration bone marrow | 0 | 0 | 0.168 | 1 | 2.406 |  |  |  |  |  | 
COVID19_JANSSEN | Non-24-hour sleep-wake disorder | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Device related infection | 0 | 0 | 0.108 | 1 | 2.649 |  |  |  |  |  | 
COVID19_JANSSEN | Cataract operation | 0 | 0.001 | 0.229 | 1 | 2.213 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate malignant tumours (SMQ) [broad] | 0 | 0 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_JANSSEN | pH urine normal | 0 | 0 | 0.271 | 1 | 2.101 |  |  |  |  |  | 
COVID19_JANSSEN | Larynx irritation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumothorax | 0 | 0 | 0.169 | 1 | 2.401 |  |  |  |  |  | 
COVID19_JANSSEN | Physiotherapy | 0 | 0 | 0.014 | 1 | 3.485 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal hypertrophy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell disorder | 0 | 0 | 0.305 | 1 | 2.021 |  |  |  |  |  | 
COVID19_JANSSEN | Cytogenetic analysis | 0 | 0 | 0.41 | 1 | 1.801 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve paresis | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital haematoma | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Barium enema | 0 | 0 | 0.002 | 1 | 3.966 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral ataxia | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising enterocolitis neonatal | 0 | 0 | 0.01 | 1 | 3.575 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth injury | 0 | 0 | 0.015 | 1 | 3.457 |  |  |  |  |  | 
COVID19_JANSSEN | Liver tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal septum deviation | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Brain scan abnormal | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Bicytopenia | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal light reflex test abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Weight gain poor | 0 | 0 | 0.104 | 1 | 2.668 |  |  |  |  |  | 
COVID19_JANSSEN | Acute stress disorder | 0 | 0 | 0.043 | 1 | 3.069 |  |  |  |  |  | 
COVID19_JANSSEN | Vibratory sense increased | 0 | 0 | 0.241 | 1 | 2.181 |  |  |  |  |  | 
COVID19_JANSSEN | Humidity intolerance | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cystectomy | 0 | 0 | 0.03 | 1 | 3.215 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Enzyme level test | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Blood electrolytes abnormal | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival hyperaemia | 0 | 0 | 0.199 | 1 | 2.304 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy spinal cord | 0 | 0 | 0.061 | 1 | 2.924 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site eczema | 0 | 0 | 0 | 1 | 5.158 |  |  |  |  |  | 
COVID19_JANSSEN | Monocytosis | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_JANSSEN | Viral load | 0 | 0 | 0.002 | 1 | 4.023 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter culture positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival follicles | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Glassy eyes | 0 | 0 | 0.47 | 1 | 1.691 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine dilation and evacuation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Liver tenderness | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site coldness | 0 | 0 | 0.097 | 1 | 2.701 |  |  |  |  |  | 
COVID19_JANSSEN | Lividity | 0 | 0 | 0.008 | 1 | 3.629 |  |  |  |  |  | 
COVID19_JANSSEN | Adductor vocal cord weakness | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Acute flaccid myelitis | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitis necrotising | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Skin sensitisation | 0 | 0 | 0.248 | 1 | 2.162 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to pelvis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Rubella antibody positive | 0 | 0 | 0 | 1 | 4.912 |  |  |  |  |  | 
COVID19_JANSSEN | Hypovitaminosis | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | Patient uncooperative | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary resection | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Saliva analysis normal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon calcification | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Vasodilation procedure | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasm prostate | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis bacterial | 0 | 0 | 0.227 | 1 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | Mania | 0 | 0 | 0.165 | 1 | 2.414 |  |  |  |  |  | 
COVID19_JANSSEN | Echoencephalogram normal | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin A | 0 | 0 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin I | 0 | 0.001 | 0.249 | 1 | 2.158 |  |  |  |  |  | 
COVID19_JANSSEN | Target skin lesion | 0 | 0 | 0.114 | 1 | 2.618 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-glomerular basement membrane antibody negative | 0 | 0 | 0 | 1 | 5.546 |  |  |  |  |  | 
COVID19_JANSSEN | Lip disorder | 0 | 0 | 0.257 | 1 | 2.138 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic valve disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Perivascular dermatitis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Brachytherapy | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin resistance | 0 | 0 | 0 | 1 | 4.92 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary tuberculosis | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Colostomy | 0 | 0 | 0.002 | 1 | 3.994 |  |  |  |  |  | 
COVID19_JANSSEN | Iron deficiency | 0 | 0 | 0.027 | 1 | 3.248 |  |  |  |  |  | 
COVID19_JANSSEN | Skin indentation | 0 | 0 | 0.202 | 1 | 2.295 |  |  |  |  |  | 
COVID19_JANSSEN | Hand-eye coordination impaired | 0 | 0 | 0.15 | 1 | 2.471 |  |  |  |  |  | 
COVID19_JANSSEN | Indifference | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Antiacetylcholine receptor antibody positive | 0 | 0 | 0.006 | 1 | 3.745 |  |  |  |  |  | 
COVID19_JANSSEN | Reactogenicity event | 0 | 0 | 0 | 1 | 4.408 |  |  |  |  |  | 
COVID19_JANSSEN | Pupil dilation procedure | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte count abnormal | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Artificial crown procedure | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter placement | 0 | 0.001 | 0.185 | 1 | 2.347 |  |  |  |  |  | 
COVID19_JANSSEN | Primary hypothyroidism | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vasculitis | 0 | 0 | 0.171 | 1 | 2.393 |  |  |  |  |  | 
COVID19_JANSSEN | Suicide threat | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Stool analysis normal | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound antenatal screen normal | 0 | 0 | 0.001 | 1 | 4.277 |  |  |  |  |  | 
COVID19_JANSSEN | Precancerous skin lesion | 0 | 0 | 0 | 1 | 5.068 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilia | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet function test | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube dysfunction | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [narrow] | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Medical device pain | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophilic dermatosis | 0 | 0 | 0 | 1 | 5.249 |  |  |  |  |  | 
COVID19_JANSSEN | Aspergillus test negative | 0 | 0 | 0.022 | 1 | 3.316 |  |  |  |  |  | 
COVID19_JANSSEN | Head lag | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Listeria test | 0 | 0 | 0.002 | 1 | 3.978 |  |  |  |  |  | 
COVID19_JANSSEN | Bartonellosis | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal leukoplakia | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Fundoscopy normal | 0 | 0 | 0.011 | 1 | 3.556 |  |  |  |  |  | 
COVID19_JANSSEN | Myeloblast percentage | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune pancreatitis | 0 | 0 | 0.041 | 1 | 3.092 |  |  |  |  |  | 
COVID19_JANSSEN | Ear, nose and throat examination abnormal | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Antimicrobial susceptibility test intermediate | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure diastolic abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Barotitis media | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Hair colour changes | 0 | 0 | 0.002 | 1 | 4.034 |  |  |  |  |  | 
COVID19_JANSSEN | Dengue virus test positive | 0 | 0 | 0.001 | 1 | 4.171 |  |  |  |  |  | 
COVID19_JANSSEN | Hypernatraemia | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Renal function test normal | 0 | 0 | 0.03 | 1 | 3.214 |  |  |  |  |  | 
COVID19_JANSSEN | Brain oedema | 0 | 0.001 | 0.103 | 1 | 2.671 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow oedema | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac ventricular disorder | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal angioedema | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid haematoma | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Subcutaneous biopsy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Joint manipulation | 0 | 0 | 0.002 | 1 | 3.961 |  |  |  |  |  | 
COVID19_JANSSEN | Granulomatosis with polyangiitis | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Thermometry | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Chest tube insertion | 0 | 0 | 0.247 | 1 | 2.166 |  |  |  |  |  | 
COVID19_JANSSEN | Intellectual disability | 0 | 0 | 0.02 | 1 | 3.359 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal anuria | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Cheilitis | 0 | 0 | 0.274 | 1 | 2.096 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aldosterone decreased | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Middle ear disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal calprotectin | 0 | 0 | 0.026 | 1 | 3.265 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal candidiasis | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Hereditary disorder | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid arthritis | 0 | 0 | 0.024 | 1 | 3.289 |  |  |  |  |  | 
COVID19_JANSSEN | Suicide/self-injury (SMQ) [narrow] | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Romberg test positive | 0 | 0 | 0.039 | 1 | 3.11 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite stool test negative | 0 | 0 | 0.006 | 1 | 3.748 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal stoma complication | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid myoclonus | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_JANSSEN | Yersinia test | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Myelopathy | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Diaphragmatic paralysis | 0 | 0 | 0.13 | 1 | 2.551 |  |  |  |  |  | 
COVID19_JANSSEN | Cystatin C | 0 | 0 | 0 | 1 | 4.433 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal lymphadenopathy | 0 | 0 | 0.122 | 1 | 2.583 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolar rhabdomyosarcoma | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mineral supplementation | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Parakeratosis | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital teratoma | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin urine normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal oedema | 0 | 0 | 0.003 | 1 | 3.931 |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube cancer metastatic | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess intestinal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Heart injury | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal disorder | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Culture stool | 0 | 0 | 0.099 | 1 | 2.691 |  |  |  |  |  | 
COVID19_JANSSEN | Lasegue's test | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic carcinoma | 0 | 0 | 0.12 | 1 | 2.593 |  |  |  |  |  | 
COVID19_JANSSEN | Bicuspid aortic valve | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | FEV1/FVC ratio | 0 | 0 | 0.032 | 1 | 3.191 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal dialysis | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Similar reaction on previous exposure to drug | 0 | 0 | 0.24 | 1 | 2.183 |  |  |  |  |  | 
COVID19_JANSSEN | Nail dystrophy | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Anuria | 0 | 0 | 0.011 | 1 | 3.55 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary system X-ray | 0 | 0 | 0.196 | 1 | 2.313 |  |  |  |  |  | 
COVID19_JANSSEN | Aphthous ulcer | 0 | 0 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_JANSSEN | Cushingoid | 0 | 0 | 0.029 | 1 | 3.228 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus test | 0 | 0.002 | 0.279 | 1 | 2.082 |  |  |  |  |  | 
COVID19_JANSSEN | Typhus | 0 | 0 | 0.001 | 1 | 4.099 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcium increased | 0 | 0 | 0.12 | 1 | 2.592 |  |  |  |  |  | 
COVID19_JANSSEN | Paronychia | 0 | 0 | 0.012 | 1 | 3.523 |  |  |  |  |  | 
COVID19_JANSSEN | Prolonged pregnancy | 0 | 0 | 0.015 | 1 | 3.463 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-cyclic citrullinated peptide antibody negative | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Eye inflammation | 0 | 0.001 | 0.276 | 1 | 2.09 |  |  |  |  |  | 
COVID19_JANSSEN | Pigmentation lip | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | CSF myelin basic protein normal | 0 | 0 | 0.016 | 1 | 3.436 |  |  |  |  |  | 
COVID19_JANSSEN | Medical device site joint pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Rash neonatal | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Enterocolitis bacterial | 0 | 0 | 0.019 | 1 | 3.378 |  |  |  |  |  | 
COVID19_JANSSEN | Mammoplasty | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Amylase | 0 | 0 | 0.258 | 1 | 2.136 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder operation | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Disease prodromal stage | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram spine | 0 | 0.002 | 0.33 | 1 | 1.962 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve infarction | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Nail picking | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular ischaemic syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Discouragement | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Rapid eye movements sleep abnormal | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Neurodegenerative disorder | 0 | 0 | 0.003 | 1 | 3.887 |  |  |  |  |  | 
COVID19_JANSSEN | Opportunistic infection | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema eyelids | 0 | 0 | 0.005 | 1 | 3.769 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulopathy | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous lupus erythematosus | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoprotein (a) | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Amoebic dysentery | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Epidural blood patch | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Rotavirus test | 0 | 0 | 0.003 | 1 | 3.939 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary haemorrhage | 0 | 0 | 0.229 | 1 | 2.215 |  |  |  |  |  | 
COVID19_JANSSEN | Pyramidal tract syndrome | 0 | 0 | 0.002 | 1 | 3.958 |  |  |  |  |  | 
COVID19_JANSSEN | Undifferentiated connective tissue disease | 0 | 0 | 0.098 | 1 | 2.699 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac imaging procedure normal | 0 | 0 | 0.022 | 1 | 3.322 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MB normal | 0 | 0 | 0.008 | 1 | 3.645 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract infection bacterial | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_JANSSEN | Mixed connective tissue disease | 0 | 0 | 0 | 1 | 4.532 |  |  |  |  |  | 
COVID19_JANSSEN | Opiates negative | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Cold agglutinins | 0 | 0 | 0 | 1 | 4.341 |  |  |  |  |  | 
COVID19_JANSSEN | Urge incontinence | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Simple partial seizures | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Prohormone brain natriuretic peptide increased | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Lung diffusion test decreased | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site discolouration | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor level normal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site necrosis | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Urine aluminium increased | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell scan | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Primary progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctivitis viral | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram P wave abnormal | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular insufficiency | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Aldosterone urine | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Histone antibody | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle haemorrhage | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site hypertrophy | 0 | 0 | 0.037 | 1 | 3.129 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary retention | 0 | 0.001 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Skin tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.122 | 1 | 2.582 |  |  |  |  |  | 
COVID19_JANSSEN | Polyomavirus test positive | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic cavity infection | 0 | 0 | 0 | 1 | 5.653 |  |  |  |  |  | 
COVID19_JANSSEN | Optic neuropathy | 0 | 0 | 0.013 | 1 | 3.494 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal operation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound uterus | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic duct dilatation | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Reversible airways obstruction | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin level | 0 | 0 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_JANSSEN | CSF protein normal | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_JANSSEN | Palliative care | 0 | 0 | 0.165 | 1 | 2.417 |  |  |  |  |  | 
COVID19_JANSSEN | Interferon alpha level decreased | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bicarbonate abnormal | 0 | 0 | 0.023 | 1 | 3.302 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoid tissue hyperplasia | 0 | 0 | 0.007 | 1 | 3.689 |  |  |  |  |  | 
COVID19_JANSSEN | Amyotrophy | 0 | 0 | 0.034 | 1 | 3.164 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil count normal | 0 | 0.001 | 0.253 | 1 | 2.147 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic prolapse | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune dermatitis | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic embolisation | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Impetigo | 0 | 0 | 0.252 | 1 | 2.152 |  |  |  |  |  | 
COVID19_JANSSEN | Non-haematological tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Chorioretinal disorder | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Urogenital disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid boil | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Free thyroxine index increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalocele | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Mineral deficiency | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Craniectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell burr cells present | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary alveolar haemorrhage | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet adhesiveness | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Paraesthesia mucosal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Parathyroid scan normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfective oophoritis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal tachypnoea | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric vascular insufficiency | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Median nerve injury | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemoid reaction | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Ichthyosis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular filtration rate abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram Q waves | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness congenital | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | BRCA1 gene mutation assay | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anomaly of external ear congenital | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Anaemia of chronic disease | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | CSF test abnormal | 0 | 0 | 0.03 | 1 | 3.207 |  |  |  |  |  | 
COVID19_JANSSEN | Extravasation events (injections, infusions and implants) (SMQ) [narrow] | 0 | 0.001 | 0.108 | 1 | 2.646 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy test | 0 | 0.001 | 0.459 | 1 | 1.71 |  |  |  |  |  | 
COVID19_JANSSEN | Concussion | 0 | 0 | 0.211 | 1 | 2.265 |  |  |  |  |  | 
COVID19_JANSSEN | Neuritis | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_JANSSEN | Occult blood negative | 0 | 0 | 0.053 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Inadequate aseptic technique in use of product | 0 | 0 | 0.206 | 1 | 2.28 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram pulmonary normal | 0 | 0.001 | 0.265 | 1 | 2.117 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired quality of life | 0 | 0 | 0.004 | 1 | 3.829 |  |  |  |  |  | 
COVID19_JANSSEN | Saliva altered | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial haemorrhage | 0 | 0 | 0.022 | 1 | 3.33 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell morphology normal | 0 | 0 | 0.022 | 1 | 3.32 |  |  |  |  |  | 
COVID19_JANSSEN | Red cell distribution width decreased | 0 | 0 | 0.102 | 1 | 2.679 |  |  |  |  |  | 
COVID19_JANSSEN | Precancerous mucosal lesion | 0 | 0 | 0 | 1 | 4.815 |  |  |  |  |  | 
COVID19_JANSSEN | Adverse food reaction | 0 | 0 | 0.001 | 1 | 4.124 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural effusion | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_JANSSEN | Mastocytoma | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Gulf war syndrome | 0 | 0 | 0.04 | 1 | 3.102 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal nerve stimulator implantation | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster necrotising retinopathy | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A antigen negative | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopic ultrasound abnormal | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Cystatin C increased | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_JANSSEN | CSF electrophoresis normal | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Spermatorrhoea | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Small intestine operation | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis bacterial | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Gamma-glutamyltransferase abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Gardnerella test positive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuser | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital renal disorder | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Antral follicle count | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Arthropod bite | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus test positive | 0 | 0 | 0.082 | 1 | 2.787 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site haemorrhage | 0 | 0 | 0.003 | 1 | 3.909 |  |  |  |  |  | 
COVID19_JANSSEN | Skin striae | 0 | 0 | 0.016 | 1 | 3.421 |  |  |  |  |  | 
COVID19_JANSSEN | Optical coherence tomography abnormal | 0 | 0 | 0.001 | 1 | 4.106 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray of pelvis and hip | 0 | 0 | 0.416 | 1 | 1.788 |  |  |  |  |  | 
COVID19_JANSSEN | Toxoplasma serology | 0 | 0 | 0 | 1 | 5.674 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous degeneration | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine mass | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal vein thrombosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Myeloproliferative neoplasm | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Myalgia intercostal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoblast count increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Fear of eating | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema marginatum | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy gastrointestinal normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Colour vision tests abnormal red-green | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Burkholderia test positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Alcoholic hangover | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | CSF test normal | 0 | 0.001 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Pyelonephritis | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatosplenomegaly | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Effusion | 0 | 0 | 0.196 | 1 | 2.313 |  |  |  |  |  | 
COVID19_JANSSEN | Basal ganglia stroke | 0 | 0 | 0.027 | 1 | 3.245 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue disorder | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet disorder | 0 | 0 | 0.183 | 1 | 2.355 |  |  |  |  |  | 
COVID19_JANSSEN | Peak expiratory flow rate decreased | 0 | 0 | 0.002 | 1 | 4.033 |  |  |  |  |  | 
COVID19_JANSSEN | Homeopathy | 0 | 0 | 0 | 1 | 4.589 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumomediastinum | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_JANSSEN | Neurone-specific enolase | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis erosive | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling of relaxation | 0 | 0 | 0.099 | 1 | 2.693 |  |  |  |  |  | 
COVID19_JANSSEN | Dyslexia | 0 | 0 | 0.089 | 1 | 2.746 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal obstruction | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis shigella | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Anticoagulation drug level | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong dose | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Provisional tic disorder | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Protein albumin ratio increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Nail matrix biopsy | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin-like growth factor decreased | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema vaccinatum | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Cystic lymphangioma | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Contact lens intolerance | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Change in sustained attention | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_JANSSEN | Product quality issue | 0 | 0 | 0.026 | 1 | 3.264 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint pain | 0 | 0.001 | 0.443 | 1 | 1.738 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site movement impairment | 0 | 0.001 | 0.139 | 1 | 2.512 |  |  |  |  |  | 
COVID19_JANSSEN | Learning disorder | 0 | 0 | 0.001 | 1 | 4.198 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac discomfort | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhoids | 0 | 0 | 0.172 | 1 | 2.392 |  |  |  |  |  | 
COVID19_JANSSEN | Mastoiditis | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_JANSSEN | Psychiatric evaluation normal | 0 | 0 | 0.001 | 1 | 4.139 |  |  |  |  |  | 
COVID19_JANSSEN | Vasoconstriction | 0 | 0 | 0.181 | 1 | 2.359 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal disorder | 0 | 0 | 0.021 | 1 | 3.334 |  |  |  |  |  | 
COVID19_JANSSEN | Left atrial enlargement | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Syringomyelia | 0 | 0 | 0.031 | 1 | 3.194 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy brain normal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | T-cell type acute leukaemia | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin electrophoresis normal | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Ejection fraction abnormal | 0 | 0 | 0.072 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Carditis | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_JANSSEN | Blood electrolytes decreased | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenocortical steroid therapy | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | White coat hypertension | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Threatened labour | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Subcorneal pustular dermatosis | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis necrotising | 0 | 0 | 0.043 | 1 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Fat necrosis | 0 | 0 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin urine present | 0 | 0 | 0.017 | 1 | 3.413 |  |  |  |  |  | 
COVID19_JANSSEN | Viral cardiomyopathy | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Type V hyperlipidaemia | 0 | 0 | 0.008 | 1 | 3.649 |  |  |  |  |  | 
COVID19_JANSSEN | Anembryonic gestation | 0 | 0 | 0.004 | 1 | 3.812 |  |  |  |  |  | 
COVID19_JANSSEN | Viral load undetectable | 0 | 0 | 0.001 | 1 | 4.125 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoconcentration | 0 | 0 | 0 | 1 | 4.79 |  |  |  |  |  | 
COVID19_JANSSEN | Nail growth abnormal | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_JANSSEN | Hypocoagulable state | 0 | 0 | 0.007 | 1 | 3.686 |  |  |  |  |  | 
COVID19_JANSSEN | Drug level increased | 0 | 0 | 0 | 1 | 4.748 |  |  |  |  |  | 
COVID19_JANSSEN | Somnolence neonatal | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial rupture | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial septal defect repair | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B6 increased | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Oestriol normal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_JANSSEN | Natural killer T cell count | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Nail hypertrophy | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal calprotectin decreased | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Buttock injury | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time ratio increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intussusception | 0 | 0 | 0.002 | 1 | 4.005 |  |  |  |  |  | 
COVID19_JANSSEN | Gallstone related disorders (SMQ) [broad] | 0 | 0.001 | 0.309 | 1 | 2.009 |  |  |  |  |  | 
COVID19_JANSSEN | Skin fissures | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Anion gap normal | 0 | 0 | 0.128 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone marrow normal | 0 | 0 | 0.023 | 1 | 3.31 |  |  |  |  |  | 
COVID19_JANSSEN | Blood heavy metal increased | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Proctalgia | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Excessive cerumen production | 0 | 0 | 0.163 | 1 | 2.422 |  |  |  |  |  | 
COVID19_JANSSEN | Cytopenia | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Drug-induced liver injury | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Osteonecrosis | 0 | 0 | 0.089 | 1 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestine perforation | 0 | 0 | 0 | 1 | 4.407 |  |  |  |  |  | 
COVID19_JANSSEN | Genital lesion | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Colour vision tests normal | 0 | 0 | 0 | 1 | 5.046 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure systolic abnormal | 0 | 0 | 0.009 | 1 | 3.6 |  |  |  |  |  | 
COVID19_JANSSEN | Bartonella test | 0 | 0 | 0.006 | 1 | 3.728 |  |  |  |  |  | 
COVID19_JANSSEN | Maculopathy | 0 | 0 | 0.104 | 1 | 2.665 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral circulatory failure | 0 | 0 | 0 | 1 | 5.045 |  |  |  |  |  | 
COVID19_JANSSEN | Abdomen scan | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_JANSSEN | Product odour abnormal | 0 | 0 | 0 | 1 | 5.742 |  |  |  |  |  | 
COVID19_JANSSEN | Serratia infection | 0 | 0 | 0.141 | 1 | 2.505 |  |  |  |  |  | 
COVID19_JANSSEN | Decorticate posture | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem haemorrhage | 0 | 0 | 0.098 | 1 | 2.699 |  |  |  |  |  | 
COVID19_JANSSEN | Visual snow syndrome | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid crystal | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Premenstrual headache | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngoscopy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Leukaemia in remission | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Body height below normal | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin normal | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_JANSSEN | Escherichia test positive | 0 | 0 | 0.118 | 1 | 2.602 |  |  |  |  |  | 
COVID19_JANSSEN | Product complaint | 0 | 0 | 0 | 1 | 5.03 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess drainage | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Lip pain | 0 | 0 | 0.135 | 1 | 2.531 |  |  |  |  |  | 
COVID19_JANSSEN | C-reactive protein decreased | 0 | 0 | 0.012 | 1 | 3.522 |  |  |  |  |  | 
COVID19_JANSSEN | Acute coronary syndrome | 0 | 0 | 0.131 | 1 | 2.543 |  |  |  |  |  | 
COVID19_JANSSEN | Coma scale | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time ratio | 0 | 0 | 0 | 1 | 4.376 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal plaque | 0 | 0 | 0.039 | 1 | 3.106 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoproteinaemia | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_JANSSEN | False positive investigation result | 0 | 0 | 0.096 | 1 | 2.71 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal deformity | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 globulin | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-1 test | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Keloid scar | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Hypercapnia | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperemesis gravidarum | 0 | 0 | 0.01 | 1 | 3.585 |  |  |  |  |  | 
COVID19_JANSSEN | Drop attacks | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Saccadic eye movement | 0 | 0 | 0.019 | 1 | 3.38 |  |  |  |  |  | 
COVID19_JANSSEN | Botulism | 0 | 0 | 0 | 1 | 4.667 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to plants | 0 | 0 | 0.025 | 1 | 3.273 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal decompression | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Prealbumin decreased | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Speech rehabilitation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell hyperchromic morphology present | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Infective exacerbation of chronic obstructive airways disease | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cell marker decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | CD8 lymphocyte percentage decreased | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy vagina | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan normal | 0 | 0.001 | 0.282 | 1 | 2.074 |  |  |  |  |  | 
COVID19_JANSSEN | Septic shock | 0 | 0 | 0.104 | 1 | 2.667 |  |  |  |  |  | 
COVID19_JANSSEN | Furuncle | 0 | 0 | 0.413 | 1 | 1.793 |  |  |  |  |  | 
COVID19_JANSSEN | Dark circles under eyes | 0 | 0 | 0.42 | 1 | 1.781 |  |  |  |  |  | 
COVID19_JANSSEN | T-lymphocyte count decreased | 0 | 0 | 0.001 | 1 | 4.149 |  |  |  |  |  | 
COVID19_JANSSEN | Mastitis | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_JANSSEN | Oliguria | 0 | 0 | 0 | 1 | 4.688 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue dry | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal vein occlusion | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Lhermitte's sign | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Hip surgery | 0 | 0 | 0.005 | 1 | 3.786 |  |  |  |  |  | 
COVID19_JANSSEN | Smear site unspecified abnormal | 0 | 0 | 0.146 | 1 | 2.484 |  |  |  |  |  | 
COVID19_JANSSEN | Chest scan | 0 | 0 | 0.002 | 1 | 4.043 |  |  |  |  |  | 
COVID19_JANSSEN | Benign rolandic epilepsy | 0 | 0 | 0.018 | 1 | 3.392 |  |  |  |  |  | 
COVID19_JANSSEN | Fine motor delay | 0 | 0 | 0 | 1 | 4.913 |  |  |  |  |  | 
COVID19_JANSSEN | Oestradiol decreased | 0 | 0 | 0.002 | 1 | 3.956 |  |  |  |  |  | 
COVID19_JANSSEN | Barium swallow normal | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis allergic | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Opsoclonus myoclonus | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Dehydroepiandrosterone test | 0 | 0 | 0.032 | 1 | 3.183 |  |  |  |  |  | 
COVID19_JANSSEN | Urine copper | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Head circumference abnormal | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Blood zinc increased | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_JANSSEN | Automatism | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Optic discs blurred | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Device power source issue | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical diathermy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy spinal cord abnormal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid index | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombocytopenic purpura | 0 | 0 | 0.003 | 1 | 3.923 |  |  |  |  |  | 
COVID19_JANSSEN | Haemolytic disorders (SMQ) [broad] | 0 | 0.001 | 0.161 | 1 | 2.427 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus test negative | 0 | 0 | 0.276 | 1 | 2.091 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose urine absent | 0 | 0 | 0.178 | 1 | 2.369 |  |  |  |  |  | 
COVID19_JANSSEN | Lipids | 0 | 0.002 | 0.42 | 1 | 1.781 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin concentration decreased | 0 | 0 | 0.218 | 1 | 2.246 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus infection | 0 | 0 | 0.004 | 1 | 3.864 |  |  |  |  |  | 
COVID19_JANSSEN | Functional lactation disorders (SMQ) [narrow] | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Product prescribing error | 0 | 0 | 0.176 | 1 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial hyperreactivity | 0 | 0 | 0.284 | 1 | 2.07 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet count abnormal | 0 | 0 | 0.179 | 1 | 2.369 |  |  |  |  |  | 
COVID19_JANSSEN | Cytokine test | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol use | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular arrhythmia | 0 | 0 | 0.037 | 1 | 3.126 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour excision | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Antimitochondrial antibody normal | 0 | 0 | 0.085 | 1 | 2.765 |  |  |  |  |  | 
COVID19_JANSSEN | Steatohepatitis | 0 | 0 | 0.002 | 1 | 4.023 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital pulmonary hypertension | 0 | 0 | 0 | 1 | 4.725 |  |  |  |  |  | 
COVID19_JANSSEN | Product administration interrupted | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal hypomotility | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Lung carcinoma cell type unspecified recurrent | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac perfusion defect | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Capillaritis | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol use disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Grunting | 0 | 0 | 0.302 | 1 | 2.027 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy upper gastrointestinal tract | 0 | 0 | 0.002 | 1 | 3.996 |  |  |  |  |  | 
COVID19_JANSSEN | Ear, nose and throat examination | 0 | 0 | 0.204 | 1 | 2.289 |  |  |  |  |  | 
COVID19_JANSSEN | Limb immobilisation | 0 | 0 | 0.009 | 1 | 3.625 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal pain | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Fontanelle depressed | 0 | 0 | 0 | 1 | 4.455 |  |  |  |  |  | 
COVID19_JANSSEN | Anorectal discomfort | 0 | 0 | 0.134 | 1 | 2.532 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder cancer | 0 | 0 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_JANSSEN | Autoinflammatory disease | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Giardia test | 0 | 0 | 0.029 | 1 | 3.228 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin urine absent | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_JANSSEN | Gait spastic | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | Onychalgia | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Application site nodule | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Urine chloride increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Residual urine volume | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Opticokinetic nystagmus tests normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Nipple disorder | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasm progression | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Klebsiella sepsis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Intraductal papillary mucinous neoplasm | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatoglyphic anomaly | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Blood arsenic increased | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_JANSSEN | Transient hypogammaglobulinaemia of infancy | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Immunodeficiency | 0 | 0 | 0.129 | 1 | 2.555 |  |  |  |  |  | 
COVID19_JANSSEN | Amniocentesis abnormal | 0 | 0 | 0.002 | 1 | 3.996 |  |  |  |  |  | 
COVID19_JANSSEN | Pericoronitis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cyanosis central | 0 | 0 | 0.017 | 1 | 3.418 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth disorder | 0 | 0 | 0.1 | 1 | 2.687 |  |  |  |  |  | 
COVID19_JANSSEN | Drug reaction with eosinophilia and systemic symptoms | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal (SMQ) [broad] | 0 | 0 | 0.219 | 1 | 2.243 |  |  |  |  |  | 
COVID19_JANSSEN | CSF monocyte count increased | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_JANSSEN | Myelodysplastic syndrome | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-GAD antibody | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Hernia repair | 0 | 0 | 0.133 | 1 | 2.536 |  |  |  |  |  | 
COVID19_JANSSEN | Lichenification | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatocellular carcinoma | 0 | 0 | 0 | 1 | 5.131 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic infection | 0 | 0 | 0.024 | 1 | 3.29 |  |  |  |  |  | 
COVID19_JANSSEN | Plasma viscosity normal | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Microphthalmos | 0 | 0 | 0.001 | 1 | 4.124 |  |  |  |  |  | 
COVID19_JANSSEN | Eye laser surgery | 0 | 0 | 0.025 | 1 | 3.28 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pH | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin decreased | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Teeth brittle | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_JANSSEN | Radioactive iodine therapy | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Non-tobacco user | 0 | 0 | 0.005 | 1 | 3.763 |  |  |  |  |  | 
COVID19_JANSSEN | Lasegue's test positive | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes virus test abnormal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid infection | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Complication of delivery | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Carbohydrate antigen 125 normal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Antimitochondrial antibody | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth socket haemorrhage | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic hypothermia | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Methaemoglobinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant neoplasm progression | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Astringent therapy | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration tracheal normal | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Mood altered | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_JANSSEN | Antinuclear antibody positive | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine and fallopian tube tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.635 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid disorder | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Twin pregnancy | 0 | 0 | 0 | 1 | 5.725 |  |  |  |  |  | 
COVID19_JANSSEN | T-lymphocyte count normal | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Seborrhoeic dermatitis | 0 | 0 | 0.12 | 1 | 2.592 |  |  |  |  |  | 
COVID19_JANSSEN | Acute haemorrhagic oedema of infancy | 0 | 0 | 0.002 | 1 | 4.052 |  |  |  |  |  | 
COVID19_JANSSEN | Colposcopy abnormal | 0 | 0 | 0 | 1 | 5.749 |  |  |  |  |  | 
COVID19_JANSSEN | Brudzinski's sign | 0 | 0 | 0 | 1 | 4.741 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric panniculitis | 0 | 0 | 0.01 | 1 | 3.569 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound bladder normal | 0 | 0 | 0.01 | 1 | 3.582 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular torsion | 0 | 0 | 0.008 | 1 | 3.653 |  |  |  |  |  | 
COVID19_JANSSEN | Renal haemorrhage | 0 | 0 | 0.087 | 1 | 2.755 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoparathyroidism | 0 | 0 | 0.032 | 1 | 3.182 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract infection pseudomonal | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract endoscopy | 0 | 0 | 0.019 | 1 | 3.374 |  |  |  |  |  | 
COVID19_JANSSEN | Oestradiol increased | 0 | 0 | 0.014 | 1 | 3.468 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic cerebellar infarction | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc disorder | 0 | 0 | 0.209 | 1 | 2.274 |  |  |  |  |  | 
COVID19_JANSSEN | Discoloured vomit | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site pain | 0 | 0 | 0.024 | 1 | 3.286 |  |  |  |  |  | 
COVID19_JANSSEN | Hepcidin test | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Cholera | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical radiculopathy | 0 | 0 | 0.176 | 1 | 2.377 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital central nervous system anomaly | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Enzyme activity assay | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic pneumonia | 0 | 0 | 0.033 | 1 | 3.171 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria pressure | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Non-haematological tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Anosognosia | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Blood carbon monoxide increased | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_JANSSEN | Finger deformity | 0 | 0 | 0.003 | 1 | 3.916 |  |  |  |  |  | 
COVID19_JANSSEN | Atrioventricular block second degree | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Hypofibrinogenaemia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Brain operation | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_JANSSEN | Candida test negative | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Procedural dizziness | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | IIIrd nerve paralysis | 0 | 0 | 0.178 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival pallor | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_JANSSEN | Tattoo | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal ulcer | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagitis | 0 | 0 | 0.017 | 1 | 3.408 |  |  |  |  |  | 
COVID19_JANSSEN | Haemodynamic instability | 0 | 0 | 0.036 | 1 | 3.137 |  |  |  |  |  | 
COVID19_JANSSEN | Antinuclear antibody | 0 | 0.002 | 0.336 | 1 | 1.949 |  |  |  |  |  | 
COVID19_JANSSEN | Xanthelasma | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram T wave abnormal | 0 | 0 | 0.251 | 1 | 2.153 |  |  |  |  |  | 
COVID19_JANSSEN | Exostosis | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Choroid plexus papilloma | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Neurogenic shock | 0 | 0 | 0 | 1 | 5.289 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal cord insertion | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Myositis | 0 | 0.001 | 0.278 | 1 | 2.086 |  |  |  |  |  | 
COVID19_JANSSEN | Waxy flexibility | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Wound infection staphylococcal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Urine albumin/creatinine ratio | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Antiacetylcholine receptor antibody | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular function test abnormal | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to heart | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Alcohol intolerance | 0 | 0 | 0 | 1 | 5.525 |  |  |  |  |  | 
COVID19_JANSSEN | Accident | 0 | 0 | 0.034 | 1 | 3.162 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal oedema | 0 | 0 | 0.008 | 1 | 3.658 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal stromal tumour | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Coxiella test | 0 | 0 | 0 | 1 | 4.561 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid sensory disorder | 0 | 0 | 0.013 | 1 | 3.508 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal uterine bleeding | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract inflammation | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Factitious disorder | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Symphysiolysis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | POEMS syndrome | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Affective disorder | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary physical examination | 0 | 0 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_JANSSEN | Matrix metalloproteinase-3 | 0 | 0 | 0.002 | 1 | 4.053 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site extravasation | 0 | 0 | 0.125 | 1 | 2.57 |  |  |  |  |  | 
COVID19_JANSSEN | Skin tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.159 | 1 | 2.435 |  |  |  |  |  | 
COVID19_JANSSEN | Crystal urine present | 0 | 0 | 0.007 | 1 | 3.678 |  |  |  |  |  | 
COVID19_JANSSEN | Migraine with aura | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Sacroiliitis | 0 | 0 | 0.034 | 1 | 3.161 |  |  |  |  |  | 
COVID19_JANSSEN | Microvillous inclusion disease | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_JANSSEN | Continuous positive airway pressure | 0 | 0 | 0.077 | 1 | 2.811 |  |  |  |  |  | 
COVID19_JANSSEN | Cancer in remission | 0 | 0 | 0.074 | 1 | 2.836 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity total | 0 | 0 | 0.072 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | General anaesthesia | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac fibrillation | 0 | 0 | 0.154 | 1 | 2.456 |  |  |  |  |  | 
COVID19_JANSSEN | Eye oedema | 0 | 0 | 0.286 | 1 | 2.066 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella keratitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic haemorrhage | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Partial seizures with secondary generalisation | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Measles antibody positive | 0 | 0 | 0 | 1 | 4.379 |  |  |  |  |  | 
COVID19_JANSSEN | Tubulointerstitial nephritis and uveitis syndrome | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | QRS axis abnormal | 0 | 0 | 0.002 | 1 | 3.958 |  |  |  |  |  | 
COVID19_JANSSEN | Diastasis recti abdominis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord infarction | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Auditory nerve disorder | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | CSF lymphocyte count abnormal | 0 | 0 | 0.142 | 1 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Gravitational oedema | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Gluten sensitivity | 0 | 0 | 0.017 | 1 | 3.416 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose-6-phosphate dehydrogenase abnormal | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | CSF pressure increased | 0 | 0.001 | 0.161 | 1 | 2.429 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound pelvis normal | 0 | 0 | 0.139 | 1 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | End-tidal CO2 decreased | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_JANSSEN | Neurotic disorder of childhood | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | IgM nephropathy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Mitochondrial encephalomyopathy | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Clostridium test | 0 | 0 | 0.203 | 1 | 2.29 |  |  |  |  |  | 
COVID19_JANSSEN | Antibody test positive | 0 | 0 | 0.04 | 1 | 3.094 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to liver | 0 | 0 | 0.008 | 1 | 3.658 |  |  |  |  |  | 
COVID19_JANSSEN | Oophoritis | 0 | 0 | 0.003 | 1 | 3.873 |  |  |  |  |  | 
COVID19_JANSSEN | Delayed myelination | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Haemolytic uraemic syndrome | 0 | 0 | 0 | 1 | 5.718 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoscopy abnormal | 0 | 0 | 0.087 | 1 | 2.755 |  |  |  |  |  | 
COVID19_JANSSEN | Mean platelet volume | 0 | 0 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_JANSSEN | Apallic syndrome | 0 | 0 | 0 | 1 | 4.304 |  |  |  |  |  | 
COVID19_JANSSEN | Labelled drug-drug interaction medication error | 0 | 0 | 0 | 1 | 4.935 |  |  |  |  |  | 
COVID19_JANSSEN | Microangiopathy | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cystoscopy abnormal | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_JANSSEN | Laparotomy | 0 | 0 | 0.002 | 1 | 4.048 |  |  |  |  |  | 
COVID19_JANSSEN | Blood beta-D-glucan positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Omentectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac output | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Atypical mycobacterium pericarditis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic vasculitis | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Taciturnity | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic enzyme | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue discomfort | 0 | 0.001 | 0.151 | 1 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Slit-lamp tests normal | 0 | 0 | 0 | 1 | 5.568 |  |  |  |  |  | 
COVID19_JANSSEN | Atrophy | 0 | 0 | 0.143 | 1 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal ischaemia | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Endometrial cancer | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical vertebral fracture | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Skin discomfort | 0 | 0.001 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Fluid retention | 0 | 0 | 0.137 | 1 | 2.522 |  |  |  |  |  | 
COVID19_JANSSEN | Urea urine normal | 0 | 0 | 0 | 1 | 5.424 |  |  |  |  |  | 
COVID19_JANSSEN | Appetite disorder | 0 | 0.001 | 0.235 | 1 | 2.197 |  |  |  |  |  | 
COVID19_JANSSEN | Ileus | 0 | 0 | 0.009 | 1 | 3.625 |  |  |  |  |  | 
COVID19_JANSSEN | Animal scratch | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Circulating anticoagulant | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Haptoglobin decreased | 0 | 0 | 0.031 | 1 | 3.2 |  |  |  |  |  | 
COVID19_JANSSEN | Radioallergosorbent test positive | 0 | 0 | 0.029 | 1 | 3.222 |  |  |  |  |  | 
COVID19_JANSSEN | Oral discharge | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Ototoxicity | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine malposition | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte morphology | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | End-tidal CO2 | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cryotherapy | 0 | 0 | 0.002 | 1 | 4.071 |  |  |  |  |  | 
COVID19_JANSSEN | Poliovirus test positive | 0 | 0 | 0 | 1 | 4.341 |  |  |  |  |  | 
COVID19_JANSSEN | Chromosomal analysis | 0 | 0 | 0.098 | 1 | 2.7 |  |  |  |  |  | 
COVID19_JANSSEN | Analgesic therapy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc space narrowing | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Meningococcal bacteraemia | 0 | 0 | 0 | 1 | 5.23 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine inflammation | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Acute disseminated encephalomyelitis | 0 | 0.001 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Benign soft tissue neoplasm | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Coronavirus test negative | 0 | 0 | 0.19 | 1 | 2.331 |  |  |  |  |  | 
COVID19_JANSSEN | Brain herniation | 0 | 0 | 0.164 | 1 | 2.418 |  |  |  |  |  | 
COVID19_JANSSEN | Haematoma evacuation | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage subepidermal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Medication error | 0 | 0 | 0.23 | 1 | 2.211 |  |  |  |  |  | 
COVID19_JANSSEN | Normal pressure hydrocephalus | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial drainage test abnormal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Visual evoked potentials | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Application site pruritus | 0 | 0 | 0.001 | 1 | 4.099 |  |  |  |  |  | 
COVID19_JANSSEN | Device dependence | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal examination normal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Stereotypy | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin D increased | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_JANSSEN | Cytology abnormal | 0 | 0 | 0.02 | 1 | 3.355 |  |  |  |  |  | 
COVID19_JANSSEN | Capnogram abnormal | 0 | 0 | 0.06 | 1 | 2.924 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune thyroid disorder | 0 | 0 | 0.033 | 1 | 3.173 |  |  |  |  |  | 
COVID19_JANSSEN | Serotonin syndrome | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Nail discomfort | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Feeding intolerance | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_JANSSEN | Camptodactyly acquired | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_JANSSEN | Glaucoma | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_JANSSEN | Leukoencephalopathy | 0 | 0 | 0.128 | 1 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperbaric oxygen therapy | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Paroxysmal sympathetic hyperactivity | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Adenosine deaminase normal | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil degranulation test | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Faecal elastase concentration decreased | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_JANSSEN | Cholelithiasis | 0 | 0.002 | 0.33 | 1 | 1.963 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site coldness | 0 | 0 | 0.102 | 1 | 2.676 |  |  |  |  |  | 
COVID19_JANSSEN | Emphysema | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Factor VII deficiency | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ketone body present | 0 | 0 | 0.127 | 1 | 2.564 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-glycyl-tRNA synthetase antibody positive | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Azotaemia | 0 | 0 | 0.176 | 1 | 2.379 |  |  |  |  |  | 
COVID19_JANSSEN | Ejection fraction | 0 | 0 | 0.004 | 1 | 3.815 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal haemorrhage | 0 | 0 | 0.001 | 1 | 4.18 |  |  |  |  |  | 
COVID19_JANSSEN | Thinking abnormal | 0 | 0.001 | 0.463 | 1 | 1.703 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngospasm | 0 | 0 | 0.198 | 1 | 2.307 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid bleeding | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine abnormal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis adenovirus | 0 | 0 | 0 | 1 | 4.784 |  |  |  |  |  | 
COVID19_JANSSEN | Multi-vitamin deficiency | 0 | 0 | 0.017 | 1 | 3.419 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic enzymes | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac tamponade | 0 | 0 | 0.014 | 1 | 3.477 |  |  |  |  |  | 
COVID19_JANSSEN | Ejaculation disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Joint stabilisation | 0 | 0 | 0.065 | 1 | 2.889 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration joint abnormal | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrogen breath test | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic respiratory disease | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_JANSSEN | Tenodesis | 0 | 0 | 0 | 1 | 4.305 |  |  |  |  |  | 
COVID19_JANSSEN | Umbilical hernia repair | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal non-stress test | 0 | 0 | 0.013 | 1 | 3.491 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular discomfort | 0 | 0.002 | 0.443 | 1 | 1.737 |  |  |  |  |  | 
COVID19_JANSSEN | Palisaded neutrophilic granulomatous dermatitis | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Presbyacusis | 0 | 0 | 0 | 1 | 5.275 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatological examination | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VIII level normal | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased gait velocity | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Molluscum contagiosum | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_JANSSEN | Mutism | 0 | 0 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_JANSSEN | Bundle branch block | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Purpura neonatal | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray dental | 0 | 0 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillitis bacterial | 0 | 0 | 0 | 1 | 4.728 |  |  |  |  |  | 
COVID19_JANSSEN | Sensation of blood flow | 0 | 0 | 0.011 | 1 | 3.55 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site induration | 0 | 0 | 0.005 | 1 | 3.755 |  |  |  |  |  | 
COVID19_JANSSEN | Infective pulmonary exacerbation of cystic fibrosis | 0 | 0 | 0 | 1 | 5.801 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalopathy neonatal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Traumatic haemorrhage | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoscopy normal | 0 | 0 | 0.128 | 1 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Viral vasculitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic cirrhosis | 0 | 0.001 | 0.266 | 1 | 2.116 |  |  |  |  |  | 
COVID19_JANSSEN | Hand-foot-and-mouth disease | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_JANSSEN | Bone density decreased | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_JANSSEN | Skin hypertrophy | 0 | 0 | 0.005 | 1 | 3.797 |  |  |  |  |  | 
COVID19_JANSSEN | Dehydroepiandrosterone decreased | 0 | 0 | 0 | 1 | 5.083 |  |  |  |  |  | 
COVID19_JANSSEN | Neuro-ophthalmological test normal | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrous histiocytoma | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Epididymitis | 0 | 0 | 0.231 | 1 | 2.209 |  |  |  |  |  | 
COVID19_JANSSEN | CSF protein increased | 0 | 0.001 | 0.123 | 1 | 2.577 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular graft complication | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil percentage | 0 | 0 | 0.308 | 1 | 2.013 |  |  |  |  |  | 
COVID19_JANSSEN | Reticulocyte count increased | 0 | 0 | 0.106 | 1 | 2.658 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise electrocardiogram | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuse | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhoids thrombosed | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia cytomegaloviral | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Lung carcinoma cell type unspecified stage I | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lenticular opacities | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Purpura | 0 | 0.001 | 0.249 | 1 | 2.158 |  |  |  |  |  | 
COVID19_JANSSEN | Venous oxygen saturation normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Perioral dermatitis | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal tenderness | 0 | 0.001 | 0.214 | 1 | 2.257 |  |  |  |  |  | 
COVID19_JANSSEN | Phospholipidosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Fear of injection | 0 | 0 | 0.195 | 1 | 2.316 |  |  |  |  |  | 
COVID19_JANSSEN | Xerophthalmia | 0 | 0 | 0.063 | 1 | 2.909 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic enzymes increased | 0 | 0 | 0.129 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Relapsing fever | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxin binding globulin increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate examination | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Post lumbar puncture syndrome | 0 | 0 | 0.006 | 1 | 3.722 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial cyst | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Acute lymphocytic leukaemia recurrent | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0 | 0.2 | 1 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital cystic kidney disease | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic stroke | 0 | 0.001 | 0.182 | 1 | 2.356 |  |  |  |  |  | 
COVID19_JANSSEN | Avulsion fracture | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Itching scar | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoaesthesia eye | 0 | 0.001 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_JANSSEN | Product residue present | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Needle track marks | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocytosis | 0 | 0 | 0.185 | 1 | 2.349 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Peptic ulcer | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Vibrio test positive | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Micturition urgency | 0 | 0 | 0.175 | 1 | 2.381 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal valve collapse | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatorenal syndrome | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Amino acid level | 0 | 0 | 0.134 | 1 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Mycoplasma test negative | 0 | 0.001 | 0.102 | 1 | 2.676 |  |  |  |  |  | 
COVID19_JANSSEN | Ammonia decreased | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic embolisation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation increased | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Drug intolerance | 0 | 0 | 0.14 | 1 | 2.511 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal oedema | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Aldolase increased | 0 | 0 | 0.036 | 1 | 3.145 |  |  |  |  |  | 
COVID19_JANSSEN | Blood fibrinogen | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid volume | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Brow presentation | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrophic anal papilla | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Single photon emission computerised tomogram abnormal | 0 | 0 | 0 | 1 | 5.436 |  |  |  |  |  | 
COVID19_JANSSEN | CSF oligoclonal band absent | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | Insurance issue | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Lactation disorder | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis bacterial | 0 | 0 | 0 | 1 | 5.08 |  |  |  |  |  | 
COVID19_JANSSEN | Device malfunction | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Haemangioma of bone | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary physical examination normal | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid stimulating immunoglobulin | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Stress echocardiogram normal | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Post vaccination challenge strain shedding | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_JANSSEN | Prohormone brain natriuretic peptide | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Skin maceration | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary imaging procedure abnormal | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Progesterone | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Polyomavirus test negative | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Ligamentitis | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Hyper IgE syndrome | 0 | 0 | 0.002 | 1 | 3.964 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via unknown route | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Blood grouping | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Application site inflammation | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Wound dehiscence | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Tandem gait test normal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Stem cell therapy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Stoma care | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary valve stenosis congenital | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudopapilloedema | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Primary hyperaldosteronism | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Penile blister | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant neoplasm of unknown primary site | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | General physical condition | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Familial amyotrophic lateral sclerosis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Factor V Leiden mutation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Chest wall abscess | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Caffeine allergy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lung normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Application site odour | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Amplified musculoskeletal pain syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis viral | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site mass | 0 | 0.001 | 0.122 | 1 | 2.583 |  |  |  |  |  | 
COVID19_JANSSEN | CSF cell count increased | 0 | 0 | 0.003 | 1 | 3.895 |  |  |  |  |  | 
COVID19_JANSSEN | CSF mononuclear cell count decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Increased insulin requirement | 0 | 0 | 0.116 | 1 | 2.61 |  |  |  |  |  | 
COVID19_JANSSEN | Alloimmunisation | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Skin weeping | 0 | 0 | 0.218 | 1 | 2.246 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bicarbonate decreased | 0 | 0.001 | 0.285 | 1 | 2.067 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem glioma | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell anisocytes present | 0 | 0 | 0.194 | 1 | 2.318 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular injury | 0 | 0 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_JANSSEN | Arthropod sting | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocauterisation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Echoencephalogram abnormal | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Stress fracture | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_JANSSEN | Penicillium test negative | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Product taste abnormal | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal asphyxia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanometry | 0 | 0 | 0.108 | 1 | 2.647 |  |  |  |  |  | 
COVID19_JANSSEN | Irregular sleep phase | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal motility disorder | 0 | 0 | 0.075 | 1 | 2.829 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant lymphomas (SMQ) [narrow] | 0 | 0 | 0.145 | 1 | 2.489 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth avulsion | 0 | 0 | 0.01 | 1 | 3.571 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic alkalosis | 0 | 0 | 0 | 1 | 5.396 |  |  |  |  |  | 
COVID19_JANSSEN | Periodic limb movement disorder | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Microvascular coronary artery disease | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Friedreich's ataxia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure ambulatory | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriovenous fistula occlusion | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-erythrocyte antibody negative | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Anomalous pulmonary venous connection | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin globulin ratio abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumococcal infection | 0 | 0 | 0 | 1 | 5.825 |  |  |  |  |  | 
COVID19_JANSSEN | Viral test | 0 | 0.001 | 0.221 | 1 | 2.238 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time normal | 0 | 0.001 | 0.305 | 1 | 2.021 |  |  |  |  |  | 
COVID19_JANSSEN | Croup infectious | 0 | 0 | 0.02 | 1 | 3.364 |  |  |  |  |  | 
COVID19_JANSSEN | Regurgitation | 0 | 0 | 0.018 | 1 | 3.393 |  |  |  |  |  | 
COVID19_JANSSEN | CSF glucose | 0 | 0 | 0 | 1 | 4.546 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactate dehydrogenase normal | 0 | 0 | 0.12 | 1 | 2.591 |  |  |  |  |  | 
COVID19_JANSSEN | Packed red blood cell transfusion | 0 | 0.001 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Mean platelet volume increased | 0 | 0 | 0.05 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Microbiology test normal | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_JANSSEN | Still's disease | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Urticarial vasculitis | 0 | 0 | 0.002 | 1 | 4.009 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine increased | 0 | 0.001 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin blood increased | 0 | 0 | 0.002 | 1 | 3.998 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar inflammation | 0 | 0 | 0.143 | 1 | 2.497 |  |  |  |  |  | 
COVID19_JANSSEN | Abdomen scan normal | 0 | 0 | 0.001 | 1 | 4.209 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint movement impairment | 0 | 0 | 0.015 | 1 | 3.444 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ketone body | 0 | 0 | 0.119 | 1 | 2.598 |  |  |  |  |  | 
COVID19_JANSSEN | Peritonsillar abscess | 0 | 0 | 0.006 | 1 | 3.71 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell count positive | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_JANSSEN | Otoscopy abnormal | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Procalcitonin decreased | 0 | 0 | 0.095 | 1 | 2.715 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal dryness | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound biliary tract normal | 0 | 0 | 0.105 | 1 | 2.66 |  |  |  |  |  | 
COVID19_JANSSEN | Naevus flammeus | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter gastritis | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate increased | 0 | 0 | 0 | 1 | 5.658 |  |  |  |  |  | 
COVID19_JANSSEN | Deja vu | 0 | 0 | 0.031 | 1 | 3.193 |  |  |  |  |  | 
COVID19_JANSSEN | Spontaneous haematoma | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Self-medication | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Genital labial adhesions | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular function test normal | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteric obstruction | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon sheath incision | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Stoma site haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella bacteraemia | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Pericarditis rheumatic | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cancer stage IV | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal gastrointestinal disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Macroprolactinaemia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via body fluid | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil cationic protein increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal dystrophy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound kidney abnormal | 0 | 0 | 0.141 | 1 | 2.506 |  |  |  |  |  | 
COVID19_JANSSEN | Loose tooth | 0 | 0 | 0.172 | 1 | 2.393 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary artery aneurysm | 0 | 0 | 0 | 1 | 4.716 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholinesterase increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Autoscopy | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoperfusion | 0 | 0 | 0.002 | 1 | 3.957 |  |  |  |  |  | 
COVID19_JANSSEN | COVID-19 immunisation | 0 | 0 | 0.001 | 1 | 4.074 |  |  |  |  |  | 
COVID19_JANSSEN | Vulval disorder | 0 | 0 | 0.002 | 1 | 3.965 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site dysaesthesia | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine disorder | 0 | 0 | 0.065 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Enterococcus test | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchomalacia | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Thalassaemia | 0 | 0 | 0.007 | 1 | 3.666 |  |  |  |  |  | 
COVID19_JANSSEN | Swollen joint count | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr viraemia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Breast disorder female | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Skin cyst excision | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Painful erection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal rupture | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Microangiopathic haemolytic anaemia | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Leucine aminopeptidase | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Infected bite | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Iliac vein occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | High risk sexual behaviour | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic cancer stage IV | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival oedema | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Cautery to nose | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy pharynx normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased activity | 0 | 0 | 0.247 | 1 | 2.164 |  |  |  |  |  | 
COVID19_JANSSEN | Skin test positive | 0 | 0 | 0.008 | 1 | 3.649 |  |  |  |  |  | 
COVID19_JANSSEN | Bed rest | 0 | 0 | 0.243 | 1 | 2.175 |  |  |  |  |  | 
COVID19_JANSSEN | Joint dislocation | 0 | 0 | 0.186 | 1 | 2.344 |  |  |  |  |  | 
COVID19_JANSSEN | Diverticulitis | 0 | 0.001 | 0.223 | 1 | 2.231 |  |  |  |  |  | 
COVID19_JANSSEN | Irritability postvaccinal | 0 | 0 | 0 | 1 | 4.615 |  |  |  |  |  | 
COVID19_JANSSEN | Bone disorder | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Somnambulism | 0 | 0 | 0.114 | 1 | 2.621 |  |  |  |  |  | 
COVID19_JANSSEN | Facial neuralgia | 0 | 0 | 0.157 | 1 | 2.446 |  |  |  |  |  | 
COVID19_JANSSEN | Skull fracture | 0 | 0 | 0.017 | 1 | 3.418 |  |  |  |  |  | 
COVID19_JANSSEN | Body height decreased | 0 | 0 | 0.011 | 1 | 3.545 |  |  |  |  |  | 
COVID19_JANSSEN | Purpura fulminans | 0 | 0 | 0 | 1 | 5.326 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpes virus 6 serology | 0 | 0 | 0.008 | 1 | 3.65 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngoscopy | 0 | 0 | 0.185 | 1 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Skin graft | 0 | 0 | 0.115 | 1 | 2.617 |  |  |  |  |  | 
COVID19_JANSSEN | Klebsiella test positive | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid arteriosclerosis | 0 | 0 | 0.018 | 1 | 3.394 |  |  |  |  |  | 
COVID19_JANSSEN | Jaundice cholestatic | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram PR segment depression | 0 | 0 | 0.005 | 1 | 3.773 |  |  |  |  |  | 
COVID19_JANSSEN | Vasogenic cerebral oedema | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site erythema | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Phalen's test positive | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Forceps delivery | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral microangiopathy | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Blood parathyroid hormone | 0 | 0 | 0.104 | 1 | 2.666 |  |  |  |  |  | 
COVID19_JANSSEN | Porokeratosis | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Parvovirus B19 infection | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte stimulation test negative | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Breast conserving surgery | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Blood corticotrophin decreased | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Astrocytoma | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_JANSSEN | Adenosine deaminase increased | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin K deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Vessel puncture site erythema | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Vessel puncture site haemorrhage | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Right atrial enlargement | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Postictal psychosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial diarrhoea | 0 | 0 | 0.006 | 1 | 3.726 |  |  |  |  |  | 
COVID19_JANSSEN | Product sterility lacking | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic mass | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Follicle centre lymphoma diffuse small cell lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Femoral nerve palsy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral congestion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Aspergillus test positive | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal sinus mucosal hypertrophy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Keratopathy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Infusion site joint movement impairment | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Factor VIII inhibition | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | CSF electrophoresis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Blood beta-D-glucan increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy placenta | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Apolipoprotein B | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Nephrotic syndrome | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy abnormal | 0 | 0 | 0.002 | 1 | 4.027 |  |  |  |  |  | 
COVID19_JANSSEN | Globulin | 0 | 0.001 | 0.114 | 1 | 2.617 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil percentage increased | 0 | 0 | 0.126 | 1 | 2.565 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine free | 0 | 0 | 0.033 | 1 | 3.172 |  |  |  |  |  | 
COVID19_JANSSEN | Trigger finger | 0 | 0 | 0.136 | 1 | 2.525 |  |  |  |  |  | 
COVID19_JANSSEN | Malaria | 0 | 0 | 0 | 1 | 5.704 |  |  |  |  |  | 
COVID19_JANSSEN | Drainage | 0 | 0 | 0.007 | 1 | 3.679 |  |  |  |  |  | 
COVID19_JANSSEN | Retinogram abnormal | 0 | 0 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic failure | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Subretinal fluid | 0 | 0 | 0.003 | 1 | 3.919 |  |  |  |  |  | 
COVID19_JANSSEN | Balanoposthitis | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Myasthenic syndrome | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_JANSSEN | CSF myelin basic protein | 0 | 0 | 0.019 | 1 | 3.367 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure orthostatic | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_JANSSEN | Aspergillus test | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal injury | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Von Willebrand's factor antigen increased | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Proctitis haemorrhagic | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph node tuberculosis | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster reactivation | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilia | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Crystalluria | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_JANSSEN | Cranial nerve injury | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Bulimia nervosa | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal metaplasia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-uterine contraceptive device insertion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Deformity of orbit | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital hiatus hernia | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Immunisation | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral vascular disorder | 0 | 0 | 0.009 | 1 | 3.603 |  |  |  |  |  | 
COVID19_JANSSEN | Skin test | 0 | 0 | 0.226 | 1 | 2.223 |  |  |  |  |  | 
COVID19_JANSSEN | Protrusion tongue | 0 | 0 | 0.302 | 1 | 2.027 |  |  |  |  |  | 
COVID19_JANSSEN | Foreign travel | 0 | 0 | 0.162 | 1 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Foot fracture | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_JANSSEN | Obstruction | 0 | 0 | 0.006 | 1 | 3.746 |  |  |  |  |  | 
COVID19_JANSSEN | Convulsions local | 0 | 0 | 0.009 | 1 | 3.608 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C RNA increased | 0 | 0 | 0 | 1 | 4.859 |  |  |  |  |  | 
COVID19_JANSSEN | Personality change | 0 | 0 | 0.147 | 1 | 2.483 |  |  |  |  |  | 
COVID19_JANSSEN | Photopsia | 0 | 0 | 0.243 | 1 | 2.175 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple use of single-use product | 0 | 0 | 0 | 1 | 4.079 |  |  |  |  |  | 
COVID19_JANSSEN | Parotitis | 0 | 0 | 0 | 1 | 4.32 |  |  |  |  |  | 
COVID19_JANSSEN | Urine bilirubin decreased | 0 | 0 | 0.191 | 1 | 2.328 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammatory bowel disease | 0 | 0 | 0 | 1 | 4.659 |  |  |  |  |  | 
COVID19_JANSSEN | Lichenoid keratosis | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular endothelial growth factor assay | 0 | 0 | 0 | 1 | 5.815 |  |  |  |  |  | 
COVID19_JANSSEN | Campylobacter infection | 0 | 0 | 0 | 1 | 5.793 |  |  |  |  |  | 
COVID19_JANSSEN | Blood prolactin increased | 0 | 0 | 0.092 | 1 | 2.727 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.028 |  |  |  |  |  | 
COVID19_JANSSEN | Morose | 0 | 0 | 0 | 1 | 5.602 |  |  |  |  |  | 
COVID19_JANSSEN | Perfume sensitivity | 0 | 0 | 0.03 | 1 | 3.209 |  |  |  |  |  | 
COVID19_JANSSEN | In vitro fertilisation | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Bickerstaff's encephalitis | 0 | 0 | 0.08 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal lymphadenopathy | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_JANSSEN | Portal tract inflammation | 0 | 0 | 0.002 | 1 | 4.026 |  |  |  |  |  | 
COVID19_JANSSEN | Menarche | 0 | 0 | 0 | 1 | 4.622 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of libido | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_JANSSEN | Reactive airways dysfunction syndrome | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin blood decreased | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Glossopharyngeal neuralgia | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Exercise test normal | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system function test | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Adenosine deaminase | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic injury | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal roughening | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Hormone refractory breast cancer | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral vasoconstriction | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Wheelchair user | 0 | 0 | 0.03 | 1 | 3.205 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell count negative | 0 | 0 | 0.128 | 1 | 2.557 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure fluctuation | 0 | 0.002 | 0.418 | 1 | 1.783 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal X-ray normal | 0 | 0 | 0.252 | 1 | 2.152 |  |  |  |  |  | 
COVID19_JANSSEN | Vertigo positional | 0 | 0.001 | 0.272 | 1 | 2.1 |  |  |  |  |  | 
COVID19_JANSSEN | CD4 lymphocytes decreased | 0 | 0 | 0.008 | 1 | 3.64 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral atrophy | 0 | 0 | 0.135 | 1 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral foraminal stenosis | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Pupillary light reflex tests normal | 0 | 0 | 0.028 | 1 | 3.242 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema mucosal | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Dysplasia | 0 | 0 | 0 | 1 | 4.675 |  |  |  |  |  | 
COVID19_JANSSEN | CSF neutrophil count negative | 0 | 0 | 0 | 1 | 5.265 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy colon abnormal | 0 | 0 | 0.006 | 1 | 3.716 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrophy | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Anal haemorrhage | 0 | 0 | 0.129 | 1 | 2.555 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site oedema | 0 | 0 | 0.004 | 1 | 3.86 |  |  |  |  |  | 
COVID19_JANSSEN | Syphilis | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve stimulation test abnormal | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte count abnormal | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_JANSSEN | Dizziness exertional | 0 | 0 | 0.048 | 1 | 3.028 |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystitis acute | 0 | 0 | 0.003 | 1 | 3.95 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor X level normal | 0 | 0 | 0 | 1 | 4.722 |  |  |  |  |  | 
COVID19_JANSSEN | Blood osmolarity increased | 0 | 0 | 0.091 | 1 | 2.736 |  |  |  |  |  | 
COVID19_JANSSEN | Russell's viper venom time | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_JANSSEN | Breech delivery | 0 | 0 | 0.001 | 1 | 4.141 |  |  |  |  |  | 
COVID19_JANSSEN | Asplenia | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal vascular disorder | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian germ cell teratoma | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Blood selenium decreased | 0 | 0 | 0.034 | 1 | 3.167 |  |  |  |  |  | 
COVID19_JANSSEN | Bite | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Salpingitis | 0 | 0 | 0 | 1 | 4.738 |  |  |  |  |  | 
COVID19_JANSSEN | Product substitution | 0 | 0 | 0.001 | 1 | 4.176 |  |  |  |  |  | 
COVID19_JANSSEN | Microsomia | 0 | 0 | 0 | 1 | 5.568 |  |  |  |  |  | 
COVID19_JANSSEN | Eye infection bacterial | 0 | 0 | 0.102 | 1 | 2.679 |  |  |  |  |  | 
COVID19_JANSSEN | Mini mental status examination | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous symptom | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Cold-stimulus headache | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral thrombosis | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell poikilocytes present | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Phagocytosis | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Heparin-induced thrombocytopenia | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_JANSSEN | Fluorescent in situ hybridisation positive | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Defect conduction intraventricular | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Blood electrolytes increased | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Urobilinogen faeces normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Renal hypertension | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Premature ageing | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral arterial occlusive disease | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Karyotype analysis abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Implant site infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Food contamination | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Diplacusis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Breath sounds absent | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy vagina normal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Acne varioliformis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte percentage | 0 | 0.001 | 0.178 | 1 | 2.369 |  |  |  |  |  | 
COVID19_JANSSEN | Wound | 0 | 0 | 0.026 | 1 | 3.26 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis atopic | 0 | 0 | 0.013 | 1 | 3.496 |  |  |  |  |  | 
COVID19_JANSSEN | Chemotherapy | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival bleeding | 0 | 0.001 | 0.255 | 1 | 2.142 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal obstruction | 0 | 0 | 0.023 | 1 | 3.298 |  |  |  |  |  | 
COVID19_JANSSEN | Ulcer | 0 | 0.001 | 0.311 | 1 | 2.006 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic failure | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Grimacing | 0 | 0 | 0.253 | 1 | 2.15 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal wall thickening | 0 | 0 | 0.005 | 1 | 3.783 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon injury | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_JANSSEN | Lactic acidosis | 0 | 0 | 0.162 | 1 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Single photon emission computerised tomogram normal | 0 | 0 | 0 | 1 | 5.823 |  |  |  |  |  | 
COVID19_JANSSEN | Bed sharing | 0 | 0 | 0.129 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 increased | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal exfoliation | 0 | 0 | 0.234 | 1 | 2.201 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital pain | 0 | 0 | 0.125 | 1 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Bulbar palsy | 0 | 0 | 0.013 | 1 | 3.505 |  |  |  |  |  | 
COVID19_JANSSEN | Blood beryllium | 0 | 0 | 0 | 1 | 4.999 |  |  |  |  |  | 
COVID19_JANSSEN | Hypercoagulation | 0 | 0 | 0.005 | 1 | 3.772 |  |  |  |  |  | 
COVID19_JANSSEN | Widal test | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Freezing phenomenon | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheo-oesophageal fistula | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Claudication of jaw muscles | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral vein occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Penile ulceration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Normochromic anaemia | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte adoptive therapy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal mask airway insertion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac disorder | 0 | 0.001 | 0.167 | 1 | 2.409 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural haematoma | 0 | 0 | 0.062 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerulonephritis proliferative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Breast milk discolouration | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil percentage | 0 | 0 | 0.15 | 1 | 2.47 |  |  |  |  |  | 
COVID19_JANSSEN | Urine ketone body absent | 0 | 0 | 0.206 | 1 | 2.28 |  |  |  |  |  | 
COVID19_JANSSEN | Tilt table test | 0 | 0 | 0 | 1 | 4.505 |  |  |  |  |  | 
COVID19_JANSSEN | Skin neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.024 | 1 | 3.295 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor positive | 0 | 0 | 0.003 | 1 | 3.902 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccine virus shedding | 0 | 0 | 0 | 1 | 4.932 |  |  |  |  |  | 
COVID19_JANSSEN | Premature rupture of membranes | 0 | 0 | 0.002 | 1 | 4.038 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test urine | 0 | 0 | 0.096 | 1 | 2.706 |  |  |  |  |  | 
COVID19_JANSSEN | Orchitis | 0 | 0 | 0 | 1 | 5.502 |  |  |  |  |  | 
COVID19_JANSSEN | Coronavirus infection | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Gene mutation | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Bone scan | 0 | 0 | 0.106 | 1 | 2.658 |  |  |  |  |  | 
COVID19_JANSSEN | Parvovirus B19 test | 0 | 0 | 0.204 | 1 | 2.286 |  |  |  |  |  | 
COVID19_JANSSEN | Liver transplant | 0 | 0 | 0 | 1 | 4.603 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site injury | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal disorder | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow disorder | 0 | 0 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy salivary gland normal | 0 | 0 | 0 | 1 | 4.547 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic pulmonary fibrosis | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_JANSSEN | Infertility male | 0 | 0 | 0.009 | 1 | 3.617 |  |  |  |  |  | 
COVID19_JANSSEN | Sphincter of Oddi dysfunction | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_JANSSEN | Peritonitis bacterial | 0 | 0 | 0.008 | 1 | 3.645 |  |  |  |  |  | 
COVID19_JANSSEN | Sinonasal obstruction | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_JANSSEN | Micrographic skin surgery | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis cryptococcal | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Instillation site erythema | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal deposits | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Venous pressure jugular increased | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_JANSSEN | Somatic hallucination | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Renal cancer metastatic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Prader-Willi syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Porphyria screen | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonic plague | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Focal nodular hyperplasia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Erythroblast count normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic ulcer | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs indirect test | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor VII level increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Bile culture positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Face injury | 0 | 0.001 | 0.246 | 1 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella virus test | 0 | 0 | 0.041 | 1 | 3.093 |  |  |  |  |  | 
COVID19_JANSSEN | Torticollis | 0 | 0 | 0.256 | 1 | 2.142 |  |  |  |  |  | 
COVID19_JANSSEN | Ear disorder | 0 | 0 | 0.016 | 1 | 3.435 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy site unspecified abnormal | 0 | 0 | 0.077 | 1 | 2.815 |  |  |  |  |  | 
COVID19_JANSSEN | Blood albumin increased | 0 | 0 | 0.137 | 1 | 2.521 |  |  |  |  |  | 
COVID19_JANSSEN | Oophorectomy | 0 | 0 | 0 | 1 | 4.957 |  |  |  |  |  | 
COVID19_JANSSEN | Refusal of vaccination | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Prenatal screening test abnormal | 0 | 0 | 0 | 1 | 5.159 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebrobasilar insufficiency | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperkinesia | 0 | 0 | 0 | 1 | 5.261 |  |  |  |  |  | 
COVID19_JANSSEN | Fundoscopy | 0 | 0 | 0.037 | 1 | 3.133 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal discharge | 0 | 0 | 0.012 | 1 | 3.515 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular failure | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy mucosa abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrocholecystis | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_JANSSEN | Dental examination normal | 0 | 0 | 0.141 | 1 | 2.506 |  |  |  |  |  | 
COVID19_JANSSEN | Mammogram normal | 0 | 0 | 0.025 | 1 | 3.283 |  |  |  |  |  | 
COVID19_JANSSEN | Apgar score | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis meningococcal | 0 | 0 | 0 | 1 | 5.276 |  |  |  |  |  | 
COVID19_JANSSEN | Masticatory pain | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Progesterone abnormal | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoalveolar lavage abnormal | 0 | 0 | 0.023 | 1 | 3.313 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral ischaemia | 0 | 0 | 0 | 1 | 4.548 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell schistocytes present | 0 | 0 | 0.036 | 1 | 3.142 |  |  |  |  |  | 
COVID19_JANSSEN | Microcephaly | 0 | 0 | 0 | 1 | 5.075 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic specific antigen normal | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial catheterisation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hemianopia | 0 | 0 | 0 | 1 | 4.566 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal disorder | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level increased | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy large bowel abnormal | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular retrobulbar haemorrhage | 0 | 0 | 0.053 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac asthma | 0 | 0 | 0 | 1 | 5.159 |  |  |  |  |  | 
COVID19_JANSSEN | Blood catecholamines normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Surfactant protein increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray gastrointestinal tract normal | 0 | 0 | 0.003 | 1 | 3.888 |  |  |  |  |  | 
COVID19_JANSSEN | Benign neoplasm of skin | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Tourette's disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray with contrast upper gastrointestinal tract | 0 | 0 | 0.025 | 1 | 3.275 |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular end-diastolic pressure increased | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Mammogram | 0 | 0 | 0.189 | 1 | 2.334 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic arteriosclerosis | 0 | 0 | 0.034 | 1 | 3.163 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis psoriasiform | 0 | 0 | 0.01 | 1 | 3.593 |  |  |  |  |  | 
COVID19_JANSSEN | Discharge | 0 | 0 | 0.155 | 1 | 2.451 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatofibroma removal | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetes mellitus | 0 | 0.001 | 0.132 | 1 | 2.538 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxin binding globulin | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Drug administered in wrong device | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function test normal | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus antigen positive | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Adnexa uteri pain | 0 | 0 | 0 | 1 | 4.703 |  |  |  |  |  | 
COVID19_JANSSEN | High density lipoprotein increased | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Acute macular outer retinopathy | 0 | 0 | 0 | 1 | 5.782 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulins normal | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocytic lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Eustachian tube operation | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_JANSSEN | Cephalo-pelvic disproportion | 0 | 0 | 0.007 | 1 | 3.666 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary nitrogen increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Trendelenburg position | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Skin implant | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory level | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Pudendal canal syndrome | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Product dosage form confusion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy-related hepatic disorders (SMQ) [narrow] | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombocytopenia neonatal | 0 | 0 | 0.002 | 1 | 4.011 |  |  |  |  |  | 
COVID19_JANSSEN | Kidney small | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | Clinically isolated syndrome | 0 | 0 | 0 | 1 | 5.651 |  |  |  |  |  | 
COVID19_JANSSEN | Band neutrophil count increased | 0 | 0 | 0.172 | 1 | 2.39 |  |  |  |  |  | 
COVID19_JANSSEN | Faeces pale | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bone marrow | 0 | 0 | 0.148 | 1 | 2.477 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aluminium abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs direct test | 0 | 0 | 0.134 | 1 | 2.533 |  |  |  |  |  | 
COVID19_JANSSEN | Protein C deficiency | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Blood folate normal | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine cancer | 0 | 0 | 0.025 | 1 | 3.275 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy urethra normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Enterovirus test | 0 | 0 | 0.183 | 1 | 2.355 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal examination | 0 | 0 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_JANSSEN | Ear haemorrhage | 0 | 0 | 0.198 | 1 | 2.307 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy skin normal | 0 | 0 | 0.004 | 1 | 3.845 |  |  |  |  |  | 
COVID19_JANSSEN | Brachial plexopathy | 0 | 0 | 0.028 | 1 | 3.24 |  |  |  |  |  | 
COVID19_JANSSEN | Application site wound | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Beta-2 glycoprotein antibody | 0 | 0 | 0.027 | 1 | 3.255 |  |  |  |  |  | 
COVID19_JANSSEN | Calcium ionised increased | 0 | 0 | 0.126 | 1 | 2.568 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumatosis | 0 | 0 | 0.011 | 1 | 3.557 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza A virus test | 0 | 0.001 | 0.278 | 1 | 2.085 |  |  |  |  |  | 
COVID19_JANSSEN | Antiribosomal P antibody | 0 | 0 | 0.07 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Irregular sleep wake rhythm disorder | 0 | 0 | 0 | 1 | 5.253 |  |  |  |  |  | 
COVID19_JANSSEN | Paraparesis | 0 | 0 | 0 | 1 | 5.473 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriosclerotic retinopathy | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Otoacoustic emissions test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Mouth breathing | 0 | 0 | 0.276 | 1 | 2.09 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal myelogram | 0 | 0 | 0.103 | 1 | 2.673 |  |  |  |  |  | 
COVID19_JANSSEN | Scan bone marrow abnormal | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thrombin | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Aspartate aminotransferase | 0 | 0 | 0.193 | 1 | 2.322 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic neuropathy | 0 | 0 | 0.047 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Protein C decreased | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem auditory evoked response normal | 0 | 0 | 0.002 | 1 | 3.957 |  |  |  |  |  | 
COVID19_JANSSEN | Amblyopia strabismic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site swelling | 0 | 0 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time ratio abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Emergency care examination | 0 | 0 | 0 | 1 | 5.361 |  |  |  |  |  | 
COVID19_JANSSEN | Histology abnormal | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_JANSSEN | Severe myoclonic epilepsy of infancy | 0 | 0 | 0 | 1 | 5.299 |  |  |  |  |  | 
COVID19_JANSSEN | Essential tremor | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Mitochondrial cytopathy | 0 | 0 | 0 | 1 | 4.394 |  |  |  |  |  | 
COVID19_JANSSEN | Renal function test abnormal | 0 | 0 | 0.176 | 1 | 2.377 |  |  |  |  |  | 
COVID19_JANSSEN | Blood gases abnormal | 0 | 0 | 0.007 | 1 | 3.683 |  |  |  |  |  | 
COVID19_JANSSEN | Menstrual disorder | 0 | 0 | 0 | 1 | 5.804 |  |  |  |  |  | 
COVID19_JANSSEN | Skin hyperpigmentation | 0 | 0 | 0.339 | 1 | 1.943 |  |  |  |  |  | 
COVID19_JANSSEN | Germ cell neoplasm | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Joint prosthesis user | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriosclerosis | 0 | 0.001 | 0.15 | 1 | 2.468 |  |  |  |  |  | 
COVID19_JANSSEN | Caecum operation | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple organ dysfunction syndrome | 0 | 0 | 0.102 | 1 | 2.678 |  |  |  |  |  | 
COVID19_JANSSEN | Developmental hip dysplasia | 0 | 0 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_JANSSEN | Myoclonus | 0 | 0 | 0.213 | 1 | 2.261 |  |  |  |  |  | 
COVID19_JANSSEN | AST/ALT ratio abnormal | 0 | 0 | 0 | 1 | 4.649 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antibody positive | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_JANSSEN | Blood phosphorus normal | 0 | 0 | 0.305 | 1 | 2.02 |  |  |  |  |  | 
COVID19_JANSSEN | Immune system disorder | 0 | 0 | 0.099 | 1 | 2.691 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve sheath haemorrhage | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Aspartate aminotransferase abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary function test abnormal | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombolysis | 0 | 0 | 0.014 | 1 | 3.464 |  |  |  |  |  | 
COVID19_JANSSEN | Necrobiosis lipoidica diabeticorum | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pubic pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Mononucleosis heterophile test positive | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | Right ventricular enlargement | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Cyst removal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Infectious pleural effusion | 0 | 0 | 0 | 1 | 5.058 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal foreign body | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Skin operation | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_JANSSEN | Mannose-binding lectin deficiency | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Application site swelling | 0 | 0 | 0.034 | 1 | 3.162 |  |  |  |  |  | 
COVID19_JANSSEN | Ear swelling | 0 | 0.002 | 0.385 | 1 | 1.847 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant lymphomas (SMQ) [broad] | 0 | 0.001 | 0.138 | 1 | 2.517 |  |  |  |  |  | 
COVID19_JANSSEN | Red cell distribution width normal | 0 | 0.001 | 0.229 | 1 | 2.213 |  |  |  |  |  | 
COVID19_JANSSEN | Cord blood transplant therapy | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Acute hepatitis B | 0 | 0 | 0 | 1 | 4.651 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic skin eruption | 0 | 0 | 0.014 | 1 | 3.475 |  |  |  |  |  | 
COVID19_JANSSEN | Calcium ionised | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Dacryostenosis acquired | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour haemorrhage | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pasteurella test positive | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Adjustment disorder | 0 | 0 | 0.003 | 1 | 3.941 |  |  |  |  |  | 
COVID19_JANSSEN | Diagnostic aspiration | 0 | 0 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac septal defect residual shunt | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Donor specific antibody present | 0 | 0 | 0.004 | 1 | 3.848 |  |  |  |  |  | 
COVID19_JANSSEN | Increased tendency to bruise | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Macular detachment | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroma | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram carotid normal | 0 | 0.001 | 0.268 | 1 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Copper deficiency | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal pain | 0 | 0 | 0.185 | 1 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Complications of transplanted heart | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Beta globulin normal | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_JANSSEN | Acute lung injury | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis D virus test | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | PCO2 normal | 0 | 0 | 0.041 | 1 | 3.093 |  |  |  |  |  | 
COVID19_JANSSEN | Flail chest | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy gastrointestinal abnormal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Optic ischaemic neuropathy | 0 | 0 | 0.026 | 1 | 3.261 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature decreased | 0 | 0.002 | 0.467 | 1 | 1.694 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperammonaemia | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Legionella test | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Pancytopenia | 0 | 0.001 | 0.157 | 1 | 2.443 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer female | 0 | 0 | 0.145 | 1 | 2.49 |  |  |  |  |  | 
COVID19_JANSSEN | Immature granulocyte count increased | 0 | 0.001 | 0.182 | 1 | 2.357 |  |  |  |  |  | 
COVID19_JANSSEN | Mini mental status examination normal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphoedema | 0 | 0.001 | 0.326 | 1 | 1.971 |  |  |  |  |  | 
COVID19_JANSSEN | Non-consummation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Stomatococcus test positive | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Antiphospholipid antibodies positive | 0 | 0 | 0.174 | 1 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Selective polysaccharide antibody deficiency | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal erosion | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-transglutaminase antibody negative | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_JANSSEN | Dysentery | 0 | 0 | 0.008 | 1 | 3.629 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanic membrane hyperaemia | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate deceleration abnormality | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Seizure cluster | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site papule | 0 | 0 | 0.261 | 1 | 2.128 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal abscess | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic foot infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | CSF protein | 0 | 0 | 0.001 | 1 | 4.138 |  |  |  |  |  | 
COVID19_JANSSEN | Ejaculation failure | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenopathy mediastinal | 0 | 0 | 0.176 | 1 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic pain | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_JANSSEN | Debridement | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia bacterial | 0 | 0 | 0.026 | 1 | 3.261 |  |  |  |  |  | 
COVID19_JANSSEN | Infant irritability | 0 | 0 | 0.12 | 1 | 2.594 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal oedema | 0 | 0 | 0.395 | 1 | 1.829 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital laryngeal stridor | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Velo-cardio-facial syndrome | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_JANSSEN | Schellong test | 0 | 0 | 0 | 1 | 5.563 |  |  |  |  |  | 
COVID19_JANSSEN | Cytokine abnormal | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Intermittent positive pressure breathing | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Transplant rejection | 0 | 0 | 0 | 1 | 5.432 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriospasm coronary | 0 | 0 | 0 | 1 | 4.352 |  |  |  |  |  | 
COVID19_JANSSEN | Axonal and demyelinating polyneuropathy | 0 | 0 | 0.016 | 1 | 3.422 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatobiliary scan | 0 | 0 | 0.208 | 1 | 2.274 |  |  |  |  |  | 
COVID19_JANSSEN | CSF cell count abnormal | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Chromosomal deletion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site laceration | 0 | 0 | 0.003 | 1 | 3.874 |  |  |  |  |  | 
COVID19_JANSSEN | CSF myelin basic protein increased | 0 | 0 | 0.007 | 1 | 3.693 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram pelvis abnormal | 0 | 0.001 | 0.215 | 1 | 2.253 |  |  |  |  |  | 
COVID19_JANSSEN | Perinatal brain damage | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0 | 0.2 | 1 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal obstruction reduction | 0 | 0 | 0 | 1 | 5.628 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to abdominal cavity | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder injury | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Proteinuria (SMQ) [broad] | 0 | 0.001 | 0.202 | 1 | 2.292 |  |  |  |  |  | 
COVID19_JANSSEN | Catarrh | 0 | 0 | 0.004 | 1 | 3.839 |  |  |  |  |  | 
COVID19_JANSSEN | Tonic clonic movements | 0 | 0 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_JANSSEN | Lip blister | 0 | 0.001 | 0.211 | 1 | 2.267 |  |  |  |  |  | 
COVID19_JANSSEN | Bone cancer | 0 | 0 | 0.009 | 1 | 3.624 |  |  |  |  |  | 
COVID19_JANSSEN | Radioisotope scan normal | 0 | 0 | 0 | 1 | 4.934 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal ischaemia | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_JANSSEN | Faecaloma | 0 | 0 | 0.201 | 1 | 2.297 |  |  |  |  |  | 
COVID19_JANSSEN | Yellow fever | 0 | 0 | 0 | 1 | 5.67 |  |  |  |  |  | 
COVID19_JANSSEN | Mediastinal mass | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte stimulation test positive | 0 | 0 | 0 | 1 | 5.404 |  |  |  |  |  | 
COVID19_JANSSEN | Dexamethasone suppression test | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Drug screen negative | 0 | 0.002 | 0.383 | 1 | 1.852 |  |  |  |  |  | 
COVID19_JANSSEN | Rubella antibody test | 0 | 0 | 0 | 1 | 4.806 |  |  |  |  |  | 
COVID19_JANSSEN | Cholinergic syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Mumps | 0 | 0 | 0 | 1 | 5.657 |  |  |  |  |  | 
COVID19_JANSSEN | Chromosome analysis abnormal | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion | 0 | 0 | 0 | 1 | 4.901 |  |  |  |  |  | 
COVID19_JANSSEN | Polypectomy | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_JANSSEN | Parietal cell antibody positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Culture throat negative | 0 | 0 | 0.414 | 1 | 1.792 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic neoplasm | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Salpingo-oophorectomy unilateral | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Connective tissue disorder | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram PR segment elevation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess limb | 0 | 0 | 0.195 | 1 | 2.317 |  |  |  |  |  | 
COVID19_JANSSEN | Lung lobectomy | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_JANSSEN | Urine copper increased | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Benign lymph node neoplasm | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Rasmussen encephalitis | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Water deprivation test | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal erosion | 0 | 0 | 0.027 | 1 | 3.245 |  |  |  |  |  | 
COVID19_JANSSEN | Addison's disease | 0 | 0 | 0.017 | 1 | 3.402 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary fibrosis | 0 | 0 | 0.02 | 1 | 3.361 |  |  |  |  |  | 
COVID19_JANSSEN | Drug level therapeutic | 0 | 0 | 0.08 | 1 | 2.799 |  |  |  |  |  | 
COVID19_JANSSEN | Invasive ductal breast carcinoma | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_JANSSEN | Euphoric mood | 0 | 0 | 0.151 | 1 | 2.465 |  |  |  |  |  | 
COVID19_JANSSEN | Social (pragmatic) communication disorder | 0 | 0 | 0.035 | 1 | 3.152 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolar lung disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin saturation increased | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral discitis | 0 | 0 | 0.027 | 1 | 3.251 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy with contraceptive device | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pyelonephritis acute | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Rotator cuff repair | 0 | 0 | 0.001 | 1 | 4.139 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonitis chemical | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Renal tubular necrosis | 0 | 0 | 0.006 | 1 | 3.727 |  |  |  |  |  | 
COVID19_JANSSEN | Osteomyelitis | 0 | 0 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_JANSSEN | Postictal state | 0 | 0.002 | 0.422 | 1 | 1.776 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs test | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic fatigue syndrome | 0 | 0 | 0 | 1 | 4.783 |  |  |  |  |  | 
COVID19_JANSSEN | Philadelphia chromosome positive | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Latent syphilis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C antibody positive | 0 | 0 | 0 | 1 | 4.75 |  |  |  |  |  | 
COVID19_JANSSEN | Ankyloglossia congenital | 0 | 0 | 0.037 | 1 | 3.129 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum abnormal | 0 | 0 | 0.164 | 1 | 2.419 |  |  |  |  |  | 
COVID19_JANSSEN | Oral pustule | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_JANSSEN | Endometritis | 0 | 0 | 0.001 | 1 | 4.078 |  |  |  |  |  | 
COVID19_JANSSEN | Meningoencephalitis viral | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Orchidopexy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Thermal burns of eye | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle spasticity | 0 | 0 | 0.024 | 1 | 3.294 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray gastrointestinal tract | 0 | 0 | 0.003 | 1 | 3.945 |  |  |  |  |  | 
COVID19_JANSSEN | Blood oestrogen decreased | 0 | 0 | 0.005 | 1 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Urethral discharge | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site joint pain | 0 | 0 | 0.034 | 1 | 3.16 |  |  |  |  |  | 
COVID19_JANSSEN | Surgical procedure repeated | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Heat stroke | 0 | 0 | 0.028 | 1 | 3.23 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal mucosal blistering | 0 | 0 | 0.037 | 1 | 3.133 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure acute | 0 | 0 | 0.14 | 1 | 2.508 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular septal defect | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin-like growth factor | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Tensilon test normal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Eye allergy | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrospinal fluid leakage | 0 | 0 | 0.001 | 1 | 4.297 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar atrophy | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Kaposi's sarcoma | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_JANSSEN | Eczema | 0 | 0.001 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site paraesthesia | 0 | 0.003 | 0.469 | 1 | 1.691 |  |  |  |  |  | 
COVID19_JANSSEN | Scratch | 0 | 0 | 0.012 | 1 | 3.527 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella virus test negative | 0 | 0 | 0.125 | 1 | 2.569 |  |  |  |  |  | 
COVID19_JANSSEN | Immunology test abnormal | 0 | 0 | 0.018 | 1 | 3.386 |  |  |  |  |  | 
COVID19_JANSSEN | Physical disability | 0 | 0 | 0 | 1 | 4.647 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised oedema | 0 | 0 | 0.172 | 1 | 2.391 |  |  |  |  |  | 
COVID19_JANSSEN | Immature granulocyte percentage increased | 0 | 0.001 | 0.24 | 1 | 2.183 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic neuropathy | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_JANSSEN | Atopy | 0 | 0 | 0.1 | 1 | 2.688 |  |  |  |  |  | 
COVID19_JANSSEN | Subacute sclerosing panencephalitis | 0 | 0 | 0 | 1 | 5.042 |  |  |  |  |  | 
COVID19_JANSSEN | Heart disease congenital | 0 | 0 | 0.014 | 1 | 3.468 |  |  |  |  |  | 
COVID19_JANSSEN | Growing pains | 0 | 0 | 0.001 | 1 | 4.291 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell schistocytes | 0 | 0 | 0.023 | 1 | 3.303 |  |  |  |  |  | 
COVID19_JANSSEN | Blood phosphorus | 0 | 0.001 | 0.347 | 1 | 1.926 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune neuropathy | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural thickening | 0 | 0 | 0.04 | 1 | 3.103 |  |  |  |  |  | 
COVID19_JANSSEN | Polymyalgia rheumatica | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal migraine | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal carcinoma | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia measles | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle rigidity | 0 | 0.001 | 0.272 | 1 | 2.1 |  |  |  |  |  | 
COVID19_JANSSEN | Lung adenocarcinoma | 0 | 0 | 0 | 1 | 5.599 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site abscess sterile | 0 | 0 | 0.001 | 1 | 4.286 |  |  |  |  |  | 
COVID19_JANSSEN | Female sex hormone level | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Distractibility | 0 | 0 | 0 | 1 | 4.312 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal warts | 0 | 0 | 0.011 | 1 | 3.564 |  |  |  |  |  | 
COVID19_JANSSEN | Localised oedema | 0 | 0 | 0.237 | 1 | 2.191 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperkinetic heart syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy cervix normal | 0 | 0 | 0.035 | 1 | 3.156 |  |  |  |  |  | 
COVID19_JANSSEN | Blood copper | 0 | 0 | 0.005 | 1 | 3.791 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine renal clearance | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Lysinuric protein intolerance | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Lipoedema | 0 | 0 | 0.013 | 1 | 3.506 |  |  |  |  |  | 
COVID19_JANSSEN | Matrix metalloproteinase-3 increased | 0 | 0 | 0.005 | 1 | 3.789 |  |  |  |  |  | 
COVID19_JANSSEN | Oral surgery | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_JANSSEN | Precursor T-lymphoblastic lymphoma/leukaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Bleeding time normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy muscle | 0 | 0 | 0.045 | 1 | 3.051 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Infected cyst | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Peak nasal inspiratory flow abnormal | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal sepsis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound chest | 0 | 0 | 0.251 | 1 | 2.155 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cyst ruptured | 0 | 0 | 0 | 1 | 5.414 |  |  |  |  |  | 
COVID19_JANSSEN | Tenoplasty | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Atypical mycobacterium test positive | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 globulin normal | 0 | 0 | 0.147 | 1 | 2.482 |  |  |  |  |  | 
COVID19_JANSSEN | Hypometabolism | 0 | 0 | 0 | 1 | 4.716 |  |  |  |  |  | 
COVID19_JANSSEN | Microencephaly | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital biliary disorders (SMQ) [narrow] | 0 | 0 | 0 | 1 | 5.733 |  |  |  |  |  | 
COVID19_JANSSEN | Scan adrenal gland normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site joint erythema | 0 | 0 | 0.028 | 1 | 3.235 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle neoplasm | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Aortogram abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood ketone body increased | 0 | 0 | 0.147 | 1 | 2.483 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue mass | 0 | 0 | 0 | 1 | 4.969 |  |  |  |  |  | 
COVID19_JANSSEN | Neutropenic sepsis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Human herpes virus 6 serology positive | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemic coma | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis D | 0 | 0 | 0.002 | 1 | 4.023 |  |  |  |  |  | 
COVID19_JANSSEN | Velopharyngeal incompetence | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Sickle cell disease | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Serial transverse enteroplasty | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_JANSSEN | Product barcode issue | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Poverty of speech | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Plasmodium ovale infection | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Metatarsalgia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mast cell degranulation present | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site infection | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac pharmacologic stress test | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Brow ptosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MM decreased | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Accelerated idioventricular rhythm | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin G decreased | 0 | 0 | 0.04 | 1 | 3.094 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus test positive | 0 | 0 | 0.092 | 1 | 2.729 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin M increased | 0 | 0 | 0.013 | 1 | 3.507 |  |  |  |  |  | 
COVID19_JANSSEN | Skin necrosis | 0 | 0 | 0.088 | 1 | 2.748 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte percentage decreased | 0 | 0 | 0.209 | 1 | 2.272 |  |  |  |  |  | 
COVID19_JANSSEN | Poliomyelitis | 0 | 0 | 0 | 1 | 5.694 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A virus test positive | 0 | 0 | 0 | 1 | 5.704 |  |  |  |  |  | 
COVID19_JANSSEN | Subchorionic haematoma | 0 | 0 | 0 | 1 | 5.507 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic urticaria | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E virus test | 0 | 0 | 0.036 | 1 | 3.139 |  |  |  |  |  | 
COVID19_JANSSEN | Prealbumin | 0 | 0 | 0.037 | 1 | 3.127 |  |  |  |  |  | 
COVID19_JANSSEN | Vitreous haemorrhage | 0 | 0 | 0.001 | 1 | 4.182 |  |  |  |  |  | 
COVID19_JANSSEN | Fluorescence angiogram | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Dental examination | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial fluid analysis abnormal | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_JANSSEN | Scan myocardial perfusion abnormal | 0 | 0 | 0.006 | 1 | 3.744 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve injury | 0 | 0 | 0.011 | 1 | 3.539 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroendocrine tumour | 0 | 0 | 0 | 1 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Menstruation normal | 0 | 0 | 0.087 | 1 | 2.756 |  |  |  |  |  | 
COVID19_JANSSEN | Ligament laxity | 0 | 0 | 0.036 | 1 | 3.136 |  |  |  |  |  | 
COVID19_JANSSEN | Stenotrophomonas infection | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal transit time decreased | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Blood oestrogen normal | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial rupture | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Ruptured ectopic pregnancy | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Retinogram normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Peritoneal tuberculosis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Migraine prophylaxis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph node rupture | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hernia pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Hereditary spherocytosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Heart transplant | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Dilated pores | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic retinopathy | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Clumsy child syndrome | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Body mass index increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Blood product transfusion dependent | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolar oxygen partial pressure decreased | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site movement impairment | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site haemorrhage | 0 | 0 | 0.062 | 1 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal wall neoplasm malignant | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide increased | 0 | 0 | 0.24 | 1 | 2.183 |  |  |  |  |  | 
COVID19_JANSSEN | Paranoia | 0 | 0 | 0.298 | 1 | 2.036 |  |  |  |  |  | 
COVID19_JANSSEN | Blood premalignant disorders (SMQ) [broad] | 0 | 0 | 0.155 | 1 | 2.452 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal dryness | 0 | 0 | 0.258 | 1 | 2.137 |  |  |  |  |  | 
COVID19_JANSSEN | Episcleritis | 0 | 0 | 0.021 | 1 | 3.336 |  |  |  |  |  | 
COVID19_JANSSEN | Temporal lobe epilepsy | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Housebound | 0 | 0 | 0.013 | 1 | 3.51 |  |  |  |  |  | 
COVID19_JANSSEN | Evans syndrome | 0 | 0 | 0.001 | 1 | 4.294 |  |  |  |  |  | 
COVID19_JANSSEN | May-Thurner syndrome | 0 | 0 | 0.004 | 1 | 3.832 |  |  |  |  |  | 
COVID19_JANSSEN | Overlap syndrome | 0 | 0 | 0 | 1 | 4.417 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis bacterial | 0 | 0 | 0.03 | 1 | 3.212 |  |  |  |  |  | 
COVID19_JANSSEN | Forced vital capacity decreased | 0 | 0 | 0 | 1 | 5.568 |  |  |  |  |  | 
COVID19_JANSSEN | Product prescribing issue | 0 | 0 | 0.007 | 1 | 3.685 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis enteroviral | 0 | 0 | 0 | 1 | 5.81 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital and neonatal arrhythmias (SMQ) [narrow] | 0 | 0 | 0.034 | 1 | 3.16 |  |  |  |  |  | 
COVID19_JANSSEN | Appendicolith | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal cord lipoma | 0 | 0 | 0.085 | 1 | 2.765 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell macrocytes present | 0 | 0 | 0.017 | 1 | 3.406 |  |  |  |  |  | 
COVID19_JANSSEN | Protein-losing gastroenteropathy | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Otic examination normal | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Neurosensory hypoacusis | 0 | 0 | 0.007 | 1 | 3.697 |  |  |  |  |  | 
COVID19_JANSSEN | Malformation venous | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin D dimer decreased | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy heart | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Renal cyst haemorrhage | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal hypotension | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Enanthema | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Dandy-Walker syndrome | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Cutis laxa | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy pharynx abnormal | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombectomy | 0 | 0.001 | 0.267 | 1 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Macrophage count | 0 | 0 | 0 | 1 | 5.826 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral venous sinus thrombosis | 0 | 0 | 0.016 | 1 | 3.44 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine increased | 0 | 0 | 0.009 | 1 | 3.607 |  |  |  |  |  | 
COVID19_JANSSEN | HLA-B*27 assay | 0 | 0 | 0.006 | 1 | 3.714 |  |  |  |  |  | 
COVID19_JANSSEN | Protein S normal | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema infectiosum | 0 | 0 | 0.012 | 1 | 3.511 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site hypertrichosis | 0 | 0 | 0 | 1 | 5.794 |  |  |  |  |  | 
COVID19_JANSSEN | Febrile neutropenia | 0 | 0 | 0.114 | 1 | 2.621 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site oedema | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_JANSSEN | Product used for unknown indication | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Microcytosis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue necrosis | 0 | 0 | 0.111 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | Gynaecological examination abnormal | 0 | 0 | 0.031 | 1 | 3.201 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin degradation products increased | 0 | 0 | 0 | 1 | 4.8 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular function test normal | 0 | 0 | 0.009 | 1 | 3.605 |  |  |  |  |  | 
COVID19_JANSSEN | Suspected product contamination | 0 | 0 | 0.004 | 1 | 3.815 |  |  |  |  |  | 
COVID19_JANSSEN | Low density lipoprotein decreased | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Carboxyhaemoglobin decreased | 0 | 0 | 0.009 | 1 | 3.611 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal renal imaging abnormal | 0 | 0 | 0.002 | 1 | 4.073 |  |  |  |  |  | 
COVID19_JANSSEN | Eye ulcer | 0 | 0 | 0.008 | 1 | 3.661 |  |  |  |  |  | 
COVID19_JANSSEN | Cytokine release syndrome | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral artery embolism | 0 | 0 | 0.014 | 1 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Amputation | 0 | 0 | 0 | 1 | 5.031 |  |  |  |  |  | 
COVID19_JANSSEN | Viral labyrinthitis | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Tachycardia paroxysmal | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_JANSSEN | Radius fracture | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal examination | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_JANSSEN | Blood methaemoglobin present | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic product effective for unapproved indication | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Limbic encephalitis | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_JANSSEN | Extrapulmonary tuberculosis | 0 | 0 | 0.001 | 1 | 4.161 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QT interval abnormal | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspnoea paroxysmal nocturnal | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_JANSSEN | Auscultation | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal adhesions | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Venoocclusive disease | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine injury | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Protein albumin ratio abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Product selection error | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Myelocyte percentage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Large intestinal ulcer | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoreactive trypsinogen increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Forced vital capacity normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Brain lobectomy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Alcoholic liver disease | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Menstruation irregular | 0 | 0 | 0 | 1 | 5.159 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte count decreased | 0 | 0.001 | 0.167 | 1 | 2.407 |  |  |  |  |  | 
COVID19_JANSSEN | Hyporeflexia | 0 | 0 | 0.128 | 1 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Therapeutic response decreased | 0 | 0 | 0 | 1 | 4.363 |  |  |  |  |  | 
COVID19_JANSSEN | Culture urine positive | 0 | 0 | 0.204 | 1 | 2.288 |  |  |  |  |  | 
COVID19_JANSSEN | Blood fibrinogen normal | 0 | 0 | 0.01 | 1 | 3.591 |  |  |  |  |  | 
COVID19_JANSSEN | Polyuria | 0 | 0 | 0.206 | 1 | 2.281 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased interest | 0 | 0 | 0.254 | 1 | 2.146 |  |  |  |  |  | 
COVID19_JANSSEN | Somatic symptom disorder | 0 | 0 | 0 | 1 | 5.431 |  |  |  |  |  | 
COVID19_JANSSEN | Feeding tube user | 0 | 0 | 0.151 | 1 | 2.465 |  |  |  |  |  | 
COVID19_JANSSEN | Mental fatigue | 0 | 0 | 0.149 | 1 | 2.473 |  |  |  |  |  | 
COVID19_JANSSEN | Calcium ionised normal | 0 | 0 | 0.254 | 1 | 2.145 |  |  |  |  |  | 
COVID19_JANSSEN | Granulocytopenia | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C3 decreased | 0 | 0 | 0.007 | 1 | 3.68 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue coated | 0 | 0 | 0.165 | 1 | 2.415 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumocystis jirovecii pneumonia | 0 | 0 | 0 | 1 | 4.964 |  |  |  |  |  | 
COVID19_JANSSEN | Blood heavy metal normal | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_JANSSEN | Steroid therapy | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_JANSSEN | Impulsive behaviour | 0 | 0 | 0.004 | 1 | 3.831 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration joint normal | 0 | 0 | 0.144 | 1 | 2.494 |  |  |  |  |  | 
COVID19_JANSSEN | Retinogram | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-platelet antibody negative | 0 | 0 | 0.006 | 1 | 3.709 |  |  |  |  |  | 
COVID19_JANSSEN | West Nile virus test positive | 0 | 0 | 0 | 1 | 5.549 |  |  |  |  |  | 
COVID19_JANSSEN | Intercepted product prescribing error | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Glucose-6-phosphate dehydrogenase | 0 | 0 | 0 | 1 | 4.45 |  |  |  |  |  | 
COVID19_JANSSEN | Postoperative wound infection | 0 | 0 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_JANSSEN | Perfusion brain scan | 0 | 0 | 0.007 | 1 | 3.695 |  |  |  |  |  | 
COVID19_JANSSEN | CSF polymorphonuclear cell count increased | 0 | 0 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_JANSSEN | Surgical failure | 0 | 0 | 0.014 | 1 | 3.474 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve hypoplasia | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Disease risk factor | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Psychological trauma | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Otitis media chronic | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Human polyomavirus infection | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocution | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Ecouvillonage | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Blood catecholamines decreased | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Automatism epileptic | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral disorders (SMQ) [narrow] | 0 | 0 | 0.198 | 1 | 2.305 |  |  |  |  |  | 
COVID19_JANSSEN | Relapsing-remitting multiple sclerosis | 0 | 0 | 0.003 | 1 | 3.928 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose fluctuation | 0 | 0 | 0.198 | 1 | 2.305 |  |  |  |  |  | 
COVID19_JANSSEN | Product leakage | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial obstruction | 0 | 0 | 0.014 | 1 | 3.482 |  |  |  |  |  | 
COVID19_JANSSEN | Binocular eye movement disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Recalled product administered | 0 | 0 | 0 | 1 | 5.331 |  |  |  |  |  | 
COVID19_JANSSEN | Nail disorder | 0 | 0 | 0.022 | 1 | 3.329 |  |  |  |  |  | 
COVID19_JANSSEN | Spleen scan normal | 0 | 0 | 0.173 | 1 | 2.389 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lung | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram T wave normal | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein | 0 | 0 | 0.031 | 1 | 3.198 |  |  |  |  |  | 
COVID19_JANSSEN | Total cholesterol/HDL ratio | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urine | 0 | 0 | 0.113 | 1 | 2.624 |  |  |  |  |  | 
COVID19_JANSSEN | Thymectomy | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_JANSSEN | Granular cell tumour | 0 | 0 | 0.003 | 1 | 3.91 |  |  |  |  |  | 
COVID19_JANSSEN | Free fatty acids | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Extravasation blood | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Cortical dysplasia | 0 | 0 | 0 | 1 | 5.718 |  |  |  |  |  | 
COVID19_JANSSEN | pH urine increased | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin C | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Prealbumin increased | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Osteosarcoma | 0 | 0 | 0.006 | 1 | 3.719 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-glomerular basement membrane antibody positive | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Adenocarcinoma of colon | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Sex hormone binding globulin | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Scleral oedema | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Product closure removal difficult | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Pericarditis tuberculous | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Oocyte harvest | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | H2N2 influenza | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Dwarfism | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | CHARGE syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure difference of extremities | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy intestine normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha tumour necrosis factor | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract infection | 0 | 0.001 | 0.184 | 1 | 2.35 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site infection | 0 | 0 | 0.24 | 1 | 2.185 |  |  |  |  |  | 
COVID19_JANSSEN | Disability | 0 | 0 | 0.035 | 1 | 3.152 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue ulceration | 0 | 0 | 0.297 | 1 | 2.039 |  |  |  |  |  | 
COVID19_JANSSEN | Enlarged uvula | 0 | 0.001 | 0.327 | 1 | 1.97 |  |  |  |  |  | 
COVID19_JANSSEN | Haematocrit increased | 0 | 0 | 0.28 | 1 | 2.081 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract infection viral | 0 | 0 | 0.002 | 1 | 3.959 |  |  |  |  |  | 
COVID19_JANSSEN | Globulins decreased | 0 | 0.001 | 0.211 | 1 | 2.264 |  |  |  |  |  | 
COVID19_JANSSEN | Jaw fracture | 0 | 0 | 0.215 | 1 | 2.255 |  |  |  |  |  | 
COVID19_JANSSEN | Bone scan abnormal | 0 | 0 | 0.112 | 1 | 2.628 |  |  |  |  |  | 
COVID19_JANSSEN | Infarction | 0 | 0 | 0.178 | 1 | 2.371 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine normal | 0 | 0 | 0.159 | 1 | 2.436 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram PR interval | 0 | 0 | 0.037 | 1 | 3.134 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus infection | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic function test abnormal | 0 | 0.001 | 0.095 | 1 | 2.712 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site atrophy | 0 | 0 | 0.362 | 1 | 1.895 |  |  |  |  |  | 
COVID19_JANSSEN | Norovirus test | 0 | 0 | 0 | 1 | 5.289 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin CSF increased | 0 | 0 | 0.006 | 1 | 3.724 |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular dysfunction | 0 | 0.001 | 0.165 | 1 | 2.413 |  |  |  |  |  | 
COVID19_JANSSEN | Hair texture abnormal | 0 | 0 | 0 | 1 | 4.544 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram change | 0 | 0.001 | 0.227 | 1 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant melanoma | 0 | 0 | 0.013 | 1 | 3.508 |  |  |  |  |  | 
COVID19_JANSSEN | Kyphosis | 0 | 0 | 0.004 | 1 | 3.817 |  |  |  |  |  | 
COVID19_JANSSEN | Critical illness | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_JANSSEN | Retrograde amnesia | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Substance use | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.011 | 1 | 3.564 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrest neonatal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Anticonvulsant drug level below therapeutic | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolar proteinosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Acquired tracheo-oesophageal fistula | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Otitis media | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_JANSSEN | Regressive behaviour | 0 | 0 | 0.178 | 1 | 2.37 |  |  |  |  |  | 
COVID19_JANSSEN | Incontinence | 0 | 0.001 | 0.434 | 1 | 1.755 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature fluctuation | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil percentage increased | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_JANSSEN | T-lymphocyte count | 0 | 0 | 0 | 1 | 4.855 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased vibratory sense | 0 | 0 | 0.005 | 1 | 3.762 |  |  |  |  |  | 
COVID19_JANSSEN | Interleukin level increased | 0 | 0 | 0 | 1 | 4.474 |  |  |  |  |  | 
COVID19_JANSSEN | Malabsorption | 0 | 0 | 0.002 | 1 | 4.065 |  |  |  |  |  | 
COVID19_JANSSEN | Knee arthroplasty | 0 | 0 | 0.106 | 1 | 2.655 |  |  |  |  |  | 
COVID19_JANSSEN | Stress cardiomyopathy | 0 | 0 | 0.239 | 1 | 2.185 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden visual loss | 0 | 0 | 0.168 | 1 | 2.406 |  |  |  |  |  | 
COVID19_JANSSEN | Blood mercury abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Reflex test abnormal | 0 | 0 | 0 | 1 | 4.831 |  |  |  |  |  | 
COVID19_JANSSEN | Pica | 0 | 0 | 0.013 | 1 | 3.498 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperplasia | 0 | 0 | 0.002 | 1 | 4.012 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site nodule | 0 | 0 | 0.098 | 1 | 2.697 |  |  |  |  |  | 
COVID19_JANSSEN | Nocturnal dyspnoea | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Device breakage | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound biliary tract abnormal | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic bacterial infection | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Post thrombotic syndrome | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Neurotransmitter level altered | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_JANSSEN | Gastritis haemorrhagic | 0 | 0 | 0.067 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal abscess | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | Vital capacity | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Venolymphatic malformation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal neoplasm | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | T-cell lymphoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Selective mutism | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory ganglionitis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Renal failure neonatal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Myelosuppression | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis allergic | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Diastolic hypertension | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Creatinine urine decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood testosterone increased | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Adenoidal disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Agranulocytosis (SMQ) [narrow] | 0 | 0.001 | 0.254 | 1 | 2.145 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle swelling | 0 | 0.001 | 0.203 | 1 | 2.289 |  |  |  |  |  | 
COVID19_JANSSEN | Ear pruritus | 0 | 0.001 | 0.527 | 1 | 1.594 |  |  |  |  |  | 
COVID19_JANSSEN | Faeces soft | 0 | 0 | 0.006 | 1 | 3.73 |  |  |  |  |  | 
COVID19_JANSSEN | Premature menopause | 0 | 0 | 0 | 1 | 5.75 |  |  |  |  |  | 
COVID19_JANSSEN | Scan brain | 0 | 0 | 0.252 | 1 | 2.152 |  |  |  |  |  | 
COVID19_JANSSEN | Carpal tunnel syndrome | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_JANSSEN | Vitiligo | 0 | 0 | 0.001 | 1 | 4.171 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase decreased | 0 | 0 | 0.006 | 1 | 3.706 |  |  |  |  |  | 
COVID19_JANSSEN | Corrective lens user | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | B-lymphocyte count | 0 | 0 | 0 | 1 | 4.462 |  |  |  |  |  | 
COVID19_JANSSEN | Genital herpes simplex | 0 | 0 | 0.031 | 1 | 3.199 |  |  |  |  |  | 
COVID19_JANSSEN | Central pain syndrome | 0 | 0 | 0 | 1 | 5.402 |  |  |  |  |  | 
COVID19_JANSSEN | Stertor | 0 | 0 | 0 | 1 | 4.32 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosa haematoma | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Dependent rubor | 0 | 0 | 0.102 | 1 | 2.676 |  |  |  |  |  | 
COVID19_JANSSEN | Choroidal neovascularisation | 0 | 0 | 0.039 | 1 | 3.108 |  |  |  |  |  | 
COVID19_JANSSEN | Wrist surgery | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbosacral radiculopathy | 0 | 0 | 0.1 | 1 | 2.685 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic tonsillitis | 0 | 0 | 0.007 | 1 | 3.683 |  |  |  |  |  | 
COVID19_JANSSEN | Traumatic tooth displacement | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound pancreas normal | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic rupture | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Opiates positive | 0 | 0 | 0.044 | 1 | 3.064 |  |  |  |  |  | 
COVID19_JANSSEN | Nocardiosis | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Cryptorchism | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Bone loss | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Blast cell count increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy lymph gland normal | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatic heart disease | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Partner stress | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Orchidectomy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Glaucoma traumatic | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Engraft failure | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Breast discharge infected | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Atelectasis neonatal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Altered pitch perception | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Adenosine deaminase decreased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological examination normal | 0 | 0.001 | 0.197 | 1 | 2.307 |  |  |  |  |  | 
COVID19_JANSSEN | Henoch-Schonlein purpura | 0 | 0 | 0.2 | 1 | 2.298 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor negative | 0 | 0 | 0.047 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Neisseria test positive | 0 | 0 | 0 | 1 | 5.656 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyarrhythmia terms, nonspecific (SMQ) [narrow] | 0 | 0.002 | 0.382 | 1 | 1.853 |  |  |  |  |  | 
COVID19_JANSSEN | Dysaesthesia | 0 | 0 | 0.004 | 1 | 3.854 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram normal | 0 | 0.001 | 0.268 | 1 | 2.109 |  |  |  |  |  | 
COVID19_JANSSEN | Myasthenia gravis | 0 | 0 | 0.248 | 1 | 2.163 |  |  |  |  |  | 
COVID19_JANSSEN | Electroneuromyography | 0 | 0 | 0.002 | 1 | 4.034 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep paralysis | 0 | 0 | 0.001 | 1 | 4.296 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess increased | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfective gingivitis | 0 | 0 | 0.069 | 1 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Intraventricular haemorrhage | 0 | 0 | 0.002 | 1 | 4.023 |  |  |  |  |  | 
COVID19_JANSSEN | Blood testosterone decreased | 0 | 0 | 0.002 | 1 | 4.009 |  |  |  |  |  | 
COVID19_JANSSEN | Blood zinc decreased | 0 | 0 | 0.01 | 1 | 3.592 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound therapy | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Wolff-Parkinson-White syndrome | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_JANSSEN | Schizoaffective disorder | 0 | 0 | 0 | 1 | 4.76 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity total decreased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Cystoscopy normal | 0 | 0 | 0.029 | 1 | 3.223 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal infiltrates | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Necrosis ischaemic | 0 | 0 | 0.015 | 1 | 3.449 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic graft versus host disease | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy small intestine abnormal | 0 | 0 | 0.053 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Sweat test | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Severe invasive streptococcal infection | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory disorder neonatal | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary arterial hypertension | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural infection | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_JANSSEN | Plantar erythema | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue tie operation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroglobulin absent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Penile size reduced | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic enzymes decreased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Oral viral infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicitis human papilloma virus | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Drooling | 0 | 0.001 | 0.549 | 1 | 1.561 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic fibrosis | 0 | 0 | 0.002 | 1 | 3.99 |  |  |  |  |  | 
COVID19_JANSSEN | Angular cheilitis | 0 | 0 | 0.026 | 1 | 3.267 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin CSF | 0 | 0 | 0.014 | 1 | 3.469 |  |  |  |  |  | 
COVID19_JANSSEN | Uveitis | 0 | 0 | 0.008 | 1 | 3.632 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis bullous | 0 | 0 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Joint effusion | 0 | 0.001 | 0.224 | 1 | 2.229 |  |  |  |  |  | 
COVID19_JANSSEN | Psychomotor skills impaired | 0 | 0 | 0.025 | 1 | 3.273 |  |  |  |  |  | 
COVID19_JANSSEN | Urobilinogen urine | 0 | 0 | 0.224 | 1 | 2.229 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple allergies | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_JANSSEN | Specialist consultation | 0 | 0 | 0.216 | 1 | 2.25 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocytic infiltration | 0 | 0 | 0.037 | 1 | 3.13 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy liver abnormal | 0 | 0 | 0.004 | 1 | 3.826 |  |  |  |  |  | 
COVID19_JANSSEN | Transient global amnesia | 0 | 0 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial cyst | 0 | 0 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder dysfunction | 0 | 0 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_JANSSEN | Acute lymphocytic leukaemia | 0 | 0 | 0.133 | 1 | 2.539 |  |  |  |  |  | 
COVID19_JANSSEN | Mycoplasma infection | 0 | 0 | 0.025 | 1 | 3.28 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cortisol | 0 | 0 | 0.017 | 1 | 3.415 |  |  |  |  |  | 
COVID19_JANSSEN | Wound haemorrhage | 0 | 0 | 0.168 | 1 | 2.406 |  |  |  |  |  | 
COVID19_JANSSEN | Subcutaneous haematoma | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound liver abnormal | 0 | 0 | 0.001 | 1 | 4.083 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle abscess | 0 | 0 | 0.01 | 1 | 3.586 |  |  |  |  |  | 
COVID19_JANSSEN | Metastases to lung | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Flashback | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin normal | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary immunodeficiency | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural stroke | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Parechovirus infection | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Lysozyme increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Idiopathic partial epilepsy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperarousal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Borderline glaucoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thromboplastin increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Blood insulin increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-complement antibody | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Head injury | 0 | 0.001 | 0.337 | 1 | 1.949 |  |  |  |  |  | 
COVID19_JANSSEN | Skin tightness | 0 | 0.002 | 0.316 | 1 | 1.994 |  |  |  |  |  | 
COVID19_JANSSEN | Skin ulcer | 0 | 0.001 | 0.296 | 1 | 2.04 |  |  |  |  |  | 
COVID19_JANSSEN | Mumps antibody test negative | 0 | 0 | 0 | 1 | 5.591 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza B virus test positive | 0 | 0 | 0 | 1 | 4.56 |  |  |  |  |  | 
COVID19_JANSSEN | Partial seizures | 0 | 0 | 0.276 | 1 | 2.091 |  |  |  |  |  | 
COVID19_JANSSEN | Microscopy | 0 | 0 | 0.23 | 1 | 2.211 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal motility disorder | 0 | 0 | 0.001 | 1 | 4.092 |  |  |  |  |  | 
COVID19_JANSSEN | CSF oligoclonal band present | 0 | 0 | 0.005 | 1 | 3.752 |  |  |  |  |  | 
COVID19_JANSSEN | Blood triglycerides normal | 0 | 0 | 0.136 | 1 | 2.525 |  |  |  |  |  | 
COVID19_JANSSEN | Tetany | 0 | 0 | 0.164 | 1 | 2.419 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix disorder | 0 | 0 | 0 | 1 | 5.154 |  |  |  |  |  | 
COVID19_JANSSEN | Genital swelling | 0 | 0 | 0.234 | 1 | 2.199 |  |  |  |  |  | 
COVID19_JANSSEN | Viral myocarditis | 0 | 0 | 0.003 | 1 | 3.933 |  |  |  |  |  | 
COVID19_JANSSEN | Bloody discharge | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Vacuum extractor delivery | 0 | 0 | 0 | 1 | 4.995 |  |  |  |  |  | 
COVID19_JANSSEN | Continuous haemodiafiltration | 0 | 0 | 0.097 | 1 | 2.705 |  |  |  |  |  | 
COVID19_JANSSEN | Cell death | 0 | 0 | 0 | 1 | 4.882 |  |  |  |  |  | 
COVID19_JANSSEN | Polycythaemia | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Shock hypoglycaemic | 0 | 0 | 0.04 | 1 | 3.095 |  |  |  |  |  | 
COVID19_JANSSEN | Ear canal erythema | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteric stenosis | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular pseudoaneurysm | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Amylase decreased | 0 | 0 | 0 | 1 | 5.755 |  |  |  |  |  | 
COVID19_JANSSEN | Blood acid phosphatase | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | CSF cell count | 0 | 0 | 0.01 | 1 | 3.572 |  |  |  |  |  | 
COVID19_JANSSEN | Rhabdomyosarcoma | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Concomitant disease progression | 0 | 0 | 0 | 1 | 4.529 |  |  |  |  |  | 
COVID19_JANSSEN | Lichen planus | 0 | 0 | 0.003 | 1 | 3.933 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising ulcerative gingivostomatitis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid pain | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Ileocolectomy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Internal hernia | 0 | 0 | 0 | 1 | 4.751 |  |  |  |  |  | 
COVID19_JANSSEN | Alveolar oxygen partial pressure increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Apoptosis | 0 | 0 | 0 | 1 | 4.904 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet aggregation abnormal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site pruritus | 0 | 0 | 0.021 | 1 | 3.342 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet function test normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Urine arsenic increased | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site plaque | 0 | 0 | 0.218 | 1 | 2.246 |  |  |  |  |  | 
COVID19_JANSSEN | Enterobacter test positive | 0 | 0 | 0.019 | 1 | 3.368 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal operation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Poikilocytosis | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Light chain analysis | 0 | 0 | 0.001 | 1 | 4.269 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic injury | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve degeneration | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural fistula | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Non-cardiac chest pain | 0 | 0 | 0.209 | 1 | 2.271 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory depth decreased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ambulatory abnormal | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal variceal ligation | 0 | 0 | 0 | 1 | 5.754 |  |  |  |  |  | 
COVID19_JANSSEN | Sense of oppression | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_JANSSEN | pH body fluid increased | 0 | 0 | 0.001 | 1 | 4.087 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system abscess | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Apparent life threatening event | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_JANSSEN | End stage renal disease | 0 | 0 | 0.023 | 1 | 3.314 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-NMDA antibody positive | 0 | 0 | 0 | 1 | 4.766 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy rectum abnormal | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_JANSSEN | Varicocele | 0 | 0 | 0 | 1 | 5.038 |  |  |  |  |  | 
COVID19_JANSSEN | Gluten free diet | 0 | 0 | 0 | 1 | 4.641 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal non-stress test normal | 0 | 0 | 0 | 1 | 5.798 |  |  |  |  |  | 
COVID19_JANSSEN | Skin neoplasm excision | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatochalasis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalocele repair | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional overdose | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue erythema | 0 | 0 | 0.275 | 1 | 2.093 |  |  |  |  |  | 
COVID19_JANSSEN | Lip pruritus | 0 | 0.001 | 0.291 | 1 | 2.053 |  |  |  |  |  | 
COVID19_JANSSEN | Russell's viper venom time normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Antiphospholipid syndrome | 0 | 0 | 0 | 1 | 4.615 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic neoplasm | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_JANSSEN | Genitourinary symptom | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Lip discolouration | 0 | 0 | 0.312 | 1 | 2.005 |  |  |  |  |  | 
COVID19_JANSSEN | Gram stain negative | 0 | 0 | 0.208 | 1 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Crepitations | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | Inappropriate antidiuretic hormone secretion | 0 | 0 | 0.179 | 1 | 2.366 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophagogastroduodenoscopy abnormal | 0 | 0 | 0.202 | 1 | 2.293 |  |  |  |  |  | 
COVID19_JANSSEN | Peripancreatic fluid collection | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_JANSSEN | Scan | 0 | 0.001 | 0.101 | 1 | 2.679 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to arthropod sting | 0 | 0 | 0.155 | 1 | 2.453 |  |  |  |  |  | 
COVID19_JANSSEN | Dropped head syndrome | 0 | 0 | 0.034 | 1 | 3.163 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac hypertrophy | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site plaque | 0 | 0 | 0.001 | 1 | 4.131 |  |  |  |  |  | 
COVID19_JANSSEN | Urine sodium | 0 | 0 | 0 | 1 | 4.578 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram cerebral normal | 0 | 0.001 | 0.297 | 1 | 2.037 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal examination abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Alopecia universalis | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_JANSSEN | Tri-iodothyronine free increased | 0 | 0 | 0.034 | 1 | 3.162 |  |  |  |  |  | 
COVID19_JANSSEN | Urine protein/creatinine ratio increased | 0 | 0 | 0 | 1 | 4.979 |  |  |  |  |  | 
COVID19_JANSSEN | Haemangioma of skin | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_JANSSEN | Breast cancer in situ | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Giardia test negative | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_JANSSEN | Amniotic fluid index decreased | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [narrow] | 0 | 0.001 | 0.304 | 1 | 2.021 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary casts present | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine tenderness | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Antimitochondrial antibody positive | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Urine protein/creatinine ratio | 0 | 0 | 0.001 | 1 | 4.122 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil function disorder | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy brain | 0 | 0 | 0 | 1 | 5.794 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory level abnormal | 0 | 0 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | UV light therapy | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis mumps | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Activated protein C resistance test positive | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Scrotal erythema | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to communicable disease | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle mass | 0 | 0 | 0.007 | 1 | 3.668 |  |  |  |  |  | 
COVID19_JANSSEN | Product physical consistency issue | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Chondropathy | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Otitis media bacterial | 0 | 0 | 0.001 | 1 | 4.099 |  |  |  |  |  | 
COVID19_JANSSEN | Infection susceptibility increased | 0 | 0 | 0 | 1 | 4.587 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin D | 0 | 0.001 | 0.376 | 1 | 1.865 |  |  |  |  |  | 
COVID19_JANSSEN | Phrenic nerve injury | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcitonin normal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Serous retinal detachment | 0 | 0 | 0.02 | 1 | 3.36 |  |  |  |  |  | 
COVID19_JANSSEN | Paradoxical drug reaction | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | pH urine decreased | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal sepsis | 0 | 0 | 0.008 | 1 | 3.646 |  |  |  |  |  | 
COVID19_JANSSEN | Venous stent insertion | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac telemetry normal | 0 | 0 | 0.006 | 1 | 3.726 |  |  |  |  |  | 
COVID19_JANSSEN | Squamous cell carcinoma of lung | 0 | 0 | 0.004 | 1 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Catheterisation venous | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure systolic increased | 0 | 0.001 | 0.344 | 1 | 1.932 |  |  |  |  |  | 
COVID19_JANSSEN | Blood parathyroid hormone increased | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Angina bullosa haemorrhagica | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Extremity contracture | 0 | 0 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_JANSSEN | Folliculitis | 0 | 0.001 | 0.274 | 1 | 2.095 |  |  |  |  |  | 
COVID19_JANSSEN | Ear congestion | 0 | 0 | 0.381 | 1 | 1.856 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal resection | 0 | 0 | 0.004 | 1 | 3.851 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemia | 0 | 0.001 | 0.193 | 1 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian malignant tumours (SMQ) [narrow] | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor | 0 | 0 | 0.046 | 1 | 3.045 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal obstruction | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis infective | 0 | 0 | 0.21 | 1 | 2.269 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular function test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Joint vibration | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillectomy | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_JANSSEN | Cor pulmonale chronic | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Breast discharge | 0 | 0 | 0.001 | 1 | 4.222 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal infarction | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_JANSSEN | Thoracic cavity drainage | 0 | 0 | 0 | 1 | 4.685 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroleptic malignant syndrome (SMQ) [narrow] | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging abdominal abnormal | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Pityriasis lichenoides et varioliformis acuta | 0 | 0 | 0.001 | 1 | 4.089 |  |  |  |  |  | 
COVID19_JANSSEN | Vanillyl mandelic acid urine increased | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Booster dose missed | 0 | 0 | 0.036 | 1 | 3.142 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid mass | 0 | 0 | 0.227 | 1 | 2.22 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract irritation | 0 | 0 | 0.008 | 1 | 3.648 |  |  |  |  |  | 
COVID19_JANSSEN | Hospitalisation | 0 | 0 | 0.119 | 1 | 2.599 |  |  |  |  |  | 
COVID19_JANSSEN | Viral titre increased | 0 | 0 | 0.039 | 1 | 3.108 |  |  |  |  |  | 
COVID19_JANSSEN | Coccydynia | 0 | 0 | 0.176 | 1 | 2.377 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin urine | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to toxic agent | 0 | 0 | 0.008 | 1 | 3.648 |  |  |  |  |  | 
COVID19_JANSSEN | Beta-2 glycoprotein antibody negative | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_JANSSEN | Trigeminal nerve disorder | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_JANSSEN | Galactostasis | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Ehlers-Danlos syndrome | 0 | 0 | 0 | 1 | 5.162 |  |  |  |  |  | 
COVID19_JANSSEN | Bacillus bacteraemia | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Yersinia test negative | 0 | 0 | 0.004 | 1 | 3.829 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive encephalopathy | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Scalloped tongue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Wound evisceration | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Amaurosis | 0 | 0 | 0.002 | 1 | 4.015 |  |  |  |  |  | 
COVID19_JANSSEN | Presbyopia | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Haemangioma | 0 | 0 | 0.194 | 1 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Oppositional defiant disorder | 0 | 0 | 0.002 | 1 | 3.986 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemia | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_JANSSEN | Strawberry tongue | 0 | 0 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_JANSSEN | Shock haemorrhagic | 0 | 0 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_JANSSEN | Foaming at mouth | 0 | 0.001 | 0.355 | 1 | 1.91 |  |  |  |  |  | 
COVID19_JANSSEN | Apparent death | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_JANSSEN | Viral tonsillitis | 0 | 0 | 0.05 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Smear test | 0 | 0 | 0.161 | 1 | 2.431 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy kidney abnormal | 0 | 0 | 0.006 | 1 | 3.732 |  |  |  |  |  | 
COVID19_JANSSEN | Lesion excision | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctivitis bacterial | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchoalveolar lavage | 0 | 0 | 0.1 | 1 | 2.687 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor IX level normal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheomalacia | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_JANSSEN | Pus in stool | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_JANSSEN | Ankyloglossia acquired | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma stage I | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Macular pigmentation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital bladder anomaly | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Ketonuria | 0 | 0 | 0.018 | 1 | 3.388 |  |  |  |  |  | 
COVID19_JANSSEN | Loose body in joint | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Acrophobia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal disorder | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_JANSSEN | Lip injury | 0 | 0 | 0.446 | 1 | 1.733 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea abnormal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Product label issue | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Palmar-plantar erythrodysaesthesia syndrome | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | Immunophenotyping | 0 | 0 | 0.001 | 1 | 4.165 |  |  |  |  |  | 
COVID19_JANSSEN | Adverse event following immunisation | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin K decreased | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchiectasis | 0 | 0 | 0.004 | 1 | 3.842 |  |  |  |  |  | 
COVID19_JANSSEN | Hypercholesterolaemia | 0 | 0 | 0 | 1 | 4.503 |  |  |  |  |  | 
COVID19_JANSSEN | Nasoendoscopy | 0 | 0 | 0.103 | 1 | 2.67 |  |  |  |  |  | 
COVID19_JANSSEN | Stool heavy metal positive | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Coronary arterial stent insertion | 0 | 0.001 | 0.154 | 1 | 2.453 |  |  |  |  |  | 
COVID19_JANSSEN | Genital ulceration | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_JANSSEN | Bacillus test positive | 0 | 0 | 0.002 | 1 | 4.049 |  |  |  |  |  | 
COVID19_JANSSEN | Oromandibular dystonia | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Naturopathy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin therapy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet distribution width | 0 | 0 | 0.007 | 1 | 3.692 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal haemorrhage | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_JANSSEN | Hair metal test abnormal | 0 | 0 | 0.224 | 1 | 2.229 |  |  |  |  |  | 
COVID19_JANSSEN | Serositis | 0 | 0 | 0.03 | 1 | 3.212 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal function test normal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Focal dyscognitive seizures | 0 | 0 | 0.149 | 1 | 2.474 |  |  |  |  |  | 
COVID19_JANSSEN | Blood zinc normal | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac stress test abnormal | 0 | 0 | 0.243 | 1 | 2.175 |  |  |  |  |  | 
COVID19_JANSSEN | Trichoglossia | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_JANSSEN | Post-traumatic epilepsy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Fundus autofluorescence | 0 | 0 | 0.035 | 1 | 3.149 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric ulcer | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure keratitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound abdomen normal | 0 | 0 | 0.144 | 1 | 2.493 |  |  |  |  |  | 
COVID19_JANSSEN | Human ehrlichiosis | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune nephritis | 0 | 0 | 0.001 | 1 | 4.075 |  |  |  |  |  | 
COVID19_JANSSEN | Extra dose administered | 0 | 0.001 | 0.163 | 1 | 2.421 |  |  |  |  |  | 
COVID19_JANSSEN | Tinea cruris | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Erosive oesophagitis | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian injury | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic cough | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Mite allergy | 0 | 0 | 0.001 | 1 | 4.111 |  |  |  |  |  | 
COVID19_JANSSEN | Ergotherapy | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Culture throat positive | 0 | 0 | 0.018 | 1 | 3.396 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphatic system neoplasm | 0 | 0 | 0.002 | 1 | 4.063 |  |  |  |  |  | 
COVID19_JANSSEN | Deposit eye | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Oral allergy syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Blood catecholamines increased | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour pain | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation factor V level decreased | 0 | 0 | 0 | 1 | 5.602 |  |  |  |  |  | 
COVID19_JANSSEN | Cognitive linguistic deficit | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal test | 0 | 0 | 0.006 | 1 | 3.708 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis enteroviral | 0 | 0 | 0 | 1 | 5.365 |  |  |  |  |  | 
COVID19_JANSSEN | Organic brain syndrome | 0 | 0 | 0 | 1 | 4.558 |  |  |  |  |  | 
COVID19_JANSSEN | Bone giant cell tumour | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Bacterial test positive | 0 | 0 | 0.158 | 1 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Capillary nail refill test | 0 | 0 | 0.126 | 1 | 2.567 |  |  |  |  |  | 
COVID19_JANSSEN | Oculogyric crisis | 0 | 0 | 0.007 | 1 | 3.665 |  |  |  |  |  | 
COVID19_JANSSEN | Acute zonal occult outer retinopathy | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Skin abrasion | 0 | 0 | 0.35 | 1 | 1.92 |  |  |  |  |  | 
COVID19_JANSSEN | Ketogenic diet | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_JANSSEN | CD8 lymphocytes decreased | 0 | 0 | 0 | 1 | 4.575 |  |  |  |  |  | 
COVID19_JANSSEN | Heart valve incompetence | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_JANSSEN | Histology | 0 | 0 | 0.008 | 1 | 3.663 |  |  |  |  |  | 
COVID19_JANSSEN | Porphyria acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Albuminuria | 0 | 0 | 0.016 | 1 | 3.433 |  |  |  |  |  | 
COVID19_JANSSEN | Milk soy protein intolerance | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Campylobacter gastroenteritis | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via direct contact | 0 | 0 | 0.001 | 1 | 4.209 |  |  |  |  |  | 
COVID19_JANSSEN | Clostridium test positive | 0 | 0 | 0.19 | 1 | 2.332 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular purpura | 0 | 0 | 0.001 | 1 | 4.184 |  |  |  |  |  | 
COVID19_JANSSEN | Ear irrigation | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell analysis | 0 | 0 | 0.097 | 1 | 2.704 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival disorder | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Urine zinc | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Catheter site discharge | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Dust allergy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Synovectomy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Eye patch application | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte count increased | 0 | 0 | 0.03 | 1 | 3.205 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site recall reaction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Prophylaxis against HIV infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood smear test | 0 | 0.001 | 0.136 | 1 | 2.525 |  |  |  |  |  | 
COVID19_JANSSEN | Rhegmatogenous retinal detachment | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Eye movement disorder | 0 | 0.002 | 0.325 | 1 | 1.973 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrocardiac syndrome | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Skeletal survey abnormal | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Puncture site reaction | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Tilt table test positive | 0 | 0 | 0 | 1 | 5.315 |  |  |  |  |  | 
COVID19_JANSSEN | Product availability issue | 0 | 0 | 0.004 | 1 | 3.809 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalomalacia | 0 | 0 | 0.176 | 1 | 2.379 |  |  |  |  |  | 
COVID19_JANSSEN | Arrhythmia related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.001 | 0.256 | 1 | 2.139 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy liver normal | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_JANSSEN | CSF polymorphonuclear cell count decreased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chloride | 0 | 0 | 0.001 | 1 | 4.126 |  |  |  |  |  | 
COVID19_JANSSEN | Anal inflammation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Lumboperitoneal shunt | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Non-Hodgkin's lymphoma | 0 | 0 | 0.009 | 1 | 3.612 |  |  |  |  |  | 
COVID19_JANSSEN | Neutralising antibodies negative | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs direct test positive | 0 | 0 | 0.002 | 1 | 4.006 |  |  |  |  |  | 
COVID19_JANSSEN | Anaesthetic complication | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil percentage increased | 0 | 0 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory level normal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Nucleated red cells | 0 | 0 | 0.244 | 1 | 2.173 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging hepatobiliary abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Petit mal epilepsy | 0 | 0 | 0.121 | 1 | 2.587 |  |  |  |  |  | 
COVID19_JANSSEN | Ehrlichia test | 0 | 0 | 0.225 | 1 | 2.225 |  |  |  |  |  | 
COVID19_JANSSEN | Thromboembolectomy | 0 | 0 | 0.009 | 1 | 3.606 |  |  |  |  |  | 
COVID19_JANSSEN | Tissue discolouration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Polyarthritis | 0 | 0.001 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Cortisol normal | 0 | 0 | 0.222 | 1 | 2.233 |  |  |  |  |  | 
COVID19_JANSSEN | Respirovirus test positive | 0 | 0 | 0.01 | 1 | 3.579 |  |  |  |  |  | 
COVID19_JANSSEN | Manufacturing product shipping issue | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound foetal | 0 | 0 | 0.005 | 1 | 3.787 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus bronchiolitis | 0 | 0 | 0.001 | 1 | 4.11 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram QT interval normal | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Superficial vein prominence | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Cervicobrachial syndrome | 0 | 0 | 0.006 | 1 | 3.723 |  |  |  |  |  | 
COVID19_JANSSEN | Morphoea | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous tuberculosis | 0 | 0 | 0.012 | 1 | 3.531 |  |  |  |  |  | 
COVID19_JANSSEN | Cortical visual impairment | 0 | 0 | 0 | 1 | 5.741 |  |  |  |  |  | 
COVID19_JANSSEN | Beta 2 microglobulin | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | Hysteroscopy | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell rouleaux formation present | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmia neonatorum | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Laryngeal pain | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Female reproductive tract disorder | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_JANSSEN | Urine cannabinoids increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Strongyloidiasis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Product delivery mechanism issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet aggregation decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Orbital apex syndrome | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Mitochondrial toxicity | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract inflammation | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular neuronitis | 0 | 0.001 | 0.314 | 1 | 1.998 |  |  |  |  |  | 
COVID19_JANSSEN | Miller Fisher syndrome | 0 | 0 | 0.03 | 1 | 3.209 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-VGCC antibody negative | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Shift to the right | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_JANSSEN | Seroconversion test negative | 0 | 0 | 0 | 1 | 5.218 |  |  |  |  |  | 
COVID19_JANSSEN | Colitis microscopic | 0 | 0 | 0.003 | 1 | 3.873 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangiocarcinoma | 0 | 0 | 0.085 | 1 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Ceruloplasmin | 0 | 0 | 0.093 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram peripheral normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvar dysplasia | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Thymol turbidity test | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate cancer metastatic | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_JANSSEN | Gitelman's syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis chronic | 0 | 0 | 0 | 1 | 4.982 |  |  |  |  |  | 
COVID19_JANSSEN | BK virus infection | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy liver | 0 | 0 | 0.021 | 1 | 3.347 |  |  |  |  |  | 
COVID19_JANSSEN | Cholangitis | 0 | 0 | 0.027 | 1 | 3.25 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatic enlargement | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_JANSSEN | Aspiration bursa | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Periventricular leukomalacia | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_JANSSEN | Adenovirus test positive | 0 | 0 | 0.034 | 1 | 3.165 |  |  |  |  |  | 
COVID19_JANSSEN | Libido disorder | 0 | 0 | 0.03 | 1 | 3.206 |  |  |  |  |  | 
COVID19_JANSSEN | Optic disc hyperaemia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Urine uric acid decreased | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cyst | 0 | 0 | 0.001 | 1 | 4.17 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth extraction | 0 | 0 | 0.135 | 1 | 2.529 |  |  |  |  |  | 
COVID19_JANSSEN | Suspected transmission of an infectious agent via product | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness permanent | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site pustule | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic wall hypertrophy | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Irlen syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes dermatitis | 0 | 0 | 0.063 | 1 | 2.909 |  |  |  |  |  | 
COVID19_JANSSEN | Brain natriuretic peptide | 0 | 0.001 | 0.373 | 1 | 1.873 |  |  |  |  |  | 
COVID19_JANSSEN | Acute promyelocytic leukaemia | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Single component of a two-component product administered | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary necrosis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Purpura non-thrombocytopenic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal alloimmune thrombocytopenia | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Menstrual cycle management | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Medication overuse headache | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Medical device implantation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Intraductal proliferative breast lesion | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Gardnerella infection | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Eye paraesthesia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Elephantiasis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | CSWS syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitis (SMQ) [narrow] | 0 | 0.001 | 0.197 | 1 | 2.309 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal behaviour | 0 | 0.001 | 0.315 | 1 | 1.998 |  |  |  |  |  | 
COVID19_JANSSEN | Bowel movement irregularity | 0 | 0 | 0.187 | 1 | 2.341 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time shortened | 0 | 0 | 0.252 | 1 | 2.151 |  |  |  |  |  | 
COVID19_JANSSEN | Breast neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.181 | 1 | 2.362 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroxine free | 0 | 0 | 0.319 | 1 | 1.989 |  |  |  |  |  | 
COVID19_JANSSEN | Premature separation of placenta | 0 | 0 | 0 | 1 | 4.409 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal discolouration | 0 | 0 | 0.311 | 1 | 2.007 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram coronary normal | 0 | 0.001 | 0.23 | 1 | 2.209 |  |  |  |  |  | 
COVID19_JANSSEN | Arrested labour | 0 | 0 | 0 | 1 | 5.654 |  |  |  |  |  | 
COVID19_JANSSEN | Intrusive thoughts | 0 | 0 | 0.01 | 1 | 3.592 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal hypermotility | 0 | 0 | 0 | 1 | 5.048 |  |  |  |  |  | 
COVID19_JANSSEN | Endotracheal intubation complication | 0 | 0 | 0.157 | 1 | 2.446 |  |  |  |  |  | 
COVID19_JANSSEN | Paraesthesia ear | 0 | 0 | 0.002 | 1 | 4.064 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram PR prolongation | 0 | 0 | 0.087 | 1 | 2.754 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor increased | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid gland scan abnormal | 0 | 0 | 0.037 | 1 | 3.134 |  |  |  |  |  | 
COVID19_JANSSEN | Post procedural haemorrhage | 0 | 0 | 0.014 | 1 | 3.478 |  |  |  |  |  | 
COVID19_JANSSEN | Oral papule | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginitis | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Venous haemorrhage | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Urine alcohol test negative | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Urine mercury | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Panencephalitis | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_JANSSEN | Lower motor neurone lesion | 0 | 0 | 0.011 | 1 | 3.537 |  |  |  |  |  | 
COVID19_JANSSEN | Environmental exposure | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Cell marker | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site extravasation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombin-antithrombin III complex normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Ptosis repair | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Porcelain gallbladder | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_JANSSEN | Monocyte percentage abnormal | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Iodine uptake normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Insulin C-peptide abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Cisternogram | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Bone cancer metastatic | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_JANSSEN | Blood 1,25-dihydroxycholecalciferol increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic stent insertion | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin G normal | 0 | 0.001 | 0.115 | 1 | 2.612 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin M decreased | 0 | 0 | 0.019 | 1 | 3.38 |  |  |  |  |  | 
COVID19_JANSSEN | Nerve compression | 0 | 0 | 0.223 | 1 | 2.232 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc degeneration | 0 | 0 | 0.015 | 1 | 3.448 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin | 0 | 0 | 0.036 | 1 | 3.137 |  |  |  |  |  | 
COVID19_JANSSEN | Intermenstrual bleeding | 0 | 0 | 0.028 | 1 | 3.236 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia mycoplasmal | 0 | 0 | 0.002 | 1 | 3.997 |  |  |  |  |  | 
COVID19_JANSSEN | ACTH stimulation test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Coma | 0 | 0 | 0.251 | 1 | 2.154 |  |  |  |  |  | 
COVID19_JANSSEN | Coeliac disease | 0 | 0 | 0.03 | 1 | 3.207 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [broad] | 0 | 0 | 0 | 1 | 5.123 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival haemorrhage | 0 | 0 | 0.036 | 1 | 3.135 |  |  |  |  |  | 
COVID19_JANSSEN | Serology normal | 0 | 0 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_JANSSEN | Cancer surgery | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Peau d'orange | 0 | 0 | 0.033 | 1 | 3.173 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombotic microangiopathy | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular pain | 0 | 0 | 0.001 | 1 | 4.093 |  |  |  |  |  | 
COVID19_JANSSEN | Staphylococcal bacteraemia | 0 | 0 | 0.025 | 1 | 3.271 |  |  |  |  |  | 
COVID19_JANSSEN | Hypomenorrhoea | 0 | 0 | 0 | 1 | 5.308 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging whole body | 0 | 0 | 0.011 | 1 | 3.541 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin abnormal | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Coombs test positive | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound bladder | 0 | 0 | 0.027 | 1 | 3.245 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic scleroderma | 0 | 0 | 0.116 | 1 | 2.612 |  |  |  |  |  | 
COVID19_JANSSEN | Temperature difference of extremities | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_JANSSEN | Opticokinetic nystagmus tests abnormal | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_JANSSEN | Meningoencephalitis bacterial | 0 | 0 | 0.02 | 1 | 3.359 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine rupture | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_JANSSEN | Sensitisation | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumoconiosis | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Lung neoplasm | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_JANSSEN | Intra-aortic balloon placement | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Electronystagmogram normal | 0 | 0 | 0.002 | 1 | 3.987 |  |  |  |  |  | 
COVID19_JANSSEN | Atrioventricular block first degree | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_JANSSEN | Guthrie test | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil count abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactoid syndrome of pregnancy | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination complication | 0 | 0.003 | 0.451 | 1 | 1.722 |  |  |  |  |  | 
COVID19_JANSSEN | Adenovirus test | 0 | 0 | 0.029 | 1 | 3.222 |  |  |  |  |  | 
COVID19_JANSSEN | Beta haemolytic streptococcal infection | 0 | 0 | 0.002 | 1 | 4.057 |  |  |  |  |  | 
COVID19_JANSSEN | Prostate neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.2 | 1 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Visual field tests | 0 | 0.001 | 0.201 | 1 | 2.296 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan vagina | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic enzyme abnormal | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal compression fracture | 0 | 0 | 0.012 | 1 | 3.518 |  |  |  |  |  | 
COVID19_JANSSEN | Visual acuity tests | 0 | 0 | 0.028 | 1 | 3.239 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site streaking | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Personal relationship issue | 0 | 0 | 0.04 | 1 | 3.097 |  |  |  |  |  | 
COVID19_JANSSEN | External ear inflammation | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site lymphadenopathy | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Eye abscess | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Blood testosterone | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Appendix disorder | 0 | 0 | 0.024 | 1 | 3.288 |  |  |  |  |  | 
COVID19_JANSSEN | Gilbert's syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Chondrocalcinosis pyrophosphate | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_JANSSEN | Ciliary hyperaemia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Burn oral cavity | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Breath sounds | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Urine amphetamine positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound ovary abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Total complement activity increased | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_JANSSEN | Muscular dystrophy | 0 | 0 | 0.122 | 1 | 2.586 |  |  |  |  |  | 
COVID19_JANSSEN | Diarrhoea infectious | 0 | 0 | 0.002 | 1 | 3.987 |  |  |  |  |  | 
COVID19_JANSSEN | Mandibular mass | 0 | 0 | 0.111 | 1 | 2.633 |  |  |  |  |  | 
COVID19_JANSSEN | Breakthrough pain | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha tumour necrosis factor increased | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheal deviation | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal manometry | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple epiphyseal dysplasia | 0 | 0 | 0.043 | 1 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Benzodiazepine drug level | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_JANSSEN | Trigeminal palsy | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal shock | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | PFAPA syndrome | 0 | 0 | 0.019 | 1 | 3.373 |  |  |  |  |  | 
COVID19_JANSSEN | Warm type haemolytic anaemia | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_JANSSEN | Punctate keratitis | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Restrictive pulmonary disease | 0 | 0 | 0.007 | 1 | 3.702 |  |  |  |  |  | 
COVID19_JANSSEN | Iris adhesions | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Aneurysm ruptured | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Priapism | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure orthostatic increased | 0 | 0 | 0.077 | 1 | 2.817 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic dilatation | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic vascular disorder | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Anaplastic lymphoma kinase gene mutation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal mass | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Accelerated hypertension | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Haematemesis | 0 | 0.001 | 0.17 | 1 | 2.397 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperglycaemia | 0 | 0.001 | 0.21 | 1 | 2.268 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus test | 0 | 0.001 | 0.209 | 1 | 2.271 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue movement disturbance | 0 | 0 | 0.097 | 1 | 2.7 |  |  |  |  |  | 
COVID19_JANSSEN | Ammonia normal | 0 | 0 | 0.2 | 1 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Human metapneumovirus test | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Blood phosphorus increased | 0 | 0 | 0.127 | 1 | 2.564 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site scar | 0 | 0 | 0 | 1 | 4.687 |  |  |  |  |  | 
COVID19_JANSSEN | Culture wound negative | 0 | 0 | 0.027 | 1 | 3.244 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST segment abnormal | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_JANSSEN | Ear infection viral | 0 | 0 | 0.101 | 1 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral artery occlusion | 0 | 0 | 0.005 | 1 | 3.804 |  |  |  |  |  | 
COVID19_JANSSEN | Proctitis | 0 | 0 | 0.115 | 1 | 2.617 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram T wave peaked | 0 | 0 | 0.003 | 1 | 3.932 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroblastoma | 0 | 0 | 0.009 | 1 | 3.606 |  |  |  |  |  | 
COVID19_JANSSEN | Electronystagmogram | 0 | 0 | 0.004 | 1 | 3.833 |  |  |  |  |  | 
COVID19_JANSSEN | Clavicle fracture | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebral lesion | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertrichosis | 0 | 0 | 0.038 | 1 | 3.123 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatitis exfoliative | 0 | 0 | 0.006 | 1 | 3.711 |  |  |  |  |  | 
COVID19_JANSSEN | Bullous impetigo | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_JANSSEN | Vital capacity decreased | 0 | 0 | 0.007 | 1 | 3.673 |  |  |  |  |  | 
COVID19_JANSSEN | Transient acantholytic dermatosis | 0 | 0 | 0.008 | 1 | 3.661 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic shock syndrome streptococcal | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_JANSSEN | Product origin unknown | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_JANSSEN | Neuritis cranial | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_JANSSEN | Disease complication | 0 | 0 | 0.031 | 1 | 3.195 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aldosterone normal | 0 | 0 | 0 | 1 | 4.372 |  |  |  |  |  | 
COVID19_JANSSEN | Upper motor neurone lesion | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal ulcer | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_JANSSEN | Eye colour change | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Anal fistula | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell morphology | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian cyst torsion | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Oestrogen therapy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Group B streptococcus neonatal sepsis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood viscosity increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood growth hormone decreased | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Poor quality sleep | 0 | 0.002 | 0.407 | 1 | 1.806 |  |  |  |  |  | 
COVID19_JANSSEN | Immunology test normal | 0 | 0 | 0.19 | 1 | 2.331 |  |  |  |  |  | 
COVID19_JANSSEN | Imaging procedure | 0 | 0.001 | 0.315 | 1 | 1.996 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatinine decreased | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Angiotensin converting enzyme | 0 | 0 | 0.002 | 1 | 4 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertensive crisis | 0 | 0 | 0.228 | 1 | 2.216 |  |  |  |  |  | 
COVID19_JANSSEN | Complication of pregnancy | 0 | 0 | 0 | 1 | 5.826 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound kidney | 0 | 0 | 0.344 | 1 | 1.933 |  |  |  |  |  | 
COVID19_JANSSEN | Vital signs measurement | 0 | 0.001 | 0.157 | 1 | 2.444 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin level normal | 0 | 0 | 0.193 | 1 | 2.323 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary gland pain | 0 | 0 | 0.002 | 1 | 4.008 |  |  |  |  |  | 
COVID19_JANSSEN | Endocrine test | 0 | 0 | 0 | 1 | 5.525 |  |  |  |  |  | 
COVID19_JANSSEN | Extraocular muscle disorder | 0 | 0 | 0 | 1 | 5.336 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothalamo-pituitary disorder | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_JANSSEN | Tissue injury | 0 | 0 | 0.081 | 1 | 2.792 |  |  |  |  |  | 
COVID19_JANSSEN | Left atrial dilatation | 0 | 0 | 0.1 | 1 | 2.689 |  |  |  |  |  | 
COVID19_JANSSEN | Crystal urine absent | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_JANSSEN | Product use complaint | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_JANSSEN | Pityriasis rubra pilaris | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Mixed anxiety and depressive disorder | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Hand dermatitis | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Fibula fracture | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Obstruction gastric | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_JANSSEN | Mediastinitis | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbosacral plexopathy | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine release test | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Bone marrow infiltration | 0 | 0 | 0.005 | 1 | 3.771 |  |  |  |  |  | 
COVID19_JANSSEN | Transmission of an infectious agent via transplant | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hilum mass | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Product substitution error | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Premature baby death | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Past-pointing | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal drugs affecting foetus | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_JANSSEN | Mechanical ventilation complication | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Macular dystrophy congenital | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc displacement | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube cancer | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system necrosis | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chloride abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Depressed mood | 0 | 0 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of control of legs | 0 | 0 | 0.109 | 1 | 2.645 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory syncytial virus test | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site eczema | 0 | 0 | 0.01 | 1 | 3.589 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site induration | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_JANSSEN | West Nile virus test | 0 | 0 | 0.123 | 1 | 2.58 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised vaccinia | 0 | 0 | 0 | 1 | 5.574 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound liver | 0 | 0 | 0.107 | 1 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Blood cholesterol decreased | 0 | 0 | 0.172 | 1 | 2.392 |  |  |  |  |  | 
COVID19_JANSSEN | Retinopathy | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_JANSSEN | Multifocal motor neuropathy | 0 | 0 | 0.09 | 1 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Neuro-ophthalmological test | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Mini mental status examination abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Incision site pain | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Frontal lobe epilepsy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Colorectal cancer metastatic | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-IA2 antibody | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Skin neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.139 | 1 | 2.514 |  |  |  |  |  | 
COVID19_JANSSEN | Viral test positive | 0 | 0.001 | 0.224 | 1 | 2.226 |  |  |  |  |  | 
COVID19_JANSSEN | Head titubation | 0 | 0 | 0.309 | 1 | 2.011 |  |  |  |  |  | 
COVID19_JANSSEN | CSF glucose decreased | 0 | 0 | 0.162 | 1 | 2.424 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired gastric emptying | 0 | 0 | 0.001 | 1 | 4.188 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal hypoxia | 0 | 0 | 0 | 1 | 4.89 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure immeasurable | 0 | 0 | 0.226 | 1 | 2.224 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess sterile | 0 | 0 | 0.008 | 1 | 3.634 |  |  |  |  |  | 
COVID19_JANSSEN | Cytology normal | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Herpangina | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_JANSSEN | Combined immunodeficiency | 0 | 0 | 0.001 | 1 | 4.19 |  |  |  |  |  | 
COVID19_JANSSEN | Premalignant disorders, general conditions and other site specific disorders (SMQ) [narrow] | 0 | 0 | 0 | 1 | 5.175 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic encephalopathy | 0 | 0.001 | 0.215 | 1 | 2.254 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram retina | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Myopia | 0 | 0 | 0.026 | 1 | 3.262 |  |  |  |  |  | 
COVID19_JANSSEN | Fluid overload | 0 | 0 | 0.157 | 1 | 2.445 |  |  |  |  |  | 
COVID19_JANSSEN | Osteopenia | 0 | 0 | 0.108 | 1 | 2.645 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital cellulitis | 0 | 0 | 0.029 | 1 | 3.22 |  |  |  |  |  | 
COVID19_JANSSEN | Barium double contrast | 0 | 0 | 0 | 1 | 4.732 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong technique in device usage process | 0 | 0 | 0.026 | 1 | 3.257 |  |  |  |  |  | 
COVID19_JANSSEN | Myoglobin urine present | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Injury corneal | 0 | 0 | 0.001 | 1 | 4.106 |  |  |  |  |  | 
COVID19_JANSSEN | Stress echocardiogram | 0 | 0 | 0.054 | 1 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Laziness | 0 | 0 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_JANSSEN | CSF white blood cell count | 0 | 0 | 0.112 | 1 | 2.627 |  |  |  |  |  | 
COVID19_JANSSEN | Blood corticotrophin increased | 0 | 0 | 0 | 1 | 5.779 |  |  |  |  |  | 
COVID19_JANSSEN | Removal of foreign body | 0 | 0 | 0.067 | 1 | 2.882 |  |  |  |  |  | 
COVID19_JANSSEN | Jaw operation | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Finger amputation | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Pustular psoriasis | 0 | 0 | 0.034 | 1 | 3.161 |  |  |  |  |  | 
COVID19_JANSSEN | Oversensing | 0 | 0 | 0.012 | 1 | 3.53 |  |  |  |  |  | 
COVID19_JANSSEN | Head deformity | 0 | 0 | 0 | 1 | 5.111 |  |  |  |  |  | 
COVID19_JANSSEN | Blood heavy metal abnormal | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Rehabilitation therapy | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary valve stenosis | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal oedema | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_JANSSEN | Visceral congestion | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary lipids present | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Ulnar nerve palsy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue thrust | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Secondary thrombocytosis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_JANSSEN | Postural tremor | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Normal tension glaucoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_JANSSEN | Lead urine increased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotonia neonatal | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic varicella syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Congestive hepatopathy | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchial aspiration procedure | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchopulmonary disease | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder catheter temporary | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Angiopathic neuropathy | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_JANSSEN | AIDS related complication | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | 5'nucleotidase increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Increased appetite | 0 | 0 | 0.018 | 1 | 3.401 |  |  |  |  |  | 
COVID19_JANSSEN | Double stranded DNA antibody positive | 0 | 0 | 0 | 1 | 4.433 |  |  |  |  |  | 
COVID19_JANSSEN | C-reactive protein abnormal | 0 | 0 | 0.128 | 1 | 2.559 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite stool test positive | 0 | 0 | 0 | 1 | 5.264 |  |  |  |  |  | 
COVID19_JANSSEN | Enterocolitis haemorrhagic | 0 | 0 | 0 | 1 | 5.392 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine leiomyoma | 0 | 0 | 0.001 | 1 | 4.283 |  |  |  |  |  | 
COVID19_JANSSEN | Hemianaesthesia | 0 | 0 | 0 | 1 | 4.803 |  |  |  |  |  | 
COVID19_JANSSEN | Trichomoniasis | 0 | 0 | 0 | 1 | 4.337 |  |  |  |  |  | 
COVID19_JANSSEN | Polyp | 0 | 0 | 0.001 | 1 | 4.198 |  |  |  |  |  | 
COVID19_JANSSEN | Joint irrigation | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic mastocytosis | 0 | 0 | 0.06 | 1 | 2.924 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural abscess | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site hypertrichosis | 0 | 0 | 0 | 1 | 5.263 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebellar atrophy | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_JANSSEN | Walking distance test abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Urine amphetamine negative | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_JANSSEN | Toxoplasma serology positive | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Precipitate labour | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis astroviral | 0 | 0 | 0.001 | 1 | 4.11 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac imaging procedure | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_JANSSEN | Blood selenium | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Agoraphobia | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Temperature perception test decreased | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic immune activation | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Soft tissue sarcoma | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Removal of foreign body from rectum | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Paranoid personality disorder | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity unsaturated decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Endothelial dysfunction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Echinococciasis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal abscess | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic leukaemia | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Central cord syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular somatic symptom disorder | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell volume decreased | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_JANSSEN | Head banging | 0 | 0 | 0.282 | 1 | 2.074 |  |  |  |  |  | 
COVID19_JANSSEN | Rash rubelliform | 0 | 0 | 0 | 1 | 5.037 |  |  |  |  |  | 
COVID19_JANSSEN | Behaviour disorder | 0 | 0 | 0.005 | 1 | 3.774 |  |  |  |  |  | 
COVID19_JANSSEN | Facial discomfort | 0 | 0.001 | 0.193 | 1 | 2.321 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum culture positive | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site muscle weakness | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine dilation and curettage | 0 | 0 | 0.268 | 1 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctivitis allergic | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_JANSSEN | Arthroscopy | 0 | 0 | 0.002 | 1 | 4.039 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of employment | 0 | 0 | 0.002 | 1 | 4.058 |  |  |  |  |  | 
COVID19_JANSSEN | Fungal test positive | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_JANSSEN | Circumoral swelling | 0 | 0 | 0.018 | 1 | 3.388 |  |  |  |  |  | 
COVID19_JANSSEN | Splenitis | 0 | 0 | 0 | 1 | 5.822 |  |  |  |  |  | 
COVID19_JANSSEN | Infection transmission via personal contact | 0 | 0 | 0 | 1 | 5.795 |  |  |  |  |  | 
COVID19_JANSSEN | Thalamic infarction | 0 | 0 | 0.009 | 1 | 3.597 |  |  |  |  |  | 
COVID19_JANSSEN | Portal hypertension | 0 | 0 | 0.019 | 1 | 3.371 |  |  |  |  |  | 
COVID19_JANSSEN | Acute cardiac event | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_JANSSEN | Histology normal | 0 | 0 | 0.002 | 1 | 4.051 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric pH decreased | 0 | 0 | 0.023 | 1 | 3.312 |  |  |  |  |  | 
COVID19_JANSSEN | Blood methaemoglobin absent | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune retinopathy | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon dislocation | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Physical thyroid examination abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Perseveration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal injury | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal scab | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal scar | 0 | 0 | 0.012 | 1 | 3.535 |  |  |  |  |  | 
COVID19_JANSSEN | Blepharitis | 0 | 0 | 0.203 | 1 | 2.292 |  |  |  |  |  | 
COVID19_JANSSEN | Product dispensing issue | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatomegaly | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_JANSSEN | Cold urticaria | 0 | 0 | 0.034 | 1 | 3.161 |  |  |  |  |  | 
COVID19_JANSSEN | Cryoglobulins present | 0 | 0 | 0 | 1 | 4.68 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha 1 foetoprotein amniotic fluid increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Autologous haematopoietic stem cell transplant | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyarrhythmia terms, nonspecific (SMQ) [broad] | 0 | 0.002 | 0.382 | 1 | 1.853 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopic retrograde cholangiopancreatography abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Skin cancer | 0 | 0 | 0.022 | 1 | 3.319 |  |  |  |  |  | 
COVID19_JANSSEN | Aldolase decreased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Benign lung neoplasm | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Genital rash | 0 | 0 | 0.253 | 1 | 2.148 |  |  |  |  |  | 
COVID19_JANSSEN | Meningeal disorder | 0 | 0 | 0.031 | 1 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Tenosynovitis | 0 | 0 | 0.232 | 1 | 2.207 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal prolapse | 0 | 0 | 0.006 | 1 | 3.751 |  |  |  |  |  | 
COVID19_JANSSEN | Anal sphincter atony | 0 | 0 | 0.022 | 1 | 3.321 |  |  |  |  |  | 
COVID19_JANSSEN | Adnexa uteri cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Tuberculous pleurisy | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Interleukin-2 receptor increased | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Skin atrophy | 0 | 0 | 0.036 | 1 | 3.137 |  |  |  |  |  | 
COVID19_JANSSEN | Arthroscopic surgery | 0 | 0 | 0.091 | 1 | 2.733 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine level | 0 | 0 | 0.023 | 1 | 3.307 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotonia | 0 | 0.001 | 0.147 | 1 | 2.48 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchitis chronic | 0 | 0 | 0.012 | 1 | 3.534 |  |  |  |  |  | 
COVID19_JANSSEN | Administration site joint pain | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_JANSSEN | Social anxiety disorder | 0 | 0 | 0 | 1 | 4.665 |  |  |  |  |  | 
COVID19_JANSSEN | Antisynthetase syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Tympanometry abnormal | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrospinal fluid drainage | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Defiant behaviour | 0 | 0 | 0.024 | 1 | 3.294 |  |  |  |  |  | 
COVID19_JANSSEN | Ammonia | 0 | 0 | 0 | 1 | 4.466 |  |  |  |  |  | 
COVID19_JANSSEN | Ruptured cerebral aneurysm | 0 | 0 | 0.016 | 1 | 3.425 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract infection neonatal | 0 | 0 | 0.004 | 1 | 3.867 |  |  |  |  |  | 
COVID19_JANSSEN | Schizotypal personality disorder | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Skull fractured base | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_JANSSEN | Ear infection bacterial | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure orthostatic abnormal | 0 | 0 | 0.012 | 1 | 3.514 |  |  |  |  |  | 
COVID19_JANSSEN | Blood aluminium normal | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Viral diarrhoea | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour marker decreased | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_JANSSEN | Subclavian vein thrombosis | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Otoacoustic emissions test abnormal | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Blood luteinising hormone | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Renal artery stenosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet morphology | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Perthes disease | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve decompression | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube cyst | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Epileptic aura | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Ear lobe infection | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Antipsychotic drug level | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Allergic sinusitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Allen's test | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Acoustic neuroma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Type 1 diabetes mellitus | 0 | 0 | 0.033 | 1 | 3.17 |  |  |  |  |  | 
COVID19_JANSSEN | Madarosis | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy thyroid gland abnormal | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Ependymitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Jaw clicking | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Aura | 0 | 0.001 | 0.208 | 1 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Hunt and Hess scale | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site indentation | 0 | 0 | 0.418 | 1 | 1.785 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte count normal | 0 | 0.001 | 0.201 | 1 | 2.296 |  |  |  |  |  | 
COVID19_JANSSEN | Visual evoked potentials normal | 0 | 0 | 0 | 1 | 4.929 |  |  |  |  |  | 
COVID19_JANSSEN | Pityriasis rosea | 0 | 0 | 0.266 | 1 | 2.114 |  |  |  |  |  | 
COVID19_JANSSEN | Good syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Bradypnoea | 0 | 0 | 0.018 | 1 | 3.388 |  |  |  |  |  | 
COVID19_JANSSEN | High-pitched crying | 0 | 0 | 0.038 | 1 | 3.117 |  |  |  |  |  | 
COVID19_JANSSEN | Type IV hypersensitivity reaction | 0 | 0 | 0.233 | 1 | 2.204 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic function abnormal | 0 | 0 | 0.011 | 1 | 3.546 |  |  |  |  |  | 
COVID19_JANSSEN | Sickle cell anaemia with crisis | 0 | 0 | 0.019 | 1 | 3.381 |  |  |  |  |  | 
COVID19_JANSSEN | Occupational exposure to product | 0 | 0 | 0.017 | 1 | 3.404 |  |  |  |  |  | 
COVID19_JANSSEN | Macrophages increased | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Intestinal malrotation repair | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | BRCA2 gene mutation assay | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Post viral fatigue syndrome | 0 | 0 | 0 | 1 | 4.761 |  |  |  |  |  | 
COVID19_JANSSEN | Fallopian tube disorder | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Salmonella test positive | 0 | 0 | 0 | 1 | 5.164 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular germ cell tumour | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Shoulder operation | 0 | 0 | 0.199 | 1 | 2.304 |  |  |  |  |  | 
COVID19_JANSSEN | Interleukin-2 receptor assay | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_JANSSEN | Clinical death | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Anal pap smear | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_JANSSEN | Eating disorder | 0 | 0.001 | 0.421 | 1 | 1.778 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional product use issue | 0 | 0 | 0.017 | 1 | 3.406 |  |  |  |  |  | 
COVID19_JANSSEN | Transplant evaluation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis E antigen negative | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosal blistering | 0 | 0.001 | 0.185 | 1 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system lupus | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Back disorder | 0 | 0 | 0.135 | 1 | 2.53 |  |  |  |  |  | 
COVID19_JANSSEN | Heart block congenital | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Visual analogue scale | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_JANSSEN | Adhesion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Immunosuppressant drug level | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Lupus-like syndrome | 0 | 0 | 0.027 | 1 | 3.248 |  |  |  |  |  | 
COVID19_JANSSEN | Viral uveitis | 0 | 0 | 0.034 | 1 | 3.167 |  |  |  |  |  | 
COVID19_JANSSEN | Bladder catheterisation | 0 | 0 | 0.258 | 1 | 2.135 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory overload | 0 | 0 | 0.001 | 1 | 4.231 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival swelling | 0 | 0.001 | 0.177 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Scan bone marrow | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Acute pulmonary oedema | 0 | 0 | 0.012 | 1 | 3.53 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site discharge | 0 | 0 | 0.229 | 1 | 2.213 |  |  |  |  |  | 
COVID19_JANSSEN | Transferrin | 0 | 0 | 0.001 | 1 | 4.08 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenitis bacterial | 0 | 0 | 0 | 1 | 5.061 |  |  |  |  |  | 
COVID19_JANSSEN | Sickle cell trait | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_JANSSEN | Night blindness | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphangioma | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_JANSSEN | Coating in mouth | 0 | 0 | 0.129 | 1 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular filtration rate normal | 0 | 0 | 0.33 | 1 | 1.963 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocytic hypophysitis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_JANSSEN | Penile swelling | 0 | 0 | 0.192 | 1 | 2.324 |  |  |  |  |  | 
COVID19_JANSSEN | Arrhythmia neonatal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmoplegia | 0 | 0 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Differential white blood cell count abnormal | 0 | 0 | 0.148 | 1 | 2.478 |  |  |  |  |  | 
COVID19_JANSSEN | Human papilloma virus test negative | 0 | 0 | 0 | 1 | 5.014 |  |  |  |  |  | 
COVID19_JANSSEN | Therapy partial responder | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Blood uric acid abnormal | 0 | 0 | 0.016 | 1 | 3.427 |  |  |  |  |  | 
COVID19_JANSSEN | Viral rhinitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Otitis media acute | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactate dehydrogenase | 0 | 0 | 0.333 | 1 | 1.957 |  |  |  |  |  | 
COVID19_JANSSEN | Lipids abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site phlebitis | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_JANSSEN | Limb operation | 0 | 0 | 0.017 | 1 | 3.405 |  |  |  |  |  | 
COVID19_JANSSEN | Nosocomial infection | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_JANSSEN | Necrotising retinitis | 0 | 0 | 0 | 1 | 4.342 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperresponsive to stimuli | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal oedema | 0 | 0 | 0.013 | 1 | 3.499 |  |  |  |  |  | 
COVID19_JANSSEN | Quadrantanopia | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Left ventricular hypertrophy | 0 | 0 | 0.155 | 1 | 2.45 |  |  |  |  |  | 
COVID19_JANSSEN | Prostatic disorder | 0 | 0 | 0.008 | 1 | 3.643 |  |  |  |  |  | 
COVID19_JANSSEN | Swelling of eyelid | 0 | 0.003 | 0.598 | 1 | 1.486 |  |  |  |  |  | 
COVID19_JANSSEN | Macrocephaly | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriovenous fistula | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Belligerence | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Coordination abnormal | 0 | 0.001 | 0.367 | 1 | 1.885 |  |  |  |  |  | 
COVID19_JANSSEN | Heterosexuality | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal hernia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_JANSSEN | Mesangioproliferative glomerulonephritis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Noonan syndrome | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Atypical haemolytic uraemic syndrome | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_JANSSEN | Albumin globulin ratio decreased | 0 | 0 | 0.011 | 1 | 3.553 |  |  |  |  |  | 
COVID19_JANSSEN | Eye symptom | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Piriformis syndrome | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune blistering disease | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Microbiology test abnormal | 0 | 0 | 0.001 | 1 | 4.262 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C virus test | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_JANSSEN | Post polio syndrome | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Teething | 0 | 0 | 0.118 | 1 | 2.604 |  |  |  |  |  | 
COVID19_JANSSEN | Bundle branch block left | 0 | 0 | 0.023 | 1 | 3.31 |  |  |  |  |  | 
COVID19_JANSSEN | Myeloid leukaemia | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_JANSSEN | Lipids increased | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_JANSSEN | Creatine urine increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging hepatobiliary | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy gastrointestinal | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_JANSSEN | Gomori methenamine silver stain | 0 | 0 | 0.002 | 1 | 3.974 |  |  |  |  |  | 
COVID19_JANSSEN | Drug withdrawal convulsions | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_JANSSEN | Akathisia (SMQ) [narrow] | 0 | 0 | 0 | 1 | 5.302 |  |  |  |  |  | 
COVID19_JANSSEN | Tracheostomy tube removal | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Gait apraxia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Glutamate dehydrogenase increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B DNA increased | 0 | 0 | 0 | 1 | 4.177 |  |  |  |  |  | 
COVID19_JANSSEN | Venous injury | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_JANSSEN | Acute phase reaction | 0 | 0 | 0.004 | 1 | 3.838 |  |  |  |  |  | 
COVID19_JANSSEN | Product monitoring error | 0 | 0 | 0.004 | 1 | 3.859 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal cavity packing | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure normal | 0 | 0 | 0.192 | 1 | 2.323 |  |  |  |  |  | 
COVID19_JANSSEN | Inferior vena cava stenosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity urine normal | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | SeHCAT test | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac monitoring abnormal | 0 | 0 | 0.173 | 1 | 2.388 |  |  |  |  |  | 
COVID19_JANSSEN | Haematological malignancy | 0 | 0 | 0.107 | 1 | 2.652 |  |  |  |  |  | 
COVID19_JANSSEN | Subdural haemorrhage | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_JANSSEN | Accident at work | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Meniscus injury | 0 | 0 | 0.135 | 1 | 2.53 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chromium decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Scaphoid abdomen | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Allodynia | 0 | 0 | 0.02 | 1 | 3.354 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal obstruction | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_JANSSEN | Fibroadenoma of breast | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Renal artery arteriosclerosis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory integration therapy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_JANSSEN | Cutaneous sarcoidosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_JANSSEN | Meningism | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_JANSSEN | Urine bilirubin increased | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_JANSSEN | Visual acuity tests abnormal | 0 | 0 | 0.001 | 1 | 4.181 |  |  |  |  |  | 
COVID19_JANSSEN | LE cells | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_JANSSEN | Thumb sucking | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_JANSSEN | Acute abdomen | 0 | 0 | 0.031 | 1 | 3.2 |  |  |  |  |  | 
COVID19_JANSSEN | Genital herpes | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_JANSSEN | Cholecystitis chronic | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_JANSSEN | Aorta hypoplasia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Carotid artery disease | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Splinter haemorrhages | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Traumatic lumbar puncture | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus node dysfunction | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiovascular disorder | 0 | 0 | 0.005 | 1 | 3.767 |  |  |  |  |  | 
COVID19_JANSSEN | Tendon pain | 0 | 0 | 0.278 | 1 | 2.085 |  |  |  |  |  | 
COVID19_JANSSEN | Progesterone decreased | 0 | 0 | 0.003 | 1 | 3.881 |  |  |  |  |  | 
COVID19_JANSSEN | Scan myocardial perfusion normal | 0 | 0 | 0.104 | 1 | 2.668 |  |  |  |  |  | 
COVID19_JANSSEN | Cholestasis | 0 | 0 | 0.022 | 1 | 3.315 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammation scan | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_JANSSEN | Neoplasm malignant | 0 | 0 | 0.015 | 1 | 3.46 |  |  |  |  |  | 
COVID19_JANSSEN | Lip infection | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital HIV infection | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Vocal cord paralysis | 0 | 0 | 0.184 | 1 | 2.352 |  |  |  |  |  | 
COVID19_JANSSEN | Helicobacter test | 0 | 0 | 0.178 | 1 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect disposal of product | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Community acquired infection | 0 | 0 | 0 | 1 | 4.973 |  |  |  |  |  | 
COVID19_JANSSEN | Complication of device insertion | 0 | 0 | 0.044 | 1 | 3.064 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial flutter | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_JANSSEN | Optic disc disorder | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis neonatal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_JANSSEN | Bone debridement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal candidiasis | 0 | 0 | 0.029 | 1 | 3.222 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperthermia | 0 | 0 | 0.008 | 1 | 3.633 |  |  |  |  |  | 
COVID19_JANSSEN | Arteritis coronary | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Mycoplasma test | 0 | 0 | 0.268 | 1 | 2.109 |  |  |  |  |  | 
COVID19_JANSSEN | Spinal retrolisthesis | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion spontaneous incomplete | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Dermatologic examination abnormal | 0 | 0 | 0.131 | 1 | 2.547 |  |  |  |  |  | 
COVID19_JANSSEN | Enlarged cerebral perivascular spaces | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_JANSSEN | Neuroleptic malignant syndrome (SMQ) [algorithm] | 0 | 0 | 0.134 | 1 | 2.533 |  |  |  |  |  | 
COVID19_JANSSEN | HLA marker study positive | 0 | 0 | 0 | 1 | 5.31 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchitis bacterial | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis haemorrhagic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular icterus | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Iron binding capacity total increased | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian malignant tumours (SMQ) [broad] | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_JANSSEN | Lipohypertrophy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Skin candida | 0 | 0 | 0.001 | 1 | 4.168 |  |  |  |  |  | 
COVID19_JANSSEN | Blood iron abnormal | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_JANSSEN | General physical condition normal | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy oesophagus abnormal | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertonic bladder | 0 | 0 | 0 | 1 | 5.041 |  |  |  |  |  | 
COVID19_JANSSEN | Lipids normal | 0 | 0.001 | 0.177 | 1 | 2.374 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory integrative dysfunction | 0 | 0 | 0 | 1 | 4.558 |  |  |  |  |  | 
COVID19_JANSSEN | Vitello-intestinal duct remnant | 0 | 0 | 0 | 1 | 4.405 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchogram abnormal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Hypermobility syndrome | 0 | 0 | 0 | 1 | 4.402 |  |  |  |  |  | 
COVID19_JANSSEN | Urogenital infection fungal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Paranasal cyst | 0 | 0 | 0.091 | 1 | 2.736 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis normal | 0 | 0 | 0.047 | 1 | 3.037 |  |  |  |  |  | 
COVID19_JANSSEN | Joint abscess | 0 | 0 | 0.036 | 1 | 3.141 |  |  |  |  |  | 
COVID19_JANSSEN | Developmental delay | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral nerve palsy | 0 | 0 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_JANSSEN | Malaria antibody test negative | 0 | 0 | 0 | 1 | 5.698 |  |  |  |  |  | 
COVID19_JANSSEN | Biopsy bladder normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_JANSSEN | Bone scan normal | 0 | 0 | 0.154 | 1 | 2.455 |  |  |  |  |  | 
COVID19_JANSSEN | Vertebroplasty | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Rheumatoid factor quantitative | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Specific gravity urine increased | 0 | 0 | 0.142 | 1 | 2.501 |  |  |  |  |  | 
COVID19_JANSSEN | Brain stem stroke | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Oestradiol abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin E | 0 | 0 | 0.133 | 1 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Extraskeletal ossification | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Protein urine present | 0 | 0.001 | 0.206 | 1 | 2.28 |  |  |  |  |  | 
COVID19_JANSSEN | ADAMTS13 activity increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Agonal death struggle | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Model for end stage liver disease score | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Metal poisoning | 0 | 0 | 0.004 | 1 | 3.824 |  |  |  |  |  | 
COVID19_JANSSEN | Methylenetetrahydrofolate reductase gene mutation | 0 | 0 | 0.193 | 1 | 2.321 |  |  |  |  |  | 
COVID19_JANSSEN | Foster care | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopox virus infection | 0 | 0 | 0.001 | 1 | 4.14 |  |  |  |  |  | 
COVID19_JANSSEN | Extubation | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_JANSSEN | VIth nerve disorder | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular filtration rate | 0 | 0.001 | 0.448 | 1 | 1.729 |  |  |  |  |  | 
COVID19_JANSSEN | Hypercalcaemia | 0 | 0 | 0.031 | 1 | 3.193 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal mass | 0 | 0 | 0 | 1 | 4.701 |  |  |  |  |  | 
COVID19_JANSSEN | Clonic convulsion | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C2 | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_JANSSEN | Genital herpes zoster | 0 | 0 | 0 | 1 | 4.983 |  |  |  |  |  | 
COVID19_JANSSEN | Mesenteric cyst | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal dystrophy | 0 | 0 | 0.012 | 1 | 3.526 |  |  |  |  |  | 
COVID19_JANSSEN | Ureteral disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site necrosis | 0 | 0 | 0.024 | 1 | 3.288 |  |  |  |  |  | 
COVID19_JANSSEN | T-lymphocyte count increased | 0 | 0 | 0.007 | 1 | 3.666 |  |  |  |  |  | 
COVID19_JANSSEN | Spirometry abnormal | 0 | 0 | 0 | 1 | 5.192 |  |  |  |  |  | 
COVID19_JANSSEN | Parasite urine test negative | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Arterial catheterisation normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Carcinoid syndrome | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Upper respiratory tract irritation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Abdomen crushing | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Auditory disorder | 0 | 0 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Viral sinusitis | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_JANSSEN | Lipodystrophy acquired | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_JANSSEN | Renovascular disorders (SMQ) [narrow] | 0 | 0 | 0.081 | 1 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Positron emission tomogram | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal inflammation | 0 | 0 | 0.163 | 1 | 2.424 |  |  |  |  |  | 
COVID19_JANSSEN | Catheterisation cardiac abnormal | 0 | 0.001 | 0.261 | 1 | 2.128 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric emptying study | 0 | 0 | 0.102 | 1 | 2.679 |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitic rash | 0 | 0 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Coxsackie viral infection | 0 | 0 | 0.007 | 1 | 3.679 |  |  |  |  |  | 
COVID19_JANSSEN | Aortic stenosis | 0 | 0 | 0.008 | 1 | 3.658 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_JANSSEN | Terminal state | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Burns second degree | 0 | 0 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_JANSSEN | Anterior chamber cell | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary duct inflammation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue pigmentation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Optic disc drusen | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral small vessel ischaemic disease | 0 | 0 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenal gland cancer metastatic | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_JANSSEN | Skull X-ray normal | 0 | 0 | 0.158 | 1 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis brain stem | 0 | 0 | 0 | 1 | 5.547 |  |  |  |  |  | 
COVID19_JANSSEN | Diabetic nephropathy | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_JANSSEN | Histamine intolerance | 0 | 0 | 0.246 | 1 | 2.167 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure systolic | 0 | 0 | 0.001 | 1 | 4.251 |  |  |  |  |  | 
COVID19_JANSSEN | Implantable defibrillator insertion | 0 | 0 | 0.002 | 1 | 3.955 |  |  |  |  |  | 
COVID19_JANSSEN | Genital discomfort | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_JANSSEN | Vulvovaginal inflammation | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site irritation | 0 | 0 | 0.012 | 1 | 3.521 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thromboplastin normal | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_JANSSEN | Synovial cyst removal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_JANSSEN | Fixed eruption | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological examination | 0 | 0.001 | 0.218 | 1 | 2.245 |  |  |  |  |  | 
COVID19_JANSSEN | Blood potassium increased | 0 | 0 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_JANSSEN | Base excess decreased | 0 | 0 | 0.097 | 1 | 2.705 |  |  |  |  |  | 
COVID19_JANSSEN | Oral mucosa erosion | 0 | 0 | 0.004 | 1 | 3.836 |  |  |  |  |  | 
COVID19_JANSSEN | Treponema test false positive | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell count | 0 | 0.001 | 0.161 | 1 | 2.427 |  |  |  |  |  | 
COVID19_JANSSEN | Psychomotor hyperactivity | 0 | 0 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal tract irritation | 0 | 0 | 0.073 | 1 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Vascular access complication | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_JANSSEN | Amputation stump pain | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_JANSSEN | Application site erythema | 0 | 0 | 0 | 1 | 5.146 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antibody negative | 0 | 0 | 0 | 1 | 5.128 |  |  |  |  |  | 
COVID19_JANSSEN | Normocytic anaemia | 0 | 0 | 0.082 | 1 | 2.787 |  |  |  |  |  | 
COVID19_JANSSEN | Euglycaemic diabetic ketoacidosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_JANSSEN | Burn oesophageal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Blood uric acid increased | 0 | 0 | 0.285 | 1 | 2.067 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil percentage decreased | 0 | 0.001 | 0.047 | 0.999 | 3.033 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time normal | 0 | 0.002 | 0.323 | 0.999 | 1.978 |  |  |  |  |  | 
COVID19_JANSSEN | Non-haematological malignant tumours (SMQ) [narrow] | 0 | 0.001 | 0.018 | 0.999 | 3.382 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging spinal | 0 | 0.002 | 0.204 | 0.999 | 2.286 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid dysfunction (SMQ) [narrow] | 0 | 0.001 | 0.042 | 0.999 | 3.073 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic pneumonia (SMQ) [algorithm] | 0 | 0.002 | 0.116 | 0.999 | 2.606 |  |  |  |  |  | 
COVID19_JANSSEN | Alopecia | 0 | 0.001 | 0.066 | 0.999 | 2.885 |  |  |  |  |  | 
COVID19_JANSSEN | Pelvic pain | 0 | 0 | 0.027 | 0.999 | 3.247 |  |  |  |  |  | 
COVID19_JANSSEN | Catheterisation cardiac | 0 | 0.005 | 0.396 | 0.999 | 1.824 |  |  |  |  |  | 
COVID19_JANSSEN | Osteoarthritis | 0 | 0.001 | 0.111 | 0.999 | 2.632 |  |  |  |  |  | 
COVID19_JANSSEN | Urea urine | 0 | 0 | 0 | 0.999 | 5.644 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant tumours (SMQ) [narrow] | 0 | 0.001 | 0.071 | 0.999 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin concentration | 0 | 0 | 0.012 | 0.999 | 3.519 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar puncture normal | 0 | 0.002 | 0.316 | 0.999 | 1.992 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract infection | 0 | 0 | 0.001 | 0.999 | 4.103 |  |  |  |  |  | 
COVID19_JANSSEN | C-reactive protein | 0 | 0.003 | 0.266 | 0.999 | 2.112 |  |  |  |  |  | 
COVID19_JANSSEN | Rash morbilliform | 0 | 0 | 0.008 | 0.999 | 3.648 |  |  |  |  |  | 
COVID19_JANSSEN | Illusion | 0 | 0 | 0 | 0.999 | 4.689 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antigen | 0 | 0 | 0 | 0.999 | 4.414 |  |  |  |  |  | 
COVID19_JANSSEN | Stent placement | 0 | 0.003 | 0.317 | 0.999 | 1.991 |  |  |  |  |  | 
COVID19_JANSSEN | Lumbar puncture | 0 | 0.006 | 0.386 | 0.999 | 1.843 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis norovirus | 0 | 0 | 0 | 0.999 | 5.818 |  |  |  |  |  | 
COVID19_JANSSEN | Allergy to vaccine | 0 | 0.001 | 0.004 | 0.999 | 3.847 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus disorder | 0 | 0.001 | 0.038 | 0.999 | 3.116 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune encephalopathy | 0 | 0 | 0 | 0.999 | 5.634 |  |  |  |  |  | 
COVID19_JANSSEN | Urine analysis abnormal | 0 | 0.002 | 0.244 | 0.999 | 2.171 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchospasm | 0 | 0.001 | 0.154 | 0.999 | 2.452 |  |  |  |  |  | 
COVID19_JANSSEN | Angina pectoris | 0 | 0.002 | 0.088 | 0.999 | 2.744 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ambulatory | 0 | 0.001 | 0.13 | 0.999 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperthyroidism (SMQ) [narrow] | 0 | 0.001 | 0.057 | 0.999 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder related disorders (SMQ) [broad] | 0 | 0.002 | 0.226 | 0.999 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B virus test positive | 0 | 0 | 0 | 0.999 | 5.581 |  |  |  |  |  | 
COVID19_JANSSEN | Low density lipoprotein increased | 0 | 0.001 | 0.085 | 0.999 | 2.763 |  |  |  |  |  | 
COVID19_JANSSEN | Acute febrile neutrophilic dermatosis | 0 | 0 | 0 | 0.999 | 4.611 |  |  |  |  |  | 
COVID19_JANSSEN | Oesophageal varices haemorrhage | 0 | 0 | 0 | 0.999 | 5.651 |  |  |  |  |  | 
COVID19_JANSSEN | Acute pancreatitis (SMQ) [narrow] | 0 | 0.003 | 0.284 | 0.999 | 2.068 |  |  |  |  |  | 
COVID19_JANSSEN | Antibody test | 0 | 0.001 | 0.037 | 0.999 | 3.127 |  |  |  |  |  | 
COVID19_JANSSEN | Skin burning sensation | 0 | 0.002 | 0.369 | 0.999 | 1.88 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperaesthesia | 0 | 0.002 | 0.219 | 0.999 | 2.241 |  |  |  |  |  | 
COVID19_JANSSEN | Walking aid user | 0 | 0.001 | 0.169 | 0.999 | 2.4 |  |  |  |  |  | 
COVID19_JANSSEN | Posture abnormal | 0 | 0.002 | 0.267 | 0.999 | 2.112 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antigen negative | 0 | 0 | 0 | 0.999 | 5.284 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve disorders (SMQ) [narrow] | 0 | 0.001 | 0.061 | 0.999 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram neck | 0 | 0.003 | 0.281 | 0.999 | 2.075 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B DNA assay negative | 0 | 0 | 0 | 0.999 | 5.735 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired driving ability | 0 | 0.003 | 0.387 | 0.999 | 1.843 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmological examination | 0 | 0.002 | 0.241 | 0.999 | 2.178 |  |  |  |  |  | 
COVID19_JANSSEN | Jaundice | 0 | 0.001 | 0.053 | 0.999 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [narrow] | 0 | 0.002 | 0.137 | 0.999 | 2.517 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophilic pneumonia (SMQ) [narrow] | 0 | 0.001 | 0.123 | 0.999 | 2.578 |  |  |  |  |  | 
COVID19_JANSSEN | Tooth discolouration | 0 | 0 | 0 | 0.999 | 5.576 |  |  |  |  |  | 
COVID19_JANSSEN | Laboratory test abnormal | 0 | 0.001 | 0.235 | 0.999 | 2.195 |  |  |  |  |  | 
COVID19_JANSSEN | Tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.001 | 0.068 | 0.999 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Meningococcal sepsis | 0 | 0 | 0 | 0.999 | 5.806 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thyroid stimulating hormone | 0 | 0.004 | 0.48 | 0.999 | 1.672 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase increased | 0 | 0.002 | 0.121 | 0.999 | 2.584 |  |  |  |  |  | 
COVID19_JANSSEN | Blood albumin decreased | 0 | 0.001 | 0.143 | 0.999 | 2.497 |  |  |  |  |  | 
COVID19_JANSSEN | Pulse absent | 0 | 0.003 | 0.307 | 0.999 | 2.014 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic varices haemorrhage | 0 | 0 | 0 | 0.999 | 4.827 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal exposure during pregnancy | 0 | 0 | 0 | 0.999 | 4.86 |  |  |  |  |  | 
COVID19_JANSSEN | Mouth swelling | 0 | 0.002 | 0.21 | 0.999 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Tension headache | 0 | 0.001 | 0.072 | 0.999 | 2.843 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation normal | 0 | 0.001 | 0.217 | 0.999 | 2.248 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal pruritus | 0 | 0 | 0 | 0.999 | 5.017 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic disorder | 0 | 0 | 0.003 | 0.999 | 3.885 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumococcal bacteraemia | 0 | 0 | 0 | 0.999 | 4.909 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial necrosis marker increased | 0 | 0.001 | 0.088 | 0.999 | 2.751 |  |  |  |  |  | 
COVID19_JANSSEN | Coxsackie virus test positive | 0 | 0 | 0.014 | 0.999 | 3.47 |  |  |  |  |  | 
COVID19_JANSSEN | Periarthritis | 0 | 0.001 | 0.08 | 0.999 | 2.793 |  |  |  |  |  | 
COVID19_JANSSEN | Stomatitis | 0 | 0.001 | 0.236 | 0.999 | 2.194 |  |  |  |  |  | 
COVID19_JANSSEN | Culture urine | 0 | 0.002 | 0.277 | 0.999 | 2.085 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac monitoring | 0 | 0.003 | 0.202 | 0.999 | 2.29 |  |  |  |  |  | 
COVID19_JANSSEN | Renal pain | 0 | 0.001 | 0.244 | 0.999 | 2.172 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin T increased | 0 | 0 | 0.002 | 0.999 | 4.051 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccinia virus infection | 0 | 0 | 0 | 0.999 | 4.697 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiogenic shock | 0 | 0.001 | 0.067 | 0.999 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Seizure like phenomena | 0 | 0.002 | 0.269 | 0.999 | 2.107 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory failure | 0 | 0.002 | 0.157 | 0.999 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Hallucination | 0 | 0.002 | 0.322 | 0.999 | 1.98 |  |  |  |  |  | 
COVID19_JANSSEN | HIV test | 0 | 0.001 | 0.018 | 0.999 | 3.385 |  |  |  |  |  | 
COVID19_JANSSEN | Procalcitonin | 0 | 0.001 | 0.006 | 0.999 | 3.713 |  |  |  |  |  | 
COVID19_JANSSEN | Basophil count decreased | 0 | 0 | 0.014 | 0.999 | 3.471 |  |  |  |  |  | 
COVID19_JANSSEN | Conduction defects (SMQ) [broad] | 0 | 0.002 | 0.132 | 0.999 | 2.538 |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive premalignant disorders (SMQ) [narrow] | 0 | 0 | 0 | 0.999 | 5.414 |  |  |  |  |  | 
COVID19_JANSSEN | Emotional distress | 0 | 0.002 | 0.21 | 0.999 | 2.269 |  |  |  |  |  | 
COVID19_JANSSEN | Differential white blood cell count normal | 0 | 0.003 | 0.397 | 0.999 | 1.823 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactic acid increased | 0 | 0.002 | 0.214 | 0.999 | 2.254 |  |  |  |  |  | 
COVID19_JANSSEN | Rectal haemorrhage | 0 | 0.001 | 0.055 | 0.999 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal discomfort | 0 | 0.001 | 0.051 | 0.999 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Animal bite | 0 | 0 | 0 | 0.999 | 5.747 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant or unspecified tumours (SMQ) [narrow] | 0 | 0.001 | 0.086 | 0.999 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil count normal | 0 | 0.001 | 0.084 | 0.999 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Urine analysis normal | 0 | 0.004 | 0.454 | 0.999 | 1.718 |  |  |  |  |  | 
COVID19_JANSSEN | Papilloma viral infection | 0 | 0 | 0 | 0.999 | 5.733 |  |  |  |  |  | 
COVID19_JANSSEN | Eyelid function disorder | 0 | 0.003 | 0.434 | 0.999 | 1.753 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling jittery | 0 | 0.003 | 0.406 | 0.999 | 1.806 |  |  |  |  |  | 
COVID19_JANSSEN | Haemolytic anaemia | 0 | 0.001 | 0.253 | 0.999 | 2.147 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antibody | 0 | 0 | 0 | 0.999 | 4.911 |  |  |  |  |  | 
COVID19_JANSSEN | Mucosal hyperaemia | 0 | 0 | 0 | 0.999 | 5.172 |  |  |  |  |  | 
COVID19_JANSSEN | Intentional product misuse | 0 | 0 | 0 | 0.999 | 5.58 |  |  |  |  |  | 
COVID19_JANSSEN | Viral test negative | 0 | 0.002 | 0.144 | 0.999 | 2.49 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune demyelinating disease | 0 | 0 | 0 | 0.999 | 4.925 |  |  |  |  |  | 
COVID19_JANSSEN | CSF virus no organisms observed | 0 | 0 | 0.004 | 0.999 | 3.815 |  |  |  |  |  | 
COVID19_JANSSEN | Vaginal haemorrhage | 0 | 0.002 | 0.098 | 0.999 | 2.691 |  |  |  |  |  | 
COVID19_JANSSEN | Bone pain | 0 | 0.005 | 0.339 | 0.999 | 1.94 |  |  |  |  |  | 
COVID19_JANSSEN | Apgar score normal | 0 | 0 | 0 | 0.999 | 5.36 |  |  |  |  |  | 
COVID19_JANSSEN | Livedo reticularis | 0 | 0.001 | 0.153 | 0.999 | 2.456 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoacusis | 0 | 0.004 | 0.321 | 0.999 | 1.981 |  |  |  |  |  | 
COVID19_JANSSEN | Epstein-Barr virus antibody positive | 0 | 0.001 | 0.21 | 0.999 | 2.267 |  |  |  |  |  | 
COVID19_JANSSEN | Enteritis | 0 | 0 | 0.041 | 0.999 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | Culture urine negative | 0 | 0.002 | 0.079 | 0.999 | 2.795 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonitis | 0 | 0.001 | 0.113 | 0.999 | 2.622 |  |  |  |  |  | 
COVID19_JANSSEN | Urine analysis | 0 | 0.01 | 0.569 | 0.999 | 1.528 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine and fallopian tube malignant tumours (SMQ) [broad] | 0 | 0 | 0 | 0.999 | 5.821 |  |  |  |  |  | 
COVID19_JANSSEN | Blood culture | 0 | 0.004 | 0.354 | 0.999 | 1.91 |  |  |  |  |  | 
COVID19_JANSSEN | Haemodialysis | 0 | 0 | 0 | 0.999 | 4.56 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical dysplasia | 0 | 0 | 0 | 0.999 | 5.263 |  |  |  |  |  | 
COVID19_JANSSEN | Infection via vaccinee | 0 | 0 | 0 | 0.999 | 5.001 |  |  |  |  |  | 
COVID19_JANSSEN | Glomerular filtration rate decreased | 0 | 0.003 | 0.342 | 0.999 | 1.936 |  |  |  |  |  | 
COVID19_JANSSEN | Cardioversion | 0 | 0.002 | 0.379 | 0.999 | 1.859 |  |  |  |  |  | 
COVID19_JANSSEN | Hypogeusia | 0 | 0.001 | 0.135 | 0.999 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Neurone-specific enolase decreased | 0 | 0 | 0 | 0.999 | 5.213 |  |  |  |  |  | 
COVID19_JANSSEN | Dry throat | 0 | 0.004 | 0.42 | 0.999 | 1.779 |  |  |  |  |  | 
COVID19_JANSSEN | Transaminases increased | 0 | 0.001 | 0.037 | 0.999 | 3.123 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal loss of weight | 0 | 0.001 | 0.01 | 0.999 | 3.582 |  |  |  |  |  | 
COVID19_JANSSEN | Rotavirus infection | 0 | 0 | 0 | 0.999 | 5.186 |  |  |  |  |  | 
COVID19_JANSSEN | Depression (excl suicide and self injury) (SMQ) [narrow] | 0 | 0.001 | 0.088 | 0.999 | 2.746 |  |  |  |  |  | 
COVID19_JANSSEN | Electroencephalogram abnormal | 0 | 0.001 | 0.208 | 0.999 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Hypovolaemic shock conditions (SMQ) [narrow] | 0 | 0.001 | 0.09 | 0.999 | 2.738 |  |  |  |  |  | 
COVID19_JANSSEN | Cytomegalovirus test negative | 0 | 0.001 | 0.061 | 0.999 | 2.917 |  |  |  |  |  | 
COVID19_JANSSEN | Toothache | 0 | 0.002 | 0.194 | 0.999 | 2.315 |  |  |  |  |  | 
COVID19_JANSSEN | Testicular pain | 0 | 0.002 | 0.303 | 0.999 | 2.024 |  |  |  |  |  | 
COVID19_JANSSEN | Blindness transient | 0 | 0.001 | 0.1 | 0.999 | 2.684 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemic and neurogenic shock conditions (SMQ) [narrow] | 0 | 0.001 | 0.077 | 0.999 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Blood culture positive | 0 | 0 | 0.001 | 0.999 | 4.226 |  |  |  |  |  | 
COVID19_JANSSEN | Near death experience | 0 | 0 | 0.016 | 0.999 | 3.421 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose increased | 0 | 0.007 | 0.429 | 0.999 | 1.762 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A antibody negative | 0 | 0 | 0 | 0.999 | 4.671 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong product administered | 0 | 0.001 | 0.054 | 0.999 | 2.974 |  |  |  |  |  | 
COVID19_JANSSEN | Tonsillar hypertrophy | 0 | 0.001 | 0.055 | 0.999 | 2.966 |  |  |  |  |  | 
COVID19_JANSSEN | Accidental overdose | 0 | 0.001 | 0.03 | 0.999 | 3.201 |  |  |  |  |  | 
COVID19_JANSSEN | Blood albumin normal | 0 | 0.001 | 0.192 | 0.999 | 2.322 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea decreased | 0 | 0.001 | 0.053 | 0.999 | 2.98 |  |  |  |  |  | 
COVID19_JANSSEN | Dyslipidaemia (SMQ) [broad] | 0 | 0.002 | 0.179 | 0.999 | 2.365 |  |  |  |  |  | 
COVID19_JANSSEN | Activated partial thromboplastin time prolonged | 0 | 0.001 | 0.048 | 0.999 | 3.024 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular tachycardia | 0 | 0.001 | 0.025 | 0.999 | 3.276 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory rate increased | 0 | 0.003 | 0.363 | 0.999 | 1.892 |  |  |  |  |  | 
COVID19_JANSSEN | Upper-airway cough syndrome | 0 | 0.002 | 0.25 | 0.999 | 2.153 |  |  |  |  |  | 
COVID19_JANSSEN | Cervix carcinoma | 0 | 0 | 0 | 0.999 | 5.51 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular extrasystoles | 0 | 0.002 | 0.205 | 0.999 | 2.282 |  |  |  |  |  | 
COVID19_JANSSEN | Colposcopy | 0 | 0 | 0 | 0.999 | 5.644 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site cellulitis | 0 | 0.003 | 0.25 | 0.999 | 2.154 |  |  |  |  |  | 
COVID19_JANSSEN | Lyssavirus test positive | 0 | 0 | 0 | 0.999 | 1.294 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis, non-infectious (SMQ) [narrow] | 0 | 0.001 | 0.048 | 0.999 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Nodule | 0 | 0.002 | 0.215 | 0.999 | 2.252 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling of body temperature change | 0 | 0.005 | 0.336 | 0.999 | 1.946 |  |  |  |  |  | 
COVID19_JANSSEN | Ejection fraction normal | 0 | 0.001 | 0.014 | 0.999 | 3.464 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site discomfort | 0 | 0.005 | 0.385 | 0.999 | 1.845 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness neurosensory | 0 | 0.002 | 0.059 | 0.999 | 2.932 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis | 0 | 0.001 | 0.078 | 0.999 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Salivary hypersecretion | 0 | 0.001 | 0.107 | 0.999 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroiditis subacute | 0 | 0 | 0 | 0.999 | 4.699 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant tumours (SMQ) [broad] | 0 | 0.001 | 0.071 | 0.999 | 2.852 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised tonic-clonic seizure | 0 | 0.004 | 0.34 | 0.999 | 1.94 |  |  |  |  |  | 
COVID19_JANSSEN | Leukocytosis | 0 | 0.002 | 0.113 | 0.999 | 2.619 |  |  |  |  |  | 
COVID19_JANSSEN | Electromyogram abnormal | 0 | 0.001 | 0.027 | 0.999 | 3.239 |  |  |  |  |  | 
COVID19_JANSSEN | Red cell distribution width increased | 0 | 0.001 | 0.086 | 0.999 | 2.757 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell volume normal | 0 | 0.002 | 0.13 | 0.999 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [broad] | 0 | 0.002 | 0.175 | 0.999 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Haemolytic disorders (SMQ) [narrow] | 0 | 0.001 | 0.125 | 0.999 | 2.568 |  |  |  |  |  | 
COVID19_JANSSEN | Stillbirth | 0 | 0 | 0 | 0.999 | 4.884 |  |  |  |  |  | 
COVID19_JANSSEN | Catheterisation cardiac normal | 0 | 0.003 | 0.365 | 0.999 | 1.887 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial disease | 0 | 0 | 0 | 0.999 | 4.094 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide decreased | 0 | 0.002 | 0.225 | 0.999 | 2.222 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site discomfort | 0 | 0.001 | 0.018 | 0.999 | 3.395 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombophlebitis (SMQ) [narrow] | 0 | 0.001 | 0.099 | 0.999 | 2.688 |  |  |  |  |  | 
COVID19_JANSSEN | Dyskinesia (SMQ) [narrow] | 0 | 0.002 | 0.219 | 0.999 | 2.241 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis protein normal | 0 | 0 | 0.011 | 0.999 | 3.537 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of proprioception | 0 | 0 | 0.003 | 0.999 | 3.923 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory acidosis | 0 | 0 | 0.009 | 0.999 | 3.613 |  |  |  |  |  | 
COVID19_JANSSEN | Anticholinergic syndrome (SMQ) [algorithm] | 0 | 0.003 | 0.233 | 0.999 | 2.2 |  |  |  |  |  | 
COVID19_JANSSEN | Lipodystrophy (SMQ) [broad] | 0 | 0.004 | 0.279 | 0.999 | 2.078 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil count decreased | 0 | 0.001 | 0.04 | 0.999 | 3.095 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C4 | 0 | 0.001 | 0.067 | 0.999 | 2.874 |  |  |  |  |  | 
COVID19_JANSSEN | Polymerase chain reaction positive | 0 | 0 | 0.013 | 0.999 | 3.499 |  |  |  |  |  | 
COVID19_JANSSEN | Differential white blood cell count | 0 | 0.004 | 0.461 | 0.999 | 1.705 |  |  |  |  |  | 
COVID19_JANSSEN | Fear | 0 | 0.003 | 0.418 | 0.999 | 1.783 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [broad] | 0 | 0 | 0 | 0.999 | 4.506 |  |  |  |  |  | 
COVID19_JANSSEN | Body height | 0 | 0 | 0 | 0.999 | 4.316 |  |  |  |  |  | 
COVID19_JANSSEN | Stool analysis abnormal | 0 | 0 | 0 | 0.999 | 4.68 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site inflammation | 0 | 0.003 | 0.343 | 0.999 | 1.933 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial necrosis marker normal | 0 | 0.001 | 0.145 | 0.999 | 2.488 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site bruising | 0 | 0.005 | 0.355 | 0.999 | 1.907 |  |  |  |  |  | 
COVID19_JANSSEN | Coagulation test normal | 0 | 0.001 | 0.067 | 0.999 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antibody negative | 0 | 0 | 0 | 0.999 | 4.597 |  |  |  |  |  | 
COVID19_JANSSEN | Respiration abnormal | 0 | 0.002 | 0.191 | 0.999 | 2.325 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B core antibody positive | 0 | 0 | 0 | 0.999 | 5.728 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet transfusion | 0 | 0.001 | 0.058 | 0.999 | 2.936 |  |  |  |  |  | 
COVID19_JANSSEN | Hypokalaemia | 0 | 0.001 | 0.102 | 0.999 | 2.673 |  |  |  |  |  | 
COVID19_JANSSEN | Urine sodium normal | 0 | 0 | 0 | 0.999 | 5.714 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect route of product administration | 0 | 0.001 | 0.128 | 0.999 | 2.558 |  |  |  |  |  | 
COVID19_JANSSEN | Olfactory test abnormal | 0 | 0 | 0 | 0.999 | 5.622 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal pain | 0 | 0.001 | 0.165 | 0.999 | 2.415 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate decreased | 0 | 0.005 | 0.436 | 0.999 | 1.75 |  |  |  |  |  | 
COVID19_JANSSEN | Movement disorder | 0 | 0.001 | 0.046 | 0.999 | 3.041 |  |  |  |  |  | 
COVID19_JANSSEN | Facial pain | 0 | 0.004 | 0.269 | 0.999 | 2.105 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose | 0 | 0.003 | 0.401 | 0.999 | 1.815 |  |  |  |  |  | 
COVID19_JANSSEN | Liver function test increased | 0 | 0.003 | 0.28 | 0.999 | 2.077 |  |  |  |  |  | 
COVID19_JANSSEN | Raynaud's phenomenon | 0 | 0 | 0.009 | 0.999 | 3.595 |  |  |  |  |  | 
COVID19_JANSSEN | Malignant or unspecified tumours (SMQ) [broad] | 0 | 0.001 | 0.086 | 0.999 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Blindness | 0 | 0.002 | 0.195 | 0.999 | 2.312 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngitis | 0 | 0.001 | 0.105 | 0.999 | 2.66 |  |  |  |  |  | 
COVID19_JANSSEN | Osteoporosis/osteopenia (SMQ) [broad] | 0 | 0.001 | 0.202 | 0.999 | 2.292 |  |  |  |  |  | 
COVID19_JANSSEN | Haematuria | 0 | 0.001 | 0.106 | 0.999 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B test negative | 0 | 0.001 | 0.039 | 0.999 | 3.101 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram abdomen | 0 | 0.005 | 0.437 | 0.999 | 1.746 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenitis | 0 | 0.003 | 0.234 | 0.999 | 2.197 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase normal | 0 | 0.001 | 0.162 | 0.999 | 2.423 |  |  |  |  |  | 
COVID19_JANSSEN | Occupational exposure to SARS-CoV-2 | 0 | 0 | 0.001 | 0.999 | 4.087 |  |  |  |  |  | 
COVID19_JANSSEN | Procalcitonin increased | 0 | 0.001 | 0.023 | 0.999 | 3.299 |  |  |  |  |  | 
COVID19_JANSSEN | Nasopharyngitis | 0 | 0.004 | 0.23 | 0.999 | 2.207 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcium normal | 0 | 0.002 | 0.245 | 0.999 | 2.169 |  |  |  |  |  | 
COVID19_JANSSEN | Gene mutation identification test negative | 0 | 0 | 0 | 0.999 | 4.464 |  |  |  |  |  | 
COVID19_JANSSEN | Appendicitis perforated | 0 | 0.001 | 0.031 | 0.999 | 3.192 |  |  |  |  |  | 
COVID19_JANSSEN | Choking sensation | 0 | 0.001 | 0.152 | 0.999 | 2.459 |  |  |  |  |  | 
COVID19_JANSSEN | Irritability | 0 | 0.003 | 0.331 | 0.999 | 1.961 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactate dehydrogenase increased | 0 | 0.001 | 0.049 | 0.999 | 3.014 |  |  |  |  |  | 
COVID19_JANSSEN | Electrophoresis | 0 | 0 | 0 | 0.999 | 5.615 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmic herpes zoster | 0 | 0 | 0 | 0.999 | 5.061 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctivitis | 0 | 0.001 | 0.089 | 0.999 | 2.742 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis viral test negative | 0 | 0.001 | 0.064 | 0.999 | 2.897 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital oedema | 0 | 0.001 | 0.126 | 0.999 | 2.563 |  |  |  |  |  | 
COVID19_JANSSEN | Bradycardia | 0 | 0.002 | 0.148 | 0.999 | 2.475 |  |  |  |  |  | 
COVID19_JANSSEN | Acoustic stimulation tests abnormal | 0 | 0.001 | 0.147 | 0.999 | 2.48 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphocyte percentage decreased | 0 | 0.001 | 0.125 | 0.999 | 2.568 |  |  |  |  |  | 
COVID19_JANSSEN | Nystagmus | 0 | 0.001 | 0.112 | 0.999 | 2.629 |  |  |  |  |  | 
COVID19_JANSSEN | Bronchitis | 0 | 0.001 | 0.147 | 0.999 | 2.478 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy | 0 | 0.002 | 0.24 | 0.999 | 2.183 |  |  |  |  |  | 
COVID19_JANSSEN | Contusion | 0 | 0.006 | 0.45 | 0.999 | 1.724 |  |  |  |  |  | 
COVID19_JANSSEN | Dry skin | 0 | 0.002 | 0.233 | 0.999 | 2.2 |  |  |  |  |  | 
COVID19_JANSSEN | Blood sodium decreased | 0 | 0.003 | 0.177 | 0.999 | 2.37 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal ulceration (SMQ) [broad] | 0 | 0.001 | 0.127 | 0.999 | 2.559 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiolipin antibody negative | 0 | 0 | 0.009 | 0.999 | 3.601 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombotic thrombocytopenic purpura | 0 | 0 | 0.028 | 0.999 | 3.24 |  |  |  |  |  | 
COVID19_JANSSEN | Orthostatic hypotension | 0 | 0.001 | 0.019 | 0.999 | 3.366 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea normal | 0 | 0.002 | 0.174 | 0.999 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin increased | 0 | 0 | 0.027 | 0.999 | 3.247 |  |  |  |  |  | 
COVID19_JANSSEN | Sluggishness | 0 | 0.003 | 0.349 | 0.999 | 1.92 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pH decreased | 0 | 0.001 | 0.181 | 0.999 | 2.359 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram cerebral | 0 | 0.002 | 0.289 | 0.999 | 2.056 |  |  |  |  |  | 
COVID19_JANSSEN | Intervertebral disc protrusion | 0 | 0.001 | 0.095 | 0.999 | 2.711 |  |  |  |  |  | 
COVID19_JANSSEN | Head discomfort | 0 | 0.007 | 0.425 | 0.999 | 1.768 |  |  |  |  |  | 
COVID19_JANSSEN | Supraventricular tachycardia | 0 | 0.004 | 0.347 | 0.999 | 1.923 |  |  |  |  |  | 
COVID19_JANSSEN | Joint stiffness | 0 | 0.003 | 0.198 | 0.999 | 2.302 |  |  |  |  |  | 
COVID19_JANSSEN | Feeding disorder | 0 | 0.003 | 0.338 | 0.999 | 1.944 |  |  |  |  |  | 
COVID19_JANSSEN | Measles antibody negative | 0 | 0 | 0 | 0.999 | 5.335 |  |  |  |  |  | 
COVID19_JANSSEN | Crohn's disease | 0 | 0.001 | 0.022 | 0.999 | 3.315 |  |  |  |  |  | 
COVID19_JANSSEN | Pancreatitis acute | 0 | 0.002 | 0.237 | 0.999 | 2.191 |  |  |  |  |  | 
COVID19_JANSSEN | Splenomegaly | 0 | 0.001 | 0.058 | 0.999 | 2.941 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle fatigue | 0 | 0.003 | 0.258 | 0.999 | 2.134 |  |  |  |  |  | 
COVID19_JANSSEN | Incomplete course of vaccination | 0 | 0.001 | 0.001 | 0.999 | 4.255 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram pelvis | 0 | 0.002 | 0.222 | 0.999 | 2.233 |  |  |  |  |  | 
COVID19_JANSSEN | Rales | 0 | 0.001 | 0.016 | 0.999 | 3.429 |  |  |  |  |  | 
COVID19_JANSSEN | Disorientation | 0 | 0.006 | 0.367 | 0.999 | 1.882 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site induration | 0 | 0.002 | 0.246 | 0.999 | 2.167 |  |  |  |  |  | 
COVID19_JANSSEN | Bordetella test positive | 0 | 0 | 0 | 0.999 | 5.785 |  |  |  |  |  | 
COVID19_JANSSEN | Liver function test | 0 | 0.004 | 0.368 | 0.999 | 1.881 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis D antibody negative | 0 | 0 | 0 | 0.999 | 5.708 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site rash | 0 | 0.002 | 0.182 | 0.999 | 2.354 |  |  |  |  |  | 
COVID19_JANSSEN | Hyponatraemia/SIADH (SMQ) [narrow] | 0 | 0.003 | 0.194 | 0.999 | 2.315 |  |  |  |  |  | 
COVID19_JANSSEN | Nightmare | 0 | 0.001 | 0.174 | 0.999 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Peritonitis | 0 | 0 | 0.015 | 0.999 | 3.445 |  |  |  |  |  | 
COVID19_JANSSEN | Haemophilus sepsis | 0 | 0 | 0 | 0.999 | 5.745 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle twitching | 0 | 0.005 | 0.358 | 0.999 | 1.9 |  |  |  |  |  | 
COVID19_JANSSEN | Electroencephalogram normal | 0 | 0.002 | 0.243 | 0.999 | 2.172 |  |  |  |  |  | 
COVID19_JANSSEN | Blood magnesium decreased | 0 | 0.002 | 0.25 | 0.999 | 2.155 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness | 0 | 0.003 | 0.177 | 0.999 | 2.37 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal haemorrhage | 0 | 0.001 | 0.033 | 0.999 | 3.163 |  |  |  |  |  | 
COVID19_JANSSEN | Ovarian disorder | 0 | 0 | 0 | 0.999 | 5.805 |  |  |  |  |  | 
COVID19_JANSSEN | Weight decreased | 0 | 0.003 | 0.19 | 0.999 | 2.328 |  |  |  |  |  | 
COVID19_JANSSEN | Skin laceration | 0 | 0.002 | 0.263 | 0.999 | 2.122 |  |  |  |  |  | 
COVID19_JANSSEN | Rhabdomyolysis | 0 | 0.001 | 0.043 | 0.999 | 3.068 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific inflammation (SMQ) [narrow] | 0 | 0.002 | 0.134 | 0.999 | 2.53 |  |  |  |  |  | 
COVID19_JANSSEN | Paresis | 0 | 0 | 0.003 | 0.999 | 3.88 |  |  |  |  |  | 
COVID19_JANSSEN | Interleukin level | 0 | 0 | 0 | 0.999 | 4.634 |  |  |  |  |  | 
COVID19_JANSSEN | Typhoid fever | 0 | 0 | 0 | 0.999 | 5.776 |  |  |  |  |  | 
COVID19_JANSSEN | Local reaction | 0 | 0.002 | 0.319 | 0.999 | 1.987 |  |  |  |  |  | 
COVID19_JANSSEN | Deafness unilateral | 0 | 0.003 | 0.312 | 0.999 | 2.002 |  |  |  |  |  | 
COVID19_JANSSEN | Hemiplegia | 0 | 0.001 | 0.085 | 0.999 | 2.765 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza virus test | 0 | 0.002 | 0.164 | 0.999 | 2.416 |  |  |  |  |  | 
COVID19_JANSSEN | Stridor | 0 | 0.002 | 0.118 | 0.999 | 2.596 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin I normal | 0 | 0.001 | 0.054 | 0.999 | 2.975 |  |  |  |  |  | 
COVID19_JANSSEN | Encephalitis | 0 | 0.002 | 0.132 | 0.999 | 2.539 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thyroid stimulating hormone decreased | 0 | 0.001 | 0.203 | 0.999 | 2.288 |  |  |  |  |  | 
COVID19_JANSSEN | Myelodysplastic syndrome (SMQ) [broad] | 0 | 0.002 | 0.256 | 0.999 | 2.139 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular fibrillation | 0 | 0.001 | 0.146 | 0.999 | 2.482 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor C3 | 0 | 0.001 | 0.083 | 0.999 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Agitation | 0 | 0.002 | 0.239 | 0.999 | 2.185 |  |  |  |  |  | 
COVID19_JANSSEN | Motor dysfunction | 0 | 0.001 | 0.1 | 0.999 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | N-terminal prohormone brain natriuretic peptide increased | 0 | 0.001 | 0.077 | 0.999 | 2.811 |  |  |  |  |  | 
COVID19_JANSSEN | Odynophagia | 0 | 0.002 | 0.245 | 0.999 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Obesity | 0 | 0 | 0.02 | 0.999 | 3.353 |  |  |  |  |  | 
COVID19_JANSSEN | Severe cutaneous adverse reactions (SMQ) [narrow] | 0 | 0.004 | 0.361 | 0.999 | 1.894 |  |  |  |  |  | 
COVID19_JANSSEN | Conduction defects (SMQ) [narrow] | 0 | 0.002 | 0.132 | 0.999 | 2.538 |  |  |  |  |  | 
COVID19_JANSSEN | Dyskinesia | 0 | 0.002 | 0.196 | 0.999 | 2.31 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancy related conditions (SMQ) [broad] | 0 | 0.001 | 0.026 | 0.999 | 3.26 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cells urine positive | 0 | 0.001 | 0.087 | 0.999 | 2.756 |  |  |  |  |  | 
COVID19_JANSSEN | Depressed level of consciousness | 0 | 0.002 | 0.256 | 0.999 | 2.139 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-thyroid antibody positive | 0 | 0 | 0.004 | 0.999 | 3.83 |  |  |  |  |  | 
COVID19_JANSSEN | Walking disability | 0 | 0.001 | 0.015 | 0.999 | 3.444 |  |  |  |  |  | 
COVID19_JANSSEN | Pollakiuria | 0 | 0.002 | 0.227 | 0.999 | 2.219 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram thorax | 0 | 0.006 | 0.505 | 0.999 | 1.629 |  |  |  |  |  | 
COVID19_JANSSEN | Choking | 0 | 0.001 | 0.142 | 0.999 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Vitamin B12 normal | 0 | 0.001 | 0.202 | 0.999 | 2.291 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil percentage increased | 0 | 0.002 | 0.105 | 0.999 | 2.659 |  |  |  |  |  | 
COVID19_JANSSEN | Thirst | 0 | 0.003 | 0.411 | 0.999 | 1.796 |  |  |  |  |  | 
COVID19_JANSSEN | Protein total normal | 0 | 0.002 | 0.182 | 0.999 | 2.355 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory arrest | 0 | 0.003 | 0.258 | 0.999 | 2.132 |  |  |  |  |  | 
COVID19_JANSSEN | Human chorionic gonadotropin negative | 0 | 0.001 | 0.013 | 0.999 | 3.49 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram abnormal | 0 | 0.001 | 0.057 | 0.999 | 2.945 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal pain lower | 0 | 0.002 | 0.158 | 0.999 | 2.438 |  |  |  |  |  | 
COVID19_JANSSEN | Asymptomatic COVID-19 | 0 | 0 | 0 | 0.999 | 4.676 |  |  |  |  |  | 
COVID19_JANSSEN | Eye discharge | 0 | 0.001 | 0.104 | 0.999 | 2.667 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital, familial and genetic disorders (SMQ) [narrow] | 0 | 0.001 | 0.106 | 0.999 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Norovirus test positive | 0 | 0 | 0 | 0.999 | 5.632 |  |  |  |  |  | 
COVID19_JANSSEN | Sputum discoloured | 0 | 0.001 | 0.086 | 0.999 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram normal | 0 | 0.009 | 0.494 | 0.999 | 1.647 |  |  |  |  |  | 
COVID19_JANSSEN | Blood magnesium | 0 | 0.002 | 0.368 | 0.999 | 1.881 |  |  |  |  |  | 
COVID19_JANSSEN | Arteriogram abnormal | 0 | 0 | 0 | 0.999 | 5.721 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival disorders (SMQ) [broad] | 0 | 0.002 | 0.272 | 0.999 | 2.097 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging spinal normal | 0 | 0.001 | 0.23 | 0.999 | 2.211 |  |  |  |  |  | 
COVID19_JANSSEN | Product dose omission issue | 0 | 0 | 0 | 0.999 | 4.596 |  |  |  |  |  | 
COVID19_JANSSEN | Cervical conisation | 0 | 0 | 0 | 0.999 | 5.62 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancy related conditions (SMQ) [narrow] | 0 | 0.001 | 0.026 | 0.999 | 3.26 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological symptom | 0 | 0.002 | 0.256 | 0.999 | 2.138 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal heart rate abnormal | 0 | 0.001 | 0.01 | 0.999 | 3.567 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell count normal | 0 | 0.001 | 0.128 | 0.999 | 2.557 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound abdomen abnormal | 0 | 0.001 | 0.043 | 0.999 | 3.061 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site haemorrhage | 0 | 0.001 | 0.225 | 0.999 | 2.224 |  |  |  |  |  | 
COVID19_JANSSEN | Joint swelling | 0 | 0.006 | 0.44 | 0.999 | 1.741 |  |  |  |  |  | 
COVID19_JANSSEN | Wrong technique in product usage process | 0 | 0.001 | 0.001 | 0.999 | 4.069 |  |  |  |  |  | 
COVID19_JANSSEN | Rhabdomyolysis/myopathy (SMQ) [narrow] | 0 | 0.001 | 0.071 | 0.999 | 2.85 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antibody positive | 0 | 0 | 0 | 0.999 | 5.618 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple sclerosis relapse | 0 | 0.001 | 0.06 | 0.999 | 2.923 |  |  |  |  |  | 
COVID19_JANSSEN | Scab | 0 | 0.001 | 0.098 | 0.999 | 2.693 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic lupus erythematosus (SMQ) [narrow] | 0 | 0.001 | 0.054 | 0.999 | 2.969 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin normal | 0 | 0.002 | 0.108 | 0.999 | 2.646 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B core antibody negative | 0 | 0 | 0 | 0.999 | 5.645 |  |  |  |  |  | 
COVID19_JANSSEN | Laparoscopic surgery | 0 | 0.001 | 0.068 | 0.999 | 2.871 |  |  |  |  |  | 
COVID19_JANSSEN | General physical health deterioration | 0 | 0.001 | 0.077 | 0.999 | 2.814 |  |  |  |  |  | 
COVID19_JANSSEN | Varicella | 0 | 0 | 0.001 | 0.999 | 4.28 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound skull | 0 | 0 | 0.001 | 0.999 | 4.084 |  |  |  |  |  | 
COVID19_JANSSEN | Grip strength decreased | 0 | 0.004 | 0.297 | 0.999 | 2.036 |  |  |  |  |  | 
COVID19_JANSSEN | Therapy non-responder | 0 | 0 | 0 | 0.999 | 5.701 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0 | 0.999 | 5.746 |  |  |  |  |  | 
COVID19_JANSSEN | Abscess | 0 | 0.001 | 0.067 | 0.999 | 2.879 |  |  |  |  |  | 
COVID19_JANSSEN | Blood chloride normal | 0 | 0.003 | 0.187 | 0.999 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Hypokinesia | 0 | 0.001 | 0.15 | 0.999 | 2.47 |  |  |  |  |  | 
COVID19_JANSSEN | Ophthalmological examination abnormal | 0 | 0.001 | 0.1 | 0.999 | 2.684 |  |  |  |  |  | 
COVID19_JANSSEN | Tunnel vision | 0 | 0.003 | 0.295 | 0.999 | 2.041 |  |  |  |  |  | 
COVID19_JANSSEN | Inflammation | 0 | 0.007 | 0.401 | 0.999 | 1.813 |  |  |  |  |  | 
COVID19_JANSSEN | Indirect infection transmission | 0 | 0 | 0 | 0.999 | 5.606 |  |  |  |  |  | 
COVID19_JANSSEN | Yellow fever vaccine-associated neurotropic disease | 0 | 0 | 0 | 0.999 | 5.248 |  |  |  |  |  | 
COVID19_JANSSEN | Adrenocortical insufficiency acute | 0 | 0 | 0 | 0.999 | 5.102 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet count increased | 0 | 0.001 | 0.078 | 0.999 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal erythema | 0 | 0.001 | 0.078 | 0.999 | 2.805 |  |  |  |  |  | 
COVID19_JANSSEN | Ear discomfort | 0 | 0.005 | 0.46 | 0.999 | 1.705 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound abdomen | 0 | 0.001 | 0.068 | 0.999 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [broad] | 0 | 0.002 | 0.137 | 0.999 | 2.517 |  |  |  |  |  | 
COVID19_JANSSEN | Painful respiration | 0 | 0.003 | 0.146 | 0.999 | 2.483 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antigen positive | 0 | 0 | 0 | 0.999 | 4.139 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal death | 0 | 0.001 | 0.002 | 0.999 | 4.066 |  |  |  |  |  | 
COVID19_JANSSEN | H3N2 influenza | 0 | 0 | 0 | 0.999 | 4.947 |  |  |  |  |  | 
COVID19_JANSSEN | Serum ferritin increased | 0 | 0.002 | 0.067 | 0.999 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Maternal exposure during breast feeding | 0 | 0.001 | 0.005 | 0.999 | 3.794 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell count increased | 0 | 0.001 | 0.198 | 0.999 | 2.306 |  |  |  |  |  | 
COVID19_JANSSEN | Product preparation error | 0 | 0 | 0.002 | 0.999 | 4.023 |  |  |  |  |  | 
COVID19_JANSSEN | Blood thyroid stimulating hormone normal | 0 | 0.002 | 0.184 | 0.999 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | H1N1 influenza | 0 | 0 | 0 | 0.999 | 5.695 |  |  |  |  |  | 
COVID19_JANSSEN | Anticoagulant therapy | 0 | 0 | 0.033 | 0.999 | 3.172 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital and eyelid disorders (SMQ) [narrow] | 0 | 0.015 | 0.556 | 0.999 | 1.546 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray normal | 0 | 0.003 | 0.41 | 0.999 | 1.798 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcus test | 0 | 0.002 | 0.286 | 0.999 | 2.064 |  |  |  |  |  | 
COVID19_JANSSEN | Glare | 0 | 0 | 0 | 0.999 | 5.735 |  |  |  |  |  | 
COVID19_JANSSEN | Mean cell haemoglobin concentration normal | 0 | 0.001 | 0.107 | 0.999 | 2.648 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoptysis | 0 | 0.001 | 0.126 | 0.999 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 antibody test | 0 | 0.001 | 0.021 | 0.999 | 3.341 |  |  |  |  |  | 
COVID19_JANSSEN | Tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.001 | 0.068 | 0.999 | 2.869 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatine phosphokinase MB | 0 | 0 | 0.001 | 0.999 | 4.072 |  |  |  |  |  | 
COVID19_JANSSEN | Rash macular | 0 | 0.01 | 0.57 | 0.999 | 1.525 |  |  |  |  |  | 
COVID19_JANSSEN | Reproductive premalignant disorders (SMQ) [broad] | 0 | 0 | 0 | 0.999 | 5.414 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal premalignant disorders (SMQ) [narrow] | 0 | 0.001 | 0.033 | 0.999 | 3.174 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic steatosis | 0 | 0 | 0 | 0.999 | 4.337 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia aspiration | 0 | 0.001 | 0.058 | 0.999 | 2.942 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site movement impairment | 0 | 0.002 | 0.179 | 0.999 | 2.366 |  |  |  |  |  | 
COVID19_JANSSEN | HBV-DNA polymerase increased | 0 | 0 | 0 | 0.999 | 4.082 |  |  |  |  |  | 
COVID19_JANSSEN | Vasculitis (SMQ) [broad] | 0 | 0.002 | 0.207 | 0.999 | 2.276 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram head | 0 | 0.01 | 0.589 | 0.999 | 1.497 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect product formulation administered | 0 | 0 | 0 | 0.999 | 5.012 |  |  |  |  |  | 
COVID19_JANSSEN | Prosopagnosia | 0 | 0 | 0 | 0.999 | 5.573 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B DNA assay | 0 | 0 | 0 | 0.999 | 5.801 |  |  |  |  |  | 
COVID19_JANSSEN | Trismus | 0 | 0.001 | 0.124 | 0.999 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound Doppler normal | 0 | 0.002 | 0.265 | 0.999 | 2.116 |  |  |  |  |  | 
COVID19_JANSSEN | Antinuclear antibody negative | 0 | 0.001 | 0.132 | 0.999 | 2.541 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B core antigen positive | 0 | 0 | 0 | 0.999 | 5.632 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound Doppler abnormal | 0 | 0.001 | 0.128 | 0.999 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Polyneuropathy | 0 | 0.001 | 0.05 | 0.999 | 3.007 |  |  |  |  |  | 
COVID19_JANSSEN | Colonoscopy abnormal | 0 | 0.001 | 0.076 | 0.999 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Brain natriuretic peptide increased | 0 | 0.001 | 0.051 | 0.999 | 2.998 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hypertension (SMQ) [narrow] | 0 | 0.001 | 0.11 | 0.999 | 2.638 |  |  |  |  |  | 
COVID19_JANSSEN | Nervous system disorder | 0 | 0.001 | 0.051 | 0.999 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | International normalised ratio | 0 | 0.002 | 0.207 | 0.999 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy test positive | 0 | 0 | 0.006 | 0.999 | 3.709 |  |  |  |  |  | 
COVID19_JANSSEN | Skin discolouration | 0 | 0.005 | 0.477 | 0.999 | 1.677 |  |  |  |  |  | 
COVID19_JANSSEN | Plethysmography | 0 | 0 | 0 | 0.999 | 5.189 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular hypokinesia | 0 | 0.001 | 0.077 | 0.999 | 2.814 |  |  |  |  |  | 
COVID19_JANSSEN | Eosinophil count normal | 0 | 0.001 | 0.152 | 0.999 | 2.461 |  |  |  |  |  | 
COVID19_JANSSEN | Autonomic nervous system imbalance | 0 | 0 | 0.001 | 0.999 | 4.168 |  |  |  |  |  | 
COVID19_JANSSEN | Renovascular disorders (SMQ) [broad] | 0 | 0.001 | 0.057 | 0.999 | 2.946 |  |  |  |  |  | 
COVID19_JANSSEN | Large for dates baby | 0 | 0 | 0 | 0.999 | 5.259 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic obstructive pulmonary disease | 0 | 0 | 0 | 0.999 | 4.606 |  |  |  |  |  | 
COVID19_JANSSEN | Anti-myelin-associated glycoprotein antibodies positive | 0 | 0 | 0 | 0.999 | 5.373 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell sedimentation rate | 0 | 0.004 | 0.429 | 0.999 | 1.762 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site hypoaesthesia | 0 | 0.003 | 0.41 | 0.999 | 1.799 |  |  |  |  |  | 
COVID19_JANSSEN | Productive cough | 0 | 0.004 | 0.255 | 0.999 | 2.14 |  |  |  |  |  | 
COVID19_JANSSEN | Mycobacterium tuberculosis complex test negative | 0 | 0.001 | 0.031 | 0.999 | 3.197 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal chest pain | 0 | 0.003 | 0.352 | 0.999 | 1.914 |  |  |  |  |  | 
COVID19_JANSSEN | PCO2 increased | 0 | 0.001 | 0.031 | 0.999 | 3.201 |  |  |  |  |  | 
COVID19_JANSSEN | Gingival disorders (SMQ) [narrow] | 0 | 0.002 | 0.272 | 0.999 | 2.097 |  |  |  |  |  | 
COVID19_JANSSEN | Scan with contrast | 0 | 0.006 | 0.43 | 0.999 | 1.76 |  |  |  |  |  | 
COVID19_JANSSEN | PCO2 decreased | 0 | 0.001 | 0.049 | 0.999 | 3.016 |  |  |  |  |  | 
COVID19_JANSSEN | Culture negative | 0 | 0.002 | 0.154 | 0.999 | 2.453 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal ulceration (SMQ) [narrow] | 0 | 0.001 | 0.127 | 0.999 | 2.559 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic lupus erythematosus (SMQ) [algorithm] | 0 | 0.001 | 0.057 | 0.999 | 2.95 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza virus test positive | 0 | 0 | 0 | 0.999 | 4.43 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiomyopathy | 0 | 0.001 | 0.028 | 0.999 | 3.234 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory viral panel | 0 | 0.003 | 0.286 | 0.999 | 2.063 |  |  |  |  |  | 
COVID19_JANSSEN | Pleuritic pain | 0 | 0.002 | 0.075 | 0.999 | 2.823 |  |  |  |  |  | 
COVID19_JANSSEN | Acute respiratory distress syndrome | 0 | 0 | 0.015 | 0.999 | 3.448 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph node palpable | 0 | 0.001 | 0.09 | 0.999 | 2.739 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial necrosis marker | 0 | 0.001 | 0.044 | 0.999 | 3.061 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging spinal abnormal | 0 | 0.002 | 0.134 | 0.999 | 2.53 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal disorders (SMQ) [narrow] | 0 | 0.001 | 0.113 | 0.999 | 2.623 |  |  |  |  |  | 
COVID19_JANSSEN | HIV test negative | 0 | 0.001 | 0.103 | 0.999 | 2.672 |  |  |  |  |  | 
COVID19_JANSSEN | Axillary mass | 0 | 0.002 | 0.341 | 0.999 | 1.939 |  |  |  |  |  | 
COVID19_JANSSEN | Transient ischaemic attack | 0 | 0.001 | 0.148 | 0.999 | 2.477 |  |  |  |  |  | 
COVID19_JANSSEN | Device connection issue | 0 | 0 | 0.019 | 0.999 | 3.365 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram head abnormal | 0 | 0.004 | 0.299 | 0.999 | 2.031 |  |  |  |  |  | 
COVID19_JANSSEN | Hyponatraemia | 0 | 0.001 | 0.084 | 0.999 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Disorders of sinus node function (SMQ) [broad] | 0 | 0.001 | 0.068 | 0.999 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Oral herpes | 0 | 0.002 | 0.107 | 0.999 | 2.651 |  |  |  |  |  | 
COVID19_JANSSEN | Skin swelling | 0 | 0.002 | 0.325 | 0.999 | 1.974 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes ophthalmic | 0 | 0 | 0 | 0.999 | 4.363 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site lymphadenopathy | 0 | 0 | 0.017 | 0.999 | 3.413 |  |  |  |  |  | 
COVID19_JANSSEN | Acute respiratory failure | 0 | 0.001 | 0.097 | 0.999 | 2.7 |  |  |  |  |  | 
COVID19_JANSSEN | Chromaturia | 0 | 0.002 | 0.316 | 0.999 | 1.993 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal disorders (SMQ) [narrow] | 0 | 0 | 0.038 | 0.999 | 3.113 |  |  |  |  |  | 
COVID19_JANSSEN | Endoscopy | 0 | 0 | 0.017 | 0.999 | 3.413 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST segment depression | 0 | 0.001 | 0.126 | 0.999 | 2.567 |  |  |  |  |  | 
COVID19_JANSSEN | Motion sickness | 0 | 0.001 | 0.013 | 0.999 | 3.494 |  |  |  |  |  | 
COVID19_JANSSEN | Post vaccination autoinoculation | 0 | 0 | 0 | 0.999 | 5.301 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcus test negative | 0 | 0.002 | 0.311 | 0.999 | 2.005 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune hepatitis | 0 | 0 | 0.002 | 0.999 | 4.002 |  |  |  |  |  | 
COVID19_JANSSEN | Bilirubin conjugated | 0 | 0 | 0.008 | 0.999 | 3.65 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell count decreased | 0 | 0.002 | 0.184 | 0.999 | 2.347 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antibody | 0 | 0 | 0 | 0.999 | 3.398 |  |  |  |  |  | 
COVID19_JANSSEN | Shoulder injury related to vaccine administration | 0 | 0.001 | 0.027 | 0.999 | 3.25 |  |  |  |  |  | 
COVID19_JANSSEN | Scan with contrast abnormal | 0 | 0.003 | 0.267 | 0.999 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Sciatica | 0 | 0.002 | 0.235 | 0.999 | 2.195 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen therapy | 0 | 0.001 | 0.173 | 0.999 | 2.386 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophil count | 0 | 0.001 | 0.075 | 0.999 | 2.826 |  |  |  |  |  | 
COVID19_JANSSEN | Suspected COVID-19 | 0 | 0.001 | 0.054 | 0.999 | 2.971 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic kidney disease (SMQ) [narrow] | 0 | 0.001 | 0.169 | 0.999 | 2.4 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus tachycardia | 0 | 0.002 | 0.184 | 0.999 | 2.348 |  |  |  |  |  | 
COVID19_JANSSEN | Electroencephalogram | 0 | 0.003 | 0.317 | 0.999 | 1.991 |  |  |  |  |  | 
COVID19_JANSSEN | Non-haematological malignant tumours (SMQ) [broad] | 0 | 0.001 | 0.018 | 0.999 | 3.382 |  |  |  |  |  | 
COVID19_JANSSEN | Splenic artery embolisation | 0 | 0 | 0 | 0.999 | 4.915 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site pruritus | 0 | 0.001 | 0.02 | 0.999 | 3.354 |  |  |  |  |  | 
COVID19_JANSSEN | Delirium | 0 | 0.002 | 0.332 | 0.999 | 1.957 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia pneumococcal | 0 | 0 | 0 | 0.999 | 5.491 |  |  |  |  |  | 
COVID19_JANSSEN | Oral pruritus | 0 | 0.003 | 0.35 | 0.999 | 1.919 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral hypoperfusion | 0 | 0 | 0 | 0.999 | 5.823 |  |  |  |  |  | 
COVID19_JANSSEN | Fever neonatal | 0 | 0 | 0 | 0.999 | 4.953 |  |  |  |  |  | 
COVID19_JANSSEN | Linear IgA disease | 0 | 0 | 0 | 0.999 | 5.811 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis, non-infectious (SMQ) [broad] | 0 | 0.001 | 0.048 | 0.999 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Carbon dioxide normal | 0 | 0.002 | 0.203 | 0.999 | 2.288 |  |  |  |  |  | 
COVID19_JANSSEN | Hypothyroidism (SMQ) [broad] | 0 | 0.002 | 0.081 | 0.999 | 2.783 |  |  |  |  |  | 
COVID19_JANSSEN | International normalised ratio increased | 0 | 0.002 | 0.179 | 0.999 | 2.366 |  |  |  |  |  | 
COVID19_JANSSEN | Pulseless electrical activity | 0 | 0.001 | 0.182 | 0.999 | 2.357 |  |  |  |  |  | 
COVID19_JANSSEN | Pain of skin | 0 | 0.005 | 0.374 | 0.999 | 1.868 |  |  |  |  |  | 
COVID19_JANSSEN | Panic attack | 0 | 0.001 | 0.151 | 0.999 | 2.464 |  |  |  |  |  | 
COVID19_JANSSEN | Hypopnoea | 0 | 0.002 | 0.28 | 0.999 | 2.078 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic-septic shock conditions (SMQ) [narrow] | 0 | 0.001 | 0.126 | 0.999 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary congestion | 0 | 0.001 | 0.142 | 0.999 | 2.498 |  |  |  |  |  | 
COVID19_JANSSEN | Blood immunoglobulin A decreased | 0 | 0 | 0.014 | 0.999 | 3.477 |  |  |  |  |  | 
COVID19_JANSSEN | Gastric variceal ligation | 0 | 0 | 0 | 0.999 | 5.229 |  |  |  |  |  | 
COVID19_JANSSEN | Eye irritation | 0 | 0.005 | 0.474 | 0.999 | 1.681 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure | 0 | 0.001 | 0.067 | 0.999 | 2.877 |  |  |  |  |  | 
COVID19_JANSSEN | Erectile dysfunction | 0 | 0.001 | 0.031 | 0.999 | 3.193 |  |  |  |  |  | 
COVID19_JANSSEN | Human papilloma virus test positive | 0 | 0 | 0 | 0.999 | 5.78 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatomegaly | 0 | 0 | 0.017 | 0.999 | 3.41 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperacusis | 0 | 0.001 | 0.045 | 0.999 | 3.051 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 antibody test negative | 0 | 0.003 | 0.383 | 0.999 | 1.852 |  |  |  |  |  | 
COVID19_JANSSEN | Lactic acidosis (SMQ) [narrow] | 0 | 0.002 | 0.174 | 0.999 | 2.381 |  |  |  |  |  | 
COVID19_JANSSEN | Photosensitivity reaction | 0 | 0.001 | 0.015 | 0.999 | 3.46 |  |  |  |  |  | 
COVID19_JANSSEN | Liver function test normal | 0 | 0.001 | 0.084 | 0.999 | 2.771 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid function test normal | 0 | 0.001 | 0.056 | 0.999 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B core antibody | 0 | 0 | 0 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_JANSSEN | Jaundice neonatal | 0 | 0 | 0 | 0.999 | 5.814 |  |  |  |  |  | 
COVID19_JANSSEN | Surgery | 0 | 0.002 | 0.144 | 0.999 | 2.489 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin normal | 0 | 0.002 | 0.088 | 0.999 | 2.746 |  |  |  |  |  | 
COVID19_JANSSEN | CSF red blood cell count positive | 0 | 0 | 0.015 | 0.999 | 3.445 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A virus test | 0 | 0 | 0.015 | 0.999 | 3.452 |  |  |  |  |  | 
COVID19_JANSSEN | Aspartate aminotransferase normal | 0 | 0.001 | 0.103 | 0.999 | 2.67 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemia (SMQ) [narrow] | 0 | 0.002 | 0.268 | 0.999 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage laboratory terms (SMQ) [narrow] | 0 | 0.002 | 0.212 | 0.999 | 2.261 |  |  |  |  |  | 
COVID19_JANSSEN | Retching | 0 | 0.006 | 0.51 | 0.999 | 1.621 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden hearing loss | 0 | 0.001 | 0.051 | 0.999 | 3 |  |  |  |  |  | 
COVID19_JANSSEN | Depression and suicide/self-injury (SMQ) [narrow] | 0 | 0.001 | 0.097 | 0.999 | 2.698 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular infections (SMQ) [narrow] | 0 | 0.001 | 0.03 | 0.999 | 3.207 |  |  |  |  |  | 
COVID19_JANSSEN | Complement factor normal | 0 | 0.001 | 0.039 | 0.999 | 3.106 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis A | 0 | 0 | 0 | 0.999 | 5.665 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature abnormal | 0 | 0.001 | 0.031 | 0.999 | 3.195 |  |  |  |  |  | 
COVID19_JANSSEN | Judgement impaired | 0 | 0 | 0 | 0.999 | 5.633 |  |  |  |  |  | 
COVID19_JANSSEN | Asthenopia | 0 | 0.001 | 0.062 | 0.999 | 2.907 |  |  |  |  |  | 
COVID19_JANSSEN | Sinus congestion | 0 | 0.005 | 0.393 | 0.999 | 1.831 |  |  |  |  |  | 
COVID19_JANSSEN | Premature labour | 0 | 0.001 | 0.003 | 0.999 | 3.925 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site discolouration | 0 | 0.002 | 0.327 | 0.999 | 1.97 |  |  |  |  |  | 
COVID19_JANSSEN | Prothrombin time prolonged | 0 | 0.001 | 0.152 | 0.999 | 2.461 |  |  |  |  |  | 
COVID19_JANSSEN | Disorders of sinus node function (SMQ) [narrow] | 0 | 0.001 | 0.068 | 0.999 | 2.872 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal seizure | 0 | 0 | 0 | 0.999 | 5.37 |  |  |  |  |  | 
COVID19_JANSSEN | Multiple sclerosis | 0 | 0 | 0.001 | 0.999 | 4.11 |  |  |  |  |  | 
COVID19_JANSSEN | Visual field defect | 0 | 0.001 | 0.076 | 0.999 | 2.821 |  |  |  |  |  | 
COVID19_JANSSEN | Sudden death | 0 | 0.001 | 0.068 | 0.999 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperpyrexia | 0 | 0 | 0 | 0.999 | 4.304 |  |  |  |  |  | 
COVID19_JANSSEN | Dystonia (SMQ) [narrow] | 0 | 0.001 | 0.204 | 0.999 | 2.285 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic lupus erythematosus | 0 | 0 | 0.011 | 0.999 | 3.549 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site scab | 0 | 0.001 | 0.104 | 0.999 | 2.668 |  |  |  |  |  | 
COVID19_JANSSEN | Renal transplant failure | 0 | 0 | 0 | 0.999 | 5.414 |  |  |  |  |  | 
COVID19_JANSSEN | Protein total decreased | 0 | 0.001 | 0.041 | 0.999 | 3.088 |  |  |  |  |  | 
COVID19_JANSSEN | HIV antigen negative | 0 | 0 | 0 | 0.999 | 5.823 |  |  |  |  |  | 
COVID19_JANSSEN | Dyscalculia | 0 | 0 | 0 | 0.999 | 5.818 |  |  |  |  |  | 
COVID19_JANSSEN | Autoimmune disorder | 0 | 0.001 | 0.046 | 0.999 | 3.035 |  |  |  |  |  | 
COVID19_JANSSEN | Gallbladder related disorders (SMQ) [narrow] | 0 | 0.002 | 0.226 | 0.999 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Psychotic disorder | 0 | 0.001 | 0.033 | 0.999 | 3.174 |  |  |  |  |  | 
COVID19_JANSSEN | Dysuria | 0 | 0.001 | 0.082 | 0.999 | 2.784 |  |  |  |  |  | 
COVID19_JANSSEN | Diarrhoea haemorrhagic | 0 | 0.001 | 0.056 | 0.999 | 2.956 |  |  |  |  |  | 
COVID19_JANSSEN | Low birth weight baby | 0 | 0 | 0 | 0.999 | 5.734 |  |  |  |  |  | 
COVID19_JANSSEN | Neurological examination abnormal | 0 | 0.001 | 0.103 | 0.999 | 2.669 |  |  |  |  |  | 
COVID19_JANSSEN | Microagglutination test | 0 | 0 | 0 | 0.999 | 5.179 |  |  |  |  |  | 
COVID19_JANSSEN | Meningitis haemophilus | 0 | 0 | 0 | 0.999 | 5.499 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine and fallopian tube malignant tumours (SMQ) [narrow] | 0 | 0 | 0 | 0.999 | 5.746 |  |  |  |  |  | 
COVID19_JANSSEN | Apathy | 0 | 0 | 0.014 | 0.999 | 3.462 |  |  |  |  |  | 
COVID19_JANSSEN | Dyslipidaemia (SMQ) [narrow] | 0 | 0.002 | 0.179 | 0.999 | 2.365 |  |  |  |  |  | 
COVID19_JANSSEN | Congenital, familial and genetic disorders (SMQ) [broad] | 0 | 0.001 | 0.106 | 0.999 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema multiforme | 0 | 0.003 | 0.32 | 0.999 | 1.984 |  |  |  |  |  | 
COVID19_JANSSEN | Smear cervix abnormal | 0 | 0 | 0 | 0.999 | 5.629 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine contractions during pregnancy | 0 | 0 | 0 | 0.999 | 4.771 |  |  |  |  |  | 
COVID19_JANSSEN | Liver function test abnormal | 0 | 0.001 | 0.186 | 0.999 | 2.343 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal premalignant disorders (SMQ) [broad] | 0 | 0.001 | 0.033 | 0.999 | 3.174 |  |  |  |  |  | 
COVID19_JANSSEN | Meningococcal infection | 0 | 0 | 0 | 0.999 | 4.946 |  |  |  |  |  | 
COVID19_JANSSEN | Tendinopathies and ligament disorders (SMQ) [narrow] | 0 | 0.002 | 0.19 | 0.999 | 2.328 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram thorax normal | 0 | 0.002 | 0.134 | 0.999 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphopenia | 0 | 0 | 0.002 | 0.999 | 4.051 |  |  |  |  |  | 
COVID19_JANSSEN | Alpha hydroxybutyrate dehydrogenase | 0 | 0 | 0 | 0.999 | 5.786 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site oedema | 0 | 0.001 | 0.137 | 0.999 | 2.52 |  |  |  |  |  | 
COVID19_JANSSEN | Neutrophilia | 0 | 0 | 0.003 | 0.999 | 3.928 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital swelling | 0 | 0.003 | 0.285 | 0.999 | 2.066 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alkaline phosphatase normal | 0 | 0.001 | 0.162 | 0.999 | 2.423 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic hepatitis B | 0 | 0 | 0 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_JANSSEN | Urinary tract infection | 0 | 0.002 | 0.159 | 0.999 | 2.432 |  |  |  |  |  | 
COVID19_JANSSEN | Agranulocytosis (SMQ) [broad] | 0 | 0.003 | 0.209 | 0.999 | 2.268 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C test negative | 0 | 0.001 | 0.013 | 0.999 | 3.49 |  |  |  |  |  | 
COVID19_JANSSEN | Streptococcus test positive | 0 | 0 | 0.002 | 0.999 | 4.064 |  |  |  |  |  | 
COVID19_JANSSEN | Measles post vaccine | 0 | 0 | 0 | 0.999 | 5.46 |  |  |  |  |  | 
COVID19_JANSSEN | Faeces discoloured | 0 | 0.001 | 0.084 | 0.999 | 2.768 |  |  |  |  |  | 
COVID19_JANSSEN | Periorbital and eyelid disorders (SMQ) [broad] | 0 | 0.015 | 0.556 | 0.999 | 1.546 |  |  |  |  |  | 
COVID19_JANSSEN | Obstructive airways disorder | 0 | 0.001 | 0.131 | 0.999 | 2.542 |  |  |  |  |  | 
COVID19_JANSSEN | Torsade de pointes/QT prolongation (SMQ) [narrow] | 0 | 0.001 | 0.02 | 0.999 | 3.348 |  |  |  |  |  | 
COVID19_JANSSEN | Periodic acid Schiff stain | 0 | 0 | 0 | 0.999 | 5.672 |  |  |  |  |  | 
COVID19_JANSSEN | Skin lesion | 0 | 0.001 | 0.14 | 0.999 | 2.507 |  |  |  |  |  | 
COVID19_JANSSEN | International normalised ratio normal | 0 | 0.001 | 0.165 | 0.999 | 2.415 |  |  |  |  |  | 
COVID19_JANSSEN | Blood calcium decreased | 0 | 0.003 | 0.389 | 0.999 | 1.839 |  |  |  |  |  | 
COVID19_JANSSEN | Diphtheria | 0 | 0 | 0 | 0.999 | 5.579 |  |  |  |  |  | 
COVID19_JANSSEN | Cyanosis | 0 | 0.002 | 0.256 | 0.999 | 2.14 |  |  |  |  |  | 
COVID19_JANSSEN | Serology positive | 0 | 0 | 0 | 0.999 | 5.808 |  |  |  |  |  | 
COVID19_JANSSEN | Mood swings | 0 | 0 | 0.016 | 0.999 | 3.421 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin T normal | 0 | 0 | 0.029 | 0.999 | 3.221 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate irregular | 0 | 0.002 | 0.207 | 0.999 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Treponema test negative | 0 | 0.001 | 0.06 | 0.999 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Bacteraemia | 0 | 0 | 0 | 0.999 | 4.968 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antibody | 0 | 0 | 0 | 0.999 | 5.558 |  |  |  |  |  | 
COVID19_JANSSEN | Parkinson-like events (SMQ) [narrow] | 0 | 0.001 | 0.126 | 0.999 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal paraesthesia | 0 | 0.003 | 0.188 | 0.999 | 2.334 |  |  |  |  |  | 
COVID19_JANSSEN | Dysphemia | 0 | 0.001 | 0.049 | 0.999 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging abnormal | 0 | 0.005 | 0.26 | 0.998 | 2.126 |  |  |  |  |  | 
COVID19_JANSSEN | Premature delivery | 0 | 0 | 0 | 0.998 | 4.85 |  |  |  |  |  | 
COVID19_JANSSEN | Speech disorder | 0 | 0.009 | 0.344 | 0.998 | 1.929 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific dysfunction (SMQ) [narrow] | 0 | 0.005 | 0.23 | 0.998 | 2.205 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tract disorders (SMQ) [broad] | 0 | 0.002 | 0.054 | 0.998 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoxia | 0 | 0.005 | 0.265 | 0.998 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Musculoskeletal stiffness | 0 | 0.016 | 0.53 | 0.998 | 1.587 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal hypoaesthesia | 0 | 0.003 | 0.154 | 0.998 | 2.45 |  |  |  |  |  | 
COVID19_JANSSEN | Fertility disorders (SMQ) [narrow] | 0 | 0.001 | 0.003 | 0.998 | 3.866 |  |  |  |  |  | 
COVID19_JANSSEN | Facial paresis | 0 | 0.005 | 0.252 | 0.998 | 2.147 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory tract congestion | 0 | 0.009 | 0.351 | 0.998 | 1.912 |  |  |  |  |  | 
COVID19_JANSSEN | Eye swelling | 0 | 0.011 | 0.477 | 0.998 | 1.675 |  |  |  |  |  | 
COVID19_JANSSEN | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [narrow] | 0 | 0.001 | 0.019 | 0.998 | 3.373 |  |  |  |  |  | 
COVID19_JANSSEN | Blood urea increased | 0 | 0.003 | 0.138 | 0.998 | 2.511 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal haemorrhage (SMQ) [broad] | 0 | 0.004 | 0.126 | 0.998 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal exposures via breast milk (SMQ) [narrow] | 0 | 0.001 | 0.004 | 0.998 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular motility disorders (SMQ) [narrow] | 0 | 0.009 | 0.345 | 0.998 | 1.925 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombosis | 0 | 0.004 | 0.152 | 0.998 | 2.455 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage | 0 | 0.003 | 0.161 | 0.998 | 2.423 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell count normal | 0 | 0.005 | 0.219 | 0.998 | 2.237 |  |  |  |  |  | 
COVID19_JANSSEN | Cardio-respiratory arrest | 0 | 0.002 | 0.085 | 0.998 | 2.762 |  |  |  |  |  | 
COVID19_JANSSEN | Mental impairment | 0 | 0.002 | 0.022 | 0.998 | 3.322 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic shock | 0 | 0.002 | 0.078 | 0.998 | 2.804 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza A virus test positive | 0 | 0 | 0 | 0.998 | 5.091 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza A virus test negative | 0 | 0.002 | 0.072 | 0.998 | 2.839 |  |  |  |  |  | 
COVID19_JANSSEN | Extrapyramidal syndrome (SMQ) [narrow] | 0 | 0.005 | 0.217 | 0.998 | 2.243 |  |  |  |  |  | 
COVID19_JANSSEN | Neonatal exposures via breast milk (SMQ) [broad] | 0 | 0.001 | 0.004 | 0.998 | 3.805 |  |  |  |  |  | 
COVID19_JANSSEN | Restlessness | 0 | 0.004 | 0.121 | 0.998 | 2.582 |  |  |  |  |  | 
COVID19_JANSSEN | Paralysis | 0 | 0.001 | 0.041 | 0.998 | 3.086 |  |  |  |  |  | 
COVID19_JANSSEN | Lung infiltration | 0 | 0.002 | 0.088 | 0.998 | 2.747 |  |  |  |  |  | 
COVID19_JANSSEN | Liver-related coagulation and bleeding disturbances (SMQ) [broad] | 0 | 0.003 | 0.141 | 0.998 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Acute pancreatitis (SMQ) [algorithm] | 0 | 0.004 | 0.173 | 0.998 | 2.382 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific dysfunction (SMQ) [broad] | 0 | 0.005 | 0.214 | 0.998 | 2.25 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal distension | 0 | 0.004 | 0.116 | 0.998 | 2.601 |  |  |  |  |  | 
COVID19_JANSSEN | Mechanical ventilation | 0 | 0.004 | 0.122 | 0.998 | 2.575 |  |  |  |  |  | 
COVID19_JANSSEN | Laboratory test normal | 0 | 0.012 | 0.376 | 0.998 | 1.86 |  |  |  |  |  | 
COVID19_JANSSEN | Lip swelling | 0 | 0.018 | 0.494 | 0.998 | 1.643 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin D dimer | 0 | 0.005 | 0.228 | 0.998 | 2.211 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [narrow] | 0 | 0.003 | 0.111 | 0.998 | 2.627 |  |  |  |  |  | 
COVID19_JANSSEN | Rash vesicular | 0 | 0.002 | 0.035 | 0.998 | 3.145 |  |  |  |  |  | 
COVID19_JANSSEN | Bilevel positive airway pressure | 0 | 0.001 | 0.013 | 0.998 | 3.503 |  |  |  |  |  | 
COVID19_JANSSEN | Investigation | 0 | 0.001 | 0.005 | 0.998 | 3.767 |  |  |  |  |  | 
COVID19_JANSSEN | Tumour lysis syndrome (SMQ) [algorithm] | 0 | 0.002 | 0.059 | 0.998 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Limb discomfort | 0 | 0.018 | 0.504 | 0.998 | 1.628 |  |  |  |  |  | 
COVID19_JANSSEN | Temperature regulation disorder | 0 | 0.001 | 0 | 0.998 | 4.865 |  |  |  |  |  | 
COVID19_JANSSEN | Sepsis (SMQ) [narrow] | 0 | 0.003 | 0.131 | 0.998 | 2.539 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site swelling | 0 | 0.005 | 0.251 | 0.998 | 2.148 |  |  |  |  |  | 
COVID19_JANSSEN | Torsade de pointes, shock-associated conditions (SMQ) [narrow] | 0 | 0.002 | 0.039 | 0.998 | 3.099 |  |  |  |  |  | 
COVID19_JANSSEN | Dysarthria | 0 | 0.006 | 0.325 | 0.998 | 1.97 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrest | 0 | 0.008 | 0.298 | 0.998 | 2.03 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan | 0 | 0.006 | 0.34 | 0.998 | 1.939 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival disorders (SMQ) [narrow] | 0 | 0.004 | 0.175 | 0.998 | 2.376 |  |  |  |  |  | 
COVID19_JANSSEN | Expired product administered | 0 | 0.001 | 0.036 | 0.998 | 3.13 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site nodule | 0 | 0.005 | 0.225 | 0.998 | 2.222 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell count decreased | 0 | 0.001 | 0.048 | 0.998 | 3.018 |  |  |  |  |  | 
COVID19_JANSSEN | Rotavirus test positive | 0 | 0 | 0 | 0.998 | 5.448 |  |  |  |  |  | 
COVID19_JANSSEN | Initial insomnia | 0 | 0.001 | 0.006 | 0.998 | 3.717 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site mass | 0 | 0.008 | 0.324 | 0.998 | 1.971 |  |  |  |  |  | 
COVID19_JANSSEN | Hypokalaemia (SMQ) [narrow] | 0 | 0.006 | 0.303 | 0.998 | 2.02 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation (SMQ) [narrow] | 0 | 0.002 | 0.055 | 0.998 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [broad] | 0 | 0.001 | 0.019 | 0.998 | 3.373 |  |  |  |  |  | 
COVID19_JANSSEN | Dysmenorrhoea | 0 | 0 | 0 | 0.998 | 5.502 |  |  |  |  |  | 
COVID19_JANSSEN | Device leakage | 0 | 0 | 0 | 0.998 | 5.753 |  |  |  |  |  | 
COVID19_JANSSEN | Sensation of foreign body | 0 | 0.005 | 0.185 | 0.998 | 2.34 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin D dimer normal | 0 | 0.002 | 0.062 | 0.998 | 2.905 |  |  |  |  |  | 
COVID19_JANSSEN | Blood bilirubin increased | 0 | 0.002 | 0.057 | 0.998 | 2.941 |  |  |  |  |  | 
COVID19_JANSSEN | Flavivirus test positive | 0 | 0 | 0 | 0.998 | 2.713 |  |  |  |  |  | 
COVID19_JANSSEN | Lung opacity | 0 | 0.004 | 0.22 | 0.998 | 2.236 |  |  |  |  |  | 
COVID19_JANSSEN | Gastroenteritis rotavirus | 0 | 0 | 0 | 0.998 | 5.467 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic function test normal | 0 | 0.01 | 0.366 | 0.998 | 1.88 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram pulmonary abnormal | 0 | 0.003 | 0.118 | 0.998 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal infections (SMQ) [broad] | 0 | 0.004 | 0.21 | 0.998 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antigen positive | 0 | 0 | 0 | 0.998 | 5.284 |  |  |  |  |  | 
COVID19_JANSSEN | Lung consolidation | 0 | 0.001 | 0.019 | 0.998 | 3.373 |  |  |  |  |  | 
COVID19_JANSSEN | Eye pruritus | 0 | 0.006 | 0.265 | 0.998 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Chest X-ray | 0 | 0.023 | 0.619 | 0.998 | 1.451 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B | 0 | 0 | 0 | 0.998 | 5.428 |  |  |  |  |  | 
COVID19_JANSSEN | Opportunistic infections (SMQ) [narrow] | 0 | 0.001 | 0.024 | 0.998 | 3.279 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure via skin contact | 0 | 0.001 | 0.006 | 0.998 | 3.724 |  |  |  |  |  | 
COVID19_JANSSEN | Haematocrit decreased | 0 | 0.002 | 0.051 | 0.998 | 2.989 |  |  |  |  |  | 
COVID19_JANSSEN | Haematocrit normal | 0 | 0.004 | 0.209 | 0.998 | 2.268 |  |  |  |  |  | 
COVID19_JANSSEN | Product administered to patient of inappropriate age | 0 | 0.001 | 0.008 | 0.998 | 3.638 |  |  |  |  |  | 
COVID19_JANSSEN | Stress | 0 | 0.001 | 0.004 | 0.998 | 3.856 |  |  |  |  |  | 
COVID19_JANSSEN | Tubulointerstitial diseases (SMQ) [broad] | 0 | 0.004 | 0.203 | 0.998 | 2.286 |  |  |  |  |  | 
COVID19_JANSSEN | Hyponatraemia/SIADH (SMQ) [broad] | 0 | 0.005 | 0.266 | 0.998 | 2.11 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular infections (SMQ) [broad] | 0 | 0.004 | 0.134 | 0.998 | 2.526 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperthyroidism (SMQ) [broad] | 0 | 0.002 | 0.069 | 0.998 | 2.862 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory distress | 0 | 0.003 | 0.071 | 0.998 | 2.844 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperventilation | 0 | 0.002 | 0.028 | 0.998 | 3.224 |  |  |  |  |  | 
COVID19_JANSSEN | Blood lactic acid | 0 | 0.007 | 0.268 | 0.998 | 2.104 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antigen | 0 | 0 | 0 | 0.998 | 4.368 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [narrow] | 0 | 0 | 0 | 0.998 | 5.094 |  |  |  |  |  | 
COVID19_JANSSEN | Balance disorder | 0 | 0.008 | 0.337 | 0.998 | 1.942 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin normal | 0 | 0.005 | 0.178 | 0.998 | 2.363 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging head | 0 | 0.008 | 0.374 | 0.998 | 1.867 |  |  |  |  |  | 
COVID19_JANSSEN | Alanine aminotransferase normal | 0 | 0.002 | 0.053 | 0.998 | 2.977 |  |  |  |  |  | 
COVID19_JANSSEN | Cholestasis and jaundice of hepatic origin (SMQ) [narrow] | 0 | 0.002 | 0.05 | 0.998 | 3.001 |  |  |  |  |  | 
COVID19_JANSSEN | Cognitive disorder | 0 | 0.001 | 0.009 | 0.998 | 3.621 |  |  |  |  |  | 
COVID19_JANSSEN | Flatulence | 0 | 0.002 | 0.068 | 0.998 | 2.867 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific inflammation (SMQ) [broad] | 0 | 0.004 | 0.144 | 0.998 | 2.486 |  |  |  |  |  | 
COVID19_JANSSEN | Abnormal dreams | 0 | 0.001 | 0.012 | 0.998 | 3.511 |  |  |  |  |  | 
COVID19_JANSSEN | Petechiae | 0 | 0.004 | 0.236 | 0.998 | 2.189 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram head normal | 0 | 0.006 | 0.337 | 0.998 | 1.944 |  |  |  |  |  | 
COVID19_JANSSEN | Arrhythmia | 0 | 0.002 | 0.057 | 0.998 | 2.944 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 antibody test positive | 0 | 0.004 | 0.203 | 0.998 | 2.286 |  |  |  |  |  | 
COVID19_JANSSEN | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0 | 0 | 0.998 | 5.816 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B surface antibody negative | 0 | 0 | 0 | 0.998 | 5.811 |  |  |  |  |  | 
COVID19_JANSSEN | Treponema test | 0 | 0.001 | 0 | 0.998 | 4.807 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation (SMQ) [broad] | 0 | 0.002 | 0.055 | 0.998 | 2.961 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory loss | 0 | 0.004 | 0.237 | 0.998 | 2.187 |  |  |  |  |  | 
COVID19_JANSSEN | Lactic acidosis (SMQ) [broad] | 0 | 0.004 | 0.206 | 0.998 | 2.275 |  |  |  |  |  | 
COVID19_JANSSEN | Ear pain | 0 | 0.007 | 0.299 | 0.998 | 2.028 |  |  |  |  |  | 
COVID19_JANSSEN | Constipation | 0 | 0.003 | 0.099 | 0.998 | 2.684 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site warmth | 0 | 0.004 | 0.19 | 0.998 | 2.325 |  |  |  |  |  | 
COVID19_JANSSEN | Blood alkaline phosphatase increased | 0 | 0.003 | 0.12 | 0.998 | 2.584 |  |  |  |  |  | 
COVID19_JANSSEN | Blood potassium decreased | 0 | 0.006 | 0.316 | 0.998 | 1.989 |  |  |  |  |  | 
COVID19_JANSSEN | Blood sodium normal | 0 | 0.004 | 0.192 | 0.998 | 2.32 |  |  |  |  |  | 
COVID19_JANSSEN | Off label use | 0 | 0.001 | 0.009 | 0.998 | 3.601 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure measurement | 0 | 0.002 | 0.082 | 0.998 | 2.778 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombocytopenia | 0 | 0.003 | 0.142 | 0.998 | 2.497 |  |  |  |  |  | 
COVID19_JANSSEN | Systemic inflammatory response syndrome | 0 | 0.001 | 0.006 | 0.998 | 3.717 |  |  |  |  |  | 
COVID19_JANSSEN | Adverse event | 0 | 0.002 | 0.056 | 0.998 | 2.951 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure decreased | 0 | 0.005 | 0.221 | 0.998 | 2.231 |  |  |  |  |  | 
COVID19_JANSSEN | Swollen tongue | 0 | 0.019 | 0.496 | 0.998 | 1.64 |  |  |  |  |  | 
COVID19_JANSSEN | Liver-related coagulation and bleeding disturbances (SMQ) [narrow] | 0 | 0.003 | 0.141 | 0.998 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Hostility/aggression (SMQ) [broad] | 0 | 0.011 | 0.385 | 0.998 | 1.843 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary oedema | 0 | 0.003 | 0.132 | 0.998 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging normal | 0 | 0.005 | 0.267 | 0.998 | 2.109 |  |  |  |  |  | 
COVID19_JANSSEN | Pain in jaw | 0 | 0.008 | 0.375 | 0.998 | 1.865 |  |  |  |  |  | 
COVID19_JANSSEN | Premalignant disorders (SMQ) [broad] | 0 | 0.001 | 0.009 | 0.998 | 3.59 |  |  |  |  |  | 
COVID19_JANSSEN | Conjunctival disorders (SMQ) [broad] | 0 | 0.004 | 0.175 | 0.998 | 2.376 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell sedimentation rate normal | 0 | 0.004 | 0.166 | 0.998 | 2.406 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram | 0 | 0.024 | 0.558 | 0.998 | 1.542 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site erythema | 0 | 0.004 | 0.15 | 0.998 | 2.465 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic erythropenia (SMQ) [narrow] | 0 | 0.002 | 0.066 | 0.998 | 2.878 |  |  |  |  |  | 
COVID19_JANSSEN | X-ray | 0 | 0.007 | 0.287 | 0.998 | 2.057 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal disorders (SMQ) [narrow] | 0 | 0.006 | 0.209 | 0.998 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimation increased | 0 | 0.006 | 0.295 | 0.998 | 2.038 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [broad] | 0 | 0.003 | 0.109 | 0.998 | 2.634 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin normal | 0 | 0.005 | 0.216 | 0.998 | 2.245 |  |  |  |  |  | 
COVID19_JANSSEN | Sepsis | 0 | 0.002 | 0.123 | 0.998 | 2.573 |  |  |  |  |  | 
COVID19_JANSSEN | Vertical infection transmission | 0 | 0 | 0 | 0.998 | 2.947 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging head abnormal | 0 | 0.003 | 0.135 | 0.998 | 2.523 |  |  |  |  |  | 
COVID19_JANSSEN | CSF culture negative | 0 | 0.001 | 0.033 | 0.998 | 3.166 |  |  |  |  |  | 
COVID19_JANSSEN | Heavy menstrual bleeding | 0 | 0.001 | 0.002 | 0.998 | 3.979 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious encephalopathy/delirium (SMQ) [narrow] | 0 | 0.003 | 0.126 | 0.998 | 2.561 |  |  |  |  |  | 
COVID19_JANSSEN | Cholestasis and jaundice of hepatic origin (SMQ) [broad] | 0 | 0.002 | 0.103 | 0.998 | 2.669 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza B virus test | 0 | 0.003 | 0.08 | 0.998 | 2.79 |  |  |  |  |  | 
COVID19_JANSSEN | Blood culture negative | 0 | 0.004 | 0.127 | 0.998 | 2.556 |  |  |  |  |  | 
COVID19_JANSSEN | Thyroid dysfunction (SMQ) [broad] | 0 | 0.002 | 0.079 | 0.998 | 2.796 |  |  |  |  |  | 
COVID19_JANSSEN | Sensitive skin | 0 | 0.002 | 0.063 | 0.998 | 2.9 |  |  |  |  |  | 
COVID19_JANSSEN | Pericardial effusion | 0 | 0.002 | 0.073 | 0.998 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Blood glucose normal | 0 | 0.007 | 0.329 | 0.998 | 1.96 |  |  |  |  |  | 
COVID19_JANSSEN | Tongue pruritus | 0 | 0.003 | 0.154 | 0.998 | 2.449 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal infections (SMQ) [narrow] | 0 | 0.004 | 0.21 | 0.998 | 2.266 |  |  |  |  |  | 
COVID19_JANSSEN | Autopsy | 0 | 0.002 | 0.082 | 0.998 | 2.779 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound scan abnormal | 0 | 0.004 | 0.165 | 0.998 | 2.407 |  |  |  |  |  | 
COVID19_JANSSEN | Liver infections (SMQ) [broad] | 0 | 0 | 0 | 0.998 | 4.793 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular hyperaemia | 0 | 0.005 | 0.236 | 0.998 | 2.188 |  |  |  |  |  | 
COVID19_JANSSEN | Immune thrombocytopenia | 0 | 0.003 | 0.147 | 0.998 | 2.475 |  |  |  |  |  | 
COVID19_JANSSEN | Protein total | 0 | 0.001 | 0.006 | 0.998 | 3.725 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal discomfort | 0 | 0.004 | 0.24 | 0.998 | 2.18 |  |  |  |  |  | 
COVID19_JANSSEN | Sneezing | 0 | 0.003 | 0.158 | 0.998 | 2.435 |  |  |  |  |  | 
COVID19_JANSSEN | Polymerase chain reaction | 0 | 0.001 | 0.017 | 0.998 | 3.413 |  |  |  |  |  | 
COVID19_JANSSEN | Red blood cell sedimentation rate increased | 0 | 0.005 | 0.237 | 0.998 | 2.188 |  |  |  |  |  | 
COVID19_JANSSEN | Tachypnoea | 0 | 0.004 | 0.167 | 0.998 | 2.404 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal haemorrhage (SMQ) [narrow] | 0 | 0.004 | 0.126 | 0.998 | 2.56 |  |  |  |  |  | 
COVID19_JANSSEN | Dysstasia | 0 | 0.005 | 0.29 | 0.998 | 2.051 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiomyopathy (SMQ) [narrow] | 0 | 0.004 | 0.116 | 0.998 | 2.604 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatinine normal | 0 | 0.003 | 0.174 | 0.998 | 2.378 |  |  |  |  |  | 
COVID19_JANSSEN | Cold sweat | 0 | 0.015 | 0.45 | 0.998 | 1.721 |  |  |  |  |  | 
COVID19_JANSSEN | Discomfort | 0 | 0.014 | 0.463 | 0.998 | 1.697 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary tract disorders (SMQ) [narrow] | 0 | 0.002 | 0.054 | 0.998 | 2.967 |  |  |  |  |  | 
COVID19_JANSSEN | Fall | 0 | 0.009 | 0.382 | 0.998 | 1.85 |  |  |  |  |  | 
COVID19_JANSSEN | Blood potassium normal | 0 | 0.004 | 0.196 | 0.998 | 2.307 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram abnormal | 0 | 0.006 | 0.247 | 0.998 | 2.158 |  |  |  |  |  | 
COVID19_JANSSEN | Premalignant disorders (SMQ) [narrow] | 0 | 0.001 | 0.009 | 0.998 | 3.59 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious encephalitis (SMQ) [narrow] | 0 | 0.002 | 0.115 | 0.998 | 2.608 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuse and dependence (SMQ) [broad] | 0 | 0.007 | 0.269 | 0.998 | 2.101 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspepsia | 0 | 0.004 | 0.204 | 0.998 | 2.281 |  |  |  |  |  | 
COVID19_JANSSEN | Haematochezia | 0 | 0.002 | 0.065 | 0.998 | 2.889 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet count normal | 0 | 0.006 | 0.218 | 0.998 | 2.238 |  |  |  |  |  | 
COVID19_JANSSEN | Ejection fraction decreased | 0 | 0.002 | 0.041 | 0.998 | 3.085 |  |  |  |  |  | 
COVID19_JANSSEN | Post herpetic neuralgia | 0 | 0 | 0 | 0.998 | 5.723 |  |  |  |  |  | 
COVID19_JANSSEN | Acute myocardial infarction | 0 | 0.002 | 0.045 | 0.998 | 3.046 |  |  |  |  |  | 
COVID19_JANSSEN | Blood albumin | 0 | 0.001 | 0.006 | 0.998 | 3.731 |  |  |  |  |  | 
COVID19_JANSSEN | Pertussis | 0 | 0 | 0 | 0.998 | 5.524 |  |  |  |  |  | 
COVID19_JANSSEN | Underdose | 0 | 0.001 | 0.007 | 0.998 | 3.656 |  |  |  |  |  | 
COVID19_JANSSEN | Amnesia | 0 | 0.002 | 0.076 | 0.998 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B e antibody positive | 0 | 0 | 0 | 0.998 | 3.578 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound antenatal screen abnormal | 0 | 0.001 | 0.002 | 0.998 | 4.035 |  |  |  |  |  | 
COVID19_JANSSEN | Resuscitation | 0 | 0.006 | 0.279 | 0.998 | 2.076 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B DNA assay positive | 0 | 0 | 0 | 0.998 | 4.299 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis C antibody negative | 0 | 0.001 | 0.001 | 0.998 | 4.286 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate | 0 | 0.002 | 0.03 | 0.998 | 3.199 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersomnia | 0 | 0.006 | 0.16 | 0.997 | 2.425 |  |  |  |  |  | 
COVID19_JANSSEN | Drug related hepatic disorders - severe events only (SMQ) [broad] | 0 | 0.005 | 0.105 | 0.997 | 2.653 |  |  |  |  |  | 
COVID19_JANSSEN | Epistaxis | 0 | 0.005 | 0.167 | 0.997 | 2.401 |  |  |  |  |  | 
COVID19_JANSSEN | Echocardiogram abnormal | 0 | 0.003 | 0.07 | 0.997 | 2.848 |  |  |  |  |  | 
COVID19_JANSSEN | Acute central respiratory depression (SMQ) [narrow] | 0 | 0.011 | 0.297 | 0.997 | 2.031 |  |  |  |  |  | 
COVID19_JANSSEN | Tenderness | 0 | 0.016 | 0.439 | 0.997 | 1.739 |  |  |  |  |  | 
COVID19_JANSSEN | Neuropathy peripheral | 0 | 0.003 | 0.028 | 0.997 | 3.225 |  |  |  |  |  | 
COVID19_JANSSEN | Drug related hepatic disorders - severe events only (SMQ) [narrow] | 0 | 0.005 | 0.105 | 0.997 | 2.654 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal obstruction (SMQ) [narrow] | 0 | 0.002 | 0.016 | 0.997 | 3.423 |  |  |  |  |  | 
COVID19_JANSSEN | Chest X-ray abnormal | 0 | 0.008 | 0.225 | 0.997 | 2.217 |  |  |  |  |  | 
COVID19_JANSSEN | Haemoglobin decreased | 0 | 0.004 | 0.13 | 0.997 | 2.544 |  |  |  |  |  | 
COVID19_JANSSEN | Ultrasound Doppler | 0 | 0.003 | 0.065 | 0.997 | 2.886 |  |  |  |  |  | 
COVID19_JANSSEN | Asthma | 0 | 0.004 | 0.086 | 0.997 | 2.753 |  |  |  |  |  | 
COVID19_JANSSEN | Alanine aminotransferase increased | 0 | 0.005 | 0.136 | 0.997 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | Bursitis | 0 | 0.002 | 0.034 | 0.997 | 3.157 |  |  |  |  |  | 
COVID19_JANSSEN | Cellulitis | 0 | 0.006 | 0.155 | 0.997 | 2.442 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersensitivity | 0 | 0.015 | 0.357 | 0.997 | 1.898 |  |  |  |  |  | 
COVID19_JANSSEN | Dysphonia | 0 | 0.007 | 0.251 | 0.997 | 2.148 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic erythropenia (SMQ) [broad] | 0 | 0.005 | 0.17 | 0.997 | 2.39 |  |  |  |  |  | 
COVID19_JANSSEN | Burning sensation | 0 | 0.018 | 0.424 | 0.997 | 1.765 |  |  |  |  |  | 
COVID19_JANSSEN | Dehydration | 0 | 0.009 | 0.245 | 0.997 | 2.162 |  |  |  |  |  | 
COVID19_JANSSEN | Gait inability | 0 | 0.007 | 0.227 | 0.997 | 2.21 |  |  |  |  |  | 
COVID19_JANSSEN | C-reactive protein normal | 0 | 0.004 | 0.12 | 0.997 | 2.586 |  |  |  |  |  | 
COVID19_JANSSEN | Lethargy | 0 | 0.018 | 0.429 | 0.997 | 1.756 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperglycaemia/new onset diabetes mellitus (SMQ) [narrow] | 0 | 0.01 | 0.306 | 0.997 | 2.01 |  |  |  |  |  | 
COVID19_JANSSEN | Throat clearing | 0 | 0.004 | 0.105 | 0.997 | 2.656 |  |  |  |  |  | 
COVID19_JANSSEN | Swelling face | 0 | 0.024 | 0.516 | 0.997 | 1.607 |  |  |  |  |  | 
COVID19_JANSSEN | Taste disorder | 0 | 0.005 | 0.18 | 0.997 | 2.355 |  |  |  |  |  | 
COVID19_JANSSEN | Orthopoxvirus test positive | 0 | 0 | 0 | 0.997 | 1.156 |  |  |  |  |  | 
COVID19_JANSSEN | Confusional state | 0 | 0.01 | 0.314 | 0.997 | 1.993 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis (SMQ) [narrow] | 0 | 0.005 | 0.105 | 0.997 | 2.65 |  |  |  |  |  | 
COVID19_JANSSEN | Rash papular | 0 | 0.008 | 0.261 | 0.997 | 2.121 |  |  |  |  |  | 
COVID19_JANSSEN | Angioedema | 0 | 0.006 | 0.217 | 0.997 | 2.24 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimal disorders (SMQ) [broad] | 0 | 0.007 | 0.261 | 0.997 | 2.12 |  |  |  |  |  | 
COVID19_JANSSEN | Psychosis and psychotic disorders (SMQ) [narrow] | 0 | 0.004 | 0.14 | 0.997 | 2.502 |  |  |  |  |  | 
COVID19_JANSSEN | Interstitial lung disease (SMQ) [broad] | 0 | 0.006 | 0.138 | 0.997 | 2.506 |  |  |  |  |  | 
COVID19_JANSSEN | Oedema peripheral | 0 | 0.008 | 0.271 | 0.997 | 2.096 |  |  |  |  |  | 
COVID19_JANSSEN | Aerophobia | 0 | 0 | 0 | 0.997 | 1.201 |  |  |  |  |  | 
COVID19_JANSSEN | Acute kidney injury | 0 | 0.003 | 0.083 | 0.997 | 2.769 |  |  |  |  |  | 
COVID19_JANSSEN | Acute renal failure (SMQ) [narrow] | 0 | 0.005 | 0.147 | 0.997 | 2.473 |  |  |  |  |  | 
COVID19_JANSSEN | Postural orthostatic tachycardia syndrome | 0 | 0.001 | 0 | 0.997 | 4.427 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmia terms, nonspecific (SMQ) [broad] | 0 | 0.005 | 0.144 | 0.997 | 2.484 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal obstruction (SMQ) [broad] | 0 | 0.002 | 0.016 | 0.997 | 3.423 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebral haemorrhage | 0 | 0.002 | 0.01 | 0.997 | 3.561 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site urticaria | 0 | 0.011 | 0.306 | 0.997 | 2.009 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmia terms, nonspecific (SMQ) [narrow] | 0 | 0.005 | 0.144 | 0.997 | 2.484 |  |  |  |  |  | 
COVID19_JANSSEN | Drug abuse, dependence and withdrawal (SMQ) [broad] | 0 | 0.008 | 0.268 | 0.997 | 2.102 |  |  |  |  |  | 
COVID19_JANSSEN | Induration | 0 | 0.009 | 0.281 | 0.997 | 2.069 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle tightness | 0 | 0.007 | 0.253 | 0.997 | 2.141 |  |  |  |  |  | 
COVID19_JANSSEN | Memory impairment | 0 | 0.002 | 0.018 | 0.997 | 3.388 |  |  |  |  |  | 
COVID19_JANSSEN | Blood test normal | 0 | 0.009 | 0.267 | 0.997 | 2.104 |  |  |  |  |  | 
COVID19_JANSSEN | Blister | 0 | 0.005 | 0.137 | 0.997 | 2.511 |  |  |  |  |  | 
COVID19_JANSSEN | Dry eye | 0 | 0.002 | 0.025 | 0.997 | 3.274 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic leukopenia (SMQ) [narrow] | 0 | 0.005 | 0.154 | 0.997 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Dehydration (SMQ) [narrow] | 0 | 0.009 | 0.252 | 0.997 | 2.143 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging heart | 0 | 0.001 | 0.002 | 0.997 | 4.039 |  |  |  |  |  | 
COVID19_JANSSEN | Syringe issue | 0 | 0.001 | 0.003 | 0.997 | 3.874 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary system related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.003 | 0.064 | 0.997 | 2.889 |  |  |  |  |  | 
COVID19_JANSSEN | Diplopia | 0 | 0.004 | 0.09 | 0.997 | 2.729 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site reaction | 0 | 0.015 | 0.362 | 0.997 | 1.886 |  |  |  |  |  | 
COVID19_JANSSEN | Osteonecrosis (SMQ) [broad] | 0 | 0.015 | 0.407 | 0.997 | 1.798 |  |  |  |  |  | 
COVID19_JANSSEN | Liver infections (SMQ) [narrow] | 0 | 0.001 | 0 | 0.997 | 5.013 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging | 0 | 0.017 | 0.426 | 0.997 | 1.763 |  |  |  |  |  | 
COVID19_JANSSEN | Product administered at inappropriate site | 0 | 0.005 | 0.137 | 0.997 | 2.515 |  |  |  |  |  | 
COVID19_JANSSEN | Aspartate aminotransferase increased | 0 | 0.006 | 0.157 | 0.997 | 2.435 |  |  |  |  |  | 
COVID19_JANSSEN | Product administration error | 0 | 0.001 | 0 | 0.997 | 4.598 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary system related investigations, signs and symptoms (SMQ) [broad] | 0 | 0.007 | 0.171 | 0.997 | 2.384 |  |  |  |  |  | 
COVID19_JANSSEN | Eye pain | 0 | 0.008 | 0.224 | 0.997 | 2.22 |  |  |  |  |  | 
COVID19_JANSSEN | Hemiparesis | 0 | 0.008 | 0.243 | 0.997 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin | 0 | 0.004 | 0.089 | 0.997 | 2.732 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet-derived growth factor receptor assay | 0 | 0 | 0 | 0.997 | 3.546 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram thorax abnormal | 0 | 0.004 | 0.085 | 0.997 | 2.759 |  |  |  |  |  | 
COVID19_JANSSEN | Aphasia | 0 | 0.007 | 0.216 | 0.997 | 2.243 |  |  |  |  |  | 
COVID19_JANSSEN | Asthma/bronchospasm (SMQ) [narrow] | 0 | 0.006 | 0.139 | 0.997 | 2.501 |  |  |  |  |  | 
COVID19_JANSSEN | Lacrimal disorders (SMQ) [narrow] | 0 | 0.007 | 0.261 | 0.997 | 2.12 |  |  |  |  |  | 
COVID19_JANSSEN | Immediate post-injection reaction | 0 | 0.024 | 0.527 | 0.997 | 1.589 |  |  |  |  |  | 
COVID19_JANSSEN | Functional, inflammatory and gallstone related biliary disorders (SMQ) [broad] | 0 | 0.008 | 0.182 | 0.996 | 2.345 |  |  |  |  |  | 
COVID19_JANSSEN | Normal pregnancy conditions and outcomes (SMQ) [narrow] | 0 | 0.002 | 0.008 | 0.996 | 3.64 |  |  |  |  |  | 
COVID19_JANSSEN | Throat irritation | 0 | 0.019 | 0.347 | 0.996 | 1.915 |  |  |  |  |  | 
COVID19_JANSSEN | Supraventricular tachyarrhythmias (SMQ) [narrow] | 0 | 0.014 | 0.303 | 0.996 | 2.014 |  |  |  |  |  | 
COVID19_JANSSEN | Rash erythematous | 0 | 0.028 | 0.448 | 0.996 | 1.719 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature | 0 | 0.004 | 0.059 | 0.996 | 2.922 |  |  |  |  |  | 
COVID19_JANSSEN | Platelet count decreased | 0 | 0.011 | 0.237 | 0.996 | 2.179 |  |  |  |  |  | 
COVID19_JANSSEN | Rabies | 0 | 0 | 0 | 0.996 | 1.307 |  |  |  |  |  | 
COVID19_JANSSEN | Deep vein thrombosis | 0 | 0.007 | 0.15 | 0.996 | 2.458 |  |  |  |  |  | 
COVID19_JANSSEN | Cerebrovascular accident | 0 | 0.008 | 0.172 | 0.996 | 2.381 |  |  |  |  |  | 
COVID19_JANSSEN | Full blood count normal | 0 | 0.017 | 0.36 | 0.996 | 1.89 |  |  |  |  |  | 
COVID19_JANSSEN | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [narrow] | 0 | 0.008 | 0.196 | 0.996 | 2.302 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site induration | 0 | 0.013 | 0.274 | 0.996 | 2.083 |  |  |  |  |  | 
COVID19_JANSSEN | Insomnia | 0 | 0.018 | 0.387 | 0.996 | 1.835 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic leukopenia (SMQ) [broad] | 0 | 0.008 | 0.198 | 0.996 | 2.297 |  |  |  |  |  | 
COVID19_JANSSEN | Angiogram | 0 | 0.006 | 0.142 | 0.996 | 2.489 |  |  |  |  |  | 
COVID19_JANSSEN | Magnetic resonance imaging head normal | 0 | 0.006 | 0.111 | 0.996 | 2.62 |  |  |  |  |  | 
COVID19_JANSSEN | Flushing | 0 | 0.03 | 0.455 | 0.996 | 1.706 |  |  |  |  |  | 
COVID19_JANSSEN | Blood pressure increased | 0 | 0.021 | 0.382 | 0.996 | 1.844 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancy related therapeutic and diagnostic procedures (SMQ) [narrow] | 0 | 0.008 | 0.188 | 0.996 | 2.325 |  |  |  |  |  | 
COVID19_JANSSEN | Unresponsive to stimuli | 0 | 0.014 | 0.293 | 0.996 | 2.036 |  |  |  |  |  | 
COVID19_JANSSEN | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [algorithm] | 0 | 0.009 | 0.174 | 0.996 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Interstitial lung disease (SMQ) [narrow] | 0 | 0.006 | 0.141 | 0.996 | 2.495 |  |  |  |  |  | 
COVID19_JANSSEN | Blood creatinine increased | 0 | 0.006 | 0.091 | 0.996 | 2.72 |  |  |  |  |  | 
COVID19_JANSSEN | Ocular motility disorders (SMQ) [broad] | 0 | 0.013 | 0.29 | 0.996 | 2.045 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial infarction | 0 | 0.009 | 0.213 | 0.996 | 2.249 |  |  |  |  |  | 
COVID19_JANSSEN | Thrombophlebitis (SMQ) [broad] | 0 | 0.013 | 0.266 | 0.996 | 2.104 |  |  |  |  |  | 
COVID19_JANSSEN | Fertility disorders (SMQ) [broad] | 0 | 0.002 | 0.005 | 0.996 | 3.737 |  |  |  |  |  | 
COVID19_JANSSEN | Fibrin D dimer increased | 0 | 0.01 | 0.219 | 0.996 | 2.232 |  |  |  |  |  | 
COVID19_JANSSEN | Parosmia | 0 | 0.002 | 0.004 | 0.996 | 3.828 |  |  |  |  |  | 
COVID19_JANSSEN | Akathisia (SMQ) [broad] | 0 | 0.006 | 0.099 | 0.996 | 2.678 |  |  |  |  |  | 
COVID19_JANSSEN | Oxygen saturation decreased | 0 | 0.011 | 0.254 | 0.996 | 2.135 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatitis B antibody negative | 0 | 0 | 0 | 0.996 | 5.802 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of personal independence in daily activities | 0 | 0.009 | 0.216 | 0.996 | 2.24 |  |  |  |  |  | 
COVID19_JANSSEN | Acute renal failure (SMQ) [broad] | 0 | 0.012 | 0.251 | 0.996 | 2.143 |  |  |  |  |  | 
COVID19_JANSSEN | Anosmia | 0 | 0.005 | 0.071 | 0.996 | 2.842 |  |  |  |  |  | 
COVID19_JANSSEN | Forced expiratory volume decreased | 0 | 0 | 0 | 0.996 | 5.72 |  |  |  |  |  | 
COVID19_JANSSEN | Axillary pain | 0 | 0.018 | 0.342 | 0.996 | 1.925 |  |  |  |  |  | 
COVID19_JANSSEN | Sepsis (SMQ) [broad] | 0 | 0.005 | 0.063 | 0.996 | 2.889 |  |  |  |  |  | 
COVID19_JANSSEN | Sensory disturbance | 0 | 0.004 | 0.052 | 0.996 | 2.978 |  |  |  |  |  | 
COVID19_JANSSEN | Functional, inflammatory and gallstone related biliary disorders (SMQ) [narrow] | 0 | 0.005 | 0.09 | 0.996 | 2.727 |  |  |  |  |  | 
COVID19_JANSSEN | Supraventricular tachyarrhythmias (SMQ) [broad] | 0 | 0.014 | 0.296 | 0.996 | 2.029 |  |  |  |  |  | 
COVID19_JANSSEN | Computerised tomogram abdomen abnormal | 0 | 0.005 | 0.063 | 0.996 | 2.895 |  |  |  |  |  | 
COVID19_JANSSEN | Neuralgia | 0 | 0.006 | 0.093 | 0.996 | 2.708 |  |  |  |  |  | 
COVID19_JANSSEN | Neutralising antibodies | 0 | 0 | 0 | 0.996 | 0.375 |  |  |  |  |  | 
COVID19_JANSSEN | Other ischaemic heart disease (SMQ) [narrow] | 0 | 0.004 | 0.055 | 0.996 | 2.952 |  |  |  |  |  | 
COVID19_JANSSEN | Interchange of vaccine products | 0 | 0.001 | 0 | 0.996 | 4.545 |  |  |  |  |  | 
COVID19_JANSSEN | Drug ineffective | 0 | 0.002 | 0.006 | 0.996 | 3.695 |  |  |  |  |  | 
COVID19_JANSSEN | Nervousness | 0 | 0.005 | 0.083 | 0.996 | 2.765 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary disorders (SMQ) [narrow] | 0 | 0.005 | 0.075 | 0.996 | 2.813 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral coldness | 0 | 0.007 | 0.159 | 0.996 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza | 0 | 0.003 | 0.013 | 0.996 | 3.486 |  |  |  |  |  | 
COVID19_JANSSEN | Seizure | 0 | 0.01 | 0.21 | 0.996 | 2.256 |  |  |  |  |  | 
COVID19_JANSSEN | Endotracheal intubation | 0 | 0.008 | 0.206 | 0.996 | 2.272 |  |  |  |  |  | 
COVID19_JANSSEN | Severe cutaneous adverse reactions (SMQ) [broad] | 0 | 0.013 | 0.276 | 0.996 | 2.078 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic colitis (SMQ) [broad] | 0 | 0.006 | 0.125 | 0.996 | 2.559 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancy related therapeutic and diagnostic procedures (SMQ) [broad] | 0 | 0.008 | 0.188 | 0.996 | 2.325 |  |  |  |  |  | 
COVID19_JANSSEN | Appendicectomy | 0 | 0.004 | 0.06 | 0.996 | 2.918 |  |  |  |  |  | 
COVID19_JANSSEN | Pallor | 0 | 0.014 | 0.282 | 0.996 | 2.064 |  |  |  |  |  | 
COVID19_JANSSEN | Biliary disorders (SMQ) [broad] | 0 | 0.008 | 0.161 | 0.996 | 2.419 |  |  |  |  |  | 
COVID19_JANSSEN | Intensive care | 0 | 0.014 | 0.285 | 0.996 | 2.056 |  |  |  |  |  | 
COVID19_JANSSEN | Night sweats | 0 | 0.013 | 0.266 | 0.996 | 2.103 |  |  |  |  |  | 
COVID19_JANSSEN | Immunoglobulin therapy | 0 | 0.006 | 0.123 | 0.996 | 2.568 |  |  |  |  |  | 
COVID19_JANSSEN | Visual impairment | 0 | 0.008 | 0.152 | 0.996 | 2.45 |  |  |  |  |  | 
COVID19_JANSSEN | Guillain-Barre syndrome | 0 | 0.004 | 0.055 | 0.996 | 2.953 |  |  |  |  |  | 
COVID19_JANSSEN | Dyskinesia (SMQ) [broad] | 0 | 0.011 | 0.235 | 0.996 | 2.186 |  |  |  |  |  | 
COVID19_JANSSEN | Guillain-Barre syndrome (SMQ) [narrow] | 0 | 0.005 | 0.058 | 0.995 | 2.929 |  |  |  |  |  | 
COVID19_JANSSEN | Somnolence | 0 | 0.013 | 0.253 | 0.995 | 2.136 |  |  |  |  |  | 
COVID19_JANSSEN | Ageusia | 0 | 0.007 | 0.097 | 0.995 | 2.685 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular tachyarrhythmias (SMQ) [broad] | 0 | 0.004 | 0.036 | 0.995 | 3.126 |  |  |  |  |  | 
COVID19_JANSSEN | Injected limb mobility decreased | 0 | 0.01 | 0.184 | 0.995 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Joint range of motion decreased | 0 | 0.008 | 0.116 | 0.995 | 2.594 |  |  |  |  |  | 
COVID19_JANSSEN | C-reactive protein increased | 0 | 0.009 | 0.149 | 0.995 | 2.46 |  |  |  |  |  | 
COVID19_JANSSEN | Neck pain | 0 | 0.032 | 0.428 | 0.995 | 1.752 |  |  |  |  |  | 
COVID19_JANSSEN | Wheezing | 0 | 0.019 | 0.315 | 0.995 | 1.983 |  |  |  |  |  | 
COVID19_JANSSEN | Rash pruritic | 0 | 0.021 | 0.352 | 0.995 | 1.903 |  |  |  |  |  | 
COVID19_JANSSEN | Nasal congestion | 0 | 0.011 | 0.209 | 0.995 | 2.258 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemic and neurogenic shock conditions (SMQ) [broad] | 0 | 0.009 | 0.138 | 0.995 | 2.501 |  |  |  |  |  | 
COVID19_JANSSEN | Accidents and injuries (SMQ) [narrow] | 0 | 0.028 | 0.417 | 0.995 | 1.774 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic thrombocytopenia (SMQ) [narrow] | 0 | 0.013 | 0.227 | 0.995 | 2.204 |  |  |  |  |  | 
COVID19_JANSSEN | Hypovolaemic shock conditions (SMQ) [broad] | 0 | 0.009 | 0.148 | 0.995 | 2.461 |  |  |  |  |  | 
COVID19_JANSSEN | Vision blurred | 0 | 0.021 | 0.338 | 0.995 | 1.933 |  |  |  |  |  | 
COVID19_JANSSEN | Dizziness postural | 0 | 0.003 | 0.009 | 0.995 | 3.603 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal disorders (SMQ) [broad] | 0 | 0.002 | 0.001 | 0.995 | 4.115 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory failure (SMQ) [narrow] | 0 | 0.013 | 0.246 | 0.995 | 2.154 |  |  |  |  |  | 
COVID19_JANSSEN | Ventricular tachyarrhythmias (SMQ) [narrow] | 0 | 0.004 | 0.036 | 0.995 | 3.126 |  |  |  |  |  | 
COVID19_JANSSEN | Presyncope | 0 | 0.011 | 0.18 | 0.995 | 2.35 |  |  |  |  |  | 
COVID19_JANSSEN | Tinnitus | 0 | 0.014 | 0.252 | 0.995 | 2.136 |  |  |  |  |  | 
COVID19_JANSSEN | Incorrect dose administered | 0 | 0.004 | 0.03 | 0.995 | 3.193 |  |  |  |  |  | 
COVID19_JANSSEN | Pharyngeal swelling | 0 | 0.015 | 0.282 | 0.995 | 2.062 |  |  |  |  |  | 
COVID19_JANSSEN | Foetal disorders (SMQ) [narrow] | 0 | 0.002 | 0.001 | 0.995 | 4.205 |  |  |  |  |  | 
COVID19_JANSSEN | Pneumonia | 0 | 0.007 | 0.105 | 0.995 | 2.648 |  |  |  |  |  | 
COVID19_JANSSEN | White blood cell count increased | 0 | 0.01 | 0.169 | 0.995 | 2.387 |  |  |  |  |  | 
COVID19_JANSSEN | Dry mouth | 0 | 0.008 | 0.152 | 0.995 | 2.448 |  |  |  |  |  | 
COVID19_JANSSEN | Disturbance in attention | 0 | 0.005 | 0.047 | 0.995 | 3.013 |  |  |  |  |  | 
COVID19_JANSSEN | Laboratory test | 0 | 0.028 | 0.439 | 0.995 | 1.734 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancies (SMQ) [broad] | 0 | 0.01 | 0.159 | 0.995 | 2.42 |  |  |  |  |  | 
COVID19_JANSSEN | Normal pregnancy conditions and outcomes (SMQ) [broad] | 0 | 0.003 | 0.008 | 0.995 | 3.621 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal discomfort | 0 | 0.013 | 0.241 | 0.995 | 2.168 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure (SMQ) [narrow] | 0 | 0.007 | 0.087 | 0.995 | 2.741 |  |  |  |  |  | 
COVID19_JANSSEN | Pleural effusion | 0 | 0.004 | 0.02 | 0.995 | 3.335 |  |  |  |  |  | 
COVID19_JANSSEN | Dysphagia | 0 | 0.019 | 0.339 | 0.995 | 1.931 |  |  |  |  |  | 
COVID19_JANSSEN | Toxic-septic shock conditions (SMQ) [broad] | 0 | 0.009 | 0.164 | 0.995 | 2.404 |  |  |  |  |  | 
COVID19_JANSSEN | Skin warm | 0 | 0.023 | 0.383 | 0.995 | 1.839 |  |  |  |  |  | 
COVID19_JANSSEN | Liver related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.012 | 0.195 | 0.995 | 2.301 |  |  |  |  |  | 
COVID19_JANSSEN | Malignancies (SMQ) [narrow] | 0 | 0.01 | 0.159 | 0.995 | 2.42 |  |  |  |  |  | 
COVID19_JANSSEN | Muscle spasms | 0 | 0.016 | 0.246 | 0.994 | 2.152 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal allergic conditions (SMQ) [broad] | 0 | 0.027 | 0.353 | 0.994 | 1.897 |  |  |  |  |  | 
COVID19_JANSSEN | Other ischaemic heart disease (SMQ) [broad] | 0 | 0.008 | 0.082 | 0.994 | 2.764 |  |  |  |  |  | 
COVID19_JANSSEN | Product use issue | 0 | 0.002 | 0 | 0.994 | 4.657 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, venous (SMQ) [narrow] | 0 | 0.015 | 0.241 | 0.994 | 2.164 |  |  |  |  |  | 
COVID19_JANSSEN | Atrial fibrillation | 0 | 0.006 | 0.054 | 0.994 | 2.959 |  |  |  |  |  | 
COVID19_JANSSEN | Product preparation issue | 0 | 0.002 | 0 | 0.994 | 4.563 |  |  |  |  |  | 
COVID19_JANSSEN | Lymph node pain | 0 | 0.016 | 0.219 | 0.994 | 2.224 |  |  |  |  |  | 
COVID19_JANSSEN | Full blood count | 0 | 0.032 | 0.412 | 0.994 | 1.781 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic central nervous system vascular conditions (SMQ) [broad] | 0 | 0.011 | 0.174 | 0.994 | 2.368 |  |  |  |  |  | 
COVID19_JANSSEN | Photophobia | 0 | 0.007 | 0.071 | 0.994 | 2.831 |  |  |  |  |  | 
COVID19_JANSSEN | Urticaria | 0 | 0.079 | 0.597 | 0.994 | 1.474 |  |  |  |  |  | 
COVID19_JANSSEN | Dysgeusia | 0 | 0.015 | 0.203 | 0.994 | 2.272 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, venous (SMQ) [broad] | 0 | 0.015 | 0.241 | 0.994 | 2.164 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site rash | 0 | 0.017 | 0.257 | 0.994 | 2.121 |  |  |  |  |  | 
COVID19_JANSSEN | Throat tightness | 0 | 0.031 | 0.402 | 0.994 | 1.8 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin I increased | 0 | 0.001 | 0 | 0.994 | 4.931 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [broad] | 0 | 0.014 | 0.219 | 0.994 | 2.228 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic central nervous system vascular conditions (SMQ) [broad] | 0 | 0.015 | 0.227 | 0.994 | 2.202 |  |  |  |  |  | 
COVID19_JANSSEN | Appendicitis (narrow) (Custom Term) | 0 | 0.005 | 0.038 | 0.994 | 3.102 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage laboratory terms (SMQ) [broad] | 0 | 0.016 | 0.237 | 0.994 | 2.175 |  |  |  |  |  | 
COVID19_JANSSEN | Abortion spontaneous | 0 | 0.005 | 0.02 | 0.994 | 3.325 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhagic central nervous system vascular conditions (SMQ) [narrow] | 0 | 0.011 | 0.174 | 0.994 | 2.368 |  |  |  |  |  | 
COVID19_JANSSEN | Chest X-ray normal | 0 | 0.019 | 0.276 | 0.994 | 2.073 |  |  |  |  |  | 
COVID19_JANSSEN | Liver related investigations, signs and symptoms (SMQ) [broad] | 0 | 0.013 | 0.198 | 0.994 | 2.287 |  |  |  |  |  | 
COVID19_JANSSEN | Swelling | 0 | 0.029 | 0.365 | 0.994 | 1.872 |  |  |  |  |  | 
COVID19_JANSSEN | Accidents and injuries (SMQ) [broad] | 0 | 0.03 | 0.379 | 0.994 | 1.844 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertension | 0 | 0.024 | 0.325 | 0.994 | 1.958 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious meningitis (SMQ) [narrow] | 0 | 0.007 | 0.083 | 0.994 | 2.758 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal allergic conditions (SMQ) [narrow] | 0 | 0.027 | 0.353 | 0.994 | 1.897 |  |  |  |  |  | 
COVID19_JANSSEN | Gait disturbance | 0 | 0.014 | 0.212 | 0.994 | 2.246 |  |  |  |  |  | 
COVID19_JANSSEN | Vaccination site pain | 0 | 0.018 | 0.28 | 0.994 | 2.064 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic central nervous system vascular conditions (SMQ) [narrow] | 0 | 0.015 | 0.227 | 0.994 | 2.202 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling cold | 0 | 0.018 | 0.268 | 0.994 | 2.094 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic thrombocytopenia (SMQ) [broad] | 0 | 0.014 | 0.224 | 0.994 | 2.212 |  |  |  |  |  | 
COVID19_JANSSEN | Body temperature increased | 0 | 0.031 | 0.39 | 0.994 | 1.823 |  |  |  |  |  | 
COVID19_JANSSEN | Torsade de pointes, shock-associated conditions (SMQ) [broad] | 0 | 0.01 | 0.129 | 0.994 | 2.535 |  |  |  |  |  | 
COVID19_JANSSEN | Facial paralysis | 0 | 0.03 | 0.404 | 0.994 | 1.797 |  |  |  |  |  | 
COVID19_JANSSEN | Corneal disorders (SMQ) [broad] | 0 | 0.017 | 0.2 | 0.993 | 2.278 |  |  |  |  |  | 
COVID19_JANSSEN | Echocardiogram normal | 0 | 0.009 | 0.085 | 0.993 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Loss of consciousness | 0 | 0.019 | 0.248 | 0.993 | 2.141 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of efficacy/effect (SMQ) [narrow] | 0 | 0.004 | 0.01 | 0.993 | 3.567 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary embolism | 0 | 0.009 | 0.1 | 0.993 | 2.666 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised convulsive seizures following immunisation (SMQ) [narrow] | 0 | 0.015 | 0.188 | 0.993 | 2.317 |  |  |  |  |  | 
COVID19_JANSSEN | Hypotension | 0 | 0.017 | 0.222 | 0.993 | 2.216 |  |  |  |  |  | 
COVID19_JANSSEN | Mobility decreased | 0 | 0.025 | 0.311 | 0.993 | 1.988 |  |  |  |  |  | 
COVID19_JANSSEN | Drug related hepatic disorders - comprehensive search (SMQ) [broad] | 0 | 0.017 | 0.199 | 0.993 | 2.281 |  |  |  |  |  | 
COVID19_JANSSEN | Vertigo | 0 | 0.019 | 0.236 | 0.993 | 2.175 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic cytopenias (SMQ) [narrow] | 0 | 0.017 | 0.219 | 0.993 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure to SARS-CoV-2 | 0 | 0.001 | 0 | 0.993 | 5.032 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspnoea exertional | 0 | 0.005 | 0.018 | 0.993 | 3.361 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal pain upper | 0 | 0.015 | 0.177 | 0.993 | 2.352 |  |  |  |  |  | 
COVID19_JANSSEN | Feeling abnormal | 0 | 0.051 | 0.475 | 0.993 | 1.664 |  |  |  |  |  | 
COVID19_JANSSEN | Psychosis and psychotic disorders (SMQ) [broad] | 0 | 0.018 | 0.23 | 0.993 | 2.19 |  |  |  |  |  | 
COVID19_JANSSEN | Lack of efficacy/effect (SMQ) [broad] | 0 | 0.004 | 0.01 | 0.993 | 3.567 |  |  |  |  |  | 
COVID19_JANSSEN | Hydrophobia | 0 | 0 | 0 | 0.993 | 0.112 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 test | 0 | 0.015 | 0.178 | 0.993 | 2.349 |  |  |  |  |  | 
COVID19_JANSSEN | Blood test | 0 | 0.037 | 0.395 | 0.993 | 1.81 |  |  |  |  |  | 
COVID19_JANSSEN | Metabolic function test | 0 | 0.028 | 0.346 | 0.993 | 1.911 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage terms (excl laboratory terms) (SMQ) [broad] | 0 | 0.052 | 0.451 | 0.992 | 1.704 |  |  |  |  |  | 
COVID19_JANSSEN | Demyelination (SMQ) [broad] | 0 | 0.01 | 0.08 | 0.992 | 2.77 |  |  |  |  |  | 
COVID19_JANSSEN | Termination of pregnancy and risk of abortion (SMQ) [broad] | 0 | 0.006 | 0.023 | 0.992 | 3.272 |  |  |  |  |  | 
COVID19_JANSSEN | Convulsions (SMQ) [narrow] | 0 | 0.019 | 0.206 | 0.992 | 2.257 |  |  |  |  |  | 
COVID19_JANSSEN | Decreased appetite | 0 | 0.032 | 0.344 | 0.992 | 1.912 |  |  |  |  |  | 
COVID19_JANSSEN | Infective pneumonia (SMQ) [narrow] | 0 | 0.01 | 0.096 | 0.992 | 2.683 |  |  |  |  |  | 
COVID19_JANSSEN | Termination of pregnancy and risk of abortion (SMQ) [narrow] | 0 | 0.006 | 0.023 | 0.992 | 3.272 |  |  |  |  |  | 
COVID19_JANSSEN | Echocardiogram | 0 | 0.013 | 0.132 | 0.992 | 2.516 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhage terms (excl laboratory terms) (SMQ) [narrow] | 0 | 0.052 | 0.451 | 0.992 | 1.704 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram ST segment elevation | 0 | 0.003 | 0.001 | 0.992 | 4.205 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [narrow] | 0 | 0.011 | 0.098 | 0.992 | 2.671 |  |  |  |  |  | 
COVID19_JANSSEN | Generalised convulsive seizures following immunisation (SMQ) [algorithm] | 0 | 0.016 | 0.182 | 0.992 | 2.334 |  |  |  |  |  | 
COVID19_JANSSEN | Drug related hepatic disorders - comprehensive search (SMQ) [narrow] | 0 | 0.016 | 0.188 | 0.992 | 2.314 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [narrow] | 0 | 0.02 | 0.22 | 0.992 | 2.217 |  |  |  |  |  | 
COVID19_JANSSEN | Haematopoietic cytopenias (SMQ) [broad] | 0 | 0.023 | 0.252 | 0.992 | 2.127 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral swelling | 0 | 0.035 | 0.361 | 0.992 | 1.877 |  |  |  |  |  | 
COVID19_JANSSEN | Convulsions (SMQ) [broad] | 0 | 0.018 | 0.2 | 0.992 | 2.278 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperhidrosis | 0 | 0.071 | 0.52 | 0.992 | 1.588 |  |  |  |  |  | 
COVID19_JANSSEN | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [broad] | 0 | 0.02 | 0.218 | 0.992 | 2.221 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhages (SMQ) [narrow] | 0 | 0.052 | 0.45 | 0.992 | 1.706 |  |  |  |  |  | 
COVID19_JANSSEN | Demyelination (SMQ) [narrow] | 0 | 0.009 | 0.073 | 0.992 | 2.816 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular disorders (SMQ) [narrow] | 0 | 0.02 | 0.226 | 0.992 | 2.199 |  |  |  |  |  | 
COVID19_JANSSEN | Back pain | 0 | 0.028 | 0.308 | 0.992 | 1.99 |  |  |  |  |  | 
COVID19_JANSSEN | Depression (excl suicide and self injury) (SMQ) [broad] | 0 | 0.022 | 0.231 | 0.991 | 2.185 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram normal | 0 | 0.024 | 0.239 | 0.991 | 2.16 |  |  |  |  |  | 
COVID19_JANSSEN | Depression and suicide/self-injury (SMQ) [broad] | 0 | 0.022 | 0.226 | 0.991 | 2.198 |  |  |  |  |  | 
COVID19_JANSSEN | Condition aggravated | 0 | 0.034 | 0.334 | 0.991 | 1.931 |  |  |  |  |  | 
COVID19_JANSSEN | Lens disorders (SMQ) [broad] | 0 | 0.024 | 0.239 | 0.991 | 2.161 |  |  |  |  |  | 
COVID19_JANSSEN | Oropharyngeal pain | 0 | 0.026 | 0.249 | 0.991 | 2.134 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing impairment (SMQ) [narrow] | 0 | 0.021 | 0.225 | 0.991 | 2.201 |  |  |  |  |  | 
COVID19_JANSSEN | Heart rate increased | 0 | 0.036 | 0.348 | 0.991 | 1.902 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic reaction | 0 | 0.016 | 0.159 | 0.991 | 2.412 |  |  |  |  |  | 
COVID19_JANSSEN | Tremor | 0 | 0.039 | 0.365 | 0.991 | 1.867 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza virus test negative | 0 | 0.008 | 0.035 | 0.991 | 3.119 |  |  |  |  |  | 
COVID19_JANSSEN | Appendicitis | 0 | 0.008 | 0.028 | 0.99 | 3.205 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram | 0 | 0.032 | 0.289 | 0.99 | 2.031 |  |  |  |  |  | 
COVID19_JANSSEN | Pericarditis | 0 | 0.005 | 0.004 | 0.99 | 3.781 |  |  |  |  |  | 
COVID19_JANSSEN | Syncope | 0 | 0.025 | 0.223 | 0.99 | 2.204 |  |  |  |  |  | 
COVID19_JANSSEN | Migraine | 0 | 0.021 | 0.195 | 0.99 | 2.289 |  |  |  |  |  | 
COVID19_JANSSEN | Haemorrhages (SMQ) [broad] | 0 | 0.068 | 0.447 | 0.99 | 1.704 |  |  |  |  |  | 
COVID19_JANSSEN | Electrocardiogram abnormal | 0 | 0.012 | 0.066 | 0.99 | 2.85 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac failure (SMQ) [broad] | 0 | 0.055 | 0.408 | 0.99 | 1.778 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic reaction (SMQ) [narrow] | 0 | 0.019 | 0.154 | 0.99 | 2.426 |  |  |  |  |  | 
COVID19_JANSSEN | Erythema | 0 | 0.064 | 0.442 | 0.99 | 1.716 |  |  |  |  |  | 
COVID19_JANSSEN | Inappropriate schedule of product administration | 0 | 0.008 | 0.021 | 0.989 | 3.294 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic/anaphylactoid shock conditions (SMQ) [narrow] | 0 | 0.019 | 0.154 | 0.989 | 2.424 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [narrow] | 0 | 0.024 | 0.206 | 0.989 | 2.252 |  |  |  |  |  | 
COVID19_JANSSEN | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [narrow] | 0 | 0.02 | 0.153 | 0.989 | 2.424 |  |  |  |  |  | 
COVID19_JANSSEN | Muscular weakness | 0 | 0.026 | 0.2 | 0.989 | 2.267 |  |  |  |  |  | 
COVID19_JANSSEN | Rhinorrhoea | 0 | 0.017 | 0.118 | 0.989 | 2.566 |  |  |  |  |  | 
COVID19_JANSSEN | Angioedema (SMQ) [narrow] | 0 | 0.151 | 0.6 | 0.989 | 1.458 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertension (SMQ) [broad] | 0 | 0.046 | 0.345 | 0.989 | 1.902 |  |  |  |  |  | 
COVID19_JANSSEN | Optic nerve disorders (SMQ) [broad] | 0 | 0.017 | 0.112 | 0.988 | 2.593 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 test negative | 0 | 0.049 | 0.336 | 0.988 | 1.918 |  |  |  |  |  | 
COVID19_JANSSEN | Hypertension (SMQ) [narrow] | 0 | 0.043 | 0.316 | 0.988 | 1.964 |  |  |  |  |  | 
COVID19_JANSSEN | Taste and smell disorders (SMQ) [narrow] | 0 | 0.025 | 0.178 | 0.988 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Chronic kidney disease (SMQ) [broad] | 0 | 0.021 | 0.142 | 0.988 | 2.462 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy and neonatal topics (SMQ) [broad] | 0 | 0.02 | 0.132 | 0.988 | 2.504 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [broad] | 0 | 0.024 | 0.167 | 0.988 | 2.372 |  |  |  |  |  | 
COVID19_JANSSEN | Taste and smell disorders (SMQ) [broad] | 0 | 0.025 | 0.178 | 0.988 | 2.336 |  |  |  |  |  | 
COVID19_JANSSEN | Impaired work ability | 0 | 0.03 | 0.225 | 0.988 | 2.191 |  |  |  |  |  | 
COVID19_JANSSEN | Tachycardia | 0 | 0.028 | 0.209 | 0.988 | 2.239 |  |  |  |  |  | 
COVID19_JANSSEN | Anxiety | 0 | 0.019 | 0.11 | 0.987 | 2.597 |  |  |  |  |  | 
COVID19_JANSSEN | Rash | 0 | 0.102 | 0.483 | 0.987 | 1.636 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [narrow] | 0 | 0.028 | 0.185 | 0.987 | 2.308 |  |  |  |  |  | 
COVID19_JANSSEN | Chest discomfort | 0 | 0.055 | 0.342 | 0.987 | 1.902 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [broad] | 0 | 0.028 | 0.185 | 0.987 | 2.31 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site warmth | 0 | 0.033 | 0.22 | 0.987 | 2.202 |  |  |  |  |  | 
COVID19_JANSSEN | Asthma/bronchospasm (SMQ) [broad] | 0 | 0.037 | 0.251 | 0.987 | 2.117 |  |  |  |  |  | 
COVID19_JANSSEN | Hypokalaemia (SMQ) [broad] | 0 | 0.032 | 0.215 | 0.987 | 2.215 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy and neonatal topics (SMQ) [narrow] | 0 | 0.02 | 0.126 | 0.987 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic disorders (SMQ) [broad] | 0 | 0.017 | 0.081 | 0.987 | 2.748 |  |  |  |  |  | 
COVID19_JANSSEN | Abdominal pain | 0 | 0.023 | 0.154 | 0.987 | 2.419 |  |  |  |  |  | 
COVID19_JANSSEN | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [broad] | 0 | 0.02 | 0.121 | 0.987 | 2.549 |  |  |  |  |  | 
COVID19_JANSSEN | Myocarditis | 0 | 0.008 | 0.007 | 0.987 | 3.617 |  |  |  |  |  | 
COVID19_JANSSEN | Troponin increased | 0 | 0.014 | 0.046 | 0.986 | 2.995 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, arterial (SMQ) [narrow] | 0 | 0.017 | 0.081 | 0.986 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic/anaphylactoid shock conditions (SMQ) [broad] | 0 | 0.027 | 0.161 | 0.986 | 2.389 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vascular disorders (SMQ) [narrow] | 0 | 0.025 | 0.148 | 0.986 | 2.436 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmias (SMQ) [narrow] | 0 | 0.029 | 0.179 | 0.986 | 2.326 |  |  |  |  |  | 
COVID19_JANSSEN | Hepatic disorders (SMQ) [narrow] | 0 | 0.016 | 0.067 | 0.986 | 2.834 |  |  |  |  |  | 
COVID19_JANSSEN | Influenza like illness | 0 | 0.022 | 0.125 | 0.986 | 2.528 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated/autoimmune disorders (SMQ) [narrow] | 0 | 0.021 | 0.123 | 0.986 | 2.538 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, arterial (SMQ) [broad] | 0 | 0.017 | 0.081 | 0.986 | 2.743 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral neuropathy (SMQ) [narrow] | 0 | 0.023 | 0.115 | 0.985 | 2.569 |  |  |  |  |  | 
COVID19_JANSSEN | Glaucoma (SMQ) [broad] | 0 | 0.049 | 0.283 | 0.985 | 2.032 |  |  |  |  |  | 
COVID19_JANSSEN | Dystonia (SMQ) [broad] | 0 | 0.059 | 0.334 | 0.985 | 1.916 |  |  |  |  |  | 
COVID19_JANSSEN | Retinal disorders (SMQ) [broad] | 0 | 0.037 | 0.225 | 0.985 | 2.184 |  |  |  |  |  | 
COVID19_JANSSEN | Sleep disorder | 0 | 0.02 | 0.093 | 0.985 | 2.676 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing and vestibular disorders (SMQ) [narrow] | 0 | 0.042 | 0.251 | 0.985 | 2.113 |  |  |  |  |  | 
COVID19_JANSSEN | Shock (SMQ) [narrow] | 0 | 0.037 | 0.198 | 0.984 | 2.26 |  |  |  |  |  | 
COVID19_JANSSEN | Torsade de pointes/QT prolongation (SMQ) [broad] | 0 | 0.049 | 0.266 | 0.984 | 2.07 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing impairment (SMQ) [broad] | 0 | 0.054 | 0.293 | 0.984 | 2.005 |  |  |  |  |  | 
COVID19_JANSSEN | Parkinson-like events (SMQ) [broad] | 0 | 0.101 | 0.427 | 0.983 | 1.726 |  |  |  |  |  | 
COVID19_JANSSEN | Pruritus | 0 | 0.104 | 0.429 | 0.983 | 1.72 |  |  |  |  |  | 
COVID19_JANSSEN | Palpitations | 0 | 0.031 | 0.155 | 0.983 | 2.402 |  |  |  |  |  | 
COVID19_JANSSEN | Exposure during pregnancy | 0 | 0.014 | 0.03 | 0.983 | 3.146 |  |  |  |  |  | 
COVID19_JANSSEN | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [broad] | 0 | 0.03 | 0.146 | 0.983 | 2.435 |  |  |  |  |  | 
COVID19_JANSSEN | Illness | 0 | 0.005 | 0 | 0.982 | 4.573 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [broad] | 0 | 0.024 | 0.091 | 0.982 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Hyperglycaemia/new onset diabetes mellitus (SMQ) [broad] | 0 | 0.07 | 0.322 | 0.982 | 1.932 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [narrow] | 0 | 0.024 | 0.091 | 0.982 | 2.677 |  |  |  |  |  | 
COVID19_JANSSEN | Anaphylactic reaction (SMQ) [algorithm] | 0 | 0.087 | 0.373 | 0.982 | 1.826 |  |  |  |  |  | 
COVID19_JANSSEN | Angioedema (SMQ) [broad] | 0 | 0.27 | 0.602 | 0.982 | 1.437 |  |  |  |  |  | 
COVID19_JANSSEN | Diarrhoea | 0 | 0.063 | 0.284 | 0.981 | 2.017 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site pruritus | 0 | 0.03 | 0.119 | 0.981 | 2.54 |  |  |  |  |  | 
COVID19_JANSSEN | Pseudomembranous colitis (SMQ) [broad] | 0 | 0.064 | 0.287 | 0.981 | 2.01 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [broad] | 0 | 0.016 | 0.029 | 0.981 | 3.161 |  |  |  |  |  | 
COVID19_JANSSEN | Respiratory failure (SMQ) [broad] | 0 | 0.051 | 0.241 | 0.981 | 2.127 |  |  |  |  |  | 
COVID19_JANSSEN | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [narrow] | 0 | 0.015 | 0.029 | 0.981 | 3.16 |  |  |  |  |  | 
COVID19_JANSSEN | Retroperitoneal fibrosis (SMQ) [broad] | 0 | 0.066 | 0.291 | 0.98 | 2 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [broad] | 0 | 0.035 | 0.14 | 0.98 | 2.447 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious diarrhoea (SMQ) [narrow] | 0 | 0.065 | 0.283 | 0.98 | 2.019 |  |  |  |  |  | 
COVID19_JANSSEN | Central nervous system vascular disorders (SMQ) [broad] | 0 | 0.035 | 0.129 | 0.979 | 2.487 |  |  |  |  |  | 
COVID19_JANSSEN | Vomiting | 0 | 0.108 | 0.391 | 0.979 | 1.783 |  |  |  |  |  | 
COVID19_JANSSEN | Shock (SMQ) [broad] | 0 | 0.045 | 0.178 | 0.978 | 2.308 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site swelling | 0 | 0.063 | 0.25 | 0.978 | 2.095 |  |  |  |  |  | 
COVID19_JANSSEN | Asthenia | 0 | 0.08 | 0.3 | 0.977 | 1.97 |  |  |  |  |  | 
COVID19_JANSSEN | COVID-19 pneumonia | 0 | 0.003 | 0 | 0.977 | 5.572 |  |  |  |  |  | 
COVID19_JANSSEN | Malaise | 0 | 0.073 | 0.278 | 0.977 | 2.023 |  |  |  |  |  | 
COVID19_JANSSEN | Lymphadenopathy | 0 | 0.067 | 0.258 | 0.977 | 2.073 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site erythema | 0 | 0.068 | 0.25 | 0.976 | 2.089 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious diarrhoea (SMQ) [broad] | 0 | 0.073 | 0.259 | 0.976 | 2.064 |  |  |  |  |  | 
COVID19_JANSSEN | Extrapyramidal syndrome (SMQ) [broad] | 0 | 0.143 | 0.39 | 0.973 | 1.768 |  |  |  |  |  | 
COVID19_JANSSEN | Dyspnoea | 0 | 0.131 | 0.374 | 0.973 | 1.8 |  |  |  |  |  | 
COVID19_JANSSEN | Arthritis (SMQ) [broad] | 0 | 0.186 | 0.436 | 0.972 | 1.679 |  |  |  |  |  | 
COVID19_JANSSEN | Pulmonary hypertension (SMQ) [broad] | 0 | 0.141 | 0.379 | 0.972 | 1.788 |  |  |  |  |  | 
COVID19_JANSSEN | Medication errors (SMQ) [narrow] | 0 | 0.036 | 0.083 | 0.972 | 2.687 |  |  |  |  |  | 
COVID19_JANSSEN | Chest pain | 0 | 0.061 | 0.173 | 0.971 | 2.3 |  |  |  |  |  | 
COVID19_JANSSEN | Product storage error | 0 | 0.014 | 0.003 | 0.971 | 3.781 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersensitivity (SMQ) [broad] | 0 | 0.487 | 0.602 | 0.969 | 1.408 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial infarction (SMQ) [broad] | 0 | 0.03 | 0.04 | 0.969 | 2.986 |  |  |  |  |  | 
COVID19_JANSSEN | Hypersensitivity (SMQ) [narrow] | 0 | 0.337 | 0.535 | 0.969 | 1.507 |  |  |  |  |  | 
COVID19_JANSSEN | Dehydration (SMQ) [broad] | 0 | 0.151 | 0.354 | 0.967 | 1.824 |  |  |  |  |  | 
COVID19_JANSSEN | Dementia (SMQ) [broad] | 0 | 0.117 | 0.296 | 0.967 | 1.952 |  |  |  |  |  | 
COVID19_JANSSEN | Herpes zoster | 0 | 0.018 | 0.004 | 0.966 | 3.681 |  |  |  |  |  | 
COVID19_JANSSEN | Cough | 0 | 0.068 | 0.166 | 0.966 | 2.312 |  |  |  |  |  | 
COVID19_JANSSEN | Haemodynamic oedema, effusions and fluid overload (SMQ) [broad] | 0 | 0.181 | 0.388 | 0.966 | 1.755 |  |  |  |  |  | 
COVID19_JANSSEN | Medication errors (SMQ) [broad] | 0 | 0.045 | 0.087 | 0.966 | 2.646 |  |  |  |  |  | 
COVID19_JANSSEN | Haemodynamic oedema, effusions and fluid overload (SMQ) [narrow] | 0 | 0.181 | 0.388 | 0.966 | 1.755 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoaesthesia | 0 | 0.075 | 0.183 | 0.966 | 2.253 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic heart disease (SMQ) [broad] | 0 | 0.035 | 0.044 | 0.965 | 2.938 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events (SMQ) [broad] | 0 | 0.056 | 0.116 | 0.964 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Embolic and thrombotic events (SMQ) [narrow] | 0 | 0.056 | 0.116 | 0.964 | 2.5 |  |  |  |  |  | 
COVID19_JANSSEN | Ischaemic heart disease (SMQ) [narrow] | 0 | 0.03 | 0.027 | 0.964 | 3.121 |  |  |  |  |  | 
COVID19_JANSSEN | COVID-19 (SMQ) [broad] | 0 | 0.089 | 0.196 | 0.962 | 2.202 |  |  |  |  |  | 
COVID19_JANSSEN | Paraesthesia | 0 | 0.09 | 0.198 | 0.962 | 2.195 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious meningitis (SMQ) [broad] | 0 | 0.189 | 0.362 | 0.961 | 1.792 |  |  |  |  |  | 
COVID19_JANSSEN | No adverse event | 0 | 0.028 | 0.016 | 0.961 | 3.283 |  |  |  |  |  | 
COVID19_JANSSEN | Death | 0 | 0.043 | 0.057 | 0.961 | 2.82 |  |  |  |  |  | 
COVID19_JANSSEN | Myocardial infarction (SMQ) [narrow] | 0 | 0.027 | 0.011 | 0.959 | 3.379 |  |  |  |  |  | 
COVID19_JANSSEN | Acute central respiratory depression (SMQ) [broad] | 0 | 0.162 | 0.301 | 0.957 | 1.912 |  |  |  |  |  | 
COVID19_JANSSEN | Pain | 0 | 0.308 | 0.446 | 0.957 | 1.626 |  |  |  |  |  | 
COVID19_JANSSEN | Arthralgia | 0 | 0.134 | 0.262 | 0.957 | 2.005 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious encephalopathy/delirium (SMQ) [broad] | 0 | 0.216 | 0.363 | 0.956 | 1.778 |  |  |  |  |  | 
COVID19_JANSSEN | Immune-mediated/autoimmune disorders (SMQ) [broad] | 0 | 0.082 | 0.141 | 0.955 | 2.367 |  |  |  |  |  | 
COVID19_JANSSEN | Noninfectious encephalitis (SMQ) [broad] | 0 | 0.201 | 0.34 | 0.955 | 1.821 |  |  |  |  |  | 
COVID19_JANSSEN | Pain in extremity | 0 | 0.188 | 0.311 | 0.952 | 1.878 |  |  |  |  |  | 
COVID19_JANSSEN | Nausea | 0 | 0.249 | 0.367 | 0.951 | 1.755 |  |  |  |  |  | 
COVID19_JANSSEN | Vestibular disorders (SMQ) [broad] | 0 | 0.242 | 0.363 | 0.951 | 1.766 |  |  |  |  |  | 
COVID19_JANSSEN | Arrhythmia related investigations, signs and symptoms (SMQ) [broad] | 0 | 0.199 | 0.31 | 0.95 | 1.873 |  |  |  |  |  | 
COVID19_JANSSEN | Hearing and vestibular disorders (SMQ) [broad] | 0 | 0.29 | 0.393 | 0.95 | 1.702 |  |  |  |  |  | 
COVID19_JANSSEN | COVID-19 (SMQ) [narrow] | 0 | 0.026 | 0.004 | 0.95 | 3.635 |  |  |  |  |  | 
COVID19_JANSSEN | Fatal outcome (Custom Term) | 0 | 0.054 | 0.052 | 0.95 | 2.818 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiomyopathy (SMQ) [broad] | 0 | 0.269 | 0.363 | 0.947 | 1.753 |  |  |  |  |  | 
COVID19_JANSSEN | Hypoglycaemia (SMQ) [broad] | 0 | 0.294 | 0.378 | 0.946 | 1.721 |  |  |  |  |  | 
COVID19_JANSSEN | Rhabdomyolysis/myopathy (SMQ) [broad] | 0 | 0.252 | 0.341 | 0.945 | 1.794 |  |  |  |  |  | 
COVID19_JANSSEN | Cardiac arrhythmias (SMQ) [broad] | 0 | 0.211 | 0.298 | 0.944 | 1.886 |  |  |  |  |  | 
COVID19_JANSSEN | SARS-CoV-2 test positive | 0 | 0.018 | 0 | 0.944 | 4.293 |  |  |  |  |  | 
COVID19_JANSSEN | Peripheral neuropathy (SMQ) [broad] | 0 | 0.191 | 0.274 | 0.944 | 1.941 |  |  |  |  |  | 
COVID19_JANSSEN | Opportunistic infections (SMQ) [broad] | 0 | 0.116 | 0.159 | 0.943 | 2.265 |  |  |  |  |  | 
COVID19_JANSSEN | Pyrexia | 0 | 0.392 | 0.426 | 0.943 | 1.625 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [narrow] | 0 | 0.352 | 0.394 | 0.941 | 1.677 |  |  |  |  |  | 
COVID19_JANSSEN | Injection site pain | 0 | 0.188 | 0.253 | 0.94 | 1.981 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [narrow] | 0 | 0.348 | 0.39 | 0.94 | 1.684 |  |  |  |  |  | 
COVID19_JANSSEN | Dizziness | 0 | 0.223 | 0.283 | 0.938 | 1.903 |  |  |  |  |  | 
COVID19_JANSSEN | COVID-19 | 0 | 0.014 | 0 | 0.937 | 4.76 |  |  |  |  |  | 
COVID19_JANSSEN | Myalgia | 0 | 0.203 | 0.243 | 0.934 | 1.989 |  |  |  |  |  | 
COVID19_JANSSEN | Tendinopathies and ligament disorders (SMQ) [broad] | 0 | 0.391 | 0.386 | 0.933 | 1.672 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [broad] | 0 | 0.419 | 0.399 | 0.933 | 1.647 |  |  |  |  |  | 
COVID19_JANSSEN | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [broad] | 0 | 0.415 | 0.395 | 0.932 | 1.653 |  |  |  |  |  | 
COVID19_JANSSEN | Extravasation events (injections, infusions and implants) (SMQ) [broad] | 0 | 0.323 | 0.308 | 0.923 | 1.805 |  |  |  |  |  | 
COVID19_JANSSEN | Infective pneumonia (SMQ) [broad] | 0 | 0.131 | 0.098 | 0.916 | 2.43 |  |  |  |  |  | 
COVID19_JANSSEN | Chills | 0 | 0.353 | 0.283 | 0.909 | 1.823 |  |  |  |  |  | 
COVID19_MODERNA | Product label confusion | 42 | 21.459 | 7.207 | 9.457 | 11.958 | 1.397 | 1.797 | 2.282 | 1.957 | 26.558 | 484.765
COVID19_MODERNA | Device connection issue | 29 | 9.942 | 5.296 | 7.37 | 9.726 | 1.759 | 2.386 | 3.204 | 2.917 | 42.068 | 414.089
COVID19_MODERNA | Uterine spasm | 3 | 1.217 | 2.031 | 6.817 | 13.886 | 0.615 | 1.256 | 2.357 | 2.464 | 73.982 | 36.681
COVID19_MODERNA | Cerebral mass effect | 3 | 1.528 | 1.806 | 5.94 | 12.014 | 0.577 | 1.177 | 2.199 | 1.963 | 73.982 | 36.681
COVID19_MODERNA | Suppressed lactation | 4 | 1.752 | 1.939 | 5.313 | 10.037 | 0.681 | 1.317 | 2.363 | 2.284 | 98.643 | 58.338
COVID19_MODERNA | Cholecystitis infective | 3 | 1.581 | 1.416 | 4.523 | 9.053 | 0.571 | 1.165 | 2.175 | 1.898 | 24.661 | 22.855
COVID19_MODERNA | Ultrasound foetal | 3 | 2.137 | 1.38 | 4.438 | 8.904 | 0.516 | 1.05 | 1.956 | 1.404 | 18.495 | 18.922
COVID19_MODERNA | Hypophosphataemia | 3 | 1.205 | 1.374 | 4.413 | 8.85 | 0.616 | 1.26 | 2.364 | 2.49 | 18.495 | 18.922
COVID19_MODERNA | Suprapubic pain | 2 | 0.683 | 0.997 | 4.364 | 9.669 | 0.537 | 1.182 | 2.349 | 2.928 | 123.294 | 26.998
COVID19_MODERNA | Product monitoring error | 2 | 0.738 | 0.997 | 4.364 | 9.669 | 0.53 | 1.165 | 2.312 | 2.71 | 123.294 | 26.998
COVID19_MODERNA | Cranial nerve injury | 2 | 1.016 | 0.997 | 4.364 | 9.669 | 0.498 | 1.091 | 2.153 | 1.969 | 123.294 | 26.998
COVID19_MODERNA | Hyperdynamic left ventricle | 2 | 1.02 | 0.997 | 4.364 | 9.669 | 0.497 | 1.09 | 2.15 | 1.961 | 123.294 | 26.998
COVID19_MODERNA | Embolic cerebral infarction | 2 | 1.02 | 0.997 | 4.364 | 9.669 | 0.497 | 1.09 | 2.15 | 1.961 | 123.294 | 26.998
COVID19_MODERNA | Bladder hypertrophy | 2 | 1.034 | 0.997 | 4.364 | 9.669 | 0.496 | 1.087 | 2.143 | 1.935 | 123.294 | 26.998
COVID19_MODERNA | Labia enlarged | 2 | 1.042 | 0.997 | 4.364 | 9.669 | 0.495 | 1.085 | 2.139 | 1.919 | 123.294 | 26.998
COVID19_MODERNA | Coagulation time | 2 | 1.046 | 0.997 | 4.364 | 9.669 | 0.494 | 1.084 | 2.137 | 1.911 | 123.294 | 26.998
COVID19_MODERNA | Serum serotonin | 2 | 1.069 | 0.997 | 4.364 | 9.669 | 0.492 | 1.078 | 2.126 | 1.872 | 123.294 | 26.998
COVID19_MODERNA | Ventilation/perfusion scan | 3 | 1.564 | 1.368 | 4.324 | 8.624 | 0.573 | 1.169 | 2.183 | 1.918 | 24.661 | 22.855
COVID19_MODERNA | Blood pressure systolic abnormal | 3 | 0.892 | 1.367 | 4.321 | 8.617 | 0.66 | 1.357 | 2.578 | 3.363 | 24.661 | 22.855
COVID19_MODERNA | Adult failure to thrive | 2 | 1.532 | 0.96 | 4.261 | 9.479 | 0.447 | 0.979 | 1.925 | 1.305 | 49.321 | 17.026
COVID19_MODERNA | Blood creatine phosphokinase MB decreased | 2 | 1.546 | 0.96 | 4.261 | 9.479 | 0.446 | 0.976 | 1.92 | 1.294 | 49.321 | 17.026
COVID19_MODERNA | Implantable defibrillator insertion | 2 | 1.546 | 0.96 | 4.261 | 9.479 | 0.446 | 0.976 | 1.92 | 1.294 | 49.321 | 17.026
COVID19_MODERNA | Plasminogen activator inhibitor | 2 | 1.554 | 0.96 | 4.261 | 9.479 | 0.445 | 0.975 | 1.917 | 1.287 | 49.321 | 17.026
COVID19_MODERNA | NIH stroke scale score increased | 2 | 1.564 | 0.96 | 4.261 | 9.479 | 0.444 | 0.973 | 1.913 | 1.279 | 49.321 | 17.026
COVID19_MODERNA | Oral blood blister | 2 | 1.581 | 0.96 | 4.261 | 9.479 | 0.443 | 0.97 | 1.907 | 1.265 | 49.321 | 17.026
COVID19_MODERNA | Pulmonary infarction | 5 | 3.651 | 1.743 | 4.195 | 7.507 | 0.6 | 1.107 | 1.906 | 1.37 | 41.101 | 58.548
COVID19_MODERNA | COVID-19 immunisation | 4 | 3.135 | 1.524 | 4.17 | 7.874 | 0.541 | 1.043 | 1.86 | 1.276 | 49.321 | 47.475
COVID19_MODERNA | Product packaging quantity issue | 2 | 1.14 | 0.914 | 4.043 | 8.985 | 0.484 | 1.061 | 2.092 | 1.754 | 4.484 | 2.027
COVID19_MODERNA | CSF monocyte count | 1 | 0.508 | 0.305 | 4.001 | 11.276 | 0.404 | 0.98 | 2.085 | 1.969 | 2.242 | 0.002
COVID19_MODERNA | Spinal compression fracture | 3 | 1.706 | 1.273 | 3.992 | 7.937 | 0.558 | 1.137 | 2.121 | 1.759 | 18.495 | 18.922
COVID19_MODERNA | Injection site pruritus | 881 | 507.779 | 3.681 | 3.894 | 4.112 | 1.635 | 1.729 | 1.826 | 1.735 | 3.363 | 1313.217
COVID19_MODERNA | Vaccination site discharge | 3 | 1.234 | 1.202 | 3.864 | 7.751 | 0.613 | 1.252 | 2.348 | 2.432 | 10.569 | 11.891
COVID19_MODERNA | Product substitution | 3 | 2.058 | 1.154 | 3.817 | 7.737 | 0.523 | 1.065 | 1.984 | 1.458 | 73.982 | 36.681
COVID19_MODERNA | Perfusion brain scan | 2 | 1.03 | 0.889 | 3.793 | 8.341 | 0.496 | 1.088 | 2.146 | 1.942 | 49.321 | 17.026
COVID19_MODERNA | Lack of spontaneous speech | 4 | 2.211 | 1.415 | 3.785 | 7.081 | 0.627 | 1.21 | 2.163 | 1.809 | 32.881 | 39.728
COVID19_MODERNA | Peritonitis bacterial | 2 | 1.02 | 0.876 | 3.706 | 8.13 | 0.497 | 1.09 | 2.15 | 1.961 | 49.321 | 17.026
COVID19_MODERNA | Electrocardiogram PR segment depression | 2 | 1.674 | 0.858 | 3.706 | 8.18 | 0.435 | 0.952 | 1.872 | 1.195 | 24.661 | 12.06
COVID19_MODERNA | Hypercoagulation | 2 | 1.286 | 0.858 | 3.704 | 8.175 | 0.47 | 1.029 | 2.026 | 1.555 | 24.661 | 12.06
COVID19_MODERNA | Catecholamines urine | 2 | 1.069 | 0.875 | 3.694 | 8.101 | 0.492 | 1.078 | 2.126 | 1.872 | 49.321 | 17.026
COVID19_MODERNA | Coagulation factor V level | 2 | 1.129 | 0.85 | 3.652 | 8.047 | 0.486 | 1.064 | 2.097 | 1.772 | 24.661 | 12.06
COVID19_MODERNA | Sedative therapy | 2 | 1.528 | 0.849 | 3.647 | 8.036 | 0.447 | 0.98 | 1.927 | 1.309 | 24.661 | 12.06
COVID19_MODERNA | Diastolic dysfunction | 2 | 2.583 | 0.746 | 3.634 | 8.3 | 0.369 | 0.811 | 1.594 | 0.774 | 4.932 | 2.372
COVID19_MODERNA | Accidental underdose | 6 | 3 | 1.62 | 3.629 | 6.286 | 0.769 | 1.369 | 2.298 | 2 | 3.288 | 6.46
COVID19_MODERNA | Accidental overdose | 11 | 3.711 | 2.078 | 3.617 | 5.503 | 1.216 | 1.939 | 3.008 | 2.964 | 10.433 | 59.218
COVID19_MODERNA | Cholecystitis acute | 3 | 2.093 | 1.11 | 3.617 | 7.29 | 0.52 | 1.059 | 1.971 | 1.433 | 73.982 | 36.681
COVID19_MODERNA | Foetal monitoring | 2 | 1.366 | 0.836 | 3.554 | 7.807 | 0.462 | 1.012 | 1.992 | 1.464 | 24.661 | 12.06
COVID19_MODERNA | Albumin globulin ratio decreased | 2 | 1.056 | 0.853 | 3.551 | 7.752 | 0.493 | 1.081 | 2.132 | 1.894 | 49.321 | 17.026
COVID19_MODERNA | Urinary system x-ray abnormal | 2 | 1.056 | 0.853 | 3.551 | 7.752 | 0.493 | 1.081 | 2.132 | 1.894 | 49.321 | 17.026
COVID19_MODERNA | Pulmonary vascular disorder | 2 | 1.043 | 0.846 | 3.5 | 7.627 | 0.495 | 1.084 | 2.139 | 1.918 | 49.321 | 17.026
COVID19_MODERNA | Blood pressure orthostatic abnormal | 2 | 0.671 | 0.844 | 3.485 | 7.591 | 0.539 | 1.185 | 2.358 | 2.982 | 49.321 | 17.026
COVID19_MODERNA | Hyperbilirubinaemia | 3 | 1.591 | 1.093 | 3.461 | 6.908 | 0.57 | 1.162 | 2.17 | 1.886 | 2.74 | 1.577
COVID19_MODERNA | Wrong technique in device usage process | 3 | 0.927 | 1.13 | 3.438 | 6.761 | 0.655 | 1.345 | 2.549 | 3.236 | 14.796 | 15.982
COVID19_MODERNA | Protein S | 2 | 1.143 | 0.817 | 3.418 | 7.473 | 0.484 | 1.061 | 2.09 | 1.75 | 24.661 | 12.06
COVID19_MODERNA | N-terminal prohormone brain natriuretic peptide | 2 | 1.528 | 0.817 | 3.417 | 7.471 | 0.447 | 0.98 | 1.927 | 1.309 | 24.661 | 12.06
COVID19_MODERNA | Dental discomfort | 2 | 1.042 | 0.833 | 3.414 | 7.418 | 0.495 | 1.085 | 2.139 | 1.919 | 49.321 | 17.026
COVID19_MODERNA | Cerebral artery embolism | 2 | 1.047 | 0.833 | 3.414 | 7.418 | 0.494 | 1.083 | 2.137 | 1.909 | 49.321 | 17.026
COVID19_MODERNA | Bone swelling | 2 | 1.235 | 0.777 | 3.378 | 7.472 | 0.475 | 1.04 | 2.048 | 1.62 | 12.33 | 7.135
COVID19_MODERNA | Coronary artery stenosis | 2 | 2.054 | 0.776 | 3.37 | 7.451 | 0.405 | 0.888 | 1.744 | 0.974 | 12.33 | 7.135
COVID19_MODERNA | Autoimmune demyelinating disease | 1 | 0.534 | 0.189 | 3.329 | 9.828 | 0.401 | 0.974 | 2.07 | 1.872 | 4.11 | 0.197
COVID19_MODERNA | Splenic infarction | 2 | 1.046 | 0.804 | 3.326 | 7.249 | 0.494 | 1.084 | 2.137 | 1.911 | 24.661 | 12.06
COVID19_MODERNA | Vasopressive therapy | 2 | 1.034 | 0.798 | 3.284 | 7.144 | 0.496 | 1.087 | 2.143 | 1.935 | 24.661 | 12.06
COVID19_MODERNA | Blood catecholamines | 2 | 1.217 | 0.797 | 3.273 | 7.118 | 0.477 | 1.044 | 2.056 | 1.643 | 24.661 | 12.06
COVID19_MODERNA | Underdose | 51 | 30.26 | 2.516 | 3.215 | 3.985 | 1.269 | 1.595 | 1.985 | 1.685 | 0.945 | 0.108
COVID19_MODERNA | Histamine level | 2 | 1.069 | 0.796 | 3.152 | 6.779 | 0.492 | 1.078 | 2.126 | 1.872 | 49.321 | 17.026
COVID19_MODERNA | Ultrasound foetal abnormal | 2 | 1.603 | 0.762 | 3.141 | 6.835 | 0.441 | 0.966 | 1.898 | 1.248 | 16.44 | 9.097
COVID19_MODERNA | Atrial enlargement | 2 | 0.528 | 0.778 | 3.136 | 6.78 | 0.558 | 1.233 | 2.473 | 3.785 | 24.661 | 12.06
COVID19_MODERNA | Foetal non-stress test | 2 | 1.603 | 0.761 | 3.13 | 6.808 | 0.441 | 0.966 | 1.898 | 1.248 | 16.44 | 9.097
COVID19_MODERNA | Electrocardiogram ST-T segment abnormal | 2 | 1.548 | 0.777 | 3.129 | 6.765 | 0.445 | 0.976 | 1.919 | 1.292 | 24.661 | 12.06
COVID19_MODERNA | Cardiac assistance device user | 4 | 2.741 | 1.161 | 3.086 | 5.759 | 0.575 | 1.108 | 1.977 | 1.459 | 19.729 | 29.425
COVID19_MODERNA | Infusion | 3 | 1.772 | 0.964 | 3.056 | 6.101 | 0.551 | 1.123 | 2.093 | 1.693 | 36.991 | 28.377
COVID19_MODERNA | Menstruation irregular | 2 | 1.268 | 0.604 | 3.035 | 6.987 | 0.472 | 1.033 | 2.034 | 1.577 | 0.235 | 4.184
COVID19_MODERNA | Thalamic infarction | 3 | 2.059 | 0.959 | 3.031 | 6.043 | 0.523 | 1.065 | 1.983 | 1.457 | 36.991 | 28.377
COVID19_MODERNA | Oesophageal varices haemorrhage | 1 | 0.508 | 0.18 | 3.027 | 8.876 | 0.404 | 0.98 | 2.085 | 1.969 | 3.523 | 0.118
COVID19_MODERNA | Blood urea nitrogen/creatinine ratio increased | 2 | 2.056 | 0.729 | 3.008 | 6.548 | 0.405 | 0.887 | 1.744 | 0.973 | 12.33 | 7.135
COVID19_MODERNA | Time perception altered | 2 | 1.677 | 0.743 | 2.992 | 6.466 | 0.434 | 0.952 | 1.871 | 1.193 | 16.44 | 9.097
COVID19_MODERNA | Palatal oedema | 3 | 0.997 | 1.004 | 2.977 | 5.797 | 0.645 | 1.321 | 2.497 | 3.008 | 10.569 | 11.891
COVID19_MODERNA | Cerebral artery stenosis | 2 | 2.076 | 0.725 | 2.974 | 6.465 | 0.403 | 0.884 | 1.738 | 0.963 | 12.33 | 7.135
COVID19_MODERNA | Product container issue | 1 | 0.152 | 0.242 | 2.951 | 8.215 | 0.445 | 1.092 | 2.366 | 6.594 | 0.425 | 0.289
COVID19_MODERNA | Antithrombin III | 3 | 1.655 | 0.917 | 2.939 | 5.892 | 0.563 | 1.148 | 2.142 | 1.813 | 6.726 | 7.285
COVID19_MODERNA | Electrolyte imbalance | 2 | 1.582 | 0.625 | 2.912 | 6.568 | 0.443 | 0.969 | 1.906 | 1.264 | 1.701 | 0.073
COVID19_MODERNA | Nucleic acid test | 2 | 1.879 | 0.731 | 2.9 | 6.239 | 0.418 | 0.916 | 1.801 | 1.065 | 16.44 | 9.097
COVID19_MODERNA | Intentional product use issue | 2 | 1.838 | 0.716 | 2.895 | 6.265 | 0.421 | 0.923 | 1.814 | 1.088 | 12.33 | 7.135
COVID19_MODERNA | Hip surgery | 2 | 2.061 | 0.668 | 2.893 | 6.388 | 0.404 | 0.887 | 1.742 | 0.971 | 7.046 | 3.919
COVID19_MODERNA | Steroid therapy | 2 | 1.205 | 0.667 | 2.878 | 6.35 | 0.478 | 1.047 | 2.062 | 1.66 | 7.046 | 3.919
COVID19_MODERNA | Vertebral foraminal stenosis | 3 | 2.099 | 0.979 | 2.859 | 5.536 | 0.519 | 1.057 | 1.969 | 1.429 | 10.569 | 11.891
COVID19_MODERNA | Decompressive craniectomy | 2 | 1.046 | 0.74 | 2.854 | 6.085 | 0.494 | 1.084 | 2.137 | 1.911 | 24.661 | 12.06
COVID19_MODERNA | Ultrasound pelvis | 2 | 1.603 | 0.691 | 2.844 | 6.188 | 0.441 | 0.966 | 1.898 | 1.248 | 3.083 | 0.946
COVID19_MODERNA | Ketoacidosis | 2 | 1.034 | 0.607 | 2.837 | 6.404 | 0.496 | 1.087 | 2.143 | 1.935 | 3.794 | 1.492
COVID19_MODERNA | Anticonvulsant drug level decreased | 2 | 1.243 | 0.737 | 2.827 | 6.019 | 0.474 | 1.039 | 2.045 | 1.61 | 24.661 | 12.06
COVID19_MODERNA | Tonsillar erythema | 2 | 0.298 | 0.709 | 2.805 | 6.029 | 0.594 | 1.341 | 2.815 | 6.715 | 3.523 | 1.282
COVID19_MODERNA | Pneumococcal sepsis | 1 | 0.536 | 0.226 | 2.804 | 7.832 | 0.401 | 0.973 | 2.069 | 1.865 | 0.474 | 0.161
COVID19_MODERNA | Acute leukaemia | 2 | 1.021 | 0.73 | 2.776 | 5.894 | 0.497 | 1.09 | 2.15 | 1.959 | 24.661 | 12.06
COVID19_MODERNA | Myoglobin blood increased | 2 | 1.143 | 0.615 | 2.747 | 6.121 | 0.484 | 1.061 | 2.09 | 1.75 | 3.794 | 1.492
COVID19_MODERNA | Dependence on oxygen therapy | 2 | 1.024 | 0.725 | 2.74 | 5.805 | 0.497 | 1.089 | 2.148 | 1.952 | 24.661 | 12.06
COVID19_MODERNA | Embolism venous | 1 | 0.508 | 0.239 | 2.731 | 7.519 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Subdural haematoma | 6 | 4.675 | 1.247 | 2.729 | 4.677 | 0.613 | 1.09 | 1.824 | 1.283 | 4.773 | 11.886
COVID19_MODERNA | C-reactive protein decreased | 2 | 0.526 | 0.659 | 2.727 | 5.943 | 0.558 | 1.234 | 2.475 | 3.799 | 3.083 | 0.946
COVID19_MODERNA | Magnetic resonance imaging heart | 8 | 7.729 | 1.387 | 2.727 | 4.433 | 0.579 | 0.973 | 1.554 | 1.035 | 5.978 | 22.69
COVID19_MODERNA | Blood gases abnormal | 6 | 4.639 | 1.234 | 2.711 | 4.654 | 0.616 | 1.095 | 1.832 | 1.293 | 5.919 | 15.868
COVID19_MODERNA | Bell's palsy | 3 | 2.767 | 0.812 | 2.707 | 5.501 | 0.464 | 0.946 | 1.76 | 1.084 | 24.661 | 22.855
COVID19_MODERNA | Acute respiratory distress syndrome | 8 | 5.409 | 1.383 | 2.689 | 4.346 | 0.728 | 1.223 | 1.955 | 1.479 | 2.779 | 6.609
COVID19_MODERNA | Electrocardiogram ST segment elevation | 21 | 16.159 | 1.808 | 2.687 | 3.709 | 0.859 | 1.215 | 1.679 | 1.3 | 11.77 | 132.632
COVID19_MODERNA | Sinus rhythm | 3 | 3.227 | 0.805 | 2.684 | 5.455 | 0.433 | 0.882 | 1.641 | 0.93 | 14.796 | 15.982
COVID19_MODERNA | Asymptomatic COVID-19 | 4 | 6.369 | 0.96 | 2.684 | 5.112 | 0.364 | 0.704 | 1.256 | 0.628 | 6.576 | 10.702
COVID19_MODERNA | Akathisia (SMQ) [narrow] | 1 | 0.15 | 0.198 | 2.647 | 7.488 | 0.445 | 1.093 | 2.367 | 6.653 | 4.11 | 0.197
COVID19_MODERNA | Akathisia | 1 | 0.15 | 0.198 | 2.647 | 7.488 | 0.445 | 1.093 | 2.367 | 6.653 | 4.11 | 0.197
COVID19_MODERNA | Injection site induration | 275 | 160.652 | 2.39 | 2.646 | 2.912 | 1.532 | 1.693 | 1.866 | 1.712 | 1.601 | 58.445
COVID19_MODERNA | Superficial vein prominence | 2 | 0.717 | 0.697 | 2.622 | 5.547 | 0.533 | 1.171 | 2.326 | 2.791 | 16.44 | 9.097
COVID19_MODERNA | Lung hyperinflation | 2 | 1.319 | 0.655 | 2.617 | 5.644 | 0.467 | 1.022 | 2.012 | 1.517 | 8.22 | 4.713
COVID19_MODERNA | Electrocardiogram ST-T change | 2 | 1.046 | 0.68 | 2.59 | 5.502 | 0.494 | 1.084 | 2.137 | 1.912 | 12.33 | 7.135
COVID19_MODERNA | Vaccination site cellulitis | 5 | 2.159 | 1.125 | 2.582 | 4.523 | 0.756 | 1.398 | 2.424 | 2.316 | 1.028 | 0.029
COVID19_MODERNA | Bundle branch block left | 2 | 1.784 | 0.651 | 2.58 | 5.55 | 0.426 | 0.933 | 1.833 | 1.121 | 8.22 | 4.713
COVID19_MODERNA | Pulmonary granuloma | 2 | 1.173 | 0.692 | 2.576 | 5.431 | 0.481 | 1.054 | 2.076 | 1.705 | 16.44 | 9.097
COVID19_MODERNA | Aneurysm | 2 | 2.072 | 0.636 | 2.574 | 5.571 | 0.404 | 0.885 | 1.739 | 0.965 | 7.046 | 3.919
COVID19_MODERNA | Red blood cells urine | 2 | 1.564 | 0.678 | 2.568 | 5.447 | 0.444 | 0.973 | 1.913 | 1.278 | 12.33 | 7.135
COVID19_MODERNA | Physical examination abnormal | 2 | 2.113 | 0.635 | 2.566 | 5.551 | 0.401 | 0.878 | 1.726 | 0.946 | 7.046 | 3.919
COVID19_MODERNA | Vaccination site irritation | 3 | 1.371 | 0.816 | 2.558 | 5.087 | 0.596 | 1.215 | 2.275 | 2.188 | 3.083 | 2.073
COVID19_MODERNA | Orbital oedema | 2 | 0.743 | 0.676 | 2.553 | 5.408 | 0.53 | 1.164 | 2.309 | 2.692 | 12.33 | 7.135
COVID19_MODERNA | Staphylococcal bacteraemia | 2 | 1.542 | 0.647 | 2.544 | 5.458 | 0.446 | 0.977 | 1.921 | 1.297 | 8.22 | 4.713
COVID19_MODERNA | Acute left ventricular failure | 3 | 2.557 | 0.76 | 2.537 | 5.157 | 0.48 | 0.978 | 1.821 | 1.173 | 12.33 | 13.705
COVID19_MODERNA | Ventricular tachycardia | 10 | 6.734 | 1.402 | 2.518 | 3.898 | 0.783 | 1.26 | 1.943 | 1.485 | 9.485 | 48.633
COVID19_MODERNA | Haemodialysis | 4 | 3.528 | 0.896 | 2.497 | 4.748 | 0.511 | 0.985 | 1.757 | 1.134 | 3.946 | 5.172
COVID19_MODERNA | Injection site rash | 353 | 231.914 | 2.28 | 2.493 | 2.714 | 1.384 | 1.512 | 1.648 | 1.522 | 1.819 | 122.347
COVID19_MODERNA | End stage renal disease | 2 | 2.049 | 0.628 | 2.493 | 5.364 | 0.405 | 0.889 | 1.746 | 0.976 | 7.046 | 3.919
COVID19_MODERNA | Brain stem infarction | 2 | 1.046 | 0.668 | 2.485 | 5.236 | 0.494 | 1.084 | 2.137 | 1.911 | 12.33 | 7.135
COVID19_MODERNA | Cardiac death | 1 | 0.929 | 0.284 | 2.485 | 6.505 | 0.364 | 0.885 | 1.877 | 1.076 | 12.33 | 1.306
COVID19_MODERNA | Prohormone brain natriuretic peptide | 1 | 1.195 | 0.284 | 2.485 | 6.505 | 0.343 | 0.834 | 1.77 | 0.837 | 12.33 | 1.306
COVID19_MODERNA | Abdominal wall haematoma | 1 | 1.528 | 0.284 | 2.485 | 6.505 | 0.319 | 0.778 | 1.654 | 0.654 | 12.33 | 1.306
COVID19_MODERNA | Biliary dilatation | 1 | 1.538 | 0.284 | 2.485 | 6.505 | 0.318 | 0.777 | 1.65 | 0.65 | 12.33 | 1.306
COVID19_MODERNA | Complicated appendicitis | 1 | 1.59 | 0.284 | 2.485 | 6.505 | 0.314 | 0.769 | 1.634 | 0.629 | 12.33 | 1.306
COVID19_MODERNA | Agonal rhythm | 2 | 2.076 | 0.573 | 2.479 | 5.476 | 0.403 | 0.884 | 1.738 | 0.963 | 24.661 | 12.06
COVID19_MODERNA | Injection site warmth | 701 | 454.013 | 2.287 | 2.436 | 2.589 | 1.445 | 1.538 | 1.636 | 1.544 | 1.339 | 59.083
COVID19_MODERNA | Posterior reversible encephalopathy syndrome | 2 | 1.042 | 0.634 | 2.408 | 5.109 | 0.495 | 1.085 | 2.139 | 1.919 | 8.22 | 4.713
COVID19_MODERNA | Haemorrhage urinary tract | 2 | 1.264 | 0.533 | 2.406 | 5.379 | 0.472 | 1.034 | 2.035 | 1.582 | 4.484 | 2.027
COVID19_MODERNA | Cardiac telemetry | 6 | 3.98 | 1.145 | 2.394 | 4.013 | 0.669 | 1.19 | 1.993 | 1.507 | 12.33 | 34.159
COVID19_MODERNA | Hyperaesthesia teeth | 3 | 1.24 | 0.773 | 2.391 | 4.729 | 0.612 | 1.25 | 2.344 | 2.419 | 6.165 | 6.531
COVID19_MODERNA | Capillary fragility | 1 | 0.534 | 0.265 | 2.391 | 6.299 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Magnetic resonance imaging abdominal abnormal | 2 | 1.568 | 0.656 | 2.369 | 4.946 | 0.444 | 0.972 | 1.911 | 1.275 | 12.33 | 7.135
COVID19_MODERNA | Injection site lymphadenopathy | 9 | 4.444 | 1.269 | 2.365 | 3.737 | 0.91 | 1.496 | 2.353 | 2.025 | 27.743 | 96.485
COVID19_MODERNA | Facial bones fracture | 3 | 1.611 | 0.825 | 2.355 | 4.519 | 0.568 | 1.158 | 2.162 | 1.863 | 4.11 | 3.596
COVID19_MODERNA | Pregnancy test urine positive | 1 | 0.852 | 0.242 | 2.355 | 6.297 | 0.371 | 0.901 | 1.911 | 1.173 | 0.343 | 0.662
COVID19_MODERNA | CSF culture positive | 1 | 0.534 | 0.227 | 2.354 | 6.365 | 0.401 | 0.974 | 2.07 | 1.872 | 0.484 | 0.142
COVID19_MODERNA | Granulocyte count decreased | 2 | 1.042 | 0.616 | 2.353 | 5.002 | 0.495 | 1.085 | 2.139 | 1.919 | 7.046 | 3.919
COVID19_MODERNA | Ejection fraction | 3 | 3.535 | 0.728 | 2.347 | 4.714 | 0.414 | 0.844 | 1.57 | 0.849 | 12.33 | 13.705
COVID19_MODERNA | Gene mutation identification test | 2 | 1.164 | 0.644 | 2.344 | 4.906 | 0.482 | 1.056 | 2.081 | 1.719 | 3.523 | 1.282
COVID19_MODERNA | Sickle cell anaemia with crisis | 2 | 1.051 | 0.58 | 2.335 | 5.045 | 0.494 | 1.083 | 2.135 | 1.904 | 4.484 | 2.027
COVID19_MODERNA | Poor quality product administered | 3 | 0.914 | 0.782 | 2.331 | 4.548 | 0.657 | 1.349 | 2.56 | 3.282 | 1.681 | 0.254
COVID19_MODERNA | Viral cardiomyopathy | 2 | 1.046 | 0.665 | 2.329 | 4.815 | 0.494 | 1.084 | 2.137 | 1.911 | 16.44 | 9.097
COVID19_MODERNA | Nuchal rigidity | 3 | 1.599 | 0.753 | 2.322 | 4.59 | 0.569 | 1.161 | 2.167 | 1.876 | 2 | 0.591
COVID19_MODERNA | Haemorrhage in pregnancy | 2 | 1.96 | 0.6 | 2.322 | 4.956 | 0.412 | 0.903 | 1.774 | 1.02 | 6.165 | 3.292
COVID19_MODERNA | Cardiac telemetry normal | 3 | 2.828 | 0.725 | 2.318 | 4.643 | 0.46 | 0.937 | 1.743 | 1.061 | 12.33 | 13.705
COVID19_MODERNA | Ophthalmic herpes simplex | 1 | 0.526 | 0.2 | 2.301 | 6.344 | 0.402 | 0.976 | 2.074 | 1.9 | 1.37 | 0.081
COVID19_MODERNA | Injection site erythema | 1361 | 913.264 | 2.196 | 2.297 | 2.4 | 1.423 | 1.488 | 1.555 | 1.49 | 1.09 | 10.655
COVID19_MODERNA | Vitreous detachment | 2 | 1.797 | 0.58 | 2.257 | 4.825 | 0.425 | 0.931 | 1.829 | 1.113 | 2.901 | 0.811
COVID19_MODERNA | Autoimmune hepatitis | 2 | 1.216 | 0.505 | 2.255 | 5.027 | 0.477 | 1.044 | 2.057 | 1.644 | 1.147 | 0.038
COVID19_MODERNA | Explorative laparotomy | 1 | 0.534 | 0.224 | 2.247 | 6.041 | 0.401 | 0.974 | 2.07 | 1.872 | 1.298 | 0.104
COVID19_MODERNA | Gastric ulcer | 2 | 1.046 | 0.611 | 2.237 | 4.691 | 0.494 | 1.084 | 2.137 | 1.911 | 5.48 | 2.786
COVID19_MODERNA | Biopsy bone marrow | 5 | 4.01 | 1.022 | 2.216 | 3.78 | 0.572 | 1.054 | 1.816 | 1.247 | 3.736 | 6.406
COVID19_MODERNA | Exposure via skin contact | 21 | 11.677 | 1.491 | 2.213 | 3.051 | 1.111 | 1.572 | 2.174 | 1.798 | 1.863 | 6.997
COVID19_MODERNA | Renal tubular necrosis | 1 | 1.546 | 0.271 | 2.206 | 5.69 | 0.317 | 0.776 | 1.648 | 0.647 | 8.22 | 0.79
COVID19_MODERNA | Urinary occult blood positive | 1 | 2.08 | 0.272 | 2.196 | 5.659 | 0.284 | 0.7 | 1.492 | 0.481 | 8.22 | 0.79
COVID19_MODERNA | Paraesthesia ear | 2 | 1.475 | 0.487 | 2.192 | 4.897 | 0.452 | 0.99 | 1.947 | 1.356 | 16.44 | 9.097
COVID19_MODERNA | Aortic aneurysm rupture | 2 | 2.04 | 0.522 | 2.192 | 4.798 | 0.406 | 0.89 | 1.749 | 0.98 | 16.44 | 9.097
COVID19_MODERNA | Human chorionic gonadotropin positive | 1 | 1.069 | 0.195 | 2.188 | 6.002 | 0.353 | 0.858 | 1.819 | 0.936 | 0.771 | 0.037
COVID19_MODERNA | Patient isolation | 2 | 1.174 | 0.546 | 2.181 | 4.702 | 0.481 | 1.054 | 2.076 | 1.703 | 2.349 | 0.423
COVID19_MODERNA | Viral pericarditis | 1 | 1.238 | 0.272 | 2.177 | 5.595 | 0.339 | 0.827 | 1.754 | 0.808 | 8.22 | 0.79
COVID19_MODERNA | Absence of immediate treatment response | 1 | 1.546 | 0.273 | 2.175 | 5.589 | 0.317 | 0.776 | 1.648 | 0.647 | 8.22 | 0.79
COVID19_MODERNA | Hypertrophic cardiomyopathy | 1 | 0.534 | 0.232 | 2.17 | 5.756 | 0.401 | 0.974 | 2.07 | 1.872 | 4.932 | 0.315
COVID19_MODERNA | Mycobacterium tuberculosis complex test negative | 3 | 1.193 | 0.717 | 2.164 | 4.243 | 0.618 | 1.263 | 2.371 | 2.514 | 2.114 | 0.73
COVID19_MODERNA | Atrial flutter | 4 | 4.256 | 0.862 | 2.163 | 3.942 | 0.464 | 0.894 | 1.593 | 0.94 | 6.165 | 9.882
COVID19_MODERNA | Interleukin level | 2 | 0.988 | 0.45 | 2.161 | 4.917 | 0.501 | 1.098 | 2.167 | 2.024 | 1.541 | 0.024
COVID19_MODERNA | Gastrointestinal oedema | 2 | 1.529 | 0.486 | 2.148 | 4.774 | 0.447 | 0.98 | 1.926 | 1.308 | 2.901 | 0.811
COVID19_MODERNA | Blood creatine phosphokinase MB | 5 | 4.702 | 0.885 | 2.145 | 3.849 | 0.524 | 0.966 | 1.664 | 1.063 | 3.978 | 7.115
COVID19_MODERNA | Haemoperitoneum | 1 | 1.582 | 0.274 | 2.143 | 5.483 | 0.315 | 0.77 | 1.636 | 0.632 | 8.22 | 0.79
COVID19_MODERNA | Device leakage | 1 | 0.524 | 0.14 | 2.139 | 6.178 | 0.402 | 0.976 | 2.076 | 1.91 | 0.548 | 0.05
COVID19_MODERNA | Carboxyhaemoglobin decreased | 1 | 0.509 | 0.276 | 2.138 | 5.458 | 0.404 | 0.98 | 2.084 | 1.963 | 8.22 | 0.79
COVID19_MODERNA | Immunisation anxiety related reaction | 1 | 0.832 | 0.274 | 2.135 | 5.459 | 0.373 | 0.905 | 1.92 | 1.202 | 8.22 | 0.79
COVID19_MODERNA | Respirovirus test | 2 | 0.617 | 0.599 | 2.133 | 4.433 | 0.546 | 1.203 | 2.398 | 3.243 | 7.046 | 3.919
COVID19_MODERNA | Brachial plexus injury | 1 | 1.314 | 0.176 | 2.122 | 5.9 | 0.334 | 0.814 | 1.727 | 0.761 | 1.451 | 0.06
COVID19_MODERNA | Vaccination site scar | 1 | 0.532 | 0.187 | 2.121 | 5.833 | 0.401 | 0.974 | 2.071 | 1.879 | 1.298 | 0.104
COVID19_MODERNA | Respiratory syncytial virus test | 2 | 1.244 | 0.586 | 2.119 | 4.426 | 0.474 | 1.038 | 2.044 | 1.608 | 1.541 | 0.024
COVID19_MODERNA | Retinal vein occlusion | 2 | 1.669 | 0.585 | 2.113 | 4.41 | 0.435 | 0.953 | 1.874 | 1.198 | 6.165 | 3.292
COVID19_MODERNA | Salmonella test positive | 1 | 0.513 | 0.163 | 2.112 | 5.938 | 0.403 | 0.979 | 2.082 | 1.949 | 1.121 | 0.182
COVID19_MODERNA | CSF myelin basic protein normal | 1 | 0.508 | 0.295 | 2.106 | 5.282 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Behaviour disorder | 1 | 1.044 | 0.254 | 2.103 | 5.449 | 0.355 | 0.863 | 1.829 | 0.958 | 1.028 | 0.24
COVID19_MODERNA | Carotid arteriosclerosis | 2 | 2.044 | 0.518 | 2.092 | 4.524 | 0.406 | 0.889 | 1.747 | 0.978 | 16.44 | 9.097
COVID19_MODERNA | Manufacturing product shipping issue | 2 | 1.139 | 0.584 | 2.088 | 4.345 | 0.485 | 1.062 | 2.092 | 1.755 | 6.165 | 3.292
COVID19_MODERNA | Lymphocyte count increased | 8 | 4.664 | 1.078 | 2.082 | 3.352 | 0.794 | 1.334 | 2.134 | 1.715 | 0.843 | 0.096
COVID19_MODERNA | Varicella zoster virus infection | 1 | 0.364 | 0.206 | 2.078 | 5.591 | 0.419 | 1.019 | 2.175 | 2.749 | 0.433 | 0.266
COVID19_MODERNA | Anisocytosis | 2 | 1.057 | 0.618 | 2.076 | 4.228 | 0.493 | 1.081 | 2.132 | 1.892 | 9.864 | 5.745
COVID19_MODERNA | Embolism | 1 | 1.538 | 0.278 | 2.075 | 5.258 | 0.318 | 0.777 | 1.65 | 0.65 | 8.22 | 0.79
COVID19_MODERNA | Gallbladder enlargement | 1 | 1.046 | 0.278 | 2.072 | 5.249 | 0.354 | 0.862 | 1.828 | 0.956 | 8.22 | 0.79
COVID19_MODERNA | Peau d'orange | 1 | 0.538 | 0.332 | 2.066 | 5.023 | 0.401 | 0.973 | 2.068 | 1.858 | 2.466 | 0.012
COVID19_MODERNA | Apgar score normal | 1 | 0.57 | 0.152 | 2.061 | 5.843 | 0.397 | 0.965 | 2.05 | 1.755 | 0.126 | 5.136
COVID19_MODERNA | Hypomagnesaemia | 3 | 3.129 | 0.644 | 2.052 | 4.104 | 0.439 | 0.895 | 1.665 | 0.959 | 12.33 | 13.705
COVID19_MODERNA | Metastases to liver | 1 | 1.046 | 0.259 | 2.049 | 5.252 | 0.354 | 0.862 | 1.828 | 0.956 | 6.165 | 0.497
COVID19_MODERNA | Orthostatic hypertension | 1 | 0.508 | 0.261 | 2.028 | 5.182 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Transient global amnesia | 5 | 2.982 | 0.931 | 2.019 | 3.445 | 0.661 | 1.22 | 2.104 | 1.677 | 6.85 | 15.077
COVID19_MODERNA | Hypertensive emergency | 2 | 2.386 | 0.477 | 2.019 | 4.43 | 0.382 | 0.838 | 1.647 | 0.838 | 9.864 | 5.745
COVID19_MODERNA | Product administered to patient of inappropriate age | 104 | 88.018 | 1.704 | 2.018 | 2.353 | 0.994 | 1.168 | 1.366 | 1.182 | 0.44 | 73.674
COVID19_MODERNA | Enteritis | 3 | 2.093 | 0.679 | 2.017 | 3.933 | 0.52 | 1.058 | 1.971 | 1.433 | 1.396 | 0.048
COVID19_MODERNA | Catatonia | 2 | 0.686 | 0.627 | 2.012 | 4.035 | 0.537 | 1.181 | 2.347 | 2.916 | 2.144 | 0.295
COVID19_MODERNA | Atrioventricular block complete | 2 | 1.544 | 0.591 | 2.01 | 4.113 | 0.446 | 0.977 | 1.92 | 1.295 | 7.046 | 3.919
COVID19_MODERNA | Glucose tolerance test abnormal | 1 | 0.683 | 0.262 | 2.004 | 5.103 | 0.386 | 0.938 | 1.991 | 1.464 | 6.165 | 0.497
COVID19_MODERNA | Autoscopy | 3 | 1.861 | 0.675 | 2.002 | 3.899 | 0.542 | 1.104 | 2.058 | 1.612 | 12.33 | 13.705
COVID19_MODERNA | Craniotomy | 2 | 1.58 | 0.591 | 2.001 | 4.089 | 0.443 | 0.97 | 1.907 | 1.266 | 7.046 | 3.919
COVID19_MODERNA | Torsade de pointes/QT prolongation (SMQ) [narrow] | 13 | 10.016 | 1.2 | 1.995 | 2.956 | 0.767 | 1.176 | 1.742 | 1.298 | 5.343 | 34.105
COVID19_MODERNA | Hemianopia | 1 | 1.564 | 0.182 | 1.995 | 5.453 | 0.316 | 0.773 | 1.642 | 0.639 | 3.083 | 0.066
COVID19_MODERNA | Intestinal obstruction | 4 | 3.215 | 0.762 | 1.991 | 3.689 | 0.535 | 1.031 | 1.838 | 1.244 | 1.43 | 0.157
COVID19_MODERNA | Depersonalisation/derealisation disorder | 2 | 1.151 | 0.578 | 1.983 | 4.069 | 0.483 | 1.059 | 2.087 | 1.738 | 6.165 | 3.292
COVID19_MODERNA | Blood premalignant disorders (SMQ) [broad] | 3 | 1.365 | 0.762 | 1.982 | 3.664 | 0.596 | 1.217 | 2.278 | 2.198 | 3.363 | 2.486
COVID19_MODERNA | Blood premalignant disorders (SMQ) [narrow] | 3 | 1.365 | 0.762 | 1.982 | 3.664 | 0.596 | 1.217 | 2.278 | 2.198 | 3.363 | 2.486
COVID19_MODERNA | Vein discolouration | 2 | 1.151 | 0.612 | 1.982 | 3.988 | 0.483 | 1.059 | 2.087 | 1.738 | 9.864 | 5.745
COVID19_MODERNA | Hypertriglyceridaemia | 1 | 0.522 | 0.302 | 1.981 | 4.874 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Drug abuse and dependence (SMQ) [narrow] | 1 | 0.522 | 0.172 | 1.979 | 5.456 | 0.402 | 0.977 | 2.077 | 1.917 | 1.451 | 0.06
COVID19_MODERNA | Injection site swelling | 1000 | 705.614 | 1.877 | 1.978 | 2.082 | 1.342 | 1.414 | 1.489 | 1.417 | 1.047 | 2.102
COVID19_MODERNA | Body fluid analysis | 2 | 1.024 | 0.6 | 1.969 | 3.978 | 0.497 | 1.089 | 2.148 | 1.952 | 8.22 | 4.713
COVID19_MODERNA | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [narrow] | 3 | 1.281 | 0.708 | 1.966 | 3.734 | 0.607 | 1.239 | 2.322 | 2.342 | 4.352 | 3.953
COVID19_MODERNA | Derealisation | 1 | 0.299 | 0.203 | 1.962 | 5.236 | 0.426 | 1.039 | 2.223 | 3.348 | 3.083 | 0.066
COVID19_MODERNA | Sudden cardiac death | 3 | 2.792 | 0.637 | 1.962 | 3.878 | 0.462 | 0.942 | 1.753 | 1.075 | 12.33 | 13.705
COVID19_MODERNA | Troponin T | 3 | 2.382 | 0.654 | 1.961 | 3.836 | 0.494 | 1.007 | 1.874 | 1.259 | 10.569 | 11.891
COVID19_MODERNA | Blast cells present | 2 | 1.046 | 0.588 | 1.956 | 3.97 | 0.494 | 1.084 | 2.137 | 1.911 | 7.046 | 3.919
COVID19_MODERNA | Prothrombin level | 2 | 1.564 | 0.588 | 1.956 | 3.969 | 0.444 | 0.973 | 1.913 | 1.279 | 7.046 | 3.919
COVID19_MODERNA | Transverse sinus thrombosis | 1 | 0.534 | 0.304 | 1.955 | 4.79 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Left ventricular end-diastolic pressure increased | 1 | 0.55 | 0.323 | 1.953 | 4.716 | 0.399 | 0.97 | 2.061 | 1.817 | 24.661 | 2.378
COVID19_MODERNA | Gastrointestinal pathogen panel | 1 | 0.671 | 0.323 | 1.953 | 4.716 | 0.388 | 0.941 | 1.997 | 1.491 | 24.661 | 2.378
COVID19_MODERNA | Galactostasis | 1 | 0.683 | 0.323 | 1.953 | 4.716 | 0.386 | 0.938 | 1.991 | 1.464 | 24.661 | 2.378
COVID19_MODERNA | Herpes simplex reactivation | 1 | 0.683 | 0.323 | 1.953 | 4.716 | 0.386 | 0.938 | 1.991 | 1.464 | 24.661 | 2.378
COVID19_MODERNA | Ultrasound eye | 1 | 1.016 | 0.323 | 1.953 | 4.716 | 0.357 | 0.868 | 1.841 | 0.984 | 24.661 | 2.378
COVID19_MODERNA | Hypertensive encephalopathy | 1 | 1.02 | 0.323 | 1.953 | 4.716 | 0.357 | 0.867 | 1.839 | 0.98 | 24.661 | 2.378
COVID19_MODERNA | Neurologic neglect syndrome | 1 | 1.02 | 0.323 | 1.953 | 4.716 | 0.357 | 0.867 | 1.839 | 0.98 | 24.661 | 2.378
COVID19_MODERNA | Vertebral artery occlusion | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Chronic left ventricular failure | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Patient elopement | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Femoral neck fracture | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Systolic hypertension | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Internal capsule infarction | 1 | 1.024 | 0.323 | 1.953 | 4.716 | 0.356 | 0.866 | 1.837 | 0.976 | 24.661 | 2.378
COVID19_MODERNA | Chillblains | 1 | 1.03 | 0.323 | 1.953 | 4.716 | 0.356 | 0.865 | 1.835 | 0.971 | 24.661 | 2.378
COVID19_MODERNA | Water pollution | 1 | 1.034 | 0.323 | 1.953 | 4.716 | 0.355 | 0.864 | 1.833 | 0.967 | 24.661 | 2.378
COVID19_MODERNA | Retinal artery thrombosis | 1 | 1.034 | 0.323 | 1.953 | 4.716 | 0.355 | 0.864 | 1.833 | 0.967 | 24.661 | 2.378
COVID19_MODERNA | Pelvic haemorrhage | 1 | 1.046 | 0.323 | 1.953 | 4.716 | 0.354 | 0.862 | 1.828 | 0.956 | 24.661 | 2.378
COVID19_MODERNA | Pelvic fluid collection | 1 | 1.046 | 0.323 | 1.953 | 4.716 | 0.354 | 0.862 | 1.828 | 0.956 | 24.661 | 2.378
COVID19_MODERNA | Thrombotic stroke | 1 | 1.046 | 0.323 | 1.953 | 4.716 | 0.354 | 0.862 | 1.828 | 0.956 | 24.661 | 2.378
COVID19_MODERNA | NIH stroke scale | 1 | 1.056 | 0.323 | 1.953 | 4.716 | 0.354 | 0.86 | 1.824 | 0.947 | 24.661 | 2.378
COVID19_MODERNA | Hypertrophy of tongue papillae | 1 | 1.069 | 0.323 | 1.953 | 4.716 | 0.353 | 0.858 | 1.819 | 0.936 | 24.661 | 2.378
COVID19_MODERNA | General physical condition normal | 1 | 1.069 | 0.323 | 1.953 | 4.716 | 0.353 | 0.858 | 1.819 | 0.936 | 24.661 | 2.378
COVID19_MODERNA | Ultrasound scan vagina abnormal | 1 | 1.069 | 0.323 | 1.953 | 4.716 | 0.353 | 0.858 | 1.819 | 0.936 | 24.661 | 2.378
COVID19_MODERNA | Phrenic nerve injury | 1 | 1.069 | 0.323 | 1.953 | 4.716 | 0.353 | 0.858 | 1.819 | 0.936 | 24.661 | 2.378
COVID19_MODERNA | Wound complication | 2 | 0.834 | 0.61 | 1.95 | 3.904 | 0.518 | 1.138 | 2.252 | 2.397 | 9.864 | 5.745
COVID19_MODERNA | Total bile acids | 1 | 0.534 | 0.264 | 1.95 | 4.931 | 0.401 | 0.974 | 2.07 | 1.872 | 4.932 | 0.315
COVID19_MODERNA | Drug reaction with eosinophilia and systemic symptoms | 3 | 1.28 | 0.662 | 1.949 | 3.787 | 0.607 | 1.239 | 2.322 | 2.344 | 6.726 | 7.285
COVID19_MODERNA | Diarrhoea haemorrhagic | 13 | 9.491 | 1.178 | 1.947 | 2.873 | 0.798 | 1.224 | 1.812 | 1.37 | 1.341 | 0.761
COVID19_MODERNA | Adverse event following immunisation | 2 | 1.288 | 0.519 | 1.946 | 4.115 | 0.47 | 1.029 | 2.025 | 1.553 | 2.242 | 0.355
COVID19_MODERNA | Osteitis | 1 | 0.535 | 0.338 | 1.945 | 4.641 | 0.401 | 0.973 | 2.069 | 1.869 | 2.466 | 0.012
COVID19_MODERNA | Carotid artery occlusion | 2 | 1.577 | 0.599 | 1.944 | 3.914 | 0.443 | 0.97 | 1.908 | 1.269 | 8.22 | 4.713
COVID19_MODERNA | Injection site haematoma | 13 | 5.227 | 1.242 | 1.943 | 2.772 | 1.185 | 1.822 | 2.718 | 2.487 | 2.226 | 6.93
COVID19_MODERNA | COVID-19 pneumonia | 34 | 34.36 | 1.428 | 1.941 | 2.517 | 0.739 | 0.975 | 1.268 | 0.99 | 16.124 | 282.277
COVID19_MODERNA | Thrombolysis | 1 | 1.564 | 0.268 | 1.935 | 4.867 | 0.316 | 0.773 | 1.642 | 0.639 | 6.165 | 0.497
COVID19_MODERNA | Pericardial excision | 1 | 0.657 | 0.204 | 1.932 | 5.137 | 0.389 | 0.944 | 2.004 | 1.522 | 3.083 | 0.066
COVID19_MODERNA | Injection site coldness | 2 | 0.423 | 0.576 | 1.927 | 3.921 | 0.573 | 1.275 | 2.587 | 4.73 | 6.165 | 3.292
COVID19_MODERNA | Helicobacter test negative | 2 | 1.046 | 0.609 | 1.926 | 3.842 | 0.494 | 1.084 | 2.137 | 1.911 | 1.265 | 0.006
COVID19_MODERNA | Interleukin level increased | 1 | 0.523 | 0.18 | 1.925 | 5.233 | 0.402 | 0.977 | 2.076 | 1.914 | 1.298 | 0.104
COVID19_MODERNA | Wrong technique in product usage process | 10 | 8.538 | 1.06 | 1.925 | 3 | 0.667 | 1.073 | 1.654 | 1.171 | 0.324 | 13.297
COVID19_MODERNA | Radial nerve injury | 1 | 0.522 | 0.307 | 1.921 | 4.677 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Hormone level abnormal | 1 | 1.516 | 0.168 | 1.921 | 5.286 | 0.319 | 0.78 | 1.657 | 0.66 | 0.632 | 0.002
COVID19_MODERNA | Intraventricular haemorrhage | 1 | 1.037 | 0.21 | 1.917 | 5.064 | 0.355 | 0.864 | 1.832 | 0.964 | 3.523 | 0.118
COVID19_MODERNA | Halo vision | 2 | 0.48 | 0.608 | 1.914 | 3.813 | 0.565 | 1.251 | 2.521 | 4.167 | 9.864 | 5.745
COVID19_MODERNA | Aortic aneurysm | 2 | 2.18 | 0.513 | 1.909 | 4.026 | 0.396 | 0.868 | 1.706 | 0.918 | 4.932 | 2.372
COVID19_MODERNA | Pharyngeal paraesthesia | 34 | 31.814 | 1.415 | 1.904 | 2.454 | 0.792 | 1.045 | 1.359 | 1.069 | 5.989 | 109.61
COVID19_MODERNA | Right ventricular hypertrophy | 1 | 1.542 | 0.289 | 1.902 | 4.684 | 0.318 | 0.776 | 1.649 | 0.649 | 8.22 | 0.79
COVID19_MODERNA | Pregnancy test negative | 4 | 3.558 | 0.739 | 1.897 | 3.49 | 0.509 | 0.981 | 1.749 | 1.124 | 2.013 | 1.037
COVID19_MODERNA | Mastocytosis | 1 | 0.23 | 0.271 | 1.893 | 4.726 | 0.435 | 1.062 | 2.281 | 4.348 | 6.165 | 0.497
COVID19_MODERNA | pH body fluid | 1 | 1.069 | 0.221 | 1.884 | 4.909 | 0.353 | 0.858 | 1.819 | 0.936 | 3.523 | 0.118
COVID19_MODERNA | Skin papilloma | 1 | 0.155 | 0.211 | 1.881 | 4.946 | 0.444 | 1.091 | 2.361 | 6.446 | 0.391 | 0.412
COVID19_MODERNA | Portal hypertension | 1 | 1.578 | 0.272 | 1.881 | 4.684 | 0.315 | 0.771 | 1.638 | 0.634 | 6.165 | 0.497
COVID19_MODERNA | Gout | 6 | 4.029 | 0.904 | 1.88 | 3.143 | 0.665 | 1.183 | 1.98 | 1.489 | 2.508 | 3.617
COVID19_MODERNA | Biopsy stomach | 1 | 0.534 | 0.291 | 1.879 | 4.606 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Sudden death | 23 | 18.256 | 1.297 | 1.879 | 2.55 | 0.854 | 1.19 | 1.625 | 1.26 | 5.507 | 65.591
COVID19_MODERNA | Cardiac tamponade | 2 | 1.746 | 0.458 | 1.878 | 4.082 | 0.429 | 0.939 | 1.846 | 1.145 | 4.484 | 2.027
COVID19_MODERNA | Culture wound positive | 2 | 1.03 | 0.585 | 1.877 | 3.763 | 0.496 | 1.088 | 2.146 | 1.942 | 7.046 | 3.919
COVID19_MODERNA | Vulvovaginal candidiasis | 1 | 0.683 | 0.292 | 1.869 | 4.573 | 0.386 | 0.938 | 1.991 | 1.464 | 8.22 | 0.79
COVID19_MODERNA | Dementia | 9 | 8.334 | 1.028 | 1.868 | 2.911 | 0.614 | 1.007 | 1.579 | 1.08 | 5.284 | 22.209
COVID19_MODERNA | Procalcitonin | 7 | 6.506 | 0.906 | 1.867 | 3.107 | 0.575 | 0.992 | 1.618 | 1.076 | 3.083 | 6.936
COVID19_MODERNA | PO2 decreased | 5 | 2.449 | 0.828 | 1.865 | 3.239 | 0.719 | 1.328 | 2.298 | 2.041 | 2.021 | 1.504
COVID19_MODERNA | Spirometry | 1 | 0.535 | 0.243 | 1.862 | 4.746 | 0.401 | 0.973 | 2.069 | 1.869 | 1.644 | 0.025
COVID19_MODERNA | Syringe issue | 16 | 12.68 | 1.177 | 1.862 | 2.675 | 0.79 | 1.168 | 1.677 | 1.262 | 0.702 | 1.68
COVID19_MODERNA | Sputum increased | 1 | 1.079 | 0.189 | 1.861 | 4.985 | 0.352 | 0.856 | 1.815 | 0.927 | 1.451 | 0.06
COVID19_MODERNA | Protein C | 3 | 2.186 | 0.649 | 1.856 | 3.566 | 0.511 | 1.041 | 1.939 | 1.372 | 7.398 | 8.162
COVID19_MODERNA | Dystonic tremor | 1 | 0.109 | 0.347 | 1.852 | 4.331 | 0.45 | 1.113 | 2.429 | 9.188 | 73.977 | 5.675
COVID19_MODERNA | Coagulation factor XII level | 1 | 0.109 | 0.347 | 1.852 | 4.331 | 0.45 | 1.113 | 2.429 | 9.188 | 73.977 | 5.675
COVID19_MODERNA | Blood pressure systolic normal | 1 | 0.149 | 0.347 | 1.852 | 4.331 | 0.445 | 1.093 | 2.369 | 6.715 | 73.977 | 5.675
COVID19_MODERNA | Infusion site joint movement impairment | 1 | 0.149 | 0.347 | 1.852 | 4.331 | 0.445 | 1.093 | 2.369 | 6.715 | 73.977 | 5.675
COVID19_MODERNA | Barbiturates positive | 1 | 0.149 | 0.347 | 1.852 | 4.331 | 0.445 | 1.093 | 2.369 | 6.715 | 73.977 | 5.675
COVID19_MODERNA | Heat therapy | 1 | 0.149 | 0.347 | 1.852 | 4.331 | 0.445 | 1.093 | 2.369 | 6.715 | 73.977 | 5.675
COVID19_MODERNA | Symptom recurrence | 1 | 0.209 | 0.347 | 1.852 | 4.331 | 0.438 | 1.069 | 2.302 | 4.792 | 73.977 | 5.675
COVID19_MODERNA | Product dispensing issue | 1 | 0.209 | 0.347 | 1.852 | 4.331 | 0.438 | 1.069 | 2.302 | 4.792 | 73.977 | 5.675
COVID19_MODERNA | Femoral nerve injury | 1 | 0.209 | 0.347 | 1.852 | 4.331 | 0.438 | 1.069 | 2.302 | 4.792 | 73.977 | 5.675
COVID19_MODERNA | Hemidysaesthesia | 1 | 0.209 | 0.347 | 1.852 | 4.331 | 0.438 | 1.069 | 2.302 | 4.792 | 73.977 | 5.675
COVID19_MODERNA | Therapeutic response delayed | 1 | 0.23 | 0.347 | 1.852 | 4.331 | 0.435 | 1.062 | 2.281 | 4.348 | 73.977 | 5.675
COVID19_MODERNA | Venous oxygen saturation normal | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Vertebrobasilar stroke | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Discouragement | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Imaging procedure artifact | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Methaemoglobin urine absent | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Microvascular coronary artery disease | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Acute monocytic leukaemia | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Arteriovenous fistula | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Blood urea abnormal | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | C1 esterase inhibitor test | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Allen's test | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Crossmatch | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Blood creatine abnormal | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Venous oxygen partial pressure | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Dermatillomania | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Monocyte percentage abnormal | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Renal artery arteriosclerosis | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Deposit eye | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Withdrawal hypertension | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Foreign body ingestion | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | CSF electrophoresis | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Renal embolism | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Accelerated hypertension | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Pericardial drainage test normal | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Hepatic embolisation | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Endoscopic swallowing evaluation | 1 | 0.508 | 0.347 | 1.852 | 4.331 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Pulmonary hilum mass | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Vascular cauterisation | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Electrocardiogram P wave biphasic | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Blood beta-D-glucan normal | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Bladder injury | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Cardiac pacemaker adjustment | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Bile culture negative | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Intraductal papillary mucinous neoplasm | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Right ventricular systolic pressure | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Bladder cancer stage IV | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Cubital tunnel syndrome | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Vertebroplasty | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Pericardial drainage test | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Malignant ascites | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Vitamin K decreased | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Model for end stage liver disease score | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Hypocapnia | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Bladder catheter replacement | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Piriformis syndrome | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Catheter site haemorrhage | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Agonal death struggle | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Factor II mutation | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Musculoskeletal foreign body | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Retroperitoneal oedema | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | SCORTEN score | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Pacemaker generated rhythm | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Abdominal rebound tenderness | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Abdominal wall mass | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Abdominal wall oedema | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Vitamin K | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Anti factor Xa assay normal | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Anaemia of chronic disease | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Colloid brain cyst | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Continuous glucose monitoring | 1 | 0.512 | 0.347 | 1.852 | 4.331 | 0.403 | 0.979 | 2.082 | 1.952 | 73.977 | 5.675
COVID19_MODERNA | Gastrointestinal disorder prophylaxis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Administration site joint movement impairment | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Computerised tomogram coronary artery | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Carcinoid syndrome | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Cardiac perfusion defect | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Pudendal canal syndrome | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Retroperitoneal effusion | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Hepatic vein thrombosis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Endoscopy gastrointestinal normal | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Abscess intestinal | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Laryngotracheobronchoscopy | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Phaeochromocytoma | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Multisystem inflammatory syndrome in children | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Normetanephrine urine increased | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Blood urea nitrogen/creatinine ratio decreased | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Spinal retrolisthesis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Traumatic haemorrhage | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Laryngeal mask airway insertion | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Terminal ileitis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Accessory muscle | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Oropharyngeal stenosis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Oscillopsia | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Pericardial fibrosis | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Pericardial cyst | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Renal cyst haemorrhage | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Splenic granuloma | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Splenic haemorrhage | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Electrocardiogram ST-T segment elevation | 1 | 0.522 | 0.347 | 1.852 | 4.331 | 0.402 | 0.977 | 2.077 | 1.917 | 73.977 | 5.675
COVID19_MODERNA | Electric shock sensation | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Procedure aborted | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Device dispensing error | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Cardiac ventriculogram left normal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Haemorrhage subepidermal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Amniotic membrane rupture test negative | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Pericoronitis | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Pregnancy-related hepatic disorders (SMQ) [narrow] | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Apolipoprotein | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Abdomen crushing | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Endoscopic retrograde cholangiopancreatography | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Vena cava filter insertion | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Amniotic fluid index decreased | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Blood calcitonin normal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Omental necrosis | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Laryngeal tremor | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Placental calcification | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Fear of eating | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Venous stent insertion | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Oropharyngeal oedema | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Tendon dislocation | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Adrenal adenoma | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Reduction of increased intracranial pressure | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Vascular operation | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Injection | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Foetal heart rate normal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Mast cell degranulation test | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Histamine abnormal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Peritoneal lavage | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Pregnancy-related hepatic disorders (SMQ) [broad] | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Smear vaginal normal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Rebound effect | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Vitamin B6 increased | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Vocal cord thickening | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Skin lesion inflammation | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Cholestasis of pregnancy | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Biopsy small intestine normal | 1 | 0.534 | 0.347 | 1.852 | 4.331 | 0.401 | 0.974 | 2.07 | 1.872 | 73.977 | 5.675
COVID19_MODERNA | Tracheobronchitis | 1 | 0.51 | 0.197 | 1.851 | 4.914 | 0.403 | 0.98 | 2.084 | 1.962 | 3.083 | 0.066
COVID19_MODERNA | Bradykinesia | 3 | 3.903 | 0.57 | 1.85 | 3.726 | 0.393 | 0.802 | 1.493 | 0.769 | 10.569 | 11.891
COVID19_MODERNA | Gynaecological examination | 1 | 0.508 | 0.228 | 1.843 | 4.749 | 0.404 | 0.98 | 2.085 | 1.969 | 2.466 | 0.012
COVID19_MODERNA | Pancreatic duct dilatation | 1 | 0.508 | 0.348 | 1.841 | 4.299 | 0.404 | 0.98 | 2.085 | 1.969 | 73.977 | 5.675
COVID19_MODERNA | Tri-iodothyronine free | 1 | 0.55 | 0.295 | 1.834 | 4.458 | 0.399 | 0.97 | 2.061 | 1.817 | 2.055 | 0
COVID19_MODERNA | Apnoeic attack | 2 | 1.559 | 0.511 | 1.834 | 3.82 | 0.445 | 0.974 | 1.915 | 1.283 | 1.174 | 0.028
COVID19_MODERNA | Slit-lamp tests abnormal | 1 | 0.536 | 0.195 | 1.833 | 4.868 | 0.401 | 0.973 | 2.069 | 1.866 | 2.74 | 0.032
COVID19_MODERNA | Chronic obstructive pulmonary disease | 9 | 9.146 | 0.962 | 1.822 | 2.903 | 0.575 | 0.943 | 1.478 | 0.984 | 1.162 | 0.067
COVID19_MODERNA | Dyspnoea at rest | 1 | 1.034 | 0.315 | 1.819 | 4.341 | 0.355 | 0.864 | 1.833 | 0.967 | 12.33 | 1.306
COVID19_MODERNA | Impaired gastric emptying | 1 | 0.852 | 0.187 | 1.818 | 4.857 | 0.371 | 0.901 | 1.911 | 1.173 | 0.632 | 0.002
COVID19_MODERNA | Haemorrhagic stroke | 9 | 5.816 | 1.02 | 1.816 | 2.799 | 0.777 | 1.277 | 2.003 | 1.547 | 17.073 | 70.897
COVID19_MODERNA | Erectile dysfunction | 3 | 2.767 | 0.601 | 1.814 | 3.556 | 0.464 | 0.946 | 1.76 | 1.084 | 2.387 | 1.084
COVID19_MODERNA | Cerebral artery occlusion | 2 | 2.57 | 0.418 | 1.814 | 4.01 | 0.37 | 0.813 | 1.598 | 0.778 | 9.864 | 5.745
COVID19_MODERNA | Heart valve incompetence | 1 | 0.534 | 0.316 | 1.812 | 4.317 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Haematuria | 12 | 8.746 | 1.081 | 1.811 | 2.694 | 0.782 | 1.216 | 1.823 | 1.372 | 2.426 | 7.857
COVID19_MODERNA | Amyloidosis | 1 | 1.016 | 0.316 | 1.811 | 4.314 | 0.357 | 0.868 | 1.841 | 0.984 | 12.33 | 1.306
COVID19_MODERNA | Ultrasound bladder | 1 | 0.534 | 0.28 | 1.81 | 4.44 | 0.401 | 0.974 | 2.07 | 1.872 | 6.165 | 0.497
COVID19_MODERNA | Cardiac failure congestive | 21 | 23.379 | 1.224 | 1.804 | 2.477 | 0.63 | 0.89 | 1.23 | 0.898 | 6.394 | 71.507
COVID19_MODERNA | Allergy to animal | 1 | 0.672 | 0.226 | 1.802 | 4.629 | 0.387 | 0.94 | 1.996 | 1.487 | 0.948 | 0.198
COVID19_MODERNA | Hyperkalaemia | 2 | 2.638 | 0.407 | 1.801 | 4.003 | 0.366 | 0.804 | 1.58 | 0.758 | 1.761 | 0.097
COVID19_MODERNA | Biopsy oesophagus normal | 1 | 1.069 | 0.317 | 1.799 | 4.276 | 0.353 | 0.858 | 1.819 | 0.936 | 12.33 | 1.306
COVID19_MODERNA | Spinal disorder | 1 | 0.018 | 0.267 | 1.796 | 4.445 | 0.464 | 1.184 | 2.718 | 55.731 | 1.028 | 0.24
COVID19_MODERNA | Mammogram normal | 1 | 0.689 | 0.272 | 1.796 | 4.427 | 0.386 | 0.937 | 1.988 | 1.451 | 4.11 | 0.197
COVID19_MODERNA | Optical coherence tomography | 1 | 2.076 | 0.243 | 1.794 | 4.534 | 0.284 | 0.7 | 1.493 | 0.482 | 4.11 | 0.197
COVID19_MODERNA | Cardioactive drug level | 1 | 0.524 | 0.318 | 1.792 | 4.25 | 0.402 | 0.976 | 2.076 | 1.908 | 12.33 | 1.306
COVID19_MODERNA | Gynaecological examination abnormal | 1 | 1.078 | 0.282 | 1.786 | 4.358 | 0.352 | 0.856 | 1.815 | 0.927 | 6.165 | 0.497
COVID19_MODERNA | Acute abdomen | 1 | 0.522 | 0.282 | 1.785 | 4.356 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Nasal cavity packing | 1 | 1.024 | 0.319 | 1.784 | 4.224 | 0.356 | 0.866 | 1.837 | 0.976 | 12.33 | 1.306
COVID19_MODERNA | Vaccination site lymphadenopathy | 1 | 1.069 | 0.319 | 1.784 | 4.224 | 0.353 | 0.858 | 1.819 | 0.936 | 12.33 | 1.306
COVID19_MODERNA | Cardiac electrophysiologic study | 1 | 0.522 | 0.283 | 1.783 | 4.348 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Drainage | 2 | 2.129 | 0.419 | 1.783 | 3.917 | 0.4 | 0.876 | 1.721 | 0.939 | 7.046 | 3.919
COVID19_MODERNA | Electrocardiogram QRS complex abnormal | 1 | 1.651 | 0.283 | 1.782 | 4.346 | 0.31 | 0.76 | 1.615 | 0.606 | 6.165 | 0.497
COVID19_MODERNA | Epiglottitis | 1 | 1.272 | 0.18 | 1.781 | 4.776 | 0.337 | 0.821 | 1.742 | 0.786 | 2.242 | 0.002
COVID19_MODERNA | Aortic stenosis | 2 | 2.548 | 0.42 | 1.781 | 3.909 | 0.372 | 0.816 | 1.603 | 0.785 | 9.864 | 5.745
COVID19_MODERNA | Blood potassium increased | 11 | 9.057 | 1.037 | 1.78 | 2.686 | 0.701 | 1.108 | 1.682 | 1.215 | 2.009 | 4.234
COVID19_MODERNA | Chronic respiratory failure | 1 | 1.533 | 0.264 | 1.78 | 4.409 | 0.318 | 0.778 | 1.652 | 0.652 | 4.932 | 0.315
COVID19_MODERNA | Biopsy colon abnormal | 1 | 0.522 | 0.22 | 1.777 | 4.581 | 0.402 | 0.977 | 2.077 | 1.917 | 3.083 | 0.066
COVID19_MODERNA | Chronic kidney disease | 4 | 3.289 | 0.712 | 1.777 | 3.231 | 0.529 | 1.019 | 1.818 | 1.216 | 5.48 | 8.477
COVID19_MODERNA | Urine electrolytes normal | 1 | 1.043 | 0.32 | 1.774 | 4.193 | 0.355 | 0.863 | 1.829 | 0.958 | 12.33 | 1.306
COVID19_MODERNA | Anaemia macrocytic | 1 | 1.02 | 0.32 | 1.773 | 4.189 | 0.357 | 0.867 | 1.839 | 0.98 | 12.33 | 1.306
COVID19_MODERNA | Staphylococcal sepsis | 1 | 2.074 | 0.226 | 1.773 | 4.541 | 0.285 | 0.701 | 1.493 | 0.482 | 3.523 | 0.118
COVID19_MODERNA | Peritoneal fluid analysis abnormal | 1 | 0.512 | 0.338 | 1.771 | 4.125 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Dyspnoea paroxysmal nocturnal | 1 | 0.534 | 0.338 | 1.771 | 4.126 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Hypermagnesaemia | 1 | 0.512 | 0.338 | 1.77 | 4.121 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Activated protein C resistance test positive | 1 | 0.534 | 0.338 | 1.77 | 4.123 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Lysozyme | 1 | 0.109 | 0.338 | 1.769 | 4.118 | 0.45 | 1.113 | 2.429 | 9.188 | 24.661 | 2.378
COVID19_MODERNA | Optical coherence tomography normal | 1 | 0.109 | 0.338 | 1.769 | 4.12 | 0.45 | 1.113 | 2.429 | 9.188 | 24.661 | 2.378
COVID19_MODERNA | Dupuytren's contracture | 1 | 0.512 | 0.338 | 1.769 | 4.12 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Hepatorenal syndrome | 1 | 0.512 | 0.338 | 1.769 | 4.118 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Electrocardiogram PR shortened | 1 | 0.522 | 0.338 | 1.769 | 4.121 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Adjusted calcium | 1 | 0.528 | 0.246 | 1.769 | 4.446 | 0.402 | 0.975 | 2.073 | 1.893 | 4.11 | 0.197
COVID19_MODERNA | Blood pH normal | 4 | 2.107 | 0.714 | 1.768 | 3.203 | 0.639 | 1.232 | 2.205 | 1.898 | 1.472 | 0.202
COVID19_MODERNA | Escherichia bacteraemia | 1 | 1.02 | 0.321 | 1.767 | 4.168 | 0.357 | 0.867 | 1.839 | 0.98 | 12.33 | 1.306
COVID19_MODERNA | Exercise test | 1 | 0.508 | 0.338 | 1.766 | 4.11 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Foreign body in throat | 1 | 0.534 | 0.338 | 1.766 | 4.111 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Histamine release test | 1 | 0.534 | 0.338 | 1.766 | 4.11 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Abdominal adhesions | 1 | 0.535 | 0.338 | 1.766 | 4.111 | 0.401 | 0.973 | 2.069 | 1.869 | 24.661 | 2.378
COVID19_MODERNA | Arteritis coronary | 1 | 0.508 | 0.338 | 1.762 | 4.098 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Macrophages increased | 1 | 0.508 | 0.338 | 1.762 | 4.098 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Anosognosia | 1 | 0.512 | 0.338 | 1.762 | 4.098 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Hydrocholecystis | 1 | 0.534 | 0.338 | 1.762 | 4.097 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Viral labyrinthitis | 1 | 0.534 | 0.339 | 1.761 | 4.094 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Drug interaction | 1 | 1.163 | 0.178 | 1.761 | 4.723 | 0.345 | 0.84 | 1.782 | 0.86 | 0.425 | 0.289
COVID19_MODERNA | Angina unstable | 1 | 1.169 | 0.247 | 1.761 | 4.415 | 0.345 | 0.839 | 1.78 | 0.855 | 4.11 | 0.197
COVID19_MODERNA | Thunderclap headache | 1 | 0.671 | 0.339 | 1.76 | 4.089 | 0.388 | 0.941 | 1.997 | 1.491 | 24.661 | 2.378
COVID19_MODERNA | Antidepressant drug level | 1 | 0.149 | 0.339 | 1.759 | 4.087 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Hepatitis A antigen negative | 1 | 0.522 | 0.339 | 1.757 | 4.078 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Ultrasound biliary tract abnormal | 1 | 0.534 | 0.339 | 1.757 | 4.079 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Aortic dissection | 1 | 0.617 | 0.339 | 1.757 | 4.079 | 0.393 | 0.953 | 2.025 | 1.621 | 24.661 | 2.378
COVID19_MODERNA | Belligerence | 1 | 1.024 | 0.322 | 1.757 | 4.137 | 0.356 | 0.866 | 1.837 | 0.976 | 12.33 | 1.306
COVID19_MODERNA | Defect conduction intraventricular | 1 | 0.508 | 0.339 | 1.754 | 4.069 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Intestinal angioedema | 1 | 0.508 | 0.339 | 1.754 | 4.07 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Ureterolithiasis | 1 | 0.534 | 0.339 | 1.754 | 4.071 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Atrioventricular block first degree | 1 | 0.683 | 0.339 | 1.754 | 4.071 | 0.386 | 0.938 | 1.991 | 1.464 | 24.661 | 2.378
COVID19_MODERNA | Aerophagia | 1 | 0.508 | 0.339 | 1.753 | 4.067 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Tachycardia | 285 | 256.488 | 1.586 | 1.753 | 1.926 | 1.004 | 1.107 | 1.219 | 1.111 | 5.183 | 795.315
COVID19_MODERNA | Cytokine release syndrome | 1 | 1.016 | 0.322 | 1.752 | 4.119 | 0.357 | 0.868 | 1.841 | 0.984 | 12.33 | 1.306
COVID19_MODERNA | Splenic rupture | 1 | 0.523 | 0.34 | 1.751 | 4.061 | 0.402 | 0.977 | 2.076 | 1.914 | 24.661 | 2.378
COVID19_MODERNA | Distributive shock | 1 | 0.513 | 0.34 | 1.75 | 4.056 | 0.403 | 0.979 | 2.082 | 1.949 | 24.661 | 2.378
COVID19_MODERNA | Vaccination site reaction | 9 | 6.807 | 0.952 | 1.75 | 2.745 | 0.704 | 1.155 | 1.811 | 1.322 | 0.586 | 2.176
COVID19_MODERNA | Hydrops foetalis | 1 | 0.149 | 0.34 | 1.748 | 4.051 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Ejection fraction abnormal | 1 | 0.512 | 0.34 | 1.748 | 4.051 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Angiogram pulmonary | 1 | 0.534 | 0.34 | 1.748 | 4.051 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Bradycardia foetal | 1 | 0.534 | 0.34 | 1.748 | 4.051 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [narrow] | 4 | 2.189 | 0.618 | 1.747 | 3.342 | 0.63 | 1.215 | 2.172 | 1.827 | 1.265 | 0.03
COVID19_MODERNA | Ventricular arrhythmia | 1 | 1.152 | 0.287 | 1.744 | 4.214 | 0.346 | 0.842 | 1.787 | 0.868 | 6.165 | 0.497
COVID19_MODERNA | Vascular occlusion | 1 | 0.512 | 0.341 | 1.743 | 4.032 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Osteonecrosis of jaw | 1 | 0.534 | 0.341 | 1.743 | 4.032 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Bone fragmentation | 1 | 0.534 | 0.341 | 1.743 | 4.032 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Cyclic vomiting syndrome | 1 | 0.55 | 0.243 | 1.743 | 4.38 | 0.399 | 0.97 | 2.061 | 1.817 | 3.523 | 0.118
COVID19_MODERNA | Pigmentation disorder | 1 | 0.685 | 0.269 | 1.741 | 4.271 | 0.386 | 0.938 | 1.99 | 1.461 | 0.747 | 0.024
COVID19_MODERNA | Withdrawal of life support | 1 | 2.08 | 0.23 | 1.74 | 4.418 | 0.284 | 0.7 | 1.492 | 0.481 | 3.523 | 0.118
COVID19_MODERNA | Visual acuity tests | 1 | 1.59 | 0.269 | 1.739 | 4.263 | 0.314 | 0.769 | 1.634 | 0.629 | 4.932 | 0.315
COVID19_MODERNA | Nasal septum deviation | 1 | 0.149 | 0.341 | 1.738 | 4.016 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Venogram abnormal | 1 | 0.534 | 0.341 | 1.736 | 4.012 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Superior sagittal sinus thrombosis | 1 | 0.534 | 0.341 | 1.736 | 4.012 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Anterograde amnesia | 1 | 0.149 | 0.341 | 1.735 | 4.009 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Oesophageal stenosis | 1 | 0.534 | 0.341 | 1.735 | 4.009 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Contrast media allergy | 1 | 0.534 | 0.342 | 1.735 | 4.008 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Biliary catheter insertion | 1 | 0.512 | 0.342 | 1.731 | 3.993 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Electrocardiogram Q wave abnormal | 1 | 0.522 | 0.342 | 1.731 | 3.993 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Otic examination normal | 1 | 0.657 | 0.342 | 1.731 | 3.993 | 0.389 | 0.944 | 2.004 | 1.522 | 24.661 | 2.378
COVID19_MODERNA | Temperature regulation disorder | 2 | 1.587 | 0.353 | 1.731 | 3.962 | 0.442 | 0.968 | 1.904 | 1.26 | 0.536 | 0.384
COVID19_MODERNA | Paroxysmal sympathetic hyperactivity | 1 | 1.315 | 0.342 | 1.731 | 3.993 | 0.334 | 0.813 | 1.726 | 0.761 | 24.661 | 2.378
COVID19_MODERNA | Basophil percentage decreased | 6 | 3.448 | 0.842 | 1.729 | 2.874 | 0.72 | 1.281 | 2.147 | 1.74 | 1.383 | 0.284
COVID19_MODERNA | Skin maceration | 1 | 0.209 | 0.342 | 1.728 | 3.986 | 0.438 | 1.069 | 2.302 | 4.792 | 24.661 | 2.378
COVID19_MODERNA | Blood insulin | 1 | 0.512 | 0.342 | 1.728 | 3.986 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Visual snow syndrome | 1 | 0.534 | 0.342 | 1.728 | 3.986 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Intervertebral disc operation | 1 | 0.55 | 0.342 | 1.728 | 3.986 | 0.399 | 0.97 | 2.061 | 1.817 | 24.661 | 2.378
COVID19_MODERNA | Peptostreptococcus infection | 1 | 0.512 | 0.342 | 1.727 | 3.983 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Completed suicide | 1 | 1.489 | 0.217 | 1.727 | 4.436 | 0.321 | 0.785 | 1.667 | 0.672 | 1.541 | 0.041
COVID19_MODERNA | Rales | 7 | 6.675 | 0.843 | 1.724 | 2.858 | 0.566 | 0.975 | 1.591 | 1.049 | 2.697 | 5.242
COVID19_MODERNA | Small intestinal resection | 1 | 0.536 | 0.29 | 1.722 | 4.138 | 0.401 | 0.973 | 2.069 | 1.867 | 6.165 | 0.497
COVID19_MODERNA | Leukopenia | 4 | 2.11 | 0.674 | 1.719 | 3.152 | 0.638 | 1.232 | 2.203 | 1.896 | 0.939 | 0.016
COVID19_MODERNA | Prohormone brain natriuretic peptide increased | 1 | 0.522 | 0.326 | 1.719 | 4.01 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Herpes zoster reactivation | 1 | 0.522 | 0.343 | 1.719 | 3.957 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Retinal deposits | 1 | 0.508 | 0.344 | 1.718 | 3.951 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Bladder transitional cell carcinoma | 1 | 0.512 | 0.344 | 1.718 | 3.951 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Aortitis | 1 | 0.657 | 0.344 | 1.718 | 3.951 | 0.389 | 0.944 | 2.004 | 1.522 | 24.661 | 2.378
COVID19_MODERNA | Drug abuse | 1 | 0.522 | 0.327 | 1.717 | 4.002 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Amylase increased | 1 | 0.662 | 0.204 | 1.717 | 4.459 | 0.388 | 0.943 | 2.002 | 1.511 | 1.37 | 0.081
COVID19_MODERNA | Confabulation | 1 | 0.512 | 0.327 | 1.716 | 3.999 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Cauda equina syndrome | 1 | 0.534 | 0.327 | 1.715 | 3.995 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Urinary bladder haemorrhage | 1 | 0.512 | 0.327 | 1.711 | 3.981 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Cerebral microangiopathy | 1 | 0.513 | 0.327 | 1.711 | 3.982 | 0.403 | 0.979 | 2.082 | 1.949 | 12.33 | 1.306
COVID19_MODERNA | Laryngoscopy | 2 | 1.048 | 0.591 | 1.71 | 3.3 | 0.494 | 1.083 | 2.136 | 1.909 | 8.22 | 4.713
COVID19_MODERNA | Catheterisation venous | 1 | 1.02 | 0.328 | 1.709 | 3.974 | 0.357 | 0.867 | 1.839 | 0.98 | 12.33 | 1.306
COVID19_MODERNA | Culture tissue specimen | 1 | 0.508 | 0.328 | 1.708 | 3.973 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Calculus urinary | 1 | 0.643 | 0.328 | 1.707 | 3.968 | 0.39 | 0.947 | 2.011 | 1.555 | 12.33 | 1.306
COVID19_MODERNA | Electrocardiogram ST segment abnormal | 4 | 3.804 | 0.646 | 1.706 | 3.174 | 0.492 | 0.948 | 1.691 | 1.051 | 7.046 | 11.618
COVID19_MODERNA | Biopsy small intestine | 1 | 0.522 | 0.328 | 1.705 | 3.962 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Nasal pruritus | 3 | 2.797 | 0.494 | 1.705 | 3.507 | 0.462 | 0.941 | 1.751 | 1.072 | 2.642 | 1.438
COVID19_MODERNA | Aortic valve calcification | 1 | 0.017 | 0.345 | 1.704 | 3.905 | 0.465 | 1.185 | 2.724 | 58.59 | 24.661 | 2.378
COVID19_MODERNA | Blood grouping | 1 | 0.508 | 0.345 | 1.704 | 3.905 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Prostate cancer metastatic | 1 | 0.512 | 0.345 | 1.704 | 3.905 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Fungal disease carrier | 1 | 0.512 | 0.345 | 1.704 | 3.905 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Creatinine renal clearance normal | 1 | 0.522 | 0.345 | 1.704 | 3.905 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Full blood count decreased | 1 | 0.522 | 0.345 | 1.704 | 3.905 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Panophthalmitis | 1 | 0.534 | 0.345 | 1.704 | 3.905 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Interchange of vaccine products | 12 | 11.198 | 0.991 | 1.704 | 2.574 | 0.653 | 1.015 | 1.521 | 1.072 | 0.54 | 4.151
COVID19_MODERNA | Intraosseous access placement | 1 | 1.03 | 0.328 | 1.704 | 3.959 | 0.356 | 0.865 | 1.835 | 0.971 | 12.33 | 1.306
COVID19_MODERNA | Amphetamines positive | 1 | 0.149 | 0.345 | 1.703 | 3.902 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Cardiac septal hypertrophy | 1 | 0.512 | 0.345 | 1.703 | 3.902 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Atypical mycobacterial infection | 1 | 0.522 | 0.345 | 1.703 | 3.902 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Patient uncooperative | 1 | 0.534 | 0.345 | 1.703 | 3.902 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Pneumothorax | 3 | 2.532 | 0.665 | 1.703 | 3.13 | 0.482 | 0.982 | 1.828 | 1.185 | 1.761 | 0.331
COVID19_MODERNA | Auscultation | 1 | 0.534 | 0.345 | 1.702 | 3.899 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Ovarian necrosis | 1 | 0.534 | 0.346 | 1.699 | 3.889 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Infusion site warmth | 1 | 0.149 | 0.346 | 1.698 | 3.886 | 0.445 | 1.093 | 2.369 | 6.715 | 24.661 | 2.378
COVID19_MODERNA | Arteriovenous fistula operation | 1 | 0.512 | 0.346 | 1.698 | 3.885 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Multipathogen PCR test | 1 | 0.534 | 0.346 | 1.698 | 3.886 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Genital pain | 1 | 0.518 | 0.149 | 1.695 | 4.661 | 0.403 | 0.978 | 2.079 | 1.932 | 1.233 | 0.129
COVID19_MODERNA | Exposure to SARS-CoV-2 | 11 | 39.082 | 0.956 | 1.694 | 2.602 | 0.205 | 0.327 | 0.498 | 0.281 | 2.826 | 10.003
COVID19_MODERNA | Lower respiratory tract congestion | 1 | 0.483 | 0.224 | 1.692 | 4.296 | 0.406 | 0.987 | 2.1 | 2.072 | 1.451 | 0.06
COVID19_MODERNA | Pelvic fracture | 1 | 0.528 | 0.313 | 1.691 | 3.97 | 0.402 | 0.975 | 2.073 | 1.893 | 8.22 | 0.79
COVID19_MODERNA | Spinal cord lipoma | 1 | 0.512 | 0.347 | 1.69 | 3.859 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Mediastinal disorder | 1 | 0.512 | 0.347 | 1.689 | 3.857 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | High risk pregnancy | 1 | 0.684 | 0.295 | 1.689 | 4.024 | 0.386 | 0.938 | 1.991 | 1.462 | 6.165 | 0.497
COVID19_MODERNA | Basophil count decreased | 5 | 4.213 | 0.713 | 1.687 | 2.996 | 0.557 | 1.027 | 1.768 | 1.187 | 0.887 | 0.002
COVID19_MODERNA | Anion gap increased | 4 | 3.407 | 0.662 | 1.686 | 3.091 | 0.52 | 1.002 | 1.787 | 1.174 | 5.48 | 8.477
COVID19_MODERNA | Quarantine | 1 | 1.495 | 0.258 | 1.686 | 4.147 | 0.321 | 0.784 | 1.665 | 0.669 | 4.11 | 0.197
COVID19_MODERNA | Caffeine consumption | 1 | 0.522 | 0.348 | 1.685 | 3.842 | 0.402 | 0.977 | 2.077 | 1.917 | 24.661 | 2.378
COVID19_MODERNA | Morning sickness | 1 | 0.535 | 0.296 | 1.685 | 4.008 | 0.401 | 0.973 | 2.069 | 1.868 | 6.165 | 0.497
COVID19_MODERNA | Amniorrhoea | 1 | 0.534 | 0.331 | 1.684 | 3.892 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Blood creatinine decreased | 2 | 1.043 | 0.46 | 1.683 | 3.528 | 0.495 | 1.084 | 2.139 | 1.917 | 0.725 | 0.02
COVID19_MODERNA | Extubation | 1 | 0.512 | 0.331 | 1.683 | 3.889 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Infectious mononucleosis | 2 | 1.092 | 0.425 | 1.682 | 3.617 | 0.49 | 1.073 | 2.115 | 1.832 | 0.525 | 0.429
COVID19_MODERNA | Pulmonary physical examination | 1 | 0.508 | 0.331 | 1.682 | 3.883 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Gastrointestinal scan | 1 | 0.508 | 0.348 | 1.681 | 3.829 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Ear, nose and throat examination abnormal | 1 | 0.534 | 0.346 | 1.681 | 3.836 | 0.401 | 0.974 | 2.07 | 1.872 | 2.242 | 0.002
COVID19_MODERNA | Anti factor VIII antibody increased | 1 | 0.534 | 0.331 | 1.681 | 3.881 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Ileus | 2 | 1.542 | 0.399 | 1.681 | 3.685 | 0.446 | 0.977 | 1.921 | 1.297 | 2.596 | 0.591
COVID19_MODERNA | Intestinal mass | 1 | 0.508 | 0.314 | 1.68 | 3.933 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | Subdural haematoma evacuation | 1 | 0.512 | 0.348 | 1.68 | 3.827 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Hypercapnia | 1 | 1.056 | 0.314 | 1.68 | 3.933 | 0.354 | 0.86 | 1.824 | 0.947 | 8.22 | 0.79
COVID19_MODERNA | Sensation of foreign body | 50 | 50.301 | 1.315 | 1.678 | 2.078 | 0.781 | 0.984 | 1.226 | 0.994 | 3.829 | 88.039
COVID19_MODERNA | Chronic hepatitis C | 1 | 0.508 | 0.332 | 1.677 | 3.868 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Product colour issue | 1 | 0.296 | 0.245 | 1.676 | 4.165 | 0.427 | 1.04 | 2.225 | 3.377 | 1.541 | 0.041
COVID19_MODERNA | Refusal of treatment by relative | 1 | 0.512 | 0.332 | 1.676 | 3.865 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Blood methaemoglobin | 1 | 1.022 | 0.279 | 1.676 | 4.042 | 0.356 | 0.867 | 1.838 | 0.979 | 4.932 | 0.315
COVID19_MODERNA | Aneurysm ruptured | 1 | 1.03 | 0.332 | 1.676 | 3.864 | 0.356 | 0.865 | 1.835 | 0.971 | 12.33 | 1.306
COVID19_MODERNA | Therapeutic embolisation | 1 | 1.046 | 0.332 | 1.676 | 3.864 | 0.354 | 0.862 | 1.828 | 0.956 | 12.33 | 1.306
COVID19_MODERNA | Lacunar stroke | 1 | 1.065 | 0.332 | 1.676 | 3.864 | 0.353 | 0.858 | 1.821 | 0.939 | 12.33 | 1.306
COVID19_MODERNA | Myocardial strain | 1 | 1.143 | 0.332 | 1.676 | 3.864 | 0.347 | 0.844 | 1.79 | 0.875 | 12.33 | 1.306
COVID19_MODERNA | Hyperuricaemia | 1 | 0.512 | 0.332 | 1.675 | 3.862 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Ketonuria | 1 | 0.534 | 0.24 | 1.675 | 4.179 | 0.401 | 0.974 | 2.07 | 1.872 | 3.523 | 0.118
COVID19_MODERNA | Von Willebrand's factor antigen increased | 1 | 0.534 | 0.349 | 1.675 | 3.811 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Mineral supplementation | 1 | 0.149 | 0.332 | 1.674 | 3.858 | 0.445 | 1.093 | 2.369 | 6.715 | 12.33 | 1.306
COVID19_MODERNA | Injection site movement impairment | 9 | 5.136 | 0.929 | 1.674 | 2.596 | 0.838 | 1.376 | 2.161 | 1.752 | 1.321 | 0.387
COVID19_MODERNA | Refusal of vaccination | 1 | 0.511 | 0.297 | 1.674 | 3.969 | 0.403 | 0.98 | 2.083 | 1.958 | 6.165 | 0.497
COVID19_MODERNA | Ovarian malignant tumours (SMQ) [broad] | 1 | 1.555 | 0.293 | 1.673 | 3.983 | 0.317 | 0.774 | 1.645 | 0.643 | 1.761 | 0.013
COVID19_MODERNA | Radius fracture | 1 | 0.508 | 0.349 | 1.672 | 3.8 | 0.404 | 0.98 | 2.085 | 1.969 | 24.661 | 2.378
COVID19_MODERNA | Embolic cerebellar infarction | 1 | 0.509 | 0.349 | 1.672 | 3.8 | 0.404 | 0.98 | 2.084 | 1.965 | 24.661 | 2.378
COVID19_MODERNA | Pulmonary contusion | 1 | 0.534 | 0.349 | 1.672 | 3.8 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Sweating fever | 1 | 0.534 | 0.349 | 1.672 | 3.8 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Anal hypoaesthesia | 1 | 0.534 | 0.349 | 1.672 | 3.8 | 0.401 | 0.974 | 2.07 | 1.872 | 24.661 | 2.378
COVID19_MODERNA | Biopsy bone marrow abnormal | 6 | 5.994 | 0.798 | 1.672 | 2.805 | 0.529 | 0.94 | 1.573 | 1.001 | 2.845 | 4.833
COVID19_MODERNA | Intestinal infarction | 1 | 0.509 | 0.35 | 1.671 | 3.797 | 0.404 | 0.98 | 2.084 | 1.963 | 24.661 | 2.378
COVID19_MODERNA | Ventricular enlargement | 1 | 0.523 | 0.35 | 1.671 | 3.797 | 0.402 | 0.976 | 2.076 | 1.912 | 24.661 | 2.378
COVID19_MODERNA | Haemolysis | 2 | 1.811 | 0.423 | 1.67 | 3.586 | 0.424 | 0.928 | 1.824 | 1.104 | 1.265 | 0.006
COVID19_MODERNA | Foetal exposure during pregnancy | 2 | 2.911 | 0.341 | 1.67 | 3.82 | 0.35 | 0.77 | 1.514 | 0.687 | 0.093 | 16.75
COVID19_MODERNA | Adjusted calcium increased | 1 | 0.512 | 0.35 | 1.669 | 3.791 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Dyshidrotic eczema | 1 | 0.522 | 0.333 | 1.669 | 3.841 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Psychotherapy | 1 | 0.559 | 0.333 | 1.669 | 3.841 | 0.398 | 0.967 | 2.056 | 1.787 | 12.33 | 1.306
COVID19_MODERNA | Enzyme abnormality | 1 | 0.512 | 0.333 | 1.668 | 3.837 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Amniotic membrane rupture test positive | 1 | 0.534 | 0.333 | 1.668 | 3.839 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Antiacetylcholine receptor antibody positive | 1 | 0.512 | 0.203 | 1.667 | 4.308 | 0.403 | 0.979 | 2.082 | 1.952 | 2.74 | 0.032
COVID19_MODERNA | Joint vibration | 1 | 0.534 | 0.333 | 1.667 | 3.835 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Antiphospholipid syndrome | 1 | 0.519 | 0.15 | 1.666 | 4.565 | 0.403 | 0.978 | 2.079 | 1.928 | 1.644 | 0.025
COVID19_MODERNA | Myocardial necrosis marker | 10 | 6.792 | 0.933 | 1.666 | 2.572 | 0.779 | 1.253 | 1.932 | 1.472 | 9.864 | 50.505
COVID19_MODERNA | Ischaemic stroke | 9 | 11.583 | 0.917 | 1.666 | 2.596 | 0.482 | 0.792 | 1.241 | 0.777 | 5.044 | 20.862
COVID19_MODERNA | Birth mark | 1 | 0.508 | 0.334 | 1.665 | 3.828 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Vaccination site dysaesthesia | 1 | 0.522 | 0.334 | 1.665 | 3.827 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Endoscopy | 3 | 2.72 | 0.537 | 1.665 | 3.297 | 0.468 | 0.953 | 1.773 | 1.103 | 1.298 | 0.012
COVID19_MODERNA | Stress echocardiogram | 1 | 0.534 | 0.299 | 1.664 | 3.937 | 0.401 | 0.974 | 2.07 | 1.872 | 6.165 | 0.497
COVID19_MODERNA | Basal ganglia infarction | 1 | 1.577 | 0.299 | 1.664 | 3.934 | 0.315 | 0.771 | 1.638 | 0.634 | 6.165 | 0.497
COVID19_MODERNA | Abscess neck | 1 | 0.534 | 0.334 | 1.663 | 3.819 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Pyuria | 1 | 1.046 | 0.317 | 1.663 | 3.875 | 0.354 | 0.862 | 1.828 | 0.956 | 8.22 | 0.79
COVID19_MODERNA | Injection site pallor | 2 | 1.046 | 0.49 | 1.662 | 3.397 | 0.494 | 1.084 | 2.137 | 1.912 | 3.288 | 1.102
COVID19_MODERNA | Blood parathyroid hormone increased | 1 | 0.671 | 0.317 | 1.662 | 3.872 | 0.388 | 0.941 | 1.997 | 1.491 | 8.22 | 0.79
COVID19_MODERNA | Behcet's syndrome | 1 | 0.508 | 0.241 | 1.661 | 4.136 | 0.404 | 0.98 | 2.085 | 1.969 | 2.466 | 0.012
COVID19_MODERNA | Impaired self-care | 1 | 0.512 | 0.351 | 1.661 | 3.765 | 0.403 | 0.979 | 2.082 | 1.952 | 24.661 | 2.378
COVID19_MODERNA | Mixed anxiety and depressive disorder | 1 | 0.719 | 0.334 | 1.661 | 3.814 | 0.383 | 0.93 | 1.973 | 1.391 | 12.33 | 1.306
COVID19_MODERNA | Diverticulum | 1 | 2.04 | 0.223 | 1.661 | 4.206 | 0.287 | 0.705 | 1.502 | 0.49 | 3.083 | 0.066
COVID19_MODERNA | Repetitive speech | 3 | 1.763 | 0.653 | 1.66 | 3.041 | 0.552 | 1.124 | 2.097 | 1.702 | 7.398 | 8.162
COVID19_MODERNA | Paraesthesia oral | 238 | 223.729 | 1.488 | 1.66 | 1.84 | 0.953 | 1.06 | 1.177 | 1.064 | 5.569 | 726.617
COVID19_MODERNA | Needle issue | 10 | 5.597 | 0.943 | 1.659 | 2.538 | 0.88 | 1.416 | 2.187 | 1.787 | 1.522 | 1.215
COVID19_MODERNA | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [broad] | 5 | 3.21 | 0.677 | 1.659 | 2.992 | 0.639 | 1.178 | 2.031 | 1.557 | 1.451 | 0.292
COVID19_MODERNA | Retroperitoneal lymphadenopathy | 1 | 0.523 | 0.335 | 1.659 | 3.805 | 0.402 | 0.977 | 2.076 | 1.914 | 12.33 | 1.306
COVID19_MODERNA | Ear, nose and throat examination normal | 1 | 1.058 | 0.238 | 1.656 | 4.129 | 0.353 | 0.86 | 1.823 | 0.945 | 0.822 | 0.073
COVID19_MODERNA | Implantable cardiac monitor insertion | 1 | 1.066 | 0.3 | 1.656 | 3.909 | 0.353 | 0.858 | 1.82 | 0.938 | 6.165 | 0.497
COVID19_MODERNA | Stress echocardiogram normal | 1 | 1.069 | 0.318 | 1.656 | 3.849 | 0.353 | 0.858 | 1.819 | 0.936 | 8.22 | 0.79
COVID19_MODERNA | Obstructive airways disorder | 12 | 7.205 | 0.992 | 1.655 | 2.455 | 0.894 | 1.39 | 2.085 | 1.666 | 5.284 | 30.761
COVID19_MODERNA | Chest injury | 1 | 1.532 | 0.282 | 1.655 | 3.967 | 0.318 | 0.778 | 1.652 | 0.653 | 4.932 | 0.315
COVID19_MODERNA | Bronchoalveolar lavage normal | 1 | 0.522 | 0.318 | 1.654 | 3.843 | 0.402 | 0.977 | 2.077 | 1.917 | 8.22 | 0.79
COVID19_MODERNA | Scan bone marrow normal | 1 | 0.522 | 0.336 | 1.653 | 3.786 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Tryptase increased | 1 | 0.211 | 0.222 | 1.652 | 4.184 | 0.437 | 1.069 | 2.3 | 4.748 | 2.74 | 0.032
COVID19_MODERNA | Sputum normal | 1 | 0.512 | 0.336 | 1.652 | 3.783 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Axillary vein thrombosis | 1 | 0.512 | 0.336 | 1.651 | 3.78 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Varices oesophageal | 1 | 0.522 | 0.336 | 1.651 | 3.779 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Haemangioma of skin | 1 | 0.522 | 0.336 | 1.649 | 3.772 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | White blood cell morphology abnormal | 1 | 0.534 | 0.336 | 1.649 | 3.774 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Vitamin B12 deficiency | 1 | 1.247 | 0.156 | 1.649 | 4.48 | 0.339 | 0.825 | 1.751 | 0.802 | 0.881 | 0.126
COVID19_MODERNA | Food craving | 1 | 0.56 | 0.283 | 1.648 | 3.943 | 0.398 | 0.967 | 2.055 | 1.785 | 4.932 | 0.315
COVID19_MODERNA | Tracheal inflammation | 1 | 0.209 | 0.319 | 1.647 | 3.82 | 0.438 | 1.069 | 2.302 | 4.792 | 8.22 | 0.79
COVID19_MODERNA | Acute psychosis | 1 | 0.534 | 0.32 | 1.646 | 3.815 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Breast discomfort | 1 | 0.534 | 0.302 | 1.645 | 3.868 | 0.401 | 0.974 | 2.07 | 1.872 | 6.165 | 0.497
COVID19_MODERNA | Myelodysplastic syndrome | 1 | 0.21 | 0.284 | 1.642 | 3.918 | 0.437 | 1.069 | 2.301 | 4.772 | 4.932 | 0.315
COVID19_MODERNA | Psychomotor skills impaired | 1 | 0.513 | 0.25 | 1.642 | 4.043 | 0.403 | 0.979 | 2.082 | 1.949 | 0.474 | 0.161
COVID19_MODERNA | Tonsillar haemorrhage | 1 | 0.534 | 0.337 | 1.641 | 3.747 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Haematoma evacuation | 1 | 0.508 | 0.338 | 1.639 | 3.739 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Vitamin D deficiency | 2 | 1.229 | 0.392 | 1.639 | 3.581 | 0.475 | 1.042 | 2.051 | 1.627 | 0.771 | 0.002
COVID19_MODERNA | Flushing | 316 | 301.102 | 1.491 | 1.638 | 1.791 | 0.954 | 1.047 | 1.147 | 1.049 | 4.027 | 619.537
COVID19_MODERNA | COVID-19 | 161 | 323.242 | 1.432 | 1.638 | 1.856 | 0.441 | 0.502 | 0.57 | 0.498 | 5.097 | 437.044
COVID19_MODERNA | Delirium febrile | 1 | 0.508 | 0.227 | 1.637 | 4.116 | 0.404 | 0.98 | 2.085 | 1.969 | 3.083 | 0.066
COVID19_MODERNA | Gonorrhoea | 1 | 0.531 | 0.338 | 1.637 | 3.732 | 0.401 | 0.974 | 2.071 | 1.882 | 12.33 | 1.306
COVID19_MODERNA | Complement factor C4 | 4 | 3.149 | 0.654 | 1.637 | 2.978 | 0.54 | 1.041 | 1.856 | 1.27 | 1.203 | 0.007
COVID19_MODERNA | SARS-CoV-2 test positive | 182 | 474.156 | 1.443 | 1.637 | 1.842 | 0.343 | 0.387 | 0.436 | 0.384 | 3.81 | 325.495
COVID19_MODERNA | Agnosia | 1 | 0.522 | 0.321 | 1.636 | 3.781 | 0.402 | 0.977 | 2.077 | 1.917 | 8.22 | 0.79
COVID19_MODERNA | Arterial stenosis | 1 | 0.508 | 0.338 | 1.635 | 3.726 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Breakthrough pain | 1 | 0.671 | 0.339 | 1.633 | 3.718 | 0.388 | 0.941 | 1.997 | 1.491 | 12.33 | 1.306
COVID19_MODERNA | Vaccination site joint movement impairment | 1 | 0.187 | 0.228 | 1.632 | 4.096 | 0.44 | 1.077 | 2.324 | 5.34 | 3.083 | 0.066
COVID19_MODERNA | Renal cyst | 3 | 1.546 | 0.662 | 1.632 | 2.951 | 0.575 | 1.173 | 2.191 | 1.94 | 5.284 | 5.303
COVID19_MODERNA | Cardio-respiratory arrest | 29 | 30.059 | 1.176 | 1.631 | 2.148 | 0.705 | 0.951 | 1.26 | 0.965 | 5.767 | 88.685
COVID19_MODERNA | Occult blood | 4 | 1.73 | 0.682 | 1.63 | 2.908 | 0.684 | 1.322 | 2.374 | 2.312 | 3.182 | 3.481
COVID19_MODERNA | Parkinson's disease | 3 | 2.05 | 0.628 | 1.63 | 3.012 | 0.524 | 1.067 | 1.987 | 1.464 | 2.551 | 1.31
COVID19_MODERNA | Cognitive linguistic deficit | 1 | 0.534 | 0.34 | 1.626 | 3.695 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Liver abscess | 1 | 0.522 | 0.305 | 1.625 | 3.798 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Pancreatic enzymes normal | 1 | 0.534 | 0.34 | 1.625 | 3.692 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Hemiparaesthesia | 1 | 0.658 | 0.288 | 1.622 | 3.847 | 0.389 | 0.944 | 2.004 | 1.52 | 4.932 | 0.315
COVID19_MODERNA | Eye irrigation | 1 | 0.644 | 0.268 | 1.618 | 3.906 | 0.39 | 0.947 | 2.011 | 1.553 | 0.56 | 0.038
COVID19_MODERNA | Critical illness | 1 | 1.862 | 0.27 | 1.618 | 3.898 | 0.297 | 0.729 | 1.552 | 0.537 | 4.11 | 0.197
COVID19_MODERNA | Ventricular drainage | 1 | 2.094 | 0.251 | 1.618 | 3.966 | 0.283 | 0.698 | 1.488 | 0.477 | 3.523 | 0.118
COVID19_MODERNA | Portal vein thrombosis | 1 | 0.512 | 0.325 | 1.616 | 3.711 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Spinal deformity | 1 | 0.522 | 0.307 | 1.616 | 3.767 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Neck injury | 1 | 2.093 | 0.21 | 1.616 | 4.118 | 0.284 | 0.698 | 1.488 | 0.478 | 2.74 | 0.032
COVID19_MODERNA | Blood pressure inadequately controlled | 1 | 0.508 | 0.307 | 1.615 | 3.766 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Reversible cerebral vasoconstriction syndrome | 1 | 0.522 | 0.325 | 1.615 | 3.709 | 0.402 | 0.977 | 2.077 | 1.917 | 8.22 | 0.79
COVID19_MODERNA | Skin lesion | 16 | 14.244 | 1.039 | 1.615 | 2.294 | 0.721 | 1.066 | 1.53 | 1.123 | 0.411 | 12.724
COVID19_MODERNA | T-lymphocyte count increased | 1 | 0.514 | 0.204 | 1.614 | 4.141 | 0.403 | 0.979 | 2.081 | 1.944 | 2.466 | 0.012
COVID19_MODERNA | Anosmia | 34 | 64.517 | 1.194 | 1.614 | 2.086 | 0.412 | 0.543 | 0.707 | 0.527 | 4.46 | 74.313
COVID19_MODERNA | Postoperative wound infection | 1 | 0.512 | 0.342 | 1.613 | 3.65 | 0.403 | 0.979 | 2.082 | 1.952 | 12.33 | 1.306
COVID19_MODERNA | Myeloid leukaemia | 1 | 0.508 | 0.271 | 1.612 | 3.875 | 0.404 | 0.98 | 2.085 | 1.969 | 4.11 | 0.197
COVID19_MODERNA | Metastases to bone | 1 | 0.512 | 0.271 | 1.612 | 3.877 | 0.403 | 0.979 | 2.082 | 1.952 | 4.11 | 0.197
COVID19_MODERNA | Robust take following exposure to vaccinia virus | 1 | 0.726 | 0.106 | 1.612 | 4.652 | 0.382 | 0.928 | 1.97 | 1.378 | 2.055 | 0
COVID19_MODERNA | Vasogenic cerebral oedema | 1 | 1.042 | 0.342 | 1.612 | 3.648 | 0.355 | 0.863 | 1.83 | 0.96 | 12.33 | 1.306
COVID19_MODERNA | Coronary artery disease | 4 | 4.982 | 0.619 | 1.611 | 2.978 | 0.424 | 0.818 | 1.458 | 0.803 | 3.653 | 4.525
COVID19_MODERNA | Anaphylactoid reaction | 5 | 3.819 | 0.753 | 1.609 | 2.727 | 0.586 | 1.081 | 1.863 | 1.309 | 3.523 | 5.775
COVID19_MODERNA | Oral mucosal blistering | 10 | 6.127 | 0.928 | 1.606 | 2.435 | 0.832 | 1.339 | 2.066 | 1.632 | 1.8 | 2.585
COVID19_MODERNA | Oesophagitis | 1 | 0.537 | 0.228 | 1.606 | 4.016 | 0.401 | 0.973 | 2.069 | 1.864 | 2.74 | 0.032
COVID19_MODERNA | Renal function test abnormal | 3 | 1.587 | 0.631 | 1.605 | 2.94 | 0.571 | 1.163 | 2.172 | 1.891 | 3.523 | 2.724
COVID19_MODERNA | Brain natriuretic peptide increased | 17 | 21.743 | 1.037 | 1.605 | 2.273 | 0.54 | 0.79 | 1.124 | 0.782 | 6.654 | 59.787
COVID19_MODERNA | Cerebellar atrophy | 1 | 0.531 | 0.343 | 1.604 | 3.621 | 0.401 | 0.975 | 2.072 | 1.885 | 12.33 | 1.306
COVID19_MODERNA | Quadrantanopia | 1 | 0.534 | 0.327 | 1.604 | 3.673 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Urinary casts absent | 1 | 0.534 | 0.343 | 1.604 | 3.62 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Gastrointestinal haemorrhage | 11 | 10.534 | 0.922 | 1.603 | 2.438 | 0.628 | 0.992 | 1.507 | 1.044 | 5.319 | 28.148
COVID19_MODERNA | Culture stool negative | 5 | 3.232 | 0.717 | 1.602 | 2.773 | 0.637 | 1.175 | 2.025 | 1.547 | 0.833 | 0.037
COVID19_MODERNA | Device dependence | 1 | 0.529 | 0.344 | 1.601 | 3.612 | 0.401 | 0.975 | 2.073 | 1.889 | 12.33 | 1.306
COVID19_MODERNA | Fibrosis | 1 | 0.717 | 0.327 | 1.601 | 3.661 | 0.383 | 0.93 | 1.974 | 1.395 | 8.22 | 0.79
COVID19_MODERNA | Drug eruption | 2 | 1.219 | 0.452 | 1.599 | 3.316 | 0.476 | 1.044 | 2.055 | 1.641 | 1.298 | 0.002
COVID19_MODERNA | Haemodynamic test normal | 1 | 0.523 | 0.328 | 1.597 | 3.648 | 0.402 | 0.977 | 2.076 | 1.914 | 8.22 | 0.79
COVID19_MODERNA | Aura | 7 | 3.661 | 0.842 | 1.595 | 2.542 | 0.8 | 1.381 | 2.261 | 1.912 | 8.22 | 27.901
COVID19_MODERNA | Albumin CSF normal | 1 | 0.508 | 0.328 | 1.595 | 3.641 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | X-ray of pelvis and hip abnormal | 2 | 1.082 | 0.578 | 1.594 | 3.017 | 0.491 | 1.075 | 2.119 | 1.848 | 3.083 | 0.946
COVID19_MODERNA | Intermenstrual bleeding | 4 | 2.883 | 0.613 | 1.594 | 2.947 | 0.562 | 1.083 | 1.933 | 1.387 | 4.932 | 7.319
COVID19_MODERNA | Troponin I normal | 5 | 3.95 | 0.695 | 1.594 | 2.791 | 0.576 | 1.063 | 1.83 | 1.266 | 4.567 | 8.83
COVID19_MODERNA | Blood immunoglobulin E normal | 1 | 0.358 | 0.311 | 1.592 | 3.687 | 0.42 | 1.021 | 2.18 | 2.797 | 0.796 | 0.053
COVID19_MODERNA | Neutrophil percentage increased | 16 | 11.852 | 1.021 | 1.592 | 2.268 | 0.833 | 1.231 | 1.767 | 1.35 | 1.547 | 2.405
COVID19_MODERNA | Bilevel positive airway pressure | 11 | 13.309 | 0.91 | 1.592 | 2.429 | 0.525 | 0.829 | 1.259 | 0.826 | 5.425 | 28.886
COVID19_MODERNA | CSF polymorphonuclear cell count increased | 1 | 0.523 | 0.346 | 1.591 | 3.576 | 0.402 | 0.976 | 2.076 | 1.912 | 12.33 | 1.306
COVID19_MODERNA | Cardiac function test | 3 | 1.571 | 0.632 | 1.589 | 2.898 | 0.572 | 1.167 | 2.179 | 1.91 | 2.114 | 0.73
COVID19_MODERNA | Injection site urticaria | 105 | 66.125 | 1.347 | 1.589 | 1.848 | 1.319 | 1.549 | 1.81 | 1.588 | 1.756 | 31.287
COVID19_MODERNA | Corrective lens user | 1 | 0.683 | 0.315 | 1.589 | 3.664 | 0.386 | 0.938 | 1.991 | 1.464 | 1.072 | 0.211
COVID19_MODERNA | Atrioventricular block second degree | 1 | 1.02 | 0.276 | 1.589 | 3.792 | 0.357 | 0.867 | 1.839 | 0.98 | 4.11 | 0.197
COVID19_MODERNA | Crystal urine absent | 1 | 1.069 | 0.329 | 1.589 | 3.618 | 0.353 | 0.858 | 1.819 | 0.936 | 8.22 | 0.79
COVID19_MODERNA | Hyperammonaemia | 1 | 0.522 | 0.312 | 1.588 | 3.671 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Genital blister | 1 | 0.55 | 0.33 | 1.587 | 3.612 | 0.399 | 0.97 | 2.061 | 1.817 | 8.22 | 0.79
COVID19_MODERNA | Genital lesion | 1 | 0.657 | 0.295 | 1.586 | 3.719 | 0.389 | 0.944 | 2.004 | 1.522 | 4.932 | 0.315
COVID19_MODERNA | Transient ischaemic attack | 19 | 19.932 | 1.059 | 1.585 | 2.198 | 0.651 | 0.936 | 1.311 | 0.953 | 4.781 | 44.366
COVID19_MODERNA | Injection site oedema | 19 | 12.868 | 1.057 | 1.584 | 2.197 | 0.93 | 1.337 | 1.873 | 1.477 | 0.524 | 7.611
COVID19_MODERNA | Hepatobiliary scan abnormal | 1 | 0.536 | 0.33 | 1.584 | 3.603 | 0.401 | 0.973 | 2.069 | 1.864 | 8.22 | 0.79
COVID19_MODERNA | Injection site abscess | 6 | 3.061 | 0.776 | 1.583 | 2.622 | 0.762 | 1.356 | 2.276 | 1.96 | 0.571 | 1.477
COVID19_MODERNA | Acute kidney injury | 39 | 33.634 | 1.196 | 1.583 | 2.014 | 0.87 | 1.128 | 1.444 | 1.16 | 5.256 | 107.229
COVID19_MODERNA | Acute myocardial infarction | 25 | 31.697 | 1.109 | 1.583 | 2.127 | 0.576 | 0.794 | 1.072 | 0.789 | 9.944 | 136.799
COVID19_MODERNA | Paranasal cyst | 1 | 0.149 | 0.331 | 1.581 | 3.591 | 0.445 | 1.093 | 2.369 | 6.715 | 8.22 | 0.79
COVID19_MODERNA | Blood osmolarity increased | 1 | 0.643 | 0.331 | 1.581 | 3.591 | 0.39 | 0.947 | 2.011 | 1.555 | 8.22 | 0.79
COVID19_MODERNA | Suicidal ideation | 2 | 1.637 | 0.467 | 1.581 | 3.228 | 0.438 | 0.959 | 1.885 | 1.221 | 0.525 | 0.429
COVID19_MODERNA | Thirst decreased | 1 | 1.058 | 0.243 | 1.578 | 3.875 | 0.353 | 0.86 | 1.823 | 0.945 | 1.451 | 0.06
COVID19_MODERNA | Genital burning sensation | 1 | 0.508 | 0.348 | 1.577 | 3.528 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Gallbladder operation | 1 | 1.056 | 0.332 | 1.577 | 3.577 | 0.354 | 0.86 | 1.824 | 0.947 | 8.22 | 0.79
COVID19_MODERNA | Biopsy kidney abnormal | 1 | 0.534 | 0.193 | 1.576 | 4.068 | 0.401 | 0.974 | 2.07 | 1.872 | 0.474 | 0.161
COVID19_MODERNA | Mean cell haemoglobin increased | 4 | 3.034 | 0.606 | 1.576 | 2.915 | 0.549 | 1.059 | 1.888 | 1.318 | 2.406 | 1.81
COVID19_MODERNA | Antiphospholipid antibodies | 5 | 2.225 | 0.718 | 1.575 | 2.702 | 0.747 | 1.381 | 2.394 | 2.248 | 8.807 | 19.864
COVID19_MODERNA | Cardiac imaging procedure abnormal | 1 | 1.03 | 0.332 | 1.575 | 3.569 | 0.356 | 0.865 | 1.835 | 0.971 | 8.22 | 0.79
COVID19_MODERNA | Cystoscopy abnormal | 1 | 0.512 | 0.332 | 1.574 | 3.566 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Congenital and neonatal arrhythmias (SMQ) [broad] | 1 | 1.021 | 0.175 | 1.572 | 4.138 | 0.356 | 0.867 | 1.839 | 0.98 | 1.174 | 0.155
COVID19_MODERNA | Diverticulum intestinal | 1 | 1.532 | 0.298 | 1.572 | 3.667 | 0.318 | 0.778 | 1.652 | 0.653 | 4.932 | 0.315
COVID19_MODERNA | Eosinophil percentage decreased | 6 | 3.777 | 0.735 | 1.571 | 2.66 | 0.688 | 1.223 | 2.049 | 1.589 | 1.437 | 0.384
COVID19_MODERNA | Generalised oedema | 3 | 1.71 | 0.615 | 1.57 | 2.881 | 0.557 | 1.136 | 2.119 | 1.755 | 2.055 | 0.658
COVID19_MODERNA | Hepatitis C test negative | 3 | 3.007 | 0.502 | 1.57 | 3.118 | 0.447 | 0.911 | 1.696 | 0.998 | 0.597 | 0.442
COVID19_MODERNA | Body temperature abnormal | 8 | 5.534 | 0.813 | 1.569 | 2.527 | 0.718 | 1.206 | 1.928 | 1.445 | 5.192 | 18.911
COVID19_MODERNA | Lung infiltration | 21 | 21.824 | 1.065 | 1.569 | 2.153 | 0.668 | 0.945 | 1.305 | 0.962 | 6.093 | 67.517
COVID19_MODERNA | Prothrombin level increased | 1 | 0.534 | 0.35 | 1.568 | 3.498 | 0.401 | 0.974 | 2.07 | 1.872 | 12.33 | 1.306
COVID19_MODERNA | Labour complication | 1 | 0.683 | 0.333 | 1.567 | 3.545 | 0.386 | 0.938 | 1.991 | 1.464 | 8.22 | 0.79
COVID19_MODERNA | Vaccination site discolouration | 2 | 2.039 | 0.41 | 1.567 | 3.332 | 0.406 | 0.89 | 1.749 | 0.981 | 0.809 | 0.001
COVID19_MODERNA | Renal failure | 14 | 14.682 | 0.989 | 1.567 | 2.252 | 0.615 | 0.931 | 1.363 | 0.954 | 3.055 | 15.378
COVID19_MODERNA | Sudden visual loss | 2 | 1.134 | 0.526 | 1.564 | 3.051 | 0.485 | 1.063 | 2.095 | 1.764 | 4.932 | 2.372
COVID19_MODERNA | Reaction to previous exposure to any vaccine | 2 | 1.076 | 0.534 | 1.563 | 3.03 | 0.491 | 1.076 | 2.123 | 1.859 | 5.48 | 2.786
COVID19_MODERNA | Cerebral ventricle dilatation | 1 | 1.02 | 0.317 | 1.563 | 3.581 | 0.357 | 0.867 | 1.839 | 0.98 | 6.165 | 0.497
COVID19_MODERNA | Product label issue | 1 | 0.111 | 0.281 | 1.562 | 3.693 | 0.45 | 1.112 | 2.426 | 9.026 | 4.11 | 0.197
COVID19_MODERNA | Intracranial mass | 1 | 1.179 | 0.334 | 1.562 | 3.527 | 0.344 | 0.837 | 1.776 | 0.848 | 8.22 | 0.79
COVID19_MODERNA | Red blood cell schistocytes present | 1 | 0.512 | 0.255 | 1.561 | 3.781 | 0.403 | 0.979 | 2.082 | 1.952 | 3.083 | 0.066
COVID19_MODERNA | Throat irritation | 188 | 181.782 | 1.38 | 1.561 | 1.751 | 0.913 | 1.03 | 1.159 | 1.034 | 3.782 | 332.387
COVID19_MODERNA | Human chorionic gonadotropin abnormal | 1 | 0.743 | 0.318 | 1.56 | 3.57 | 0.381 | 0.924 | 1.962 | 1.346 | 6.165 | 0.497
COVID19_MODERNA | Rhonchi | 3 | 2.072 | 0.602 | 1.559 | 2.878 | 0.521 | 1.062 | 1.979 | 1.448 | 8.22 | 9.191
COVID19_MODERNA | Glycosylated haemoglobin decreased | 1 | 0.109 | 0.352 | 1.558 | 3.466 | 0.45 | 1.113 | 2.429 | 9.188 | 12.33 | 1.306
COVID19_MODERNA | Synovitis | 3 | 1.371 | 0.586 | 1.558 | 2.908 | 0.595 | 1.215 | 2.275 | 2.188 | 0.822 | 0.004
COVID19_MODERNA | Feeling of relaxation | 1 | 0.119 | 0.336 | 1.557 | 3.509 | 0.449 | 1.108 | 2.413 | 8.434 | 8.22 | 0.79
COVID19_MODERNA | Extradural abscess | 1 | 1.03 | 0.319 | 1.557 | 3.559 | 0.356 | 0.865 | 1.835 | 0.971 | 6.165 | 0.497
COVID19_MODERNA | May-Thurner syndrome | 1 | 2.632 | 0.183 | 1.557 | 4.054 | 0.255 | 0.635 | 1.359 | 0.38 | 6.165 | 0.497
COVID19_MODERNA | Cryoglobulins | 1 | 0.109 | 0.319 | 1.555 | 3.553 | 0.45 | 1.113 | 2.429 | 9.188 | 6.165 | 0.497
COVID19_MODERNA | X-ray with contrast lower gastrointestinal tract | 1 | 0.508 | 0.336 | 1.555 | 3.502 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | Left atrial dilatation | 1 | 1.034 | 0.336 | 1.555 | 3.502 | 0.355 | 0.864 | 1.833 | 0.967 | 8.22 | 0.79
COVID19_MODERNA | Generalised anxiety disorder | 1 | 0.534 | 0.264 | 1.554 | 3.729 | 0.401 | 0.974 | 2.07 | 1.872 | 3.523 | 0.118
COVID19_MODERNA | Magnetic resonance imaging thoracic | 1 | 1.056 | 0.273 | 1.553 | 3.693 | 0.354 | 0.86 | 1.824 | 0.947 | 1.541 | 0.041
COVID19_MODERNA | Shock haemorrhagic | 1 | 0.508 | 0.337 | 1.551 | 3.488 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | Left atrial enlargement | 1 | 1.024 | 0.302 | 1.551 | 3.592 | 0.356 | 0.866 | 1.837 | 0.976 | 4.932 | 0.315
COVID19_MODERNA | Laryngoscopy normal | 1 | 0.534 | 0.32 | 1.55 | 3.534 | 0.401 | 0.974 | 2.07 | 1.872 | 6.165 | 0.497
COVID19_MODERNA | Arterial occlusive disease | 1 | 0.522 | 0.354 | 1.549 | 3.433 | 0.402 | 0.977 | 2.077 | 1.917 | 12.33 | 1.306
COVID19_MODERNA | Eye infection bacterial | 1 | 0.534 | 0.337 | 1.549 | 3.481 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Opiates negative | 1 | 0.671 | 0.337 | 1.549 | 3.479 | 0.388 | 0.941 | 1.997 | 1.491 | 8.22 | 0.79
COVID19_MODERNA | Left ventricular failure | 1 | 1.529 | 0.265 | 1.549 | 3.71 | 0.319 | 0.778 | 1.653 | 0.654 | 3.523 | 0.118
COVID19_MODERNA | Myasthenia gravis crisis | 1 | 0.508 | 0.354 | 1.548 | 3.429 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Hypochromic anaemia | 1 | 1.042 | 0.32 | 1.548 | 3.526 | 0.355 | 0.863 | 1.83 | 0.96 | 6.165 | 0.497
COVID19_MODERNA | Hemiplegia | 15 | 12.084 | 0.975 | 1.547 | 2.228 | 0.769 | 1.149 | 1.665 | 1.241 | 3.662 | 22.932
COVID19_MODERNA | Erythema multiforme | 25 | 14.202 | 1.103 | 1.545 | 2.048 | 1.142 | 1.574 | 2.126 | 1.76 | 1.635 | 5.19
COVID19_MODERNA | Biopsy peripheral nerve | 1 | 0.534 | 0.266 | 1.544 | 3.688 | 0.401 | 0.974 | 2.07 | 1.872 | 3.523 | 0.118
COVID19_MODERNA | Vaccination site streaking | 1 | 0.557 | 0.303 | 1.544 | 3.569 | 0.399 | 0.968 | 2.057 | 1.796 | 4.932 | 0.315
COVID19_MODERNA | Brain hypoxia | 1 | 0.508 | 0.304 | 1.543 | 3.564 | 0.404 | 0.98 | 2.085 | 1.969 | 4.932 | 0.315
COVID19_MODERNA | Spinal cord injury | 1 | 0.722 | 0.247 | 1.543 | 3.755 | 0.383 | 0.929 | 1.972 | 1.386 | 3.083 | 0.066
COVID19_MODERNA | Blood ethanol normal | 1 | 0.522 | 0.322 | 1.542 | 3.506 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Venous oxygen saturation decreased | 1 | 0.508 | 0.355 | 1.541 | 3.405 | 0.404 | 0.98 | 2.085 | 1.969 | 12.33 | 1.306
COVID19_MODERNA | Terminal state | 1 | 1.035 | 0.322 | 1.541 | 3.503 | 0.355 | 0.864 | 1.833 | 0.966 | 6.165 | 0.497
COVID19_MODERNA | Lymph node abscess | 1 | 0.535 | 0.227 | 1.54 | 3.82 | 0.401 | 0.973 | 2.069 | 1.868 | 2.74 | 0.032
COVID19_MODERNA | Leukocytosis | 17 | 15.79 | 1.002 | 1.54 | 2.173 | 0.706 | 1.032 | 1.469 | 1.077 | 1.508 | 2.268
COVID19_MODERNA | Ultrasound biliary tract normal | 1 | 0.534 | 0.339 | 1.539 | 3.447 | 0.401 | 0.974 | 2.07 | 1.872 | 8.22 | 0.79
COVID19_MODERNA | Pericardial drainage | 2 | 2.04 | 0.377 | 1.539 | 3.34 | 0.406 | 0.89 | 1.749 | 0.98 | 2.596 | 0.591
COVID19_MODERNA | Use of accessory respiratory muscles | 2 | 1.561 | 0.468 | 1.538 | 3.11 | 0.444 | 0.973 | 1.914 | 1.281 | 0.948 | 0.077
COVID19_MODERNA | Tumour lysis syndrome (SMQ) [algorithm] | 17 | 16.051 | 0.995 | 1.538 | 2.178 | 0.696 | 1.019 | 1.45 | 1.059 | 3.955 | 29.761
COVID19_MODERNA | Ascites | 5 | 5.187 | 0.692 | 1.538 | 2.656 | 0.495 | 0.913 | 1.572 | 0.964 | 2.802 | 3.657
COVID19_MODERNA | Vaccination site joint pain | 1 | 0.71 | 0.248 | 1.536 | 3.728 | 0.384 | 0.932 | 1.978 | 1.408 | 3.083 | 0.066
COVID19_MODERNA | Binocular eye movement disorder | 1 | 0.149 | 0.268 | 1.535 | 3.655 | 0.445 | 1.093 | 2.369 | 6.715 | 3.523 | 0.118
COVID19_MODERNA | Haematological malignancy | 1 | 0.512 | 0.34 | 1.535 | 3.431 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Plicated tongue | 1 | 0.534 | 0.323 | 1.535 | 3.48 | 0.401 | 0.974 | 2.07 | 1.872 | 6.165 | 0.497
COVID19_MODERNA | Corneal abrasion | 1 | 0.544 | 0.249 | 1.535 | 3.722 | 0.4 | 0.971 | 2.064 | 1.837 | 3.083 | 0.066
COVID19_MODERNA | Bilirubin conjugated | 2 | 2.068 | 0.363 | 1.535 | 3.369 | 0.404 | 0.886 | 1.74 | 0.967 | 2.596 | 0.591
COVID19_MODERNA | Conjunctivitis allergic | 1 | 0.358 | 0.268 | 1.533 | 3.652 | 0.42 | 1.021 | 2.18 | 2.797 | 1.897 | 0.004
COVID19_MODERNA | Blood homocysteine | 1 | 0.534 | 0.288 | 1.533 | 3.584 | 0.401 | 0.974 | 2.07 | 1.872 | 4.11 | 0.197
COVID19_MODERNA | Injection site infection | 5 | 3.935 | 0.747 | 1.533 | 2.546 | 0.577 | 1.065 | 1.834 | 1.271 | 0.403 | 3.766
COVID19_MODERNA | Karyotype analysis normal | 1 | 0.513 | 0.341 | 1.532 | 3.421 | 0.403 | 0.979 | 2.082 | 1.949 | 8.22 | 0.79
COVID19_MODERNA | Herpes ophthalmic | 1 | 0.841 | 0.149 | 1.532 | 4.139 | 0.372 | 0.903 | 1.916 | 1.189 | 0.667 | 0
COVID19_MODERNA | Compression fracture | 1 | 1.021 | 0.307 | 1.531 | 3.52 | 0.356 | 0.867 | 1.839 | 0.979 | 4.932 | 0.315
COVID19_MODERNA | Skin texture abnormal | 2 | 0.848 | 0.492 | 1.53 | 3.033 | 0.517 | 1.134 | 2.244 | 2.358 | 4.11 | 1.737
COVID19_MODERNA | Monocytosis | 1 | 1.042 | 0.288 | 1.53 | 3.576 | 0.355 | 0.863 | 1.83 | 0.96 | 4.11 | 0.197
COVID19_MODERNA | Gastritis erosive | 1 | 0.512 | 0.341 | 1.529 | 3.411 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Procalcitonin decreased | 1 | 1.03 | 0.325 | 1.529 | 3.46 | 0.356 | 0.865 | 1.835 | 0.971 | 6.165 | 0.497
COVID19_MODERNA | Induration | 88 | 58.729 | 1.275 | 1.528 | 1.8 | 1.225 | 1.46 | 1.729 | 1.498 | 1.15 | 1.509
COVID19_MODERNA | Blood creatine phosphokinase abnormal | 1 | 0.643 | 0.342 | 1.527 | 3.402 | 0.39 | 0.947 | 2.011 | 1.555 | 8.22 | 0.79
COVID19_MODERNA | Angiogram abnormal | 6 | 6.756 | 0.719 | 1.526 | 2.578 | 0.49 | 0.871 | 1.457 | 0.888 | 3.363 | 6.737
COVID19_MODERNA | Reflux laryngitis | 1 | 0.15 | 0.343 | 1.523 | 3.389 | 0.445 | 1.093 | 2.368 | 6.676 | 8.22 | 0.79
COVID19_MODERNA | Procalcitonin normal | 3 | 3.256 | 0.501 | 1.523 | 2.992 | 0.431 | 0.878 | 1.634 | 0.921 | 1.51 | 0.115
COVID19_MODERNA | Drug screen positive | 1 | 1.194 | 0.199 | 1.522 | 3.877 | 0.343 | 0.835 | 1.77 | 0.837 | 2.242 | 0.002
COVID19_MODERNA | Blood urine | 1 | 0.512 | 0.343 | 1.52 | 3.379 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Vascular test | 1 | 0.792 | 0.327 | 1.519 | 3.422 | 0.376 | 0.914 | 1.939 | 1.263 | 6.165 | 0.497
COVID19_MODERNA | PO2 abnormal | 1 | 0.512 | 0.344 | 1.518 | 3.372 | 0.403 | 0.979 | 2.082 | 1.952 | 8.22 | 0.79
COVID19_MODERNA | Intestinal ischaemia | 1 | 1.543 | 0.273 | 1.518 | 3.592 | 0.318 | 0.776 | 1.649 | 0.648 | 3.523 | 0.118
COVID19_MODERNA | Target skin lesion | 1 | 0.522 | 0.344 | 1.517 | 3.367 | 0.402 | 0.977 | 2.077 | 1.917 | 8.22 | 0.79
COVID19_MODERNA | Blood smear test abnormal | 4 | 2.116 | 0.603 | 1.516 | 2.764 | 0.638 | 1.23 | 2.201 | 1.89 | 3.794 | 4.836
COVID19_MODERNA | Hepatic steatosis | 3 | 1.809 | 0.454 | 1.516 | 3.083 | 0.547 | 1.115 | 2.078 | 1.659 | 2.845 | 1.728
COVID19_MODERNA | Lid sulcus deepened | 1 | 0.534 | 0.342 | 1.515 | 3.371 | 0.401 | 0.974 | 2.07 | 1.872 | 1.897 | 0.004
COVID19_MODERNA | Prostatic specific antigen increased | 1 | 0.621 | 0.306 | 1.515 | 3.474 | 0.392 | 0.952 | 2.023 | 1.61 | 1.644 | 0.025
COVID19_MODERNA | Ageusia | 53 | 76.077 | 1.193 | 1.514 | 1.867 | 0.562 | 0.703 | 0.871 | 0.697 | 5.027 | 138.691
COVID19_MODERNA | Scratch | 5 | 4.224 | 0.638 | 1.513 | 2.691 | 0.556 | 1.025 | 1.766 | 1.184 | 0.553 | 1.343
COVID19_MODERNA | COVID-19 (SMQ) [narrow] | 265 | 607.117 | 1.363 | 1.513 | 1.669 | 0.396 | 0.439 | 0.485 | 0.436 | 4.16 | 544.383
COVID19_MODERNA | Eosinophil count decreased | 8 | 5.675 | 0.786 | 1.512 | 2.43 | 0.707 | 1.188 | 1.899 | 1.41 | 1.953 | 2.592
COVID19_MODERNA | Speech sound disorder | 1 | 0.149 | 0.329 | 1.511 | 3.395 | 0.445 | 1.093 | 2.369 | 6.715 | 6.165 | 0.497
COVID19_MODERNA | Intellectual disability | 1 | 0.745 | 0.22 | 1.51 | 3.755 | 0.38 | 0.924 | 1.961 | 1.342 | 0.548 | 0.05
COVID19_MODERNA | Antibiotic therapy | 1 | 0.643 | 0.346 | 1.508 | 3.336 | 0.39 | 0.947 | 2.011 | 1.555 | 8.22 | 0.79
COVID19_MODERNA | Arterial disorder | 1 | 1.02 | 0.33 | 1.508 | 3.384 | 0.357 | 0.867 | 1.839 | 0.98 | 6.165 | 0.497
COVID19_MODERNA | Angiogram retina abnormal | 1 | 0.109 | 0.276 | 1.506 | 3.547 | 0.45 | 1.113 | 2.429 | 9.188 | 3.523 | 0.118
COVID19_MODERNA | SARS-CoV-1 test | 1 | 1.16 | 0.177 | 1.506 | 3.922 | 0.345 | 0.841 | 1.784 | 0.862 | 8.22 | 0.79
COVID19_MODERNA | Spinal operation | 1 | 1.271 | 0.206 | 1.506 | 3.796 | 0.337 | 0.821 | 1.742 | 0.787 | 1.761 | 0.013
COVID19_MODERNA | Cardiac failure chronic | 1 | 1.767 | 0.177 | 1.506 | 3.922 | 0.303 | 0.743 | 1.579 | 0.566 | 8.22 | 0.79
COVID19_MODERNA | Bacterial test positive | 6 | 4.883 | 0.742 | 1.505 | 2.485 | 0.598 | 1.063 | 1.779 | 1.229 | 1.357 | 0.241
COVID19_MODERNA | Palpitations | 306 | 313.383 | 1.367 | 1.505 | 1.649 | 0.887 | 0.975 | 1.069 | 0.976 | 3.686 | 522.343
COVID19_MODERNA | Breast cancer | 1 | 0.21 | 0.295 | 1.504 | 3.477 | 0.437 | 1.069 | 2.301 | 4.77 | 4.11 | 0.197
COVID19_MODERNA | Severe cutaneous adverse reactions (SMQ) [narrow] | 33 | 21.324 | 1.123 | 1.504 | 1.93 | 1.09 | 1.445 | 1.885 | 1.548 | 1.181 | 0.706
COVID19_MODERNA | Faeces discoloured | 9 | 6.254 | 0.823 | 1.504 | 2.35 | 0.743 | 1.22 | 1.913 | 1.439 | 0.663 | 1.185
COVID19_MODERNA | Blood pressure increased | 206 | 216.568 | 1.337 | 1.504 | 1.678 | 0.846 | 0.949 | 1.062 | 0.951 | 4.269 | 438.479
COVID19_MODERNA | Protein S normal | 1 | 1.556 | 0.276 | 1.503 | 3.535 | 0.317 | 0.774 | 1.645 | 0.643 | 3.523 | 0.118
COVID19_MODERNA | Oesophageal pain | 1 | 0.806 | 0.331 | 1.501 | 3.36 | 0.375 | 0.911 | 1.932 | 1.241 | 6.165 | 0.497
COVID19_MODERNA | Myosclerosis | 4 | 1.547 | 0.68 | 1.5 | 2.58 | 0.709 | 1.372 | 2.471 | 2.585 | 2.406 | 1.81
COVID19_MODERNA | Intranasal hypoaesthesia | 1 | 0.407 | 0.296 | 1.5 | 3.463 | 0.414 | 1.007 | 2.147 | 2.459 | 4.11 | 0.197
COVID19_MODERNA | Beta-2 glycoprotein antibody negative | 1 | 1.034 | 0.296 | 1.5 | 3.461 | 0.355 | 0.864 | 1.833 | 0.967 | 4.11 | 0.197
COVID19_MODERNA | Labyrinthitis | 2 | 1.413 | 0.468 | 1.497 | 2.999 | 0.458 | 1.003 | 1.972 | 1.415 | 1.203 | 0.019
COVID19_MODERNA | Ceruloplasmin | 1 | 0.522 | 0.315 | 1.496 | 3.392 | 0.402 | 0.977 | 2.077 | 1.917 | 4.932 | 0.315
COVID19_MODERNA | Ulna fracture | 1 | 0.508 | 0.35 | 1.494 | 3.289 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | Left ventricular hypertrophy | 4 | 4.134 | 0.639 | 1.494 | 2.637 | 0.471 | 0.908 | 1.618 | 0.968 | 10.96 | 18.405
COVID19_MODERNA | Cardio-respiratory distress | 1 | 0.508 | 0.333 | 1.493 | 3.329 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Muscle swelling | 10 | 7.272 | 0.867 | 1.493 | 2.257 | 0.744 | 1.197 | 1.846 | 1.375 | 2.652 | 7.805
COVID19_MODERNA | External ear pain | 1 | 1.577 | 0.298 | 1.493 | 3.435 | 0.315 | 0.771 | 1.638 | 0.634 | 4.11 | 0.197
COVID19_MODERNA | Progesterone normal | 1 | 0.683 | 0.316 | 1.492 | 3.377 | 0.386 | 0.938 | 1.991 | 1.464 | 4.932 | 0.315
COVID19_MODERNA | CSF virus no organisms observed | 1 | 0.522 | 0.176 | 1.49 | 3.873 | 0.402 | 0.977 | 2.077 | 1.917 | 0.747 | 0.024
COVID19_MODERNA | Drug screen | 5 | 3.626 | 0.735 | 1.49 | 2.459 | 0.602 | 1.11 | 1.913 | 1.379 | 3.425 | 5.486
COVID19_MODERNA | Arteriosclerosis coronary artery | 2 | 2.076 | 0.371 | 1.49 | 3.218 | 0.403 | 0.884 | 1.738 | 0.963 | 6.165 | 3.292
COVID19_MODERNA | Urinary casts | 1 | 1.564 | 0.299 | 1.49 | 3.426 | 0.316 | 0.773 | 1.642 | 0.639 | 4.11 | 0.197
COVID19_MODERNA | Increased tendency to bruise | 2 | 1.737 | 0.435 | 1.489 | 3.054 | 0.429 | 0.941 | 1.849 | 1.151 | 0.759 | 0.005
COVID19_MODERNA | Hypovitaminosis | 1 | 0.512 | 0.275 | 1.487 | 3.49 | 0.403 | 0.979 | 2.082 | 1.952 | 1.451 | 0.06
COVID19_MODERNA | Lactic acidosis | 4 | 4.098 | 0.64 | 1.487 | 2.62 | 0.473 | 0.912 | 1.626 | 0.976 | 6.165 | 9.882
COVID19_MODERNA | Cellulitis | 75 | 65.611 | 1.218 | 1.486 | 1.775 | 0.932 | 1.127 | 1.353 | 1.143 | 0.497 | 37.289
COVID19_MODERNA | Psychomotor hyperactivity | 3 | 1.604 | 0.547 | 1.484 | 2.793 | 0.569 | 1.159 | 2.165 | 1.87 | 0.532 | 0.778
COVID19_MODERNA | Analgesic drug level therapeutic | 1 | 0.544 | 0.344 | 1.484 | 3.275 | 0.4 | 0.971 | 2.064 | 1.838 | 1.897 | 0.004
COVID19_MODERNA | Coating in mouth | 1 | 0.55 | 0.352 | 1.484 | 3.251 | 0.399 | 0.97 | 2.061 | 1.817 | 8.22 | 0.79
COVID19_MODERNA | Hepatitis | 4 | 2.964 | 0.635 | 1.483 | 2.618 | 0.555 | 1.07 | 1.909 | 1.35 | 1.218 | 0.011
COVID19_MODERNA | Paracentesis | 1 | 1.024 | 0.319 | 1.482 | 3.342 | 0.356 | 0.866 | 1.837 | 0.976 | 4.932 | 0.315
COVID19_MODERNA | Ultrasound pelvis normal | 1 | 0.15 | 0.362 | 1.481 | 3.216 | 0.445 | 1.093 | 2.368 | 6.671 | 2.055 | 0
COVID19_MODERNA | Vein rupture | 1 | 0.743 | 0.336 | 1.481 | 3.286 | 0.381 | 0.924 | 1.962 | 1.346 | 6.165 | 0.497
COVID19_MODERNA | Haemodynamic instability | 1 | 1.022 | 0.243 | 1.481 | 3.585 | 0.356 | 0.867 | 1.838 | 0.979 | 2.74 | 0.032
COVID19_MODERNA | Injection site hypersensitivity | 8 | 4.396 | 0.824 | 1.48 | 2.291 | 0.82 | 1.379 | 2.207 | 1.82 | 1.361 | 0.413
COVID19_MODERNA | Fundoscopy | 1 | 0.514 | 0.243 | 1.48 | 3.58 | 0.403 | 0.979 | 2.081 | 1.944 | 2.74 | 0.032
COVID19_MODERNA | Tongue erythema | 4 | 3.054 | 0.696 | 1.48 | 2.501 | 0.548 | 1.056 | 1.883 | 1.31 | 4.697 | 6.814
COVID19_MODERNA | Dementia (SMQ) [narrow] | 9 | 10.415 | 0.803 | 1.48 | 2.324 | 0.522 | 0.858 | 1.345 | 0.864 | 3.699 | 13.07
COVID19_MODERNA | Culture wound negative | 1 | 0.512 | 0.228 | 1.478 | 3.627 | 0.403 | 0.979 | 2.082 | 1.952 | 1.298 | 0.104
COVID19_MODERNA | Cerebral haemorrhage | 18 | 19.959 | 0.962 | 1.477 | 2.081 | 0.616 | 0.892 | 1.259 | 0.902 | 4.722 | 41.147
COVID19_MODERNA | Increased insulin requirement | 1 | 1.528 | 0.337 | 1.477 | 3.274 | 0.319 | 0.778 | 1.654 | 0.654 | 6.165 | 0.497
COVID19_MODERNA | Anti-muscle specific kinase antibody | 1 | 0.528 | 0.338 | 1.476 | 3.271 | 0.402 | 0.975 | 2.073 | 1.893 | 6.165 | 0.497
COVID19_MODERNA | Toxicologic test abnormal | 1 | 0.508 | 0.338 | 1.475 | 3.266 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Prostate tumours of unspecified malignancy (SMQ) [broad] | 1 | 0.621 | 0.298 | 1.475 | 3.385 | 0.392 | 0.952 | 2.023 | 1.61 | 1.541 | 0.041
COVID19_MODERNA | Prostate tumours of unspecified malignancy (SMQ) [narrow] | 1 | 0.621 | 0.298 | 1.475 | 3.385 | 0.392 | 0.952 | 2.023 | 1.61 | 1.541 | 0.041
COVID19_MODERNA | Paroxysmal nocturnal haemoglobinuria | 1 | 1.047 | 0.297 | 1.475 | 3.386 | 0.354 | 0.862 | 1.828 | 0.955 | 2.466 | 0.012
COVID19_MODERNA | Duodenitis | 1 | 0.512 | 0.339 | 1.473 | 3.257 | 0.403 | 0.979 | 2.082 | 1.952 | 6.165 | 0.497
COVID19_MODERNA | Decerebrate posture | 1 | 0.671 | 0.322 | 1.472 | 3.304 | 0.388 | 0.941 | 1.997 | 1.491 | 4.932 | 0.315
COVID19_MODERNA | X-ray with contrast | 1 | 1.026 | 0.339 | 1.472 | 3.253 | 0.356 | 0.866 | 1.837 | 0.975 | 6.165 | 0.497
COVID19_MODERNA | Bladder cancer | 1 | 0.522 | 0.339 | 1.47 | 3.249 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Vaccination site necrosis | 1 | 0.523 | 0.235 | 1.467 | 3.568 | 0.402 | 0.977 | 2.076 | 1.914 | 2.242 | 0.002
COVID19_MODERNA | Myocarditis | 27 | 23.741 | 1.038 | 1.465 | 1.953 | 0.806 | 1.098 | 1.468 | 1.137 | 3.542 | 40.809
COVID19_MODERNA | Blood pressure diastolic increased | 1 | 0.832 | 0.306 | 1.465 | 3.332 | 0.373 | 0.905 | 1.92 | 1.202 | 4.11 | 0.197
COVID19_MODERNA | Fungal infection | 2 | 2.006 | 0.463 | 1.465 | 2.922 | 0.409 | 0.895 | 1.759 | 0.997 | 0.736 | 0.014
COVID19_MODERNA | Herpes zoster cutaneous disseminated | 1 | 0.753 | 0.233 | 1.463 | 3.566 | 0.38 | 0.922 | 1.957 | 1.328 | 1.644 | 0.025
COVID19_MODERNA | Hand fracture | 1 | 1.552 | 0.288 | 1.463 | 3.379 | 0.317 | 0.775 | 1.646 | 0.644 | 3.523 | 0.118
COVID19_MODERNA | Taste and smell disorders (SMQ) [narrow] | 202 | 230.777 | 1.298 | 1.462 | 1.634 | 0.779 | 0.875 | 0.98 | 0.875 | 4.444 | 455.528
COVID19_MODERNA | Taste and smell disorders (SMQ) [broad] | 202 | 230.777 | 1.298 | 1.462 | 1.634 | 0.779 | 0.875 | 0.98 | 0.875 | 4.444 | 455.528
COVID19_MODERNA | PO2 increased | 2 | 1.532 | 0.421 | 1.459 | 3.006 | 0.447 | 0.979 | 1.925 | 1.305 | 3.083 | 0.946
COVID19_MODERNA | Blood creatine phosphokinase MB increased | 4 | 2.927 | 0.538 | 1.458 | 2.742 | 0.558 | 1.076 | 1.92 | 1.366 | 1.591 | 0.348
COVID19_MODERNA | Biliary colic | 1 | 1.699 | 0.308 | 1.458 | 3.305 | 0.307 | 0.752 | 1.6 | 0.589 | 4.11 | 0.197
COVID19_MODERNA | Retinal haemorrhage | 2 | 1.542 | 0.423 | 1.457 | 2.995 | 0.446 | 0.977 | 1.921 | 1.297 | 1.541 | 0.024
COVID19_MODERNA | Proteinuria | 3 | 3.265 | 0.465 | 1.457 | 2.899 | 0.43 | 0.877 | 1.632 | 0.919 | 1.138 | 0.009
COVID19_MODERNA | Granulocyte percentage | 4 | 2.337 | 0.678 | 1.456 | 2.472 | 0.614 | 1.184 | 2.115 | 1.711 | 2.242 | 1.477
COVID19_MODERNA | IL-2 receptor assay | 1 | 0.512 | 0.344 | 1.455 | 3.192 | 0.403 | 0.979 | 2.082 | 1.952 | 6.165 | 0.497
COVID19_MODERNA | Seizure cluster | 1 | 0.523 | 0.251 | 1.455 | 3.479 | 0.402 | 0.976 | 2.076 | 1.912 | 2.74 | 0.032
COVID19_MODERNA | Injection site mass | 100 | 69.761 | 1.228 | 1.455 | 1.698 | 1.191 | 1.404 | 1.646 | 1.433 | 1.3 | 6.32
COVID19_MODERNA | Fluid overload | 3 | 2.067 | 0.561 | 1.455 | 2.689 | 0.522 | 1.063 | 1.981 | 1.452 | 7.398 | 8.162
COVID19_MODERNA | Autopsy | 17 | 15.739 | 0.943 | 1.455 | 2.057 | 0.707 | 1.035 | 1.473 | 1.08 | 1.327 | 0.996
COVID19_MODERNA | Epigastric discomfort | 1 | 0.195 | 0.288 | 1.453 | 3.352 | 0.439 | 1.074 | 2.316 | 5.127 | 1.541 | 0.041
COVID19_MODERNA | Acute coronary syndrome | 3 | 1.687 | 0.545 | 1.453 | 2.714 | 0.56 | 1.141 | 2.129 | 1.778 | 9.248 | 10.415
COVID19_MODERNA | Saliva altered | 1 | 0.832 | 0.291 | 1.453 | 3.341 | 0.373 | 0.905 | 1.92 | 1.202 | 3.523 | 0.118
COVID19_MODERNA | Palatal disorder | 2 | 1.922 | 0.471 | 1.453 | 2.871 | 0.415 | 0.909 | 1.787 | 1.041 | 4.484 | 2.027
COVID19_MODERNA | Ear injury | 1 | 0.508 | 0.344 | 1.452 | 3.183 | 0.404 | 0.98 | 2.085 | 1.969 | 6.165 | 0.497
COVID19_MODERNA | Skin irritation | 13 | 8.633 | 0.907 | 1.452 | 2.102 | 0.854 | 1.309 | 1.939 | 1.506 | 1.038 | 0
COVID19_MODERNA | Eustachian tube obstruction | 1 | 0.538 | 0.344 | 1.452 | 3.181 | 0.401 | 0.973 | 2.068 | 1.859 | 6.165 | 0.497
COVID19_MODERNA | Pharyngeal erythema | 7 | 5.983 | 0.73 | 1.452 | 2.374 | 0.606 | 1.046 | 1.706 | 1.17 | 0.693 | 0.64
COVID19_MODERNA | Hypoaesthesia oral | 123 | 140.497 | 1.247 | 1.452 | 1.67 | 0.754 | 0.875 | 1.01 | 0.875 | 4.296 | 262.658
COVID19_MODERNA | Giant cell arteritis | 1 | 0.294 | 0.211 | 1.45 | 3.607 | 0.427 | 1.04 | 2.227 | 3.405 | 0.881 | 0.126
COVID19_MODERNA | Retroperitoneal fibrosis (SMQ) [narrow] | 1 | 0.508 | 0.274 | 1.45 | 3.384 | 0.404 | 0.98 | 2.085 | 1.969 | 1.451 | 0.06
COVID19_MODERNA | Blood culture positive | 5 | 5.336 | 0.595 | 1.449 | 2.605 | 0.487 | 0.898 | 1.546 | 0.937 | 0.667 | 0.51
COVID19_MODERNA | Pulse absent | 37 | 38.106 | 1.095 | 1.448 | 1.842 | 0.735 | 0.96 | 1.235 | 0.971 | 7.866 | 162.818
COVID19_MODERNA | Undifferentiated connective tissue disease | 1 | 1.069 | 0.311 | 1.448 | 3.267 | 0.353 | 0.858 | 1.819 | 0.936 | 4.11 | 0.197
COVID19_MODERNA | Status asthmaticus | 1 | 0.683 | 0.311 | 1.447 | 3.263 | 0.386 | 0.938 | 1.991 | 1.464 | 4.11 | 0.197
COVID19_MODERNA | Proctitis | 1 | 1.056 | 0.329 | 1.447 | 3.212 | 0.354 | 0.86 | 1.824 | 0.947 | 4.932 | 0.315
COVID19_MODERNA | Renovascular disorders (SMQ) [narrow] | 2 | 1.673 | 0.419 | 1.445 | 2.972 | 0.435 | 0.953 | 1.873 | 1.196 | 4.11 | 1.737
COVID19_MODERNA | Ultrasound spleen | 1 | 1.044 | 0.346 | 1.445 | 3.158 | 0.355 | 0.862 | 1.829 | 0.958 | 6.165 | 0.497
COVID19_MODERNA | Atopy | 1 | 0.258 | 0.312 | 1.444 | 3.25 | 0.431 | 1.052 | 2.256 | 3.88 | 4.11 | 0.197
COVID19_MODERNA | Congestive cardiomyopathy | 1 | 0.508 | 0.358 | 1.444 | 3.122 | 0.404 | 0.98 | 2.085 | 1.969 | 1.897 | 0.004
COVID19_MODERNA | Rash pustular | 3 | 3.358 | 0.473 | 1.444 | 2.843 | 0.424 | 0.865 | 1.61 | 0.893 | 0.221 | 7.397
COVID19_MODERNA | Central nervous system vasculitis | 1 | 0.583 | 0.387 | 1.443 | 3.043 | 0.396 | 0.962 | 2.043 | 1.716 | 2.242 | 0.002
COVID19_MODERNA | Hyperphagia | 1 | 0.508 | 0.167 | 1.442 | 3.768 | 0.404 | 0.98 | 2.085 | 1.969 | 1.761 | 0.013
COVID19_MODERNA | Infantile spitting up | 1 | 0.542 | 0.241 | 1.441 | 3.471 | 0.4 | 0.972 | 2.066 | 1.846 | 0.237 | 1.709
COVID19_MODERNA | Thyroid hormones increased | 1 | 0.683 | 0.313 | 1.441 | 3.239 | 0.386 | 0.938 | 1.991 | 1.464 | 4.11 | 0.197
COVID19_MODERNA | Haematology test normal | 2 | 1.184 | 0.435 | 1.44 | 2.919 | 0.48 | 1.052 | 2.071 | 1.69 | 1.495 | 0.014
COVID19_MODERNA | Toxic encephalopathy | 1 | 0.534 | 0.295 | 1.439 | 3.289 | 0.401 | 0.974 | 2.07 | 1.872 | 3.523 | 0.118
COVID19_MODERNA | Food poisoning | 1 | 0.828 | 0.331 | 1.439 | 3.182 | 0.373 | 0.906 | 1.922 | 1.207 | 4.932 | 0.315
COVID19_MODERNA | Renal mass | 1 | 0.522 | 0.348 | 1.438 | 3.132 | 0.402 | 0.977 | 2.077 | 1.917 | 6.165 | 0.497
COVID19_MODERNA | Vaginal discharge | 1 | 0.842 | 0.194 | 1.438 | 3.636 | 0.372 | 0.903 | 1.916 | 1.188 | 1.897 | 0.004
COVID19_MODERNA | Intervertebral disc degeneration | 2 | 1.899 | 0.352 | 1.438 | 3.12 | 0.417 | 0.913 | 1.794 | 1.053 | 1.121 | 0.05
COVID19_MODERNA | Chronic kidney disease (SMQ) [narrow] | 28 | 28.769 | 1.035 | 1.438 | 1.896 | 0.707 | 0.958 | 1.275 | 0.973 | 3.401 | 39.578
COVID19_MODERNA | Initial insomnia | 4 | 2.866 | 0.534 | 1.437 | 2.694 | 0.564 | 1.086 | 1.938 | 1.396 | 1.108 | 0.004
COVID19_MODERNA | C-reactive protein abnormal | 1 | 0.565 | 0.34 | 1.436 | 3.149 | 0.398 | 0.966 | 2.053 | 1.771 | 1.761 | 0.013
COVID19_MODERNA | Peripheral sensorimotor neuropathy | 1 | 0.567 | 0.379 | 1.435 | 3.042 | 0.398 | 0.966 | 2.052 | 1.765 | 2.242 | 0.002
COVID19_MODERNA | Red blood cell sedimentation rate abnormal | 1 | 0.55 | 0.35 | 1.433 | 3.114 | 0.399 | 0.97 | 2.061 | 1.817 | 6.165 | 0.497
COVID19_MODERNA | Breast feeding | 1 | 0.685 | 0.315 | 1.433 | 3.21 | 0.386 | 0.938 | 1.99 | 1.461 | 4.11 | 0.197
COVID19_MODERNA | Gastrointestinal premalignant disorders (SMQ) [broad] | 4 | 4.801 | 0.554 | 1.433 | 2.644 | 0.433 | 0.836 | 1.49 | 0.833 | 0.829 | 0.019
COVID19_MODERNA | Gastrointestinal premalignant disorders (SMQ) [narrow] | 4 | 4.801 | 0.554 | 1.433 | 2.644 | 0.433 | 0.836 | 1.49 | 0.833 | 0.829 | 0.019
COVID19_MODERNA | Metabolic acidosis | 2 | 2.61 | 0.391 | 1.433 | 3.005 | 0.368 | 0.808 | 1.587 | 0.766 | 0.609 | 0.174
COVID19_MODERNA | Acute respiratory failure | 11 | 15.036 | 0.834 | 1.433 | 2.163 | 0.476 | 0.752 | 1.143 | 0.732 | 3.569 | 15.517
COVID19_MODERNA | Injection site reaction | 172 | 122.918 | 1.26 | 1.432 | 1.614 | 1.22 | 1.383 | 1.564 | 1.399 | 0.925 | 0.945
COVID19_MODERNA | Albumin urine present | 1 | 0.684 | 0.359 | 1.432 | 3.086 | 0.386 | 0.938 | 1.991 | 1.462 | 1.897 | 0.004
COVID19_MODERNA | Oedema mouth | 2 | 1.058 | 0.385 | 1.431 | 3.016 | 0.493 | 1.081 | 2.131 | 1.89 | 6.165 | 3.292
COVID19_MODERNA | Angiogram retina | 2 | 2.58 | 0.434 | 1.431 | 2.895 | 0.37 | 0.812 | 1.595 | 0.775 | 4.11 | 1.737
COVID19_MODERNA | Cytokine storm | 1 | 1.565 | 0.334 | 1.431 | 3.152 | 0.316 | 0.773 | 1.642 | 0.639 | 4.932 | 0.315
COVID19_MODERNA | Gastric emptying study | 1 | 0.832 | 0.311 | 1.43 | 3.215 | 0.373 | 0.905 | 1.92 | 1.202 | 1.541 | 0.041
COVID19_MODERNA | Premalignant disorders (SMQ) [broad] | 7 | 6.684 | 0.696 | 1.43 | 2.376 | 0.565 | 0.974 | 1.59 | 1.047 | 0.568 | 1.834
COVID19_MODERNA | Premalignant disorders (SMQ) [narrow] | 7 | 6.684 | 0.696 | 1.43 | 2.376 | 0.565 | 0.974 | 1.59 | 1.047 | 0.568 | 1.834
COVID19_MODERNA | Antinuclear antibody increased | 1 | 0.586 | 0.381 | 1.427 | 3.013 | 0.396 | 0.961 | 2.041 | 1.706 | 1.174 | 0.155
COVID19_MODERNA | Thirst | 30 | 22.033 | 1.057 | 1.427 | 1.844 | 0.96 | 1.288 | 1.7 | 1.362 | 2.802 | 29.591
COVID19_MODERNA | Dermatitis allergic | 9 | 6.524 | 0.784 | 1.427 | 2.226 | 0.723 | 1.187 | 1.862 | 1.38 | 1.396 | 0.607
COVID19_MODERNA | Ultrasound thyroid | 1 | 1.234 | 0.28 | 1.426 | 3.294 | 0.34 | 0.828 | 1.756 | 0.811 | 3.083 | 0.066
COVID19_MODERNA | Aortic valve incompetence | 1 | 1.533 | 0.26 | 1.426 | 3.361 | 0.318 | 0.778 | 1.652 | 0.652 | 2.74 | 0.032
COVID19_MODERNA | Trigeminal nerve disorder | 1 | 1.708 | 0.3 | 1.426 | 3.235 | 0.307 | 0.751 | 1.597 | 0.585 | 3.523 | 0.118
COVID19_MODERNA | Blood bilirubin | 3 | 2.825 | 0.476 | 1.425 | 2.784 | 0.46 | 0.937 | 1.744 | 1.062 | 1.897 | 0.474
COVID19_MODERNA | Polypectomy | 1 | 0.523 | 0.3 | 1.424 | 3.228 | 0.402 | 0.977 | 2.076 | 1.914 | 3.523 | 0.118
COVID19_MODERNA | Slow response to stimuli | 2 | 1.48 | 0.451 | 1.424 | 2.839 | 0.452 | 0.989 | 1.945 | 1.351 | 0.649 | 0.1
COVID19_MODERNA | Vaccination site rash | 19 | 16.12 | 0.955 | 1.424 | 1.97 | 0.777 | 1.116 | 1.564 | 1.179 | 1.985 | 7.683
COVID19_MODERNA | Human chorionic gonadotropin negative | 7 | 7.761 | 0.694 | 1.421 | 2.358 | 0.511 | 0.882 | 1.439 | 0.902 | 5.754 | 18.465
COVID19_MODERNA | Colitis ischaemic | 1 | 1.559 | 0.32 | 1.421 | 3.162 | 0.317 | 0.774 | 1.644 | 0.642 | 4.11 | 0.197
COVID19_MODERNA | Osteoarthritis | 7 | 6.166 | 0.723 | 1.42 | 2.307 | 0.595 | 1.026 | 1.674 | 1.135 | 1.856 | 1.81
COVID19_MODERNA | Hydronephrosis | 1 | 0.508 | 0.338 | 1.419 | 3.107 | 0.404 | 0.98 | 2.085 | 1.969 | 4.932 | 0.315
COVID19_MODERNA | Cardiac discomfort | 3 | 1.407 | 0.559 | 1.417 | 2.592 | 0.591 | 1.206 | 2.257 | 2.132 | 3.523 | 2.724
COVID19_MODERNA | Blood creatine | 1 | 1.564 | 0.263 | 1.417 | 3.323 | 0.316 | 0.773 | 1.642 | 0.639 | 2.74 | 0.032
COVID19_MODERNA | Chest wall mass | 1 | 0.508 | 0.371 | 1.416 | 3.008 | 0.404 | 0.98 | 2.085 | 1.969 | 8.22 | 0.79
COVID19_MODERNA | Atypical pneumonia | 1 | 0.538 | 0.296 | 1.416 | 3.22 | 0.401 | 0.973 | 2.068 | 1.86 | 0.913 | 0.159
COVID19_MODERNA | X-ray abnormal | 7 | 6.282 | 0.729 | 1.415 | 2.285 | 0.588 | 1.014 | 1.655 | 1.114 | 0.913 | 0.003
COVID19_MODERNA | Livedo reticularis | 15 | 11.046 | 0.898 | 1.414 | 2.026 | 0.823 | 1.23 | 1.783 | 1.358 | 2.681 | 12.726
COVID19_MODERNA | Malignancy related conditions (SMQ) [broad] | 2 | 1.558 | 0.361 | 1.414 | 3.032 | 0.445 | 0.974 | 1.915 | 1.284 | 0.948 | 0.077
COVID19_MODERNA | Malignancy related conditions (SMQ) [narrow] | 2 | 1.558 | 0.361 | 1.414 | 3.032 | 0.445 | 0.974 | 1.915 | 1.284 | 0.948 | 0.077
COVID19_MODERNA | Necrosis | 1 | 0.796 | 0.278 | 1.414 | 3.268 | 0.376 | 0.913 | 1.937 | 1.256 | 0.725 | 0.014
COVID19_MODERNA | White blood cells urine | 1 | 0.509 | 0.285 | 1.413 | 3.241 | 0.404 | 0.98 | 2.084 | 1.965 | 3.083 | 0.066
COVID19_MODERNA | Tachypnoea | 30 | 22.879 | 1.027 | 1.412 | 1.846 | 0.929 | 1.247 | 1.645 | 1.311 | 4.204 | 59.797
COVID19_MODERNA | Meningitis aseptic | 2 | 2.248 | 0.355 | 1.412 | 3.038 | 0.391 | 0.858 | 1.686 | 0.89 | 0.567 | 0.281
COVID19_MODERNA | Hepatic enzyme | 1 | 1.272 | 0.28 | 1.412 | 3.255 | 0.337 | 0.821 | 1.742 | 0.786 | 1.541 | 0.041
COVID19_MODERNA | White matter lesion | 3 | 3.249 | 0.491 | 1.411 | 2.715 | 0.431 | 0.879 | 1.635 | 0.923 | 1.138 | 0.009
COVID19_MODERNA | Inability to crawl | 1 | 0.51 | 0.269 | 1.41 | 3.282 | 0.403 | 0.98 | 2.084 | 1.96 | 0.587 | 0.019
COVID19_MODERNA | Ventricular hypokinesia | 3 | 3.14 | 0.497 | 1.41 | 2.699 | 0.438 | 0.893 | 1.662 | 0.955 | 5.691 | 5.876
COVID19_MODERNA | Monocyte percentage decreased | 4 | 2.29 | 0.629 | 1.409 | 2.442 | 0.619 | 1.194 | 2.133 | 1.747 | 5.192 | 7.871
COVID19_MODERNA | Autoantibody positive | 1 | 0.522 | 0.319 | 1.407 | 3.122 | 0.402 | 0.977 | 2.077 | 1.917 | 1.541 | 0.041
COVID19_MODERNA | Joint contracture | 2 | 1.727 | 0.471 | 1.407 | 2.748 | 0.43 | 0.943 | 1.853 | 1.158 | 2.144 | 0.295
COVID19_MODERNA | Intraocular pressure test | 1 | 1.663 | 0.267 | 1.407 | 3.28 | 0.31 | 0.758 | 1.611 | 0.601 | 2.74 | 0.032
COVID19_MODERNA | Tongue dry | 2 | 1.989 | 0.396 | 1.406 | 2.917 | 0.41 | 0.898 | 1.765 | 1.006 | 3.523 | 1.282
COVID19_MODERNA | Lymphocyte count decreased | 10 | 6.95 | 0.809 | 1.405 | 2.135 | 0.767 | 1.234 | 1.903 | 1.439 | 2.108 | 4.356
COVID19_MODERNA | Cardiolipin antibody | 1 | 0.662 | 0.268 | 1.405 | 3.273 | 0.388 | 0.943 | 2.002 | 1.511 | 2.74 | 0.032
COVID19_MODERNA | Hypercalcaemia | 2 | 3.174 | 0.364 | 1.405 | 2.998 | 0.336 | 0.74 | 1.455 | 0.63 | 3.523 | 1.282
COVID19_MODERNA | Fear of death | 2 | 1.022 | 0.398 | 1.404 | 2.908 | 0.497 | 1.09 | 2.15 | 1.957 | 4.484 | 2.027
COVID19_MODERNA | Drug abuse, dependence and withdrawal (SMQ) [narrow] | 1 | 0.671 | 0.169 | 1.403 | 3.634 | 0.387 | 0.941 | 1.997 | 1.489 | 0.986 | 0.243
COVID19_MODERNA | Immature granulocyte count increased | 5 | 3.999 | 0.66 | 1.403 | 2.37 | 0.573 | 1.056 | 1.818 | 1.25 | 20.551 | 40.237
COVID19_MODERNA | Migraine with aura | 6 | 5.601 | 0.658 | 1.403 | 2.375 | 0.551 | 0.98 | 1.64 | 1.071 | 2.551 | 3.77
COVID19_MODERNA | Gamma-glutamyltransferase increased | 1 | 0.662 | 0.209 | 1.402 | 3.468 | 0.388 | 0.943 | 2.002 | 1.51 | 0.202 | 2.355
COVID19_MODERNA | Protein total | 4 | 4.063 | 0.521 | 1.402 | 2.629 | 0.475 | 0.916 | 1.633 | 0.984 | 2.192 | 1.379
COVID19_MODERNA | Haematocrit increased | 3 | 1.855 | 0.615 | 1.401 | 2.447 | 0.542 | 1.105 | 2.06 | 1.617 | 2.114 | 0.73
COVID19_MODERNA | Tongue oedema | 3 | 1.734 | 0.576 | 1.4 | 2.518 | 0.555 | 1.131 | 2.109 | 1.73 | 4.352 | 3.953
COVID19_MODERNA | Myelodysplastic syndrome (SMQ) [narrow] | 1 | 0.21 | 0.27 | 1.399 | 3.248 | 0.437 | 1.069 | 2.301 | 4.772 | 2.74 | 0.032
COVID19_MODERNA | Emergency care | 1 | 0.514 | 0.362 | 1.397 | 2.98 | 0.403 | 0.979 | 2.082 | 1.947 | 6.165 | 0.497
COVID19_MODERNA | Myoglobin blood | 1 | 0.637 | 0.31 | 1.397 | 3.124 | 0.391 | 0.949 | 2.014 | 1.569 | 3.523 | 0.118
COVID19_MODERNA | Injection site nodule | 49 | 35.045 | 1.092 | 1.396 | 1.731 | 1.066 | 1.346 | 1.681 | 1.398 | 0.92 | 0.257
COVID19_MODERNA | Dialysis | 7 | 6.299 | 0.749 | 1.396 | 2.206 | 0.587 | 1.012 | 1.652 | 1.111 | 6.165 | 20.126
COVID19_MODERNA | Hypernatraemia | 2 | 2.601 | 0.397 | 1.396 | 2.888 | 0.368 | 0.809 | 1.59 | 0.769 | 6.165 | 3.292
COVID19_MODERNA | Vitamin B6 normal | 1 | 0.514 | 0.291 | 1.395 | 3.17 | 0.403 | 0.979 | 2.081 | 1.944 | 3.083 | 0.066
COVID19_MODERNA | Osteonecrosis (SMQ) [narrow] | 1 | 0.55 | 0.395 | 1.395 | 2.889 | 0.399 | 0.97 | 2.061 | 1.817 | 2.242 | 0.002
COVID19_MODERNA | Coronary artery bypass | 1 | 1.769 | 0.279 | 1.395 | 3.208 | 0.303 | 0.742 | 1.579 | 0.565 | 2.466 | 0.012
COVID19_MODERNA | Biopsy kidney | 2 | 1.034 | 0.452 | 1.394 | 2.754 | 0.496 | 1.087 | 2.143 | 1.935 | 4.932 | 2.372
COVID19_MODERNA | Vaccination site inflammation | 3 | 2.699 | 0.511 | 1.394 | 2.63 | 0.469 | 0.956 | 1.779 | 1.112 | 0.446 | 1.505
COVID19_MODERNA | Lipase normal | 8 | 5.656 | 0.8 | 1.393 | 2.119 | 0.709 | 1.191 | 1.903 | 1.414 | 4.11 | 13.485
COVID19_MODERNA | Fibrin D dimer normal | 13 | 11.83 | 0.843 | 1.392 | 2.053 | 0.677 | 1.038 | 1.537 | 1.099 | 6.679 | 44.862
COVID19_MODERNA | Bradycardia | 21 | 20.097 | 0.948 | 1.391 | 1.903 | 0.717 | 1.014 | 1.4 | 1.045 | 1.484 | 2.672
COVID19_MODERNA | Septic shock | 7 | 6.347 | 0.706 | 1.39 | 2.262 | 0.584 | 1.007 | 1.644 | 1.103 | 1.817 | 1.67
COVID19_MODERNA | Interstitial lung disease | 2 | 2.454 | 0.34 | 1.39 | 3.017 | 0.378 | 0.829 | 1.628 | 0.815 | 0.601 | 0.19
COVID19_MODERNA | Immune-mediated adverse reaction | 2 | 1.206 | 0.498 | 1.389 | 2.642 | 0.478 | 1.047 | 2.061 | 1.659 | 3.794 | 1.492
COVID19_MODERNA | Vulvovaginal rash | 1 | 1.042 | 0.294 | 1.389 | 3.147 | 0.355 | 0.863 | 1.83 | 0.96 | 3.083 | 0.066
COVID19_MODERNA | CSF mononuclear cell count increased | 1 | 0.522 | 0.331 | 1.388 | 3.038 | 0.402 | 0.977 | 2.077 | 1.917 | 4.11 | 0.197
COVID19_MODERNA | Infectious biliary disorders (SMQ) [broad] | 7 | 4.689 | 0.697 | 1.388 | 2.27 | 0.701 | 1.209 | 1.974 | 1.493 | 7.847 | 26.552
COVID19_MODERNA | Infectious biliary disorders (SMQ) [narrow] | 7 | 4.689 | 0.697 | 1.388 | 2.27 | 0.701 | 1.209 | 1.974 | 1.493 | 7.847 | 26.552
COVID19_MODERNA | Liver function test normal | 8 | 6.389 | 0.731 | 1.386 | 2.211 | 0.657 | 1.103 | 1.762 | 1.252 | 0.85 | 0.081
COVID19_MODERNA | Red blood cell count normal | 13 | 11.101 | 0.848 | 1.386 | 2.033 | 0.711 | 1.09 | 1.613 | 1.171 | 0.767 | 0.674
COVID19_MODERNA | Abortion missed | 1 | 1.069 | 0.295 | 1.386 | 3.136 | 0.353 | 0.858 | 1.819 | 0.936 | 3.083 | 0.066
COVID19_MODERNA | Dermatitis psoriasiform | 1 | 0.661 | 0.181 | 1.385 | 3.529 | 0.388 | 0.943 | 2.002 | 1.513 | 1.761 | 0.013
COVID19_MODERNA | Conduction defects (SMQ) [broad] | 17 | 17.531 | 0.902 | 1.384 | 1.951 | 0.647 | 0.947 | 1.348 | 0.97 | 3.955 | 29.761
COVID19_MODERNA | Conduction defects (SMQ) [narrow] | 17 | 17.531 | 0.902 | 1.384 | 1.951 | 0.647 | 0.947 | 1.348 | 0.97 | 3.955 | 29.761
COVID19_MODERNA | Systemic inflammatory response syndrome | 8 | 7.412 | 0.707 | 1.383 | 2.242 | 0.596 | 1.001 | 1.598 | 1.079 | 2.666 | 6.035
COVID19_MODERNA | Vasculitis | 5 | 3.046 | 0.691 | 1.382 | 2.265 | 0.655 | 1.208 | 2.083 | 1.642 | 0.785 | 0.109
COVID19_MODERNA | Treatment noncompliance | 1 | 0.619 | 0.277 | 1.381 | 3.173 | 0.392 | 0.953 | 2.024 | 1.616 | 2.74 | 0.032
COVID19_MODERNA | Lacunar infarction | 3 | 3.631 | 0.515 | 1.381 | 2.587 | 0.408 | 0.833 | 1.549 | 0.826 | 9.248 | 10.415
COVID19_MODERNA | Smear test | 1 | 0.752 | 0.359 | 1.38 | 2.938 | 0.38 | 0.922 | 1.957 | 1.33 | 2.466 | 0.012
COVID19_MODERNA | Staphylococcus test negative | 4 | 2.746 | 0.669 | 1.379 | 2.296 | 0.574 | 1.107 | 1.976 | 1.457 | 4.289 | 5.926
COVID19_MODERNA | Mycobacterium test negative | 1 | 0.513 | 0.264 | 1.378 | 3.206 | 0.403 | 0.979 | 2.082 | 1.949 | 1.298 | 0.104
COVID19_MODERNA | Ejection fraction normal | 5 | 5.363 | 0.582 | 1.378 | 2.447 | 0.485 | 0.895 | 1.541 | 0.932 | 3.853 | 6.75
COVID19_MODERNA | Normocytic anaemia | 1 | 1.532 | 0.279 | 1.377 | 3.157 | 0.318 | 0.778 | 1.652 | 0.653 | 2.74 | 0.032
COVID19_MODERNA | Wound secretion | 2 | 0.717 | 0.464 | 1.376 | 2.68 | 0.533 | 1.171 | 2.325 | 2.788 | 1.298 | 0.002
COVID19_MODERNA | Endocarditis | 1 | 0.51 | 0.279 | 1.376 | 3.151 | 0.403 | 0.98 | 2.084 | 1.962 | 2.74 | 0.032
COVID19_MODERNA | Reaction to preservatives | 6 | 3.675 | 0.686 | 1.375 | 2.256 | 0.697 | 1.24 | 2.078 | 1.633 | 5.102 | 13.052
COVID19_MODERNA | Hypoalbuminaemia | 1 | 0.534 | 0.408 | 1.374 | 2.804 | 0.401 | 0.974 | 2.07 | 1.872 | 1.174 | 0.155
COVID19_MODERNA | Hypermetropia | 1 | 0.536 | 0.397 | 1.374 | 2.828 | 0.401 | 0.973 | 2.069 | 1.867 | 2.055 | 0
COVID19_MODERNA | Facial discomfort | 9 | 6.703 | 0.774 | 1.374 | 2.114 | 0.711 | 1.167 | 1.829 | 1.343 | 15.853 | 67.124
COVID19_MODERNA | Blood fibrinogen normal | 1 | 0.771 | 0.179 | 1.374 | 3.5 | 0.378 | 0.918 | 1.948 | 1.297 | 0.525 | 0.076
COVID19_MODERNA | Injection site joint discomfort | 1 | 0.706 | 0.337 | 1.373 | 2.979 | 0.384 | 0.933 | 1.98 | 1.417 | 4.11 | 0.197
COVID19_MODERNA | Nucleated red cells | 4 | 3.608 | 0.629 | 1.373 | 2.348 | 0.505 | 0.974 | 1.737 | 1.109 | 8.22 | 13.809
COVID19_MODERNA | Encephalopathy | 12 | 11.538 | 0.817 | 1.373 | 2.047 | 0.638 | 0.992 | 1.487 | 1.04 | 1.265 | 0.398
COVID19_MODERNA | Cardiomegaly | 6 | 7.318 | 0.658 | 1.373 | 2.3 | 0.465 | 0.826 | 1.382 | 0.82 | 3.083 | 5.702
COVID19_MODERNA | Urine bilirubin decreased | 1 | 0.258 | 0.387 | 1.372 | 2.848 | 0.431 | 1.052 | 2.256 | 3.88 | 0.822 | 0.073
COVID19_MODERNA | Circumoral oedema | 1 | 0.743 | 0.281 | 1.371 | 3.133 | 0.381 | 0.924 | 1.962 | 1.346 | 2.74 | 0.032
COVID19_MODERNA | Keratitis | 1 | 0.782 | 0.187 | 1.371 | 3.458 | 0.377 | 0.916 | 1.943 | 1.279 | 0.948 | 0.198
COVID19_MODERNA | Coronary artery occlusion | 4 | 3.959 | 0.598 | 1.371 | 2.402 | 0.482 | 0.929 | 1.656 | 1.01 | 10.96 | 18.405
COVID19_MODERNA | Aspartate aminotransferase normal | 15 | 13.151 | 0.865 | 1.37 | 1.97 | 0.72 | 1.076 | 1.559 | 1.141 | 1.163 | 0.186
COVID19_MODERNA | Parkinson-like events (SMQ) [narrow] | 16 | 14.81 | 0.88 | 1.37 | 1.948 | 0.699 | 1.033 | 1.483 | 1.08 | 0.687 | 1.911
COVID19_MODERNA | Neutrophil count increased | 9 | 8.338 | 0.747 | 1.369 | 2.142 | 0.613 | 1.007 | 1.578 | 1.079 | 0.705 | 0.806
COVID19_MODERNA | Large intestine polyp | 1 | 0.538 | 0.302 | 1.368 | 3.063 | 0.401 | 0.973 | 2.068 | 1.859 | 3.083 | 0.066
COVID19_MODERNA | Bilirubin conjugated normal | 1 | 0.513 | 0.243 | 1.367 | 3.243 | 0.403 | 0.979 | 2.082 | 1.949 | 0.601 | 0.012
COVID19_MODERNA | Mean cell volume increased | 5 | 5.048 | 0.646 | 1.367 | 2.304 | 0.503 | 0.928 | 1.597 | 0.991 | 3.627 | 6.081
COVID19_MODERNA | Cardiac ablation | 1 | 1.155 | 0.339 | 1.367 | 2.956 | 0.346 | 0.842 | 1.785 | 0.866 | 4.11 | 0.197
COVID19_MODERNA | Carotid artery stenosis | 1 | 1.538 | 0.302 | 1.367 | 3.059 | 0.318 | 0.777 | 1.65 | 0.65 | 3.083 | 0.066
COVID19_MODERNA | Polychromasia | 1 | 1.047 | 0.322 | 1.366 | 3.002 | 0.354 | 0.862 | 1.828 | 0.955 | 3.523 | 0.118
COVID19_MODERNA | Blood gases normal | 2 | 1.188 | 0.481 | 1.364 | 2.611 | 0.48 | 1.051 | 2.069 | 1.683 | 1.409 | 0.002
COVID19_MODERNA | Hepatitis A antibody negative | 1 | 0.673 | 0.12 | 1.364 | 3.749 | 0.387 | 0.94 | 1.996 | 1.485 | 0.493 | 0.124
COVID19_MODERNA | Sputum abnormal | 1 | 1.042 | 0.358 | 1.363 | 2.894 | 0.355 | 0.863 | 1.83 | 0.96 | 4.932 | 0.315
COVID19_MODERNA | Cardiac monitoring | 27 | 23.446 | 0.976 | 1.362 | 1.801 | 0.815 | 1.11 | 1.484 | 1.152 | 5.503 | 77.581
COVID19_MODERNA | Disseminated intravascular coagulation | 4 | 3.672 | 0.55 | 1.362 | 2.469 | 0.501 | 0.966 | 1.721 | 1.089 | 3.288 | 3.716
COVID19_MODERNA | Blood bilirubin decreased | 3 | 3.005 | 0.526 | 1.362 | 2.516 | 0.447 | 0.912 | 1.696 | 0.998 | 1.423 | 0.062
COVID19_MODERNA | Bilirubin urine present | 1 | 1.532 | 0.285 | 1.362 | 3.096 | 0.318 | 0.778 | 1.652 | 0.653 | 2.74 | 0.032
COVID19_MODERNA | Spinal cord compression | 1 | 0.535 | 0.359 | 1.361 | 2.888 | 0.401 | 0.973 | 2.069 | 1.868 | 4.932 | 0.315
COVID19_MODERNA | Coxsackie virus test | 1 | 1.043 | 0.324 | 1.361 | 2.982 | 0.355 | 0.863 | 1.829 | 0.958 | 3.523 | 0.118
COVID19_MODERNA | Basal ganglia stroke | 2 | 3.111 | 0.348 | 1.361 | 2.913 | 0.339 | 0.747 | 1.469 | 0.643 | 6.165 | 3.292
COVID19_MODERNA | Bicytopenia | 1 | 0.512 | 0.324 | 1.36 | 2.975 | 0.403 | 0.979 | 2.082 | 1.952 | 3.523 | 0.118
COVID19_MODERNA | Computerised tomogram thorax abnormal | 26 | 28.774 | 0.961 | 1.359 | 1.814 | 0.655 | 0.896 | 1.204 | 0.904 | 3.542 | 39.226
COVID19_MODERNA | Injection site inflammation | 38 | 28.118 | 1.033 | 1.358 | 1.72 | 0.994 | 1.293 | 1.66 | 1.351 | 0.704 | 4.338
COVID19_MODERNA | Cytology | 1 | 0.617 | 0.343 | 1.358 | 2.92 | 0.393 | 0.953 | 2.025 | 1.621 | 4.11 | 0.197
COVID19_MODERNA | Joint instability | 5 | 3.245 | 0.663 | 1.357 | 2.251 | 0.636 | 1.172 | 2.021 | 1.541 | 11.209 | 25.079
COVID19_MODERNA | Myocardial ischaemia | 2 | 2.585 | 0.39 | 1.357 | 2.796 | 0.369 | 0.811 | 1.594 | 0.774 | 4.932 | 2.372
COVID19_MODERNA | Cholecystitis | 4 | 2.597 | 0.569 | 1.356 | 2.416 | 0.588 | 1.134 | 2.024 | 1.54 | 9.864 | 16.648
COVID19_MODERNA | Injection site irritation | 11 | 8.206 | 0.839 | 1.355 | 1.972 | 0.751 | 1.187 | 1.804 | 1.34 | 0.789 | 0.41
COVID19_MODERNA | Peripheral motor neuropathy | 1 | 0.706 | 0.288 | 1.355 | 3.066 | 0.384 | 0.933 | 1.98 | 1.417 | 2.74 | 0.032
COVID19_MODERNA | Mean cell haemoglobin concentration normal | 13 | 10.993 | 0.826 | 1.355 | 1.99 | 0.716 | 1.098 | 1.625 | 1.183 | 1.21 | 0.267
COVID19_MODERNA | Facet joint syndrome | 1 | 1.057 | 0.344 | 1.355 | 2.906 | 0.354 | 0.86 | 1.824 | 0.946 | 4.11 | 0.197
COVID19_MODERNA | Protein urine | 2 | 1.022 | 0.499 | 1.354 | 2.549 | 0.497 | 1.09 | 2.15 | 1.957 | 1.827 | 0.126
COVID19_MODERNA | Fraction of inspired oxygen | 1 | 0.51 | 0.378 | 1.354 | 2.819 | 0.403 | 0.98 | 2.084 | 1.96 | 6.165 | 0.497
COVID19_MODERNA | Skin tightness | 20 | 14.609 | 0.93 | 1.354 | 1.842 | 0.887 | 1.264 | 1.758 | 1.369 | 1.655 | 4.246
COVID19_MODERNA | Pregnancy test urine | 3 | 1.901 | 0.488 | 1.352 | 2.565 | 0.538 | 1.096 | 2.042 | 1.578 | 6.165 | 6.531
COVID19_MODERNA | Cardiac fibrillation | 1 | 0.764 | 0.345 | 1.352 | 2.897 | 0.379 | 0.92 | 1.952 | 1.308 | 4.11 | 0.197
COVID19_MODERNA | Injection site dermatitis | 1 | 0.149 | 0.372 | 1.351 | 2.826 | 0.445 | 1.093 | 2.369 | 6.715 | 1.761 | 0.013
COVID19_MODERNA | HIV test negative | 5 | 4.295 | 0.607 | 1.351 | 2.333 | 0.551 | 1.016 | 1.75 | 1.164 | 0.501 | 1.952
COVID19_MODERNA | Carbon dioxide increased | 4 | 3.817 | 0.617 | 1.349 | 2.311 | 0.491 | 0.947 | 1.688 | 1.048 | 4.484 | 6.351
COVID19_MODERNA | Blood ketone body | 1 | 1.036 | 0.31 | 1.349 | 2.982 | 0.355 | 0.864 | 1.832 | 0.965 | 3.083 | 0.066
COVID19_MODERNA | SARS-CoV-2 test | 120 | 222.59 | 1.155 | 1.349 | 1.556 | 0.468 | 0.544 | 0.629 | 0.539 | 5.637 | 369.327
COVID19_MODERNA | Multi-organ disorder | 1 | 0.522 | 0.291 | 1.348 | 3.035 | 0.402 | 0.977 | 2.077 | 1.917 | 2.74 | 0.032
COVID19_MODERNA | Monoplegia | 4 | 3.628 | 0.527 | 1.348 | 2.475 | 0.504 | 0.972 | 1.732 | 1.102 | 0.398 | 3.002
COVID19_MODERNA | Troponin increased | 72 | 73.725 | 1.1 | 1.348 | 1.618 | 0.799 | 0.97 | 1.168 | 0.977 | 11.238 | 454.328
COVID19_MODERNA | Complement factor normal | 2 | 1.432 | 0.356 | 1.345 | 2.849 | 0.456 | 0.999 | 1.965 | 1.397 | 0.594 | 0.207
COVID19_MODERNA | Immune complex assay | 1 | 0.683 | 0.322 | 1.345 | 2.941 | 0.386 | 0.938 | 1.991 | 1.464 | 1.451 | 0.06
COVID19_MODERNA | Herpes zoster oticus | 1 | 1.463 | 0.138 | 1.345 | 3.595 | 0.323 | 0.789 | 1.675 | 0.684 | 0.297 | 1
COVID19_MODERNA | Tongue coated | 1 | 0.274 | 0.354 | 1.344 | 2.852 | 0.429 | 1.047 | 2.243 | 3.651 | 2.242 | 0.002
COVID19_MODERNA | Blood lactic acid normal | 11 | 6.974 | 0.813 | 1.342 | 1.978 | 0.839 | 1.326 | 2.015 | 1.577 | 3.391 | 14.192
COVID19_MODERNA | Bronchoscopy | 1 | 0.522 | 0.277 | 1.342 | 3.06 | 0.402 | 0.977 | 2.077 | 1.917 | 1.233 | 0.129
COVID19_MODERNA | Inappropriate antidiuretic hormone secretion | 1 | 0.513 | 0.367 | 1.341 | 2.809 | 0.403 | 0.979 | 2.082 | 1.949 | 4.932 | 0.315
COVID19_MODERNA | Orthosis user | 1 | 0.676 | 0.359 | 1.341 | 2.83 | 0.387 | 0.939 | 1.994 | 1.478 | 0.747 | 0.024
COVID19_MODERNA | Sensation of blood flow | 1 | 1.725 | 0.178 | 1.341 | 3.402 | 0.306 | 0.749 | 1.592 | 0.58 | 6.165 | 0.497
COVID19_MODERNA | Hypertension (SMQ) [narrow] | 361 | 386.834 | 1.227 | 1.34 | 1.458 | 0.855 | 0.932 | 1.015 | 0.933 | 4.203 | 755.598
COVID19_MODERNA | Lymphocyte count | 4 | 3.758 | 0.576 | 1.339 | 2.36 | 0.495 | 0.954 | 1.701 | 1.064 | 1.794 | 0.653
COVID19_MODERNA | Meningioma | 1 | 1.065 | 0.351 | 1.339 | 2.847 | 0.353 | 0.858 | 1.821 | 0.939 | 4.11 | 0.197
COVID19_MODERNA | Percutaneous coronary intervention | 1 | 2.08 | 0.179 | 1.338 | 3.39 | 0.284 | 0.7 | 1.492 | 0.481 | 6.165 | 0.497
COVID19_MODERNA | Antiphospholipid antibodies negative | 1 | 0.662 | 0.181 | 1.337 | 3.377 | 0.388 | 0.943 | 2.002 | 1.511 | 0.796 | 0.053
COVID19_MODERNA | Red cell distribution width increased | 7 | 6.354 | 0.674 | 1.337 | 2.182 | 0.584 | 1.007 | 1.643 | 1.102 | 2.398 | 3.957
COVID19_MODERNA | Hepatitis C antibody negative | 2 | 2.211 | 0.288 | 1.335 | 3.007 | 0.394 | 0.864 | 1.697 | 0.904 | 0.401 | 1.202
COVID19_MODERNA | Vaccination site nodule | 2 | 1.875 | 0.428 | 1.334 | 2.647 | 0.418 | 0.917 | 1.802 | 1.067 | 0.479 | 0.645
COVID19_MODERNA | Skin warm | 283 | 225.88 | 1.207 | 1.333 | 1.465 | 1.13 | 1.246 | 1.372 | 1.253 | 0.836 | 8.927
COVID19_MODERNA | Anal pruritus | 1 | 0.524 | 0.354 | 1.332 | 2.816 | 0.402 | 0.976 | 2.076 | 1.908 | 4.11 | 0.197
COVID19_MODERNA | Heart sounds abnormal | 1 | 0.806 | 0.31 | 1.332 | 2.934 | 0.375 | 0.911 | 1.932 | 1.241 | 1.37 | 0.081
COVID19_MODERNA | Oral pustule | 1 | 0.879 | 0.354 | 1.332 | 2.816 | 0.368 | 0.895 | 1.899 | 1.137 | 4.11 | 0.197
COVID19_MODERNA | Hyperglycaemia | 9 | 9.424 | 0.753 | 1.331 | 2.042 | 0.562 | 0.923 | 1.447 | 0.955 | 3.415 | 11.384
COVID19_MODERNA | Lung consolidation | 5 | 6.458 | 0.565 | 1.331 | 2.358 | 0.432 | 0.798 | 1.373 | 0.774 | 3.083 | 4.476
COVID19_MODERNA | Skin indentation | 1 | 0.699 | 0.385 | 1.33 | 2.736 | 0.385 | 0.934 | 1.983 | 1.43 | 1.897 | 0.004
COVID19_MODERNA | White blood cell count normal | 45 | 38.268 | 1.029 | 1.33 | 1.662 | 0.899 | 1.147 | 1.445 | 1.176 | 1.232 | 1.65
COVID19_MODERNA | Glucose tolerance impaired | 1 | 0.523 | 0.219 | 1.329 | 3.213 | 0.402 | 0.977 | 2.076 | 1.914 | 1.897 | 0.004
COVID19_MODERNA | Coma scale abnormal | 2 | 2.203 | 0.358 | 1.329 | 2.8 | 0.394 | 0.865 | 1.699 | 0.908 | 1.451 | 0.007
COVID19_MODERNA | Cardiac operation | 1 | 0.508 | 0.3 | 1.328 | 2.952 | 0.404 | 0.98 | 2.085 | 1.969 | 2.74 | 0.032
COVID19_MODERNA | Psychotic disorder | 4 | 2.984 | 0.514 | 1.328 | 2.45 | 0.553 | 1.067 | 1.903 | 1.341 | 2.013 | 1.037
COVID19_MODERNA | Injection site joint movement impairment | 3 | 2.236 | 0.519 | 1.328 | 2.441 | 0.507 | 1.032 | 1.922 | 1.342 | 1.013 | 0.075
COVID19_MODERNA | Peripheral sensory neuropathy | 1 | 0.724 | 0.347 | 1.328 | 2.824 | 0.382 | 0.929 | 1.971 | 1.382 | 0.948 | 0.198
COVID19_MODERNA | Debridement | 1 | 0.81 | 0.234 | 1.328 | 3.154 | 0.375 | 0.91 | 1.93 | 1.235 | 0.948 | 0.198
COVID19_MODERNA | Rhabdomyolysis/myopathy (SMQ) [narrow] | 11 | 10.638 | 0.769 | 1.328 | 2.011 | 0.623 | 0.985 | 1.495 | 1.034 | 1.75 | 2.615
COVID19_MODERNA | Injection site muscle weakness | 3 | 3.838 | 0.453 | 1.328 | 2.574 | 0.397 | 0.809 | 1.506 | 0.782 | 5.691 | 5.876
COVID19_MODERNA | Injection site cellulitis | 26 | 21.515 | 0.948 | 1.327 | 1.758 | 0.844 | 1.155 | 1.552 | 1.208 | 0.48 | 13.873
COVID19_MODERNA | Heart rate increased | 308 | 325.39 | 1.205 | 1.326 | 1.452 | 0.86 | 0.945 | 1.037 | 0.947 | 3.411 | 462.269
COVID19_MODERNA | Trigger finger | 1 | 0.534 | 0.321 | 1.325 | 2.884 | 0.401 | 0.974 | 2.07 | 1.872 | 3.083 | 0.066
COVID19_MODERNA | Discharge | 1 | 0.792 | 0.34 | 1.325 | 2.836 | 0.376 | 0.914 | 1.939 | 1.263 | 3.523 | 0.118
COVID19_MODERNA | Nephropathy | 1 | 1.314 | 0.322 | 1.325 | 2.883 | 0.334 | 0.814 | 1.727 | 0.761 | 3.083 | 0.066
COVID19_MODERNA | Contraindication to vaccination | 3 | 2.27 | 0.424 | 1.324 | 2.629 | 0.504 | 1.026 | 1.911 | 1.322 | 0.396 | 2.143
COVID19_MODERNA | Alanine aminotransferase | 2 | 2.075 | 0.405 | 1.324 | 2.672 | 0.403 | 0.884 | 1.738 | 0.964 | 1.028 | 0.107
COVID19_MODERNA | Band neutrophil percentage increased | 1 | 1.057 | 0.312 | 1.324 | 2.907 | 0.354 | 0.86 | 1.824 | 0.946 | 1.37 | 0.081
COVID19_MODERNA | Hypertension (SMQ) [broad] | 386 | 412.649 | 1.216 | 1.324 | 1.437 | 0.859 | 0.935 | 1.015 | 0.935 | 4.175 | 800.525
COVID19_MODERNA | Romberg test positive | 1 | 0.677 | 0.22 | 1.323 | 3.188 | 0.387 | 0.939 | 1.994 | 1.476 | 0.986 | 0.243
COVID19_MODERNA | Localised infection | 3 | 2.587 | 0.482 | 1.323 | 2.501 | 0.478 | 0.974 | 1.812 | 1.16 | 0.711 | 0.112
COVID19_MODERNA | Blood immunoglobulin E | 2 | 1.069 | 0.421 | 1.322 | 2.632 | 0.492 | 1.078 | 2.126 | 1.872 | 1.644 | 0.053
COVID19_MODERNA | Product dose omission issue | 2 | 1.92 | 0.276 | 1.322 | 3.005 | 0.415 | 0.91 | 1.787 | 1.042 | 0.465 | 0.722
COVID19_MODERNA | Coagulopathy | 3 | 4.228 | 0.47 | 1.322 | 2.523 | 0.377 | 0.769 | 1.431 | 0.709 | 1.51 | 0.115
COVID19_MODERNA | Acute pulmonary oedema | 2 | 3.048 | 0.319 | 1.322 | 2.883 | 0.343 | 0.754 | 1.483 | 0.656 | 4.932 | 2.372
COVID19_MODERNA | X-ray limb normal | 8 | 6.316 | 0.76 | 1.321 | 2.009 | 0.662 | 1.111 | 1.775 | 1.267 | 0.744 | 0.448
COVID19_MODERNA | Bedridden | 10 | 11.748 | 0.742 | 1.321 | 2.036 | 0.527 | 0.848 | 1.308 | 0.851 | 0.647 | 1.534
COVID19_MODERNA | Epstein-Barr virus antigen positive | 1 | 0.523 | 0.304 | 1.32 | 2.918 | 0.402 | 0.977 | 2.076 | 1.914 | 2.74 | 0.032
COVID19_MODERNA | Pneumonia aspiration | 6 | 9.911 | 0.622 | 1.32 | 2.23 | 0.375 | 0.668 | 1.117 | 0.605 | 2.959 | 5.249
COVID19_MODERNA | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [narrow] | 21 | 21.038 | 0.898 | 1.319 | 1.805 | 0.689 | 0.975 | 1.347 | 0.998 | 3.523 | 30.958
COVID19_MODERNA | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [broad] | 21 | 21.038 | 0.898 | 1.319 | 1.805 | 0.689 | 0.975 | 1.347 | 0.998 | 3.523 | 30.958
COVID19_MODERNA | Superinfection | 1 | 1.046 | 0.343 | 1.319 | 2.811 | 0.354 | 0.862 | 1.828 | 0.956 | 3.523 | 0.118
COVID19_MODERNA | Aspiration bursa | 1 | 0.522 | 0.361 | 1.318 | 2.763 | 0.402 | 0.977 | 2.077 | 1.917 | 4.11 | 0.197
COVID19_MODERNA | Blood ethanol | 1 | 0.671 | 0.378 | 1.317 | 2.718 | 0.388 | 0.941 | 1.997 | 1.491 | 4.932 | 0.315
COVID19_MODERNA | Red blood cells urine positive | 4 | 3.244 | 0.512 | 1.317 | 2.424 | 0.532 | 1.026 | 1.83 | 1.233 | 0.873 | 0.001
COVID19_MODERNA | PCO2 increased | 3 | 4.346 | 0.436 | 1.317 | 2.582 | 0.371 | 0.757 | 1.409 | 0.69 | 1.644 | 0.22
COVID19_MODERNA | Fear of injection | 2 | 1.543 | 0.462 | 1.316 | 2.525 | 0.446 | 0.977 | 1.921 | 1.296 | 1.495 | 0.014
COVID19_MODERNA | Intervertebral disc disorder | 2 | 1.848 | 0.471 | 1.316 | 2.504 | 0.421 | 0.922 | 1.811 | 1.082 | 2.74 | 0.693
COVID19_MODERNA | Endoscopy abnormal | 1 | 1.378 | 0.144 | 1.316 | 3.479 | 0.329 | 0.803 | 1.704 | 0.726 | 0.649 | 0
COVID19_MODERNA | Oral mucosal erythema | 2 | 1.29 | 0.437 | 1.315 | 2.576 | 0.469 | 1.028 | 2.024 | 1.55 | 1.121 | 0.05
COVID19_MODERNA | Dysuria | 9 | 8.762 | 0.72 | 1.315 | 2.057 | 0.592 | 0.972 | 1.524 | 1.027 | 0.881 | 0.046
COVID19_MODERNA | Yawning | 2 | 1.047 | 0.474 | 1.314 | 2.494 | 0.494 | 1.083 | 2.137 | 1.91 | 1.701 | 0.073
COVID19_MODERNA | Periorbital pain | 1 | 0.532 | 0.308 | 1.314 | 2.889 | 0.401 | 0.974 | 2.071 | 1.881 | 2.74 | 0.032
COVID19_MODERNA | Brain herniation | 1 | 1.02 | 0.345 | 1.314 | 2.789 | 0.357 | 0.867 | 1.839 | 0.98 | 3.523 | 0.118
COVID19_MODERNA | Gastrointestinal obstruction (SMQ) [narrow] | 13 | 14.527 | 0.789 | 1.314 | 1.947 | 0.577 | 0.884 | 1.308 | 0.895 | 0.333 | 16.551
COVID19_MODERNA | Gastrointestinal obstruction (SMQ) [broad] | 13 | 14.527 | 0.789 | 1.314 | 1.947 | 0.577 | 0.884 | 1.308 | 0.895 | 0.333 | 16.551
COVID19_MODERNA | Lagophthalmos | 1 | 0.406 | 0.327 | 1.313 | 2.834 | 0.414 | 1.007 | 2.147 | 2.465 | 3.083 | 0.066
COVID19_MODERNA | Troponin I | 8 | 6.317 | 0.73 | 1.313 | 2.035 | 0.662 | 1.111 | 1.775 | 1.266 | 6.364 | 24.487
COVID19_MODERNA | Urine output decreased | 4 | 3.646 | 0.59 | 1.313 | 2.267 | 0.503 | 0.969 | 1.728 | 1.097 | 0.913 | 0.004
COVID19_MODERNA | Blood pressure measurement | 20 | 53.138 | 0.882 | 1.313 | 1.814 | 0.284 | 0.405 | 0.564 | 0.376 | 4.11 | 37.633
COVID19_MODERNA | Oral fungal infection | 1 | 0.512 | 0.364 | 1.312 | 2.737 | 0.403 | 0.979 | 2.082 | 1.952 | 4.11 | 0.197
COVID19_MODERNA | Injection site plaque | 1 | 0.536 | 0.395 | 1.312 | 2.661 | 0.401 | 0.973 | 2.069 | 1.867 | 0.747 | 0.024
COVID19_MODERNA | Breath sounds abnormal | 12 | 9.507 | 0.782 | 1.312 | 1.954 | 0.737 | 1.146 | 1.717 | 1.262 | 1.566 | 1.787
COVID19_MODERNA | Haemophagocytic lymphohistiocytosis | 2 | 1.547 | 0.371 | 1.312 | 2.72 | 0.446 | 0.976 | 1.919 | 1.293 | 1.203 | 0.019
COVID19_MODERNA | Speech disorder developmental | 1 | 0.541 | 0.229 | 1.309 | 3.119 | 0.4 | 0.972 | 2.066 | 1.85 | 0.135 | 4.669
COVID19_MODERNA | Internal haemorrhage | 2 | 2.116 | 0.366 | 1.309 | 2.722 | 0.401 | 0.878 | 1.725 | 0.945 | 4.932 | 2.372
COVID19_MODERNA | Body temperature increased | 251 | 195.496 | 1.176 | 1.308 | 1.445 | 1.149 | 1.276 | 1.413 | 1.284 | 1.96 | 109.515
COVID19_MODERNA | Medical induction of coma | 2 | 1.044 | 0.415 | 1.307 | 2.605 | 0.495 | 1.084 | 2.138 | 1.916 | 2.466 | 0.501
COVID19_MODERNA | Head titubation | 5 | 2.494 | 0.666 | 1.306 | 2.12 | 0.714 | 1.318 | 2.279 | 2.005 | 2.569 | 2.987
COVID19_MODERNA | Platelet transfusion | 11 | 10.962 | 0.755 | 1.306 | 1.98 | 0.609 | 0.963 | 1.462 | 1.004 | 4.049 | 19.057
COVID19_MODERNA | Microbiology test | 1 | 1.133 | 0.349 | 1.306 | 2.756 | 0.347 | 0.846 | 1.794 | 0.882 | 3.523 | 0.118
COVID19_MODERNA | Anion gap normal | 3 | 2.03 | 0.488 | 1.305 | 2.442 | 0.525 | 1.071 | 1.994 | 1.478 | 2.642 | 1.438
COVID19_MODERNA | Infection | 8 | 8.719 | 0.72 | 1.305 | 2.032 | 0.533 | 0.895 | 1.429 | 0.918 | 0.302 | 12.056
COVID19_MODERNA | Vaccination site haemorrhage | 1 | 2.054 | 0.149 | 1.305 | 3.417 | 0.286 | 0.703 | 1.498 | 0.487 | 0.548 | 0.05
COVID19_MODERNA | Ligament rupture | 1 | 0.125 | 0.332 | 1.304 | 2.797 | 0.448 | 1.104 | 2.403 | 7.998 | 3.083 | 0.066
COVID19_MODERNA | Sleep deficit | 1 | 0.671 | 0.367 | 1.304 | 2.708 | 0.387 | 0.941 | 1.997 | 1.491 | 4.11 | 0.197
COVID19_MODERNA | Troponin | 44 | 46.395 | 1.002 | 1.304 | 1.638 | 0.736 | 0.94 | 1.188 | 0.948 | 8.038 | 199.1
COVID19_MODERNA | Pulmonary embolism | 55 | 61.654 | 1.032 | 1.304 | 1.602 | 0.713 | 0.889 | 1.098 | 0.892 | 10.938 | 337.085
COVID19_MODERNA | Secretion discharge | 8 | 5.551 | 0.745 | 1.303 | 1.987 | 0.717 | 1.204 | 1.924 | 1.441 | 0.774 | 0.311
COVID19_MODERNA | Abdominal distension | 29 | 26.463 | 0.941 | 1.303 | 1.714 | 0.79 | 1.065 | 1.411 | 1.096 | 1.478 | 3.774
COVID19_MODERNA | Barium swallow | 1 | 0.657 | 0.296 | 1.302 | 2.889 | 0.389 | 0.944 | 2.004 | 1.522 | 2.466 | 0.012
COVID19_MODERNA | Rhabdomyolysis | 9 | 9.065 | 0.704 | 1.301 | 2.046 | 0.578 | 0.949 | 1.488 | 0.993 | 2.018 | 3.349
COVID19_MODERNA | Orthopaedic examination abnormal | 1 | 0.538 | 0.315 | 1.3 | 2.833 | 0.401 | 0.973 | 2.068 | 1.859 | 2.74 | 0.032
COVID19_MODERNA | Nipple pain | 1 | 0.767 | 0.217 | 1.3 | 3.129 | 0.378 | 0.919 | 1.95 | 1.303 | 2.055 | 0
COVID19_MODERNA | Local reaction | 30 | 25.41 | 0.955 | 1.3 | 1.689 | 0.848 | 1.138 | 1.502 | 1.181 | 0.339 | 37.77
COVID19_MODERNA | Bacterial infection | 3 | 2.646 | 0.521 | 1.3 | 2.362 | 0.473 | 0.964 | 1.794 | 1.134 | 0.376 | 2.463
COVID19_MODERNA | Blood chloride decreased | 8 | 8.863 | 0.713 | 1.3 | 2.029 | 0.526 | 0.884 | 1.412 | 0.903 | 4.384 | 14.882
COVID19_MODERNA | Red blood cell count decreased | 16 | 17.762 | 0.828 | 1.3 | 1.858 | 0.602 | 0.89 | 1.278 | 0.901 | 1.769 | 4.278
COVID19_MODERNA | Arthropod bite | 1 | 0.343 | 0.235 | 1.298 | 3.065 | 0.421 | 1.025 | 2.19 | 2.912 | 0.418 | 0.313
COVID19_MODERNA | Sensory processing disorder | 1 | 0.522 | 0.361 | 1.298 | 2.706 | 0.402 | 0.977 | 2.077 | 1.916 | 0.649 | 0
COVID19_MODERNA | Extravasation events (injections, infusions and implants) (SMQ) [broad] | 2970 | 2338.079 | 1.259 | 1.298 | 1.338 | 1.232 | 1.27 | 1.308 | 1.27 | 1.097 | 30.322
COVID19_MODERNA | White blood cells urine negative | 2 | 1.194 | 0.411 | 1.296 | 2.583 | 0.479 | 1.049 | 2.067 | 1.675 | 0.695 | 0.044
COVID19_MODERNA | Complication associated with device | 2 | 1.532 | 0.461 | 1.296 | 2.473 | 0.447 | 0.979 | 1.925 | 1.305 | 4.484 | 2.027
COVID19_MODERNA | Lymphocyte percentage decreased | 11 | 10.188 | 0.759 | 1.296 | 1.95 | 0.643 | 1.017 | 1.544 | 1.08 | 1.274 | 0.374
COVID19_MODERNA | Tympanic membrane perforation | 1 | 0.553 | 0.409 | 1.295 | 2.585 | 0.399 | 0.969 | 2.059 | 1.809 | 1.072 | 0.211
COVID19_MODERNA | Antinuclear antibody positive | 4 | 3.681 | 0.538 | 1.295 | 2.318 | 0.5 | 0.964 | 1.719 | 1.087 | 0.601 | 0.666
COVID19_MODERNA | Influenza virus test positive | 2 | 2.84 | 0.275 | 1.294 | 2.927 | 0.354 | 0.778 | 1.53 | 0.704 | 0.308 | 2.398
COVID19_MODERNA | Benign prostatic hyperplasia | 1 | 0.644 | 0.338 | 1.293 | 2.749 | 0.39 | 0.947 | 2.011 | 1.554 | 3.083 | 0.066
COVID19_MODERNA | Spleen disorder | 1 | 1.056 | 0.356 | 1.293 | 2.706 | 0.354 | 0.86 | 1.824 | 0.947 | 3.523 | 0.118
COVID19_MODERNA | Angioplasty | 2 | 2.701 | 0.449 | 1.293 | 2.489 | 0.362 | 0.796 | 1.564 | 0.74 | 5.48 | 2.786
COVID19_MODERNA | Contraindicated product administered | 1 | 0.682 | 0.234 | 1.292 | 3.049 | 0.386 | 0.938 | 1.991 | 1.466 | 1.233 | 0.129
COVID19_MODERNA | Respiratory distress | 35 | 29.735 | 0.958 | 1.29 | 1.662 | 0.867 | 1.14 | 1.477 | 1.177 | 1.897 | 12.95
COVID19_MODERNA | Dermatologic examination | 1 | 0.508 | 0.34 | 1.289 | 2.733 | 0.404 | 0.98 | 2.085 | 1.969 | 3.083 | 0.066
COVID19_MODERNA | Venogram normal | 1 | 0.558 | 0.322 | 1.289 | 2.781 | 0.399 | 0.968 | 2.057 | 1.793 | 2.74 | 0.032
COVID19_MODERNA | Cardiac pacemaker insertion | 5 | 4.268 | 0.641 | 1.289 | 2.12 | 0.553 | 1.02 | 1.756 | 1.172 | 4.742 | 9.335
COVID19_MODERNA | Ophthalmoplegia | 3 | 2.989 | 0.527 | 1.289 | 2.323 | 0.448 | 0.914 | 1.7 | 1.004 | 1.608 | 0.19
COVID19_MODERNA | Rash papular | 76 | 62.119 | 1.058 | 1.287 | 1.534 | 0.996 | 1.202 | 1.441 | 1.223 | 2.005 | 34.524
COVID19_MODERNA | Prostate neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 0.666 | 0.371 | 1.286 | 2.649 | 0.388 | 0.942 | 1.999 | 1.501 | 0.986 | 0.243
COVID19_MODERNA | Functional lactation disorders (SMQ) [narrow] | 5 | 5.826 | 0.566 | 1.286 | 2.243 | 0.461 | 0.851 | 1.465 | 0.858 | 4.11 | 7.504
COVID19_MODERNA | Functional lactation disorders (SMQ) [broad] | 5 | 5.826 | 0.566 | 1.286 | 2.243 | 0.461 | 0.851 | 1.465 | 0.858 | 4.11 | 7.504
COVID19_MODERNA | Preterm premature rupture of membranes | 1 | 1.963 | 0.111 | 1.286 | 3.546 | 0.291 | 0.715 | 1.523 | 0.509 | 1.541 | 0.041
COVID19_MODERNA | Vaccination site swelling | 52 | 44.695 | 1.014 | 1.285 | 1.584 | 0.908 | 1.139 | 1.414 | 1.163 | 1.057 | 0.103
COVID19_MODERNA | Gastric dilatation | 1 | 1.08 | 0.287 | 1.285 | 2.867 | 0.352 | 0.856 | 1.815 | 0.926 | 1.298 | 0.104
COVID19_MODERNA | Axillary pain | 133 | 107.516 | 1.109 | 1.284 | 1.47 | 1.061 | 1.224 | 1.406 | 1.237 | 4.136 | 268.771
COVID19_MODERNA | Urobilinogen urine | 2 | 1.742 | 0.471 | 1.284 | 2.422 | 0.429 | 0.94 | 1.848 | 1.148 | 1.495 | 0.014
COVID19_MODERNA | Blood cholesterol decreased | 1 | 1.017 | 0.344 | 1.283 | 2.706 | 0.357 | 0.868 | 1.84 | 0.984 | 3.083 | 0.066
COVID19_MODERNA | Shock | 5 | 4.475 | 0.589 | 1.282 | 2.193 | 0.539 | 0.993 | 1.711 | 1.117 | 0.9 | 0
COVID19_MODERNA | Vitamin D decreased | 2 | 1.852 | 0.357 | 1.282 | 2.673 | 0.42 | 0.921 | 1.81 | 1.08 | 0.649 | 0.1
COVID19_MODERNA | Ventricular tachyarrhythmias (SMQ) [narrow] | 30 | 34.501 | 0.927 | 1.281 | 1.682 | 0.646 | 0.867 | 1.144 | 0.87 | 5.48 | 86.169
COVID19_MODERNA | Ventricular tachyarrhythmias (SMQ) [broad] | 30 | 34.501 | 0.927 | 1.281 | 1.682 | 0.646 | 0.867 | 1.144 | 0.87 | 5.48 | 86.169
COVID19_MODERNA | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [narrow] | 59 | 56.972 | 1.024 | 1.28 | 1.561 | 0.827 | 1.024 | 1.256 | 1.036 | 3.88 | 106.539
COVID19_MODERNA | Skin test negative | 1 | 0.249 | 0.323 | 1.279 | 2.749 | 0.433 | 1.055 | 2.264 | 4.016 | 0.536 | 0.062
COVID19_MODERNA | Ammonia normal | 1 | 0.534 | 0.369 | 1.279 | 2.633 | 0.401 | 0.974 | 2.07 | 1.872 | 0.948 | 0.198
COVID19_MODERNA | Hallucination | 26 | 21.241 | 0.919 | 1.279 | 1.688 | 0.853 | 1.168 | 1.569 | 1.224 | 2.375 | 17.607
COVID19_MODERNA | Tendon pain | 2 | 1.166 | 0.508 | 1.278 | 2.331 | 0.482 | 1.056 | 2.08 | 1.716 | 1.007 | 0.124
COVID19_MODERNA | Craniocerebral injury | 1 | 1.547 | 0.203 | 1.278 | 3.115 | 0.317 | 0.776 | 1.647 | 0.646 | 1.233 | 0.129
COVID19_MODERNA | Alanine aminotransferase normal | 15 | 14.412 | 0.801 | 1.277 | 1.844 | 0.669 | 1 | 1.45 | 1.041 | 0.953 | 0.003
COVID19_MODERNA | N-terminal prohormone brain natriuretic peptide increased | 3 | 4.28 | 0.451 | 1.277 | 2.444 | 0.374 | 0.764 | 1.421 | 0.701 | 4.352 | 3.953
COVID19_MODERNA | Telangiectasia | 1 | 0.21 | 0.348 | 1.276 | 2.678 | 0.437 | 1.069 | 2.301 | 4.772 | 3.083 | 0.066
COVID19_MODERNA | Increased viscosity of upper respiratory secretion | 1 | 0.726 | 0.277 | 1.276 | 2.87 | 0.382 | 0.928 | 1.97 | 1.378 | 1.644 | 0.025
COVID19_MODERNA | Prothrombin level normal | 2 | 1.565 | 0.446 | 1.276 | 2.453 | 0.444 | 0.973 | 1.912 | 1.278 | 4.484 | 2.027
COVID19_MODERNA | Blood urea increased | 32 | 35.653 | 0.937 | 1.276 | 1.658 | 0.671 | 0.892 | 1.168 | 0.898 | 4.36 | 67.511
COVID19_MODERNA | Culture urine | 14 | 11.901 | 0.813 | 1.275 | 1.821 | 0.726 | 1.098 | 1.607 | 1.176 | 1.951 | 5.131
COVID19_MODERNA | Aggression | 7 | 5.113 | 0.695 | 1.274 | 1.995 | 0.667 | 1.15 | 1.878 | 1.369 | 0.767 | 0.274
COVID19_MODERNA | Paresis | 1 | 1.205 | 0.147 | 1.273 | 3.326 | 0.342 | 0.833 | 1.767 | 0.83 | 0.357 | 0.575
COVID19_MODERNA | Amylase | 2 | 1.578 | 0.491 | 1.272 | 2.351 | 0.443 | 0.97 | 1.908 | 1.268 | 4.11 | 1.737
COVID19_MODERNA | X-ray of pelvis and hip | 5 | 3.556 | 0.702 | 1.271 | 1.977 | 0.608 | 1.121 | 1.932 | 1.406 | 4.932 | 9.876
COVID19_MODERNA | Catheterisation cardiac normal | 13 | 9.501 | 0.815 | 1.271 | 1.809 | 0.798 | 1.223 | 1.81 | 1.368 | 13.358 | 88.255
COVID19_MODERNA | Blood count abnormal | 3 | 2.312 | 0.534 | 1.271 | 2.263 | 0.5 | 1.019 | 1.897 | 1.298 | 2.74 | 1.577
COVID19_MODERNA | Feeding tube user | 1 | 1.044 | 0.323 | 1.271 | 2.73 | 0.355 | 0.863 | 1.829 | 0.958 | 1.298 | 0.104
COVID19_MODERNA | Hypoxia | 59 | 67.238 | 1.017 | 1.271 | 1.548 | 0.707 | 0.876 | 1.074 | 0.877 | 8.459 | 283.392
COVID19_MODERNA | Iridocyclitis | 1 | 1.346 | 0.163 | 1.271 | 3.25 | 0.331 | 0.808 | 1.715 | 0.743 | 0.881 | 0.126
COVID19_MODERNA | Haemodynamic oedema, effusions and fluid overload (SMQ) [narrow] | 1723 | 1404.812 | 1.22 | 1.27 | 1.321 | 1.178 | 1.226 | 1.275 | 1.226 | 0.921 | 12.954
COVID19_MODERNA | Haemodynamic oedema, effusions and fluid overload (SMQ) [broad] | 1723 | 1404.812 | 1.22 | 1.27 | 1.321 | 1.178 | 1.226 | 1.275 | 1.226 | 0.921 | 12.954
COVID19_MODERNA | Lumbar puncture normal | 8 | 7.645 | 0.725 | 1.27 | 1.939 | 0.584 | 0.98 | 1.565 | 1.046 | 0.655 | 1.085
COVID19_MODERNA | C-reactive protein increased | 42 | 43.867 | 0.972 | 1.27 | 1.602 | 0.738 | 0.948 | 1.204 | 0.957 | 0.646 | 7.637
COVID19_MODERNA | Rash erythematous | 254 | 204.491 | 1.143 | 1.269 | 1.401 | 1.113 | 1.235 | 1.367 | 1.242 | 1.293 | 15.986
COVID19_MODERNA | Spinal fracture | 1 | 1.02 | 0.352 | 1.269 | 2.648 | 0.357 | 0.867 | 1.839 | 0.98 | 3.083 | 0.066
COVID19_MODERNA | Lip ulceration | 1 | 1.156 | 0.334 | 1.267 | 2.688 | 0.346 | 0.841 | 1.785 | 0.865 | 2.74 | 0.032
COVID19_MODERNA | Gastrostomy | 2 | 1.044 | 0.319 | 1.266 | 2.724 | 0.495 | 1.084 | 2.139 | 1.916 | 1.37 | 0
COVID19_MODERNA | Phonophobia | 1 | 0.671 | 0.34 | 1.266 | 2.668 | 0.388 | 0.941 | 1.997 | 1.491 | 1.174 | 0.155
COVID19_MODERNA | Blood chloride normal | 18 | 17.405 | 0.84 | 1.266 | 1.763 | 0.69 | 1.001 | 1.412 | 1.034 | 1.536 | 2.668
COVID19_MODERNA | Hepatitis B core antibody negative | 1 | 1.325 | 0.086 | 1.266 | 3.633 | 0.333 | 0.812 | 1.723 | 0.755 | 0.129 | 4.98
COVID19_MODERNA | Red blood cells urine negative | 1 | 0.285 | 0.336 | 1.265 | 2.675 | 0.428 | 1.043 | 2.234 | 3.508 | 0.667 | 0
COVID19_MODERNA | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [broad] | 1222 | 1232.98 | 1.207 | 1.265 | 1.325 | 0.945 | 0.991 | 1.038 | 0.991 | 2.809 | 1322.934
COVID19_MODERNA | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [narrow] | 1222 | 1232.98 | 1.207 | 1.265 | 1.325 | 0.945 | 0.991 | 1.038 | 0.991 | 2.809 | 1322.934
COVID19_MODERNA | Tachyarrhythmia | 1 | 0.683 | 0.337 | 1.264 | 2.671 | 0.386 | 0.938 | 1.991 | 1.464 | 2.74 | 0.032
COVID19_MODERNA | Occult blood negative | 1 | 0.516 | 0.226 | 1.263 | 2.991 | 0.403 | 0.978 | 2.08 | 1.939 | 0.685 | 0.002
COVID19_MODERNA | Prostate neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 0.666 | 0.365 | 1.263 | 2.601 | 0.388 | 0.942 | 1.999 | 1.501 | 0.948 | 0.198
COVID19_MODERNA | Skin disorder | 4 | 3.216 | 0.541 | 1.263 | 2.23 | 0.535 | 1.03 | 1.837 | 1.244 | 0.448 | 2.134
COVID19_MODERNA | Blood calcium normal | 16 | 14.779 | 0.824 | 1.263 | 1.779 | 0.7 | 1.035 | 1.485 | 1.083 | 1.746 | 4.067
COVID19_MODERNA | Coronavirus test negative | 1 | 1.41 | 0.356 | 1.263 | 2.623 | 0.327 | 0.797 | 1.693 | 0.709 | 3.083 | 0.066
COVID19_MODERNA | CSF white blood cell count increased | 2 | 1.764 | 0.349 | 1.262 | 2.635 | 0.427 | 0.936 | 1.84 | 1.134 | 0.285 | 2.849
COVID19_MODERNA | Loose tooth | 1 | 0.512 | 0.338 | 1.261 | 2.661 | 0.403 | 0.979 | 2.082 | 1.952 | 2.74 | 0.032
COVID19_MODERNA | Blood alkaline phosphatase increased | 22 | 23.027 | 0.866 | 1.261 | 1.717 | 0.669 | 0.94 | 1.29 | 0.955 | 2.699 | 19.66
COVID19_MODERNA | Hiccups | 2 | 1.461 | 0.494 | 1.26 | 2.313 | 0.453 | 0.993 | 1.953 | 1.369 | 1.451 | 0.007
COVID19_MODERNA | Dysacusis | 1 | 0.812 | 0.359 | 1.259 | 2.603 | 0.374 | 0.909 | 1.929 | 1.232 | 3.083 | 0.066
COVID19_MODERNA | Sinus pain | 5 | 4.386 | 0.564 | 1.259 | 2.176 | 0.545 | 1.004 | 1.73 | 1.14 | 1.868 | 1.13
COVID19_MODERNA | Blood pressure systolic | 1 | 3.192 | 0.127 | 1.259 | 3.378 | 0.229 | 0.578 | 1.246 | 0.313 | 3.523 | 0.118
COVID19_MODERNA | Injection site exfoliation | 1 | 0.55 | 0.408 | 1.258 | 2.488 | 0.399 | 0.97 | 2.061 | 1.817 | 1.028 | 0.24
COVID19_MODERNA | Basophil count normal | 6 | 5.157 | 0.65 | 1.258 | 2.029 | 0.579 | 1.03 | 1.723 | 1.163 | 1.48 | 0.472
COVID19_MODERNA | Mechanical urticaria | 1 | 0.901 | 0.24 | 1.258 | 2.93 | 0.367 | 0.891 | 1.889 | 1.11 | 1.37 | 0.081
COVID19_MODERNA | Proteinuria (SMQ) [narrow] | 9 | 9.905 | 0.712 | 1.258 | 1.93 | 0.542 | 0.89 | 1.395 | 0.909 | 1.062 | 0
COVID19_MODERNA | Subdural haemorrhage | 3 | 2.571 | 0.446 | 1.257 | 2.4 | 0.479 | 0.976 | 1.816 | 1.167 | 7.398 | 8.162
COVID19_MODERNA | Activated partial thromboplastin time prolonged | 5 | 4.375 | 0.546 | 1.257 | 2.206 | 0.545 | 1.006 | 1.732 | 1.143 | 2.623 | 3.142
COVID19_MODERNA | Protein total normal | 16 | 14.361 | 0.813 | 1.257 | 1.78 | 0.716 | 1.059 | 1.52 | 1.114 | 2.307 | 9.636
COVID19_MODERNA | Skin reaction | 22 | 15.779 | 0.9 | 1.256 | 1.66 | 0.919 | 1.291 | 1.772 | 1.394 | 1.333 | 1.425
COVID19_MODERNA | Blood urea normal | 17 | 16.782 | 0.822 | 1.256 | 1.766 | 0.671 | 0.982 | 1.398 | 1.013 | 1.298 | 0.83
COVID19_MODERNA | Endoscopy normal | 2 | 2.119 | 0.351 | 1.256 | 2.614 | 0.4 | 0.878 | 1.725 | 0.944 | 1.761 | 0.097
COVID19_MODERNA | Anion gap decreased | 4 | 2.627 | 0.621 | 1.255 | 2.067 | 0.585 | 1.128 | 2.014 | 1.523 | 9.864 | 16.648
COVID19_MODERNA | Muscle rigidity | 9 | 8.048 | 0.724 | 1.255 | 1.905 | 0.629 | 1.032 | 1.617 | 1.118 | 0.75 | 0.499
COVID19_MODERNA | PCO2 normal | 1 | 1.071 | 0.211 | 1.255 | 3.019 | 0.352 | 0.857 | 1.818 | 0.933 | 0.514 | 0.091
COVID19_MODERNA | Cardiomyopathy | 3 | 3.326 | 0.414 | 1.255 | 2.466 | 0.426 | 0.869 | 1.617 | 0.902 | 1.574 | 0.162
COVID19_MODERNA | Bundle branch block right | 2 | 2.44 | 0.406 | 1.254 | 2.48 | 0.378 | 0.831 | 1.632 | 0.82 | 2.055 | 0.243
COVID19_MODERNA | Cerebral ischaemia | 2 | 1.534 | 0.455 | 1.253 | 2.373 | 0.447 | 0.979 | 1.924 | 1.304 | 2.901 | 0.811
COVID19_MODERNA | Macule | 2 | 1.548 | 0.489 | 1.253 | 2.304 | 0.446 | 0.976 | 1.919 | 1.292 | 0.56 | 0.301
COVID19_MODERNA | Angioedema | 49 | 44.703 | 0.98 | 1.253 | 1.554 | 0.853 | 1.077 | 1.345 | 1.096 | 2.431 | 36.298
COVID19_MODERNA | Antineutrophil cytoplasmic antibody negative | 2 | 1.963 | 0.342 | 1.253 | 2.628 | 0.412 | 0.902 | 1.773 | 1.019 | 0.479 | 0.645
COVID19_MODERNA | Toxicity to various agents | 1 | 0.523 | 0.334 | 1.252 | 2.648 | 0.402 | 0.977 | 2.076 | 1.913 | 2.055 | 0
COVID19_MODERNA | Oropharyngeal disorders (SMQ) [broad] | 1285 | 1299.838 | 1.195 | 1.252 | 1.309 | 0.944 | 0.988 | 1.034 | 0.989 | 2.499 | 1092.739
COVID19_MODERNA | Oropharyngeal disorders (SMQ) [narrow] | 1285 | 1299.838 | 1.195 | 1.252 | 1.309 | 0.944 | 0.988 | 1.034 | 0.989 | 2.499 | 1092.739
COVID19_MODERNA | Embolic stroke | 1 | 3.092 | 0.149 | 1.251 | 3.248 | 0.234 | 0.588 | 1.265 | 0.323 | 3.523 | 0.118
COVID19_MODERNA | Heart rate normal | 1 | 0.693 | 0.418 | 1.25 | 2.442 | 0.385 | 0.936 | 1.986 | 1.443 | 1.028 | 0.24
COVID19_MODERNA | Injection site erosion | 1 | 0.683 | 0.337 | 1.249 | 2.628 | 0.386 | 0.938 | 1.991 | 1.464 | 1.298 | 0.104
COVID19_MODERNA | Dark circles under eyes | 2 | 0.702 | 0.608 | 1.248 | 2.073 | 0.535 | 1.176 | 2.336 | 2.848 | 1.203 | 0.019
COVID19_MODERNA | Skin necrosis | 1 | 0.233 | 0.259 | 1.248 | 2.842 | 0.434 | 1.061 | 2.278 | 4.291 | 0.822 | 0.073
COVID19_MODERNA | CSF red blood cell count | 1 | 0.618 | 0.35 | 1.248 | 2.594 | 0.393 | 0.953 | 2.024 | 1.618 | 0.881 | 0.126
COVID19_MODERNA | Unevaluable event | 68 | 61.028 | 1.014 | 1.247 | 1.5 | 0.901 | 1.099 | 1.33 | 1.114 | 1.432 | 7.987
COVID19_MODERNA | Increased upper airway secretion | 4 | 3.243 | 0.577 | 1.246 | 2.121 | 0.532 | 1.026 | 1.83 | 1.234 | 1.451 | 0.179
COVID19_MODERNA | Calcium ionised normal | 1 | 0.694 | 0.408 | 1.245 | 2.45 | 0.385 | 0.935 | 1.985 | 1.44 | 1.644 | 0.025
COVID19_MODERNA | Type IV hypersensitivity reaction | 5 | 4.022 | 0.604 | 1.245 | 2.073 | 0.571 | 1.052 | 1.813 | 1.243 | 3.978 | 7.115
COVID19_MODERNA | Ultrasound skull | 2 | 1.583 | 0.276 | 1.245 | 2.785 | 0.442 | 0.969 | 1.906 | 1.263 | 1.203 | 0.019
COVID19_MODERNA | Blood fibrinogen | 2 | 3.091 | 0.344 | 1.245 | 2.603 | 0.341 | 0.749 | 1.473 | 0.647 | 2.596 | 0.591
COVID19_MODERNA | Gastrointestinal ulceration (SMQ) [broad] | 6 | 5.794 | 0.605 | 1.244 | 2.069 | 0.54 | 0.96 | 1.606 | 1.036 | 0.86 | 0.029
COVID19_MODERNA | Gastrointestinal ulceration (SMQ) [narrow] | 6 | 5.794 | 0.605 | 1.244 | 2.069 | 0.54 | 0.96 | 1.606 | 1.036 | 0.86 | 0.029
COVID19_MODERNA | Hepatitis, non-infectious (SMQ) [broad] | 6 | 6.359 | 0.583 | 1.244 | 2.106 | 0.509 | 0.906 | 1.515 | 0.943 | 0.902 | 0.002
COVID19_MODERNA | Hepatitis, non-infectious (SMQ) [narrow] | 6 | 6.359 | 0.583 | 1.244 | 2.106 | 0.509 | 0.906 | 1.515 | 0.943 | 0.902 | 0.002
COVID19_MODERNA | Pancytopenia | 7 | 7.821 | 0.644 | 1.244 | 2.003 | 0.509 | 0.878 | 1.432 | 0.895 | 3.836 | 10.278
COVID19_MODERNA | Injection site ulcer | 2 | 1.47 | 0.557 | 1.243 | 2.15 | 0.452 | 0.991 | 1.949 | 1.36 | 0.931 | 0.062
COVID19_MODERNA | Urinary tract infection | 52 | 50.975 | 0.978 | 1.243 | 1.534 | 0.804 | 1.008 | 1.252 | 1.02 | 2.794 | 52.211
COVID19_MODERNA | Magnetic resonance imaging thoracic abnormal | 2 | 2.581 | 0.407 | 1.243 | 2.448 | 0.37 | 0.812 | 1.595 | 0.775 | 2.596 | 0.591
COVID19_MODERNA | Lacrimation increased | 34 | 27.883 | 0.927 | 1.242 | 1.594 | 0.891 | 1.176 | 1.528 | 1.219 | 2.065 | 16.25
COVID19_MODERNA | Serum ferritin increased | 7 | 8.632 | 0.622 | 1.242 | 2.035 | 0.475 | 0.819 | 1.337 | 0.811 | 2.83 | 5.822
COVID19_MODERNA | Oedema | 17 | 16.751 | 0.834 | 1.241 | 1.715 | 0.672 | 0.984 | 1.4 | 1.015 | 0.746 | 1.184
COVID19_MODERNA | Vaccination site pruritus | 10 | 11.118 | 0.69 | 1.241 | 1.923 | 0.55 | 0.885 | 1.364 | 0.899 | 2.466 | 6.599
COVID19_MODERNA | Radiculopathy | 2 | 1.673 | 0.396 | 1.24 | 2.465 | 0.435 | 0.953 | 1.873 | 1.196 | 0.624 | 0.142
COVID19_MODERNA | Injection site papule | 2 | 1.915 | 0.476 | 1.24 | 2.297 | 0.415 | 0.91 | 1.789 | 1.044 | 0.498 | 0.545
COVID19_MODERNA | Lymphopenia | 1 | 1.167 | 0.134 | 1.24 | 3.283 | 0.345 | 0.839 | 1.781 | 0.857 | 0.493 | 0.124
COVID19_MODERNA | Kidney infection | 2 | 3.725 | 0.332 | 1.238 | 2.611 | 0.31 | 0.683 | 1.345 | 0.537 | 1.495 | 0.014
COVID19_MODERNA | Colonoscopy abnormal | 2 | 2.224 | 0.355 | 1.237 | 2.551 | 0.393 | 0.862 | 1.693 | 0.899 | 1.174 | 0.028
COVID19_MODERNA | Blood pressure systolic decreased | 2 | 0.846 | 0.466 | 1.236 | 2.306 | 0.517 | 1.135 | 2.245 | 2.365 | 4.932 | 2.372
COVID19_MODERNA | Blood blister | 2 | 1.546 | 0.502 | 1.236 | 2.234 | 0.446 | 0.976 | 1.92 | 1.293 | 2.466 | 0.501
COVID19_MODERNA | Tongue disorder | 21 | 16.176 | 0.878 | 1.233 | 1.638 | 0.859 | 1.214 | 1.678 | 1.298 | 5.127 | 54.281
COVID19_MODERNA | Malnutrition | 1 | 1.207 | 0.177 | 1.233 | 3.077 | 0.342 | 0.832 | 1.766 | 0.828 | 0.948 | 0.198
COVID19_MODERNA | Injection site streaking | 8 | 6.669 | 0.674 | 1.232 | 1.925 | 0.639 | 1.073 | 1.714 | 1.2 | 1.37 | 0.437
COVID19_MODERNA | Pericarditis | 22 | 22.527 | 0.838 | 1.232 | 1.688 | 0.682 | 0.958 | 1.315 | 0.977 | 3.288 | 28.859
COVID19_MODERNA | COVID-19 (SMQ) [broad] | 655 | 1163.36 | 1.154 | 1.232 | 1.312 | 0.529 | 0.564 | 0.601 | 0.563 | 5.555 | 2013.74
COVID19_MODERNA | Pulmonary congestion | 12 | 12.121 | 0.739 | 1.231 | 1.824 | 0.614 | 0.955 | 1.432 | 0.99 | 3.946 | 20.189
COVID19_MODERNA | Colitis ulcerative | 2 | 2.126 | 0.321 | 1.23 | 2.618 | 0.4 | 0.877 | 1.722 | 0.941 | 0.624 | 0.142
COVID19_MODERNA | Rash macular | 110 | 88.579 | 1.052 | 1.229 | 1.418 | 1.048 | 1.226 | 1.427 | 1.242 | 1.48 | 15.772
COVID19_MODERNA | Visual acuity tests abnormal | 1 | 0.795 | 0.127 | 1.229 | 3.281 | 0.376 | 0.913 | 1.937 | 1.258 | 0.601 | 0.012
COVID19_MODERNA | Nasal congestion | 74 | 85.111 | 1.007 | 1.229 | 1.469 | 0.717 | 0.868 | 1.043 | 0.869 | 1.933 | 30.106
COVID19_MODERNA | Respiration abnormal | 10 | 9.351 | 0.711 | 1.228 | 1.86 | 0.625 | 1.005 | 1.55 | 1.069 | 1.34 | 0.518
COVID19_MODERNA | Coronary arterial stent insertion | 5 | 5.493 | 0.569 | 1.228 | 2.092 | 0.478 | 0.882 | 1.519 | 0.91 | 7.706 | 17.235
COVID19_MODERNA | Palatal swelling | 2 | 1.388 | 0.491 | 1.227 | 2.231 | 0.46 | 1.008 | 1.983 | 1.441 | 3.523 | 1.282
COVID19_MODERNA | Vaccination site warmth | 31 | 26.24 | 0.898 | 1.227 | 1.597 | 0.853 | 1.14 | 1.498 | 1.181 | 1.138 | 0.367
COVID19_MODERNA | Faeces soft | 1 | 0.798 | 0.151 | 1.227 | 3.167 | 0.376 | 0.912 | 1.936 | 1.253 | 0.457 | 0.201
COVID19_MODERNA | Rosacea | 1 | 0.717 | 0.43 | 1.226 | 2.354 | 0.383 | 0.93 | 1.974 | 1.396 | 1.028 | 0.24
COVID19_MODERNA | Blood lactic acid increased | 19 | 22.266 | 0.824 | 1.225 | 1.691 | 0.593 | 0.851 | 1.192 | 0.853 | 3.577 | 28.518
COVID19_MODERNA | Visual field defect | 8 | 8.184 | 0.644 | 1.224 | 1.956 | 0.557 | 0.935 | 1.494 | 0.978 | 1.578 | 1.078
COVID19_MODERNA | Gastrointestinal haemorrhage (SMQ) [narrow] | 40 | 46.916 | 0.929 | 1.224 | 1.552 | 0.659 | 0.852 | 1.087 | 0.853 | 0.599 | 10.161
COVID19_MODERNA | Gastrointestinal haemorrhage (SMQ) [broad] | 40 | 46.916 | 0.929 | 1.224 | 1.552 | 0.659 | 0.852 | 1.087 | 0.853 | 0.599 | 10.161
COVID19_MODERNA | Globulin | 4 | 3.38 | 0.508 | 1.223 | 2.19 | 0.522 | 1.006 | 1.794 | 1.183 | 2.901 | 2.865
COVID19_MODERNA | Clostridium difficile infection | 1 | 1.173 | 0.37 | 1.223 | 2.477 | 0.344 | 0.838 | 1.778 | 0.852 | 2.242 | 0.002
COVID19_MODERNA | Injection site hypoaesthesia | 25 | 19.393 | 0.881 | 1.222 | 1.608 | 0.885 | 1.218 | 1.645 | 1.289 | 1.722 | 6.398
COVID19_MODERNA | Ultrasound kidney | 3 | 1.543 | 0.574 | 1.22 | 2.061 | 0.575 | 1.173 | 2.192 | 1.944 | 3.699 | 2.986
COVID19_MODERNA | Hypokalaemia | 9 | 10.454 | 0.671 | 1.22 | 1.901 | 0.521 | 0.855 | 1.341 | 0.861 | 3.363 | 11.077
COVID19_MODERNA | Irregular breathing | 1 | 1.531 | 0.263 | 1.22 | 2.749 | 0.318 | 0.778 | 1.653 | 0.653 | 0.601 | 0.012
COVID19_MODERNA | Vaccination site bruising | 6 | 4.479 | 0.617 | 1.219 | 1.985 | 0.628 | 1.117 | 1.868 | 1.34 | 1.451 | 0.412
COVID19_MODERNA | Dry skin | 14 | 13.168 | 0.771 | 1.219 | 1.75 | 0.671 | 1.015 | 1.486 | 1.063 | 0.913 | 0.041
COVID19_MODERNA | Blood bilirubin increased | 12 | 12.687 | 0.722 | 1.219 | 1.821 | 0.593 | 0.922 | 1.382 | 0.946 | 1.502 | 1.439
COVID19_MODERNA | Blood phosphorus decreased | 4 | 2.263 | 0.551 | 1.218 | 2.097 | 0.622 | 1.199 | 2.143 | 1.767 | 3.653 | 4.525
COVID19_MODERNA | Dry mouth | 60 | 54.763 | 0.975 | 1.218 | 1.484 | 0.874 | 1.08 | 1.322 | 1.096 | 3.325 | 83.963
COVID19_MODERNA | Cerebral disorder | 1 | 1.043 | 0.259 | 1.218 | 2.753 | 0.355 | 0.863 | 1.83 | 0.959 | 0.385 | 0.438
COVID19_MODERNA | Mean platelet volume decreased | 1 | 0.655 | 0.348 | 1.217 | 2.512 | 0.389 | 0.944 | 2.005 | 1.527 | 1.028 | 0.24
COVID19_MODERNA | Blood folate | 3 | 2.606 | 0.484 | 1.217 | 2.219 | 0.476 | 0.97 | 1.806 | 1.151 | 4.932 | 4.799
COVID19_MODERNA | SARS-CoV-2 antibody test | 6 | 16.871 | 0.561 | 1.217 | 2.077 | 0.245 | 0.439 | 0.737 | 0.356 | 3.894 | 8.696
COVID19_MODERNA | Injection site pain | 1485 | 1239.917 | 1.165 | 1.216 | 1.269 | 1.146 | 1.197 | 1.248 | 1.198 | 1.254 | 79.443
COVID19_MODERNA | Blood bilirubin normal | 13 | 16.266 | 0.739 | 1.216 | 1.789 | 0.526 | 0.807 | 1.194 | 0.799 | 1.595 | 2.161
COVID19_MODERNA | Hot flush | 97 | 84.572 | 1.023 | 1.215 | 1.421 | 0.96 | 1.134 | 1.333 | 1.147 | 4.446 | 216.901
COVID19_MODERNA | Injection site vesicles | 13 | 12.419 | 0.754 | 1.214 | 1.763 | 0.652 | 1 | 1.48 | 1.047 | 0.362 | 13.775
COVID19_MODERNA | C-reactive protein | 24 | 23.13 | 0.857 | 1.214 | 1.623 | 0.729 | 1.011 | 1.372 | 1.038 | 1.276 | 1.101
COVID19_MODERNA | Blindness unilateral | 7 | 8.359 | 0.662 | 1.214 | 1.901 | 0.486 | 0.838 | 1.367 | 0.837 | 1.37 | 0.348
COVID19_MODERNA | X-ray of pelvis and hip normal | 1 | 0.518 | 0.361 | 1.213 | 2.473 | 0.403 | 0.978 | 2.079 | 1.932 | 0.649 | 0
COVID19_MODERNA | Road traffic accident | 4 | 2.968 | 0.617 | 1.213 | 1.971 | 0.555 | 1.069 | 1.908 | 1.348 | 1.541 | 0.284
COVID19_MODERNA | Granulocyte count | 3 | 2.203 | 0.518 | 1.213 | 2.145 | 0.51 | 1.038 | 1.933 | 1.362 | 2.959 | 1.893
COVID19_MODERNA | Oesophageal spasm | 3 | 2.409 | 0.524 | 1.213 | 2.134 | 0.492 | 1.002 | 1.866 | 1.245 | 9.248 | 10.415
COVID19_MODERNA | Cardiovascular examination | 2 | 1.604 | 0.295 | 1.213 | 2.636 | 0.441 | 0.965 | 1.898 | 1.247 | 1.233 | 0.012
COVID19_MODERNA | Blood gases | 9 | 7.946 | 0.687 | 1.213 | 1.86 | 0.634 | 1.041 | 1.632 | 1.133 | 4.268 | 16.413
COVID19_MODERNA | Mydriasis | 9 | 7.063 | 0.691 | 1.212 | 1.852 | 0.687 | 1.127 | 1.767 | 1.274 | 1.261 | 0.241
COVID19_MODERNA | Skin test positive | 1 | 0.234 | 0.154 | 1.21 | 3.101 | 0.434 | 1.06 | 2.277 | 4.265 | 0.196 | 2.502
COVID19_MODERNA | Epididymitis | 1 | 0.544 | 0.376 | 1.21 | 2.427 | 0.4 | 0.971 | 2.064 | 1.837 | 2.74 | 0.032
COVID19_MODERNA | Lymphadenitis | 16 | 13.917 | 0.788 | 1.21 | 1.707 | 0.734 | 1.086 | 1.558 | 1.15 | 1.844 | 4.964
COVID19_MODERNA | Functional, inflammatory and gallstone related biliary disorders (SMQ) [narrow] | 33 | 33.808 | 0.891 | 1.21 | 1.569 | 0.727 | 0.963 | 1.256 | 0.976 | 1.919 | 12.626
COVID19_MODERNA | Haematocrit decreased | 20 | 20.92 | 0.81 | 1.209 | 1.673 | 0.659 | 0.939 | 1.306 | 0.956 | 1.586 | 3.518
COVID19_MODERNA | Blood count | 1 | 1.153 | 0.223 | 1.209 | 2.841 | 0.346 | 0.842 | 1.786 | 0.867 | 0.548 | 0.05
COVID19_MODERNA | Blood calcium increased | 2 | 2.076 | 0.376 | 1.208 | 2.424 | 0.403 | 0.884 | 1.738 | 0.964 | 1.028 | 0.107
COVID19_MODERNA | Sluggishness | 16 | 13.403 | 0.801 | 1.207 | 1.681 | 0.757 | 1.118 | 1.605 | 1.194 | 2.294 | 9.494
COVID19_MODERNA | Myocardial necrosis marker normal | 7 | 6.539 | 0.622 | 1.207 | 1.948 | 0.573 | 0.988 | 1.613 | 1.071 | 3.139 | 7.184
COVID19_MODERNA | Biliary disorders (SMQ) [narrow] | 34 | 34.834 | 0.893 | 1.207 | 1.56 | 0.73 | 0.963 | 1.252 | 0.976 | 1.835 | 11.239
COVID19_MODERNA | Suicide/self-injury (SMQ) [narrow] | 3 | 3.365 | 0.414 | 1.207 | 2.336 | 0.424 | 0.864 | 1.608 | 0.891 | 0.333 | 3.296
COVID19_MODERNA | Suicide/self-injury (SMQ) [broad] | 3 | 3.365 | 0.414 | 1.207 | 2.336 | 0.424 | 0.864 | 1.608 | 0.891 | 0.333 | 3.296
COVID19_MODERNA | Stent placement | 13 | 10.181 | 0.764 | 1.206 | 1.73 | 0.758 | 1.162 | 1.721 | 1.277 | 20.037 | 119.037
COVID19_MODERNA | Lactic acidosis (SMQ) [narrow] | 22 | 25.322 | 0.831 | 1.206 | 1.638 | 0.616 | 0.865 | 1.188 | 0.869 | 3.794 | 36.769
COVID19_MODERNA | Exposure via breast milk | 3 | 2.407 | 0.424 | 1.205 | 2.307 | 0.492 | 1.003 | 1.867 | 1.247 | 6.726 | 7.285
COVID19_MODERNA | Sciatica | 9 | 7.996 | 0.687 | 1.205 | 1.84 | 0.631 | 1.037 | 1.625 | 1.126 | 3.171 | 9.936
COVID19_MODERNA | Oropharyngeal discomfort | 45 | 38.417 | 0.932 | 1.204 | 1.505 | 0.896 | 1.143 | 1.44 | 1.171 | 8.738 | 221.891
COVID19_MODERNA | PO2 normal | 1 | 1.773 | 0.336 | 1.204 | 2.509 | 0.303 | 0.742 | 1.578 | 0.564 | 1.37 | 0.081
COVID19_MODERNA | Chills | 2163 | 1899.219 | 1.161 | 1.203 | 1.246 | 1.099 | 1.138 | 1.179 | 1.139 | 2.81 | 2411.705
COVID19_MODERNA | Faecaloma | 1 | 1.044 | 0.348 | 1.203 | 2.474 | 0.355 | 0.862 | 1.829 | 0.957 | 2.466 | 0.012
COVID19_MODERNA | Hyponatraemia/SIADH (SMQ) [narrow] | 24 | 28.518 | 0.844 | 1.203 | 1.615 | 0.607 | 0.841 | 1.142 | 0.842 | 2.137 | 12.3
COVID19_MODERNA | Dermatologic examination abnormal | 1 | 0.508 | 0.287 | 1.202 | 2.629 | 0.404 | 0.98 | 2.085 | 1.969 | 2.466 | 0.012
COVID19_MODERNA | Visual acuity tests normal | 1 | 0.671 | 0.337 | 1.202 | 2.499 | 0.388 | 0.941 | 1.997 | 1.491 | 2.055 | 0
COVID19_MODERNA | Protein total increased | 4 | 3.379 | 0.506 | 1.202 | 2.138 | 0.522 | 1.006 | 1.794 | 1.184 | 2.013 | 1.037
COVID19_MODERNA | Noninfectious encephalopathy/delirium (SMQ) [narrow] | 32 | 34.654 | 0.882 | 1.202 | 1.563 | 0.688 | 0.915 | 1.199 | 0.923 | 1.437 | 3.612
COVID19_MODERNA | Echocardiogram abnormal | 19 | 21.126 | 0.798 | 1.202 | 1.673 | 0.62 | 0.891 | 1.247 | 0.899 | 2.308 | 11.674
COVID19_MODERNA | Pericardial effusion | 10 | 13.696 | 0.677 | 1.202 | 1.848 | 0.468 | 0.753 | 1.161 | 0.73 | 2.596 | 7.44
COVID19_MODERNA | Induced labour | 2 | 1.752 | 0.343 | 1.201 | 2.481 | 0.428 | 0.938 | 1.844 | 1.142 | 4.484 | 2.027
COVID19_MODERNA | Localised oedema | 4 | 3.66 | 0.548 | 1.201 | 2.06 | 0.502 | 0.967 | 1.724 | 1.093 | 0.873 | 0.001
COVID19_MODERNA | Sudden hearing loss | 7 | 7.753 | 0.597 | 1.201 | 1.974 | 0.512 | 0.883 | 1.44 | 0.903 | 1.644 | 1.087
COVID19_MODERNA | Blood albumin normal | 13 | 13.196 | 0.742 | 1.2 | 1.749 | 0.622 | 0.954 | 1.412 | 0.985 | 2.068 | 5.635
COVID19_MODERNA | Orthostatic hypotension | 8 | 8.696 | 0.618 | 1.2 | 1.938 | 0.534 | 0.896 | 1.432 | 0.92 | 2.349 | 4.449
COVID19_MODERNA | Differential white blood cell count | 32 | 24.914 | 0.9 | 1.198 | 1.531 | 0.923 | 1.228 | 1.608 | 1.284 | 2.474 | 24.186
COVID19_MODERNA | Vertigo positional | 7 | 7.063 | 0.65 | 1.198 | 1.882 | 0.545 | 0.94 | 1.533 | 0.991 | 4.666 | 13.898
COVID19_MODERNA | Diabetes mellitus | 6 | 6.672 | 0.584 | 1.198 | 1.99 | 0.494 | 0.878 | 1.469 | 0.899 | 1.495 | 0.504
COVID19_MODERNA | Seizure | 77 | 79.381 | 0.985 | 1.197 | 1.426 | 0.8 | 0.964 | 1.155 | 0.97 | 0.448 | 51.413
COVID19_MODERNA | Increased bronchial secretion | 1 | 1.07 | 0.225 | 1.197 | 2.8 | 0.352 | 0.858 | 1.819 | 0.935 | 1.644 | 0.025
COVID19_MODERNA | Partial seizures | 2 | 1.102 | 0.474 | 1.196 | 2.186 | 0.488 | 1.07 | 2.11 | 1.815 | 0.376 | 1.446
COVID19_MODERNA | Asthenopia | 8 | 7.563 | 0.626 | 1.196 | 1.914 | 0.588 | 0.987 | 1.577 | 1.058 | 3.401 | 9.827
COVID19_MODERNA | Blood pressure normal | 2 | 1.055 | 0.418 | 1.195 | 2.296 | 0.493 | 1.081 | 2.133 | 1.895 | 1.644 | 0.053
COVID19_MODERNA | Tongue eruption | 4 | 2.6 | 0.598 | 1.195 | 1.959 | 0.588 | 1.133 | 2.023 | 1.538 | 5.48 | 8.477
COVID19_MODERNA | Acute hepatic failure | 1 | 1.016 | 0.199 | 1.195 | 2.881 | 0.357 | 0.868 | 1.841 | 0.984 | 1.644 | 0.025
COVID19_MODERNA | Scan myocardial perfusion | 3 | 1.712 | 0.53 | 1.194 | 2.075 | 0.557 | 1.135 | 2.118 | 1.753 | 7.398 | 8.162
COVID19_MODERNA | Inappropriate affect | 1 | 0.536 | 0.438 | 1.194 | 2.252 | 0.401 | 0.973 | 2.069 | 1.864 | 0.685 | 0.002
COVID19_MODERNA | Blood bicarbonate increased | 3 | 2.576 | 0.461 | 1.194 | 2.204 | 0.479 | 0.975 | 1.815 | 1.165 | 3.363 | 2.486
COVID19_MODERNA | Amylase normal | 2 | 1.564 | 0.534 | 1.193 | 2.066 | 0.444 | 0.973 | 1.913 | 1.279 | 1.591 | 0.037
COVID19_MODERNA | Tearfulness | 4 | 3.332 | 0.479 | 1.193 | 2.167 | 0.526 | 1.013 | 1.807 | 1.201 | 0.71 | 0.215
COVID19_MODERNA | Haemoglobin decreased | 54 | 52.915 | 0.943 | 1.193 | 1.468 | 0.808 | 1.009 | 1.248 | 1.021 | 2.316 | 35.737
COVID19_MODERNA | Eosinophilia | 2 | 2.195 | 0.328 | 1.193 | 2.497 | 0.395 | 0.866 | 1.702 | 0.911 | 0.695 | 0.044
COVID19_MODERNA | Tic | 2 | 2.357 | 0.507 | 1.193 | 2.113 | 0.384 | 0.842 | 1.655 | 0.849 | 0.188 | 6.139
COVID19_MODERNA | Protrusion tongue | 1 | 0.686 | 0.433 | 1.192 | 2.256 | 0.386 | 0.937 | 1.99 | 1.458 | 0.948 | 0.198
COVID19_MODERNA | Electroencephalogram | 22 | 19.619 | 0.832 | 1.191 | 1.603 | 0.767 | 1.077 | 1.479 | 1.121 | 0.91 | 0.109
COVID19_MODERNA | Dizziness postural | 22 | 20.285 | 0.811 | 1.191 | 1.631 | 0.746 | 1.047 | 1.438 | 1.085 | 2.024 | 9.585
COVID19_MODERNA | Echocardiogram | 83 | 82.788 | 0.985 | 1.19 | 1.41 | 0.831 | 0.996 | 1.185 | 1.003 | 6.11 | 280.377
COVID19_MODERNA | Spinal stenosis | 2 | 1.556 | 0.431 | 1.189 | 2.253 | 0.445 | 0.974 | 1.916 | 1.285 | 4.11 | 1.737
COVID19_MODERNA | Pyrexia | 2357 | 2126.819 | 1.149 | 1.189 | 1.23 | 1.071 | 1.108 | 1.146 | 1.108 | 1.415 | 310.192
COVID19_MODERNA | Epinephrine | 7 | 6.14 | 0.646 | 1.188 | 1.864 | 0.597 | 1.029 | 1.679 | 1.14 | 21.578 | 62.292
COVID19_MODERNA | Gastrooesophageal reflux disease | 11 | 10.141 | 0.705 | 1.188 | 1.774 | 0.646 | 1.02 | 1.55 | 1.085 | 0.976 | 0.005
COVID19_MODERNA | Lip exfoliation | 1 | 0.535 | 0.398 | 1.187 | 2.317 | 0.401 | 0.973 | 2.069 | 1.869 | 1.37 | 0.081
COVID19_MODERNA | Foaming at mouth | 7 | 5.029 | 0.67 | 1.187 | 1.823 | 0.673 | 1.161 | 1.896 | 1.392 | 1.191 | 0.058
COVID19_MODERNA | Uveitis | 1 | 0.649 | 0.152 | 1.187 | 3.036 | 0.39 | 0.946 | 2.008 | 1.54 | 0.242 | 1.639
COVID19_MODERNA | Hepatitis B test negative | 3 | 2.345 | 0.399 | 1.187 | 2.316 | 0.497 | 1.013 | 1.886 | 1.279 | 0.74 | 0.068
COVID19_MODERNA | Respiratory failure | 29 | 31.642 | 0.858 | 1.187 | 1.559 | 0.674 | 0.909 | 1.204 | 0.916 | 2.629 | 24.97
COVID19_MODERNA | Osteoporosis/osteopenia (SMQ) [broad] | 18 | 22.542 | 0.789 | 1.187 | 1.652 | 0.555 | 0.804 | 1.135 | 0.799 | 2.69 | 15.694
COVID19_MODERNA | Acute renal failure (SMQ) [narrow] | 61 | 61.314 | 0.951 | 1.186 | 1.443 | 0.8 | 0.986 | 1.206 | 0.995 | 3.207 | 80.112
COVID19_MODERNA | Oesophagogastroduodenoscopy abnormal | 1 | 1.046 | 0.344 | 1.186 | 2.437 | 0.354 | 0.862 | 1.828 | 0.956 | 2.242 | 0.002
COVID19_MODERNA | Glycosylated haemoglobin increased | 3 | 4.164 | 0.444 | 1.186 | 2.219 | 0.38 | 0.775 | 1.442 | 0.72 | 1.48 | 0.095
COVID19_MODERNA | Hypoxic-ischaemic encephalopathy | 1 | 0.515 | 0.224 | 1.185 | 2.765 | 0.403 | 0.978 | 2.081 | 1.94 | 1.174 | 0.155
COVID19_MODERNA | Myelitis | 2 | 2.071 | 0.297 | 1.185 | 2.554 | 0.404 | 0.885 | 1.739 | 0.966 | 0.414 | 1.083
COVID19_MODERNA | Chromosome analysis normal | 1 | 1.408 | 0.151 | 1.184 | 3.031 | 0.327 | 0.798 | 1.694 | 0.71 | 1.37 | 0.081
COVID19_MODERNA | Oral herpes | 19 | 20.083 | 0.788 | 1.183 | 1.644 | 0.647 | 0.93 | 1.302 | 0.946 | 1.151 | 0.226
COVID19_MODERNA | Blood creatinine increased | 53 | 57.257 | 0.932 | 1.183 | 1.459 | 0.735 | 0.921 | 1.141 | 0.926 | 4.097 | 103.777
COVID19_MODERNA | Affective disorder | 1 | 0.508 | 0.323 | 1.182 | 2.478 | 0.404 | 0.98 | 2.085 | 1.969 | 0.747 | 0.024
COVID19_MODERNA | Noninfectious meningitis (SMQ) [narrow] | 46 | 44.974 | 0.914 | 1.182 | 1.478 | 0.794 | 1.009 | 1.269 | 1.023 | 0.829 | 1.404
COVID19_MODERNA | Blood alkaline phosphatase normal | 12 | 11.791 | 0.713 | 1.182 | 1.748 | 0.628 | 0.976 | 1.462 | 1.018 | 1.635 | 2.191
COVID19_MODERNA | Cold sweat | 91 | 76.238 | 0.991 | 1.181 | 1.384 | 0.991 | 1.178 | 1.391 | 1.194 | 1.869 | 33.443
COVID19_MODERNA | Proteinuria (SMQ) [broad] | 12 | 11.945 | 0.718 | 1.181 | 1.739 | 0.621 | 0.966 | 1.448 | 1.005 | 1.02 | 0.006
COVID19_MODERNA | Angiogram pulmonary abnormal | 11 | 12.935 | 0.691 | 1.181 | 1.779 | 0.537 | 0.848 | 1.288 | 0.85 | 18.084 | 92.433
COVID19_MODERNA | Haemoglobin normal | 28 | 24.836 | 0.85 | 1.18 | 1.556 | 0.805 | 1.091 | 1.451 | 1.127 | 0.803 | 1.124
COVID19_MODERNA | Chlamydia test | 1 | 1.323 | 0.202 | 1.18 | 2.824 | 0.333 | 0.812 | 1.723 | 0.756 | 1.644 | 0.025
COVID19_MODERNA | Psoriasis | 2 | 1.159 | 0.391 | 1.179 | 2.31 | 0.482 | 1.057 | 2.083 | 1.725 | 0.408 | 1.142
COVID19_MODERNA | Catheter placement | 2 | 1.556 | 0.407 | 1.179 | 2.275 | 0.445 | 0.974 | 1.916 | 1.286 | 3.083 | 0.946
COVID19_MODERNA | Blood urea nitrogen/creatinine ratio | 5 | 4.883 | 0.588 | 1.179 | 1.935 | 0.513 | 0.946 | 1.628 | 1.024 | 4.252 | 7.917
COVID19_MODERNA | Tongue ulceration | 2 | 2.039 | 0.482 | 1.179 | 2.126 | 0.406 | 0.89 | 1.749 | 0.981 | 1.265 | 0.006
COVID19_MODERNA | Hypokalaemia (SMQ) [narrow] | 42 | 42.307 | 0.906 | 1.178 | 1.48 | 0.763 | 0.981 | 1.245 | 0.993 | 4.603 | 96.77
COVID19_MODERNA | Metamorphopsia | 3 | 2.374 | 0.555 | 1.177 | 1.987 | 0.495 | 1.008 | 1.877 | 1.264 | 3.894 | 3.275
COVID19_MODERNA | Cardiac arrest | 74 | 83.04 | 0.966 | 1.177 | 1.405 | 0.734 | 0.889 | 1.068 | 0.891 | 6.965 | 290.256
COVID19_MODERNA | Injection site discomfort | 37 | 29.869 | 0.894 | 1.176 | 1.49 | 0.916 | 1.196 | 1.539 | 1.239 | 1.346 | 2.791
COVID19_MODERNA | Rash pruritic | 157 | 144.656 | 1.028 | 1.176 | 1.333 | 0.946 | 1.079 | 1.227 | 1.085 | 1.401 | 16.823
COVID19_MODERNA | Oral contusion | 1 | 1.207 | 0.241 | 1.176 | 2.686 | 0.342 | 0.832 | 1.766 | 0.828 | 2.055 | 0
COVID19_MODERNA | Diabetic ketoacidosis | 8 | 5.864 | 0.681 | 1.175 | 1.778 | 0.693 | 1.164 | 1.86 | 1.364 | 10.383 | 41.117
COVID19_MODERNA | Micturition urgency | 3 | 2.828 | 0.462 | 1.175 | 2.153 | 0.46 | 0.937 | 1.743 | 1.061 | 1.213 | 0
COVID19_MODERNA | Adrenocortical insufficiency acute | 1 | 2.086 | 0.092 | 1.175 | 3.297 | 0.284 | 0.699 | 1.49 | 0.479 | 1.897 | 0.004
COVID19_MODERNA | Rheumatoid factor negative | 3 | 3.001 | 0.399 | 1.174 | 2.28 | 0.448 | 0.912 | 1.697 | 1 | 0.385 | 2.302
COVID19_MODERNA | Iron deficiency anaemia | 2 | 2.074 | 0.314 | 1.174 | 2.479 | 0.403 | 0.885 | 1.738 | 0.964 | 2.055 | 0.243
COVID19_MODERNA | Blood pressure immeasurable | 2 | 2.191 | 0.432 | 1.174 | 2.212 | 0.395 | 0.867 | 1.703 | 0.913 | 1.451 | 0.007
COVID19_MODERNA | Tongue discomfort | 8 | 13.546 | 0.631 | 1.174 | 1.851 | 0.382 | 0.643 | 1.027 | 0.591 | 2.666 | 6.035
COVID19_MODERNA | Anti-cyclic citrullinated peptide antibody negative | 1 | 0.927 | 0.27 | 1.173 | 2.592 | 0.364 | 0.886 | 1.878 | 1.079 | 0.632 | 0.002
COVID19_MODERNA | Sepsis | 31 | 33.482 | 0.857 | 1.173 | 1.53 | 0.687 | 0.917 | 1.206 | 0.926 | 1.541 | 5.037
COVID19_MODERNA | Haemolytic disorders (SMQ) [broad] | 8 | 8.956 | 0.632 | 1.171 | 1.844 | 0.523 | 0.878 | 1.402 | 0.893 | 0.962 | 0.005
COVID19_MODERNA | Concussion | 4 | 3.245 | 0.523 | 1.17 | 2.026 | 0.532 | 1.026 | 1.829 | 1.233 | 1.017 | 0.05
COVID19_MODERNA | Lymph node pain | 107 | 93.917 | 0.992 | 1.169 | 1.359 | 0.962 | 1.128 | 1.316 | 1.139 | 4.398 | 235.885
COVID19_MODERNA | Red blood cell nucleated morphology | 6 | 3.586 | 0.621 | 1.168 | 1.854 | 0.706 | 1.256 | 2.104 | 1.673 | 9.864 | 27.87
COVID19_MODERNA | Blood sodium decreased | 19 | 20.981 | 0.783 | 1.168 | 1.617 | 0.624 | 0.896 | 1.255 | 0.906 | 2.055 | 8.52
COVID19_MODERNA | Blood triglycerides increased | 3 | 1.759 | 0.464 | 1.167 | 2.129 | 0.552 | 1.125 | 2.099 | 1.705 | 2.114 | 0.73
COVID19_MODERNA | Papilloedema | 1 | 0.558 | 0.36 | 1.167 | 2.349 | 0.399 | 0.968 | 2.057 | 1.793 | 0.418 | 0.313
COVID19_MODERNA | Cyanosis | 23 | 19.863 | 0.817 | 1.167 | 1.569 | 0.795 | 1.109 | 1.513 | 1.158 | 0.446 | 15.083
COVID19_MODERNA | Tremor | 298 | 260.649 | 1.059 | 1.167 | 1.28 | 1.035 | 1.139 | 1.251 | 1.143 | 1.581 | 60.172
COVID19_MODERNA | Nephrolithiasis | 4 | 3.709 | 0.513 | 1.167 | 2.038 | 0.498 | 0.961 | 1.713 | 1.078 | 1.861 | 0.766
COVID19_MODERNA | Blood osmolarity decreased | 2 | 1.342 | 0.405 | 1.166 | 2.244 | 0.464 | 1.017 | 2.002 | 1.49 | 3.523 | 1.282
COVID19_MODERNA | Delusion | 4 | 2.961 | 0.635 | 1.166 | 1.828 | 0.555 | 1.071 | 1.91 | 1.351 | 2.989 | 3.057
COVID19_MODERNA | Stool analysis normal | 1 | 0.78 | 0.22 | 1.166 | 2.724 | 0.377 | 0.916 | 1.944 | 1.282 | 0.18 | 2.911
COVID19_MODERNA | Hip arthroplasty | 2 | 1.729 | 0.369 | 1.166 | 2.325 | 0.43 | 0.942 | 1.852 | 1.157 | 3.794 | 1.492
COVID19_MODERNA | Haematopoietic leukopenia (SMQ) [narrow] | 41 | 40.031 | 0.889 | 1.166 | 1.474 | 0.783 | 1.009 | 1.284 | 1.024 | 1.014 | 0
COVID19_MODERNA | Spinal X-ray normal | 1 | 1.114 | 0.38 | 1.166 | 2.299 | 0.349 | 0.849 | 1.801 | 0.898 | 0.514 | 0.091
COVID19_MODERNA | Granulocytopenia | 1 | 0.512 | 0.214 | 1.165 | 2.742 | 0.403 | 0.979 | 2.082 | 1.952 | 2.055 | 0
COVID19_MODERNA | Acute pancreatitis (SMQ) [algorithm] | 21 | 20.727 | 0.796 | 1.165 | 1.592 | 0.698 | 0.987 | 1.364 | 1.013 | 2.589 | 17.085
COVID19_MODERNA | Lymphoedema | 7 | 5.019 | 0.648 | 1.164 | 1.802 | 0.674 | 1.163 | 1.898 | 1.395 | 4.316 | 12.383
COVID19_MODERNA | Haemorrhoids | 1 | 0.833 | 0.312 | 1.164 | 2.456 | 0.373 | 0.905 | 1.92 | 1.201 | 1.121 | 0.182
COVID19_MODERNA | Head injury | 27 | 25.414 | 0.842 | 1.164 | 1.529 | 0.76 | 1.035 | 1.383 | 1.062 | 0.798 | 1.139
COVID19_MODERNA | Magnetic resonance imaging head abnormal | 40 | 42.994 | 0.884 | 1.164 | 1.476 | 0.714 | 0.923 | 1.178 | 0.93 | 1.728 | 10.776
COVID19_MODERNA | Cardiac murmur | 2 | 1.264 | 0.404 | 1.163 | 2.239 | 0.472 | 1.034 | 2.036 | 1.583 | 0.881 | 0.026
COVID19_MODERNA | Anticoagulant therapy | 3 | 3.155 | 0.387 | 1.163 | 2.278 | 0.437 | 0.891 | 1.658 | 0.951 | 3.894 | 3.275
COVID19_MODERNA | Resuscitation | 59 | 67.187 | 0.932 | 1.163 | 1.417 | 0.708 | 0.876 | 1.075 | 0.878 | 4.008 | 112.043
COVID19_MODERNA | Inguinal hernia | 1 | 0.514 | 0.294 | 1.162 | 2.499 | 0.403 | 0.979 | 2.082 | 1.947 | 2.055 | 0
COVID19_MODERNA | Base excess decreased | 1 | 0.661 | 0.248 | 1.162 | 2.625 | 0.388 | 0.943 | 2.002 | 1.514 | 0.425 | 0.289
COVID19_MODERNA | Seizure like phenomena | 20 | 17.933 | 0.794 | 1.162 | 1.587 | 0.75 | 1.069 | 1.487 | 1.115 | 1.007 | 0.007
COVID19_MODERNA | Blood creatinine normal | 25 | 25.598 | 0.82 | 1.162 | 1.553 | 0.697 | 0.96 | 1.295 | 0.977 | 1.489 | 3.328
COVID19_MODERNA | Skin weeping | 1 | 1.432 | 0.35 | 1.162 | 2.358 | 0.325 | 0.794 | 1.685 | 0.698 | 1.451 | 0.06
COVID19_MODERNA | Influenza A virus test | 5 | 3.84 | 0.58 | 1.161 | 1.905 | 0.585 | 1.078 | 1.857 | 1.302 | 2.936 | 4.046
COVID19_MODERNA | Cholecystectomy | 8 | 6.486 | 0.643 | 1.161 | 1.803 | 0.651 | 1.093 | 1.745 | 1.233 | 7.891 | 31.246
COVID19_MODERNA | Cervical spinal stenosis | 1 | 1.036 | 0.315 | 1.161 | 2.442 | 0.355 | 0.864 | 1.832 | 0.965 | 2.466 | 0.012
COVID19_MODERNA | Reticulocyte count increased | 1 | 1.047 | 0.256 | 1.161 | 2.599 | 0.354 | 0.862 | 1.828 | 0.955 | 1.897 | 0.004
COVID19_MODERNA | Electrocardiogram ambulatory | 10 | 11.34 | 0.663 | 1.161 | 1.773 | 0.542 | 0.872 | 1.344 | 0.882 | 3.203 | 11.459
COVID19_MODERNA | Drug abuse and dependence (SMQ) [broad] | 78 | 76.809 | 0.955 | 1.159 | 1.378 | 0.837 | 1.008 | 1.205 | 1.016 | 0.537 | 30.302
COVID19_MODERNA | Drug abuse, dependence and withdrawal (SMQ) [broad] | 79 | 78.001 | 0.957 | 1.159 | 1.377 | 0.835 | 1.005 | 1.201 | 1.013 | 0.543 | 29.676
COVID19_MODERNA | Biliary system related investigations, signs and symptoms (SMQ) [narrow] | 19 | 19.688 | 0.769 | 1.159 | 1.615 | 0.658 | 0.946 | 1.324 | 0.965 | 1.433 | 1.944
COVID19_MODERNA | Tongue discolouration | 1 | 1.209 | 0.415 | 1.159 | 2.207 | 0.342 | 0.832 | 1.765 | 0.827 | 0.771 | 0.037
COVID19_MODERNA | Heart rate | 16 | 54.256 | 0.736 | 1.159 | 1.659 | 0.221 | 0.328 | 0.471 | 0.295 | 3.653 | 24.514
COVID19_MODERNA | Stevens-Johnson syndrome | 2 | 1.489 | 0.475 | 1.157 | 2.083 | 0.451 | 0.987 | 1.942 | 1.343 | 0.796 | 0
COVID19_MODERNA | Confusional state | 130 | 119.62 | 0.998 | 1.157 | 1.327 | 0.934 | 1.079 | 1.242 | 1.087 | 2.8 | 133.906
COVID19_MODERNA | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [broad] | 15 | 16.234 | 0.737 | 1.157 | 1.655 | 0.608 | 0.909 | 1.316 | 0.924 | 1.927 | 5.342
COVID19_MODERNA | Pharyngeal hypoaesthesia | 18 | 16.858 | 0.764 | 1.156 | 1.614 | 0.709 | 1.027 | 1.45 | 1.068 | 6.936 | 66.644
COVID19_MODERNA | International normalised ratio increased | 14 | 15.472 | 0.725 | 1.156 | 1.668 | 0.59 | 0.892 | 1.306 | 0.905 | 3.055 | 15.378
COVID19_MODERNA | Limb mass | 8 | 8.14 | 0.672 | 1.155 | 1.743 | 0.559 | 0.939 | 1.499 | 0.983 | 0.728 | 0.539
COVID19_MODERNA | Injection site joint swelling | 2 | 1.069 | 0.43 | 1.154 | 2.162 | 0.492 | 1.078 | 2.126 | 1.87 | 2.349 | 0.423
COVID19_MODERNA | Facial nerve disorder | 1 | 1.159 | 0.319 | 1.154 | 2.411 | 0.345 | 0.841 | 1.784 | 0.863 | 1.451 | 0.06
COVID19_MODERNA | Failure to thrive | 2 | 1.846 | 0.33 | 1.153 | 2.379 | 0.421 | 0.922 | 1.812 | 1.084 | 0.897 | 0.036
COVID19_MODERNA | Sinus tachycardia | 13 | 19.379 | 0.711 | 1.153 | 1.681 | 0.455 | 0.697 | 1.032 | 0.671 | 2.941 | 13.135
COVID19_MODERNA | Injection site extravasation | 5 | 4.475 | 0.525 | 1.152 | 1.978 | 0.539 | 0.993 | 1.711 | 1.117 | 0.811 | 0.065
COVID19_MODERNA | Pain of skin | 38 | 38.101 | 0.878 | 1.152 | 1.457 | 0.756 | 0.984 | 1.262 | 0.997 | 2.154 | 20.552
COVID19_MODERNA | Neck mass | 4 | 3.023 | 0.609 | 1.151 | 1.833 | 0.55 | 1.061 | 1.892 | 1.323 | 1.973 | 0.963
COVID19_MODERNA | Vein disorder | 2 | 1.738 | 0.385 | 1.151 | 2.248 | 0.429 | 0.941 | 1.849 | 1.151 | 3.523 | 1.282
COVID19_MODERNA | Blood lactic acid | 35 | 29.296 | 0.861 | 1.15 | 1.473 | 0.879 | 1.156 | 1.497 | 1.195 | 7.638 | 149.006
COVID19_MODERNA | Coagulation test normal | 2 | 2.275 | 0.324 | 1.15 | 2.388 | 0.389 | 0.854 | 1.678 | 0.879 | 0.56 | 0.301
COVID19_MODERNA | Overdose | 1 | 2.784 | 0.12 | 1.15 | 3.063 | 0.248 | 0.618 | 1.326 | 0.359 | 0.104 | 6.787
COVID19_MODERNA | Monocyte count normal | 8 | 7.063 | 0.626 | 1.148 | 1.8 | 0.615 | 1.034 | 1.651 | 1.133 | 1.746 | 1.712
COVID19_MODERNA | Food intolerance | 1 | 0.964 | 0.221 | 1.148 | 2.667 | 0.361 | 0.878 | 1.862 | 1.038 | 0.249 | 1.535
COVID19_MODERNA | Atrioventricular block | 3 | 3.584 | 0.461 | 1.148 | 2.084 | 0.411 | 0.838 | 1.559 | 0.837 | 6.726 | 7.285
COVID19_MODERNA | Influenza B virus test | 19 | 17.134 | 0.762 | 1.147 | 1.596 | 0.739 | 1.062 | 1.487 | 1.109 | 1.977 | 7.583
COVID19_MODERNA | Panic attack | 14 | 12.762 | 0.716 | 1.146 | 1.659 | 0.688 | 1.04 | 1.523 | 1.097 | 1.569 | 2.192
COVID19_MODERNA | Pulmonary function test | 2 | 1.855 | 0.308 | 1.146 | 2.417 | 0.42 | 0.921 | 1.809 | 1.078 | 1.028 | 0.107
COVID19_MODERNA | Haemolytic disorders (SMQ) [narrow] | 7 | 8.441 | 0.586 | 1.146 | 1.857 | 0.483 | 0.832 | 1.358 | 0.829 | 0.899 | 0.009
COVID19_MODERNA | Rectal haemorrhage | 6 | 6.842 | 0.538 | 1.145 | 1.935 | 0.486 | 0.864 | 1.445 | 0.877 | 1.608 | 0.77
COVID19_MODERNA | Angiogram | 35 | 42.189 | 0.853 | 1.145 | 1.473 | 0.631 | 0.83 | 1.076 | 0.83 | 5.641 | 104.932
COVID19_MODERNA | Pulmonary mass | 2 | 2.823 | 0.352 | 1.145 | 2.305 | 0.355 | 0.781 | 1.535 | 0.709 | 1.591 | 0.037
COVID19_MODERNA | Arteriogram carotid abnormal | 5 | 4.638 | 0.574 | 1.144 | 1.87 | 0.528 | 0.974 | 1.677 | 1.078 | 20.551 | 40.237
COVID19_MODERNA | Painful respiration | 19 | 17.724 | 0.764 | 1.144 | 1.586 | 0.719 | 1.033 | 1.446 | 1.072 | 3.3 | 24.801
COVID19_MODERNA | Pneumonia | 86 | 90.721 | 0.951 | 1.144 | 1.353 | 0.79 | 0.944 | 1.12 | 0.948 | 1.01 | 0.002
COVID19_MODERNA | Incorrect route of product administration | 24 | 21.583 | 0.798 | 1.142 | 1.537 | 0.774 | 1.073 | 1.456 | 1.112 | 0.327 | 32.368
COVID19_MODERNA | Neurological examination normal | 8 | 7.235 | 0.623 | 1.142 | 1.787 | 0.606 | 1.017 | 1.624 | 1.106 | 0.439 | 5.07
COVID19_MODERNA | Torticollis | 1 | 0.553 | 0.375 | 1.141 | 2.242 | 0.399 | 0.969 | 2.059 | 1.808 | 0.617 | 0.006
COVID19_MODERNA | Epstein-Barr virus antibody | 1 | 0.834 | 0.333 | 1.141 | 2.341 | 0.372 | 0.905 | 1.919 | 1.199 | 1.174 | 0.155
COVID19_MODERNA | Appendicectomy | 17 | 21.116 | 0.738 | 1.141 | 1.615 | 0.554 | 0.81 | 1.153 | 0.805 | 4.932 | 41.079
COVID19_MODERNA | CSF glucose decreased | 1 | 0.633 | 0.298 | 1.14 | 2.425 | 0.391 | 0.95 | 2.017 | 1.58 | 0.574 | 0.028
COVID19_MODERNA | Anticholinergic syndrome (SMQ) [algorithm] | 27 | 23.982 | 0.818 | 1.14 | 1.505 | 0.799 | 1.088 | 1.455 | 1.126 | 1.556 | 4.518
COVID19_MODERNA | Erythema | 624 | 568.724 | 1.066 | 1.14 | 1.215 | 1.025 | 1.096 | 1.169 | 1.097 | 0.736 | 60.88
COVID19_MODERNA | Blood sodium normal | 24 | 25.438 | 0.8 | 1.14 | 1.53 | 0.672 | 0.93 | 1.263 | 0.943 | 1.558 | 3.981
COVID19_MODERNA | Mean cell volume normal | 14 | 13.849 | 0.71 | 1.139 | 1.651 | 0.645 | 0.975 | 1.428 | 1.011 | 1.375 | 1.015
COVID19_MODERNA | Muscle contracture | 2 | 1.14 | 0.44 | 1.138 | 2.1 | 0.485 | 1.062 | 2.092 | 1.755 | 1.333 | 0
COVID19_MODERNA | Appendicitis (narrow) (Custom Term) | 25 | 30.369 | 0.797 | 1.138 | 1.529 | 0.599 | 0.825 | 1.114 | 0.823 | 6.559 | 88.554
COVID19_MODERNA | Adverse reaction | 7 | 9.156 | 0.59 | 1.138 | 1.832 | 0.455 | 0.786 | 1.282 | 0.765 | 0.295 | 10.954
COVID19_MODERNA | Stress cardiomyopathy | 4 | 3.175 | 0.519 | 1.137 | 1.948 | 0.538 | 1.037 | 1.849 | 1.26 | 9.864 | 16.648
COVID19_MODERNA | Arteriogram coronary normal | 4 | 3.181 | 0.516 | 1.136 | 1.954 | 0.537 | 1.036 | 1.847 | 1.257 | 8.968 | 15.131
COVID19_MODERNA | Pharyngitis streptococcal | 1 | 0.768 | 0.339 | 1.136 | 2.312 | 0.378 | 0.919 | 1.95 | 1.302 | 0.391 | 0.412
COVID19_MODERNA | Electrocardiogram | 229 | 209.797 | 1.016 | 1.136 | 1.261 | 0.975 | 1.087 | 1.21 | 1.092 | 4.644 | 550.2
COVID19_MODERNA | Sinus bradycardia | 1 | 1.423 | 0.16 | 1.136 | 2.847 | 0.326 | 0.795 | 1.689 | 0.703 | 0.913 | 0.159
COVID19_MODERNA | Ovarian neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 1.555 | 0.213 | 1.136 | 2.66 | 0.317 | 0.774 | 1.645 | 0.643 | 1.121 | 0.182
COVID19_MODERNA | Bilirubin conjugated increased | 2 | 3.107 | 0.293 | 1.135 | 2.424 | 0.34 | 0.747 | 1.469 | 0.644 | 0.931 | 0.062
COVID19_MODERNA | Ophthalmic herpes zoster | 2 | 4.503 | 0.228 | 1.135 | 2.608 | 0.278 | 0.616 | 1.216 | 0.444 | 0.102 | 14.829
COVID19_MODERNA | Ultrasound chest | 2 | 1.198 | 0.432 | 1.133 | 2.102 | 0.478 | 1.048 | 2.065 | 1.669 | 2.596 | 0.591
COVID19_MODERNA | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [algorithm] | 56 | 53.966 | 0.9 | 1.133 | 1.388 | 0.824 | 1.025 | 1.264 | 1.038 | 1.077 | 0.226
COVID19_MODERNA | Albumin globulin ratio | 2 | 2.062 | 0.313 | 1.133 | 2.366 | 0.404 | 0.886 | 1.742 | 0.97 | 2.242 | 0.355
COVID19_MODERNA | Ear haemorrhage | 1 | 0.551 | 0.325 | 1.132 | 2.335 | 0.399 | 0.969 | 2.06 | 1.815 | 1.761 | 0.013
COVID19_MODERNA | Ear congestion | 3 | 2.343 | 0.555 | 1.132 | 1.874 | 0.498 | 1.014 | 1.887 | 1.281 | 1.072 | 0.035
COVID19_MODERNA | Hepatic cirrhosis | 3 | 3.011 | 0.489 | 1.132 | 1.99 | 0.447 | 0.911 | 1.695 | 0.996 | 5.691 | 5.876
COVID19_MODERNA | Pyelonephritis | 1 | 1.191 | 0.221 | 1.132 | 2.621 | 0.343 | 0.835 | 1.772 | 0.84 | 0.685 | 0.002
COVID19_MODERNA | Renal function test | 4 | 3.696 | 0.562 | 1.131 | 1.861 | 0.499 | 0.962 | 1.716 | 1.082 | 3.653 | 4.525
COVID19_MODERNA | Brain natriuretic peptide normal | 7 | 8.5 | 0.582 | 1.131 | 1.827 | 0.48 | 0.828 | 1.352 | 0.824 | 4.426 | 12.864
COVID19_MODERNA | Mania | 2 | 1.205 | 0.379 | 1.13 | 2.206 | 0.478 | 1.047 | 2.062 | 1.66 | 5.48 | 2.786
COVID19_MODERNA | Myalgia | 1064 | 996.538 | 1.074 | 1.13 | 1.187 | 1.014 | 1.067 | 1.122 | 1.068 | 2.23 | 687.098
COVID19_MODERNA | Electrophoresis protein normal | 1 | 0.631 | 0.151 | 1.129 | 2.861 | 0.391 | 0.95 | 2.018 | 1.586 | 0.685 | 0.002
COVID19_MODERNA | Headache | 2794 | 2559.025 | 1.094 | 1.129 | 1.165 | 1.058 | 1.091 | 1.126 | 1.092 | 2.623 | 2770.72
COVID19_MODERNA | Meningism | 1 | 0.51 | 0.183 | 1.128 | 2.738 | 0.403 | 0.98 | 2.084 | 1.96 | 0.385 | 0.438
COVID19_MODERNA | Haemorrhage laboratory terms (SMQ) [narrow] | 17 | 18.867 | 0.741 | 1.128 | 1.58 | 0.609 | 0.891 | 1.268 | 0.901 | 1.375 | 1.296
COVID19_MODERNA | Prostate malignant tumours (SMQ) [narrow] | 1 | 0.557 | 0.337 | 1.127 | 2.294 | 0.399 | 0.968 | 2.057 | 1.794 | 2.466 | 0.012
COVID19_MODERNA | Appetite disorder | 2 | 1.614 | 0.42 | 1.127 | 2.111 | 0.44 | 0.963 | 1.894 | 1.239 | 0.986 | 0.115
COVID19_MODERNA | Swelling | 272 | 245.343 | 1.018 | 1.127 | 1.241 | 0.999 | 1.105 | 1.219 | 1.109 | 0.763 | 19.791
COVID19_MODERNA | Non-cardiac chest pain | 1 | 0.298 | 0.333 | 1.126 | 2.301 | 0.427 | 1.039 | 2.224 | 3.358 | 1.897 | 0.004
COVID19_MODERNA | Scan | 3 | 2.653 | 0.409 | 1.126 | 2.132 | 0.473 | 0.963 | 1.792 | 1.131 | 0.986 | 0.073
COVID19_MODERNA | Hostility/aggression (SMQ) [narrow] | 13 | 11.749 | 0.712 | 1.126 | 1.618 | 0.681 | 1.044 | 1.545 | 1.106 | 0.881 | 0.101
COVID19_MODERNA | Respiratory arrest | 32 | 35.97 | 0.831 | 1.125 | 1.455 | 0.665 | 0.885 | 1.159 | 0.89 | 1.902 | 11.858
COVID19_MODERNA | Nocturia | 1 | 0.7 | 0.305 | 1.124 | 2.364 | 0.385 | 0.934 | 1.983 | 1.429 | 0.747 | 0.024
COVID19_MODERNA | Myasthenia gravis | 4 | 3.223 | 0.517 | 1.124 | 1.921 | 0.534 | 1.029 | 1.836 | 1.241 | 2.055 | 1.115
COVID19_MODERNA | Respiratory rate increased | 21 | 18.522 | 0.784 | 1.124 | 1.515 | 0.768 | 1.086 | 1.5 | 1.134 | 1.969 | 8.372
COVID19_MODERNA | Pruritus | 832 | 742.737 | 1.06 | 1.123 | 1.188 | 1.057 | 1.119 | 1.184 | 1.12 | 1.773 | 270.75
COVID19_MODERNA | Medication errors (SMQ) [narrow] | 464 | 445.317 | 1.039 | 1.123 | 1.21 | 0.964 | 1.04 | 1.122 | 1.042 | 0.157 | 2661.805
COVID19_MODERNA | Communication disorder | 7 | 8.017 | 0.58 | 1.123 | 1.811 | 0.5 | 0.863 | 1.408 | 0.873 | 2.431 | 4.1
COVID19_MODERNA | SARS-CoV-2 test negative | 284 | 384.563 | 1.017 | 1.123 | 1.235 | 0.67 | 0.739 | 0.814 | 0.738 | 7.959 | 1305.355
COVID19_MODERNA | Eye contusion | 3 | 1.847 | 0.49 | 1.122 | 1.965 | 0.543 | 1.107 | 2.063 | 1.624 | 2.959 | 1.893
COVID19_MODERNA | White blood cell count decreased | 21 | 21.337 | 0.767 | 1.122 | 1.531 | 0.681 | 0.963 | 1.331 | 0.984 | 1.126 | 0.171
COVID19_MODERNA | Blood culture negative | 24 | 27.64 | 0.784 | 1.122 | 1.51 | 0.624 | 0.865 | 1.174 | 0.868 | 0.883 | 0.25
COVID19_MODERNA | Vaginal haemorrhage | 14 | 16.234 | 0.696 | 1.122 | 1.631 | 0.567 | 0.858 | 1.256 | 0.862 | 3.596 | 20.611
COVID19_MODERNA | Troponin normal | 31 | 34.355 | 0.822 | 1.121 | 1.458 | 0.671 | 0.896 | 1.178 | 0.902 | 6.02 | 100.188
COVID19_MODERNA | Carbon dioxide | 1 | 1.173 | 0.334 | 1.121 | 2.284 | 0.344 | 0.838 | 1.779 | 0.853 | 2.466 | 0.012
COVID19_MODERNA | Reflexes abnormal | 1 | 1.18 | 0.321 | 1.121 | 2.315 | 0.344 | 0.837 | 1.776 | 0.848 | 2.055 | 0
COVID19_MODERNA | Urine leukocyte esterase | 3 | 3.524 | 0.515 | 1.121 | 1.917 | 0.414 | 0.845 | 1.572 | 0.851 | 2.114 | 0.73
COVID19_MODERNA | Depressed level of consciousness | 20 | 18.269 | 0.764 | 1.12 | 1.532 | 0.739 | 1.053 | 1.464 | 1.095 | 1.002 | 0.011
COVID19_MODERNA | Vasculitis (SMQ) [narrow] | 14 | 12.918 | 0.704 | 1.12 | 1.614 | 0.681 | 1.03 | 1.508 | 1.084 | 0.338 | 17.27
COVID19_MODERNA | Blood albumin | 3 | 4.042 | 0.35 | 1.12 | 2.244 | 0.386 | 0.788 | 1.465 | 0.742 | 1.644 | 0.22
COVID19_MODERNA | Choking sensation | 5 | 4.538 | 0.518 | 1.119 | 1.907 | 0.534 | 0.986 | 1.697 | 1.102 | 2.868 | 3.847
COVID19_MODERNA | Raynaud's phenomenon | 2 | 1.89 | 0.267 | 1.119 | 2.449 | 0.417 | 0.915 | 1.797 | 1.058 | 0.715 | 0.027
COVID19_MODERNA | Infective pneumonia (SMQ) [narrow] | 121 | 129.816 | 0.958 | 1.119 | 1.291 | 0.8 | 0.93 | 1.075 | 0.932 | 1.17 | 2.7
COVID19_MODERNA | Injection site discolouration | 19 | 17.63 | 0.762 | 1.118 | 1.529 | 0.722 | 1.037 | 1.453 | 1.078 | 0.588 | 4.962
COVID19_MODERNA | General physical condition abnormal | 4 | 3.157 | 0.465 | 1.117 | 1.998 | 0.539 | 1.039 | 1.854 | 1.267 | 3.401 | 3.967
COVID19_MODERNA | Complement factor | 1 | 0.833 | 0.193 | 1.117 | 2.668 | 0.373 | 0.905 | 1.92 | 1.201 | 1.644 | 0.025
COVID19_MODERNA | Nausea | 1747 | 1570.279 | 1.074 | 1.117 | 1.162 | 1.069 | 1.112 | 1.156 | 1.113 | 2.545 | 1570.776
COVID19_MODERNA | Prothrombin time prolonged | 8 | 8.789 | 0.601 | 1.117 | 1.761 | 0.53 | 0.89 | 1.421 | 0.91 | 2.349 | 4.449
COVID19_MODERNA | Hyponatraemia | 7 | 9.29 | 0.563 | 1.117 | 1.824 | 0.451 | 0.778 | 1.269 | 0.753 | 2.213 | 3.192
COVID19_MODERNA | Troponin I increased | 8 | 10.603 | 0.562 | 1.117 | 1.825 | 0.462 | 0.776 | 1.24 | 0.755 | 2.242 | 3.931
COVID19_MODERNA | Musculoskeletal discomfort | 24 | 20.645 | 0.805 | 1.116 | 1.469 | 0.804 | 1.114 | 1.512 | 1.163 | 2.152 | 12.547
COVID19_MODERNA | Pollakiuria | 13 | 12.899 | 0.694 | 1.116 | 1.619 | 0.633 | 0.971 | 1.437 | 1.008 | 1.382 | 0.951
COVID19_MODERNA | Essential hypertension | 2 | 2.569 | 0.355 | 1.116 | 2.221 | 0.37 | 0.813 | 1.598 | 0.779 | 4.11 | 1.737
COVID19_MODERNA | Incoherent | 12 | 10.525 | 0.742 | 1.115 | 1.55 | 0.684 | 1.063 | 1.593 | 1.14 | 2.487 | 8.339
COVID19_MODERNA | Hospitalisation | 3 | 3.2 | 0.412 | 1.115 | 2.094 | 0.434 | 0.886 | 1.647 | 0.938 | 6.165 | 6.531
COVID19_MODERNA | Sepsis (SMQ) [narrow] | 40 | 44.233 | 0.847 | 1.115 | 1.414 | 0.696 | 0.899 | 1.148 | 0.904 | 1.348 | 3.073
COVID19_MODERNA | Skin hyperpigmentation | 4 | 2.261 | 0.553 | 1.114 | 1.833 | 0.622 | 1.2 | 2.144 | 1.769 | 2.055 | 1.115
COVID19_MODERNA | Injection site indentation | 3 | 1.824 | 0.569 | 1.114 | 1.805 | 0.545 | 1.112 | 2.072 | 1.644 | 2.242 | 0.893
COVID19_MODERNA | Dermatitis | 8 | 6.361 | 0.633 | 1.114 | 1.704 | 0.659 | 1.106 | 1.767 | 1.258 | 0.926 | 0.002
COVID19_MODERNA | Coagulation test | 6 | 4.981 | 0.587 | 1.114 | 1.776 | 0.591 | 1.051 | 1.759 | 1.204 | 5.919 | 15.868
COVID19_MODERNA | Tonsillar hypertrophy | 5 | 4.742 | 0.486 | 1.114 | 1.949 | 0.521 | 0.962 | 1.656 | 1.055 | 0.839 | 0.032
COVID19_MODERNA | Hyposmia | 2 | 2.345 | 0.249 | 1.114 | 2.483 | 0.385 | 0.844 | 1.658 | 0.853 | 2.349 | 0.423
COVID19_MODERNA | Hyperlipidaemia | 2 | 2.682 | 0.391 | 1.114 | 2.137 | 0.363 | 0.798 | 1.569 | 0.746 | 2.596 | 0.591
COVID19_MODERNA | Troponin T increased | 1 | 1.696 | 0.12 | 1.114 | 2.95 | 0.307 | 0.753 | 1.6 | 0.589 | 0.948 | 0.198
COVID19_MODERNA | Flank pain | 23 | 19.923 | 0.81 | 1.113 | 1.455 | 0.793 | 1.106 | 1.509 | 1.154 | 2.865 | 23.317
COVID19_MODERNA | Haematopoietic erythropenia (SMQ) [narrow] | 17 | 19.858 | 0.721 | 1.113 | 1.575 | 0.583 | 0.854 | 1.214 | 0.856 | 1.638 | 3.363
COVID19_MODERNA | Pruritus genital | 2 | 1.593 | 0.413 | 1.112 | 2.087 | 0.442 | 0.967 | 1.902 | 1.256 | 3.523 | 1.282
COVID19_MODERNA | Sleep disorder | 137 | 126.02 | 0.961 | 1.112 | 1.272 | 0.938 | 1.08 | 1.239 | 1.087 | 1.707 | 37.08
COVID19_MODERNA | Arrhythmia related investigations, signs and symptoms (SMQ) [narrow] | 3 | 2.901 | 0.476 | 1.112 | 1.963 | 0.455 | 0.926 | 1.723 | 1.034 | 7.398 | 8.162
COVID19_MODERNA | Blood creatine increased | 3 | 3.128 | 0.434 | 1.112 | 2.044 | 0.439 | 0.895 | 1.665 | 0.959 | 5.691 | 5.876
COVID19_MODERNA | Influenza virus test | 14 | 14.192 | 0.695 | 1.111 | 1.605 | 0.632 | 0.957 | 1.4 | 0.986 | 2.213 | 7.428
COVID19_MODERNA | Walking aid user | 15 | 17.132 | 0.707 | 1.111 | 1.589 | 0.582 | 0.869 | 1.26 | 0.876 | 1.042 | 0
COVID19_MODERNA | Protein urine absent | 2 | 2.4 | 0.378 | 1.111 | 2.155 | 0.381 | 0.836 | 1.643 | 0.833 | 0.676 | 0.064
COVID19_MODERNA | Vomiting projectile | 6 | 6.059 | 0.549 | 1.11 | 1.831 | 0.525 | 0.934 | 1.562 | 0.99 | 0.558 | 1.626
COVID19_MODERNA | Angiogram normal | 6 | 6.362 | 0.578 | 1.11 | 1.782 | 0.509 | 0.906 | 1.515 | 0.943 | 2.349 | 3.059
COVID19_MODERNA | Imaging procedure abnormal | 2 | 2.513 | 0.345 | 1.11 | 2.227 | 0.374 | 0.821 | 1.612 | 0.796 | 2.144 | 0.295
COVID19_MODERNA | Cerebellar stroke | 4 | 3.63 | 0.5 | 1.109 | 1.912 | 0.504 | 0.971 | 1.731 | 1.102 | 12.33 | 20.461
COVID19_MODERNA | Hypertensive crisis | 2 | 1.922 | 0.409 | 1.109 | 2.086 | 0.415 | 0.909 | 1.786 | 1.04 | 1.897 | 0.159
COVID19_MODERNA | Prostate malignant tumours (SMQ) [broad] | 1 | 0.557 | 0.288 | 1.108 | 2.361 | 0.399 | 0.968 | 2.057 | 1.794 | 2.242 | 0.002
COVID19_MODERNA | CD4/CD8 ratio | 1 | 0.832 | 0.235 | 1.108 | 2.508 | 0.373 | 0.905 | 1.92 | 1.202 | 2.466 | 0.012
COVID19_MODERNA | Tenderness | 133 | 125.261 | 0.958 | 1.108 | 1.266 | 0.915 | 1.056 | 1.213 | 1.062 | 1.002 | 0
COVID19_MODERNA | Pleuritic pain | 8 | 9.187 | 0.583 | 1.108 | 1.771 | 0.513 | 0.862 | 1.377 | 0.871 | 3.946 | 12.641
COVID19_MODERNA | Corneal disorders (SMQ) [narrow] | 5 | 6.389 | 0.501 | 1.108 | 1.908 | 0.435 | 0.803 | 1.383 | 0.783 | 1.063 | 0.01
COVID19_MODERNA | Cheilitis | 6 | 5.021 | 0.577 | 1.106 | 1.773 | 0.589 | 1.046 | 1.751 | 1.195 | 1.423 | 0.357
COVID19_MODERNA | Vomiting | 739 | 678.448 | 1.04 | 1.106 | 1.173 | 1.024 | 1.088 | 1.155 | 1.089 | 1.536 | 134.68
COVID19_MODERNA | Central venous catheterisation | 3 | 2.882 | 0.48 | 1.106 | 1.943 | 0.456 | 0.929 | 1.728 | 1.041 | 1.804 | 0.374
COVID19_MODERNA | Illusion | 1 | 1.088 | 0.097 | 1.106 | 3.042 | 0.351 | 0.854 | 1.812 | 0.919 | 0.391 | 0.412
COVID19_MODERNA | Nasal dryness | 1 | 0.532 | 0.365 | 1.105 | 2.169 | 0.401 | 0.974 | 2.071 | 1.881 | 2.466 | 0.012
COVID19_MODERNA | Pain in jaw | 48 | 45.946 | 0.867 | 1.105 | 1.367 | 0.814 | 1.03 | 1.289 | 1.045 | 2.546 | 39.445
COVID19_MODERNA | Endotracheal intubation | 59 | 59.45 | 0.884 | 1.105 | 1.347 | 0.795 | 0.984 | 1.206 | 0.992 | 3.345 | 83.385
COVID19_MODERNA | Angina pectoris | 11 | 13.526 | 0.642 | 1.105 | 1.67 | 0.518 | 0.819 | 1.244 | 0.813 | 2.917 | 10.675
COVID19_MODERNA | Aortic arteriosclerosis | 1 | 3.075 | 0.178 | 1.105 | 2.684 | 0.235 | 0.589 | 1.268 | 0.325 | 2.74 | 0.032
COVID19_MODERNA | Gastrointestinal disorder | 9 | 9.207 | 0.608 | 1.104 | 1.719 | 0.572 | 0.939 | 1.471 | 0.978 | 0.527 | 3.275
COVID19_MODERNA | Optic ischaemic neuropathy | 1 | 0.528 | 0.169 | 1.103 | 2.712 | 0.402 | 0.975 | 2.073 | 1.893 | 1.451 | 0.06
COVID19_MODERNA | Vocal cord paralysis | 1 | 0.539 | 0.306 | 1.103 | 2.303 | 0.4 | 0.972 | 2.067 | 1.856 | 2.055 | 0
COVID19_MODERNA | Oesophagogastroduodenoscopy | 4 | 3.68 | 0.501 | 1.103 | 1.895 | 0.5 | 0.965 | 1.72 | 1.087 | 8.968 | 15.131
COVID19_MODERNA | Fatigue | 1967 | 1864.901 | 1.063 | 1.103 | 1.144 | 1.016 | 1.054 | 1.094 | 1.055 | 2.51 | 1729.428
COVID19_MODERNA | Eosinophil count normal | 7 | 7.319 | 0.569 | 1.102 | 1.777 | 0.532 | 0.918 | 1.497 | 0.956 | 1.046 | 0.006
COVID19_MODERNA | Legionella test | 2 | 3.078 | 0.311 | 1.102 | 2.288 | 0.341 | 0.75 | 1.476 | 0.65 | 2.349 | 0.423
COVID19_MODERNA | Cerebral venous sinus thrombosis | 2 | 1.069 | 0.27 | 1.101 | 2.388 | 0.492 | 1.078 | 2.126 | 1.872 | 5.48 | 2.786
COVID19_MODERNA | Vaccination site induration | 12 | 11.185 | 0.674 | 1.101 | 1.612 | 0.653 | 1.016 | 1.522 | 1.073 | 0.916 | 0.025
COVID19_MODERNA | Psychosis and psychotic disorders (SMQ) [narrow] | 42 | 39.407 | 0.842 | 1.101 | 1.388 | 0.814 | 1.047 | 1.329 | 1.066 | 1.69 | 10.423
COVID19_MODERNA | Computerised tomogram spine | 10 | 9.557 | 0.663 | 1.101 | 1.629 | 0.615 | 0.99 | 1.526 | 1.046 | 10.275 | 52.489
COVID19_MODERNA | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [broad] | 112 | 120.845 | 0.938 | 1.101 | 1.276 | 0.791 | 0.924 | 1.075 | 0.927 | 1.086 | 0.654
COVID19_MODERNA | Urinary retention | 9 | 10.12 | 0.603 | 1.101 | 1.72 | 0.534 | 0.876 | 1.373 | 0.889 | 1.451 | 0.789
COVID19_MODERNA | Cognitive disorder | 10 | 11.305 | 0.61 | 1.101 | 1.71 | 0.543 | 0.874 | 1.347 | 0.885 | 0.472 | 5.293
COVID19_MODERNA | Complement factor C3 | 3 | 3.681 | 0.391 | 1.101 | 2.102 | 0.405 | 0.827 | 1.538 | 0.815 | 0.705 | 0.124
COVID19_MODERNA | Pleural effusion | 22 | 26.503 | 0.751 | 1.101 | 1.507 | 0.592 | 0.831 | 1.141 | 0.83 | 3.308 | 29.173
COVID19_MODERNA | Ocular infections (SMQ) [narrow] | 7 | 11.889 | 0.543 | 1.101 | 1.818 | 0.375 | 0.647 | 1.056 | 0.589 | 0.248 | 15.066
COVID19_MODERNA | Hip fracture | 7 | 6.08 | 0.61 | 1.099 | 1.705 | 0.6 | 1.035 | 1.689 | 1.151 | 8.631 | 29.352
COVID19_MODERNA | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [narrow] | 9 | 8.855 | 0.641 | 1.099 | 1.656 | 0.588 | 0.965 | 1.513 | 1.016 | 2.522 | 6.134
COVID19_MODERNA | Inflammatory marker increased | 3 | 2.864 | 0.462 | 1.098 | 1.953 | 0.457 | 0.932 | 1.733 | 1.047 | 0.465 | 1.305
COVID19_MODERNA | Oesophagogastroduodenoscopy normal | 1 | 1.035 | 0.259 | 1.098 | 2.412 | 0.355 | 0.864 | 1.833 | 0.966 | 2.466 | 0.012
COVID19_MODERNA | Cryptococcus test | 2 | 2.625 | 0.471 | 1.098 | 1.936 | 0.367 | 0.806 | 1.584 | 0.762 | 1.897 | 0.159
COVID19_MODERNA | Eye pruritus | 41 | 40.181 | 0.84 | 1.097 | 1.383 | 0.78 | 1.005 | 1.28 | 1.02 | 2.198 | 23.484
COVID19_MODERNA | Colonoscopy | 3 | 4.278 | 0.395 | 1.097 | 2.085 | 0.374 | 0.764 | 1.422 | 0.701 | 1 | 0.086
COVID19_MODERNA | Immunosuppression | 1 | 1.048 | 0.346 | 1.096 | 2.186 | 0.354 | 0.862 | 1.827 | 0.954 | 0.913 | 0.159
COVID19_MODERNA | Gram stain | 2 | 2.116 | 0.363 | 1.096 | 2.151 | 0.4 | 0.878 | 1.725 | 0.945 | 1.096 | 0.062
COVID19_MODERNA | Otorrhoea | 2 | 1.126 | 0.334 | 1.095 | 2.213 | 0.486 | 1.065 | 2.098 | 1.777 | 1.451 | 0.007
COVID19_MODERNA | Pain | 1930 | 1819.868 | 1.054 | 1.095 | 1.136 | 1.021 | 1.06 | 1.1 | 1.061 | 1.631 | 485.841
COVID19_MODERNA | Asthma | 27 | 26.458 | 0.779 | 1.095 | 1.454 | 0.733 | 0.999 | 1.335 | 1.02 | 0.946 | 0.036
COVID19_MODERNA | Motor dysfunction | 7 | 7.666 | 0.555 | 1.095 | 1.782 | 0.516 | 0.89 | 1.451 | 0.913 | 0.876 | 0.027
COVID19_MODERNA | Arteriogram carotid | 8 | 8.181 | 0.622 | 1.094 | 1.673 | 0.557 | 0.935 | 1.494 | 0.978 | 15.176 | 56.768
COVID19_MODERNA | Hepatitis B surface antigen negative | 1 | 1.067 | 0.082 | 1.094 | 3.092 | 0.353 | 0.858 | 1.82 | 0.937 | 0.088 | 8.494
COVID19_MODERNA | Abdominal discomfort | 95 | 101.746 | 0.919 | 1.094 | 1.283 | 0.786 | 0.93 | 1.095 | 0.934 | 1.244 | 4.098
COVID19_MODERNA | Tryptase | 12 | 10.371 | 0.682 | 1.093 | 1.583 | 0.691 | 1.075 | 1.611 | 1.157 | 5.919 | 35.543
COVID19_MODERNA | Dystonia (SMQ) [narrow] | 9 | 8.536 | 0.618 | 1.093 | 1.679 | 0.603 | 0.99 | 1.552 | 1.054 | 0.514 | 3.581
COVID19_MODERNA | Biliary system related investigations, signs and symptoms (SMQ) [broad] | 38 | 39.291 | 0.825 | 1.093 | 1.392 | 0.735 | 0.956 | 1.227 | 0.967 | 1.287 | 2.044
COVID19_MODERNA | Functional gastrointestinal disorder | 1 | 0.532 | 0.394 | 1.092 | 2.074 | 0.401 | 0.974 | 2.071 | 1.879 | 0.56 | 0.038
COVID19_MODERNA | Carbon dioxide decreased | 16 | 13.394 | 0.71 | 1.092 | 1.541 | 0.757 | 1.119 | 1.606 | 1.195 | 5.48 | 44.22
COVID19_MODERNA | Hiatus hernia | 2 | 2.054 | 0.35 | 1.092 | 2.166 | 0.405 | 0.888 | 1.744 | 0.974 | 5.48 | 2.786
COVID19_MODERNA | Throat tightness | 224 | 209.775 | 0.974 | 1.09 | 1.211 | 0.953 | 1.064 | 1.185 | 1.068 | 4.333 | 487.594
COVID19_MODERNA | Photophobia | 43 | 41.202 | 0.835 | 1.09 | 1.373 | 0.801 | 1.027 | 1.301 | 1.044 | 1.135 | 0.537
COVID19_MODERNA | Ultrasound scan normal | 13 | 13.632 | 0.685 | 1.09 | 1.572 | 0.607 | 0.93 | 1.376 | 0.954 | 0.784 | 0.55
COVID19_MODERNA | Retinal artery occlusion | 2 | 1.549 | 0.361 | 1.089 | 2.135 | 0.445 | 0.976 | 1.919 | 1.291 | 4.11 | 1.737
COVID19_MODERNA | Paranasal sinus discomfort | 13 | 11.878 | 0.686 | 1.089 | 1.567 | 0.675 | 1.035 | 1.532 | 1.095 | 4.646 | 28.197
COVID19_MODERNA | Peripheral swelling | 314 | 310.203 | 0.991 | 1.089 | 1.192 | 0.92 | 1.01 | 1.107 | 1.012 | 0.664 | 53.424
COVID19_MODERNA | Posture abnormal | 19 | 19.554 | 0.737 | 1.089 | 1.498 | 0.662 | 0.951 | 1.332 | 0.972 | 0.753 | 1.253
COVID19_MODERNA | Hypovolaemia | 2 | 2.573 | 0.427 | 1.089 | 1.997 | 0.37 | 0.813 | 1.597 | 0.777 | 4.484 | 2.027
COVID19_MODERNA | CSF immunoglobulin | 1 | 0.658 | 0.224 | 1.088 | 2.483 | 0.389 | 0.944 | 2.004 | 1.52 | 1.897 | 0.004
COVID19_MODERNA | Dry throat | 28 | 24.563 | 0.799 | 1.088 | 1.414 | 0.813 | 1.101 | 1.466 | 1.14 | 5.271 | 76.252
COVID19_MODERNA | Urine analysis | 80 | 71.953 | 0.908 | 1.088 | 1.282 | 0.914 | 1.099 | 1.311 | 1.112 | 2.313 | 53.41
COVID19_MODERNA | Oropharyngeal pain | 173 | 212.463 | 0.957 | 1.088 | 1.227 | 0.719 | 0.815 | 0.921 | 0.814 | 1.461 | 23.526
COVID19_MODERNA | Gram stain negative | 1 | 1.379 | 0.32 | 1.088 | 2.226 | 0.329 | 0.803 | 1.704 | 0.725 | 0.425 | 0.289
COVID19_MODERNA | Eye oedema | 1 | 1.745 | 0.382 | 1.088 | 2.085 | 0.304 | 0.746 | 1.586 | 0.573 | 1.072 | 0.211
COVID19_MODERNA | Paranasal sinus hypersecretion | 6 | 4.701 | 0.574 | 1.087 | 1.732 | 0.611 | 1.087 | 1.818 | 1.276 | 3.363 | 6.737
COVID19_MODERNA | Cortisol normal | 1 | 1.191 | 0.331 | 1.087 | 2.196 | 0.343 | 0.835 | 1.772 | 0.84 | 2.055 | 0
COVID19_MODERNA | Faeces pale | 1 | 0.632 | 0.191 | 1.086 | 2.583 | 0.391 | 0.95 | 2.017 | 1.583 | 0.493 | 0.124
COVID19_MODERNA | Serology test | 1 | 0.742 | 0.176 | 1.086 | 2.635 | 0.381 | 0.925 | 1.962 | 1.347 | 0.32 | 0.812
COVID19_MODERNA | Hypoglycaemia | 6 | 8.267 | 0.544 | 1.086 | 1.778 | 0.427 | 0.76 | 1.272 | 0.726 | 1.345 | 0.221
COVID19_MODERNA | Gestational hypertension | 1 | 2.023 | 0.08 | 1.086 | 3.077 | 0.288 | 0.707 | 1.507 | 0.494 | 1.121 | 0.182
COVID19_MODERNA | Thinking abnormal | 8 | 6.55 | 0.666 | 1.085 | 1.587 | 0.646 | 1.086 | 1.734 | 1.221 | 2.321 | 4.314
COVID19_MODERNA | Chromaturia | 13 | 11.5 | 0.687 | 1.085 | 1.556 | 0.692 | 1.061 | 1.57 | 1.13 | 1.791 | 3.503
COVID19_MODERNA | Subarachnoid haemorrhage | 6 | 5.349 | 0.558 | 1.085 | 1.754 | 0.567 | 1.008 | 1.686 | 1.122 | 8.704 | 24.606
COVID19_MODERNA | Thrombectomy | 6 | 5.845 | 0.564 | 1.085 | 1.743 | 0.537 | 0.955 | 1.598 | 1.027 | 21.138 | 51.215
COVID19_MODERNA | Blood calcium | 3 | 3.283 | 0.535 | 1.084 | 1.79 | 0.429 | 0.875 | 1.627 | 0.914 | 2.74 | 1.577
COVID19_MODERNA | Joint fluid drainage | 1 | 1.23 | 0.369 | 1.084 | 2.105 | 0.34 | 0.828 | 1.757 | 0.813 | 1.644 | 0.025
COVID19_MODERNA | Nitrite urine present | 3 | 1.59 | 0.405 | 1.083 | 2.026 | 0.57 | 1.163 | 2.171 | 1.887 | 6.726 | 7.285
COVID19_MODERNA | Interstitial lung disease (SMQ) [broad] | 47 | 55.433 | 0.84 | 1.082 | 1.349 | 0.668 | 0.847 | 1.063 | 0.848 | 1.951 | 19.328
COVID19_MODERNA | Ear pruritus | 11 | 9.558 | 0.719 | 1.081 | 1.504 | 0.674 | 1.065 | 1.618 | 1.151 | 3.716 | 16.604
COVID19_MODERNA | Oropharyngeal blistering | 1 | 0.941 | 0.308 | 1.081 | 2.235 | 0.363 | 0.883 | 1.872 | 1.063 | 1.121 | 0.182
COVID19_MODERNA | Otitis media | 1 | 1.401 | 0.228 | 1.081 | 2.45 | 0.327 | 0.799 | 1.696 | 0.714 | 0.102 | 6.945
COVID19_MODERNA | Diaphragmalgia | 2 | 1.24 | 0.399 | 1.08 | 2.031 | 0.474 | 1.039 | 2.046 | 1.613 | 3.794 | 1.492
COVID19_MODERNA | Muscle oedema | 1 | 1.077 | 0.147 | 1.08 | 2.729 | 0.352 | 0.856 | 1.816 | 0.928 | 1.121 | 0.182
COVID19_MODERNA | Mouth swelling | 15 | 14.835 | 0.69 | 1.079 | 1.537 | 0.654 | 0.977 | 1.416 | 1.011 | 1.897 | 5.076
COVID19_MODERNA | Biliary disorders (SMQ) [broad] | 51 | 52.369 | 0.847 | 1.079 | 1.334 | 0.768 | 0.965 | 1.201 | 0.974 | 1.478 | 6.993
COVID19_MODERNA | Ultrasound abdomen abnormal | 6 | 6.386 | 0.504 | 1.079 | 1.829 | 0.508 | 0.903 | 1.511 | 0.94 | 0.39 | 5.021
COVID19_MODERNA | Torsade de pointes, shock-associated conditions (SMQ) [broad] | 104 | 110.383 | 0.912 | 1.079 | 1.257 | 0.799 | 0.939 | 1.098 | 0.942 | 2.384 | 75.115
COVID19_MODERNA | Lumbar puncture abnormal | 6 | 6.439 | 0.558 | 1.079 | 1.738 | 0.505 | 0.899 | 1.503 | 0.932 | 0.85 | 0.039
COVID19_MODERNA | Vaccination site mass | 5 | 4.781 | 0.49 | 1.078 | 1.852 | 0.519 | 0.957 | 1.648 | 1.046 | 1.245 | 0.051
COVID19_MODERNA | White blood cell count increased | 84 | 90.684 | 0.894 | 1.078 | 1.276 | 0.771 | 0.923 | 1.097 | 0.926 | 1.255 | 3.926
COVID19_MODERNA | Myelodysplastic syndrome (SMQ) [broad] | 17 | 18.745 | 0.713 | 1.078 | 1.505 | 0.612 | 0.896 | 1.275 | 0.907 | 1.718 | 4.101
COVID19_MODERNA | Mouth injury | 1 | 1.161 | 0.302 | 1.078 | 2.243 | 0.345 | 0.841 | 1.783 | 0.862 | 1.897 | 0.004
COVID19_MODERNA | Oral discomfort | 14 | 13.256 | 0.724 | 1.077 | 1.488 | 0.667 | 1.01 | 1.478 | 1.056 | 2.74 | 12.347
COVID19_MODERNA | Lacrimal disorders (SMQ) [narrow] | 41 | 39.068 | 0.824 | 1.077 | 1.357 | 0.8 | 1.032 | 1.313 | 1.049 | 1.558 | 7.183
COVID19_MODERNA | Lacrimal disorders (SMQ) [broad] | 41 | 39.068 | 0.824 | 1.077 | 1.357 | 0.8 | 1.032 | 1.313 | 1.049 | 1.558 | 7.183
COVID19_MODERNA | Night sweats | 62 | 60.302 | 0.867 | 1.077 | 1.306 | 0.826 | 1.017 | 1.242 | 1.028 | 2.701 | 58.399
COVID19_MODERNA | Medication errors (SMQ) [broad] | 518 | 515.666 | 1 | 1.077 | 1.156 | 0.933 | 1.003 | 1.078 | 1.005 | 0.169 | 2708.319
COVID19_MODERNA | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [broad] | 166 | 189.238 | 0.944 | 1.077 | 1.218 | 0.771 | 0.876 | 0.993 | 0.877 | 0.849 | 4.213
COVID19_MODERNA | Oedema peripheral | 59 | 57.346 | 0.862 | 1.076 | 1.311 | 0.822 | 1.018 | 1.248 | 1.029 | 1.969 | 25.183
COVID19_MODERNA | Nasal discomfort | 5 | 5.11 | 0.468 | 1.076 | 1.885 | 0.499 | 0.921 | 1.586 | 0.979 | 2.202 | 1.973
COVID19_MODERNA | Eyelid irritation | 1 | 0.315 | 0.294 | 1.075 | 2.254 | 0.425 | 1.034 | 2.211 | 3.176 | 1.541 | 0.041
COVID19_MODERNA | Ecchymosis | 4 | 4.633 | 0.474 | 1.075 | 1.873 | 0.442 | 0.853 | 1.52 | 0.863 | 0.771 | 0.084
COVID19_MODERNA | Antinuclear antibody negative | 4 | 4.938 | 0.452 | 1.075 | 1.913 | 0.426 | 0.822 | 1.466 | 0.81 | 0.32 | 5.024
COVID19_MODERNA | Functional, inflammatory and gallstone related biliary disorders (SMQ) [broad] | 50 | 51.343 | 0.841 | 1.074 | 1.33 | 0.766 | 0.965 | 1.203 | 0.974 | 1.504 | 7.484
COVID19_MODERNA | Neurological examination | 9 | 8.798 | 0.608 | 1.073 | 1.643 | 0.591 | 0.97 | 1.52 | 1.023 | 1.213 | 0.144
COVID19_MODERNA | Deafness transitory | 1 | 1.043 | 0.238 | 1.073 | 2.398 | 0.355 | 0.863 | 1.83 | 0.959 | 1.541 | 0.041
COVID19_MODERNA | Generalised convulsive seizures following immunisation (SMQ) [narrow] | 89 | 95.424 | 0.895 | 1.073 | 1.265 | 0.781 | 0.929 | 1.1 | 0.933 | 0.329 | 122.187
COVID19_MODERNA | Ultrasound biliary tract | 1 | 1.151 | 0.269 | 1.073 | 2.312 | 0.346 | 0.842 | 1.787 | 0.869 | 1.541 | 0.041
COVID19_MODERNA | Lymphadenopathy | 361 | 344.715 | 0.981 | 1.072 | 1.166 | 0.958 | 1.045 | 1.138 | 1.047 | 3.342 | 524.236
COVID19_MODERNA | Agranulocytosis (SMQ) [narrow] | 7 | 7.822 | 0.577 | 1.072 | 1.69 | 0.509 | 0.877 | 1.432 | 0.895 | 1.744 | 1.414
COVID19_MODERNA | Cerebrovascular accident | 100 | 111.8 | 0.903 | 1.072 | 1.252 | 0.757 | 0.893 | 1.047 | 0.894 | 5.669 | 309.221
COVID19_MODERNA | Interstitial lung disease (SMQ) [narrow] | 44 | 52.448 | 0.825 | 1.072 | 1.346 | 0.656 | 0.839 | 1.06 | 0.839 | 2.339 | 29.575
COVID19_MODERNA | Apathy | 2 | 1.647 | 0.262 | 1.071 | 2.327 | 0.437 | 0.957 | 1.882 | 1.214 | 0.176 | 6.83
COVID19_MODERNA | Sedation | 8 | 7.483 | 0.64 | 1.071 | 1.592 | 0.592 | 0.994 | 1.588 | 1.069 | 5.978 | 22.69
COVID19_MODERNA | Hypotension | 109 | 107.655 | 0.91 | 1.071 | 1.243 | 0.86 | 1.007 | 1.173 | 1.012 | 2.473 | 85.821
COVID19_MODERNA | Disorientation | 49 | 49.142 | 0.842 | 1.071 | 1.323 | 0.781 | 0.986 | 1.232 | 0.997 | 1.78 | 14.894
COVID19_MODERNA | Breast swelling | 4 | 4.227 | 0.46 | 1.071 | 1.887 | 0.465 | 0.897 | 1.599 | 0.946 | 1.827 | 0.708
COVID19_MODERNA | Urinary system X-ray | 1 | 0.513 | 0.305 | 1.07 | 2.21 | 0.403 | 0.979 | 2.082 | 1.949 | 1.121 | 0.182
COVID19_MODERNA | Flow cytometry | 2 | 2.377 | 0.386 | 1.07 | 2.032 | 0.383 | 0.839 | 1.649 | 0.841 | 1.007 | 0.124
COVID19_MODERNA | Tongue blistering | 4 | 3.441 | 0.493 | 1.068 | 1.821 | 0.517 | 0.997 | 1.778 | 1.162 | 3.288 | 3.716
COVID19_MODERNA | Haemorrhagic central nervous system vascular conditions (SMQ) [narrow] | 144 | 155.213 | 0.927 | 1.068 | 1.218 | 0.807 | 0.926 | 1.058 | 0.928 | 5.497 | 430.395
COVID19_MODERNA | Haemorrhagic central nervous system vascular conditions (SMQ) [broad] | 144 | 155.213 | 0.927 | 1.068 | 1.218 | 0.807 | 0.926 | 1.058 | 0.928 | 5.497 | 430.395
COVID19_MODERNA | Mycoplasma test | 1 | 0.523 | 0.361 | 1.067 | 2.075 | 0.402 | 0.977 | 2.076 | 1.914 | 0.685 | 0.002
COVID19_MODERNA | Vaccination complication | 29 | 29.874 | 0.79 | 1.067 | 1.378 | 0.709 | 0.957 | 1.267 | 0.971 | 0.397 | 25.617
COVID19_MODERNA | Embolic and thrombotic events, venous (SMQ) [broad] | 75 | 87.45 | 0.876 | 1.067 | 1.274 | 0.709 | 0.857 | 1.028 | 0.858 | 6.606 | 277.103
COVID19_MODERNA | Embolic and thrombotic events, venous (SMQ) [narrow] | 75 | 87.45 | 0.876 | 1.067 | 1.274 | 0.709 | 0.857 | 1.028 | 0.858 | 6.606 | 277.103
COVID19_MODERNA | Blood magnesium | 16 | 14.227 | 0.71 | 1.066 | 1.48 | 0.722 | 1.067 | 1.531 | 1.125 | 5.124 | 40.503
COVID19_MODERNA | Blood uric acid increased | 2 | 1.775 | 0.428 | 1.066 | 1.937 | 0.426 | 0.934 | 1.836 | 1.127 | 1.298 | 0.002
COVID19_MODERNA | Respiratory disorder | 5 | 4.777 | 0.506 | 1.066 | 1.793 | 0.519 | 0.958 | 1.649 | 1.047 | 0.55 | 1.368
COVID19_MODERNA | Magnetic resonance cholangiopancreatography | 3 | 2.89 | 0.472 | 1.066 | 1.854 | 0.455 | 0.928 | 1.726 | 1.038 | 7.398 | 8.162
COVID19_MODERNA | Pharyngeal swelling | 111 | 113.525 | 0.907 | 1.066 | 1.235 | 0.833 | 0.973 | 1.133 | 0.978 | 6.776 | 424.63
COVID19_MODERNA | Acute renal failure (SMQ) [broad] | 117 | 122.389 | 0.911 | 1.066 | 1.231 | 0.818 | 0.953 | 1.104 | 0.956 | 2.804 | 120.656
COVID19_MODERNA | Gaze palsy | 6 | 7.542 | 0.529 | 1.066 | 1.753 | 0.455 | 0.81 | 1.354 | 0.796 | 0.41 | 4.434
COVID19_MODERNA | Apnoea | 3 | 3.911 | 0.374 | 1.066 | 2.044 | 0.393 | 0.801 | 1.491 | 0.767 | 0.13 | 16.59
COVID19_MODERNA | Neurological symptom | 20 | 25.36 | 0.727 | 1.066 | 1.457 | 0.558 | 0.795 | 1.106 | 0.789 | 2.005 | 8.381
COVID19_MODERNA | Pulmonary hypertension | 2 | 3.078 | 0.342 | 1.066 | 2.114 | 0.341 | 0.75 | 1.476 | 0.65 | 2.242 | 0.355
COVID19_MODERNA | Productive cough | 23 | 24.419 | 0.745 | 1.065 | 1.432 | 0.666 | 0.929 | 1.267 | 0.942 | 1.093 | 0.094
COVID19_MODERNA | Hyperventilation | 13 | 12.242 | 0.641 | 1.064 | 1.575 | 0.66 | 1.011 | 1.497 | 1.062 | 1.076 | 0.012
COVID19_MODERNA | Euphoric mood | 3 | 2.693 | 0.407 | 1.061 | 1.966 | 0.47 | 0.957 | 1.781 | 1.114 | 4.624 | 4.351
COVID19_MODERNA | Formication | 6 | 5.604 | 0.611 | 1.061 | 1.612 | 0.551 | 0.98 | 1.639 | 1.071 | 1.156 | 0.015
COVID19_MODERNA | Retching | 44 | 41.506 | 0.832 | 1.061 | 1.312 | 0.815 | 1.042 | 1.317 | 1.06 | 2.444 | 32.843
COVID19_MODERNA | Glomerular filtration rate | 10 | 9.796 | 0.67 | 1.061 | 1.527 | 0.604 | 0.972 | 1.498 | 1.021 | 4.11 | 17.497
COVID19_MODERNA | Convulsions (SMQ) [broad] | 121 | 122.226 | 0.909 | 1.061 | 1.223 | 0.848 | 0.986 | 1.14 | 0.99 | 0.387 | 117.852
COVID19_MODERNA | Tubulointerstitial diseases (SMQ) [broad] | 31 | 34.424 | 0.778 | 1.061 | 1.381 | 0.67 | 0.895 | 1.176 | 0.901 | 1.493 | 4.296
COVID19_MODERNA | Feeling of body temperature change | 32 | 28.173 | 0.787 | 1.06 | 1.366 | 0.828 | 1.102 | 1.443 | 1.136 | 2.554 | 25.995
COVID19_MODERNA | Limb discomfort | 128 | 120.332 | 0.915 | 1.06 | 1.213 | 0.914 | 1.057 | 1.218 | 1.064 | 2.415 | 95.736
COVID19_MODERNA | Lip injury | 2 | 1.896 | 0.535 | 1.06 | 1.729 | 0.417 | 0.914 | 1.795 | 1.055 | 0.695 | 0.044
COVID19_MODERNA | Blood glucose increased | 57 | 61.214 | 0.85 | 1.06 | 1.289 | 0.746 | 0.926 | 1.139 | 0.931 | 2.56 | 47.731
COVID19_MODERNA | Scan brain | 3 | 3.354 | 0.452 | 1.06 | 1.876 | 0.425 | 0.866 | 1.611 | 0.894 | 1.721 | 0.29
COVID19_MODERNA | Life support | 4 | 4.919 | 0.464 | 1.06 | 1.854 | 0.427 | 0.824 | 1.469 | 0.813 | 2.901 | 2.865
COVID19_MODERNA | Multiple sclerosis | 2 | 2.527 | 0.234 | 1.059 | 2.369 | 0.373 | 0.819 | 1.609 | 0.791 | 0.15 | 8.693
COVID19_MODERNA | Chest tube insertion | 2 | 1.556 | 0.401 | 1.058 | 1.968 | 0.445 | 0.974 | 1.916 | 1.286 | 3.794 | 1.492
COVID19_MODERNA | Eye haemorrhage | 9 | 8.169 | 0.633 | 1.057 | 1.568 | 0.622 | 1.021 | 1.601 | 1.102 | 5.044 | 20.862
COVID19_MODERNA | Glucose urine absent | 2 | 2.9 | 0.361 | 1.057 | 2.047 | 0.351 | 0.771 | 1.516 | 0.69 | 0.617 | 0.158
COVID19_MODERNA | Social avoidant behaviour | 1 | 0.523 | 0.253 | 1.056 | 2.307 | 0.402 | 0.976 | 2.076 | 1.912 | 0.213 | 2.137
COVID19_MODERNA | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [narrow] | 2353 | 2241.213 | 1.02 | 1.056 | 1.092 | 1.014 | 1.05 | 1.086 | 1.05 | 1.735 | 763.819
COVID19_MODERNA | Nervousness | 38 | 38.327 | 0.795 | 1.056 | 1.347 | 0.752 | 0.978 | 1.256 | 0.991 | 2.028 | 17.357
COVID19_MODERNA | Blood potassium normal | 23 | 26.164 | 0.736 | 1.056 | 1.425 | 0.627 | 0.874 | 1.193 | 0.879 | 1.567 | 3.902
COVID19_MODERNA | Metabolic function test | 153 | 152.644 | 0.921 | 1.055 | 1.197 | 0.874 | 0.999 | 1.137 | 1.002 | 3.784 | 270.153
COVID19_MODERNA | Disability | 3 | 3.393 | 0.352 | 1.055 | 2.063 | 0.422 | 0.861 | 1.602 | 0.884 | 0.3 | 4.165
COVID19_MODERNA | Pelvic pain | 4 | 4.968 | 0.405 | 1.055 | 1.951 | 0.425 | 0.819 | 1.461 | 0.805 | 1.591 | 0.348
COVID19_MODERNA | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [narrow] | 2372 | 2261.155 | 1.018 | 1.054 | 1.089 | 1.014 | 1.049 | 1.085 | 1.049 | 1.729 | 761.617
COVID19_MODERNA | General symptom | 1 | 0.752 | 0.295 | 1.053 | 2.192 | 0.38 | 0.923 | 1.958 | 1.33 | 0.986 | 0.243
COVID19_MODERNA | Peroneal nerve palsy | 2 | 2.045 | 0.431 | 1.053 | 1.898 | 0.406 | 0.889 | 1.747 | 0.978 | 0.913 | 0.048
COVID19_MODERNA | Injected limb mobility decreased | 102 | 109.208 | 0.889 | 1.053 | 1.229 | 0.791 | 0.931 | 1.09 | 0.934 | 0.576 | 31.169
COVID19_MODERNA | Occupational exposure to product | 1 | 1.286 | 0.15 | 1.053 | 2.633 | 0.336 | 0.818 | 1.737 | 0.778 | 0.357 | 0.575
COVID19_MODERNA | Injection site paraesthesia | 22 | 20.339 | 0.752 | 1.052 | 1.392 | 0.744 | 1.045 | 1.435 | 1.082 | 1.61 | 4.199
COVID19_MODERNA | Computerised tomogram abnormal | 42 | 46.709 | 0.808 | 1.052 | 1.324 | 0.696 | 0.895 | 1.136 | 0.899 | 4.228 | 85.575
COVID19_MODERNA | Hepatic enzyme increased | 8 | 9.261 | 0.586 | 1.052 | 1.628 | 0.51 | 0.857 | 1.369 | 0.864 | 1.361 | 0.413
COVID19_MODERNA | Encephalitis viral | 1 | 0.513 | 0.261 | 1.051 | 2.27 | 0.403 | 0.979 | 2.082 | 1.948 | 0.44 | 0.244
COVID19_MODERNA | Pneumonia viral | 4 | 3.148 | 0.525 | 1.051 | 1.724 | 0.54 | 1.041 | 1.856 | 1.271 | 4.11 | 5.534
COVID19_MODERNA | Gallbladder related disorders (SMQ) [broad] | 16 | 16.248 | 0.683 | 1.051 | 1.483 | 0.648 | 0.958 | 1.375 | 0.985 | 4.932 | 38.469
COVID19_MODERNA | Gallbladder related disorders (SMQ) [narrow] | 16 | 16.248 | 0.683 | 1.051 | 1.483 | 0.648 | 0.958 | 1.375 | 0.985 | 4.932 | 38.469
COVID19_MODERNA | Magnetic resonance imaging neck | 10 | 11.687 | 0.634 | 1.051 | 1.553 | 0.529 | 0.852 | 1.313 | 0.856 | 8.807 | 45.191
COVID19_MODERNA | Monocyte count decreased | 4 | 4.798 | 0.454 | 1.051 | 1.848 | 0.433 | 0.836 | 1.49 | 0.834 | 3.794 | 4.836
COVID19_MODERNA | Polyuria | 3 | 3.915 | 0.426 | 1.051 | 1.899 | 0.393 | 0.801 | 1.49 | 0.766 | 1.681 | 0.254
COVID19_MODERNA | Sunburn | 1 | 0.804 | 0.282 | 1.05 | 2.213 | 0.375 | 0.911 | 1.933 | 1.243 | 0.667 | 0
COVID19_MODERNA | Anti-cyclic citrullinated peptide antibody | 2 | 2.382 | 0.403 | 1.05 | 1.944 | 0.382 | 0.839 | 1.648 | 0.84 | 4.484 | 2.027
COVID19_MODERNA | Lip dry | 2 | 2.103 | 0.389 | 1.049 | 1.97 | 0.401 | 0.88 | 1.729 | 0.951 | 0.783 | 0
COVID19_MODERNA | Inappropriate schedule of product administration | 63 | 67.526 | 0.842 | 1.049 | 1.274 | 0.755 | 0.928 | 1.131 | 0.933 | 0.353 | 74.03
COVID19_MODERNA | Arthritis (SMQ) [narrow] | 38 | 44.48 | 0.79 | 1.049 | 1.338 | 0.656 | 0.853 | 1.095 | 0.854 | 0.522 | 15.913
COVID19_MODERNA | Computerised tomogram abdomen abnormal | 21 | 27.124 | 0.71 | 1.049 | 1.44 | 0.553 | 0.782 | 1.08 | 0.774 | 3.836 | 35.61
COVID19_MODERNA | Breast neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 1.781 | 0.304 | 1.049 | 2.156 | 0.302 | 0.741 | 1.575 | 0.562 | 0.465 | 0.181
COVID19_MODERNA | Breast malignant tumours (SMQ) [broad] | 1 | 1.781 | 0.304 | 1.049 | 2.156 | 0.302 | 0.741 | 1.575 | 0.562 | 0.465 | 0.181
COVID19_MODERNA | Miosis | 2 | 1.639 | 0.394 | 1.048 | 1.957 | 0.438 | 0.959 | 1.885 | 1.22 | 2.055 | 0.243
COVID19_MODERNA | Lip erythema | 4 | 3.726 | 0.432 | 1.048 | 1.881 | 0.497 | 0.959 | 1.709 | 1.074 | 1.861 | 0.766
COVID19_MODERNA | Thrombocytopenia | 26 | 28.89 | 0.743 | 1.048 | 1.395 | 0.652 | 0.893 | 1.2 | 0.9 | 1.391 | 2.335
COVID19_MODERNA | Enlarged uvula | 5 | 4.365 | 0.54 | 1.047 | 1.688 | 0.546 | 1.007 | 1.734 | 1.145 | 3.523 | 5.775
COVID19_MODERNA | Mouth breathing | 1 | 1.172 | 0.36 | 1.047 | 2.024 | 0.344 | 0.839 | 1.779 | 0.853 | 1.233 | 0.129
COVID19_MODERNA | Panic disorder | 1 | 1.195 | 0.213 | 1.047 | 2.396 | 0.343 | 0.834 | 1.77 | 0.837 | 1.451 | 0.06
COVID19_MODERNA | Corneal oedema | 1 | 0.635 | 0.168 | 1.046 | 2.543 | 0.391 | 0.949 | 2.016 | 1.576 | 1.897 | 0.004
COVID19_MODERNA | Optic nerve disorders (SMQ) [narrow] | 5 | 8.403 | 0.459 | 1.046 | 1.828 | 0.361 | 0.668 | 1.151 | 0.595 | 0.342 | 5.608
COVID19_MODERNA | Blood uric acid | 1 | 0.799 | 0.394 | 1.045 | 1.948 | 0.376 | 0.912 | 1.935 | 1.252 | 0.986 | 0.243
COVID19_MODERNA | Urine abnormality | 3 | 2.574 | 0.442 | 1.045 | 1.855 | 0.479 | 0.976 | 1.815 | 1.166 | 1.804 | 0.374
COVID19_MODERNA | Neutrophil count decreased | 8 | 8.499 | 0.571 | 1.045 | 1.635 | 0.542 | 0.911 | 1.455 | 0.941 | 0.812 | 0.175
COVID19_MODERNA | Oxygen saturation decreased | 75 | 85.003 | 0.858 | 1.045 | 1.248 | 0.728 | 0.881 | 1.057 | 0.882 | 3.869 | 135.593
COVID19_MODERNA | Ischaemic colitis (SMQ) [broad] | 42 | 54.015 | 0.799 | 1.045 | 1.318 | 0.608 | 0.781 | 0.992 | 0.778 | 0.572 | 12.79
COVID19_MODERNA | Paranoia | 1 | 0.407 | 0.377 | 1.044 | 1.981 | 0.414 | 1.007 | 2.147 | 2.459 | 1.028 | 0.24
COVID19_MODERNA | Toxic-septic shock conditions (SMQ) [broad] | 102 | 111.806 | 0.881 | 1.044 | 1.218 | 0.773 | 0.91 | 1.065 | 0.912 | 2.047 | 49.609
COVID19_MODERNA | Blood electrolytes | 7 | 5.302 | 0.562 | 1.043 | 1.646 | 0.653 | 1.126 | 1.837 | 1.32 | 3.029 | 6.696
COVID19_MODERNA | Dizziness | 1485 | 1433.535 | 0.999 | 1.043 | 1.088 | 0.992 | 1.035 | 1.08 | 1.036 | 2.421 | 1184.497
COVID19_MODERNA | Arthralgia | 775 | 750.197 | 0.982 | 1.043 | 1.105 | 0.973 | 1.032 | 1.094 | 1.033 | 2.085 | 414.488
COVID19_MODERNA | Staring | 7 | 8.595 | 0.583 | 1.043 | 1.612 | 0.476 | 0.822 | 1.341 | 0.814 | 0.316 | 9.548
COVID19_MODERNA | Blood potassium decreased | 36 | 34.279 | 0.786 | 1.042 | 1.329 | 0.786 | 1.03 | 1.33 | 1.05 | 5.044 | 93.503
COVID19_MODERNA | Hypersensitivity (SMQ) [broad] | 3571 | 3441.45 | 1.013 | 1.042 | 1.071 | 1.009 | 1.037 | 1.066 | 1.038 | 1.112 | 51.047
COVID19_MODERNA | Brain natriuretic peptide | 13 | 12.61 | 0.669 | 1.042 | 1.482 | 0.645 | 0.988 | 1.463 | 1.031 | 12.33 | 82.553
COVID19_MODERNA | Mean platelet volume increased | 3 | 2.926 | 0.355 | 1.042 | 2.02 | 0.453 | 0.923 | 1.717 | 1.025 | 2.114 | 0.73
COVID19_MODERNA | International normalised ratio normal | 9 | 9.894 | 0.582 | 1.042 | 1.61 | 0.543 | 0.891 | 1.396 | 0.91 | 1.776 | 2.142
COVID19_MODERNA | Heart rate irregular | 24 | 27.62 | 0.731 | 1.042 | 1.397 | 0.625 | 0.866 | 1.175 | 0.869 | 3.035 | 27.324
COVID19_MODERNA | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [broad] | 2682 | 2596.311 | 1.008 | 1.041 | 1.074 | 1 | 1.033 | 1.066 | 1.033 | 1.801 | 1006.22
COVID19_MODERNA | Dermatitis bullous | 1 | 1.095 | 0.271 | 1.041 | 2.217 | 0.35 | 0.853 | 1.809 | 0.913 | 0.247 | 1.569
COVID19_MODERNA | Chest X-ray abnormal | 68 | 74.931 | 0.846 | 1.041 | 1.253 | 0.741 | 0.904 | 1.095 | 0.908 | 2.709 | 64.599
COVID19_MODERNA | Hypoglycaemic and neurogenic shock conditions (SMQ) [broad] | 95 | 106.122 | 0.872 | 1.04 | 1.22 | 0.755 | 0.893 | 1.052 | 0.895 | 1.994 | 42.749
COVID19_MODERNA | Electrocardiogram T wave abnormal | 3 | 1.86 | 0.443 | 1.039 | 1.84 | 0.542 | 1.104 | 2.058 | 1.613 | 3.699 | 2.986
COVID19_MODERNA | Hyperaesthesia | 18 | 17.474 | 0.692 | 1.039 | 1.444 | 0.688 | 0.997 | 1.408 | 1.03 | 0.816 | 0.551
COVID19_MODERNA | Respiratory depression | 8 | 7.924 | 0.604 | 1.039 | 1.57 | 0.569 | 0.956 | 1.527 | 1.01 | 7.046 | 27.575
COVID19_MODERNA | Blood urine present | 16 | 16.024 | 0.694 | 1.039 | 1.44 | 0.656 | 0.969 | 1.391 | 0.999 | 2.099 | 7.466
COVID19_MODERNA | Respiratory failure (SMQ) [narrow] | 137 | 147.842 | 0.898 | 1.039 | 1.187 | 0.803 | 0.925 | 1.06 | 0.927 | 1.381 | 13.38
COVID19_MODERNA | Blood lactic acid decreased | 1 | 3.455 | 0.153 | 1.039 | 2.578 | 0.218 | 0.555 | 1.199 | 0.289 | 1.37 | 0.081
COVID19_MODERNA | Medication error | 1 | 0.671 | 0.322 | 1.038 | 2.084 | 0.387 | 0.941 | 1.997 | 1.49 | 0.235 | 1.744
COVID19_MODERNA | Spinal X-ray abnormal | 1 | 0.672 | 0.246 | 1.038 | 2.276 | 0.387 | 0.94 | 1.996 | 1.487 | 0.685 | 0.002
COVID19_MODERNA | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [broad] | 2701 | 2621.59 | 1.006 | 1.038 | 1.071 | 0.998 | 1.03 | 1.063 | 1.03 | 1.791 | 996.036
COVID19_MODERNA | Hyporesponsive to stimuli | 6 | 5.962 | 0.517 | 1.038 | 1.704 | 0.531 | 0.943 | 1.578 | 1.006 | 0.525 | 2.07
COVID19_MODERNA | Limb injury | 4 | 4.26 | 0.56 | 1.038 | 1.636 | 0.463 | 0.893 | 1.592 | 0.939 | 0.628 | 0.522
COVID19_MODERNA | Radicular pain | 1 | 1.235 | 0.271 | 1.038 | 2.209 | 0.34 | 0.827 | 1.755 | 0.81 | 2.466 | 0.012
COVID19_MODERNA | Dyspnoea exertional | 25 | 30.616 | 0.725 | 1.037 | 1.395 | 0.595 | 0.819 | 1.106 | 0.817 | 5.181 | 66.182
COVID19_MODERNA | Mean cell haemoglobin decreased | 3 | 3.923 | 0.364 | 1.037 | 1.99 | 0.392 | 0.8 | 1.489 | 0.765 | 0.51 | 0.928
COVID19_MODERNA | Mitral valve incompetence | 2 | 3.105 | 0.322 | 1.037 | 2.082 | 0.34 | 0.747 | 1.47 | 0.644 | 1.973 | 0.198
COVID19_MODERNA | Tonsillar inflammation | 1 | 0.298 | 0.257 | 1.036 | 2.241 | 0.427 | 1.039 | 2.224 | 3.358 | 2.055 | 0
COVID19_MODERNA | Decreased appetite | 232 | 226.663 | 0.928 | 1.036 | 1.149 | 0.916 | 1.021 | 1.135 | 1.024 | 1.252 | 11.123
COVID19_MODERNA | Rhabdomyolysis/myopathy (SMQ) [broad] | 1334 | 1342.556 | 0.99 | 1.036 | 1.083 | 0.949 | 0.993 | 1.039 | 0.994 | 1.622 | 318.512
COVID19_MODERNA | Pustule | 4 | 5.52 | 0.515 | 1.036 | 1.705 | 0.399 | 0.77 | 1.372 | 0.725 | 1.472 | 0.202
COVID19_MODERNA | Noninfectious diarrhoea (SMQ) [narrow] | 452 | 473.141 | 0.957 | 1.035 | 1.116 | 0.883 | 0.954 | 1.03 | 0.955 | 1.38 | 45.534
COVID19_MODERNA | Lipase increased | 6 | 5.429 | 0.545 | 1.034 | 1.65 | 0.562 | 0.999 | 1.671 | 1.105 | 5.691 | 15.094
COVID19_MODERNA | SARS-CoV-2 antibody test positive | 11 | 10.519 | 0.615 | 1.034 | 1.541 | 0.628 | 0.993 | 1.508 | 1.046 | 16.954 | 88.28
COVID19_MODERNA | Blood creatine phosphokinase increased | 14 | 15.652 | 0.643 | 1.034 | 1.5 | 0.584 | 0.884 | 1.294 | 0.894 | 1.211 | 0.305
COVID19_MODERNA | Uterine dilation and curettage | 2 | 2.302 | 0.405 | 1.034 | 1.898 | 0.388 | 0.85 | 1.671 | 0.869 | 3.794 | 1.492
COVID19_MODERNA | Eosinophil percentage | 8 | 9.155 | 0.561 | 1.034 | 1.626 | 0.514 | 0.864 | 1.38 | 0.874 | 1.072 | 0
COVID19_MODERNA | Defaecation urgency | 2 | 2.39 | 0.38 | 1.034 | 1.946 | 0.382 | 0.838 | 1.646 | 0.837 | 1.174 | 0.028
COVID19_MODERNA | Atelectasis | 15 | 14.455 | 0.679 | 1.033 | 1.446 | 0.668 | 0.998 | 1.446 | 1.038 | 7.114 | 56.342
COVID19_MODERNA | Pain in extremity | 1290 | 1260.975 | 0.986 | 1.033 | 1.081 | 0.977 | 1.022 | 1.07 | 1.023 | 1.284 | 83.117
COVID19_MODERNA | Anxiety | 148 | 154.811 | 0.898 | 1.033 | 1.176 | 0.832 | 0.953 | 1.088 | 0.956 | 2.011 | 68.97
COVID19_MODERNA | Hyperglycaemia/new onset diabetes mellitus (SMQ) [narrow] | 76 | 84.94 | 0.85 | 1.033 | 1.231 | 0.739 | 0.892 | 1.07 | 0.895 | 1.854 | 27.063
COVID19_MODERNA | Aspiration joint | 1 | 1.597 | 0.345 | 1.033 | 2.019 | 0.314 | 0.768 | 1.631 | 0.626 | 1.233 | 0.129
COVID19_MODERNA | Toothache | 19 | 18.231 | 0.693 | 1.032 | 1.427 | 0.702 | 1.009 | 1.413 | 1.042 | 2.533 | 14.577
COVID19_MODERNA | Gastrointestinal inflammation | 2 | 1.938 | 0.344 | 1.032 | 2.019 | 0.414 | 0.907 | 1.782 | 1.032 | 1.096 | 0.062
COVID19_MODERNA | Mechanical ventilation | 28 | 30.106 | 0.741 | 1.032 | 1.363 | 0.679 | 0.92 | 1.225 | 0.93 | 2.061 | 13.131
COVID19_MODERNA | Biliary tract disorders (SMQ) [narrow] | 11 | 12.452 | 0.596 | 1.032 | 1.566 | 0.553 | 0.873 | 1.327 | 0.883 | 1.227 | 0.245
COVID19_MODERNA | Biliary tract disorders (SMQ) [broad] | 11 | 12.452 | 0.596 | 1.032 | 1.566 | 0.553 | 0.873 | 1.327 | 0.883 | 1.227 | 0.245
COVID19_MODERNA | Moaning | 3 | 3.463 | 0.41 | 1.032 | 1.884 | 0.418 | 0.852 | 1.586 | 0.866 | 0.433 | 1.653
COVID19_MODERNA | Electrocardiogram abnormal | 58 | 66.584 | 0.821 | 1.032 | 1.262 | 0.701 | 0.869 | 1.068 | 0.871 | 3.48 | 87.708
COVID19_MODERNA | Dystonia | 1 | 1.582 | 0.36 | 1.032 | 1.983 | 0.315 | 0.77 | 1.636 | 0.632 | 0.363 | 0.547
COVID19_MODERNA | Oral candidiasis | 1 | 0.672 | 0.271 | 1.031 | 2.191 | 0.387 | 0.94 | 1.996 | 1.487 | 0.601 | 0.012
COVID19_MODERNA | Oropharyngeal allergic conditions (SMQ) [broad] | 188 | 188.009 | 0.912 | 1.031 | 1.157 | 0.884 | 0.997 | 1.121 | 1 | 2.257 | 120.196
COVID19_MODERNA | Oropharyngeal allergic conditions (SMQ) [narrow] | 188 | 188.009 | 0.912 | 1.031 | 1.157 | 0.884 | 0.997 | 1.121 | 1 | 2.257 | 120.196
COVID19_MODERNA | Magnetic resonance imaging spinal abnormal | 12 | 12.76 | 0.618 | 1.031 | 1.529 | 0.59 | 0.918 | 1.376 | 0.94 | 0.996 | 0.018
COVID19_MODERNA | Drug related hepatic disorders - severe events only (SMQ) [broad] | 19 | 23.194 | 0.686 | 1.031 | 1.433 | 0.572 | 0.822 | 1.151 | 0.819 | 0.999 | 0.013
COVID19_MODERNA | Lymph node palpable | 4 | 2.572 | 0.419 | 1.03 | 1.86 | 0.59 | 1.138 | 2.032 | 1.555 | 3.794 | 4.836
COVID19_MODERNA | Full blood count | 181 | 181.901 | 0.909 | 1.03 | 1.157 | 0.877 | 0.992 | 1.118 | 0.995 | 2.597 | 160.162
COVID19_MODERNA | Cerebral small vessel ischaemic disease | 3 | 4.738 | 0.418 | 1.03 | 1.864 | 0.353 | 0.722 | 1.343 | 0.633 | 8.22 | 9.191
COVID19_MODERNA | Blood culture | 19 | 19.876 | 0.705 | 1.029 | 1.403 | 0.653 | 0.938 | 1.314 | 0.956 | 1.411 | 1.77
COVID19_MODERNA | Platelet count decreased | 65 | 70.907 | 0.832 | 1.029 | 1.243 | 0.745 | 0.913 | 1.11 | 0.917 | 1.629 | 14.245
COVID19_MODERNA | Angiogram cerebral abnormal | 6 | 5.869 | 0.55 | 1.028 | 1.629 | 0.536 | 0.953 | 1.593 | 1.022 | 9.248 | 26.162
COVID19_MODERNA | Oxygen saturation | 17 | 17.274 | 0.691 | 1.028 | 1.419 | 0.655 | 0.959 | 1.365 | 0.984 | 9.75 | 89.267
COVID19_MODERNA | Blood phosphorus normal | 2 | 2.044 | 0.425 | 1.028 | 1.844 | 0.406 | 0.889 | 1.747 | 0.978 | 0.609 | 0.174
COVID19_MODERNA | Dermatitis contact | 3 | 3.311 | 0.555 | 1.028 | 1.618 | 0.427 | 0.871 | 1.621 | 0.906 | 0.667 | 0.208
COVID19_MODERNA | Acupuncture | 1 | 1.142 | 0.226 | 1.028 | 2.303 | 0.347 | 0.844 | 1.791 | 0.876 | 0.304 | 0.936
COVID19_MODERNA | Mean cell haemoglobin normal | 11 | 12.649 | 0.6 | 1.028 | 1.55 | 0.546 | 0.863 | 1.311 | 0.87 | 1.317 | 0.514
COVID19_MODERNA | Amnesia | 18 | 21.89 | 0.675 | 1.028 | 1.442 | 0.569 | 0.825 | 1.164 | 0.822 | 1.203 | 0.404
COVID19_MODERNA | Drug related hepatic disorders - severe events only (SMQ) [narrow] | 19 | 23.194 | 0.684 | 1.028 | 1.428 | 0.572 | 0.822 | 1.151 | 0.819 | 1.001 | 0.013
COVID19_MODERNA | Diplegia | 1 | 1.413 | 0.189 | 1.028 | 2.419 | 0.327 | 0.797 | 1.692 | 0.708 | 0.191 | 2.613
COVID19_MODERNA | Flatulence | 14 | 13.938 | 0.635 | 1.027 | 1.497 | 0.642 | 0.97 | 1.421 | 1.004 | 1.001 | 0.018
COVID19_MODERNA | Taste disorder | 36 | 36.889 | 0.769 | 1.026 | 1.315 | 0.736 | 0.964 | 1.244 | 0.976 | 9.152 | 184.595
COVID19_MODERNA | Aplastic anaemia | 1 | 1.048 | 0.297 | 1.026 | 2.111 | 0.354 | 0.862 | 1.828 | 0.954 | 1.451 | 0.06
COVID19_MODERNA | Apraxia | 1 | 1.056 | 0.344 | 1.026 | 2.003 | 0.354 | 0.86 | 1.824 | 0.947 | 1.644 | 0.025
COVID19_MODERNA | Opisthotonus | 1 | 0.497 | 0.239 | 1.025 | 2.256 | 0.405 | 0.983 | 2.091 | 2.01 | 0.122 | 5.409
COVID19_MODERNA | Haematocrit normal | 20 | 19.859 | 0.696 | 1.025 | 1.406 | 0.689 | 0.981 | 1.365 | 1.007 | 1.224 | 0.575
COVID19_MODERNA | Liver-related coagulation and bleeding disturbances (SMQ) [narrow] | 16 | 19.719 | 0.66 | 1.025 | 1.456 | 0.552 | 0.816 | 1.171 | 0.811 | 2.003 | 6.501
COVID19_MODERNA | Liver-related coagulation and bleeding disturbances (SMQ) [broad] | 16 | 19.719 | 0.66 | 1.025 | 1.456 | 0.552 | 0.816 | 1.171 | 0.811 | 2.003 | 6.501
COVID19_MODERNA | Pneumonia bacterial | 2 | 3.237 | 0.261 | 1.025 | 2.197 | 0.333 | 0.733 | 1.441 | 0.618 | 1.333 | 0
COVID19_MODERNA | Cardiovascular evaluation | 9 | 8.465 | 0.604 | 1.024 | 1.534 | 0.607 | 0.996 | 1.562 | 1.063 | 7.16 | 32.165
COVID19_MODERNA | Dysphagia | 126 | 127.262 | 0.881 | 1.024 | 1.176 | 0.851 | 0.986 | 1.137 | 0.99 | 2.762 | 126.187
COVID19_MODERNA | X-ray limb | 12 | 12.137 | 0.642 | 1.024 | 1.48 | 0.614 | 0.954 | 1.43 | 0.989 | 1.053 | 0.001
COVID19_MODERNA | Torsade de pointes, shock-associated conditions (SMQ) [narrow] | 13 | 14.035 | 0.618 | 1.024 | 1.513 | 0.593 | 0.908 | 1.345 | 0.926 | 1.113 | 0.053
COVID19_MODERNA | Lactic acidosis (SMQ) [broad] | 38 | 43.245 | 0.774 | 1.024 | 1.303 | 0.673 | 0.876 | 1.124 | 0.879 | 2.582 | 31.894
COVID19_MODERNA | Agitation | 16 | 19.043 | 0.667 | 1.024 | 1.444 | 0.568 | 0.84 | 1.206 | 0.84 | 1.108 | 0.072
COVID19_MODERNA | Expired product administered | 13 | 17.693 | 0.618 | 1.024 | 1.514 | 0.491 | 0.752 | 1.114 | 0.735 | 0.049 | 240.463
COVID19_MODERNA | Dysentery | 1 | 1.756 | 0.131 | 1.024 | 2.618 | 0.304 | 0.744 | 1.582 | 0.569 | 0.587 | 0.019
COVID19_MODERNA | Acidosis | 2 | 3.35 | 0.341 | 1.024 | 2.003 | 0.327 | 0.721 | 1.418 | 0.597 | 1.761 | 0.097
COVID19_MODERNA | Joint effusion | 2 | 1.772 | 0.375 | 1.023 | 1.929 | 0.427 | 0.935 | 1.837 | 1.129 | 0.617 | 0.158
COVID19_MODERNA | Pulmonary pain | 7 | 6.805 | 0.596 | 1.023 | 1.544 | 0.559 | 0.963 | 1.571 | 1.029 | 3.753 | 9.909
COVID19_MODERNA | Dysarthria | 50 | 56.954 | 0.805 | 1.023 | 1.263 | 0.695 | 0.876 | 1.091 | 0.878 | 2.802 | 50.448
COVID19_MODERNA | Respiratory viral panel | 12 | 14.984 | 0.633 | 1.023 | 1.49 | 0.52 | 0.808 | 1.211 | 0.801 | 2.33 | 7.111
COVID19_MODERNA | Blood pressure systolic increased | 4 | 3.895 | 0.51 | 1.022 | 1.677 | 0.486 | 0.937 | 1.67 | 1.027 | 3.794 | 4.836
COVID19_MODERNA | Tendinopathies and ligament disorders (SMQ) [broad] | 2381 | 2334.606 | 0.988 | 1.022 | 1.057 | 0.986 | 1.02 | 1.054 | 1.02 | 1.41 | 307.789
COVID19_MODERNA | Vestibular disorders (SMQ) [broad] | 1560 | 1537.693 | 0.98 | 1.022 | 1.065 | 0.973 | 1.014 | 1.057 | 1.015 | 2.303 | 1109.904
COVID19_MODERNA | Hypersensitivity (SMQ) [narrow] | 2350 | 2318.104 | 0.988 | 1.022 | 1.057 | 0.98 | 1.013 | 1.048 | 1.014 | 1.072 | 12.934
COVID19_MODERNA | Pseudomembranous colitis (SMQ) [broad] | 457 | 476.339 | 0.945 | 1.022 | 1.102 | 0.887 | 0.958 | 1.034 | 0.959 | 1.378 | 45.684
COVID19_MODERNA | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [narrow] | 159 | 170.847 | 0.894 | 1.022 | 1.159 | 0.815 | 0.929 | 1.055 | 0.931 | 4.042 | 311.11
COVID19_MODERNA | Stool analysis | 1 | 1.303 | 0.177 | 1.022 | 2.439 | 0.334 | 0.815 | 1.73 | 0.767 | 0.184 | 2.799
COVID19_MODERNA | Tachyphrenia | 1 | 1.341 | 0.394 | 1.022 | 1.888 | 0.332 | 0.809 | 1.717 | 0.746 | 1.451 | 0.06
COVID19_MODERNA | Specific gravity urine normal | 3 | 4.031 | 0.378 | 1.022 | 1.92 | 0.386 | 0.789 | 1.468 | 0.744 | 0.611 | 0.382
COVID19_MODERNA | Tonic convulsion | 1 | 0.702 | 0.215 | 1.021 | 2.316 | 0.385 | 0.934 | 1.982 | 1.425 | 0.277 | 1.196
COVID19_MODERNA | Catheterisation cardiac | 16 | 15.95 | 0.685 | 1.021 | 1.413 | 0.658 | 0.973 | 1.396 | 1.003 | 10.96 | 93.231
COVID19_MODERNA | Asthma/bronchospasm (SMQ) [broad] | 224 | 231.34 | 0.913 | 1.021 | 1.136 | 0.865 | 0.966 | 1.076 | 0.968 | 1.97 | 99.027
COVID19_MODERNA | Diarrhoea | 442 | 460.72 | 0.943 | 1.021 | 1.102 | 0.886 | 0.958 | 1.035 | 0.959 | 1.401 | 48.76
COVID19_MODERNA | Hypovolaemic shock conditions (SMQ) [broad] | 94 | 106.143 | 0.856 | 1.021 | 1.199 | 0.746 | 0.884 | 1.042 | 0.886 | 1.986 | 41.82
COVID19_MODERNA | PCO2 decreased | 4 | 3.969 | 0.401 | 1.02 | 1.87 | 0.481 | 0.928 | 1.654 | 1.008 | 1.761 | 0.601
COVID19_MODERNA | Hyperhidrosis | 368 | 366.987 | 0.935 | 1.02 | 1.107 | 0.919 | 1.001 | 1.09 | 1.003 | 2.015 | 175.455
COVID19_MODERNA | Disorganised speech | 3 | 3.362 | 0.465 | 1.02 | 1.749 | 0.424 | 0.865 | 1.609 | 0.892 | 4.932 | 4.799
COVID19_MODERNA | Central nervous system vascular disorders (SMQ) [narrow] | 229 | 240.125 | 0.912 | 1.019 | 1.132 | 0.854 | 0.952 | 1.059 | 0.954 | 4.478 | 522.84
COVID19_MODERNA | Abdominal pain | 132 | 144.525 | 0.878 | 1.019 | 1.168 | 0.79 | 0.912 | 1.048 | 0.913 | 1.174 | 3.102
COVID19_MODERNA | Base excess increased | 1 | 1.557 | 0.207 | 1.019 | 2.334 | 0.317 | 0.774 | 1.644 | 0.642 | 1.644 | 0.025
COVID19_MODERNA | Fluid intake reduced | 11 | 10.42 | 0.643 | 1.018 | 1.465 | 0.633 | 1 | 1.519 | 1.056 | 2.299 | 6.202
COVID19_MODERNA | Cardiac failure (SMQ) [broad] | 457 | 470.242 | 0.941 | 1.018 | 1.097 | 0.899 | 0.971 | 1.048 | 0.972 | 0.846 | 12.814
COVID19_MODERNA | Muscle tightness | 45 | 46.683 | 0.788 | 1.018 | 1.271 | 0.749 | 0.955 | 1.203 | 0.964 | 1.985 | 19.46
COVID19_MODERNA | Platelet count normal | 28 | 30.887 | 0.734 | 1.018 | 1.339 | 0.664 | 0.899 | 1.197 | 0.907 | 1.008 | 0.003
COVID19_MODERNA | Haematemesis | 5 | 7.25 | 0.475 | 1.018 | 1.725 | 0.4 | 0.739 | 1.273 | 0.69 | 1.245 | 0.051
COVID19_MODERNA | Urine leukocyte esterase positive | 5 | 4.327 | 0.526 | 1.017 | 1.639 | 0.549 | 1.012 | 1.743 | 1.155 | 6.165 | 13.278
COVID19_MODERNA | Death | 602 | 617.301 | 0.95 | 1.017 | 1.086 | 0.911 | 0.974 | 1.041 | 0.975 | 4.642 | 1460.904
COVID19_MODERNA | Ischaemic heart disease (SMQ) [narrow] | 151 | 172.762 | 0.885 | 1.017 | 1.157 | 0.764 | 0.873 | 0.995 | 0.874 | 5.5 | 451.893
COVID19_MODERNA | Abdominal pain lower | 15 | 17.323 | 0.646 | 1.017 | 1.456 | 0.576 | 0.861 | 1.248 | 0.866 | 2.256 | 8.45
COVID19_MODERNA | Hypokalaemia (SMQ) [broad] | 212 | 221.001 | 0.904 | 1.016 | 1.132 | 0.855 | 0.957 | 1.07 | 0.959 | 2.451 | 165.421
COVID19_MODERNA | Bruxism | 2 | 2.403 | 0.397 | 1.016 | 1.867 | 0.381 | 0.836 | 1.642 | 0.832 | 0.747 | 0.009
COVID19_MODERNA | Abnormal behaviour | 13 | 15.287 | 0.643 | 1.016 | 1.459 | 0.553 | 0.848 | 1.256 | 0.85 | 0.396 | 11.185
COVID19_MODERNA | Dysgeusia | 108 | 101.111 | 0.861 | 1.015 | 1.179 | 0.905 | 1.06 | 1.236 | 1.068 | 4.116 | 216.074
COVID19_MODERNA | Sepsis (SMQ) [broad] | 58 | 67.532 | 0.807 | 1.014 | 1.24 | 0.692 | 0.858 | 1.054 | 0.859 | 0.923 | 0.289
COVID19_MODERNA | Blood glucose decreased | 10 | 12.866 | 0.598 | 1.014 | 1.519 | 0.491 | 0.791 | 1.219 | 0.777 | 1.158 | 0.079
COVID19_MODERNA | Wrong product administered | 46 | 40.519 | 0.783 | 1.013 | 1.268 | 0.874 | 1.111 | 1.397 | 1.135 | 0.303 | 72.925
COVID19_MODERNA | Myocardial infarction (SMQ) [broad] | 153 | 172.286 | 0.882 | 1.013 | 1.151 | 0.776 | 0.887 | 1.01 | 0.888 | 4.647 | 366.296
COVID19_MODERNA | Blood smear test normal | 2 | 1.579 | 0.322 | 1.012 | 2.014 | 0.443 | 0.97 | 1.907 | 1.267 | 2.466 | 0.501
COVID19_MODERNA | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [narrow] | 226 | 238.484 | 0.905 | 1.012 | 1.125 | 0.848 | 0.946 | 1.053 | 0.948 | 4.652 | 544.222
COVID19_MODERNA | Oxygen saturation abnormal | 2 | 2.285 | 0.349 | 1.012 | 1.954 | 0.389 | 0.853 | 1.675 | 0.875 | 4.11 | 1.737
COVID19_MODERNA | Tension | 2 | 2.636 | 0.371 | 1.012 | 1.907 | 0.366 | 0.804 | 1.581 | 0.759 | 0.385 | 1.353
COVID19_MODERNA | Injury | 2 | 2.801 | 0.33 | 1.012 | 1.998 | 0.356 | 0.783 | 1.54 | 0.714 | 0.343 | 1.861
COVID19_MODERNA | Glycosylated haemoglobin | 9 | 8.693 | 0.617 | 1.011 | 1.484 | 0.596 | 0.978 | 1.533 | 1.035 | 5.162 | 21.522
COVID19_MODERNA | Skin swelling | 12 | 11.973 | 0.631 | 1.011 | 1.464 | 0.62 | 0.965 | 1.445 | 1.002 | 2.715 | 10.161
COVID19_MODERNA | Myocardial infarction (SMQ) [narrow] | 133 | 152.461 | 0.872 | 1.011 | 1.159 | 0.755 | 0.872 | 1.001 | 0.872 | 6.119 | 452.981
COVID19_MODERNA | Immobile | 3 | 3.717 | 0.419 | 1.011 | 1.811 | 0.403 | 0.823 | 1.531 | 0.807 | 0.813 | 0.008
COVID19_MODERNA | Multiple organ dysfunction syndrome | 4 | 5.279 | 0.415 | 1.011 | 1.818 | 0.41 | 0.791 | 1.41 | 0.758 | 1.147 | 0
COVID19_MODERNA | Arthritis (SMQ) [broad] | 1116 | 1110.6 | 0.961 | 1.01 | 1.06 | 0.956 | 1.004 | 1.055 | 1.005 | 1.514 | 193.886
COVID19_MODERNA | Furuncle | 1 | 1.002 | 0.456 | 1.01 | 1.741 | 0.358 | 0.871 | 1.847 | 0.998 | 0.465 | 0.181
COVID19_MODERNA | Arthritis | 9 | 10.094 | 0.552 | 1.01 | 1.58 | 0.535 | 0.878 | 1.376 | 0.892 | 0.406 | 7.121
COVID19_MODERNA | Pulmonary fibrosis | 1 | 1.369 | 0.147 | 1.01 | 2.512 | 0.33 | 0.804 | 1.707 | 0.73 | 0.796 | 0.053
COVID19_MODERNA | Angioedema (SMQ) [broad] | 1846 | 1855.42 | 0.97 | 1.009 | 1.047 | 0.957 | 0.995 | 1.033 | 0.995 | 1.162 | 44.919
COVID19_MODERNA | Skin hypertrophy | 1 | 1.195 | 0.12 | 1.009 | 2.618 | 0.343 | 0.835 | 1.77 | 0.837 | 0.685 | 0.002
COVID19_MODERNA | Intracranial aneurysm | 4 | 4.138 | 0.468 | 1.008 | 1.714 | 0.471 | 0.907 | 1.617 | 0.967 | 14.092 | 22.898
COVID19_MODERNA | Vitreous floaters | 5 | 5.209 | 0.521 | 1.008 | 1.623 | 0.494 | 0.911 | 1.568 | 0.96 | 1.666 | 0.683
COVID19_MODERNA | Colonoscopy normal | 1 | 1.073 | 0.338 | 1.008 | 1.966 | 0.352 | 0.857 | 1.818 | 0.932 | 1.028 | 0.24
COVID19_MODERNA | Supraventricular extrasystoles | 1 | 1.175 | 0.336 | 1.008 | 1.973 | 0.344 | 0.838 | 1.778 | 0.851 | 1.174 | 0.155
COVID19_MODERNA | Specialist consultation | 1 | 1.191 | 0.303 | 1.008 | 2.048 | 0.343 | 0.835 | 1.772 | 0.84 | 0.747 | 0.024
COVID19_MODERNA | Tendon rupture | 1 | 1.382 | 0.281 | 1.008 | 2.099 | 0.329 | 0.802 | 1.703 | 0.724 | 0.617 | 0.006
COVID19_MODERNA | Blood phosphorus | 3 | 2.724 | 0.476 | 1.007 | 1.699 | 0.467 | 0.952 | 1.772 | 1.101 | 3.083 | 2.073
COVID19_MODERNA | Electrocardiogram normal | 121 | 126.977 | 0.863 | 1.007 | 1.161 | 0.818 | 0.95 | 1.098 | 0.953 | 2.622 | 108.632
COVID19_MODERNA | Splenomegaly | 4 | 4.723 | 0.399 | 1.007 | 1.839 | 0.437 | 0.844 | 1.504 | 0.847 | 1.333 | 0.073
COVID19_MODERNA | Orthopnoea | 1 | 1.564 | 0.168 | 1.007 | 2.427 | 0.316 | 0.773 | 1.642 | 0.639 | 1.644 | 0.025
COVID19_MODERNA | Red blood cell count increased | 3 | 3.144 | 0.405 | 1.006 | 1.826 | 0.438 | 0.893 | 1.661 | 0.954 | 1.85 | 0.422
COVID19_MODERNA | Dysstasia | 52 | 55.008 | 0.794 | 1.006 | 1.238 | 0.748 | 0.939 | 1.166 | 0.945 | 1.579 | 9.85
COVID19_MODERNA | Psychosis and psychotic disorders (SMQ) [broad] | 137 | 146.172 | 0.87 | 1.006 | 1.15 | 0.812 | 0.935 | 1.072 | 0.937 | 1.169 | 3.045
COVID19_MODERNA | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [narrow] | 1 | 3.133 | 0.163 | 1.006 | 2.441 | 0.232 | 0.584 | 1.257 | 0.319 | 0.514 | 0.091
COVID19_MODERNA | Skin infection | 1 | 0.805 | 0.328 | 1.005 | 1.981 | 0.375 | 0.911 | 1.932 | 1.242 | 0.196 | 2.502
COVID19_MODERNA | Disorders of sinus node function (SMQ) [broad] | 4 | 4.184 | 0.402 | 1.005 | 1.828 | 0.468 | 0.902 | 1.608 | 0.956 | 2.099 | 1.198
COVID19_MODERNA | Disorders of sinus node function (SMQ) [narrow] | 4 | 4.184 | 0.402 | 1.005 | 1.828 | 0.468 | 0.902 | 1.608 | 0.956 | 2.099 | 1.198
COVID19_MODERNA | Product administered at inappropriate site | 36 | 43.545 | 0.752 | 1.005 | 1.289 | 0.632 | 0.828 | 1.069 | 0.827 | 0.648 | 6.381
COVID19_MODERNA | Other ischaemic heart disease (SMQ) [broad] | 43 | 53.575 | 0.77 | 1.005 | 1.266 | 0.628 | 0.805 | 1.019 | 0.803 | 4.126 | 84.556
COVID19_MODERNA | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [narrow] | 9 | 11.504 | 0.54 | 1.005 | 1.588 | 0.485 | 0.796 | 1.248 | 0.782 | 2.412 | 5.508
COVID19_MODERNA | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [broad] | 9 | 11.504 | 0.54 | 1.005 | 1.588 | 0.485 | 0.796 | 1.248 | 0.782 | 2.412 | 5.508
COVID19_MODERNA | Non-haematological tumours of unspecified malignancy (SMQ) [narrow] | 1 | 0.921 | 0.197 | 1.004 | 2.322 | 0.365 | 0.887 | 1.88 | 1.085 | 0.32 | 0.812
COVID19_MODERNA | Non-haematological tumours of unspecified malignancy (SMQ) [broad] | 1 | 0.921 | 0.197 | 1.004 | 2.322 | 0.365 | 0.887 | 1.88 | 1.085 | 0.32 | 0.812
COVID19_MODERNA | Presyncope | 66 | 69.917 | 0.812 | 1.004 | 1.212 | 0.767 | 0.939 | 1.139 | 0.944 | 1.362 | 5.688
COVID19_MODERNA | Muscle fatigue | 11 | 11.868 | 0.605 | 1.004 | 1.485 | 0.574 | 0.906 | 1.377 | 0.927 | 1.952 | 3.858
COVID19_MODERNA | Uterine haemorrhage | 1 | 1.753 | 0.164 | 1.004 | 2.43 | 0.304 | 0.745 | 1.584 | 0.571 | 2.466 | 0.012
COVID19_MODERNA | Prothrombin time shortened | 1 | 1.568 | 0.209 | 1.003 | 2.281 | 0.316 | 0.772 | 1.641 | 0.638 | 0.948 | 0.198
COVID19_MODERNA | Computerised tomogram head normal | 55 | 60.172 | 0.797 | 1.002 | 1.226 | 0.73 | 0.91 | 1.123 | 0.914 | 2.003 | 24.662
COVID19_MODERNA | Eyelid disorder | 4 | 3.296 | 0.508 | 1.001 | 1.628 | 0.528 | 1.018 | 1.816 | 1.214 | 4.697 | 6.814
COVID19_MODERNA | Swollen tongue | 127 | 127.984 | 0.863 | 1.001 | 1.146 | 0.854 | 0.988 | 1.139 | 0.992 | 3.724 | 218.019
COVID19_MODERNA | Generalised convulsive seizures following immunisation (SMQ) [algorithm] | 92 | 97.742 | 0.837 | 1.001 | 1.176 | 0.79 | 0.938 | 1.107 | 0.941 | 0.327 | 127.45
COVID19_MODERNA | Tension headache | 5 | 6.686 | 0.442 | 1.001 | 1.744 | 0.423 | 0.78 | 1.343 | 0.748 | 1.581 | 0.515
COVID19_MODERNA | Supraventricular tachycardia | 18 | 17.712 | 0.678 | 1 | 1.374 | 0.68 | 0.986 | 1.392 | 1.016 | 5.102 | 45.731
COVID19_MODERNA | Urticaria | 500 | 507.455 | 0.928 | 1 | 1.073 | 0.914 | 0.984 | 1.059 | 0.985 | 1.3 | 33.623
COVID19_MODERNA | Restlessness | 23 | 25.954 | 0.693 | 1 | 1.354 | 0.631 | 0.88 | 1.202 | 0.886 | 0.862 | 0.363
COVID19_MODERNA | Myoclonus | 2 | 2.718 | 0.361 | 1 | 1.899 | 0.361 | 0.794 | 1.56 | 0.736 | 0.333 | 1.993
COVID19_MODERNA | Ultrasound Doppler | 22 | 30.534 | 0.684 | 1 | 1.365 | 0.522 | 0.733 | 1.006 | 0.721 | 3.848 | 37.606
COVID19_MODERNA | Computerised tomogram thorax | 36 | 36.257 | 0.766 | 0.999 | 1.258 | 0.747 | 0.979 | 1.264 | 0.993 | 8.968 | 180.928
COVID19_MODERNA | Hypersomnia | 45 | 48.458 | 0.772 | 0.999 | 1.251 | 0.723 | 0.922 | 1.162 | 0.929 | 1.057 | 0.082
COVID19_MODERNA | CSF lymphocyte count normal | 1 | 1.189 | 0.4 | 0.999 | 1.818 | 0.343 | 0.836 | 1.773 | 0.841 | 1.121 | 0.182
COVID19_MODERNA | Dehydration (SMQ) [narrow] | 56 | 64.986 | 0.795 | 0.999 | 1.223 | 0.692 | 0.861 | 1.061 | 0.862 | 1.409 | 5.916
COVID19_MODERNA | Monocyte count increased | 4 | 6.013 | 0.385 | 0.999 | 1.847 | 0.378 | 0.73 | 1.302 | 0.665 | 0.416 | 2.653
COVID19_MODERNA | Foetal heart rate abnormal | 5 | 5.742 | 0.419 | 0.998 | 1.776 | 0.465 | 0.859 | 1.478 | 0.871 | 4.11 | 7.504
COVID19_MODERNA | Blood bicarbonate normal | 3 | 3.661 | 0.346 | 0.998 | 1.925 | 0.406 | 0.829 | 1.542 | 0.819 | 0.544 | 0.706
COVID19_MODERNA | Cardiomyopathy (SMQ) [narrow] | 16 | 19.311 | 0.641 | 0.998 | 1.421 | 0.562 | 0.83 | 1.192 | 0.829 | 2.859 | 15.65
COVID19_MODERNA | Meningitis viral | 3 | 3.974 | 0.336 | 0.998 | 1.944 | 0.389 | 0.795 | 1.479 | 0.755 | 0.725 | 0.089
COVID19_MODERNA | Dysphonia | 53 | 57.03 | 0.788 | 0.997 | 1.226 | 0.738 | 0.924 | 1.145 | 0.929 | 1.989 | 23.237
COVID19_MODERNA | Ischaemic central nervous system vascular conditions (SMQ) [narrow] | 155 | 172.027 | 0.87 | 0.997 | 1.131 | 0.788 | 0.9 | 1.024 | 0.901 | 5.145 | 425.77
COVID19_MODERNA | Ischaemic central nervous system vascular conditions (SMQ) [broad] | 155 | 172.027 | 0.87 | 0.997 | 1.131 | 0.788 | 0.9 | 1.024 | 0.901 | 5.145 | 425.77
COVID19_MODERNA | Butterfly rash | 1 | 1.218 | 0.227 | 0.997 | 2.212 | 0.341 | 0.83 | 1.761 | 0.821 | 0.881 | 0.126
COVID19_MODERNA | Musculoskeletal disorder | 10 | 12.098 | 0.603 | 0.997 | 1.472 | 0.516 | 0.83 | 1.279 | 0.827 | 0.531 | 3.585
COVID19_MODERNA | Myositis | 3 | 4.036 | 0.436 | 0.997 | 1.742 | 0.386 | 0.788 | 1.467 | 0.743 | 0.477 | 1.194
COVID19_MODERNA | Dehydration (SMQ) [broad] | 952 | 965.622 | 0.944 | 0.996 | 1.049 | 0.934 | 0.985 | 1.039 | 0.986 | 2.717 | 955.562
COVID19_MODERNA | Transaminases | 1 | 1.03 | 0.215 | 0.996 | 2.241 | 0.356 | 0.865 | 1.835 | 0.971 | 1.072 | 0.211
COVID19_MODERNA | Migraine | 117 | 120.577 | 0.851 | 0.996 | 1.151 | 0.83 | 0.967 | 1.12 | 0.97 | 2.214 | 70.637
COVID19_MODERNA | Epstein-Barr virus test negative | 1 | 1.337 | 0.235 | 0.996 | 2.188 | 0.332 | 0.81 | 1.719 | 0.748 | 0.143 | 4.243
COVID19_MODERNA | Pallor | 97 | 98.566 | 0.837 | 0.995 | 1.164 | 0.828 | 0.979 | 1.151 | 0.984 | 0.581 | 28.481
COVID19_MODERNA | Fatal outcome (Custom Term) | 704 | 732.249 | 0.934 | 0.995 | 1.058 | 0.903 | 0.961 | 1.022 | 0.961 | 4.788 | 1786.204
COVID19_MODERNA | Respiratory failure (SMQ) [broad] | 420 | 439.483 | 0.917 | 0.995 | 1.076 | 0.881 | 0.955 | 1.033 | 0.956 | 2.403 | 316.441
COVID19_MODERNA | Nerve conduction studies | 2 | 2.17 | 0.342 | 0.995 | 1.924 | 0.397 | 0.87 | 1.709 | 0.922 | 0.382 | 1.384
COVID19_MODERNA | X-ray normal | 14 | 15.003 | 0.654 | 0.995 | 1.393 | 0.605 | 0.915 | 1.339 | 0.933 | 0.876 | 0.128
COVID19_MODERNA | Speech disorder | 57 | 63.755 | 0.795 | 0.995 | 1.213 | 0.717 | 0.891 | 1.096 | 0.894 | 1.716 | 15.282
COVID19_MODERNA | Chest X-ray | 144 | 145.161 | 0.868 | 0.994 | 1.126 | 0.861 | 0.988 | 1.13 | 0.992 | 4.013 | 278.273
COVID19_MODERNA | Asthma/bronchospasm (SMQ) [narrow] | 33 | 34.091 | 0.734 | 0.994 | 1.287 | 0.721 | 0.956 | 1.247 | 0.968 | 0.942 | 0.063
COVID19_MODERNA | Chronic kidney disease (SMQ) [broad] | 158 | 173.929 | 0.868 | 0.994 | 1.127 | 0.795 | 0.907 | 1.031 | 0.908 | 2.005 | 73.133
COVID19_MODERNA | Cholestasis and jaundice of hepatic origin (SMQ) [narrow] | 8 | 10.017 | 0.518 | 0.994 | 1.594 | 0.482 | 0.809 | 1.293 | 0.799 | 0.885 | 0.029
COVID19_MODERNA | Contusion | 52 | 53.038 | 0.789 | 0.993 | 1.215 | 0.774 | 0.971 | 1.206 | 0.98 | 0.684 | 7.136
COVID19_MODERNA | Noninfectious diarrhoea (SMQ) [broad] | 472 | 495.644 | 0.919 | 0.993 | 1.069 | 0.882 | 0.951 | 1.025 | 0.952 | 1.279 | 27.886
COVID19_MODERNA | Blood pH increased | 3 | 3.557 | 0.393 | 0.993 | 1.814 | 0.412 | 0.841 | 1.565 | 0.843 | 3.363 | 2.486
COVID19_MODERNA | Cystitis | 2 | 4.077 | 0.236 | 0.993 | 2.174 | 0.295 | 0.651 | 1.283 | 0.491 | 0.617 | 0.158
COVID19_MODERNA | Gallbladder disorder | 2 | 1.96 | 0.35 | 0.992 | 1.9 | 0.412 | 0.903 | 1.774 | 1.021 | 4.11 | 1.737
COVID19_MODERNA | Prenatal screening test | 1 | 4.865 | 0.071 | 0.992 | 2.823 | 0.167 | 0.451 | 0.997 | 0.206 | 0.185 | 2.762
COVID19_MODERNA | Prothrombin time | 16 | 16.052 | 0.663 | 0.991 | 1.372 | 0.655 | 0.968 | 1.389 | 0.997 | 4.932 | 38.469
COVID19_MODERNA | Haematopoietic leukopenia (SMQ) [broad] | 51 | 57.031 | 0.779 | 0.991 | 1.225 | 0.709 | 0.891 | 1.108 | 0.894 | 0.853 | 1.106
COVID19_MODERNA | pH urine normal | 4 | 4.668 | 0.465 | 0.991 | 1.678 | 0.44 | 0.849 | 1.514 | 0.857 | 0.986 | 0.051
COVID19_MODERNA | Hyponatraemia/SIADH (SMQ) [broad] | 29 | 33.515 | 0.721 | 0.991 | 1.296 | 0.64 | 0.863 | 1.143 | 0.865 | 1.882 | 10.313
COVID19_MODERNA | Skin discomfort | 3 | 2.426 | 0.383 | 0.99 | 1.827 | 0.491 | 1 | 1.861 | 1.237 | 3.083 | 2.073
COVID19_MODERNA | Immature granulocyte percentage increased | 3 | 2.745 | 0.416 | 0.99 | 1.761 | 0.466 | 0.949 | 1.766 | 1.093 | 9.248 | 10.415
COVID19_MODERNA | Pregnancy | 9 | 8.995 | 0.565 | 0.99 | 1.511 | 0.581 | 0.954 | 1.496 | 1.001 | 11.097 | 50.014
COVID19_MODERNA | Peripheral coldness | 51 | 53.61 | 0.777 | 0.99 | 1.224 | 0.751 | 0.944 | 1.175 | 0.951 | 1.852 | 17.825
COVID19_MODERNA | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [narrow] | 206 | 225.994 | 0.88 | 0.99 | 1.106 | 0.811 | 0.91 | 1.019 | 0.912 | 2.521 | 171.214
COVID19_MODERNA | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [broad] | 206 | 225.994 | 0.88 | 0.99 | 1.106 | 0.811 | 0.91 | 1.019 | 0.912 | 2.521 | 171.214
COVID19_MODERNA | Hostility/aggression (SMQ) [broad] | 69 | 79.301 | 0.808 | 0.99 | 1.187 | 0.713 | 0.869 | 1.05 | 0.87 | 0.306 | 108.292
COVID19_MODERNA | Cardiac stress test normal | 5 | 6.045 | 0.563 | 0.99 | 1.516 | 0.451 | 0.832 | 1.432 | 0.827 | 2.163 | 1.87
COVID19_MODERNA | Mastication disorder | 6 | 6.559 | 0.565 | 0.989 | 1.509 | 0.499 | 0.888 | 1.485 | 0.915 | 3.894 | 8.696
COVID19_MODERNA | Extrapyramidal syndrome (SMQ) [narrow] | 45 | 50.848 | 0.765 | 0.989 | 1.237 | 0.692 | 0.882 | 1.111 | 0.885 | 0.486 | 23.587
COVID19_MODERNA | Purulent discharge | 1 | 0.712 | 0.241 | 0.988 | 2.148 | 0.384 | 0.931 | 1.977 | 1.404 | 0.228 | 1.85
COVID19_MODERNA | Drug screen negative | 5 | 4.414 | 0.531 | 0.988 | 1.558 | 0.543 | 1.001 | 1.724 | 1.133 | 1.761 | 0.886
COVID19_MODERNA | Tri-iodothyronine normal | 1 | 0.819 | 0.24 | 0.987 | 2.146 | 0.374 | 0.908 | 1.926 | 1.22 | 1.897 | 0.004
COVID19_MODERNA | Ill-defined disorder | 2 | 2.439 | 0.304 | 0.987 | 1.988 | 0.379 | 0.831 | 1.633 | 0.82 | 0.32 | 2.194
COVID19_MODERNA | Eye infection | 1 | 1.415 | 0.191 | 0.987 | 2.288 | 0.326 | 0.797 | 1.691 | 0.707 | 0.56 | 0.038
COVID19_MODERNA | Drug hypersensitivity | 3 | 4.064 | 0.371 | 0.987 | 1.844 | 0.385 | 0.785 | 1.461 | 0.738 | 0.366 | 2.626
COVID19_MODERNA | Herpes simplex encephalitis | 1 | 2.11 | 0.242 | 0.987 | 2.142 | 0.283 | 0.696 | 1.484 | 0.474 | 1.644 | 0.025
COVID19_MODERNA | Skin mass | 3 | 3.232 | 0.426 | 0.986 | 1.734 | 0.432 | 0.881 | 1.639 | 0.928 | 0.611 | 0.382
COVID19_MODERNA | Staphylococcus test positive | 2 | 2.33 | 0.485 | 0.986 | 1.63 | 0.386 | 0.846 | 1.663 | 0.858 | 0.484 | 0.619
COVID19_MODERNA | Basophil percentage | 6 | 7.333 | 0.525 | 0.986 | 1.565 | 0.464 | 0.825 | 1.38 | 0.818 | 1.345 | 0.221
COVID19_MODERNA | Foot deformity | 1 | 1.031 | 0.32 | 0.985 | 1.945 | 0.356 | 0.865 | 1.835 | 0.97 | 1.121 | 0.182
COVID19_MODERNA | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [broad] | 240 | 256.17 | 0.883 | 0.985 | 1.092 | 0.841 | 0.936 | 1.038 | 0.937 | 3.498 | 374.799
COVID19_MODERNA | Dehydration | 54 | 61.869 | 0.78 | 0.985 | 1.21 | 0.697 | 0.871 | 1.077 | 0.873 | 1.405 | 5.582
COVID19_MODERNA | Obsessive-compulsive disorder | 1 | 0.915 | 0.258 | 0.984 | 2.09 | 0.365 | 0.888 | 1.883 | 1.093 | 0.385 | 0.438
COVID19_MODERNA | Hypophagia | 15 | 14.781 | 0.652 | 0.984 | 1.372 | 0.656 | 0.98 | 1.42 | 1.015 | 1.186 | 0.252
COVID19_MODERNA | Clostridium test positive | 1 | 1.196 | 0.277 | 0.984 | 2.043 | 0.343 | 0.834 | 1.77 | 0.836 | 0.948 | 0.198
COVID19_MODERNA | Roseola | 0 | 0.043 | 0.239 | 0.984 | 2.141 |  |  |  |  |  | 
COVID19_MODERNA | Extrapyramidal disorder | 0 | 0.043 | 0.222 | 0.983 | 2.186 |  |  |  |  |  | 
COVID19_MODERNA | Ehrlichia test | 0 | 0.042 | 0.222 | 0.983 | 2.187 |  |  |  |  |  | 
COVID19_MODERNA | Radioallergosorbent test | 0 | 0.042 | 0.215 | 0.983 | 2.206 |  |  |  |  |  | 
COVID19_MODERNA | Neck pain | 213 | 219.7 | 0.876 | 0.982 | 1.094 | 0.864 | 0.967 | 1.08 | 0.97 | 1.501 | 33.474
COVID19_MODERNA | Culture negative | 6 | 8.365 | 0.483 | 0.982 | 1.623 | 0.424 | 0.754 | 1.261 | 0.717 | 0.736 | 0.317
COVID19_MODERNA | Vitamin B1 | 0 | 0.043 | 0.208 | 0.982 | 2.222 |  |  |  |  |  | 
COVID19_MODERNA | Testicular pain | 3 | 2.849 | 0.441 | 0.981 | 1.693 | 0.458 | 0.934 | 1.737 | 1.053 | 2.055 | 0.658
COVID19_MODERNA | Cardiac flutter | 9 | 9.832 | 0.566 | 0.981 | 1.49 | 0.545 | 0.895 | 1.403 | 0.915 | 3.963 | 14.629
COVID19_MODERNA | Aspiration | 6 | 6.635 | 0.536 | 0.981 | 1.536 | 0.496 | 0.882 | 1.474 | 0.904 | 2.551 | 3.77
COVID19_MODERNA | Strabismus | 1 | 1.193 | 0.303 | 0.981 | 1.974 | 0.343 | 0.835 | 1.771 | 0.838 | 0.147 | 4.089
COVID19_MODERNA | Lip disorder | 2 | 2.42 | 0.378 | 0.981 | 1.814 | 0.38 | 0.833 | 1.638 | 0.826 | 4.11 | 1.737
COVID19_MODERNA | Respiratory tract congestion | 51 | 68.885 | 0.774 | 0.981 | 1.207 | 0.593 | 0.745 | 0.927 | 0.74 | 1.526 | 8.23
COVID19_MODERNA | Urine ketone body present | 3 | 2.918 | 0.488 | 0.98 | 1.611 | 0.453 | 0.924 | 1.719 | 1.028 | 0.936 | 0.03
COVID19_MODERNA | Blood magnesium normal | 14 | 13.744 | 0.657 | 0.98 | 1.355 | 0.649 | 0.981 | 1.436 | 1.019 | 3.452 | 19.221
COVID19_MODERNA | Musculoskeletal stiffness | 116 | 119.587 | 0.84 | 0.98 | 1.128 | 0.829 | 0.966 | 1.121 | 0.97 | 0.88 | 1.734
COVID19_MODERNA | Brain oedema | 3 | 3.121 | 0.356 | 0.98 | 1.854 | 0.44 | 0.896 | 1.667 | 0.961 | 0.813 | 0.008
COVID19_MODERNA | Anaphylactic shock | 13 | 14.82 | 0.595 | 0.98 | 1.443 | 0.567 | 0.87 | 1.288 | 0.877 | 1.471 | 1.415
COVID19_MODERNA | Electrocardiogram T wave inversion | 3 | 3.736 | 0.399 | 0.98 | 1.767 | 0.402 | 0.821 | 1.527 | 0.803 | 5.284 | 5.303
COVID19_MODERNA | Back injury | 1 | 1.735 | 0.353 | 0.98 | 1.862 | 0.305 | 0.747 | 1.589 | 0.576 | 1.451 | 0.06
COVID19_MODERNA | Impetigo | 0 | 0.057 | 0.247 | 0.98 | 2.108 |  |  |  |  |  | 
COVID19_MODERNA | Gianotti-Crosti syndrome | 0 | 0.049 | 0.223 | 0.98 | 2.176 |  |  |  |  |  | 
COVID19_MODERNA | Effusion | 0 | 0.045 | 0.192 | 0.98 | 2.266 |  |  |  |  |  | 
COVID19_MODERNA | Swelling of eyelid | 19 | 18.969 | 0.715 | 0.979 | 1.278 | 0.679 | 0.976 | 1.367 | 1.002 | 2.12 | 9.315
COVID19_MODERNA | Blood test abnormal | 8 | 9.796 | 0.548 | 0.979 | 1.513 | 0.49 | 0.823 | 1.314 | 0.817 | 0.676 | 0.907
COVID19_MODERNA | Laboratory test | 168 | 180.266 | 0.859 | 0.978 | 1.103 | 0.819 | 0.93 | 1.053 | 0.932 | 2.097 | 88.323
COVID19_MODERNA | Lipase | 5 | 5.94 | 0.553 | 0.978 | 1.5 | 0.456 | 0.841 | 1.448 | 0.842 | 3.425 | 5.486
COVID19_MODERNA | Depressed mood | 3 | 3.384 | 0.366 | 0.977 | 1.828 | 0.423 | 0.862 | 1.604 | 0.887 | 0.351 | 2.924
COVID19_MODERNA | Loss of consciousness | 162 | 185.019 | 0.855 | 0.977 | 1.105 | 0.768 | 0.875 | 0.993 | 0.876 | 0.84 | 4.66
COVID19_MODERNA | Other ischaemic heart disease (SMQ) [narrow] | 30 | 39.595 | 0.708 | 0.977 | 1.283 | 0.57 | 0.765 | 1.009 | 0.758 | 3.794 | 51.039
COVID19_MODERNA | Red blood cell sedimentation rate | 15 | 14.905 | 0.652 | 0.975 | 1.351 | 0.652 | 0.974 | 1.411 | 1.006 | 1.456 | 1.603
COVID19_MODERNA | Convulsions (SMQ) [narrow] | 111 | 116.427 | 0.829 | 0.975 | 1.13 | 0.812 | 0.95 | 1.105 | 0.953 | 0.366 | 122.13
COVID19_MODERNA | Snoring | 1 | 1.187 | 0.251 | 0.975 | 2.084 | 0.343 | 0.836 | 1.773 | 0.842 | 0.404 | 0.362
COVID19_MODERNA | Borrelia test | 1 | 1.357 | 0.418 | 0.975 | 1.72 | 0.331 | 0.806 | 1.711 | 0.737 | 0.188 | 2.687
COVID19_MODERNA | Eye irritation | 24 | 24.305 | 0.706 | 0.974 | 1.278 | 0.699 | 0.968 | 1.314 | 0.987 | 1.691 | 5.693
COVID19_MODERNA | Hypocalcaemia | 2 | 2.115 | 0.346 | 0.974 | 1.861 | 0.401 | 0.878 | 1.726 | 0.946 | 4.484 | 2.027
COVID19_MODERNA | Melaena | 2 | 2.271 | 0.272 | 0.974 | 2.028 | 0.39 | 0.855 | 1.68 | 0.881 | 0.658 | 0.087
COVID19_MODERNA | Breast malignant tumours (SMQ) [narrow] | 1 | 1.781 | 0.267 | 0.974 | 2.038 | 0.302 | 0.741 | 1.575 | 0.562 | 0.493 | 0.124
COVID19_MODERNA | Breast neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 1.781 | 0.267 | 0.974 | 2.038 | 0.302 | 0.741 | 1.575 | 0.562 | 0.493 | 0.124
COVID19_MODERNA | Investigation abnormal | 0 | 0.044 | 0.132 | 0.974 | 2.461 |  |  |  |  |  | 
COVID19_MODERNA | Hearing and vestibular disorders (SMQ) [broad] | 1744 | 1797.51 | 0.935 | 0.973 | 1.012 | 0.932 | 0.97 | 1.009 | 0.97 | 2.205 | 1123.723
COVID19_MODERNA | Cardiolipin antibody negative | 1 | 1.184 | 0.126 | 0.973 | 2.482 | 0.344 | 0.836 | 1.775 | 0.845 | 0.796 | 0.053
COVID19_MODERNA | Haemorrhage laboratory terms (SMQ) [broad] | 114 | 128.739 | 0.83 | 0.973 | 1.126 | 0.758 | 0.884 | 1.027 | 0.886 | 2.1 | 59.702
COVID19_MODERNA | CSF lymphocyte count | 0 | 0.042 | 0.115 | 0.973 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Viral pharyngitis | 0 | 0.043 | 0.118 | 0.973 | 2.518 |  |  |  |  |  | 
COVID19_MODERNA | Administration site bruise | 0 | 0.047 | 0.139 | 0.973 | 2.43 |  |  |  |  |  | 
COVID19_MODERNA | Leukoencephalopathy | 0 | 0.045 | 0.124 | 0.973 | 2.489 |  |  |  |  |  | 
COVID19_MODERNA | Skin tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.044 | 0.119 | 0.972 | 2.51 |  |  |  |  |  | 
COVID19_MODERNA | Mutism | 0 | 0.043 | 0.111 | 0.972 | 2.546 |  |  |  |  |  | 
COVID19_MODERNA | Neoplasm skin | 0 | 0.044 | 0.119 | 0.972 | 2.51 |  |  |  |  |  | 
COVID19_MODERNA | Arrhythmia related investigations, signs and symptoms (SMQ) [broad] | 1271 | 1325.223 | 0.927 | 0.971 | 1.016 | 0.915 | 0.959 | 1.004 | 0.959 | 1.977 | 597.417
COVID19_MODERNA | Haematopoietic thrombocytopenia (SMQ) [narrow] | 76 | 83.177 | 0.798 | 0.971 | 1.159 | 0.754 | 0.911 | 1.092 | 0.914 | 1.575 | 14.492
COVID19_MODERNA | Skin discolouration | 34 | 37.449 | 0.736 | 0.971 | 1.232 | 0.683 | 0.902 | 1.172 | 0.908 | 0.715 | 3.471
COVID19_MODERNA | Hypogammaglobulinaemia | 0 | 0.047 | 0.125 | 0.971 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis bacterial | 1 | 1.227 | 0.299 | 0.97 | 1.953 | 0.34 | 0.829 | 1.758 | 0.815 | 0.587 | 0.019
COVID19_MODERNA | Gastrointestinal sounds abnormal | 1 | 1.32 | 0.194 | 0.97 | 2.231 | 0.333 | 0.813 | 1.725 | 0.758 | 0.649 | 0
COVID19_MODERNA | Aspiration pleural cavity | 2 | 2.598 | 0.306 | 0.97 | 1.937 | 0.369 | 0.809 | 1.59 | 0.77 | 2.144 | 0.295
COVID19_MODERNA | Uterine contractions during pregnancy | 1 | 1.603 | 0.083 | 0.97 | 2.68 | 0.314 | 0.767 | 1.63 | 0.624 | 1.174 | 0.155
COVID19_MODERNA | No reaction on previous exposure to drug | 1 | 1.648 | 0.27 | 0.97 | 2.022 | 0.311 | 0.76 | 1.615 | 0.607 | 1.451 | 0.06
COVID19_MODERNA | Blood bicarbonate | 0 | 0.05 | 0.128 | 0.97 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram abdomen | 31 | 31.103 | 0.723 | 0.969 | 1.245 | 0.734 | 0.98 | 1.288 | 0.997 | 7.281 | 124.729
COVID19_MODERNA | Haematopoietic cytopenias (SMQ) [narrow] | 111 | 122.014 | 0.825 | 0.969 | 1.124 | 0.776 | 0.908 | 1.056 | 0.91 | 1.299 | 7.017
COVID19_MODERNA | Transfusion | 11 | 12.507 | 0.608 | 0.969 | 1.398 | 0.551 | 0.871 | 1.322 | 0.879 | 1.871 | 3.346
COVID19_MODERNA | CSF glucose normal | 3 | 4.288 | 0.368 | 0.969 | 1.801 | 0.374 | 0.763 | 1.42 | 0.7 | 0.409 | 1.956
COVID19_MODERNA | Wrong patient received product | 1 | 1.722 | 0.398 | 0.969 | 1.745 | 0.306 | 0.749 | 1.593 | 0.581 | 0.411 | 0.337
COVID19_MODERNA | Biopsy lymph gland abnormal | 0 | 0.043 | 0.095 | 0.969 | 2.616 |  |  |  |  |  | 
COVID19_MODERNA | Blood glucose normal | 51 | 55.167 | 0.764 | 0.968 | 1.193 | 0.731 | 0.919 | 1.143 | 0.924 | 1.302 | 3.11
COVID19_MODERNA | Fall | 132 | 143.612 | 0.836 | 0.968 | 1.108 | 0.795 | 0.917 | 1.054 | 0.919 | 1.338 | 10.435
COVID19_MODERNA | Tonic clonic movements | 1 | 1.133 | 0.252 | 0.968 | 2.063 | 0.347 | 0.846 | 1.794 | 0.883 | 0.143 | 4.243
COVID19_MODERNA | Genital swelling | 0 | 0.084 | 0.227 | 0.968 | 2.129 |  |  |  |  |  | 
COVID19_MODERNA | Foot fracture | 0 | 0.063 | 0.163 | 0.968 | 2.327 |  |  |  |  |  | 
COVID19_MODERNA | Allergic reaction to excipient | 0 | 0.044 | 0.094 | 0.968 | 2.614 |  |  |  |  |  | 
COVID19_MODERNA | Viral load decreased | 0 | 0.039 | 0.072 | 0.968 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Philadelphia chromosome positive | 0 | 0.039 | 0.071 | 0.968 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Blood prolactin increased | 0 | 0.044 | 0.089 | 0.968 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Cough | 374 | 400.479 | 0.886 | 0.967 | 1.05 | 0.857 | 0.933 | 1.015 | 0.934 | 1.525 | 64.46
COVID19_MODERNA | Bone pain | 26 | 28.563 | 0.696 | 0.967 | 1.275 | 0.659 | 0.902 | 1.212 | 0.91 | 1.192 | 0.588
COVID19_MODERNA | Shift to the right | 0 | 0.039 | 0.069 | 0.967 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | Wrong schedule | 0 | 0.039 | 0.069 | 0.967 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Penicillium test negative | 0 | 0.039 | 0.07 | 0.967 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland calculus | 0 | 0.039 | 0.067 | 0.967 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Auditory neuropathy spectrum disorder | 0 | 0.039 | 0.069 | 0.967 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell morphology | 0 | 0.039 | 0.069 | 0.967 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Rasmussen encephalitis | 0 | 0.039 | 0.067 | 0.967 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Back pain | 210 | 223.655 | 0.86 | 0.966 | 1.078 | 0.836 | 0.937 | 1.048 | 0.939 | 1.482 | 30.894
COVID19_MODERNA | Paraplegia | 1 | 1.171 | 0.157 | 0.966 | 2.342 | 0.344 | 0.839 | 1.779 | 0.854 | 0.617 | 0.006
COVID19_MODERNA | Aphasia | 54 | 62.851 | 0.764 | 0.966 | 1.187 | 0.687 | 0.858 | 1.061 | 0.859 | 2.426 | 39.926
COVID19_MODERNA | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [narrow] | 60 | 76.85 | 0.772 | 0.966 | 1.177 | 0.634 | 0.783 | 0.959 | 0.781 | 0.592 | 16.176
COVID19_MODERNA | Haemorrhage intracranial | 1 | 2.106 | 0.206 | 0.966 | 2.184 | 0.283 | 0.697 | 1.485 | 0.475 | 1.541 | 0.041
COVID19_MODERNA | Blood albumin abnormal | 0 | 0.039 | 0.061 | 0.966 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac ventriculogram left | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cautery to nose | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Mean arterial pressure decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Euglycaemic diabetic ketoacidosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urine retinol binding protein increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure management | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Craniectomy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hysterosalpingo-oophorectomy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to surgical sutures | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Gestational age test abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | General physical condition | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Uterine cervical pain | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Wall motion score index abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Paranoid personality disorder | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Myocarditis infectious | 0 | 0.039 | 0.063 | 0.966 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Vertebral lateral recess stenosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Acute undifferentiated leukaemia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hypnopompic hallucination | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Tidal volume decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram pancreas normal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Migraine prophylaxis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Vena cava embolism | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure diastolic abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Diplacusis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood calcium abnormal | 0 | 0.039 | 0.064 | 0.966 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic varicella syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Progressive bulbar palsy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Endothelial dysfunction | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Intracerebral haematoma evacuation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Streptobacillus infection | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary hilar enlargement | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Splenic lesion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Living in residential institution | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Coronary artery thrombosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Forced expiratory flow | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopic ultrasound | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Paraganglion neoplasm | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram aorta | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic enzyme decreased | 0 | 0.039 | 0.061 | 0.966 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Incarcerated hernia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Aortic thrombosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Otoacoustic emissions test | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Ewing's sarcoma | 0 | 0.039 | 0.062 | 0.966 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Intranasal paraesthesia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram PR segment elevation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Application site haemorrhage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonitis chemical | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Bullous haemorrhagic dermatosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Paraproteinaemia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Directional Doppler flow tests | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Creatine urine increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Abstains from alcohol | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Albumin globulin ratio abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Carotid artery stent insertion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy muscle normal | 0 | 0.045 | 0.082 | 0.966 | 2.672 |  |  |  |  |  | 
COVID19_MODERNA | Ocular rosacea | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Uterine tenderness | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Burkitt's lymphoma | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Mallampati score | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hereditary spherocytosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract irritation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Protein albumin ratio increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Ileocolectomy | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Venous recanalisation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Human herpesvirus 6 encephalitis | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Insulin resistant diabetes | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Renal atrophy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urinary nitrogen increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urine amphetamine positive | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Splenic artery aneurysm | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Oral viral infection | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Injection site muscle atrophy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Chondritis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Fluid balance assessment | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Assisted reproductive technology | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Vasodilation procedure | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Posthaemorrhagic hydrocephalus | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cystic lung disease | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Femoral nerve palsy | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Cerebellar haemorrhage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood pyruvic acid normal | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Rash maculovesicular | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Product delivery mechanism issue | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Iliac vein occlusion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic wound | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Transplant evaluation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis mumps | 0 | 0.039 | 0.062 | 0.966 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Iodine uptake normal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Focal peritonitis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hypertensive cerebrovascular disease | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood insulin increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Microembolism | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Holmes-Adie pupil | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Omentectomy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Silent myocardial infarction | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Scalloped tongue | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Victim of child abuse | 0 | 0.039 | 0.061 | 0.966 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Antipsychotic drug level | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Product design issue | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Sulphur dioxide test | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Portal hypertensive gastropathy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Binge drinking | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic foot infection | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Platelet aggregation decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy vagina | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Left ventricular dilatation | 0 | 0.039 | 0.061 | 0.966 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Myelocyte percentage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Product substitution issue | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Poikilocytosis | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Lens extraction | 0 | 0.039 | 0.061 | 0.966 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Hunt and Hess scale | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cor pulmonale acute | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Brain natriuretic peptide decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary amyloidosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Sleep disorder due to general medical condition, insomnia type | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic skin ulcer | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Small intestinal haemorrhage | 0 | 0.039 | 0.064 | 0.966 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Penile blister | 0 | 0.039 | 0.061 | 0.966 | 2.802 |  |  |  |  |  | 
COVID19_MODERNA | Itching scar | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Transcutaneous pacing | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Basilar artery occlusion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blood beta-D-glucan positive | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Malignant hypertension | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Aldosterone urine | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal stoma complication | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic response shortened | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Good syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Intercepted product preparation error | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral vein occlusion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Incision site rash | 0 | 0.039 | 0.064 | 0.966 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Diverticulitis intestinal perforated | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal wall haemorrhage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Vanishing twin syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Dementia with Lewy bodies | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Epstein-Barr virus infection reactivation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell microcytes | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Retinal operation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Small intestinal anastomosis | 0 | 0.039 | 0.061 | 0.966 | 2.802 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic haematoma | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Coma acidotic | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin time ratio abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Waist circumference increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | SARS-CoV-2 test false positive | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Lung carcinoma cell type unspecified stage I | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Internal injury | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urine porphobilinogen increased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Gastritis bacterial | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | EGFR gene mutation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urinary assistance device user | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral artery stent insertion | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound uterus abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Breath sounds absent | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Free thyroxine index | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urinary lipids present | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Acoustic neuritis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Splenic varices | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Blue toe syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Eye paraesthesia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmic artery thrombosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Lung hypoinflation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Gastric varices | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic pneumonia acute | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Instillation site pain | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Fibronectin normal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Postmenopausal haemorrhage | 0 | 0.039 | 0.064 | 0.966 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Thrombin-antithrombin III complex normal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Post-traumatic neuralgia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Russell's viper venom time normal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urethral meatus stenosis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | LDL/HDL ratio decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Chronic myeloid leukaemia recurrent | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral arteriosclerosis | 0 | 0.039 | 0.064 | 0.966 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Arteriovenous fistula aneurysm | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Breast milk discolouration | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Mass excision | 0 | 0.051 | 0.108 | 0.966 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Insulin therapy | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | SARS-CoV-2 test false negative | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic abscess | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Dermatophagia | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Product dose omission in error | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac pacemaker replacement | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Porphyria acute | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Bone density abnormal | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Right ventricular systolic pressure decreased | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Oocyte harvest | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Retroperitoneal haemorrhage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular function test | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Alveolar lung disease | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Jaw clicking | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Stoma site haemorrhage | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Renin | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Locked-in syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Crystal urine | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Mucosa vesicle | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Wound evisceration | 0 | 0.039 | 0.061 | 0.966 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Implant site pruritus | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Injection site recall reaction | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Arterial catheterisation | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urinary stone analysis | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Central cord syndrome | 0 | 0.039 | 0.062 | 0.966 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue swelling | 2 | 1.715 | 0.313 | 0.965 | 1.905 | 0.431 | 0.945 | 1.857 | 1.166 | 1.233 | 0.012
COVID19_MODERNA | Feeling cold | 115 | 128.456 | 0.823 | 0.965 | 1.115 | 0.766 | 0.894 | 1.037 | 0.895 | 1.566 | 21.692
COVID19_MODERNA | Respiratory syncytial virus test negative | 6 | 6.938 | 0.504 | 0.965 | 1.547 | 0.481 | 0.856 | 1.432 | 0.865 | 0.85 | 0.039
COVID19_MODERNA | Diplopia | 20 | 24.08 | 0.649 | 0.965 | 1.333 | 0.584 | 0.832 | 1.157 | 0.831 | 1.385 | 1.67
COVID19_MODERNA | Oropharyngeal infections (SMQ) [narrow] | 26 | 32.212 | 0.687 | 0.965 | 1.282 | 0.592 | 0.81 | 1.089 | 0.807 | 0.497 | 12.482
COVID19_MODERNA | Oropharyngeal infections (SMQ) [broad] | 26 | 32.212 | 0.687 | 0.965 | 1.282 | 0.592 | 0.81 | 1.089 | 0.807 | 0.497 | 12.482
COVID19_MODERNA | Primary hyperaldosteronism | 0 | 0.039 | 0.057 | 0.965 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis echo viral | 0 | 0.039 | 0.058 | 0.965 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocytic lymphoma | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Salmonella bacteraemia | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Malignant splenic neoplasm | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Tracheostomy tube removal | 0 | 0.039 | 0.059 | 0.965 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Body mass index increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | T-lymphocyte count abnormal | 0 | 0.039 | 0.058 | 0.965 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Myalgia intercostal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Dyskinesia oesophageal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Brain tumour operation | 0 | 0.039 | 0.059 | 0.965 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Blast cell proliferation | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body in ear | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Herpes oesophagitis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Wound contamination | 0 | 0.039 | 0.058 | 0.965 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Melanaemia | 0 | 0.039 | 0.057 | 0.965 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Velo-cardio-facial syndrome | 0 | 0.039 | 0.057 | 0.965 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Rectal cancer stage IV | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Food interaction | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Occupational therapy | 0 | 0.039 | 0.057 | 0.965 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Carnett's sign positive | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | SUNCT syndrome | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Breast ulceration | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Citrobacter infection | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Visceral congestion | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Large intestinal polypectomy | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Potassium hydroxide preparation negative | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Catheter site infection | 0 | 0.039 | 0.059 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Anastomotic ulcer | 0 | 0.039 | 0.059 | 0.965 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Administration site irritation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Osteoarthropathy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Lack of injection site rotation | 0 | 0.039 | 0.057 | 0.965 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic limb pain | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis neonatal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Medical device site joint pain | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Blood 1,25-dihydroxycholecalciferol increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic pain | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Procedural intestinal perforation | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Alveolar oxygen partial pressure decreased | 0 | 0.039 | 0.057 | 0.965 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Echoencephalogram abnormal | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Temperature perception test decreased | 0 | 0.039 | 0.059 | 0.965 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac septal defect | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Serial transverse enteroplasty | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte morphology | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrohepatorenal syndrome | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Acquired diaphragmatic eventration | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Diverticulectomy | 0 | 0.039 | 0.057 | 0.965 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Osteosclerosis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster pharyngitis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Cooling therapy | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoblast count | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Tenosynovitis stenosans | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Diffuse large B-cell lymphoma | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Colorectal cancer metastatic | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Insulin-like growth factor increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Corneal dystrophy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Analgesic therapy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Renal artery stenosis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Loose body in joint | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Hyperchromic anaemia | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Arterial fibrosis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Plasminogen decreased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated lung disease | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | PCO2 abnormal | 0 | 0.039 | 0.058 | 0.965 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Visual agnosia | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Dissociative amnesia | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Corneal neovascularisation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Alcoholic hangover | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Mastoid effusion | 0 | 0.039 | 0.057 | 0.965 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal dilatation | 0 | 0.039 | 0.059 | 0.965 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Antemortem blood drug level | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Capnogram abnormal | 0 | 0.039 | 0.058 | 0.965 | 2.822 |  |  |  |  |  | 
COVID19_MODERNA | Drain of cerebral subdural space | 0 | 0.039 | 0.057 | 0.965 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve sheath haemorrhage | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Long thoracic nerve palsy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | BRCA1 gene mutation assay | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Hyperkeratosis lenticularis perstans | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | 5'nucleotidase increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy mucosa normal | 0 | 0.039 | 0.06 | 0.965 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal malrotation repair | 0 | 0.039 | 0.059 | 0.965 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Microcytic anaemia | 0 | 0.086 | 0.206 | 0.965 | 2.178 |  |  |  |  |  | 
COVID19_MODERNA | Pubic pain | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Dental implantation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Urine phosphorus | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Positive expiratory pressure therapy | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Hyperparathyroidism primary | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Leptospira test | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Electroglottography | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VII level increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Application site odour | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal neoplasm | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Nipple disorder | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Lipase abnormal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Contraindication to medical treatment | 0 | 0.039 | 0.059 | 0.965 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VIII level decreased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Coombs positive haemolytic anaemia | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Cor pulmonale chronic | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosal ulcer | 0 | 0.039 | 0.06 | 0.965 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Electrolyte depletion | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Adrenalectomy | 0 | 0.039 | 0.058 | 0.965 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal inflammation | 0 | 0.039 | 0.058 | 0.965 | 2.827 |  |  |  |  |  | 
COVID19_MODERNA | Meibomian gland dysfunction | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Hyperoxia | 0 | 0.039 | 0.057 | 0.965 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VIII level increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Penile ulceration | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Ototoxicity | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Parathyroid tumour | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid boil | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Amimia | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Urticaria pressure | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Urine albumin/creatinine ratio increased | 0 | 0.039 | 0.06 | 0.965 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Lichen planopilaris | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Colonic fistula | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune blistering disease | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Thyroglobulin increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Thrombin-antithrombin III complex increased | 0 | 0.039 | 0.057 | 0.965 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Infusion site swelling | 0 | 0.039 | 0.059 | 0.965 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal transit time increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Angiotensin II increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Diffuse cutaneous mastocytosis | 0 | 0.039 | 0.059 | 0.965 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Biliary tract disorder | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic operation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Metastasis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Hyperadrenalism | 0 | 0.039 | 0.058 | 0.965 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Small intestine operation | 0 | 0.039 | 0.06 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Glutamate dehydrogenase increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy rectum normal | 0 | 0.039 | 0.059 | 0.965 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Macular dystrophy congenital | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Rectal fissure | 0 | 0.039 | 0.057 | 0.965 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Chromosomal deletion | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cancer stage IV | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Pigmentation lip | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Exploding head syndrome | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Electrocution | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Macular pseudohole | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric arterial occlusion | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Tongue thrust | 0 | 0.039 | 0.059 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Electrogastrogram | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Hernial eventration | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Telangiectasia congenital | 0 | 0.039 | 0.059 | 0.965 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Hyper IgD syndrome | 0 | 0.039 | 0.058 | 0.965 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Vascular rupture | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Joint surgery | 0 | 0.039 | 0.061 | 0.965 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Ulnar nerve palsy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Stem cell therapy | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Inborn error of lipid metabolism | 0 | 0.039 | 0.057 | 0.965 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Administration site haemorrhage | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Somatic dysfunction | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | White blood cells stool | 0 | 0.039 | 0.06 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Purpura neonatal | 0 | 0.039 | 0.058 | 0.965 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Incorrect disposal of product | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging breast normal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | BRCA2 gene mutation assay | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural haematoma | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac contusion | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Bicuspid aortic valve | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Vitreal cells | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Insurance issue | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Anisochromia | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Joint adhesion | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Parasite urine test negative | 0 | 0.039 | 0.059 | 0.965 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Stomach lesion excision | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Bronchogram abnormal | 0 | 0.039 | 0.058 | 0.965 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Blood thromboplastin normal | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Macular cyst | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Iliotibial band syndrome | 0 | 0.039 | 0.06 | 0.965 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Sigmoidoscopy abnormal | 0 | 0.039 | 0.057 | 0.965 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy eyelid | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Postoperative adhesion | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Burns third degree | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Rinne tuning fork test abnormal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Hyperarousal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Dihydrotestosterone decreased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure difference of extremities | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Barbiturates negative | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Small intestine adenocarcinoma | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Enterococcal sepsis | 0 | 0.039 | 0.058 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural constipation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Lymph node rupture | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Viral myelitis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital inflammation | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Blood loss anaemia | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site joint infection | 0 | 0.039 | 0.058 | 0.965 | 2.827 |  |  |  |  |  | 
COVID19_MODERNA | Roseolovirus test | 0 | 0.039 | 0.059 | 0.965 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Paracentesis eye | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Exocrine pancreatic function test normal | 0 | 0.039 | 0.058 | 0.965 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Saliva analysis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Malignant nipple neoplasm female | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Muscle neoplasm | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Intentional underdose | 0 | 0.039 | 0.057 | 0.965 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Leptin level increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Follicle centre lymphoma diffuse small cell lymphoma | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Urine uric acid decreased | 0 | 0.039 | 0.059 | 0.965 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Nail injury | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Diastolic hypertension | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Plasmin inhibitor | 0 | 0.039 | 0.057 | 0.965 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Breast cancer stage I | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Selective mutism | 0 | 0.039 | 0.06 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Swollen tear duct | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Blood pregnenolone increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Nephrocalcinosis | 0 | 0.039 | 0.057 | 0.965 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Parechovirus infection | 0 | 0.039 | 0.058 | 0.965 | 2.825 |  |  |  |  |  | 
COVID19_MODERNA | Procedural haemorrhage | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal mass | 0 | 0.039 | 0.057 | 0.965 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Plastic surgery to the face | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Vasomotor rhinitis | 0 | 0.039 | 0.06 | 0.965 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid crystal present | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Jaundice acholuric | 0 | 0.039 | 0.057 | 0.965 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatitis viral | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophil count abnormal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Ileocaecal resection | 0 | 0.039 | 0.059 | 0.965 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic hypertrophy | 0 | 0.039 | 0.057 | 0.965 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Carbohydrate antigen 19-9 increased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Von Willebrand's factor multimers test | 0 | 0.039 | 0.058 | 0.965 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Pneumoperitoneum | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia moraxella | 0 | 0.039 | 0.059 | 0.965 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Brachioradial pruritus | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Early satiety | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Blood triglycerides decreased | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Pseudocyst | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Eye complication associated with device | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Lymph nodes scan abnormal | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Maternal drugs affecting foetus | 0 | 0.039 | 0.06 | 0.965 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Epidural lipomatosis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Elephantiasis | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Opticokinetic nystagmus tests | 0 | 0.039 | 0.059 | 0.965 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | T-cell receptor gene rearrangement test | 0 | 0.039 | 0.058 | 0.965 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoblast count increased | 0 | 0.039 | 0.059 | 0.965 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Liver transplant rejection | 0 | 0.039 | 0.061 | 0.965 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac arrhythmias (SMQ) [broad] | 1363 | 1426.818 | 0.921 | 0.964 | 1.007 | 0.913 | 0.955 | 0.998 | 0.955 | 2.041 | 704.786
COVID19_MODERNA | End stage AIDS | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system necrosis | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Incision site cellulitis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Ecouvillonage | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Plasma viscosity abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Intravascular haemolysis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Norepinephrine | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Double ureter | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | B-cell lymphoma recurrent | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal irritation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic cancer | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Vulval haemorrhage | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Phytotherapy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Apolipoprotein B | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging abdominal normal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Urine zinc | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Colon cancer metastatic | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic specific antigen decreased | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor XI level normal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Purpura non-thrombocytopenic | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bronchus normal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Fungal sepsis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Blood arsenic increased | 0 | 0.039 | 0.056 | 0.964 | 2.836 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration tracheal normal | 0 | 0.039 | 0.057 | 0.964 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Bone cancer metastatic | 0 | 0.039 | 0.054 | 0.964 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Vital dye staining cornea absent | 0 | 0.039 | 0.057 | 0.964 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil/lymphocyte ratio increased | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Hyperchloraemia | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Bone abscess | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia cryptococcal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal injury | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cold exposure injury | 0 | 0.039 | 0.054 | 0.964 | 2.852 |  |  |  |  |  | 
COVID19_MODERNA | Cholelithotomy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cardiospasm | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Anal polyp | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobinaemia | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Secondary immunodeficiency | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cholangitis infective | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian prolapse | 0 | 0.039 | 0.055 | 0.964 | 2.844 |  |  |  |  |  | 
COVID19_MODERNA | Trigeminal palsy | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Spermatic cord disorder | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Metanephrine urine | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Clot retraction | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Fibrosarcoma | 0 | 0.039 | 0.056 | 0.964 | 2.836 |  |  |  |  |  | 
COVID19_MODERNA | Anaplastic lymphoma kinase gene mutation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Ligament sprain | 0 | 0.121 | 0.278 | 0.964 | 1.985 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal gland cancer metastatic | 0 | 0.039 | 0.054 | 0.964 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac index | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Pseudocellulitis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell hypochromic morphology present | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem glioma | 0 | 0.039 | 0.053 | 0.964 | 2.855 |  |  |  |  |  | 
COVID19_MODERNA | Urine albumin/creatinine ratio | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Encephalocele repair | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Anaplastic large-cell lymphoma | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Secondary adrenocortical insufficiency | 0 | 0.039 | 0.056 | 0.964 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Anaemia postoperative | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Application site movement impairment | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Childhood asthma | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Vascular imaging | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Premature ejaculation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Ear lobe infection | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Cystitis haemorrhagic | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Application site mass | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Therapy partial responder | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated neuropathy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | CSF polymorphonuclear cell count decreased | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Arterial wall hypertrophy | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Rectal tube insertion | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor IX level normal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Septic embolus | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral artery occlusion | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Malignant neoplasm progression | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Carbon dioxide combining power decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Incision site discharge | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Hypersplenism | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Coxiella test positive | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Injection site telangiectasia | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Magnesium deficiency | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Tick-borne fever | 0 | 0.039 | 0.054 | 0.964 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophils urine | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Sickle cell disease | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue neoplasm | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Venous stenosis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Mononuclear cell count | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Product sterility lacking | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Joint prosthesis user | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Investigation noncompliance | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Ergotherapy | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Stool heavy metal positive | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Leucine aminopeptidase | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal erythema | 0 | 0.039 | 0.055 | 0.964 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Pelvi-ureteric obstruction | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac output | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Inhibiting antibodies positive | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin D abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Peak nasal inspiratory flow abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.85 |  |  |  |  |  | 
COVID19_MODERNA | Inborn error of metabolism | 0 | 0.039 | 0.054 | 0.964 | 2.85 |  |  |  |  |  | 
COVID19_MODERNA | X-ray therapy to joint | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Macular detachment | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal anuria | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory fatigue | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Penile size reduced | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Benign soft tissue neoplasm | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatobiliary sphincterotomy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Wound decomposition | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac ventricular disorder | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Product commingling | 0 | 0.039 | 0.053 | 0.964 | 2.857 |  |  |  |  |  | 
COVID19_MODERNA | Intraductal proliferative breast lesion | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Thyroglobulin present | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Post concussion syndrome | 0 | 0.039 | 0.053 | 0.964 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Obsessive-compulsive personality disorder | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system mass | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal tuberculosis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Incision site swelling | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Stoma site reaction | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Alloimmunisation | 0 | 0.039 | 0.056 | 0.964 | 2.836 |  |  |  |  |  | 
COVID19_MODERNA | Genitourinary tract infection | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Breast tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Amino acid level abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobin blood present | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Mentally late developer | 0 | 0.039 | 0.056 | 0.964 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Platelet adhesiveness | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Schistosomiasis | 0 | 0.039 | 0.053 | 0.964 | 2.854 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor X level decreased | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Breast engorgement | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | CSF glucose abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic vascular disorder | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Congenital HIV infection | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Cell marker decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Biliary tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Platelet aggregation normal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Nasal operation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Candida pneumonia | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Beta-N-acetyl-D-glucosaminidase | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Dermabrasion | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Chronic tic disorder | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Latent tuberculosis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Complications of transplanted heart | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site dermatitis | 0 | 0.039 | 0.056 | 0.964 | 2.837 |  |  |  |  |  | 
COVID19_MODERNA | Platelet morphology | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Vascular graft complication | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary alveolar haemorrhage | 0 | 0.039 | 0.056 | 0.964 | 2.839 |  |  |  |  |  | 
COVID19_MODERNA | Hypothenar hammer syndrome | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Bronchopulmonary disease | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Gastrectomy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Porcelain gallbladder | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Macrophage activation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Hyperoxaluria | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Apolipoprotein A-I | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Alanine aminotransferase abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Macrophages decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated dermatitis | 0 | 0.039 | 0.056 | 0.964 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal operation | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Hair growth rate abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site infection | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Iliac artery disease | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Genetic counselling | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Platelet function test | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Application site haematoma | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Renal hydrocele | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Myocardial fibrosis | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Peak expiratory flow rate normal | 0 | 0.039 | 0.054 | 0.964 | 2.853 |  |  |  |  |  | 
COVID19_MODERNA | Lower respiratory tract infection fungal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Chest tube removal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid factor quantitative | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Foot operation | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Scrub typhus | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Androgen deficiency | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid gland abscess | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Hypotonia neonatal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Cellulitis of male external genital organ | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Xanthogranuloma | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Platelet anisocytosis | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Blood growth hormone abnormal | 0 | 0.039 | 0.053 | 0.964 | 2.857 |  |  |  |  |  | 
COVID19_MODERNA | Adenoiditis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Aspartate aminotransferase abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Cryptococcal cutaneous infection | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Administration site movement impairment | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Sarcopenia | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B1 decreased | 0 | 0.039 | 0.053 | 0.964 | 2.857 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral ventricle collapse | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic nephropathy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid haematoma | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cavernous sinus thrombosis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival follicles | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | IVth nerve paresis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Bleeding time abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Skeletal muscle enzymes | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia cytomegaloviral | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Cystatin C abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Breast reconstruction | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Blood mercury normal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Systemic immune activation | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid bleeding | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Biliary tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil morphology normal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Gastric bypass | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Drug physiologic incompatibility | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Vanillyl mandelic acid urine increased | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal clotting factor | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Liver scan | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Right hemisphere deficit syndrome | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Stoma site erythema | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Dandy-Walker syndrome | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis haemorrhagic | 0 | 0.039 | 0.054 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Large intestine infection | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcal osteomyelitis | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Hyperchromasia | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Tuberous sclerosis complex | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin A decreased | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Apolipoprotein B increased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic operation | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Blood calcitonin increased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Thyroglobulin absent | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Adenosine deaminase decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Mitogen stimulation test abnormal | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Sitophobia | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue sarcoma | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Inflammation scan | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal odour | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Lung induration | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Ductal adenocarcinoma of pancreas | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic dysplasia | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Residual urine volume increased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngitis bacterial | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Mesangioproliferative glomerulonephritis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Secondary thrombocytosis | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Lysozyme increased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Embolia cutis medicamentosa | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Paranasal sinus haemorrhage | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Adrenomegaly | 0 | 0.039 | 0.056 | 0.964 | 2.837 |  |  |  |  |  | 
COVID19_MODERNA | Vaginitis gardnerella | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Phimosis | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal operation | 0 | 0.039 | 0.054 | 0.964 | 2.85 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell scan | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Breast injury | 0 | 0.039 | 0.056 | 0.964 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Bence Jones protein urine present | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Breast neoplasm | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Gardnerella test positive | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral calcification | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Caecum operation | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Head circumference | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Blood acid phosphatase | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Escharotomy | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Lung carcinoma cell type unspecified recurrent | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Acute lung injury | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Nasal herpes | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal adhesion lysis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Deltaretrovirus test positive | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QRS complex shortened | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Precocious puberty | 0 | 0.039 | 0.056 | 0.964 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | CD8 lymphocytes abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasm | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Rhesus antibodies positive | 0 | 0.039 | 0.054 | 0.964 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Elbow operation | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Infantile haemangioma | 0 | 0.039 | 0.055 | 0.964 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrospinal fluid reservoir placement | 0 | 0.039 | 0.055 | 0.964 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Blood thromboplastin increased | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopic retrograde cholangiopancreatography abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Insulin C-peptide abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Alveolar oxygen partial pressure increased | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Inguinal hernia, obstructive | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Nasal septum disorder | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Hyperinsulinism | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal mucosal necrosis | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Testicular failure | 0 | 0.039 | 0.057 | 0.964 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid factor decreased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Platelet-large cell ratio increased | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Joint arthroplasty | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Dopamine transporter scintigraphy abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Corneal light reflex test abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Mini mental status examination normal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Mineral deficiency | 0 | 0.039 | 0.053 | 0.964 | 2.857 |  |  |  |  |  | 
COVID19_MODERNA | Angiogram peripheral abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Perichondritis | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Oculocephalogyric reflex absent | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Excessive skin | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising ulcerative gingivostomatitis | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Multiple system atrophy | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Breast milk substitute intolerance | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Blood corticotrophin abnormal | 0 | 0.039 | 0.053 | 0.964 | 2.854 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site laceration | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid lung | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Application site wound | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Brain empyema | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Stiff leg syndrome | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Postsplenectomy syndrome | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Progesterone abnormal | 0 | 0.039 | 0.054 | 0.964 | 2.852 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic hypothermia | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Hydrogen breath test | 0 | 0.039 | 0.056 | 0.964 | 2.837 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal dilation procedure | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Drug ineffective for unapproved indication | 0 | 0.039 | 0.055 | 0.964 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Anti-erythrocyte antibody negative | 0 | 0.039 | 0.055 | 0.964 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Skin discharge | 0 | 0.039 | 0.054 | 0.964 | 2.851 |  |  |  |  |  | 
COVID19_MODERNA | Urine arsenic increased | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Splenic abscess | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B12 absorption test | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Cardio-respiratory arrest neonatal | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic aspiration | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Urobilinogen faeces normal | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Heart sounds normal | 0 | 0.039 | 0.057 | 0.964 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Confluent and reticulate papillomatosis | 0 | 0.039 | 0.056 | 0.964 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Urine aluminium increased | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal oedema | 0 | 0.039 | 0.055 | 0.964 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Neoplasm prostate | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Pinguecula | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Peak expiratory flow rate abnormal | 0 | 0.039 | 0.055 | 0.964 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Dwarfism | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Chronic leukaemia | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Skin implant | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Perthes disease | 0 | 0.039 | 0.055 | 0.964 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Jaundice hepatocellular | 0 | 0.039 | 0.054 | 0.964 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Aspartate aminotransferase | 3 | 2.608 | 0.386 | 0.963 | 1.752 | 0.476 | 0.97 | 1.805 | 1.15 | 1.897 | 0.474
COVID19_MODERNA | Coordination abnormal | 7 | 7.084 | 0.547 | 0.963 | 1.474 | 0.544 | 0.938 | 1.53 | 0.988 | 0.97 | 0.012
COVID19_MODERNA | Chest discomfort | 309 | 329.475 | 0.876 | 0.963 | 1.055 | 0.853 | 0.937 | 1.027 | 0.938 | 3.841 | 563.011
COVID19_MODERNA | Ischaemic heart disease (SMQ) [broad] | 177 | 200.123 | 0.847 | 0.963 | 1.084 | 0.781 | 0.884 | 0.997 | 0.884 | 4.387 | 391.29
COVID19_MODERNA | Injection site discharge | 1 | 1.338 | 0.298 | 0.963 | 1.934 | 0.332 | 0.81 | 1.718 | 0.748 | 0.183 | 2.836
COVID19_MODERNA | Myocardial necrosis marker increased | 4 | 5.025 | 0.391 | 0.963 | 1.739 | 0.422 | 0.814 | 1.451 | 0.796 | 2.989 | 3.057
COVID19_MODERNA | Radiotherapy to breast | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound bladder abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Insulin-like growth factor decreased | 0 | 0.039 | 0.052 | 0.963 | 2.867 |  |  |  |  |  | 
COVID19_MODERNA | CSF neutrophil count positive | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy intestine normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic pouch procedure | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine operation | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Malignant renal hypertension | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Fistulogram | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Breast cancer metastatic | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Prostate cancer stage IV | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Collagen-vascular disease | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Adrenergic syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal cancer | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis allergic | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract procedural complication | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | JC polyomavirus test | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy vocal cord abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Hypertensive nephropathy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy foetal abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Left-handedness | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Cervicitis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Orbital apex syndrome | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Intervertebral disc displacement | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urine potassium normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | B precursor type acute leukaemia | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Hypertrophic anal papilla | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Superficial injury of eye | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem stroke | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine injury | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Reflexology | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Delayed puberty | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vitreoretinal traction syndrome | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Sweat gland infection | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Inspiratory capacity | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Corneal infection | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Erythema toxicum neonatorum | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Buttock injury | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Removal of foreign body from rectum | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Blood prolactin decreased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Blood insulin normal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Bone formation increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Neoplasm progression | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Oral allergy syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Blood lead abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract discomfort | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Generalised onset non-motor seizure | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Blood triglycerides abnormal | 0 | 0.039 | 0.053 | 0.963 | 2.858 |  |  |  |  |  | 
COVID19_MODERNA | Angiogram peripheral normal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Enlarged cerebral perivascular spaces | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Factor VIII inhibition | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmic vein thrombosis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Procedural dizziness | 0 | 0.039 | 0.05 | 0.963 | 2.877 |  |  |  |  |  | 
COVID19_MODERNA | Norepinephrine increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Breast discharge infected | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic haematoma | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Smear buccal | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Product administration interrupted | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lung normal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Vulval cancer stage 0 | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Retinoschisis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Pilonidal cyst | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis chronic | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cervical laser therapy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Plasma cell mastitis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Jugular vein thrombosis | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Viral vasculitis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Normal pressure hydrocephalus | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Humidity intolerance | 0 | 0.039 | 0.051 | 0.963 | 2.87 |  |  |  |  |  | 
COVID19_MODERNA | Middle ear disorder | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric cyst | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy tongue | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B2 | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Suicide threat | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Congenital cerebellar agenesis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cervical cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Corticobasal degeneration | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal wall cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Abortion late | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Parathyroid scan normal | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Electric shock | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculosis of central nervous system | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time ratio increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urinary casts present | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site atrophy | 0 | 0.039 | 0.05 | 0.963 | 2.88 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site reaction | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Detrusor sphincter dyssynergia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cervicogenic headache | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cancer pain | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Spinal meningeal cyst | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Intrinsic factor antibody | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic coma | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Hyperlactacidaemia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Medical device implantation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anti-zinc transporter 8 antibody positive | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Selective abortion | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Latent tetany | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Phospholipidosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine haematoma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Total lung capacity | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Uterine mass | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Septic rash | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Administration site hypoaesthesia | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Vitreous degeneration | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis herpes | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | ACTH stimulation test | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Needle fatigue | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | C1 esterase inhibitor test normal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cervical diathermy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Atypical mycobacterium test positive | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Painful erection | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Lenticular opacities | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Dilatation ventricular | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Blood oestrogen abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Acne varioliformis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urine cannabinoids increased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral congestion | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Blindness congenital | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Antisynthetase syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Subcutaneous biopsy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Product contamination with body fluid | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian germ cell tumour | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Blood chromium decreased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Intracranial hypotension | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic infection | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Genital neoplasm malignant female | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Ocular retrobulbar haemorrhage | 0 | 0.039 | 0.051 | 0.963 | 2.875 |  |  |  |  |  | 
COVID19_MODERNA | Naturopathy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hypopyon | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Pterygium | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Congenital bladder anomaly | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Trigeminal nerve paresis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Adnexa uteri cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Platelet aggregation abnormal | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder obstruction | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Cervix injury | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Spinal stroke | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Single photon emission computerised tomogram | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Oestrogen therapy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Incision site pain | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Postictal psychosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration bursa abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal malformation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Trabeculectomy | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract pain | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Tenotomy | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Retinal aneurysm | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Lateral medullary syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Muscle hypoxia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Post streptococcal glomerulonephritis | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Rectal ultrasound normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Arterial catheterisation normal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Brain neoplasm malignant | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Satoyoshi syndrome | 0 | 0.039 | 0.052 | 0.963 | 2.867 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via body fluid | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Basosquamous carcinoma | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Antral follicle count | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Exchange blood transfusion | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal neoplasm | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Duodenogastric reflux | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Pulse pressure increased | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Klebsiella sepsis | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Bile acid malabsorption | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Insulin C-peptide increased | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Bacillus infection | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anaplastic astrocytoma | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Acrophobia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Pleurisy viral | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Lumbosacral plexus lesion | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic partial epilepsy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vth nerve injury | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Long QT syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Nitrituria | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Change in sustained attention | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Poor personal hygiene | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Oxygen consumption decreased | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Hernia pain | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Herpes sepsis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | CSWS syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve operation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Macular pigmentation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Coronavirus test | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Argon plasma coagulation | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Tumour rupture | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Caffeine allergy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Acute zonal occult outer retinopathy | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Acute haemorrhagic conjunctivitis | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Hostility | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Wernicke-Korsakoff syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Progesterone increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Marburg's variant multiple sclerosis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Mitogen stimulation test | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic adenoma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Keratopathy | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Injection site deformation | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Acoustic neuroma | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal suppression | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Reflux nephropathy | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Pseudopapilloedema | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Inhibin B | 0 | 0.039 | 0.052 | 0.963 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | CSF white blood cell count decreased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Premature ageing | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Fulguration | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic erosive gastritis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy large bowel | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Keratitis interstitial | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Cholangiogram normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord operation | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Silent thyroiditis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Genital tract inflammation | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Forced vital capacity normal | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Myelosuppression | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Infected bite | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic discomfort | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder rupture | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Counterfeit product administered | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hepatobiliary disease | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Venous ligation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy large bowel abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Gitelman's syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Mutagenic effect | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hypergammaglobulinaemia benign monoclonal | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Alien limb syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhoids thrombosed | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Congenital thrombocyte disorder | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal uterine bleeding | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Immunosuppressant drug level increased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Laboratory test interference | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Blepharochalasis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Postoperative wound complication | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Paranasal sinus inflammation | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Neuroborreliosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte morphology normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cleft lip and palate | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Sinobronchitis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Neuro-ophthalmological test | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Benign neoplasm | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Renal graft infection | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Moyamoya disease | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal papilloma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Glossopharyngeal nerve disorder | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil function disorder | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | CD4 lymphocytes abnormal | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | VIIth nerve injury | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Pericardial drainage test abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Bladder hydrodistension | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Myxoedema | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Catheter culture positive | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Sucrose intolerance | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Scan spleen | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Family stress | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Exercise electrocardiogram abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral ataxia | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Psychological trauma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil hypersegmented morphology present | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Vision correction operation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid stimulating immunoglobulin increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Nerve root injury cervical | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival erosion | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Bowen's disease | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Serum serotonin decreased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | CSF mononuclear cell count decreased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hyperamylasaemia | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Proctoscopy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Hypoosmolar state | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxin binding globulin increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Tumour pain | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy anus abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary function challenge test | 0 | 0.039 | 0.053 | 0.963 | 2.861 |  |  |  |  |  | 
COVID19_MODERNA | Gastric pH increased | 0 | 0.039 | 0.05 | 0.963 | 2.88 |  |  |  |  |  | 
COVID19_MODERNA | Anal ulcer | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Culture cervix | 0 | 0.039 | 0.051 | 0.963 | 2.875 |  |  |  |  |  | 
COVID19_MODERNA | Neuromuscular toxicity | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Laryngotracheal oedema | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Follicular mucinosis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Brain lobectomy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram pacemaker spike | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound uterus | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Human anaplasmosis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Sterile pyuria | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | CD8 lymphocyte percentage decreased | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Performance fear | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Inspiratory capacity normal | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic pustular folliculitis | 0 | 0.039 | 0.051 | 0.963 | 2.875 |  |  |  |  |  | 
COVID19_MODERNA | SeHCAT test | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Herpes simplex meningitis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Chest wall abscess | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cervix cautery | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Short stature | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Traumatic lumbar puncture | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Female orgasmic disorder | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Alcoholism | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram U wave present | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Accident at work | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated encephalitis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral artery thrombosis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Neutropenic sepsis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Congenital hiatus hernia | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Varicella keratitis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Irlen syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urethritis noninfective | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular autonomic function test abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Prostate examination normal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal sleep-related event | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Turbinectomy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Sternal injury | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hypotony of eye | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic ulcer | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Weber tuning fork test abnormal | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Thoracic outlet syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Pyoderma | 0 | 0.039 | 0.051 | 0.963 | 2.873 |  |  |  |  |  | 
COVID19_MODERNA | Urine chloride increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Neurotic disorder of childhood | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Mitochondrial toxicity | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis staphylococcal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anoxia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to spine | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Iodine uptake increased | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Mucocutaneous rash | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Brow ptosis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Thermoanaesthesia | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Renal hypertension | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Hair injury | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Electrocochleogram | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary function challenge test normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic transformation stroke | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Convalescent | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic fluid volume increased | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Dermatochalasis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | CHARGE syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Post infection glomerulonephritis | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Administration site abscess | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Carotid artery disease | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculous pleurisy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Renal cancer metastatic | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Hypobarism | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Embedded device | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Anti factor VIII antibody test | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cirrhosis alcoholic | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Poisoning deliberate | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Dexamethasone suppression test | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vitreous opacities | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Rectocele | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Germ cell neoplasm | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Paranasal sinus mucosal hypertrophy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Reaction to colouring | 0 | 0.039 | 0.052 | 0.963 | 2.866 |  |  |  |  |  | 
COVID19_MODERNA | Cutis laxa | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve destruction | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Aortic elongation | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Double hit lymphoma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital haematoma | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Incision site erythema | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Sepsis syndrome | 0 | 0.039 | 0.049 | 0.963 | 2.883 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal ulcer | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Antidiuretic hormone abnormality | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anaemia of pregnancy | 0 | 0.039 | 0.053 | 0.963 | 2.861 |  |  |  |  |  | 
COVID19_MODERNA | Aicardi's syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Cervicitis human papilloma virus | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anti-saccharomyces cerevisiae antibody | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Total complement activity increased | 0 | 0.039 | 0.052 | 0.963 | 2.866 |  |  |  |  |  | 
COVID19_MODERNA | Snapping hip syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Acute promyelocytic leukaemia | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Oestriol normal | 0 | 0.039 | 0.052 | 0.963 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Contact lens intolerance | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Charles Bonnet syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system stimulation | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Blood product transfusion dependent | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Exertional headache | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anaesthetic complication | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vascular stent insertion | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Barium double contrast abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Platelet dysfunction | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Granulocytes maturation arrest | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Factor VII deficiency | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Blood chloride abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 microglobulin | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Acanthosis nigricans | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Protein albumin ratio abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Meigs' syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Natural killer cell activity normal | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Insulinoma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosa biopsy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac pharmacologic stress test | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Shunt malfunction | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Osmophobia | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Transplantation complication | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue atrophy | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Oesophagogastric fundoplasty | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cyst torsion | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Functional endoscopic sinus surgery | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Multinucleate cell angiohistiocytoma | 0 | 0.039 | 0.051 | 0.963 | 2.873 |  |  |  |  |  | 
COVID19_MODERNA | Laparoscopy abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urine sodium decreased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Spondyloarthropathy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Nephrological examination | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Canthoplasty | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Blood growth hormone decreased | 0 | 0.039 | 0.052 | 0.963 | 2.867 |  |  |  |  |  | 
COVID19_MODERNA | Renal scan abnormal | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Post-traumatic pain | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Cervicogenic vertigo | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Autotransfusion | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Female genital tract fistula | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cortisol abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Erythroblast count normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Therapy naive | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Stasis dermatitis | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Splenic infection | 0 | 0.039 | 0.051 | 0.963 | 2.875 |  |  |  |  |  | 
COVID19_MODERNA | Instillation site vesicles | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial tracheitis | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis enteropathic | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Tendon sheath incision | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Superior mesenteric artery syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Teratoma | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Larynx irritation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Vulvitis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vascular pseudoaneurysm | 0 | 0.039 | 0.051 | 0.963 | 2.871 |  |  |  |  |  | 
COVID19_MODERNA | Familial amyotrophic lateral sclerosis | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Peroneal nerve injury | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic ovarian cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anticonvulsant drug level abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Single component of a two-component product administered | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Lumboperitoneal shunt | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Intra-uterine contraceptive device insertion | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Incision site pruritus | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Immune complex level increased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Chronic granulomatous disease | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Iron metabolism disorder | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | AIDS related complication | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Tumour haemorrhage | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Poverty of speech | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Bone deformity | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Amputation stump pain | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Eczema impetiginous | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Echinococciasis | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Convulsive threshold lowered | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Congenital syphilitic osteochondritis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Compulsions | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Amplified musculoskeletal pain syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Osteogenesis imperfecta | 0 | 0.039 | 0.052 | 0.963 | 2.866 |  |  |  |  |  | 
COVID19_MODERNA | Exposure keratitis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Tendon laxity | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Procedural headache | 0 | 0.039 | 0.05 | 0.963 | 2.877 |  |  |  |  |  | 
COVID19_MODERNA | Alveolar proteinosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urticaria contact | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Neutralising antibodies negative | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Nail picking | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Dermatitis herpetiformis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy pharynx abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.873 |  |  |  |  |  | 
COVID19_MODERNA | Thermogram abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine polyp | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic enzymes decreased | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Lipohypertrophy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Infection reactivation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Biliary cyst | 0 | 0.039 | 0.051 | 0.963 | 2.875 |  |  |  |  |  | 
COVID19_MODERNA | Accidental exposure to product by child | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Urethral injury | 0 | 0.039 | 0.05 | 0.963 | 2.877 |  |  |  |  |  | 
COVID19_MODERNA | Ulnar tunnel syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.871 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy with contraceptive device | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Infective exacerbation of bronchiectasis | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Hysterosalpingogram | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte adoptive therapy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Gastric perforation | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Decompression sickness | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Amblyopia strabismic | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Retinal artery embolism | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Leiomyosarcoma | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Vascular access complication | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Pyloromyotomy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Product quality control issue | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal lesion | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosal hypertrophy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Female sex hormone level | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Macroglossia | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Pearly penile papules | 0 | 0.039 | 0.052 | 0.963 | 2.866 |  |  |  |  |  | 
COVID19_MODERNA | Malignant respiratory tract neoplasm | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E antibody positive | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Symphysiolysis | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Frontal lobe epilepsy | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Tendon calcification | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Necrobiosis lipoidica diabeticorum | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anorectal swelling | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell analysis abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Rhegmatogenous retinal detachment | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Orthostatic heart rate response increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Astringent therapy | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy pharynx normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine abscess | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Glomerular vascular disorder | 0 | 0.039 | 0.052 | 0.963 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Relapsing multiple sclerosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Testis cancer | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell agglutination present | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Suspiciousness | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve operation | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Lymphatic obstruction | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophil cationic protein increased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Splenic injury | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Incorrect dosage administered | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Hyperandrogenism | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Transplant | 0 | 0.039 | 0.052 | 0.963 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Renal sympathetic nerve ablation | 0 | 0.039 | 0.051 | 0.963 | 2.873 |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube disorder | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via partner | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Nephrectomy | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Ptosis repair | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Keratitis viral | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosal roughening | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Duodenal ulcer | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma recurrent | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Lobular breast carcinoma in situ | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Interferon gamma release assay positive | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal transit time | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Complications of transplanted lung | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Large granular lymphocytosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal neoplasm | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Polyomavirus-associated nephropathy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Substance abuse | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Renal abscess | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Retention cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Alcoholic liver disease | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Carcinogenicity | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Uterine malposition | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Anal pap smear abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Urethral spasm | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Janus kinase 2 mutation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Interferon gamma normal | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Anticonvulsant drug level below therapeutic | 0 | 0.039 | 0.052 | 0.963 | 2.865 |  |  |  |  |  | 
COVID19_MODERNA | Orthognathic surgery | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Lip infection | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Neuroprosthesis implantation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Hypothyroidic goitre | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Hyperkinetic heart syndrome | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Cervix operation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy urethra normal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Agglutination test | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Animal scratch | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Vena cava thrombosis | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Thiopurine methyltransferase decreased | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Provisional tic disorder | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Enzyme activity normal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Deep brain stimulation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Decreased gait velocity | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Uterine cyst | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Leser-Trelat sign | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral toxoplasmosis | 0 | 0.039 | 0.05 | 0.963 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Anti-thrombin antibody | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic exenteration | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Single functional kidney | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Opticokinetic nystagmus tests normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Keratoconus | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Compulsive lip biting | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Non-consummation | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Congenital ureterovesical junction anomaly | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Urine potassium increased | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Urine aluminium | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Reactive attachment disorder of infancy or early childhood | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Recall phenomenon | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Bacille Calmette-Guerin scar reactivation | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Scan bone marrow | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Viral keratouveitis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian granulosa cell tumour | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Porphyrins urine | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Bladder operation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Peptostreptococcus test positive | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Coital bleeding | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Renal failure neonatal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Lipoprotein (a) abnormal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Thermometry normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctivochalasis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal erosion | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Product contamination chemical | 0 | 0.039 | 0.05 | 0.963 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Capillaritis | 0 | 0.039 | 0.053 | 0.963 | 2.858 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy vagina abnormal | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Benign ovarian tumour | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Large intestinal ulcer haemorrhage | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Eye opacity | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster meningomyelitis | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Ballismus | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Application site pallor | 0 | 0.039 | 0.049 | 0.963 | 2.883 |  |  |  |  |  | 
COVID19_MODERNA | Rhesus antigen negative | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Prosthesis user | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Right atrial enlargement | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Hormone refractory breast cancer | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal mucosal atrophy | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Psychogenic respiratory distress | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Anti-HLA antibody test positive | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 microglobulin urine normal | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Tongue neoplasm malignant stage unspecified | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Kleihauer-Betke test positive | 0 | 0.039 | 0.05 | 0.963 | 2.882 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic mass | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Eczema nummular | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Reynold's syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bladder normal | 0 | 0.039 | 0.051 | 0.963 | 2.874 |  |  |  |  |  | 
COVID19_MODERNA | Goodpasture's syndrome | 0 | 0.039 | 0.05 | 0.963 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Device difficult to use | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy tonsil | 0 | 0.039 | 0.051 | 0.963 | 2.872 |  |  |  |  |  | 
COVID19_MODERNA | Altered pitch perception | 0 | 0.039 | 0.05 | 0.963 | 2.881 |  |  |  |  |  | 
COVID19_MODERNA | Insulin C-peptide normal | 0 | 0.039 | 0.052 | 0.963 | 2.866 |  |  |  |  |  | 
COVID19_MODERNA | Corneal operation | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Amnestic disorder | 0 | 0.039 | 0.052 | 0.963 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract stoma complication | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Cranial nerve infection | 0 | 0.039 | 0.052 | 0.963 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Iris injury | 0 | 0.039 | 0.049 | 0.963 | 2.883 |  |  |  |  |  | 
COVID19_MODERNA | Angioedema (SMQ) [narrow] | 940 | 988.73 | 0.911 | 0.962 | 1.014 | 0.9 | 0.95 | 1.002 | 0.951 | 1.554 | 182.795
COVID19_MODERNA | Haematopoietic erythropenia (SMQ) [broad] | 63 | 74.026 | 0.774 | 0.962 | 1.166 | 0.692 | 0.851 | 1.037 | 0.851 | 1.451 | 7.919
COVID19_MODERNA | Alopecia | 6 | 7.491 | 0.455 | 0.962 | 1.623 | 0.457 | 0.813 | 1.36 | 0.801 | 0.332 | 7.307
COVID19_MODERNA | Ischaemia | 2 | 2.623 | 0.281 | 0.962 | 1.975 | 0.367 | 0.806 | 1.584 | 0.763 | 3.083 | 0.946
COVID19_MODERNA | Herpes simplex | 2 | 3.785 | 0.263 | 0.962 | 2.015 | 0.307 | 0.678 | 1.334 | 0.528 | 0.58 | 0.243
COVID19_MODERNA | Salmonella sepsis | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Septic arthritis streptococcal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Accidental exposure to product packaging | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin C deficiency | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Vessel puncture site erythema | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis D RNA negative | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Orbital infection | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to kidney | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Constricted affect | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Anal fistula repair | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Selective IgG subclass deficiency | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Instillation site reaction | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Treponema test false positive | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Severe acute respiratory syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal respiratory depression | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Epileptic aura | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Eustachian tube disorder | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin distribution width increased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Gardnerella infection | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to contaminated air | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Anaphylactoid syndrome of pregnancy | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 2 globulin increased | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Nail pitting | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Hyperthermia therapy | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Glaucoma traumatic | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Retinal thickening | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia measles | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Karyotype analysis abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis chronic active | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal ischaemia | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body in respiratory tract | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Foetal malposition | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Foetal biophysical profile score normal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Diastasis recti abdominis | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac output decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Blood aluminium abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Arrhythmia neonatal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Anti-HLA antibody test | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal intestinal perforation | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Blood acid phosphatase decreased | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | BK virus infection | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Autophobia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Allergic stomatitis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Radical prostatectomy | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Product substitution error | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Disseminated cytomegaloviral infection | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal tachypnoea | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Cryopyrin associated periodic syndrome | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin electrophoresis | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Primary hyperthyroidism | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Product closure removal difficult | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Interferon alpha level decreased | 0 | 0.039 | 0.049 | 0.962 | 2.887 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary artery stenosis congenital | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Flour sensitivity | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Lack of vaccination site rotation | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Tongue tie operation | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Anotia | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Neuroma | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Umbilical hernia repair | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Urethral pain | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal discomfort | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Rhinotracheitis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Medical device site joint infection | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Encephalocele | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Taciturnity | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Ocular ischaemic syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Adjustment disorder with anxiety | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Noninfective myringitis | 0 | 0.039 | 0.049 | 0.962 | 2.883 |  |  |  |  |  | 
COVID19_MODERNA | Ankyloglossia acquired | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Adrenoleukodystrophy | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to meninges | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal hypertrophy | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Blood alkaline phosphatase abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy vagina normal | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Urogenital infection fungal | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival disorder | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Aortic aneurysm repair | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Xanthoma | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Thoracotomy | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell vacuolisation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Methaemoglobinaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Lumbar hernia | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Lipectomy | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Gamma-glutamyltransferase abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Choroid plexus papilloma | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Acute graft versus host disease in liver | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Urogram abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Iris neovascularisation | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Hereditary disorder | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis california | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic fluid index | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | International normalised ratio fluctuation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Blood viscosity increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Liver scan abnormal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Residual urine volume | 0 | 0.039 | 0.049 | 0.962 | 2.886 |  |  |  |  |  | 
COVID19_MODERNA | Enanthema | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Artificial crown procedure | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Acquired syringomyelia | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic retinopathy | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune colitis | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic cyst | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Umbilical cord prolapse | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Oculomotor study normal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Patella fracture | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Foetal heart rate disorder | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Autonomic seizure | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Compulsive handwashing | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Anti-JC virus antibody index | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Dialysis efficacy test | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Gastrooesophageal sphincter insufficiency | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Brown-Sequard syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Lasegue's test | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Procedural hypotension | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Genotype drug resistance test | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Intra-cerebral aneurysm operation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Congenital pulmonary valve disorder | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Elective surgery | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Paroxysmal extreme pain disorder | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Coombs indirect test negative | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Fractured coccyx | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Punctate basophilia | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Conductive deafness | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin A normal | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Septum pellucidum agenesis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Device infusion issue | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Partner stress | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Base excess positive | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Aspergillus test positive | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Anti-IA2 antibody | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Patient dissatisfaction with device | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Congenital skin disorder | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy intestine | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial vulvovaginitis | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Homosexuality | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Blood beta-D-glucan increased | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Burnout syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Atonic urinary bladder | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Apgar score | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Anal inflammation | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Tongue atrophy | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal congestion | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Corneal diameter increased | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Carotid aneurysm rupture | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Medical observation normal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Peristalsis visible | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Arthrolysis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial aspiration procedure | 0 | 0.039 | 0.049 | 0.962 | 2.888 |  |  |  |  |  | 
COVID19_MODERNA | Uterine leiomyoma embolisation | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Stenotrophomonas sepsis | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Shunt occlusion | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Cholangiogram | 0 | 0.039 | 0.049 | 0.962 | 2.884 |  |  |  |  |  | 
COVID19_MODERNA | VIIIth nerve lesion | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Aortic valve disease | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram Q waves | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Postmortem blood drug level increased | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | HTLV-2 test | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Glomerular filtration rate abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Cisternogram | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Prolonged rupture of membranes | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Heart transplant | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Iatrogenic infection | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Floating patella | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C core antibody positive | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Tumefactive multiple sclerosis | 0 | 0.039 | 0.049 | 0.962 | 2.887 |  |  |  |  |  | 
COVID19_MODERNA | Young's syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Sulcus vocalis | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | CDKL5 deficiency disorder | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Normal tension glaucoma | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Tensilon test normal | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Uterine hypertonus | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid vasculitis | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Pasteurella test positive | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Lung squamous cell carcinoma stage IV | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Eustachian tube patulous | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Blood testosterone increased | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Primary progressive multiple sclerosis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Influenza C virus test | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Menstrual cycle management | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Anamnestic reaction | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Urogenital disorder | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Scaphoid abdomen | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Renal hypoplasia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatitis mumps | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Palmoplantar pustulosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic cancer stage IV | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Vascular neoplasm | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Perineal erythema | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Factor I deficiency | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Device power source issue | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein amniotic fluid increased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin K deficiency | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Drug withdrawal convulsions | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Brief psychotic disorder with marked stressors | 0 | 0.039 | 0.049 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Boredom | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase MM decreased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Salivary duct inflammation | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Neurologic somatic symptom disorder | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Engraft failure | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Clotting factor transfusion | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Alpha tumour necrosis factor | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Air embolism | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pituitary enlargement | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Foster care | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Placenta praevia haemorrhage | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Ear infection fungal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Chromosome banding normal | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac arrest neonatal | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Primitive reflex test | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Palmoplantar keratoderma | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Injection site thrombosis | 0 | 0.039 | 0.049 | 0.962 | 2.888 |  |  |  |  |  | 
COVID19_MODERNA | Graft complication | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial irritation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Blood 1,25-dihydroxycholecalciferol decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Sympathicotonia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Physical breast examination | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric vascular insufficiency | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Capillary fragility increased | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Tangentiality | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Nail hypertrophy | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis chemical | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Jugular vein distension | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hashimoto's encephalopathy | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Brow presentation | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Muscle graft | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Lithotripsy | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Anticonvulsant drug level above therapeutic | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol test positive | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Phakomatosis | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Implant site discolouration | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Hypogonadism | 0 | 0.039 | 0.047 | 0.962 | 2.904 |  |  |  |  |  | 
COVID19_MODERNA | Ear infection staphylococcal | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Blood catecholamines decreased | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Endometrial disorder | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Argininosuccinate lyase deficiency | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Anaemia neonatal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Water deprivation test | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Bleeding time normal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Right ventricular enlargement | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Procedural nausea | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Metaphyseal dysplasia | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Manifest refraction normal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Ebstein's anomaly | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Truncus coeliacus thrombosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Transcranial magnetic stimulation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Mononuclear cell count increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune endocrine disorder | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Urine calcium/creatinine ratio | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Plasma cells increased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Eczema vaccinatum | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VIII level | 0 | 0.039 | 0.049 | 0.962 | 2.884 |  |  |  |  |  | 
COVID19_MODERNA | Implant site swelling | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Abortion spontaneous incomplete | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Suture related complication | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Subretinal hyperreflective exudation | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Retinal function test normal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Dennie-Morgan fold | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy anus normal | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Acute graft versus host disease in intestine | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Trisomy 12 | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Dumping syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Colour blindness acquired | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune enteropathy | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Spinal shock | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal perforation | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Product selection error | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Osteomyelitis acute | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Microangiopathy | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Foetal growth abnormality | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Cystic fibrosis related diabetes | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Perineal ulceration | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Intrauterine infection | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Thrombosis in device | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure ambulatory | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Speech rehabilitation | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Rhesus antigen | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Congenital pneumonia | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Precursor T-lymphoblastic lymphoma/leukaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Renal cortical necrosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hyponatriuria | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Thymol turbidity test | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic therapy | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Anti-neuronal antibody positive | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to heart | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Nail ridging | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell analysis abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Polyomavirus test positive | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal alloimmune thrombocytopenia | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Fibrocystic breast disease | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobinaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Medication overuse headache | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Liver dialysis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Eyeball avulsion | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Metatarsalgia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Glossoptosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 microglobulin urine | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Adenoidal disorder | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal ulceration | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic contracture of the left ventricle | 0 | 0.039 | 0.049 | 0.962 | 2.887 |  |  |  |  |  | 
COVID19_MODERNA | Chordee | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | BK polyomavirus test negative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Surfactant protein increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Transposition of the great vessels | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Scleral haemorrhage | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic ketosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Urinary straining | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Haemofiltration | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Nodular fasciitis | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin A2 | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | HTLV test | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Dislocation of vertebra | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Breathing-related sleep disorder | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Allergic sinusitis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Urine albumin/creatinine ratio normal | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Urethral discharge | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Sensory integration therapy | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Acalculia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Abscess of salivary gland | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Optic disc hyperaemia | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | End-tidal CO2 | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | CD25 antigen positive | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary artery atresia | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Oligodendroglioma | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Intracardiac mass | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Directional Doppler flow tests abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Blood lactate dehydrogenase abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Amoebic dysentery | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal metaplasia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Aorta hypoplasia | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Promyelocyte count decreased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Immunoreactive trypsinogen increased | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Huntington's disease | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Device alarm issue | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid calcification | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Early onset familial Alzheimer's disease | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Cystic lymphangioma | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy pericardium abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Wound dehiscence | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Visual perseveration | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Tandem gait test normal | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Parasite tissue specimen test negative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Calcific deposits removal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal injury | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Ilium fracture | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Portal shunt procedure | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to central nervous system | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrovascular arteriovenous malformation | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein amniotic fluid | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Tongue pigmentation | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Nikolsky's sign | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Dermoid cyst | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Progressive multiple sclerosis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular somatic symptom disorder | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Low cardiac output syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Corneal abscess | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Catheter site pain | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Anomalous pulmonary venous connection | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Personality disorder of childhood | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Intentional device misuse | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid ptosis congenital | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Serum procollagen type III N-terminal propeptide | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary necrosis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve decompression | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Burn oesophageal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Acute oesophageal mucosal lesion | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Acquired Von Willebrand's disease | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Large cell lung cancer | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Dermatofibrosarcoma protuberans | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Axial spondyloarthritis | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product effect increased | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Stomatococcal infection | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Biliary tract infection fungal | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Protein C deficiency | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Paradoxical drug reaction | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac malposition | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Viral rhinitis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Blood prolactin abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein amniotic fluid normal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | African trypanosomiasis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Cervical incompetence | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Term birth | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Apolipoprotein A-I normal | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Coombs negative haemolytic anaemia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Gingival cyst | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Sex hormone binding globulin | 0 | 0.039 | 0.047 | 0.962 | 2.904 |  |  |  |  |  | 
COVID19_MODERNA | Infective exacerbation of chronic obstructive airways disease | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian adenoma | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Product residue present | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Plasmodium ovale infection | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Parkinsonian gait | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antigen | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Cross sensitivity reaction | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Prolapse | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity unsaturated decreased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | IgM nephropathy | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | External hydrocephalus | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal exploration | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Uterine dehiscence | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Limb reduction defect | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Carbuncle | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Urea urine decreased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Violence-related symptom | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hyperglobulinaemia | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Ependymitis | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Aortic stent insertion | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Anti-vimentin antibody positive | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Venous pressure jugular increased | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Kidney small | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Foetal biophysical profile score abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Faecal calprotectin decreased | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Adenoviral meningitis | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound ovary abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Temperature perception test abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure orthostatic decreased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal gastrointestinal disorder | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Congenital vesicoureteric reflux | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal hypotension | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Lysinuric protein intolerance | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy tendon abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Procedural vomiting | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Montreal cognitive assessment | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Glucose tolerance increased | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Flavivirus test | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Porphyrins urine increased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve infection | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Anticoagulation drug level below therapeutic | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Reye's syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital disorder | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Paraesthesia mucosal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Hookworm infection | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy placenta | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Artificial rupture of membranes | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Paraneoplastic neurological syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Nail matrix biopsy | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric artery aneurysm | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Subretinal fibrosis | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Intra-abdominal haematoma | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Extraskeletal ossification | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Neovascularisation | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E antigen negative | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Corneal degeneration | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal atrophy | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Catheter site discharge | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | X-ray with contrast lower gastrointestinal tract normal | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcal toxaemia | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Removal of foreign body from nose | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Impaired fasting glucose | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | DiGeorge's syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Chylothorax | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Bleeding anovulatory | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Atelectasis neonatal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Schizoid personality disorder | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Postural tremor | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Resting tremor | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Foetal megacystis | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Infusion site haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory depth decreased | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Perseveration | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Leiomyoma | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Orbital decompression | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Hooded prepuce | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Thyroglobulin decreased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell elliptocytes present | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Induced abortion failed | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Arterial ligation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Bile output increased | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Thymus hypoplasia | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic organ injury | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal asphyxia | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Hyperglycinaemia | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Brain stent insertion | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Acid base balance | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Lipids abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | JC virus CSF test positive | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Iodine uptake abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Heterosexuality | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | CSF granulocyte count normal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Cutaneous sarcoidosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Parietal cell antibody positive | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Myeloproliferative neoplasm | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | HTLV-1 test | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Blood catecholamines increased | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin C increased | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Non-24-hour sleep-wake disorder | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Leukoplakia oral | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Fluorescent in situ hybridisation negative | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Glycocholic acid increased | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic foetopathy | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Maternal distress during labour | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Median nerve injury | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Chorioretinal scar | 0 | 0.039 | 0.047 | 0.962 | 2.904 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy spinal cord abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Lymphadenitis viral | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Ichthyosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Preictal state | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Noonan syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Perineurial cyst | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory gas exchange disorder | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Renal tubular injury | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Myeloblast percentage | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Fallot's tetralogy | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Parotid abscess | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Breast haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Uterine inversion | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Skin cyst excision | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | ADAMTS13 inhibitor screen assay | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Friedreich's ataxia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Vascular encephalopathy | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Macroprolactinaemia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Persecutory delusion | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin S increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Foetal movement disorder | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular function test abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Bush-Francis catatonia rating scale | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Visual acuity reduced transiently | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Transillumination | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Dental gangrene | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Spasmodic dysphonia | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Lewis-Sumner syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Infantile septic granulomatosis | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Disability assessment scale score decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Aldolase | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal disorder | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Salpingo-oophorectomy unilateral | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Free thyroxine index increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Clinical death | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product effect delayed | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Normochromic anaemia | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Insulin-like growth factor | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Lenticulostriatal vasculopathy | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Noctiphobia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Urine calcium | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Scan adrenal gland normal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Modified Rankin score decreased | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal stoma output increased | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Chronic recurrent multifocal osteomyelitis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival suffusion | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Barotitis media | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal dysplasia | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Rinne tuning fork test | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral arterial occlusive disease | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging hepatobiliary abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Guthrie test | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Pseudobulbar palsy | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Pericardial operation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Psychotic symptom | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Systemic viral infection | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Sexual transmission of infection | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Enteropathic spondylitis | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Mucormycosis | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Alagille syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian dysplasia | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal wall disorder | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Cellulitis streptococcal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Dilated pores | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal examination abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Glossopharyngeal nerve paralysis | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Nicotinamide | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C core antibody negative | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonic plague | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Autosomal chromosome anomaly | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Aortic disorder | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy small intestine normal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Carbohydrate deficient transferrin test | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Von Willebrand's disease | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Colonic lavage | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to pelvis | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Hypofibrinogenaemia | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Vertebral artery hypoplasia | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Acute graft versus host disease in skin | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Tooth socket haemorrhage | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Porphyria non-acute | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Hypercreatinaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Hallucination, tactile | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Drug resistance | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Anterior chamber fibrin | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Ureteric obstruction | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Natural killer T cell count | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Visual pathway disorder | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Skin ulcer haemorrhage | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Otoplasty | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Limb fracture | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Intention tremor | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Hyperchylomicronaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Eczema asteatotic | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Breast cellulitis | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Deformity of orbit | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Visual brightness | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid cell count | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Megakaryocytes abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian injury | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Blood aldosterone decreased | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Malignant neoplasm of unknown primary site | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Heparin-induced thrombocytopenia test positive | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Mucocutaneous haemorrhage | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Cervical spinal cord paralysis | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Gait apraxia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Verbigeration | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Product dosage form confusion | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Parathyroid hormone-related protein | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Optic discs blurred | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Lice infestation | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Arterial stent insertion | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Rickettsiosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Latent syphilis | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Ambidexterity | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Diaphragm muscle weakness | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatic heart disease | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Benign muscle neoplasm | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Noninfective oophoritis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Reactive gastropathy | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Alpha-1 anti-trypsin increased | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin receptor assay | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Kluver-Bucy syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Infected cyst | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Blood magnesium abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Blood insulin decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Urethritis gonococcal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hyposomnia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Hypertensive cardiomegaly | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Drug-disease interaction | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Angiosarcoma | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Ureteral stent insertion | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy with advanced maternal age | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Exomphalos | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Fistula repair | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Neurosyphilis | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Orchidectomy | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Hairy cell leukaemia | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Forearm fracture | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Endometrial cancer | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Duodenal ulcer perforation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Chronic allograft nephropathy | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pericarditis tuberculous | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Marcus Gunn syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal dialysis complication | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | PUVA | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural fistula | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Uterine repair | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Acquired tracheo-oesophageal fistula | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Intelligence test | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Device defective | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid hormones decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Interferon alpha level | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Granulomatous liver disease | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Drug withdrawal headache | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac ventriculogram normal | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Blood thrombin | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system abscess | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Lung neoplasm surgery | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Transmission of an infectious agent via transplant | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Foetal therapeutic procedure | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Type IIa hyperlipidaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Progressive relapsing multiple sclerosis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Group B streptococcus neonatal sepsis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Factitious disorder | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Alpha-2 macroglobulin increased | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Yersinia infection | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Trendelenburg position | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Necrobiosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Moraxella test positive | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Premature baby death | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin degradation products normal | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Leukostasis syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Lead urine increased | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Bone lesion | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Retrograde ejaculation | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Blood galactose | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Catheter site phlebitis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Stomatococcus test positive | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Erythropenia | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Congenital genital malformation | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Anti-complement antibody | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Pyogenic granuloma | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Ureteric dilatation | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Perinatal brain damage | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Inferior vena cava stenosis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Graft versus host disease in skin | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Device function test | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosal scab | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Hypopituitarism | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Nail discomfort | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Ureteric stenosis | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Myelocyte percentage increased | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Syndactyly | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Cervix enlargement | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Pleural rub | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Dermatopathic lymphadenopathy | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Protein S deficiency | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Mini mental status examination abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrospinal fluid drainage | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Dermatoglyphic anomaly | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar atrophy | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal cord insertion | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Scleral oedema | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Opportunistic infection | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Proctitis ulcerative | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal hypomotility | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Histoplasmosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Aplasia cutis congenita | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Selenium deficiency | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Heart block congenital | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Trousseau's sign | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Epidermoid cyst excision | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Cytomegalovirus hepatitis | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Yersinia test | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine uptake | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Prophylaxis against Rh isoimmunisation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Pancreas infection | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis proliferative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic cancer metastatic | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Congenital thrombocytopenia | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Blood catecholamines normal | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | American trypanosomiasis | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Congenital cytomegalovirus infection | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | CSF myelin basic protein abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Uvulitis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Sensory level normal | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal surgery | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Focal nodular hyperplasia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Human polyomavirus infection | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Accelerated idioventricular rhythm | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Adductor vocal cord weakness | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Micrognathia | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site anaesthesia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Superior vena cava stenosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Bile duct stent insertion | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VII level | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Congestive hepatopathy | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Epilepsy congenital | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor C2 | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Borderline glaucoma | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal oedema | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Antimicrobial susceptibility test intermediate | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord ischaemia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Oedema blister | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Incarcerated umbilical hernia | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Chikungunya virus infection | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | CSF lactate abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Helminthic infection | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Alveolar rhabdomyosarcoma | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Arteriovenous fistula occlusion | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Arterial thrombosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Uterine dilation and evacuation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Bladder catheter temporary | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Vessel puncture site haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Strongyloidiasis | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Stomach scan | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Intravascular papillary endothelial hyperplasia | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Giardia test positive | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Congenital thymus absence | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Retinal vein thrombosis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Palatal palsy | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Ciliary body disorder | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Anti-IA2 antibody negative | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Adjustment disorder with mixed anxiety and depressed mood | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Twin reversed arterial perfusion sequence malformation | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Synovial rupture | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Otitis media chronic | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Faecal calprotectin abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Chronic myelomonocytic leukaemia | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Automatism epileptic | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Urethral haemorrhage | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Kidney malrotation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Gingival oedema | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Disorder of orbit | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Carnitine abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Benign lung neoplasm | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Wrong dose | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal pain | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Sensory level | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Angiopathic neuropathy | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | H2N2 influenza | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Female sex hormone level abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Choluria | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Systemic mycosis | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | ABO incompatibility | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Mean platelet volume abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Appendix cancer | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Joint deposit | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Acute lymphocytic leukaemia recurrent | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Evacuation of retained products of conception | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Congenital laryngeal stridor | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | T-cell lymphoma | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobin blood absent | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | VIth nerve paresis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Complications of transplanted kidney | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Small intestine polyp | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Drug abuser | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Histamine normal | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Deafness congenital | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Factor XIII deficiency | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Placental insufficiency | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Phenylalanine screen positive | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Onycholysis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Tyrosinaemia | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Left-to-right cardiac shunt | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Secondary progressive multiple sclerosis | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Blunted affect | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Needle biopsy site unspecified normal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Essential thrombocythaemia | 0 | 0.039 | 0.049 | 0.962 | 2.884 |  |  |  |  |  | 
COVID19_MODERNA | Rectal examination normal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis cytomegalovirus | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Retirement | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Bone decalcification | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | CD4/CD8 ratio increased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Administration site nerve damage | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Post-traumatic epilepsy | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bronchus abnormal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Anti-glycyl-tRNA synthetase antibody negative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Vital capacity | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Suicide of relative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Palisaded neutrophilic granulomatous dermatitis | 0 | 0.039 | 0.048 | 0.962 | 2.894 |  |  |  |  |  | 
COVID19_MODERNA | Application site papules | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Antipsychotic drug level decreased | 0 | 0.039 | 0.049 | 0.962 | 2.884 |  |  |  |  |  | 
COVID19_MODERNA | Venous bruit | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Tissue discolouration | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Polyneuropathy in malignant disease | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Nasal valve collapse | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Myocarditis bacterial | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Alice in wonderland syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Past-pointing | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Mediastinal mass | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Colour vision tests abnormal red-green | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Large intestinal ulcer | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Granulomatous lymphadenitis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Kinematic imbalances due to suboccipital strain | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Missed labour | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Adenine phosphoribosyl transferase deficiency | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal mesothelial hyperplasia | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary valve stenosis congenital | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell hyperchromic morphology present | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Obstructive defaecation | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Manipulation | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Gastrocardiac syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Toxic leukoencephalopathy | 0 | 0.039 | 0.047 | 0.962 | 2.904 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site extravasation | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Venolymphatic malformation | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Mast cell degranulation present | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pathological doubt | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral vasoconstriction | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Venous occlusion | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Thermohypoaesthesia | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Cystitis escherichia | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal stromal tumour | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic injury | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Ebola disease | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Ruptured ectopic pregnancy | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy with young maternal age | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Phenylalanine screen | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal rupture | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Medical observation | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Seroconversion test positive | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Cell marker increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Analgesic drug level increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Acid-base balance disorder mixed | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Prophylaxis against HIV infection | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Periphlebitis | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid thickening | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal cancer | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Testicular operation | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Micturition frequency decreased | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Duodenal polyp | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Venoocclusive disease | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Somatostatin receptor scan abnormal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Listeria test positive | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Gradenigo's syndrome | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Stress echocardiogram abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Oligoarthritis | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Cervix cancer metastatic | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Testicular germ cell tumour | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Synovectomy | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Hydromyelia | 0 | 0.039 | 0.047 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | End-tidal CO2 increased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Adactyly | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Pericarditis meningococcal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Omenn syndrome | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Personality change due to a general medical condition | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Eye muscle operation | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Myelocyte percentage decreased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Implant site infection | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Encephalopathy neonatal | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site pallor | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Blood thromboplastin abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral haemorrhage foetal | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Uterine infection | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Mononucleosis syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lip abnormal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal transit time abnormal | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Tear break up time test | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Acute interstitial pneumonitis | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Injury to brachial plexus due to birth trauma | 0 | 0.039 | 0.049 | 0.962 | 2.887 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin S normal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Sensory ganglionitis | 0 | 0.039 | 0.048 | 0.962 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal scar | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Microencephaly | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Urine phosphorus increased | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Umbilical cord around neck | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Platelet function test normal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Nerve root injury thoracic | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Foot and mouth disease | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Bacillus bacteraemia | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal hypertrophy | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system neoplasm | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | CSF measles antibody positive | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Thymoma | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Spotted fever rickettsia test positive | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Macula thickness measurement | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Cows milk free diet | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Velopharyngeal incompetence | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Enzyme activity assay | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Urea renal clearance | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to the mediastinum | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol use disorder | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | CSF monocyte count increased | 0 | 0.043 | 0.061 | 0.962 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Porphyria screen | 0 | 0.039 | 0.048 | 0.962 | 2.895 |  |  |  |  |  | 
COVID19_MODERNA | Metabolic surgery | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic band syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal wall neoplasm malignant | 0 | 0.039 | 0.048 | 0.962 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Nodal osteoarthritis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine urine decreased | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Wound abscess | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to chemicals | 0 | 0.046 | 0.068 | 0.962 | 2.742 |  |  |  |  |  | 
COVID19_MODERNA | Erythema marginatum | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Paracentesis eye normal | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Meningococcal carditis | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Bone debridement | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Foetal haemoglobin | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bladder | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Acrodermatitis enteropathica | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Hepatopulmonary syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Hypertrophic scar | 0 | 0.039 | 0.046 | 0.962 | 2.907 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QT shortened | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Carcinoid tumour | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Renal necrosis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Retinal drusen | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Secondary cerebellar degeneration | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Anti-insulin antibody | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Antimitochondrial antibody positive | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Retinogram normal | 0 | 0.039 | 0.046 | 0.962 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis post transfusion | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Manual lymphatic drainage | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Camptodactyly acquired | 0 | 0.039 | 0.048 | 0.962 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Murphy's sign test | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Meconium abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.9 |  |  |  |  |  | 
COVID19_MODERNA | Ectopic kidney | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Barrel chest | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Aortogram abnormal | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Transcranial electrical motor evoked potential monitoring abnormal | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Rickets | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Expanded disability status scale | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Radiation injury | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Paracentesis ear | 0 | 0.039 | 0.048 | 0.962 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | Lupus enteritis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Locomotive syndrome | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Traction | 0 | 0.039 | 0.048 | 0.962 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Stoma care | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Oestradiol abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Micropenis | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Congenital teratoma | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Barium swallow abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Urine mercury abnormal | 0 | 0.039 | 0.047 | 0.962 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Forced expiratory volume increased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Medial tibial stress syndrome | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic fluid volume | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Clumsy child syndrome | 0 | 0.039 | 0.048 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Urine osmolarity decreased | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Lasegue's test negative | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Bone giant cell tumour | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Leukaemoid reaction | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Brachytherapy | 0 | 0.039 | 0.047 | 0.962 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Renin increased | 0 | 0.039 | 0.049 | 0.962 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Radiation pneumonitis | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Ventricular flutter | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival ulcer | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Bile culture positive | 0 | 0.039 | 0.047 | 0.962 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Milk-alkali syndrome | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Right aortic arch | 0 | 0.039 | 0.047 | 0.962 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Anomaly of external ear congenital | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac septal defect residual shunt | 0 | 0.039 | 0.047 | 0.962 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Oedematous kidney | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Infective tenosynovitis | 0 | 0.039 | 0.046 | 0.962 | 2.906 |  |  |  |  |  | 
COVID19_MODERNA | Congenital renal disorder | 0 | 0.039 | 0.049 | 0.962 | 2.885 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor IX level increased | 0 | 0.039 | 0.047 | 0.962 | 2.897 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural stroke | 0 | 0.039 | 0.047 | 0.962 | 2.901 |  |  |  |  |  | 
COVID19_MODERNA | Throat clearing | 21 | 21.947 | 0.653 | 0.961 | 1.317 | 0.665 | 0.94 | 1.299 | 0.957 | 8.631 | 99.179
COVID19_MODERNA | Acute central respiratory depression (SMQ) [broad] | 1064 | 1131.34 | 0.913 | 0.961 | 1.01 | 0.894 | 0.94 | 0.988 | 0.94 | 2.264 | 712.725
COVID19_MODERNA | Anaphylactic reaction (SMQ) [algorithm] | 558 | 595.549 | 0.895 | 0.961 | 1.028 | 0.873 | 0.936 | 1.003 | 0.937 | 2.004 | 264.237
COVID19_MODERNA | Ventricular extrasystoles | 13 | 14.663 | 0.595 | 0.961 | 1.398 | 0.572 | 0.877 | 1.299 | 0.887 | 4.646 | 28.197
COVID19_MODERNA | Joint range of motion decreased | 46 | 56.257 | 0.744 | 0.961 | 1.201 | 0.644 | 0.819 | 1.03 | 0.818 | 0.842 | 1.177
COVID19_MODERNA | Gastrointestinal nonspecific inflammation (SMQ) [narrow] | 9 | 11.544 | 0.533 | 0.961 | 1.491 | 0.483 | 0.794 | 1.244 | 0.78 | 0.841 | 0.127
COVID19_MODERNA | Congenital rubella infection | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Corneal perforation | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Somatic hallucination | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Lentigo | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin A deficiency | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Arterial therapeutic procedure | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Device inappropriate shock delivery | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Factor V Leiden mutation | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Neutralising antibodies positive | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase BB | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Hypereosinophilic syndrome | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Physical thyroid examination abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Euthyroid sick syndrome | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Skull malformation | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Pre-existing disease | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis Japanese B | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar cyst | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Product intolerance | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Blood beryllium increased | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Rhinoplasty | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Ureteral disorder | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Dysplastic naevus | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxin binding globulin | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin saturation increased | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Brucellosis | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal disorder | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Gastric mucosa erythema | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Endocardial fibrosis | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Flail chest | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Oesophagogastroscopy abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Fulminant type 1 diabetes mellitus | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Acute post asthmatic amyotrophy | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Palpatory finding abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Gingival erosion | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase MM normal | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Glaucoma drainage device placement | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Waldenstrom's macroglobulinaemia | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal anastomosis | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube cancer metastatic | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Bipolar II disorder | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Unemployment | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Urine odour abnormal | 0 | 0.141 | 0.298 | 0.961 | 1.931 |  |  |  |  |  | 
COVID19_MODERNA | Spermatorrhoea | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow myelogram normal | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Plasma cells present | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Mechanical ventilation complication | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Kounis syndrome | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Fallopian tube cancer | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Microangiopathic haemolytic anaemia | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Denture wearer | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | High risk sexual behaviour | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Oesophagostomy | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis tuberculous | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Oral cavity fistula | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Shigella test positive | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Brucella test positive | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Nail pigmentation | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Primary adrenal insufficiency | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Plague | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Cardiopulmonary exercise test abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Ejaculation disorder | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Saliva analysis normal | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial parotitis | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Lymph gland infection | 0 | 0.093 | 0.202 | 0.961 | 2.182 |  |  |  |  |  | 
COVID19_MODERNA | Orchidopexy | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Cholera | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Burkholderia test positive | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Tattoo | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Endometrial ablation | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | CSF protein decreased | 0 | 0.125 | 0.27 | 0.961 | 1.998 |  |  |  |  |  | 
COVID19_MODERNA | Pleural disorder | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Neurofibroma | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Poliovirus test | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Vulva cyst | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Aldolase decreased | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Periodic limb movement disorder | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Gastric fluid analysis | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Skin adhesion | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Hydrogen breath test abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal pigmentation | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Product barcode issue | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Procedural site reaction | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Benign neoplasm of skin | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Atypical mycobacterium pericarditis | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Blastocystis infection | 0 | 0.039 | 0.046 | 0.961 | 2.908 |  |  |  |  |  | 
COVID19_MODERNA | Coombs indirect test | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Murphy's sign positive | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor abnormal | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Blood copper increased | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Risus sardonicus | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Food contamination | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal disorder | 0 | 0.047 | 0.071 | 0.961 | 2.726 |  |  |  |  |  | 
COVID19_MODERNA | Patent ductus arteriosus repair | 0 | 0.039 | 0.046 | 0.961 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Pericarditis rheumatic | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Prader-Willi syndrome | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Sinoscopy | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Foetal damage | 0 | 0.039 | 0.046 | 0.961 | 2.91 |  |  |  |  |  | 
COVID19_MODERNA | Hypertonia | 1 | 0.682 | 0.153 | 0.96 | 2.338 | 0.386 | 0.938 | 1.992 | 1.466 | 0.106 | 6.628
COVID19_MODERNA | Glomerular filtration rate decreased | 15 | 15.434 | 0.629 | 0.96 | 1.349 | 0.633 | 0.947 | 1.372 | 0.972 | 6.979 | 55.15
COVID19_MODERNA | Oral pruritus | 18 | 19.396 | 0.651 | 0.96 | 1.319 | 0.631 | 0.914 | 1.29 | 0.928 | 4.484 | 38.229
COVID19_MODERNA | Hypertension | 148 | 161.899 | 0.836 | 0.96 | 1.092 | 0.797 | 0.913 | 1.041 | 0.914 | 4.392 | 327.058
COVID19_MODERNA | Acute central respiratory depression (SMQ) [narrow] | 101 | 117.809 | 0.811 | 0.96 | 1.12 | 0.727 | 0.857 | 1.004 | 0.857 | 1.274 | 5.425
COVID19_MODERNA | Hypoglycaemia (SMQ) [narrow] | 13 | 19.05 | 0.602 | 0.96 | 1.387 | 0.461 | 0.707 | 1.047 | 0.682 | 1.087 | 0.021
COVID19_MODERNA | Ear tube insertion | 0 | 0.094 | 0.196 | 0.96 | 2.195 |  |  |  |  |  | 
COVID19_MODERNA | Blepharitis | 0 | 0.093 | 0.194 | 0.96 | 2.2 |  |  |  |  |  | 
COVID19_MODERNA | Osteoporosis | 0 | 0.089 | 0.184 | 0.96 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell count abnormal | 1 | 1.499 | 0.327 | 0.959 | 1.859 | 0.321 | 0.783 | 1.663 | 0.667 | 1.174 | 0.155
COVID19_MODERNA | Biopsy site unspecified abnormal | 0 | 0.051 | 0.074 | 0.959 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Postictal state | 4 | 4.004 | 0.513 | 0.958 | 1.514 | 0.479 | 0.924 | 1.646 | 0.999 | 0.649 | 0.427
COVID19_MODERNA | Acute pancreatitis (SMQ) [narrow] | 13 | 13.709 | 0.602 | 0.958 | 1.38 | 0.604 | 0.926 | 1.37 | 0.948 | 3.602 | 19.031
COVID19_MODERNA | Imaging procedure | 5 | 5.636 | 0.49 | 0.958 | 1.551 | 0.471 | 0.869 | 1.495 | 0.887 | 1.451 | 0.292
COVID19_MODERNA | Oral pain | 10 | 11.212 | 0.601 | 0.958 | 1.383 | 0.546 | 0.879 | 1.355 | 0.892 | 1.591 | 1.526
COVID19_MODERNA | Chronic spontaneous urticaria | 0 | 0.044 | 0.052 | 0.958 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Skin induration | 4 | 4.179 | 0.489 | 0.957 | 1.552 | 0.468 | 0.903 | 1.609 | 0.957 | 1.701 | 0.506
COVID19_MODERNA | Injection site dryness | 1 | 1.086 | 0.311 | 0.957 | 1.891 | 0.351 | 0.855 | 1.813 | 0.921 | 0.725 | 0.014
COVID19_MODERNA | Catheterisation cardiac abnormal | 5 | 5.321 | 0.473 | 0.957 | 1.579 | 0.488 | 0.899 | 1.548 | 0.94 | 7.253 | 16.105
COVID19_MODERNA | Parkinson-like events (SMQ) [broad] | 714 | 757.637 | 0.9 | 0.957 | 1.017 | 0.885 | 0.942 | 1.001 | 0.942 | 1.041 | 1.121
COVID19_MODERNA | Eosinophil count | 1 | 1.144 | 0.261 | 0.957 | 2.008 | 0.347 | 0.844 | 1.79 | 0.874 | 1.028 | 0.24
COVID19_MODERNA | Angiogram pulmonary normal | 5 | 5.792 | 0.474 | 0.957 | 1.577 | 0.463 | 0.854 | 1.47 | 0.863 | 13.7 | 29.825
COVID19_MODERNA | Food refusal | 2 | 3.795 | 0.259 | 0.957 | 2.014 | 0.307 | 0.677 | 1.333 | 0.527 | 1.174 | 0.028
COVID19_MODERNA | Anal fissure | 0 | 0.083 | 0.152 | 0.957 | 2.332 |  |  |  |  |  | 
COVID19_MODERNA | Chapped lips | 3 | 2.679 | 0.419 | 0.956 | 1.672 | 0.471 | 0.959 | 1.785 | 1.12 | 1.213 | 0
COVID19_MODERNA | Vulvovaginal pruritus | 2 | 2.039 | 0.313 | 0.956 | 1.885 | 0.406 | 0.89 | 1.749 | 0.981 | 2.74 | 0.693
COVID19_MODERNA | Hemiparesis | 39 | 40.403 | 0.726 | 0.956 | 1.212 | 0.736 | 0.955 | 1.222 | 0.965 | 3.699 | 64.426
COVID19_MODERNA | Pancreatitis | 6 | 6.525 | 0.536 | 0.956 | 1.475 | 0.501 | 0.891 | 1.49 | 0.92 | 2.901 | 5.037
COVID19_MODERNA | Central nervous system vascular disorders (SMQ) [broad] | 304 | 335.12 | 0.868 | 0.956 | 1.048 | 0.824 | 0.906 | 0.995 | 0.907 | 2.022 | 145.948
COVID19_MODERNA | Acute myeloid leukaemia | 3 | 4.42 | 0.427 | 0.956 | 1.656 | 0.367 | 0.75 | 1.396 | 0.679 | 4.11 | 3.596
COVID19_MODERNA | Blister rupture | 1 | 1.729 | 0.401 | 0.956 | 1.705 | 0.305 | 0.748 | 1.591 | 0.578 | 0.771 | 0.037
COVID19_MODERNA | Spirometry normal | 0 | 0.043 | 0.042 | 0.956 | 2.928 |  |  |  |  |  | 
COVID19_MODERNA | Dyspnoea | 793 | 844.206 | 0.9 | 0.955 | 1.011 | 0.885 | 0.939 | 0.995 | 0.939 | 2.637 | 744.249
COVID19_MODERNA | Osteonecrosis (SMQ) [broad] | 83 | 89.401 | 0.794 | 0.955 | 1.128 | 0.772 | 0.925 | 1.101 | 0.928 | 1.418 | 9.323
COVID19_MODERNA | Computerised tomogram | 145 | 161.521 | 0.832 | 0.955 | 1.084 | 0.782 | 0.896 | 1.024 | 0.898 | 3.551 | 230.743
COVID19_MODERNA | Hyporeflexia | 1 | 1.374 | 0.226 | 0.955 | 2.094 | 0.329 | 0.803 | 1.705 | 0.728 | 0.287 | 1.097
COVID19_MODERNA | X-ray limb abnormal | 3 | 3.109 | 0.421 | 0.954 | 1.661 | 0.44 | 0.898 | 1.67 | 0.965 | 0.48 | 1.166
COVID19_MODERNA | Inflammation | 42 | 45.769 | 0.738 | 0.954 | 1.194 | 0.709 | 0.912 | 1.158 | 0.918 | 0.609 | 9.954
COVID19_MODERNA | Skin plaque | 1 | 1.384 | 0.3 | 0.954 | 1.906 | 0.329 | 0.802 | 1.702 | 0.723 | 0.204 | 2.319
COVID19_MODERNA | Blood lactate dehydrogenase | 2 | 2.951 | 0.411 | 0.954 | 1.682 | 0.348 | 0.765 | 1.504 | 0.678 | 1.333 | 0
COVID19_MODERNA | Carbon dioxide normal | 9 | 13.863 | 0.539 | 0.954 | 1.465 | 0.419 | 0.688 | 1.079 | 0.649 | 1.834 | 2.423
COVID19_MODERNA | Hodgkin's disease | 0 | 0.091 | 0.157 | 0.954 | 2.305 |  |  |  |  |  | 
COVID19_MODERNA | Bone scan normal | 0 | 0.087 | 0.147 | 0.954 | 2.341 |  |  |  |  |  | 
COVID19_MODERNA | Joint stiffness | 17 | 19.105 | 0.626 | 0.953 | 1.337 | 0.603 | 0.882 | 1.255 | 0.89 | 0.932 | 0.028
COVID19_MODERNA | Rib fracture | 1 | 1.353 | 0.296 | 0.953 | 1.913 | 0.331 | 0.807 | 1.713 | 0.739 | 1.174 | 0.155
COVID19_MODERNA | CSF lymphocyte count abnormal | 0 | 0.084 | 0.136 | 0.953 | 2.382 |  |  |  |  |  | 
COVID19_MODERNA | Neuropsychological test | 0 | 0.048 | 0.045 | 0.953 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary haemorrhage | 0 | 0.123 | 0.218 | 0.953 | 2.111 |  |  |  |  |  | 
COVID19_MODERNA | West Nile virus test negative | 0 | 0.112 | 0.195 | 0.953 | 2.176 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary hypertension (SMQ) [broad] | 862 | 921.499 | 0.899 | 0.952 | 1.005 | 0.884 | 0.935 | 0.988 | 0.935 | 2.733 | 873.583
COVID19_MODERNA | Wheezing | 86 | 92.932 | 0.793 | 0.952 | 1.123 | 0.772 | 0.922 | 1.094 | 0.925 | 1.761 | 25.786
COVID19_MODERNA | Blood urine absent | 1 | 1.56 | 0.338 | 0.952 | 1.818 | 0.316 | 0.773 | 1.643 | 0.641 | 0.649 | 0
COVID19_MODERNA | Blood homocysteine normal | 0 | 0.085 | 0.136 | 0.952 | 2.379 |  |  |  |  |  | 
COVID19_MODERNA | Hair metal test abnormal | 0 | 0.125 | 0.213 | 0.952 | 2.121 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular insufficiency | 0 | 0.07 | 0.097 | 0.952 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase | 11 | 11.469 | 0.604 | 0.951 | 1.362 | 0.589 | 0.93 | 1.413 | 0.959 | 2.188 | 5.431
COVID19_MODERNA | Retroperitoneal fibrosis (SMQ) [broad] | 454 | 486.42 | 0.879 | 0.951 | 1.025 | 0.863 | 0.933 | 1.007 | 0.933 | 1.504 | 73.539
COVID19_MODERNA | Injection site bruising | 43 | 46.797 | 0.736 | 0.951 | 1.19 | 0.712 | 0.913 | 1.156 | 0.919 | 0.571 | 13.157
COVID19_MODERNA | Lethargy | 118 | 130.484 | 0.815 | 0.951 | 1.096 | 0.775 | 0.903 | 1.046 | 0.904 | 0.924 | 0.647
COVID19_MODERNA | Ligament pain | 1 | 0.699 | 0.167 | 0.95 | 2.26 | 0.385 | 0.934 | 1.983 | 1.43 | 2.242 | 0.002
COVID19_MODERNA | Trismus | 5 | 5.281 | 0.432 | 0.95 | 1.631 | 0.49 | 0.903 | 1.555 | 0.947 | 1.197 | 0.021
COVID19_MODERNA | Monocyte percentage | 7 | 8.101 | 0.496 | 0.95 | 1.524 | 0.497 | 0.857 | 1.398 | 0.864 | 0.872 | 0.031
COVID19_MODERNA | Gastrointestinal nonspecific dysfunction (SMQ) [broad] | 35 | 40.618 | 0.709 | 0.95 | 1.219 | 0.654 | 0.86 | 1.114 | 0.862 | 1.125 | 0.352
COVID19_MODERNA | Sleep study normal | 0 | 0.125 | 0.205 | 0.95 | 2.139 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary function test decreased | 0 | 0.047 | 0.037 | 0.95 | 2.958 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatitis acute | 7 | 7.184 | 0.507 | 0.949 | 1.503 | 0.539 | 0.929 | 1.516 | 0.974 | 4.666 | 13.898
COVID19_MODERNA | Feeling hot | 248 | 261.925 | 0.854 | 0.949 | 1.048 | 0.851 | 0.945 | 1.048 | 0.947 | 2.227 | 153.991
COVID19_MODERNA | Sinus congestion | 16 | 17.248 | 0.636 | 0.949 | 1.314 | 0.617 | 0.912 | 1.31 | 0.928 | 2.391 | 10.53
COVID19_MODERNA | Haematopoietic thrombocytopenia (SMQ) [broad] | 76 | 84.354 | 0.78 | 0.949 | 1.132 | 0.744 | 0.898 | 1.077 | 0.901 | 1.562 | 13.953
COVID19_MODERNA | Extravasation events (injections, infusions and implants) (SMQ) [narrow] | 5 | 5.63 | 0.428 | 0.949 | 1.636 | 0.471 | 0.869 | 1.496 | 0.888 | 0.785 | 0.109
COVID19_MODERNA | Metabolic function test normal | 49 | 56.591 | 0.746 | 0.949 | 1.172 | 0.684 | 0.864 | 1.079 | 0.866 | 1.868 | 17.567
COVID19_MODERNA | Magnetic resonance imaging head | 42 | 49.78 | 0.732 | 0.949 | 1.188 | 0.656 | 0.843 | 1.071 | 0.844 | 2.69 | 38.694
COVID19_MODERNA | General physical health deterioration | 21 | 27.579 | 0.644 | 0.949 | 1.303 | 0.545 | 0.77 | 1.064 | 0.761 | 1.191 | 0.437
COVID19_MODERNA | Gastroenteritis viral | 1 | 1.998 | 0.408 | 0.949 | 1.673 | 0.289 | 0.711 | 1.514 | 0.501 | 0.324 | 0.781
COVID19_MODERNA | Nodule | 19 | 21.008 | 0.638 | 0.948 | 1.309 | 0.623 | 0.895 | 1.253 | 0.904 | 0.621 | 3.908
COVID19_MODERNA | Shock (SMQ) [broad] | 349 | 388.885 | 0.866 | 0.948 | 1.032 | 0.821 | 0.897 | 0.978 | 0.897 | 2.775 | 358.018
COVID19_MODERNA | Aphthous ulcer | 2 | 2.531 | 0.295 | 0.948 | 1.901 | 0.373 | 0.818 | 1.608 | 0.79 | 0.56 | 0.301
COVID19_MODERNA | Injection site atrophy | 0 | 0.241 | 0.343 | 0.948 | 1.796 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular neuronitis | 3 | 3.02 | 0.431 | 0.947 | 1.625 | 0.446 | 0.91 | 1.692 | 0.993 | 2.176 | 0.808
COVID19_MODERNA | Refusal of treatment by patient | 5 | 5.496 | 0.445 | 0.947 | 1.601 | 0.478 | 0.882 | 1.518 | 0.91 | 8.807 | 19.864
COVID19_MODERNA | Injection site scab | 4 | 4.642 | 0.39 | 0.947 | 1.702 | 0.442 | 0.852 | 1.518 | 0.862 | 0.649 | 0.427
COVID19_MODERNA | Hypotonia | 7 | 8.507 | 0.488 | 0.947 | 1.528 | 0.48 | 0.828 | 1.351 | 0.823 | 0.111 | 49.079
COVID19_MODERNA | Hospice care | 2 | 3.08 | 0.344 | 0.947 | 1.794 | 0.341 | 0.75 | 1.475 | 0.649 | 3.794 | 1.492
COVID19_MODERNA | Low density lipoprotein normal | 1 | 2.084 | 0.343 | 0.947 | 1.795 | 0.284 | 0.699 | 1.491 | 0.48 | 0.913 | 0.159
COVID19_MODERNA | Cytogenetic analysis | 1 | 2.119 | 0.424 | 0.947 | 1.637 | 0.282 | 0.695 | 1.481 | 0.472 | 0.411 | 0.337
COVID19_MODERNA | Tricuspid valve incompetence | 2 | 3.915 | 0.306 | 0.947 | 1.876 | 0.301 | 0.666 | 1.311 | 0.511 | 2.242 | 0.355
COVID19_MODERNA | Amino acid level | 0 | 0.091 | 0.126 | 0.947 | 2.401 |  |  |  |  |  | 
COVID19_MODERNA | Shoulder operation | 0 | 0.123 | 0.188 | 0.947 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Gingival swelling | 4 | 4.629 | 0.412 | 0.946 | 1.658 | 0.442 | 0.853 | 1.521 | 0.864 | 2.013 | 1.037
COVID19_MODERNA | Skin haemorrhage | 1 | 1.366 | 0.288 | 0.946 | 1.912 | 0.33 | 0.805 | 1.708 | 0.732 | 0.385 | 0.438
COVID19_MODERNA | Mean platelet volume normal | 7 | 9.071 | 0.501 | 0.946 | 1.506 | 0.458 | 0.791 | 1.291 | 0.772 | 1.488 | 0.633
COVID19_MODERNA | Lymphocyte percentage | 4 | 5.513 | 0.437 | 0.946 | 1.611 | 0.399 | 0.77 | 1.373 | 0.725 | 0.533 | 1.161
COVID19_MODERNA | Laparoscopic surgery | 4 | 6.412 | 0.378 | 0.946 | 1.722 | 0.363 | 0.701 | 1.25 | 0.624 | 3.288 | 3.716
COVID19_MODERNA | Serum sickness-like reaction | 0 | 0.078 | 0.095 | 0.946 | 2.541 |  |  |  |  |  | 
COVID19_MODERNA | CSF virus identified | 0 | 0.085 | 0.109 | 0.946 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [broad] | 301 | 333.515 | 0.857 | 0.945 | 1.036 | 0.82 | 0.902 | 0.99 | 0.903 | 2.038 | 147.729
COVID19_MODERNA | Chest X-ray normal | 87 | 97.229 | 0.788 | 0.945 | 1.115 | 0.748 | 0.893 | 1.058 | 0.895 | 2.214 | 52.159
COVID19_MODERNA | Gallstone related disorders (SMQ) [broad] | 6 | 7.192 | 0.503 | 0.945 | 1.499 | 0.47 | 0.836 | 1.398 | 0.834 | 4.773 | 11.886
COVID19_MODERNA | Gallstone related disorders (SMQ) [narrow] | 6 | 7.192 | 0.503 | 0.945 | 1.499 | 0.47 | 0.836 | 1.398 | 0.834 | 4.773 | 11.886
COVID19_MODERNA | Grunting | 1 | 1.733 | 0.344 | 0.945 | 1.787 | 0.305 | 0.748 | 1.589 | 0.577 | 0.32 | 0.812
COVID19_MODERNA | Cast application | 1 | 2.592 | 0.149 | 0.945 | 2.309 | 0.257 | 0.639 | 1.368 | 0.386 | 2.74 | 0.032
COVID19_MODERNA | Mononucleosis heterophile test | 0 | 0.212 | 0.3 | 0.945 | 1.881 |  |  |  |  |  | 
COVID19_MODERNA | Radioisotope scan abnormal | 0 | 0.043 | 0.019 | 0.945 | 3.165 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell burr cells present | 0 | 0.078 | 0.091 | 0.945 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Sick relative | 0 | 0.042 | 0.018 | 0.945 | 3.183 |  |  |  |  |  | 
COVID19_MODERNA | Bile duct stone | 0 | 0.078 | 0.091 | 0.945 | 2.557 |  |  |  |  |  | 
COVID19_MODERNA | Nail bed disorder | 0 | 0.078 | 0.089 | 0.945 | 2.565 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil toxic granulation present | 0 | 0.078 | 0.091 | 0.945 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Hypoglycaemia (SMQ) [broad] | 1852 | 1979.944 | 0.908 | 0.944 | 0.98 | 0.9 | 0.935 | 0.971 | 0.935 | 1.174 | 51.618
COVID19_MODERNA | Epstein-Barr virus antibody positive | 3 | 3.328 | 0.385 | 0.944 | 1.704 | 0.426 | 0.869 | 1.617 | 0.901 | 1.174 | 0.002
COVID19_MODERNA | Skin burning sensation | 17 | 18.85 | 0.636 | 0.944 | 1.301 | 0.609 | 0.892 | 1.269 | 0.902 | 1.612 | 3.14
COVID19_MODERNA | Corneal disorders (SMQ) [broad] | 93 | 104.597 | 0.79 | 0.944 | 1.108 | 0.748 | 0.887 | 1.046 | 0.889 | 1.203 | 2.864
COVID19_MODERNA | Torsade de pointes/QT prolongation (SMQ) [broad] | 433 | 493.155 | 0.871 | 0.944 | 1.02 | 0.811 | 0.878 | 0.949 | 0.878 | 1.022 | 0.18
COVID19_MODERNA | Thrombosis | 22 | 33.878 | 0.65 | 0.944 | 1.284 | 0.475 | 0.668 | 0.917 | 0.649 | 3.903 | 38.465
COVID19_MODERNA | Large intestinal obstruction | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Thoracic vertebral fracture | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Hypervigilance | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram pancreas abnormal | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic girdle pain | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Vascular graft | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Withdrawal syndrome | 0 | 0.078 | 0.087 | 0.944 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Passive smoking | 0 | 0.078 | 0.087 | 0.944 | 2.577 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary imaging procedure abnormal | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral embolism | 0 | 0.078 | 0.088 | 0.944 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Intra-uterine contraceptive device removal | 0 | 0.078 | 0.087 | 0.944 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid analysis | 0 | 0.078 | 0.088 | 0.944 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | End-tidal CO2 decreased | 0 | 0.078 | 0.089 | 0.944 | 2.568 |  |  |  |  |  | 
COVID19_MODERNA | Blast cell crisis | 0 | 0.078 | 0.088 | 0.944 | 2.571 |  |  |  |  |  | 
COVID19_MODERNA | Lipoprotein (a) | 0 | 0.078 | 0.087 | 0.944 | 2.573 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmological examination | 6 | 6.573 | 0.484 | 0.943 | 1.526 | 0.499 | 0.887 | 1.483 | 0.913 | 1.608 | 0.77
COVID19_MODERNA | Folliculitis | 2 | 2.297 | 0.372 | 0.943 | 1.726 | 0.388 | 0.851 | 1.672 | 0.871 | 1.973 | 0.198
COVID19_MODERNA | Muscle discomfort | 2 | 2.764 | 0.369 | 0.943 | 1.732 | 0.359 | 0.788 | 1.549 | 0.724 | 2.242 | 0.355
COVID19_MODERNA | Pneumonia fungal | 0 | 0.078 | 0.083 | 0.943 | 2.592 |  |  |  |  |  | 
COVID19_MODERNA | Basal ganglia haematoma | 0 | 0.078 | 0.083 | 0.943 | 2.59 |  |  |  |  |  | 
COVID19_MODERNA | West Nile virus test | 0 | 0.093 | 0.116 | 0.943 | 2.433 |  |  |  |  |  | 
COVID19_MODERNA | Pleurodesis | 0 | 0.078 | 0.084 | 0.943 | 2.586 |  |  |  |  |  | 
COVID19_MODERNA | Dermal cyst | 0 | 0.086 | 0.101 | 0.943 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Limb asymmetry | 0 | 0.078 | 0.083 | 0.943 | 2.592 |  |  |  |  |  | 
COVID19_MODERNA | Sexual dysfunction | 0 | 0.081 | 0.091 | 0.943 | 2.549 |  |  |  |  |  | 
COVID19_MODERNA | Nitrite urine | 0 | 0.078 | 0.084 | 0.943 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Haemangioma | 0 | 0.129 | 0.183 | 0.943 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Skin test | 1 | 1.156 | 0.289 | 0.942 | 1.897 | 0.346 | 0.842 | 1.785 | 0.865 | 0.601 | 0.012
COVID19_MODERNA | Parvovirus B19 test negative | 1 | 1.444 | 0.18 | 0.942 | 2.195 | 0.324 | 0.792 | 1.682 | 0.693 | 0.368 | 0.519
COVID19_MODERNA | Hypothermia | 4 | 6.505 | 0.366 | 0.942 | 1.736 | 0.359 | 0.695 | 1.239 | 0.615 | 0.685 | 0.29
COVID19_MODERNA | Spinal column injury | 0 | 0.078 | 0.081 | 0.942 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Patient restraint | 0 | 0.078 | 0.081 | 0.942 | 2.6 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic complication | 0 | 0.078 | 0.081 | 0.942 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy heart abnormal | 0 | 0.078 | 0.081 | 0.942 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Axillary mass | 12 | 13.302 | 0.59 | 0.941 | 1.358 | 0.571 | 0.889 | 1.332 | 0.902 | 2.114 | 5.465
COVID19_MODERNA | Haematocrit | 2 | 2.591 | 0.29 | 0.941 | 1.895 | 0.369 | 0.81 | 1.592 | 0.772 | 1.701 | 0.073
COVID19_MODERNA | Retinal disorders (SMQ) [narrow] | 31 | 39.891 | 0.689 | 0.941 | 1.224 | 0.585 | 0.782 | 1.028 | 0.777 | 1.523 | 4.749
COVID19_MODERNA | Ultrasound Doppler abnormal | 6 | 8.583 | 0.458 | 0.941 | 1.564 | 0.416 | 0.741 | 1.239 | 0.699 | 2.466 | 3.469
COVID19_MODERNA | Comminuted fracture | 0 | 0.078 | 0.078 | 0.941 | 2.615 |  |  |  |  |  | 
COVID19_MODERNA | Urine osmolarity normal | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral microhaemorrhage | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Large intestine anastomosis | 0 | 0.078 | 0.079 | 0.941 | 2.612 |  |  |  |  |  | 
COVID19_MODERNA | Developmental hip dysplasia | 0 | 0.089 | 0.103 | 0.941 | 2.489 |  |  |  |  |  | 
COVID19_MODERNA | Blood bilirubin unconjugated | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Lung carcinoma cell type unspecified stage IV | 0 | 0.078 | 0.079 | 0.941 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Injection site joint effusion | 0 | 0.162 | 0.222 | 0.941 | 2.065 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site papule | 0 | 0.178 | 0.246 | 0.941 | 2.003 |  |  |  |  |  | 
COVID19_MODERNA | Cholangiocarcinoma | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Lower urinary tract symptoms | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Tooth injury | 0 | 0.042 | 0.014 | 0.941 | 3.252 |  |  |  |  |  | 
COVID19_MODERNA | Coccidioidomycosis | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Stenotrophomonas infection | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Dysbiosis | 0 | 0.082 | 0.088 | 0.941 | 2.563 |  |  |  |  |  | 
COVID19_MODERNA | Diagnostic aspiration | 0 | 0.128 | 0.171 | 0.941 | 2.219 |  |  |  |  |  | 
COVID19_MODERNA | Capillary nail refill test | 0 | 0.097 | 0.119 | 0.941 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system function test | 0 | 0.078 | 0.077 | 0.941 | 2.619 |  |  |  |  |  | 
COVID19_MODERNA | Thrombophlebitis superficial | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Fibrinous bronchitis | 0 | 0.078 | 0.077 | 0.941 | 2.619 |  |  |  |  |  | 
COVID19_MODERNA | Biliary malignant tumours (SMQ) [narrow] | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Biliary malignant tumours (SMQ) [broad] | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | X-ray with contrast upper gastrointestinal tract abnormal | 0 | 0.078 | 0.078 | 0.941 | 2.617 |  |  |  |  |  | 
COVID19_MODERNA | Legionella infection | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Analgesic drug level decreased | 0 | 0.078 | 0.08 | 0.941 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis A virus test | 1 | 0.742 | 0.131 | 0.94 | 2.361 | 0.381 | 0.925 | 1.962 | 1.348 | 0.986 | 0.243
COVID19_MODERNA | Mucosal hypertrophy | 0 | 0.078 | 0.074 | 0.94 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | Aortic valve stenosis | 0 | 0.078 | 0.076 | 0.94 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Perioral dermatitis | 0 | 0.078 | 0.076 | 0.94 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Rectal examination | 0 | 0.078 | 0.074 | 0.94 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | VIIIth nerve injury | 0 | 0.078 | 0.076 | 0.94 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Band sensation | 0 | 0.078 | 0.076 | 0.94 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Administration site vesicles | 0 | 0.078 | 0.077 | 0.94 | 2.621 |  |  |  |  |  | 
COVID19_MODERNA | Sports injury | 0 | 0.078 | 0.076 | 0.94 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary resection | 0 | 0.078 | 0.076 | 0.94 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Tendinous contracture | 0 | 0.078 | 0.076 | 0.94 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Plantar erythema | 0 | 0.078 | 0.077 | 0.94 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Macular hole | 0 | 0.078 | 0.076 | 0.94 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Face and mouth X-ray normal | 0 | 0.078 | 0.074 | 0.94 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | Spinal nerve stimulator implantation | 0 | 0.078 | 0.076 | 0.94 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Ocular vascular disorder | 0 | 0.078 | 0.074 | 0.94 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | T-cell type acute leukaemia | 0 | 0.078 | 0.077 | 0.94 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Peripancreatic fluid collection | 0 | 0.078 | 0.075 | 0.94 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Cytogenetic analysis normal | 1 | 1.356 | 0.323 | 0.939 | 1.815 | 0.331 | 0.806 | 1.712 | 0.738 | 0.391 | 0.412
COVID19_MODERNA | Cardiac failure (SMQ) [narrow] | 51 | 68.105 | 0.736 | 0.939 | 1.162 | 0.599 | 0.753 | 0.937 | 0.749 | 3.418 | 74.504
COVID19_MODERNA | Frustration tolerance decreased | 1 | 1.626 | 0.289 | 0.939 | 1.89 | 0.312 | 0.763 | 1.622 | 0.615 | 0.44 | 0.244
COVID19_MODERNA | Thyroxine | 1 | 1.975 | 0.318 | 0.939 | 1.827 | 0.29 | 0.714 | 1.52 | 0.506 | 0.913 | 0.159
COVID19_MODERNA | Infusion site pain | 0 | 0.078 | 0.072 | 0.939 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Self-medication | 0 | 0.078 | 0.073 | 0.939 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Thrombocytosis | 0 | 0.118 | 0.147 | 0.939 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Masticatory pain | 0 | 0.078 | 0.072 | 0.939 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure orthostatic increased | 0 | 0.078 | 0.072 | 0.939 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Overgrowth fungal | 0 | 0.078 | 0.073 | 0.939 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Neuromyotonia | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Protein albumin ratio normal | 0 | 0.078 | 0.072 | 0.939 | 2.642 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary sarcoidosis | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Pneumocystis test negative | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Irregular sleep phase | 0 | 0.078 | 0.072 | 0.939 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Gastric cancer | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Tachycardia foetal | 0 | 0.078 | 0.074 | 0.939 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Progesterone | 0 | 0.078 | 0.072 | 0.939 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Cor pulmonale | 0 | 0.078 | 0.073 | 0.939 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Intra-aortic balloon placement | 0 | 0.078 | 0.072 | 0.939 | 2.641 |  |  |  |  |  | 
COVID19_MODERNA | Illiteracy | 0 | 0.078 | 0.072 | 0.939 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Vibrio test positive | 0 | 0.078 | 0.073 | 0.939 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Surgical procedure repeated | 0 | 0.078 | 0.073 | 0.939 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Right ventricular ejection fraction decreased | 0 | 0.078 | 0.072 | 0.939 | 2.642 |  |  |  |  |  | 
COVID19_MODERNA | Rhinovirus infection | 0 | 0.081 | 0.079 | 0.939 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Amblyopia | 0 | 0.127 | 0.164 | 0.939 | 2.239 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac imaging procedure | 0 | 0.078 | 0.072 | 0.939 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Erythroblast count increased | 0 | 0.078 | 0.072 | 0.939 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Fat tissue increased | 0 | 0.078 | 0.074 | 0.939 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Shortened cervix | 0 | 0.078 | 0.074 | 0.939 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Medical device pain | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Prescription drug used without a prescription | 0 | 0.078 | 0.074 | 0.939 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Blood sodium | 2 | 2.117 | 0.374 | 0.938 | 1.708 | 0.4 | 0.878 | 1.725 | 0.945 | 2.466 | 0.501
COVID19_MODERNA | Gastrointestinal nonspecific dysfunction (SMQ) [narrow] | 32 | 36.672 | 0.692 | 0.938 | 1.215 | 0.654 | 0.87 | 1.139 | 0.873 | 1.347 | 2.381
COVID19_MODERNA | Tooth repair | 0 | 0.078 | 0.071 | 0.938 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatological examination | 0 | 0.078 | 0.069 | 0.938 | 2.657 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary calcification | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Prostate examination | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Cardiolipin antibody positive | 0 | 0.043 | 0.012 | 0.938 | 3.277 |  |  |  |  |  | 
COVID19_MODERNA | Neovascular age-related macular degeneration | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Mastectomy | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Colon operation | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve infarction | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Product packaging issue | 0 | 0.094 | 0.1 | 0.938 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Grimacing | 0 | 0.182 | 0.237 | 0.938 | 2.017 |  |  |  |  |  | 
COVID19_MODERNA | Carotid artery thrombosis | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Retinal infarction | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Acute chest syndrome | 0 | 0.078 | 0.071 | 0.938 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Mediastinitis | 0 | 0.078 | 0.07 | 0.938 | 2.655 |  |  |  |  |  | 
COVID19_MODERNA | Post thrombotic syndrome | 0 | 0.078 | 0.07 | 0.938 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Breast cancer recurrent | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Breath sounds | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Eye infection viral | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Hypomania | 0 | 0.078 | 0.07 | 0.938 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid infection | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Haemarthrosis | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Corneal erosion | 0 | 0.078 | 0.07 | 0.938 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | B-lymphocyte abnormalities | 0 | 0.078 | 0.069 | 0.938 | 2.658 |  |  |  |  |  | 
COVID19_MODERNA | Purulence | 0 | 0.145 | 0.187 | 0.938 | 2.159 |  |  |  |  |  | 
COVID19_MODERNA | Excessive cerumen production | 0 | 0.124 | 0.153 | 0.938 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Intra-abdominal haemorrhage | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Malformation venous | 0 | 0.078 | 0.071 | 0.938 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram liver | 0 | 0.078 | 0.07 | 0.938 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia klebsiella | 0 | 0.078 | 0.071 | 0.938 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Vertebral column mass | 0 | 0.078 | 0.071 | 0.938 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Calcium ionised | 0 | 0.078 | 0.071 | 0.938 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Uterine contractions abnormal | 0 | 0.078 | 0.069 | 0.938 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Neurotransmitter level altered | 0 | 0.078 | 0.07 | 0.938 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Visual acuity reduced | 1 | 0.753 | 0.134 | 0.937 | 2.34 | 0.38 | 0.922 | 1.957 | 1.328 | 0.16 | 3.553
COVID19_MODERNA | Feeling jittery | 19 | 20.778 | 0.647 | 0.937 | 1.27 | 0.629 | 0.903 | 1.265 | 0.914 | 3.779 | 31.217
COVID19_MODERNA | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [broad] | 161 | 185.298 | 0.819 | 0.937 | 1.061 | 0.762 | 0.868 | 0.986 | 0.869 | 1.35 | 13.664
COVID19_MODERNA | Intensive care | 79 | 96.151 | 0.773 | 0.937 | 1.113 | 0.683 | 0.822 | 0.982 | 0.822 | 1.789 | 24.955
COVID19_MODERNA | Sensitive skin | 11 | 15.976 | 0.542 | 0.937 | 1.419 | 0.453 | 0.716 | 1.088 | 0.689 | 2.055 | 4.535
COVID19_MODERNA | Eyeglasses therapy | 0 | 0.078 | 0.067 | 0.937 | 2.667 |  |  |  |  |  | 
COVID19_MODERNA | Tarsal tunnel syndrome | 0 | 0.078 | 0.069 | 0.937 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Anaesthesia oral | 0 | 0.078 | 0.069 | 0.937 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Haematoma infection | 0 | 0.078 | 0.068 | 0.937 | 2.664 |  |  |  |  |  | 
COVID19_MODERNA | Urine amphetamine negative | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Breast induration | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Endometrial thickening | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Nodal rhythm | 0 | 0.078 | 0.068 | 0.937 | 2.663 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram coronary artery normal | 0 | 0.078 | 0.068 | 0.937 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Lipase decreased | 0 | 0.078 | 0.068 | 0.937 | 2.664 |  |  |  |  |  | 
COVID19_MODERNA | Morbid thoughts | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Hypoaesthesia teeth | 0 | 0.078 | 0.067 | 0.937 | 2.668 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal disorder | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Cystatin C increased | 0 | 0.078 | 0.069 | 0.937 | 2.659 |  |  |  |  |  | 
COVID19_MODERNA | Orbital myositis | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Penile oedema | 0 | 0.078 | 0.068 | 0.937 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Perineal pain | 0 | 0.078 | 0.067 | 0.937 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Intercepted product dispensing error | 0 | 0.078 | 0.068 | 0.937 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Disease prodromal stage | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Instillation site paraesthesia | 0 | 0.078 | 0.069 | 0.937 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Open reduction of fracture | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Invasive ductal breast carcinoma | 0 | 0.078 | 0.068 | 0.937 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Cell-mediated immune deficiency | 0 | 0.078 | 0.067 | 0.937 | 2.667 |  |  |  |  |  | 
COVID19_MODERNA | Deafness permanent | 0 | 0.078 | 0.067 | 0.937 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol interaction | 0 | 0.078 | 0.067 | 0.937 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin time abnormal | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil function test abnormal | 0 | 0.078 | 0.067 | 0.937 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Tinel's sign | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Creutzfeldt-Jakob disease | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord injury cervical | 0 | 0.078 | 0.067 | 0.937 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Normochromic normocytic anaemia | 0 | 0.043 | 0.011 | 0.937 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Sinonasal obstruction | 0 | 0.078 | 0.067 | 0.937 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Severe invasive streptococcal infection | 0 | 0.078 | 0.069 | 0.937 | 2.659 |  |  |  |  |  | 
COVID19_MODERNA | Smooth muscle antibody | 0 | 0.078 | 0.068 | 0.937 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal symptom | 0 | 0.078 | 0.069 | 0.937 | 2.659 |  |  |  |  |  | 
COVID19_MODERNA | Pseudomonal bacteraemia | 0 | 0.078 | 0.069 | 0.937 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Hearing disability | 0 | 0.078 | 0.067 | 0.937 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to synthetic fabric | 0 | 0.078 | 0.068 | 0.937 | 2.664 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopic ultrasound abnormal | 0 | 0.078 | 0.068 | 0.937 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy thyroid gland normal | 0 | 0.078 | 0.067 | 0.937 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Iodine uptake decreased | 0 | 0.078 | 0.067 | 0.937 | 2.671 |  |  |  |  |  | 
COVID19_MODERNA | Blood potassium abnormal | 0 | 0.078 | 0.068 | 0.937 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Tobacco abuse | 0 | 0.078 | 0.067 | 0.937 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to extreme temperature | 0 | 0.078 | 0.067 | 0.937 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Paraesthesia | 521 | 559.579 | 0.87 | 0.936 | 1.004 | 0.866 | 0.93 | 0.999 | 0.931 | 2.115 | 286.531
COVID19_MODERNA | Electrophoresis protein | 1 | 1.388 | 0.275 | 0.936 | 1.914 | 0.328 | 0.801 | 1.701 | 0.72 | 1.174 | 0.155
COVID19_MODERNA | Neutrophil count normal | 7 | 9.076 | 0.472 | 0.936 | 1.528 | 0.458 | 0.791 | 1.29 | 0.771 | 0.855 | 0.053
COVID19_MODERNA | Klebsiella infection | 0 | 0.078 | 0.066 | 0.936 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Blood sodium abnormal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Carbohydrate antigen 125 normal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Haemangioma of liver | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin normal | 0 | 0.078 | 0.065 | 0.936 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Parasitic test | 0 | 0.077 | 0.064 | 0.936 | 2.687 |  |  |  |  |  | 
COVID19_MODERNA | Injection site phlebitis | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy prostate | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Thermometry | 0 | 0.078 | 0.066 | 0.936 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Total cholesterol/HDL ratio normal | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Herpes simplex meningoencephalitis | 0 | 0.078 | 0.065 | 0.936 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid crystal | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | AST/ALT ratio | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis cryptococcal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Mammoplasty | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Spleen palpable | 0 | 0.078 | 0.064 | 0.936 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging breast abnormal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Blood lead normal | 0 | 0.078 | 0.066 | 0.936 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal deviation | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Antiribosomal P antibody | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Tender joint count | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Immunosuppressant drug level | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Foetal monitoring normal | 0 | 0.078 | 0.066 | 0.936 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Upper motor neurone lesion | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Urine electrophoresis abnormal | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Haematospermia | 0 | 0.078 | 0.066 | 0.936 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Genital labial adhesions | 0 | 0.078 | 0.066 | 0.936 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Non-high-density lipoprotein cholesterol increased | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Sleep disorder due to a general medical condition | 0 | 0.078 | 0.066 | 0.936 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Cholecystitis chronic | 0 | 0.078 | 0.066 | 0.936 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Priapism | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | CSF lactate dehydrogenase normal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | CSF electrophoresis normal | 0 | 0.078 | 0.065 | 0.936 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal obstruction | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Intermittent positive pressure breathing | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Fibromuscular dysplasia | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Chondrocalcinosis | 0 | 0.078 | 0.064 | 0.936 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Prealbumin increased | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Type II hypersensitivity | 0 | 0.078 | 0.065 | 0.936 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Swollen joint count | 0 | 0.078 | 0.065 | 0.936 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Crystalluria | 0 | 0.078 | 0.065 | 0.936 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Tenoplasty | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Systemic bacterial infection | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Cerebellar tumour | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Breast disorder female | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Synovial cyst removal | 0 | 0.078 | 0.066 | 0.936 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Gouty arthritis | 0 | 0.078 | 0.065 | 0.936 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Atrial septal defect repair | 0 | 0.078 | 0.066 | 0.936 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Noninfectious encephalopathy/delirium (SMQ) [broad] | 1491 | 1607.272 | 0.895 | 0.935 | 0.975 | 0.889 | 0.927 | 0.968 | 0.928 | 1.049 | 3.59
COVID19_MODERNA | Computerised tomogram head | 71 | 76.892 | 0.773 | 0.935 | 1.109 | 0.757 | 0.92 | 1.109 | 0.923 | 3.917 | 130.687
COVID19_MODERNA | Chest pain | 283 | 311.093 | 0.845 | 0.935 | 1.027 | 0.824 | 0.909 | 1.001 | 0.91 | 2.717 | 277.234
COVID19_MODERNA | Blood pressure fluctuation | 9 | 10.151 | 0.572 | 0.935 | 1.372 | 0.533 | 0.874 | 1.37 | 0.887 | 2.92 | 8.456
COVID19_MODERNA | Familial mediterranean fever | 0 | 0.078 | 0.062 | 0.935 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Sinus node dysfunction | 0 | 0.078 | 0.064 | 0.935 | 2.685 |  |  |  |  |  | 
COVID19_MODERNA | Polymorphic light eruption | 0 | 0.078 | 0.064 | 0.935 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Pyruvate kinase | 0 | 0.078 | 0.063 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Oromandibular dystonia | 0 | 0.078 | 0.064 | 0.935 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Adenocarcinoma of colon | 0 | 0.078 | 0.062 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Lymphangiopathy | 0 | 0.078 | 0.062 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Internal fixation of fracture | 0 | 0.078 | 0.064 | 0.935 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Anti-insulin antibody decreased | 0 | 0.078 | 0.063 | 0.935 | 2.689 |  |  |  |  |  | 
COVID19_MODERNA | Haemophilia | 0 | 0.078 | 0.062 | 0.935 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Dental care | 0 | 0.078 | 0.062 | 0.935 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Spinal decompression | 0 | 0.078 | 0.062 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Adenoidal hypertrophy | 0 | 0.083 | 0.071 | 0.935 | 2.636 |  |  |  |  |  | 
COVID19_MODERNA | Genital hypoaesthesia | 0 | 0.078 | 0.062 | 0.935 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Platelet distribution width decreased | 0 | 0.078 | 0.062 | 0.935 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Red man syndrome | 0 | 0.078 | 0.062 | 0.935 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Gingival ulceration | 0 | 0.078 | 0.062 | 0.935 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Myelofibrosis | 0 | 0.078 | 0.062 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Blood homocysteine increased | 0 | 0.078 | 0.063 | 0.935 | 2.69 |  |  |  |  |  | 
COVID19_MODERNA | Solar lentigo | 0 | 0.078 | 0.063 | 0.935 | 2.691 |  |  |  |  |  | 
COVID19_MODERNA | Karyotype analysis | 0 | 0.078 | 0.063 | 0.935 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy rectum abnormal | 0 | 0.078 | 0.062 | 0.935 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Product physical consistency issue | 0 | 0.078 | 0.063 | 0.935 | 2.691 |  |  |  |  |  | 
COVID19_MODERNA | Listeriosis | 0 | 0.078 | 0.064 | 0.935 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Thumb sucking | 0 | 0.078 | 0.062 | 0.935 | 2.695 |  |  |  |  |  | 
COVID19_MODERNA | Sexually transmitted disease test | 0 | 0.078 | 0.062 | 0.935 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound uterus normal | 0 | 0.078 | 0.063 | 0.935 | 2.691 |  |  |  |  |  | 
COVID19_MODERNA | Serratia infection | 0 | 0.117 | 0.132 | 0.935 | 2.343 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin E | 0 | 0.078 | 0.062 | 0.935 | 2.695 |  |  |  |  |  | 
COVID19_MODERNA | Posterior capsule opacification | 0 | 0.078 | 0.062 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Post polio syndrome | 0 | 0.078 | 0.063 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Volvulus of small bowel | 0 | 0.078 | 0.063 | 0.935 | 2.691 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor XIII level decreased | 0 | 0.078 | 0.064 | 0.935 | 2.685 |  |  |  |  |  | 
COVID19_MODERNA | Postmenopause | 0 | 0.078 | 0.062 | 0.935 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Gastritis haemorrhagic | 0 | 0.078 | 0.062 | 0.935 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time ratio normal | 0 | 0.078 | 0.064 | 0.935 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Anticoagulation drug level | 0 | 0.078 | 0.062 | 0.935 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Porokeratosis | 0 | 0.078 | 0.063 | 0.935 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Vision blurred | 90 | 102.625 | 0.781 | 0.934 | 1.098 | 0.736 | 0.876 | 1.035 | 0.877 | 1.468 | 12.271
COVID19_MODERNA | Embolic and thrombotic events (SMQ) [narrow] | 355 | 405.486 | 0.854 | 0.934 | 1.017 | 0.802 | 0.875 | 0.954 | 0.875 | 3.137 | 460.696
COVID19_MODERNA | Embolic and thrombotic events (SMQ) [broad] | 355 | 405.486 | 0.854 | 0.934 | 1.017 | 0.802 | 0.875 | 0.954 | 0.875 | 3.137 | 460.696
COVID19_MODERNA | Blood cholesterol increased | 4 | 4.732 | 0.409 | 0.934 | 1.634 | 0.437 | 0.843 | 1.502 | 0.845 | 1.541 | 0.284
COVID19_MODERNA | Toxic-septic shock conditions (SMQ) [narrow] | 13 | 16.516 | 0.571 | 0.934 | 1.369 | 0.52 | 0.796 | 1.179 | 0.787 | 0.664 | 1.832
COVID19_MODERNA | Surgery | 9 | 11.743 | 0.519 | 0.934 | 1.447 | 0.477 | 0.784 | 1.228 | 0.766 | 0.737 | 0.574
COVID19_MODERNA | Influenza like illness | 119 | 162.465 | 0.798 | 0.934 | 1.078 | 0.632 | 0.735 | 0.851 | 0.732 | 0.513 | 54.469
COVID19_MODERNA | Continuous positive airway pressure | 1 | 2.022 | 0.186 | 0.934 | 2.151 | 0.288 | 0.707 | 1.507 | 0.495 | 0.385 | 0.438
COVID19_MODERNA | Optic neuritis | 3 | 6.737 | 0.313 | 0.934 | 1.824 | 0.283 | 0.581 | 1.083 | 0.445 | 0.32 | 3.605
COVID19_MODERNA | Nail infection | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Citrobacter test positive | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QRS complex | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Prinzmetal angina | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | CSF cell count decreased | 0 | 0.078 | 0.06 | 0.934 | 2.708 |  |  |  |  |  | 
COVID19_MODERNA | Eustachian tube operation | 0 | 0.078 | 0.061 | 0.934 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Beta globulin normal | 0 | 0.078 | 0.06 | 0.934 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Costochondritis | 0 | 0.104 | 0.107 | 0.934 | 2.443 |  |  |  |  |  | 
COVID19_MODERNA | Anti-transglutaminase antibody increased | 0 | 0.078 | 0.06 | 0.934 | 2.703 |  |  |  |  |  | 
COVID19_MODERNA | Epidural analgesia | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland neoplasm | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Mucocutaneous candidiasis | 0 | 0.078 | 0.06 | 0.934 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Blood methaemoglobin absent | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Mallory-Weiss syndrome | 0 | 0.078 | 0.061 | 0.934 | 2.699 |  |  |  |  |  | 
COVID19_MODERNA | Sweat test | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Blood cholinesterase | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal polyp | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Arteritis | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | pH urine increased | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Basophil degranulation test | 0 | 0.078 | 0.061 | 0.934 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy thyroid gland | 0 | 0.078 | 0.061 | 0.934 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | Procalcitonin abnormal | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Nephritic syndrome | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Merycism | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Genital infection fungal | 0 | 0.078 | 0.061 | 0.934 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Ligamentitis | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Urine mercury | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival pallor | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Infected skin ulcer | 0 | 0.078 | 0.061 | 0.934 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time abnormal | 0 | 0.078 | 0.061 | 0.934 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | Intraocular pressure test abnormal | 0 | 0.078 | 0.061 | 0.934 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | Corneal thinning | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Instillation site erythema | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Renal infarct | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Familial tremor | 0 | 0.078 | 0.06 | 0.934 | 2.704 |  |  |  |  |  | 
COVID19_MODERNA | Product impurity | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Body mass index decreased | 0 | 0.078 | 0.059 | 0.934 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Malaria antibody test | 0 | 0.078 | 0.06 | 0.934 | 2.708 |  |  |  |  |  | 
COVID19_MODERNA | Corneal disorder | 0 | 0.078 | 0.061 | 0.934 | 2.703 |  |  |  |  |  | 
COVID19_MODERNA | Kaposi's sarcoma | 0 | 0.078 | 0.06 | 0.934 | 2.704 |  |  |  |  |  | 
COVID19_MODERNA | Carbon dioxide abnormal | 0 | 0.078 | 0.06 | 0.934 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Cogan's syndrome | 0 | 0.078 | 0.06 | 0.934 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Solar dermatitis | 0 | 0.078 | 0.06 | 0.934 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Chondrocalcinosis pyrophosphate | 0 | 0.078 | 0.06 | 0.934 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Synovial cyst | 0 | 0.206 | 0.247 | 0.934 | 1.978 |  |  |  |  |  | 
COVID19_MODERNA | Heart injury | 1 | 1.022 | 0.171 | 0.933 | 2.193 | 0.356 | 0.867 | 1.838 | 0.979 | 2.466 | 0.012
COVID19_MODERNA | Tunnel vision | 13 | 14.881 | 0.588 | 0.933 | 1.343 | 0.566 | 0.867 | 1.283 | 0.874 | 4.007 | 22.625
COVID19_MODERNA | Pulseless electrical activity | 11 | 14.939 | 0.552 | 0.933 | 1.394 | 0.479 | 0.756 | 1.149 | 0.736 | 10.851 | 61.387
COVID19_MODERNA | Protein urine present | 4 | 6.704 | 0.415 | 0.933 | 1.618 | 0.352 | 0.681 | 1.215 | 0.597 | 0.736 | 0.149
COVID19_MODERNA | Ischaemic colitis (SMQ) [narrow] | 2 | 4.358 | 0.254 | 0.933 | 1.959 | 0.284 | 0.628 | 1.238 | 0.459 | 0.771 | 0.002
COVID19_MODERNA | Pancreatic neoplasm | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Photopheresis | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac resynchronisation therapy | 0 | 0.078 | 0.059 | 0.933 | 2.711 |  |  |  |  |  | 
COVID19_MODERNA | Parietal cell antibody negative | 0 | 0.078 | 0.058 | 0.933 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Otoacoustic emissions test abnormal | 0 | 0.078 | 0.057 | 0.933 | 2.722 |  |  |  |  |  | 
COVID19_MODERNA | Urine copper increased | 0 | 0.078 | 0.059 | 0.933 | 2.71 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal oedema | 0 | 0.078 | 0.059 | 0.933 | 2.71 |  |  |  |  |  | 
COVID19_MODERNA | Pedal pulse decreased | 0 | 0.078 | 0.058 | 0.933 | 2.719 |  |  |  |  |  | 
COVID19_MODERNA | Drug monitoring procedure not performed | 0 | 0.078 | 0.059 | 0.933 | 2.713 |  |  |  |  |  | 
COVID19_MODERNA | Lasegue's test positive | 0 | 0.078 | 0.059 | 0.933 | 2.713 |  |  |  |  |  | 
COVID19_MODERNA | Otosalpingitis | 0 | 0.078 | 0.059 | 0.933 | 2.71 |  |  |  |  |  | 
COVID19_MODERNA | Micrographic skin surgery | 0 | 0.078 | 0.059 | 0.933 | 2.711 |  |  |  |  |  | 
COVID19_MODERNA | Hyposplenism | 0 | 0.078 | 0.057 | 0.933 | 2.721 |  |  |  |  |  | 
COVID19_MODERNA | Urine output | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Heat illness | 0 | 0.078 | 0.058 | 0.933 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Hippocampal sclerosis | 0 | 0.078 | 0.057 | 0.933 | 2.721 |  |  |  |  |  | 
COVID19_MODERNA | Gingival injury | 0 | 0.078 | 0.059 | 0.933 | 2.71 |  |  |  |  |  | 
COVID19_MODERNA | Antimitochondrial antibody | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Traumatic haematoma | 0 | 0.078 | 0.059 | 0.933 | 2.711 |  |  |  |  |  | 
COVID19_MODERNA | Blood chromium | 0 | 0.078 | 0.057 | 0.933 | 2.721 |  |  |  |  |  | 
COVID19_MODERNA | Head banging | 0 | 0.225 | 0.263 | 0.933 | 1.935 |  |  |  |  |  | 
COVID19_MODERNA | Complement fixation test positive | 0 | 0.078 | 0.059 | 0.933 | 2.711 |  |  |  |  |  | 
COVID19_MODERNA | Acid base balance abnormal | 0 | 0.078 | 0.058 | 0.933 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Tympanometry normal | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital haemorrhage | 0 | 0.078 | 0.058 | 0.933 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Bladder dysfunction | 0 | 0.115 | 0.121 | 0.933 | 2.381 |  |  |  |  |  | 
COVID19_MODERNA | Leukaemia in remission | 0 | 0.078 | 0.058 | 0.933 | 2.717 |  |  |  |  |  | 
COVID19_MODERNA | Athetosis | 0 | 0.078 | 0.058 | 0.933 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | Somnolence | 86 | 93.611 | 0.776 | 0.932 | 1.101 | 0.767 | 0.916 | 1.087 | 0.919 | 0.757 | 6.326
COVID19_MODERNA | Audiogram | 3 | 4.092 | 0.449 | 0.932 | 1.556 | 0.383 | 0.782 | 1.456 | 0.733 | 2.74 | 1.577
COVID19_MODERNA | Periventricular leukomalacia | 0 | 0.078 | 0.055 | 0.932 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell sedimentation rate decreased | 0 | 0.078 | 0.057 | 0.932 | 2.723 |  |  |  |  |  | 
COVID19_MODERNA | Bursa removal | 0 | 0.078 | 0.057 | 0.932 | 2.723 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell analysis normal | 0 | 0.078 | 0.056 | 0.932 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis shigella | 0 | 0.078 | 0.055 | 0.932 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis lethargica | 0 | 0.078 | 0.055 | 0.932 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Platelet aggregation test | 0 | 0.078 | 0.055 | 0.932 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Aortic valve replacement | 0 | 0.078 | 0.055 | 0.932 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VIII level normal | 0 | 0.078 | 0.055 | 0.932 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Urine iodine increased | 0 | 0.078 | 0.055 | 0.932 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Glioblastoma | 0 | 0.078 | 0.057 | 0.932 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular function test normal | 0 | 0.078 | 0.055 | 0.932 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin electrophoresis normal | 0 | 0.078 | 0.056 | 0.932 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Hoffmann's sign | 0 | 0.078 | 0.056 | 0.932 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Fluorescent in situ hybridisation positive | 0 | 0.078 | 0.056 | 0.932 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Sciatic nerve neuropathy | 0 | 0.078 | 0.056 | 0.932 | 2.725 |  |  |  |  |  | 
COVID19_MODERNA | Administration site haematoma | 0 | 0.078 | 0.057 | 0.932 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Acetonaemia | 0 | 0.078 | 0.056 | 0.932 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Coronary angioplasty | 0 | 0.078 | 0.056 | 0.932 | 2.726 |  |  |  |  |  | 
COVID19_MODERNA | Diffuse alveolar damage | 0 | 0.078 | 0.055 | 0.932 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Pericardial rub | 0 | 0.078 | 0.056 | 0.932 | 2.727 |  |  |  |  |  | 
COVID19_MODERNA | Injection site calcification | 0 | 0.078 | 0.056 | 0.932 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound pancreas normal | 0 | 0.078 | 0.055 | 0.932 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Carcinoembryonic antigen increased | 0 | 0.078 | 0.057 | 0.932 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site cyst | 0 | 0.078 | 0.056 | 0.932 | 2.727 |  |  |  |  |  | 
COVID19_MODERNA | Blood luteinising hormone | 0 | 0.078 | 0.056 | 0.932 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Pneumothorax spontaneous | 0 | 0.078 | 0.056 | 0.932 | 2.728 |  |  |  |  |  | 
COVID19_MODERNA | Echoencephalogram normal | 0 | 0.078 | 0.055 | 0.932 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Lipoatrophy | 0 | 0.078 | 0.056 | 0.932 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Wrist deformity | 0 | 0.078 | 0.055 | 0.932 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia legionella | 0 | 0.078 | 0.057 | 0.932 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Cancer surgery | 0 | 0.087 | 0.071 | 0.932 | 2.628 |  |  |  |  |  | 
COVID19_MODERNA | Chronic pigmented purpura | 0 | 0.078 | 0.056 | 0.932 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Head circumference normal | 0 | 0.078 | 0.056 | 0.932 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell analysis | 0 | 0.078 | 0.055 | 0.932 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Body height | 1 | 7.756 | 0.092 | 0.931 | 2.508 | 0.083 | 0.308 | 0.737 | 0.129 | 1.761 | 0.013
COVID19_MODERNA | Central nervous system injury | 0 | 0.078 | 0.054 | 0.931 | 2.741 |  |  |  |  |  | 
COVID19_MODERNA | Ureteritis | 0 | 0.078 | 0.053 | 0.931 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Protein C decreased | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Hair metal test normal | 0 | 0.078 | 0.055 | 0.931 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Mitochondrial encephalomyopathy | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Device use issue | 0 | 0.078 | 0.053 | 0.931 | 2.743 |  |  |  |  |  | 
COVID19_MODERNA | Chorioretinal atrophy | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Ketogenic diet | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Splinter haemorrhages | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Invasive lobular breast carcinoma | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Accessory spleen | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Nocardiosis | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Urine lactic acid increased | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Splenosis | 0 | 0.078 | 0.055 | 0.931 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Circulating anticoagulant | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Penile swelling | 0 | 0.159 | 0.179 | 0.931 | 2.163 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac hypertrophy | 0 | 0.078 | 0.054 | 0.931 | 2.742 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal transit time decreased | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Antigliadin antibody positive | 0 | 0.078 | 0.053 | 0.931 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Deficiency anaemia | 0 | 0.078 | 0.054 | 0.931 | 2.742 |  |  |  |  |  | 
COVID19_MODERNA | Tongue geographic | 0 | 0.078 | 0.055 | 0.931 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Total bile acids increased | 0 | 0.078 | 0.055 | 0.931 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract infection pseudomonal | 0 | 0.078 | 0.055 | 0.931 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Mannose-binding lectin deficiency | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic disorders specifically reported as alcohol-related (SMQ) [narrow] | 0 | 0.078 | 0.053 | 0.931 | 2.743 |  |  |  |  |  | 
COVID19_MODERNA | Scleroedema | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Sputum retention | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Toe amputation | 0 | 0.078 | 0.054 | 0.931 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte percentage | 0 | 0.078 | 0.054 | 0.931 | 2.742 |  |  |  |  |  | 
COVID19_MODERNA | Lactate pyruvate ratio | 0 | 0.078 | 0.055 | 0.931 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Vertebrobasilar insufficiency | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Somnolence neonatal | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via mucosa | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular ataxia | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Human ehrlichiosis | 0 | 0.078 | 0.053 | 0.931 | 2.743 |  |  |  |  |  | 
COVID19_MODERNA | Encephalopathy allergic | 0 | 0.078 | 0.053 | 0.931 | 2.746 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation time shortened | 0 | 0.078 | 0.053 | 0.931 | 2.743 |  |  |  |  |  | 
COVID19_MODERNA | Skeletal survey | 0 | 0.078 | 0.053 | 0.931 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Heterophoria | 0 | 0.078 | 0.055 | 0.931 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Meige's syndrome | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Periodontitis | 0 | 0.078 | 0.054 | 0.931 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal respiratory distress | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Coarctation of the aorta | 0 | 0.078 | 0.053 | 0.931 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Granuloma annulare | 0 | 0.132 | 0.141 | 0.931 | 2.293 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary valve stenosis | 0 | 0.078 | 0.054 | 0.931 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Developmental coordination disorder | 0 | 0.078 | 0.054 | 0.931 | 2.742 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal abscess | 0 | 0.078 | 0.054 | 0.931 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobin blood decreased | 0 | 0.078 | 0.053 | 0.931 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic disorders specifically reported as alcohol-related (SMQ) [broad] | 0 | 0.078 | 0.053 | 0.931 | 2.743 |  |  |  |  |  | 
COVID19_MODERNA | Food allergy | 3 | 3.64 | 0.365 | 0.93 | 1.705 | 0.408 | 0.831 | 1.547 | 0.824 | 0.253 | 5.792
COVID19_MODERNA | Eyelid oedema | 1 | 1.61 | 0.468 | 0.93 | 1.519 | 0.313 | 0.766 | 1.627 | 0.621 | 0.066 | 12.218
COVID19_MODERNA | Congenital syphilis | 0 | 0.078 | 0.052 | 0.93 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Astrocytoma | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial fistula | 0 | 0.078 | 0.053 | 0.93 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrovascular stenosis | 0 | 0.078 | 0.052 | 0.93 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | ACTH stimulation test normal | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Breast cancer in situ | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol test | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Cytokine abnormal | 0 | 0.078 | 0.051 | 0.93 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Intercostal neuralgia | 0 | 0.078 | 0.053 | 0.93 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Spherocytic anaemia | 0 | 0.078 | 0.053 | 0.93 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure orthostatic normal | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Agoraphobia | 0 | 0.078 | 0.052 | 0.93 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Acute graft versus host disease | 0 | 0.078 | 0.053 | 0.93 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Ejaculation failure | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Specific gravity urine abnormal | 0 | 0.078 | 0.052 | 0.93 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy prostate abnormal | 0 | 0.078 | 0.051 | 0.93 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Polyomavirus test negative | 0 | 0.078 | 0.052 | 0.93 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Hyperresponsive to stimuli | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Xanthelasma | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Rehabilitation therapy | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor | 0 | 0.078 | 0.052 | 0.93 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid hormone replacement therapy | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Bartonellosis | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine decreased | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Suicidal behaviour | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Lipoma excision | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Prenatal care | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Obstruction gastric | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Wound infection staphylococcal | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid operation | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Apheresis | 0 | 0.078 | 0.053 | 0.93 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Tubulointerstitial nephritis and uveitis syndrome | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 microglobulin normal | 0 | 0.078 | 0.052 | 0.93 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian germ cell teratoma | 0 | 0.078 | 0.053 | 0.93 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Hypophonesis | 0 | 0.078 | 0.053 | 0.93 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Adenosine deaminase | 0 | 0.078 | 0.051 | 0.93 | 2.758 |  |  |  |  |  | 
COVID19_MODERNA | Enamel anomaly | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Blood HIV RNA decreased | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Reactive airways dysfunction syndrome | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Blood selenium | 0 | 0.078 | 0.052 | 0.93 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell poikilocytes present | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Somatotropin stimulation test | 0 | 0.078 | 0.052 | 0.93 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | Benzodiazepine drug level | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Human herpes virus 6 serology positive | 0 | 0.078 | 0.053 | 0.93 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Oestrogen deficiency | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Blood electrolytes increased | 0 | 0.078 | 0.051 | 0.93 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram coronary artery abnormal | 0 | 0.078 | 0.053 | 0.93 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia pseudomonal | 0 | 0.078 | 0.051 | 0.93 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Otoscopy | 0 | 0.078 | 0.051 | 0.93 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | ADAMTS13 activity increased | 0 | 0.078 | 0.052 | 0.93 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Lymph node tuberculosis | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma stage I | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Blood cadmium increased | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Ileocolostomy | 0 | 0.078 | 0.052 | 0.93 | 2.755 |  |  |  |  |  | 
COVID19_MODERNA | Tolosa-Hunt syndrome | 0 | 0.078 | 0.052 | 0.93 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte stimulation test negative | 0 | 0.078 | 0.052 | 0.93 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder hypofunction | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Crystal arthropathy | 0 | 0.078 | 0.051 | 0.93 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | Liver tenderness | 0 | 0.078 | 0.053 | 0.93 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Lymphangioma | 0 | 0.078 | 0.052 | 0.93 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Extremity necrosis | 0 | 0.078 | 0.052 | 0.93 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve transposition | 0 | 0.078 | 0.052 | 0.93 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Irritability | 12 | 12.808 | 0.581 | 0.929 | 1.343 | 0.589 | 0.915 | 1.372 | 0.937 | 0.108 | 88.133
COVID19_MODERNA | Influenza A virus test negative | 14 | 15.446 | 0.574 | 0.929 | 1.353 | 0.591 | 0.894 | 1.308 | 0.906 | 1.514 | 1.828
COVID19_MODERNA | Joint swelling | 38 | 42.687 | 0.711 | 0.929 | 1.17 | 0.681 | 0.886 | 1.137 | 0.89 | 0.931 | 0.127
COVID19_MODERNA | Mental disorder | 3 | 3.821 | 0.322 | 0.929 | 1.791 | 0.398 | 0.811 | 1.509 | 0.785 | 0.465 | 1.305
COVID19_MODERNA | Optic nerve hypoplasia | 0 | 0.078 | 0.051 | 0.929 | 2.758 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal enanthema | 0 | 0.078 | 0.051 | 0.929 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy oesophagus abnormal | 0 | 0.078 | 0.049 | 0.929 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Blood group B | 0 | 0.078 | 0.05 | 0.929 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Lennox-Gastaut syndrome | 0 | 0.078 | 0.051 | 0.929 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy blood vessel abnormal | 0 | 0.078 | 0.049 | 0.929 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem ischaemia | 0 | 0.078 | 0.049 | 0.929 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Angiomyolipoma | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Erosive oesophagitis | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin C | 0 | 0.078 | 0.049 | 0.929 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Subclavian vein thrombosis | 0 | 0.078 | 0.05 | 0.929 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Non-alcoholic steatohepatitis | 0 | 0.117 | 0.113 | 0.929 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Disease risk factor | 0 | 0.078 | 0.05 | 0.929 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Vesicoureteral reflux surgery | 0 | 0.078 | 0.05 | 0.929 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Coombs test | 0 | 0.078 | 0.05 | 0.929 | 2.764 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal cyst | 0 | 0.078 | 0.05 | 0.929 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Claudication of jaw muscles | 0 | 0.078 | 0.05 | 0.929 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Anterior interosseous syndrome | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Avulsion fracture | 0 | 0.078 | 0.05 | 0.929 | 2.764 |  |  |  |  |  | 
COVID19_MODERNA | Submaxillary gland enlargement | 0 | 0.117 | 0.113 | 0.929 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | Anticonvulsant drug level increased | 0 | 0.078 | 0.05 | 0.929 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | PCO2 | 0 | 0.127 | 0.128 | 0.929 | 2.339 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginitis | 0 | 0.078 | 0.051 | 0.929 | 2.758 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bone | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Splenic cyst | 0 | 0.078 | 0.051 | 0.929 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Failed induction of labour | 0 | 0.078 | 0.05 | 0.929 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Eye infection staphylococcal | 0 | 0.078 | 0.049 | 0.929 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis membranoproliferative | 0 | 0.078 | 0.049 | 0.929 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Ocular myasthenia | 0 | 0.078 | 0.051 | 0.929 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Renal aplasia | 0 | 0.078 | 0.05 | 0.929 | 2.766 |  |  |  |  |  | 
COVID19_MODERNA | Pneumoconiosis | 0 | 0.078 | 0.05 | 0.929 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Anti-glomerular basement membrane antibody positive | 0 | 0.078 | 0.049 | 0.929 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Limb amputation | 0 | 0.078 | 0.049 | 0.929 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Ehrlichia test positive | 0 | 0.078 | 0.049 | 0.929 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Histiocytic necrotising lymphadenitis | 0 | 0.078 | 0.049 | 0.929 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Administration site necrosis | 0 | 0.078 | 0.051 | 0.929 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral arteritis | 0 | 0.078 | 0.05 | 0.929 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Sinusitis bacterial | 0 | 0.078 | 0.049 | 0.929 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Burning sensation mucosal | 0 | 0.078 | 0.05 | 0.929 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Bone loss | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Penile discharge | 0 | 0.078 | 0.05 | 0.929 | 2.764 |  |  |  |  |  | 
COVID19_MODERNA | Epidural injection | 0 | 0.078 | 0.05 | 0.929 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Prealbumin decreased | 0 | 0.078 | 0.051 | 0.929 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Body height below normal | 0 | 0.078 | 0.05 | 0.929 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Transient hypogammaglobulinaemia of infancy | 0 | 0.078 | 0.05 | 0.929 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Chemotherapy | 2 | 2.421 | 0.295 | 0.928 | 1.848 | 0.38 | 0.833 | 1.637 | 0.826 | 0.368 | 1.54
COVID19_MODERNA | Biopsy kidney normal | 0 | 0.078 | 0.048 | 0.928 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Ear irrigation | 0 | 0.078 | 0.049 | 0.928 | 2.772 |  |  |  |  |  | 
COVID19_MODERNA | Human anti-human antibody test | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Koebner phenomenon | 0 | 0.078 | 0.049 | 0.928 | 2.772 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal leukoplakia | 0 | 0.078 | 0.048 | 0.928 | 2.774 |  |  |  |  |  | 
COVID19_MODERNA | Olfactory nerve disorder | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Gilbert's syndrome | 0 | 0.078 | 0.048 | 0.928 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | False negative investigation result | 0 | 0.078 | 0.047 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Herpes virus test abnormal | 0 | 0.078 | 0.047 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Retinal migraine | 0 | 0.117 | 0.111 | 0.928 | 2.411 |  |  |  |  |  | 
COVID19_MODERNA | Tinea infection | 0 | 0.13 | 0.127 | 0.928 | 2.337 |  |  |  |  |  | 
COVID19_MODERNA | Corneal deposits | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | External ear cellulitis | 0 | 0.078 | 0.048 | 0.928 | 2.776 |  |  |  |  |  | 
COVID19_MODERNA | Neuroleptic malignant syndrome (SMQ) [narrow] | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Rapid eye movement sleep behaviour disorder | 0 | 0.078 | 0.048 | 0.928 | 2.777 |  |  |  |  |  | 
COVID19_MODERNA | Dependence | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Muscle operation | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system function test normal | 0 | 0.078 | 0.048 | 0.928 | 2.775 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance elastography | 0 | 0.078 | 0.048 | 0.928 | 2.776 |  |  |  |  |  | 
COVID19_MODERNA | Acne conglobata | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Monomelic amyotrophy | 0 | 0.078 | 0.048 | 0.928 | 2.774 |  |  |  |  |  | 
COVID19_MODERNA | Chorioretinal disorder | 0 | 0.078 | 0.049 | 0.928 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Urticaria pigmentosa | 0 | 0.078 | 0.048 | 0.928 | 2.777 |  |  |  |  |  | 
COVID19_MODERNA | Trisomy 13 | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Serotonin syndrome | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Renal tubular disorder | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Lumbosacral plexopathy | 0 | 0.078 | 0.048 | 0.928 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Vital dye staining cornea present | 0 | 0.078 | 0.047 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | HIV antibody positive | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocytic hypophysitis | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Hypertensive heart disease | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal carcinoma | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Cholinergic syndrome | 0 | 0.078 | 0.048 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine renal clearance | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Skin dystrophy | 0 | 0.078 | 0.048 | 0.928 | 2.776 |  |  |  |  |  | 
COVID19_MODERNA | Blood methaemoglobin present | 0 | 0.117 | 0.11 | 0.928 | 2.414 |  |  |  |  |  | 
COVID19_MODERNA | Cytomegalovirus chorioretinitis | 0 | 0.078 | 0.048 | 0.928 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Kidney fibrosis | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Keratouveitis | 0 | 0.078 | 0.047 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Environmental exposure | 0 | 0.078 | 0.048 | 0.928 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Blood acid phosphatase normal | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Keratoplasty | 0 | 0.078 | 0.047 | 0.928 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Heparin-induced thrombocytopenia | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Encapsulation reaction | 0 | 0.078 | 0.048 | 0.928 | 2.776 |  |  |  |  |  | 
COVID19_MODERNA | Colectomy total | 0 | 0.078 | 0.048 | 0.928 | 2.776 |  |  |  |  |  | 
COVID19_MODERNA | Bone graft | 0 | 0.078 | 0.048 | 0.928 | 2.775 |  |  |  |  |  | 
COVID19_MODERNA | Trisomy 18 | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Arteriovenous malformation | 0 | 0.117 | 0.109 | 0.928 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Flat affect | 0 | 0.173 | 0.189 | 0.928 | 2.125 |  |  |  |  |  | 
COVID19_MODERNA | Haemostasis | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Congenital pyelocaliectasis | 0 | 0.078 | 0.049 | 0.928 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Steatorrhoea | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal inflammation | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Blood aldosterone increased | 0 | 0.078 | 0.048 | 0.928 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Massage | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | HIV antigen positive | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Burn oral cavity | 0 | 0.078 | 0.049 | 0.928 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Congenital hand malformation | 0 | 0.078 | 0.047 | 0.928 | 2.781 |  |  |  |  |  | 
COVID19_MODERNA | Investigation normal | 0 | 0.045 | 0.008 | 0.928 | 3.377 |  |  |  |  |  | 
COVID19_MODERNA | Clumsiness | 2 | 1.734 | 0.288 | 0.927 | 1.86 | 0.43 | 0.941 | 1.85 | 1.153 | 0.809 | 0.001
COVID19_MODERNA | Oxygen therapy | 12 | 11.416 | 0.56 | 0.927 | 1.369 | 0.643 | 1 | 1.499 | 1.051 | 5.102 | 29.358
COVID19_MODERNA | Incisional drainage | 1 | 1.016 | 0.288 | 0.927 | 1.86 | 0.357 | 0.868 | 1.841 | 0.985 | 0.254 | 1.466
COVID19_MODERNA | Gingival bleeding | 5 | 5.202 | 0.456 | 0.927 | 1.532 | 0.494 | 0.911 | 1.569 | 0.961 | 1.787 | 0.943
COVID19_MODERNA | Gram stain positive | 1 | 1.131 | 0.274 | 0.927 | 1.892 | 0.348 | 0.846 | 1.795 | 0.884 | 0.986 | 0.243
COVID19_MODERNA | Rash | 660 | 722.121 | 0.869 | 0.927 | 0.987 | 0.857 | 0.914 | 0.973 | 0.914 | 0.853 | 17.127
COVID19_MODERNA | Ultrasound Doppler normal | 6 | 7.284 | 0.482 | 0.927 | 1.49 | 0.466 | 0.829 | 1.386 | 0.824 | 1.897 | 1.576
COVID19_MODERNA | CSF protein normal | 2 | 2.624 | 0.264 | 0.927 | 1.916 | 0.367 | 0.806 | 1.584 | 0.762 | 0.388 | 1.322
COVID19_MODERNA | Constipation | 13 | 18.389 | 0.565 | 0.927 | 1.362 | 0.475 | 0.729 | 1.079 | 0.707 | 0.445 | 8.285
COVID19_MODERNA | Vein collapse | 0 | 0.078 | 0.047 | 0.927 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Eye colour change | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Eccentric fixation | 0 | 0.078 | 0.047 | 0.927 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Alphavirus test | 0 | 0.078 | 0.047 | 0.927 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy mucosa abnormal | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac dysfunction | 0 | 0.078 | 0.047 | 0.927 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Electroconvulsive therapy | 0 | 0.078 | 0.046 | 0.927 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Tongue exfoliation | 0 | 0.078 | 0.046 | 0.927 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Anti-islet cell antibody negative | 0 | 0.078 | 0.046 | 0.927 | 2.787 |  |  |  |  |  | 
COVID19_MODERNA | Parvovirus B19 infection | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Divorced | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin decreased | 0 | 0.078 | 0.047 | 0.927 | 2.784 |  |  |  |  |  | 
COVID19_MODERNA | Sensitisation | 0 | 0.078 | 0.046 | 0.927 | 2.788 |  |  |  |  |  | 
COVID19_MODERNA | Allergic bronchitis | 0 | 0.078 | 0.047 | 0.927 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract obstruction | 0 | 0.078 | 0.047 | 0.927 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Premenstrual headache | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Molluscum contagiosum | 0 | 0.122 | 0.115 | 0.927 | 2.389 |  |  |  |  |  | 
COVID19_MODERNA | Disinhibition | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Dacryostenosis acquired | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Vocal cord paresis | 0 | 0.078 | 0.047 | 0.927 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal dilation procedure | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Cord blood transplant therapy | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Complication of delivery | 0 | 0.078 | 0.046 | 0.927 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | Bloch-Sulzberger syndrome | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Viral diarrhoea | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Non-high-density lipoprotein cholesterol | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Hemianopia homonymous | 0 | 0.078 | 0.046 | 0.927 | 2.788 |  |  |  |  |  | 
COVID19_MODERNA | Blast cell count increased | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Neurodevelopment test | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia respiratory syncytial viral | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Viral tonsillitis | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Congenital hydrocephalus | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bone abnormal | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Gastric fluid analysis abnormal | 0 | 0.078 | 0.046 | 0.927 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | Reversible airways obstruction | 0 | 0.078 | 0.047 | 0.927 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Rhesus antibodies negative | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Hand-foot-and-mouth disease | 0 | 0.123 | 0.115 | 0.927 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Tracheo-oesophageal fistula | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac murmur functional | 0 | 0.078 | 0.046 | 0.927 | 2.787 |  |  |  |  |  | 
COVID19_MODERNA | Neurological infection | 0 | 0.078 | 0.047 | 0.927 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Yellow nail syndrome | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Pyelonephritis acute | 0 | 0.078 | 0.046 | 0.927 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Immune tolerance induction | 0 | 0.078 | 0.046 | 0.927 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Asthenia | 562 | 612.1 | 0.863 | 0.926 | 0.991 | 0.856 | 0.918 | 0.983 | 0.918 | 1.564 | 110.066
COVID19_MODERNA | Vitamin D | 2 | 2.739 | 0.424 | 0.926 | 1.585 | 0.36 | 0.791 | 1.555 | 0.73 | 0.747 | 0.009
COVID19_MODERNA | Globulins increased | 1 | 1.681 | 0.207 | 0.926 | 2.067 | 0.308 | 0.755 | 1.605 | 0.595 | 2.242 | 0.002
COVID19_MODERNA | Secondary hypogonadism | 0 | 0.078 | 0.045 | 0.926 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Epstein-Barr viraemia | 0 | 0.078 | 0.045 | 0.926 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Angioscopy | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid retraction | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Liver tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Serum ferritin abnormal | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Urine cytology | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Anorexia nervosa | 0 | 0.078 | 0.044 | 0.926 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy stomach normal | 0 | 0.078 | 0.044 | 0.926 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram kidney normal | 0 | 0.078 | 0.045 | 0.926 | 2.793 |  |  |  |  |  | 
COVID19_MODERNA | Optic disc drusen | 0 | 0.078 | 0.045 | 0.926 | 2.793 |  |  |  |  |  | 
COVID19_MODERNA | CSF cell count abnormal | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Histone antibody | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Culture tissue specimen positive | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Viral myositis | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Alpha-1 anti-trypsin normal | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Starvation | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B12 absorption test normal | 0 | 0.078 | 0.044 | 0.926 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal manometry | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Paranasal sinus hyposecretion | 0 | 0.117 | 0.103 | 0.926 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Adhesion | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Waterhouse-Friderichsen syndrome | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Liver tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Metastatic neoplasm | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor level normal | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity total increased | 0 | 0.078 | 0.044 | 0.926 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid skin dryness | 0 | 0.078 | 0.045 | 0.926 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Anti factor V antibody | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Vibration test normal | 0 | 0.078 | 0.045 | 0.926 | 2.793 |  |  |  |  |  | 
COVID19_MODERNA | Smear buccal abnormal | 0 | 0.078 | 0.045 | 0.926 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Precipitate labour | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Scan gallium abnormal | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Sexually active | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Blood bilirubin abnormal | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Thyroiditis | 0 | 0.171 | 0.178 | 0.926 | 2.15 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal labour affecting foetus | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Benign breast neoplasm | 0 | 0.078 | 0.045 | 0.926 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | CSF monocyte count negative | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Blood 25-hydroxycholecalciferol decreased | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Joint laxity | 0 | 0.078 | 0.044 | 0.926 | 2.8 |  |  |  |  |  | 
COVID19_MODERNA | Aortic dilatation | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Venous haemorrhage | 0 | 0.078 | 0.045 | 0.926 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Diet noncompliance | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Stenotrophomonas test positive | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Walking distance test abnormal | 0 | 0.078 | 0.044 | 0.926 | 2.802 |  |  |  |  |  | 
COVID19_MODERNA | Application site nodule | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Blood corticotrophin normal | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngoscopy | 0 | 0.078 | 0.044 | 0.926 | 2.8 |  |  |  |  |  | 
COVID19_MODERNA | Drug provocation test | 0 | 0.078 | 0.045 | 0.926 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Ciliary hyperaemia | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosal erosion | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Cleft palate | 0 | 0.078 | 0.045 | 0.926 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Myringitis | 0 | 0.078 | 0.044 | 0.926 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Quantitative sudomotor axon reflex test | 0 | 0.078 | 0.045 | 0.926 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Arthrogram abnormal | 0 | 0.078 | 0.044 | 0.926 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Sitting disability | 0 | 0.117 | 0.103 | 0.926 | 2.435 |  |  |  |  |  | 
COVID19_MODERNA | Pain threshold decreased | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Perineal abscess | 0 | 0.078 | 0.044 | 0.926 | 2.804 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic angioedema | 0 | 0.078 | 0.044 | 0.926 | 2.8 |  |  |  |  |  | 
COVID19_MODERNA | Night blindness | 0 | 0.078 | 0.045 | 0.926 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Splenic calcification | 0 | 0.078 | 0.044 | 0.926 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Arterial haemorrhage | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Mandibular mass | 0 | 0.117 | 0.103 | 0.926 | 2.437 |  |  |  |  |  | 
COVID19_MODERNA | Heterotaxia | 0 | 0.078 | 0.045 | 0.926 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Sweat gland disorder | 0 | 0.078 | 0.045 | 0.926 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal migraine | 0 | 0.078 | 0.044 | 0.926 | 2.8 |  |  |  |  |  | 
COVID19_MODERNA | Blood oestrogen | 0 | 0.078 | 0.045 | 0.926 | 2.793 |  |  |  |  |  | 
COVID19_MODERNA | Prostatitis | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic neoplasm | 0 | 0.078 | 0.045 | 0.926 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via unknown route | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Waxy flexibility | 0 | 0.078 | 0.044 | 0.926 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Cardiomyopathy (SMQ) [broad] | 1616 | 1761.712 | 0.887 | 0.925 | 0.963 | 0.88 | 0.917 | 0.955 | 0.917 | 2.067 | 874.228
COVID19_MODERNA | Ocular hyperaemia | 27 | 31.251 | 0.664 | 0.925 | 1.222 | 0.632 | 0.861 | 1.152 | 0.864 | 0.86 | 0.461
COVID19_MODERNA | Cardiac stress test abnormal | 1 | 1.256 | 0.296 | 0.925 | 1.837 | 0.338 | 0.824 | 1.747 | 0.796 | 2.466 | 0.012
COVID19_MODERNA | Antibody test negative | 2 | 2.944 | 0.221 | 0.925 | 2.024 | 0.348 | 0.766 | 1.506 | 0.679 | 0.098 | 15.589
COVID19_MODERNA | Subcorneal pustular dermatosis | 0 | 0.078 | 0.042 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Economic problem | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Barrett's oesophagus | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Hypoglycaemic coma | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Toxoplasma serology positive | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Threatened labour | 0 | 0.078 | 0.043 | 0.925 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | CSF volume increased | 0 | 0.078 | 0.042 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Automatism | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Anaemia vitamin B12 deficiency | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Penile wart | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Hodgkin's disease recurrent | 0 | 0.078 | 0.043 | 0.925 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Limbic encephalitis | 0 | 0.078 | 0.042 | 0.925 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic ketoacidotic hyperglycaemic coma | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Nutritional condition abnormal | 0 | 0.078 | 0.043 | 0.925 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Cryptococcosis | 0 | 0.078 | 0.042 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Spontaneous haematoma | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Hepcidin test | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Clostridium test | 0 | 0.181 | 0.188 | 0.925 | 2.119 |  |  |  |  |  | 
COVID19_MODERNA | Extradural haematoma | 0 | 0.078 | 0.043 | 0.925 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Free thyroxine index normal | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Faecal vomiting | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal stenosis | 0 | 0.078 | 0.042 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal pain | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Toxic neuropathy | 0 | 0.078 | 0.043 | 0.925 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Psychotic behaviour | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Transplant failure | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis influenzal | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Dermatofibroma removal | 0 | 0.078 | 0.042 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Ulnar nerve injury | 0 | 0.078 | 0.043 | 0.925 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Biofeedback therapy | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Lumbar vertebral fracture | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Unintended pregnancy | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Factor VIII deficiency | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory syncytial virus bronchitis | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Blastic plasmacytoid dendritic cell neoplasia | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Cryptorchism | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy thymus gland abnormal | 0 | 0.078 | 0.043 | 0.925 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Thought blocking | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Vasculitis necrotising | 0 | 0.078 | 0.042 | 0.925 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulosclerosis | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Blood luteinising hormone normal | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord infarction | 0 | 0.078 | 0.043 | 0.925 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Female reproductive tract disorder | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis rapidly progressive | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Blood acid phosphatase increased | 0 | 0.078 | 0.043 | 0.925 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Testis discomfort | 0 | 0.078 | 0.043 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Haptoglobin abnormal | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal fungal infection | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Haptoglobin | 0 | 0.117 | 0.1 | 0.925 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Sigmoidoscopy normal | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Paresis cranial nerve | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Aeromonas infection | 0 | 0.078 | 0.043 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | POEMS syndrome | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Viral sinusitis | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin D dimer decreased | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Product container seal issue | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Acantholysis | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid neoplasm | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Heart valve operation | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Acquired epidermolysis bullosa | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmia neonatorum | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Congenital skin dimples | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Osteopetrosis | 0 | 0.078 | 0.042 | 0.925 | 2.815 |  |  |  |  |  | 
COVID19_MODERNA | Retained placenta or membranes | 0 | 0.078 | 0.042 | 0.925 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | White blood cells stool positive | 0 | 0.041 | 0.004 | 0.925 | 3.525 |  |  |  |  |  | 
COVID19_MODERNA | Blood androstenedione | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Hypocomplementaemia | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Antigliadin antibody | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Lung neoplasm | 0 | 0.078 | 0.043 | 0.925 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral atrophy congenital | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B complex deficiency | 0 | 0.078 | 0.042 | 0.925 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Neuropsychiatric lupus | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Ectropion of cervix | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Malignant melanoma in situ | 0 | 0.078 | 0.044 | 0.925 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Aeromonas test positive | 0 | 0.078 | 0.043 | 0.925 | 2.813 |  |  |  |  |  | 
COVID19_MODERNA | Copper deficiency | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic colitis | 0 | 0.078 | 0.043 | 0.925 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging joint | 0 | 0.117 | 0.102 | 0.925 | 2.44 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bone normal | 0 | 0.078 | 0.043 | 0.925 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine free normal | 0 | 0.085 | 0.053 | 0.925 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary arterial hypertension | 0 | 0.078 | 0.043 | 0.925 | 2.81 |  |  |  |  |  | 
COVID19_MODERNA | Fibroadenoma of breast | 0 | 0.078 | 0.043 | 0.925 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy thyroid gland abnormal | 0 | 0.078 | 0.043 | 0.925 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Choroidal effusion | 0 | 0.078 | 0.043 | 0.925 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Hepatobiliary scan | 2 | 1.625 | 0.331 | 0.924 | 1.759 | 0.439 | 0.961 | 1.89 | 1.23 | 3.794 | 1.492
COVID19_MODERNA | Blood test | 198 | 221.019 | 0.82 | 0.924 | 1.033 | 0.796 | 0.895 | 1.004 | 0.896 | 1.928 | 81.75
COVID19_MODERNA | Shock (SMQ) [narrow] | 271 | 305.875 | 0.834 | 0.924 | 1.018 | 0.801 | 0.885 | 0.977 | 0.886 | 2.76 | 274.152
COVID19_MODERNA | Red blood cell sedimentation rate increased | 21 | 25.383 | 0.635 | 0.924 | 1.257 | 0.586 | 0.829 | 1.145 | 0.827 | 1 | 0.012
COVID19_MODERNA | Syncope | 175 | 219.915 | 0.813 | 0.924 | 1.041 | 0.703 | 0.796 | 0.899 | 0.796 | 0.686 | 24.688
COVID19_MODERNA | Nail dystrophy | 0 | 0.078 | 0.041 | 0.924 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Capillary fragility test | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin normal | 0 | 0.078 | 0.041 | 0.924 | 2.825 |  |  |  |  |  | 
COVID19_MODERNA | Blood zinc increased | 0 | 0.078 | 0.042 | 0.924 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Anal pap smear | 0 | 0.078 | 0.041 | 0.924 | 2.827 |  |  |  |  |  | 
COVID19_MODERNA | Radioactive iodine therapy | 0 | 0.078 | 0.041 | 0.924 | 2.822 |  |  |  |  |  | 
COVID19_MODERNA | Injection site joint infection | 0 | 0.078 | 0.041 | 0.924 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Primary hypothyroidism | 0 | 0.078 | 0.042 | 0.924 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Inadequate diet | 0 | 0.078 | 0.041 | 0.924 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QT interval abnormal | 0 | 0.078 | 0.041 | 0.924 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Rash neonatal | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Foetal heart rate deceleration abnormality | 0 | 0.078 | 0.041 | 0.924 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Perinatal HBV infection | 0 | 0.078 | 0.041 | 0.924 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Hand amputation | 0 | 0.078 | 0.041 | 0.924 | 2.825 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosal hypertrophy | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Uterine rupture | 0 | 0.078 | 0.041 | 0.924 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin A abnormal | 0 | 0.078 | 0.042 | 0.924 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Metamyelocyte percentage increased | 0 | 0.078 | 0.041 | 0.924 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Abortion incomplete | 0 | 0.078 | 0.042 | 0.924 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Blood cholesterol abnormal | 0 | 0.117 | 0.099 | 0.924 | 2.451 |  |  |  |  |  | 
COVID19_MODERNA | Rash papulosquamous | 0 | 0.078 | 0.041 | 0.924 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Specific gravity body fluid | 0 | 0.078 | 0.042 | 0.924 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Laryngitis allergic | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Basophilia | 0 | 0.078 | 0.041 | 0.924 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Scan bone marrow abnormal | 0 | 0.078 | 0.041 | 0.924 | 2.822 |  |  |  |  |  | 
COVID19_MODERNA | Monoclonal immunoglobulin present | 0 | 0.078 | 0.041 | 0.924 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Prolonged expiration | 0 | 0.078 | 0.042 | 0.924 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Hyperintensity in brain deep nuclei | 0 | 0.078 | 0.041 | 0.924 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteritis | 0 | 0.117 | 0.1 | 0.924 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Omphalitis | 0 | 0.078 | 0.041 | 0.924 | 2.825 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic foot | 0 | 0.078 | 0.042 | 0.924 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Blood electrolytes abnormal | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Coxsackie virus test negative | 0 | 0.083 | 0.048 | 0.924 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Hyphaema | 0 | 0.078 | 0.042 | 0.924 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Urethral stenosis | 0 | 0.078 | 0.041 | 0.924 | 2.825 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid nodule | 0 | 0.078 | 0.041 | 0.924 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound scan vagina normal | 0 | 0.078 | 0.041 | 0.924 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Incorrect product administration duration | 0 | 0.078 | 0.041 | 0.924 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Neck surgery | 0 | 0.078 | 0.042 | 0.924 | 2.819 |  |  |  |  |  | 
COVID19_MODERNA | Rash follicular | 0 | 0.117 | 0.098 | 0.924 | 2.453 |  |  |  |  |  | 
COVID19_MODERNA | Blood oestrogen normal | 0 | 0.078 | 0.042 | 0.924 | 2.816 |  |  |  |  |  | 
COVID19_MODERNA | Dyspepsia | 23 | 28.047 | 0.643 | 0.923 | 1.245 | 0.59 | 0.822 | 1.122 | 0.82 | 1.767 | 6.426
COVID19_MODERNA | Scleritis | 0 | 0.158 | 0.151 | 0.923 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | Base excess abnormal | 0 | 0.078 | 0.039 | 0.923 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal injury | 0 | 0.078 | 0.04 | 0.923 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Needle track marks | 0 | 0.078 | 0.04 | 0.923 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Complication of device insertion | 0 | 0.078 | 0.04 | 0.923 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory disorder neonatal | 0 | 0.078 | 0.04 | 0.923 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Typical aura without headache | 0 | 0.078 | 0.04 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary hypoplasia | 0 | 0.078 | 0.039 | 0.923 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Scan myocardial perfusion normal | 0 | 0.117 | 0.096 | 0.923 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Corynebacterium bacteraemia | 0 | 0.078 | 0.039 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Anti-islet cell antibody | 0 | 0.078 | 0.039 | 0.923 | 2.837 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E antigen positive | 0 | 0.078 | 0.04 | 0.923 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac function test abnormal | 0 | 0.078 | 0.04 | 0.923 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Exercise test normal | 0 | 0.078 | 0.039 | 0.923 | 2.837 |  |  |  |  |  | 
COVID19_MODERNA | Mitochondrial myopathy | 0 | 0.078 | 0.04 | 0.923 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | ADAMTS13 activity normal | 0 | 0.078 | 0.04 | 0.923 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | CSF electrophoresis abnormal | 0 | 0.078 | 0.04 | 0.923 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Zinc deficiency | 0 | 0.078 | 0.04 | 0.923 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Tachycardia paroxysmal | 0 | 0.078 | 0.04 | 0.923 | 2.827 |  |  |  |  |  | 
COVID19_MODERNA | Polyneuropathy idiopathic progressive | 0 | 0.078 | 0.04 | 0.923 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Motor neurone disease | 0 | 0.147 | 0.139 | 0.923 | 2.28 |  |  |  |  |  | 
COVID19_MODERNA | Vascular insufficiency | 0 | 0.078 | 0.04 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatitis necrotising | 0 | 0.078 | 0.039 | 0.923 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Culture throat negative | 0 | 0.456 | 0.382 | 0.923 | 1.654 |  |  |  |  |  | 
COVID19_MODERNA | Interleukin therapy | 0 | 0.078 | 0.04 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Opiates positive | 0 | 0.078 | 0.04 | 0.923 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis viral | 0 | 0.078 | 0.04 | 0.923 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Blood lead | 0 | 0.084 | 0.048 | 0.923 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | Saliva discolouration | 0 | 0.117 | 0.097 | 0.923 | 2.459 |  |  |  |  |  | 
COVID19_MODERNA | Onychoclasis | 0 | 0.086 | 0.052 | 0.923 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Autologous haematopoietic stem cell transplant | 0 | 0.078 | 0.04 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Blood parathyroid hormone | 0 | 0.117 | 0.096 | 0.923 | 2.461 |  |  |  |  |  | 
COVID19_MODERNA | X-ray with contrast upper gastrointestinal tract normal | 0 | 0.117 | 0.095 | 0.923 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Testicular retraction | 0 | 0.078 | 0.04 | 0.923 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Multiple epiphyseal dysplasia | 0 | 0.078 | 0.039 | 0.923 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Seizure anoxic | 0 | 0.078 | 0.04 | 0.923 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | Faecal elastase concentration decreased | 0 | 0.078 | 0.039 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Catheter site erythema | 0 | 0.078 | 0.04 | 0.923 | 2.828 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal pneumonia | 0 | 0.078 | 0.04 | 0.923 | 2.832 |  |  |  |  |  | 
COVID19_MODERNA | UV light therapy | 0 | 0.078 | 0.04 | 0.923 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Torsade de pointes | 0 | 0.078 | 0.04 | 0.923 | 2.834 |  |  |  |  |  | 
COVID19_MODERNA | Arteriogram | 0 | 0.117 | 0.097 | 0.923 | 2.459 |  |  |  |  |  | 
COVID19_MODERNA | Amoeba test positive | 0 | 0.078 | 0.039 | 0.923 | 2.835 |  |  |  |  |  | 
COVID19_MODERNA | Malaria antibody test positive | 0 | 0.078 | 0.04 | 0.923 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Blood alkaline phosphatase decreased | 0 | 0.117 | 0.096 | 0.923 | 2.46 |  |  |  |  |  | 
COVID19_MODERNA | Sputum culture positive | 0 | 0.117 | 0.098 | 0.923 | 2.454 |  |  |  |  |  | 
COVID19_MODERNA | CSF glucose increased | 1 | 1.079 | 0.175 | 0.922 | 2.151 | 0.352 | 0.856 | 1.815 | 0.927 | 0.617 | 0.006
COVID19_MODERNA | Extrapyramidal syndrome (SMQ) [broad] | 926 | 1013.931 | 0.873 | 0.922 | 0.973 | 0.865 | 0.913 | 0.963 | 0.913 | 1.002 | 0.002
COVID19_MODERNA | Vaccination site erythema | 26 | 31.794 | 0.654 | 0.922 | 1.227 | 0.599 | 0.82 | 1.101 | 0.818 | 1.212 | 0.722
COVID19_MODERNA | Mononucleosis heterophile test negative | 2 | 2.713 | 0.374 | 0.922 | 1.667 | 0.362 | 0.794 | 1.561 | 0.737 | 0.452 | 0.802
COVID19_MODERNA | Hepatic haemorrhage | 0 | 0.078 | 0.039 | 0.922 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Urine uric acid normal | 0 | 0.078 | 0.038 | 0.922 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Tongue operation | 0 | 0.078 | 0.039 | 0.922 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Cleft lip | 0 | 0.078 | 0.038 | 0.922 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | N-terminal prohormone brain natriuretic peptide normal | 0 | 0.117 | 0.094 | 0.922 | 2.469 |  |  |  |  |  | 
COVID19_MODERNA | Murine typhus | 0 | 0.078 | 0.038 | 0.922 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Typhus rickettsia test positive | 0 | 0.078 | 0.038 | 0.922 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Tongue cyst | 0 | 0.078 | 0.039 | 0.922 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Self-induced vomiting | 0 | 0.078 | 0.038 | 0.922 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy heart | 0 | 0.078 | 0.038 | 0.922 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 microglobulin urine increased | 0 | 0.078 | 0.038 | 0.922 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Sickle cell trait | 0 | 0.078 | 0.038 | 0.922 | 2.844 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal lymphadenopathy | 0 | 0.13 | 0.113 | 0.922 | 2.381 |  |  |  |  |  | 
COVID19_MODERNA | Application site inflammation | 0 | 0.078 | 0.038 | 0.922 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Schistosoma test negative | 0 | 0.078 | 0.038 | 0.922 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Benign neoplasm of thyroid gland | 0 | 0.078 | 0.039 | 0.922 | 2.839 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic pneumonia | 0 | 0.078 | 0.038 | 0.922 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Visual field tests normal | 0 | 0.078 | 0.038 | 0.922 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Blood copper decreased | 0 | 0.078 | 0.038 | 0.922 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Bulimia nervosa | 0 | 0.078 | 0.038 | 0.922 | 2.845 |  |  |  |  |  | 
COVID19_MODERNA | Anti-VGKC antibody positive | 0 | 0.078 | 0.038 | 0.922 | 2.844 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site coldness | 0 | 0.117 | 0.094 | 0.922 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Enterocolitis infectious | 0 | 0.078 | 0.039 | 0.922 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Tooth extraction | 0 | 0.139 | 0.124 | 0.922 | 2.331 |  |  |  |  |  | 
COVID19_MODERNA | Nodular rash | 0 | 0.117 | 0.093 | 0.922 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune retinopathy | 0 | 0.078 | 0.038 | 0.922 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Venipuncture | 0 | 0.078 | 0.038 | 0.922 | 2.842 |  |  |  |  |  | 
COVID19_MODERNA | Blood corticotrophin decreased | 0 | 0.078 | 0.038 | 0.922 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia influenzal | 0 | 0.078 | 0.039 | 0.922 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Allergic oedema | 0 | 0.078 | 0.039 | 0.922 | 2.84 |  |  |  |  |  | 
COVID19_MODERNA | Hilar lymphadenopathy | 0 | 0.117 | 0.094 | 0.922 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Fungal test negative | 1 | 1.041 | 0.312 | 0.921 | 1.791 | 0.355 | 0.863 | 1.83 | 0.96 | 0.667 | 0
COVID19_MODERNA | Retinal disorders (SMQ) [broad] | 220 | 256.156 | 0.822 | 0.921 | 1.025 | 0.768 | 0.859 | 0.957 | 0.859 | 1.192 | 6.398
COVID19_MODERNA | Hereditary ataxia | 0 | 0.078 | 0.037 | 0.921 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Anal fistula | 0 | 0.078 | 0.037 | 0.921 | 2.852 |  |  |  |  |  | 
COVID19_MODERNA | Tumour marker decreased | 0 | 0.078 | 0.037 | 0.921 | 2.855 |  |  |  |  |  | 
COVID19_MODERNA | Haemangioma-thrombocytopenia syndrome | 0 | 0.078 | 0.037 | 0.921 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Encopresis | 0 | 0.078 | 0.037 | 0.921 | 2.851 |  |  |  |  |  | 
COVID19_MODERNA | Organ failure | 0 | 0.213 | 0.209 | 0.921 | 2.045 |  |  |  |  |  | 
COVID19_MODERNA | Retinal vascular disorder | 0 | 0.078 | 0.037 | 0.921 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Microvillous inclusion disease | 0 | 0.078 | 0.037 | 0.921 | 2.855 |  |  |  |  |  | 
COVID19_MODERNA | Faecal volume increased | 0 | 0.082 | 0.042 | 0.921 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Exfoliative rash | 0 | 0.302 | 0.286 | 0.921 | 1.848 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal ulcer | 0 | 0.078 | 0.037 | 0.921 | 2.854 |  |  |  |  |  | 
COVID19_MODERNA | Lumbosacral radiculopathy | 0 | 0.117 | 0.092 | 0.921 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune pancreatitis | 0 | 0.078 | 0.037 | 0.921 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Acquired immunodeficiency syndrome | 0 | 0.078 | 0.037 | 0.921 | 2.854 |  |  |  |  |  | 
COVID19_MODERNA | Shock hypoglycaemic | 0 | 0.078 | 0.037 | 0.921 | 2.851 |  |  |  |  |  | 
COVID19_MODERNA | Kidney enlargement | 0 | 0.117 | 0.093 | 0.921 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Giardiasis | 0 | 0.078 | 0.036 | 0.921 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Albumin CSF abnormal | 0 | 0.078 | 0.036 | 0.921 | 2.859 |  |  |  |  |  | 
COVID19_MODERNA | Mood swings | 2 | 1.833 | 0.227 | 0.92 | 1.994 | 0.422 | 0.924 | 1.816 | 1.091 | 0.53 | 0.406
COVID19_MODERNA | Breast tenderness | 3 | 3.118 | 0.423 | 0.92 | 1.572 | 0.44 | 0.896 | 1.667 | 0.962 | 2.959 | 1.893
COVID19_MODERNA | Toxicologic test normal | 2 | 2.221 | 0.391 | 0.92 | 1.631 | 0.393 | 0.862 | 1.694 | 0.901 | 1.298 | 0.002
COVID19_MODERNA | Liver related investigations, signs and symptoms (SMQ) [broad] | 67 | 80.882 | 0.746 | 0.92 | 1.11 | 0.678 | 0.829 | 1.005 | 0.828 | 1.251 | 2.975
COVID19_MODERNA | Plasmapheresis | 3 | 4.922 | 0.315 | 0.92 | 1.783 | 0.345 | 0.706 | 1.314 | 0.61 | 0.406 | 1.987
COVID19_MODERNA | Cholangitis sclerosing | 0 | 0.078 | 0.036 | 0.92 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Chromosomal analysis | 0 | 0.117 | 0.09 | 0.92 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Trichoglossia | 0 | 0.117 | 0.089 | 0.92 | 2.487 |  |  |  |  |  | 
COVID19_MODERNA | Blood alcohol increased | 0 | 0.078 | 0.036 | 0.92 | 2.86 |  |  |  |  |  | 
COVID19_MODERNA | Injection site macule | 0 | 0.276 | 0.262 | 0.92 | 1.902 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem haemorrhage | 0 | 0.117 | 0.09 | 0.92 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Echo virus infection | 0 | 0.117 | 0.088 | 0.92 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Teeth brittle | 0 | 0.078 | 0.036 | 0.92 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Saliva analysis abnormal | 0 | 0.078 | 0.036 | 0.92 | 2.864 |  |  |  |  |  | 
COVID19_MODERNA | Haematoma muscle | 0 | 0.117 | 0.088 | 0.92 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Papule | 2 | 2.214 | 0.283 | 0.919 | 1.849 | 0.394 | 0.863 | 1.696 | 0.903 | 0.146 | 9.045
COVID19_MODERNA | Purpura | 5 | 7.234 | 0.45 | 0.919 | 1.521 | 0.401 | 0.74 | 1.275 | 0.691 | 0.434 | 3.07
COVID19_MODERNA | Auricular swelling | 0 | 0.117 | 0.086 | 0.919 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Metabolic syndrome | 0 | 0.117 | 0.086 | 0.919 | 2.498 |  |  |  |  |  | 
COVID19_MODERNA | Device failure | 0 | 0.117 | 0.086 | 0.919 | 2.497 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosal blistering | 0 | 0.078 | 0.034 | 0.919 | 2.878 |  |  |  |  |  | 
COVID19_MODERNA | Immunisation reaction | 0 | 0.174 | 0.161 | 0.919 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Blood thyroid stimulating hormone | 18 | 19.985 | 0.64 | 0.918 | 1.238 | 0.615 | 0.891 | 1.258 | 0.901 | 2.581 | 14.331
COVID19_MODERNA | Grip strength decreased | 17 | 19.173 | 0.611 | 0.918 | 1.276 | 0.601 | 0.879 | 1.251 | 0.887 | 1.152 | 0.192
COVID19_MODERNA | Cardiac failure | 7 | 12.526 | 0.46 | 0.918 | 1.504 | 0.36 | 0.621 | 1.014 | 0.559 | 1.528 | 0.74
COVID19_MODERNA | Autoimmune dermatitis | 0 | 0.117 | 0.084 | 0.918 | 2.506 |  |  |  |  |  | 
COVID19_MODERNA | Blood testosterone | 0 | 0.117 | 0.085 | 0.918 | 2.504 |  |  |  |  |  | 
COVID19_MODERNA | Arachnoiditis | 0 | 0.078 | 0.033 | 0.918 | 2.886 |  |  |  |  |  | 
COVID19_MODERNA | Ulnar neuritis | 0 | 0.117 | 0.084 | 0.918 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Haematocrit abnormal | 0 | 0.156 | 0.136 | 0.918 | 2.275 |  |  |  |  |  | 
COVID19_MODERNA | Urge incontinence | 0 | 0.117 | 0.084 | 0.918 | 2.508 |  |  |  |  |  | 
COVID19_MODERNA | Hysteroscopy | 0 | 0.117 | 0.084 | 0.918 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Pleuropericarditis | 0 | 0.117 | 0.084 | 0.918 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Lipids increased | 0 | 0.117 | 0.085 | 0.918 | 2.504 |  |  |  |  |  | 
COVID19_MODERNA | Adrenal insufficiency | 0 | 0.086 | 0.044 | 0.918 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal injury | 0 | 0.117 | 0.085 | 0.918 | 2.504 |  |  |  |  |  | 
COVID19_MODERNA | Giardia test negative | 0 | 0.061 | 0.015 | 0.918 | 3.149 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to contaminated device | 0 | 0.117 | 0.085 | 0.918 | 2.501 |  |  |  |  |  | 
COVID19_MODERNA | Skin depigmentation | 0 | 0.045 | 0.003 | 0.917 | 3.541 |  |  |  |  |  | 
COVID19_MODERNA | Excessive eye blinking | 0 | 0.415 | 0.342 | 0.917 | 1.717 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy colon | 0 | 0.117 | 0.083 | 0.917 | 2.512 |  |  |  |  |  | 
COVID19_MODERNA | Urine alcohol test negative | 0 | 0.078 | 0.031 | 0.917 | 2.902 |  |  |  |  |  | 
COVID19_MODERNA | Gastric ulcer haemorrhage | 0 | 0.117 | 0.083 | 0.917 | 2.512 |  |  |  |  |  | 
COVID19_MODERNA | Barium enema abnormal | 0 | 0.081 | 0.035 | 0.917 | 2.859 |  |  |  |  |  | 
COVID19_MODERNA | Inflammatory pain | 0 | 0.117 | 0.083 | 0.917 | 2.509 |  |  |  |  |  | 
COVID19_MODERNA | Pityriasis | 0 | 0.117 | 0.082 | 0.917 | 2.516 |  |  |  |  |  | 
COVID19_MODERNA | Xanthopsia | 0 | 0.117 | 0.082 | 0.917 | 2.516 |  |  |  |  |  | 
COVID19_MODERNA | Sialoadenitis | 0 | 0.131 | 0.1 | 0.917 | 2.423 |  |  |  |  |  | 
COVID19_MODERNA | Substance use | 0 | 0.117 | 0.083 | 0.917 | 2.509 |  |  |  |  |  | 
COVID19_MODERNA | Guillain-Barre syndrome (SMQ) [broad] | 2187 | 2411.869 | 0.884 | 0.916 | 0.948 | 0.875 | 0.907 | 0.939 | 0.907 | 1.619 | 541.476
COVID19_MODERNA | Incontinence | 6 | 6.865 | 0.528 | 0.916 | 1.391 | 0.485 | 0.862 | 1.442 | 0.874 | 1.437 | 0.384
COVID19_MODERNA | Chalazion | 0 | 0.117 | 0.081 | 0.916 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Iris adhesions | 0 | 0.117 | 0.08 | 0.916 | 2.521 |  |  |  |  |  | 
COVID19_MODERNA | Tardive dyskinesia | 0 | 0.214 | 0.195 | 0.916 | 2.071 |  |  |  |  |  | 
COVID19_MODERNA | Renal haemorrhage | 0 | 0.117 | 0.08 | 0.916 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Wound drainage | 0 | 0.156 | 0.131 | 0.916 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil count abnormal | 0 | 0.156 | 0.13 | 0.916 | 2.291 |  |  |  |  |  | 
COVID19_MODERNA | Menstruation normal | 0 | 0.117 | 0.08 | 0.916 | 2.524 |  |  |  |  |  | 
COVID19_MODERNA | Neuromuscular pain | 0 | 0.117 | 0.079 | 0.916 | 2.524 |  |  |  |  |  | 
COVID19_MODERNA | Milk soy protein intolerance | 0 | 0.117 | 0.079 | 0.916 | 2.525 |  |  |  |  |  | 
COVID19_MODERNA | Product confusion | 0 | 0.117 | 0.081 | 0.916 | 2.519 |  |  |  |  |  | 
COVID19_MODERNA | Subperiosteal abscess | 0 | 0.117 | 0.081 | 0.916 | 2.519 |  |  |  |  |  | 
COVID19_MODERNA | Haematopoietic cytopenias (SMQ) [broad] | 151 | 177.835 | 0.797 | 0.915 | 1.039 | 0.742 | 0.849 | 0.967 | 0.849 | 1.203 | 4.785
COVID19_MODERNA | Hypothyroidism | 3 | 4.38 | 0.307 | 0.915 | 1.784 | 0.369 | 0.754 | 1.403 | 0.685 | 0.822 | 0.004
COVID19_MODERNA | Oesophageal carcinoma | 0 | 0.117 | 0.077 | 0.915 | 2.533 |  |  |  |  |  | 
COVID19_MODERNA | General anaesthesia | 0 | 0.117 | 0.078 | 0.915 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Decreased interest | 0 | 0.257 | 0.232 | 0.915 | 1.965 |  |  |  |  |  | 
COVID19_MODERNA | Squamous cell carcinoma of skin | 0 | 0.117 | 0.077 | 0.915 | 2.533 |  |  |  |  |  | 
COVID19_MODERNA | Oxygen saturation increased | 0 | 0.117 | 0.077 | 0.915 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Phalen's test positive | 0 | 0.117 | 0.078 | 0.915 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Decorticate posture | 0 | 0.117 | 0.079 | 0.915 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric vein thrombosis | 0 | 0.117 | 0.078 | 0.915 | 2.531 |  |  |  |  |  | 
COVID19_MODERNA | Product lot number issue | 0 | 0.046 | 0.003 | 0.915 | 3.523 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar ulcer | 0 | 0.156 | 0.127 | 0.915 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Megacolon | 0 | 0.117 | 0.079 | 0.915 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Lip and/or oral cavity cancer | 0 | 0.117 | 0.079 | 0.915 | 2.527 |  |  |  |  |  | 
COVID19_MODERNA | Histamine intolerance | 1 | 0.683 | 0.295 | 0.914 | 1.811 | 0.386 | 0.938 | 1.991 | 1.464 | 2.242 | 0.002
COVID19_MODERNA | Scan with contrast normal | 9 | 9.521 | 0.575 | 0.914 | 1.317 | 0.558 | 0.916 | 1.436 | 0.945 | 2.522 | 6.134
COVID19_MODERNA | White blood cell disorder | 1 | 1.251 | 0.334 | 0.914 | 1.725 | 0.338 | 0.825 | 1.749 | 0.799 | 2.055 | 0
COVID19_MODERNA | Cholestasis and jaundice of hepatic origin (SMQ) [broad] | 9 | 10.796 | 0.502 | 0.914 | 1.424 | 0.509 | 0.835 | 1.309 | 0.834 | 0.763 | 0.428
COVID19_MODERNA | Vascular test normal | 0 | 0.117 | 0.076 | 0.914 | 2.539 |  |  |  |  |  | 
COVID19_MODERNA | Intertrigo | 0 | 0.117 | 0.076 | 0.914 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis infective | 0 | 0.218 | 0.192 | 0.914 | 2.073 |  |  |  |  |  | 
COVID19_MODERNA | Neurosurgery | 0 | 0.117 | 0.076 | 0.914 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Chorioretinopathy | 0 | 0.117 | 0.075 | 0.914 | 2.541 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram P wave abnormal | 0 | 0.117 | 0.076 | 0.914 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Head lag | 0 | 0.117 | 0.076 | 0.914 | 2.539 |  |  |  |  |  | 
COVID19_MODERNA | Intraocular lens implant | 0 | 0.156 | 0.127 | 0.914 | 2.3 |  |  |  |  |  | 
COVID19_MODERNA | Delayed fontanelle closure | 0 | 0.117 | 0.077 | 0.914 | 2.535 |  |  |  |  |  | 
COVID19_MODERNA | Ingrown hair | 0 | 0.117 | 0.076 | 0.914 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin degradation products | 0 | 0.117 | 0.076 | 0.914 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Hand dermatitis | 0 | 0.117 | 0.075 | 0.914 | 2.542 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine free abnormal | 0 | 0.117 | 0.075 | 0.914 | 2.542 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine urine increased | 0 | 0.117 | 0.076 | 0.914 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Haemophilus test | 0 | 0.117 | 0.077 | 0.914 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Histamine level increased | 0 | 0.117 | 0.076 | 0.914 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral thrombosis | 0 | 0.117 | 0.076 | 0.914 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Hypotonic-hyporesponsive episode (SMQ) [algorithm] | 2 | 0.787 | 0.253 | 0.913 | 1.904 | 0.524 | 1.151 | 2.281 | 2.541 | 0.051 | 34.645
COVID19_MODERNA | Noninfectious encephalitis (SMQ) [broad] | 1374 | 1539.359 | 0.873 | 0.913 | 0.953 | 0.854 | 0.892 | 0.933 | 0.893 | 1.022 | 0.679
COVID19_MODERNA | Lip swelling | 113 | 127.696 | 0.781 | 0.913 | 1.054 | 0.757 | 0.884 | 1.027 | 0.885 | 1.951 | 47.879
COVID19_MODERNA | Mass | 14 | 16.255 | 0.614 | 0.913 | 1.261 | 0.567 | 0.857 | 1.255 | 0.861 | 0.638 | 2.449
COVID19_MODERNA | Bursitis | 10 | 13.889 | 0.51 | 0.913 | 1.411 | 0.463 | 0.745 | 1.148 | 0.72 | 0.513 | 4.06
COVID19_MODERNA | Oxygen consumption increased | 0 | 0.117 | 0.075 | 0.913 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Biliary obstruction | 0 | 0.117 | 0.074 | 0.913 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Nasal odour | 0 | 0.117 | 0.075 | 0.913 | 2.544 |  |  |  |  |  | 
COVID19_MODERNA | Urine ketone body | 0 | 0.117 | 0.075 | 0.913 | 2.545 |  |  |  |  |  | 
COVID19_MODERNA | Inflammatory marker decreased | 0 | 0.087 | 0.038 | 0.913 | 2.817 |  |  |  |  |  | 
COVID19_MODERNA | Foetal non-stress test abnormal | 0 | 0.117 | 0.073 | 0.913 | 2.55 |  |  |  |  |  | 
COVID19_MODERNA | Cystogram | 0 | 0.117 | 0.074 | 0.913 | 2.546 |  |  |  |  |  | 
COVID19_MODERNA | Panniculitis | 0 | 0.129 | 0.089 | 0.913 | 2.463 |  |  |  |  |  | 
COVID19_MODERNA | Enterostomy | 0 | 0.117 | 0.075 | 0.913 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Blood calcitonin | 0 | 0.117 | 0.073 | 0.913 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Chlamydia test positive | 0 | 0.044 | 0.002 | 0.913 | 3.62 |  |  |  |  |  | 
COVID19_MODERNA | Arrhythmia supraventricular | 0 | 0.117 | 0.073 | 0.913 | 2.55 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial secretion retention | 0 | 0.117 | 0.075 | 0.913 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Pyramidal tract syndrome | 0 | 0.044 | 0.002 | 0.913 | 3.613 |  |  |  |  |  | 
COVID19_MODERNA | Cryptococcus test positive | 0 | 0.117 | 0.073 | 0.913 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Drug withdrawal (SMQ) [broad] | 1 | 1.192 | 0.276 | 0.912 | 1.848 | 0.343 | 0.835 | 1.771 | 0.839 | 2.466 | 0.012
COVID19_MODERNA | Anaphylactic/anaphylactoid shock conditions (SMQ) [broad] | 193 | 229.589 | 0.807 | 0.912 | 1.022 | 0.746 | 0.841 | 0.944 | 0.841 | 1.923 | 79.055
COVID19_MODERNA | Cardiac disorder | 8 | 12.437 | 0.493 | 0.912 | 1.434 | 0.409 | 0.687 | 1.098 | 0.643 | 1.389 | 0.487
COVID19_MODERNA | Glossopharyngeal neuralgia | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Retinal ischaemia | 0 | 0.117 | 0.072 | 0.912 | 2.554 |  |  |  |  |  | 
COVID19_MODERNA | Drug administered in wrong device | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Social fear | 0 | 0.117 | 0.073 | 0.912 | 2.552 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site erythema | 0 | 0.117 | 0.073 | 0.912 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Fasting | 0 | 0.117 | 0.073 | 0.912 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lymph gland normal | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy abdominal wall abnormal | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Cytopenia | 0 | 0.087 | 0.035 | 0.912 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Uterine inflammation | 0 | 0.117 | 0.073 | 0.912 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Onychalgia | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Diverticular perforation | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Drug level therapeutic | 0 | 0.117 | 0.073 | 0.912 | 2.553 |  |  |  |  |  | 
COVID19_MODERNA | Corneal transplant | 0 | 0.117 | 0.071 | 0.912 | 2.559 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine free abnormal | 0 | 0.117 | 0.071 | 0.912 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Migraine without aura | 0 | 0.117 | 0.073 | 0.912 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Flashback | 0 | 0.117 | 0.071 | 0.912 | 2.559 |  |  |  |  |  | 
COVID19_MODERNA | Eye symptom | 0 | 0.117 | 0.072 | 0.912 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Sciatic nerve injury | 0 | 0.078 | 0.026 | 0.912 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Freezing phenomenon | 0 | 0.117 | 0.073 | 0.912 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Polymerase chain reaction | 7 | 8.75 | 0.446 | 0.911 | 1.51 | 0.47 | 0.812 | 1.324 | 0.8 | 0.115 | 46.786
COVID19_MODERNA | Restless legs syndrome | 1 | 2.404 | 0.108 | 0.911 | 2.366 | 0.267 | 0.66 | 1.411 | 0.416 | 0.379 | 0.465
COVID19_MODERNA | Mastocytoma | 0 | 0.117 | 0.07 | 0.911 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Scleral disorder | 0 | 0.156 | 0.118 | 0.911 | 2.323 |  |  |  |  |  | 
COVID19_MODERNA | Benign breast lump removal | 0 | 0.117 | 0.07 | 0.911 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic enzymes increased | 0 | 0.156 | 0.117 | 0.911 | 2.328 |  |  |  |  |  | 
COVID19_MODERNA | Head circumference abnormal | 0 | 0.117 | 0.07 | 0.911 | 2.565 |  |  |  |  |  | 
COVID19_MODERNA | Asplenia | 0 | 0.117 | 0.07 | 0.911 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Paraneoplastic syndrome | 0 | 0.117 | 0.07 | 0.911 | 2.563 |  |  |  |  |  | 
COVID19_MODERNA | Blood aluminium increased | 0 | 0.048 | 0.003 | 0.911 | 3.518 |  |  |  |  |  | 
COVID19_MODERNA | Blood zinc normal | 0 | 0.117 | 0.07 | 0.911 | 2.565 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound eye normal | 0 | 0.117 | 0.07 | 0.911 | 2.562 |  |  |  |  |  | 
COVID19_MODERNA | Anterior chamber cell | 0 | 0.117 | 0.07 | 0.911 | 2.565 |  |  |  |  |  | 
COVID19_MODERNA | Corneal epithelium defect | 0 | 0.117 | 0.07 | 0.911 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Device breakage | 0 | 0.117 | 0.071 | 0.911 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Naevus flammeus | 0 | 0.117 | 0.07 | 0.911 | 2.564 |  |  |  |  |  | 
COVID19_MODERNA | Application site induration | 0 | 0.117 | 0.07 | 0.911 | 2.565 |  |  |  |  |  | 
COVID19_MODERNA | Blood group A | 0 | 0.117 | 0.07 | 0.911 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic specific antigen | 0 | 0.156 | 0.117 | 0.911 | 2.327 |  |  |  |  |  | 
COVID19_MODERNA | Renal replacement therapy | 0 | 0.117 | 0.071 | 0.911 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic metabolic decompensation | 0 | 0.117 | 0.068 | 0.91 | 2.573 |  |  |  |  |  | 
COVID19_MODERNA | Mini mental status examination | 0 | 0.117 | 0.068 | 0.91 | 2.571 |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder polyp | 0 | 0.117 | 0.068 | 0.91 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid analysis abnormal | 0 | 0.117 | 0.068 | 0.91 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Gravitational oedema | 0 | 0.117 | 0.069 | 0.91 | 2.568 |  |  |  |  |  | 
COVID19_MODERNA | Self-injurious ideation | 0 | 0.117 | 0.069 | 0.91 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Oral papule | 0 | 0.117 | 0.068 | 0.91 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Anti-NMDA antibody | 0 | 0.117 | 0.069 | 0.91 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Pupillary light reflex tests | 0 | 0.117 | 0.069 | 0.91 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Ileal perforation | 0 | 0.078 | 0.024 | 0.91 | 2.965 |  |  |  |  |  | 
COVID19_MODERNA | Meralgia paraesthetica | 0 | 0.117 | 0.068 | 0.91 | 2.571 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular function test abnormal | 0 | 0.117 | 0.069 | 0.91 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Laryngospasm | 0 | 0.217 | 0.18 | 0.91 | 2.098 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin M abnormal | 0 | 0.117 | 0.069 | 0.91 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic encephalopathy | 0 | 0.117 | 0.068 | 0.91 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Streptococcal abscess | 0 | 0.078 | 0.024 | 0.91 | 2.966 |  |  |  |  |  | 
COVID19_MODERNA | Retinal vascular occlusion | 0 | 0.117 | 0.069 | 0.91 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Groin infection | 0 | 0.117 | 0.069 | 0.91 | 2.568 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic oesophagitis | 0 | 0.117 | 0.069 | 0.91 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Eye movement disorder | 11 | 11.991 | 0.558 | 0.909 | 1.331 | 0.569 | 0.899 | 1.366 | 0.917 | 0.251 | 23.62
COVID19_MODERNA | Cardiac arrhythmia terms, nonspecific (SMQ) [broad] | 47 | 62.018 | 0.706 | 0.909 | 1.134 | 0.601 | 0.762 | 0.956 | 0.758 | 2.695 | 43.67
COVID19_MODERNA | Cardiac arrhythmia terms, nonspecific (SMQ) [narrow] | 47 | 62.018 | 0.706 | 0.909 | 1.134 | 0.601 | 0.762 | 0.956 | 0.758 | 2.695 | 43.67
COVID19_MODERNA | Blood lactate dehydrogenase normal | 1 | 1.481 | 0.21 | 0.909 | 2.008 | 0.322 | 0.786 | 1.669 | 0.675 | 0.433 | 0.266
COVID19_MODERNA | Optic disc haemorrhage | 0 | 0.117 | 0.066 | 0.909 | 2.581 |  |  |  |  |  | 
COVID19_MODERNA | Neuritis cranial | 0 | 0.117 | 0.067 | 0.909 | 2.575 |  |  |  |  |  | 
COVID19_MODERNA | Dairy intolerance | 0 | 0.191 | 0.151 | 0.909 | 2.191 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterium test positive | 0 | 0.129 | 0.082 | 0.909 | 2.491 |  |  |  |  |  | 
COVID19_MODERNA | Blood aluminium normal | 0 | 0.117 | 0.067 | 0.909 | 2.577 |  |  |  |  |  | 
COVID19_MODERNA | Free fatty acids | 0 | 0.117 | 0.066 | 0.909 | 2.583 |  |  |  |  |  | 
COVID19_MODERNA | Aspergillus test | 0 | 0.117 | 0.067 | 0.909 | 2.579 |  |  |  |  |  | 
COVID19_MODERNA | Toxic shock syndrome | 0 | 0.117 | 0.067 | 0.909 | 2.578 |  |  |  |  |  | 
COVID19_MODERNA | Breast inflammation | 0 | 0.156 | 0.114 | 0.909 | 2.338 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic enzymes | 0 | 0.117 | 0.067 | 0.909 | 2.577 |  |  |  |  |  | 
COVID19_MODERNA | Choreoathetosis | 0 | 0.156 | 0.113 | 0.909 | 2.339 |  |  |  |  |  | 
COVID19_MODERNA | Epidermal necrosis | 0 | 0.127 | 0.079 | 0.909 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Ephelides | 0 | 0.117 | 0.066 | 0.909 | 2.58 |  |  |  |  |  | 
COVID19_MODERNA | Pityriasis rosea | 0 | 0.293 | 0.242 | 0.909 | 1.922 |  |  |  |  |  | 
COVID19_MODERNA | Administration site discolouration | 0 | 0.117 | 0.067 | 0.909 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid contusion | 0 | 0.156 | 0.113 | 0.909 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Protein S decreased | 0 | 0.117 | 0.066 | 0.909 | 2.583 |  |  |  |  |  | 
COVID19_MODERNA | Glucose-6-phosphate dehydrogenase abnormal | 0 | 0.117 | 0.067 | 0.909 | 2.579 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal tract irritation | 0 | 0.117 | 0.066 | 0.909 | 2.582 |  |  |  |  |  | 
COVID19_MODERNA | CD4/CD8 ratio decreased | 0 | 0.117 | 0.066 | 0.909 | 2.582 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QT prolonged | 3 | 3.282 | 0.355 | 0.908 | 1.669 | 0.429 | 0.875 | 1.628 | 0.914 | 2.466 | 1.193
COVID19_MODERNA | Neonatal exposures via breast milk (SMQ) [broad] | 5 | 7.43 | 0.378 | 0.908 | 1.623 | 0.394 | 0.727 | 1.252 | 0.673 | 1.897 | 1.198
COVID19_MODERNA | Neonatal exposures via breast milk (SMQ) [narrow] | 5 | 7.43 | 0.378 | 0.908 | 1.623 | 0.394 | 0.727 | 1.252 | 0.673 | 1.897 | 1.198
COVID19_MODERNA | Blood creatinine abnormal | 0 | 0.117 | 0.065 | 0.908 | 2.586 |  |  |  |  |  | 
COVID19_MODERNA | Carboxyhaemoglobin normal | 0 | 0.234 | 0.192 | 0.908 | 2.057 |  |  |  |  |  | 
COVID19_MODERNA | Pityriasis rubra pilaris | 0 | 0.117 | 0.065 | 0.908 | 2.585 |  |  |  |  |  | 
COVID19_MODERNA | Throat cancer | 0 | 0.117 | 0.065 | 0.908 | 2.588 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord abscess | 0 | 0.117 | 0.065 | 0.908 | 2.585 |  |  |  |  |  | 
COVID19_MODERNA | Tympanic membrane hyperaemia | 0 | 0.082 | 0.026 | 0.908 | 2.929 |  |  |  |  |  | 
COVID19_MODERNA | Candida nappy rash | 0 | 0.117 | 0.064 | 0.908 | 2.59 |  |  |  |  |  | 
COVID19_MODERNA | Abscess rupture | 0 | 0.117 | 0.064 | 0.908 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Scintillating scotoma | 0 | 0.156 | 0.111 | 0.908 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Visceral pain | 0 | 0.117 | 0.065 | 0.908 | 2.588 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic prolapse | 0 | 0.117 | 0.064 | 0.908 | 2.59 |  |  |  |  |  | 
COVID19_MODERNA | Blood uric acid decreased | 0 | 0.117 | 0.065 | 0.908 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Lipids | 9 | 9.651 | 0.555 | 0.907 | 1.33 | 0.553 | 0.907 | 1.422 | 0.933 | 3.827 | 13.824
COVID19_MODERNA | Periorbital swelling | 20 | 22.79 | 0.621 | 0.907 | 1.237 | 0.612 | 0.872 | 1.213 | 0.878 | 3.853 | 34.037
COVID19_MODERNA | Oral disorder | 1 | 1.32 | 0.366 | 0.907 | 1.644 | 0.333 | 0.813 | 1.724 | 0.757 | 0.433 | 0.266
COVID19_MODERNA | Glassy eyes | 2 | 2.819 | 0.474 | 0.907 | 1.454 | 0.355 | 0.781 | 1.535 | 0.71 | 0.667 | 0.075
COVID19_MODERNA | Coagulation factor XII level normal | 0 | 0.078 | 0.021 | 0.907 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Enterococcus test | 0 | 0.117 | 0.063 | 0.907 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Genital discomfort | 0 | 0.117 | 0.063 | 0.907 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Retinal perivascular sheathing | 0 | 0.117 | 0.064 | 0.907 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell analysis normal | 0 | 0.078 | 0.021 | 0.907 | 3 |  |  |  |  |  | 
COVID19_MODERNA | Bone densitometry | 0 | 0.07 | 0.015 | 0.907 | 3.112 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic fluid volume decreased | 0 | 0.117 | 0.063 | 0.907 | 2.598 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord neoplasm | 0 | 0.117 | 0.063 | 0.907 | 2.596 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmic fluid-air exchange procedure | 0 | 0.117 | 0.064 | 0.907 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Lung diffusion test decreased | 0 | 0.117 | 0.063 | 0.907 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Macrocytosis | 0 | 0.117 | 0.063 | 0.907 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Infant irritability | 0 | 0.156 | 0.109 | 0.907 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal dryness | 0 | 0.156 | 0.108 | 0.907 | 2.355 |  |  |  |  |  | 
COVID19_MODERNA | Cardiopulmonary exercise test normal | 0 | 0.078 | 0.021 | 0.907 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Chronic graft versus host disease | 0 | 0.117 | 0.064 | 0.907 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Meniscus operation | 0 | 0.117 | 0.063 | 0.907 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic carcinoma | 0 | 0.156 | 0.109 | 0.907 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Pus in stool | 0 | 0.117 | 0.063 | 0.907 | 2.597 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site nerve damage | 0 | 0.117 | 0.063 | 0.907 | 2.596 |  |  |  |  |  | 
COVID19_MODERNA | Administration site infection | 0 | 0.078 | 0.021 | 0.907 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Sphincter of Oddi dysfunction | 0 | 0.117 | 0.063 | 0.907 | 2.597 |  |  |  |  |  | 
COVID19_MODERNA | Genitourinary symptom | 0 | 0.117 | 0.063 | 0.907 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | High density lipoprotein increased | 0 | 0.117 | 0.063 | 0.907 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Gun shot wound | 0 | 0.156 | 0.108 | 0.907 | 2.354 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid operation | 0 | 0.117 | 0.062 | 0.907 | 2.598 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin D increased | 0 | 0.117 | 0.062 | 0.907 | 2.598 |  |  |  |  |  | 
COVID19_MODERNA | Atrophy | 1 | 1.171 | 0.224 | 0.906 | 1.96 | 0.344 | 0.839 | 1.779 | 0.854 | 0.948 | 0.198
COVID19_MODERNA | Haemorrhage terms (excl laboratory terms) (SMQ) [narrow] | 354 | 396.463 | 0.829 | 0.906 | 0.986 | 0.817 | 0.892 | 0.973 | 0.893 | 0.914 | 2.768
COVID19_MODERNA | Haemorrhage terms (excl laboratory terms) (SMQ) [broad] | 354 | 396.463 | 0.829 | 0.906 | 0.986 | 0.817 | 0.892 | 0.973 | 0.893 | 0.914 | 2.768
COVID19_MODERNA | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [broad] | 13 | 16.984 | 0.552 | 0.906 | 1.33 | 0.508 | 0.778 | 1.152 | 0.765 | 1.024 | 0.003
COVID19_MODERNA | Fluid retention | 3 | 4.792 | 0.342 | 0.906 | 1.69 | 0.351 | 0.717 | 1.334 | 0.626 | 0.891 | 0.007
COVID19_MODERNA | Polymyalgia rheumatica | 3 | 4.948 | 0.307 | 0.906 | 1.76 | 0.344 | 0.704 | 1.31 | 0.606 | 0.448 | 1.476
COVID19_MODERNA | Congenital megacolon | 0 | 0.117 | 0.062 | 0.906 | 2.602 |  |  |  |  |  | 
COVID19_MODERNA | Fibula fracture | 0 | 0.117 | 0.062 | 0.906 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Actinic keratosis | 0 | 0.117 | 0.061 | 0.906 | 2.605 |  |  |  |  |  | 
COVID19_MODERNA | Skeletal survey abnormal | 0 | 0.117 | 0.062 | 0.906 | 2.6 |  |  |  |  |  | 
COVID19_MODERNA | Oligodipsia | 0 | 0.117 | 0.061 | 0.906 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | Laryngitis viral | 0 | 0.078 | 0.02 | 0.906 | 3.008 |  |  |  |  |  | 
COVID19_MODERNA | Sweat test normal | 0 | 0.117 | 0.061 | 0.906 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Gait spastic | 0 | 0.117 | 0.062 | 0.906 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Opticokinetic nystagmus tests abnormal | 0 | 0.117 | 0.061 | 0.906 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Asymptomatic bacteriuria | 0 | 0.117 | 0.061 | 0.906 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve neurostimulation | 0 | 0.117 | 0.061 | 0.906 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | Typhus rickettsia test | 0 | 0.205 | 0.158 | 0.906 | 2.159 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal achalasia | 0 | 0.117 | 0.061 | 0.906 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Cerumen impaction | 0 | 0.117 | 0.061 | 0.906 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | CSF white blood cell differential | 0 | 0.125 | 0.072 | 0.906 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary sepsis | 0 | 0.117 | 0.061 | 0.906 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhages (SMQ) [narrow] | 354 | 396.976 | 0.828 | 0.905 | 0.985 | 0.816 | 0.891 | 0.972 | 0.892 | 0.912 | 2.914
COVID19_MODERNA | Accidents and injuries (SMQ) [narrow] | 236 | 271.367 | 0.811 | 0.905 | 1.003 | 0.781 | 0.869 | 0.966 | 0.87 | 0.927 | 1.264
COVID19_MODERNA | Tachyarrhythmia terms, nonspecific (SMQ) [broad] | 13 | 16.129 | 0.583 | 0.905 | 1.285 | 0.53 | 0.812 | 1.202 | 0.806 | 2.672 | 10.753
COVID19_MODERNA | Tachyarrhythmia terms, nonspecific (SMQ) [narrow] | 13 | 16.129 | 0.583 | 0.905 | 1.285 | 0.53 | 0.812 | 1.202 | 0.806 | 2.672 | 10.753
COVID19_MODERNA | Small intestinal obstruction | 5 | 6.374 | 0.456 | 0.905 | 1.479 | 0.436 | 0.804 | 1.385 | 0.784 | 7.253 | 16.105
COVID19_MODERNA | Abdominal pain upper | 101 | 126.898 | 0.763 | 0.905 | 1.056 | 0.677 | 0.797 | 0.934 | 0.796 | 0.971 | 0.056
COVID19_MODERNA | Electrocardiogram change | 2 | 2.894 | 0.333 | 0.905 | 1.703 | 0.351 | 0.772 | 1.518 | 0.691 | 5.48 | 2.786
COVID19_MODERNA | Subdural effusion | 0 | 0.117 | 0.06 | 0.905 | 2.611 |  |  |  |  |  | 
COVID19_MODERNA | Product availability issue | 0 | 0.054 | 0.004 | 0.905 | 3.446 |  |  |  |  |  | 
COVID19_MODERNA | Lacrimation decreased | 0 | 0.156 | 0.104 | 0.905 | 2.366 |  |  |  |  |  | 
COVID19_MODERNA | Carbohydrate antigen 125 increased | 0 | 0.078 | 0.019 | 0.905 | 3.019 |  |  |  |  |  | 
COVID19_MODERNA | Blood osmolarity | 0 | 0.156 | 0.105 | 0.905 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to arthropod bite | 0 | 0.156 | 0.104 | 0.905 | 2.366 |  |  |  |  |  | 
COVID19_MODERNA | Delayed myelination | 0 | 0.117 | 0.06 | 0.905 | 2.609 |  |  |  |  |  | 
COVID19_MODERNA | Impaired reasoning | 0 | 0.117 | 0.06 | 0.905 | 2.61 |  |  |  |  |  | 
COVID19_MODERNA | EGFR status assay | 0 | 0.156 | 0.105 | 0.905 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Cerumen removal | 0 | 0.156 | 0.105 | 0.905 | 2.365 |  |  |  |  |  | 
COVID19_MODERNA | Cerebellar ataxia | 0 | 0.142 | 0.089 | 0.905 | 2.44 |  |  |  |  |  | 
COVID19_MODERNA | Blood carbon monoxide increased | 0 | 0.117 | 0.059 | 0.905 | 2.614 |  |  |  |  |  | 
COVID19_MODERNA | Seronegative arthritis | 0 | 0.117 | 0.06 | 0.905 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Neurosarcoidosis | 0 | 0.117 | 0.06 | 0.905 | 2.612 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine renal clearance increased | 0 | 0.117 | 0.06 | 0.905 | 2.611 |  |  |  |  |  | 
COVID19_MODERNA | Systemic scleroderma | 0 | 0.156 | 0.105 | 0.905 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram normal | 49 | 56.637 | 0.716 | 0.904 | 1.11 | 0.684 | 0.864 | 1.079 | 0.865 | 1.871 | 17.656
COVID19_MODERNA | Lip oedema | 2 | 2.812 | 0.316 | 0.904 | 1.735 | 0.356 | 0.782 | 1.537 | 0.711 | 1.049 | 0.091
COVID19_MODERNA | CSF test normal | 3 | 4.179 | 0.33 | 0.904 | 1.708 | 0.379 | 0.774 | 1.44 | 0.718 | 0.291 | 4.414
COVID19_MODERNA | Nocturnal dyspnoea | 0 | 0.117 | 0.058 | 0.904 | 2.619 |  |  |  |  |  | 
COVID19_MODERNA | Toxic shock syndrome streptococcal | 0 | 0.117 | 0.059 | 0.904 | 2.616 |  |  |  |  |  | 
COVID19_MODERNA | Skin hypopigmentation | 0 | 0.127 | 0.07 | 0.904 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric evaluation normal | 0 | 0.043 | 0.001 | 0.904 | 3.741 |  |  |  |  |  | 
COVID19_MODERNA | Russell's viper venom time | 0 | 0.117 | 0.059 | 0.904 | 2.617 |  |  |  |  |  | 
COVID19_MODERNA | Application site abscess | 0 | 0.117 | 0.059 | 0.904 | 2.615 |  |  |  |  |  | 
COVID19_MODERNA | HIV antigen | 0 | 0.117 | 0.058 | 0.904 | 2.618 |  |  |  |  |  | 
COVID19_MODERNA | Wrist surgery | 0 | 0.117 | 0.058 | 0.904 | 2.619 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C antibody | 0 | 0.117 | 0.057 | 0.904 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Nail growth abnormal | 0 | 0.117 | 0.058 | 0.904 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Platelet function test abnormal | 0 | 0.117 | 0.058 | 0.904 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Application site rash | 0 | 0.117 | 0.058 | 0.904 | 2.617 |  |  |  |  |  | 
COVID19_MODERNA | Coombs direct test negative | 0 | 0.174 | 0.122 | 0.904 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial toxaemia | 0 | 0.117 | 0.059 | 0.904 | 2.615 |  |  |  |  |  | 
COVID19_MODERNA | Proteus test positive | 0 | 0.078 | 0.019 | 0.904 | 3.026 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhages (SMQ) [broad] | 432 | 482.432 | 0.834 | 0.903 | 0.976 | 0.827 | 0.895 | 0.968 | 0.895 | 1.03 | 0.347
COVID19_MODERNA | Unresponsive to stimuli | 130 | 153.213 | 0.779 | 0.903 | 1.036 | 0.734 | 0.848 | 0.976 | 0.848 | 1.783 | 41.166
COVID19_MODERNA | Sleep study | 1 | 1.601 | 0.224 | 0.903 | 1.951 | 0.314 | 0.767 | 1.63 | 0.625 | 0.474 | 0.161
COVID19_MODERNA | Tenosynovitis | 1 | 1.78 | 0.281 | 0.903 | 1.812 | 0.302 | 0.741 | 1.575 | 0.562 | 0.948 | 0.198
COVID19_MODERNA | Knee deformity | 0 | 0.117 | 0.057 | 0.903 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral artery thrombosis | 0 | 0.156 | 0.101 | 0.903 | 2.375 |  |  |  |  |  | 
COVID19_MODERNA | Herpes pharyngitis | 0 | 0.117 | 0.057 | 0.903 | 2.625 |  |  |  |  |  | 
COVID19_MODERNA | Adenoma benign | 0 | 0.117 | 0.056 | 0.903 | 2.628 |  |  |  |  |  | 
COVID19_MODERNA | Band neutrophil count increased | 0 | 0.211 | 0.156 | 0.903 | 2.158 |  |  |  |  |  | 
COVID19_MODERNA | Victim of crime | 0 | 0.117 | 0.057 | 0.903 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Bone disorder | 0 | 0.139 | 0.082 | 0.903 | 2.469 |  |  |  |  |  | 
COVID19_MODERNA | Arm amputation | 0 | 0.117 | 0.057 | 0.903 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Carditis | 0 | 0.117 | 0.057 | 0.903 | 2.626 |  |  |  |  |  | 
COVID19_MODERNA | Drug trough level | 0 | 0.078 | 0.018 | 0.903 | 3.036 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram intestine | 0 | 0.156 | 0.1 | 0.903 | 2.378 |  |  |  |  |  | 
COVID19_MODERNA | Xerophthalmia | 0 | 0.117 | 0.057 | 0.903 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Echoencephalogram | 0 | 0.078 | 0.018 | 0.903 | 3.037 |  |  |  |  |  | 
COVID19_MODERNA | Blood pH | 0 | 0.117 | 0.057 | 0.903 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Decreased nasolabial fold | 0 | 0.078 | 0.018 | 0.903 | 3.037 |  |  |  |  |  | 
COVID19_MODERNA | Tissue infiltration | 0 | 0.117 | 0.056 | 0.903 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QRS complex prolonged | 0 | 0.156 | 0.1 | 0.903 | 2.38 |  |  |  |  |  | 
COVID19_MODERNA | Microscopy | 0 | 0.269 | 0.208 | 0.903 | 1.997 |  |  |  |  |  | 
COVID19_MODERNA | Intentional overdose | 0 | 0.117 | 0.057 | 0.903 | 2.625 |  |  |  |  |  | 
COVID19_MODERNA | Interleukin-2 receptor assay | 0 | 0.117 | 0.056 | 0.903 | 2.629 |  |  |  |  |  | 
COVID19_MODERNA | Hypersensitivity vasculitis | 1 | 1.127 | 0.169 | 0.902 | 2.111 | 0.348 | 0.847 | 1.796 | 0.887 | 0.347 | 0.633
COVID19_MODERNA | Arteriosclerosis | 4 | 4.501 | 0.385 | 0.902 | 1.595 | 0.449 | 0.867 | 1.545 | 0.889 | 7.046 | 11.618
COVID19_MODERNA | Ear swelling | 11 | 12.461 | 0.564 | 0.902 | 1.305 | 0.552 | 0.873 | 1.326 | 0.883 | 1.717 | 2.422
COVID19_MODERNA | Product use complaint | 0 | 0.117 | 0.056 | 0.902 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Helicobacter gastritis | 0 | 0.117 | 0.055 | 0.902 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | Candida test negative | 0 | 0.117 | 0.055 | 0.902 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Plagiocephaly | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Iontophoresis | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract endoscopy | 0 | 0.078 | 0.017 | 0.902 | 3.044 |  |  |  |  |  | 
COVID19_MODERNA | Spinal myelogram abnormal | 0 | 0.117 | 0.056 | 0.902 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Antiendomysial antibody test | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Pseudoparalysis | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Metapneumovirus infection | 0 | 0.043 | 0.001 | 0.902 | 3.757 |  |  |  |  |  | 
COVID19_MODERNA | Joint ankylosis | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Injection site joint warmth | 0 | 0.117 | 0.055 | 0.902 | 2.634 |  |  |  |  |  | 
COVID19_MODERNA | Plateletcrit increased | 0 | 0.117 | 0.055 | 0.902 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | Tinnitus | 66 | 80.179 | 0.73 | 0.901 | 1.087 | 0.673 | 0.824 | 1 | 0.823 | 1.492 | 9.648
COVID19_MODERNA | Ammonia increased | 2 | 2.588 | 0.398 | 0.901 | 1.568 | 0.369 | 0.811 | 1.593 | 0.773 | 2.055 | 0.243
COVID19_MODERNA | Blood pressure abnormal | 14 | 17.424 | 0.615 | 0.901 | 1.231 | 0.535 | 0.81 | 1.185 | 0.803 | 4.015 | 24.63
COVID19_MODERNA | Gait inability | 50 | 64.258 | 0.707 | 0.901 | 1.115 | 0.62 | 0.781 | 0.974 | 0.778 | 0.977 | 0.008
COVID19_MODERNA | Blood pyruvic acid increased | 0 | 0.078 | 0.016 | 0.901 | 3.054 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell agglutination present | 0 | 0.117 | 0.054 | 0.901 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Bandaemia | 0 | 0.234 | 0.172 | 0.901 | 2.097 |  |  |  |  |  | 
COVID19_MODERNA | Renal scan | 0 | 0.117 | 0.054 | 0.901 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Injection site joint inflammation | 0 | 0.225 | 0.164 | 0.901 | 2.124 |  |  |  |  |  | 
COVID19_MODERNA | Lung cancer metastatic | 0 | 0.117 | 0.054 | 0.901 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Bradypnoea | 0 | 0.078 | 0.016 | 0.901 | 3.052 |  |  |  |  |  | 
COVID19_MODERNA | CD4 lymphocyte percentage decreased | 0 | 0.156 | 0.097 | 0.901 | 2.389 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C virus test positive | 0 | 0.156 | 0.096 | 0.901 | 2.391 |  |  |  |  |  | 
COVID19_MODERNA | Haemothorax | 0 | 0.078 | 0.016 | 0.901 | 3.054 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcus test | 0 | 0.21 | 0.152 | 0.901 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Drug dependence | 0 | 0.117 | 0.054 | 0.901 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Total complement activity test | 0 | 0.073 | 0.013 | 0.901 | 3.128 |  |  |  |  |  | 
COVID19_MODERNA | Cold type haemolytic anaemia | 0 | 0.156 | 0.096 | 0.901 | 2.393 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral neuropathy (SMQ) [broad] | 1098 | 1228.29 | 0.855 | 0.9 | 0.945 | 0.85 | 0.894 | 0.939 | 0.894 | 1.332 | 91.826
COVID19_MODERNA | Noninfectious meningitis (SMQ) [broad] | 1206 | 1350.556 | 0.858 | 0.9 | 0.943 | 0.851 | 0.893 | 0.936 | 0.893 | 1.009 | 0.085
COVID19_MODERNA | Burning sensation | 110 | 124.999 | 0.767 | 0.9 | 1.041 | 0.751 | 0.879 | 1.023 | 0.88 | 1.356 | 9.44
COVID19_MODERNA | Nystagmus | 4 | 5.131 | 0.373 | 0.9 | 1.613 | 0.417 | 0.804 | 1.434 | 0.78 | 0.822 | 0.024
COVID19_MODERNA | Screaming | 4 | 5.317 | 0.404 | 0.9 | 1.556 | 0.408 | 0.787 | 1.404 | 0.752 | 0.086 | 37.786
COVID19_MODERNA | Pneumonitis | 3 | 4.46 | 0.331 | 0.9 | 1.694 | 0.366 | 0.747 | 1.389 | 0.673 | 1.121 | 0.014
COVID19_MODERNA | Sputum culture | 1 | 1.816 | 0.286 | 0.9 | 1.792 | 0.3 | 0.735 | 1.565 | 0.551 | 1.897 | 0.004
COVID19_MODERNA | Pulmonary hypertension (SMQ) [narrow] | 4 | 8.468 | 0.372 | 0.9 | 1.614 | 0.3 | 0.581 | 1.037 | 0.472 | 1.566 | 0.315
COVID19_MODERNA | Blood brain barrier defect | 0 | 0.117 | 0.052 | 0.9 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Mitral valve repair | 0 | 0.117 | 0.053 | 0.9 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Adenosine deaminase normal | 0 | 0.117 | 0.052 | 0.9 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Blood heavy metal abnormal | 0 | 0.117 | 0.052 | 0.9 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Epidural blood patch | 0 | 0.117 | 0.053 | 0.9 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Intra-ocular injection | 0 | 0.117 | 0.052 | 0.9 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Growth hormone deficiency | 0 | 0.117 | 0.052 | 0.9 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site joint effusion | 0 | 0.117 | 0.053 | 0.9 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging abdominal | 0 | 0.203 | 0.143 | 0.9 | 2.195 |  |  |  |  |  | 
COVID19_MODERNA | Product origin unknown | 0 | 0.117 | 0.053 | 0.9 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Fistula | 0 | 0.117 | 0.052 | 0.9 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Nasal obstruction | 0 | 0.131 | 0.068 | 0.9 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Cartilage injury | 0 | 0.103 | 0.038 | 0.9 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Capillary disorder | 0 | 0.117 | 0.053 | 0.9 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell macrocytes present | 0 | 0.078 | 0.016 | 0.9 | 3.064 |  |  |  |  |  | 
COVID19_MODERNA | Angina bullosa haemorrhagica | 0 | 0.117 | 0.053 | 0.9 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular examination abnormal | 0 | 0.117 | 0.052 | 0.9 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Blood magnesium decreased | 6 | 5.265 | 0.463 | 0.899 | 1.45 | 0.572 | 1.018 | 1.702 | 1.14 | 5.284 | 13.69
COVID19_MODERNA | Blood creatine normal | 1 | 1.551 | 0.233 | 0.899 | 1.918 | 0.317 | 0.775 | 1.646 | 0.645 | 2.466 | 0.012
COVID19_MODERNA | Periarthritis | 5 | 7.439 | 0.399 | 0.899 | 1.561 | 0.393 | 0.727 | 1.251 | 0.672 | 0.352 | 5.23
COVID19_MODERNA | Dyslipidaemia (SMQ) [broad] | 10 | 14.885 | 0.519 | 0.899 | 1.363 | 0.438 | 0.704 | 1.086 | 0.672 | 1.477 | 1.022
COVID19_MODERNA | Dyslipidaemia (SMQ) [narrow] | 10 | 14.885 | 0.519 | 0.899 | 1.363 | 0.438 | 0.704 | 1.086 | 0.672 | 1.477 | 1.022
COVID19_MODERNA | Nightmare | 5 | 7.848 | 0.421 | 0.899 | 1.522 | 0.379 | 0.701 | 1.207 | 0.637 | 0.862 | 0.013
COVID19_MODERNA | Bullous impetigo | 0 | 0.156 | 0.092 | 0.899 | 2.404 |  |  |  |  |  | 
COVID19_MODERNA | Recurrent cancer | 0 | 0.117 | 0.051 | 0.899 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Spinal myelogram | 0 | 0.156 | 0.092 | 0.899 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Splint application | 0 | 0.195 | 0.131 | 0.899 | 2.234 |  |  |  |  |  | 
COVID19_MODERNA | Dependent rubor | 0 | 0.156 | 0.092 | 0.899 | 2.405 |  |  |  |  |  | 
COVID19_MODERNA | Ventricular dysfunction | 0 | 0.117 | 0.051 | 0.899 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Protein total abnormal | 0 | 0.117 | 0.051 | 0.899 | 2.654 |  |  |  |  |  | 
COVID19_MODERNA | Poor weight gain neonatal | 0 | 0.117 | 0.051 | 0.899 | 2.657 |  |  |  |  |  | 
COVID19_MODERNA | CNS ventriculitis | 0 | 0.078 | 0.015 | 0.899 | 3.074 |  |  |  |  |  | 
COVID19_MODERNA | Blood selenium normal | 0 | 0.117 | 0.051 | 0.899 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Selective eating disorder | 0 | 0.134 | 0.069 | 0.899 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Influenza virus test negative | 46 | 51.367 | 0.694 | 0.898 | 1.125 | 0.701 | 0.892 | 1.121 | 0.896 | 0.797 | 2.122
COVID19_MODERNA | Eye disorder | 5 | 6.225 | 0.415 | 0.898 | 1.531 | 0.442 | 0.816 | 1.406 | 0.803 | 0.894 | 0.001
COVID19_MODERNA | Embolic and thrombotic events, arterial (SMQ) [narrow] | 111 | 141.751 | 0.763 | 0.898 | 1.042 | 0.671 | 0.784 | 0.913 | 0.783 | 4.086 | 219.663
COVID19_MODERNA | Embolic and thrombotic events, arterial (SMQ) [broad] | 111 | 141.751 | 0.763 | 0.898 | 1.042 | 0.671 | 0.784 | 0.913 | 0.783 | 4.086 | 219.663
COVID19_MODERNA | Ulcer | 1 | 1.451 | 0.333 | 0.898 | 1.686 | 0.324 | 0.791 | 1.679 | 0.689 | 0.601 | 0.012
COVID19_MODERNA | Petechiae | 24 | 31.53 | 0.632 | 0.898 | 1.203 | 0.555 | 0.769 | 1.044 | 0.761 | 0.819 | 0.762
COVID19_MODERNA | Bladder catheterisation | 2 | 2.866 | 0.347 | 0.898 | 1.66 | 0.353 | 0.775 | 1.524 | 0.698 | 0.836 | 0.007
COVID19_MODERNA | Heart rate abnormal | 3 | 4.337 | 0.392 | 0.898 | 1.571 | 0.371 | 0.758 | 1.411 | 0.692 | 1.51 | 0.115
COVID19_MODERNA | Poor quality device used | 0 | 0.078 | 0.014 | 0.898 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Allergic cough | 0 | 0.117 | 0.049 | 0.898 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Skin temperature | 0 | 0.078 | 0.014 | 0.898 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Aortic wall hypertrophy | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Chorea | 0 | 0.286 | 0.206 | 0.898 | 1.986 |  |  |  |  |  | 
COVID19_MODERNA | Bronchitis bacterial | 0 | 0.117 | 0.05 | 0.898 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell scan | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Adrenocortical steroid therapy | 0 | 0.117 | 0.05 | 0.898 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Tongue paralysis | 0 | 0.209 | 0.143 | 0.898 | 2.188 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal disorder | 0 | 0.4 | 0.28 | 0.898 | 1.8 |  |  |  |  |  | 
COVID19_MODERNA | Testicular disorder | 0 | 0.117 | 0.049 | 0.898 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Extravasation blood | 0 | 0.117 | 0.049 | 0.898 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis eosinophilic | 0 | 0.117 | 0.05 | 0.898 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Fibrinolysis | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | pH urine decreased | 0 | 0.117 | 0.05 | 0.898 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Pleural fibrosis | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Administration related reaction | 0 | 0.117 | 0.05 | 0.898 | 2.663 |  |  |  |  |  | 
COVID19_MODERNA | Adenosine deaminase increased | 0 | 0.078 | 0.014 | 0.898 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Skin neoplasm excision | 0 | 0.078 | 0.015 | 0.898 | 3.076 |  |  |  |  |  | 
COVID19_MODERNA | IIIrd nerve disorder | 0 | 0.117 | 0.049 | 0.898 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Parasite blood test positive | 0 | 0.117 | 0.05 | 0.898 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration pleural cavity abnormal | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system lupus | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Blood 1,25-dihydroxycholecalciferol | 0 | 0.078 | 0.014 | 0.898 | 3.079 |  |  |  |  |  | 
COVID19_MODERNA | Trance | 0 | 0.117 | 0.049 | 0.898 | 2.663 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural infection | 0 | 0.078 | 0.014 | 0.898 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Blood uric acid abnormal | 0 | 0.078 | 0.015 | 0.898 | 3.078 |  |  |  |  |  | 
COVID19_MODERNA | Diffuse alopecia | 0 | 0.117 | 0.049 | 0.898 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Red cell distribution width decreased | 0 | 0.156 | 0.091 | 0.898 | 2.407 |  |  |  |  |  | 
COVID19_MODERNA | Trichorrhexis | 0 | 0.117 | 0.05 | 0.898 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic vasculitis | 0 | 0.117 | 0.049 | 0.898 | 2.663 |  |  |  |  |  | 
COVID19_MODERNA | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [narrow] | 131 | 156.97 | 0.773 | 0.897 | 1.028 | 0.723 | 0.835 | 0.96 | 0.835 | 4.307 | 281.02
COVID19_MODERNA | Weight bearing difficulty | 8 | 10.023 | 0.507 | 0.897 | 1.376 | 0.482 | 0.809 | 1.292 | 0.798 | 0.498 | 3.472
COVID19_MODERNA | Serum sickness | 1 | 1.795 | 0.412 | 0.897 | 1.533 | 0.301 | 0.739 | 1.571 | 0.557 | 0.329 | 0.751
COVID19_MODERNA | Incomplete course of vaccination | 6 | 10.369 | 0.402 | 0.897 | 1.549 | 0.362 | 0.646 | 1.08 | 0.579 | 0.194 | 19.128
COVID19_MODERNA | Simple partial seizures | 0 | 0.117 | 0.048 | 0.897 | 2.672 |  |  |  |  |  | 
COVID19_MODERNA | Nasal turbinate hypertrophy | 0 | 0.117 | 0.048 | 0.897 | 2.671 |  |  |  |  |  | 
COVID19_MODERNA | Benign lymph node neoplasm | 0 | 0.156 | 0.088 | 0.897 | 2.419 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulin G4 related disease | 0 | 0.117 | 0.048 | 0.897 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Promyelocyte count | 0 | 0.117 | 0.048 | 0.897 | 2.671 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy liver normal | 0 | 0.117 | 0.048 | 0.897 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Supportive care | 0 | 0.156 | 0.088 | 0.897 | 2.419 |  |  |  |  |  | 
COVID19_MODERNA | CSF monocyte count decreased | 0 | 0.366 | 0.258 | 0.897 | 1.85 |  |  |  |  |  | 
COVID19_MODERNA | Administration site nodule | 0 | 0.156 | 0.088 | 0.897 | 2.418 |  |  |  |  |  | 
COVID19_MODERNA | Meningoradiculitis | 0 | 0.117 | 0.048 | 0.897 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Urine nitrogen | 0 | 0.117 | 0.047 | 0.897 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Convulsion in childhood | 0 | 0.117 | 0.048 | 0.897 | 2.668 |  |  |  |  |  | 
COVID19_MODERNA | Bundle branch block | 0 | 0.117 | 0.048 | 0.897 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin D dimer increased | 36 | 40.431 | 0.672 | 0.896 | 1.146 | 0.676 | 0.886 | 1.144 | 0.89 | 8.22 | 165.712
COVID19_MODERNA | Pregnancy test urine negative | 1 | 1.237 | 0.193 | 0.896 | 2.019 | 0.339 | 0.827 | 1.755 | 0.808 | 1.233 | 0.129
COVID19_MODERNA | Severe cutaneous adverse reactions (SMQ) [broad] | 89 | 104.779 | 0.748 | 0.896 | 1.055 | 0.713 | 0.849 | 1.005 | 0.849 | 0.445 | 60.973
COVID19_MODERNA | Full blood count normal | 73 | 86.772 | 0.735 | 0.896 | 1.07 | 0.694 | 0.841 | 1.012 | 0.841 | 1.458 | 9.497
COVID19_MODERNA | Cutaneous symptom | 0 | 0.117 | 0.047 | 0.896 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Therapy change | 0 | 0.117 | 0.046 | 0.896 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Weight abnormal | 0 | 0.117 | 0.046 | 0.896 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Schizotypal personality disorder | 0 | 0.117 | 0.047 | 0.896 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Oestradiol | 0 | 0.156 | 0.086 | 0.896 | 2.425 |  |  |  |  |  | 
COVID19_MODERNA | Anti-VGCC antibody | 0 | 0.117 | 0.046 | 0.896 | 2.679 |  |  |  |  |  | 
COVID19_MODERNA | Granulocytes abnormal | 0 | 0.117 | 0.047 | 0.896 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Genital ulceration | 0 | 0.156 | 0.087 | 0.896 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Aversion | 0 | 0.117 | 0.047 | 0.896 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Optic disc disorder | 0 | 0.117 | 0.047 | 0.896 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Pseudomonas infection | 0 | 0.156 | 0.087 | 0.896 | 2.423 |  |  |  |  |  | 
COVID19_MODERNA | Monocyte count abnormal | 0 | 0.117 | 0.047 | 0.896 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Breast enlargement | 0 | 0.117 | 0.047 | 0.896 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Hypochromasia | 0 | 0.156 | 0.087 | 0.896 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Intervertebral disc space narrowing | 0 | 0.117 | 0.047 | 0.896 | 2.679 |  |  |  |  |  | 
COVID19_MODERNA | Carotid artery dissection | 0 | 0.117 | 0.046 | 0.896 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Haptoglobin increased | 0 | 0.117 | 0.047 | 0.896 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Central vision loss | 0 | 0.156 | 0.087 | 0.896 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy small intestine abnormal | 0 | 0.117 | 0.047 | 0.896 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [broad] | 131 | 157.079 | 0.772 | 0.895 | 1.027 | 0.722 | 0.834 | 0.959 | 0.834 | 4.29 | 279.388
COVID19_MODERNA | Echocardiogram normal | 30 | 40.972 | 0.649 | 0.895 | 1.174 | 0.552 | 0.741 | 0.978 | 0.732 | 2.228 | 17.495
COVID19_MODERNA | Cardiovascular symptom | 0 | 0.156 | 0.085 | 0.895 | 2.429 |  |  |  |  |  | 
COVID19_MODERNA | Anti-platelet antibody | 0 | 0.117 | 0.046 | 0.895 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Onychomycosis | 0 | 0.156 | 0.084 | 0.895 | 2.43 |  |  |  |  |  | 
COVID19_MODERNA | Tumour excision | 0 | 0.156 | 0.084 | 0.895 | 2.431 |  |  |  |  |  | 
COVID19_MODERNA | Enterocolitis viral | 0 | 0.078 | 0.013 | 0.895 | 3.102 |  |  |  |  |  | 
COVID19_MODERNA | Dust allergy | 0 | 0.117 | 0.045 | 0.895 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Glutathione decreased | 0 | 0.078 | 0.013 | 0.895 | 3.104 |  |  |  |  |  | 
COVID19_MODERNA | Vulvar dysplasia | 0 | 0.117 | 0.046 | 0.895 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Surgical failure | 0 | 0.078 | 0.013 | 0.895 | 3.108 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy soft tissue | 0 | 0.078 | 0.013 | 0.895 | 3.106 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis enteroviral | 0 | 0.078 | 0.013 | 0.895 | 3.101 |  |  |  |  |  | 
COVID19_MODERNA | Leptospirosis | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms malignant and unspecified (SMQ) [broad] | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy gastrointestinal abnormal | 0 | 0.117 | 0.045 | 0.895 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Injection related reaction | 0 | 0.117 | 0.046 | 0.895 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Liver palpable | 0 | 0.117 | 0.046 | 0.895 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Anogenital dysplasia | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Menstrual discomfort | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms malignant and unspecified (SMQ) [narrow] | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Septic encephalopathy | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular autonomic function test normal | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Oestradiol increased | 0 | 0.078 | 0.013 | 0.895 | 3.104 |  |  |  |  |  | 
COVID19_MODERNA | Circumstance or information capable of leading to device use error | 0 | 0.117 | 0.046 | 0.895 | 2.681 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to lung | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Similar reaction on previous exposure to drug | 0 | 0.309 | 0.215 | 0.895 | 1.953 |  |  |  |  |  | 
COVID19_MODERNA | Premenstrual dysphoric disorder | 0 | 0.117 | 0.046 | 0.895 | 2.683 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal hernia | 0 | 0.117 | 0.045 | 0.895 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol test negative | 0 | 0.078 | 0.013 | 0.895 | 3.106 |  |  |  |  |  | 
COVID19_MODERNA | Ear infection bacterial | 0 | 0.117 | 0.046 | 0.895 | 2.684 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy brain normal | 0 | 0.117 | 0.045 | 0.895 | 2.687 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic response changed | 0 | 0.078 | 0.013 | 0.895 | 3.104 |  |  |  |  |  | 
COVID19_MODERNA | Cytology abnormal | 0 | 0.086 | 0.018 | 0.895 | 3.001 |  |  |  |  |  | 
COVID19_MODERNA | Adnexa uteri mass | 0 | 0.078 | 0.013 | 0.895 | 3.108 |  |  |  |  |  | 
COVID19_MODERNA | Glomerular filtration rate normal | 4 | 4.309 | 0.44 | 0.894 | 1.476 | 0.46 | 0.888 | 1.583 | 0.928 | 1.934 | 0.894
COVID19_MODERNA | Dementia (SMQ) [broad] | 798 | 903.29 | 0.843 | 0.894 | 0.947 | 0.833 | 0.883 | 0.936 | 0.883 | 1.227 | 33.281
COVID19_MODERNA | Accidents and injuries (SMQ) [broad] | 255 | 296.426 | 0.805 | 0.894 | 0.987 | 0.775 | 0.86 | 0.952 | 0.86 | 0.912 | 2.042
COVID19_MODERNA | Ear pain | 50 | 59.257 | 0.703 | 0.894 | 1.104 | 0.67 | 0.844 | 1.051 | 0.844 | 1.62 | 10.569
COVID19_MODERNA | Anticonvulsant drug level therapeutic | 0 | 0.156 | 0.084 | 0.894 | 2.432 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound breast | 0 | 0.156 | 0.084 | 0.894 | 2.432 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 globulin increased | 0 | 0.156 | 0.083 | 0.894 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Mental disability | 0 | 0.117 | 0.044 | 0.894 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Coronary artery dilatation | 0 | 0.244 | 0.165 | 0.894 | 2.1 |  |  |  |  |  | 
COVID19_MODERNA | Scan thyroid gland | 0 | 0.234 | 0.156 | 0.894 | 2.131 |  |  |  |  |  | 
COVID19_MODERNA | Blood corticotrophin | 0 | 0.195 | 0.121 | 0.894 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Legal problem | 0 | 0.117 | 0.044 | 0.894 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Weight gain poor | 0 | 0.165 | 0.093 | 0.894 | 2.386 |  |  |  |  |  | 
COVID19_MODERNA | Encephalomalacia | 0 | 0.234 | 0.157 | 0.894 | 2.128 |  |  |  |  |  | 
COVID19_MODERNA | Immune reconstitution inflammatory syndrome | 0 | 0.117 | 0.044 | 0.894 | 2.693 |  |  |  |  |  | 
COVID19_MODERNA | Neuro-ophthalmological test normal | 0 | 0.117 | 0.045 | 0.894 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Spinal anaesthesia | 0 | 0.078 | 0.012 | 0.894 | 3.111 |  |  |  |  |  | 
COVID19_MODERNA | Meniscus injury | 0 | 0.195 | 0.12 | 0.894 | 2.261 |  |  |  |  |  | 
COVID19_MODERNA | Skin sensitisation | 2 | 1.686 | 0.339 | 0.893 | 1.66 | 0.434 | 0.95 | 1.868 | 1.187 | 2.349 | 0.423
COVID19_MODERNA | Hypokinesia | 5 | 5.94 | 0.412 | 0.893 | 1.522 | 0.456 | 0.841 | 1.448 | 0.842 | 0.725 | 0.266
COVID19_MODERNA | Herpes simplex test negative | 2 | 3.392 | 0.278 | 0.893 | 1.792 | 0.325 | 0.716 | 1.409 | 0.59 | 0.185 | 6.331
COVID19_MODERNA | Penile haemorrhage | 0 | 0.195 | 0.118 | 0.893 | 2.267 |  |  |  |  |  | 
COVID19_MODERNA | Vagus nerve disorder | 0 | 0.117 | 0.043 | 0.893 | 2.699 |  |  |  |  |  | 
COVID19_MODERNA | Spleen scan normal | 0 | 0.234 | 0.154 | 0.893 | 2.134 |  |  |  |  |  | 
COVID19_MODERNA | Cervical dilatation | 0 | 0.117 | 0.043 | 0.893 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Enterovirus test | 0 | 0.245 | 0.163 | 0.893 | 2.103 |  |  |  |  |  | 
COVID19_MODERNA | B-lymphocyte count increased | 0 | 0.117 | 0.043 | 0.893 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Hernia repair | 0 | 0.195 | 0.119 | 0.893 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | Anticonvulsant drug level | 0 | 0.195 | 0.119 | 0.893 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | External ear inflammation | 0 | 0.156 | 0.081 | 0.893 | 2.443 |  |  |  |  |  | 
COVID19_MODERNA | Positron emission tomography-magnetic resonance imaging | 0 | 0.156 | 0.081 | 0.893 | 2.443 |  |  |  |  |  | 
COVID19_MODERNA | Tinea cruris | 0 | 0.117 | 0.043 | 0.893 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Urodynamics measurement | 0 | 0.156 | 0.082 | 0.893 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster meningoencephalitis | 0 | 0.058 | 0.003 | 0.893 | 3.478 |  |  |  |  |  | 
COVID19_MODERNA | Cranial nerve palsies multiple | 0 | 0.117 | 0.043 | 0.893 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Widal test | 0 | 0.117 | 0.043 | 0.893 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Terminal insomnia | 0 | 0.156 | 0.081 | 0.893 | 2.443 |  |  |  |  |  | 
COVID19_MODERNA | Breath sounds normal | 0 | 0.195 | 0.119 | 0.893 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | Dental operation | 0 | 0.117 | 0.043 | 0.893 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary tuberculosis | 0 | 0.117 | 0.044 | 0.893 | 2.695 |  |  |  |  |  | 
COVID19_MODERNA | Haemolytic anaemia | 4 | 3.572 | 0.412 | 0.892 | 1.521 | 0.508 | 0.979 | 1.746 | 1.12 | 2.74 | 2.516
COVID19_MODERNA | Computerised tomogram head abnormal | 26 | 28.708 | 0.639 | 0.892 | 1.179 | 0.656 | 0.898 | 1.207 | 0.906 | 3.542 | 39.226
COVID19_MODERNA | Cholelithiasis | 6 | 7.192 | 0.48 | 0.892 | 1.406 | 0.47 | 0.836 | 1.398 | 0.834 | 4.932 | 12.452
COVID19_MODERNA | Liver related investigations, signs and symptoms (SMQ) [narrow] | 56 | 72.279 | 0.709 | 0.892 | 1.093 | 0.625 | 0.778 | 0.959 | 0.775 | 1.142 | 0.815
COVID19_MODERNA | CSF culture | 1 | 1.908 | 0.178 | 0.892 | 2.052 | 0.294 | 0.723 | 1.538 | 0.524 | 0.514 | 0.091
COVID19_MODERNA | Product taste abnormal | 0 | 0.117 | 0.042 | 0.892 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Blood follicle stimulating hormone normal | 0 | 0.117 | 0.042 | 0.892 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Dyslexia | 0 | 0.156 | 0.079 | 0.892 | 2.449 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary arterial pressure increased | 0 | 0.117 | 0.042 | 0.892 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Electrolyte substitution therapy | 0 | 0.117 | 0.042 | 0.892 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound kidney abnormal | 0 | 0.204 | 0.126 | 0.892 | 2.236 |  |  |  |  |  | 
COVID19_MODERNA | Patellofemoral pain syndrome | 0 | 0.156 | 0.08 | 0.892 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Jaw operation | 0 | 0.156 | 0.079 | 0.892 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Lung transplant | 0 | 0.117 | 0.042 | 0.892 | 2.704 |  |  |  |  |  | 
COVID19_MODERNA | Alpha tumour necrosis factor increased | 0 | 0.117 | 0.041 | 0.892 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Gallbladder oedema | 0 | 0.117 | 0.042 | 0.892 | 2.708 |  |  |  |  |  | 
COVID19_MODERNA | Subacute inflammatory demyelinating polyneuropathy | 0 | 0.117 | 0.041 | 0.892 | 2.708 |  |  |  |  |  | 
COVID19_MODERNA | Knee operation | 0 | 0.156 | 0.079 | 0.892 | 2.449 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram liver abnormal | 0 | 0.117 | 0.042 | 0.892 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Tumour markers (SMQ) [narrow] | 2 | 2.524 | 0.229 | 0.891 | 1.905 | 0.373 | 0.819 | 1.61 | 0.792 | 0.667 | 0.075
COVID19_MODERNA | Tumour markers (SMQ) [broad] | 2 | 2.524 | 0.229 | 0.891 | 1.905 | 0.373 | 0.819 | 1.61 | 0.792 | 0.667 | 0.075
COVID19_MODERNA | Blood creatine phosphokinase normal | 7 | 8.853 | 0.462 | 0.891 | 1.433 | 0.467 | 0.805 | 1.313 | 0.791 | 0.774 | 0.249
COVID19_MODERNA | Activated partial thromboplastin time shortened | 2 | 3.278 | 0.341 | 0.891 | 1.652 | 0.331 | 0.728 | 1.433 | 0.61 | 0.986 | 0.115
COVID19_MODERNA | Rhabdomyosarcoma | 0 | 0.117 | 0.04 | 0.891 | 2.714 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0.156 | 0.078 | 0.891 | 2.452 |  |  |  |  |  | 
COVID19_MODERNA | Vasospasm | 0 | 0.117 | 0.041 | 0.891 | 2.712 |  |  |  |  |  | 
COVID19_MODERNA | Enzyme level test | 0 | 0.156 | 0.078 | 0.891 | 2.452 |  |  |  |  |  | 
COVID19_MODERNA | Nerve degeneration | 0 | 0.117 | 0.04 | 0.891 | 2.714 |  |  |  |  |  | 
COVID19_MODERNA | Amoeba test negative | 0 | 0.117 | 0.041 | 0.891 | 2.713 |  |  |  |  |  | 
COVID19_MODERNA | Acidosis hyperchloraemic | 0 | 0.117 | 0.04 | 0.891 | 2.715 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0.156 | 0.078 | 0.891 | 2.452 |  |  |  |  |  | 
COVID19_MODERNA | Breast abscess | 0 | 0.117 | 0.04 | 0.891 | 2.714 |  |  |  |  |  | 
COVID19_MODERNA | Stomach mass | 0 | 0.117 | 0.041 | 0.891 | 2.71 |  |  |  |  |  | 
COVID19_MODERNA | Skull fractured base | 0 | 0.117 | 0.041 | 0.891 | 2.712 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram PR prolongation | 0 | 0.156 | 0.078 | 0.891 | 2.454 |  |  |  |  |  | 
COVID19_MODERNA | Relapsing fever | 0 | 0.117 | 0.041 | 0.891 | 2.712 |  |  |  |  |  | 
COVID19_MODERNA | Hypoaesthesia | 416 | 475.847 | 0.819 | 0.89 | 0.962 | 0.806 | 0.874 | 0.946 | 0.874 | 1.827 | 146.891
COVID19_MODERNA | Odynophagia | 7 | 8.274 | 0.477 | 0.89 | 1.407 | 0.489 | 0.844 | 1.377 | 0.846 | 1.78 | 1.538
COVID19_MODERNA | Neuroleptic malignant syndrome (SMQ) [algorithm] | 2 | 2.948 | 0.283 | 0.89 | 1.771 | 0.348 | 0.766 | 1.505 | 0.679 | 0.213 | 5.003
COVID19_MODERNA | Blood cholesterol normal | 1 | 2.132 | 0.304 | 0.89 | 1.725 | 0.281 | 0.693 | 1.478 | 0.469 | 0.617 | 0.006
COVID19_MODERNA | Glomerular filtration rate increased | 0 | 0.117 | 0.04 | 0.89 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | Canalith repositioning procedure | 0 | 0.156 | 0.076 | 0.89 | 2.461 |  |  |  |  |  | 
COVID19_MODERNA | Erythromelalgia | 0 | 0.117 | 0.04 | 0.89 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Finger amputation | 0 | 0.156 | 0.077 | 0.89 | 2.457 |  |  |  |  |  | 
COVID19_MODERNA | Nasal polyps | 0 | 0.156 | 0.076 | 0.89 | 2.459 |  |  |  |  |  | 
COVID19_MODERNA | Retinal degeneration | 0 | 0.156 | 0.076 | 0.89 | 2.46 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor VII level decreased | 0 | 0.117 | 0.039 | 0.89 | 2.72 |  |  |  |  |  | 
COVID19_MODERNA | Device issue | 0 | 0.117 | 0.04 | 0.89 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | Bronchopneumopathy | 0 | 0.156 | 0.077 | 0.89 | 2.458 |  |  |  |  |  | 
COVID19_MODERNA | Exophthalmos | 0 | 0.101 | 0.026 | 0.89 | 2.87 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid cyst | 0 | 0.156 | 0.077 | 0.89 | 2.456 |  |  |  |  |  | 
COVID19_MODERNA | Urine copper | 0 | 0.117 | 0.04 | 0.89 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Thymectomy | 0 | 0.117 | 0.04 | 0.89 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Antimitochondrial antibody normal | 0 | 0.156 | 0.076 | 0.89 | 2.46 |  |  |  |  |  | 
COVID19_MODERNA | Gastritis viral | 0 | 0.156 | 0.077 | 0.89 | 2.458 |  |  |  |  |  | 
COVID19_MODERNA | Bronchopulmonary aspergillosis | 0 | 0.156 | 0.077 | 0.89 | 2.457 |  |  |  |  |  | 
COVID19_MODERNA | Foetal monitoring abnormal | 0 | 0.117 | 0.04 | 0.89 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | Lower motor neurone lesion | 0 | 0.078 | 0.01 | 0.89 | 3.147 |  |  |  |  |  | 
COVID19_MODERNA | Gastroschisis | 0 | 0.117 | 0.04 | 0.89 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral infarction | 9 | 10.921 | 0.51 | 0.889 | 1.352 | 0.504 | 0.828 | 1.298 | 0.824 | 3.699 | 13.07
COVID19_MODERNA | Ultrasound scan | 28 | 34.184 | 0.647 | 0.889 | 1.162 | 0.606 | 0.821 | 1.093 | 0.819 | 1.164 | 0.469
COVID19_MODERNA | Nerve stimulation test abnormal | 0 | 0.156 | 0.074 | 0.889 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Nasal irrigation | 0 | 0.078 | 0.01 | 0.889 | 3.153 |  |  |  |  |  | 
COVID19_MODERNA | Regressive behaviour | 0 | 0.25 | 0.159 | 0.889 | 2.107 |  |  |  |  |  | 
COVID19_MODERNA | Acute stress disorder | 0 | 0.117 | 0.038 | 0.889 | 2.727 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmic scan | 0 | 0.156 | 0.074 | 0.889 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Drop attacks | 0 | 0.156 | 0.075 | 0.889 | 2.463 |  |  |  |  |  | 
COVID19_MODERNA | Oedematous pancreatitis | 0 | 0.117 | 0.039 | 0.889 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Idiosyncratic drug reaction | 0 | 0.117 | 0.038 | 0.889 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor increased | 0 | 0.156 | 0.076 | 0.889 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Calcium ionised increased | 0 | 0.195 | 0.112 | 0.889 | 2.284 |  |  |  |  |  | 
COVID19_MODERNA | Retinal vasculitis | 0 | 0.156 | 0.074 | 0.889 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Arterial injury | 0 | 0.156 | 0.075 | 0.889 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Pituitary tumour | 0 | 0.117 | 0.039 | 0.889 | 2.725 |  |  |  |  |  | 
COVID19_MODERNA | Skin culture positive | 0 | 0.156 | 0.075 | 0.889 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol abuse | 0 | 0.117 | 0.038 | 0.889 | 2.728 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster necrotising retinopathy | 0 | 0.078 | 0.01 | 0.889 | 3.15 |  |  |  |  |  | 
COVID19_MODERNA | Corneal endotheliitis | 0 | 0.078 | 0.01 | 0.889 | 3.15 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure orthostatic | 0 | 0.117 | 0.039 | 0.889 | 2.725 |  |  |  |  |  | 
COVID19_MODERNA | Retinal injury | 0 | 0.078 | 0.01 | 0.889 | 3.15 |  |  |  |  |  | 
COVID19_MODERNA | Blood iron abnormal | 0 | 0.117 | 0.038 | 0.889 | 2.727 |  |  |  |  |  | 
COVID19_MODERNA | Macular fibrosis | 0 | 0.078 | 0.01 | 0.889 | 3.15 |  |  |  |  |  | 
COVID19_MODERNA | Retinal depigmentation | 0 | 0.117 | 0.038 | 0.889 | 2.727 |  |  |  |  |  | 
COVID19_MODERNA | Blood HIV RNA below assay limit | 0 | 0.195 | 0.112 | 0.889 | 2.284 |  |  |  |  |  | 
COVID19_MODERNA | Heart rate decreased | 23 | 25.994 | 0.635 | 0.888 | 1.175 | 0.63 | 0.879 | 1.2 | 0.885 | 2.07 | 10.742
COVID19_MODERNA | Lens disorders (SMQ) [broad] | 131 | 155.98 | 0.765 | 0.888 | 1.018 | 0.727 | 0.84 | 0.966 | 0.84 | 1.109 | 1.257
COVID19_MODERNA | Glaucoma (SMQ) [broad] | 261 | 311.042 | 0.8 | 0.888 | 0.98 | 0.758 | 0.839 | 0.927 | 0.839 | 1.112 | 2.748
COVID19_MODERNA | Pulpitis dental | 0 | 0.156 | 0.074 | 0.888 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Synovial biopsy abnormal | 0 | 0.117 | 0.037 | 0.888 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Galactorrhoea | 0 | 0.117 | 0.037 | 0.888 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Vertebral osteophyte | 0 | 0.156 | 0.074 | 0.888 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Pneumatosis | 0 | 0.078 | 0.01 | 0.888 | 3.16 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal discomfort | 0 | 0.195 | 0.11 | 0.888 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging hepatobiliary | 0 | 0.117 | 0.038 | 0.888 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Morphoea | 0 | 0.156 | 0.073 | 0.888 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Sexually transmitted disease | 0 | 0.117 | 0.037 | 0.888 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Blood HIV RNA increased | 0 | 0.156 | 0.074 | 0.888 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Ear canal erythema | 0 | 0.156 | 0.073 | 0.888 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Fluorescence angiogram | 0 | 0.156 | 0.073 | 0.888 | 2.472 |  |  |  |  |  | 
COVID19_MODERNA | Iodine allergy | 0 | 0.117 | 0.037 | 0.888 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Myocardial oedema | 0 | 0.117 | 0.037 | 0.888 | 2.735 |  |  |  |  |  | 
COVID19_MODERNA | Meconium in amniotic fluid | 0 | 0.117 | 0.038 | 0.888 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Reproductive tract disorder | 0 | 0.117 | 0.037 | 0.888 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Blood copper normal | 0 | 0.156 | 0.073 | 0.888 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Auditory nerve disorder | 0 | 0.156 | 0.074 | 0.888 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Hair metal test | 0 | 0.117 | 0.037 | 0.888 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Antimicrobial susceptibility test sensitive | 0 | 0.044 | 0 | 0.888 | 3.878 |  |  |  |  |  | 
COVID19_MODERNA | Excessive granulation tissue | 0 | 0.156 | 0.073 | 0.888 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Ketosis | 0 | 0.156 | 0.073 | 0.888 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Human herpes virus 8 test | 0 | 0.117 | 0.037 | 0.888 | 2.736 |  |  |  |  |  | 
COVID19_MODERNA | Gastric volvulus | 0 | 0.117 | 0.037 | 0.888 | 2.733 |  |  |  |  |  | 
COVID19_MODERNA | Insomnia | 97 | 112.568 | 0.748 | 0.887 | 1.037 | 0.728 | 0.861 | 1.012 | 0.862 | 0.706 | 11.342
COVID19_MODERNA | Spinal pain | 10 | 11.783 | 0.546 | 0.887 | 1.295 | 0.526 | 0.846 | 1.305 | 0.849 | 1.086 | 0.008
COVID19_MODERNA | Feeling abnormal | 310 | 369.366 | 0.806 | 0.887 | 0.97 | 0.764 | 0.839 | 0.92 | 0.839 | 1.764 | 96.368
COVID19_MODERNA | Bronchospasm | 5 | 6.636 | 0.411 | 0.887 | 1.51 | 0.425 | 0.784 | 1.349 | 0.753 | 0.971 | 0.026
COVID19_MODERNA | Pyloric stenosis | 0 | 0.156 | 0.071 | 0.887 | 2.479 |  |  |  |  |  | 
COVID19_MODERNA | Frostbite | 0 | 0.117 | 0.036 | 0.887 | 2.741 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body in gastrointestinal tract | 0 | 0.117 | 0.036 | 0.887 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Oestradiol normal | 0 | 0.117 | 0.036 | 0.887 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site macule | 0 | 0.156 | 0.071 | 0.887 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine urine normal | 0 | 0.117 | 0.037 | 0.887 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Bickerstaff's encephalitis | 0 | 0.156 | 0.071 | 0.887 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Graft versus host disease in gastrointestinal tract | 0 | 0.117 | 0.036 | 0.887 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Nasal crusting | 0 | 0.117 | 0.037 | 0.887 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Premenstrual syndrome | 0 | 0.156 | 0.072 | 0.887 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Chemical burn | 0 | 0.117 | 0.036 | 0.887 | 2.741 |  |  |  |  |  | 
COVID19_MODERNA | Tooth avulsion | 0 | 0.078 | 0.009 | 0.887 | 3.168 |  |  |  |  |  | 
COVID19_MODERNA | Plasma viscosity normal | 0 | 0.117 | 0.036 | 0.887 | 2.739 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 microglobulin increased | 0 | 0.117 | 0.036 | 0.887 | 2.741 |  |  |  |  |  | 
COVID19_MODERNA | Histology abnormal | 0 | 0.156 | 0.072 | 0.887 | 2.475 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac pacemaker evaluation | 0 | 0.234 | 0.141 | 0.887 | 2.163 |  |  |  |  |  | 
COVID19_MODERNA | Corneal infiltrates | 0 | 0.156 | 0.072 | 0.887 | 2.475 |  |  |  |  |  | 
COVID19_MODERNA | Lower gastrointestinal haemorrhage | 0 | 0.117 | 0.037 | 0.887 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Tissue injury | 0 | 0.156 | 0.072 | 0.887 | 2.476 |  |  |  |  |  | 
COVID19_MODERNA | Atrial fibrillation | 65 | 74.434 | 0.715 | 0.886 | 1.073 | 0.711 | 0.872 | 1.059 | 0.873 | 5.434 | 189.133
COVID19_MODERNA | Culture urine negative | 11 | 14.233 | 0.514 | 0.886 | 1.34 | 0.497 | 0.786 | 1.194 | 0.773 | 0.745 | 0.691
COVID19_MODERNA | Thrombin time | 0 | 0.195 | 0.106 | 0.886 | 2.301 |  |  |  |  |  | 
COVID19_MODERNA | Retinogram abnormal | 0 | 0.195 | 0.106 | 0.886 | 2.3 |  |  |  |  |  | 
COVID19_MODERNA | Intra-abdominal fluid collection | 0 | 0.156 | 0.071 | 0.886 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Sydenham's chorea | 0 | 0.156 | 0.07 | 0.886 | 2.483 |  |  |  |  |  | 
COVID19_MODERNA | Borrelia infection | 0 | 0.117 | 0.035 | 0.886 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid myoclonus | 0 | 0.117 | 0.035 | 0.886 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Borderline personality disorder | 0 | 0.117 | 0.035 | 0.886 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Albumin CSF | 0 | 0.086 | 0.013 | 0.886 | 3.072 |  |  |  |  |  | 
COVID19_MODERNA | Adjustment disorder with depressed mood | 0 | 0.117 | 0.036 | 0.886 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Gulf war syndrome | 0 | 0.117 | 0.035 | 0.886 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | CSF volume | 0 | 0.117 | 0.035 | 0.886 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Bed sharing | 0 | 0.204 | 0.114 | 0.886 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | Lipids normal | 3 | 3.178 | 0.348 | 0.885 | 1.62 | 0.436 | 0.888 | 1.653 | 0.944 | 2.74 | 1.577
COVID19_MODERNA | Magnetic resonance imaging | 93 | 114.343 | 0.744 | 0.885 | 1.037 | 0.686 | 0.814 | 0.96 | 0.813 | 1.487 | 13.596
COVID19_MODERNA | Colour vision tests abnormal | 0 | 0.117 | 0.035 | 0.885 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | Coccydynia | 0 | 0.259 | 0.156 | 0.885 | 2.102 |  |  |  |  |  | 
COVID19_MODERNA | Blood disorder | 0 | 0.252 | 0.152 | 0.885 | 2.117 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound testes normal | 0 | 0.117 | 0.035 | 0.885 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Anal cancer | 0 | 0.117 | 0.034 | 0.885 | 2.752 |  |  |  |  |  | 
COVID19_MODERNA | Sarcoma | 0 | 0.156 | 0.069 | 0.885 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Sinus arrest | 0 | 0.156 | 0.069 | 0.885 | 2.486 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to arthropod sting | 0 | 0.234 | 0.137 | 0.885 | 2.171 |  |  |  |  |  | 
COVID19_MODERNA | Blood HIV RNA | 0 | 0.117 | 0.034 | 0.885 | 2.754 |  |  |  |  |  | 
COVID19_MODERNA | X-ray dental | 0 | 0.195 | 0.104 | 0.885 | 2.304 |  |  |  |  |  | 
COVID19_MODERNA | New daily persistent headache | 0 | 0.069 | 0.005 | 0.885 | 3.321 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E virus test positive | 0 | 0.117 | 0.035 | 0.885 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Skin oedema | 0 | 0.126 | 0.042 | 0.885 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Loss of libido | 0 | 0.117 | 0.035 | 0.885 | 2.751 |  |  |  |  |  | 
COVID19_MODERNA | Perinatal depression | 0 | 0.117 | 0.034 | 0.885 | 2.752 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [narrow] | 13 | 16.984 | 0.539 | 0.884 | 1.298 | 0.508 | 0.778 | 1.152 | 0.765 | 1.028 | 0.002
COVID19_MODERNA | Cytomegalovirus test negative | 2 | 2.904 | 0.246 | 0.884 | 1.843 | 0.351 | 0.771 | 1.515 | 0.689 | 0.2 | 5.569
COVID19_MODERNA | Fluorescence angiogram abnormal | 0 | 0.117 | 0.033 | 0.884 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary pneumatocele | 0 | 0.156 | 0.067 | 0.884 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Sleep terror | 0 | 0.357 | 0.221 | 0.884 | 1.908 |  |  |  |  |  | 
COVID19_MODERNA | Vascular injury | 0 | 0.267 | 0.16 | 0.884 | 2.087 |  |  |  |  |  | 
COVID19_MODERNA | Blood electrolytes decreased | 0 | 0.117 | 0.033 | 0.884 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Analgesic drug level | 0 | 0.195 | 0.103 | 0.884 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Beta 2 globulin | 0 | 0.117 | 0.033 | 0.884 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Urine uric acid increased | 0 | 0.117 | 0.033 | 0.884 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 microglobulin increased | 0 | 0.117 | 0.033 | 0.884 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Albumin CSF decreased | 0 | 0.156 | 0.068 | 0.884 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Antineutrophil cytoplasmic antibody increased | 0 | 0.156 | 0.067 | 0.884 | 2.496 |  |  |  |  |  | 
COVID19_MODERNA | Scleral discolouration | 0 | 0.156 | 0.067 | 0.884 | 2.496 |  |  |  |  |  | 
COVID19_MODERNA | Febrile infection-related epilepsy syndrome | 0 | 0.117 | 0.033 | 0.884 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram repolarisation abnormality | 0 | 0.117 | 0.034 | 0.884 | 2.758 |  |  |  |  |  | 
COVID19_MODERNA | Breast pain | 17 | 20.82 | 0.611 | 0.883 | 1.195 | 0.56 | 0.82 | 1.167 | 0.817 | 2.206 | 9.179
COVID19_MODERNA | White blood cells urine positive | 4 | 5.873 | 0.359 | 0.883 | 1.596 | 0.384 | 0.741 | 1.321 | 0.681 | 0.685 | 0.29
COVID19_MODERNA | Gene mutation identification test positive | 0 | 0.225 | 0.126 | 0.883 | 2.207 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal candidiasis | 0 | 0.117 | 0.032 | 0.883 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Otitis externa | 0 | 0.212 | 0.114 | 0.883 | 2.253 |  |  |  |  |  | 
COVID19_MODERNA | Astigmatism | 0 | 0.072 | 0.005 | 0.883 | 3.287 |  |  |  |  |  | 
COVID19_MODERNA | Hair follicle tumour benign | 0 | 0.117 | 0.033 | 0.883 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Rectal discharge | 0 | 0.078 | 0.008 | 0.883 | 3.198 |  |  |  |  |  | 
COVID19_MODERNA | Insulin C-peptide decreased | 0 | 0.156 | 0.066 | 0.883 | 2.498 |  |  |  |  |  | 
COVID19_MODERNA | Scan adrenal gland | 0 | 0.156 | 0.066 | 0.883 | 2.499 |  |  |  |  |  | 
COVID19_MODERNA | Ligament laxity | 0 | 0.117 | 0.032 | 0.883 | 2.768 |  |  |  |  |  | 
COVID19_MODERNA | Platelet morphology abnormal | 0 | 0.156 | 0.065 | 0.883 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Congenital central nervous system anomaly | 0 | 0.156 | 0.065 | 0.883 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal motility disorder | 0 | 0.156 | 0.066 | 0.883 | 2.498 |  |  |  |  |  | 
COVID19_MODERNA | Phenylketonuria | 0 | 0.117 | 0.032 | 0.883 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid gland scan abnormal | 0 | 0.117 | 0.032 | 0.883 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia chlamydial | 0 | 0.156 | 0.065 | 0.883 | 2.501 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic myocarditis | 0 | 0.117 | 0.032 | 0.883 | 2.766 |  |  |  |  |  | 
COVID19_MODERNA | Learning disability | 0 | 0.085 | 0.011 | 0.883 | 3.096 |  |  |  |  |  | 
COVID19_MODERNA | Epistaxis | 28 | 35.16 | 0.634 | 0.882 | 1.163 | 0.591 | 0.8 | 1.065 | 0.796 | 1.531 | 4.356
COVID19_MODERNA | Pharyngeal oedema | 2 | 2.727 | 0.414 | 0.882 | 1.492 | 0.361 | 0.793 | 1.558 | 0.733 | 0.082 | 19.601
COVID19_MODERNA | Blood albumin decreased | 7 | 11.249 | 0.454 | 0.882 | 1.424 | 0.391 | 0.675 | 1.101 | 0.622 | 1.04 | 0.009
COVID19_MODERNA | Metabolic encephalopathy | 2 | 3.695 | 0.319 | 0.882 | 1.673 | 0.311 | 0.686 | 1.351 | 0.541 | 3.794 | 1.492
COVID19_MODERNA | Platelet disorder | 0 | 0.273 | 0.161 | 0.882 | 2.078 |  |  |  |  |  | 
COVID19_MODERNA | Oral papilloma | 0 | 0.078 | 0.007 | 0.882 | 3.205 |  |  |  |  |  | 
COVID19_MODERNA | Cutaneous T-cell lymphoma | 0 | 0.156 | 0.065 | 0.882 | 2.503 |  |  |  |  |  | 
COVID19_MODERNA | Cervical vertebral fracture | 0 | 0.156 | 0.064 | 0.882 | 2.505 |  |  |  |  |  | 
COVID19_MODERNA | CSF white blood cell count | 0 | 0.195 | 0.099 | 0.882 | 2.318 |  |  |  |  |  | 
COVID19_MODERNA | Autoantibody test | 0 | 0.195 | 0.098 | 0.882 | 2.321 |  |  |  |  |  | 
COVID19_MODERNA | Dandruff | 0 | 0.117 | 0.031 | 0.882 | 2.772 |  |  |  |  |  | 
COVID19_MODERNA | Weight decrease neonatal | 0 | 0.078 | 0.007 | 0.882 | 3.205 |  |  |  |  |  | 
COVID19_MODERNA | Palatal ulcer | 0 | 0.117 | 0.032 | 0.882 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Drug intolerance | 0 | 0.224 | 0.123 | 0.882 | 2.215 |  |  |  |  |  | 
COVID19_MODERNA | Dermatitis diaper | 0 | 0.72 | 0.361 | 0.882 | 1.587 |  |  |  |  |  | 
COVID19_MODERNA | Booster dose missed | 0 | 0.117 | 0.032 | 0.882 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Administration site joint pain | 0 | 0.117 | 0.031 | 0.882 | 2.772 |  |  |  |  |  | 
COVID19_MODERNA | Mammogram | 0 | 0.282 | 0.167 | 0.882 | 2.058 |  |  |  |  |  | 
COVID19_MODERNA | Growth disorder | 0 | 0.156 | 0.065 | 0.882 | 2.503 |  |  |  |  |  | 
COVID19_MODERNA | Maternal exposure timing unspecified | 0 | 0.117 | 0.031 | 0.882 | 2.774 |  |  |  |  |  | 
COVID19_MODERNA | Traumatic tooth displacement | 0 | 0.078 | 0.007 | 0.882 | 3.205 |  |  |  |  |  | 
COVID19_MODERNA | Foetal malformation | 0 | 0.117 | 0.032 | 0.882 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product effective for unapproved indication | 0 | 0.078 | 0.007 | 0.882 | 3.205 |  |  |  |  |  | 
COVID19_MODERNA | Second primary malignancy | 0 | 0.078 | 0.007 | 0.882 | 3.205 |  |  |  |  |  | 
COVID19_MODERNA | Diverticulitis | 4 | 5.963 | 0.397 | 0.881 | 1.52 | 0.38 | 0.734 | 1.309 | 0.671 | 2.74 | 2.516
COVID19_MODERNA | Forceps delivery | 0 | 0.117 | 0.031 | 0.881 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Blood folate increased | 0 | 0.156 | 0.064 | 0.881 | 2.508 |  |  |  |  |  | 
COVID19_MODERNA | Gastric haemorrhage | 0 | 0.195 | 0.097 | 0.881 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival oedema | 0 | 0.273 | 0.158 | 0.881 | 2.085 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue necrosis | 0 | 0.195 | 0.097 | 0.881 | 2.323 |  |  |  |  |  | 
COVID19_MODERNA | Social (pragmatic) communication disorder | 0 | 0.117 | 0.031 | 0.881 | 2.777 |  |  |  |  |  | 
COVID19_MODERNA | Inappropriate release of product for distribution | 0 | 0.078 | 0.007 | 0.881 | 3.216 |  |  |  |  |  | 
COVID19_MODERNA | Allergy test negative | 0 | 0.492 | 0.28 | 0.881 | 1.752 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow disorder | 0 | 0.273 | 0.159 | 0.881 | 2.081 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobin urine absent | 0 | 0.195 | 0.096 | 0.881 | 2.326 |  |  |  |  |  | 
COVID19_MODERNA | Joint hyperextension | 0 | 0.301 | 0.177 | 0.881 | 2.022 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal dermatitis | 0 | 0.156 | 0.063 | 0.881 | 2.508 |  |  |  |  |  | 
COVID19_MODERNA | Burns second degree | 0 | 0.234 | 0.13 | 0.881 | 2.187 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 globulin normal | 0 | 0.234 | 0.129 | 0.881 | 2.188 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal bacterial overgrowth | 0 | 0.156 | 0.063 | 0.881 | 2.509 |  |  |  |  |  | 
COVID19_MODERNA | Acne infantile | 0 | 0.117 | 0.031 | 0.881 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow myelogram abnormal | 0 | 0.156 | 0.063 | 0.881 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy artery | 0 | 0.156 | 0.063 | 0.881 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Carpal tunnel decompression | 0 | 0.195 | 0.097 | 0.881 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Hypothermia neonatal | 0 | 0.117 | 0.031 | 0.881 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Conduction disorder | 0 | 0.195 | 0.097 | 0.881 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Thymus enlargement | 0 | 0.156 | 0.063 | 0.881 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid stimulating immunoglobulin | 0 | 0.156 | 0.064 | 0.881 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Wolff-Parkinson-White syndrome | 0 | 0.156 | 0.063 | 0.881 | 2.51 |  |  |  |  |  | 
COVID19_MODERNA | Oxygen saturation normal | 6 | 6.845 | 0.446 | 0.88 | 1.433 | 0.486 | 0.864 | 1.445 | 0.877 | 2.242 | 2.692
COVID19_MODERNA | Sinus operation | 3 | 3.866 | 0.397 | 0.88 | 1.518 | 0.395 | 0.806 | 1.5 | 0.776 | 5.284 | 5.303
COVID19_MODERNA | Urinary incontinence | 12 | 16.46 | 0.564 | 0.88 | 1.254 | 0.481 | 0.749 | 1.122 | 0.729 | 0.648 | 1.903
COVID19_MODERNA | Alanine aminotransferase increased | 24 | 32.885 | 0.615 | 0.88 | 1.184 | 0.534 | 0.741 | 1.005 | 0.73 | 1.22 | 0.705
COVID19_MODERNA | Spinal osteoarthritis | 1 | 2.244 | 0.155 | 0.88 | 2.09 | 0.275 | 0.679 | 1.449 | 0.446 | 0.747 | 0.024
COVID19_MODERNA | Autoimmune arthritis | 0 | 0.117 | 0.03 | 0.88 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Inguinal hernia repair | 0 | 0.234 | 0.126 | 0.88 | 2.194 |  |  |  |  |  | 
COVID19_MODERNA | JC polyomavirus test positive | 0 | 0.117 | 0.029 | 0.88 | 2.787 |  |  |  |  |  | 
COVID19_MODERNA | Nonreassuring foetal heart rate pattern | 0 | 0.117 | 0.03 | 0.88 | 2.784 |  |  |  |  |  | 
COVID19_MODERNA | Congenital and neonatal arrhythmias (SMQ) [narrow] | 0 | 0.117 | 0.03 | 0.88 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity total normal | 0 | 0.21 | 0.108 | 0.88 | 2.272 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal candidiasis | 0 | 0.156 | 0.062 | 0.88 | 2.514 |  |  |  |  |  | 
COVID19_MODERNA | Enterobacter infection | 0 | 0.156 | 0.062 | 0.88 | 2.514 |  |  |  |  |  | 
COVID19_MODERNA | Product package associated injury | 0 | 0.156 | 0.062 | 0.88 | 2.514 |  |  |  |  |  | 
COVID19_MODERNA | Thalassaemia | 0 | 0.078 | 0.007 | 0.88 | 3.225 |  |  |  |  |  | 
COVID19_MODERNA | Eye abscess | 0 | 0.117 | 0.03 | 0.88 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Micturition disorder | 0 | 0.293 | 0.17 | 0.88 | 2.041 |  |  |  |  |  | 
COVID19_MODERNA | Nasal disorder | 0 | 0.312 | 0.183 | 0.88 | 2.002 |  |  |  |  |  | 
COVID19_MODERNA | Corneal lesion | 0 | 0.117 | 0.03 | 0.88 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Helicobacter test | 0 | 0.273 | 0.156 | 0.88 | 2.087 |  |  |  |  |  | 
COVID19_MODERNA | Progressive multifocal leukoencephalopathy | 0 | 0.078 | 0.007 | 0.88 | 3.225 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin level decreased | 0 | 0.094 | 0.015 | 0.88 | 3.007 |  |  |  |  |  | 
COVID19_MODERNA | Cephalo-pelvic disproportion | 0 | 0.078 | 0.007 | 0.88 | 3.225 |  |  |  |  |  | 
COVID19_MODERNA | Pustular psoriasis | 0 | 0.117 | 0.03 | 0.88 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Allogenic stem cell transplantation | 0 | 0.117 | 0.03 | 0.88 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Myotonia | 0 | 0.156 | 0.061 | 0.88 | 2.518 |  |  |  |  |  | 
COVID19_MODERNA | Leukocyturia | 0 | 0.166 | 0.07 | 0.88 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | In vitro fertilisation | 0 | 0.156 | 0.061 | 0.88 | 2.516 |  |  |  |  |  | 
COVID19_MODERNA | Viral uveitis | 0 | 0.117 | 0.03 | 0.88 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Mastitis | 2 | 4.013 | 0.247 | 0.879 | 1.828 | 0.297 | 0.657 | 1.294 | 0.498 | 2.144 | 0.295
COVID19_MODERNA | Eosinophilic pneumonia | 0 | 0.117 | 0.029 | 0.879 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Glucose urine present | 0 | 0.295 | 0.17 | 0.879 | 2.04 |  |  |  |  |  | 
COVID19_MODERNA | Stenosis | 0 | 0.117 | 0.029 | 0.879 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Spinal flattening | 0 | 0.117 | 0.029 | 0.879 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular function test | 0 | 0.156 | 0.06 | 0.879 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Eye haematoma | 0 | 0.117 | 0.029 | 0.879 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Liver function test decreased | 0 | 0.156 | 0.06 | 0.879 | 2.521 |  |  |  |  |  | 
COVID19_MODERNA | Nephrotic syndrome | 0 | 0.18 | 0.082 | 0.879 | 2.396 |  |  |  |  |  | 
COVID19_MODERNA | Coronary artery dissection | 0 | 0.156 | 0.06 | 0.879 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Conversion disorder | 1 | 1.236 | 0.172 | 0.878 | 2.029 | 0.34 | 0.827 | 1.755 | 0.809 | 0.425 | 0.289
COVID19_MODERNA | Beta 2 microglobulin | 0 | 0.156 | 0.059 | 0.878 | 2.527 |  |  |  |  |  | 
COVID19_MODERNA | Anti-aquaporin-4 antibody | 0 | 0.351 | 0.204 | 0.878 | 1.937 |  |  |  |  |  | 
COVID19_MODERNA | Vertebral lesion | 0 | 0.156 | 0.059 | 0.878 | 2.524 |  |  |  |  |  | 
COVID19_MODERNA | Herpes simplex test | 0 | 0.349 | 0.201 | 0.878 | 1.942 |  |  |  |  |  | 
COVID19_MODERNA | Removal of foreign body | 0 | 0.156 | 0.058 | 0.878 | 2.529 |  |  |  |  |  | 
COVID19_MODERNA | Meniere's disease | 0 | 0.328 | 0.189 | 0.878 | 1.978 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis D virus test | 0 | 0.156 | 0.059 | 0.878 | 2.527 |  |  |  |  |  | 
COVID19_MODERNA | Groin abscess | 0 | 0.156 | 0.059 | 0.878 | 2.526 |  |  |  |  |  | 
COVID19_MODERNA | Scar pain | 0 | 0.117 | 0.028 | 0.878 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Maculopathy | 0 | 0.195 | 0.092 | 0.878 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site swelling | 0 | 0.195 | 0.092 | 0.878 | 2.339 |  |  |  |  |  | 
COVID19_MODERNA | Selective IgA immunodeficiency | 0 | 0.195 | 0.092 | 0.878 | 2.338 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal swelling | 0 | 0.117 | 0.028 | 0.878 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Hypoparathyroidism | 0 | 0.117 | 0.028 | 0.878 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Warm type haemolytic anaemia | 0 | 0.156 | 0.059 | 0.878 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia mycoplasmal | 0 | 0.062 | 0.002 | 0.878 | 3.508 |  |  |  |  |  | 
COVID19_MODERNA | Administration site odour | 0 | 0.117 | 0.028 | 0.878 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulins abnormal | 0 | 0.156 | 0.059 | 0.878 | 2.526 |  |  |  |  |  | 
COVID19_MODERNA | Glucose-6-phosphate dehydrogenase deficiency | 0 | 0.156 | 0.059 | 0.878 | 2.527 |  |  |  |  |  | 
COVID19_MODERNA | Rhinorrhoea | 95 | 114.956 | 0.736 | 0.877 | 1.029 | 0.698 | 0.827 | 0.973 | 0.826 | 1.174 | 2.176
COVID19_MODERNA | Prothrombin time normal | 5 | 6.926 | 0.446 | 0.877 | 1.426 | 0.413 | 0.762 | 1.312 | 0.722 | 1.312 | 0.111
COVID19_MODERNA | Vibratory sense increased | 1 | 1.752 | 0.279 | 0.877 | 1.745 | 0.304 | 0.745 | 1.584 | 0.571 | 1.644 | 0.025
COVID19_MODERNA | Dental examination | 0 | 0.156 | 0.058 | 0.877 | 2.531 |  |  |  |  |  | 
COVID19_MODERNA | Presbyopia | 0 | 0.117 | 0.028 | 0.877 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Occipital neuralgia | 0 | 0.224 | 0.113 | 0.877 | 2.239 |  |  |  |  |  | 
COVID19_MODERNA | Disease complication | 0 | 0.117 | 0.027 | 0.877 | 2.802 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve paresis | 0 | 0.156 | 0.058 | 0.877 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Chondropathy | 0 | 0.156 | 0.058 | 0.877 | 2.529 |  |  |  |  |  | 
COVID19_MODERNA | Neurosensory hypoacusis | 0 | 0.078 | 0.006 | 0.877 | 3.243 |  |  |  |  |  | 
COVID19_MODERNA | Deja vu | 0 | 0.117 | 0.027 | 0.877 | 2.802 |  |  |  |  |  | 
COVID19_MODERNA | Laziness | 0 | 0.195 | 0.09 | 0.877 | 2.344 |  |  |  |  |  | 
COVID19_MODERNA | Oral surgery | 0 | 0.156 | 0.058 | 0.877 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol poisoning | 0 | 0.156 | 0.058 | 0.877 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Parasomnia | 0 | 0.117 | 0.028 | 0.877 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Joint stabilisation | 0 | 0.156 | 0.057 | 0.877 | 2.533 |  |  |  |  |  | 
COVID19_MODERNA | Neurodevelopmental disorder | 0 | 0.156 | 0.057 | 0.877 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Low density lipoprotein | 0 | 0.195 | 0.089 | 0.877 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Intervertebral disc protrusion | 4 | 5.036 | 0.358 | 0.876 | 1.578 | 0.421 | 0.813 | 1.449 | 0.794 | 1.644 | 0.422
COVID19_MODERNA | Liver function test increased | 9 | 11.861 | 0.507 | 0.876 | 1.327 | 0.474 | 0.778 | 1.219 | 0.759 | 2.336 | 5.079
COVID19_MODERNA | Left ventricular dysfunction | 2 | 3.349 | 0.294 | 0.876 | 1.711 | 0.327 | 0.721 | 1.418 | 0.597 | 4.11 | 1.737
COVID19_MODERNA | Eosinophil count increased | 3 | 5.629 | 0.304 | 0.876 | 1.686 | 0.318 | 0.651 | 1.214 | 0.533 | 0.569 | 0.569
COVID19_MODERNA | Hypoglycaemia neonatal | 0 | 0.117 | 0.027 | 0.876 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Breast oedema | 0 | 0.117 | 0.027 | 0.876 | 2.808 |  |  |  |  |  | 
COVID19_MODERNA | Growth failure | 0 | 0.156 | 0.057 | 0.876 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Transcranial electrical motor evoked potential monitoring | 0 | 0.117 | 0.027 | 0.876 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Xerosis | 0 | 0.156 | 0.056 | 0.876 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body reaction | 0 | 0.195 | 0.089 | 0.876 | 2.348 |  |  |  |  |  | 
COVID19_MODERNA | Libido disorder | 0 | 0.117 | 0.027 | 0.876 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin time ratio decreased | 0 | 0.156 | 0.057 | 0.876 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Uterine disorder | 0 | 0.156 | 0.057 | 0.876 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal infection | 0 | 0.117 | 0.026 | 0.876 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral haematoma | 0 | 0.234 | 0.12 | 0.876 | 2.21 |  |  |  |  |  | 
COVID19_MODERNA | Muscle spasms | 85 | 99.588 | 0.727 | 0.875 | 1.034 | 0.714 | 0.853 | 1.013 | 0.854 | 1.01 | 0.001
COVID19_MODERNA | Akathisia (SMQ) [broad] | 38 | 49.814 | 0.659 | 0.875 | 1.116 | 0.59 | 0.768 | 0.986 | 0.763 | 0.697 | 4.595
COVID19_MODERNA | Hepatic disorders (SMQ) [narrow] | 72 | 99.677 | 0.714 | 0.875 | 1.05 | 0.599 | 0.726 | 0.875 | 0.722 | 0.723 | 7.184
COVID19_MODERNA | Shoulder injury related to vaccine administration | 4 | 7.008 | 0.336 | 0.875 | 1.619 | 0.342 | 0.661 | 1.18 | 0.571 | 0.736 | 0.149
COVID19_MODERNA | Partial seizures with secondary generalisation | 0 | 0.156 | 0.056 | 0.875 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Parkinsonism | 0 | 0.351 | 0.197 | 0.875 | 1.947 |  |  |  |  |  | 
COVID19_MODERNA | Anti-IA2 antibody positive | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Bronchoalveolar lavage | 0 | 0.195 | 0.088 | 0.875 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Androgenetic alopecia | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Anorectal discomfort | 0 | 0.234 | 0.118 | 0.875 | 2.215 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal mucosal blistering | 0 | 0.195 | 0.088 | 0.875 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Positive end-expiratory pressure | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Multimorbidity | 0 | 0.117 | 0.026 | 0.875 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Drug withdrawal syndrome | 0 | 0.156 | 0.056 | 0.875 | 2.54 |  |  |  |  |  | 
COVID19_MODERNA | Anti-glycyl-tRNA synthetase antibody positive | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Osteosarcoma | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma stage III | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Proctitis haemorrhagic | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocytic leukaemia | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Endocervical curettage | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Male reproductive tract disorder | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Squamous cell carcinoma of the oral cavity | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Arteriosclerotic retinopathy | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Gastric atony | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Persistent depressive disorder | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Genital abscess | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial diarrhoea | 0 | 0.078 | 0.005 | 0.875 | 3.26 |  |  |  |  |  | 
COVID19_MODERNA | Lactose tolerance test normal | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Breast conserving surgery | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Herpes dermatitis | 0 | 0.156 | 0.055 | 0.875 | 2.544 |  |  |  |  |  | 
COVID19_MODERNA | Urogram | 0 | 0.078 | 0.005 | 0.875 | 3.256 |  |  |  |  |  | 
COVID19_MODERNA | Streptococcus test | 7 | 7.838 | 0.477 | 0.874 | 1.368 | 0.508 | 0.876 | 1.43 | 0.893 | 1.04 | 0.009
COVID19_MODERNA | Gastrointestinal pain | 3 | 4.026 | 0.347 | 0.874 | 1.595 | 0.387 | 0.789 | 1.469 | 0.745 | 0.661 | 0.224
COVID19_MODERNA | Agraphia | 0 | 0.117 | 0.025 | 0.874 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Low density lipoprotein decreased | 0 | 0.156 | 0.054 | 0.874 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | HIV test positive | 0 | 0.273 | 0.144 | 0.874 | 2.111 |  |  |  |  |  | 
COVID19_MODERNA | Lichenification | 0 | 0.156 | 0.054 | 0.874 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Separation anxiety disorder | 0 | 0.195 | 0.086 | 0.874 | 2.357 |  |  |  |  |  | 
COVID19_MODERNA | Bacteriuria | 0 | 0.156 | 0.054 | 0.874 | 2.546 |  |  |  |  |  | 
COVID19_MODERNA | Subcutaneous abscess | 0 | 0.483 | 0.261 | 0.874 | 1.778 |  |  |  |  |  | 
COVID19_MODERNA | Von Willebrand's factor activity increased | 0 | 0.117 | 0.025 | 0.874 | 2.823 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract inflammation | 0 | 0.166 | 0.062 | 0.874 | 2.492 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell anisocytes present | 0 | 0.312 | 0.17 | 0.874 | 2.025 |  |  |  |  |  | 
COVID19_MODERNA | Blood parathyroid hormone decreased | 0 | 0.117 | 0.025 | 0.874 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Anti-transglutaminase antibody negative | 0 | 0.076 | 0.005 | 0.873 | 3.291 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract disorder | 0 | 0.12 | 0.026 | 0.873 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy spinal cord | 0 | 0.156 | 0.053 | 0.873 | 2.553 |  |  |  |  |  | 
COVID19_MODERNA | Muscle electrostimulation therapy | 0 | 0.156 | 0.053 | 0.873 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Stress at work | 0 | 0.195 | 0.084 | 0.873 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal injury | 0 | 0.195 | 0.084 | 0.873 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell analysis | 0 | 0.195 | 0.084 | 0.873 | 2.362 |  |  |  |  |  | 
COVID19_MODERNA | Transmission of an infectious agent via product | 0 | 0.156 | 0.053 | 0.873 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Antithrombin III decreased | 0 | 0.117 | 0.024 | 0.873 | 2.83 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic necrosis | 0 | 0.234 | 0.114 | 0.873 | 2.223 |  |  |  |  |  | 
COVID19_MODERNA | Peak expiratory flow rate | 0 | 0.195 | 0.084 | 0.873 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Ocular hypertension | 0 | 0.156 | 0.053 | 0.873 | 2.55 |  |  |  |  |  | 
COVID19_MODERNA | High-pitched crying | 0 | 0.13 | 0.033 | 0.873 | 2.72 |  |  |  |  |  | 
COVID19_MODERNA | Ammonia decreased | 0 | 0.156 | 0.052 | 0.873 | 2.555 |  |  |  |  |  | 
COVID19_MODERNA | Retinitis viral | 0 | 0.195 | 0.084 | 0.873 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Liver function test abnormal | 5 | 6.255 | 0.411 | 0.872 | 1.472 | 0.441 | 0.814 | 1.401 | 0.799 | 1.258 | 0.061
COVID19_MODERNA | Electrocardiogram ST segment depression | 3 | 4.414 | 0.325 | 0.872 | 1.633 | 0.368 | 0.751 | 1.397 | 0.68 | 6.165 | 6.531
COVID19_MODERNA | Right ventricular dilatation | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity total decreased | 0 | 0.156 | 0.051 | 0.872 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital discomfort | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Anhedonia | 0 | 0.156 | 0.051 | 0.872 | 2.559 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal mass | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal aspirate culture | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Histone antibody negative | 0 | 0.156 | 0.052 | 0.872 | 2.557 |  |  |  |  |  | 
COVID19_MODERNA | Hyperleukocytosis | 0 | 0.195 | 0.083 | 0.872 | 2.367 |  |  |  |  |  | 
COVID19_MODERNA | Nipple swelling | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Myokymia | 0 | 0.117 | 0.024 | 0.872 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal discolouration | 0 | 0.515 | 0.271 | 0.872 | 1.75 |  |  |  |  |  | 
COVID19_MODERNA | Airway secretion clearance therapy | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | White coat hypertension | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Mean arterial pressure | 0 | 0.078 | 0.005 | 0.872 | 3.276 |  |  |  |  |  | 
COVID19_MODERNA | Arterial rupture | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Angle closure glaucoma | 0 | 0.156 | 0.052 | 0.872 | 2.557 |  |  |  |  |  | 
COVID19_MODERNA | Non-tobacco user | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Balance test | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure diastolic | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell count abnormal | 0 | 0.078 | 0.005 | 0.872 | 3.28 |  |  |  |  |  | 
COVID19_MODERNA | Fluctuance | 0 | 0.156 | 0.052 | 0.872 | 2.556 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time | 13 | 14.992 | 0.561 | 0.871 | 1.236 | 0.562 | 0.862 | 1.276 | 0.867 | 4.932 | 30.644
COVID19_MODERNA | Drug related hepatic disorders - comprehensive search (SMQ) [broad] | 81 | 105.221 | 0.72 | 0.871 | 1.034 | 0.643 | 0.772 | 0.921 | 0.77 | 1.083 | 0.419
COVID19_MODERNA | Ataxia | 5 | 6.743 | 0.404 | 0.871 | 1.48 | 0.42 | 0.776 | 1.335 | 0.742 | 0.518 | 1.733
COVID19_MODERNA | Basophil count increased | 1 | 1.584 | 0.147 | 0.871 | 2.091 | 0.315 | 0.77 | 1.635 | 0.631 | 0.667 | 0
COVID19_MODERNA | Varicella virus test negative | 1 | 1.697 | 0.205 | 0.871 | 1.914 | 0.307 | 0.753 | 1.6 | 0.589 | 0.172 | 3.136
COVID19_MODERNA | Polydactyly | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Cell marker | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Anal erosion | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Waist circumference decreased | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Purulent pericarditis | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Penoscrotal fusion | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Phagocytosis | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Cheyne-Stokes respiration | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Metastases to abdominal cavity | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | LE cells | 0 | 0.195 | 0.08 | 0.871 | 2.374 |  |  |  |  |  | 
COVID19_MODERNA | Rouleaux formation | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Parathyroid hormone-related protein increased | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Anti-glomerular basement membrane antibody | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow infiltration | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Heart alternation | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Nasal mucosal discolouration | 0 | 0.195 | 0.081 | 0.871 | 2.371 |  |  |  |  |  | 
COVID19_MODERNA | Hepatobiliary scan normal | 0 | 0.195 | 0.081 | 0.871 | 2.372 |  |  |  |  |  | 
COVID19_MODERNA | Genital erosion | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Marginal zone lymphoma | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Anti-VGCC antibody negative | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Surfactant protein | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound breast abnormal | 0 | 0.195 | 0.082 | 0.871 | 2.37 |  |  |  |  |  | 
COVID19_MODERNA | Acute sinusitis | 0 | 0.312 | 0.165 | 0.871 | 2.032 |  |  |  |  |  | 
COVID19_MODERNA | Bladder scan | 0 | 0.273 | 0.14 | 0.871 | 2.12 |  |  |  |  |  | 
COVID19_MODERNA | Avian influenza | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Hyperchlorhydria | 0 | 0.156 | 0.051 | 0.871 | 2.561 |  |  |  |  |  | 
COVID19_MODERNA | Echovirus test negative | 0 | 0.195 | 0.082 | 0.871 | 2.37 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell rouleaux formation present | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Anti-muscle specific kinase antibody negative | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | Blood chromogranin A increased | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | 5-hydroxyindolacetic acid in urine decreased | 0 | 0.078 | 0.004 | 0.871 | 3.285 |  |  |  |  |  | 
COVID19_MODERNA | B-cell lymphoma | 0 | 0.195 | 0.081 | 0.871 | 2.372 |  |  |  |  |  | 
COVID19_MODERNA | Appendicitis | 24 | 28.229 | 0.604 | 0.87 | 1.176 | 0.613 | 0.849 | 1.152 | 0.85 | 7.131 | 93.273
COVID19_MODERNA | Cardiac arrhythmias (SMQ) [narrow] | 188 | 225.812 | 0.769 | 0.87 | 0.976 | 0.738 | 0.833 | 0.936 | 0.833 | 3.721 | 323.923
COVID19_MODERNA | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [broad] | 185 | 223.02 | 0.768 | 0.87 | 0.977 | 0.735 | 0.83 | 0.934 | 0.83 | 3.688 | 314.196
COVID19_MODERNA | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [narrow] | 185 | 223.02 | 0.768 | 0.87 | 0.977 | 0.735 | 0.83 | 0.934 | 0.83 | 3.691 | 314.606
COVID19_MODERNA | Scan with contrast | 20 | 25.241 | 0.609 | 0.87 | 1.169 | 0.56 | 0.798 | 1.11 | 0.792 | 4.365 | 41.167
COVID19_MODERNA | Eyelid pain | 1 | 1.526 | 0.277 | 0.87 | 1.73 | 0.319 | 0.779 | 1.654 | 0.655 | 0.617 | 0.006
COVID19_MODERNA | Sickle cell anaemia | 0 | 0.117 | 0.022 | 0.87 | 2.844 |  |  |  |  |  | 
COVID19_MODERNA | Chorioretinitis | 0 | 0.195 | 0.079 | 0.87 | 2.378 |  |  |  |  |  | 
COVID19_MODERNA | Arthroscopic surgery | 0 | 0.195 | 0.079 | 0.87 | 2.377 |  |  |  |  |  | 
COVID19_MODERNA | Hypermetabolism | 0 | 0.195 | 0.08 | 0.87 | 2.376 |  |  |  |  |  | 
COVID19_MODERNA | Knee arthroplasty | 0 | 0.212 | 0.093 | 0.87 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy breast normal | 0 | 0.156 | 0.049 | 0.87 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Oedema genital | 0 | 0.156 | 0.049 | 0.87 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to plants | 0 | 0.117 | 0.022 | 0.87 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Balanoposthitis | 0 | 0.156 | 0.05 | 0.87 | 2.567 |  |  |  |  |  | 
COVID19_MODERNA | Bartonella test negative | 0 | 0.351 | 0.186 | 0.87 | 1.964 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system viral infection | 0 | 0.195 | 0.079 | 0.87 | 2.377 |  |  |  |  |  | 
COVID19_MODERNA | Urine analysis abnormal | 11 | 13.002 | 0.522 | 0.869 | 1.289 | 0.534 | 0.845 | 1.283 | 0.846 | 1.966 | 3.949
COVID19_MODERNA | Hyperglycaemia/new onset diabetes mellitus (SMQ) [broad] | 487 | 576.303 | 0.805 | 0.869 | 0.934 | 0.784 | 0.845 | 0.91 | 0.845 | 1.12 | 6.061
COVID19_MODERNA | Hepatic disorders (SMQ) [broad] | 83 | 107.293 | 0.719 | 0.869 | 1.03 | 0.648 | 0.776 | 0.923 | 0.774 | 0.765 | 5.629
COVID19_MODERNA | Dermatitis acneiform | 1 | 1.676 | 0.336 | 0.869 | 1.604 | 0.309 | 0.756 | 1.607 | 0.597 | 1.028 | 0.24
COVID19_MODERNA | Eye laser surgery | 0 | 0.117 | 0.022 | 0.869 | 2.851 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin E decreased | 0 | 0.273 | 0.135 | 0.869 | 2.13 |  |  |  |  |  | 
COVID19_MODERNA | Breath holding | 0 | 0.292 | 0.147 | 0.869 | 2.084 |  |  |  |  |  | 
COVID19_MODERNA | Endotracheal intubation complication | 0 | 0.273 | 0.136 | 0.869 | 2.127 |  |  |  |  |  | 
COVID19_MODERNA | Immunosuppressant drug therapy | 0 | 0.298 | 0.151 | 0.869 | 2.07 |  |  |  |  |  | 
COVID19_MODERNA | VIth nerve disorder | 0 | 0.156 | 0.048 | 0.869 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Prostatomegaly | 0 | 0.195 | 0.079 | 0.869 | 2.38 |  |  |  |  |  | 
COVID19_MODERNA | Pupil dilation procedure | 0 | 0.195 | 0.078 | 0.869 | 2.382 |  |  |  |  |  | 
COVID19_MODERNA | Hemihypertrophy | 0 | 0.156 | 0.048 | 0.869 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Onychomadesis | 0 | 0.273 | 0.136 | 0.869 | 2.128 |  |  |  |  |  | 
COVID19_MODERNA | Methylenetetrahydrofolate reductase gene mutation | 0 | 0.324 | 0.168 | 0.869 | 2.016 |  |  |  |  |  | 
COVID19_MODERNA | Low density lipoprotein increased | 3 | 2.273 | 0.309 | 0.868 | 1.655 | 0.503 | 1.026 | 1.91 | 1.32 | 3.894 | 3.275
COVID19_MODERNA | Blood bicarbonate decreased | 5 | 5.204 | 0.435 | 0.868 | 1.42 | 0.494 | 0.911 | 1.569 | 0.961 | 1.84 | 1.065
COVID19_MODERNA | White blood cell count | 6 | 10.35 | 0.429 | 0.868 | 1.432 | 0.363 | 0.647 | 1.082 | 0.58 | 0.817 | 0.089
COVID19_MODERNA | Procedural pain | 0 | 0.312 | 0.16 | 0.868 | 2.042 |  |  |  |  |  | 
COVID19_MODERNA | Lipodystrophy acquired | 0 | 0.195 | 0.077 | 0.868 | 2.386 |  |  |  |  |  | 
COVID19_MODERNA | Urticaria papular | 0 | 0.273 | 0.134 | 0.868 | 2.13 |  |  |  |  |  | 
COVID19_MODERNA | Systemic infection | 0 | 0.117 | 0.021 | 0.868 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Total cholesterol/HDL ratio | 0 | 0.156 | 0.047 | 0.868 | 2.578 |  |  |  |  |  | 
COVID19_MODERNA | Oculomucocutaneous syndrome | 0 | 0.156 | 0.048 | 0.868 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor C3 increased | 0 | 0.124 | 0.025 | 0.868 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Penile rash | 0 | 0.156 | 0.048 | 0.868 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Fructose intolerance | 0 | 0.195 | 0.077 | 0.868 | 2.383 |  |  |  |  |  | 
COVID19_MODERNA | Neurone-specific enolase | 0 | 0.156 | 0.047 | 0.868 | 2.58 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue inflammation | 0 | 0.148 | 0.041 | 0.868 | 2.628 |  |  |  |  |  | 
COVID19_MODERNA | Appendix disorder | 0 | 0.117 | 0.021 | 0.868 | 2.855 |  |  |  |  |  | 
COVID19_MODERNA | Glucose tolerance test | 0 | 0.195 | 0.077 | 0.868 | 2.384 |  |  |  |  |  | 
COVID19_MODERNA | Nosocomial infection | 0 | 0.195 | 0.077 | 0.868 | 2.384 |  |  |  |  |  | 
COVID19_MODERNA | Electroencephalogram normal | 12 | 15.592 | 0.531 | 0.867 | 1.27 | 0.503 | 0.783 | 1.173 | 0.77 | 0.386 | 10.956
COVID19_MODERNA | Anal incontinence | 5 | 7.26 | 0.429 | 0.867 | 1.429 | 0.4 | 0.739 | 1.272 | 0.689 | 0.948 | 0.011
COVID19_MODERNA | High density lipoprotein | 0 | 0.195 | 0.076 | 0.867 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Subcutaneous emphysema | 0 | 0.117 | 0.02 | 0.867 | 2.861 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell schistocytes | 0 | 0.117 | 0.02 | 0.867 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Bladder discomfort | 0 | 0.156 | 0.046 | 0.867 | 2.584 |  |  |  |  |  | 
COVID19_MODERNA | Keloid scar | 0 | 0.156 | 0.046 | 0.867 | 2.584 |  |  |  |  |  | 
COVID19_MODERNA | Hyperbilirubinaemia neonatal | 0 | 0.156 | 0.046 | 0.867 | 2.585 |  |  |  |  |  | 
COVID19_MODERNA | Blood bicarbonate abnormal | 0 | 0.117 | 0.02 | 0.867 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal haemorrhage | 0 | 0.156 | 0.046 | 0.867 | 2.582 |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve injury | 0 | 0.091 | 0.008 | 0.867 | 3.134 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal swelling | 0 | 0.122 | 0.023 | 0.867 | 2.82 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid mass | 0 | 0.381 | 0.197 | 0.867 | 1.924 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms (SMQ) [broad] | 0 | 0.273 | 0.131 | 0.867 | 2.136 |  |  |  |  |  | 
COVID19_MODERNA | Biliary neoplasms (SMQ) [narrow] | 0 | 0.273 | 0.131 | 0.867 | 2.136 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia sepsis | 0 | 0.195 | 0.076 | 0.867 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal bacterial infection | 0 | 0.156 | 0.046 | 0.867 | 2.583 |  |  |  |  |  | 
COVID19_MODERNA | Myringotomy | 0 | 0.195 | 0.076 | 0.867 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Drooling | 6 | 7.926 | 0.546 | 0.866 | 1.246 | 0.44 | 0.783 | 1.309 | 0.757 | 0.8 | 0.124
COVID19_MODERNA | Pseudomembranous colitis (SMQ) [narrow] | 2 | 3.395 | 0.376 | 0.866 | 1.519 | 0.325 | 0.716 | 1.409 | 0.589 | 1.072 | 0.076
COVID19_MODERNA | Gastric pH decreased | 0 | 0.117 | 0.02 | 0.866 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Pituitary-dependent Cushing's syndrome | 0 | 0.156 | 0.045 | 0.866 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal compartment syndrome | 0 | 0.156 | 0.046 | 0.866 | 2.585 |  |  |  |  |  | 
COVID19_MODERNA | Erythema annulare | 0 | 0.234 | 0.103 | 0.866 | 2.25 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal lesion | 0 | 0.195 | 0.074 | 0.866 | 2.393 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoid hyperplasia of intestine | 0 | 0.156 | 0.045 | 0.866 | 2.587 |  |  |  |  |  | 
COVID19_MODERNA | LDL/HDL ratio | 0 | 0.117 | 0.02 | 0.866 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Tocolysis | 0 | 0.078 | 0.003 | 0.866 | 3.32 |  |  |  |  |  | 
COVID19_MODERNA | Parasite blood test | 0 | 0.234 | 0.103 | 0.866 | 2.25 |  |  |  |  |  | 
COVID19_MODERNA | Renal cancer | 0 | 0.156 | 0.046 | 0.866 | 2.585 |  |  |  |  |  | 
COVID19_MODERNA | Platelet count abnormal | 0 | 0.312 | 0.155 | 0.866 | 2.051 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract oedema | 0 | 0.144 | 0.037 | 0.866 | 2.663 |  |  |  |  |  | 
COVID19_MODERNA | Reduced facial expression | 0 | 0.234 | 0.103 | 0.866 | 2.249 |  |  |  |  |  | 
COVID19_MODERNA | Venous injury | 0 | 0.156 | 0.045 | 0.866 | 2.588 |  |  |  |  |  | 
COVID19_MODERNA | Dystonia (SMQ) [broad] | 344 | 410.945 | 0.79 | 0.865 | 0.943 | 0.766 | 0.837 | 0.914 | 0.837 | 0.901 | 3.65
COVID19_MODERNA | Oral discharge | 0 | 0.156 | 0.044 | 0.865 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial disease carrier | 0 | 0.195 | 0.072 | 0.865 | 2.4 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosa haematoma | 0 | 0.156 | 0.044 | 0.865 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Babinski reflex test | 0 | 0.125 | 0.024 | 0.865 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Post-traumatic neck syndrome | 0 | 0.195 | 0.072 | 0.865 | 2.399 |  |  |  |  |  | 
COVID19_MODERNA | Psychomotor disadaptation syndrome | 0 | 0.156 | 0.044 | 0.865 | 2.592 |  |  |  |  |  | 
COVID19_MODERNA | Penile pain | 0 | 0.234 | 0.102 | 0.865 | 2.253 |  |  |  |  |  | 
COVID19_MODERNA | White blood cells stool negative | 0 | 0.195 | 0.073 | 0.865 | 2.397 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis toxic | 0 | 0.078 | 0.003 | 0.865 | 3.323 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell morphology abnormal | 0 | 0.195 | 0.073 | 0.865 | 2.399 |  |  |  |  |  | 
COVID19_MODERNA | Henoch-Schonlein purpura nephritis | 0 | 0.234 | 0.101 | 0.865 | 2.254 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoproliferative disorder | 0 | 0.117 | 0.019 | 0.865 | 2.871 |  |  |  |  |  | 
COVID19_MODERNA | Spinal myelogram normal | 0 | 0.234 | 0.101 | 0.865 | 2.254 |  |  |  |  |  | 
COVID19_MODERNA | Dysmetropsia | 0 | 0.078 | 0.003 | 0.865 | 3.327 |  |  |  |  |  | 
COVID19_MODERNA | Apolipoprotein A-I decreased | 0 | 0.078 | 0.003 | 0.865 | 3.325 |  |  |  |  |  | 
COVID19_MODERNA | Volume blood decreased | 0 | 0.156 | 0.044 | 0.865 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Corneal graft rejection | 0 | 0.195 | 0.073 | 0.865 | 2.398 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral paralysis | 0 | 0.156 | 0.044 | 0.865 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Meningocele acquired | 0 | 0.078 | 0.003 | 0.865 | 3.327 |  |  |  |  |  | 
COVID19_MODERNA | Infantile colic | 0 | 0.074 | 0.002 | 0.865 | 3.391 |  |  |  |  |  | 
COVID19_MODERNA | Mononucleosis heterophile test positive | 0 | 0.22 | 0.092 | 0.865 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Gingival discolouration | 0 | 0.195 | 0.071 | 0.864 | 2.404 |  |  |  |  |  | 
COVID19_MODERNA | Synovial fluid white blood cells positive | 0 | 0.195 | 0.071 | 0.864 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrovascular disorder | 0 | 0.251 | 0.112 | 0.864 | 2.206 |  |  |  |  |  | 
COVID19_MODERNA | Congenital cystic kidney disease | 0 | 0.156 | 0.043 | 0.864 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic disorder | 0 | 0.195 | 0.072 | 0.864 | 2.401 |  |  |  |  |  | 
COVID19_MODERNA | Back disorder | 0 | 0.258 | 0.116 | 0.864 | 2.185 |  |  |  |  |  | 
COVID19_MODERNA | Lymphadenectomy | 0 | 0.207 | 0.081 | 0.864 | 2.351 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site hypersensitivity | 0 | 0.195 | 0.072 | 0.864 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | Diverticulum intestinal haemorrhagic | 0 | 0.117 | 0.018 | 0.864 | 2.88 |  |  |  |  |  | 
COVID19_MODERNA | Lymphadenopathy mediastinal | 0 | 0.312 | 0.152 | 0.864 | 2.055 |  |  |  |  |  | 
COVID19_MODERNA | Pulse abnormal | 10 | 12.119 | 0.55 | 0.863 | 1.232 | 0.515 | 0.828 | 1.277 | 0.825 | 1.854 | 2.881
COVID19_MODERNA | Mobility decreased | 177 | 216.323 | 0.76 | 0.863 | 0.971 | 0.723 | 0.819 | 0.924 | 0.818 | 0.785 | 10.003
COVID19_MODERNA | Abnormal faeces | 1 | 1.333 | 0.223 | 0.863 | 1.844 | 0.332 | 0.81 | 1.72 | 0.75 | 0.128 | 5.019
COVID19_MODERNA | Generalised tonic-clonic seizure | 9 | 11.484 | 0.51 | 0.863 | 1.291 | 0.485 | 0.797 | 1.249 | 0.784 | 0.377 | 8.523
COVID19_MODERNA | Administration site pruritus | 0 | 0.117 | 0.018 | 0.863 | 2.884 |  |  |  |  |  | 
COVID19_MODERNA | Colon cancer | 0 | 0.195 | 0.07 | 0.863 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Noninfective sialoadenitis | 0 | 0.195 | 0.07 | 0.863 | 2.408 |  |  |  |  |  | 
COVID19_MODERNA | Gingival disorder | 0 | 0.195 | 0.07 | 0.863 | 2.408 |  |  |  |  |  | 
COVID19_MODERNA | Beta globulin | 0 | 0.195 | 0.07 | 0.863 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Teething | 0 | 0.238 | 0.101 | 0.863 | 2.247 |  |  |  |  |  | 
COVID19_MODERNA | Lipoma | 0 | 0.27 | 0.122 | 0.863 | 2.159 |  |  |  |  |  | 
COVID19_MODERNA | Punctate keratitis | 0 | 0.156 | 0.042 | 0.863 | 2.602 |  |  |  |  |  | 
COVID19_MODERNA | Primary biliary cholangitis | 0 | 0.156 | 0.042 | 0.863 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Blood lactate dehydrogenase decreased | 0 | 0.195 | 0.07 | 0.863 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Allergy test positive | 0 | 0.879 | 0.36 | 0.863 | 1.541 |  |  |  |  |  | 
COVID19_MODERNA | Cold agglutinins negative | 0 | 0.117 | 0.018 | 0.862 | 2.887 |  |  |  |  |  | 
COVID19_MODERNA | Vitreous haze | 0 | 0.117 | 0.017 | 0.862 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Intercepted product prescribing error | 0 | 0.156 | 0.041 | 0.862 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune neutropenia | 0 | 0.084 | 0.004 | 0.862 | 3.258 |  |  |  |  |  | 
COVID19_MODERNA | Electronystagmogram abnormal | 0 | 0.195 | 0.069 | 0.862 | 2.411 |  |  |  |  |  | 
COVID19_MODERNA | Hypoventilation | 0 | 0.126 | 0.022 | 0.862 | 2.814 |  |  |  |  |  | 
COVID19_MODERNA | Bipolar I disorder | 0 | 0.156 | 0.041 | 0.862 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Ventriculo-peritoneal shunt | 0 | 0.158 | 0.043 | 0.862 | 2.591 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging renal | 0 | 0.156 | 0.042 | 0.862 | 2.605 |  |  |  |  |  | 
COVID19_MODERNA | Blood alcohol normal | 0 | 0.195 | 0.069 | 0.862 | 2.411 |  |  |  |  |  | 
COVID19_MODERNA | Dizziness exertional | 0 | 0.156 | 0.041 | 0.862 | 2.609 |  |  |  |  |  | 
COVID19_MODERNA | Noninfective gingivitis | 0 | 0.182 | 0.06 | 0.862 | 2.467 |  |  |  |  |  | 
COVID19_MODERNA | Suffocation feeling | 0 | 0.273 | 0.123 | 0.862 | 2.153 |  |  |  |  |  | 
COVID19_MODERNA | Poisoning | 0 | 0.207 | 0.077 | 0.862 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Bleeding varicose vein | 0 | 0.078 | 0.003 | 0.861 | 3.349 |  |  |  |  |  | 
COVID19_MODERNA | Meningoencephalitis bacterial | 0 | 0.117 | 0.017 | 0.861 | 2.893 |  |  |  |  |  | 
COVID19_MODERNA | CSF myelin basic protein | 0 | 0.117 | 0.017 | 0.861 | 2.898 |  |  |  |  |  | 
COVID19_MODERNA | Abscess soft tissue | 0 | 0.156 | 0.04 | 0.861 | 2.612 |  |  |  |  |  | 
COVID19_MODERNA | Clavicle fracture | 0 | 0.195 | 0.067 | 0.861 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Mammogram abnormal | 0 | 0.111 | 0.014 | 0.861 | 2.947 |  |  |  |  |  | 
COVID19_MODERNA | Dental examination normal | 0 | 0.273 | 0.121 | 0.861 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | Barium swallow normal | 0 | 0.195 | 0.067 | 0.861 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary physical examination abnormal | 0 | 0.117 | 0.017 | 0.861 | 2.896 |  |  |  |  |  | 
COVID19_MODERNA | Balance disorder | 57 | 70.534 | 0.688 | 0.86 | 1.049 | 0.652 | 0.81 | 0.996 | 0.808 | 1.324 | 3.979
COVID19_MODERNA | Delirium | 13 | 16.502 | 0.547 | 0.86 | 1.231 | 0.52 | 0.797 | 1.18 | 0.788 | 1.661 | 2.594
COVID19_MODERNA | Anaphylactic reaction | 84 | 107.285 | 0.713 | 0.86 | 1.018 | 0.656 | 0.785 | 0.933 | 0.783 | 1.89 | 31.958
COVID19_MODERNA | Haemorrhage | 19 | 27.971 | 0.576 | 0.86 | 1.192 | 0.485 | 0.698 | 0.977 | 0.679 | 1.034 | 0.001
COVID19_MODERNA | Computerised tomogram thorax normal | 10 | 15.48 | 0.492 | 0.86 | 1.313 | 0.424 | 0.683 | 1.052 | 0.646 | 2.71 | 8.187
COVID19_MODERNA | Pregnancy test | 1 | 1.972 | 0.192 | 0.86 | 1.918 | 0.291 | 0.714 | 1.521 | 0.507 | 0.822 | 0.073
COVID19_MODERNA | Serum ferritin | 1 | 2.67 | 0.245 | 0.86 | 1.779 | 0.253 | 0.63 | 1.351 | 0.375 | 1.37 | 0.081
COVID19_MODERNA | Lactation disorder | 0 | 0.156 | 0.04 | 0.86 | 2.616 |  |  |  |  |  | 
COVID19_MODERNA | Panencephalitis | 0 | 0.078 | 0.003 | 0.86 | 3.356 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site eschar | 0 | 0.08 | 0.003 | 0.86 | 3.32 |  |  |  |  |  | 
COVID19_MODERNA | Ventricular hypertrophy | 0 | 0.078 | 0.003 | 0.86 | 3.357 |  |  |  |  |  | 
COVID19_MODERNA | Chronic hepatitis | 0 | 0.078 | 0.003 | 0.86 | 3.355 |  |  |  |  |  | 
COVID19_MODERNA | Bronchitis viral | 0 | 0.195 | 0.067 | 0.86 | 2.419 |  |  |  |  |  | 
COVID19_MODERNA | Very low density lipoprotein normal | 0 | 0.156 | 0.039 | 0.86 | 2.618 |  |  |  |  |  | 
COVID19_MODERNA | Impatience | 0 | 0.156 | 0.039 | 0.86 | 2.616 |  |  |  |  |  | 
COVID19_MODERNA | Protein-losing gastroenteropathy | 0 | 0.078 | 0.003 | 0.86 | 3.357 |  |  |  |  |  | 
COVID19_MODERNA | Gliosis | 0 | 0.273 | 0.121 | 0.86 | 2.158 |  |  |  |  |  | 
COVID19_MODERNA | Allergic gastroenteritis | 0 | 0.078 | 0.003 | 0.86 | 3.357 |  |  |  |  |  | 
COVID19_MODERNA | Culture wound | 0 | 0.174 | 0.052 | 0.86 | 2.515 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac stress test | 5 | 5.246 | 0.397 | 0.859 | 1.465 | 0.492 | 0.907 | 1.561 | 0.953 | 2.09 | 1.679
COVID19_MODERNA | Disturbance in attention | 25 | 30.878 | 0.602 | 0.859 | 1.154 | 0.59 | 0.813 | 1.097 | 0.81 | 0.653 | 4.155
COVID19_MODERNA | Anaphylactic/anaphylactoid shock conditions (SMQ) [narrow] | 107 | 135.61 | 0.728 | 0.859 | 0.999 | 0.674 | 0.79 | 0.922 | 0.789 | 1.542 | 18.769
COVID19_MODERNA | Anaphylactic reaction (SMQ) [narrow] | 106 | 135.101 | 0.728 | 0.859 | 1 | 0.67 | 0.786 | 0.918 | 0.785 | 1.515 | 17.095
COVID19_MODERNA | Dyskinesia (SMQ) [narrow] | 22 | 29.124 | 0.594 | 0.859 | 1.163 | 0.545 | 0.765 | 1.05 | 0.755 | 0.383 | 20.976
COVID19_MODERNA | Lip blister | 4 | 6.167 | 0.384 | 0.859 | 1.488 | 0.372 | 0.719 | 1.282 | 0.649 | 0.977 | 0.042
COVID19_MODERNA | Ejection fraction decreased | 6 | 10.773 | 0.401 | 0.859 | 1.458 | 0.352 | 0.627 | 1.05 | 0.557 | 2.387 | 3.19
COVID19_MODERNA | Peptic ulcer | 0 | 0.156 | 0.038 | 0.859 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Enterocolitis bacterial | 0 | 0.117 | 0.016 | 0.859 | 2.903 |  |  |  |  |  | 
COVID19_MODERNA | Intercepted product administration error | 0 | 0.195 | 0.065 | 0.859 | 2.423 |  |  |  |  |  | 
COVID19_MODERNA | Emotional disorder | 0 | 0.355 | 0.168 | 0.859 | 1.987 |  |  |  |  |  | 
COVID19_MODERNA | Libido decreased | 0 | 0.156 | 0.039 | 0.859 | 2.619 |  |  |  |  |  | 
COVID19_MODERNA | Bone cyst | 0 | 0.156 | 0.039 | 0.859 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Saccadic eye movement | 0 | 0.117 | 0.016 | 0.859 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Drug withdrawal syndrome neonatal | 0 | 0.078 | 0.003 | 0.859 | 3.36 |  |  |  |  |  | 
COVID19_MODERNA | Tinea pedis | 0 | 0.195 | 0.065 | 0.859 | 2.425 |  |  |  |  |  | 
COVID19_MODERNA | Rapid eye movements sleep abnormal | 0 | 0.195 | 0.066 | 0.859 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Retinal exudates | 0 | 0.237 | 0.094 | 0.859 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillitis streptococcal | 0 | 0.156 | 0.038 | 0.859 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine normal | 2 | 2.016 | 0.331 | 0.858 | 1.584 | 0.408 | 0.894 | 1.756 | 0.992 | 1.761 | 0.097
COVID19_MODERNA | Swelling face | 133 | 158.612 | 0.743 | 0.858 | 0.98 | 0.727 | 0.839 | 0.963 | 0.839 | 1.557 | 24.576
COVID19_MODERNA | Nasopharyngitis | 23 | 31.184 | 0.599 | 0.858 | 1.155 | 0.536 | 0.748 | 1.021 | 0.738 | 0.495 | 11.12
COVID19_MODERNA | Hallucination, visual | 3 | 4.691 | 0.404 | 0.858 | 1.449 | 0.355 | 0.726 | 1.351 | 0.64 | 0.925 | 0.023
COVID19_MODERNA | Tongue spasm | 0 | 0.195 | 0.064 | 0.858 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Lower limb fracture | 0 | 0.234 | 0.091 | 0.858 | 2.281 |  |  |  |  |  | 
COVID19_MODERNA | Ceruloplasmin normal | 0 | 0.156 | 0.038 | 0.858 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Cold agglutinins positive | 0 | 0.117 | 0.015 | 0.858 | 2.911 |  |  |  |  |  | 
COVID19_MODERNA | Genital rash | 0 | 0.458 | 0.218 | 0.858 | 1.843 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculin test positive | 0 | 0.13 | 0.022 | 0.858 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Retinopexy | 0 | 0.195 | 0.064 | 0.858 | 2.426 |  |  |  |  |  | 
COVID19_MODERNA | Aptyalism | 0 | 0.234 | 0.091 | 0.858 | 2.279 |  |  |  |  |  | 
COVID19_MODERNA | Ligament disorder | 0 | 0.156 | 0.037 | 0.858 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal mycotic infection | 0 | 0.195 | 0.064 | 0.858 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Palliative care | 0 | 0.312 | 0.141 | 0.858 | 2.074 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy breast abnormal | 0 | 0.156 | 0.038 | 0.858 | 2.626 |  |  |  |  |  | 
COVID19_MODERNA | Tobacco user | 0 | 0.117 | 0.015 | 0.858 | 2.912 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic disorder | 0 | 0.195 | 0.064 | 0.858 | 2.427 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcal abscess | 0 | 0.117 | 0.016 | 0.858 | 2.909 |  |  |  |  |  | 
COVID19_MODERNA | Winged scapula | 0 | 0.213 | 0.077 | 0.858 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal burning sensation | 0 | 0.273 | 0.117 | 0.858 | 2.165 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound therapy | 0 | 0.195 | 0.064 | 0.858 | 2.426 |  |  |  |  |  | 
COVID19_MODERNA | Vasculitis (SMQ) [broad] | 14 | 14.78 | 0.54 | 0.857 | 1.234 | 0.612 | 0.926 | 1.356 | 0.947 | 0.276 | 25.617
COVID19_MODERNA | Muscle contractions involuntary | 3 | 4.913 | 0.406 | 0.857 | 1.444 | 0.346 | 0.707 | 1.316 | 0.611 | 0.383 | 2.334
COVID19_MODERNA | Injection site dysaesthesia | 0 | 0.195 | 0.062 | 0.857 | 2.433 |  |  |  |  |  | 
COVID19_MODERNA | DNA antibody | 0 | 0.234 | 0.09 | 0.857 | 2.283 |  |  |  |  |  | 
COVID19_MODERNA | Bone density decreased | 0 | 0.156 | 0.037 | 0.857 | 2.629 |  |  |  |  |  | 
COVID19_MODERNA | Body tinea | 0 | 0.195 | 0.062 | 0.857 | 2.433 |  |  |  |  |  | 
COVID19_MODERNA | Total lung capacity decreased | 0 | 0.074 | 0.002 | 0.857 | 3.437 |  |  |  |  |  | 
COVID19_MODERNA | Acute flaccid myelitis | 0 | 0.156 | 0.037 | 0.857 | 2.629 |  |  |  |  |  | 
COVID19_MODERNA | Vasculitic rash | 0 | 0.335 | 0.154 | 0.857 | 2.029 |  |  |  |  |  | 
COVID19_MODERNA | Autoinflammatory disease | 0 | 0.195 | 0.062 | 0.857 | 2.434 |  |  |  |  |  | 
COVID19_MODERNA | Subdural abscess | 0 | 0.156 | 0.037 | 0.857 | 2.631 |  |  |  |  |  | 
COVID19_MODERNA | Pleural fluid analysis | 0 | 0.041 | 0 | 0.857 | 4.163 |  |  |  |  |  | 
COVID19_MODERNA | Bell's phenomenon | 0 | 0.156 | 0.037 | 0.857 | 2.629 |  |  |  |  |  | 
COVID19_MODERNA | Glycosylated haemoglobin normal | 2 | 2.98 | 0.379 | 0.856 | 1.487 | 0.346 | 0.762 | 1.498 | 0.671 | 0.986 | 0.115
COVID19_MODERNA | Myopia | 0 | 0.132 | 0.022 | 0.856 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Swallow study abnormal | 0 | 0.234 | 0.089 | 0.856 | 2.286 |  |  |  |  |  | 
COVID19_MODERNA | Blood fibrinogen decreased | 0 | 0.294 | 0.127 | 0.856 | 2.121 |  |  |  |  |  | 
COVID19_MODERNA | Breast tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.195 | 0.061 | 0.856 | 2.438 |  |  |  |  |  | 
COVID19_MODERNA | Urethritis | 0 | 0.156 | 0.036 | 0.856 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Reaction to food additive | 0 | 0.156 | 0.036 | 0.856 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Medical diet | 0 | 0.156 | 0.036 | 0.856 | 2.635 |  |  |  |  |  | 
COVID19_MODERNA | Ventilation/perfusion scan normal | 0 | 0.234 | 0.088 | 0.856 | 2.289 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocytic infiltration | 0 | 0.149 | 0.032 | 0.856 | 2.678 |  |  |  |  |  | 
COVID19_MODERNA | Erythrosis | 0 | 0.156 | 0.036 | 0.856 | 2.636 |  |  |  |  |  | 
COVID19_MODERNA | Oral infection | 0 | 0.195 | 0.061 | 0.856 | 2.437 |  |  |  |  |  | 
COVID19_MODERNA | Lacrimal disorder | 0 | 0.195 | 0.061 | 0.856 | 2.437 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine renal clearance decreased | 0 | 0.156 | 0.036 | 0.856 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Scleral hyperaemia | 0 | 0.195 | 0.061 | 0.856 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Lipodystrophy (SMQ) [broad] | 27 | 36.512 | 0.616 | 0.855 | 1.126 | 0.549 | 0.748 | 1.001 | 0.739 | 1.648 | 5.841
COVID19_MODERNA | Axonal and demyelinating polyneuropathy | 0 | 0.117 | 0.014 | 0.855 | 2.926 |  |  |  |  |  | 
COVID19_MODERNA | Reflux gastritis | 0 | 0.156 | 0.035 | 0.855 | 2.64 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte count abnormal | 0 | 0.156 | 0.035 | 0.855 | 2.638 |  |  |  |  |  | 
COVID19_MODERNA | Sputum purulent | 0 | 0.156 | 0.035 | 0.855 | 2.639 |  |  |  |  |  | 
COVID19_MODERNA | Oxygen saturation immeasurable | 0 | 0.117 | 0.014 | 0.855 | 2.925 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia haemophilus | 0 | 0.117 | 0.014 | 0.855 | 2.927 |  |  |  |  |  | 
COVID19_MODERNA | Valsalva maneuver | 0 | 0.156 | 0.035 | 0.855 | 2.639 |  |  |  |  |  | 
COVID19_MODERNA | Vocal cord dysfunction | 0 | 0.195 | 0.06 | 0.855 | 2.441 |  |  |  |  |  | 
COVID19_MODERNA | Albumin urine absent | 0 | 0.156 | 0.035 | 0.855 | 2.638 |  |  |  |  |  | 
COVID19_MODERNA | Oligomenorrhoea | 0 | 0.091 | 0.005 | 0.855 | 3.207 |  |  |  |  |  | 
COVID19_MODERNA | Multi-vitamin deficiency | 0 | 0.117 | 0.014 | 0.855 | 2.925 |  |  |  |  |  | 
COVID19_MODERNA | Lymphatic disorder | 0 | 0.351 | 0.158 | 0.855 | 2.008 |  |  |  |  |  | 
COVID19_MODERNA | Lung lobectomy | 0 | 0.117 | 0.014 | 0.855 | 2.927 |  |  |  |  |  | 
COVID19_MODERNA | Hand deformity | 0 | 0.195 | 0.061 | 0.855 | 2.438 |  |  |  |  |  | 
COVID19_MODERNA | Seborrhoea | 0 | 0.195 | 0.061 | 0.855 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Polychondritis | 0 | 0.117 | 0.014 | 0.855 | 2.927 |  |  |  |  |  | 
COVID19_MODERNA | Oesophagram | 0 | 0.195 | 0.061 | 0.855 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Poor quality sleep | 15 | 20.139 | 0.568 | 0.854 | 1.188 | 0.508 | 0.759 | 1.1 | 0.745 | 0.685 | 1.81
COVID19_MODERNA | Hypothyroidism (SMQ) [narrow] | 3 | 4.38 | 0.279 | 0.854 | 1.682 | 0.369 | 0.754 | 1.403 | 0.685 | 0.747 | 0.059
COVID19_MODERNA | Aspiration bone marrow | 0 | 0.326 | 0.143 | 0.854 | 2.056 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor C4 increased | 0 | 0.156 | 0.035 | 0.854 | 2.642 |  |  |  |  |  | 
COVID19_MODERNA | Diaphragmatic paralysis | 0 | 0.273 | 0.111 | 0.854 | 2.179 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic cerebral infarction | 0 | 0.312 | 0.134 | 0.854 | 2.088 |  |  |  |  |  | 
COVID19_MODERNA | Nervous system injury | 0 | 0.195 | 0.059 | 0.854 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Chromosome analysis abnormal | 0 | 0.156 | 0.035 | 0.854 | 2.641 |  |  |  |  |  | 
COVID19_MODERNA | Inadequate aseptic technique in use of product | 0 | 0.386 | 0.176 | 0.854 | 1.948 |  |  |  |  |  | 
COVID19_MODERNA | Allergic respiratory symptom | 0 | 0.273 | 0.111 | 0.854 | 2.178 |  |  |  |  |  | 
COVID19_MODERNA | Hyper IgE syndrome | 0 | 0.078 | 0.002 | 0.854 | 3.387 |  |  |  |  |  | 
COVID19_MODERNA | Skull X-ray normal | 0 | 0.312 | 0.135 | 0.854 | 2.086 |  |  |  |  |  | 
COVID19_MODERNA | Jaundice cholestatic | 0 | 0.156 | 0.034 | 0.854 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Campylobacter test positive | 0 | 0.088 | 0.004 | 0.854 | 3.24 |  |  |  |  |  | 
COVID19_MODERNA | Traumatic lung injury | 0 | 0.156 | 0.035 | 0.854 | 2.642 |  |  |  |  |  | 
COVID19_MODERNA | Gomori methenamine silver stain | 0 | 0.078 | 0.002 | 0.854 | 3.392 |  |  |  |  |  | 
COVID19_MODERNA | Temporomandibular joint syndrome | 1 | 1.343 | 0.185 | 0.853 | 1.918 | 0.332 | 0.809 | 1.716 | 0.744 | 0.632 | 0.002
COVID19_MODERNA | Glossodynia | 11 | 14.255 | 0.551 | 0.853 | 1.208 | 0.497 | 0.785 | 1.193 | 0.772 | 2.634 | 8.597
COVID19_MODERNA | Skin abrasion | 2 | 2.963 | 0.376 | 0.853 | 1.485 | 0.347 | 0.764 | 1.502 | 0.675 | 0.414 | 1.083
COVID19_MODERNA | Vitamin B12 normal | 5 | 7.535 | 0.406 | 0.853 | 1.433 | 0.39 | 0.72 | 1.24 | 0.664 | 1.197 | 0.021
COVID19_MODERNA | Mean cell haemoglobin concentration decreased | 3 | 5.444 | 0.351 | 0.853 | 1.534 | 0.325 | 0.665 | 1.238 | 0.551 | 1.37 | 0.036
COVID19_MODERNA | Blood 25-hydroxycholecalciferol | 0 | 0.34 | 0.149 | 0.853 | 2.032 |  |  |  |  |  | 
COVID19_MODERNA | Vasoconstriction | 0 | 0.351 | 0.155 | 0.853 | 2.012 |  |  |  |  |  | 
COVID19_MODERNA | Chronic respiratory disease | 0 | 0.117 | 0.013 | 0.853 | 2.935 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 2 globulin normal | 0 | 0.195 | 0.058 | 0.853 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Exploratory operation | 0 | 0.234 | 0.083 | 0.853 | 2.3 |  |  |  |  |  | 
COVID19_MODERNA | Panniculitis lobular | 0 | 0.156 | 0.034 | 0.853 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Humerus fracture | 0 | 0.273 | 0.109 | 0.853 | 2.182 |  |  |  |  |  | 
COVID19_MODERNA | Drug dispensed to wrong patient | 0 | 0.322 | 0.138 | 0.853 | 2.069 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product ineffective | 0 | 0.156 | 0.034 | 0.853 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Anal haemorrhage | 0 | 0.273 | 0.11 | 0.853 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Choroidal neovascularisation | 0 | 0.156 | 0.033 | 0.853 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic hepatitis | 0 | 0.117 | 0.013 | 0.853 | 2.937 |  |  |  |  |  | 
COVID19_MODERNA | Syphilis | 0 | 0.156 | 0.033 | 0.853 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Hydrocephalus | 0 | 0.421 | 0.191 | 0.853 | 1.902 |  |  |  |  |  | 
COVID19_MODERNA | Multipathogen PCR test positive | 0 | 0.117 | 0.013 | 0.853 | 2.935 |  |  |  |  |  | 
COVID19_MODERNA | Metastatic malignant melanoma | 0 | 0.117 | 0.013 | 0.853 | 2.935 |  |  |  |  |  | 
COVID19_MODERNA | Vitreous disorder | 0 | 0.117 | 0.013 | 0.853 | 2.935 |  |  |  |  |  | 
COVID19_MODERNA | Macrocephaly | 0 | 0.195 | 0.058 | 0.853 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Myelopathy | 1 | 1.092 | 0.165 | 0.852 | 1.976 | 0.351 | 0.853 | 1.81 | 0.916 | 1.233 | 0.129
COVID19_MODERNA | Femur fracture | 0 | 0.273 | 0.108 | 0.852 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | Continuous haemodiafiltration | 0 | 0.234 | 0.082 | 0.852 | 2.303 |  |  |  |  |  | 
COVID19_MODERNA | Tendon discomfort | 0 | 0.195 | 0.057 | 0.852 | 2.452 |  |  |  |  |  | 
COVID19_MODERNA | Electronystagmogram normal | 0 | 0.078 | 0.002 | 0.852 | 3.399 |  |  |  |  |  | 
COVID19_MODERNA | Hypervolaemia | 0 | 0.156 | 0.033 | 0.852 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Necrosis ischaemic | 0 | 0.117 | 0.013 | 0.852 | 2.94 |  |  |  |  |  | 
COVID19_MODERNA | Blood ketone body present | 0 | 0.273 | 0.108 | 0.852 | 2.185 |  |  |  |  |  | 
COVID19_MODERNA | Abortion early | 0 | 0.078 | 0.002 | 0.852 | 3.403 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QRS complex normal | 0 | 0.312 | 0.131 | 0.852 | 2.092 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis mumps | 0 | 0.078 | 0.002 | 0.852 | 3.403 |  |  |  |  |  | 
COVID19_MODERNA | Foetal cardiac disorder | 0 | 0.156 | 0.033 | 0.852 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Amniocentesis abnormal | 0 | 0.078 | 0.002 | 0.852 | 3.403 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue injury | 0 | 0.351 | 0.154 | 0.852 | 2.014 |  |  |  |  |  | 
COVID19_MODERNA | Rathke's cleft cyst | 0 | 0.078 | 0.002 | 0.852 | 3.401 |  |  |  |  |  | 
COVID19_MODERNA | Impaired work ability | 130 | 157.709 | 0.733 | 0.851 | 0.976 | 0.714 | 0.825 | 0.949 | 0.824 | 2.194 | 76.822
COVID19_MODERNA | VIth nerve paralysis | 2 | 2.724 | 0.346 | 0.851 | 1.537 | 0.361 | 0.793 | 1.559 | 0.734 | 0.931 | 0.062
COVID19_MODERNA | Streptococcal sepsis | 0 | 0.234 | 0.082 | 0.851 | 2.305 |  |  |  |  |  | 
COVID19_MODERNA | Leg amputation | 0 | 0.195 | 0.056 | 0.851 | 2.456 |  |  |  |  |  | 
COVID19_MODERNA | Body mass index | 0 | 0.117 | 0.012 | 0.851 | 2.947 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic mass | 0 | 0.156 | 0.032 | 0.851 | 2.658 |  |  |  |  |  | 
COVID19_MODERNA | Fungal skin infection | 0 | 0.164 | 0.037 | 0.851 | 2.605 |  |  |  |  |  | 
COVID19_MODERNA | Wound closure | 0 | 0.273 | 0.106 | 0.851 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | False positive investigation result | 0 | 0.234 | 0.081 | 0.851 | 2.306 |  |  |  |  |  | 
COVID19_MODERNA | Hypertrichosis | 0 | 0.156 | 0.032 | 0.851 | 2.658 |  |  |  |  |  | 
COVID19_MODERNA | Hypergammaglobulinaemia | 0 | 0.156 | 0.032 | 0.851 | 2.658 |  |  |  |  |  | 
COVID19_MODERNA | Anorectal disorder | 0 | 0.195 | 0.057 | 0.851 | 2.453 |  |  |  |  |  | 
COVID19_MODERNA | Anti-islet cell antibody positive | 0 | 0.195 | 0.056 | 0.851 | 2.456 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid cancer | 0 | 0.195 | 0.057 | 0.851 | 2.453 |  |  |  |  |  | 
COVID19_MODERNA | Lower respiratory tract infection viral | 0 | 0.156 | 0.032 | 0.851 | 2.658 |  |  |  |  |  | 
COVID19_MODERNA | Right atrial dilatation | 0 | 0.117 | 0.012 | 0.851 | 2.945 |  |  |  |  |  | 
COVID19_MODERNA | Colour blindness | 0 | 0.096 | 0.005 | 0.851 | 3.166 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin urine absent | 0 | 0.273 | 0.106 | 0.851 | 2.19 |  |  |  |  |  | 
COVID19_MODERNA | Human bocavirus infection | 0 | 0.156 | 0.032 | 0.851 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Scleral disorders (SMQ) [broad] | 0 | 0.388 | 0.168 | 0.85 | 1.958 |  |  |  |  |  | 
COVID19_MODERNA | Endocrine ophthalmopathy | 0 | 0.156 | 0.032 | 0.85 | 2.659 |  |  |  |  |  | 
COVID19_MODERNA | Acute cardiac event | 0 | 0.195 | 0.055 | 0.85 | 2.459 |  |  |  |  |  | 
COVID19_MODERNA | Pineal gland cyst | 0 | 0.156 | 0.031 | 0.85 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Urinary sediment abnormal | 0 | 0.234 | 0.08 | 0.85 | 2.31 |  |  |  |  |  | 
COVID19_MODERNA | Product dispensing error | 0 | 0.234 | 0.081 | 0.85 | 2.308 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis allergic | 0 | 0.195 | 0.055 | 0.85 | 2.459 |  |  |  |  |  | 
COVID19_MODERNA | Scleral disorders (SMQ) [narrow] | 0 | 0.388 | 0.168 | 0.85 | 1.958 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site hypertrophy | 0 | 0.156 | 0.031 | 0.85 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Ankyloglossia congenital | 0 | 0.156 | 0.032 | 0.85 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Anti-GAD antibody | 0 | 0.234 | 0.08 | 0.85 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy stomach abnormal | 0 | 0.234 | 0.08 | 0.85 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal erythema | 0 | 0.312 | 0.128 | 0.85 | 2.097 |  |  |  |  |  | 
COVID19_MODERNA | Stress urinary incontinence | 0 | 0.156 | 0.032 | 0.85 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Feeding intolerance | 0 | 0.195 | 0.055 | 0.85 | 2.46 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian operation | 0 | 0.156 | 0.031 | 0.85 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Anti-thyroid antibody | 0 | 0.354 | 0.152 | 0.85 | 2.013 |  |  |  |  |  | 
COVID19_MODERNA | Sleep apnoea syndrome | 1 | 1.289 | 0.136 | 0.849 | 2.063 | 0.336 | 0.818 | 1.735 | 0.776 | 0.308 | 0.905
COVID19_MODERNA | Gastrointestinal nonspecific inflammation (SMQ) [broad] | 18 | 24.555 | 0.561 | 0.849 | 1.186 | 0.515 | 0.747 | 1.054 | 0.733 | 1.002 | 0.013
COVID19_MODERNA | CSF white blood cell count negative | 1 | 1.652 | 0.201 | 0.849 | 1.861 | 0.31 | 0.759 | 1.614 | 0.605 | 0.19 | 2.65
COVID19_MODERNA | Placental disorder | 1 | 2.855 | 0.07 | 0.849 | 2.358 | 0.245 | 0.611 | 1.312 | 0.35 | 0.85 | 0.097
COVID19_MODERNA | Muscular dystrophy | 0 | 0.273 | 0.103 | 0.849 | 2.195 |  |  |  |  |  | 
COVID19_MODERNA | Infusion site extravasation | 0 | 0.117 | 0.012 | 0.849 | 2.954 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis D | 0 | 0.078 | 0.002 | 0.849 | 3.416 |  |  |  |  |  | 
COVID19_MODERNA | Human rhinovirus test positive | 0 | 0.284 | 0.11 | 0.849 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Joint abscess | 0 | 0.156 | 0.03 | 0.849 | 2.666 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural haemorrhage | 0 | 0.117 | 0.012 | 0.849 | 2.954 |  |  |  |  |  | 
COVID19_MODERNA | Steatohepatitis | 0 | 0.078 | 0.002 | 0.849 | 3.416 |  |  |  |  |  | 
COVID19_MODERNA | Fibrous histiocytoma | 0 | 0.195 | 0.054 | 0.849 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Pleural decortication | 0 | 0.156 | 0.03 | 0.849 | 2.667 |  |  |  |  |  | 
COVID19_MODERNA | Viral load | 0 | 0.078 | 0.002 | 0.849 | 3.416 |  |  |  |  |  | 
COVID19_MODERNA | Cellulitis staphylococcal | 0 | 0.195 | 0.055 | 0.849 | 2.461 |  |  |  |  |  | 
COVID19_MODERNA | Depression (excl suicide and self injury) (SMQ) [broad] | 137 | 173.612 | 0.734 | 0.848 | 0.97 | 0.686 | 0.79 | 0.906 | 0.789 | 0.376 | 142.606
COVID19_MODERNA | Ear discomfort | 28 | 37.099 | 0.626 | 0.848 | 1.098 | 0.562 | 0.762 | 1.014 | 0.755 | 2.635 | 24.18
COVID19_MODERNA | Band neutrophil percentage | 1 | 1.532 | 0.253 | 0.848 | 1.727 | 0.318 | 0.778 | 1.652 | 0.653 | 1.072 | 0.211
COVID19_MODERNA | Orthopaedic examination | 0 | 0.273 | 0.101 | 0.848 | 2.2 |  |  |  |  |  | 
COVID19_MODERNA | Ligament injury | 0 | 0.234 | 0.077 | 0.848 | 2.317 |  |  |  |  |  | 
COVID19_MODERNA | Human herpes virus 6 serology negative | 0 | 0.365 | 0.154 | 0.848 | 2 |  |  |  |  |  | 
COVID19_MODERNA | Perivascular dermatitis | 0 | 0.195 | 0.053 | 0.848 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Polycythaemia | 0 | 0.195 | 0.053 | 0.848 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Blood zinc | 0 | 0.156 | 0.03 | 0.848 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Anti-neuronal antibody | 0 | 0.234 | 0.078 | 0.848 | 2.314 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising soft tissue infection | 0 | 0.117 | 0.011 | 0.848 | 2.962 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac electrophysiologic study abnormal | 0 | 0.156 | 0.03 | 0.848 | 2.669 |  |  |  |  |  | 
COVID19_MODERNA | Inflammatory marker test | 1 | 1.258 | 0.258 | 0.847 | 1.713 | 0.338 | 0.823 | 1.747 | 0.795 | 0.26 | 1.397
COVID19_MODERNA | C-reactive protein normal | 14 | 18.424 | 0.527 | 0.847 | 1.229 | 0.511 | 0.773 | 1.131 | 0.76 | 0.462 | 8.109
COVID19_MODERNA | CSF shunt operation | 0 | 0.156 | 0.029 | 0.847 | 2.672 |  |  |  |  |  | 
COVID19_MODERNA | Aldolase normal | 0 | 0.232 | 0.075 | 0.847 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Synovial disorder | 0 | 0.195 | 0.052 | 0.847 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy cervix normal | 0 | 0.156 | 0.029 | 0.847 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity unsaturated | 0 | 0.156 | 0.029 | 0.847 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Blood parathyroid hormone normal | 0 | 0.312 | 0.123 | 0.847 | 2.107 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell volume | 0 | 0.405 | 0.172 | 0.847 | 1.939 |  |  |  |  |  | 
COVID19_MODERNA | Developmental regression | 0 | 0.208 | 0.06 | 0.847 | 2.417 |  |  |  |  |  | 
COVID19_MODERNA | Echolalia | 0 | 0.195 | 0.052 | 0.847 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Gangrene | 0 | 0.156 | 0.029 | 0.847 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Protein albumin ratio | 0 | 0.156 | 0.029 | 0.847 | 2.673 |  |  |  |  |  | 
COVID19_MODERNA | Hypoproteinaemia | 0 | 0.234 | 0.076 | 0.847 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | Nasal discharge discolouration | 0 | 0.205 | 0.058 | 0.847 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Smear site unspecified abnormal | 0 | 0.312 | 0.124 | 0.847 | 2.105 |  |  |  |  |  | 
COVID19_MODERNA | Intercepted medication error | 0 | 0.156 | 0.029 | 0.847 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Urine analysis normal | 27 | 33.667 | 0.621 | 0.846 | 1.1 | 0.591 | 0.806 | 1.077 | 0.802 | 0.74 | 2.149
COVID19_MODERNA | Toxicologic test | 2 | 2.61 | 0.351 | 0.846 | 1.516 | 0.368 | 0.808 | 1.587 | 0.766 | 1.541 | 0.024
COVID19_MODERNA | Ultrasound liver normal | 0 | 0.373 | 0.156 | 0.846 | 1.99 |  |  |  |  |  | 
COVID19_MODERNA | Retroviral infection | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Pseudomononucleosis | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Amyotrophy | 0 | 0.156 | 0.029 | 0.846 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Prurigo | 0 | 0.195 | 0.051 | 0.846 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Tracheomalacia | 0 | 0.195 | 0.051 | 0.846 | 2.476 |  |  |  |  |  | 
COVID19_MODERNA | Upper gastrointestinal haemorrhage | 0 | 0.234 | 0.076 | 0.846 | 2.322 |  |  |  |  |  | 
COVID19_MODERNA | Babesiosis | 0 | 0.117 | 0.01 | 0.846 | 2.973 |  |  |  |  |  | 
COVID19_MODERNA | Lymphatic system neoplasm | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Temperature difference of extremities | 0 | 0.156 | 0.028 | 0.846 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte count decreased | 0 | 0.195 | 0.052 | 0.846 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Systemic mastocytosis | 0 | 0.195 | 0.051 | 0.846 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic generalised epilepsy | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell abnormality | 0 | 0.351 | 0.144 | 0.846 | 2.03 |  |  |  |  |  | 
COVID19_MODERNA | Cephalhaematoma | 0 | 0.117 | 0.01 | 0.846 | 2.973 |  |  |  |  |  | 
COVID19_MODERNA | Precancerous condition | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Ovulation disorder | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract haemorrhage | 0 | 0.078 | 0.001 | 0.846 | 3.435 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid sensory disorder | 0 | 0.117 | 0.011 | 0.846 | 2.969 |  |  |  |  |  | 
COVID19_MODERNA | Encephalomyelitis | 0 | 0.197 | 0.052 | 0.846 | 2.467 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine free increased | 0 | 0.156 | 0.029 | 0.846 | 2.676 |  |  |  |  |  | 
COVID19_MODERNA | Abulia | 0 | 0.156 | 0.028 | 0.846 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal examination | 0 | 0.195 | 0.051 | 0.846 | 2.475 |  |  |  |  |  | 
COVID19_MODERNA | Anti factor VIII antibody negative | 0 | 0.078 | 0.001 | 0.845 | 3.436 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune thyroid disorder | 0 | 0.156 | 0.028 | 0.845 | 2.682 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve palsy | 0 | 0.273 | 0.097 | 0.845 | 2.209 |  |  |  |  |  | 
COVID19_MODERNA | Specific gravity urine increased | 0 | 0.312 | 0.12 | 0.845 | 2.113 |  |  |  |  |  | 
COVID19_MODERNA | Skull X-ray abnormal | 0 | 0.195 | 0.051 | 0.845 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Increased viscosity of bronchial secretion | 0 | 0.195 | 0.05 | 0.845 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatic disorder | 0 | 0.25 | 0.084 | 0.845 | 2.274 |  |  |  |  |  | 
COVID19_MODERNA | Hyperkeratosis | 0 | 0.338 | 0.136 | 0.845 | 2.056 |  |  |  |  |  | 
COVID19_MODERNA | Chronic disease | 0 | 0.156 | 0.028 | 0.845 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine free decreased | 0 | 0.273 | 0.097 | 0.845 | 2.208 |  |  |  |  |  | 
COVID19_MODERNA | Vulval ulceration | 0 | 0.195 | 0.05 | 0.845 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin D dimer | 19 | 23.458 | 0.569 | 0.844 | 1.164 | 0.566 | 0.814 | 1.14 | 0.81 | 5.857 | 57.839
COVID19_MODERNA | Arrhythmia | 12 | 20.481 | 0.5 | 0.844 | 1.262 | 0.401 | 0.624 | 0.935 | 0.586 | 1.364 | 0.774
COVID19_MODERNA | Alpha 1 globulin | 0 | 0.195 | 0.049 | 0.844 | 2.481 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal respiratory distress syndrome | 0 | 0.117 | 0.01 | 0.844 | 2.981 |  |  |  |  |  | 
COVID19_MODERNA | Febrile neutropenia | 0 | 0.273 | 0.096 | 0.844 | 2.211 |  |  |  |  |  | 
COVID19_MODERNA | Pericarditis lupus | 0 | 0.078 | 0.001 | 0.844 | 3.444 |  |  |  |  |  | 
COVID19_MODERNA | Dehydroepiandrosterone test | 0 | 0.156 | 0.027 | 0.844 | 2.686 |  |  |  |  |  | 
COVID19_MODERNA | Blood mercury | 0 | 0.234 | 0.073 | 0.844 | 2.33 |  |  |  |  |  | 
COVID19_MODERNA | Oversensing | 0 | 0.117 | 0.01 | 0.844 | 2.979 |  |  |  |  |  | 
COVID19_MODERNA | Nerve stimulation test | 0 | 0.312 | 0.119 | 0.844 | 2.115 |  |  |  |  |  | 
COVID19_MODERNA | Joint debridement | 0 | 0.156 | 0.027 | 0.844 | 2.688 |  |  |  |  |  | 
COVID19_MODERNA | Psychogenic visual disorder | 0 | 0.078 | 0.001 | 0.844 | 3.444 |  |  |  |  |  | 
COVID19_MODERNA | Pain management | 0 | 0.39 | 0.16 | 0.844 | 1.969 |  |  |  |  |  | 
COVID19_MODERNA | Retinal dystrophy | 0 | 0.117 | 0.01 | 0.844 | 2.978 |  |  |  |  |  | 
COVID19_MODERNA | Corneal scar | 0 | 0.117 | 0.01 | 0.844 | 2.982 |  |  |  |  |  | 
COVID19_MODERNA | Skin graft | 0 | 0.273 | 0.097 | 0.844 | 2.21 |  |  |  |  |  | 
COVID19_MODERNA | Thermohyperaesthesia | 0 | 0.078 | 0.001 | 0.844 | 3.444 |  |  |  |  |  | 
COVID19_MODERNA | Underweight | 0 | 0.085 | 0.002 | 0.844 | 3.339 |  |  |  |  |  | 
COVID19_MODERNA | Head discomfort | 37 | 47.756 | 0.643 | 0.843 | 1.066 | 0.597 | 0.779 | 1.003 | 0.775 | 2.486 | 28.507
COVID19_MODERNA | Hepatitis E | 0 | 0.078 | 0.001 | 0.843 | 3.45 |  |  |  |  |  | 
COVID19_MODERNA | IVth nerve paralysis | 0 | 0.312 | 0.117 | 0.843 | 2.119 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis viral test positive | 0 | 0.078 | 0.001 | 0.843 | 3.45 |  |  |  |  |  | 
COVID19_MODERNA | Laparotomy | 0 | 0.08 | 0.001 | 0.843 | 3.413 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve injury | 0 | 0.117 | 0.01 | 0.843 | 2.984 |  |  |  |  |  | 
COVID19_MODERNA | Syringomyelia | 0 | 0.156 | 0.026 | 0.843 | 2.692 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising fasciitis | 0 | 0.197 | 0.05 | 0.843 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | FEV1/FVC ratio | 0 | 0.156 | 0.027 | 0.843 | 2.69 |  |  |  |  |  | 
COVID19_MODERNA | Spondylitis | 0 | 0.214 | 0.059 | 0.843 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Appendicolith | 0 | 0.117 | 0.01 | 0.843 | 2.985 |  |  |  |  |  | 
COVID19_MODERNA | Antiacetylcholine receptor antibody | 0 | 0.212 | 0.058 | 0.843 | 2.415 |  |  |  |  |  | 
COVID19_MODERNA | Congenital choroid plexus cyst | 0 | 0.156 | 0.027 | 0.843 | 2.689 |  |  |  |  |  | 
COVID19_MODERNA | Hypochloraemia | 0 | 0.234 | 0.072 | 0.843 | 2.333 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging spinal | 10 | 13.499 | 0.489 | 0.842 | 1.273 | 0.473 | 0.762 | 1.174 | 0.741 | 1.451 | 0.917
COVID19_MODERNA | Aspartate aminotransferase increased | 26 | 35.761 | 0.598 | 0.842 | 1.12 | 0.538 | 0.737 | 0.99 | 0.727 | 1.406 | 2.502
COVID19_MODERNA | Epstein-Barr virus antibody negative | 1 | 1.6 | 0.238 | 0.842 | 1.745 | 0.314 | 0.767 | 1.63 | 0.625 | 0.418 | 0.313
COVID19_MODERNA | Hair disorder | 0 | 0.092 | 0.003 | 0.842 | 3.263 |  |  |  |  |  | 
COVID19_MODERNA | Anti-ganglioside antibody | 0 | 0.195 | 0.047 | 0.842 | 2.491 |  |  |  |  |  | 
COVID19_MODERNA | Proctalgia | 0 | 0.215 | 0.06 | 0.842 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | Foetal heart rate decreased | 0 | 0.156 | 0.026 | 0.842 | 2.696 |  |  |  |  |  | 
COVID19_MODERNA | Granuloma skin | 0 | 0.156 | 0.026 | 0.842 | 2.695 |  |  |  |  |  | 
COVID19_MODERNA | Albumin urine | 0 | 0.273 | 0.094 | 0.842 | 2.215 |  |  |  |  |  | 
COVID19_MODERNA | Product contamination | 0 | 0.234 | 0.07 | 0.842 | 2.337 |  |  |  |  |  | 
COVID19_MODERNA | Eye operation | 0 | 0.297 | 0.107 | 0.842 | 2.155 |  |  |  |  |  | 
COVID19_MODERNA | Typhus | 0 | 0.078 | 0.001 | 0.842 | 3.452 |  |  |  |  |  | 
COVID19_MODERNA | Visual impairment | 48 | 58.049 | 0.655 | 0.841 | 1.047 | 0.654 | 0.828 | 1.036 | 0.827 | 0.85 | 1.08
COVID19_MODERNA | Laboratory test normal | 55 | 67.125 | 0.67 | 0.841 | 1.028 | 0.658 | 0.82 | 1.013 | 0.819 | 1.086 | 0.279
COVID19_MODERNA | Aphonia | 8 | 12.077 | 0.48 | 0.841 | 1.284 | 0.418 | 0.703 | 1.123 | 0.662 | 1.63 | 1.266
COVID19_MODERNA | Eczema weeping | 0 | 0.195 | 0.047 | 0.841 | 2.491 |  |  |  |  |  | 
COVID19_MODERNA | Seborrhoeic dermatitis | 0 | 0.287 | 0.101 | 0.841 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Pressure of speech | 0 | 0.156 | 0.025 | 0.841 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal erythema | 0 | 0.078 | 0.001 | 0.841 | 3.458 |  |  |  |  |  | 
COVID19_MODERNA | Myasthenic syndrome | 0 | 0.117 | 0.009 | 0.841 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Vascular dementia | 0 | 0.117 | 0.009 | 0.841 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal warts | 0 | 0.117 | 0.009 | 0.841 | 2.996 |  |  |  |  |  | 
COVID19_MODERNA | Epiglottic erythema | 0 | 0.078 | 0.001 | 0.841 | 3.458 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram T wave amplitude decreased | 0 | 0.078 | 0.001 | 0.841 | 3.458 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis bacterial | 0 | 0.156 | 0.025 | 0.841 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Urine bilirubin increased | 0 | 0.273 | 0.093 | 0.841 | 2.218 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis astroviral | 0 | 0.078 | 0.001 | 0.841 | 3.457 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic enlargement | 0 | 0.156 | 0.025 | 0.841 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Ischaemic cardiomyopathy | 0 | 0.117 | 0.009 | 0.841 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.117 | 0.009 | 0.841 | 2.996 |  |  |  |  |  | 
COVID19_MODERNA | Radial pulse abnormal | 0 | 0.117 | 0.009 | 0.841 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Lesion excision | 0 | 0.156 | 0.025 | 0.841 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Salmonellosis | 0 | 0.07 | 0 | 0.84 | 3.601 |  |  |  |  |  | 
COVID19_MODERNA | Essential tremor | 0 | 0.205 | 0.051 | 0.84 | 2.451 |  |  |  |  |  | 
COVID19_MODERNA | Disease susceptibility | 0 | 0.195 | 0.046 | 0.84 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Urobilinogen urine decreased | 0 | 0.368 | 0.143 | 0.84 | 2.013 |  |  |  |  |  | 
COVID19_MODERNA | Dysmorphism | 0 | 0.156 | 0.025 | 0.84 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cystectomy | 0 | 0.156 | 0.025 | 0.84 | 2.702 |  |  |  |  |  | 
COVID19_MODERNA | Incarcerated inguinal hernia | 0 | 0.156 | 0.025 | 0.84 | 2.702 |  |  |  |  |  | 
COVID19_MODERNA | Upper airway obstruction | 0 | 0.273 | 0.091 | 0.84 | 2.222 |  |  |  |  |  | 
COVID19_MODERNA | Tympanometry | 0 | 0.273 | 0.091 | 0.84 | 2.223 |  |  |  |  |  | 
COVID19_MODERNA | Coombs direct test | 0 | 0.312 | 0.113 | 0.84 | 2.127 |  |  |  |  |  | 
COVID19_MODERNA | Facial neuralgia | 0 | 0.346 | 0.131 | 0.84 | 2.054 |  |  |  |  |  | 
COVID19_MODERNA | Poliovirus test negative | 0 | 0.156 | 0.025 | 0.84 | 2.703 |  |  |  |  |  | 
COVID19_MODERNA | Lung opacity | 23 | 28.371 | 0.585 | 0.839 | 1.131 | 0.584 | 0.814 | 1.111 | 0.811 | 12.891 | 157.677
COVID19_MODERNA | Dysphemia | 2 | 2.994 | 0.227 | 0.839 | 1.764 | 0.346 | 0.76 | 1.495 | 0.668 | 0.53 | 0.406
COVID19_MODERNA | Thermal burn | 1 | 1.772 | 0.301 | 0.839 | 1.595 | 0.303 | 0.742 | 1.578 | 0.564 | 1.233 | 0.129
COVID19_MODERNA | Glucose urine | 0 | 0.117 | 0.008 | 0.839 | 3.005 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising enterocolitis neonatal | 0 | 0.117 | 0.009 | 0.839 | 3.001 |  |  |  |  |  | 
COVID19_MODERNA | Antisocial behaviour | 0 | 0.195 | 0.044 | 0.839 | 2.501 |  |  |  |  |  | 
COVID19_MODERNA | Fasciotomy | 0 | 0.156 | 0.024 | 0.839 | 2.706 |  |  |  |  |  | 
COVID19_MODERNA | Lip discolouration | 0 | 0.679 | 0.261 | 0.839 | 1.681 |  |  |  |  |  | 
COVID19_MODERNA | Cushingoid | 0 | 0.156 | 0.024 | 0.839 | 2.708 |  |  |  |  |  | 
COVID19_MODERNA | Cystoscopy normal | 0 | 0.156 | 0.024 | 0.839 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Giardia test | 0 | 0.156 | 0.024 | 0.839 | 2.707 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram T wave normal | 0 | 0.195 | 0.045 | 0.839 | 2.499 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal tube insertion | 2 | 3.247 | 0.266 | 0.838 | 1.671 | 0.332 | 0.732 | 1.439 | 0.616 | 0.542 | 0.363
COVID19_MODERNA | CSF protein increased | 5 | 8.454 | 0.381 | 0.838 | 1.439 | 0.36 | 0.665 | 1.146 | 0.591 | 0.339 | 5.712
COVID19_MODERNA | Cachexia | 0 | 0.234 | 0.066 | 0.838 | 2.35 |  |  |  |  |  | 
COVID19_MODERNA | Orthopox virus infection | 0 | 0.078 | 0.001 | 0.838 | 3.471 |  |  |  |  |  | 
COVID19_MODERNA | Product packaging confusion | 0 | 0.114 | 0.007 | 0.838 | 3.032 |  |  |  |  |  | 
COVID19_MODERNA | Perfusion brain scan abnormal | 0 | 0.117 | 0.008 | 0.838 | 3.005 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal hypomotility | 0 | 0.312 | 0.111 | 0.838 | 2.13 |  |  |  |  |  | 
COVID19_MODERNA | Abscess oral | 0 | 0.195 | 0.044 | 0.838 | 2.502 |  |  |  |  |  | 
COVID19_MODERNA | Blister infected | 0 | 0.195 | 0.044 | 0.838 | 2.502 |  |  |  |  |  | 
COVID19_MODERNA | Breast cyst | 0 | 0.117 | 0.008 | 0.838 | 3.005 |  |  |  |  |  | 
COVID19_MODERNA | Renal pain | 6 | 6.841 | 0.43 | 0.837 | 1.353 | 0.486 | 0.864 | 1.445 | 0.877 | 1.681 | 0.959
COVID19_MODERNA | Supraventricular tachyarrhythmias (SMQ) [narrow] | 93 | 111.879 | 0.702 | 0.837 | 0.982 | 0.701 | 0.832 | 0.98 | 0.831 | 4.36 | 202.05
COVID19_MODERNA | Immune thrombocytopenia | 16 | 21.29 | 0.539 | 0.837 | 1.188 | 0.517 | 0.764 | 1.097 | 0.752 | 0.817 | 0.465
COVID19_MODERNA | SARS-CoV-2 antibody test negative | 10 | 13.388 | 0.514 | 0.837 | 1.224 | 0.476 | 0.767 | 1.182 | 0.747 | 9.864 | 50.505
COVID19_MODERNA | Rhesus antigen positive | 0 | 0.234 | 0.065 | 0.837 | 2.351 |  |  |  |  |  | 
COVID19_MODERNA | Sense of oppression | 0 | 0.195 | 0.043 | 0.837 | 2.506 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body aspiration | 0 | 0.156 | 0.023 | 0.837 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | Overweight | 0 | 0.312 | 0.108 | 0.837 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Nephritis | 0 | 0.126 | 0.011 | 0.837 | 2.926 |  |  |  |  |  | 
COVID19_MODERNA | Eye patch application | 0 | 0.234 | 0.065 | 0.837 | 2.351 |  |  |  |  |  | 
COVID19_MODERNA | Familial periodic paralysis | 0 | 0.117 | 0.008 | 0.837 | 3.013 |  |  |  |  |  | 
COVID19_MODERNA | Hyperbaric oxygen therapy | 0 | 0.195 | 0.043 | 0.837 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Carotid pulse abnormal | 0 | 0.156 | 0.023 | 0.837 | 2.713 |  |  |  |  |  | 
COVID19_MODERNA | Retinitis | 0 | 0.351 | 0.13 | 0.837 | 2.052 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal spasm | 0 | 0.117 | 0.008 | 0.837 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal erosion | 0 | 0.156 | 0.023 | 0.837 | 2.716 |  |  |  |  |  | 
COVID19_MODERNA | CSF pressure | 0 | 0.117 | 0.008 | 0.837 | 3.013 |  |  |  |  |  | 
COVID19_MODERNA | Supraventricular tachyarrhythmias (SMQ) [broad] | 93 | 111.988 | 0.701 | 0.836 | 0.981 | 0.7 | 0.831 | 0.98 | 0.83 | 4.335 | 200.39
COVID19_MODERNA | Respiratory rate | 3 | 4.053 | 0.38 | 0.836 | 1.435 | 0.385 | 0.786 | 1.463 | 0.74 | 5.284 | 5.303
COVID19_MODERNA | Acne | 2 | 3.125 | 0.25 | 0.836 | 1.702 | 0.339 | 0.745 | 1.465 | 0.64 | 0.173 | 7.023
COVID19_MODERNA | Haemoglobin | 4 | 6.713 | 0.37 | 0.836 | 1.454 | 0.352 | 0.68 | 1.214 | 0.596 | 1.249 | 0.023
COVID19_MODERNA | Indifference | 0 | 0.195 | 0.042 | 0.836 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Fat necrosis | 0 | 0.312 | 0.108 | 0.836 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Eye allergy | 0 | 0.195 | 0.042 | 0.836 | 2.51 |  |  |  |  |  | 
COVID19_MODERNA | Foot amputation | 0 | 0.156 | 0.022 | 0.836 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Neurotoxicity | 0 | 0.195 | 0.042 | 0.836 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Nasoendoscopy | 0 | 0.273 | 0.087 | 0.836 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid pain | 0 | 0.234 | 0.064 | 0.836 | 2.356 |  |  |  |  |  | 
COVID19_MODERNA | Vibration test abnormal | 0 | 0.156 | 0.022 | 0.836 | 2.72 |  |  |  |  |  | 
COVID19_MODERNA | Thromboembolectomy | 0 | 0.117 | 0.008 | 0.836 | 3.015 |  |  |  |  |  | 
COVID19_MODERNA | Intracardiac thrombus | 0 | 0.117 | 0.008 | 0.836 | 3.017 |  |  |  |  |  | 
COVID19_MODERNA | Human metapneumovirus test positive | 0 | 0.128 | 0.011 | 0.836 | 2.924 |  |  |  |  |  | 
COVID19_MODERNA | Extrapulmonary tuberculosis | 0 | 0.078 | 0.001 | 0.836 | 3.48 |  |  |  |  |  | 
COVID19_MODERNA | Piloerection | 2 | 2.812 | 0.347 | 0.835 | 1.493 | 0.356 | 0.782 | 1.537 | 0.711 | 1.37 | 0
COVID19_MODERNA | Lung neoplasm malignant | 1 | 1.765 | 0.252 | 0.835 | 1.694 | 0.303 | 0.743 | 1.58 | 0.567 | 1.451 | 0.06
COVID19_MODERNA | Dengue virus test positive | 0 | 0.078 | 0.001 | 0.835 | 3.484 |  |  |  |  |  | 
COVID19_MODERNA | Bone scan abnormal | 0 | 0.289 | 0.094 | 0.835 | 2.194 |  |  |  |  |  | 
COVID19_MODERNA | Enteroclysis | 0 | 0.117 | 0.007 | 0.835 | 3.019 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac aneurysm | 0 | 0.156 | 0.022 | 0.835 | 2.722 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte haemoglobin equivalent | 0 | 0.156 | 0.022 | 0.835 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Motor developmental delay | 0 | 0.119 | 0.008 | 0.835 | 3.005 |  |  |  |  |  | 
COVID19_MODERNA | Status epilepticus | 2 | 2.63 | 0.284 | 0.834 | 1.619 | 0.367 | 0.805 | 1.582 | 0.761 | 0.329 | 2.06
COVID19_MODERNA | Depression and suicide/self-injury (SMQ) [broad] | 140 | 176.213 | 0.722 | 0.834 | 0.952 | 0.692 | 0.795 | 0.911 | 0.794 | 0.38 | 142.302
COVID19_MODERNA | Vaccination site urticaria | 0 | 0.262 | 0.078 | 0.834 | 2.269 |  |  |  |  |  | 
COVID19_MODERNA | Faecal calprotectin | 0 | 0.156 | 0.022 | 0.834 | 2.724 |  |  |  |  |  | 
COVID19_MODERNA | Menopause | 0 | 0.195 | 0.041 | 0.834 | 2.516 |  |  |  |  |  | 
COVID19_MODERNA | Detoxification | 0 | 0.224 | 0.057 | 0.834 | 2.396 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated myositis | 0 | 0.156 | 0.021 | 0.834 | 2.726 |  |  |  |  |  | 
COVID19_MODERNA | Bone cancer | 0 | 0.117 | 0.007 | 0.834 | 3.023 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin abnormal | 0 | 0.234 | 0.062 | 0.834 | 2.362 |  |  |  |  |  | 
COVID19_MODERNA | Chronic myeloid leukaemia | 0 | 0.195 | 0.041 | 0.834 | 2.516 |  |  |  |  |  | 
COVID19_MODERNA | Aspartate aminotransferase decreased | 0 | 0.234 | 0.062 | 0.834 | 2.362 |  |  |  |  |  | 
COVID19_MODERNA | Brain abscess | 0 | 0.195 | 0.04 | 0.834 | 2.518 |  |  |  |  |  | 
COVID19_MODERNA | Autonomic nervous system imbalance | 1 | 1.199 | 0.086 | 0.833 | 2.223 | 0.342 | 0.834 | 1.769 | 0.834 | 0.111 | 6.234
COVID19_MODERNA | Spinal X-ray | 3 | 5.038 | 0.419 | 0.833 | 1.362 | 0.34 | 0.696 | 1.296 | 0.595 | 1.276 | 0.007
COVID19_MODERNA | Meningeal disorder | 0 | 0.168 | 0.026 | 0.833 | 2.659 |  |  |  |  |  | 
COVID19_MODERNA | Uterine cancer | 0 | 0.156 | 0.021 | 0.833 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Electrocauterisation | 0 | 0.195 | 0.04 | 0.833 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Retinogram | 0 | 0.312 | 0.103 | 0.833 | 2.145 |  |  |  |  |  | 
COVID19_MODERNA | Cutaneous vasculitis | 0 | 0.195 | 0.039 | 0.833 | 2.522 |  |  |  |  |  | 
COVID19_MODERNA | Blood prolactin | 0 | 0.156 | 0.021 | 0.833 | 2.731 |  |  |  |  |  | 
COVID19_MODERNA | Anger | 5 | 6.124 | 0.411 | 0.832 | 1.374 | 0.447 | 0.825 | 1.42 | 0.816 | 0.856 | 0.017
COVID19_MODERNA | Dyskinesia | 21 | 27.08 | 0.57 | 0.832 | 1.135 | 0.554 | 0.783 | 1.082 | 0.775 | 0.394 | 18.71
COVID19_MODERNA | Blood ketone body increased | 0 | 0.351 | 0.122 | 0.832 | 2.065 |  |  |  |  |  | 
COVID19_MODERNA | Electrophoresis normal | 0 | 0.195 | 0.039 | 0.832 | 2.525 |  |  |  |  |  | 
COVID19_MODERNA | Nail bed bleeding | 0 | 0.156 | 0.02 | 0.832 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Methylmalonic aciduria | 0 | 0.156 | 0.02 | 0.832 | 2.735 |  |  |  |  |  | 
COVID19_MODERNA | Application site vesicles | 0 | 0.117 | 0.007 | 0.832 | 3.032 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral palsy | 0 | 0.352 | 0.122 | 0.832 | 2.063 |  |  |  |  |  | 
COVID19_MODERNA | Neuropsychiatric symptoms | 0 | 0.195 | 0.039 | 0.832 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Audiogram normal | 0 | 0.312 | 0.103 | 0.832 | 2.146 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site pain | 0 | 0.156 | 0.02 | 0.832 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Dyschromatopsia | 0 | 0.299 | 0.095 | 0.832 | 2.177 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B6 | 0 | 0.234 | 0.06 | 0.832 | 2.368 |  |  |  |  |  | 
COVID19_MODERNA | Gastric infection | 0 | 0.156 | 0.02 | 0.832 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Papilloma | 0 | 0.117 | 0.007 | 0.832 | 3.032 |  |  |  |  |  | 
COVID19_MODERNA | Post transfusion purpura | 0 | 0.078 | 0.001 | 0.832 | 3.5 |  |  |  |  |  | 
COVID19_MODERNA | Gross motor delay | 0 | 0.161 | 0.022 | 0.832 | 2.704 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract infection bacterial | 0 | 0.195 | 0.039 | 0.832 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Abdomen scan | 0 | 0.195 | 0.038 | 0.831 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Wound haemorrhage | 0 | 0.39 | 0.139 | 0.831 | 1.999 |  |  |  |  |  | 
COVID19_MODERNA | Anal abscess | 0 | 0.195 | 0.038 | 0.831 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Testicular torsion | 0 | 0.117 | 0.006 | 0.831 | 3.036 |  |  |  |  |  | 
COVID19_MODERNA | Varicella virus test | 0 | 0.185 | 0.034 | 0.831 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Arthropod sting | 0 | 0.39 | 0.14 | 0.831 | 1.997 |  |  |  |  |  | 
COVID19_MODERNA | Foreign travel | 0 | 0.38 | 0.135 | 0.831 | 2.015 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatic failure | 0 | 0.195 | 0.038 | 0.831 | 2.527 |  |  |  |  |  | 
COVID19_MODERNA | Skin laceration | 7 | 11.07 | 0.448 | 0.83 | 1.306 | 0.396 | 0.683 | 1.115 | 0.632 | 0.722 | 0.473
COVID19_MODERNA | Product used for unknown indication | 0 | 0.234 | 0.058 | 0.83 | 2.372 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis viral | 0 | 0.195 | 0.038 | 0.83 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Eye ulcer | 0 | 0.117 | 0.006 | 0.83 | 3.04 |  |  |  |  |  | 
COVID19_MODERNA | Feelings of worthlessness | 0 | 0.117 | 0.006 | 0.83 | 3.04 |  |  |  |  |  | 
COVID19_MODERNA | Peritoneal dialysis | 0 | 0.195 | 0.038 | 0.83 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration joint normal | 0 | 0.351 | 0.119 | 0.83 | 2.07 |  |  |  |  |  | 
COVID19_MODERNA | Blood bilirubin unconjugated increased | 0 | 0.085 | 0.001 | 0.83 | 3.41 |  |  |  |  |  | 
COVID19_MODERNA | Transient acantholytic dermatosis | 0 | 0.117 | 0.006 | 0.83 | 3.04 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis A antibody | 0 | 0.156 | 0.019 | 0.83 | 2.741 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral venous disease | 0 | 0.312 | 0.1 | 0.83 | 2.15 |  |  |  |  |  | 
COVID19_MODERNA | Mouth haemorrhage | 5 | 5.771 | 0.429 | 0.829 | 1.336 | 0.464 | 0.856 | 1.474 | 0.866 | 1.561 | 0.478
COVID19_MODERNA | Product administration error | 5 | 7.604 | 0.337 | 0.829 | 1.496 | 0.388 | 0.716 | 1.233 | 0.658 | 0.391 | 4.058
COVID19_MODERNA | Obsessive-compulsive symptom | 0 | 0.156 | 0.019 | 0.829 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration joint abnormal | 0 | 0.234 | 0.057 | 0.829 | 2.378 |  |  |  |  |  | 
COVID19_MODERNA | Oedema mucosal | 0 | 0.39 | 0.137 | 0.829 | 2.003 |  |  |  |  |  | 
COVID19_MODERNA | Focal dyscognitive seizures | 0 | 0.362 | 0.124 | 0.829 | 2.051 |  |  |  |  |  | 
COVID19_MODERNA | Bordetella test negative | 0 | 0.414 | 0.148 | 0.829 | 1.964 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract infection bacterial | 0 | 0.195 | 0.037 | 0.829 | 2.533 |  |  |  |  |  | 
COVID19_MODERNA | Laryngomalacia | 0 | 0.273 | 0.078 | 0.829 | 2.254 |  |  |  |  |  | 
COVID19_MODERNA | Vital capacity decreased | 0 | 0.117 | 0.006 | 0.829 | 3.045 |  |  |  |  |  | 
COVID19_MODERNA | CSF white blood cell count positive | 0 | 0.273 | 0.078 | 0.829 | 2.253 |  |  |  |  |  | 
COVID19_MODERNA | Chelation therapy | 0 | 0.234 | 0.057 | 0.829 | 2.376 |  |  |  |  |  | 
COVID19_MODERNA | Blood pressure diastolic decreased | 0 | 0.195 | 0.037 | 0.829 | 2.535 |  |  |  |  |  | 
COVID19_MODERNA | Acid base balance normal | 0 | 0.156 | 0.019 | 0.829 | 2.747 |  |  |  |  |  | 
COVID19_MODERNA | Gene mutation | 0 | 0.239 | 0.06 | 0.829 | 2.357 |  |  |  |  |  | 
COVID19_MODERNA | Selective polysaccharide antibody deficiency | 0 | 0.195 | 0.036 | 0.829 | 2.535 |  |  |  |  |  | 
COVID19_MODERNA | Alopecia universalis | 0 | 0.195 | 0.037 | 0.829 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Basilar migraine | 0 | 0.117 | 0.006 | 0.829 | 3.047 |  |  |  |  |  | 
COVID19_MODERNA | Guttate psoriasis | 0 | 0.273 | 0.078 | 0.829 | 2.253 |  |  |  |  |  | 
COVID19_MODERNA | Senile dementia | 0 | 0.078 | 0.001 | 0.829 | 3.511 |  |  |  |  |  | 
COVID19_MODERNA | Sensory disturbance | 20 | 24.544 | 0.555 | 0.828 | 1.146 | 0.574 | 0.818 | 1.138 | 0.815 | 0.874 | 0.234
COVID19_MODERNA | Discomfort | 75 | 92.69 | 0.683 | 0.828 | 0.984 | 0.67 | 0.81 | 0.972 | 0.809 | 0.912 | 0.538
COVID19_MODERNA | Red blood cell morphology normal | 0 | 0.39 | 0.136 | 0.828 | 2.004 |  |  |  |  |  | 
COVID19_MODERNA | Tongue haemorrhage | 0 | 0.273 | 0.077 | 0.828 | 2.255 |  |  |  |  |  | 
COVID19_MODERNA | Tourette's disorder | 0 | 0.207 | 0.042 | 0.828 | 2.486 |  |  |  |  |  | 
COVID19_MODERNA | Bronchopulmonary dysplasia | 0 | 0.117 | 0.006 | 0.828 | 3.047 |  |  |  |  |  | 
COVID19_MODERNA | Injection site cyst | 0 | 0.603 | 0.219 | 0.828 | 1.754 |  |  |  |  |  | 
COVID19_MODERNA | Chronic tonsillitis | 0 | 0.117 | 0.006 | 0.828 | 3.049 |  |  |  |  |  | 
COVID19_MODERNA | White blood cell morphology normal | 0 | 0.156 | 0.018 | 0.828 | 2.749 |  |  |  |  |  | 
COVID19_MODERNA | Infarction | 0 | 0.416 | 0.147 | 0.828 | 1.963 |  |  |  |  |  | 
COVID19_MODERNA | Rectal examination abnormal | 0 | 0.195 | 0.036 | 0.828 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Hypocoagulable state | 0 | 0.117 | 0.006 | 0.828 | 3.051 |  |  |  |  |  | 
COVID19_MODERNA | Product prescribing issue | 0 | 0.117 | 0.006 | 0.828 | 3.05 |  |  |  |  |  | 
COVID19_MODERNA | Anti-thyroid antibody negative | 0 | 0.208 | 0.043 | 0.828 | 2.479 |  |  |  |  |  | 
COVID19_MODERNA | Blood bilirubin unconjugated decreased | 0 | 0.234 | 0.056 | 0.828 | 2.38 |  |  |  |  |  | 
COVID19_MODERNA | Ankle fracture | 0 | 0.351 | 0.117 | 0.828 | 2.074 |  |  |  |  |  | 
COVID19_MODERNA | Angiogram cerebral | 8 | 11.307 | 0.467 | 0.827 | 1.271 | 0.44 | 0.739 | 1.181 | 0.708 | 8.968 | 35.676
COVID19_MODERNA | Gynaecological examination normal | 0 | 0.156 | 0.018 | 0.827 | 2.753 |  |  |  |  |  | 
COVID19_MODERNA | Blood testosterone normal | 0 | 0.195 | 0.035 | 0.827 | 2.542 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic pulmonary fibrosis | 0 | 0.195 | 0.035 | 0.827 | 2.542 |  |  |  |  |  | 
COVID19_MODERNA | Urticaria chronic | 0 | 0.273 | 0.076 | 0.827 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Tooth loss | 0 | 0.251 | 0.065 | 0.827 | 2.323 |  |  |  |  |  | 
COVID19_MODERNA | Stomatitis | 9 | 11.394 | 0.471 | 0.826 | 1.261 | 0.488 | 0.802 | 1.257 | 0.79 | 1.067 | 0
COVID19_MODERNA | Red cell distribution width normal | 8 | 11.456 | 0.456 | 0.826 | 1.285 | 0.436 | 0.732 | 1.169 | 0.698 | 1.257 | 0.185
COVID19_MODERNA | Vascular headache | 0 | 0.156 | 0.017 | 0.826 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | CSF oligoclonal band absent | 0 | 0.211 | 0.043 | 0.826 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Meningoencephalitis viral | 0 | 0.159 | 0.019 | 0.826 | 2.735 |  |  |  |  |  | 
COVID19_MODERNA | Administration site reaction | 0 | 0.407 | 0.141 | 0.826 | 1.981 |  |  |  |  |  | 
COVID19_MODERNA | Multifocal motor neuropathy | 0 | 0.273 | 0.074 | 0.826 | 2.263 |  |  |  |  |  | 
COVID19_MODERNA | Bite | 0 | 0.195 | 0.035 | 0.826 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Parakeratosis | 0 | 0.195 | 0.034 | 0.826 | 2.544 |  |  |  |  |  | 
COVID19_MODERNA | Cystic fibrosis | 0 | 0.117 | 0.005 | 0.826 | 3.058 |  |  |  |  |  | 
COVID19_MODERNA | Panic reaction | 5 | 6.697 | 0.41 | 0.825 | 1.357 | 0.422 | 0.779 | 1.341 | 0.747 | 1.601 | 0.554
COVID19_MODERNA | Oral mucosal eruption | 3 | 4.642 | 0.43 | 0.825 | 1.323 | 0.357 | 0.73 | 1.359 | 0.646 | 0.725 | 0.089
COVID19_MODERNA | Protein total decreased | 2 | 3.8 | 0.219 | 0.825 | 1.746 | 0.306 | 0.676 | 1.332 | 0.526 | 0.465 | 0.722
COVID19_MODERNA | Fluid replacement | 0 | 0.234 | 0.053 | 0.825 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Jaw fracture | 0 | 0.5 | 0.177 | 0.825 | 1.86 |  |  |  |  |  | 
COVID19_MODERNA | Otitis media acute | 0 | 0.192 | 0.033 | 0.825 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Hyperprolactinaemia | 0 | 0.117 | 0.005 | 0.825 | 3.059 |  |  |  |  |  | 
COVID19_MODERNA | Puncture site haemorrhage | 0 | 0.195 | 0.034 | 0.825 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Pneumomediastinum | 0 | 0.195 | 0.034 | 0.825 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Interleukin-2 receptor increased | 0 | 0.195 | 0.034 | 0.825 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Cryoglobulinaemia | 0 | 0.072 | 0 | 0.825 | 3.62 |  |  |  |  |  | 
COVID19_MODERNA | Decubitus ulcer | 0 | 0.234 | 0.053 | 0.825 | 2.389 |  |  |  |  |  | 
COVID19_MODERNA | Muscle rupture | 0 | 0.351 | 0.113 | 0.825 | 2.081 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site hypoaesthesia | 0 | 0.156 | 0.017 | 0.825 | 2.759 |  |  |  |  |  | 
COVID19_MODERNA | Venogram | 2 | 2.117 | 0.314 | 0.824 | 1.529 | 0.4 | 0.878 | 1.725 | 0.945 | 3.523 | 1.282
COVID19_MODERNA | Consciousness fluctuating | 2 | 3.101 | 0.344 | 0.824 | 1.472 | 0.34 | 0.748 | 1.471 | 0.645 | 1.049 | 0.091
COVID19_MODERNA | Megakaryocytes | 0 | 0.156 | 0.017 | 0.824 | 2.764 |  |  |  |  |  | 
COVID19_MODERNA | Urinary hesitation | 0 | 0.273 | 0.073 | 0.824 | 2.266 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterial infection | 0 | 0.156 | 0.017 | 0.824 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Horner's syndrome | 0 | 0.234 | 0.052 | 0.824 | 2.391 |  |  |  |  |  | 
COVID19_MODERNA | Personal relationship issue | 0 | 0.195 | 0.033 | 0.824 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin increased | 2 | 2.729 | 0.301 | 0.823 | 1.552 | 0.361 | 0.792 | 1.557 | 0.733 | 1.37 | 0
COVID19_MODERNA | Tympanometry abnormal | 0 | 0.195 | 0.033 | 0.823 | 2.553 |  |  |  |  |  | 
COVID19_MODERNA | Serous retinal detachment | 0 | 0.156 | 0.016 | 0.823 | 2.766 |  |  |  |  |  | 
COVID19_MODERNA | Hypertransaminasaemia | 0 | 0.287 | 0.078 | 0.823 | 2.231 |  |  |  |  |  | 
COVID19_MODERNA | Drain placement | 0 | 0.39 | 0.129 | 0.823 | 2.014 |  |  |  |  |  | 
COVID19_MODERNA | Opsoclonus myoclonus | 0 | 0.156 | 0.016 | 0.823 | 2.766 |  |  |  |  |  | 
COVID19_MODERNA | pH body fluid normal | 0 | 0.135 | 0.009 | 0.823 | 2.915 |  |  |  |  |  | 
COVID19_MODERNA | Muscle injury | 0 | 0.456 | 0.157 | 0.823 | 1.916 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy gastrointestinal | 0 | 0.234 | 0.051 | 0.823 | 2.395 |  |  |  |  |  | 
COVID19_MODERNA | Natural killer cell count decreased | 0 | 0.156 | 0.016 | 0.823 | 2.765 |  |  |  |  |  | 
COVID19_MODERNA | Alveolitis | 0 | 0.117 | 0.005 | 0.823 | 3.068 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial wall thickening | 0 | 0.178 | 0.025 | 0.823 | 2.637 |  |  |  |  |  | 
COVID19_MODERNA | Pyomyositis | 0 | 0.117 | 0.005 | 0.823 | 3.068 |  |  |  |  |  | 
COVID19_MODERNA | Penis disorder | 0 | 0.195 | 0.032 | 0.823 | 2.554 |  |  |  |  |  | 
COVID19_MODERNA | Type 1 diabetes mellitus | 1 | 0.871 | 0.132 | 0.822 | 1.999 | 0.369 | 0.897 | 1.902 | 1.147 | 0.158 | 3.629
COVID19_MODERNA | Blood magnesium increased | 2 | 2.733 | 0.335 | 0.822 | 1.482 | 0.36 | 0.792 | 1.556 | 0.732 | 1.701 | 0.073
COVID19_MODERNA | Musculoskeletal chest pain | 14 | 18.617 | 0.533 | 0.822 | 1.162 | 0.506 | 0.766 | 1.122 | 0.752 | 1.255 | 0.463
COVID19_MODERNA | Wound treatment | 0 | 0.371 | 0.119 | 0.822 | 2.049 |  |  |  |  |  | 
COVID19_MODERNA | Myocardial reperfusion injury | 0 | 0.273 | 0.07 | 0.822 | 2.272 |  |  |  |  |  | 
COVID19_MODERNA | Enterobacter test positive | 0 | 0.156 | 0.016 | 0.822 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Still's disease | 0 | 0.248 | 0.058 | 0.822 | 2.348 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia necrotising | 0 | 0.117 | 0.005 | 0.822 | 3.071 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary physical examination normal | 0 | 0.234 | 0.05 | 0.822 | 2.398 |  |  |  |  |  | 
COVID19_MODERNA | Pituitary tumour benign | 0 | 0.156 | 0.016 | 0.822 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | Parainfluenzae virus infection | 0 | 0.282 | 0.075 | 0.822 | 2.245 |  |  |  |  |  | 
COVID19_MODERNA | Borrelia test positive | 0 | 0.189 | 0.029 | 0.822 | 2.584 |  |  |  |  |  | 
COVID19_MODERNA | Hypospadias | 0 | 0.195 | 0.032 | 0.822 | 2.557 |  |  |  |  |  | 
COVID19_MODERNA | Negativism | 0 | 0.234 | 0.051 | 0.822 | 2.397 |  |  |  |  |  | 
COVID19_MODERNA | Selective IgM immunodeficiency | 0 | 0.117 | 0.005 | 0.822 | 3.071 |  |  |  |  |  | 
COVID19_MODERNA | Fracture treatment | 0 | 0.117 | 0.005 | 0.822 | 3.071 |  |  |  |  |  | 
COVID19_MODERNA | Sinus arrhythmia | 3 | 2.762 | 0.346 | 0.821 | 1.461 | 0.465 | 0.947 | 1.761 | 1.086 | 4.11 | 3.596
COVID19_MODERNA | Parasite stool test | 0 | 0.234 | 0.05 | 0.821 | 2.399 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 2 globulin | 0 | 0.195 | 0.031 | 0.821 | 2.559 |  |  |  |  |  | 
COVID19_MODERNA | Device related infection | 0 | 0.312 | 0.088 | 0.821 | 2.174 |  |  |  |  |  | 
COVID19_MODERNA | CSF neutrophil count | 0 | 0.156 | 0.015 | 0.821 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Choroiditis | 0 | 0.234 | 0.05 | 0.821 | 2.399 |  |  |  |  |  | 
COVID19_MODERNA | Scan myocardial perfusion abnormal | 0 | 0.117 | 0.005 | 0.821 | 3.075 |  |  |  |  |  | 
COVID19_MODERNA | Cranial nerve disorder | 0 | 0.442 | 0.148 | 0.821 | 1.939 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract inflammation | 0 | 0.234 | 0.05 | 0.821 | 2.399 |  |  |  |  |  | 
COVID19_MODERNA | Ear infection | 3 | 3.952 | 0.332 | 0.82 | 1.483 | 0.391 | 0.797 | 1.483 | 0.759 | 0.184 | 9.959
COVID19_MODERNA | Rheumatoid factor | 2 | 2.705 | 0.302 | 0.82 | 1.544 | 0.362 | 0.795 | 1.563 | 0.739 | 0.771 | 0.002
COVID19_MODERNA | Differential white blood cell count abnormal | 1 | 1.669 | 0.206 | 0.82 | 1.766 | 0.309 | 0.757 | 1.609 | 0.599 | 0.667 | 0
COVID19_MODERNA | Tongue biting | 1 | 2.033 | 0.27 | 0.82 | 1.611 | 0.287 | 0.706 | 1.504 | 0.492 | 0.548 | 0.05
COVID19_MODERNA | Bursitis infective | 0 | 0.117 | 0.004 | 0.82 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Human herpesvirus 6 infection | 0 | 0.156 | 0.015 | 0.82 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Thrombophlebitis | 0 | 0.351 | 0.106 | 0.82 | 2.092 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal obstruction | 0 | 0.195 | 0.03 | 0.82 | 2.564 |  |  |  |  |  | 
COVID19_MODERNA | Prealbumin | 0 | 0.195 | 0.031 | 0.82 | 2.563 |  |  |  |  |  | 
COVID19_MODERNA | Cystitis noninfective | 0 | 0.234 | 0.049 | 0.82 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site ulcer | 0 | 0.234 | 0.049 | 0.82 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | Neuropathic muscular atrophy | 0 | 0.234 | 0.049 | 0.82 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | High density lipoprotein normal | 0 | 0.34 | 0.102 | 0.82 | 2.112 |  |  |  |  |  | 
COVID19_MODERNA | Anti-GAD antibody negative | 0 | 0.195 | 0.031 | 0.82 | 2.562 |  |  |  |  |  | 
COVID19_MODERNA | Lipaemic index score | 0 | 0.117 | 0.004 | 0.82 | 3.081 |  |  |  |  |  | 
COVID19_MODERNA | Serum amyloid A protein increased | 0 | 0.156 | 0.015 | 0.82 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Corneal opacity | 0 | 0.351 | 0.106 | 0.82 | 2.093 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary oedema | 15 | 18.743 | 0.519 | 0.819 | 1.175 | 0.54 | 0.807 | 1.169 | 0.8 | 4.867 | 35.215
COVID19_MODERNA | Vestibular disorders (SMQ) [narrow] | 91 | 118.398 | 0.685 | 0.819 | 0.964 | 0.649 | 0.771 | 0.91 | 0.769 | 1.704 | 24.175
COVID19_MODERNA | Pituitary cyst | 0 | 0.117 | 0.004 | 0.819 | 3.084 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculin test negative | 0 | 0.141 | 0.01 | 0.819 | 2.888 |  |  |  |  |  | 
COVID19_MODERNA | Infrequent bowel movements | 0 | 0.147 | 0.012 | 0.819 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Lumbar spinal stenosis | 0 | 0.312 | 0.086 | 0.819 | 2.179 |  |  |  |  |  | 
COVID19_MODERNA | Eczema eyelids | 0 | 0.117 | 0.004 | 0.819 | 3.085 |  |  |  |  |  | 
COVID19_MODERNA | Post-tussive vomiting | 0 | 0.211 | 0.037 | 0.819 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram pelvis abnormal | 4 | 6.407 | 0.367 | 0.818 | 1.414 | 0.363 | 0.701 | 1.251 | 0.624 | 5.48 | 8.477
COVID19_MODERNA | Neuritis | 1 | 1.898 | 0.164 | 0.818 | 1.88 | 0.295 | 0.724 | 1.541 | 0.527 | 0.304 | 0.936
COVID19_MODERNA | Abdomen scan normal | 0 | 0.086 | 0.001 | 0.818 | 3.444 |  |  |  |  |  | 
COVID19_MODERNA | Urine flow decreased | 0 | 0.273 | 0.066 | 0.818 | 2.283 |  |  |  |  |  | 
COVID19_MODERNA | Post vaccination challenge strain shedding | 0 | 0.117 | 0.004 | 0.818 | 3.086 |  |  |  |  |  | 
COVID19_MODERNA | Haematology test abnormal | 0 | 0.273 | 0.066 | 0.818 | 2.282 |  |  |  |  |  | 
COVID19_MODERNA | Urinary sediment | 0 | 0.117 | 0.004 | 0.818 | 3.085 |  |  |  |  |  | 
COVID19_MODERNA | Bleeding time prolonged | 0 | 0.156 | 0.014 | 0.818 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Sweat test abnormal | 0 | 0.156 | 0.014 | 0.818 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Coombs test positive | 0 | 0.234 | 0.047 | 0.818 | 2.409 |  |  |  |  |  | 
COVID19_MODERNA | Metamyelocyte percentage | 0 | 0.234 | 0.047 | 0.818 | 2.409 |  |  |  |  |  | 
COVID19_MODERNA | Acute lymphocytic leukaemia | 0 | 0.359 | 0.109 | 0.818 | 2.078 |  |  |  |  |  | 
COVID19_MODERNA | Langerhans' cell histiocytosis | 0 | 0.156 | 0.014 | 0.818 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | X-ray gastrointestinal tract normal | 0 | 0.108 | 0.003 | 0.818 | 3.18 |  |  |  |  |  | 
COVID19_MODERNA | Calcinosis | 0 | 0.273 | 0.066 | 0.818 | 2.283 |  |  |  |  |  | 
COVID19_MODERNA | Lichen striatus | 0 | 0.117 | 0.004 | 0.818 | 3.087 |  |  |  |  |  | 
COVID19_MODERNA | Vertigo | 87 | 112.414 | 0.68 | 0.817 | 0.964 | 0.65 | 0.776 | 0.92 | 0.774 | 1.733 | 24.591
COVID19_MODERNA | Malignant lymphomas (SMQ) [broad] | 6 | 8.917 | 0.399 | 0.817 | 1.355 | 0.405 | 0.721 | 1.206 | 0.673 | 0.576 | 1.428
COVID19_MODERNA | Hair texture abnormal | 0 | 0.068 | 0 | 0.817 | 3.715 |  |  |  |  |  | 
COVID19_MODERNA | Inner ear disorder | 0 | 0.433 | 0.138 | 0.817 | 1.96 |  |  |  |  |  | 
COVID19_MODERNA | Seborrhoeic keratosis | 0 | 0.234 | 0.047 | 0.817 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Adenotonsillectomy | 0 | 0.234 | 0.046 | 0.817 | 2.412 |  |  |  |  |  | 
COVID19_MODERNA | Mean platelet volume | 0 | 0.39 | 0.12 | 0.817 | 2.027 |  |  |  |  |  | 
COVID19_MODERNA | B-lymphocyte count | 0 | 0.073 | 0 | 0.817 | 3.646 |  |  |  |  |  | 
COVID19_MODERNA | Aldolase increased | 0 | 0.195 | 0.029 | 0.817 | 2.571 |  |  |  |  |  | 
COVID19_MODERNA | Reflex test normal | 0 | 0.179 | 0.023 | 0.817 | 2.649 |  |  |  |  |  | 
COVID19_MODERNA | Acute haemorrhagic leukoencephalitis | 0 | 0.117 | 0.004 | 0.817 | 3.091 |  |  |  |  |  | 
COVID19_MODERNA | Granulomatosis with polyangiitis | 0 | 0.234 | 0.047 | 0.817 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine free increased | 0 | 0.195 | 0.029 | 0.817 | 2.573 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body | 0 | 0.195 | 0.029 | 0.817 | 2.571 |  |  |  |  |  | 
COVID19_MODERNA | Personality change | 1 | 1.524 | 0.204 | 0.816 | 1.759 | 0.319 | 0.779 | 1.655 | 0.656 | 0.176 | 3.023
COVID19_MODERNA | Facial pain | 20 | 27.463 | 0.558 | 0.816 | 1.115 | 0.52 | 0.741 | 1.031 | 0.728 | 1.401 | 1.799
COVID19_MODERNA | Streptococcus test positive | 3 | 4.849 | 0.248 | 0.816 | 1.649 | 0.348 | 0.712 | 1.326 | 0.619 | 0.116 | 19.295
COVID19_MODERNA | Bone scan | 0 | 0.319 | 0.086 | 0.816 | 2.168 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow failure | 0 | 0.167 | 0.017 | 0.816 | 2.72 |  |  |  |  |  | 
COVID19_MODERNA | Diabetic neuropathy | 0 | 0.273 | 0.065 | 0.816 | 2.286 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin saturation | 0 | 0.273 | 0.064 | 0.816 | 2.287 |  |  |  |  |  | 
COVID19_MODERNA | Squamous cell carcinoma of the cervix | 0 | 0.117 | 0.004 | 0.816 | 3.096 |  |  |  |  |  | 
COVID19_MODERNA | Fontanelle bulging | 0 | 0.224 | 0.042 | 0.816 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Somnambulism | 0 | 0.331 | 0.093 | 0.816 | 2.139 |  |  |  |  |  | 
COVID19_MODERNA | Shoulder arthroplasty | 0 | 0.195 | 0.028 | 0.816 | 2.575 |  |  |  |  |  | 
COVID19_MODERNA | Matrix metalloproteinase-3 increased | 0 | 0.117 | 0.004 | 0.816 | 3.093 |  |  |  |  |  | 
COVID19_MODERNA | Vasodilatation | 0 | 0.835 | 0.264 | 0.816 | 1.615 |  |  |  |  |  | 
COVID19_MODERNA | Incorrect dose administered | 33 | 53.798 | 0.599 | 0.815 | 1.059 | 0.474 | 0.628 | 0.819 | 0.613 | 0.701 | 3.81
COVID19_MODERNA | Herpangina | 0 | 0.247 | 0.051 | 0.815 | 2.372 |  |  |  |  |  | 
COVID19_MODERNA | Ruptured cerebral aneurysm | 0 | 0.156 | 0.013 | 0.815 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Androgens increased | 0 | 0.117 | 0.004 | 0.815 | 3.099 |  |  |  |  |  | 
COVID19_MODERNA | Blood oestrogen decreased | 0 | 0.117 | 0.004 | 0.815 | 3.099 |  |  |  |  |  | 
COVID19_MODERNA | Ear infection viral | 0 | 0.312 | 0.082 | 0.815 | 2.187 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein abnormal | 0 | 0.156 | 0.013 | 0.815 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma stage II | 0 | 0.117 | 0.004 | 0.815 | 3.099 |  |  |  |  |  | 
COVID19_MODERNA | Blood oestrogen increased | 0 | 0.117 | 0.004 | 0.815 | 3.099 |  |  |  |  |  | 
COVID19_MODERNA | Cholestasis | 0 | 0.171 | 0.018 | 0.815 | 2.701 |  |  |  |  |  | 
COVID19_MODERNA | JC polyomavirus test negative | 0 | 0.156 | 0.013 | 0.815 | 2.793 |  |  |  |  |  | 
COVID19_MODERNA | Bartonella test positive | 0 | 0.117 | 0.004 | 0.815 | 3.099 |  |  |  |  |  | 
COVID19_MODERNA | Diet refusal | 6 | 7.136 | 0.412 | 0.814 | 1.325 | 0.472 | 0.84 | 1.406 | 0.841 | 0.451 | 3.398
COVID19_MODERNA | Posturing | 2 | 3.419 | 0.25 | 0.814 | 1.639 | 0.324 | 0.714 | 1.404 | 0.585 | 1.072 | 0.076
COVID19_MODERNA | Ultrasound breast normal | 0 | 0.156 | 0.013 | 0.814 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Anorectal manometry | 0 | 0.156 | 0.013 | 0.814 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Sandifer's syndrome | 0 | 0.156 | 0.013 | 0.814 | 2.798 |  |  |  |  |  | 
COVID19_MODERNA | Parenteral nutrition | 0 | 0.115 | 0.003 | 0.814 | 3.12 |  |  |  |  |  | 
COVID19_MODERNA | Blood selenium decreased | 0 | 0.195 | 0.027 | 0.814 | 2.58 |  |  |  |  |  | 
COVID19_MODERNA | Bladder sphincter atony | 0 | 0.156 | 0.013 | 0.814 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B virus test | 0 | 0.259 | 0.056 | 0.814 | 2.333 |  |  |  |  |  | 
COVID19_MODERNA | Condition aggravated | 199 | 261.33 | 0.722 | 0.813 | 0.91 | 0.678 | 0.763 | 0.855 | 0.761 | 1.737 | 57.879
COVID19_MODERNA | Upper-airway cough syndrome | 10 | 13.488 | 0.478 | 0.813 | 1.22 | 0.474 | 0.762 | 1.175 | 0.741 | 2.163 | 4.693
COVID19_MODERNA | Rash maculo-papular | 6 | 9.055 | 0.431 | 0.813 | 1.293 | 0.4 | 0.713 | 1.193 | 0.663 | 0.269 | 11.103
COVID19_MODERNA | Hypertrophy | 0 | 0.273 | 0.062 | 0.813 | 2.294 |  |  |  |  |  | 
COVID19_MODERNA | Candida test | 0 | 0.117 | 0.003 | 0.813 | 3.106 |  |  |  |  |  | 
COVID19_MODERNA | Nasal ulcer | 0 | 0.273 | 0.061 | 0.813 | 2.295 |  |  |  |  |  | 
COVID19_MODERNA | Lumbar radiculopathy | 0 | 0.234 | 0.043 | 0.813 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Toxoplasmosis | 0 | 0.312 | 0.08 | 0.813 | 2.191 |  |  |  |  |  | 
COVID19_MODERNA | Suspected transmission of an infectious agent via product | 0 | 0.312 | 0.08 | 0.813 | 2.192 |  |  |  |  |  | 
COVID19_MODERNA | Tooth abscess | 0 | 0.39 | 0.115 | 0.813 | 2.035 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac monitoring abnormal | 3 | 4.625 | 0.318 | 0.812 | 1.49 | 0.358 | 0.732 | 1.362 | 0.649 | 3.363 | 2.486
COVID19_MODERNA | Haematochezia | 8 | 14.553 | 0.425 | 0.812 | 1.299 | 0.361 | 0.607 | 0.97 | 0.55 | 0.177 | 29.665
COVID19_MODERNA | Biopsy skin | 2 | 4.487 | 0.21 | 0.812 | 1.734 | 0.279 | 0.618 | 1.218 | 0.446 | 0.32 | 2.194
COVID19_MODERNA | Muscle contusion | 0 | 0.195 | 0.026 | 0.812 | 2.586 |  |  |  |  |  | 
COVID19_MODERNA | Rubber sensitivity | 0 | 0.43 | 0.131 | 0.812 | 1.972 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord infection | 0 | 0.234 | 0.043 | 0.812 | 2.424 |  |  |  |  |  | 
COVID19_MODERNA | Right ventricular dysfunction | 0 | 0.156 | 0.012 | 0.812 | 2.803 |  |  |  |  |  | 
COVID19_MODERNA | Adhesiolysis | 0 | 0.117 | 0.003 | 0.812 | 3.11 |  |  |  |  |  | 
COVID19_MODERNA | Osteomyelitis chronic | 0 | 0.117 | 0.003 | 0.812 | 3.108 |  |  |  |  |  | 
COVID19_MODERNA | Retrograde amnesia | 0 | 0.234 | 0.043 | 0.812 | 2.424 |  |  |  |  |  | 
COVID19_MODERNA | Immediate post-injection reaction | 132 | 170.324 | 0.702 | 0.811 | 0.927 | 0.673 | 0.776 | 0.892 | 0.775 | 0.764 | 9.254
COVID19_MODERNA | Eczema | 4 | 5.668 | 0.337 | 0.811 | 1.451 | 0.392 | 0.757 | 1.35 | 0.706 | 0.165 | 15.934
COVID19_MODERNA | Near death experience | 1 | 3.129 | 0.115 | 0.811 | 2.032 | 0.232 | 0.584 | 1.258 | 0.32 | 0.601 | 0.012
COVID19_MODERNA | Ultrasound ovary | 0 | 0.156 | 0.012 | 0.811 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal pseudo-obstruction | 0 | 0.117 | 0.003 | 0.811 | 3.112 |  |  |  |  |  | 
COVID19_MODERNA | Muscle enzyme increased | 0 | 0.312 | 0.077 | 0.811 | 2.197 |  |  |  |  |  | 
COVID19_MODERNA | Cancer in remission | 0 | 0.273 | 0.06 | 0.811 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar disorder | 0 | 0.39 | 0.113 | 0.811 | 2.037 |  |  |  |  |  | 
COVID19_MODERNA | Face presentation | 0 | 0.117 | 0.003 | 0.811 | 3.11 |  |  |  |  |  | 
COVID19_MODERNA | Product leakage | 0 | 0.243 | 0.046 | 0.811 | 2.395 |  |  |  |  |  | 
COVID19_MODERNA | Antithrombin III increased | 0 | 0.156 | 0.012 | 0.811 | 2.807 |  |  |  |  |  | 
COVID19_MODERNA | Diagnostic procedure | 0 | 0.901 | 0.27 | 0.811 | 1.587 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis viral test | 0 | 0.639 | 0.204 | 0.811 | 1.747 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound thyroid normal | 0 | 0.312 | 0.078 | 0.811 | 2.195 |  |  |  |  |  | 
COVID19_MODERNA | Thyrotoxic crisis | 0 | 0.195 | 0.025 | 0.811 | 2.59 |  |  |  |  |  | 
COVID19_MODERNA | Metamyelocyte count | 0 | 0.195 | 0.026 | 0.811 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Eustachian tube dysfunction | 0 | 0.234 | 0.042 | 0.811 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral venous thrombosis | 0 | 0.195 | 0.026 | 0.811 | 2.589 |  |  |  |  |  | 
COVID19_MODERNA | Poor peripheral circulation | 2 | 2.247 | 0.255 | 0.81 | 1.617 | 0.391 | 0.858 | 1.686 | 0.89 | 1.233 | 0.012
COVID19_MODERNA | Mental status changes | 34 | 43.656 | 0.617 | 0.81 | 1.025 | 0.594 | 0.783 | 1.018 | 0.779 | 3.212 | 43.861
COVID19_MODERNA | Muscular weakness | 133 | 173.231 | 0.699 | 0.81 | 0.928 | 0.667 | 0.769 | 0.884 | 0.768 | 0.832 | 4.27
COVID19_MODERNA | Genital herpes simplex | 0 | 0.195 | 0.025 | 0.81 | 2.592 |  |  |  |  |  | 
COVID19_MODERNA | Menopausal symptoms | 0 | 0.156 | 0.012 | 0.81 | 2.809 |  |  |  |  |  | 
COVID19_MODERNA | DNA antibody positive | 0 | 0.195 | 0.025 | 0.81 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Donor specific antibody present | 0 | 0.117 | 0.003 | 0.81 | 3.116 |  |  |  |  |  | 
COVID19_MODERNA | Insulin C-peptide | 0 | 0.195 | 0.025 | 0.81 | 2.593 |  |  |  |  |  | 
COVID19_MODERNA | Ear operation | 0 | 0.195 | 0.025 | 0.81 | 2.591 |  |  |  |  |  | 
COVID19_MODERNA | Joint irrigation | 0 | 0.2 | 0.027 | 0.81 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Tibia fracture | 0 | 0.234 | 0.042 | 0.81 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Paracentesis eye abnormal | 0 | 0.195 | 0.025 | 0.81 | 2.592 |  |  |  |  |  | 
COVID19_MODERNA | Physical deconditioning | 0 | 0.351 | 0.095 | 0.81 | 2.111 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein | 0 | 0.195 | 0.025 | 0.81 | 2.591 |  |  |  |  |  | 
COVID19_MODERNA | Arthropathy | 2 | 3.489 | 0.281 | 0.809 | 1.556 | 0.321 | 0.706 | 1.39 | 0.573 | 0.331 | 2.026
COVID19_MODERNA | Acute vestibular syndrome | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Fracture | 0 | 0.351 | 0.093 | 0.809 | 2.115 |  |  |  |  |  | 
COVID19_MODERNA | Parophthalmia | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Light chain analysis increased | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Renal vasculitis | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Hypothalamo-pituitary disorder | 0 | 0.195 | 0.024 | 0.809 | 2.597 |  |  |  |  |  | 
COVID19_MODERNA | Arthroscopy abnormal | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Squamous cell carcinoma of lung | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Bronchomalacia | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Agranulocytosis | 0 | 0.085 | 0 | 0.809 | 3.483 |  |  |  |  |  | 
COVID19_MODERNA | Cold-stimulus headache | 0 | 0.117 | 0.003 | 0.809 | 3.119 |  |  |  |  |  | 
COVID19_MODERNA | Mevalonate kinase deficiency | 0 | 0.117 | 0.003 | 0.809 | 3.118 |  |  |  |  |  | 
COVID19_MODERNA | Atypical haemolytic uraemic syndrome | 0 | 0.273 | 0.058 | 0.809 | 2.304 |  |  |  |  |  | 
COVID19_MODERNA | Non-small cell lung cancer | 0 | 0.117 | 0.003 | 0.809 | 3.117 |  |  |  |  |  | 
COVID19_MODERNA | Eye swelling | 55 | 71.399 | 0.648 | 0.808 | 0.984 | 0.621 | 0.774 | 0.955 | 0.77 | 1.231 | 2.051
COVID19_MODERNA | Blood urea | 1 | 2.951 | 0.173 | 0.808 | 1.824 | 0.24 | 0.601 | 1.292 | 0.339 | 0.587 | 0.019
COVID19_MODERNA | Serositis | 0 | 0.195 | 0.024 | 0.808 | 2.597 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal abscess | 0 | 0.351 | 0.092 | 0.808 | 2.117 |  |  |  |  |  | 
COVID19_MODERNA | Device malfunction | 0 | 0.312 | 0.075 | 0.808 | 2.202 |  |  |  |  |  | 
COVID19_MODERNA | Allergic colitis | 0 | 0.117 | 0.003 | 0.808 | 3.123 |  |  |  |  |  | 
COVID19_MODERNA | Blood alcohol | 0 | 0.312 | 0.074 | 0.808 | 2.203 |  |  |  |  |  | 
COVID19_MODERNA | Skin operation | 0 | 0.273 | 0.057 | 0.808 | 2.307 |  |  |  |  |  | 
COVID19_MODERNA | Tympanic membrane disorder | 0 | 0.39 | 0.109 | 0.808 | 2.044 |  |  |  |  |  | 
COVID19_MODERNA | Visual analogue scale | 0 | 0.234 | 0.04 | 0.808 | 2.434 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte percentage normal | 0 | 0.234 | 0.04 | 0.808 | 2.435 |  |  |  |  |  | 
COVID19_MODERNA | Urinary tract infection neonatal | 0 | 0.117 | 0.003 | 0.808 | 3.123 |  |  |  |  |  | 
COVID19_MODERNA | Emphysema | 1 | 1.532 | 0.151 | 0.807 | 1.887 | 0.318 | 0.778 | 1.652 | 0.653 | 1.541 | 0.041
COVID19_MODERNA | Computerised tomogram abdomen normal | 5 | 6.966 | 0.408 | 0.807 | 1.316 | 0.411 | 0.759 | 1.307 | 0.718 | 1.713 | 0.78
COVID19_MODERNA | Drug related hepatic disorders - comprehensive search (SMQ) [narrow] | 70 | 97.606 | 0.657 | 0.807 | 0.969 | 0.593 | 0.722 | 0.871 | 0.717 | 1.028 | 0.028
COVID19_MODERNA | Muscle strain | 4 | 6.131 | 0.408 | 0.807 | 1.316 | 0.373 | 0.721 | 1.286 | 0.652 | 1.134 | 0.001
COVID19_MODERNA | Jaundice | 5 | 7.633 | 0.352 | 0.807 | 1.414 | 0.387 | 0.714 | 1.23 | 0.655 | 0.801 | 0.081
COVID19_MODERNA | Lymphangitis | 1 | 2.185 | 0.125 | 0.807 | 1.981 | 0.278 | 0.687 | 1.465 | 0.458 | 0.391 | 0.412
COVID19_MODERNA | Injection site laceration | 0 | 0.117 | 0.003 | 0.807 | 3.126 |  |  |  |  |  | 
COVID19_MODERNA | Blood group O | 0 | 0.234 | 0.039 | 0.807 | 2.437 |  |  |  |  |  | 
COVID19_MODERNA | Radioallergosorbent test positive | 0 | 0.195 | 0.023 | 0.807 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Cytogenetic analysis abnormal | 0 | 0.299 | 0.068 | 0.807 | 2.237 |  |  |  |  |  | 
COVID19_MODERNA | Otoscopy abnormal | 0 | 0.234 | 0.039 | 0.807 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Administration site induration | 0 | 0.298 | 0.067 | 0.807 | 2.24 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctivitis bacterial | 0 | 0.273 | 0.056 | 0.807 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Defaecation disorder | 0 | 0.273 | 0.056 | 0.807 | 2.308 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation time prolonged | 0 | 0.234 | 0.039 | 0.807 | 2.438 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine increased | 0 | 0.234 | 0.039 | 0.807 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Skin injury | 0 | 0.186 | 0.02 | 0.807 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Hypersensitivity | 74 | 97.888 | 0.662 | 0.806 | 0.961 | 0.627 | 0.759 | 0.912 | 0.756 | 0.64 | 14.334
COVID19_MODERNA | Eyelid ptosis | 5 | 8.008 | 0.47 | 0.806 | 1.215 | 0.374 | 0.691 | 1.19 | 0.624 | 0.796 | 0.09
COVID19_MODERNA | Vaccination site paraesthesia | 0 | 0.195 | 0.023 | 0.806 | 2.605 |  |  |  |  |  | 
COVID19_MODERNA | Microcytosis | 0 | 0.234 | 0.038 | 0.806 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Urine output increased | 0 | 0.607 | 0.186 | 0.806 | 1.78 |  |  |  |  |  | 
COVID19_MODERNA | Neuropsychological test abnormal | 0 | 0.234 | 0.039 | 0.806 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Henoch-Schonlein purpura | 1 | 1.111 | 0.233 | 0.805 | 1.658 | 0.349 | 0.85 | 1.802 | 0.9 | 0.111 | 6.234
COVID19_MODERNA | Memory impairment | 19 | 25.238 | 0.532 | 0.805 | 1.125 | 0.531 | 0.764 | 1.07 | 0.753 | 0.633 | 3.581
COVID19_MODERNA | Cytomegalovirus viraemia | 0 | 0.156 | 0.01 | 0.805 | 2.824 |  |  |  |  |  | 
COVID19_MODERNA | Eating disorder symptom | 0 | 0.117 | 0.003 | 0.805 | 3.131 |  |  |  |  |  | 
COVID19_MODERNA | Throat lesion | 0 | 0.234 | 0.038 | 0.805 | 2.442 |  |  |  |  |  | 
COVID19_MODERNA | Blood triglycerides | 0 | 0.234 | 0.038 | 0.805 | 2.442 |  |  |  |  |  | 
COVID19_MODERNA | Extravasation | 0 | 0.078 | 0 | 0.805 | 3.601 |  |  |  |  |  | 
COVID19_MODERNA | Injection site joint erythema | 0 | 0.195 | 0.023 | 0.805 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | Feeling drunk | 5 | 6.875 | 0.382 | 0.804 | 1.352 | 0.415 | 0.766 | 1.319 | 0.727 | 1.761 | 0.886
COVID19_MODERNA | Skin fragility | 0 | 0.156 | 0.01 | 0.804 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Trisomy 21 | 0 | 0.234 | 0.037 | 0.804 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Focal segmental glomerulosclerosis | 0 | 0.195 | 0.022 | 0.804 | 2.609 |  |  |  |  |  | 
COVID19_MODERNA | CSF lactate | 0 | 0.126 | 0.004 | 0.804 | 3.051 |  |  |  |  |  | 
COVID19_MODERNA | Base excess | 1 | 1.183 | 0.16 | 0.803 | 1.847 | 0.344 | 0.837 | 1.775 | 0.845 | 1.761 | 0.013
COVID19_MODERNA | Viral infection | 3 | 3.507 | 0.388 | 0.803 | 1.341 | 0.415 | 0.847 | 1.576 | 0.856 | 0.125 | 17.344
COVID19_MODERNA | Multiple sclerosis relapse | 1 | 2.272 | 0.149 | 0.803 | 1.884 | 0.274 | 0.676 | 1.443 | 0.44 | 0.474 | 0.161
COVID19_MODERNA | Joint injury | 1 | 2.306 | 0.348 | 0.803 | 1.41 | 0.272 | 0.672 | 1.434 | 0.434 | 0.363 | 0.547
COVID19_MODERNA | Rheumatoid arthritis | 4 | 8.429 | 0.308 | 0.803 | 1.488 | 0.301 | 0.583 | 1.041 | 0.475 | 0.33 | 4.711
COVID19_MODERNA | Chlamydia test negative | 0 | 0.541 | 0.161 | 0.803 | 1.847 |  |  |  |  |  | 
COVID19_MODERNA | Granular cell tumour | 0 | 0.117 | 0.002 | 0.803 | 3.139 |  |  |  |  |  | 
COVID19_MODERNA | Streptococcal bacteraemia | 0 | 0.085 | 0 | 0.803 | 3.503 |  |  |  |  |  | 
COVID19_MODERNA | Muscle strength abnormal | 0 | 0.273 | 0.053 | 0.803 | 2.318 |  |  |  |  |  | 
COVID19_MODERNA | Antineutrophil cytoplasmic antibody | 2 | 2.313 | 0.288 | 0.802 | 1.525 | 0.387 | 0.849 | 1.667 | 0.865 | 2.466 | 0.501
COVID19_MODERNA | Tumours of unspecified malignancy (SMQ) [broad] | 1 | 1.446 | 0.154 | 0.802 | 1.866 | 0.324 | 0.792 | 1.681 | 0.692 | 0.26 | 1.397
COVID19_MODERNA | Tumours of unspecified malignancy (SMQ) [narrow] | 1 | 1.446 | 0.154 | 0.802 | 1.866 | 0.324 | 0.792 | 1.681 | 0.692 | 0.26 | 1.397
COVID19_MODERNA | Optic nerve disorders (SMQ) [broad] | 93 | 123.269 | 0.672 | 0.802 | 0.943 | 0.638 | 0.757 | 0.892 | 0.754 | 0.783 | 5.265
COVID19_MODERNA | Cutaneous tuberculosis | 0 | 0.156 | 0.009 | 0.802 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Brain scan abnormal | 0 | 0.25 | 0.043 | 0.802 | 2.392 |  |  |  |  |  | 
COVID19_MODERNA | Lipodystrophy (SMQ) [narrow] | 0 | 0.312 | 0.069 | 0.802 | 2.216 |  |  |  |  |  | 
COVID19_MODERNA | Fasciitis | 0 | 0.48 | 0.138 | 0.802 | 1.92 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram kidney abnormal | 0 | 0.234 | 0.036 | 0.802 | 2.45 |  |  |  |  |  | 
COVID19_MODERNA | Dreamy state | 0 | 0.312 | 0.069 | 0.802 | 2.216 |  |  |  |  |  | 
COVID19_MODERNA | Renal vein compression | 0 | 0.078 | 0 | 0.802 | 3.607 |  |  |  |  |  | 
COVID19_MODERNA | Gait disturbance | 90 | 115.491 | 0.669 | 0.801 | 0.943 | 0.657 | 0.781 | 0.923 | 0.779 | 0.815 | 3.487
COVID19_MODERNA | Stridor | 8 | 12.79 | 0.427 | 0.801 | 1.271 | 0.4 | 0.672 | 1.074 | 0.625 | 1.861 | 2.19
COVID19_MODERNA | Alopecia areata | 0 | 0.359 | 0.089 | 0.801 | 2.112 |  |  |  |  |  | 
COVID19_MODERNA | Angiopathy | 0 | 0.144 | 0.006 | 0.801 | 2.922 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis membranous | 0 | 0.117 | 0.002 | 0.801 | 3.143 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia pyelonephritis | 0 | 0.117 | 0.002 | 0.801 | 3.144 |  |  |  |  |  | 
COVID19_MODERNA | Band neutrophil count | 0 | 0.47 | 0.132 | 0.801 | 1.934 |  |  |  |  |  | 
COVID19_MODERNA | Malaise | 368 | 492.995 | 0.733 | 0.8 | 0.869 | 0.685 | 0.747 | 0.813 | 0.746 | 0.874 | 6.504
COVID19_MODERNA | Wheelchair user | 4 | 8.168 | 0.309 | 0.8 | 1.478 | 0.308 | 0.596 | 1.064 | 0.49 | 0.343 | 4.331
COVID19_MODERNA | Hypohidrosis | 0 | 0.312 | 0.067 | 0.8 | 2.218 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy upper gastrointestinal tract abnormal | 0 | 0.414 | 0.11 | 0.8 | 2.016 |  |  |  |  |  | 
COVID19_MODERNA | Systemic lupus erythematosus rash | 0 | 0.156 | 0.009 | 0.8 | 2.839 |  |  |  |  |  | 
COVID19_MODERNA | Cytology normal | 0 | 0.284 | 0.055 | 0.8 | 2.293 |  |  |  |  |  | 
COVID19_MODERNA | CD8 lymphocytes increased | 0 | 0.273 | 0.051 | 0.8 | 2.323 |  |  |  |  |  | 
COVID19_MODERNA | Emotional poverty | 0 | 0.188 | 0.018 | 0.8 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Takayasu's arteritis | 0 | 0.234 | 0.034 | 0.8 | 2.455 |  |  |  |  |  | 
COVID19_MODERNA | Red cell distribution width | 2 | 2.094 | 0.26 | 0.799 | 1.577 | 0.402 | 0.882 | 1.732 | 0.955 | 2.349 | 0.423
COVID19_MODERNA | Blood glucose abnormal | 1 | 2.593 | 0.258 | 0.799 | 1.582 | 0.257 | 0.639 | 1.368 | 0.386 | 0.685 | 0.002
COVID19_MODERNA | Blood immunoglobulin G abnormal | 0 | 0.195 | 0.02 | 0.799 | 2.621 |  |  |  |  |  | 
COVID19_MODERNA | Anti-neuronal antibody negative | 0 | 0.273 | 0.05 | 0.799 | 2.326 |  |  |  |  |  | 
COVID19_MODERNA | Visual tracking test abnormal | 0 | 0.234 | 0.034 | 0.799 | 2.456 |  |  |  |  |  | 
COVID19_MODERNA | Gamma-glutamyltransferase normal | 0 | 0.336 | 0.076 | 0.799 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Carcinoma in situ | 0 | 0.156 | 0.009 | 0.799 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor C3 decreased | 0 | 0.142 | 0.006 | 0.799 | 2.94 |  |  |  |  |  | 
COVID19_MODERNA | Endocrine test abnormal | 0 | 0.156 | 0.009 | 0.799 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Disease progression | 0 | 0.156 | 0.009 | 0.799 | 2.841 |  |  |  |  |  | 
COVID19_MODERNA | Labour induction | 0 | 0.195 | 0.02 | 0.799 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Anti-Muellerian hormone level decreased | 0 | 0.156 | 0.009 | 0.799 | 2.843 |  |  |  |  |  | 
COVID19_MODERNA | Dermatitis exfoliative generalised | 1 | 1.198 | 0.195 | 0.798 | 1.733 | 0.342 | 0.834 | 1.769 | 0.834 | 2.466 | 0.012
COVID19_MODERNA | Blood chloride increased | 7 | 8.712 | 0.44 | 0.798 | 1.241 | 0.472 | 0.814 | 1.328 | 0.804 | 3.083 | 6.936
COVID19_MODERNA | Eyelids pruritus | 4 | 5.459 | 0.366 | 0.798 | 1.365 | 0.402 | 0.775 | 1.382 | 0.733 | 2.818 | 2.685
COVID19_MODERNA | Staphylococcal infection | 1 | 2.809 | 0.376 | 0.798 | 1.349 | 0.247 | 0.616 | 1.321 | 0.356 | 0.177 | 2.986
COVID19_MODERNA | Vaccination site injury | 0 | 0.351 | 0.081 | 0.798 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Dysphoria | 0 | 0.39 | 0.098 | 0.798 | 2.061 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system inflammation | 0 | 0.354 | 0.083 | 0.798 | 2.127 |  |  |  |  |  | 
COVID19_MODERNA | Cyst aspiration | 0 | 0.156 | 0.008 | 0.798 | 2.846 |  |  |  |  |  | 
COVID19_MODERNA | Kinesitherapy | 0 | 0.156 | 0.008 | 0.798 | 2.844 |  |  |  |  |  | 
COVID19_MODERNA | Neisseria test | 0 | 0.351 | 0.082 | 0.798 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Tooth disorder | 0 | 0.347 | 0.08 | 0.798 | 2.144 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital and eyelid disorders (SMQ) [broad] | 72 | 91.125 | 0.658 | 0.797 | 0.946 | 0.653 | 0.792 | 0.954 | 0.79 | 1.22 | 2.526
COVID19_MODERNA | Periorbital and eyelid disorders (SMQ) [narrow] | 72 | 91.125 | 0.658 | 0.797 | 0.946 | 0.653 | 0.792 | 0.954 | 0.79 | 1.22 | 2.526
COVID19_MODERNA | Globulins decreased | 1 | 1.568 | 0.237 | 0.797 | 1.625 | 0.316 | 0.772 | 1.641 | 0.638 | 1.541 | 0.041
COVID19_MODERNA | Helplessness | 0 | 0.156 | 0.008 | 0.797 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Viral skin infection | 0 | 0.156 | 0.008 | 0.797 | 2.849 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobin urine present | 0 | 0.312 | 0.064 | 0.797 | 2.225 |  |  |  |  |  | 
COVID19_MODERNA | Superinfection bacterial | 0 | 0.312 | 0.065 | 0.797 | 2.224 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial hyperreactivity | 0 | 0.8 | 0.227 | 0.797 | 1.65 |  |  |  |  |  | 
COVID19_MODERNA | Arteriogram coronary abnormal | 0 | 0.312 | 0.064 | 0.797 | 2.225 |  |  |  |  |  | 
COVID19_MODERNA | X-ray dental abnormal | 0 | 0.234 | 0.033 | 0.797 | 2.461 |  |  |  |  |  | 
COVID19_MODERNA | Allergic respiratory disease | 0 | 0.156 | 0.008 | 0.797 | 2.847 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulins decreased | 0 | 0.351 | 0.08 | 0.797 | 2.137 |  |  |  |  |  | 
COVID19_MODERNA | Nitrite urine absent | 3 | 5.595 | 0.35 | 0.796 | 1.388 | 0.319 | 0.654 | 1.218 | 0.536 | 0.822 | 0.004
COVID19_MODERNA | Platelet-large cell ratio | 0 | 0.09 | 0 | 0.796 | 3.461 |  |  |  |  |  | 
COVID19_MODERNA | Acinetobacter test positive | 0 | 0.195 | 0.019 | 0.796 | 2.629 |  |  |  |  |  | 
COVID19_MODERNA | Inner ear inflammation | 0 | 0.195 | 0.018 | 0.796 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Anxiety disorder | 0 | 0.143 | 0.005 | 0.796 | 2.941 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin C normal | 0 | 0.117 | 0.002 | 0.796 | 3.159 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound bladder normal | 0 | 0.156 | 0.008 | 0.796 | 2.851 |  |  |  |  |  | 
COVID19_MODERNA | CSF pressure increased | 1 | 1.056 | 0.207 | 0.795 | 1.692 | 0.354 | 0.86 | 1.824 | 0.947 | 1.233 | 0.129
COVID19_MODERNA | Gingival erythema | 1 | 1.194 | 0.201 | 0.795 | 1.707 | 0.343 | 0.835 | 1.77 | 0.837 | 1.644 | 0.025
COVID19_MODERNA | Blood uric acid normal | 1 | 1.497 | 0.218 | 0.795 | 1.664 | 0.321 | 0.783 | 1.664 | 0.668 | 0.503 | 0.107
COVID19_MODERNA | Tendinopathies and ligament disorders (SMQ) [narrow] | 12 | 18.621 | 0.482 | 0.795 | 1.172 | 0.435 | 0.676 | 1.013 | 0.644 | 0.381 | 11.261
COVID19_MODERNA | Blindness cortical | 0 | 0.195 | 0.018 | 0.795 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Intracranial infection | 0 | 0.117 | 0.002 | 0.795 | 3.163 |  |  |  |  |  | 
COVID19_MODERNA | Coma scale | 0 | 0.312 | 0.063 | 0.795 | 2.228 |  |  |  |  |  | 
COVID19_MODERNA | Toe walking | 0 | 0.168 | 0.01 | 0.795 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Pleural thickening | 0 | 0.234 | 0.031 | 0.795 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Temporal lobe epilepsy | 0 | 0.273 | 0.047 | 0.795 | 2.335 |  |  |  |  |  | 
COVID19_MODERNA | Hyperemesis gravidarum | 0 | 0.156 | 0.008 | 0.795 | 2.852 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time normal | 6 | 7.218 | 0.426 | 0.794 | 1.254 | 0.469 | 0.834 | 1.395 | 0.831 | 1.541 | 0.609
COVID19_MODERNA | Tendonitis | 3 | 4.361 | 0.284 | 0.794 | 1.513 | 0.37 | 0.756 | 1.407 | 0.688 | 0.323 | 3.536
COVID19_MODERNA | Viral parotitis | 0 | 0.117 | 0.002 | 0.794 | 3.165 |  |  |  |  |  | 
COVID19_MODERNA | Culture throat positive | 0 | 0.183 | 0.014 | 0.794 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | CSF lactate decreased | 0 | 0.117 | 0.002 | 0.794 | 3.166 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal plaque | 0 | 0.234 | 0.031 | 0.794 | 2.467 |  |  |  |  |  | 
COVID19_MODERNA | Small for dates baby | 0 | 0.074 | 0 | 0.794 | 3.697 |  |  |  |  |  | 
COVID19_MODERNA | Platelet distribution width | 0 | 0.145 | 0.005 | 0.794 | 2.932 |  |  |  |  |  | 
COVID19_MODERNA | IgA nephropathy | 1 | 0.535 | 0.128 | 0.793 | 1.927 | 0.401 | 0.973 | 2.069 | 1.869 | 2.466 | 0.012
COVID19_MODERNA | CSF culture negative | 3 | 5.129 | 0.264 | 0.793 | 1.552 | 0.337 | 0.689 | 1.283 | 0.585 | 0.286 | 4.592
COVID19_MODERNA | Eczema herpeticum | 0 | 0.234 | 0.03 | 0.793 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QT interval normal | 0 | 0.234 | 0.03 | 0.793 | 2.472 |  |  |  |  |  | 
COVID19_MODERNA | Lordosis | 0 | 0.273 | 0.045 | 0.793 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Soliloquy | 0 | 0.156 | 0.007 | 0.793 | 2.859 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular function test normal | 0 | 0.156 | 0.007 | 0.793 | 2.859 |  |  |  |  |  | 
COVID19_MODERNA | Thoracic operation | 0 | 0.312 | 0.061 | 0.793 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | Deafness bilateral | 1 | 1.631 | 0.154 | 0.792 | 1.834 | 0.312 | 0.763 | 1.621 | 0.613 | 0.632 | 0.002
COVID19_MODERNA | Skin exfoliation | 9 | 13.498 | 0.483 | 0.792 | 1.164 | 0.428 | 0.703 | 1.102 | 0.667 | 0.449 | 5.425
COVID19_MODERNA | Axonal neuropathy | 0 | 0.245 | 0.034 | 0.792 | 2.431 |  |  |  |  |  | 
COVID19_MODERNA | Bronchitis chronic | 0 | 0.165 | 0.009 | 0.792 | 2.801 |  |  |  |  |  | 
COVID19_MODERNA | Administration site erythema | 0 | 0.252 | 0.037 | 0.792 | 2.407 |  |  |  |  |  | 
COVID19_MODERNA | HIV infection | 0 | 0.312 | 0.06 | 0.792 | 2.235 |  |  |  |  |  | 
COVID19_MODERNA | Fixed eruption | 0 | 0.273 | 0.045 | 0.792 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Tongue injury | 0 | 0.273 | 0.044 | 0.791 | 2.342 |  |  |  |  |  | 
COVID19_MODERNA | Dyslipidaemia | 0 | 0.351 | 0.075 | 0.791 | 2.147 |  |  |  |  |  | 
COVID19_MODERNA | Thrombocytopenia neonatal | 0 | 0.117 | 0.002 | 0.791 | 3.173 |  |  |  |  |  | 
COVID19_MODERNA | Laparoscopy | 0 | 0.156 | 0.007 | 0.791 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antibody abnormal | 0 | 0.117 | 0.002 | 0.791 | 3.172 |  |  |  |  |  | 
COVID19_MODERNA | Infertility male | 0 | 0.156 | 0.007 | 0.791 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Osteochondritis | 0 | 0.156 | 0.007 | 0.791 | 2.863 |  |  |  |  |  | 
COVID19_MODERNA | Anaemia | 10 | 17.342 | 0.451 | 0.79 | 1.206 | 0.386 | 0.622 | 0.959 | 0.577 | 0.701 | 0.961
COVID19_MODERNA | Biopsy liver | 0 | 0.195 | 0.016 | 0.79 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular migraine | 0 | 0.195 | 0.016 | 0.79 | 2.645 |  |  |  |  |  | 
COVID19_MODERNA | Spondylolisthesis | 0 | 0.312 | 0.059 | 0.79 | 2.237 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E virus test | 0 | 0.234 | 0.029 | 0.79 | 2.478 |  |  |  |  |  | 
COVID19_MODERNA | Blood pyruvic acid | 0 | 0.234 | 0.029 | 0.79 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Thyroidectomy | 0 | 0.234 | 0.029 | 0.79 | 2.478 |  |  |  |  |  | 
COVID19_MODERNA | Plantar fasciitis | 0 | 0.273 | 0.043 | 0.79 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Cerebellar infarction | 0 | 0.234 | 0.029 | 0.79 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Administration site warmth | 0 | 0.526 | 0.138 | 0.79 | 1.88 |  |  |  |  |  | 
COVID19_MODERNA | Albumin globulin ratio normal | 1 | 1.469 | 0.27 | 0.789 | 1.529 | 0.323 | 0.788 | 1.673 | 0.681 | 1.233 | 0.129
COVID19_MODERNA | Tendon disorder | 1 | 2.077 | 0.154 | 0.789 | 1.828 | 0.284 | 0.7 | 1.492 | 0.481 | 0.391 | 0.412
COVID19_MODERNA | Alpha haemolytic streptococcal infection | 0 | 0.156 | 0.006 | 0.789 | 2.87 |  |  |  |  |  | 
COVID19_MODERNA | Pemphigus | 0 | 0.25 | 0.034 | 0.789 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Keratosis pilaris | 0 | 0.351 | 0.073 | 0.789 | 2.151 |  |  |  |  |  | 
COVID19_MODERNA | Myopathy | 0 | 0.25 | 0.034 | 0.789 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Campylobacter gastroenteritis | 0 | 0.273 | 0.043 | 0.789 | 2.347 |  |  |  |  |  | 
COVID19_MODERNA | Maternal condition affecting foetus | 0 | 0.117 | 0.001 | 0.789 | 3.178 |  |  |  |  |  | 
COVID19_MODERNA | Dyspraxia | 0 | 0.286 | 0.047 | 0.789 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Strawberry tongue | 0 | 0.401 | 0.093 | 0.789 | 2.055 |  |  |  |  |  | 
COVID19_MODERNA | Chest crushing | 0 | 0.156 | 0.007 | 0.789 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Food aversion | 0 | 0.222 | 0.024 | 0.789 | 2.525 |  |  |  |  |  | 
COVID19_MODERNA | Portal tract inflammation | 0 | 0.117 | 0.001 | 0.789 | 3.178 |  |  |  |  |  | 
COVID19_MODERNA | Infantile spasms | 0 | 0.349 | 0.072 | 0.789 | 2.154 |  |  |  |  |  | 
COVID19_MODERNA | Platelet count increased | 7 | 8.974 | 0.396 | 0.788 | 1.288 | 0.462 | 0.797 | 1.301 | 0.78 | 0.595 | 1.494
COVID19_MODERNA | Blood thyroid stimulating hormone normal | 9 | 12.812 | 0.443 | 0.788 | 1.214 | 0.446 | 0.733 | 1.148 | 0.702 | 0.995 | 0.024
COVID19_MODERNA | Type III immune complex mediated reaction | 1 | 1.886 | 0.161 | 0.788 | 1.8 | 0.296 | 0.726 | 1.545 | 0.53 | 0.181 | 2.873
COVID19_MODERNA | Mucosal dryness | 0 | 0.299 | 0.052 | 0.788 | 2.274 |  |  |  |  |  | 
COVID19_MODERNA | Palmar-plantar erythrodysaesthesia syndrome | 0 | 0.273 | 0.042 | 0.788 | 2.349 |  |  |  |  |  | 
COVID19_MODERNA | Urinary system x-ray normal | 0 | 0.273 | 0.042 | 0.788 | 2.349 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosal discolouration | 0 | 0.273 | 0.042 | 0.788 | 2.349 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic disorder | 0 | 0.156 | 0.006 | 0.788 | 2.871 |  |  |  |  |  | 
COVID19_MODERNA | Drug-induced liver injury | 0 | 0.196 | 0.016 | 0.788 | 2.646 |  |  |  |  |  | 
COVID19_MODERNA | Fundus autofluorescence | 0 | 0.234 | 0.028 | 0.788 | 2.481 |  |  |  |  |  | 
COVID19_MODERNA | Human chorionic gonadotropin decreased | 2 | 4.423 | 0.266 | 0.787 | 1.532 | 0.281 | 0.623 | 1.228 | 0.452 | 4.484 | 2.027
COVID19_MODERNA | Alcohol use | 0 | 0.273 | 0.041 | 0.787 | 2.352 |  |  |  |  |  | 
COVID19_MODERNA | Macular degeneration | 0 | 0.312 | 0.056 | 0.787 | 2.243 |  |  |  |  |  | 
COVID19_MODERNA | Iron binding capacity total | 0 | 0.312 | 0.056 | 0.787 | 2.243 |  |  |  |  |  | 
COVID19_MODERNA | Immunology test normal | 0 | 0.574 | 0.15 | 0.787 | 1.833 |  |  |  |  |  | 
COVID19_MODERNA | Product storage error | 67 | 48.503 | 0.636 | 0.786 | 0.95 | 1.1 | 1.344 | 1.629 | 1.381 | 0.039 | 1804.303
COVID19_MODERNA | Dry eye | 7 | 9.747 | 0.387 | 0.786 | 1.3 | 0.435 | 0.751 | 1.225 | 0.718 | 1.004 | 0.034
COVID19_MODERNA | Feeding disorder | 20 | 28.122 | 0.542 | 0.786 | 1.067 | 0.509 | 0.726 | 1.009 | 0.711 | 1.312 | 1.117
COVID19_MODERNA | Histology normal | 0 | 0.117 | 0.001 | 0.786 | 3.185 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic enzyme abnormal | 0 | 0.351 | 0.07 | 0.786 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | PFAPA syndrome | 0 | 0.195 | 0.015 | 0.786 | 2.653 |  |  |  |  |  | 
COVID19_MODERNA | Clostridium difficile colitis | 0 | 0.39 | 0.086 | 0.786 | 2.079 |  |  |  |  |  | 
COVID19_MODERNA | Osteopenia | 0 | 0.39 | 0.085 | 0.786 | 2.08 |  |  |  |  |  | 
COVID19_MODERNA | Dropped head syndrome | 0 | 0.234 | 0.027 | 0.786 | 2.486 |  |  |  |  |  | 
COVID19_MODERNA | Osteochondrosis | 0 | 0.234 | 0.027 | 0.786 | 2.486 |  |  |  |  |  | 
COVID19_MODERNA | Matrix metalloproteinase-3 | 0 | 0.117 | 0.001 | 0.786 | 3.186 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal oedema | 0 | 0.156 | 0.006 | 0.786 | 2.876 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal swelling | 0 | 0.39 | 0.085 | 0.786 | 2.08 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram neck | 10 | 13.402 | 0.466 | 0.785 | 1.173 | 0.476 | 0.766 | 1.181 | 0.746 | 9.485 | 48.633
COVID19_MODERNA | Borrelia test negative | 2 | 4.103 | 0.304 | 0.785 | 1.449 | 0.294 | 0.649 | 1.279 | 0.487 | 0.167 | 7.448
COVID19_MODERNA | Mouth ulceration | 1 | 2.413 | 0.22 | 0.785 | 1.633 | 0.266 | 0.659 | 1.409 | 0.414 | 0.216 | 2.065
COVID19_MODERNA | Clonic convulsion | 0 | 0.267 | 0.038 | 0.785 | 2.371 |  |  |  |  |  | 
COVID19_MODERNA | Mononeuropathy multiplex | 0 | 0.195 | 0.014 | 0.785 | 2.656 |  |  |  |  |  | 
COVID19_MODERNA | Squamous cell carcinoma | 0 | 0.228 | 0.024 | 0.785 | 2.51 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound liver | 0 | 0.39 | 0.084 | 0.785 | 2.082 |  |  |  |  |  | 
COVID19_MODERNA | Ear, nose and throat examination | 0 | 0.614 | 0.16 | 0.785 | 1.797 |  |  |  |  |  | 
COVID19_MODERNA | Major depression | 0 | 0.35 | 0.069 | 0.785 | 2.16 |  |  |  |  |  | 
COVID19_MODERNA | pH body fluid decreased | 0 | 0.073 | 0 | 0.785 | 3.721 |  |  |  |  |  | 
COVID19_MODERNA | Vitrectomy | 0 | 0.351 | 0.07 | 0.785 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | Osteonecrosis | 0 | 0.351 | 0.07 | 0.785 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | Histone antibody positive | 0 | 0.156 | 0.006 | 0.785 | 2.879 |  |  |  |  |  | 
COVID19_MODERNA | Pseudolymphoma | 0 | 0.234 | 0.026 | 0.784 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Foetal renal imaging abnormal | 0 | 0.117 | 0.001 | 0.784 | 3.192 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia test | 0 | 0.273 | 0.039 | 0.784 | 2.357 |  |  |  |  |  | 
COVID19_MODERNA | Haemangioma of bone | 0 | 0.273 | 0.039 | 0.784 | 2.357 |  |  |  |  |  | 
COVID19_MODERNA | Angiotensin converting enzyme increased | 0 | 0.312 | 0.054 | 0.784 | 2.249 |  |  |  |  |  | 
COVID19_MODERNA | Radioisotope scan | 0 | 0.181 | 0.011 | 0.784 | 2.728 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid margin crusting | 2 | 3.065 | 0.318 | 0.783 | 1.415 | 0.342 | 0.752 | 1.479 | 0.653 | 1.121 | 0.05
COVID19_MODERNA | Human chorionic gonadotropin | 4 | 6.158 | 0.326 | 0.783 | 1.399 | 0.372 | 0.719 | 1.283 | 0.65 | 3.182 | 3.481
COVID19_MODERNA | Blood electrolytes normal | 3 | 5.03 | 0.287 | 0.783 | 1.475 | 0.341 | 0.697 | 1.298 | 0.596 | 0.374 | 2.496
COVID19_MODERNA | Thyroid function test | 3 | 5.535 | 0.414 | 0.783 | 1.246 | 0.321 | 0.658 | 1.226 | 0.542 | 1.104 | 0.02
COVID19_MODERNA | Jaw disorder | 1 | 2.557 | 0.221 | 0.783 | 1.624 | 0.259 | 0.643 | 1.375 | 0.391 | 1.644 | 0.025
COVID19_MODERNA | Autoimmune nephritis | 0 | 0.117 | 0.001 | 0.783 | 3.193 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue disorder | 0 | 0.351 | 0.068 | 0.783 | 2.161 |  |  |  |  |  | 
COVID19_MODERNA | Bursa disorder | 0 | 0.307 | 0.051 | 0.783 | 2.264 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising retinitis | 0 | 0.098 | 0 | 0.783 | 3.399 |  |  |  |  |  | 
COVID19_MODERNA | Acne cystic | 0 | 0.195 | 0.014 | 0.783 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Blood lead increased | 0 | 0.195 | 0.014 | 0.783 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal examination normal | 0 | 0.273 | 0.038 | 0.783 | 2.359 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterium avium complex infection | 0 | 0.117 | 0.001 | 0.783 | 3.195 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte percentage increased | 0 | 0.17 | 0.008 | 0.783 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Nasal flaring | 0 | 0.273 | 0.038 | 0.783 | 2.359 |  |  |  |  |  | 
COVID19_MODERNA | Thrombotic microangiopathy | 0 | 0.351 | 0.067 | 0.783 | 2.161 |  |  |  |  |  | 
COVID19_MODERNA | Sudden onset of sleep | 0 | 0.202 | 0.015 | 0.782 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoid tissue hyperplasia | 0 | 0.156 | 0.005 | 0.782 | 2.886 |  |  |  |  |  | 
COVID19_MODERNA | CD8 lymphocytes decreased | 0 | 0.083 | 0 | 0.782 | 3.58 |  |  |  |  |  | 
COVID19_MODERNA | CSF oligoclonal band | 0 | 0.642 | 0.164 | 0.782 | 1.776 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin time ratio increased | 0 | 0.117 | 0.001 | 0.782 | 3.197 |  |  |  |  |  | 
COVID19_MODERNA | Epiglottic oedema | 0 | 0.234 | 0.025 | 0.782 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Seroma | 0 | 0.273 | 0.038 | 0.782 | 2.361 |  |  |  |  |  | 
COVID19_MODERNA | Hepatosplenomegaly | 0 | 0.324 | 0.056 | 0.782 | 2.223 |  |  |  |  |  | 
COVID19_MODERNA | Gingival disorders (SMQ) [broad] | 8 | 13.149 | 0.438 | 0.781 | 1.204 | 0.391 | 0.658 | 1.051 | 0.608 | 1.108 | 0.009
COVID19_MODERNA | Gingival disorders (SMQ) [narrow] | 8 | 13.149 | 0.438 | 0.781 | 1.204 | 0.391 | 0.658 | 1.051 | 0.608 | 1.108 | 0.009
COVID19_MODERNA | Cardiogenic shock | 2 | 3.634 | 0.22 | 0.781 | 1.622 | 0.314 | 0.692 | 1.362 | 0.55 | 2.74 | 0.693
COVID19_MODERNA | Erythema of eyelid | 2 | 3.961 | 0.397 | 0.781 | 1.27 | 0.299 | 0.662 | 1.303 | 0.505 | 0.554 | 0.321
COVID19_MODERNA | Deafness neurosensory | 5 | 9.987 | 0.342 | 0.781 | 1.365 | 0.319 | 0.59 | 1.017 | 0.501 | 1.011 | 0.042
COVID19_MODERNA | Pathogen resistance | 0 | 0.117 | 0.001 | 0.781 | 3.2 |  |  |  |  |  | 
COVID19_MODERNA | Restrictive pulmonary disease | 0 | 0.156 | 0.005 | 0.781 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Albumin globulin ratio increased | 0 | 0.156 | 0.005 | 0.781 | 2.889 |  |  |  |  |  | 
COVID19_MODERNA | Asterixis | 0 | 0.204 | 0.015 | 0.781 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Basophil count | 0 | 0.513 | 0.123 | 0.781 | 1.906 |  |  |  |  |  | 
COVID19_MODERNA | Anti-insulin antibody positive | 0 | 0.078 | 0 | 0.781 | 3.66 |  |  |  |  |  | 
COVID19_MODERNA | Skull X-ray | 0 | 0.816 | 0.207 | 0.781 | 1.653 |  |  |  |  |  | 
COVID19_MODERNA | Otitis media bacterial | 0 | 0.117 | 0.001 | 0.781 | 3.2 |  |  |  |  |  | 
COVID19_MODERNA | Non-Hodgkin's lymphoma | 0 | 0.166 | 0.007 | 0.781 | 2.821 |  |  |  |  |  | 
COVID19_MODERNA | Bloody discharge | 0 | 0.273 | 0.037 | 0.781 | 2.363 |  |  |  |  |  | 
COVID19_MODERNA | Application site pruritus | 0 | 0.117 | 0.001 | 0.781 | 3.2 |  |  |  |  |  | 
COVID19_MODERNA | Blood ketone body absent | 0 | 0.312 | 0.052 | 0.781 | 2.254 |  |  |  |  |  | 
COVID19_MODERNA | Logorrhoea | 0 | 0.234 | 0.024 | 0.781 | 2.496 |  |  |  |  |  | 
COVID19_MODERNA | Dissociative disorder | 2 | 1.752 | 0.255 | 0.78 | 1.539 | 0.428 | 0.938 | 1.844 | 1.142 | 3.523 | 1.282
COVID19_MODERNA | Face oedema | 3 | 4.03 | 0.328 | 0.78 | 1.39 | 0.387 | 0.789 | 1.468 | 0.744 | 0.601 | 0.422
COVID19_MODERNA | Gastrointestinal viral infection | 0 | 0.39 | 0.079 | 0.78 | 2.089 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocytosis | 0 | 0.156 | 0.005 | 0.78 | 2.891 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal pH | 0 | 0.156 | 0.005 | 0.78 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Exostosis | 0 | 0.32 | 0.054 | 0.78 | 2.236 |  |  |  |  |  | 
COVID19_MODERNA | Enterocolitis | 0 | 0.141 | 0.003 | 0.78 | 2.997 |  |  |  |  |  | 
COVID19_MODERNA | Blood calcium decreased | 9 | 12.909 | 0.47 | 0.779 | 1.151 | 0.443 | 0.728 | 1.142 | 0.697 | 2.197 | 4.31
COVID19_MODERNA | Dermatitis exfoliative | 0 | 0.156 | 0.005 | 0.779 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Impaired healing | 0 | 0.399 | 0.082 | 0.779 | 2.074 |  |  |  |  |  | 
COVID19_MODERNA | Perfume sensitivity | 0 | 0.234 | 0.023 | 0.779 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound kidney normal | 0 | 0.437 | 0.096 | 0.779 | 2.01 |  |  |  |  |  | 
COVID19_MODERNA | Cranial nerve paralysis | 0 | 0.351 | 0.064 | 0.779 | 2.167 |  |  |  |  |  | 
COVID19_MODERNA | Sensitivity to weather change | 0 | 0.195 | 0.013 | 0.779 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Cytomegalovirus test | 1 | 1.949 | 0.23 | 0.778 | 1.591 | 0.292 | 0.717 | 1.527 | 0.513 | 0.548 | 0.05
COVID19_MODERNA | Albuminuria | 0 | 0.195 | 0.012 | 0.778 | 2.672 |  |  |  |  |  | 
COVID19_MODERNA | Anaesthesia | 0 | 0.351 | 0.063 | 0.778 | 2.169 |  |  |  |  |  | 
COVID19_MODERNA | IIIrd nerve paresis | 0 | 0.312 | 0.05 | 0.778 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Microphthalmos | 0 | 0.117 | 0.001 | 0.778 | 3.207 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillar exudate | 0 | 0.273 | 0.036 | 0.778 | 2.368 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic granulomatosis with polyangiitis | 0 | 0.312 | 0.049 | 0.778 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis autoimmune | 0 | 0.157 | 0.005 | 0.777 | 2.89 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine free | 0 | 1.045 | 0.247 | 0.777 | 1.545 |  |  |  |  |  | 
COVID19_MODERNA | Neoplasm | 0 | 0.209 | 0.016 | 0.777 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric symptom | 0 | 0.329 | 0.054 | 0.777 | 2.22 |  |  |  |  |  | 
COVID19_MODERNA | Helicobacter test positive | 0 | 0.351 | 0.062 | 0.777 | 2.171 |  |  |  |  |  | 
COVID19_MODERNA | Spinal muscular atrophy | 0 | 0.195 | 0.012 | 0.777 | 2.674 |  |  |  |  |  | 
COVID19_MODERNA | Tonic posturing | 0 | 0.351 | 0.063 | 0.777 | 2.17 |  |  |  |  |  | 
COVID19_MODERNA | Heat stroke | 0 | 0.234 | 0.022 | 0.776 | 2.506 |  |  |  |  |  | 
COVID19_MODERNA | Abscess limb | 0 | 0.624 | 0.151 | 0.776 | 1.797 |  |  |  |  |  | 
COVID19_MODERNA | Application site swelling | 0 | 0.248 | 0.026 | 0.776 | 2.455 |  |  |  |  |  | 
COVID19_MODERNA | Congenital pulmonary hypertension | 0 | 0.078 | 0 | 0.776 | 3.669 |  |  |  |  |  | 
COVID19_MODERNA | Erythrodermic psoriasis | 0 | 0.195 | 0.012 | 0.776 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Gynaecomastia | 0 | 0.156 | 0.005 | 0.776 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Bronchoscopy abnormal | 0 | 0.368 | 0.068 | 0.776 | 2.137 |  |  |  |  |  | 
COVID19_MODERNA | Lyme disease | 0 | 0.205 | 0.014 | 0.775 | 2.627 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow oedema | 0 | 0.345 | 0.059 | 0.775 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | Breech delivery | 0 | 0.117 | 0.001 | 0.775 | 3.212 |  |  |  |  |  | 
COVID19_MODERNA | Palmar erythema | 0 | 0.579 | 0.138 | 0.775 | 1.839 |  |  |  |  |  | 
COVID19_MODERNA | Visual evoked potentials | 0 | 0.312 | 0.047 | 0.775 | 2.264 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration bone marrow normal | 0 | 0.273 | 0.034 | 0.775 | 2.374 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol withdrawal syndrome | 0 | 0.117 | 0.001 | 0.775 | 3.213 |  |  |  |  |  | 
COVID19_MODERNA | Eye pain | 41 | 55.734 | 0.592 | 0.774 | 0.977 | 0.576 | 0.742 | 0.944 | 0.736 | 1.121 | 0.4
COVID19_MODERNA | Crying | 9 | 13.746 | 0.445 | 0.774 | 1.176 | 0.422 | 0.693 | 1.087 | 0.655 | 0.057 | 141.517
COVID19_MODERNA | Prolonged pregnancy | 0 | 0.195 | 0.011 | 0.774 | 2.68 |  |  |  |  |  | 
COVID19_MODERNA | Pyoderma gangrenosum | 0 | 0.061 | 0 | 0.774 | 3.941 |  |  |  |  |  | 
COVID19_MODERNA | Listless | 1 | 1.526 | 0.156 | 0.773 | 1.773 | 0.319 | 0.779 | 1.654 | 0.655 | 0.087 | 8.574
COVID19_MODERNA | Deafness unilateral | 16 | 22.941 | 0.509 | 0.773 | 1.081 | 0.485 | 0.717 | 1.029 | 0.697 | 1.483 | 1.928
COVID19_MODERNA | Allergy test | 1 | 3.524 | 0.378 | 0.773 | 1.282 | 0.216 | 0.549 | 1.188 | 0.284 | 0.163 | 3.439
COVID19_MODERNA | Cholangitis | 0 | 0.234 | 0.021 | 0.773 | 2.512 |  |  |  |  |  | 
COVID19_MODERNA | Anti-cyclic citrullinated peptide antibody positive | 0 | 0.214 | 0.016 | 0.773 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Juvenile myoclonic epilepsy | 0 | 0.071 | 0 | 0.773 | 3.778 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lymph gland | 0 | 0.312 | 0.046 | 0.773 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Internal hernia | 0 | 0.078 | 0 | 0.773 | 3.674 |  |  |  |  |  | 
COVID19_MODERNA | Lupus-like syndrome | 0 | 0.234 | 0.021 | 0.773 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral atrophy | 2 | 2.601 | 0.246 | 0.772 | 1.534 | 0.368 | 0.809 | 1.59 | 0.769 | 2.055 | 0.243
COVID19_MODERNA | Hallucination, auditory | 1 | 2.615 | 0.151 | 0.772 | 1.788 | 0.256 | 0.636 | 1.363 | 0.382 | 0.465 | 0.181
COVID19_MODERNA | Thrombin time normal | 0 | 0.117 | 0.001 | 0.772 | 3.22 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte stimulation test | 0 | 0.078 | 0 | 0.772 | 3.677 |  |  |  |  |  | 
COVID19_MODERNA | Erythroblast count | 0 | 0.273 | 0.032 | 0.772 | 2.379 |  |  |  |  |  | 
COVID19_MODERNA | Immunology test abnormal | 0 | 0.21 | 0.014 | 0.772 | 2.614 |  |  |  |  |  | 
COVID19_MODERNA | Developmental delay | 0 | 0.338 | 0.055 | 0.772 | 2.205 |  |  |  |  |  | 
COVID19_MODERNA | Cortisol decreased | 0 | 0.273 | 0.032 | 0.772 | 2.378 |  |  |  |  |  | 
COVID19_MODERNA | Pyelocaliectasis | 0 | 0.206 | 0.013 | 0.772 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Band neutrophil count decreased | 0 | 0.312 | 0.045 | 0.772 | 2.269 |  |  |  |  |  | 
COVID19_MODERNA | Blood sodium increased | 1 | 4.243 | 0.107 | 0.771 | 1.937 | 0.189 | 0.493 | 1.078 | 0.236 | 1.233 | 0.129
COVID19_MODERNA | Sensorimotor disorder | 0 | 0.096 | 0 | 0.771 | 3.445 |  |  |  |  |  | 
COVID19_MODERNA | Skin culture | 0 | 0.312 | 0.044 | 0.771 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Arthritis reactive | 0 | 0.46 | 0.095 | 0.771 | 1.987 |  |  |  |  |  | 
COVID19_MODERNA | Physiotherapy | 0 | 0.195 | 0.01 | 0.771 | 2.687 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antibody negative | 1 | 0.855 | 0.048 | 0.77 | 2.239 | 0.371 | 0.9 | 1.91 | 1.169 | 0.103 | 6.866
COVID19_MODERNA | Abdominal X-ray | 1 | 2.055 | 0.144 | 0.77 | 1.802 | 0.286 | 0.703 | 1.498 | 0.487 | 0.143 | 4.243
COVID19_MODERNA | Eyelid rash | 1 | 2.193 | 0.208 | 0.77 | 1.62 | 0.278 | 0.686 | 1.462 | 0.456 | 0.283 | 1.13
COVID19_MODERNA | Vaccination site haematoma | 0 | 0.218 | 0.015 | 0.77 | 2.582 |  |  |  |  |  | 
COVID19_MODERNA | Rhinoscleroma | 0 | 0.156 | 0.004 | 0.77 | 2.912 |  |  |  |  |  | 
COVID19_MODERNA | Viral rash | 0 | 0.603 | 0.139 | 0.77 | 1.821 |  |  |  |  |  | 
COVID19_MODERNA | Angular cheilitis | 0 | 0.234 | 0.02 | 0.77 | 2.517 |  |  |  |  |  | 
COVID19_MODERNA | Prophylaxis | 1 | 0.823 | 0.068 | 0.769 | 2.113 | 0.373 | 0.907 | 1.924 | 1.215 | 2.242 | 0.002
COVID19_MODERNA | Retinal tear | 1 | 2.478 | 0.143 | 0.769 | 1.804 | 0.263 | 0.652 | 1.393 | 0.404 | 2.242 | 0.002
COVID19_MODERNA | Acute generalised exanthematous pustulosis | 0 | 0.557 | 0.124 | 0.769 | 1.869 |  |  |  |  |  | 
COVID19_MODERNA | Blood iron increased | 0 | 0.312 | 0.043 | 0.769 | 2.273 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal ulceration | 0 | 0.863 | 0.201 | 0.769 | 1.634 |  |  |  |  |  | 
COVID19_MODERNA | Seasonal allergy | 0 | 0.285 | 0.035 | 0.769 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic urticaria | 0 | 0.273 | 0.031 | 0.769 | 2.384 |  |  |  |  |  | 
COVID19_MODERNA | Exercise electrocardiogram | 0 | 0.351 | 0.056 | 0.769 | 2.182 |  |  |  |  |  | 
COVID19_MODERNA | Hearing and vestibular disorders (SMQ) [narrow] | 180 | 245.235 | 0.677 | 0.768 | 0.864 | 0.65 | 0.736 | 0.829 | 0.734 | 1.253 | 8.61
COVID19_MODERNA | Eructation | 3 | 4.778 | 0.351 | 0.768 | 1.316 | 0.351 | 0.718 | 1.337 | 0.628 | 1.088 | 0.027
COVID19_MODERNA | Renovascular disorders (SMQ) [broad] | 3 | 5.96 | 0.264 | 0.768 | 1.484 | 0.307 | 0.629 | 1.171 | 0.503 | 1.042 | 0.053
COVID19_MODERNA | Smooth muscle antibody positive | 0 | 0.156 | 0.004 | 0.768 | 2.916 |  |  |  |  |  | 
COVID19_MODERNA | Basophil percentage increased | 0 | 0.337 | 0.051 | 0.768 | 2.214 |  |  |  |  |  | 
COVID19_MODERNA | Treponema test positive | 0 | 0.39 | 0.069 | 0.768 | 2.105 |  |  |  |  |  | 
COVID19_MODERNA | Faecal calprotectin normal | 0 | 0.273 | 0.03 | 0.768 | 2.386 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte transformation test | 0 | 0.117 | 0.001 | 0.768 | 3.228 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis Escherichia coli | 0 | 0.156 | 0.004 | 0.768 | 2.917 |  |  |  |  |  | 
COVID19_MODERNA | Thermal burns of eye | 0 | 0.351 | 0.056 | 0.768 | 2.183 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal sensation in eye | 3 | 5.612 | 0.358 | 0.767 | 1.301 | 0.319 | 0.653 | 1.216 | 0.535 | 2 | 0.591
COVID19_MODERNA | Vitamin B12 | 2 | 4.244 | 0.295 | 0.767 | 1.42 | 0.288 | 0.637 | 1.256 | 0.471 | 1.147 | 0.038
COVID19_MODERNA | Skin wrinkling | 0 | 0.351 | 0.055 | 0.767 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | CSF protein abnormal | 0 | 0.234 | 0.018 | 0.767 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte count normal | 0 | 0.39 | 0.068 | 0.767 | 2.106 |  |  |  |  |  | 
COVID19_MODERNA | Injection site hypertrophy | 0 | 0.156 | 0.003 | 0.767 | 2.92 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation time normal | 0 | 0.156 | 0.003 | 0.767 | 2.92 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic cyst | 0 | 0.39 | 0.068 | 0.767 | 2.106 |  |  |  |  |  | 
COVID19_MODERNA | Ocular motility disorders (SMQ) [broad] | 62 | 84.035 | 0.617 | 0.766 | 0.928 | 0.603 | 0.742 | 0.906 | 0.738 | 0.586 | 17.376
COVID19_MODERNA | Blood pressure decreased | 29 | 40.631 | 0.556 | 0.766 | 1.004 | 0.537 | 0.724 | 0.959 | 0.714 | 1.4 | 2.753
COVID19_MODERNA | Klebsiella test positive | 0 | 0.273 | 0.029 | 0.766 | 2.389 |  |  |  |  |  | 
COVID19_MODERNA | Epstein-Barr virus test positive | 0 | 0.399 | 0.071 | 0.766 | 2.091 |  |  |  |  |  | 
COVID19_MODERNA | Stress fracture | 0 | 0.39 | 0.067 | 0.766 | 2.108 |  |  |  |  |  | 
COVID19_MODERNA | Systolic dysfunction | 0 | 0.195 | 0.009 | 0.766 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Suspected product contamination | 0 | 0.156 | 0.003 | 0.766 | 2.922 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid function disorder | 10 | 14.641 | 0.48 | 0.765 | 1.105 | 0.444 | 0.714 | 1.101 | 0.683 | 1.713 | 2.123
COVID19_MODERNA | Thyroxine free normal | 0 | 0.47 | 0.093 | 0.765 | 1.98 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid function test abnormal | 0 | 0.298 | 0.037 | 0.765 | 2.316 |  |  |  |  |  | 
COVID19_MODERNA | Hypersomnia-bulimia syndrome | 0 | 0.156 | 0.003 | 0.765 | 2.923 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary function test normal | 0 | 0.496 | 0.101 | 0.765 | 1.944 |  |  |  |  |  | 
COVID19_MODERNA | Whole body scan | 0 | 0.312 | 0.041 | 0.765 | 2.279 |  |  |  |  |  | 
COVID19_MODERNA | Paronychia | 0 | 0.195 | 0.009 | 0.765 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Retinal pigment epitheliopathy | 0 | 0.087 | 0 | 0.765 | 3.56 |  |  |  |  |  | 
COVID19_MODERNA | Blood urea decreased | 2 | 3.095 | 0.209 | 0.764 | 1.602 | 0.34 | 0.749 | 1.472 | 0.646 | 0.881 | 0.026
COVID19_MODERNA | Anion gap | 7 | 10.742 | 0.429 | 0.764 | 1.178 | 0.405 | 0.699 | 1.14 | 0.652 | 2.398 | 3.957
COVID19_MODERNA | Monocyte percentage increased | 1 | 2.063 | 0.203 | 0.764 | 1.618 | 0.285 | 0.702 | 1.496 | 0.485 | 0.115 | 5.919
COVID19_MODERNA | Body temperature | 18 | 79.65 | 0.501 | 0.764 | 1.072 | 0.172 | 0.251 | 0.355 | 0.226 | 1.387 | 1.481
COVID19_MODERNA | DNA test for fragile X | 0 | 0.351 | 0.053 | 0.764 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Administration site oedema | 0 | 0.273 | 0.028 | 0.764 | 2.392 |  |  |  |  |  | 
COVID19_MODERNA | Emotional disorder of childhood | 0 | 0.156 | 0.003 | 0.764 | 2.925 |  |  |  |  |  | 
COVID19_MODERNA | Cyanosis central | 0 | 0.214 | 0.013 | 0.764 | 2.611 |  |  |  |  |  | 
COVID19_MODERNA | Decreased vibratory sense | 0 | 0.164 | 0.004 | 0.764 | 2.873 |  |  |  |  |  | 
COVID19_MODERNA | Hearing impairment (SMQ) [narrow] | 95 | 135.991 | 0.641 | 0.763 | 0.895 | 0.593 | 0.702 | 0.827 | 0.699 | 0.992 | 0
COVID19_MODERNA | Nervous system disorder | 3 | 4.586 | 0.261 | 0.763 | 1.48 | 0.36 | 0.735 | 1.368 | 0.654 | 0.228 | 7.021
COVID19_MODERNA | Acute phase reaction | 0 | 0.156 | 0.003 | 0.763 | 2.928 |  |  |  |  |  | 
COVID19_MODERNA | Pupillary disorder | 0 | 0.234 | 0.017 | 0.763 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Parvovirus B19 test | 0 | 0.698 | 0.156 | 0.763 | 1.745 |  |  |  |  |  | 
COVID19_MODERNA | Right ventricular failure | 0 | 0.273 | 0.028 | 0.763 | 2.393 |  |  |  |  |  | 
COVID19_MODERNA | Specific gravity urine | 0 | 0.156 | 0.003 | 0.763 | 2.926 |  |  |  |  |  | 
COVID19_MODERNA | Scrotal pain | 0 | 0.369 | 0.058 | 0.763 | 2.152 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosa erosion | 0 | 0.156 | 0.003 | 0.763 | 2.927 |  |  |  |  |  | 
COVID19_MODERNA | Obsessive thoughts | 0 | 0.156 | 0.003 | 0.763 | 2.927 |  |  |  |  |  | 
COVID19_MODERNA | Asocial behaviour | 0 | 0.124 | 0.001 | 0.763 | 3.177 |  |  |  |  |  | 
COVID19_MODERNA | Hypopnoea | 9 | 13.568 | 0.441 | 0.762 | 1.155 | 0.426 | 0.7 | 1.098 | 0.663 | 1.121 | 0.024
COVID19_MODERNA | Anal sphincter atony | 0 | 0.234 | 0.017 | 0.762 | 2.531 |  |  |  |  |  | 
COVID19_MODERNA | Feeling of despair | 0 | 0.323 | 0.042 | 0.762 | 2.257 |  |  |  |  |  | 
COVID19_MODERNA | Eyelid injury | 0 | 0.273 | 0.027 | 0.762 | 2.396 |  |  |  |  |  | 
COVID19_MODERNA | Infusion related reaction | 0 | 0.156 | 0.003 | 0.762 | 2.929 |  |  |  |  |  | 
COVID19_MODERNA | Varicose vein | 0 | 0.218 | 0.013 | 0.762 | 2.598 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated/autoimmune disorders (SMQ) [broad] | 305 | 414.606 | 0.691 | 0.761 | 0.834 | 0.67 | 0.737 | 0.808 | 0.736 | 0.665 | 51.716
COVID19_MODERNA | Renal disorder | 1 | 3.552 | 0.211 | 0.761 | 1.589 | 0.215 | 0.547 | 1.183 | 0.281 | 0.44 | 0.244
COVID19_MODERNA | Affect lability | 0 | 0.393 | 0.064 | 0.761 | 2.109 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia staphylococcal | 0 | 0.273 | 0.027 | 0.761 | 2.398 |  |  |  |  |  | 
COVID19_MODERNA | Lichenoid keratosis | 0 | 0.384 | 0.061 | 0.761 | 2.124 |  |  |  |  |  | 
COVID19_MODERNA | Post procedural complication | 0 | 0.234 | 0.016 | 0.761 | 2.534 |  |  |  |  |  | 
COVID19_MODERNA | Glaucoma (SMQ) [narrow] | 3 | 5.262 | 0.276 | 0.76 | 1.438 | 0.332 | 0.679 | 1.264 | 0.57 | 0.493 | 1.059
COVID19_MODERNA | Hypovolaemic shock conditions (SMQ) [narrow] | 6 | 10.847 | 0.363 | 0.76 | 1.275 | 0.35 | 0.624 | 1.045 | 0.553 | 0.375 | 5.553
COVID19_MODERNA | Sinus disorder | 4 | 7.701 | 0.296 | 0.76 | 1.399 | 0.321 | 0.621 | 1.108 | 0.519 | 1.072 | 0.016
COVID19_MODERNA | Nasal mucosal disorder | 0 | 0.234 | 0.016 | 0.76 | 2.535 |  |  |  |  |  | 
COVID19_MODERNA | Blood mercury abnormal | 0 | 0.312 | 0.038 | 0.76 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal discomfort | 0 | 0.312 | 0.038 | 0.76 | 2.286 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis sapovirus | 0 | 0.117 | 0 | 0.76 | 3.243 |  |  |  |  |  | 
COVID19_MODERNA | Post-traumatic stress disorder | 0 | 0.241 | 0.018 | 0.76 | 2.507 |  |  |  |  |  | 
COVID19_MODERNA | Sneezing | 16 | 23.258 | 0.489 | 0.759 | 1.077 | 0.479 | 0.708 | 1.017 | 0.688 | 0.838 | 0.337
COVID19_MODERNA | Hepatic failure | 0 | 0.411 | 0.068 | 0.759 | 2.079 |  |  |  |  |  | 
COVID19_MODERNA | Mesenteric panniculitis | 0 | 0.195 | 0.008 | 0.759 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcal skin infection | 0 | 0.195 | 0.008 | 0.759 | 2.709 |  |  |  |  |  | 
COVID19_MODERNA | Injection site scar | 0 | 0.719 | 0.157 | 0.759 | 1.732 |  |  |  |  |  | 
COVID19_MODERNA | Ocular dysmetria | 0 | 0.078 | 0 | 0.759 | 3.693 |  |  |  |  |  | 
COVID19_MODERNA | Pathology test | 2 | 3.259 | 0.268 | 0.758 | 1.449 | 0.332 | 0.73 | 1.437 | 0.614 | 0.771 | 0.002
COVID19_MODERNA | Cutaneous lupus erythematosus | 0 | 0.39 | 0.061 | 0.758 | 2.118 |  |  |  |  |  | 
COVID19_MODERNA | Oophoritis | 0 | 0.156 | 0.003 | 0.758 | 2.936 |  |  |  |  |  | 
COVID19_MODERNA | T-lymphocyte count normal | 0 | 0.284 | 0.029 | 0.758 | 2.367 |  |  |  |  |  | 
COVID19_MODERNA | Axillary nerve injury | 0 | 0.39 | 0.061 | 0.758 | 2.118 |  |  |  |  |  | 
COVID19_MODERNA | Febrile infection | 0 | 0.331 | 0.042 | 0.758 | 2.243 |  |  |  |  |  | 
COVID19_MODERNA | Adenoidectomy | 0 | 0.234 | 0.016 | 0.758 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Pupils unequal | 0 | 0.412 | 0.068 | 0.758 | 2.078 |  |  |  |  |  | 
COVID19_MODERNA | Noninfective encephalitis | 2 | 2.661 | 0.284 | 0.757 | 1.413 | 0.365 | 0.801 | 1.574 | 0.751 | 0.913 | 0.048
COVID19_MODERNA | Extra dose administered | 19 | 26.844 | 0.506 | 0.757 | 1.048 | 0.503 | 0.723 | 1.013 | 0.708 | 0.132 | 108.124
COVID19_MODERNA | Hypoglycaemic and neurogenic shock conditions (SMQ) [narrow] | 6 | 10.318 | 0.36 | 0.757 | 1.272 | 0.364 | 0.648 | 1.084 | 0.582 | 0.37 | 5.722
COVID19_MODERNA | Keratic precipitates | 0 | 0.234 | 0.015 | 0.757 | 2.539 |  |  |  |  |  | 
COVID19_MODERNA | Epiphyses delayed fusion | 0 | 0.195 | 0.008 | 0.757 | 2.712 |  |  |  |  |  | 
COVID19_MODERNA | Breast cancer female | 0 | 0.551 | 0.11 | 0.757 | 1.885 |  |  |  |  |  | 
COVID19_MODERNA | Abortion induced | 0 | 0.233 | 0.015 | 0.757 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Angiotensin converting enzyme decreased | 0 | 0.217 | 0.012 | 0.757 | 2.608 |  |  |  |  |  | 
COVID19_MODERNA | Apallic syndrome | 0 | 0.116 | 0 | 0.757 | 3.259 |  |  |  |  |  | 
COVID19_MODERNA | Serology abnormal | 0 | 0.131 | 0.001 | 0.757 | 3.124 |  |  |  |  |  | 
COVID19_MODERNA | Myocardial infarction | 35 | 46.173 | 0.565 | 0.756 | 0.97 | 0.581 | 0.764 | 0.99 | 0.758 | 4.849 | 86.1
COVID19_MODERNA | Polyarthritis | 1 | 1.81 | 0.147 | 0.755 | 1.747 | 0.3 | 0.736 | 1.567 | 0.553 | 0.28 | 1.163
COVID19_MODERNA | Retinopathy | 0 | 0.273 | 0.024 | 0.755 | 2.405 |  |  |  |  |  | 
COVID19_MODERNA | Hyperpathia | 0 | 0.117 | 0 | 0.755 | 3.252 |  |  |  |  |  | 
COVID19_MODERNA | Deformity | 0 | 0.312 | 0.035 | 0.755 | 2.294 |  |  |  |  |  | 
COVID19_MODERNA | Pityriasis lichenoides et varioliformis acuta | 0 | 0.136 | 0.001 | 0.755 | 3.086 |  |  |  |  |  | 
COVID19_MODERNA | Change of bowel habit | 0 | 0.273 | 0.024 | 0.755 | 2.407 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulins normal | 0 | 0.356 | 0.048 | 0.755 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Toxic epidermal necrolysis | 0 | 0.219 | 0.011 | 0.755 | 2.605 |  |  |  |  |  | 
COVID19_MODERNA | Facial paresis | 15 | 22.911 | 0.486 | 0.754 | 1.071 | 0.455 | 0.68 | 0.985 | 0.655 | 1.878 | 4.905
COVID19_MODERNA | Congenital, familial and genetic disorders (SMQ) [narrow] | 5 | 9.147 | 0.34 | 0.754 | 1.301 | 0.34 | 0.629 | 1.084 | 0.547 | 0.206 | 14.371
COVID19_MODERNA | Congenital, familial and genetic disorders (SMQ) [broad] | 5 | 9.147 | 0.34 | 0.754 | 1.301 | 0.34 | 0.629 | 1.084 | 0.547 | 0.206 | 14.371
COVID19_MODERNA | Electrophoresis protein abnormal | 0 | 0.239 | 0.015 | 0.754 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Procedural complication | 0 | 0.156 | 0.002 | 0.754 | 2.944 |  |  |  |  |  | 
COVID19_MODERNA | Periostitis | 0 | 0.195 | 0.007 | 0.754 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Neuroblastoma | 0 | 0.195 | 0.007 | 0.754 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Ocular motility disorders (SMQ) [narrow] | 44 | 63.445 | 0.584 | 0.753 | 0.94 | 0.549 | 0.701 | 0.886 | 0.694 | 0.47 | 25.454
COVID19_MODERNA | Immunoglobulin therapy | 24 | 35.253 | 0.526 | 0.753 | 1.013 | 0.502 | 0.696 | 0.944 | 0.681 | 0.604 | 5.706
COVID19_MODERNA | Non-haematological malignant tumours (SMQ) [narrow] | 6 | 11.669 | 0.347 | 0.753 | 1.286 | 0.331 | 0.59 | 0.989 | 0.514 | 0.297 | 9.198
COVID19_MODERNA | Non-haematological malignant tumours (SMQ) [broad] | 6 | 11.669 | 0.347 | 0.753 | 1.286 | 0.331 | 0.59 | 0.989 | 0.514 | 0.297 | 9.198
COVID19_MODERNA | Brain injury | 1 | 2.63 | 0.271 | 0.753 | 1.429 | 0.255 | 0.635 | 1.359 | 0.38 | 0.23 | 1.815
COVID19_MODERNA | Renal transplant | 0 | 0.258 | 0.02 | 0.753 | 2.456 |  |  |  |  |  | 
COVID19_MODERNA | Pneumocystis jirovecii pneumonia | 0 | 0.075 | 0 | 0.753 | 3.74 |  |  |  |  |  | 
COVID19_MODERNA | Infective myositis | 0 | 0.234 | 0.014 | 0.753 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Injection site haemorrhage | 9 | 14.391 | 0.427 | 0.752 | 1.15 | 0.407 | 0.668 | 1.048 | 0.625 | 0.361 | 9.378
COVID19_MODERNA | Subretinal fluid | 0 | 0.156 | 0.002 | 0.752 | 2.947 |  |  |  |  |  | 
COVID19_MODERNA | Venous thrombosis | 0 | 0.234 | 0.014 | 0.752 | 2.548 |  |  |  |  |  | 
COVID19_MODERNA | Fontanelle depressed | 0 | 0.108 | 0 | 0.752 | 3.348 |  |  |  |  |  | 
COVID19_MODERNA | Brain scan normal | 0 | 0.326 | 0.037 | 0.752 | 2.263 |  |  |  |  |  | 
COVID19_MODERNA | Finger deformity | 0 | 0.156 | 0.002 | 0.752 | 2.946 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune neuropathy | 0 | 0.234 | 0.014 | 0.752 | 2.548 |  |  |  |  |  | 
COVID19_MODERNA | Specific gravity urine decreased | 0 | 0.273 | 0.023 | 0.752 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Gingival pruritus | 0 | 0.195 | 0.007 | 0.752 | 2.722 |  |  |  |  |  | 
COVID19_MODERNA | Claustrophobia | 0 | 0.39 | 0.056 | 0.752 | 2.125 |  |  |  |  |  | 
COVID19_MODERNA | Haemoptysis | 5 | 9.196 | 0.342 | 0.751 | 1.288 | 0.339 | 0.626 | 1.08 | 0.544 | 1.326 | 0.126
COVID19_MODERNA | Enteritis infectious | 0 | 0.234 | 0.013 | 0.751 | 2.55 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory paralysis | 0 | 0.195 | 0.006 | 0.751 | 2.723 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal disorder | 0 | 0.351 | 0.044 | 0.751 | 2.206 |  |  |  |  |  | 
COVID19_MODERNA | Cyanosis neonatal | 0 | 0.234 | 0.013 | 0.751 | 2.549 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac function test normal | 3 | 4.485 | 0.368 | 0.75 | 1.242 | 0.364 | 0.744 | 1.385 | 0.669 | 1.608 | 0.19
COVID19_MODERNA | Colitis | 2 | 4.581 | 0.214 | 0.75 | 1.549 | 0.275 | 0.61 | 1.204 | 0.437 | 0.649 | 0.1
COVID19_MODERNA | Drug withdrawal (SMQ) [narrow] | 0 | 0.312 | 0.032 | 0.75 | 2.301 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract inflammation | 0 | 0.273 | 0.022 | 0.75 | 2.413 |  |  |  |  |  | 
COVID19_MODERNA | Fungal test positive | 0 | 0.39 | 0.055 | 0.75 | 2.127 |  |  |  |  |  | 
COVID19_MODERNA | Arachnoid cyst | 0 | 0.156 | 0.002 | 0.75 | 2.95 |  |  |  |  |  | 
COVID19_MODERNA | Subcutaneous haematoma | 0 | 0.355 | 0.045 | 0.75 | 2.197 |  |  |  |  |  | 
COVID19_MODERNA | Energy increased | 0 | 0.312 | 0.033 | 0.75 | 2.3 |  |  |  |  |  | 
COVID19_MODERNA | Urinary sediment present | 2 | 2.226 | 0.256 | 0.749 | 1.45 | 0.393 | 0.861 | 1.692 | 0.898 | 1.174 | 0.028
COVID19_MODERNA | Motion sickness | 3 | 3.868 | 0.239 | 0.749 | 1.488 | 0.395 | 0.806 | 1.5 | 0.776 | 1.298 | 0.012
COVID19_MODERNA | Gingival pain | 3 | 4.777 | 0.319 | 0.749 | 1.325 | 0.351 | 0.718 | 1.337 | 0.628 | 1.254 | 0.003
COVID19_MODERNA | Neutrophil percentage | 3 | 4.824 | 0.287 | 0.749 | 1.388 | 0.349 | 0.714 | 1.33 | 0.622 | 0.462 | 1.333
COVID19_MODERNA | Temperature intolerance | 2 | 3.46 | 0.231 | 0.749 | 1.506 | 0.322 | 0.709 | 1.396 | 0.578 | 0.514 | 0.474
COVID19_MODERNA | Injection site abscess sterile | 0 | 0.327 | 0.036 | 0.749 | 2.264 |  |  |  |  |  | 
COVID19_MODERNA | Limb operation | 0 | 0.234 | 0.013 | 0.749 | 2.552 |  |  |  |  |  | 
COVID19_MODERNA | Skin cancer | 0 | 0.252 | 0.017 | 0.749 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Type V hyperlipidaemia | 0 | 0.195 | 0.006 | 0.748 | 2.728 |  |  |  |  |  | 
COVID19_MODERNA | Acute motor-sensory axonal neuropathy | 0 | 0.351 | 0.042 | 0.748 | 2.209 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase decreased | 0 | 0.186 | 0.005 | 0.748 | 2.771 |  |  |  |  |  | 
COVID19_MODERNA | X-ray gastrointestinal tract | 0 | 0.156 | 0.002 | 0.748 | 2.953 |  |  |  |  |  | 
COVID19_MODERNA | Mitral valve prolapse | 0 | 0.234 | 0.013 | 0.748 | 2.554 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctivitis viral | 0 | 0.312 | 0.031 | 0.748 | 2.303 |  |  |  |  |  | 
COVID19_MODERNA | Electromyogram | 2 | 5.925 | 0.3 | 0.747 | 1.357 | 0.233 | 0.522 | 1.034 | 0.338 | 0.228 | 4.406
COVID19_MODERNA | QRS axis abnormal | 0 | 0.156 | 0.002 | 0.747 | 2.956 |  |  |  |  |  | 
COVID19_MODERNA | Subdural hygroma | 0 | 0.113 | 0 | 0.747 | 3.304 |  |  |  |  |  | 
COVID19_MODERNA | Anti-Muellerian hormone level | 0 | 0.195 | 0.006 | 0.747 | 2.729 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound testes | 0 | 0.156 | 0.002 | 0.747 | 2.956 |  |  |  |  |  | 
COVID19_MODERNA | Blood aldosterone normal | 0 | 0.117 | 0 | 0.747 | 3.264 |  |  |  |  |  | 
COVID19_MODERNA | Facial paralysis | 120 | 167.811 | 0.64 | 0.746 | 0.859 | 0.617 | 0.718 | 0.83 | 0.715 | 2.358 | 84.717
COVID19_MODERNA | Eosinophilic pneumonia (SMQ) [algorithm] | 5 | 8.738 | 0.338 | 0.746 | 1.284 | 0.352 | 0.65 | 1.12 | 0.572 | 1.072 | 0.007
COVID19_MODERNA | Exercise electrocardiogram normal | 0 | 0.273 | 0.021 | 0.746 | 2.418 |  |  |  |  |  | 
COVID19_MODERNA | Administration site inflammation | 0 | 0.39 | 0.053 | 0.746 | 2.131 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy artery abnormal | 0 | 0.273 | 0.021 | 0.746 | 2.418 |  |  |  |  |  | 
COVID19_MODERNA | Akinesia | 0 | 0.234 | 0.012 | 0.746 | 2.556 |  |  |  |  |  | 
COVID19_MODERNA | Blood prolactin normal | 0 | 0.351 | 0.041 | 0.746 | 2.211 |  |  |  |  |  | 
COVID19_MODERNA | Foetal death | 3 | 5.183 | 0.227 | 0.745 | 1.506 | 0.335 | 0.685 | 1.275 | 0.579 | 0.925 | 0.023
COVID19_MODERNA | Orthopaedic examination normal | 0 | 0.234 | 0.012 | 0.745 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Sick building syndrome | 0 | 0.078 | 0 | 0.745 | 3.705 |  |  |  |  |  | 
COVID19_MODERNA | Electroencephalogram abnormal | 2 | 3.557 | 0.266 | 0.744 | 1.416 | 0.317 | 0.7 | 1.377 | 0.562 | 0.13 | 10.658
COVID19_MODERNA | Vaccine positive rechallenge | 1 | 8.596 | 0.107 | 0.744 | 1.856 | 0.063 | 0.277 | 0.683 | 0.116 | 0.039 | 22.968
COVID19_MODERNA | Beta-2 glycoprotein antibody | 0 | 0.273 | 0.02 | 0.744 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Ileus paralytic | 0 | 0.312 | 0.029 | 0.744 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Sputum test | 0 | 0.156 | 0.002 | 0.744 | 2.959 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatic fever | 0 | 0.273 | 0.02 | 0.744 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | NIH stroke scale abnormal | 0 | 0.156 | 0.002 | 0.744 | 2.959 |  |  |  |  |  | 
COVID19_MODERNA | Basal ganglia haemorrhage | 0 | 0.234 | 0.011 | 0.744 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Dental paraesthesia | 0 | 0.156 | 0.002 | 0.744 | 2.959 |  |  |  |  |  | 
COVID19_MODERNA | Vaccine breakthrough infection | 0 | 0.338 | 0.036 | 0.744 | 2.245 |  |  |  |  |  | 
COVID19_MODERNA | Wisdom teeth removal | 0 | 0.195 | 0.005 | 0.744 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Breath odour | 0 | 0.304 | 0.027 | 0.744 | 2.329 |  |  |  |  |  | 
COVID19_MODERNA | Multiple chemical sensitivity | 0 | 0.39 | 0.051 | 0.744 | 2.134 |  |  |  |  |  | 
COVID19_MODERNA | Optic neuropathy | 0 | 0.224 | 0.01 | 0.744 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Myoglobinuria | 0 | 0.156 | 0.002 | 0.744 | 2.96 |  |  |  |  |  | 
COVID19_MODERNA | Liver function test | 8 | 11.651 | 0.434 | 0.743 | 1.12 | 0.43 | 0.723 | 1.154 | 0.687 | 1.861 | 2.19
COVID19_MODERNA | Post inflammatory pigmentation change | 0 | 0.144 | 0.001 | 0.743 | 3.046 |  |  |  |  |  | 
COVID19_MODERNA | Crystal urine present | 0 | 0.195 | 0.005 | 0.743 | 2.734 |  |  |  |  |  | 
COVID19_MODERNA | Diarrhoea infectious | 0 | 0.156 | 0.002 | 0.743 | 2.962 |  |  |  |  |  | 
COVID19_MODERNA | Granulocyte count increased | 0 | 0.351 | 0.039 | 0.743 | 2.215 |  |  |  |  |  | 
COVID19_MODERNA | Bronchial disorder | 0 | 0.234 | 0.012 | 0.743 | 2.558 |  |  |  |  |  | 
COVID19_MODERNA | Systemic lupus erythematosus (SMQ) [narrow] | 6 | 9.8 | 0.349 | 0.742 | 1.255 | 0.378 | 0.673 | 1.126 | 0.612 | 0.385 | 5.186
COVID19_MODERNA | Gestational diabetes | 1 | 2.62 | 0.064 | 0.742 | 2.049 | 0.256 | 0.636 | 1.361 | 0.382 | 0.601 | 0.012
COVID19_MODERNA | Laryngoscopy abnormal | 0 | 0.39 | 0.05 | 0.742 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Injection site injury | 0 | 0.413 | 0.056 | 0.742 | 2.093 |  |  |  |  |  | 
COVID19_MODERNA | Tensilon test abnormal | 0 | 0.195 | 0.005 | 0.742 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to communicable disease | 0 | 0.435 | 0.063 | 0.742 | 2.056 |  |  |  |  |  | 
COVID19_MODERNA | Blood lactate dehydrogenase increased | 5 | 8.099 | 0.322 | 0.741 | 1.3 | 0.371 | 0.685 | 1.181 | 0.617 | 0.514 | 1.787
COVID19_MODERNA | Procalcitonin increased | 6 | 10.204 | 0.342 | 0.741 | 1.263 | 0.367 | 0.653 | 1.093 | 0.588 | 0.961 | 0.012
COVID19_MODERNA | Fine motor skill dysfunction | 2 | 4.355 | 0.357 | 0.741 | 1.237 | 0.284 | 0.628 | 1.239 | 0.459 | 0.725 | 0.02
COVID19_MODERNA | Blood cholinesterase increased | 0 | 0.351 | 0.038 | 0.741 | 2.217 |  |  |  |  |  | 
COVID19_MODERNA | PO2 | 0 | 0.39 | 0.049 | 0.741 | 2.137 |  |  |  |  |  | 
COVID19_MODERNA | Scan abdomen abnormal | 0 | 0.195 | 0.005 | 0.741 | 2.738 |  |  |  |  |  | 
COVID19_MODERNA | Hernia | 0 | 0.383 | 0.047 | 0.741 | 2.151 |  |  |  |  |  | 
COVID19_MODERNA | CSF myelin basic protein increased | 0 | 0.195 | 0.005 | 0.741 | 2.737 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system infection | 0 | 0.203 | 0.006 | 0.741 | 2.699 |  |  |  |  |  | 
COVID19_MODERNA | Tooth fracture | 0 | 0.968 | 0.187 | 0.741 | 1.592 |  |  |  |  |  | 
COVID19_MODERNA | Hearing impairment (SMQ) [broad] | 218 | 304.369 | 0.66 | 0.74 | 0.823 | 0.642 | 0.718 | 0.801 | 0.716 | 1.491 | 33.116
COVID19_MODERNA | Glaucoma | 0 | 0.431 | 0.06 | 0.74 | 2.064 |  |  |  |  |  | 
COVID19_MODERNA | Cyst removal | 0 | 0.351 | 0.038 | 0.74 | 2.218 |  |  |  |  |  | 
COVID19_MODERNA | Amyotrophic lateral sclerosis | 0 | 0.116 | 0 | 0.74 | 3.283 |  |  |  |  |  | 
COVID19_MODERNA | Epstein-Barr virus infection | 0 | 0.498 | 0.078 | 0.74 | 1.965 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation test abnormal | 0 | 0.468 | 0.071 | 0.74 | 2.006 |  |  |  |  |  | 
COVID19_MODERNA | Band neutrophil percentage decreased | 0 | 0.273 | 0.018 | 0.74 | 2.427 |  |  |  |  |  | 
COVID19_MODERNA | Heart disease congenital | 0 | 0.234 | 0.011 | 0.74 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Suspected counterfeit product | 0 | 0.234 | 0.01 | 0.739 | 2.567 |  |  |  |  |  | 
COVID19_MODERNA | Dyslalia | 0 | 0.234 | 0.01 | 0.739 | 2.566 |  |  |  |  |  | 
COVID19_MODERNA | Foreign body sensation in eyes | 0 | 1.017 | 0.194 | 0.739 | 1.569 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterium tuberculosis complex test positive | 0 | 0.191 | 0.004 | 0.739 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia escherichia | 0 | 0.078 | 0 | 0.739 | 3.708 |  |  |  |  |  | 
COVID19_MODERNA | Product deposit | 0 | 0.156 | 0.001 | 0.739 | 2.968 |  |  |  |  |  | 
COVID19_MODERNA | Choking | 4 | 6.882 | 0.313 | 0.738 | 1.309 | 0.346 | 0.669 | 1.194 | 0.581 | 0.413 | 2.716
COVID19_MODERNA | Adenovirus infection | 0 | 0.319 | 0.028 | 0.738 | 2.298 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal ulceration | 0 | 0.39 | 0.047 | 0.738 | 2.139 |  |  |  |  |  | 
COVID19_MODERNA | X-ray with contrast upper gastrointestinal tract | 0 | 0.277 | 0.019 | 0.738 | 2.415 |  |  |  |  |  | 
COVID19_MODERNA | Yersinia test negative | 0 | 0.179 | 0.003 | 0.738 | 2.826 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory syncytial virus test positive | 0 | 0.437 | 0.06 | 0.738 | 2.056 |  |  |  |  |  | 
COVID19_MODERNA | Skin erosion | 0 | 0.885 | 0.168 | 0.738 | 1.635 |  |  |  |  |  | 
COVID19_MODERNA | Megakaryocytes increased | 0 | 0.234 | 0.01 | 0.738 | 2.567 |  |  |  |  |  | 
COVID19_MODERNA | Hypoaesthesia eye | 3 | 4.555 | 0.288 | 0.737 | 1.355 | 0.361 | 0.738 | 1.373 | 0.659 | 3.363 | 2.486
COVID19_MODERNA | Parosmia | 8 | 12.808 | 0.376 | 0.737 | 1.195 | 0.4 | 0.672 | 1.073 | 0.625 | 2.217 | 3.81
COVID19_MODERNA | Defiant behaviour | 0 | 0.273 | 0.018 | 0.737 | 2.43 |  |  |  |  |  | 
COVID19_MODERNA | Hearing aid user | 0 | 0.214 | 0.007 | 0.737 | 2.65 |  |  |  |  |  | 
COVID19_MODERNA | Palpable purpura | 0 | 0.219 | 0.008 | 0.737 | 2.632 |  |  |  |  |  | 
COVID19_MODERNA | IIIrd nerve paralysis | 0 | 0.715 | 0.131 | 0.737 | 1.747 |  |  |  |  |  | 
COVID19_MODERNA | Slit-lamp examination | 0 | 0.273 | 0.017 | 0.737 | 2.431 |  |  |  |  |  | 
COVID19_MODERNA | Pernicious anaemia | 0 | 0.234 | 0.01 | 0.737 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Cervicobrachial syndrome | 0 | 0.195 | 0.004 | 0.737 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Fundoscopy abnormal | 0 | 0.24 | 0.011 | 0.737 | 2.544 |  |  |  |  |  | 
COVID19_MODERNA | Drug level | 0 | 0.234 | 0.01 | 0.737 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Lip pruritus | 7 | 11.302 | 0.402 | 0.736 | 1.15 | 0.39 | 0.672 | 1.098 | 0.619 | 2.271 | 3.431
COVID19_MODERNA | Magnetic resonance imaging abnormal | 17 | 27.628 | 0.487 | 0.736 | 1.028 | 0.438 | 0.641 | 0.912 | 0.615 | 0.619 | 3.513
COVID19_MODERNA | Joint noise | 1 | 2.512 | 0.258 | 0.736 | 1.412 | 0.261 | 0.648 | 1.386 | 0.398 | 0.252 | 1.5
COVID19_MODERNA | Mononuclear cell percentage | 0 | 0.195 | 0.004 | 0.736 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Hypermobility syndrome | 0 | 0.121 | 0 | 0.736 | 3.24 |  |  |  |  |  | 
COVID19_MODERNA | CSF immunoglobulin decreased | 0 | 0.273 | 0.017 | 0.736 | 2.432 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis fulminant | 0 | 0.195 | 0.004 | 0.736 | 2.745 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic procedure | 0 | 0.269 | 0.016 | 0.736 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Varicella zoster pneumonia | 0 | 0.057 | 0 | 0.736 | 4.001 |  |  |  |  |  | 
COVID19_MODERNA | Miliaria | 0 | 1.136 | 0.21 | 0.736 | 1.521 |  |  |  |  |  | 
COVID19_MODERNA | Blood test normal | 40 | 58.437 | 0.56 | 0.735 | 0.928 | 0.536 | 0.694 | 0.885 | 0.685 | 0.722 | 3.895
COVID19_MODERNA | Laboratory test abnormal | 8 | 13.996 | 0.407 | 0.735 | 1.142 | 0.372 | 0.626 | 1.001 | 0.572 | 0.562 | 2.244
COVID19_MODERNA | Neutrophil count | 2 | 4.487 | 0.21 | 0.735 | 1.517 | 0.279 | 0.618 | 1.218 | 0.446 | 0.836 | 0.007
COVID19_MODERNA | Cytokine test | 0 | 0.312 | 0.025 | 0.735 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | Ventricular septal defect | 0 | 0.312 | 0.025 | 0.735 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | Dengue virus test negative | 0 | 0.273 | 0.017 | 0.735 | 2.433 |  |  |  |  |  | 
COVID19_MODERNA | Face and mouth X-ray abnormal | 0 | 0.312 | 0.025 | 0.735 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | X-ray | 34 | 52.307 | 0.548 | 0.734 | 0.942 | 0.502 | 0.662 | 0.861 | 0.65 | 0.843 | 0.816
COVID19_MODERNA | Emotional distress | 7 | 11.472 | 0.388 | 0.734 | 1.17 | 0.385 | 0.665 | 1.085 | 0.61 | 0.297 | 10.845
COVID19_MODERNA | Lipoedema | 0 | 0.234 | 0.009 | 0.734 | 2.573 |  |  |  |  |  | 
COVID19_MODERNA | Accident | 0 | 0.312 | 0.025 | 0.734 | 2.32 |  |  |  |  |  | 
COVID19_MODERNA | Sacroiliitis | 0 | 0.312 | 0.025 | 0.734 | 2.32 |  |  |  |  |  | 
COVID19_MODERNA | Bacillus test positive | 0 | 0.156 | 0.001 | 0.734 | 2.973 |  |  |  |  |  | 
COVID19_MODERNA | Infantile apnoea | 0 | 0.352 | 0.035 | 0.734 | 2.221 |  |  |  |  |  | 
COVID19_MODERNA | Nasal inflammation | 0 | 0.312 | 0.025 | 0.734 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | Organising pneumonia | 0 | 0.351 | 0.035 | 0.734 | 2.225 |  |  |  |  |  | 
COVID19_MODERNA | Daydreaming | 0 | 0.24 | 0.01 | 0.734 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Bradyphrenia | 3 | 3.701 | 0.268 | 0.733 | 1.383 | 0.404 | 0.825 | 1.534 | 0.811 | 2.466 | 1.193
COVID19_MODERNA | Cardiac imaging procedure normal | 0 | 0.273 | 0.016 | 0.733 | 2.435 |  |  |  |  |  | 
COVID19_MODERNA | Prostatic specific antigen normal | 0 | 0.312 | 0.025 | 0.733 | 2.321 |  |  |  |  |  | 
COVID19_MODERNA | Housebound | 0 | 0.234 | 0.009 | 0.733 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Tetany | 1 | 1.369 | 0.192 | 0.732 | 1.554 | 0.33 | 0.804 | 1.707 | 0.731 | 1.897 | 0.004
COVID19_MODERNA | Puncture site induration | 0 | 0.195 | 0.004 | 0.732 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Nail disorder | 0 | 0.273 | 0.016 | 0.732 | 2.436 |  |  |  |  |  | 
COVID19_MODERNA | Negative thoughts | 0 | 0.195 | 0.004 | 0.732 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | CSF immunoglobulin G index | 0 | 0.341 | 0.031 | 0.732 | 2.248 |  |  |  |  |  | 
COVID19_MODERNA | Renal tubular acidosis | 0 | 0.156 | 0.001 | 0.731 | 2.978 |  |  |  |  |  | 
COVID19_MODERNA | Spinal fusion surgery | 0 | 0.351 | 0.033 | 0.731 | 2.228 |  |  |  |  |  | 
COVID19_MODERNA | Nerve conduction studies normal | 0 | 0.413 | 0.049 | 0.731 | 2.104 |  |  |  |  |  | 
COVID19_MODERNA | Muscle atrophy | 2 | 3.146 | 0.205 | 0.73 | 1.517 | 0.338 | 0.743 | 1.461 | 0.636 | 0.404 | 1.172
COVID19_MODERNA | Respiratory rate decreased | 1 | 2.301 | 0.24 | 0.73 | 1.436 | 0.272 | 0.672 | 1.436 | 0.435 | 0.493 | 0.124
COVID19_MODERNA | International normalised ratio decreased | 1 | 3.07 | 0.157 | 0.73 | 1.644 | 0.235 | 0.59 | 1.269 | 0.326 | 2.055 | 0
COVID19_MODERNA | Renal injury | 0 | 0.778 | 0.138 | 0.73 | 1.705 |  |  |  |  |  | 
COVID19_MODERNA | Impaired quality of life | 0 | 0.186 | 0.003 | 0.73 | 2.796 |  |  |  |  |  | 
COVID19_MODERNA | Volvulus | 0 | 0.39 | 0.042 | 0.73 | 2.147 |  |  |  |  |  | 
COVID19_MODERNA | Altered visual depth perception | 0 | 0.351 | 0.033 | 0.73 | 2.229 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging normal | 23 | 34.522 | 0.511 | 0.729 | 0.98 | 0.489 | 0.683 | 0.932 | 0.666 | 0.759 | 1.472
COVID19_MODERNA | Allodynia | 1 | 1.746 | 0.106 | 0.729 | 1.812 | 0.304 | 0.746 | 1.585 | 0.573 | 0.514 | 0.091
COVID19_MODERNA | Concentric sclerosis | 0 | 0.078 | 0 | 0.729 | 3.71 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lung | 0 | 0.234 | 0.008 | 0.729 | 2.579 |  |  |  |  |  | 
COVID19_MODERNA | Gingival blister | 0 | 0.312 | 0.023 | 0.729 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal disorder | 0 | 0.681 | 0.116 | 0.729 | 1.778 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis | 1 | 1.52 | 0.142 | 0.728 | 1.687 | 0.319 | 0.78 | 1.656 | 0.658 | 0.088 | 8.454
COVID19_MODERNA | Roseolovirus test positive | 0 | 0.356 | 0.033 | 0.728 | 2.219 |  |  |  |  |  | 
COVID19_MODERNA | Bronchiolitis | 0 | 0.424 | 0.05 | 0.728 | 2.086 |  |  |  |  |  | 
COVID19_MODERNA | Tinea capitis | 0 | 0.156 | 0.001 | 0.728 | 2.98 |  |  |  |  |  | 
COVID19_MODERNA | Bone marrow transplant | 0 | 0.132 | 0 | 0.728 | 3.154 |  |  |  |  |  | 
COVID19_MODERNA | Sensory loss | 12 | 19.847 | 0.445 | 0.727 | 1.066 | 0.412 | 0.641 | 0.96 | 0.605 | 0.85 | 0.174
COVID19_MODERNA | Cardiopulmonary failure | 0 | 0.305 | 0.021 | 0.727 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Prostate cancer | 0 | 0.312 | 0.022 | 0.727 | 2.327 |  |  |  |  |  | 
COVID19_MODERNA | Gamma-glutamyltransferase decreased | 0 | 0.156 | 0.001 | 0.727 | 2.982 |  |  |  |  |  | 
COVID19_MODERNA | Abortion threatened | 0 | 0.351 | 0.031 | 0.727 | 2.232 |  |  |  |  |  | 
COVID19_MODERNA | Capillary nail refill test abnormal | 0 | 0.696 | 0.117 | 0.727 | 1.767 |  |  |  |  |  | 
COVID19_MODERNA | Impaired driving ability | 15 | 21.947 | 0.481 | 0.726 | 1.013 | 0.472 | 0.705 | 1.022 | 0.683 | 1.045 | 0.001
COVID19_MODERNA | Hyperferritinaemia | 0 | 0.234 | 0.008 | 0.726 | 2.583 |  |  |  |  |  | 
COVID19_MODERNA | Toxic skin eruption | 0 | 0.249 | 0.01 | 0.726 | 2.524 |  |  |  |  |  | 
COVID19_MODERNA | Radioallergosorbent test negative | 0 | 0.64 | 0.103 | 0.726 | 1.816 |  |  |  |  |  | 
COVID19_MODERNA | Osteomyelitis | 0 | 0.766 | 0.131 | 0.726 | 1.714 |  |  |  |  |  | 
COVID19_MODERNA | Minimum inhibitory concentration | 0 | 0.195 | 0.003 | 0.726 | 2.757 |  |  |  |  |  | 
COVID19_MODERNA | Exaggerated startle response | 0 | 0.299 | 0.019 | 0.725 | 2.365 |  |  |  |  |  | 
COVID19_MODERNA | Dermatologic examination normal | 0 | 0.273 | 0.014 | 0.725 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Vulvovaginal pain | 0 | 0.214 | 0.005 | 0.725 | 2.668 |  |  |  |  |  | 
COVID19_MODERNA | Autoantibody negative | 0 | 0.336 | 0.027 | 0.725 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary function test abnormal | 0 | 0.341 | 0.028 | 0.725 | 2.256 |  |  |  |  |  | 
COVID19_MODERNA | Polyserositis | 0 | 0.273 | 0.014 | 0.725 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Spinal laminectomy | 0 | 0.273 | 0.014 | 0.725 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Oral mucosal exfoliation | 0 | 0.967 | 0.169 | 0.725 | 1.596 |  |  |  |  |  | 
COVID19_MODERNA | Erythema nodosum | 1 | 1.071 | 0.128 | 0.724 | 1.717 | 0.352 | 0.857 | 1.818 | 0.933 | 0.503 | 0.107
COVID19_MODERNA | Brain contusion | 0 | 0.234 | 0.008 | 0.724 | 2.584 |  |  |  |  |  | 
COVID19_MODERNA | Urobilinogen urine increased | 0 | 0.89 | 0.154 | 0.724 | 1.636 |  |  |  |  |  | 
COVID19_MODERNA | Viral load undetectable | 0 | 0.156 | 0.001 | 0.724 | 2.986 |  |  |  |  |  | 
COVID19_MODERNA | Osteomyelitis bacterial | 0 | 0.195 | 0.003 | 0.724 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Adverse food reaction | 0 | 0.156 | 0.001 | 0.724 | 2.985 |  |  |  |  |  | 
COVID19_MODERNA | Anembryonic gestation | 0 | 0.195 | 0.003 | 0.724 | 2.76 |  |  |  |  |  | 
COVID19_MODERNA | Streptococcal infection | 0 | 0.492 | 0.065 | 0.724 | 1.985 |  |  |  |  |  | 
COVID19_MODERNA | Neurological examination abnormal | 4 | 7.147 | 0.298 | 0.723 | 1.3 | 0.338 | 0.653 | 1.165 | 0.56 | 0.442 | 2.223
COVID19_MODERNA | Culture | 3 | 6.008 | 0.309 | 0.723 | 1.276 | 0.305 | 0.625 | 1.166 | 0.499 | 0.37 | 2.561
COVID19_MODERNA | Legionella test positive | 0 | 0.195 | 0.003 | 0.723 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Cochlea implant | 0 | 0.203 | 0.004 | 0.723 | 2.721 |  |  |  |  |  | 
COVID19_MODERNA | Adenovirus test positive | 0 | 0.329 | 0.024 | 0.723 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid factor increased | 0 | 0.693 | 0.113 | 0.723 | 1.771 |  |  |  |  |  | 
COVID19_MODERNA | Bilirubin conjugated decreased | 0 | 0.39 | 0.039 | 0.723 | 2.153 |  |  |  |  |  | 
COVID19_MODERNA | Dementia Alzheimer's type | 0 | 0.273 | 0.013 | 0.723 | 2.446 |  |  |  |  |  | 
COVID19_MODERNA | Body temperature decreased | 5 | 9.572 | 0.416 | 0.722 | 1.097 | 0.329 | 0.609 | 1.049 | 0.522 | 0.639 | 0.663
COVID19_MODERNA | Vaginal dysplasia | 0 | 0.195 | 0.003 | 0.722 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Folate deficiency | 0 | 0.156 | 0.001 | 0.722 | 2.988 |  |  |  |  |  | 
COVID19_MODERNA | Serology negative | 0 | 0.286 | 0.015 | 0.722 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Circumoral swelling | 0 | 0.273 | 0.013 | 0.722 | 2.447 |  |  |  |  |  | 
COVID19_MODERNA | Amino acid level normal | 0 | 0.246 | 0.009 | 0.722 | 2.538 |  |  |  |  |  | 
COVID19_MODERNA | Lhermitte's sign | 0 | 0.39 | 0.038 | 0.721 | 2.155 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid disorder | 0 | 0.382 | 0.036 | 0.721 | 2.169 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem auditory evoked response abnormal | 0 | 0.273 | 0.013 | 0.721 | 2.447 |  |  |  |  |  | 
COVID19_MODERNA | Endodontic procedure | 0 | 0.273 | 0.013 | 0.721 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Benign rolandic epilepsy | 0 | 0.273 | 0.013 | 0.721 | 2.447 |  |  |  |  |  | 
COVID19_MODERNA | Electronystagmogram | 0 | 0.195 | 0.003 | 0.721 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Hypersensitivity pneumonitis | 0 | 0.273 | 0.013 | 0.721 | 2.448 |  |  |  |  |  | 
COVID19_MODERNA | Blood zinc decreased | 0 | 0.234 | 0.007 | 0.72 | 2.588 |  |  |  |  |  | 
COVID19_MODERNA | Suture insertion | 2 | 4.38 | 0.34 | 0.719 | 1.213 | 0.283 | 0.626 | 1.235 | 0.457 | 0.695 | 0.044
COVID19_MODERNA | Labile blood pressure | 0 | 0.234 | 0.007 | 0.719 | 2.59 |  |  |  |  |  | 
COVID19_MODERNA | Hypnagogic hallucination | 0 | 0.082 | 0 | 0.719 | 3.661 |  |  |  |  |  | 
COVID19_MODERNA | Congenital tricuspid valve incompetence | 0 | 0.117 | 0 | 0.719 | 3.292 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory muscle weakness | 0 | 0.076 | 0 | 0.719 | 3.736 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac asthma | 0 | 0.078 | 0 | 0.719 | 3.707 |  |  |  |  |  | 
COVID19_MODERNA | Helicobacter infection | 0 | 0.974 | 0.163 | 0.718 | 1.594 |  |  |  |  |  | 
COVID19_MODERNA | Antiphospholipid antibodies positive | 0 | 0.775 | 0.125 | 0.718 | 1.711 |  |  |  |  |  | 
COVID19_MODERNA | Spirometry abnormal | 0 | 0.076 | 0 | 0.718 | 3.727 |  |  |  |  |  | 
COVID19_MODERNA | Anterior chamber inflammation | 0 | 0.156 | 0.001 | 0.718 | 2.991 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound urinary system | 0 | 0.351 | 0.027 | 0.718 | 2.239 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin urine present | 0 | 0.273 | 0.012 | 0.718 | 2.451 |  |  |  |  |  | 
COVID19_MODERNA | Eye injury | 0 | 0.281 | 0.014 | 0.718 | 2.424 |  |  |  |  |  | 
COVID19_MODERNA | Intervertebral discitis | 0 | 0.312 | 0.019 | 0.718 | 2.335 |  |  |  |  |  | 
COVID19_MODERNA | Agranulocytosis (SMQ) [broad] | 19 | 27.589 | 0.482 | 0.717 | 0.991 | 0.491 | 0.706 | 0.989 | 0.689 | 0.386 | 17.75
COVID19_MODERNA | Puncture site oedema | 0 | 0.195 | 0.003 | 0.717 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Blood follicle stimulating hormone | 0 | 0.117 | 0 | 0.717 | 3.293 |  |  |  |  |  | 
COVID19_MODERNA | Prerenal failure | 0 | 0.195 | 0.003 | 0.717 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell haemoglobin | 1 | 1.718 | 0.156 | 0.716 | 1.609 | 0.306 | 0.75 | 1.594 | 0.582 | 1.451 | 0.06
COVID19_MODERNA | Middle ear effusion | 2 | 4.085 | 0.277 | 0.716 | 1.32 | 0.294 | 0.651 | 1.282 | 0.49 | 1.265 | 0.006
COVID19_MODERNA | Guillain-Barre syndrome | 18 | 33.542 | 0.469 | 0.716 | 1.005 | 0.39 | 0.566 | 0.799 | 0.537 | 0.306 | 27.371
COVID19_MODERNA | Face injury | 2 | 4.305 | 0.271 | 0.716 | 1.332 | 0.286 | 0.632 | 1.246 | 0.465 | 0.324 | 2.127
COVID19_MODERNA | Vitreous haemorrhage | 0 | 0.156 | 0.001 | 0.716 | 2.993 |  |  |  |  |  | 
COVID19_MODERNA | Umbilical cord abnormality | 0 | 0.195 | 0.003 | 0.716 | 2.768 |  |  |  |  |  | 
COVID19_MODERNA | Enterococcus test positive | 0 | 0.312 | 0.018 | 0.716 | 2.338 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy muscle | 0 | 0.377 | 0.032 | 0.716 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | Bronchoscopy normal | 0 | 0.628 | 0.091 | 0.716 | 1.832 |  |  |  |  |  | 
COVID19_MODERNA | Corneal reflex decreased | 2 | 3.308 | 0.276 | 0.715 | 1.321 | 0.329 | 0.725 | 1.427 | 0.605 | 3.288 | 1.102
COVID19_MODERNA | Application site warmth | 0 | 0.209 | 0.004 | 0.715 | 2.7 |  |  |  |  |  | 
COVID19_MODERNA | Skeletal injury | 0 | 0.429 | 0.044 | 0.715 | 2.087 |  |  |  |  |  | 
COVID19_MODERNA | Bronchoalveolar lavage abnormal | 0 | 0.3 | 0.016 | 0.715 | 2.371 |  |  |  |  |  | 
COVID19_MODERNA | Visual field tests abnormal | 0 | 0.679 | 0.102 | 0.715 | 1.786 |  |  |  |  |  | 
COVID19_MODERNA | Muscle haemorrhage | 0 | 0.39 | 0.035 | 0.715 | 2.159 |  |  |  |  |  | 
COVID19_MODERNA | Atrial septal defect | 1 | 1.7 | 0.129 | 0.714 | 1.688 | 0.307 | 0.752 | 1.599 | 0.588 | 0.796 | 0.053
COVID19_MODERNA | Systemic lupus erythematosus (SMQ) [algorithm] | 6 | 10.334 | 0.336 | 0.714 | 1.205 | 0.363 | 0.647 | 1.083 | 0.581 | 0.376 | 5.486
COVID19_MODERNA | Blister | 25 | 42.472 | 0.503 | 0.714 | 0.955 | 0.442 | 0.608 | 0.821 | 0.589 | 0.204 | 76.681
COVID19_MODERNA | Altered state of consciousness | 5 | 10.31 | 0.337 | 0.714 | 1.205 | 0.311 | 0.576 | 0.993 | 0.485 | 0.245 | 10.76
COVID19_MODERNA | CD4 lymphocytes normal | 0 | 0.239 | 0.007 | 0.714 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antibody | 0 | 0.127 | 0 | 0.714 | 3.209 |  |  |  |  |  | 
COVID19_MODERNA | Disseminated Bacillus Calmette-Guerin infection | 0 | 0.234 | 0.006 | 0.714 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Stupor | 0 | 0.27 | 0.011 | 0.714 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging head normal | 23 | 35.866 | 0.493 | 0.713 | 0.965 | 0.473 | 0.659 | 0.9 | 0.641 | 0.769 | 1.333
COVID19_MODERNA | Death neonatal | 0 | 0.08 | 0 | 0.713 | 3.682 |  |  |  |  |  | 
COVID19_MODERNA | Menarche | 0 | 0.117 | 0 | 0.713 | 3.296 |  |  |  |  |  | 
COVID19_MODERNA | Wound infection | 0 | 0.251 | 0.008 | 0.713 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Congenital naevus | 0 | 0.156 | 0.001 | 0.713 | 2.995 |  |  |  |  |  | 
COVID19_MODERNA | Anal erythema | 0 | 0.153 | 0.001 | 0.713 | 3.015 |  |  |  |  |  | 
COVID19_MODERNA | Abscess | 1 | 1.724 | 0.136 | 0.712 | 1.659 | 0.306 | 0.749 | 1.592 | 0.58 | 0.156 | 3.705
COVID19_MODERNA | Hypoacusis | 13 | 21.118 | 0.451 | 0.712 | 1.02 | 0.423 | 0.648 | 0.96 | 0.616 | 0.94 | 0.007
COVID19_MODERNA | Extraocular muscle paresis | 1 | 2.758 | 0.181 | 0.712 | 1.528 | 0.249 | 0.621 | 1.332 | 0.363 | 1.761 | 0.013
COVID19_MODERNA | Viral test | 2 | 5.243 | 0.26 | 0.712 | 1.345 | 0.253 | 0.563 | 1.114 | 0.381 | 0.363 | 1.603
COVID19_MODERNA | Human rhinovirus test | 0 | 0.932 | 0.15 | 0.712 | 1.616 |  |  |  |  |  | 
COVID19_MODERNA | Lymphoma | 0 | 0.766 | 0.118 | 0.712 | 1.719 |  |  |  |  |  | 
COVID19_MODERNA | Bronchitis | 4 | 7.116 | 0.302 | 0.711 | 1.258 | 0.339 | 0.655 | 1.168 | 0.562 | 0.203 | 11.625
COVID19_MODERNA | Vaccination site infection | 0 | 0.288 | 0.013 | 0.711 | 2.409 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral cyst | 0 | 0.156 | 0.001 | 0.711 | 2.997 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia urinary tract infection | 0 | 0.98 | 0.157 | 0.711 | 1.591 |  |  |  |  |  | 
COVID19_MODERNA | Genital herpes | 1 | 2.74 | 0.148 | 0.71 | 1.614 | 0.25 | 0.623 | 1.335 | 0.365 | 0.574 | 0.028
COVID19_MODERNA | Treatment failure | 0 | 0.156 | 0.001 | 0.71 | 2.998 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival hyperaemia | 0 | 0.897 | 0.141 | 0.71 | 1.635 |  |  |  |  |  | 
COVID19_MODERNA | Candida test positive | 0 | 0.351 | 0.024 | 0.71 | 2.245 |  |  |  |  |  | 
COVID19_MODERNA | Staphylococcal scalded skin syndrome | 0 | 0.312 | 0.017 | 0.71 | 2.343 |  |  |  |  |  | 
COVID19_MODERNA | Lividity | 0 | 0.239 | 0.006 | 0.71 | 2.578 |  |  |  |  |  | 
COVID19_MODERNA | Ankylosing spondylitis | 0 | 0.142 | 0 | 0.71 | 3.097 |  |  |  |  |  | 
COVID19_MODERNA | Faecal volume decreased | 0 | 0.273 | 0.01 | 0.71 | 2.458 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac failure acute | 4 | 6.648 | 0.3 | 0.709 | 1.259 | 0.354 | 0.685 | 1.221 | 0.602 | 4.932 | 7.319
COVID19_MODERNA | AST/ALT ratio abnormal | 0 | 0.117 | 0 | 0.709 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | HELLP syndrome | 0 | 0.234 | 0.005 | 0.709 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Cervical radiculopathy | 0 | 0.813 | 0.125 | 0.709 | 1.687 |  |  |  |  |  | 
COVID19_MODERNA | Diaphragmatic spasm | 0 | 0.117 | 0 | 0.709 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac telemetry abnormal | 0 | 0.117 | 0 | 0.709 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Mastoid disorder | 0 | 0.117 | 0 | 0.709 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell volume abnormal | 0 | 0.117 | 0 | 0.709 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Haematology test | 2 | 3.761 | 0.247 | 0.708 | 1.362 | 0.308 | 0.68 | 1.339 | 0.532 | 1.591 | 0.037
COVID19_MODERNA | Hyperthyroidism | 1 | 2.288 | 0.146 | 0.708 | 1.613 | 0.273 | 0.674 | 1.439 | 0.437 | 0.525 | 0.076
COVID19_MODERNA | Product prescribing error | 0 | 0.818 | 0.124 | 0.708 | 1.684 |  |  |  |  |  | 
COVID19_MODERNA | International normalised ratio | 10 | 15.274 | 0.411 | 0.707 | 1.069 | 0.429 | 0.69 | 1.064 | 0.655 | 4.653 | 21.039
COVID19_MODERNA | Neuralgia | 23 | 38.899 | 0.489 | 0.707 | 0.958 | 0.439 | 0.612 | 0.836 | 0.591 | 0.519 | 9.564
COVID19_MODERNA | Hangover | 1 | 2.181 | 0.191 | 0.707 | 1.489 | 0.279 | 0.687 | 1.465 | 0.459 | 1.897 | 0.004
COVID19_MODERNA | Lip pain | 1 | 2.518 | 0.171 | 0.707 | 1.542 | 0.261 | 0.647 | 1.384 | 0.397 | 0.514 | 0.091
COVID19_MODERNA | Intestinal haemorrhage | 0 | 0.16 | 0.001 | 0.707 | 2.974 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin saturation decreased | 0 | 0.39 | 0.031 | 0.707 | 2.165 |  |  |  |  |  | 
COVID19_MODERNA | Growth retardation | 0 | 0.354 | 0.024 | 0.707 | 2.241 |  |  |  |  |  | 
COVID19_MODERNA | Skull fracture | 0 | 0.287 | 0.012 | 0.707 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Diabetes insipidus | 0 | 0.207 | 0.003 | 0.707 | 2.718 |  |  |  |  |  | 
COVID19_MODERNA | Product contamination physical | 0 | 0.234 | 0.005 | 0.707 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Botulism | 0 | 0.117 | 0 | 0.707 | 3.298 |  |  |  |  |  | 
COVID19_MODERNA | Aspergillus test negative | 0 | 0.312 | 0.016 | 0.707 | 2.345 |  |  |  |  |  | 
COVID19_MODERNA | Apparent death | 0 | 0.424 | 0.038 | 0.707 | 2.101 |  |  |  |  |  | 
COVID19_MODERNA | Blood triglycerides normal | 1 | 2.221 | 0.171 | 0.706 | 1.537 | 0.276 | 0.682 | 1.455 | 0.45 | 0.822 | 0.073
COVID19_MODERNA | Epstein-Barr virus test | 1 | 2.318 | 0.244 | 0.706 | 1.361 | 0.271 | 0.67 | 1.431 | 0.431 | 0.503 | 0.107
COVID19_MODERNA | Blood alkaline phosphatase | 0 | 0.676 | 0.094 | 0.706 | 1.792 |  |  |  |  |  | 
COVID19_MODERNA | Parotitis | 0 | 0.148 | 0 | 0.706 | 3.052 |  |  |  |  |  | 
COVID19_MODERNA | Reticulocyte count | 0 | 0.349 | 0.022 | 0.706 | 2.251 |  |  |  |  |  | 
COVID19_MODERNA | Faeces hard | 0 | 0.341 | 0.021 | 0.706 | 2.272 |  |  |  |  |  | 
COVID19_MODERNA | CSF cell count normal | 1 | 2.29 | 0.12 | 0.705 | 1.69 | 0.273 | 0.674 | 1.438 | 0.437 | 0.32 | 0.812
COVID19_MODERNA | Pericardial haemorrhage | 0 | 0.312 | 0.015 | 0.705 | 2.347 |  |  |  |  |  | 
COVID19_MODERNA | Sensory level abnormal | 0 | 0.597 | 0.076 | 0.705 | 1.868 |  |  |  |  |  | 
COVID19_MODERNA | Rubella | 0 | 0.07 | 0 | 0.705 | 3.795 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site discomfort | 2 | 5.469 | 0.174 | 0.704 | 1.523 | 0.246 | 0.549 | 1.086 | 0.366 | 1.233 | 0.012
COVID19_MODERNA | Subileus | 0 | 0.156 | 0 | 0.704 | 3.002 |  |  |  |  |  | 
COVID19_MODERNA | Retinal oedema | 0 | 0.273 | 0.009 | 0.704 | 2.463 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy peripheral nerve abnormal | 0 | 0.312 | 0.015 | 0.704 | 2.347 |  |  |  |  |  | 
COVID19_MODERNA | Chromatopsia | 0 | 0.234 | 0.005 | 0.704 | 2.603 |  |  |  |  |  | 
COVID19_MODERNA | Bipolar disorder | 0 | 0.379 | 0.027 | 0.704 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cancer | 0 | 0.312 | 0.015 | 0.704 | 2.347 |  |  |  |  |  | 
COVID19_MODERNA | Pica | 0 | 0.273 | 0.009 | 0.704 | 2.463 |  |  |  |  |  | 
COVID19_MODERNA | Rectal tenesmus | 0 | 0.201 | 0.002 | 0.704 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory symptom | 2 | 4.314 | 0.316 | 0.703 | 1.212 | 0.285 | 0.631 | 1.245 | 0.464 | 0.452 | 0.802
COVID19_MODERNA | Skin premalignant disorders (SMQ) [narrow] | 0 | 0.286 | 0.011 | 0.703 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Injection site necrosis | 0 | 0.326 | 0.017 | 0.703 | 2.311 |  |  |  |  |  | 
COVID19_MODERNA | Oestradiol decreased | 0 | 0.195 | 0.002 | 0.703 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Blood bilirubin unconjugated normal | 0 | 0.204 | 0.002 | 0.703 | 2.735 |  |  |  |  |  | 
COVID19_MODERNA | Adnexal torsion | 0 | 0.156 | 0 | 0.703 | 3.003 |  |  |  |  |  | 
COVID19_MODERNA | Sudden infant death syndrome | 0 | 0.435 | 0.039 | 0.703 | 2.085 |  |  |  |  |  | 
COVID19_MODERNA | Skin premalignant disorders (SMQ) [broad] | 0 | 0.286 | 0.011 | 0.703 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Mycoplasma infection | 0 | 0.328 | 0.017 | 0.703 | 2.306 |  |  |  |  |  | 
COVID19_MODERNA | Neutrophil percentage decreased | 2 | 4.43 | 0.205 | 0.702 | 1.441 | 0.281 | 0.622 | 1.227 | 0.452 | 0.16 | 7.952
COVID19_MODERNA | Asthma exercise induced | 0 | 0.312 | 0.015 | 0.702 | 2.348 |  |  |  |  |  | 
COVID19_MODERNA | Norovirus test | 0 | 0.077 | 0 | 0.702 | 3.712 |  |  |  |  |  | 
COVID19_MODERNA | Joint manipulation | 0 | 0.195 | 0.002 | 0.702 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Lung abscess | 0 | 0.273 | 0.009 | 0.702 | 2.464 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal oedema | 1 | 1.841 | 0.083 | 0.701 | 1.821 | 0.298 | 0.732 | 1.558 | 0.543 | 0.747 | 0.024
COVID19_MODERNA | Vulval disorder | 0 | 0.195 | 0.002 | 0.701 | 2.78 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site abscess sterile | 0 | 0.156 | 0 | 0.701 | 3.004 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein increased | 0 | 0.156 | 0 | 0.701 | 3.004 |  |  |  |  |  | 
COVID19_MODERNA | Calcium ionised decreased | 0 | 0.166 | 0.001 | 0.701 | 2.942 |  |  |  |  |  | 
COVID19_MODERNA | CD4 lymphocytes decreased | 0 | 0.247 | 0.006 | 0.701 | 2.553 |  |  |  |  |  | 
COVID19_MODERNA | Streptococcus test negative | 9 | 15.83 | 0.409 | 0.7 | 1.054 | 0.376 | 0.619 | 0.97 | 0.569 | 0.377 | 8.49
COVID19_MODERNA | Ocular infections (SMQ) [broad] | 14 | 26.179 | 0.436 | 0.7 | 1.014 | 0.378 | 0.572 | 0.837 | 0.535 | 0.245 | 31.681
COVID19_MODERNA | Bowel movement irregularity | 1 | 2.384 | 0.195 | 0.7 | 1.457 | 0.268 | 0.662 | 1.415 | 0.419 | 0.465 | 0.181
COVID19_MODERNA | Visual field tests | 1 | 3.175 | 0.203 | 0.7 | 1.441 | 0.23 | 0.58 | 1.249 | 0.315 | 1.451 | 0.06
COVID19_MODERNA | Laryngitis | 1 | 2.059 | 0.176 | 0.699 | 1.505 | 0.285 | 0.703 | 1.497 | 0.486 | 0.233 | 1.779
COVID19_MODERNA | Eschar | 0 | 0.39 | 0.027 | 0.699 | 2.17 |  |  |  |  |  | 
COVID19_MODERNA | Bartonella test | 0 | 0.234 | 0.004 | 0.699 | 2.607 |  |  |  |  |  | 
COVID19_MODERNA | Myelitis transverse | 5 | 9.168 | 0.341 | 0.698 | 1.159 | 0.34 | 0.628 | 1.082 | 0.545 | 0.541 | 1.47
COVID19_MODERNA | Light chain analysis normal | 0 | 0.195 | 0.002 | 0.698 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Mite allergy | 0 | 0.179 | 0.001 | 0.698 | 2.868 |  |  |  |  |  | 
COVID19_MODERNA | Pneumocystis jirovecii infection | 0 | 0.156 | 0 | 0.698 | 3.006 |  |  |  |  |  | 
COVID19_MODERNA | Hyperthyroidism (SMQ) [narrow] | 1 | 3.27 | 0.127 | 0.697 | 1.643 | 0.226 | 0.571 | 1.232 | 0.306 | 0.239 | 1.674
COVID19_MODERNA | Antineutrophil cytoplasmic antibody positive | 0 | 0.307 | 0.012 | 0.697 | 2.366 |  |  |  |  |  | 
COVID19_MODERNA | Dependence on respirator | 0 | 0.195 | 0.001 | 0.697 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin M increased | 0 | 0.28 | 0.009 | 0.697 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Renal colic | 0 | 0.195 | 0.001 | 0.697 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Injury corneal | 0 | 0.18 | 0.001 | 0.697 | 2.862 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging whole body | 0 | 0.273 | 0.008 | 0.697 | 2.468 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic fibrosis | 0 | 0.195 | 0.002 | 0.697 | 2.783 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord oedema | 0 | 0.233 | 0.004 | 0.696 | 2.614 |  |  |  |  |  | 
COVID19_MODERNA | Stertor | 0 | 0.156 | 0 | 0.696 | 3.007 |  |  |  |  |  | 
COVID19_MODERNA | Gamma-glutamyltransferase | 0 | 0.258 | 0.006 | 0.696 | 2.517 |  |  |  |  |  | 
COVID19_MODERNA | Blood glucose fluctuation | 0 | 0.959 | 0.138 | 0.696 | 1.604 |  |  |  |  |  | 
COVID19_MODERNA | Bursa injury | 0 | 0.539 | 0.057 | 0.696 | 1.938 |  |  |  |  |  | 
COVID19_MODERNA | Drug level increased | 0 | 0.117 | 0 | 0.695 | 3.3 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cyst | 0 | 0.174 | 0.001 | 0.695 | 2.899 |  |  |  |  |  | 
COVID19_MODERNA | Opportunistic infections (SMQ) [narrow] | 7 | 13.792 | 0.341 | 0.694 | 1.148 | 0.333 | 0.576 | 0.94 | 0.508 | 0.171 | 27.19
COVID19_MODERNA | Haematological malignant tumours (SMQ) [broad] | 5 | 11.083 | 0.338 | 0.694 | 1.152 | 0.294 | 0.545 | 0.941 | 0.451 | 0.553 | 1.343
COVID19_MODERNA | Haematological malignant tumours (SMQ) [narrow] | 5 | 11.083 | 0.338 | 0.694 | 1.152 | 0.294 | 0.545 | 0.941 | 0.451 | 0.553 | 1.343
COVID19_MODERNA | Light chain analysis abnormal | 0 | 0.156 | 0 | 0.694 | 3.008 |  |  |  |  |  | 
COVID19_MODERNA | Intermittent claudication | 0 | 0.195 | 0.001 | 0.694 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Milk allergy | 0 | 0.529 | 0.054 | 0.694 | 1.951 |  |  |  |  |  | 
COVID19_MODERNA | Progesterone decreased | 0 | 0.214 | 0.002 | 0.694 | 2.693 |  |  |  |  |  | 
COVID19_MODERNA | Muscle twitching | 21 | 32.716 | 0.483 | 0.693 | 0.934 | 0.468 | 0.662 | 0.914 | 0.642 | 0.634 | 3.976
COVID19_MODERNA | Blood heavy metal increased | 0 | 0.335 | 0.016 | 0.693 | 2.294 |  |  |  |  |  | 
COVID19_MODERNA | Cold agglutinins | 0 | 0.156 | 0 | 0.693 | 3.008 |  |  |  |  |  | 
COVID19_MODERNA | Genital erythema | 0 | 0.273 | 0.007 | 0.693 | 2.47 |  |  |  |  |  | 
COVID19_MODERNA | Retinal detachment | 0 | 0.294 | 0.01 | 0.693 | 2.404 |  |  |  |  |  | 
COVID19_MODERNA | Poliovirus test positive | 0 | 0.156 | 0 | 0.693 | 3.008 |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland pain | 0 | 0.196 | 0.001 | 0.693 | 2.778 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral nerve lesion | 0 | 0.351 | 0.018 | 0.693 | 2.256 |  |  |  |  |  | 
COVID19_MODERNA | Haptoglobin normal | 0 | 0.351 | 0.018 | 0.693 | 2.256 |  |  |  |  |  | 
COVID19_MODERNA | Lacrimation disorder | 0 | 0.351 | 0.018 | 0.693 | 2.256 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram PR interval | 0 | 0.39 | 0.025 | 0.693 | 2.173 |  |  |  |  |  | 
COVID19_MODERNA | Enthesopathy | 0 | 0.385 | 0.024 | 0.693 | 2.182 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B DNA decreased | 0 | 0.195 | 0.001 | 0.693 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Skin atrophy | 0 | 0.39 | 0.025 | 0.693 | 2.173 |  |  |  |  |  | 
COVID19_MODERNA | Cataract operation | 0 | 1.108 | 0.159 | 0.693 | 1.534 |  |  |  |  |  | 
COVID19_MODERNA | Dyskinesia (SMQ) [broad] | 61 | 89.98 | 0.555 | 0.692 | 0.84 | 0.555 | 0.684 | 0.836 | 0.678 | 0.501 | 29.545
COVID19_MODERNA | Neutropenia | 2 | 3.277 | 0.229 | 0.692 | 1.359 | 0.331 | 0.728 | 1.433 | 0.61 | 0.292 | 2.709
COVID19_MODERNA | Ultrasound abdomen normal | 1 | 2.606 | 0.172 | 0.692 | 1.496 | 0.256 | 0.637 | 1.365 | 0.384 | 0.093 | 7.857
COVID19_MODERNA | Pseudomonas test positive | 0 | 0.165 | 0 | 0.692 | 2.95 |  |  |  |  |  | 
COVID19_MODERNA | Floppy infant | 0 | 0.222 | 0.003 | 0.692 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Idiopathic intracranial hypertension | 0 | 0.328 | 0.014 | 0.692 | 2.313 |  |  |  |  |  | 
COVID19_MODERNA | Blood osmolarity normal | 0 | 0.234 | 0.004 | 0.692 | 2.612 |  |  |  |  |  | 
COVID19_MODERNA | Atrial tachycardia | 0 | 0.351 | 0.018 | 0.692 | 2.257 |  |  |  |  |  | 
COVID19_MODERNA | Hyperreflexia | 1 | 3.792 | 0.142 | 0.691 | 1.576 | 0.205 | 0.527 | 1.144 | 0.264 | 0.324 | 0.781
COVID19_MODERNA | Exercise lack of | 0 | 0.156 | 0 | 0.691 | 3.009 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory syncytial virus infection | 0 | 0.339 | 0.016 | 0.691 | 2.285 |  |  |  |  |  | 
COVID19_MODERNA | Arteriospasm coronary | 0 | 0.156 | 0 | 0.691 | 3.009 |  |  |  |  |  | 
COVID19_MODERNA | Bladder pain | 0 | 0.657 | 0.078 | 0.691 | 1.813 |  |  |  |  |  | 
COVID19_MODERNA | Eczema infantile | 0 | 0.2 | 0.001 | 0.69 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | HLA-B*27 positive | 0 | 0.351 | 0.017 | 0.69 | 2.258 |  |  |  |  |  | 
COVID19_MODERNA | Viral upper respiratory tract infection | 0 | 0.538 | 0.053 | 0.69 | 1.941 |  |  |  |  |  | 
COVID19_MODERNA | Melanocytic naevus | 0 | 0.273 | 0.007 | 0.689 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Gingivitis | 0 | 0.685 | 0.082 | 0.689 | 1.788 |  |  |  |  |  | 
COVID19_MODERNA | Culture throat | 0 | 1.136 | 0.159 | 0.689 | 1.522 |  |  |  |  |  | 
COVID19_MODERNA | Tilt table test | 0 | 0.142 | 0 | 0.689 | 3.104 |  |  |  |  |  | 
COVID19_MODERNA | Muscle abscess | 0 | 0.273 | 0.007 | 0.689 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Nasal oedema | 1 | 1.776 | 0.206 | 0.688 | 1.398 | 0.302 | 0.741 | 1.577 | 0.563 | 1.541 | 0.041
COVID19_MODERNA | Differential white blood cell count normal | 7 | 11.382 | 0.398 | 0.688 | 1.043 | 0.387 | 0.669 | 1.092 | 0.615 | 1.1 | 0.002
COVID19_MODERNA | Antinuclear antibody | 4 | 6.847 | 0.341 | 0.688 | 1.133 | 0.347 | 0.672 | 1.198 | 0.584 | 0.742 | 0.137
COVID19_MODERNA | Lower respiratory tract infection | 1 | 2.178 | 0.079 | 0.688 | 1.799 | 0.279 | 0.687 | 1.466 | 0.459 | 0.121 | 5.448
COVID19_MODERNA | Wrist fracture | 0 | 0.649 | 0.074 | 0.688 | 1.821 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor C4 decreased | 0 | 0.196 | 0.001 | 0.688 | 2.785 |  |  |  |  |  | 
COVID19_MODERNA | Pain assessment | 0 | 0.195 | 0.001 | 0.688 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Cerebellar syndrome | 0 | 0.07 | 0 | 0.688 | 3.762 |  |  |  |  |  | 
COVID19_MODERNA | Serology normal | 0 | 0.73 | 0.09 | 0.688 | 1.751 |  |  |  |  |  | 
COVID19_MODERNA | Intrusive thoughts | 0 | 0.273 | 0.007 | 0.688 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Cold urticaria | 0 | 0.39 | 0.023 | 0.688 | 2.175 |  |  |  |  |  | 
COVID19_MODERNA | Limb deformity | 0 | 0.273 | 0.006 | 0.687 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Injection site eczema | 0 | 0.275 | 0.007 | 0.687 | 2.466 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C virus test | 0 | 0.536 | 0.051 | 0.687 | 1.944 |  |  |  |  |  | 
COVID19_MODERNA | Alpha hydroxybutyrate dehydrogenase increased | 0 | 0.234 | 0.003 | 0.687 | 2.614 |  |  |  |  |  | 
COVID19_MODERNA | Blood thyroid stimulating hormone abnormal | 0 | 0.195 | 0.001 | 0.687 | 2.789 |  |  |  |  |  | 
COVID19_MODERNA | Myofascial pain syndrome | 0 | 0.39 | 0.023 | 0.687 | 2.176 |  |  |  |  |  | 
COVID19_MODERNA | Candida infection | 1 | 2.077 | 0.149 | 0.686 | 1.542 | 0.284 | 0.7 | 1.493 | 0.482 | 0.385 | 0.438
COVID19_MODERNA | DNA antibody negative | 0 | 0.175 | 0.001 | 0.686 | 2.892 |  |  |  |  |  | 
COVID19_MODERNA | Enterococcal infection | 0 | 0.234 | 0.003 | 0.686 | 2.615 |  |  |  |  |  | 
COVID19_MODERNA | Rectal prolapse | 0 | 0.244 | 0.004 | 0.686 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram ST segment normal | 0 | 0.194 | 0.001 | 0.686 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin A | 0 | 0.689 | 0.081 | 0.686 | 1.785 |  |  |  |  |  | 
COVID19_MODERNA | Multiple allergies | 1 | 1.605 | 0.119 | 0.685 | 1.633 | 0.313 | 0.767 | 1.629 | 0.623 | 0.725 | 0.014
COVID19_MODERNA | Blood glucose | 14 | 23.665 | 0.449 | 0.685 | 0.961 | 0.412 | 0.624 | 0.914 | 0.592 | 1.521 | 1.871
COVID19_MODERNA | Yellow skin | 1 | 2.59 | 0.229 | 0.685 | 1.339 | 0.257 | 0.639 | 1.368 | 0.386 | 0.262 | 1.363
COVID19_MODERNA | Romberg test | 0 | 0.312 | 0.011 | 0.685 | 2.359 |  |  |  |  |  | 
COVID19_MODERNA | Hormone replacement therapy | 0 | 0.117 | 0 | 0.685 | 3.299 |  |  |  |  |  | 
COVID19_MODERNA | Juvenile idiopathic arthritis | 0 | 0.256 | 0.005 | 0.685 | 2.53 |  |  |  |  |  | 
COVID19_MODERNA | Oesophageal papilloma | 0 | 0.117 | 0 | 0.685 | 3.299 |  |  |  |  |  | 
COVID19_MODERNA | Dyschezia | 0 | 0.364 | 0.018 | 0.685 | 2.23 |  |  |  |  |  | 
COVID19_MODERNA | Ovulation pain | 0 | 0.117 | 0 | 0.685 | 3.299 |  |  |  |  |  | 
COVID19_MODERNA | Endocrine disorder | 0 | 0.234 | 0.003 | 0.685 | 2.616 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy bone marrow normal | 0 | 0.35 | 0.016 | 0.684 | 2.264 |  |  |  |  |  | 
COVID19_MODERNA | Application site pain | 0 | 0.242 | 0.003 | 0.684 | 2.583 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal infection | 0 | 0.182 | 0.001 | 0.684 | 2.856 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia test negative | 0 | 0.307 | 0.01 | 0.684 | 2.373 |  |  |  |  |  | 
COVID19_MODERNA | Transferrin | 0 | 0.195 | 0.001 | 0.684 | 2.79 |  |  |  |  |  | 
COVID19_MODERNA | Culture tissue specimen negative | 0 | 0.273 | 0.006 | 0.683 | 2.476 |  |  |  |  |  | 
COVID19_MODERNA | Glucose tolerance test normal | 0 | 0.351 | 0.015 | 0.683 | 2.262 |  |  |  |  |  | 
COVID19_MODERNA | Executive dysfunction | 0 | 0.195 | 0.001 | 0.683 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | Gingival discomfort | 0 | 0.312 | 0.01 | 0.683 | 2.36 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterium tuberculosis complex test | 0 | 0.374 | 0.019 | 0.683 | 2.209 |  |  |  |  |  | 
COVID19_MODERNA | Sigmoidoscopy | 0 | 0.156 | 0 | 0.683 | 3.011 |  |  |  |  |  | 
COVID19_MODERNA | Mononeuritis | 0 | 0.312 | 0.01 | 0.682 | 2.36 |  |  |  |  |  | 
COVID19_MODERNA | Overlap syndrome | 0 | 0.156 | 0 | 0.682 | 3.011 |  |  |  |  |  | 
COVID19_MODERNA | Decreased eye contact | 0 | 0.749 | 0.089 | 0.682 | 1.737 |  |  |  |  |  | 
COVID19_MODERNA | Educational problem | 0 | 0.123 | 0 | 0.682 | 3.247 |  |  |  |  |  | 
COVID19_MODERNA | Platelet morphology normal | 0 | 0.273 | 0.006 | 0.682 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Oral lichen planus | 0 | 0.273 | 0.006 | 0.682 | 2.476 |  |  |  |  |  | 
COVID19_MODERNA | Parapsoriasis | 0 | 0.312 | 0.01 | 0.682 | 2.36 |  |  |  |  |  | 
COVID19_MODERNA | FEV1/FVC ratio decreased | 0 | 0.117 | 0 | 0.681 | 3.298 |  |  |  |  |  | 
COVID19_MODERNA | Immunoelectrophoresis | 0 | 0.39 | 0.021 | 0.681 | 2.178 |  |  |  |  |  | 
COVID19_MODERNA | Burning mouth syndrome | 0 | 0.149 | 0 | 0.681 | 3.056 |  |  |  |  |  | 
COVID19_MODERNA | Learning disorder | 0 | 0.182 | 0.001 | 0.681 | 2.859 |  |  |  |  |  | 
COVID19_MODERNA | Plateletcrit | 0 | 0.204 | 0.001 | 0.681 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Relapsing-remitting multiple sclerosis | 0 | 0.22 | 0.002 | 0.681 | 2.675 |  |  |  |  |  | 
COVID19_MODERNA | Parotid gland enlargement | 0 | 0.236 | 0.003 | 0.68 | 2.609 |  |  |  |  |  | 
COVID19_MODERNA | Sarcoidosis | 0 | 0.472 | 0.035 | 0.68 | 2.035 |  |  |  |  |  | 
COVID19_MODERNA | Neuromyopathy | 0 | 0.39 | 0.021 | 0.68 | 2.179 |  |  |  |  |  | 
COVID19_MODERNA | Upper limb fracture | 0 | 1.091 | 0.144 | 0.68 | 1.54 |  |  |  |  |  | 
COVID19_MODERNA | Blood creatine phosphokinase MB normal | 0 | 0.273 | 0.005 | 0.68 | 2.478 |  |  |  |  |  | 
COVID19_MODERNA | Acoustic stimulation tests abnormal | 6 | 9.565 | 0.333 | 0.679 | 1.124 | 0.385 | 0.685 | 1.146 | 0.627 | 2.242 | 2.692
COVID19_MODERNA | Ultrasound abdomen | 3 | 5.062 | 0.237 | 0.679 | 1.306 | 0.34 | 0.694 | 1.293 | 0.593 | 0.448 | 1.476
COVID19_MODERNA | Human chorionic gonadotropin increased | 0 | 0.312 | 0.009 | 0.679 | 2.362 |  |  |  |  |  | 
COVID19_MODERNA | Quadriparesis | 0 | 0.263 | 0.005 | 0.679 | 2.511 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem auditory evoked response | 0 | 0.351 | 0.015 | 0.679 | 2.263 |  |  |  |  |  | 
COVID19_MODERNA | Brain neoplasm | 0 | 0.335 | 0.012 | 0.679 | 2.3 |  |  |  |  |  | 
COVID19_MODERNA | Dyssomnia | 0 | 0.195 | 0.001 | 0.679 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | X-ray with contrast lower gastrointestinal tract abnormal | 0 | 0.117 | 0 | 0.679 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Organic acid analysis | 0 | 0.195 | 0.001 | 0.679 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Episcleritis | 0 | 0.351 | 0.014 | 0.679 | 2.263 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to toxic agent | 0 | 0.273 | 0.005 | 0.679 | 2.478 |  |  |  |  |  | 
COVID19_MODERNA | Loss of personal independence in daily activities | 51 | 79.112 | 0.533 | 0.678 | 0.837 | 0.52 | 0.653 | 0.813 | 0.645 | 0.411 | 42.159
COVID19_MODERNA | Cardioversion | 9 | 15.178 | 0.407 | 0.678 | 1.005 | 0.39 | 0.64 | 1.004 | 0.593 | 4.439 | 17.404
COVID19_MODERNA | Bronchial obstruction | 0 | 0.312 | 0.009 | 0.678 | 2.362 |  |  |  |  |  | 
COVID19_MODERNA | Capsule endoscopy | 0 | 0.195 | 0.001 | 0.678 | 2.792 |  |  |  |  |  | 
COVID19_MODERNA | Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 0 | 0.398 | 0.021 | 0.678 | 2.163 |  |  |  |  |  | 
COVID19_MODERNA | Administration site rash | 0 | 0.647 | 0.067 | 0.678 | 1.824 |  |  |  |  |  | 
COVID19_MODERNA | Glucose-6-phosphate dehydrogenase | 0 | 0.156 | 0 | 0.677 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Bladder irritation | 0 | 0.156 | 0 | 0.677 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Coronavirus infection | 0 | 0.481 | 0.035 | 0.677 | 2.022 |  |  |  |  |  | 
COVID19_MODERNA | Histology | 0 | 0.273 | 0.005 | 0.677 | 2.479 |  |  |  |  |  | 
COVID19_MODERNA | Periorbital cellulitis | 0 | 0.39 | 0.02 | 0.677 | 2.18 |  |  |  |  |  | 
COVID19_MODERNA | Epicondylitis | 0 | 0.589 | 0.055 | 0.677 | 1.884 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal haemorrhage | 0 | 0.188 | 0.001 | 0.677 | 2.829 |  |  |  |  |  | 
COVID19_MODERNA | Blood thyroid stimulating hormone decreased | 2 | 3.679 | 0.24 | 0.676 | 1.291 | 0.312 | 0.688 | 1.354 | 0.544 | 0.783 | 0
COVID19_MODERNA | Pelvic venous thrombosis | 0 | 0.207 | 0.001 | 0.676 | 2.735 |  |  |  |  |  | 
COVID19_MODERNA | Application site reaction | 0 | 0.21 | 0.001 | 0.676 | 2.72 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac electrophysiologic study normal | 0 | 0.234 | 0.002 | 0.676 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Otoscopy normal | 0 | 0.39 | 0.02 | 0.676 | 2.18 |  |  |  |  |  | 
COVID19_MODERNA | Testicular swelling | 0 | 0.677 | 0.072 | 0.676 | 1.797 |  |  |  |  |  | 
COVID19_MODERNA | Hyperacusis | 6 | 9.773 | 0.316 | 0.675 | 1.144 | 0.379 | 0.675 | 1.129 | 0.614 | 0.416 | 4.273
COVID19_MODERNA | Angiogram cerebral normal | 8 | 13.07 | 0.382 | 0.675 | 1.034 | 0.393 | 0.661 | 1.056 | 0.612 | 6.364 | 24.487
COVID19_MODERNA | Full blood count abnormal | 4 | 9.07 | 0.345 | 0.674 | 1.093 | 0.285 | 0.553 | 0.988 | 0.441 | 0.85 | 0.007
COVID19_MODERNA | Lymphocyte count normal | 3 | 7.253 | 0.272 | 0.674 | 1.222 | 0.268 | 0.553 | 1.032 | 0.414 | 0.454 | 1.419
COVID19_MODERNA | Endoscopy upper gastrointestinal tract normal | 0 | 0.351 | 0.013 | 0.674 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | Personality disorder | 0 | 0.289 | 0.006 | 0.674 | 2.43 |  |  |  |  |  | 
COVID19_MODERNA | Neurodegenerative disorder | 0 | 0.234 | 0.002 | 0.674 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell microcytes present | 0 | 0.312 | 0.009 | 0.674 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Tracheal aspiration procedure | 0 | 0.273 | 0.005 | 0.674 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory syncytial virus bronchiolitis | 0 | 0.2 | 0.001 | 0.674 | 2.768 |  |  |  |  |  | 
COVID19_MODERNA | Oculorespiratory syndrome | 0 | 0.201 | 0.001 | 0.674 | 2.762 |  |  |  |  |  | 
COVID19_MODERNA | Erythema infectiosum | 0 | 0.312 | 0.008 | 0.673 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Eczema infected | 0 | 0.273 | 0.005 | 0.673 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Coagulation factor X level normal | 0 | 0.132 | 0 | 0.673 | 3.176 |  |  |  |  |  | 
COVID19_MODERNA | Pupillary light reflex tests normal | 0 | 0.39 | 0.019 | 0.673 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Product contamination microbial | 0 | 0.156 | 0 | 0.673 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Obliterative bronchiolitis | 0 | 0.234 | 0.002 | 0.673 | 2.621 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac valve disease | 0 | 0.312 | 0.008 | 0.672 | 2.364 |  |  |  |  |  | 
COVID19_MODERNA | Cryoglobulins absent | 0 | 0.344 | 0.012 | 0.672 | 2.281 |  |  |  |  |  | 
COVID19_MODERNA | Nerve block | 0 | 0.371 | 0.016 | 0.672 | 2.221 |  |  |  |  |  | 
COVID19_MODERNA | Phantom limb syndrome | 0 | 0.253 | 0.003 | 0.672 | 2.547 |  |  |  |  |  | 
COVID19_MODERNA | Product appearance confusion | 0 | 0.287 | 0.006 | 0.672 | 2.435 |  |  |  |  |  | 
COVID19_MODERNA | Skin striae | 0 | 0.337 | 0.011 | 0.672 | 2.298 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic pneumonia (SMQ) [narrow] | 3 | 6.015 | 0.249 | 0.671 | 1.259 | 0.305 | 0.625 | 1.165 | 0.499 | 0.936 | 0.03
COVID19_MODERNA | Areflexia | 1 | 3.166 | 0.127 | 0.671 | 1.568 | 0.231 | 0.581 | 1.251 | 0.316 | 0.123 | 5.37
COVID19_MODERNA | Iritis | 0 | 0.321 | 0.009 | 0.671 | 2.339 |  |  |  |  |  | 
COVID19_MODERNA | Ex-tobacco user | 0 | 0.117 | 0 | 0.671 | 3.293 |  |  |  |  |  | 
COVID19_MODERNA | Tongue pruritus | 13 | 19.968 | 0.411 | 0.67 | 0.98 | 0.443 | 0.68 | 1.006 | 0.651 | 4.163 | 23.998
COVID19_MODERNA | Immunodeficiency | 1 | 2.512 | 0.159 | 0.67 | 1.468 | 0.261 | 0.648 | 1.386 | 0.398 | 0.188 | 2.687
COVID19_MODERNA | Vaccination site abscess | 0 | 0.329 | 0.01 | 0.67 | 2.319 |  |  |  |  |  | 
COVID19_MODERNA | Pneumocystis test positive | 0 | 0.156 | 0 | 0.67 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Application site oedema | 0 | 0.169 | 0 | 0.67 | 2.932 |  |  |  |  |  | 
COVID19_MODERNA | Administration site swelling | 0 | 1.038 | 0.127 | 0.67 | 1.563 |  |  |  |  |  | 
COVID19_MODERNA | Cushing's syndrome | 0 | 0.156 | 0 | 0.67 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal operation | 0 | 0.19 | 0.001 | 0.67 | 2.818 |  |  |  |  |  | 
COVID19_MODERNA | Computerised tomogram pelvis | 5 | 7.936 | 0.322 | 0.669 | 1.116 | 0.376 | 0.695 | 1.197 | 0.63 | 1.541 | 0.443
COVID19_MODERNA | Peritonsillar abscess | 0 | 0.273 | 0.004 | 0.669 | 2.482 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [broad] | 80 | 133.655 | 0.55 | 0.668 | 0.794 | 0.503 | 0.605 | 0.722 | 0.599 | 0.568 | 25.514
COVID19_MODERNA | Cafe au lait spots | 0 | 0.2 | 0.001 | 0.668 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Cellulitis orbital | 0 | 0.26 | 0.003 | 0.668 | 2.525 |  |  |  |  |  | 
COVID19_MODERNA | Glossitis | 0 | 0.981 | 0.117 | 0.668 | 1.591 |  |  |  |  |  | 
COVID19_MODERNA | Poor feeding infant | 0 | 0.525 | 0.039 | 0.667 | 1.963 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian malignant tumours (SMQ) [narrow] | 0 | 0.801 | 0.087 | 0.667 | 1.699 |  |  |  |  |  | 
COVID19_MODERNA | Enteral nutrition | 0 | 0.234 | 0.002 | 0.667 | 2.622 |  |  |  |  |  | 
COVID19_MODERNA | Sepsis neonatal | 0 | 0.351 | 0.012 | 0.667 | 2.267 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram T wave peaked | 0 | 0.234 | 0.002 | 0.667 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Scar | 1 | 3.523 | 0.183 | 0.666 | 1.396 | 0.216 | 0.549 | 1.188 | 0.284 | 0.126 | 5.136
COVID19_MODERNA | Addison's disease | 0 | 0.351 | 0.012 | 0.666 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Brain malformation | 0 | 0.195 | 0.001 | 0.666 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Forced vital capacity | 0 | 0.156 | 0 | 0.666 | 3.012 |  |  |  |  |  | 
COVID19_MODERNA | Herpes virus test | 0 | 0.576 | 0.047 | 0.666 | 1.901 |  |  |  |  |  | 
COVID19_MODERNA | Male sexual dysfunction | 0 | 0.195 | 0.001 | 0.666 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Blood folate decreased | 0 | 0.351 | 0.012 | 0.666 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Blepharospasm | 5 | 8.455 | 0.347 | 0.665 | 1.067 | 0.36 | 0.665 | 1.146 | 0.591 | 1.045 | 0.019
COVID19_MODERNA | Urine ketone body absent | 1 | 2.742 | 0.195 | 0.665 | 1.363 | 0.25 | 0.623 | 1.335 | 0.365 | 0.352 | 0.604
COVID19_MODERNA | Breast discharge | 0 | 0.193 | 0 | 0.665 | 2.806 |  |  |  |  |  | 
COVID19_MODERNA | Positron emission tomogram abnormal | 0 | 0.43 | 0.022 | 0.665 | 2.107 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis viral test negative | 1 | 2.832 | 0.125 | 0.664 | 1.551 | 0.246 | 0.613 | 1.316 | 0.353 | 0.287 | 1.097
COVID19_MODERNA | Metabolic function test abnormal | 2 | 5.069 | 0.198 | 0.664 | 1.354 | 0.258 | 0.575 | 1.136 | 0.395 | 1.265 | 0.006
COVID19_MODERNA | Brachial plexopathy | 0 | 0.406 | 0.018 | 0.664 | 2.152 |  |  |  |  |  | 
COVID19_MODERNA | X-ray dental normal | 0 | 0.682 | 0.064 | 0.664 | 1.793 |  |  |  |  |  | 
COVID19_MODERNA | Type 2 lepra reaction | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Neurogenic bowel | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Neuroendocrine tumour | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Retroperitoneal mass | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Neurilemmoma benign | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Lack of satiety | 0 | 0.195 | 0.001 | 0.664 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Intraocular pressure decreased | 0 | 0.117 | 0 | 0.664 | 3.289 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis minimal lesion | 0 | 0.39 | 0.016 | 0.664 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | Audiogram abnormal | 3 | 6.927 | 0.325 | 0.663 | 1.098 | 0.277 | 0.57 | 1.064 | 0.433 | 1.681 | 0.254
COVID19_MODERNA | Talipes | 0 | 0.312 | 0.007 | 0.663 | 2.367 |  |  |  |  |  | 
COVID19_MODERNA | Microbiology test normal | 0 | 0.758 | 0.077 | 0.663 | 1.73 |  |  |  |  |  | 
COVID19_MODERNA | Pulmonary thrombosis | 0 | 0.323 | 0.008 | 0.663 | 2.338 |  |  |  |  |  | 
COVID19_MODERNA | Acanthosis | 0 | 0.234 | 0.002 | 0.663 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Aspiration bone marrow abnormal | 0 | 0.251 | 0.002 | 0.662 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Performance status decreased | 0 | 0.334 | 0.009 | 0.662 | 2.308 |  |  |  |  |  | 
COVID19_MODERNA | Type I hypersensitivity | 0 | 0.171 | 0 | 0.662 | 2.92 |  |  |  |  |  | 
COVID19_MODERNA | Laryngeal disorder | 0 | 0.206 | 0.001 | 0.662 | 2.744 |  |  |  |  |  | 
COVID19_MODERNA | Lichen planus | 0 | 0.24 | 0.002 | 0.661 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Faecal calprotectin increased | 0 | 0.224 | 0.001 | 0.661 | 2.664 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound joint | 0 | 0.714 | 0.068 | 0.661 | 1.766 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy intestine abnormal | 0 | 0.273 | 0.004 | 0.661 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Lung assist device therapy | 0 | 0.222 | 0.001 | 0.661 | 2.671 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy and neonatal topics (SMQ) [broad] | 106 | 173 | 0.559 | 0.66 | 0.768 | 0.526 | 0.617 | 0.721 | 0.613 | 0.504 | 51.13
COVID19_MODERNA | Pleurisy | 2 | 4.537 | 0.252 | 0.66 | 1.223 | 0.277 | 0.614 | 1.211 | 0.441 | 1.096 | 0.062
COVID19_MODERNA | Scleroderma | 0 | 0.348 | 0.01 | 0.66 | 2.276 |  |  |  |  |  | 
COVID19_MODERNA | Blood folate normal | 1 | 2.311 | 0.12 | 0.659 | 1.553 | 0.272 | 0.671 | 1.433 | 0.433 | 0.574 | 0.028
COVID19_MODERNA | Product name confusion | 0 | 0.421 | 0.019 | 0.659 | 2.124 |  |  |  |  |  | 
COVID19_MODERNA | Alopecia totalis | 0 | 0.234 | 0.001 | 0.659 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Spinal cord disorder | 0 | 0.662 | 0.058 | 0.659 | 1.811 |  |  |  |  |  | 
COVID19_MODERNA | Enterovirus test negative | 0 | 0.647 | 0.055 | 0.659 | 1.826 |  |  |  |  |  | 
COVID19_MODERNA | Scan normal | 0 | 0.9 | 0.096 | 0.658 | 1.635 |  |  |  |  |  | 
COVID19_MODERNA | Nonspecific reaction | 0 | 0.476 | 0.027 | 0.658 | 2.034 |  |  |  |  |  | 
COVID19_MODERNA | Respirovirus test positive | 0 | 0.317 | 0.007 | 0.658 | 2.354 |  |  |  |  |  | 
COVID19_MODERNA | Oppositional defiant disorder | 0 | 0.234 | 0.001 | 0.658 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Bacteraemia | 1 | 2.585 | 0.053 | 0.657 | 1.831 | 0.258 | 0.64 | 1.369 | 0.387 | 0.23 | 1.815
COVID19_MODERNA | Nerve stimulation test normal | 0 | 0.234 | 0.001 | 0.657 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Smallpox | 0 | 0.273 | 0.003 | 0.657 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C | 0 | 0.273 | 0.003 | 0.657 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Tubulointerstitial nephritis | 0 | 0.417 | 0.018 | 0.657 | 2.132 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [narrow] | 78 | 132.615 | 0.539 | 0.656 | 0.782 | 0.494 | 0.595 | 0.711 | 0.588 | 0.557 | 26.749
COVID19_MODERNA | Renal function test normal | 1 | 2.138 | 0.103 | 0.656 | 1.604 | 0.281 | 0.692 | 1.477 | 0.468 | 0.156 | 3.705
COVID19_MODERNA | Conjunctival disorders (SMQ) [narrow] | 12 | 21.585 | 0.396 | 0.656 | 0.968 | 0.383 | 0.596 | 0.894 | 0.556 | 0.391 | 10.585
COVID19_MODERNA | Conjunctival disorders (SMQ) [broad] | 12 | 21.585 | 0.396 | 0.656 | 0.968 | 0.383 | 0.596 | 0.894 | 0.556 | 0.391 | 10.585
COVID19_MODERNA | Trigeminal neuralgia | 1 | 2.558 | 0.111 | 0.656 | 1.573 | 0.259 | 0.643 | 1.375 | 0.391 | 0.29 | 1.065
COVID19_MODERNA | CSF test | 1 | 3.173 | 0.128 | 0.656 | 1.519 | 0.23 | 0.58 | 1.25 | 0.315 | 0.183 | 2.836
COVID19_MODERNA | Vaccination site scab | 0 | 0.271 | 0.003 | 0.656 | 2.489 |  |  |  |  |  | 
COVID19_MODERNA | Phobia | 0 | 0.36 | 0.011 | 0.656 | 2.248 |  |  |  |  |  | 
COVID19_MODERNA | Stem cell transplant | 0 | 0.35 | 0.009 | 0.656 | 2.272 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance neurography | 0 | 0.273 | 0.003 | 0.656 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Injection site nerve damage | 0 | 0.957 | 0.103 | 0.656 | 1.602 |  |  |  |  |  | 
COVID19_MODERNA | Exposure during pregnancy | 74 | 124.12 | 0.535 | 0.655 | 0.784 | 0.498 | 0.603 | 0.725 | 0.596 | 0.662 | 12.206
COVID19_MODERNA | Dermatitis infected | 0 | 0.273 | 0.003 | 0.655 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Amputation | 0 | 0.115 | 0 | 0.655 | 3.297 |  |  |  |  |  | 
COVID19_MODERNA | Double stranded DNA antibody | 0 | 0.335 | 0.008 | 0.655 | 2.309 |  |  |  |  |  | 
COVID19_MODERNA | Mycobacterium test | 0 | 0.29 | 0.004 | 0.655 | 2.431 |  |  |  |  |  | 
COVID19_MODERNA | Light chain analysis | 0 | 0.195 | 0 | 0.655 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Decreased activity | 0 | 1.419 | 0.162 | 0.655 | 1.418 |  |  |  |  |  | 
COVID19_MODERNA | Administration site cellulitis | 0 | 0.302 | 0.005 | 0.655 | 2.395 |  |  |  |  |  | 
COVID19_MODERNA | Blindness | 9 | 17.614 | 0.368 | 0.654 | 1.005 | 0.345 | 0.567 | 0.889 | 0.511 | 0.572 | 2.401
COVID19_MODERNA | Intentional self-injury | 0 | 0.324 | 0.007 | 0.654 | 2.335 |  |  |  |  |  | 
COVID19_MODERNA | Electroneuromyography | 0 | 0.23 | 0.001 | 0.654 | 2.638 |  |  |  |  |  | 
COVID19_MODERNA | Acute haemorrhagic oedema of infancy | 0 | 0.227 | 0.001 | 0.654 | 2.652 |  |  |  |  |  | 
COVID19_MODERNA | Hyperplasia | 0 | 0.234 | 0.001 | 0.654 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Osteoporosis/osteopenia (SMQ) [narrow] | 0 | 1.191 | 0.134 | 0.654 | 1.495 |  |  |  |  |  | 
COVID19_MODERNA | Amaurosis | 0 | 0.234 | 0.001 | 0.654 | 2.625 |  |  |  |  |  | 
COVID19_MODERNA | Erythema induratum | 0 | 0.39 | 0.014 | 0.654 | 2.185 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal dilatation | 0 | 0.351 | 0.009 | 0.654 | 2.27 |  |  |  |  |  | 
COVID19_MODERNA | Madarosis | 0 | 0.487 | 0.027 | 0.654 | 2.017 |  |  |  |  |  | 
COVID19_MODERNA | Asphyxia | 0 | 0.404 | 0.016 | 0.654 | 2.156 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract congestion | 1 | 2.76 | 0.131 | 0.653 | 1.503 | 0.249 | 0.621 | 1.331 | 0.362 | 0.484 | 0.142
COVID19_MODERNA | Concomitant disease aggravated | 0 | 0.229 | 0.001 | 0.653 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Immune-mediated/autoimmune disorders (SMQ) [narrow] | 85 | 142.867 | 0.541 | 0.652 | 0.771 | 0.503 | 0.601 | 0.714 | 0.595 | 0.328 | 117.228
COVID19_MODERNA | Gastrointestinal infection | 0 | 0.542 | 0.035 | 0.652 | 1.942 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell nucleated morphology present | 0 | 0.39 | 0.013 | 0.652 | 2.186 |  |  |  |  |  | 
COVID19_MODERNA | Crepitations | 1 | 2.173 | 0.119 | 0.651 | 1.531 | 0.279 | 0.688 | 1.467 | 0.46 | 0.771 | 0.037
COVID19_MODERNA | Therapeutic response unexpected | 1 | 2.377 | 0.081 | 0.651 | 1.676 | 0.268 | 0.663 | 1.417 | 0.421 | 0.277 | 1.196
COVID19_MODERNA | Kyphosis | 0 | 0.273 | 0.003 | 0.651 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Injection site pustule | 0 | 0.695 | 0.059 | 0.651 | 1.782 |  |  |  |  |  | 
COVID19_MODERNA | Lactose intolerance | 0 | 0.423 | 0.017 | 0.651 | 2.123 |  |  |  |  |  | 
COVID19_MODERNA | Light chain analysis decreased | 0 | 0.156 | 0 | 0.651 | 3.008 |  |  |  |  |  | 
COVID19_MODERNA | Eye discharge | 3 | 6.166 | 0.237 | 0.65 | 1.23 | 0.3 | 0.615 | 1.147 | 0.487 | 0.352 | 2.891
COVID19_MODERNA | Guillain-Barre syndrome (SMQ) [narrow] | 18 | 35.921 | 0.426 | 0.65 | 0.913 | 0.367 | 0.532 | 0.751 | 0.501 | 0.285 | 31.277
COVID19_MODERNA | Weight increased | 2 | 5.113 | 0.185 | 0.65 | 1.343 | 0.257 | 0.572 | 1.131 | 0.391 | 0.276 | 3.061
COVID19_MODERNA | Thyroxine decreased | 0 | 0.351 | 0.009 | 0.65 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy and neonatal topics (SMQ) [narrow] | 102 | 166.884 | 0.548 | 0.649 | 0.758 | 0.523 | 0.616 | 0.721 | 0.611 | 0.503 | 49.179
COVID19_MODERNA | Salivary hypersecretion | 3 | 5.791 | 0.237 | 0.649 | 1.226 | 0.312 | 0.64 | 1.193 | 0.518 | 0.556 | 0.636
COVID19_MODERNA | Nephropathy toxic | 0 | 0.156 | 0 | 0.649 | 3.007 |  |  |  |  |  | 
COVID19_MODERNA | Irritability postvaccinal | 0 | 0.158 | 0 | 0.649 | 2.997 |  |  |  |  |  | 
COVID19_MODERNA | Circadian rhythm sleep disorder | 0 | 0.194 | 0 | 0.649 | 2.799 |  |  |  |  |  | 
COVID19_MODERNA | Blood iron | 0 | 1.101 | 0.118 | 0.649 | 1.531 |  |  |  |  |  | 
COVID19_MODERNA | Tenodesis | 0 | 0.195 | 0 | 0.649 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Patent ductus arteriosus | 0 | 0.195 | 0 | 0.649 | 2.795 |  |  |  |  |  | 
COVID19_MODERNA | Papillitis | 0 | 0.273 | 0.003 | 0.649 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal dreams | 3 | 6.326 | 0.207 | 0.648 | 1.288 | 0.295 | 0.605 | 1.128 | 0.474 | 0.87 | 0.002
COVID19_MODERNA | Anti factor VIII antibody positive | 0 | 0.078 | 0 | 0.648 | 3.595 |  |  |  |  |  | 
COVID19_MODERNA | Central auditory processing disorder | 0 | 0.117 | 0 | 0.648 | 3.274 |  |  |  |  |  | 
COVID19_MODERNA | Bulbar palsy | 0 | 0.351 | 0.008 | 0.648 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Kawasaki's disease | 0 | 0.463 | 0.022 | 0.648 | 2.054 |  |  |  |  |  | 
COVID19_MODERNA | Fungal test | 0 | 0.3 | 0.004 | 0.648 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Physical examination | 2 | 4.863 | 0.239 | 0.647 | 1.217 | 0.265 | 0.59 | 1.164 | 0.411 | 3.083 | 0.946
COVID19_MODERNA | Carnitine | 0 | 0.234 | 0.001 | 0.647 | 2.625 |  |  |  |  |  | 
COVID19_MODERNA | Urogram normal | 0 | 0.195 | 0 | 0.647 | 2.794 |  |  |  |  |  | 
COVID19_MODERNA | Rubulavirus test positive | 0 | 0.098 | 0 | 0.647 | 3.427 |  |  |  |  |  | 
COVID19_MODERNA | Parvovirus B19 test positive | 0 | 0.37 | 0.01 | 0.647 | 2.227 |  |  |  |  |  | 
COVID19_MODERNA | Coma | 1 | 3.069 | 0.21 | 0.646 | 1.275 | 0.235 | 0.59 | 1.269 | 0.326 | 0.204 | 2.319
COVID19_MODERNA | Coronavirus test positive | 1 | 3.71 | 0.208 | 0.646 | 1.28 | 0.208 | 0.534 | 1.157 | 0.27 | 0.771 | 0.037
COVID19_MODERNA | Rotavirus test | 0 | 0.256 | 0.002 | 0.646 | 2.544 |  |  |  |  |  | 
COVID19_MODERNA | West Nile viral infection | 0 | 0.194 | 0 | 0.646 | 2.797 |  |  |  |  |  | 
COVID19_MODERNA | Obstruction | 0 | 0.294 | 0.004 | 0.646 | 2.419 |  |  |  |  |  | 
COVID19_MODERNA | Neuropathy peripheral | 12 | 22.426 | 0.38 | 0.645 | 0.967 | 0.371 | 0.577 | 0.865 | 0.535 | 0.577 | 3.227
COVID19_MODERNA | Physical disability | 0 | 0.157 | 0 | 0.645 | 2.997 |  |  |  |  |  | 
COVID19_MODERNA | Coxsackie viral infection | 0 | 0.312 | 0.005 | 0.644 | 2.37 |  |  |  |  |  | 
COVID19_MODERNA | Cerebrospinal fluid leakage | 0 | 0.2 | 0 | 0.644 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Tubulointerstitial diseases (SMQ) [narrow] | 0 | 0.528 | 0.029 | 0.644 | 1.962 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.874 | 0.082 | 0.644 | 1.649 |  |  |  |  |  | 
COVID19_MODERNA | Myoclonic epilepsy | 0 | 0.33 | 0.006 | 0.644 | 2.321 |  |  |  |  |  | 
COVID19_MODERNA | Scan abnormal | 0 | 0.438 | 0.017 | 0.644 | 2.097 |  |  |  |  |  | 
COVID19_MODERNA | CSF lactate increased | 0 | 0.273 | 0.002 | 0.644 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Cardiovascular disorder | 1 | 2.614 | 0.078 | 0.643 | 1.665 | 0.256 | 0.636 | 1.363 | 0.383 | 0.312 | 0.874
COVID19_MODERNA | Application site cellulitis | 0 | 0.2 | 0 | 0.643 | 2.768 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via direct contact | 0 | 0.214 | 0.001 | 0.643 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Endometritis | 0 | 0.234 | 0.001 | 0.643 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Positron emission tomogram normal | 0 | 0.49 | 0.023 | 0.642 | 2.013 |  |  |  |  |  | 
COVID19_MODERNA | Toxoplasma serology negative | 0 | 0.442 | 0.017 | 0.642 | 2.089 |  |  |  |  |  | 
COVID19_MODERNA | pH body fluid increased | 0 | 0.234 | 0.001 | 0.642 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Blood heavy metal normal | 0 | 0.673 | 0.05 | 0.641 | 1.801 |  |  |  |  |  | 
COVID19_MODERNA | Rotator cuff syndrome | 0 | 0.433 | 0.016 | 0.641 | 2.105 |  |  |  |  |  | 
COVID19_MODERNA | Repetitive strain injury | 0 | 0.234 | 0.001 | 0.641 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Pneumovirus test positive | 0 | 0.273 | 0.002 | 0.64 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Anti-GAD antibody positive | 0 | 0.582 | 0.036 | 0.64 | 1.894 |  |  |  |  |  | 
COVID19_MODERNA | Lower respiratory tract infection bacterial | 0 | 0.273 | 0.002 | 0.64 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Anti-SRP antibody positive | 0 | 0.156 | 0 | 0.64 | 3.002 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis adenovirus | 0 | 0.146 | 0 | 0.64 | 3.064 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial sepsis | 0 | 0.351 | 0.007 | 0.64 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Cluster headache | 1 | 2.234 | 0.202 | 0.639 | 1.275 | 0.276 | 0.68 | 1.452 | 0.448 | 1.37 | 0.081
COVID19_MODERNA | Disseminated varicella zoster virus infection | 0 | 0.228 | 0.001 | 0.639 | 2.648 |  |  |  |  |  | 
COVID19_MODERNA | Anti-platelet antibody negative | 0 | 0.312 | 0.004 | 0.639 | 2.37 |  |  |  |  |  | 
COVID19_MODERNA | Viral titre | 0 | 0.324 | 0.005 | 0.639 | 2.338 |  |  |  |  |  | 
COVID19_MODERNA | Skin odour abnormal | 0 | 0.331 | 0.005 | 0.639 | 2.318 |  |  |  |  |  | 
COVID19_MODERNA | Thrombophlebitis (SMQ) [broad] | 39 | 63.982 | 0.485 | 0.638 | 0.808 | 0.479 | 0.622 | 0.796 | 0.61 | 3.713 | 64.83
COVID19_MODERNA | Weight fluctuation | 0 | 0.141 | 0 | 0.638 | 3.094 |  |  |  |  |  | 
COVID19_MODERNA | Endometriosis | 0 | 0.161 | 0 | 0.638 | 2.973 |  |  |  |  |  | 
COVID19_MODERNA | Coeliac disease | 0 | 0.468 | 0.019 | 0.638 | 2.047 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobin distribution width | 0 | 0.117 | 0 | 0.638 | 3.262 |  |  |  |  |  | 
COVID19_MODERNA | Head deformity | 0 | 0.117 | 0 | 0.638 | 3.262 |  |  |  |  |  | 
COVID19_MODERNA | Antibody test normal | 0 | 0.273 | 0.002 | 0.638 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Serum ferritin decreased | 0 | 0.378 | 0.009 | 0.638 | 2.211 |  |  |  |  |  | 
COVID19_MODERNA | Disturbance in social behaviour | 0 | 0.388 | 0.01 | 0.638 | 2.19 |  |  |  |  |  | 
COVID19_MODERNA | Abortion spontaneous | 16 | 29.145 | 0.404 | 0.637 | 0.912 | 0.393 | 0.581 | 0.834 | 0.549 | 1.754 | 4.137
COVID19_MODERNA | Lip haemorrhage | 0 | 1.802 | 0.182 | 0.637 | 1.317 |  |  |  |  |  | 
COVID19_MODERNA | Small fibre neuropathy | 0 | 0.45 | 0.016 | 0.636 | 2.075 |  |  |  |  |  | 
COVID19_MODERNA | Adenocarcinoma | 0 | 0.195 | 0 | 0.636 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulins | 0 | 1.546 | 0.158 | 0.636 | 1.376 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site plaque | 0 | 0.234 | 0.001 | 0.635 | 2.623 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal malrotation | 0 | 0.287 | 0.002 | 0.635 | 2.441 |  |  |  |  |  | 
COVID19_MODERNA | Blood albumin increased | 0 | 0.95 | 0.087 | 0.635 | 1.602 |  |  |  |  |  | 
COVID19_MODERNA | Bordetella infection | 0 | 0.195 | 0 | 0.635 | 2.791 |  |  |  |  |  | 
COVID19_MODERNA | T-lymphocyte count decreased | 0 | 0.231 | 0.001 | 0.635 | 2.633 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculosis | 0 | 0.428 | 0.014 | 0.635 | 2.113 |  |  |  |  |  | 
COVID19_MODERNA | Renal impairment | 1 | 4.756 | 0.185 | 0.634 | 1.299 | 0.171 | 0.458 | 1.011 | 0.21 | 0.233 | 1.779
COVID19_MODERNA | Bronchopulmonary aspergillosis allergic | 0 | 0.078 | 0 | 0.634 | 3.555 |  |  |  |  |  | 
COVID19_MODERNA | Retinal disorder | 0 | 0.39 | 0.01 | 0.634 | 2.186 |  |  |  |  |  | 
COVID19_MODERNA | Anti-NMDA antibody negative | 0 | 0.363 | 0.007 | 0.634 | 2.244 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site vesicles | 0 | 0.4 | 0.011 | 0.634 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Bursal fluid accumulation | 0 | 0.595 | 0.035 | 0.633 | 1.879 |  |  |  |  |  | 
COVID19_MODERNA | Occupational exposure to SARS-CoV-2 | 1 | 6.474 | 0.067 | 0.632 | 1.678 | 0.118 | 0.363 | 0.834 | 0.154 | 1.174 | 0.155
COVID19_MODERNA | Salpingitis | 0 | 0.156 | 0 | 0.632 | 2.997 |  |  |  |  |  | 
COVID19_MODERNA | Dermatosis | 0 | 0.312 | 0.004 | 0.632 | 2.369 |  |  |  |  |  | 
COVID19_MODERNA | Meningococcal bacteraemia | 0 | 0.11 | 0 | 0.632 | 3.308 |  |  |  |  |  | 
COVID19_MODERNA | Injection site hyperaesthesia | 0 | 0.39 | 0.009 | 0.631 | 2.186 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging thoracic normal | 0 | 0.845 | 0.07 | 0.631 | 1.665 |  |  |  |  |  | 
COVID19_MODERNA | Documented hypersensitivity to administered product | 0 | 0.627 | 0.038 | 0.631 | 1.845 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral neuropathy (SMQ) [narrow] | 85 | 140.062 | 0.523 | 0.63 | 0.746 | 0.513 | 0.613 | 0.728 | 0.607 | 0.523 | 36.193
COVID19_MODERNA | Vaccination site pain | 69 | 121.748 | 0.513 | 0.63 | 0.757 | 0.472 | 0.575 | 0.695 | 0.567 | 1.233 | 2.679
COVID19_MODERNA | Vitamin B12 increased | 0 | 0.78 | 0.059 | 0.63 | 1.71 |  |  |  |  |  | 
COVID19_MODERNA | Corynebacterium infection | 0 | 0.27 | 0.002 | 0.63 | 2.494 |  |  |  |  |  | 
COVID19_MODERNA | Pregnancy test positive | 2 | 4.946 | 0.147 | 0.629 | 1.385 | 0.262 | 0.584 | 1.153 | 0.404 | 0.333 | 1.993
COVID19_MODERNA | Ocular discomfort | 5 | 11.637 | 0.355 | 0.629 | 0.966 | 0.283 | 0.525 | 0.907 | 0.43 | 1.152 | 0.004
COVID19_MODERNA | Schizoaffective disorder | 0 | 0.156 | 0 | 0.629 | 2.994 |  |  |  |  |  | 
COVID19_MODERNA | Child abuse | 0 | 0.156 | 0 | 0.629 | 2.994 |  |  |  |  |  | 
COVID19_MODERNA | Smear site unspecified normal | 0 | 0.338 | 0.005 | 0.629 | 2.302 |  |  |  |  |  | 
COVID19_MODERNA | Polydipsia | 0 | 0.881 | 0.073 | 0.629 | 1.641 |  |  |  |  |  | 
COVID19_MODERNA | Convulsions local | 0 | 0.351 | 0.006 | 0.629 | 2.271 |  |  |  |  |  | 
COVID19_MODERNA | Nerve injury | 3 | 7.859 | 0.276 | 0.628 | 1.096 | 0.253 | 0.523 | 0.977 | 0.382 | 0.323 | 3.536
COVID19_MODERNA | Eating disorder | 1 | 5.017 | 0.287 | 0.628 | 1.075 | 0.163 | 0.442 | 0.979 | 0.199 | 0.158 | 3.629
COVID19_MODERNA | CSF lactate normal | 0 | 0.234 | 0.001 | 0.628 | 2.621 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal inflammation | 0 | 0.967 | 0.084 | 0.628 | 1.591 |  |  |  |  |  | 
COVID19_MODERNA | Ventricular fibrillation | 6 | 11.819 | 0.308 | 0.627 | 1.038 | 0.328 | 0.585 | 0.979 | 0.508 | 4.773 | 11.886
COVID19_MODERNA | Dysgraphia | 1 | 2.577 | 0.124 | 0.627 | 1.446 | 0.258 | 0.641 | 1.371 | 0.388 | 0.379 | 0.465
COVID19_MODERNA | HLA-B*27 assay | 0 | 0.327 | 0.004 | 0.627 | 2.329 |  |  |  |  |  | 
COVID19_MODERNA | Neuropsychiatric syndrome | 0 | 0.351 | 0.005 | 0.627 | 2.27 |  |  |  |  |  | 
COVID19_MODERNA | Foetal disorders (SMQ) [narrow] | 10 | 18.568 | 0.344 | 0.626 | 0.976 | 0.365 | 0.587 | 0.906 | 0.539 | 0.741 | 0.64
COVID19_MODERNA | Extrasystoles | 2 | 4.849 | 0.243 | 0.626 | 1.153 | 0.266 | 0.591 | 1.166 | 0.412 | 1.007 | 0.124
COVID19_MODERNA | Thyroid dysfunction (SMQ) [broad] | 7 | 15.707 | 0.315 | 0.626 | 1.023 | 0.3 | 0.518 | 0.847 | 0.446 | 0.325 | 9.014
COVID19_MODERNA | Gastritis | 1 | 3.29 | 0.134 | 0.626 | 1.413 | 0.225 | 0.569 | 1.228 | 0.304 | 0.333 | 0.721
COVID19_MODERNA | Rotavirus test negative | 0 | 0.344 | 0.005 | 0.626 | 2.285 |  |  |  |  |  | 
COVID19_MODERNA | Marrow hyperplasia | 0 | 0.273 | 0.002 | 0.626 | 2.484 |  |  |  |  |  | 
COVID19_MODERNA | Schizophrenia | 0 | 0.185 | 0 | 0.626 | 2.833 |  |  |  |  |  | 
COVID19_MODERNA | Salivary gland enlargement | 0 | 0.336 | 0.004 | 0.625 | 2.306 |  |  |  |  |  | 
COVID19_MODERNA | Extremity contracture | 0 | 1.152 | 0.106 | 0.625 | 1.502 |  |  |  |  |  | 
COVID19_MODERNA | Blood copper | 0 | 0.312 | 0.003 | 0.625 | 2.368 |  |  |  |  |  | 
COVID19_MODERNA | Lichen sclerosus | 0 | 0.312 | 0.003 | 0.625 | 2.368 |  |  |  |  |  | 
COVID19_MODERNA | Optic nerve disorder | 0 | 0.346 | 0.005 | 0.625 | 2.282 |  |  |  |  |  | 
COVID19_MODERNA | Deep vein thrombosis | 18 | 30.518 | 0.412 | 0.624 | 0.871 | 0.425 | 0.616 | 0.87 | 0.59 | 5.619 | 51.83
COVID19_MODERNA | Polyp | 0 | 0.234 | 0.001 | 0.624 | 2.62 |  |  |  |  |  | 
COVID19_MODERNA | Haemoconcentration | 0 | 0.156 | 0 | 0.624 | 2.99 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram ambulatory normal | 0 | 0.35 | 0.005 | 0.624 | 2.273 |  |  |  |  |  | 
COVID19_MODERNA | Genital herpes zoster | 0 | 0.136 | 0 | 0.624 | 3.108 |  |  |  |  |  | 
COVID19_MODERNA | Liver infections (SMQ) [narrow] | 2 | 2.504 | 0.125 | 0.623 | 1.431 | 0.374 | 0.822 | 1.615 | 0.799 | 0.055 | 31.359
COVID19_MODERNA | Illness | 18 | 31.596 | 0.404 | 0.623 | 0.881 | 0.412 | 0.597 | 0.843 | 0.57 | 0.957 | 0.004
COVID19_MODERNA | Vaccination site joint erythema | 0 | 0.262 | 0.001 | 0.623 | 2.518 |  |  |  |  |  | 
COVID19_MODERNA | Sensory overload | 0 | 0.229 | 0 | 0.623 | 2.638 |  |  |  |  |  | 
COVID19_MODERNA | Tooth infection | 0 | 0.94 | 0.078 | 0.623 | 1.604 |  |  |  |  |  | 
COVID19_MODERNA | Cyst | 0 | 0.662 | 0.039 | 0.623 | 1.809 |  |  |  |  |  | 
COVID19_MODERNA | Urine potassium | 0 | 0.072 | 0 | 0.623 | 3.56 |  |  |  |  |  | 
COVID19_MODERNA | Urticarial vasculitis | 0 | 0.268 | 0.001 | 0.623 | 2.498 |  |  |  |  |  | 
COVID19_MODERNA | Malignant melanoma | 0 | 0.39 | 0.008 | 0.623 | 2.185 |  |  |  |  |  | 
COVID19_MODERNA | Parasite stool test negative | 0 | 0.326 | 0.003 | 0.622 | 2.331 |  |  |  |  |  | 
COVID19_MODERNA | Amino acid level increased | 0 | 0.351 | 0.005 | 0.622 | 2.27 |  |  |  |  |  | 
COVID19_MODERNA | Human herpes virus 6 serology | 0 | 0.351 | 0.005 | 0.622 | 2.27 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract irritation | 0 | 0.351 | 0.005 | 0.622 | 2.27 |  |  |  |  |  | 
COVID19_MODERNA | Blood pH decreased | 3 | 5.201 | 0.246 | 0.621 | 1.135 | 0.334 | 0.683 | 1.273 | 0.577 | 0.961 | 0.049
COVID19_MODERNA | Thyroid dysfunction (SMQ) [narrow] | 4 | 7.65 | 0.243 | 0.621 | 1.142 | 0.322 | 0.623 | 1.113 | 0.523 | 0.493 | 1.559
COVID19_MODERNA | Injection site joint pain | 3 | 8.417 | 0.327 | 0.621 | 0.992 | 0.241 | 0.498 | 0.932 | 0.356 | 0.335 | 3.262
COVID19_MODERNA | Hidradenitis | 0 | 0.273 | 0.001 | 0.621 | 2.482 |  |  |  |  |  | 
COVID19_MODERNA | Histiocytosis | 0 | 0.195 | 0 | 0.621 | 2.784 |  |  |  |  |  | 
COVID19_MODERNA | Quadriplegia | 0 | 0.27 | 0.001 | 0.621 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Shoulder deformity | 0 | 0.195 | 0 | 0.621 | 2.784 |  |  |  |  |  | 
COVID19_MODERNA | Polymyositis | 0 | 0.295 | 0.002 | 0.621 | 2.413 |  |  |  |  |  | 
COVID19_MODERNA | Blood thyroid stimulating hormone increased | 0 | 1.088 | 0.095 | 0.621 | 1.528 |  |  |  |  |  | 
COVID19_MODERNA | Fear | 11 | 20.046 | 0.393 | 0.62 | 0.891 | 0.375 | 0.593 | 0.901 | 0.549 | 1.443 | 1.012
COVID19_MODERNA | Lung disorder | 1 | 3.473 | 0.128 | 0.62 | 1.414 | 0.218 | 0.553 | 1.196 | 0.288 | 0.254 | 1.466
COVID19_MODERNA | Muscle disorder | 1 | 3.832 | 0.171 | 0.62 | 1.296 | 0.204 | 0.524 | 1.138 | 0.261 | 0.228 | 1.85
COVID19_MODERNA | Acoustic stimulation tests normal | 0 | 0.576 | 0.027 | 0.62 | 1.898 |  |  |  |  |  | 
COVID19_MODERNA | Mycoplasma test positive | 0 | 0.32 | 0.003 | 0.62 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Precancerous mucosal lesion | 0 | 0.156 | 0 | 0.62 | 2.986 |  |  |  |  |  | 
COVID19_MODERNA | Parvovirus infection | 0 | 0.234 | 0 | 0.62 | 2.618 |  |  |  |  |  | 
COVID19_MODERNA | Foetal gastrointestinal tract imaging abnormal | 0 | 0.156 | 0 | 0.62 | 2.986 |  |  |  |  |  | 
COVID19_MODERNA | Anti-transglutaminase antibody | 0 | 0.273 | 0.001 | 0.62 | 2.482 |  |  |  |  |  | 
COVID19_MODERNA | Rhinitis | 1 | 1.742 | 0.11 | 0.619 | 1.468 | 0.305 | 0.746 | 1.587 | 0.574 | 0.109 | 6.352
COVID19_MODERNA | Frequent bowel movements | 2 | 5.175 | 0.185 | 0.619 | 1.259 | 0.255 | 0.568 | 1.123 | 0.386 | 0.32 | 2.194
COVID19_MODERNA | Base excess negative | 0 | 0.404 | 0.008 | 0.619 | 2.156 |  |  |  |  |  | 
COVID19_MODERNA | Acute polyneuropathy | 0 | 0.351 | 0.005 | 0.619 | 2.269 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal operation | 0 | 0.303 | 0.002 | 0.619 | 2.391 |  |  |  |  |  | 
COVID19_MODERNA | Lumbar puncture | 15 | 29.63 | 0.409 | 0.618 | 0.862 | 0.362 | 0.542 | 0.786 | 0.506 | 0.596 | 3.626
COVID19_MODERNA | HIV test | 2 | 5.449 | 0.153 | 0.618 | 1.337 | 0.246 | 0.55 | 1.089 | 0.367 | 1.096 | 0.062
COVID19_MODERNA | Intracranial pressure increased | 0 | 1.276 | 0.114 | 0.618 | 1.451 |  |  |  |  |  | 
COVID19_MODERNA | Fear of falling | 0 | 0.195 | 0 | 0.618 | 2.782 |  |  |  |  |  | 
COVID19_MODERNA | Attention deficit hyperactivity disorder | 0 | 0.496 | 0.017 | 0.618 | 2.002 |  |  |  |  |  | 
COVID19_MODERNA | Labelled drug-disease interaction medication error | 0 | 0.234 | 0 | 0.618 | 2.618 |  |  |  |  |  | 
COVID19_MODERNA | Postictal paralysis | 0 | 0.39 | 0.007 | 0.617 | 2.184 |  |  |  |  |  | 
COVID19_MODERNA | Exanthema subitum | 0 | 0.405 | 0.008 | 0.617 | 2.155 |  |  |  |  |  | 
COVID19_MODERNA | Retinol binding protein | 0 | 0.2 | 0 | 0.617 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Herpes simplex test positive | 0 | 0.596 | 0.029 | 0.617 | 1.875 |  |  |  |  |  | 
COVID19_MODERNA | Scab | 5 | 13.156 | 0.276 | 0.616 | 1.065 | 0.257 | 0.477 | 0.824 | 0.38 | 0.233 | 11.777
COVID19_MODERNA | Herpes zoster infection neurological | 0 | 0.206 | 0 | 0.616 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Bilirubin urine | 1 | 2.618 | 0.194 | 0.615 | 1.227 | 0.256 | 0.636 | 1.362 | 0.382 | 0.913 | 0.159
COVID19_MODERNA | Precancerous cells present | 0 | 0.25 | 0.001 | 0.615 | 2.556 |  |  |  |  |  | 
COVID19_MODERNA | Peak expiratory flow rate decreased | 0 | 0.273 | 0.001 | 0.615 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Face and mouth X-ray | 0 | 0.246 | 0.001 | 0.615 | 2.569 |  |  |  |  |  | 
COVID19_MODERNA | Foetal disorders (SMQ) [broad] | 10 | 18.569 | 0.338 | 0.614 | 0.956 | 0.365 | 0.587 | 0.906 | 0.539 | 0.727 | 0.736
COVID19_MODERNA | Combined immunodeficiency | 0 | 0.245 | 0.001 | 0.614 | 2.574 |  |  |  |  |  | 
COVID19_MODERNA | Dermatomyositis | 0 | 0.236 | 0 | 0.614 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | Rhinitis allergic | 0 | 0.966 | 0.075 | 0.614 | 1.587 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal motility disorder | 0 | 0.263 | 0.001 | 0.614 | 2.512 |  |  |  |  |  | 
COVID19_MODERNA | Antimicrobial susceptibility test resistant | 0 | 0.273 | 0.001 | 0.614 | 2.48 |  |  |  |  |  | 
COVID19_MODERNA | Administration site pain | 0 | 1.844 | 0.164 | 0.614 | 1.297 |  |  |  |  |  | 
COVID19_MODERNA | Infective pneumonia (SMQ) [broad] | 555 | 930.136 | 0.571 | 0.613 | 0.656 | 0.557 | 0.598 | 0.64 | 0.597 | 1.291 | 35.513
COVID19_MODERNA | Depression and suicide/self-injury (SMQ) [narrow] | 9 | 17.668 | 0.337 | 0.613 | 0.956 | 0.344 | 0.565 | 0.886 | 0.509 | 0.24 | 20.741
COVID19_MODERNA | Tracheostomy | 0 | 0.254 | 0.001 | 0.613 | 2.541 |  |  |  |  |  | 
COVID19_MODERNA | Interferon gamma release assay | 0 | 0.195 | 0 | 0.613 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C RNA decreased | 0 | 0.156 | 0 | 0.613 | 2.979 |  |  |  |  |  | 
COVID19_MODERNA | Mixed connective tissue disease | 0 | 0.195 | 0 | 0.613 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Auditory disorder | 1 | 2.241 | 0.161 | 0.612 | 1.298 | 0.275 | 0.68 | 1.45 | 0.446 | 1.072 | 0.211
COVID19_MODERNA | Immunology test | 1 | 2.667 | 0.112 | 0.612 | 1.441 | 0.253 | 0.631 | 1.351 | 0.375 | 0.09 | 8.255
COVID19_MODERNA | Hepatocellular injury | 0 | 0.162 | 0 | 0.612 | 2.943 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal necrosis | 0 | 0.227 | 0 | 0.612 | 2.642 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal inflammation | 0 | 1.394 | 0.122 | 0.612 | 1.409 |  |  |  |  |  | 
COVID19_MODERNA | Chiropractic | 0 | 0.928 | 0.069 | 0.612 | 1.608 |  |  |  |  |  | 
COVID19_MODERNA | Troponin T normal | 1 | 2.47 | 0.096 | 0.611 | 1.496 | 0.263 | 0.653 | 1.395 | 0.405 | 1.233 | 0.129
COVID19_MODERNA | Abscess sterile | 0 | 0.372 | 0.005 | 0.611 | 2.22 |  |  |  |  |  | 
COVID19_MODERNA | Blood iron normal | 0 | 1.589 | 0.14 | 0.611 | 1.353 |  |  |  |  |  | 
COVID19_MODERNA | Poor sucking reflex | 0 | 0.281 | 0.001 | 0.611 | 2.455 |  |  |  |  |  | 
COVID19_MODERNA | Nerve compression | 1 | 3.695 | 0.186 | 0.61 | 1.232 | 0.209 | 0.535 | 1.16 | 0.271 | 0.457 | 0.201
COVID19_MODERNA | Blood creatinine | 1 | 3.847 | 0.135 | 0.61 | 1.363 | 0.203 | 0.522 | 1.136 | 0.26 | 0.312 | 0.874
COVID19_MODERNA | Colostomy | 0 | 0.287 | 0.001 | 0.61 | 2.435 |  |  |  |  |  | 
COVID19_MODERNA | Barium enema | 0 | 0.294 | 0.001 | 0.609 | 2.415 |  |  |  |  |  | 
COVID19_MODERNA | Endocrine test normal | 0 | 0.351 | 0.004 | 0.609 | 2.266 |  |  |  |  |  | 
COVID19_MODERNA | Post lumbar puncture syndrome | 0 | 0.351 | 0.004 | 0.609 | 2.267 |  |  |  |  |  | 
COVID19_MODERNA | Growing pains | 0 | 0.234 | 0 | 0.609 | 2.613 |  |  |  |  |  | 
COVID19_MODERNA | Mastoiditis | 0 | 0.339 | 0.003 | 0.609 | 2.295 |  |  |  |  |  | 
COVID19_MODERNA | Fundoscopy normal | 0 | 0.397 | 0.007 | 0.609 | 2.167 |  |  |  |  |  | 
COVID19_MODERNA | Central nervous system lesion | 1 | 3.26 | 0.147 | 0.608 | 1.325 | 0.227 | 0.572 | 1.234 | 0.307 | 0.228 | 1.85
COVID19_MODERNA | Chronic sinusitis | 0 | 0.347 | 0.003 | 0.608 | 2.275 |  |  |  |  |  | 
COVID19_MODERNA | Macular oedema | 0 | 0.273 | 0.001 | 0.608 | 2.477 |  |  |  |  |  | 
COVID19_MODERNA | Graft versus host disease | 0 | 0.39 | 0.006 | 0.608 | 2.182 |  |  |  |  |  | 
COVID19_MODERNA | Evans syndrome | 0 | 0.234 | 0 | 0.608 | 2.613 |  |  |  |  |  | 
COVID19_MODERNA | Dental caries | 0 | 0.117 | 0 | 0.608 | 3.212 |  |  |  |  |  | 
COVID19_MODERNA | Macrosomia | 0 | 0.195 | 0 | 0.608 | 2.775 |  |  |  |  |  | 
COVID19_MODERNA | Hypoperfusion | 0 | 0.297 | 0.002 | 0.608 | 2.404 |  |  |  |  |  | 
COVID19_MODERNA | Petit mal epilepsy | 0 | 0.989 | 0.074 | 0.608 | 1.572 |  |  |  |  |  | 
COVID19_MODERNA | Crohn's disease | 1 | 3.079 | 0.09 | 0.607 | 1.501 | 0.234 | 0.589 | 1.267 | 0.325 | 0.254 | 1.466
COVID19_MODERNA | Bladder disorder | 0 | 0.63 | 0.029 | 0.607 | 1.836 |  |  |  |  |  | 
COVID19_MODERNA | Croup infectious | 0 | 0.469 | 0.012 | 0.607 | 2.041 |  |  |  |  |  | 
COVID19_MODERNA | Loss of control of legs | 0 | 0.928 | 0.066 | 0.607 | 1.606 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillectomy | 0 | 0.341 | 0.003 | 0.607 | 2.289 |  |  |  |  |  | 
COVID19_MODERNA | Miller Fisher syndrome | 0 | 0.535 | 0.018 | 0.606 | 1.946 |  |  |  |  |  | 
COVID19_MODERNA | Packed red blood cell transfusion | 2 | 4.689 | 0.218 | 0.605 | 1.149 | 0.271 | 0.602 | 1.189 | 0.427 | 0.948 | 0.077
COVID19_MODERNA | Urine organic acid test | 0 | 0.39 | 0.006 | 0.605 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Gluten sensitivity | 0 | 0.453 | 0.01 | 0.605 | 2.067 |  |  |  |  |  | 
COVID19_MODERNA | Amoebiasis | 0 | 0.113 | 0 | 0.605 | 3.231 |  |  |  |  |  | 
COVID19_MODERNA | Salt craving | 0 | 0.156 | 0 | 0.605 | 2.969 |  |  |  |  |  | 
COVID19_MODERNA | Cystoid macular oedema | 0 | 0.156 | 0 | 0.605 | 2.969 |  |  |  |  |  | 
COVID19_MODERNA | Thyroxine increased | 0 | 0.39 | 0.006 | 0.605 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 1.446 | 0.121 | 0.604 | 1.39 |  |  |  |  |  | 
COVID19_MODERNA | Steroid dependence | 0 | 0.117 | 0 | 0.604 | 3.203 |  |  |  |  |  | 
COVID19_MODERNA | Immunoglobulins increased | 0 | 0.39 | 0.005 | 0.604 | 2.181 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site pustule | 0 | 0.155 | 0 | 0.604 | 2.971 |  |  |  |  |  | 
COVID19_MODERNA | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [broad] | 0 | 1.446 | 0.121 | 0.604 | 1.39 |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric evaluation | 0 | 0.324 | 0.002 | 0.603 | 2.33 |  |  |  |  |  | 
COVID19_MODERNA | Rheumatoid factor positive | 0 | 0.314 | 0.002 | 0.603 | 2.355 |  |  |  |  |  | 
COVID19_MODERNA | Hydrocele | 0 | 0.312 | 0.002 | 0.603 | 2.361 |  |  |  |  |  | 
COVID19_MODERNA | Myelocyte count | 0 | 0.105 | 0 | 0.602 | 3.278 |  |  |  |  |  | 
COVID19_MODERNA | Weaning failure | 0 | 0.195 | 0 | 0.602 | 2.77 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis cholestatic | 0 | 0.117 | 0 | 0.602 | 3.198 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C RNA negative | 0 | 0.195 | 0 | 0.602 | 2.769 |  |  |  |  |  | 
COVID19_MODERNA | Haptoglobin decreased | 0 | 0.55 | 0.018 | 0.602 | 1.926 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product effect decreased | 0 | 0.312 | 0.002 | 0.602 | 2.36 |  |  |  |  |  | 
COVID19_MODERNA | Vitello-intestinal duct remnant | 0 | 0.223 | 0 | 0.602 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Intraocular pressure increased | 0 | 0.885 | 0.058 | 0.602 | 1.629 |  |  |  |  |  | 
COVID19_MODERNA | Paralysis | 8 | 15.669 | 0.313 | 0.601 | 0.966 | 0.34 | 0.572 | 0.914 | 0.511 | 0.31 | 11.478
COVID19_MODERNA | Transaminases increased | 1 | 3.262 | 0.099 | 0.601 | 1.453 | 0.226 | 0.572 | 1.233 | 0.307 | 0.287 | 1.097
COVID19_MODERNA | Metal poisoning | 0 | 0.338 | 0.003 | 0.6 | 2.293 |  |  |  |  |  | 
COVID19_MODERNA | Urine protein/creatinine ratio | 0 | 0.273 | 0.001 | 0.6 | 2.473 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic lesion | 0 | 0.229 | 0 | 0.6 | 2.624 |  |  |  |  |  | 
COVID19_MODERNA | Tri-iodothyronine | 0 | 0.317 | 0.002 | 0.599 | 2.346 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis meningococcal | 0 | 0.156 | 0 | 0.599 | 2.961 |  |  |  |  |  | 
COVID19_MODERNA | Postpartum haemorrhage | 0 | 0.195 | 0 | 0.599 | 2.767 |  |  |  |  |  | 
COVID19_MODERNA | Premature labour | 2 | 4.398 | 0.135 | 0.598 | 1.328 | 0.282 | 0.625 | 1.232 | 0.455 | 1.007 | 0.124
COVID19_MODERNA | Neurogenic shock | 0 | 0.121 | 0 | 0.598 | 3.166 |  |  |  |  |  | 
COVID19_MODERNA | Vascular malformation | 0 | 0.132 | 0 | 0.598 | 3.096 |  |  |  |  |  | 
COVID19_MODERNA | Ulcer haemorrhage | 0 | 0.156 | 0 | 0.598 | 2.959 |  |  |  |  |  | 
COVID19_MODERNA | Skin ulcer | 1 | 3.922 | 0.215 | 0.597 | 1.135 | 0.2 | 0.517 | 1.124 | 0.255 | 0.139 | 4.436
COVID19_MODERNA | Groin pain | 2 | 6.402 | 0.22 | 0.596 | 1.121 | 0.22 | 0.496 | 0.984 | 0.312 | 0.379 | 1.415
COVID19_MODERNA | Scarlet fever | 0 | 0.288 | 0.001 | 0.596 | 2.424 |  |  |  |  |  | 
COVID19_MODERNA | Platelet count | 5 | 10.574 | 0.32 | 0.595 | 0.941 | 0.305 | 0.565 | 0.975 | 0.473 | 1.101 | 0.001
COVID19_MODERNA | Haematological tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.671 | 0.029 | 0.595 | 1.791 |  |  |  |  |  | 
COVID19_MODERNA | Brucella test negative | 0 | 0.281 | 0.001 | 0.595 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Haematological tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.671 | 0.029 | 0.595 | 1.791 |  |  |  |  |  | 
COVID19_MODERNA | Gluten free diet | 0 | 0.195 | 0 | 0.595 | 2.763 |  |  |  |  |  | 
COVID19_MODERNA | Visual evoked potentials abnormal | 0 | 0.162 | 0 | 0.595 | 2.921 |  |  |  |  |  | 
COVID19_MODERNA | Skeletal survey normal | 0 | 0.243 | 0 | 0.595 | 2.572 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram ambulatory abnormal | 0 | 0.751 | 0.038 | 0.594 | 1.721 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory papilloma | 0 | 0.178 | 0 | 0.594 | 2.838 |  |  |  |  |  | 
COVID19_MODERNA | Oliguria | 0 | 0.19 | 0 | 0.594 | 2.786 |  |  |  |  |  | 
COVID19_MODERNA | Corynebacterium test positive | 0 | 0.176 | 0 | 0.594 | 2.853 |  |  |  |  |  | 
COVID19_MODERNA | Demyelination (SMQ) [narrow] | 30 | 60.902 | 0.43 | 0.593 | 0.778 | 0.381 | 0.512 | 0.676 | 0.493 | 0.282 | 53.965
COVID19_MODERNA | Ultrasound thyroid abnormal | 0 | 0.296 | 0.001 | 0.593 | 2.4 |  |  |  |  |  | 
COVID19_MODERNA | Muscle mass | 0 | 0.39 | 0.004 | 0.593 | 2.177 |  |  |  |  |  | 
COVID19_MODERNA | Skin candida | 0 | 0.273 | 0.001 | 0.592 | 2.469 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy muscle abnormal | 0 | 0.137 | 0 | 0.592 | 3.053 |  |  |  |  |  | 
COVID19_MODERNA | CSF neutrophil count increased | 0 | 0.797 | 0.043 | 0.592 | 1.686 |  |  |  |  |  | 
COVID19_MODERNA | Somatosensory evoked potentials abnormal | 0 | 0.283 | 0.001 | 0.592 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Listeria test | 0 | 0.312 | 0.001 | 0.592 | 2.357 |  |  |  |  |  | 
COVID19_MODERNA | Enema administration | 0 | 0.466 | 0.009 | 0.592 | 2.041 |  |  |  |  |  | 
COVID19_MODERNA | Fertility disorders (SMQ) [narrow] | 3 | 6.995 | 0.183 | 0.591 | 1.189 | 0.275 | 0.566 | 1.057 | 0.429 | 0.366 | 2.626
COVID19_MODERNA | Gastrointestinal perforation (SMQ) [narrow] | 4 | 11.39 | 0.234 | 0.591 | 1.08 | 0.239 | 0.466 | 0.835 | 0.351 | 1.265 | 0.03
COVID19_MODERNA | Gastrointestinal perforation (SMQ) [broad] | 4 | 11.39 | 0.234 | 0.591 | 1.08 | 0.239 | 0.466 | 0.835 | 0.351 | 1.265 | 0.03
COVID19_MODERNA | Cytomegalovirus test positive | 0 | 0.672 | 0.028 | 0.591 | 1.789 |  |  |  |  |  | 
COVID19_MODERNA | No adverse event | 136 | 138.35 | 0.509 | 0.59 | 0.675 | 0.85 | 0.979 | 1.124 | 0.983 | 0.059 | 2421.468
COVID19_MODERNA | Termination of pregnancy and risk of abortion (SMQ) [narrow] | 20 | 35.935 | 0.394 | 0.59 | 0.818 | 0.408 | 0.582 | 0.81 | 0.557 | 1.258 | 0.77
COVID19_MODERNA | Termination of pregnancy and risk of abortion (SMQ) [broad] | 20 | 35.935 | 0.394 | 0.59 | 0.818 | 0.408 | 0.582 | 0.81 | 0.557 | 1.258 | 0.77
COVID19_MODERNA | Impulsive behaviour | 0 | 0.351 | 0.002 | 0.59 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Vitritis | 0 | 0.351 | 0.002 | 0.589 | 2.259 |  |  |  |  |  | 
COVID19_MODERNA | Body temperature normal | 1 | 1.603 | 0.149 | 0.588 | 1.263 | 0.314 | 0.767 | 1.63 | 0.624 | 1.897 | 0.004
COVID19_MODERNA | Red blood cell sedimentation rate normal | 9 | 18.156 | 0.329 | 0.588 | 0.908 | 0.336 | 0.552 | 0.866 | 0.496 | 0.578 | 2.3
COVID19_MODERNA | Culture stool | 1 | 2.635 | 0.127 | 0.588 | 1.324 | 0.255 | 0.634 | 1.358 | 0.379 | 0.398 | 0.387
COVID19_MODERNA | Blood immunoglobulin E increased | 0 | 0.618 | 0.021 | 0.588 | 1.842 |  |  |  |  |  | 
COVID19_MODERNA | Parasitic blood test negative | 0 | 0.351 | 0.002 | 0.588 | 2.258 |  |  |  |  |  | 
COVID19_MODERNA | Bone contusion | 0 | 0.234 | 0 | 0.588 | 2.598 |  |  |  |  |  | 
COVID19_MODERNA | Blood aluminium | 0 | 0.312 | 0.001 | 0.588 | 2.354 |  |  |  |  |  | 
COVID19_MODERNA | Salmonella test negative | 0 | 0.394 | 0.004 | 0.588 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Somatosensory evoked potentials | 0 | 0.215 | 0 | 0.588 | 2.67 |  |  |  |  |  | 
COVID19_MODERNA | Blood testosterone decreased | 0 | 0.312 | 0.001 | 0.587 | 2.353 |  |  |  |  |  | 
COVID19_MODERNA | Trichotillomania | 0 | 0.273 | 0 | 0.587 | 2.465 |  |  |  |  |  | 
COVID19_MODERNA | Liver infections (SMQ) [broad] | 2 | 2.506 | 0.12 | 0.586 | 1.338 | 0.374 | 0.821 | 1.614 | 0.798 | 0.053 | 32.657
COVID19_MODERNA | Urea urine normal | 0 | 0.114 | 0 | 0.586 | 3.18 |  |  |  |  |  | 
COVID19_MODERNA | Normal pregnancy conditions and outcomes (SMQ) [narrow] | 14 | 32.589 | 0.357 | 0.585 | 0.857 | 0.31 | 0.47 | 0.689 | 0.43 | 0.543 | 4.828
COVID19_MODERNA | Anti-neutrophil cytoplasmic antibody positive vasculitis | 0 | 0.246 | 0 | 0.585 | 2.553 |  |  |  |  |  | 
COVID19_MODERNA | Hallucinations, mixed | 0 | 0.39 | 0.004 | 0.585 | 2.173 |  |  |  |  |  | 
COVID19_MODERNA | Scoliosis | 0 | 0.334 | 0.002 | 0.585 | 2.296 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis | 0 | 0.234 | 0 | 0.585 | 2.595 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis | 3 | 6.468 | 0.219 | 0.584 | 1.091 | 0.291 | 0.596 | 1.112 | 0.464 | 0.192 | 9.303
COVID19_MODERNA | Rhinalgia | 0 | 0.371 | 0.003 | 0.584 | 2.211 |  |  |  |  |  | 
COVID19_MODERNA | Iron deficiency | 0 | 0.569 | 0.016 | 0.584 | 1.895 |  |  |  |  |  | 
COVID19_MODERNA | Hemiplegic migraine | 0 | 0.273 | 0 | 0.584 | 2.463 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound eye abnormal | 0 | 0.234 | 0 | 0.584 | 2.594 |  |  |  |  |  | 
COVID19_MODERNA | Malignant tumours (SMQ) [narrow] | 11 | 22.543 | 0.338 | 0.583 | 0.883 | 0.339 | 0.536 | 0.815 | 0.488 | 0.385 | 10.021
COVID19_MODERNA | Malignant tumours (SMQ) [broad] | 11 | 22.543 | 0.338 | 0.583 | 0.883 | 0.339 | 0.536 | 0.815 | 0.488 | 0.385 | 10.021
COVID19_MODERNA | Abdominal tenderness | 1 | 3.503 | 0.174 | 0.583 | 1.186 | 0.217 | 0.551 | 1.191 | 0.286 | 0.338 | 0.691
COVID19_MODERNA | Leukodystrophy | 0 | 0.273 | 0 | 0.583 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Cytogenetic abnormality | 0 | 0.351 | 0.002 | 0.583 | 2.255 |  |  |  |  |  | 
COVID19_MODERNA | Hepatotoxicity | 0 | 0.195 | 0 | 0.583 | 2.75 |  |  |  |  |  | 
COVID19_MODERNA | Abscess drainage | 0 | 0.857 | 0.045 | 0.583 | 1.64 |  |  |  |  |  | 
COVID19_MODERNA | Eosinophilic cellulitis | 0 | 0.258 | 0 | 0.583 | 2.509 |  |  |  |  |  | 
COVID19_MODERNA | Hair colour changes | 0 | 0.312 | 0.001 | 0.583 | 2.351 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster meningitis | 0 | 0.127 | 0 | 0.582 | 3.09 |  |  |  |  |  | 
COVID19_MODERNA | Human metapneumovirus test | 0 | 0.936 | 0.053 | 0.582 | 1.59 |  |  |  |  |  | 
COVID19_MODERNA | Blood heavy metal test | 0 | 0.551 | 0.014 | 0.582 | 1.917 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis post immunisation | 0 | 0.254 | 0 | 0.582 | 2.522 |  |  |  |  |  | 
COVID19_MODERNA | Cystoscopy | 0 | 0.351 | 0.002 | 0.582 | 2.255 |  |  |  |  |  | 
COVID19_MODERNA | Varicocele | 0 | 0.156 | 0 | 0.582 | 2.935 |  |  |  |  |  | 
COVID19_MODERNA | Leukaemia | 0 | 1.299 | 0.091 | 0.582 | 1.426 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy site unspecified normal | 0 | 0.139 | 0 | 0.581 | 3.022 |  |  |  |  |  | 
COVID19_MODERNA | Hyperaemia | 0 | 0.801 | 0.038 | 0.581 | 1.678 |  |  |  |  |  | 
COVID19_MODERNA | Chest scan | 0 | 0.312 | 0.001 | 0.581 | 2.35 |  |  |  |  |  | 
COVID19_MODERNA | Skin lesion removal | 0 | 0.351 | 0.002 | 0.581 | 2.254 |  |  |  |  |  | 
COVID19_MODERNA | Malignant or unspecified tumours (SMQ) [narrow] | 12 | 23.759 | 0.345 | 0.58 | 0.864 | 0.353 | 0.549 | 0.823 | 0.505 | 0.376 | 11.601
COVID19_MODERNA | Malignant or unspecified tumours (SMQ) [broad] | 12 | 23.759 | 0.345 | 0.58 | 0.864 | 0.353 | 0.549 | 0.823 | 0.505 | 0.376 | 11.601
COVID19_MODERNA | Muscle spasticity | 0 | 0.554 | 0.014 | 0.58 | 1.912 |  |  |  |  |  | 
COVID19_MODERNA | Noninfectious encephalitis (SMQ) [narrow] | 5 | 13.012 | 0.262 | 0.579 | 0.997 | 0.259 | 0.481 | 0.831 | 0.384 | 0.171 | 19.069
COVID19_MODERNA | Neurodermatitis | 0 | 0.241 | 0 | 0.579 | 2.563 |  |  |  |  |  | 
COVID19_MODERNA | Endoscopy upper gastrointestinal tract | 0 | 0.325 | 0.001 | 0.579 | 2.314 |  |  |  |  |  | 
COVID19_MODERNA | Sleep study abnormal | 0 | 0.368 | 0.002 | 0.579 | 2.214 |  |  |  |  |  | 
COVID19_MODERNA | Sinusitis | 3 | 8.667 | 0.227 | 0.578 | 1.059 | 0.235 | 0.487 | 0.913 | 0.346 | 0.253 | 5.792
COVID19_MODERNA | Joint warmth | 0 | 0.899 | 0.047 | 0.578 | 1.61 |  |  |  |  |  | 
COVID19_MODERNA | Amaurosis fugax | 0 | 0.269 | 0 | 0.578 | 2.471 |  |  |  |  |  | 
COVID19_MODERNA | Cervix disorder | 0 | 0.146 | 0 | 0.578 | 2.979 |  |  |  |  |  | 
COVID19_MODERNA | Coma scale normal | 0 | 0.668 | 0.023 | 0.577 | 1.787 |  |  |  |  |  | 
COVID19_MODERNA | Facial asymmetry | 1 | 4.902 | 0.184 | 0.576 | 1.146 | 0.166 | 0.449 | 0.993 | 0.204 | 0.503 | 0.107
COVID19_MODERNA | Microbiology test abnormal | 0 | 0.273 | 0 | 0.576 | 2.457 |  |  |  |  |  | 
COVID19_MODERNA | Glucose-6-phosphate dehydrogenase normal | 0 | 0.075 | 0 | 0.576 | 3.339 |  |  |  |  |  | 
COVID19_MODERNA | Vaginal disorder | 0 | 0.195 | 0 | 0.576 | 2.74 |  |  |  |  |  | 
COVID19_MODERNA | Stillbirth | 1 | 2.438 | 0.048 | 0.575 | 1.596 | 0.265 | 0.656 | 1.403 | 0.41 | 0.379 | 0.465
COVID19_MODERNA | Cortisol increased | 0 | 0.39 | 0.003 | 0.575 | 2.168 |  |  |  |  |  | 
COVID19_MODERNA | Connective tissue disorder | 0 | 0.51 | 0.009 | 0.575 | 1.967 |  |  |  |  |  | 
COVID19_MODERNA | Maternal exposure before pregnancy | 0 | 0.26 | 0 | 0.575 | 2.497 |  |  |  |  |  | 
COVID19_MODERNA | Demyelination (SMQ) [broad] | 31 | 63.459 | 0.418 | 0.574 | 0.749 | 0.38 | 0.507 | 0.667 | 0.489 | 0.282 | 55.747
COVID19_MODERNA | Vocal cord disorder | 0 | 0.665 | 0.022 | 0.574 | 1.788 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral circulatory failure | 0 | 0.351 | 0.002 | 0.574 | 2.25 |  |  |  |  |  | 
COVID19_MODERNA | Small intestinal intussusception reduction | 0 | 0.166 | 0 | 0.574 | 2.87 |  |  |  |  |  | 
COVID19_MODERNA | Blood phosphorus increased | 0 | 1.17 | 0.073 | 0.573 | 1.47 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmological examination normal | 0 | 0.897 | 0.045 | 0.573 | 1.609 |  |  |  |  |  | 
COVID19_MODERNA | Nail discolouration | 0 | 0.524 | 0.01 | 0.573 | 1.947 |  |  |  |  |  | 
COVID19_MODERNA | Penile erythema | 0 | 0.152 | 0 | 0.573 | 2.938 |  |  |  |  |  | 
COVID19_MODERNA | Menstruation delayed | 0 | 0.41 | 0.004 | 0.573 | 2.127 |  |  |  |  |  | 
COVID19_MODERNA | Appendicitis perforated | 1 | 4.773 | 0.091 | 0.572 | 1.395 | 0.171 | 0.457 | 1.008 | 0.21 | 1.37 | 0.081
COVID19_MODERNA | Carpal tunnel syndrome | 0 | 0.986 | 0.053 | 0.572 | 1.556 |  |  |  |  |  | 
COVID19_MODERNA | Hypothyroidism (SMQ) [broad] | 6 | 14.204 | 0.272 | 0.571 | 0.959 | 0.283 | 0.506 | 0.848 | 0.422 | 0.321 | 7.836
COVID19_MODERNA | Secondary transmission | 0 | 0.249 | 0 | 0.571 | 2.529 |  |  |  |  |  | 
COVID19_MODERNA | Blood count normal | 0 | 1.1 | 0.065 | 0.571 | 1.5 |  |  |  |  |  | 
COVID19_MODERNA | Glomerulonephritis acute | 0 | 0.234 | 0 | 0.571 | 2.582 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound skull abnormal | 0 | 0.27 | 0 | 0.57 | 2.46 |  |  |  |  |  | 
COVID19_MODERNA | Hepatocellular carcinoma | 0 | 0.153 | 0 | 0.57 | 2.926 |  |  |  |  |  | 
COVID19_MODERNA | Vestibular disorder | 0 | 0.569 | 0.013 | 0.57 | 1.888 |  |  |  |  |  | 
COVID19_MODERNA | Adjustment disorder | 0 | 0.351 | 0.002 | 0.57 | 2.247 |  |  |  |  |  | 
COVID19_MODERNA | Osteolysis | 0 | 0.312 | 0.001 | 0.57 | 2.342 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy | 1 | 4.038 | 0.188 | 0.569 | 1.117 | 0.196 | 0.508 | 1.107 | 0.248 | 0.252 | 1.5
COVID19_MODERNA | Eosinophil percentage increased | 0 | 1.701 | 0.116 | 0.569 | 1.302 |  |  |  |  |  | 
COVID19_MODERNA | Fibrin degradation products increased | 0 | 0.195 | 0 | 0.569 | 2.73 |  |  |  |  |  | 
COVID19_MODERNA | Clonus | 0 | 0.769 | 0.03 | 0.569 | 1.695 |  |  |  |  |  | 
COVID19_MODERNA | Self esteem decreased | 0 | 0.312 | 0.001 | 0.568 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Distractibility | 0 | 0.273 | 0 | 0.568 | 2.45 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy salivary gland normal | 0 | 0.234 | 0 | 0.567 | 2.576 |  |  |  |  |  | 
COVID19_MODERNA | Enterovirus test positive | 0 | 0.479 | 0.006 | 0.567 | 2.008 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocytosis | 0 | 1.576 | 0.105 | 0.567 | 1.331 |  |  |  |  |  | 
COVID19_MODERNA | Mycotic allergy | 0 | 0.312 | 0.001 | 0.567 | 2.339 |  |  |  |  |  | 
COVID19_MODERNA | Optical coherence tomography abnormal | 0 | 0.317 | 0.001 | 0.566 | 2.325 |  |  |  |  |  | 
COVID19_MODERNA | Complement deficiency disease | 0 | 0.156 | 0 | 0.566 | 2.905 |  |  |  |  |  | 
COVID19_MODERNA | Culture stool positive | 0 | 0.183 | 0 | 0.565 | 2.773 |  |  |  |  |  | 
COVID19_MODERNA | Anogenital warts | 0 | 0.113 | 0 | 0.565 | 3.12 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngitis | 2 | 4.452 | 0.171 | 0.564 | 1.141 | 0.28 | 0.62 | 1.224 | 0.449 | 0.181 | 6.561
COVID19_MODERNA | Escherichia test positive | 0 | 1.163 | 0.066 | 0.564 | 1.468 |  |  |  |  |  | 
COVID19_MODERNA | Vascular pain | 0 | 0.323 | 0.001 | 0.564 | 2.308 |  |  |  |  |  | 
COVID19_MODERNA | Papilloma excision | 0 | 0.246 | 0 | 0.564 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Glycosuria | 0 | 0.39 | 0.002 | 0.564 | 2.16 |  |  |  |  |  | 
COVID19_MODERNA | Trichomoniasis | 0 | 0.273 | 0 | 0.564 | 2.446 |  |  |  |  |  | 
COVID19_MODERNA | Culture urine positive | 1 | 3.139 | 0.164 | 0.563 | 1.157 | 0.232 | 0.583 | 1.256 | 0.319 | 0.411 | 0.337
COVID19_MODERNA | Tonsillitis | 0 | 0.696 | 0.022 | 0.563 | 1.754 |  |  |  |  |  | 
COVID19_MODERNA | Upper respiratory tract infection | 2 | 5.629 | 0.194 | 0.562 | 1.085 | 0.241 | 0.539 | 1.067 | 0.355 | 0.094 | 16.47
COVID19_MODERNA | Antimicrobial susceptibility test | 0 | 0.39 | 0.002 | 0.562 | 2.159 |  |  |  |  |  | 
COVID19_MODERNA | Human chorionic gonadotropin normal | 0 | 0.312 | 0.001 | 0.562 | 2.335 |  |  |  |  |  | 
COVID19_MODERNA | Adnexa uteri pain | 0 | 0.214 | 0 | 0.562 | 2.643 |  |  |  |  |  | 
COVID19_MODERNA | Psychiatric evaluation abnormal | 0 | 0.234 | 0 | 0.562 | 2.57 |  |  |  |  |  | 
COVID19_MODERNA | Barium double contrast | 0 | 0.211 | 0 | 0.561 | 2.654 |  |  |  |  |  | 
COVID19_MODERNA | Mucous stools | 0 | 0.721 | 0.023 | 0.561 | 1.73 |  |  |  |  |  | 
COVID19_MODERNA | Hysterectomy | 0 | 0.188 | 0 | 0.561 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Compartment syndrome | 0 | 0.39 | 0.002 | 0.56 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | Radiotherapy | 0 | 0.988 | 0.048 | 0.56 | 1.549 |  |  |  |  |  | 
COVID19_MODERNA | Foetal disorder | 0 | 0.282 | 0 | 0.56 | 2.416 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctival haemorrhage | 1 | 2.604 | 0.092 | 0.559 | 1.352 | 0.257 | 0.638 | 1.365 | 0.384 | 0.649 | 0
COVID19_MODERNA | Neurological decompensation | 0 | 0.409 | 0.003 | 0.559 | 2.119 |  |  |  |  |  | 
COVID19_MODERNA | Palindromic rheumatism | 0 | 0.312 | 0.001 | 0.559 | 2.332 |  |  |  |  |  | 
COVID19_MODERNA | Splenectomy | 0 | 0.486 | 0.006 | 0.559 | 1.993 |  |  |  |  |  | 
COVID19_MODERNA | Infantile back arching | 0 | 0.309 | 0 | 0.559 | 2.34 |  |  |  |  |  | 
COVID19_MODERNA | Schellong test | 0 | 0.112 | 0 | 0.559 | 3.108 |  |  |  |  |  | 
COVID19_MODERNA | Regurgitation | 0 | 0.56 | 0.01 | 0.558 | 1.892 |  |  |  |  |  | 
COVID19_MODERNA | Social anxiety disorder | 0 | 0.224 | 0 | 0.557 | 2.601 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal resection | 0 | 0.397 | 0.002 | 0.556 | 2.14 |  |  |  |  |  | 
COVID19_MODERNA | Breech presentation | 0 | 0.212 | 0 | 0.556 | 2.644 |  |  |  |  |  | 
COVID19_MODERNA | Colitis microscopic | 0 | 0.39 | 0.002 | 0.556 | 2.155 |  |  |  |  |  | 
COVID19_MODERNA | Hyperthermia | 0 | 0.467 | 0.005 | 0.556 | 2.019 |  |  |  |  |  | 
COVID19_MODERNA | Mental impairment | 8 | 17.936 | 0.287 | 0.555 | 0.896 | 0.304 | 0.511 | 0.818 | 0.446 | 0.854 | 0.074
COVID19_MODERNA | Ultrasound antenatal screen | 1 | 3.068 | 0.055 | 0.554 | 1.49 | 0.235 | 0.59 | 1.27 | 0.326 | 0.32 | 0.812
COVID19_MODERNA | Rash vesicular | 8 | 22.081 | 0.287 | 0.554 | 0.891 | 0.253 | 0.428 | 0.685 | 0.362 | 0.05 | 144.118
COVID19_MODERNA | Measles antibody | 0 | 0.359 | 0.001 | 0.554 | 2.216 |  |  |  |  |  | 
COVID19_MODERNA | Hordeolum | 1 | 2.676 | 0.171 | 0.553 | 1.112 | 0.253 | 0.63 | 1.349 | 0.374 | 1.028 | 0.24
COVID19_MODERNA | Apoptosis | 0 | 0.193 | 0 | 0.553 | 2.712 |  |  |  |  |  | 
COVID19_MODERNA | Product reconstitution quality issue | 0 | 0.198 | 0 | 0.553 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Polymenorrhoea | 0 | 0.245 | 0 | 0.553 | 2.523 |  |  |  |  |  | 
COVID19_MODERNA | Depression suicidal | 0 | 0.178 | 0 | 0.553 | 2.774 |  |  |  |  |  | 
COVID19_MODERNA | Pupillary reflex impaired | 0 | 1.403 | 0.081 | 0.552 | 1.372 |  |  |  |  |  | 
COVID19_MODERNA | Cervicectomy | 0 | 0.195 | 0 | 0.552 | 2.705 |  |  |  |  |  | 
COVID19_MODERNA | Necrotising colitis | 0 | 0.324 | 0.001 | 0.552 | 2.297 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune hypothyroidism | 0 | 0.195 | 0 | 0.552 | 2.704 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem auditory evoked response normal | 0 | 0.373 | 0.001 | 0.552 | 2.185 |  |  |  |  |  | 
COVID19_MODERNA | Malignant lymphomas (SMQ) [narrow] | 0 | 1.403 | 0.08 | 0.551 | 1.371 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to vaccine | 3 | 8.091 | 0.17 | 0.55 | 1.105 | 0.248 | 0.512 | 0.958 | 0.371 | 0.149 | 13.587
COVID19_MODERNA | Intestinal perforation | 0 | 0.437 | 0.003 | 0.55 | 2.064 |  |  |  |  |  | 
COVID19_MODERNA | Bronchiectasis | 0 | 0.408 | 0.002 | 0.55 | 2.115 |  |  |  |  |  | 
COVID19_MODERNA | Viral titre decreased | 0 | 0.164 | 0 | 0.55 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Malignancy related therapeutic and diagnostic procedures (SMQ) [broad] | 25 | 52.533 | 0.388 | 0.549 | 0.733 | 0.362 | 0.499 | 0.674 | 0.476 | 0.387 | 23.351
COVID19_MODERNA | Malignancy related therapeutic and diagnostic procedures (SMQ) [narrow] | 25 | 52.533 | 0.388 | 0.549 | 0.733 | 0.362 | 0.499 | 0.674 | 0.476 | 0.387 | 23.351
COVID19_MODERNA | Soft tissue infection | 0 | 0.274 | 0 | 0.549 | 2.427 |  |  |  |  |  | 
COVID19_MODERNA | Arthrogram | 0 | 0.195 | 0 | 0.549 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Perfusion brain scan normal | 0 | 0.331 | 0.001 | 0.548 | 2.276 |  |  |  |  |  | 
COVID19_MODERNA | Cystatin C | 0 | 0.273 | 0 | 0.548 | 2.428 |  |  |  |  |  | 
COVID19_MODERNA | Skin bacterial infection | 0 | 0.8 | 0.026 | 0.548 | 1.66 |  |  |  |  |  | 
COVID19_MODERNA | Skin neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.631 | 0.013 | 0.548 | 1.807 |  |  |  |  |  | 
COVID19_MODERNA | Treponema test negative | 1 | 3.74 | 0.101 | 0.547 | 1.285 | 0.207 | 0.531 | 1.152 | 0.267 | 0.176 | 3.023
COVID19_MODERNA | Pyelitis | 0 | 0.312 | 0 | 0.547 | 2.321 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac monitoring normal | 0 | 1.814 | 0.108 | 0.547 | 1.261 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B core antigen | 0 | 0.075 | 0 | 0.547 | 3.189 |  |  |  |  |  | 
COVID19_MODERNA | Asthmatic crisis | 0 | 0.286 | 0 | 0.547 | 2.388 |  |  |  |  |  | 
COVID19_MODERNA | Circumstance or information capable of leading to medication error | 1 | 2.264 | 0.13 | 0.546 | 1.194 | 0.274 | 0.677 | 1.445 | 0.442 | 0.106 | 6.589
COVID19_MODERNA | Viral myocarditis | 0 | 0.39 | 0.001 | 0.546 | 2.146 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound liver abnormal | 0 | 0.351 | 0.001 | 0.545 | 2.226 |  |  |  |  |  | 
COVID19_MODERNA | Q fever | 0 | 0.23 | 0 | 0.545 | 2.56 |  |  |  |  |  | 
COVID19_MODERNA | Precancerous skin lesion | 0 | 0.178 | 0 | 0.544 | 2.756 |  |  |  |  |  | 
COVID19_MODERNA | Mononeuropathy | 0 | 1.119 | 0.052 | 0.544 | 1.474 |  |  |  |  |  | 
COVID19_MODERNA | Neurosis | 0 | 0.193 | 0 | 0.544 | 2.698 |  |  |  |  |  | 
COVID19_MODERNA | Blood follicle stimulating hormone increased | 0 | 0.242 | 0 | 0.544 | 2.519 |  |  |  |  |  | 
COVID19_MODERNA | Presbyacusis | 0 | 0.152 | 0 | 0.544 | 2.871 |  |  |  |  |  | 
COVID19_MODERNA | Photopsia | 1 | 4.712 | 0.174 | 0.543 | 1.078 | 0.173 | 0.461 | 1.016 | 0.212 | 0.28 | 1.163
COVID19_MODERNA | Coombs indirect test positive | 0 | 0.195 | 0 | 0.543 | 2.687 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal hypoxia | 0 | 0.204 | 0 | 0.543 | 2.654 |  |  |  |  |  | 
COVID19_MODERNA | Arteriogram carotid normal | 5 | 10.621 | 0.269 | 0.542 | 0.891 | 0.304 | 0.563 | 0.971 | 0.471 | 3.978 | 7.115
COVID19_MODERNA | Pupil fixed | 1 | 3.744 | 0.168 | 0.542 | 1.089 | 0.207 | 0.531 | 1.152 | 0.267 | 0.649 | 0
COVID19_MODERNA | CSF cell count | 0 | 0.517 | 0.006 | 0.542 | 1.936 |  |  |  |  |  | 
COVID19_MODERNA | Ammonia | 0 | 0.273 | 0 | 0.542 | 2.421 |  |  |  |  |  | 
COVID19_MODERNA | Stereotypy | 0 | 0.885 | 0.031 | 0.542 | 1.598 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal rigidity | 0 | 1.315 | 0.068 | 0.542 | 1.395 |  |  |  |  |  | 
COVID19_MODERNA | Clinically isolated syndrome | 0 | 0.109 | 0 | 0.542 | 3.063 |  |  |  |  |  | 
COVID19_MODERNA | Acute disseminated encephalomyelitis | 1 | 3.628 | 0.108 | 0.541 | 1.244 | 0.212 | 0.54 | 1.17 | 0.276 | 0.126 | 5.136
COVID19_MODERNA | Coagulation factor V level decreased | 0 | 0.115 | 0 | 0.541 | 3.031 |  |  |  |  |  | 
COVID19_MODERNA | Cryotherapy | 0 | 0.359 | 0.001 | 0.541 | 2.204 |  |  |  |  |  | 
COVID19_MODERNA | Injection site hypertrichosis | 0 | 0.156 | 0 | 0.541 | 2.848 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic product effect incomplete | 0 | 0.122 | 0 | 0.54 | 2.999 |  |  |  |  |  | 
COVID19_MODERNA | Excessive ocular convergence | 0 | 0.078 | 0 | 0.54 | 3.147 |  |  |  |  |  | 
COVID19_MODERNA | Malignancies (SMQ) [broad] | 35 | 73.841 | 0.401 | 0.539 | 0.692 | 0.373 | 0.491 | 0.636 | 0.474 | 0.381 | 34.249
COVID19_MODERNA | Malignancies (SMQ) [narrow] | 35 | 73.841 | 0.401 | 0.539 | 0.692 | 0.373 | 0.491 | 0.636 | 0.474 | 0.381 | 34.249
COVID19_MODERNA | Discoloured vomit | 0 | 1.122 | 0.05 | 0.539 | 1.469 |  |  |  |  |  | 
COVID19_MODERNA | Oculogyric crisis | 0 | 0.488 | 0.004 | 0.539 | 1.974 |  |  |  |  |  | 
COVID19_MODERNA | Electromyogram normal | 1 | 4.317 | 0.095 | 0.538 | 1.278 | 0.186 | 0.487 | 1.067 | 0.232 | 0.206 | 2.282
COVID19_MODERNA | Radial nerve palsy | 0 | 0.43 | 0.002 | 0.538 | 2.065 |  |  |  |  |  | 
COVID19_MODERNA | Malabsorption | 0 | 0.365 | 0.001 | 0.538 | 2.189 |  |  |  |  |  | 
COVID19_MODERNA | Natural killer cell count | 0 | 0.326 | 0 | 0.538 | 2.275 |  |  |  |  |  | 
COVID19_MODERNA | Treponema test | 2 | 5.505 | 0.11 | 0.537 | 1.227 | 0.245 | 0.547 | 1.082 | 0.363 | 1.007 | 0.124
COVID19_MODERNA | Lymphocyte percentage increased | 1 | 3.175 | 0.106 | 0.537 | 1.239 | 0.23 | 0.58 | 1.249 | 0.315 | 0.092 | 8.056
COVID19_MODERNA | Uterine leiomyoma | 0 | 0.316 | 0 | 0.537 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Product use in unapproved indication | 0 | 0.274 | 0 | 0.537 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Pancreatitis chronic | 0 | 0.195 | 0 | 0.537 | 2.677 |  |  |  |  |  | 
COVID19_MODERNA | Acoustic stimulation tests | 2 | 6.489 | 0.207 | 0.536 | 0.989 | 0.218 | 0.491 | 0.976 | 0.308 | 0.736 | 0.014
COVID19_MODERNA | Single photon emission computerised tomogram normal | 0 | 0.073 | 0 | 0.536 | 3.122 |  |  |  |  |  | 
COVID19_MODERNA | Sensory integrative dysfunction | 0 | 0.263 | 0 | 0.536 | 2.443 |  |  |  |  |  | 
COVID19_MODERNA | Sleep talking | 0 | 1.054 | 0.043 | 0.536 | 1.499 |  |  |  |  |  | 
COVID19_MODERNA | Vesicoureteric reflux | 0 | 0.234 | 0 | 0.535 | 2.533 |  |  |  |  |  | 
COVID19_MODERNA | Conjunctivitis | 2 | 5.184 | 0.157 | 0.534 | 1.093 | 0.255 | 0.567 | 1.122 | 0.386 | 0.167 | 7.448
COVID19_MODERNA | Vital functions abnormal | 2 | 5.763 | 0.175 | 0.534 | 1.053 | 0.237 | 0.531 | 1.052 | 0.347 | 3.523 | 1.282
COVID19_MODERNA | CD8 lymphocytes | 0 | 0.268 | 0 | 0.534 | 2.424 |  |  |  |  |  | 
COVID19_MODERNA | Varicella post vaccine | 0 | 0.221 | 0 | 0.534 | 2.575 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune haemolytic anaemia | 0 | 1.262 | 0.059 | 0.534 | 1.408 |  |  |  |  |  | 
COVID19_MODERNA | Intestinal anastomosis | 0 | 0.234 | 0 | 0.534 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Tongue movement disturbance | 1 | 3.491 | 0.114 | 0.533 | 1.202 | 0.217 | 0.552 | 1.193 | 0.286 | 0.771 | 0.037
COVID19_MODERNA | Immobilisation syndrome | 0 | 0.154 | 0 | 0.533 | 2.836 |  |  |  |  |  | 
COVID19_MODERNA | Prothrombin time ratio | 0 | 0.225 | 0 | 0.533 | 2.559 |  |  |  |  |  | 
COVID19_MODERNA | Coombs direct test positive | 0 | 0.39 | 0.001 | 0.533 | 2.134 |  |  |  |  |  | 
COVID19_MODERNA | Catarrh | 0 | 0.438 | 0.002 | 0.533 | 2.047 |  |  |  |  |  | 
COVID19_MODERNA | Depression (excl suicide and self injury) (SMQ) [narrow] | 6 | 15.065 | 0.254 | 0.532 | 0.892 | 0.27 | 0.482 | 0.808 | 0.398 | 0.19 | 19.827
COVID19_MODERNA | Hepatitis C antibody positive | 0 | 0.234 | 0 | 0.532 | 2.528 |  |  |  |  |  | 
COVID19_MODERNA | Electrocardiogram QT interval | 0 | 0.39 | 0.001 | 0.532 | 2.133 |  |  |  |  |  | 
COVID19_MODERNA | Cytomegalovirus infection | 0 | 0.432 | 0.002 | 0.532 | 2.057 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin M normal | 0 | 1.095 | 0.044 | 0.53 | 1.475 |  |  |  |  |  | 
COVID19_MODERNA | Cystitis interstitial | 0 | 0.317 | 0 | 0.529 | 2.288 |  |  |  |  |  | 
COVID19_MODERNA | Tumour marker test | 0 | 0.234 | 0 | 0.528 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Coxsackie virus test positive | 0 | 0.592 | 0.007 | 0.528 | 1.834 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin A increased | 0 | 0.951 | 0.032 | 0.528 | 1.548 |  |  |  |  |  | 
COVID19_MODERNA | Activated partial thromboplastin time ratio | 0 | 0.307 | 0 | 0.528 | 2.31 |  |  |  |  |  | 
COVID19_MODERNA | Vascular purpura | 0 | 0.351 | 0 | 0.528 | 2.208 |  |  |  |  |  | 
COVID19_MODERNA | Hypotonic-hyporesponsive episode | 0 | 0.695 | 0.013 | 0.528 | 1.73 |  |  |  |  |  | 
COVID19_MODERNA | Hypotonic-hyporesponsive episode (SMQ) [narrow] | 0 | 0.695 | 0.013 | 0.528 | 1.73 |  |  |  |  |  | 
COVID19_MODERNA | CSF oligoclonal band present | 0 | 0.479 | 0.003 | 0.527 | 1.978 |  |  |  |  |  | 
COVID19_MODERNA | Reactogenicity event | 0 | 0.302 | 0 | 0.527 | 2.322 |  |  |  |  |  | 
COVID19_MODERNA | Hypercholesterolaemia | 0 | 0.283 | 0 | 0.526 | 2.371 |  |  |  |  |  | 
COVID19_MODERNA | Skin fissures | 0 | 1.119 | 0.044 | 0.526 | 1.461 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral circulatory failure | 0 | 0.195 | 0 | 0.526 | 2.655 |  |  |  |  |  | 
COVID19_MODERNA | Colposcopy abnormal | 0 | 0.101 | 0 | 0.526 | 3.025 |  |  |  |  |  | 
COVID19_MODERNA | Immunophenotyping | 0 | 0.357 | 0.001 | 0.526 | 2.193 |  |  |  |  |  | 
COVID19_MODERNA | Measles antibody positive | 0 | 0.308 | 0 | 0.526 | 2.305 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound scan abnormal | 9 | 19.216 | 0.293 | 0.525 | 0.81 | 0.32 | 0.527 | 0.826 | 0.468 | 0.52 | 3.441
COVID19_MODERNA | Vascular endothelial growth factor assay | 0 | 0.073 | 0 | 0.525 | 3.051 |  |  |  |  |  | 
COVID19_MODERNA | Meningoencephalitis herpetic | 0 | 0.39 | 0.001 | 0.525 | 2.126 |  |  |  |  |  | 
COVID19_MODERNA | Diabetes mellitus inadequate control | 0 | 2.207 | 0.117 | 0.525 | 1.171 |  |  |  |  |  | 
COVID19_MODERNA | Emergency care examination | 0 | 0.154 | 0 | 0.524 | 2.811 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis enteroviral | 0 | 0.154 | 0 | 0.524 | 2.812 |  |  |  |  |  | 
COVID19_MODERNA | Cryoglobulins present | 0 | 0.253 | 0 | 0.524 | 2.455 |  |  |  |  |  | 
COVID19_MODERNA | Loss of employment | 0 | 0.39 | 0.001 | 0.523 | 2.124 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal weight gain | 0 | 0.239 | 0 | 0.523 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Urine sodium | 0 | 0.273 | 0 | 0.523 | 2.395 |  |  |  |  |  | 
COVID19_MODERNA | Monoclonal gammopathy | 0 | 0.234 | 0 | 0.523 | 2.512 |  |  |  |  |  | 
COVID19_MODERNA | Limb immobilisation | 0 | 0.539 | 0.004 | 0.522 | 1.891 |  |  |  |  |  | 
COVID19_MODERNA | Foetal heart rate increased | 0 | 0.117 | 0 | 0.522 | 2.953 |  |  |  |  |  | 
COVID19_MODERNA | Skin malignant tumours (SMQ) [broad] | 0 | 0.522 | 0.004 | 0.522 | 1.913 |  |  |  |  |  | 
COVID19_MODERNA | Normal pregnancy conditions and outcomes (SMQ) [broad] | 14 | 32.591 | 0.318 | 0.521 | 0.763 | 0.31 | 0.47 | 0.689 | 0.43 | 0.53 | 5.27
COVID19_MODERNA | Homeopathy | 0 | 0.273 | 0 | 0.521 | 2.392 |  |  |  |  |  | 
COVID19_MODERNA | Phlebitis | 0 | 0.933 | 0.028 | 0.521 | 1.553 |  |  |  |  |  | 
COVID19_MODERNA | Lens disorders (SMQ) [narrow] | 0 | 1.092 | 0.039 | 0.521 | 1.469 |  |  |  |  |  | 
COVID19_MODERNA | Optic atrophy | 0 | 0.369 | 0.001 | 0.521 | 2.163 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract infection bacterial | 0 | 0.234 | 0 | 0.521 | 2.509 |  |  |  |  |  | 
COVID19_MODERNA | Beta-2 glycoprotein antibody positive | 0 | 0.351 | 0 | 0.519 | 2.198 |  |  |  |  |  | 
COVID19_MODERNA | Culture positive | 0 | 0.711 | 0.012 | 0.519 | 1.709 |  |  |  |  |  | 
COVID19_MODERNA | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [broad] | 0 | 0.189 | 0 | 0.519 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin G normal | 1 | 3.391 | 0.118 | 0.518 | 1.149 | 0.221 | 0.56 | 1.21 | 0.295 | 0.174 | 3.098
COVID19_MODERNA | Abortion | 0 | 0.223 | 0 | 0.518 | 2.537 |  |  |  |  |  | 
COVID19_MODERNA | Antibody test abnormal | 0 | 0.475 | 0.002 | 0.518 | 1.975 |  |  |  |  |  | 
COVID19_MODERNA | Magnetic resonance imaging spinal normal | 2 | 6.509 | 0.191 | 0.517 | 0.972 | 0.217 | 0.49 | 0.974 | 0.307 | 0.28 | 2.954
COVID19_MODERNA | Cortical dysplasia | 0 | 0.11 | 0 | 0.516 | 2.952 |  |  |  |  |  | 
COVID19_MODERNA | Body temperature fluctuation | 0 | 0.857 | 0.021 | 0.516 | 1.597 |  |  |  |  |  | 
COVID19_MODERNA | Bed rest | 0 | 2.484 | 0.125 | 0.516 | 1.123 |  |  |  |  |  | 
COVID19_MODERNA | T-lymphocyte count | 0 | 0.233 | 0 | 0.515 | 2.503 |  |  |  |  |  | 
COVID19_MODERNA | Chronic lymphocytic leukaemia | 0 | 0.39 | 0.001 | 0.515 | 2.114 |  |  |  |  |  | 
COVID19_MODERNA | Alanine aminotransferase decreased | 0 | 0.351 | 0 | 0.515 | 2.193 |  |  |  |  |  | 
COVID19_MODERNA | Skin turgor decreased | 0 | 0.312 | 0 | 0.515 | 2.282 |  |  |  |  |  | 
COVID19_MODERNA | Metabolic alkalosis | 0 | 0.156 | 0 | 0.514 | 2.775 |  |  |  |  |  | 
COVID19_MODERNA | Hirsutism | 0 | 0.286 | 0 | 0.514 | 2.344 |  |  |  |  |  | 
COVID19_MODERNA | Product temperature excursion issue | 0 | 0.222 | 0 | 0.514 | 2.532 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract infection viral | 0 | 0.435 | 0.001 | 0.514 | 2.034 |  |  |  |  |  | 
COVID19_MODERNA | Phototherapy | 0 | 0.262 | 0 | 0.513 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Coombs test negative | 0 | 0.39 | 0.001 | 0.513 | 2.113 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis C RNA increased | 0 | 0.234 | 0 | 0.513 | 2.495 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal neoplasms (SMQ) [broad] | 0 | 1.251 | 0.048 | 0.512 | 1.395 |  |  |  |  |  | 
COVID19_MODERNA | Oropharyngeal neoplasms (SMQ) [narrow] | 0 | 1.251 | 0.048 | 0.512 | 1.395 |  |  |  |  |  | 
COVID19_MODERNA | Heavy menstrual bleeding | 2 | 4.691 | 0.115 | 0.511 | 1.137 | 0.271 | 0.602 | 1.188 | 0.426 | 0.401 | 1.202
COVID19_MODERNA | Blood cortisol | 0 | 0.664 | 0.009 | 0.511 | 1.745 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin A normal | 0 | 1.074 | 0.034 | 0.511 | 1.47 |  |  |  |  |  | 
COVID19_MODERNA | Colectomy | 0 | 0.353 | 0 | 0.511 | 2.183 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin M | 1 | 3.304 | 0.157 | 0.51 | 1.027 | 0.225 | 0.568 | 1.226 | 0.303 | 0.448 | 0.222
COVID19_MODERNA | Skin malignant tumours (SMQ) [narrow] | 0 | 0.433 | 0.001 | 0.51 | 2.033 |  |  |  |  |  | 
COVID19_MODERNA | Cell death | 0 | 0.234 | 0 | 0.509 | 2.487 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin G | 1 | 3.661 | 0.104 | 0.507 | 1.16 | 0.21 | 0.537 | 1.165 | 0.273 | 0.277 | 1.196
COVID19_MODERNA | Neutrophilic dermatosis | 0 | 0.181 | 0 | 0.507 | 2.662 |  |  |  |  |  | 
COVID19_MODERNA | Human papilloma virus test negative | 0 | 0.215 | 0 | 0.507 | 2.543 |  |  |  |  |  | 
COVID19_MODERNA | Scan with contrast abnormal | 5 | 12.039 | 0.251 | 0.506 | 0.833 | 0.276 | 0.512 | 0.883 | 0.415 | 1.601 | 0.554
COVID19_MODERNA | Coagulation factor V level normal | 0 | 0.273 | 0 | 0.506 | 2.367 |  |  |  |  |  | 
COVID19_MODERNA | Haemophilus infection | 0 | 0.141 | 0 | 0.506 | 2.805 |  |  |  |  |  | 
COVID19_MODERNA | Blood cholesterol | 0 | 1.612 | 0.069 | 0.506 | 1.276 |  |  |  |  |  | 
COVID19_MODERNA | Prenatal screening test abnormal | 0 | 0.195 | 0 | 0.505 | 2.606 |  |  |  |  |  | 
COVID19_MODERNA | CSF cell count increased | 0 | 0.471 | 0.002 | 0.505 | 1.968 |  |  |  |  |  | 
COVID19_MODERNA | Sleep paralysis | 0 | 0.355 | 0 | 0.505 | 2.172 |  |  |  |  |  | 
COVID19_MODERNA | Tuberculin test | 0 | 1.021 | 0.029 | 0.505 | 1.491 |  |  |  |  |  | 
COVID19_MODERNA | Postural orthostatic tachycardia syndrome | 1 | 3.898 | 0.048 | 0.504 | 1.367 | 0.201 | 0.519 | 1.128 | 0.257 | 0.062 | 13.144
COVID19_MODERNA | X-ray gastrointestinal tract abnormal | 0 | 0.344 | 0 | 0.504 | 2.192 |  |  |  |  |  | 
COVID19_MODERNA | Gastric hypomotility | 0 | 0.152 | 0 | 0.504 | 2.761 |  |  |  |  |  | 
COVID19_MODERNA | Ileostomy | 0 | 0.371 | 0 | 0.504 | 2.137 |  |  |  |  |  | 
COVID19_MODERNA | Fine motor delay | 0 | 0.234 | 0 | 0.504 | 2.476 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal infection | 0 | 0.234 | 0 | 0.503 | 2.474 |  |  |  |  |  | 
COVID19_MODERNA | Language disorder | 0 | 0.843 | 0.017 | 0.503 | 1.594 |  |  |  |  |  | 
COVID19_MODERNA | Concomitant disease progression | 0 | 0.307 | 0 | 0.502 | 2.273 |  |  |  |  |  | 
COVID19_MODERNA | Rubella antibody test | 0 | 0.254 | 0 | 0.501 | 2.41 |  |  |  |  |  | 
COVID19_MODERNA | Exposure via eye contact | 0 | 0.469 | 0.001 | 0.501 | 1.966 |  |  |  |  |  | 
COVID19_MODERNA | Barium enema normal | 0 | 0.215 | 0 | 0.501 | 2.531 |  |  |  |  |  | 
COVID19_MODERNA | Ophthalmological examination abnormal | 2 | 6.168 | 0.15 | 0.5 | 1.016 | 0.226 | 0.508 | 1.008 | 0.324 | 0.488 | 0.594
COVID19_MODERNA | Sputum discoloured | 1 | 3.609 | 0.103 | 0.5 | 1.141 | 0.212 | 0.542 | 1.174 | 0.277 | 0.294 | 1.032
COVID19_MODERNA | Microscopic polyangiitis | 0 | 0.312 | 0 | 0.5 | 2.258 |  |  |  |  |  | 
COVID19_MODERNA | Blood smear test | 1 | 3.335 | 0.121 | 0.499 | 1.086 | 0.223 | 0.565 | 1.22 | 0.3 | 1.644 | 0.025
COVID19_MODERNA | Colour vision tests normal | 0 | 0.217 | 0 | 0.499 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Eye inflammation | 0 | 3.056 | 0.138 | 0.499 | 1.043 |  |  |  |  |  | 
COVID19_MODERNA | Basedow's disease | 0 | 0.825 | 0.015 | 0.498 | 1.602 |  |  |  |  |  | 
COVID19_MODERNA | Drowning | 0 | 0.312 | 0 | 0.498 | 2.255 |  |  |  |  |  | 
COVID19_MODERNA | Viral titre increased | 0 | 0.908 | 0.019 | 0.498 | 1.548 |  |  |  |  |  | 
COVID19_MODERNA | Maternal exposure during breast feeding | 2 | 5.023 | 0.115 | 0.497 | 1.099 | 0.26 | 0.578 | 1.142 | 0.398 | 0.913 | 0.048
COVID19_MODERNA | Deafness | 9 | 23.204 | 0.279 | 0.497 | 0.767 | 0.272 | 0.448 | 0.703 | 0.388 | 0.59 | 2.103
COVID19_MODERNA | Hypovolaemic shock | 0 | 0.334 | 0 | 0.497 | 2.204 |  |  |  |  |  | 
COVID19_MODERNA | Humoral immune defect | 0 | 0.153 | 0 | 0.497 | 2.732 |  |  |  |  |  | 
COVID19_MODERNA | Coxiella test | 0 | 0.309 | 0 | 0.495 | 2.258 |  |  |  |  |  | 
COVID19_MODERNA | Slow speech | 0 | 1.116 | 0.031 | 0.495 | 1.436 |  |  |  |  |  | 
COVID19_MODERNA | Fibromyalgia | 1 | 3.023 | 0.059 | 0.494 | 1.285 | 0.237 | 0.594 | 1.278 | 0.331 | 0.084 | 9.092
COVID19_MODERNA | Vaccination site movement impairment | 2 | 6.558 | 0.169 | 0.494 | 0.957 | 0.216 | 0.488 | 0.969 | 0.305 | 1.203 | 0.019
COVID19_MODERNA | Smear cervix normal | 0 | 0.28 | 0 | 0.494 | 2.326 |  |  |  |  |  | 
COVID19_MODERNA | Soft tissue mass | 0 | 0.234 | 0 | 0.494 | 2.455 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy skin normal | 0 | 0.511 | 0.002 | 0.494 | 1.898 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site eczema | 0 | 0.204 | 0 | 0.494 | 2.551 |  |  |  |  |  | 
COVID19_MODERNA | Forced vital capacity decreased | 0 | 0.145 | 0 | 0.493 | 2.746 |  |  |  |  |  | 
COVID19_MODERNA | Microsomia | 0 | 0.145 | 0 | 0.493 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Organic brain syndrome | 0 | 0.312 | 0 | 0.493 | 2.248 |  |  |  |  |  | 
COVID19_MODERNA | ADAMTS13 activity decreased | 0 | 0.145 | 0 | 0.493 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Slit-lamp tests normal | 0 | 0.145 | 0 | 0.493 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | FEV1/FVC ratio abnormal | 0 | 0.145 | 0 | 0.493 | 2.748 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound antenatal screen abnormal | 3 | 7.591 | 0.15 | 0.492 | 0.993 | 0.26 | 0.536 | 1.001 | 0.395 | 0.732 | 0.079
COVID19_MODERNA | Oesophageal variceal ligation | 0 | 0.115 | 0 | 0.492 | 2.831 |  |  |  |  |  | 
COVID19_MODERNA | Chronic inflammatory demyelinating polyradiculoneuropathy | 0 | 0.822 | 0.013 | 0.492 | 1.598 |  |  |  |  |  | 
COVID19_MODERNA | Mitochondrial cytopathy | 0 | 0.351 | 0 | 0.492 | 2.16 |  |  |  |  |  | 
COVID19_MODERNA | Insulin resistance | 0 | 0.245 | 0 | 0.491 | 2.418 |  |  |  |  |  | 
COVID19_MODERNA | Injury associated with device | 0 | 0.795 | 0.012 | 0.49 | 1.616 |  |  |  |  |  | 
COVID19_MODERNA | Severe myoclonic epilepsy of infancy | 0 | 0.186 | 0 | 0.49 | 2.599 |  |  |  |  |  | 
COVID19_MODERNA | Oophorectomy | 0 | 0.239 | 0 | 0.49 | 2.431 |  |  |  |  |  | 
COVID19_MODERNA | Blood beryllium | 0 | 0.234 | 0 | 0.489 | 2.444 |  |  |  |  |  | 
COVID19_MODERNA | Large intestine perforation | 0 | 0.351 | 0 | 0.489 | 2.157 |  |  |  |  |  | 
COVID19_MODERNA | Mood altered | 0 | 1.387 | 0.046 | 0.489 | 1.327 |  |  |  |  |  | 
COVID19_MODERNA | Vacuum extractor delivery | 0 | 0.234 | 0 | 0.489 | 2.445 |  |  |  |  |  | 
COVID19_MODERNA | Enuresis | 0 | 0.782 | 0.011 | 0.489 | 1.625 |  |  |  |  |  | 
COVID19_MODERNA | Varicella | 1 | 2.785 | 0.049 | 0.488 | 1.313 | 0.248 | 0.618 | 1.326 | 0.359 | 0.076 | 10.252
COVID19_MODERNA | Pre-eclampsia | 1 | 3.899 | 0.048 | 0.488 | 1.318 | 0.201 | 0.518 | 1.128 | 0.256 | 0.465 | 0.181
COVID19_MODERNA | Blood immunoglobulin M decreased | 0 | 0.748 | 0.009 | 0.488 | 1.651 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis acute | 0 | 0.844 | 0.014 | 0.488 | 1.58 |  |  |  |  |  | 
COVID19_MODERNA | Congenital anomaly | 0 | 0.241 | 0 | 0.488 | 2.422 |  |  |  |  |  | 
COVID19_MODERNA | Hypometabolism | 0 | 0.286 | 0 | 0.487 | 2.299 |  |  |  |  |  | 
COVID19_MODERNA | Myelocyte present | 0 | 0.156 | 0 | 0.487 | 2.689 |  |  |  |  |  | 
COVID19_MODERNA | Immunodeficiency common variable | 0 | 0.312 | 0 | 0.486 | 2.236 |  |  |  |  |  | 
COVID19_MODERNA | Renin normal | 0 | 0.153 | 0 | 0.486 | 2.694 |  |  |  |  |  | 
COVID19_MODERNA | Mast cell activation syndrome | 0 | 0.395 | 0 | 0.486 | 2.068 |  |  |  |  |  | 
COVID19_MODERNA | Intraocular pressure test normal | 0 | 0.428 | 0.001 | 0.486 | 2.011 |  |  |  |  |  | 
COVID19_MODERNA | Serum ferritin normal | 0 | 2.69 | 0.113 | 0.486 | 1.071 |  |  |  |  |  | 
COVID19_MODERNA | Umbilical hernia | 0 | 0.312 | 0 | 0.485 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | Influenza | 11 | 24.256 | 0.277 | 0.484 | 0.738 | 0.318 | 0.503 | 0.765 | 0.453 | 0.103 | 85.445
COVID19_MODERNA | Hyperthyroidism (SMQ) [broad] | 4 | 11.477 | 0.194 | 0.484 | 0.881 | 0.237 | 0.463 | 0.83 | 0.349 | 0.214 | 10.707
COVID19_MODERNA | Liver injury | 1 | 3.708 | 0.148 | 0.484 | 0.976 | 0.208 | 0.534 | 1.157 | 0.27 | 0.725 | 0.014
COVID19_MODERNA | Ear disorder | 0 | 0.728 | 0.008 | 0.484 | 1.662 |  |  |  |  |  | 
COVID19_MODERNA | Natural killer cell count increased | 0 | 0.27 | 0 | 0.484 | 2.332 |  |  |  |  |  | 
COVID19_MODERNA | Radioisotope scan normal | 0 | 0.251 | 0 | 0.483 | 2.383 |  |  |  |  |  | 
COVID19_MODERNA | Opportunistic infections (SMQ) [broad] | 398 | 840.399 | 0.443 | 0.482 | 0.522 | 0.437 | 0.475 | 0.515 | 0.474 | 0.454 | 273.12
COVID19_MODERNA | Neonatal disorders (SMQ) [broad] | 3 | 10.615 | 0.168 | 0.481 | 0.925 | 0.199 | 0.418 | 0.787 | 0.283 | 0.049 | 54.365
COVID19_MODERNA | Viral sepsis | 0 | 0.146 | 0 | 0.481 | 2.697 |  |  |  |  |  | 
COVID19_MODERNA | Premalignant disorders, general conditions and other site specific disorders (SMQ) [narrow] | 0 | 0.212 | 0 | 0.481 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Administration site abscess sterile | 0 | 0.078 | 0 | 0.481 | 2.779 |  |  |  |  |  | 
COVID19_MODERNA | Abdominal mass | 0 | 0.297 | 0 | 0.481 | 2.262 |  |  |  |  |  | 
COVID19_MODERNA | Ectopic pregnancy | 0 | 0.312 | 0 | 0.481 | 2.228 |  |  |  |  |  | 
COVID19_MODERNA | Premalignant disorders, general conditions and other site specific disorders (SMQ) [broad] | 0 | 0.212 | 0 | 0.481 | 2.49 |  |  |  |  |  | 
COVID19_MODERNA | Subacute sclerosing panencephalitis | 0 | 0.234 | 0 | 0.481 | 2.426 |  |  |  |  |  | 
COVID19_MODERNA | Dehydroepiandrosterone decreased | 0 | 0.228 | 0 | 0.48 | 2.442 |  |  |  |  |  | 
COVID19_MODERNA | CSF lymphocyte count increased | 0 | 1.016 | 0.021 | 0.48 | 1.472 |  |  |  |  |  | 
COVID19_MODERNA | Reflex test abnormal | 0 | 0.273 | 0 | 0.48 | 2.318 |  |  |  |  |  | 
COVID19_MODERNA | Brain operation | 0 | 0.934 | 0.016 | 0.48 | 1.515 |  |  |  |  |  | 
COVID19_MODERNA | West Nile virus test positive | 0 | 0.155 | 0 | 0.48 | 2.665 |  |  |  |  |  | 
COVID19_MODERNA | Anti-platelet antibody positive | 0 | 0.312 | 0 | 0.479 | 2.224 |  |  |  |  |  | 
COVID19_MODERNA | Intraventricular haemorrhage neonatal | 0 | 0.156 | 0 | 0.479 | 2.661 |  |  |  |  |  | 
COVID19_MODERNA | Congenital neurological disorder | 0 | 0.116 | 0 | 0.478 | 2.764 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal wall thickening | 0 | 0.57 | 0.002 | 0.478 | 1.809 |  |  |  |  |  | 
COVID19_MODERNA | Acarodermatitis | 0 | 1.141 | 0.027 | 0.478 | 1.41 |  |  |  |  |  | 
COVID19_MODERNA | Aspergillus infection | 0 | 0.156 | 0 | 0.477 | 2.651 |  |  |  |  |  | 
COVID19_MODERNA | Monocyte count | 0 | 0.813 | 0.01 | 0.476 | 1.589 |  |  |  |  |  | 
COVID19_MODERNA | Albumin CSF increased | 0 | 0.6 | 0.003 | 0.476 | 1.773 |  |  |  |  |  | 
COVID19_MODERNA | Exercise tolerance decreased | 1 | 3.232 | 0.074 | 0.475 | 1.162 | 0.228 | 0.575 | 1.239 | 0.309 | 0.187 | 2.724
COVID19_MODERNA | Lymphadenitis bacterial | 0 | 0.237 | 0 | 0.475 | 2.402 |  |  |  |  |  | 
COVID19_MODERNA | CD4 lymphocytes | 0 | 0.323 | 0 | 0.474 | 2.19 |  |  |  |  |  | 
COVID19_MODERNA | Joint dislocation | 0 | 2.3 | 0.088 | 0.474 | 1.112 |  |  |  |  |  | 
COVID19_MODERNA | Infantile vomiting | 0 | 0.286 | 0 | 0.474 | 2.274 |  |  |  |  |  | 
COVID19_MODERNA | Urine protein/creatinine ratio increased | 0 | 0.253 | 0 | 0.473 | 2.354 |  |  |  |  |  | 
COVID19_MODERNA | Cataract | 0 | 1.233 | 0.031 | 0.473 | 1.368 |  |  |  |  |  | 
COVID19_MODERNA | Azotaemia | 0 | 2.207 | 0.083 | 0.473 | 1.125 |  |  |  |  |  | 
COVID19_MODERNA | Prolonged labour | 0 | 0.39 | 0 | 0.473 | 2.058 |  |  |  |  |  | 
COVID19_MODERNA | Blood luteinising hormone increased | 0 | 0.286 | 0 | 0.472 | 2.268 |  |  |  |  |  | 
COVID19_MODERNA | Dermatitis atopic | 0 | 0.726 | 0.006 | 0.472 | 1.652 |  |  |  |  |  | 
COVID19_MODERNA | Shift to the left | 0 | 1.215 | 0.03 | 0.472 | 1.374 |  |  |  |  |  | 
COVID19_MODERNA | Joint injection | 0 | 1.105 | 0.023 | 0.472 | 1.42 |  |  |  |  |  | 
COVID19_MODERNA | Neurogenic bladder | 0 | 0.344 | 0 | 0.472 | 2.142 |  |  |  |  |  | 
COVID19_MODERNA | Liver neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.312 | 0 | 0.471 | 2.208 |  |  |  |  |  | 
COVID19_MODERNA | Uterine pain | 0 | 0.287 | 0 | 0.471 | 2.265 |  |  |  |  |  | 
COVID19_MODERNA | Measles | 0 | 0.478 | 0.001 | 0.471 | 1.916 |  |  |  |  |  | 
COVID19_MODERNA | Liver neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.312 | 0 | 0.471 | 2.208 |  |  |  |  |  | 
COVID19_MODERNA | Procedural failure | 0 | 0.234 | 0 | 0.471 | 2.401 |  |  |  |  |  | 
COVID19_MODERNA | Chronic gastritis | 0 | 0.312 | 0 | 0.47 | 2.206 |  |  |  |  |  | 
COVID19_MODERNA | Hepatomegaly | 0 | 0.786 | 0.008 | 0.469 | 1.602 |  |  |  |  |  | 
COVID19_MODERNA | Dysplasia | 0 | 0.317 | 0 | 0.469 | 2.191 |  |  |  |  |  | 
COVID19_MODERNA | Psychomotor retardation | 0 | 0.372 | 0 | 0.469 | 2.082 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site joint swelling | 0 | 0.294 | 0 | 0.468 | 2.243 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial test negative | 0 | 2.223 | 0.081 | 0.468 | 1.118 |  |  |  |  |  | 
COVID19_MODERNA | CSF red blood cell count positive | 1 | 3.742 | 0.065 | 0.467 | 1.172 | 0.207 | 0.531 | 1.152 | 0.267 | 0.149 | 4.012
COVID19_MODERNA | Adverse drug reaction | 0 | 1.235 | 0.029 | 0.467 | 1.361 |  |  |  |  |  | 
COVID19_MODERNA | Ehlers-Danlos syndrome | 0 | 0.228 | 0 | 0.466 | 2.404 |  |  |  |  |  | 
COVID19_MODERNA | Skin wound | 0 | 0.297 | 0 | 0.466 | 2.233 |  |  |  |  |  | 
COVID19_MODERNA | Intelligence test abnormal | 0 | 0.231 | 0 | 0.465 | 2.392 |  |  |  |  |  | 
COVID19_MODERNA | Brudzinski's sign | 0 | 0.309 | 0 | 0.464 | 2.2 |  |  |  |  |  | 
COVID19_MODERNA | Sinus headache | 1 | 3.577 | 0.112 | 0.463 | 1.007 | 0.214 | 0.544 | 1.179 | 0.28 | 0.379 | 0.465
COVID19_MODERNA | Hypogeusia | 1 | 4.404 | 0.112 | 0.463 | 1.009 | 0.183 | 0.481 | 1.056 | 0.227 | 1.072 | 0.211
COVID19_MODERNA | Meningitis meningococcal | 0 | 0.212 | 0 | 0.462 | 2.439 |  |  |  |  |  | 
COVID19_MODERNA | Electroneurography | 0 | 0.286 | 0 | 0.462 | 2.25 |  |  |  |  |  | 
COVID19_MODERNA | Antibody test positive | 0 | 1.066 | 0.019 | 0.461 | 1.428 |  |  |  |  |  | 
COVID19_MODERNA | Dermo-hypodermitis | 0 | 0.319 | 0 | 0.46 | 2.17 |  |  |  |  |  | 
COVID19_MODERNA | Central pain syndrome | 0 | 0.193 | 0 | 0.46 | 2.485 |  |  |  |  |  | 
COVID19_MODERNA | Coronary artery aneurysm | 0 | 0.32 | 0 | 0.46 | 2.168 |  |  |  |  |  | 
COVID19_MODERNA | Double stranded DNA antibody positive | 0 | 0.389 | 0 | 0.459 | 2.037 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis enteroviral | 0 | 0.116 | 0 | 0.458 | 2.66 |  |  |  |  |  | 
COVID19_MODERNA | Vogt-Koyanagi-Harada disease | 0 | 0.217 | 0 | 0.458 | 2.414 |  |  |  |  |  | 
COVID19_MODERNA | Dissociation | 0 | 1.038 | 0.016 | 0.458 | 1.437 |  |  |  |  |  | 
COVID19_MODERNA | Arthroscopy | 0 | 0.513 | 0.001 | 0.458 | 1.852 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin G decreased | 0 | 1.079 | 0.019 | 0.458 | 1.418 |  |  |  |  |  | 
COVID19_MODERNA | Visual evoked potentials normal | 0 | 0.279 | 0 | 0.457 | 2.251 |  |  |  |  |  | 
COVID19_MODERNA | Arnold-Chiari malformation | 0 | 0.349 | 0 | 0.457 | 2.105 |  |  |  |  |  | 
COVID19_MODERNA | High density lipoprotein decreased | 0 | 1.07 | 0.018 | 0.457 | 1.421 |  |  |  |  |  | 
COVID19_MODERNA | Psoriatic arthropathy | 0 | 1.132 | 0.021 | 0.457 | 1.392 |  |  |  |  |  | 
COVID19_MODERNA | Tandem gait test abnormal | 0 | 0.326 | 0 | 0.456 | 2.149 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound scan vagina | 0 | 1.349 | 0.031 | 0.456 | 1.308 |  |  |  |  |  | 
COVID19_MODERNA | Polyhydramnios | 0 | 0.259 | 0 | 0.455 | 2.296 |  |  |  |  |  | 
COVID19_MODERNA | Cardiac massage | 0 | 0.273 | 0 | 0.455 | 2.262 |  |  |  |  |  | 
COVID19_MODERNA | Joint lock | 0 | 1.193 | 0.023 | 0.455 | 1.365 |  |  |  |  |  | 
COVID19_MODERNA | Granuloma | 0 | 0.359 | 0 | 0.455 | 2.082 |  |  |  |  |  | 
COVID19_MODERNA | Orchitis | 0 | 0.18 | 0 | 0.454 | 2.5 |  |  |  |  |  | 
COVID19_MODERNA | Mumps antibody test positive | 0 | 0.262 | 0 | 0.454 | 2.286 |  |  |  |  |  | 
COVID19_MODERNA | Gastrointestinal hypermotility | 0 | 0.26 | 0 | 0.454 | 2.291 |  |  |  |  |  | 
COVID19_MODERNA | Autonomic neuropathy | 0 | 0.241 | 0 | 0.453 | 2.337 |  |  |  |  |  | 
COVID19_MODERNA | Creatinine urine | 0 | 0.147 | 0 | 0.453 | 2.579 |  |  |  |  |  | 
COVID19_MODERNA | CSF glucose | 0 | 0.371 | 0 | 0.452 | 2.054 |  |  |  |  |  | 
COVID19_MODERNA | Mycoplasma test negative | 0 | 1.676 | 0.046 | 0.452 | 1.21 |  |  |  |  |  | 
COVID19_MODERNA | Tonsillitis bacterial | 0 | 0.327 | 0 | 0.452 | 2.14 |  |  |  |  |  | 
COVID19_MODERNA | Adenocarcinoma of the cervix | 0 | 0.214 | 0 | 0.452 | 2.403 |  |  |  |  |  | 
COVID19_MODERNA | Astrovirus test positive | 0 | 0.193 | 0 | 0.452 | 2.458 |  |  |  |  |  | 
COVID19_MODERNA | Macrophage count | 0 | 0.107 | 0 | 0.451 | 2.63 |  |  |  |  |  | 
COVID19_MODERNA | Angiocardiogram | 0 | 1.021 | 0.014 | 0.451 | 1.438 |  |  |  |  |  | 
COVID19_MODERNA | Clostridium test negative | 0 | 1.309 | 0.028 | 0.451 | 1.317 |  |  |  |  |  | 
COVID19_MODERNA | Bone erosion | 0 | 0.351 | 0 | 0.451 | 2.09 |  |  |  |  |  | 
COVID19_MODERNA | Kidney transplant rejection | 0 | 0.326 | 0 | 0.451 | 2.138 |  |  |  |  |  | 
COVID19_MODERNA | Chlamydial infection | 0 | 0.247 | 0 | 0.451 | 2.315 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis E antibody negative | 0 | 0.336 | 0 | 0.45 | 2.115 |  |  |  |  |  | 
COVID19_MODERNA | Urosepsis | 0 | 1.046 | 0.015 | 0.45 | 1.425 |  |  |  |  |  | 
COVID19_MODERNA | Pleocytosis | 0 | 0.575 | 0.001 | 0.449 | 1.765 |  |  |  |  |  | 
COVID19_MODERNA | Phrenic nerve paralysis | 0 | 0.217 | 0 | 0.449 | 2.386 |  |  |  |  |  | 
COVID19_MODERNA | Hand-eye coordination impaired | 0 | 2.173 | 0.067 | 0.448 | 1.106 |  |  |  |  |  | 
COVID19_MODERNA | Blood iron decreased | 0 | 1.382 | 0.03 | 0.448 | 1.289 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte morphology abnormal | 0 | 0.429 | 0 | 0.448 | 1.953 |  |  |  |  |  | 
COVID19_MODERNA | Middle ear inflammation | 0 | 0.303 | 0 | 0.448 | 2.18 |  |  |  |  |  | 
COVID19_MODERNA | Apgar score abnormal | 0 | 0.216 | 0 | 0.448 | 2.384 |  |  |  |  |  | 
COVID19_MODERNA | Pupillary light reflex tests abnormal | 0 | 0.465 | 0 | 0.447 | 1.898 |  |  |  |  |  | 
COVID19_MODERNA | Stress | 3 | 8.88 | 0.138 | 0.446 | 0.897 | 0.231 | 0.479 | 0.897 | 0.338 | 0.318 | 3.675
COVID19_MODERNA | Liver malignant tumours (SMQ) [narrow] | 0 | 0.229 | 0 | 0.446 | 2.345 |  |  |  |  |  | 
COVID19_MODERNA | Liver malignant tumours (SMQ) [broad] | 0 | 0.229 | 0 | 0.446 | 2.345 |  |  |  |  |  | 
COVID19_MODERNA | Oligohydramnios | 0 | 0.227 | 0 | 0.446 | 2.349 |  |  |  |  |  | 
COVID19_MODERNA | Haemoglobinuria | 0 | 0.22 | 0 | 0.446 | 2.368 |  |  |  |  |  | 
COVID19_MODERNA | Muscle tone disorder | 0 | 0.372 | 0 | 0.444 | 2.036 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngotonsillitis | 0 | 0.374 | 0 | 0.444 | 2.033 |  |  |  |  |  | 
COVID19_MODERNA | Blood potassium | 1 | 5.336 | 0.143 | 0.443 | 0.878 | 0.152 | 0.423 | 0.944 | 0.187 | 0.725 | 0.014
COVID19_MODERNA | Blood immunoglobulin A decreased | 0 | 0.829 | 0.006 | 0.443 | 1.54 |  |  |  |  |  | 
COVID19_MODERNA | Enterovirus infection | 0 | 0.404 | 0 | 0.443 | 1.982 |  |  |  |  |  | 
COVID19_MODERNA | Apgar score low | 0 | 0.065 | 0 | 0.443 | 2.376 |  |  |  |  |  | 
COVID19_MODERNA | Escherichia infection | 0 | 1.478 | 0.033 | 0.443 | 1.254 |  |  |  |  |  | 
COVID19_MODERNA | Child maltreatment syndrome | 0 | 0.153 | 0 | 0.442 | 2.52 |  |  |  |  |  | 
COVID19_MODERNA | Ulcerative keratitis | 0 | 0.233 | 0 | 0.442 | 2.324 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell volume decreased | 0 | 1.327 | 0.025 | 0.441 | 1.3 |  |  |  |  |  | 
COVID19_MODERNA | Occult blood positive | 0 | 0.986 | 0.011 | 0.441 | 1.445 |  |  |  |  |  | 
COVID19_MODERNA | Single umbilical artery | 0 | 0.234 | 0 | 0.44 | 2.316 |  |  |  |  |  | 
COVID19_MODERNA | Flavivirus test negative | 0 | 0.357 | 0 | 0.44 | 2.056 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral ischaemia | 0 | 0.39 | 0 | 0.439 | 1.998 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site granuloma | 0 | 0.177 | 0 | 0.439 | 2.451 |  |  |  |  |  | 
COVID19_MODERNA | Viral test positive | 0 | 3.134 | 0.099 | 0.439 | 0.978 |  |  |  |  |  | 
COVID19_MODERNA | Wound | 0 | 1.007 | 0.012 | 0.439 | 1.432 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic function abnormal | 0 | 0.8 | 0.005 | 0.438 | 1.555 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory acidosis | 0 | 0.758 | 0.004 | 0.438 | 1.585 |  |  |  |  |  | 
COVID19_MODERNA | Liquid product physical issue | 0 | 0.273 | 0 | 0.437 | 2.219 |  |  |  |  |  | 
COVID19_MODERNA | Rubella antibody positive | 0 | 0.306 | 0 | 0.437 | 2.147 |  |  |  |  |  | 
COVID19_MODERNA | Neuralgic amyotrophy | 1 | 4.185 | 0.104 | 0.436 | 0.953 | 0.191 | 0.497 | 1.086 | 0.239 | 0.207 | 2.246
COVID19_MODERNA | Haematoma | 1 | 5.49 | 0.134 | 0.436 | 0.878 | 0.148 | 0.414 | 0.927 | 0.182 | 0.114 | 5.998
COVID19_MODERNA | Recalled product administered | 0 | 0.226 | 0 | 0.435 | 2.321 |  |  |  |  |  | 
COVID19_MODERNA | Peripheral vascular disorder | 0 | 0.777 | 0.004 | 0.435 | 1.567 |  |  |  |  |  | 
COVID19_MODERNA | Depression | 2 | 9.889 | 0.111 | 0.434 | 0.927 | 0.149 | 0.358 | 0.727 | 0.202 | 0.098 | 15.589
COVID19_MODERNA | Cat scratch disease | 0 | 0.21 | 0 | 0.434 | 2.356 |  |  |  |  |  | 
COVID19_MODERNA | Therapeutic response decreased | 0 | 0.451 | 0 | 0.434 | 1.895 |  |  |  |  |  | 
COVID19_MODERNA | Infertility | 0 | 0.287 | 0 | 0.434 | 2.177 |  |  |  |  |  | 
COVID19_MODERNA | CD4 lymphocytes increased | 0 | 0.293 | 0 | 0.433 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Skin tumours of unspecified malignancy (SMQ) [broad] | 0 | 2.407 | 0.069 | 0.433 | 1.055 |  |  |  |  |  | 
COVID19_MODERNA | Stiff person syndrome | 0 | 0.385 | 0 | 0.433 | 1.994 |  |  |  |  |  | 
COVID19_MODERNA | Pelvic inflammatory disease | 0 | 0.211 | 0 | 0.433 | 2.347 |  |  |  |  |  | 
COVID19_MODERNA | Blood fibrinogen increased | 0 | 0.714 | 0.003 | 0.433 | 1.612 |  |  |  |  |  | 
COVID19_MODERNA | Congenital absence of bile ducts | 0 | 0.191 | 0 | 0.432 | 2.393 |  |  |  |  |  | 
COVID19_MODERNA | ACTH stimulation test abnormal | 0 | 0.19 | 0 | 0.432 | 2.393 |  |  |  |  |  | 
COVID19_MODERNA | Post vaccination syndrome | 0 | 0.306 | 0 | 0.431 | 2.132 |  |  |  |  |  | 
COVID19_MODERNA | Blood immunoglobulin G increased | 0 | 1.448 | 0.028 | 0.431 | 1.25 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory alkalosis | 0 | 0.253 | 0 | 0.431 | 2.247 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy cervix | 0 | 0.25 | 0 | 0.431 | 2.251 |  |  |  |  |  | 
COVID19_MODERNA | Depressive symptom | 0 | 0.15 | 0 | 0.431 | 2.478 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy lung abnormal | 0 | 0.343 | 0 | 0.43 | 2.06 |  |  |  |  |  | 
COVID19_MODERNA | Liver transplant | 0 | 0.39 | 0 | 0.43 | 1.98 |  |  |  |  |  | 
COVID19_MODERNA | Weight decreased | 7 | 21.94 | 0.225 | 0.429 | 0.687 | 0.224 | 0.391 | 0.64 | 0.319 | 0.211 | 19.791
COVID19_MODERNA | Periorbital oedema | 1 | 4.121 | 0.101 | 0.429 | 0.941 | 0.193 | 0.502 | 1.095 | 0.243 | 0.411 | 0.337
COVID19_MODERNA | Congenital biliary disorders (SMQ) [narrow] | 0 | 0.153 | 0 | 0.429 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Congenital biliary disorders (SMQ) [broad] | 0 | 0.153 | 0 | 0.429 | 2.462 |  |  |  |  |  | 
COVID19_MODERNA | Foetal hypokinesia | 0 | 0.364 | 0 | 0.429 | 2.021 |  |  |  |  |  | 
COVID19_MODERNA | Subglottic laryngitis | 0 | 0.213 | 0 | 0.428 | 2.33 |  |  |  |  |  | 
COVID19_MODERNA | Complement factor decreased | 0 | 0.273 | 0 | 0.428 | 2.194 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound pelvis abnormal | 0 | 0.807 | 0.004 | 0.427 | 1.536 |  |  |  |  |  | 
COVID19_MODERNA | Liver disorder | 0 | 0.841 | 0.005 | 0.427 | 1.513 |  |  |  |  |  | 
COVID19_MODERNA | Laser therapy | 0 | 0.36 | 0 | 0.426 | 2.021 |  |  |  |  |  | 
COVID19_MODERNA | Extraocular muscle disorder | 0 | 0.234 | 0 | 0.426 | 2.272 |  |  |  |  |  | 
COVID19_MODERNA | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [narrow] | 0 | 0.312 | 0 | 0.426 | 2.11 |  |  |  |  |  | 
COVID19_MODERNA | Sjogren's syndrome | 0 | 0.78 | 0.003 | 0.425 | 1.551 |  |  |  |  |  | 
COVID19_MODERNA | Encephalitis brain stem | 0 | 0.195 | 0 | 0.425 | 2.356 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma stage 0 | 0 | 0.199 | 0 | 0.425 | 2.348 |  |  |  |  |  | 
COVID19_MODERNA | Pharyngeal haematoma | 0 | 0.117 | 0 | 0.425 | 2.475 |  |  |  |  |  | 
COVID19_MODERNA | B-lymphocyte count decreased | 0 | 0.39 | 0 | 0.424 | 1.968 |  |  |  |  |  | 
COVID19_MODERNA | Sapovirus test positive | 0 | 0.155 | 0 | 0.424 | 2.434 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhage subcutaneous | 0 | 0.709 | 0.002 | 0.424 | 1.604 |  |  |  |  |  | 
COVID19_MODERNA | Bordetella test | 0 | 0.301 | 0 | 0.424 | 2.125 |  |  |  |  |  | 
COVID19_MODERNA | Live birth | 0 | 0.521 | 0 | 0.424 | 1.788 |  |  |  |  |  | 
COVID19_MODERNA | Hemianaesthesia | 0 | 0.351 | 0 | 0.422 | 2.029 |  |  |  |  |  | 
COVID19_MODERNA | Cortical visual impairment | 0 | 0.156 | 0 | 0.422 | 2.423 |  |  |  |  |  | 
COVID19_MODERNA | Anti-thyroid antibody positive | 0 | 0.689 | 0.002 | 0.422 | 1.617 |  |  |  |  |  | 
COVID19_MODERNA | Thyroiditis subacute | 0 | 0.376 | 0 | 0.422 | 1.986 |  |  |  |  |  | 
COVID19_MODERNA | Photosensitivity reaction | 1 | 3.318 | 0.058 | 0.421 | 1.058 | 0.224 | 0.567 | 1.223 | 0.301 | 0.151 | 3.897
COVID19_MODERNA | Kernig's sign | 0 | 0.39 | 0 | 0.42 | 1.958 |  |  |  |  |  | 
COVID19_MODERNA | Injection site granuloma | 0 | 0.344 | 0 | 0.42 | 2.034 |  |  |  |  |  | 
COVID19_MODERNA | Morbillivirus test positive | 0 | 0.305 | 0 | 0.42 | 2.108 |  |  |  |  |  | 
COVID19_MODERNA | Systemic lupus erythematosus | 1 | 4.343 | 0.056 | 0.419 | 1.064 | 0.185 | 0.486 | 1.064 | 0.23 | 0.122 | 5.409
COVID19_MODERNA | Empyema | 0 | 0.16 | 0 | 0.419 | 2.4 |  |  |  |  |  | 
COVID19_MODERNA | Basal cell carcinoma | 0 | 0.339 | 0 | 0.419 | 2.041 |  |  |  |  |  | 
COVID19_MODERNA | Mental fatigue | 0 | 2.445 | 0.062 | 0.418 | 1.034 |  |  |  |  |  | 
COVID19_MODERNA | Blindness transient | 1 | 5.082 | 0.09 | 0.416 | 0.936 | 0.16 | 0.438 | 0.972 | 0.197 | 0.268 | 1.296
COVID19_MODERNA | School refusal | 0 | 0.145 | 0 | 0.415 | 2.406 |  |  |  |  |  | 
COVID19_MODERNA | Bradycardia neonatal | 0 | 0.219 | 0 | 0.414 | 2.263 |  |  |  |  |  | 
COVID19_MODERNA | Hair growth abnormal | 0 | 0.361 | 0 | 0.413 | 1.989 |  |  |  |  |  | 
COVID19_MODERNA | Rash rubelliform | 0 | 0.311 | 0 | 0.412 | 2.074 |  |  |  |  |  | 
COVID19_MODERNA | CSF immunoglobulin increased | 0 | 0.873 | 0.004 | 0.412 | 1.472 |  |  |  |  |  | 
COVID19_MODERNA | Heat oedema | 0 | 0.24 | 0 | 0.412 | 2.214 |  |  |  |  |  | 
COVID19_MODERNA | Tendon injury | 0 | 1.279 | 0.016 | 0.411 | 1.282 |  |  |  |  |  | 
COVID19_MODERNA | Ileectomy | 0 | 0.26 | 0 | 0.41 | 2.166 |  |  |  |  |  | 
COVID19_MODERNA | Walking disability | 0 | 0.983 | 0.006 | 0.408 | 1.405 |  |  |  |  |  | 
COVID19_MODERNA | Neisseria test positive | 0 | 0.186 | 0 | 0.407 | 2.304 |  |  |  |  |  | 
COVID19_MODERNA | Accidental exposure to product | 0 | 1.321 | 0.016 | 0.407 | 1.262 |  |  |  |  |  | 
COVID19_MODERNA | Swallow study | 0 | 2.249 | 0.05 | 0.406 | 1.05 |  |  |  |  |  | 
COVID19_MODERNA | Hyperkinesia | 0 | 0.27 | 0 | 0.406 | 2.135 |  |  |  |  |  | 
COVID19_MODERNA | Atonic seizures | 0 | 0.377 | 0 | 0.406 | 1.947 |  |  |  |  |  | 
COVID19_MODERNA | Psychogenic seizure | 0 | 0.279 | 0 | 0.405 | 2.114 |  |  |  |  |  | 
COVID19_MODERNA | Infectious pleural effusion | 0 | 0.315 | 0 | 0.405 | 2.048 |  |  |  |  |  | 
COVID19_MODERNA | Fertility disorders (SMQ) [broad] | 5 | 10.269 | 0.169 | 0.404 | 0.722 | 0.312 | 0.578 | 0.996 | 0.487 | 0.23 | 11.966
COVID19_MODERNA | Microcephaly | 0 | 0.312 | 0 | 0.404 | 2.052 |  |  |  |  |  | 
COVID19_MODERNA | Anti-NMDA antibody positive | 0 | 0.39 | 0 | 0.403 | 1.921 |  |  |  |  |  | 
COVID19_MODERNA | Reading disorder | 0 | 0.637 | 0.001 | 0.403 | 1.634 |  |  |  |  |  | 
COVID19_MODERNA | Myofascitis | 0 | 0.239 | 0 | 0.403 | 2.186 |  |  |  |  |  | 
COVID19_MODERNA | Vitamin B12 decreased | 0 | 0.786 | 0.002 | 0.403 | 1.515 |  |  |  |  |  | 
COVID19_MODERNA | Forced expiratory volume | 0 | 0.39 | 0 | 0.402 | 1.92 |  |  |  |  |  | 
COVID19_MODERNA | Application site erythema | 0 | 0.299 | 0 | 0.402 | 2.07 |  |  |  |  |  | 
COVID19_MODERNA | Pemphigoid | 0 | 1.457 | 0.02 | 0.402 | 1.213 |  |  |  |  |  | 
COVID19_MODERNA | Granulomatous dermatitis | 0 | 0.212 | 0 | 0.401 | 2.231 |  |  |  |  |  | 
COVID19_MODERNA | Extensor plantar response | 0 | 0.791 | 0.002 | 0.401 | 1.509 |  |  |  |  |  | 
COVID19_MODERNA | Antibody test | 1 | 3.986 | 0.066 | 0.4 | 0.968 | 0.198 | 0.512 | 1.115 | 0.251 | 0.233 | 1.779
COVID19_MODERNA | Campylobacter infection | 0 | 0.113 | 0 | 0.4 | 2.315 |  |  |  |  |  | 
COVID19_MODERNA | Expanded disability status scale score increased | 0 | 0.095 | 0 | 0.399 | 2.26 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.329 | 0 | 0.399 | 2.008 |  |  |  |  |  | 
COVID19_MODERNA | Plasma cell myeloma | 0 | 0.731 | 0.001 | 0.399 | 1.549 |  |  |  |  |  | 
COVID19_MODERNA | Parasite stool test positive | 0 | 0.073 | 0 | 0.399 | 2.098 |  |  |  |  |  | 
COVID19_MODERNA | Increased appetite | 0 | 1.058 | 0.007 | 0.399 | 1.356 |  |  |  |  |  | 
COVID19_MODERNA | Viraemia | 0 | 0.142 | 0 | 0.398 | 2.318 |  |  |  |  |  | 
COVID19_MODERNA | Facial spasm | 0 | 2.715 | 0.061 | 0.398 | 0.978 |  |  |  |  |  | 
COVID19_MODERNA | Tilt table test positive | 0 | 0.267 | 0 | 0.398 | 2.115 |  |  |  |  |  | 
COVID19_MODERNA | Rotator cuff repair | 0 | 0.614 | 0 | 0.397 | 1.644 |  |  |  |  |  | 
COVID19_MODERNA | Blood chloride | 0 | 0.62 | 0 | 0.397 | 1.638 |  |  |  |  |  | 
COVID19_MODERNA | Cataplexy | 0 | 0.301 | 0 | 0.395 | 2.044 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell haemoglobin concentration increased | 0 | 0.272 | 0 | 0.394 | 2.093 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy liver abnormal | 0 | 0.778 | 0.002 | 0.394 | 1.507 |  |  |  |  |  | 
COVID19_MODERNA | Thoracic cavity drainage | 0 | 0.431 | 0 | 0.392 | 1.837 |  |  |  |  |  | 
COVID19_MODERNA | Epileptic encephalopathy | 0 | 0.304 | 0 | 0.391 | 2.027 |  |  |  |  |  | 
COVID19_MODERNA | Peritonitis | 0 | 1.054 | 0.006 | 0.391 | 1.347 |  |  |  |  |  | 
COVID19_MODERNA | Vitiligo | 0 | 0.62 | 0 | 0.389 | 1.624 |  |  |  |  |  | 
COVID19_MODERNA | Seroconversion test negative | 0 | 0.299 | 0 | 0.389 | 2.029 |  |  |  |  |  | 
COVID19_MODERNA | Product supply issue | 0 | 0.168 | 0 | 0.389 | 2.246 |  |  |  |  |  | 
COVID19_MODERNA | Decreased immune responsiveness | 0 | 0.786 | 0.002 | 0.388 | 1.493 |  |  |  |  |  | 
COVID19_MODERNA | Labelled drug-drug interaction medication error | 0 | 0.369 | 0 | 0.388 | 1.913 |  |  |  |  |  | 
COVID19_MODERNA | Dengue fever | 0 | 0.156 | 0 | 0.388 | 2.252 |  |  |  |  |  | 
COVID19_MODERNA | Febrile convulsion | 0 | 2.455 | 0.048 | 0.388 | 0.998 |  |  |  |  |  | 
COVID19_MODERNA | Cataract nuclear | 0 | 0.317 | 0 | 0.387 | 1.994 |  |  |  |  |  | 
COVID19_MODERNA | Twin pregnancy | 0 | 0.186 | 0 | 0.386 | 2.208 |  |  |  |  |  | 
COVID19_MODERNA | Hypertonic bladder | 0 | 0.346 | 0 | 0.385 | 1.943 |  |  |  |  |  | 
COVID19_MODERNA | Anti-ganglioside antibody positive | 0 | 0.308 | 0 | 0.385 | 2.002 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis salmonella | 0 | 0.257 | 0 | 0.385 | 2.089 |  |  |  |  |  | 
COVID19_MODERNA | Monoparesis | 0 | 0.654 | 0 | 0.383 | 1.583 |  |  |  |  |  | 
COVID19_MODERNA | Inflammatory bowel disease | 0 | 0.456 | 0 | 0.383 | 1.784 |  |  |  |  |  | 
COVID19_MODERNA | Lymphocyte stimulation test positive | 0 | 0.265 | 0 | 0.382 | 2.063 |  |  |  |  |  | 
COVID19_MODERNA | Product expiration date issue | 0 | 0.379 | 0 | 0.38 | 1.879 |  |  |  |  |  | 
COVID19_MODERNA | Endocrine test | 0 | 0.239 | 0 | 0.38 | 2.102 |  |  |  |  |  | 
COVID19_MODERNA | Gastric disorder | 0 | 3.828 | 0.081 | 0.379 | 0.857 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy skin abnormal | 0 | 2.886 | 0.056 | 0.378 | 0.935 |  |  |  |  |  | 
COVID19_MODERNA | Immunohistochemistry | 0 | 0.319 | 0 | 0.378 | 1.965 |  |  |  |  |  | 
COVID19_MODERNA | Brain stem syndrome | 0 | 2.232 | 0.037 | 0.378 | 1.019 |  |  |  |  |  | 
COVID19_MODERNA | Joint range of motion measurement | 0 | 1.036 | 0.004 | 0.378 | 1.336 |  |  |  |  |  | 
COVID19_MODERNA | Obesity | 0 | 1.204 | 0.008 | 0.377 | 1.265 |  |  |  |  |  | 
COVID19_MODERNA | Hepatic pain | 0 | 1.647 | 0.019 | 0.377 | 1.131 |  |  |  |  |  | 
COVID19_MODERNA | CSF neutrophil count negative | 0 | 0.305 | 0 | 0.376 | 1.978 |  |  |  |  |  | 
COVID19_MODERNA | Irregular sleep wake rhythm disorder | 0 | 0.307 | 0 | 0.376 | 1.976 |  |  |  |  |  | 
COVID19_MODERNA | Viral load increased | 0 | 0.299 | 0 | 0.375 | 1.986 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antibody positive | 0 | 0.368 | 0 | 0.375 | 1.881 |  |  |  |  |  | 
COVID19_MODERNA | Viral test negative | 3 | 12.387 | 0.142 | 0.374 | 0.694 | 0.173 | 0.369 | 0.699 | 0.242 | 0.153 | 13.194
COVID19_MODERNA | Anuria | 0 | 1.044 | 0.004 | 0.374 | 1.327 |  |  |  |  |  | 
COVID19_MODERNA | Maternal exposure during pregnancy | 0 | 2.631 | 0.047 | 0.374 | 0.959 |  |  |  |  |  | 
COVID19_MODERNA | Movement disorder | 4 | 14.947 | 0.146 | 0.373 | 0.684 | 0.189 | 0.374 | 0.674 | 0.268 | 0.284 | 6.415
COVID19_MODERNA | Pneumatosis intestinalis | 0 | 0.273 | 0 | 0.373 | 2.02 |  |  |  |  |  | 
COVID19_MODERNA | Middle insomnia | 0 | 4.528 | 0.092 | 0.373 | 0.808 |  |  |  |  |  | 
COVID19_MODERNA | Acute macular outer retinopathy | 0 | 0.177 | 0 | 0.373 | 2.158 |  |  |  |  |  | 
COVID19_MODERNA | Immune system disorder | 0 | 2.305 | 0.037 | 0.371 | 0.999 |  |  |  |  |  | 
COVID19_MODERNA | Herpes virus infection | 0 | 1.645 | 0.018 | 0.371 | 1.124 |  |  |  |  |  | 
COVID19_MODERNA | Suicide attempt | 0 | 0.42 | 0 | 0.371 | 1.801 |  |  |  |  |  | 
COVID19_MODERNA | Product complaint | 0 | 0.373 | 0 | 0.37 | 1.86 |  |  |  |  |  | 
COVID19_MODERNA | Thrombocytopenic purpura | 0 | 0.805 | 0.001 | 0.369 | 1.449 |  |  |  |  |  | 
COVID19_MODERNA | Sleep attacks | 0 | 0.385 | 0 | 0.369 | 1.84 |  |  |  |  |  | 
COVID19_MODERNA | Neuromyelitis optica spectrum disorder | 0 | 0.486 | 0 | 0.368 | 1.714 |  |  |  |  |  | 
COVID19_MODERNA | Mean cell haemoglobin concentration | 0 | 1.093 | 0.004 | 0.368 | 1.297 |  |  |  |  |  | 
COVID19_MODERNA | Post viral fatigue syndrome | 0 | 0.455 | 0 | 0.367 | 1.749 |  |  |  |  |  | 
COVID19_MODERNA | Shock symptom | 0 | 2.74 | 0.047 | 0.367 | 0.937 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound testes abnormal | 0 | 0.212 | 0 | 0.366 | 2.083 |  |  |  |  |  | 
COVID19_MODERNA | Red blood cell count | 0 | 1.209 | 0.006 | 0.366 | 1.247 |  |  |  |  |  | 
COVID19_MODERNA | Loop electrosurgical excision procedure | 0 | 0.163 | 0 | 0.365 | 2.123 |  |  |  |  |  | 
COVID19_MODERNA | Enterobiasis | 0 | 0.164 | 0 | 0.365 | 2.122 |  |  |  |  |  | 
COVID19_MODERNA | Infection susceptibility increased | 0 | 0.517 | 0 | 0.365 | 1.676 |  |  |  |  |  | 
COVID19_MODERNA | Hypomenorrhoea | 0 | 0.308 | 0 | 0.365 | 1.94 |  |  |  |  |  | 
COVID19_MODERNA | Mumps antibody test negative | 0 | 0.241 | 0 | 0.364 | 2.033 |  |  |  |  |  | 
COVID19_MODERNA | Premature menopause | 0 | 0.196 | 0 | 0.363 | 2.09 |  |  |  |  |  | 
COVID19_MODERNA | Urine chloride | 0 | 0.143 | 0 | 0.361 | 2.101 |  |  |  |  |  | 
COVID19_MODERNA | Rubivirus test positive | 0 | 0.221 | 0 | 0.36 | 2.045 |  |  |  |  |  | 
COVID19_MODERNA | Demyelinating polyneuropathy | 0 | 1.406 | 0.009 | 0.359 | 1.171 |  |  |  |  |  | 
COVID19_MODERNA | Smear cervix | 0 | 0.569 | 0 | 0.359 | 1.611 |  |  |  |  |  | 
COVID19_MODERNA | Disseminated varicella zoster vaccine virus infection | 0 | 0.343 | 0 | 0.358 | 1.867 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy artery normal | 0 | 0.348 | 0 | 0.357 | 1.857 |  |  |  |  |  | 
COVID19_MODERNA | Anti-ganglioside antibody negative | 0 | 0.41 | 0 | 0.357 | 1.776 |  |  |  |  |  | 
COVID19_MODERNA | Intussusception | 0 | 0.799 | 0.001 | 0.357 | 1.432 |  |  |  |  |  | 
COVID19_MODERNA | Goitre | 0 | 1.58 | 0.013 | 0.356 | 1.119 |  |  |  |  |  | 
COVID19_MODERNA | Dysmetria | 0 | 0.352 | 0 | 0.356 | 1.846 |  |  |  |  |  | 
COVID19_MODERNA | Brain death | 0 | 2.377 | 0.033 | 0.355 | 0.969 |  |  |  |  |  | 
COVID19_MODERNA | Septic screen | 0 | 0.58 | 0 | 0.354 | 1.588 |  |  |  |  |  | 
COVID19_MODERNA | Expanded disability status scale score decreased | 0 | 0.125 | 0 | 0.353 | 2.023 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound skull normal | 0 | 0.419 | 0 | 0.352 | 1.75 |  |  |  |  |  | 
COVID19_MODERNA | Product quality issue | 0 | 1.454 | 0.009 | 0.351 | 1.146 |  |  |  |  |  | 
COVID19_MODERNA | CSF pressure normal | 0 | 0.312 | 0 | 0.351 | 1.887 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy brain abnormal | 0 | 0.475 | 0 | 0.351 | 1.684 |  |  |  |  |  | 
COVID19_MODERNA | Physical examination normal | 0 | 2.448 | 0.032 | 0.349 | 0.951 |  |  |  |  |  | 
COVID19_MODERNA | Allergy to metals | 0 | 0.436 | 0 | 0.349 | 1.724 |  |  |  |  |  | 
COVID19_MODERNA | Acute motor axonal neuropathy | 0 | 0.313 | 0 | 0.347 | 1.869 |  |  |  |  |  | 
COVID19_MODERNA | Smooth muscle antibody negative | 0 | 1.655 | 0.012 | 0.345 | 1.085 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site hypertrichosis | 0 | 0.195 | 0 | 0.344 | 1.995 |  |  |  |  |  | 
COVID19_MODERNA | Erysipelas | 0 | 0.684 | 0 | 0.344 | 1.484 |  |  |  |  |  | 
COVID19_MODERNA | Alcohol intolerance | 0 | 0.28 | 0 | 0.344 | 1.899 |  |  |  |  |  | 
COVID19_MODERNA | Quality of life decreased | 0 | 1.11 | 0.003 | 0.343 | 1.249 |  |  |  |  |  | 
COVID19_MODERNA | Breast mass | 0 | 1.282 | 0.005 | 0.343 | 1.187 |  |  |  |  |  | 
COVID19_MODERNA | Product distribution issue | 0 | 0.17 | 0 | 0.343 | 1.997 |  |  |  |  |  | 
COVID19_MODERNA | Apparent life threatening event | 0 | 2.16 | 0.023 | 0.342 | 0.984 |  |  |  |  |  | 
COVID19_MODERNA | Skin neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 3.21 | 0.047 | 0.342 | 0.86 |  |  |  |  |  | 
COVID19_MODERNA | Product physical issue | 0 | 0.263 | 0 | 0.341 | 1.911 |  |  |  |  |  | 
COVID19_MODERNA | Electrophoresis abnormal | 0 | 0.256 | 0 | 0.341 | 1.92 |  |  |  |  |  | 
COVID19_MODERNA | Generalised vaccinia | 0 | 0.113 | 0 | 0.341 | 1.903 |  |  |  |  |  | 
COVID19_MODERNA | Polyneuropathy | 0 | 1.916 | 0.017 | 0.34 | 1.023 |  |  |  |  |  | 
COVID19_MODERNA | Immunisation | 0 | 2.245 | 0.024 | 0.34 | 0.968 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal disorders (SMQ) [narrow] | 1 | 5.535 | 0.056 | 0.339 | 0.818 | 0.146 | 0.411 | 0.923 | 0.181 | 0.019 | 50.851
COVID19_MODERNA | Influenza B virus test positive | 0 | 0.592 | 0 | 0.339 | 1.544 |  |  |  |  |  | 
COVID19_MODERNA | Positron emission tomogram | 0 | 2.107 | 0.021 | 0.338 | 0.986 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia streptococcal | 0 | 0.334 | 0 | 0.338 | 1.809 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site oedema | 0 | 1.667 | 0.011 | 0.338 | 1.073 |  |  |  |  |  | 
COVID19_MODERNA | Adenovirus test | 0 | 1.608 | 0.01 | 0.336 | 1.083 |  |  |  |  |  | 
COVID19_MODERNA | Ocular icterus | 0 | 1.822 | 0.014 | 0.335 | 1.034 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian cyst ruptured | 0 | 0.323 | 0 | 0.335 | 1.812 |  |  |  |  |  | 
COVID19_MODERNA | Varicella virus test positive | 0 | 1.12 | 0.002 | 0.333 | 1.229 |  |  |  |  |  | 
COVID19_MODERNA | Anti-aquaporin-4 antibody positive | 0 | 0.218 | 0 | 0.333 | 1.921 |  |  |  |  |  | 
COVID19_MODERNA | Acute hepatitis B | 0 | 0.076 | 0 | 0.332 | 1.546 |  |  |  |  |  | 
COVID19_MODERNA | Genital haemorrhage | 0 | 0.23 | 0 | 0.331 | 1.901 |  |  |  |  |  | 
COVID19_MODERNA | Haemorrhagic diathesis | 0 | 0.341 | 0 | 0.331 | 1.777 |  |  |  |  |  | 
COVID19_MODERNA | Hereditary neuropathy with liability to pressure palsies | 0 | 0.152 | 0 | 0.331 | 1.918 |  |  |  |  |  | 
COVID19_MODERNA | Eclampsia | 0 | 0.459 | 0 | 0.33 | 1.644 |  |  |  |  |  | 
COVID19_MODERNA | Transplant rejection | 0 | 0.326 | 0 | 0.329 | 1.788 |  |  |  |  |  | 
COVID19_MODERNA | Exposure to vaccinated person | 0 | 0.349 | 0 | 0.329 | 1.761 |  |  |  |  |  | 
COVID19_MODERNA | CSF protein | 0 | 0.831 | 0 | 0.327 | 1.355 |  |  |  |  |  | 
COVID19_MODERNA | Gene sequencing | 0 | 0.338 | 0 | 0.327 | 1.766 |  |  |  |  |  | 
COVID19_MODERNA | Rash scarlatiniform | 0 | 0.361 | 0 | 0.326 | 1.736 |  |  |  |  |  | 
COVID19_MODERNA | Haemolytic uraemic syndrome | 0 | 0.244 | 0 | 0.326 | 1.865 |  |  |  |  |  | 
COVID19_MODERNA | Autism spectrum disorder | 0 | 1.738 | 0.01 | 0.325 | 1.037 |  |  |  |  |  | 
COVID19_MODERNA | Anti-aquaporin-4 antibody negative | 0 | 0.397 | 0 | 0.325 | 1.694 |  |  |  |  |  | 
COVID19_MODERNA | Subchorionic haematoma | 0 | 0.312 | 0 | 0.324 | 1.784 |  |  |  |  |  | 
COVID19_MODERNA | HIV antibody negative | 0 | 0.424 | 0 | 0.324 | 1.663 |  |  |  |  |  | 
COVID19_MODERNA | Abnormal loss of weight | 0 | 1.266 | 0.003 | 0.324 | 1.161 |  |  |  |  |  | 
COVID19_MODERNA | Foetal distress syndrome | 0 | 0.219 | 0 | 0.322 | 1.866 |  |  |  |  |  | 
COVID19_MODERNA | Reaction to excipient | 0 | 0.479 | 0 | 0.322 | 1.603 |  |  |  |  |  | 
COVID19_MODERNA | Rubella antibody negative | 0 | 0.429 | 0 | 0.321 | 1.648 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis bacterial | 0 | 0.446 | 0 | 0.321 | 1.63 |  |  |  |  |  | 
COVID19_MODERNA | Alpha 1 foetoprotein normal | 0 | 0.402 | 0 | 0.321 | 1.674 |  |  |  |  |  | 
COVID19_MODERNA | Nerve conduction studies abnormal | 0 | 1.567 | 0.007 | 0.32 | 1.069 |  |  |  |  |  | 
COVID19_MODERNA | Large intestinal obstruction reduction | 0 | 0.281 | 0 | 0.32 | 1.801 |  |  |  |  |  | 
COVID19_MODERNA | Neoplasm malignant | 0 | 1.428 | 0.005 | 0.319 | 1.103 |  |  |  |  |  | 
COVID19_MODERNA | Lupus nephritis | 0 | 0.512 | 0 | 0.318 | 1.56 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis A virus test positive | 0 | 0.259 | 0 | 0.317 | 1.809 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy brain | 0 | 0.221 | 0 | 0.317 | 1.835 |  |  |  |  |  | 
COVID19_MODERNA | Product preparation error | 1 | 6.214 | 0.034 | 0.314 | 0.829 | 0.126 | 0.376 | 0.857 | 0.161 | 0.036 | 24.631
COVID19_MODERNA | Product odour abnormal | 0 | 0.152 | 0 | 0.313 | 1.797 |  |  |  |  |  | 
COVID19_MODERNA | Social problem | 0 | 0.386 | 0 | 0.313 | 1.664 |  |  |  |  |  | 
COVID19_MODERNA | Tetanus | 0 | 0.24 | 0 | 0.312 | 1.799 |  |  |  |  |  | 
COVID19_MODERNA | Drug effective for unapproved indication | 0 | 0.28 | 0 | 0.311 | 1.764 |  |  |  |  |  | 
COVID19_MODERNA | Enterocolitis haemorrhagic | 0 | 0.367 | 0 | 0.311 | 1.676 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination error | 0 | 1.078 | 0.001 | 0.31 | 1.203 |  |  |  |  |  | 
COVID19_MODERNA | Muscle necrosis | 0 | 0.233 | 0 | 0.31 | 1.791 |  |  |  |  |  | 
COVID19_MODERNA | Purpura fulminans | 0 | 0.39 | 0 | 0.309 | 1.649 |  |  |  |  |  | 
COVID19_MODERNA | Morose | 0 | 0.306 | 0 | 0.308 | 1.724 |  |  |  |  |  | 
COVID19_MODERNA | Arrested labour | 0 | 0.289 | 0 | 0.307 | 1.734 |  |  |  |  |  | 
COVID19_MODERNA | Subchorionic haemorrhage | 0 | 0.298 | 0 | 0.307 | 1.727 |  |  |  |  |  | 
COVID19_MODERNA | Infection transmission via personal contact | 0 | 0.233 | 0 | 0.305 | 1.767 |  |  |  |  |  | 
COVID19_MODERNA | Sopor | 0 | 0.368 | 0 | 0.304 | 1.648 |  |  |  |  |  | 
COVID19_MODERNA | Paraparesis | 0 | 0.361 | 0 | 0.299 | 1.636 |  |  |  |  |  | 
COVID19_MODERNA | Lung adenocarcinoma | 0 | 0.32 | 0 | 0.299 | 1.673 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune thyroiditis | 0 | 1.332 | 0.002 | 0.298 | 1.096 |  |  |  |  |  | 
COVID19_MODERNA | Rash morbilliform | 0 | 1.371 | 0.002 | 0.296 | 1.081 |  |  |  |  |  | 
COVID19_MODERNA | Muscle enzyme | 0 | 0.351 | 0 | 0.295 | 1.63 |  |  |  |  |  | 
COVID19_MODERNA | HLA marker study | 0 | 0.327 | 0 | 0.294 | 1.646 |  |  |  |  |  | 
COVID19_MODERNA | Epiglottitis haemophilus | 0 | 0.232 | 0 | 0.292 | 1.696 |  |  |  |  |  | 
COVID19_MODERNA | Yellow fever | 0 | 0.154 | 0 | 0.292 | 1.656 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune disorder | 1 | 6.277 | 0.05 | 0.291 | 0.695 | 0.124 | 0.373 | 0.852 | 0.159 | 0.075 | 10.492
COVID19_MODERNA | Hypertensive urgency | 0 | 1.054 | 0 | 0.291 | 1.176 |  |  |  |  |  | 
COVID19_MODERNA | Biopsy cervix abnormal | 0 | 0.217 | 0 | 0.291 | 1.695 |  |  |  |  |  | 
COVID19_MODERNA | Vulval cancer | 0 | 0.192 | 0 | 0.288 | 1.673 |  |  |  |  |  | 
COVID19_MODERNA | Nasal injury | 0 | 1.512 | 0.003 | 0.288 | 1.029 |  |  |  |  |  | 
COVID19_MODERNA | Electromyogram abnormal | 1 | 6.564 | 0.044 | 0.287 | 0.704 | 0.116 | 0.359 | 0.827 | 0.152 | 0.095 | 7.698
COVID19_MODERNA | Premature separation of placenta | 0 | 0.836 | 0 | 0.287 | 1.264 |  |  |  |  |  | 
COVID19_MODERNA | Splenitis | 0 | 0.23 | 0 | 0.286 | 1.667 |  |  |  |  |  | 
COVID19_MODERNA | Suspected COVID-19 | 0 | 2.565 | 0.015 | 0.285 | 0.847 |  |  |  |  |  | 
COVID19_MODERNA | Mumps | 0 | 0.32 | 0 | 0.285 | 1.612 |  |  |  |  |  | 
COVID19_MODERNA | Polycystic ovaries | 0 | 0.396 | 0 | 0.284 | 1.548 |  |  |  |  |  | 
COVID19_MODERNA | Thrombotic thrombocytopenic purpura | 0 | 2.026 | 0.008 | 0.284 | 0.919 |  |  |  |  |  | 
COVID19_MODERNA | Mumps antibody test | 0 | 0.554 | 0 | 0.283 | 1.423 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis pneumococcal | 0 | 0.396 | 0 | 0.281 | 1.538 |  |  |  |  |  | 
COVID19_MODERNA | Tracheitis | 0 | 1.185 | 0.001 | 0.281 | 1.11 |  |  |  |  |  | 
COVID19_MODERNA | Thrombophlebitis (SMQ) [narrow] | 0 | 3.499 | 0.028 | 0.281 | 0.754 |  |  |  |  |  | 
COVID19_MODERNA | Musculoskeletal pain | 6 | 27.778 | 0.138 | 0.28 | 0.461 | 0.154 | 0.282 | 0.479 | 0.216 | 0.041 | 136.007
COVID19_MODERNA | Bacterial test | 0 | 3.497 | 0.028 | 0.28 | 0.753 |  |  |  |  |  | 
COVID19_MODERNA | Blood corticotrophin increased | 0 | 0.19 | 0 | 0.279 | 1.613 |  |  |  |  |  | 
COVID19_MODERNA | Corynebacterium test negative | 0 | 0.308 | 0 | 0.278 | 1.59 |  |  |  |  |  | 
COVID19_MODERNA | Infertility female | 0 | 0.24 | 0 | 0.276 | 1.607 |  |  |  |  |  | 
COVID19_MODERNA | Hunger | 0 | 2.927 | 0.018 | 0.276 | 0.796 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination site dryness | 0 | 0.248 | 0 | 0.275 | 1.598 |  |  |  |  |  | 
COVID19_MODERNA | Amniocentesis normal | 0 | 0.336 | 0 | 0.271 | 1.539 |  |  |  |  |  | 
COVID19_MODERNA | Shoulder dystocia | 0 | 0.335 | 0 | 0.271 | 1.54 |  |  |  |  |  | 
COVID19_MODERNA | Type 2 diabetes mellitus | 0 | 3.419 | 0.023 | 0.27 | 0.746 |  |  |  |  |  | 
COVID19_MODERNA | Haemophilus test positive | 0 | 0.391 | 0 | 0.27 | 1.497 |  |  |  |  |  | 
COVID19_MODERNA | Anti-glomerular basement membrane antibody negative | 0 | 0.39 | 0 | 0.269 | 1.495 |  |  |  |  |  | 
COVID19_MODERNA | Yellow fever vaccine-associated viscerotropic disease | 0 | 0.113 | 0 | 0.269 | 1.325 |  |  |  |  |  | 
COVID19_MODERNA | Infective pulmonary exacerbation of cystic fibrosis | 0 | 0.273 | 0 | 0.269 | 1.559 |  |  |  |  |  | 
COVID19_MODERNA | Urine potassium decreased | 0 | 0.185 | 0 | 0.267 | 1.53 |  |  |  |  |  | 
COVID19_MODERNA | Total complement activity decreased | 0 | 0.39 | 0 | 0.267 | 1.483 |  |  |  |  |  | 
COVID19_MODERNA | Collagen disorder | 0 | 0.39 | 0 | 0.267 | 1.486 |  |  |  |  |  | 
COVID19_MODERNA | Ultrasound antenatal screen normal | 0 | 1.014 | 0 | 0.266 | 1.137 |  |  |  |  |  | 
COVID19_MODERNA | Dyspareunia | 0 | 0.234 | 0 | 0.262 | 1.528 |  |  |  |  |  | 
COVID19_MODERNA | Complex regional pain syndrome | 0 | 1.145 | 0 | 0.262 | 1.082 |  |  |  |  |  | 
COVID19_MODERNA | Vaccine associated paralytic poliomyelitis | 0 | 0.233 | 0 | 0.262 | 1.523 |  |  |  |  |  | 
COVID19_MODERNA | Radiculitis brachial | 0 | 2.99 | 0.015 | 0.26 | 0.765 |  |  |  |  |  | 
COVID19_MODERNA | Community acquired infection | 0 | 0.123 | 0 | 0.259 | 1.287 |  |  |  |  |  | 
COVID19_MODERNA | Herpes zoster | 34 | 102.672 | 0.19 | 0.258 | 0.334 | 0.263 | 0.348 | 0.453 | 0.331 | 0.081 | 364.899
COVID19_MODERNA | Tilt table test normal | 0 | 0.28 | 0 | 0.258 | 1.497 |  |  |  |  |  | 
COVID19_MODERNA | Poliomyelitis | 0 | 0.354 | 0 | 0.256 | 1.457 |  |  |  |  |  | 
COVID19_MODERNA | Product closure issue | 0 | 0.098 | 0 | 0.256 | 1.089 |  |  |  |  |  | 
COVID19_MODERNA | Demyelination | 0 | 2.205 | 0.006 | 0.256 | 0.846 |  |  |  |  |  | 
COVID19_MODERNA | Malaria | 0 | 0.351 | 0 | 0.255 | 1.455 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis A antibody positive | 0 | 0.562 | 0 | 0.255 | 1.325 |  |  |  |  |  | 
COVID19_MODERNA | Polyarteritis nodosa | 0 | 0.379 | 0 | 0.254 | 1.434 |  |  |  |  |  | 
COVID19_MODERNA | Metabolic disorder | 0 | 1.427 | 0.001 | 0.253 | 0.984 |  |  |  |  |  | 
COVID19_MODERNA | Orthostatic intolerance | 0 | 0.341 | 0 | 0.253 | 1.451 |  |  |  |  |  | 
COVID19_MODERNA | Vital signs measurement | 0 | 5.396 | 0.04 | 0.252 | 0.617 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian failure | 0 | 0.287 | 0 | 0.251 | 1.46 |  |  |  |  |  | 
COVID19_MODERNA | Vaccine virus shedding | 0 | 0.126 | 0 | 0.25 | 1.235 |  |  |  |  |  | 
COVID19_MODERNA | Single photon emission computerised tomogram abnormal | 0 | 0.16 | 0 | 0.25 | 1.36 |  |  |  |  |  | 
COVID19_MODERNA | Uterine and fallopian tube tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.392 | 0 | 0.25 | 1.409 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antigen negative | 0 | 0.21 | 0 | 0.25 | 1.439 |  |  |  |  |  | 
COVID19_MODERNA | Somatic symptom disorder | 0 | 0.49 | 0 | 0.247 | 1.339 |  |  |  |  |  | 
COVID19_MODERNA | Multiple use of single-use product | 0 | 0.098 | 0 | 0.246 | 1.004 |  |  |  |  |  | 
COVID19_MODERNA | Product preparation issue | 4 | 37.723 | 0.088 | 0.245 | 0.466 | 0.057 | 0.145 | 0.291 | 0.106 | 0.165 | 16.012
COVID19_MODERNA | Infection parasitic | 0 | 0.345 | 0 | 0.244 | 1.404 |  |  |  |  |  | 
COVID19_MODERNA | Thermometry abnormal | 0 | 0.346 | 0 | 0.244 | 1.404 |  |  |  |  |  | 
COVID19_MODERNA | Delivery | 0 | 0.678 | 0 | 0.243 | 1.223 |  |  |  |  |  | 
COVID19_MODERNA | CSF test abnormal | 0 | 2.604 | 0.007 | 0.241 | 0.772 |  |  |  |  |  | 
COVID19_MODERNA | Chronic fatigue syndrome | 0 | 0.829 | 0 | 0.239 | 1.142 |  |  |  |  |  | 
COVID19_MODERNA | Malaria antibody test negative | 0 | 0.387 | 0 | 0.238 | 1.357 |  |  |  |  |  | 
COVID19_MODERNA | Salmonella test | 0 | 0.322 | 0 | 0.238 | 1.381 |  |  |  |  |  | 
COVID19_MODERNA | Placenta praevia | 0 | 0.666 | 0 | 0.238 | 1.213 |  |  |  |  |  | 
COVID19_MODERNA | Vaccination failure | 0 | 1.72 | 0.001 | 0.234 | 0.884 |  |  |  |  |  | 
COVID19_MODERNA | Narcolepsy | 0 | 0.69 | 0 | 0.233 | 1.187 |  |  |  |  |  | 
COVID19_MODERNA | Pneumococcal infection | 0 | 0.285 | 0 | 0.233 | 1.36 |  |  |  |  |  | 
COVID19_MODERNA | Labelled drug-food interaction medication error | 0 | 0.156 | 0 | 0.232 | 1.205 |  |  |  |  |  | 
COVID19_MODERNA | Amenorrhoea | 0 | 0.791 | 0 | 0.232 | 1.138 |  |  |  |  |  | 
COVID19_MODERNA | Amylase decreased | 0 | 0.367 | 0 | 0.232 | 1.337 |  |  |  |  |  | 
COVID19_MODERNA | Beta haemolytic streptococcal infection | 0 | 1.421 | 0 | 0.231 | 0.939 |  |  |  |  |  | 
COVID19_MODERNA | Glare | 0 | 0.381 | 0 | 0.231 | 1.326 |  |  |  |  |  | 
COVID19_MODERNA | Premature rupture of membranes | 0 | 1.45 | 0 | 0.23 | 0.93 |  |  |  |  |  | 
COVID19_MODERNA | Arteriogram abnormal | 0 | 0.226 | 0 | 0.23 | 1.314 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis | 0 | 2.167 | 0.003 | 0.229 | 0.804 |  |  |  |  |  | 
COVID19_MODERNA | Stool analysis abnormal | 0 | 0.933 | 0 | 0.229 | 1.075 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B DNA assay | 0 | 0.262 | 0 | 0.228 | 1.323 |  |  |  |  |  | 
COVID19_MODERNA | HIV antigen negative | 0 | 0.29 | 0 | 0.228 | 1.33 |  |  |  |  |  | 
COVID19_MODERNA | Alpha hydroxybutyrate dehydrogenase | 0 | 0.356 | 0 | 0.226 | 1.31 |  |  |  |  |  | 
COVID19_MODERNA | Dysaesthesia | 0 | 1.691 | 0.001 | 0.226 | 0.873 |  |  |  |  |  | 
COVID19_MODERNA | Ovarian disorder | 0 | 0.344 | 0 | 0.223 | 1.296 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal disorder | 0 | 1.083 | 0 | 0.222 | 1.006 |  |  |  |  |  | 
COVID19_MODERNA | Linear IgA disease | 0 | 0.34 | 0 | 0.221 | 1.287 |  |  |  |  |  | 
COVID19_MODERNA | Oral administration complication | 0 | 0.664 | 0 | 0.221 | 1.157 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B antigen positive | 0 | 0.205 | 0 | 0.221 | 1.232 |  |  |  |  |  | 
COVID19_MODERNA | Autoimmune encephalopathy | 0 | 0.218 | 0 | 0.22 | 1.242 |  |  |  |  |  | 
COVID19_MODERNA | Investigation | 1 | 21.18 | 0.026 | 0.219 | 0.567 | 0.005 | 0.06 | 0.291 | 0.047 | 0.184 | 2.799
COVID19_MODERNA | Neutrophilia | 0 | 1.676 | 0.001 | 0.219 | 0.859 |  |  |  |  |  | 
COVID19_MODERNA | Dyscalculia | 0 | 0.336 | 0 | 0.218 | 1.268 |  |  |  |  |  | 
COVID19_MODERNA | Meningococcal sepsis | 0 | 0.355 | 0 | 0.217 | 1.262 |  |  |  |  |  | 
COVID19_MODERNA | Serology positive | 0 | 0.286 | 0 | 0.217 | 1.259 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B core antibody | 0 | 0.115 | 0 | 0.217 | 0.891 |  |  |  |  |  | 
COVID19_MODERNA | Low birth weight baby | 0 | 0.253 | 0 | 0.213 | 1.224 |  |  |  |  |  | 
COVID19_MODERNA | Splenic varices haemorrhage | 0 | 0.149 | 0 | 0.213 | 1.03 |  |  |  |  |  | 
COVID19_MODERNA | Prosopagnosia | 0 | 0.219 | 0 | 0.212 | 1.18 |  |  |  |  |  | 
COVID19_MODERNA | Jaundice neonatal | 0 | 0.361 | 0 | 0.209 | 1.217 |  |  |  |  |  | 
COVID19_MODERNA | Irritable bowel syndrome | 0 | 2.352 | 0.002 | 0.208 | 0.741 |  |  |  |  |  | 
COVID19_MODERNA | Angiotensin converting enzyme | 0 | 1.702 | 0 | 0.208 | 0.831 |  |  |  |  |  | 
COVID19_MODERNA | Gastroenteritis norovirus | 0 | 0.362 | 0 | 0.206 | 1.196 |  |  |  |  |  | 
COVID19_MODERNA | Gastric variceal ligation | 0 | 0.185 | 0 | 0.206 | 1.076 |  |  |  |  |  | 
COVID19_MODERNA | HLA marker study positive | 0 | 0.692 | 0 | 0.204 | 1.082 |  |  |  |  |  | 
COVID19_MODERNA | Thyroid function test normal | 0 | 4.082 | 0.011 | 0.203 | 0.6 |  |  |  |  |  | 
COVID19_MODERNA | Diphtheria | 0 | 0.232 | 0 | 0.202 | 1.13 |  |  |  |  |  | 
COVID19_MODERNA | Gene mutation identification test negative | 0 | 1.28 | 0 | 0.201 | 0.9 |  |  |  |  |  | 
COVID19_MODERNA | Renal transplant failure | 0 | 0.213 | 0 | 0.199 | 1.078 |  |  |  |  |  | 
COVID19_MODERNA | Measles antibody negative | 0 | 0.702 | 0 | 0.198 | 1.057 |  |  |  |  |  | 
COVID19_MODERNA | Post vaccination autoinoculation | 0 | 0.202 | 0 | 0.197 | 1.045 |  |  |  |  |  | 
COVID19_MODERNA | Premature baby | 0 | 0.476 | 0 | 0.197 | 1.126 |  |  |  |  |  | 
COVID19_MODERNA | Vaccinia virus infection | 0 | 0.159 | 0 | 0.195 | 0.917 |  |  |  |  |  | 
COVID19_MODERNA | Circulatory collapse | 0 | 3.235 | 0.005 | 0.194 | 0.636 |  |  |  |  |  | 
COVID19_MODERNA | Loss of proprioception | 0 | 1.955 | 0.001 | 0.194 | 0.761 |  |  |  |  |  | 
COVID19_MODERNA | Measles post vaccine | 0 | 0.656 | 0 | 0.192 | 1.048 |  |  |  |  |  | 
COVID19_MODERNA | Polymerase chain reaction positive | 0 | 2.739 | 0.002 | 0.191 | 0.669 |  |  |  |  |  | 
COVID19_MODERNA | Body height decreased | 0 | 2.65 | 0.002 | 0.191 | 0.677 |  |  |  |  |  | 
COVID19_MODERNA | Indirect infection transmission | 0 | 0.258 | 0 | 0.19 | 1.063 |  |  |  |  |  | 
COVID19_MODERNA | Epilepsy | 0 | 2.871 | 0.003 | 0.19 | 0.655 |  |  |  |  |  | 
COVID19_MODERNA | Urine sodium normal | 0 | 0.289 | 0 | 0.188 | 1.075 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis D antibody negative | 0 | 0.289 | 0 | 0.187 | 1.068 |  |  |  |  |  | 
COVID19_MODERNA | Smear cervix abnormal | 0 | 0.266 | 0 | 0.187 | 1.056 |  |  |  |  |  | 
COVID19_MODERNA | Cervical conisation | 0 | 0.267 | 0 | 0.186 | 1.046 |  |  |  |  |  | 
COVID19_MODERNA | Large for dates baby | 0 | 0.213 | 0 | 0.186 | 0.977 |  |  |  |  |  | 
COVID19_MODERNA | H3N2 influenza | 0 | 0.187 | 0 | 0.185 | 0.916 |  |  |  |  |  | 
COVID19_MODERNA | Animal bite | 0 | 0.308 | 0 | 0.185 | 1.063 |  |  |  |  |  | 
COVID19_MODERNA | Haemophilus sepsis | 0 | 0.309 | 0 | 0.184 | 1.057 |  |  |  |  |  | 
COVID19_MODERNA | Meningitis haemophilus | 0 | 0.25 | 0 | 0.182 | 1.004 |  |  |  |  |  | 
COVID19_MODERNA | Intentional product misuse | 0 | 0.266 | 0 | 0.182 | 1.014 |  |  |  |  |  | 
COVID19_MODERNA | Menstrual disorder | 0 | 0.452 | 0 | 0.18 | 1.047 |  |  |  |  |  | 
COVID19_MODERNA | Tooth discolouration | 0 | 0.271 | 0 | 0.179 | 0.997 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B surface antibody | 0 | 0.271 | 0 | 0.176 | 0.98 |  |  |  |  |  | 
COVID19_MODERNA | Acute febrile neutrophilic dermatosis | 0 | 1.37 | 0 | 0.176 | 0.81 |  |  |  |  |  | 
COVID19_MODERNA | Cerebral hypoperfusion | 0 | 0.417 | 0 | 0.175 | 1.017 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis A | 0 | 0.302 | 0 | 0.174 | 0.986 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B DNA assay negative | 0 | 0.33 | 0 | 0.172 | 0.99 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B core antigen positive | 0 | 0.297 | 0 | 0.172 | 0.969 |  |  |  |  |  | 
COVID19_MODERNA | Colposcopy | 0 | 0.301 | 0 | 0.172 | 0.97 |  |  |  |  |  | 
COVID19_MODERNA | Olfactory test abnormal | 0 | 0.296 | 0 | 0.171 | 0.963 |  |  |  |  |  | 
COVID19_MODERNA | Extensive swelling of vaccinated limb | 0 | 3.096 | 0.002 | 0.171 | 0.601 |  |  |  |  |  | 
COVID19_MODERNA | H1N1 influenza | 0 | 0.593 | 0 | 0.17 | 0.969 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B DNA increased | 0 | 0.16 | 0 | 0.17 | 0.709 |  |  |  |  |  | 
COVID19_MODERNA | Amniotic cavity infection | 0 | 0.626 | 0 | 0.17 | 0.961 |  |  |  |  |  | 
COVID19_MODERNA | Foetal non-stress test normal | 0 | 0.499 | 0 | 0.169 | 0.983 |  |  |  |  |  | 
COVID19_MODERNA | Norovirus test positive | 0 | 0.303 | 0 | 0.169 | 0.951 |  |  |  |  |  | 
COVID19_MODERNA | Weight | 0 | 0.932 | 0 | 0.166 | 0.872 |  |  |  |  |  | 
COVID19_MODERNA | Rotavirus infection | 0 | 1.002 | 0 | 0.163 | 0.844 |  |  |  |  |  | 
COVID19_MODERNA | Periodic acid Schiff stain | 0 | 0.335 | 0 | 0.161 | 0.911 |  |  |  |  |  | 
COVID19_MODERNA | Human papilloma virus test positive | 0 | 0.559 | 0 | 0.159 | 0.917 |  |  |  |  |  | 
COVID19_MODERNA | Urea urine | 0 | 0.333 | 0 | 0.158 | 0.89 |  |  |  |  |  | 
COVID19_MODERNA | Judgement impaired | 0 | 0.341 | 0 | 0.153 | 0.863 |  |  |  |  |  | 
COVID19_MODERNA | Lyssavirus test positive | 0 | 0.086 | 0 | 0.15 | 0.194 |  |  |  |  |  | 
COVID19_MODERNA | Plethysmography | 0 | 0.267 | 0 | 0.15 | 0.778 |  |  |  |  |  | 
COVID19_MODERNA | Electrophoresis | 0 | 0.344 | 0 | 0.15 | 0.844 |  |  |  |  |  | 
COVID19_MODERNA | Pneumococcal bacteraemia | 0 | 0.238 | 0 | 0.149 | 0.732 |  |  |  |  |  | 
COVID19_MODERNA | Cervix carcinoma | 0 | 0.319 | 0 | 0.149 | 0.824 |  |  |  |  |  | 
COVID19_MODERNA | Typhoid fever | 0 | 0.421 | 0 | 0.148 | 0.857 |  |  |  |  |  | 
COVID19_MODERNA | Pericardial disease | 0 | 0.184 | 0 | 0.148 | 0.606 |  |  |  |  |  | 
COVID19_MODERNA | Hyperpyrexia | 0 | 2.086 | 0 | 0.147 | 0.634 |  |  |  |  |  | 
COVID19_MODERNA | Adverse event | 1 | 15.911 | 0.026 | 0.143 | 0.337 | 0.01 | 0.109 | 0.4 | 0.063 | 0.025 | 36.419
COVID19_MODERNA | Yellow fever vaccine-associated neurotropic disease | 0 | 0.292 | 0 | 0.142 | 0.747 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antibody | 0 | 0.163 | 0 | 0.139 | 0.474 |  |  |  |  |  | 
COVID19_MODERNA | Premature delivery | 1 | 12.826 | 0.011 | 0.137 | 0.379 | 0.018 | 0.161 | 0.492 | 0.078 | 0.179 | 2.948
COVID19_MODERNA | Disease recurrence | 0 | 4.614 | 0.003 | 0.135 | 0.455 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antibody negative | 0 | 0.249 | 0 | 0.13 | 0.6 |  |  |  |  |  | 
COVID19_MODERNA | Mucosal hyperaemia | 0 | 0.316 | 0 | 0.129 | 0.666 |  |  |  |  |  | 
COVID19_MODERNA | Bacterial vaginosis | 0 | 0.804 | 0 | 0.129 | 0.736 |  |  |  |  |  | 
COVID19_MODERNA | Caesarean section | 0 | 0.965 | 0 | 0.127 | 0.705 |  |  |  |  |  | 
COVID19_MODERNA | Pneumonia pneumococcal | 0 | 0.384 | 0 | 0.126 | 0.693 |  |  |  |  |  | 
COVID19_MODERNA | Neonatal seizure | 0 | 0.359 | 0 | 0.126 | 0.676 |  |  |  |  |  | 
COVID19_MODERNA | Uterine and fallopian tube malignant tumours (SMQ) [broad] | 0 | 0.611 | 0 | 0.125 | 0.728 |  |  |  |  |  | 
COVID19_MODERNA | Fever neonatal | 0 | 0.3 | 0 | 0.124 | 0.615 |  |  |  |  |  | 
COVID19_MODERNA | Neurone-specific enolase decreased | 0 | 0.338 | 0 | 0.123 | 0.644 |  |  |  |  |  | 
COVID19_MODERNA | Microagglutination test | 0 | 0.335 | 0 | 0.123 | 0.635 |  |  |  |  |  | 
COVID19_MODERNA | Therapy non-responder | 0 | 0.893 | 0 | 0.119 | 0.676 |  |  |  |  |  | 
COVID19_MODERNA | Off label use | 1 | 18.17 | 0.015 | 0.118 | 0.302 | 0.007 | 0.083 | 0.347 | 0.055 | 0.162 | 3.477
COVID19_MODERNA | Hepatitis B virus test positive | 0 | 0.444 | 0 | 0.118 | 0.657 |  |  |  |  |  | 
COVID19_MODERNA | Anti-myelin-associated glycoprotein antibodies positive | 0 | 0.388 | 0 | 0.118 | 0.632 |  |  |  |  |  | 
COVID19_MODERNA | Drug ineffective | 1 | 42.083 | 0.014 | 0.117 | 0.3 | 0.001 | 0.016 | 0.101 | 0.024 | 0.068 | 11.816
COVID19_MODERNA | Splenic artery embolisation | 0 | 0.316 | 0 | 0.117 | 0.576 |  |  |  |  |  | 
COVID19_MODERNA | Chronic hepatitis B | 0 | 0.24 | 0 | 0.117 | 0.481 |  |  |  |  |  | 
COVID19_MODERNA | Uterine and fallopian tube malignant tumours (SMQ) [narrow] | 0 | 0.53 | 0 | 0.117 | 0.673 |  |  |  |  |  | 
COVID19_MODERNA | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.53 | 0 | 0.117 | 0.673 |  |  |  |  |  | 
COVID19_MODERNA | Forced expiratory volume decreased | 0 | 0.524 | 0 | 0.116 | 0.669 |  |  |  |  |  | 
COVID19_MODERNA | Foetal growth restriction | 0 | 0.812 | 0 | 0.113 | 0.656 |  |  |  |  |  | 
COVID19_MODERNA | Papilloma viral infection | 0 | 0.546 | 0 | 0.112 | 0.642 |  |  |  |  |  | 
COVID19_MODERNA | Respiratory tract infection | 0 | 3.359 | 0 | 0.11 | 0.45 |  |  |  |  |  | 
COVID19_MODERNA | Meningococcal infection | 0 | 0.343 | 0 | 0.11 | 0.544 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B surface antibody positive | 0 | 1.077 | 0 | 0.11 | 0.617 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antigen positive | 0 | 0.292 | 0 | 0.1 | 0.413 |  |  |  |  |  | 
COVID19_MODERNA | Infection via vaccinee | 0 | 0.4 | 0 | 0.098 | 0.49 |  |  |  |  |  | 
COVID19_MODERNA | HBV-DNA polymerase increased | 0 | 0.294 | 0 | 0.098 | 0.399 |  |  |  |  |  | 
COVID19_MODERNA | Incorrect product formulation administered | 0 | 2.083 | 0 | 0.096 | 0.481 |  |  |  |  |  | 
COVID19_MODERNA | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.935 | 0 | 0.087 | 0.509 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antigen | 0 | 0.364 | 0 | 0.087 | 0.381 |  |  |  |  |  | 
COVID19_MODERNA | Cervical dysplasia | 0 | 0.526 | 0 | 0.085 | 0.447 |  |  |  |  |  | 
COVID19_MODERNA | Reproductive premalignant disorders (SMQ) [narrow] | 0 | 0.579 | 0 | 0.084 | 0.454 |  |  |  |  |  | 
COVID19_MODERNA | Reproductive premalignant disorders (SMQ) [broad] | 0 | 0.579 | 0 | 0.084 | 0.454 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B e antibody positive | 0 | 0.307 | 0 | 0.083 | 0.297 |  |  |  |  |  | 
COVID19_MODERNA | Bordetella test positive | 0 | 1.132 | 0 | 0.083 | 0.483 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B core antibody positive | 0 | 0.765 | 0 | 0.082 | 0.471 |  |  |  |  |  | 
COVID19_MODERNA | Rotavirus test positive | 0 | 1.803 | 0 | 0.08 | 0.436 |  |  |  |  |  | 
COVID19_MODERNA | Lack of efficacy/effect (SMQ) [narrow] | 3 | 52.969 | 0.025 | 0.079 | 0.158 | 0.019 | 0.062 | 0.165 | 0.057 | 0.014 | 208.604
COVID19_MODERNA | Lack of efficacy/effect (SMQ) [broad] | 3 | 52.969 | 0.025 | 0.079 | 0.158 | 0.019 | 0.062 | 0.165 | 0.057 | 0.014 | 208.604
COVID19_MODERNA | Gastroenteritis rotavirus | 0 | 1.986 | 0 | 0.072 | 0.394 |  |  |  |  |  | 
COVID19_MODERNA | Dysmenorrhoea | 0 | 1.99 | 0 | 0.069 | 0.383 |  |  |  |  |  | 
COVID19_MODERNA | Complication of pregnancy | 0 | 1.207 | 0 | 0.069 | 0.403 |  |  |  |  |  | 
COVID19_MODERNA | Flavivirus test positive | 0 | 0.307 | 0 | 0.068 | 0.184 |  |  |  |  |  | 
COVID19_MODERNA | Pertussis | 0 | 1.995 | 0 | 0.068 | 0.377 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B surface antibody negative | 0 | 1.324 | 0 | 0.066 | 0.382 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B surface antigen positive | 0 | 0.819 | 0 | 0.057 | 0.301 |  |  |  |  |  | 
COVID19_MODERNA | Post herpetic neuralgia | 0 | 1.901 | 0 | 0.057 | 0.328 |  |  |  |  |  | 
COVID19_MODERNA | Influenza A virus test positive | 0 | 3.88 | 0 | 0.051 | 0.259 |  |  |  |  |  | 
COVID19_MODERNA | Orthopoxvirus test positive | 0 | 0.269 | 0 | 0.051 | 0.059 |  |  |  |  |  | 
COVID19_MODERNA | Vertical infection transmission | 0 | 0.438 | 0 | 0.051 | 0.151 |  |  |  |  |  | 
COVID19_MODERNA | Aerophobia | 0 | 0.308 | 0 | 0.046 | 0.055 |  |  |  |  |  | 
COVID19_MODERNA | Platelet-derived growth factor receptor assay | 0 | 0.612 | 0 | 0.043 | 0.154 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B | 0 | 1.213 | 0 | 0.042 | 0.229 |  |  |  |  |  | 
COVID19_MODERNA | Toxoplasma serology | 0 | 1.502 | 0 | 0.041 | 0.232 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B DNA assay positive | 0 | 0.795 | 0 | 0.041 | 0.177 |  |  |  |  |  | 
COVID19_MODERNA | HIV antibody | 0 | 0.966 | 0 | 0.041 | 0.204 |  |  |  |  |  | 
COVID19_MODERNA | Neutralising antibodies | 0 | 0.27 | 0 | 0.037 | 0.014 |  |  |  |  |  | 
COVID19_MODERNA | Rabies | 0 | 0.513 | 0 | 0.029 | 0.038 |  |  |  |  |  | 
COVID19_MODERNA | Hydrophobia | 0 | 0.345 | 0 | 0.023 | 0.003 |  |  |  |  |  | 
COVID19_MODERNA | Product use issue | 0 | 14.306 | 0 | 0.019 | 0.089 |  |  |  |  |  | 
COVID19_MODERNA | Hepatitis B surface antigen | 0 | 2.509 | 0 | 0.014 | 0.061 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight | 18 | 8.279 | 10.243 | 15.807 | 22.357 | 1.221 | 1.772 | 2.508 | 2.174 | 325.082 | 288.36
COVID19_PFIZER/BIONTECH | Exposure to SARS-CoV-2 | 95 | 52.965 | 10.342 | 12.347 | 14.5 | 1.463 | 1.733 | 2.04 | 1.794 | 142.976 | 1485.77
COVID19_PFIZER/BIONTECH | Body height | 14 | 7.088 | 6.153 | 10.105 | 14.854 | 1.052 | 1.593 | 2.337 | 1.975 | 252.841 | 216.748
COVID19_PFIZER/BIONTECH | Asymptomatic COVID-19 | 15 | 9.622 | 5.584 | 9.014 | 13.111 | 0.911 | 1.363 | 1.975 | 1.559 | 67.725 | 193.051
COVID19_PFIZER/BIONTECH | Occupational exposure to SARS-CoV-2 | 21 | 10.524 | 5.534 | 8.222 | 11.346 | 1.202 | 1.701 | 2.354 | 1.995 | 379.262 | 342.221
COVID19_PFIZER/BIONTECH | Mean cell volume abnormal | 3 | 1.298 | 2.186 | 7.424 | 15.185 | 0.604 | 1.234 | 2.313 | 2.311 | 126.414 | 36.797
COVID19_PFIZER/BIONTECH | Mastoid disorder | 3 | 1.383 | 2.186 | 7.424 | 15.185 | 0.594 | 1.212 | 2.269 | 2.17 | 126.414 | 36.797
COVID19_PFIZER/BIONTECH | Diaphragmatic spasm | 3 | 1.405 | 2.186 | 7.424 | 15.185 | 0.591 | 1.207 | 2.258 | 2.135 | 126.414 | 36.797
COVID19_PFIZER/BIONTECH | AST/ALT ratio abnormal | 3 | 1.418 | 2.186 | 7.424 | 15.185 | 0.59 | 1.204 | 2.251 | 2.116 | 126.414 | 36.797
COVID19_PFIZER/BIONTECH | Cardiac telemetry abnormal | 3 | 1.634 | 2.186 | 7.424 | 15.185 | 0.565 | 1.153 | 2.151 | 1.836 | 126.414 | 36.797
COVID19_PFIZER/BIONTECH | Hypertensive urgency | 10 | 3.784 | 4.05 | 7.354 | 11.455 | 1.097 | 1.773 | 2.766 | 2.643 | 180.601 | 145.6
COVID19_PFIZER/BIONTECH | SARS-CoV-2 test positive | 1155 | 731.132 | 6.651 | 6.985 | 7.327 | 1.501 | 1.576 | 1.654 | 1.58 | 101.753 | 17422.409
COVID19_PFIZER/BIONTECH | Heart rate | 100 | 59.939 | 5.694 | 6.763 | 7.907 | 1.375 | 1.621 | 1.901 | 1.668 | 75.25 | 1403.393
COVID19_PFIZER/BIONTECH | Investigation | 47 | 25.254 | 4.981 | 6.436 | 8.044 | 1.366 | 1.734 | 2.175 | 1.861 | 9.646 | 231.6
COVID19_PFIZER/BIONTECH | Drug ineffective | 135 | 88.963 | 5.474 | 6.343 | 7.265 | 1.294 | 1.491 | 1.711 | 1.517 | 10.647 | 736.758
COVID19_PFIZER/BIONTECH | Pelvic venous thrombosis | 4 | 1.777 | 2.282 | 6.238 | 11.772 | 0.678 | 1.31 | 2.351 | 2.251 | 36.12 | 34.014
COVID19_PFIZER/BIONTECH | Blood pressure measurement | 100 | 62.083 | 5.103 | 6.059 | 7.082 | 1.33 | 1.568 | 1.839 | 1.611 | 45.15 | 1220.723
COVID19_PFIZER/BIONTECH | Body temperature | 168 | 100.512 | 5.278 | 6.019 | 6.8 | 1.446 | 1.643 | 1.86 | 1.671 | 17.848 | 1336.214
COVID19_PFIZER/BIONTECH | SARS-CoV-2 antibody test | 36 | 21.121 | 4.344 | 5.832 | 7.499 | 1.204 | 1.578 | 2.039 | 1.704 | 81.27 | 503.718
COVID19_PFIZER/BIONTECH | Anosmia | 145 | 82.22 | 4.806 | 5.537 | 6.311 | 1.504 | 1.725 | 1.971 | 1.764 | 34.009 | 1600.3
COVID19_PFIZER/BIONTECH | Blood pressure systolic | 7 | 3.168 | 2.649 | 5.513 | 9.22 | 0.859 | 1.484 | 2.435 | 2.21 | 126.421 | 92.96
COVID19_PFIZER/BIONTECH | COVID-19 (SMQ) [narrow] | 1443 | 943.903 | 5.141 | 5.372 | 5.606 | 1.461 | 1.526 | 1.593 | 1.529 | 66.312 | 19962.417
COVID19_PFIZER/BIONTECH | Perfusion brain scan normal | 4 | 1.875 | 1.897 | 5.208 | 9.847 | 0.666 | 1.286 | 2.305 | 2.133 | 162.532 | 54.438
COVID19_PFIZER/BIONTECH | Dental paraesthesia | 3 | 1.435 | 1.594 | 5.202 | 10.492 | 0.588 | 1.2 | 2.243 | 2.091 | 54.18 | 26.375
COVID19_PFIZER/BIONTECH | NIH stroke scale abnormal | 3 | 1.475 | 1.594 | 5.202 | 10.492 | 0.583 | 1.19 | 2.224 | 2.034 | 54.18 | 26.375
COVID19_PFIZER/BIONTECH | COVID-19 | 703 | 483.988 | 4.834 | 5.149 | 5.473 | 1.361 | 1.448 | 1.54 | 1.453 | 53.571 | 9155.344
COVID19_PFIZER/BIONTECH | Blood lactic acid decreased | 9 | 3.711 | 2.753 | 5.123 | 8.089 | 1.002 | 1.65 | 2.607 | 2.426 | 16.254 | 59.606
COVID19_PFIZER/BIONTECH | Diastolic dysfunction | 3 | 2.355 | 1.492 | 5.103 | 10.462 | 0.497 | 1.012 | 1.883 | 1.274 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Pain assessment | 3 | 1.411 | 1.511 | 4.96 | 10.025 | 0.591 | 1.205 | 2.255 | 2.126 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Dependence on respirator | 3 | 1.433 | 1.485 | 4.853 | 9.793 | 0.588 | 1.2 | 2.244 | 2.093 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Hemiplegic migraine | 3 | 1.383 | 1.359 | 4.508 | 9.145 | 0.594 | 1.212 | 2.269 | 2.17 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Intestinal perforation | 5 | 2.911 | 1.78 | 4.265 | 7.617 | 0.668 | 1.233 | 2.127 | 1.718 | 6.45 | 12.993
COVID19_PFIZER/BIONTECH | Gingival pruritus | 3 | 1.062 | 1.33 | 4.213 | 8.408 | 0.635 | 1.301 | 2.452 | 2.824 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Arteriospasm coronary | 2 | 1.197 | 0.901 | 4.202 | 9.481 | 0.479 | 1.049 | 2.065 | 1.671 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Large intestine perforation | 3 | 2.152 | 1.23 | 4.127 | 8.405 | 0.514 | 1.048 | 1.951 | 1.394 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | SARS-CoV-2 test | 444 | 281.561 | 3.755 | 4.066 | 4.388 | 1.449 | 1.568 | 1.693 | 1.577 | 39.894 | 5243.754
COVID19_PFIZER/BIONTECH | May-Thurner syndrome | 4 | 2.333 | 1.481 | 4.005 | 7.528 | 0.614 | 1.185 | 2.117 | 1.714 | 72.24 | 42.173
COVID19_PFIZER/BIONTECH | Alanine aminotransferase decreased | 3 | 1.408 | 1.2 | 3.991 | 8.103 | 0.591 | 1.206 | 2.256 | 2.13 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Nipple swelling | 2 | 0.092 | 0.924 | 3.985 | 8.792 | 0.641 | 1.662 | 9.926 | 21.733 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | White coat hypertension | 2 | 0.708 | 0.924 | 3.985 | 8.792 | 0.534 | 1.174 | 2.332 | 2.824 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Periorbital discomfort | 2 | 0.708 | 0.924 | 3.985 | 8.792 | 0.534 | 1.174 | 2.332 | 2.824 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Non-tobacco user | 2 | 0.825 | 0.924 | 3.985 | 8.792 | 0.52 | 1.141 | 2.258 | 2.426 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Pharyngeal mass | 2 | 0.922 | 0.924 | 3.985 | 8.792 | 0.508 | 1.115 | 2.202 | 2.17 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Tracheal aspirate culture | 2 | 0.935 | 0.924 | 3.985 | 8.792 | 0.507 | 1.111 | 2.195 | 2.14 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Airway secretion clearance therapy | 2 | 0.941 | 0.924 | 3.985 | 8.792 | 0.506 | 1.11 | 2.192 | 2.126 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Balance test | 2 | 0.941 | 0.924 | 3.985 | 8.792 | 0.506 | 1.11 | 2.192 | 2.125 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Arterial rupture | 2 | 0.944 | 0.924 | 3.985 | 8.792 | 0.506 | 1.109 | 2.19 | 2.118 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Red blood cell count abnormal | 2 | 0.947 | 0.924 | 3.985 | 8.792 | 0.505 | 1.108 | 2.189 | 2.111 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Blood pressure diastolic | 2 | 0.947 | 0.924 | 3.985 | 8.792 | 0.505 | 1.108 | 2.189 | 2.111 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Right ventricular dilatation | 2 | 1.204 | 0.924 | 3.985 | 8.792 | 0.478 | 1.047 | 2.062 | 1.661 | 90.296 | 19.575
COVID19_PFIZER/BIONTECH | Vaccination site haemorrhage | 6 | 4.344 | 1.792 | 3.96 | 6.818 | 0.639 | 1.136 | 1.901 | 1.381 | 2.709 | 4.167
COVID19_PFIZER/BIONTECH | Psychogenic seizure | 2 | 0.747 | 0.777 | 3.919 | 9.036 | 0.529 | 1.163 | 2.306 | 2.677 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Prohormone brain natriuretic peptide | 2 | 1.289 | 0.885 | 3.901 | 8.659 | 0.47 | 1.029 | 2.025 | 1.552 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Complicated appendicitis | 2 | 1.392 | 0.885 | 3.901 | 8.659 | 0.46 | 1.007 | 1.981 | 1.436 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Biliary dilatation | 2 | 1.43 | 0.885 | 3.901 | 8.659 | 0.456 | 0.999 | 1.965 | 1.398 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Abdominal wall haematoma | 2 | 1.434 | 0.885 | 3.901 | 8.659 | 0.456 | 0.998 | 1.964 | 1.395 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Cardiac death | 2 | 1.872 | 0.885 | 3.901 | 8.659 | 0.419 | 0.918 | 1.803 | 1.069 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Blood sodium increased | 8 | 4.159 | 1.995 | 3.881 | 6.271 | 0.846 | 1.422 | 2.277 | 1.924 | 11.114 | 39.215
COVID19_PFIZER/BIONTECH | Product preparation issue | 80 | 43.15 | 3.142 | 3.815 | 4.541 | 1.478 | 1.776 | 2.12 | 1.854 | 2.763 | 76.558
COVID19_PFIZER/BIONTECH | Embolic stroke | 5 | 2.845 | 1.584 | 3.802 | 6.795 | 0.675 | 1.246 | 2.15 | 1.758 | 30.1 | 41.863
COVID19_PFIZER/BIONTECH | Pupillary light reflex tests abnormal | 3 | 1.29 | 1.134 | 3.768 | 7.648 | 0.605 | 1.236 | 2.317 | 2.326 | 2.58 | 1.291
COVID19_PFIZER/BIONTECH | Norovirus test | 1 | 0.401 | 0.28 | 3.739 | 10.57 | 0.415 | 1.009 | 2.15 | 2.492 | 0.516 | 0.084
COVID19_PFIZER/BIONTECH | Basal ganglia haemorrhage | 3 | 1.022 | 1.191 | 3.705 | 7.345 | 0.641 | 1.314 | 2.48 | 2.937 | 18.06 | 16.009
COVID19_PFIZER/BIONTECH | Optical coherence tomography | 3 | 1.885 | 1.151 | 3.605 | 7.166 | 0.539 | 1.099 | 2.048 | 1.592 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Staphylococcal sepsis | 3 | 1.938 | 1.129 | 3.585 | 7.161 | 0.534 | 1.088 | 2.028 | 1.548 | 10.836 | 10.882
COVID19_PFIZER/BIONTECH | Ageusia | 150 | 94.095 | 3.037 | 3.49 | 3.97 | 1.369 | 1.566 | 1.786 | 1.594 | 16.62 | 1139.201
COVID19_PFIZER/BIONTECH | Withdrawal of life support | 3 | 1.879 | 1.107 | 3.485 | 6.939 | 0.54 | 1.1 | 2.051 | 1.597 | 10.836 | 10.882
COVID19_PFIZER/BIONTECH | Sensory overload | 2 | 0.708 | 0.752 | 3.458 | 7.772 | 0.534 | 1.174 | 2.332 | 2.824 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Intracardiac thrombus | 2 | 1.437 | 0.821 | 3.45 | 7.554 | 0.456 | 0.998 | 1.963 | 1.392 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Circumoral swelling | 3 | 1.118 | 1.115 | 3.447 | 6.818 | 0.628 | 1.285 | 2.417 | 2.684 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Thromboembolectomy | 2 | 0.95 | 0.82 | 3.444 | 7.539 | 0.505 | 1.107 | 2.187 | 2.104 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Oropharyngeal spasm | 2 | 0.825 | 0.818 | 3.433 | 7.512 | 0.52 | 1.141 | 2.258 | 2.426 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Perfusion brain scan abnormal | 2 | 0.941 | 0.815 | 3.413 | 7.463 | 0.506 | 1.11 | 2.192 | 2.126 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Respiratory tract irritation | 3 | 0.429 | 1.073 | 3.408 | 6.808 | 0.744 | 1.616 | 3.842 | 6.988 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Tongue discomfort | 36 | 19.412 | 2.528 | 3.379 | 4.331 | 1.294 | 1.696 | 2.191 | 1.855 | 14.134 | 238.819
COVID19_PFIZER/BIONTECH | Radial pulse abnormal | 2 | 0.935 | 0.811 | 3.379 | 7.379 | 0.507 | 1.111 | 2.195 | 2.14 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Ischaemic cardiomyopathy | 2 | 0.954 | 0.811 | 3.379 | 7.379 | 0.505 | 1.107 | 2.185 | 2.097 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Vascular dementia | 2 | 1.647 | 0.811 | 3.379 | 7.379 | 0.437 | 0.957 | 1.882 | 1.214 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Renal tubular necrosis | 2 | 1.418 | 0.787 | 3.374 | 7.431 | 0.457 | 1.002 | 1.97 | 1.411 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Urinary occult blood positive | 2 | 1.879 | 0.785 | 3.357 | 7.388 | 0.418 | 0.916 | 1.801 | 1.065 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Appendicolith | 2 | 0.935 | 0.806 | 3.347 | 7.302 | 0.507 | 1.111 | 2.195 | 2.14 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Peripheral nerve injury | 2 | 0.931 | 0.806 | 3.346 | 7.298 | 0.507 | 1.112 | 2.197 | 2.147 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | COVID-19 (SMQ) [broad] | 2389 | 1574.747 | 3.224 | 3.336 | 3.449 | 1.465 | 1.516 | 1.567 | 1.517 | 36.751 | 27653.937
COVID19_PFIZER/BIONTECH | Oversensing | 2 | 0.825 | 0.804 | 3.331 | 7.263 | 0.52 | 1.141 | 2.258 | 2.426 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Viral pericarditis | 2 | 1.694 | 0.78 | 3.321 | 7.3 | 0.433 | 0.949 | 1.865 | 1.181 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Absence of immediate treatment response | 2 | 1.422 | 0.779 | 3.317 | 7.291 | 0.457 | 1.001 | 1.969 | 1.406 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Eyelid sensory disorder | 2 | 0.708 | 0.8 | 3.299 | 7.184 | 0.534 | 1.174 | 2.332 | 2.824 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Diverticulum | 3 | 1.907 | 1.048 | 3.289 | 6.543 | 0.537 | 1.095 | 2.04 | 1.573 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Quarantine | 3 | 3.285 | 1.078 | 3.282 | 6.455 | 0.429 | 0.875 | 1.627 | 0.913 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Haemoperitoneum | 2 | 1.449 | 0.772 | 3.259 | 7.145 | 0.454 | 0.995 | 1.958 | 1.38 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Post procedural haemorrhage | 2 | 0.935 | 0.794 | 3.257 | 7.079 | 0.507 | 1.111 | 2.195 | 2.14 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Infusion site extravasation | 2 | 1.2 | 0.794 | 3.257 | 7.079 | 0.478 | 1.048 | 2.064 | 1.666 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin concentration | 5 | 2.406 | 1.371 | 3.254 | 5.786 | 0.725 | 1.338 | 2.315 | 2.078 | 4.3 | 7.609
COVID19_PFIZER/BIONTECH | Immunisation anxiety related reaction | 2 | 1.169 | 0.77 | 3.245 | 7.111 | 0.481 | 1.055 | 2.078 | 1.711 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Menstruation delayed | 3 | 1.631 | 1.013 | 3.237 | 6.481 | 0.566 | 1.153 | 2.153 | 1.839 | 1.868 | 0.424
COVID19_PFIZER/BIONTECH | Body mass index | 2 | 0.935 | 0.791 | 3.235 | 7.026 | 0.507 | 1.111 | 2.195 | 2.14 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Right atrial dilatation | 2 | 0.944 | 0.79 | 3.23 | 7.013 | 0.506 | 1.109 | 2.19 | 2.118 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Ischaemic hepatitis | 2 | 0.954 | 0.787 | 3.206 | 6.956 | 0.505 | 1.107 | 2.185 | 2.097 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Product substitution | 3 | 1.901 | 0.967 | 3.2 | 6.486 | 0.538 | 1.096 | 2.042 | 1.578 | 54.18 | 26.375
COVID19_PFIZER/BIONTECH | Drainage | 5 | 2.74 | 1.339 | 3.198 | 5.705 | 0.686 | 1.266 | 2.187 | 1.825 | 22.575 | 36.261
COVID19_PFIZER/BIONTECH | Neck injury | 3 | 1.869 | 1.012 | 3.198 | 6.376 | 0.541 | 1.102 | 2.055 | 1.605 | 7.74 | 7.849
COVID19_PFIZER/BIONTECH | Axonal and demyelinating polyneuropathy | 2 | 0.993 | 0.782 | 3.175 | 6.878 | 0.5 | 1.097 | 2.164 | 2.014 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Electrocardiogram T wave peaked | 2 | 0.773 | 0.713 | 3.153 | 7.008 | 0.526 | 1.155 | 2.29 | 2.589 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Embolism | 2 | 1.43 | 0.755 | 3.133 | 6.832 | 0.456 | 0.999 | 1.965 | 1.398 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Ventricular drainage | 3 | 1.87 | 1.025 | 3.111 | 6.112 | 0.541 | 1.102 | 2.054 | 1.604 | 10.836 | 10.882
COVID19_PFIZER/BIONTECH | Crystal urine present | 2 | 0.931 | 0.729 | 3.102 | 6.816 | 0.507 | 1.112 | 2.197 | 2.147 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Adrenocortical insufficiency acute | 3 | 1.936 | 0.895 | 3.1 | 6.384 | 0.534 | 1.089 | 2.029 | 1.55 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Hyperkalaemia | 4 | 2.444 | 1.137 | 3.093 | 5.825 | 0.603 | 1.163 | 2.076 | 1.636 | 2.778 | 2.488
COVID19_PFIZER/BIONTECH | Diverticulum intestinal haemorrhagic | 2 | 0.944 | 0.765 | 3.049 | 6.569 | 0.506 | 1.109 | 2.19 | 2.118 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Pharyngeal paraesthesia | 77 | 43.98 | 2.505 | 3.046 | 3.63 | 1.394 | 1.682 | 2.014 | 1.751 | 14.336 | 524.988
COVID19_PFIZER/BIONTECH | Bone swelling | 2 | 1.368 | 0.7 | 3.046 | 6.737 | 0.462 | 1.012 | 1.991 | 1.462 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Coronary artery stenosis | 2 | 1.898 | 0.7 | 3.04 | 6.721 | 0.417 | 0.913 | 1.795 | 1.054 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Vaccination site joint erythema | 2 | 1.024 | 0.676 | 3.037 | 6.78 | 0.497 | 1.089 | 2.148 | 1.953 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Kidney infection | 7 | 4.946 | 1.503 | 3.029 | 4.986 | 0.68 | 1.173 | 1.915 | 1.415 | 4.515 | 12.502
COVID19_PFIZER/BIONTECH | Right ventricular dysfunction | 2 | 1.217 | 0.742 | 3.028 | 6.572 | 0.477 | 1.044 | 2.056 | 1.643 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Hypertensive emergency | 4 | 2.584 | 1.126 | 3.016 | 5.646 | 0.589 | 1.136 | 2.028 | 1.548 | 24.08 | 28.203
COVID19_PFIZER/BIONTECH | Atrial tachycardia | 3 | 1.276 | 0.988 | 3.008 | 5.917 | 0.607 | 1.24 | 2.325 | 2.351 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Hidradenitis | 2 | 0.764 | 0.673 | 3.004 | 6.693 | 0.527 | 1.158 | 2.295 | 2.617 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Ejection fraction | 5 | 4.275 | 1.25 | 3.003 | 5.368 | 0.552 | 1.019 | 1.754 | 1.169 | 22.575 | 36.261
COVID19_PFIZER/BIONTECH | Cardiac failure chronic | 3 | 2.114 | 0.928 | 2.997 | 6.022 | 0.518 | 1.055 | 1.964 | 1.419 | 54.18 | 26.375
COVID19_PFIZER/BIONTECH | SARS-CoV-1 test | 3 | 2.654 | 0.928 | 2.997 | 6.022 | 0.473 | 0.963 | 1.792 | 1.13 | 54.18 | 26.375
COVID19_PFIZER/BIONTECH | Ruptured cerebral aneurysm | 2 | 0.935 | 0.737 | 2.994 | 6.488 | 0.507 | 1.111 | 2.195 | 2.14 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Aortic arteriosclerosis | 5 | 2.932 | 1.283 | 2.983 | 5.256 | 0.666 | 1.229 | 2.12 | 1.705 | 18.06 | 31.79
COVID19_PFIZER/BIONTECH | Hemianopia | 2 | 1.411 | 0.624 | 2.974 | 6.753 | 0.458 | 1.003 | 1.973 | 1.417 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Nail discolouration | 3 | 1.323 | 0.937 | 2.9 | 5.739 | 0.601 | 1.228 | 2.3 | 2.267 | 2.709 | 1.463
COVID19_PFIZER/BIONTECH | Vaccination site hypoaesthesia | 2 | 1.295 | 0.725 | 2.895 | 6.241 | 0.469 | 1.027 | 2.022 | 1.544 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Multimorbidity | 2 | 0.96 | 0.744 | 2.886 | 6.166 | 0.504 | 1.105 | 2.182 | 2.084 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Appendicitis perforated | 8 | 4.224 | 1.49 | 2.878 | 4.633 | 0.839 | 1.41 | 2.257 | 1.894 | 13.135 | 44.776
COVID19_PFIZER/BIONTECH | Thrombolysis | 2 | 1.411 | 0.702 | 2.871 | 6.235 | 0.458 | 1.003 | 1.973 | 1.417 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Breast oedema | 2 | 0.708 | 0.742 | 2.87 | 6.126 | 0.534 | 1.174 | 2.332 | 2.824 | 36.12 | 12.087
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [narrow] | 5 | 2.955 | 1.231 | 2.86 | 5.038 | 0.664 | 1.225 | 2.113 | 1.692 | 2.052 | 1.528
COVID19_PFIZER/BIONTECH | Vitamin B12 decreased | 4 | 2.179 | 1.054 | 2.841 | 5.332 | 0.631 | 1.217 | 2.176 | 1.835 | 2.778 | 2.488
COVID19_PFIZER/BIONTECH | HIV antibody negative | 2 | 0.758 | 0.567 | 2.839 | 6.534 | 0.528 | 1.159 | 2.299 | 2.638 | 0.401 | 1.184
COVID19_PFIZER/BIONTECH | Methylmalonic aciduria | 2 | 0.947 | 0.717 | 2.827 | 6.072 | 0.505 | 1.108 | 2.189 | 2.111 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Product preparation error | 17 | 9.477 | 1.808 | 2.819 | 4.013 | 1.046 | 1.531 | 2.181 | 1.794 | 0.462 | 9.835
COVID19_PFIZER/BIONTECH | Right ventricular hypertrophy | 2 | 1.424 | 0.714 | 2.809 | 6.028 | 0.457 | 1 | 1.968 | 1.404 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Sinus rhythm | 4 | 3.091 | 1.012 | 2.796 | 5.299 | 0.545 | 1.05 | 1.872 | 1.294 | 18.06 | 23.858
COVID19_PFIZER/BIONTECH | Gastrointestinal wall thickening | 3 | 1.206 | 0.863 | 2.775 | 5.568 | 0.616 | 1.259 | 2.363 | 2.487 | 2.709 | 1.463
COVID19_PFIZER/BIONTECH | Portal hypertension | 2 | 1.402 | 0.69 | 2.771 | 5.983 | 0.459 | 1.005 | 1.977 | 1.427 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Tilt table test | 1 | 0.354 | 0.257 | 2.77 | 7.544 | 0.42 | 1.022 | 2.182 | 2.824 | 0.278 | 1.174
COVID19_PFIZER/BIONTECH | Carotid pulse abnormal | 2 | 0.815 | 0.709 | 2.767 | 5.923 | 0.521 | 1.143 | 2.264 | 2.454 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Forced expiratory volume decreased | 2 | 1.353 | 0.513 | 2.767 | 6.493 | 0.463 | 1.015 | 1.997 | 1.479 | 0.602 | 0.184
COVID19_PFIZER/BIONTECH | Sinus tachycardia | 41 | 23.197 | 2.106 | 2.76 | 3.486 | 1.274 | 1.643 | 2.091 | 1.767 | 9.142 | 191.785
COVID19_PFIZER/BIONTECH | Blood urea nitrogen/creatinine ratio increased | 2 | 1.899 | 0.668 | 2.754 | 5.996 | 0.417 | 0.913 | 1.794 | 1.053 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Vestibular migraine | 2 | 0.941 | 0.687 | 2.747 | 5.923 | 0.506 | 1.11 | 2.192 | 2.126 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Taste and smell disorders (SMQ) [broad] | 478 | 298.711 | 2.535 | 2.737 | 2.946 | 1.475 | 1.591 | 1.714 | 1.6 | 10.216 | 2541.984
COVID19_PFIZER/BIONTECH | Taste and smell disorders (SMQ) [narrow] | 478 | 298.711 | 2.535 | 2.737 | 2.946 | 1.475 | 1.591 | 1.714 | 1.6 | 10.216 | 2541.984
COVID19_PFIZER/BIONTECH | Pancreatic enlargement | 2 | 0.935 | 0.705 | 2.733 | 5.838 | 0.507 | 1.111 | 2.195 | 2.14 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Pressure of speech | 2 | 0.941 | 0.705 | 2.729 | 5.828 | 0.506 | 1.11 | 2.192 | 2.125 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Cerebral artery stenosis | 2 | 1.885 | 0.665 | 2.728 | 5.928 | 0.418 | 0.915 | 1.799 | 1.061 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Haemoconcentration | 1 | 0.825 | 0.23 | 2.686 | 7.426 | 0.373 | 0.907 | 1.923 | 1.213 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Monocyte count | 4 | 2.063 | 1.009 | 2.646 | 4.909 | 0.644 | 1.242 | 2.223 | 1.939 | 2.258 | 1.451
COVID19_PFIZER/BIONTECH | Brain natriuretic peptide increased | 28 | 21.178 | 1.891 | 2.643 | 3.499 | 0.924 | 1.252 | 1.666 | 1.322 | 9.725 | 136.57
COVID19_PFIZER/BIONTECH | Vaccination site paraesthesia | 2 | 1.204 | 0.674 | 2.624 | 5.614 | 0.478 | 1.047 | 2.062 | 1.661 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Hypoaesthesia oral | 299 | 182.262 | 2.38 | 2.622 | 2.875 | 1.477 | 1.625 | 1.784 | 1.64 | 10.189 | 1581.749
COVID19_PFIZER/BIONTECH | Lung abscess | 2 | 0.954 | 0.634 | 2.614 | 5.693 | 0.505 | 1.107 | 2.185 | 2.097 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Body height decreased | 8 | 3.964 | 1.339 | 2.609 | 4.221 | 0.867 | 1.459 | 2.338 | 2.018 | 20.64 | 60.436
COVID19_PFIZER/BIONTECH | Chronic respiratory failure | 2 | 1.481 | 0.65 | 2.586 | 5.566 | 0.451 | 0.989 | 1.945 | 1.35 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Electrocardiogram QRS complex abnormal | 2 | 1.69 | 0.669 | 2.584 | 5.514 | 0.433 | 0.95 | 1.866 | 1.184 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Pupillary disorder | 2 | 0.922 | 0.65 | 2.58 | 5.551 | 0.508 | 1.115 | 2.202 | 2.17 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Urethritis | 2 | 1.031 | 0.686 | 2.57 | 5.431 | 0.496 | 1.087 | 2.145 | 1.939 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Sensation of blood flow | 3 | 1.756 | 0.814 | 2.562 | 5.1 | 0.552 | 1.126 | 2.1 | 1.709 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Angina unstable | 2 | 1.308 | 0.628 | 2.555 | 5.538 | 0.468 | 1.024 | 2.016 | 1.529 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Percutaneous coronary intervention | 3 | 1.879 | 0.813 | 2.553 | 5.079 | 0.54 | 1.1 | 2.051 | 1.597 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Paraesthesia ear | 3 | 1.896 | 0.777 | 2.552 | 5.158 | 0.538 | 1.097 | 2.044 | 1.583 | 27.09 | 20.145
COVID19_PFIZER/BIONTECH | Viral titre | 2 | 0.536 | 0.602 | 2.549 | 5.594 | 0.557 | 1.23 | 2.466 | 3.733 | 2.125 | 0.268
COVID19_PFIZER/BIONTECH | Hip surgery | 2 | 1.938 | 0.587 | 2.539 | 5.607 | 0.414 | 0.906 | 1.781 | 1.032 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Sensation of foreign body | 102 | 66.167 | 2.141 | 2.536 | 2.958 | 1.279 | 1.505 | 1.762 | 1.542 | 6.823 | 363.838
COVID19_PFIZER/BIONTECH | Ear disorder | 3 | 1.38 | 0.813 | 2.528 | 5.009 | 0.594 | 1.213 | 2.27 | 2.175 | 1.868 | 0.424
COVID19_PFIZER/BIONTECH | Vaccination site discomfort | 9 | 5.427 | 1.353 | 2.521 | 3.983 | 0.811 | 1.332 | 2.09 | 1.658 | 4.925 | 18.99
COVID19_PFIZER/BIONTECH | Intraocular pressure test | 3 | 1.788 | 0.875 | 2.513 | 4.837 | 0.549 | 1.119 | 2.087 | 1.678 | 7.74 | 7.849
COVID19_PFIZER/BIONTECH | Ventricular arrhythmia | 2 | 1.207 | 0.662 | 2.512 | 5.33 | 0.478 | 1.046 | 2.061 | 1.658 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Visual acuity tests | 2 | 1.392 | 0.643 | 2.507 | 5.366 | 0.46 | 1.007 | 1.981 | 1.436 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Iridocyclitis | 3 | 1.751 | 0.784 | 2.484 | 4.96 | 0.553 | 1.127 | 2.102 | 1.713 | 2.084 | 0.664
COVID19_PFIZER/BIONTECH | High density lipoprotein decreased | 4 | 1.514 | 0.963 | 2.472 | 4.548 | 0.713 | 1.381 | 2.49 | 2.641 | 4.013 | 5.032
COVID19_PFIZER/BIONTECH | Pulmonary thrombosis | 2 | 1.214 | 0.595 | 2.465 | 5.373 | 0.477 | 1.045 | 2.058 | 1.648 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Drug screen positive | 2 | 1.297 | 0.587 | 2.458 | 5.377 | 0.469 | 1.027 | 2.021 | 1.543 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Off label use | 35 | 19.687 | 1.82 | 2.456 | 3.17 | 1.241 | 1.633 | 2.116 | 1.778 | 5.357 | 92.179
COVID19_PFIZER/BIONTECH | Acute myocardial infarction | 38 | 30.418 | 1.844 | 2.453 | 3.133 | 0.927 | 1.206 | 1.547 | 1.249 | 14.006 | 250.871
COVID19_PFIZER/BIONTECH | Penile rash | 2 | 0.552 | 0.672 | 2.446 | 5.118 | 0.555 | 1.225 | 2.452 | 3.623 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Lower respiratory tract congestion | 2 | 1.401 | 0.585 | 2.438 | 5.324 | 0.459 | 1.005 | 1.977 | 1.428 | 2.258 | 0.345
COVID19_PFIZER/BIONTECH | Thrombotic thrombocytopenic purpura | 6 | 2.599 | 1.128 | 2.437 | 4.149 | 0.819 | 1.46 | 2.459 | 2.309 | 7.224 | 18.531
COVID19_PFIZER/BIONTECH | Urinary tract infection bacterial | 2 | 1.004 | 0.654 | 2.437 | 5.139 | 0.499 | 1.094 | 2.158 | 1.991 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Flushing | 643 | 401.746 | 2.279 | 2.434 | 2.593 | 1.493 | 1.594 | 1.699 | 1.601 | 7.222 | 2473.816
COVID19_PFIZER/BIONTECH | Cardiac telemetry normal | 4 | 2.877 | 0.904 | 2.432 | 4.56 | 0.563 | 1.084 | 1.935 | 1.39 | 14.448 | 20.491
COVID19_PFIZER/BIONTECH | Blood urea | 6 | 3.45 | 1.163 | 2.424 | 4.059 | 0.72 | 1.28 | 2.146 | 1.739 | 2.929 | 4.923
COVID19_PFIZER/BIONTECH | Restless legs syndrome | 4 | 2.756 | 0.896 | 2.421 | 4.548 | 0.573 | 1.105 | 1.972 | 1.451 | 1.165 | 0
COVID19_PFIZER/BIONTECH | Breast mass | 5 | 2.448 | 1.022 | 2.416 | 4.29 | 0.719 | 1.329 | 2.298 | 2.042 | 5.312 | 10.236
COVID19_PFIZER/BIONTECH | Cerebellar infarction | 2 | 0.954 | 0.633 | 2.411 | 5.12 | 0.505 | 1.107 | 2.185 | 2.097 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Electrocardiogram ambulatory normal | 2 | 0.999 | 0.568 | 2.4 | 5.266 | 0.5 | 1.095 | 2.162 | 2.003 | 1.032 | 0.106
COVID19_PFIZER/BIONTECH | Bacterial sepsis | 2 | 1.003 | 0.576 | 2.396 | 5.229 | 0.499 | 1.094 | 2.159 | 1.993 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Ischaemic stroke | 14 | 11.598 | 1.485 | 2.391 | 3.472 | 0.74 | 1.12 | 1.639 | 1.207 | 6.483 | 43.617
COVID19_PFIZER/BIONTECH | Acute pulmonary oedema | 4 | 2.88 | 0.895 | 2.377 | 4.436 | 0.562 | 1.084 | 1.934 | 1.389 | 9.03 | 13.812
COVID19_PFIZER/BIONTECH | Ovarian malignant tumours (SMQ) [broad] | 2 | 1.469 | 0.644 | 2.377 | 5 | 0.453 | 0.991 | 1.95 | 1.362 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Reaction to excipient | 2 | 1.42 | 0.48 | 2.376 | 5.448 | 0.457 | 1.001 | 1.97 | 1.409 | 0.266 | 3.277
COVID19_PFIZER/BIONTECH | Lung hyperinflation | 2 | 1.716 | 0.593 | 2.372 | 5.115 | 0.431 | 0.945 | 1.857 | 1.166 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Oral blood blister | 1 | 1.395 | 0.265 | 2.364 | 6.212 | 0.328 | 0.8 | 1.698 | 0.717 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | NIH stroke scale score increased | 1 | 1.411 | 0.265 | 2.364 | 6.212 | 0.327 | 0.797 | 1.693 | 0.709 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Plasminogen activator inhibitor | 1 | 1.414 | 0.265 | 2.364 | 6.212 | 0.326 | 0.797 | 1.691 | 0.707 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Implantable defibrillator insertion | 1 | 1.418 | 0.265 | 2.364 | 6.212 | 0.326 | 0.796 | 1.69 | 0.705 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MB decreased | 1 | 1.418 | 0.265 | 2.364 | 6.212 | 0.326 | 0.796 | 1.69 | 0.705 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Adult failure to thrive | 1 | 1.427 | 0.265 | 2.364 | 6.212 | 0.326 | 0.795 | 1.687 | 0.701 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Basal ganglia infarction | 2 | 1.46 | 0.646 | 2.357 | 4.937 | 0.453 | 0.993 | 1.953 | 1.369 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Dysmenorrhoea | 5 | 2.66 | 0.944 | 2.356 | 4.282 | 0.695 | 1.283 | 2.216 | 1.88 | 0.507 | 1.85
COVID19_PFIZER/BIONTECH | Anal erythema | 1 | 0.474 | 0.239 | 2.355 | 6.309 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Chest injury | 2 | 1.427 | 0.628 | 2.348 | 4.958 | 0.456 | 1 | 1.967 | 1.401 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Bundle branch block left | 2 | 2.108 | 0.591 | 2.344 | 5.041 | 0.401 | 0.879 | 1.728 | 0.949 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Urine sodium normal | 1 | 0.48 | 0.14 | 2.34 | 6.85 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Coronary artery disease | 7 | 5.377 | 1.152 | 2.339 | 3.865 | 0.647 | 1.116 | 1.822 | 1.302 | 5.268 | 15.414
COVID19_PFIZER/BIONTECH | Coronary artery bypass | 3 | 2.226 | 0.825 | 2.333 | 4.463 | 0.508 | 1.034 | 1.925 | 1.347 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Hyposmia | 6 | 3.467 | 1.05 | 2.327 | 4.011 | 0.718 | 1.277 | 2.141 | 1.731 | 6.374 | 16.122
COVID19_PFIZER/BIONTECH | Paraesthesia oral | 453 | 295.295 | 2.146 | 2.322 | 2.503 | 1.412 | 1.526 | 1.647 | 1.534 | 9.751 | 2313.128
COVID19_PFIZER/BIONTECH | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [broad] | 1 | 0.594 | 0.182 | 2.321 | 6.516 | 0.395 | 0.959 | 2.037 | 1.682 | 0.42 | 0.299
COVID19_PFIZER/BIONTECH | Blood pressure increased | 408 | 269.722 | 2.136 | 2.32 | 2.511 | 1.386 | 1.504 | 1.63 | 1.513 | 7.458 | 1616.579
COVID19_PFIZER/BIONTECH | Tachycardia | 495 | 329.537 | 2.146 | 2.314 | 2.487 | 1.388 | 1.495 | 1.608 | 1.502 | 7.801 | 2054.493
COVID19_PFIZER/BIONTECH | Scrotal dermatitis | 2 | 0.797 | 0.658 | 2.309 | 4.775 | 0.523 | 1.148 | 2.275 | 2.51 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Aneurysm | 2 | 1.891 | 0.57 | 2.306 | 4.992 | 0.417 | 0.914 | 1.797 | 1.057 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | COVID-19 pneumonia | 39 | 35.375 | 1.731 | 2.301 | 2.938 | 0.831 | 1.078 | 1.38 | 1.102 | 14.986 | 270.266
COVID19_PFIZER/BIONTECH | Physical examination abnormal | 2 | 1.864 | 0.57 | 2.301 | 4.977 | 0.419 | 0.919 | 1.806 | 1.073 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Hysterectomy | 1 | 0.553 | 0.191 | 2.3 | 6.391 | 0.399 | 0.969 | 2.06 | 1.81 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Pneumonia aspiration | 12 | 10.83 | 1.357 | 2.292 | 3.425 | 0.669 | 1.041 | 1.56 | 1.108 | 4.925 | 26.336
COVID19_PFIZER/BIONTECH | PCO2 increased | 6 | 4.485 | 1.06 | 2.284 | 3.885 | 0.628 | 1.116 | 1.867 | 1.338 | 2.58 | 3.726
COVID19_PFIZER/BIONTECH | Endoscopy upper gastrointestinal tract normal | 2 | 0.947 | 0.568 | 2.276 | 4.911 | 0.505 | 1.108 | 2.189 | 2.111 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Acute cardiac event | 2 | 1.016 | 0.638 | 2.271 | 4.721 | 0.498 | 1.091 | 2.152 | 1.968 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Product use issue | 34 | 17.12 | 1.671 | 2.268 | 2.94 | 1.353 | 1.787 | 2.325 | 1.986 | 3.549 | 49.838
COVID19_PFIZER/BIONTECH | Lumbar radiculopathy | 2 | 0.931 | 0.621 | 2.266 | 4.748 | 0.507 | 1.112 | 2.197 | 2.147 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Palpitations | 600 | 402.044 | 2.112 | 2.262 | 2.415 | 1.39 | 1.487 | 1.589 | 1.492 | 6.181 | 1950.875
COVID19_PFIZER/BIONTECH | Gingival blister | 2 | 1.208 | 0.585 | 2.257 | 4.813 | 0.478 | 1.046 | 2.06 | 1.655 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation (SMQ) [narrow] | 18 | 11.49 | 1.472 | 2.247 | 3.156 | 0.961 | 1.393 | 1.966 | 1.567 | 5.079 | 42.739
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation (SMQ) [broad] | 18 | 11.49 | 1.472 | 2.247 | 3.156 | 0.961 | 1.393 | 1.966 | 1.567 | 5.079 | 42.739
COVID19_PFIZER/BIONTECH | Nipple pain | 3 | 0.991 | 0.755 | 2.246 | 4.381 | 0.646 | 1.324 | 2.501 | 3.028 | 5.418 | 5.114
COVID19_PFIZER/BIONTECH | End stage renal disease | 2 | 1.895 | 0.566 | 2.246 | 4.833 | 0.417 | 0.914 | 1.796 | 1.056 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | SARS-CoV-2 test negative | 637 | 437.205 | 2.098 | 2.242 | 2.39 | 1.36 | 1.452 | 1.549 | 1.457 | 21.83 | 5741.865
COVID19_PFIZER/BIONTECH | Throat irritation | 366 | 243.098 | 2.051 | 2.239 | 2.434 | 1.372 | 1.496 | 1.628 | 1.506 | 6.307 | 1212.311
COVID19_PFIZER/BIONTECH | Metamyelocyte percentage | 2 | 0.941 | 0.618 | 2.236 | 4.672 | 0.506 | 1.11 | 2.192 | 2.125 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Completed suicide | 2 | 2.236 | 0.525 | 2.232 | 4.903 | 0.392 | 0.86 | 1.69 | 0.894 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Bilevel positive airway pressure | 15 | 12.742 | 1.382 | 2.216 | 3.211 | 0.738 | 1.102 | 1.598 | 1.177 | 5.889 | 42.112
COVID19_PFIZER/BIONTECH | Tongue spasm | 2 | 0.923 | 0.632 | 2.208 | 4.56 | 0.508 | 1.114 | 2.202 | 2.166 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Brain operation | 3 | 1.405 | 0.735 | 2.205 | 4.315 | 0.591 | 1.207 | 2.258 | 2.135 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Vaginal infection | 1 | 0.357 | 0.227 | 2.194 | 5.856 | 0.42 | 1.021 | 2.18 | 2.803 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Decubitus ulcer | 2 | 0.996 | 0.614 | 2.19 | 4.552 | 0.5 | 1.096 | 2.163 | 2.007 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Alcohol use | 2 | 0.487 | 0.598 | 2.189 | 4.592 | 0.564 | 1.249 | 2.513 | 4.103 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Diverticulum intestinal | 2 | 1.427 | 0.614 | 2.186 | 4.541 | 0.456 | 1 | 1.967 | 1.401 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Insulin resistance | 1 | 0.47 | 0.18 | 2.185 | 6.078 | 0.408 | 0.99 | 2.107 | 2.125 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Overdose | 4 | 4.958 | 0.796 | 2.185 | 4.13 | 0.425 | 0.82 | 1.463 | 0.807 | 0.309 | 5.395
COVID19_PFIZER/BIONTECH | Hypogeusia | 11 | 5.277 | 1.28 | 2.182 | 3.28 | 0.999 | 1.581 | 2.41 | 2.084 | 15.282 | 71.577
COVID19_PFIZER/BIONTECH | Hypoglycaemia | 15 | 9.512 | 1.392 | 2.18 | 3.112 | 0.919 | 1.374 | 1.992 | 1.577 | 2.682 | 12.281
COVID19_PFIZER/BIONTECH | Ejection fraction decreased | 17 | 11.678 | 1.407 | 2.179 | 3.089 | 0.895 | 1.31 | 1.865 | 1.456 | 6.02 | 49.484
COVID19_PFIZER/BIONTECH | Food refusal | 6 | 4.166 | 1.021 | 2.179 | 3.689 | 0.653 | 1.162 | 1.945 | 1.44 | 2.852 | 4.657
COVID19_PFIZER/BIONTECH | Pregnancy test negative | 9 | 5.988 | 1.176 | 2.176 | 3.424 | 0.764 | 1.254 | 1.966 | 1.503 | 3.694 | 12.417
COVID19_PFIZER/BIONTECH | Rash morbilliform | 5 | 3.048 | 0.911 | 2.174 | 3.875 | 0.654 | 1.207 | 2.082 | 1.641 | 0.225 | 12.437
COVID19_PFIZER/BIONTECH | Bell's palsy | 3 | 3.076 | 0.652 | 2.173 | 4.416 | 0.443 | 0.902 | 1.678 | 0.975 | 18.06 | 16.009
COVID19_PFIZER/BIONTECH | Neonatal exposures via breast milk (SMQ) [broad] | 14 | 8.2 | 1.326 | 2.171 | 3.186 | 0.953 | 1.442 | 2.113 | 1.707 | 4.515 | 27.759
COVID19_PFIZER/BIONTECH | Neonatal exposures via breast milk (SMQ) [narrow] | 14 | 8.2 | 1.326 | 2.171 | 3.186 | 0.953 | 1.442 | 2.113 | 1.707 | 4.515 | 27.759
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin negative | 13 | 8.719 | 1.301 | 2.168 | 3.214 | 0.848 | 1.3 | 1.926 | 1.491 | 9.783 | 60.618
COVID19_PFIZER/BIONTECH | Cystitis | 6 | 4.89 | 0.989 | 2.168 | 3.718 | 0.598 | 1.063 | 1.778 | 1.227 | 1.426 | 0.352
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging heart | 7 | 7.888 | 1.044 | 2.166 | 3.617 | 0.506 | 0.872 | 1.423 | 0.887 | 3.718 | 9.28
COVID19_PFIZER/BIONTECH | Energy increased | 2 | 0.861 | 0.579 | 2.164 | 4.569 | 0.515 | 1.131 | 2.236 | 2.323 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Bacteraemia | 4 | 2.472 | 0.767 | 2.163 | 4.132 | 0.6 | 1.157 | 2.067 | 1.618 | 0.695 | 0.253
COVID19_PFIZER/BIONTECH | Left ventricular failure | 2 | 1.488 | 0.579 | 2.161 | 4.561 | 0.451 | 0.988 | 1.942 | 1.344 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Disease recurrence | 13 | 7.228 | 1.293 | 2.152 | 3.188 | 0.965 | 1.48 | 2.193 | 1.798 | 58.695 | 159.45
COVID19_PFIZER/BIONTECH | Congenital anomaly | 1 | 0.508 | 0.175 | 2.141 | 5.967 | 0.404 | 0.98 | 2.085 | 1.968 | 0.311 | 0.868
COVID19_PFIZER/BIONTECH | Pulmonary hypertension (SMQ) [narrow] | 13 | 9.151 | 1.305 | 2.14 | 3.143 | 0.819 | 1.256 | 1.86 | 1.421 | 4.348 | 24.241
COVID19_PFIZER/BIONTECH | Haemorrhage intracranial | 4 | 2.039 | 0.873 | 2.136 | 3.848 | 0.646 | 1.248 | 2.233 | 1.962 | 5.557 | 8.049
COVID19_PFIZER/BIONTECH | T-lymphocyte count | 1 | 0.487 | 0.179 | 2.133 | 5.914 | 0.406 | 0.986 | 2.097 | 2.052 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Aspartate aminotransferase decreased | 2 | 0.935 | 0.61 | 2.132 | 4.404 | 0.507 | 1.111 | 2.195 | 2.14 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Haemoglobin abnormal | 2 | 1.301 | 0.61 | 2.132 | 4.403 | 0.468 | 1.026 | 2.019 | 1.537 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Sialoadenitis | 2 | 0.815 | 0.651 | 2.131 | 4.305 | 0.521 | 1.143 | 2.264 | 2.454 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Angiocardiogram | 3 | 1.43 | 0.707 | 2.13 | 4.174 | 0.588 | 1.201 | 2.245 | 2.097 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Acute respiratory failure | 18 | 15.128 | 1.398 | 2.126 | 2.979 | 0.774 | 1.122 | 1.584 | 1.19 | 4.711 | 38.698
COVID19_PFIZER/BIONTECH | Peritonitis | 3 | 1.405 | 0.683 | 2.125 | 4.214 | 0.591 | 1.207 | 2.258 | 2.135 | 4.515 | 3.935
COVID19_PFIZER/BIONTECH | Phobia | 2 | 1.572 | 0.522 | 2.122 | 4.6 | 0.443 | 0.971 | 1.91 | 1.273 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Agonal rhythm | 2 | 1.885 | 0.49 | 2.121 | 4.684 | 0.418 | 0.915 | 1.799 | 1.061 | 18.06 | 8.37
COVID19_PFIZER/BIONTECH | Cardiac failure | 20 | 14.785 | 1.423 | 2.12 | 2.932 | 0.878 | 1.252 | 1.741 | 1.353 | 3.612 | 29.236
COVID19_PFIZER/BIONTECH | Nasal congestion | 163 | 109.297 | 1.853 | 2.117 | 2.395 | 1.292 | 1.47 | 1.668 | 1.491 | 3.443 | 235.861
COVID19_PFIZER/BIONTECH | Spinal operation | 2 | 1.716 | 0.514 | 2.112 | 4.594 | 0.431 | 0.945 | 1.857 | 1.166 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Apparent life threatening event | 6 | 3.364 | 0.999 | 2.111 | 3.557 | 0.729 | 1.296 | 2.173 | 1.784 | 0.918 | 0
COVID19_PFIZER/BIONTECH | Noninfective gingivitis | 2 | 1.204 | 0.598 | 2.111 | 4.374 | 0.478 | 1.047 | 2.062 | 1.661 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Intestinal ischaemia | 2 | 1.425 | 0.575 | 2.1 | 4.401 | 0.457 | 1 | 1.967 | 1.403 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Hypertension (SMQ) [narrow] | 690 | 477.044 | 1.97 | 2.099 | 2.232 | 1.354 | 1.442 | 1.534 | 1.446 | 6.966 | 2558.222
COVID19_PFIZER/BIONTECH | Atrial flutter | 4 | 4.032 | 0.835 | 2.096 | 3.819 | 0.477 | 0.92 | 1.64 | 0.992 | 4.515 | 6.041
COVID19_PFIZER/BIONTECH | Liquid product physical issue | 1 | 0.5 | 0.166 | 2.093 | 5.862 | 0.404 | 0.982 | 2.089 | 2 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Haemorrhage in pregnancy | 2 | 2.48 | 0.54 | 2.09 | 4.462 | 0.376 | 0.825 | 1.621 | 0.806 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Cast application | 4 | 2.362 | 0.805 | 2.086 | 3.854 | 0.611 | 1.179 | 2.106 | 1.694 | 12.04 | 17.808
COVID19_PFIZER/BIONTECH | Cerebral artery occlusion | 3 | 2.374 | 0.647 | 2.082 | 4.179 | 0.495 | 1.008 | 1.877 | 1.264 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Sinus bradycardia | 3 | 1.821 | 0.67 | 2.08 | 4.122 | 0.546 | 1.112 | 2.074 | 1.647 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Electrocardiogram ST segment normal | 1 | 0.266 | 0.223 | 2.079 | 5.513 | 0.43 | 1.05 | 2.25 | 3.765 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Erectile dysfunction | 4 | 3.965 | 0.803 | 2.079 | 3.839 | 0.481 | 0.928 | 1.655 | 1.009 | 2.408 | 1.743
COVID19_PFIZER/BIONTECH | Therapeutic response unexpected | 5 | 2.935 | 0.868 | 2.075 | 3.702 | 0.666 | 1.228 | 2.119 | 1.704 | 1.062 | 0.011
COVID19_PFIZER/BIONTECH | Spinal fusion surgery | 2 | 0.988 | 0.557 | 2.074 | 4.372 | 0.501 | 1.098 | 2.167 | 2.024 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Illusion | 3 | 1.787 | 0.609 | 2.074 | 4.244 | 0.549 | 1.119 | 2.087 | 1.679 | 0.888 | 0.006
COVID19_PFIZER/BIONTECH | Hypercoagulation | 1 | 1.625 | 0.25 | 2.074 | 5.37 | 0.312 | 0.764 | 1.623 | 0.615 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Electrocardiogram PR segment depression | 1 | 1.677 | 0.25 | 2.074 | 5.373 | 0.309 | 0.756 | 1.606 | 0.596 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Ultrasound scan vagina | 4 | 2.48 | 0.829 | 2.072 | 3.769 | 0.599 | 1.156 | 2.064 | 1.613 | 9.03 | 13.812
COVID19_PFIZER/BIONTECH | Protein S normal | 2 | 1.415 | 0.574 | 2.071 | 4.323 | 0.458 | 1.002 | 1.972 | 1.414 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Organising pneumonia | 2 | 1.208 | 0.556 | 2.062 | 4.341 | 0.477 | 1.046 | 2.06 | 1.655 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Polymenorrhoea | 1 | 0.515 | 0.188 | 2.06 | 5.629 | 0.403 | 0.978 | 2.081 | 1.942 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Coagulopathy | 6 | 5.169 | 0.982 | 2.06 | 3.459 | 0.579 | 1.029 | 1.721 | 1.161 | 2.356 | 2.972
COVID19_PFIZER/BIONTECH | Hepatic lesion | 1 | 0.47 | 0.199 | 2.059 | 5.565 | 0.408 | 0.99 | 2.107 | 2.125 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Hypertension (SMQ) [broad] | 724 | 505.168 | 1.931 | 2.054 | 2.181 | 1.344 | 1.429 | 1.518 | 1.433 | 6.733 | 2590.373
COVID19_PFIZER/BIONTECH | Coagulation factor V level | 1 | 1.219 | 0.251 | 2.054 | 5.305 | 0.341 | 0.83 | 1.761 | 0.82 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Sedative therapy | 1 | 1.434 | 0.252 | 2.053 | 5.299 | 0.325 | 0.794 | 1.685 | 0.698 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Upper gastrointestinal haemorrhage | 2 | 1.008 | 0.604 | 2.052 | 4.196 | 0.499 | 1.093 | 2.157 | 1.985 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | Blood heavy metal test | 2 | 1.428 | 0.519 | 2.05 | 4.404 | 0.456 | 1 | 1.966 | 1.401 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Intermittent claudication | 1 | 0.48 | 0.225 | 2.049 | 5.41 | 0.407 | 0.987 | 2.101 | 2.084 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Aortic stenosis | 3 | 2.387 | 0.643 | 2.045 | 4.087 | 0.494 | 1.006 | 1.873 | 1.257 | 13.545 | 13.071
COVID19_PFIZER/BIONTECH | Blood iron decreased | 5 | 3.082 | 0.899 | 2.042 | 3.562 | 0.651 | 1.201 | 2.071 | 1.622 | 1.389 | 0.197
COVID19_PFIZER/BIONTECH | External ear pain | 2 | 1.46 | 0.588 | 2.04 | 4.201 | 0.453 | 0.993 | 1.953 | 1.369 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Complement factor C4 decreased | 1 | 0.507 | 0.221 | 2.038 | 5.395 | 0.404 | 0.981 | 2.085 | 1.973 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Blood cholesterol | 6 | 2.816 | 0.994 | 2.036 | 3.379 | 0.791 | 1.409 | 2.368 | 2.13 | 9.03 | 23.194
COVID19_PFIZER/BIONTECH | Urinary casts | 2 | 1.47 | 0.588 | 2.035 | 4.189 | 0.452 | 0.991 | 1.949 | 1.36 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Coxsackie virus test positive | 2 | 0.79 | 0.496 | 2.032 | 4.416 | 0.524 | 1.15 | 2.279 | 2.531 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Dementia | 12 | 13.177 | 1.211 | 2.028 | 3.016 | 0.576 | 0.895 | 1.342 | 0.911 | 5.557 | 30.717
COVID19_PFIZER/BIONTECH | International normalised ratio decreased | 5 | 2.858 | 0.906 | 2.021 | 3.493 | 0.674 | 1.243 | 2.145 | 1.75 | 11.288 | 22.556
COVID19_PFIZER/BIONTECH | Wheelchair user | 18 | 10.418 | 1.319 | 2.019 | 2.84 | 1.034 | 1.499 | 2.118 | 1.728 | 1.186 | 0.328
COVID19_PFIZER/BIONTECH | Urosepsis | 3 | 1.697 | 0.672 | 2.019 | 3.953 | 0.559 | 1.139 | 2.124 | 1.767 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Foetal monitoring | 1 | 1.63 | 0.254 | 2.018 | 5.182 | 0.312 | 0.763 | 1.621 | 0.614 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Slow speech | 5 | 1.962 | 0.885 | 2.015 | 3.519 | 0.783 | 1.449 | 2.522 | 2.549 | 2.913 | 3.81
COVID19_PFIZER/BIONTECH | Septic screen | 2 | 1.284 | 0.425 | 2.013 | 4.56 | 0.47 | 1.03 | 2.027 | 1.558 | 1.095 | 0.065
COVID19_PFIZER/BIONTECH | Blood fibrinogen | 4 | 2.835 | 0.796 | 2.01 | 3.672 | 0.566 | 1.092 | 1.948 | 1.411 | 4.249 | 5.51
COVID19_PFIZER/BIONTECH | Acute motor-sensory axonal neuropathy | 2 | 0.931 | 0.554 | 2.009 | 4.199 | 0.507 | 1.112 | 2.197 | 2.147 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Neutrophil count | 8 | 4.969 | 1.054 | 2.005 | 3.204 | 0.766 | 1.286 | 2.057 | 1.61 | 2.726 | 6.097
COVID19_PFIZER/BIONTECH | Vocal cord disorder | 4 | 2.055 | 0.78 | 2.004 | 3.687 | 0.645 | 1.244 | 2.226 | 1.947 | 9.03 | 13.812
COVID19_PFIZER/BIONTECH | Oesophageal disorder | 2 | 0.935 | 0.554 | 2 | 4.176 | 0.507 | 1.111 | 2.195 | 2.14 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Blood creatinine | 7 | 4.081 | 1.016 | 2 | 3.251 | 0.757 | 1.305 | 2.133 | 1.715 | 1.732 | 1.334
COVID19_PFIZER/BIONTECH | Clostridium test negative | 4 | 2.043 | 0.795 | 1.999 | 3.647 | 0.646 | 1.247 | 2.231 | 1.958 | 1.852 | 0.724
COVID19_PFIZER/BIONTECH | Ischaemic colitis (SMQ) [narrow] | 6 | 4.54 | 0.937 | 1.997 | 3.378 | 0.623 | 1.108 | 1.855 | 1.322 | 1.806 | 1.265
COVID19_PFIZER/BIONTECH | Polychondritis | 1 | 0.48 | 0.282 | 1.996 | 4.999 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hand fracture | 2 | 1.422 | 0.57 | 1.991 | 4.111 | 0.457 | 1.001 | 1.969 | 1.406 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Respiratory tract congestion | 141 | 91.432 | 1.725 | 1.988 | 2.267 | 1.319 | 1.515 | 1.734 | 1.542 | 3.469 | 206.232
COVID19_PFIZER/BIONTECH | Blood pressure diastolic increased | 2 | 1.169 | 0.585 | 1.985 | 4.058 | 0.481 | 1.055 | 2.078 | 1.711 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | CSF neutrophil count increased | 3 | 2.188 | 0.695 | 1.983 | 3.804 | 0.511 | 1.041 | 1.938 | 1.371 | 1.868 | 0.424
COVID19_PFIZER/BIONTECH | Cardiac failure congestive | 24 | 24.535 | 1.378 | 1.979 | 2.67 | 0.693 | 0.96 | 1.303 | 0.978 | 5.557 | 64.974
COVID19_PFIZER/BIONTECH | Maternal exposure during breast feeding | 11 | 5.728 | 1.126 | 1.978 | 3.025 | 0.951 | 1.504 | 2.289 | 1.92 | 4.415 | 20.544
COVID19_PFIZER/BIONTECH | Rectal tenesmus | 1 | 0.462 | 0.226 | 1.978 | 5.182 | 0.408 | 0.992 | 2.112 | 2.163 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Angiogram abnormal | 8 | 6.394 | 1.034 | 1.978 | 3.17 | 0.657 | 1.103 | 1.761 | 1.251 | 3.44 | 9.569
COVID19_PFIZER/BIONTECH | Saliva altered | 2 | 1.169 | 0.569 | 1.971 | 4.058 | 0.481 | 1.055 | 2.078 | 1.711 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Biliary colic | 2 | 1.775 | 0.584 | 1.971 | 4.021 | 0.426 | 0.934 | 1.836 | 1.127 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Protein S | 1 | 1.21 | 0.258 | 1.967 | 5.009 | 0.342 | 0.832 | 1.765 | 0.827 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | N-terminal prohormone brain natriuretic peptide | 1 | 1.434 | 0.258 | 1.967 | 5.008 | 0.325 | 0.794 | 1.685 | 0.698 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Mammogram abnormal | 1 | 0.853 | 0.277 | 1.964 | 4.919 | 0.371 | 0.901 | 1.911 | 1.173 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Arteriogram coronary abnormal | 2 | 0.941 | 0.569 | 1.963 | 4.036 | 0.506 | 1.11 | 2.192 | 2.126 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Carbon dioxide normal | 21 | 13.961 | 1.343 | 1.961 | 2.675 | 0.967 | 1.367 | 1.89 | 1.504 | 3.479 | 28.966
COVID19_PFIZER/BIONTECH | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [narrow] | 21 | 13.218 | 1.323 | 1.96 | 2.7 | 1.01 | 1.428 | 1.974 | 1.589 | 4.741 | 46.034
COVID19_PFIZER/BIONTECH | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [broad] | 21 | 13.218 | 1.323 | 1.96 | 2.7 | 1.01 | 1.428 | 1.974 | 1.589 | 4.741 | 46.034
COVID19_PFIZER/BIONTECH | Smear cervix normal | 1 | 0.48 | 0.171 | 1.958 | 5.393 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Anembryonic gestation | 1 | 0.461 | 0.232 | 1.954 | 5.078 | 0.409 | 0.992 | 2.113 | 2.17 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Laparoscopic surgery | 9 | 5.957 | 1.064 | 1.953 | 3.059 | 0.766 | 1.258 | 1.973 | 1.511 | 6.502 | 26.689
COVID19_PFIZER/BIONTECH | Skin wound | 1 | 0.812 | 0.166 | 1.946 | 5.38 | 0.374 | 0.909 | 1.929 | 1.231 | 0.384 | 0.435
COVID19_PFIZER/BIONTECH | Craniocerebral injury | 2 | 1.472 | 0.504 | 1.944 | 4.146 | 0.452 | 0.991 | 1.949 | 1.359 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Near death experience | 4 | 3.709 | 0.737 | 1.943 | 3.615 | 0.498 | 0.961 | 1.713 | 1.079 | 1.901 | 0.805
COVID19_PFIZER/BIONTECH | Mycoplasma test negative | 5 | 2.392 | 0.873 | 1.942 | 3.355 | 0.726 | 1.342 | 2.321 | 2.09 | 1.29 | 0.086
COVID19_PFIZER/BIONTECH | Aortic valve incompetence | 2 | 1.481 | 0.536 | 1.942 | 4.059 | 0.451 | 0.989 | 1.945 | 1.35 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Hyperglycaemia | 14 | 9.318 | 1.224 | 1.941 | 2.794 | 0.871 | 1.317 | 1.929 | 1.502 | 4.214 | 25.149
COVID19_PFIZER/BIONTECH | Gallbladder enlargement | 1 | 0.935 | 0.26 | 1.939 | 4.912 | 0.364 | 0.884 | 1.875 | 1.07 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Behaviour disorder | 1 | 0.945 | 0.233 | 1.937 | 5.017 | 0.363 | 0.882 | 1.87 | 1.058 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Dementia (SMQ) [narrow] | 15 | 16.387 | 1.215 | 1.937 | 2.796 | 0.603 | 0.902 | 1.306 | 0.915 | 5.017 | 34.516
COVID19_PFIZER/BIONTECH | Dysentery | 3 | 2.269 | 0.611 | 1.936 | 3.865 | 0.504 | 1.026 | 1.911 | 1.322 | 1.355 | 0.028
COVID19_PFIZER/BIONTECH | Heart rate increased | 581 | 413.606 | 1.804 | 1.934 | 2.067 | 1.307 | 1.4 | 1.498 | 1.405 | 5.37 | 1600.998
COVID19_PFIZER/BIONTECH | Cardiomegaly | 9 | 7.062 | 1.061 | 1.933 | 3.017 | 0.687 | 1.127 | 1.767 | 1.274 | 3.612 | 11.964
COVID19_PFIZER/BIONTECH | Interchange of vaccine products | 14 | 11.827 | 1.176 | 1.933 | 2.843 | 0.729 | 1.103 | 1.615 | 1.184 | 0.463 | 7.967
COVID19_PFIZER/BIONTECH | Retinal vein occlusion | 2 | 1.782 | 0.536 | 1.933 | 4.034 | 0.426 | 0.933 | 1.834 | 1.122 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase decreased | 1 | 0.354 | 0.24 | 1.932 | 4.975 | 0.42 | 1.022 | 2.182 | 2.824 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Facial asymmetry | 14 | 7.796 | 1.222 | 1.929 | 2.767 | 0.987 | 1.494 | 2.189 | 1.796 | 7.023 | 47.601
COVID19_PFIZER/BIONTECH | Suspected COVID-19 | 7 | 4.832 | 0.961 | 1.929 | 3.168 | 0.689 | 1.188 | 1.941 | 1.449 | 31.605 | 64.153
COVID19_PFIZER/BIONTECH | Nasoendoscopy | 2 | 0.815 | 0.582 | 1.927 | 3.906 | 0.521 | 1.143 | 2.264 | 2.454 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Infrequent bowel movements | 1 | 0.48 | 0.267 | 1.927 | 4.847 | 0.407 | 0.987 | 2.101 | 2.084 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Oropharyngeal pain | 402 | 277.684 | 1.772 | 1.926 | 2.087 | 1.326 | 1.44 | 1.561 | 1.448 | 2.698 | 375.605
COVID19_PFIZER/BIONTECH | Basal ganglia stroke | 4 | 2.937 | 0.74 | 1.925 | 3.561 | 0.557 | 1.075 | 1.917 | 1.362 | 12.04 | 17.808
COVID19_PFIZER/BIONTECH | Blood creatine | 2 | 1.442 | 0.535 | 1.923 | 4.008 | 0.455 | 0.997 | 1.96 | 1.387 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Ultrasound pelvis abnormal | 2 | 1.276 | 0.459 | 1.922 | 4.205 | 0.471 | 1.031 | 2.03 | 1.568 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Respiratory acidosis | 2 | 0.825 | 0.456 | 1.92 | 4.205 | 0.52 | 1.141 | 2.258 | 2.426 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Progesterone decreased | 1 | 0.461 | 0.222 | 1.919 | 5.015 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Red blood cell schistocytes | 1 | 0.514 | 0.287 | 1.917 | 4.737 | 0.403 | 0.979 | 2.081 | 1.946 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hypothermia | 11 | 7.888 | 1.102 | 1.916 | 2.913 | 0.772 | 1.22 | 1.854 | 1.394 | 1.45 | 1.017
COVID19_PFIZER/BIONTECH | Trigeminal nerve disorder | 2 | 1.816 | 0.567 | 1.916 | 3.912 | 0.423 | 0.927 | 1.822 | 1.101 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Product leakage | 2 | 1.47 | 0.528 | 1.914 | 4.001 | 0.453 | 0.991 | 1.949 | 1.361 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Device malfunction | 2 | 0.785 | 0.567 | 1.912 | 3.9 | 0.524 | 1.152 | 2.282 | 2.549 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Bilirubin conjugated increased | 4 | 2.934 | 0.737 | 1.911 | 3.529 | 0.558 | 1.075 | 1.918 | 1.363 | 1.416 | 0.138
COVID19_PFIZER/BIONTECH | Irregular breathing | 3 | 2.308 | 0.69 | 1.906 | 3.612 | 0.501 | 1.02 | 1.898 | 1.3 | 1.389 | 0.042
COVID19_PFIZER/BIONTECH | Eosinophil count increased | 9 | 6.185 | 1.037 | 1.904 | 2.984 | 0.748 | 1.228 | 1.926 | 1.455 | 1.311 | 0.351
COVID19_PFIZER/BIONTECH | Cerebral haemorrhage | 23 | 20.608 | 1.307 | 1.903 | 2.589 | 0.771 | 1.075 | 1.467 | 1.116 | 4.667 | 49.65
COVID19_PFIZER/BIONTECH | Adverse event | 46 | 32.357 | 1.47 | 1.902 | 2.38 | 1.072 | 1.363 | 1.714 | 1.422 | 0.898 | 0.41
COVID19_PFIZER/BIONTECH | Left ventricular end-diastolic pressure increased | 1 | 0.499 | 0.314 | 1.9 | 4.588 | 0.405 | 0.983 | 2.09 | 2.006 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Galactostasis | 1 | 0.815 | 0.314 | 1.9 | 4.588 | 0.374 | 0.909 | 1.928 | 1.227 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Herpes simplex reactivation | 1 | 0.815 | 0.314 | 1.9 | 4.588 | 0.374 | 0.909 | 1.928 | 1.227 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Gastrointestinal pathogen panel | 1 | 0.825 | 0.314 | 1.9 | 4.588 | 0.373 | 0.907 | 1.923 | 1.213 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | General physical condition normal | 1 | 0.922 | 0.314 | 1.9 | 4.588 | 0.365 | 0.887 | 1.88 | 1.085 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Ultrasound scan vagina abnormal | 1 | 0.922 | 0.314 | 1.9 | 4.588 | 0.365 | 0.887 | 1.88 | 1.085 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hypertrophy of tongue papillae | 1 | 0.922 | 0.314 | 1.9 | 4.588 | 0.365 | 0.887 | 1.88 | 1.085 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Phrenic nerve injury | 1 | 0.922 | 0.314 | 1.9 | 4.588 | 0.365 | 0.887 | 1.88 | 1.085 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | NIH stroke scale | 1 | 0.931 | 0.314 | 1.9 | 4.588 | 0.364 | 0.885 | 1.876 | 1.074 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pelvic fluid collection | 1 | 0.935 | 0.314 | 1.9 | 4.588 | 0.364 | 0.884 | 1.875 | 1.07 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Thrombotic stroke | 1 | 0.935 | 0.314 | 1.9 | 4.588 | 0.364 | 0.884 | 1.875 | 1.07 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pelvic haemorrhage | 1 | 0.935 | 0.314 | 1.9 | 4.588 | 0.364 | 0.884 | 1.875 | 1.07 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Water pollution | 1 | 0.944 | 0.314 | 1.9 | 4.588 | 0.363 | 0.882 | 1.871 | 1.059 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Retinal artery thrombosis | 1 | 0.944 | 0.314 | 1.9 | 4.588 | 0.363 | 0.882 | 1.871 | 1.059 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Femoral neck fracture | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Internal capsule infarction | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Systolic hypertension | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Chronic left ventricular failure | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Vertebral artery occlusion | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Patient elopement | 1 | 0.947 | 0.314 | 1.9 | 4.588 | 0.363 | 0.881 | 1.869 | 1.056 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Chillblains | 1 | 0.95 | 0.314 | 1.9 | 4.588 | 0.362 | 0.881 | 1.868 | 1.052 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hypertensive encephalopathy | 1 | 0.954 | 0.314 | 1.9 | 4.588 | 0.362 | 0.88 | 1.867 | 1.049 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Neurologic neglect syndrome | 1 | 0.954 | 0.314 | 1.9 | 4.588 | 0.362 | 0.88 | 1.867 | 1.049 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Vaccination site discolouration | 3 | 2.896 | 0.634 | 1.9 | 3.717 | 0.455 | 0.927 | 1.725 | 1.036 | 0.903 | 0.012
COVID19_PFIZER/BIONTECH | Ultrasound eye | 1 | 0.96 | 0.314 | 1.9 | 4.588 | 0.362 | 0.879 | 1.864 | 1.042 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Parosmia | 26 | 15.014 | 1.336 | 1.899 | 2.544 | 1.138 | 1.559 | 2.095 | 1.732 | 6.614 | 86.418
COVID19_PFIZER/BIONTECH | Scan abdomen abnormal | 1 | 0.743 | 0.237 | 1.899 | 4.885 | 0.381 | 0.924 | 1.961 | 1.345 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Slow response to stimuli | 4 | 2.177 | 0.796 | 1.895 | 3.375 | 0.631 | 1.217 | 2.177 | 1.837 | 0.976 | 0.043
COVID19_PFIZER/BIONTECH | Mycobacterium tuberculosis complex test | 2 | 1.223 | 0.486 | 1.895 | 4.055 | 0.476 | 1.043 | 2.053 | 1.635 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Colitis ischaemic | 2 | 1.408 | 0.581 | 1.895 | 3.822 | 0.458 | 1.004 | 1.974 | 1.42 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Cranial nerve paralysis | 2 | 1.295 | 0.551 | 1.894 | 3.889 | 0.469 | 1.027 | 2.022 | 1.544 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Bradykinesia | 4 | 3.963 | 0.697 | 1.893 | 3.564 | 0.482 | 0.928 | 1.655 | 1.009 | 12.04 | 17.808
COVID19_PFIZER/BIONTECH | Cardiopulmonary failure | 2 | 0.789 | 0.486 | 1.892 | 4.044 | 0.524 | 1.15 | 2.279 | 2.533 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [narrow] | 1 | 0.487 | 0.155 | 1.891 | 5.267 | 0.406 | 0.986 | 2.097 | 2.052 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | COVID-19 immunisation | 2 | 2.81 | 0.419 | 1.889 | 4.223 | 0.356 | 0.782 | 1.538 | 0.712 | 9.03 | 4.709
COVID19_PFIZER/BIONTECH | N-terminal prohormone brain natriuretic peptide increased | 5 | 4.173 | 0.835 | 1.886 | 3.28 | 0.56 | 1.032 | 1.777 | 1.198 | 6.02 | 11.977
COVID19_PFIZER/BIONTECH | Scleral disorders (SMQ) [broad] | 3 | 1.351 | 0.759 | 1.885 | 3.419 | 0.598 | 1.221 | 2.285 | 2.22 | 1.594 | 0.17
COVID19_PFIZER/BIONTECH | Scleral disorders (SMQ) [narrow] | 3 | 1.351 | 0.759 | 1.885 | 3.419 | 0.598 | 1.221 | 2.285 | 2.22 | 1.594 | 0.17
COVID19_PFIZER/BIONTECH | Metastases to liver | 1 | 0.935 | 0.238 | 1.883 | 4.828 | 0.364 | 0.884 | 1.875 | 1.07 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Haemoptysis | 15 | 9.989 | 1.191 | 1.882 | 2.702 | 0.887 | 1.326 | 1.922 | 1.502 | 3.264 | 17.982
COVID19_PFIZER/BIONTECH | Mucous stools | 3 | 1.856 | 0.633 | 1.88 | 3.664 | 0.542 | 1.105 | 2.06 | 1.616 | 0.191 | 9.37
COVID19_PFIZER/BIONTECH | Type V hyperlipidaemia | 1 | 0.577 | 0.239 | 1.879 | 4.813 | 0.397 | 0.963 | 2.046 | 1.734 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Trichomoniasis | 1 | 1.542 | 0.184 | 1.879 | 5.069 | 0.318 | 0.776 | 1.649 | 0.648 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Hepatic enzyme abnormal | 2 | 1.225 | 0.55 | 1.87 | 3.824 | 0.476 | 1.042 | 2.053 | 1.633 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Aortic aneurysm rupture | 2 | 1.907 | 0.445 | 1.87 | 4.094 | 0.416 | 0.912 | 1.791 | 1.049 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Blood parathyroid hormone decreased | 1 | 1.967 | 0.292 | 1.869 | 4.577 | 0.291 | 0.715 | 1.522 | 0.508 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Angina pectoris | 20 | 13.884 | 1.254 | 1.866 | 2.577 | 0.924 | 1.316 | 1.831 | 1.441 | 4.3 | 38.158
COVID19_PFIZER/BIONTECH | Claustrophobia | 2 | 0.828 | 0.535 | 1.865 | 3.85 | 0.519 | 1.14 | 2.256 | 2.416 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Lumbar spinal stenosis | 2 | 1.042 | 0.565 | 1.865 | 3.776 | 0.495 | 1.085 | 2.139 | 1.919 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Lung consolidation | 7 | 6.365 | 0.913 | 1.863 | 3.085 | 0.583 | 1.006 | 1.641 | 1.1 | 3.327 | 7.659
COVID19_PFIZER/BIONTECH | Hypoglycaemia (SMQ) [narrow] | 33 | 21.767 | 1.382 | 1.861 | 2.399 | 1.071 | 1.42 | 1.852 | 1.516 | 2.167 | 17.455
COVID19_PFIZER/BIONTECH | Orthostatic hypotension | 15 | 9.89 | 1.162 | 1.861 | 2.695 | 0.893 | 1.336 | 1.936 | 1.517 | 3.518 | 20.464
COVID19_PFIZER/BIONTECH | Uterine contractions during pregnancy | 2 | 1.383 | 0.383 | 1.86 | 4.246 | 0.461 | 1.009 | 1.985 | 1.446 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Electrocardiogram ST-T segment abnormal | 1 | 1.465 | 0.267 | 1.859 | 4.637 | 0.323 | 0.789 | 1.674 | 0.683 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin positive | 1 | 0.922 | 0.166 | 1.858 | 5.098 | 0.365 | 0.887 | 1.88 | 1.085 | 0.564 | 0.033
COVID19_PFIZER/BIONTECH | Legionella test | 4 | 2.845 | 0.741 | 1.855 | 3.376 | 0.565 | 1.09 | 1.945 | 1.406 | 3.802 | 4.6
COVID19_PFIZER/BIONTECH | Thyroiditis subacute | 1 | 0.508 | 0.162 | 1.854 | 5.103 | 0.404 | 0.98 | 2.085 | 1.968 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Nightmare | 15 | 9.982 | 1.181 | 1.854 | 2.651 | 0.887 | 1.326 | 1.923 | 1.503 | 2.037 | 6.168
COVID19_PFIZER/BIONTECH | Blood bilirubin normal | 23 | 17.014 | 1.282 | 1.854 | 2.514 | 0.905 | 1.262 | 1.723 | 1.352 | 2.175 | 11.951
COVID19_PFIZER/BIONTECH | Bronchoscopy abnormal | 2 | 1.015 | 0.543 | 1.852 | 3.792 | 0.498 | 1.091 | 2.153 | 1.97 | 2.125 | 0.268
COVID19_PFIZER/BIONTECH | Tonsillitis | 3 | 1.967 | 0.621 | 1.852 | 3.616 | 0.531 | 1.083 | 2.017 | 1.525 | 0.299 | 4.142
COVID19_PFIZER/BIONTECH | Colitis | 7 | 4.893 | 0.929 | 1.851 | 3.029 | 0.684 | 1.18 | 1.927 | 1.431 | 1.781 | 1.495
COVID19_PFIZER/BIONTECH | Wound closure | 2 | 1.09 | 0.58 | 1.849 | 3.7 | 0.49 | 1.073 | 2.116 | 1.835 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Deja vu | 1 | 0.266 | 0.294 | 1.848 | 4.506 | 0.43 | 1.05 | 2.25 | 3.765 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Dyslipidaemia | 2 | 1.46 | 0.55 | 1.848 | 3.766 | 0.453 | 0.993 | 1.953 | 1.37 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Hypokalaemia | 14 | 10.528 | 1.146 | 1.846 | 2.682 | 0.796 | 1.204 | 1.764 | 1.33 | 4.145 | 24.544
COVID19_PFIZER/BIONTECH | Antibody test abnormal | 2 | 1.268 | 0.424 | 1.845 | 4.08 | 0.472 | 1.033 | 2.033 | 1.577 | 0.592 | 0.207
COVID19_PFIZER/BIONTECH | Normocytic anaemia | 2 | 1.427 | 0.534 | 1.841 | 3.784 | 0.456 | 1 | 1.967 | 1.401 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Thrombosis | 46 | 35.513 | 1.425 | 1.84 | 2.299 | 0.985 | 1.253 | 1.575 | 1.295 | 7.224 | 171.616
COVID19_PFIZER/BIONTECH | Chronic spontaneous urticaria | 1 | 0.489 | 0.331 | 1.835 | 4.336 | 0.406 | 0.985 | 2.096 | 2.045 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Coronavirus infection | 3 | 2.753 | 0.628 | 1.835 | 3.556 | 0.465 | 0.948 | 1.764 | 1.09 | 4.515 | 3.935
COVID19_PFIZER/BIONTECH | Diaphragmatic paralysis | 2 | 1.206 | 0.579 | 1.831 | 3.652 | 0.478 | 1.047 | 2.061 | 1.658 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Allergic respiratory symptom | 2 | 0.836 | 0.579 | 1.83 | 3.648 | 0.518 | 1.138 | 2.251 | 2.393 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Fasciitis | 3 | 1.86 | 0.716 | 1.83 | 3.36 | 0.542 | 1.104 | 2.058 | 1.613 | 3.187 | 2.117
COVID19_PFIZER/BIONTECH | Abnormal loss of weight | 3 | 1.467 | 0.579 | 1.829 | 3.645 | 0.584 | 1.192 | 2.228 | 2.045 | 1.129 | 0.012
COVID19_PFIZER/BIONTECH | Angiopathy | 1 | 0.41 | 0.232 | 1.829 | 4.685 | 0.414 | 1.006 | 2.145 | 2.442 | 0.531 | 0.065
COVID19_PFIZER/BIONTECH | Mastitis | 6 | 4.062 | 0.863 | 1.827 | 3.081 | 0.662 | 1.178 | 1.971 | 1.477 | 5.703 | 14.116
COVID19_PFIZER/BIONTECH | Stridor | 21 | 12.943 | 1.242 | 1.826 | 2.501 | 1.026 | 1.452 | 2.007 | 1.623 | 4.078 | 37.208
COVID19_PFIZER/BIONTECH | Neisseria test | 2 | 0.737 | 0.55 | 1.822 | 3.695 | 0.53 | 1.165 | 2.312 | 2.713 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Urinary assistance device user | 1 | 0.046 | 0.344 | 1.821 | 4.254 | 0.46 | 1.155 | 2.583 | 21.733 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | SARS-CoV-2 test false positive | 1 | 0.046 | 0.344 | 1.821 | 4.254 | 0.46 | 1.155 | 2.583 | 21.733 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Internal injury | 1 | 0.046 | 0.344 | 1.821 | 4.254 | 0.46 | 1.155 | 2.583 | 21.733 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Upper respiratory tract irritation | 1 | 0.054 | 0.344 | 1.821 | 4.254 | 0.458 | 1.148 | 2.556 | 18.498 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Instillation site pain | 1 | 0.054 | 0.344 | 1.821 | 4.254 | 0.458 | 1.148 | 2.556 | 18.498 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Vasodilation procedure | 1 | 0.054 | 0.344 | 1.821 | 4.254 | 0.458 | 1.148 | 2.556 | 18.498 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Therapeutic response shortened | 1 | 0.266 | 0.344 | 1.821 | 4.254 | 0.43 | 1.05 | 2.25 | 3.765 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Endothelial dysfunction | 1 | 0.266 | 0.344 | 1.821 | 4.254 | 0.43 | 1.05 | 2.25 | 3.765 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Intercepted product preparation error | 1 | 0.266 | 0.344 | 1.821 | 4.254 | 0.43 | 1.05 | 2.25 | 3.765 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Product design issue | 1 | 0.266 | 0.344 | 1.821 | 4.254 | 0.43 | 1.05 | 2.25 | 3.765 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Scalloped tongue | 1 | 0.266 | 0.344 | 1.821 | 4.254 | 0.43 | 1.05 | 2.25 | 3.765 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Insulin resistant diabetes | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Diplacusis | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Holmes-Adie pupil | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urinary stone analysis | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | SARS-CoV-2 test false negative | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Breast milk discolouration | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Antipsychotic drug level | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Product delivery mechanism issue | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Blood insulin increased | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Iodine uptake normal | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Product dose omission in error | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Splenic lesion | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Transcutaneous pacing | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Jaw clicking | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Eye paraesthesia | 1 | 0.354 | 0.344 | 1.821 | 4.254 | 0.42 | 1.022 | 2.182 | 2.824 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Euglycaemic diabetic ketoacidosis | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Peripheral artery stent insertion | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Sulphur dioxide test | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Assisted reproductive technology | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Hypnopompic hallucination | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cerebellar haemorrhage | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Blood pressure diastolic abnormal | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urine porphobilinogen increased | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Splenic artery aneurysm | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Omentectomy | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Malignant hypertension | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Waist circumference increased | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Blood pressure management | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Ultrasound uterus abnormal | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Splenic varices | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Uterine cervical pain | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Pulmonary hilar enlargement | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Otoacoustic emissions test | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Paraproteinaemia | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Portal hypertensive gastropathy | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Locked-in syndrome | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Mallampati score | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Gastric varices | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Hysterosalpingo-oophorectomy | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Iliac vein occlusion | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Implant site pruritus | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Mucosa vesicle | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Transplant evaluation | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Vertebral lateral recess stenosis | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Focal peritonitis | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Oocyte harvest | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Injection site recall reaction | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Fibronectin normal | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Allergy to surgical sutures | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Pelvic abscess | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Sleep disorder due to general medical condition, insomnia type | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Pelvic haematoma | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Vanishing twin syndrome | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Coma acidotic | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Directional Doppler flow tests | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Gestational age test abnormal | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Epstein-Barr virus infection reactivation | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cautery to nose | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Binge drinking | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Ocular rosacea | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urine amphetamine positive | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Itching scar | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Uterine tenderness | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Oral viral infection | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Forced expiratory flow | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Porphyria acute | 1 | 0.461 | 0.344 | 1.821 | 4.254 | 0.409 | 0.992 | 2.113 | 2.17 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Craniectomy | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Wall motion score index abnormal | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Thrombin-antithrombin III complex normal | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Retinal operation | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Hereditary spherocytosis | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Good syndrome | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Creatine urine increased | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Abstains from alcohol | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Ophthalmic artery thrombosis | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cardiac ventriculogram left | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Russell's viper venom time normal | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urinary lipids present | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Diverticulitis intestinal perforated | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Computerised tomogram pancreas normal | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Breath sounds absent | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Bullous haemorrhagic dermatosis | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Application site haemorrhage | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Tidal volume decreased | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Electrocardiogram PR segment elevation | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Endoscopic ultrasound | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Brain natriuretic peptide decreased | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Myelocyte percentage | 1 | 0.47 | 0.344 | 1.821 | 4.254 | 0.408 | 0.99 | 2.107 | 2.125 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Retroperitoneal haemorrhage | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Acute undifferentiated leukaemia | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Prothrombin time ratio abnormal | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Carotid artery stent insertion | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Platelet aggregation decreased | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Albumin globulin ratio abnormal | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Dermatophagia | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Rash maculovesicular | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Dementia with Lewy bodies | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Blood beta-D-glucan positive | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Coronary artery thrombosis | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Alveolar lung disease | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Arteriovenous fistula aneurysm | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Basilar artery occlusion | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Central cord syndrome | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | EGFR gene mutation | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Burkitt's lymphoma | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Hunt and Hess scale | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Incarcerated hernia | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Stoma site haemorrhage | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Progressive bulbar palsy | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Insulin therapy | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Arterial catheterisation | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Acoustic neuritis | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Free thyroxine index | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Posthaemorrhagic hydrocephalus | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Pneumonitis chemical | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Intracerebral haematoma evacuation | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urethral meatus stenosis | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Red blood cell microcytes | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Silent myocardial infarction | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Product substitution issue | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Protein albumin ratio increased | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Renal atrophy | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Right ventricular systolic pressure decreased | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Peripheral vein occlusion | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Ischaemic skin ulcer | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Lung hypoinflation | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cystic lung disease | 1 | 0.474 | 0.344 | 1.821 | 4.254 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Injection site muscle atrophy | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Crystal urine | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Mean arterial pressure decreased | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Gastrointestinal stoma complication | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Gastritis bacterial | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | LDL/HDL ratio decreased | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Intranasal paraesthesia | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Paranoid personality disorder | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Pulmonary amyloidosis | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Vena cava embolism | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Bone density abnormal | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urine retinol binding protein increased | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | General physical condition | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Aortic thrombosis | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Urinary nitrogen increased | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Biopsy vagina | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Migraine prophylaxis | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Chondritis | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cardiovascular function test | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Haemorrhagic varicella syndrome | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Abdominal wall haemorrhage | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Post-traumatic neuralgia | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Computerised tomogram aorta | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Hypertensive cerebrovascular disease | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Eosinophilic pneumonia acute | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cor pulmonale acute | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Venous recanalisation | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cardiac pacemaker replacement | 1 | 0.48 | 0.344 | 1.821 | 4.254 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Chronic myeloid leukaemia recurrent | 1 | 0.693 | 0.344 | 1.821 | 4.254 | 0.385 | 0.936 | 1.986 | 1.442 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Paraganglion neoplasm | 1 | 0.693 | 0.344 | 1.821 | 4.254 | 0.385 | 0.936 | 1.986 | 1.442 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Blue toe syndrome | 1 | 0.693 | 0.344 | 1.821 | 4.254 | 0.385 | 0.936 | 1.986 | 1.442 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Fluid balance assessment | 1 | 0.693 | 0.344 | 1.821 | 4.254 | 0.385 | 0.936 | 1.986 | 1.442 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Diabetic wound | 1 | 0.693 | 0.344 | 1.821 | 4.254 | 0.385 | 0.936 | 1.986 | 1.442 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Streptobacillus infection | 1 | 0.705 | 0.344 | 1.821 | 4.254 | 0.384 | 0.933 | 1.98 | 1.419 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Microembolism | 1 | 0.743 | 0.344 | 1.821 | 4.254 | 0.381 | 0.924 | 1.961 | 1.345 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Lung carcinoma cell type unspecified stage I | 1 | 0.743 | 0.344 | 1.821 | 4.254 | 0.381 | 0.924 | 1.961 | 1.345 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Living in residential institution | 1 | 0.743 | 0.344 | 1.821 | 4.254 | 0.381 | 0.924 | 1.961 | 1.345 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Diabetic foot infection | 1 | 0.743 | 0.344 | 1.821 | 4.254 | 0.381 | 0.924 | 1.961 | 1.345 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Red blood cell count | 3 | 1.611 | 0.588 | 1.82 | 3.602 | 0.568 | 1.158 | 2.162 | 1.862 | 1.426 | 0.06
COVID19_PFIZER/BIONTECH | Polyneuropathy | 5 | 2.568 | 0.791 | 1.818 | 3.187 | 0.705 | 1.302 | 2.251 | 1.947 | 0.951 | 0.013
COVID19_PFIZER/BIONTECH | Heavy menstrual bleeding | 10 | 5.805 | 1.002 | 1.818 | 2.832 | 0.86 | 1.385 | 2.137 | 1.723 | 1.57 | 1.393
COVID19_PFIZER/BIONTECH | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [broad] | 2226 | 1579.992 | 1.753 | 1.816 | 1.879 | 1.359 | 1.408 | 1.457 | 1.409 | 4.134 | 4458.217
COVID19_PFIZER/BIONTECH | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [narrow] | 2226 | 1579.992 | 1.753 | 1.816 | 1.879 | 1.359 | 1.408 | 1.457 | 1.409 | 4.134 | 4458.217
COVID19_PFIZER/BIONTECH | Hepatic cyst | 2 | 0.95 | 0.534 | 1.815 | 3.712 | 0.505 | 1.107 | 2.187 | 2.104 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Lymphocyte count normal | 13 | 8.139 | 1.122 | 1.814 | 2.64 | 0.89 | 1.365 | 2.021 | 1.597 | 1.535 | 1.742
COVID19_PFIZER/BIONTECH | Salivary gland pain | 1 | 0.62 | 0.199 | 1.814 | 4.787 | 0.392 | 0.953 | 2.023 | 1.614 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Hepatitis A antibody | 1 | 0.461 | 0.272 | 1.813 | 4.479 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Small intestinal haemorrhage | 1 | 0.474 | 0.345 | 1.812 | 4.223 | 0.407 | 0.989 | 2.105 | 2.111 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Cerebral arteriosclerosis | 1 | 0.48 | 0.345 | 1.812 | 4.223 | 0.407 | 0.987 | 2.101 | 2.084 | 54.177 | 4.029
COVID19_PFIZER/BIONTECH | Bilirubin urine present | 2 | 1.427 | 0.534 | 1.811 | 3.701 | 0.456 | 1 | 1.967 | 1.401 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Metabolic acidosis | 3 | 2.414 | 0.619 | 1.81 | 3.507 | 0.492 | 1.002 | 1.864 | 1.243 | 0.677 | 0.177
COVID19_PFIZER/BIONTECH | Ultrasound foetal abnormal | 1 | 1.383 | 0.246 | 1.81 | 4.57 | 0.329 | 0.802 | 1.702 | 0.723 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Carotid artery stenosis | 2 | 1.529 | 0.55 | 1.809 | 3.66 | 0.447 | 0.98 | 1.926 | 1.308 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Carotid arteriosclerosis | 2 | 1.901 | 0.448 | 1.807 | 3.909 | 0.416 | 0.913 | 1.794 | 1.052 | 12.04 | 6.163
COVID19_PFIZER/BIONTECH | Foetal non-stress test | 1 | 1.383 | 0.247 | 1.806 | 4.556 | 0.329 | 0.802 | 1.702 | 0.723 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Audiogram normal | 2 | 0.941 | 0.564 | 1.804 | 3.611 | 0.506 | 1.11 | 2.192 | 2.125 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Metabolic disorder | 3 | 1.432 | 0.556 | 1.802 | 3.627 | 0.588 | 1.2 | 2.245 | 2.095 | 2.258 | 0.875
COVID19_PFIZER/BIONTECH | Mental impairment | 28 | 18.33 | 1.287 | 1.802 | 2.388 | 1.044 | 1.414 | 1.882 | 1.528 | 2.397 | 18.851
COVID19_PFIZER/BIONTECH | Herpes virus test | 2 | 0.737 | 0.512 | 1.801 | 3.728 | 0.53 | 1.165 | 2.312 | 2.712 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Sputum discoloured | 7 | 4.129 | 0.908 | 1.801 | 2.939 | 0.752 | 1.297 | 2.12 | 1.695 | 1.621 | 0.986
COVID19_PFIZER/BIONTECH | Troponin T increased | 2 | 1.723 | 0.4 | 1.801 | 4.022 | 0.431 | 0.943 | 1.854 | 1.161 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Reactogenicity event | 1 | 0.487 | 0.172 | 1.799 | 4.875 | 0.406 | 0.986 | 2.097 | 2.052 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Bartonella test | 1 | 0.554 | 0.221 | 1.798 | 4.64 | 0.399 | 0.969 | 2.059 | 1.804 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Cardio-respiratory arrest | 31 | 30.215 | 1.311 | 1.798 | 2.348 | 0.753 | 1.006 | 1.322 | 1.026 | 4.589 | 66.427
COVID19_PFIZER/BIONTECH | Blood fibrinogen increased | 2 | 0.959 | 0.419 | 1.797 | 3.959 | 0.504 | 1.105 | 2.182 | 2.085 | 1.29 | 0.004
COVID19_PFIZER/BIONTECH | Dental examination normal | 2 | 0.815 | 0.578 | 1.795 | 3.558 | 0.521 | 1.143 | 2.264 | 2.454 | 7.224 | 3.687
COVID19_PFIZER/BIONTECH | Coxsackie virus test negative | 1 | 0.461 | 0.32 | 1.795 | 4.253 | 0.409 | 0.992 | 2.113 | 2.17 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Computerised tomogram abdomen abnormal | 35 | 26.51 | 1.328 | 1.788 | 2.304 | 0.96 | 1.262 | 1.636 | 1.32 | 5.224 | 89.335
COVID19_PFIZER/BIONTECH | Bundle branch block right | 4 | 3.023 | 0.758 | 1.786 | 3.165 | 0.55 | 1.06 | 1.891 | 1.323 | 3.284 | 3.53
COVID19_PFIZER/BIONTECH | Overweight | 2 | 0.922 | 0.564 | 1.784 | 3.559 | 0.508 | 1.115 | 2.202 | 2.17 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin concentration decreased | 9 | 5.33 | 1.011 | 1.783 | 2.731 | 0.82 | 1.346 | 2.113 | 1.689 | 3.386 | 10.714
COVID19_PFIZER/BIONTECH | Pericardial effusion | 16 | 15.393 | 1.139 | 1.783 | 2.545 | 0.677 | 1.001 | 1.437 | 1.039 | 3.247 | 19.129
COVID19_PFIZER/BIONTECH | Fracture | 2 | 0.955 | 0.549 | 1.782 | 3.587 | 0.504 | 1.106 | 2.184 | 2.094 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Discoloured vomit | 4 | 2.26 | 0.727 | 1.782 | 3.214 | 0.622 | 1.2 | 2.144 | 1.77 | 5.557 | 8.049
COVID19_PFIZER/BIONTECH | Transaminases increased | 5 | 3.418 | 0.768 | 1.781 | 3.135 | 0.62 | 1.143 | 1.97 | 1.463 | 1.101 | 0.001
COVID19_PFIZER/BIONTECH | Red blood cell count decreased | 23 | 18.242 | 1.228 | 1.781 | 2.418 | 0.854 | 1.191 | 1.626 | 1.261 | 1.923 | 8.356
COVID19_PFIZER/BIONTECH | Maternal exposure before pregnancy | 1 | 1.335 | 0.174 | 1.779 | 4.801 | 0.332 | 0.81 | 1.719 | 0.749 | 0.142 | 4.277
COVID19_PFIZER/BIONTECH | Blood triglycerides normal | 5 | 2.349 | 0.815 | 1.778 | 3.044 | 0.732 | 1.352 | 2.339 | 2.129 | 3.473 | 5.359
COVID19_PFIZER/BIONTECH | White blood cell count | 18 | 14.548 | 1.176 | 1.777 | 2.48 | 0.799 | 1.158 | 1.634 | 1.237 | 1.924 | 6.363
COVID19_PFIZER/BIONTECH | Gastric volvulus | 1 | 0.743 | 0.301 | 1.777 | 4.265 | 0.381 | 0.924 | 1.961 | 1.345 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MB | 4 | 4.589 | 0.649 | 1.777 | 3.355 | 0.445 | 0.857 | 1.528 | 0.872 | 2.258 | 1.451
COVID19_PFIZER/BIONTECH | Other ischaemic heart disease (SMQ) [narrow] | 55 | 40.426 | 1.404 | 1.776 | 2.183 | 1.057 | 1.318 | 1.627 | 1.361 | 5.843 | 163.078
COVID19_PFIZER/BIONTECH | Ventricular hypokinesia | 4 | 2.857 | 0.715 | 1.776 | 3.221 | 0.564 | 1.088 | 1.941 | 1.4 | 6.02 | 8.9
COVID19_PFIZER/BIONTECH | Hepatic enzyme | 2 | 1.634 | 0.511 | 1.776 | 3.662 | 0.438 | 0.96 | 1.887 | 1.224 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Angiogram retina | 3 | 2.442 | 0.648 | 1.775 | 3.354 | 0.489 | 0.997 | 1.855 | 1.228 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Serum ferritin increased | 10 | 8.159 | 0.998 | 1.773 | 2.728 | 0.688 | 1.107 | 1.707 | 1.226 | 3.114 | 10.413
COVID19_PFIZER/BIONTECH | Oxygen saturation normal | 23 | 11.608 | 1.235 | 1.771 | 2.386 | 1.227 | 1.712 | 2.339 | 1.981 | 8.477 | 97.953
COVID19_PFIZER/BIONTECH | Renal disorder | 6 | 4.234 | 0.884 | 1.771 | 2.907 | 0.648 | 1.152 | 1.927 | 1.417 | 2.125 | 2.223
COVID19_PFIZER/BIONTECH | Blood pressure orthostatic | 1 | 0.054 | 0.302 | 1.77 | 4.24 | 0.458 | 1.148 | 2.556 | 18.498 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Upper respiratory tract congestion | 6 | 3.772 | 0.842 | 1.77 | 2.975 | 0.688 | 1.224 | 2.05 | 1.591 | 2.356 | 2.972
COVID19_PFIZER/BIONTECH | Metabolic function test abnormal | 8 | 5.239 | 0.936 | 1.77 | 2.818 | 0.742 | 1.247 | 1.993 | 1.527 | 4.378 | 14.039
COVID19_PFIZER/BIONTECH | Renovascular disorders (SMQ) [broad] | 8 | 5.863 | 0.925 | 1.769 | 2.834 | 0.693 | 1.164 | 1.861 | 1.364 | 2.189 | 3.558
COVID19_PFIZER/BIONTECH | Jaw disorder | 6 | 2.925 | 0.886 | 1.768 | 2.897 | 0.778 | 1.385 | 2.326 | 2.051 | 10.836 | 27.309
COVID19_PFIZER/BIONTECH | Oropharyngeal disorders (SMQ) [broad] | 2317 | 1671.955 | 1.707 | 1.767 | 1.828 | 1.338 | 1.385 | 1.433 | 1.386 | 3.592 | 3768.185
COVID19_PFIZER/BIONTECH | Oropharyngeal disorders (SMQ) [narrow] | 2317 | 1671.955 | 1.707 | 1.767 | 1.828 | 1.338 | 1.385 | 1.433 | 1.386 | 3.592 | 3768.185
COVID19_PFIZER/BIONTECH | Phantom limb syndrome | 1 | 0.746 | 0.211 | 1.766 | 4.581 | 0.38 | 0.924 | 1.96 | 1.341 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Vaccination site urticaria | 2 | 1.204 | 0.524 | 1.764 | 3.597 | 0.478 | 1.047 | 2.062 | 1.661 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Arrhythmia | 31 | 23.567 | 1.285 | 1.764 | 2.306 | 0.937 | 1.252 | 1.646 | 1.315 | 2.828 | 30.036
COVID19_PFIZER/BIONTECH | Haematemesis | 11 | 7.994 | 1.041 | 1.763 | 2.639 | 0.765 | 1.209 | 1.837 | 1.376 | 2.136 | 4.922
COVID19_PFIZER/BIONTECH | Rales | 8 | 7.203 | 0.906 | 1.762 | 2.846 | 0.607 | 1.02 | 1.629 | 1.111 | 2.293 | 4.038
COVID19_PFIZER/BIONTECH | Transient ischaemic attack | 22 | 20.424 | 1.212 | 1.761 | 2.394 | 0.742 | 1.041 | 1.43 | 1.077 | 4.182 | 40.585
COVID19_PFIZER/BIONTECH | Brachial plexus injury | 1 | 1.551 | 0.146 | 1.761 | 4.897 | 0.317 | 0.775 | 1.646 | 0.645 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Hypoaesthesia eye | 12 | 6.094 | 1.062 | 1.76 | 2.601 | 0.996 | 1.551 | 2.329 | 1.969 | 16.671 | 83.528
COVID19_PFIZER/BIONTECH | Myocardial ischaemia | 3 | 2.445 | 0.62 | 1.758 | 3.365 | 0.489 | 0.996 | 1.854 | 1.227 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Time perception altered | 1 | 1.671 | 0.253 | 1.758 | 4.383 | 0.309 | 0.757 | 1.608 | 0.599 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Appendicitis (narrow) (Custom Term) | 37 | 29.824 | 1.315 | 1.757 | 2.251 | 0.917 | 1.197 | 1.541 | 1.241 | 8.149 | 154.802
COVID19_PFIZER/BIONTECH | Shift to the left | 3 | 1.444 | 0.608 | 1.755 | 3.382 | 0.587 | 1.197 | 2.238 | 2.077 | 1.693 | 0.253
COVID19_PFIZER/BIONTECH | Osteopenia | 2 | 0.954 | 0.535 | 1.754 | 3.544 | 0.505 | 1.107 | 2.185 | 2.097 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Contraindicated product administered | 2 | 1.035 | 0.483 | 1.754 | 3.669 | 0.496 | 1.086 | 2.143 | 1.932 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Clostridium difficile colitis | 2 | 1.055 | 0.535 | 1.753 | 3.54 | 0.493 | 1.081 | 2.133 | 1.895 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Dyspnoea at rest | 1 | 0.944 | 0.304 | 1.753 | 4.184 | 0.363 | 0.882 | 1.871 | 1.059 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lower respiratory tract infection | 5 | 3.558 | 0.727 | 1.751 | 3.135 | 0.608 | 1.121 | 1.931 | 1.405 | 0.454 | 2.671
COVID19_PFIZER/BIONTECH | Appendicectomy | 25 | 19.488 | 1.228 | 1.751 | 2.351 | 0.881 | 1.213 | 1.638 | 1.283 | 5.864 | 72.332
COVID19_PFIZER/BIONTECH | Labile blood pressure | 1 | 0.461 | 0.227 | 1.75 | 4.461 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Coma scale normal | 2 | 0.88 | 0.464 | 1.749 | 3.702 | 0.513 | 1.126 | 2.226 | 2.272 | 1.003 | 0.129
COVID19_PFIZER/BIONTECH | Occult blood positive | 3 | 1.933 | 0.574 | 1.749 | 3.442 | 0.535 | 1.089 | 2.03 | 1.552 | 0.488 | 1.087
COVID19_PFIZER/BIONTECH | Troponin I increased | 13 | 10.759 | 1.04 | 1.749 | 2.607 | 0.728 | 1.115 | 1.651 | 1.208 | 2.829 | 11.675
COVID19_PFIZER/BIONTECH | Procalcitonin increased | 15 | 10.184 | 1.092 | 1.748 | 2.529 | 0.874 | 1.307 | 1.895 | 1.473 | 1.868 | 4.689
COVID19_PFIZER/BIONTECH | Coma scale abnormal | 3 | 2.278 | 0.593 | 1.748 | 3.398 | 0.503 | 1.025 | 1.908 | 1.317 | 1.642 | 0.209
COVID19_PFIZER/BIONTECH | Specific gravity urine increased | 2 | 0.935 | 0.564 | 1.747 | 3.459 | 0.507 | 1.111 | 2.195 | 2.14 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Amyloidosis | 1 | 0.96 | 0.305 | 1.746 | 4.159 | 0.362 | 0.879 | 1.864 | 1.042 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Extraocular muscle paresis | 5 | 2.85 | 0.807 | 1.745 | 2.974 | 0.675 | 1.245 | 2.148 | 1.754 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | Vital signs measurement | 10 | 4.692 | 1.001 | 1.744 | 2.653 | 0.976 | 1.573 | 2.434 | 2.131 | 20.067 | 76.553
COVID19_PFIZER/BIONTECH | CSF cell count | 2 | 1.843 | 0.418 | 1.744 | 3.81 | 0.421 | 0.922 | 1.813 | 1.085 | 1.246 | 0.01
COVID19_PFIZER/BIONTECH | Acidosis | 5 | 3.547 | 0.809 | 1.741 | 2.959 | 0.609 | 1.123 | 1.934 | 1.41 | 3.612 | 5.741
COVID19_PFIZER/BIONTECH | Urinary tract disorder | 1 | 0.705 | 0.273 | 1.741 | 4.256 | 0.384 | 0.933 | 1.98 | 1.419 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Tongue dry | 5 | 3.46 | 0.765 | 1.739 | 3.033 | 0.616 | 1.136 | 1.958 | 1.445 | 8.209 | 16.847
COVID19_PFIZER/BIONTECH | Incorrect dose administered | 80 | 64.948 | 1.433 | 1.738 | 2.068 | 1.008 | 1.211 | 1.445 | 1.232 | 1.297 | 4.804
COVID19_PFIZER/BIONTECH | Brain contusion | 1 | 0.47 | 0.229 | 1.737 | 4.417 | 0.408 | 0.99 | 2.107 | 2.125 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Colostomy | 1 | 0.461 | 0.192 | 1.736 | 4.577 | 0.409 | 0.992 | 2.113 | 2.17 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Biopsy oesophagus normal | 1 | 0.922 | 0.306 | 1.736 | 4.125 | 0.365 | 0.887 | 1.88 | 1.085 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pupillary reflex impaired | 4 | 1.905 | 0.737 | 1.734 | 3.071 | 0.662 | 1.279 | 2.291 | 2.1 | 1.605 | 0.354
COVID19_PFIZER/BIONTECH | Cardiac tamponade | 2 | 2.174 | 0.422 | 1.733 | 3.768 | 0.396 | 0.869 | 1.708 | 0.92 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Biliary neoplasms malignant and unspecified (SMQ) [broad] | 1 | 0.474 | 0.307 | 1.729 | 4.103 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Biliary neoplasms malignant and unspecified (SMQ) [narrow] | 1 | 0.474 | 0.307 | 1.729 | 4.103 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Septic encephalopathy | 1 | 0.48 | 0.307 | 1.729 | 4.103 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Cardioactive drug level | 1 | 0.518 | 0.307 | 1.729 | 4.102 | 0.403 | 0.978 | 2.079 | 1.932 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lacunar infarction | 4 | 3.358 | 0.724 | 1.729 | 3.084 | 0.524 | 1.009 | 1.8 | 1.191 | 10.32 | 15.623
COVID19_PFIZER/BIONTECH | Thoracic cavity drainage | 1 | 0.474 | 0.152 | 1.728 | 4.751 | 0.407 | 0.989 | 2.105 | 2.111 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Haematochezia | 23 | 17.772 | 1.192 | 1.728 | 2.344 | 0.873 | 1.217 | 1.661 | 1.294 | 0.378 | 22.545
COVID19_PFIZER/BIONTECH | Therapy change | 1 | 0.354 | 0.307 | 1.727 | 4.095 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Vital functions abnormal | 10 | 5.632 | 0.99 | 1.727 | 2.63 | 0.876 | 1.411 | 2.178 | 1.776 | 30.1 | 94.302
COVID19_PFIZER/BIONTECH | Uterine leiomyoma | 1 | 0.869 | 0.172 | 1.726 | 4.641 | 0.369 | 0.897 | 1.903 | 1.151 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Vaccination site lymphadenopathy | 1 | 0.922 | 0.308 | 1.722 | 4.078 | 0.365 | 0.887 | 1.88 | 1.085 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Nasal cavity packing | 1 | 0.947 | 0.308 | 1.722 | 4.078 | 0.363 | 0.881 | 1.869 | 1.056 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Gastrointestinal sounds abnormal | 3 | 1.737 | 0.609 | 1.721 | 3.291 | 0.554 | 1.13 | 2.108 | 1.728 | 1.505 | 0.106
COVID19_PFIZER/BIONTECH | Glaucoma | 2 | 2.142 | 0.499 | 1.72 | 3.536 | 0.399 | 0.874 | 1.717 | 0.934 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | Respiratory tract oedema | 1 | 0.354 | 0.292 | 1.719 | 4.123 | 0.42 | 1.022 | 2.182 | 2.824 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Priapism | 1 | 0.47 | 0.332 | 1.719 | 3.992 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | PO2 normal | 3 | 2.155 | 0.684 | 1.719 | 3.136 | 0.514 | 1.047 | 1.95 | 1.392 | 3.386 | 2.392
COVID19_PFIZER/BIONTECH | Hypercalcaemia | 3 | 4.617 | 0.57 | 1.719 | 3.369 | 0.358 | 0.732 | 1.363 | 0.65 | 4.168 | 3.467
COVID19_PFIZER/BIONTECH | Upper motor neurone lesion | 1 | 0.461 | 0.332 | 1.718 | 3.988 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Total cholesterol/HDL ratio normal | 1 | 0.474 | 0.332 | 1.718 | 3.989 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Non-high-density lipoprotein cholesterol increased | 1 | 0.474 | 0.332 | 1.718 | 3.989 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Haematospermia | 1 | 0.47 | 0.332 | 1.717 | 3.986 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cholecystitis chronic | 1 | 0.474 | 0.332 | 1.717 | 3.985 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Atrial septal defect repair | 1 | 0.727 | 0.332 | 1.717 | 3.985 | 0.382 | 0.928 | 1.97 | 1.376 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Conjunctival haemorrhage | 7 | 4.14 | 0.849 | 1.716 | 2.83 | 0.751 | 1.295 | 2.117 | 1.691 | 3.951 | 10.233
COVID19_PFIZER/BIONTECH | Foetal monitoring normal | 1 | 0.461 | 0.332 | 1.716 | 3.983 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Klebsiella infection | 1 | 0.474 | 0.332 | 1.716 | 3.982 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Thermometry | 1 | 0.475 | 0.332 | 1.716 | 3.982 | 0.407 | 0.989 | 2.104 | 2.105 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Nasal pruritus | 3 | 2.725 | 0.497 | 1.716 | 3.53 | 0.467 | 0.952 | 1.772 | 1.101 | 1.935 | 0.495
COVID19_PFIZER/BIONTECH | Sleep disorder due to a general medical condition | 1 | 0.461 | 0.332 | 1.715 | 3.979 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | CSF lactate dehydrogenase normal | 1 | 0.815 | 0.332 | 1.715 | 3.977 | 0.374 | 0.909 | 1.928 | 1.227 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Blood sodium abnormal | 1 | 0.474 | 0.332 | 1.714 | 3.976 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Stress | 18 | 13.686 | 1.115 | 1.714 | 2.418 | 0.839 | 1.216 | 1.716 | 1.315 | 1.491 | 2.234
COVID19_PFIZER/BIONTECH | Urine electrolytes normal | 1 | 0.941 | 0.309 | 1.714 | 4.049 | 0.363 | 0.883 | 1.872 | 1.063 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Plasma cell myeloma | 2 | 3.264 | 0.39 | 1.714 | 3.802 | 0.332 | 0.73 | 1.436 | 0.613 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Palindromic rheumatism | 1 | 0.354 | 0.177 | 1.713 | 4.573 | 0.42 | 1.022 | 2.182 | 2.824 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Iodine uptake decreased | 1 | 0.47 | 0.332 | 1.713 | 3.971 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Bronchial wall thickening | 1 | 0.474 | 0.27 | 1.713 | 4.181 | 0.407 | 0.989 | 2.105 | 2.111 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Globulins increased | 3 | 1.781 | 0.627 | 1.713 | 3.233 | 0.55 | 1.121 | 2.09 | 1.684 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Hypervolaemia | 1 | 0.511 | 0.285 | 1.713 | 4.132 | 0.403 | 0.979 | 2.083 | 1.956 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Ultrasound foetal | 1 | 1.844 | 0.205 | 1.713 | 4.441 | 0.298 | 0.732 | 1.557 | 0.542 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Open reduction of fracture | 1 | 0.461 | 0.333 | 1.712 | 3.969 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Sinonasal obstruction | 1 | 0.461 | 0.333 | 1.712 | 3.969 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Tinel's sign | 1 | 0.461 | 0.333 | 1.712 | 3.97 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Prothrombin time abnormal | 1 | 0.474 | 0.333 | 1.712 | 3.97 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Anaemia macrocytic | 1 | 0.954 | 0.309 | 1.712 | 4.046 | 0.362 | 0.88 | 1.867 | 1.049 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Exposure to extreme temperature | 1 | 0.375 | 0.333 | 1.711 | 3.965 | 0.418 | 1.016 | 2.168 | 2.668 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Biopsy thyroid gland normal | 1 | 0.461 | 0.333 | 1.711 | 3.965 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Alcohol interaction | 1 | 0.461 | 0.333 | 1.711 | 3.965 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hearing disability | 1 | 0.461 | 0.333 | 1.711 | 3.965 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Spinal cord injury cervical | 1 | 0.474 | 0.333 | 1.711 | 3.965 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Blood electrolytes normal | 10 | 6.168 | 0.972 | 1.71 | 2.617 | 0.828 | 1.333 | 2.057 | 1.621 | 0.946 | 0
COVID19_PFIZER/BIONTECH | Hypoaesthesia teeth | 1 | 0.48 | 0.333 | 1.71 | 3.963 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin decreased | 6 | 4.041 | 0.848 | 1.71 | 2.816 | 0.664 | 1.181 | 1.977 | 1.485 | 15.48 | 35.919
COVID19_PFIZER/BIONTECH | Neutrophil function test abnormal | 1 | 0.354 | 0.333 | 1.709 | 3.958 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Eyeglasses therapy | 1 | 0.47 | 0.333 | 1.709 | 3.96 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Periorbital pain | 2 | 1.277 | 0.536 | 1.709 | 3.419 | 0.471 | 1.031 | 2.03 | 1.566 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Computerised tomogram coronary artery normal | 1 | 0.354 | 0.333 | 1.708 | 3.956 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Intercepted product dispensing error | 1 | 0.5 | 0.333 | 1.708 | 3.954 | 0.404 | 0.982 | 2.089 | 2 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Allergy to synthetic fabric | 1 | 0.038 | 0.333 | 1.707 | 3.952 | 0.461 | 1.163 | 2.616 | 26.583 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Coccydynia | 2 | 1.118 | 0.582 | 1.707 | 3.311 | 0.487 | 1.067 | 2.102 | 1.789 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Ankle fracture | 2 | 1.244 | 0.55 | 1.707 | 3.38 | 0.474 | 1.038 | 2.044 | 1.608 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Escherichia bacteraemia | 1 | 0.954 | 0.31 | 1.707 | 4.026 | 0.362 | 0.88 | 1.867 | 1.049 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Periorbital oedema | 11 | 5.099 | 0.999 | 1.706 | 2.567 | 1.02 | 1.614 | 2.462 | 2.157 | 3.973 | 17.574
COVID19_PFIZER/BIONTECH | Pernicious anaemia | 1 | 0.354 | 0.234 | 1.706 | 4.301 | 0.42 | 1.022 | 2.182 | 2.824 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Nodal rhythm | 1 | 0.474 | 0.333 | 1.706 | 3.95 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hypovolaemic shock | 1 | 0.461 | 0.162 | 1.705 | 4.626 | 0.409 | 0.992 | 2.113 | 2.17 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Endoscopic ultrasound abnormal | 1 | 0.474 | 0.333 | 1.705 | 3.946 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Anaesthesia oral | 1 | 0.354 | 0.334 | 1.704 | 3.941 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pseudomonal bacteraemia | 1 | 0.461 | 0.334 | 1.704 | 3.941 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Instillation site paraesthesia | 1 | 0.461 | 0.334 | 1.704 | 3.941 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cystatin C increased | 1 | 0.475 | 0.334 | 1.703 | 3.938 | 0.407 | 0.989 | 2.104 | 2.105 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Complement factor C4 increased | 1 | 0.48 | 0.286 | 1.703 | 4.096 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Abdominal symptom | 1 | 0.501 | 0.334 | 1.703 | 3.938 | 0.404 | 0.982 | 2.089 | 1.997 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Self esteem decreased | 1 | 0.347 | 0.179 | 1.7 | 4.522 | 0.421 | 1.024 | 2.187 | 2.879 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Uterine contractions abnormal | 1 | 0.461 | 0.334 | 1.7 | 3.929 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Mediastinitis | 1 | 0.47 | 0.334 | 1.7 | 3.927 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Electrocardiogram ambulatory | 15 | 11.686 | 1.077 | 1.7 | 2.44 | 0.789 | 1.179 | 1.708 | 1.284 | 3.763 | 22.83
COVID19_PFIZER/BIONTECH | Ventricular tachyarrhythmias (SMQ) [broad] | 49 | 38.567 | 1.325 | 1.7 | 2.115 | 0.977 | 1.233 | 1.541 | 1.271 | 7.629 | 193.627
COVID19_PFIZER/BIONTECH | Ventricular tachyarrhythmias (SMQ) [narrow] | 49 | 38.567 | 1.325 | 1.7 | 2.115 | 0.977 | 1.233 | 1.541 | 1.271 | 7.629 | 193.627
COVID19_PFIZER/BIONTECH | Lymphocyte count abnormal | 1 | 0.472 | 0.287 | 1.699 | 4.082 | 0.407 | 0.99 | 2.106 | 2.119 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood heavy metal abnormal | 1 | 0.474 | 0.311 | 1.699 | 4 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hypoperfusion | 1 | 0.47 | 0.19 | 1.698 | 4.465 | 0.408 | 0.99 | 2.107 | 2.125 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Tension headache | 12 | 8.253 | 1.008 | 1.698 | 2.533 | 0.815 | 1.267 | 1.899 | 1.454 | 3.052 | 12.377
COVID19_PFIZER/BIONTECH | Belligerence | 1 | 0.947 | 0.311 | 1.698 | 3.998 | 0.363 | 0.881 | 1.869 | 1.056 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Creatinine renal clearance decreased | 1 | 0.1 | 0.287 | 1.697 | 4.076 | 0.452 | 1.117 | 2.445 | 9.993 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Gastrointestinal haemorrhage | 12 | 11.265 | 1.001 | 1.697 | 2.544 | 0.65 | 1.01 | 1.514 | 1.065 | 4.334 | 22.071
COVID19_PFIZER/BIONTECH | Sinusitis | 17 | 12.658 | 1.11 | 1.695 | 2.381 | 0.841 | 1.231 | 1.752 | 1.343 | 1.104 | 0.071
COVID19_PFIZER/BIONTECH | Breath sounds | 1 | 0.354 | 0.335 | 1.694 | 3.91 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Intra-abdominal haemorrhage | 1 | 0.462 | 0.335 | 1.694 | 3.91 | 0.408 | 0.992 | 2.112 | 2.163 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Retinal infarction | 1 | 0.47 | 0.335 | 1.694 | 3.91 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pulmonary calcification | 1 | 0.474 | 0.335 | 1.694 | 3.91 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Haemarthrosis | 1 | 0.474 | 0.335 | 1.694 | 3.91 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pneumonia klebsiella | 1 | 0.48 | 0.335 | 1.694 | 3.91 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cytokine release syndrome | 1 | 0.96 | 0.312 | 1.694 | 3.982 | 0.362 | 0.879 | 1.864 | 1.042 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Computerised tomogram thorax normal | 24 | 17.286 | 1.183 | 1.693 | 2.278 | 0.933 | 1.293 | 1.756 | 1.388 | 5.629 | 65.997
COVID19_PFIZER/BIONTECH | Blood pressure orthostatic increased | 1 | 0.354 | 0.335 | 1.69 | 3.895 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Progesterone | 1 | 0.461 | 0.335 | 1.69 | 3.895 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Irregular sleep phase | 1 | 0.474 | 0.335 | 1.69 | 3.895 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Masticatory pain | 1 | 0.48 | 0.335 | 1.69 | 3.895 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Illiteracy | 1 | 0.48 | 0.335 | 1.69 | 3.895 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Viral test negative | 22 | 14.626 | 1.162 | 1.689 | 2.297 | 0.977 | 1.372 | 1.885 | 1.504 | 0.853 | 0.398
COVID19_PFIZER/BIONTECH | Intra-aortic balloon placement | 1 | 0.47 | 0.336 | 1.688 | 3.887 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Right ventricular ejection fraction decreased | 1 | 0.47 | 0.336 | 1.688 | 3.888 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Protein albumin ratio normal | 1 | 0.474 | 0.336 | 1.688 | 3.888 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Functional lactation disorders (SMQ) [broad] | 9 | 6.754 | 0.92 | 1.688 | 2.644 | 0.707 | 1.161 | 1.82 | 1.333 | 6.252 | 25.523
COVID19_PFIZER/BIONTECH | Functional lactation disorders (SMQ) [narrow] | 9 | 6.754 | 0.92 | 1.688 | 2.644 | 0.707 | 1.161 | 1.82 | 1.333 | 6.252 | 25.523
COVID19_PFIZER/BIONTECH | Deafness neurosensory | 15 | 12.513 | 1.06 | 1.688 | 2.435 | 0.748 | 1.118 | 1.62 | 1.199 | 2.419 | 9.731
COVID19_PFIZER/BIONTECH | Wound infection | 1 | 0.375 | 0.225 | 1.686 | 4.277 | 0.418 | 1.016 | 2.168 | 2.668 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Ceruloplasmin normal | 1 | 0.461 | 0.289 | 1.685 | 4.032 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Arteriosclerosis coronary artery | 3 | 2.019 | 0.546 | 1.685 | 3.33 | 0.526 | 1.073 | 1.998 | 1.486 | 7.74 | 7.849
COVID19_PFIZER/BIONTECH | Overgrowth fungal | 1 | 0.461 | 0.336 | 1.684 | 3.875 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Self-medication | 1 | 0.461 | 0.336 | 1.684 | 3.874 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Surgical procedure repeated | 1 | 0.499 | 0.336 | 1.684 | 3.874 | 0.405 | 0.983 | 2.09 | 2.006 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cor pulmonale | 1 | 0.526 | 0.336 | 1.684 | 3.874 | 0.402 | 0.976 | 2.075 | 1.901 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pulmonary hypertension | 4 | 2.845 | 0.712 | 1.683 | 2.989 | 0.565 | 1.09 | 1.945 | 1.406 | 3.612 | 4.209
COVID19_PFIZER/BIONTECH | Glycosylated haemoglobin increased | 5 | 3.831 | 0.768 | 1.683 | 2.886 | 0.585 | 1.08 | 1.86 | 1.305 | 1.881 | 1.122
COVID19_PFIZER/BIONTECH | Shortened cervix | 1 | 0.461 | 0.337 | 1.682 | 3.867 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Fat tissue increased | 1 | 0.506 | 0.337 | 1.682 | 3.867 | 0.404 | 0.981 | 2.086 | 1.975 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Ovarian neoplasms, malignant and unspecified (SMQ) [broad] | 2 | 1.469 | 0.47 | 1.682 | 3.501 | 0.453 | 0.991 | 1.95 | 1.362 | 1.72 | 0.075
COVID19_PFIZER/BIONTECH | Tachycardia foetal | 1 | 0.705 | 0.337 | 1.682 | 3.868 | 0.384 | 0.933 | 1.98 | 1.419 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pulmonary sarcoidosis | 1 | 0.026 | 0.337 | 1.681 | 3.865 | 0.463 | 1.174 | 2.668 | 37.747 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Tracheal aspiration procedure | 1 | 0.461 | 0.211 | 1.679 | 4.313 | 0.409 | 0.992 | 2.113 | 2.17 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Libido decreased | 1 | 0.48 | 0.29 | 1.679 | 4.013 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Frequent bowel movements | 11 | 6.804 | 0.976 | 1.677 | 2.532 | 0.852 | 1.347 | 2.048 | 1.617 | 1.37 | 0.692
COVID19_PFIZER/BIONTECH | Lactation disorder | 1 | 0.708 | 0.29 | 1.677 | 4.004 | 0.384 | 0.932 | 1.979 | 1.412 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood glucose decreased | 21 | 14.235 | 1.154 | 1.676 | 2.277 | 0.952 | 1.346 | 1.861 | 1.475 | 1.878 | 6.99
COVID19_PFIZER/BIONTECH | Intraventricular haemorrhage | 1 | 1.045 | 0.183 | 1.676 | 4.427 | 0.354 | 0.862 | 1.829 | 0.957 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Intentional product use issue | 1 | 1.054 | 0.239 | 1.676 | 4.191 | 0.354 | 0.861 | 1.825 | 0.949 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Gynaecological examination abnormal | 1 | 0.923 | 0.265 | 1.675 | 4.089 | 0.365 | 0.886 | 1.88 | 1.083 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Upper-airway cough syndrome | 26 | 14.954 | 1.195 | 1.674 | 2.218 | 1.142 | 1.564 | 2.102 | 1.739 | 4.791 | 58.548
COVID19_PFIZER/BIONTECH | Sports injury | 1 | 0.47 | 0.338 | 1.673 | 3.839 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pleuritic pain | 13 | 9.446 | 1.015 | 1.673 | 2.465 | 0.801 | 1.228 | 1.818 | 1.376 | 5.217 | 31.023
COVID19_PFIZER/BIONTECH | Pulmonary resection | 1 | 0.461 | 0.338 | 1.672 | 3.836 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Band sensation | 1 | 0.461 | 0.338 | 1.672 | 3.835 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | VIIIth nerve injury | 1 | 0.47 | 0.338 | 1.672 | 3.836 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Aortic valve stenosis | 1 | 0.474 | 0.338 | 1.672 | 3.836 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Spinal nerve stimulator implantation | 1 | 0.743 | 0.338 | 1.672 | 3.836 | 0.381 | 0.924 | 1.961 | 1.345 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Plantar erythema | 1 | 0.48 | 0.338 | 1.67 | 3.827 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hepatomegaly | 2 | 1.013 | 0.412 | 1.668 | 3.611 | 0.498 | 1.092 | 2.154 | 1.974 | 0.657 | 0.085
COVID19_PFIZER/BIONTECH | Computerised tomogram thorax abnormal | 32 | 29.016 | 1.223 | 1.668 | 2.171 | 0.807 | 1.074 | 1.406 | 1.103 | 3.302 | 41.422
COVID19_PFIZER/BIONTECH | pH body fluid | 1 | 0.922 | 0.195 | 1.668 | 4.347 | 0.365 | 0.887 | 1.88 | 1.085 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Blood urea increased | 42 | 35.3 | 1.275 | 1.667 | 2.102 | 0.9 | 1.157 | 1.469 | 1.19 | 4.436 | 86.9
COVID19_PFIZER/BIONTECH | Comminuted fracture | 1 | 0.038 | 0.339 | 1.666 | 3.814 | 0.461 | 1.163 | 2.616 | 26.583 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Spinal osteoarthritis | 3 | 2.498 | 0.568 | 1.666 | 3.232 | 0.485 | 0.988 | 1.838 | 1.201 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Chronic obstructive pulmonary disease | 10 | 11.096 | 0.913 | 1.666 | 2.603 | 0.551 | 0.886 | 1.366 | 0.901 | 0.951 | 0
COVID19_PFIZER/BIONTECH | Vitreous detachment | 2 | 3.311 | 0.428 | 1.666 | 3.561 | 0.329 | 0.725 | 1.426 | 0.604 | 2.125 | 0.268
COVID19_PFIZER/BIONTECH | Culture tissue specimen negative | 1 | 0.461 | 0.214 | 1.663 | 4.252 | 0.409 | 0.992 | 2.113 | 2.17 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Mean cell volume increased | 7 | 5.221 | 0.872 | 1.663 | 2.661 | 0.659 | 1.136 | 1.854 | 1.341 | 3.951 | 10.233
COVID19_PFIZER/BIONTECH | Physical examination | 9 | 5.856 | 0.945 | 1.662 | 2.542 | 0.774 | 1.271 | 1.994 | 1.537 | 18.06 | 63.8
COVID19_PFIZER/BIONTECH | Hypomagnesaemia | 3 | 2.877 | 0.522 | 1.662 | 3.324 | 0.456 | 0.93 | 1.73 | 1.043 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Dissociation | 4 | 1.598 | 0.645 | 1.661 | 3.06 | 0.702 | 1.357 | 2.443 | 2.503 | 4.515 | 6.041
COVID19_PFIZER/BIONTECH | Abnormal dreams | 10 | 7.167 | 0.921 | 1.661 | 2.577 | 0.752 | 1.209 | 1.865 | 1.395 | 2.315 | 5.452
COVID19_PFIZER/BIONTECH | Renal impairment | 7 | 5.419 | 0.876 | 1.661 | 2.649 | 0.644 | 1.111 | 1.813 | 1.292 | 1.264 | 0.148
COVID19_PFIZER/BIONTECH | Thrombophlebitis superficial | 1 | 0.461 | 0.34 | 1.66 | 3.793 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Biliary malignant tumours (SMQ) [broad] | 1 | 0.474 | 0.34 | 1.66 | 3.793 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Blood bilirubin unconjugated | 1 | 0.474 | 0.34 | 1.66 | 3.793 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cerebral microhaemorrhage | 1 | 0.474 | 0.34 | 1.66 | 3.793 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Biliary malignant tumours (SMQ) [narrow] | 1 | 0.474 | 0.34 | 1.66 | 3.793 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Cholangiocarcinoma | 1 | 0.474 | 0.34 | 1.66 | 3.793 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Urine osmolarity normal | 1 | 0.48 | 0.34 | 1.66 | 3.793 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Lung carcinoma cell type unspecified stage IV | 1 | 0.506 | 0.34 | 1.66 | 3.795 | 0.404 | 0.981 | 2.086 | 1.975 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Serum ferritin | 4 | 2.634 | 0.732 | 1.66 | 2.892 | 0.585 | 1.127 | 2.012 | 1.519 | 4.816 | 6.634
COVID19_PFIZER/BIONTECH | Coccidioidomycosis | 1 | 0.781 | 0.34 | 1.66 | 3.793 | 0.377 | 0.916 | 1.944 | 1.28 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Analgesic drug level decreased | 1 | 0.461 | 0.34 | 1.659 | 3.791 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Stenotrophomonas infection | 1 | 0.474 | 0.34 | 1.659 | 3.791 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Lower urinary tract symptoms | 1 | 0.5 | 0.34 | 1.659 | 3.791 | 0.404 | 0.982 | 2.089 | 1.999 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Tricuspid valve incompetence | 6 | 4.008 | 0.81 | 1.656 | 2.744 | 0.667 | 1.186 | 1.986 | 1.497 | 6.02 | 15.075
COVID19_PFIZER/BIONTECH | Cardiac disorder | 19 | 16.493 | 1.109 | 1.656 | 2.294 | 0.763 | 1.096 | 1.535 | 1.152 | 2.619 | 15.16
COVID19_PFIZER/BIONTECH | Blood phosphorus increased | 3 | 1.408 | 0.617 | 1.655 | 3.098 | 0.591 | 1.206 | 2.256 | 2.13 | 2.356 | 0.998
COVID19_PFIZER/BIONTECH | Biopsy heart abnormal | 1 | 0.48 | 0.34 | 1.655 | 3.776 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Catheterisation venous | 1 | 0.954 | 0.317 | 1.655 | 3.849 | 0.362 | 0.88 | 1.867 | 1.049 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Inner ear disorder | 2 | 0.967 | 0.557 | 1.653 | 3.221 | 0.503 | 1.103 | 2.178 | 2.067 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Diabetic complication | 1 | 0.693 | 0.341 | 1.653 | 3.771 | 0.385 | 0.936 | 1.986 | 1.442 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Mean platelet volume | 2 | 0.989 | 0.538 | 1.652 | 3.26 | 0.501 | 1.098 | 2.167 | 2.023 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Amniotic fluid volume decreased | 1 | 0.461 | 0.318 | 1.652 | 3.838 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pituitary-dependent Cushing's syndrome | 1 | 0.461 | 0.294 | 1.651 | 3.913 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Platelet count abnormal | 2 | 1.26 | 0.565 | 1.651 | 3.198 | 0.472 | 1.035 | 2.037 | 1.587 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Intraosseous access placement | 1 | 0.95 | 0.318 | 1.651 | 3.835 | 0.362 | 0.881 | 1.868 | 1.052 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Oral contusion | 2 | 1.333 | 0.482 | 1.648 | 3.379 | 0.465 | 1.019 | 2.006 | 1.501 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Hyperreflexia | 5 | 3.586 | 0.734 | 1.648 | 2.858 | 0.605 | 1.117 | 1.924 | 1.394 | 1.254 | 0.055
COVID19_PFIZER/BIONTECH | Angiogram | 48 | 39.773 | 1.283 | 1.648 | 2.051 | 0.929 | 1.176 | 1.472 | 1.207 | 6.192 | 151.646
COVID19_PFIZER/BIONTECH | Mycobacterium test | 1 | 0.828 | 0.204 | 1.648 | 4.245 | 0.373 | 0.906 | 1.922 | 1.208 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Abdominal pain lower | 28 | 18.49 | 1.184 | 1.646 | 2.171 | 1.036 | 1.404 | 1.869 | 1.514 | 3.349 | 36.87
COVID19_PFIZER/BIONTECH | Nitrite urine | 1 | 0.47 | 0.342 | 1.645 | 3.743 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Aortic aneurysm | 2 | 2.174 | 0.442 | 1.645 | 3.468 | 0.396 | 0.869 | 1.708 | 0.92 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Visceral pain | 1 | 0.461 | 0.319 | 1.644 | 3.81 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pleurodesis | 1 | 0.461 | 0.342 | 1.643 | 3.736 | 0.409 | 0.992 | 2.113 | 2.17 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Prealbumin | 1 | 0.48 | 0.271 | 1.642 | 3.968 | 0.407 | 0.987 | 2.101 | 2.084 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Lyme disease | 1 | 0.562 | 0.236 | 1.642 | 4.097 | 0.398 | 0.967 | 2.054 | 1.779 | 0.323 | 0.784
COVID19_PFIZER/BIONTECH | Hypoxia | 74 | 63.836 | 1.346 | 1.642 | 1.961 | 0.944 | 1.142 | 1.372 | 1.159 | 8.512 | 328.302
COVID19_PFIZER/BIONTECH | Lung infiltration | 22 | 21.782 | 1.124 | 1.64 | 2.236 | 0.702 | 0.986 | 1.353 | 1.01 | 4.73 | 48.224
COVID19_PFIZER/BIONTECH | Antineutrophil cytoplasmic antibody positive | 1 | 0.474 | 0.235 | 1.638 | 4.088 | 0.407 | 0.989 | 2.105 | 2.111 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Neutrophil count normal | 15 | 10.083 | 1.032 | 1.638 | 2.359 | 0.881 | 1.317 | 1.909 | 1.488 | 1.396 | 1.203
COVID19_PFIZER/BIONTECH | Tri-iodothyronine | 1 | 0.828 | 0.186 | 1.637 | 4.291 | 0.373 | 0.906 | 1.922 | 1.208 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Glucose-6-phosphate dehydrogenase abnormal | 1 | 0.461 | 0.321 | 1.636 | 3.782 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Aspergillus test | 1 | 1.167 | 0.321 | 1.636 | 3.783 | 0.345 | 0.84 | 1.781 | 0.857 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Post vaccination syndrome | 1 | 0.355 | 0.134 | 1.635 | 4.553 | 0.42 | 1.022 | 2.181 | 2.815 | 0.12 | 5.55
COVID19_PFIZER/BIONTECH | Skin oedema | 1 | 0.463 | 0.285 | 1.634 | 3.891 | 0.408 | 0.992 | 2.112 | 2.162 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Withdrawal syndrome | 1 | 0.48 | 0.343 | 1.634 | 3.709 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Polyuria | 6 | 4.125 | 0.824 | 1.634 | 2.667 | 0.657 | 1.168 | 1.955 | 1.455 | 2.643 | 3.941
COVID19_PFIZER/BIONTECH | Intra-uterine contraceptive device removal | 1 | 0.815 | 0.343 | 1.634 | 3.709 | 0.374 | 0.909 | 1.928 | 1.227 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Troponin normal | 53 | 38.104 | 1.289 | 1.633 | 2.009 | 1.073 | 1.343 | 1.664 | 1.391 | 9.116 | 248.957
COVID19_PFIZER/BIONTECH | Hepatic encephalopathy | 1 | 0.461 | 0.321 | 1.632 | 3.769 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lipoprotein (a) | 1 | 0.47 | 0.344 | 1.632 | 3.7 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Hypervigilance | 1 | 0.354 | 0.344 | 1.631 | 3.698 | 0.42 | 1.022 | 2.182 | 2.824 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pulmonary imaging procedure abnormal | 1 | 0.474 | 0.344 | 1.631 | 3.698 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Blast cell crisis | 1 | 0.474 | 0.344 | 1.631 | 3.696 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Vascular graft | 1 | 0.474 | 0.344 | 1.631 | 3.698 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Thoracic vertebral fracture | 1 | 0.48 | 0.344 | 1.631 | 3.698 | 0.407 | 0.987 | 2.101 | 2.084 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Large intestinal obstruction | 1 | 0.518 | 0.344 | 1.631 | 3.698 | 0.403 | 0.978 | 2.079 | 1.932 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Peripheral embolism | 1 | 0.526 | 0.344 | 1.631 | 3.698 | 0.402 | 0.976 | 2.075 | 1.901 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Computerised tomogram pancreas abnormal | 1 | 0.62 | 0.344 | 1.631 | 3.698 | 0.392 | 0.953 | 2.023 | 1.614 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pelvic girdle pain | 1 | 0.62 | 0.344 | 1.631 | 3.698 | 0.392 | 0.953 | 2.023 | 1.614 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Glucose urine present | 2 | 0.954 | 0.571 | 1.63 | 3.13 | 0.505 | 1.107 | 2.185 | 2.097 | 1.389 | 0.001
COVID19_PFIZER/BIONTECH | Tongue pruritus | 40 | 23.393 | 1.238 | 1.629 | 2.064 | 1.232 | 1.594 | 2.034 | 1.71 | 14.448 | 270.405
COVID19_PFIZER/BIONTECH | Visual field tests | 5 | 2.835 | 0.775 | 1.629 | 2.737 | 0.676 | 1.248 | 2.153 | 1.764 | 6.946 | 14.129
COVID19_PFIZER/BIONTECH | Pupillary light reflex tests | 1 | 0.461 | 0.322 | 1.629 | 3.759 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Synovial fluid analysis | 1 | 0.474 | 0.344 | 1.629 | 3.692 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Retinal vascular occlusion | 1 | 0.95 | 0.322 | 1.628 | 3.755 | 0.362 | 0.881 | 1.868 | 1.052 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hyponatraemia/SIADH (SMQ) [narrow] | 35 | 28.945 | 1.214 | 1.627 | 2.09 | 0.888 | 1.168 | 1.513 | 1.209 | 2.376 | 23.41
COVID19_PFIZER/BIONTECH | Therapeutic embolisation | 1 | 0.935 | 0.322 | 1.626 | 3.748 | 0.364 | 0.884 | 1.875 | 1.07 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Aneurysm ruptured | 1 | 0.95 | 0.322 | 1.626 | 3.748 | 0.362 | 0.881 | 1.868 | 1.052 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lacunar stroke | 1 | 0.987 | 0.322 | 1.626 | 3.748 | 0.359 | 0.874 | 1.853 | 1.013 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Myocardial strain | 1 | 1.21 | 0.322 | 1.626 | 3.748 | 0.342 | 0.832 | 1.765 | 0.827 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Nail bed disorder | 1 | 0.4 | 0.345 | 1.625 | 3.677 | 0.415 | 1.009 | 2.151 | 2.499 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Pulmonary embolism | 64 | 56.979 | 1.309 | 1.625 | 1.969 | 0.901 | 1.106 | 1.346 | 1.123 | 10.051 | 329.185
COVID19_PFIZER/BIONTECH | Mycoplasma test positive | 1 | 0.463 | 0.195 | 1.624 | 4.21 | 0.408 | 0.992 | 2.111 | 2.158 | 0.306 | 0.911
COVID19_PFIZER/BIONTECH | Fungal test | 1 | 0.989 | 0.201 | 1.624 | 4.182 | 0.359 | 0.873 | 1.852 | 1.012 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Paraneoplastic syndrome | 1 | 0.47 | 0.323 | 1.622 | 3.737 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Ultrasound eye normal | 1 | 0.474 | 0.323 | 1.622 | 3.734 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Protein total decreased | 5 | 3.831 | 0.701 | 1.622 | 2.852 | 0.585 | 1.08 | 1.86 | 1.305 | 0.877 | 0.005
COVID19_PFIZER/BIONTECH | Sleep paralysis | 1 | 0.354 | 0.161 | 1.621 | 4.363 | 0.42 | 1.022 | 2.182 | 2.824 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Herpes simplex encephalitis | 3 | 2.036 | 0.613 | 1.621 | 3.018 | 0.525 | 1.069 | 1.992 | 1.474 | 4.168 | 3.467
COVID19_PFIZER/BIONTECH | Hyponatraemia | 11 | 9.664 | 0.942 | 1.621 | 2.451 | 0.669 | 1.057 | 1.605 | 1.138 | 2.685 | 8.637
COVID19_PFIZER/BIONTECH | Device breakage | 1 | 0.461 | 0.323 | 1.62 | 3.729 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Neutrophil toxic granulation present | 1 | 0.474 | 0.346 | 1.62 | 3.661 | 0.407 | 0.989 | 2.105 | 2.111 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Red blood cell burr cells present | 1 | 0.475 | 0.346 | 1.62 | 3.661 | 0.407 | 0.989 | 2.104 | 2.105 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Renal replacement therapy | 1 | 0.497 | 0.323 | 1.62 | 3.729 | 0.405 | 0.983 | 2.091 | 2.012 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Bile duct stone | 1 | 0.47 | 0.346 | 1.619 | 3.657 | 0.408 | 0.99 | 2.107 | 2.125 | 18.06 | 1.57
COVID19_PFIZER/BIONTECH | Thyroxine free abnormal | 1 | 0.461 | 0.323 | 1.618 | 3.723 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Eosinophil count normal | 14 | 9.325 | 1.01 | 1.617 | 2.339 | 0.87 | 1.317 | 1.928 | 1.501 | 1.6 | 2.344
COVID19_PFIZER/BIONTECH | Lip oedema | 5 | 3.575 | 0.766 | 1.616 | 2.722 | 0.606 | 1.118 | 1.927 | 1.399 | 2.052 | 1.528
COVID19_PFIZER/BIONTECH | Immune system disorder | 7 | 5.876 | 0.819 | 1.616 | 2.631 | 0.613 | 1.057 | 1.726 | 1.191 | 0.504 | 2.843
COVID19_PFIZER/BIONTECH | Sudden cardiac death | 3 | 3.071 | 0.524 | 1.616 | 3.193 | 0.443 | 0.903 | 1.679 | 0.977 | 9.03 | 9.191
COVID19_PFIZER/BIONTECH | Lip pruritus | 25 | 14.655 | 1.149 | 1.615 | 2.145 | 1.114 | 1.535 | 2.073 | 1.706 | 7.785 | 98.38
COVID19_PFIZER/BIONTECH | Retinal ischaemia | 1 | 0.48 | 0.324 | 1.615 | 3.711 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Rectal examination abnormal | 1 | 0.529 | 0.275 | 1.615 | 3.871 | 0.401 | 0.975 | 2.073 | 1.891 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Oedema mouth | 3 | 1.952 | 0.548 | 1.615 | 3.139 | 0.533 | 1.086 | 2.023 | 1.537 | 7.74 | 7.849
COVID19_PFIZER/BIONTECH | Haematopoietic erythropenia (SMQ) [narrow] | 26 | 20.299 | 1.141 | 1.615 | 2.157 | 0.886 | 1.214 | 1.631 | 1.281 | 1.901 | 9.212
COVID19_PFIZER/BIONTECH | Fasting | 1 | 0.354 | 0.324 | 1.613 | 3.703 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Migraine without aura | 1 | 0.354 | 0.324 | 1.612 | 3.703 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Freezing phenomenon | 1 | 0.461 | 0.324 | 1.612 | 3.703 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Uterine inflammation | 1 | 0.461 | 0.324 | 1.612 | 3.703 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Foetal non-stress test abnormal | 1 | 0.461 | 0.325 | 1.612 | 3.701 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hunger | 6 | 3.665 | 0.762 | 1.612 | 2.717 | 0.698 | 1.242 | 2.081 | 1.637 | 2.306 | 2.807
COVID19_PFIZER/BIONTECH | Electromyogram normal | 5 | 3.83 | 0.702 | 1.612 | 2.825 | 0.586 | 1.08 | 1.86 | 1.305 | 0.778 | 0.12
COVID19_PFIZER/BIONTECH | Arrhythmia supraventricular | 1 | 0.772 | 0.325 | 1.612 | 3.701 | 0.378 | 0.918 | 1.948 | 1.295 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Carpal tunnel syndrome | 3 | 2.902 | 0.58 | 1.612 | 3.063 | 0.455 | 0.926 | 1.723 | 1.034 | 1.389 | 0.042
COVID19_PFIZER/BIONTECH | Thrombophlebitis (SMQ) [narrow] | 6 | 2.711 | 0.773 | 1.611 | 2.694 | 0.804 | 1.433 | 2.411 | 2.213 | 9.851 | 25.127
COVID19_PFIZER/BIONTECH | Bacteriuria | 1 | 0.474 | 0.301 | 1.611 | 3.772 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Ventricular fibrillation | 17 | 10.926 | 1.051 | 1.611 | 2.268 | 0.942 | 1.378 | 1.961 | 1.556 | 15.351 | 115.246
COVID19_PFIZER/BIONTECH | Pharyngeal hypoaesthesia | 31 | 20.287 | 1.178 | 1.611 | 2.101 | 1.066 | 1.424 | 1.872 | 1.528 | 10.978 | 168.404
COVID19_PFIZER/BIONTECH | Hypercapnia | 1 | 0.931 | 0.301 | 1.61 | 3.769 | 0.364 | 0.885 | 1.876 | 1.074 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Biliary obstruction | 1 | 0.48 | 0.325 | 1.609 | 3.691 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Adjusted calcium | 1 | 0.511 | 0.224 | 1.609 | 4.042 | 0.403 | 0.979 | 2.083 | 1.956 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Uterine and fallopian tube tumours of unspecified malignancy (SMQ) [broad] | 1 | 0.609 | 0.11 | 1.609 | 4.617 | 0.393 | 0.955 | 2.029 | 1.642 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Nasal odour | 1 | 0.48 | 0.325 | 1.607 | 3.683 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Dyspnoea exertional | 39 | 30.985 | 1.212 | 1.607 | 2.049 | 0.937 | 1.215 | 1.555 | 1.259 | 6.708 | 133.823
COVID19_PFIZER/BIONTECH | Bronchial secretion retention | 1 | 0.461 | 0.326 | 1.606 | 3.68 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pancytopenia | 10 | 9.527 | 0.922 | 1.606 | 2.443 | 0.617 | 0.992 | 1.529 | 1.05 | 4.3 | 17.742
COVID19_PFIZER/BIONTECH | Extrasystoles | 13 | 6.95 | 1.004 | 1.605 | 2.319 | 0.99 | 1.519 | 2.252 | 1.87 | 6.178 | 38.074
COVID19_PFIZER/BIONTECH | Hand dermatitis | 1 | 0.354 | 0.326 | 1.605 | 3.676 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Tri-iodothyronine free abnormal | 1 | 0.461 | 0.326 | 1.605 | 3.676 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pleural effusion | 31 | 25.439 | 1.167 | 1.605 | 2.101 | 0.877 | 1.171 | 1.539 | 1.219 | 3.612 | 46.551
COVID19_PFIZER/BIONTECH | Chorioretinopathy | 1 | 0.497 | 0.326 | 1.604 | 3.675 | 0.405 | 0.983 | 2.091 | 2.012 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Forced expiratory volume | 1 | 0.654 | 0.138 | 1.604 | 4.429 | 0.389 | 0.945 | 2.006 | 1.529 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Vitamin B12 increased | 2 | 0.954 | 0.477 | 1.603 | 3.267 | 0.505 | 1.107 | 2.185 | 2.097 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Cerebral thrombosis | 1 | 0.48 | 0.326 | 1.603 | 3.671 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Ultrasound pelvis | 1 | 1.383 | 0.219 | 1.603 | 4.046 | 0.329 | 0.802 | 1.702 | 0.723 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Histamine level increased | 1 | 0.354 | 0.326 | 1.602 | 3.666 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Bladder pain | 2 | 1.303 | 0.493 | 1.602 | 3.228 | 0.468 | 1.026 | 2.018 | 1.535 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Circulatory collapse | 9 | 7.867 | 0.862 | 1.602 | 2.527 | 0.639 | 1.048 | 1.643 | 1.144 | 0.742 | 0.535
COVID19_PFIZER/BIONTECH | Hospice care | 5 | 2.994 | 0.769 | 1.601 | 2.678 | 0.66 | 1.217 | 2.1 | 1.67 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | Sjogren's syndrome | 2 | 1.465 | 0.378 | 1.601 | 3.513 | 0.453 | 0.992 | 1.952 | 1.366 | 0.592 | 0.207
COVID19_PFIZER/BIONTECH | Viral test | 10 | 7.172 | 0.933 | 1.6 | 2.413 | 0.751 | 1.209 | 1.864 | 1.394 | 1.411 | 0.745
COVID19_PFIZER/BIONTECH | Uterine haemorrhage | 2 | 1.791 | 0.42 | 1.6 | 3.401 | 0.425 | 0.932 | 1.831 | 1.117 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Phalen's test positive | 1 | 0.461 | 0.327 | 1.597 | 3.649 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Troponin | 61 | 50.022 | 1.279 | 1.597 | 1.943 | 0.968 | 1.194 | 1.459 | 1.219 | 9.336 | 293.694
COVID19_PFIZER/BIONTECH | Hormone level abnormal | 1 | 2.038 | 0.14 | 1.597 | 4.395 | 0.287 | 0.705 | 1.503 | 0.491 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Culture wound | 1 | 0.462 | 0.296 | 1.596 | 3.744 | 0.408 | 0.992 | 2.112 | 2.164 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Mesenteric vein thrombosis | 1 | 0.525 | 0.327 | 1.596 | 3.647 | 0.402 | 0.976 | 2.075 | 1.906 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Asthenopia | 15 | 10.911 | 1.002 | 1.596 | 2.301 | 0.831 | 1.242 | 1.799 | 1.375 | 5.312 | 37.136
COVID19_PFIZER/BIONTECH | Other ischaemic heart disease (SMQ) [broad] | 71 | 55.156 | 1.301 | 1.596 | 1.917 | 1.037 | 1.26 | 1.519 | 1.287 | 5.599 | 201.245
COVID19_PFIZER/BIONTECH | Scrotal pain | 2 | 0.531 | 0.458 | 1.595 | 3.29 | 0.558 | 1.232 | 2.47 | 3.765 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Ultrasound Doppler | 34 | 29.559 | 1.179 | 1.595 | 2.062 | 0.846 | 1.116 | 1.451 | 1.15 | 4.76 | 76.847
COVID19_PFIZER/BIONTECH | Blood parathyroid hormone increased | 1 | 0.825 | 0.304 | 1.595 | 3.715 | 0.373 | 0.907 | 1.923 | 1.213 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Bilirubin conjugated | 2 | 1.888 | 0.377 | 1.595 | 3.499 | 0.417 | 0.915 | 1.798 | 1.059 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Pyuria | 1 | 0.961 | 0.304 | 1.595 | 3.717 | 0.361 | 0.879 | 1.864 | 1.041 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Megacolon | 1 | 0.475 | 0.328 | 1.594 | 3.639 | 0.407 | 0.989 | 2.104 | 2.105 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Raynaud's phenomenon | 3 | 2.006 | 0.505 | 1.594 | 3.179 | 0.528 | 1.075 | 2.003 | 1.495 | 0.797 | 0.014
COVID19_PFIZER/BIONTECH | Menopause | 1 | 0.461 | 0.28 | 1.593 | 3.791 | 0.409 | 0.992 | 2.113 | 2.17 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Stiff person syndrome | 1 | 0.601 | 0.144 | 1.593 | 4.362 | 0.394 | 0.957 | 2.033 | 1.663 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Unevaluable event | 142 | 96.325 | 1.381 | 1.592 | 1.816 | 1.264 | 1.451 | 1.66 | 1.474 | 2.338 | 95.348
COVID19_PFIZER/BIONTECH | Coronary artery dissection | 1 | 0.47 | 0.305 | 1.591 | 3.701 | 0.408 | 0.99 | 2.107 | 2.125 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Menstruation normal | 1 | 0.354 | 0.328 | 1.59 | 3.625 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Renal haemorrhage | 1 | 0.474 | 0.329 | 1.59 | 3.625 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Cerebral small vessel ischaemic disease | 6 | 4.702 | 0.801 | 1.59 | 2.597 | 0.611 | 1.087 | 1.818 | 1.276 | 18.06 | 39.765
COVID19_PFIZER/BIONTECH | Stress echocardiogram normal | 1 | 0.922 | 0.305 | 1.589 | 3.694 | 0.365 | 0.887 | 1.88 | 1.085 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Iris adhesions | 1 | 0.354 | 0.329 | 1.588 | 3.617 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Goitre | 3 | 2.199 | 0.53 | 1.588 | 3.105 | 0.51 | 1.039 | 1.935 | 1.364 | 2.356 | 0.998
COVID19_PFIZER/BIONTECH | Sputum increased | 1 | 1.098 | 0.161 | 1.588 | 4.253 | 0.35 | 0.852 | 1.808 | 0.911 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Breakthrough pain | 1 | 0.825 | 0.329 | 1.587 | 3.614 | 0.373 | 0.907 | 1.923 | 1.213 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging thoracic abnormal | 3 | 2.425 | 0.608 | 1.586 | 2.938 | 0.491 | 1 | 1.861 | 1.237 | 3.01 | 1.873
COVID19_PFIZER/BIONTECH | Blood lactic acid increased | 25 | 22.105 | 1.122 | 1.586 | 2.115 | 0.791 | 1.09 | 1.471 | 1.131 | 3.612 | 37.104
COVID19_PFIZER/BIONTECH | Xanthopsia | 1 | 0.743 | 0.33 | 1.584 | 3.603 | 0.381 | 0.924 | 1.961 | 1.345 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood bilirubin decreased | 4 | 3.383 | 0.68 | 1.584 | 2.795 | 0.522 | 1.006 | 1.793 | 1.182 | 1.416 | 0.138
COVID19_PFIZER/BIONTECH | Tachyarrhythmia terms, nonspecific (SMQ) [narrow] | 35 | 22.809 | 1.194 | 1.583 | 2.017 | 1.095 | 1.439 | 1.865 | 1.534 | 6.45 | 114.607
COVID19_PFIZER/BIONTECH | Tachyarrhythmia terms, nonspecific (SMQ) [broad] | 35 | 22.809 | 1.194 | 1.583 | 2.017 | 1.095 | 1.439 | 1.865 | 1.534 | 6.45 | 114.607
COVID19_PFIZER/BIONTECH | Conduction defects (SMQ) [broad] | 21 | 18.927 | 1.077 | 1.582 | 2.165 | 0.754 | 1.066 | 1.473 | 1.11 | 3.718 | 32.28
COVID19_PFIZER/BIONTECH | Conduction defects (SMQ) [narrow] | 21 | 18.927 | 1.077 | 1.582 | 2.165 | 0.754 | 1.066 | 1.473 | 1.11 | 3.718 | 32.28
COVID19_PFIZER/BIONTECH | Biopsy colon | 1 | 0.461 | 0.33 | 1.581 | 3.594 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Gastric ulcer haemorrhage | 1 | 0.474 | 0.33 | 1.581 | 3.594 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lip blister | 12 | 7.9 | 0.962 | 1.581 | 2.326 | 0.84 | 1.306 | 1.958 | 1.519 | 2.33 | 6.878
COVID19_PFIZER/BIONTECH | Emotional distress | 23 | 15.641 | 1.101 | 1.58 | 2.129 | 0.969 | 1.352 | 1.846 | 1.47 | 0.734 | 1.875
COVID19_PFIZER/BIONTECH | Blister infected | 1 | 0.825 | 0.282 | 1.58 | 3.741 | 0.373 | 0.907 | 1.923 | 1.213 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Substance use | 1 | 1.047 | 0.331 | 1.579 | 3.585 | 0.354 | 0.862 | 1.828 | 0.955 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Inflammatory pain | 1 | 0.48 | 0.331 | 1.578 | 3.584 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Hysteroscopy | 1 | 0.354 | 0.331 | 1.577 | 3.579 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Urge incontinence | 1 | 0.461 | 0.331 | 1.577 | 3.581 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Ulnar neuritis | 1 | 0.47 | 0.331 | 1.577 | 3.578 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Gastrointestinal haemorrhage (SMQ) [narrow] | 63 | 56.34 | 1.268 | 1.577 | 1.913 | 0.896 | 1.101 | 1.342 | 1.118 | 0.7 | 7.522
COVID19_PFIZER/BIONTECH | Gastrointestinal haemorrhage (SMQ) [broad] | 63 | 56.34 | 1.268 | 1.577 | 1.913 | 0.896 | 1.101 | 1.342 | 1.118 | 0.7 | 7.522
COVID19_PFIZER/BIONTECH | Blood testosterone | 1 | 0.47 | 0.331 | 1.575 | 3.572 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Abdominal injury | 1 | 0.474 | 0.331 | 1.575 | 3.572 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Lipids increased | 1 | 0.497 | 0.331 | 1.575 | 3.572 | 0.405 | 0.983 | 2.091 | 2.012 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood iron | 3 | 1.432 | 0.623 | 1.573 | 2.875 | 0.588 | 1.2 | 2.245 | 2.096 | 2.258 | 0.875
COVID19_PFIZER/BIONTECH | Food aversion | 1 | 0.517 | 0.249 | 1.573 | 3.836 | 0.403 | 0.978 | 2.08 | 1.935 | 0.41 | 0.331
COVID19_PFIZER/BIONTECH | Blood albumin decreased | 14 | 11.214 | 0.982 | 1.573 | 2.277 | 0.759 | 1.149 | 1.682 | 1.248 | 1.59 | 2.276
COVID19_PFIZER/BIONTECH | Hypernatraemia | 3 | 2.408 | 0.551 | 1.572 | 3.017 | 0.492 | 1.003 | 1.866 | 1.246 | 7.74 | 7.849
COVID19_PFIZER/BIONTECH | Neutrophil percentage decreased | 7 | 4.655 | 0.791 | 1.571 | 2.565 | 0.704 | 1.214 | 1.983 | 1.504 | 0.416 | 5.033
COVID19_PFIZER/BIONTECH | Haemoglobin | 9 | 6.157 | 0.886 | 1.571 | 2.414 | 0.75 | 1.232 | 1.932 | 1.462 | 2.196 | 4.166
COVID19_PFIZER/BIONTECH | Abortion spontaneous | 39 | 29.575 | 1.185 | 1.571 | 2.002 | 0.976 | 1.266 | 1.621 | 1.319 | 3.487 | 55.839
COVID19_PFIZER/BIONTECH | Insulin C-peptide decreased | 1 | 0.474 | 0.309 | 1.57 | 3.625 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Implantable cardiac monitor insertion | 1 | 0.933 | 0.285 | 1.57 | 3.705 | 0.364 | 0.884 | 1.876 | 1.072 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Pericardial drainage | 2 | 1.907 | 0.384 | 1.57 | 3.408 | 0.416 | 0.912 | 1.791 | 1.049 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Vasogenic cerebral oedema | 1 | 0.941 | 0.333 | 1.568 | 3.549 | 0.363 | 0.883 | 1.872 | 1.063 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Red blood cells urine | 1 | 1.47 | 0.259 | 1.568 | 3.785 | 0.323 | 0.788 | 1.673 | 0.68 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Antineutrophil cytoplasmic antibody increased | 1 | 0.474 | 0.31 | 1.567 | 3.617 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Pulmonary pneumatocele | 1 | 0.474 | 0.31 | 1.567 | 3.615 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Posturing | 5 | 3.44 | 0.709 | 1.567 | 2.699 | 0.618 | 1.14 | 1.964 | 1.454 | 2.1 | 1.646
COVID19_PFIZER/BIONTECH | Haematoma muscle | 1 | 0.407 | 0.334 | 1.564 | 3.533 | 0.414 | 1.007 | 2.146 | 2.457 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Rhinorrhoea | 220 | 150.387 | 1.395 | 1.564 | 1.74 | 1.296 | 1.448 | 1.615 | 1.463 | 2.124 | 116.686
COVID19_PFIZER/BIONTECH | Blood methaemoglobin | 1 | 0.955 | 0.26 | 1.564 | 3.772 | 0.362 | 0.88 | 1.866 | 1.047 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Dry mouth | 98 | 68.636 | 1.314 | 1.562 | 1.828 | 1.184 | 1.398 | 1.642 | 1.428 | 4.349 | 201.123
COVID19_PFIZER/BIONTECH | Trichoglossia | 1 | 0.092 | 0.334 | 1.561 | 3.525 | 0.453 | 1.122 | 2.461 | 10.908 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Pleural thickening | 1 | 0.474 | 0.261 | 1.561 | 3.761 | 0.407 | 0.989 | 2.105 | 2.111 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Pulmonary infarction | 2 | 3.293 | 0.356 | 1.561 | 3.461 | 0.33 | 0.727 | 1.43 | 0.607 | 6.02 | 2.934
COVID19_PFIZER/BIONTECH | Sinus arrest | 1 | 0.474 | 0.311 | 1.56 | 3.589 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood urea normal | 26 | 19.743 | 1.108 | 1.56 | 2.075 | 0.908 | 1.243 | 1.67 | 1.317 | 1.495 | 3.476
COVID19_PFIZER/BIONTECH | Brain stem haemorrhage | 1 | 0.461 | 0.335 | 1.559 | 3.516 | 0.409 | 0.992 | 2.113 | 2.17 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Chromosomal analysis | 1 | 0.462 | 0.334 | 1.559 | 3.518 | 0.408 | 0.992 | 2.112 | 2.164 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Angiogram pulmonary abnormal | 14 | 11.806 | 0.97 | 1.559 | 2.263 | 0.73 | 1.105 | 1.617 | 1.186 | 21.07 | 113.955
COVID19_PFIZER/BIONTECH | Neurological symptom | 32 | 27.493 | 1.151 | 1.559 | 2.017 | 0.846 | 1.126 | 1.474 | 1.164 | 2.47 | 23.294
COVID19_PFIZER/BIONTECH | Diabetes mellitus | 10 | 9.523 | 0.89 | 1.559 | 2.379 | 0.617 | 0.992 | 1.529 | 1.05 | 1.901 | 3.053
COVID19_PFIZER/BIONTECH | Postural orthostatic tachycardia syndrome | 5 | 4.817 | 0.637 | 1.559 | 2.81 | 0.517 | 0.953 | 1.641 | 1.038 | 0.23 | 11.92
COVID19_PFIZER/BIONTECH | Ear, nose and throat examination normal | 1 | 1.005 | 0.224 | 1.559 | 3.888 | 0.358 | 0.87 | 1.845 | 0.995 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Peripheral circulatory failure | 1 | 0.357 | 0.177 | 1.558 | 4.083 | 0.42 | 1.021 | 2.18 | 2.802 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Toxic epidermal necrolysis | 1 | 0.58 | 0.217 | 1.557 | 3.91 | 0.396 | 0.962 | 2.044 | 1.723 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Ascites | 5 | 4.715 | 0.7 | 1.557 | 2.688 | 0.523 | 0.965 | 1.661 | 1.06 | 2.052 | 1.528
COVID19_PFIZER/BIONTECH | Increased viscosity of bronchial secretion | 1 | 0.461 | 0.287 | 1.556 | 3.655 | 0.409 | 0.992 | 2.113 | 2.17 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Dysphonia | 109 | 74.178 | 1.322 | 1.556 | 1.805 | 1.23 | 1.44 | 1.678 | 1.469 | 3.275 | 144.126
COVID19_PFIZER/BIONTECH | Anxiety | 287 | 200.023 | 1.409 | 1.556 | 1.71 | 1.292 | 1.424 | 1.567 | 1.435 | 3.093 | 347.093
COVID19_PFIZER/BIONTECH | Tracheomalacia | 1 | 0.354 | 0.288 | 1.555 | 3.651 | 0.42 | 1.022 | 2.182 | 2.824 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Gastrointestinal examination | 1 | 0.474 | 0.288 | 1.554 | 3.646 | 0.407 | 0.989 | 2.105 | 2.111 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Band neutrophil percentage decreased | 1 | 0.474 | 0.236 | 1.554 | 3.83 | 0.407 | 0.989 | 2.105 | 2.111 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Prurigo | 1 | 1.154 | 0.288 | 1.553 | 3.642 | 0.346 | 0.842 | 1.786 | 0.866 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Vaccination site macule | 1 | 0.461 | 0.313 | 1.552 | 3.562 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Gingival disorders (SMQ) [narrow] | 22 | 15.449 | 1.079 | 1.552 | 2.096 | 0.935 | 1.313 | 1.803 | 1.424 | 2.423 | 14.917
COVID19_PFIZER/BIONTECH | Gingival disorders (SMQ) [broad] | 22 | 15.449 | 1.079 | 1.552 | 2.096 | 0.935 | 1.313 | 1.803 | 1.424 | 2.423 | 14.917
COVID19_PFIZER/BIONTECH | Lumbosacral radiculopathy | 1 | 0.48 | 0.336 | 1.551 | 3.491 | 0.407 | 0.987 | 2.101 | 2.084 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Sneezing | 45 | 30.614 | 1.198 | 1.551 | 1.942 | 1.101 | 1.403 | 1.768 | 1.47 | 1.839 | 14.853
COVID19_PFIZER/BIONTECH | Tissue injury | 1 | 0.583 | 0.313 | 1.551 | 3.56 | 0.396 | 0.962 | 2.043 | 1.715 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Visual tracking test abnormal | 1 | 0.266 | 0.263 | 1.55 | 3.718 | 0.43 | 1.05 | 2.25 | 3.765 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Nodular rash | 1 | 0.292 | 0.336 | 1.55 | 3.487 | 0.427 | 1.041 | 2.228 | 3.424 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Arteriogram carotid normal | 20 | 10.845 | 1.059 | 1.55 | 2.118 | 1.118 | 1.594 | 2.219 | 1.844 | 22.575 | 173.322
COVID19_PFIZER/BIONTECH | Glossitis | 4 | 2.162 | 0.673 | 1.55 | 2.719 | 0.633 | 1.22 | 2.182 | 1.85 | 4.515 | 6.041
COVID19_PFIZER/BIONTECH | Defaecation urgency | 6 | 3.371 | 0.79 | 1.55 | 2.517 | 0.728 | 1.295 | 2.171 | 1.78 | 2.852 | 4.657
COVID19_PFIZER/BIONTECH | Premenstrual syndrome | 1 | 0.461 | 0.313 | 1.55 | 3.554 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Corneal infiltrates | 1 | 0.47 | 0.313 | 1.55 | 3.556 | 0.408 | 0.99 | 2.107 | 2.125 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Imaging procedure abnormal | 4 | 3.424 | 0.646 | 1.55 | 2.77 | 0.519 | 1 | 1.783 | 1.168 | 3.44 | 3.854
COVID19_PFIZER/BIONTECH | Hilar lymphadenopathy | 1 | 0.47 | 0.337 | 1.549 | 3.481 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Cystoscopy | 1 | 0.828 | 0.179 | 1.549 | 4.046 | 0.373 | 0.906 | 1.922 | 1.208 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Throat clearing | 41 | 25.944 | 1.179 | 1.548 | 1.959 | 1.155 | 1.49 | 1.896 | 1.58 | 18.512 | 326.416
COVID19_PFIZER/BIONTECH | Renal failure | 16 | 16.927 | 1.006 | 1.548 | 2.185 | 0.627 | 0.927 | 1.33 | 0.945 | 2.603 | 12.373
COVID19_PFIZER/BIONTECH | N-terminal prohormone brain natriuretic peptide normal | 1 | 0.354 | 0.337 | 1.547 | 3.476 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood copper normal | 1 | 0.461 | 0.314 | 1.547 | 3.543 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Vaccination site coldness | 1 | 0.474 | 0.337 | 1.547 | 3.474 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Ketosis | 1 | 0.47 | 0.314 | 1.546 | 3.54 | 0.408 | 0.99 | 2.107 | 2.125 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Beta-2 glycoprotein antibody | 1 | 0.879 | 0.238 | 1.546 | 3.797 | 0.369 | 0.895 | 1.899 | 1.138 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Vaccination site pruritus | 13 | 12.963 | 0.929 | 1.546 | 2.29 | 0.631 | 0.967 | 1.432 | 1.003 | 2.42 | 8.282
COVID19_PFIZER/BIONTECH | Hepatic pain | 3 | 1.383 | 0.527 | 1.545 | 2.994 | 0.594 | 1.212 | 2.269 | 2.17 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | X-ray with contrast upper gastrointestinal tract normal | 1 | 0.474 | 0.338 | 1.544 | 3.463 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Nasal discomfort | 11 | 7.618 | 0.891 | 1.544 | 2.343 | 0.791 | 1.25 | 1.899 | 1.444 | 3.973 | 17.574
COVID19_PFIZER/BIONTECH | Internal haemorrhage | 3 | 3.224 | 0.536 | 1.544 | 2.974 | 0.433 | 0.882 | 1.641 | 0.93 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Ophthalmic scan | 1 | 0.461 | 0.315 | 1.543 | 3.529 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Scan myocardial perfusion normal | 1 | 0.516 | 0.338 | 1.542 | 3.459 | 0.403 | 0.978 | 2.08 | 1.936 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Fibrosis | 1 | 1.223 | 0.315 | 1.542 | 3.526 | 0.34 | 0.829 | 1.76 | 0.817 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood alkaline phosphatase decreased | 1 | 0.474 | 0.338 | 1.541 | 3.453 | 0.407 | 0.989 | 2.105 | 2.111 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | International normalised ratio normal | 16 | 10.768 | 0.995 | 1.541 | 2.186 | 0.895 | 1.323 | 1.9 | 1.486 | 2.449 | 10.773
COVID19_PFIZER/BIONTECH | Electrocardiogram ST segment depression | 6 | 4.393 | 0.749 | 1.541 | 2.562 | 0.635 | 1.129 | 1.889 | 1.366 | 12.04 | 29.789
COVID19_PFIZER/BIONTECH | Left ventricular dysfunction | 5 | 3.519 | 0.718 | 1.54 | 2.614 | 0.611 | 1.127 | 1.942 | 1.421 | 10.033 | 20.373
COVID19_PFIZER/BIONTECH | Foetal hypokinesia | 1 | 0.923 | 0.135 | 1.54 | 4.24 | 0.365 | 0.886 | 1.88 | 1.083 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Haemodynamic test normal | 1 | 0.525 | 0.316 | 1.539 | 3.514 | 0.402 | 0.976 | 2.075 | 1.906 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Saliva discolouration | 1 | 0.743 | 0.339 | 1.539 | 3.449 | 0.381 | 0.924 | 1.961 | 1.345 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Antimitochondrial antibody normal | 1 | 0.564 | 0.316 | 1.538 | 3.512 | 0.398 | 0.966 | 2.053 | 1.773 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Necrotising fasciitis | 1 | 0.552 | 0.283 | 1.537 | 3.61 | 0.399 | 0.969 | 2.06 | 1.813 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Retinal tear | 3 | 2.974 | 0.532 | 1.537 | 2.965 | 0.449 | 0.916 | 1.704 | 1.009 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Laryngeal oedema | 3 | 2.144 | 0.476 | 1.536 | 3.084 | 0.515 | 1.049 | 1.953 | 1.399 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Skin odour abnormal | 1 | 0.736 | 0.197 | 1.536 | 3.927 | 0.381 | 0.926 | 1.965 | 1.359 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Intermenstrual bleeding | 5 | 3.722 | 0.657 | 1.535 | 2.711 | 0.594 | 1.096 | 1.888 | 1.343 | 4.753 | 8.804
COVID19_PFIZER/BIONTECH | Diverticulitis | 12 | 9.671 | 0.936 | 1.535 | 2.254 | 0.728 | 1.132 | 1.696 | 1.241 | 7.74 | 44.453
COVID19_PFIZER/BIONTECH | Suicide attempt | 1 | 0.743 | 0.129 | 1.535 | 4.255 | 0.381 | 0.924 | 1.961 | 1.345 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Thyroid cancer | 1 | 0.801 | 0.292 | 1.535 | 3.576 | 0.375 | 0.912 | 1.934 | 1.248 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Coronary artery occlusion | 5 | 4.305 | 0.721 | 1.535 | 2.596 | 0.55 | 1.015 | 1.747 | 1.161 | 11.288 | 22.556
COVID19_PFIZER/BIONTECH | Intervertebral disc degeneration | 3 | 2.269 | 0.493 | 1.534 | 3.042 | 0.504 | 1.027 | 1.911 | 1.322 | 1.26 | 0.003
COVID19_PFIZER/BIONTECH | Tendon discomfort | 1 | 0.825 | 0.293 | 1.534 | 3.571 | 0.373 | 0.907 | 1.923 | 1.213 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Left ventricular hypertrophy | 4 | 3.776 | 0.657 | 1.534 | 2.709 | 0.494 | 0.952 | 1.697 | 1.059 | 8.027 | 12.288
COVID19_PFIZER/BIONTECH | Electrocardiogram PR prolongation | 1 | 0.48 | 0.317 | 1.533 | 3.494 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Cardiogenic shock | 5 | 3.4 | 0.674 | 1.533 | 2.674 | 0.622 | 1.146 | 1.976 | 1.471 | 6.02 | 11.977
COVID19_PFIZER/BIONTECH | Enzyme level test | 1 | 0.461 | 0.317 | 1.532 | 3.49 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Mesenteritis | 1 | 0.47 | 0.34 | 1.532 | 3.422 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Cardiac flutter | 20 | 13.89 | 1.047 | 1.532 | 2.093 | 0.923 | 1.316 | 1.83 | 1.44 | 8.027 | 80.13
COVID19_PFIZER/BIONTECH | Platelet transfusion | 13 | 11.128 | 0.926 | 1.531 | 2.258 | 0.71 | 1.088 | 1.61 | 1.168 | 3.612 | 18.234
COVID19_PFIZER/BIONTECH | Crystal urine absent | 1 | 0.922 | 0.317 | 1.531 | 3.487 | 0.365 | 0.887 | 1.88 | 1.085 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Temperature intolerance | 6 | 3.503 | 0.74 | 1.53 | 2.551 | 0.714 | 1.271 | 2.129 | 1.713 | 1.178 | 0.026
COVID19_PFIZER/BIONTECH | Feeling drunk | 13 | 7.859 | 0.947 | 1.53 | 2.228 | 0.912 | 1.398 | 2.071 | 1.654 | 3.787 | 19.68
COVID19_PFIZER/BIONTECH | Haptoglobin | 1 | 0.47 | 0.341 | 1.53 | 3.414 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Dyslexia | 1 | 0.32 | 0.318 | 1.529 | 3.48 | 0.424 | 1.032 | 2.207 | 3.128 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Romberg test | 1 | 0.48 | 0.214 | 1.529 | 3.839 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Migraine with aura | 9 | 7.136 | 0.829 | 1.528 | 2.4 | 0.682 | 1.119 | 1.755 | 1.261 | 2.955 | 8.312
COVID19_PFIZER/BIONTECH | Haemorrhage | 41 | 35.795 | 1.166 | 1.528 | 1.931 | 0.867 | 1.117 | 1.422 | 1.145 | 1.718 | 10.568
COVID19_PFIZER/BIONTECH | Osteoporosis/osteopenia (SMQ) [broad] | 25 | 23.812 | 1.08 | 1.528 | 2.039 | 0.742 | 1.022 | 1.38 | 1.05 | 2.858 | 24.413
COVID19_PFIZER/BIONTECH | Similar reaction on previous exposure to drug | 2 | 1.13 | 0.573 | 1.526 | 2.85 | 0.485 | 1.064 | 2.096 | 1.769 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging joint | 1 | 1.081 | 0.342 | 1.526 | 3.401 | 0.352 | 0.856 | 1.815 | 0.925 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood chloride normal | 25 | 19.297 | 1.077 | 1.525 | 2.037 | 0.888 | 1.223 | 1.652 | 1.296 | 1.601 | 4.62
COVID19_PFIZER/BIONTECH | Hallucination, auditory | 4 | 3.329 | 0.612 | 1.525 | 2.77 | 0.526 | 1.013 | 1.807 | 1.201 | 1.445 | 0.166
COVID19_PFIZER/BIONTECH | Blood sodium decreased | 26 | 21.567 | 1.083 | 1.524 | 2.026 | 0.842 | 1.153 | 1.549 | 1.206 | 2.125 | 12.818
COVID19_PFIZER/BIONTECH | Blood osmolarity increased | 1 | 0.753 | 0.319 | 1.524 | 3.463 | 0.38 | 0.922 | 1.957 | 1.328 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Cardiac failure (SMQ) [narrow] | 88 | 73.944 | 1.269 | 1.524 | 1.798 | 0.985 | 1.174 | 1.39 | 1.19 | 4.801 | 206.328
COVID19_PFIZER/BIONTECH | Mandibular mass | 1 | 0.354 | 0.342 | 1.523 | 3.393 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Mean cell volume | 2 | 0.989 | 0.541 | 1.523 | 2.908 | 0.501 | 1.098 | 2.167 | 2.023 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | Blood bilirubin increased | 16 | 13.105 | 0.971 | 1.523 | 2.176 | 0.77 | 1.138 | 1.634 | 1.221 | 1.497 | 1.98
COVID19_PFIZER/BIONTECH | Multiple organ dysfunction syndrome | 8 | 6.828 | 0.807 | 1.523 | 2.422 | 0.629 | 1.057 | 1.688 | 1.172 | 1.762 | 1.725
COVID19_PFIZER/BIONTECH | Lactic acidosis (SMQ) [narrow] | 28 | 24.972 | 1.096 | 1.523 | 2.008 | 0.801 | 1.086 | 1.445 | 1.121 | 3.691 | 43.308
COVID19_PFIZER/BIONTECH | Paranasal sinus hyposecretion | 1 | 0.526 | 0.342 | 1.522 | 3.389 | 0.402 | 0.976 | 2.075 | 1.901 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Fluid retention | 6 | 4.54 | 0.743 | 1.522 | 2.526 | 0.623 | 1.108 | 1.854 | 1.321 | 1.355 | 0.228
COVID19_PFIZER/BIONTECH | Urodynamics measurement | 1 | 0.736 | 0.32 | 1.522 | 3.453 | 0.381 | 0.926 | 1.965 | 1.359 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Seborrhoea | 1 | 0.743 | 0.295 | 1.522 | 3.53 | 0.381 | 0.924 | 1.961 | 1.345 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Hemiparaesthesia | 1 | 0.855 | 0.27 | 1.522 | 3.61 | 0.371 | 0.9 | 1.91 | 1.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Gallbladder operation | 1 | 0.931 | 0.32 | 1.521 | 3.449 | 0.364 | 0.885 | 1.876 | 1.074 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Tongue movement disturbance | 6 | 3.488 | 0.729 | 1.52 | 2.544 | 0.716 | 1.274 | 2.134 | 1.72 | 4.013 | 8.658
COVID19_PFIZER/BIONTECH | Angioplasty | 3 | 2.618 | 0.606 | 1.52 | 2.769 | 0.475 | 0.969 | 1.802 | 1.146 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Fibrin D dimer normal | 16 | 12.669 | 0.969 | 1.519 | 2.169 | 0.791 | 1.169 | 1.678 | 1.263 | 6.421 | 49.895
COVID19_PFIZER/BIONTECH | Cardiac imaging procedure abnormal | 1 | 0.95 | 0.32 | 1.519 | 3.443 | 0.362 | 0.881 | 1.868 | 1.052 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Mean platelet volume normal | 15 | 10.33 | 0.972 | 1.518 | 2.164 | 0.865 | 1.293 | 1.875 | 1.452 | 2.508 | 10.593
COVID19_PFIZER/BIONTECH | Nitrite urine absent | 9 | 5.89 | 0.878 | 1.517 | 2.297 | 0.771 | 1.267 | 1.987 | 1.528 | 1.935 | 2.836
COVID19_PFIZER/BIONTECH | Brain natriuretic peptide normal | 12 | 9.931 | 0.912 | 1.517 | 2.249 | 0.714 | 1.11 | 1.663 | 1.208 | 6.374 | 36.11
COVID19_PFIZER/BIONTECH | Corrective lens user | 1 | 0.815 | 0.301 | 1.517 | 3.498 | 0.374 | 0.909 | 1.928 | 1.227 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Ultrasound joint | 2 | 1.088 | 0.458 | 1.516 | 3.073 | 0.49 | 1.074 | 2.117 | 1.839 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin increased | 4 | 3.411 | 0.583 | 1.516 | 2.804 | 0.52 | 1.002 | 1.786 | 1.173 | 1.762 | 0.58
COVID19_PFIZER/BIONTECH | Blood bicarbonate normal | 6 | 4.284 | 0.715 | 1.515 | 2.557 | 0.644 | 1.144 | 1.915 | 1.401 | 0.815 | 0.091
COVID19_PFIZER/BIONTECH | Ultrasound Doppler abnormal | 10 | 8.003 | 0.864 | 1.515 | 2.313 | 0.697 | 1.122 | 1.73 | 1.25 | 3.225 | 11.111
COVID19_PFIZER/BIONTECH | Nasal discharge discolouration | 1 | 0.354 | 0.291 | 1.514 | 3.518 | 0.42 | 1.022 | 2.182 | 2.824 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Intestinal obstruction | 3 | 3.283 | 0.495 | 1.514 | 2.983 | 0.429 | 0.875 | 1.627 | 0.914 | 0.774 | 0.03
COVID19_PFIZER/BIONTECH | Electrocardiogram abnormal | 96 | 74.007 | 1.27 | 1.513 | 1.774 | 1.078 | 1.276 | 1.501 | 1.297 | 4.648 | 215.86
COVID19_PFIZER/BIONTECH | Cardiovascular symptom | 1 | 0.743 | 0.322 | 1.513 | 3.423 | 0.381 | 0.924 | 1.961 | 1.345 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Thyroid function test normal | 8 | 5.734 | 0.79 | 1.512 | 2.423 | 0.703 | 1.181 | 1.887 | 1.395 | 1.055 | 0.002
COVID19_PFIZER/BIONTECH | Orthopnoea | 2 | 1.411 | 0.4 | 1.512 | 3.203 | 0.458 | 1.003 | 1.973 | 1.417 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Capillary nail refill test | 1 | 0.815 | 0.356 | 1.511 | 3.319 | 0.374 | 0.909 | 1.928 | 1.227 | 0.583 | 0.02
COVID19_PFIZER/BIONTECH | Escherichia test positive | 3 | 1.562 | 0.558 | 1.51 | 2.838 | 0.573 | 1.169 | 2.183 | 1.921 | 0.821 | 0.004
COVID19_PFIZER/BIONTECH | Metabolic encephalopathy | 5 | 3.617 | 0.725 | 1.51 | 2.527 | 0.603 | 1.112 | 1.915 | 1.382 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | Multiple sclerosis relapse | 3 | 2.379 | 0.522 | 1.51 | 2.914 | 0.495 | 1.007 | 1.875 | 1.261 | 1.084 | 0.03
COVID19_PFIZER/BIONTECH | Stillbirth | 3 | 2.647 | 0.44 | 1.51 | 3.1 | 0.473 | 0.964 | 1.794 | 1.133 | 0.86 | 0
COVID19_PFIZER/BIONTECH | Head discomfort | 84 | 56.569 | 1.257 | 1.509 | 1.78 | 1.209 | 1.446 | 1.719 | 1.485 | 4.741 | 193.507
COVID19_PFIZER/BIONTECH | Crohn's disease | 5 | 5.001 | 0.643 | 1.509 | 2.67 | 0.506 | 0.933 | 1.606 | 1 | 0.971 | 0.026
COVID19_PFIZER/BIONTECH | Procalcitonin | 6 | 6.528 | 0.686 | 1.509 | 2.592 | 0.501 | 0.891 | 1.49 | 0.919 | 1.901 | 1.538
COVID19_PFIZER/BIONTECH | Genital ulceration | 1 | 0.266 | 0.323 | 1.508 | 3.406 | 0.43 | 1.05 | 2.25 | 3.765 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Arteriovenous malformation | 1 | 0.47 | 0.346 | 1.508 | 3.337 | 0.408 | 0.99 | 2.107 | 2.125 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Heart rate irregular | 43 | 33.185 | 1.159 | 1.508 | 1.895 | 0.976 | 1.251 | 1.584 | 1.296 | 4.412 | 88.383
COVID19_PFIZER/BIONTECH | Right ventricular failure | 1 | 0.739 | 0.247 | 1.508 | 3.647 | 0.381 | 0.925 | 1.963 | 1.353 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Central vision loss | 1 | 0.882 | 0.323 | 1.508 | 3.403 | 0.368 | 0.895 | 1.898 | 1.134 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Intracranial mass | 1 | 1.359 | 0.323 | 1.508 | 3.404 | 0.33 | 0.806 | 1.711 | 0.736 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Hypochromasia | 1 | 0.474 | 0.323 | 1.507 | 3.401 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | CSF culture | 3 | 2.46 | 0.533 | 1.507 | 2.883 | 0.488 | 0.994 | 1.85 | 1.219 | 1.178 | 0.002
COVID19_PFIZER/BIONTECH | Illness | 52 | 51.314 | 1.182 | 1.507 | 1.866 | 0.799 | 1.002 | 1.244 | 1.013 | 2.184 | 28.713
COVID19_PFIZER/BIONTECH | Cranial nerve disorder | 2 | 0.96 | 0.516 | 1.504 | 2.911 | 0.504 | 1.105 | 2.182 | 2.083 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | Retinal migraine | 1 | 0.825 | 0.347 | 1.504 | 3.324 | 0.373 | 0.907 | 1.923 | 1.213 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Panic reaction | 15 | 8.811 | 0.971 | 1.502 | 2.129 | 0.971 | 1.452 | 2.106 | 1.702 | 4.043 | 25.517
COVID19_PFIZER/BIONTECH | Asthma exercise induced | 1 | 0.588 | 0.221 | 1.502 | 3.73 | 0.396 | 0.96 | 2.04 | 1.701 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Left atrial dilatation | 1 | 0.944 | 0.324 | 1.502 | 3.382 | 0.363 | 0.882 | 1.871 | 1.059 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Pulmonary function test abnormal | 1 | 0.47 | 0.25 | 1.501 | 3.619 | 0.408 | 0.99 | 2.107 | 2.125 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging abdominal abnormal | 1 | 1.405 | 0.276 | 1.5 | 3.526 | 0.327 | 0.798 | 1.695 | 0.712 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Ovarian cancer | 1 | 0.48 | 0.221 | 1.499 | 3.718 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Hypertension | 277 | 193.519 | 1.355 | 1.499 | 1.649 | 1.286 | 1.421 | 1.566 | 1.431 | 7.126 | 1044.459
COVID19_PFIZER/BIONTECH | Treponema test negative | 5 | 4.355 | 0.656 | 1.499 | 2.619 | 0.547 | 1.008 | 1.736 | 1.148 | 0.664 | 0.514
COVID19_PFIZER/BIONTECH | Submaxillary gland enlargement | 1 | 0.354 | 0.348 | 1.498 | 3.303 | 0.42 | 1.022 | 2.182 | 2.824 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Non-alcoholic steatohepatitis | 1 | 0.482 | 0.348 | 1.498 | 3.304 | 0.406 | 0.987 | 2.1 | 2.076 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood albumin | 5 | 4.636 | 0.625 | 1.498 | 2.675 | 0.528 | 0.974 | 1.677 | 1.078 | 2.1 | 1.646
COVID19_PFIZER/BIONTECH | Critical illness | 1 | 1.017 | 0.25 | 1.498 | 3.609 | 0.357 | 0.868 | 1.84 | 0.983 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Hot flush | 155 | 109.418 | 1.307 | 1.497 | 1.698 | 1.225 | 1.398 | 1.591 | 1.417 | 5.832 | 466.082
COVID19_PFIZER/BIONTECH | Red cell distribution width decreased | 1 | 0.708 | 0.326 | 1.497 | 3.364 | 0.384 | 0.932 | 1.979 | 1.412 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Vaginal haemorrhage | 20 | 17.47 | 1.007 | 1.497 | 2.066 | 0.767 | 1.092 | 1.519 | 1.145 | 4.013 | 34.478
COVID19_PFIZER/BIONTECH | Opiates negative | 1 | 0.825 | 0.326 | 1.496 | 3.361 | 0.373 | 0.907 | 1.923 | 1.213 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Pupil fixed | 7 | 3.689 | 0.796 | 1.495 | 2.372 | 0.797 | 1.376 | 2.252 | 1.897 | 3.951 | 10.233
COVID19_PFIZER/BIONTECH | Colon cancer | 1 | 0.506 | 0.302 | 1.495 | 3.427 | 0.404 | 0.981 | 2.086 | 1.975 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Mouth ulceration | 7 | 4.624 | 0.783 | 1.495 | 2.392 | 0.707 | 1.219 | 1.99 | 1.514 | 1.171 | 0.038
COVID19_PFIZER/BIONTECH | Parasite stool test | 1 | 0.461 | 0.277 | 1.494 | 3.503 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Cardiac monitoring abnormal | 9 | 5.719 | 0.837 | 1.494 | 2.305 | 0.786 | 1.29 | 2.024 | 1.574 | 10.159 | 41.58
COVID19_PFIZER/BIONTECH | Chronic kidney disease | 3 | 3.275 | 0.523 | 1.494 | 2.87 | 0.43 | 0.876 | 1.629 | 0.916 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Gingival discolouration | 1 | 0.47 | 0.303 | 1.493 | 3.421 | 0.408 | 0.99 | 2.107 | 2.125 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Urinary tract inflammation | 1 | 0.525 | 0.278 | 1.493 | 3.5 | 0.402 | 0.976 | 2.075 | 1.906 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Cerebral ventricle dilatation | 1 | 0.954 | 0.303 | 1.493 | 3.42 | 0.362 | 0.88 | 1.867 | 1.049 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Feeling jittery | 40 | 25.105 | 1.147 | 1.492 | 1.874 | 1.159 | 1.498 | 1.913 | 1.593 | 7.014 | 144.081
COVID19_PFIZER/BIONTECH | Ear discomfort | 67 | 45.659 | 1.217 | 1.491 | 1.788 | 1.163 | 1.421 | 1.723 | 1.467 | 5.426 | 182.593
COVID19_PFIZER/BIONTECH | Miliaria | 4 | 2.088 | 0.706 | 1.49 | 2.507 | 0.641 | 1.237 | 2.213 | 1.916 | 1.57 | 0.309
COVID19_PFIZER/BIONTECH | CSF lymphocyte count abnormal | 1 | 0.461 | 0.368 | 1.49 | 3.224 | 0.409 | 0.992 | 2.113 | 2.17 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Pregnancy test | 5 | 3.048 | 0.673 | 1.49 | 2.568 | 0.654 | 1.207 | 2.082 | 1.641 | 3.473 | 5.359
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin abnormal | 1 | 1.204 | 0.304 | 1.49 | 3.41 | 0.342 | 0.833 | 1.767 | 0.83 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Anuria | 2 | 1.508 | 0.358 | 1.489 | 3.251 | 0.449 | 0.984 | 1.935 | 1.326 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | Ischaemic colitis (SMQ) [broad] | 72 | 66.233 | 1.215 | 1.489 | 1.785 | 0.885 | 1.074 | 1.294 | 1.087 | 0.73 | 6.669
COVID19_PFIZER/BIONTECH | Corneal graft rejection | 1 | 0.47 | 0.304 | 1.488 | 3.404 | 0.408 | 0.99 | 2.107 | 2.125 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Anaphylactoid reaction | 7 | 5.594 | 0.775 | 1.488 | 2.39 | 0.632 | 1.09 | 1.779 | 1.251 | 3.831 | 9.743
COVID19_PFIZER/BIONTECH | Pulse absent | 36 | 35.645 | 1.121 | 1.488 | 1.898 | 0.759 | 0.994 | 1.284 | 1.01 | 5.557 | 99.275
COVID19_PFIZER/BIONTECH | Blood cholesterol normal | 4 | 2.064 | 0.698 | 1.487 | 2.515 | 0.644 | 1.242 | 2.222 | 1.938 | 1.952 | 0.893
COVID19_PFIZER/BIONTECH | Extradural abscess | 1 | 0.977 | 0.304 | 1.487 | 3.4 | 0.36 | 0.876 | 1.857 | 1.024 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Panic attack | 24 | 16.749 | 1.039 | 1.485 | 1.997 | 0.958 | 1.328 | 1.802 | 1.433 | 2.064 | 10.835
COVID19_PFIZER/BIONTECH | CD4 lymphocyte percentage decreased | 1 | 0.461 | 0.329 | 1.484 | 3.316 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Dyslipidaemia (SMQ) [broad] | 19 | 16.639 | 0.995 | 1.484 | 2.054 | 0.757 | 1.088 | 1.524 | 1.142 | 2.172 | 9.653
COVID19_PFIZER/BIONTECH | Dyslipidaemia (SMQ) [narrow] | 19 | 16.639 | 0.995 | 1.484 | 2.054 | 0.757 | 1.088 | 1.524 | 1.142 | 2.172 | 9.653
COVID19_PFIZER/BIONTECH | Staphylococcal bacteraemia | 1 | 1.424 | 0.226 | 1.483 | 3.651 | 0.326 | 0.795 | 1.688 | 0.702 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Lymphocyte percentage increased | 5 | 2.937 | 0.655 | 1.482 | 2.578 | 0.666 | 1.228 | 2.119 | 1.702 | 0.341 | 5.599
COVID19_PFIZER/BIONTECH | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [narrow] | 246 | 179.708 | 1.33 | 1.482 | 1.639 | 1.223 | 1.358 | 1.506 | 1.369 | 6.997 | 909.075
COVID19_PFIZER/BIONTECH | Heart rate abnormal | 10 | 6.166 | 0.876 | 1.48 | 2.213 | 0.828 | 1.333 | 2.057 | 1.622 | 4.3 | 17.742
COVID19_PFIZER/BIONTECH | Lactic acidosis | 4 | 3.808 | 0.637 | 1.48 | 2.607 | 0.492 | 0.948 | 1.69 | 1.05 | 4.515 | 6.041
COVID19_PFIZER/BIONTECH | Hypochromic anaemia | 1 | 0.941 | 0.306 | 1.48 | 3.371 | 0.363 | 0.883 | 1.872 | 1.063 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Intervertebral discitis | 1 | 0.48 | 0.228 | 1.478 | 3.629 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [broad] | 246 | 179.973 | 1.327 | 1.478 | 1.635 | 1.221 | 1.356 | 1.504 | 1.367 | 6.964 | 904.568
COVID19_PFIZER/BIONTECH | Procalcitonin normal | 3 | 3.264 | 0.487 | 1.478 | 2.904 | 0.43 | 0.877 | 1.632 | 0.919 | 1.106 | 0.02
COVID19_PFIZER/BIONTECH | Electrocardiogram QRS complex prolonged | 1 | 0.48 | 0.331 | 1.477 | 3.291 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Computerised tomogram intestine | 1 | 0.506 | 0.331 | 1.476 | 3.287 | 0.404 | 0.981 | 2.086 | 1.975 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Atrioventricular block second degree | 1 | 0.954 | 0.256 | 1.476 | 3.522 | 0.362 | 0.88 | 1.867 | 1.049 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Idiopathic intracranial hypertension | 1 | 0.461 | 0.217 | 1.475 | 3.662 | 0.409 | 0.992 | 2.113 | 2.17 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Weight decreased | 33 | 25.614 | 1.091 | 1.475 | 1.907 | 0.93 | 1.233 | 1.608 | 1.288 | 0.751 | 2.384
COVID19_PFIZER/BIONTECH | Blood creatinine normal | 38 | 29.556 | 1.113 | 1.475 | 1.878 | 0.951 | 1.237 | 1.588 | 1.286 | 1.711 | 9.603
COVID19_PFIZER/BIONTECH | Gastrointestinal obstruction (SMQ) [narrow] | 16 | 15.608 | 0.935 | 1.475 | 2.114 | 0.67 | 0.99 | 1.421 | 1.025 | 0.301 | 24.947
COVID19_PFIZER/BIONTECH | Gastrointestinal obstruction (SMQ) [broad] | 16 | 15.608 | 0.935 | 1.475 | 2.114 | 0.67 | 0.99 | 1.421 | 1.025 | 0.301 | 24.947
COVID19_PFIZER/BIONTECH | Prostatomegaly | 1 | 0.092 | 0.308 | 1.474 | 3.348 | 0.453 | 1.122 | 2.46 | 10.867 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Increased viscosity of upper respiratory secretion | 2 | 1.011 | 0.443 | 1.474 | 2.992 | 0.498 | 1.092 | 2.155 | 1.978 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Full blood count abnormal | 14 | 9.167 | 0.96 | 1.474 | 2.078 | 0.881 | 1.333 | 1.952 | 1.527 | 2.385 | 8.703
COVID19_PFIZER/BIONTECH | Cardiac arrhythmia terms, nonspecific (SMQ) [narrow] | 88 | 69.56 | 1.228 | 1.474 | 1.739 | 1.044 | 1.244 | 1.473 | 1.265 | 4.086 | 164.824
COVID19_PFIZER/BIONTECH | Cardiac arrhythmia terms, nonspecific (SMQ) [broad] | 88 | 69.56 | 1.228 | 1.474 | 1.739 | 1.044 | 1.244 | 1.473 | 1.265 | 4.086 | 164.824
COVID19_PFIZER/BIONTECH | Cardiac arrest | 91 | 83.564 | 1.234 | 1.474 | 1.732 | 0.908 | 1.079 | 1.274 | 1.089 | 6.708 | 318.227
COVID19_PFIZER/BIONTECH | Terminal state | 1 | 0.965 | 0.308 | 1.474 | 3.351 | 0.361 | 0.878 | 1.862 | 1.036 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Eyelids pruritus | 11 | 7.057 | 0.884 | 1.473 | 2.183 | 0.832 | 1.315 | 1.999 | 1.559 | 7.095 | 36.866
COVID19_PFIZER/BIONTECH | Cerebral artery thrombosis | 1 | 0.52 | 0.332 | 1.473 | 3.279 | 0.402 | 0.977 | 2.078 | 1.924 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Bulbar palsy | 1 | 0.474 | 0.2 | 1.472 | 3.72 | 0.407 | 0.989 | 2.105 | 2.111 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Gene mutation identification test | 1 | 1.21 | 0.266 | 1.472 | 3.476 | 0.341 | 0.832 | 1.764 | 0.826 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Herpangina | 1 | 0.266 | 0.275 | 1.471 | 3.444 | 0.43 | 1.05 | 2.25 | 3.765 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Hypermetabolism | 1 | 0.47 | 0.309 | 1.471 | 3.338 | 0.408 | 0.99 | 2.107 | 2.125 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Hospitalisation | 5 | 4.561 | 0.667 | 1.47 | 2.528 | 0.533 | 0.983 | 1.692 | 1.096 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | Rhinalgia | 1 | 0.485 | 0.176 | 1.469 | 3.81 | 0.406 | 0.986 | 2.098 | 2.061 | 0.475 | 0.154
COVID19_PFIZER/BIONTECH | Epidermal necrosis | 1 | 0.515 | 0.303 | 1.469 | 3.351 | 0.403 | 0.978 | 2.081 | 1.942 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Carbon dioxide | 2 | 1.311 | 0.53 | 1.469 | 2.788 | 0.467 | 1.024 | 2.015 | 1.526 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Red cell distribution width normal | 18 | 12.813 | 0.978 | 1.468 | 2.038 | 0.883 | 1.28 | 1.807 | 1.405 | 2.211 | 9.538
COVID19_PFIZER/BIONTECH | Nasal mucosal discolouration | 1 | 0.354 | 0.31 | 1.467 | 3.324 | 0.42 | 1.022 | 2.182 | 2.824 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Blood potassium | 9 | 5.122 | 0.84 | 1.467 | 2.237 | 0.839 | 1.379 | 2.164 | 1.757 | 6.252 | 25.523
COVID19_PFIZER/BIONTECH | Lacrimation decreased | 1 | 0.553 | 0.334 | 1.467 | 3.254 | 0.399 | 0.969 | 2.06 | 1.81 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Echovirus test negative | 1 | 0.47 | 0.31 | 1.466 | 3.319 | 0.408 | 0.99 | 2.107 | 2.125 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Ultrasound breast abnormal | 1 | 0.815 | 0.31 | 1.466 | 3.321 | 0.374 | 0.909 | 1.928 | 1.227 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Cerumen removal | 1 | 0.834 | 0.334 | 1.466 | 3.251 | 0.372 | 0.905 | 1.919 | 1.199 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Ear, nose and throat examination | 2 | 0.941 | 0.521 | 1.465 | 2.797 | 0.506 | 1.11 | 2.192 | 2.126 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Systemic scleroderma | 1 | 0.461 | 0.334 | 1.465 | 3.25 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Vitamin B6 | 1 | 0.472 | 0.285 | 1.465 | 3.394 | 0.407 | 0.99 | 2.106 | 2.119 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Intestinal dilatation | 1 | 0.506 | 0.202 | 1.465 | 3.688 | 0.404 | 0.981 | 2.086 | 1.975 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Sputum culture positive | 1 | 0.553 | 0.324 | 1.465 | 3.277 | 0.399 | 0.969 | 2.06 | 1.81 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Left atrial enlargement | 1 | 0.947 | 0.285 | 1.465 | 3.394 | 0.363 | 0.881 | 1.869 | 1.056 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | EGFR status assay | 1 | 0.474 | 0.334 | 1.464 | 3.246 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood osmolarity | 1 | 0.693 | 0.334 | 1.464 | 3.245 | 0.385 | 0.936 | 1.986 | 1.442 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Respiratory viral panel | 20 | 16.32 | 1.002 | 1.464 | 1.998 | 0.811 | 1.155 | 1.607 | 1.225 | 3.035 | 21.574
COVID19_PFIZER/BIONTECH | Procalcitonin decreased | 1 | 0.95 | 0.311 | 1.464 | 3.313 | 0.362 | 0.881 | 1.868 | 1.052 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Anal incontinence | 11 | 7.654 | 0.882 | 1.462 | 2.16 | 0.788 | 1.246 | 1.893 | 1.437 | 1.602 | 1.741
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin decreased | 5 | 4.017 | 0.645 | 1.462 | 2.547 | 0.571 | 1.053 | 1.814 | 1.245 | 0.631 | 0.698
COVID19_PFIZER/BIONTECH | Stress at work | 1 | 0.354 | 0.312 | 1.461 | 3.303 | 0.42 | 1.022 | 2.182 | 2.824 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Peak expiratory flow rate | 1 | 0.48 | 0.312 | 1.461 | 3.301 | 0.407 | 0.987 | 2.101 | 2.084 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Subdural haematoma | 3 | 4.392 | 0.463 | 1.461 | 2.911 | 0.369 | 0.753 | 1.401 | 0.683 | 1.594 | 0.17
COVID19_PFIZER/BIONTECH | Red blood cell analysis | 1 | 0.474 | 0.312 | 1.46 | 3.296 | 0.407 | 0.989 | 2.105 | 2.111 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Anti-NMDA antibody negative | 1 | 0.461 | 0.195 | 1.459 | 3.698 | 0.409 | 0.992 | 2.113 | 2.17 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Cardiac assistance device user | 2 | 2.706 | 0.352 | 1.459 | 3.182 | 0.362 | 0.795 | 1.563 | 0.739 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Taste disorder | 59 | 42.525 | 1.165 | 1.458 | 1.778 | 1.086 | 1.344 | 1.649 | 1.387 | 14.399 | 401.638
COVID19_PFIZER/BIONTECH | Gun shot wound | 1 | 0.887 | 0.336 | 1.458 | 3.221 | 0.368 | 0.894 | 1.895 | 1.127 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Infant irritability | 1 | 0.56 | 0.336 | 1.457 | 3.218 | 0.398 | 0.967 | 2.056 | 1.786 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Troponin increased | 73 | 68.57 | 1.19 | 1.457 | 1.746 | 0.869 | 1.053 | 1.267 | 1.065 | 8.397 | 319.627
COVID19_PFIZER/BIONTECH | Angiogram cerebral normal | 21 | 12.78 | 1.006 | 1.456 | 1.973 | 1.037 | 1.466 | 2.027 | 1.643 | 21.07 | 175.666
COVID19_PFIZER/BIONTECH | Serratia infection | 1 | 0.528 | 0.359 | 1.456 | 3.155 | 0.402 | 0.975 | 2.074 | 1.895 | 9.03 | 0.787
COVID19_PFIZER/BIONTECH | Blood glucose abnormal | 4 | 2.388 | 0.669 | 1.455 | 2.486 | 0.609 | 1.174 | 2.097 | 1.675 | 2.189 | 1.321
COVID19_PFIZER/BIONTECH | Deep vein thrombosis | 41 | 28.292 | 1.109 | 1.455 | 1.839 | 1.07 | 1.38 | 1.757 | 1.449 | 13.223 | 260.109
COVID19_PFIZER/BIONTECH | Vaccination site pain | 198 | 154 | 1.29 | 1.455 | 1.628 | 1.134 | 1.275 | 1.43 | 1.286 | 2.858 | 205.735
COVID19_PFIZER/BIONTECH | Base excess increased | 2 | 1.416 | 0.423 | 1.454 | 2.987 | 0.457 | 1.002 | 1.971 | 1.412 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Ejection fraction normal | 5 | 5 | 0.614 | 1.454 | 2.583 | 0.506 | 0.933 | 1.606 | 1 | 2.822 | 3.56
COVID19_PFIZER/BIONTECH | Sleep talking | 2 | 1.336 | 0.42 | 1.453 | 2.989 | 0.465 | 1.019 | 2.004 | 1.497 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Sinus disorder | 12 | 10.491 | 0.857 | 1.453 | 2.177 | 0.685 | 1.066 | 1.597 | 1.144 | 2.58 | 8.756
COVID19_PFIZER/BIONTECH | Cardioversion | 24 | 15.258 | 1.037 | 1.452 | 1.925 | 1.034 | 1.433 | 1.945 | 1.573 | 12.384 | 141.973
COVID19_PFIZER/BIONTECH | Scintillating scotoma | 1 | 0.474 | 0.338 | 1.452 | 3.201 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Cytokine test | 1 | 0.515 | 0.235 | 1.452 | 3.522 | 0.403 | 0.978 | 2.081 | 1.942 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Glucose urine absent | 4 | 3.109 | 0.633 | 1.452 | 2.544 | 0.543 | 1.047 | 1.867 | 1.286 | 0.926 | 0.01
COVID19_PFIZER/BIONTECH | Intestinal resection | 1 | 0.462 | 0.17 | 1.451 | 3.783 | 0.408 | 0.992 | 2.112 | 2.163 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Cachexia | 1 | 0.5 | 0.29 | 1.451 | 3.337 | 0.404 | 0.982 | 2.089 | 1.999 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Echocardiogram normal | 48 | 40.374 | 1.129 | 1.451 | 1.807 | 0.917 | 1.16 | 1.452 | 1.189 | 2.761 | 45.207
COVID19_PFIZER/BIONTECH | Blood chloride decreased | 9 | 8.391 | 0.821 | 1.45 | 2.224 | 0.611 | 1.002 | 1.571 | 1.073 | 3.694 | 12.417
COVID19_PFIZER/BIONTECH | Compression fracture | 1 | 1.008 | 0.29 | 1.45 | 3.333 | 0.358 | 0.869 | 1.844 | 0.992 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Eyelid contusion | 1 | 0.354 | 0.339 | 1.448 | 3.187 | 0.42 | 1.022 | 2.182 | 2.824 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Choreoathetosis | 1 | 0.461 | 0.339 | 1.447 | 3.183 | 0.409 | 0.992 | 2.113 | 2.17 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Pleurisy | 9 | 5.648 | 0.83 | 1.447 | 2.205 | 0.792 | 1.3 | 2.039 | 1.593 | 4.277 | 15.585
COVID19_PFIZER/BIONTECH | Bronchospasm | 10 | 7.646 | 0.83 | 1.447 | 2.202 | 0.719 | 1.158 | 1.785 | 1.308 | 1.48 | 1.01
COVID19_PFIZER/BIONTECH | Breast inflammation | 1 | 1.169 | 0.339 | 1.447 | 3.181 | 0.345 | 0.839 | 1.78 | 0.855 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Clonic convulsion | 1 | 0.292 | 0.253 | 1.446 | 3.441 | 0.427 | 1.041 | 2.228 | 3.424 | 0.722 | 0.014
COVID19_PFIZER/BIONTECH | Laziness | 1 | 0.461 | 0.316 | 1.446 | 3.246 | 0.409 | 0.992 | 2.113 | 2.17 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Middle ear effusion | 7 | 4.333 | 0.78 | 1.446 | 2.278 | 0.732 | 1.263 | 2.064 | 1.615 | 3.718 | 9.28
COVID19_PFIZER/BIONTECH | Arterial disorder | 1 | 0.954 | 0.316 | 1.446 | 3.246 | 0.362 | 0.88 | 1.867 | 1.049 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Continuous positive airway pressure | 3 | 2.858 | 0.51 | 1.445 | 2.765 | 0.458 | 0.933 | 1.735 | 1.05 | 0.874 | 0.002
COVID19_PFIZER/BIONTECH | Oral pruritus | 37 | 24.908 | 1.094 | 1.444 | 1.833 | 1.075 | 1.404 | 1.807 | 1.485 | 8.353 | 158.541
COVID19_PFIZER/BIONTECH | Ventricular extrasystoles | 26 | 18.614 | 1.028 | 1.444 | 1.918 | 0.954 | 1.306 | 1.755 | 1.397 | 8.385 | 110.256
COVID19_PFIZER/BIONTECH | SARS-CoV-2 antibody test positive | 16 | 13.244 | 0.937 | 1.444 | 2.042 | 0.764 | 1.129 | 1.621 | 1.208 | 26.269 | 147.781
COVID19_PFIZER/BIONTECH | Periorbital swelling | 45 | 30.9 | 1.119 | 1.443 | 1.801 | 1.091 | 1.392 | 1.754 | 1.456 | 7.89 | 183.493
COVID19_PFIZER/BIONTECH | Viral test positive | 6 | 3.381 | 0.734 | 1.442 | 2.344 | 0.727 | 1.293 | 2.168 | 1.775 | 1.426 | 0.352
COVID19_PFIZER/BIONTECH | Aphonia | 20 | 14.791 | 0.99 | 1.441 | 1.961 | 0.878 | 1.251 | 1.741 | 1.352 | 3.314 | 25.287
COVID19_PFIZER/BIONTECH | Bradycardia | 24 | 21.531 | 1.008 | 1.441 | 1.938 | 0.776 | 1.075 | 1.459 | 1.115 | 1.253 | 0.909
COVID19_PFIZER/BIONTECH | Oesophageal pain | 1 | 1.188 | 0.318 | 1.441 | 3.224 | 0.343 | 0.836 | 1.773 | 0.842 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Pancreatic enzymes increased | 1 | 0.48 | 0.342 | 1.44 | 3.154 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | International normalised ratio | 22 | 15.082 | 0.995 | 1.44 | 1.951 | 0.954 | 1.339 | 1.839 | 1.459 | 9.691 | 105.72
COVID19_PFIZER/BIONTECH | Supraventricular extrasystoles | 4 | 2.18 | 0.669 | 1.439 | 2.445 | 0.631 | 1.217 | 2.175 | 1.835 | 4.013 | 5.032
COVID19_PFIZER/BIONTECH | Prostatic specific antigen | 1 | 0.474 | 0.342 | 1.439 | 3.152 | 0.407 | 0.989 | 2.105 | 2.111 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Demyelinating polyneuropathy | 3 | 3.329 | 0.473 | 1.439 | 2.831 | 0.426 | 0.869 | 1.617 | 0.901 | 1.129 | 0.012
COVID19_PFIZER/BIONTECH | Coronary arterial stent insertion | 6 | 5.689 | 0.708 | 1.438 | 2.376 | 0.546 | 0.971 | 1.624 | 1.055 | 7.224 | 18.531
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging thoracic | 1 | 0.931 | 0.253 | 1.438 | 3.42 | 0.364 | 0.885 | 1.876 | 1.074 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Scleral disorder | 1 | 0.354 | 0.342 | 1.437 | 3.144 | 0.42 | 1.022 | 2.182 | 2.824 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Protein C | 2 | 2.155 | 0.407 | 1.437 | 2.977 | 0.398 | 0.872 | 1.714 | 0.928 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Thyroid function test abnormal | 1 | 0.431 | 0.251 | 1.436 | 3.422 | 0.412 | 1.001 | 2.131 | 2.322 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Refusal of treatment by patient | 8 | 5.467 | 0.78 | 1.436 | 2.254 | 0.724 | 1.215 | 1.943 | 1.463 | 13.135 | 44.776
COVID19_PFIZER/BIONTECH | Presyncope | 126 | 93.728 | 1.234 | 1.436 | 1.651 | 1.144 | 1.326 | 1.529 | 1.344 | 2.005 | 56.382
COVID19_PFIZER/BIONTECH | Human metapneumovirus test | 2 | 0.981 | 0.424 | 1.435 | 2.93 | 0.502 | 1.1 | 2.171 | 2.04 | 1.505 | 0.014
COVID19_PFIZER/BIONTECH | Episcleritis | 1 | 0.461 | 0.212 | 1.435 | 3.56 | 0.409 | 0.992 | 2.113 | 2.17 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Hepatitis viral test negative | 4 | 3.006 | 0.571 | 1.434 | 2.612 | 0.552 | 1.063 | 1.896 | 1.33 | 0.87 | 0.001
COVID19_PFIZER/BIONTECH | Conduction disorder | 1 | 0.5 | 0.32 | 1.433 | 3.194 | 0.404 | 0.982 | 2.089 | 1.999 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Gastric haemorrhage | 1 | 0.693 | 0.32 | 1.433 | 3.195 | 0.385 | 0.936 | 1.986 | 1.442 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Nasopharyngitis | 53 | 43.599 | 1.132 | 1.433 | 1.763 | 0.948 | 1.187 | 1.471 | 1.216 | 0.858 | 1.046
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [narrow] | 101 | 88.436 | 1.209 | 1.433 | 1.674 | 0.959 | 1.13 | 1.324 | 1.142 | 0.742 | 8.5
COVID19_PFIZER/BIONTECH | Myocardial necrosis marker normal | 11 | 7.852 | 0.842 | 1.432 | 2.151 | 0.775 | 1.224 | 1.86 | 1.401 | 3.895 | 17.043
COVID19_PFIZER/BIONTECH | Radicular pain | 2 | 1.334 | 0.477 | 1.432 | 2.801 | 0.465 | 1.019 | 2.005 | 1.499 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Liver-related coagulation and bleeding disturbances (SMQ) [broad] | 23 | 19.891 | 0.993 | 1.432 | 1.937 | 0.794 | 1.107 | 1.511 | 1.156 | 2.186 | 12.12
COVID19_PFIZER/BIONTECH | Liver-related coagulation and bleeding disturbances (SMQ) [narrow] | 23 | 19.891 | 0.993 | 1.432 | 1.937 | 0.794 | 1.107 | 1.511 | 1.156 | 2.186 | 12.12
COVID19_PFIZER/BIONTECH | Monocytosis | 1 | 0.967 | 0.27 | 1.432 | 3.345 | 0.361 | 0.877 | 1.861 | 1.034 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Autoantibody test | 1 | 0.48 | 0.321 | 1.43 | 3.184 | 0.407 | 0.987 | 2.101 | 2.084 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Frustration tolerance decreased | 4 | 2.874 | 0.647 | 1.43 | 2.462 | 0.563 | 1.085 | 1.936 | 1.392 | 1.363 | 0.092
COVID19_PFIZER/BIONTECH | Eosinophil percentage | 13 | 9.711 | 0.88 | 1.429 | 2.086 | 0.785 | 1.203 | 1.782 | 1.339 | 1.312 | 0.617
COVID19_PFIZER/BIONTECH | Thirst decreased | 1 | 0.954 | 0.22 | 1.429 | 3.509 | 0.362 | 0.88 | 1.867 | 1.049 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Dysgeusia | 226 | 138.985 | 1.276 | 1.428 | 1.587 | 1.439 | 1.606 | 1.788 | 1.626 | 7.716 | 922.687
COVID19_PFIZER/BIONTECH | Dry throat | 51 | 34.408 | 1.131 | 1.428 | 1.754 | 1.13 | 1.421 | 1.768 | 1.482 | 8.528 | 224.955
COVID19_PFIZER/BIONTECH | CSF white blood cell count | 1 | 0.641 | 0.322 | 1.428 | 3.176 | 0.39 | 0.948 | 2.012 | 1.56 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Computerised tomogram pelvis abnormal | 8 | 6.091 | 0.785 | 1.428 | 2.228 | 0.677 | 1.137 | 1.817 | 1.314 | 10.32 | 36.822
COVID19_PFIZER/BIONTECH | Muscle strength abnormal | 1 | 0.701 | 0.271 | 1.428 | 3.332 | 0.385 | 0.934 | 1.982 | 1.427 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Petechiae | 42 | 33.639 | 1.096 | 1.428 | 1.797 | 0.94 | 1.209 | 1.534 | 1.249 | 1.076 | 0.144
COVID19_PFIZER/BIONTECH | General physical health deterioration | 35 | 30.946 | 1.061 | 1.428 | 1.839 | 0.837 | 1.1 | 1.426 | 1.131 | 1.501 | 4.94
COVID19_PFIZER/BIONTECH | Poisoning | 1 | 0.487 | 0.297 | 1.427 | 3.247 | 0.406 | 0.986 | 2.097 | 2.052 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Vitamin B12 | 6 | 4.775 | 0.738 | 1.427 | 2.3 | 0.606 | 1.077 | 1.802 | 1.256 | 2.778 | 4.405
COVID19_PFIZER/BIONTECH | Trigeminal neuralgia | 5 | 3.978 | 0.617 | 1.427 | 2.506 | 0.574 | 1.059 | 1.823 | 1.257 | 1.115 | 0
COVID19_PFIZER/BIONTECH | Monocyte percentage | 13 | 8.809 | 0.879 | 1.426 | 2.08 | 0.842 | 1.291 | 1.912 | 1.476 | 1.223 | 0.299
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, arterial (SMQ) [narrow] | 177 | 146.442 | 1.255 | 1.426 | 1.606 | 1.06 | 1.2 | 1.354 | 1.209 | 5.292 | 474.147
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, arterial (SMQ) [broad] | 177 | 146.442 | 1.255 | 1.426 | 1.606 | 1.06 | 1.2 | 1.354 | 1.209 | 5.292 | 474.147
COVID19_PFIZER/BIONTECH | Hyperacusis | 19 | 13.458 | 0.943 | 1.424 | 1.986 | 0.898 | 1.291 | 1.808 | 1.412 | 1 | 0.013
COVID19_PFIZER/BIONTECH | Exercise tolerance decreased | 6 | 4.493 | 0.66 | 1.424 | 2.423 | 0.627 | 1.115 | 1.865 | 1.336 | 0.853 | 0.035
COVID19_PFIZER/BIONTECH | Fertility disorders (SMQ) [narrow] | 9 | 8.477 | 0.758 | 1.424 | 2.259 | 0.606 | 0.995 | 1.56 | 1.062 | 0.829 | 0.155
COVID19_PFIZER/BIONTECH | Oculogyric crisis | 1 | 0.475 | 0.18 | 1.423 | 3.652 | 0.407 | 0.989 | 2.104 | 2.105 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Nervousness | 67 | 50.368 | 1.152 | 1.423 | 1.717 | 1.062 | 1.297 | 1.572 | 1.33 | 2.795 | 65.328
COVID19_PFIZER/BIONTECH | Monocyte count decreased | 6 | 4.641 | 0.705 | 1.423 | 2.344 | 0.616 | 1.095 | 1.831 | 1.293 | 4.515 | 10.336
COVID19_PFIZER/BIONTECH | Vein rupture | 1 | 1.204 | 0.323 | 1.423 | 3.159 | 0.342 | 0.833 | 1.767 | 0.83 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Acute left ventricular failure | 2 | 2.427 | 0.307 | 1.423 | 3.206 | 0.379 | 0.832 | 1.636 | 0.824 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Essential hypertension | 3 | 2.413 | 0.535 | 1.422 | 2.654 | 0.492 | 1.002 | 1.865 | 1.243 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Lung disorder | 6 | 5.859 | 0.679 | 1.422 | 2.386 | 0.536 | 0.954 | 1.595 | 1.024 | 1.178 | 0.026
COVID19_PFIZER/BIONTECH | Reaction to previous exposure to any vaccine | 2 | 2.396 | 0.486 | 1.422 | 2.757 | 0.381 | 0.837 | 1.644 | 0.835 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Pulmonary congestion | 16 | 14.971 | 0.915 | 1.421 | 2.019 | 0.693 | 1.024 | 1.47 | 1.069 | 4.07 | 27.657
COVID19_PFIZER/BIONTECH | Cardiac telemetry | 5 | 4.849 | 0.635 | 1.421 | 2.462 | 0.515 | 0.949 | 1.635 | 1.031 | 6.946 | 14.129
COVID19_PFIZER/BIONTECH | Increased insulin requirement | 1 | 1.434 | 0.324 | 1.421 | 3.148 | 0.325 | 0.794 | 1.685 | 0.698 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Epistaxis | 53 | 40.806 | 1.12 | 1.42 | 1.749 | 1.008 | 1.261 | 1.563 | 1.299 | 2.247 | 31.501
COVID19_PFIZER/BIONTECH | Tonsillar ulcer | 1 | 0.743 | 0.348 | 1.42 | 3.083 | 0.381 | 0.924 | 1.961 | 1.345 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Hepatic disorders (SMQ) [narrow] | 125 | 108.596 | 1.219 | 1.42 | 1.635 | 0.985 | 1.141 | 1.316 | 1.151 | 0.94 | 0.402
COVID19_PFIZER/BIONTECH | Blood creatinine increased | 63 | 56.915 | 1.142 | 1.42 | 1.723 | 0.887 | 1.091 | 1.33 | 1.107 | 3.682 | 100.012
COVID19_PFIZER/BIONTECH | Abdominal lymphadenopathy | 1 | 0.515 | 0.33 | 1.419 | 3.128 | 0.403 | 0.978 | 2.081 | 1.942 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin | 11 | 7.336 | 0.83 | 1.419 | 2.137 | 0.811 | 1.282 | 1.948 | 1.499 | 8.278 | 43.143
COVID19_PFIZER/BIONTECH | Anti-GAD antibody | 1 | 0.48 | 0.301 | 1.418 | 3.21 | 0.407 | 0.987 | 2.101 | 2.084 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | X-ray dental | 1 | 0.534 | 0.325 | 1.418 | 3.138 | 0.401 | 0.974 | 2.07 | 1.873 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Chest discomfort | 553 | 401.992 | 1.32 | 1.418 | 1.518 | 1.278 | 1.371 | 1.469 | 1.376 | 5.74 | 1649.795
COVID19_PFIZER/BIONTECH | Coronavirus test positive | 16 | 12.342 | 0.925 | 1.418 | 1.997 | 0.807 | 1.193 | 1.712 | 1.296 | 16.998 | 115.569
COVID19_PFIZER/BIONTECH | Product dispensing error | 1 | 0.356 | 0.301 | 1.417 | 3.206 | 0.42 | 1.022 | 2.181 | 2.812 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Mouth injury | 2 | 1.208 | 0.492 | 1.417 | 2.729 | 0.478 | 1.046 | 2.06 | 1.656 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Acute febrile neutrophilic dermatosis | 2 | 0.922 | 0.296 | 1.416 | 3.22 | 0.508 | 1.115 | 2.202 | 2.17 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Cardiomyopathy | 4 | 3.793 | 0.545 | 1.416 | 2.619 | 0.493 | 0.95 | 1.693 | 1.055 | 1.57 | 0.309
COVID19_PFIZER/BIONTECH | X-ray with contrast | 1 | 0.949 | 0.326 | 1.416 | 3.13 | 0.363 | 0.881 | 1.869 | 1.054 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Capillary nail refill test abnormal | 3 | 1.196 | 0.548 | 1.415 | 2.609 | 0.618 | 1.262 | 2.37 | 2.509 | 2.709 | 1.463
COVID19_PFIZER/BIONTECH | Mean cell volume decreased | 3 | 1.731 | 0.487 | 1.415 | 2.735 | 0.555 | 1.131 | 2.11 | 1.733 | 0.29 | 4.432
COVID19_PFIZER/BIONTECH | Retinogram abnormal | 1 | 0.47 | 0.326 | 1.415 | 3.126 | 0.408 | 0.99 | 2.107 | 2.125 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Neutrophil count abnormal | 1 | 0.48 | 0.349 | 1.415 | 3.064 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood potassium normal | 34 | 27.827 | 1.052 | 1.415 | 1.823 | 0.892 | 1.178 | 1.531 | 1.222 | 1.749 | 9.254
COVID19_PFIZER/BIONTECH | Cardiomyopathy (SMQ) [narrow] | 24 | 20.267 | 0.988 | 1.415 | 1.906 | 0.817 | 1.132 | 1.536 | 1.184 | 3.334 | 31.074
COVID19_PFIZER/BIONTECH | Constipation | 23 | 20.489 | 0.979 | 1.415 | 1.917 | 0.774 | 1.08 | 1.474 | 1.123 | 0.585 | 6.153
COVID19_PFIZER/BIONTECH | Paroxysmal nocturnal haemoglobinuria | 1 | 1.042 | 0.285 | 1.415 | 3.249 | 0.355 | 0.863 | 1.83 | 0.96 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Pulmonary mass | 3 | 3.18 | 0.521 | 1.415 | 2.664 | 0.436 | 0.888 | 1.652 | 0.943 | 1.806 | 0.36
COVID19_PFIZER/BIONTECH | Photopsia | 10 | 7.874 | 0.83 | 1.414 | 2.125 | 0.705 | 1.135 | 1.749 | 1.27 | 2.286 | 5.275
COVID19_PFIZER/BIONTECH | Haematocrit decreased | 24 | 20.769 | 0.983 | 1.414 | 1.909 | 0.8 | 1.109 | 1.505 | 1.156 | 1.412 | 2.289
COVID19_PFIZER/BIONTECH | Blood mercury abnormal | 1 | 0.474 | 0.249 | 1.413 | 3.36 | 0.407 | 0.989 | 2.105 | 2.111 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Wound drainage | 1 | 0.48 | 0.35 | 1.413 | 3.056 | 0.407 | 0.987 | 2.101 | 2.084 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Groin pain | 12 | 9.05 | 0.863 | 1.413 | 2.074 | 0.763 | 1.187 | 1.779 | 1.326 | 1.806 | 3.19
COVID19_PFIZER/BIONTECH | Influenza virus test | 22 | 17.049 | 0.973 | 1.413 | 1.919 | 0.863 | 1.211 | 1.663 | 1.29 | 2.685 | 18.738
COVID19_PFIZER/BIONTECH | Vulvovaginal discomfort | 1 | 0.461 | 0.249 | 1.412 | 3.354 | 0.409 | 0.992 | 2.113 | 2.17 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Amino acid level | 1 | 0.544 | 0.34 | 1.412 | 3.081 | 0.4 | 0.971 | 2.064 | 1.837 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Pharyngeal erythema | 9 | 8 | 0.772 | 1.412 | 2.209 | 0.631 | 1.036 | 1.624 | 1.125 | 0.658 | 1.215
COVID19_PFIZER/BIONTECH | Blood gases abnormal | 3 | 4.331 | 0.443 | 1.412 | 2.824 | 0.372 | 0.759 | 1.412 | 0.693 | 1.935 | 0.495
COVID19_PFIZER/BIONTECH | Exploratory operation | 1 | 0.461 | 0.303 | 1.411 | 3.183 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Blood alkaline phosphatase increased | 24 | 22.114 | 0.985 | 1.411 | 1.899 | 0.758 | 1.051 | 1.426 | 1.085 | 2.178 | 12.569
COVID19_PFIZER/BIONTECH | Autoantibody negative | 1 | 0.461 | 0.232 | 1.41 | 3.406 | 0.409 | 0.992 | 2.113 | 2.17 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Blood glucose normal | 98 | 69.744 | 1.188 | 1.41 | 1.648 | 1.166 | 1.377 | 1.617 | 1.405 | 1.926 | 38.657
COVID19_PFIZER/BIONTECH | Paracentesis | 1 | 0.947 | 0.303 | 1.41 | 3.18 | 0.363 | 0.881 | 1.869 | 1.056 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Intranasal hypoaesthesia | 1 | 0.974 | 0.278 | 1.409 | 3.252 | 0.36 | 0.876 | 1.858 | 1.027 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Mucosal disorder | 2 | 1.1 | 0.467 | 1.408 | 2.761 | 0.489 | 1.071 | 2.111 | 1.819 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Infective pneumonia (SMQ) [broad] | 1797 | 1341.117 | 1.353 | 1.408 | 1.463 | 1.287 | 1.339 | 1.391 | 1.34 | 3.468 | 2735.44
COVID19_PFIZER/BIONTECH | Cytology normal | 1 | 0.834 | 0.271 | 1.408 | 3.272 | 0.372 | 0.905 | 1.919 | 1.199 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Beta-2 glycoprotein antibody negative | 1 | 0.944 | 0.278 | 1.408 | 3.25 | 0.363 | 0.882 | 1.871 | 1.059 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Oesophageal discomfort | 1 | 0.354 | 0.329 | 1.407 | 3.095 | 0.42 | 1.022 | 2.182 | 2.824 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | CSF cell count normal | 3 | 2.543 | 0.476 | 1.407 | 2.739 | 0.481 | 0.981 | 1.825 | 1.18 | 0.722 | 0.09
COVID19_PFIZER/BIONTECH | Prothrombin time shortened | 2 | 1.432 | 0.414 | 1.406 | 2.875 | 0.456 | 0.999 | 1.965 | 1.397 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Eosinophil percentage increased | 4 | 2.429 | 0.624 | 1.405 | 2.438 | 0.605 | 1.166 | 2.082 | 1.647 | 0.675 | 0.318
COVID19_PFIZER/BIONTECH | Metabolic function test normal | 92 | 68.751 | 1.178 | 1.405 | 1.648 | 1.106 | 1.313 | 1.55 | 1.338 | 2.751 | 87.555
COVID19_PFIZER/BIONTECH | Jaundice | 10 | 8.749 | 0.788 | 1.405 | 2.166 | 0.655 | 1.054 | 1.625 | 1.143 | 1.212 | 0.17
COVID19_PFIZER/BIONTECH | Diabetes mellitus inadequate control | 4 | 2.136 | 0.633 | 1.404 | 2.42 | 0.636 | 1.226 | 2.193 | 1.873 | 9.03 | 13.812
COVID19_PFIZER/BIONTECH | Dysphagia | 215 | 156.402 | 1.252 | 1.404 | 1.564 | 1.217 | 1.363 | 1.521 | 1.375 | 3.748 | 357.654
COVID19_PFIZER/BIONTECH | Whole body scan | 1 | 0.746 | 0.252 | 1.404 | 3.322 | 0.38 | 0.924 | 1.96 | 1.341 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Haematocrit abnormal | 1 | 1.093 | 0.353 | 1.404 | 3.024 | 0.351 | 0.853 | 1.809 | 0.915 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Blood HIV RNA below assay limit | 1 | 1.154 | 0.33 | 1.404 | 3.084 | 0.346 | 0.842 | 1.786 | 0.866 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus test negative | 13 | 8.706 | 0.88 | 1.403 | 2.024 | 0.849 | 1.302 | 1.928 | 1.493 | 1.406 | 1.044
COVID19_PFIZER/BIONTECH | Atrioventricular block | 4 | 3.361 | 0.62 | 1.403 | 2.442 | 0.523 | 1.009 | 1.799 | 1.19 | 7.224 | 10.989
COVID19_PFIZER/BIONTECH | Ischaemic heart disease (SMQ) [narrow] | 204 | 173.912 | 1.245 | 1.402 | 1.567 | 1.039 | 1.166 | 1.306 | 1.173 | 5.904 | 623.903
COVID19_PFIZER/BIONTECH | Decerebrate posture | 1 | 0.825 | 0.306 | 1.402 | 3.147 | 0.373 | 0.907 | 1.923 | 1.213 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Lymphangitis | 3 | 2.804 | 0.462 | 1.402 | 2.755 | 0.462 | 0.94 | 1.75 | 1.07 | 0.888 | 0.006
COVID19_PFIZER/BIONTECH | Oxygen saturation decreased | 106 | 91.206 | 1.188 | 1.401 | 1.629 | 0.98 | 1.15 | 1.342 | 1.162 | 4.283 | 213.149
COVID19_PFIZER/BIONTECH | Spinal cord injury | 1 | 1.271 | 0.224 | 1.401 | 3.409 | 0.337 | 0.821 | 1.742 | 0.787 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Alanine aminotransferase increased | 40 | 33.307 | 1.064 | 1.4 | 1.776 | 0.901 | 1.165 | 1.487 | 1.201 | 1.54 | 6.48
COVID19_PFIZER/BIONTECH | Electrolyte imbalance | 1 | 1.397 | 0.137 | 1.4 | 3.778 | 0.328 | 0.8 | 1.698 | 0.716 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [broad] | 334 | 253.238 | 1.276 | 1.399 | 1.527 | 1.199 | 1.312 | 1.434 | 1.319 | 5.544 | 952.13
COVID19_PFIZER/BIONTECH | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [narrow] | 334 | 253.238 | 1.276 | 1.399 | 1.527 | 1.199 | 1.312 | 1.434 | 1.319 | 5.549 | 953.183
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, venous (SMQ) [narrow] | 94 | 82.802 | 1.173 | 1.399 | 1.641 | 0.948 | 1.123 | 1.323 | 1.135 | 6.504 | 317.999
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, venous (SMQ) [broad] | 94 | 82.802 | 1.173 | 1.399 | 1.641 | 0.948 | 1.123 | 1.323 | 1.135 | 6.504 | 317.999
COVID19_PFIZER/BIONTECH | Cardiac failure acute | 9 | 6.195 | 0.776 | 1.398 | 2.169 | 0.747 | 1.227 | 1.924 | 1.453 | 10.836 | 43.947
COVID19_PFIZER/BIONTECH | Cough | 689 | 521.152 | 1.312 | 1.398 | 1.487 | 1.238 | 1.319 | 1.403 | 1.322 | 2.171 | 394.961
COVID19_PFIZER/BIONTECH | Blood alkaline phosphatase normal | 17 | 13.553 | 0.914 | 1.398 | 1.966 | 0.798 | 1.167 | 1.661 | 1.254 | 1.744 | 4.237
COVID19_PFIZER/BIONTECH | Nerve block | 1 | 0.815 | 0.209 | 1.398 | 3.455 | 0.374 | 0.909 | 1.928 | 1.227 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Lower limb fracture | 1 | 0.518 | 0.308 | 1.397 | 3.128 | 0.403 | 0.978 | 2.079 | 1.932 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Joint contracture | 2 | 1.76 | 0.468 | 1.397 | 2.729 | 0.428 | 0.937 | 1.841 | 1.136 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Aptyalism | 1 | 0.487 | 0.309 | 1.396 | 3.122 | 0.406 | 0.986 | 2.097 | 2.052 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Blood glucose | 36 | 24.732 | 1.059 | 1.396 | 1.772 | 1.051 | 1.377 | 1.778 | 1.456 | 3.172 | 43.633
COVID19_PFIZER/BIONTECH | Pharyngeal swelling | 179 | 139.496 | 1.231 | 1.396 | 1.571 | 1.124 | 1.272 | 1.435 | 1.283 | 9.621 | 897.622
COVID19_PFIZER/BIONTECH | Tumour lysis syndrome (SMQ) [algorithm] | 15 | 15.691 | 0.876 | 1.396 | 2.014 | 0.625 | 0.934 | 1.353 | 0.956 | 2.508 | 10.593
COVID19_PFIZER/BIONTECH | Vaccination site joint pain | 1 | 1.177 | 0.226 | 1.396 | 3.388 | 0.344 | 0.838 | 1.777 | 0.85 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Salivary hypersecretion | 9 | 6.914 | 0.768 | 1.395 | 2.173 | 0.696 | 1.143 | 1.792 | 1.302 | 1.28 | 0.276
COVID19_PFIZER/BIONTECH | Skin culture | 1 | 0.693 | 0.255 | 1.395 | 3.284 | 0.385 | 0.936 | 1.986 | 1.442 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Coombs direct test negative | 1 | 0.487 | 0.337 | 1.394 | 3.039 | 0.406 | 0.986 | 2.097 | 2.052 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Adenovirus infection | 1 | 0.577 | 0.231 | 1.394 | 3.363 | 0.397 | 0.963 | 2.046 | 1.734 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Tongue discolouration | 2 | 1.36 | 0.566 | 1.393 | 2.516 | 0.463 | 1.013 | 1.994 | 1.47 | 1.165 | 0.033
COVID19_PFIZER/BIONTECH | Ocular icterus | 3 | 2.125 | 0.469 | 1.393 | 2.715 | 0.517 | 1.053 | 1.96 | 1.412 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Condition aggravated | 401 | 309.424 | 1.281 | 1.393 | 1.509 | 1.188 | 1.291 | 1.4 | 1.296 | 2.76 | 392.258
COVID19_PFIZER/BIONTECH | Rectal haemorrhage | 8 | 7.438 | 0.728 | 1.393 | 2.232 | 0.594 | 0.998 | 1.595 | 1.076 | 1.605 | 1.142
COVID19_PFIZER/BIONTECH | Ultrasound spleen | 1 | 1.048 | 0.334 | 1.393 | 3.044 | 0.354 | 0.862 | 1.828 | 0.954 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Penile haemorrhage | 1 | 0.474 | 0.334 | 1.392 | 3.041 | 0.407 | 0.989 | 2.105 | 2.111 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Cardiac arrhythmias (SMQ) [narrow] | 337 | 256.309 | 1.27 | 1.392 | 1.519 | 1.196 | 1.308 | 1.429 | 1.315 | 5.548 | 961.565
COVID19_PFIZER/BIONTECH | Abdominal pain | 221 | 175.592 | 1.242 | 1.392 | 1.549 | 1.119 | 1.25 | 1.393 | 1.259 | 1.487 | 32.378
COVID19_PFIZER/BIONTECH | Pericarditis | 25 | 24.805 | 0.972 | 1.392 | 1.874 | 0.716 | 0.986 | 1.332 | 1.008 | 2.787 | 23.222
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level | 1 | 0.266 | 0.335 | 1.391 | 3.034 | 0.43 | 1.05 | 2.25 | 3.765 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Hernia repair | 1 | 0.474 | 0.335 | 1.391 | 3.034 | 0.407 | 0.989 | 2.105 | 2.111 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Breath sounds normal | 1 | 0.481 | 0.335 | 1.391 | 3.036 | 0.406 | 0.987 | 2.1 | 2.078 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Incorrect product formulation administered | 4 | 2.677 | 0.493 | 1.391 | 2.659 | 0.581 | 1.119 | 1.998 | 1.494 | 0.144 | 19.245
COVID19_PFIZER/BIONTECH | Anaphylactic reaction | 171 | 138.946 | 1.222 | 1.391 | 1.57 | 1.076 | 1.221 | 1.38 | 1.231 | 3.061 | 201.718
COVID19_PFIZER/BIONTECH | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [narrow] | 24 | 22.513 | 0.972 | 1.391 | 1.871 | 0.747 | 1.035 | 1.404 | 1.066 | 3.01 | 25.836
COVID19_PFIZER/BIONTECH | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [broad] | 24 | 22.513 | 0.972 | 1.391 | 1.871 | 0.747 | 1.035 | 1.404 | 1.066 | 3.01 | 25.836
COVID19_PFIZER/BIONTECH | Supraventricular tachycardia | 29 | 20.099 | 1.018 | 1.39 | 1.81 | 1.002 | 1.351 | 1.79 | 1.443 | 6.891 | 101.297
COVID19_PFIZER/BIONTECH | Electrocardiogram ST segment abnormal | 3 | 3.63 | 0.447 | 1.39 | 2.755 | 0.408 | 0.833 | 1.549 | 0.827 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | Prothrombin time normal | 10 | 6.726 | 0.829 | 1.389 | 2.065 | 0.784 | 1.261 | 1.945 | 1.487 | 2.029 | 3.768
COVID19_PFIZER/BIONTECH | Oral discomfort | 30 | 20.508 | 1.037 | 1.389 | 1.783 | 1.02 | 1.369 | 1.807 | 1.463 | 4.925 | 70.553
COVID19_PFIZER/BIONTECH | Herpes simplex | 6 | 7.4 | 0.652 | 1.389 | 2.348 | 0.461 | 0.82 | 1.372 | 0.811 | 1.338 | 0.202
COVID19_PFIZER/BIONTECH | Sudden death | 20 | 25.971 | 0.932 | 1.389 | 1.92 | 0.546 | 0.779 | 1.083 | 0.77 | 3.408 | 26.533
COVID19_PFIZER/BIONTECH | Diagnostic procedure | 3 | 1.035 | 0.645 | 1.388 | 2.359 | 0.639 | 1.31 | 2.47 | 2.899 | 1.464 | 0.081
COVID19_PFIZER/BIONTECH | Physical examination normal | 5 | 1.984 | 0.62 | 1.388 | 2.403 | 0.78 | 1.443 | 2.51 | 2.52 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | CSF immunoglobulin G index | 1 | 0.474 | 0.236 | 1.388 | 3.329 | 0.407 | 0.989 | 2.105 | 2.111 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Amblyopia | 1 | 0.461 | 0.375 | 1.387 | 2.92 | 0.409 | 0.992 | 2.113 | 2.17 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Blood corticotrophin | 1 | 0.461 | 0.336 | 1.387 | 3.018 | 0.409 | 0.992 | 2.113 | 2.17 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Anion gap increased | 3 | 3.42 | 0.471 | 1.387 | 2.695 | 0.421 | 0.858 | 1.595 | 0.877 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Abnormal sensation in eye | 10 | 6.165 | 0.837 | 1.386 | 2.048 | 0.828 | 1.333 | 2.057 | 1.622 | 6.02 | 27.552
COVID19_PFIZER/BIONTECH | Motor neurone disease | 1 | 0.533 | 0.351 | 1.386 | 2.979 | 0.401 | 0.974 | 2.07 | 1.875 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Lack of efficacy/effect (SMQ) [broad] | 140 | 129.788 | 1.199 | 1.385 | 1.583 | 0.933 | 1.072 | 1.228 | 1.079 | 0.495 | 70.575
COVID19_PFIZER/BIONTECH | Lack of efficacy/effect (SMQ) [narrow] | 140 | 129.788 | 1.199 | 1.385 | 1.583 | 0.933 | 1.072 | 1.228 | 1.079 | 0.495 | 70.575
COVID19_PFIZER/BIONTECH | Full blood count normal | 136 | 101.477 | 1.198 | 1.384 | 1.582 | 1.148 | 1.323 | 1.518 | 1.34 | 2.096 | 69.044
COVID19_PFIZER/BIONTECH | Facial discomfort | 12 | 9.12 | 0.839 | 1.384 | 2.04 | 0.759 | 1.181 | 1.77 | 1.316 | 19.702 | 92.67
COVID19_PFIZER/BIONTECH | IIIrd nerve paresis | 1 | 0.48 | 0.26 | 1.383 | 3.234 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Facial paresis | 32 | 24.379 | 1.021 | 1.383 | 1.79 | 0.941 | 1.251 | 1.639 | 1.313 | 3.211 | 39.424
COVID19_PFIZER/BIONTECH | Proctitis | 1 | 0.931 | 0.314 | 1.382 | 3.067 | 0.364 | 0.885 | 1.876 | 1.074 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Echocardiogram abnormal | 22 | 21.001 | 0.946 | 1.382 | 1.886 | 0.724 | 1.017 | 1.396 | 1.048 | 1.987 | 8.802
COVID19_PFIZER/BIONTECH | Pemphigoid | 3 | 3.225 | 0.47 | 1.381 | 2.68 | 0.433 | 0.882 | 1.641 | 0.93 | 0.785 | 0.022
COVID19_PFIZER/BIONTECH | Thrombophlebitis (SMQ) [broad] | 86 | 64.247 | 1.148 | 1.38 | 1.629 | 1.099 | 1.312 | 1.557 | 1.339 | 7.326 | 329.775
COVID19_PFIZER/BIONTECH | Red blood cell nucleated morphology present | 1 | 0.474 | 0.202 | 1.379 | 3.426 | 0.407 | 0.989 | 2.105 | 2.111 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Supraventricular tachyarrhythmias (SMQ) [narrow] | 170 | 124.604 | 1.212 | 1.379 | 1.556 | 1.189 | 1.349 | 1.527 | 1.364 | 6.838 | 611.257
COVID19_PFIZER/BIONTECH | Blood pressure immeasurable | 4 | 3.082 | 0.623 | 1.379 | 2.376 | 0.545 | 1.051 | 1.875 | 1.298 | 2.258 | 1.451
COVID19_PFIZER/BIONTECH | Blood bilirubin | 3 | 3.154 | 0.461 | 1.379 | 2.696 | 0.437 | 0.892 | 1.658 | 0.951 | 1.389 | 0.042
COVID19_PFIZER/BIONTECH | Language disorder | 2 | 1.122 | 0.359 | 1.378 | 2.934 | 0.486 | 1.066 | 2.1 | 1.782 | 0.457 | 0.76
COVID19_PFIZER/BIONTECH | Spinal myelogram normal | 1 | 0.474 | 0.315 | 1.378 | 3.051 | 0.407 | 0.989 | 2.105 | 2.111 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Supraventricular tachyarrhythmias (SMQ) [broad] | 170 | 124.87 | 1.21 | 1.378 | 1.554 | 1.187 | 1.347 | 1.523 | 1.361 | 6.793 | 606.917
COVID19_PFIZER/BIONTECH | Aspartate aminotransferase increased | 44 | 35.467 | 1.061 | 1.378 | 1.729 | 0.941 | 1.203 | 1.52 | 1.241 | 1.814 | 13.861
COVID19_PFIZER/BIONTECH | Dyschezia | 1 | 0.737 | 0.212 | 1.378 | 3.385 | 0.381 | 0.926 | 1.964 | 1.356 | 0.645 | 0
COVID19_PFIZER/BIONTECH | Blepharospasm | 19 | 11.807 | 0.941 | 1.377 | 1.881 | 0.994 | 1.429 | 2.003 | 1.609 | 3.299 | 23.742
COVID19_PFIZER/BIONTECH | Penile pain | 1 | 0.474 | 0.316 | 1.377 | 3.049 | 0.407 | 0.989 | 2.105 | 2.111 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | CSF lymphocyte count increased | 2 | 1.16 | 0.369 | 1.377 | 2.907 | 0.482 | 1.057 | 2.082 | 1.724 | 0.785 | 0
COVID19_PFIZER/BIONTECH | Bronchoalveolar lavage abnormal | 1 | 0.722 | 0.205 | 1.377 | 3.408 | 0.383 | 0.929 | 1.972 | 1.386 | 0.645 | 0
COVID19_PFIZER/BIONTECH | Eosinophilic pneumonia (SMQ) [algorithm] | 11 | 9.891 | 0.805 | 1.377 | 2.075 | 0.658 | 1.039 | 1.578 | 1.112 | 1.823 | 2.964
COVID19_PFIZER/BIONTECH | Myocardial infarction (SMQ) [narrow] | 176 | 152.297 | 1.21 | 1.376 | 1.551 | 1.014 | 1.148 | 1.296 | 1.156 | 6.447 | 593.878
COVID19_PFIZER/BIONTECH | Reduced facial expression | 1 | 0.48 | 0.317 | 1.375 | 3.038 | 0.407 | 0.987 | 2.101 | 2.084 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Parasite blood test | 1 | 0.829 | 0.317 | 1.375 | 3.039 | 0.373 | 0.906 | 1.921 | 1.206 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Food poisoning | 1 | 1.234 | 0.317 | 1.375 | 3.041 | 0.34 | 0.827 | 1.756 | 0.81 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Dyspepsia | 44 | 34.798 | 1.059 | 1.374 | 1.722 | 0.958 | 1.224 | 1.547 | 1.264 | 2.649 | 37.918
COVID19_PFIZER/BIONTECH | Diagnostic aspiration | 1 | 0.815 | 0.379 | 1.374 | 2.874 | 0.374 | 0.909 | 1.928 | 1.227 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Drug related hepatic disorders - comprehensive search (SMQ) [narrow] | 124 | 102.844 | 1.179 | 1.373 | 1.581 | 1.029 | 1.193 | 1.378 | 1.206 | 1.378 | 11.645
COVID19_PFIZER/BIONTECH | Altered visual depth perception | 1 | 0.461 | 0.236 | 1.372 | 3.281 | 0.409 | 0.992 | 2.113 | 2.17 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Scan with contrast abnormal | 20 | 12.829 | 0.937 | 1.372 | 1.874 | 0.983 | 1.401 | 1.949 | 1.559 | 5.826 | 56.674
COVID19_PFIZER/BIONTECH | Splint application | 1 | 0.48 | 0.342 | 1.371 | 2.957 | 0.407 | 0.987 | 2.101 | 2.084 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Streptococcus test negative | 25 | 19.004 | 0.977 | 1.37 | 1.818 | 0.9 | 1.239 | 1.673 | 1.316 | 0.789 | 1.144
COVID19_PFIZER/BIONTECH | Antibody test | 7 | 5.011 | 0.677 | 1.369 | 2.257 | 0.675 | 1.164 | 1.9 | 1.397 | 1.264 | 0.148
COVID19_PFIZER/BIONTECH | Culture throat positive | 1 | 1.035 | 0.196 | 1.369 | 3.42 | 0.355 | 0.864 | 1.833 | 0.966 | 0.583 | 0.02
COVID19_PFIZER/BIONTECH | Macular degeneration | 1 | 1.199 | 0.266 | 1.369 | 3.174 | 0.342 | 0.834 | 1.769 | 0.834 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Palatal disorder | 2 | 2.54 | 0.444 | 1.369 | 2.706 | 0.372 | 0.817 | 1.606 | 0.787 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Cytokine storm | 1 | 1.465 | 0.319 | 1.369 | 3.015 | 0.323 | 0.788 | 1.674 | 0.682 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Lymphoma | 2 | 1.088 | 0.459 | 1.368 | 2.672 | 0.49 | 1.074 | 2.116 | 1.838 | 1.003 | 0.129
COVID19_PFIZER/BIONTECH | Status asthmaticus | 1 | 0.815 | 0.294 | 1.368 | 3.084 | 0.374 | 0.909 | 1.928 | 1.227 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Undifferentiated connective tissue disease | 1 | 0.922 | 0.294 | 1.368 | 3.087 | 0.365 | 0.887 | 1.88 | 1.085 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Photosensitivity reaction | 7 | 4.865 | 0.667 | 1.365 | 2.263 | 0.686 | 1.184 | 1.933 | 1.439 | 0.805 | 0.15
COVID19_PFIZER/BIONTECH | Pulseless electrical activity | 16 | 13.763 | 0.883 | 1.365 | 1.933 | 0.741 | 1.095 | 1.572 | 1.163 | 14.448 | 103.531
COVID19_PFIZER/BIONTECH | Immunoglobulins | 3 | 1.47 | 0.579 | 1.364 | 2.418 | 0.584 | 1.191 | 2.226 | 2.041 | 1.935 | 0.495
COVID19_PFIZER/BIONTECH | Thyroid hormones increased | 1 | 0.815 | 0.296 | 1.363 | 3.063 | 0.374 | 0.909 | 1.928 | 1.227 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Blood sodium normal | 32 | 27.598 | 1.002 | 1.362 | 1.767 | 0.844 | 1.122 | 1.469 | 1.159 | 1.554 | 5.293
COVID19_PFIZER/BIONTECH | Resuscitation | 68 | 65.308 | 1.107 | 1.362 | 1.638 | 0.845 | 1.031 | 1.248 | 1.041 | 3.469 | 98.196
COVID19_PFIZER/BIONTECH | Gaze palsy | 11 | 9.539 | 0.804 | 1.361 | 2.036 | 0.675 | 1.067 | 1.621 | 1.153 | 0.558 | 3.3
COVID19_PFIZER/BIONTECH | Lymph gland infection | 1 | 0.461 | 0.402 | 1.36 | 2.778 | 0.409 | 0.992 | 2.113 | 2.17 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Blood calcium | 5 | 3.244 | 0.733 | 1.36 | 2.143 | 0.636 | 1.173 | 2.021 | 1.541 | 3.612 | 5.741
COVID19_PFIZER/BIONTECH | Scleritis | 1 | 0.536 | 0.357 | 1.36 | 2.888 | 0.401 | 0.973 | 2.069 | 1.865 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Thoracic operation | 1 | 0.553 | 0.27 | 1.36 | 3.135 | 0.399 | 0.969 | 2.06 | 1.81 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Feeling abnormal | 605 | 474.652 | 1.271 | 1.36 | 1.452 | 1.189 | 1.271 | 1.358 | 1.275 | 2.706 | 572.121
COVID19_PFIZER/BIONTECH | Sinus operation | 6 | 3.647 | 0.722 | 1.359 | 2.16 | 0.7 | 1.245 | 2.086 | 1.645 | 9.851 | 25.127
COVID19_PFIZER/BIONTECH | Malignant lymphomas (SMQ) [narrow] | 3 | 2.082 | 0.517 | 1.359 | 2.524 | 0.521 | 1.061 | 1.975 | 1.441 | 0.669 | 0.197
COVID19_PFIZER/BIONTECH | Electrocardiogram normal | 197 | 151.099 | 1.205 | 1.359 | 1.521 | 1.149 | 1.293 | 1.45 | 1.304 | 3.35 | 272.883
COVID19_PFIZER/BIONTECH | Platelet count normal | 42 | 33.749 | 1.042 | 1.359 | 1.711 | 0.938 | 1.205 | 1.53 | 1.244 | 1.13 | 0.473
COVID19_PFIZER/BIONTECH | Occipital neuralgia | 1 | 0.487 | 0.323 | 1.358 | 2.974 | 0.406 | 0.986 | 2.097 | 2.052 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Malaise | 802 | 670.129 | 1.279 | 1.357 | 1.437 | 1.127 | 1.195 | 1.266 | 1.197 | 1.456 | 109.108
COVID19_PFIZER/BIONTECH | Breast feeding | 1 | 0.816 | 0.299 | 1.357 | 3.039 | 0.374 | 0.908 | 1.927 | 1.225 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Basophil percentage | 10 | 7.623 | 0.811 | 1.356 | 2.016 | 0.721 | 1.16 | 1.789 | 1.312 | 1.704 | 2.022
COVID19_PFIZER/BIONTECH | Coma scale | 1 | 0.736 | 0.272 | 1.356 | 3.117 | 0.381 | 0.926 | 1.965 | 1.359 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Myocardial necrosis marker increased | 6 | 4.922 | 0.648 | 1.356 | 2.275 | 0.595 | 1.059 | 1.771 | 1.219 | 3.496 | 6.886
COVID19_PFIZER/BIONTECH | Mean platelet volume increased | 4 | 3.055 | 0.533 | 1.355 | 2.481 | 0.547 | 1.055 | 1.882 | 1.309 | 2.125 | 1.201
COVID19_PFIZER/BIONTECH | Weight increased | 7 | 6.337 | 0.68 | 1.355 | 2.217 | 0.585 | 1.008 | 1.646 | 1.105 | 0.727 | 0.443
COVID19_PFIZER/BIONTECH | Periorbital cellulitis | 1 | 0.515 | 0.212 | 1.354 | 3.313 | 0.403 | 0.978 | 2.081 | 1.942 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Blood creatine increased | 4 | 2.881 | 0.585 | 1.353 | 2.379 | 0.562 | 1.084 | 1.933 | 1.388 | 6.02 | 8.9
COVID19_PFIZER/BIONTECH | Dysarthria | 73 | 61.091 | 1.11 | 1.353 | 1.617 | 0.97 | 1.175 | 1.413 | 1.195 | 3.162 | 90.012
COVID19_PFIZER/BIONTECH | Anorectal discomfort | 1 | 0.506 | 0.326 | 1.352 | 2.946 | 0.404 | 0.981 | 2.086 | 1.975 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Swollen tongue | 206 | 151.458 | 1.204 | 1.352 | 1.507 | 1.201 | 1.348 | 1.508 | 1.36 | 4.882 | 498.826
COVID19_PFIZER/BIONTECH | Rash pustular | 5 | 5.772 | 0.577 | 1.352 | 2.391 | 0.464 | 0.856 | 1.474 | 0.866 | 0.271 | 8.915
COVID19_PFIZER/BIONTECH | Anion gap | 16 | 11.104 | 0.895 | 1.351 | 1.882 | 0.875 | 1.293 | 1.857 | 1.441 | 4.587 | 32.839
COVID19_PFIZER/BIONTECH | Lip disorder | 4 | 2.875 | 0.626 | 1.351 | 2.3 | 0.563 | 1.085 | 1.935 | 1.391 | 7.224 | 10.989
COVID19_PFIZER/BIONTECH | Pneumonia bacterial | 3 | 3.377 | 0.443 | 1.35 | 2.654 | 0.423 | 0.863 | 1.605 | 0.888 | 1.505 | 0.106
COVID19_PFIZER/BIONTECH | Biopsy bone marrow | 3 | 5.721 | 0.516 | 1.35 | 2.504 | 0.315 | 0.645 | 1.202 | 0.524 | 1.548 | 0.136
COVID19_PFIZER/BIONTECH | Deafness | 35 | 32.283 | 1.006 | 1.349 | 1.733 | 0.806 | 1.059 | 1.373 | 1.084 | 1.806 | 10.697
COVID19_PFIZER/BIONTECH | International normalised ratio increased | 17 | 15.731 | 0.884 | 1.349 | 1.896 | 0.708 | 1.036 | 1.473 | 1.081 | 2.791 | 15.332
COVID19_PFIZER/BIONTECH | Cerebral haematoma | 1 | 0.461 | 0.328 | 1.348 | 2.932 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Roseola | 1 | 0.481 | 0.431 | 1.348 | 2.677 | 0.406 | 0.987 | 2.1 | 2.078 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Specific gravity urine normal | 5 | 4.354 | 0.611 | 1.348 | 2.317 | 0.547 | 1.009 | 1.737 | 1.148 | 0.759 | 0.164
COVID19_PFIZER/BIONTECH | Enthesopathy | 1 | 0.518 | 0.219 | 1.347 | 3.265 | 0.403 | 0.978 | 2.079 | 1.931 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time shortened | 6 | 4.156 | 0.695 | 1.346 | 2.171 | 0.654 | 1.163 | 1.947 | 1.444 | 2.356 | 2.972
COVID19_PFIZER/BIONTECH | Peripheral coldness | 93 | 71.725 | 1.127 | 1.346 | 1.581 | 1.075 | 1.275 | 1.503 | 1.297 | 2.637 | 81.123
COVID19_PFIZER/BIONTECH | Dreamy state | 1 | 0.728 | 0.276 | 1.346 | 3.073 | 0.382 | 0.928 | 1.969 | 1.374 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Packed red blood cell transfusion | 7 | 4.384 | 0.712 | 1.345 | 2.142 | 0.728 | 1.255 | 2.051 | 1.597 | 2.69 | 5.009
COVID19_PFIZER/BIONTECH | Ocular discomfort | 23 | 15.217 | 0.964 | 1.345 | 1.779 | 0.991 | 1.382 | 1.887 | 1.511 | 4.667 | 49.65
COVID19_PFIZER/BIONTECH | Blood pressure systolic increased | 7 | 4.905 | 0.755 | 1.345 | 2.072 | 0.683 | 1.178 | 1.924 | 1.427 | 5.497 | 16.272
COVID19_PFIZER/BIONTECH | Fibrin D dimer | 33 | 24 | 0.996 | 1.345 | 1.737 | 0.985 | 1.305 | 1.702 | 1.375 | 9.03 | 151.543
COVID19_PFIZER/BIONTECH | Computerised tomogram pelvis | 12 | 8.374 | 0.819 | 1.343 | 1.973 | 0.806 | 1.254 | 1.88 | 1.433 | 2.969 | 11.733
COVID19_PFIZER/BIONTECH | Pregnancy test urine negative | 2 | 1.278 | 0.402 | 1.343 | 2.731 | 0.471 | 1.031 | 2.029 | 1.565 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Dehydration (SMQ) [broad] | 1585 | 1196.157 | 1.288 | 1.343 | 1.399 | 1.27 | 1.324 | 1.379 | 1.325 | 3.574 | 2521.978
COVID19_PFIZER/BIONTECH | Vertigo | 173 | 138.609 | 1.181 | 1.343 | 1.514 | 1.092 | 1.238 | 1.399 | 1.248 | 2.712 | 161.638
COVID19_PFIZER/BIONTECH | Mitral valve incompetence | 3 | 2.826 | 0.497 | 1.343 | 2.523 | 0.46 | 0.937 | 1.744 | 1.062 | 2.258 | 0.875
COVID19_PFIZER/BIONTECH | Thyroxine free decreased | 1 | 0.47 | 0.305 | 1.342 | 2.976 | 0.408 | 0.99 | 2.107 | 2.125 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Peripheral nerve palsy | 1 | 0.47 | 0.305 | 1.342 | 2.977 | 0.408 | 0.99 | 2.107 | 2.125 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Vein discolouration | 1 | 1.206 | 0.305 | 1.342 | 2.976 | 0.342 | 0.832 | 1.766 | 0.829 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Escherichia infection | 3 | 2.095 | 0.472 | 1.341 | 2.57 | 0.519 | 1.058 | 1.971 | 1.432 | 1.505 | 0.106
COVID19_PFIZER/BIONTECH | Basophil count normal | 8 | 6.189 | 0.747 | 1.341 | 2.076 | 0.67 | 1.126 | 1.798 | 1.293 | 1.474 | 0.713
COVID19_PFIZER/BIONTECH | Dermatitis psoriasiform | 1 | 0.828 | 0.175 | 1.341 | 3.417 | 0.373 | 0.906 | 1.922 | 1.208 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Adenovirus test | 3 | 1.562 | 0.442 | 1.34 | 2.631 | 0.573 | 1.169 | 2.183 | 1.92 | 0.274 | 4.971
COVID19_PFIZER/BIONTECH | Blood urea decreased | 5 | 3.513 | 0.584 | 1.34 | 2.347 | 0.612 | 1.128 | 1.944 | 1.423 | 1.704 | 0.736
COVID19_PFIZER/BIONTECH | Butterfly rash | 2 | 1.335 | 0.413 | 1.34 | 2.696 | 0.465 | 1.019 | 2.005 | 1.498 | 1.338 | 0
COVID19_PFIZER/BIONTECH | Paranasal sinus discomfort | 21 | 15.7 | 0.926 | 1.34 | 1.816 | 0.88 | 1.244 | 1.719 | 1.338 | 6.217 | 64.378
COVID19_PFIZER/BIONTECH | Hyperthyroidism (SMQ) [narrow] | 4 | 4.189 | 0.531 | 1.34 | 2.449 | 0.468 | 0.902 | 1.607 | 0.955 | 0.722 | 0.177
COVID19_PFIZER/BIONTECH | Blood thyroid stimulating hormone increased | 3 | 1.587 | 0.514 | 1.339 | 2.48 | 0.571 | 1.163 | 2.172 | 1.89 | 1.321 | 0.017
COVID19_PFIZER/BIONTECH | Tongue paralysis | 1 | 0.462 | 0.347 | 1.339 | 2.855 | 0.408 | 0.992 | 2.112 | 2.163 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Liver related investigations, signs and symptoms (SMQ) [narrow] | 87 | 74.024 | 1.115 | 1.339 | 1.58 | 0.972 | 1.16 | 1.375 | 1.175 | 1.334 | 6.468
COVID19_PFIZER/BIONTECH | Iritis | 1 | 0.846 | 0.183 | 1.339 | 3.376 | 0.371 | 0.902 | 1.914 | 1.182 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Haemodynamic instability | 1 | 1.088 | 0.219 | 1.339 | 3.24 | 0.351 | 0.854 | 1.812 | 0.919 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Subcutaneous haematoma | 1 | 0.392 | 0.247 | 1.338 | 3.141 | 0.416 | 1.011 | 2.156 | 2.553 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Inguinal hernia repair | 1 | 0.491 | 0.332 | 1.338 | 2.893 | 0.405 | 0.985 | 2.095 | 2.036 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Low density lipoprotein normal | 3 | 2.006 | 0.6 | 1.338 | 2.313 | 0.528 | 1.075 | 2.003 | 1.495 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Lymphocyte percentage decreased | 12 | 10.616 | 0.801 | 1.338 | 1.986 | 0.679 | 1.056 | 1.583 | 1.13 | 1.022 | 0.006
COVID19_PFIZER/BIONTECH | Facial pain | 46 | 37.467 | 1.039 | 1.337 | 1.666 | 0.938 | 1.194 | 1.5 | 1.228 | 2.548 | 36.546
COVID19_PFIZER/BIONTECH | Red cell distribution width increased | 7 | 6.058 | 0.675 | 1.337 | 2.183 | 0.602 | 1.038 | 1.693 | 1.156 | 1.756 | 1.413
COVID19_PFIZER/BIONTECH | Anion gap normal | 4 | 2.514 | 0.56 | 1.336 | 2.381 | 0.596 | 1.149 | 2.052 | 1.591 | 2.676 | 2.278
COVID19_PFIZER/BIONTECH | Throat tightness | 343 | 261.489 | 1.22 | 1.336 | 1.456 | 1.194 | 1.305 | 1.425 | 1.312 | 5.359 | 938.376
COVID19_PFIZER/BIONTECH | Abdominal tenderness | 6 | 5.007 | 0.677 | 1.336 | 2.177 | 0.589 | 1.048 | 1.753 | 1.198 | 1.594 | 0.711
COVID19_PFIZER/BIONTECH | Eye oedema | 2 | 1.813 | 0.537 | 1.336 | 2.426 | 0.423 | 0.928 | 1.823 | 1.103 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Lymphocyte percentage | 8 | 6.404 | 0.744 | 1.335 | 2.067 | 0.656 | 1.102 | 1.76 | 1.249 | 0.798 | 0.214
COVID19_PFIZER/BIONTECH | Alpha 1 globulin normal | 1 | 0.354 | 0.334 | 1.334 | 2.876 | 0.42 | 1.022 | 2.182 | 2.824 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Burns second degree | 1 | 0.461 | 0.334 | 1.334 | 2.874 | 0.409 | 0.992 | 2.113 | 2.17 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Genital swelling | 1 | 0.266 | 0.418 | 1.332 | 2.665 | 0.43 | 1.05 | 2.25 | 3.765 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Fear | 34 | 23.117 | 1.004 | 1.332 | 1.698 | 1.05 | 1.385 | 1.801 | 1.471 | 3.721 | 53.781
COVID19_PFIZER/BIONTECH | Bowel movement irregularity | 4 | 2.695 | 0.584 | 1.332 | 2.326 | 0.579 | 1.116 | 1.992 | 1.484 | 1.445 | 0.166
COVID19_PFIZER/BIONTECH | Electrocardiogram T wave inversion | 6 | 4.229 | 0.673 | 1.332 | 2.172 | 0.648 | 1.152 | 1.929 | 1.419 | 9.851 | 25.127
COVID19_PFIZER/BIONTECH | Liver disorder | 2 | 1.603 | 0.321 | 1.332 | 2.905 | 0.441 | 0.965 | 1.898 | 1.248 | 0.769 | 0.002
COVID19_PFIZER/BIONTECH | Neurological decompensation | 1 | 1.417 | 0.159 | 1.332 | 3.456 | 0.326 | 0.796 | 1.691 | 0.706 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Muscle enzyme increased | 1 | 0.47 | 0.283 | 1.331 | 3.008 | 0.408 | 0.99 | 2.107 | 2.125 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Blood albumin normal | 18 | 15.7 | 0.884 | 1.331 | 1.854 | 0.751 | 1.089 | 1.537 | 1.146 | 2.167 | 9.038
COVID19_PFIZER/BIONTECH | Haemorrhage urinary tract | 1 | 1.637 | 0.142 | 1.331 | 3.532 | 0.311 | 0.762 | 1.619 | 0.611 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Thyroxine | 3 | 2.379 | 0.576 | 1.33 | 2.335 | 0.495 | 1.008 | 1.875 | 1.261 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Lactic acidosis (SMQ) [broad] | 49 | 42.743 | 1.04 | 1.33 | 1.649 | 0.889 | 1.122 | 1.402 | 1.146 | 2.514 | 37.874
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin | 3 | 1.84 | 0.482 | 1.329 | 2.516 | 0.544 | 1.108 | 2.066 | 1.631 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | Pulse abnormal | 23 | 14.898 | 0.956 | 1.327 | 1.748 | 1.008 | 1.406 | 1.92 | 1.544 | 3.462 | 31.653
COVID19_PFIZER/BIONTECH | Lymphocyte count | 4 | 3.747 | 0.571 | 1.327 | 2.337 | 0.496 | 0.956 | 1.704 | 1.068 | 1.313 | 0.056
COVID19_PFIZER/BIONTECH | Palatal oedema | 1 | 1.614 | 0.225 | 1.327 | 3.182 | 0.313 | 0.765 | 1.626 | 0.62 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Toxoplasmosis | 1 | 0.474 | 0.286 | 1.326 | 2.989 | 0.407 | 0.989 | 2.105 | 2.111 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Staphylococcus test | 1 | 0.5 | 0.353 | 1.326 | 2.805 | 0.404 | 0.982 | 2.089 | 2 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Culture stool | 4 | 2.524 | 0.544 | 1.326 | 2.387 | 0.595 | 1.147 | 2.049 | 1.585 | 1.224 | 0.012
COVID19_PFIZER/BIONTECH | Movement disorder | 22 | 18.568 | 0.906 | 1.326 | 1.812 | 0.804 | 1.128 | 1.549 | 1.185 | 1.208 | 0.546
COVID19_PFIZER/BIONTECH | Haemorrhage laboratory terms (SMQ) [narrow] | 23 | 21.893 | 0.925 | 1.326 | 1.788 | 0.732 | 1.021 | 1.393 | 1.051 | 1.389 | 1.965
COVID19_PFIZER/BIONTECH | Thyroiditis | 1 | 0.515 | 0.375 | 1.325 | 2.745 | 0.403 | 0.978 | 2.081 | 1.942 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Biliary system related investigations, signs and symptoms (SMQ) [narrow] | 23 | 20.983 | 0.914 | 1.325 | 1.797 | 0.759 | 1.058 | 1.444 | 1.096 | 1.286 | 1.1
COVID19_PFIZER/BIONTECH | Humerus fracture | 1 | 0.511 | 0.314 | 1.324 | 2.903 | 0.403 | 0.979 | 2.083 | 1.956 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Eye haemorrhage | 15 | 11.471 | 0.873 | 1.324 | 1.851 | 0.8 | 1.195 | 1.732 | 1.308 | 7.129 | 52.135
COVID19_PFIZER/BIONTECH | Allergy to arthropod sting | 1 | 0.969 | 0.339 | 1.324 | 2.835 | 0.361 | 0.877 | 1.86 | 1.032 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Anal haemorrhage | 1 | 0.48 | 0.314 | 1.323 | 2.9 | 0.407 | 0.987 | 2.101 | 2.084 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Electrocardiogram change | 4 | 2.947 | 0.599 | 1.323 | 2.278 | 0.557 | 1.073 | 1.914 | 1.358 | 10.32 | 15.623
COVID19_PFIZER/BIONTECH | Dry eye | 15 | 12.139 | 0.826 | 1.323 | 1.914 | 0.766 | 1.145 | 1.659 | 1.236 | 1.652 | 2.934
COVID19_PFIZER/BIONTECH | Hypovolaemia | 3 | 2.412 | 0.574 | 1.323 | 2.321 | 0.492 | 1.002 | 1.865 | 1.244 | 5.418 | 5.114
COVID19_PFIZER/BIONTECH | Chronic kidney disease (SMQ) [narrow] | 28 | 31.507 | 0.951 | 1.322 | 1.743 | 0.652 | 0.884 | 1.176 | 0.889 | 2.491 | 20.613
COVID19_PFIZER/BIONTECH | Breath odour | 1 | 0.745 | 0.217 | 1.321 | 3.193 | 0.381 | 0.924 | 1.961 | 1.343 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Cognitive disorder | 13 | 11.934 | 0.792 | 1.321 | 1.961 | 0.673 | 1.031 | 1.526 | 1.089 | 0.452 | 7.908
COVID19_PFIZER/BIONTECH | Ultrasound thyroid | 1 | 1.314 | 0.26 | 1.321 | 3.051 | 0.334 | 0.814 | 1.727 | 0.761 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Blood lactate dehydrogenase | 5 | 3.322 | 0.685 | 1.32 | 2.124 | 0.629 | 1.159 | 1.998 | 1.505 | 2.656 | 3.106
COVID19_PFIZER/BIONTECH | Acoustic stimulation tests | 9 | 7.006 | 0.758 | 1.32 | 2.008 | 0.69 | 1.133 | 1.777 | 1.285 | 2.709 | 6.944
COVID19_PFIZER/BIONTECH | Oral mucosal exfoliation | 2 | 1.03 | 0.491 | 1.319 | 2.473 | 0.496 | 1.088 | 2.145 | 1.942 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Cardiac pacemaker evaluation | 1 | 0.549 | 0.342 | 1.319 | 2.814 | 0.399 | 0.97 | 2.062 | 1.822 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Troponin T normal | 4 | 2.895 | 0.508 | 1.319 | 2.438 | 0.561 | 1.082 | 1.929 | 1.382 | 4.249 | 5.51
COVID19_PFIZER/BIONTECH | Blood lactate dehydrogenase increased | 10 | 8.136 | 0.739 | 1.319 | 2.034 | 0.69 | 1.109 | 1.71 | 1.229 | 0.769 | 0.455
COVID19_PFIZER/BIONTECH | Dyschromatopsia | 1 | 0.727 | 0.299 | 1.318 | 2.924 | 0.382 | 0.928 | 1.97 | 1.376 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Gastrointestinal premalignant disorders (SMQ) [narrow] | 5 | 6.861 | 0.566 | 1.318 | 2.323 | 0.415 | 0.767 | 1.32 | 0.729 | 0.765 | 0.149
COVID19_PFIZER/BIONTECH | Gastrointestinal premalignant disorders (SMQ) [broad] | 5 | 6.861 | 0.566 | 1.318 | 2.323 | 0.415 | 0.767 | 1.32 | 0.729 | 0.765 | 0.149
COVID19_PFIZER/BIONTECH | Scan with contrast | 31 | 24.216 | 0.982 | 1.317 | 1.693 | 0.915 | 1.223 | 1.607 | 1.28 | 5.489 | 83.714
COVID19_PFIZER/BIONTECH | Blood urea nitrogen/creatinine ratio | 7 | 5.433 | 0.716 | 1.317 | 2.066 | 0.643 | 1.109 | 1.811 | 1.288 | 4.682 | 13.161
COVID19_PFIZER/BIONTECH | CSF test abnormal | 4 | 2.776 | 0.508 | 1.316 | 2.431 | 0.572 | 1.102 | 1.966 | 1.441 | 0.43 | 2.395
COVID19_PFIZER/BIONTECH | Dehydration (SMQ) [narrow] | 84 | 73.959 | 1.092 | 1.316 | 1.556 | 0.938 | 1.122 | 1.334 | 1.136 | 1.594 | 16.544
COVID19_PFIZER/BIONTECH | Feeling hot | 475 | 359.139 | 1.218 | 1.315 | 1.414 | 1.222 | 1.318 | 1.42 | 1.323 | 3.406 | 682.946
COVID19_PFIZER/BIONTECH | Small intestinal obstruction | 8 | 5.957 | 0.743 | 1.315 | 2.02 | 0.687 | 1.153 | 1.842 | 1.343 | 10.32 | 36.822
COVID19_PFIZER/BIONTECH | Conjunctival disorders (SMQ) [narrow] | 38 | 31.633 | 0.993 | 1.315 | 1.675 | 0.895 | 1.164 | 1.494 | 1.201 | 0.94 | 0.084
COVID19_PFIZER/BIONTECH | Conjunctival disorders (SMQ) [broad] | 38 | 31.633 | 0.993 | 1.315 | 1.675 | 0.895 | 1.164 | 1.494 | 1.201 | 0.94 | 0.084
COVID19_PFIZER/BIONTECH | Increased appetite | 3 | 1.591 | 0.424 | 1.314 | 2.601 | 0.57 | 1.162 | 2.17 | 1.886 | 3.386 | 2.392
COVID19_PFIZER/BIONTECH | Pulmonary haemorrhage | 1 | 0.487 | 0.406 | 1.314 | 2.641 | 0.406 | 0.986 | 2.097 | 2.052 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Culture negative | 9 | 8.248 | 0.732 | 1.314 | 2.033 | 0.618 | 1.014 | 1.59 | 1.091 | 0.821 | 0.18
COVID19_PFIZER/BIONTECH | Facial paralysis | 247 | 198.531 | 1.18 | 1.313 | 1.452 | 1.113 | 1.237 | 1.371 | 1.244 | 3.955 | 446.562
COVID19_PFIZER/BIONTECH | Vestibular disorders (SMQ) [narrow] | 180 | 145.488 | 1.157 | 1.313 | 1.477 | 1.085 | 1.228 | 1.384 | 1.237 | 2.647 | 160.064
COVID19_PFIZER/BIONTECH | Blood glucose increased | 78 | 65.405 | 1.087 | 1.313 | 1.558 | 0.975 | 1.174 | 1.404 | 1.193 | 2.668 | 69.467
COVID19_PFIZER/BIONTECH | Psoriatic arthropathy | 2 | 1.505 | 0.352 | 1.312 | 2.767 | 0.449 | 0.984 | 1.936 | 1.329 | 1.129 | 0.048
COVID19_PFIZER/BIONTECH | Helicobacter test positive | 1 | 0.727 | 0.264 | 1.312 | 3.012 | 0.382 | 0.928 | 1.97 | 1.376 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Sputum abnormal | 1 | 0.941 | 0.345 | 1.312 | 2.787 | 0.363 | 0.883 | 1.872 | 1.063 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Flat affect | 1 | 0.462 | 0.382 | 1.31 | 2.69 | 0.408 | 0.992 | 2.112 | 2.163 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Torsade de pointes/QT prolongation (SMQ) [narrow] | 10 | 11.457 | 0.729 | 1.31 | 2.03 | 0.537 | 0.865 | 1.333 | 0.873 | 2.867 | 8.861
COVID19_PFIZER/BIONTECH | Gliosis | 1 | 0.739 | 0.322 | 1.309 | 2.838 | 0.381 | 0.925 | 1.963 | 1.353 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Eyelid rash | 6 | 4.964 | 0.65 | 1.309 | 2.152 | 0.592 | 1.053 | 1.762 | 1.209 | 1.321 | 0.178
COVID19_PFIZER/BIONTECH | Hyperthyroidism (SMQ) [broad] | 18 | 16.54 | 0.859 | 1.309 | 1.837 | 0.72 | 1.044 | 1.473 | 1.088 | 0.726 | 1.53
COVID19_PFIZER/BIONTECH | Premature baby | 3 | 4.851 | 0.369 | 1.309 | 2.718 | 0.348 | 0.712 | 1.325 | 0.618 | 0.323 | 3.524
COVID19_PFIZER/BIONTECH | Vertebral foraminal stenosis | 1 | 1.957 | 0.235 | 1.309 | 3.097 | 0.291 | 0.716 | 1.525 | 0.511 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Hypovolaemic shock conditions (SMQ) [narrow] | 16 | 16.168 | 0.837 | 1.308 | 1.864 | 0.651 | 0.962 | 1.381 | 0.99 | 0.751 | 1.035
COVID19_PFIZER/BIONTECH | Termination of pregnancy and risk of abortion (SMQ) [broad] | 47 | 37.232 | 1.012 | 1.307 | 1.633 | 0.965 | 1.225 | 1.536 | 1.262 | 2.326 | 30.27
COVID19_PFIZER/BIONTECH | Termination of pregnancy and risk of abortion (SMQ) [narrow] | 47 | 37.232 | 1.012 | 1.307 | 1.633 | 0.965 | 1.225 | 1.536 | 1.262 | 2.326 | 30.27
COVID19_PFIZER/BIONTECH | Functional, inflammatory and gallstone related biliary disorders (SMQ) [narrow] | 37 | 35.708 | 0.98 | 1.307 | 1.672 | 0.78 | 1.018 | 1.311 | 1.036 | 1.591 | 6.912
COVID19_PFIZER/BIONTECH | Blood potassium increased | 8 | 9.079 | 0.693 | 1.307 | 2.08 | 0.518 | 0.869 | 1.388 | 0.881 | 1.047 | 0.004
COVID19_PFIZER/BIONTECH | Suffocation feeling | 1 | 0.528 | 0.323 | 1.306 | 2.825 | 0.402 | 0.975 | 2.074 | 1.895 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Choking | 9 | 7.924 | 0.726 | 1.306 | 2.025 | 0.635 | 1.043 | 1.635 | 1.136 | 0.695 | 0.875
COVID19_PFIZER/BIONTECH | CSF red blood cell count positive | 5 | 4.514 | 0.552 | 1.306 | 2.318 | 0.536 | 0.989 | 1.702 | 1.108 | 0.557 | 1.282
COVID19_PFIZER/BIONTECH | Lens disorders (SMQ) [narrow] | 3 | 3.9 | 0.46 | 1.306 | 2.501 | 0.393 | 0.803 | 1.493 | 0.769 | 1.022 | 0.069
COVID19_PFIZER/BIONTECH | Carotid artery occlusion | 1 | 1.554 | 0.296 | 1.306 | 2.9 | 0.317 | 0.774 | 1.645 | 0.644 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Yellow skin | 5 | 3.537 | 0.645 | 1.305 | 2.151 | 0.61 | 1.124 | 1.937 | 1.414 | 1.003 | 0.05
COVID19_PFIZER/BIONTECH | Cardiac ablation | 1 | 1.2 | 0.324 | 1.305 | 2.821 | 0.342 | 0.834 | 1.768 | 0.833 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Myocardial infarction | 63 | 50.951 | 1.05 | 1.304 | 1.58 | 0.984 | 1.21 | 1.475 | 1.236 | 7.585 | 248.93
COVID19_PFIZER/BIONTECH | Escherichia urinary tract infection | 2 | 1.44 | 0.475 | 1.303 | 2.462 | 0.455 | 0.997 | 1.961 | 1.389 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Spleen scan normal | 1 | 0.47 | 0.35 | 1.302 | 2.744 | 0.408 | 0.99 | 2.107 | 2.125 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Volvulus | 1 | 0.48 | 0.239 | 1.302 | 3.062 | 0.407 | 0.987 | 2.101 | 2.084 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Tunnel vision | 23 | 17.061 | 0.914 | 1.302 | 1.746 | 0.903 | 1.259 | 1.719 | 1.348 | 5.934 | 67.176
COVID19_PFIZER/BIONTECH | Oropharyngeal allergic conditions (SMQ) [narrow] | 290 | 232.317 | 1.179 | 1.302 | 1.429 | 1.127 | 1.242 | 1.366 | 1.248 | 2.683 | 266.797
COVID19_PFIZER/BIONTECH | Oropharyngeal allergic conditions (SMQ) [broad] | 290 | 232.317 | 1.179 | 1.302 | 1.429 | 1.127 | 1.242 | 1.366 | 1.248 | 2.683 | 266.797
COVID19_PFIZER/BIONTECH | Drug related hepatic disorders - comprehensive search (SMQ) [broad] | 128 | 110.512 | 1.12 | 1.302 | 1.495 | 0.992 | 1.148 | 1.323 | 1.158 | 1.286 | 7.382
COVID19_PFIZER/BIONTECH | Interstitial lung disease (SMQ) [narrow] | 54 | 53.469 | 1.029 | 1.302 | 1.601 | 0.8 | 0.999 | 1.236 | 1.01 | 2.148 | 28.584
COVID19_PFIZER/BIONTECH | Vitrectomy | 1 | 0.47 | 0.27 | 1.301 | 2.961 | 0.408 | 0.99 | 2.107 | 2.125 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Platelet count | 17 | 12.231 | 0.878 | 1.301 | 1.792 | 0.864 | 1.264 | 1.799 | 1.39 | 3.07 | 18.465
COVID19_PFIZER/BIONTECH | Ophthalmological examination abnormal | 8 | 6.478 | 0.689 | 1.301 | 2.069 | 0.651 | 1.093 | 1.747 | 1.235 | 1.521 | 0.858
COVID19_PFIZER/BIONTECH | Hyperthyroidism | 3 | 2.472 | 0.465 | 1.301 | 2.478 | 0.487 | 0.992 | 1.846 | 1.214 | 1.204 | 0
COVID19_PFIZER/BIONTECH | Scratch | 6 | 5.848 | 0.596 | 1.301 | 2.228 | 0.537 | 0.955 | 1.597 | 1.026 | 0.488 | 2.634
COVID19_PFIZER/BIONTECH | Atrioventricular block complete | 1 | 1.471 | 0.27 | 1.301 | 2.962 | 0.322 | 0.788 | 1.672 | 0.68 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Thrombocytosis | 1 | 0.687 | 0.334 | 1.3 | 2.779 | 0.386 | 0.937 | 1.989 | 1.455 | 0.564 | 0.033
COVID19_PFIZER/BIONTECH | Cardiac monitoring | 29 | 25.809 | 0.942 | 1.3 | 1.705 | 0.807 | 1.089 | 1.442 | 1.124 | 4.401 | 58.461
COVID19_PFIZER/BIONTECH | Myocardial infarction (SMQ) [broad] | 194 | 172.977 | 1.151 | 1.3 | 1.457 | 0.991 | 1.116 | 1.253 | 1.122 | 4.544 | 426.702
COVID19_PFIZER/BIONTECH | Scan thyroid gland | 1 | 0.853 | 0.351 | 1.3 | 2.737 | 0.371 | 0.901 | 1.911 | 1.173 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Protein urine absent | 3 | 2.717 | 0.511 | 1.3 | 2.382 | 0.468 | 0.953 | 1.774 | 1.104 | 0.753 | 0.051
COVID19_PFIZER/BIONTECH | Oropharyngeal discomfort | 62 | 47.986 | 1.045 | 1.299 | 1.576 | 1.023 | 1.26 | 1.538 | 1.292 | 10.179 | 322.212
COVID19_PFIZER/BIONTECH | Meningitis viral | 5 | 5.38 | 0.562 | 1.299 | 2.283 | 0.484 | 0.893 | 1.538 | 0.929 | 0.903 | 0
COVID19_PFIZER/BIONTECH | Microcytic anaemia | 1 | 0.541 | 0.388 | 1.298 | 2.642 | 0.4 | 0.972 | 2.066 | 1.847 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Blood calcium decreased | 18 | 12.988 | 0.887 | 1.298 | 1.775 | 0.874 | 1.267 | 1.788 | 1.386 | 3.533 | 25.164
COVID19_PFIZER/BIONTECH | Ischaemia | 3 | 2.389 | 0.462 | 1.298 | 2.478 | 0.494 | 1.006 | 1.872 | 1.256 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | Peripheral venous disease | 1 | 0.781 | 0.301 | 1.298 | 2.865 | 0.377 | 0.916 | 1.944 | 1.281 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Craniotomy | 1 | 1.449 | 0.272 | 1.298 | 2.95 | 0.324 | 0.791 | 1.68 | 0.69 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Communication disorder | 8 | 7.832 | 0.698 | 1.297 | 2.047 | 0.574 | 0.964 | 1.54 | 1.021 | 2.064 | 2.995
COVID19_PFIZER/BIONTECH | Oral herpes | 27 | 28.729 | 0.924 | 1.297 | 1.721 | 0.682 | 0.929 | 1.241 | 0.94 | 1.222 | 0.814
COVID19_PFIZER/BIONTECH | Anaphylactic reaction (SMQ) [narrow] | 206 | 180.104 | 1.151 | 1.296 | 1.447 | 1.014 | 1.138 | 1.273 | 1.144 | 2.289 | 132.283
COVID19_PFIZER/BIONTECH | Biliary neoplasms (SMQ) [narrow] | 1 | 0.528 | 0.329 | 1.295 | 2.78 | 0.402 | 0.975 | 2.074 | 1.895 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Biliary neoplasms (SMQ) [broad] | 1 | 0.528 | 0.329 | 1.295 | 2.78 | 0.402 | 0.975 | 2.074 | 1.895 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Tryptase | 18 | 12.631 | 0.873 | 1.295 | 1.783 | 0.893 | 1.295 | 1.828 | 1.425 | 7.388 | 65.868
COVID19_PFIZER/BIONTECH | Retinogram | 1 | 0.815 | 0.303 | 1.295 | 2.849 | 0.374 | 0.909 | 1.928 | 1.227 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Vulvovaginal rash | 1 | 0.941 | 0.274 | 1.295 | 2.934 | 0.363 | 0.883 | 1.872 | 1.063 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Facet joint syndrome | 1 | 0.985 | 0.329 | 1.295 | 2.778 | 0.359 | 0.874 | 1.853 | 1.015 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Eye infection | 2 | 2.156 | 0.368 | 1.295 | 2.68 | 0.398 | 0.872 | 1.713 | 0.928 | 0.84 | 0.009
COVID19_PFIZER/BIONTECH | Cholecystitis acute | 1 | 1.869 | 0.146 | 1.295 | 3.403 | 0.297 | 0.728 | 1.55 | 0.535 | 6.02 | 0.423
COVID19_PFIZER/BIONTECH | Angiogram cerebral | 13 | 10.53 | 0.815 | 1.294 | 1.864 | 0.74 | 1.134 | 1.678 | 1.235 | 13.811 | 80.052
COVID19_PFIZER/BIONTECH | Blood culture positive | 5 | 5.304 | 0.532 | 1.294 | 2.327 | 0.488 | 0.901 | 1.551 | 0.943 | 0.488 | 2.115
COVID19_PFIZER/BIONTECH | Facial spasm | 4 | 2.235 | 0.553 | 1.293 | 2.283 | 0.625 | 1.205 | 2.154 | 1.79 | 4.013 | 5.032
COVID19_PFIZER/BIONTECH | Stomatitis | 19 | 14.183 | 0.872 | 1.293 | 1.783 | 0.862 | 1.238 | 1.734 | 1.34 | 1.733 | 4.696
COVID19_PFIZER/BIONTECH | Paraesthesia | 975 | 760.348 | 1.226 | 1.293 | 1.362 | 1.214 | 1.28 | 1.349 | 1.282 | 3.133 | 1228.256
COVID19_PFIZER/BIONTECH | Muscle tightness | 79 | 63.223 | 1.067 | 1.293 | 1.537 | 1.02 | 1.227 | 1.466 | 1.25 | 2.718 | 73.107
COVID19_PFIZER/BIONTECH | Vaginal ulceration | 1 | 0.708 | 0.244 | 1.293 | 3.02 | 0.384 | 0.932 | 1.979 | 1.412 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Bronchiectasis | 1 | 0.787 | 0.152 | 1.293 | 3.367 | 0.377 | 0.915 | 1.941 | 1.271 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Abortion missed | 1 | 0.922 | 0.275 | 1.293 | 2.924 | 0.365 | 0.887 | 1.88 | 1.085 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Cardiac fibrillation | 1 | 1.154 | 0.33 | 1.293 | 2.77 | 0.346 | 0.842 | 1.786 | 0.866 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Lymphocytosis | 3 | 2.119 | 0.513 | 1.292 | 2.357 | 0.517 | 1.054 | 1.962 | 1.416 | 1.642 | 0.209
COVID19_PFIZER/BIONTECH | Rhinitis | 5 | 3.659 | 0.563 | 1.292 | 2.264 | 0.599 | 1.105 | 1.904 | 1.366 | 0.407 | 3.643
COVID19_PFIZER/BIONTECH | Basophil count increased | 2 | 1.443 | 0.344 | 1.292 | 2.732 | 0.455 | 0.997 | 1.96 | 1.386 | 1.003 | 0.129
COVID19_PFIZER/BIONTECH | Intensive care | 114 | 100.73 | 1.102 | 1.292 | 1.494 | 0.961 | 1.122 | 1.302 | 1.132 | 1.953 | 47.126
COVID19_PFIZER/BIONTECH | Polychromasia | 1 | 0.989 | 0.304 | 1.292 | 2.838 | 0.359 | 0.873 | 1.852 | 1.012 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Patient isolation | 1 | 1.382 | 0.19 | 1.292 | 3.207 | 0.329 | 0.802 | 1.703 | 0.724 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging head normal | 46 | 38.687 | 0.999 | 1.291 | 1.614 | 0.911 | 1.159 | 1.457 | 1.189 | 1.162 | 0.823
COVID19_PFIZER/BIONTECH | Endotracheal intubation complication | 1 | 0.745 | 0.332 | 1.29 | 2.756 | 0.38 | 0.924 | 1.96 | 1.341 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin normal | 16 | 14.083 | 0.827 | 1.29 | 1.837 | 0.728 | 1.075 | 1.544 | 1.136 | 1.438 | 1.571
COVID19_PFIZER/BIONTECH | Respiratory arrest | 38 | 36.255 | 0.977 | 1.29 | 1.639 | 0.791 | 1.029 | 1.321 | 1.048 | 1.678 | 8.892
COVID19_PFIZER/BIONTECH | Albumin CSF increased | 1 | 0.48 | 0.159 | 1.289 | 3.325 | 0.407 | 0.987 | 2.101 | 2.084 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Monocyte count normal | 11 | 8.243 | 0.765 | 1.289 | 1.925 | 0.749 | 1.184 | 1.798 | 1.335 | 1.806 | 2.866
COVID19_PFIZER/BIONTECH | Sensory disturbance | 40 | 31.122 | 0.976 | 1.289 | 1.636 | 0.958 | 1.239 | 1.581 | 1.285 | 1.328 | 2.709
COVID19_PFIZER/BIONTECH | PCO2 decreased | 5 | 4.073 | 0.56 | 1.289 | 2.261 | 0.567 | 1.045 | 1.801 | 1.227 | 1.642 | 0.613
COVID19_PFIZER/BIONTECH | Hand-eye coordination impaired | 3 | 1.775 | 0.493 | 1.288 | 2.387 | 0.55 | 1.122 | 2.092 | 1.69 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Coagulation test abnormal | 1 | 0.527 | 0.274 | 1.288 | 2.911 | 0.402 | 0.976 | 2.074 | 1.899 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Coxsackie virus test | 1 | 0.941 | 0.306 | 1.288 | 2.822 | 0.363 | 0.883 | 1.872 | 1.063 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Sarcoidosis | 1 | 0.579 | 0.229 | 1.287 | 3.052 | 0.396 | 0.963 | 2.045 | 1.728 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Noninfectious encephalitis (SMQ) [narrow] | 17 | 15.586 | 0.837 | 1.287 | 1.816 | 0.713 | 1.043 | 1.485 | 1.091 | 0.434 | 11.684
COVID19_PFIZER/BIONTECH | Small fibre neuropathy | 1 | 0.976 | 0.197 | 1.287 | 3.165 | 0.36 | 0.876 | 1.857 | 1.024 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Bladder scan | 1 | 0.474 | 0.334 | 1.286 | 2.739 | 0.407 | 0.989 | 2.105 | 2.111 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Blood pressure abnormal | 25 | 18.638 | 0.946 | 1.286 | 1.67 | 0.915 | 1.26 | 1.701 | 1.341 | 6.02 | 74.589
COVID19_PFIZER/BIONTECH | Biopsy | 7 | 5.306 | 0.693 | 1.286 | 2.028 | 0.652 | 1.125 | 1.837 | 1.319 | 1.374 | 0.347
COVID19_PFIZER/BIONTECH | Immunoglobulins decreased | 1 | 1.154 | 0.279 | 1.286 | 2.892 | 0.346 | 0.842 | 1.786 | 0.867 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Prothrombin level | 1 | 1.411 | 0.279 | 1.286 | 2.891 | 0.327 | 0.797 | 1.693 | 0.709 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Gastrointestinal hypomotility | 1 | 0.474 | 0.308 | 1.285 | 2.808 | 0.407 | 0.989 | 2.105 | 2.111 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Respiratory rate | 6 | 4.349 | 0.686 | 1.285 | 2.037 | 0.638 | 1.135 | 1.899 | 1.38 | 9.851 | 25.127
COVID19_PFIZER/BIONTECH | Hepatic disorders (SMQ) [broad] | 129 | 116.452 | 1.105 | 1.285 | 1.475 | 0.951 | 1.1 | 1.266 | 1.108 | 0.886 | 1.71
COVID19_PFIZER/BIONTECH | Basophil count decreased | 4 | 4.682 | 0.485 | 1.285 | 2.394 | 0.44 | 0.848 | 1.511 | 0.854 | 0.516 | 1.304
COVID19_PFIZER/BIONTECH | Genital rash | 2 | 1.401 | 0.492 | 1.284 | 2.378 | 0.459 | 1.005 | 1.977 | 1.428 | 0.682 | 0.054
COVID19_PFIZER/BIONTECH | Sensory loss | 29 | 24.521 | 0.933 | 1.284 | 1.682 | 0.844 | 1.138 | 1.508 | 1.183 | 1.582 | 5.168
COVID19_PFIZER/BIONTECH | Anaphylactic/anaphylactoid shock conditions (SMQ) [narrow] | 206 | 180.628 | 1.141 | 1.284 | 1.434 | 1.011 | 1.135 | 1.269 | 1.14 | 2.308 | 134.89
COVID19_PFIZER/BIONTECH | Hypokalaemia (SMQ) [narrow] | 49 | 43.726 | 1.007 | 1.284 | 1.589 | 0.87 | 1.099 | 1.373 | 1.121 | 4.059 | 89.699
COVID19_PFIZER/BIONTECH | Coombs direct test | 1 | 0.568 | 0.31 | 1.283 | 2.797 | 0.398 | 0.965 | 2.051 | 1.761 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | High density lipoprotein normal | 1 | 0.619 | 0.3 | 1.283 | 2.822 | 0.393 | 0.953 | 2.024 | 1.616 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Cryptococcus test | 3 | 2.395 | 0.596 | 1.283 | 2.181 | 0.493 | 1.005 | 1.87 | 1.253 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Meningioma | 1 | 0.987 | 0.336 | 1.283 | 2.727 | 0.359 | 0.874 | 1.853 | 1.013 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Streptococcus test | 13 | 9.281 | 0.807 | 1.282 | 1.848 | 0.811 | 1.243 | 1.841 | 1.401 | 1.467 | 1.363
COVID19_PFIZER/BIONTECH | Haemorrhage laboratory terms (SMQ) [broad] | 156 | 134.607 | 1.12 | 1.282 | 1.454 | 1.008 | 1.151 | 1.308 | 1.159 | 2.172 | 87.361
COVID19_PFIZER/BIONTECH | Carbon dioxide increased | 4 | 3.847 | 0.586 | 1.282 | 2.195 | 0.489 | 0.943 | 1.681 | 1.04 | 3.284 | 3.53
COVID19_PFIZER/BIONTECH | HIV test positive | 1 | 0.266 | 0.337 | 1.281 | 2.718 | 0.43 | 1.05 | 2.25 | 3.765 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Bandaemia | 1 | 0.474 | 0.362 | 1.281 | 2.658 | 0.407 | 0.989 | 2.105 | 2.111 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Appendicitis | 34 | 27.933 | 0.946 | 1.281 | 1.658 | 0.889 | 1.174 | 1.526 | 1.217 | 8.412 | 146.238
COVID19_PFIZER/BIONTECH | Blindness transient | 7 | 5.876 | 0.649 | 1.281 | 2.086 | 0.613 | 1.058 | 1.726 | 1.191 | 1.47 | 0.568
COVID19_PFIZER/BIONTECH | Injection site muscle weakness | 5 | 5.455 | 0.558 | 1.281 | 2.245 | 0.48 | 0.886 | 1.525 | 0.917 | 8.209 | 16.847
COVID19_PFIZER/BIONTECH | Influenza virus test positive | 3 | 4.02 | 0.381 | 1.281 | 2.61 | 0.387 | 0.79 | 1.47 | 0.746 | 0.341 | 3.105
COVID19_PFIZER/BIONTECH | Hyperglycaemia/new onset diabetes mellitus (SMQ) [narrow] | 109 | 98.463 | 1.088 | 1.28 | 1.485 | 0.937 | 1.098 | 1.279 | 1.107 | 2.013 | 49.181
COVID19_PFIZER/BIONTECH | Alanine aminotransferase normal | 18 | 16.908 | 0.838 | 1.28 | 1.797 | 0.707 | 1.025 | 1.446 | 1.065 | 0.844 | 0.349
COVID19_PFIZER/BIONTECH | Blood thyroid stimulating hormone decreased | 6 | 4.318 | 0.644 | 1.279 | 2.089 | 0.641 | 1.139 | 1.907 | 1.389 | 1.837 | 1.352
COVID19_PFIZER/BIONTECH | Mental status changes | 58 | 43.984 | 1.032 | 1.279 | 1.548 | 1.034 | 1.282 | 1.575 | 1.319 | 4.42 | 120.518
COVID19_PFIZER/BIONTECH | Acute myeloid leukaemia | 6 | 4.811 | 0.676 | 1.279 | 2.036 | 0.603 | 1.073 | 1.794 | 1.247 | 7.224 | 18.531
COVID19_PFIZER/BIONTECH | Urobilinogen urine | 2 | 1.827 | 0.469 | 1.279 | 2.412 | 0.422 | 0.925 | 1.818 | 1.095 | 1.095 | 0.065
COVID19_PFIZER/BIONTECH | Abdominal X-ray | 3 | 2.851 | 0.443 | 1.279 | 2.464 | 0.458 | 0.934 | 1.737 | 1.052 | 0.319 | 3.618
COVID19_PFIZER/BIONTECH | Human rhinovirus test | 2 | 0.981 | 0.459 | 1.278 | 2.429 | 0.502 | 1.1 | 2.171 | 2.04 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | IVth nerve paralysis | 1 | 0.481 | 0.312 | 1.278 | 2.775 | 0.406 | 0.987 | 2.1 | 2.078 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Oral disorder | 5 | 2.756 | 0.672 | 1.277 | 2.038 | 0.685 | 1.263 | 2.181 | 1.814 | 1.704 | 0.736
COVID19_PFIZER/BIONTECH | Asthma | 40 | 34.473 | 0.968 | 1.277 | 1.62 | 0.874 | 1.13 | 1.442 | 1.16 | 1.045 | 0.036
COVID19_PFIZER/BIONTECH | Areflexia | 4 | 3.922 | 0.509 | 1.277 | 2.326 | 0.484 | 0.934 | 1.664 | 1.02 | 0.365 | 3.705
COVID19_PFIZER/BIONTECH | Hypopnoea | 19 | 14.714 | 0.865 | 1.276 | 1.753 | 0.837 | 1.202 | 1.684 | 1.291 | 1.825 | 5.675
COVID19_PFIZER/BIONTECH | Troponin I normal | 5 | 4.758 | 0.557 | 1.276 | 2.235 | 0.52 | 0.96 | 1.653 | 1.051 | 3.344 | 5.003
COVID19_PFIZER/BIONTECH | Agranulocytosis (SMQ) [narrow] | 10 | 9.662 | 0.751 | 1.276 | 1.914 | 0.61 | 0.982 | 1.513 | 1.035 | 1.881 | 2.945
COVID19_PFIZER/BIONTECH | Facial nerve disorder | 2 | 2.019 | 0.44 | 1.276 | 2.465 | 0.408 | 0.893 | 1.755 | 0.991 | 2.258 | 0.345
COVID19_PFIZER/BIONTECH | Splenectomy | 1 | 1.095 | 0.169 | 1.276 | 3.242 | 0.35 | 0.853 | 1.809 | 0.913 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Infantile spitting up | 1 | 0.594 | 0.213 | 1.275 | 3.071 | 0.395 | 0.959 | 2.037 | 1.683 | 0.174 | 3.08
COVID19_PFIZER/BIONTECH | Aspiration joint | 2 | 1.541 | 0.495 | 1.275 | 2.35 | 0.446 | 0.977 | 1.922 | 1.298 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Chest X-ray abnormal | 85 | 76.166 | 1.06 | 1.275 | 1.508 | 0.923 | 1.103 | 1.31 | 1.116 | 2.55 | 68.889
COVID19_PFIZER/BIONTECH | Premature labour | 6 | 5.652 | 0.576 | 1.275 | 2.195 | 0.548 | 0.975 | 1.631 | 1.062 | 2.408 | 3.147
COVID19_PFIZER/BIONTECH | Monocyte count increased | 6 | 6.866 | 0.591 | 1.275 | 2.169 | 0.485 | 0.862 | 1.442 | 0.874 | 0.461 | 3.153
COVID19_PFIZER/BIONTECH | Dizziness | 2311 | 1836.362 | 1.23 | 1.274 | 1.317 | 1.215 | 1.258 | 1.301 | 1.258 | 2.919 | 2636.497
COVID19_PFIZER/BIONTECH | Anaphylactic reaction (SMQ) [algorithm] | 923 | 751.65 | 1.206 | 1.274 | 1.343 | 1.161 | 1.226 | 1.294 | 1.228 | 2.563 | 786.413
COVID19_PFIZER/BIONTECH | Treatment noncompliance | 1 | 0.747 | 0.256 | 1.274 | 2.927 | 0.38 | 0.924 | 1.96 | 1.339 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [broad] | 243 | 244.155 | 1.143 | 1.274 | 1.41 | 0.893 | 0.993 | 1.101 | 0.995 | 0.925 | 1.348
COVID19_PFIZER/BIONTECH | Sepsis | 37 | 38.09 | 0.957 | 1.274 | 1.63 | 0.735 | 0.96 | 1.236 | 0.971 | 1.364 | 2.995
COVID19_PFIZER/BIONTECH | Tenosynovitis | 4 | 2.914 | 0.578 | 1.273 | 2.188 | 0.559 | 1.078 | 1.924 | 1.373 | 3.141 | 3.234
COVID19_PFIZER/BIONTECH | Blood pressure decreased | 58 | 47.986 | 1.016 | 1.273 | 1.554 | 0.954 | 1.183 | 1.453 | 1.209 | 2.173 | 31.744
COVID19_PFIZER/BIONTECH | Prothrombin time prolonged | 9 | 8.774 | 0.709 | 1.273 | 1.971 | 0.592 | 0.971 | 1.523 | 1.026 | 1.958 | 2.951
COVID19_PFIZER/BIONTECH | Arthritis infective | 1 | 0.473 | 0.376 | 1.272 | 2.596 | 0.407 | 0.989 | 2.105 | 2.113 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Blood disorder | 1 | 0.562 | 0.342 | 1.272 | 2.682 | 0.398 | 0.967 | 2.054 | 1.78 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Exposure via breast milk | 3 | 2.473 | 0.448 | 1.272 | 2.436 | 0.487 | 0.992 | 1.846 | 1.213 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Cutaneous lupus erythematosus | 1 | 0.835 | 0.256 | 1.272 | 2.921 | 0.372 | 0.905 | 1.919 | 1.198 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Liver function test | 17 | 12.674 | 0.856 | 1.271 | 1.753 | 0.841 | 1.23 | 1.75 | 1.341 | 3.165 | 19.53
COVID19_PFIZER/BIONTECH | Lung neoplasm malignant | 3 | 2.219 | 0.523 | 1.271 | 2.284 | 0.508 | 1.035 | 1.928 | 1.352 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | Type 2 diabetes mellitus | 5 | 3.792 | 0.566 | 1.271 | 2.205 | 0.589 | 1.085 | 1.87 | 1.319 | 2.58 | 2.9
COVID19_PFIZER/BIONTECH | Dehydration | 80 | 71.085 | 1.05 | 1.271 | 1.509 | 0.925 | 1.112 | 1.327 | 1.125 | 1.567 | 14.602
COVID19_PFIZER/BIONTECH | Agitation | 22 | 20.739 | 0.881 | 1.271 | 1.72 | 0.732 | 1.028 | 1.411 | 1.061 | 1.135 | 0.213
COVID19_PFIZER/BIONTECH | Biliary disorders (SMQ) [narrow] | 38 | 36.816 | 0.956 | 1.271 | 1.622 | 0.78 | 1.015 | 1.303 | 1.032 | 1.515 | 5.654
COVID19_PFIZER/BIONTECH | Laryngospasm | 1 | 0.487 | 0.364 | 1.27 | 2.619 | 0.406 | 0.986 | 2.097 | 2.052 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Vestibular disorders (SMQ) [broad] | 2458 | 1965.01 | 1.229 | 1.27 | 1.313 | 1.209 | 1.25 | 1.292 | 1.251 | 2.808 | 2615.396
COVID19_PFIZER/BIONTECH | Gastrointestinal tube insertion | 4 | 3.234 | 0.534 | 1.27 | 2.262 | 0.533 | 1.028 | 1.832 | 1.237 | 0.812 | 0.031
COVID19_PFIZER/BIONTECH | Dyspnoea | 1224 | 985.329 | 1.211 | 1.269 | 1.33 | 1.184 | 1.241 | 1.3 | 1.242 | 3.164 | 1577.951
COVID19_PFIZER/BIONTECH | Myelodysplastic syndrome (SMQ) [broad] | 22 | 20.159 | 0.881 | 1.269 | 1.715 | 0.75 | 1.053 | 1.446 | 1.091 | 1.662 | 4.7
COVID19_PFIZER/BIONTECH | Vascular injury | 1 | 0.461 | 0.349 | 1.268 | 2.654 | 0.409 | 0.992 | 2.113 | 2.17 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Physical deconditioning | 1 | 0.565 | 0.29 | 1.268 | 2.807 | 0.398 | 0.966 | 2.053 | 1.769 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Skin burning sensation | 33 | 25.785 | 0.947 | 1.268 | 1.626 | 0.925 | 1.226 | 1.599 | 1.28 | 2.443 | 23.462
COVID19_PFIZER/BIONTECH | Chest pain | 441 | 360.372 | 1.171 | 1.268 | 1.369 | 1.128 | 1.22 | 1.318 | 1.224 | 3.303 | 601.775
COVID19_PFIZER/BIONTECH | Aphasia | 72 | 63.562 | 1.037 | 1.268 | 1.52 | 0.92 | 1.117 | 1.345 | 1.133 | 2.449 | 53.104
COVID19_PFIZER/BIONTECH | Madarosis | 1 | 1.024 | 0.214 | 1.268 | 3.046 | 0.356 | 0.866 | 1.837 | 0.976 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Depersonalisation/derealisation disorder | 1 | 1.206 | 0.259 | 1.268 | 2.9 | 0.342 | 0.832 | 1.766 | 0.829 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Monocyte percentage increased | 4 | 2.764 | 0.548 | 1.267 | 2.228 | 0.573 | 1.104 | 1.97 | 1.447 | 0.341 | 4.35
COVID19_PFIZER/BIONTECH | Helicobacter test | 1 | 0.815 | 0.345 | 1.267 | 2.66 | 0.374 | 0.909 | 1.928 | 1.227 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Hypertensive crisis | 3 | 2.616 | 0.526 | 1.267 | 2.266 | 0.476 | 0.969 | 1.803 | 1.147 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Circumoral oedema | 1 | 1.204 | 0.26 | 1.267 | 2.895 | 0.342 | 0.833 | 1.767 | 0.83 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Liver injury | 6 | 3.309 | 0.645 | 1.266 | 2.057 | 0.734 | 1.307 | 2.191 | 1.813 | 3.737 | 7.715
COVID19_PFIZER/BIONTECH | Eating disorder | 9 | 5.959 | 0.775 | 1.266 | 1.856 | 0.766 | 1.257 | 1.972 | 1.51 | 1.098 | 0.009
COVID19_PFIZER/BIONTECH | Impaired work ability | 240 | 193.159 | 1.136 | 1.266 | 1.403 | 1.11 | 1.235 | 1.371 | 1.243 | 3.208 | 309.243
COVID19_PFIZER/BIONTECH | Ischaemic heart disease (SMQ) [broad] | 232 | 202.605 | 1.133 | 1.266 | 1.406 | 1.023 | 1.14 | 1.267 | 1.145 | 4.457 | 497.799
COVID19_PFIZER/BIONTECH | Blood ketone body | 1 | 0.946 | 0.291 | 1.266 | 2.799 | 0.363 | 0.882 | 1.87 | 1.058 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Memory impairment | 37 | 30.62 | 0.946 | 1.265 | 1.622 | 0.896 | 1.169 | 1.505 | 1.208 | 0.926 | 0.143
COVID19_PFIZER/BIONTECH | Bone marrow disorder | 1 | 0.461 | 0.347 | 1.264 | 2.646 | 0.409 | 0.992 | 2.113 | 2.17 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Autoimmune thyroiditis | 3 | 3.427 | 0.397 | 1.264 | 2.528 | 0.42 | 0.857 | 1.594 | 0.875 | 0.437 | 1.585
COVID19_PFIZER/BIONTECH | Blood albumin increased | 3 | 1.59 | 0.477 | 1.263 | 2.353 | 0.57 | 1.163 | 2.171 | 1.887 | 4.515 | 3.935
COVID19_PFIZER/BIONTECH | Blood chloride | 1 | 0.531 | 0.133 | 1.263 | 3.36 | 0.401 | 0.975 | 2.072 | 1.885 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Nasal injury | 2 | 1.23 | 0.302 | 1.263 | 2.76 | 0.475 | 1.041 | 2.05 | 1.625 | 2.125 | 0.268
COVID19_PFIZER/BIONTECH | Pulmonary hypertension (SMQ) [broad] | 1312 | 1062.607 | 1.206 | 1.263 | 1.32 | 1.178 | 1.233 | 1.29 | 1.235 | 3.234 | 1759.877
COVID19_PFIZER/BIONTECH | Ear pain | 89 | 72.981 | 1.055 | 1.263 | 1.486 | 1.009 | 1.202 | 1.422 | 1.219 | 2.226 | 52.496
COVID19_PFIZER/BIONTECH | Disturbance in attention | 49 | 40.806 | 0.984 | 1.263 | 1.571 | 0.928 | 1.171 | 1.463 | 1.201 | 0.962 | 0.037
COVID19_PFIZER/BIONTECH | Phonophobia | 1 | 0.825 | 0.339 | 1.263 | 2.662 | 0.373 | 0.907 | 1.923 | 1.213 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Electrocardiogram QRS complex normal | 1 | 0.266 | 0.323 | 1.262 | 2.703 | 0.43 | 1.05 | 2.25 | 3.765 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Platelet disorder | 1 | 0.461 | 0.349 | 1.262 | 2.637 | 0.409 | 0.992 | 2.113 | 2.17 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Haematological malignant tumours (SMQ) [narrow] | 15 | 14.863 | 0.811 | 1.262 | 1.793 | 0.653 | 0.976 | 1.414 | 1.009 | 1.272 | 0.569
COVID19_PFIZER/BIONTECH | Haematological malignant tumours (SMQ) [broad] | 15 | 14.863 | 0.811 | 1.262 | 1.793 | 0.653 | 0.976 | 1.414 | 1.009 | 1.272 | 0.569
COVID19_PFIZER/BIONTECH | Autoscopy | 2 | 2.002 | 0.337 | 1.262 | 2.667 | 0.409 | 0.896 | 1.761 | 0.999 | 5.16 | 2.361
COVID19_PFIZER/BIONTECH | Blood smear test | 5 | 3.557 | 0.578 | 1.261 | 2.158 | 0.608 | 1.121 | 1.932 | 1.406 | 8.209 | 16.847
COVID19_PFIZER/BIONTECH | Carboxyhaemoglobin normal | 1 | 0.5 | 0.374 | 1.26 | 2.569 | 0.404 | 0.982 | 2.089 | 1.999 | 3.612 | 0.115
COVID19_PFIZER/BIONTECH | Euphoric mood | 5 | 3.171 | 0.582 | 1.26 | 2.147 | 0.642 | 1.185 | 2.043 | 1.577 | 6.45 | 12.993
COVID19_PFIZER/BIONTECH | Anti-GAD antibody positive | 1 | 0.649 | 0.229 | 1.26 | 2.972 | 0.39 | 0.946 | 2.008 | 1.541 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Opportunistic infections (SMQ) [broad] | 1646 | 1366.578 | 1.209 | 1.26 | 1.312 | 1.156 | 1.204 | 1.253 | 1.204 | 1.461 | 236.123
COVID19_PFIZER/BIONTECH | Acute kidney injury | 30 | 33.316 | 0.913 | 1.26 | 1.652 | 0.666 | 0.894 | 1.18 | 0.9 | 2.822 | 28.898
COVID19_PFIZER/BIONTECH | Thermal burn | 3 | 1.876 | 0.562 | 1.259 | 2.181 | 0.54 | 1.101 | 2.052 | 1.599 | 3.01 | 1.873
COVID19_PFIZER/BIONTECH | Ischaemic cerebral infarction | 1 | 0.525 | 0.324 | 1.259 | 2.691 | 0.402 | 0.976 | 2.075 | 1.906 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Body temperature decreased | 18 | 12.358 | 0.875 | 1.259 | 1.701 | 0.908 | 1.317 | 1.859 | 1.457 | 1.806 | 5.141
COVID19_PFIZER/BIONTECH | Gastrointestinal pain | 8 | 5.974 | 0.684 | 1.259 | 1.974 | 0.685 | 1.151 | 1.839 | 1.339 | 1.35 | 0.376
COVID19_PFIZER/BIONTECH | Gastric disorder | 8 | 6.141 | 0.691 | 1.259 | 1.965 | 0.674 | 1.131 | 1.807 | 1.303 | 1.313 | 0.292
COVID19_PFIZER/BIONTECH | White matter lesion | 3 | 3.396 | 0.438 | 1.259 | 2.424 | 0.422 | 0.861 | 1.601 | 0.883 | 0.834 | 0.001
COVID19_PFIZER/BIONTECH | Computerised tomogram head normal | 75 | 63.635 | 1.034 | 1.258 | 1.499 | 0.96 | 1.16 | 1.393 | 1.179 | 2.062 | 35.88
COVID19_PFIZER/BIONTECH | Protein total | 4 | 4.622 | 0.468 | 1.258 | 2.359 | 0.443 | 0.854 | 1.522 | 0.865 | 1.605 | 0.354
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific dysfunction (SMQ) [narrow] | 57 | 47.947 | 1.001 | 1.257 | 1.536 | 0.937 | 1.164 | 1.433 | 1.189 | 1.835 | 18.902
COVID19_PFIZER/BIONTECH | Pelvic pain | 7 | 6.997 | 0.619 | 1.257 | 2.077 | 0.548 | 0.946 | 1.543 | 1 | 2.143 | 2.812
COVID19_PFIZER/BIONTECH | Respiratory symptom | 7 | 4.078 | 0.713 | 1.256 | 1.923 | 0.757 | 1.306 | 2.134 | 1.716 | 1.216 | 0.083
COVID19_PFIZER/BIONTECH | Corneal opacity | 1 | 0.472 | 0.299 | 1.256 | 2.75 | 0.407 | 0.99 | 2.106 | 2.119 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Hyponatraemia/SIADH (SMQ) [broad] | 40 | 35.055 | 0.959 | 1.256 | 1.588 | 0.861 | 1.113 | 1.42 | 1.141 | 1.958 | 16.028
COVID19_PFIZER/BIONTECH | Muscle disorder | 5 | 4.606 | 0.591 | 1.256 | 2.123 | 0.53 | 0.978 | 1.683 | 1.086 | 0.868 | 0.009
COVID19_PFIZER/BIONTECH | Superinfection | 1 | 0.961 | 0.326 | 1.256 | 2.677 | 0.361 | 0.879 | 1.864 | 1.041 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Thrombophlebitis | 1 | 0.474 | 0.299 | 1.255 | 2.749 | 0.407 | 0.989 | 2.105 | 2.111 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Blood fibrinogen decreased | 1 | 0.645 | 0.315 | 1.255 | 2.703 | 0.39 | 0.947 | 2.01 | 1.551 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Laboratory test normal | 98 | 77.597 | 1.058 | 1.255 | 1.465 | 1.053 | 1.244 | 1.461 | 1.263 | 1.468 | 13.1
COVID19_PFIZER/BIONTECH | Blood culture negative | 28 | 28.527 | 0.901 | 1.255 | 1.657 | 0.713 | 0.965 | 1.285 | 0.982 | 0.759 | 1.818
COVID19_PFIZER/BIONTECH | Injection site coldness | 1 | 1.011 | 0.269 | 1.254 | 2.83 | 0.357 | 0.869 | 1.843 | 0.989 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Antithrombin III | 1 | 1.683 | 0.152 | 1.254 | 3.244 | 0.308 | 0.755 | 1.604 | 0.594 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Arrhythmia related investigations, signs and symptoms (SMQ) [broad] | 2068 | 1688.824 | 1.208 | 1.253 | 1.299 | 1.18 | 1.224 | 1.269 | 1.225 | 2.481 | 1690.744
COVID19_PFIZER/BIONTECH | Liver function test increased | 14 | 11.677 | 0.799 | 1.253 | 1.789 | 0.736 | 1.114 | 1.631 | 1.199 | 2.809 | 12.518
COVID19_PFIZER/BIONTECH | Depression | 11 | 13.283 | 0.719 | 1.253 | 1.907 | 0.525 | 0.831 | 1.261 | 0.828 | 0.403 | 8.925
COVID19_PFIZER/BIONTECH | Joint dislocation | 4 | 2.605 | 0.549 | 1.252 | 2.187 | 0.587 | 1.132 | 2.021 | 1.536 | 1.901 | 0.805
COVID19_PFIZER/BIONTECH | Dystonia | 2 | 1.397 | 0.501 | 1.252 | 2.277 | 0.459 | 1.006 | 1.979 | 1.432 | 0.539 | 0.366
COVID19_PFIZER/BIONTECH | Palliative care | 1 | 0.743 | 0.33 | 1.252 | 2.656 | 0.381 | 0.924 | 1.961 | 1.345 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Pulmonary oedema | 24 | 20.172 | 0.875 | 1.252 | 1.684 | 0.82 | 1.136 | 1.542 | 1.19 | 6.469 | 77.531
COVID19_PFIZER/BIONTECH | Brain herniation | 1 | 0.98 | 0.329 | 1.252 | 2.658 | 0.36 | 0.875 | 1.856 | 1.02 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Urinary retention | 11 | 11.075 | 0.727 | 1.252 | 1.892 | 0.605 | 0.955 | 1.451 | 0.993 | 1.316 | 0.497
COVID19_PFIZER/BIONTECH | Pleocytosis | 1 | 0.635 | 0.142 | 1.251 | 3.281 | 0.391 | 0.949 | 2.015 | 1.574 | 0.194 | 2.521
COVID19_PFIZER/BIONTECH | Thrombocytopenia | 33 | 30.256 | 0.923 | 1.251 | 1.62 | 0.803 | 1.064 | 1.388 | 1.091 | 1.313 | 1.998
COVID19_PFIZER/BIONTECH | Cerebrovascular accident | 126 | 122.179 | 1.075 | 1.251 | 1.439 | 0.886 | 1.026 | 1.183 | 1.031 | 5.564 | 357.482
COVID19_PFIZER/BIONTECH | Immunoglobulins normal | 1 | 0.482 | 0.235 | 1.25 | 2.922 | 0.406 | 0.987 | 2.1 | 2.074 | 0.384 | 0.435
COVID19_PFIZER/BIONTECH | Cardiac discomfort | 4 | 2.608 | 0.545 | 1.25 | 2.189 | 0.587 | 1.132 | 2.02 | 1.534 | 3.612 | 4.209
COVID19_PFIZER/BIONTECH | Coma | 5 | 3.857 | 0.613 | 1.25 | 2.069 | 0.583 | 1.076 | 1.853 | 1.296 | 0.772 | 0.134
COVID19_PFIZER/BIONTECH | Alanine aminotransferase | 2 | 1.993 | 0.382 | 1.25 | 2.524 | 0.41 | 0.898 | 1.764 | 1.004 | 0.753 | 0.006
COVID19_PFIZER/BIONTECH | Interstitial lung disease (SMQ) [broad] | 57 | 58.255 | 0.994 | 1.25 | 1.53 | 0.781 | 0.97 | 1.194 | 0.978 | 1.763 | 16.444
COVID19_PFIZER/BIONTECH | Lip swelling | 202 | 165.007 | 1.111 | 1.249 | 1.394 | 1.083 | 1.216 | 1.362 | 1.224 | 2.725 | 190.88
COVID19_PFIZER/BIONTECH | Atrial fibrillation | 94 | 79.535 | 1.046 | 1.249 | 1.467 | 0.985 | 1.167 | 1.375 | 1.182 | 6.382 | 311.394
COVID19_PFIZER/BIONTECH | Gallbladder disorder | 3 | 2.58 | 0.503 | 1.249 | 2.265 | 0.478 | 0.975 | 1.814 | 1.163 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Heart sounds abnormal | 1 | 1.188 | 0.291 | 1.249 | 2.751 | 0.343 | 0.836 | 1.773 | 0.842 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Nephropathy | 1 | 1.551 | 0.303 | 1.249 | 2.718 | 0.317 | 0.775 | 1.646 | 0.645 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [broad] | 2 | 2.937 | 0.234 | 1.249 | 2.922 | 0.349 | 0.767 | 1.508 | 0.681 | 0.138 | 9.771
COVID19_PFIZER/BIONTECH | Infarction | 1 | 0.474 | 0.34 | 1.248 | 2.62 | 0.407 | 0.989 | 2.105 | 2.111 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Muscle rupture | 1 | 0.561 | 0.304 | 1.248 | 2.716 | 0.398 | 0.967 | 2.055 | 1.783 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Injection site nerve damage | 2 | 1.364 | 0.413 | 1.248 | 2.448 | 0.462 | 1.013 | 1.993 | 1.466 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Blood creatine normal | 2 | 1.421 | 0.414 | 1.248 | 2.447 | 0.457 | 1.001 | 1.969 | 1.408 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Swelling face | 246 | 197.298 | 1.123 | 1.248 | 1.38 | 1.116 | 1.239 | 1.374 | 1.247 | 2.229 | 148.241
COVID19_PFIZER/BIONTECH | Hypoaesthesia | 754 | 616.102 | 1.175 | 1.248 | 1.324 | 1.15 | 1.222 | 1.296 | 1.224 | 2.581 | 648.96
COVID19_PFIZER/BIONTECH | Aspiration pleural cavity | 3 | 2.468 | 0.466 | 1.248 | 2.334 | 0.487 | 0.993 | 1.847 | 1.215 | 2.463 | 1.136
COVID19_PFIZER/BIONTECH | Urine leukocyte esterase | 4 | 3.864 | 0.61 | 1.248 | 2.07 | 0.488 | 0.941 | 1.677 | 1.035 | 2.125 | 1.201
COVID19_PFIZER/BIONTECH | Sepsis (SMQ) [broad] | 76 | 74.368 | 1.024 | 1.248 | 1.491 | 0.839 | 1.013 | 1.215 | 1.022 | 0.896 | 0.777
COVID19_PFIZER/BIONTECH | C-reactive protein increased | 49 | 52.435 | 0.974 | 1.248 | 1.549 | 0.735 | 0.928 | 1.16 | 0.934 | 0.554 | 16.683
COVID19_PFIZER/BIONTECH | Oropharyngeal neoplasms (SMQ) [broad] | 2 | 1.622 | 0.37 | 1.247 | 2.544 | 0.439 | 0.962 | 1.891 | 1.233 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Oropharyngeal neoplasms (SMQ) [narrow] | 2 | 1.622 | 0.37 | 1.247 | 2.544 | 0.439 | 0.962 | 1.891 | 1.233 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Pneumonitis | 5 | 4.785 | 0.564 | 1.247 | 2.147 | 0.519 | 0.957 | 1.647 | 1.045 | 1.411 | 0.226
COVID19_PFIZER/BIONTECH | Hypoglycaemic and neurogenic shock conditions (SMQ) [narrow] | 15 | 15.755 | 0.784 | 1.247 | 1.796 | 0.623 | 0.931 | 1.349 | 0.952 | 0.693 | 1.669
COVID19_PFIZER/BIONTECH | Sinus headache | 8 | 5.465 | 0.667 | 1.246 | 1.97 | 0.724 | 1.216 | 1.943 | 1.464 | 2.491 | 4.969
COVID19_PFIZER/BIONTECH | Culture | 8 | 6.205 | 0.695 | 1.246 | 1.928 | 0.669 | 1.124 | 1.795 | 1.289 | 0.741 | 0.459
COVID19_PFIZER/BIONTECH | Hearing and vestibular disorders (SMQ) [broad] | 2836 | 2289.182 | 1.208 | 1.246 | 1.284 | 1.2 | 1.238 | 1.277 | 1.239 | 2.782 | 2990.7
COVID19_PFIZER/BIONTECH | Asthma/bronchospasm (SMQ) [narrow] | 52 | 43.733 | 0.98 | 1.246 | 1.539 | 0.927 | 1.162 | 1.443 | 1.189 | 1.111 | 0.443
COVID19_PFIZER/BIONTECH | Microbiology test | 1 | 1.213 | 0.333 | 1.246 | 2.63 | 0.341 | 0.831 | 1.764 | 0.824 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Eosinophilic pneumonia (SMQ) [narrow] | 7 | 6.199 | 0.636 | 1.245 | 2.018 | 0.593 | 1.023 | 1.669 | 1.129 | 1.686 | 1.185
COVID19_PFIZER/BIONTECH | Eye inflammation | 5 | 2.741 | 0.62 | 1.244 | 2.043 | 0.686 | 1.266 | 2.186 | 1.824 | 1.48 | 0.328
COVID19_PFIZER/BIONTECH | Cardiac arrhythmias (SMQ) [broad] | 2210 | 1804.387 | 1.201 | 1.244 | 1.288 | 1.182 | 1.224 | 1.267 | 1.225 | 2.556 | 1933.206
COVID19_PFIZER/BIONTECH | Retinal disorders (SMQ) [narrow] | 54 | 51.531 | 0.984 | 1.244 | 1.529 | 0.828 | 1.034 | 1.279 | 1.048 | 2.036 | 24.648
COVID19_PFIZER/BIONTECH | Haemolytic disorders (SMQ) [narrow] | 9 | 10.43 | 0.688 | 1.244 | 1.934 | 0.522 | 0.857 | 1.343 | 0.863 | 0.855 | 0.089
COVID19_PFIZER/BIONTECH | Vulvovaginal swelling | 1 | 0.728 | 0.277 | 1.243 | 2.776 | 0.382 | 0.928 | 1.969 | 1.374 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Ultrasound abdomen normal | 4 | 3.429 | 0.528 | 1.243 | 2.203 | 0.518 | 0.999 | 1.781 | 1.167 | 0.277 | 6.717
COVID19_PFIZER/BIONTECH | Apnoeic attack | 1 | 1.435 | 0.232 | 1.243 | 2.914 | 0.325 | 0.793 | 1.685 | 0.697 | 0.42 | 0.299
COVID19_PFIZER/BIONTECH | Lymphadenopathy mediastinal | 1 | 0.497 | 0.337 | 1.242 | 2.61 | 0.405 | 0.983 | 2.091 | 2.012 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Ultrasound scan abnormal | 26 | 21.686 | 0.882 | 1.242 | 1.652 | 0.838 | 1.147 | 1.541 | 1.199 | 1.145 | 0.318
COVID19_PFIZER/BIONTECH | Band neutrophil percentage increased | 1 | 1.012 | 0.293 | 1.242 | 2.727 | 0.357 | 0.869 | 1.842 | 0.988 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Cholestasis and jaundice of hepatic origin (SMQ) [narrow] | 11 | 11.409 | 0.716 | 1.241 | 1.883 | 0.591 | 0.934 | 1.419 | 0.964 | 0.903 | 0.033
COVID19_PFIZER/BIONTECH | Brain death | 3 | 1.484 | 0.446 | 1.24 | 2.358 | 0.582 | 1.188 | 2.22 | 2.022 | 3.01 | 1.873
COVID19_PFIZER/BIONTECH | Haematocrit | 3 | 2.432 | 0.456 | 1.24 | 2.334 | 0.49 | 0.999 | 1.859 | 1.233 | 1.935 | 0.495
COVID19_PFIZER/BIONTECH | Laboratory test abnormal | 18 | 16.449 | 0.827 | 1.24 | 1.722 | 0.723 | 1.048 | 1.48 | 1.094 | 0.953 | 0.006
COVID19_PFIZER/BIONTECH | Iron deficiency | 1 | 0.883 | 0.191 | 1.24 | 3.044 | 0.368 | 0.895 | 1.897 | 1.133 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging neck | 12 | 11.659 | 0.776 | 1.24 | 1.792 | 0.633 | 0.984 | 1.475 | 1.029 | 8.335 | 47.843
COVID19_PFIZER/BIONTECH | Blood ketone body increased | 1 | 0.525 | 0.31 | 1.239 | 2.672 | 0.402 | 0.976 | 2.075 | 1.906 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Biopsy liver abnormal | 1 | 0.816 | 0.146 | 1.239 | 3.223 | 0.374 | 0.909 | 1.927 | 1.225 | 0.564 | 0.033
COVID19_PFIZER/BIONTECH | Anticoagulant therapy | 3 | 2.867 | 0.412 | 1.239 | 2.425 | 0.457 | 0.931 | 1.733 | 1.046 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Crepitations | 3 | 2.247 | 0.427 | 1.238 | 2.392 | 0.506 | 1.03 | 1.919 | 1.335 | 1.806 | 0.36
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific dysfunction (SMQ) [broad] | 61 | 53.025 | 0.994 | 1.238 | 1.504 | 0.917 | 1.13 | 1.382 | 1.15 | 1.487 | 8.533
COVID19_PFIZER/BIONTECH | Liver related investigations, signs and symptoms (SMQ) [broad] | 93 | 82.451 | 1.037 | 1.238 | 1.453 | 0.941 | 1.116 | 1.316 | 1.128 | 1.297 | 5.635
COVID19_PFIZER/BIONTECH | Blood count normal | 2 | 1.031 | 0.38 | 1.237 | 2.492 | 0.496 | 1.087 | 2.145 | 1.939 | 0.384 | 1.349
COVID19_PFIZER/BIONTECH | Extremity contracture | 2 | 1.172 | 0.417 | 1.237 | 2.41 | 0.481 | 1.054 | 2.077 | 1.706 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Mouth breathing | 2 | 1.339 | 0.49 | 1.237 | 2.26 | 0.465 | 1.018 | 2.003 | 1.494 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Hallucination, visual | 8 | 6.659 | 0.715 | 1.237 | 1.875 | 0.64 | 1.074 | 1.716 | 1.201 | 1.926 | 2.398
COVID19_PFIZER/BIONTECH | Painful respiration | 26 | 21.874 | 0.877 | 1.237 | 1.647 | 0.832 | 1.139 | 1.53 | 1.189 | 3.478 | 36.351
COVID19_PFIZER/BIONTECH | Noninfectious diarrhoea (SMQ) [narrow] | 691 | 598.879 | 1.16 | 1.237 | 1.315 | 1.082 | 1.152 | 1.226 | 1.154 | 1.592 | 142.799
COVID19_PFIZER/BIONTECH | Spleen disorder | 1 | 0.931 | 0.34 | 1.237 | 2.587 | 0.364 | 0.885 | 1.876 | 1.074 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Allergy test | 6 | 3.804 | 0.726 | 1.236 | 1.857 | 0.685 | 1.219 | 2.041 | 1.577 | 0.742 | 0.288
COVID19_PFIZER/BIONTECH | Acute central respiratory depression (SMQ) [broad] | 1543 | 1292.906 | 1.185 | 1.236 | 1.288 | 1.143 | 1.192 | 1.243 | 1.193 | 2.508 | 1274.099
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging normal | 42 | 37.076 | 0.949 | 1.236 | 1.554 | 0.861 | 1.107 | 1.405 | 1.133 | 1.042 | 0.032
COVID19_PFIZER/BIONTECH | Upper limb fracture | 3 | 2.027 | 0.504 | 1.235 | 2.228 | 0.526 | 1.071 | 1.995 | 1.48 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Candida infection | 4 | 2.825 | 0.507 | 1.235 | 2.222 | 0.567 | 1.093 | 1.951 | 1.416 | 1.184 | 0.002
COVID19_PFIZER/BIONTECH | Periorbital and eyelid disorders (SMQ) [narrow] | 156 | 122.367 | 1.082 | 1.235 | 1.397 | 1.106 | 1.262 | 1.436 | 1.275 | 2.055 | 75.2
COVID19_PFIZER/BIONTECH | Periorbital and eyelid disorders (SMQ) [broad] | 156 | 122.367 | 1.082 | 1.235 | 1.397 | 1.106 | 1.262 | 1.436 | 1.275 | 2.055 | 75.2
COVID19_PFIZER/BIONTECH | Musculoskeletal chest pain | 31 | 25.186 | 0.913 | 1.235 | 1.596 | 0.884 | 1.182 | 1.553 | 1.231 | 2.17 | 16.387
COVID19_PFIZER/BIONTECH | H1N1 influenza | 1 | 0.847 | 0.083 | 1.235 | 3.555 | 0.371 | 0.902 | 1.913 | 1.181 | 0.262 | 1.357
COVID19_PFIZER/BIONTECH | Systemic lupus erythematosus | 6 | 6.18 | 0.565 | 1.235 | 2.115 | 0.519 | 0.922 | 1.543 | 0.971 | 0.55 | 1.708
COVID19_PFIZER/BIONTECH | Procedural pain | 1 | 0.48 | 0.342 | 1.234 | 2.577 | 0.407 | 0.987 | 2.101 | 2.084 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Band neutrophil count | 1 | 0.528 | 0.325 | 1.234 | 2.618 | 0.402 | 0.975 | 2.074 | 1.895 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Rash maculo-papular | 17 | 14.555 | 0.821 | 1.234 | 1.715 | 0.754 | 1.103 | 1.569 | 1.168 | 0.569 | 4.972
COVID19_PFIZER/BIONTECH | Eye disorder | 9 | 8.274 | 0.687 | 1.234 | 1.91 | 0.617 | 1.012 | 1.587 | 1.088 | 1.213 | 0.14
COVID19_PFIZER/BIONTECH | Hypothyroidism (SMQ) [broad] | 20 | 20.097 | 0.829 | 1.234 | 1.705 | 0.682 | 0.971 | 1.351 | 0.995 | 0.808 | 0.691
COVID19_PFIZER/BIONTECH | Chest X-ray normal | 119 | 100.23 | 1.056 | 1.233 | 1.423 | 1.01 | 1.175 | 1.361 | 1.187 | 2.294 | 76.072
COVID19_PFIZER/BIONTECH | Retinitis | 1 | 0.869 | 0.316 | 1.232 | 2.635 | 0.369 | 0.897 | 1.903 | 1.151 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Lip pain | 5 | 3.709 | 0.563 | 1.231 | 2.107 | 0.595 | 1.098 | 1.891 | 1.348 | 2.052 | 1.528
COVID19_PFIZER/BIONTECH | Endoscopy normal | 2 | 1.904 | 0.344 | 1.231 | 2.562 | 0.416 | 0.912 | 1.793 | 1.051 | 1.29 | 0.004
COVID19_PFIZER/BIONTECH | Dysphoria | 1 | 0.743 | 0.287 | 1.23 | 2.71 | 0.381 | 0.924 | 1.961 | 1.345 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Focal dyscognitive seizures | 1 | 0.461 | 0.31 | 1.229 | 2.644 | 0.409 | 0.992 | 2.113 | 2.17 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Haematology test | 5 | 3.745 | 0.581 | 1.229 | 2.072 | 0.592 | 1.092 | 1.882 | 1.335 | 3.225 | 4.673
COVID19_PFIZER/BIONTECH | Acute sinusitis | 1 | 0.68 | 0.346 | 1.229 | 2.553 | 0.387 | 0.939 | 1.992 | 1.47 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Basophil percentage increased | 1 | 0.781 | 0.234 | 1.229 | 2.864 | 0.377 | 0.916 | 1.944 | 1.281 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | CSF culture negative | 6 | 5.65 | 0.571 | 1.228 | 2.087 | 0.548 | 0.975 | 1.631 | 1.062 | 0.423 | 4.034
COVID19_PFIZER/BIONTECH | Urine ketone body absent | 4 | 2.813 | 0.546 | 1.227 | 2.128 | 0.568 | 1.095 | 1.955 | 1.422 | 1.078 | 0.014
COVID19_PFIZER/BIONTECH | Cardiomyopathy (SMQ) [broad] | 2553 | 2108.624 | 1.188 | 1.227 | 1.267 | 1.171 | 1.21 | 1.25 | 1.211 | 2.514 | 2175.564
COVID19_PFIZER/BIONTECH | Orthosis user | 1 | 0.823 | 0.329 | 1.227 | 2.588 | 0.373 | 0.907 | 1.924 | 1.216 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | Red blood cell anisocytes present | 1 | 0.5 | 0.349 | 1.226 | 2.536 | 0.404 | 0.982 | 2.089 | 1.999 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Acute generalised exanthematous pustulosis | 2 | 1 | 0.407 | 1.224 | 2.395 | 0.499 | 1.095 | 2.161 | 1.999 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Retinal exudates | 1 | 0.585 | 0.273 | 1.224 | 2.73 | 0.396 | 0.961 | 2.042 | 1.709 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Enlarged uvula | 9 | 6.413 | 0.72 | 1.224 | 1.837 | 0.731 | 1.2 | 1.882 | 1.403 | 5.243 | 20.61
COVID19_PFIZER/BIONTECH | Hearing impairment (SMQ) [broad] | 443 | 382.779 | 1.131 | 1.224 | 1.321 | 1.067 | 1.154 | 1.247 | 1.157 | 2.366 | 311.242
COVID19_PFIZER/BIONTECH | Micturition disorder | 1 | 0.841 | 0.347 | 1.224 | 2.534 | 0.372 | 0.903 | 1.916 | 1.188 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Seasonal allergy | 1 | 1.767 | 0.211 | 1.224 | 2.927 | 0.303 | 0.743 | 1.579 | 0.566 | 0.254 | 1.449
COVID19_PFIZER/BIONTECH | Facial neuralgia | 1 | 0.508 | 0.315 | 1.223 | 2.614 | 0.404 | 0.98 | 2.085 | 1.968 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Phlebitis | 2 | 1.69 | 0.335 | 1.223 | 2.563 | 0.433 | 0.949 | 1.866 | 1.183 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Breast swelling | 6 | 5.322 | 0.604 | 1.223 | 2.017 | 0.569 | 1.011 | 1.691 | 1.127 | 2.084 | 2.094
COVID19_PFIZER/BIONTECH | Anaphylactic/anaphylactoid shock conditions (SMQ) [broad] | 307 | 279.076 | 1.111 | 1.223 | 1.34 | 0.998 | 1.097 | 1.203 | 1.1 | 2.348 | 210.722
COVID19_PFIZER/BIONTECH | Respiratory failure | 31 | 32.505 | 0.894 | 1.223 | 1.594 | 0.705 | 0.942 | 1.238 | 0.954 | 2.074 | 14.469
COVID19_PFIZER/BIONTECH | Pregnancy test positive | 6 | 6.385 | 0.556 | 1.223 | 2.1 | 0.508 | 0.904 | 1.511 | 0.94 | 0.753 | 0.252
COVID19_PFIZER/BIONTECH | Sepsis (SMQ) [narrow] | 47 | 49.104 | 0.948 | 1.222 | 1.523 | 0.748 | 0.949 | 1.19 | 0.957 | 1.171 | 0.939
COVID19_PFIZER/BIONTECH | Oxygen saturation | 21 | 19.634 | 0.851 | 1.221 | 1.645 | 0.731 | 1.034 | 1.428 | 1.07 | 9.725 | 100.962
COVID19_PFIZER/BIONTECH | Red blood cell abnormality | 1 | 0.461 | 0.326 | 1.22 | 2.577 | 0.409 | 0.992 | 2.113 | 2.17 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Tympanic membrane disorder | 1 | 0.708 | 0.295 | 1.22 | 2.659 | 0.384 | 0.932 | 1.979 | 1.412 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Tongue biting | 3 | 2.5 | 0.523 | 1.22 | 2.155 | 0.485 | 0.987 | 1.838 | 1.2 | 1.26 | 0.003
COVID19_PFIZER/BIONTECH | Blood folate normal | 3 | 2.507 | 0.42 | 1.22 | 2.358 | 0.484 | 0.986 | 1.835 | 1.196 | 1.321 | 0.017
COVID19_PFIZER/BIONTECH | Unresponsive to stimuli | 180 | 156.577 | 1.076 | 1.22 | 1.372 | 1.01 | 1.143 | 1.288 | 1.15 | 1.86 | 64.407
COVID19_PFIZER/BIONTECH | Uveitis | 2 | 1.98 | 0.289 | 1.22 | 2.675 | 0.41 | 0.9 | 1.768 | 1.01 | 0.358 | 1.647
COVID19_PFIZER/BIONTECH | Eye pain | 86 | 72.779 | 1.014 | 1.219 | 1.439 | 0.976 | 1.165 | 1.383 | 1.182 | 1.812 | 27.761
COVID19_PFIZER/BIONTECH | Haemoglobin decreased | 55 | 52.455 | 0.965 | 1.219 | 1.497 | 0.83 | 1.035 | 1.278 | 1.049 | 1.73 | 14.809
COVID19_PFIZER/BIONTECH | Herpes virus infection | 4 | 4.638 | 0.479 | 1.219 | 2.234 | 0.442 | 0.852 | 1.519 | 0.862 | 0.675 | 0.318
COVID19_PFIZER/BIONTECH | Clostridium difficile infection | 1 | 1.301 | 0.369 | 1.219 | 2.469 | 0.335 | 0.816 | 1.731 | 0.768 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Haematocrit normal | 27 | 21.934 | 0.873 | 1.218 | 1.611 | 0.863 | 1.175 | 1.571 | 1.231 | 1.231 | 0.883
COVID19_PFIZER/BIONTECH | Blood cholesterol decreased | 1 | 1.014 | 0.327 | 1.218 | 2.57 | 0.357 | 0.868 | 1.842 | 0.986 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Culture throat | 2 | 1.055 | 0.451 | 1.217 | 2.285 | 0.493 | 1.082 | 2.133 | 1.896 | 0.516 | 0.456
COVID19_PFIZER/BIONTECH | Electrocardiogram QT prolonged | 6 | 4.055 | 0.603 | 1.217 | 2.004 | 0.663 | 1.179 | 1.973 | 1.48 | 4.013 | 8.658
COVID19_PFIZER/BIONTECH | Axillary mass | 20 | 15.855 | 0.839 | 1.217 | 1.653 | 0.83 | 1.183 | 1.645 | 1.261 | 2.736 | 17.587
COVID19_PFIZER/BIONTECH | Neutrophil percentage | 7 | 5.599 | 0.628 | 1.217 | 1.962 | 0.632 | 1.089 | 1.778 | 1.25 | 0.81 | 0.137
COVID19_PFIZER/BIONTECH | Fatigue | 2651 | 2366.329 | 1.179 | 1.217 | 1.256 | 1.085 | 1.12 | 1.156 | 1.12 | 2.569 | 2370.752
COVID19_PFIZER/BIONTECH | Red blood cell count normal | 13 | 12.702 | 0.744 | 1.217 | 1.784 | 0.641 | 0.983 | 1.455 | 1.023 | 0.562 | 3.881
COVID19_PFIZER/BIONTECH | Drug related hepatic disorders - severe events only (SMQ) [broad] | 25 | 25.501 | 0.855 | 1.217 | 1.631 | 0.699 | 0.963 | 1.3 | 0.98 | 0.975 | 0
COVID19_PFIZER/BIONTECH | Troponin T | 2 | 2.59 | 0.318 | 1.217 | 2.589 | 0.369 | 0.81 | 1.592 | 0.772 | 4.515 | 1.914
COVID19_PFIZER/BIONTECH | Tonsillar disorder | 1 | 0.408 | 0.298 | 1.216 | 2.639 | 0.414 | 1.007 | 2.146 | 2.45 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Gingival pain | 8 | 6.148 | 0.677 | 1.216 | 1.883 | 0.673 | 1.131 | 1.806 | 1.301 | 2.676 | 5.853
COVID19_PFIZER/BIONTECH | Hypoacusis | 34 | 28.983 | 0.909 | 1.216 | 1.559 | 0.861 | 1.136 | 1.477 | 1.173 | 1.919 | 12.675
COVID19_PFIZER/BIONTECH | Diarrhoea | 670 | 582.907 | 1.14 | 1.216 | 1.295 | 1.077 | 1.147 | 1.222 | 1.149 | 1.602 | 142.092
COVID19_PFIZER/BIONTECH | Computerised tomogram abnormal | 50 | 47.721 | 0.954 | 1.216 | 1.504 | 0.82 | 1.033 | 1.288 | 1.048 | 3.81 | 83.215
COVID19_PFIZER/BIONTECH | Tooth abscess | 1 | 0.461 | 0.299 | 1.215 | 2.631 | 0.409 | 0.992 | 2.113 | 2.17 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Culture urine positive | 5 | 3.074 | 0.579 | 1.215 | 2.039 | 0.652 | 1.203 | 2.074 | 1.627 | 1.613 | 0.557
COVID19_PFIZER/BIONTECH | Sinus congestion | 26 | 20.716 | 0.88 | 1.215 | 1.595 | 0.871 | 1.193 | 1.603 | 1.255 | 3.029 | 28.479
COVID19_PFIZER/BIONTECH | Allodynia | 3 | 2.698 | 0.395 | 1.215 | 2.4 | 0.469 | 0.956 | 1.779 | 1.112 | 1.178 | 0.002
COVID19_PFIZER/BIONTECH | Back disorder | 1 | 1.082 | 0.294 | 1.215 | 2.647 | 0.352 | 0.855 | 1.814 | 0.925 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Hernia | 1 | 1.296 | 0.228 | 1.215 | 2.841 | 0.335 | 0.817 | 1.733 | 0.772 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Nasal disorder | 1 | 0.474 | 0.358 | 1.214 | 2.484 | 0.407 | 0.989 | 2.105 | 2.111 | 2.58 | 0.016
COVID19_PFIZER/BIONTECH | Positron emission tomogram normal | 1 | 0.507 | 0.199 | 1.214 | 2.936 | 0.404 | 0.981 | 2.085 | 1.973 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Calcium ionised normal | 1 | 0.844 | 0.398 | 1.214 | 2.39 | 0.372 | 0.903 | 1.915 | 1.185 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Chorea | 1 | 0.56 | 0.376 | 1.213 | 2.436 | 0.398 | 0.967 | 2.055 | 1.784 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Thyroid function test | 9 | 6.427 | 0.752 | 1.213 | 1.763 | 0.73 | 1.199 | 1.88 | 1.4 | 2.665 | 6.698
COVID19_PFIZER/BIONTECH | Protein total increased | 4 | 3.506 | 0.511 | 1.213 | 2.158 | 0.513 | 0.988 | 1.762 | 1.141 | 1.474 | 0.196
COVID19_PFIZER/BIONTECH | Haematopoietic erythropenia (SMQ) [broad] | 85 | 79.756 | 1.007 | 1.213 | 1.434 | 0.883 | 1.056 | 1.254 | 1.066 | 1.463 | 11.127
COVID19_PFIZER/BIONTECH | Eyelid function disorder | 21 | 16.309 | 0.856 | 1.212 | 1.62 | 0.853 | 1.206 | 1.667 | 1.288 | 2.852 | 20.159
COVID19_PFIZER/BIONTECH | Audiogram | 5 | 4.357 | 0.643 | 1.212 | 1.926 | 0.547 | 1.008 | 1.736 | 1.147 | 3.612 | 5.741
COVID19_PFIZER/BIONTECH | Drug related hepatic disorders - severe events only (SMQ) [narrow] | 25 | 25.501 | 0.852 | 1.212 | 1.624 | 0.699 | 0.963 | 1.3 | 0.98 | 0.977 | 0
COVID19_PFIZER/BIONTECH | Azotaemia | 3 | 1.434 | 0.476 | 1.211 | 2.218 | 0.588 | 1.2 | 2.244 | 2.093 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Vasoconstriction | 1 | 0.461 | 0.333 | 1.211 | 2.532 | 0.409 | 0.992 | 2.113 | 2.17 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Soft tissue injury | 1 | 0.47 | 0.333 | 1.211 | 2.536 | 0.408 | 0.99 | 2.107 | 2.125 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Conjunctivitis | 9 | 7.344 | 0.664 | 1.211 | 1.892 | 0.669 | 1.098 | 1.722 | 1.226 | 0.562 | 2.543
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events (SMQ) [narrow] | 458 | 425.376 | 1.12 | 1.211 | 1.306 | 0.995 | 1.075 | 1.159 | 1.077 | 3.077 | 551.945
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events (SMQ) [broad] | 458 | 425.376 | 1.12 | 1.211 | 1.306 | 0.995 | 1.075 | 1.159 | 1.077 | 3.077 | 551.945
COVID19_PFIZER/BIONTECH | Menstruation irregular | 1 | 1.357 | 0.094 | 1.211 | 3.405 | 0.331 | 0.806 | 1.711 | 0.737 | 0.086 | 8.791
COVID19_PFIZER/BIONTECH | Pseudomembranous colitis (SMQ) [broad] | 687 | 601.231 | 1.136 | 1.21 | 1.287 | 1.071 | 1.141 | 1.214 | 1.143 | 1.561 | 130.279
COVID19_PFIZER/BIONTECH | Biliary system related investigations, signs and symptoms (SMQ) [broad] | 44 | 40.948 | 0.932 | 1.21 | 1.518 | 0.826 | 1.055 | 1.333 | 1.075 | 1.101 | 0.289
COVID19_PFIZER/BIONTECH | Echocardiogram | 80 | 78.85 | 0.998 | 1.21 | 1.438 | 0.838 | 1.007 | 1.202 | 1.015 | 4.275 | 159.688
COVID19_PFIZER/BIONTECH | Haptoglobin decreased | 1 | 0.738 | 0.191 | 1.209 | 2.951 | 0.381 | 0.926 | 1.964 | 1.356 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Electroencephalogram normal | 18 | 14.973 | 0.807 | 1.209 | 1.677 | 0.781 | 1.132 | 1.597 | 1.202 | 0.427 | 12.952
COVID19_PFIZER/BIONTECH | Disorganised speech | 4 | 3.547 | 0.588 | 1.209 | 2.011 | 0.51 | 0.983 | 1.752 | 1.128 | 5.16 | 7.299
COVID19_PFIZER/BIONTECH | Apnoea | 5 | 4.817 | 0.534 | 1.209 | 2.105 | 0.517 | 0.953 | 1.641 | 1.038 | 0.159 | 21.27
COVID19_PFIZER/BIONTECH | Lymphatic disorder | 1 | 0.487 | 0.335 | 1.208 | 2.521 | 0.406 | 0.986 | 2.097 | 2.052 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Speech disorder | 80 | 73.499 | 1 | 1.208 | 1.433 | 0.896 | 1.077 | 1.285 | 1.088 | 1.815 | 25.899
COVID19_PFIZER/BIONTECH | Red blood cell sedimentation rate increased | 29 | 27.782 | 0.877 | 1.208 | 1.581 | 0.757 | 1.02 | 1.352 | 1.044 | 1.027 | 0.002
COVID19_PFIZER/BIONTECH | Productive cough | 31 | 29.811 | 0.887 | 1.208 | 1.569 | 0.762 | 1.018 | 1.338 | 1.04 | 1.096 | 0.158
COVID19_PFIZER/BIONTECH | Spinal fracture | 1 | 0.954 | 0.335 | 1.208 | 2.521 | 0.362 | 0.88 | 1.867 | 1.049 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Angioedema | 56 | 55.714 | 0.96 | 1.208 | 1.48 | 0.8 | 0.995 | 1.226 | 1.005 | 2.064 | 26.61
COVID19_PFIZER/BIONTECH | Dysuria | 10 | 10.353 | 0.682 | 1.208 | 1.856 | 0.58 | 0.933 | 1.438 | 0.966 | 0.72 | 0.787
COVID19_PFIZER/BIONTECH | Livedo reticularis | 15 | 13.339 | 0.767 | 1.207 | 1.729 | 0.712 | 1.064 | 1.541 | 1.124 | 1.963 | 5.511
COVID19_PFIZER/BIONTECH | Nerve conduction studies normal | 1 | 1.277 | 0.23 | 1.207 | 2.81 | 0.336 | 0.82 | 1.74 | 0.783 | 0.282 | 1.13
COVID19_PFIZER/BIONTECH | Foreign travel | 1 | 0.515 | 0.315 | 1.206 | 2.565 | 0.403 | 0.978 | 2.081 | 1.942 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Piloerection | 6 | 4.328 | 0.642 | 1.206 | 1.914 | 0.64 | 1.138 | 1.904 | 1.386 | 3.386 | 6.509
COVID19_PFIZER/BIONTECH | Immunosuppressant drug therapy | 1 | 0.609 | 0.326 | 1.205 | 2.537 | 0.393 | 0.955 | 2.029 | 1.642 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Thyroid dysfunction (SMQ) [broad] | 21 | 22.338 | 0.817 | 1.205 | 1.654 | 0.655 | 0.926 | 1.279 | 0.94 | 0.734 | 1.694
COVID19_PFIZER/BIONTECH | Mood altered | 3 | 3.267 | 0.434 | 1.205 | 2.289 | 0.43 | 0.877 | 1.631 | 0.918 | 0.24 | 6.373
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific inflammation (SMQ) [broad] | 31 | 30.426 | 0.88 | 1.204 | 1.57 | 0.748 | 1 | 1.314 | 1.019 | 1.302 | 1.742
COVID19_PFIZER/BIONTECH | Coronavirus test negative | 1 | 1.965 | 0.339 | 1.204 | 2.5 | 0.291 | 0.715 | 1.523 | 0.509 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Drain placement | 1 | 0.487 | 0.309 | 1.203 | 2.573 | 0.406 | 0.986 | 2.097 | 2.052 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | CSF cell count increased | 1 | 0.625 | 0.138 | 1.203 | 3.148 | 0.392 | 0.952 | 2.021 | 1.6 | 0.212 | 2.123
COVID19_PFIZER/BIONTECH | Asthma/bronchospasm (SMQ) [broad] | 293 | 258.864 | 1.09 | 1.203 | 1.32 | 1.024 | 1.128 | 1.24 | 1.132 | 1.935 | 119.701
COVID19_PFIZER/BIONTECH | Abnormal behaviour | 19 | 17.522 | 0.819 | 1.203 | 1.647 | 0.726 | 1.042 | 1.46 | 1.084 | 0.427 | 13.694
COVID19_PFIZER/BIONTECH | Aspartate aminotransferase normal | 16 | 15.68 | 0.771 | 1.203 | 1.713 | 0.667 | 0.986 | 1.416 | 1.02 | 0.912 | 0.057
COVID19_PFIZER/BIONTECH | Nerve conduction studies abnormal | 3 | 3.947 | 0.392 | 1.203 | 2.375 | 0.391 | 0.798 | 1.484 | 0.76 | 0.35 | 2.922
COVID19_PFIZER/BIONTECH | Shock (SMQ) [narrow] | 393 | 355.62 | 1.104 | 1.202 | 1.303 | 1.014 | 1.102 | 1.197 | 1.105 | 3.087 | 475.517
COVID19_PFIZER/BIONTECH | Specialist consultation | 2 | 1.29 | 0.436 | 1.201 | 2.276 | 0.469 | 1.028 | 2.024 | 1.55 | 1.129 | 0.048
COVID19_PFIZER/BIONTECH | Affect lability | 1 | 0.763 | 0.245 | 1.201 | 2.746 | 0.379 | 0.92 | 1.952 | 1.311 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Lip erythema | 6 | 5.014 | 0.578 | 1.201 | 2.005 | 0.589 | 1.047 | 1.752 | 1.197 | 2.125 | 2.223
COVID19_PFIZER/BIONTECH | Human herpes virus 6 serology negative | 1 | 0.825 | 0.331 | 1.201 | 2.511 | 0.373 | 0.907 | 1.923 | 1.213 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Tubulointerstitial diseases (SMQ) [narrow] | 1 | 0.915 | 0.207 | 1.201 | 2.87 | 0.365 | 0.888 | 1.883 | 1.093 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Dysacusis | 1 | 1.165 | 0.342 | 1.201 | 2.483 | 0.345 | 0.84 | 1.781 | 0.858 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Hearing and vestibular disorders (SMQ) [narrow] | 367 | 318.831 | 1.099 | 1.2 | 1.305 | 1.053 | 1.148 | 1.249 | 1.151 | 1.976 | 160.2
COVID19_PFIZER/BIONTECH | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [narrow] | 192 | 180.723 | 1.062 | 1.2 | 1.346 | 0.939 | 1.058 | 1.188 | 1.062 | 3.701 | 312.738
COVID19_PFIZER/BIONTECH | Hypoglycaemic and neurogenic shock conditions (SMQ) [broad] | 117 | 116.336 | 1.025 | 1.2 | 1.387 | 0.859 | 1.001 | 1.16 | 1.006 | 1.833 | 39.537
COVID19_PFIZER/BIONTECH | Leukocytosis | 14 | 17.266 | 0.746 | 1.2 | 1.742 | 0.539 | 0.816 | 1.194 | 0.811 | 0.9 | 0.065
COVID19_PFIZER/BIONTECH | Ocular motility disorders (SMQ) [narrow] | 89 | 76.857 | 1.002 | 1.199 | 1.411 | 0.961 | 1.144 | 1.353 | 1.158 | 0.71 | 9.923
COVID19_PFIZER/BIONTECH | Meniere's disease | 1 | 0.825 | 0.36 | 1.199 | 2.437 | 0.373 | 0.907 | 1.923 | 1.213 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Platelet count decreased | 76 | 71.305 | 0.985 | 1.198 | 1.428 | 0.874 | 1.055 | 1.265 | 1.066 | 1.411 | 8.055
COVID19_PFIZER/BIONTECH | Faecaloma | 1 | 0.969 | 0.347 | 1.198 | 2.464 | 0.361 | 0.877 | 1.86 | 1.032 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Fibrin D dimer increased | 49 | 40.664 | 0.936 | 1.197 | 1.485 | 0.931 | 1.175 | 1.468 | 1.205 | 9.315 | 234.289
COVID19_PFIZER/BIONTECH | Electrocardiogram | 268 | 232.805 | 1.08 | 1.197 | 1.319 | 1.036 | 1.146 | 1.265 | 1.151 | 4.112 | 513.689
COVID19_PFIZER/BIONTECH | Lip ulceration | 1 | 1.221 | 0.316 | 1.197 | 2.538 | 0.341 | 0.83 | 1.761 | 0.819 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Testicular swelling | 2 | 0.604 | 0.363 | 1.196 | 2.42 | 0.548 | 1.207 | 2.408 | 3.313 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Intracranial pressure increased | 2 | 1.001 | 0.413 | 1.196 | 2.309 | 0.499 | 1.095 | 2.16 | 1.998 | 1.032 | 0.106
COVID19_PFIZER/BIONTECH | Brain injury | 4 | 2.733 | 0.573 | 1.196 | 2.002 | 0.575 | 1.109 | 1.98 | 1.464 | 0.695 | 0.253
COVID19_PFIZER/BIONTECH | Influenza A virus test negative | 23 | 19.032 | 0.826 | 1.196 | 1.622 | 0.824 | 1.15 | 1.569 | 1.208 | 1.897 | 7.994
COVID19_PFIZER/BIONTECH | Tongue ulceration | 3 | 2.529 | 0.535 | 1.196 | 2.071 | 0.482 | 0.983 | 1.829 | 1.186 | 1.426 | 0.06
COVID19_PFIZER/BIONTECH | Anti-thyroid antibody positive | 1 | 0.826 | 0.141 | 1.196 | 3.112 | 0.373 | 0.906 | 1.923 | 1.211 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Wound haemorrhage | 1 | 0.553 | 0.317 | 1.195 | 2.53 | 0.399 | 0.969 | 2.06 | 1.81 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Mental disorder | 5 | 4.89 | 0.524 | 1.195 | 2.088 | 0.512 | 0.945 | 1.627 | 1.022 | 0.575 | 1.118
COVID19_PFIZER/BIONTECH | Hypovolaemic shock conditions (SMQ) [broad] | 118 | 116.269 | 1.021 | 1.195 | 1.38 | 0.867 | 1.01 | 1.17 | 1.015 | 1.864 | 42.204
COVID19_PFIZER/BIONTECH | Injury associated with device | 2 | 1.973 | 0.302 | 1.195 | 2.567 | 0.411 | 0.901 | 1.77 | 1.014 | 0.446 | 0.834
COVID19_PFIZER/BIONTECH | Blood lactate dehydrogenase normal | 2 | 2.087 | 0.372 | 1.195 | 2.398 | 0.403 | 0.883 | 1.734 | 0.958 | 0.645 | 0.102
COVID19_PFIZER/BIONTECH | Blood magnesium increased | 4 | 2.603 | 0.572 | 1.194 | 2.001 | 0.587 | 1.133 | 2.022 | 1.537 | 2.676 | 2.278
COVID19_PFIZER/BIONTECH | Nystagmus | 6 | 4.508 | 0.577 | 1.194 | 1.992 | 0.626 | 1.113 | 1.862 | 1.331 | 0.918 | 0
COVID19_PFIZER/BIONTECH | Migraine | 178 | 154.57 | 1.051 | 1.194 | 1.344 | 1.011 | 1.144 | 1.291 | 1.152 | 2.588 | 150.913
COVID19_PFIZER/BIONTECH | Tachyarrhythmia | 1 | 0.815 | 0.318 | 1.194 | 2.524 | 0.374 | 0.909 | 1.928 | 1.227 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Vision blurred | 149 | 130.666 | 1.04 | 1.194 | 1.357 | 0.989 | 1.132 | 1.291 | 1.14 | 1.852 | 52.404
COVID19_PFIZER/BIONTECH | Feeding tube user | 1 | 1.054 | 0.303 | 1.194 | 2.564 | 0.354 | 0.861 | 1.825 | 0.949 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Fungal infection | 2 | 2.881 | 0.378 | 1.194 | 2.382 | 0.352 | 0.774 | 1.521 | 0.694 | 0.539 | 0.366
COVID19_PFIZER/BIONTECH | Oral mucosal eruption | 8 | 5.801 | 0.721 | 1.193 | 1.761 | 0.698 | 1.172 | 1.873 | 1.379 | 1.489 | 0.76
COVID19_PFIZER/BIONTECH | Guillain-Barre syndrome (SMQ) [broad] | 3557 | 3040.185 | 1.16 | 1.193 | 1.226 | 1.138 | 1.17 | 1.202 | 1.17 | 2.011 | 1815.269
COVID19_PFIZER/BIONTECH | Corneal disorders (SMQ) [broad] | 153 | 133.573 | 1.04 | 1.193 | 1.354 | 0.995 | 1.137 | 1.295 | 1.145 | 1.497 | 22.955
COVID19_PFIZER/BIONTECH | White blood cells urine positive | 6 | 5.613 | 0.57 | 1.193 | 2.002 | 0.551 | 0.979 | 1.638 | 1.069 | 0.763 | 0.218
COVID19_PFIZER/BIONTECH | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [narrow] | 56 | 58.367 | 0.948 | 1.193 | 1.461 | 0.765 | 0.952 | 1.174 | 0.959 | 2.676 | 49.715
COVID19_PFIZER/BIONTECH | Premature separation of placenta | 2 | 3.4 | 0.254 | 1.193 | 2.697 | 0.325 | 0.715 | 1.408 | 0.588 | 2.125 | 0.268
COVID19_PFIZER/BIONTECH | Vaccination site movement impairment | 7 | 5.922 | 0.622 | 1.192 | 1.911 | 0.61 | 1.052 | 1.717 | 1.182 | 3.512 | 8.427
COVID19_PFIZER/BIONTECH | Noninfectious diarrhoea (SMQ) [broad] | 714 | 625.183 | 1.12 | 1.192 | 1.267 | 1.072 | 1.14 | 1.212 | 1.142 | 1.456 | 96.662
COVID19_PFIZER/BIONTECH | Tongue coated | 1 | 0.657 | 0.314 | 1.191 | 2.527 | 0.389 | 0.944 | 2.004 | 1.521 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | SARS-CoV-2 antibody test negative | 18 | 14.559 | 0.812 | 1.191 | 1.63 | 0.798 | 1.157 | 1.634 | 1.236 | 19.122 | 141.025
COVID19_PFIZER/BIONTECH | Ophthalmological examination | 8 | 6.527 | 0.66 | 1.191 | 1.849 | 0.648 | 1.088 | 1.738 | 1.226 | 1.605 | 1.142
COVID19_PFIZER/BIONTECH | Wheezing | 122 | 107.724 | 1.022 | 1.191 | 1.371 | 0.967 | 1.123 | 1.298 | 1.133 | 1.886 | 45.339
COVID19_PFIZER/BIONTECH | Electrocardiogram ST segment elevation | 9 | 15.262 | 0.631 | 1.191 | 1.895 | 0.388 | 0.637 | 0.999 | 0.59 | 2.903 | 8.018
COVID19_PFIZER/BIONTECH | Haematopoietic leukopenia (SMQ) [broad] | 70 | 64.555 | 0.97 | 1.19 | 1.43 | 0.88 | 1.071 | 1.293 | 1.084 | 0.869 | 1.198
COVID19_PFIZER/BIONTECH | Biopsy skin | 5 | 5.393 | 0.511 | 1.19 | 2.1 | 0.484 | 0.892 | 1.536 | 0.927 | 0.598 | 0.93
COVID19_PFIZER/BIONTECH | Glassy eyes | 6 | 3.601 | 0.704 | 1.189 | 1.779 | 0.705 | 1.253 | 2.1 | 1.666 | 1.548 | 0.606
COVID19_PFIZER/BIONTECH | Gram stain positive | 2 | 1.321 | 0.427 | 1.189 | 2.26 | 0.466 | 1.022 | 2.011 | 1.515 | 1.505 | 0.014
COVID19_PFIZER/BIONTECH | Autoimmune disorder | 10 | 9.177 | 0.666 | 1.189 | 1.835 | 0.633 | 1.019 | 1.571 | 1.09 | 0.563 | 2.868
COVID19_PFIZER/BIONTECH | Staring | 10 | 9.644 | 0.717 | 1.189 | 1.758 | 0.611 | 0.983 | 1.515 | 1.037 | 0.333 | 12.488
COVID19_PFIZER/BIONTECH | Ultrasound Doppler normal | 8 | 7.197 | 0.664 | 1.188 | 1.834 | 0.608 | 1.021 | 1.63 | 1.112 | 1.901 | 2.291
COVID19_PFIZER/BIONTECH | Base excess | 2 | 1.298 | 0.342 | 1.187 | 2.444 | 0.469 | 1.026 | 2.02 | 1.541 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Hypokalaemia (SMQ) [broad] | 275 | 246.436 | 1.072 | 1.187 | 1.306 | 1.006 | 1.112 | 1.226 | 1.116 | 2.399 | 198.17
COVID19_PFIZER/BIONTECH | Back injury | 2 | 1.825 | 0.485 | 1.187 | 2.139 | 0.422 | 0.926 | 1.819 | 1.096 | 2.258 | 0.345
COVID19_PFIZER/BIONTECH | Thyroid mass | 1 | 0.936 | 0.366 | 1.187 | 2.39 | 0.364 | 0.884 | 1.874 | 1.069 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Interstitial lung disease | 2 | 3.178 | 0.29 | 1.187 | 2.577 | 0.336 | 0.739 | 1.454 | 0.629 | 0.44 | 0.871
COVID19_PFIZER/BIONTECH | Oesophagogastroduodenoscopy abnormal | 1 | 0.935 | 0.344 | 1.186 | 2.439 | 0.364 | 0.884 | 1.875 | 1.07 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Autoimmune haemolytic anaemia | 2 | 1.927 | 0.363 | 1.186 | 2.393 | 0.414 | 0.908 | 1.785 | 1.038 | 0.803 | 0
COVID19_PFIZER/BIONTECH | Positron emission tomogram abnormal | 1 | 0.969 | 0.191 | 1.186 | 2.881 | 0.361 | 0.877 | 1.86 | 1.032 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Rhabdomyolysis | 8 | 8.663 | 0.617 | 1.186 | 1.904 | 0.535 | 0.899 | 1.435 | 0.923 | 1.302 | 0.267
COVID19_PFIZER/BIONTECH | Keratitis | 1 | 1.348 | 0.162 | 1.186 | 2.993 | 0.331 | 0.808 | 1.714 | 0.742 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Facial bones fracture | 1 | 1.563 | 0.231 | 1.186 | 2.75 | 0.316 | 0.773 | 1.642 | 0.64 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Osteoporosis/osteopenia (SMQ) [narrow] | 2 | 1.055 | 0.422 | 1.185 | 2.26 | 0.493 | 1.082 | 2.133 | 1.896 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Pharyngitis | 8 | 6.578 | 0.629 | 1.185 | 1.884 | 0.645 | 1.083 | 1.73 | 1.216 | 0.541 | 2.573
COVID19_PFIZER/BIONTECH | Muscle twitching | 49 | 41.473 | 0.932 | 1.185 | 1.464 | 0.914 | 1.154 | 1.441 | 1.181 | 1.122 | 0.495
COVID19_PFIZER/BIONTECH | Mononucleosis heterophile test | 1 | 0.819 | 0.445 | 1.185 | 2.213 | 0.374 | 0.908 | 1.926 | 1.221 | 0.306 | 0.911
COVID19_PFIZER/BIONTECH | Blood thyroid stimulating hormone normal | 17 | 14.891 | 0.776 | 1.184 | 1.663 | 0.74 | 1.083 | 1.54 | 1.142 | 1.428 | 1.625
COVID19_PFIZER/BIONTECH | Haemorrhagic central nervous system vascular conditions (SMQ) [narrow] | 168 | 164.805 | 1.039 | 1.184 | 1.337 | 0.894 | 1.016 | 1.15 | 1.019 | 4.878 | 405.522
COVID19_PFIZER/BIONTECH | Haemorrhagic central nervous system vascular conditions (SMQ) [broad] | 168 | 164.805 | 1.039 | 1.184 | 1.337 | 0.894 | 1.016 | 1.15 | 1.019 | 4.878 | 405.522
COVID19_PFIZER/BIONTECH | Vaccination site erythema | 40 | 39.36 | 0.899 | 1.184 | 1.5 | 0.774 | 1.001 | 1.278 | 1.016 | 1.403 | 3.913
COVID19_PFIZER/BIONTECH | Scar | 5 | 5.075 | 0.556 | 1.184 | 2.002 | 0.501 | 0.925 | 1.592 | 0.985 | 0.473 | 2.349
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus test positive | 1 | 0.553 | 0.239 | 1.183 | 2.713 | 0.399 | 0.969 | 2.06 | 1.81 | 0.323 | 0.784
COVID19_PFIZER/BIONTECH | Noninfectious meningitis (SMQ) [narrow] | 59 | 57.278 | 0.944 | 1.183 | 1.444 | 0.823 | 1.019 | 1.249 | 1.03 | 0.786 | 3.081
COVID19_PFIZER/BIONTECH | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [broad] | 19 | 18.616 | 0.788 | 1.183 | 1.643 | 0.69 | 0.991 | 1.388 | 1.021 | 1.118 | 0.12
COVID19_PFIZER/BIONTECH | Sensitive skin | 17 | 21.789 | 0.766 | 1.183 | 1.675 | 0.539 | 0.789 | 1.122 | 0.78 | 2.437 | 11.392
COVID19_PFIZER/BIONTECH | Acute central respiratory depression (SMQ) [narrow] | 130 | 122.321 | 1.018 | 1.182 | 1.355 | 0.914 | 1.056 | 1.216 | 1.063 | 1.219 | 4.606
COVID19_PFIZER/BIONTECH | Blood cholesterol increased | 6 | 5.701 | 0.59 | 1.182 | 1.94 | 0.545 | 0.97 | 1.622 | 1.052 | 1.748 | 1.105
COVID19_PFIZER/BIONTECH | Vitamin B12 normal | 8 | 7.879 | 0.647 | 1.182 | 1.849 | 0.572 | 0.96 | 1.533 | 1.015 | 1.445 | 0.626
COVID19_PFIZER/BIONTECH | Mental fatigue | 3 | 1.746 | 0.452 | 1.181 | 2.189 | 0.553 | 1.128 | 2.104 | 1.718 | 3.612 | 2.704
COVID19_PFIZER/BIONTECH | Increased upper airway secretion | 6 | 4.657 | 0.611 | 1.181 | 1.902 | 0.614 | 1.093 | 1.828 | 1.288 | 1.642 | 0.829
COVID19_PFIZER/BIONTECH | Metabolic function test | 183 | 162.113 | 1.043 | 1.181 | 1.327 | 0.994 | 1.123 | 1.264 | 1.129 | 3.418 | 261.936
COVID19_PFIZER/BIONTECH | Parkinsonism | 1 | 0.528 | 0.362 | 1.18 | 2.379 | 0.402 | 0.975 | 2.074 | 1.895 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Pain management | 1 | 0.743 | 0.332 | 1.18 | 2.451 | 0.381 | 0.924 | 1.961 | 1.345 | 2.007 | 0.001
COVID19_PFIZER/BIONTECH | Mammogram | 1 | 0.743 | 0.331 | 1.18 | 2.451 | 0.381 | 0.924 | 1.961 | 1.345 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Ischaemic central nervous system vascular conditions (SMQ) [broad] | 189 | 181.464 | 1.044 | 1.18 | 1.324 | 0.92 | 1.038 | 1.167 | 1.042 | 4.814 | 448.968
COVID19_PFIZER/BIONTECH | Ischaemic central nervous system vascular conditions (SMQ) [narrow] | 189 | 181.464 | 1.044 | 1.18 | 1.324 | 0.92 | 1.038 | 1.167 | 1.042 | 4.814 | 448.968
COVID19_PFIZER/BIONTECH | Drug interaction | 1 | 2.456 | 0.119 | 1.18 | 3.163 | 0.264 | 0.654 | 1.399 | 0.407 | 0.311 | 0.868
COVID19_PFIZER/BIONTECH | Influenza virus test negative | 72 | 61.581 | 0.962 | 1.179 | 1.415 | 0.948 | 1.151 | 1.386 | 1.169 | 0.93 | 0.294
COVID19_PFIZER/BIONTECH | Choking sensation | 5 | 4.444 | 0.545 | 1.179 | 2.008 | 0.541 | 0.997 | 1.717 | 1.125 | 2.1 | 1.646
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [broad] | 153 | 164.735 | 1.028 | 1.179 | 1.339 | 0.811 | 0.927 | 1.055 | 0.929 | 1.104 | 1.331
COVID19_PFIZER/BIONTECH | Meningitis aseptic | 2 | 2.383 | 0.297 | 1.179 | 2.536 | 0.382 | 0.839 | 1.648 | 0.839 | 0.415 | 1.064
COVID19_PFIZER/BIONTECH | Suture insertion | 7 | 5.058 | 0.682 | 1.178 | 1.785 | 0.671 | 1.157 | 1.89 | 1.384 | 1.915 | 1.965
COVID19_PFIZER/BIONTECH | Atelectasis | 17 | 14.321 | 0.792 | 1.178 | 1.626 | 0.763 | 1.117 | 1.589 | 1.187 | 6.14 | 50.63
COVID19_PFIZER/BIONTECH | Herpes simplex test | 1 | 0.781 | 0.365 | 1.178 | 2.367 | 0.377 | 0.916 | 1.944 | 1.281 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Eye pruritus | 53 | 48.093 | 0.932 | 1.178 | 1.449 | 0.866 | 1.084 | 1.343 | 1.102 | 2.137 | 27.633
COVID19_PFIZER/BIONTECH | Rosacea | 1 | 0.911 | 0.413 | 1.178 | 2.261 | 0.366 | 0.889 | 1.885 | 1.098 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Blood pH increased | 5 | 3.891 | 0.554 | 1.177 | 1.989 | 0.581 | 1.071 | 1.845 | 1.285 | 4.515 | 8.18
COVID19_PFIZER/BIONTECH | Gastritis | 4 | 4.064 | 0.482 | 1.177 | 2.12 | 0.475 | 0.916 | 1.633 | 0.984 | 1.017 | 0.051
COVID19_PFIZER/BIONTECH | Gastrointestinal oedema | 1 | 1.435 | 0.133 | 1.177 | 3.088 | 0.325 | 0.793 | 1.685 | 0.697 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Sensory level abnormal | 1 | 0.506 | 0.261 | 1.176 | 2.627 | 0.404 | 0.981 | 2.086 | 1.975 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Glomerular filtration rate decreased | 18 | 14.761 | 0.796 | 1.176 | 1.616 | 0.79 | 1.145 | 1.616 | 1.219 | 6.502 | 57.432
COVID19_PFIZER/BIONTECH | Shock (SMQ) [broad] | 481 | 443.553 | 1.09 | 1.176 | 1.266 | 1.004 | 1.082 | 1.166 | 1.084 | 2.925 | 528.011
COVID19_PFIZER/BIONTECH | Nucleated red cells | 3 | 3.312 | 0.497 | 1.176 | 2.089 | 0.427 | 0.871 | 1.62 | 0.906 | 4.168 | 3.467
COVID19_PFIZER/BIONTECH | Anti-aquaporin-4 antibody | 1 | 0.549 | 0.367 | 1.175 | 2.356 | 0.399 | 0.97 | 2.062 | 1.822 | 2.258 | 0.002
COVID19_PFIZER/BIONTECH | Pain in jaw | 62 | 55.352 | 0.949 | 1.175 | 1.422 | 0.896 | 1.103 | 1.346 | 1.12 | 2.483 | 46.973
COVID19_PFIZER/BIONTECH | Oxygen saturation abnormal | 3 | 2.633 | 0.466 | 1.175 | 2.146 | 0.474 | 0.966 | 1.798 | 1.139 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Ecchymosis | 5 | 5.069 | 0.557 | 1.175 | 1.978 | 0.502 | 0.925 | 1.593 | 0.986 | 0.711 | 0.31
COVID19_PFIZER/BIONTECH | Blood pH decreased | 7 | 4.813 | 0.613 | 1.174 | 1.882 | 0.691 | 1.191 | 1.945 | 1.454 | 1.732 | 1.334
COVID19_PFIZER/BIONTECH | Mononucleosis heterophile test negative | 4 | 3.681 | 0.56 | 1.174 | 1.971 | 0.5 | 0.964 | 1.719 | 1.087 | 0.675 | 0.318
COVID19_PFIZER/BIONTECH | Protein urine present | 6 | 7.095 | 0.592 | 1.174 | 1.917 | 0.474 | 0.844 | 1.411 | 0.846 | 0.821 | 0.08
COVID19_PFIZER/BIONTECH | Malnutrition | 1 | 1.341 | 0.169 | 1.174 | 2.928 | 0.332 | 0.809 | 1.717 | 0.746 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Bordetella test negative | 1 | 0.52 | 0.32 | 1.173 | 2.459 | 0.402 | 0.977 | 2.078 | 1.924 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Odynophagia | 14 | 11.554 | 0.744 | 1.173 | 1.682 | 0.742 | 1.123 | 1.644 | 1.212 | 2.809 | 12.518
COVID19_PFIZER/BIONTECH | Laboratory test | 223 | 196.791 | 1.048 | 1.173 | 1.303 | 1.01 | 1.128 | 1.257 | 1.133 | 2.097 | 114.274
COVID19_PFIZER/BIONTECH | Feeling cold | 180 | 171.72 | 1.034 | 1.173 | 1.319 | 0.923 | 1.044 | 1.177 | 1.048 | 1.862 | 64.646
COVID19_PFIZER/BIONTECH | Diarrhoea haemorrhagic | 9 | 12.611 | 0.637 | 1.173 | 1.84 | 0.452 | 0.742 | 1.163 | 0.714 | 0.669 | 1.106
COVID19_PFIZER/BIONTECH | Spinal cord disorder | 1 | 0.497 | 0.243 | 1.172 | 2.668 | 0.405 | 0.983 | 2.091 | 2.012 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Headache | 3581 | 3256.181 | 1.14 | 1.172 | 1.205 | 1.07 | 1.099 | 1.13 | 1.1 | 2.538 | 3197.486
COVID19_PFIZER/BIONTECH | Biliary disorders (SMQ) [broad] | 57 | 54.812 | 0.932 | 1.172 | 1.434 | 0.827 | 1.027 | 1.264 | 1.04 | 1.218 | 1.883
COVID19_PFIZER/BIONTECH | Dizziness postural | 25 | 23.066 | 0.818 | 1.171 | 1.576 | 0.763 | 1.051 | 1.418 | 1.084 | 1.704 | 5.985
COVID19_PFIZER/BIONTECH | Torsade de pointes, shock-associated conditions (SMQ) [broad] | 121 | 120.363 | 1.002 | 1.171 | 1.35 | 0.861 | 1 | 1.157 | 1.005 | 2.064 | 58.724
COVID19_PFIZER/BIONTECH | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [narrow] | 19 | 18.616 | 0.779 | 1.17 | 1.625 | 0.69 | 0.991 | 1.388 | 1.021 | 1.121 | 0.13
COVID19_PFIZER/BIONTECH | Fine motor skill dysfunction | 7 | 5.167 | 0.682 | 1.169 | 1.762 | 0.663 | 1.143 | 1.866 | 1.355 | 2.007 | 2.298
COVID19_PFIZER/BIONTECH | Hyperhidrosis | 551 | 477.079 | 1.089 | 1.169 | 1.252 | 1.074 | 1.153 | 1.235 | 1.155 | 2.303 | 364.259
COVID19_PFIZER/BIONTECH | Arteriogram carotid | 8 | 7.717 | 0.665 | 1.169 | 1.789 | 0.58 | 0.974 | 1.555 | 1.037 | 11.114 | 39.215
COVID19_PFIZER/BIONTECH | Iron deficiency anaemia | 2 | 1.951 | 0.313 | 1.169 | 2.469 | 0.413 | 0.904 | 1.777 | 1.025 | 1.505 | 0.014
COVID19_PFIZER/BIONTECH | Bilirubin urine | 4 | 2.416 | 0.533 | 1.168 | 2.004 | 0.606 | 1.168 | 2.087 | 1.656 | 3.01 | 2.964
COVID19_PFIZER/BIONTECH | Audiogram abnormal | 9 | 6.954 | 0.702 | 1.168 | 1.731 | 0.694 | 1.139 | 1.785 | 1.294 | 4.277 | 15.585
COVID19_PFIZER/BIONTECH | Heart rate decreased | 37 | 30.555 | 0.891 | 1.168 | 1.475 | 0.897 | 1.172 | 1.508 | 1.211 | 2.57 | 29.661
COVID19_PFIZER/BIONTECH | Computerised tomogram normal | 70 | 60.945 | 0.959 | 1.168 | 1.394 | 0.93 | 1.131 | 1.366 | 1.149 | 2.023 | 31.653
COVID19_PFIZER/BIONTECH | Gout | 4 | 5.447 | 0.48 | 1.168 | 2.1 | 0.402 | 0.776 | 1.383 | 0.734 | 1.184 | 0.002
COVID19_PFIZER/BIONTECH | Emphysema | 2 | 1.454 | 0.327 | 1.167 | 2.428 | 0.454 | 0.994 | 1.956 | 1.376 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Retinal disorders (SMQ) [broad] | 366 | 336.662 | 1.069 | 1.167 | 1.268 | 0.995 | 1.085 | 1.181 | 1.087 | 1.501 | 56.737
COVID19_PFIZER/BIONTECH | Tinnitus | 111 | 103.435 | 0.993 | 1.167 | 1.352 | 0.911 | 1.065 | 1.239 | 1.073 | 1.917 | 43.26
COVID19_PFIZER/BIONTECH | Immune thrombocytopenia | 24 | 22.52 | 0.815 | 1.166 | 1.567 | 0.746 | 1.034 | 1.404 | 1.066 | 0.913 | 0.114
COVID19_PFIZER/BIONTECH | Haematopoietic cytopenias (SMQ) [broad] | 210 | 194.645 | 1.037 | 1.165 | 1.3 | 0.959 | 1.075 | 1.201 | 1.079 | 1.249 | 9.613
COVID19_PFIZER/BIONTECH | Fluid overload | 2 | 2.022 | 0.385 | 1.165 | 2.287 | 0.407 | 0.893 | 1.754 | 0.989 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Oropharyngeal infections (SMQ) [narrow] | 45 | 47.03 | 0.901 | 1.165 | 1.457 | 0.744 | 0.948 | 1.195 | 0.957 | 0.64 | 8.475
COVID19_PFIZER/BIONTECH | Oropharyngeal infections (SMQ) [broad] | 45 | 47.03 | 0.901 | 1.165 | 1.457 | 0.744 | 0.948 | 1.195 | 0.957 | 0.64 | 8.475
COVID19_PFIZER/BIONTECH | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [broad] | 2 | 0.95 | 0.411 | 1.164 | 2.227 | 0.505 | 1.107 | 2.187 | 2.104 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [narrow] | 2 | 0.95 | 0.411 | 1.164 | 2.227 | 0.505 | 1.107 | 2.187 | 2.104 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Chronic kidney disease (SMQ) [broad] | 190 | 180.882 | 1.03 | 1.164 | 1.306 | 0.928 | 1.046 | 1.176 | 1.05 | 1.796 | 60.536
COVID19_PFIZER/BIONTECH | Gastric dilatation | 1 | 1.064 | 0.26 | 1.164 | 2.595 | 0.353 | 0.859 | 1.821 | 0.94 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Dysgraphia | 3 | 3.047 | 0.41 | 1.163 | 2.227 | 0.444 | 0.906 | 1.685 | 0.984 | 0.86 | 0
COVID19_PFIZER/BIONTECH | Splenomegaly | 5 | 5.389 | 0.509 | 1.163 | 2.033 | 0.484 | 0.892 | 1.536 | 0.928 | 1.237 | 0.043
COVID19_PFIZER/BIONTECH | Sleep terror | 1 | 0.464 | 0.377 | 1.162 | 2.296 | 0.408 | 0.992 | 2.111 | 2.157 | 0.384 | 0.435
COVID19_PFIZER/BIONTECH | Blood urine absent | 2 | 1.41 | 0.47 | 1.162 | 2.102 | 0.458 | 1.003 | 1.974 | 1.419 | 0.976 | 0.106
COVID19_PFIZER/BIONTECH | Ultrasound abdomen | 6 | 5.097 | 0.549 | 1.161 | 1.957 | 0.583 | 1.037 | 1.735 | 1.177 | 0.669 | 0.642
COVID19_PFIZER/BIONTECH | Protrusion tongue | 1 | 0.818 | 0.422 | 1.161 | 2.196 | 0.374 | 0.908 | 1.927 | 1.223 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Radioallergosorbent test negative | 1 | 0.828 | 0.287 | 1.161 | 2.513 | 0.373 | 0.906 | 1.922 | 1.208 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Feeding disorder | 37 | 33.675 | 0.879 | 1.161 | 1.474 | 0.822 | 1.074 | 1.382 | 1.099 | 1.861 | 12.573
COVID19_PFIZER/BIONTECH | Basophil count | 1 | 0.529 | 0.3 | 1.16 | 2.477 | 0.401 | 0.975 | 2.073 | 1.89 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [broad] | 212 | 201.119 | 1.033 | 1.16 | 1.294 | 0.938 | 1.05 | 1.173 | 1.054 | 1.325 | 15.593
COVID19_PFIZER/BIONTECH | Stool analysis | 2 | 1.96 | 0.313 | 1.16 | 2.444 | 0.412 | 0.903 | 1.774 | 1.02 | 0.272 | 3.131
COVID19_PFIZER/BIONTECH | Blood pressure fluctuation | 13 | 10.442 | 0.755 | 1.159 | 1.635 | 0.744 | 1.141 | 1.689 | 1.245 | 3.261 | 15.303
COVID19_PFIZER/BIONTECH | Peripheral neuropathy (SMQ) [broad] | 1871 | 1632.043 | 1.115 | 1.159 | 1.203 | 1.103 | 1.146 | 1.19 | 1.146 | 1.728 | 558.722
COVID19_PFIZER/BIONTECH | Angiogram pulmonary normal | 6 | 5.243 | 0.602 | 1.159 | 1.863 | 0.574 | 1.02 | 1.706 | 1.144 | 13.545 | 32.631
COVID19_PFIZER/BIONTECH | Haemoglobin normal | 31 | 28.086 | 0.848 | 1.159 | 1.51 | 0.803 | 1.074 | 1.411 | 1.104 | 0.653 | 5.171
COVID19_PFIZER/BIONTECH | Lipodystrophy (SMQ) [broad] | 45 | 44.402 | 0.899 | 1.159 | 1.447 | 0.785 | 1 | 1.261 | 1.013 | 2.105 | 22.387
COVID19_PFIZER/BIONTECH | Urine odour abnormal | 1 | 1.099 | 0.429 | 1.159 | 2.178 | 0.35 | 0.852 | 1.807 | 0.91 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Laryngitis | 3 | 2.576 | 0.442 | 1.158 | 2.147 | 0.479 | 0.975 | 1.815 | 1.164 | 0.521 | 0.84
COVID19_PFIZER/BIONTECH | Cervical spinal stenosis | 1 | 0.991 | 0.314 | 1.158 | 2.435 | 0.359 | 0.873 | 1.851 | 1.009 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Infective pneumonia (SMQ) [narrow] | 142 | 156.26 | 1.004 | 1.158 | 1.322 | 0.79 | 0.907 | 1.038 | 0.909 | 1.014 | 0.013
COVID19_PFIZER/BIONTECH | Impaired driving ability | 33 | 27.659 | 0.866 | 1.157 | 1.483 | 0.87 | 1.152 | 1.503 | 1.193 | 1.774 | 9.423
COVID19_PFIZER/BIONTECH | Hypersomnia | 66 | 62.96 | 0.936 | 1.157 | 1.397 | 0.847 | 1.037 | 1.259 | 1.048 | 1.158 | 1.194
COVID19_PFIZER/BIONTECH | Paresis | 1 | 1.338 | 0.134 | 1.157 | 3.025 | 0.332 | 0.809 | 1.718 | 0.747 | 0.262 | 1.357
COVID19_PFIZER/BIONTECH | Bronchoscopy normal | 1 | 0.474 | 0.273 | 1.156 | 2.536 | 0.407 | 0.989 | 2.105 | 2.111 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Nerve compression | 6 | 5.221 | 0.588 | 1.156 | 1.878 | 0.575 | 1.023 | 1.711 | 1.149 | 2.211 | 2.5
COVID19_PFIZER/BIONTECH | Angioedema (SMQ) [narrow] | 1453 | 1280.984 | 1.107 | 1.156 | 1.206 | 1.085 | 1.133 | 1.183 | 1.134 | 1.822 | 512.776
COVID19_PFIZER/BIONTECH | Hepatitis C antibody negative | 2 | 2.207 | 0.249 | 1.156 | 2.603 | 0.394 | 0.864 | 1.698 | 0.906 | 0.294 | 2.651
COVID19_PFIZER/BIONTECH | Motion sickness | 7 | 5.186 | 0.564 | 1.155 | 1.917 | 0.661 | 1.141 | 1.862 | 1.35 | 2.385 | 3.768
COVID19_PFIZER/BIONTECH | Sluggishness | 18 | 15.548 | 0.783 | 1.155 | 1.587 | 0.757 | 1.098 | 1.549 | 1.158 | 1.912 | 6.243
COVID19_PFIZER/BIONTECH | Disorders of sinus node function (SMQ) [narrow] | 5 | 4.451 | 0.508 | 1.155 | 2.014 | 0.54 | 0.996 | 1.716 | 1.123 | 1.963 | 1.313
COVID19_PFIZER/BIONTECH | Disorders of sinus node function (SMQ) [broad] | 5 | 4.451 | 0.508 | 1.155 | 2.014 | 0.54 | 0.996 | 1.716 | 1.123 | 1.963 | 1.313
COVID19_PFIZER/BIONTECH | Toxic-septic shock conditions (SMQ) [broad] | 120 | 121.788 | 0.989 | 1.155 | 1.332 | 0.844 | 0.981 | 1.135 | 0.985 | 1.79 | 37.43
COVID19_PFIZER/BIONTECH | Haematopoietic cytopenias (SMQ) [narrow] | 141 | 130.28 | 1.001 | 1.154 | 1.317 | 0.936 | 1.076 | 1.231 | 1.082 | 1.226 | 5.316
COVID19_PFIZER/BIONTECH | PCO2 normal | 1 | 1.029 | 0.194 | 1.153 | 2.774 | 0.356 | 0.865 | 1.835 | 0.972 | 0.376 | 0.471
COVID19_PFIZER/BIONTECH | Lip haemorrhage | 3 | 1.736 | 0.509 | 1.152 | 2.006 | 0.555 | 1.13 | 2.108 | 1.728 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Injury | 4 | 5.225 | 0.49 | 1.152 | 2.039 | 0.412 | 0.796 | 1.418 | 0.766 | 0.509 | 1.376
COVID19_PFIZER/BIONTECH | Lymphadenopathy | 444 | 396.704 | 1.063 | 1.151 | 1.242 | 1.032 | 1.117 | 1.206 | 1.119 | 3.107 | 544.181
COVID19_PFIZER/BIONTECH | Lung opacity | 30 | 26.977 | 0.84 | 1.151 | 1.503 | 0.805 | 1.08 | 1.425 | 1.112 | 14.643 | 202.759
COVID19_PFIZER/BIONTECH | Hearing impairment (SMQ) [narrow] | 197 | 184.069 | 1.021 | 1.151 | 1.289 | 0.947 | 1.066 | 1.195 | 1.07 | 1.575 | 37.75
COVID19_PFIZER/BIONTECH | White blood cell count increased | 93 | 96.28 | 0.963 | 1.151 | 1.351 | 0.811 | 0.961 | 1.134 | 0.966 | 1.024 | 0.027
COVID19_PFIZER/BIONTECH | HIV test | 6 | 6.758 | 0.529 | 1.151 | 1.965 | 0.49 | 0.871 | 1.457 | 0.888 | 2.643 | 3.941
COVID19_PFIZER/BIONTECH | Infusion | 1 | 2.117 | 0.147 | 1.151 | 2.944 | 0.282 | 0.695 | 1.482 | 0.472 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Toothache | 27 | 24.304 | 0.823 | 1.15 | 1.521 | 0.79 | 1.076 | 1.438 | 1.111 | 2.755 | 24.621
COVID19_PFIZER/BIONTECH | Reticulocyte count increased | 1 | 0.989 | 0.254 | 1.15 | 2.574 | 0.359 | 0.873 | 1.852 | 1.012 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Torsade de pointes, shock-associated conditions (SMQ) [narrow] | 19 | 19.323 | 0.761 | 1.15 | 1.604 | 0.669 | 0.961 | 1.345 | 0.983 | 1.217 | 0.49
COVID19_PFIZER/BIONTECH | Thalamic infarction | 1 | 1.901 | 0.15 | 1.15 | 2.932 | 0.295 | 0.724 | 1.541 | 0.526 | 4.515 | 0.227
COVID19_PFIZER/BIONTECH | Mucosal inflammation | 2 | 1.034 | 0.406 | 1.149 | 2.199 | 0.496 | 1.087 | 2.143 | 1.934 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Blood immunoglobulin E increased | 1 | 0.582 | 0.189 | 1.149 | 2.779 | 0.396 | 0.962 | 2.044 | 1.719 | 0.296 | 0.997
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin concentration normal | 13 | 13.301 | 0.7 | 1.149 | 1.687 | 0.618 | 0.948 | 1.403 | 0.977 | 0.886 | 0.085
COVID19_PFIZER/BIONTECH | Motor dysfunction | 9 | 9.503 | 0.632 | 1.149 | 1.792 | 0.559 | 0.917 | 1.438 | 0.947 | 0.834 | 0.143
COVID19_PFIZER/BIONTECH | Lens disorders (SMQ) [broad] | 228 | 207.82 | 1.027 | 1.148 | 1.276 | 0.979 | 1.093 | 1.216 | 1.097 | 1.463 | 30.704
COVID19_PFIZER/BIONTECH | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [broad] | 17 | 18.905 | 0.752 | 1.148 | 1.613 | 0.608 | 0.89 | 1.266 | 0.899 | 1.616 | 3.093
COVID19_PFIZER/BIONTECH | Tongue disorder | 24 | 20.581 | 0.832 | 1.147 | 1.504 | 0.806 | 1.117 | 1.516 | 1.166 | 4.423 | 48.226
COVID19_PFIZER/BIONTECH | Respiratory rate decreased | 4 | 3.435 | 0.531 | 1.147 | 1.954 | 0.518 | 0.998 | 1.78 | 1.164 | 1.537 | 0.268
COVID19_PFIZER/BIONTECH | Respiratory failure (SMQ) [narrow] | 158 | 154.806 | 1.002 | 1.147 | 1.299 | 0.891 | 1.016 | 1.155 | 1.021 | 1.177 | 3.792
COVID19_PFIZER/BIONTECH | Acute renal failure (SMQ) [broad] | 128 | 126.61 | 0.987 | 1.147 | 1.317 | 0.87 | 1.006 | 1.159 | 1.011 | 2.271 | 79.947
COVID19_PFIZER/BIONTECH | Colonoscopy abnormal | 2 | 2.389 | 0.329 | 1.147 | 2.365 | 0.382 | 0.838 | 1.646 | 0.837 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Chlamydia test negative | 1 | 0.573 | 0.331 | 1.146 | 2.358 | 0.397 | 0.964 | 2.049 | 1.746 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Herpes zoster cutaneous disseminated | 1 | 1.073 | 0.182 | 1.146 | 2.794 | 0.352 | 0.857 | 1.818 | 0.932 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Tooth disorder | 1 | 1.101 | 0.248 | 1.145 | 2.577 | 0.35 | 0.852 | 1.806 | 0.908 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Pseudomembranous colitis (SMQ) [narrow] | 4 | 3.704 | 0.569 | 1.144 | 1.882 | 0.499 | 0.961 | 1.714 | 1.08 | 1.642 | 0.404
COVID19_PFIZER/BIONTECH | Foetal death | 6 | 6.071 | 0.516 | 1.144 | 1.973 | 0.525 | 0.933 | 1.56 | 0.988 | 1.407 | 0.318
COVID19_PFIZER/BIONTECH | Pneumonia | 98 | 114.477 | 0.962 | 1.144 | 1.34 | 0.724 | 0.856 | 1.005 | 0.856 | 0.848 | 2.413
COVID19_PFIZER/BIONTECH | Cerebral disorder | 1 | 1.021 | 0.243 | 1.143 | 2.584 | 0.356 | 0.867 | 1.838 | 0.979 | 0.282 | 1.13
COVID19_PFIZER/BIONTECH | Disseminated intravascular coagulation | 3 | 3.326 | 0.404 | 1.143 | 2.185 | 0.426 | 0.869 | 1.617 | 0.902 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Tonic clonic movements | 2 | 1.254 | 0.379 | 1.142 | 2.236 | 0.473 | 1.036 | 2.04 | 1.595 | 0.211 | 5.032
COVID19_PFIZER/BIONTECH | Dermatitis exfoliative generalised | 2 | 1.344 | 0.367 | 1.142 | 2.265 | 0.464 | 1.017 | 2.001 | 1.488 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Major depression | 1 | 0.727 | 0.236 | 1.142 | 2.602 | 0.382 | 0.928 | 1.97 | 1.376 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Tongue erythema | 4 | 4.433 | 0.537 | 1.142 | 1.931 | 0.453 | 0.874 | 1.558 | 0.902 | 3.44 | 3.854
COVID19_PFIZER/BIONTECH | Anaemia | 20 | 22.359 | 0.77 | 1.142 | 1.573 | 0.622 | 0.887 | 1.233 | 0.894 | 1.056 | 0.014
COVID19_PFIZER/BIONTECH | Blood immunoglobulin G | 5 | 5.652 | 0.508 | 1.142 | 1.982 | 0.47 | 0.867 | 1.493 | 0.885 | 1.062 | 0.011
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging head abnormal | 40 | 44.838 | 0.867 | 1.142 | 1.448 | 0.687 | 0.888 | 1.133 | 0.892 | 1.265 | 1.827
COVID19_PFIZER/BIONTECH | Dialysis | 5 | 5.977 | 0.559 | 1.142 | 1.893 | 0.454 | 0.838 | 1.442 | 0.837 | 3.01 | 4.078
COVID19_PFIZER/BIONTECH | Streptococcal infection | 1 | 0.562 | 0.238 | 1.141 | 2.595 | 0.398 | 0.967 | 2.054 | 1.779 | 0.306 | 0.911
COVID19_PFIZER/BIONTECH | Complement factor | 2 | 1.276 | 0.307 | 1.141 | 2.404 | 0.471 | 1.031 | 2.03 | 1.567 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Vibratory sense increased | 2 | 1.737 | 0.429 | 1.141 | 2.129 | 0.43 | 0.941 | 1.85 | 1.152 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus test | 1 | 1.662 | 0.209 | 1.141 | 2.686 | 0.31 | 0.758 | 1.611 | 0.602 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | Functional, inflammatory and gallstone related biliary disorders (SMQ) [broad] | 56 | 53.73 | 0.906 | 1.14 | 1.397 | 0.827 | 1.029 | 1.269 | 1.042 | 1.242 | 2.251
COVID19_PFIZER/BIONTECH | Conjunctivitis allergic | 1 | 1.098 | 0.199 | 1.14 | 2.716 | 0.35 | 0.852 | 1.808 | 0.911 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Neurological examination abnormal | 9 | 8.815 | 0.627 | 1.139 | 1.776 | 0.59 | 0.968 | 1.518 | 1.021 | 0.746 | 0.515
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [broad] | 247 | 244.142 | 1.023 | 1.139 | 1.26 | 0.908 | 1.009 | 1.118 | 1.012 | 2.26 | 154.008
COVID19_PFIZER/BIONTECH | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [narrow] | 247 | 244.142 | 1.023 | 1.139 | 1.26 | 0.908 | 1.009 | 1.118 | 1.012 | 2.26 | 154.008
COVID19_PFIZER/BIONTECH | Abdominal discomfort | 128 | 142.237 | 0.98 | 1.139 | 1.308 | 0.777 | 0.898 | 1.035 | 0.9 | 1.249 | 5.728
COVID19_PFIZER/BIONTECH | CSF monocyte count decreased | 1 | 0.58 | 0.401 | 1.138 | 2.178 | 0.396 | 0.962 | 2.045 | 1.724 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Electrocardiogram ambulatory abnormal | 2 | 1.667 | 0.319 | 1.138 | 2.367 | 0.435 | 0.954 | 1.875 | 1.2 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Mean cell volume normal | 16 | 15.5 | 0.731 | 1.138 | 1.617 | 0.674 | 0.996 | 1.429 | 1.032 | 1.16 | 0.194
COVID19_PFIZER/BIONTECH | Gait inability | 73 | 74.327 | 0.931 | 1.138 | 1.362 | 0.805 | 0.975 | 1.173 | 0.982 | 1.064 | 0.207
COVID19_PFIZER/BIONTECH | Haemodialysis | 2 | 4.375 | 0.239 | 1.137 | 2.582 | 0.283 | 0.627 | 1.236 | 0.457 | 1.338 | 0
COVID19_PFIZER/BIONTECH | Acoustic stimulation tests abnormal | 12 | 10.067 | 0.683 | 1.136 | 1.682 | 0.707 | 1.099 | 1.647 | 1.192 | 3.612 | 16.665
COVID19_PFIZER/BIONTECH | Glaucoma (SMQ) [broad] | 448 | 416.118 | 1.05 | 1.136 | 1.226 | 0.994 | 1.075 | 1.16 | 1.077 | 1.444 | 57.282
COVID19_PFIZER/BIONTECH | Respiratory rate increased | 26 | 22.937 | 0.819 | 1.135 | 1.494 | 0.798 | 1.093 | 1.469 | 1.134 | 1.82 | 7.965
COVID19_PFIZER/BIONTECH | Blood test normal | 74 | 68.471 | 0.931 | 1.135 | 1.356 | 0.883 | 1.069 | 1.284 | 1.081 | 1.003 | 0.001
COVID19_PFIZER/BIONTECH | Biopsy bone marrow abnormal | 4 | 6.344 | 0.461 | 1.135 | 2.051 | 0.365 | 0.706 | 1.259 | 0.631 | 1.338 | 0.072
COVID19_PFIZER/BIONTECH | Balance disorder | 96 | 90.613 | 0.954 | 1.134 | 1.327 | 0.888 | 1.051 | 1.236 | 1.059 | 1.695 | 24.413
COVID19_PFIZER/BIONTECH | Surgery | 12 | 12.994 | 0.682 | 1.134 | 1.681 | 0.582 | 0.905 | 1.356 | 0.923 | 0.727 | 0.92
COVID19_PFIZER/BIONTECH | Albumin globulin ratio | 2 | 1.921 | 0.313 | 1.133 | 2.366 | 0.415 | 0.909 | 1.787 | 1.041 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Acute hepatic failure | 1 | 1.013 | 0.189 | 1.133 | 2.731 | 0.357 | 0.868 | 1.842 | 0.987 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Life support | 5 | 6.131 | 0.534 | 1.133 | 1.913 | 0.447 | 0.824 | 1.419 | 0.816 | 2.736 | 3.326
COVID19_PFIZER/BIONTECH | Wrist fracture | 1 | 0.582 | 0.252 | 1.132 | 2.529 | 0.396 | 0.962 | 2.044 | 1.719 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Catheterisation cardiac abnormal | 6 | 4.961 | 0.587 | 1.132 | 1.822 | 0.593 | 1.054 | 1.763 | 1.21 | 6.773 | 17.269
COVID19_PFIZER/BIONTECH | Haematopoietic thrombocytopenia (SMQ) [narrow] | 90 | 85.164 | 0.945 | 1.132 | 1.332 | 0.881 | 1.048 | 1.239 | 1.057 | 1.382 | 8.494
COVID19_PFIZER/BIONTECH | Agranulocytosis (SMQ) [broad] | 39 | 34.48 | 0.858 | 1.131 | 1.435 | 0.851 | 1.103 | 1.412 | 1.131 | 0.589 | 10.425
COVID19_PFIZER/BIONTECH | Haematopoietic thrombocytopenia (SMQ) [broad] | 92 | 86.351 | 0.946 | 1.13 | 1.328 | 0.89 | 1.056 | 1.247 | 1.065 | 1.403 | 9.54
COVID19_PFIZER/BIONTECH | Haemolytic disorders (SMQ) [broad] | 9 | 10.959 | 0.631 | 1.13 | 1.747 | 0.503 | 0.826 | 1.294 | 0.821 | 0.797 | 0.265
COVID19_PFIZER/BIONTECH | Cataract operation | 2 | 1.418 | 0.417 | 1.129 | 2.122 | 0.457 | 1.001 | 1.97 | 1.41 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Glycosylated haemoglobin | 11 | 9.439 | 0.714 | 1.129 | 1.623 | 0.68 | 1.075 | 1.633 | 1.165 | 4.845 | 23.369
COVID19_PFIZER/BIONTECH | Hiatus hernia | 2 | 1.898 | 0.362 | 1.129 | 2.239 | 0.417 | 0.913 | 1.795 | 1.054 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Increased bronchial secretion | 1 | 1.061 | 0.212 | 1.129 | 2.642 | 0.353 | 0.859 | 1.822 | 0.942 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Cytomegalovirus test | 3 | 2.425 | 0.459 | 1.128 | 2.035 | 0.491 | 1 | 1.861 | 1.237 | 1.26 | 0.003
COVID19_PFIZER/BIONTECH | Full blood count | 214 | 197.211 | 1.005 | 1.128 | 1.256 | 0.965 | 1.081 | 1.207 | 1.085 | 2.292 | 137.916
COVID19_PFIZER/BIONTECH | Biliary tract disorders (SMQ) [broad] | 13 | 13.51 | 0.682 | 1.128 | 1.665 | 0.611 | 0.936 | 1.386 | 0.962 | 1.072 | 0.009
COVID19_PFIZER/BIONTECH | Biliary tract disorders (SMQ) [narrow] | 13 | 13.51 | 0.682 | 1.128 | 1.665 | 0.611 | 0.936 | 1.386 | 0.962 | 1.072 | 0.009
COVID19_PFIZER/BIONTECH | Retroperitoneal fibrosis (SMQ) [broad] | 656 | 597.76 | 1.056 | 1.127 | 1.2 | 1.027 | 1.096 | 1.168 | 1.097 | 1.636 | 151.692
COVID19_PFIZER/BIONTECH | Arthropod bite | 1 | 0.903 | 0.204 | 1.127 | 2.662 | 0.366 | 0.89 | 1.889 | 1.108 | 0.306 | 0.911
COVID19_PFIZER/BIONTECH | Radiculopathy | 2 | 2.652 | 0.36 | 1.126 | 2.238 | 0.365 | 0.802 | 1.577 | 0.754 | 0.457 | 0.76
COVID19_PFIZER/BIONTECH | Maternal exposure during pregnancy | 3 | 1.68 | 0.42 | 1.125 | 2.106 | 0.56 | 1.142 | 2.131 | 1.785 | 4.515 | 3.935
COVID19_PFIZER/BIONTECH | Urine output increased | 1 | 0.534 | 0.35 | 1.125 | 2.257 | 0.401 | 0.974 | 2.07 | 1.873 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Drooling | 11 | 8.489 | 0.757 | 1.125 | 1.554 | 0.734 | 1.16 | 1.761 | 1.296 | 1.104 | 0.024
COVID19_PFIZER/BIONTECH | Glossodynia | 18 | 14.937 | 0.782 | 1.125 | 1.52 | 0.782 | 1.134 | 1.6 | 1.205 | 3.386 | 23.42
COVID19_PFIZER/BIONTECH | Gallstone related disorders (SMQ) [narrow] | 8 | 7.194 | 0.64 | 1.125 | 1.72 | 0.608 | 1.021 | 1.631 | 1.112 | 4.982 | 16.801
COVID19_PFIZER/BIONTECH | Gallstone related disorders (SMQ) [broad] | 8 | 7.194 | 0.64 | 1.125 | 1.72 | 0.608 | 1.021 | 1.631 | 1.112 | 4.982 | 16.801
COVID19_PFIZER/BIONTECH | Wrong patient received product | 2 | 1.781 | 0.505 | 1.125 | 1.945 | 0.426 | 0.933 | 1.834 | 1.123 | 0.612 | 0.162
COVID19_PFIZER/BIONTECH | Grunting | 2 | 1.886 | 0.463 | 1.125 | 2.022 | 0.418 | 0.915 | 1.799 | 1.061 | 0.475 | 0.654
COVID19_PFIZER/BIONTECH | Acute renal failure (SMQ) [narrow] | 59 | 64.622 | 0.899 | 1.125 | 1.373 | 0.735 | 0.909 | 1.115 | 0.913 | 2.262 | 35.811
COVID19_PFIZER/BIONTECH | Drug hypersensitivity | 5 | 5.825 | 0.514 | 1.125 | 1.928 | 0.461 | 0.851 | 1.465 | 0.858 | 0.452 | 2.712
COVID19_PFIZER/BIONTECH | Nasal dryness | 2 | 1.277 | 0.433 | 1.124 | 2.076 | 0.471 | 1.031 | 2.03 | 1.566 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Reflexes abnormal | 1 | 1.306 | 0.322 | 1.124 | 2.322 | 0.334 | 0.815 | 1.729 | 0.766 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Nasal oedema | 3 | 1.924 | 0.461 | 1.123 | 2.022 | 0.536 | 1.091 | 2.033 | 1.559 | 3.87 | 3.06
COVID19_PFIZER/BIONTECH | Culture positive | 1 | 0.829 | 0.169 | 1.123 | 2.772 | 0.373 | 0.906 | 1.921 | 1.206 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Ataxia | 8 | 7.545 | 0.606 | 1.123 | 1.769 | 0.589 | 0.989 | 1.579 | 1.06 | 0.615 | 1.496
COVID19_PFIZER/BIONTECH | Congenital, familial and genetic disorders (SMQ) [broad] | 10 | 11.558 | 0.638 | 1.123 | 1.72 | 0.534 | 0.859 | 1.324 | 0.865 | 0.305 | 14.93
COVID19_PFIZER/BIONTECH | Congenital, familial and genetic disorders (SMQ) [narrow] | 10 | 11.558 | 0.638 | 1.123 | 1.72 | 0.534 | 0.859 | 1.324 | 0.865 | 0.305 | 14.93
COVID19_PFIZER/BIONTECH | Breast tenderness | 5 | 3.367 | 0.577 | 1.122 | 1.812 | 0.624 | 1.152 | 1.985 | 1.485 | 3.926 | 6.6
COVID19_PFIZER/BIONTECH | Dementia (SMQ) [broad] | 1237 | 1132.405 | 1.07 | 1.122 | 1.175 | 1.042 | 1.092 | 1.143 | 1.092 | 1.432 | 156.592
COVID19_PFIZER/BIONTECH | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [broad] | 282 | 271.417 | 1.014 | 1.122 | 1.233 | 0.939 | 1.036 | 1.141 | 1.039 | 3.087 | 339.784
COVID19_PFIZER/BIONTECH | Oesophagogastroduodenoscopy normal | 1 | 0.998 | 0.264 | 1.122 | 2.464 | 0.358 | 0.871 | 1.848 | 1.002 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Melaena | 3 | 2.598 | 0.388 | 1.121 | 2.162 | 0.477 | 0.972 | 1.808 | 1.155 | 0.732 | 0.076
COVID19_PFIZER/BIONTECH | Computerised tomogram abdomen normal | 9 | 7.492 | 0.652 | 1.12 | 1.692 | 0.66 | 1.084 | 1.699 | 1.201 | 2.39 | 5.198
COVID19_PFIZER/BIONTECH | Skin bacterial infection | 1 | 0.827 | 0.195 | 1.12 | 2.669 | 0.373 | 0.906 | 1.922 | 1.209 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Haematological tumours of unspecified malignancy (SMQ) [broad] | 1 | 0.593 | 0.197 | 1.119 | 2.661 | 0.395 | 0.959 | 2.038 | 1.687 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Haematological tumours of unspecified malignancy (SMQ) [narrow] | 1 | 0.593 | 0.197 | 1.119 | 2.661 | 0.395 | 0.959 | 2.038 | 1.687 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [broad] | 3641 | 3319.972 | 1.088 | 1.119 | 1.149 | 1.067 | 1.096 | 1.127 | 1.097 | 1.814 | 1368.56
COVID19_PFIZER/BIONTECH | Night sweats | 76 | 70.902 | 0.92 | 1.119 | 1.334 | 0.878 | 1.061 | 1.271 | 1.072 | 2.487 | 58.104
COVID19_PFIZER/BIONTECH | Bacterial test negative | 4 | 3.791 | 0.486 | 1.119 | 1.965 | 0.493 | 0.95 | 1.694 | 1.055 | 0.224 | 9.811
COVID19_PFIZER/BIONTECH | Polymyalgia rheumatica | 5 | 6.585 | 0.486 | 1.119 | 1.963 | 0.427 | 0.788 | 1.356 | 0.759 | 0.554 | 1.316
COVID19_PFIZER/BIONTECH | Glomerular filtration rate normal | 8 | 5.611 | 0.642 | 1.118 | 1.701 | 0.712 | 1.196 | 1.912 | 1.426 | 3.074 | 7.789
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [broad] | 3604 | 3287.482 | 1.086 | 1.117 | 1.147 | 1.066 | 1.096 | 1.126 | 1.096 | 1.818 | 1362.222
COVID19_PFIZER/BIONTECH | Aphthous ulcer | 5 | 4.546 | 0.507 | 1.117 | 1.92 | 0.534 | 0.985 | 1.696 | 1.1 | 1.062 | 0.011
COVID19_PFIZER/BIONTECH | Initial insomnia | 4 | 3.659 | 0.415 | 1.117 | 2.094 | 0.502 | 0.967 | 1.725 | 1.093 | 0.812 | 0.031
COVID19_PFIZER/BIONTECH | Respiratory failure (SMQ) [broad] | 484 | 460.701 | 1.035 | 1.117 | 1.202 | 0.973 | 1.049 | 1.129 | 1.051 | 2.058 | 238.703
COVID19_PFIZER/BIONTECH | Blood urine present | 19 | 18.555 | 0.768 | 1.117 | 1.519 | 0.692 | 0.994 | 1.392 | 1.024 | 1.855 | 5.998
COVID19_PFIZER/BIONTECH | Differential white blood cell count normal | 16 | 12.445 | 0.748 | 1.116 | 1.544 | 0.802 | 1.185 | 1.701 | 1.286 | 1.952 | 5.835
COVID19_PFIZER/BIONTECH | Lacrimal disorders (SMQ) [narrow] | 54 | 49.634 | 0.885 | 1.116 | 1.371 | 0.857 | 1.071 | 1.325 | 1.088 | 1.533 | 8.742
COVID19_PFIZER/BIONTECH | Lacrimal disorders (SMQ) [broad] | 54 | 49.634 | 0.885 | 1.116 | 1.371 | 0.857 | 1.071 | 1.325 | 1.088 | 1.533 | 8.742
COVID19_PFIZER/BIONTECH | Hiccups | 2 | 1.915 | 0.437 | 1.116 | 2.048 | 0.415 | 0.91 | 1.789 | 1.045 | 1.062 | 0.084
COVID19_PFIZER/BIONTECH | Ear pruritus | 17 | 14.284 | 0.783 | 1.115 | 1.495 | 0.765 | 1.119 | 1.593 | 1.19 | 4.582 | 35.028
COVID19_PFIZER/BIONTECH | Neuroleptic malignant syndrome (SMQ) [algorithm] | 4 | 3.783 | 0.47 | 1.115 | 1.984 | 0.493 | 0.951 | 1.696 | 1.057 | 0.314 | 5.203
COVID19_PFIZER/BIONTECH | Systemic inflammatory response syndrome | 6 | 7.004 | 0.507 | 1.115 | 1.915 | 0.478 | 0.851 | 1.423 | 0.857 | 1.426 | 0.352
COVID19_PFIZER/BIONTECH | Electromyogram | 6 | 7.933 | 0.586 | 1.115 | 1.782 | 0.44 | 0.782 | 1.308 | 0.756 | 0.511 | 2.251
COVID19_PFIZER/BIONTECH | Optic neuritis | 5 | 7.452 | 0.481 | 1.115 | 1.962 | 0.393 | 0.726 | 1.25 | 0.671 | 0.394 | 3.951
COVID19_PFIZER/BIONTECH | Cold sweat | 114 | 101.638 | 0.953 | 1.114 | 1.286 | 0.953 | 1.112 | 1.291 | 1.122 | 1.748 | 32.661
COVID19_PFIZER/BIONTECH | Tonsillar hypertrophy | 7 | 6.738 | 0.555 | 1.114 | 1.83 | 0.562 | 0.969 | 1.582 | 1.039 | 0.872 | 0.03
COVID19_PFIZER/BIONTECH | Blood culture | 21 | 20.301 | 0.775 | 1.113 | 1.501 | 0.711 | 1.005 | 1.388 | 1.034 | 1.149 | 0.249
COVID19_PFIZER/BIONTECH | Mouth swelling | 21 | 20.351 | 0.763 | 1.113 | 1.517 | 0.709 | 1.003 | 1.385 | 1.032 | 2.007 | 8.618
COVID19_PFIZER/BIONTECH | Sputum culture | 2 | 2.177 | 0.418 | 1.113 | 2.08 | 0.396 | 0.869 | 1.707 | 0.919 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Band neutrophil percentage | 2 | 1.427 | 0.401 | 1.112 | 2.11 | 0.456 | 1 | 1.967 | 1.401 | 1.642 | 0.049
COVID19_PFIZER/BIONTECH | Oesophageal spasm | 3 | 2.63 | 0.48 | 1.112 | 1.956 | 0.475 | 0.967 | 1.799 | 1.141 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Differential white blood cell count abnormal | 2 | 1.697 | 0.362 | 1.111 | 2.192 | 0.433 | 0.948 | 1.864 | 1.179 | 1.003 | 0.129
COVID19_PFIZER/BIONTECH | Atrial septal defect | 2 | 1.712 | 0.305 | 1.111 | 2.325 | 0.432 | 0.945 | 1.858 | 1.168 | 1.204 | 0.02
COVID19_PFIZER/BIONTECH | Spinal X-ray normal | 1 | 1.026 | 0.362 | 1.111 | 2.191 | 0.356 | 0.866 | 1.836 | 0.974 | 0.376 | 0.471
COVID19_PFIZER/BIONTECH | Acoustic stimulation tests normal | 1 | 1.147 | 0.19 | 1.111 | 2.662 | 0.346 | 0.843 | 1.788 | 0.872 | 0.531 | 0.065
COVID19_PFIZER/BIONTECH | Pityriasis rosea | 1 | 0.746 | 0.374 | 1.11 | 2.163 | 0.38 | 0.924 | 1.96 | 1.34 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Hostility/aggression (SMQ) [broad] | 93 | 97.63 | 0.932 | 1.11 | 1.301 | 0.8 | 0.949 | 1.118 | 0.953 | 0.303 | 147.97
COVID19_PFIZER/BIONTECH | Neutropenia | 5 | 3.709 | 0.514 | 1.109 | 1.888 | 0.595 | 1.098 | 1.891 | 1.348 | 0.544 | 1.418
COVID19_PFIZER/BIONTECH | Transfusion | 13 | 11.734 | 0.717 | 1.109 | 1.571 | 0.682 | 1.045 | 1.546 | 1.108 | 1.642 | 2.402
COVID19_PFIZER/BIONTECH | Lack of spontaneous speech | 1 | 2.248 | 0.142 | 1.109 | 2.836 | 0.275 | 0.679 | 1.448 | 0.445 | 3.01 | 0.051
COVID19_PFIZER/BIONTECH | Depression (excl suicide and self injury) (SMQ) [broad] | 240 | 236.912 | 0.993 | 1.108 | 1.227 | 0.908 | 1.01 | 1.121 | 1.013 | 0.488 | 128.069
COVID19_PFIZER/BIONTECH | Malignancy related therapeutic and diagnostic procedures (SMQ) [broad] | 66 | 66.837 | 0.897 | 1.108 | 1.337 | 0.801 | 0.98 | 1.189 | 0.987 | 0.769 | 4.203
COVID19_PFIZER/BIONTECH | Malignancy related therapeutic and diagnostic procedures (SMQ) [narrow] | 66 | 66.837 | 0.897 | 1.108 | 1.337 | 0.801 | 0.98 | 1.189 | 0.987 | 0.769 | 4.203
COVID19_PFIZER/BIONTECH | White blood cell count abnormal | 2 | 2.316 | 0.436 | 1.108 | 2.029 | 0.387 | 0.848 | 1.666 | 0.863 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Intellectual disability | 1 | 1.253 | 0.161 | 1.108 | 2.754 | 0.338 | 0.824 | 1.749 | 0.798 | 0.401 | 0.365
COVID19_PFIZER/BIONTECH | Blood count | 1 | 1.288 | 0.204 | 1.108 | 2.605 | 0.336 | 0.818 | 1.736 | 0.776 | 0.401 | 0.365
COVID19_PFIZER/BIONTECH | CSF oligoclonal band | 1 | 0.474 | 0.327 | 1.107 | 2.261 | 0.407 | 0.989 | 2.105 | 2.111 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Bursa injury | 1 | 1.011 | 0.224 | 1.107 | 2.537 | 0.357 | 0.869 | 1.843 | 0.989 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Arrhythmia related investigations, signs and symptoms (SMQ) [narrow] | 3 | 3.337 | 0.474 | 1.107 | 1.955 | 0.426 | 0.868 | 1.615 | 0.899 | 5.418 | 5.114
COVID19_PFIZER/BIONTECH | Transient global amnesia | 2 | 3.497 | 0.36 | 1.107 | 2.185 | 0.32 | 0.706 | 1.389 | 0.572 | 1.72 | 0.075
COVID19_PFIZER/BIONTECH | Ear haemorrhage | 1 | 0.557 | 0.317 | 1.106 | 2.282 | 0.399 | 0.968 | 2.057 | 1.794 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Photophobia | 55 | 51.694 | 0.875 | 1.106 | 1.359 | 0.842 | 1.049 | 1.296 | 1.064 | 1.077 | 0.217
COVID19_PFIZER/BIONTECH | Skin laceration | 13 | 14.143 | 0.692 | 1.106 | 1.598 | 0.589 | 0.903 | 1.337 | 0.919 | 1.008 | 0.014
COVID19_PFIZER/BIONTECH | Hyporeflexia | 2 | 2.021 | 0.348 | 1.105 | 2.207 | 0.407 | 0.893 | 1.755 | 0.99 | 0.425 | 0.986
COVID19_PFIZER/BIONTECH | Gastrooesophageal reflux disease | 15 | 15.134 | 0.705 | 1.105 | 1.577 | 0.644 | 0.962 | 1.394 | 0.991 | 0.989 | 0.008
COVID19_PFIZER/BIONTECH | Acute disseminated encephalomyelitis | 4 | 3.159 | 0.446 | 1.104 | 2.001 | 0.539 | 1.039 | 1.853 | 1.266 | 0.376 | 3.435
COVID19_PFIZER/BIONTECH | Central nervous system vascular disorders (SMQ) [broad] | 371 | 363.075 | 1.011 | 1.104 | 1.199 | 0.936 | 1.02 | 1.11 | 1.022 | 1.841 | 130.018
COVID19_PFIZER/BIONTECH | Central nervous system vascular disorders (SMQ) [narrow] | 253 | 251.816 | 0.993 | 1.104 | 1.221 | 0.903 | 1.002 | 1.11 | 1.005 | 3.694 | 412.077
COVID19_PFIZER/BIONTECH | Hepatitis viral test | 1 | 0.47 | 0.359 | 1.103 | 2.176 | 0.408 | 0.99 | 2.107 | 2.125 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Urobilinogen urine decreased | 1 | 0.808 | 0.295 | 1.103 | 2.328 | 0.375 | 0.91 | 1.931 | 1.237 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging head | 50 | 49.932 | 0.87 | 1.103 | 1.36 | 0.786 | 0.99 | 1.234 | 1.001 | 2.395 | 34.634
COVID19_PFIZER/BIONTECH | Dyskinesia (SMQ) [narrow] | 39 | 37.57 | 0.836 | 1.102 | 1.397 | 0.787 | 1.021 | 1.306 | 1.038 | 0.503 | 18.151
COVID19_PFIZER/BIONTECH | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [broad] | 371 | 361.61 | 1.01 | 1.102 | 1.198 | 0.94 | 1.024 | 1.114 | 1.026 | 1.876 | 138.194
COVID19_PFIZER/BIONTECH | Urine output decreased | 3 | 3.337 | 0.453 | 1.102 | 1.981 | 0.426 | 0.868 | 1.615 | 0.899 | 0.497 | 1.014
COVID19_PFIZER/BIONTECH | Sciatica | 8 | 9.358 | 0.609 | 1.102 | 1.712 | 0.506 | 0.851 | 1.358 | 0.855 | 2.035 | 2.867
COVID19_PFIZER/BIONTECH | Central nervous system lesion | 4 | 5.182 | 0.464 | 1.102 | 1.96 | 0.414 | 0.8 | 1.425 | 0.772 | 0.688 | 0.274
COVID19_PFIZER/BIONTECH | White blood cell disorder | 2 | 1.701 | 0.455 | 1.101 | 1.975 | 0.432 | 0.947 | 1.862 | 1.176 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Blood alkaline phosphatase | 1 | 0.856 | 0.265 | 1.101 | 2.403 | 0.371 | 0.9 | 1.909 | 1.169 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [narrow] | 253 | 250.274 | 0.99 | 1.101 | 1.217 | 0.909 | 1.008 | 1.116 | 1.011 | 3.902 | 448.388
COVID19_PFIZER/BIONTECH | Enterovirus test negative | 1 | 0.504 | 0.225 | 1.1 | 2.516 | 0.404 | 0.981 | 2.087 | 1.983 | 0.135 | 4.646
COVID19_PFIZER/BIONTECH | Feeling of body temperature change | 42 | 36.161 | 0.847 | 1.1 | 1.38 | 0.881 | 1.132 | 1.437 | 1.161 | 2.537 | 32.914
COVID19_PFIZER/BIONTECH | Abscess limb | 1 | 0.851 | 0.313 | 1.1 | 2.275 | 0.371 | 0.901 | 1.911 | 1.175 | 0.516 | 0.084
COVID19_PFIZER/BIONTECH | Visual field tests abnormal | 1 | 1.179 | 0.272 | 1.1 | 2.38 | 0.344 | 0.837 | 1.776 | 0.848 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Disorientation | 58 | 56.343 | 0.881 | 1.099 | 1.337 | 0.821 | 1.018 | 1.25 | 1.029 | 1.563 | 10.32
COVID19_PFIZER/BIONTECH | Vertigo positional | 6 | 7.682 | 0.572 | 1.098 | 1.761 | 0.45 | 0.8 | 1.338 | 0.781 | 2.852 | 4.657
COVID19_PFIZER/BIONTECH | Appetite disorder | 2 | 2.684 | 0.409 | 1.098 | 2.057 | 0.363 | 0.798 | 1.568 | 0.745 | 0.722 | 0.02
COVID19_PFIZER/BIONTECH | Adverse event following immunisation | 1 | 1.707 | 0.186 | 1.098 | 2.636 | 0.307 | 0.751 | 1.597 | 0.586 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Dyskinesia (SMQ) [broad] | 124 | 113.287 | 0.941 | 1.097 | 1.262 | 0.937 | 1.087 | 1.254 | 1.095 | 0.761 | 8.753
COVID19_PFIZER/BIONTECH | Disability | 4 | 3.961 | 0.425 | 1.097 | 2.021 | 0.482 | 0.929 | 1.655 | 1.01 | 0.294 | 5.978
COVID19_PFIZER/BIONTECH | Noninfectious encephalopathy/delirium (SMQ) [narrow] | 32 | 36.412 | 0.805 | 1.097 | 1.426 | 0.658 | 0.875 | 1.146 | 0.879 | 1.053 | 0.036
COVID19_PFIZER/BIONTECH | Scan normal | 2 | 1.59 | 0.356 | 1.096 | 2.164 | 0.442 | 0.968 | 1.903 | 1.258 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Akathisia (SMQ) [broad] | 64 | 64.815 | 0.883 | 1.096 | 1.328 | 0.798 | 0.98 | 1.192 | 0.987 | 0.876 | 0.949
COVID19_PFIZER/BIONTECH | Ovarian malignant tumours (SMQ) [narrow] | 1 | 0.534 | 0.261 | 1.095 | 2.397 | 0.401 | 0.974 | 2.07 | 1.873 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Lip dry | 3 | 2.696 | 0.457 | 1.095 | 1.957 | 0.469 | 0.957 | 1.78 | 1.113 | 0.874 | 0.002
COVID19_PFIZER/BIONTECH | Deafness bilateral | 2 | 1.733 | 0.311 | 1.094 | 2.264 | 0.43 | 0.942 | 1.851 | 1.154 | 0.951 | 0.081
COVID19_PFIZER/BIONTECH | Angiogram cerebral abnormal | 6 | 5.55 | 0.585 | 1.094 | 1.732 | 0.555 | 0.986 | 1.649 | 1.081 | 6.773 | 17.269
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific inflammation (SMQ) [narrow] | 12 | 12.818 | 0.656 | 1.094 | 1.623 | 0.588 | 0.915 | 1.371 | 0.936 | 0.83 | 0.245
COVID19_PFIZER/BIONTECH | Nephrolithiasis | 5 | 5.692 | 0.517 | 1.094 | 1.844 | 0.468 | 0.863 | 1.486 | 0.878 | 1.737 | 0.804
COVID19_PFIZER/BIONTECH | Hyperlipidaemia | 3 | 3.605 | 0.439 | 1.093 | 1.986 | 0.41 | 0.836 | 1.554 | 0.832 | 3.01 | 1.873
COVID19_PFIZER/BIONTECH | Hepatitis, non-infectious (SMQ) [narrow] | 6 | 7.182 | 0.512 | 1.093 | 1.851 | 0.47 | 0.837 | 1.399 | 0.835 | 0.661 | 0.693
COVID19_PFIZER/BIONTECH | Hepatitis, non-infectious (SMQ) [broad] | 6 | 7.182 | 0.512 | 1.093 | 1.851 | 0.47 | 0.837 | 1.399 | 0.835 | 0.661 | 0.693
COVID19_PFIZER/BIONTECH | Pregnancy test urine | 2 | 2.091 | 0.326 | 1.092 | 2.224 | 0.402 | 0.882 | 1.733 | 0.957 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Neuropathy peripheral | 31 | 36.049 | 0.794 | 1.092 | 1.429 | 0.642 | 0.858 | 1.128 | 0.86 | 1.133 | 0.335
COVID19_PFIZER/BIONTECH | HLA marker study positive | 1 | 0.582 | 0.081 | 1.091 | 3.088 | 0.396 | 0.962 | 2.044 | 1.719 | 0.354 | 0.584
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time | 19 | 16.027 | 0.751 | 1.091 | 1.483 | 0.781 | 1.122 | 1.571 | 1.186 | 5.816 | 53.546
COVID19_PFIZER/BIONTECH | Lipase | 7 | 6.369 | 0.649 | 1.091 | 1.626 | 0.583 | 1.005 | 1.64 | 1.099 | 3.718 | 9.28
COVID19_PFIZER/BIONTECH | Gingivitis | 1 | 0.534 | 0.251 | 1.09 | 2.41 | 0.401 | 0.974 | 2.07 | 1.873 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Ocular motility disorders (SMQ) [broad] | 107 | 100.442 | 0.925 | 1.09 | 1.266 | 0.902 | 1.057 | 1.234 | 1.065 | 0.754 | 8.039
COVID19_PFIZER/BIONTECH | Eyelid pain | 3 | 2.074 | 0.459 | 1.089 | 1.936 | 0.521 | 1.062 | 1.978 | 1.446 | 1.426 | 0.06
COVID19_PFIZER/BIONTECH | Conversion disorder | 2 | 1.813 | 0.311 | 1.089 | 2.25 | 0.423 | 0.928 | 1.823 | 1.103 | 0.634 | 0.121
COVID19_PFIZER/BIONTECH | Bacterial test | 4 | 3.854 | 0.446 | 1.089 | 1.961 | 0.489 | 0.942 | 1.679 | 1.038 | 0.777 | 0.072
COVID19_PFIZER/BIONTECH | Intervertebral disc protrusion | 5 | 4.938 | 0.487 | 1.089 | 1.884 | 0.509 | 0.94 | 1.618 | 1.013 | 1.531 | 0.41
COVID19_PFIZER/BIONTECH | Mechanical ventilation | 29 | 28.691 | 0.786 | 1.089 | 1.432 | 0.735 | 0.992 | 1.314 | 1.011 | 1.568 | 4.959
COVID19_PFIZER/BIONTECH | Myositis | 4 | 4.281 | 0.513 | 1.089 | 1.839 | 0.462 | 0.891 | 1.588 | 0.934 | 0.469 | 1.829
COVID19_PFIZER/BIONTECH | Cardiac stress test normal | 6 | 6.829 | 0.636 | 1.089 | 1.642 | 0.486 | 0.865 | 1.447 | 0.879 | 1.935 | 1.639
COVID19_PFIZER/BIONTECH | Retching | 58 | 52.478 | 0.878 | 1.088 | 1.316 | 0.878 | 1.088 | 1.337 | 1.105 | 2.436 | 41.998
COVID19_PFIZER/BIONTECH | Abdominal distension | 28 | 30.591 | 0.781 | 1.088 | 1.437 | 0.67 | 0.907 | 1.207 | 0.915 | 1.043 | 0.013
COVID19_PFIZER/BIONTECH | Face oedema | 7 | 5.655 | 0.581 | 1.087 | 1.721 | 0.628 | 1.083 | 1.767 | 1.238 | 1.062 | 0.002
COVID19_PFIZER/BIONTECH | Psychosis and psychotic disorders (SMQ) [broad] | 176 | 173.485 | 0.957 | 1.087 | 1.224 | 0.893 | 1.011 | 1.141 | 1.014 | 1.115 | 1.855
COVID19_PFIZER/BIONTECH | Gingival bleeding | 6 | 5.38 | 0.562 | 1.086 | 1.75 | 0.565 | 1.005 | 1.68 | 1.115 | 1.594 | 0.711
COVID19_PFIZER/BIONTECH | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [narrow] | 10 | 10.552 | 0.649 | 1.086 | 1.616 | 0.572 | 0.92 | 1.418 | 0.948 | 2.076 | 4.036
COVID19_PFIZER/BIONTECH | Hypoglycaemia (SMQ) [broad] | 2657 | 2498.503 | 1.051 | 1.085 | 1.12 | 1.03 | 1.063 | 1.097 | 1.063 | 1.26 | 150.68
COVID19_PFIZER/BIONTECH | Red blood cell sedimentation rate normal | 21 | 20.91 | 0.741 | 1.085 | 1.483 | 0.693 | 0.98 | 1.354 | 1.004 | 1.02 | 0.001
COVID19_PFIZER/BIONTECH | Bladder catheterisation | 3 | 3.032 | 0.465 | 1.085 | 1.915 | 0.446 | 0.908 | 1.689 | 0.989 | 0.934 | 0.03
COVID19_PFIZER/BIONTECH | Polymerase chain reaction | 13 | 13.28 | 0.652 | 1.085 | 1.609 | 0.619 | 0.949 | 1.405 | 0.979 | 0.157 | 57.745
COVID19_PFIZER/BIONTECH | Blood calcium normal | 16 | 17.531 | 0.708 | 1.085 | 1.529 | 0.609 | 0.9 | 1.292 | 0.913 | 1.279 | 0.654
COVID19_PFIZER/BIONTECH | X-ray abnormal | 6 | 7.788 | 0.532 | 1.085 | 1.798 | 0.445 | 0.792 | 1.325 | 0.77 | 0.57 | 1.47
COVID19_PFIZER/BIONTECH | Chest X-ray | 169 | 154.113 | 0.956 | 1.084 | 1.219 | 0.961 | 1.091 | 1.234 | 1.097 | 3.549 | 257.123
COVID19_PFIZER/BIONTECH | Ulcer | 2 | 1.936 | 0.452 | 1.084 | 1.937 | 0.414 | 0.907 | 1.782 | 1.033 | 0.903 | 0.042
COVID19_PFIZER/BIONTECH | Crying | 21 | 22.181 | 0.747 | 1.084 | 1.473 | 0.659 | 0.932 | 1.287 | 0.947 | 0.097 | 176.188
COVID19_PFIZER/BIONTECH | Loss of proprioception | 2 | 1.276 | 0.245 | 1.083 | 2.406 | 0.471 | 1.031 | 2.03 | 1.568 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Serum ferritin normal | 4 | 3.127 | 0.492 | 1.083 | 1.859 | 0.542 | 1.044 | 1.862 | 1.279 | 1.246 | 0.02
COVID19_PFIZER/BIONTECH | Ear swelling | 20 | 17.28 | 0.752 | 1.083 | 1.464 | 0.774 | 1.102 | 1.533 | 1.157 | 2.424 | 13.465
COVID19_PFIZER/BIONTECH | Chills | 2378 | 2431.747 | 1.047 | 1.083 | 1.12 | 0.945 | 0.978 | 1.011 | 0.978 | 2.288 | 1630.751
COVID19_PFIZER/BIONTECH | Lymphopenia | 1 | 1.252 | 0.117 | 1.083 | 2.868 | 0.338 | 0.824 | 1.749 | 0.798 | 0.361 | 0.545
COVID19_PFIZER/BIONTECH | Cortisol normal | 1 | 1.295 | 0.33 | 1.083 | 2.188 | 0.335 | 0.817 | 1.733 | 0.772 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Hepatitis C virus test | 1 | 1.385 | 0.213 | 1.083 | 2.501 | 0.329 | 0.802 | 1.701 | 0.722 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Colonoscopy | 4 | 6.02 | 0.442 | 1.083 | 1.953 | 0.378 | 0.73 | 1.301 | 0.664 | 0.99 | 0.055
COVID19_PFIZER/BIONTECH | Pathology test | 4 | 3.389 | 0.48 | 1.082 | 1.88 | 0.521 | 1.005 | 1.792 | 1.18 | 1.165 | 0
COVID19_PFIZER/BIONTECH | Prothrombin time | 19 | 16.766 | 0.745 | 1.082 | 1.47 | 0.752 | 1.081 | 1.514 | 1.133 | 4.456 | 37.991
COVID19_PFIZER/BIONTECH | IIIrd nerve paralysis | 1 | 0.828 | 0.295 | 1.081 | 2.27 | 0.373 | 0.906 | 1.922 | 1.208 | 0.722 | 0.014
COVID19_PFIZER/BIONTECH | Subcutaneous abscess | 1 | 0.88 | 0.391 | 1.081 | 2.05 | 0.368 | 0.895 | 1.898 | 1.136 | 0.43 | 0.267
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [narrow] | 3056 | 2862.674 | 1.049 | 1.081 | 1.114 | 1.036 | 1.067 | 1.099 | 1.068 | 1.685 | 870.045
COVID19_PFIZER/BIONTECH | Lacrimation increased | 37 | 35.445 | 0.817 | 1.081 | 1.376 | 0.785 | 1.025 | 1.319 | 1.044 | 1.658 | 8.238
COVID19_PFIZER/BIONTECH | Depression and suicide/self-injury (SMQ) [broad] | 243 | 241.45 | 0.97 | 1.081 | 1.197 | 0.903 | 1.004 | 1.114 | 1.006 | 0.489 | 129.167
COVID19_PFIZER/BIONTECH | Lymphoedema | 7 | 5.936 | 0.601 | 1.08 | 1.672 | 0.609 | 1.051 | 1.715 | 1.179 | 3.161 | 6.966
COVID19_PFIZER/BIONTECH | Base excess decreased | 1 | 0.944 | 0.231 | 1.08 | 2.438 | 0.363 | 0.882 | 1.871 | 1.059 | 0.311 | 0.868
COVID19_PFIZER/BIONTECH | Epstein-Barr virus antibody negative | 2 | 1.513 | 0.377 | 1.079 | 2.073 | 0.449 | 0.983 | 1.932 | 1.322 | 0.623 | 0.141
COVID19_PFIZER/BIONTECH | Nausea | 2143 | 2005.179 | 1.041 | 1.079 | 1.117 | 1.031 | 1.068 | 1.107 | 1.069 | 2.342 | 1541.524
COVID19_PFIZER/BIONTECH | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [narrow] | 3081 | 2888.114 | 1.048 | 1.079 | 1.112 | 1.035 | 1.067 | 1.098 | 1.067 | 1.68 | 867.256
COVID19_PFIZER/BIONTECH | Computerised tomogram | 172 | 168.923 | 0.951 | 1.079 | 1.213 | 0.894 | 1.014 | 1.147 | 1.018 | 3.17 | 216.105
COVID19_PFIZER/BIONTECH | Lumbar puncture normal | 7 | 7.737 | 0.597 | 1.079 | 1.675 | 0.513 | 0.884 | 1.442 | 0.905 | 0.419 | 4.945
COVID19_PFIZER/BIONTECH | Urine analysis normal | 41 | 38.708 | 0.834 | 1.078 | 1.347 | 0.807 | 1.04 | 1.324 | 1.059 | 0.836 | 1.108
COVID19_PFIZER/BIONTECH | Bone pain | 40 | 38.214 | 0.826 | 1.078 | 1.359 | 0.796 | 1.029 | 1.313 | 1.047 | 1.379 | 3.508
COVID19_PFIZER/BIONTECH | Haematopoietic leukopenia (SMQ) [narrow] | 43 | 44.873 | 0.828 | 1.078 | 1.357 | 0.741 | 0.949 | 1.202 | 0.958 | 0.78 | 2.335
COVID19_PFIZER/BIONTECH | Somnolence | 124 | 118.902 | 0.923 | 1.075 | 1.237 | 0.894 | 1.037 | 1.197 | 1.043 | 0.81 | 5.129
COVID19_PFIZER/BIONTECH | Renal injury | 1 | 0.48 | 0.301 | 1.074 | 2.234 | 0.407 | 0.987 | 2.101 | 2.084 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Mean platelet volume decreased | 1 | 0.729 | 0.308 | 1.074 | 2.219 | 0.382 | 0.928 | 1.968 | 1.371 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Intracranial aneurysm | 4 | 3.779 | 0.498 | 1.074 | 1.826 | 0.494 | 0.952 | 1.696 | 1.058 | 10.32 | 15.623
COVID19_PFIZER/BIONTECH | Hypotension | 121 | 119.92 | 0.92 | 1.074 | 1.238 | 0.864 | 1.004 | 1.161 | 1.009 | 2.033 | 56.293
COVID19_PFIZER/BIONTECH | Influenza B virus test | 21 | 19.911 | 0.728 | 1.073 | 1.473 | 0.722 | 1.022 | 1.411 | 1.055 | 1.614 | 3.929
COVID19_PFIZER/BIONTECH | Culture urine negative | 15 | 15.356 | 0.676 | 1.073 | 1.546 | 0.636 | 0.951 | 1.377 | 0.977 | 0.753 | 0.936
COVID19_PFIZER/BIONTECH | Encephalitis | 10 | 10.317 | 0.612 | 1.073 | 1.637 | 0.582 | 0.936 | 1.442 | 0.969 | 0.478 | 5.043
COVID19_PFIZER/BIONTECH | Snoring | 2 | 2.231 | 0.354 | 1.073 | 2.106 | 0.392 | 0.861 | 1.691 | 0.897 | 0.602 | 0.184
COVID19_PFIZER/BIONTECH | Adverse drug reaction | 3 | 4.484 | 0.372 | 1.073 | 2.069 | 0.364 | 0.744 | 1.385 | 0.669 | 0.264 | 5.317
COVID19_PFIZER/BIONTECH | Aura | 5 | 4.704 | 0.512 | 1.072 | 1.798 | 0.524 | 0.966 | 1.663 | 1.063 | 3.926 | 6.6
COVID19_PFIZER/BIONTECH | Osteonecrosis (SMQ) [broad] | 120 | 114.233 | 0.919 | 1.072 | 1.234 | 0.898 | 1.044 | 1.208 | 1.05 | 1.541 | 20.594
COVID19_PFIZER/BIONTECH | Sedation | 8 | 8.136 | 0.64 | 1.072 | 1.593 | 0.559 | 0.939 | 1.5 | 0.983 | 4.378 | 14.039
COVID19_PFIZER/BIONTECH | Parvovirus B19 test | 1 | 0.58 | 0.312 | 1.071 | 2.197 | 0.396 | 0.962 | 2.045 | 1.724 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Microbiology test normal | 1 | 0.607 | 0.245 | 1.071 | 2.373 | 0.394 | 0.956 | 2.03 | 1.649 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Extensor plantar response | 1 | 0.48 | 0.129 | 1.07 | 2.771 | 0.407 | 0.987 | 2.101 | 2.084 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Emotional disorder | 1 | 0.595 | 0.306 | 1.07 | 2.211 | 0.395 | 0.959 | 2.037 | 1.681 | 0.166 | 3.337
COVID19_PFIZER/BIONTECH | Serology normal | 1 | 0.634 | 0.256 | 1.07 | 2.34 | 0.391 | 0.949 | 2.016 | 1.577 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Hypersensitivity | 137 | 137.079 | 0.926 | 1.07 | 1.222 | 0.864 | 0.995 | 1.141 | 0.999 | 0.888 | 1.756
COVID19_PFIZER/BIONTECH | Myalgia | 1215 | 1264.136 | 1.02 | 1.07 | 1.121 | 0.916 | 0.961 | 1.007 | 0.961 | 1.89 | 477.794
COVID19_PFIZER/BIONTECH | Malignancies (SMQ) [broad] | 92 | 98.126 | 0.895 | 1.07 | 1.258 | 0.787 | 0.934 | 1.102 | 0.938 | 0.753 | 6.988
COVID19_PFIZER/BIONTECH | Malignancies (SMQ) [narrow] | 92 | 98.126 | 0.895 | 1.07 | 1.258 | 0.787 | 0.934 | 1.102 | 0.938 | 0.753 | 6.988
COVID19_PFIZER/BIONTECH | Postictal state | 5 | 3.939 | 0.593 | 1.069 | 1.659 | 0.577 | 1.064 | 1.833 | 1.269 | 0.598 | 0.93
COVID19_PFIZER/BIONTECH | Death | 682 | 682.987 | 1.003 | 1.069 | 1.137 | 0.937 | 0.998 | 1.062 | 0.999 | 3.95 | 1244.406
COVID19_PFIZER/BIONTECH | Vein disorder | 2 | 2.231 | 0.358 | 1.069 | 2.088 | 0.392 | 0.861 | 1.691 | 0.896 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Pyelonephritis | 1 | 1.348 | 0.209 | 1.069 | 2.476 | 0.331 | 0.808 | 1.715 | 0.742 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Eyelid oedema | 3 | 2.317 | 0.584 | 1.068 | 1.669 | 0.5 | 1.018 | 1.895 | 1.295 | 0.146 | 13.995
COVID19_PFIZER/BIONTECH | Antiphospholipid antibodies positive | 1 | 0.825 | 0.289 | 1.068 | 2.247 | 0.373 | 0.907 | 1.923 | 1.213 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Fatal outcome (Custom Term) | 814 | 804.379 | 1.008 | 1.068 | 1.131 | 0.954 | 1.011 | 1.071 | 1.012 | 4.181 | 1617.667
COVID19_PFIZER/BIONTECH | Restlessness | 34 | 35.348 | 0.791 | 1.068 | 1.379 | 0.72 | 0.95 | 1.236 | 0.962 | 0.949 | 0.045
COVID19_PFIZER/BIONTECH | Dyskinesia | 36 | 34.944 | 0.8 | 1.067 | 1.366 | 0.773 | 1.012 | 1.307 | 1.03 | 0.501 | 17.019
COVID19_PFIZER/BIONTECH | Arteriosclerosis | 5 | 4.925 | 0.493 | 1.067 | 1.819 | 0.51 | 0.941 | 1.62 | 1.015 | 6.946 | 14.129
COVID19_PFIZER/BIONTECH | Uterine dilation and curettage | 2 | 2.235 | 0.418 | 1.067 | 1.959 | 0.392 | 0.86 | 1.69 | 0.895 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Hepatic cirrhosis | 3 | 3.849 | 0.461 | 1.067 | 1.876 | 0.396 | 0.808 | 1.504 | 0.779 | 4.168 | 3.467
COVID19_PFIZER/BIONTECH | Muscle spasticity | 1 | 1.318 | 0.161 | 1.066 | 2.632 | 0.333 | 0.813 | 1.725 | 0.759 | 0.334 | 0.702
COVID19_PFIZER/BIONTECH | Bronchial hyperreactivity | 2 | 1.26 | 0.427 | 1.065 | 1.937 | 0.472 | 1.035 | 2.037 | 1.588 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Corneal reflex decreased | 4 | 3.205 | 0.494 | 1.065 | 1.813 | 0.535 | 1.032 | 1.84 | 1.248 | 5.557 | 8.049
COVID19_PFIZER/BIONTECH | Viral rash | 1 | 0.793 | 0.292 | 1.064 | 2.228 | 0.376 | 0.914 | 1.938 | 1.261 | 0.179 | 2.926
COVID19_PFIZER/BIONTECH | Gait disturbance | 147 | 141.986 | 0.925 | 1.064 | 1.211 | 0.899 | 1.03 | 1.176 | 1.035 | 0.996 | 0
COVID19_PFIZER/BIONTECH | Optic nerve disorders (SMQ) [broad] | 163 | 163.284 | 0.931 | 1.064 | 1.204 | 0.874 | 0.995 | 1.128 | 0.998 | 1.029 | 0.102
COVID19_PFIZER/BIONTECH | Confusional state | 131 | 131.253 | 0.918 | 1.064 | 1.22 | 0.86 | 0.994 | 1.143 | 0.998 | 2.068 | 64.07
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time normal | 9 | 7.184 | 0.624 | 1.063 | 1.596 | 0.679 | 1.115 | 1.747 | 1.253 | 1.748 | 1.956
COVID19_PFIZER/BIONTECH | Noninfectious encephalitis (SMQ) [broad] | 1922 | 1877.562 | 1.023 | 1.063 | 1.103 | 0.986 | 1.023 | 1.062 | 1.024 | 1.065 | 7.873
COVID19_PFIZER/BIONTECH | Oedema peripheral | 71 | 69.948 | 0.868 | 1.063 | 1.274 | 0.828 | 1.006 | 1.214 | 1.015 | 1.764 | 20.714
COVID19_PFIZER/BIONTECH | Immunosuppression | 1 | 1.009 | 0.336 | 1.063 | 2.12 | 0.357 | 0.869 | 1.843 | 0.991 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Tic | 2 | 2.525 | 0.452 | 1.063 | 1.883 | 0.373 | 0.819 | 1.609 | 0.792 | 0.138 | 9.825
COVID19_PFIZER/BIONTECH | Hyperventilation | 15 | 14.349 | 0.664 | 1.062 | 1.537 | 0.672 | 1.004 | 1.455 | 1.045 | 0.915 | 0.043
COVID19_PFIZER/BIONTECH | Formication | 6 | 6.212 | 0.612 | 1.062 | 1.614 | 0.517 | 0.919 | 1.538 | 0.966 | 0.847 | 0.042
COVID19_PFIZER/BIONTECH | Leukaemia | 2 | 2.364 | 0.351 | 1.062 | 2.086 | 0.383 | 0.841 | 1.653 | 0.846 | 0.769 | 0.002
COVID19_PFIZER/BIONTECH | Ammonia increased | 3 | 2.359 | 0.503 | 1.061 | 1.786 | 0.496 | 1.011 | 1.882 | 1.272 | 2.356 | 0.998
COVID19_PFIZER/BIONTECH | Glaucoma (SMQ) [narrow] | 7 | 7.67 | 0.538 | 1.061 | 1.727 | 0.516 | 0.889 | 1.451 | 0.913 | 0.866 | 0.037
COVID19_PFIZER/BIONTECH | Tubulointerstitial diseases (SMQ) [broad] | 32 | 35.753 | 0.781 | 1.061 | 1.376 | 0.669 | 0.89 | 1.165 | 0.895 | 1.131 | 0.336
COVID19_PFIZER/BIONTECH | Blindness unilateral | 7 | 9.657 | 0.579 | 1.061 | 1.662 | 0.438 | 0.756 | 1.234 | 0.725 | 1.003 | 0.035
COVID19_PFIZER/BIONTECH | Joint fluid drainage | 1 | 1.379 | 0.36 | 1.06 | 2.059 | 0.329 | 0.803 | 1.704 | 0.725 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Platelet count increased | 10 | 8.586 | 0.598 | 1.059 | 1.627 | 0.664 | 1.068 | 1.647 | 1.165 | 0.629 | 1.751
COVID19_PFIZER/BIONTECH | Cerebral infarction | 11 | 11.557 | 0.638 | 1.059 | 1.567 | 0.585 | 0.925 | 1.405 | 0.952 | 3.425 | 13.802
COVID19_PFIZER/BIONTECH | Blood test abnormal | 11 | 11.676 | 0.639 | 1.059 | 1.566 | 0.581 | 0.918 | 1.394 | 0.942 | 0.687 | 1.206
COVID19_PFIZER/BIONTECH | Herpes simplex test negative | 4 | 4.73 | 0.441 | 1.059 | 1.893 | 0.437 | 0.843 | 1.502 | 0.846 | 0.273 | 6.916
COVID19_PFIZER/BIONTECH | Generalised tonic-clonic seizure | 13 | 12.249 | 0.674 | 1.058 | 1.512 | 0.659 | 1.011 | 1.496 | 1.061 | 0.401 | 10.766
COVID19_PFIZER/BIONTECH | Hypotonia | 11 | 11.589 | 0.622 | 1.058 | 1.588 | 0.584 | 0.923 | 1.402 | 0.949 | 0.128 | 64.433
COVID19_PFIZER/BIONTECH | Cholestasis and jaundice of hepatic origin (SMQ) [broad] | 12 | 12.75 | 0.631 | 1.058 | 1.574 | 0.591 | 0.919 | 1.377 | 0.941 | 0.753 | 0.704
COVID19_PFIZER/BIONTECH | Bronchitis | 10 | 12.605 | 0.606 | 1.058 | 1.612 | 0.499 | 0.804 | 1.239 | 0.793 | 0.376 | 9.509
COVID19_PFIZER/BIONTECH | Blood potassium decreased | 39 | 35.857 | 0.806 | 1.057 | 1.337 | 0.821 | 1.065 | 1.363 | 1.088 | 4.071 | 71.162
COVID19_PFIZER/BIONTECH | Bladder disorder | 1 | 1.011 | 0.185 | 1.057 | 2.518 | 0.357 | 0.869 | 1.843 | 0.989 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Ileus | 1 | 1.424 | 0.136 | 1.057 | 2.702 | 0.326 | 0.795 | 1.688 | 0.702 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Blood immunoglobulin G decreased | 2 | 2.791 | 0.281 | 1.057 | 2.236 | 0.357 | 0.785 | 1.542 | 0.717 | 0.452 | 0.797
COVID19_PFIZER/BIONTECH | Rheumatoid arthritis | 9 | 12.839 | 0.568 | 1.057 | 1.667 | 0.445 | 0.731 | 1.146 | 0.701 | 0.553 | 2.719
COVID19_PFIZER/BIONTECH | Psychosis and psychotic disorders (SMQ) [narrow] | 48 | 50.853 | 0.822 | 1.056 | 1.314 | 0.74 | 0.937 | 1.173 | 0.944 | 1.428 | 5.309
COVID19_PFIZER/BIONTECH | Blood thyroid stimulating hormone | 25 | 22.887 | 0.769 | 1.055 | 1.377 | 0.768 | 1.058 | 1.428 | 1.092 | 2.736 | 22.369
COVID19_PFIZER/BIONTECH | Toxic-septic shock conditions (SMQ) [narrow] | 19 | 21.815 | 0.704 | 1.055 | 1.464 | 0.603 | 0.866 | 1.214 | 0.871 | 0.719 | 1.728
COVID19_PFIZER/BIONTECH | Corneal disorders (SMQ) [narrow] | 6 | 7.983 | 0.51 | 1.055 | 1.76 | 0.438 | 0.779 | 1.303 | 0.752 | 0.942 | 0.004
COVID19_PFIZER/BIONTECH | Cholelithiasis | 8 | 7.194 | 0.605 | 1.054 | 1.605 | 0.608 | 1.021 | 1.631 | 1.112 | 5.16 | 17.595
COVID19_PFIZER/BIONTECH | Poor peripheral circulation | 3 | 2.232 | 0.394 | 1.053 | 1.971 | 0.507 | 1.033 | 1.924 | 1.344 | 1.389 | 0.042
COVID19_PFIZER/BIONTECH | Dysphemia | 4 | 3.953 | 0.414 | 1.053 | 1.929 | 0.482 | 0.93 | 1.657 | 1.012 | 0.794 | 0.05
COVID19_PFIZER/BIONTECH | Culture urine | 12 | 12.45 | 0.65 | 1.053 | 1.535 | 0.602 | 0.936 | 1.402 | 0.964 | 1.211 | 0.231
COVID19_PFIZER/BIONTECH | Injection site injury | 1 | 1.269 | 0.208 | 1.053 | 2.43 | 0.337 | 0.821 | 1.743 | 0.788 | 0.311 | 0.868
COVID19_PFIZER/BIONTECH | Staphylococcal infection | 4 | 3.839 | 0.571 | 1.052 | 1.651 | 0.49 | 0.944 | 1.683 | 1.042 | 0.531 | 1.164
COVID19_PFIZER/BIONTECH | Visual impairment | 84 | 82.792 | 0.872 | 1.052 | 1.245 | 0.842 | 1.007 | 1.197 | 1.015 | 1.119 | 0.887
COVID19_PFIZER/BIONTECH | Ovarian neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 0.534 | 0.249 | 1.051 | 2.304 | 0.401 | 0.974 | 2.07 | 1.873 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Deafness unilateral | 27 | 27.526 | 0.758 | 1.05 | 1.38 | 0.708 | 0.964 | 1.289 | 0.981 | 1.912 | 9.781
COVID19_PFIZER/BIONTECH | Viral titre increased | 1 | 1.204 | 0.175 | 1.05 | 2.531 | 0.342 | 0.833 | 1.767 | 0.83 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Culture throat negative | 1 | 0.515 | 0.474 | 1.049 | 1.808 | 0.403 | 0.978 | 2.081 | 1.942 | 0.244 | 1.591
COVID19_PFIZER/BIONTECH | Tearfulness | 5 | 4.746 | 0.463 | 1.049 | 1.827 | 0.521 | 0.961 | 1.655 | 1.054 | 0.654 | 0.564
COVID19_PFIZER/BIONTECH | Incontinence | 8 | 7.675 | 0.634 | 1.049 | 1.55 | 0.582 | 0.977 | 1.561 | 1.042 | 1.431 | 0.586
COVID19_PFIZER/BIONTECH | Neurological examination | 9 | 9.406 | 0.595 | 1.049 | 1.607 | 0.563 | 0.924 | 1.449 | 0.957 | 0.888 | 0.034
COVID19_PFIZER/BIONTECH | Abdominal pain upper | 155 | 173.288 | 0.915 | 1.049 | 1.19 | 0.782 | 0.893 | 1.016 | 0.894 | 1.115 | 1.639
COVID19_PFIZER/BIONTECH | Hepatic enzyme increased | 9 | 11.297 | 0.602 | 1.049 | 1.598 | 0.492 | 0.807 | 1.265 | 0.797 | 1.129 | 0.029
COVID19_PFIZER/BIONTECH | Acute pancreatitis (SMQ) [algorithm] | 20 | 22.067 | 0.709 | 1.048 | 1.441 | 0.629 | 0.897 | 1.247 | 0.906 | 1.797 | 5.692
COVID19_PFIZER/BIONTECH | CSF glucose normal | 4 | 5.117 | 0.444 | 1.048 | 1.858 | 0.417 | 0.805 | 1.436 | 0.782 | 0.401 | 2.905
COVID19_PFIZER/BIONTECH | Strawberry tongue | 1 | 0.798 | 0.24 | 1.047 | 2.317 | 0.376 | 0.913 | 1.936 | 1.254 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Anti-cyclic citrullinated peptide antibody | 2 | 2.473 | 0.402 | 1.047 | 1.939 | 0.376 | 0.826 | 1.623 | 0.809 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Globulins decreased | 2 | 1.432 | 0.376 | 1.046 | 1.988 | 0.456 | 0.999 | 1.965 | 1.397 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Gallbladder related disorders (SMQ) [narrow] | 16 | 16.465 | 0.68 | 1.046 | 1.476 | 0.641 | 0.948 | 1.361 | 0.972 | 3.612 | 22.947
COVID19_PFIZER/BIONTECH | Gallbladder related disorders (SMQ) [broad] | 16 | 16.465 | 0.68 | 1.046 | 1.476 | 0.641 | 0.948 | 1.361 | 0.972 | 3.612 | 22.947
COVID19_PFIZER/BIONTECH | Basophil percentage decreased | 4 | 4.389 | 0.439 | 1.046 | 1.863 | 0.456 | 0.879 | 1.567 | 0.911 | 0.663 | 0.363
COVID19_PFIZER/BIONTECH | Blood magnesium normal | 18 | 15.572 | 0.727 | 1.045 | 1.41 | 0.756 | 1.096 | 1.547 | 1.156 | 3.386 | 23.42
COVID19_PFIZER/BIONTECH | Coagulation test | 5 | 4.83 | 0.527 | 1.045 | 1.707 | 0.516 | 0.952 | 1.638 | 1.035 | 3.473 | 5.359
COVID19_PFIZER/BIONTECH | Angiogram normal | 6 | 6.635 | 0.544 | 1.045 | 1.678 | 0.496 | 0.881 | 1.474 | 0.904 | 1.72 | 1.03
COVID19_PFIZER/BIONTECH | Psychotic disorder | 3 | 4.37 | 0.347 | 1.045 | 2.047 | 0.37 | 0.755 | 1.405 | 0.686 | 1.084 | 0.03
COVID19_PFIZER/BIONTECH | Breast pain | 26 | 25.638 | 0.766 | 1.044 | 1.357 | 0.725 | 0.992 | 1.333 | 1.014 | 2.594 | 20.839
COVID19_PFIZER/BIONTECH | Skull X-ray | 1 | 0.501 | 0.351 | 1.043 | 2.034 | 0.404 | 0.982 | 2.089 | 1.997 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Regurgitation | 1 | 1.076 | 0.149 | 1.043 | 2.604 | 0.352 | 0.856 | 1.817 | 0.93 | 0.212 | 2.123
COVID19_PFIZER/BIONTECH | Extrapyramidal syndrome (SMQ) [narrow] | 60 | 64.276 | 0.834 | 1.041 | 1.267 | 0.751 | 0.928 | 1.137 | 0.933 | 0.478 | 33.014
COVID19_PFIZER/BIONTECH | Sudden visual loss | 1 | 1.267 | 0.276 | 1.041 | 2.204 | 0.337 | 0.822 | 1.744 | 0.789 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Gram stain negative | 1 | 1.798 | 0.307 | 1.041 | 2.13 | 0.301 | 0.738 | 1.57 | 0.556 | 0.311 | 0.868
COVID19_PFIZER/BIONTECH | Dysstasia | 66 | 67.08 | 0.843 | 1.04 | 1.254 | 0.798 | 0.976 | 1.185 | 0.984 | 1.494 | 9.496
COVID19_PFIZER/BIONTECH | Protein total normal | 15 | 16.268 | 0.663 | 1.04 | 1.486 | 0.607 | 0.907 | 1.314 | 0.922 | 1.575 | 2.366
COVID19_PFIZER/BIONTECH | Scan brain | 3 | 3.513 | 0.443 | 1.04 | 1.839 | 0.415 | 0.846 | 1.575 | 0.854 | 1.26 | 0.003
COVID19_PFIZER/BIONTECH | Toxicologic test | 3 | 2.346 | 0.47 | 1.039 | 1.788 | 0.497 | 1.013 | 1.886 | 1.279 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Blood phosphorus | 3 | 2.616 | 0.491 | 1.039 | 1.752 | 0.476 | 0.969 | 1.803 | 1.147 | 2.258 | 0.875
COVID19_PFIZER/BIONTECH | Eye irritation | 32 | 29.867 | 0.782 | 1.039 | 1.326 | 0.786 | 1.046 | 1.37 | 1.071 | 1.69 | 7.596
COVID19_PFIZER/BIONTECH | White blood cell count normal | 40 | 43.081 | 0.791 | 1.039 | 1.315 | 0.713 | 0.922 | 1.176 | 0.928 | 0.797 | 1.778
COVID19_PFIZER/BIONTECH | Lumbar puncture | 32 | 33.526 | 0.774 | 1.038 | 1.335 | 0.709 | 0.943 | 1.235 | 0.954 | 0.957 | 0.024
COVID19_PFIZER/BIONTECH | Eructation | 7 | 5.979 | 0.575 | 1.037 | 1.609 | 0.607 | 1.046 | 1.707 | 1.171 | 1.975 | 2.182
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging spinal | 13 | 14.181 | 0.642 | 1.037 | 1.51 | 0.588 | 0.901 | 1.334 | 0.917 | 1.406 | 1.044
COVID19_PFIZER/BIONTECH | Asthenia | 759 | 744.811 | 0.975 | 1.036 | 1.098 | 0.959 | 1.018 | 1.08 | 1.019 | 1.582 | 153.238
COVID19_PFIZER/BIONTECH | Arteriogram carotid abnormal | 4 | 4.366 | 0.492 | 1.036 | 1.742 | 0.457 | 0.881 | 1.571 | 0.916 | 10.32 | 15.623
COVID19_PFIZER/BIONTECH | Limb injury | 5 | 5.916 | 0.578 | 1.036 | 1.603 | 0.457 | 0.843 | 1.451 | 0.845 | 0.579 | 1.086
COVID19_PFIZER/BIONTECH | Multiple allergies | 2 | 1.491 | 0.279 | 1.035 | 2.178 | 0.451 | 0.987 | 1.941 | 1.342 | 1.095 | 0.065
COVID19_PFIZER/BIONTECH | Muscle spasms | 134 | 132.367 | 0.894 | 1.035 | 1.184 | 0.874 | 1.008 | 1.157 | 1.012 | 1.194 | 3.815
COVID19_PFIZER/BIONTECH | Shock symptom | 3 | 1.814 | 0.387 | 1.034 | 1.934 | 0.546 | 1.114 | 2.076 | 1.654 | 2.167 | 0.764
COVID19_PFIZER/BIONTECH | Cluster headache | 3 | 2.173 | 0.434 | 1.034 | 1.843 | 0.512 | 1.044 | 1.944 | 1.381 | 3.386 | 2.392
COVID19_PFIZER/BIONTECH | Blood chloride increased | 10 | 8.6 | 0.619 | 1.034 | 1.536 | 0.663 | 1.067 | 1.645 | 1.163 | 3.408 | 12.255
COVID19_PFIZER/BIONTECH | Noninfectious meningitis (SMQ) [broad] | 1679 | 1652.365 | 0.993 | 1.034 | 1.075 | 0.976 | 1.016 | 1.057 | 1.016 | 1.045 | 3.354
COVID19_PFIZER/BIONTECH | Hyperglycaemia/new onset diabetes mellitus (SMQ) [broad] | 672 | 683.05 | 0.969 | 1.034 | 1.1 | 0.922 | 0.983 | 1.047 | 0.984 | 1.152 | 12.878
COVID19_PFIZER/BIONTECH | Mastication disorder | 6 | 6.224 | 0.59 | 1.034 | 1.578 | 0.516 | 0.918 | 1.536 | 0.964 | 2.852 | 4.657
COVID19_PFIZER/BIONTECH | Urobilinogen urine increased | 1 | 0.474 | 0.308 | 1.033 | 2.105 | 0.407 | 0.989 | 2.105 | 2.111 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Pharyngeal oedema | 4 | 3.31 | 0.539 | 1.033 | 1.657 | 0.527 | 1.016 | 1.812 | 1.208 | 0.12 | 24.664
COVID19_PFIZER/BIONTECH | Red blood cell count increased | 3 | 2.925 | 0.416 | 1.033 | 1.875 | 0.453 | 0.923 | 1.717 | 1.026 | 1.355 | 0.028
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging thoracic normal | 1 | 1.208 | 0.231 | 1.033 | 2.302 | 0.342 | 0.832 | 1.765 | 0.828 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Ultrasound biliary tract | 1 | 1.233 | 0.259 | 1.033 | 2.225 | 0.34 | 0.828 | 1.756 | 0.811 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Carbon dioxide decreased | 15 | 13.433 | 0.662 | 1.032 | 1.469 | 0.708 | 1.058 | 1.533 | 1.117 | 3.711 | 22.333
COVID19_PFIZER/BIONTECH | Varicella virus test negative | 2 | 2.042 | 0.324 | 1.032 | 2.063 | 0.406 | 0.89 | 1.748 | 0.979 | 0.254 | 3.571
COVID19_PFIZER/BIONTECH | Lipids | 11 | 10.139 | 0.653 | 1.031 | 1.479 | 0.646 | 1.02 | 1.55 | 1.085 | 3.548 | 14.65
COVID19_PFIZER/BIONTECH | Muscle strain | 9 | 8.816 | 0.614 | 1.031 | 1.535 | 0.59 | 0.968 | 1.517 | 1.021 | 1.982 | 3.069
COVID19_PFIZER/BIONTECH | Haematoma | 7 | 7.181 | 0.548 | 1.031 | 1.638 | 0.539 | 0.93 | 1.517 | 0.975 | 0.599 | 1.432
COVID19_PFIZER/BIONTECH | Thrombectomy | 5 | 5.38 | 0.511 | 1.031 | 1.697 | 0.484 | 0.893 | 1.538 | 0.929 | 11.288 | 22.556
COVID19_PFIZER/BIONTECH | Renal function test | 3 | 3.337 | 0.483 | 1.031 | 1.747 | 0.426 | 0.868 | 1.615 | 0.899 | 1.935 | 0.495
COVID19_PFIZER/BIONTECH | Gastroenteritis viral | 2 | 2.661 | 0.479 | 1.031 | 1.752 | 0.365 | 0.801 | 1.574 | 0.752 | 0.482 | 0.62
COVID19_PFIZER/BIONTECH | Use of accessory respiratory muscles | 1 | 1.49 | 0.229 | 1.031 | 2.305 | 0.321 | 0.784 | 1.666 | 0.671 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Computerised tomogram thorax | 37 | 36.327 | 0.792 | 1.03 | 1.294 | 0.768 | 1.002 | 1.29 | 1.019 | 6.819 | 128.994
COVID19_PFIZER/BIONTECH | Bacterial test positive | 4 | 5.143 | 0.442 | 1.03 | 1.817 | 0.416 | 0.803 | 1.431 | 0.778 | 0.651 | 0.412
COVID19_PFIZER/BIONTECH | Blood immunoglobulin A decreased | 1 | 0.872 | 0.141 | 1.029 | 2.594 | 0.369 | 0.897 | 1.902 | 1.146 | 0.393 | 0.399
COVID19_PFIZER/BIONTECH | Dystonia (SMQ) [broad] | 540 | 541.247 | 0.957 | 1.029 | 1.102 | 0.928 | 0.997 | 1.069 | 0.998 | 1.057 | 1.572
COVID19_PFIZER/BIONTECH | Lip discolouration | 1 | 1.241 | 0.382 | 1.029 | 1.931 | 0.339 | 0.826 | 1.753 | 0.806 | 0.274 | 1.219
COVID19_PFIZER/BIONTECH | Back pain | 296 | 296.65 | 0.933 | 1.028 | 1.128 | 0.905 | 0.996 | 1.094 | 0.998 | 1.568 | 56.122
COVID19_PFIZER/BIONTECH | Joint stiffness | 25 | 25.695 | 0.727 | 1.028 | 1.372 | 0.694 | 0.956 | 1.291 | 0.973 | 1.021 | 0
COVID19_PFIZER/BIONTECH | pH urine normal | 5 | 5.161 | 0.511 | 1.028 | 1.69 | 0.496 | 0.916 | 1.576 | 0.969 | 0.912 | 0
COVID19_PFIZER/BIONTECH | Blood uric acid | 1 | 1.201 | 0.388 | 1.028 | 1.916 | 0.342 | 0.833 | 1.768 | 0.833 | 0.722 | 0.014
COVID19_PFIZER/BIONTECH | Arthropathy | 4 | 4.774 | 0.452 | 1.028 | 1.794 | 0.435 | 0.838 | 1.495 | 0.838 | 0.491 | 1.561
COVID19_PFIZER/BIONTECH | Computerised tomogram neck | 14 | 13.128 | 0.656 | 1.027 | 1.467 | 0.673 | 1.017 | 1.489 | 1.066 | 11.493 | 75.341
COVID19_PFIZER/BIONTECH | Computerised tomogram head | 82 | 79.258 | 0.86 | 1.027 | 1.206 | 0.856 | 1.026 | 1.222 | 1.035 | 3.397 | 114.77
COVID19_PFIZER/BIONTECH | Endotracheal intubation | 54 | 58.23 | 0.813 | 1.027 | 1.262 | 0.738 | 0.922 | 1.141 | 0.927 | 2.216 | 31.023
COVID19_PFIZER/BIONTECH | Globulin | 3 | 3.466 | 0.378 | 1.027 | 1.933 | 0.418 | 0.852 | 1.585 | 0.866 | 1.548 | 0.136
COVID19_PFIZER/BIONTECH | Blood test | 234 | 235.056 | 0.919 | 1.026 | 1.137 | 0.891 | 0.993 | 1.104 | 0.996 | 1.692 | 60.435
COVID19_PFIZER/BIONTECH | Tachypnoea | 24 | 25.42 | 0.719 | 1.026 | 1.379 | 0.672 | 0.931 | 1.264 | 0.944 | 2.382 | 15.74
COVID19_PFIZER/BIONTECH | Hepatic function abnormal | 1 | 0.564 | 0.136 | 1.025 | 2.601 | 0.398 | 0.966 | 2.053 | 1.774 | 0.215 | 2.073
COVID19_PFIZER/BIONTECH | Noninfectious encephalopathy/delirium (SMQ) [broad] | 2002 | 1982.61 | 0.988 | 1.025 | 1.063 | 0.973 | 1.009 | 1.047 | 1.01 | 1.047 | 4.35
COVID19_PFIZER/BIONTECH | Polydipsia | 1 | 0.475 | 0.234 | 1.024 | 2.27 | 0.407 | 0.989 | 2.104 | 2.105 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase | 13 | 12.122 | 0.669 | 1.024 | 1.44 | 0.665 | 1.019 | 1.508 | 1.072 | 1.924 | 4.374
COVID19_PFIZER/BIONTECH | Hemiparesis | 42 | 41.152 | 0.786 | 1.024 | 1.288 | 0.783 | 1.006 | 1.277 | 1.021 | 2.951 | 44.865
COVID19_PFIZER/BIONTECH | Imaging procedure | 6 | 5.882 | 0.547 | 1.024 | 1.621 | 0.535 | 0.951 | 1.591 | 1.02 | 1.29 | 0.135
COVID19_PFIZER/BIONTECH | Body temperature increased | 248 | 248.602 | 0.92 | 1.024 | 1.132 | 0.896 | 0.995 | 1.103 | 0.998 | 1.417 | 28.086
COVID19_PFIZER/BIONTECH | Ventricular tachycardia | 4 | 7.402 | 0.392 | 1.024 | 1.895 | 0.33 | 0.638 | 1.138 | 0.54 | 2.258 | 1.451
COVID19_PFIZER/BIONTECH | Diet refusal | 8 | 6.774 | 0.562 | 1.023 | 1.595 | 0.632 | 1.062 | 1.697 | 1.181 | 0.443 | 4.909
COVID19_PFIZER/BIONTECH | Haemoglobin increased | 3 | 2.725 | 0.423 | 1.023 | 1.835 | 0.467 | 0.952 | 1.772 | 1.101 | 1.548 | 0.136
COVID19_PFIZER/BIONTECH | Hypocalcaemia | 2 | 1.856 | 0.363 | 1.023 | 1.953 | 0.42 | 0.92 | 1.808 | 1.077 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Immediate post-injection reaction | 249 | 253.194 | 0.921 | 1.023 | 1.13 | 0.884 | 0.981 | 1.087 | 0.983 | 1.085 | 1.488
COVID19_PFIZER/BIONTECH | Epinephrine | 5 | 5.8 | 0.511 | 1.023 | 1.679 | 0.463 | 0.853 | 1.469 | 0.862 | 9.03 | 18.489
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time prolonged | 4 | 4.701 | 0.402 | 1.023 | 1.876 | 0.439 | 0.846 | 1.508 | 0.851 | 1.505 | 0.23
COVID19_PFIZER/BIONTECH | Eye swelling | 94 | 94.112 | 0.861 | 1.022 | 1.195 | 0.838 | 0.993 | 1.17 | 0.999 | 1.597 | 18.765
COVID19_PFIZER/BIONTECH | Vitreous floaters | 7 | 7.129 | 0.57 | 1.022 | 1.581 | 0.542 | 0.934 | 1.524 | 0.982 | 1.756 | 1.413
COVID19_PFIZER/BIONTECH | Visual field defect | 8 | 9.893 | 0.537 | 1.021 | 1.631 | 0.486 | 0.817 | 1.305 | 0.809 | 1.156 | 0.041
COVID19_PFIZER/BIONTECH | Apraxia | 1 | 0.931 | 0.342 | 1.02 | 1.991 | 0.364 | 0.885 | 1.876 | 1.074 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Urine analysis abnormal | 14 | 13.708 | 0.647 | 1.02 | 1.463 | 0.65 | 0.983 | 1.439 | 1.021 | 1.873 | 4.361
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase increased | 15 | 16.93 | 0.646 | 1.02 | 1.465 | 0.587 | 0.878 | 1.272 | 0.886 | 0.954 | 0.002
COVID19_PFIZER/BIONTECH | Drug screen | 3 | 4.278 | 0.438 | 1.02 | 1.798 | 0.374 | 0.764 | 1.422 | 0.701 | 1.426 | 0.06
COVID19_PFIZER/BIONTECH | Skin weeping | 1 | 1.953 | 0.308 | 1.02 | 2.07 | 0.292 | 0.717 | 1.526 | 0.512 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Vasodilatation | 1 | 0.834 | 0.387 | 1.019 | 1.893 | 0.372 | 0.905 | 1.919 | 1.199 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Computerised tomogram head abnormal | 29 | 27.796 | 0.743 | 1.019 | 1.331 | 0.756 | 1.02 | 1.351 | 1.043 | 2.942 | 30.255
COVID19_PFIZER/BIONTECH | Tremor | 338 | 340.37 | 0.931 | 1.019 | 1.112 | 0.906 | 0.991 | 1.083 | 0.993 | 1.325 | 25.151
COVID19_PFIZER/BIONTECH | Sinus pain | 5 | 5.954 | 0.457 | 1.019 | 1.761 | 0.455 | 0.84 | 1.446 | 0.84 | 1.368 | 0.17
COVID19_PFIZER/BIONTECH | Dermatitis diaper | 1 | 0.651 | 0.456 | 1.018 | 1.76 | 0.389 | 0.945 | 2.007 | 1.536 | 0.196 | 2.471
COVID19_PFIZER/BIONTECH | Faeces pale | 1 | 0.817 | 0.179 | 1.017 | 2.417 | 0.374 | 0.908 | 1.927 | 1.224 | 0.361 | 0.545
COVID19_PFIZER/BIONTECH | Rhabdomyolysis/myopathy (SMQ) [broad] | 1597 | 1703.032 | 0.975 | 1.017 | 1.059 | 0.9 | 0.938 | 0.977 | 0.938 | 1.441 | 212.784
COVID19_PFIZER/BIONTECH | Respiration abnormal | 9 | 10.386 | 0.573 | 1.017 | 1.565 | 0.524 | 0.86 | 1.347 | 0.867 | 0.879 | 0.048
COVID19_PFIZER/BIONTECH | Urticaria | 664 | 664.289 | 0.952 | 1.016 | 1.081 | 0.937 | 0.999 | 1.064 | 1 | 1.287 | 40.536
COVID19_PFIZER/BIONTECH | Oral pain | 13 | 13.265 | 0.665 | 1.016 | 1.428 | 0.62 | 0.95 | 1.406 | 0.98 | 1.545 | 1.802
COVID19_PFIZER/BIONTECH | Blindness | 21 | 24.686 | 0.695 | 1.016 | 1.386 | 0.601 | 0.849 | 1.173 | 0.851 | 1.009 | 0.005
COVID19_PFIZER/BIONTECH | Neutrophilia | 2 | 1.522 | 0.229 | 1.015 | 2.255 | 0.448 | 0.981 | 1.929 | 1.314 | 0.695 | 0.041
COVID19_PFIZER/BIONTECH | Hyperaemia | 1 | 0.884 | 0.193 | 1.015 | 2.367 | 0.368 | 0.894 | 1.897 | 1.132 | 0.244 | 1.591
COVID19_PFIZER/BIONTECH | Mechanical urticaria | 1 | 1.346 | 0.193 | 1.015 | 2.366 | 0.331 | 0.808 | 1.715 | 0.743 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Face injury | 5 | 5.46 | 0.496 | 1.014 | 1.682 | 0.48 | 0.885 | 1.524 | 0.916 | 0.606 | 0.87
COVID19_PFIZER/BIONTECH | Panic disorder | 1 | 1.289 | 0.206 | 1.013 | 2.318 | 0.336 | 0.818 | 1.736 | 0.776 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Blood gases normal | 1 | 1.332 | 0.291 | 1.013 | 2.088 | 0.332 | 0.81 | 1.72 | 0.751 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Drug eruption | 1 | 1.389 | 0.194 | 1.013 | 2.358 | 0.328 | 0.801 | 1.7 | 0.72 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Coagulation test normal | 2 | 2.468 | 0.285 | 1.012 | 2.101 | 0.377 | 0.827 | 1.624 | 0.81 | 0.41 | 1.104
COVID19_PFIZER/BIONTECH | Amylase | 1 | 1.406 | 0.335 | 1.012 | 1.986 | 0.327 | 0.798 | 1.694 | 0.711 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Staphylococcus test negative | 2 | 2.709 | 0.423 | 1.012 | 1.806 | 0.362 | 0.795 | 1.562 | 0.738 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Cardiovascular disorder | 3 | 5.019 | 0.315 | 1.012 | 2.03 | 0.341 | 0.698 | 1.299 | 0.598 | 0.704 | 0.122
COVID19_PFIZER/BIONTECH | Abscess drainage | 1 | 0.914 | 0.201 | 1.011 | 2.329 | 0.366 | 0.888 | 1.884 | 1.095 | 0.323 | 0.784
COVID19_PFIZER/BIONTECH | White blood cell count decreased | 21 | 23.257 | 0.691 | 1.011 | 1.38 | 0.632 | 0.894 | 1.236 | 0.903 | 0.824 | 0.585
COVID19_PFIZER/BIONTECH | Purpura | 7 | 8.423 | 0.543 | 1.011 | 1.597 | 0.483 | 0.834 | 1.36 | 0.831 | 0.448 | 4.09
COVID19_PFIZER/BIONTECH | Vomiting | 803 | 812.809 | 0.953 | 1.01 | 1.07 | 0.931 | 0.987 | 1.046 | 0.988 | 1.229 | 33.111
COVID19_PFIZER/BIONTECH | Inflammatory marker test | 2 | 1.587 | 0.369 | 1.009 | 1.905 | 0.442 | 0.968 | 1.904 | 1.26 | 0.384 | 1.349
COVID19_PFIZER/BIONTECH | Hangover | 3 | 2.757 | 0.396 | 1.009 | 1.85 | 0.465 | 0.947 | 1.763 | 1.088 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Delusion | 3 | 3.315 | 0.528 | 1.009 | 1.614 | 0.427 | 0.871 | 1.62 | 0.905 | 1.594 | 0.17
COVID19_PFIZER/BIONTECH | Tachyphrenia | 1 | 1.649 | 0.389 | 1.009 | 1.864 | 0.311 | 0.76 | 1.615 | 0.606 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Influenza like illness | 171 | 253.675 | 0.885 | 1.008 | 1.138 | 0.596 | 0.676 | 0.765 | 0.674 | 0.544 | 63.933
COVID19_PFIZER/BIONTECH | Cardiovascular evaluation | 9 | 8.425 | 0.594 | 1.007 | 1.509 | 0.609 | 1 | 1.567 | 1.068 | 5.243 | 20.61
COVID19_PFIZER/BIONTECH | Failure to thrive | 2 | 2.532 | 0.289 | 1.007 | 2.078 | 0.373 | 0.818 | 1.607 | 0.79 | 0.657 | 0.085
COVID19_PFIZER/BIONTECH | Amylase normal | 1 | 1.411 | 0.412 | 1.007 | 1.815 | 0.327 | 0.797 | 1.693 | 0.709 | 0.564 | 0.033
COVID19_PFIZER/BIONTECH | Abdominal rigidity | 2 | 1.405 | 0.315 | 1.006 | 2.011 | 0.458 | 1.004 | 1.975 | 1.423 | 1.246 | 0.01
COVID19_PFIZER/BIONTECH | Stress cardiomyopathy | 3 | 2.935 | 0.423 | 1.006 | 1.792 | 0.452 | 0.921 | 1.714 | 1.022 | 4.925 | 4.479
COVID19_PFIZER/BIONTECH | Granulocyte count | 2 | 2.256 | 0.385 | 1.006 | 1.863 | 0.391 | 0.857 | 1.684 | 0.886 | 1.389 | 0.001
COVID19_PFIZER/BIONTECH | Haematology test normal | 1 | 1.352 | 0.22 | 1.006 | 2.258 | 0.331 | 0.807 | 1.713 | 0.74 | 0.531 | 0.065
COVID19_PFIZER/BIONTECH | Deafness transitory | 1 | 0.995 | 0.223 | 1.005 | 2.246 | 0.359 | 0.872 | 1.849 | 1.005 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Glycosylated haemoglobin normal | 3 | 3.159 | 0.478 | 1.005 | 1.688 | 0.437 | 0.891 | 1.657 | 0.95 | 1.106 | 0.02
COVID19_PFIZER/BIONTECH | Stereotypy | 1 | 0.527 | 0.184 | 1.004 | 2.364 | 0.402 | 0.976 | 2.074 | 1.899 | 0.254 | 1.449
COVID19_PFIZER/BIONTECH | Arthralgia | 946 | 952.237 | 0.951 | 1.004 | 1.058 | 0.941 | 0.993 | 1.047 | 0.993 | 1.899 | 374.505
COVID19_PFIZER/BIONTECH | General symptom | 1 | 1.164 | 0.281 | 1.004 | 2.09 | 0.345 | 0.84 | 1.782 | 0.859 | 0.722 | 0.014
COVID19_PFIZER/BIONTECH | Neonatal disorders (SMQ) [broad] | 15 | 20.66 | 0.631 | 1.004 | 1.448 | 0.497 | 0.743 | 1.076 | 0.726 | 0.181 | 54.282
COVID19_PFIZER/BIONTECH | Decreased activity | 2 | 1.48 | 0.381 | 1.003 | 1.864 | 0.452 | 0.989 | 1.945 | 1.351 | 0.181 | 6.534
COVID19_PFIZER/BIONTECH | Mucosal discolouration | 1 | 0.887 | 0.372 | 1.003 | 1.884 | 0.368 | 0.894 | 1.896 | 1.128 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Immune-mediated/autoimmune disorders (SMQ) [broad] | 501 | 531.588 | 0.931 | 1.003 | 1.078 | 0.875 | 0.942 | 1.013 | 0.942 | 0.814 | 21.021
COVID19_PFIZER/BIONTECH | Neutrophil percentage increased | 10 | 12.951 | 0.569 | 1.003 | 1.537 | 0.489 | 0.787 | 1.213 | 0.772 | 0.692 | 1.027
COVID19_PFIZER/BIONTECH | Hemiplegia | 9 | 12.314 | 0.549 | 1.003 | 1.568 | 0.46 | 0.755 | 1.184 | 0.731 | 1.519 | 1.011
COVID19_PFIZER/BIONTECH | Immature granulocyte percentage increased | 3 | 2.592 | 0.422 | 1.002 | 1.783 | 0.477 | 0.973 | 1.81 | 1.157 | 6.773 | 6.762
COVID19_PFIZER/BIONTECH | Swelling of eyelid | 28 | 26.884 | 0.761 | 1.002 | 1.271 | 0.751 | 1.018 | 1.354 | 1.042 | 2.385 | 18.641
COVID19_PFIZER/BIONTECH | Acute pancreatitis (SMQ) [narrow] | 15 | 15.13 | 0.649 | 1.002 | 1.417 | 0.644 | 0.962 | 1.394 | 0.991 | 3.114 | 16.511
COVID19_PFIZER/BIONTECH | Pulmonary function test normal | 1 | 1.169 | 0.24 | 1.002 | 2.188 | 0.345 | 0.839 | 1.78 | 0.855 | 0.564 | 0.033
COVID19_PFIZER/BIONTECH | Jaw fracture | 1 | 1.297 | 0.3 | 1.002 | 2.038 | 0.335 | 0.817 | 1.733 | 0.771 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Respiratory depression | 7 | 7.41 | 0.566 | 1.001 | 1.537 | 0.528 | 0.91 | 1.485 | 0.945 | 4.359 | 11.883
COVID19_PFIZER/BIONTECH | Delirium | 18 | 19.407 | 0.677 | 1.001 | 1.378 | 0.63 | 0.914 | 1.289 | 0.928 | 1.729 | 4.376
COVID19_PFIZER/BIONTECH | Malignant lymphomas (SMQ) [broad] | 9 | 9.948 | 0.555 | 1.001 | 1.552 | 0.54 | 0.887 | 1.391 | 0.905 | 0.64 | 1.414
COVID19_PFIZER/BIONTECH | Blood folate | 2 | 2.344 | 0.347 | 1.001 | 1.931 | 0.385 | 0.844 | 1.659 | 0.853 | 2.258 | 0.345
COVID19_PFIZER/BIONTECH | Faeces soft | 1 | 1.21 | 0.123 | 1.001 | 2.582 | 0.342 | 0.832 | 1.765 | 0.827 | 0.334 | 0.702
COVID19_PFIZER/BIONTECH | Basedow's disease | 1 | 1.288 | 0.157 | 1.001 | 2.449 | 0.336 | 0.818 | 1.736 | 0.776 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Bruxism | 3 | 3.481 | 0.433 | 1 | 1.757 | 0.417 | 0.85 | 1.582 | 0.862 | 0.834 | 0.001
COVID19_PFIZER/BIONTECH | Palmar erythema | 1 | 0.286 | 0.272 | 0.999 | 2.097 | 0.428 | 1.043 | 2.233 | 3.492 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Colonoscopy normal | 1 | 1.028 | 0.335 | 0.999 | 1.95 | 0.356 | 0.866 | 1.836 | 0.973 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Pyrexia | 2431 | 2759.725 | 0.966 | 0.999 | 1.032 | 0.852 | 0.881 | 0.911 | 0.881 | 1.07 | 12.126
COVID19_PFIZER/BIONTECH | Cerebral atrophy | 3 | 2.466 | 0.376 | 0.998 | 1.861 | 0.487 | 0.993 | 1.848 | 1.217 | 2.356 | 0.998
COVID19_PFIZER/BIONTECH | Clonus | 1 | 0.863 | 0.179 | 0.998 | 2.362 | 0.37 | 0.899 | 1.906 | 1.158 | 0.194 | 2.521
COVID19_PFIZER/BIONTECH | Blood immunoglobulin G increased | 2 | 1.81 | 0.28 | 0.998 | 2.076 | 0.424 | 0.928 | 1.824 | 1.105 | 0.43 | 0.947
COVID19_PFIZER/BIONTECH | Transaminases | 1 | 0.95 | 0.216 | 0.998 | 2.246 | 0.362 | 0.881 | 1.868 | 1.052 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Syncope | 246 | 293.158 | 0.896 | 0.998 | 1.105 | 0.755 | 0.839 | 0.93 | 0.839 | 0.714 | 27.358
COVID19_PFIZER/BIONTECH | Interleukin level | 1 | 1.834 | 0.089 | 0.998 | 2.739 | 0.299 | 0.733 | 1.56 | 0.545 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | Pallor | 135 | 133.003 | 0.861 | 0.997 | 1.14 | 0.877 | 1.01 | 1.16 | 1.015 | 0.598 | 35.303
COVID19_PFIZER/BIONTECH | Myocardial necrosis marker | 6 | 7.029 | 0.466 | 0.997 | 1.69 | 0.477 | 0.849 | 1.42 | 0.854 | 3.737 | 7.715
COVID19_PFIZER/BIONTECH | Blood immunoglobulin A | 1 | 0.856 | 0.228 | 0.996 | 2.203 | 0.37 | 0.9 | 1.909 | 1.168 | 0.41 | 0.331
COVID19_PFIZER/BIONTECH | Burning sensation | 165 | 168.868 | 0.874 | 0.996 | 1.124 | 0.857 | 0.974 | 1.104 | 0.977 | 1.531 | 27.697
COVID19_PFIZER/BIONTECH | Streptococcus test positive | 6 | 7.412 | 0.449 | 0.996 | 1.718 | 0.461 | 0.819 | 1.37 | 0.809 | 0.17 | 23.196
COVID19_PFIZER/BIONTECH | Blood blister | 1 | 1.565 | 0.356 | 0.996 | 1.899 | 0.316 | 0.773 | 1.642 | 0.639 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Catheterisation cardiac | 15 | 15.883 | 0.66 | 0.995 | 1.386 | 0.619 | 0.925 | 1.34 | 0.944 | 7.322 | 53.614
COVID19_PFIZER/BIONTECH | Walking aid user | 15 | 19.322 | 0.633 | 0.995 | 1.423 | 0.526 | 0.786 | 1.139 | 0.776 | 0.763 | 0.833
COVID19_PFIZER/BIONTECH | Antinuclear antibody | 8 | 7.599 | 0.572 | 0.994 | 1.51 | 0.586 | 0.984 | 1.572 | 1.053 | 1.12 | 0.014
COVID19_PFIZER/BIONTECH | Blood magnesium | 16 | 15.407 | 0.662 | 0.994 | 1.38 | 0.677 | 1.001 | 1.436 | 1.038 | 3.753 | 24.405
COVID19_PFIZER/BIONTECH | Complication associated with device | 1 | 1.427 | 0.29 | 0.994 | 2.041 | 0.326 | 0.795 | 1.687 | 0.701 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Cerebellar stroke | 3 | 3.299 | 0.41 | 0.993 | 1.782 | 0.428 | 0.873 | 1.623 | 0.909 | 6.02 | 5.865
COVID19_PFIZER/BIONTECH | Computerised tomogram spine | 8 | 8.863 | 0.57 | 0.993 | 1.511 | 0.526 | 0.884 | 1.412 | 0.903 | 5.557 | 19.333
COVID19_PFIZER/BIONTECH | Micturition urgency | 3 | 4.003 | 0.39 | 0.993 | 1.82 | 0.388 | 0.792 | 1.473 | 0.749 | 0.888 | 0.006
COVID19_PFIZER/BIONTECH | Cardiac function test normal | 5 | 4.456 | 0.533 | 0.992 | 1.566 | 0.54 | 0.996 | 1.715 | 1.122 | 2.052 | 1.528
COVID19_PFIZER/BIONTECH | Pruritus | 943 | 960.322 | 0.939 | 0.992 | 1.045 | 0.93 | 0.981 | 1.035 | 0.982 | 1.486 | 143.234
COVID19_PFIZER/BIONTECH | Neck mass | 3 | 3.591 | 0.502 | 0.992 | 1.617 | 0.41 | 0.837 | 1.557 | 0.835 | 1.062 | 0.041
COVID19_PFIZER/BIONTECH | CSF lymphocyte count normal | 1 | 1.388 | 0.397 | 0.992 | 1.804 | 0.328 | 0.801 | 1.701 | 0.721 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Intraocular pressure increased | 1 | 0.81 | 0.211 | 0.991 | 2.238 | 0.375 | 0.91 | 1.93 | 1.235 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Urine ketone body present | 3 | 2.988 | 0.493 | 0.991 | 1.628 | 0.448 | 0.914 | 1.7 | 1.004 | 0.686 | 0.158
COVID19_PFIZER/BIONTECH | Flatulence | 16 | 17.113 | 0.633 | 0.991 | 1.415 | 0.621 | 0.918 | 1.318 | 0.935 | 0.842 | 0.306
COVID19_PFIZER/BIONTECH | Antineutrophil cytoplasmic antibody | 3 | 2.402 | 0.403 | 0.99 | 1.787 | 0.493 | 1.004 | 1.868 | 1.249 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Rash | 946 | 979.499 | 0.936 | 0.989 | 1.042 | 0.915 | 0.965 | 1.018 | 0.966 | 0.908 | 8.72
COVID19_PFIZER/BIONTECH | Radiculitis brachial | 4 | 4.255 | 0.392 | 0.989 | 1.805 | 0.464 | 0.894 | 1.593 | 0.94 | 1.147 | 0
COVID19_PFIZER/BIONTECH | Muscle fatigue | 13 | 14.142 | 0.618 | 0.989 | 1.43 | 0.589 | 0.903 | 1.337 | 0.919 | 1.714 | 2.876
COVID19_PFIZER/BIONTECH | Flow cytometry | 2 | 2.809 | 0.356 | 0.988 | 1.875 | 0.356 | 0.782 | 1.538 | 0.712 | 0.737 | 0.012
COVID19_PFIZER/BIONTECH | Suicide/self-injury (SMQ) [broad] | 4 | 5.586 | 0.39 | 0.988 | 1.806 | 0.396 | 0.764 | 1.362 | 0.716 | 0.327 | 4.774
COVID19_PFIZER/BIONTECH | Suicide/self-injury (SMQ) [narrow] | 4 | 5.586 | 0.39 | 0.988 | 1.806 | 0.396 | 0.764 | 1.362 | 0.716 | 0.327 | 4.774
COVID19_PFIZER/BIONTECH | Oesophagogastroduodenoscopy | 3 | 3.272 | 0.411 | 0.987 | 1.763 | 0.43 | 0.876 | 1.63 | 0.917 | 4.515 | 3.935
COVID19_PFIZER/BIONTECH | Vaccination site rash | 13 | 17.666 | 0.609 | 0.987 | 1.439 | 0.491 | 0.753 | 1.115 | 0.736 | 0.97 | 0.001
COVID19_PFIZER/BIONTECH | Blood pressure systolic decreased | 2 | 1.285 | 0.371 | 0.986 | 1.839 | 0.47 | 1.029 | 2.026 | 1.556 | 3.612 | 1.27
COVID19_PFIZER/BIONTECH | Discomfort | 121 | 123.838 | 0.847 | 0.986 | 1.134 | 0.838 | 0.973 | 1.125 | 0.977 | 1.102 | 0.984
COVID19_PFIZER/BIONTECH | Influenza B virus test positive | 1 | 1.631 | 0.09 | 0.986 | 2.693 | 0.312 | 0.763 | 1.621 | 0.613 | 0.112 | 6.086
COVID19_PFIZER/BIONTECH | Rash vesicular | 25 | 42.56 | 0.69 | 0.986 | 1.325 | 0.441 | 0.607 | 0.82 | 0.587 | 0.115 | 169.457
COVID19_PFIZER/BIONTECH | Epstein-Barr virus test | 3 | 2.511 | 0.432 | 0.985 | 1.721 | 0.484 | 0.986 | 1.834 | 1.195 | 1.153 | 0.006
COVID19_PFIZER/BIONTECH | Renal pain | 10 | 9.95 | 0.578 | 0.985 | 1.481 | 0.597 | 0.961 | 1.481 | 1.005 | 2.15 | 4.467
COVID19_PFIZER/BIONTECH | Pancreatitis | 7 | 7.365 | 0.568 | 0.985 | 1.495 | 0.53 | 0.914 | 1.491 | 0.95 | 2.528 | 4.347
COVID19_PFIZER/BIONTECH | Eye discharge | 9 | 10.401 | 0.542 | 0.985 | 1.536 | 0.523 | 0.859 | 1.346 | 0.865 | 0.797 | 0.265
COVID19_PFIZER/BIONTECH | Helicobacter infection | 2 | 2.004 | 0.362 | 0.984 | 1.853 | 0.409 | 0.896 | 1.76 | 0.998 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Injection site paraesthesia | 30 | 30.054 | 0.733 | 0.983 | 1.263 | 0.731 | 0.981 | 1.295 | 0.998 | 1.647 | 6.38
COVID19_PFIZER/BIONTECH | Limb discomfort | 154 | 158.268 | 0.86 | 0.983 | 1.113 | 0.849 | 0.97 | 1.104 | 0.973 | 2.171 | 86.112
COVID19_PFIZER/BIONTECH | Haemorrhages (SMQ) [broad] | 571 | 588.339 | 0.916 | 0.982 | 1.05 | 0.905 | 0.97 | 1.038 | 0.971 | 1.011 | 0.053
COVID19_PFIZER/BIONTECH | Lymph node pain | 105 | 110.126 | 0.832 | 0.982 | 1.143 | 0.809 | 0.95 | 1.11 | 0.953 | 3.15 | 129.546
COVID19_PFIZER/BIONTECH | Body temperature abnormal | 6 | 7.314 | 0.456 | 0.982 | 1.67 | 0.465 | 0.827 | 1.383 | 0.82 | 2.709 | 4.167
COVID19_PFIZER/BIONTECH | Brain stem syndrome | 2 | 1.422 | 0.294 | 0.981 | 1.993 | 0.457 | 1.001 | 1.969 | 1.407 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Blood sodium | 2 | 1.884 | 0.391 | 0.981 | 1.787 | 0.418 | 0.915 | 1.799 | 1.061 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Pancreatitis acute | 8 | 7.738 | 0.543 | 0.981 | 1.524 | 0.579 | 0.972 | 1.552 | 1.034 | 4.013 | 12.323
COVID19_PFIZER/BIONTECH | Foot deformity | 1 | 0.971 | 0.319 | 0.981 | 1.937 | 0.361 | 0.877 | 1.859 | 1.03 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Tumours of unspecified malignancy (SMQ) [broad] | 2 | 2.327 | 0.277 | 0.981 | 2.034 | 0.386 | 0.847 | 1.664 | 0.86 | 0.384 | 1.349
COVID19_PFIZER/BIONTECH | Tumours of unspecified malignancy (SMQ) [narrow] | 2 | 2.327 | 0.277 | 0.981 | 2.034 | 0.386 | 0.847 | 1.664 | 0.86 | 0.384 | 1.349
COVID19_PFIZER/BIONTECH | Autopsy | 12 | 16.396 | 0.583 | 0.981 | 1.462 | 0.483 | 0.751 | 1.126 | 0.732 | 0.675 | 1.494
COVID19_PFIZER/BIONTECH | Walking disability | 1 | 0.825 | 0.137 | 0.98 | 2.461 | 0.373 | 0.907 | 1.923 | 1.213 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Ear congestion | 4 | 4.356 | 0.505 | 0.98 | 1.582 | 0.458 | 0.883 | 1.573 | 0.918 | 1.062 | 0.022
COVID19_PFIZER/BIONTECH | Gastrointestinal disorder | 13 | 14.442 | 0.597 | 0.98 | 1.439 | 0.579 | 0.888 | 1.315 | 0.9 | 0.563 | 3.845
COVID19_PFIZER/BIONTECH | Dermatitis acneiform | 3 | 2.437 | 0.455 | 0.979 | 1.664 | 0.49 | 0.998 | 1.857 | 1.231 | 2.463 | 1.136
COVID19_PFIZER/BIONTECH | Lethargy | 146 | 162.346 | 0.852 | 0.979 | 1.113 | 0.783 | 0.898 | 1.025 | 0.899 | 0.845 | 3.871
COVID19_PFIZER/BIONTECH | Gastrointestinal inflammation | 2 | 2.463 | 0.327 | 0.979 | 1.916 | 0.377 | 0.827 | 1.626 | 0.812 | 0.803 | 0
COVID19_PFIZER/BIONTECH | Cardiolipin antibody negative | 1 | 1.379 | 0.127 | 0.979 | 2.496 | 0.329 | 0.803 | 1.704 | 0.725 | 0.583 | 0.02
COVID19_PFIZER/BIONTECH | Intervertebral disc disorder | 1 | 2.071 | 0.289 | 0.979 | 2.001 | 0.285 | 0.701 | 1.494 | 0.483 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Pain of skin | 40 | 50.829 | 0.75 | 0.978 | 1.23 | 0.611 | 0.79 | 1.009 | 0.787 | 1.668 | 9.182
COVID19_PFIZER/BIONTECH | CSF protein increased | 8 | 10.561 | 0.522 | 0.978 | 1.55 | 0.463 | 0.778 | 1.243 | 0.758 | 0.4 | 6.436
COVID19_PFIZER/BIONTECH | Swallow study | 2 | 0.922 | 0.305 | 0.977 | 1.958 | 0.508 | 1.115 | 2.202 | 2.17 | 2.408 | 0.438
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging | 112 | 123.582 | 0.834 | 0.977 | 1.13 | 0.774 | 0.904 | 1.052 | 0.906 | 1.328 | 8.177
COVID19_PFIZER/BIONTECH | Prothrombin level normal | 1 | 1.413 | 0.277 | 0.977 | 2.023 | 0.327 | 0.797 | 1.692 | 0.708 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Radioallergosorbent test | 0 | 0.056 | 0.213 | 0.977 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extrapyramidal disorder | 0 | 0.058 | 0.22 | 0.977 | 2.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ehrlichia test | 0 | 0.057 | 0.22 | 0.977 | 2.175 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid ptosis | 10 | 10.278 | 0.625 | 0.976 | 1.39 | 0.583 | 0.938 | 1.446 | 0.973 | 1.204 | 0.154
COVID19_PFIZER/BIONTECH | Liver function test normal | 7 | 7.951 | 0.492 | 0.976 | 1.594 | 0.503 | 0.868 | 1.416 | 0.88 | 0.543 | 2.175
COVID19_PFIZER/BIONTECH | Blood count abnormal | 2 | 2.733 | 0.366 | 0.976 | 1.824 | 0.36 | 0.792 | 1.556 | 0.732 | 1.29 | 0.004
COVID19_PFIZER/BIONTECH | Vitamin B1 | 0 | 0.058 | 0.207 | 0.976 | 2.209 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal X-ray | 6 | 7.03 | 0.55 | 0.975 | 1.498 | 0.477 | 0.849 | 1.419 | 0.854 | 1.97 | 1.744
COVID19_PFIZER/BIONTECH | PO2 increased | 1 | 1.427 | 0.195 | 0.975 | 2.245 | 0.326 | 0.795 | 1.687 | 0.701 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Sudden hearing loss | 7 | 10.743 | 0.485 | 0.975 | 1.603 | 0.405 | 0.699 | 1.14 | 0.652 | 1.204 | 0.07
COVID19_PFIZER/BIONTECH | Angioedema (SMQ) [broad] | 2325 | 2443.996 | 0.941 | 0.974 | 1.007 | 0.919 | 0.951 | 0.984 | 0.951 | 1.085 | 16.413
COVID19_PFIZER/BIONTECH | Paralysis | 17 | 19.992 | 0.629 | 0.974 | 1.381 | 0.58 | 0.849 | 1.208 | 0.85 | 0.489 | 8.343
COVID19_PFIZER/BIONTECH | Impetigo | 0 | 0.075 | 0.245 | 0.974 | 2.095 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body sensation in eyes | 2 | 1.631 | 0.378 | 0.973 | 1.792 | 0.438 | 0.96 | 1.888 | 1.226 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | Trismus | 5 | 5.353 | 0.443 | 0.973 | 1.671 | 0.486 | 0.896 | 1.543 | 0.934 | 0.877 | 0.005
COVID19_PFIZER/BIONTECH | Chapped lips | 3 | 3.274 | 0.426 | 0.973 | 1.701 | 0.43 | 0.876 | 1.63 | 0.916 | 0.888 | 0.006
COVID19_PFIZER/BIONTECH | Hepatitis C test negative | 2 | 3.442 | 0.236 | 0.973 | 2.117 | 0.323 | 0.711 | 1.399 | 0.581 | 0.289 | 2.746
COVID19_PFIZER/BIONTECH | Effusion | 0 | 0.06 | 0.191 | 0.973 | 2.25 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth fracture | 2 | 1.792 | 0.372 | 0.972 | 1.801 | 0.425 | 0.931 | 1.83 | 1.116 | 0.821 | 0.003
COVID19_PFIZER/BIONTECH | Neuralgia | 46 | 59.058 | 0.752 | 0.972 | 1.215 | 0.615 | 0.782 | 0.984 | 0.779 | 0.777 | 2.606
COVID19_PFIZER/BIONTECH | Fibromyalgia | 4 | 5.586 | 0.36 | 0.972 | 1.827 | 0.396 | 0.764 | 1.363 | 0.716 | 0.247 | 8.275
COVID19_PFIZER/BIONTECH | Hip fracture | 6 | 6.76 | 0.52 | 0.971 | 1.536 | 0.49 | 0.871 | 1.456 | 0.888 | 5.16 | 12.424
COVID19_PFIZER/BIONTECH | Neutrophil count increased | 9 | 11.746 | 0.53 | 0.971 | 1.519 | 0.477 | 0.783 | 1.228 | 0.766 | 0.516 | 3.495
COVID19_PFIZER/BIONTECH | Joint swelling | 54 | 56.967 | 0.773 | 0.97 | 1.184 | 0.754 | 0.941 | 1.164 | 0.948 | 0.984 | 0.002
COVID19_PFIZER/BIONTECH | Rash pruritic | 156 | 186.05 | 0.848 | 0.97 | 1.1 | 0.735 | 0.838 | 0.954 | 0.838 | 1.019 | 0.037
COVID19_PFIZER/BIONTECH | Blood phosphorus normal | 2 | 2.619 | 0.4 | 0.969 | 1.738 | 0.367 | 0.806 | 1.585 | 0.764 | 0.446 | 0.834
COVID19_PFIZER/BIONTECH | Muscle discomfort | 4 | 4.375 | 0.453 | 0.968 | 1.64 | 0.457 | 0.88 | 1.569 | 0.914 | 3.612 | 4.209
COVID19_PFIZER/BIONTECH | Polyarthritis | 2 | 2.209 | 0.276 | 0.968 | 2.002 | 0.394 | 0.864 | 1.697 | 0.905 | 0.415 | 1.064
COVID19_PFIZER/BIONTECH | X-ray | 53 | 61.138 | 0.766 | 0.968 | 1.19 | 0.691 | 0.865 | 1.072 | 0.867 | 0.981 | 0.005
COVID19_PFIZER/BIONTECH | Urinary incontinence | 17 | 19.684 | 0.658 | 0.968 | 1.327 | 0.588 | 0.86 | 1.223 | 0.864 | 0.679 | 2.169
COVID19_PFIZER/BIONTECH | Neck pain | 277 | 290.028 | 0.875 | 0.967 | 1.064 | 0.864 | 0.954 | 1.051 | 0.955 | 1.456 | 36.614
COVID19_PFIZER/BIONTECH | CSF immunoglobulin increased | 1 | 0.615 | 0.127 | 0.966 | 2.458 | 0.393 | 0.954 | 2.026 | 1.627 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Aplastic anaemia | 1 | 1.043 | 0.279 | 0.966 | 1.988 | 0.355 | 0.863 | 1.83 | 0.959 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Extrapyramidal syndrome (SMQ) [broad] | 1278 | 1348.318 | 0.922 | 0.966 | 1.011 | 0.905 | 0.948 | 0.992 | 0.948 | 1.029 | 1.016
COVID19_PFIZER/BIONTECH | Pulmonary pain | 7 | 7.748 | 0.563 | 0.966 | 1.459 | 0.512 | 0.883 | 1.441 | 0.904 | 2.748 | 5.251
COVID19_PFIZER/BIONTECH | Cytomegalovirus test negative | 3 | 3.481 | 0.334 | 0.966 | 1.864 | 0.417 | 0.85 | 1.582 | 0.862 | 0.22 | 7.395
COVID19_PFIZER/BIONTECH | Blood bicarbonate increased | 2 | 2.368 | 0.32 | 0.966 | 1.893 | 0.383 | 0.841 | 1.652 | 0.845 | 1.57 | 0.029
COVID19_PFIZER/BIONTECH | Peroneal nerve palsy | 2 | 2.829 | 0.395 | 0.966 | 1.741 | 0.355 | 0.78 | 1.533 | 0.707 | 0.669 | 0.069
COVID19_PFIZER/BIONTECH | Blood bicarbonate | 0 | 0.057 | 0.128 | 0.966 | 2.454 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhages (SMQ) [narrow] | 467 | 499.17 | 0.893 | 0.965 | 1.039 | 0.866 | 0.935 | 1.008 | 0.936 | 0.891 | 5.958
COVID19_PFIZER/BIONTECH | Folliculitis | 2 | 2.307 | 0.381 | 0.965 | 1.764 | 0.387 | 0.849 | 1.669 | 0.867 | 1.445 | 0.005
COVID19_PFIZER/BIONTECH | CSF lymphocyte count | 0 | 0.057 | 0.114 | 0.964 | 2.506 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral pharyngitis | 0 | 0.057 | 0.117 | 0.964 | 2.495 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhage terms (excl laboratory terms) (SMQ) [narrow] | 466 | 498.642 | 0.892 | 0.963 | 1.037 | 0.865 | 0.934 | 1.007 | 0.935 | 0.891 | 5.936
COVID19_PFIZER/BIONTECH | Haemorrhage terms (excl laboratory terms) (SMQ) [broad] | 466 | 498.642 | 0.892 | 0.963 | 1.037 | 0.865 | 0.934 | 1.007 | 0.935 | 0.891 | 5.936
COVID19_PFIZER/BIONTECH | Poor quality sleep | 27 | 29.738 | 0.702 | 0.963 | 1.257 | 0.661 | 0.9 | 1.204 | 0.908 | 0.924 | 0.095
COVID19_PFIZER/BIONTECH | Neoplasm skin | 0 | 0.059 | 0.118 | 0.963 | 2.486 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukoencephalopathy | 0 | 0.06 | 0.123 | 0.963 | 2.466 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.059 | 0.118 | 0.963 | 2.486 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Irritability | 16 | 16.274 | 0.636 | 0.962 | 1.342 | 0.647 | 0.957 | 1.374 | 0.983 | 0.105 | 120.963
COVID19_PFIZER/BIONTECH | Myocarditis | 18 | 25.823 | 0.626 | 0.962 | 1.356 | 0.493 | 0.715 | 1.008 | 0.697 | 1.65 | 3.622
COVID19_PFIZER/BIONTECH | Tendon rupture | 1 | 1.749 | 0.269 | 0.962 | 2.004 | 0.304 | 0.745 | 1.585 | 0.572 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Increased tendency to bruise | 1 | 1.813 | 0.197 | 0.962 | 2.198 | 0.3 | 0.736 | 1.566 | 0.552 | 0.274 | 1.219
COVID19_PFIZER/BIONTECH | Mutism | 0 | 0.057 | 0.11 | 0.962 | 2.522 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased appetite | 249 | 264.035 | 0.864 | 0.961 | 1.063 | 0.848 | 0.942 | 1.043 | 0.943 | 0.988 | 0.024
COVID19_PFIZER/BIONTECH | Skin ulcer | 6 | 6.765 | 0.508 | 0.961 | 1.531 | 0.489 | 0.87 | 1.456 | 0.887 | 0.63 | 0.911
COVID19_PFIZER/BIONTECH | Clostridium test positive | 1 | 1.347 | 0.27 | 0.961 | 1.996 | 0.331 | 0.808 | 1.715 | 0.742 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Staphylococcus test positive | 2 | 2.682 | 0.473 | 0.961 | 1.589 | 0.363 | 0.798 | 1.569 | 0.746 | 0.354 | 1.691
COVID19_PFIZER/BIONTECH | Rhinitis allergic | 1 | 0.904 | 0.223 | 0.96 | 2.116 | 0.366 | 0.89 | 1.888 | 1.106 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Type III immune complex mediated reaction | 2 | 2.137 | 0.281 | 0.96 | 1.969 | 0.399 | 0.875 | 1.719 | 0.936 | 0.268 | 3.228
COVID19_PFIZER/BIONTECH | Incoherent | 12 | 13.425 | 0.639 | 0.96 | 1.335 | 0.567 | 0.882 | 1.322 | 0.894 | 1.821 | 3.289
COVID19_PFIZER/BIONTECH | Vomiting projectile | 6 | 6.959 | 0.475 | 0.96 | 1.584 | 0.48 | 0.854 | 1.429 | 0.862 | 0.409 | 4.425
COVID19_PFIZER/BIONTECH | Fear of injection | 2 | 2.89 | 0.336 | 0.959 | 1.84 | 0.351 | 0.772 | 1.519 | 0.692 | 1.095 | 0.065
COVID19_PFIZER/BIONTECH | Rhabdomyolysis/myopathy (SMQ) [narrow] | 8 | 11.054 | 0.503 | 0.959 | 1.532 | 0.448 | 0.752 | 1.201 | 0.724 | 0.914 | 0.005
COVID19_PFIZER/BIONTECH | Biopsy lymph gland abnormal | 0 | 0.058 | 0.094 | 0.959 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Grip strength decreased | 22 | 23.368 | 0.668 | 0.958 | 1.291 | 0.661 | 0.928 | 1.274 | 0.941 | 1.107 | 0.121
COVID19_PFIZER/BIONTECH | Paranasal sinus hypersecretion | 6 | 7.177 | 0.506 | 0.958 | 1.526 | 0.471 | 0.837 | 1.4 | 0.836 | 2.463 | 3.33
COVID19_PFIZER/BIONTECH | Stool analysis abnormal | 1 | 1.278 | 0.084 | 0.958 | 2.636 | 0.336 | 0.82 | 1.74 | 0.782 | 0.184 | 2.774
COVID19_PFIZER/BIONTECH | C-reactive protein | 21 | 25.844 | 0.66 | 0.958 | 1.302 | 0.577 | 0.816 | 1.127 | 0.813 | 0.812 | 0.695
COVID19_PFIZER/BIONTECH | Thyroxine free | 2 | 1.139 | 0.403 | 0.957 | 1.702 | 0.485 | 1.062 | 2.092 | 1.756 | 1.129 | 0.048
COVID19_PFIZER/BIONTECH | Neuralgic amyotrophy | 5 | 5.313 | 0.437 | 0.957 | 1.641 | 0.488 | 0.9 | 1.549 | 0.941 | 0.785 | 0.106
COVID19_PFIZER/BIONTECH | Philadelphia chromosome positive | 0 | 0.052 | 0.07 | 0.957 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auditory neuropathy spectrum disorder | 0 | 0.052 | 0.068 | 0.957 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penicillium test negative | 0 | 0.052 | 0.069 | 0.957 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood prolactin increased | 0 | 0.058 | 0.088 | 0.957 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral load decreased | 0 | 0.052 | 0.071 | 0.957 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin hypertrophy | 1 | 1.246 | 0.114 | 0.956 | 2.48 | 0.339 | 0.825 | 1.751 | 0.803 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Malignant tumours (SMQ) [narrow] | 26 | 34.478 | 0.676 | 0.956 | 1.277 | 0.557 | 0.762 | 1.024 | 0.754 | 0.682 | 3.419
COVID19_PFIZER/BIONTECH | Malignant tumours (SMQ) [broad] | 26 | 34.478 | 0.676 | 0.956 | 1.277 | 0.557 | 0.762 | 1.024 | 0.754 | 0.682 | 3.419
COVID19_PFIZER/BIONTECH | Salivary gland calculus | 0 | 0.052 | 0.066 | 0.956 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell morphology | 0 | 0.052 | 0.068 | 0.956 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shift to the right | 0 | 0.052 | 0.068 | 0.956 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrong schedule | 0 | 0.052 | 0.068 | 0.956 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rasmussen encephalitis | 0 | 0.052 | 0.067 | 0.956 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site dryness | 1 | 1.013 | 0.31 | 0.955 | 1.887 | 0.357 | 0.868 | 1.842 | 0.987 | 0.531 | 0.065
COVID19_PFIZER/BIONTECH | Brain natriuretic peptide | 12 | 12.71 | 0.604 | 0.955 | 1.37 | 0.592 | 0.921 | 1.38 | 0.944 | 8.027 | 46.103
COVID19_PFIZER/BIONTECH | Epstein-Barr virus antibody positive | 3 | 3.284 | 0.39 | 0.955 | 1.723 | 0.429 | 0.875 | 1.627 | 0.914 | 0.86 | 0
COVID19_PFIZER/BIONTECH | Palatal swelling | 2 | 2.497 | 0.382 | 0.955 | 1.737 | 0.375 | 0.823 | 1.617 | 0.801 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Blood immunoglobulin G normal | 4 | 4.953 | 0.397 | 0.955 | 1.709 | 0.426 | 0.821 | 1.463 | 0.808 | 0.52 | 1.269
COVID19_PFIZER/BIONTECH | Parkinson-like events (SMQ) [narrow] | 15 | 19.562 | 0.605 | 0.955 | 1.371 | 0.521 | 0.778 | 1.127 | 0.767 | 0.471 | 8.157
COVID19_PFIZER/BIONTECH | Postmenopausal haemorrhage | 0 | 0.052 | 0.063 | 0.955 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myocarditis infectious | 0 | 0.052 | 0.062 | 0.955 | 2.763 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site rash | 0 | 0.052 | 0.063 | 0.955 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood calcium abnormal | 0 | 0.052 | 0.063 | 0.955 | 2.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic duct dilatation | 0 | 0.052 | 0.062 | 0.955 | 2.762 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anger | 6 | 5.509 | 0.494 | 0.954 | 1.535 | 0.557 | 0.99 | 1.657 | 1.089 | 0.758 | 0.234
COVID19_PFIZER/BIONTECH | Urine leukocyte esterase positive | 4 | 4.105 | 0.47 | 0.954 | 1.575 | 0.473 | 0.911 | 1.624 | 0.974 | 3.44 | 3.854
COVID19_PFIZER/BIONTECH | Intraductal papillary mucinous neoplasm | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF electrophoresis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Femoral nerve palsy | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin lesion inflammation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary hilum mass | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemia of chronic disease | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Methaemoglobin urine absent | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipase abnormal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical device site joint pain | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericoronitis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site infection | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypocapnia | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon dislocation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Roseolovirus test | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cells stool | 0 | 0.052 | 0.059 | 0.954 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal cyst haemorrhage | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vocal cord thickening | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal tremor | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poikilocytosis | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allen's test | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymph nodes scan abnormal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal artery stenosis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Placental calcification | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile ulceration | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram ST-T segment elevation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ischaemic limb pain | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint adhesion | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholestasis of pregnancy | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal disorder prophylaxis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colonic fistula | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incorrect disposal of product | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cor pulmonale chronic | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail injury | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | SUNCT syndrome | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal cancer stage IV | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophil count abnormal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Terminal ileitis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood 1,25-dihydroxycholecalciferol increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Agonal death struggle | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oscillopsia | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lens extraction | 0 | 0.052 | 0.061 | 0.954 | 2.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nipple disorder | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barbiturates negative | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopic swallowing evaluation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile culture negative | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic fluid index decreased | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epidural lipomatosis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phaeochromocytoma | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renin | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brachioradial pruritus | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic operation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Elephantiasis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ewing's sarcoma | 0 | 0.052 | 0.061 | 0.954 | 2.766 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carnett's sign positive | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure systolic normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroglottography | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pyruvic acid normal | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Symptom recurrence | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective mutism | 0 | 0.052 | 0.059 | 0.954 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | SCORTEN score | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebrobasilar stroke | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant splenic neoplasm | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy-related hepatic disorders (SMQ) [broad] | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traumatic haemorrhage | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normetanephrine urine increased | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular rupture | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal oedema | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual agnosia | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular cyst | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic embolisation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Withdrawal hypertension | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dystonic tremor | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcoholic hangover | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous stent insertion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram P wave biphasic | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site odour | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deposit eye | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device dispensing error | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal adenoma | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plastic surgery to the face | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic pain | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multisystem inflammatory syndrome in children | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Model for end stage liver disease score | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess intestinal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestinal anastomosis | 0 | 0.052 | 0.061 | 0.954 | 2.769 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histamine abnormal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Discouragement | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant ascites | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pubic pain | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural constipation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Maternal drugs affecting foetus | 0 | 0.052 | 0.059 | 0.954 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous oxygen partial pressure | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rebound effect | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasminogen decreased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial cyst | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dissociative amnesia | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site haemorrhage | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant nipple neoplasm female | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy-related hepatic disorders (SMQ) [narrow] | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial fluid crystal present | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal lavage | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheostomy tube removal | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meibomian gland dysfunction | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carcinoid syndrome | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac contusion | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cubital tunnel syndrome | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis mumps | 0 | 0.052 | 0.061 | 0.954 | 2.765 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic haemorrhage | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopic retrograde cholangiopancreatography | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body ingestion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Follicle centre lymphoma diffuse small cell lymphoma | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster pharyngitis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes oesophagitis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine albumin/creatinine ratio increased | 0 | 0.052 | 0.06 | 0.954 | 2.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Imaging procedure artifact | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperkeratosis lenticularis perstans | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | 5'nucleotidase increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ulnar nerve palsy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteoarthropathy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mast cell degranulation test | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Early satiety | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood calcitonin normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral myelitis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue thrust | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural haematoma | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Swollen tear duct | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal dystrophy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbohydrate antigen 19-9 increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood albumin abnormal | 0 | 0.052 | 0.06 | 0.954 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder cancer stage IV | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrolyte depletion | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site irritation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accelerated hypertension | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monocyte percentage abnormal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial fibrosis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal foreign body | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestine operation | 0 | 0.052 | 0.059 | 0.954 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedure aborted | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Left ventricular dilatation | 0 | 0.052 | 0.06 | 0.954 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Continuous glucose monitoring | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bicuspid aortic valve | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasomotor rhinitis | 0 | 0.052 | 0.06 | 0.954 | 2.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood beta-D-glucan normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdomen crushing | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial fibrosis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatitis viral | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Long thoracic nerve palsy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iliotibial band syndrome | 0 | 0.052 | 0.059 | 0.954 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parathyroid tumour | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast ulceration | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial drainage test normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteosclerosis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram coronary artery | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colorectal cancer metastatic | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileocolectomy | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myalgia intercostal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestinal polypectomy | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opticokinetic nystagmus tests | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood thromboplastin normal | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion site swelling | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestine adenocarcinoma | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroperitoneal effusion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insurance issue | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exploding head syndrome | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy mucosa normal | 0 | 0.052 | 0.059 | 0.954 | 2.778 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aldosterone urine | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barbiturates positive | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal wall oedema | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reduction of increased intracranial pressure | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rinne tuning fork test abnormal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint surgery | 0 | 0.052 | 0.06 | 0.954 | 2.774 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blast cell proliferation | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body in ear | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amimia | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymph node rupture | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VIII level decreased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body mass index increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngotracheobronchoscopy | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileocaecal resection | 0 | 0.052 | 0.059 | 0.954 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stem cell therapy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin K | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor Xa assay normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin K decreased | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human herpesvirus 6 encephalitis | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental implantation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial drainage test | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac ventriculogram left normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy eyelid | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac pacemaker adjustment | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leptospira test | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperchromic anaemia | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diffuse large B-cell lymphoma | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune blistering disease | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pudendal canal syndrome | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tenosynovitis stenosans | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriovenous fistula | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | C1 esterase inhibitor test | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroglobulin increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pacemaker generated rhythm | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product dispensing issue | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stomach lesion excision | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | BRCA2 gene mutation assay | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paracentesis eye | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood triglycerides decreased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer stage I | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vena cava filter insertion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colloid brain cyst | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine phosphorus | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesenteric arterial occlusion | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal rebound tenderness | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyskinesia oesophageal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastasis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous oxygen saturation normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile blister | 0 | 0.052 | 0.061 | 0.954 | 2.769 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serial transverse enteroplasty | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Right ventricular systolic pressure | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Saliva analysis | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal neovascularisation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site haemorrhage | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis neonatal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular operation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular cauterisation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocytic lymphoma | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural intestinal perforation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Potassium hydroxide preparation negative | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatillomania | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chromosomal deletion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Food interaction | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired diaphragmatic eventration | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal malrotation repair | 0 | 0.052 | 0.058 | 0.954 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhage subepidermal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder injury | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic membrane rupture test negative | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | BRCA1 gene mutation assay | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal mucosal ulcer | 0 | 0.052 | 0.059 | 0.954 | 2.777 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood urea abnormal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticaria pressure | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye complication associated with device | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Femoral nerve injury | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic response delayed | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Positive expiratory pressure therapy | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear vaginal normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postoperative adhesion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichen planopilaris | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fear of eating | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder catheter replacement | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal stenosis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac perfusion defect | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Crossmatch | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor II mutation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood urea nitrogen/creatinine ratio decreased | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal retrolisthesis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging breast normal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal embolism | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid boil | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal wall mass | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocution | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute monocytic leukaemia | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periorbital inflammation | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle neoplasm | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heat therapy | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pigmentation lip | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural haemorrhage | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreal cells | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diffuse cutaneous mastocytosis | 0 | 0.052 | 0.059 | 0.954 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Omental necrosis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudocyst | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver transplant rejection | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperarousal | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glutamate dehydrogenase increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy gastrointestinal normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accessory muscle | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diastolic hypertension | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperparathyroidism primary | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular dystrophy congenital | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal mask airway insertion | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burns third degree | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B6 increased | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumoperitoneum | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary tract disorder | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebroplasty | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine abnormal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic vein thrombosis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site joint movement impairment | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonella bacteraemia | 0 | 0.052 | 0.059 | 0.954 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Piriformis syndrome | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular pseudohole | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic enzyme decreased | 0 | 0.052 | 0.06 | 0.954 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loose body in joint | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian cancer stage IV | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic granuloma | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve sheath haemorrhage | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microvascular coronary artery disease | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure difference of extremities | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electric shock sensation | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroperitoneal oedema | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal artery arteriosclerosis | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ototoxicity | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor XII level | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy small intestine normal | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hemidysaesthesia | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Analgesic therapy | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound evisceration | 0 | 0.052 | 0.06 | 0.954 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion site joint movement impairment | 0 | 0.052 | 0.06 | 0.954 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Victim of child abuse | 0 | 0.052 | 0.06 | 0.954 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatic dysfunction | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VII level increased | 0 | 0.052 | 0.059 | 0.954 | 2.781 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheterisation cardiac normal | 8 | 9.718 | 0.556 | 0.953 | 1.437 | 0.493 | 0.828 | 1.322 | 0.823 | 4.982 | 16.801
COVID19_PFIZER/BIONTECH | Abdominal neoplasm | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hernial eventration | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiotensin II increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sigmoidoscopy abnormal | 0 | 0.052 | 0.056 | 0.953 | 2.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound contamination | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intentional underdose | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain tumour operation | 0 | 0.052 | 0.058 | 0.953 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VIII level increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal mass | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site joint infection | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phimosis | 0 | 0.052 | 0.056 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood loss anaemia | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alloimmunisation | 0 | 0.052 | 0.056 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leptin level increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lack of injection site rotation | 0 | 0.052 | 0.056 | 0.953 | 2.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood arsenic increased | 0 | 0.052 | 0.055 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purpura neonatal | 0 | 0.052 | 0.057 | 0.953 | 2.789 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Confluent and reticulate papillomatosis | 0 | 0.052 | 0.056 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrosarcoma | 0 | 0.052 | 0.055 | 0.953 | 2.802 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal inflammation | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal mucosal necrosis | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Contraindication to medical treatment | 0 | 0.052 | 0.058 | 0.953 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated lung disease | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pregnenolone increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Temperature perception test decreased | 0 | 0.052 | 0.058 | 0.953 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasmin inhibitor | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephrocalcinosis | 0 | 0.052 | 0.057 | 0.953 | 2.794 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyper IgD syndrome | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal polyp | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vital dye staining cornea absent | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn error of lipid metabolism | 0 | 0.052 | 0.056 | 0.953 | 2.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anisochromia | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Melanaemia | 0 | 0.052 | 0.056 | 0.953 | 2.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-lymphocyte count abnormal | 0 | 0.052 | 0.057 | 0.953 | 2.789 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exocrine pancreatic function test normal | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jaundice acholuric | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac septal defect | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site wound | 0 | 0.052 | 0.056 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Telangiectasia congenital | 0 | 0.052 | 0.058 | 0.953 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parechovirus infection | 0 | 0.052 | 0.057 | 0.953 | 2.791 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary hyperaldosteronism | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Occupational therapy | 0 | 0.052 | 0.057 | 0.953 | 2.794 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart sounds normal | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterococcal sepsis | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mentally late developer | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrogen breath test | 0 | 0.052 | 0.055 | 0.953 | 2.802 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitogen stimulation test abnormal | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine uric acid decreased | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs positive haemolytic anaemia | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Citrobacter infection | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspiration tracheal normal | 0 | 0.052 | 0.056 | 0.953 | 2.799 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy rectum normal | 0 | 0.052 | 0.058 | 0.953 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal dilatation | 0 | 0.052 | 0.058 | 0.953 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cooling therapy | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte morphology | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperoxia | 0 | 0.052 | 0.056 | 0.953 | 2.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular failure | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dihydrotestosterone decreased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echoencephalogram abnormal | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anastomotic ulcer | 0 | 0.052 | 0.058 | 0.953 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal tube insertion | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porcelain gallbladder | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-cell receptor gene rearrangement test | 0 | 0.052 | 0.057 | 0.953 | 2.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary adrenocortical insufficiency | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Velo-cardio-facial syndrome | 0 | 0.052 | 0.057 | 0.953 | 2.795 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestine infection | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF polymorphonuclear cell count decreased | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphoblast count increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary thrombocytosis | 0 | 0.052 | 0.056 | 0.953 | 2.8 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasite urine test negative | 0 | 0.052 | 0.058 | 0.953 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchogram abnormal | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenalectomy | 0 | 0.052 | 0.057 | 0.953 | 2.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphoblast count | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrogastrogram | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombin-antithrombin III complex increased | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperadrenalism | 0 | 0.052 | 0.057 | 0.953 | 2.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrohepatorenal syndrome | 0 | 0.052 | 0.058 | 0.953 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal fissure | 0 | 0.052 | 0.057 | 0.953 | 2.794 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis echo viral | 0 | 0.052 | 0.058 | 0.953 | 2.789 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastoid effusion | 0 | 0.052 | 0.057 | 0.953 | 2.795 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenomegaly | 0 | 0.052 | 0.055 | 0.953 | 2.802 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin-like growth factor increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alveolar oxygen partial pressure decreased | 0 | 0.052 | 0.056 | 0.953 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site dermatitis | 0 | 0.052 | 0.055 | 0.953 | 2.803 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal transit time increased | 0 | 0.052 | 0.058 | 0.953 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic hypertrophy | 0 | 0.052 | 0.057 | 0.953 | 2.795 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drain of cerebral subdural space | 0 | 0.052 | 0.057 | 0.953 | 2.794 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PCO2 abnormal | 0 | 0.052 | 0.057 | 0.953 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia moraxella | 0 | 0.052 | 0.058 | 0.953 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic hypothermia | 0 | 0.052 | 0.056 | 0.953 | 2.801 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visceral congestion | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diverticulectomy | 0 | 0.052 | 0.057 | 0.953 | 2.794 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antemortem blood drug level | 0 | 0.052 | 0.058 | 0.953 | 2.784 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypersplenism | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvi-ureteric obstruction | 0 | 0.052 | 0.056 | 0.953 | 2.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Von Willebrand's factor multimers test | 0 | 0.052 | 0.057 | 0.953 | 2.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capnogram abnormal | 0 | 0.052 | 0.058 | 0.953 | 2.788 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver function test abnormal | 6 | 6.522 | 0.476 | 0.952 | 1.562 | 0.501 | 0.891 | 1.491 | 0.92 | 1.117 | 0.002
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging spinal normal | 7 | 7.648 | 0.507 | 0.952 | 1.51 | 0.517 | 0.891 | 1.454 | 0.915 | 0.739 | 0.382
COVID19_PFIZER/BIONTECH | Muscular weakness | 201 | 222.048 | 0.845 | 0.952 | 1.065 | 0.805 | 0.904 | 1.013 | 0.905 | 0.937 | 0.768
COVID19_PFIZER/BIONTECH | Amnesia | 19 | 25.706 | 0.633 | 0.952 | 1.326 | 0.523 | 0.751 | 1.053 | 0.739 | 0.932 | 0.034
COVID19_PFIZER/BIONTECH | Adenosine deaminase decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginitis gardnerella | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progesterone abnormal | 0 | 0.052 | 0.053 | 0.952 | 2.816 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatobiliary sphincterotomy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet-large cell ratio increased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberous sclerosis complex | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngitis bacterial | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal irritation | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Embolia cutis medicamentosa | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site cellulitis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skeletal muscle enzymes | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Septic embolus | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jaundice hepatocellular | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid lung | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal hydrocele | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal oedema | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid bleeding | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous stenosis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amino acid level abnormal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD8 lymphocytes abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystitis haemorrhagic | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lysozyme increased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system mass | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cell marker decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound decomposition | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic cancer | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian prolapse | 0 | 0.052 | 0.054 | 0.952 | 2.809 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Caecum operation | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid factor quantitative | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein B increased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine albumin/creatinine ratio | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint prosthesis user | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast neoplasm | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic leukaemia | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peak expiratory flow rate normal | 0 | 0.052 | 0.053 | 0.952 | 2.817 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbon dioxide combining power decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metanephrine urine | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung induration | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear lobe infection | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral calcification | 0 | 0.052 | 0.054 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasma viscosity abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperchromasia | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood calcitonin increased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic operation | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | IVth nerve paresis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood acid phosphatase | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoiditis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Residual urine volume increased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intraductal proliferative breast lesion | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermabrasion | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin blood present | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet function test | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cellulitis of male external genital organ | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schistosomiasis | 0 | 0.052 | 0.053 | 0.952 | 2.819 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purpura non-thrombocytopenic | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet adhesiveness | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deltaretrovirus test positive | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrospinal fluid reservoir placement | 0 | 0.052 | 0.055 | 0.952 | 2.807 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stoma site reaction | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-erythrocyte antibody negative | 0 | 0.052 | 0.055 | 0.952 | 2.807 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site movement impairment | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inguinal hernia, obstructive | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile haemangioma | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fungal sepsis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystatin C abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral ventricle collapse | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-cell lymphoma recurrent | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dandy-Walker syndrome | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrectomy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia cytomegaloviral | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vanillyl mandelic acid urine increased | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tick-borne fever | 0 | 0.052 | 0.054 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast reconstruction | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obsessive-compulsive personality disorder | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile size reduced | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ductal adenocarcinoma of pancreas | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemia postoperative | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sarcopenia | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholelithotomy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiogram peripheral abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pinguecula | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary immunodeficiency | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone cancer metastatic | 0 | 0.052 | 0.054 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Norepinephrine | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sickle cell disease | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine arsenic increased | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast milk substitute intolerance | 0 | 0.052 | 0.054 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin implant | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone abscess | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta-N-acetyl-D-glucosaminidase | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperoxaluria | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal adhesion lysis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dopamine transporter scintigraphy abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac index | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver scan | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair growth rate abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site laceration | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perthes disease | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood mercury normal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bence Jones protein urine present | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Escharotomy | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric bypass | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchopulmonary disease | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mini mental status examination normal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary alveolar haemorrhage | 0 | 0.052 | 0.055 | 0.952 | 2.804 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post concussion syndrome | 0 | 0.052 | 0.053 | 0.952 | 2.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | End stage AIDS | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Right hemisphere deficit syndrome | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhesus antibodies positive | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product sterility lacking | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypotonia neonatal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Staphylococcal osteomyelitis | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononuclear cell count | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic aspiration | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sitophobia | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premature ejaculation | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cavernous sinus thrombosis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B12 absorption test | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lower respiratory tract infection fungal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor XI level normal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac ventricular disorder | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic immune activation | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein B | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Investigation noncompliance | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaplastic lymphoma kinase gene mutation | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postsplenectomy syndrome | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast engorgement | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic vascular disorder | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell hypochromic morphology present | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal anuria | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspartate aminotransferase abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular graft complication | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine aluminium increased | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inhibiting antibodies positive | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal operation | 0 | 0.052 | 0.053 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genitourinary tract infection | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clot retraction | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem glioma | 0 | 0.052 | 0.053 | 0.952 | 2.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrophages decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutrophil/lymphocyte ratio increased | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inborn error of metabolism | 0 | 0.052 | 0.053 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug ineffective for unapproved indication | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin A decreased | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complications of transplanted heart | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iliac artery disease | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stoma site erythema | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrophage activation | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colon cancer metastatic | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal injury | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal light reflex test abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin D abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stiff leg syndrome | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine zinc | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid gland abscess | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperinsulinism | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Childhood asthma | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal operation | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head circumference | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor X level decreased | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic tic disorder | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system necrosis | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalocele repair | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant neoplasm progression | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precocious puberty | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paranasal sinus haemorrhage | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray therapy to joint | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesangioproliferative glomerulonephritis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis haemorrhagic | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site haematoma | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alveolar oxygen partial pressure increased | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrub typhus | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site swelling | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal septum disorder | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ergotherapy | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholangitis infective | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain empyema | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Excessive skin | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site discharge | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alanine aminotransferase abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intravascular haemolysis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peak nasal inspiratory flow abnormal | 0 | 0.052 | 0.053 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bleeding time abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site infection | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell scan | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory fatigue | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac output | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myocardial fibrosis | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapy partial responder | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic nephropathy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrotising ulcerative gingivostomatitis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Androgen deficiency | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval haemorrhage | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryptococcal cutaneous infection | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood thromboplastin increased | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phytotherapy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival follicles | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal gland cancer metastatic | 0 | 0.052 | 0.054 | 0.952 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Latent tuberculosis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chest tube removal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bronchus normal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothenar hammer syndrome | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal dilation procedure | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gardnerella test positive | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trigeminal palsy | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foot operation | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor IX level normal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site movement impairment | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oculocephalogyric reflex absent | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Double ureter | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary neoplasm | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic abscess | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophils urine | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal tuberculosis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ecouvillonage | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic dysplasia | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin C-peptide abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site telangiectasia | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue sarcoma | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal odour | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardio-respiratory arrest neonatal | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin discharge | 0 | 0.052 | 0.053 | 0.952 | 2.816 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peak expiratory flow rate abnormal | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaplastic large-cell lymphoma | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stool heavy metal positive | 0 | 0.052 | 0.055 | 0.952 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet anisocytosis | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign soft tissue neoplasm | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroglobulin present | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug physiologic incompatibility | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperchloraemia | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnesium deficiency | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site mass | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perichondritis | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood corticotrophin abnormal | 0 | 0.052 | 0.053 | 0.952 | 2.819 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dwarfism | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial wall hypertrophy | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet aggregation normal | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spermatic cord disorder | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urobilinogen faeces normal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular imaging | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudocellulitis | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic specific antigen decreased | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF glucose abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet morphology | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid haematoma | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neoplasm prostate | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital HIV infection | 0 | 0.052 | 0.054 | 0.952 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobinaemia | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast injury | 0 | 0.052 | 0.055 | 0.952 | 2.803 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue neoplasm | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung carcinoma cell type unspecified recurrent | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging abdominal normal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopic retrograde cholangiopancreatography abnormal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold exposure injury | 0 | 0.052 | 0.053 | 0.952 | 2.817 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inflammation scan | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrotal erythema | 0 | 0.052 | 0.055 | 0.952 | 2.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Elbow operation | 0 | 0.052 | 0.054 | 0.952 | 2.809 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal herpes | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid factor decreased | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated neuropathy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Candida pneumonia | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroglobulin absent | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated dermatitis | 0 | 0.052 | 0.055 | 0.952 | 2.803 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutrophil morphology normal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein A-I | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia cryptococcal | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Xanthogranuloma | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular detachment | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple system atrophy | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genetic counselling | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coxiella test positive | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QRS complex shortened | 0 | 0.052 | 0.054 | 0.952 | 2.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiospasm | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leucine aminopeptidase | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal operation | 0 | 0.052 | 0.054 | 0.952 | 2.812 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral artery occlusion | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal clotting factor | 0 | 0.052 | 0.055 | 0.952 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute lung injury | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint arthroplasty | 0 | 0.052 | 0.054 | 0.952 | 2.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premature rupture of membranes | 2 | 2.231 | 0.212 | 0.951 | 2.123 | 0.392 | 0.861 | 1.691 | 0.896 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Skin discolouration | 44 | 48.799 | 0.744 | 0.951 | 1.18 | 0.702 | 0.897 | 1.133 | 0.902 | 0.684 | 5.9
COVID19_PFIZER/BIONTECH | Tongue blistering | 3 | 3.398 | 0.405 | 0.951 | 1.682 | 0.422 | 0.86 | 1.601 | 0.883 | 1.748 | 0.303
COVID19_PFIZER/BIONTECH | Cardiac stress test abnormal | 1 | 1.36 | 0.304 | 0.951 | 1.889 | 0.33 | 0.806 | 1.711 | 0.736 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Vth nerve injury | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traumatic lumbar puncture | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudopapilloedema | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basosquamous carcinoma | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fistulogram | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laboratory test interference | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan spleen | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemia of pregnancy | 0 | 0.052 | 0.052 | 0.951 | 2.825 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chest wall abscess | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alien limb syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood prolactin decreased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy pharynx abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.837 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes sepsis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerular vascular disorder | 0 | 0.052 | 0.051 | 0.951 | 2.832 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye opacity | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acoustic neuroma | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreous opacities | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autotransfusion | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site reaction | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anorectal swelling | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic transformation stroke | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reactive attachment disorder of infancy or early childhood | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleurisy viral | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcoholism | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound uterus | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic coma | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital thrombocyte disorder | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy anus abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood insulin normal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella keratitis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peptostreptococcus test positive | 0 | 0.052 | 0.05 | 0.951 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratitis viral | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4 lymphocytes abnormal | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | VIIth nerve injury | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticaria contact | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhegmatogenous retinal detachment | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proctoscopy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian cyst torsion | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyoderma | 0 | 0.052 | 0.05 | 0.951 | 2.837 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic haematoma | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reaction to colouring | 0 | 0.052 | 0.051 | 0.951 | 2.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet aggregation abnormal | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amplified musculoskeletal pain syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon sheath incision | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product quality control issue | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ACTH stimulation test | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthognathic surgery | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subcutaneous biopsy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abortion late | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteogenesis imperfecta | 0 | 0.052 | 0.051 | 0.951 | 2.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuro-ophthalmological test | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic granulomatous disease | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervicitis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Substance abuse | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Follicular mucinosis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic enzymes decreased | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infected bite | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitogen stimulation test | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corticobasal degeneration | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal mucosa biopsy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osmophobia | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular retrobulbar haemorrhage | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 microglobulin | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestrogen therapy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multinucleate cell angiohistiocytoma | 0 | 0.052 | 0.05 | 0.951 | 2.837 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal cancer metastatic | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin C-peptide increased | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Larynx irritation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcoholic liver disease | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site pain | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normal pressure hydrocephalus | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspiration bursa abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infection reactivation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intrinsic factor antibody | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glossopharyngeal nerve disorder | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine injury | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Removal of foreign body from rectum | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orbital apex syndrome | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Agglutination test | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal hypertension | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy lung normal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular pigmentation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial catheterisation normal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood growth hormone decreased | 0 | 0.052 | 0.051 | 0.951 | 2.831 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF white blood cell count decreased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign neoplasm | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amblyopia strabismic | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal sympathetic nerve ablation | 0 | 0.052 | 0.05 | 0.951 | 2.837 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal scan abnormal | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cancer pain | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine cannabinoids increased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin-like growth factor decreased | 0 | 0.052 | 0.051 | 0.951 | 2.831 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ophthalmic vein thrombosis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hostility | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shunt malfunction | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinoschisis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foot fracture | 0 | 0.1 | 0.16 | 0.951 | 2.285 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transplantation complication | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroprosthesis implantation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Middle ear disorder | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Satoyoshi syndrome | 0 | 0.052 | 0.051 | 0.951 | 2.831 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral spasm | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meigs' syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Germ cell neoplasm | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromuscular toxicity | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leiomyosarcoma | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor VIII antibody test | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amnestic disorder | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes simplex meningitis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestriol normal | 0 | 0.052 | 0.052 | 0.951 | 2.827 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal suppression | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inhibin B | 0 | 0.052 | 0.052 | 0.951 | 2.827 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enzyme activity normal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral artery thrombosis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue atrophy | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood product transfusion dependent | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Astringent therapy | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | C1 esterase inhibitor test normal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system stimulation | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal operation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute zonal occult outer retinopathy | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porphyrins urine | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periorbital haematoma | 0 | 0.052 | 0.05 | 0.951 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic ulcer | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ulnar tunnel syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trabeculectomy | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal cancer | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail picking | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperamylasaemia | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric perforation | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal graft infection | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypotony of eye | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Short stature | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary function challenge test | 0 | 0.052 | 0.052 | 0.951 | 2.825 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulse pressure increased | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital ureterovesical junction anomaly | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total complement activity increased | 0 | 0.052 | 0.051 | 0.951 | 2.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal abscess | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital tract inflammation | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hernia pain | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Provisional tic disorder | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder operation | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethritis noninfective | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelosuppression | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy vocal cord abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine potassium increased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron metabolism disorder | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate cancer stage IV | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Compulsive lip biting | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary cyst | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine operation | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte adoptive therapy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Duodenogastric reflux | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Canthoplasty | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertrophic anal papilla | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune complex level increased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhoids thrombosed | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychogenic respiratory distress | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutralising antibodies negative | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site erythema | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aicardi's syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | JC polyomavirus test | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to spine | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder rupture | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Buttock injury | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macroglossia | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood triglycerides abnormal | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic infection | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy tonsil | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radiotherapy to breast | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal stroke | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Right atrial enlargement | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Moyamoya disease | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lateral medullary syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal meningeal cyst | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculous pleurisy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon calcification | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cranial nerve infection | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreous degeneration | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Familial amyotrophic lateral sclerosis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial drainage test abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin C-peptide normal | 0 | 0.052 | 0.051 | 0.951 | 2.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell analysis abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratitis interstitial | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B precursor type acute leukaemia | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site hypoaesthesia | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Natural killer cell activity normal | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brow ptosis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix injury | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level below therapeutic | 0 | 0.052 | 0.051 | 0.951 | 2.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal failure neonatal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour pain | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thoracic outlet syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral keratouveitis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fulguration | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube disorder | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate examination normal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival erosion | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial tracheitis | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Humidity intolerance | 0 | 0.052 | 0.051 | 0.951 | 2.834 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant renal hypertension | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreoretinal traction syndrome | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Functional endoscopic sinus surgery | 0 | 0.052 | 0.05 | 0.951 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosal roughening | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy large bowel abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctivochalasis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pearly penile papules | 0 | 0.052 | 0.051 | 0.951 | 2.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperkinetic heart syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflux nephropathy | 0 | 0.052 | 0.05 | 0.951 | 2.84 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular pseudoaneurysm | 0 | 0.052 | 0.05 | 0.951 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B1 decreased | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blepharochalasis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical diathermy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital syphilitic osteochondritis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Frontal lobe epilepsy | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product commingling | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human anaplasmosis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased gait velocity | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy urethra normal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Klebsiella sepsis | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypobarism | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood growth hormone abnormal | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster meningomyelitis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram pacemaker spike | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ptosis repair | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Needle fatigue | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunosuppressant drug level increased | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single functional kidney | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superficial injury of eye | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single component of a two-component product administered | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post-traumatic pain | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intracranial hypotension | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complications of transplanted lung | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute haemorrhagic conjunctivitis | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sterile pyuria | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy foetal abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic discomfort | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephrectomy | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Septic rash | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hysterosalpingogram | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accidental exposure to product by child | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transplant | 0 | 0.052 | 0.051 | 0.951 | 2.832 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutrophil hypersegmented morphology present | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Generalised onset non-motor seizure | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interferon gamma normal | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leser-Trelat sign | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumboperitoneal shunt | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poverty of speech | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trigeminal nerve paresis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Culture cervix | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiogram peripheral normal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaplastic astrocytoma | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Embedded device | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral vasculitis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coronavirus test | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atypical mycobacterium test positive | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postoperative wound complication | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Symphysiolysis | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Latent tetany | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Instillation site vesicles | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute promyelocytic leukaemia | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor VII deficiency | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Argon plasma coagulation | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product contamination chemical | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract stoma complication | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testis cancer | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal lesion | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal sleep-related event | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal artery embolism | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incision site pruritus | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord operation | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weber tuning fork test abnormal | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypergammaglobulinaemia benign monoclonal | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal aneurysm | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Left-handedness | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mineral deficiency | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic pustular folliculitis | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervicogenic vertigo | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSWS syndrome | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure keratitis | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Marburg's variant multiple sclerosis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bladder normal | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amputation stump pain | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract discomfort | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capillaritis | 0 | 0.052 | 0.052 | 0.951 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapy naive | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer metastatic | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Painful erection | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervicogenic headache | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear buccal | 0 | 0.052 | 0.05 | 0.951 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cirrhosis alcoholic | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder obstruction | 0 | 0.052 | 0.05 | 0.951 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy vagina abnormal | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratopathy | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasma cell mastitis | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve operation | 0 | 0.052 | 0.051 | 0.951 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrotal ulcer | 0 | 0.052 | 0.05 | 0.951 | 2.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device difficult to use | 0 | 0.052 | 0.052 | 0.951 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerular filtration rate | 9 | 10.269 | 0.589 | 0.95 | 1.381 | 0.528 | 0.867 | 1.359 | 0.876 | 2.665 | 6.698
COVID19_PFIZER/BIONTECH | Immunodeficiency | 4 | 5.71 | 0.399 | 0.95 | 1.692 | 0.391 | 0.754 | 1.344 | 0.701 | 0.564 | 0.897
COVID19_PFIZER/BIONTECH | Acid base balance | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large granular lymphocytosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystitis escherichia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pathological doubt | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Murphy's sign test | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electric shock | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal cord insertion | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Septic arthritis streptococcal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Janus kinase 2 mutation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | African trypanosomiasis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decompression sickness | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesenteric vascular insufficiency | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve root injury cervical | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cortisol abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parathyroid hormone-related protein | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premature ageing | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix operation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dialysis efficacy test | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytomegalovirus hepatitis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peristalsis visible | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Montreal cognitive assessment | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total lung capacity | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thiopurine methyltransferase decreased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute interstitial pneumonitis | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood magnesium abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal stoma output increased | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glycocholic acid increased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serum serotonin decreased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroglobulin decreased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stenotrophomonas sepsis | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gardnerella infection | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign ovarian tumour | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Surfactant protein increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Preictal state | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic fluid volume increased | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour haemorrhage | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acanthosis nigricans | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metabolic surgery | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperandrogenism | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermogram abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pilonidal cyst | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningococcal carditis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lip infection | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Base excess positive | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Noninfective myringitis | 0 | 0.052 | 0.049 | 0.95 | 2.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy with contraceptive device | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis chemical | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intra-cerebral aneurysm operation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enteropathic spondylitis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain neoplasm malignant | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaphylactoid syndrome of pregnancy | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ruptured ectopic pregnancy | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porphyria non-acute | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholangiogram normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal atrophy | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval cancer stage 0 | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood galactose | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primitive reflex test | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective IgG subclass deficiency | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder catheter temporary | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord ischaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucocutaneous rash | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injury to brachial plexus due to birth trauma | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hormone refractory breast cancer | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Double hit lymphoma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convulsive threshold lowered | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial ligation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine dilation and evacuation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4/CD8 ratio increased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hereditary disorder | 0 | 0.052 | 0.049 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve destruction | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venoocclusive disease | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic mass | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary cerebellar degeneration | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug withdrawal convulsions | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy large bowel | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colonic lavage | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product substitution error | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tissue discolouration | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adductor vocal cord weakness | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratoconus | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E antibody positive | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema nummular | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disability assessment scale score decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brow presentation | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal biophysical profile score abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laparoscopy abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accident at work | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic adenoma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | American trypanosomiasis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine phosphorus increased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal hypomotility | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | JC virus CSF test positive | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Family stress | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-IA2 antibody | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ischaemic contracture of the left ventricle | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail matrix biopsy | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic cancer stage IV | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy pharynx normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngotracheal oedema | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal exploration | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis chronic | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autosomal chromosome anomaly | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthrolysis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortogram abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal asphyxia | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial operation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor VIII inhibition | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vital capacity | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural vomiting | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital bladder anomaly | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein A-I normal | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic cancer metastatic | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary casts present | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast discharge infected | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single photon emission computerised tomogram | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pterygium | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphatic obstruction | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retention cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychological trauma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parkinsonian gait | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inspiratory capacity normal | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrooesophageal sphincter insufficiency | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal ischaemia | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metaphyseal dysplasia | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genotype drug resistance test | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor XIII deficiency | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dilatation ventricular | 0 | 0.052 | 0.049 | 0.95 | 2.841 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choroid plexus papilloma | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis proliferative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Forced expiratory volume increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculosis of central nervous system | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nodular fasciitis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem stroke | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-thrombin antibody | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-neuronal antibody positive | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dexamethasone suppression test | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Caffeine allergy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Placental insufficiency | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteric dilatation | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reynold's syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasmodium ovale infection | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemofiltration | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bowen's disease | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vision correction operation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Duodenal ulcer | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital hiatus hernia | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ciliary body disorder | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Air embolism | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensory integration therapy | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oedematous kidney | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical incompetence | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound dehiscence | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis staphylococcal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory gas exchange disorder | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchial aspiration procedure | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood chromium decreased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy intestine | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral pain | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Huntington's disease | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mast cell degranulation present | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inspiratory capacity | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incorrect dosage administered | 0 | 0.052 | 0.049 | 0.95 | 2.841 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant respiratory tract neoplasm | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypercreatinaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product selection error | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD8 lymphocyte percentage decreased | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Low cardiac output syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal dysplasia | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Median nerve injury | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carcinogenicity | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy tendon abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocochleogram | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female sex hormone level | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suicide of relative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Silent thyroiditis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyloromyotomy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet dysfunction | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema toxicum neonatorum | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous occlusion | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous ligation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyogenic granuloma | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunoreactive trypsinogen increased | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-zinc transporter 8 antibody positive | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood alkaline phosphatase abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Norepinephrine increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxin binding globulin increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Resting tremor | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paranasal sinus inflammation | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Promyelocyte count decreased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Manipulation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kidney small | 0 | 0.052 | 0.048 | 0.95 | 2.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brief psychotic disorder with marked stressors | 0 | 0.052 | 0.048 | 0.95 | 2.852 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone lesion | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Homosexuality | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine mass | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postictal psychosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oligoarthritis | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lasegue's test negative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body in respiratory tract | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dennie-Morgan fold | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal wall neoplasm malignant | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic pouch procedure | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | International normalised ratio fluctuation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phospholipidosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coital bleeding | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone deformity | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via body fluid | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iatrogenic infection | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device alarm issue | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Collagen-vascular disease | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deformity of orbit | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prosthesis user | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectocele | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical device implantation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid hormones decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine uptake | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cell marker increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal perforation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Forearm fracture | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Duodenal ulcer perforation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin S increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suspiciousness | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha-2 macroglobulin increased | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acne varioliformis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure to contaminated air | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth socket haemorrhage | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary artery atresia | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine hypertonus | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell elliptocytes present | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrobiosis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iris neovascularisation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Evacuation of retained products of conception | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breathing-related sleep disorder | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anoxia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superior mesenteric artery syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular ischaemic syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Turbinectomy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traction | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal ultrasound normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour rupture | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product dosage form confusion | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-consummation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspergillus test positive | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic elongation | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperchylomicronaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha tumour necrosis factor | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal congestion | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radiation pneumonitis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal cancer | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site pallor | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal inflammation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestine polyp | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Goodpasture's syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Karyotype analysis abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Type IIa hyperlipidaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle hypoxia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oligodendroglioma | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonic plague | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hookworm infection | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apgar score | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CHARGE syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain lobectomy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoosmolar state | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal megacystis | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neoplasm progression | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensory ganglionitis | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interferon gamma release assay positive | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertensive cardiomegaly | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enlarged cerebral perivascular spaces | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal intestinal perforation | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microangiopathy | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stasis dermatitis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Residual urine volume | 0 | 0.052 | 0.048 | 0.95 | 2.849 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myeloblast percentage | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoviral meningitis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral allergy syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestinal ulcer haemorrhage | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intra-uterine contraceptive device insertion | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Animal scratch | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bush-Francis catatonia rating scale | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Teratoma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal surgery | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothyroidic goitre | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram U wave present | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal metaplasia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophil cationic protein increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervicitis human papilloma virus | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Von Willebrand's disease | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesenteric artery aneurysm | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myxoedema | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Duodenal polyp | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Artificial rupture of membranes | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kidney malrotation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heterosexuality | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cellulitis streptococcal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral ataxia | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porphyria screen | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Essential thrombocythaemia | 0 | 0.052 | 0.049 | 0.95 | 2.847 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital laryngeal stridor | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipohypertrophy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacille Calmette-Guerin scar reactivation | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lobular breast carcinoma in situ | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transcranial magnetic stimulation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perineurial cyst | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Counterfeit product administered | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukostasis syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic sinusitis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphadenitis viral | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superior vena cava stenosis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Engraft failure | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonella sepsis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sternal injury | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal thickening | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron binding capacity unsaturated decreased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerular filtration rate abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital cytomegalovirus infection | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal pap smear abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine malposition | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macula thickness measurement | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product contamination with body fluid | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephrological examination | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF mononuclear cell count decreased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retrograde ejaculation | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin urine normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipoprotein (a) abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin C increased | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | SeHCAT test | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal hypertrophy | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peroneal nerve injury | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal mucosal atrophy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Charles Bonnet syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone formation increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroborreliosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma recurrent | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal mucosal hypertrophy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Milk-alkali syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ichthyosis | 0 | 0.052 | 0.049 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous bruit | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trisomy 12 | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precursor T-lymphoblastic lymphoma/leukaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periphlebitis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertensive nephropathy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histoplasmosis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose tolerance increased | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blindness congenital | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Artificial crown procedure | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral toxoplasmosis | 0 | 0.052 | 0.05 | 0.95 | 2.841 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood oestrogen abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anamnestic reaction | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic valve disease | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis herpetiformis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic fluid volume | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital genital malformation | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choluria | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ballismus | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | AIDS related complication | 0 | 0.052 | 0.05 | 0.95 | 2.841 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutrophil function disorder | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Methaemoglobinaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug-disease interaction | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermoid cyst | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wernicke-Korsakoff syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflexology | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise electrocardiogram abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood chloride abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute graft versus host disease in skin | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound bladder abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein C deficiency | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parathyroid scan normal | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiopathic neuropathy | 0 | 0.052 | 0.048 | 0.95 | 2.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mutagenic effect | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacillus infection | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antral follicle count | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-JC virus antibody index | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenergic syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail pitting | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endometrial cancer | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Altered pitch perception | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile output increased | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatic heart disease | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy tongue | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal uterine bleeding | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyneuropathy in malignant disease | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Expanded disability status scale | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-24-hour sleep-wake disorder | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium double contrast abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Megakaryocytes abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitochondrial toxicity | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF neutrophil count positive | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Temperature perception test abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progesterone increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrobiosis lipoidica diabeticorum | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site deformation | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulomatous lymphadenitis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral haemorrhage foetal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sucrose intolerance | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scaphoid abdomen | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jugular vein thrombosis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasite tissue specimen test negative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial fluid cell count | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweat gland infection | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paranasal sinus mucosal hypertrophy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucocutaneous haemorrhage | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythroblast count normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interferon alpha level | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infective exacerbation of chronic obstructive airways disease | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic exenteration | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via partner | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ebola disease | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convalescent | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural headache | 0 | 0.052 | 0.05 | 0.95 | 2.84 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transposition of the great vessels | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nitrituria | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood insulin decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis cytomegalovirus | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine haematoma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin ulcer haemorrhage | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phakomatosis | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | H2N2 influenza | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal movement disorder | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colour blindness acquired | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ankyloglossia acquired | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patella fracture | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Irlen syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital renal disorder | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-saccharomyces cerevisiae antibody | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine osmolarity decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver scan abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female genital tract fistula | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acrodermatitis enteropathica | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Portal shunt procedure | 0 | 0.052 | 0.048 | 0.95 | 2.852 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palisaded neutrophilic granulomatous dermatitis | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Detrusor sphincter dyssynergia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral injury | 0 | 0.052 | 0.05 | 0.95 | 2.84 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermoanaesthesia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sepsis syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail discomfort | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell agglutination present | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumefactive multiple sclerosis | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opticokinetic nystagmus tests normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product effect delayed | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time ratio increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echinococciasis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystic fibrosis related diabetes | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impaired fasting glucose | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder hydrodistension | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic allograft nephropathy | 0 | 0.052 | 0.049 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Boredom | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obstructive defaecation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to central nervous system | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipectomy | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal ulcer | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deep brain stimulation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutis laxa | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy anus normal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix cautery | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononuclear cell count increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy intestine normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan bone marrow | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normochromic anaemia | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exertional headache | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan adrenal gland normal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian germ cell tumour | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired syringomyelia | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Recall phenomenon | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phenylalanine screen positive | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carotid artery disease | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Umbilical cord around neck | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin receptor assay | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infective exacerbation of bronchiectasis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood viscosity increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic injury | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile duct stent insertion | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural hypotension | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antisynthetase syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yersinia infection | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Micrognathia | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Guthrie test | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial vulvovaginitis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-HLA antibody test positive | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-glycyl-tRNA synthetase antibody negative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic discs blurred | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallot's tetralogy | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin distribution width increased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal scar | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic infection | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retirement | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Physical breast examination | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-insulin antibody | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Syndactyly | 0 | 0.052 | 0.049 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian granulosa cell tumour | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Maternal distress during labour | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchial irritation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HTLV-2 test | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular autonomic function test abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oxygen consumption decreased | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Change in sustained attention | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis enteropathic | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatitis mumps | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lenticular opacities | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatobiliary disease | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antidiuretic hormone abnormality | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic mycosis | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post streptococcal glomerulonephritis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve root injury thoracic | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal infection | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy placenta | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Umbilical cord prolapse | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trousseau's sign | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic ovarian cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatochalasis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon laxity | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile acid malabsorption | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reye's syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periorbital disorder | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device infusion issue | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site atrophy | 0 | 0.052 | 0.049 | 0.95 | 2.843 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte morphology normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulocytes maturation arrest | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid stimulating immunoglobulin increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prophylaxis against Rh isoimmunisation | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nodal osteoarthritis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular stent insertion | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal erosion | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine repair | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product administration interrupted | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Omenn syndrome | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis allergic | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic viral infection | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Punctate basophilia | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroma | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Manifest refraction normal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gradenigo's syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic retinopathy | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleral oedema | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthostatic heart rate response increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E antigen negative | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Delayed puberty | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site abscess | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine sodium decreased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal tubular injury | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell vacuolisation | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric pH increased | 0 | 0.052 | 0.049 | 0.95 | 2.843 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital cerebellar agenesis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone decalcification | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Strongyloidiasis | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spondyloarthropathy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine polyp | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chromosome banding normal | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine potassium normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intracardiac mass | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurotic disorder of childhood | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stoma care | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhesus antigen negative | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor personal hygiene | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microencephaly | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flavivirus test | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Compulsions | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sinobronchitis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophagogastric fundoplasty | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesenteric cyst | 0 | 0.052 | 0.049 | 0.95 | 2.841 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema impetiginous | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acrophobia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lead abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermometry normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical laser therapy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CDKL5 deficiency disorder | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ADAMTS13 inhibitor screen assay | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal hypoplasia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac arrest neonatal | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF monocyte count increased | 0 | 0.058 | 0.061 | 0.95 | 2.756 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal neoplasm | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post infection glomerulonephritis | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iris injury | 0 | 0.052 | 0.049 | 0.95 | 2.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extraskeletal ossification | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrovascular arteriovenous malformation | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adnexa uteri cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal transit time abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VIII level | 0 | 0.052 | 0.049 | 0.95 | 2.847 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid vasculitis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural dizziness | 0 | 0.052 | 0.05 | 0.95 | 2.84 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mean platelet volume abnormal | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patient dissatisfaction with device | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvitis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renin increased | 0 | 0.052 | 0.048 | 0.95 | 2.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site nerve damage | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve operation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell analysis abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood thromboplastin abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Needle biopsy site unspecified normal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paroxysmal extreme pain disorder | 0 | 0.052 | 0.048 | 0.95 | 2.852 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HTLV-1 test | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autophobia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Relapsing multiple sclerosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein amniotic fluid normal | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine abscess | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aldolase | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumbosacral plexus lesion | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tenotomy | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intervertebral disc displacement | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal neoplasm | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholangiogram | 0 | 0.052 | 0.049 | 0.95 | 2.847 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suicide threat | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal malformation | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | End-tidal CO2 | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Camptodactyly acquired | 0 | 0.052 | 0.048 | 0.95 | 2.855 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alveolar proteinosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paracentesis ear | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iodine uptake increased | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intrauterine infection | 0 | 0.052 | 0.048 | 0.95 | 2.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yersinia test | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Snapping hip syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Performance fear | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis herpes | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac pharmacologic stress test | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal papilloma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaesthetic complication | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue atrophy | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suture related complication | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical observation normal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mediastinal mass | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Long QT syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral congestion | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exchange blood transfusion | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dumping syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site thrombosis | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperlactacidaemia | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal stromal tumour | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal calprotectin decreased | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary function challenge test normal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B2 | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kleihauer-Betke test positive | 0 | 0.052 | 0.049 | 0.95 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Forced vital capacity normal | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paraneoplastic neurological syndrome | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine chloride increased | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular access complication | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product closure removal difficult | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival cyst | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dilated pores | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray with contrast lower gastrointestinal tract normal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site pallor | 0 | 0.052 | 0.049 | 0.95 | 2.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein albumin ratio abnormal | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor C2 | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone debridement | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Analgesic drug level increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vena cava thrombosis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Placenta praevia haemorrhage | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tensilon test normal | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatostatin receptor scan abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anterior chamber fibrin | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue neoplasm malignant stage unspecified | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypopyon | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Contact lens intolerance | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood 1,25-dihydroxycholecalciferol decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | BK polyomavirus test negative | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perseveration | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female orgasmic disorder | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy lip abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutropenic sepsis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulinoma | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deafness congenital | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Automatism epileptic | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobinaemia | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interferon alpha level decreased | 0 | 0.052 | 0.048 | 0.95 | 2.85 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Verbigeration | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venolymphatic malformation | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HTLV test | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract procedural complication | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Free thyroxine index increased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine aluminium | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal necrosis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiopathic partial epilepsy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryopyrin associated periodic syndrome | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival disorder | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac output decreased | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post-traumatic epilepsy | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poisoning deliberate | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukoplakia oral | 0 | 0.052 | 0.047 | 0.95 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal transit time | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colour vision tests abnormal red-green | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Truncus coeliacus thrombosis | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyomavirus-associated nephropathy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gitelman's syndrome | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cleft lip and palate | 0 | 0.052 | 0.049 | 0.95 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective abortion | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heparin-induced thrombocytopenia test positive | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal diameter increased | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis california | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair injury | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebral artery hypoplasia | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelocyte percentage decreased | 0 | 0.052 | 0.047 | 0.95 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic erosive gastritis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital neoplasm malignant female | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated encephalitis | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin electrophoresis | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian adenoma | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Listeria test positive | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ectopic kidney | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired Von Willebrand's disease | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urogenital infection fungal | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract pain | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell hyperchromic morphology present | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Naturopathy | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter culture positive | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha-1 anti-trypsin increased | 0 | 0.052 | 0.047 | 0.95 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal wall cyst | 0 | 0.052 | 0.049 | 0.95 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal respiratory depression | 0 | 0.052 | 0.048 | 0.95 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | VIIIth nerve lesion | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bronchus abnormal | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital teratoma | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dislocation of vertebra | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine calcium/creatinine ratio | 0 | 0.052 | 0.048 | 0.95 | 2.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antipsychotic drug level decreased | 0 | 0.052 | 0.049 | 0.95 | 2.847 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tangentiality | 0 | 0.052 | 0.048 | 0.95 | 2.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital and neonatal arrhythmias (SMQ) [broad] | 1 | 1.902 | 0.105 | 0.949 | 2.498 | 0.295 | 0.724 | 1.54 | 0.526 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Vaccination site anaesthesia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Removal of foreign body from nose | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disorder of orbit | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Friedreich's ataxia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stress echocardiogram abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal examination normal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensory level | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Implant site infection | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Implant site swelling | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal cortical necrosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anomalous pulmonary venous connection | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis D RNA negative | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythropenia | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal vein thrombosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metatarsalgia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diaphragm muscle weakness | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug resistance | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glaucoma traumatic | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gamma-glutamyltransferase abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal mesothelial hyperplasia | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perinatal brain damage | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aluminium abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palmoplantar keratoderma | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orchidectomy | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb fracture | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Helminthic infection | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired tracheo-oesophageal fistula | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal anastomosis | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product intolerance | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bleeding time normal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eustachian tube patulous | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival suffusion | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix cancer metastatic | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sympathicotonia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seroconversion test positive | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neovascularisation | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Natural killer T cell count | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung squamous cell carcinoma stage IV | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-cell lymphoma | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypereosinophilic syndrome | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glossopharyngeal nerve paralysis | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic foetopathy | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute graft versus host disease in intestine | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foster care | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiopulmonary exercise test abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hairy cell leukaemia | 0 | 0.052 | 0.047 | 0.949 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shigella test positive | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar atrophy | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic cyst | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural site reaction | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poliovirus test | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Missed labour | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parotid abscess | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypofibrinogenaemia | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis chronic active | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial parotitis | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pasteurella test positive | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paradoxical drug reaction | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endometrial disorder | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amoebic dysentery | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy spinal cord abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteric obstruction | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patent ductus arteriosus repair | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperthermia therapy | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atypical mycobacterium pericarditis | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prolonged rupture of membranes | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion site haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal malposition | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human polyomavirus infection | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal valve collapse | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paraesthesia mucosal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinogram normal | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging hepatobiliary abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myocarditis bacterial | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxin binding globulin | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear infection staphylococcal | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrocystic breast disease | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin adhesion | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal abscess | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Unemployment | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy small intestine normal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chorioretinal scar | 0 | 0.052 | 0.046 | 0.949 | 2.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Right aortic arch | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Early onset familial Alzheimer's disease | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual brightness | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurosyphilis | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lewis-Sumner syndrome | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic ketosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Axial spondyloarthritis | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site extravasation | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serum procollagen type III N-terminal propeptide | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal discomfort | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate disorder | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burkholderia test positive | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atelectasis neonatal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Right ventricular enlargement | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurologic somatic symptom disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure orthostatic decreased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimicrobial susceptibility test intermediate | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urea renal clearance | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD25 antigen positive | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shunt occlusion | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal hypotension | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medial tibial stress syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bladder | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intelligence test | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal calprotectin abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug withdrawal headache | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otitis media chronic | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cellulitis | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prophylaxis against HIV infection | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic disorder | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute post asthmatic amyotrophy | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemoid reaction | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hallucination, tactile | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lupus enteritis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine albumin/creatinine ratio normal | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nicotinamide | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female sex hormone level abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epidermoid cyst excision | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital pulmonary valve disorder | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vessel puncture site haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sinoscopy | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid ptosis congenital | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial stent insertion | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plague | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral arterial occlusive disease | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microangiopathic haemolytic anaemia | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | External hydrocephalus | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy pericardium abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute graft versus host disease in liver | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix enlargement | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Constricted affect | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flail chest | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tandem gait test normal | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epileptic aura | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brown-Sequard syndrome | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perineal ulceration | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral discharge | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Locomotive syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Graft versus host disease in skin | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase BB | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Noctiphobia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertrophic scar | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudobulbar palsy | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jugular vein distension | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fulminant type 1 diabetes mellitus | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign lung neoplasm | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Argininosuccinate lyase deficiency | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 2 globulin increased | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trendelenburg position | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymol turbidity test | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial rupture | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant neoplasm of unknown primary site | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestinal ulcer | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infective tenosynovitis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foot and mouth disease | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glossoptosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orbital infection | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute oesophageal mucosal lesion | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic leukoencephalopathy | 0 | 0.052 | 0.046 | 0.949 | 2.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rickettsiosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transillumination | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteric stenosis | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric mucosa erythema | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oculomotor study normal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononucleosis syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Micropenis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasma cells present | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Implant site discolouration | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site discharge | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethritis gonococcal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreas infection | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin S normal | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube cancer | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine dehiscence | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical device site joint infection | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large cell lung cancer | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune enteropathy | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutaneous sarcoidosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tear break up time test | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal function test normal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prolapse | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin A2 | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal damage | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal shock | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericarditis meningococcal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lasegue's test | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocardial fibrosis | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device inappropriate shock delivery | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone giant cell tumour | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lithotripsy | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Speech rehabilitation | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal biophysical profile score normal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Elective surgery | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune colitis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intra-abdominal haematoma | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cross sensitivity reaction | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Septum pellucidum agenesis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aldolase decreased | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue tie operation | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Giardia test positive | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clumsy child syndrome | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic recurrent multifocal osteomyelitis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal wall disorder | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uvulitis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site phlebitis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemia neonatal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blastocystis infection | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin A normal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound ovary abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product barcode issue | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Water deprivation test | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Treponema test false positive | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product effect increased | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy to chemicals | 0 | 0.062 | 0.067 | 0.949 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lentigo | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine urine decreased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ABO incompatibility | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bipolar II disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestradiol abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF measles antibody positive | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal drusen | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paracentesis eye normal | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood acid phosphatase decreased | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile septic granulomatosis | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lactate dehydrogenase abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pituitary enlargement | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis tuberculous | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VII level | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alice in wonderland syndrome | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalocele | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abortion spontaneous incomplete | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteral disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Murphy's sign positive | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein amniotic fluid increased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salivary duct inflammation | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burnout syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary tract infection fungal | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acid-base balance disorder mixed | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lysinuric protein intolerance | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival oedema | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Severe acute respiratory syndrome | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enanthema | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysplastic naevus | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood beta-D-glucan increased | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chordee | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy vagina normal | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Saliva analysis normal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phenylalanine screen | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis post transfusion | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor V Leiden mutation | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inferior vena cava stenosis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatopulmonary syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ebstein's anomaly | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs indirect test negative | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal oedema | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin K deficiency | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine infection | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine calcium | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opportunistic infection | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Partner stress | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Menstrual cycle management | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival erosion | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carotid aneurysm rupture | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrogen breath test abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | End-tidal CO2 increased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous pressure jugular increased | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine inversion | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Instillation site reaction | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Influenza C virus test | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Marcus Gunn syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin A deficiency | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatofibrosarcoma protuberans | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian dysplasia | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrospinal fluid drainage | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacillus bacteraemia | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood beryllium increased | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arrhythmia neonatal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye muscle operation | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | DiGeorge's syndrome | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Young's syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory depth decreased | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reactive gastropathy | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Latent syphilis | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kounis syndrome | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Euthyroid sick syndrome | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Xanthoma | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perineal erythema | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kluver-Bucy syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carcinoid tumour | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progressive relapsing multiple sclerosis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbohydrate deficient transferrin test | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-IA2 antibody negative | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infected cyst | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to kidney | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung neoplasm surgery | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensory level normal | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nikolsky's sign | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device power source issue | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sulcus vocalis | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal rupture | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brucellosis | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium swallow abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol use disorder | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tattoo | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural rub | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | High risk sexual behaviour | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periodic limb movement disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal hypertrophy | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess of salivary gland | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholera | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MM normal | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood catecholamines normal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrotal disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail pigmentation | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluorescent in situ hybridisation negative | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radical prostatectomy | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iodine uptake abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aorta hypoplasia | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucosal pigmentation | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimitochondrial antibody positive | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema vaccinatum | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue pigmentation | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal injury | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palpatory finding abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exomphalos | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor IX level increased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site pain | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anotia | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumbar hernia | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bile culture positive | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypopituitarism | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mini mental status examination abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histamine normal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alveolar rhabdomyosarcoma | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Taciturnity | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postural tremor | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteral stent insertion | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Moraxella test positive | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enzyme activity assay | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF myelin basic protein abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burn oesophageal | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | BK virus infection | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aplasia cutis congenita | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericarditis rheumatic | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal examination abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac malposition | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatic hallucination | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Physical thyroid examination abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hooded prepuce | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival ulcer | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermohypoaesthesia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosal scab | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Micturition frequency decreased | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual acuity reduced transiently | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic injury | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal growth abnormality | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral vasoconstriction | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capillary fragility increased | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine mercury abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital thymus absence | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiosarcoma | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lack of vaccination site rotation | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal alloimmune thrombocytopenia | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventricular flutter | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal fistula repair | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orchidopexy | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lenticulostriatal vasculopathy | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve infection | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thoracotomy | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial thrombosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orbital decompression | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lead urine increased | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical spinal cord paralysis | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accidental exposure to product packaging | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urea urine decreased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulva cyst | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatoglyphic anomaly | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Modified Rankin score decreased | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Onycholysis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hashimoto's encephalopathy | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acalculia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skull malformation | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clinical death | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Floating patella | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Persecutory delusion | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Noninfective oophoritis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Staphylococcal toxaemia | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality change due to a general medical condition | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperglycinaemia | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device function test | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyponatriuria | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericarditis tuberculous | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system abscess | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin blood absent | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stent insertion | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin saturation increased | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to pelvis | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophagostomy | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Denture wearer | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic myelomonocytic leukaemia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Appendix cancer | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenoleukodystrophy | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb reduction defect | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Left-to-right cardiac shunt | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular somatic symptom disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schizoid personality disorder | 0 | 0.052 | 0.047 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural fistula | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle graft | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalopathy neonatal | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-HLA antibody test | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MM decreased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borderline glaucoma | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutralising antibodies positive | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic therapy | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myeloproliferative neoplasm | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor I deficiency | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyposomnia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Food contamination | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factitious disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calcific deposits removal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymoma | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital skin disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complications of transplanted kidney | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin-like growth factor | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Group B streptococcus neonatal sepsis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leiomyoma | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleral haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Violence-related symptom | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary progressive multiple sclerosis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barrel chest | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glaucoma drainage device placement | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ependymitis | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transcranial electrical motor evoked potential monitoring abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema asteatotic | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood prolactin abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear infection fungal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incarcerated umbilical hernia | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Velopharyngeal incompetence | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Term birth | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis Japanese B | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary straining | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart transplant | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin C deficiency | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol test positive | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurofibroma | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intentional device misuse | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyomavirus test positive | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydromyelia | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diastasis recti abdominis | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site papules | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary necrosis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mechanical ventilation complication | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood catecholamines increased | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrong dose | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound abscess | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypogonadism | 0 | 0.052 | 0.046 | 0.949 | 2.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progressive multiple sclerosis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | VIth nerve paresis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intention tremor | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperglobulinaemia | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital rubella infection | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhinotracheitis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kinematic imbalances due to suboccipital strain | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood thrombin | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal perforation | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychotic symptom | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endometrial ablation | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flour sensitivity | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipids abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet function test normal | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic organ injury | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric fluid analysis | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid thickening | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular function test abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pre-existing disease | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radiation injury | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic aneurysm repair | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salpingo-oophorectomy unilateral | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovectomy | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congestive hepatopathy | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein S deficiency | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urogram abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selenium deficiency | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gait apraxia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriovenous fistula occlusion | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic band syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac ventriculogram normal | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ejaculation disorder | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart block congenital | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary valve stenosis congenital | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal therapeutic procedure | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs negative haemolytic anaemia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conductive deafness | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual perseveration | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proctitis ulcerative | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to meninges | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic fluid index | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood copper increased | 0 | 0.052 | 0.045 | 0.949 | 2.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteomyelitis acute | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stomach scan | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stomatococcal infection | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic stent insertion | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital vesicoureteric reflux | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail ridging | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autonomic seizure | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clotting factor transfusion | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level above therapeutic | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parietal cell antibody positive | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical observation | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve decompression | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disseminated cytomegaloviral infection | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Twin reversed arterial perfusion sequence malformation | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic disc hyperaemia | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute lymphocytic leukaemia recurrent | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medication overuse headache | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental gangrene | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin urine | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fallopian tube cancer metastatic | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PUVA | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail hypertrophy | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign muscle neoplasm | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C core antibody negative | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brachytherapy | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-complement antibody | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrocardiac syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram Q waves | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy with young maternal age | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal haemorrhage | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjustment disorder with mixed anxiety and depressed mood | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine leiomyoma embolisation | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subretinal fibrosis | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Directional Doppler flow tests abnormal | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device defective | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cows milk free diet | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Graft complication | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vessel puncture site erythema | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QT shortened | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal tachypnoea | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adactyly | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premature baby death | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjustment disorder with anxiety | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rickets | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anomaly of external ear congenital | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral rhinitis | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atonic urinary bladder | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatopathic lymphadenopathy | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sexual transmission of infection | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucormycosis | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Umbilical hernia repair | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spotted fever rickettsia test positive | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Noonan syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital pneumonia | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary progressive multiple sclerosis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cisternogram | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C core antibody positive | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sex hormone binding globulin | 0 | 0.052 | 0.046 | 0.949 | 2.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rinne tuning fork test | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary artery stenosis congenital | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to the mediastinum | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | IgM nephropathy | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood testosterone increased | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aldosterone decreased | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular neoplasm | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural stroke | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug abuser | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Compulsive handwashing | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-vimentin antibody positive | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial therapeutic procedure | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin cyst excision | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intravascular papillary endothelial hyperplasia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Induced abortion failed | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alagille syndrome | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular encephalopathy | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fistula repair | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brucella test positive | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral cavity fistula | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal gastrointestinal disorder | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transmission of an infectious agent via transplant | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palatal palsy | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Waldenstrom's macroglobulinaemia | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal degeneration | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema marginatum | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ilium fracture | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality disorder of childhood | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oedema blister | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ambidexterity | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular germ cell tumour | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Past-pointing | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural nausea | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postmortem blood drug level increased | 0 | 0.052 | 0.046 | 0.949 | 2.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhesus antigen | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal ulceration | 0 | 0.052 | 0.047 | 0.949 | 2.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Focal nodular hyperplasia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein amniotic fluid | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tyrosinaemia | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian injury | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blunted affect | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbuncle | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs indirect test | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune endocrine disorder | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver dialysis | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palmoplantar pustulosis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhinoplasty | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eustachian tube disorder | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyeball avulsion | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood catecholamines decreased | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar cyst | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normal tension glaucoma | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticoagulation drug level below therapeutic | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelocyte percentage increased | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF lactate abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Manual lymphatic drainage | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital thrombocytopenia | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular operation | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spasmodic dysphonia | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia measles | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal dialysis complication | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system neoplasm | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otoplasty | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymus hypoplasia | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy with advanced maternal age | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic stomatitis | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombosis in device | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fractured coccyx | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid calcification | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meconium abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macroprolactinaemia | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow myelogram normal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bleeding anovulatory | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barotitis media | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint deposit | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoidal disorder | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal pain | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary hyperthyroidism | 0 | 0.052 | 0.046 | 0.949 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasma cells increased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophagogastroscopy abnormal | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antigen | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF granulocyte count normal | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual pathway disorder | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stomatococcus test positive | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prader-Willi syndrome | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to heart | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrin degradation products normal | 0 | 0.052 | 0.046 | 0.949 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chikungunya virus infection | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure ambulatory | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Risus sardonicus | 0 | 0.052 | 0.045 | 0.949 | 2.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accelerated idioventricular rhythm | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulomatous liver disease | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lice infestation | 0 | 0.052 | 0.046 | 0.949 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spermatorrhoea | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary adrenal insufficiency | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product residue present | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urogenital disorder | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal haemoglobin | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystic lymphangioma | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carnitine abnormal | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subretinal hyperreflective exudation | 0 | 0.052 | 0.046 | 0.949 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porphyrins urine increased | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac septal defect residual shunt | 0 | 0.052 | 0.047 | 0.949 | 2.86 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chylothorax | 0 | 0.052 | 0.046 | 0.949 | 2.862 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenine phosphoribosyl transferase deficiency | 0 | 0.052 | 0.047 | 0.949 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign neoplasm of skin | 0 | 0.052 | 0.045 | 0.949 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epilepsy congenital | 0 | 0.052 | 0.046 | 0.949 | 2.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histamine intolerance | 1 | 0.815 | 0.305 | 0.948 | 1.877 | 0.374 | 0.909 | 1.928 | 1.227 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Testicular pain | 3 | 2.956 | 0.427 | 0.948 | 1.636 | 0.451 | 0.919 | 1.709 | 1.015 | 1.505 | 0.106
COVID19_PFIZER/BIONTECH | Respiratory distress | 28 | 32.816 | 0.679 | 0.948 | 1.254 | 0.629 | 0.852 | 1.134 | 0.853 | 1.095 | 0.132
COVID19_PFIZER/BIONTECH | Cerebral ischaemia | 1 | 1.502 | 0.286 | 0.948 | 1.924 | 0.32 | 0.783 | 1.662 | 0.666 | 1.003 | 0.261
COVID19_PFIZER/BIONTECH | Adrenal disorder | 0 | 0.064 | 0.07 | 0.948 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF protein decreased | 0 | 0.169 | 0.266 | 0.948 | 1.971 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypersensitivity (SMQ) [broad] | 4298 | 4582.922 | 0.924 | 0.947 | 0.971 | 0.914 | 0.938 | 0.961 | 0.938 | 0.989 | 0.588
COVID19_PFIZER/BIONTECH | Metamorphopsia | 2 | 2.62 | 0.415 | 0.947 | 1.656 | 0.367 | 0.806 | 1.585 | 0.763 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Vaccine positive rechallenge | 3 | 21.437 | 0.306 | 0.947 | 1.872 | 0.088 | 0.22 | 0.44 | 0.14 | 0.085 | 28.488
COVID19_PFIZER/BIONTECH | Hypoalbuminaemia | 0 | 0.13 | 0.2 | 0.947 | 2.146 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngitis streptococcal | 1 | 1.304 | 0.282 | 0.946 | 1.925 | 0.334 | 0.815 | 1.73 | 0.767 | 0.287 | 1.085
COVID19_PFIZER/BIONTECH | Limb immobilisation | 1 | 0.783 | 0.121 | 0.945 | 2.415 | 0.377 | 0.916 | 1.943 | 1.276 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Noninfective encephalitis | 3 | 2.443 | 0.397 | 0.944 | 1.68 | 0.489 | 0.997 | 1.855 | 1.228 | 1.022 | 0.069
COVID19_PFIZER/BIONTECH | Aspiration | 6 | 7.05 | 0.516 | 0.944 | 1.478 | 0.476 | 0.847 | 1.417 | 0.851 | 1.868 | 1.443
COVID19_PFIZER/BIONTECH | Gianotti-Crosti syndrome | 0 | 0.148 | 0.214 | 0.944 | 2.094 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal fissure | 0 | 0.112 | 0.15 | 0.943 | 2.298 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteoarthritis | 5 | 7.117 | 0.425 | 0.942 | 1.623 | 0.405 | 0.748 | 1.289 | 0.703 | 0.951 | 0.013
COVID19_PFIZER/BIONTECH | Biopsy muscle normal | 0 | 0.077 | 0.08 | 0.942 | 2.607 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spirometry normal | 0 | 0.058 | 0.041 | 0.942 | 2.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hallucination | 22 | 27.774 | 0.658 | 0.941 | 1.266 | 0.568 | 0.798 | 1.095 | 0.792 | 1.45 | 2.424
COVID19_PFIZER/BIONTECH | Mouth haemorrhage | 6 | 6.084 | 0.506 | 0.94 | 1.482 | 0.524 | 0.932 | 1.558 | 0.986 | 1.389 | 0.286
COVID19_PFIZER/BIONTECH | Oral mucosal erythema | 2 | 2.26 | 0.312 | 0.94 | 1.841 | 0.39 | 0.856 | 1.682 | 0.885 | 0.821 | 0.003
COVID19_PFIZER/BIONTECH | Ocular hyperaemia | 38 | 43.98 | 0.711 | 0.94 | 1.195 | 0.663 | 0.862 | 1.107 | 0.864 | 0.899 | 0.313
COVID19_PFIZER/BIONTECH | Pregnancy | 8 | 8.437 | 0.52 | 0.939 | 1.457 | 0.545 | 0.916 | 1.462 | 0.948 | 6.88 | 24.794
COVID19_PFIZER/BIONTECH | Pain | 2192 | 2472.273 | 0.906 | 0.939 | 0.972 | 0.856 | 0.887 | 0.918 | 0.887 | 1.369 | 222.605
COVID19_PFIZER/BIONTECH | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [algorithm] | 48 | 57.239 | 0.731 | 0.939 | 1.167 | 0.663 | 0.839 | 1.05 | 0.839 | 0.672 | 7.107
COVID19_PFIZER/BIONTECH | Administration site bruise | 0 | 0.11 | 0.134 | 0.939 | 2.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone scan normal | 0 | 0.117 | 0.145 | 0.939 | 2.305 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seizure like phenomena | 18 | 20.989 | 0.628 | 0.938 | 1.299 | 0.59 | 0.855 | 1.207 | 0.858 | 0.661 | 2.693
COVID19_PFIZER/BIONTECH | Clumsiness | 2 | 1.694 | 0.292 | 0.937 | 1.881 | 0.433 | 0.949 | 1.865 | 1.18 | 0.592 | 0.207
COVID19_PFIZER/BIONTECH | Blood gases | 6 | 7.326 | 0.474 | 0.937 | 1.526 | 0.464 | 0.826 | 1.381 | 0.819 | 1.97 | 1.744
COVID19_PFIZER/BIONTECH | Neurological examination normal | 8 | 10.093 | 0.512 | 0.937 | 1.467 | 0.479 | 0.805 | 1.286 | 0.793 | 0.322 | 10.557
COVID19_PFIZER/BIONTECH | Blood homocysteine normal | 0 | 0.114 | 0.134 | 0.937 | 2.341 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxicologic test normal | 2 | 2.133 | 0.398 | 0.936 | 1.66 | 0.399 | 0.875 | 1.72 | 0.938 | 0.951 | 0.081
COVID19_PFIZER/BIONTECH | Hypersensitivity (SMQ) [narrow] | 2838 | 3078.874 | 0.907 | 0.936 | 0.965 | 0.894 | 0.922 | 0.95 | 0.922 | 0.957 | 6.302
COVID19_PFIZER/BIONTECH | Pneumothorax | 1 | 3.349 | 0.25 | 0.936 | 1.979 | 0.223 | 0.564 | 1.218 | 0.299 | 0.41 | 0.331
COVID19_PFIZER/BIONTECH | Biopsy site unspecified abnormal | 0 | 0.081 | 0.072 | 0.936 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blepharitis | 0 | 0.152 | 0.19 | 0.936 | 2.146 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament sprain | 0 | 0.218 | 0.27 | 0.936 | 1.929 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair metal test abnormal | 0 | 0.168 | 0.21 | 0.936 | 2.086 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis acute | 1 | 0.785 | 0.145 | 0.935 | 2.291 | 0.377 | 0.915 | 1.942 | 1.275 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase normal | 10 | 11.249 | 0.538 | 0.935 | 1.422 | 0.545 | 0.877 | 1.352 | 0.889 | 0.821 | 0.215
COVID19_PFIZER/BIONTECH | Injection site scab | 4 | 4.764 | 0.385 | 0.935 | 1.68 | 0.435 | 0.839 | 1.496 | 0.84 | 0.475 | 1.751
COVID19_PFIZER/BIONTECH | Urinary tract infection | 48 | 65.069 | 0.727 | 0.934 | 1.161 | 0.587 | 0.743 | 0.93 | 0.738 | 1.872 | 16.877
COVID19_PFIZER/BIONTECH | Cytogenetic analysis | 1 | 1.774 | 0.419 | 0.934 | 1.616 | 0.302 | 0.741 | 1.577 | 0.564 | 0.301 | 0.954
COVID19_PFIZER/BIONTECH | Sleep study normal | 0 | 0.168 | 0.201 | 0.934 | 2.103 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blister rupture | 2 | 2.549 | 0.425 | 0.933 | 1.6 | 0.372 | 0.816 | 1.603 | 0.785 | 1.165 | 0.033
COVID19_PFIZER/BIONTECH | Eosinophil count | 1 | 1.318 | 0.254 | 0.932 | 1.955 | 0.333 | 0.813 | 1.725 | 0.759 | 0.753 | 0.029
COVID19_PFIZER/BIONTECH | Serum sickness | 3 | 3.761 | 0.48 | 0.932 | 1.506 | 0.401 | 0.818 | 1.521 | 0.798 | 0.742 | 0.063
COVID19_PFIZER/BIONTECH | Diplopia | 21 | 26.407 | 0.633 | 0.932 | 1.279 | 0.566 | 0.801 | 1.106 | 0.795 | 1.068 | 0.032
COVID19_PFIZER/BIONTECH | Posture abnormal | 22 | 26.387 | 0.647 | 0.931 | 1.257 | 0.594 | 0.834 | 1.146 | 0.834 | 0.642 | 3.895
COVID19_PFIZER/BIONTECH | Drug withdrawal (SMQ) [broad] | 1 | 1.375 | 0.281 | 0.931 | 1.888 | 0.329 | 0.803 | 1.705 | 0.727 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Rhonchi | 1 | 1.891 | 0.241 | 0.931 | 1.987 | 0.295 | 0.725 | 1.543 | 0.529 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | Injection site atrophy | 0 | 0.324 | 0.337 | 0.931 | 1.764 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hodgkin's disease | 0 | 0.14 | 0.154 | 0.931 | 2.249 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug screen negative | 4 | 4.103 | 0.48 | 0.93 | 1.499 | 0.473 | 0.912 | 1.625 | 0.975 | 1.017 | 0.051
COVID19_PFIZER/BIONTECH | Arthritis bacterial | 1 | 1.552 | 0.287 | 0.93 | 1.872 | 0.317 | 0.775 | 1.646 | 0.644 | 0.43 | 0.267
COVID19_PFIZER/BIONTECH | Neutrophil count decreased | 8 | 9.442 | 0.508 | 0.929 | 1.454 | 0.503 | 0.845 | 1.35 | 0.847 | 0.595 | 1.748
COVID19_PFIZER/BIONTECH | Hypogammaglobulinaemia | 0 | 0.122 | 0.12 | 0.929 | 2.372 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loss of control of legs | 1 | 1.218 | 0.207 | 0.928 | 2.071 | 0.341 | 0.83 | 1.762 | 0.821 | 0.296 | 0.997
COVID19_PFIZER/BIONTECH | Pulmonary function test decreased | 0 | 0.07 | 0.036 | 0.928 | 2.888 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF virus identified | 0 | 0.115 | 0.107 | 0.928 | 2.426 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sick relative | 0 | 0.056 | 0.018 | 0.928 | 3.123 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue eruption | 3 | 2.943 | 0.438 | 0.927 | 1.564 | 0.452 | 0.92 | 1.712 | 1.019 | 2.852 | 1.656
COVID19_PFIZER/BIONTECH | Torsade de pointes/QT prolongation (SMQ) [broad] | 533 | 630.503 | 0.862 | 0.927 | 0.994 | 0.787 | 0.845 | 0.907 | 0.845 | 0.93 | 2.676
COVID19_PFIZER/BIONTECH | Radioisotope scan abnormal | 0 | 0.058 | 0.019 | 0.927 | 3.105 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan with contrast normal | 10 | 10.17 | 0.592 | 0.926 | 1.321 | 0.588 | 0.946 | 1.458 | 0.983 | 2.076 | 4.036
COVID19_PFIZER/BIONTECH | Parkinson-like events (SMQ) [broad] | 922 | 1016.846 | 0.876 | 0.926 | 0.976 | 0.859 | 0.906 | 0.957 | 0.907 | 0.997 | 0.007
COVID19_PFIZER/BIONTECH | Blood glucose fluctuation | 1 | 1.225 | 0.266 | 0.926 | 1.91 | 0.34 | 0.829 | 1.759 | 0.816 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Haematocrit increased | 1 | 2.075 | 0.321 | 0.926 | 1.784 | 0.285 | 0.7 | 1.493 | 0.482 | 0.488 | 0.129
COVID19_PFIZER/BIONTECH | Passive smoking | 0 | 0.105 | 0.085 | 0.926 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impaired self-care | 0 | 0.105 | 0.086 | 0.926 | 2.522 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | End-tidal CO2 decreased | 0 | 0.105 | 0.087 | 0.926 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear infection | 6 | 6.674 | 0.466 | 0.925 | 1.511 | 0.494 | 0.878 | 1.469 | 0.899 | 0.272 | 10.817
COVID19_PFIZER/BIONTECH | Embolic cerebellar infarction | 0 | 0.105 | 0.083 | 0.925 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventricular enlargement | 0 | 0.105 | 0.084 | 0.925 | 2.532 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radius fracture | 0 | 0.105 | 0.083 | 0.925 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweating fever | 0 | 0.105 | 0.083 | 0.925 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal infarction | 0 | 0.105 | 0.084 | 0.925 | 2.532 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Von Willebrand's factor antigen increased | 0 | 0.105 | 0.083 | 0.925 | 2.537 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal hypoaesthesia | 0 | 0.105 | 0.083 | 0.925 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | West Nile virus test | 0 | 0.125 | 0.114 | 0.925 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjusted calcium increased | 0 | 0.105 | 0.084 | 0.925 | 2.53 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary contusion | 0 | 0.105 | 0.083 | 0.925 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sexual dysfunction | 0 | 0.109 | 0.09 | 0.925 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site swelling | 42 | 55.043 | 0.709 | 0.924 | 1.163 | 0.597 | 0.768 | 0.975 | 0.763 | 0.62 | 9.093
COVID19_PFIZER/BIONTECH | Complement factor C3 | 3 | 4.635 | 0.328 | 0.924 | 1.764 | 0.358 | 0.731 | 1.36 | 0.647 | 0.516 | 0.874
COVID19_PFIZER/BIONTECH | Subdural haematoma evacuation | 0 | 0.105 | 0.081 | 0.924 | 2.542 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia fungal | 0 | 0.105 | 0.081 | 0.924 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal scan | 0 | 0.105 | 0.081 | 0.924 | 2.543 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb asymmetry | 0 | 0.105 | 0.081 | 0.924 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basal ganglia haematoma | 0 | 0.105 | 0.082 | 0.924 | 2.54 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Caffeine consumption | 0 | 0.105 | 0.08 | 0.924 | 2.546 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monoparesis | 1 | 1.242 | 0.097 | 0.923 | 2.458 | 0.339 | 0.826 | 1.753 | 0.805 | 0.274 | 1.219
COVID19_PFIZER/BIONTECH | Legionella infection | 0 | 0.105 | 0.078 | 0.923 | 2.555 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mediastinal disorder | 0 | 0.105 | 0.079 | 0.923 | 2.551 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Developmental hip dysplasia | 0 | 0.12 | 0.101 | 0.923 | 2.439 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal column injury | 0 | 0.105 | 0.08 | 0.923 | 2.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord lipoma | 0 | 0.105 | 0.079 | 0.923 | 2.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site papule | 0 | 0.238 | 0.241 | 0.923 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patient restraint | 0 | 0.105 | 0.08 | 0.923 | 2.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Type 1 diabetes mellitus | 2 | 1.756 | 0.24 | 0.922 | 1.964 | 0.428 | 0.938 | 1.843 | 1.139 | 0.233 | 4.219
COVID19_PFIZER/BIONTECH | Peripheral neuropathy (SMQ) [narrow] | 175 | 199.574 | 0.811 | 0.922 | 1.039 | 0.773 | 0.876 | 0.99 | 0.877 | 0.806 | 7.679
COVID19_PFIZER/BIONTECH | Central venous catheterisation | 2 | 3.218 | 0.361 | 0.922 | 1.692 | 0.334 | 0.735 | 1.445 | 0.621 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Allergy test positive | 1 | 1.785 | 0.419 | 0.922 | 1.585 | 0.302 | 0.74 | 1.574 | 0.56 | 0.152 | 3.857
COVID19_PFIZER/BIONTECH | T-cell type acute leukaemia | 0 | 0.105 | 0.075 | 0.922 | 2.567 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestine anastomosis | 0 | 0.105 | 0.077 | 0.922 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth injury | 0 | 0.057 | 0.014 | 0.922 | 3.186 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic valve calcification | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Panophthalmitis | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patient uncooperative | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Full blood count decreased | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multipathogen PCR test | 0 | 0.105 | 0.077 | 0.922 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate cancer metastatic | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac septal hypertrophy | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auscultation | 0 | 0.105 | 0.076 | 0.922 | 2.565 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray with contrast upper gastrointestinal tract abnormal | 0 | 0.105 | 0.076 | 0.922 | 2.564 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion site warmth | 0 | 0.105 | 0.077 | 0.922 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system function test | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amphetamines positive | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fungal disease carrier | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood grouping | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriovenous fistula operation | 0 | 0.105 | 0.077 | 0.922 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian necrosis | 0 | 0.105 | 0.077 | 0.922 | 2.561 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atypical mycobacterial infection | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine renal clearance normal | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrinous bronchitis | 0 | 0.105 | 0.076 | 0.922 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis (SMQ) [broad] | 1337 | 1463.19 | 0.88 | 0.921 | 0.963 | 0.873 | 0.914 | 0.955 | 0.914 | 1.345 | 116.114
COVID19_PFIZER/BIONTECH | Lip injury | 1 | 2.197 | 0.44 | 0.921 | 1.544 | 0.278 | 0.685 | 1.461 | 0.455 | 0.251 | 1.496
COVID19_PFIZER/BIONTECH | Tendinous contracture | 0 | 0.105 | 0.074 | 0.921 | 2.573 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perioral dermatitis | 0 | 0.105 | 0.074 | 0.921 | 2.573 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular hole | 0 | 0.105 | 0.075 | 0.921 | 2.569 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site vesicles | 0 | 0.105 | 0.075 | 0.921 | 2.568 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Grimacing | 0 | 0.236 | 0.233 | 0.921 | 1.981 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripancreatic fluid collection | 0 | 0.105 | 0.073 | 0.921 | 2.576 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid margin crusting | 3 | 3.395 | 0.41 | 0.92 | 1.597 | 0.422 | 0.861 | 1.601 | 0.884 | 1.26 | 0.003
COVID19_PFIZER/BIONTECH | Parkinson's disease | 1 | 1.949 | 0.237 | 0.92 | 1.968 | 0.292 | 0.717 | 1.527 | 0.513 | 0.583 | 0.02
COVID19_PFIZER/BIONTECH | Face and mouth X-ray normal | 0 | 0.105 | 0.073 | 0.92 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster reactivation | 0 | 0.105 | 0.072 | 0.92 | 2.582 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prescription drug used without a prescription | 0 | 0.105 | 0.073 | 0.92 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucosal hypertrophy | 0 | 0.105 | 0.073 | 0.92 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortitis | 0 | 0.105 | 0.072 | 0.92 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric cancer | 0 | 0.105 | 0.073 | 0.92 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal examination | 0 | 0.105 | 0.073 | 0.92 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular vascular disorder | 0 | 0.105 | 0.073 | 0.92 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumocystis test negative | 0 | 0.105 | 0.073 | 0.92 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical device pain | 0 | 0.105 | 0.073 | 0.92 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal deposits | 0 | 0.105 | 0.072 | 0.92 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromyotonia | 0 | 0.105 | 0.073 | 0.92 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder transitional cell carcinoma | 0 | 0.105 | 0.072 | 0.92 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear, nose and throat examination abnormal | 0 | 0.11 | 0.079 | 0.92 | 2.538 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vibrio test positive | 0 | 0.105 | 0.072 | 0.92 | 2.582 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hordeolum | 4 | 3.483 | 0.416 | 0.919 | 1.581 | 0.514 | 0.992 | 1.768 | 1.149 | 3.44 | 3.854
COVID19_PFIZER/BIONTECH | Hyporesponsive to stimuli | 6 | 6.731 | 0.458 | 0.919 | 1.508 | 0.491 | 0.873 | 1.461 | 0.891 | 0.384 | 5.182
COVID19_PFIZER/BIONTECH | Depression (excl suicide and self injury) (SMQ) [narrow] | 16 | 20.67 | 0.588 | 0.919 | 1.31 | 0.53 | 0.784 | 1.125 | 0.774 | 0.375 | 15.698
COVID19_PFIZER/BIONTECH | Paroxysmal sympathetic hyperactivity | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve infarction | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carotid artery thrombosis | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer recurrent | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteonecrosis (SMQ) [narrow] | 0 | 0.187 | 0.177 | 0.919 | 2.135 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neovascular age-related macular degeneration | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye infection viral | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastectomy | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otic examination normal | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion site pain | 0 | 0.105 | 0.07 | 0.919 | 2.59 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid infection | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calcium ionised | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary catheter insertion | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intervertebral disc operation | 0 | 0.105 | 0.07 | 0.919 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac imaging procedure | 0 | 0.105 | 0.07 | 0.919 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate examination | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram Q wave abnormal | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth repair | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebral column mass | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythroblast count increased | 0 | 0.105 | 0.07 | 0.919 | 2.59 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colon operation | 0 | 0.105 | 0.069 | 0.919 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin maceration | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual snow syndrome | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malformation venous | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peptostreptococcus infection | 0 | 0.105 | 0.07 | 0.919 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood insulin | 0 | 0.105 | 0.07 | 0.919 | 2.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticholinergic syndrome (SMQ) [algorithm] | 24 | 27.871 | 0.646 | 0.918 | 1.229 | 0.62 | 0.859 | 1.165 | 0.861 | 1.006 | 0.006
COVID19_PFIZER/BIONTECH | Thirst | 21 | 26.545 | 0.645 | 0.918 | 1.23 | 0.563 | 0.797 | 1.101 | 0.791 | 1.389 | 1.764
COVID19_PFIZER/BIONTECH | Anterograde amnesia | 0 | 0.105 | 0.068 | 0.918 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Contrast media allergy | 0 | 0.105 | 0.068 | 0.918 | 2.598 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tarsal tunnel syndrome | 0 | 0.105 | 0.067 | 0.918 | 2.603 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-lymphocyte abnormalities | 0 | 0.105 | 0.068 | 0.918 | 2.602 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venogram abnormal | 0 | 0.105 | 0.068 | 0.918 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal septum deviation | 0 | 0.105 | 0.068 | 0.918 | 2.601 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatological examination | 0 | 0.105 | 0.068 | 0.918 | 2.6 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiolipin antibody positive | 0 | 0.058 | 0.012 | 0.918 | 3.208 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute chest syndrome | 0 | 0.105 | 0.069 | 0.918 | 2.595 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal stenosis | 0 | 0.105 | 0.068 | 0.918 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Severe invasive streptococcal infection | 0 | 0.105 | 0.067 | 0.918 | 2.603 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurotransmitter level altered | 0 | 0.105 | 0.069 | 0.918 | 2.596 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram liver | 0 | 0.105 | 0.069 | 0.918 | 2.596 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Excessive cerumen production | 0 | 0.167 | 0.15 | 0.918 | 2.224 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypomania | 0 | 0.105 | 0.068 | 0.918 | 2.6 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post thrombotic syndrome | 0 | 0.105 | 0.068 | 0.918 | 2.6 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal erosion | 0 | 0.105 | 0.069 | 0.918 | 2.596 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superior sagittal sinus thrombosis | 0 | 0.105 | 0.068 | 0.918 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram abdomen | 30 | 32.419 | 0.681 | 0.917 | 1.181 | 0.683 | 0.917 | 1.21 | 0.925 | 5.111 | 74.01
COVID19_PFIZER/BIONTECH | Creutzfeldt-Jakob disease | 0 | 0.105 | 0.067 | 0.917 | 2.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haematoma infection | 0 | 0.105 | 0.066 | 0.917 | 2.607 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile oedema | 0 | 0.105 | 0.067 | 0.917 | 2.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Distributive shock | 0 | 0.105 | 0.065 | 0.917 | 2.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteonecrosis of jaw | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tobacco abuse | 0 | 0.105 | 0.066 | 0.917 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine amphetamine negative | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood potassium abnormal | 0 | 0.105 | 0.066 | 0.917 | 2.608 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipase decreased | 0 | 0.105 | 0.066 | 0.917 | 2.608 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrops foetalis | 0 | 0.105 | 0.066 | 0.917 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smooth muscle antibody | 0 | 0.105 | 0.066 | 0.917 | 2.608 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ejection fraction abnormal | 0 | 0.105 | 0.066 | 0.917 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Morbid thoughts | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orbital myositis | 0 | 0.105 | 0.065 | 0.917 | 2.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast induration | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone fragmentation | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disease prodromal stage | 0 | 0.105 | 0.065 | 0.917 | 2.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cell-mediated immune deficiency | 0 | 0.105 | 0.066 | 0.917 | 2.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perineal pain | 0 | 0.105 | 0.066 | 0.917 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular occlusion | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bradycardia foetal | 0 | 0.105 | 0.066 | 0.917 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal disorder | 0 | 0.105 | 0.065 | 0.917 | 2.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Invasive ductal breast carcinoma | 0 | 0.105 | 0.067 | 0.917 | 2.604 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endometrial thickening | 0 | 0.105 | 0.067 | 0.917 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deafness permanent | 0 | 0.105 | 0.066 | 0.917 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiogram pulmonary | 0 | 0.105 | 0.066 | 0.917 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart injury | 1 | 1.062 | 0.168 | 0.916 | 2.153 | 0.353 | 0.859 | 1.822 | 0.942 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Dystonia (SMQ) [narrow] | 8 | 9.477 | 0.501 | 0.916 | 1.432 | 0.502 | 0.843 | 1.346 | 0.844 | 0.334 | 9.785
COVID19_PFIZER/BIONTECH | Oral mucosal blistering | 7 | 8.574 | 0.479 | 0.916 | 1.466 | 0.477 | 0.823 | 1.343 | 0.816 | 0.903 | 0.006
COVID19_PFIZER/BIONTECH | Antiribosomal P antibody | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intermittent positive pressure breathing | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis cryptococcal | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mammoplasty | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic dissection | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal deviation | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | AST/ALT ratio | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Defect conduction intraventricular | 0 | 0.105 | 0.064 | 0.916 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prealbumin increased | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast disorder female | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tender joint count | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine electrophoresis abnormal | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbohydrate antigen 125 normal | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis A antigen negative | 0 | 0.105 | 0.064 | 0.916 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial cyst removal | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site phlebitis | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atrioventricular block first degree | 0 | 0.105 | 0.064 | 0.916 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital labial adhesions | 0 | 0.105 | 0.064 | 0.916 | 2.618 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemangioma of liver | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebellar tumour | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging breast abnormal | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound biliary tract abnormal | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial fluid crystal | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal angioedema | 0 | 0.105 | 0.064 | 0.916 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic rupture | 0 | 0.105 | 0.065 | 0.916 | 2.614 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal obstruction | 0 | 0.105 | 0.064 | 0.916 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aerophagia | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Crystalluria | 0 | 0.105 | 0.063 | 0.916 | 2.622 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tenoplasty | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunosuppressant drug level | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureterolithiasis | 0 | 0.105 | 0.064 | 0.916 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic bacterial infection | 0 | 0.105 | 0.065 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Swollen joint count | 0 | 0.105 | 0.064 | 0.916 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Type II hypersensitivity | 0 | 0.105 | 0.064 | 0.916 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lead normal | 0 | 0.105 | 0.064 | 0.916 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy prostate | 0 | 0.105 | 0.065 | 0.916 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibromuscular dysplasia | 0 | 0.105 | 0.064 | 0.916 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess | 2 | 2.042 | 0.258 | 0.915 | 1.9 | 0.406 | 0.89 | 1.748 | 0.979 | 0.23 | 4.32
COVID19_PFIZER/BIONTECH | Fall | 146 | 170.073 | 0.796 | 0.915 | 1.041 | 0.749 | 0.858 | 0.98 | 0.858 | 1.09 | 0.943
COVID19_PFIZER/BIONTECH | Arteritis coronary | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spleen palpable | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF electrophoresis normal | 0 | 0.105 | 0.063 | 0.915 | 2.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chondrocalcinosis | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sinus node dysfunction | 0 | 0.105 | 0.062 | 0.915 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes simplex meningoencephalitis | 0 | 0.105 | 0.063 | 0.915 | 2.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrophages increased | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral labyrinthitis | 0 | 0.105 | 0.063 | 0.915 | 2.624 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antidepressant drug level | 0 | 0.105 | 0.063 | 0.915 | 2.622 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise test | 0 | 0.105 | 0.062 | 0.915 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oromandibular dystonia | 0 | 0.105 | 0.062 | 0.915 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anosognosia | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal adhesions | 0 | 0.105 | 0.062 | 0.915 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time ratio normal | 0 | 0.105 | 0.062 | 0.915 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypermetropia | 0 | 0.206 | 0.184 | 0.915 | 2.102 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-insulin antibody decreased | 0 | 0.105 | 0.062 | 0.915 | 2.63 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Listeriosis | 0 | 0.105 | 0.062 | 0.915 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrocholecystis | 0 | 0.105 | 0.063 | 0.915 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polymorphic light eruption | 0 | 0.105 | 0.062 | 0.915 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body in throat | 0 | 0.105 | 0.062 | 0.915 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Karyotype analysis | 0 | 0.105 | 0.062 | 0.915 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histamine release test | 0 | 0.105 | 0.062 | 0.915 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor XIII level decreased | 0 | 0.105 | 0.062 | 0.915 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrin normal | 0 | 0.105 | 0.063 | 0.915 | 2.622 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gouty arthritis | 0 | 0.105 | 0.063 | 0.915 | 2.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thunderclap headache | 0 | 0.105 | 0.063 | 0.915 | 2.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Internal fixation of fracture | 0 | 0.105 | 0.062 | 0.915 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bicarbonate decreased | 5 | 4.788 | 0.458 | 0.914 | 1.495 | 0.519 | 0.956 | 1.647 | 1.044 | 1.348 | 0.146
COVID19_PFIZER/BIONTECH | Lymphangiopathy | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product physical consistency issue | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound uterus normal | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypermagnesaemia | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin E | 0 | 0.105 | 0.061 | 0.914 | 2.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thumb sucking | 0 | 0.105 | 0.061 | 0.914 | 2.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet distribution width decreased | 0 | 0.105 | 0.06 | 0.914 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental care | 0 | 0.105 | 0.06 | 0.914 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Posterior capsule opacification | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dupuytren's contracture | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram PR shortened | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenocarcinoma of colon | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mallory-Weiss syndrome | 0 | 0.105 | 0.06 | 0.914 | 2.639 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Porokeratosis | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal fluid analysis abnormal | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post polio syndrome | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatorenal syndrome | 0 | 0.105 | 0.061 | 0.914 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Familial mediterranean fever | 0 | 0.105 | 0.06 | 0.914 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyspnoea paroxysmal nocturnal | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelofibrosis | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Activated protein C resistance test positive | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyruvate kinase | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optical coherence tomography normal | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophilia | 0 | 0.105 | 0.06 | 0.914 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital infection fungal | 0 | 0.105 | 0.06 | 0.914 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postmenopause | 0 | 0.105 | 0.06 | 0.914 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival ulceration | 0 | 0.105 | 0.061 | 0.914 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Volvulus of small bowel | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastritis haemorrhagic | 0 | 0.105 | 0.061 | 0.914 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eustachian tube operation | 0 | 0.105 | 0.06 | 0.914 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lysozyme | 0 | 0.105 | 0.061 | 0.914 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sexually transmitted disease test | 0 | 0.105 | 0.06 | 0.914 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Investigation abnormal | 0 | 0.155 | 0.124 | 0.914 | 2.309 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red man syndrome | 0 | 0.105 | 0.061 | 0.914 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood homocysteine increased | 0 | 0.105 | 0.061 | 0.914 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy rectum abnormal | 0 | 0.105 | 0.06 | 0.914 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticoagulation drug level | 0 | 0.105 | 0.061 | 0.914 | 2.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basophil degranulation test | 0 | 0.105 | 0.06 | 0.914 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal decompression | 0 | 0.105 | 0.061 | 0.914 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital hypoaesthesia | 0 | 0.105 | 0.06 | 0.914 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Solar lentigo | 0 | 0.105 | 0.061 | 0.914 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malaria antibody test | 0 | 0.105 | 0.058 | 0.913 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal thinning | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-transglutaminase antibody increased | 0 | 0.105 | 0.059 | 0.913 | 2.643 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salivary gland neoplasm | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligamentitis | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteritis | 0 | 0.105 | 0.059 | 0.913 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood cholinesterase | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Instillation site erythema | 0 | 0.105 | 0.059 | 0.913 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal polyp | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time abnormal | 0 | 0.105 | 0.06 | 0.913 | 2.64 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival pallor | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infected skin ulcer | 0 | 0.105 | 0.06 | 0.913 | 2.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephritic syndrome | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Citrobacter test positive | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QRS complex | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal disorder | 0 | 0.105 | 0.059 | 0.913 | 2.642 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweat test | 0 | 0.105 | 0.059 | 0.913 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product impurity | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intraocular pressure test abnormal | 0 | 0.105 | 0.059 | 0.913 | 2.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procalcitonin abnormal | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail infection | 0 | 0.105 | 0.059 | 0.913 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Familial tremor | 0 | 0.105 | 0.059 | 0.913 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chondrocalcinosis pyrophosphate | 0 | 0.105 | 0.058 | 0.913 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kaposi's sarcoma | 0 | 0.105 | 0.059 | 0.913 | 2.643 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucocutaneous candidiasis | 0 | 0.105 | 0.058 | 0.913 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prinzmetal angina | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epidural analgesia | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy thyroid gland | 0 | 0.105 | 0.06 | 0.913 | 2.64 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body mass index decreased | 0 | 0.105 | 0.058 | 0.913 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | pH urine increased | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF cell count decreased | 0 | 0.105 | 0.058 | 0.913 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Solar dermatitis | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbon dioxide abnormal | 0 | 0.105 | 0.059 | 0.913 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta globulin normal | 0 | 0.105 | 0.058 | 0.913 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal infarct | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood methaemoglobin absent | 0 | 0.105 | 0.059 | 0.913 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cogan's syndrome | 0 | 0.105 | 0.058 | 0.913 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parietal cell antibody negative | 0 | 0.105 | 0.056 | 0.912 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug monitoring procedure not performed | 0 | 0.105 | 0.057 | 0.912 | 2.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pedal pulse decreased | 0 | 0.105 | 0.056 | 0.912 | 2.657 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otosalpingitis | 0 | 0.105 | 0.058 | 0.912 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heat illness | 0 | 0.105 | 0.057 | 0.912 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periorbital haemorrhage | 0 | 0.105 | 0.056 | 0.912 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tympanometry normal | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acid base balance abnormal | 0 | 0.105 | 0.056 | 0.912 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac resynchronisation therapy | 0 | 0.105 | 0.058 | 0.912 | 2.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine copper increased | 0 | 0.105 | 0.058 | 0.912 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine mercury | 0 | 0.105 | 0.058 | 0.912 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Athetosis | 0 | 0.105 | 0.057 | 0.912 | 2.654 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival injury | 0 | 0.105 | 0.058 | 0.912 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lasegue's test positive | 0 | 0.105 | 0.057 | 0.912 | 2.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement fixation test positive | 0 | 0.105 | 0.058 | 0.912 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal oedema | 0 | 0.105 | 0.058 | 0.912 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic neoplasm | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Merycism | 0 | 0.105 | 0.058 | 0.912 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimitochondrial antibody | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traumatic haematoma | 0 | 0.105 | 0.058 | 0.912 | 2.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukaemia in remission | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine output | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Micrographic skin surgery | 0 | 0.105 | 0.058 | 0.912 | 2.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Photopheresis | 0 | 0.105 | 0.057 | 0.912 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thinking abnormal | 7 | 7.805 | 0.548 | 0.911 | 1.348 | 0.51 | 0.879 | 1.434 | 0.897 | 1.47 | 0.568
COVID19_PFIZER/BIONTECH | Hypertonia | 2 | 2.439 | 0.237 | 0.911 | 1.941 | 0.379 | 0.831 | 1.632 | 0.82 | 0.156 | 8.223
COVID19_PFIZER/BIONTECH | Vitamin D | 2 | 3.335 | 0.417 | 0.911 | 1.56 | 0.328 | 0.722 | 1.421 | 0.6 | 0.547 | 0.337
COVID19_PFIZER/BIONTECH | Carcinoembryonic antigen increased | 0 | 0.105 | 0.055 | 0.911 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site haematoma | 0 | 0.105 | 0.055 | 0.911 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood chromium | 0 | 0.105 | 0.056 | 0.911 | 2.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial rub | 0 | 0.105 | 0.055 | 0.911 | 2.664 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermal cyst | 0 | 0.139 | 0.098 | 0.911 | 2.416 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | West Nile virus test negative | 0 | 0.22 | 0.187 | 0.911 | 2.081 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell sedimentation rate decreased | 0 | 0.105 | 0.056 | 0.911 | 2.661 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otoacoustic emissions test abnormal | 0 | 0.105 | 0.056 | 0.911 | 2.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hippocampal sclerosis | 0 | 0.105 | 0.056 | 0.911 | 2.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bursa removal | 0 | 0.105 | 0.056 | 0.911 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coronary angioplasty | 0 | 0.105 | 0.055 | 0.911 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint effusion | 0 | 0.251 | 0.215 | 0.911 | 2 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia legionella | 0 | 0.105 | 0.055 | 0.911 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glioblastoma | 0 | 0.105 | 0.055 | 0.911 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site cyst | 0 | 0.105 | 0.055 | 0.911 | 2.664 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sciatic nerve neuropathy | 0 | 0.105 | 0.055 | 0.911 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyposplenism | 0 | 0.105 | 0.056 | 0.911 | 2.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acetonaemia | 0 | 0.105 | 0.054 | 0.91 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis shigella | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair metal test normal | 0 | 0.105 | 0.053 | 0.91 | 2.672 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mannose-binding lectin deficiency | 0 | 0.105 | 0.053 | 0.91 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood luteinising hormone | 0 | 0.105 | 0.054 | 0.91 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin electrophoresis normal | 0 | 0.105 | 0.054 | 0.91 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cancer surgery | 0 | 0.117 | 0.069 | 0.91 | 2.568 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diffuse alveolar damage | 0 | 0.105 | 0.054 | 0.91 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound pancreas normal | 0 | 0.105 | 0.054 | 0.91 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Invasive lobular breast carcinoma | 0 | 0.105 | 0.053 | 0.91 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toe amputation | 0 | 0.105 | 0.053 | 0.91 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipoatrophy | 0 | 0.105 | 0.055 | 0.91 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VIII level normal | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet aggregation test | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis lethargica | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total bile acids increased | 0 | 0.105 | 0.053 | 0.91 | 2.672 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periventricular leukomalacia | 0 | 0.105 | 0.054 | 0.91 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head circumference normal | 0 | 0.105 | 0.055 | 0.91 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell analysis | 0 | 0.105 | 0.054 | 0.91 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lactate pyruvate ratio | 0 | 0.105 | 0.053 | 0.91 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site calcification | 0 | 0.105 | 0.055 | 0.91 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heterophoria | 0 | 0.105 | 0.053 | 0.91 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic pigmented purpura | 0 | 0.105 | 0.054 | 0.91 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular function test normal | 0 | 0.105 | 0.054 | 0.91 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echoencephalogram normal | 0 | 0.105 | 0.054 | 0.91 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chorioretinal atrophy | 0 | 0.105 | 0.053 | 0.91 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenosis | 0 | 0.105 | 0.053 | 0.91 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluorescent in situ hybridisation positive | 0 | 0.105 | 0.054 | 0.91 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic valve replacement | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periodontitis | 0 | 0.105 | 0.053 | 0.91 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic reaction to excipient | 0 | 0.133 | 0.089 | 0.91 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract infection pseudomonal | 0 | 0.105 | 0.053 | 0.91 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine iodine increased | 0 | 0.105 | 0.054 | 0.91 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell analysis normal | 0 | 0.105 | 0.054 | 0.91 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue geographic | 0 | 0.105 | 0.054 | 0.91 | 2.671 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hoffmann's sign | 0 | 0.105 | 0.054 | 0.91 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumothorax spontaneous | 0 | 0.105 | 0.055 | 0.91 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrist deformity | 0 | 0.105 | 0.054 | 0.91 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalopathy | 8 | 10.938 | 0.479 | 0.909 | 1.45 | 0.451 | 0.758 | 1.211 | 0.731 | 0.607 | 1.589
COVID19_PFIZER/BIONTECH | Mitochondrial encephalomyopathy | 0 | 0.105 | 0.053 | 0.909 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via mucosa | 0 | 0.105 | 0.053 | 0.909 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal abscess | 0 | 0.105 | 0.053 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation time shortened | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coarctation of the aorta | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte percentage | 0 | 0.105 | 0.052 | 0.909 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granuloma annulare | 0 | 0.178 | 0.138 | 0.909 | 2.239 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antigliadin antibody positive | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deficiency anaemia | 0 | 0.105 | 0.052 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute graft versus host disease | 0 | 0.105 | 0.052 | 0.909 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian germ cell teratoma | 0 | 0.105 | 0.052 | 0.909 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sputum retention | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin blood decreased | 0 | 0.105 | 0.052 | 0.909 | 2.681 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ketogenic diet | 0 | 0.105 | 0.053 | 0.909 | 2.676 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalopathy allergic | 0 | 0.105 | 0.052 | 0.909 | 2.681 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somnolence neonatal | 0 | 0.105 | 0.053 | 0.909 | 2.676 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein C decreased | 0 | 0.105 | 0.053 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic disorders specifically reported as alcohol-related (SMQ) [narrow] | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac hypertrophy | 0 | 0.105 | 0.052 | 0.909 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine lactic acid increased | 0 | 0.105 | 0.053 | 0.909 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spherocytic anaemia | 0 | 0.105 | 0.052 | 0.909 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intercostal neuralgia | 0 | 0.105 | 0.052 | 0.909 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meige's syndrome | 0 | 0.105 | 0.053 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nocardiosis | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Circulating anticoagulant | 0 | 0.105 | 0.053 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human ehrlichiosis | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ureteritis | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic disorders specifically reported as alcohol-related (SMQ) [broad] | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary valve stenosis | 0 | 0.105 | 0.053 | 0.909 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accessory spleen | 0 | 0.105 | 0.053 | 0.909 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal transit time decreased | 0 | 0.105 | 0.053 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebrobasilar insufficiency | 0 | 0.105 | 0.053 | 0.909 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system injury | 0 | 0.105 | 0.052 | 0.909 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal respiratory distress | 0 | 0.105 | 0.053 | 0.909 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device use issue | 0 | 0.105 | 0.052 | 0.909 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Developmental coordination disorder | 0 | 0.105 | 0.052 | 0.909 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skeletal survey | 0 | 0.105 | 0.052 | 0.909 | 2.681 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splinter haemorrhages | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vestibular ataxia | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleroedema | 0 | 0.105 | 0.052 | 0.909 | 2.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin test | 1 | 1.259 | 0.279 | 0.908 | 1.829 | 0.338 | 0.823 | 1.747 | 0.794 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Herpes zoster oticus | 1 | 2.254 | 0.093 | 0.908 | 2.428 | 0.275 | 0.678 | 1.447 | 0.444 | 0.218 | 2.024
COVID19_PFIZER/BIONTECH | Bartonellosis | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Specific gravity urine abnormal | 0 | 0.105 | 0.051 | 0.908 | 2.685 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine decreased | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood electrolytes increased | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell poikilocytes present | 0 | 0.105 | 0.05 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benzodiazepine drug level | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphangioma | 0 | 0.105 | 0.051 | 0.908 | 2.685 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure orthostatic normal | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid hormone replacement therapy | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood HIV RNA decreased | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperresponsive to stimuli | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suicidal behaviour | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrovascular stenosis | 0 | 0.105 | 0.051 | 0.908 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipoma excision | 0 | 0.105 | 0.051 | 0.908 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid operation | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy prostate abnormal | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestrogen deficiency | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tubulointerstitial nephritis and uveitis syndrome | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileocolostomy | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve transposition | 0 | 0.105 | 0.051 | 0.908 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ACTH stimulation test normal | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extremity necrosis | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatotropin stimulation test | 0 | 0.105 | 0.051 | 0.908 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Astrocytoma | 0 | 0.105 | 0.05 | 0.908 | 2.691 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antinuclear antibody increased | 0 | 0.196 | 0.155 | 0.908 | 2.177 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver tenderness | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound infection staphylococcal | 0 | 0.105 | 0.051 | 0.908 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart rate normal | 0 | 0.292 | 0.239 | 0.908 | 1.927 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tolosa-Hunt syndrome | 0 | 0.105 | 0.051 | 0.908 | 2.685 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytokine abnormal | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer in situ | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human herpes virus 6 serology positive | 0 | 0.105 | 0.051 | 0.908 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apheresis | 0 | 0.105 | 0.051 | 0.908 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enamel anomaly | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood selenium | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prenatal care | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Agoraphobia | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol test | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma stage I | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ADAMTS13 activity increased | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor | 0 | 0.105 | 0.051 | 0.908 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder hypofunction | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchial fistula | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram coronary artery abnormal | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rehabilitation therapy | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Xanthelasma | 0 | 0.105 | 0.05 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood cadmium increased | 0 | 0.105 | 0.051 | 0.908 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyomavirus test negative | 0 | 0.105 | 0.051 | 0.908 | 2.684 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital syphilis | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ejaculation failure | 0 | 0.105 | 0.05 | 0.908 | 2.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymph node tuberculosis | 0 | 0.105 | 0.051 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reactive airways dysfunction syndrome | 0 | 0.105 | 0.05 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin normal | 0 | 0.105 | 0.051 | 0.908 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypophonesis | 0 | 0.105 | 0.051 | 0.908 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obstruction gastric | 0 | 0.105 | 0.05 | 0.908 | 2.691 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia pseudomonal | 0 | 0.105 | 0.05 | 0.908 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte stimulation test negative | 0 | 0.105 | 0.05 | 0.908 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flank pain | 21 | 24.318 | 0.652 | 0.907 | 1.195 | 0.608 | 0.86 | 1.189 | 0.864 | 1.896 | 7.223
COVID19_PFIZER/BIONTECH | Otoscopy | 0 | 0.105 | 0.05 | 0.907 | 2.691 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiomyolipoma | 0 | 0.105 | 0.05 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bone | 0 | 0.105 | 0.05 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anterior interosseous syndrome | 0 | 0.105 | 0.05 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Avulsion fracture | 0 | 0.105 | 0.049 | 0.907 | 2.698 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disease risk factor | 0 | 0.105 | 0.049 | 0.907 | 2.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenosine deaminase | 0 | 0.105 | 0.05 | 0.907 | 2.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prealbumin decreased | 0 | 0.105 | 0.05 | 0.907 | 2.693 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subclavian vein thrombosis | 0 | 0.105 | 0.049 | 0.907 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vesicoureteral reflux surgery | 0 | 0.105 | 0.049 | 0.907 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal enanthema | 0 | 0.105 | 0.049 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular myasthenia | 0 | 0.105 | 0.049 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic cyst | 0 | 0.105 | 0.049 | 0.907 | 2.695 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lennox-Gastaut syndrome | 0 | 0.105 | 0.049 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site necrosis | 0 | 0.105 | 0.049 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burning sensation mucosal | 0 | 0.105 | 0.049 | 0.907 | 2.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Failed induction of labour | 0 | 0.105 | 0.049 | 0.907 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erosive oesophagitis | 0 | 0.105 | 0.05 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginitis | 0 | 0.105 | 0.05 | 0.907 | 2.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level increased | 0 | 0.105 | 0.049 | 0.907 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transient hypogammaglobulinaemia of infancy | 0 | 0.105 | 0.049 | 0.907 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumoconiosis | 0 | 0.105 | 0.049 | 0.907 | 2.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Claudication of jaw muscles | 0 | 0.105 | 0.049 | 0.907 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Crystal arthropathy | 0 | 0.105 | 0.05 | 0.907 | 2.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epidural injection | 0 | 0.105 | 0.049 | 0.907 | 2.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone loss | 0 | 0.105 | 0.05 | 0.907 | 2.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal cyst | 0 | 0.105 | 0.049 | 0.907 | 2.695 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PCO2 | 0 | 0.17 | 0.125 | 0.907 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve hypoplasia | 0 | 0.105 | 0.05 | 0.907 | 2.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral arteritis | 0 | 0.105 | 0.049 | 0.907 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile discharge | 0 | 0.105 | 0.049 | 0.907 | 2.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs test | 0 | 0.105 | 0.049 | 0.907 | 2.698 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheitis | 1 | 0.923 | 0.102 | 0.906 | 2.38 | 0.365 | 0.886 | 1.88 | 1.083 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Electromyogram abnormal | 7 | 8.788 | 0.446 | 0.906 | 1.497 | 0.469 | 0.809 | 1.32 | 0.797 | 0.498 | 2.959
COVID19_PFIZER/BIONTECH | Diabetic ketoacidosis | 5 | 6.781 | 0.476 | 0.906 | 1.448 | 0.419 | 0.773 | 1.33 | 0.737 | 4.105 | 7.084
COVID19_PFIZER/BIONTECH | Live birth | 1 | 1.523 | 0.092 | 0.906 | 2.425 | 0.319 | 0.779 | 1.655 | 0.657 | 1.642 | 0.028
COVID19_PFIZER/BIONTECH | X-ray of pelvis and hip | 2 | 3.36 | 0.439 | 0.906 | 1.51 | 0.327 | 0.72 | 1.416 | 0.595 | 1.29 | 0.004
COVID19_PFIZER/BIONTECH | Ehrlichia test positive | 0 | 0.105 | 0.048 | 0.906 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital pyelocaliectasis | 0 | 0.105 | 0.048 | 0.906 | 2.704 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body height below normal | 0 | 0.105 | 0.048 | 0.906 | 2.7 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal deposits | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal aplasia | 0 | 0.105 | 0.048 | 0.906 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kidney fibrosis | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis membranoproliferative | 0 | 0.105 | 0.048 | 0.906 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye infection staphylococcal | 0 | 0.105 | 0.048 | 0.906 | 2.701 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burn oral cavity | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product packaging issue | 0 | 0.147 | 0.097 | 0.906 | 2.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle operation | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine renal clearance | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal tubular disorder | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroleptic malignant syndrome (SMQ) [narrow] | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear irrigation | 0 | 0.105 | 0.048 | 0.906 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chorioretinal disorder | 0 | 0.105 | 0.048 | 0.906 | 2.704 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monomelic amyotrophy | 0 | 0.105 | 0.047 | 0.906 | 2.707 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dependence | 0 | 0.105 | 0.047 | 0.906 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sinusitis bacterial | 0 | 0.105 | 0.048 | 0.906 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb amputation | 0 | 0.105 | 0.048 | 0.906 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human anti-human antibody test | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood group B | 0 | 0.105 | 0.048 | 0.906 | 2.7 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Massage | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem ischaemia | 0 | 0.105 | 0.048 | 0.906 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone graft | 0 | 0.105 | 0.047 | 0.906 | 2.707 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-glomerular basement membrane antibody positive | 0 | 0.105 | 0.048 | 0.906 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serotonin syndrome | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin C | 0 | 0.105 | 0.048 | 0.906 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Koebner phenomenon | 0 | 0.105 | 0.047 | 0.906 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histiocytic necrotising lymphadenitis | 0 | 0.105 | 0.048 | 0.906 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal leukoplakia | 0 | 0.105 | 0.047 | 0.906 | 2.707 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy blood vessel abnormal | 0 | 0.105 | 0.048 | 0.906 | 2.701 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocytic hypophysitis | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal carcinoma | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous oxygen saturation decreased | 0 | 0.157 | 0.108 | 0.906 | 2.352 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood acid phosphatase normal | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemostasis | 0 | 0.105 | 0.047 | 0.906 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy oesophagus abnormal | 0 | 0.105 | 0.048 | 0.906 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte count decreased | 8 | 9.085 | 0.49 | 0.905 | 1.425 | 0.517 | 0.869 | 1.388 | 0.881 | 1.214 | 0.111
COVID19_PFIZER/BIONTECH | Myelitis transverse | 9 | 10.827 | 0.517 | 0.905 | 1.381 | 0.508 | 0.833 | 1.306 | 0.831 | 0.726 | 0.641
COVID19_PFIZER/BIONTECH | Acne conglobata | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HIV antigen positive | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratoplasty | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance elastography | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Environmental exposure | 0 | 0.105 | 0.046 | 0.905 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratouveitis | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital hand malformation | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Olfactory nerve disorder | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trisomy 13 | 0 | 0.105 | 0.047 | 0.905 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Steatorrhoea | 0 | 0.105 | 0.047 | 0.905 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertensive heart disease | 0 | 0.105 | 0.047 | 0.905 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder dysfunction | 0 | 0.168 | 0.117 | 0.905 | 2.31 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myasthenia gravis crisis | 0 | 0.157 | 0.106 | 0.905 | 2.359 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aldosterone increased | 0 | 0.105 | 0.047 | 0.905 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurological infection | 0 | 0.105 | 0.046 | 0.905 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheo-oesophageal fistula | 0 | 0.105 | 0.046 | 0.905 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes virus test abnormal | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parvovirus B19 infection | 0 | 0.105 | 0.046 | 0.905 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac dysfunction | 0 | 0.105 | 0.046 | 0.905 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tinea infection | 0 | 0.174 | 0.124 | 0.905 | 2.28 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrin | 0 | 0.105 | 0.046 | 0.905 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal inflammation | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-high-density lipoprotein cholesterol | 0 | 0.105 | 0.046 | 0.905 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholinergic syndrome | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gilbert's syndrome | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system function test normal | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heparin-induced thrombocytopenia | 0 | 0.105 | 0.047 | 0.905 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rapid eye movement sleep behaviour disorder | 0 | 0.105 | 0.047 | 0.905 | 2.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alphavirus test | 0 | 0.105 | 0.046 | 0.905 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytomegalovirus chorioretinitis | 0 | 0.105 | 0.046 | 0.905 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin dystrophy | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colectomy total | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticaria pigmentosa | 0 | 0.105 | 0.047 | 0.905 | 2.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HIV antibody positive | 0 | 0.105 | 0.046 | 0.905 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumbosacral plexopathy | 0 | 0.105 | 0.046 | 0.905 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vital dye staining cornea present | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encapsulation reaction | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vein collapse | 0 | 0.105 | 0.046 | 0.905 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial occlusive disease | 0 | 0.157 | 0.105 | 0.905 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disinhibition | 0 | 0.105 | 0.046 | 0.905 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reversible airways obstruction | 0 | 0.105 | 0.046 | 0.905 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood methaemoglobin present | 0 | 0.157 | 0.107 | 0.905 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | False negative investigation result | 0 | 0.105 | 0.046 | 0.905 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | External ear cellulitis | 0 | 0.105 | 0.047 | 0.905 | 2.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trisomy 18 | 0 | 0.105 | 0.047 | 0.905 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy kidney normal | 0 | 0.105 | 0.046 | 0.905 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypophagia | 14 | 15.239 | 0.591 | 0.904 | 1.27 | 0.597 | 0.903 | 1.323 | 0.919 | 0.808 | 0.434
COVID19_PFIZER/BIONTECH | Generalised oedema | 1 | 1.844 | 0.243 | 0.904 | 1.907 | 0.298 | 0.732 | 1.557 | 0.542 | 0.475 | 0.154
COVID19_PFIZER/BIONTECH | Biopsy bone abnormal | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital hydrocephalus | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhesus antibodies negative | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hemianopia homonymous | 0 | 0.105 | 0.045 | 0.904 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cord blood transplant therapy | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral tonsillitis | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complication of delivery | 0 | 0.105 | 0.045 | 0.904 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric fluid analysis abnormal | 0 | 0.105 | 0.045 | 0.904 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy mucosa abnormal | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bloch-Sulzberger syndrome | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin decreased | 0 | 0.105 | 0.046 | 0.904 | 2.716 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia respiratory syncytial viral | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blast cell count increased | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyelonephritis acute | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-islet cell antibody negative | 0 | 0.105 | 0.045 | 0.904 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vocal cord paresis | 0 | 0.105 | 0.046 | 0.904 | 2.716 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eccentric fixation | 0 | 0.105 | 0.045 | 0.904 | 2.717 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteoporosis | 0 | 0.225 | 0.173 | 0.904 | 2.104 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune tolerance induction | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal dilation procedure | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensitisation | 0 | 0.105 | 0.045 | 0.904 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hand-foot-and-mouth disease | 0 | 0.165 | 0.112 | 0.904 | 2.329 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac murmur functional | 0 | 0.105 | 0.045 | 0.904 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue exfoliation | 0 | 0.105 | 0.044 | 0.904 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract obstruction | 0 | 0.105 | 0.045 | 0.904 | 2.717 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yellow nail syndrome | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye colour change | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premenstrual headache | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Divorced | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dacryostenosis acquired | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurodevelopment test | 0 | 0.105 | 0.045 | 0.904 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic bronchitis | 0 | 0.105 | 0.046 | 0.904 | 2.716 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroconvulsive therapy | 0 | 0.105 | 0.044 | 0.904 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral diarrhoea | 0 | 0.105 | 0.045 | 0.904 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Molluscum contagiosum | 0 | 0.164 | 0.112 | 0.904 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fungal test negative | 1 | 1.065 | 0.306 | 0.903 | 1.756 | 0.353 | 0.858 | 1.821 | 0.939 | 0.488 | 0.129
COVID19_PFIZER/BIONTECH | Dermatitis bullous | 1 | 1.281 | 0.235 | 0.903 | 1.923 | 0.336 | 0.819 | 1.739 | 0.781 | 0.181 | 2.875
COVID19_PFIZER/BIONTECH | Viral myositis | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myringitis | 0 | 0.105 | 0.043 | 0.903 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vibration test normal | 0 | 0.105 | 0.044 | 0.903 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor level normal | 0 | 0.105 | 0.044 | 0.903 | 2.727 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glycosylated haemoglobin decreased | 0 | 0.157 | 0.102 | 0.903 | 2.371 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stenotrophomonas test positive | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic calcification | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF monocyte count negative | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precipitate labour | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine cytology | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid skin dryness | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug provocation test | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Quantitative sudomotor axon reflex test | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron binding capacity total increased | 0 | 0.105 | 0.043 | 0.903 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secondary hypogonadism | 0 | 0.105 | 0.044 | 0.903 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serum ferritin abnormal | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood corticotrophin normal | 0 | 0.105 | 0.044 | 0.903 | 2.727 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site nodule | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heterotaxia | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood oestrogen | 0 | 0.105 | 0.044 | 0.903 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood 25-hydroxycholecalciferol decreased | 0 | 0.105 | 0.044 | 0.903 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous haemorrhage | 0 | 0.105 | 0.043 | 0.903 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngoscopy | 0 | 0.105 | 0.043 | 0.903 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial haemorrhage | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angioscopy | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal manometry | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal labour affecting foetus | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adhesion | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sexually active | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic dilatation | 0 | 0.105 | 0.044 | 0.903 | 2.727 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ciliary hyperaemia | 0 | 0.105 | 0.044 | 0.903 | 2.727 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor V antibody | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sitting disability | 0 | 0.157 | 0.101 | 0.903 | 2.374 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cleft palate | 0 | 0.105 | 0.044 | 0.903 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bilirubin abnormal | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha-1 anti-trypsin normal | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweat gland disorder | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatitis | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear buccal abnormal | 0 | 0.105 | 0.044 | 0.903 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal migraine | 0 | 0.105 | 0.043 | 0.903 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inappropriate affect | 0 | 0.369 | 0.277 | 0.903 | 1.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epstein-Barr viraemia | 0 | 0.105 | 0.044 | 0.903 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Culture tissue specimen positive | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Walking distance test abnormal | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign breast neoplasm | 0 | 0.105 | 0.043 | 0.903 | 2.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Waterhouse-Friderichsen syndrome | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pain threshold decreased | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint laxity | 0 | 0.105 | 0.043 | 0.903 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiopathic angioedema | 0 | 0.105 | 0.043 | 0.903 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal mucosal erosion | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram kidney normal | 0 | 0.105 | 0.044 | 0.903 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diet noncompliance | 0 | 0.105 | 0.043 | 0.903 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic disc drusen | 0 | 0.105 | 0.044 | 0.903 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Night blindness | 0 | 0.105 | 0.044 | 0.903 | 2.726 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic neoplasm | 0 | 0.105 | 0.044 | 0.903 | 2.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histone antibody | 0 | 0.105 | 0.044 | 0.903 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan gallium abnormal | 0 | 0.105 | 0.043 | 0.903 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin globulin ratio normal | 2 | 1.946 | 0.356 | 0.902 | 1.652 | 0.413 | 0.905 | 1.779 | 1.028 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Cerebral atrophy congenital | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blastic plasmacytoid dendritic cell neoplasia | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal pain | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hodgkin's disease recurrent | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal fungal infection | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoglycaemic coma | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haptoglobin abnormal | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | POEMS syndrome | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid retraction | 0 | 0.105 | 0.043 | 0.902 | 2.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrin D dimer decreased | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Threatened labour | 0 | 0.105 | 0.042 | 0.902 | 2.738 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic neuropathy | 0 | 0.105 | 0.042 | 0.902 | 2.738 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perineal abscess | 0 | 0.105 | 0.043 | 0.902 | 2.734 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal vomiting | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF cell count abnormal | 0 | 0.105 | 0.043 | 0.902 | 2.733 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B12 absorption test normal | 0 | 0.105 | 0.043 | 0.902 | 2.733 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Starvation | 0 | 0.105 | 0.043 | 0.902 | 2.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Copper deficiency | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy stomach normal | 0 | 0.105 | 0.043 | 0.902 | 2.733 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy thymus gland abnormal | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulosclerosis | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaemia vitamin B12 deficiency | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary arterial hypertension | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic colitis | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis influenzal | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dark circles under eyes | 0 | 0.611 | 0.379 | 0.902 | 1.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spontaneous haematoma | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood androstenedione | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuropsychiatric lupus | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Waxy flexibility | 0 | 0.105 | 0.043 | 0.902 | 2.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile wart | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choroidal effusion | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thought blocking | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy thyroid gland abnormal | 0 | 0.105 | 0.042 | 0.902 | 2.738 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Economic problem | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood acid phosphatase increased | 0 | 0.105 | 0.042 | 0.902 | 2.738 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral sinusitis | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepcidin test | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic ketoacidotic hyperglycaemic coma | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumbar vertebral fracture | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung neoplasm | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ectropion of cervix | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart valve operation | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cells stool positive | 0 | 0.056 | 0.004 | 0.902 | 3.436 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypocomplementaemia | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood luteinising hormone normal | 0 | 0.105 | 0.043 | 0.902 | 2.734 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Automatism | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bone normal | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthrogram abnormal | 0 | 0.105 | 0.043 | 0.902 | 2.734 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Unintended pregnancy | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis rapidly progressive | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Free thyroxine index normal | 0 | 0.105 | 0.043 | 0.902 | 2.734 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychotic behaviour | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paresis cranial nerve | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastatic neoplasm | 0 | 0.105 | 0.043 | 0.902 | 2.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Female reproductive tract disorder | 0 | 0.105 | 0.042 | 0.902 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antigliadin antibody | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord infarction | 0 | 0.105 | 0.042 | 0.902 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ophthalmia neonatorum | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biofeedback therapy | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired epidermolysis bullosa | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anorexia nervosa | 0 | 0.105 | 0.043 | 0.902 | 2.734 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transplant failure | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibroadenoma of breast | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sigmoidoscopy normal | 0 | 0.105 | 0.042 | 0.902 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid neoplasm | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital skin dimples | 0 | 0.105 | 0.042 | 0.902 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via unknown route | 0 | 0.105 | 0.043 | 0.902 | 2.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barrett's oesophagus | 0 | 0.105 | 0.042 | 0.902 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant melanoma in situ | 0 | 0.105 | 0.043 | 0.902 | 2.735 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borrelia test | 1 | 1.749 | 0.387 | 0.901 | 1.59 | 0.304 | 0.745 | 1.585 | 0.572 | 0.138 | 4.487
COVID19_PFIZER/BIONTECH | Retained placenta or membranes | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extradural haematoma | 0 | 0.105 | 0.042 | 0.901 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system vasculitis | 0 | 0.213 | 0.155 | 0.901 | 2.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary hypothyroidism | 0 | 0.105 | 0.041 | 0.901 | 2.744 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasculitis necrotising | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngitis allergic | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capillary fragility test | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood electrolytes abnormal | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subcorneal pustular dermatosis | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Specific gravity body fluid | 0 | 0.105 | 0.041 | 0.901 | 2.745 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abortion incomplete | 0 | 0.105 | 0.041 | 0.901 | 2.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus bronchitis | 0 | 0.105 | 0.042 | 0.901 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nutritional condition abnormal | 0 | 0.105 | 0.042 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood oestrogen normal | 0 | 0.105 | 0.041 | 0.901 | 2.744 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatofibroma removal | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Factor VIII deficiency | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood zinc increased | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryptococcosis | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acantholysis | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteopetrosis | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosal hypertrophy | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin A abnormal | 0 | 0.105 | 0.041 | 0.901 | 2.745 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash neonatal | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prothrombin level increased | 0 | 0.157 | 0.098 | 0.901 | 2.381 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aeromonas infection | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prolonged expiration | 0 | 0.105 | 0.041 | 0.901 | 2.745 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product container seal issue | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B complex deficiency | 0 | 0.105 | 0.041 | 0.901 | 2.742 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal stenosis | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxoplasma serology positive | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ulnar nerve injury | 0 | 0.105 | 0.042 | 0.901 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine free normal | 0 | 0.114 | 0.051 | 0.901 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF volume increased | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testis discomfort | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neck surgery | 0 | 0.105 | 0.041 | 0.901 | 2.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limbic encephalitis | 0 | 0.105 | 0.041 | 0.901 | 2.742 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile swelling | 0 | 0.236 | 0.173 | 0.901 | 2.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aeromonas test positive | 0 | 0.105 | 0.041 | 0.901 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyphaema | 0 | 0.105 | 0.041 | 0.901 | 2.746 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic foot | 0 | 0.105 | 0.041 | 0.901 | 2.745 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryptorchism | 0 | 0.105 | 0.041 | 0.901 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema | 7 | 8.348 | 0.459 | 0.9 | 1.461 | 0.486 | 0.839 | 1.369 | 0.838 | 0.213 | 19.364
COVID19_PFIZER/BIONTECH | Ocular infections (SMQ) [narrow] | 9 | 20.661 | 0.485 | 0.9 | 1.418 | 0.301 | 0.495 | 0.777 | 0.436 | 0.234 | 21.5
COVID19_PFIZER/BIONTECH | Blood cholesterol abnormal | 0 | 0.157 | 0.096 | 0.9 | 2.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inadequate diet | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail dystrophy | 0 | 0.105 | 0.04 | 0.9 | 2.749 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate deceleration abnormality | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tachycardia paroxysmal | 0 | 0.105 | 0.039 | 0.9 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metamyelocyte percentage increased | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyneuropathy idiopathic progressive | 0 | 0.105 | 0.039 | 0.9 | 2.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine rupture | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan bone marrow abnormal | 0 | 0.105 | 0.04 | 0.9 | 2.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monoclonal immunoglobulin present | 0 | 0.105 | 0.04 | 0.9 | 2.748 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash follicular | 0 | 0.157 | 0.096 | 0.9 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incorrect product administration duration | 0 | 0.105 | 0.04 | 0.9 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal pap smear | 0 | 0.105 | 0.039 | 0.9 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular retraction | 0 | 0.105 | 0.039 | 0.9 | 2.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital burning sensation | 0 | 0.157 | 0.096 | 0.9 | 2.391 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urethral stenosis | 0 | 0.105 | 0.04 | 0.9 | 2.753 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash papulosquamous | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperintensity in brain deep nuclei | 0 | 0.105 | 0.04 | 0.9 | 2.748 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site plaque | 0 | 0.263 | 0.196 | 0.9 | 2.023 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint infection | 0 | 0.105 | 0.04 | 0.9 | 2.749 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin normal | 0 | 0.105 | 0.04 | 0.9 | 2.752 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound scan vagina normal | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radioactive iodine therapy | 0 | 0.105 | 0.04 | 0.9 | 2.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Omphalitis | 0 | 0.105 | 0.04 | 0.9 | 2.752 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perinatal HBV infection | 0 | 0.105 | 0.04 | 0.9 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QT interval abnormal | 0 | 0.105 | 0.04 | 0.9 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ADAMTS13 activity normal | 0 | 0.105 | 0.039 | 0.9 | 2.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid nodule | 0 | 0.105 | 0.04 | 0.9 | 2.748 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catheter site erythema | 0 | 0.105 | 0.039 | 0.9 | 2.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hand amputation | 0 | 0.105 | 0.04 | 0.9 | 2.752 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basophilia | 0 | 0.105 | 0.04 | 0.9 | 2.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breath sounds abnormal | 8 | 9.848 | 0.475 | 0.899 | 1.431 | 0.488 | 0.82 | 1.309 | 0.812 | 0.749 | 0.419
COVID19_PFIZER/BIONTECH | Syringe issue | 12 | 20.582 | 0.525 | 0.899 | 1.354 | 0.399 | 0.621 | 0.931 | 0.583 | 0.383 | 11.077
COVID19_PFIZER/BIONTECH | Zinc deficiency | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary hypoplasia | 0 | 0.105 | 0.038 | 0.899 | 2.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood parathyroid hormone | 0 | 0.157 | 0.094 | 0.899 | 2.397 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis viral | 0 | 0.105 | 0.039 | 0.899 | 2.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal elastase concentration decreased | 0 | 0.105 | 0.038 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal pneumonia | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Needle track marks | 0 | 0.105 | 0.039 | 0.899 | 2.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatitis necrotising | 0 | 0.105 | 0.038 | 0.899 | 2.762 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complication of device insertion | 0 | 0.105 | 0.039 | 0.899 | 2.756 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amoeba test positive | 0 | 0.105 | 0.038 | 0.899 | 2.762 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chest wall mass | 0 | 0.21 | 0.147 | 0.899 | 2.177 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opiates positive | 0 | 0.105 | 0.039 | 0.899 | 2.756 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interleukin therapy | 0 | 0.105 | 0.039 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-islet cell antibody | 0 | 0.105 | 0.038 | 0.899 | 2.763 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitochondrial myopathy | 0 | 0.105 | 0.039 | 0.899 | 2.759 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple epiphyseal dysplasia | 0 | 0.105 | 0.038 | 0.899 | 2.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Torsade de pointes | 0 | 0.105 | 0.039 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | UV light therapy | 0 | 0.105 | 0.039 | 0.899 | 2.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac function test abnormal | 0 | 0.105 | 0.039 | 0.899 | 2.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory disorder neonatal | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autologous haematopoietic stem cell transplant | 0 | 0.105 | 0.039 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF electrophoresis abnormal | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriogram | 0 | 0.157 | 0.094 | 0.899 | 2.395 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular insufficiency | 0 | 0.105 | 0.039 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malaria antibody test positive | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corynebacterium bacteraemia | 0 | 0.105 | 0.038 | 0.899 | 2.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seizure anoxic | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal injury | 0 | 0.105 | 0.039 | 0.899 | 2.759 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typical aura without headache | 0 | 0.105 | 0.039 | 0.899 | 2.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E antigen positive | 0 | 0.105 | 0.039 | 0.899 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance cholangiopancreatography | 2 | 2.953 | 0.362 | 0.898 | 1.627 | 0.348 | 0.765 | 1.504 | 0.677 | 3.284 | 1.035
COVID19_PFIZER/BIONTECH | Base excess abnormal | 0 | 0.105 | 0.038 | 0.898 | 2.764 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venipuncture | 0 | 0.105 | 0.037 | 0.898 | 2.768 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia influenzal | 0 | 0.105 | 0.038 | 0.898 | 2.766 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schistosoma test negative | 0 | 0.105 | 0.037 | 0.898 | 2.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cleft lip | 0 | 0.105 | 0.037 | 0.898 | 2.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic oedema | 0 | 0.105 | 0.038 | 0.898 | 2.766 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin urine increased | 0 | 0.105 | 0.037 | 0.898 | 2.768 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual field tests normal | 0 | 0.105 | 0.037 | 0.898 | 2.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Self-induced vomiting | 0 | 0.105 | 0.037 | 0.898 | 2.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign neoplasm of thyroid gland | 0 | 0.105 | 0.038 | 0.898 | 2.765 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic haemorrhage | 0 | 0.105 | 0.038 | 0.898 | 2.764 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterocolitis infectious | 0 | 0.105 | 0.038 | 0.898 | 2.766 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site inflammation | 0 | 0.105 | 0.037 | 0.898 | 2.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bulimia nervosa | 0 | 0.105 | 0.037 | 0.898 | 2.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-VGKC antibody positive | 0 | 0.105 | 0.037 | 0.898 | 2.769 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typhus rickettsia test positive | 0 | 0.105 | 0.037 | 0.898 | 2.768 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise test normal | 0 | 0.105 | 0.038 | 0.898 | 2.763 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood copper decreased | 0 | 0.105 | 0.037 | 0.898 | 2.768 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue cyst | 0 | 0.105 | 0.038 | 0.898 | 2.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sickle cell trait | 0 | 0.105 | 0.037 | 0.898 | 2.769 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue operation | 0 | 0.105 | 0.038 | 0.898 | 2.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hostility/aggression (SMQ) [narrow] | 10 | 11.326 | 0.536 | 0.897 | 1.333 | 0.542 | 0.872 | 1.345 | 0.883 | 0.492 | 4.6
COVID19_PFIZER/BIONTECH | Scab | 12 | 19.438 | 0.535 | 0.897 | 1.335 | 0.419 | 0.652 | 0.977 | 0.617 | 0.414 | 9.128
COVID19_PFIZER/BIONTECH | Haemorrhagic pneumonia | 0 | 0.105 | 0.037 | 0.897 | 2.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shock hypoglycaemic | 0 | 0.105 | 0.036 | 0.897 | 2.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acquired immunodeficiency syndrome | 0 | 0.105 | 0.036 | 0.897 | 2.778 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune retinopathy | 0 | 0.105 | 0.037 | 0.897 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal ulcer | 0 | 0.105 | 0.036 | 0.897 | 2.778 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Murine typhus | 0 | 0.105 | 0.037 | 0.897 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal volume increased | 0 | 0.11 | 0.041 | 0.897 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine uric acid normal | 0 | 0.105 | 0.037 | 0.897 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal fistula | 0 | 0.105 | 0.036 | 0.897 | 2.777 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy heart | 0 | 0.105 | 0.037 | 0.897 | 2.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF polymorphonuclear cell count increased | 0 | 0.157 | 0.091 | 0.897 | 2.406 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood corticotrophin decreased | 0 | 0.105 | 0.037 | 0.897 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hereditary ataxia | 0 | 0.105 | 0.036 | 0.897 | 2.774 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encopresis | 0 | 0.105 | 0.036 | 0.897 | 2.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kidney enlargement | 0 | 0.157 | 0.09 | 0.897 | 2.408 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune pancreatitis | 0 | 0.105 | 0.036 | 0.897 | 2.774 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Screaming | 6 | 8.114 | 0.454 | 0.896 | 1.459 | 0.433 | 0.77 | 1.288 | 0.739 | 0.095 | 50.758
COVID19_PFIZER/BIONTECH | Spinal stenosis | 1 | 1.523 | 0.269 | 0.896 | 1.82 | 0.319 | 0.779 | 1.655 | 0.657 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Haemangioma-thrombocytopenia syndrome | 0 | 0.105 | 0.036 | 0.896 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholangitis sclerosing | 0 | 0.105 | 0.035 | 0.896 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin CSF abnormal | 0 | 0.105 | 0.035 | 0.896 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood alcohol increased | 0 | 0.105 | 0.035 | 0.896 | 2.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device dependence | 0 | 0.157 | 0.088 | 0.896 | 2.417 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microvillous inclusion disease | 0 | 0.105 | 0.036 | 0.896 | 2.779 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour marker decreased | 0 | 0.105 | 0.036 | 0.896 | 2.779 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal vascular disorder | 0 | 0.105 | 0.036 | 0.896 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Giardiasis | 0 | 0.105 | 0.036 | 0.896 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Teeth brittle | 0 | 0.105 | 0.035 | 0.895 | 2.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Saliva analysis abnormal | 0 | 0.105 | 0.035 | 0.895 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuropsychological test | 0 | 0.113 | 0.042 | 0.895 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary casts absent | 0 | 0.157 | 0.087 | 0.895 | 2.419 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteitis | 0 | 0.113 | 0.042 | 0.895 | 2.718 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site exfoliation | 0 | 0.32 | 0.223 | 0.895 | 1.933 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebellar atrophy | 0 | 0.157 | 0.087 | 0.895 | 2.419 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echo virus infection | 0 | 0.157 | 0.086 | 0.895 | 2.423 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lumbar puncture abnormal | 5 | 6.906 | 0.44 | 0.894 | 1.477 | 0.414 | 0.763 | 1.315 | 0.724 | 0.516 | 1.739
COVID19_PFIZER/BIONTECH | Macule | 1 | 2.354 | 0.301 | 0.894 | 1.742 | 0.269 | 0.666 | 1.423 | 0.425 | 0.203 | 2.321
COVID19_PFIZER/BIONTECH | Postoperative wound infection | 0 | 0.157 | 0.084 | 0.894 | 2.428 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysbiosis | 0 | 0.156 | 0.083 | 0.894 | 2.434 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clostridium test | 0 | 0.266 | 0.182 | 0.894 | 2.047 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device failure | 0 | 0.157 | 0.084 | 0.894 | 2.429 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal mucosal blistering | 0 | 0.105 | 0.033 | 0.894 | 2.799 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mass excision | 0 | 0.172 | 0.1 | 0.894 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metabolic syndrome | 0 | 0.157 | 0.084 | 0.894 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Circumstance or information capable of leading to medication error | 4 | 3.739 | 0.375 | 0.893 | 1.59 | 0.496 | 0.957 | 1.706 | 1.07 | 0.315 | 5.155
COVID19_PFIZER/BIONTECH | Tongue oedema | 2 | 2.637 | 0.324 | 0.893 | 1.69 | 0.366 | 0.804 | 1.58 | 0.759 | 2.007 | 0.204
COVID19_PFIZER/BIONTECH | Malignant or unspecified tumours (SMQ) [broad] | 27 | 36.111 | 0.636 | 0.893 | 1.187 | 0.555 | 0.756 | 1.011 | 0.748 | 0.632 | 5.216
COVID19_PFIZER/BIONTECH | Malignant or unspecified tumours (SMQ) [narrow] | 27 | 36.111 | 0.636 | 0.893 | 1.187 | 0.555 | 0.756 | 1.011 | 0.748 | 0.632 | 5.216
COVID19_PFIZER/BIONTECH | Arachnoiditis | 0 | 0.105 | 0.032 | 0.893 | 2.806 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tympanic membrane perforation | 0 | 0.312 | 0.212 | 0.893 | 1.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasitic test | 0 | 0.136 | 0.061 | 0.893 | 2.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure to contaminated device | 0 | 0.157 | 0.083 | 0.893 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auricular swelling | 0 | 0.157 | 0.083 | 0.893 | 2.431 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyanosis | 21 | 24.317 | 0.614 | 0.892 | 1.212 | 0.608 | 0.86 | 1.189 | 0.864 | 0.297 | 33.683
COVID19_PFIZER/BIONTECH | Pleuropericarditis | 0 | 0.157 | 0.082 | 0.892 | 2.437 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune dermatitis | 0 | 0.157 | 0.082 | 0.892 | 2.436 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemangioma | 0 | 0.259 | 0.173 | 0.892 | 2.07 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cognitive linguistic deficit | 0 | 0.157 | 0.08 | 0.892 | 2.442 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic enzymes normal | 0 | 0.157 | 0.081 | 0.892 | 2.441 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subarachnoid haemorrhage | 4 | 5.138 | 0.409 | 0.891 | 1.523 | 0.416 | 0.804 | 1.432 | 0.779 | 3.802 | 4.6
COVID19_PFIZER/BIONTECH | Pityriasis | 0 | 0.157 | 0.079 | 0.891 | 2.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine alcohol test negative | 0 | 0.105 | 0.03 | 0.891 | 2.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium enema abnormal | 0 | 0.109 | 0.034 | 0.891 | 2.779 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personality change | 2 | 2.661 | 0.29 | 0.89 | 1.758 | 0.365 | 0.801 | 1.574 | 0.752 | 0.26 | 3.423
COVID19_PFIZER/BIONTECH | Vaccination site mass | 4 | 5.349 | 0.371 | 0.89 | 1.589 | 0.407 | 0.785 | 1.399 | 0.748 | 0.722 | 0.177
COVID19_PFIZER/BIONTECH | Inflammatory marker increased | 3 | 4.581 | 0.375 | 0.89 | 1.583 | 0.36 | 0.736 | 1.369 | 0.655 | 0.341 | 3.105
COVID19_PFIZER/BIONTECH | Product confusion | 0 | 0.157 | 0.078 | 0.89 | 2.448 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subperiosteal abscess | 0 | 0.157 | 0.079 | 0.89 | 2.448 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral sensorimotor neuropathy | 0 | 0.234 | 0.147 | 0.89 | 2.148 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromuscular pain | 0 | 0.157 | 0.077 | 0.89 | 2.453 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Milk soy protein intolerance | 0 | 0.157 | 0.077 | 0.89 | 2.453 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gonorrhoea | 0 | 0.157 | 0.077 | 0.89 | 2.452 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial stenosis | 0 | 0.157 | 0.078 | 0.89 | 2.45 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purulence | 0 | 0.273 | 0.178 | 0.89 | 2.048 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tardive dyskinesia | 0 | 0.287 | 0.19 | 0.89 | 2.013 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chalazion | 0 | 0.157 | 0.078 | 0.89 | 2.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival swelling | 5 | 6.737 | 0.417 | 0.889 | 1.503 | 0.42 | 0.776 | 1.336 | 0.742 | 1.881 | 1.122
COVID19_PFIZER/BIONTECH | Haematoma evacuation | 0 | 0.157 | 0.077 | 0.889 | 2.454 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoidal hypertrophy | 0 | 0.149 | 0.068 | 0.889 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lip and/or oral cavity cancer | 0 | 0.157 | 0.077 | 0.889 | 2.455 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shoulder operation | 0 | 0.273 | 0.177 | 0.889 | 2.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound pelvis normal | 0 | 0.209 | 0.123 | 0.889 | 2.235 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar haemorrhage | 0 | 0.157 | 0.076 | 0.889 | 2.457 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decorticate posture | 0 | 0.157 | 0.076 | 0.889 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Temperature regulation disorder | 1 | 1.403 | 0.074 | 0.888 | 2.466 | 0.327 | 0.799 | 1.695 | 0.713 | 0.194 | 2.521
COVID19_PFIZER/BIONTECH | Depression and suicide/self-injury (SMQ) [narrow] | 19 | 25.209 | 0.591 | 0.888 | 1.234 | 0.532 | 0.764 | 1.071 | 0.754 | 0.375 | 18.798
COVID19_PFIZER/BIONTECH | Wrong technique in product usage process | 7 | 13.821 | 0.428 | 0.888 | 1.483 | 0.333 | 0.575 | 0.939 | 0.506 | 0.165 | 28.446
COVID19_PFIZER/BIONTECH | Haemangioma of skin | 0 | 0.157 | 0.074 | 0.888 | 2.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell morphology abnormal | 0 | 0.157 | 0.074 | 0.888 | 2.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fraction of inspired oxygen | 0 | 0.262 | 0.166 | 0.888 | 2.08 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oxygen saturation increased | 0 | 0.157 | 0.075 | 0.888 | 2.461 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophilus test | 0 | 0.157 | 0.074 | 0.888 | 2.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal carcinoma | 0 | 0.157 | 0.075 | 0.888 | 2.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Delayed fontanelle closure | 0 | 0.157 | 0.075 | 0.888 | 2.462 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurosurgery | 0 | 0.157 | 0.074 | 0.888 | 2.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | General anaesthesia | 0 | 0.157 | 0.075 | 0.888 | 2.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ingrown hair | 0 | 0.157 | 0.074 | 0.888 | 2.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intraocular lens implant | 0 | 0.21 | 0.123 | 0.888 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine urine increased | 0 | 0.157 | 0.074 | 0.888 | 2.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Squamous cell carcinoma of skin | 0 | 0.157 | 0.075 | 0.888 | 2.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan | 2 | 2.364 | 0.267 | 0.887 | 1.801 | 0.383 | 0.841 | 1.653 | 0.846 | 0.475 | 0.654
COVID19_PFIZER/BIONTECH | Catheter placement | 1 | 1.415 | 0.246 | 0.887 | 1.849 | 0.326 | 0.797 | 1.691 | 0.707 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Generalised convulsive seizures following immunisation (SMQ) [narrow] | 91 | 120.117 | 0.741 | 0.887 | 1.043 | 0.64 | 0.76 | 0.898 | 0.758 | 0.246 | 210.644
COVID19_PFIZER/BIONTECH | Intertrigo | 0 | 0.157 | 0.073 | 0.887 | 2.467 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sputum normal | 0 | 0.157 | 0.073 | 0.887 | 2.467 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterostomy | 0 | 0.157 | 0.073 | 0.887 | 2.469 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oxygen consumption increased | 0 | 0.157 | 0.073 | 0.887 | 2.469 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular test normal | 0 | 0.157 | 0.074 | 0.887 | 2.465 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine ketone body | 0 | 0.157 | 0.072 | 0.887 | 2.47 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Axillary vein thrombosis | 0 | 0.157 | 0.074 | 0.887 | 2.466 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varices oesophageal | 0 | 0.157 | 0.074 | 0.887 | 2.466 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrin degradation products | 0 | 0.157 | 0.074 | 0.887 | 2.466 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head lag | 0 | 0.157 | 0.074 | 0.887 | 2.465 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram P wave abnormal | 0 | 0.157 | 0.073 | 0.887 | 2.467 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan bone marrow normal | 0 | 0.157 | 0.073 | 0.887 | 2.468 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignancy related conditions (SMQ) [narrow] | 1 | 1.523 | 0.136 | 0.886 | 2.178 | 0.319 | 0.779 | 1.655 | 0.657 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Malignancy related conditions (SMQ) [broad] | 1 | 1.523 | 0.136 | 0.886 | 2.178 | 0.319 | 0.779 | 1.655 | 0.657 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Glossopharyngeal neuralgia | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy abdominal wall abnormal | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryptococcus test positive | 0 | 0.157 | 0.071 | 0.886 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diverticular perforation | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site erythema | 0 | 0.157 | 0.071 | 0.886 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chlamydia test positive | 0 | 0.059 | 0.002 | 0.886 | 3.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Onychalgia | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroperitoneal lymphadenopathy | 0 | 0.157 | 0.072 | 0.886 | 2.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular insufficiency | 0 | 0.179 | 0.091 | 0.886 | 2.369 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normochromic normocytic anaemia | 0 | 0.082 | 0.011 | 0.886 | 3.117 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy lymph gland normal | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyramidal tract syndrome | 0 | 0.059 | 0.002 | 0.886 | 3.508 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sciatic nerve injury | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood calcitonin | 0 | 0.157 | 0.071 | 0.886 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mixed anxiety and depressive disorder | 0 | 0.157 | 0.071 | 0.886 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystogram | 0 | 0.157 | 0.072 | 0.886 | 2.471 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug administered in wrong device | 0 | 0.105 | 0.025 | 0.886 | 2.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash macular | 105 | 121.565 | 0.754 | 0.885 | 1.024 | 0.735 | 0.863 | 1.008 | 0.864 | 1.032 | 0.068
COVID19_PFIZER/BIONTECH | Chromaturia | 12 | 14.375 | 0.552 | 0.885 | 1.283 | 0.537 | 0.836 | 1.252 | 0.835 | 1.204 | 0.213
COVID19_PFIZER/BIONTECH | Eosinophil percentage decreased | 3 | 4.335 | 0.3 | 0.885 | 1.719 | 0.371 | 0.758 | 1.411 | 0.692 | 0.511 | 0.909
COVID19_PFIZER/BIONTECH | Joint vibration | 0 | 0.157 | 0.069 | 0.885 | 2.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug level therapeutic | 0 | 0.157 | 0.07 | 0.885 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Social fear | 0 | 0.157 | 0.071 | 0.885 | 2.477 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Birth mark | 0 | 0.157 | 0.07 | 0.885 | 2.48 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess neck | 0 | 0.157 | 0.071 | 0.885 | 2.477 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye symptom | 0 | 0.157 | 0.069 | 0.885 | 2.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site dysaesthesia | 0 | 0.157 | 0.07 | 0.885 | 2.479 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Demyelination | 3 | 3.495 | 0.289 | 0.884 | 1.741 | 0.416 | 0.849 | 1.579 | 0.858 | 0.382 | 2.342
COVID19_PFIZER/BIONTECH | Troponin I | 6 | 7.482 | 0.456 | 0.884 | 1.427 | 0.458 | 0.814 | 1.362 | 0.802 | 3.284 | 6.153
COVID19_PFIZER/BIONTECH | Congestive cardiomyopathy | 0 | 0.225 | 0.127 | 0.884 | 2.205 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal transplant | 0 | 0.157 | 0.069 | 0.884 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enzyme abnormality | 0 | 0.157 | 0.069 | 0.884 | 2.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychotherapy | 0 | 0.157 | 0.069 | 0.884 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Naevus flammeus | 0 | 0.157 | 0.068 | 0.884 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin indentation | 0 | 0.292 | 0.178 | 0.884 | 2.028 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyshidrotic eczema | 0 | 0.157 | 0.069 | 0.884 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site macule | 0 | 0.416 | 0.252 | 0.884 | 1.827 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flashback | 0 | 0.157 | 0.069 | 0.884 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic membrane rupture test positive | 0 | 0.157 | 0.069 | 0.884 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelopathy | 1 | 1.022 | 0.171 | 0.883 | 2.047 | 0.356 | 0.867 | 1.838 | 0.979 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Bed rest | 4 | 4.491 | 0.404 | 0.883 | 1.51 | 0.45 | 0.868 | 1.547 | 0.891 | 0.769 | 0.085
COVID19_PFIZER/BIONTECH | Hepatitis | 2 | 3.495 | 0.291 | 0.883 | 1.733 | 0.32 | 0.706 | 1.389 | 0.572 | 0.435 | 0.909
COVID19_PFIZER/BIONTECH | Head circumference abnormal | 0 | 0.157 | 0.068 | 0.883 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal epithelium defect | 0 | 0.157 | 0.068 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign breast lump removal | 0 | 0.157 | 0.067 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic oesophagitis | 0 | 0.157 | 0.067 | 0.883 | 2.491 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Refusal of treatment by relative | 0 | 0.157 | 0.067 | 0.883 | 2.49 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Streptococcal abscess | 0 | 0.105 | 0.023 | 0.883 | 2.877 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Asplenia | 0 | 0.157 | 0.068 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin M abnormal | 0 | 0.157 | 0.067 | 0.883 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site induration | 0 | 0.157 | 0.068 | 0.883 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic hepatitis C | 0 | 0.157 | 0.067 | 0.883 | 2.491 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anterior chamber cell | 0 | 0.157 | 0.068 | 0.883 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meralgia paraesthetica | 0 | 0.157 | 0.066 | 0.883 | 2.493 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Groin infection | 0 | 0.157 | 0.067 | 0.883 | 2.49 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Self-injurious ideation | 0 | 0.157 | 0.067 | 0.883 | 2.493 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperuricaemia | 0 | 0.157 | 0.067 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastocytoma | 0 | 0.157 | 0.068 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood group A | 0 | 0.157 | 0.068 | 0.883 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mineral supplementation | 0 | 0.157 | 0.068 | 0.883 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood zinc normal | 0 | 0.157 | 0.068 | 0.883 | 2.488 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileal perforation | 0 | 0.105 | 0.023 | 0.883 | 2.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vestibular function test abnormal | 0 | 0.157 | 0.067 | 0.883 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gravitational oedema | 0 | 0.157 | 0.067 | 0.883 | 2.491 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-NMDA antibody | 0 | 0.157 | 0.067 | 0.883 | 2.493 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coating in mouth | 0 | 0.21 | 0.114 | 0.883 | 2.257 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal exposure during pregnancy | 4 | 8.574 | 0.314 | 0.882 | 1.683 | 0.297 | 0.576 | 1.028 | 0.467 | 0.137 | 20.811
COVID19_PFIZER/BIONTECH | Pulmonary physical examination | 0 | 0.157 | 0.066 | 0.882 | 2.495 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor VIII antibody increased | 0 | 0.157 | 0.066 | 0.882 | 2.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral papule | 0 | 0.157 | 0.066 | 0.882 | 2.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuritis cranial | 0 | 0.157 | 0.065 | 0.882 | 2.497 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic metabolic decompensation | 0 | 0.157 | 0.066 | 0.882 | 2.495 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder polyp | 0 | 0.157 | 0.066 | 0.882 | 2.496 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extubation | 0 | 0.157 | 0.066 | 0.882 | 2.496 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial fluid analysis abnormal | 0 | 0.157 | 0.066 | 0.882 | 2.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aluminium normal | 0 | 0.157 | 0.065 | 0.882 | 2.498 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniorrhoea | 0 | 0.157 | 0.065 | 0.882 | 2.497 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Onychoclasis | 0 | 0.139 | 0.049 | 0.882 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site discolouration | 0 | 0.157 | 0.065 | 0.882 | 2.498 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mini mental status examination | 0 | 0.157 | 0.066 | 0.882 | 2.493 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood uric acid normal | 2 | 2.044 | 0.302 | 0.881 | 1.704 | 0.406 | 0.889 | 1.748 | 0.978 | 0.753 | 0.006
COVID19_PFIZER/BIONTECH | Ultrasound abdomen abnormal | 5 | 6.667 | 0.381 | 0.881 | 1.547 | 0.423 | 0.781 | 1.345 | 0.75 | 0.238 | 11.302
COVID19_PFIZER/BIONTECH | Pruritus genital | 1 | 1.466 | 0.275 | 0.881 | 1.766 | 0.323 | 0.788 | 1.674 | 0.682 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Seizure | 72 | 99.222 | 0.72 | 0.881 | 1.055 | 0.601 | 0.73 | 0.879 | 0.726 | 0.307 | 111.668
COVID19_PFIZER/BIONTECH | Product lot number issue | 0 | 0.067 | 0.003 | 0.881 | 3.392 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein S decreased | 0 | 0.157 | 0.064 | 0.881 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal tract irritation | 0 | 0.157 | 0.064 | 0.881 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ephelides | 0 | 0.157 | 0.064 | 0.881 | 2.501 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic shock syndrome | 0 | 0.157 | 0.065 | 0.881 | 2.499 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4/CD8 ratio decreased | 0 | 0.157 | 0.064 | 0.881 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Free fatty acids | 0 | 0.157 | 0.064 | 0.881 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic disc haemorrhage | 0 | 0.157 | 0.064 | 0.881 | 2.502 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunisation reaction | 0 | 0.268 | 0.154 | 0.881 | 2.097 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ulna fracture | 0 | 0.21 | 0.109 | 0.881 | 2.269 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic enzymes | 0 | 0.157 | 0.065 | 0.881 | 2.499 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cataract | 2 | 2.524 | 0.247 | 0.88 | 1.828 | 0.373 | 0.819 | 1.61 | 0.793 | 1.003 | 0.129
COVID19_PFIZER/BIONTECH | Blood creatinine abnormal | 0 | 0.157 | 0.063 | 0.88 | 2.506 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood uric acid decreased | 0 | 0.157 | 0.063 | 0.88 | 2.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Throat cancer | 0 | 0.157 | 0.063 | 0.88 | 2.508 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord abscess | 0 | 0.157 | 0.063 | 0.88 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic prolapse | 0 | 0.157 | 0.062 | 0.88 | 2.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pityriasis rubra pilaris | 0 | 0.157 | 0.063 | 0.88 | 2.506 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess rupture | 0 | 0.157 | 0.062 | 0.88 | 2.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oxygen therapy | 11 | 11.305 | 0.519 | 0.879 | 1.315 | 0.595 | 0.941 | 1.429 | 0.973 | 3.367 | 13.398
COVID19_PFIZER/BIONTECH | Fluid intake reduced | 9 | 10.61 | 0.535 | 0.879 | 1.292 | 0.515 | 0.846 | 1.326 | 0.848 | 1.355 | 0.468
COVID19_PFIZER/BIONTECH | Stool analysis normal | 1 | 1.41 | 0.166 | 0.879 | 2.055 | 0.327 | 0.797 | 1.693 | 0.709 | 0.132 | 4.805
COVID19_PFIZER/BIONTECH | Enterococcus test | 0 | 0.157 | 0.061 | 0.879 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrocytosis | 0 | 0.157 | 0.061 | 0.879 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic carcinoma | 0 | 0.21 | 0.105 | 0.879 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | High density lipoprotein increased | 0 | 0.157 | 0.061 | 0.879 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord neoplasm | 0 | 0.157 | 0.061 | 0.879 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ophthalmic fluid-air exchange procedure | 0 | 0.157 | 0.062 | 0.879 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital discomfort | 0 | 0.157 | 0.061 | 0.879 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Candida nappy rash | 0 | 0.157 | 0.062 | 0.879 | 2.51 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiopulmonary exercise test normal | 0 | 0.105 | 0.021 | 0.879 | 2.902 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung diffusion test decreased | 0 | 0.157 | 0.061 | 0.879 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genitourinary symptom | 0 | 0.157 | 0.061 | 0.879 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meniscus operation | 0 | 0.157 | 0.061 | 0.879 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site infection | 0 | 0.105 | 0.021 | 0.879 | 2.902 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic graft versus host disease | 0 | 0.157 | 0.062 | 0.879 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal perivascular sheathing | 0 | 0.157 | 0.062 | 0.879 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor XII level normal | 0 | 0.105 | 0.021 | 0.879 | 2.902 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint pain | 11 | 13.015 | 0.561 | 0.878 | 1.252 | 0.534 | 0.844 | 1.282 | 0.845 | 0.933 | 0.006
COVID19_PFIZER/BIONTECH | Faeces discoloured | 6 | 7.817 | 0.419 | 0.878 | 1.474 | 0.444 | 0.79 | 1.322 | 0.768 | 0.321 | 7.806
COVID19_PFIZER/BIONTECH | Culture tissue specimen | 0 | 0.157 | 0.06 | 0.878 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy small intestine | 0 | 0.157 | 0.061 | 0.878 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF white blood cell differential | 0 | 0.169 | 0.069 | 0.878 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calculus urinary | 0 | 0.157 | 0.06 | 0.878 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antibiotic therapy | 0 | 0.21 | 0.104 | 0.878 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Giardia test negative | 0 | 0.095 | 0.014 | 0.878 | 3.012 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skeletal survey abnormal | 0 | 0.157 | 0.06 | 0.878 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal dryness | 0 | 0.21 | 0.104 | 0.878 | 2.281 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibula fracture | 0 | 0.157 | 0.06 | 0.878 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gait spastic | 0 | 0.157 | 0.06 | 0.878 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin D increased | 0 | 0.157 | 0.06 | 0.878 | 2.517 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pus in stool | 0 | 0.157 | 0.061 | 0.878 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sphincter of Oddi dysfunction | 0 | 0.157 | 0.061 | 0.878 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital megacolon | 0 | 0.157 | 0.06 | 0.878 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell analysis normal | 0 | 0.105 | 0.02 | 0.878 | 2.906 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site nerve damage | 0 | 0.157 | 0.061 | 0.878 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid operation | 0 | 0.157 | 0.061 | 0.878 | 2.517 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain oedema | 3 | 3.944 | 0.319 | 0.877 | 1.658 | 0.391 | 0.798 | 1.485 | 0.761 | 0.595 | 0.439
COVID19_PFIZER/BIONTECH | Cytogenetic analysis normal | 1 | 1.745 | 0.302 | 0.877 | 1.695 | 0.304 | 0.746 | 1.586 | 0.573 | 0.287 | 1.085
COVID19_PFIZER/BIONTECH | Actinic keratosis | 0 | 0.157 | 0.059 | 0.877 | 2.523 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweat test normal | 0 | 0.157 | 0.06 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cauda equina syndrome | 0 | 0.157 | 0.058 | 0.877 | 2.525 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opticokinetic nystagmus tests abnormal | 0 | 0.157 | 0.059 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typhus rickettsia test | 0 | 0.276 | 0.153 | 0.877 | 2.091 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral microangiopathy | 0 | 0.157 | 0.059 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Asymptomatic bacteriuria | 0 | 0.157 | 0.059 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seronegative arthritis | 0 | 0.157 | 0.058 | 0.877 | 2.525 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oligodipsia | 0 | 0.157 | 0.059 | 0.877 | 2.524 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngitis viral | 0 | 0.105 | 0.019 | 0.877 | 2.913 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve neurostimulation | 0 | 0.157 | 0.059 | 0.877 | 2.523 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary sepsis | 0 | 0.157 | 0.059 | 0.877 | 2.523 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal achalasia | 0 | 0.157 | 0.06 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerumen impaction | 0 | 0.157 | 0.059 | 0.877 | 2.523 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary bladder haemorrhage | 0 | 0.157 | 0.059 | 0.877 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF glucose increased | 1 | 1.036 | 0.166 | 0.876 | 2.045 | 0.355 | 0.864 | 1.832 | 0.965 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Eyelid disorder | 3 | 3.233 | 0.422 | 0.876 | 1.463 | 0.432 | 0.881 | 1.639 | 0.928 | 2.463 | 1.136
COVID19_PFIZER/BIONTECH | Blood lead | 0 | 0.142 | 0.046 | 0.876 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subdural effusion | 0 | 0.157 | 0.058 | 0.876 | 2.528 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Target skin lesion | 0 | 0.21 | 0.1 | 0.876 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Delayed myelination | 0 | 0.157 | 0.058 | 0.876 | 2.526 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product availability issue | 0 | 0.073 | 0.004 | 0.876 | 3.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug abuse | 0 | 0.157 | 0.058 | 0.876 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurosarcoidosis | 0 | 0.157 | 0.058 | 0.876 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carbohydrate antigen 125 increased | 0 | 0.105 | 0.019 | 0.876 | 2.922 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy to arthropod bite | 0 | 0.21 | 0.101 | 0.876 | 2.291 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Confabulation | 0 | 0.157 | 0.058 | 0.876 | 2.526 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prohormone brain natriuretic peptide increased | 0 | 0.157 | 0.058 | 0.876 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood carbon monoxide increased | 0 | 0.157 | 0.057 | 0.876 | 2.53 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impaired reasoning | 0 | 0.157 | 0.058 | 0.876 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site dermatitis | 0 | 0.286 | 0.159 | 0.876 | 2.069 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine renal clearance increased | 0 | 0.157 | 0.058 | 0.876 | 2.528 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic lupus erythematosus (SMQ) [algorithm] | 10 | 13.672 | 0.492 | 0.875 | 1.349 | 0.468 | 0.754 | 1.162 | 0.731 | 0.464 | 5.495
COVID19_PFIZER/BIONTECH | HIV antigen | 0 | 0.157 | 0.056 | 0.875 | 2.534 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic shock syndrome streptococcal | 0 | 0.157 | 0.057 | 0.875 | 2.532 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PO2 abnormal | 0 | 0.21 | 0.1 | 0.875 | 2.294 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nocturnal dyspnoea | 0 | 0.157 | 0.056 | 0.875 | 2.534 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth extraction | 0 | 0.235 | 0.118 | 0.875 | 2.212 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proteus test positive | 0 | 0.105 | 0.018 | 0.875 | 2.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site rash | 0 | 0.157 | 0.057 | 0.875 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail growth abnormal | 0 | 0.157 | 0.056 | 0.875 | 2.536 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood urine | 0 | 0.21 | 0.099 | 0.875 | 2.296 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin hypopigmentation | 0 | 0.172 | 0.068 | 0.875 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrist surgery | 0 | 0.157 | 0.056 | 0.875 | 2.535 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased interest | 0 | 0.396 | 0.222 | 0.875 | 1.879 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Emergency care | 0 | 0.262 | 0.139 | 0.875 | 2.133 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet function test abnormal | 0 | 0.157 | 0.056 | 0.875 | 2.535 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site abscess | 0 | 0.157 | 0.057 | 0.875 | 2.531 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychiatric evaluation normal | 0 | 0.058 | 0.001 | 0.875 | 3.621 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Russell's viper venom time | 0 | 0.157 | 0.057 | 0.875 | 2.533 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial toxaemia | 0 | 0.157 | 0.057 | 0.875 | 2.532 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroencephalogram abnormal | 4 | 4.528 | 0.39 | 0.874 | 1.516 | 0.448 | 0.864 | 1.54 | 0.883 | 0.192 | 12.629
COVID19_PFIZER/BIONTECH | Intentional overdose | 0 | 0.157 | 0.055 | 0.874 | 2.54 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arm amputation | 0 | 0.157 | 0.055 | 0.874 | 2.538 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone disorder | 0 | 0.187 | 0.08 | 0.874 | 2.389 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C antibody | 0 | 0.157 | 0.056 | 0.874 | 2.537 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflux laryngitis | 0 | 0.21 | 0.098 | 0.874 | 2.299 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carditis | 0 | 0.157 | 0.055 | 0.874 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Victim of crime | 0 | 0.157 | 0.056 | 0.874 | 2.537 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes pharyngitis | 0 | 0.157 | 0.055 | 0.874 | 2.54 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pH | 0 | 0.157 | 0.056 | 0.874 | 2.537 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood ethanol | 0 | 0.315 | 0.173 | 0.874 | 2.017 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Knee deformity | 0 | 0.157 | 0.055 | 0.874 | 2.538 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Xerophthalmia | 0 | 0.157 | 0.055 | 0.874 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Candida test negative | 0 | 0.157 | 0.054 | 0.873 | 2.546 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metapneumovirus infection | 0 | 0.058 | 0.001 | 0.873 | 3.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoma benign | 0 | 0.157 | 0.054 | 0.873 | 2.542 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tissue infiltration | 0 | 0.157 | 0.055 | 0.873 | 2.542 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug trough level | 0 | 0.105 | 0.017 | 0.873 | 2.937 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased nasolabial fold | 0 | 0.105 | 0.017 | 0.873 | 2.938 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Helicobacter gastritis | 0 | 0.157 | 0.054 | 0.873 | 2.546 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interleukin-2 receptor assay | 0 | 0.157 | 0.054 | 0.873 | 2.543 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Band neutrophil count increased | 0 | 0.283 | 0.15 | 0.873 | 2.087 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plateletcrit increased | 0 | 0.157 | 0.054 | 0.873 | 2.546 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product use complaint | 0 | 0.157 | 0.054 | 0.873 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase abnormal | 0 | 0.21 | 0.096 | 0.873 | 2.302 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear tube insertion | 0 | 0.328 | 0.178 | 0.873 | 1.996 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal myelogram abnormal | 0 | 0.157 | 0.054 | 0.873 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echoencephalogram | 0 | 0.105 | 0.017 | 0.873 | 2.938 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastritis erosive | 0 | 0.21 | 0.095 | 0.873 | 2.305 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cells urine negative | 1 | 1.451 | 0.209 | 0.872 | 1.905 | 0.324 | 0.791 | 1.679 | 0.689 | 0.251 | 1.496
COVID19_PFIZER/BIONTECH | Karyotype analysis normal | 0 | 0.21 | 0.094 | 0.872 | 2.308 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plagiocephaly | 0 | 0.157 | 0.053 | 0.872 | 2.547 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iontophoresis | 0 | 0.157 | 0.053 | 0.872 | 2.547 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head banging | 0 | 0.457 | 0.246 | 0.872 | 1.809 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antiendomysial antibody test | 0 | 0.157 | 0.053 | 0.872 | 2.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint warmth | 0 | 0.157 | 0.053 | 0.872 | 2.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudoparalysis | 0 | 0.157 | 0.053 | 0.872 | 2.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint ankylosis | 0 | 0.157 | 0.053 | 0.872 | 2.547 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper respiratory tract endoscopy | 0 | 0.105 | 0.017 | 0.872 | 2.944 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product administration error | 8 | 13.594 | 0.44 | 0.871 | 1.421 | 0.381 | 0.641 | 1.024 | 0.588 | 0.463 | 4.323
COVID19_PFIZER/BIONTECH | Cold type haemolytic anaemia | 0 | 0.21 | 0.093 | 0.871 | 2.313 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haematological malignancy | 0 | 0.21 | 0.093 | 0.871 | 2.311 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell agglutination present | 0 | 0.157 | 0.052 | 0.871 | 2.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pyruvic acid increased | 0 | 0.105 | 0.016 | 0.871 | 2.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal scan | 0 | 0.157 | 0.052 | 0.871 | 2.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal obstruction | 0 | 0.176 | 0.066 | 0.871 | 2.459 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung cancer metastatic | 0 | 0.157 | 0.052 | 0.871 | 2.553 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C virus test positive | 0 | 0.21 | 0.093 | 0.871 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bradypnoea | 0 | 0.105 | 0.016 | 0.871 | 2.951 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemothorax | 0 | 0.105 | 0.016 | 0.871 | 2.953 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug dependence | 0 | 0.157 | 0.052 | 0.871 | 2.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auditory disorder | 3 | 2.995 | 0.338 | 0.87 | 1.602 | 0.448 | 0.913 | 1.699 | 1.002 | 2.58 | 1.291
COVID19_PFIZER/BIONTECH | Erythema of eyelid | 5 | 5.541 | 0.494 | 0.87 | 1.331 | 0.476 | 0.878 | 1.511 | 0.902 | 1.05 | 0.017
COVID19_PFIZER/BIONTECH | Lid sulcus deepened | 0 | 0.219 | 0.098 | 0.87 | 2.285 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging abdominal | 0 | 0.273 | 0.138 | 0.87 | 2.122 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Growth hormone deficiency | 0 | 0.157 | 0.05 | 0.87 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitral valve repair | 0 | 0.157 | 0.051 | 0.87 | 2.558 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angina bullosa haemorrhagica | 0 | 0.157 | 0.051 | 0.87 | 2.558 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epidural blood patch | 0 | 0.157 | 0.051 | 0.87 | 2.557 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site joint effusion | 0 | 0.157 | 0.051 | 0.87 | 2.557 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound biliary tract normal | 0 | 0.21 | 0.092 | 0.87 | 2.315 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capillary disorder | 0 | 0.157 | 0.051 | 0.87 | 2.558 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood brain barrier defect | 0 | 0.157 | 0.051 | 0.87 | 2.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product origin unknown | 0 | 0.157 | 0.051 | 0.87 | 2.557 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular examination abnormal | 0 | 0.157 | 0.05 | 0.87 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fistula | 0 | 0.157 | 0.05 | 0.87 | 2.561 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pollakiuria | 11 | 15.459 | 0.52 | 0.869 | 1.292 | 0.465 | 0.736 | 1.117 | 0.712 | 0.849 | 0.151
COVID19_PFIZER/BIONTECH | Spinal myelogram | 0 | 0.21 | 0.089 | 0.869 | 2.322 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein total abnormal | 0 | 0.157 | 0.049 | 0.869 | 2.565 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intra-ocular injection | 0 | 0.157 | 0.05 | 0.869 | 2.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Recurrent cancer | 0 | 0.157 | 0.049 | 0.869 | 2.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell macrocytes present | 0 | 0.105 | 0.015 | 0.869 | 2.961 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Costochondritis | 0 | 0.223 | 0.1 | 0.869 | 2.273 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bullous impetigo | 0 | 0.21 | 0.089 | 0.869 | 2.323 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventricular dysfunction | 0 | 0.157 | 0.05 | 0.869 | 2.563 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenosine deaminase normal | 0 | 0.157 | 0.05 | 0.869 | 2.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin M | 4 | 4.621 | 0.392 | 0.868 | 1.494 | 0.443 | 0.854 | 1.522 | 0.866 | 1.389 | 0.113
COVID19_PFIZER/BIONTECH | Blood iron normal | 1 | 1.658 | 0.268 | 0.868 | 1.745 | 0.31 | 0.759 | 1.612 | 0.603 | 0.516 | 0.084
COVID19_PFIZER/BIONTECH | Aspiration pleural cavity abnormal | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood selenium normal | 0 | 0.157 | 0.049 | 0.868 | 2.567 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trichorrhexis | 0 | 0.157 | 0.048 | 0.868 | 2.571 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aortic wall hypertrophy | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dependent rubor | 0 | 0.21 | 0.089 | 0.868 | 2.324 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shock haemorrhagic | 0 | 0.21 | 0.088 | 0.868 | 2.327 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye infection bacterial | 0 | 0.21 | 0.088 | 0.868 | 2.325 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural fibrosis | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood uric acid abnormal | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CNS ventriculitis | 0 | 0.105 | 0.014 | 0.868 | 2.969 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis eosinophilic | 0 | 0.157 | 0.048 | 0.868 | 2.571 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell scan | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasite blood test positive | 0 | 0.157 | 0.048 | 0.868 | 2.571 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | pH urine decreased | 0 | 0.157 | 0.048 | 0.868 | 2.57 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor weight gain neonatal | 0 | 0.157 | 0.049 | 0.868 | 2.567 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system lupus | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchitis bacterial | 0 | 0.157 | 0.048 | 0.868 | 2.571 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrinolysis | 0 | 0.105 | 0.014 | 0.868 | 2.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sleep disorder | 144 | 170.995 | 0.752 | 0.867 | 0.989 | 0.734 | 0.842 | 0.962 | 0.842 | 1.319 | 10.093
COVID19_PFIZER/BIONTECH | CSF protein normal | 2 | 2.564 | 0.248 | 0.867 | 1.793 | 0.371 | 0.814 | 1.599 | 0.78 | 0.284 | 2.842
COVID19_PFIZER/BIONTECH | Ocular infections (SMQ) [broad] | 28 | 40.419 | 0.623 | 0.867 | 1.144 | 0.52 | 0.705 | 0.938 | 0.693 | 0.362 | 30.34
COVID19_PFIZER/BIONTECH | Induced labour | 1 | 1.737 | 0.17 | 0.867 | 2.005 | 0.305 | 0.747 | 1.588 | 0.576 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Enteritis | 1 | 2.155 | 0.146 | 0.867 | 2.084 | 0.28 | 0.69 | 1.472 | 0.464 | 0.328 | 0.743
COVID19_PFIZER/BIONTECH | Allergic cough | 0 | 0.157 | 0.047 | 0.867 | 2.575 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray with contrast lower gastrointestinal tract | 0 | 0.21 | 0.086 | 0.867 | 2.331 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural infection | 0 | 0.105 | 0.014 | 0.867 | 2.976 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trance | 0 | 0.157 | 0.048 | 0.867 | 2.572 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood 1,25-dihydroxycholecalciferol | 0 | 0.105 | 0.014 | 0.867 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extravasation blood | 0 | 0.157 | 0.047 | 0.867 | 2.575 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin temperature | 0 | 0.105 | 0.014 | 0.867 | 2.976 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor quality device used | 0 | 0.105 | 0.014 | 0.867 | 2.976 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine bilirubin decreased | 0 | 0.325 | 0.166 | 0.867 | 2.019 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular disorder | 0 | 0.157 | 0.047 | 0.867 | 2.574 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diffuse alopecia | 0 | 0.157 | 0.047 | 0.867 | 2.573 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration related reaction | 0 | 0.157 | 0.048 | 0.867 | 2.572 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | IIIrd nerve disorder | 0 | 0.157 | 0.047 | 0.867 | 2.575 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenocortical steroid therapy | 0 | 0.157 | 0.048 | 0.867 | 2.572 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenosine deaminase increased | 0 | 0.105 | 0.014 | 0.867 | 2.976 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic vasculitis | 0 | 0.157 | 0.048 | 0.867 | 2.573 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteomyelitis | 1 | 1.328 | 0.238 | 0.866 | 1.812 | 0.333 | 0.811 | 1.722 | 0.753 | 0.328 | 0.743
COVID19_PFIZER/BIONTECH | Benign lymph node neoplasm | 0 | 0.21 | 0.085 | 0.866 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Feeling of relaxation | 0 | 0.21 | 0.086 | 0.866 | 2.333 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Promyelocyte count | 0 | 0.157 | 0.046 | 0.866 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal turbinate hypertrophy | 0 | 0.157 | 0.046 | 0.866 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site nodule | 0 | 0.21 | 0.085 | 0.866 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bundle branch block | 0 | 0.157 | 0.046 | 0.866 | 2.58 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningoradiculitis | 0 | 0.157 | 0.046 | 0.866 | 2.58 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convulsion in childhood | 0 | 0.157 | 0.047 | 0.866 | 2.577 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy liver normal | 0 | 0.157 | 0.046 | 0.866 | 2.58 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Supportive care | 0 | 0.21 | 0.085 | 0.866 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Simple partial seizures | 0 | 0.157 | 0.046 | 0.866 | 2.579 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial cyst | 0 | 0.45 | 0.229 | 0.866 | 1.834 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunoglobulin G4 related disease | 0 | 0.157 | 0.046 | 0.866 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemolytic anaemia | 4 | 4.27 | 0.4 | 0.865 | 1.474 | 0.463 | 0.892 | 1.59 | 0.937 | 2.007 | 0.988
COVID19_PFIZER/BIONTECH | Monocyte count abnormal | 0 | 0.157 | 0.045 | 0.865 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inappropriate antidiuretic hormone secretion | 0 | 0.315 | 0.155 | 0.865 | 2.047 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic disc disorder | 0 | 0.157 | 0.046 | 0.865 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schizotypal personality disorder | 0 | 0.157 | 0.046 | 0.865 | 2.582 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-VGCC antibody | 0 | 0.157 | 0.045 | 0.865 | 2.586 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intervertebral disc space narrowing | 0 | 0.157 | 0.045 | 0.865 | 2.585 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutaneous symptom | 0 | 0.157 | 0.045 | 0.865 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aversion | 0 | 0.157 | 0.045 | 0.865 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haptoglobin increased | 0 | 0.157 | 0.045 | 0.865 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulocytes abnormal | 0 | 0.157 | 0.046 | 0.865 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudomonas infection | 0 | 0.21 | 0.084 | 0.865 | 2.339 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy small intestine abnormal | 0 | 0.157 | 0.045 | 0.865 | 2.583 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast enlargement | 0 | 0.157 | 0.045 | 0.865 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine nitrogen | 0 | 0.157 | 0.046 | 0.865 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Narcolepsy | 1 | 0.876 | 0.068 | 0.864 | 2.422 | 0.369 | 0.896 | 1.9 | 1.141 | 0.124 | 5.284
COVID19_PFIZER/BIONTECH | Infection | 7 | 12.823 | 0.459 | 0.864 | 1.371 | 0.353 | 0.61 | 0.996 | 0.546 | 0.193 | 22.525
COVID19_PFIZER/BIONTECH | Glutathione decreased | 0 | 0.105 | 0.012 | 0.864 | 2.995 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear infection bacterial | 0 | 0.157 | 0.044 | 0.864 | 2.59 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leptospirosis | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell sedimentation rate abnormal | 0 | 0.262 | 0.119 | 0.864 | 2.174 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premenstrual dysphoric disorder | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular autonomic function test normal | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to lung | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvar dysplasia | 0 | 0.157 | 0.044 | 0.864 | 2.588 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis enteroviral | 0 | 0.105 | 0.013 | 0.864 | 2.992 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labour complication | 0 | 0.21 | 0.082 | 0.864 | 2.343 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight abnormal | 0 | 0.157 | 0.045 | 0.864 | 2.587 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterocolitis viral | 0 | 0.105 | 0.012 | 0.864 | 2.993 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestradiol | 0 | 0.21 | 0.083 | 0.864 | 2.34 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Menstrual discomfort | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver palpable | 0 | 0.157 | 0.045 | 0.864 | 2.587 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-platelet antibody | 0 | 0.157 | 0.044 | 0.864 | 2.588 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic response changed | 0 | 0.105 | 0.012 | 0.864 | 2.995 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anogenital dysplasia | 0 | 0.157 | 0.044 | 0.864 | 2.589 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carotid artery dissection | 0 | 0.157 | 0.045 | 0.864 | 2.586 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestradiol increased | 0 | 0.105 | 0.012 | 0.864 | 2.995 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Circumstance or information capable of leading to device use error | 0 | 0.157 | 0.045 | 0.864 | 2.587 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection related reaction | 0 | 0.157 | 0.044 | 0.864 | 2.588 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure normal | 2 | 1.647 | 0.302 | 0.863 | 1.658 | 0.437 | 0.957 | 1.882 | 1.214 | 1.204 | 0.02
COVID19_PFIZER/BIONTECH | Venogram | 2 | 1.884 | 0.329 | 0.863 | 1.602 | 0.418 | 0.915 | 1.799 | 1.061 | 2.58 | 0.549
COVID19_PFIZER/BIONTECH | Atrophy | 1 | 1.41 | 0.214 | 0.863 | 1.866 | 0.327 | 0.797 | 1.693 | 0.709 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Skin haemorrhage | 1 | 1.836 | 0.263 | 0.863 | 1.746 | 0.299 | 0.733 | 1.559 | 0.545 | 0.282 | 1.13
COVID19_PFIZER/BIONTECH | Genital herpes | 2 | 3.489 | 0.254 | 0.863 | 1.763 | 0.321 | 0.706 | 1.39 | 0.573 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Pharyngeal disorder | 0 | 0.562 | 0.269 | 0.863 | 1.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour excision | 0 | 0.21 | 0.081 | 0.863 | 2.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adnexa uteri mass | 0 | 0.105 | 0.012 | 0.863 | 2.998 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dust allergy | 0 | 0.157 | 0.043 | 0.863 | 2.593 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal hernia | 0 | 0.157 | 0.043 | 0.863 | 2.593 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy soft tissue | 0 | 0.105 | 0.012 | 0.863 | 2.997 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coronary artery dilatation | 0 | 0.328 | 0.16 | 0.863 | 2.026 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol test negative | 0 | 0.105 | 0.012 | 0.863 | 2.997 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Surgical failure | 0 | 0.105 | 0.012 | 0.863 | 2.998 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy gastrointestinal abnormal | 0 | 0.157 | 0.043 | 0.863 | 2.593 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Excessive eye blinking | 0 | 0.721 | 0.322 | 0.863 | 1.618 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Onychomycosis | 0 | 0.21 | 0.081 | 0.863 | 2.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level therapeutic | 0 | 0.21 | 0.081 | 0.863 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound breast | 0 | 0.21 | 0.081 | 0.863 | 2.347 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuro-ophthalmological test normal | 0 | 0.157 | 0.043 | 0.863 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal anaesthesia | 0 | 0.105 | 0.012 | 0.863 | 3.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalomalacia | 0 | 0.315 | 0.151 | 0.863 | 2.053 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy brain normal | 0 | 0.157 | 0.043 | 0.863 | 2.593 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diaphragmalgia | 1 | 1.322 | 0.267 | 0.862 | 1.732 | 0.333 | 0.812 | 1.724 | 0.756 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Nuchal rigidity | 1 | 2.568 | 0.125 | 0.862 | 2.146 | 0.258 | 0.642 | 1.373 | 0.389 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Cartilage injury | 0 | 0.148 | 0.036 | 0.862 | 2.654 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Legal problem | 0 | 0.157 | 0.043 | 0.862 | 2.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin neoplasm excision | 0 | 0.111 | 0.014 | 0.862 | 2.95 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 globulin increased | 0 | 0.21 | 0.08 | 0.862 | 2.35 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary tuberculosis | 0 | 0.157 | 0.042 | 0.862 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune reconstitution inflammatory syndrome | 0 | 0.157 | 0.042 | 0.862 | 2.598 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mental disability | 0 | 0.157 | 0.043 | 0.862 | 2.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meniscus injury | 0 | 0.262 | 0.116 | 0.862 | 2.181 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal mass | 0 | 0.262 | 0.117 | 0.862 | 2.179 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystoscopy abnormal | 0 | 0.21 | 0.08 | 0.862 | 2.348 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound scan | 31 | 39.639 | 0.636 | 0.861 | 1.113 | 0.589 | 0.787 | 1.034 | 0.782 | 0.949 | 0.038
COVID19_PFIZER/BIONTECH | Serology test | 1 | 1.47 | 0.14 | 0.861 | 2.09 | 0.323 | 0.788 | 1.673 | 0.68 | 0.235 | 1.733
COVID19_PFIZER/BIONTECH | Dental operation | 0 | 0.157 | 0.041 | 0.861 | 2.604 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cranial nerve palsies multiple | 0 | 0.157 | 0.042 | 0.861 | 2.601 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vagus nerve disorder | 0 | 0.157 | 0.042 | 0.861 | 2.602 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart valve incompetence | 0 | 0.157 | 0.041 | 0.861 | 2.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Positron emission tomography-magnetic resonance imaging | 0 | 0.21 | 0.078 | 0.861 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Organ failure | 0 | 0.4 | 0.195 | 0.861 | 1.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paranasal cyst | 0 | 0.21 | 0.078 | 0.861 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-lymphocyte count increased | 0 | 0.157 | 0.041 | 0.861 | 2.603 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | External ear inflammation | 0 | 0.21 | 0.078 | 0.861 | 2.356 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tinea cruris | 0 | 0.157 | 0.042 | 0.861 | 2.601 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical dilatation | 0 | 0.157 | 0.041 | 0.861 | 2.603 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Widal test | 0 | 0.157 | 0.042 | 0.861 | 2.601 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Terminal insomnia | 0 | 0.21 | 0.078 | 0.861 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body temperature normal | 2 | 1.383 | 0.281 | 0.86 | 1.694 | 0.461 | 1.009 | 1.985 | 1.446 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Blood follicle stimulating hormone normal | 0 | 0.157 | 0.04 | 0.86 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram liver abnormal | 0 | 0.157 | 0.04 | 0.86 | 2.608 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung transplant | 0 | 0.157 | 0.041 | 0.86 | 2.607 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product taste abnormal | 0 | 0.157 | 0.04 | 0.86 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrolyte substitution therapy | 0 | 0.157 | 0.04 | 0.86 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary arterial pressure increased | 0 | 0.157 | 0.04 | 0.86 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Regressive behaviour | 0 | 0.328 | 0.153 | 0.86 | 2.037 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patellofemoral pain syndrome | 0 | 0.21 | 0.077 | 0.86 | 2.357 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jaw operation | 0 | 0.21 | 0.076 | 0.86 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatobiliary scan abnormal | 0 | 0.21 | 0.077 | 0.86 | 2.358 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound kidney abnormal | 0 | 0.274 | 0.121 | 0.86 | 2.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer female | 1 | 2.22 | 0.214 | 0.859 | 1.855 | 0.276 | 0.682 | 1.455 | 0.45 | 0.516 | 0.084
COVID19_PFIZER/BIONTECH | Alpha tumour necrosis factor increased | 0 | 0.157 | 0.04 | 0.859 | 2.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gallbladder oedema | 0 | 0.157 | 0.04 | 0.859 | 2.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stomach mass | 0 | 0.157 | 0.04 | 0.859 | 2.612 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0.21 | 0.075 | 0.859 | 2.363 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0.21 | 0.075 | 0.859 | 2.363 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital blister | 0 | 0.21 | 0.076 | 0.859 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasospasm | 0 | 0.157 | 0.039 | 0.859 | 2.614 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skull fractured base | 0 | 0.157 | 0.039 | 0.859 | 2.614 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subacute inflammatory demyelinating polyneuropathy | 0 | 0.157 | 0.04 | 0.859 | 2.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Knee operation | 0 | 0.21 | 0.076 | 0.859 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Relapsing fever | 0 | 0.157 | 0.039 | 0.859 | 2.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin plaque | 1 | 1.962 | 0.27 | 0.858 | 1.715 | 0.291 | 0.715 | 1.523 | 0.51 | 0.149 | 3.962
COVID19_PFIZER/BIONTECH | Dairy intolerance | 0 | 0.315 | 0.143 | 0.858 | 2.068 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerular filtration rate increased | 0 | 0.157 | 0.039 | 0.858 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal monitoring abnormal | 0 | 0.157 | 0.039 | 0.858 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast abscess | 0 | 0.157 | 0.039 | 0.858 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhabdomyosarcoma | 0 | 0.157 | 0.039 | 0.858 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acidosis hyperchloraemic | 0 | 0.157 | 0.039 | 0.858 | 2.616 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Finger amputation | 0 | 0.21 | 0.074 | 0.858 | 2.367 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear injury | 0 | 0.262 | 0.11 | 0.858 | 2.194 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythromelalgia | 0 | 0.157 | 0.038 | 0.858 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eustachian tube obstruction | 0 | 0.262 | 0.11 | 0.858 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device issue | 0 | 0.157 | 0.039 | 0.858 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine copper | 0 | 0.157 | 0.038 | 0.858 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchopulmonary aspergillosis | 0 | 0.21 | 0.074 | 0.858 | 2.367 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid cyst | 0 | 0.21 | 0.074 | 0.858 | 2.366 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve degeneration | 0 | 0.157 | 0.039 | 0.858 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroschisis | 0 | 0.157 | 0.038 | 0.858 | 2.618 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymectomy | 0 | 0.157 | 0.038 | 0.858 | 2.618 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amoeba test negative | 0 | 0.157 | 0.039 | 0.858 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchopneumopathy | 0 | 0.21 | 0.074 | 0.858 | 2.368 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site nodule | 1 | 2.164 | 0.21 | 0.857 | 1.861 | 0.28 | 0.689 | 1.47 | 0.462 | 0.174 | 3.08
COVID19_PFIZER/BIONTECH | Retinal injury | 0 | 0.105 | 0.01 | 0.857 | 3.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calcium ionised increased | 0 | 0.262 | 0.108 | 0.857 | 2.199 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastritis viral | 0 | 0.21 | 0.074 | 0.857 | 2.368 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Analgesic drug level therapeutic | 0 | 0.256 | 0.104 | 0.857 | 2.218 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster necrotising retinopathy | 0 | 0.105 | 0.01 | 0.857 | 3.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | IL-2 receptor assay | 0 | 0.262 | 0.109 | 0.857 | 2.197 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor increased | 0 | 0.21 | 0.073 | 0.857 | 2.371 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord compression | 0 | 0.315 | 0.141 | 0.857 | 2.071 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drop attacks | 0 | 0.21 | 0.073 | 0.857 | 2.372 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin CSF normal | 0 | 0.21 | 0.074 | 0.857 | 2.368 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lower motor neurone lesion | 0 | 0.105 | 0.01 | 0.857 | 3.032 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal degeneration | 0 | 0.21 | 0.073 | 0.857 | 2.37 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular fibrosis | 0 | 0.105 | 0.01 | 0.857 | 3.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Canalith repositioning procedure | 0 | 0.21 | 0.073 | 0.857 | 2.37 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal polyps | 0 | 0.21 | 0.074 | 0.857 | 2.368 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Helicobacter test negative | 0 | 0.267 | 0.111 | 0.857 | 2.186 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor VII level decreased | 0 | 0.157 | 0.038 | 0.857 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal endotheliitis | 0 | 0.105 | 0.01 | 0.857 | 3.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sleep study | 1 | 1.485 | 0.213 | 0.856 | 1.85 | 0.322 | 0.785 | 1.668 | 0.674 | 0.347 | 0.623
COVID19_PFIZER/BIONTECH | Eosinophil count decreased | 4 | 5.859 | 0.334 | 0.856 | 1.574 | 0.384 | 0.742 | 1.323 | 0.683 | 0.688 | 0.274
COVID19_PFIZER/BIONTECH | Retinal vasculitis | 0 | 0.21 | 0.072 | 0.856 | 2.374 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol abuse | 0 | 0.157 | 0.037 | 0.856 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arterial injury | 0 | 0.21 | 0.072 | 0.856 | 2.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal irrigation | 0 | 0.105 | 0.01 | 0.856 | 3.036 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve stimulation test abnormal | 0 | 0.21 | 0.072 | 0.856 | 2.375 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood iron abnormal | 0 | 0.157 | 0.037 | 0.856 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiosyncratic drug reaction | 0 | 0.157 | 0.037 | 0.856 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute stress disorder | 0 | 0.157 | 0.037 | 0.856 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oedematous pancreatitis | 0 | 0.157 | 0.037 | 0.856 | 2.624 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pituitary tumour | 0 | 0.157 | 0.037 | 0.856 | 2.624 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin culture positive | 0 | 0.21 | 0.072 | 0.856 | 2.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal depigmentation | 0 | 0.157 | 0.037 | 0.856 | 2.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine and fallopian tube malignant tumours (SMQ) [broad] | 1 | 2.383 | 0.054 | 0.855 | 2.486 | 0.268 | 0.663 | 1.416 | 0.42 | 0.073 | 10.866
COVID19_PFIZER/BIONTECH | Vertebral osteophyte | 0 | 0.21 | 0.071 | 0.855 | 2.377 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulpitis dental | 0 | 0.21 | 0.071 | 0.855 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iodine allergy | 0 | 0.157 | 0.036 | 0.855 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sexually transmitted disease | 0 | 0.157 | 0.036 | 0.855 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood HIV RNA increased | 0 | 0.21 | 0.071 | 0.855 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Excessive granulation tissue | 0 | 0.21 | 0.07 | 0.855 | 2.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging hepatobiliary | 0 | 0.157 | 0.036 | 0.855 | 2.628 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumatosis | 0 | 0.105 | 0.009 | 0.855 | 3.042 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Morphoea | 0 | 0.21 | 0.071 | 0.855 | 2.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear canal erythema | 0 | 0.21 | 0.071 | 0.855 | 2.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial biopsy abnormal | 0 | 0.157 | 0.036 | 0.855 | 2.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycobacterium test positive | 0 | 0.219 | 0.077 | 0.855 | 2.343 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Auditory nerve disorder | 0 | 0.21 | 0.071 | 0.855 | 2.377 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Quadrantanopia | 0 | 0.21 | 0.071 | 0.855 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair metal test | 0 | 0.157 | 0.036 | 0.855 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meconium in amniotic fluid | 0 | 0.157 | 0.036 | 0.855 | 2.629 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive tract disorder | 0 | 0.157 | 0.036 | 0.855 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendinopathies and ligament disorders (SMQ) [broad] | 2662 | 3132.851 | 0.827 | 0.854 | 0.881 | 0.823 | 0.85 | 0.877 | 0.85 | 1.162 | 64.83
COVID19_PFIZER/BIONTECH | Creatinine urine normal | 0 | 0.157 | 0.035 | 0.854 | 2.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal crusting | 0 | 0.157 | 0.035 | 0.854 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lower gastrointestinal haemorrhage | 0 | 0.157 | 0.035 | 0.854 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Galactorrhoea | 0 | 0.157 | 0.036 | 0.854 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasma viscosity normal | 0 | 0.157 | 0.035 | 0.854 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human herpes virus 8 test | 0 | 0.157 | 0.036 | 0.854 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Graft versus host disease in gastrointestinal tract | 0 | 0.157 | 0.035 | 0.854 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth avulsion | 0 | 0.105 | 0.009 | 0.854 | 3.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestradiol normal | 0 | 0.157 | 0.035 | 0.854 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myocardial oedema | 0 | 0.157 | 0.036 | 0.854 | 2.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluorescence angiogram | 0 | 0.21 | 0.07 | 0.854 | 2.38 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body in gastrointestinal tract | 0 | 0.157 | 0.035 | 0.854 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyloric stenosis | 0 | 0.21 | 0.068 | 0.853 | 2.385 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reversible cerebral vasoconstriction syndrome | 0 | 0.21 | 0.068 | 0.853 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bickerstaff's encephalitis | 0 | 0.21 | 0.069 | 0.853 | 2.384 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjustment disorder with depressed mood | 0 | 0.157 | 0.034 | 0.853 | 2.64 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Portal vein thrombosis | 0 | 0.21 | 0.068 | 0.853 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intra-abdominal fluid collection | 0 | 0.21 | 0.068 | 0.853 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder cancer | 0 | 0.262 | 0.102 | 0.853 | 2.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Frostbite | 0 | 0.157 | 0.035 | 0.853 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bed sharing | 0 | 0.274 | 0.11 | 0.853 | 2.18 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid myoclonus | 0 | 0.157 | 0.034 | 0.853 | 2.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borderline personality disorder | 0 | 0.157 | 0.034 | 0.853 | 2.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chemical burn | 0 | 0.157 | 0.035 | 0.853 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin increased | 0 | 0.157 | 0.035 | 0.853 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging abnormal | 26 | 35.553 | 0.609 | 0.852 | 1.128 | 0.541 | 0.741 | 0.996 | 0.731 | 0.703 | 2.853
COVID19_PFIZER/BIONTECH | Sleep deficit | 0 | 0.367 | 0.162 | 0.852 | 1.986 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombin time | 0 | 0.262 | 0.102 | 0.852 | 2.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sarcoma | 0 | 0.21 | 0.067 | 0.852 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Duodenitis | 0 | 0.262 | 0.101 | 0.852 | 2.215 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borrelia infection | 0 | 0.157 | 0.034 | 0.852 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E virus test positive | 0 | 0.157 | 0.033 | 0.852 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound testes normal | 0 | 0.157 | 0.033 | 0.852 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sydenham's chorea | 0 | 0.21 | 0.067 | 0.852 | 2.389 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gulf war syndrome | 0 | 0.157 | 0.034 | 0.852 | 2.643 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF volume | 0 | 0.157 | 0.034 | 0.852 | 2.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemolysis | 1 | 2.312 | 0.128 | 0.851 | 2.098 | 0.272 | 0.671 | 1.433 | 0.433 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Perinatal depression | 0 | 0.157 | 0.033 | 0.851 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal cancer | 0 | 0.157 | 0.033 | 0.851 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxicologic test abnormal | 0 | 0.262 | 0.1 | 0.851 | 2.217 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-muscle specific kinase antibody | 0 | 0.262 | 0.099 | 0.851 | 2.219 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colour vision tests abnormal | 0 | 0.157 | 0.033 | 0.851 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin urine present | 0 | 0.306 | 0.125 | 0.851 | 2.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | New daily persistent headache | 0 | 0.093 | 0.005 | 0.851 | 3.194 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood HIV RNA | 0 | 0.157 | 0.033 | 0.851 | 2.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loss of libido | 0 | 0.157 | 0.033 | 0.851 | 2.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aggression | 4 | 5.344 | 0.403 | 0.85 | 1.432 | 0.407 | 0.785 | 1.399 | 0.749 | 0.317 | 5.107
COVID19_PFIZER/BIONTECH | Blood electrolytes decreased | 0 | 0.157 | 0.032 | 0.85 | 2.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram repolarisation abnormality | 0 | 0.157 | 0.032 | 0.85 | 2.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 microglobulin increased | 0 | 0.157 | 0.032 | 0.85 | 2.654 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Febrile infection-related epilepsy syndrome | 0 | 0.157 | 0.032 | 0.85 | 2.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine uric acid increased | 0 | 0.157 | 0.032 | 0.85 | 2.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 globulin | 0 | 0.157 | 0.032 | 0.85 | 2.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Analgesic drug level | 0 | 0.262 | 0.099 | 0.85 | 2.22 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin CSF decreased | 0 | 0.21 | 0.065 | 0.85 | 2.395 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhinovirus infection | 0 | 0.22 | 0.072 | 0.85 | 2.357 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate abnormal | 5 | 6.698 | 0.357 | 0.849 | 1.512 | 0.422 | 0.779 | 1.341 | 0.746 | 3.01 | 4.078
COVID19_PFIZER/BIONTECH | Strabismus | 1 | 1.509 | 0.262 | 0.849 | 1.708 | 0.32 | 0.781 | 1.66 | 0.662 | 0.108 | 6.463
COVID19_PFIZER/BIONTECH | Hypokinesia | 6 | 8.433 | 0.417 | 0.849 | 1.404 | 0.421 | 0.75 | 1.254 | 0.712 | 0.641 | 0.827
COVID19_PFIZER/BIONTECH | Parvovirus B19 test negative | 1 | 2.16 | 0.162 | 0.849 | 1.978 | 0.28 | 0.69 | 1.471 | 0.463 | 0.27 | 1.265
COVID19_PFIZER/BIONTECH | Oropharyngeal candidiasis | 0 | 0.157 | 0.031 | 0.849 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluorescence angiogram abnormal | 0 | 0.157 | 0.032 | 0.849 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal discharge | 0 | 0.105 | 0.007 | 0.849 | 3.074 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gene mutation identification test positive | 0 | 0.303 | 0.121 | 0.849 | 2.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic myocarditis | 0 | 0.157 | 0.031 | 0.849 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair follicle tumour benign | 0 | 0.157 | 0.032 | 0.849 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleral discolouration | 0 | 0.21 | 0.064 | 0.849 | 2.399 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral fungal infection | 0 | 0.367 | 0.156 | 0.849 | 1.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal motility disorder | 0 | 0.21 | 0.063 | 0.849 | 2.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phenylketonuria | 0 | 0.157 | 0.031 | 0.849 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scan adrenal gland | 0 | 0.21 | 0.063 | 0.849 | 2.402 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve disorders (SMQ) [narrow] | 5 | 10.052 | 0.372 | 0.848 | 1.482 | 0.317 | 0.587 | 1.012 | 0.497 | 0.25 | 10.33
COVID19_PFIZER/BIONTECH | Agnosia | 0 | 0.21 | 0.063 | 0.848 | 2.403 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia chlamydial | 0 | 0.21 | 0.063 | 0.848 | 2.404 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palatal ulcer | 0 | 0.157 | 0.031 | 0.848 | 2.661 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster meningoencephalitis | 0 | 0.086 | 0.003 | 0.848 | 3.302 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Growth disorder | 0 | 0.21 | 0.062 | 0.848 | 2.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lip exfoliation | 0 | 0.52 | 0.224 | 0.848 | 1.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traumatic tooth displacement | 0 | 0.105 | 0.007 | 0.848 | 3.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral papilloma | 0 | 0.105 | 0.007 | 0.848 | 3.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight decrease neonatal | 0 | 0.105 | 0.007 | 0.848 | 3.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Second primary malignancy | 0 | 0.105 | 0.007 | 0.848 | 3.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product effective for unapproved indication | 0 | 0.105 | 0.007 | 0.848 | 3.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital central nervous system anomaly | 0 | 0.21 | 0.063 | 0.848 | 2.402 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid gland scan abnormal | 0 | 0.157 | 0.031 | 0.848 | 2.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutaneous T-cell lymphoma | 0 | 0.21 | 0.062 | 0.848 | 2.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal malformation | 0 | 0.157 | 0.03 | 0.848 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament laxity | 0 | 0.157 | 0.031 | 0.848 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet morphology abnormal | 0 | 0.21 | 0.063 | 0.848 | 2.403 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue necrosis | 0 | 0.262 | 0.094 | 0.847 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical vertebral fracture | 0 | 0.21 | 0.062 | 0.847 | 2.406 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dandruff | 0 | 0.157 | 0.03 | 0.847 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Booster dose missed | 0 | 0.157 | 0.03 | 0.847 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood folate increased | 0 | 0.21 | 0.061 | 0.847 | 2.409 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site joint pain | 0 | 0.157 | 0.03 | 0.847 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Maternal exposure timing unspecified | 0 | 0.157 | 0.03 | 0.847 | 2.665 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid stimulating immunoglobulin | 0 | 0.21 | 0.061 | 0.847 | 2.408 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated/autoimmune disorders (SMQ) [narrow] | 144 | 189.666 | 0.734 | 0.846 | 0.964 | 0.663 | 0.761 | 0.87 | 0.759 | 0.41 | 120.971
COVID19_PFIZER/BIONTECH | Epstein-Barr virus test negative | 1 | 1.943 | 0.199 | 0.846 | 1.858 | 0.292 | 0.718 | 1.529 | 0.515 | 0.105 | 6.678
COVID19_PFIZER/BIONTECH | Oedema | 12 | 20.272 | 0.533 | 0.846 | 1.218 | 0.404 | 0.629 | 0.943 | 0.592 | 0.382 | 11.123
COVID19_PFIZER/BIONTECH | Acute psychosis | 0 | 0.21 | 0.06 | 0.846 | 2.412 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow myelogram abnormal | 0 | 0.21 | 0.06 | 0.846 | 2.412 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carpal tunnel decompression | 0 | 0.262 | 0.093 | 0.846 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin urine absent | 0 | 0.262 | 0.093 | 0.846 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wolff-Parkinson-White syndrome | 0 | 0.21 | 0.06 | 0.846 | 2.411 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy artery | 0 | 0.21 | 0.06 | 0.846 | 2.411 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothermia neonatal | 0 | 0.157 | 0.029 | 0.846 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Social (pragmatic) communication disorder | 0 | 0.157 | 0.03 | 0.846 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheal inflammation | 0 | 0.21 | 0.06 | 0.846 | 2.413 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint hyperextension | 0 | 0.405 | 0.17 | 0.846 | 1.942 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Forceps delivery | 0 | 0.157 | 0.029 | 0.846 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thymus enlargement | 0 | 0.21 | 0.06 | 0.846 | 2.411 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspiration bursa | 0 | 0.367 | 0.151 | 0.846 | 2.002 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardio-respiratory distress | 0 | 0.262 | 0.093 | 0.846 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inappropriate release of product for distribution | 0 | 0.105 | 0.007 | 0.846 | 3.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal bacterial overgrowth | 0 | 0.21 | 0.061 | 0.846 | 2.41 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acne infantile | 0 | 0.157 | 0.029 | 0.846 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival oedema | 0 | 0.367 | 0.151 | 0.846 | 2.002 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Septic shock | 4 | 6.415 | 0.348 | 0.845 | 1.518 | 0.363 | 0.701 | 1.25 | 0.624 | 0.737 | 0.143
COVID19_PFIZER/BIONTECH | Leukocyturia | 0 | 0.223 | 0.067 | 0.845 | 2.366 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterobacter infection | 0 | 0.21 | 0.06 | 0.845 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product package associated injury | 0 | 0.21 | 0.06 | 0.845 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prothrombin level decreased | 0 | 0.127 | 0.014 | 0.845 | 2.887 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral uveitis | 0 | 0.157 | 0.028 | 0.845 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allogenic stem cell transplantation | 0 | 0.157 | 0.028 | 0.845 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal candidiasis | 0 | 0.21 | 0.06 | 0.845 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | In vitro fertilisation | 0 | 0.21 | 0.059 | 0.845 | 2.415 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progressive multifocal leukoencephalopathy | 0 | 0.105 | 0.006 | 0.845 | 3.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal lesion | 0 | 0.157 | 0.028 | 0.845 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye abscess | 0 | 0.157 | 0.028 | 0.845 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cephalo-pelvic disproportion | 0 | 0.105 | 0.006 | 0.845 | 3.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thalassaemia | 0 | 0.105 | 0.006 | 0.845 | 3.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune arthritis | 0 | 0.157 | 0.028 | 0.845 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pustular psoriasis | 0 | 0.157 | 0.029 | 0.845 | 2.672 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ammonia normal | 0 | 0.405 | 0.169 | 0.845 | 1.944 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nonreassuring foetal heart rate pattern | 0 | 0.157 | 0.029 | 0.845 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital and neonatal arrhythmias (SMQ) [narrow] | 0 | 0.157 | 0.029 | 0.845 | 2.671 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tetany | 2 | 1.631 | 0.282 | 0.844 | 1.65 | 0.438 | 0.96 | 1.888 | 1.226 | 3.01 | 0.842
COVID19_PFIZER/BIONTECH | Lipase increased | 5 | 5.995 | 0.425 | 0.844 | 1.377 | 0.453 | 0.836 | 1.439 | 0.834 | 3.344 | 5.003
COVID19_PFIZER/BIONTECH | VIth nerve paralysis | 2 | 2.838 | 0.344 | 0.844 | 1.525 | 0.354 | 0.779 | 1.531 | 0.705 | 0.682 | 0.054
COVID19_PFIZER/BIONTECH | Depressed mood | 3 | 4.411 | 0.316 | 0.844 | 1.578 | 0.368 | 0.751 | 1.398 | 0.68 | 0.257 | 5.617
COVID19_PFIZER/BIONTECH | Vaccination site bruising | 4 | 6.56 | 0.378 | 0.844 | 1.46 | 0.357 | 0.691 | 1.232 | 0.61 | 0.695 | 0.253
COVID19_PFIZER/BIONTECH | Vestibular function test | 0 | 0.21 | 0.058 | 0.844 | 2.419 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver function test decreased | 0 | 0.21 | 0.058 | 0.844 | 2.419 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebellar ataxia | 0 | 0.251 | 0.083 | 0.844 | 2.274 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterovirus test | 0 | 0.377 | 0.154 | 0.844 | 1.988 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchoalveolar lavage normal | 0 | 0.21 | 0.058 | 0.844 | 2.418 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | JC polyomavirus test positive | 0 | 0.157 | 0.028 | 0.844 | 2.676 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal flattening | 0 | 0.157 | 0.028 | 0.844 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stenosis | 0 | 0.157 | 0.028 | 0.844 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic pneumonia | 0 | 0.157 | 0.028 | 0.844 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myotonia | 0 | 0.21 | 0.059 | 0.844 | 2.417 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radial nerve injury | 0 | 0.157 | 0.027 | 0.843 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective IgA immunodeficiency | 0 | 0.262 | 0.088 | 0.843 | 2.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site odour | 0 | 0.157 | 0.027 | 0.843 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal swelling | 0 | 0.157 | 0.027 | 0.843 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scar pain | 0 | 0.157 | 0.027 | 0.843 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye haematoma | 0 | 0.157 | 0.028 | 0.843 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertebral lesion | 0 | 0.21 | 0.057 | 0.843 | 2.422 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histology abnormal | 0 | 0.229 | 0.068 | 0.843 | 2.35 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site swelling | 0 | 0.262 | 0.088 | 0.843 | 2.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoparathyroidism | 0 | 0.157 | 0.027 | 0.843 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF pressure increased | 1 | 0.931 | 0.219 | 0.842 | 1.793 | 0.364 | 0.885 | 1.876 | 1.074 | 0.903 | 0.152
COVID19_PFIZER/BIONTECH | Muscle atrophy | 3 | 3.789 | 0.293 | 0.842 | 1.622 | 0.399 | 0.815 | 1.516 | 0.792 | 0.448 | 1.466
COVID19_PFIZER/BIONTECH | Immunoglobulins abnormal | 0 | 0.21 | 0.057 | 0.842 | 2.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta 2 microglobulin | 0 | 0.21 | 0.056 | 0.842 | 2.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Removal of foreign body | 0 | 0.21 | 0.056 | 0.842 | 2.426 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Warm type haemolytic anaemia | 0 | 0.21 | 0.056 | 0.842 | 2.425 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Maculopathy | 0 | 0.262 | 0.088 | 0.842 | 2.245 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose-6-phosphate dehydrogenase deficiency | 0 | 0.21 | 0.056 | 0.842 | 2.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chondropathy | 0 | 0.21 | 0.056 | 0.842 | 2.426 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol poisoning | 0 | 0.21 | 0.056 | 0.842 | 2.427 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Groin abscess | 0 | 0.21 | 0.057 | 0.842 | 2.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis D virus test | 0 | 0.21 | 0.056 | 0.842 | 2.425 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasomnia | 0 | 0.157 | 0.026 | 0.842 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Presbyopia | 0 | 0.157 | 0.026 | 0.842 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine analysis | 66 | 80.994 | 0.69 | 0.841 | 1.004 | 0.667 | 0.816 | 0.99 | 0.815 | 1.375 | 5.921
COVID19_PFIZER/BIONTECH | Dental examination | 0 | 0.21 | 0.056 | 0.841 | 2.427 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurodevelopmental disorder | 0 | 0.21 | 0.055 | 0.841 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve paresis | 0 | 0.21 | 0.055 | 0.841 | 2.428 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disease complication | 0 | 0.157 | 0.026 | 0.841 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint stabilisation | 0 | 0.21 | 0.055 | 0.841 | 2.429 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral surgery | 0 | 0.21 | 0.055 | 0.841 | 2.429 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurosensory hypoacusis | 0 | 0.105 | 0.006 | 0.841 | 3.111 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Low density lipoprotein | 0 | 0.262 | 0.086 | 0.841 | 2.25 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hip arthroplasty | 1 | 1.83 | 0.2 | 0.84 | 1.838 | 0.299 | 0.734 | 1.561 | 0.547 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Speech sound disorder | 0 | 0.262 | 0.085 | 0.84 | 2.251 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine disorder | 0 | 0.21 | 0.054 | 0.84 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytology abnormal | 0 | 0.139 | 0.017 | 0.84 | 2.818 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body reaction | 0 | 0.262 | 0.085 | 0.84 | 2.251 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Growth failure | 0 | 0.21 | 0.055 | 0.84 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Libido disorder | 0 | 0.157 | 0.025 | 0.84 | 2.693 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoglycaemia neonatal | 0 | 0.157 | 0.026 | 0.84 | 2.693 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Xerosis | 0 | 0.21 | 0.054 | 0.84 | 2.433 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prothrombin time ratio decreased | 0 | 0.21 | 0.055 | 0.84 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transcranial electrical motor evoked potential monitoring | 0 | 0.157 | 0.026 | 0.84 | 2.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stevens-Johnson syndrome | 1 | 2.479 | 0.304 | 0.839 | 1.589 | 0.263 | 0.652 | 1.393 | 0.403 | 0.287 | 1.085
COVID19_PFIZER/BIONTECH | Urogram | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensory processing disorder | 0 | 0.397 | 0.156 | 0.839 | 1.968 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Androgenetic alopecia | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Squamous cell carcinoma of the oral cavity | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Persistent depressive disorder | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteosarcoma | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast conserving surgery | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal pruritus | 0 | 0.367 | 0.142 | 0.839 | 2.017 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-IA2 antibody positive | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral pustule | 0 | 0.367 | 0.142 | 0.839 | 2.017 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug withdrawal syndrome | 0 | 0.21 | 0.053 | 0.839 | 2.435 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchoalveolar lavage | 0 | 0.262 | 0.084 | 0.839 | 2.255 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lactose tolerance test normal | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Male reproductive tract disorder | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric atony | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proctitis haemorrhagic | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocytic leukaemia | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma stage III | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriosclerotic retinopathy | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Positive end-expiratory pressure | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-glycyl-tRNA synthetase antibody positive | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Partial seizures with secondary generalisation | 0 | 0.21 | 0.053 | 0.839 | 2.435 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocervical curettage | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital abscess | 0 | 0.105 | 0.005 | 0.839 | 3.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal infection | 0 | 0.157 | 0.025 | 0.839 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal mucosal blistering | 0 | 0.262 | 0.084 | 0.839 | 2.254 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular test | 0 | 0.262 | 0.083 | 0.838 | 2.258 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Separation anxiety disorder | 0 | 0.262 | 0.082 | 0.838 | 2.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial diarrhoea | 0 | 0.105 | 0.005 | 0.838 | 3.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichenification | 0 | 0.21 | 0.052 | 0.838 | 2.44 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes dermatitis | 0 | 0.21 | 0.053 | 0.838 | 2.438 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal mass | 0 | 0.21 | 0.052 | 0.838 | 2.439 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin D decreased | 1 | 2.064 | 0.156 | 0.837 | 1.963 | 0.285 | 0.702 | 1.496 | 0.485 | 0.235 | 1.733
COVID19_PFIZER/BIONTECH | Anti-transglutaminase antibody negative | 0 | 0.103 | 0.004 | 0.837 | 3.153 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Agraphia | 0 | 0.157 | 0.024 | 0.837 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Von Willebrand's factor activity increased | 0 | 0.157 | 0.024 | 0.837 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Low density lipoprotein decreased | 0 | 0.21 | 0.052 | 0.837 | 2.441 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle electrostimulation therapy | 0 | 0.21 | 0.051 | 0.837 | 2.444 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper respiratory tract inflammation | 0 | 0.224 | 0.059 | 0.837 | 2.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transmission of an infectious agent via product | 0 | 0.21 | 0.051 | 0.837 | 2.444 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transverse sinus thrombosis | 0 | 0.157 | 0.024 | 0.837 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular hypertension | 0 | 0.21 | 0.051 | 0.837 | 2.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antithrombin III decreased | 0 | 0.157 | 0.023 | 0.836 | 2.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy spinal cord | 0 | 0.21 | 0.051 | 0.836 | 2.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic necrosis | 0 | 0.315 | 0.109 | 0.836 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ammonia decreased | 0 | 0.21 | 0.05 | 0.836 | 2.447 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinitis viral | 0 | 0.262 | 0.08 | 0.836 | 2.263 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal injury | 0 | 0.262 | 0.08 | 0.836 | 2.264 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inflammatory marker decreased | 0 | 0.181 | 0.035 | 0.836 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bedridden | 10 | 18.098 | 0.469 | 0.835 | 1.288 | 0.373 | 0.6 | 0.925 | 0.553 | 0.474 | 5.165
COVID19_PFIZER/BIONTECH | Histone antibody negative | 0 | 0.21 | 0.05 | 0.835 | 2.448 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angle closure glaucoma | 0 | 0.21 | 0.05 | 0.835 | 2.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic fracture | 0 | 0.21 | 0.05 | 0.835 | 2.447 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydronephrosis | 0 | 0.315 | 0.108 | 0.835 | 2.132 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anhedonia | 0 | 0.21 | 0.049 | 0.835 | 2.45 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluctuance | 0 | 0.21 | 0.05 | 0.835 | 2.448 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mean arterial pressure | 0 | 0.105 | 0.005 | 0.835 | 3.137 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperleukocytosis | 0 | 0.262 | 0.079 | 0.835 | 2.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myokymia | 0 | 0.157 | 0.023 | 0.835 | 2.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid irritation | 1 | 0.8 | 0.228 | 0.834 | 1.747 | 0.376 | 0.912 | 1.935 | 1.25 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Arteriogram coronary normal | 2 | 2.865 | 0.309 | 0.834 | 1.566 | 0.353 | 0.775 | 1.524 | 0.698 | 2.778 | 0.682
COVID19_PFIZER/BIONTECH | Rouleaux formation | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Marginal zone lymphoma | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Surfactant protein | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-glomerular basement membrane antibody | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cell marker | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-VGCC antibody negative | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal erosion | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catatonia | 0 | 0.303 | 0.101 | 0.834 | 2.161 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperchlorhydria | 0 | 0.21 | 0.049 | 0.834 | 2.451 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Astigmatism | 0 | 0.109 | 0.005 | 0.834 | 3.104 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polydactyly | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital erosion | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phagocytosis | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Waist circumference decreased | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-muscle specific kinase antibody negative | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to abdominal cavity | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart alternation | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood chromogranin A increased | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatobiliary scan normal | 0 | 0.262 | 0.077 | 0.834 | 2.271 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow infiltration | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell rouleaux formation present | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | 5-hydroxyindolacetic acid in urine decreased | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penoscrotal fusion | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purulent pericarditis | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parathyroid hormone-related protein increased | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-cell lymphoma | 0 | 0.262 | 0.077 | 0.834 | 2.271 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron binding capacity total decreased | 0 | 0.21 | 0.049 | 0.834 | 2.451 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Avian influenza | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cheyne-Stokes respiration | 0 | 0.105 | 0.004 | 0.834 | 3.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red cell distribution width | 2 | 1.923 | 0.271 | 0.833 | 1.645 | 0.415 | 0.909 | 1.786 | 1.04 | 1.72 | 0.075
COVID19_PFIZER/BIONTECH | Loss of consciousness | 184 | 252.826 | 0.735 | 0.833 | 0.936 | 0.646 | 0.729 | 0.821 | 0.728 | 0.702 | 22.382
COVID19_PFIZER/BIONTECH | Sickle cell anaemia | 0 | 0.157 | 0.021 | 0.833 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Balanoposthitis | 0 | 0.21 | 0.048 | 0.833 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertriglyceridaemia | 0 | 0.157 | 0.021 | 0.833 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plicated tongue | 0 | 0.262 | 0.077 | 0.833 | 2.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | LE cells | 0 | 0.262 | 0.077 | 0.833 | 2.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bradyphrenia | 4 | 4.019 | 0.344 | 0.832 | 1.492 | 0.478 | 0.922 | 1.643 | 0.995 | 2.491 | 1.907
COVID19_PFIZER/BIONTECH | Accidents and injuries (SMQ) [broad] | 301 | 376.335 | 0.755 | 0.832 | 0.912 | 0.728 | 0.8 | 0.878 | 0.8 | 0.794 | 15.58
COVID19_PFIZER/BIONTECH | Accidents and injuries (SMQ) [narrow] | 275 | 344.775 | 0.752 | 0.832 | 0.915 | 0.722 | 0.798 | 0.88 | 0.798 | 0.796 | 13.843
COVID19_PFIZER/BIONTECH | Haematuria | 5 | 8.861 | 0.375 | 0.832 | 1.436 | 0.348 | 0.643 | 1.109 | 0.564 | 0.7 | 0.352
COVID19_PFIZER/BIONTECH | Iron binding capacity total normal | 0 | 0.312 | 0.102 | 0.832 | 2.146 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthroscopic surgery | 0 | 0.262 | 0.076 | 0.832 | 2.274 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Methylenetetrahydrofolate reductase gene mutation | 0 | 0.433 | 0.161 | 0.832 | 1.93 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Onychomadesis | 0 | 0.367 | 0.13 | 0.832 | 2.035 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peau d'orange | 0 | 0.172 | 0.028 | 0.832 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system viral infection | 0 | 0.262 | 0.076 | 0.832 | 2.274 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy breast normal | 0 | 0.21 | 0.047 | 0.832 | 2.459 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bartonella test negative | 0 | 0.473 | 0.178 | 0.832 | 1.879 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chorioretinitis | 0 | 0.262 | 0.076 | 0.832 | 2.276 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oedema genital | 0 | 0.21 | 0.047 | 0.832 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy to plants | 0 | 0.157 | 0.021 | 0.832 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculin test | 1 | 1.346 | 0.152 | 0.831 | 1.959 | 0.331 | 0.808 | 1.715 | 0.743 | 0.41 | 0.331
COVID19_PFIZER/BIONTECH | Spinal pain | 14 | 17.964 | 0.544 | 0.831 | 1.168 | 0.522 | 0.789 | 1.156 | 0.779 | 1.134 | 0.096
COVID19_PFIZER/BIONTECH | Chest tube insertion | 1 | 1.527 | 0.268 | 0.831 | 1.646 | 0.319 | 0.779 | 1.654 | 0.655 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Learning disability | 0 | 0.131 | 0.011 | 0.831 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hemihypertrophy | 0 | 0.21 | 0.046 | 0.831 | 2.462 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pupil dilation procedure | 0 | 0.262 | 0.075 | 0.831 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oculomucocutaneous syndrome | 0 | 0.21 | 0.046 | 0.831 | 2.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticaria papular | 0 | 0.367 | 0.129 | 0.831 | 2.037 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngoscopy | 0 | 0.42 | 0.154 | 0.831 | 1.951 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fructose intolerance | 0 | 0.262 | 0.074 | 0.831 | 2.279 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye laser surgery | 0 | 0.157 | 0.021 | 0.831 | 2.727 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood ethanol normal | 0 | 0.262 | 0.075 | 0.831 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | VIth nerve disorder | 0 | 0.21 | 0.046 | 0.831 | 2.462 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin E decreased | 0 | 0.367 | 0.129 | 0.831 | 2.037 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convulsions (SMQ) [broad] | 119 | 153.983 | 0.71 | 0.83 | 0.958 | 0.666 | 0.774 | 0.896 | 0.773 | 0.279 | 223.359
COVID19_PFIZER/BIONTECH | Foaming at mouth | 4 | 5.428 | 0.418 | 0.83 | 1.357 | 0.403 | 0.778 | 1.386 | 0.737 | 0.488 | 1.599
COVID19_PFIZER/BIONTECH | Systemic infection | 0 | 0.157 | 0.02 | 0.83 | 2.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total cholesterol/HDL ratio | 0 | 0.21 | 0.045 | 0.83 | 2.465 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nosocomial infection | 0 | 0.262 | 0.074 | 0.83 | 2.28 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose tolerance test | 0 | 0.262 | 0.074 | 0.83 | 2.28 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipodystrophy acquired | 0 | 0.262 | 0.073 | 0.83 | 2.282 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Appendix disorder | 0 | 0.157 | 0.02 | 0.83 | 2.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor C3 increased | 0 | 0.167 | 0.024 | 0.83 | 2.672 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray dental normal | 1 | 1.011 | 0.177 | 0.829 | 1.871 | 0.357 | 0.869 | 1.843 | 0.989 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Paraplegia | 1 | 1.512 | 0.135 | 0.829 | 2.011 | 0.32 | 0.781 | 1.659 | 0.661 | 0.452 | 0.208
COVID19_PFIZER/BIONTECH | Altered state of consciousness | 10 | 14.557 | 0.479 | 0.829 | 1.256 | 0.446 | 0.717 | 1.106 | 0.687 | 0.363 | 10.347
COVID19_PFIZER/BIONTECH | Skin disorder | 4 | 6.105 | 0.355 | 0.829 | 1.463 | 0.374 | 0.723 | 1.29 | 0.655 | 0.328 | 4.726
COVID19_PFIZER/BIONTECH | Joint injury | 2 | 3.274 | 0.388 | 0.829 | 1.406 | 0.331 | 0.729 | 1.434 | 0.611 | 0.539 | 0.366
COVID19_PFIZER/BIONTECH | Dermatitis contact | 2 | 4.207 | 0.43 | 0.829 | 1.333 | 0.289 | 0.64 | 1.262 | 0.475 | 0.323 | 2.139
COVID19_PFIZER/BIONTECH | Escherichia sepsis | 0 | 0.262 | 0.073 | 0.829 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrotal swelling | 0 | 0.164 | 0.022 | 0.829 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal haemorrhage | 0 | 0.21 | 0.044 | 0.829 | 2.468 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngoscopy normal | 0 | 0.262 | 0.072 | 0.829 | 2.285 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurone-specific enolase | 0 | 0.21 | 0.045 | 0.829 | 2.467 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tympanic membrane hyperaemia | 0 | 0.168 | 0.024 | 0.829 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keloid scar | 0 | 0.21 | 0.044 | 0.829 | 2.47 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subcutaneous emphysema | 0 | 0.157 | 0.019 | 0.829 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otitis externa | 0 | 0.328 | 0.107 | 0.829 | 2.117 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | High density lipoprotein | 0 | 0.262 | 0.073 | 0.829 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal bacterial infection | 0 | 0.21 | 0.044 | 0.829 | 2.469 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bicarbonate abnormal | 0 | 0.157 | 0.019 | 0.829 | 2.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myringotomy | 0 | 0.262 | 0.073 | 0.829 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Localised oedema | 3 | 4.845 | 0.347 | 0.828 | 1.475 | 0.348 | 0.712 | 1.326 | 0.619 | 0.475 | 1.197
COVID19_PFIZER/BIONTECH | Erythema annulare | 0 | 0.315 | 0.099 | 0.828 | 2.15 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histamine level | 0 | 0.157 | 0.019 | 0.828 | 2.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal cancer | 0 | 0.21 | 0.044 | 0.828 | 2.471 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venous injury | 0 | 0.21 | 0.043 | 0.828 | 2.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperbilirubinaemia neonatal | 0 | 0.21 | 0.044 | 0.828 | 2.47 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric pH decreased | 0 | 0.157 | 0.019 | 0.828 | 2.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal lesion | 0 | 0.262 | 0.071 | 0.828 | 2.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal compartment syndrome | 0 | 0.21 | 0.044 | 0.828 | 2.471 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | LDL/HDL ratio | 0 | 0.157 | 0.019 | 0.828 | 2.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder discomfort | 0 | 0.21 | 0.044 | 0.828 | 2.47 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epididymitis | 0 | 0.525 | 0.191 | 0.828 | 1.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphoid hyperplasia of intestine | 0 | 0.21 | 0.043 | 0.828 | 2.472 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exfoliative rash | 0 | 0.732 | 0.257 | 0.828 | 1.661 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphoproliferative disorder | 0 | 0.157 | 0.018 | 0.827 | 2.743 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tocolysis | 0 | 0.105 | 0.003 | 0.827 | 3.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cells stool negative | 0 | 0.262 | 0.07 | 0.827 | 2.291 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Panniculitis | 0 | 0.282 | 0.081 | 0.827 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis toxic | 0 | 0.105 | 0.003 | 0.827 | 3.175 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytology | 0 | 0.367 | 0.124 | 0.827 | 2.045 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryoglobulins | 0 | 0.262 | 0.07 | 0.827 | 2.289 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post-traumatic neck syndrome | 0 | 0.262 | 0.069 | 0.826 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosa haematoma | 0 | 0.21 | 0.042 | 0.826 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apolipoprotein A-I decreased | 0 | 0.105 | 0.003 | 0.826 | 3.176 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial disease carrier | 0 | 0.262 | 0.069 | 0.826 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Volume blood decreased | 0 | 0.21 | 0.042 | 0.826 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychomotor disadaptation syndrome | 0 | 0.21 | 0.042 | 0.826 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell morphology abnormal | 0 | 0.262 | 0.069 | 0.826 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral discharge | 0 | 0.21 | 0.042 | 0.826 | 2.477 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Furuncle | 0 | 1.144 | 0.341 | 0.826 | 1.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral paralysis | 0 | 0.21 | 0.042 | 0.826 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oligomenorrhoea | 0 | 0.113 | 0.005 | 0.826 | 3.097 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic disorder | 0 | 0.262 | 0.069 | 0.826 | 2.293 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningocele acquired | 0 | 0.105 | 0.003 | 0.826 | 3.178 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysmetropsia | 0 | 0.105 | 0.003 | 0.826 | 3.178 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphadenectomy | 0 | 0.279 | 0.077 | 0.826 | 2.246 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Henoch-Schonlein purpura nephritis | 0 | 0.315 | 0.097 | 0.826 | 2.154 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pain in extremity | 1403 | 1729.744 | 0.789 | 0.825 | 0.862 | 0.776 | 0.811 | 0.847 | 0.811 | 1.027 | 1.02
COVID19_PFIZER/BIONTECH | Musculoskeletal discomfort | 21 | 26.842 | 0.583 | 0.825 | 1.1 | 0.558 | 0.789 | 1.09 | 0.782 | 1.364 | 1.56
COVID19_PFIZER/BIONTECH | Cerebrovascular disorder | 0 | 0.338 | 0.107 | 0.825 | 2.106 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serum serotonin | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial fluid white blood cells positive | 0 | 0.262 | 0.068 | 0.825 | 2.295 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cranial nerve injury | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suprapubic pain | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product monitoring error | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labia enlarged | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation time | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital cystic kidney disease | 0 | 0.21 | 0.041 | 0.825 | 2.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder hypertrophy | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Embolic cerebral infarction | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperdynamic left ventricle | 0 | 0.105 | 0.003 | 0.825 | 3.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site hypersensitivity | 0 | 0.262 | 0.068 | 0.825 | 2.294 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accidental exposure to product | 2 | 2.568 | 0.218 | 0.824 | 1.746 | 0.37 | 0.813 | 1.598 | 0.779 | 0.142 | 9.396
COVID19_PFIZER/BIONTECH | Vaccination site irritation | 1 | 1.731 | 0.111 | 0.824 | 2.085 | 0.305 | 0.748 | 1.59 | 0.578 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Gingival disorder | 0 | 0.262 | 0.067 | 0.824 | 2.298 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Punctate keratitis | 0 | 0.21 | 0.04 | 0.824 | 2.484 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Noninfective sialoadenitis | 0 | 0.262 | 0.067 | 0.824 | 2.299 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta globulin | 0 | 0.262 | 0.067 | 0.824 | 2.297 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lactate dehydrogenase decreased | 0 | 0.262 | 0.067 | 0.824 | 2.297 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Primary biliary cholangitis | 0 | 0.21 | 0.04 | 0.824 | 2.485 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Teething | 0 | 0.321 | 0.097 | 0.824 | 2.145 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site pruritus | 0 | 0.157 | 0.017 | 0.824 | 2.754 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Consciousness fluctuating | 3 | 3.549 | 0.374 | 0.823 | 1.414 | 0.413 | 0.842 | 1.567 | 0.845 | 1.178 | 0.002
COVID19_PFIZER/BIONTECH | Ventriculo-peritoneal shunt | 0 | 0.213 | 0.041 | 0.823 | 2.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune neutropenia | 0 | 0.113 | 0.004 | 0.823 | 3.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoventilation | 0 | 0.169 | 0.021 | 0.823 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electronystagmogram abnormal | 0 | 0.262 | 0.066 | 0.823 | 2.301 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood alcohol normal | 0 | 0.262 | 0.066 | 0.823 | 2.301 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreous haze | 0 | 0.157 | 0.017 | 0.823 | 2.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective eating disorder | 0 | 0.256 | 0.063 | 0.823 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold agglutinins negative | 0 | 0.157 | 0.017 | 0.823 | 2.756 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging renal | 0 | 0.21 | 0.04 | 0.823 | 2.486 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal blistering | 1 | 1.461 | 0.234 | 0.822 | 1.699 | 0.323 | 0.789 | 1.676 | 0.684 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Dizziness exertional | 0 | 0.21 | 0.039 | 0.822 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone densitometry | 0 | 0.148 | 0.013 | 0.822 | 2.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intercepted product prescribing error | 0 | 0.21 | 0.039 | 0.822 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bipolar I disorder | 0 | 0.21 | 0.039 | 0.822 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningoencephalitis bacterial | 0 | 0.157 | 0.016 | 0.822 | 2.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral vascular disorder | 1 | 1.39 | 0.106 | 0.821 | 2.093 | 0.328 | 0.801 | 1.7 | 0.719 | 0.347 | 0.623
COVID19_PFIZER/BIONTECH | C-reactive protein normal | 18 | 23.656 | 0.541 | 0.821 | 1.149 | 0.532 | 0.771 | 1.089 | 0.761 | 0.437 | 12.206
COVID19_PFIZER/BIONTECH | Pulmonary physical examination abnormal | 0 | 0.157 | 0.016 | 0.821 | 2.763 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium swallow normal | 0 | 0.262 | 0.064 | 0.821 | 2.305 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess soft tissue | 0 | 0.21 | 0.038 | 0.821 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Torticollis | 0 | 0.61 | 0.21 | 0.821 | 1.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bleeding varicose vein | 0 | 0.105 | 0.003 | 0.821 | 3.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clavicle fracture | 0 | 0.262 | 0.064 | 0.821 | 2.305 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF myelin basic protein | 0 | 0.157 | 0.016 | 0.821 | 2.764 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival erythema | 1 | 1.279 | 0.208 | 0.82 | 1.762 | 0.336 | 0.82 | 1.739 | 0.782 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Panencephalitis | 0 | 0.105 | 0.003 | 0.82 | 3.201 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic hepatitis | 0 | 0.105 | 0.003 | 0.82 | 3.2 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impatience | 0 | 0.21 | 0.038 | 0.82 | 2.495 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint discomfort | 0 | 0.367 | 0.115 | 0.82 | 2.059 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein-losing gastroenteropathy | 0 | 0.105 | 0.003 | 0.82 | 3.201 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventricular hypertrophy | 0 | 0.105 | 0.003 | 0.82 | 3.202 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Very low density lipoprotein normal | 0 | 0.21 | 0.037 | 0.82 | 2.497 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchitis viral | 0 | 0.262 | 0.063 | 0.82 | 2.307 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rapid eye movements sleep abnormal | 0 | 0.262 | 0.063 | 0.82 | 2.309 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterocolitis bacterial | 0 | 0.157 | 0.015 | 0.82 | 2.768 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic gastroenteritis | 0 | 0.105 | 0.003 | 0.82 | 3.201 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis | 6 | 7.766 | 0.436 | 0.819 | 1.301 | 0.446 | 0.794 | 1.328 | 0.773 | 0.504 | 2.364
COVID19_PFIZER/BIONTECH | Peptic ulcer | 0 | 0.21 | 0.037 | 0.819 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Winged scapula | 0 | 0.286 | 0.074 | 0.819 | 2.243 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillitis streptococcal | 0 | 0.21 | 0.037 | 0.819 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytopenia | 0 | 0.198 | 0.031 | 0.819 | 2.553 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tinea pedis | 0 | 0.262 | 0.062 | 0.819 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone cyst | 0 | 0.21 | 0.037 | 0.819 | 2.499 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug withdrawal syndrome neonatal | 0 | 0.105 | 0.002 | 0.819 | 3.204 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intercepted product administration error | 0 | 0.262 | 0.062 | 0.819 | 2.31 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Saccadic eye movement | 0 | 0.157 | 0.015 | 0.819 | 2.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy breast abnormal | 0 | 0.21 | 0.036 | 0.818 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray of pelvis and hip abnormal | 0 | 0.529 | 0.178 | 0.818 | 1.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal burning sensation | 0 | 0.367 | 0.112 | 0.818 | 2.064 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight gain poor | 0 | 0.311 | 0.085 | 0.818 | 2.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic disorder | 0 | 0.262 | 0.061 | 0.818 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound therapy | 0 | 0.262 | 0.061 | 0.818 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold agglutinins positive | 0 | 0.157 | 0.015 | 0.818 | 2.775 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal mycotic infection | 0 | 0.262 | 0.061 | 0.818 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Staphylococcal abscess | 0 | 0.157 | 0.015 | 0.818 | 2.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculin test positive | 0 | 0.175 | 0.021 | 0.818 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinopexy | 0 | 0.262 | 0.061 | 0.818 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperammonaemia | 0 | 0.262 | 0.061 | 0.817 | 2.315 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | DNA antibody | 0 | 0.315 | 0.085 | 0.817 | 2.176 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural fluid analysis | 0 | 0.056 | 0 | 0.817 | 3.966 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bell's phenomenon | 0 | 0.21 | 0.035 | 0.817 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tobacco user | 0 | 0.157 | 0.015 | 0.817 | 2.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament disorder | 0 | 0.21 | 0.036 | 0.817 | 2.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasculitic rash | 0 | 0.452 | 0.146 | 0.817 | 1.933 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone density decreased | 0 | 0.21 | 0.035 | 0.817 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute flaccid myelitis | 0 | 0.21 | 0.035 | 0.817 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal ulceration | 1 | 0.71 | 0.272 | 0.816 | 1.596 | 0.384 | 0.932 | 1.978 | 1.409 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Eye movement disorder | 13 | 15.562 | 0.518 | 0.816 | 1.17 | 0.545 | 0.836 | 1.238 | 0.835 | 0.218 | 35.388
COVID19_PFIZER/BIONTECH | Injection site dysaesthesia | 0 | 0.262 | 0.059 | 0.816 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoinflammatory disease | 0 | 0.262 | 0.059 | 0.816 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subdural abscess | 0 | 0.21 | 0.035 | 0.816 | 2.507 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reaction to food additive | 0 | 0.21 | 0.035 | 0.816 | 2.508 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body tinea | 0 | 0.262 | 0.059 | 0.816 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Swallow study abnormal | 0 | 0.315 | 0.084 | 0.816 | 2.178 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral cardiomyopathy | 0 | 0.262 | 0.059 | 0.816 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical diet | 0 | 0.21 | 0.034 | 0.815 | 2.51 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Halo vision | 0 | 0.367 | 0.108 | 0.815 | 2.071 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lacrimal disorder | 0 | 0.262 | 0.058 | 0.815 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythrosis | 0 | 0.21 | 0.034 | 0.815 | 2.511 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventilation/perfusion scan normal | 0 | 0.315 | 0.083 | 0.815 | 2.18 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral infection | 0 | 0.262 | 0.058 | 0.815 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hand deformity | 0 | 0.262 | 0.058 | 0.815 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleral hyperaemia | 0 | 0.262 | 0.059 | 0.815 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.262 | 0.058 | 0.815 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multi-vitamin deficiency | 0 | 0.157 | 0.014 | 0.815 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sputum purulent | 0 | 0.21 | 0.034 | 0.814 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia haemophilus | 0 | 0.157 | 0.013 | 0.814 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophagram | 0 | 0.262 | 0.058 | 0.814 | 2.323 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimicrobial susceptibility test sensitive | 0 | 0.079 | 0 | 0.814 | 3.556 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.504 | 0.163 | 0.814 | 1.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oxygen saturation immeasurable | 0 | 0.157 | 0.013 | 0.814 | 2.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung lobectomy | 0 | 0.157 | 0.013 | 0.814 | 2.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chromosome analysis abnormal | 0 | 0.21 | 0.033 | 0.814 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Valsalva maneuver | 0 | 0.21 | 0.034 | 0.814 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflux gastritis | 0 | 0.21 | 0.033 | 0.814 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vocal cord dysfunction | 0 | 0.262 | 0.057 | 0.814 | 2.324 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin urine absent | 0 | 0.21 | 0.034 | 0.814 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic lupus erythematosus (SMQ) [narrow] | 9 | 13.211 | 0.442 | 0.813 | 1.277 | 0.435 | 0.715 | 1.121 | 0.681 | 0.427 | 6.205
COVID19_PFIZER/BIONTECH | Aspiration bone marrow | 0 | 0.438 | 0.136 | 0.813 | 1.957 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Traumatic lung injury | 0 | 0.21 | 0.033 | 0.813 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site ulcer | 0 | 1.002 | 0.294 | 0.813 | 1.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyper IgE syndrome | 0 | 0.105 | 0.002 | 0.813 | 3.225 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jaundice cholestatic | 0 | 0.21 | 0.033 | 0.813 | 2.517 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skull X-ray normal | 0 | 0.42 | 0.128 | 0.813 | 1.985 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inadequate aseptic technique in use of product | 0 | 0.52 | 0.168 | 0.813 | 1.855 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF mononuclear cell count increased | 0 | 0.367 | 0.106 | 0.813 | 2.074 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nervous system injury | 0 | 0.262 | 0.057 | 0.813 | 2.326 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaphylactic shock | 13 | 21.15 | 0.493 | 0.812 | 1.195 | 0.422 | 0.647 | 0.958 | 0.615 | 1.077 | 0.013
COVID19_PFIZER/BIONTECH | Suicidal ideation | 1 | 2.575 | 0.17 | 0.812 | 1.844 | 0.258 | 0.641 | 1.371 | 0.388 | 0.19 | 2.622
COVID19_PFIZER/BIONTECH | Multipathogen PCR test positive | 0 | 0.157 | 0.013 | 0.812 | 2.793 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic respiratory disease | 0 | 0.157 | 0.013 | 0.812 | 2.793 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononucleosis heterophile test positive | 0 | 0.327 | 0.086 | 0.812 | 2.157 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product ineffective | 0 | 0.21 | 0.032 | 0.812 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF myelin basic protein normal | 0 | 0.157 | 0.013 | 0.812 | 2.792 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Panniculitis lobular | 0 | 0.21 | 0.032 | 0.812 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dependence on oxygen therapy | 0 | 0.21 | 0.032 | 0.812 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood 25-hydroxycholecalciferol | 0 | 0.457 | 0.142 | 0.812 | 1.934 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug dispensed to wrong patient | 0 | 0.433 | 0.132 | 0.812 | 1.968 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreous disorder | 0 | 0.157 | 0.013 | 0.812 | 2.793 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gomori methenamine silver stain | 0 | 0.105 | 0.002 | 0.812 | 3.228 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastatic malignant melanoma | 0 | 0.157 | 0.013 | 0.812 | 2.793 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Generalised convulsive seizures following immunisation (SMQ) [algorithm] | 94 | 123.971 | 0.68 | 0.811 | 0.952 | 0.642 | 0.761 | 0.896 | 0.758 | 0.245 | 219.52
COVID19_PFIZER/BIONTECH | Microscopy | 0 | 0.586 | 0.187 | 0.811 | 1.793 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Discharge | 0 | 0.42 | 0.126 | 0.811 | 1.989 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood ketone body present | 0 | 0.367 | 0.103 | 0.811 | 2.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adrenal insufficiency | 0 | 0.226 | 0.039 | 0.811 | 2.455 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Femur fracture | 0 | 0.367 | 0.103 | 0.811 | 2.078 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electronystagmogram normal | 0 | 0.105 | 0.002 | 0.811 | 3.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrocephaly | 0 | 0.262 | 0.055 | 0.811 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choroidal neovascularisation | 0 | 0.21 | 0.032 | 0.811 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal cardiac disorder | 0 | 0.21 | 0.031 | 0.811 | 2.522 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Syphilis | 0 | 0.21 | 0.032 | 0.811 | 2.521 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 2 globulin normal | 0 | 0.262 | 0.055 | 0.811 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrosis ischaemic | 0 | 0.157 | 0.012 | 0.811 | 2.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Continuous haemodiafiltration | 0 | 0.315 | 0.078 | 0.81 | 2.191 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abortion early | 0 | 0.105 | 0.002 | 0.81 | 3.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rathke's cleft cyst | 0 | 0.105 | 0.002 | 0.81 | 3.235 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual acuity tests normal | 0 | 0.491 | 0.153 | 0.81 | 1.893 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis mumps | 0 | 0.105 | 0.002 | 0.81 | 3.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniocentesis abnormal | 0 | 0.105 | 0.002 | 0.81 | 3.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anorectal disorder | 0 | 0.262 | 0.054 | 0.81 | 2.333 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fungal skin infection | 0 | 0.221 | 0.036 | 0.81 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Streptococcal sepsis | 0 | 0.315 | 0.078 | 0.81 | 2.192 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia mycoplasmal | 0 | 0.105 | 0.002 | 0.81 | 3.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Telangiectasia | 0 | 0.472 | 0.144 | 0.809 | 1.919 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human bocavirus infection | 0 | 0.21 | 0.031 | 0.809 | 2.526 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure inadequately controlled | 0 | 0.262 | 0.053 | 0.809 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leg amputation | 0 | 0.262 | 0.053 | 0.809 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin urine absent | 0 | 0.367 | 0.101 | 0.809 | 2.082 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalomyelitis | 0 | 0.254 | 0.05 | 0.809 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic mass | 0 | 0.21 | 0.03 | 0.809 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lower respiratory tract infection viral | 0 | 0.21 | 0.03 | 0.809 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertrichosis | 0 | 0.21 | 0.03 | 0.809 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal deformity | 0 | 0.262 | 0.053 | 0.809 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-islet cell antibody positive | 0 | 0.262 | 0.053 | 0.809 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-thyroid antibody | 0 | 0.476 | 0.145 | 0.809 | 1.914 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypergammaglobulinaemia | 0 | 0.21 | 0.03 | 0.809 | 2.527 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine ophthalmopathy | 0 | 0.21 | 0.03 | 0.809 | 2.528 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | False positive investigation result | 0 | 0.315 | 0.077 | 0.809 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrocephalus | 0 | 0.578 | 0.181 | 0.809 | 1.803 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy test negative | 0 | 0.855 | 0.258 | 0.809 | 1.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac pacemaker insertion | 2 | 4.193 | 0.318 | 0.808 | 1.48 | 0.29 | 0.641 | 1.264 | 0.477 | 1.246 | 0.01
COVID19_PFIZER/BIONTECH | Ovarian operation | 0 | 0.21 | 0.03 | 0.808 | 2.53 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary sediment abnormal | 0 | 0.315 | 0.076 | 0.808 | 2.196 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy stomach abnormal | 0 | 0.315 | 0.076 | 0.808 | 2.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ankyloglossia congenital | 0 | 0.21 | 0.03 | 0.808 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis allergic | 0 | 0.262 | 0.053 | 0.808 | 2.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal erythema | 0 | 0.42 | 0.122 | 0.808 | 1.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pineal gland cyst | 0 | 0.21 | 0.03 | 0.808 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound complication | 0 | 0.367 | 0.1 | 0.808 | 2.084 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental discomfort | 0 | 0.157 | 0.011 | 0.808 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute leukaemia | 0 | 0.21 | 0.03 | 0.808 | 2.53 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Feeding intolerance | 0 | 0.262 | 0.052 | 0.808 | 2.339 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stress urinary incontinence | 0 | 0.21 | 0.03 | 0.808 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Progesterone normal | 0 | 0.315 | 0.076 | 0.808 | 2.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral artery embolism | 0 | 0.157 | 0.011 | 0.808 | 2.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray of pelvis and hip normal | 0 | 0.551 | 0.171 | 0.808 | 1.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site hypertrophy | 0 | 0.21 | 0.03 | 0.808 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anion gap decreased | 1 | 2.33 | 0.314 | 0.807 | 1.484 | 0.271 | 0.669 | 1.428 | 0.429 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Cellulitis staphylococcal | 0 | 0.262 | 0.052 | 0.807 | 2.339 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral load | 0 | 0.105 | 0.002 | 0.807 | 3.247 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile colic | 0 | 0.113 | 0.002 | 0.807 | 3.166 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscular dystrophy | 0 | 0.367 | 0.098 | 0.807 | 2.086 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver abscess | 0 | 0.262 | 0.051 | 0.807 | 2.341 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fibrous histiocytoma | 0 | 0.262 | 0.051 | 0.807 | 2.341 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Steatohepatitis | 0 | 0.105 | 0.002 | 0.807 | 3.247 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint abscess | 0 | 0.21 | 0.029 | 0.807 | 2.534 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis D | 0 | 0.105 | 0.002 | 0.807 | 3.247 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ceruloplasmin | 0 | 0.315 | 0.075 | 0.806 | 2.198 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pleural decortication | 0 | 0.21 | 0.029 | 0.806 | 2.534 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood zinc | 0 | 0.21 | 0.029 | 0.806 | 2.535 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac electrophysiologic study abnormal | 0 | 0.21 | 0.028 | 0.806 | 2.536 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perivascular dermatitis | 0 | 0.262 | 0.051 | 0.806 | 2.343 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-neuronal antibody | 0 | 0.315 | 0.074 | 0.806 | 2.199 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctival hyperaemia | 1 | 1.462 | 0.232 | 0.805 | 1.661 | 0.323 | 0.789 | 1.675 | 0.684 | 0.282 | 1.13
COVID19_PFIZER/BIONTECH | Skin exfoliation | 15 | 20.458 | 0.536 | 0.805 | 1.119 | 0.501 | 0.749 | 1.086 | 0.733 | 0.555 | 4.75
COVID19_PFIZER/BIONTECH | Granulocyte percentage | 1 | 2.585 | 0.27 | 0.805 | 1.572 | 0.257 | 0.64 | 1.369 | 0.387 | 0.384 | 0.435
COVID19_PFIZER/BIONTECH | Necrotising soft tissue infection | 0 | 0.157 | 0.011 | 0.805 | 2.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gangrene | 0 | 0.21 | 0.028 | 0.805 | 2.539 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polycythaemia | 0 | 0.262 | 0.05 | 0.805 | 2.344 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthopaedic examination | 0 | 0.367 | 0.096 | 0.805 | 2.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF shunt operation | 0 | 0.21 | 0.028 | 0.805 | 2.538 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear site unspecified abnormal | 0 | 0.42 | 0.118 | 0.805 | 2 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament injury | 0 | 0.315 | 0.073 | 0.805 | 2.201 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein albumin ratio | 0 | 0.21 | 0.028 | 0.805 | 2.539 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Echolalia | 0 | 0.262 | 0.05 | 0.805 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray normal | 14 | 19.877 | 0.529 | 0.804 | 1.126 | 0.479 | 0.725 | 1.062 | 0.704 | 0.642 | 2.354
COVID19_PFIZER/BIONTECH | Scan myocardial perfusion | 1 | 1.648 | 0.285 | 0.804 | 1.537 | 0.311 | 0.76 | 1.615 | 0.607 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Non-haematological tumours of unspecified malignancy (SMQ) [broad] | 1 | 1.734 | 0.158 | 0.804 | 1.86 | 0.305 | 0.747 | 1.589 | 0.577 | 0.235 | 1.733
COVID19_PFIZER/BIONTECH | Non-haematological tumours of unspecified malignancy (SMQ) [narrow] | 1 | 1.734 | 0.158 | 0.804 | 1.86 | 0.305 | 0.747 | 1.589 | 0.577 | 0.235 | 1.733
COVID19_PFIZER/BIONTECH | Toxicity to various agents | 0 | 0.47 | 0.136 | 0.804 | 1.93 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intercepted medication error | 0 | 0.21 | 0.028 | 0.804 | 2.54 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovial disorder | 0 | 0.262 | 0.049 | 0.804 | 2.347 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Investigation normal | 0 | 0.142 | 0.007 | 0.804 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoproteinaemia | 0 | 0.315 | 0.073 | 0.804 | 2.203 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine free increased | 0 | 0.21 | 0.027 | 0.804 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte count decreased | 0 | 0.262 | 0.049 | 0.804 | 2.348 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy cervix normal | 0 | 0.21 | 0.028 | 0.804 | 2.539 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron binding capacity unsaturated | 0 | 0.21 | 0.028 | 0.804 | 2.54 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood parathyroid hormone normal | 0 | 0.42 | 0.117 | 0.804 | 2.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash papular | 60 | 79.833 | 0.644 | 0.803 | 0.977 | 0.611 | 0.755 | 0.925 | 0.752 | 1.139 | 0.832
COVID19_PFIZER/BIONTECH | Pregnancy and neonatal topics (SMQ) [broad] | 178 | 243.52 | 0.707 | 0.803 | 0.904 | 0.647 | 0.733 | 0.826 | 0.731 | 0.628 | 38.123
COVID19_PFIZER/BIONTECH | Temperature difference of extremities | 0 | 0.21 | 0.027 | 0.803 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anticonvulsant drug level decreased | 0 | 0.21 | 0.027 | 0.803 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudomononucleosis | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroviral infection | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic mastocytosis | 0 | 0.262 | 0.049 | 0.803 | 2.349 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovulation disorder | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF red blood cell count | 0 | 0.515 | 0.152 | 0.803 | 1.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract haemorrhage | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amyotrophy | 0 | 0.21 | 0.027 | 0.803 | 2.542 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Babesiosis | 0 | 0.157 | 0.01 | 0.803 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abulia | 0 | 0.21 | 0.027 | 0.803 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precancerous condition | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiopathic generalised epilepsy | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cephalhaematoma | 0 | 0.157 | 0.01 | 0.803 | 2.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphatic system neoplasm | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint inflammation | 0 | 0.501 | 0.146 | 0.803 | 1.893 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor VIII antibody negative | 0 | 0.105 | 0.001 | 0.803 | 3.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | C-reactive protein abnormal | 0 | 0.388 | 0.103 | 0.803 | 2.055 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site eschar | 0 | 0.121 | 0.003 | 0.803 | 3.099 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure orthostatic abnormal | 0 | 0.157 | 0.01 | 0.803 | 2.821 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary vascular disorder | 0 | 0.157 | 0.01 | 0.802 | 2.824 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune thyroid disorder | 0 | 0.21 | 0.027 | 0.802 | 2.545 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic disease | 0 | 0.21 | 0.027 | 0.802 | 2.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skull X-ray abnormal | 0 | 0.262 | 0.048 | 0.802 | 2.351 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Depressed level of consciousness | 16 | 20.907 | 0.523 | 0.801 | 1.127 | 0.525 | 0.776 | 1.114 | 0.765 | 0.583 | 4.225
COVID19_PFIZER/BIONTECH | Vestibular neuronitis | 2 | 3.449 | 0.335 | 0.801 | 1.428 | 0.322 | 0.711 | 1.398 | 0.58 | 1.032 | 0.106
COVID19_PFIZER/BIONTECH | Breast discomfort | 0 | 0.262 | 0.047 | 0.801 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatologic examination | 0 | 0.472 | 0.133 | 0.801 | 1.932 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 globulin | 0 | 0.262 | 0.047 | 0.801 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermohyperaesthesia | 0 | 0.105 | 0.001 | 0.801 | 3.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval ulceration | 0 | 0.262 | 0.047 | 0.801 | 2.353 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericarditis lupus | 0 | 0.105 | 0.001 | 0.801 | 3.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychogenic visual disorder | 0 | 0.105 | 0.001 | 0.801 | 3.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin graft | 0 | 0.367 | 0.092 | 0.801 | 2.097 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve stimulation test | 0 | 0.42 | 0.113 | 0.801 | 2.006 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal dystrophy | 0 | 0.157 | 0.01 | 0.801 | 2.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dehydroepiandrosterone test | 0 | 0.21 | 0.026 | 0.801 | 2.549 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood electrolytes | 5 | 6.007 | 0.393 | 0.8 | 1.322 | 0.453 | 0.835 | 1.438 | 0.832 | 1.531 | 0.41
COVID19_PFIZER/BIONTECH | Stent placement | 7 | 10.123 | 0.443 | 0.8 | 1.242 | 0.423 | 0.73 | 1.192 | 0.691 | 5.746 | 17.194
COVID19_PFIZER/BIONTECH | Congenital choroid plexus cyst | 0 | 0.21 | 0.025 | 0.8 | 2.551 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decompressive craniectomy | 0 | 0.21 | 0.025 | 0.8 | 2.551 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Febrile neutropenia | 0 | 0.367 | 0.091 | 0.8 | 2.098 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | FEV1/FVC ratio | 0 | 0.21 | 0.025 | 0.8 | 2.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Babinski reflex test | 0 | 0.201 | 0.022 | 0.8 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint debridement | 0 | 0.21 | 0.026 | 0.8 | 2.55 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal respiratory distress syndrome | 0 | 0.157 | 0.009 | 0.8 | 2.828 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood mercury | 0 | 0.315 | 0.069 | 0.8 | 2.211 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal scar | 0 | 0.157 | 0.009 | 0.8 | 2.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smooth muscle antibody negative | 1 | 0.514 | 0.13 | 0.799 | 1.935 | 0.403 | 0.979 | 2.081 | 1.946 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Antiacetylcholine receptor antibody | 0 | 0.285 | 0.055 | 0.799 | 2.29 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proctalgia | 0 | 0.29 | 0.057 | 0.799 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Functional gastrointestinal disorder | 0 | 0.838 | 0.238 | 0.799 | 1.628 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typhus | 0 | 0.105 | 0.001 | 0.799 | 3.273 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Syringomyelia | 0 | 0.21 | 0.025 | 0.799 | 2.553 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spondylitis | 0 | 0.288 | 0.056 | 0.799 | 2.282 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin urine | 0 | 0.367 | 0.089 | 0.799 | 2.101 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E | 0 | 0.105 | 0.001 | 0.799 | 3.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis viral test positive | 0 | 0.105 | 0.001 | 0.799 | 3.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypochloraemia | 0 | 0.315 | 0.068 | 0.799 | 2.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convulsions (SMQ) [narrow] | 111 | 145.871 | 0.679 | 0.798 | 0.925 | 0.652 | 0.763 | 0.888 | 0.761 | 0.268 | 222.738
COVID19_PFIZER/BIONTECH | Urine bilirubin increased | 0 | 0.367 | 0.088 | 0.798 | 2.103 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair disorder | 0 | 0.123 | 0.003 | 0.798 | 3.094 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary system x-ray abnormal | 0 | 0.157 | 0.009 | 0.798 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin globulin ratio decreased | 0 | 0.157 | 0.009 | 0.798 | 2.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye operation | 0 | 0.4 | 0.102 | 0.798 | 2.043 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign prostatic hyperplasia | 0 | 0.472 | 0.13 | 0.798 | 1.935 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema weeping | 0 | 0.262 | 0.044 | 0.798 | 2.362 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exophthalmos | 0 | 0.206 | 0.023 | 0.798 | 2.574 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate decreased | 0 | 0.21 | 0.024 | 0.798 | 2.556 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granuloma skin | 0 | 0.21 | 0.025 | 0.798 | 2.555 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product contamination | 0 | 0.315 | 0.067 | 0.798 | 2.216 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-ganglioside antibody | 0 | 0.262 | 0.045 | 0.798 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seborrhoeic dermatitis | 0 | 0.386 | 0.096 | 0.798 | 2.068 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia viral | 2 | 2.975 | 0.35 | 0.797 | 1.393 | 0.347 | 0.762 | 1.499 | 0.672 | 1.389 | 0.001
COVID19_PFIZER/BIONTECH | Temporomandibular joint syndrome | 1 | 1.6 | 0.173 | 0.797 | 1.793 | 0.314 | 0.767 | 1.63 | 0.625 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Skin swelling | 10 | 14.302 | 0.479 | 0.797 | 1.18 | 0.452 | 0.727 | 1.122 | 0.699 | 1.627 | 1.652
COVID19_PFIZER/BIONTECH | Gastroenteritis bacterial | 0 | 0.21 | 0.024 | 0.797 | 2.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis astroviral | 0 | 0.105 | 0.001 | 0.797 | 3.277 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram T wave amplitude decreased | 0 | 0.105 | 0.001 | 0.797 | 3.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lesion excision | 0 | 0.21 | 0.024 | 0.797 | 2.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal erythema | 0 | 0.105 | 0.001 | 0.797 | 3.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epiglottic erythema | 0 | 0.105 | 0.001 | 0.797 | 3.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal warts | 0 | 0.157 | 0.008 | 0.797 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.157 | 0.008 | 0.797 | 2.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myasthenic syndrome | 0 | 0.157 | 0.008 | 0.797 | 2.838 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Influenza A virus test | 3 | 4.449 | 0.348 | 0.796 | 1.391 | 0.366 | 0.748 | 1.391 | 0.674 | 1.231 | 0
COVID19_PFIZER/BIONTECH | Extravasation events (injections, infusions and implants) (SMQ) [narrow] | 6 | 9.657 | 0.384 | 0.796 | 1.33 | 0.382 | 0.68 | 1.138 | 0.621 | 0.695 | 0.497
COVID19_PFIZER/BIONTECH | Proteinuria (SMQ) [narrow] | 6 | 11.34 | 0.402 | 0.796 | 1.298 | 0.339 | 0.604 | 1.01 | 0.529 | 0.511 | 2.251
COVID19_PFIZER/BIONTECH | Poliovirus test negative | 0 | 0.21 | 0.023 | 0.796 | 2.561 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incarcerated inguinal hernia | 0 | 0.21 | 0.023 | 0.796 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian cystectomy | 0 | 0.21 | 0.024 | 0.796 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysmorphism | 0 | 0.21 | 0.024 | 0.796 | 2.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper airway obstruction | 0 | 0.367 | 0.087 | 0.796 | 2.105 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tympanometry | 0 | 0.367 | 0.086 | 0.796 | 2.106 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disease susceptibility | 0 | 0.262 | 0.043 | 0.796 | 2.365 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radiotherapy | 1 | 1.361 | 0.163 | 0.795 | 1.816 | 0.33 | 0.806 | 1.71 | 0.734 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | Autoantibody positive | 0 | 0.382 | 0.091 | 0.795 | 2.08 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stress echocardiogram | 0 | 0.262 | 0.043 | 0.795 | 2.367 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.568 | 0.159 | 0.795 | 1.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal candidiasis | 0 | 0.21 | 0.023 | 0.795 | 2.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystoscopy normal | 0 | 0.21 | 0.023 | 0.795 | 2.563 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fasciotomy | 0 | 0.21 | 0.023 | 0.795 | 2.563 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrotising enterocolitis neonatal | 0 | 0.157 | 0.008 | 0.795 | 2.843 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram T wave normal | 0 | 0.262 | 0.043 | 0.795 | 2.367 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear test | 0 | 0.478 | 0.128 | 0.795 | 1.932 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle rigidity | 7 | 10.624 | 0.431 | 0.794 | 1.247 | 0.408 | 0.705 | 1.15 | 0.659 | 0.424 | 4.772
COVID19_PFIZER/BIONTECH | Serum sickness-like reaction | 0 | 0.356 | 0.079 | 0.794 | 2.133 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cyst | 0 | 0.157 | 0.008 | 0.794 | 2.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Giardia test | 0 | 0.21 | 0.023 | 0.794 | 2.564 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthopox virus infection | 0 | 0.105 | 0.001 | 0.794 | 3.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess oral | 0 | 0.262 | 0.042 | 0.794 | 2.37 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antisocial behaviour | 0 | 0.262 | 0.042 | 0.794 | 2.369 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cushingoid | 0 | 0.21 | 0.023 | 0.794 | 2.565 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral sensory neuropathy | 0 | 0.483 | 0.129 | 0.794 | 1.926 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin depigmentation | 0 | 0.128 | 0.003 | 0.794 | 3.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose urine | 0 | 0.157 | 0.008 | 0.794 | 2.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhesus antigen positive | 0 | 0.315 | 0.062 | 0.793 | 2.226 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound liver normal | 0 | 0.537 | 0.146 | 0.793 | 1.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy stomach | 0 | 0.21 | 0.022 | 0.793 | 2.568 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperkeratosis | 0 | 0.482 | 0.127 | 0.793 | 1.929 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myopia | 0 | 0.206 | 0.021 | 0.793 | 2.586 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye patch application | 0 | 0.315 | 0.062 | 0.793 | 2.226 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sense of oppression | 0 | 0.262 | 0.041 | 0.793 | 2.372 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Detoxification | 0 | 0.294 | 0.054 | 0.793 | 2.279 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug intolerance | 0 | 0.441 | 0.11 | 0.792 | 1.988 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fat necrosis | 0 | 0.42 | 0.102 | 0.792 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Refusal of vaccination | 0 | 0.262 | 0.041 | 0.792 | 2.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body aspiration | 0 | 0.21 | 0.022 | 0.792 | 2.57 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF pressure | 0 | 0.157 | 0.007 | 0.792 | 2.852 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Familial periodic paralysis | 0 | 0.157 | 0.007 | 0.792 | 2.852 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucosal erosion | 0 | 0.21 | 0.022 | 0.792 | 2.57 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperbaric oxygen therapy | 0 | 0.262 | 0.041 | 0.792 | 2.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bicytopenia | 0 | 0.42 | 0.103 | 0.792 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine abnormality | 2 | 3.015 | 0.299 | 0.791 | 1.473 | 0.345 | 0.758 | 1.49 | 0.663 | 0.86 | 0.017
COVID19_PFIZER/BIONTECH | Rib fracture | 1 | 1.834 | 0.246 | 0.791 | 1.587 | 0.299 | 0.733 | 1.56 | 0.545 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Indifference | 0 | 0.262 | 0.04 | 0.791 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye allergy | 0 | 0.262 | 0.04 | 0.791 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vibration test abnormal | 0 | 0.21 | 0.021 | 0.791 | 2.573 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid pain | 0 | 0.315 | 0.06 | 0.791 | 2.229 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament rupture | 0 | 0.472 | 0.121 | 0.791 | 1.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foot amputation | 0 | 0.21 | 0.021 | 0.791 | 2.572 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurotoxicity | 0 | 0.262 | 0.04 | 0.791 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extrapulmonary tuberculosis | 0 | 0.105 | 0.001 | 0.791 | 3.293 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin A normal | 1 | 1.516 | 0.151 | 0.79 | 1.84 | 0.319 | 0.78 | 1.658 | 0.66 | 0.174 | 3.08
COVID19_PFIZER/BIONTECH | Retinal artery occlusion | 1 | 1.58 | 0.205 | 0.79 | 1.685 | 0.315 | 0.77 | 1.637 | 0.633 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Enteroclysis | 0 | 0.157 | 0.007 | 0.79 | 2.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dengue virus test positive | 0 | 0.105 | 0.001 | 0.79 | 3.297 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac aneurysm | 0 | 0.21 | 0.021 | 0.79 | 2.575 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic specific antigen increased | 0 | 0.327 | 0.064 | 0.79 | 2.202 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Axillary pain | 91 | 122.778 | 0.66 | 0.789 | 0.926 | 0.626 | 0.744 | 0.879 | 0.741 | 1.968 | 38.272
COVID19_PFIZER/BIONTECH | Immune-mediated myositis | 0 | 0.21 | 0.02 | 0.789 | 2.578 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte haemoglobin equivalent | 0 | 0.21 | 0.02 | 0.789 | 2.576 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain abscess | 0 | 0.262 | 0.038 | 0.789 | 2.381 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal calprotectin | 0 | 0.21 | 0.02 | 0.789 | 2.577 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aluminium increased | 0 | 0.131 | 0.003 | 0.789 | 3.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone cancer | 0 | 0.157 | 0.007 | 0.789 | 2.859 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephrotic syndrome | 0 | 0.352 | 0.073 | 0.789 | 2.149 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic myeloid leukaemia | 0 | 0.262 | 0.039 | 0.789 | 2.379 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain hypoxia | 0 | 0.315 | 0.059 | 0.789 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Morning sickness | 0 | 0.262 | 0.039 | 0.789 | 2.38 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total complement activity test | 0 | 0.178 | 0.011 | 0.788 | 2.736 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine cancer | 0 | 0.21 | 0.02 | 0.788 | 2.58 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral palsy | 0 | 0.469 | 0.116 | 0.788 | 1.954 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loose tooth | 0 | 0.525 | 0.135 | 0.788 | 1.885 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | High risk pregnancy | 0 | 0.262 | 0.038 | 0.788 | 2.382 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocauterisation | 0 | 0.262 | 0.038 | 0.788 | 2.382 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atopy | 0 | 0.367 | 0.079 | 0.788 | 2.119 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site streaking | 0 | 0.315 | 0.058 | 0.788 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fertility disorders (SMQ) [broad] | 13 | 12.964 | 0.471 | 0.787 | 1.169 | 0.631 | 0.967 | 1.432 | 1.003 | 0.446 | 8.207
COVID19_PFIZER/BIONTECH | Aspartate aminotransferase | 2 | 2.479 | 0.275 | 0.787 | 1.512 | 0.376 | 0.825 | 1.622 | 0.807 | 0.903 | 0.042
COVID19_PFIZER/BIONTECH | Red blood cell sedimentation rate | 12 | 16.181 | 0.507 | 0.787 | 1.116 | 0.488 | 0.759 | 1.138 | 0.742 | 0.843 | 0.195
COVID19_PFIZER/BIONTECH | Injection site hypoaesthesia | 20 | 27.32 | 0.549 | 0.787 | 1.061 | 0.522 | 0.745 | 1.036 | 0.732 | 0.995 | 0.009
COVID19_PFIZER/BIONTECH | Neuropsychiatric symptoms | 0 | 0.262 | 0.037 | 0.787 | 2.385 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycoplasma test | 0 | 0.799 | 0.211 | 0.787 | 1.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutaneous vasculitis | 0 | 0.262 | 0.037 | 0.787 | 2.384 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catecholamines urine | 0 | 0.157 | 0.006 | 0.787 | 2.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper respiratory tract infection bacterial | 0 | 0.262 | 0.037 | 0.787 | 2.385 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood prolactin | 0 | 0.21 | 0.02 | 0.787 | 2.581 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy and neonatal topics (SMQ) [narrow] | 170 | 236.648 | 0.69 | 0.786 | 0.887 | 0.635 | 0.72 | 0.815 | 0.718 | 0.623 | 37.668
COVID19_PFIZER/BIONTECH | Acute respiratory distress syndrome | 2 | 5.631 | 0.193 | 0.786 | 1.705 | 0.241 | 0.539 | 1.067 | 0.355 | 0.469 | 0.689
COVID19_PFIZER/BIONTECH | Gross motor delay | 0 | 0.216 | 0.021 | 0.786 | 2.555 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site vesicles | 0 | 0.157 | 0.006 | 0.786 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail bed bleeding | 0 | 0.21 | 0.019 | 0.786 | 2.583 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric infection | 0 | 0.21 | 0.019 | 0.786 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrophoresis normal | 0 | 0.262 | 0.037 | 0.786 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post transfusion purpura | 0 | 0.105 | 0.001 | 0.786 | 3.307 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papilloma | 0 | 0.157 | 0.006 | 0.786 | 2.865 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site pain | 0 | 0.21 | 0.019 | 0.786 | 2.584 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritonitis bacterial | 0 | 0.157 | 0.006 | 0.786 | 2.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Differential white blood cell count | 21 | 27.699 | 0.557 | 0.785 | 1.045 | 0.543 | 0.768 | 1.06 | 0.758 | 1.149 | 0.249
COVID19_PFIZER/BIONTECH | Immunoglobulin therapy | 28 | 36.907 | 0.564 | 0.785 | 1.037 | 0.565 | 0.766 | 1.019 | 0.759 | 0.518 | 11.744
COVID19_PFIZER/BIONTECH | Incisional drainage | 1 | 1.758 | 0.244 | 0.785 | 1.576 | 0.304 | 0.744 | 1.582 | 0.569 | 0.186 | 2.723
COVID19_PFIZER/BIONTECH | Ophthalmoplegia | 1 | 2.47 | 0.234 | 0.785 | 1.599 | 0.263 | 0.653 | 1.395 | 0.405 | 0.376 | 0.471
COVID19_PFIZER/BIONTECH | Arthropod sting | 0 | 0.525 | 0.132 | 0.785 | 1.887 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal abscess | 0 | 0.262 | 0.036 | 0.785 | 2.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Testicular torsion | 0 | 0.157 | 0.006 | 0.785 | 2.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aldolase normal | 0 | 0.352 | 0.07 | 0.785 | 2.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdomen scan | 0 | 0.262 | 0.036 | 0.785 | 2.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatic failure | 0 | 0.262 | 0.036 | 0.785 | 2.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lagophthalmos | 0 | 0.472 | 0.114 | 0.785 | 1.953 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Miosis | 2 | 2.359 | 0.295 | 0.784 | 1.465 | 0.384 | 0.842 | 1.655 | 0.848 | 1.505 | 0.014
COVID19_PFIZER/BIONTECH | Musculoskeletal stiffness | 132 | 171.373 | 0.679 | 0.784 | 0.896 | 0.668 | 0.772 | 0.887 | 0.77 | 0.737 | 11.763
COVID19_PFIZER/BIONTECH | Feelings of worthlessness | 0 | 0.157 | 0.006 | 0.784 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transient acantholytic dermatosis | 0 | 0.157 | 0.006 | 0.784 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peritoneal dialysis | 0 | 0.262 | 0.036 | 0.784 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anisocytosis | 0 | 0.367 | 0.075 | 0.784 | 2.125 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary granuloma | 0 | 0.262 | 0.035 | 0.784 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis viral | 0 | 0.262 | 0.036 | 0.784 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product used for unknown indication | 0 | 0.315 | 0.055 | 0.784 | 2.241 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspiration joint normal | 0 | 0.472 | 0.113 | 0.784 | 1.955 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye ulcer | 0 | 0.157 | 0.006 | 0.784 | 2.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pustule | 6 | 10.575 | 0.424 | 0.783 | 1.231 | 0.357 | 0.636 | 1.065 | 0.567 | 1.667 | 0.893
COVID19_PFIZER/BIONTECH | CSF white blood cell count positive | 0 | 0.367 | 0.074 | 0.783 | 2.127 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chelation therapy | 0 | 0.315 | 0.054 | 0.783 | 2.243 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure diastolic decreased | 0 | 0.262 | 0.035 | 0.783 | 2.393 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vital capacity decreased | 0 | 0.157 | 0.006 | 0.783 | 2.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Senile dementia | 0 | 0.105 | 0.001 | 0.783 | 3.315 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune complex assay | 0 | 0.445 | 0.103 | 0.783 | 1.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obsessive-compulsive symptom | 0 | 0.21 | 0.018 | 0.783 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Guttate psoriasis | 0 | 0.367 | 0.074 | 0.783 | 2.127 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alopecia universalis | 0 | 0.262 | 0.035 | 0.783 | 2.392 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric emptying study | 0 | 0.382 | 0.08 | 0.783 | 2.098 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monocyte percentage decreased | 1 | 2.201 | 0.231 | 0.782 | 1.597 | 0.278 | 0.685 | 1.46 | 0.454 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Aspiration joint abnormal | 0 | 0.315 | 0.054 | 0.782 | 2.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngomalacia | 0 | 0.367 | 0.073 | 0.782 | 2.128 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell morphology normal | 0 | 0.525 | 0.128 | 0.782 | 1.892 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oedema mucosal | 0 | 0.525 | 0.129 | 0.782 | 1.891 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basilar migraine | 0 | 0.157 | 0.006 | 0.782 | 2.876 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue haemorrhage | 0 | 0.367 | 0.073 | 0.782 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchopulmonary dysplasia | 0 | 0.157 | 0.006 | 0.782 | 2.876 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acid base balance normal | 0 | 0.21 | 0.018 | 0.782 | 2.593 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site erosion | 0 | 0.55 | 0.136 | 0.782 | 1.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective polysaccharide antibody deficiency | 0 | 0.262 | 0.034 | 0.782 | 2.393 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tourette's disorder | 0 | 0.277 | 0.039 | 0.782 | 2.348 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-thyroid antibody negative | 0 | 0.28 | 0.04 | 0.782 | 2.34 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypocoagulable state | 0 | 0.157 | 0.005 | 0.781 | 2.879 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cell morphology normal | 0 | 0.21 | 0.017 | 0.781 | 2.594 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic tonsillitis | 0 | 0.157 | 0.005 | 0.781 | 2.878 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bilirubin unconjugated decreased | 0 | 0.315 | 0.053 | 0.781 | 2.246 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product prescribing issue | 0 | 0.157 | 0.005 | 0.781 | 2.878 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium swallow | 0 | 0.418 | 0.09 | 0.78 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gynaecological examination normal | 0 | 0.21 | 0.017 | 0.78 | 2.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perfusion brain scan | 0 | 0.157 | 0.005 | 0.78 | 2.881 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiopathic pulmonary fibrosis | 0 | 0.262 | 0.033 | 0.78 | 2.398 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood testosterone normal | 0 | 0.262 | 0.033 | 0.78 | 2.398 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate malignant tumours (SMQ) [narrow] | 0 | 0.661 | 0.167 | 0.78 | 1.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine free | 0 | 0.24 | 0.026 | 0.78 | 2.475 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical radiculopathy | 1 | 1.437 | 0.212 | 0.779 | 1.638 | 0.325 | 0.793 | 1.684 | 0.696 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Multifocal motor neuropathy | 0 | 0.367 | 0.07 | 0.779 | 2.134 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otitis media acute | 0 | 0.258 | 0.031 | 0.779 | 2.415 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystic fibrosis | 0 | 0.157 | 0.005 | 0.779 | 2.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borrelia test positive | 0 | 0.248 | 0.028 | 0.779 | 2.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parakeratosis | 0 | 0.262 | 0.033 | 0.779 | 2.4 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bite | 0 | 0.262 | 0.033 | 0.779 | 2.399 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular headache | 0 | 0.21 | 0.016 | 0.779 | 2.6 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary fibrosis | 1 | 1.898 | 0.113 | 0.778 | 1.936 | 0.295 | 0.724 | 1.541 | 0.527 | 0.583 | 0.02
COVID19_PFIZER/BIONTECH | Interleukin-2 receptor increased | 0 | 0.262 | 0.032 | 0.778 | 2.402 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Knee arthroplasty | 0 | 0.404 | 0.083 | 0.778 | 2.067 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superficial vein prominence | 0 | 0.262 | 0.032 | 0.778 | 2.402 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestinal resection | 0 | 0.262 | 0.032 | 0.778 | 2.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperprolactinaemia | 0 | 0.157 | 0.005 | 0.778 | 2.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breath holding | 0 | 0.55 | 0.132 | 0.778 | 1.867 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fluid replacement | 0 | 0.315 | 0.05 | 0.778 | 2.252 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site haemorrhage | 0 | 0.262 | 0.032 | 0.778 | 2.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumomediastinum | 0 | 0.262 | 0.032 | 0.778 | 2.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Demyelination (SMQ) [broad] | 57 | 84.347 | 0.617 | 0.777 | 0.951 | 0.549 | 0.682 | 0.84 | 0.676 | 0.383 | 55.159
COVID19_PFIZER/BIONTECH | Mycobacterial infection | 0 | 0.21 | 0.016 | 0.777 | 2.604 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary hesitation | 0 | 0.367 | 0.069 | 0.777 | 2.136 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Horner's syndrome | 0 | 0.315 | 0.049 | 0.777 | 2.254 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trigger finger | 0 | 0.472 | 0.106 | 0.777 | 1.963 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tympanometry abnormal | 0 | 0.262 | 0.031 | 0.776 | 2.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | pH body fluid normal | 0 | 0.181 | 0.009 | 0.776 | 2.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Personal relationship issue | 0 | 0.262 | 0.031 | 0.776 | 2.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alveolitis | 0 | 0.157 | 0.005 | 0.776 | 2.891 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Megakaryocytes | 0 | 0.21 | 0.016 | 0.776 | 2.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serous retinal detachment | 0 | 0.21 | 0.015 | 0.776 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opsoclonus myoclonus | 0 | 0.21 | 0.015 | 0.776 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Natural killer cell count decreased | 0 | 0.21 | 0.015 | 0.776 | 2.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphadenitis | 12 | 17.048 | 0.473 | 0.775 | 1.136 | 0.468 | 0.728 | 1.09 | 0.704 | 0.994 | 0.016
COVID19_PFIZER/BIONTECH | Penis disorder | 0 | 0.262 | 0.031 | 0.775 | 2.406 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia necrotising | 0 | 0.157 | 0.005 | 0.775 | 2.893 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fracture treatment | 0 | 0.157 | 0.005 | 0.775 | 2.893 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy gastrointestinal | 0 | 0.315 | 0.048 | 0.775 | 2.256 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Selective IgM immunodeficiency | 0 | 0.157 | 0.005 | 0.775 | 2.893 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Essential tremor | 0 | 0.312 | 0.047 | 0.775 | 2.263 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertransaminasaemia | 0 | 0.387 | 0.074 | 0.775 | 2.102 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyomyositis | 0 | 0.157 | 0.005 | 0.775 | 2.891 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 3.573 | 0.224 | 0.774 | 1.591 | 0.214 | 0.545 | 1.179 | 0.28 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Breast malignant tumours (SMQ) [broad] | 1 | 3.573 | 0.224 | 0.774 | 1.591 | 0.214 | 0.545 | 1.179 | 0.28 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Negativism | 0 | 0.315 | 0.048 | 0.774 | 2.258 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterobacter test positive | 0 | 0.21 | 0.015 | 0.774 | 2.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary physical examination normal | 0 | 0.315 | 0.047 | 0.774 | 2.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myocardial reperfusion injury | 0 | 0.367 | 0.066 | 0.774 | 2.14 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypospadias | 0 | 0.262 | 0.03 | 0.774 | 2.408 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parainfluenzae virus infection | 0 | 0.38 | 0.071 | 0.774 | 2.115 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pituitary tumour benign | 0 | 0.21 | 0.015 | 0.774 | 2.61 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Choroiditis | 0 | 0.315 | 0.047 | 0.774 | 2.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound treatment | 0 | 0.5 | 0.112 | 0.774 | 1.93 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue inflammation | 0 | 0.283 | 0.037 | 0.774 | 2.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholecystectomy | 4 | 5.91 | 0.353 | 0.773 | 1.325 | 0.382 | 0.738 | 1.316 | 0.677 | 2.491 | 1.907
COVID19_PFIZER/BIONTECH | Non-haematological malignant tumours (SMQ) [broad] | 11 | 20.412 | 0.443 | 0.773 | 1.179 | 0.369 | 0.584 | 0.887 | 0.539 | 0.402 | 8.97
COVID19_PFIZER/BIONTECH | Non-haematological malignant tumours (SMQ) [narrow] | 11 | 20.412 | 0.443 | 0.773 | 1.179 | 0.369 | 0.584 | 0.887 | 0.539 | 0.402 | 8.97
COVID19_PFIZER/BIONTECH | Scan myocardial perfusion abnormal | 0 | 0.157 | 0.004 | 0.773 | 2.896 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 2 globulin | 0 | 0.262 | 0.03 | 0.773 | 2.41 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device related infection | 0 | 0.42 | 0.083 | 0.773 | 2.047 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF neutrophil count | 0 | 0.21 | 0.015 | 0.773 | 2.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningoencephalitis viral | 0 | 0.222 | 0.018 | 0.773 | 2.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Affective disorder | 0 | 0.591 | 0.138 | 0.773 | 1.83 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital lesion | 0 | 0.315 | 0.047 | 0.773 | 2.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Body fluid analysis | 0 | 0.42 | 0.084 | 0.773 | 2.046 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiovascular examination | 1 | 1.496 | 0.106 | 0.772 | 1.945 | 0.321 | 0.784 | 1.664 | 0.669 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Myoglobin blood | 0 | 0.42 | 0.083 | 0.772 | 2.048 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bursitis infective | 0 | 0.157 | 0.004 | 0.772 | 2.9 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuropathic muscular atrophy | 0 | 0.315 | 0.046 | 0.772 | 2.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipoma | 0 | 0.501 | 0.109 | 0.772 | 1.931 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-GAD antibody negative | 0 | 0.262 | 0.029 | 0.772 | 2.412 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site ulcer | 0 | 0.315 | 0.046 | 0.772 | 2.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total lung capacity decreased | 0 | 0.131 | 0.002 | 0.772 | 3.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystitis noninfective | 0 | 0.315 | 0.046 | 0.772 | 2.262 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site haemorrhage | 17 | 24.656 | 0.507 | 0.771 | 1.079 | 0.484 | 0.709 | 1.008 | 0.689 | 0.507 | 7.46
COVID19_PFIZER/BIONTECH | Demyelination (SMQ) [narrow] | 52 | 80.369 | 0.606 | 0.771 | 0.953 | 0.522 | 0.655 | 0.814 | 0.647 | 0.361 | 57.527
COVID19_PFIZER/BIONTECH | Lipaemic index score | 0 | 0.157 | 0.004 | 0.771 | 2.9 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atrial enlargement | 0 | 0.21 | 0.014 | 0.771 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serum amyloid A protein increased | 0 | 0.21 | 0.014 | 0.771 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal obstruction | 0 | 0.262 | 0.029 | 0.771 | 2.413 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human herpesvirus 6 infection | 0 | 0.21 | 0.014 | 0.771 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging spinal abnormal | 10 | 14.663 | 0.44 | 0.77 | 1.175 | 0.443 | 0.713 | 1.099 | 0.682 | 0.604 | 2.126
COVID19_PFIZER/BIONTECH | Blood uric acid increased | 1 | 2.032 | 0.27 | 0.77 | 1.477 | 0.287 | 0.706 | 1.504 | 0.492 | 0.463 | 0.18
COVID19_PFIZER/BIONTECH | Post vaccination challenge strain shedding | 0 | 0.157 | 0.004 | 0.77 | 2.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdomen scan normal | 0 | 0.115 | 0.001 | 0.77 | 3.24 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella virus test | 0 | 0.273 | 0.031 | 0.77 | 2.382 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pituitary cyst | 0 | 0.157 | 0.004 | 0.77 | 2.902 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary sediment | 0 | 0.157 | 0.004 | 0.77 | 2.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute lymphocytic leukaemia | 0 | 0.484 | 0.102 | 0.77 | 1.955 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema eyelids | 0 | 0.157 | 0.004 | 0.77 | 2.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac failure (SMQ) [broad] | 454 | 636.938 | 0.711 | 0.769 | 0.829 | 0.66 | 0.713 | 0.77 | 0.713 | 0.615 | 109.809
COVID19_PFIZER/BIONTECH | Otitis media | 1 | 2.598 | 0.162 | 0.769 | 1.742 | 0.257 | 0.638 | 1.366 | 0.385 | 0.075 | 10.428
COVID19_PFIZER/BIONTECH | Coombs test positive | 0 | 0.315 | 0.044 | 0.769 | 2.266 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve injury | 0 | 0.177 | 0.007 | 0.769 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair texture abnormal | 0 | 0.092 | 0 | 0.769 | 3.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seborrhoeic keratosis | 0 | 0.315 | 0.044 | 0.769 | 2.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sweat test abnormal | 0 | 0.21 | 0.013 | 0.769 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine flow decreased | 0 | 0.367 | 0.062 | 0.769 | 2.147 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Langerhans' cell histiocytosis | 0 | 0.21 | 0.013 | 0.769 | 2.619 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichen striatus | 0 | 0.157 | 0.004 | 0.769 | 2.904 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aldolase increased | 0 | 0.262 | 0.027 | 0.769 | 2.418 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foreign body | 0 | 0.262 | 0.027 | 0.769 | 2.418 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray gastrointestinal tract normal | 0 | 0.145 | 0.003 | 0.769 | 2.992 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bleeding time prolonged | 0 | 0.21 | 0.013 | 0.769 | 2.618 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haematology test abnormal | 0 | 0.367 | 0.062 | 0.769 | 2.147 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calcinosis | 0 | 0.367 | 0.062 | 0.769 | 2.147 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulomatosis with polyangiitis | 0 | 0.315 | 0.044 | 0.769 | 2.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colour blindness | 0 | 0.164 | 0.005 | 0.769 | 2.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Status epilepticus | 2 | 2.759 | 0.261 | 0.768 | 1.492 | 0.359 | 0.789 | 1.55 | 0.725 | 0.241 | 3.968
COVID19_PFIZER/BIONTECH | Antinuclear antibody negative | 3 | 6.677 | 0.288 | 0.768 | 1.435 | 0.284 | 0.584 | 1.09 | 0.449 | 0.175 | 10.688
COVID19_PFIZER/BIONTECH | Somnambulism | 0 | 0.446 | 0.087 | 0.768 | 2.012 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetic neuropathy | 0 | 0.367 | 0.061 | 0.768 | 2.149 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxine free increased | 0 | 0.262 | 0.027 | 0.768 | 2.42 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute haemorrhagic leukoencephalitis | 0 | 0.157 | 0.004 | 0.768 | 2.907 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fontanelle bulging | 0 | 0.302 | 0.039 | 0.768 | 2.302 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflex test normal | 0 | 0.242 | 0.021 | 0.768 | 2.491 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenotonsillectomy | 0 | 0.315 | 0.044 | 0.768 | 2.268 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Venogram normal | 0 | 0.525 | 0.112 | 0.767 | 1.907 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Matrix metalloproteinase-3 increased | 0 | 0.157 | 0.004 | 0.767 | 2.908 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shoulder arthroplasty | 0 | 0.262 | 0.027 | 0.767 | 2.421 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Squamous cell carcinoma of the cervix | 0 | 0.157 | 0.004 | 0.767 | 2.91 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin saturation | 0 | 0.367 | 0.061 | 0.767 | 2.15 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute coronary syndrome | 1 | 1.847 | 0.183 | 0.766 | 1.675 | 0.298 | 0.731 | 1.556 | 0.541 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Monoplegia | 3 | 6.188 | 0.259 | 0.766 | 1.49 | 0.299 | 0.614 | 1.144 | 0.485 | 0.218 | 7.549
COVID19_PFIZER/BIONTECH | Nephritis | 0 | 0.199 | 0.01 | 0.766 | 2.677 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Underweight | 0 | 0.14 | 0.002 | 0.766 | 3.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein abnormal | 0 | 0.21 | 0.013 | 0.766 | 2.624 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | JC polyomavirus test negative | 0 | 0.21 | 0.012 | 0.766 | 2.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear infection viral | 0 | 0.42 | 0.077 | 0.766 | 2.055 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract infection | 4 | 3.8 | 0.279 | 0.765 | 1.445 | 0.492 | 0.949 | 1.692 | 1.053 | 0.07 | 48.13
COVID19_PFIZER/BIONTECH | Mydriasis | 7 | 9.888 | 0.408 | 0.765 | 1.212 | 0.431 | 0.743 | 1.213 | 0.708 | 0.71 | 0.529
COVID19_PFIZER/BIONTECH | Papilloedema | 0 | 0.763 | 0.174 | 0.765 | 1.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parenteral nutrition | 0 | 0.155 | 0.003 | 0.765 | 2.931 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood oestrogen increased | 0 | 0.157 | 0.003 | 0.765 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood oestrogen decreased | 0 | 0.157 | 0.003 | 0.765 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Androgens increased | 0 | 0.157 | 0.003 | 0.765 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bartonella test positive | 0 | 0.157 | 0.003 | 0.765 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B virus test | 0 | 0.349 | 0.053 | 0.765 | 2.192 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth loss | 0 | 0.37 | 0.06 | 0.765 | 2.147 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma stage II | 0 | 0.157 | 0.003 | 0.765 | 2.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder sphincter atony | 0 | 0.21 | 0.012 | 0.765 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood selenium decreased | 0 | 0.262 | 0.026 | 0.765 | 2.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anorectal manometry | 0 | 0.21 | 0.012 | 0.765 | 2.628 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle swelling | 5 | 8.61 | 0.364 | 0.764 | 1.283 | 0.355 | 0.657 | 1.131 | 0.581 | 0.921 | 0.002
COVID19_PFIZER/BIONTECH | Hypertrophy | 0 | 0.367 | 0.058 | 0.764 | 2.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Culture wound positive | 0 | 0.472 | 0.093 | 0.764 | 1.977 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sandifer's syndrome | 0 | 0.21 | 0.012 | 0.764 | 2.628 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound breast normal | 0 | 0.21 | 0.012 | 0.764 | 2.628 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF test | 2 | 3.491 | 0.217 | 0.763 | 1.579 | 0.32 | 0.706 | 1.39 | 0.573 | 0.27 | 3.179
COVID19_PFIZER/BIONTECH | Shock | 3 | 5.547 | 0.289 | 0.763 | 1.42 | 0.321 | 0.657 | 1.224 | 0.541 | 0.39 | 2.211
COVID19_PFIZER/BIONTECH | Muscle contusion | 0 | 0.262 | 0.025 | 0.763 | 2.428 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Candida test | 0 | 0.157 | 0.003 | 0.763 | 2.917 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suspected transmission of an infectious agent via product | 0 | 0.42 | 0.075 | 0.763 | 2.059 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal ulcer | 0 | 0.367 | 0.057 | 0.763 | 2.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood smear test normal | 1 | 1.484 | 0.183 | 0.762 | 1.662 | 0.322 | 0.786 | 1.668 | 0.674 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Wound | 1 | 1.69 | 0.117 | 0.762 | 1.873 | 0.308 | 0.754 | 1.602 | 0.592 | 0.129 | 4.964
COVID19_PFIZER/BIONTECH | Osteomyelitis chronic | 0 | 0.157 | 0.003 | 0.762 | 2.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Face presentation | 0 | 0.157 | 0.003 | 0.762 | 2.92 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retrograde amnesia | 0 | 0.315 | 0.04 | 0.762 | 2.276 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adhesiolysis | 0 | 0.157 | 0.003 | 0.762 | 2.919 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord infection | 0 | 0.315 | 0.04 | 0.762 | 2.276 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cells urine negative | 0 | 0.599 | 0.128 | 0.762 | 1.831 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubber sensitivity | 0 | 0.579 | 0.123 | 0.762 | 1.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.381 | 0.062 | 0.762 | 2.128 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.381 | 0.062 | 0.762 | 2.128 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound thyroid normal | 0 | 0.42 | 0.074 | 0.762 | 2.06 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac electrophysiologic study | 0 | 0.262 | 0.024 | 0.761 | 2.431 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast cancer | 0 | 0.367 | 0.056 | 0.761 | 2.158 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral venous thrombosis | 0 | 0.262 | 0.024 | 0.761 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound ovary | 0 | 0.21 | 0.011 | 0.761 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eustachian tube dysfunction | 0 | 0.315 | 0.039 | 0.761 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antithrombin III increased | 0 | 0.21 | 0.011 | 0.761 | 2.634 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cancer in remission | 0 | 0.367 | 0.056 | 0.761 | 2.158 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metamyelocyte count | 0 | 0.262 | 0.024 | 0.761 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tibia fracture | 0 | 0.315 | 0.039 | 0.761 | 2.279 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal pseudo-obstruction | 0 | 0.157 | 0.003 | 0.761 | 2.92 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyrotoxic crisis | 0 | 0.262 | 0.024 | 0.761 | 2.431 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lactic acid | 21 | 28.108 | 0.524 | 0.76 | 1.033 | 0.536 | 0.758 | 1.047 | 0.747 | 2.986 | 22.053
COVID19_PFIZER/BIONTECH | Culture stool negative | 2 | 3.553 | 0.226 | 0.76 | 1.55 | 0.318 | 0.7 | 1.378 | 0.563 | 0.239 | 4.018
COVID19_PFIZER/BIONTECH | DNA antibody positive | 0 | 0.262 | 0.023 | 0.76 | 2.433 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paracentesis eye abnormal | 0 | 0.262 | 0.024 | 0.76 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute abdomen | 0 | 0.262 | 0.023 | 0.76 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ear operation | 0 | 0.262 | 0.024 | 0.76 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Menopausal symptoms | 0 | 0.21 | 0.011 | 0.76 | 2.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Insulin C-peptide | 0 | 0.262 | 0.023 | 0.76 | 2.433 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint irrigation | 0 | 0.27 | 0.026 | 0.76 | 2.407 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin CSF | 0 | 0.21 | 0.011 | 0.76 | 2.635 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital herpes simplex | 0 | 0.262 | 0.023 | 0.76 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Donor specific antibody present | 0 | 0.157 | 0.003 | 0.76 | 2.923 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein | 0 | 0.262 | 0.024 | 0.76 | 2.432 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis | 2 | 2.971 | 0.216 | 0.759 | 1.57 | 0.347 | 0.763 | 1.5 | 0.673 | 0.13 | 10.685
COVID19_PFIZER/BIONTECH | Cardiac murmur | 1 | 1.902 | 0.213 | 0.759 | 1.578 | 0.295 | 0.724 | 1.54 | 0.526 | 0.317 | 0.826
COVID19_PFIZER/BIONTECH | Adverse reaction | 7 | 13.897 | 0.393 | 0.759 | 1.222 | 0.331 | 0.572 | 0.935 | 0.504 | 0.216 | 18.893
COVID19_PFIZER/BIONTECH | Arthroscopy abnormal | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Squamous cell carcinoma of lung | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal vasculitis | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parophthalmia | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Light chain analysis increased | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-small cell lung cancer | 0 | 0.157 | 0.003 | 0.759 | 2.924 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchomalacia | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute vestibular syndrome | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Agranulocytosis | 0 | 0.114 | 0 | 0.759 | 3.268 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atypical haemolytic uraemic syndrome | 0 | 0.367 | 0.054 | 0.759 | 2.161 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mevalonate kinase deficiency | 0 | 0.157 | 0.003 | 0.759 | 2.924 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold-stimulus headache | 0 | 0.157 | 0.003 | 0.759 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plasmapheresis | 3 | 5.436 | 0.259 | 0.758 | 1.467 | 0.325 | 0.665 | 1.239 | 0.552 | 0.298 | 4.19
COVID19_PFIZER/BIONTECH | Breast malignant tumours (SMQ) [narrow] | 1 | 3.573 | 0.208 | 0.758 | 1.586 | 0.214 | 0.545 | 1.179 | 0.28 | 0.361 | 0.545
COVID19_PFIZER/BIONTECH | Breast neoplasms, malignant and unspecified (SMQ) [narrow] | 1 | 3.573 | 0.208 | 0.758 | 1.586 | 0.214 | 0.545 | 1.179 | 0.28 | 0.361 | 0.545
COVID19_PFIZER/BIONTECH | Visual analogue scale | 0 | 0.315 | 0.037 | 0.758 | 2.282 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serositis | 0 | 0.262 | 0.023 | 0.758 | 2.435 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthopaedic examination abnormal | 0 | 0.525 | 0.102 | 0.758 | 1.916 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothalamo-pituitary disorder | 0 | 0.262 | 0.023 | 0.758 | 2.435 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polypectomy | 0 | 0.42 | 0.07 | 0.758 | 2.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Petit mal epilepsy | 1 | 1.378 | 0.176 | 0.757 | 1.67 | 0.329 | 0.803 | 1.704 | 0.726 | 0.107 | 6.516
COVID19_PFIZER/BIONTECH | General physical condition abnormal | 2 | 2.851 | 0.235 | 0.757 | 1.52 | 0.354 | 0.777 | 1.528 | 0.702 | 1.165 | 0.033
COVID19_PFIZER/BIONTECH | Blood catecholamines | 0 | 0.21 | 0.01 | 0.757 | 2.64 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood alcohol | 0 | 0.42 | 0.07 | 0.757 | 2.066 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site induration | 0 | 0.401 | 0.063 | 0.757 | 2.1 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary tract infection neonatal | 0 | 0.157 | 0.003 | 0.757 | 2.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal abscess | 0 | 0.472 | 0.086 | 0.757 | 1.984 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otoscopy abnormal | 0 | 0.315 | 0.037 | 0.757 | 2.284 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site reaction | 0 | 0.621 | 0.129 | 0.757 | 1.815 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic colitis | 0 | 0.157 | 0.003 | 0.757 | 2.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin operation | 0 | 0.367 | 0.053 | 0.757 | 2.163 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood group O | 0 | 0.315 | 0.037 | 0.757 | 2.284 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine increased | 0 | 0.315 | 0.037 | 0.757 | 2.284 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte percentage normal | 0 | 0.315 | 0.037 | 0.757 | 2.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Defaecation disorder | 0 | 0.367 | 0.053 | 0.757 | 2.164 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell nucleated morphology | 3 | 3.817 | 0.342 | 0.756 | 1.302 | 0.398 | 0.812 | 1.51 | 0.786 | 3.01 | 1.873
COVID19_PFIZER/BIONTECH | Cryoglobulinaemia | 0 | 0.11 | 0 | 0.756 | 3.317 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctivitis bacterial | 0 | 0.367 | 0.052 | 0.756 | 2.164 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation time prolonged | 0 | 0.315 | 0.036 | 0.756 | 2.285 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasopressive therapy | 0 | 0.21 | 0.01 | 0.756 | 2.642 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuropsychological test abnormal | 0 | 0.315 | 0.036 | 0.756 | 2.286 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site laceration | 0 | 0.157 | 0.003 | 0.756 | 2.93 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radioallergosorbent test positive | 0 | 0.262 | 0.022 | 0.756 | 2.438 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin sensitisation | 2 | 2.379 | 0.287 | 0.755 | 1.402 | 0.382 | 0.839 | 1.649 | 0.841 | 1.72 | 0.075
COVID19_PFIZER/BIONTECH | Cheilitis | 5 | 7.029 | 0.376 | 0.755 | 1.241 | 0.409 | 0.755 | 1.299 | 0.711 | 0.86 | 0.013
COVID19_PFIZER/BIONTECH | Microcytosis | 0 | 0.315 | 0.036 | 0.755 | 2.286 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Still's disease | 0 | 0.371 | 0.053 | 0.755 | 2.158 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extravasation | 0 | 0.105 | 0 | 0.754 | 3.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint erythema | 0 | 0.262 | 0.021 | 0.754 | 2.441 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytomegalovirus viraemia | 0 | 0.21 | 0.01 | 0.754 | 2.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood triglycerides | 0 | 0.315 | 0.035 | 0.754 | 2.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric ulcer | 0 | 0.33 | 0.039 | 0.754 | 2.251 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Throat lesion | 0 | 0.315 | 0.035 | 0.754 | 2.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eating disorder symptom | 0 | 0.157 | 0.002 | 0.754 | 2.933 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory disorder | 4 | 6.058 | 0.333 | 0.753 | 1.31 | 0.376 | 0.727 | 1.296 | 0.66 | 0.321 | 4.964
COVID19_PFIZER/BIONTECH | Vaccination site induration | 8 | 11.933 | 0.418 | 0.753 | 1.167 | 0.422 | 0.71 | 1.134 | 0.67 | 0.442 | 4.951
COVID19_PFIZER/BIONTECH | Central nervous system inflammation | 0 | 0.459 | 0.079 | 0.753 | 2.007 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound bladder | 0 | 0.262 | 0.021 | 0.753 | 2.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trisomy 21 | 0 | 0.315 | 0.035 | 0.753 | 2.289 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelodysplastic syndrome | 0 | 0.315 | 0.035 | 0.753 | 2.289 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF lactate | 0 | 0.17 | 0.004 | 0.753 | 2.857 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin fragility | 0 | 0.21 | 0.009 | 0.753 | 2.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Focal segmental glomerulosclerosis | 0 | 0.262 | 0.021 | 0.753 | 2.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin M normal | 1 | 2.043 | 0.153 | 0.752 | 1.723 | 0.286 | 0.705 | 1.502 | 0.49 | 0.174 | 3.08
COVID19_PFIZER/BIONTECH | Splenic infarction | 0 | 0.21 | 0.009 | 0.752 | 2.649 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Streptococcal bacteraemia | 0 | 0.114 | 0 | 0.752 | 3.279 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem infarction | 0 | 0.315 | 0.034 | 0.752 | 2.29 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Food craving | 0 | 0.315 | 0.034 | 0.751 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granular cell tumour | 0 | 0.157 | 0.002 | 0.751 | 2.938 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal vein compression | 0 | 0.105 | 0 | 0.751 | 3.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cutaneous tuberculosis | 0 | 0.21 | 0.009 | 0.751 | 2.651 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid dysfunction (SMQ) [narrow] | 7 | 10.396 | 0.372 | 0.75 | 1.235 | 0.415 | 0.716 | 1.169 | 0.673 | 0.642 | 1.012
COVID19_PFIZER/BIONTECH | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [narrow] | 124 | 198.105 | 0.643 | 0.75 | 0.864 | 0.543 | 0.63 | 0.727 | 0.626 | 0.657 | 21.311
COVID19_PFIZER/BIONTECH | Glomerulonephritis membranous | 0 | 0.157 | 0.002 | 0.75 | 2.941 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipodystrophy (SMQ) [narrow] | 0 | 0.42 | 0.064 | 0.75 | 2.073 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Computerised tomogram kidney abnormal | 0 | 0.315 | 0.033 | 0.75 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antineutrophil cytoplasmic antibody negative | 1 | 2.469 | 0.133 | 0.749 | 1.775 | 0.263 | 0.653 | 1.396 | 0.405 | 0.174 | 3.08
COVID19_PFIZER/BIONTECH | Premalignant disorders (SMQ) [broad] | 5 | 10.512 | 0.315 | 0.749 | 1.334 | 0.307 | 0.568 | 0.979 | 0.476 | 0.295 | 7.575
COVID19_PFIZER/BIONTECH | Premalignant disorders (SMQ) [narrow] | 5 | 10.512 | 0.315 | 0.749 | 1.334 | 0.307 | 0.568 | 0.979 | 0.476 | 0.295 | 7.575
COVID19_PFIZER/BIONTECH | Large intestine polyp | 0 | 0.472 | 0.079 | 0.749 | 1.992 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic encephalopathy | 0 | 0.42 | 0.064 | 0.749 | 2.074 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypohidrosis | 0 | 0.42 | 0.063 | 0.749 | 2.075 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Escherichia pyelonephritis | 0 | 0.157 | 0.002 | 0.749 | 2.941 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD8 lymphocytes increased | 0 | 0.367 | 0.048 | 0.749 | 2.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood magnesium decreased | 4 | 4.666 | 0.345 | 0.748 | 1.277 | 0.44 | 0.849 | 1.514 | 0.857 | 2.408 | 1.743
COVID19_PFIZER/BIONTECH | Skin abrasion | 2 | 3.898 | 0.33 | 0.748 | 1.303 | 0.302 | 0.667 | 1.314 | 0.513 | 0.304 | 2.463
COVID19_PFIZER/BIONTECH | Emotional poverty | 0 | 0.254 | 0.017 | 0.748 | 2.48 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human rhinovirus test positive | 0 | 0.54 | 0.097 | 0.748 | 1.907 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Takayasu's arteritis | 0 | 0.315 | 0.032 | 0.748 | 2.296 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy upper gastrointestinal tract abnormal | 0 | 0.558 | 0.102 | 0.748 | 1.886 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood homocysteine | 0 | 0.367 | 0.047 | 0.748 | 2.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systemic lupus erythematosus rash | 0 | 0.21 | 0.008 | 0.748 | 2.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholestasis | 0 | 0.254 | 0.017 | 0.748 | 2.479 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin G abnormal | 0 | 0.262 | 0.019 | 0.748 | 2.451 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal faeces | 1 | 2.038 | 0.193 | 0.747 | 1.594 | 0.287 | 0.705 | 1.503 | 0.491 | 0.094 | 7.759
COVID19_PFIZER/BIONTECH | Disease progression | 0 | 0.21 | 0.008 | 0.747 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine test abnormal | 0 | 0.21 | 0.008 | 0.747 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-neuronal antibody negative | 0 | 0.367 | 0.047 | 0.747 | 2.175 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carcinoma in situ | 0 | 0.21 | 0.008 | 0.747 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labour induction | 0 | 0.262 | 0.018 | 0.747 | 2.452 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-Muellerian hormone level decreased | 0 | 0.21 | 0.008 | 0.747 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor C3 decreased | 0 | 0.191 | 0.005 | 0.747 | 2.748 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal ulceration (SMQ) [broad] | 4 | 7.172 | 0.313 | 0.746 | 1.329 | 0.337 | 0.651 | 1.162 | 0.558 | 0.415 | 2.647
COVID19_PFIZER/BIONTECH | Gastrointestinal ulceration (SMQ) [narrow] | 4 | 7.172 | 0.313 | 0.746 | 1.329 | 0.337 | 0.651 | 1.162 | 0.558 | 0.415 | 2.647
COVID19_PFIZER/BIONTECH | Vaccination site injury | 0 | 0.472 | 0.076 | 0.746 | 1.996 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kinesitherapy | 0 | 0.21 | 0.008 | 0.746 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Preterm premature rupture of membranes | 1 | 3.1 | 0.064 | 0.745 | 2.054 | 0.233 | 0.587 | 1.263 | 0.323 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Helplessness | 0 | 0.21 | 0.008 | 0.745 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatologic examination abnormal | 0 | 0.548 | 0.097 | 0.745 | 1.898 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Superinfection bacterial | 0 | 0.42 | 0.06 | 0.745 | 2.078 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergic respiratory disease | 0 | 0.21 | 0.008 | 0.745 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray dental abnormal | 0 | 0.315 | 0.031 | 0.745 | 2.3 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyst aspiration | 0 | 0.21 | 0.008 | 0.745 | 2.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound skull | 1 | 1.558 | 0.079 | 0.744 | 1.975 | 0.317 | 0.774 | 1.644 | 0.642 | 0.43 | 0.267
COVID19_PFIZER/BIONTECH | Injection site pain | 1282 | 1763.579 | 0.71 | 0.744 | 0.778 | 0.694 | 0.727 | 0.761 | 0.727 | 0.787 | 77.521
COVID19_PFIZER/BIONTECH | Carboxyhaemoglobin decreased | 0 | 0.204 | 0.007 | 0.744 | 2.688 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral skin infection | 0 | 0.21 | 0.008 | 0.744 | 2.661 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin C normal | 0 | 0.157 | 0.002 | 0.744 | 2.95 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin urine present | 0 | 0.42 | 0.06 | 0.744 | 2.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blast cells present | 0 | 0.472 | 0.075 | 0.744 | 1.997 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acinetobacter test positive | 0 | 0.262 | 0.017 | 0.744 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound bladder normal | 0 | 0.21 | 0.007 | 0.743 | 2.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inner ear inflammation | 0 | 0.262 | 0.017 | 0.743 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperemesis gravidarum | 0 | 0.21 | 0.007 | 0.743 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toe walking | 0 | 0.225 | 0.01 | 0.743 | 2.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post-tussive vomiting | 0 | 0.33 | 0.034 | 0.743 | 2.263 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epstein-Barr virus antigen positive | 0 | 0.525 | 0.089 | 0.743 | 1.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oropharyngeal plaque | 0 | 0.315 | 0.029 | 0.742 | 2.303 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nucleic acid test | 0 | 0.262 | 0.017 | 0.742 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orbital oedema | 0 | 0.315 | 0.029 | 0.742 | 2.303 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Temporal lobe epilepsy | 0 | 0.367 | 0.044 | 0.742 | 2.18 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blindness cortical | 0 | 0.262 | 0.017 | 0.742 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intracranial infection | 0 | 0.157 | 0.002 | 0.742 | 2.953 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [broad] | 124 | 199.111 | 0.636 | 0.741 | 0.854 | 0.54 | 0.627 | 0.723 | 0.623 | 0.653 | 21.929
COVID19_PFIZER/BIONTECH | Skin induration | 2 | 4.401 | 0.337 | 0.741 | 1.273 | 0.282 | 0.625 | 1.232 | 0.454 | 0.602 | 0.184
COVID19_PFIZER/BIONTECH | CSF lactate decreased | 0 | 0.157 | 0.002 | 0.741 | 2.955 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral parotitis | 0 | 0.157 | 0.002 | 0.741 | 2.954 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningeal disorder | 0 | 0.292 | 0.023 | 0.741 | 2.365 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatobiliary scan | 1 | 1.429 | 0.218 | 0.74 | 1.512 | 0.325 | 0.794 | 1.687 | 0.7 | 1.29 | 0.11
COVID19_PFIZER/BIONTECH | Skin lesion | 9 | 18.617 | 0.411 | 0.74 | 1.147 | 0.329 | 0.541 | 0.848 | 0.483 | 0.168 | 35.953
COVID19_PFIZER/BIONTECH | Injection site indentation | 0 | 1.944 | 0.309 | 0.74 | 1.322 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soliloquy | 0 | 0.21 | 0.007 | 0.74 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vestibular function test normal | 0 | 0.21 | 0.007 | 0.74 | 2.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema herpeticum | 0 | 0.315 | 0.028 | 0.74 | 2.306 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lordosis | 0 | 0.367 | 0.042 | 0.74 | 2.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bilirubin unconjugated increased | 0 | 0.145 | 0.001 | 0.74 | 3.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ophthalmological examination normal | 1 | 1.698 | 0.148 | 0.739 | 1.699 | 0.307 | 0.753 | 1.6 | 0.589 | 0.203 | 2.321
COVID19_PFIZER/BIONTECH | Inguinal hernia | 0 | 0.621 | 0.111 | 0.739 | 1.827 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site erythema | 0 | 0.34 | 0.034 | 0.739 | 2.245 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QT interval normal | 0 | 0.315 | 0.028 | 0.739 | 2.306 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis autoimmune | 0 | 0.194 | 0.005 | 0.739 | 2.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gamma-glutamyltransferase normal | 0 | 0.471 | 0.07 | 0.739 | 2.003 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nocturia | 0 | 0.699 | 0.13 | 0.739 | 1.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fixed eruption | 0 | 0.367 | 0.042 | 0.739 | 2.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid factor | 2 | 3.304 | 0.272 | 0.738 | 1.389 | 0.33 | 0.726 | 1.427 | 0.605 | 0.564 | 0.283
COVID19_PFIZER/BIONTECH | Eye contusion | 1 | 2.249 | 0.253 | 0.738 | 1.429 | 0.275 | 0.679 | 1.448 | 0.445 | 0.669 | 0.001
COVID19_PFIZER/BIONTECH | Thrombocytopenia neonatal | 0 | 0.157 | 0.001 | 0.738 | 2.959 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HIV infection | 0 | 0.42 | 0.056 | 0.738 | 2.085 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infertility male | 0 | 0.21 | 0.007 | 0.738 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laparoscopy | 0 | 0.21 | 0.006 | 0.738 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antibody abnormal | 0 | 0.157 | 0.001 | 0.738 | 2.958 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteochondritis | 0 | 0.21 | 0.006 | 0.738 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tongue injury | 0 | 0.367 | 0.041 | 0.738 | 2.185 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proteinuria (SMQ) [broad] | 8 | 13.947 | 0.403 | 0.737 | 1.153 | 0.373 | 0.628 | 1.003 | 0.574 | 0.491 | 3.596
COVID19_PFIZER/BIONTECH | Spondylolisthesis | 0 | 0.42 | 0.055 | 0.737 | 2.086 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pyruvic acid | 0 | 0.315 | 0.027 | 0.737 | 2.309 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac operation | 0 | 0.525 | 0.084 | 0.737 | 1.933 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy liver | 0 | 0.262 | 0.015 | 0.737 | 2.465 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diplegia | 1 | 2.855 | 0.135 | 0.736 | 1.731 | 0.245 | 0.611 | 1.312 | 0.35 | 0.14 | 4.382
COVID19_PFIZER/BIONTECH | Hepatitis E virus test | 0 | 0.315 | 0.027 | 0.736 | 2.31 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram ST-T change | 0 | 0.315 | 0.027 | 0.736 | 2.31 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroidectomy | 0 | 0.315 | 0.027 | 0.736 | 2.31 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Portal tract inflammation | 0 | 0.157 | 0.001 | 0.736 | 2.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plantar fasciitis | 0 | 0.367 | 0.04 | 0.736 | 2.187 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alopecia areata | 0 | 0.521 | 0.081 | 0.736 | 1.939 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site warmth | 0 | 0.708 | 0.129 | 0.736 | 1.753 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Campylobacter gastroenteritis | 0 | 0.367 | 0.04 | 0.735 | 2.187 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product label issue | 0 | 0.367 | 0.04 | 0.735 | 2.187 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyspraxia | 0 | 0.385 | 0.044 | 0.735 | 2.151 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Maternal condition affecting foetus | 0 | 0.157 | 0.001 | 0.735 | 2.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha haemolytic streptococcal infection | 0 | 0.21 | 0.006 | 0.735 | 2.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pemphigus | 0 | 0.336 | 0.032 | 0.735 | 2.256 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain scan abnormal | 0 | 0.365 | 0.039 | 0.735 | 2.192 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chest crushing | 0 | 0.21 | 0.006 | 0.735 | 2.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratosis pilaris | 0 | 0.472 | 0.068 | 0.735 | 2.005 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary system x-ray normal | 0 | 0.367 | 0.039 | 0.734 | 2.189 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic disorder | 0 | 0.21 | 0.006 | 0.734 | 2.675 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucosal dryness | 0 | 0.403 | 0.048 | 0.734 | 2.119 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF oligoclonal band absent | 0 | 0.365 | 0.038 | 0.734 | 2.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palmar-plantar erythrodysaesthesia syndrome | 0 | 0.367 | 0.039 | 0.734 | 2.188 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fundus autofluorescence | 0 | 0.315 | 0.026 | 0.734 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosal discolouration | 0 | 0.367 | 0.039 | 0.734 | 2.188 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculin test negative | 0 | 0.229 | 0.009 | 0.734 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary system X-ray | 0 | 0.785 | 0.144 | 0.734 | 1.698 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroencephalogram | 13 | 19.763 | 0.464 | 0.733 | 1.052 | 0.447 | 0.686 | 1.015 | 0.658 | 0.388 | 11.677
COVID19_PFIZER/BIONTECH | Vitamin B6 normal | 0 | 0.472 | 0.066 | 0.733 | 2.006 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Iron binding capacity total | 0 | 0.42 | 0.052 | 0.733 | 2.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radioisotope scan | 0 | 0.24 | 0.01 | 0.733 | 2.549 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Matrix metalloproteinase-3 | 0 | 0.157 | 0.001 | 0.732 | 2.966 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scrotal oedema | 0 | 0.21 | 0.006 | 0.732 | 2.678 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dropped head syndrome | 0 | 0.315 | 0.025 | 0.732 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histology normal | 0 | 0.157 | 0.001 | 0.732 | 2.966 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PFAPA syndrome | 0 | 0.262 | 0.014 | 0.732 | 2.47 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | High-pitched crying | 0 | 0.329 | 0.028 | 0.731 | 2.279 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteochondrosis | 0 | 0.315 | 0.025 | 0.731 | 2.315 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononeuropathy multiplex | 0 | 0.262 | 0.013 | 0.731 | 2.472 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteonecrosis | 0 | 0.472 | 0.065 | 0.731 | 2.008 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histone antibody positive | 0 | 0.21 | 0.005 | 0.731 | 2.679 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatic disorder | 0 | 0.503 | 0.073 | 0.73 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | pH body fluid decreased | 0 | 0.099 | 0 | 0.73 | 3.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Escherichia test | 0 | 0.367 | 0.037 | 0.73 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound liver | 0 | 0.525 | 0.078 | 0.73 | 1.937 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemangioma of bone | 0 | 0.367 | 0.036 | 0.729 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocytic infiltration | 0 | 0.329 | 0.027 | 0.729 | 2.282 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiotensin converting enzyme increased | 0 | 0.42 | 0.05 | 0.729 | 2.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune nephritis | 0 | 0.157 | 0.001 | 0.729 | 2.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pseudolymphoma | 0 | 0.315 | 0.024 | 0.729 | 2.317 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal renal imaging abnormal | 0 | 0.157 | 0.001 | 0.729 | 2.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mammogram normal | 0 | 0.288 | 0.018 | 0.729 | 2.393 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastocytosis | 0 | 0.262 | 0.013 | 0.729 | 2.474 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site oedema | 2 | 3.157 | 0.19 | 0.728 | 1.551 | 0.337 | 0.742 | 1.458 | 0.633 | 0.204 | 5.34
COVID19_PFIZER/BIONTECH | Soft tissue disorder | 0 | 0.472 | 0.063 | 0.728 | 2.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycobacterium avium complex infection | 0 | 0.157 | 0.001 | 0.728 | 2.971 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombotic microangiopathy | 0 | 0.472 | 0.063 | 0.728 | 2.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal flaring | 0 | 0.367 | 0.036 | 0.728 | 2.194 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acne cystic | 0 | 0.262 | 0.013 | 0.728 | 2.475 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal examination normal | 0 | 0.367 | 0.036 | 0.728 | 2.194 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lead increased | 0 | 0.262 | 0.013 | 0.728 | 2.475 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin mass | 2 | 4.005 | 0.284 | 0.727 | 1.337 | 0.298 | 0.658 | 1.296 | 0.499 | 0.296 | 2.604
COVID19_PFIZER/BIONTECH | Type IV hypersensitivity reaction | 2 | 4.547 | 0.27 | 0.727 | 1.364 | 0.276 | 0.613 | 1.209 | 0.44 | 1.062 | 0.084
COVID19_PFIZER/BIONTECH | Gram stain | 1 | 2.825 | 0.187 | 0.727 | 1.553 | 0.246 | 0.614 | 1.318 | 0.354 | 0.393 | 0.399
COVID19_PFIZER/BIONTECH | Blood calcium increased | 1 | 3.298 | 0.168 | 0.727 | 1.606 | 0.225 | 0.569 | 1.227 | 0.303 | 0.369 | 0.508
COVID19_PFIZER/BIONTECH | Lymphoid tissue hyperplasia | 0 | 0.21 | 0.005 | 0.727 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epiglottic oedema | 0 | 0.315 | 0.023 | 0.727 | 2.319 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Protein urine | 0 | 0.933 | 0.165 | 0.727 | 1.613 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seroma | 0 | 0.367 | 0.035 | 0.727 | 2.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sudden onset of sleep | 0 | 0.272 | 0.014 | 0.727 | 2.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prothrombin time ratio increased | 0 | 0.157 | 0.001 | 0.727 | 2.972 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Logorrhoea | 0 | 0.315 | 0.023 | 0.726 | 2.32 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Asterixis | 0 | 0.275 | 0.014 | 0.726 | 2.437 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albumin globulin ratio increased | 0 | 0.21 | 0.005 | 0.726 | 2.685 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-insulin antibody positive | 0 | 0.105 | 0 | 0.726 | 3.402 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin injury | 0 | 0.294 | 0.018 | 0.726 | 2.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood ketone body absent | 0 | 0.42 | 0.048 | 0.726 | 2.095 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bloody discharge | 0 | 0.367 | 0.035 | 0.726 | 2.196 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otitis media bacterial | 0 | 0.157 | 0.001 | 0.725 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pathogen resistance | 0 | 0.157 | 0.001 | 0.725 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site pruritus | 0 | 0.157 | 0.001 | 0.725 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Restrictive pulmonary disease | 0 | 0.21 | 0.005 | 0.725 | 2.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocytosis | 0 | 0.21 | 0.005 | 0.725 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human metapneumovirus test positive | 0 | 0.246 | 0.009 | 0.725 | 2.536 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood triglycerides increased | 1 | 1.834 | 0.202 | 0.724 | 1.509 | 0.299 | 0.733 | 1.56 | 0.545 | 0.488 | 0.129
COVID19_PFIZER/BIONTECH | Moaning | 3 | 5.285 | 0.288 | 0.724 | 1.321 | 0.331 | 0.677 | 1.26 | 0.568 | 0.317 | 3.665
COVID19_PFIZER/BIONTECH | Oesophageal pH | 0 | 0.21 | 0.005 | 0.724 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis exfoliative | 0 | 0.21 | 0.005 | 0.724 | 2.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal viral infection | 0 | 0.525 | 0.073 | 0.724 | 1.941 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensitivity to weather change | 0 | 0.262 | 0.012 | 0.724 | 2.48 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Perfume sensitivity | 0 | 0.315 | 0.022 | 0.724 | 2.322 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Juvenile myoclonic epilepsy | 0 | 0.092 | 0 | 0.724 | 3.538 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon pain | 0 | 1.173 | 0.201 | 0.723 | 1.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atypical pneumonia | 0 | 0.494 | 0.065 | 0.723 | 1.982 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Albuminuria | 0 | 0.262 | 0.011 | 0.723 | 2.481 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar exudate | 0 | 0.367 | 0.033 | 0.723 | 2.199 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic granulomatosis with polyangiitis | 0 | 0.42 | 0.046 | 0.722 | 2.098 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anaesthesia | 0 | 0.472 | 0.059 | 0.722 | 2.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonic posturing | 0 | 0.472 | 0.058 | 0.722 | 2.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal muscular atrophy | 0 | 0.262 | 0.011 | 0.722 | 2.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multi-organ disorder | 0 | 0.525 | 0.072 | 0.722 | 1.942 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microphthalmos | 0 | 0.157 | 0.001 | 0.722 | 2.977 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gene mutation | 0 | 0.447 | 0.052 | 0.722 | 2.052 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar inflammation | 1 | 0.735 | 0.179 | 0.721 | 1.56 | 0.381 | 0.926 | 1.966 | 1.361 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Administration site pain | 2 | 2.914 | 0.282 | 0.721 | 1.325 | 0.35 | 0.77 | 1.513 | 0.686 | 0.502 | 0.52
COVID19_PFIZER/BIONTECH | Nervous system disorder | 4 | 6.408 | 0.284 | 0.721 | 1.321 | 0.363 | 0.701 | 1.251 | 0.624 | 0.223 | 9.915
COVID19_PFIZER/BIONTECH | Congenital pulmonary hypertension | 0 | 0.105 | 0 | 0.721 | 3.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product packaging confusion | 0 | 0.229 | 0.006 | 0.721 | 2.606 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | White blood cells urine | 0 | 0.472 | 0.058 | 0.721 | 2.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychiatric symptom | 0 | 0.442 | 0.05 | 0.721 | 2.061 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laparotomy | 0 | 0.167 | 0.001 | 0.721 | 2.92 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythrodermic psoriasis | 0 | 0.262 | 0.011 | 0.721 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gynaecomastia | 0 | 0.21 | 0.004 | 0.721 | 2.691 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Guillain-Barre syndrome | 26 | 48.253 | 0.508 | 0.72 | 0.962 | 0.409 | 0.56 | 0.752 | 0.539 | 0.326 | 35.124
COVID19_PFIZER/BIONTECH | Heat stroke | 0 | 0.315 | 0.02 | 0.72 | 2.326 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exostosis | 0 | 0.441 | 0.049 | 0.72 | 2.064 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epigastric discomfort | 0 | 0.463 | 0.055 | 0.72 | 2.03 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site swelling | 0 | 0.333 | 0.024 | 0.72 | 2.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breech delivery | 0 | 0.157 | 0.001 | 0.719 | 2.98 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow oedema | 0 | 0.465 | 0.055 | 0.719 | 2.027 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspiration bone marrow normal | 0 | 0.367 | 0.031 | 0.719 | 2.202 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillar erythema | 0 | 0.298 | 0.017 | 0.719 | 2.372 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual evoked potentials | 0 | 0.42 | 0.044 | 0.719 | 2.101 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol withdrawal syndrome | 0 | 0.157 | 0.001 | 0.719 | 2.98 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle contractions involuntary | 4 | 7.967 | 0.36 | 0.718 | 1.175 | 0.313 | 0.606 | 1.082 | 0.502 | 0.376 | 3.435
COVID19_PFIZER/BIONTECH | Prolonged pregnancy | 0 | 0.262 | 0.01 | 0.718 | 2.486 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pyoderma gangrenosum | 0 | 0.082 | 0 | 0.718 | 3.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sensorimotor disorder | 0 | 0.127 | 0 | 0.718 | 3.208 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pigmentation disorder | 0 | 0.314 | 0.02 | 0.718 | 2.329 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonellosis | 0 | 0.144 | 0 | 0.718 | 3.077 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Severe cutaneous adverse reactions (SMQ) [broad] | 103 | 154.261 | 0.607 | 0.717 | 0.835 | 0.571 | 0.672 | 0.786 | 0.668 | 0.378 | 104.199
COVID19_PFIZER/BIONTECH | Coordination abnormal | 6 | 9.332 | 0.395 | 0.717 | 1.116 | 0.392 | 0.698 | 1.167 | 0.643 | 0.605 | 1.118
COVID19_PFIZER/BIONTECH | Guillain-Barre syndrome (SMQ) [narrow] | 29 | 51.742 | 0.517 | 0.717 | 0.945 | 0.429 | 0.579 | 0.767 | 0.56 | 0.339 | 36.176
COVID19_PFIZER/BIONTECH | Peripheral motor neuropathy | 0 | 0.525 | 0.068 | 0.717 | 1.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Internal hernia | 0 | 0.105 | 0 | 0.717 | 3.407 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholangitis | 0 | 0.315 | 0.019 | 0.717 | 2.329 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-cyclic citrullinated peptide antibody positive | 0 | 0.287 | 0.014 | 0.717 | 2.406 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lupus-like syndrome | 0 | 0.315 | 0.019 | 0.717 | 2.329 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymph node palpable | 3 | 2.936 | 0.257 | 0.716 | 1.363 | 0.452 | 0.921 | 1.714 | 1.022 | 2.007 | 0.575
COVID19_PFIZER/BIONTECH | Pyelocaliectasis | 0 | 0.278 | 0.012 | 0.716 | 2.438 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cortisol decreased | 0 | 0.367 | 0.03 | 0.716 | 2.204 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Band neutrophil count decreased | 0 | 0.42 | 0.042 | 0.716 | 2.103 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy lymph gland | 0 | 0.42 | 0.042 | 0.716 | 2.102 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac stress test | 4 | 5.589 | 0.305 | 0.715 | 1.265 | 0.396 | 0.764 | 1.362 | 0.716 | 1.204 | 0.006
COVID19_PFIZER/BIONTECH | Erythroblast count | 0 | 0.367 | 0.03 | 0.715 | 2.205 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound kidney normal | 0 | 0.615 | 0.088 | 0.715 | 1.845 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatosplenomegaly | 0 | 0.461 | 0.052 | 0.715 | 2.035 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte stimulation test | 0 | 0.105 | 0 | 0.715 | 3.407 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombin time normal | 0 | 0.157 | 0.001 | 0.715 | 2.984 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rhinoscleroma | 0 | 0.21 | 0.004 | 0.714 | 2.698 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myeloid leukaemia | 0 | 0.367 | 0.029 | 0.714 | 2.206 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metastases to bone | 0 | 0.367 | 0.029 | 0.714 | 2.206 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Physiotherapy | 0 | 0.262 | 0.01 | 0.714 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiogram retina abnormal | 0 | 0.42 | 0.041 | 0.714 | 2.104 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angular cheilitis | 0 | 0.315 | 0.018 | 0.714 | 2.331 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound scan normal | 9 | 16.579 | 0.413 | 0.713 | 1.08 | 0.362 | 0.596 | 0.934 | 0.543 | 0.394 | 7.626
COVID19_PFIZER/BIONTECH | Blood iron increased | 0 | 0.42 | 0.04 | 0.713 | 2.105 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise electrocardiogram | 0 | 0.472 | 0.052 | 0.712 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Idiopathic urticaria | 0 | 0.367 | 0.028 | 0.712 | 2.207 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mobility decreased | 200 | 301.096 | 0.631 | 0.711 | 0.795 | 0.593 | 0.666 | 0.747 | 0.664 | 0.653 | 35.925
COVID19_PFIZER/BIONTECH | Injection site lymphadenopathy | 3 | 4.908 | 0.229 | 0.711 | 1.408 | 0.346 | 0.707 | 1.316 | 0.611 | 3.87 | 3.06
COVID19_PFIZER/BIONTECH | Gastroenteritis Escherichia coli | 0 | 0.21 | 0.003 | 0.711 | 2.7 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermal burns of eye | 0 | 0.472 | 0.052 | 0.711 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Treponema test positive | 0 | 0.525 | 0.064 | 0.711 | 1.949 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smooth muscle antibody positive | 0 | 0.21 | 0.003 | 0.711 | 2.7 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte transformation test | 0 | 0.157 | 0.001 | 0.711 | 2.987 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal calprotectin normal | 0 | 0.367 | 0.028 | 0.711 | 2.208 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypovitaminosis | 0 | 0.434 | 0.043 | 0.711 | 2.081 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site hypertrophy | 0 | 0.21 | 0.003 | 0.71 | 2.701 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin wrinkling | 0 | 0.472 | 0.051 | 0.71 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation time normal | 0 | 0.21 | 0.003 | 0.71 | 2.701 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte count normal | 0 | 0.525 | 0.063 | 0.71 | 1.949 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stress fracture | 0 | 0.525 | 0.062 | 0.709 | 1.95 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Klebsiella test positive | 0 | 0.367 | 0.027 | 0.709 | 2.21 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF protein abnormal | 0 | 0.315 | 0.017 | 0.709 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound kidney | 0 | 1.66 | 0.244 | 0.709 | 1.37 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psoriasis | 1 | 2.249 | 0.183 | 0.708 | 1.51 | 0.275 | 0.679 | 1.448 | 0.445 | 0.148 | 4.014
COVID19_PFIZER/BIONTECH | Paronychia | 0 | 0.262 | 0.009 | 0.708 | 2.495 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suspected product contamination | 0 | 0.21 | 0.003 | 0.708 | 2.702 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunology test normal | 0 | 0.873 | 0.135 | 0.708 | 1.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Axonal neuropathy | 0 | 0.385 | 0.03 | 0.708 | 2.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypersomnia-bulimia syndrome | 0 | 0.21 | 0.003 | 0.708 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Squamous cell carcinoma | 0 | 0.343 | 0.022 | 0.708 | 2.265 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Systolic dysfunction | 0 | 0.262 | 0.009 | 0.708 | 2.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema nodosum | 1 | 1.077 | 0.125 | 0.707 | 1.678 | 0.352 | 0.856 | 1.816 | 0.928 | 0.369 | 0.508
COVID19_PFIZER/BIONTECH | CSF white blood cell count increased | 1 | 1.959 | 0.13 | 0.707 | 1.664 | 0.291 | 0.716 | 1.524 | 0.51 | 0.104 | 6.786
COVID19_PFIZER/BIONTECH | Skin hyperpigmentation | 1 | 2.238 | 0.277 | 0.707 | 1.297 | 0.276 | 0.68 | 1.451 | 0.447 | 0.354 | 0.584
COVID19_PFIZER/BIONTECH | Complement factor normal | 1 | 2.465 | 0.118 | 0.707 | 1.705 | 0.264 | 0.653 | 1.397 | 0.406 | 0.215 | 2.073
COVID19_PFIZER/BIONTECH | Epstein-Barr virus test positive | 0 | 0.543 | 0.065 | 0.707 | 1.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | DNA test for fragile X | 0 | 0.472 | 0.049 | 0.707 | 2.023 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yawning | 0 | 0.972 | 0.15 | 0.706 | 1.596 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Specific gravity urine | 0 | 0.21 | 0.003 | 0.706 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site oedema | 0 | 0.367 | 0.026 | 0.706 | 2.212 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Emotional disorder of childhood | 0 | 0.21 | 0.003 | 0.706 | 2.704 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyanosis central | 0 | 0.288 | 0.012 | 0.706 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sleep apnoea syndrome | 1 | 1.687 | 0.113 | 0.705 | 1.714 | 0.308 | 0.754 | 1.603 | 0.593 | 0.226 | 1.878
COVID19_PFIZER/BIONTECH | Reticulocyte percentage increased | 0 | 0.256 | 0.007 | 0.705 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral mucosa erosion | 0 | 0.21 | 0.003 | 0.705 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute phase reaction | 0 | 0.21 | 0.003 | 0.705 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obsessive thoughts | 0 | 0.21 | 0.003 | 0.705 | 2.705 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone scan | 0 | 0.59 | 0.075 | 0.705 | 1.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Asocial behaviour | 0 | 0.166 | 0.001 | 0.705 | 2.936 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sinus arrhythmia | 2 | 2.63 | 0.265 | 0.704 | 1.314 | 0.367 | 0.805 | 1.582 | 0.76 | 1.901 | 0.152
COVID19_PFIZER/BIONTECH | Ultrasound antenatal screen abnormal | 6 | 10.332 | 0.317 | 0.704 | 1.214 | 0.363 | 0.647 | 1.083 | 0.581 | 1.106 | 0
COVID19_PFIZER/BIONTECH | Bronchitis chronic | 0 | 0.264 | 0.008 | 0.704 | 2.49 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anal sphincter atony | 0 | 0.315 | 0.016 | 0.704 | 2.339 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicose vein | 0 | 0.293 | 0.012 | 0.704 | 2.4 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eyelid injury | 0 | 0.367 | 0.025 | 0.704 | 2.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infusion related reaction | 0 | 0.21 | 0.003 | 0.704 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone scan abnormal | 0 | 0.615 | 0.079 | 0.704 | 1.849 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate malignant tumours (SMQ) [broad] | 0 | 0.777 | 0.113 | 0.704 | 1.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total bile acids | 0 | 0.27 | 0.009 | 0.704 | 2.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Campylobacter test positive | 0 | 0.218 | 0.003 | 0.704 | 2.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichenoid keratosis | 0 | 0.517 | 0.057 | 0.703 | 1.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxine free normal | 0 | 0.649 | 0.085 | 0.703 | 1.817 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Contusion | 50 | 74.511 | 0.556 | 0.702 | 0.863 | 0.539 | 0.679 | 0.846 | 0.671 | 0.481 | 26.923
COVID19_PFIZER/BIONTECH | Exposure during pregnancy | 111 | 183.184 | 0.596 | 0.702 | 0.815 | 0.522 | 0.61 | 0.71 | 0.606 | 0.737 | 9.825
COVID19_PFIZER/BIONTECH | Nasal mucosal disorder | 0 | 0.315 | 0.015 | 0.702 | 2.34 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia staphylococcal | 0 | 0.367 | 0.024 | 0.702 | 2.214 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post procedural complication | 0 | 0.315 | 0.015 | 0.702 | 2.34 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocarditis | 0 | 0.525 | 0.058 | 0.702 | 1.953 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Borrelia test negative | 3 | 6.064 | 0.301 | 0.701 | 1.235 | 0.303 | 0.622 | 1.159 | 0.495 | 0.184 | 9.948
COVID19_PFIZER/BIONTECH | Respirovirus test | 0 | 0.472 | 0.045 | 0.701 | 2.026 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ocular dysmetria | 0 | 0.105 | 0 | 0.701 | 3.409 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis sapovirus | 0 | 0.157 | 0 | 0.701 | 2.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Staphylococcal skin infection | 0 | 0.262 | 0.007 | 0.701 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post-traumatic stress disorder | 0 | 0.325 | 0.016 | 0.701 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mesenteric panniculitis | 0 | 0.262 | 0.007 | 0.701 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oophoritis | 0 | 0.21 | 0.002 | 0.7 | 2.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pupils unequal | 0 | 0.554 | 0.063 | 0.7 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Axillary nerve injury | 0 | 0.525 | 0.056 | 0.7 | 1.954 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenoidectomy | 0 | 0.315 | 0.014 | 0.7 | 2.342 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxine normal | 1 | 2.368 | 0.231 | 0.699 | 1.37 | 0.269 | 0.664 | 1.419 | 0.422 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | No reaction on previous exposure to drug | 1 | 2.516 | 0.194 | 0.699 | 1.456 | 0.261 | 0.647 | 1.385 | 0.397 | 1.062 | 0.221
COVID19_PFIZER/BIONTECH | Binocular eye movement disorder | 0 | 0.42 | 0.034 | 0.699 | 2.113 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Keratic precipitates | 0 | 0.315 | 0.014 | 0.699 | 2.342 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Febrile infection | 0 | 0.445 | 0.039 | 0.699 | 2.07 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal disorder | 10 | 18.096 | 0.422 | 0.698 | 1.031 | 0.373 | 0.6 | 0.925 | 0.553 | 0.389 | 8.774
COVID19_PFIZER/BIONTECH | Immature granulocyte count increased | 2 | 3.963 | 0.24 | 0.698 | 1.35 | 0.299 | 0.661 | 1.303 | 0.505 | 4.013 | 1.558
COVID19_PFIZER/BIONTECH | Epiphyses delayed fusion | 0 | 0.262 | 0.007 | 0.698 | 2.502 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serology abnormal | 0 | 0.176 | 0.001 | 0.698 | 2.882 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose tolerance test abnormal | 0 | 0.262 | 0.007 | 0.698 | 2.502 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abortion induced | 0 | 0.314 | 0.014 | 0.698 | 2.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue swelling | 1 | 1.759 | 0.174 | 0.697 | 1.503 | 0.303 | 0.744 | 1.582 | 0.569 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Inappropriate schedule of product administration | 64 | 115.035 | 0.561 | 0.697 | 0.845 | 0.46 | 0.565 | 0.688 | 0.556 | 0.263 | 131.611
COVID19_PFIZER/BIONTECH | Non-Hodgkin's lymphoma | 0 | 0.258 | 0.006 | 0.697 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site cyst | 0 | 1.262 | 0.185 | 0.697 | 1.477 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperaesthesia | 16 | 23.799 | 0.452 | 0.696 | 0.983 | 0.47 | 0.694 | 0.997 | 0.672 | 0.529 | 6.046
COVID19_PFIZER/BIONTECH | Lipids normal | 2 | 3.601 | 0.237 | 0.696 | 1.351 | 0.315 | 0.695 | 1.369 | 0.555 | 1.29 | 0.004
COVID19_PFIZER/BIONTECH | Haemorrhagic stroke | 2 | 5.621 | 0.239 | 0.696 | 1.346 | 0.241 | 0.54 | 1.068 | 0.356 | 1.806 | 0.109
COVID19_PFIZER/BIONTECH | Pityriasis lichenoides et varioliformis acuta | 0 | 0.183 | 0.001 | 0.696 | 2.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Deformity | 0 | 0.42 | 0.032 | 0.696 | 2.115 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinopathy | 0 | 0.367 | 0.022 | 0.696 | 2.218 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vocal cord paralysis | 0 | 0.897 | 0.128 | 0.696 | 1.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periostitis | 0 | 0.262 | 0.006 | 0.695 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroperitoneal fibrosis (SMQ) [narrow] | 0 | 0.485 | 0.045 | 0.695 | 2.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Change of bowel habit | 0 | 0.367 | 0.022 | 0.695 | 2.218 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy peripheral nerve | 0 | 0.42 | 0.032 | 0.695 | 2.115 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperpathia | 0 | 0.157 | 0 | 0.695 | 2.997 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroblastoma | 0 | 0.262 | 0.006 | 0.694 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural complication | 0 | 0.21 | 0.002 | 0.694 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal inflammation | 1 | 1.116 | 0.167 | 0.693 | 1.51 | 0.349 | 0.849 | 1.8 | 0.896 | 0.785 | 0.049
COVID19_PFIZER/BIONTECH | Skin reaction | 13 | 22.136 | 0.461 | 0.693 | 0.963 | 0.406 | 0.623 | 0.922 | 0.587 | 0.564 | 3.809
COVID19_PFIZER/BIONTECH | Venous thrombosis | 0 | 0.315 | 0.013 | 0.693 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin E normal | 0 | 0.514 | 0.05 | 0.693 | 1.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infective myositis | 0 | 0.315 | 0.013 | 0.693 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Finger deformity | 0 | 0.21 | 0.002 | 0.693 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash erythematous | 171 | 258.152 | 0.609 | 0.692 | 0.78 | 0.586 | 0.665 | 0.752 | 0.662 | 0.627 | 36.895
COVID19_PFIZER/BIONTECH | Autoimmune neuropathy | 0 | 0.315 | 0.013 | 0.692 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fontanelle depressed | 0 | 0.145 | 0 | 0.692 | 3.083 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthostatic hypertension | 0 | 0.262 | 0.006 | 0.692 | 2.506 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Specific gravity urine decreased | 0 | 0.367 | 0.021 | 0.692 | 2.22 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subretinal fluid | 0 | 0.21 | 0.002 | 0.692 | 2.714 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyanosis neonatal | 0 | 0.315 | 0.012 | 0.691 | 2.347 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arachnoid cyst | 0 | 0.21 | 0.002 | 0.691 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin test negative | 0 | 0.786 | 0.104 | 0.691 | 1.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enteritis infectious | 0 | 0.315 | 0.012 | 0.691 | 2.347 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory paralysis | 0 | 0.262 | 0.006 | 0.691 | 2.507 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram T wave abnormal | 1 | 2.087 | 0.225 | 0.69 | 1.361 | 0.284 | 0.699 | 1.49 | 0.479 | 0.821 | 0.075
COVID19_PFIZER/BIONTECH | Myopathy | 0 | 0.42 | 0.03 | 0.69 | 2.118 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchoscopy | 0 | 0.569 | 0.06 | 0.69 | 1.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract inflammation | 0 | 0.367 | 0.02 | 0.69 | 2.221 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fungal test positive | 0 | 0.525 | 0.051 | 0.69 | 1.957 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb operation | 0 | 0.315 | 0.012 | 0.69 | 2.348 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug withdrawal (SMQ) [narrow] | 0 | 0.42 | 0.03 | 0.69 | 2.118 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site abscess sterile | 0 | 0.44 | 0.033 | 0.689 | 2.083 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Generalised anxiety disorder | 0 | 0.42 | 0.029 | 0.689 | 2.118 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray gastrointestinal tract | 0 | 0.21 | 0.002 | 0.688 | 2.716 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitral valve prolapse | 0 | 0.315 | 0.012 | 0.688 | 2.349 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Conjunctivitis viral | 0 | 0.42 | 0.029 | 0.688 | 2.118 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood osmolarity decreased | 1 | 1.704 | 0.193 | 0.687 | 1.427 | 0.307 | 0.752 | 1.598 | 0.587 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | CSF white blood cell count negative | 1 | 2.474 | 0.163 | 0.687 | 1.507 | 0.263 | 0.652 | 1.394 | 0.404 | 0.139 | 4.435
COVID19_PFIZER/BIONTECH | Injection site extravasation | 4 | 8.43 | 0.287 | 0.687 | 1.225 | 0.301 | 0.583 | 1.04 | 0.474 | 0.472 | 1.79
COVID19_PFIZER/BIONTECH | Endoscopy | 1 | 3.561 | 0.097 | 0.687 | 1.718 | 0.214 | 0.546 | 1.181 | 0.281 | 0.306 | 0.911
COVID19_PFIZER/BIONTECH | Post inflammatory pigmentation change | 0 | 0.19 | 0.001 | 0.687 | 2.816 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-Muellerian hormone level | 0 | 0.262 | 0.005 | 0.687 | 2.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subdural hygroma | 0 | 0.152 | 0 | 0.687 | 3.038 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | QRS axis abnormal | 0 | 0.21 | 0.002 | 0.686 | 2.717 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Akinesia | 0 | 0.315 | 0.011 | 0.686 | 2.35 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy artery abnormal | 0 | 0.367 | 0.019 | 0.686 | 2.223 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound testes | 0 | 0.21 | 0.002 | 0.686 | 2.717 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle injury | 0 | 0.972 | 0.131 | 0.686 | 1.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site inflammation | 0 | 0.525 | 0.048 | 0.686 | 1.959 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood prolactin normal | 0 | 0.472 | 0.038 | 0.686 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aldosterone normal | 0 | 0.157 | 0 | 0.686 | 3.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise electrocardiogram normal | 0 | 0.367 | 0.019 | 0.686 | 2.223 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PO2 decreased | 1 | 2.755 | 0.139 | 0.685 | 1.57 | 0.249 | 0.621 | 1.332 | 0.363 | 0.278 | 1.174
COVID19_PFIZER/BIONTECH | Orthopaedic examination normal | 0 | 0.315 | 0.011 | 0.685 | 2.351 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sick building syndrome | 0 | 0.105 | 0 | 0.685 | 3.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myelodysplastic syndrome (SMQ) [narrow] | 0 | 0.525 | 0.048 | 0.685 | 1.959 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inability to crawl | 0 | 0.516 | 0.046 | 0.685 | 1.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obesity | 1 | 1.725 | 0.1 | 0.684 | 1.7 | 0.306 | 0.749 | 1.592 | 0.58 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Insomnia | 102 | 155.017 | 0.579 | 0.684 | 0.796 | 0.562 | 0.662 | 0.775 | 0.658 | 0.545 | 37.606
COVID19_PFIZER/BIONTECH | Rheumatic fever | 0 | 0.367 | 0.018 | 0.684 | 2.224 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sputum test | 0 | 0.21 | 0.002 | 0.684 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple chemical sensitivity | 0 | 0.525 | 0.047 | 0.683 | 1.96 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wisdom teeth removal | 0 | 0.262 | 0.005 | 0.683 | 2.511 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileus paralytic | 0 | 0.42 | 0.027 | 0.683 | 2.12 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobinuria | 0 | 0.21 | 0.002 | 0.683 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngoscopy abnormal | 0 | 0.525 | 0.046 | 0.682 | 1.96 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulocyte count increased | 0 | 0.472 | 0.036 | 0.682 | 2.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal cyst | 0 | 1.054 | 0.14 | 0.682 | 1.557 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood premalignant disorders (SMQ) [broad] | 0 | 0.843 | 0.106 | 0.682 | 1.671 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capillary fragility | 0 | 0.21 | 0.002 | 0.682 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood premalignant disorders (SMQ) [narrow] | 0 | 0.843 | 0.106 | 0.682 | 1.671 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diarrhoea infectious | 0 | 0.21 | 0.001 | 0.682 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis (SMQ) [narrow] | 39 | 66.776 | 0.515 | 0.681 | 0.866 | 0.46 | 0.597 | 0.764 | 0.584 | 0.392 | 35.48
COVID19_PFIZER/BIONTECH | CSF protein | 1 | 2.189 | 0.071 | 0.681 | 1.813 | 0.278 | 0.686 | 1.463 | 0.457 | 0.192 | 2.571
COVID19_PFIZER/BIONTECH | Nerve injury | 6 | 11.476 | 0.357 | 0.681 | 1.089 | 0.335 | 0.598 | 1.001 | 0.523 | 0.479 | 2.791
COVID19_PFIZER/BIONTECH | Renal transplant | 0 | 0.37 | 0.018 | 0.681 | 2.22 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tensilon test abnormal | 0 | 0.262 | 0.005 | 0.681 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow failure | 0 | 0.346 | 0.014 | 0.681 | 2.273 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medication error | 0 | 1.177 | 0.157 | 0.681 | 1.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impaired healing | 0 | 0.659 | 0.072 | 0.681 | 1.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiolipin antibody | 0 | 0.525 | 0.045 | 0.68 | 1.961 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood cholinesterase increased | 0 | 0.472 | 0.035 | 0.68 | 2.035 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | PO2 | 0 | 0.525 | 0.045 | 0.68 | 1.961 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF myelin basic protein increased | 0 | 0.262 | 0.005 | 0.68 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Upper respiratory tract infection | 5 | 8.987 | 0.32 | 0.679 | 1.146 | 0.344 | 0.637 | 1.097 | 0.556 | 0.173 | 18.702
COVID19_PFIZER/BIONTECH | Joint instability | 1 | 3.076 | 0.218 | 0.679 | 1.346 | 0.234 | 0.589 | 1.268 | 0.325 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | CSF glucose decreased | 0 | 0.884 | 0.11 | 0.679 | 1.646 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product packaging quantity issue | 0 | 0.222 | 0.002 | 0.679 | 2.668 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heart disease congenital | 0 | 0.315 | 0.01 | 0.679 | 2.353 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone marrow transplant | 0 | 0.167 | 0 | 0.679 | 2.942 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apallic syndrome | 0 | 0.17 | 0 | 0.679 | 2.924 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Behcet's syndrome | 0 | 0.34 | 0.013 | 0.679 | 2.288 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system infection | 0 | 0.273 | 0.005 | 0.679 | 2.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyst removal | 0 | 0.472 | 0.035 | 0.679 | 2.035 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Posterior reversible encephalopathy syndrome | 0 | 0.42 | 0.025 | 0.679 | 2.122 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loss of personal independence in daily activities | 78 | 119.722 | 0.559 | 0.678 | 0.807 | 0.545 | 0.657 | 0.786 | 0.652 | 0.464 | 46.882
COVID19_PFIZER/BIONTECH | Obstructive airways disorder | 5 | 8.632 | 0.31 | 0.678 | 1.162 | 0.355 | 0.656 | 1.129 | 0.579 | 1.433 | 0.257
COVID19_PFIZER/BIONTECH | Subdural haemorrhage | 1 | 2.401 | 0.137 | 0.678 | 1.552 | 0.267 | 0.661 | 1.411 | 0.416 | 1.505 | 0.051
COVID19_PFIZER/BIONTECH | Dyslalia | 0 | 0.315 | 0.01 | 0.678 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia escherichia | 0 | 0.105 | 0 | 0.678 | 3.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycobacterium tuberculosis complex test positive | 0 | 0.257 | 0.004 | 0.678 | 2.532 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dry skin | 9 | 17.191 | 0.386 | 0.677 | 1.034 | 0.352 | 0.578 | 0.907 | 0.524 | 0.424 | 6.292
COVID19_PFIZER/BIONTECH | Megakaryocytes increased | 0 | 0.315 | 0.009 | 0.677 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yersinia test negative | 0 | 0.241 | 0.003 | 0.677 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product deposit | 0 | 0.21 | 0.001 | 0.677 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immune-mediated adverse reaction | 0 | 1.094 | 0.141 | 0.677 | 1.539 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suspected counterfeit product | 0 | 0.315 | 0.009 | 0.677 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile spasms | 0 | 0.627 | 0.062 | 0.676 | 1.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug level | 0 | 0.315 | 0.009 | 0.676 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray with contrast upper gastrointestinal tract | 0 | 0.373 | 0.017 | 0.676 | 2.214 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Defiant behaviour | 0 | 0.367 | 0.016 | 0.676 | 2.227 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin fissures | 1 | 1.809 | 0.137 | 0.675 | 1.546 | 0.3 | 0.737 | 1.567 | 0.553 | 0.547 | 0.048
COVID19_PFIZER/BIONTECH | Cervicobrachial syndrome | 0 | 0.262 | 0.004 | 0.675 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Palpable purpura | 0 | 0.295 | 0.007 | 0.675 | 2.412 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Manufacturing product shipping issue | 0 | 0.525 | 0.043 | 0.675 | 1.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Slit-lamp examination | 0 | 0.367 | 0.016 | 0.675 | 2.228 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononuclear cell percentage | 0 | 0.262 | 0.004 | 0.674 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypermobility syndrome | 0 | 0.163 | 0 | 0.674 | 2.969 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis fulminant | 0 | 0.262 | 0.004 | 0.674 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF immunoglobulin decreased | 0 | 0.367 | 0.016 | 0.674 | 2.228 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrotising retinitis | 0 | 0.17 | 0 | 0.674 | 2.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood phosphorus decreased | 1 | 2.264 | 0.207 | 0.673 | 1.355 | 0.274 | 0.677 | 1.445 | 0.442 | 0.602 | 0.01
COVID19_PFIZER/BIONTECH | Face and mouth X-ray abnormal | 0 | 0.42 | 0.023 | 0.673 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile apnoea | 0 | 0.472 | 0.032 | 0.673 | 2.036 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dengue virus test negative | 0 | 0.367 | 0.015 | 0.673 | 2.228 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nasal inflammation | 0 | 0.42 | 0.023 | 0.673 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin infection | 0 | 1.338 | 0.17 | 0.673 | 1.448 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventricular septal defect | 0 | 0.42 | 0.023 | 0.673 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchial disorder | 0 | 0.331 | 0.01 | 0.672 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound chest | 0 | 1.336 | 0.169 | 0.672 | 1.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lipoedema | 0 | 0.315 | 0.009 | 0.672 | 2.356 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacillus test positive | 0 | 0.21 | 0.001 | 0.672 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis reactive | 0 | 0.757 | 0.083 | 0.672 | 1.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accident | 0 | 0.42 | 0.023 | 0.672 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Daydreaming | 0 | 0.323 | 0.009 | 0.672 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sacroiliitis | 0 | 0.42 | 0.023 | 0.672 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Delivery | 1 | 17.566 | 0.054 | 0.671 | 1.876 | 0.007 | 0.089 | 0.361 | 0.057 | 0.115 | 5.872
COVID19_PFIZER/BIONTECH | Housebound | 0 | 0.315 | 0.008 | 0.671 | 2.356 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostatic specific antigen normal | 0 | 0.42 | 0.023 | 0.671 | 2.125 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal disorder | 0 | 0.368 | 0.015 | 0.671 | 2.227 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac imaging procedure normal | 0 | 0.367 | 0.015 | 0.671 | 2.229 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tension | 2 | 4.729 | 0.246 | 0.67 | 1.263 | 0.27 | 0.599 | 1.183 | 0.423 | 0.282 | 2.89
COVID19_PFIZER/BIONTECH | Myoclonus | 1 | 2.782 | 0.199 | 0.67 | 1.365 | 0.248 | 0.619 | 1.327 | 0.359 | 0.121 | 5.444
COVID19_PFIZER/BIONTECH | Negative thoughts | 0 | 0.262 | 0.004 | 0.67 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site induration | 0 | 0.262 | 0.004 | 0.67 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nail disorder | 0 | 0.367 | 0.014 | 0.67 | 2.229 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Synovitis | 1 | 2.654 | 0.161 | 0.668 | 1.457 | 0.254 | 0.632 | 1.354 | 0.377 | 0.196 | 2.471
COVID19_PFIZER/BIONTECH | Vaccination failure | 2 | 34.717 | 0.155 | 0.668 | 1.474 | 0.014 | 0.07 | 0.22 | 0.058 | 0.008 | 249.809
COVID19_PFIZER/BIONTECH | Renal tubular acidosis | 0 | 0.21 | 0.001 | 0.668 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycobacterium test negative | 0 | 0.561 | 0.045 | 0.668 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Concentric sclerosis | 0 | 0.105 | 0 | 0.667 | 3.391 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral mass effect | 0 | 0.21 | 0.001 | 0.667 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Underdose | 19 | 56.312 | 0.439 | 0.666 | 0.931 | 0.255 | 0.367 | 0.515 | 0.337 | 0.252 | 41.065
COVID19_PFIZER/BIONTECH | Biopsy lung | 0 | 0.315 | 0.008 | 0.666 | 2.358 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tinea capitis | 0 | 0.21 | 0.001 | 0.666 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell schistocytes present | 0 | 0.439 | 0.024 | 0.666 | 2.092 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-lymphocyte count normal | 0 | 0.446 | 0.025 | 0.666 | 2.08 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Roseolovirus test positive | 0 | 0.479 | 0.03 | 0.666 | 2.028 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypersensitivity vasculitis | 1 | 2.102 | 0.125 | 0.665 | 1.556 | 0.283 | 0.697 | 1.486 | 0.476 | 0.254 | 1.449
COVID19_PFIZER/BIONTECH | Lipase normal | 2 | 5.764 | 0.286 | 0.665 | 1.172 | 0.237 | 0.531 | 1.052 | 0.347 | 0.669 | 0.069
COVID19_PFIZER/BIONTECH | Road traffic accident | 1 | 4.25 | 0.275 | 0.665 | 1.194 | 0.188 | 0.492 | 1.077 | 0.235 | 0.27 | 1.265
COVID19_PFIZER/BIONTECH | Pneumocystis jirovecii pneumonia | 0 | 0.116 | 0 | 0.665 | 3.301 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sunburn | 0 | 0.987 | 0.115 | 0.665 | 1.588 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acarodermatitis | 1 | 1.226 | 0.121 | 0.664 | 1.564 | 0.34 | 0.829 | 1.759 | 0.816 | 1.806 | 0.011
COVID19_PFIZER/BIONTECH | Myelitis | 1 | 3.076 | 0.097 | 0.664 | 1.649 | 0.234 | 0.589 | 1.268 | 0.325 | 0.151 | 3.909
COVID19_PFIZER/BIONTECH | Abortion threatened | 0 | 0.472 | 0.028 | 0.664 | 2.039 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gamma-glutamyltransferase decreased | 0 | 0.21 | 0.001 | 0.664 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prostate cancer | 0 | 0.42 | 0.02 | 0.664 | 2.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complex regional pain syndrome | 1 | 1.721 | 0.07 | 0.663 | 1.764 | 0.306 | 0.749 | 1.593 | 0.581 | 0.19 | 2.622
COVID19_PFIZER/BIONTECH | Hyperferritinaemia | 0 | 0.315 | 0.007 | 0.663 | 2.359 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxic skin eruption | 0 | 0.335 | 0.009 | 0.663 | 2.305 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticaria chronic | 0 | 0.664 | 0.061 | 0.663 | 1.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bilirubin conjugated normal | 0 | 0.508 | 0.034 | 0.663 | 1.986 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Minimum inhibitory concentration | 0 | 0.262 | 0.003 | 0.663 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunology test | 2 | 4.306 | 0.183 | 0.662 | 1.383 | 0.286 | 0.632 | 1.246 | 0.464 | 0.132 | 10.416
COVID19_PFIZER/BIONTECH | Allergy to vaccine | 6 | 12.119 | 0.3 | 0.662 | 1.14 | 0.322 | 0.573 | 0.96 | 0.495 | 0.22 | 15.584
COVID19_PFIZER/BIONTECH | Vulvovaginal pain | 0 | 0.288 | 0.005 | 0.662 | 2.436 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal laminectomy | 0 | 0.367 | 0.013 | 0.662 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exaggerated startle response | 0 | 0.402 | 0.017 | 0.662 | 2.159 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatologic examination normal | 0 | 0.367 | 0.013 | 0.662 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyserositis | 0 | 0.367 | 0.013 | 0.662 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic neuropathy | 0 | 0.334 | 0.009 | 0.661 | 2.308 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral load undetectable | 0 | 0.21 | 0.001 | 0.661 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteomyelitis bacterial | 0 | 0.262 | 0.003 | 0.661 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Partial seizures | 0 | 1.558 | 0.182 | 0.661 | 1.382 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adverse food reaction | 0 | 0.21 | 0.001 | 0.661 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paranoia | 0 | 1.714 | 0.197 | 0.661 | 1.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholecystitis | 1 | 2.355 | 0.156 | 0.66 | 1.448 | 0.269 | 0.666 | 1.422 | 0.425 | 1.389 | 0.079
COVID19_PFIZER/BIONTECH | Varicella virus test positive | 1 | 2.525 | 0.082 | 0.66 | 1.698 | 0.26 | 0.646 | 1.383 | 0.396 | 0.065 | 12.51
COVID19_PFIZER/BIONTECH | Dementia Alzheimer's type | 0 | 0.367 | 0.012 | 0.66 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint swelling | 0 | 1.323 | 0.155 | 0.66 | 1.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Legionella test positive | 0 | 0.262 | 0.003 | 0.66 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cochlea implant | 0 | 0.273 | 0.003 | 0.66 | 2.483 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bilirubin conjugated decreased | 0 | 0.525 | 0.035 | 0.66 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal dysplasia | 0 | 0.262 | 0.003 | 0.659 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hearing aid user | 0 | 0.312 | 0.006 | 0.659 | 2.368 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amino acid level normal | 0 | 0.332 | 0.008 | 0.659 | 2.315 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem auditory evoked response abnormal | 0 | 0.367 | 0.012 | 0.658 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Benign rolandic epilepsy | 0 | 0.367 | 0.012 | 0.658 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Folate deficiency | 0 | 0.21 | 0.001 | 0.658 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood lactic acid normal | 4 | 7.475 | 0.311 | 0.657 | 1.107 | 0.327 | 0.633 | 1.13 | 0.535 | 0.83 | 0.017
COVID19_PFIZER/BIONTECH | Blood zinc decreased | 0 | 0.315 | 0.006 | 0.657 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypersensitivity pneumonitis | 0 | 0.367 | 0.012 | 0.657 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electronystagmogram | 0 | 0.262 | 0.003 | 0.657 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endodontic procedure | 0 | 0.367 | 0.012 | 0.657 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lhermitte's sign | 0 | 0.525 | 0.034 | 0.657 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychomotor skills impaired | 0 | 0.409 | 0.017 | 0.656 | 2.148 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle contracture | 0 | 1.491 | 0.171 | 0.656 | 1.398 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy kidney | 0 | 0.902 | 0.095 | 0.656 | 1.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pressure systolic abnormal | 0 | 0.315 | 0.006 | 0.656 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothyroidism | 3 | 6.207 | 0.22 | 0.655 | 1.277 | 0.299 | 0.613 | 1.142 | 0.483 | 0.602 | 0.412
COVID19_PFIZER/BIONTECH | Cardiac asthma | 0 | 0.105 | 0 | 0.655 | 3.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ventilation/perfusion scan | 0 | 0.315 | 0.006 | 0.655 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytogenetic analysis abnormal | 0 | 0.658 | 0.055 | 0.655 | 1.816 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypnagogic hallucination | 0 | 0.11 | 0 | 0.655 | 3.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital tricuspid valve incompetence | 0 | 0.157 | 0 | 0.655 | 3 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye injury | 0 | 0.379 | 0.012 | 0.654 | 2.208 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anterior chamber inflammation | 0 | 0.21 | 0.001 | 0.654 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound urinary system | 0 | 0.472 | 0.025 | 0.654 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin urine present | 0 | 0.367 | 0.011 | 0.654 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiotensin converting enzyme decreased | 0 | 0.361 | 0.01 | 0.653 | 2.248 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood follicle stimulating hormone | 0 | 0.157 | 0 | 0.653 | 2.999 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrong technique in device usage process | 0 | 0.42 | 0.017 | 0.653 | 2.128 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterocolitis | 0 | 0.266 | 0.003 | 0.653 | 2.506 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Puncture site oedema | 0 | 0.262 | 0.002 | 0.653 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prerenal failure | 0 | 0.262 | 0.002 | 0.653 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy muscle | 0 | 0.508 | 0.029 | 0.652 | 1.988 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Umbilical cord abnormality | 0 | 0.262 | 0.002 | 0.652 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitreous haemorrhage | 0 | 0.21 | 0.001 | 0.652 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight bearing difficulty | 8 | 14.651 | 0.368 | 0.651 | 0.999 | 0.359 | 0.604 | 0.965 | 0.546 | 0.365 | 8.035
COVID19_PFIZER/BIONTECH | Immobile | 2 | 5.452 | 0.239 | 0.651 | 1.227 | 0.246 | 0.55 | 1.088 | 0.367 | 0.393 | 1.266
COVID19_PFIZER/BIONTECH | Skeletal injury | 0 | 0.578 | 0.04 | 0.651 | 1.9 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterococcus test positive | 0 | 0.42 | 0.017 | 0.651 | 2.128 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site warmth | 0 | 0.281 | 0.003 | 0.651 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-lymphocyte count | 0 | 0.174 | 0 | 0.651 | 2.904 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faeces hard | 0 | 0.44 | 0.019 | 0.65 | 2.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4 lymphocytes normal | 0 | 0.321 | 0.006 | 0.65 | 2.344 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antibody | 0 | 0.171 | 0 | 0.65 | 2.921 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle haemorrhage | 0 | 0.525 | 0.031 | 0.65 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital naevus | 0 | 0.21 | 0.001 | 0.649 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disseminated Bacillus Calmette-Guerin infection | 0 | 0.315 | 0.005 | 0.649 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antinuclear antibody positive | 2 | 4.957 | 0.2 | 0.648 | 1.303 | 0.262 | 0.583 | 1.151 | 0.403 | 0.218 | 4.776
COVID19_PFIZER/BIONTECH | Menarche | 0 | 0.157 | 0 | 0.648 | 2.998 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulocyte count decreased | 0 | 0.472 | 0.023 | 0.648 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased vibratory sense | 0 | 0.288 | 0.003 | 0.648 | 2.437 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Death neonatal | 0 | 0.107 | 0 | 0.648 | 3.349 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corneal abrasion | 0 | 0.472 | 0.022 | 0.647 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Candida test positive | 0 | 0.472 | 0.022 | 0.646 | 2.041 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site necrosis | 0 | 0.466 | 0.021 | 0.646 | 2.05 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral cyst | 0 | 0.21 | 0 | 0.646 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site reaction | 4 | 8.832 | 0.256 | 0.645 | 1.176 | 0.291 | 0.564 | 1.007 | 0.453 | 0.188 | 13.05
COVID19_PFIZER/BIONTECH | Staphylococcal scalded skin syndrome | 0 | 0.42 | 0.015 | 0.645 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Motor developmental delay | 0 | 0.33 | 0.006 | 0.645 | 2.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Treatment failure | 0 | 0.21 | 0 | 0.645 | 2.724 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal volume decreased | 0 | 0.367 | 0.009 | 0.645 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint noise | 2 | 4.315 | 0.259 | 0.644 | 1.17 | 0.285 | 0.631 | 1.245 | 0.464 | 0.372 | 1.475
COVID19_PFIZER/BIONTECH | Injection site hypersensitivity | 2 | 4.768 | 0.247 | 0.644 | 1.193 | 0.269 | 0.596 | 1.177 | 0.419 | 0.239 | 4.018
COVID19_PFIZER/BIONTECH | Colitis ulcerative | 1 | 2.885 | 0.104 | 0.644 | 1.564 | 0.243 | 0.608 | 1.306 | 0.347 | 0.226 | 1.878
COVID19_PFIZER/BIONTECH | Seizure cluster | 0 | 0.525 | 0.029 | 0.644 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HELLP syndrome | 0 | 0.315 | 0.005 | 0.644 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilia | 1 | 3.298 | 0.116 | 0.643 | 1.518 | 0.225 | 0.569 | 1.227 | 0.303 | 0.251 | 1.496
COVID19_PFIZER/BIONTECH | Gynaecological examination | 0 | 0.305 | 0.004 | 0.643 | 2.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autonomic nervous system imbalance | 1 | 1.518 | 0.067 | 0.642 | 1.713 | 0.319 | 0.78 | 1.657 | 0.659 | 0.081 | 9.445
COVID19_PFIZER/BIONTECH | Aspergillus test negative | 0 | 0.42 | 0.014 | 0.642 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal haemorrhage | 0 | 0.215 | 0.001 | 0.642 | 2.7 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product contamination physical | 0 | 0.315 | 0.005 | 0.642 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin saturation decreased | 0 | 0.525 | 0.028 | 0.642 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apparent death | 0 | 0.571 | 0.035 | 0.642 | 1.908 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Botulism | 0 | 0.157 | 0 | 0.642 | 2.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bursa disorder | 0 | 0.619 | 0.042 | 0.641 | 1.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac function test | 0 | 1.167 | 0.12 | 0.641 | 1.501 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reticulocyte count | 0 | 0.47 | 0.02 | 0.641 | 2.044 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema | 489 | 812.426 | 0.594 | 0.64 | 0.688 | 0.56 | 0.603 | 0.649 | 0.602 | 0.42 | 408.548
COVID19_PFIZER/BIONTECH | Brain scan normal | 0 | 0.555 | 0.032 | 0.64 | 1.927 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site warmth | 17 | 30.25 | 0.419 | 0.639 | 0.897 | 0.404 | 0.591 | 0.842 | 0.562 | 0.448 | 10.773
COVID19_PFIZER/BIONTECH | Biopsy peripheral nerve abnormal | 0 | 0.42 | 0.014 | 0.639 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chromatopsia | 0 | 0.315 | 0.004 | 0.639 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial haemorrhage | 0 | 0.42 | 0.014 | 0.639 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stupor | 0 | 0.382 | 0.01 | 0.639 | 2.202 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pica | 0 | 0.367 | 0.008 | 0.639 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subileus | 0 | 0.21 | 0 | 0.639 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypothyroidism (SMQ) [narrow] | 3 | 6.207 | 0.209 | 0.638 | 1.258 | 0.299 | 0.613 | 1.142 | 0.483 | 0.547 | 0.676
COVID19_PFIZER/BIONTECH | Adnexal torsion | 0 | 0.21 | 0 | 0.638 | 2.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunology test abnormal | 0 | 0.403 | 0.012 | 0.638 | 2.159 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal oedema | 0 | 0.367 | 0.008 | 0.638 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Non-cardiac chest pain | 0 | 1.311 | 0.133 | 0.637 | 1.446 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Developmental regression | 0 | 0.653 | 0.045 | 0.637 | 1.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin premalignant disorders (SMQ) [broad] | 0 | 0.385 | 0.01 | 0.637 | 2.196 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cholecystitis infective | 0 | 0.315 | 0.004 | 0.637 | 2.361 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oestradiol decreased | 0 | 0.262 | 0.002 | 0.637 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycoplasma infection | 0 | 0.441 | 0.016 | 0.637 | 2.091 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin premalignant disorders (SMQ) [narrow] | 0 | 0.385 | 0.01 | 0.637 | 2.196 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD8 lymphocytes decreased | 0 | 0.171 | 0 | 0.637 | 2.915 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval disorder | 0 | 0.262 | 0.002 | 0.636 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory muscle weakness | 0 | 0.111 | 0 | 0.636 | 3.304 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyclic vomiting syndrome | 0 | 0.386 | 0.01 | 0.636 | 2.195 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint manipulation | 0 | 0.262 | 0.002 | 0.636 | 2.52 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site abscess sterile | 0 | 0.21 | 0 | 0.635 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spirometry | 0 | 0.347 | 0.006 | 0.635 | 2.28 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small for dates baby | 0 | 0.163 | 0 | 0.635 | 2.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Calcium ionised decreased | 0 | 0.223 | 0.001 | 0.635 | 2.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal compression fracture | 0 | 0.367 | 0.008 | 0.635 | 2.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein increased | 0 | 0.21 | 0 | 0.635 | 2.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononeuropathy | 1 | 1.55 | 0.135 | 0.633 | 1.43 | 0.317 | 0.775 | 1.647 | 0.645 | 1.129 | 0.182
COVID19_PFIZER/BIONTECH | Vaccination complication | 24 | 46.624 | 0.457 | 0.633 | 0.832 | 0.388 | 0.538 | 0.73 | 0.515 | 0.24 | 56.465
COVID19_PFIZER/BIONTECH | Eschar | 0 | 0.525 | 0.025 | 0.633 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic procedure | 0 | 0.435 | 0.014 | 0.633 | 2.102 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reaction to preservatives | 2 | 4.499 | 0.218 | 0.632 | 1.221 | 0.278 | 0.617 | 1.217 | 0.445 | 1.095 | 0.065
COVID19_PFIZER/BIONTECH | Pneumocystis jirovecii infection | 0 | 0.21 | 0 | 0.632 | 2.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Light chain analysis normal | 0 | 0.262 | 0.001 | 0.632 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site scar | 0 | 1.324 | 0.13 | 0.632 | 1.44 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lividity | 0 | 0.342 | 0.005 | 0.632 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tenderness | 106 | 180.677 | 0.537 | 0.631 | 0.733 | 0.504 | 0.592 | 0.691 | 0.587 | 0.58 | 31.06
COVID19_PFIZER/BIONTECH | Injection site pallor | 0 | 0.756 | 0.057 | 0.631 | 1.729 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance imaging whole body | 0 | 0.367 | 0.007 | 0.631 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic fibrosis | 0 | 0.262 | 0.001 | 0.631 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injury corneal | 0 | 0.242 | 0.001 | 0.631 | 2.591 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stertor | 0 | 0.21 | 0 | 0.63 | 2.72 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal colic | 0 | 0.262 | 0.001 | 0.63 | 2.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epstein-Barr virus antibody | 0 | 1.324 | 0.128 | 0.629 | 1.439 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug level increased | 0 | 0.157 | 0 | 0.629 | 2.985 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral swelling | 253 | 452.1 | 0.565 | 0.628 | 0.693 | 0.506 | 0.562 | 0.622 | 0.56 | 0.39 | 244.365
COVID19_PFIZER/BIONTECH | Foetal disorders (SMQ) [narrow] | 14 | 28.216 | 0.383 | 0.628 | 0.923 | 0.353 | 0.535 | 0.783 | 0.496 | 0.769 | 0.717
COVID19_PFIZER/BIONTECH | Ketonuria | 0 | 0.419 | 0.011 | 0.628 | 2.129 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Light chain analysis abnormal | 0 | 0.21 | 0 | 0.628 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anxiety disorder | 0 | 0.331 | 0.004 | 0.628 | 2.317 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram PR interval | 0 | 0.525 | 0.023 | 0.627 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood bilirubin unconjugated normal | 0 | 0.288 | 0.002 | 0.627 | 2.437 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peripheral nerve lesion | 0 | 0.472 | 0.017 | 0.627 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haptoglobin normal | 0 | 0.472 | 0.017 | 0.627 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fundoscopy | 0 | 0.525 | 0.023 | 0.627 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal disorders (SMQ) [narrow] | 7 | 14.711 | 0.31 | 0.626 | 1.031 | 0.316 | 0.547 | 0.893 | 0.476 | 0.096 | 58.618
COVID19_PFIZER/BIONTECH | Lacrimation disorder | 0 | 0.472 | 0.017 | 0.626 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eye irrigation | 0 | 0.534 | 0.024 | 0.626 | 1.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin atrophy | 0 | 0.525 | 0.023 | 0.626 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold agglutinins | 0 | 0.21 | 0 | 0.626 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood heavy metal increased | 0 | 0.451 | 0.014 | 0.626 | 2.073 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital erythema | 0 | 0.367 | 0.007 | 0.626 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poliovirus test positive | 0 | 0.21 | 0 | 0.626 | 2.719 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B DNA decreased | 0 | 0.262 | 0.001 | 0.626 | 2.518 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myasthenia gravis | 1 | 3.222 | 0.202 | 0.625 | 1.237 | 0.228 | 0.576 | 1.241 | 0.31 | 0.354 | 0.584
COVID19_PFIZER/BIONTECH | Blood osmolarity normal | 0 | 0.315 | 0.003 | 0.625 | 2.36 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Floppy infant | 0 | 0.299 | 0.002 | 0.625 | 2.404 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Social avoidant behaviour | 0 | 0.971 | 0.082 | 0.625 | 1.587 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exercise lack of | 0 | 0.21 | 0 | 0.624 | 2.718 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HLA-B*27 positive | 0 | 0.472 | 0.016 | 0.623 | 2.039 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema infantile | 0 | 0.269 | 0.001 | 0.623 | 2.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product colour issue | 0 | 0.442 | 0.013 | 0.623 | 2.088 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet distribution width | 0 | 0.337 | 0.004 | 0.623 | 2.302 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle abscess | 0 | 0.367 | 0.006 | 0.622 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Melanocytic naevus | 0 | 0.367 | 0.006 | 0.622 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral infection | 3 | 6.508 | 0.3 | 0.621 | 1.036 | 0.289 | 0.594 | 1.108 | 0.461 | 0.092 | 25.908
COVID19_PFIZER/BIONTECH | Pseudomonas test positive | 0 | 0.227 | 0 | 0.621 | 2.644 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cold urticaria | 0 | 0.525 | 0.021 | 0.621 | 1.963 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intrusive thoughts | 0 | 0.367 | 0.006 | 0.621 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Limb mass | 4 | 11.106 | 0.314 | 0.62 | 1.011 | 0.244 | 0.475 | 0.851 | 0.36 | 0.263 | 7.416
COVID19_PFIZER/BIONTECH | Limb deformity | 0 | 0.367 | 0.006 | 0.62 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha hydroxybutyrate dehydrogenase increased | 0 | 0.315 | 0.003 | 0.62 | 2.359 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site eczema | 0 | 0.371 | 0.006 | 0.62 | 2.225 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebellar syndrome | 0 | 0.095 | 0 | 0.62 | 3.395 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal cord oedema | 0 | 0.327 | 0.003 | 0.62 | 2.326 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood thyroid stimulating hormone abnormal | 0 | 0.262 | 0.001 | 0.62 | 2.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myofascial pain syndrome | 0 | 0.525 | 0.021 | 0.619 | 1.963 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rectal prolapse | 0 | 0.329 | 0.003 | 0.619 | 2.322 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterococcal infection | 0 | 0.315 | 0.003 | 0.619 | 2.359 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Debridement | 0 | 0.609 | 0.031 | 0.619 | 1.861 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gamma-glutamyltransferase | 0 | 0.363 | 0.005 | 0.619 | 2.24 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine disorder | 0 | 0.315 | 0.003 | 0.618 | 2.358 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal papilloma | 0 | 0.157 | 0 | 0.617 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Escherichia test negative | 0 | 0.413 | 0.009 | 0.617 | 2.139 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hormone replacement therapy | 0 | 0.157 | 0 | 0.617 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovulation pain | 0 | 0.157 | 0 | 0.617 | 2.974 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skull fracture | 0 | 0.429 | 0.01 | 0.617 | 2.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte count increased | 2 | 4.962 | 0.159 | 0.616 | 1.315 | 0.262 | 0.583 | 1.151 | 0.403 | 0.151 | 8.649
COVID19_PFIZER/BIONTECH | Drug-induced liver injury | 0 | 0.453 | 0.012 | 0.616 | 2.068 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Executive dysfunction | 0 | 0.262 | 0.001 | 0.616 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sigmoidoscopy | 0 | 0.21 | 0 | 0.616 | 2.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gingival discomfort | 0 | 0.42 | 0.009 | 0.616 | 2.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy bone marrow normal | 0 | 0.471 | 0.014 | 0.616 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin E | 0 | 1.012 | 0.082 | 0.616 | 1.563 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal function test abnormal | 0 | 1.24 | 0.108 | 0.616 | 1.464 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transferrin | 0 | 0.262 | 0.001 | 0.616 | 2.515 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus infection | 0 | 0.477 | 0.014 | 0.615 | 2.031 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Relapsing-remitting multiple sclerosis | 0 | 0.294 | 0.002 | 0.615 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parapsoriasis | 0 | 0.42 | 0.009 | 0.615 | 2.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral lichen planus | 0 | 0.367 | 0.005 | 0.615 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose tolerance test normal | 0 | 0.472 | 0.014 | 0.615 | 2.038 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin discomfort | 1 | 2.609 | 0.16 | 0.614 | 1.308 | 0.256 | 0.637 | 1.364 | 0.383 | 0.695 | 0.005
COVID19_PFIZER/BIONTECH | Treponema test | 4 | 9.199 | 0.219 | 0.614 | 1.17 | 0.282 | 0.547 | 0.978 | 0.435 | 1.537 | 0.268
COVID19_PFIZER/BIONTECH | Platelet morphology normal | 0 | 0.367 | 0.005 | 0.614 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunoelectrophoresis | 0 | 0.525 | 0.019 | 0.614 | 1.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Overlap syndrome | 0 | 0.21 | 0 | 0.614 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mononeuritis | 0 | 0.42 | 0.009 | 0.614 | 2.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dissociative disorder | 1 | 1.737 | 0.154 | 0.613 | 1.319 | 0.305 | 0.747 | 1.588 | 0.576 | 1.204 | 0.145
COVID19_PFIZER/BIONTECH | Mass | 12 | 23.822 | 0.403 | 0.613 | 0.859 | 0.352 | 0.548 | 0.821 | 0.504 | 0.399 | 10.026
COVID19_PFIZER/BIONTECH | Mucosal haemorrhage | 0 | 0.248 | 0.001 | 0.613 | 2.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Learning disorder | 0 | 0.245 | 0.001 | 0.613 | 2.575 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plateletcrit | 0 | 0.274 | 0.001 | 0.613 | 2.474 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine spasm | 0 | 0.21 | 0 | 0.613 | 2.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | FEV1/FVC ratio decreased | 0 | 0.157 | 0 | 0.613 | 2.969 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Burning mouth syndrome | 0 | 0.201 | 0 | 0.613 | 2.751 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose tolerance impaired | 0 | 0.558 | 0.023 | 0.613 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Quality of life decreased | 1 | 2.178 | 0.078 | 0.612 | 1.567 | 0.279 | 0.687 | 1.466 | 0.459 | 0.08 | 9.609
COVID19_PFIZER/BIONTECH | Oral candidiasis | 0 | 1.189 | 0.1 | 0.612 | 1.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem auditory evoked response | 0 | 0.472 | 0.013 | 0.612 | 2.037 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neoplasm | 0 | 0.463 | 0.012 | 0.612 | 2.052 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MB normal | 0 | 0.367 | 0.005 | 0.612 | 2.23 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diabetes insipidus | 0 | 0.316 | 0.002 | 0.612 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromyopathy | 0 | 0.525 | 0.019 | 0.612 | 1.961 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spirometry abnormal | 0 | 0.123 | 0 | 0.612 | 3.177 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Organic acid analysis | 0 | 0.262 | 0.001 | 0.612 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site bruising | 40 | 69.622 | 0.468 | 0.611 | 0.769 | 0.454 | 0.588 | 0.75 | 0.575 | 0.389 | 37.247
COVID19_PFIZER/BIONTECH | Skin tightness | 10 | 19.761 | 0.366 | 0.611 | 0.906 | 0.346 | 0.557 | 0.86 | 0.506 | 0.586 | 2.421
COVID19_PFIZER/BIONTECH | X-ray with contrast lower gastrointestinal tract abnormal | 0 | 0.157 | 0 | 0.611 | 2.967 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ankylosing spondylitis | 0 | 0.221 | 0 | 0.611 | 2.663 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyssomnia | 0 | 0.262 | 0.001 | 0.611 | 2.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin increased | 0 | 0.42 | 0.008 | 0.611 | 2.125 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure to toxic agent | 0 | 0.367 | 0.005 | 0.611 | 2.23 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal disorders (SMQ) [broad] | 14 | 28.237 | 0.372 | 0.61 | 0.897 | 0.353 | 0.535 | 0.783 | 0.496 | 0.755 | 0.838
COVID19_PFIZER/BIONTECH | Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 0 | 0.536 | 0.019 | 0.61 | 1.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Capsule endoscopy | 0 | 0.262 | 0.001 | 0.61 | 2.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchial obstruction | 0 | 0.42 | 0.008 | 0.61 | 2.125 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain neoplasm | 0 | 0.454 | 0.011 | 0.61 | 2.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis viral | 0 | 1.103 | 0.088 | 0.609 | 1.517 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bladder irritation | 0 | 0.21 | 0 | 0.609 | 2.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-cyclic citrullinated peptide antibody negative | 0 | 0.971 | 0.072 | 0.609 | 1.582 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose-6-phosphate dehydrogenase | 0 | 0.21 | 0 | 0.609 | 2.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrophoresis protein abnormal | 0 | 0.47 | 0.013 | 0.609 | 2.039 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histology | 0 | 0.367 | 0.005 | 0.608 | 2.229 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrophoresis protein | 0 | 1.469 | 0.126 | 0.608 | 1.385 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac electrophysiologic study normal | 0 | 0.315 | 0.002 | 0.608 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site reaction | 0 | 0.283 | 0.001 | 0.608 | 2.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otoscopy normal | 0 | 0.525 | 0.018 | 0.608 | 1.96 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Occult blood negative | 0 | 0.653 | 0.032 | 0.607 | 1.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroid disorder | 0 | 0.64 | 0.03 | 0.607 | 1.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Feeling of despair | 0 | 0.669 | 0.034 | 0.607 | 1.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial infection | 1 | 4.453 | 0.173 | 0.606 | 1.254 | 0.181 | 0.478 | 1.049 | 0.225 | 0.091 | 8.139
COVID19_PFIZER/BIONTECH | Neurodegenerative disorder | 0 | 0.315 | 0.002 | 0.606 | 2.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Contraindication to vaccination | 2 | 4.918 | 0.147 | 0.605 | 1.315 | 0.263 | 0.586 | 1.157 | 0.407 | 0.192 | 5.909
COVID19_PFIZER/BIONTECH | Personality disorder | 0 | 0.389 | 0.006 | 0.605 | 2.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema infectiosum | 0 | 0.42 | 0.008 | 0.605 | 2.123 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory syncytial virus bronchiolitis | 0 | 0.269 | 0.001 | 0.605 | 2.487 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cell microcytes present | 0 | 0.42 | 0.008 | 0.605 | 2.124 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Listless | 1 | 2.342 | 0.122 | 0.604 | 1.386 | 0.27 | 0.667 | 1.426 | 0.427 | 0.064 | 12.674
COVID19_PFIZER/BIONTECH | Obliterative bronchiolitis | 0 | 0.315 | 0.002 | 0.604 | 2.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product contamination microbial | 0 | 0.21 | 0 | 0.604 | 2.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eczema infected | 0 | 0.367 | 0.004 | 0.604 | 2.228 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor X level normal | 0 | 0.178 | 0 | 0.604 | 2.853 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pupillary light reflex tests normal | 0 | 0.525 | 0.017 | 0.604 | 1.959 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site oedema | 10 | 19.76 | 0.345 | 0.603 | 0.92 | 0.346 | 0.557 | 0.86 | 0.506 | 0.2 | 30.956
COVID19_PFIZER/BIONTECH | Cardiac valve disease | 0 | 0.42 | 0.007 | 0.603 | 2.123 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin striae | 0 | 0.454 | 0.01 | 0.603 | 2.064 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product appearance confusion | 0 | 0.387 | 0.005 | 0.603 | 2.186 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Growth retardation | 0 | 0.565 | 0.02 | 0.602 | 1.907 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ex-tobacco user | 0 | 0.157 | 0 | 0.602 | 2.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhoids | 0 | 1.287 | 0.103 | 0.602 | 1.44 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site oedema | 0 | 0.228 | 0 | 0.601 | 2.631 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cushing's syndrome | 0 | 0.21 | 0 | 0.601 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumocystis test positive | 0 | 0.21 | 0 | 0.601 | 2.703 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal operation | 0 | 0.256 | 0 | 0.601 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF immunoglobulin | 0 | 0.839 | 0.052 | 0.601 | 1.659 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4 lymphocytes decreased | 0 | 0.387 | 0.005 | 0.601 | 2.186 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis allergic | 4 | 8.377 | 0.246 | 0.6 | 1.08 | 0.302 | 0.585 | 1.045 | 0.477 | 0.44 | 2.23
COVID19_PFIZER/BIONTECH | Peritonsillar abscess | 0 | 0.367 | 0.004 | 0.6 | 2.226 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrosis | 0 | 0.783 | 0.044 | 0.6 | 1.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wound secretion | 0 | 1.286 | 0.102 | 0.6 | 1.44 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B core antibody negative | 1 | 3.208 | 0.041 | 0.599 | 1.72 | 0.229 | 0.577 | 1.243 | 0.312 | 0.095 | 7.705
COVID19_PFIZER/BIONTECH | Cafe au lait spots | 0 | 0.269 | 0.001 | 0.599 | 2.484 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cellulitis orbital | 0 | 0.35 | 0.003 | 0.599 | 2.265 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extravasation events (injections, infusions and implants) (SMQ) [broad] | 1859 | 3213.045 | 0.575 | 0.598 | 0.621 | 0.557 | 0.579 | 0.601 | 0.579 | 0.494 | 1176.44
COVID19_PFIZER/BIONTECH | Impaired quality of life | 0 | 0.339 | 0.002 | 0.598 | 2.291 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulocytopenia | 0 | 0.708 | 0.035 | 0.598 | 1.759 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enteral nutrition | 0 | 0.315 | 0.002 | 0.598 | 2.351 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal pigment epitheliopathy | 0 | 0.191 | 0 | 0.598 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor feeding infant | 0 | 0.707 | 0.035 | 0.598 | 1.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sepsis neonatal | 0 | 0.472 | 0.01 | 0.598 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuritis | 1 | 3.068 | 0.12 | 0.597 | 1.373 | 0.235 | 0.59 | 1.269 | 0.326 | 0.223 | 1.927
COVID19_PFIZER/BIONTECH | Forced vital capacity | 0 | 0.21 | 0 | 0.597 | 2.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Addison's disease | 0 | 0.472 | 0.01 | 0.597 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Male sexual dysfunction | 0 | 0.262 | 0.001 | 0.597 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fundoscopy abnormal | 0 | 0.454 | 0.009 | 0.597 | 2.061 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain malformation | 0 | 0.262 | 0.001 | 0.597 | 2.505 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood folate decreased | 0 | 0.472 | 0.01 | 0.597 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulvovaginal pruritus | 1 | 2.502 | 0.15 | 0.595 | 1.28 | 0.262 | 0.649 | 1.388 | 0.4 | 0.951 | 0.204
COVID19_PFIZER/BIONTECH | Type 2 lepra reaction | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pregnancy test urine positive | 0 | 0.264 | 0.001 | 0.595 | 2.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breast discharge | 0 | 0.259 | 0 | 0.595 | 2.514 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuroendocrine tumour | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site discharge | 0 | 1.702 | 0.137 | 0.595 | 1.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lack of satiety | 0 | 0.262 | 0 | 0.595 | 2.504 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurilemmoma benign | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Spinal X-ray abnormal | 0 | 1.077 | 0.076 | 0.595 | 1.523 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intraocular pressure decreased | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurogenic bowel | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retroperitoneal mass | 0 | 0.157 | 0 | 0.595 | 2.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site infection | 0 | 0.483 | 0.011 | 0.594 | 2.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Talipes | 0 | 0.42 | 0.006 | 0.594 | 2.12 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis minimal lesion | 0 | 0.525 | 0.014 | 0.594 | 1.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Type I hypersensitivity | 0 | 0.23 | 0 | 0.594 | 2.617 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Educational problem | 0 | 0.18 | 0 | 0.594 | 2.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blister | 33 | 69.757 | 0.437 | 0.593 | 0.767 | 0.37 | 0.491 | 0.641 | 0.473 | 0.198 | 106.099
COVID19_PFIZER/BIONTECH | Aspiration bone marrow abnormal | 0 | 0.337 | 0.002 | 0.593 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Developmental delay | 0 | 0.787 | 0.042 | 0.593 | 1.693 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acanthosis | 0 | 0.315 | 0.001 | 0.593 | 2.349 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Faecal calprotectin increased | 0 | 0.302 | 0.001 | 0.592 | 2.384 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy intestine abnormal | 0 | 0.367 | 0.003 | 0.592 | 2.223 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryoglobulins absent | 0 | 0.487 | 0.011 | 0.592 | 2.008 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laryngeal disorder | 0 | 0.277 | 0.001 | 0.592 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac monitoring normal | 1 | 2.558 | 0.17 | 0.591 | 1.219 | 0.259 | 0.643 | 1.375 | 0.391 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Oesophagitis | 0 | 0.484 | 0.01 | 0.591 | 2.013 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alopecia totalis | 0 | 0.315 | 0.001 | 0.59 | 2.347 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian cyst | 0 | 0.275 | 0.001 | 0.59 | 2.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site discomfort | 21 | 37.656 | 0.412 | 0.589 | 0.792 | 0.412 | 0.582 | 0.805 | 0.558 | 0.546 | 7.229
COVID19_PFIZER/BIONTECH | Hypophosphataemia | 0 | 0.367 | 0.003 | 0.589 | 2.222 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oppositional defiant disorder | 0 | 0.315 | 0.001 | 0.589 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site joint movement impairment | 0 | 0.472 | 0.009 | 0.589 | 2.03 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product name confusion | 0 | 0.567 | 0.017 | 0.589 | 1.9 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respirovirus test positive | 0 | 0.427 | 0.006 | 0.588 | 2.105 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Repetitive speech | 0 | 1.388 | 0.103 | 0.588 | 1.399 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve stimulation test normal | 0 | 0.315 | 0.001 | 0.587 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C | 0 | 0.367 | 0.003 | 0.587 | 2.221 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site haematoma | 0 | 0.512 | 0.012 | 0.587 | 1.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smallpox | 0 | 0.367 | 0.003 | 0.587 | 2.221 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Culture wound negative | 0 | 0.562 | 0.016 | 0.587 | 1.905 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Magnetic resonance neurography | 0 | 0.367 | 0.003 | 0.586 | 2.22 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Delirium febrile | 0 | 0.472 | 0.009 | 0.586 | 2.028 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site scab | 0 | 0.365 | 0.003 | 0.586 | 2.224 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Secretion discharge | 3 | 8.069 | 0.268 | 0.585 | 1 | 0.248 | 0.513 | 0.959 | 0.372 | 0.208 | 8.118
COVID19_PFIZER/BIONTECH | Injection site necrosis | 0 | 0.547 | 0.014 | 0.585 | 1.922 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site cellulitis | 0 | 0.407 | 0.005 | 0.585 | 2.14 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymph node abscess | 0 | 0.525 | 0.012 | 0.585 | 1.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amputation | 0 | 0.155 | 0 | 0.585 | 2.945 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet-large cell ratio | 0 | 0.249 | 0 | 0.585 | 2.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Light chain analysis | 0 | 0.262 | 0 | 0.585 | 2.497 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis infected | 0 | 0.367 | 0.003 | 0.585 | 2.22 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF test normal | 2 | 4.862 | 0.177 | 0.584 | 1.182 | 0.265 | 0.59 | 1.164 | 0.411 | 0.142 | 9.45
COVID19_PFIZER/BIONTECH | Acne | 2 | 5.287 | 0.174 | 0.584 | 1.187 | 0.251 | 0.561 | 1.109 | 0.378 | 0.127 | 11.062
COVID19_PFIZER/BIONTECH | Hyperplasia | 0 | 0.315 | 0.001 | 0.584 | 2.344 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema induratum | 0 | 0.525 | 0.012 | 0.584 | 1.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amaurosis | 0 | 0.315 | 0.001 | 0.584 | 2.343 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amyotrophic lateral sclerosis | 0 | 0.235 | 0 | 0.584 | 2.588 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site pain | 0 | 0.374 | 0.003 | 0.584 | 2.204 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Romberg test positive | 0 | 0.646 | 0.023 | 0.582 | 1.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oculorespiratory syndrome | 0 | 0.299 | 0.001 | 0.582 | 2.386 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scleroderma | 0 | 0.485 | 0.009 | 0.582 | 2.007 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Light chain analysis decreased | 0 | 0.21 | 0 | 0.581 | 2.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kyphosis | 0 | 0.367 | 0.003 | 0.581 | 2.217 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung assist device therapy | 0 | 0.313 | 0.001 | 0.581 | 2.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperpyrexia | 2 | 3.361 | 0.125 | 0.58 | 1.307 | 0.327 | 0.72 | 1.416 | 0.595 | 0.042 | 42.707
COVID19_PFIZER/BIONTECH | HIV test negative | 2 | 5.11 | 0.175 | 0.58 | 1.177 | 0.257 | 0.572 | 1.131 | 0.391 | 0.145 | 9.129
COVID19_PFIZER/BIONTECH | Injection site papule | 0 | 2.008 | 0.147 | 0.58 | 1.245 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxine decreased | 0 | 0.472 | 0.008 | 0.58 | 2.025 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tenodesis | 0 | 0.262 | 0 | 0.579 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mania | 0 | 1.373 | 0.096 | 0.579 | 1.399 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papillitis | 0 | 0.367 | 0.002 | 0.579 | 2.216 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nephropathy toxic | 0 | 0.21 | 0 | 0.579 | 2.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Patent ductus arteriosus | 0 | 0.262 | 0 | 0.579 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central auditory processing disorder | 0 | 0.157 | 0 | 0.578 | 2.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti factor VIII antibody positive | 0 | 0.105 | 0 | 0.577 | 3.204 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parvovirus B19 test positive | 0 | 0.498 | 0.009 | 0.577 | 1.985 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Carnitine | 0 | 0.315 | 0.001 | 0.577 | 2.339 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urogram normal | 0 | 0.262 | 0 | 0.577 | 2.49 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Performance status decreased | 0 | 0.482 | 0.008 | 0.577 | 2.009 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product quality issue | 1 | 1 | 0.088 | 0.576 | 1.417 | 0.358 | 0.871 | 1.847 | 1 | 0.058 | 14.268
COVID19_PFIZER/BIONTECH | Injection site mass | 50 | 92.473 | 0.453 | 0.576 | 0.711 | 0.438 | 0.552 | 0.688 | 0.541 | 0.464 | 29.847
COVID19_PFIZER/BIONTECH | Infectious biliary disorders (SMQ) [broad] | 2 | 4.251 | 0.165 | 0.575 | 1.186 | 0.288 | 0.637 | 1.255 | 0.47 | 1.338 | 0
COVID19_PFIZER/BIONTECH | Infectious biliary disorders (SMQ) [narrow] | 2 | 4.251 | 0.165 | 0.575 | 1.186 | 0.288 | 0.637 | 1.255 | 0.47 | 1.338 | 0
COVID19_PFIZER/BIONTECH | Obstruction | 0 | 0.396 | 0.003 | 0.575 | 2.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic failure | 0 | 0.954 | 0.052 | 0.575 | 1.576 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | West Nile viral infection | 0 | 0.261 | 0 | 0.575 | 2.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotavirus test | 0 | 0.344 | 0.002 | 0.575 | 2.266 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebrospinal fluid leakage | 0 | 0.269 | 0 | 0.574 | 2.465 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF lactate increased | 0 | 0.367 | 0.002 | 0.574 | 2.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medical induction of coma | 0 | 1.195 | 0.075 | 0.574 | 1.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lactose intolerance | 0 | 0.586 | 0.015 | 0.574 | 1.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tubulointerstitial nephritis | 0 | 0.593 | 0.016 | 0.574 | 1.863 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin cancer | 0 | 0.558 | 0.013 | 0.574 | 1.904 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint lock | 1 | 2.149 | 0.101 | 0.573 | 1.361 | 0.28 | 0.691 | 1.474 | 0.465 | 0.44 | 0.237
COVID19_PFIZER/BIONTECH | Endometritis | 0 | 0.315 | 0.001 | 0.573 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coxsackie viral infection | 0 | 0.42 | 0.004 | 0.573 | 2.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sudden infant death syndrome | 0 | 0.771 | 0.031 | 0.572 | 1.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertrophic cardiomyopathy | 0 | 0.315 | 0.001 | 0.572 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site cellulitis | 0 | 0.27 | 0 | 0.572 | 2.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | DNA antibody negative | 0 | 0.287 | 0 | 0.572 | 2.41 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via direct contact | 0 | 0.288 | 0 | 0.572 | 2.408 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Milk allergy | 0 | 0.902 | 0.044 | 0.571 | 1.605 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | pH body fluid increased | 0 | 0.315 | 0.001 | 0.571 | 2.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site abscess | 0 | 0.502 | 0.008 | 0.571 | 1.977 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site inflammation | 1 | 4.679 | 0.127 | 0.57 | 1.27 | 0.174 | 0.463 | 1.02 | 0.214 | 0.108 | 6.463
COVID19_PFIZER/BIONTECH | Repetitive strain injury | 0 | 0.315 | 0.001 | 0.57 | 2.334 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis adenovirus | 0 | 0.196 | 0 | 0.57 | 2.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella zoster pneumonia | 0 | 0.12 | 0 | 0.57 | 3.098 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumovirus test positive | 0 | 0.367 | 0.002 | 0.57 | 2.21 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Concomitant disease aggravated | 0 | 0.326 | 0.001 | 0.57 | 2.306 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tryptase increased | 0 | 0.479 | 0.007 | 0.569 | 2.009 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lower respiratory tract infection bacterial | 0 | 0.367 | 0.002 | 0.569 | 2.21 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-SRP antibody positive | 0 | 0.21 | 0 | 0.569 | 2.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin M increased | 0 | 0.489 | 0.007 | 0.568 | 1.993 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-platelet antibody negative | 0 | 0.42 | 0.004 | 0.568 | 2.106 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | C-reactive protein decreased | 0 | 0.484 | 0.007 | 0.568 | 2.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF monocyte count | 0 | 0.144 | 0 | 0.568 | 2.967 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urinary sediment present | 1 | 2.224 | 0.155 | 0.567 | 1.188 | 0.276 | 0.682 | 1.455 | 0.45 | 0.42 | 0.299
COVID19_PFIZER/BIONTECH | Serum ferritin decreased | 0 | 0.509 | 0.008 | 0.567 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head deformity | 0 | 0.157 | 0 | 0.567 | 2.899 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenovirus test positive | 0 | 0.653 | 0.019 | 0.567 | 1.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disturbance in social behaviour | 0 | 0.523 | 0.009 | 0.567 | 1.946 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weight fluctuation | 0 | 0.19 | 0 | 0.567 | 2.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antibody test normal | 0 | 0.367 | 0.002 | 0.567 | 2.208 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobin distribution width | 0 | 0.157 | 0 | 0.567 | 2.899 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bipolar disorder | 0 | 0.691 | 0.022 | 0.566 | 1.76 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antibody test negative | 2 | 5.213 | 0.135 | 0.565 | 1.237 | 0.254 | 0.565 | 1.118 | 0.384 | 0.072 | 22.913
COVID19_PFIZER/BIONTECH | Head injury | 16 | 34.562 | 0.374 | 0.564 | 0.787 | 0.337 | 0.498 | 0.716 | 0.463 | 0.342 | 19.256
COVID19_PFIZER/BIONTECH | Complement factor C4 | 1 | 3.974 | 0.108 | 0.564 | 1.313 | 0.198 | 0.513 | 1.116 | 0.252 | 0.212 | 2.123
COVID19_PFIZER/BIONTECH | Injection site pruritus | 149 | 543.067 | 0.49 | 0.564 | 0.641 | 0.243 | 0.278 | 0.317 | 0.274 | 0.374 | 155.573
COVID19_PFIZER/BIONTECH | Vaccination site plaque | 0 | 0.315 | 0.001 | 0.564 | 2.329 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal malrotation | 0 | 0.386 | 0.002 | 0.564 | 2.167 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypoxic-ischaemic encephalopathy | 0 | 0.854 | 0.037 | 0.564 | 1.632 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bordetella infection | 0 | 0.262 | 0 | 0.564 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenocarcinoma | 0 | 0.262 | 0 | 0.564 | 2.478 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-lymphocyte count decreased | 0 | 0.311 | 0.001 | 0.563 | 2.338 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brachial plexopathy | 0 | 0.622 | 0.016 | 0.563 | 1.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthritis | 9 | 18.679 | 0.307 | 0.562 | 0.879 | 0.328 | 0.539 | 0.846 | 0.482 | 0.297 | 14.022
COVID19_PFIZER/BIONTECH | Scan abnormal | 0 | 0.615 | 0.015 | 0.562 | 1.832 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal disorder | 0 | 0.525 | 0.009 | 0.562 | 1.94 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchopulmonary aspergillosis allergic | 0 | 0.105 | 0 | 0.562 | 3.154 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salpingitis | 0 | 0.21 | 0 | 0.561 | 2.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site discolouration | 11 | 23.057 | 0.344 | 0.56 | 0.819 | 0.332 | 0.526 | 0.799 | 0.477 | 0.247 | 24.227
COVID19_PFIZER/BIONTECH | Decreased eye contact | 0 | 1.263 | 0.073 | 0.56 | 1.426 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site hyperaesthesia | 0 | 0.525 | 0.008 | 0.56 | 1.939 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatosis | 0 | 0.42 | 0.003 | 0.56 | 2.101 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoclonic epilepsy | 0 | 0.47 | 0.005 | 0.56 | 2.018 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product administered at inappropriate site | 31 | 70.897 | 0.409 | 0.559 | 0.729 | 0.342 | 0.457 | 0.6 | 0.437 | 0.407 | 25.665
COVID19_PFIZER/BIONTECH | Tumour markers (SMQ) [narrow] | 1 | 2.952 | 0.087 | 0.559 | 1.368 | 0.24 | 0.601 | 1.292 | 0.339 | 0.241 | 1.638
COVID19_PFIZER/BIONTECH | Tumour markers (SMQ) [broad] | 1 | 2.952 | 0.087 | 0.559 | 1.368 | 0.24 | 0.601 | 1.292 | 0.339 | 0.241 | 1.638
COVID19_PFIZER/BIONTECH | Chlamydia test | 0 | 0.744 | 0.025 | 0.559 | 1.71 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corynebacterium infection | 0 | 0.363 | 0.001 | 0.559 | 2.211 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral upper respiratory tract infection | 0 | 0.951 | 0.043 | 0.558 | 1.568 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Child abuse | 0 | 0.21 | 0 | 0.558 | 2.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Quadriparesis | 0 | 0.441 | 0.004 | 0.558 | 2.063 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy colon abnormal | 0 | 0.435 | 0.003 | 0.558 | 2.074 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Convulsions local | 0 | 0.472 | 0.005 | 0.558 | 2.012 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Irritable bowel syndrome | 2 | 4.489 | 0.134 | 0.557 | 1.217 | 0.279 | 0.618 | 1.218 | 0.446 | 0.309 | 2.37
COVID19_PFIZER/BIONTECH | CSF lactate normal | 0 | 0.315 | 0.001 | 0.557 | 2.322 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schizoaffective disorder | 0 | 0.21 | 0 | 0.557 | 2.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Concussion | 1 | 3.894 | 0.165 | 0.556 | 1.133 | 0.201 | 0.519 | 1.128 | 0.257 | 0.181 | 2.875
COVID19_PFIZER/BIONTECH | Sickle cell anaemia with crisis | 0 | 0.569 | 0.01 | 0.556 | 1.88 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intentional self-injury | 0 | 0.489 | 0.006 | 0.556 | 1.986 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuropsychiatric syndrome | 0 | 0.472 | 0.005 | 0.555 | 2.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Marrow hyperplasia | 0 | 0.367 | 0.001 | 0.555 | 2.199 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HLA-B*27 assay | 0 | 0.44 | 0.004 | 0.555 | 2.063 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mood swings | 1 | 1.971 | 0.078 | 0.554 | 1.388 | 0.291 | 0.714 | 1.521 | 0.507 | 0.192 | 2.571
COVID19_PFIZER/BIONTECH | Myosclerosis | 0 | 2.012 | 0.127 | 0.554 | 1.227 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schizophrenia | 0 | 0.25 | 0 | 0.554 | 2.507 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accidental underdose | 1 | 4.853 | 0.051 | 0.553 | 1.51 | 0.168 | 0.452 | 0.999 | 0.206 | 0.361 | 0.545
COVID19_PFIZER/BIONTECH | Vaccine breakthrough infection | 0 | 0.791 | 0.027 | 0.553 | 1.67 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salivary gland enlargement | 0 | 0.452 | 0.004 | 0.553 | 2.041 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichen sclerosus | 0 | 0.42 | 0.003 | 0.553 | 2.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood copper | 0 | 0.42 | 0.003 | 0.553 | 2.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotavirus test negative | 0 | 0.465 | 0.004 | 0.553 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic nerve disorder | 0 | 0.465 | 0.004 | 0.553 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Influenza A virus test positive | 3 | 5.152 | 0.159 | 0.552 | 1.136 | 0.336 | 0.687 | 1.28 | 0.582 | 0.117 | 18.97
COVID19_PFIZER/BIONTECH | Genital herpes zoster | 0 | 0.184 | 0 | 0.552 | 2.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyp | 0 | 0.315 | 0 | 0.552 | 2.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin erosion | 0 | 2.023 | 0.126 | 0.552 | 1.223 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malignant melanoma | 0 | 0.525 | 0.007 | 0.551 | 1.933 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serology negative | 0 | 0.605 | 0.012 | 0.551 | 1.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine potassium | 0 | 0.096 | 0 | 0.551 | 3.149 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal haemorrhage | 0 | 1.001 | 0.045 | 0.551 | 1.536 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amino acid level increased | 0 | 0.472 | 0.004 | 0.55 | 2.007 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human herpes virus 6 serology | 0 | 0.472 | 0.004 | 0.55 | 2.007 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy to animal | 0 | 0.462 | 0.004 | 0.55 | 2.023 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | T-lymphocyte count increased | 0 | 0.466 | 0.004 | 0.55 | 2.016 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Histiocytosis | 0 | 0.262 | 0 | 0.549 | 2.461 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shoulder deformity | 0 | 0.262 | 0 | 0.549 | 2.461 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epstein-Barr virus infection | 0 | 1.16 | 0.058 | 0.549 | 1.46 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Food intolerance | 0 | 0.933 | 0.038 | 0.549 | 1.572 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polymyositis | 0 | 0.398 | 0.002 | 0.549 | 2.133 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [narrow] | 0 | 1.087 | 0.052 | 0.549 | 1.492 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parvovirus infection | 0 | 0.315 | 0 | 0.548 | 2.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal gastrointestinal tract imaging abnormal | 0 | 0.21 | 0 | 0.548 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precancerous mucosal lesion | 0 | 0.21 | 0 | 0.548 | 2.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-transglutaminase antibody | 0 | 0.367 | 0.001 | 0.548 | 2.194 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid factor increased | 0 | 1.502 | 0.085 | 0.547 | 1.338 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute polyneuropathy | 0 | 0.472 | 0.004 | 0.547 | 2.005 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Juvenile idiopathic arthritis | 0 | 0.462 | 0.004 | 0.547 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Base excess negative | 0 | 0.544 | 0.007 | 0.547 | 1.904 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal operation | 0 | 0.408 | 0.002 | 0.546 | 2.112 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labelled drug-disease interaction medication error | 0 | 0.315 | 0 | 0.546 | 2.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fear of falling | 0 | 0.262 | 0 | 0.546 | 2.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exanthema subitum | 0 | 0.545 | 0.007 | 0.545 | 1.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postictal paralysis | 0 | 0.525 | 0.006 | 0.545 | 1.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinol binding protein | 0 | 0.27 | 0 | 0.545 | 2.434 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasite stool test negative | 0 | 0.447 | 0.003 | 0.545 | 2.043 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster infection neurological | 0 | 0.277 | 0 | 0.544 | 2.41 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Obsessive-compulsive disorder | 0 | 1.571 | 0.089 | 0.544 | 1.318 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatinine decreased | 0 | 0.849 | 0.029 | 0.544 | 1.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parotid gland enlargement | 0 | 0.42 | 0.002 | 0.544 | 2.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disseminated varicella zoster virus infection | 0 | 0.339 | 0.001 | 0.543 | 2.25 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Peak expiratory flow rate decreased | 0 | 0.367 | 0.001 | 0.543 | 2.188 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Face and mouth X-ray | 0 | 0.332 | 0.001 | 0.543 | 2.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Combined immunodeficiency | 0 | 0.329 | 0 | 0.542 | 2.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear site unspecified normal | 0 | 0.484 | 0.004 | 0.542 | 1.983 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precancerous cells present | 0 | 0.337 | 0.001 | 0.542 | 2.255 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interferon gamma release assay | 0 | 0.262 | 0 | 0.541 | 2.45 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxoplasma serology negative | 0 | 0.673 | 0.014 | 0.541 | 1.761 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mixed connective tissue disease | 0 | 0.262 | 0 | 0.541 | 2.45 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C RNA decreased | 0 | 0.21 | 0 | 0.541 | 2.627 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimicrobial susceptibility test resistant | 0 | 0.367 | 0.001 | 0.541 | 2.187 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal necrosis | 0 | 0.305 | 0 | 0.539 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal motility disorder | 0 | 0.358 | 0.001 | 0.538 | 2.203 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Circadian rhythm sleep disorder | 0 | 0.309 | 0 | 0.538 | 2.319 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abscess sterile | 0 | 0.501 | 0.004 | 0.538 | 1.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Swelling | 175 | 340.506 | 0.473 | 0.537 | 0.605 | 0.457 | 0.517 | 0.584 | 0.514 | 0.355 | 205.476
COVID19_PFIZER/BIONTECH | Fundoscopy normal | 0 | 0.534 | 0.006 | 0.537 | 1.91 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic sinusitis | 0 | 0.467 | 0.003 | 0.536 | 2.003 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post lumbar puncture syndrome | 0 | 0.472 | 0.003 | 0.536 | 1.996 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Evans syndrome | 0 | 0.315 | 0 | 0.536 | 2.301 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mastoiditis | 0 | 0.456 | 0.003 | 0.536 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renovascular disorders (SMQ) [narrow] | 0 | 1.056 | 0.043 | 0.536 | 1.498 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine test normal | 0 | 0.472 | 0.003 | 0.536 | 1.996 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Growing pains | 0 | 0.315 | 0 | 0.536 | 2.301 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium enema | 0 | 0.395 | 0.001 | 0.536 | 2.127 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purulent discharge | 0 | 1.432 | 0.074 | 0.536 | 1.352 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure to communicable disease | 0 | 1.082 | 0.045 | 0.536 | 1.486 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Graft versus host disease | 0 | 0.525 | 0.005 | 0.535 | 1.921 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrosomia | 0 | 0.262 | 0 | 0.535 | 2.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macular oedema | 0 | 0.367 | 0.001 | 0.535 | 2.181 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin necrosis | 0 | 1.113 | 0.047 | 0.535 | 1.471 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tuberculosis | 0 | 0.649 | 0.011 | 0.534 | 1.779 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Positron emission tomogram | 1 | 2.104 | 0.099 | 0.533 | 1.249 | 0.283 | 0.697 | 1.485 | 0.475 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Endometriosis | 0 | 0.249 | 0 | 0.533 | 2.481 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute haemorrhagic oedema of infancy | 0 | 0.377 | 0.001 | 0.533 | 2.16 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amoebiasis | 0 | 0.152 | 0 | 0.533 | 2.842 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystoid macular oedema | 0 | 0.21 | 0 | 0.533 | 2.612 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ill-defined disorder | 1 | 4.5 | 0.121 | 0.532 | 1.181 | 0.18 | 0.475 | 1.043 | 0.222 | 0.117 | 5.764
COVID19_PFIZER/BIONTECH | Immunoglobulins increased | 0 | 0.525 | 0.005 | 0.532 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine organic acid test | 0 | 0.525 | 0.005 | 0.532 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thyroxine increased | 0 | 0.525 | 0.005 | 0.532 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salt craving | 0 | 0.21 | 0 | 0.532 | 2.612 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Steroid dependence | 0 | 0.157 | 0 | 0.531 | 2.817 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site pustule | 0 | 0.209 | 0 | 0.531 | 2.612 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nodule | 14 | 29.545 | 0.334 | 0.53 | 0.762 | 0.339 | 0.513 | 0.752 | 0.474 | 0.333 | 17.707
COVID19_PFIZER/BIONTECH | Psychiatric evaluation | 0 | 0.436 | 0.002 | 0.53 | 2.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonic convulsion | 0 | 1.162 | 0.049 | 0.53 | 1.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrocele | 0 | 0.42 | 0.002 | 0.53 | 2.076 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Explorative laparotomy | 0 | 0.325 | 0 | 0.53 | 2.268 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extra dose administered | 22 | 46.573 | 0.365 | 0.529 | 0.719 | 0.355 | 0.499 | 0.685 | 0.472 | 0.112 | 154.604
COVID19_PFIZER/BIONTECH | Vitello-intestinal duct remnant | 0 | 0.3 | 0 | 0.529 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Weaning failure | 0 | 0.262 | 0 | 0.529 | 2.435 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labyrinthitis | 0 | 1.374 | 0.065 | 0.529 | 1.365 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product effect decreased | 0 | 0.42 | 0.002 | 0.529 | 2.074 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C RNA negative | 0 | 0.262 | 0 | 0.529 | 2.434 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis cholestatic | 0 | 0.157 | 0 | 0.529 | 2.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antigen negative | 1 | 2.508 | 0.04 | 0.528 | 1.494 | 0.261 | 0.648 | 1.386 | 0.399 | 0.065 | 12.565
COVID19_PFIZER/BIONTECH | Myelocyte count | 0 | 0.142 | 0 | 0.528 | 2.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site pustule | 0 | 1.159 | 0.048 | 0.528 | 1.444 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Steroid therapy | 0 | 0.472 | 0.003 | 0.528 | 1.989 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine protein/creatinine ratio | 0 | 0.367 | 0.001 | 0.527 | 2.172 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Physical disability | 0 | 0.256 | 0 | 0.527 | 2.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis meningococcal | 0 | 0.21 | 0 | 0.526 | 2.6 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Postpartum haemorrhage | 0 | 0.262 | 0 | 0.526 | 2.43 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product dose omission issue | 1 | 3.884 | 0.047 | 0.525 | 1.437 | 0.202 | 0.52 | 1.13 | 0.257 | 0.169 | 3.234
COVID19_PFIZER/BIONTECH | Ulcer haemorrhage | 0 | 0.21 | 0 | 0.525 | 2.598 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular malformation | 0 | 0.178 | 0 | 0.525 | 2.718 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurogenic shock | 0 | 0.163 | 0 | 0.525 | 2.78 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product prescribing error | 0 | 1.803 | 0.092 | 0.524 | 1.246 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site irritation | 3 | 10.815 | 0.249 | 0.523 | 0.879 | 0.196 | 0.412 | 0.776 | 0.277 | 0.154 | 12.977
COVID19_PFIZER/BIONTECH | Rheumatoid factor positive | 0 | 0.437 | 0.002 | 0.523 | 2.04 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site vesicles | 0 | 0.632 | 0.009 | 0.523 | 1.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brucella test negative | 0 | 0.379 | 0.001 | 0.522 | 2.144 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urticarial vasculitis | 0 | 0.405 | 0.001 | 0.522 | 2.094 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gluten free diet | 0 | 0.262 | 0 | 0.522 | 2.423 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skeletal survey normal | 0 | 0.327 | 0 | 0.522 | 2.255 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Food allergy | 2 | 6.22 | 0.177 | 0.521 | 1.012 | 0.225 | 0.505 | 1.003 | 0.322 | 0.123 | 11.494
COVID19_PFIZER/BIONTECH | Oliguria | 0 | 0.255 | 0 | 0.521 | 2.444 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory papilloma | 0 | 0.24 | 0 | 0.521 | 2.489 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Head titubation | 0 | 3.216 | 0.161 | 0.521 | 1.047 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemodynamic oedema, effusions and fluid overload (SMQ) [broad] | 934 | 1904.891 | 0.493 | 0.52 | 0.548 | 0.465 | 0.491 | 0.518 | 0.49 | 0.36 | 1215.324
COVID19_PFIZER/BIONTECH | Haemodynamic oedema, effusions and fluid overload (SMQ) [narrow] | 934 | 1904.891 | 0.493 | 0.52 | 0.548 | 0.465 | 0.491 | 0.518 | 0.49 | 0.36 | 1215.324
COVID19_PFIZER/BIONTECH | Rubulavirus test positive | 0 | 0.166 | 0 | 0.52 | 2.753 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound thyroid abnormal | 0 | 0.399 | 0.001 | 0.52 | 2.103 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle mass | 0 | 0.525 | 0.004 | 0.52 | 1.908 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opportunistic infections (SMQ) [narrow] | 10 | 25.881 | 0.289 | 0.519 | 0.804 | 0.273 | 0.441 | 0.681 | 0.386 | 0.179 | 36.439
COVID19_PFIZER/BIONTECH | Skin texture abnormal | 0 | 1.557 | 0.073 | 0.519 | 1.302 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatosensory evoked potentials abnormal | 0 | 0.38 | 0.001 | 0.519 | 2.137 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin candida | 0 | 0.367 | 0.001 | 0.519 | 2.163 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Listeria test | 0 | 0.42 | 0.001 | 0.519 | 2.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitritis | 0 | 0.472 | 0.002 | 0.516 | 1.978 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual evoked potentials abnormal | 0 | 0.223 | 0 | 0.516 | 2.535 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impulsive behaviour | 0 | 0.472 | 0.002 | 0.516 | 1.978 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metal poisoning | 0 | 0.475 | 0.002 | 0.516 | 1.973 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Double stranded DNA antibody | 0 | 0.599 | 0.006 | 0.515 | 1.814 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF culture positive | 0 | 0.323 | 0 | 0.515 | 2.254 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Embolism venous | 0 | 0.259 | 0 | 0.515 | 2.422 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone contusion | 0 | 0.315 | 0 | 0.515 | 2.274 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasitic blood test negative | 0 | 0.472 | 0.002 | 0.515 | 1.976 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood aluminium | 0 | 0.42 | 0.001 | 0.514 | 2.06 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonella test negative | 0 | 0.53 | 0.004 | 0.514 | 1.896 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood testosterone decreased | 0 | 0.42 | 0.001 | 0.513 | 2.059 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urea urine normal | 0 | 0.153 | 0 | 0.513 | 2.782 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Croup infectious | 0 | 0.687 | 0.01 | 0.513 | 1.725 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Trichotillomania | 0 | 0.367 | 0 | 0.513 | 2.157 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-neutrophil cytoplasmic antibody positive vasculitis | 0 | 0.331 | 0 | 0.512 | 2.233 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glomerulonephritis | 0 | 0.315 | 0 | 0.512 | 2.269 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Quadriplegia | 0 | 0.422 | 0.001 | 0.512 | 2.053 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hallucinations, mixed | 0 | 0.525 | 0.003 | 0.511 | 1.9 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatocellular injury | 0 | 0.245 | 0 | 0.511 | 2.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatosensory evoked potentials | 0 | 0.295 | 0 | 0.51 | 2.317 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Eosinophilic cellulitis | 0 | 0.348 | 0 | 0.51 | 2.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound eye abnormal | 0 | 0.315 | 0 | 0.51 | 2.267 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antiphospholipid antibodies negative | 0 | 0.62 | 0.007 | 0.51 | 1.787 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatotoxicity | 0 | 0.262 | 0 | 0.51 | 2.403 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytogenetic abnormality | 0 | 0.472 | 0.002 | 0.509 | 1.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sleep study abnormal | 0 | 0.488 | 0.002 | 0.509 | 1.947 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor sucking reflex | 0 | 0.426 | 0.001 | 0.509 | 2.043 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicocele | 0 | 0.21 | 0 | 0.509 | 2.564 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair colour changes | 0 | 0.42 | 0.001 | 0.509 | 2.054 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antiacetylcholine receptor antibody positive | 0 | 0.518 | 0.003 | 0.509 | 1.906 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukodystrophy | 0 | 0.367 | 0 | 0.509 | 2.151 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis post immunisation | 0 | 0.342 | 0 | 0.508 | 2.203 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chest scan | 0 | 0.42 | 0.001 | 0.508 | 2.052 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin lesion removal | 0 | 0.472 | 0.002 | 0.508 | 1.969 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amylase increased | 0 | 0.496 | 0.002 | 0.508 | 1.934 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site streaking | 3 | 8.892 | 0.205 | 0.507 | 0.916 | 0.231 | 0.478 | 0.896 | 0.337 | 0.364 | 2.651
COVID19_PFIZER/BIONTECH | Influenza | 21 | 58.546 | 0.342 | 0.507 | 0.699 | 0.273 | 0.386 | 0.534 | 0.359 | 0.144 | 105.575
COVID19_PFIZER/BIONTECH | Asphyxia | 0 | 0.746 | 0.012 | 0.507 | 1.669 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy site unspecified normal | 0 | 0.187 | 0 | 0.507 | 2.639 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Low density lipoprotein increased | 1 | 2.207 | 0.104 | 0.506 | 1.155 | 0.277 | 0.684 | 1.459 | 0.453 | 0.86 | 0.109
COVID19_PFIZER/BIONTECH | Skin irritation | 5 | 12.701 | 0.248 | 0.506 | 0.837 | 0.264 | 0.491 | 0.847 | 0.394 | 0.285 | 8.118
COVID19_PFIZER/BIONTECH | Exposure via skin contact | 6 | 18.249 | 0.23 | 0.506 | 0.869 | 0.229 | 0.411 | 0.69 | 0.329 | 0.37 | 5.683
COVID19_PFIZER/BIONTECH | Endoscopy upper gastrointestinal tract | 0 | 0.438 | 0.001 | 0.505 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lichen planus | 0 | 0.459 | 0.001 | 0.505 | 1.986 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B test negative | 1 | 2.698 | 0.084 | 0.504 | 1.214 | 0.252 | 0.627 | 1.345 | 0.371 | 0.177 | 2.977
COVID19_PFIZER/BIONTECH | Amaurosis fugax | 0 | 0.362 | 0 | 0.504 | 2.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroneuromyography | 0 | 0.428 | 0.001 | 0.504 | 2.034 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cyst | 0 | 1.078 | 0.032 | 0.503 | 1.461 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microbiology test abnormal | 0 | 0.367 | 0 | 0.503 | 2.143 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mite allergy | 0 | 0.409 | 0.001 | 0.502 | 2.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaginal disorder | 0 | 0.262 | 0 | 0.502 | 2.389 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cortisol increased | 0 | 0.525 | 0.003 | 0.501 | 1.89 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Small intestinal intussusception reduction | 0 | 0.223 | 0 | 0.5 | 2.501 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray limb | 6 | 16.584 | 0.27 | 0.499 | 0.784 | 0.249 | 0.446 | 0.747 | 0.362 | 0.378 | 5.409
COVID19_PFIZER/BIONTECH | Vaccination site discharge | 0 | 0.525 | 0.002 | 0.499 | 1.887 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Penile erythema | 0 | 0.204 | 0 | 0.499 | 2.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray limb abnormal | 1 | 5.263 | 0.174 | 0.498 | 0.955 | 0.155 | 0.427 | 0.952 | 0.19 | 0.116 | 5.818
COVID19_PFIZER/BIONTECH | Glomerulonephritis acute | 0 | 0.315 | 0 | 0.498 | 2.248 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site nodule | 21 | 46.289 | 0.341 | 0.497 | 0.676 | 0.34 | 0.481 | 0.665 | 0.454 | 0.283 | 37.06
COVID19_PFIZER/BIONTECH | Herpes simplex test positive | 0 | 0.971 | 0.023 | 0.497 | 1.511 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parotitis | 0 | 0.361 | 0 | 0.497 | 2.147 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corynebacterium test positive | 0 | 0.26 | 0 | 0.497 | 2.387 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Osteolysis | 0 | 0.42 | 0.001 | 0.496 | 2.038 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound skull abnormal | 0 | 0.364 | 0 | 0.496 | 2.141 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adjustment disorder | 0 | 0.472 | 0.001 | 0.496 | 1.956 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatocellular carcinoma | 0 | 0.206 | 0 | 0.496 | 2.547 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound antenatal screen normal | 1 | 28.157 | 0.049 | 0.495 | 1.329 | 0.003 | 0.033 | 0.198 | 0.036 | 0.076 | 10.209
COVID19_PFIZER/BIONTECH | Fibrin degradation products increased | 0 | 0.262 | 0 | 0.495 | 2.376 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site rash | 0 | 1.389 | 0.049 | 0.495 | 1.333 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fear of death | 0 | 1.164 | 0.034 | 0.495 | 1.416 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperbilirubinaemia | 0 | 0.603 | 0.004 | 0.494 | 1.791 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Distractibility | 0 | 0.367 | 0 | 0.494 | 2.131 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray limb normal | 2 | 8.977 | 0.212 | 0.493 | 0.868 | 0.165 | 0.387 | 0.781 | 0.223 | 0.133 | 10.308
COVID19_PFIZER/BIONTECH | Blood fibrinogen normal | 0 | 0.621 | 0.005 | 0.493 | 1.77 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycotic allergy | 0 | 0.42 | 0.001 | 0.493 | 2.035 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy salivary gland normal | 0 | 0.315 | 0 | 0.493 | 2.24 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gluten sensitivity | 0 | 0.711 | 0.008 | 0.493 | 1.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Retinal detachment | 0 | 0.682 | 0.007 | 0.493 | 1.711 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement deficiency disease | 0 | 0.21 | 0 | 0.492 | 2.525 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Culture stool positive | 0 | 0.247 | 0 | 0.491 | 2.411 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug abuse, dependence and withdrawal (SMQ) [broad] | 57 | 138.765 | 0.391 | 0.49 | 0.598 | 0.339 | 0.422 | 0.519 | 0.411 | 0.285 | 101.056
COVID19_PFIZER/BIONTECH | CSF virus no organisms observed | 0 | 0.529 | 0.002 | 0.49 | 1.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papilloma excision | 0 | 0.331 | 0 | 0.49 | 2.2 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glycosuria | 0 | 0.525 | 0.002 | 0.49 | 1.877 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular pain | 0 | 0.435 | 0.001 | 0.49 | 2.005 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ligament pain | 0 | 1.024 | 0.024 | 0.49 | 1.477 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human chorionic gonadotropin normal | 0 | 0.42 | 0.001 | 0.488 | 2.028 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adnexa uteri pain | 0 | 0.288 | 0 | 0.488 | 2.294 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial excision | 0 | 0.43 | 0.001 | 0.488 | 2.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antimicrobial susceptibility test | 0 | 0.525 | 0.002 | 0.488 | 1.875 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychiatric evaluation abnormal | 0 | 0.315 | 0 | 0.488 | 2.232 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site swelling | 0 | 2.214 | 0.092 | 0.487 | 1.138 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium double contrast | 0 | 0.284 | 0 | 0.487 | 2.304 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chemotherapy | 1 | 4.498 | 0.117 | 0.486 | 1.061 | 0.18 | 0.475 | 1.043 | 0.222 | 0.134 | 4.699
COVID19_PFIZER/BIONTECH | Compartment syndrome | 0 | 0.525 | 0.002 | 0.486 | 1.872 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Speech disorder developmental | 0 | 1.031 | 0.023 | 0.486 | 1.469 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile back arching | 0 | 0.416 | 0 | 0.485 | 2.03 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epicondylitis | 0 | 1.308 | 0.04 | 0.485 | 1.351 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Schellong test | 0 | 0.151 | 0 | 0.485 | 2.696 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug abuse and dependence (SMQ) [broad] | 56 | 137.39 | 0.385 | 0.484 | 0.592 | 0.336 | 0.419 | 0.516 | 0.408 | 0.281 | 101.993
COVID19_PFIZER/BIONTECH | Injection site haematoma | 2 | 8.368 | 0.214 | 0.484 | 0.841 | 0.176 | 0.409 | 0.821 | 0.239 | 0.233 | 4.219
COVID19_PFIZER/BIONTECH | Social anxiety disorder | 0 | 0.301 | 0 | 0.483 | 2.255 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colitis microscopic | 0 | 0.525 | 0.002 | 0.482 | 1.868 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Derealisation | 0 | 0.425 | 0 | 0.482 | 2.011 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epilepsy | 2 | 4.531 | 0.118 | 0.481 | 1.044 | 0.277 | 0.614 | 1.212 | 0.441 | 0.051 | 34.617
COVID19_PFIZER/BIONTECH | Biopsy kidney abnormal | 0 | 0.587 | 0.003 | 0.48 | 1.791 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tonsillectomy | 0 | 0.571 | 0.002 | 0.48 | 1.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apoptosis | 0 | 0.26 | 0 | 0.479 | 2.348 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gene mutation identification test negative | 1 | 2.316 | 0.045 | 0.478 | 1.3 | 0.271 | 0.671 | 1.432 | 0.432 | 0.475 | 0.154
COVID19_PFIZER/BIONTECH | Autoimmune hypothyroidism | 0 | 0.262 | 0 | 0.478 | 2.341 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brain stem auditory evoked response normal | 0 | 0.502 | 0.001 | 0.478 | 1.891 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervicectomy | 0 | 0.262 | 0 | 0.478 | 2.342 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tri-iodothyronine normal | 0 | 1.807 | 0.065 | 0.478 | 1.205 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Necrotising colitis | 0 | 0.436 | 0 | 0.478 | 1.988 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Depression suicidal | 0 | 0.24 | 0 | 0.478 | 2.401 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophagocytic lymphohistiocytosis | 0 | 1.231 | 0.033 | 0.478 | 1.374 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Giant cell arteritis | 0 | 0.795 | 0.009 | 0.477 | 1.604 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatomyositis | 0 | 0.414 | 0 | 0.476 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Stem cell transplant | 0 | 0.735 | 0.007 | 0.476 | 1.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Attention deficit hyperactivity disorder | 0 | 0.884 | 0.013 | 0.476 | 1.543 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nonspecific reaction | 0 | 1.012 | 0.019 | 0.475 | 1.468 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bronchiolitis | 0 | 1.252 | 0.033 | 0.475 | 1.362 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medication errors (SMQ) [broad] | 355 | 818.516 | 0.434 | 0.474 | 0.516 | 0.399 | 0.435 | 0.475 | 0.434 | 0.085 | 4507.058
COVID19_PFIZER/BIONTECH | Cystatin C | 0 | 0.367 | 0 | 0.474 | 2.099 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthrogram | 0 | 0.262 | 0 | 0.474 | 2.333 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint range of motion decreased | 32 | 85.148 | 0.347 | 0.473 | 0.615 | 0.296 | 0.394 | 0.517 | 0.376 | 0.424 | 23.928
COVID19_PFIZER/BIONTECH | Renal function test normal | 1 | 3.71 | 0.074 | 0.473 | 1.157 | 0.208 | 0.533 | 1.157 | 0.27 | 0.114 | 5.925
COVID19_PFIZER/BIONTECH | Pyelitis | 0 | 0.42 | 0 | 0.473 | 2.006 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Asthmatic crisis | 0 | 0.385 | 0 | 0.472 | 2.064 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myoglobin blood increased | 0 | 0.501 | 0.001 | 0.472 | 1.885 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheobronchitis | 0 | 0.469 | 0.001 | 0.471 | 1.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound liver abnormal | 0 | 0.472 | 0.001 | 0.471 | 1.924 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Q fever | 0 | 0.31 | 0 | 0.471 | 2.211 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral myocarditis | 0 | 0.525 | 0.001 | 0.471 | 1.854 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antibody positive | 1 | 2.549 | 0.032 | 0.47 | 1.349 | 0.259 | 0.644 | 1.377 | 0.392 | 0.064 | 12.784
COVID19_PFIZER/BIONTECH | Neurosis | 0 | 0.259 | 0 | 0.47 | 2.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Precancerous skin lesion | 0 | 0.24 | 0 | 0.47 | 2.38 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Presbyacusis | 0 | 0.205 | 0 | 0.47 | 2.479 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal hypoxia | 0 | 0.274 | 0 | 0.469 | 2.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood follicle stimulating hormone increased | 0 | 0.326 | 0 | 0.469 | 2.175 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dental caries | 0 | 0.204 | 0 | 0.469 | 2.48 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Opisthotonus | 0 | 1.75 | 0.058 | 0.469 | 1.21 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ammonia | 0 | 0.367 | 0 | 0.468 | 2.09 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs indirect test positive | 0 | 0.262 | 0 | 0.468 | 2.32 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enema administration | 0 | 0.768 | 0.007 | 0.468 | 1.614 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site rash | 76 | 266.535 | 0.384 | 0.467 | 0.556 | 0.242 | 0.292 | 0.35 | 0.285 | 0.271 | 148.176
COVID19_PFIZER/BIONTECH | Injection site hypertrichosis | 0 | 0.21 | 0 | 0.467 | 2.457 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Clinically isolated syndrome | 0 | 0.147 | 0 | 0.467 | 2.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor V level decreased | 0 | 0.155 | 0 | 0.467 | 2.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryotherapy | 0 | 0.484 | 0.001 | 0.467 | 1.902 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF oligoclonal band present | 0 | 0.611 | 0.003 | 0.466 | 1.75 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Excessive ocular convergence | 0 | 0.105 | 0 | 0.466 | 2.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin papilloma | 0 | 0.528 | 0.001 | 0.466 | 1.843 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin warm | 134 | 323.716 | 0.402 | 0.465 | 0.531 | 0.363 | 0.419 | 0.481 | 0.414 | 0.285 | 242.591
COVID19_PFIZER/BIONTECH | Severe cutaneous adverse reactions (SMQ) [narrow] | 9 | 26.542 | 0.277 | 0.465 | 0.692 | 0.241 | 0.398 | 0.625 | 0.339 | 0.228 | 22.488
COVID19_PFIZER/BIONTECH | Secondary transmission | 0 | 0.38 | 0 | 0.465 | 2.063 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Slit-lamp tests abnormal | 0 | 0.479 | 0.001 | 0.465 | 1.905 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix disorder | 0 | 0.23 | 0 | 0.465 | 2.398 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poor quality product administered | 0 | 1.037 | 0.018 | 0.465 | 1.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malabsorption | 0 | 0.491 | 0.001 | 0.464 | 1.887 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pancreatitis chronic | 0 | 0.262 | 0 | 0.463 | 2.307 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tracheostomy | 0 | 0.468 | 0 | 0.463 | 1.918 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Occult blood | 0 | 1.808 | 0.058 | 0.463 | 1.19 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Red blood cells urine positive | 1 | 3.181 | 0.076 | 0.462 | 1.117 | 0.23 | 0.579 | 1.248 | 0.314 | 0.156 | 3.7
COVID19_PFIZER/BIONTECH | Caesarean section | 1 | 23.897 | 0.032 | 0.462 | 1.321 | 0.004 | 0.046 | 0.249 | 0.042 | 0.06 | 13.608
COVID19_PFIZER/BIONTECH | Sensory integrative dysfunction | 0 | 0.354 | 0 | 0.462 | 2.105 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single photon emission computerised tomogram normal | 0 | 0.098 | 0 | 0.462 | 2.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth infection | 0 | 1.821 | 0.057 | 0.461 | 1.186 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mycobacterium tuberculosis complex test negative | 0 | 0.974 | 0.014 | 0.461 | 1.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperaesthesia teeth | 0 | 0.829 | 0.008 | 0.461 | 1.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vesicoureteric reflux | 0 | 0.315 | 0 | 0.461 | 2.181 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD8 lymphocytes | 0 | 0.361 | 0 | 0.46 | 2.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Scarlet fever | 0 | 0.501 | 0.001 | 0.46 | 1.869 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kawasaki's disease | 0 | 1.004 | 0.015 | 0.46 | 1.457 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intestinal anastomosis | 0 | 0.315 | 0 | 0.46 | 2.18 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug reaction with eosinophilia and systemic symptoms | 0 | 1.142 | 0.022 | 0.459 | 1.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Catarrh | 0 | 0.59 | 0.002 | 0.459 | 1.762 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immobilisation syndrome | 0 | 0.207 | 0 | 0.459 | 2.442 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prothrombin time ratio | 0 | 0.303 | 0 | 0.459 | 2.203 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrocardiogram QT interval | 0 | 0.525 | 0.001 | 0.458 | 1.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glucose-6-phosphate dehydrogenase normal | 0 | 0.121 | 0 | 0.458 | 2.656 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis C antibody positive | 0 | 0.315 | 0 | 0.458 | 2.176 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs direct test positive | 0 | 0.525 | 0.001 | 0.458 | 1.836 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injected limb mobility decreased | 71 | 180.702 | 0.372 | 0.457 | 0.548 | 0.33 | 0.402 | 0.484 | 0.393 | 0.291 | 121.292
COVID19_PFIZER/BIONTECH | Scoliosis | 0 | 0.558 | 0.001 | 0.457 | 1.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bursal fluid accumulation | 0 | 1.225 | 0.025 | 0.456 | 1.354 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta haemolytic streptococcal infection | 1 | 4.069 | 0.049 | 0.455 | 1.206 | 0.195 | 0.506 | 1.102 | 0.246 | 0.516 | 0.084
COVID19_PFIZER/BIONTECH | Gastrointestinal infection | 0 | 1.215 | 0.024 | 0.455 | 1.356 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychomotor hyperactivity | 0 | 1.776 | 0.052 | 0.455 | 1.19 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optic ischaemic neuropathy | 0 | 0.943 | 0.012 | 0.455 | 1.485 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cystitis interstitial | 0 | 0.427 | 0 | 0.455 | 1.967 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Activated partial thromboplastin time ratio | 0 | 0.414 | 0 | 0.454 | 1.985 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular purpura | 0 | 0.472 | 0 | 0.454 | 1.898 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tumour marker test | 0 | 0.315 | 0 | 0.453 | 2.166 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product temperature excursion issue | 0 | 0.284 | 0 | 0.453 | 2.231 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningism | 0 | 1.048 | 0.016 | 0.452 | 1.426 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colposcopy abnormal | 0 | 0.136 | 0 | 0.452 | 2.599 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coeliac disease | 0 | 1.001 | 0.014 | 0.452 | 1.45 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Natural killer cell count | 0 | 0.461 | 0 | 0.452 | 1.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral circulatory failure | 0 | 0.262 | 0 | 0.452 | 2.28 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunophenotyping | 0 | 0.481 | 0 | 0.452 | 1.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningoencephalitis herpetic | 0 | 0.525 | 0.001 | 0.451 | 1.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes zoster meningitis | 0 | 0.216 | 0 | 0.451 | 2.396 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vascular endothelial growth factor assay | 0 | 0.098 | 0 | 0.45 | 2.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Emergency care examination | 0 | 0.208 | 0 | 0.45 | 2.413 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cryoglobulins present | 0 | 0.341 | 0 | 0.45 | 2.108 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis enteroviral | 0 | 0.207 | 0 | 0.45 | 2.414 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alopecia | 4 | 11.051 | 0.179 | 0.449 | 0.818 | 0.245 | 0.477 | 0.854 | 0.362 | 0.161 | 16.452
COVID19_PFIZER/BIONTECH | Urine sodium | 0 | 0.367 | 0 | 0.449 | 2.056 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Monoclonal gammopathy | 0 | 0.315 | 0 | 0.449 | 2.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loss of employment | 0 | 0.525 | 0.001 | 0.449 | 1.823 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abnormal weight gain | 0 | 0.322 | 0 | 0.449 | 2.141 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site cellulitis | 10 | 29.721 | 0.263 | 0.448 | 0.673 | 0.241 | 0.39 | 0.602 | 0.336 | 0.134 | 55.047
COVID19_PFIZER/BIONTECH | Corneal oedema | 0 | 1.047 | 0.015 | 0.448 | 1.422 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal heart rate increased | 0 | 0.157 | 0 | 0.448 | 2.534 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint effusion | 0 | 3.009 | 0.1 | 0.448 | 0.999 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Accidental overdose | 1 | 7.652 | 0.071 | 0.447 | 1.092 | 0.086 | 0.312 | 0.744 | 0.131 | 0.502 | 0.106
COVID19_PFIZER/BIONTECH | Optic atrophy | 0 | 0.496 | 0 | 0.447 | 1.855 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytomegalovirus test positive | 0 | 1.197 | 0.021 | 0.447 | 1.355 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory tract infection bacterial | 0 | 0.315 | 0 | 0.447 | 2.152 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Homeopathy | 0 | 0.367 | 0 | 0.447 | 2.052 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasculitis | 0 | 3.84 | 0.125 | 0.446 | 0.928 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gamma-glutamyltransferase increased | 0 | 0.936 | 0.01 | 0.446 | 1.479 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood creatine phosphokinase MB increased | 1 | 3.172 | 0.052 | 0.445 | 1.16 | 0.23 | 0.58 | 1.25 | 0.315 | 0.278 | 1.174
COVID19_PFIZER/BIONTECH | Inflammation | 26 | 67.186 | 0.323 | 0.445 | 0.584 | 0.299 | 0.41 | 0.551 | 0.387 | 0.273 | 48.932
COVID19_PFIZER/BIONTECH | Injection site swelling | 314 | 940.373 | 0.405 | 0.445 | 0.487 | 0.306 | 0.336 | 0.368 | 0.334 | 0.234 | 837.712
COVID19_PFIZER/BIONTECH | Epiglottitis | 0 | 0.469 | 0 | 0.445 | 1.889 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Beta-2 glycoprotein antibody positive | 0 | 0.472 | 0 | 0.445 | 1.885 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperphagia | 0 | 0.609 | 0.001 | 0.444 | 1.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasculitis (SMQ) [broad] | 9 | 22.757 | 0.25 | 0.443 | 0.68 | 0.276 | 0.455 | 0.715 | 0.395 | 0.13 | 51.565
COVID19_PFIZER/BIONTECH | Abortion | 0 | 0.301 | 0 | 0.443 | 2.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Febrile convulsion | 1 | 3.128 | 0.103 | 0.442 | 0.972 | 0.232 | 0.584 | 1.258 | 0.32 | 0.012 | 82.62
COVID19_PFIZER/BIONTECH | Cortical dysplasia | 0 | 0.149 | 0 | 0.442 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin turgor decreased | 0 | 0.42 | 0 | 0.441 | 1.954 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic lymphocytic leukaemia | 0 | 0.525 | 0.001 | 0.441 | 1.81 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Impaired gastric emptying | 0 | 0.496 | 0 | 0.441 | 1.846 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hirsutism | 0 | 0.386 | 0 | 0.44 | 2.006 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acupuncture | 0 | 1.788 | 0.046 | 0.44 | 1.172 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Metabolic alkalosis | 0 | 0.21 | 0 | 0.44 | 2.375 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colectomy | 0 | 0.469 | 0 | 0.44 | 1.88 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Placental disorder | 1 | 5.171 | 0.036 | 0.439 | 1.22 | 0.158 | 0.432 | 0.962 | 0.193 | 0.623 | 0.004
COVID19_PFIZER/BIONTECH | Hepatitis C RNA increased | 0 | 0.315 | 0 | 0.439 | 2.135 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coombs test negative | 0 | 0.525 | 0.001 | 0.439 | 1.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotator cuff syndrome | 0 | 0.989 | 0.011 | 0.438 | 1.44 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phototherapy | 0 | 0.356 | 0 | 0.437 | 2.05 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Otorrhoea | 0 | 1.847 | 0.047 | 0.437 | 1.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningococcal bacteraemia | 0 | 0.243 | 0 | 0.437 | 2.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Irritability postvaccinal | 0 | 0.376 | 0 | 0.437 | 2.017 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral titre decreased | 0 | 0.26 | 0 | 0.436 | 2.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperthermia | 0 | 0.757 | 0.004 | 0.436 | 1.582 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood heavy metal normal | 0 | 1.555 | 0.034 | 0.436 | 1.225 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendonitis | 3 | 9.133 | 0.155 | 0.435 | 0.829 | 0.226 | 0.469 | 0.879 | 0.328 | 0.237 | 6.525
COVID19_PFIZER/BIONTECH | Cell death | 0 | 0.315 | 0 | 0.435 | 2.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Measles antibody | 0 | 0.579 | 0.001 | 0.435 | 1.74 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B core antigen | 0 | 0.118 | 0 | 0.434 | 2.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rheumatoid factor negative | 1 | 4.289 | 0.075 | 0.433 | 1.031 | 0.187 | 0.489 | 1.071 | 0.233 | 0.093 | 7.868
COVID19_PFIZER/BIONTECH | Neutrophilic dermatosis | 0 | 0.243 | 0 | 0.433 | 2.274 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human papilloma virus test negative | 0 | 0.289 | 0 | 0.433 | 2.172 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coagulation factor V level normal | 0 | 0.367 | 0 | 0.432 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterovirus test positive | 0 | 0.825 | 0.005 | 0.432 | 1.529 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Miller Fisher syndrome | 0 | 1.088 | 0.013 | 0.431 | 1.384 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prenatal screening test abnormal | 0 | 0.262 | 0 | 0.431 | 2.225 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastric hypomotility | 0 | 0.204 | 0 | 0.431 | 2.357 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Henoch-Schonlein purpura | 0 | 2.934 | 0.086 | 0.43 | 0.988 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ileostomy | 0 | 0.5 | 0 | 0.43 | 1.824 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fine motor delay | 0 | 0.315 | 0 | 0.43 | 2.113 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | X-ray gastrointestinal tract abnormal | 0 | 0.463 | 0 | 0.43 | 1.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Abdominal infection | 0 | 0.315 | 0 | 0.429 | 2.111 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site induration | 56 | 197.737 | 0.341 | 0.428 | 0.523 | 0.235 | 0.293 | 0.361 | 0.283 | 0.227 | 146.703
COVID19_PFIZER/BIONTECH | Respiratory tract infection viral | 0 | 0.614 | 0.001 | 0.428 | 1.694 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Concomitant disease progression | 0 | 0.414 | 0 | 0.428 | 1.938 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin A increased | 0 | 1.425 | 0.026 | 0.428 | 1.253 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Barium enema normal | 0 | 0.289 | 0 | 0.427 | 2.158 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microscopic polyangiitis | 0 | 0.42 | 0 | 0.426 | 1.925 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Suppressed lactation | 0 | 0.56 | 0.001 | 0.426 | 1.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colour vision tests normal | 0 | 0.292 | 0 | 0.426 | 2.148 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Angiotensin converting enzyme | 1 | 3.948 | 0.047 | 0.425 | 1.12 | 0.199 | 0.515 | 1.12 | 0.253 | 0.42 | 0.299
COVID19_PFIZER/BIONTECH | CD4/CD8 ratio | 0 | 1.793 | 0.04 | 0.425 | 1.155 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site erythema | 345 | 1180.564 | 0.388 | 0.424 | 0.462 | 0.269 | 0.294 | 0.321 | 0.292 | 0.196 | 1243.019
COVID19_PFIZER/BIONTECH | Drug abuse, dependence and withdrawal (SMQ) [narrow] | 0 | 0.712 | 0.002 | 0.424 | 1.602 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Humoral immune defect | 0 | 0.206 | 0 | 0.424 | 2.327 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drowning | 0 | 0.42 | 0 | 0.424 | 1.921 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Local reaction | 13 | 41.192 | 0.268 | 0.423 | 0.607 | 0.232 | 0.357 | 0.529 | 0.316 | 0.107 | 96.38
COVID19_PFIZER/BIONTECH | Documented hypersensitivity to administered product | 0 | 1.462 | 0.026 | 0.423 | 1.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Coxiella test | 0 | 0.416 | 0 | 0.421 | 1.922 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site eczema | 0 | 0.274 | 0 | 0.421 | 2.171 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | FEV1/FVC ratio abnormal | 0 | 0.195 | 0 | 0.42 | 2.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radial nerve palsy | 0 | 0.692 | 0.002 | 0.42 | 1.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Soft tissue mass | 0 | 0.315 | 0 | 0.42 | 2.089 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mast cell activation syndrome | 0 | 0.514 | 0 | 0.42 | 1.789 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Slit-lamp tests normal | 0 | 0.195 | 0 | 0.42 | 2.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy skin normal | 0 | 0.688 | 0.002 | 0.42 | 1.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microsomia | 0 | 0.195 | 0 | 0.42 | 2.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ADAMTS13 activity decreased | 0 | 0.195 | 0 | 0.42 | 2.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubella antibody test | 0 | 0.355 | 0 | 0.419 | 2.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Forced vital capacity decreased | 0 | 0.195 | 0 | 0.419 | 2.336 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Organic brain syndrome | 0 | 0.42 | 0 | 0.419 | 1.912 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mitochondrial cytopathy | 0 | 0.472 | 0 | 0.418 | 1.837 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal variceal ligation | 0 | 0.155 | 0 | 0.418 | 2.408 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oophorectomy | 0 | 0.322 | 0 | 0.417 | 2.067 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chiropractic | 0 | 2.051 | 0.047 | 0.417 | 1.094 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site movement impairment | 2 | 7.766 | 0.134 | 0.416 | 0.826 | 0.188 | 0.433 | 0.865 | 0.258 | 0.206 | 5.237
COVID19_PFIZER/BIONTECH | Vacuum extractor delivery | 0 | 0.315 | 0 | 0.416 | 2.078 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood beryllium | 0 | 0.315 | 0 | 0.415 | 2.076 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple sclerosis | 1 | 4.162 | 0.044 | 0.414 | 1.1 | 0.192 | 0.499 | 1.089 | 0.24 | 0.055 | 15.258
COVID19_PFIZER/BIONTECH | Myelocyte present | 0 | 0.21 | 0 | 0.414 | 2.284 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypometabolism | 0 | 0.386 | 0 | 0.414 | 1.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renin normal | 0 | 0.206 | 0 | 0.413 | 2.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunodeficiency common variable | 0 | 0.42 | 0 | 0.413 | 1.898 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site warmth | 161 | 570.719 | 0.36 | 0.412 | 0.466 | 0.251 | 0.285 | 0.324 | 0.282 | 0.216 | 470.208
COVID19_PFIZER/BIONTECH | Measles antibody positive | 0 | 0.489 | 0 | 0.412 | 1.805 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubella | 0 | 0.238 | 0 | 0.412 | 2.217 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premature delivery | 7 | 24.988 | 0.196 | 0.411 | 0.691 | 0.199 | 0.348 | 0.571 | 0.28 | 0.958 | 0.006
COVID19_PFIZER/BIONTECH | Umbilical hernia | 0 | 0.42 | 0 | 0.411 | 1.895 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Natural killer cell count increased | 0 | 0.364 | 0 | 0.41 | 1.978 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Radioisotope scan normal | 0 | 0.337 | 0 | 0.41 | 2.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bursitis | 7 | 23.974 | 0.202 | 0.408 | 0.674 | 0.207 | 0.361 | 0.592 | 0.292 | 0.261 | 13.681
COVID19_PFIZER/BIONTECH | Skin tumours of unspecified malignancy (SMQ) [broad] | 1 | 6.224 | 0.106 | 0.408 | 0.869 | 0.126 | 0.375 | 0.856 | 0.161 | 0.055 | 15.203
COVID19_PFIZER/BIONTECH | Abdominal mass | 0 | 0.399 | 0 | 0.408 | 1.917 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premalignant disorders, general conditions and other site specific disorders (SMQ) [narrow] | 0 | 0.286 | 0 | 0.408 | 2.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ectopic pregnancy | 0 | 0.42 | 0 | 0.408 | 1.889 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Administration site abscess sterile | 0 | 0.105 | 0 | 0.408 | 2.356 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Premalignant disorders, general conditions and other site specific disorders (SMQ) [broad] | 0 | 0.286 | 0 | 0.408 | 2.11 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral sepsis | 0 | 0.196 | 0 | 0.408 | 2.286 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 1.113 | 0.01 | 0.408 | 1.343 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subacute sclerosing panencephalitis | 0 | 0.315 | 0 | 0.408 | 2.056 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysaesthesia | 1 | 3.149 | 0.047 | 0.407 | 1.061 | 0.231 | 0.582 | 1.254 | 0.318 | 0.241 | 1.638
COVID19_PFIZER/BIONTECH | West Nile virus test positive | 0 | 0.209 | 0 | 0.407 | 2.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dehydroepiandrosterone decreased | 0 | 0.307 | 0 | 0.407 | 2.069 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reflex test abnormal | 0 | 0.367 | 0 | 0.407 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product reconstitution quality issue | 0 | 0.357 | 0 | 0.406 | 1.981 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-platelet antibody positive | 0 | 0.42 | 0 | 0.406 | 1.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intraventricular haemorrhage neonatal | 0 | 0.21 | 0 | 0.406 | 2.254 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site vesicles | 6 | 21.301 | 0.206 | 0.405 | 0.658 | 0.199 | 0.359 | 0.605 | 0.282 | 0.121 | 37.047
COVID19_PFIZER/BIONTECH | Congenital neurological disorder | 0 | 0.156 | 0 | 0.405 | 2.341 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Breech presentation | 0 | 0.389 | 0 | 0.405 | 1.927 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint warmth | 0 | 1.814 | 0.033 | 0.404 | 1.126 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Optical coherence tomography abnormal | 0 | 0.611 | 0.001 | 0.404 | 1.658 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aspergillus infection | 0 | 0.21 | 0 | 0.404 | 2.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vasculitis (SMQ) [narrow] | 6 | 19.09 | 0.203 | 0.403 | 0.66 | 0.22 | 0.395 | 0.665 | 0.314 | 0.105 | 44.546
COVID19_PFIZER/BIONTECH | Lymphadenitis bacterial | 0 | 0.318 | 0 | 0.402 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Nerve conduction studies | 0 | 3.02 | 0.073 | 0.402 | 0.949 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normal pregnancy conditions and outcomes (SMQ) [narrow] | 16 | 55.255 | 0.254 | 0.401 | 0.576 | 0.217 | 0.322 | 0.463 | 0.29 | 0.456 | 9.607
COVID19_PFIZER/BIONTECH | Nitrite urine present | 0 | 2.367 | 0.051 | 0.401 | 1.026 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint range of motion measurement | 0 | 0.939 | 0.005 | 0.401 | 1.419 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infantile vomiting | 0 | 0.385 | 0 | 0.401 | 1.923 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Connective tissue disorder | 0 | 1.034 | 0.007 | 0.4 | 1.369 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prolonged labour | 0 | 0.525 | 0 | 0.4 | 1.741 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine protein/creatinine ratio increased | 0 | 0.341 | 0 | 0.4 | 1.99 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Severe myoclonic epilepsy of infancy | 0 | 0.268 | 0 | 0.4 | 2.118 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood luteinising hormone increased | 0 | 0.386 | 0 | 0.399 | 1.917 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurogenic bladder | 0 | 0.463 | 0 | 0.399 | 1.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood pH normal | 0 | 1.834 | 0.032 | 0.399 | 1.116 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [broad] | 1 | 3.174 | 0.037 | 0.398 | 1.083 | 0.23 | 0.58 | 1.25 | 0.315 | 0.203 | 2.321
COVID19_PFIZER/BIONTECH | Uterine pain | 0 | 0.386 | 0 | 0.398 | 1.914 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.42 | 0 | 0.398 | 1.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.42 | 0 | 0.398 | 1.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Procedural failure | 0 | 0.315 | 0 | 0.398 | 2.029 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anogenital warts | 0 | 0.224 | 0 | 0.397 | 2.19 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic gastritis | 0 | 0.42 | 0 | 0.397 | 1.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Middle insomnia | 2 | 8.487 | 0.15 | 0.396 | 0.736 | 0.174 | 0.405 | 0.813 | 0.236 | 0.063 | 26.881
COVID19_PFIZER/BIONTECH | Dysplasia | 0 | 0.427 | 0 | 0.396 | 1.851 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Psychomotor retardation | 0 | 0.501 | 0 | 0.396 | 1.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site joint swelling | 0 | 0.396 | 0 | 0.395 | 1.894 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Interleukin level increased | 0 | 0.492 | 0 | 0.395 | 1.767 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site urticaria | 27 | 75.816 | 0.284 | 0.394 | 0.518 | 0.277 | 0.378 | 0.505 | 0.356 | 0.314 | 39.251
COVID19_PFIZER/BIONTECH | Vaginal discharge | 0 | 0.989 | 0.005 | 0.393 | 1.381 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Needle issue | 2 | 8.44 | 0.12 | 0.392 | 0.79 | 0.175 | 0.406 | 0.816 | 0.237 | 0.212 | 4.98
COVID19_PFIZER/BIONTECH | Antiphospholipid antibodies | 0 | 2.449 | 0.05 | 0.392 | 1.004 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intelligence test abnormal | 0 | 0.311 | 0 | 0.392 | 2.018 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Brudzinski's sign | 0 | 0.416 | 0 | 0.391 | 1.856 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electroneurography | 0 | 0.384 | 0 | 0.39 | 1.897 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cytomegalovirus infection | 0 | 0.773 | 0.001 | 0.389 | 1.503 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella post vaccine | 0 | 0.397 | 0 | 0.389 | 1.877 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infectious mononucleosis | 0 | 1.191 | 0.009 | 0.389 | 1.287 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ketoacidosis | 0 | 0.544 | 0 | 0.388 | 1.695 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site scar | 0 | 0.437 | 0 | 0.388 | 1.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site infection | 0 | 4.119 | 0.093 | 0.388 | 0.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis | 1 | 1.648 | 0.052 | 0.387 | 0.978 | 0.311 | 0.76 | 1.615 | 0.607 | 0.041 | 21.272
COVID19_PFIZER/BIONTECH | Herpes zoster | 86 | 205.835 | 0.321 | 0.387 | 0.458 | 0.356 | 0.425 | 0.504 | 0.418 | 0.15 | 421.652
COVID19_PFIZER/BIONTECH | Coronary artery aneurysm | 0 | 0.431 | 0 | 0.387 | 1.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central pain syndrome | 0 | 0.259 | 0 | 0.387 | 2.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Double stranded DNA antibody positive | 0 | 0.523 | 0 | 0.387 | 1.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Medication errors (SMQ) [narrow] | 255 | 713.174 | 0.347 | 0.386 | 0.426 | 0.325 | 0.36 | 0.398 | 0.358 | 0.063 | 4516.446
COVID19_PFIZER/BIONTECH | Immunisation | 1 | 3.723 | 0.075 | 0.386 | 0.895 | 0.208 | 0.532 | 1.155 | 0.269 | 0.124 | 5.284
COVID19_PFIZER/BIONTECH | Vogt-Koyanagi-Harada disease | 0 | 0.292 | 0 | 0.386 | 2.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | IgA nephropathy | 0 | 1.366 | 0.013 | 0.385 | 1.219 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis enteroviral | 0 | 0.156 | 0 | 0.385 | 2.239 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arnold-Chiari malformation | 0 | 0.47 | 0 | 0.384 | 1.772 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tandem gait test abnormal | 0 | 0.439 | 0 | 0.384 | 1.808 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic product effect incomplete | 0 | 0.229 | 0 | 0.384 | 2.133 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual evoked potentials normal | 0 | 0.376 | 0 | 0.384 | 1.895 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granuloma | 0 | 0.483 | 0 | 0.383 | 1.753 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cardiac massage | 0 | 0.367 | 0 | 0.383 | 1.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrointestinal hypermotility | 0 | 0.35 | 0 | 0.382 | 1.926 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orchitis | 0 | 0.243 | 0 | 0.382 | 2.103 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Creatinine urine | 0 | 0.198 | 0 | 0.381 | 2.169 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autonomic neuropathy | 0 | 0.324 | 0 | 0.381 | 1.965 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papule | 1 | 5.041 | 0.086 | 0.38 | 0.842 | 0.162 | 0.44 | 0.977 | 0.198 | 0.053 | 15.754
COVID19_PFIZER/BIONTECH | Tonsillitis bacterial | 0 | 0.44 | 0 | 0.38 | 1.799 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Adenocarcinoma of the cervix | 0 | 0.288 | 0 | 0.38 | 2.02 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Astrovirus test positive | 0 | 0.26 | 0 | 0.38 | 2.066 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrophoresis protein normal | 0 | 1.025 | 0.004 | 0.38 | 1.345 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kidney transplant rejection | 0 | 0.439 | 0 | 0.379 | 1.796 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bone erosion | 0 | 0.472 | 0 | 0.379 | 1.756 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Macrophage count | 0 | 0.145 | 0 | 0.379 | 2.21 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ehlers-Danlos syndrome | 0 | 0.325 | 0 | 0.379 | 1.959 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vestibular disorder | 0 | 1.234 | 0.009 | 0.379 | 1.256 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis E antibody negative | 0 | 0.453 | 0 | 0.378 | 1.777 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Normal pregnancy conditions and outcomes (SMQ) [broad] | 16 | 55.296 | 0.239 | 0.377 | 0.541 | 0.217 | 0.322 | 0.463 | 0.289 | 0.445 | 10.293
COVID19_PFIZER/BIONTECH | Body temperature fluctuation | 0 | 1.514 | 0.015 | 0.377 | 1.165 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chlamydial infection | 0 | 0.336 | 0 | 0.377 | 1.934 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infectious pleural effusion | 0 | 0.354 | 0 | 0.377 | 1.909 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Phrenic nerve paralysis | 0 | 0.292 | 0 | 0.377 | 2.003 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis meningococcal | 0 | 0.303 | 0 | 0.375 | 1.98 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood immunoglobulin M decreased | 0 | 1.189 | 0.007 | 0.375 | 1.268 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemoglobinuria | 0 | 0.297 | 0 | 0.374 | 1.987 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver malignant tumours (SMQ) [narrow] | 0 | 0.309 | 0 | 0.374 | 1.968 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypercholesterolaemia | 0 | 0.528 | 0 | 0.374 | 1.683 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver malignant tumours (SMQ) [broad] | 0 | 0.309 | 0 | 0.374 | 1.968 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oligohydramnios | 0 | 0.308 | 0 | 0.373 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy muscle abnormal | 0 | 0.335 | 0 | 0.372 | 1.922 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle tone disorder | 0 | 0.501 | 0 | 0.372 | 1.707 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ophthalmic herpes simplex | 0 | 0.456 | 0 | 0.371 | 1.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Child maltreatment syndrome | 0 | 0.206 | 0 | 0.371 | 2.112 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site reaction | 56 | 166.962 | 0.295 | 0.37 | 0.451 | 0.278 | 0.346 | 0.426 | 0.335 | 0.215 | 159.879
COVID19_PFIZER/BIONTECH | Cellulitis | 25 | 97.552 | 0.261 | 0.37 | 0.494 | 0.2 | 0.276 | 0.373 | 0.256 | 0.12 | 161.56
COVID19_PFIZER/BIONTECH | Soft tissue infection | 0 | 0.569 | 0 | 0.37 | 1.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ulcerative keratitis | 0 | 0.314 | 0 | 0.37 | 1.947 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flavivirus test negative | 0 | 0.481 | 0 | 0.369 | 1.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single umbilical artery | 0 | 0.315 | 0 | 0.369 | 1.94 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pulmonary function test | 0 | 1.624 | 0.017 | 0.369 | 1.125 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Induration | 24 | 73.028 | 0.26 | 0.368 | 0.492 | 0.254 | 0.352 | 0.478 | 0.329 | 0.222 | 64.13
COVID19_PFIZER/BIONTECH | Ophthalmic herpes zoster | 1 | 10.359 | 0.029 | 0.368 | 1.03 | 0.035 | 0.221 | 0.59 | 0.097 | 0.037 | 23.816
COVID19_PFIZER/BIONTECH | Peripheral ischaemia | 0 | 0.525 | 0 | 0.368 | 1.673 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin D deficiency | 0 | 1.062 | 0.004 | 0.366 | 1.306 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubella antibody positive | 0 | 0.412 | 0 | 0.366 | 1.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella zoster virus infection | 0 | 0.635 | 0 | 0.364 | 1.562 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune hepatitis | 0 | 0.779 | 0.001 | 0.364 | 1.456 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Recalled product administered | 0 | 0.304 | 0 | 0.364 | 1.942 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cat scratch disease | 0 | 0.282 | 0 | 0.363 | 1.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumococcal sepsis | 0 | 0.391 | 0 | 0.362 | 1.813 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4 lymphocytes increased | 0 | 0.394 | 0 | 0.362 | 1.811 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infertility | 0 | 0.387 | 0 | 0.362 | 1.82 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngotonsillitis | 0 | 0.525 | 0 | 0.362 | 1.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Respiratory alkalosis | 0 | 0.341 | 0 | 0.361 | 1.877 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital absence of bile ducts | 0 | 0.257 | 0 | 0.361 | 2 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Depressive symptom | 0 | 0.202 | 0 | 0.361 | 2.07 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pelvic inflammatory disease | 0 | 0.284 | 0 | 0.361 | 1.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | ACTH stimulation test abnormal | 0 | 0.256 | 0 | 0.361 | 1.999 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy cervix | 0 | 0.337 | 0 | 0.36 | 1.88 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Genital pain | 0 | 0.493 | 0 | 0.36 | 1.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy skin abnormal | 1 | 6.178 | 0.09 | 0.359 | 0.773 | 0.127 | 0.377 | 0.861 | 0.162 | 0.058 | 14.433
COVID19_PFIZER/BIONTECH | Dermo-hypodermitis | 0 | 0.486 | 0 | 0.359 | 1.692 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver transplant | 0 | 0.525 | 0 | 0.359 | 1.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endoscopy abnormal | 0 | 0.78 | 0.001 | 0.359 | 1.447 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal disorder | 0 | 0.644 | 0 | 0.358 | 1.544 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complement factor decreased | 0 | 0.367 | 0 | 0.357 | 1.831 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyhydramnios | 0 | 0.39 | 0 | 0.357 | 1.802 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product container issue | 0 | 0.424 | 0 | 0.356 | 1.755 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CD4 lymphocytes | 0 | 0.525 | 0 | 0.356 | 1.647 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Laser therapy | 0 | 0.484 | 0 | 0.355 | 1.686 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extraocular muscle disorder | 0 | 0.315 | 0 | 0.355 | 1.895 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma stage 0 | 0 | 0.268 | 0 | 0.354 | 1.958 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Encephalitis brain stem | 0 | 0.262 | 0 | 0.354 | 1.964 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pharyngeal haematoma | 0 | 0.157 | 0 | 0.354 | 2.063 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | B-lymphocyte count decreased | 0 | 0.525 | 0 | 0.354 | 1.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sapovirus test positive | 0 | 0.208 | 0 | 0.353 | 2.029 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hemianaesthesia | 0 | 0.472 | 0 | 0.352 | 1.691 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cortical visual impairment | 0 | 0.21 | 0 | 0.352 | 2.019 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug abuse and dependence (SMQ) [narrow] | 0 | 0.501 | 0 | 0.35 | 1.655 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte morphology abnormal | 0 | 0.648 | 0 | 0.35 | 1.522 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure via eye contact | 0 | 0.878 | 0.001 | 0.35 | 1.371 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Basal cell carcinoma | 0 | 0.457 | 0 | 0.349 | 1.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Kernig's sign | 0 | 0.525 | 0 | 0.349 | 1.63 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Empyema | 0 | 0.216 | 0 | 0.348 | 1.997 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendinopathies and ligament disorders (SMQ) [narrow] | 9 | 34.382 | 0.195 | 0.347 | 0.534 | 0.189 | 0.314 | 0.495 | 0.262 | 0.209 | 25.944
COVID19_PFIZER/BIONTECH | School refusal | 0 | 0.195 | 0 | 0.345 | 2.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site joint movement impairment | 0 | 3.674 | 0.058 | 0.344 | 0.825 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bradycardia neonatal | 0 | 0.295 | 0 | 0.344 | 1.881 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hair growth abnormal | 0 | 0.486 | 0 | 0.343 | 1.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subglottic laryngitis | 0 | 0.305 | 0 | 0.343 | 1.864 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Heat oedema | 0 | 0.322 | 0 | 0.342 | 1.839 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin neoplasms, malignant and unspecified (SMQ) [broad] | 1 | 6.743 | 0.083 | 0.341 | 0.74 | 0.111 | 0.351 | 0.812 | 0.148 | 0.048 | 17.793
COVID19_PFIZER/BIONTECH | Ileectomy | 0 | 0.35 | 0 | 0.34 | 1.798 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antiphospholipid syndrome | 0 | 0.565 | 0 | 0.34 | 1.571 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Antibody test positive | 0 | 1.78 | 0.014 | 0.339 | 1.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin malignant tumours (SMQ) [broad] | 0 | 1.114 | 0.003 | 0.338 | 1.24 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Atonic seizures | 0 | 0.508 | 0 | 0.337 | 1.615 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hyperkinesia | 0 | 0.363 | 0 | 0.336 | 1.771 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic inflammatory demyelinating polyradiculoneuropathy | 0 | 1.57 | 0.009 | 0.336 | 1.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microcephaly | 0 | 0.42 | 0 | 0.335 | 1.701 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-NMDA antibody positive | 0 | 0.525 | 0 | 0.334 | 1.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF glucose | 0 | 0.61 | 0 | 0.334 | 1.517 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin malignant tumours (SMQ) [narrow] | 0 | 0.903 | 0.001 | 0.333 | 1.327 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurodermatitis | 0 | 0.666 | 0 | 0.333 | 1.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Application site erythema | 0 | 0.402 | 0 | 0.333 | 1.715 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Granulomatous dermatitis | 0 | 0.285 | 0 | 0.332 | 1.848 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.443 | 0 | 0.331 | 1.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Akathisia | 0 | 0.359 | 0 | 0.331 | 1.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product use in unapproved indication | 0 | 0.643 | 0 | 0.331 | 1.485 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Akathisia (SMQ) [narrow] | 0 | 0.359 | 0 | 0.331 | 1.757 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Expanded disability status scale score increased | 0 | 0.128 | 0 | 0.33 | 1.871 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bordetella test | 0 | 0.452 | 0 | 0.329 | 1.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy lung abnormal | 0 | 0.529 | 0 | 0.329 | 1.574 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood smear test abnormal | 0 | 2.212 | 0.02 | 0.329 | 0.957 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mean cell haemoglobin concentration increased | 0 | 0.366 | 0 | 0.326 | 1.731 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cataplexy | 0 | 0.405 | 0 | 0.326 | 1.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastrostomy | 0 | 1.561 | 0.007 | 0.326 | 1.08 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incorrect route of product administration | 13 | 48.326 | 0.199 | 0.325 | 0.477 | 0.199 | 0.307 | 0.456 | 0.269 | 0.129 | 75.571
COVID19_PFIZER/BIONTECH | Haemorrhage subcutaneous | 0 | 1.083 | 0.002 | 0.325 | 1.23 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epileptic encephalopathy | 0 | 0.41 | 0 | 0.323 | 1.674 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site cellulitis | 0 | 2.118 | 0.017 | 0.322 | 0.962 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thrombocytopenic purpura | 0 | 0.993 | 0.001 | 0.322 | 1.262 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mumps antibody test positive | 0 | 0.458 | 0 | 0.322 | 1.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apgar score abnormal | 0 | 0.371 | 0 | 0.321 | 1.709 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dengue fever | 0 | 0.21 | 0 | 0.32 | 1.858 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cataract nuclear | 0 | 0.427 | 0 | 0.319 | 1.645 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-ganglioside antibody positive | 0 | 0.415 | 0 | 0.318 | 1.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypertonic bladder | 0 | 0.466 | 0 | 0.318 | 1.602 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood cortisol | 0 | 1.488 | 0.005 | 0.318 | 1.086 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis salmonella | 0 | 0.345 | 0 | 0.317 | 1.722 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Herpes ophthalmic | 0 | 0.75 | 0 | 0.316 | 1.378 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lymphocyte stimulation test positive | 0 | 0.357 | 0 | 0.314 | 1.699 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Seroconversion test negative | 0 | 0.416 | 0 | 0.314 | 1.637 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Endocrine test | 0 | 0.322 | 0 | 0.313 | 1.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Skin test positive | 0 | 1.268 | 0.002 | 0.313 | 1.141 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product expiration date issue | 0 | 0.511 | 0 | 0.313 | 1.547 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site granuloma | 0 | 0.551 | 0 | 0.312 | 1.51 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterovirus infection | 0 | 0.715 | 0 | 0.31 | 1.387 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Inflammatory bowel disease | 0 | 0.63 | 0 | 0.31 | 1.445 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Irregular sleep wake rhythm disorder | 0 | 0.414 | 0 | 0.309 | 1.625 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viral load increased | 0 | 0.402 | 0 | 0.309 | 1.633 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF neutrophil count negative | 0 | 0.41 | 0 | 0.309 | 1.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device connection issue | 1 | 17.844 | 0.045 | 0.308 | 0.767 | 0.007 | 0.086 | 0.354 | 0.056 | 0.401 | 0.365
COVID19_PFIZER/BIONTECH | Salmonella test positive | 0 | 0.445 | 0 | 0.308 | 1.592 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antibody positive | 0 | 0.495 | 0 | 0.308 | 1.546 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute macular outer retinopathy | 0 | 0.238 | 0 | 0.307 | 1.773 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumatosis intestinalis | 0 | 0.367 | 0 | 0.307 | 1.66 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Middle ear inflammation | 0 | 0.553 | 0 | 0.307 | 1.496 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Decreased immune responsiveness | 0 | 1.135 | 0.001 | 0.305 | 1.173 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site granuloma | 0 | 0.315 | 0 | 0.305 | 1.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral venous sinus thrombosis | 0 | 1.558 | 0.005 | 0.304 | 1.045 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sleep attacks | 0 | 0.518 | 0 | 0.302 | 1.51 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Measles | 0 | 0.988 | 0 | 0.301 | 1.224 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enuresis | 0 | 1.736 | 0.007 | 0.301 | 1.001 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound testes abnormal | 0 | 0.286 | 0 | 0.3 | 1.708 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dermatitis atopic | 0 | 1.514 | 0.004 | 0.3 | 1.05 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypomenorrhoea | 0 | 0.415 | 0 | 0.3 | 1.59 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital biliary disorders (SMQ) [narrow] | 0 | 0.27 | 0 | 0.299 | 1.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterobiasis | 0 | 0.22 | 0 | 0.299 | 1.739 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Leukopenia | 0 | 2.249 | 0.014 | 0.299 | 0.91 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Congenital biliary disorders (SMQ) [broad] | 0 | 0.27 | 0 | 0.299 | 1.713 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vitamin B12 deficiency | 0 | 0.764 | 0 | 0.299 | 1.331 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle oedema | 0 | 1.523 | 0.004 | 0.298 | 1.043 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dysmetria | 0 | 0.459 | 0 | 0.298 | 1.545 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual acuity reduced | 0 | 1.659 | 0.005 | 0.297 | 1.011 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Incomplete course of vaccination | 4 | 26.223 | 0.107 | 0.296 | 0.561 | 0.101 | 0.221 | 0.414 | 0.153 | 0.095 | 33.633
COVID19_PFIZER/BIONTECH | Intraocular pressure test normal | 0 | 0.965 | 0 | 0.296 | 1.223 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine chloride | 0 | 0.192 | 0 | 0.296 | 1.721 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophilus infection | 0 | 0.344 | 0 | 0.296 | 1.641 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tilt table test positive | 0 | 0.422 | 0 | 0.295 | 1.566 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash rubelliform | 0 | 0.526 | 0 | 0.293 | 1.475 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy artery normal | 0 | 0.468 | 0 | 0.292 | 1.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-ganglioside antibody negative | 0 | 0.552 | 0 | 0.292 | 1.453 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Visual acuity tests abnormal | 0 | 0.957 | 0 | 0.291 | 1.216 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis A virus test | 0 | 1.635 | 0.004 | 0.291 | 1.006 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site abscess | 0 | 4.206 | 0.042 | 0.29 | 0.723 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Expanded disability status scale score decreased | 0 | 0.168 | 0 | 0.288 | 1.653 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | CSF pressure normal | 0 | 0.42 | 0 | 0.287 | 1.541 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reading disorder | 0 | 1.076 | 0 | 0.286 | 1.158 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubivirus test positive | 0 | 0.31 | 0 | 0.286 | 1.623 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Musculoskeletal pain | 14 | 57.538 | 0.178 | 0.284 | 0.41 | 0.181 | 0.277 | 0.407 | 0.243 | 0.07 | 174.194
COVID19_PFIZER/BIONTECH | Chromosome analysis normal | 0 | 1.468 | 0.002 | 0.284 | 1.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Disseminated varicella zoster vaccine virus infection | 0 | 0.484 | 0 | 0.283 | 1.476 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Acute motor axonal neuropathy | 0 | 0.422 | 0 | 0.283 | 1.525 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site hypertrichosis | 0 | 0.263 | 0 | 0.281 | 1.626 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alcohol intolerance | 0 | 0.378 | 0 | 0.28 | 1.548 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Generalised vaccinia | 0 | 0.152 | 0 | 0.278 | 1.55 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Electrophoresis abnormal | 0 | 0.344 | 0 | 0.278 | 1.563 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Joint injection | 0 | 2.572 | 0.014 | 0.277 | 0.834 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound skull normal | 0 | 0.597 | 0 | 0.276 | 1.373 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia streptococcal | 0 | 0.45 | 0 | 0.275 | 1.471 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Viraemia | 0 | 0.249 | 0 | 0.274 | 1.597 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Morbillivirus test positive | 0 | 0.589 | 0 | 0.273 | 1.37 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian cyst ruptured | 0 | 0.434 | 0 | 0.272 | 1.473 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy brain abnormal | 0 | 0.689 | 0 | 0.271 | 1.304 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-aquaporin-4 antibody positive | 0 | 0.294 | 0 | 0.271 | 1.56 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Therapeutic response decreased | 0 | 0.934 | 0 | 0.27 | 1.18 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periarthritis | 2 | 12.426 | 0.078 | 0.269 | 0.554 | 0.112 | 0.292 | 0.609 | 0.161 | 0.102 | 14.749
COVID19_PFIZER/BIONTECH | Genital haemorrhage | 0 | 0.31 | 0 | 0.269 | 1.543 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemorrhagic diathesis | 0 | 0.46 | 0 | 0.269 | 1.443 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hereditary neuropathy with liability to pressure palsies | 0 | 0.205 | 0 | 0.269 | 1.557 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Immunohistochemistry | 0 | 0.529 | 0 | 0.269 | 1.394 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Loop electrosurgical excision procedure | 0 | 0.256 | 0 | 0.268 | 1.559 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypotonic-hyporesponsive episode (SMQ) [narrow] | 0 | 2.119 | 0.007 | 0.268 | 0.88 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypotonic-hyporesponsive episode | 0 | 2.119 | 0.007 | 0.268 | 0.88 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Transplant rejection | 0 | 0.439 | 0 | 0.267 | 1.451 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemolytic uraemic syndrome | 0 | 0.328 | 0 | 0.264 | 1.512 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arthroscopy | 0 | 1.211 | 0 | 0.264 | 1.065 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rash scarlatiniform | 0 | 0.486 | 0 | 0.264 | 1.407 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Localised infection | 0 | 3.914 | 0.028 | 0.264 | 0.704 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon disorder | 0 | 3.252 | 0.019 | 0.262 | 0.747 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subchorionic haematoma | 0 | 0.42 | 0 | 0.262 | 1.446 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large intestinal obstruction reduction | 0 | 0.378 | 0 | 0.259 | 1.458 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intussusception | 0 | 1.273 | 0.001 | 0.259 | 1.036 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Injection site inflammation | 7 | 40.873 | 0.145 | 0.258 | 0.397 | 0.12 | 0.218 | 0.364 | 0.171 | 0.093 | 61.1
COVID19_PFIZER/BIONTECH | Premature menopause | 0 | 0.323 | 0 | 0.258 | 1.482 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labelled drug-drug interaction medication error | 0 | 0.674 | 0 | 0.257 | 1.271 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Allergy to metals | 0 | 0.675 | 0 | 0.257 | 1.27 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis A virus test positive | 0 | 0.348 | 0 | 0.256 | 1.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy brain | 0 | 0.297 | 0 | 0.256 | 1.484 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Campylobacter infection | 0 | 0.22 | 0 | 0.256 | 1.481 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tendon injury | 0 | 2.601 | 0.01 | 0.255 | 0.797 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product odour abnormal | 0 | 0.205 | 0 | 0.253 | 1.451 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tetanus | 0 | 0.323 | 0 | 0.252 | 1.453 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Drug effective for unapproved indication | 0 | 0.377 | 0 | 0.252 | 1.425 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Enterocolitis haemorrhagic | 0 | 0.494 | 0 | 0.251 | 1.353 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal distress syndrome | 0 | 0.313 | 0 | 0.25 | 1.449 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis A antibody negative | 0 | 0.839 | 0 | 0.25 | 1.171 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product complaint | 0 | 0.655 | 0 | 0.25 | 1.259 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle necrosis | 0 | 0.314 | 0 | 0.25 | 1.446 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Purpura fulminans | 0 | 0.525 | 0 | 0.25 | 1.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Morose | 0 | 0.411 | 0 | 0.248 | 1.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arrested labour | 0 | 0.39 | 0 | 0.247 | 1.399 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infection transmission via personal contact | 0 | 0.313 | 0 | 0.246 | 1.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Subchorionic haemorrhage | 0 | 0.403 | 0 | 0.246 | 1.388 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polymerase chain reaction positive | 1 | 6.517 | 0.033 | 0.242 | 0.61 | 0.117 | 0.361 | 0.831 | 0.153 | 0.017 | 55.298
COVID19_PFIZER/BIONTECH | Occupational exposure to product | 0 | 2.219 | 0.004 | 0.24 | 0.816 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-aquaporin-4 antibody negative | 0 | 0.603 | 0 | 0.24 | 1.254 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lung adenocarcinoma | 0 | 0.43 | 0 | 0.24 | 1.346 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pre-eclampsia | 1 | 7.703 | 0.023 | 0.239 | 0.644 | 0.084 | 0.31 | 0.74 | 0.13 | 0.341 | 0.662
COVID19_PFIZER/BIONTECH | Vitiligo | 0 | 1.26 | 0 | 0.239 | 0.996 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Sopor | 0 | 0.511 | 0 | 0.239 | 1.297 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post viral fatigue syndrome | 0 | 0.84 | 0 | 0.239 | 1.139 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Muscle enzyme | 0 | 0.472 | 0 | 0.237 | 1.311 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Extensive swelling of vaccinated limb | 1 | 7.391 | 0.032 | 0.236 | 0.598 | 0.093 | 0.322 | 0.762 | 0.135 | 0.038 | 23.429
COVID19_PFIZER/BIONTECH | HLA marker study | 0 | 0.44 | 0 | 0.236 | 1.323 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Biopsy cervix abnormal | 0 | 0.288 | 0 | 0.236 | 1.374 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erythema multiforme | 1 | 15.888 | 0.089 | 0.235 | 0.438 | 0.01 | 0.109 | 0.401 | 0.063 | 0.045 | 19.228
COVID19_PFIZER/BIONTECH | Acute hepatitis B | 0 | 0.124 | 0 | 0.235 | 1.094 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotator cuff repair | 0 | 1.32 | 0 | 0.235 | 0.971 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product physical issue | 0 | 0.445 | 0 | 0.235 | 1.314 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yellow fever | 0 | 0.208 | 0 | 0.235 | 1.33 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Epiglottitis haemophilus | 0 | 0.312 | 0 | 0.234 | 1.362 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vulval cancer | 0 | 0.258 | 0 | 0.231 | 1.342 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenitis | 0 | 0.309 | 0 | 0.23 | 1.337 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autism spectrum disorder | 0 | 2.812 | 0.007 | 0.229 | 0.732 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Myofascitis | 0 | 0.546 | 0 | 0.228 | 1.237 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polycystic ovaries | 0 | 0.53 | 0 | 0.228 | 1.246 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product supply issue | 0 | 0.369 | 0 | 0.225 | 1.3 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Blood corticotrophin increased | 0 | 0.256 | 0 | 0.223 | 1.291 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Corynebacterium test negative | 0 | 0.414 | 0 | 0.223 | 1.272 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear cervix | 0 | 1.118 | 0 | 0.222 | 0.994 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hypotonic-hyporesponsive episode (SMQ) [algorithm] | 0 | 3.752 | 0.013 | 0.221 | 0.648 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post herpetic neuralgia | 1 | 13.435 | 0.015 | 0.22 | 0.635 | 0.016 | 0.149 | 0.471 | 0.074 | 0.036 | 25.144
COVID19_PFIZER/BIONTECH | Twin pregnancy | 0 | 0.413 | 0 | 0.22 | 1.261 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination site dryness | 0 | 0.333 | 0 | 0.219 | 1.278 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shoulder dystocia | 0 | 0.453 | 0 | 0.216 | 1.225 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniocentesis normal | 0 | 0.452 | 0 | 0.216 | 1.229 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Parasite stool test positive | 0 | 0.177 | 0 | 0.216 | 1.136 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-glomerular basement membrane antibody negative | 0 | 0.525 | 0 | 0.215 | 1.193 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infective pulmonary exacerbation of cystic fibrosis | 0 | 0.367 | 0 | 0.214 | 1.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urine potassium decreased | 0 | 0.249 | 0 | 0.213 | 1.221 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Exposure to vaccinated person | 0 | 0.631 | 0 | 0.213 | 1.142 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Orthostatic intolerance | 0 | 0.429 | 0 | 0.213 | 1.218 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Total complement activity decreased | 0 | 0.525 | 0 | 0.213 | 1.183 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Collagen disorder | 0 | 0.525 | 0 | 0.213 | 1.185 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyspareunia | 0 | 0.315 | 0 | 0.209 | 1.217 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Paraparesis | 0 | 0.584 | 0 | 0.209 | 1.143 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccine associated paralytic poliomyelitis | 0 | 0.313 | 0 | 0.208 | 1.213 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Community acquired infection | 0 | 0.165 | 0 | 0.206 | 1.024 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis pneumococcal | 0 | 0.601 | 0 | 0.205 | 1.121 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tilt table test normal | 0 | 0.376 | 0 | 0.205 | 1.191 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product closure issue | 0 | 0.132 | 0 | 0.203 | 0.866 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malaria | 0 | 0.472 | 0 | 0.203 | 1.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis bacterial | 0 | 0.835 | 0 | 0.202 | 1.025 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Polyarteritis nodosa | 0 | 0.511 | 0 | 0.202 | 1.14 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Poliomyelitis | 0 | 0.48 | 0 | 0.202 | 1.153 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mumps antibody test negative | 0 | 0.548 | 0 | 0.201 | 1.122 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Multiple use of single-use product | 0 | 0.127 | 0 | 0.2 | 0.818 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neuromyelitis optica spectrum disorder | 0 | 1.127 | 0 | 0.2 | 0.935 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yellow fever vaccine-associated viscerotropic disease | 0 | 0.167 | 0 | 0.2 | 0.984 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Single photon emission computerised tomogram abnormal | 0 | 0.216 | 0 | 0.198 | 1.079 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Device leakage | 0 | 0.452 | 0 | 0.195 | 1.123 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infection susceptibility increased | 0 | 1.236 | 0 | 0.194 | 0.89 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mumps | 0 | 0.534 | 0 | 0.193 | 1.091 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Proteinuria | 0 | 2.657 | 0.002 | 0.193 | 0.68 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rubella antibody negative | 0 | 0.851 | 0 | 0.193 | 0.989 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Thermometry abnormal | 0 | 0.466 | 0 | 0.193 | 1.113 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infection parasitic | 0 | 0.465 | 0 | 0.193 | 1.113 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Salmonella test | 0 | 0.433 | 0 | 0.188 | 1.093 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccination error | 0 | 2.093 | 0.001 | 0.188 | 0.73 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Malaria antibody test negative | 0 | 0.521 | 0 | 0.188 | 1.073 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian failure | 0 | 0.428 | 0 | 0.183 | 1.067 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Labelled drug-food interaction medication error | 0 | 0.209 | 0 | 0.183 | 0.952 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amylase decreased | 0 | 0.494 | 0 | 0.183 | 1.056 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Serology positive | 0 | 0.352 | 0 | 0.183 | 1.064 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Glare | 0 | 0.513 | 0 | 0.183 | 1.047 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Erysipelas | 0 | 1.617 | 0 | 0.182 | 0.783 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Shoulder injury related to vaccine administration | 1 | 13.15 | 0.028 | 0.181 | 0.444 | 0.017 | 0.155 | 0.481 | 0.076 | 0.132 | 4.805
COVID19_PFIZER/BIONTECH | Eclampsia | 0 | 1.02 | 0 | 0.181 | 0.903 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apgar score low | 0 | 0.233 | 0 | 0.181 | 0.97 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Arteriogram abnormal | 0 | 0.305 | 0 | 0.181 | 1.037 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HIV antigen negative | 0 | 0.39 | 0 | 0.18 | 1.049 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B DNA assay | 0 | 0.352 | 0 | 0.18 | 1.044 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antigen | 1 | 7.329 | 0.01 | 0.179 | 0.531 | 0.094 | 0.325 | 0.767 | 0.136 | 0.384 | 0.435
COVID19_PFIZER/BIONTECH | Hepatitis A antibody positive | 0 | 0.881 | 0 | 0.179 | 0.931 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha hydroxybutyrate dehydrogenase | 0 | 0.479 | 0 | 0.178 | 1.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lupus nephritis | 0 | 1.107 | 0 | 0.177 | 0.87 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infertility female | 0 | 0.424 | 0 | 0.177 | 1.033 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apathy | 0 | 3.111 | 0.003 | 0.176 | 0.611 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ovarian disorder | 0 | 0.463 | 0 | 0.176 | 1.021 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Linear IgA disease | 0 | 0.458 | 0 | 0.174 | 1.014 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune encephalopathy | 0 | 0.294 | 0 | 0.173 | 0.978 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningococcal sepsis | 0 | 0.478 | 0 | 0.171 | 0.993 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophilus test positive | 0 | 0.703 | 0 | 0.171 | 0.947 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Dyscalculia | 0 | 0.452 | 0 | 0.171 | 0.998 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Alpha 1 foetoprotein normal | 0 | 0.93 | 0 | 0.169 | 0.884 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic varices haemorrhage | 0 | 0.201 | 0 | 0.168 | 0.809 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prosopagnosia | 0 | 0.294 | 0 | 0.166 | 0.927 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mumps antibody test | 0 | 1.097 | 0 | 0.166 | 0.835 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product distribution issue | 0 | 0.451 | 0 | 0.164 | 0.955 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver infections (SMQ) [narrow] | 1 | 7.57 | 0.013 | 0.163 | 0.455 | 0.088 | 0.315 | 0.75 | 0.132 | 0.02 | 46.564
COVID19_PFIZER/BIONTECH | Gastric variceal ligation | 0 | 0.249 | 0 | 0.161 | 0.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Liver infections (SMQ) [broad] | 1 | 7.652 | 0.014 | 0.16 | 0.443 | 0.086 | 0.312 | 0.744 | 0.131 | 0.02 | 48.343
COVID19_PFIZER/BIONTECH | Neoplasm malignant | 0 | 3.525 | 0.002 | 0.159 | 0.552 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Renal transplant failure | 0 | 0.286 | 0 | 0.156 | 0.844 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Jaundice neonatal | 0 | 0.517 | 0 | 0.156 | 0.907 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Post vaccination autoinoculation | 0 | 0.272 | 0 | 0.154 | 0.818 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic fatigue syndrome | 0 | 1.487 | 0 | 0.149 | 0.712 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Measles post vaccine | 0 | 0.897 | 0 | 0.148 | 0.807 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccine virus shedding | 0 | 0.243 | 0 | 0.148 | 0.728 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatic steatosis | 0 | 2.021 | 0 | 0.148 | 0.643 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Indirect infection transmission | 0 | 0.349 | 0 | 0.147 | 0.826 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis D antibody negative | 0 | 0.389 | 0 | 0.146 | 0.834 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Animal bite | 0 | 0.415 | 0 | 0.144 | 0.829 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Haemophilus sepsis | 0 | 0.416 | 0 | 0.143 | 0.824 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product label confusion | 0 | 3.874 | 0.002 | 0.142 | 0.5 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Intentional product misuse | 0 | 0.358 | 0 | 0.142 | 0.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningitis haemophilus | 0 | 0.338 | 0 | 0.141 | 0.779 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Diphtheria | 0 | 0.36 | 0 | 0.141 | 0.785 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumococcal infection | 0 | 0.528 | 0 | 0.141 | 0.822 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neisseria test positive | 0 | 0.789 | 0 | 0.14 | 0.79 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Tooth discolouration | 0 | 0.364 | 0 | 0.139 | 0.776 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oesophageal varices haemorrhage | 0 | 0.388 | 0 | 0.139 | 0.786 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cerebral hypoperfusion | 0 | 0.562 | 0 | 0.136 | 0.791 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vaccinia virus infection | 0 | 0.247 | 0 | 0.135 | 0.636 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Social problem | 0 | 1.125 | 0 | 0.135 | 0.718 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | H3N2 influenza | 0 | 0.273 | 0 | 0.135 | 0.666 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B core antigen positive | 0 | 0.4 | 0 | 0.134 | 0.753 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Olfactory test abnormal | 0 | 0.398 | 0 | 0.133 | 0.748 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antigen positive | 0 | 0.382 | 0 | 0.133 | 0.738 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotavirus infection | 0 | 1.276 | 0 | 0.132 | 0.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Menstrual disorder | 0 | 0.662 | 0 | 0.131 | 0.758 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Measles antibody negative | 0 | 1.153 | 0 | 0.131 | 0.697 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amenorrhoea | 0 | 1.599 | 0 | 0.13 | 0.638 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Robust take following exposure to vaccinia virus | 0 | 0.757 | 0 | 0.129 | 0.742 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B DNA assay negative | 0 | 0.467 | 0 | 0.128 | 0.737 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Oral administration complication | 0 | 1.295 | 0 | 0.127 | 0.665 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gene sequencing | 0 | 1.126 | 0 | 0.127 | 0.687 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Placenta praevia | 0 | 1.444 | 0 | 0.126 | 0.642 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Somatic symptom disorder | 0 | 1.135 | 0 | 0.124 | 0.672 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Periodic acid Schiff stain | 0 | 0.45 | 0 | 0.124 | 0.706 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Urea urine | 0 | 0.448 | 0 | 0.122 | 0.689 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Colposcopy | 0 | 0.448 | 0 | 0.122 | 0.69 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical conisation | 0 | 0.442 | 0 | 0.121 | 0.682 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Judgement impaired | 0 | 0.46 | 0 | 0.118 | 0.667 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | No adverse event | 43 | 232.894 | 0.089 | 0.117 | 0.148 | 0.15 | 0.193 | 0.245 | 0.185 | 0.014 | 3648.08
COVID19_PFIZER/BIONTECH | Electrophoresis | 0 | 0.463 | 0 | 0.116 | 0.652 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Plethysmography | 0 | 0.36 | 0 | 0.116 | 0.601 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Lyssavirus test positive | 0 | 0.116 | 0 | 0.116 | 0.15 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis A | 0 | 0.491 | 0 | 0.115 | 0.65 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal disorder | 0 | 2.404 | 0 | 0.114 | 0.516 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pericardial disease | 0 | 0.248 | 0 | 0.114 | 0.468 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Typhoid fever | 0 | 0.567 | 0 | 0.114 | 0.662 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Smear cervix abnormal | 0 | 0.496 | 0 | 0.11 | 0.62 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Yellow fever vaccine-associated neurotropic disease | 0 | 0.412 | 0 | 0.105 | 0.551 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis norovirus | 0 | 0.802 | 0 | 0.105 | 0.609 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Autoimmune demyelinating disease | 0 | 0.365 | 0 | 0.103 | 0.509 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antibody | 0 | 0.517 | 0 | 0.101 | 0.561 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antigen negative | 0 | 0.633 | 0 | 0.1 | 0.574 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Mucosal hyperaemia | 0 | 0.426 | 0 | 0.099 | 0.511 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B core antibody | 0 | 0.292 | 0 | 0.099 | 0.405 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neonatal seizure | 0 | 0.483 | 0 | 0.097 | 0.519 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prophylaxis | 0 | 2.659 | 0 | 0.096 | 0.446 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervix carcinoma | 0 | 0.531 | 0 | 0.095 | 0.526 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neurone-specific enolase decreased | 0 | 0.455 | 0 | 0.095 | 0.494 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Fever neonatal | 0 | 0.404 | 0 | 0.095 | 0.472 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Microagglutination test | 0 | 0.451 | 0 | 0.094 | 0.487 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Amniotic cavity infection | 0 | 1.286 | 0 | 0.091 | 0.513 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Anti-myelin-associated glycoprotein antibodies positive | 0 | 0.522 | 0 | 0.09 | 0.484 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Splenic artery embolisation | 0 | 0.426 | 0 | 0.09 | 0.441 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antibody | 0 | 0.282 | 0 | 0.086 | 0.292 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [narrow] | 0 | 2.232 | 0 | 0.085 | 0.434 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal non-stress test normal | 0 | 1.114 | 0 | 0.084 | 0.485 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Large for dates baby | 0 | 0.533 | 0 | 0.084 | 0.439 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumococcal bacteraemia | 0 | 0.454 | 0 | 0.084 | 0.413 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Norovirus test positive | 0 | 0.703 | 0 | 0.081 | 0.454 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pneumonia pneumococcal | 0 | 0.639 | 0 | 0.08 | 0.438 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.802 | 0 | 0.08 | 0.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B virus test positive | 0 | 0.681 | 0 | 0.08 | 0.447 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Uterine and fallopian tube malignant tumours (SMQ) [narrow] | 0 | 0.802 | 0 | 0.08 | 0.463 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gestational hypertension | 0 | 2.011 | 0 | 0.079 | 0.424 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Low birth weight baby | 0 | 0.801 | 0 | 0.079 | 0.453 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Human papilloma virus test positive | 0 | 1.293 | 0 | 0.075 | 0.436 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gestational diabetes | 0 | 3.317 | 0 | 0.074 | 0.351 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HBV-DNA polymerase increased | 0 | 0.396 | 0 | 0.074 | 0.304 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Apgar score normal | 0 | 2.169 | 0 | 0.073 | 0.389 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Ultrasound antenatal screen | 0 | 4.649 | 0 | 0.073 | 0.312 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Varicella | 0 | 4.811 | 0 | 0.071 | 0.303 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bacterial vaginosis | 0 | 1.626 | 0 | 0.068 | 0.39 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antigen positive | 0 | 0.468 | 0 | 0.065 | 0.268 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antibody positive | 0 | 0.413 | 0 | 0.063 | 0.226 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Papilloma viral infection | 0 | 1.021 | 0 | 0.063 | 0.362 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Infection via vaccinee | 0 | 0.655 | 0 | 0.062 | 0.311 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Prenatal screening test | 0 | 2.4 | 0 | 0.061 | 0.335 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Chronic hepatitis B | 0 | 0.506 | 0 | 0.059 | 0.244 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B DNA increased | 0 | 0.537 | 0 | 0.057 | 0.24 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Wrong product administered | 3 | 65.737 | 0.019 | 0.056 | 0.109 | 0.014 | 0.045 | 0.123 | 0.046 | 0.014 | 204.761
COVID19_PFIZER/BIONTECH | Therapy non-responder | 0 | 2.013 | 0 | 0.056 | 0.321 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Foetal growth restriction | 0 | 1.857 | 0 | 0.053 | 0.307 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antigen | 0 | 0.637 | 0 | 0.052 | 0.226 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rotavirus test positive | 0 | 2.859 | 0 | 0.052 | 0.283 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Flavivirus test positive | 0 | 0.413 | 0 | 0.051 | 0.139 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Bordetella test positive | 0 | 1.899 | 0 | 0.051 | 0.298 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive premalignant disorders (SMQ) [broad] | 0 | 1.127 | 0 | 0.045 | 0.243 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Cervical dysplasia | 0 | 1.047 | 0 | 0.045 | 0.235 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Reproductive premalignant disorders (SMQ) [narrow] | 0 | 1.127 | 0 | 0.045 | 0.243 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B e antibody negative | 0 | 0.816 | 0 | 0.044 | 0.202 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Gastroenteritis rotavirus | 0 | 3.315 | 0 | 0.044 | 0.243 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B core antibody positive | 0 | 1.609 | 0 | 0.041 | 0.234 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product administered to patient of inappropriate age | 2 | 75.477 | 0.009 | 0.04 | 0.087 | 0.005 | 0.022 | 0.072 | 0.026 | 0.006 | 329.235
COVID19_PFIZER/BIONTECH | Orthopoxvirus test positive | 0 | 0.362 | 0 | 0.039 | 0.045 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antibody negative | 0 | 2.416 | 0 | 0.037 | 0.216 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B antibody negative | 0 | 2.332 | 0 | 0.036 | 0.209 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Pertussis | 0 | 3.871 | 0 | 0.036 | 0.201 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Expired product administered | 0 | 23.29 | 0.001 | 0.036 | 0.114 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Aerophobia | 0 | 0.415 | 0 | 0.034 | 0.041 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Platelet-derived growth factor receptor assay | 0 | 0.823 | 0 | 0.032 | 0.115 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Meningococcal infection | 0 | 1.305 | 0 | 0.031 | 0.156 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Complication of pregnancy | 0 | 2.823 | 0 | 0.031 | 0.179 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Neutralising antibodies | 0 | 0.363 | 0 | 0.028 | 0.01 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B surface antigen positive | 0 | 1.893 | 0 | 0.025 | 0.135 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Toxoplasma serology | 0 | 3.364 | 0 | 0.019 | 0.106 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | HIV antibody | 0 | 2.107 | 0 | 0.019 | 0.096 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hydrophobia | 0 | 0.464 | 0 | 0.017 | 0.002 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Rabies | 0 | 1.032 | 0 | 0.015 | 0.019 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Vertical infection transmission | 0 | 1.645 | 0 | 0.014 | 0.042 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B DNA assay positive | 0 | 2.396 | 0 | 0.014 | 0.06 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Hepatitis B | 0 | 3.755 | 0 | 0.014 | 0.076 |  |  |  |  |  | 
COVID19_PFIZER/BIONTECH | Product storage error | 1 | 108.291 | 0.001 | 0.009 | 0.024 | 0.001 | 0.005 | 0.029 | 0.009 | 0 | 2674.767
COVID19_UNKNOWN MFR | Treponema test | 1 | 0.008 | 0.41 | 4.829 | 13.367 | 0.466 | 1.199 | 2.799 | 133.255 | 234.235 | 56.433
COVID19_UNKNOWN MFR | Chronic obstructive pulmonary disease | 1 | 0.04 | 0.374 | 4.157 | 11.387 | 0.461 | 1.16 | 2.605 | 24.874 | 58.853 | 13.667
COVID19_UNKNOWN MFR | Influenza virus test negative | 2 | 0.091 | 0.779 | 2.974 | 6.321 | 0.642 | 1.668 | 10.075 | 22.039 | 15.956 | 15.12
COVID19_UNKNOWN MFR | Fungal test | 1 | 0.005 | 0.348 | 2.808 | 7.233 | 0.467 | 1.202 | 2.823 | 199.93 | 433.769 | 103.598
COVID19_UNKNOWN MFR | COVID-19 (SMQ) [narrow] | 2 | 1.505 | 0.606 | 2.637 | 5.834 | 0.449 | 0.984 | 1.936 | 1.329 | 12.772 | 11.574
COVID19_UNKNOWN MFR | COVID-19 | 1 | 0.85 | 0.203 | 2.569 | 7.198 | 0.371 | 0.901 | 1.912 | 1.176 | 12.473 | 2.202
COVID19_UNKNOWN MFR | HIV test | 1 | 0.008 | 0.343 | 2.392 | 5.969 | 0.466 | 1.197 | 2.789 | 118.033 | 254.603 | 61.32
COVID19_UNKNOWN MFR | Nucleic acid test | 1 | 0.004 | 0.347 | 2.323 | 5.746 | 0.467 | 1.204 | 2.832 | 244.015 | 2927.94 | 584.697
COVID19_UNKNOWN MFR | Polymerase chain reaction | 1 | 0.048 | 0.324 | 2.291 | 5.734 | 0.459 | 1.153 | 2.575 | 20.767 | 7.766 | 1.074
COVID19_UNKNOWN MFR | Rash pustular | 1 | 0.009 | 0.345 | 2.28 | 5.622 | 0.466 | 1.197 | 2.789 | 117.23 | 34.753 | 7.7
COVID19_UNKNOWN MFR | SARS-CoV-2 test positive | 1 | 1.127 | 0.208 | 2.268 | 6.192 | 0.348 | 0.847 | 1.796 | 0.887 | 8.618 | 1.274
COVID19_UNKNOWN MFR | Taste and smell disorders (SMQ) [narrow] | 3 | 0.323 | 0.892 | 2.259 | 4.132 | 0.773 | 1.779 | 6.857 | 9.295 | 26.618 | 50.647
COVID19_UNKNOWN MFR | Taste and smell disorders (SMQ) [broad] | 3 | 0.323 | 0.892 | 2.259 | 4.132 | 0.773 | 1.779 | 6.857 | 9.295 | 26.618 | 50.647
COVID19_UNKNOWN MFR | Arthralgia | 6 | 1.118 | 1.144 | 2.191 | 3.512 | 1.099 | 2.125 | 5.219 | 5.367 | 7.072 | 26.257
COVID19_UNKNOWN MFR | Dysgeusia | 3 | 0.13 | 0.883 | 2.178 | 3.939 | 0.884 | 3.221 | 21.155 | 23.093 | 46.722 | 92.237
COVID19_UNKNOWN MFR | Fatal outcome (Custom Term) | 6 | 2.37 | 1.015 | 2.159 | 3.649 | 0.85 | 1.518 | 2.566 | 2.532 | 16.251 | 72.122
COVID19_UNKNOWN MFR | Conjunctival haemorrhage | 1 | 0.007 | 0.349 | 2.127 | 5.147 | 0.466 | 1.199 | 2.804 | 142.709 | 308.204 | 74.1
COVID19_UNKNOWN MFR | COVID-19 (SMQ) [broad] | 5 | 2.473 | 1.012 | 2.124 | 3.567 | 0.717 | 1.323 | 2.288 | 2.022 | 16.458 | 58.491
COVID19_UNKNOWN MFR | Chlamydia test | 1 | 0.001 | 0.352 | 2.056 | 4.92 | 0.467 | 1.208 | 2.86 | 681.552 | 780.784 | 182.037
COVID19_UNKNOWN MFR | Death | 5 | 2.006 | 0.9 | 2.055 | 3.593 | 0.777 | 1.437 | 2.499 | 2.492 | 15.431 | 54.354
COVID19_UNKNOWN MFR | Psoriatic arthropathy | 1 | 0.007 | 0.35 | 2.035 | 4.864 | 0.466 | 1.2 | 2.806 | 148.617 | 354.902 | 85.142
COVID19_UNKNOWN MFR | Interstitial lung disease (SMQ) [narrow] | 2 | 0.207 | 0.647 | 2.007 | 3.975 | 0.611 | 1.419 | 3.27 | 9.683 | 46.292 | 48.998
COVID19_UNKNOWN MFR | Pneumonia | 2 | 0.427 | 0.607 | 2.003 | 4.054 | 0.573 | 1.273 | 2.583 | 4.687 | 10.73 | 9.308
COVID19_UNKNOWN MFR | Interstitial lung disease (SMQ) [broad] | 2 | 0.229 | 0.64 | 1.993 | 3.955 | 0.606 | 1.396 | 3.092 | 8.731 | 36.657 | 38.244
COVID19_UNKNOWN MFR | Pneumonia aspiration | 1 | 0.043 | 0.353 | 1.924 | 4.527 | 0.46 | 1.158 | 2.595 | 23.338 | 212.941 | 51.307
COVID19_UNKNOWN MFR | Infective pneumonia (SMQ) [broad] | 6 | 2.788 | 0.914 | 1.897 | 3.169 | 0.794 | 1.415 | 2.38 | 2.152 | 6.303 | 22.454
COVID19_UNKNOWN MFR | Infective pneumonia (SMQ) [narrow] | 2 | 0.557 | 0.566 | 1.896 | 3.858 | 0.554 | 1.223 | 2.447 | 3.588 | 8.773 | 7.148
COVID19_UNKNOWN MFR | Myalgia | 5 | 1.51 | 0.917 | 1.859 | 3.067 | 0.854 | 1.592 | 2.819 | 3.31 | 4.567 | 11.001
COVID19_UNKNOWN MFR | Cough | 3 | 0.776 | 0.724 | 1.85 | 3.395 | 0.678 | 1.401 | 2.688 | 3.868 | 5.475 | 7.085
COVID19_UNKNOWN MFR | Neutrophil count increased | 1 | 0.024 | 0.359 | 1.821 | 4.204 | 0.464 | 1.177 | 2.684 | 42.406 | 36.259 | 8.074
COVID19_UNKNOWN MFR | Influenza A virus test negative | 1 | 0.029 | 0.355 | 1.819 | 4.212 | 0.462 | 1.171 | 2.656 | 34.628 | 48.597 | 11.129
COVID19_UNKNOWN MFR | Subdural haemorrhage | 1 | 0.005 | 0.366 | 1.803 | 4.131 | 0.467 | 1.202 | 2.822 | 194.99 | 975.98 | 224.274
COVID19_UNKNOWN MFR | Arthritis | 1 | 0.029 | 0.358 | 1.793 | 4.126 | 0.462 | 1.172 | 2.656 | 34.772 | 21.102 | 4.321
COVID19_UNKNOWN MFR | Influenza B virus test | 1 | 0.033 | 0.357 | 1.776 | 4.079 | 0.462 | 1.167 | 2.636 | 30.224 | 45.928 | 10.469
COVID19_UNKNOWN MFR | Autopsy | 1 | 0.045 | 0.359 | 1.768 | 4.05 | 0.46 | 1.156 | 2.588 | 22.459 | 35.276 | 7.83
COVID19_UNKNOWN MFR | Lung opacity | 2 | 0.095 | 0.643 | 1.766 | 3.337 | 0.64 | 1.651 | 9.603 | 21.11 | 360.362 | 390.455
COVID19_UNKNOWN MFR | Guttate psoriasis | 1 | 0.001 | 0.372 | 1.755 | 3.973 | 0.468 | 1.21 | 2.869 | 1389.17 | 1951.96 | 417.358
COVID19_UNKNOWN MFR | Chills | 7 | 2.733 | 0.967 | 1.75 | 2.721 | 0.918 | 1.59 | 2.623 | 2.561 | 3.878 | 13.017
COVID19_UNKNOWN MFR | Bacterial test | 1 | 0.004 | 0.373 | 1.731 | 3.903 | 0.467 | 1.204 | 2.832 | 242.91 | 121.997 | 29.207
COVID19_UNKNOWN MFR | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [narrow] | 2 | 0.522 | 0.556 | 1.687 | 3.314 | 0.559 | 1.235 | 2.479 | 3.831 | 20.784 | 20.509
COVID19_UNKNOWN MFR | Pulmonary hypertension (SMQ) [broad] | 6 | 1.76 | 0.926 | 1.655 | 2.557 | 0.95 | 1.713 | 2.968 | 3.41 | 8.14 | 31.556
COVID19_UNKNOWN MFR | Injection site pain | 5 | 1.85 | 0.822 | 1.655 | 2.722 | 0.799 | 1.481 | 2.584 | 2.703 | 1.908 | 1.481
COVID19_UNKNOWN MFR | Arthritis (SMQ) [broad] | 7 | 1.77 | 0.985 | 1.652 | 2.458 | 1.09 | 1.935 | 3.437 | 3.955 | 4.25 | 15.156
COVID19_UNKNOWN MFR | Acute central respiratory depression (SMQ) [broad] | 6 | 2.383 | 0.879 | 1.647 | 2.609 | 0.849 | 1.515 | 2.559 | 2.518 | 5.555 | 18.777
COVID19_UNKNOWN MFR | Injection site swelling | 3 | 1.02 | 0.696 | 1.627 | 2.874 | 0.641 | 1.314 | 2.481 | 2.942 | 1.431 | 0.084
COVID19_UNKNOWN MFR | Pulmonary embolism | 1 | 0.138 | 0.352 | 1.624 | 3.653 | 0.446 | 1.098 | 2.385 | 7.267 | 65.796 | 15.383
COVID19_UNKNOWN MFR | SARS-CoV-2 test negative | 3 | 0.643 | 0.745 | 1.59 | 2.692 | 0.701 | 1.461 | 2.866 | 4.663 | 30.263 | 58.194
COVID19_UNKNOWN MFR | Headache | 7 | 3.588 | 0.861 | 1.588 | 2.495 | 0.808 | 1.396 | 2.284 | 1.951 | 2.821 | 7.116
COVID19_UNKNOWN MFR | Rhabdomyolysis/myopathy (SMQ) [broad] | 6 | 2.363 | 0.87 | 1.585 | 2.473 | 0.852 | 1.52 | 2.569 | 2.54 | 3.253 | 7.733
COVID19_UNKNOWN MFR | Brain natriuretic peptide normal | 1 | 0.018 | 0.39 | 1.581 | 3.422 | 0.464 | 1.184 | 2.718 | 55.528 | 260.261 | 62.674
COVID19_UNKNOWN MFR | Dyspnoea | 5 | 1.52 | 0.844 | 1.567 | 2.471 | 0.852 | 1.588 | 2.811 | 3.289 | 7.137 | 21.102
COVID19_UNKNOWN MFR | Blood culture negative | 1 | 0.093 | 0.37 | 1.566 | 3.436 | 0.453 | 1.122 | 2.459 | 10.787 | 16.9 | 3.286
COVID19_UNKNOWN MFR | Resuscitation | 2 | 0.216 | 0.623 | 1.564 | 2.85 | 0.609 | 1.409 | 3.184 | 9.255 | 55.77 | 59.565
COVID19_UNKNOWN MFR | Loss of consciousness | 2 | 0.369 | 0.595 | 1.56 | 2.895 | 0.582 | 1.301 | 2.666 | 5.418 | 4.767 | 2.822
COVID19_UNKNOWN MFR | Arthritis (SMQ) [narrow] | 1 | 0.163 | 0.344 | 1.56 | 3.493 | 0.443 | 1.087 | 2.351 | 6.13 | 6.389 | 0.757
COVID19_UNKNOWN MFR | Painful respiration | 1 | 0.034 | 0.388 | 1.553 | 3.35 | 0.462 | 1.166 | 2.633 | 29.681 | 73.198 | 17.211
COVID19_UNKNOWN MFR | Liver-related coagulation and bleeding disturbances (SMQ) [narrow] | 1 | 0.063 | 0.382 | 1.551 | 3.359 | 0.457 | 1.141 | 2.528 | 15.797 | 55.244 | 12.775
COVID19_UNKNOWN MFR | Liver-related coagulation and bleeding disturbances (SMQ) [broad] | 1 | 0.063 | 0.382 | 1.551 | 3.359 | 0.457 | 1.141 | 2.528 | 15.797 | 55.244 | 12.775
COVID19_UNKNOWN MFR | Prothrombin time prolonged | 1 | 0.026 | 0.393 | 1.547 | 3.319 | 0.463 | 1.174 | 2.669 | 38.11 | 128.701 | 30.847
COVID19_UNKNOWN MFR | Tremor | 3 | 0.451 | 0.739 | 1.529 | 2.55 | 0.739 | 1.594 | 3.591 | 6.654 | 7.11 | 10.378
COVID19_UNKNOWN MFR | Hepatic disorders (SMQ) [narrow] | 1 | 0.377 | 0.292 | 1.528 | 3.555 | 0.418 | 1.016 | 2.166 | 2.653 | 4.636 | 0.377
COVID19_UNKNOWN MFR | Cardiac arrest | 2 | 0.257 | 0.621 | 1.517 | 2.732 | 0.601 | 1.371 | 2.948 | 7.768 | 70.13 | 75.544
COVID19_UNKNOWN MFR | Blister | 1 | 0.136 | 0.37 | 1.517 | 3.296 | 0.447 | 1.099 | 2.387 | 7.358 | 3.851 | 0.224
COVID19_UNKNOWN MFR | Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (SMQ) [broad] | 2 | 0.808 | 0.494 | 1.515 | 2.988 | 0.522 | 1.145 | 2.268 | 2.475 | 12.137 | 10.868
COVID19_UNKNOWN MFR | Hypoaesthesia | 2 | 0.648 | 0.523 | 1.503 | 2.892 | 0.542 | 1.193 | 2.374 | 3.087 | 3.886 | 1.919
COVID19_UNKNOWN MFR | Tachypnoea | 1 | 0.038 | 0.397 | 1.499 | 3.174 | 0.461 | 1.163 | 2.616 | 26.582 | 57.131 | 13.241
COVID19_UNKNOWN MFR | Respiratory failure (SMQ) [broad] | 3 | 1.217 | 0.632 | 1.492 | 2.648 | 0.615 | 1.256 | 2.357 | 2.465 | 7.431 | 11.032
COVID19_UNKNOWN MFR | Torsade de pointes/QT prolongation (SMQ) [broad] | 3 | 1.137 | 0.647 | 1.49 | 2.614 | 0.625 | 1.279 | 2.405 | 2.639 | 3.23 | 2.744
COVID19_UNKNOWN MFR | Pyrexia | 8 | 3.874 | 0.904 | 1.482 | 2.176 | 0.878 | 1.477 | 2.367 | 2.065 | 2.157 | 4.443
COVID19_UNKNOWN MFR | Hypoglycaemia (SMQ) [broad] | 8 | 3.946 | 0.879 | 1.481 | 2.212 | 0.869 | 1.462 | 2.344 | 2.027 | 2.299 | 5.28
COVID19_UNKNOWN MFR | International normalised ratio increased | 1 | 0.044 | 0.404 | 1.479 | 3.1 | 0.46 | 1.157 | 2.59 | 22.711 | 92.95 | 22.078
COVID19_UNKNOWN MFR | Hepatic disorders (SMQ) [broad] | 1 | 0.407 | 0.299 | 1.475 | 3.38 | 0.414 | 1.007 | 2.146 | 2.457 | 4.246 | 0.299
COVID19_UNKNOWN MFR | Asthma/bronchospasm (SMQ) [broad] | 2 | 0.517 | 0.565 | 1.473 | 2.727 | 0.559 | 1.237 | 2.483 | 3.866 | 7.741 | 6.016
COVID19_UNKNOWN MFR | Cardiac arrhythmia terms, nonspecific (SMQ) [narrow] | 1 | 0.163 | 0.366 | 1.47 | 3.174 | 0.443 | 1.087 | 2.351 | 6.142 | 24.605 | 5.187
COVID19_UNKNOWN MFR | Cardiac arrhythmia terms, nonspecific (SMQ) [broad] | 1 | 0.163 | 0.366 | 1.47 | 3.174 | 0.443 | 1.087 | 2.351 | 6.142 | 24.605 | 5.187
COVID19_UNKNOWN MFR | Pain | 7 | 2.783 | 0.883 | 1.465 | 2.166 | 0.911 | 1.577 | 2.599 | 2.516 | 2.636 | 6.124
COVID19_UNKNOWN MFR | Conjunctival disorders (SMQ) [broad] | 1 | 0.079 | 0.395 | 1.459 | 3.068 | 0.455 | 1.13 | 2.489 | 12.652 | 15.27 | 2.885
COVID19_UNKNOWN MFR | Conjunctival disorders (SMQ) [narrow] | 1 | 0.079 | 0.395 | 1.459 | 3.068 | 0.455 | 1.13 | 2.489 | 12.652 | 15.27 | 2.885
COVID19_UNKNOWN MFR | Vomiting | 4 | 1.277 | 0.763 | 1.457 | 2.331 | 0.749 | 1.455 | 2.647 | 3.132 | 3.719 | 5.672
COVID19_UNKNOWN MFR | Pulseless electrical activity | 1 | 0.051 | 0.401 | 1.456 | 3.044 | 0.459 | 1.151 | 2.565 | 19.578 | 334.622 | 80.357
COVID19_UNKNOWN MFR | Cardiomyopathy (SMQ) [broad] | 7 | 3.421 | 0.835 | 1.455 | 2.216 | 0.828 | 1.429 | 2.342 | 2.046 | 3.925 | 13.287
COVID19_UNKNOWN MFR | Cellulitis | 1 | 0.182 | 0.372 | 1.451 | 3.105 | 0.441 | 1.08 | 2.33 | 5.506 | 3.087 | 0.097
COVID19_UNKNOWN MFR | Extrapyramidal syndrome (SMQ) [broad] | 5 | 1.951 | 0.789 | 1.446 | 2.264 | 0.784 | 1.453 | 2.528 | 2.563 | 2.47 | 3.254
COVID19_UNKNOWN MFR | Shock (SMQ) [narrow] | 2 | 0.82 | 0.511 | 1.442 | 2.757 | 0.52 | 1.142 | 2.261 | 2.439 | 8.708 | 7.076
COVID19_UNKNOWN MFR | Lymphocyte count normal | 1 | 0.025 | 0.416 | 1.439 | 2.96 | 0.463 | 1.176 | 2.678 | 40.551 | 70.98 | 16.663
COVID19_UNKNOWN MFR | Paraesthesia | 2 | 0.734 | 0.51 | 1.429 | 2.724 | 0.531 | 1.166 | 2.315 | 2.725 | 3.552 | 1.59
COVID19_UNKNOWN MFR | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [algorithm] | 1 | 0.131 | 0.385 | 1.425 | 2.998 | 0.448 | 1.102 | 2.395 | 7.645 | 8.76 | 1.308
COVID19_UNKNOWN MFR | Viral test | 1 | 0.019 | 0.427 | 1.406 | 2.845 | 0.464 | 1.183 | 2.714 | 53.887 | 85.487 | 20.24
COVID19_UNKNOWN MFR | Troponin normal | 1 | 0.054 | 0.421 | 1.4 | 2.843 | 0.458 | 1.148 | 2.556 | 18.564 | 74.597 | 17.556
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [narrow] | 7 | 3.809 | 0.813 | 1.393 | 2.098 | 0.784 | 1.353 | 2.214 | 1.838 | 2.29 | 4.336
COVID19_UNKNOWN MFR | Peripheral neuropathy (SMQ) [broad] | 4 | 2.072 | 0.657 | 1.381 | 2.319 | 0.643 | 1.24 | 2.219 | 1.931 | 2.187 | 1.63
COVID19_UNKNOWN MFR | Platelet count normal | 1 | 0.086 | 0.416 | 1.377 | 2.791 | 0.454 | 1.126 | 2.473 | 11.664 | 16.449 | 3.175
COVID19_UNKNOWN MFR | Nasal congestion | 1 | 0.134 | 0.408 | 1.377 | 2.81 | 0.447 | 1.1 | 2.39 | 7.476 | 11.516 | 1.969
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [narrow] | 7 | 3.867 | 0.806 | 1.377 | 2.072 | 0.778 | 1.343 | 2.196 | 1.81 | 2.265 | 4.208
COVID19_UNKNOWN MFR | White blood cell count increased | 1 | 0.24 | 0.366 | 1.373 | 2.902 | 0.434 | 1.058 | 2.272 | 4.16 | 6.758 | 0.841
COVID19_UNKNOWN MFR | Subarachnoid haemorrhage | 1 | 0.014 | 0.44 | 1.369 | 2.715 | 0.465 | 1.189 | 2.744 | 70.292 | 532.353 | 126.334
COVID19_UNKNOWN MFR | White blood cell count normal | 1 | 0.112 | 0.412 | 1.361 | 2.758 | 0.45 | 1.111 | 2.423 | 8.893 | 12.393 | 2.182
COVID19_UNKNOWN MFR | Endotracheal intubation | 1 | 0.166 | 0.399 | 1.359 | 2.783 | 0.443 | 1.086 | 2.347 | 6.024 | 23.756 | 4.977
COVID19_UNKNOWN MFR | Activated partial thromboplastin time shortened | 1 | 0.014 | 0.443 | 1.358 | 2.676 | 0.465 | 1.189 | 2.743 | 69.696 | 229.642 | 55.329
COVID19_UNKNOWN MFR | Parkinson-like events (SMQ) [broad] | 4 | 1.468 | 0.733 | 1.353 | 2.126 | 0.72 | 1.395 | 2.518 | 2.724 | 2.658 | 2.789
COVID19_UNKNOWN MFR | Noninfectious encephalopathy/delirium (SMQ) [broad] | 6 | 3.437 | 0.747 | 1.344 | 2.084 | 0.721 | 1.283 | 2.15 | 1.746 | 1.923 | 2.034
COVID19_UNKNOWN MFR | Shock (SMQ) [broad] | 2 | 1.097 | 0.461 | 1.341 | 2.593 | 0.489 | 1.072 | 2.112 | 1.824 | 6.791 | 4.982
COVID19_UNKNOWN MFR | Extravasation events (injections, infusions and implants) (SMQ) [broad] | 6 | 3.563 | 0.723 | 1.339 | 2.108 | 0.708 | 1.26 | 2.111 | 1.684 | 1.007 | 0.044
COVID19_UNKNOWN MFR | Gait inability | 1 | 0.154 | 0.413 | 1.338 | 2.69 | 0.444 | 1.091 | 2.362 | 6.482 | 8.933 | 1.349
COVID19_UNKNOWN MFR | Condition aggravated | 2 | 0.591 | 0.575 | 1.329 | 2.334 | 0.549 | 1.211 | 2.418 | 3.381 | 7.748 | 6.024
COVID19_UNKNOWN MFR | Drug related hepatic disorders - comprehensive search (SMQ) [narrow] | 1 | 0.315 | 0.368 | 1.308 | 2.717 | 0.425 | 1.034 | 2.21 | 3.174 | 6.7 | 0.828
COVID19_UNKNOWN MFR | Respiratory viral panel | 1 | 0.039 | 0.458 | 1.303 | 2.496 | 0.461 | 1.161 | 2.61 | 25.673 | 84.868 | 20.088
COVID19_UNKNOWN MFR | Embolic and thrombotic events, venous (SMQ) [narrow] | 1 | 0.2 | 0.416 | 1.301 | 2.585 | 0.438 | 1.072 | 2.31 | 4.997 | 33.084 | 7.287
COVID19_UNKNOWN MFR | Embolic and thrombotic events, venous (SMQ) [broad] | 1 | 0.2 | 0.416 | 1.301 | 2.585 | 0.438 | 1.072 | 2.31 | 4.997 | 33.084 | 7.287
COVID19_UNKNOWN MFR | Chest X-ray abnormal | 1 | 0.238 | 0.399 | 1.3 | 2.62 | 0.434 | 1.059 | 2.274 | 4.209 | 17.073 | 3.328
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific symptoms and therapeutic procedures (SMQ) [broad] | 7 | 4.437 | 0.763 | 1.3 | 1.951 | 0.723 | 1.247 | 2.037 | 1.578 | 2.081 | 3.306
COVID19_UNKNOWN MFR | Electrocardiogram normal | 1 | 0.185 | 0.413 | 1.295 | 2.574 | 0.44 | 1.078 | 2.326 | 5.391 | 9.31 | 1.439
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific inflammation and dysfunctional conditions (SMQ) [broad] | 7 | 4.516 | 0.759 | 1.289 | 1.932 | 0.716 | 1.235 | 2.017 | 1.55 | 2.056 | 3.186
COVID19_UNKNOWN MFR | Drug related hepatic disorders - comprehensive search (SMQ) [broad] | 1 | 0.341 | 0.371 | 1.285 | 2.646 | 0.422 | 1.026 | 2.192 | 2.936 | 6.087 | 0.689
COVID19_UNKNOWN MFR | Hypotension | 1 | 0.264 | 0.392 | 1.284 | 2.593 | 0.431 | 1.05 | 2.251 | 3.786 | 9.801 | 1.556
COVID19_UNKNOWN MFR | Haemorrhagic central nervous system vascular conditions (SMQ) [narrow] | 1 | 0.401 | 0.347 | 1.284 | 2.7 | 0.415 | 1.009 | 2.15 | 2.491 | 14.844 | 2.781
COVID19_UNKNOWN MFR | Haemorrhagic central nervous system vascular conditions (SMQ) [broad] | 1 | 0.401 | 0.347 | 1.284 | 2.7 | 0.415 | 1.009 | 2.15 | 2.491 | 14.844 | 2.781
COVID19_UNKNOWN MFR | Hypoxia | 1 | 0.211 | 0.431 | 1.283 | 2.501 | 0.437 | 1.068 | 2.299 | 4.74 | 50.921 | 11.705
COVID19_UNKNOWN MFR | Dystonia (SMQ) [broad] | 2 | 0.788 | 0.553 | 1.274 | 2.237 | 0.524 | 1.151 | 2.28 | 2.538 | 2.399 | 0.549
COVID19_UNKNOWN MFR | Computerised tomogram head abnormal | 1 | 0.075 | 0.459 | 1.27 | 2.407 | 0.455 | 1.133 | 2.497 | 13.277 | 56.853 | 13.173
COVID19_UNKNOWN MFR | Oropharyngeal pain | 1 | 0.321 | 0.41 | 1.26 | 2.486 | 0.424 | 1.032 | 2.206 | 3.12 | 3.788 | 0.213
COVID19_UNKNOWN MFR | Immune-mediated/autoimmune disorders (SMQ) [narrow] | 1 | 0.564 | 0.295 | 1.258 | 2.767 | 0.398 | 0.966 | 2.053 | 1.774 | 1.807 | 0.005
COVID19_UNKNOWN MFR | Rash erythematous | 2 | 0.305 | 0.638 | 1.257 | 2.045 | 0.592 | 1.337 | 2.795 | 6.555 | 4.596 | 2.645
COVID19_UNKNOWN MFR | Muscular weakness | 1 | 0.376 | 0.365 | 1.256 | 2.582 | 0.418 | 1.016 | 2.167 | 2.66 | 2.873 | 0.067
COVID19_UNKNOWN MFR | Pustule | 1 | 0.015 | 0.49 | 1.249 | 2.292 | 0.465 | 1.189 | 2.742 | 68.801 | 167.311 | 40.26
COVID19_UNKNOWN MFR | Haemodynamic oedema, effusions and fluid overload (SMQ) [narrow] | 4 | 2.337 | 0.65 | 1.238 | 1.978 | 0.614 | 1.184 | 2.116 | 1.712 | 0.979 | 0.049
COVID19_UNKNOWN MFR | Haemodynamic oedema, effusions and fluid overload (SMQ) [broad] | 4 | 2.337 | 0.65 | 1.238 | 1.978 | 0.614 | 1.184 | 2.116 | 1.712 | 0.979 | 0.049
COVID19_UNKNOWN MFR | Tendinopathies and ligament disorders (SMQ) [broad] | 6 | 3.829 | 0.703 | 1.237 | 1.892 | 0.683 | 1.215 | 2.034 | 1.567 | 1.596 | 0.926
COVID19_UNKNOWN MFR | Injection site mass | 1 | 0.1 | 0.471 | 1.236 | 2.295 | 0.452 | 1.118 | 2.446 | 10.039 | 5.868 | 0.641
COVID19_UNKNOWN MFR | Aspiration | 1 | 0.021 | 0.497 | 1.234 | 2.238 | 0.464 | 1.181 | 2.702 | 48.622 | 185.901 | 44.771
COVID19_UNKNOWN MFR | Haemorrhage laboratory terms (SMQ) [broad] | 1 | 0.365 | 0.39 | 1.232 | 2.457 | 0.419 | 1.019 | 2.175 | 2.743 | 8.066 | 1.144
COVID19_UNKNOWN MFR | Wheezing | 1 | 0.149 | 0.461 | 1.23 | 2.298 | 0.445 | 1.093 | 2.37 | 6.727 | 9.086 | 1.385
COVID19_UNKNOWN MFR | Intensive care | 1 | 0.268 | 0.432 | 1.227 | 2.353 | 0.43 | 1.049 | 2.248 | 3.73 | 10.036 | 1.612
COVID19_UNKNOWN MFR | Severe cutaneous adverse reactions (SMQ) [broad] | 1 | 0.321 | 0.422 | 1.222 | 2.359 | 0.424 | 1.032 | 2.206 | 3.118 | 2.331 | 0.012
COVID19_UNKNOWN MFR | Metabolic function test normal | 1 | 0.09 | 0.498 | 1.203 | 2.156 | 0.453 | 1.123 | 2.464 | 11.081 | 16.851 | 3.274
COVID19_UNKNOWN MFR | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [narrow] | 1 | 0.518 | 0.336 | 1.203 | 2.502 | 0.403 | 0.978 | 2.079 | 1.93 | 8.248 | 1.187
COVID19_UNKNOWN MFR | Cardiac arrhythmia terms (incl bradyarrhythmias and tachyarrhythmias) (SMQ) [broad] | 1 | 0.518 | 0.336 | 1.203 | 2.504 | 0.403 | 0.978 | 2.079 | 1.93 | 8.242 | 1.186
COVID19_UNKNOWN MFR | Cardiac arrhythmias (SMQ) [narrow] | 1 | 0.527 | 0.331 | 1.203 | 2.516 | 0.402 | 0.976 | 2.074 | 1.899 | 8.173 | 1.169
COVID19_UNKNOWN MFR | Rash | 3 | 1.331 | 0.665 | 1.198 | 1.857 | 0.6 | 1.226 | 2.296 | 2.255 | 1.779 | 0.417
COVID19_UNKNOWN MFR | Guillain-Barre syndrome (SMQ) [broad] | 6 | 4.545 | 0.649 | 1.197 | 1.882 | 0.623 | 1.108 | 1.853 | 1.32 | 1.98 | 2.246
COVID19_UNKNOWN MFR | Lumbar puncture | 1 | 0.049 | 0.514 | 1.196 | 2.109 | 0.459 | 1.152 | 2.571 | 20.21 | 18.444 | 3.666
COVID19_UNKNOWN MFR | Confusional state | 1 | 0.29 | 0.445 | 1.192 | 2.232 | 0.428 | 1.042 | 2.23 | 3.449 | 9.193 | 1.411
COVID19_UNKNOWN MFR | Hypokalaemia (SMQ) [broad] | 1 | 0.513 | 0.358 | 1.187 | 2.406 | 0.403 | 0.979 | 2.082 | 1.951 | 4.996 | 0.452
COVID19_UNKNOWN MFR | Central nervous system vascular disorders (SMQ) [narrow] | 1 | 0.63 | 0.3 | 1.186 | 2.549 | 0.391 | 0.95 | 2.018 | 1.588 | 7.866 | 1.097
COVID19_UNKNOWN MFR | Anaphylactic reaction (SMQ) [algorithm] | 2 | 1.024 | 0.544 | 1.184 | 2.023 | 0.497 | 1.089 | 2.149 | 1.954 | 3.155 | 1.209
COVID19_UNKNOWN MFR | Back pain | 1 | 0.351 | 0.436 | 1.176 | 2.208 | 0.42 | 1.023 | 2.184 | 2.847 | 3.162 | 0.108
COVID19_UNKNOWN MFR | Unresponsive to stimuli | 1 | 0.401 | 0.42 | 1.173 | 2.233 | 0.415 | 1.009 | 2.15 | 2.493 | 6.078 | 0.687
COVID19_UNKNOWN MFR | Lymphadenopathy | 1 | 0.45 | 0.392 | 1.171 | 2.286 | 0.41 | 0.995 | 2.119 | 2.221 | 3.873 | 0.228
COVID19_UNKNOWN MFR | Blood pressure increased | 1 | 0.321 | 0.496 | 1.161 | 2.053 | 0.424 | 1.032 | 2.206 | 3.114 | 8.396 | 1.222
COVID19_UNKNOWN MFR | Noninfectious meningitis (SMQ) [broad] | 4 | 2.974 | 0.596 | 1.16 | 1.877 | 0.554 | 1.069 | 1.906 | 1.345 | 1.527 | 0.325
COVID19_UNKNOWN MFR | Insomnia | 1 | 0.216 | 0.499 | 1.158 | 2.04 | 0.436 | 1.066 | 2.294 | 4.62 | 3.363 | 0.139
COVID19_UNKNOWN MFR | Hyperhidrosis | 2 | 0.509 | 0.651 | 1.157 | 1.782 | 0.561 | 1.24 | 2.491 | 3.93 | 4.81 | 2.867
COVID19_UNKNOWN MFR | Hyperglycaemia/new onset diabetes mellitus (SMQ) [broad] | 2 | 1.331 | 0.492 | 1.152 | 2.037 | 0.465 | 1.02 | 2.006 | 1.503 | 2.09 | 0.318
COVID19_UNKNOWN MFR | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [narrow] | 1 | 0.626 | 0.339 | 1.152 | 2.356 | 0.392 | 0.951 | 2.02 | 1.597 | 8.23 | 1.183
COVID19_UNKNOWN MFR | Hypertension (SMQ) [narrow] | 1 | 0.575 | 0.433 | 1.149 | 2.143 | 0.397 | 0.963 | 2.047 | 1.738 | 4.726 | 0.396
COVID19_UNKNOWN MFR | Haemorrhage terms (excl laboratory terms) (SMQ) [broad] | 2 | 1.002 | 0.583 | 1.141 | 1.85 | 0.499 | 1.094 | 2.16 | 1.995 | 2.365 | 0.521
COVID19_UNKNOWN MFR | Haemorrhage terms (excl laboratory terms) (SMQ) [narrow] | 2 | 1.002 | 0.583 | 1.141 | 1.85 | 0.499 | 1.094 | 2.16 | 1.995 | 2.365 | 0.521
COVID19_UNKNOWN MFR | Haemorrhages (SMQ) [narrow] | 2 | 1.006 | 0.582 | 1.141 | 1.851 | 0.499 | 1.094 | 2.158 | 1.989 | 2.36 | 0.517
COVID19_UNKNOWN MFR | Cold sweat | 1 | 0.112 | 0.548 | 1.138 | 1.9 | 0.45 | 1.111 | 2.424 | 8.95 | 9.072 | 1.382
COVID19_UNKNOWN MFR | Body temperature increased | 1 | 0.334 | 0.491 | 1.132 | 1.987 | 0.422 | 1.028 | 2.196 | 2.992 | 3.437 | 0.152
COVID19_UNKNOWN MFR | Chest discomfort | 1 | 0.449 | 0.449 | 1.128 | 2.056 | 0.41 | 0.996 | 2.12 | 2.228 | 5.11 | 0.476
COVID19_UNKNOWN MFR | Decreased appetite | 1 | 0.446 | 0.449 | 1.127 | 2.054 | 0.41 | 0.996 | 2.122 | 2.243 | 2.44 | 0.02
COVID19_UNKNOWN MFR | Arrhythmia related investigations, signs and symptoms (SMQ) [broad] | 3 | 2.336 | 0.52 | 1.127 | 1.922 | 0.498 | 1.015 | 1.889 | 1.284 | 2.052 | 0.776
COVID19_UNKNOWN MFR | Hypertension (SMQ) [broad] | 1 | 0.63 | 0.448 | 1.121 | 2.041 | 0.391 | 0.95 | 2.018 | 1.586 | 4.395 | 0.329
COVID19_UNKNOWN MFR | Nausea | 3 | 2.235 | 0.552 | 1.12 | 1.848 | 0.507 | 1.033 | 1.922 | 1.342 | 1.882 | 0.545
COVID19_UNKNOWN MFR | Neck pain | 1 | 0.303 | 0.519 | 1.116 | 1.895 | 0.426 | 1.037 | 2.219 | 3.298 | 3.156 | 0.107
COVID19_UNKNOWN MFR | Haemorrhages (SMQ) [broad] | 2 | 1.218 | 0.566 | 1.111 | 1.805 | 0.476 | 1.044 | 2.056 | 1.641 | 2.174 | 0.378
COVID19_UNKNOWN MFR | Peripheral swelling | 1 | 0.535 | 0.456 | 1.109 | 1.993 | 0.401 | 0.973 | 2.069 | 1.87 | 0.978 | 0.232
COVID19_UNKNOWN MFR | Noninfectious encephalitis (SMQ) [broad] | 4 | 3.456 | 0.557 | 1.105 | 1.804 | 0.516 | 0.995 | 1.774 | 1.157 | 1.357 | 0.115
COVID19_UNKNOWN MFR | Central nervous system vascular disorders (SMQ) [broad] | 1 | 0.879 | 0.262 | 1.091 | 2.384 | 0.368 | 0.895 | 1.899 | 1.137 | 2.921 | 0.073
COVID19_UNKNOWN MFR | Central nervous system haemorrhages and cerebrovascular conditions (SMQ) [broad] | 1 | 0.876 | 0.269 | 1.088 | 2.353 | 0.369 | 0.896 | 1.901 | 1.142 | 2.971 | 0.08
COVID19_UNKNOWN MFR | Cardiac arrhythmias (SMQ) [broad] | 3 | 2.584 | 0.494 | 1.083 | 1.858 | 0.478 | 0.974 | 1.813 | 1.161 | 1.971 | 0.663
COVID19_UNKNOWN MFR | Musculoskeletal stiffness | 1 | 0.226 | 0.595 | 1.081 | 1.684 | 0.435 | 1.063 | 2.285 | 4.418 | 3.479 | 0.159
COVID19_UNKNOWN MFR | Rash macular | 1 | 0.141 | 0.629 | 1.074 | 1.615 | 0.446 | 1.097 | 2.379 | 7.073 | 6.031 | 0.677
COVID19_UNKNOWN MFR | Diarrhoea | 1 | 0.884 | 0.38 | 1.072 | 2.049 | 0.368 | 0.894 | 1.897 | 1.131 | 1.424 | 0.06
COVID19_UNKNOWN MFR | Noninfectious diarrhoea (SMQ) [narrow] | 1 | 0.919 | 0.377 | 1.068 | 2.043 | 0.365 | 0.887 | 1.881 | 1.088 | 1.373 | 0.073
COVID19_UNKNOWN MFR | Feeling abnormal | 1 | 0.634 | 0.534 | 1.057 | 1.723 | 0.391 | 0.949 | 2.016 | 1.578 | 2.523 | 0.027
COVID19_UNKNOWN MFR | Pseudomembranous colitis (SMQ) [broad] | 1 | 0.955 | 0.375 | 1.053 | 2.008 | 0.362 | 0.88 | 1.866 | 1.047 | 1.356 | 0.078
COVID19_UNKNOWN MFR | Accidents and injuries (SMQ) [broad] | 1 | 0.759 | 0.447 | 1.05 | 1.859 | 0.379 | 0.921 | 1.954 | 1.318 | 1.638 | 0.02
COVID19_UNKNOWN MFR | Noninfectious diarrhoea (SMQ) [broad] | 1 | 1.003 | 0.353 | 1.048 | 2.043 | 0.358 | 0.87 | 1.846 | 0.997 | 1.224 | 0.127
COVID19_UNKNOWN MFR | Dementia (SMQ) [broad] | 2 | 1.897 | 0.431 | 1.041 | 1.867 | 0.417 | 0.913 | 1.795 | 1.054 | 1.391 | 0.003
COVID19_UNKNOWN MFR | Cardiac failure (SMQ) [broad] | 1 | 0.959 | 0.457 | 1.016 | 1.755 | 0.362 | 0.879 | 1.864 | 1.043 | 0.85 | 0.093
COVID19_UNKNOWN MFR | Hypersensitivity (SMQ) [narrow] | 4 | 4.027 | 0.62 | 1.015 | 1.49 | 0.478 | 0.921 | 1.641 | 0.993 | 0.83 | 0.025
COVID19_UNKNOWN MFR | Retroperitoneal fibrosis (SMQ) [broad] | 1 | 1.032 | 0.365 | 1.015 | 1.929 | 0.356 | 0.865 | 1.834 | 0.969 | 1.483 | 0.046
COVID19_UNKNOWN MFR | Embolic and thrombotic events (SMQ) [narrow] | 1 | 1.077 | 0.235 | 1.015 | 2.242 | 0.352 | 0.856 | 1.816 | 0.929 | 3.724 | 0.201
COVID19_UNKNOWN MFR | Embolic and thrombotic events (SMQ) [broad] | 1 | 1.077 | 0.235 | 1.015 | 2.242 | 0.352 | 0.856 | 1.816 | 0.929 | 3.724 | 0.201
COVID19_UNKNOWN MFR | Angioedema (SMQ) [broad] | 3 | 2.988 | 0.647 | 1.005 | 1.427 | 0.449 | 0.914 | 1.701 | 1.004 | 0.856 | 0
COVID19_UNKNOWN MFR | Retrograde ejaculation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trisomy 13 | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bickerstaff's encephalitis | 0 | 0 | 0.08 | 1 | 2.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney fibrosis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal hypoplasia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macroglossia | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptorchism | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone graft | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inhibin B | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conduction disorder | 0 | 0 | 0.11 | 1 | 2.638 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria pressure | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital erosion | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective mutism | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimal disorder | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal erosion | 0 | 0 | 0.027 | 1 | 3.244 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerumen removal | 0 | 0 | 0.116 | 1 | 2.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythroblast count normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HTLV-1 test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Early onset familial Alzheimer's disease | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovectomy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononucleosis heterophile test | 0 | 0 | 0.318 | 1 | 1.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic fluid index | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial disease carrier | 0 | 0 | 0.083 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolar rhabdomyosarcoma | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic pouch procedure | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheo-oesophageal fistula | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ballismus | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aerophagia | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute haemorrhagic conjunctivitis | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site pain | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug ineffective for unapproved indication | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Euthyroid sick syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocution | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic dilatation | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal disorder | 0 | 0.001 | 0.208 | 1 | 2.274 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue sarcoma | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radical prostatectomy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Warm type haemolytic anaemia | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic cancer | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-IA2 antibody positive | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyphaema | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrist surgery | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy prostate | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell vacuolisation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration bone marrow | 0 | 0.001 | 0.168 | 1 | 2.405 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal leukoplakia | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-lymphocyte count increased | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath holding | 0 | 0.001 | 0.17 | 1 | 2.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue haemorrhage | 0 | 0.001 | 0.093 | 1 | 2.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis haemorrhagic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical diathermy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proctitis haemorrhagic | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptococcosis | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic oesophagitis | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvar dysplasia | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral keratouveitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cautery to nose | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan bone marrow | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyponatriuria | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal X-ray normal | 0 | 0.001 | 0.252 | 1 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal perforation | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cyst | 0 | 0 | 0.01 | 1 | 3.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocochleogram | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord operation | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dandy-Walker syndrome | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic tonsillitis | 0 | 0 | 0.007 | 1 | 3.682 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ethanol normal | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulosclerosis | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcitonin increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Von Willebrand's disease | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prenatal care | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulnar neuritis | 0 | 0 | 0.091 | 1 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth extraction | 0 | 0 | 0.135 | 1 | 2.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardio-respiratory arrest neonatal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperdynamic left ventricle | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant neoplasm of unknown primary site | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling of relaxation | 0 | 0 | 0.099 | 1 | 2.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lasegue's test positive | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum retention | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal flattening | 0 | 0 | 0.033 | 1 | 3.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Naevus flammeus | 0 | 0 | 0.077 | 1 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site odour | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic varicella syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Winged scapula | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal anuria | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised onset non-motor seizure | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis cryptococcal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterograde amnesia | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intravascular haemolysis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Removal of foreign body from nose | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Migraine prophylaxis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin E | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | H2N2 influenza | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adductor vocal cord weakness | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIIth nerve injury | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Caecum operation | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte count decreased | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin C increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Recurrent cancer | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precursor T-lymphoblastic lymphoma/leukaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral pustule | 0 | 0.001 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy foetal abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatobiliary sphincterotomy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic haemorrhage | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Femur fracture | 0 | 0.001 | 0.127 | 1 | 2.561 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising enterocolitis neonatal | 0 | 0 | 0.01 | 1 | 3.574 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orchidopexy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pigmentation lip | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular enlargement | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic ketoacidotic hyperglycaemic coma | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system neoplasm | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calculus urinary | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromosomal analysis | 0 | 0 | 0.097 | 1 | 2.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antigliadin antibody positive | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polymorphic light eruption | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Elephantiasis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis normal | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous stenosis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin degradation products | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal pathogen panel | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital central nervous system anomaly | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurofibroma | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal ischaemia | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine leiomyoma embolisation | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palpatory finding abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral calcification | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal blistering | 0 | 0 | 0.037 | 1 | 3.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryoglobulins | 0 | 0 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sarcoma | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Strongyloidiasis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hodgkin's disease recurrent | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival ulceration | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasodilatation | 0 | 0.001 | 0.323 | 1 | 1.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal mucosal blistering | 0 | 0 | 0.1 | 1 | 2.686 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal dilatation | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traction | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatotropin stimulation test | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oocyte harvest | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal replacement therapy | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder transitional cell carcinoma | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wernicke-Korsakoff syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site dermatitis | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sex hormone binding globulin | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pubic pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product residue present | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural fistula | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis post transfusion | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bicuspid aortic valve | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenomegaly | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal sleep-related event | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function test decreased | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound haemorrhage | 0 | 0.001 | 0.167 | 1 | 2.405 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytology | 0 | 0.001 | 0.15 | 1 | 2.471 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract inflammation | 0 | 0.001 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral discharge | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urine | 0 | 0 | 0.113 | 1 | 2.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Relapsing fever | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head circumference abnormal | 0 | 0 | 0.077 | 1 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster pharyngitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary casts absent | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subacute inflammatory demyelinating polyneuropathy | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure keratitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus haemorrhage | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lysinuric protein intolerance | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product quality control issue | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prurigo | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-HLA antibody test | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan bone marrow abnormal | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaundice cholestatic | 0 | 0 | 0.04 | 1 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine lactic acid increased | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningoradiculitis | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dwarfism | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug physiologic incompatibility | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hoffmann's sign | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site joint movement impairment | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnesium deficiency | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian malignant tumours (SMQ) [broad] | 0 | 0 | 0.048 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood growth hormone abnormal | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphadenectomy | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningococcal carditis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess rupture | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood methaemoglobin present | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autosomal chromosome anomaly | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve palsy | 0 | 0.001 | 0.115 | 1 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trichorrhexis | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystal urine absent | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal odour | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder oedema | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph node rupture | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myringotomy | 0 | 0 | 0.087 | 1 | 2.753 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varices oesophageal | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antigen | 0 | 0 | 0.064 | 1 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic respiratory disease | 0 | 0 | 0.016 | 1 | 3.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitochondrial toxicity | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrosis | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin electrophoresis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall oedema | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food interaction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fractured coccyx | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenine phosphoribosyl transferase deficiency | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peptic ulcer | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy cervix normal | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary-dependent Cushing's syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemihypertrophy | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital labial adhesions | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin normal | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired immunodeficiency syndrome | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine uric acid decreased | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic granuloma | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shunt malfunction | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prophylaxis against Rh isoimmunisation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural nausea | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parotid abscess | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ilium fracture | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital tract inflammation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor II mutation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangiogram normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site infection | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aluminium abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alkaline phosphatase abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lip abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune enteropathy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal inflammation | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aldolase | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dark circles under eyes | 0 | 0.001 | 0.42 | 1 | 1.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chlamydia test positive | 0 | 0 | 0.002 | 1 | 3.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal burning sensation | 0 | 0.001 | 0.137 | 1 | 2.522 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary sediment abnormal | 0 | 0.001 | 0.094 | 1 | 2.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Henoch-Schonlein purpura nephritis | 0 | 0.001 | 0.117 | 1 | 2.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A antibody | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar haemorrhage | 0 | 0 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sphincter of Oddi dysfunction | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systolic hypertension | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Self-induced vomiting | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic neoplasm | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngitis viral | 0 | 0 | 0.022 | 1 | 3.32 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic cerebellar infarction | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal stenosis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-24-hour sleep-wake disorder | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Murphy's sign test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mineral deficiency | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossopharyngeal nerve paralysis | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Free thyroxine index | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrocystic breast disease | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration tracheal normal | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenoplasty | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcal abscess | 0 | 0 | 0.026 | 1 | 3.258 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculous pleurisy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sulcus vocalis | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal cyst haemorrhage | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proctoscopy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestine infection | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperglycinaemia | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-complement antibody | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-IA2 antibody negative | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster meningoencephalitis | 0 | 0 | 0.003 | 1 | 3.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal obstruction | 0 | 0 | 0.037 | 1 | 3.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocauterisation | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram intestine | 0 | 0 | 0.111 | 1 | 2.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstrual discomfort | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure orthostatic | 0 | 0 | 0.043 | 1 | 3.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestinal obstruction | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heterophoria | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cheyne-Stokes respiration | 0 | 0 | 0.005 | 1 | 3.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal fungal infection | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidural analgesia | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal endotheliitis | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreal cells | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulnar nerve palsy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic leukoencephalopathy | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swollen tear duct | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia sepsis | 0 | 0 | 0.087 | 1 | 2.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint stabilisation | 0 | 0 | 0.065 | 1 | 2.888 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye infection bacterial | 0 | 0 | 0.102 | 1 | 2.678 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermohyperaesthesia | 0 | 0 | 0.001 | 1 | 4.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemia in remission | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal hypoaesthesia | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon sheath incision | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyogenic granuloma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyomavirus-associated nephropathy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthognathic surgery | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infected cyst | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital cerebellar agenesis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast neoplasm | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign ovarian tumour | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyschromatopsia | 0 | 0.001 | 0.115 | 1 | 2.615 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute cardiac event | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary pneumatocele | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic embolisation | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perfusion brain scan | 0 | 0 | 0.007 | 1 | 3.693 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional overdose | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thunderclap headache | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic calcification | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Omphalitis | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune tolerance induction | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis astroviral | 0 | 0 | 0.001 | 1 | 4.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral disorders (SMQ) [broad] | 0 | 0.001 | 0.198 | 1 | 2.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phonophobia | 0 | 0.001 | 0.172 | 1 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine flow decreased | 0 | 0.001 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alcohol normal | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder cancer | 0 | 0 | 0.119 | 1 | 2.594 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammatory pain | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hilar lymphadenopathy | 0 | 0 | 0.101 | 1 | 2.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF polymorphonuclear cell count increased | 0 | 0 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoma benign | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product physical consistency issue | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet distribution width decreased | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Merycism | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alphavirus test | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular graft complication | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine albumin/creatinine ratio increased | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Unemployment | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-lymphocyte count abnormal | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-cell receptor gene rearrangement test | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rinne tuning fork test abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal artery stenosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postoperative adhesion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patient dissatisfaction with device | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laboratory test interference | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cows milk free diet | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchopulmonary disease | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacillus bacteraemia | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute lung injury | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head banging | 0 | 0.001 | 0.282 | 1 | 2.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep study normal | 0 | 0 | 0.216 | 1 | 2.252 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cartilage injury | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorectal discomfort | 0 | 0.001 | 0.134 | 1 | 2.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangitis sclerosing | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system function test | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood zinc increased | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-islet cell antibody | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha-1 anti-trypsin normal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral load decreased | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular imaging | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal artery embolism | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal mesothelial hyperplasia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis mumps | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to meninges | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal discomfort | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotonia neonatal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic vein thrombosis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune pancreatitis | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tear break up time test | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor quantitative | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory gas exchange disorder | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pinguecula | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perthes disease | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuro-ophthalmological test | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail pitting | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hereditary disorder | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central cord syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood prolactin abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute undifferentiated leukaemia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral disorders (SMQ) [narrow] | 0 | 0.001 | 0.198 | 1 | 2.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tourette's disorder | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound pelvis normal | 0 | 0.001 | 0.139 | 1 | 2.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site eschar | 0 | 0 | 0.004 | 1 | 3.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microbiology test | 0 | 0.001 | 0.171 | 1 | 2.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull X-ray abnormal | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye allergy | 0 | 0 | 0.05 | 1 | 3.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Duodenitis | 0 | 0 | 0.118 | 1 | 2.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell count | 0 | 0 | 0.112 | 1 | 2.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic scleroderma | 0 | 0 | 0.116 | 1 | 2.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid stimulating immunoglobulin | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood prolactin | 0 | 0 | 0.025 | 1 | 3.278 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurosurgery | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Graft versus host disease in gastrointestinal tract | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Frostbite | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary contusion | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypermagnesaemia | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis shigella | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schizoid personality disorder | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal oedema | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail pigmentation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular pigmentation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Klebsiella sepsis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye opacity | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic pneumonia acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysplastic naevus | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyskinesia oesophageal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Craniectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capnogram abnormal | 0 | 0 | 0.06 | 1 | 2.924 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder catheter replacement | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axial spondyloarthritis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteritis | 0 | 0 | 0.108 | 1 | 2.649 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waist circumference decreased | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rehabilitation therapy | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Onychalgia | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oromandibular dystonia | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal irrigation | 0 | 0 | 0.011 | 1 | 3.545 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heat illness | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Denture wearer | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral haemorrhage foetal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging abdominal abnormal | 0 | 0.001 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patient elopement | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxin binding globulin | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood testosterone increased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure ambulatory | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD8 lymphocytes abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic adenoma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF myelin basic protein abnormal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-erythrocyte antibody negative | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract inflammation | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound breast | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal cyst | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infant irritability | 0 | 0 | 0.12 | 1 | 2.593 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histone antibody negative | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy artery | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renin increased | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell elliptocytes present | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal dialysis complication | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patella fracture | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Natural killer T cell count | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweat gland disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoaesthesia teeth | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle neoplasm | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute leukaemia | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroiditis | 0 | 0 | 0.193 | 1 | 2.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transmission of an infectious agent via product | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum normal | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroprosthesis implantation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basilar migraine | 0 | 0 | 0.007 | 1 | 3.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray therapy to joint | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural decortication | 0 | 0 | 0.036 | 1 | 3.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alkaline phosphatase decreased | 0 | 0 | 0.104 | 1 | 2.665 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normochromic anaemia | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical device pain | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine bilirubin decreased | 0 | 0 | 0.191 | 1 | 2.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital choroid plexus cyst | 0 | 0 | 0.032 | 1 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deja vu | 0 | 0 | 0.031 | 1 | 3.193 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulomatous lymphadenitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parkinsonism | 0 | 0.001 | 0.225 | 1 | 2.224 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration bursa | 0 | 0.001 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sense of oppression | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal perivascular sheathing | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multipathogen PCR test positive | 0 | 0 | 0.016 | 1 | 3.439 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging joint | 0 | 0 | 0.11 | 1 | 2.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VII level decreased | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida nappy rash | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermometry | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iodine uptake decreased | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Defect conduction intraventricular | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin K deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral rhinitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydromyelia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold exposure injury | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign neoplasm | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amoebic dysentery | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy site unspecified abnormal | 0 | 0 | 0.077 | 1 | 2.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure diastolic increased | 0 | 0.001 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid cancer | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal achalasia | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral column mass | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram T wave amplitude decreased | 0 | 0 | 0.001 | 1 | 4.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Double ureter | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell differential | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyomyositis | 0 | 0 | 0.006 | 1 | 3.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol abuse | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reactive attachment disorder of infancy or early childhood | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholinergic syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep disorder due to a general medical condition | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital pulmonary valve disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convulsive threshold lowered | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrogen breath test | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcitonin | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex reactivation | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign neoplasm of thyroid gland | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileocolostomy | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micrographic skin surgery | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast oedema | 0 | 0 | 0.03 | 1 | 3.203 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein amniotic fluid increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver scan abnormal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flail chest | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin degradation products normal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord infarction | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidural blood patch | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product monitoring error | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulna fracture | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-aquaporin-4 antibody | 0 | 0.001 | 0.232 | 1 | 2.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast inflammation | 0 | 0 | 0.125 | 1 | 2.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood testosterone | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aldolase decreased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemidysaesthesia | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amblyopia | 0 | 0 | 0.174 | 1 | 2.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron metabolism disorder | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint discomfort | 0 | 0.001 | 0.14 | 1 | 2.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear, nose and throat examination abnormal | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acanthosis nigricans | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrospinal fluid drainage | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemia neonatal | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve infection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stiff leg syndrome | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nodal osteoarthritis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nonreassuring foetal heart rate pattern | 0 | 0 | 0.034 | 1 | 3.162 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device issue | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | UV light therapy | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight decrease neonatal | 0 | 0 | 0.008 | 1 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid hormone replacement therapy | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seronegative arthritis | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital genital malformation | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typhus rickettsia test | 0 | 0 | 0.174 | 1 | 2.384 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine porphobilinogen increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell microcytes | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis herpes | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noonan syndrome | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Grimacing | 0 | 0 | 0.253 | 1 | 2.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tardive dyskinesia | 0 | 0 | 0.213 | 1 | 2.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvi-ureteric obstruction | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower motor neurone lesion | 0 | 0 | 0.011 | 1 | 3.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurotic disorder of childhood | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood group A | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaw operation | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic bacterial infection | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth socket haemorrhage | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convalescent | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor VIII antibody test | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess soft tissue | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site swelling | 0 | 0 | 0.105 | 1 | 2.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myokymia | 0 | 0 | 0.027 | 1 | 3.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipids increased | 0 | 0 | 0.092 | 1 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-islet cell antibody negative | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid nodule | 0 | 0 | 0.045 | 1 | 3.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial enlargement | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor quality device used | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital haematoma | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venogram abnormal | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antidepressant drug level | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural site reaction | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral tonsillitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiosarcoma | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kinematic imbalances due to suboccipital strain | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal light reflex test abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular hypertension | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendinous contracture | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine renal clearance decreased | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal pap smear | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcus test | 0 | 0 | 0.168 | 1 | 2.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone scan normal | 0 | 0 | 0.154 | 1 | 2.455 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute psychosis | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant renal hypertension | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair follicle tumour benign | 0 | 0 | 0.037 | 1 | 3.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xanthogranuloma | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye infection viral | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body mass index | 0 | 0 | 0.014 | 1 | 3.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube cancer | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product effect increased | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma cell mastitis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound uterus abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair metal test abnormal | 0 | 0 | 0.224 | 1 | 2.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound infection staphylococcal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant splenic neoplasm | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blastic plasmacytoid dendritic cell neoplasia | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foot fracture | 0 | 0 | 0.169 | 1 | 2.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperadrenalism | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dialysis efficacy test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mediastinitis | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otosalpingitis | 0 | 0 | 0.063 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porphyria non-acute | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelofibrosis | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dust allergy | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product contamination with body fluid | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoproteinaemia | 0 | 0.001 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep deficit | 0 | 0.001 | 0.19 | 1 | 2.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis necrotising | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agonal death struggle | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echoencephalogram normal | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychogenic visual disorder | 0 | 0 | 0.001 | 1 | 4.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Illiteracy | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion late | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ergotherapy | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salpingo-oophorectomy unilateral | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix enlargement | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound breast abnormal | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single functional kidney | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proctitis | 0 | 0.001 | 0.115 | 1 | 2.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic cerebral infarction | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chalazion | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | EGFR status assay | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood oestrogen decreased | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranoid personality disorder | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery disease | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 absorption test | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serial transverse enteroplasty | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-traumatic pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral vein occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis staphylococcal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical observation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated encephalitis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperlactacidaemia | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hereditary spherocytosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sickle cell anaemia | 0 | 0 | 0.026 | 1 | 3.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plagiocephaly | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal turbinate hypertrophy | 0 | 0 | 0.053 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital burning sensation | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold agglutinins positive | 0 | 0 | 0.018 | 1 | 3.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typical aura without headache | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinel's sign | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thought blocking | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | POEMS syndrome | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb asymmetry | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug monitoring procedure not performed | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteric stenosis | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulse pressure increased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericarditis meningococcal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penicillium test negative | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parathyroid tumour | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile septic granulomatosis | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic recurrent multifocal osteomyelitis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac output decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood beta-D-glucan normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood beta-D-glucan increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bence Jones protein urine present | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B precursor type acute leukaemia | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaplastic large-cell lymphoma | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal blistering | 0 | 0.001 | 0.195 | 1 | 2.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflux gastritis | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastritis erosive | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Social (pragmatic) communication disorder | 0 | 0 | 0.035 | 1 | 3.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal malformation | 0 | 0 | 0.036 | 1 | 3.14 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatostatin receptor scan abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microvillous inclusion disease | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder sphincter atony | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystic lung disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain management | 0 | 0.001 | 0.19 | 1 | 2.331 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seborrhoeic keratosis | 0 | 0.001 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heparin-induced thrombocytopenia | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cadmium increased | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine albumin/creatinine ratio normal | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid gland abscess | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electronystagmogram normal | 0 | 0 | 0.002 | 1 | 3.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perivascular dermatitis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF pressure | 0 | 0 | 0.009 | 1 | 3.6 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine iodine increased | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Refusal of vaccination | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis echo viral | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol test | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loose body in joint | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Young's syndrome | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephritic syndrome | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicide threat | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal pain | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perfusion brain scan abnormal | 0 | 0 | 0.01 | 1 | 3.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid white blood cells positive | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial disorder | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blister rupture | 0 | 0.001 | 0.373 | 1 | 1.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diaphragmatic paralysis | 0 | 0.001 | 0.13 | 1 | 2.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal discolouration | 0 | 0 | 0.093 | 1 | 2.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High risk pregnancy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Removal of foreign body | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint debridement | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product confusion | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothermia neonatal | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerumen impaction | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular enlargement | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus node dysfunction | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF cell count decreased | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sucrose intolerance | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary hilum mass | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Provisional tic disorder | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic infection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal megacystis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye muscle operation | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ewing's sarcoma | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complications of transplanted lung | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic elongation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-vimentin antibody positive | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin erosion | 0 | 0.001 | 0.228 | 1 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinogram | 0 | 0.001 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear site unspecified abnormal | 0 | 0.001 | 0.146 | 1 | 2.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total cholesterol/HDL ratio | 0 | 0 | 0.054 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Megakaryocytes | 0 | 0 | 0.02 | 1 | 3.353 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mixed anxiety and depressive disorder | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | JC polyomavirus test positive | 0 | 0 | 0.033 | 1 | 3.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinoplasty | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal cancer metastatic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Placental calcification | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PCO2 abnormal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to kidney | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mallampati score | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Investigation noncompliance | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IgM nephropathy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal biophysical profile score abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil count abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy anus normal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune endocrine disorder | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mouth breathing | 0 | 0.001 | 0.276 | 1 | 2.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Developmental hip dysplasia | 0 | 0 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reduced facial expression | 0 | 0.001 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patellofemoral pain syndrome | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sitting disability | 0 | 0 | 0.112 | 1 | 2.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iontophoresis | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovulation disorder | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial diarrhoea | 0 | 0 | 0.006 | 1 | 3.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Umbilical cord around neck | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product dose omission in error | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral artery occlusion | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericoronitis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical device site joint infection | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site telangiectasia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive cardiomegaly | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital neoplasm malignant female | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional endoscopic sinus surgery | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram PR segment elevation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dystonic tremor | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood insulin normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder injury | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Altered pitch perception | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombophlebitis superficial | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbosacral plexopathy | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antibody positive | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin D dimer decreased | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid retraction | 0 | 0 | 0.047 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eccentric fixation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transplant | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product dispensing issue | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutropenic sepsis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micropenis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kleihauer-Betke test positive | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site rash | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incarcerated umbilical hernia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperglobulinaemia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallot's tetralogy | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyeball avulsion | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Duodenal polyp | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brow presentation | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brief psychotic disorder with marked stressors | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body mass index increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-cardiac chest pain | 0 | 0.001 | 0.209 | 1 | 2.271 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin urine | 0 | 0.001 | 0.112 | 1 | 2.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal degeneration | 0 | 0 | 0.085 | 1 | 2.764 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin urine absent | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal migraine | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traumatic haematoma | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Threatened labour | 0 | 0 | 0.046 | 1 | 3.036 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint warmth | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram | 0 | 0 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine osmolarity normal | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Unintended pregnancy | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell rouleaux formation present | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary sarcoidosis | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nodal rhythm | 0 | 0 | 0.073 | 1 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin urine increased | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product barcode issue | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positive expiratory pressure therapy | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phakomatosis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuser | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Change in sustained attention | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial tracheitis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal ulcer | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiotensin II increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amplified musculoskeletal pain syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolar lung disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary nail refill test | 0 | 0 | 0.126 | 1 | 2.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Effusion | 0 | 0 | 0.196 | 1 | 2.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time ratio decreased | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite blood test positive | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipaemic index score | 0 | 0 | 0.005 | 1 | 3.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair metal test | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feelings of worthlessness | 0 | 0 | 0.008 | 1 | 3.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal disorder | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schistosoma test negative | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell poikilocytes present | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurodevelopment test | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histone antibody | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ototoxicity | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intelligence test | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hookworm infection | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal sepsis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital laryngeal stridor | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barbiturates negative | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polycythaemia | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B6 | 0 | 0.001 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Teeth brittle | 0 | 0 | 0.039 | 1 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal congestion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vesicoureteral reflux surgery | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carpal tunnel decompression | 0 | 0 | 0.11 | 1 | 2.638 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 globulin increased | 0 | 0 | 0.093 | 1 | 2.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast upper gastrointestinal tract normal | 0 | 0 | 0.103 | 1 | 2.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Galactostasis | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia klebsiella | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Norepinephrine | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis neonatal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematoma evacuation | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic prolapse | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac malposition | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein amniotic fluid | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune retinopathy | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia fungal | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcoholism | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis toxic | 0 | 0 | 0.004 | 1 | 3.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine renal clearance normal | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidural lipomatosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adnexa uteri mass | 0 | 0 | 0.014 | 1 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinusitis bacterial | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart alternation | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand amputation | 0 | 0 | 0.044 | 1 | 3.057 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Environmental exposure | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval haemorrhage | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue pigmentation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal failure neonatal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid thickening | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryopyrin associated periodic syndrome | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea nitrogen/creatinine ratio decreased | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta-N-acetyl-D-glucosaminidase | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute graft versus host disease in liver | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal pain | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lymph gland abnormal | 0 | 0 | 0.098 | 1 | 2.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site dysaesthesia | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound drainage | 0 | 0 | 0.143 | 1 | 2.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve stimulation test abnormal | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase abnormal | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein abnormal | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma viscosity normal | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterocolitis bacterial | 0 | 0 | 0.019 | 1 | 3.376 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Surgical failure | 0 | 0 | 0.014 | 1 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngoscopy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail bed disorder | 0 | 0 | 0.095 | 1 | 2.715 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspnoea paroxysmal nocturnal | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy soft tissue | 0 | 0 | 0.014 | 1 | 3.47 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purpura neonatal | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbosacral plexus lesion | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Listeria test positive | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal tremor | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone disorder | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyramidal tract syndrome | 0 | 0 | 0.002 | 1 | 3.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell morphology abnormal | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nervous system injury | 0 | 0 | 0.069 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial strain | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery dissection | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Withdrawal syndrome | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transient hypogammaglobulinaemia of infancy | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swallow study abnormal | 0 | 0.001 | 0.103 | 1 | 2.669 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral myositis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial hyperreactivity | 0 | 0.001 | 0.284 | 1 | 2.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture tissue specimen | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumboperitoneal shunt | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gynaecological examination normal | 0 | 0 | 0.022 | 1 | 3.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardioactive drug level | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal warts | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Giardia test | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental examination | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C2 | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cor pulmonale chronic | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac pacemaker evaluation | 0 | 0.001 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxiella test positive | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder rupture | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Risus sardonicus | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral contusion | 0 | 0.001 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymectomy | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single photon emission computerised tomogram | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Internal fixation of fracture | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colon cancer metastatic | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Night blindness | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocytic leukaemia | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reversible airways obstruction | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhesus antibodies negative | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Migraine without aura | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monoclonal immunoglobulin present | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decompressive craniectomy | 0 | 0 | 0.032 | 1 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myasthenia gravis crisis | 0 | 0 | 0.117 | 1 | 2.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure diastolic decreased | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue atrophy | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Instillation site pain | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver tenderness | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve hypoplasia | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin blood decreased | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctivochalasis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic lesion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperuricaemia | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiacetylcholine receptor antibody | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursitis infective | 0 | 0 | 0.005 | 1 | 3.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte haemoglobin equivalent | 0 | 0 | 0.026 | 1 | 3.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oscillopsia | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granuloma skin | 0 | 0 | 0.031 | 1 | 3.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress echocardiogram abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clostridium test | 0 | 0.001 | 0.203 | 1 | 2.289 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Relapsing multiple sclerosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematocrit abnormal | 0 | 0 | 0.148 | 1 | 2.477 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flat affect | 0 | 0 | 0.204 | 1 | 2.288 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound ovary abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary system x-ray abnormal | 0 | 0 | 0.011 | 1 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hysteroscopy | 0 | 0 | 0.091 | 1 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ciliary hyperaemia | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasculitis necrotising | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parenteral nutrition | 0 | 0 | 0.004 | 1 | 3.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-HLA antibody test positive | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site cyst | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint infection | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left atrial dilatation | 0 | 0 | 0.1 | 1 | 2.689 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood sodium abnormal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obstructive defaecation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrocardiac syndrome | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema mucosal | 0 | 0.001 | 0.165 | 1 | 2.415 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opiates positive | 0 | 0 | 0.044 | 1 | 3.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic injury | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluctuance | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrovascular disorder | 0 | 0.001 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal roughening | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida test negative | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phagocytosis | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serotonin syndrome | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proteus test positive | 0 | 0 | 0.02 | 1 | 3.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leptospira test | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin-like growth factor increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periodic limb movement disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blindness congenital | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bleeding varicose vein | 0 | 0 | 0.003 | 1 | 3.888 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obsessive-compulsive symptom | 0 | 0 | 0.023 | 1 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otitis media acute | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypopituitarism | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms (SMQ) [narrow] | 0 | 0.001 | 0.152 | 1 | 2.463 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail dystrophy | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral microangiopathy | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Instillation site paraesthesia | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrioventricular block first degree | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraesthesia mucosal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Terminal state | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anisocytosis | 0 | 0.001 | 0.095 | 1 | 2.71 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borrelia infection | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fistula | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary tumour benign | 0 | 0 | 0.019 | 1 | 3.372 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Athetosis | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic skin ulcer | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin abnormal | 0 | 0.001 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Collagen-vascular disease | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary biliary cholangitis | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile swelling | 0 | 0 | 0.192 | 1 | 2.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia measles | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrocytosis | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin D increased | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint prosthesis user | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluid balance assessment | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopox virus infection | 0 | 0 | 0.001 | 1 | 4.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Karyotype analysis | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose urine present | 0 | 0.001 | 0.194 | 1 | 2.319 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced expiratory volume increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchitis viral | 0 | 0 | 0.077 | 1 | 2.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular systolic pressure decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bed sharing | 0 | 0 | 0.128 | 1 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal cord insertion | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal ulcer | 0 | 0 | 0.04 | 1 | 3.098 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epididymitis | 0 | 0.001 | 0.231 | 1 | 2.208 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peptostreptococcus test positive | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anotia | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine cervical pain | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extrapulmonary tuberculosis | 0 | 0 | 0.001 | 1 | 4.159 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug level therapeutic | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactate dehydrogenase abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal ulcer | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance elastography | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plicated tongue | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin graft | 0 | 0.001 | 0.114 | 1 | 2.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychomotor disadaptation syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body | 0 | 0 | 0.035 | 1 | 3.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic retinopathy | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traumatic tooth displacement | 0 | 0 | 0.008 | 1 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood 25-hydroxycholecalciferol | 0 | 0.001 | 0.175 | 1 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroschisis | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | DNA antibody | 0 | 0.001 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood electrolytes abnormal | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosa biopsy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet adhesiveness | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermoid cyst | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.001 | 0.128 | 1 | 2.559 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tensilon test normal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheostomy tube removal | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IL-2 receptor assay | 0 | 0 | 0.127 | 1 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vibration test normal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Partial seizures with secondary generalisation | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue atrophy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin therapy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic wall hypertrophy | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic valve calcification | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular rupture | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle ear disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac arrest neonatal | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial therapeutic procedure | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anoxia | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic membrane rupture test negative | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenalectomy | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired syringomyelia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gene mutation identification test positive | 0 | 0 | 0.142 | 1 | 2.499 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mouth injury | 0 | 0.001 | 0.188 | 1 | 2.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve stimulation test | 0 | 0.001 | 0.141 | 1 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord compression | 0 | 0.001 | 0.165 | 1 | 2.415 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyuria | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs test | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular function test abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal polyp | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gonorrhoea | 0 | 0 | 0.087 | 1 | 2.756 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular myasthenia | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gross motor delay | 0 | 0 | 0.027 | 1 | 3.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conductive deafness | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blast cell proliferation | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyruvate kinase | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Duodenal ulcer | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated neuropathy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell sedimentation rate decreased | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoplasty | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaw fracture | 0 | 0 | 0.215 | 1 | 2.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar spinal stenosis | 0 | 0.001 | 0.105 | 1 | 2.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine albumin/creatinine ratio | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteropathic spondylitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin A deficiency | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic disc disorder | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram repolarisation abnormality | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perioral dermatitis | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Placental insufficiency | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thromboplastin normal | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestrogen deficiency | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha-1 anti-trypsin increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia of pregnancy | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinotracheitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite stool test | 0 | 0.001 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired reasoning | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuromuscular toxicity | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol test positive | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucocutaneous haemorrhage | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurotoxicity | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normetanephrine urine increased | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anomalous pulmonary venous connection | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuritis cranial | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemangioma of skin | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-high-density lipoprotein cholesterol increased | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General physical condition normal | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopic ultrasound abnormal | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal labour affecting foetus | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal ulceration | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary casts present | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal examination normal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver transplant rejection | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lenticulostriatal vasculopathy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-cerebral aneurysm operation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperandrogenism | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Humidity intolerance | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal neoplasm | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram P wave biphasic | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystitis escherichia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contact lens intolerance | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital rubella infection | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone density abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood uric acid | 0 | 0.001 | 0.32 | 1 | 1.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum abnormal | 0 | 0.001 | 0.164 | 1 | 2.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antisocial behaviour | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | In vitro fertilisation | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Zinc deficiency | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIIIth nerve injury | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic haemorrhage | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Morphoea | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic cardiomyopathy | 0 | 0 | 0.011 | 1 | 3.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Booster dose missed | 0 | 0 | 0.036 | 1 | 3.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenocortical steroid therapy | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein albumin ratio normal | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyomavirus test negative | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilia | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinoembryonic antigen increased | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acid base balance abnormal | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract pain | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic injury | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory fatigue | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function challenge test normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large granular lymphocytosis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal haemoglobin | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cross sensitivity reaction | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix injury | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy pericardium abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Similar reaction on previous exposure to drug | 0 | 0.001 | 0.24 | 1 | 2.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscular dystrophy | 0 | 0.001 | 0.121 | 1 | 2.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflux laryngitis | 0 | 0 | 0.112 | 1 | 2.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation increased | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breakthrough pain | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal aplasia | 0 | 0 | 0.053 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary hypoplasia | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perineal abscess | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmia neonatorum | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | NIH stroke scale | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ectropion of cervix | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash maculovesicular | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Instillation site vesicles | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileocolectomy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carnitine abnormal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Androgen deficiency | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum sickness | 0 | 0.003 | 0.423 | 1 | 1.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Omenn syndrome | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephrocalcinosis | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal drugs affecting foetus | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interferon gamma release assay positive | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise electrocardiogram abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema marginatum | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echinococciasis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cooling therapy | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burkitt's lymphoma | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF monocyte count decreased | 0 | 0.001 | 0.287 | 1 | 2.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diagnostic aspiration | 0 | 0 | 0.182 | 1 | 2.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngoscopy | 0 | 0.001 | 0.185 | 1 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parakeratosis | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C virus test positive | 0 | 0 | 0.107 | 1 | 2.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastritis viral | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skeletal survey abnormal | 0 | 0 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood iron abnormal | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aluminium normal | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypervigilance | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stenotrophomonas sepsis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary adrenal insufficiency | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric artery aneurysm | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inguinal hernia, obstructive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal damage | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide combining power decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy intestine normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Air embolism | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E antigen positive | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF electrophoresis abnormal | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradypnoea | 0 | 0 | 0.018 | 1 | 3.387 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin receptor assay | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-traumatic epilepsy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasmin inhibitor | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Follicle centre lymphoma diffuse small cell lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exocrine pancreatic function test normal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital teratoma | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast injury | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimitochondrial antibody positive | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament sprain | 0 | 0.001 | 0.288 | 1 | 2.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site exfoliation | 0 | 0.001 | 0.249 | 1 | 2.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal dialysis | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary tumour | 0 | 0 | 0.043 | 1 | 3.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-high-density lipoprotein cholesterol | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complication of device insertion | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual brightness | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical thyroid examination abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noctiphobia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis Japanese B | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast ulceration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcitonin normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial drainage test | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hashimoto's encephalopathy | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Family stress | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal infection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem glioma | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autophobia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hodgkin's disease | 0 | 0.001 | 0.165 | 1 | 2.415 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xerosis | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema genital | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dependent rubor | 0 | 0 | 0.102 | 1 | 2.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thromboembolectomy | 0 | 0 | 0.009 | 1 | 3.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweat test normal | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site erythema | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leser-Trelat sign | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | JC virus CSF test positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal transit time abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear lobe infection | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bush-Francis catatonia rating scale | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bipolar II disorder | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Argon plasma coagulation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | African trypanosomiasis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precipitate labour | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interferon gamma normal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endothelial dysfunction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspnoea at rest | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular retrobulbar haemorrhage | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nocardiosis | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginitis | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastectomy | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anhedonia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sialoadenitis | 0 | 0 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain herniation | 0 | 0.001 | 0.164 | 1 | 2.417 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Status asthmaticus | 0 | 0.001 | 0.098 | 1 | 2.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell sedimentation rate abnormal | 0 | 0 | 0.138 | 1 | 2.516 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site lymphadenopathy | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vagus nerve disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital haemorrhage | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermogram abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sulphur dioxide test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal lesion | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive cerebrovascular disease | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enzyme activity assay | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortisol abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site discharge | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood catecholamines decreased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaplastic lymphoma kinase gene mutation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic sinusitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms malignant and unspecified (SMQ) [broad] | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy liver normal | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound pancreas normal | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mammoplasty | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular fibrosis | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorioretinal atrophy | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selenium deficiency | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Russell's viper venom time normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opticokinetic nystagmus tests normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis chronic | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital skin disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pregnenolone increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | BK polyomavirus test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral pharyngitis | 0 | 0 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasoconstriction | 0 | 0.001 | 0.181 | 1 | 2.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhesus antigen positive | 0 | 0.001 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal examination | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subdural abscess | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic encephalopathy | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral papule | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aneurysm ruptured | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paroxysmal sympathetic hyperactivity | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limbic encephalitis | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy mucosa abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site atrophy | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord ischaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteosarcoma | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose-6-phosphate dehydrogenase deficiency | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical device site joint pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral viral infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stoma care | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via mucosa | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear infection bacterial | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroma | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac output | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | External ear inflammation | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary enlargement | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Actinic keratosis | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon calcification | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual perseveration | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteoarthropathy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival ulcer | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratitis viral | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor VIII inhibition | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound uterus normal | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell-mediated immune deficiency | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Russell's viper venom time | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Legionella infection | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract endoscopy | 0 | 0 | 0.019 | 1 | 3.374 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopic ultrasound | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gouty arthritis | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral congestion | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aldosterone decreased | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac index | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell scan | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye ulcer | 0 | 0 | 0.008 | 1 | 3.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Humerus fracture | 0 | 0.001 | 0.128 | 1 | 2.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Squamous cell carcinoma of skin | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal exposure timing unspecified | 0 | 0 | 0.035 | 1 | 3.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echolalia | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Excessive skin | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal thickening | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioallergosorbent test | 0 | 0 | 0.218 | 1 | 2.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic girdle pain | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irlen syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paracentesis | 0 | 0.001 | 0.098 | 1 | 2.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital abscess | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serous retinal detachment | 0 | 0 | 0.02 | 1 | 3.359 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriovenous fistula operation | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-glomerular basement membrane antibody positive | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacteriuria | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echo virus infection | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrospinal fluid reservoir placement | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Latent tuberculosis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endotracheal intubation complication | 0 | 0.001 | 0.157 | 1 | 2.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary granuloma | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal graft rejection | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrichosis | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial injury | 0 | 0 | 0.084 | 1 | 2.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimitochondrial antibody normal | 0 | 0 | 0.085 | 1 | 2.764 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-alcoholic steatohepatitis | 0 | 0 | 0.122 | 1 | 2.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug dependence | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar atrophy | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prealbumin decreased | 0 | 0 | 0.055 | 1 | 2.968 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal elastase concentration decreased | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychological trauma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasminogen decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peroneal nerve injury | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microembolism | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microangiopathy | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micrognathia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Analgesic drug level therapeutic | 0 | 0.001 | 0.121 | 1 | 2.587 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemothorax | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Febrile neutropenia | 0 | 0.001 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual agnosia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythromelalgia | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor IX level increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chondrocalcinosis | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocarditis bacterial | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasomotor rhinitis | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbuncle | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acrodermatitis enteropathica | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory level | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-IA2 antibody | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF glucose abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crossmatch | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brucellosis | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung squamous cell carcinoma stage IV | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atypical mycobacterial infection | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimicrobial susceptibility test intermediate | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porokeratosis | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colour vision tests abnormal red-green | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath sounds absent | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital hiatus hernia | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shift to the right | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arm amputation | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site hypoaesthesia | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal hypertension | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic immune activation | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lithotripsy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stool heavy metal positive | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephropathy | 0 | 0.001 | 0.136 | 1 | 2.523 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General physical condition | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc displacement | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatologic examination abnormal | 0 | 0 | 0.131 | 1 | 2.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral haemorrhage | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fructose intolerance | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allen's test | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal clotting factor | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercepted product preparation error | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiomyolipoma | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antemortem blood drug level | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracic vertebral fracture | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seizure anoxic | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophils urine | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous sarcoidosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteroclysis | 0 | 0 | 0.009 | 1 | 3.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic left ventricular failure | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle electrostimulation therapy | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendix cancer | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine output increased | 0 | 0.001 | 0.231 | 1 | 2.208 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxsackie virus test | 0 | 0.001 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system mass | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spherocytic anaemia | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of injection site rotation | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Focal peritonitis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progesterone | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Affective disorder | 0 | 0.001 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Internal capsule infarction | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic nephropathy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood copper decreased | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xanthoma | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperoxaluria | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cor pulmonale | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterior interosseous syndrome | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase BB | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile blister | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level abnormal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue necrosis | 0 | 0 | 0.111 | 1 | 2.635 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gitelman's syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stenosis | 0 | 0 | 0.033 | 1 | 3.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histology abnormal | 0 | 0.001 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal mass | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scar pain | 0 | 0 | 0.032 | 1 | 3.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral papilloma | 0 | 0 | 0.008 | 1 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenosine deaminase | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin K | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subretinal fibrosis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective polysaccharide antibody deficiency | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood corticotrophin | 0 | 0 | 0.136 | 1 | 2.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Larynx irritation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic ketosis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cleft lip and palate | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoacoustic emissions test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatic dysfunction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal swelling | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein B | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progesterone increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iodine allergy | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatinine abnormal | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal deviation | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudopapilloedema | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal scar | 0 | 0 | 0.012 | 1 | 3.533 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung carcinoma cell type unspecified recurrent | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ammonia decreased | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinogram abnormal | 0 | 0 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oculomucocutaneous syndrome | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perinatal depression | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean platelet volume | 0 | 0.001 | 0.147 | 1 | 2.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal injury | 0 | 0.001 | 0.188 | 1 | 2.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Camptodactyly acquired | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal stoma output increased | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eustachian tube operation | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema annulare | 0 | 0.001 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease risk factor | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Median nerve injury | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrops foetalis | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Steatohepatitis | 0 | 0 | 0.002 | 1 | 4.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Solar lentigo | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertriglyceridaemia | 0 | 0 | 0.026 | 1 | 3.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival injury | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Argininosuccinate lyase deficiency | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyloric stenosis | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product prescribing issue | 0 | 0 | 0.007 | 1 | 3.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue coated | 0 | 0 | 0.165 | 1 | 2.415 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs indirect test | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site dysaesthesia | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Giardia test negative | 0 | 0 | 0.016 | 1 | 3.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular access complication | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post infection glomerulonephritis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site plaque | 0 | 0 | 0.218 | 1 | 2.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal degeneration | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal abscess | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perineurial cyst | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrocholecystis | 0 | 0 | 0.069 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epileptic aura | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal movement disorder | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF mononuclear cell count decreased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental examination normal | 0 | 0.001 | 0.141 | 1 | 2.506 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral osteophyte | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound biliary tract normal | 0 | 0 | 0.105 | 1 | 2.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Supportive care | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular hypertrophy | 0 | 0 | 0.025 | 1 | 3.273 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Finger amputation | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysmorphism | 0 | 0 | 0.03 | 1 | 3.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic disease | 0 | 0 | 0.033 | 1 | 3.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Familial periodic paralysis | 0 | 0 | 0.009 | 1 | 3.6 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary disorder | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood heavy metal abnormal | 0 | 0 | 0.057 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenosis | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram PR shortened | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Syndactyly | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein albumin ratio increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric arterial occlusion | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine urine decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal dystrophy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cirrhosis alcoholic | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site haemorrhage | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bleeding time normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bleeding time abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin indentation | 0 | 0 | 0.201 | 1 | 2.295 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite urine test negative | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postsplenectomy syndrome | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hereditary ataxia | 0 | 0 | 0.041 | 1 | 3.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female reproductive tract disorder | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Starvation | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal fissure | 0 | 0 | 0.159 | 1 | 2.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vein rupture | 0 | 0 | 0.115 | 1 | 2.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-abdominal fluid collection | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital blister | 0 | 0 | 0.089 | 1 | 2.746 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic hepatitis | 0 | 0 | 0.015 | 1 | 3.442 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood parathyroid hormone decreased | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Photopheresis | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wall motion score index abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxin binding globulin increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Silent myocardial infarction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinoschisis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary hilar enlargement | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural haemorrhage | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal anastomosis | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myeloblast percentage | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrophage activation | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gardnerella test positive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopic swallowing evaluation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystitis haemorrhagic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Constricted affect | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholelithotomy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF polymorphonuclear cell count decreased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow myelogram normal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis acneiform | 0 | 0.002 | 0.332 | 1 | 1.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug dispensed to wrong patient | 0 | 0.001 | 0.162 | 1 | 2.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-thyroid antibody negative | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site streaking | 0 | 0.001 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echovirus test negative | 0 | 0 | 0.094 | 1 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood selenium decreased | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Langerhans' cell histiocytosis | 0 | 0 | 0.017 | 1 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rathke's cleft cyst | 0 | 0 | 0.002 | 1 | 3.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irregular sleep phase | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splinter haemorrhages | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to abdominal cavity | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise test | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychotic symptom | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pasteurella test positive | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical observation normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Graft complication | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast milk substitute intolerance | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium swallow abnormal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute monocytic leukaemia | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body fluid analysis | 0 | 0.001 | 0.108 | 1 | 2.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral lesion | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood HIV RNA increased | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinea cruris | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal crusting | 0 | 0 | 0.041 | 1 | 3.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multi-vitamin deficiency | 0 | 0 | 0.017 | 1 | 3.418 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gravitational oedema | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Surgical procedure repeated | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis enteroviral | 0 | 0 | 0.015 | 1 | 3.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circulating anticoagulant | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer in situ | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone loss | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-glomerular basement membrane antibody | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transplant evaluation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroglobulin absent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal cortical necrosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal tube insertion | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primitive reflex test | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma cells increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb fracture | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disorder of orbit | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute zonal occult outer retinopathy | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal opacity | 0 | 0.001 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blister infected | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Punctate keratitis | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestradiol | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine ketone body | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xanthelasma | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heterotaxia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal vomiting | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiglottic erythema | 0 | 0 | 0.001 | 1 | 4.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginitis gardnerella | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract irritation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal dilation procedure | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transposition of the great vessels | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal injury | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral cavity fistula | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Naturopathy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lasegue's test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossoptosis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal malformation | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix cautery | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic disorder | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic fluid volume | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal adenoma | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal odour | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine hypertonus | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin blood absent | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple system atrophy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononuclear cell count | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric cyst | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin hypopigmentation | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagram | 0 | 0 | 0.071 | 1 | 2.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-GAD antibody negative | 0 | 0 | 0.037 | 1 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keloid scar | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate decreased | 0 | 0 | 0.03 | 1 | 3.202 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic enzymes | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Solar dermatitis | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neovascular age-related macular degeneration | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect product administration duration | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site anaesthesia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type IIa hyperlipidaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transmission of an infectious agent via transplant | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sternal injury | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear buccal | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin implant | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural rub | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia cryptococcal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pilonidal cyst | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagogastric fundoplasty | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Model for end stage liver disease score | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney malrotation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exertional headache | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diplacusis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral ventricle collapse | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral arteriosclerosis | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood blister | 0 | 0.001 | 0.293 | 1 | 2.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seborrhoeic dermatitis | 0 | 0.001 | 0.12 | 1 | 2.591 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital swelling | 0 | 0 | 0.234 | 1 | 2.199 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inner ear disorder | 0 | 0.001 | 0.169 | 1 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cancer surgery | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Negativism | 0 | 0.001 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous injury | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis D virus test | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder discomfort | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibula fracture | 0 | 0 | 0.068 | 1 | 2.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystic fibrosis | 0 | 0 | 0.007 | 1 | 3.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal transplant | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typhus | 0 | 0 | 0.001 | 1 | 4.098 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Severe invasive streptococcal infection | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum serotonin | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain threshold decreased | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological infection | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastatic neoplasm | 0 | 0 | 0.047 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interleukin therapy | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular pressure test abnormal | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc operation | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture tissue specimen positive | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF red blood cell count | 0 | 0.001 | 0.189 | 1 | 2.334 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth injury | 0 | 0 | 0.015 | 1 | 3.456 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull X-ray normal | 0 | 0.001 | 0.158 | 1 | 2.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Very low density lipoprotein normal | 0 | 0 | 0.045 | 1 | 3.045 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Syphilis | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angle closure glaucoma | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular disorder | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve neurostimulation | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand dermatitis | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell analysis normal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal injury | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoinflammatory disease | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tissue infiltration | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trousseau's sign | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic rash | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflexology | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phytotherapy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Methaemoglobin urine absent | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal mucosal atrophy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acoustic neuritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngospasm | 0 | 0.001 | 0.198 | 1 | 2.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatologic examination | 0 | 0.001 | 0.166 | 1 | 2.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased insulin requirement | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholesterol abnormal | 0 | 0 | 0.107 | 1 | 2.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Walking distance test abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxoplasma serology positive | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positive end-expiratory pressure | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal pneumonia | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystalluria | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid stimulating immunoglobulin increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal haemorrhage | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sigmoidoscopy abnormal | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Residual urine volume increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal artery arteriosclerosis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | End-tidal CO2 increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraganglion neoplasm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular occlusion | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral vasculitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bloch-Sulzberger syndrome | 0 | 0 | 0.049 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood HIV RNA decreased | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary malignant tumours (SMQ) [broad] | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral artery hypoplasia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum procollagen type III N-terminal propeptide | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal hypertrophy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbital apex syndrome | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy placenta | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile culture negative | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antipsychotic drug level | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenoleukodystrophy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngomalacia | 0 | 0.001 | 0.093 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic respiratory symptom | 0 | 0.001 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Compression fracture | 0 | 0.001 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardio-respiratory distress | 0 | 0 | 0.109 | 1 | 2.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil count abnormal | 0 | 0 | 0.142 | 1 | 2.502 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total bile acids increased | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexually transmitted disease test | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurologic neglect syndrome | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhegmatogenous retinal detachment | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal scan abnormal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progressive bulbar palsy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normal tension glaucoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastasis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meconium abnormal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean arterial pressure decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional device misuse | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IVth nerve paresis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine abnormal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair injury | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic ulcer | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burkholderia test positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site pallor | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary system X-ray | 0 | 0.001 | 0.196 | 1 | 2.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull X-ray | 0 | 0.001 | 0.265 | 1 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital hypoaesthesia | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy large bowel | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septum pellucidum agenesis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.011 | 1 | 3.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangiocarcinoma | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | LDL/HDL ratio decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac ventriculogram left | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulum intestinal | 0 | 0.001 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal papilloma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to spine | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iris adhesions | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet function test | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal decompression | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin-like growth factor | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site phlebitis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye operation | 0 | 0.001 | 0.128 | 1 | 2.559 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic abscess | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteosclerosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ambidexterity | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood acid phosphatase normal | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QRS complex | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exploding head syndrome | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right atrial dilatation | 0 | 0 | 0.015 | 1 | 3.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic mass | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amimia | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal neoplasm | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal lesion | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asymptomatic bacteriuria | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex meningoencephalitis | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site nerve damage | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal exploration | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate abnormal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exploratory operation | 0 | 0.001 | 0.098 | 1 | 2.697 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | 5-hydroxyindolacetic acid in urine decreased | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CHARGE syndrome | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somnolence neonatal | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic carcinoma | 0 | 0 | 0.12 | 1 | 2.592 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual acuity tests normal | 0 | 0.001 | 0.188 | 1 | 2.335 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrist deformity | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia neonatal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fasting | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head lag | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural vomiting | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Masticatory pain | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal scan | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate cancer stage IV | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low cardiac output syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy vocal cord abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-cell type acute leukaemia | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibronectin normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord injury cervical | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal herpes | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell burr cells present | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture wound | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal depigmentation | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary physical examination normal | 0 | 0.001 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic fracture | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchopulmonary aspergillosis | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ephelides | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue exfoliation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Claudication of jaw muscles | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulva cyst | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual acuity reduced transiently | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain empyema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary immunodeficiency | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saliva analysis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 test false negative | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Milk-alkali syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fistula repair | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QRS complex shortened | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurone-specific enolase | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dehydroepiandrosterone test | 0 | 0 | 0.032 | 1 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular hole | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypopyon | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrous histiocytoma | 0 | 0 | 0.063 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone scan abnormal | 0 | 0 | 0.112 | 1 | 2.628 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic erosive gastritis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia legionella | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prolonged expiration | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shunt occlusion | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal tachypnoea | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye infection staphylococcal | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ABO incompatibility | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza C virus test | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometrial cancer | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal pap smear abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left-handedness | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chloride abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site erosion | 0 | 0.001 | 0.174 | 1 | 2.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine free | 0 | 0.001 | 0.319 | 1 | 1.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperkinetic heart syndrome | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skeletal muscle enzymes | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia influenzal | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal foreign body | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal stroke | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal injury | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine urine normal | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site nerve damage | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalocele repair | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic infection | 0 | 0 | 0.024 | 1 | 3.289 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haptoglobin | 0 | 0 | 0.109 | 1 | 2.644 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomach scan | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriosclerotic retinopathy | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular autonomic function test abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell count positive | 0 | 0.001 | 0.094 | 1 | 2.715 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abulia | 0 | 0 | 0.033 | 1 | 3.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess positive | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colon operation | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine free normal | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian necrosis | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram U wave present | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medial tibial stress syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Portal vein thrombosis | 0 | 0 | 0.08 | 1 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood oestrogen normal | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tissue injury | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute generalised exanthematous pustulosis | 0 | 0.001 | 0.161 | 1 | 2.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mammogram | 0 | 0.001 | 0.189 | 1 | 2.333 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic vein thrombosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural intestinal perforation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral spasm | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bladder normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level increased | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prosthesis user | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease susceptibility | 0 | 0 | 0.054 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perinatal HBV infection | 0 | 0 | 0.044 | 1 | 3.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute interstitial pneumonitis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urogram abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess intestinal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-transglutaminase antibody negative | 0 | 0 | 0.005 | 1 | 3.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign prostatic hyperplasia | 0 | 0.001 | 0.162 | 1 | 2.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose tolerance test | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wolff-Parkinson-White syndrome | 0 | 0 | 0.071 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal dermatitis | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gun shot wound | 0 | 0 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial stenosis | 0 | 0 | 0.087 | 1 | 2.753 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site joint pain | 0 | 0 | 0.036 | 1 | 3.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inappropriate release of product for distribution | 0 | 0 | 0.008 | 1 | 3.65 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gilbert's syndrome | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system lupus | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta globulin normal | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vessel puncture site haemorrhage | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal tubular injury | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasmodium ovale infection | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hernia repair | 0 | 0 | 0.133 | 1 | 2.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteonecrosis (SMQ) [narrow] | 0 | 0 | 0.193 | 1 | 2.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal dysplasia | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cephalhaematoma | 0 | 0 | 0.012 | 1 | 3.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leptin level increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum amyloid A protein increased | 0 | 0 | 0.018 | 1 | 3.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extradural abscess | 0 | 0 | 0.084 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neck surgery | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tissue discolouration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital thrombocytopenia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine aluminium | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular ischaemic syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid bleeding | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma stage III | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vision correction operation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal bacterial overgrowth | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schizotypal personality disorder | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paroxysmal extreme pain disorder | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral myelitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrosarcoma | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood catecholamines normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Simple partial seizures | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac imaging procedure | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung carcinoma cell type unspecified stage IV | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oligodendroglioma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meralgia paraesthetica | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinonasal obstruction | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urodynamics measurement | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelocyte percentage decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF cell count abnormal | 0 | 0 | 0.047 | 1 | 3.028 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-aortic balloon placement | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear vaginal normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulnar tunnel syndrome | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachycardia foetal | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burnout syndrome | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic cough | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterobacter test positive | 0 | 0 | 0.019 | 1 | 3.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrovascular arteriovenous malformation | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lead urine increased | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nosocomial infection | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor IX level normal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute oesophageal mucosal lesion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cogan's syndrome | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Steatorrhoea | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexual dysfunction | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatological examination | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinea infection | 0 | 0 | 0.137 | 1 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract discomfort | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexual transmission of infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedure aborted | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paracentesis eye | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedematous kidney | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-abdominal haematoma | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperkeratosis lenticularis perstans | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder obstruction | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac ventriculogram normal | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillaritis | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iodine uptake abnormal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrophic scar | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric bypass | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Citrobacter infection | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac ventriculogram left normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blepharochalasis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bleeding anovulatory | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder hydrodistension | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis infective | 0 | 0 | 0.21 | 1 | 2.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint effusion | 0 | 0 | 0.236 | 1 | 2.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Discharge | 0 | 0.001 | 0.155 | 1 | 2.451 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral fungal infection | 0 | 0.001 | 0.184 | 1 | 2.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngoscopy normal | 0 | 0 | 0.087 | 1 | 2.756 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.071 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorectal disorder | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incarcerated inguinal hernia | 0 | 0 | 0.029 | 1 | 3.215 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical dilatation | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amoeba test negative | 0 | 0 | 0.045 | 1 | 3.045 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic response changed | 0 | 0 | 0.014 | 1 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sciatic nerve neuropathy | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticular perforation | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate examination normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product closure removal difficult | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature ageing | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porcelain gallbladder | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Modified Rankin score decreased | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracardiac mass | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoreactive trypsinogen increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye paraesthesia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disseminated cytomegaloviral infection | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deposit eye | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystal urine | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival follicles | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lid sulcus deepened | 0 | 0 | 0.112 | 1 | 2.627 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound closure | 0 | 0.001 | 0.124 | 1 | 2.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper airway obstruction | 0 | 0.001 | 0.109 | 1 | 2.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Growth failure | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric infection | 0 | 0 | 0.024 | 1 | 3.285 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial oedema | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous pressure jugular increased | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional underdose | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panniculitis lobular | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system function test normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoid hyperplasia of intestine | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diastolic hypertension | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular ataxia | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gamma-glutamyltransferase abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flavivirus test | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure management | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atypical mycobacterium test positive | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram peripheral abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transplantation complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracic outlet syndrome | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal toxaemia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteomyelitis acute | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired fasting glucose | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperparathyroidism primary | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis proliferative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival disorder | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan vagina abnormal | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulnar nerve injury | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary hypothyroidism | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteonecrosis of jaw | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nitrite urine | 0 | 0 | 0.089 | 1 | 2.746 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterocolitis viral | 0 | 0 | 0.014 | 1 | 3.464 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary catheter insertion | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign breast neoplasm | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic oedema | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial rupture | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomatococcus test positive | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectocele | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palisaded neutrophilic granulomatous dermatitis | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paracentesis ear | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephrological examination | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatine urine increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone abscess | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased viscosity of upper respiratory secretion | 0 | 0.001 | 0.101 | 1 | 2.682 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IIIrd nerve disorder | 0 | 0 | 0.054 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc space narrowing | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site vesicles | 0 | 0 | 0.008 | 1 | 3.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allogenic stem cell transplantation | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral sinusitis | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratouveitis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemostasis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body in throat | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Familial mediterranean fever | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorexia nervosa | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Terminal ileitis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic viral infection | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal function test normal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant neoplasm progression | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile haemangioma | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulitis intestinal perforated | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device function test | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device dispensing error | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor XI level normal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VIII level decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical laser therapy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site pain | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacillus infection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune blistering disease | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antipsychotic drug level decreased | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired diaphragmatic eventration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpangina | 0 | 0.001 | 0.062 | 1 | 2.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal discharge discolouration | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extrapyramidal disorder | 0 | 0 | 0.226 | 1 | 2.224 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholesterol decreased | 0 | 0.001 | 0.172 | 1 | 2.391 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splint application | 0 | 0 | 0.146 | 1 | 2.485 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal bacterial infection | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose-6-phosphate dehydrogenase abnormal | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash neonatal | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercepted product dispensing error | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy rectum abnormal | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone normal | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulinoma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular vascular disorder | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foster care | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eustachian tube patulous | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device defective | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blastocystis infection | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Artificial crown procedure | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site mass | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid ptosis congenital | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid haematoma | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decompression sickness | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicogenic headache | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecaloma | 0 | 0.001 | 0.201 | 1 | 2.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypospadias | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Valsalva maneuver | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plateletcrit increased | 0 | 0 | 0.061 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mineral supplementation | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leptospirosis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Invasive ductal breast carcinoma | 0 | 0 | 0.073 | 1 | 2.838 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebroplasty | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Truncus coeliacus thrombosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombosis in device | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tandem gait test normal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve infection | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Needle fatigue | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mutagenic effect | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incarcerated hernia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiopathic neuropathy | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Analgesic therapy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal atrophy | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal pruritus | 0 | 0.001 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Onychomycosis | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac electrophysiologic study abnormal | 0 | 0 | 0.035 | 1 | 3.146 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory disorder neonatal | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yersinia test | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethritis gonococcal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transcranial magnetic stimulation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular germ cell tumour | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right hemisphere deficit syndrome | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid vasculitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to central nervous system | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leucine aminopeptidase | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal transit time | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated dermatitis | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Continuous glucose monitoring | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem stroke | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fear of injection | 0 | 0.001 | 0.195 | 1 | 2.315 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose fluctuation | 0 | 0.001 | 0.198 | 1 | 2.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculin test positive | 0 | 0 | 0.026 | 1 | 3.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loose tooth | 0 | 0.001 | 0.171 | 1 | 2.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facet joint syndrome | 0 | 0.001 | 0.152 | 1 | 2.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 globulin normal | 0 | 0.001 | 0.147 | 1 | 2.482 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile rash | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail bed bleeding | 0 | 0 | 0.024 | 1 | 3.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol poisoning | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric volvulus | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body in gastrointestinal tract | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin M abnormal | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy oesophagus normal | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple epiphyseal dysplasia | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inadequate diet | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diffuse alveolar damage | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital skin dimples | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Velopharyngeal incompetence | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haptoglobin increased | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acne conglobata | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary alveolar haemorrhage | 0 | 0 | 0.058 | 1 | 2.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypochloraemia | 0 | 0.001 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum ferritin abnormal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcium abnormal | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barrett's oesophagus | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site haematoma | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor V antibody | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival oedema | 0 | 0.001 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluorescence angiogram | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia moraxella | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Open reduction of fracture | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic infection | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular failure | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mini mental status examination | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ammonia normal | 0 | 0.001 | 0.2 | 1 | 2.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Auscultation | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxicologic test abnormal | 0 | 0 | 0.117 | 1 | 2.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site discolouration | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs positive haemolytic anaemia | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sitophobia | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacille Calmette-Guerin scar reactivation | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Passive smoking | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital thrombocyte disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phimosis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Essential tremor | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphatic disorder | 0 | 0.001 | 0.184 | 1 | 2.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural pain | 0 | 0.001 | 0.184 | 1 | 2.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enzyme level test | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram PR prolongation | 0 | 0 | 0.087 | 1 | 2.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone density decreased | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood parathyroid hormone | 0 | 0 | 0.104 | 1 | 2.666 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune dermatitis | 0 | 0 | 0.092 | 1 | 2.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluorescent in situ hybridisation positive | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal abscess | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells stool | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin A normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site pallor | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total complement activity increased | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Partner stress | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte adoptive therapy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood triglycerides decreased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy urethra normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy intestine | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian malignant tumours (SMQ) [narrow] | 0 | 0.001 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethritis | 0 | 0 | 0.042 | 1 | 3.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine free abnormal | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital and neonatal arrhythmias (SMQ) [narrow] | 0 | 0 | 0.034 | 1 | 3.159 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteritis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apheresis | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular pseudoaneurysm | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine injury | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapy naive | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature ejaculation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Past-pointing | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parechovirus infection | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelocyte percentage increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macula thickness measurement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lupus enteritis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product dosage form confusion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic cancer stage IV | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal aneurysm | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound biliary tract abnormal | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid aneurysm rupture | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular autonomic function test normal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site infection | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superinfection | 0 | 0.001 | 0.16 | 1 | 2.433 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy muscle normal | 0 | 0 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortisol normal | 0 | 0.001 | 0.222 | 1 | 2.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bullous haemorrhagic dermatosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy gastrointestinal abnormal | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subcutaneous abscess | 0 | 0.001 | 0.299 | 1 | 2.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood prolactin increased | 0 | 0 | 0.092 | 1 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Frontal lobe epilepsy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrohepatorenal syndrome | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyloromyotomy | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper gastrointestinal haemorrhage | 0 | 0.001 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic enzymes decreased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Audiogram normal | 0 | 0.001 | 0.123 | 1 | 2.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Teething | 0 | 0.001 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast reconstruction | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiolipin antibody positive | 0 | 0 | 0.013 | 1 | 3.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gait spastic | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urogenital infection fungal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous opacities | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positron emission tomography-magnetic resonance imaging | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site recall reaction | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymus hypoplasia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver palpable | 0 | 0 | 0.051 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular torsion | 0 | 0 | 0.008 | 1 | 3.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolar proteinosis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital dye staining cornea present | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood mercury | 0 | 0.001 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperinsulinism | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acalculia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung transplant | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal obstruction | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-GAD antibody | 0 | 0.001 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine cannabinoids increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem ischaemia | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis viral | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy vagina normal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocardial fibrosis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory ganglionitis | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stem cell therapy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | External ear cellulitis | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product impurity | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myotonia | 0 | 0 | 0.069 | 1 | 2.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound testes normal | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Murine typhus | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin A decreased | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram pacemaker spike | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin-like growth factor decreased | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipodystrophy acquired | 0 | 0 | 0.088 | 1 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung neoplasm surgery | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthroscopic surgery | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival suffusion | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycoplasma test | 0 | 0.001 | 0.268 | 1 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palatal swelling | 0 | 0.001 | 0.283 | 1 | 2.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic spontaneous urticaria | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs test positive | 0 | 0.001 | 0.057 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to arthropod bite | 0 | 0 | 0.115 | 1 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rosacea | 0 | 0.001 | 0.285 | 1 | 2.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site induration | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vena cava thrombosis | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate examination | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterostomy | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin distribution width increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal malposition | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal migraine | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implantable cardiac monitor insertion | 0 | 0 | 0.055 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone scan | 0 | 0 | 0.106 | 1 | 2.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal lavage | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postmenopause | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eustachian tube obstruction | 0 | 0 | 0.129 | 1 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genitourinary symptom | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic dissection | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood catecholamines increased | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy heart abnormal | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram kidney normal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colloid brain cyst | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental gangrene | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shock haemorrhagic | 0 | 0 | 0.101 | 1 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic response shortened | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial haemorrhage | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelocyte percentage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gliosis | 0 | 0.001 | 0.14 | 1 | 2.507 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin E decreased | 0 | 0.001 | 0.155 | 1 | 2.451 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypogonadism | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic specific antigen | 0 | 0 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asplenia | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic discomfort | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subperiosteal abscess | 0 | 0 | 0.088 | 1 | 2.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osmophobia | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal myelogram normal | 0 | 0.001 | 0.117 | 1 | 2.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural constipation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection reactivation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatopulmonary syndrome | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal hernia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep disorder due to general medical condition, insomnia type | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute post asthmatic amyotrophy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-VGCC antibody negative | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radial pulse abnormal | 0 | 0 | 0.011 | 1 | 3.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site warmth | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycosylated haemoglobin decreased | 0 | 0 | 0.113 | 1 | 2.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor Xa assay normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atelectasis neonatal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital discomfort | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament laxity | 0 | 0 | 0.036 | 1 | 3.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenosine deaminase decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune arthritis | 0 | 0 | 0.034 | 1 | 3.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue thrust | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Internal injury | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash papulosquamous | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric vascular insufficiency | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mast cell degranulation present | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure orthostatic normal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac function test abnormal | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pineal gland cyst | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymus enlargement | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration pleural cavity abnormal | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging abdominal | 0 | 0 | 0.159 | 1 | 2.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic disorders specifically reported as alcohol-related (SMQ) [narrow] | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal swelling | 0 | 0 | 0.027 | 1 | 3.251 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenocarcinoma of colon | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary stone analysis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptobacillus infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteogenesis imperfecta | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal injury | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal operation | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestinal polypectomy | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint adhesion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign soft tissue neoplasm | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil cationic protein increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatillomania | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal stromal tumour | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superficial vein prominence | 0 | 0 | 0.041 | 1 | 3.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PUVA | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal valve collapse | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonitis chemical | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular function test | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychiatric evaluation normal | 0 | 0 | 0.001 | 1 | 4.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cancer stage IV | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr viraemia | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lateral medullary syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical spinal cord paralysis | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell volume | 0 | 0.001 | 0.203 | 1 | 2.29 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyneuropathy idiopathic progressive | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infective tenosynovitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired tracheo-oesophageal fistula | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Priapism | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implant site pruritus | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Philadelphia chromosome positive | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine free increased | 0 | 0 | 0.035 | 1 | 3.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystic fibrosis related diabetes | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rebound effect | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemoid reaction | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoproliferative disorder | 0 | 0 | 0.022 | 1 | 3.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagogastroscopy abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging hepatobiliary | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post concussion syndrome | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex meningitis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Telangiectasia congenital | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosa haematoma | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C4 increased | 0 | 0 | 0.041 | 1 | 3.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective IgM immunodeficiency | 0 | 0 | 0.006 | 1 | 3.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meconium in amniotic fluid | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung diffusion test decreased | 0 | 0 | 0.069 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular insufficiency | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombin-antithrombin III complex normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactate pyruvate ratio | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pyruvic acid normal | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood electrolytes increased | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain abscess | 0 | 0 | 0.048 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ciliary body disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal neovascularisation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor personal hygiene | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhesus antigen | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human polyomavirus infection | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial secretion retention | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal haemorrhage | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face and mouth X-ray normal | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brachioradial pruritus | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast milk discolouration | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Verbigeration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic generalised epilepsy | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract infection bacterial | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein C decreased | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barotitis media | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-zinc transporter 8 antibody positive | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multifocal motor neuropathy | 0 | 0.001 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Morning sickness | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia chlamydial | 0 | 0 | 0.074 | 1 | 2.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Natural killer cell count decreased | 0 | 0 | 0.02 | 1 | 3.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichenification | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coating in mouth | 0 | 0 | 0.129 | 1 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Promyelocyte count | 0 | 0 | 0.053 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Knee deformity | 0 | 0 | 0.063 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheterisation venous | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aversion | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 microglobulin increased | 0 | 0 | 0.037 | 1 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metamyelocyte percentage increased | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal carcinoma | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fat tissue increased | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venolymphatic malformation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue haemorrhage | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sepsis syndrome | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purpura non-thrombocytopenic | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbital decompression | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononucleosis syndrome | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Melanaemia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratoconus | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hairy cell leukaemia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral toxoplasmosis | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursa injury | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Speech sound disorder | 0 | 0 | 0.102 | 1 | 2.678 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panophthalmitis | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine release test | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis influenzal | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased nasolabial fold | 0 | 0 | 0.02 | 1 | 3.363 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast disorder female | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acantholysis | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreoretinal traction syndrome | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trendelenburg position | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stasis dermatitis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sterile pyuria | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E antibody positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drain of cerebral subdural space | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute promyelocytic leukaemia | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired Von Willebrand's disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean platelet volume decreased | 0 | 0 | 0.197 | 1 | 2.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium swallow | 0 | 0 | 0.115 | 1 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac fibrillation | 0 | 0.001 | 0.154 | 1 | 2.456 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chelation therapy | 0 | 0.001 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinitis viral | 0 | 0 | 0.096 | 1 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterial infection | 0 | 0 | 0.02 | 1 | 3.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular test normal | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multimorbidity | 0 | 0 | 0.03 | 1 | 3.215 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia macrocytic | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular retraction | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet aggregation test | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peptostreptococcus infection | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal erosion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mallory-Weiss syndrome | 0 | 0 | 0.066 | 1 | 2.888 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site calcification | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis viral test positive | 0 | 0 | 0.001 | 1 | 4.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Economic problem | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood acid phosphatase increased | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary straining | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Punctate basophilia | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian prolapse | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor VII deficiency | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrogastrogram | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida pneumonia | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain natriuretic peptide decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aorta hypoplasia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdomen crushing | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colitis ischaemic | 0 | 0.001 | 0.112 | 1 | 2.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal lymphadenopathy | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Presbyopia | 0 | 0 | 0.031 | 1 | 3.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Febrile infection-related epilepsy syndrome | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Water pollution | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic neuropathy | 0 | 0 | 0.047 | 1 | 3.036 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phrenic nerve injury | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Morbid thoughts | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligamentitis | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder hypofunction | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ehrlichia test positive | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Velo-cardio-facial syndrome | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traumatic haemorrhage | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic abscess | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis chemical | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphatic obstruction | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypereosinophilic syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autotransfusion | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging renal | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pus in stool | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flashback | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suprapubic pain | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shock hypoglycaemic | 0 | 0 | 0.04 | 1 | 3.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Femoral neck fracture | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebrobasilar stroke | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine dehiscence | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombin-antithrombin III complex increased | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scalloped tongue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lens extraction | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal cancer | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracerebral haematoma evacuation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammation scan | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Elective surgery | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Directional Doppler flow tests abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis herpetiformis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cisternogram | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine abnormal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal rebound tenderness | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal neoplasm | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metapneumovirus infection | 0 | 0 | 0.001 | 1 | 4.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypochromic anaemia | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell morphology normal | 0 | 0 | 0.022 | 1 | 3.319 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney enlargement | 0 | 0 | 0.101 | 1 | 2.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Groin infection | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital hydrocephalus | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal abscess | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Painful erection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular rosacea | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose tolerance increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental implantation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choroid plexus papilloma | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac pacemaker adjustment | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac pacemaker replacement | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous oxygen partial pressure | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine repair | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temperature perception test abnormal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Roseolovirus test | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palmoplantar keratoderma | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal metaplasia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor X level decreased | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VII level | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF measles antibody positive | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchogram abnormal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chromium decreased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy mucosa normal | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial vulvovaginitis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein A-I normal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan thyroid gland | 0 | 0.001 | 0.174 | 1 | 2.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral hyperaemia | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fraction of inspired oxygen | 0 | 0 | 0.187 | 1 | 2.342 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram P wave abnormal | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast abscess | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphangiopathy | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram coronary artery abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrovascular stenosis | 0 | 0 | 0.056 | 1 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal fistula | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Teratoma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tattoo | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical breast examination | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbital infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcific deposits removal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidental exposure to product packaging | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic cerebral infarction | 0 | 0.001 | 0.157 | 1 | 2.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal hypomotility | 0 | 0.001 | 0.132 | 1 | 2.541 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs direct test | 0 | 0.001 | 0.134 | 1 | 2.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematology test abnormal | 0 | 0.001 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral ventricle dilatation | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemodynamic test normal | 0 | 0 | 0.085 | 1 | 2.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tobacco user | 0 | 0 | 0.018 | 1 | 3.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes pharyngitis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Androgens increased | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subcorneal pustular dermatosis | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic cyst | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuromyotonia | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant melanoma in situ | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy thyroid gland normal | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol test negative | 0 | 0 | 0.014 | 1 | 3.47 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvitis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIth nerve paresis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomatococcal infection | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcium ionised normal | 0 | 0.001 | 0.254 | 1 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine bilirubin increased | 0 | 0.001 | 0.11 | 1 | 2.635 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-neuronal antibody | 0 | 0.001 | 0.092 | 1 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choreoathetosis | 0 | 0 | 0.125 | 1 | 2.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polychondritis | 0 | 0 | 0.016 | 1 | 3.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluorescence angiogram abnormal | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subclavian vein thrombosis | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intermittent positive pressure breathing | 0 | 0 | 0.071 | 1 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypocomplementaemia | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood methaemoglobin absent | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antigliadin antibody | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephrectomy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial fistula | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpesvirus 6 encephalitis | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaplastic astrocytoma | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulpitis dental | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Groin abscess | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood osmolarity increased | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine mercury | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A antigen negative | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal disease carrier | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colectomy total | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve operation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital inflammation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial drainage test normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Performance fear | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus mucosal hypertrophy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oculocephalogyric reflex absent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma recurrent | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cellulitis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood insulin increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudomononucleosis | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle graft | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucocutaneous rash | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Marburg's variant multiple sclerosis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to arthropod sting | 0 | 0.001 | 0.155 | 1 | 2.453 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bordetella test negative | 0 | 0.001 | 0.178 | 1 | 2.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean platelet volume abnormal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell analysis | 0 | 0 | 0.06 | 1 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-consummation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital discomfort | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocytes abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal abscess | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Treponema test false positive | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour excision | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinogram normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renin | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal cancer stage IV | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural haematoma | 0 | 0 | 0.062 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phospholipidosis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peristalsis visible | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial drainage test abnormal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manual lymphatic drainage | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocytic lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver scan | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukoplakia oral | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exomphalos | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dislocation of vertebra | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest wall abscess | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MM normal | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoidal disorder | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray of pelvis and hip abnormal | 0 | 0.001 | 0.217 | 1 | 2.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fat necrosis | 0 | 0.001 | 0.129 | 1 | 2.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile haemorrhage | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypermetabolism | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 globulin | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF neutrophil count | 0 | 0 | 0.019 | 1 | 3.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary arterial pressure increased | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radial nerve injury | 0 | 0 | 0.032 | 1 | 3.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary calcification | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extradural haematoma | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-lymphocyte abnormalities | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acquired epidermolysis bullosa | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site pain | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin C-peptide increased | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ecouvillonage | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal necrosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body tinea | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site haemorrhage | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising soft tissue infection | 0 | 0 | 0.013 | 1 | 3.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal column injury | 0 | 0 | 0.086 | 1 | 2.758 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borrelia test positive | 0 | 0 | 0.036 | 1 | 3.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axonal and demyelinating polyneuropathy | 0 | 0 | 0.016 | 1 | 3.421 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interferon alpha level | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasitic test | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbohydrate antigen 19-9 increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychotherapy | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine phosphorus | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Von Willebrand's factor multimers test | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyper IgD syndrome | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperamylasaemia | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system stimulation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy prostate abnormal | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Babesiosis | 0 | 0 | 0.012 | 1 | 3.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus infection reactivation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monomelic amyotrophy | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human anti-human antibody test | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric pH increased | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenosine deaminase normal | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product effect delayed | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicogenic vertigo | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autonomic seizure | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Excessive eye blinking | 0 | 0.002 | 0.373 | 1 | 1.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product design issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrectomy | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urogenital disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foot and mouth disease | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST-T segment abnormal | 0 | 0 | 0.018 | 1 | 3.385 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve root injury thoracic | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic valve stenosis | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CDKL5 deficiency disorder | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral discharge | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour rupture | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria papular | 0 | 0.001 | 0.155 | 1 | 2.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypermetropia | 0 | 0.001 | 0.201 | 1 | 2.297 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromosomal deletion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity total increased | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Twin reversed arterial perfusion sequence malformation | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CNS ventriculitis | 0 | 0 | 0.017 | 1 | 3.42 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental operation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perichondritis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail discomfort | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personal relationship issue | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin adhesion | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation time | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Free thyroxine index normal | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Turbinectomy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin A abnormal | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve operation | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine ophthalmopathy | 0 | 0 | 0.037 | 1 | 3.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progressive relapsing multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fulminant type 1 diabetes mellitus | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichen striatus | 0 | 0 | 0.005 | 1 | 3.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bartonella test negative | 0 | 0.001 | 0.214 | 1 | 2.258 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint fluid drainage | 0 | 0.001 | 0.27 | 1 | 2.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labour complication | 0 | 0 | 0.095 | 1 | 2.711 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood grouping | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes virus test abnormal | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone cancer | 0 | 0 | 0.009 | 1 | 3.622 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurosarcoidosis | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail matrix biopsy | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic myeloid leukaemia recurrent | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine odour abnormal | 0 | 0 | 0.31 | 1 | 2.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erosive oesophagitis | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin neoplasm excision | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF protein decreased | 0 | 0 | 0.281 | 1 | 2.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapy change | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poverty of speech | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body aspiration | 0 | 0 | 0.027 | 1 | 3.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Widal test | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine level | 0 | 0 | 0.023 | 1 | 3.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plantar erythema | 0 | 0 | 0.082 | 1 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin cyst excision | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-cell lymphoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising ulcerative gingivostomatitis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral allergy syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpesvirus 6 infection | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid crystal | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine abscess | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human anaplasmosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory integration therapy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brucella test positive | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder polyp | 0 | 0 | 0.074 | 1 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cellulitis streptococcal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium double contrast abnormal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte morphology | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthrogram abnormal | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nitrituria | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emergency care | 0 | 0 | 0.159 | 1 | 2.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound eye normal | 0 | 0 | 0.077 | 1 | 2.812 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar tumour | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic neoplasm | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HTLV test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower limb fracture | 0 | 0.001 | 0.105 | 1 | 2.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament injury | 0 | 0.001 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningioma | 0 | 0.001 | 0.163 | 1 | 2.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic specific antigen increased | 0 | 0.001 | 0.081 | 1 | 2.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract disorder | 0 | 0 | 0.03 | 1 | 3.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermal cyst | 0 | 0 | 0.107 | 1 | 2.65 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postoperative wound complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudocyst | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy-related hepatic disorders (SMQ) [broad] | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site swelling | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Auditory nerve disorder | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow myelogram abnormal | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enanthema | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyphrenia | 0 | 0.002 | 0.33 | 1 | 1.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factitious disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trisomy 18 | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sympathicotonia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrogen breath test abnormal | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolar oxygen partial pressure increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waldenstrom's macroglobulinaemia | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left atrial enlargement | 0 | 0.001 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound uterus | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular systolic pressure | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Terminal insomnia | 0 | 0 | 0.091 | 1 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycocholic acid increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyarrhythmia | 0 | 0.001 | 0.169 | 1 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolia cutis medicamentosa | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood corticotrophin decreased | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood copper normal | 0 | 0 | 0.082 | 1 | 2.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic enzymes normal | 0 | 0 | 0.09 | 1 | 2.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve degeneration | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrolyte substitution therapy | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waxy flexibility | 0 | 0 | 0.048 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweat test | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestradiol increased | 0 | 0 | 0.014 | 1 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labia enlarged | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to extreme temperature | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursa removal | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uvulitis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroglobulin increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermometry normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary adrenocortical insufficiency | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pacemaker generated rhythm | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic artery thrombosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal hypertrophy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic embolisation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular somatic symptom disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cephalo-pelvic disproportion | 0 | 0 | 0.007 | 1 | 3.665 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product intolerance | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein A-I | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil/lymphocyte ratio increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyeglasses therapy | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central vision loss | 0 | 0 | 0.097 | 1 | 2.701 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right aortic arch | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder hypertrophy | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac perfusion defect | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal operation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous stent insertion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell marker increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulin G4 related disease | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General anaesthesia | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph node tuberculosis | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound treatment | 0 | 0.001 | 0.144 | 1 | 2.491 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy gastrointestinal | 0 | 0.001 | 0.062 | 1 | 2.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extraskeletal ossification | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell hypochromic morphology present | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood follicle stimulating hormone normal | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Itching scar | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escharotomy | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite blood test | 0 | 0.001 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal uterine bleeding | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal erythema | 0 | 0.001 | 0.151 | 1 | 2.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioisotope scan abnormal | 0 | 0 | 0.02 | 1 | 3.35 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor VIII antibody increased | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine rupture | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatitis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malformation venous | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid calcification | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Caffeine allergy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal fistula repair | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural infection | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parietal cell antibody negative | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress at work | 0 | 0 | 0.096 | 1 | 2.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inspiratory capacity normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leg amputation | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous ligation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micturition disorder | 0 | 0.001 | 0.193 | 1 | 2.319 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray gastrointestinal tract normal | 0 | 0 | 0.003 | 1 | 3.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphadenopathy mediastinal | 0 | 0.001 | 0.176 | 1 | 2.377 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decubitus ulcer | 0 | 0.001 | 0.064 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ceruloplasmin | 0 | 0.001 | 0.092 | 1 | 2.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspartate aminotransferase decreased | 0 | 0.001 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary vascular disorder | 0 | 0 | 0.012 | 1 | 3.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary tuberculosis | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein total abnormal | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin increased | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rouleaux formation | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perineal pain | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing disability | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine sodium decreased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular operation | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell analysis abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Norepinephrine increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Karyotype analysis abnormal | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect disposal of product | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema asteatotic | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic tic disorder | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflex test normal | 0 | 0 | 0.028 | 1 | 3.24 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypochromasia | 0 | 0 | 0.097 | 1 | 2.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy stomach | 0 | 0 | 0.028 | 1 | 3.236 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung lobectomy | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacunar stroke | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diffuse alopecia | 0 | 0 | 0.055 | 1 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Overgrowth fungal | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired self-care | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow infiltration | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood luteinising hormone normal | 0 | 0 | 0.047 | 1 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella keratitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine operation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superior vena cava stenosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peak expiratory flow rate abnormal | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otitis media chronic | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leiomyoma | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin resistant diabetes | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product availability issue | 0 | 0 | 0.004 | 1 | 3.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ketone body increased | 0 | 0.001 | 0.147 | 1 | 2.482 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Halo vision | 0 | 0.001 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillitis streptococcal | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product ineffective | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trichoglossia | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart valve incompetence | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superior sagittal sinus thrombosis | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoscopy | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil function test abnormal | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound evisceration | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutralising antibodies positive | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle hypoxia | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect dosage administered | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypergammaglobulinaemia benign monoclonal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food contamination | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Familial amyotrophic lateral sclerosis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burns third degree | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer metastatic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood beta-D-glucan positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-glycyl-tRNA synthetase antibody negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low density lipoprotein | 0 | 0 | 0.102 | 1 | 2.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electronystagmogram abnormal | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracranial mass | 0 | 0 | 0.097 | 1 | 2.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest wall mass | 0 | 0 | 0.163 | 1 | 2.421 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dissociative amnesia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Counterfeit product administered | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast haemorrhage | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body reaction | 0 | 0 | 0.101 | 1 | 2.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Growth disorder | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venipuncture | 0 | 0 | 0.042 | 1 | 3.082 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbital myositis | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weber tuning fork test abnormal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Expanded disability status scale | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood beryllium increased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticoagulation drug level below therapeutic | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid oedema | 0 | 0.003 | 0.476 | 1 | 1.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral cardiomyopathy | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aldolase increased | 0 | 0 | 0.036 | 1 | 3.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foot amputation | 0 | 0 | 0.027 | 1 | 3.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Canalith repositioning procedure | 0 | 0 | 0.085 | 1 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell morphology abnormal | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precancerous condition | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell analysis abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Satoyoshi syndrome | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil function disorder | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower respiratory tract infection fungal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QT shortened | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aplasia cutis congenita | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorectal swelling | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute sinusitis | 0 | 0.001 | 0.19 | 1 | 2.331 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reproductive tract disorder | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phalen's test positive | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune reconstitution inflammatory syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood electrolytes decreased | 0 | 0 | 0.038 | 1 | 3.121 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin temperature | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell analysis normal | 0 | 0 | 0.023 | 1 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumocystis test negative | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal septum deviation | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site muscle atrophy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalocele | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cor pulmonale acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram aorta | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholera | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thromboplastin abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthrolysis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Onychoclasis | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ankle fracture | 0 | 0.001 | 0.141 | 1 | 2.503 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear canal erythema | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transcranial electrical motor evoked potential monitoring | 0 | 0 | 0.03 | 1 | 3.203 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudoparalysis | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product taste abnormal | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilus test | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extubation | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue cyst | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell macrocytes present | 0 | 0 | 0.017 | 1 | 3.406 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Comminuted fracture | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound dehiscence | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stoma site haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intrauterine infection | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delayed puberty | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complications of transplanted kidney | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal discolouration | 0 | 0.001 | 0.311 | 1 | 2.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil count increased | 0 | 0 | 0.172 | 1 | 2.39 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperleukocytosis | 0 | 0 | 0.095 | 1 | 2.714 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate normal | 0 | 0 | 0.263 | 1 | 2.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign muscle neoplasm | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | BRCA2 gene mutation assay | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxsackie virus test negative | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid neoplasm | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post thrombotic syndrome | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-islet cell antibody positive | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diastasis recti abdominis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site abscess | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accessory muscle | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous degeneration | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-NMDA antibody | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac pharmacologic stress test | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal cancer | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal cavity packing | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal irritation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dopamine transporter scintigraphy abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transcranial electrical motor evoked potential monitoring abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal enanthema | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Substance use | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ethanol | 0 | 0.001 | 0.197 | 1 | 2.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic fluid collection | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product dispensing error | 0 | 0.001 | 0.095 | 1 | 2.713 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Speech rehabilitation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasm prostate | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis lethargica | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcium ionised | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood group B | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aldosterone increased | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product contamination chemical | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural dizziness | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Megakaryocytes abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lentigo | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes sepsis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular filtration rate abnormal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric varices | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder catheter temporary | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterior chamber fibrin | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol use disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall neoplasm malignant | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue discolouration | 0 | 0.001 | 0.294 | 1 | 2.045 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial cyst | 0 | 0 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Overweight | 0 | 0.001 | 0.129 | 1 | 2.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration joint abnormal | 0 | 0.001 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease complication | 0 | 0 | 0.031 | 1 | 3.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transplant failure | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin normal | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus bronchitis | 0 | 0 | 0.046 | 1 | 3.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteopetrosis | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic disc drusen | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal obstruction | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal erosion | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VIII level normal | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticoagulation drug level | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic exenteration | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paradoxical drug reaction | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosa vesicle | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant nipple neoplasm female | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung induration | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infective exacerbation of chronic obstructive airways disease | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic haematoma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis D RNA negative | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | External hydrocephalus | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Duodenogastric reflux | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal mass | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue geographic | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyposplenism | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anosognosia | 0 | 0 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine potassium normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Homosexuality | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic foot infection | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone cancer metastatic | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amputation stump pain | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site papule | 0 | 0 | 0.261 | 1 | 2.127 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell analysis | 0 | 0 | 0.097 | 1 | 2.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cauda equina syndrome | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF myelin basic protein normal | 0 | 0 | 0.016 | 1 | 3.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal infarction | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropsychiatric lupus | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemic coma | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster reactivation | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood 25-hydroxycholecalciferol decreased | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spasmodic dysphonia | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product commingling | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parathyroid scan normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal adhesion lysis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inhibiting antibodies positive | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Focal nodular hyperplasia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congestive hepatopathy | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral ataxia | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spondylitis | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell abnormality | 0 | 0.001 | 0.17 | 1 | 2.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventilation/perfusion scan normal | 0 | 0.001 | 0.102 | 1 | 2.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercepted product administration error | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercepted medication error | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular function test abnormal | 0 | 0 | 0.076 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paresis cranial nerve | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen consumption increased | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral surgery | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatic heart disease | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otic examination normal | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urobilinogen faeces normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy pharynx normal | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjustment disorder with depressed mood | 0 | 0 | 0.04 | 1 | 3.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated myositis | 0 | 0 | 0.026 | 1 | 3.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint deposit | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoantibody test | 0 | 0 | 0.111 | 1 | 2.632 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood oestrogen | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal examination | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tyrosinaemia | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular ejection fraction decreased | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis membranoproliferative | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral infection | 0 | 0 | 0.072 | 1 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral paralysis | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb amputation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal transit time increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchopulmonary dysplasia | 0 | 0 | 0.007 | 1 | 3.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand-foot-and-mouth disease | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal discharge | 0 | 0 | 0.009 | 1 | 3.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine polyp | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull malformation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Victim of child abuse | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body in ear | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Directional Doppler flow tests | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural stroke | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traumatic lumbar puncture | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary cyst | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tract infection fungal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast induration | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benzodiazepine drug level | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortitis | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound bladder abnormal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreas infection | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palmoplantar pustulosis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metaphyseal dysplasia | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric perforation | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disability assessment scale score decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus hepatitis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood product transfusion dependent | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin globulin ratio abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protrusion tongue | 0 | 0.001 | 0.302 | 1 | 2.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasm skin | 0 | 0 | 0.122 | 1 | 2.582 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seborrhoea | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin culture positive | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral artery thrombosis | 0 | 0 | 0.112 | 1 | 2.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial biopsy abnormal | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subdural effusion | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal scan | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte count abnormal | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous symptom | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia respiratory syncytial viral | 0 | 0 | 0.049 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Klebsiella infection | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal cyst | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupillary light reflex tests | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve transposition | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidural injection | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystal arthropathy | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram liver | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site haematoma | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thiopurine methyltransferase decreased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinobronchitis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opportunistic infection | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal stoma complication | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fulguration | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flour sensitivity | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF neutrophil count positive | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arrhythmia neonatal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus antibody | 0 | 0.001 | 0.204 | 1 | 2.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells stool positive | 0 | 0 | 0.004 | 1 | 3.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal injury | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drop attacks | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour marker decreased | 0 | 0 | 0.04 | 1 | 3.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin dystrophy | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal monitoring normal | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor VIII deficiency | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol interaction | 0 | 0 | 0.071 | 1 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion early | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin saturation increased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural hypotension | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postictal psychosis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patent ductus arteriosus repair | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Germ cell neoplasm | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Femoral nerve injury | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidermoid cyst excision | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borderline glaucoma | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperchylomicronaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Portal shunt procedure | 0 | 0 | 0.051 | 1 | 3.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood corticotrophin normal | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic myeloid leukaemia | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroglobulin decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder scan | 0 | 0.001 | 0.16 | 1 | 2.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand deformity | 0 | 0 | 0.071 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular function test | 0 | 0 | 0.069 | 1 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Freezing phenomenon | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulum intestinal haemorrhagic | 0 | 0 | 0.021 | 1 | 3.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood zinc normal | 0 | 0 | 0.077 | 1 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood oestrogen increased | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site rash | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amyloidosis | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin globulin ratio decreased | 0 | 0 | 0.011 | 1 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acidosis hyperchloraemic | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parathyroid hormone-related protein increased | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optical coherence tomography normal | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossopharyngeal neuralgia | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug administered in wrong device | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF volume increased | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lead normal | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular neoplasm | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine mass | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary assistance device user | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diet noncompliance | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adhesion | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumefactive multiple sclerosis | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar atrophy | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic aspiration | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-uterine contraceptive device insertion | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis chronic active | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gestational age test abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female genital tract fistula | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Essential thrombocythaemia | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blunted affect | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood 1,25-dihydroxycholecalciferol decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha tumour necrosis factor | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proctalgia | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human bocavirus infection | 0 | 0 | 0.038 | 1 | 3.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterobacter infection | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous disorder | 0 | 0 | 0.016 | 1 | 3.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung cancer metastatic | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decorticate posture | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circumstance or information capable of leading to device use error | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure orthostatic abnormal | 0 | 0 | 0.012 | 1 | 3.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patient restraint | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower urinary tract symptoms | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gomori methenamine silver stain | 0 | 0 | 0.002 | 1 | 3.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy thyroid gland | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transillumination | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rasmussen encephalitis | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral artery stent insertion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthostatic heart rate response increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orchidectomy | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal distress during labour | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C core antibody negative | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal growth abnormality | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema toxicum neonatorum | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile acid malabsorption | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accelerated idioventricular rhythm | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic mass | 0 | 0 | 0.037 | 1 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromosome analysis abnormal | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocyte percentage decreased | 0 | 0 | 0.107 | 1 | 2.65 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbosacral radiculopathy | 0 | 0 | 0.1 | 1 | 2.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspergillus test | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waterhouse-Friderichsen syndrome | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time abnormal | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital infection fungal | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opiates negative | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced expiratory flow | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trance | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflexes abnormal | 0 | 0.001 | 0.196 | 1 | 2.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhesus antigen negative | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transcutaneous pacing | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic response delayed | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary duct inflammation | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reynold's syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precocious puberty | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrobiosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphadenitis viral | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix cancer metastatic | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone decalcification | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood copper increased | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Focal dyscognitive seizures | 0 | 0.001 | 0.149 | 1 | 2.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary casts | 0 | 0.001 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenotonsillectomy | 0 | 0.001 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Indifference | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweat test abnormal | 0 | 0 | 0.017 | 1 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold type haemolytic anaemia | 0 | 0 | 0.106 | 1 | 2.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasospasm | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpes virus 8 test | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acne infantile | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH urine increased | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity body fluid | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purulent pericarditis | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prinzmetal angina | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basal ganglia haematoma | 0 | 0 | 0.088 | 1 | 2.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urea urine decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spermatorrhoea | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal shock | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy with young maternal age | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Onycholysis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal gastrointestinal disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Natural killer cell activity normal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forearm fracture | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluorescent in situ hybridisation negative | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometrial ablation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ebola disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Confluent and reticulate papillomatosis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood acid phosphatase | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune colitis | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congestive cardiomyopathy | 0 | 0 | 0.144 | 1 | 2.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract infection bacterial | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vibration test abnormal | 0 | 0 | 0.027 | 1 | 3.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Methylmalonic aciduria | 0 | 0 | 0.024 | 1 | 3.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus hyposecretion | 0 | 0 | 0.112 | 1 | 2.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chondrocalcinosis pyrophosphate | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood potassium abnormal | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suture related complication | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Snapping hip syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Missed labour | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair growth rate abnormal | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glaucoma traumatic | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor XIII deficiency | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye complication associated with device | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic myelomonocytic leukaemia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy pharynx abnormal | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial thrombosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spirometry normal | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhesus antibodies positive | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Removal of foreign body from rectum | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic specific antigen decreased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperthermia therapy | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein B increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue paralysis | 0 | 0 | 0.159 | 1 | 2.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein S deficiency | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Detoxification | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postural tremor | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suspiciousness | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Posterior capsule opacification | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Continuous haemodiafiltration | 0 | 0.001 | 0.097 | 1 | 2.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acetonaemia | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal septum disorder | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subcutaneous emphysema | 0 | 0 | 0.023 | 1 | 3.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV test positive | 0 | 0.001 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinopexy | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal scab | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ankyloglossia congenital | 0 | 0 | 0.037 | 1 | 3.127 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic dysplasia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obsessive-compulsive personality disorder | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell agglutination present | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal adhesions | 0 | 0 | 0.068 | 1 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urge incontinence | 0 | 0 | 0.091 | 1 | 2.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF mononuclear cell count increased | 0 | 0.001 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign breast lump removal | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular filtration rate increased | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level above therapeutic | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatorenal syndrome | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythroblast count increased | 0 | 0 | 0.076 | 1 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell morphology | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrosis ischaemic | 0 | 0 | 0.015 | 1 | 3.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inguinal hernia repair | 0 | 0.001 | 0.144 | 1 | 2.494 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complications of transplanted heart | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound complication | 0 | 0.001 | 0.123 | 1 | 2.578 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typhus rickettsia test positive | 0 | 0 | 0.042 | 1 | 3.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue operation | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye laser surgery | 0 | 0 | 0.025 | 1 | 3.279 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombin time | 0 | 0 | 0.119 | 1 | 2.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meniscus injury | 0 | 0 | 0.135 | 1 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal tract irritation | 0 | 0 | 0.073 | 1 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid operation | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic rupture | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via unknown route | 0 | 0 | 0.047 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Avulsion fracture | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Residual urine volume | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein C deficiency | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porphyria screen | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Marcus Gunn syndrome | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interferon alpha level decreased | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site cellulitis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hooded prepuce | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic cancer metastatic | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Giardia test positive | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal ischaemia | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug-disease interaction | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cavernous sinus thrombosis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carnett's sign positive | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac contusion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood mercury normal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspartate aminotransferase abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortogram abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coccydynia | 0 | 0.001 | 0.176 | 1 | 2.376 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accessory spleen | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital capacity | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary nitrogen increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian dysplasia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine disorder | 0 | 0 | 0.064 | 1 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress urinary incontinence | 0 | 0 | 0.037 | 1 | 3.127 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ingrown hair | 0 | 0 | 0.083 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiosyncratic drug reaction | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast enlargement | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral labyrinthitis | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stenotrophomonas test positive | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin unconjugated | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blast cell crisis | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aeromonas infection | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site vesicles | 0 | 0 | 0.082 | 1 | 2.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visceral congestion | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestine adenocarcinoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein albumin ratio abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mediastinal mass | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site swelling | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric mucosa erythema | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal mucosal necrosis | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear infection fungal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood galactose | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quadrantanopia | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Balanoposthitis | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oligodipsia | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracardiac thrombus | 0 | 0 | 0.009 | 1 | 3.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Auricular swelling | 0 | 0 | 0.093 | 1 | 2.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device use issue | 0 | 0 | 0.057 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bulimia nervosa | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arachnoiditis | 0 | 0 | 0.036 | 1 | 3.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B6 increased | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfective myringitis | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hormone refractory breast cancer | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic vascular disorder | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital bladder anomaly | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Charles Bonnet syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood insulin decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood acid phosphatase decreased | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy vagina abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolar oxygen partial pressure decreased | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lysozyme | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan myocardial perfusion abnormal | 0 | 0 | 0.006 | 1 | 3.742 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | False positive investigation result | 0 | 0.001 | 0.096 | 1 | 2.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein A-I decreased | 0 | 0 | 0.004 | 1 | 3.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Elbow operation | 0 | 0 | 0.057 | 1 | 2.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia urinary tract infection | 0 | 0.001 | 0.22 | 1 | 2.239 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device related infection | 0 | 0.001 | 0.108 | 1 | 2.648 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site ulcer | 0 | 0.001 | 0.06 | 1 | 2.926 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High density lipoprotein | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Volume blood decreased | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein albumin ratio | 0 | 0 | 0.035 | 1 | 3.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin C-peptide decreased | 0 | 0 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal epithelium defect | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-platelet antibody | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-tobacco user | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Airway secretion clearance therapy | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine calcium | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total lung capacity | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal examination abnormal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube cancer metastatic | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema nummular | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colonic fistula | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colorectal cancer metastatic | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial wall hypertrophy | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin saturation | 0 | 0.001 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear injury | 0 | 0 | 0.128 | 1 | 2.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reversible cerebral vasoconstriction syndrome | 0 | 0 | 0.08 | 1 | 2.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mannose-binding lectin deficiency | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemangioma-thrombocytopenia syndrome | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Familial tremor | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasodilation procedure | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomach lesion excision | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seroconversion test positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary hyperaldosteronism | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to heart | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical device implantation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iodine uptake increased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery stent insertion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Regressive behaviour | 0 | 0.001 | 0.178 | 1 | 2.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial reperfusion injury | 0 | 0.001 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menopause | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-muscle specific kinase antibody | 0 | 0 | 0.117 | 1 | 2.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site pain | 0 | 0 | 0.024 | 1 | 3.285 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pressure of speech | 0 | 0 | 0.03 | 1 | 3.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Matrix metalloproteinase-3 increased | 0 | 0 | 0.005 | 1 | 3.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute haemorrhagic leukoencephalitis | 0 | 0 | 0.005 | 1 | 3.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurosensory hypoacusis | 0 | 0 | 0.007 | 1 | 3.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver tumours of unspecified malignancy (SMQ) [broad] | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dacryostenosis acquired | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram pulmonary | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong schedule | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine chloride increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial cyst | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite tissue specimen test negative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lice infestation | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukostasis syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atonic urinary bladder | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-insulin antibody | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-JC virus antibody index | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin urine absent | 0 | 0 | 0.109 | 1 | 2.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opsoclonus myoclonus | 0 | 0 | 0.02 | 1 | 3.359 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pustular psoriasis | 0 | 0 | 0.034 | 1 | 3.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastritis haemorrhagic | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encapsulation reaction | 0 | 0 | 0.052 | 1 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin CSF abnormal | 0 | 0 | 0.039 | 1 | 3.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yersinia infection | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular cauterisation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon laxity | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestinal ulcer haemorrhage | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tract disorder | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein amniotic fluid normal | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acrophobia | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somnambulism | 0 | 0.001 | 0.114 | 1 | 2.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip and/or oral cavity cancer | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose urine | 0 | 0 | 0.01 | 1 | 3.582 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterior chamber cell | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal artery thrombosis | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procalcitonin abnormal | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperresponsive to stimuli | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extremity necrosis | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymol turbidity test | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine free | 0 | 0 | 0.033 | 1 | 3.171 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfective gingivitis | 0 | 0 | 0.069 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clavicle fracture | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament disorder | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amyotrophy | 0 | 0 | 0.034 | 1 | 3.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile wart | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram Q wave abnormal | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytokine abnormal | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholecystitis chronic | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to synthetic fabric | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberous sclerosis complex | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prolonged rupture of membranes | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleurisy viral | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Long thoracic nerve palsy | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Euglycaemic diabetic ketoacidosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival disorder | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clinical death | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy rectum normal | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site papules | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoalveolar lavage | 0 | 0 | 0.1 | 1 | 2.686 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium swallow normal | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal stenosis | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle operation | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meige's syndrome | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate deceleration abnormality | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval cancer stage 0 | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin C deficiency | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray of pelvis and hip normal | 0 | 0.001 | 0.212 | 1 | 2.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoventilation | 0 | 0 | 0.026 | 1 | 3.262 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid hormones increased | 0 | 0.001 | 0.101 | 1 | 2.68 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue spasm | 0 | 0 | 0.074 | 1 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal motility disorder | 0 | 0 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level therapeutic | 0 | 0 | 0.094 | 1 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem haemorrhage | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bartonella test positive | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quantitative sudomotor axon reflex test | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis rapidly progressive | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disinhibition | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor XIII level decreased | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous recanalisation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweat gland infection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngitis bacterial | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericarditis rheumatic | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipids abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive nephropathy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin S increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gardnerella infection | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VIII level | 0 | 0 | 0.051 | 1 | 2.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Canthoplasty | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain tumour operation | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic valve disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site atrophy | 0 | 0.001 | 0.362 | 1 | 1.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal lesion | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Squamous cell carcinoma of the cervix | 0 | 0 | 0.005 | 1 | 3.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasomnia | 0 | 0 | 0.031 | 1 | 3.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy with contraceptive device | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal operation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leiomyosarcoma | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iodine uptake normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjustment disorder with anxiety | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saliva analysis abnormal | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penoscrotal fusion | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF electrophoresis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site pruritus | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic valve replacement | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial rub | 0 | 0 | 0.06 | 1 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periventricular leukomalacia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toe amputation | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoiditis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicitis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bicytopenia | 0 | 0.001 | 0.13 | 1 | 2.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apolipoprotein | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lagophthalmos | 0 | 0.001 | 0.145 | 1 | 2.487 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermohypoaesthesia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiation injury | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parietal cell antibody positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte percentage abnormal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperchromic anaemia | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhoids thrombosed | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration bursa abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral haemorrhage | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trigeminal nerve paresis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid lung | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary hyperthyroidism | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic operation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstrual cycle management | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lobular breast carcinoma in situ | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin C-peptide abnormal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inborn error of lipid metabolism | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breathing-related sleep disorder | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone lesion | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-cell lymphoma recurrent | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anisochromia | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | 5'nucleotidase increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nipple swelling | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitogen stimulation test | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perseveration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tocolysis | 0 | 0 | 0.004 | 1 | 3.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoacoustic emissions test abnormal | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucormycosis | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hostility | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time ratio increased | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotony of eye | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal mask airway insertion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood uric acid decreased | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary scan normal | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradycardia foetal | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopaedic examination | 0 | 0.001 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal calprotectin decreased | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choroidal neovascularisation | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shigella test positive | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated adverse reaction | 0 | 0.001 | 0.209 | 1 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basilar artery occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy abdominal wall abnormal | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine free abnormal | 0 | 0 | 0.082 | 1 | 2.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic hypothermia | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic membrane rupture test positive | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Excessive granulation tissue | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myasthenic syndrome | 0 | 0 | 0.011 | 1 | 3.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | BK virus infection | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | DiGeorge's syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy kidney normal | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal respiratory depression | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypervolaemia | 0 | 0 | 0.039 | 1 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy breast normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor weight gain neonatal | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal carcinoma | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delayed myelination | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriovenous malformation | 0 | 0 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-VGCC antibody | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular graft | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sigmoidoscopy normal | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prealbumin increased | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic disorders specifically reported as alcohol-related (SMQ) [broad] | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cord blood transplant therapy | 0 | 0 | 0.049 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary fragility test | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary cerebellar degeneration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal operation | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oculomotor study normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micturition frequency decreased | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kluver-Bucy syndrome | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic contracture of the left ventricle | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated lung disease | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersplenism | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foot operation | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram Q waves | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ductal adenocarcinoma of pancreas | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lymphocyte count normal | 0 | 0.001 | 0.349 | 1 | 1.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site cyst | 0 | 0.001 | 0.265 | 1 | 2.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occipital neuralgia | 0 | 0.001 | 0.129 | 1 | 2.553 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polychromasia | 0 | 0.001 | 0.126 | 1 | 2.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal vasculitis | 0 | 0 | 0.084 | 1 | 2.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal cardiac disorder | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF shunt operation | 0 | 0 | 0.035 | 1 | 3.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site nodule | 0 | 0 | 0.098 | 1 | 2.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal monitoring abnormal | 0 | 0 | 0.045 | 1 | 3.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleurodesis | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug provocation test | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pyruvic acid increased | 0 | 0 | 0.018 | 1 | 3.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute graft versus host disease | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal symptom | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular detachment | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Janus kinase 2 mutation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraductal papillary mucinous neoplasm | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eustachian tube disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopic retrograde cholangiopancreatography | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrolyte depletion | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C1 esterase inhibitor test normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barbiturates positive | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep terror | 0 | 0.001 | 0.249 | 1 | 2.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex test | 0 | 0.001 | 0.229 | 1 | 2.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Major depression | 0 | 0 | 0.088 | 1 | 2.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysacusis | 0 | 0.001 | 0.195 | 1 | 2.315 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Methylenetetrahydrofolate reductase gene mutation | 0 | 0.001 | 0.193 | 1 | 2.32 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xerophthalmia | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reaction to food additive | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site necrosis | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterocolitis infectious | 0 | 0 | 0.042 | 1 | 3.079 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs direct test negative | 0 | 0.001 | 0.134 | 1 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Goodpasture's syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left ventricular dilatation | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implant site swelling | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heterosexuality | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-saccharomyces cerevisiae antibody | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Growth hormone deficiency | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritonitis bacterial | 0 | 0 | 0.008 | 1 | 3.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF myelin basic protein | 0 | 0 | 0.019 | 1 | 3.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary obstruction | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral load | 0 | 0 | 0.002 | 1 | 4.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestine anastomosis | 0 | 0 | 0.084 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive encephalopathy | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis D | 0 | 0 | 0.002 | 1 | 4.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbohydrate antigen 125 normal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site extravasation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature baby death | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Placenta praevia haemorrhage | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paracentesis eye normal | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast discharge infected | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Boredom | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder cancer stage IV | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy tendon abnormal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site joint movement impairment | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoviral meningitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion spontaneous incomplete | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdomen scan normal | 0 | 0 | 0.001 | 1 | 4.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestradiol normal | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptococcus test positive | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vocal cord paresis | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal injury | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer recurrent | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone fragmentation | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biofeedback therapy | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary malignant tumours (SMQ) [narrow] | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-glycyl-tRNA synthetase antibody positive | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin K decreased | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poikilocytosis | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Persecutory delusion | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve sheath haemorrhage | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to pelvis | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal disorder prophylaxis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electric shock | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dennie-Morgan fold | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital ureterovesical junction anomaly | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidental exposure to product by child | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydronephrosis | 0 | 0.001 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic mastocytosis | 0 | 0 | 0.06 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal dryness | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Syringomyelia | 0 | 0 | 0.031 | 1 | 3.193 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver function test decreased | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical diet | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal abscess | 0 | 0 | 0.018 | 1 | 3.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal vascular occlusion | 0 | 0 | 0.076 | 1 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spleen palpable | 0 | 0 | 0.069 | 1 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail infection | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Copper deficiency | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aeromonas test positive | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal hydrocele | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary artery atresia | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-traumatic neuralgia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal oedema | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis tuberculous | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood viscosity increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood albumin abnormal | 0 | 0 | 0.063 | 1 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery dilatation | 0 | 0.001 | 0.185 | 1 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oligomenorrhoea | 0 | 0 | 0.006 | 1 | 3.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral venous disease | 0 | 0.001 | 0.121 | 1 | 2.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal pain | 0 | 0 | 0.106 | 1 | 2.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperammonaemia | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile discharge | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine inversion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal pigmentation | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Moyamoya disease | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Latent tetany | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram pancreas normal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen consumption decreased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mini mental status examination normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging abdominal normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dihydrotestosterone decreased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone debridement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriovenous fistula aneurysm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agnosia | 0 | 0 | 0.074 | 1 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic hepatitis C | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cognitive linguistic deficit | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site pruritus | 0 | 0 | 0.021 | 1 | 3.341 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prescription drug used without a prescription | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngitis allergic | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrophy of tongue papillae | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye colour change | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorioretinal disorder | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alcohol increased | 0 | 0 | 0.039 | 1 | 3.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | AST/ALT ratio | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subretinal hyperreflective exudation | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal embolism | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal rupture | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurologic somatic symptom disorder | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoblast count | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic wound | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corticobasal degeneration | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Compulsive handwashing | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess of salivary gland | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory processing disorder | 0 | 0.001 | 0.185 | 1 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QRS complex normal | 0 | 0.001 | 0.154 | 1 | 2.455 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinitis | 0 | 0.001 | 0.155 | 1 | 2.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal resection | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | LE cells | 0 | 0 | 0.092 | 1 | 2.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temperature difference of extremities | 0 | 0 | 0.033 | 1 | 3.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull fractured base | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nodular rash | 0 | 0 | 0.101 | 1 | 2.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red man syndrome | 0 | 0 | 0.067 | 1 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Koebner phenomenon | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercostal neuralgia | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic foot | 0 | 0 | 0.045 | 1 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coccidioidomycosis | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter site erythema | 0 | 0 | 0.044 | 1 | 3.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal erosion | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericarditis tuberculous | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal intestinal perforation | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meigs' syndrome | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging breast normal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to contaminated air | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter culture positive | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell count decreased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal disorder | 0 | 0 | 0.159 | 1 | 2.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF virus identified | 0 | 0 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine nitrogen | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Self-injurious ideation | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prohormone brain natriuretic peptide increased | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interleukin-2 receptor assay | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forceps delivery | 0 | 0 | 0.035 | 1 | 3.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alice in wonderland syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye oedema | 0 | 0.001 | 0.286 | 1 | 2.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | West Nile virus test | 0 | 0 | 0.123 | 1 | 2.579 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B1 | 0 | 0 | 0.212 | 1 | 2.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid pain | 0 | 0.001 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site macule | 0 | 0 | 0.081 | 1 | 2.792 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular examination abnormal | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid operation | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral microhaemorrhage | 0 | 0 | 0.085 | 1 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blast cell count increased | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethritis noninfective | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteric dilatation | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracotomy | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prader-Willi syndrome | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema blister | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lysozyme increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatofibrosarcoma protuberans | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSWS syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thromboplastin increased | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin urine normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint hyperextension | 0 | 0.001 | 0.201 | 1 | 2.295 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity urine increased | 0 | 0.001 | 0.142 | 1 | 2.5 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Onychomadesis | 0 | 0.001 | 0.156 | 1 | 2.447 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower respiratory tract infection viral | 0 | 0 | 0.037 | 1 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign lymph node neoplasm | 0 | 0 | 0.098 | 1 | 2.697 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine free decreased | 0 | 0.001 | 0.115 | 1 | 2.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | N-terminal prohormone brain natriuretic peptide normal | 0 | 0 | 0.102 | 1 | 2.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytokine release syndrome | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin decreased | 0 | 0 | 0.05 | 1 | 3.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product effective for unapproved indication | 0 | 0 | 0.008 | 1 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal fluid analysis abnormal | 0 | 0 | 0.067 | 1 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin normal | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid skin dryness | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness permanent | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac murmur functional | 0 | 0 | 0.05 | 1 | 3.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral meatus stenosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteral stent insertion | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reaction to colouring | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic partial epilepsy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head circumference | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival erosion | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced vital capacity normal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Discouragement | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased gait velocity | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 2 globulin increased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis viral test | 0 | 0.001 | 0.251 | 1 | 2.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration joint normal | 0 | 0.001 | 0.144 | 1 | 2.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropathic muscular atrophy | 0 | 0.001 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye patch application | 0 | 0.001 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prealbumin | 0 | 0 | 0.037 | 1 | 3.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-traumatic neck syndrome | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure inadequately controlled | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood parathyroid hormone increased | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Von Willebrand's factor activity increased | 0 | 0 | 0.028 | 1 | 3.23 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic fluid-air exchange procedure | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureterolithiasis | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Senile dementia | 0 | 0 | 0.001 | 1 | 4.231 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan gallium abnormal | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reactive airways dysfunction syndrome | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periodontitis | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device power source issue | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic granulomatous disease | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal disorder | 0 | 0.001 | 0.312 | 1 | 2.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal candidiasis | 0 | 0 | 0.029 | 1 | 3.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid contusion | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleuropericarditis | 0 | 0 | 0.092 | 1 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oversensing | 0 | 0 | 0.012 | 1 | 3.528 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal spasm | 0 | 0 | 0.009 | 1 | 3.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraneoplastic syndrome | 0 | 0 | 0.077 | 1 | 2.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meniscus operation | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripancreatic fluid collection | 0 | 0 | 0.08 | 1 | 2.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testis cancer | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin ulcer haemorrhage | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sarcopenia | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Resting tremor | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postmortem blood drug level increased | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve destruction | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic discs blurred | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrobiosis lipoidica diabeticorum | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fracture treatment | 0 | 0 | 0.006 | 1 | 3.733 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema eyelids | 0 | 0 | 0.005 | 1 | 3.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | External ear pain | 0 | 0.001 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Xanthopsia | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin level increased | 0 | 0 | 0.109 | 1 | 2.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration related reaction | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemangioma of liver | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corynebacterium bacteraemia | 0 | 0 | 0.043 | 1 | 3.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B2 | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trabeculectomy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenotomy | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superficial injury of eye | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet function test normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Omental necrosis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meibomian gland dysfunction | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Friedreich's ataxia | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival erosion | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure diastolic abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic stent insertion | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall mass | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium enema abnormal | 0 | 0 | 0.038 | 1 | 3.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0 | 0.122 | 1 | 2.582 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropsychiatric symptoms | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival discolouration | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood testosterone normal | 0 | 0 | 0.042 | 1 | 3.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast lower gastrointestinal tract | 0 | 0 | 0.099 | 1 | 2.689 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor increased | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product use complaint | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post vaccination challenge strain shedding | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuro-ophthalmological test normal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual snow syndrome | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-muscle specific kinase antibody negative | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective abortion | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal sympathetic nerve ablation | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colour blindness acquired | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chylothorax | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer stage I | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood prolactin decreased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atypical mycobacterium pericarditis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic band syndrome | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha-2 macroglobulin increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neovascularisation | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar hernia | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High risk sexual behaviour | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastritis bacterial | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Moraxella test positive | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multinucleate cell angiohistiocytoma | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoosmolar state | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossopharyngeal nerve disorder | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electric shock sensation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholestasis of pregnancy | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site haemorrhage | 0 | 0 | 0.062 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accelerated hypertension | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratopathy | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain scan abnormal | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine potassium increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agglutination test | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pituitary cyst | 0 | 0 | 0.005 | 1 | 3.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrophages decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal dystrophy | 0 | 0 | 0.012 | 1 | 3.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile duct stone | 0 | 0 | 0.096 | 1 | 2.705 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine malposition | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypocoagulable state | 0 | 0 | 0.007 | 1 | 3.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chordee | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inappropriate antidiuretic hormone secretion | 0 | 0.001 | 0.179 | 1 | 2.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site phlebitis | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy stomach abnormal | 0 | 0.001 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | BRCA1 gene mutation assay | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic necrosis | 0 | 0.001 | 0.131 | 1 | 2.546 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary lipids present | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inborn error of metabolism | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound spleen | 0 | 0 | 0.132 | 1 | 2.542 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ceruloplasmin normal | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratitis interstitial | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rapid eye movement sleep behaviour disorder | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bicarbonate abnormal | 0 | 0 | 0.023 | 1 | 3.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear infection staphylococcal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic bronchitis | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraosseous access placement | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin S normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess abnormal | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy tongue | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth avulsion | 0 | 0 | 0.01 | 1 | 3.57 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic enzymes increased | 0 | 0 | 0.128 | 1 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vena cava embolism | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary physical examination abnormal | 0 | 0 | 0.019 | 1 | 3.363 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell hyperchromic morphology present | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myalgia intercostal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypocapnia | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis allergic | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 microglobulin | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bicarbonate | 0 | 0 | 0.132 | 1 | 2.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery occlusion | 0 | 0.001 | 0.114 | 1 | 2.617 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rapid eye movements sleep abnormal | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum purulent | 0 | 0 | 0.041 | 1 | 3.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast upper gastrointestinal tract abnormal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric fluid analysis abnormal | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac dysfunction | 0 | 0 | 0.051 | 1 | 2.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood 1,25-dihydroxycholecalciferol | 0 | 0 | 0.016 | 1 | 3.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band sensation | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Taciturnity | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum serotonin decreased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periphlebitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Holmes-Adie pupil | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product lot number issue | 0 | 0 | 0.004 | 1 | 3.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical vertebral fracture | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular dementia | 0 | 0 | 0.011 | 1 | 3.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorioretinopathy | 0 | 0 | 0.083 | 1 | 2.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Von Willebrand's factor antigen increased | 0 | 0 | 0.089 | 1 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine electrophoresis abnormal | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subdural haematoma evacuation | 0 | 0 | 0.088 | 1 | 2.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic pigmented purpura | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burning sensation mucosal | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vth nerve injury | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal meningeal cyst | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Omentectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chondritis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bowen's disease | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antral follicle count | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia postoperative | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjustment disorder with mixed anxiety and depressed mood | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acne varioliformis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasm | 0 | 0 | 0.02 | 1 | 3.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penis disorder | 0 | 0 | 0.039 | 1 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood folate increased | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord neoplasm | 0 | 0 | 0.069 | 1 | 2.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Social fear | 0 | 0 | 0.08 | 1 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary sepsis | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coma acidotic | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma viscosity abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood androstenedione | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural fibrosis | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal aspirate culture | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythropenia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Assisted reproductive technology | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract haemorrhage | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echoencephalogram | 0 | 0 | 0.02 | 1 | 3.363 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Methaemoglobinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile culture positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood triglycerides abnormal | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepcidin test | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet-large cell ratio increased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genotype drug resistance test | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal hypomotility | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microvascular coronary artery disease | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF electrophoresis normal | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint vibration | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catecholamines urine | 0 | 0 | 0.008 | 1 | 3.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panencephalitis | 0 | 0 | 0.003 | 1 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound therapy | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanometry abnormal | 0 | 0 | 0.04 | 1 | 3.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cellulitis staphylococcal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine cancer | 0 | 0 | 0.025 | 1 | 3.274 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scintillating scotoma | 0 | 0 | 0.122 | 1 | 2.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity unsaturated | 0 | 0 | 0.034 | 1 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperprolactinaemia | 0 | 0 | 0.007 | 1 | 3.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis eosinophilic | 0 | 0 | 0.055 | 1 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to contaminated device | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tobacco abuse | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid infection | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise test normal | 0 | 0 | 0.042 | 1 | 3.075 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trisomy 12 | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Term birth | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Surfactant protein increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pterygium | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet morphology | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatic hallucination | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflux nephropathy | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary valve stenosis congenital | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product substitution error | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plague | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occupational therapy | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manipulation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hallucination, tactile | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embedded device | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest tube removal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic fluid index decreased | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acid-base balance disorder mixed | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | New daily persistent headache | 0 | 0 | 0.005 | 1 | 3.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal candidiasis | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastocytoma | 0 | 0 | 0.076 | 1 | 2.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stenotrophomonas infection | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumoconiosis | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Instillation site erythema | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Divorced | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram coronary artery normal | 0 | 0 | 0.072 | 1 | 2.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic hepatitis | 0 | 0 | 0.003 | 1 | 3.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cleft lip | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia vitamin B12 deficiency | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Water deprivation test | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculosis of central nervous system | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Short stature | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet aggregation normal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pathological doubt | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestrogen therapy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laparoscopy abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via body fluid | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clotting factor transfusion | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea abnormal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Automatism epileptic | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenergic syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood parathyroid hormone normal | 0 | 0.001 | 0.145 | 1 | 2.486 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choroiditis | 0 | 0.001 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal examination abnormal | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-ganglioside antibody | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PO2 abnormal | 0 | 0 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary physical examination | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental discomfort | 0 | 0 | 0.014 | 1 | 3.47 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchitis bacterial | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal cancer | 0 | 0 | 0.039 | 1 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site odour | 0 | 0 | 0.032 | 1 | 3.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thumb sucking | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smooth muscle antibody | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Persistent depressive disorder | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antigen positive | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | False negative investigation result | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve injury | 0 | 0 | 0.004 | 1 | 3.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate dehydrogenase normal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure diastolic | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tick-borne fever | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subcutaneous biopsy | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal fissure | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female orgasmic disorder | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ependymitis | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs negative haemolytic anaemia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood corticotrophin abnormal | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site movement impairment | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-thrombin antibody | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-neuronal antibody positive | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product packaging issue | 0 | 0 | 0.107 | 1 | 2.654 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelosuppression | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic transformation stroke | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemofiltration | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Double hit lymphoma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiospasm | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MM decreased | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal mass | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIth nerve disorder | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site hypertrophy | 0 | 0 | 0.037 | 1 | 3.128 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic failure | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic enlargement | 0 | 0 | 0.03 | 1 | 3.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fasciotomy | 0 | 0 | 0.029 | 1 | 3.223 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transverse sinus thrombosis | 0 | 0 | 0.028 | 1 | 3.232 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan bone marrow normal | 0 | 0 | 0.082 | 1 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angina bullosa haemorrhagica | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral diarrhoea | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urogram | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spontaneous haematoma | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nutritional condition abnormal | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Male reproductive tract disorder | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal angioedema | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic pneumonia | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head circumference normal | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exchange blood transfusion | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal convulsions | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Compulsions | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix operation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic fluid volume increased | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aldosterone urine | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suffocation feeling | 0 | 0.001 | 0.143 | 1 | 2.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress echocardiogram normal | 0 | 0 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet morphology abnormal | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary sediment | 0 | 0 | 0.005 | 1 | 3.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic metabolic decompensation | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delayed fontanelle closure | 0 | 0 | 0.084 | 1 | 2.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic graft versus host disease | 0 | 0 | 0.07 | 1 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colour vision tests abnormal | 0 | 0 | 0.039 | 1 | 3.106 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma stage II | 0 | 0 | 0.005 | 1 | 3.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood carbon monoxide increased | 0 | 0 | 0.065 | 1 | 2.889 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial occlusive disease | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitochondrial myopathy | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Astrocytoma | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine amphetamine positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pudendal canal syndrome | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to the mediastinum | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Locomotive syndrome | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deep brain stimulation | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast engorgement | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alanine aminotransferase abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalomalacia | 0 | 0.001 | 0.175 | 1 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal inflammation | 0 | 0 | 0.071 | 1 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal compartment syndrome | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal respiratory distress syndrome | 0 | 0 | 0.012 | 1 | 3.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thalassaemia | 0 | 0 | 0.007 | 1 | 3.665 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infected skin ulcer | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chromium | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimitochondrial antibody | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time abnormal | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion incomplete | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venoocclusive disease | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine zinc | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth repair | 0 | 0 | 0.076 | 1 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tolosa-Hunt syndrome | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin maceration | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post transfusion purpura | 0 | 0 | 0.001 | 1 | 4.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal syndrome | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash follicular | 0 | 0 | 0.106 | 1 | 2.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy small intestine abnormal | 0 | 0 | 0.052 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysmetropsia | 0 | 0 | 0.004 | 1 | 3.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood selenium | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis viral | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve decompression | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular pseudohole | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kounis syndrome | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deformity of orbit | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone giant cell tumour | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcal sepsis | 0 | 0.001 | 0.096 | 1 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian operation | 0 | 0 | 0.037 | 1 | 3.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4/CD8 ratio decreased | 0 | 0 | 0.073 | 1 | 2.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoprotein (a) | 0 | 0 | 0.092 | 1 | 2.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coarctation of the aorta | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-VGKC antibody positive | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ADAMTS13 activity increased | 0 | 0 | 0.056 | 1 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Violence-related symptom | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular encephalopathy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapy partial responder | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell scan | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Murphy's sign positive | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip infection | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy tonsil | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antidiuretic hormone abnormality | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antisynthetase syndrome | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasculitic rash | 0 | 0.001 | 0.179 | 1 | 2.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventriculo-peritoneal shunt | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mutism | 0 | 0 | 0.114 | 1 | 2.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair texture abnormal | 0 | 0 | 0 | 1 | 4.542 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral injury | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temperature perception test decreased | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porphyrins urine | 0 | 0 | 0.053 | 1 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Montreal cognitive assessment | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body in respiratory tract | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatochalasis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone deformity | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy eyelid | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alagille syndrome | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site abscess | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meniere's disease | 0 | 0.001 | 0.216 | 1 | 2.252 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthropod sting | 0 | 0.001 | 0.169 | 1 | 2.402 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast | 0 | 0 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic scan | 0 | 0 | 0.084 | 1 | 2.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary scan abnormal | 0 | 0 | 0.089 | 1 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pityriasis rubra pilaris | 0 | 0 | 0.072 | 1 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematoma muscle | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendix disorder | 0 | 0 | 0.024 | 1 | 3.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanometry normal | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal syndrome neonatal | 0 | 0 | 0.003 | 1 | 3.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital syphilis | 0 | 0 | 0.055 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site nodule | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor VIII antibody negative | 0 | 0 | 0.002 | 1 | 4.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine phosphorus increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic mycosis | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic embolus | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian germ cell teratoma | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar vertebral fracture | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Listeriosis | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Balance test | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amphetamines positive | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong dose | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIIIth nerve lesion | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal erosion | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet aggregation decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital disorder | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic therapy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diaphragm muscle weakness | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatophagia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal diameter increased | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukocyturia | 0 | 0 | 0.079 | 1 | 2.8 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ehrlichia test | 0 | 0 | 0.225 | 1 | 2.225 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vocal cord dysfunction | 0 | 0 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system viral infection | 0 | 0 | 0.091 | 1 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastatic malignant melanoma | 0 | 0 | 0.016 | 1 | 3.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye haematoma | 0 | 0 | 0.033 | 1 | 3.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Marginal zone lymphoma | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal erythema | 0 | 0 | 0.001 | 1 | 4.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood insulin | 0 | 0 | 0.076 | 1 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine aluminium increased | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic artery aneurysm | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single component of a two-component product administered | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post streptococcal glomerulonephritis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurosyphilis | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin blood present | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microencephaly | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implant site infection | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heat therapy | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopic retrograde cholangiopancreatography abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lung normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bladder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Telangiectasia | 0 | 0.001 | 0.178 | 1 | 2.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carboxyhaemoglobin normal | 0 | 0.001 | 0.212 | 1 | 2.264 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuromuscular pain | 0 | 0 | 0.087 | 1 | 2.756 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye abscess | 0 | 0 | 0.034 | 1 | 3.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular hypertrophy | 0 | 0 | 0.003 | 1 | 3.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia pseudomonal | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal dilation procedure | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal hypertrophy | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal inflammation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal thinning | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath sounds | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Analgesic drug level decreased | 0 | 0 | 0.085 | 1 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vocal cord thickening | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail hypertrophy | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Guthrie test | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic coma | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VIII level increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin level decreased | 0 | 0 | 0.017 | 1 | 3.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair disorder | 0 | 0 | 0.003 | 1 | 3.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drain placement | 0 | 0.001 | 0.156 | 1 | 2.446 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile pain | 0 | 0.001 | 0.117 | 1 | 2.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin abnormal | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal cancer | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibiotic therapy | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine uric acid increased | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystogram | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agraphia | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Astringent therapy | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | American trypanosomiasis | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial wall thickening | 0 | 0 | 0.03 | 1 | 3.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal fracture | 0 | 0.001 | 0.184 | 1 | 2.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactation disorder | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypergammaglobulinaemia | 0 | 0 | 0.037 | 1 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine electrolytes normal | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sickle cell trait | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal hypertrophy | 0 | 0 | 0.045 | 1 | 3.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal respiratory distress | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpes virus 6 serology positive | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | End-tidal CO2 decreased | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deficiency anaemia | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus chorioretinitis | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation time shortened | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system injury | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiribosomal P antibody | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scaphoid abdomen | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ptosis repair | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet dysfunction | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail picking | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lenticular opacities | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngotracheal oedema | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of vaccination site rotation | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaw clicking | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | JC polyomavirus test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site deformation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic allograft nephropathy | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Binge drinking | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal gland cancer metastatic | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | AIDS related complication | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mammogram abnormal | 0 | 0 | 0.016 | 1 | 3.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peak expiratory flow rate | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperbaric oxygen therapy | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorioretinitis | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 2 globulin normal | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cystectomy | 0 | 0 | 0.03 | 1 | 3.214 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic shock syndrome | 0 | 0 | 0.074 | 1 | 2.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High density lipoprotein increased | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E virus test positive | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuse | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell count abnormal | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rickets | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy with advanced maternal age | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porphyrins urine increased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mechanical ventilation complication | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intention tremor | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary disease | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HTLV-2 test | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female sex hormone level abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor V Leiden mutation | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug resistance | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutis laxa | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcoholic liver disease | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunisation reaction | 0 | 0.001 | 0.175 | 1 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon discomfort | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular headache | 0 | 0 | 0.021 | 1 | 3.338 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint abscess | 0 | 0 | 0.036 | 1 | 3.14 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital cystic kidney disease | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvovirus B19 infection | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atopy | 0 | 0.001 | 0.1 | 1 | 2.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Promyelocyte count decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal infection | 0 | 0 | 0.03 | 1 | 3.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet disorder | 0 | 0.001 | 0.183 | 1 | 2.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperchromasia | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine uptake | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoatrophy | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catatonia | 0 | 0 | 0.121 | 1 | 2.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile duct stent insertion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibroadenoma of breast | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serratia infection | 0 | 0 | 0.141 | 1 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bundle branch block | 0 | 0 | 0.053 | 1 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deltaretrovirus test positive | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexually active | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Detrusor sphincter dyssynergia | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal ulceration | 0 | 0.001 | 0.262 | 1 | 2.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic cyst | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thymoma | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Motor neurone disease | 0 | 0.001 | 0.15 | 1 | 2.468 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyneuropathy in malignant disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasm progression | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood 1,25-dihydroxycholecalciferol increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E antigen negative | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body mass index decreased | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail injury | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal retrolisthesis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric haemorrhage | 0 | 0 | 0.11 | 1 | 2.639 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin CSF decreased | 0 | 0 | 0.077 | 1 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obstruction gastric | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspergillus test positive | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal oedema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autologous haematopoietic stem cell transplant | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premenstrual headache | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocytes maturation arrest | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary haemorrhage | 0 | 0 | 0.229 | 1 | 2.215 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clumsy child syndrome | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal therapeutic procedure | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device breakage | 0 | 0 | 0.078 | 1 | 2.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brachytherapy | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesangioproliferative glomerulonephritis | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiendomysial antibody test | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Good syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal alloimmune thrombocytopenia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Surfactant protein | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar cyst | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impatience | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Giardiasis | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lymphocyte count | 0 | 0 | 0.118 | 1 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid analysis abnormal | 0 | 0 | 0.075 | 1 | 2.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enzyme abnormality | 0 | 0 | 0.078 | 1 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carditis | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract obstruction | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocervical curettage | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug trough level | 0 | 0 | 0.02 | 1 | 3.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Caffeine consumption | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body height below normal | 0 | 0 | 0.053 | 1 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal drusen | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil hypersegmented morphology present | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manifest refraction normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptococcal cutaneous infection | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital syphilitic osteochondritis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thrombin | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial parotitis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nikolsky's sign | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestinal ulcer | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Instillation site reaction | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic enzyme decreased | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gait apraxia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema impetiginous | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brow ptosis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acoustic neuroma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal skin infection | 0 | 0 | 0.044 | 1 | 3.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product used for unknown indication | 0 | 0.001 | 0.07 | 1 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal myelogram | 0 | 0 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral disorder | 0 | 0 | 0.13 | 1 | 2.549 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudomonas infection | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy brain normal | 0 | 0 | 0.05 | 1 | 3.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitochondrial encephalomyopathy | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung neoplasm | 0 | 0 | 0.047 | 1 | 3.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibromuscular dysplasia | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy oesophagus abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous bruit | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia cytomegaloviral | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metatarsalgia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mentally late developer | 0 | 0 | 0.059 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diffuse cutaneous mastocytosis | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF granulocyte count normal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sick relative | 0 | 0 | 0.019 | 1 | 3.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Induced abortion failed | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain hypoxia | 0 | 0.001 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac septal defect | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alopecia universalis | 0 | 0 | 0.044 | 1 | 3.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Factor I deficiency | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid gland scan abnormal | 0 | 0 | 0.037 | 1 | 3.133 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan vagina normal | 0 | 0 | 0.044 | 1 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dengue virus test positive | 0 | 0 | 0.001 | 1 | 4.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoantibody positive | 0 | 0.001 | 0.114 | 1 | 2.617 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vein discolouration | 0 | 0.001 | 0.115 | 1 | 2.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastoid effusion | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary thrombocytosis | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF volume | 0 | 0 | 0.04 | 1 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parathyroid hormone-related protein | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin A2 | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anamnestic reaction | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial disorder | 0 | 0 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangitis infective | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenosynovitis stenosans | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrocephalus | 0 | 0.001 | 0.224 | 1 | 2.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail growth abnormal | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nocturnal dyspnoea | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningoencephalitis viral | 0 | 0 | 0.023 | 1 | 3.311 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lennox-Gastaut syndrome | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear, nose and throat examination | 0 | 0.001 | 0.204 | 1 | 2.288 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder dysfunction | 0 | 0 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph gland infection | 0 | 0 | 0.21 | 1 | 2.269 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall disorder | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post polio syndrome | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mental disability | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric vein thrombosis | 0 | 0 | 0.085 | 1 | 2.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute lymphocytic leukaemia recurrent | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pedal pulse decreased | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudomonal bacteraemia | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | LDL/HDL ratio | 0 | 0 | 0.023 | 1 | 3.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperintensity in brain deep nuclei | 0 | 0 | 0.045 | 1 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia necrotising | 0 | 0 | 0.006 | 1 | 3.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart valve operation | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reye's syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hysterosalpingogram | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster meningomyelitis | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Free thyroxine index increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body ingestion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dilatation ventricular | 0 | 0 | 0.052 | 1 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system abscess | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound kidney abnormal | 0 | 0 | 0.141 | 1 | 2.506 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PCO2 | 0 | 0 | 0.138 | 1 | 2.517 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombophlebitis | 0 | 0.001 | 0.129 | 1 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metamyelocyte percentage | 0 | 0.001 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aptyalism | 0 | 0.001 | 0.106 | 1 | 2.654 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic disorder | 0 | 0 | 0.083 | 1 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid cyst | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasogenic cerebral oedema | 0 | 0 | 0.094 | 1 | 2.715 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary gland neoplasm | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric atony | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteritis coronary | 0 | 0 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital dye staining cornea absent | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine mercury abnormal | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic disc hyperaemia | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutralising antibodies negative | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mini mental status examination abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaundice hepatocellular | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glaucoma drainage device placement | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Floating patella | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorioretinal scar | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stent insertion | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranoia | 0 | 0.001 | 0.298 | 1 | 2.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C3 increased | 0 | 0 | 0.029 | 1 | 3.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF monocyte count increased | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic neuropathy | 0 | 0.001 | 0.079 | 1 | 2.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal haemorrhage | 0 | 0.001 | 0.129 | 1 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar ulcer | 0 | 0 | 0.139 | 1 | 2.513 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bipolar I disorder | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premenstrual dysphoric disorder | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet function test abnormal | 0 | 0 | 0.064 | 1 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Galactorrhoea | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Belligerence | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary valve stenosis | 0 | 0 | 0.058 | 1 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glutathione decreased | 0 | 0 | 0.014 | 1 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burn oral cavity | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary gland calculus | 0 | 0 | 0.069 | 1 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prophylaxis against HIV infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product substitution issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic surgery | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left-to-right cardiac shunt | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site thrombosis | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iliotibial band syndrome | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Group B streptococcus neonatal sepsis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic aneurysm repair | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Target skin lesion | 0 | 0 | 0.114 | 1 | 2.617 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomach mass | 0 | 0 | 0.046 | 1 | 3.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoparathyroidism | 0 | 0 | 0.032 | 1 | 3.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniorrhoea | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tubulointerstitial nephritis and uveitis syndrome | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal infarct | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choroidal effusion | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Waist circumference increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraneoplastic neurological syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decerebrate posture | 0 | 0.001 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath sounds normal | 0 | 0 | 0.133 | 1 | 2.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral discolouration | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous vasculitis | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood HIV RNA below assay limit | 0 | 0 | 0.126 | 1 | 2.568 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Traumatic lung injury | 0 | 0 | 0.041 | 1 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dependence on oxygen therapy | 0 | 0 | 0.039 | 1 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection related reaction | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device failure | 0 | 0 | 0.094 | 1 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine renal clearance increased | 0 | 0 | 0.066 | 1 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shortened cervix | 0 | 0 | 0.079 | 1 | 2.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retained placenta or membranes | 0 | 0 | 0.046 | 1 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular vascular disorder | 0 | 0 | 0.079 | 1 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular flutter | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spotted fever rickettsia test positive | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal osteomyelitis | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan spleen | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medication overuse headache | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb reduction defect | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypnopompic hallucination | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperarousal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device alarm issue | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amnestic disorder | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune complex assay | 0 | 0.001 | 0.131 | 1 | 2.544 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell morphology normal | 0 | 0.001 | 0.164 | 1 | 2.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin urine absent | 0 | 0.001 | 0.124 | 1 | 2.573 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms (SMQ) [broad] | 0 | 0.001 | 0.152 | 1 | 2.463 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystitis noninfective | 0 | 0.001 | 0.059 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythrosis | 0 | 0 | 0.042 | 1 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedematous pancreatitis | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Squamous cell carcinoma of the oral cavity | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensitisation | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kaposi's sarcoma | 0 | 0 | 0.065 | 1 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine arsenic increased | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal ultrasound normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema vaccinatum | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system necrosis | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Artificial rupture of membranes | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriovenous fistula | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antineutrophil cytoplasmic antibody increased | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visceral pain | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral uveitis | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gulf war syndrome | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram liver abnormal | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoma excision | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stoma site reaction | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retirement | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mast cell degranulation test | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Latent syphilis | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Female sex hormone level | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejaculation disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Childhood asthma | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anomaly of external ear congenital | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta globulin | 0 | 0 | 0.081 | 1 | 2.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital capacity decreased | 0 | 0 | 0.007 | 1 | 3.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testis discomfort | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis mumps | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF monocyte count negative | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophilia | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine dilation and evacuation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal anastomosis | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ruptured ectopic pregnancy | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal effusion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plastic surgery to the face | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma cells present | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multisystem inflammatory syndrome in children | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular cyst | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White coat hypertension | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypomania | 0 | 0 | 0.074 | 1 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrinous bronchitis | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiation pneumonitis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Primary progressive multiple sclerosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung hypoinflation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iris neovascularisation | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | End stage AIDS | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystic lymphangioma | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute graft versus host disease in intestine | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function test normal | 0 | 0.001 | 0.132 | 1 | 2.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary colic | 0 | 0.001 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast discomfort | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal calprotectin | 0 | 0 | 0.026 | 1 | 3.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saccadic eye movement | 0 | 0 | 0.019 | 1 | 3.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helicobacter gastritis | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve palsies multiple | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy small intestine | 0 | 0 | 0.069 | 1 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute stress disorder | 0 | 0 | 0.043 | 1 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Volvulus of small bowel | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine copper increased | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Needle track marks | 0 | 0 | 0.044 | 1 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrophages increased | 0 | 0 | 0.068 | 1 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive heart disease | 0 | 0 | 0.051 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear irrigation | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor XII level normal | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Avian influenza | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Androgenetic alopecia | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stoma site erythema | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site erythema | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroglottography | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatopathic lymphadenopathy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ACTH stimulation test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthosis user | 0 | 0 | 0.171 | 1 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amylase normal | 0 | 0.001 | 0.36 | 1 | 1.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antinuclear antibody increased | 0 | 0 | 0.17 | 1 | 2.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cachexia | 0 | 0.001 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saliva discolouration | 0 | 0 | 0.105 | 1 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anogenital dysplasia | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericarditis lupus | 0 | 0 | 0.001 | 1 | 4.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurotransmitter level altered | 0 | 0 | 0.075 | 1 | 2.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroleptic malignant syndrome (SMQ) [narrow] | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipase decreased | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint laxity | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haptoglobin abnormal | 0 | 0 | 0.047 | 1 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid hormones decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin discharge | 0 | 0 | 0.056 | 1 | 2.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proctitis ulcerative | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phaeochromocytoma | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral arterial occlusive disease | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic haematoma | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parkinsonian gait | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intravascular papillary endothelial hyperplasia | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hernia pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate disorder | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital HIV infection | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac septal defect residual shunt | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure orthostatic decreased | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulomatosis with polyangiitis | 0 | 0.001 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemianopia homonymous | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine renal clearance | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac septal hypertrophy | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteral disorder | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spondyloarthropathy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrub typhus | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rinne tuning fork test | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progesterone abnormal | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Porphyria acute | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intrinsic factor antibody | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colonic lavage | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood magnesium abnormal | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barrel chest | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial catheterisation normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpes virus 6 serology negative | 0 | 0.001 | 0.182 | 1 | 2.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site dermatitis | 0 | 0 | 0.181 | 1 | 2.36 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal discomfort | 0 | 0 | 0.124 | 1 | 2.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray of pelvis and hip | 0 | 0.002 | 0.416 | 1 | 1.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helicobacter test | 0 | 0.001 | 0.178 | 1 | 2.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased viscosity of bronchial secretion | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basal ganglia infarction | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous haze | 0 | 0 | 0.02 | 1 | 3.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia bacteraemia | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yellow nail syndrome | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine output | 0 | 0 | 0.062 | 1 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear buccal abnormal | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity urine abnormal | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary imaging procedure abnormal | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil toxic granulation present | 0 | 0 | 0.096 | 1 | 2.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Massage | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematospermia | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast conserving surgery | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site laceration | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestine operation | 0 | 0 | 0.062 | 1 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal vein thrombosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis cytomegalovirus | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary fragility increased | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blue toe syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood loss anaemia | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fontanelle bulging | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood homocysteine normal | 0 | 0 | 0.143 | 1 | 2.498 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product package associated injury | 0 | 0 | 0.07 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acid base balance normal | 0 | 0 | 0.022 | 1 | 3.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transient acantholytic dermatosis | 0 | 0 | 0.008 | 1 | 3.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia haemophilus | 0 | 0 | 0.016 | 1 | 3.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint ankylosis | 0 | 0 | 0.061 | 1 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess neck | 0 | 0 | 0.08 | 1 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 absorption test normal | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual field tests normal | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejection fraction abnormal | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular lens implant | 0 | 0 | 0.138 | 1 | 2.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitral valve repair | 0 | 0 | 0.059 | 1 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte stimulation test negative | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal infarction | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histiocytic necrotising lymphadenitis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemarthrosis | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor level normal | 0 | 0 | 0.048 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid cell count | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superior mesenteric artery syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rickettsiosis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudobulbar palsy | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Portal hypertensive gastropathy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobinaemia | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enlarged cerebral perivascular spaces | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital thymus absence | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bronchus normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Auditory neuropathy spectrum disorder | 0 | 0 | 0.072 | 1 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute graft versus host disease in skin | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perineal erythema | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian granulosa cell tumour | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipase abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint arthroplasty | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperoxia | 0 | 0 | 0.059 | 1 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperchloraemia | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute lymphocytic leukaemia | 0 | 0.001 | 0.133 | 1 | 2.538 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract oedema | 0 | 0 | 0.042 | 1 | 3.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatomegaly | 0 | 0 | 0.09 | 1 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic disorder | 0 | 0 | 0.075 | 1 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ketosis | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cushingoid | 0 | 0 | 0.029 | 1 | 3.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan myocardial perfusion normal | 0 | 0 | 0.104 | 1 | 2.668 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood brain barrier defect | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patient uncooperative | 0 | 0 | 0.082 | 1 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular dysfunction | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via partner | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory level normal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helminthic infection | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis mumps | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus inflammation | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy-related hepatic disorders (SMQ) [narrow] | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfective sialoadenitis | 0 | 0 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheomalacia | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean arterial pressure | 0 | 0 | 0.005 | 1 | 3.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral sensorimotor neuropathy | 0 | 0.001 | 0.166 | 1 | 2.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tender joint count | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothenar hammer syndrome | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity total decreased | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart sounds normal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ADAMTS13 activity normal | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhabdomyosarcoma | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Living in residential institution | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell anisocytes present | 0 | 0.001 | 0.194 | 1 | 2.317 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary hypogonadism | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | JC polyomavirus test negative | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain lobectomy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-cell lymphoma | 0 | 0 | 0.093 | 1 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus arrest | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal myelogram abnormal | 0 | 0 | 0.062 | 1 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell schistocytes | 0 | 0 | 0.023 | 1 | 3.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine level increased | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alveolitis | 0 | 0 | 0.006 | 1 | 3.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound eye | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral embolism | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Automatism | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroglobulin present | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic arthritis streptococcal | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory depth decreased | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary necrosis | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal hypertrophy | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyposomnia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileal perforation | 0 | 0 | 0.026 | 1 | 3.256 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant hypertension | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dupuytren's contracture | 0 | 0 | 0.067 | 1 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chemical burn | 0 | 0 | 0.041 | 1 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichen planopilaris | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic varices | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactate dehydrogenase decreased | 0 | 0 | 0.082 | 1 | 2.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular arrhythmia | 0 | 0 | 0.037 | 1 | 3.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematoma infection | 0 | 0 | 0.072 | 1 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective IgA immunodeficiency | 0 | 0 | 0.105 | 1 | 2.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian injury | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint infection | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicidal behaviour | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QT interval abnormal | 0 | 0 | 0.044 | 1 | 3.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SeHCAT test | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inferior vena cava stenosis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign travel | 0 | 0.001 | 0.162 | 1 | 2.425 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging breast abnormal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin unconjugated decreased | 0 | 0.001 | 0.067 | 1 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval ulceration | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratoplasty | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin weeping | 0 | 0.001 | 0.218 | 1 | 2.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QRS complex prolonged | 0 | 0 | 0.11 | 1 | 2.636 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicide of relative | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal scar | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound contamination | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal haemorrhage | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombotic stroke | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device difficult to use | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granuloma annulare | 0 | 0 | 0.152 | 1 | 2.463 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red cell distribution width decreased | 0 | 0 | 0.102 | 1 | 2.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type II hypersensitivity | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | International normalised ratio fluctuation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary resection | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colon cancer | 0 | 0 | 0.081 | 1 | 2.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cubital tunnel syndrome | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intranasal paraesthesia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypofibrinogenaemia | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-ocular injection | 0 | 0 | 0.057 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD8 lymphocyte percentage decreased | 0 | 0 | 0.052 | 1 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blepharitis | 0 | 0 | 0.202 | 1 | 2.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental care | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy heart | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous oxygen saturation normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyelonephritis acute | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleritis | 0 | 0 | 0.164 | 1 | 2.42 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystatin C abnormal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte percentage | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal transit time decreased | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial fibrosis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Imaging procedure artifact | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypercapnia | 0 | 0 | 0.062 | 1 | 2.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy vagina | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site coldness | 0 | 0 | 0.102 | 1 | 2.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Victim of crime | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular dystrophy congenital | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perinatal brain damage | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocytic hypophysitis | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood osmolarity | 0 | 0 | 0.116 | 1 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level below therapeutic | 0 | 0 | 0.054 | 1 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Citrobacter test positive | 0 | 0 | 0.064 | 1 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Furuncle | 0 | 0.002 | 0.413 | 1 | 1.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal inflammation | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inappropriate affect | 0 | 0.001 | 0.306 | 1 | 2.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular test | 0 | 0 | 0.099 | 1 | 2.693 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sweating fever | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness congenital | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip exfoliation | 0 | 0.001 | 0.264 | 1 | 2.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital ulceration | 0 | 0 | 0.097 | 1 | 2.703 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Umbilical hernia repair | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroconvulsive therapy | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine decreased | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level | 0 | 0 | 0.133 | 1 | 2.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Graft versus host disease in skin | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray dental | 0 | 0 | 0.118 | 1 | 2.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 test false positive | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell agglutination present | 0 | 0 | 0.06 | 1 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histoplasmosis | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasoendoscopy | 0 | 0.001 | 0.103 | 1 | 2.669 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ankyloglossia acquired | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pearly penile papules | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ectopic kidney | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral artery thrombosis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Posthaemorrhagic hydrocephalus | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diffuse large B-cell lymphoma | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholinesterase | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papilloma | 0 | 0 | 0.008 | 1 | 3.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nodular fasciitis | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone abnormal | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Self-medication | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin abnormal | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyper IgE syndrome | 0 | 0 | 0.002 | 1 | 3.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aicardi's syndrome | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phenylalanine screen positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon dislocation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lesion excision | 0 | 0 | 0.03 | 1 | 3.209 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SCORTEN score | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver abscess | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creutzfeldt-Jakob disease | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip ulceration | 0 | 0.001 | 0.165 | 1 | 2.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Libido disorder | 0 | 0 | 0.03 | 1 | 3.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal ulcer | 0 | 0 | 0.062 | 1 | 2.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-insulin antibody decreased | 0 | 0 | 0.067 | 1 | 2.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary arterial hypertension | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil morphology normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms malignant and unspecified (SMQ) [narrow] | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Animal scratch | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Second primary malignancy | 0 | 0 | 0.008 | 1 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macroprolactinaemia | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jugular vein thrombosis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C1 esterase inhibitor test | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestradiol abnormal | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gangrene | 0 | 0 | 0.035 | 1 | 3.154 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningoencephalitis bacterial | 0 | 0 | 0.02 | 1 | 3.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site hypersensitivity | 0 | 0 | 0.083 | 1 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fistulogram | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatic duct dilatation | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal non-stress test abnormal | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine cytology | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess oral | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opticokinetic nystagmus tests abnormal | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertransaminasaemia | 0 | 0.001 | 0.095 | 1 | 2.711 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postoperative wound infection | 0 | 0 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiopulmonary exercise test abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basosquamous carcinoma | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Megacolon | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borderline personality disorder | 0 | 0 | 0.04 | 1 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spleen scan normal | 0 | 0.001 | 0.173 | 1 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan adrenal gland | 0 | 0 | 0.074 | 1 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Throat cancer | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstruation normal | 0 | 0 | 0.087 | 1 | 2.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyshidrotic eczema | 0 | 0 | 0.078 | 1 | 2.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convulsion in childhood | 0 | 0 | 0.054 | 1 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal deposits | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucocutaneous candidiasis | 0 | 0 | 0.064 | 1 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphangioma | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine calcium/creatinine ratio | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Silent thyroiditis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prolapse | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perineal ulceration | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoblast count increased | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implant site discolouration | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | End-tidal CO2 | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal headache | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic leukaemia | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alien limb syndrome | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 globulin | 0 | 0 | 0.038 | 1 | 3.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha tumour necrosis factor increased | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac ablation | 0 | 0.001 | 0.143 | 1 | 2.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palatal palsy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal deposits | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal malrotation repair | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epilepsy congenital | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngotracheobronchoscopy | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | EGFR gene mutation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site reaction | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral pain | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function challenge test | 0 | 0 | 0.055 | 1 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schistosomiasis | 0 | 0 | 0.056 | 1 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dumping syndrome | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time ratio abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infrequent bowel movements | 0 | 0 | 0.015 | 1 | 3.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sciatic nerve injury | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product selection error | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic complication | 0 | 0 | 0.086 | 1 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enzyme activity normal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulectomy | 0 | 0 | 0.059 | 1 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Substance abuse | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve infarction | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte count abnormal | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial fibrosis | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterococcus test | 0 | 0 | 0.069 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal suppression | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH urine decreased | 0 | 0 | 0.055 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complication of delivery | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial stent insertion | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological malignancy | 0 | 0 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lasegue's test | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vena cava filter insertion | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair metal test normal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrophic anal papilla | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vanillyl mandelic acid urine increased | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis allergic | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunosuppressant drug level increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C antibody | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site inflammation | 0 | 0 | 0.042 | 1 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile oedema | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal anaesthesia | 0 | 0 | 0.014 | 1 | 3.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoalveolar lavage normal | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ACTH stimulation test normal | 0 | 0 | 0.056 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound abscess | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine osmolarity decreased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinoscopy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal graft infection | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Recall phenomenon | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Preictal state | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian adenoma | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oligoarthritis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Long QT syndrome | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infected bite | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glutamate dehydrogenase increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cancer pain | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign neoplasm of skin | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactoid syndrome of pregnancy | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaesthetic complication | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic stomatitis | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroviral infection | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malaria antibody test positive | 0 | 0 | 0.043 | 1 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glioblastoma | 0 | 0 | 0.061 | 1 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal disorder | 0 | 0 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contrast media allergy | 0 | 0 | 0.074 | 1 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agoraphobia | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast lower gastrointestinal tract normal | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous occlusion | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract procedural complication | 0 | 0 | 0.052 | 1 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin lesion inflammation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right atrial enlargement | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet aggregation abnormal | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritoneal tuberculosis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatoglyphic anomaly | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical incompetence | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial aspiration procedure | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy anus abnormal | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alloimmunisation | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ADAMTS13 inhibitor screen assay | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal mycotic infection | 0 | 0 | 0.074 | 1 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laziness | 0 | 0 | 0.103 | 1 | 2.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute flaccid myelitis | 0 | 0 | 0.043 | 1 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine copper | 0 | 0 | 0.045 | 1 | 3.053 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Milk soy protein intolerance | 0 | 0 | 0.087 | 1 | 2.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mandibular mass | 0 | 0 | 0.111 | 1 | 2.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric pH decreased | 0 | 0 | 0.023 | 1 | 3.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid myoclonus | 0 | 0 | 0.04 | 1 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dandruff | 0 | 0 | 0.036 | 1 | 3.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster necrotising retinopathy | 0 | 0 | 0.011 | 1 | 3.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalopathy allergic | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encopresis | 0 | 0 | 0.04 | 1 | 3.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital pyelocaliectasis | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil degranulation test | 0 | 0 | 0.066 | 1 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaesthesia oral | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urea renal clearance | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ureteric obstruction | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tidal volume decreased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella sepsis | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peak expiratory flow rate normal | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cyst torsion | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal asphyxia | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleroedema | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-abdominal haemorrhage | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestine polyp | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoalbuminaemia | 0 | 0 | 0.211 | 1 | 2.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear infection viral | 0 | 0.001 | 0.101 | 1 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic pulmonary fibrosis | 0 | 0 | 0.042 | 1 | 3.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Karyotype analysis normal | 0 | 0 | 0.108 | 1 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulins abnormal | 0 | 0 | 0.067 | 1 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dizziness exertional | 0 | 0 | 0.047 | 1 | 3.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyslexia | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone cyst | 0 | 0 | 0.045 | 1 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasms benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0 | 0.088 | 1 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord abscess | 0 | 0 | 0.072 | 1 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral thrombosis | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enamel anomaly | 0 | 0 | 0.055 | 1 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual pathway disorder | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumoperitoneum | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial fibrosis | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large cell lung cancer | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Engraft failure | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor abnormal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clot retraction | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicitis human papilloma virus | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinoid syndrome | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanometry | 0 | 0.001 | 0.108 | 1 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burns second degree | 0 | 0.001 | 0.147 | 1 | 2.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sydenham's chorea | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Confabulation | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood selenium normal | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axillary vein thrombosis | 0 | 0 | 0.083 | 1 | 2.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram pancreas abnormal | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vanishing twin syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine tenderness | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reduction of increased intracranial pressure | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial operation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes oesophagitis | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C core antibody positive | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalopathy neonatal | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis california | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST-T segment elevation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contraindication to medical treatment | 0 | 0 | 0.061 | 1 | 2.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coital bleeding | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choluria | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood growth hormone decreased | 0 | 0 | 0.054 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corrective lens user | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral palsy | 0 | 0.001 | 0.147 | 1 | 2.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parainfluenzae virus infection | 0 | 0.001 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ketone body present | 0 | 0.001 | 0.127 | 1 | 2.563 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic limb pain | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraductal proliferative breast lesion | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injury to brachial plexus due to birth trauma | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor VII level increased | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy small intestine normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site wound | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-thyroid antibody | 0 | 0.001 | 0.179 | 1 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular injury | 0 | 0.001 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune neutropenia | 0 | 0 | 0.005 | 1 | 3.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament rupture | 0 | 0.001 | 0.152 | 1 | 2.46 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intercepted product prescribing error | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy breast abnormal | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intertrigo | 0 | 0 | 0.083 | 1 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal tubular disorder | 0 | 0 | 0.052 | 1 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E | 0 | 0 | 0.001 | 1 | 4.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometrial thickening | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejaculation failure | 0 | 0 | 0.055 | 1 | 2.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amoeba test positive | 0 | 0 | 0.043 | 1 | 3.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vibrio test positive | 0 | 0 | 0.078 | 1 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B complex deficiency | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total cholesterol/HDL ratio normal | 0 | 0 | 0.07 | 1 | 2.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal oedema | 0 | 0 | 0.063 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood homocysteine increased | 0 | 0 | 0.067 | 1 | 2.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial rupture | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site infection | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SUNCT syndrome | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfective oophoritis | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail ridging | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocarditis infectious | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jugular vein distension | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iatrogenic infection | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echoencephalogram abnormal | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Early satiety | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic foetopathy | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermabrasion | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocytes abnormal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain neoplasm malignant | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure difference of extremities | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia of chronic disease | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH body fluid normal | 0 | 0 | 0.011 | 1 | 3.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluid replacement | 0 | 0.001 | 0.065 | 1 | 2.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital megacolon | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria pigmentosa | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sports injury | 0 | 0 | 0.081 | 1 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radius fracture | 0 | 0 | 0.09 | 1 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myringitis | 0 | 0 | 0.048 | 1 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal pain | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vessel puncture site erythema | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic operation | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Potassium hydroxide preparation negative | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nipple disorder | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insurance issue | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbohydrate deficient transferrin test | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Analgesic drug level increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impetigo | 0 | 0 | 0.252 | 1 | 2.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foreign body sensation in eyes | 0 | 0.001 | 0.263 | 1 | 2.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinea pedis | 0 | 0 | 0.075 | 1 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Knee operation | 0 | 0 | 0.089 | 1 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis bacterial | 0 | 0 | 0.03 | 1 | 3.211 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poliovirus test negative | 0 | 0 | 0.029 | 1 | 3.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Refusal of treatment by relative | 0 | 0 | 0.076 | 1 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid sensory disorder | 0 | 0 | 0.013 | 1 | 3.506 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral artery embolism | 0 | 0 | 0.014 | 1 | 3.47 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine alcohol test negative | 0 | 0 | 0.034 | 1 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal vascular disorder | 0 | 0 | 0.04 | 1 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral atrophy congenital | 0 | 0 | 0.046 | 1 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral arteritis | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy blood vessel abnormal | 0 | 0 | 0.053 | 1 | 2.979 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angioscopy | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychogenic respiratory distress | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product delivery mechanism issue | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Piriformis syndrome | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraproteinaemia | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve root injury cervical | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipectomy | 0 | 0 | 0.05 | 1 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genitourinary tract infection | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palliative care | 0 | 0.001 | 0.165 | 1 | 2.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ketogenic diet | 0 | 0 | 0.058 | 1 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural haemorrhage | 0 | 0 | 0.014 | 1 | 3.477 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestriol normal | 0 | 0 | 0.054 | 1 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue tie operation | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella bacteraemia | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic colitis | 0 | 0 | 0.047 | 1 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement fixation test positive | 0 | 0 | 0.063 | 1 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site irritation | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebrobasilar insufficiency | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic myocarditis | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular symptom | 0 | 0 | 0.095 | 1 | 2.713 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apgar score | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonic plague | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arrhythmia supraventricular | 0 | 0 | 0.08 | 1 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal biophysical profile score normal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival pallor | 0 | 0 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronavirus test negative | 0 | 0.001 | 0.19 | 1 | 2.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bile output increased | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine haematoma | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bandaemia | 0 | 0.001 | 0.191 | 1 | 2.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IVth nerve paralysis | 0 | 0.001 | 0.139 | 1 | 2.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shoulder arthroplasty | 0 | 0 | 0.035 | 1 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interleukin-2 receptor increased | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Legal problem | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4/CD8 ratio increased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maculopathy | 0 | 0 | 0.104 | 1 | 2.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to lung | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary angioplasty | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Full blood count decreased | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infective exacerbation of bronchiectasis | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis enteropathic | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chillblains | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Developmental coordination disorder | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound decomposition | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress echocardiogram | 0 | 0 | 0.053 | 1 | 2.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bell's phenomenon | 0 | 0 | 0.043 | 1 | 3.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acid base balance | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac imaging procedure abnormal | 0 | 0 | 0.093 | 1 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes dermatitis | 0 | 0 | 0.063 | 1 | 2.908 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture cervix | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriovenous fistula occlusion | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine amphetamine negative | 0 | 0 | 0.073 | 1 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urethral stenosis | 0 | 0 | 0.044 | 1 | 3.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cleft palate | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine free increased | 0 | 0 | 0.034 | 1 | 3.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral vasoconstriction | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral lateral recess stenosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Undifferentiated connective tissue disease | 0 | 0.001 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular operation | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reactive gastropathy | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery dissection | 0 | 0 | 0.068 | 1 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin C | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachycardia paroxysmal | 0 | 0 | 0.044 | 1 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Distributive shock | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbohydrate antigen 125 increased | 0 | 0 | 0.021 | 1 | 3.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan adrenal gland normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personality change due to a general medical condition | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iliac vein occlusion | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fallopian tube disorder | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinogenicity | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone formation increased | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta 2 microglobulin urine | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood disorder | 0 | 0.001 | 0.172 | 1 | 2.39 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune thyroid disorder | 0 | 0 | 0.033 | 1 | 3.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung carcinoma cell type unspecified stage I | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast feeding | 0 | 0.001 | 0.105 | 1 | 2.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Femoral nerve palsy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs indirect test negative | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous T-cell lymphoma | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal calprotectin abnormal | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage subepidermal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy stomach normal | 0 | 0 | 0.047 | 1 | 3.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to plants | 0 | 0 | 0.025 | 1 | 3.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet count abnormal | 0 | 0.001 | 0.179 | 1 | 2.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital cytomegalovirus infection | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chikungunya virus infection | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Withdrawal hypertension | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incision site discharge | 0 | 0 | 0.057 | 1 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial ligation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy spinal cord | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve paresis | 0 | 0 | 0.066 | 1 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Analgesic drug level | 0 | 0 | 0.116 | 1 | 2.61 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal mass | 0 | 0 | 0.135 | 1 | 2.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Locked-in syndrome | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve injury | 0 | 0 | 0.011 | 1 | 3.538 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram coronary artery | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood arsenic increased | 0 | 0 | 0.058 | 1 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic ovarian cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myeloproliferative neoplasm | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery thrombosis | 0 | 0 | 0.075 | 1 | 2.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy spinal cord abnormal | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation immeasurable | 0 | 0 | 0.017 | 1 | 3.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site hypoaesthesia | 0 | 0 | 0.021 | 1 | 3.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poisoning deliberate | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystoscopy normal | 0 | 0 | 0.029 | 1 | 3.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic encephalopathy | 0 | 0 | 0.074 | 1 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous haemorrhage | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease prodromal stage | 0 | 0 | 0.071 | 1 | 2.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip injury | 0 | 0.002 | 0.446 | 1 | 1.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue neoplasm malignant stage unspecified | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder operation | 0 | 0 | 0.092 | 1 | 2.728 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Invasive lobular breast carcinoma | 0 | 0 | 0.058 | 1 | 2.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product contamination | 0 | 0.001 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B1 decreased | 0 | 0 | 0.055 | 1 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaundice acholuric | 0 | 0 | 0.059 | 1 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate cancer metastatic | 0 | 0 | 0.082 | 1 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural headache | 0 | 0 | 0.052 | 1 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram peripheral normal | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal polyp | 0 | 0 | 0.058 | 1 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin blood | 0 | 0.001 | 0.107 | 1 | 2.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trigger finger | 0 | 0.001 | 0.136 | 1 | 2.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid crystal present | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brown-Sequard syndrome | 0 | 0 | 0.049 | 1 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hippocampal sclerosis | 0 | 0 | 0.061 | 1 | 2.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic disc haemorrhage | 0 | 0 | 0.073 | 1 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic pustular folliculitis | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile ulceration | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometrial disorder | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumomediastinum | 0 | 0 | 0.041 | 1 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine inflammation | 0 | 0 | 0.08 | 1 | 2.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytokine storm | 0 | 0.001 | 0.123 | 1 | 2.579 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral artery occlusion | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural fluid analysis | 0 | 0 | 0 | 1 | 4.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital renal disorder | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device infusion issue | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal haemorrhage | 0 | 0 | 0.087 | 1 | 2.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypercreatinaemia | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal volume increased | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine urine increased | 0 | 0 | 0.083 | 1 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric emptying study | 0 | 0.001 | 0.102 | 1 | 2.678 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye symptom | 0 | 0 | 0.078 | 1 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal stenosis | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric fluid analysis | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis viral | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian germ cell tumour | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant ascites | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell marker | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal dryness | 0 | 0.001 | 0.258 | 1 | 2.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal disorder | 0 | 0 | 0.074 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypophonesis | 0 | 0 | 0.057 | 1 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile size reduced | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palatal ulcer | 0 | 0 | 0.036 | 1 | 3.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bartonellosis | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nicotinamide | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pityriasis | 0 | 0 | 0.089 | 1 | 2.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dependence | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sexually transmitted disease | 0 | 0 | 0.042 | 1 | 3.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic haemorrhage | 0 | 0 | 0.042 | 1 | 3.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anastomotic ulcer | 0 | 0 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spleen disorder | 0 | 0.001 | 0.181 | 1 | 2.359 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimation decreased | 0 | 0 | 0.115 | 1 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swollen joint count | 0 | 0 | 0.07 | 1 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peak nasal inspiratory flow abnormal | 0 | 0 | 0.056 | 1 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amino acid level abnormal | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermoanaesthesia | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normal pressure hydrocephalus | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multipathogen PCR test | 0 | 0 | 0.083 | 1 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lead abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Molluscum contagiosum | 0 | 0 | 0.124 | 1 | 2.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint surgery | 0 | 0 | 0.063 | 1 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronavirus test | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular stent insertion | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphatic system neoplasm | 0 | 0 | 0.002 | 1 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procalcitonin decreased | 0 | 0 | 0.094 | 1 | 2.714 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal manometry | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progesterone normal | 0 | 0.001 | 0.094 | 1 | 2.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle rupture | 0 | 0.001 | 0.137 | 1 | 2.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypobarism | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Roseola | 0 | 0 | 0.243 | 1 | 2.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spermatic cord disorder | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retention cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid pulse abnormal | 0 | 0 | 0.028 | 1 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower gastrointestinal haemorrhage | 0 | 0 | 0.041 | 1 | 3.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ruptured cerebral aneurysm | 0 | 0 | 0.016 | 1 | 3.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystatin C increased | 0 | 0 | 0.073 | 1 | 2.836 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue injury | 0 | 0.001 | 0.18 | 1 | 2.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood luteinising hormone | 0 | 0 | 0.06 | 1 | 2.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cellulitis of male external genital organ | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low density lipoprotein decreased | 0 | 0 | 0.062 | 1 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tarsal tunnel syndrome | 0 | 0 | 0.073 | 1 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product leakage | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pH | 0 | 0 | 0.064 | 1 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Needle biopsy site unspecified normal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bite | 0 | 0 | 0.042 | 1 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute chest syndrome | 0 | 0 | 0.075 | 1 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrocephaly | 0 | 0 | 0.068 | 1 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein S decreased | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microangiopathic haemolytic anaemia | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjusted calcium increased | 0 | 0 | 0.091 | 1 | 2.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site haemorrhage | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy small intestine normal | 0 | 0 | 0.048 | 1 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear test | 0 | 0 | 0.161 | 1 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective IgG subclass deficiency | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary amyloidosis | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid boil | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital pneumonia | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor XII level | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangiogram | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinoid tumour | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial irritation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder operation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal deformity | 0 | 0 | 0.066 | 1 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | FEV1/FVC ratio | 0 | 0 | 0.032 | 1 | 3.189 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous oxygen saturation decreased | 0 | 0 | 0.119 | 1 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendicolith | 0 | 0 | 0.011 | 1 | 3.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Olfactory nerve disorder | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left ventricular end-diastolic pressure increased | 0 | 0 | 0.038 | 1 | 3.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure orthostatic increased | 0 | 0 | 0.077 | 1 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine retinol binding protein increased | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Symptom recurrence | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal erythema | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product administration interrupted | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poliovirus test | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin C-peptide normal | 0 | 0 | 0.054 | 1 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD25 antigen positive | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to surgical sutures | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcinosis | 0 | 0.001 | 0.081 | 1 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupil dilation procedure | 0 | 0 | 0.09 | 1 | 2.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurodevelopmental disorder | 0 | 0 | 0.065 | 1 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticonvulsant drug level decreased | 0 | 0 | 0.033 | 1 | 3.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic vasculitis | 0 | 0 | 0.055 | 1 | 2.966 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dilated pores | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival oedema | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleral oedema | 0 | 0 | 0.05 | 1 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accident at work | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site haemorrhage | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Umbilical cord prolapse | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell marker decreased | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inspiratory capacity | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal oedema | 0 | 0 | 0.049 | 1 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy colon | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 2 globulin | 0 | 0 | 0.038 | 1 | 3.115 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Severe acute respiratory syndrome | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileocaecal resection | 0 | 0 | 0.061 | 1 | 2.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bronchus abnormal | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic syndrome | 0 | 0 | 0.094 | 1 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria contact | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudocellulitis | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postmenopausal haemorrhage | 0 | 0 | 0.066 | 1 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagostomy | 0 | 0 | 0.048 | 1 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothyroidic goitre | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Huntington's disease | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antigen | 0 | 0 | 0.049 | 1 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fear of eating | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcoholic hangover | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Excessive cerumen production | 0 | 0 | 0.163 | 1 | 2.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal candidiasis | 0 | 0 | 0.07 | 1 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Libido decreased | 0 | 0 | 0.045 | 1 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchopneumopathy | 0 | 0 | 0.086 | 1 | 2.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic shock syndrome streptococcal | 0 | 0 | 0.065 | 1 | 2.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loss of libido | 0 | 0 | 0.039 | 1 | 3.106 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion site extravasation | 0 | 0 | 0.014 | 1 | 3.477 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic fluid volume decreased | 0 | 0 | 0.069 | 1 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour pain | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dementia with Lewy bodies | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adactyly | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow disorder | 0 | 0.001 | 0.181 | 1 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperchlorhydria | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystoscopy abnormal | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary bladder haemorrhage | 0 | 0 | 0.068 | 1 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Free fatty acids | 0 | 0 | 0.072 | 1 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Birth mark | 0 | 0 | 0.079 | 1 | 2.802 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial toxaemia | 0 | 0 | 0.065 | 1 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antithrombin III decreased | 0 | 0 | 0.027 | 1 | 3.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumothorax spontaneous | 0 | 0 | 0.06 | 1 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactose tolerance test normal | 0 | 0 | 0.006 | 1 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital hand malformation | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mediastinal disorder | 0 | 0 | 0.086 | 1 | 2.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malaria antibody test | 0 | 0 | 0.064 | 1 | 2.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin electrophoresis normal | 0 | 0 | 0.06 | 1 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic gastroenteritis | 0 | 0 | 0.003 | 1 | 3.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin D abnormal | 0 | 0 | 0.057 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal surgery | 0 | 0 | 0.05 | 1 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitogen stimulation test abnormal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney small | 0 | 0 | 0.051 | 1 | 3.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gradenigo's syndrome | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ebstein's anomaly | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device inappropriate shock delivery | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arterial catheterisation | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palmar erythema | 0 | 0.001 | 0.178 | 1 | 2.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukoencephalopathy | 0 | 0 | 0.128 | 1 | 2.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food poisoning | 0 | 0.001 | 0.119 | 1 | 2.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Separation anxiety disorder | 0 | 0 | 0.098 | 1 | 2.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdomen scan | 0 | 0 | 0.046 | 1 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal polyps | 0 | 0 | 0.086 | 1 | 2.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product origin unknown | 0 | 0 | 0.059 | 1 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phenylketonuria | 0 | 0 | 0.037 | 1 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper motor neurone lesion | 0 | 0 | 0.07 | 1 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progressive multifocal leukoencephalopathy | 0 | 0 | 0.007 | 1 | 3.665 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intra-uterine contraceptive device removal | 0 | 0 | 0.092 | 1 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic angioedema | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Failed induction of labour | 0 | 0 | 0.054 | 1 | 2.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatofibroma removal | 0 | 0 | 0.046 | 1 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma stage I | 0 | 0 | 0.056 | 1 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac resynchronisation therapy | 0 | 0 | 0.063 | 1 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-transglutaminase antibody increased | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time ratio normal | 0 | 0 | 0.068 | 1 | 2.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saliva analysis normal | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal hypotension | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metanephrine urine | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune complex level increased | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ichthyosis | 0 | 0 | 0.051 | 1 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic hypertrophy | 0 | 0 | 0.059 | 1 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genetic counselling | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dexamethasone suppression test | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromosome banding normal | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Buttock injury | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine contractions abnormal | 0 | 0 | 0.074 | 1 | 2.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract infection pseudomonal | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Torsade de pointes | 0 | 0 | 0.043 | 1 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular dilatation | 0 | 0 | 0.005 | 1 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lymph gland normal | 0 | 0 | 0.029 | 1 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniocentesis abnormal | 0 | 0 | 0.002 | 1 | 3.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated protein C resistance test positive | 0 | 0 | 0.067 | 1 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract stoma complication | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial septal defect repair | 0 | 0 | 0.07 | 1 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Symphysiolysis | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiopulmonary exercise test normal | 0 | 0 | 0.023 | 1 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac hypertrophy | 0 | 0 | 0.058 | 1 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood uric acid abnormal | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy thymus gland abnormal | 0 | 0 | 0.047 | 1 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiotherapy to breast | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyomavirus test positive | 0 | 0 | 0.049 | 1 | 3.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personality disorder of childhood | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opticokinetic nystagmus tests | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroborreliosis | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hysterosalpingo-oophorectomy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrooesophageal sphincter insufficiency | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Follicular mucinosis | 0 | 0 | 0.053 | 1 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy large bowel abnormal | 0 | 0 | 0.052 | 1 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure systolic normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abstains from alcohol | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inadequate aseptic technique in use of product | 0 | 0.001 | 0.206 | 1 | 2.279 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lymphocyte count abnormal | 0 | 0 | 0.142 | 1 | 2.5 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venogram normal | 0 | 0.001 | 0.145 | 1 | 2.486 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral haematoma | 0 | 0.001 | 0.137 | 1 | 2.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema weeping | 0 | 0 | 0.056 | 1 | 2.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac aneurysm | 0 | 0 | 0.026 | 1 | 3.258 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric cancer | 0 | 0 | 0.079 | 1 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy thyroid gland abnormal | 0 | 0 | 0.046 | 1 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenosine deaminase increased | 0 | 0 | 0.016 | 1 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue neoplasm | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sickle cell disease | 0 | 0 | 0.058 | 1 | 2.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal atrophy | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myxoedema | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant respiratory tract neoplasm | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipohypertrophy | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity unsaturated decreased | 0 | 0 | 0.05 | 1 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iris injury | 0 | 0 | 0.051 | 1 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iliac artery disease | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart transplant | 0 | 0 | 0.049 | 1 | 3.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Evacuation of retained products of conception | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign lung neoplasm | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site indentation | 0 | 0.003 | 0.417 | 1 | 1.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chorea | 0 | 0.001 | 0.23 | 1 | 2.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bullous impetigo | 0 | 0 | 0.102 | 1 | 2.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin CSF normal | 0 | 0 | 0.086 | 1 | 2.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Submaxillary gland enlargement | 0 | 0 | 0.122 | 1 | 2.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold agglutinins negative | 0 | 0 | 0.02 | 1 | 3.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioactive iodine therapy | 0 | 0 | 0.045 | 1 | 3.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychotic behaviour | 0 | 0 | 0.047 | 1 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumatosis | 0 | 0 | 0.011 | 1 | 3.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour haemorrhage | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyoderma | 0 | 0 | 0.053 | 1 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phenylalanine screen | 0 | 0 | 0.049 | 1 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononuclear cell count increased | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver dialysis | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heparin-induced thrombocytopenia test positive | 0 | 0 | 0.05 | 1 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart block congenital | 0 | 0 | 0.048 | 1 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac ventricular disorder | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hunt and Hess scale | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hernial eventration | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulomatous liver disease | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy gastrointestinal normal | 0 | 0 | 0.063 | 1 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tangentiality | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary artery stenosis congenital | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic organ injury | 0 | 0 | 0.048 | 1 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoprotein (a) abnormal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterococcal sepsis | 0 | 0 | 0.061 | 1 | 2.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Duodenal ulcer perforation | 0 | 0 | 0.05 | 1 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital vesicoureteric reflux | 0 | 0 | 0.049 | 1 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amblyopia strabismic | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adnexa uteri cyst | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary hesitation | 0 | 0.001 | 0.088 | 1 | 2.747 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Horner's syndrome | 0 | 0.001 | 0.064 | 1 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperbilirubinaemia neonatal | 0 | 0 | 0.053 | 1 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bleeding time prolonged | 0 | 0 | 0.017 | 1 | 3.401 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric ulcer haemorrhage | 0 | 0 | 0.09 | 1 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device dependence | 0 | 0 | 0.098 | 1 | 2.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial fluid analysis | 0 | 0 | 0.093 | 1 | 2.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skeletal survey | 0 | 0 | 0.057 | 1 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product container seal issue | 0 | 0 | 0.046 | 1 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polydactyly | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningocele acquired | 0 | 0 | 0.004 | 1 | 3.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunosuppressant drug level | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular function test normal | 0 | 0 | 0.059 | 1 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide abnormal | 0 | 0 | 0.064 | 1 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chromogranin A increased | 0 | 0 | 0.005 | 1 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet anisocytosis | 0 | 0 | 0.057 | 1 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lewis-Sumner syndrome | 0 | 0 | 0.048 | 1 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival cyst | 0 | 0 | 0.051 | 1 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal operation | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Compulsive lip biting | 0 | 0 | 0.053 | 1 | 2.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burn oesophageal | 0 | 0 | 0.049 | 1 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary neoplasm | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to chemicals | 0 | 0 | 0.071 | 1 | 2.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeding intolerance | 0 | 0 | 0.065 | 1 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcium ionised increased | 0 | 0 | 0.126 | 1 | 2.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chondropathy | 0 | 0 | 0.066 | 1 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extravasation blood | 0 | 0 | 0.054 | 1 | 2.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic pneumonia | 0 | 0 | 0.033 | 1 | 3.171 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vein collapse | 0 | 0 | 0.051 | 1 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovial cyst removal | 0 | 0 | 0.071 | 1 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal nerve stimulator implantation | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human ehrlichiosis | 0 | 0 | 0.057 | 1 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trigeminal palsy | 0 | 0 | 0.057 | 1 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product sterility lacking | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pre-existing disease | 0 | 0 | 0.048 | 1 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging hepatobiliary abnormal | 0 | 0 | 0.049 | 1 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph nodes scan abnormal | 0 | 0 | 0.062 | 1 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte morphology normal | 0 | 0 | 0.052 | 1 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracranial hypotension | 0 | 0 | 0.054 | 1 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood oestrogen abnormal | 0 | 0 | 0.052 | 1 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site movement impairment | 0 | 0 | 0.056 | 1 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital lesion | 0 | 0.001 | 0.061 | 1 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells stool negative | 0 | 0 | 0.084 | 1 | 2.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram T wave normal | 0 | 0 | 0.053 | 1 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premenstrual syndrome | 0 | 0 | 0.081 | 1 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal infiltrates | 0 | 0 | 0.081 | 1 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood zinc | 0 | 0 | 0.035 | 1 | 3.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint effusion | 0 | 0 | 0.059 | 1 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood HIV RNA | 0 | 0 | 0.039 | 1 | 3.112 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine uric acid normal | 0 | 0 | 0.041 | 1 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord lipoma | 0 | 0 | 0.085 | 1 | 2.764 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein-losing gastroenteropathy | 0 | 0 | 0.003 | 1 | 3.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrinolysis | 0 | 0 | 0.016 | 1 | 3.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia mycoplasmal | 0 | 0 | 0.002 | 0.999 | 3.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pityriasis lichenoides et varioliformis acuta | 0 | 0 | 0.001 | 0.999 | 4.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyst aspiration | 0 | 0 | 0.01 | 0.999 | 3.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatic fever | 0 | 0.001 | 0.027 | 0.999 | 3.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atypical pneumonia | 0 | 0.001 | 0.09 | 0.999 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Still's disease | 0 | 0.001 | 0.07 | 0.999 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Marrow hyperplasia | 0 | 0.001 | 0.002 | 0.999 | 3.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal skin infection | 0 | 0 | 0.01 | 0.999 | 3.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroendocrine tumour | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxoplasmosis | 0 | 0.001 | 0.099 | 0.999 | 2.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alopecia totalis | 0 | 0.001 | 0.002 | 0.999 | 3.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyrotoxic crisis | 0 | 0 | 0.031 | 0.999 | 3.192 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Light chain analysis | 0 | 0 | 0.001 | 0.999 | 4.264 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal pseudo-obstruction | 0 | 0 | 0.004 | 0.999 | 3.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursal fluid accumulation | 0 | 0.001 | 0.055 | 0.999 | 2.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong technique in device usage process | 0 | 0.001 | 0.026 | 0.999 | 3.255 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure systolic abnormal | 0 | 0.001 | 0.009 | 0.999 | 3.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital naevus | 0 | 0 | 0.001 | 0.999 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood follicle stimulating hormone | 0 | 0 | 0 | 0.999 | 4.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | FEV1/FVC ratio decreased | 0 | 0 | 0 | 0.999 | 4.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchopulmonary aspergillosis allergic | 0 | 0 | 0 | 0.999 | 5.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint noise | 0 | 0.003 | 0.285 | 0.999 | 2.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematocrit increased | 0 | 0.004 | 0.279 | 0.999 | 2.079 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenosynovitis | 0 | 0.002 | 0.232 | 0.999 | 2.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound kidney | 0 | 0.005 | 0.344 | 0.999 | 1.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance cholangiopancreatography | 0 | 0.003 | 0.288 | 0.999 | 2.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Romberg test | 0 | 0.001 | 0.015 | 0.999 | 3.442 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seroma | 0 | 0.001 | 0.048 | 0.999 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatologic examination normal | 0 | 0.001 | 0.019 | 0.999 | 3.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan normal | 0 | 0.001 | 0.146 | 0.999 | 2.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcus test negative | 0 | 0.004 | 0.312 | 0.999 | 2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium test positive | 0 | 0.001 | 0.09 | 0.999 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gamma-glutamyltransferase decreased | 0 | 0 | 0.001 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder irritation | 0 | 0 | 0 | 0.999 | 4.444 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal laminectomy | 0 | 0.001 | 0.019 | 0.999 | 3.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary fragility | 0 | 0 | 0.002 | 0.999 | 3.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Folliculitis | 0 | 0.003 | 0.273 | 0.999 | 2.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden onset of sleep | 0 | 0 | 0.02 | 0.999 | 3.359 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteomyelitis chronic | 0 | 0 | 0.004 | 0.999 | 3.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound pelvis | 0 | 0.001 | 0.013 | 0.999 | 3.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain scan normal | 0 | 0.001 | 0.05 | 0.999 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve stimulation test normal | 0 | 0.001 | 0.002 | 0.999 | 3.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy test negative | 0 | 0.004 | 0.318 | 0.999 | 1.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | West Nile virus test negative | 0 | 0.002 | 0.205 | 0.999 | 2.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioisotope scan | 0 | 0 | 0.014 | 0.999 | 3.475 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PO2 | 0 | 0.001 | 0.066 | 0.999 | 2.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ketonuria | 0 | 0.001 | 0.018 | 0.999 | 3.385 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterococcus test positive | 0 | 0.001 | 0.026 | 0.999 | 3.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery stenosis | 0 | 0.001 | 0.004 | 0.999 | 3.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune nephritis | 0 | 0 | 0.001 | 0.999 | 4.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle injury | 0 | 0.002 | 0.191 | 0.999 | 2.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholecystitis infective | 0 | 0.001 | 0.006 | 0.999 | 3.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise electrocardiogram | 0 | 0.001 | 0.073 | 0.999 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Back disorder | 0 | 0.001 | 0.135 | 0.999 | 2.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenovirus infection | 0 | 0.001 | 0.038 | 0.999 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous lupus erythematosus | 0 | 0.001 | 0.08 | 0.999 | 2.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paracentesis eye abnormal | 0 | 0 | 0.031 | 0.999 | 3.197 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal sepsis | 0 | 0.001 | 0.008 | 0.999 | 3.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung hyperinflation | 0 | 0.001 | 0.02 | 0.999 | 3.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising fasciitis | 0 | 0.001 | 0.059 | 0.999 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan abdomen abnormal | 0 | 0 | 0.007 | 0.999 | 3.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningeal disorder | 0 | 0.001 | 0.031 | 0.999 | 3.189 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system inflammation | 0 | 0.001 | 0.104 | 0.999 | 2.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic cirrhosis | 0 | 0.003 | 0.265 | 0.999 | 2.114 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carnitine | 0 | 0.001 | 0.002 | 0.999 | 4.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil count | 0 | 0.002 | 0.165 | 0.999 | 2.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella virus test | 0 | 0.001 | 0.041 | 0.999 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumovirus test positive | 0 | 0.001 | 0.003 | 0.999 | 3.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin urine present | 0 | 0.001 | 0.09 | 0.999 | 2.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Light chain analysis normal | 0 | 0 | 0.002 | 0.999 | 3.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crystal urine present | 0 | 0 | 0.007 | 0.999 | 3.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal disorder | 0 | 0 | 0.001 | 0.999 | 4.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitello-intestinal duct remnant | 0 | 0 | 0 | 0.999 | 4.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulins | 0 | 0.003 | 0.248 | 0.999 | 2.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye contusion | 0 | 0.003 | 0.274 | 0.999 | 2.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subileus | 0 | 0 | 0.001 | 0.999 | 4.261 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosa erosion | 0 | 0 | 0.004 | 0.999 | 3.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia staphylococcal | 0 | 0.001 | 0.035 | 0.999 | 3.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Learning disorder | 0 | 0 | 0.001 | 0.999 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxsackie viral infection | 0 | 0.001 | 0.007 | 0.999 | 3.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fundus autofluorescence | 0 | 0.001 | 0.035 | 0.999 | 3.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lupus-like syndrome | 0 | 0.001 | 0.027 | 0.999 | 3.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical radiculopathy | 0 | 0.001 | 0.176 | 0.999 | 2.376 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrioventricular block | 0 | 0.003 | 0.196 | 0.999 | 2.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Formication | 0 | 0.008 | 0.432 | 0.999 | 1.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular pain | 0 | 0.004 | 0.303 | 0.999 | 2.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroneuromyography | 0 | 0 | 0.002 | 0.999 | 4.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow transplant | 0 | 0 | 0 | 0.999 | 4.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital herpes simplex | 0 | 0 | 0.031 | 0.999 | 3.198 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium avium complex infection | 0 | 0 | 0.001 | 0.999 | 4.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid pain | 0 | 0.002 | 0.241 | 0.999 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF neutrophil count increased | 0 | 0.001 | 0.072 | 0.999 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance neurography | 0 | 0.001 | 0.005 | 0.999 | 3.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intranasal hypoaesthesia | 0 | 0.001 | 0.075 | 0.999 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual field tests abnormal | 0 | 0.001 | 0.142 | 0.999 | 2.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging whole body | 0 | 0.001 | 0.011 | 0.999 | 3.537 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid function test abnormal | 0 | 0.001 | 0.048 | 0.999 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal (SMQ) [narrow] | 0 | 0.001 | 0.043 | 0.999 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononucleosis heterophile test positive | 0 | 0.001 | 0.106 | 0.999 | 2.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononeuropathy | 0 | 0.001 | 0.096 | 0.999 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asocial behaviour | 0 | 0 | 0.001 | 0.999 | 4.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctivitis viral | 0 | 0.001 | 0.042 | 0.999 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to toxic agent | 0 | 0.001 | 0.008 | 0.999 | 3.644 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Light chain analysis decreased | 0 | 0 | 0 | 0.999 | 4.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis meningococcal | 0 | 0 | 0 | 0.999 | 4.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin abrasion | 0 | 0.006 | 0.35 | 0.999 | 1.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual evoked potentials abnormal | 0 | 0 | 0 | 0.999 | 4.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicose vein | 0 | 0 | 0.017 | 0.999 | 3.408 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem auditory evoked response | 0 | 0.001 | 0.021 | 0.999 | 3.327 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual acuity tests | 0 | 0.001 | 0.028 | 0.999 | 3.237 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal plaque | 0 | 0.001 | 0.039 | 0.999 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar infarction | 0 | 0.001 | 0.036 | 0.999 | 3.134 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinalgia | 0 | 0.001 | 0.005 | 0.999 | 3.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus test | 0 | 0.001 | 0.058 | 0.999 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular pressure increased | 0 | 0.001 | 0.096 | 0.999 | 2.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gene mutation identification test | 0 | 0.001 | 0.055 | 0.999 | 2.966 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrocele | 0 | 0.001 | 0.003 | 0.999 | 3.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anembryonic gestation | 0 | 0 | 0.004 | 0.999 | 3.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Squamous cell carcinoma of lung | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchomalacia | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper limb fracture | 0 | 0.003 | 0.211 | 0.999 | 2.264 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Episcleritis | 0 | 0.001 | 0.021 | 0.999 | 3.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyst removal | 0 | 0.001 | 0.051 | 0.999 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal compression fracture | 0 | 0.001 | 0.012 | 0.999 | 3.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-neuronal antibody negative | 0 | 0.001 | 0.062 | 0.999 | 2.908 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oppositional defiant disorder | 0 | 0.001 | 0.002 | 0.999 | 3.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blast cells present | 0 | 0.001 | 0.101 | 0.999 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis infected | 0 | 0.001 | 0.005 | 0.999 | 3.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem auditory evoked response abnormal | 0 | 0.001 | 0.018 | 0.999 | 3.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual analogue scale | 0 | 0.001 | 0.049 | 0.999 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mesenteric panniculitis | 0 | 0 | 0.01 | 0.999 | 3.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF myelin basic protein increased | 0 | 0 | 0.007 | 0.999 | 3.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adnexal torsion | 0 | 0 | 0.001 | 0.999 | 4.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis contact | 0 | 0.008 | 0.465 | 0.999 | 1.697 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palpable purpura | 0 | 0 | 0.01 | 0.999 | 3.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin CSF increased | 0 | 0.001 | 0.006 | 0.999 | 3.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin premalignant disorders (SMQ) [narrow] | 0 | 0.001 | 0.015 | 0.999 | 3.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gene mutation | 0 | 0.001 | 0.072 | 0.999 | 2.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture wound positive | 0 | 0.001 | 0.121 | 0.999 | 2.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smallpox | 0 | 0.001 | 0.005 | 0.999 | 3.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face and mouth X-ray | 0 | 0.001 | 0.001 | 0.999 | 4.173 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Audiogram | 0 | 0.004 | 0.365 | 0.999 | 1.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture wound negative | 0 | 0.001 | 0.027 | 0.999 | 3.241 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ligament pain | 0 | 0.001 | 0.049 | 0.999 | 3.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile colic | 0 | 0 | 0.003 | 0.999 | 3.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-transglutaminase antibody | 0 | 0.001 | 0.002 | 0.999 | 3.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvovirus infection | 0 | 0.001 | 0.001 | 0.999 | 4.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paronychia | 0 | 0 | 0.012 | 0.999 | 3.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory muscle weakness | 0 | 0 | 0 | 0.999 | 5.189 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Roseolovirus test positive | 0 | 0.001 | 0.045 | 0.999 | 3.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sick building syndrome | 0 | 0 | 0 | 0.999 | 4.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.001 | 0.049 | 0.999 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte percentage increased | 0 | 0.001 | 0.01 | 0.999 | 3.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelocyte count | 0 | 0 | 0 | 0.999 | 5.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Live birth | 0 | 0.001 | 0.001 | 0.999 | 4.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Treponema test positive | 0 | 0.001 | 0.09 | 0.999 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple chemical sensitivity | 0 | 0.001 | 0.068 | 0.999 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulins increased | 0 | 0.001 | 0.009 | 0.999 | 3.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human herpes virus 6 serology | 0 | 0.001 | 0.008 | 0.999 | 3.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac valve disease | 0 | 0.001 | 0.012 | 0.999 | 3.517 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary system x-ray normal | 0 | 0.001 | 0.053 | 0.999 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal bacteraemia | 0 | 0.001 | 0.025 | 0.999 | 3.269 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyschezia | 0 | 0.001 | 0.027 | 0.999 | 3.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive crisis | 0 | 0.003 | 0.228 | 0.999 | 2.214 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal disorder | 0 | 0.001 | 0.015 | 0.999 | 3.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Addison's disease | 0 | 0.001 | 0.017 | 0.999 | 3.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Slit-lamp examination | 0 | 0.001 | 0.023 | 0.999 | 3.298 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sedative therapy | 0 | 0 | 0.006 | 0.999 | 3.733 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystoid macular oedema | 0 | 0 | 0 | 0.999 | 4.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Light chain analysis increased | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Frustration tolerance decreased | 0 | 0.002 | 0.227 | 0.999 | 2.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychomotor skills impaired | 0 | 0.001 | 0.025 | 0.999 | 3.27 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood magnesium increased | 0 | 0.005 | 0.296 | 0.999 | 2.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperphagia | 0 | 0.001 | 0.003 | 0.999 | 3.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amylase | 0 | 0.003 | 0.258 | 0.999 | 2.134 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subcutaneous haematoma | 0 | 0.001 | 0.06 | 0.999 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin conjugated decreased | 0 | 0.001 | 0.054 | 0.999 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain assessment | 0 | 0 | 0.002 | 0.999 | 4.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor X level normal | 0 | 0 | 0 | 0.999 | 4.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyelocaliectasis | 0 | 0 | 0.017 | 0.999 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune neuropathy | 0 | 0.001 | 0.018 | 0.999 | 3.387 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin saturation decreased | 0 | 0.001 | 0.044 | 0.999 | 3.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gamma-glutamyltransferase | 0 | 0.001 | 0.009 | 0.999 | 3.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human metapneumovirus test positive | 0 | 0.001 | 0.013 | 0.999 | 3.494 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound foetal | 0 | 0.001 | 0.005 | 0.999 | 3.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus operation | 0 | 0.005 | 0.304 | 0.999 | 2.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anion gap decreased | 0 | 0.004 | 0.335 | 0.999 | 1.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C RNA negative | 0 | 0 | 0 | 0.999 | 4.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal dilatation | 0 | 0.001 | 0.014 | 0.999 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte count normal | 0 | 0.001 | 0.089 | 0.999 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mevalonate kinase deficiency | 0 | 0 | 0.004 | 0.999 | 3.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urogram normal | 0 | 0 | 0 | 0.999 | 4.312 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Organ failure | 0 | 0.004 | 0.226 | 0.999 | 2.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | NIH stroke scale score increased | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post procedural complication | 0 | 0.001 | 0.021 | 0.999 | 3.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood heavy metal normal | 0 | 0.001 | 0.078 | 0.999 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileus paralytic | 0 | 0.001 | 0.039 | 0.999 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smooth muscle antibody positive | 0 | 0 | 0.005 | 0.999 | 3.792 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal discolouration | 0 | 0.001 | 0.053 | 0.999 | 2.979 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Repetitive strain injury | 0 | 0.001 | 0.001 | 0.999 | 4.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteopenia | 0 | 0.001 | 0.108 | 0.999 | 2.644 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site laceration | 0 | 0 | 0.003 | 0.999 | 3.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal fusion surgery | 0 | 0.001 | 0.045 | 0.999 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site eczema | 0 | 0.001 | 0.01 | 0.999 | 3.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B virus test | 0 | 0.001 | 0.069 | 0.999 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal inflammation | 0 | 0.001 | 0.034 | 0.999 | 3.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin G abnormal | 0 | 0 | 0.025 | 0.999 | 3.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity total normal | 0 | 0.001 | 0.123 | 0.999 | 2.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimicrobial susceptibility test resistant | 0 | 0.001 | 0.002 | 0.999 | 4.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocyte count decreased | 0 | 0.001 | 0.035 | 0.999 | 3.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | DNA test for fragile X | 0 | 0.001 | 0.069 | 0.999 | 2.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholesterol | 0 | 0.001 | 0.136 | 0.999 | 2.523 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eustachian tube dysfunction | 0 | 0.001 | 0.051 | 0.999 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hidradenitis | 0 | 0.001 | 0.002 | 0.999 | 3.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan brain | 0 | 0.004 | 0.252 | 0.999 | 2.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cutaneous tuberculosis | 0 | 0 | 0.012 | 0.999 | 3.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labelled drug-disease interaction medication error | 0 | 0.001 | 0.001 | 0.999 | 4.228 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitral valve prolapse | 0 | 0.001 | 0.017 | 0.999 | 3.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serositis | 0 | 0 | 0.03 | 0.999 | 3.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint dislocation | 0 | 0.003 | 0.186 | 0.999 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract infection neonatal | 0 | 0 | 0.004 | 0.999 | 3.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell schistocytes present | 0 | 0.001 | 0.036 | 0.999 | 3.14 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hip surgery | 0 | 0.001 | 0.005 | 0.999 | 3.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angioplasty | 0 | 0.003 | 0.188 | 0.999 | 2.333 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product packaging quantity issue | 0 | 0.001 | 0.003 | 0.999 | 3.926 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiphospholipid antibodies positive | 0 | 0.001 | 0.174 | 0.999 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burning mouth syndrome | 0 | 0 | 0 | 0.999 | 4.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to bone | 0 | 0.001 | 0.041 | 0.999 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoperfusion | 0 | 0.001 | 0.002 | 0.999 | 3.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Progesterone decreased | 0 | 0 | 0.003 | 0.999 | 3.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apparent death | 0 | 0.001 | 0.054 | 0.999 | 2.968 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein | 0 | 0 | 0.031 | 0.999 | 3.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emotional poverty | 0 | 0 | 0.022 | 0.999 | 3.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord injury | 0 | 0.001 | 0.032 | 0.999 | 3.178 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macule | 0 | 0.004 | 0.266 | 0.999 | 2.112 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial disorder | 0 | 0 | 0.016 | 0.999 | 3.439 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulins decreased | 0 | 0.001 | 0.101 | 0.999 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal prolapse | 0 | 0.001 | 0.006 | 0.999 | 3.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gynaecological examination abnormal | 0 | 0 | 0.031 | 0.999 | 3.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chapped lips | 0 | 0.004 | 0.277 | 0.999 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF glucose decreased | 0 | 0.001 | 0.162 | 0.999 | 2.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microbiology test normal | 0 | 0.001 | 0.116 | 0.999 | 2.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth infection | 0 | 0.001 | 0.124 | 0.999 | 2.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin unconjugated normal | 0 | 0.001 | 0.003 | 0.999 | 3.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Time perception altered | 0 | 0 | 0.018 | 0.999 | 3.382 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | DNA antibody positive | 0 | 0 | 0.031 | 0.999 | 3.201 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peak expiratory flow rate decreased | 0 | 0.001 | 0.002 | 0.999 | 4.028 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histiocytosis | 0 | 0 | 0 | 0.999 | 4.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal papilloma | 0 | 0 | 0 | 0.999 | 4.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital tricuspid valve incompetence | 0 | 0 | 0 | 0.999 | 4.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon pain | 0 | 0.004 | 0.278 | 0.999 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site haematoma | 0 | 0 | 0.02 | 0.999 | 3.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle strength abnormal | 0 | 0.001 | 0.066 | 0.999 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Negative thoughts | 0 | 0 | 0.005 | 0.999 | 3.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inability to crawl | 0 | 0.001 | 0.067 | 0.999 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product name confusion | 0 | 0.001 | 0.029 | 0.999 | 3.22 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin E | 0 | 0.001 | 0.133 | 0.999 | 2.534 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychiatric evaluation | 0 | 0.001 | 0.004 | 0.999 | 3.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pruritus genital | 0 | 0.002 | 0.232 | 0.999 | 2.203 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site reaction | 0 | 0 | 0.002 | 0.999 | 4.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venous thrombosis | 0 | 0.001 | 0.018 | 0.999 | 3.385 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albuminuria | 0 | 0 | 0.016 | 0.999 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracranial pressure increased | 0 | 0.003 | 0.184 | 0.999 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalomyelitis | 0 | 0.001 | 0.061 | 0.999 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum culture positive | 0 | 0.002 | 0.106 | 0.999 | 2.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serology abnormal | 0 | 0 | 0.001 | 0.999 | 4.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonic posturing | 0 | 0.001 | 0.081 | 0.999 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patent ductus arteriosus | 0 | 0 | 0 | 0.999 | 4.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil percentage increased | 0 | 0.001 | 0.066 | 0.999 | 2.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac discomfort | 0 | 0.002 | 0.179 | 0.999 | 2.365 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site induration | 0 | 0.001 | 0.084 | 0.999 | 2.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diaphragmalgia | 0 | 0.002 | 0.229 | 0.999 | 2.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood albumin increased | 0 | 0.001 | 0.137 | 0.999 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral titre increased | 0 | 0.001 | 0.039 | 0.999 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteonecrosis | 0 | 0.001 | 0.089 | 0.999 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheal aspiration procedure | 0 | 0.001 | 0.007 | 0.999 | 3.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture tissue specimen negative | 0 | 0.001 | 0.009 | 0.999 | 3.623 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dementia Alzheimer's type | 0 | 0.001 | 0.019 | 0.999 | 3.378 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy intestine abnormal | 0 | 0.001 | 0.005 | 0.999 | 3.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy upper gastrointestinal tract abnormal | 0 | 0.001 | 0.137 | 0.999 | 2.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeding tube user | 0 | 0.001 | 0.151 | 0.999 | 2.464 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis diaper | 0 | 0.004 | 0.41 | 0.999 | 1.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear congestion | 0 | 0.005 | 0.381 | 0.999 | 1.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyoderma gangrenosum | 0 | 0 | 0 | 0.999 | 5.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal non-stress test | 0 | 0 | 0.013 | 0.999 | 3.488 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precancerous mucosal lesion | 0 | 0 | 0 | 0.999 | 4.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood mercury abnormal | 0 | 0.001 | 0.049 | 0.999 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device malfunction | 0 | 0.001 | 0.093 | 0.999 | 2.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroidectomy | 0 | 0.001 | 0.036 | 0.999 | 3.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthostatic hypertension | 0 | 0 | 0.009 | 0.999 | 3.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Treatment noncompliance | 0 | 0.001 | 0.079 | 0.999 | 2.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin fragility | 0 | 0 | 0.012 | 0.999 | 3.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte count | 0 | 0.001 | 0.032 | 0.999 | 3.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint inflammation | 0 | 0.002 | 0.182 | 0.999 | 2.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subretinal fluid | 0 | 0 | 0.003 | 0.999 | 3.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral parotitis | 0 | 0 | 0.002 | 0.999 | 3.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual field tests | 0 | 0.003 | 0.201 | 0.999 | 2.293 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue infection | 0 | 0 | 0 | 0.999 | 4.414 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound infection | 0 | 0.001 | 0.011 | 0.999 | 3.542 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoscopy normal | 0 | 0.001 | 0.029 | 0.999 | 3.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate | 0 | 0 | 0.005 | 0.999 | 3.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac asthma | 0 | 0 | 0 | 0.999 | 5.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart sounds abnormal | 0 | 0.001 | 0.123 | 0.999 | 2.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle enzyme increased | 0 | 0.001 | 0.096 | 0.999 | 2.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy test positive | 0 | 0.004 | 0.417 | 0.999 | 1.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle discomfort | 0 | 0.004 | 0.267 | 0.999 | 2.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral motor neuropathy | 0 | 0.001 | 0.095 | 0.999 | 2.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant melanoma | 0 | 0.001 | 0.013 | 0.999 | 3.503 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract irritation | 0 | 0.001 | 0.008 | 0.999 | 3.644 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fixed eruption | 0 | 0.001 | 0.057 | 0.999 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retrograde amnesia | 0 | 0.001 | 0.053 | 0.999 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pernicious anaemia | 0 | 0.001 | 0.014 | 0.999 | 3.482 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood methaemoglobin | 0 | 0.001 | 0.039 | 0.999 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Defaecation disorder | 0 | 0.001 | 0.07 | 0.999 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serology normal | 0 | 0.002 | 0.131 | 0.999 | 2.543 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar inflammation | 0 | 0.001 | 0.143 | 0.999 | 2.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complication associated with device | 0 | 0.003 | 0.204 | 0.999 | 2.285 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheter placement | 0 | 0.002 | 0.185 | 0.999 | 2.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoperitoneum | 0 | 0 | 0.008 | 0.999 | 3.634 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Portal hypertension | 0 | 0 | 0.019 | 0.999 | 3.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenodesis | 0 | 0 | 0 | 0.999 | 4.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival erythema | 0 | 0.002 | 0.151 | 0.999 | 2.464 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exostosis | 0 | 0.001 | 0.069 | 0.999 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nocturia | 0 | 0.003 | 0.176 | 0.999 | 2.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shoulder operation | 0 | 0.001 | 0.199 | 0.999 | 2.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossitis | 0 | 0.001 | 0.175 | 0.999 | 2.38 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Concentric sclerosis | 0 | 0 | 0 | 0.999 | 5.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspraxia | 0 | 0.001 | 0.06 | 0.999 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transferrin | 0 | 0 | 0.001 | 0.999 | 4.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infective myositis | 0 | 0.001 | 0.018 | 0.999 | 3.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal erythema | 0 | 0.002 | 0.16 | 0.999 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood homocysteine | 0 | 0.001 | 0.063 | 0.999 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normocytic anaemia | 0 | 0.001 | 0.081 | 0.999 | 2.785 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise lack of | 0 | 0 | 0 | 0.999 | 4.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood premalignant disorders (SMQ) [broad] | 0 | 0.002 | 0.155 | 0.999 | 2.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Completed suicide | 0 | 0.001 | 0.007 | 0.999 | 3.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antibody abnormal | 0 | 0 | 0.002 | 0.999 | 4.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac monitoring normal | 0 | 0.002 | 0.198 | 0.999 | 2.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose tolerance test normal | 0 | 0.001 | 0.023 | 0.999 | 3.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site oedema | 0 | 0.001 | 0.037 | 0.999 | 3.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product deposit | 0 | 0 | 0.002 | 0.999 | 4.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin striae | 0 | 0.001 | 0.016 | 0.999 | 3.418 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth abscess | 0 | 0.001 | 0.141 | 0.999 | 2.503 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic lesion | 0 | 0.001 | 0 | 0.999 | 4.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema herpeticum | 0 | 0.001 | 0.038 | 0.999 | 3.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioallergosorbent test positive | 0 | 0 | 0.029 | 0.999 | 3.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombin time normal | 0 | 0 | 0.001 | 0.999 | 4.171 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dystonia | 0 | 0.003 | 0.282 | 0.999 | 2.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ambulatory normal | 0 | 0.001 | 0.008 | 0.999 | 3.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin premalignant disorders (SMQ) [broad] | 0 | 0.001 | 0.015 | 0.999 | 3.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic enzyme | 0 | 0.001 | 0.076 | 0.999 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta-2 glycoprotein antibody | 0 | 0.001 | 0.027 | 0.999 | 3.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug level | 0 | 0.001 | 0.014 | 0.999 | 3.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral load undetectable | 0 | 0 | 0.001 | 0.999 | 4.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anion gap normal | 0 | 0.002 | 0.128 | 0.999 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular malformation | 0 | 0 | 0 | 0.999 | 5.17 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Organising pneumonia | 0 | 0.001 | 0.047 | 0.999 | 3.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrospinal fluid leakage | 0 | 0 | 0.001 | 0.999 | 4.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint manipulation | 0 | 0 | 0.002 | 0.999 | 3.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capsule endoscopy | 0 | 0 | 0.001 | 0.999 | 4.113 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulcer haemorrhage | 0 | 0 | 0 | 0.999 | 4.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Light chain analysis abnormal | 0 | 0 | 0 | 0.999 | 4.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eating disorder symptom | 0 | 0 | 0.003 | 0.999 | 3.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine ketone body present | 0 | 0.005 | 0.394 | 0.999 | 1.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol use | 0 | 0.001 | 0.052 | 0.999 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupillary disorder | 0 | 0.001 | 0.022 | 0.999 | 3.315 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroblastoma | 0 | 0 | 0.009 | 0.999 | 3.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thyroid stimulating hormone increased | 0 | 0.002 | 0.152 | 0.999 | 2.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunosuppression | 0 | 0.002 | 0.238 | 0.999 | 2.187 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aldolase normal | 0 | 0.001 | 0.089 | 0.999 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug screen positive | 0 | 0.001 | 0.01 | 0.999 | 3.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal tubular necrosis | 0 | 0 | 0.006 | 0.999 | 3.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emotional disorder of childhood | 0 | 0 | 0.004 | 0.999 | 3.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum test | 0 | 0 | 0.002 | 0.999 | 3.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ex-tobacco user | 0 | 0 | 0 | 0.999 | 4.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermal burns of eye | 0 | 0.001 | 0.073 | 0.999 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyslipidaemia | 0 | 0.001 | 0.095 | 0.999 | 2.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trisomy 21 | 0 | 0.001 | 0.046 | 0.999 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amaurosis | 0 | 0.001 | 0.002 | 0.999 | 4.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Calcium ionised decreased | 0 | 0 | 0.001 | 0.999 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinea capitis | 0 | 0 | 0.001 | 0.999 | 4.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granular cell tumour | 0 | 0 | 0.003 | 0.999 | 3.908 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Road traffic accident | 0 | 0.004 | 0.366 | 0.999 | 1.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transient global amnesia | 0 | 0.003 | 0.147 | 0.999 | 2.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichenoid keratosis | 0 | 0.001 | 0.081 | 0.999 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disorganised speech | 0 | 0.003 | 0.314 | 0.999 | 1.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal test positive | 0 | 0.001 | 0.074 | 0.999 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis minimal lesion | 0 | 0.001 | 0.024 | 0.999 | 3.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal oedema | 0 | 0.005 | 0.394 | 0.999 | 1.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cataract operation | 0 | 0.002 | 0.229 | 0.999 | 2.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis adenovirus | 0 | 0 | 0 | 0.999 | 4.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal abscess | 0 | 0.001 | 0.114 | 0.999 | 2.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine test normal | 0 | 0.001 | 0.006 | 0.999 | 3.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron binding capacity total | 0 | 0.001 | 0.071 | 0.999 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythrodermic psoriasis | 0 | 0 | 0.015 | 0.999 | 3.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Overlap syndrome | 0 | 0 | 0 | 0.999 | 4.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin C normal | 0 | 0 | 0.002 | 0.999 | 3.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupils unequal | 0 | 0.001 | 0.09 | 0.999 | 2.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal oedema | 0 | 0.003 | 0.215 | 0.999 | 2.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudomonas test positive | 0 | 0 | 0.001 | 0.999 | 4.256 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Superinfection bacterial | 0 | 0.001 | 0.081 | 0.999 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal viral infection | 0 | 0.001 | 0.101 | 0.999 | 2.678 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic enzyme abnormal | 0 | 0.001 | 0.089 | 0.999 | 2.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Throat lesion | 0 | 0.001 | 0.047 | 0.999 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intermittent claudication | 0 | 0 | 0.002 | 0.999 | 4.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital herpes zoster | 0 | 0 | 0 | 0.999 | 4.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoidectomy | 0 | 0.001 | 0.021 | 0.999 | 3.344 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site hypertrophy | 0 | 0 | 0.004 | 0.999 | 3.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site dryness | 0 | 0.003 | 0.249 | 0.999 | 2.156 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronavirus test positive | 0 | 0.003 | 0.245 | 0.999 | 2.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelodysplastic syndrome (SMQ) [narrow] | 0 | 0.001 | 0.07 | 0.999 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Folate deficiency | 0 | 0 | 0.001 | 0.999 | 4.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Consciousness fluctuating | 0 | 0.005 | 0.312 | 0.999 | 2.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte percentage decreased | 0 | 0.003 | 0.209 | 0.999 | 2.27 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial bones fracture | 0 | 0.001 | 0.071 | 0.999 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plateletcrit | 0 | 0 | 0.002 | 0.999 | 4.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle haemorrhage | 0 | 0.001 | 0.048 | 0.999 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip discolouration | 0 | 0.003 | 0.311 | 0.999 | 2.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enlarged uvula | 0 | 0.005 | 0.326 | 0.999 | 1.968 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foot deformity | 0 | 0.002 | 0.25 | 0.999 | 2.156 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otitis externa | 0 | 0.001 | 0.129 | 0.999 | 2.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal malrotation | 0 | 0.001 | 0.004 | 0.999 | 3.838 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cells urine | 0 | 0.001 | 0.038 | 0.999 | 3.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Affect lability | 0 | 0.001 | 0.084 | 0.999 | 2.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site coldness | 0 | 0.001 | 0.097 | 0.999 | 2.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optical coherence tomography | 0 | 0.001 | 0.013 | 0.999 | 3.506 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin C-peptide | 0 | 0 | 0.031 | 0.999 | 3.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QRS complex abnormal | 0 | 0 | 0.031 | 0.999 | 3.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Language disorder | 0 | 0.001 | 0.033 | 0.999 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine free normal | 0 | 0.001 | 0.121 | 0.999 | 2.584 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein urine | 0 | 0.003 | 0.227 | 0.999 | 2.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thirst decreased | 0 | 0.001 | 0.027 | 0.999 | 3.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site abscess sterile | 0 | 0.001 | 0.048 | 0.999 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apallic syndrome | 0 | 0 | 0 | 0.999 | 4.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QT interval normal | 0 | 0.001 | 0.038 | 0.999 | 3.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytogenetic analysis normal | 0 | 0.004 | 0.276 | 0.999 | 2.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis autoimmune | 0 | 0 | 0.006 | 0.999 | 3.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain malformation | 0 | 0 | 0.001 | 0.999 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lead | 0 | 0.001 | 0.052 | 0.999 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary thrombosis | 0 | 0.001 | 0.012 | 0.999 | 3.523 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epicondylitis | 0 | 0.001 | 0.082 | 0.999 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trigeminal nerve disorder | 0 | 0.001 | 0.092 | 0.999 | 2.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labile blood pressure | 0 | 0.001 | 0.009 | 0.999 | 3.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-Muellerian hormone level decreased | 0 | 0 | 0.011 | 0.999 | 3.558 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interferon gamma release assay | 0 | 0 | 0 | 0.999 | 4.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin unconjugated increased | 0 | 0.001 | 0.001 | 0.999 | 4.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth loss | 0 | 0.001 | 0.078 | 0.999 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tryptase increased | 0 | 0.001 | 0.012 | 0.999 | 3.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central auditory processing disorder | 0 | 0 | 0 | 0.999 | 5.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinopathy | 0 | 0.001 | 0.032 | 0.999 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gram stain negative | 0 | 0.003 | 0.208 | 0.999 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast upper gastrointestinal tract | 0 | 0.001 | 0.025 | 0.999 | 3.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound liver | 0 | 0.001 | 0.107 | 0.999 | 2.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Finger deformity | 0 | 0 | 0.003 | 0.999 | 3.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombocytopenia neonatal | 0 | 0 | 0.002 | 0.999 | 4.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastoid disorder | 0 | 0 | 0 | 0.999 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration bone marrow abnormal | 0 | 0.001 | 0.004 | 0.999 | 3.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle mass | 0 | 0.001 | 0.007 | 0.999 | 3.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocyte count increased | 0 | 0.001 | 0.053 | 0.999 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Implantable defibrillator insertion | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Graft versus host disease | 0 | 0.001 | 0.01 | 0.999 | 3.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal disorder | 0 | 0.001 | 0.058 | 0.999 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic encephalopathy | 0 | 0.001 | 0.085 | 0.999 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular degeneration | 0 | 0.001 | 0.071 | 0.999 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema infected | 0 | 0.001 | 0.007 | 0.999 | 3.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B DNA decreased | 0 | 0 | 0.002 | 0.999 | 4.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobinuria | 0 | 0 | 0.002 | 0.999 | 3.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti factor VIII antibody positive | 0 | 0 | 0 | 0.999 | 5.546 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip dry | 0 | 0.003 | 0.231 | 0.999 | 2.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional gastrointestinal disorder | 0 | 0.005 | 0.297 | 0.999 | 2.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging thoracic | 0 | 0.001 | 0.049 | 0.999 | 3.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site urticaria | 0 | 0.001 | 0.093 | 0.999 | 2.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood copper | 0 | 0.001 | 0.005 | 0.999 | 3.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Logorrhoea | 0 | 0.001 | 0.031 | 0.999 | 3.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Treatment failure | 0 | 0 | 0.001 | 0.999 | 4.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye inflammation | 0 | 0.004 | 0.275 | 0.999 | 2.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyserositis | 0 | 0.001 | 0.019 | 0.999 | 3.37 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Executive dysfunction | 0 | 0 | 0.001 | 0.999 | 4.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenocarcinoma | 0 | 0 | 0 | 0.999 | 4.386 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia test negative | 0 | 0.001 | 0.014 | 0.999 | 3.464 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin sensitisation | 0 | 0.003 | 0.248 | 0.999 | 2.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orbital oedema | 0 | 0.001 | 0.039 | 0.999 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperemesis gravidarum | 0 | 0 | 0.01 | 0.999 | 3.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture throat | 0 | 0.003 | 0.23 | 0.999 | 2.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus infection | 0 | 0.001 | 0.023 | 0.999 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint warmth | 0 | 0.001 | 0.082 | 0.999 | 2.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion threatened | 0 | 0.001 | 0.043 | 0.999 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperferritinaemia | 0 | 0.001 | 0.011 | 0.999 | 3.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasminogen activator inhibitor | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia escherichia | 0 | 0 | 0 | 0.999 | 5.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactose intolerance | 0 | 0.001 | 0.026 | 0.999 | 3.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor positive | 0 | 0.001 | 0.003 | 0.999 | 3.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skeletal injury | 0 | 0.001 | 0.061 | 0.999 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PO2 normal | 0 | 0.001 | 0.186 | 0.999 | 2.342 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical deconditioning | 0 | 0.001 | 0.117 | 0.999 | 2.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyclic vomiting syndrome | 0 | 0.001 | 0.015 | 0.999 | 3.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E virus test | 0 | 0.001 | 0.036 | 0.999 | 3.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urobilinogen urine | 0 | 0.003 | 0.223 | 0.999 | 2.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Auditory disorder | 0 | 0.003 | 0.165 | 0.999 | 2.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysbiosis | 0 | 0.001 | 0.093 | 0.999 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histamine intolerance | 0 | 0.002 | 0.246 | 0.999 | 2.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoedema | 0 | 0.001 | 0.013 | 0.999 | 3.503 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anterior chamber inflammation | 0 | 0 | 0.001 | 0.999 | 4.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal mucosal disorder | 0 | 0.001 | 0.021 | 0.999 | 3.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb operation | 0 | 0.001 | 0.017 | 0.999 | 3.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine test abnormal | 0 | 0 | 0.011 | 0.999 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal wall haematoma | 0 | 0 | 0.003 | 0.999 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypermobility syndrome | 0 | 0 | 0 | 0.999 | 4.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan myocardial perfusion | 0 | 0.002 | 0.289 | 0.999 | 2.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure systolic decreased | 0 | 0.003 | 0.242 | 0.999 | 2.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin operation | 0 | 0.001 | 0.07 | 0.999 | 2.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Melanocytic naevus | 0 | 0.001 | 0.01 | 0.999 | 3.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suspected counterfeit product | 0 | 0.001 | 0.014 | 0.999 | 3.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal pH | 0 | 0 | 0.006 | 0.999 | 3.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face presentation | 0 | 0 | 0.004 | 0.999 | 3.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amoebiasis | 0 | 0 | 0 | 0.999 | 5.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urobilinogen urine decreased | 0 | 0.003 | 0.17 | 0.999 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Withdrawal of life support | 0 | 0.001 | 0.011 | 0.999 | 3.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicobrachial syndrome | 0 | 0 | 0.006 | 0.999 | 3.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infarction | 0 | 0.002 | 0.178 | 0.999 | 2.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal swelling | 0 | 0.001 | 0.108 | 0.999 | 2.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononeuropathy multiplex | 0 | 0 | 0.018 | 0.999 | 3.382 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obsessive thoughts | 0 | 0 | 0.004 | 0.999 | 3.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue ulceration | 0 | 0.002 | 0.297 | 0.999 | 2.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epigastric discomfort | 0 | 0.001 | 0.076 | 0.999 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory level abnormal | 0 | 0.001 | 0.107 | 0.999 | 2.649 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital cellulitis | 0 | 0.001 | 0.029 | 0.999 | 3.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood prolactin normal | 0 | 0.001 | 0.055 | 0.999 | 2.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute motor-sensory axonal neuropathy | 0 | 0.001 | 0.057 | 0.999 | 2.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pica | 0 | 0.001 | 0.013 | 0.999 | 3.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower respiratory tract infection bacterial | 0 | 0.001 | 0.003 | 0.999 | 3.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis exfoliative | 0 | 0 | 0.006 | 0.999 | 3.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary gland enlargement | 0 | 0.001 | 0.007 | 0.999 | 3.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-Hodgkin's lymphoma | 0 | 0.001 | 0.009 | 0.999 | 3.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obstruction | 0 | 0.001 | 0.006 | 0.999 | 3.742 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac electrophysiologic study | 0 | 0 | 0.031 | 0.999 | 3.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteoporosis | 0 | 0.003 | 0.191 | 0.999 | 2.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron deficiency | 0 | 0.001 | 0.027 | 0.999 | 3.244 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint movement impairment | 0 | 0.002 | 0.169 | 0.999 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [broad] | 0 | 0.002 | 0.2 | 0.999 | 2.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glassy eyes | 0 | 0.004 | 0.47 | 0.999 | 1.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound bladder normal | 0 | 0 | 0.01 | 0.999 | 3.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein S | 0 | 0 | 0.01 | 0.999 | 3.582 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthroscopy abnormal | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess negative | 0 | 0.001 | 0.014 | 0.999 | 3.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal wall thickening | 0 | 0.001 | 0.005 | 0.999 | 3.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suspected product contamination | 0 | 0 | 0.004 | 0.999 | 3.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetes mellitus inadequate control | 0 | 0.003 | 0.223 | 0.999 | 2.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal vein compression | 0 | 0 | 0 | 0.999 | 4.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract inflammation | 0 | 0.001 | 0.029 | 0.999 | 3.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrophic cardiomyopathy | 0 | 0.001 | 0.001 | 0.999 | 4.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IIIrd nerve paresis | 0 | 0.001 | 0.064 | 0.999 | 2.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intrusive thoughts | 0 | 0.001 | 0.01 | 0.999 | 3.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pigmentation disorder | 0 | 0.001 | 0.027 | 0.999 | 3.24 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound thyroid normal | 0 | 0.001 | 0.096 | 0.999 | 2.703 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal colic | 0 | 0 | 0.002 | 0.999 | 3.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor V level | 0 | 0 | 0.006 | 0.999 | 3.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal operation | 0 | 0 | 0.001 | 0.999 | 4.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagogastroduodenoscopy abnormal | 0 | 0.002 | 0.202 | 0.999 | 2.291 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clostridium difficile infection | 0 | 0.002 | 0.219 | 0.999 | 2.24 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide | 0 | 0.002 | 0.213 | 0.999 | 2.259 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multi-organ disorder | 0 | 0.001 | 0.1 | 0.999 | 2.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersomnia-bulimia syndrome | 0 | 0 | 0.004 | 0.999 | 3.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired healing | 0 | 0.001 | 0.105 | 0.999 | 2.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimation disorder | 0 | 0.001 | 0.026 | 0.999 | 3.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shoulder deformity | 0 | 0 | 0 | 0.999 | 4.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular dysmetria | 0 | 0 | 0 | 0.999 | 4.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C virus test | 0 | 0.001 | 0.074 | 0.999 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow oedema | 0 | 0.001 | 0.076 | 0.999 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytology normal | 0 | 0.001 | 0.069 | 0.999 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress cardiomyopathy | 0 | 0.003 | 0.239 | 0.999 | 2.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar disorder | 0 | 0.001 | 0.139 | 0.999 | 2.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue disorder | 0 | 0.001 | 0.086 | 0.999 | 2.758 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myeloid leukaemia | 0 | 0.001 | 0.041 | 0.999 | 3.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha hydroxybutyrate dehydrogenase increased | 0 | 0.001 | 0.005 | 0.999 | 3.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial haemorrhage | 0 | 0.001 | 0.022 | 0.999 | 3.327 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macular oedema | 0 | 0.001 | 0.001 | 0.999 | 4.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval disorder | 0 | 0 | 0.002 | 0.999 | 3.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine | 0 | 0.003 | 0.268 | 0.999 | 2.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip disorder | 0 | 0.004 | 0.257 | 0.999 | 2.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Behcet's syndrome | 0 | 0 | 0.019 | 0.999 | 3.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sigmoidoscopy | 0 | 0 | 0 | 0.999 | 4.402 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | NIH stroke scale abnormal | 0 | 0 | 0.002 | 0.999 | 3.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prohormone brain natriuretic peptide | 0 | 0 | 0.003 | 0.999 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic intracranial hypertension | 0 | 0.001 | 0.021 | 0.999 | 3.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total bile acids | 0 | 0 | 0.012 | 0.999 | 3.511 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tibia fracture | 0 | 0.001 | 0.051 | 0.999 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural thickening | 0 | 0.001 | 0.04 | 0.999 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastocytosis | 0 | 0 | 0.018 | 0.999 | 3.391 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Focal segmental glomerulosclerosis | 0 | 0 | 0.027 | 0.999 | 3.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculin test | 0 | 0.001 | 0.057 | 0.999 | 2.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood zinc decreased | 0 | 0.001 | 0.01 | 0.999 | 3.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blindness cortical | 0 | 0 | 0.023 | 0.999 | 3.312 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypercoagulation | 0 | 0 | 0.005 | 0.999 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium enema | 0 | 0.001 | 0.002 | 0.999 | 3.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human rhinovirus test | 0 | 0.003 | 0.21 | 0.999 | 2.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postictal paralysis | 0 | 0.001 | 0.011 | 0.999 | 3.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fracture | 0 | 0.001 | 0.115 | 0.999 | 2.615 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood folate decreased | 0 | 0.001 | 0.017 | 0.999 | 3.4 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Whole body scan | 0 | 0.001 | 0.053 | 0.999 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poliovirus test positive | 0 | 0 | 0 | 0.999 | 4.337 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Juvenile myoclonic epilepsy | 0 | 0 | 0 | 0.999 | 4.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal vein occlusion | 0 | 0.001 | 0.059 | 0.999 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray dental abnormal | 0 | 0.001 | 0.041 | 0.999 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurodegenerative disorder | 0 | 0.001 | 0.003 | 0.999 | 3.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Legionella test positive | 0 | 0 | 0.004 | 0.999 | 3.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoantibody negative | 0 | 0.001 | 0.037 | 0.999 | 3.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clostridium difficile colitis | 0 | 0.001 | 0.109 | 0.999 | 2.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine | 0 | 0.001 | 0.061 | 0.999 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-NMDA antibody negative | 0 | 0.001 | 0.011 | 0.999 | 3.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bulbar palsy | 0 | 0.001 | 0.013 | 0.999 | 3.501 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Takayasu's arteritis | 0 | 0.001 | 0.043 | 0.999 | 3.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells urine | 0 | 0.001 | 0.081 | 0.999 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site plaque | 0 | 0.001 | 0.001 | 0.999 | 4.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axillary nerve injury | 0 | 0.001 | 0.081 | 0.999 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong patient received product | 0 | 0.006 | 0.362 | 0.999 | 1.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respirovirus test | 0 | 0.001 | 0.065 | 0.999 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ketone body | 0 | 0.001 | 0.119 | 0.999 | 2.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine normal | 0 | 0.004 | 0.258 | 0.999 | 2.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.001 | 0.049 | 0.999 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Volvulus | 0 | 0.001 | 0.058 | 0.999 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug-induced liver injury | 0 | 0 | 0.02 | 0.999 | 3.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otoscopy abnormal | 0 | 0.001 | 0.049 | 0.999 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal muscular atrophy | 0 | 0 | 0.016 | 0.999 | 3.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic fibrosis | 0 | 0 | 0.002 | 0.999 | 3.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lead increased | 0 | 0 | 0.018 | 0.999 | 3.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular function test normal | 0 | 0 | 0.009 | 0.999 | 3.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolism | 0 | 0 | 0.012 | 0.999 | 3.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Relapsing-remitting multiple sclerosis | 0 | 0 | 0.003 | 0.999 | 3.924 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food craving | 0 | 0.001 | 0.045 | 0.999 | 3.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate cancer | 0 | 0.001 | 0.031 | 0.999 | 3.197 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatosplenomegaly | 0 | 0.001 | 0.072 | 0.999 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypovitaminosis | 0 | 0.001 | 0.06 | 0.999 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug withdrawal (SMQ) [broad] | 0 | 0.003 | 0.219 | 0.999 | 2.241 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lhermitte's sign | 0 | 0.001 | 0.052 | 0.999 | 2.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B6 normal | 0 | 0.001 | 0.09 | 0.999 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coma scale | 0 | 0.001 | 0.079 | 0.999 | 2.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus bronchiolitis | 0 | 0 | 0.001 | 0.999 | 4.106 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteritis infectious | 0 | 0.001 | 0.018 | 0.999 | 3.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis fulminant | 0 | 0 | 0.006 | 0.999 | 3.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary gland pain | 0 | 0 | 0.002 | 0.999 | 4.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Talipes | 0 | 0.001 | 0.01 | 0.999 | 3.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood iron increased | 0 | 0.001 | 0.056 | 0.999 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circumoral swelling | 0 | 0.001 | 0.018 | 0.999 | 3.386 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MB normal | 0 | 0.001 | 0.008 | 0.999 | 3.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound ovary | 0 | 0 | 0.015 | 0.999 | 3.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salt craving | 0 | 0 | 0 | 0.999 | 4.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subdural hygroma | 0 | 0 | 0 | 0.999 | 4.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture throat negative | 0 | 0.004 | 0.414 | 0.999 | 1.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropsychological test | 0 | 0.001 | 0.047 | 0.999 | 3.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exanthema subitum | 0 | 0.001 | 0.013 | 0.999 | 3.487 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngoscopy abnormal | 0 | 0.001 | 0.067 | 0.999 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial tachycardia | 0 | 0.001 | 0.026 | 0.999 | 3.261 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiotensin converting enzyme increased | 0 | 0.001 | 0.068 | 0.999 | 2.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound liver normal | 0 | 0.001 | 0.184 | 0.999 | 2.35 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal discharge | 0 | 0.001 | 0.012 | 0.999 | 3.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopaedic examination abnormal | 0 | 0.001 | 0.135 | 0.999 | 2.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemangioma of bone | 0 | 0.001 | 0.05 | 0.999 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate normal | 0 | 0.001 | 0.001 | 0.999 | 4.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of satiety | 0 | 0 | 0.001 | 0.999 | 4.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coma scale normal | 0 | 0.001 | 0.04 | 0.999 | 3.093 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acarodermatitis | 0 | 0.001 | 0.057 | 0.999 | 2.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemodynamic instability | 0 | 0.001 | 0.036 | 0.999 | 3.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensitivity to weather change | 0 | 0 | 0.016 | 0.999 | 3.425 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinoscleroma | 0 | 0 | 0.005 | 0.999 | 3.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal tubular acidosis | 0 | 0 | 0.001 | 0.999 | 4.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Matrix metalloproteinase-3 | 0 | 0 | 0.002 | 0.999 | 4.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diaphragmatic spasm | 0 | 0 | 0 | 0.999 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound secretion | 0 | 0.002 | 0.17 | 0.999 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Miosis | 0 | 0.002 | 0.24 | 0.999 | 2.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fontanelle depressed | 0 | 0 | 0 | 0.999 | 4.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropsychiatric syndrome | 0 | 0.001 | 0.009 | 0.999 | 3.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytokine test | 0 | 0.001 | 0.035 | 0.999 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertrophy | 0 | 0.001 | 0.076 | 0.999 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema infantile | 0 | 0 | 0.002 | 0.999 | 3.996 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metastases to liver | 0 | 0 | 0.008 | 0.999 | 3.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudolymphoma | 0 | 0.001 | 0.033 | 0.999 | 3.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte stimulation test | 0 | 0 | 0 | 0.999 | 4.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster cutaneous disseminated | 0 | 0.001 | 0.031 | 0.999 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site erythema | 0 | 0.001 | 0.046 | 0.999 | 3.038 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone swelling | 0 | 0.001 | 0.004 | 0.999 | 3.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gynaecomastia | 0 | 0 | 0.006 | 0.999 | 3.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid margin crusting | 0 | 0.004 | 0.292 | 0.999 | 2.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toe walking | 0 | 0 | 0.013 | 0.999 | 3.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High density lipoprotein normal | 0 | 0.002 | 0.124 | 0.999 | 2.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychiatric symptom | 0 | 0.001 | 0.07 | 0.999 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helicobacter infection | 0 | 0.001 | 0.227 | 0.999 | 2.22 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate increased | 0 | 0.001 | 0.004 | 0.999 | 3.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray with contrast lower gastrointestinal tract abnormal | 0 | 0 | 0 | 0.999 | 4.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Binocular eye movement disorder | 0 | 0.001 | 0.048 | 0.999 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose-6-phosphate dehydrogenase | 0 | 0 | 0 | 0.999 | 4.446 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar radiculopathy | 0 | 0.001 | 0.053 | 0.999 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram PR interval | 0 | 0.001 | 0.036 | 0.999 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oophoritis | 0 | 0 | 0.003 | 0.999 | 3.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oliguria | 0 | 0 | 0 | 0.999 | 4.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Steroid therapy | 0 | 0.001 | 0.005 | 0.999 | 3.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase decreased | 0 | 0 | 0.006 | 0.999 | 3.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest injury | 0 | 0.001 | 0.043 | 0.999 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Capillary nail refill test abnormal | 0 | 0.001 | 0.161 | 0.999 | 2.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vibratory sense increased | 0 | 0.002 | 0.241 | 0.999 | 2.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell nucleated morphology present | 0 | 0.001 | 0.02 | 0.999 | 3.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skeletal survey normal | 0 | 0.001 | 0 | 0.999 | 4.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labour induction | 0 | 0 | 0.025 | 0.999 | 3.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lung | 0 | 0.001 | 0.011 | 0.999 | 3.537 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test urine negative | 0 | 0.002 | 0.098 | 0.999 | 2.693 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal rash | 0 | 0.001 | 0.093 | 0.999 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site pustule | 0 | 0 | 0 | 0.999 | 4.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac function test | 0 | 0.003 | 0.187 | 0.999 | 2.339 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatobiliary scan | 0 | 0.003 | 0.208 | 0.999 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C3 decreased | 0 | 0 | 0.007 | 0.999 | 3.678 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound thyroid | 0 | 0.001 | 0.074 | 0.999 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythroblast count | 0 | 0.001 | 0.042 | 0.999 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sandifer's syndrome | 0 | 0 | 0.016 | 0.999 | 3.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infertility male | 0 | 0 | 0.009 | 0.999 | 3.615 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold agglutinins | 0 | 0 | 0 | 0.999 | 4.337 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac telemetry abnormal | 0 | 0 | 0 | 0.999 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional self-injury | 0 | 0.001 | 0.01 | 0.999 | 3.568 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue erythema | 0 | 0.002 | 0.275 | 0.999 | 2.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoscopy | 0 | 0.001 | 0.086 | 0.999 | 2.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amino acid level normal | 0 | 0.001 | 0.012 | 0.999 | 3.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4/CD8 ratio | 0 | 0.001 | 0.094 | 0.999 | 2.714 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Change of bowel habit | 0 | 0.001 | 0.032 | 0.999 | 3.187 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte percentage normal | 0 | 0.001 | 0.049 | 0.999 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemiparaesthesia | 0 | 0.001 | 0.051 | 0.999 | 2.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | West Nile viral infection | 0 | 0 | 0 | 0.999 | 4.327 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PFAPA syndrome | 0 | 0 | 0.019 | 0.999 | 3.372 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral blood blister | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased tendency to bruise | 0 | 0.001 | 0.085 | 0.999 | 2.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure immeasurable | 0 | 0.003 | 0.225 | 0.999 | 2.222 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test | 0 | 0.002 | 0.11 | 0.999 | 2.636 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue oedema | 0 | 0.003 | 0.218 | 0.999 | 2.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypnagogic hallucination | 0 | 0 | 0 | 0.999 | 5.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal volume decreased | 0 | 0.001 | 0.015 | 0.999 | 3.46 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium test negative | 0 | 0.001 | 0.068 | 0.999 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiocardiogram | 0 | 0.001 | 0.032 | 0.999 | 3.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem infarction | 0 | 0.001 | 0.046 | 0.999 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity urine | 0 | 0 | 0.004 | 0.999 | 3.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin infection | 0 | 0.003 | 0.252 | 0.999 | 2.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinitis allergic | 0 | 0.002 | 0.121 | 0.999 | 2.582 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type I hypersensitivity | 0 | 0 | 0 | 0.999 | 4.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum culture | 0 | 0.002 | 0.24 | 0.999 | 2.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radicular pain | 0 | 0.001 | 0.162 | 0.999 | 2.425 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuromyopathy | 0 | 0.001 | 0.03 | 0.999 | 3.202 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve paralysis | 0 | 0.001 | 0.083 | 0.999 | 2.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weaning failure | 0 | 0 | 0 | 0.999 | 4.592 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prolonged pregnancy | 0 | 0 | 0.015 | 0.999 | 3.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal eruption | 0 | 0.006 | 0.435 | 0.999 | 1.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clonic convulsion | 0 | 0.001 | 0.049 | 0.999 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site oedema | 0 | 0 | 0 | 0.999 | 4.372 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acupuncture | 0 | 0.002 | 0.105 | 0.999 | 2.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alopecia areata | 0 | 0.002 | 0.11 | 0.999 | 2.632 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hiccups | 0 | 0.003 | 0.268 | 0.999 | 2.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytogenetic analysis abnormal | 0 | 0.001 | 0.084 | 0.999 | 2.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood premalignant disorders (SMQ) [narrow] | 0 | 0.002 | 0.155 | 0.999 | 2.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspergillus test negative | 0 | 0.001 | 0.022 | 0.999 | 3.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord infection | 0 | 0.001 | 0.053 | 0.999 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal transplant | 0 | 0.001 | 0.026 | 0.999 | 3.257 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sepsis neonatal | 0 | 0.001 | 0.017 | 0.999 | 3.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Craniotomy | 0 | 0.001 | 0.09 | 0.999 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral lichen planus | 0 | 0.001 | 0.008 | 0.999 | 3.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal ulcer | 0 | 0.001 | 0.075 | 0.999 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin distribution width | 0 | 0 | 0 | 0.999 | 5.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema of eyelid | 0 | 0.007 | 0.45 | 0.999 | 1.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tilt table test | 0 | 0 | 0 | 0.999 | 4.502 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site swelling | 0 | 0.001 | 0.034 | 0.999 | 3.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circumoral oedema | 0 | 0.001 | 0.085 | 0.999 | 2.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy peripheral nerve | 0 | 0.001 | 0.046 | 0.999 | 3.043 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal examination normal | 0 | 0.001 | 0.049 | 0.999 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-traumatic stress disorder | 0 | 0.001 | 0.023 | 0.999 | 3.298 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium test | 0 | 0.001 | 0.006 | 0.999 | 3.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder enlargement | 0 | 0 | 0.012 | 0.999 | 3.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersensitivity pneumonitis | 0 | 0.001 | 0.018 | 0.999 | 3.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothalamo-pituitary disorder | 0 | 0 | 0.03 | 0.999 | 3.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral pericarditis | 0 | 0 | 0.007 | 0.999 | 3.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia pyelonephritis | 0 | 0 | 0.003 | 0.999 | 3.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Defiant behaviour | 0 | 0.001 | 0.024 | 0.999 | 3.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood catecholamines | 0 | 0 | 0.014 | 0.999 | 3.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function test abnormal | 0 | 0.001 | 0.039 | 0.999 | 3.108 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthropod bite | 0 | 0.002 | 0.055 | 0.999 | 2.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extravasation | 0 | 0 | 0 | 0.999 | 4.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin E normal | 0 | 0.001 | 0.072 | 0.999 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cafe au lait spots | 0 | 0 | 0.001 | 0.999 | 4.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram kidney abnormal | 0 | 0.001 | 0.044 | 0.999 | 3.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital and neonatal arrhythmias (SMQ) [broad] | 0 | 0.001 | 0.002 | 0.999 | 3.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HLA-B*27 assay | 0 | 0.001 | 0.006 | 0.999 | 3.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Floppy infant | 0 | 0 | 0.004 | 0.999 | 3.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet morphology normal | 0 | 0.001 | 0.008 | 0.999 | 3.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF immunoglobulin | 0 | 0.001 | 0.086 | 0.999 | 2.758 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound kidney normal | 0 | 0.001 | 0.123 | 0.999 | 2.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracranial infection | 0 | 0 | 0.002 | 0.999 | 3.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection | 0 | 0.001 | 0.031 | 0.999 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal ischaemia | 0 | 0.001 | 0.053 | 0.999 | 2.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lymph gland | 0 | 0.001 | 0.059 | 0.999 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity urine decreased | 0 | 0.001 | 0.03 | 0.999 | 3.203 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcus test positive | 0 | 0.007 | 0.427 | 0.999 | 1.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cancer in remission | 0 | 0.001 | 0.074 | 0.999 | 2.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Butterfly rash | 0 | 0.001 | 0.115 | 0.999 | 2.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute hepatic failure | 0 | 0.001 | 0.039 | 0.999 | 3.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue injury | 0 | 0.001 | 0.056 | 0.999 | 2.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site pallor | 0 | 0.001 | 0.09 | 0.999 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pemphigus | 0 | 0.001 | 0.043 | 0.999 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dreamy state | 0 | 0.001 | 0.085 | 0.999 | 2.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amino acid level increased | 0 | 0.001 | 0.008 | 0.999 | 3.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriospasm coronary | 0 | 0 | 0 | 0.999 | 4.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incisional drainage | 0 | 0.002 | 0.231 | 0.999 | 2.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bartonella test | 0 | 0.001 | 0.006 | 0.999 | 3.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convulsions local | 0 | 0.001 | 0.009 | 0.999 | 3.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin bacterial infection | 0 | 0.001 | 0.047 | 0.999 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephrotic syndrome | 0 | 0.001 | 0.093 | 0.999 | 2.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear disorder | 0 | 0.001 | 0.016 | 0.999 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvovirus B19 test positive | 0 | 0.001 | 0.016 | 0.999 | 3.436 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoconcentration | 0 | 0 | 0 | 0.999 | 4.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poisoning | 0 | 0.001 | 0.089 | 0.999 | 2.742 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhoids | 0 | 0.002 | 0.172 | 0.999 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram T wave inversion | 0 | 0.003 | 0.21 | 0.999 | 2.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor | 0 | 0.001 | 0.046 | 0.999 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal discomfort | 0 | 0.001 | 0.05 | 0.999 | 3.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival discomfort | 0 | 0.001 | 0.015 | 0.999 | 3.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bundle branch block left | 0 | 0.001 | 0.023 | 0.999 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine increased | 0 | 0.001 | 0.049 | 0.999 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carcinoma in situ | 0 | 0 | 0.011 | 0.999 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anorectal manometry | 0 | 0 | 0.016 | 0.999 | 3.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac death | 0 | 0 | 0.003 | 0.999 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy muscle | 0 | 0.001 | 0.045 | 0.999 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotator cuff syndrome | 0 | 0.001 | 0.024 | 0.999 | 3.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiopulmonary failure | 0 | 0.001 | 0.029 | 0.999 | 3.222 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product appearance confusion | 0 | 0.001 | 0.009 | 0.999 | 3.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteomyelitis bacterial | 0 | 0 | 0.004 | 0.999 | 3.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histone antibody positive | 0 | 0 | 0.007 | 0.999 | 3.666 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctivitis allergic | 0 | 0.001 | 0.048 | 0.999 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myopia | 0 | 0.001 | 0.026 | 0.999 | 3.259 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph node abscess | 0 | 0.001 | 0.021 | 0.999 | 3.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prerenal failure | 0 | 0 | 0.004 | 0.999 | 3.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion induced | 0 | 0.001 | 0.02 | 0.999 | 3.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum ferritin decreased | 0 | 0.001 | 0.014 | 0.999 | 3.459 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold urticaria | 0 | 0.001 | 0.034 | 0.999 | 3.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-SRP antibody positive | 0 | 0 | 0 | 0.999 | 4.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal mass | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histology normal | 0 | 0 | 0.002 | 0.999 | 4.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product contamination microbial | 0 | 0 | 0 | 0.999 | 4.474 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor increased | 0 | 0.001 | 0.156 | 0.999 | 2.447 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic sinusitis | 0 | 0.001 | 0.006 | 0.999 | 3.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menarche | 0 | 0 | 0 | 0.999 | 4.618 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antithrombin III increased | 0 | 0 | 0.015 | 0.999 | 3.46 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoma | 0 | 0.002 | 0.165 | 0.999 | 2.411 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperkeratosis | 0 | 0.001 | 0.16 | 0.999 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypovolaemia | 0 | 0.004 | 0.269 | 0.999 | 2.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint pain | 0 | 0.001 | 0.034 | 0.999 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heat stroke | 0 | 0.001 | 0.028 | 0.999 | 3.228 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary occult blood positive | 0 | 0 | 0.006 | 0.999 | 3.711 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via direct contact | 0 | 0 | 0.001 | 0.999 | 4.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corynebacterium infection | 0 | 0.001 | 0.002 | 0.999 | 3.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropsychological test abnormal | 0 | 0.001 | 0.048 | 0.999 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arachnoid cyst | 0 | 0 | 0.003 | 0.999 | 3.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helicobacter test negative | 0 | 0.001 | 0.129 | 0.999 | 2.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower respiratory tract congestion | 0 | 0.001 | 0.011 | 0.999 | 3.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF immunoglobulin G index | 0 | 0.001 | 0.043 | 0.999 | 3.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product colour issue | 0 | 0.001 | 0.02 | 0.999 | 3.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bipolar disorder | 0 | 0 | 0.039 | 0.999 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-cyclic citrullinated peptide antibody positive | 0 | 0 | 0.02 | 0.999 | 3.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysphoria | 0 | 0.001 | 0.122 | 0.999 | 2.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mammogram normal | 0 | 0 | 0.025 | 0.999 | 3.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyp | 0 | 0.001 | 0.001 | 0.999 | 4.192 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart disease congenital | 0 | 0.001 | 0.014 | 0.999 | 3.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin hyperpigmentation | 0 | 0.004 | 0.339 | 0.999 | 1.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General symptom | 0 | 0.002 | 0.187 | 0.999 | 2.338 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urosepsis | 0 | 0.001 | 0.033 | 0.999 | 3.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder disorder | 0 | 0.003 | 0.199 | 0.999 | 2.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand-eye coordination impaired | 0 | 0.002 | 0.15 | 0.999 | 2.468 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal abrasion | 0 | 0.001 | 0.035 | 0.999 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain contusion | 0 | 0.001 | 0.01 | 0.999 | 3.565 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombolysis | 0 | 0 | 0.014 | 0.999 | 3.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salpingitis | 0 | 0 | 0 | 0.999 | 4.733 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site pruritus | 0 | 0 | 0.001 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adverse food reaction | 0 | 0 | 0.001 | 0.999 | 4.121 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dependence on respirator | 0 | 0 | 0.002 | 0.999 | 3.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mechanical urticaria | 0 | 0.001 | 0.067 | 0.999 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palatal oedema | 0 | 0.001 | 0.043 | 0.999 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palmar-plantar erythrodysaesthesia syndrome | 0 | 0.001 | 0.053 | 0.999 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic venous thrombosis | 0 | 0 | 0.002 | 0.999 | 4.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray gastrointestinal tract | 0 | 0 | 0.003 | 0.999 | 3.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time ratio increased | 0 | 0 | 0.001 | 0.999 | 4.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parophthalmia | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal infection | 0 | 0 | 0.001 | 0.999 | 4.17 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Megakaryocytes increased | 0 | 0.001 | 0.014 | 0.999 | 3.474 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperpathia | 0 | 0 | 0 | 0.999 | 4.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Histology | 0 | 0.001 | 0.008 | 0.999 | 3.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryptococcus test | 0 | 0.004 | 0.331 | 0.999 | 1.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wisdom teeth removal | 0 | 0 | 0.007 | 0.999 | 3.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress fracture | 0 | 0.001 | 0.088 | 0.999 | 2.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiphyses delayed fusion | 0 | 0 | 0.01 | 0.999 | 3.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colonoscopy normal | 0 | 0.003 | 0.264 | 0.999 | 2.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axonal neuropathy | 0 | 0.001 | 0.043 | 0.999 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MB decreased | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | AST/ALT ratio abnormal | 0 | 0 | 0 | 0.999 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia test | 0 | 0.001 | 0.05 | 0.999 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood osmolarity normal | 0 | 0.001 | 0.005 | 0.999 | 3.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suspected transmission of an infectious agent via product | 0 | 0.001 | 0.098 | 0.999 | 2.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gianotti-Crosti syndrome | 0 | 0.002 | 0.227 | 0.999 | 2.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver neoplasms, benign (incl cysts and polyps) (SMQ) [narrow] | 0 | 0.002 | 0.2 | 0.999 | 2.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cellulitis orbital | 0 | 0.001 | 0.005 | 0.999 | 3.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acne cystic | 0 | 0 | 0.018 | 0.999 | 3.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kyphosis | 0 | 0.001 | 0.004 | 0.999 | 3.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fasciitis | 0 | 0.001 | 0.171 | 0.999 | 2.391 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specialist consultation | 0 | 0.001 | 0.216 | 0.999 | 2.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal haemorrhage | 0 | 0 | 0.001 | 0.999 | 4.202 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hormone replacement therapy | 0 | 0 | 0 | 0.999 | 4.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite stool test negative | 0 | 0.001 | 0.006 | 0.999 | 3.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polypectomy | 0 | 0.001 | 0.093 | 0.999 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumocystis test positive | 0 | 0 | 0 | 0.999 | 4.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Benign rolandic epilepsy | 0 | 0.001 | 0.018 | 0.999 | 3.39 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryoglobulinaemia | 0 | 0 | 0 | 0.999 | 4.382 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cells urine negative | 0 | 0.002 | 0.168 | 0.999 | 2.401 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocytosis | 0 | 0.002 | 0.184 | 0.999 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear, nose and throat examination normal | 0 | 0.001 | 0.018 | 0.999 | 3.38 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HELLP syndrome | 0 | 0.001 | 0.007 | 0.999 | 3.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site injury | 0 | 0.001 | 0.102 | 0.999 | 2.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatinine decreased | 0 | 0.001 | 0.053 | 0.999 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid ptosis | 0 | 0.01 | 0.48 | 0.999 | 1.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure normal | 0 | 0.002 | 0.192 | 0.999 | 2.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metamorphopsia | 0 | 0.004 | 0.345 | 0.999 | 1.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Daydreaming | 0 | 0.001 | 0.014 | 0.999 | 3.474 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site warmth | 0 | 0 | 0.005 | 0.999 | 3.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine increased | 0 | 0.001 | 0.009 | 0.999 | 3.602 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal condition affecting foetus | 0 | 0 | 0.002 | 0.999 | 4.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteral nutrition | 0 | 0.001 | 0.003 | 0.999 | 3.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood triglycerides | 0 | 0.001 | 0.047 | 0.999 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH body fluid decreased | 0 | 0 | 0 | 0.999 | 4.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic failure | 0 | 0.001 | 0.09 | 0.999 | 2.738 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertebral foraminal stenosis | 0 | 0.001 | 0.053 | 0.999 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth disorder | 0 | 0.001 | 0.1 | 0.999 | 2.686 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site inflammation | 0 | 0.001 | 0.07 | 0.999 | 2.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound bladder | 0 | 0 | 0.027 | 0.999 | 3.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine normal | 0 | 0.001 | 0.159 | 0.999 | 2.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neisseria test | 0 | 0.001 | 0.102 | 0.999 | 2.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell microcytes present | 0 | 0.001 | 0.013 | 0.999 | 3.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin urine present | 0 | 0.001 | 0.081 | 0.999 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol withdrawal syndrome | 0 | 0 | 0.001 | 0.999 | 4.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-cyclic citrullinated peptide antibody negative | 0 | 0.001 | 0.119 | 0.999 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood fibrinogen decreased | 0 | 0.001 | 0.148 | 0.999 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurogenic shock | 0 | 0 | 0 | 0.999 | 5.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid function test | 0 | 0.008 | 0.447 | 0.999 | 1.728 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site macule | 0 | 0.002 | 0.285 | 0.999 | 2.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath odour | 0 | 0.001 | 0.037 | 0.999 | 3.128 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac stress test abnormal | 0 | 0.001 | 0.243 | 0.999 | 2.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus antigen positive | 0 | 0.001 | 0.119 | 0.999 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratic precipitates | 0 | 0.001 | 0.02 | 0.999 | 3.35 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Strawberry tongue | 0 | 0.001 | 0.118 | 0.999 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine dilation and curettage | 0 | 0.002 | 0.268 | 0.999 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin texture abnormal | 0 | 0.001 | 0.14 | 0.999 | 2.508 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injury corneal | 0 | 0 | 0.001 | 0.999 | 4.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periostitis | 0 | 0 | 0.009 | 0.999 | 3.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal renal imaging abnormal | 0 | 0 | 0.002 | 0.999 | 4.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adult failure to thrive | 0 | 0 | 0.002 | 0.999 | 3.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transaminases | 0 | 0.001 | 0.1 | 0.999 | 2.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radial nerve palsy | 0 | 0.001 | 0.004 | 0.999 | 3.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal necrosis | 0 | 0 | 0 | 0.999 | 4.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myofascial pain syndrome | 0 | 0.001 | 0.033 | 0.999 | 3.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine | 0 | 0.001 | 0.003 | 0.999 | 3.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Housebound | 0 | 0.001 | 0.013 | 0.999 | 3.508 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrosomia | 0 | 0 | 0 | 0.999 | 4.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder disorder | 0 | 0.001 | 0.048 | 0.999 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site rash | 0 | 0.001 | 0.099 | 0.999 | 2.689 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alcohol | 0 | 0.001 | 0.092 | 0.999 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular failure | 0 | 0.001 | 0.036 | 0.999 | 3.134 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid injury | 0 | 0.001 | 0.035 | 0.999 | 3.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acanthosis | 0 | 0.001 | 0.002 | 0.999 | 3.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoid tissue hyperplasia | 0 | 0 | 0.007 | 0.999 | 3.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced vital capacity | 0 | 0 | 0 | 0.999 | 4.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diarrhoea infectious | 0 | 0 | 0.002 | 0.999 | 3.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type 2 lepra reaction | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neck mass | 0 | 0.005 | 0.408 | 0.999 | 1.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile apnoea | 0 | 0.001 | 0.048 | 0.999 | 3.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positron emission tomogram normal | 0 | 0.001 | 0.036 | 0.999 | 3.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint swelling | 0 | 0.004 | 0.235 | 0.999 | 2.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterovirus test negative | 0 | 0.002 | 0.084 | 0.999 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ambulatory abnormal | 0 | 0.001 | 0.064 | 0.999 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral titre | 0 | 0.001 | 0.008 | 0.999 | 3.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate malignant tumours (SMQ) [narrow] | 0 | 0.003 | 0.214 | 0.999 | 2.255 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar syndrome | 0 | 0 | 0 | 0.999 | 5.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanic membrane disorder | 0 | 0.001 | 0.134 | 0.999 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyelonephritis | 0 | 0.001 | 0.072 | 0.999 | 2.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar erythema | 0 | 0 | 0.024 | 0.999 | 3.297 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium tuberculosis complex test positive | 0 | 0 | 0.006 | 0.999 | 3.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac operation | 0 | 0.001 | 0.113 | 0.999 | 2.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic valve incompetence | 0 | 0.001 | 0.057 | 0.999 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diagnostic procedure | 0 | 0.002 | 0.333 | 0.999 | 1.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF immunoglobulin decreased | 0 | 0.001 | 0.023 | 0.999 | 3.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site paraesthesia | 0 | 0 | 0.028 | 0.999 | 3.232 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obliterative bronchiolitis | 0 | 0.001 | 0.003 | 0.999 | 3.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Minimum inhibitory concentration | 0 | 0 | 0.005 | 0.999 | 3.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Steroid dependence | 0 | 0 | 0 | 0.999 | 5.293 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-small cell lung cancer | 0 | 0 | 0.004 | 0.999 | 3.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital erythema | 0 | 0.001 | 0.011 | 0.999 | 3.561 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye injury | 0 | 0.001 | 0.019 | 0.999 | 3.374 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxicity to various agents | 0 | 0.001 | 0.169 | 0.999 | 2.4 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hangover | 0 | 0.002 | 0.174 | 0.999 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral nerve lesion | 0 | 0.001 | 0.027 | 0.999 | 3.251 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid artery stenosis | 0 | 0.001 | 0.106 | 0.999 | 2.654 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipodystrophy (SMQ) [narrow] | 0 | 0.001 | 0.085 | 0.999 | 2.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatosis | 0 | 0.001 | 0.006 | 0.999 | 3.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST-T change | 0 | 0.001 | 0.036 | 0.999 | 3.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral artery stenosis | 0 | 0.001 | 0.014 | 0.999 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunisation anxiety related reaction | 0 | 0 | 0.009 | 0.999 | 3.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dengue virus test negative | 0 | 0.001 | 0.023 | 0.999 | 3.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neck injury | 0 | 0.001 | 0.009 | 0.999 | 3.59 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tri-iodothyronine normal | 0 | 0.001 | 0.137 | 0.999 | 2.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bordetella infection | 0 | 0 | 0 | 0.999 | 4.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometritis | 0 | 0.001 | 0.001 | 0.999 | 4.074 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yersinia test negative | 0 | 0 | 0.004 | 0.999 | 3.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus test positive | 0 | 0.001 | 0.092 | 0.999 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Organic acid analysis | 0 | 0 | 0.001 | 0.999 | 4.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin level | 0 | 0.001 | 0.101 | 0.999 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage in pregnancy | 0 | 0.001 | 0.03 | 0.999 | 3.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Donor specific antibody present | 0 | 0 | 0.004 | 0.999 | 3.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein increased | 0 | 0 | 0.001 | 0.999 | 4.28 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood sodium | 0 | 0.004 | 0.28 | 0.999 | 2.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hip arthroplasty | 0 | 0.002 | 0.13 | 0.999 | 2.545 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cancer | 0 | 0.001 | 0.021 | 0.999 | 3.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster infection neurological | 0 | 0 | 0 | 0.999 | 4.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site bruise | 0 | 0.002 | 0.143 | 0.999 | 2.494 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sacroiliitis | 0 | 0.001 | 0.034 | 0.999 | 3.159 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accident | 0 | 0.001 | 0.034 | 0.999 | 3.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mania | 0 | 0.002 | 0.165 | 0.999 | 2.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulum | 0 | 0.001 | 0.012 | 0.999 | 3.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypohidrosis | 0 | 0.001 | 0.084 | 0.999 | 2.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood gases normal | 0 | 0.002 | 0.199 | 0.999 | 2.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parapsoriasis | 0 | 0.001 | 0.015 | 0.999 | 3.454 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute abdomen | 0 | 0 | 0.031 | 0.999 | 3.199 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest crushing | 0 | 0 | 0.008 | 0.999 | 3.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis cholestatic | 0 | 0 | 0 | 0.999 | 5.304 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell volume abnormal | 0 | 0 | 0 | 0.999 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plantar fasciitis | 0 | 0.001 | 0.054 | 0.999 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Febrile infection | 0 | 0.001 | 0.056 | 0.999 | 2.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensorimotor disorder | 0 | 0 | 0 | 0.999 | 4.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.002 | 0.2 | 0.999 | 2.298 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis Escherichia coli | 0 | 0 | 0.005 | 0.999 | 3.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food aversion | 0 | 0.001 | 0.031 | 0.999 | 3.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cushing's syndrome | 0 | 0 | 0 | 0.999 | 4.494 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF monocyte count | 0 | 0 | 0 | 0.999 | 5.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nipple pain | 0 | 0.001 | 0.04 | 0.999 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Claustrophobia | 0 | 0.001 | 0.075 | 0.999 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose tolerance impaired | 0 | 0.001 | 0.037 | 0.999 | 3.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic disorder | 0 | 0 | 0.008 | 0.999 | 3.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apraxia | 0 | 0.001 | 0.264 | 0.999 | 2.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrioventricular block second degree | 0 | 0.001 | 0.046 | 0.999 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fundoscopy normal | 0 | 0.001 | 0.011 | 0.999 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tetany | 0 | 0.002 | 0.164 | 0.999 | 2.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypogammaglobulinaemia | 0 | 0.002 | 0.129 | 0.999 | 2.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood ketone body absent | 0 | 0.001 | 0.066 | 0.999 | 2.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute phase reaction | 0 | 0 | 0.004 | 0.999 | 3.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononuclear cell percentage | 0 | 0 | 0.006 | 0.999 | 3.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocarditis | 0 | 0.001 | 0.082 | 0.999 | 2.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seizure cluster | 0 | 0.001 | 0.045 | 0.999 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal disorder | 0 | 0 | 0 | 0.999 | 4.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.001 | 0.081 | 0.999 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease progression | 0 | 0 | 0.011 | 0.999 | 3.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone densitometry | 0 | 0 | 0.016 | 0.999 | 3.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram PR segment depression | 0 | 0 | 0.005 | 0.999 | 3.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal infection | 0 | 0.006 | 0.436 | 0.999 | 1.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site scab | 0 | 0.001 | 0.005 | 0.999 | 3.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site warmth | 0 | 0.001 | 0.175 | 0.999 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lividity | 0 | 0.001 | 0.008 | 0.999 | 3.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular migraine | 0 | 0 | 0.02 | 0.999 | 3.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromatopsia | 0 | 0.001 | 0.007 | 0.999 | 3.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural complication | 0 | 0 | 0.003 | 0.999 | 3.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microphthalmos | 0 | 0 | 0.001 | 0.999 | 4.121 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb immobilisation | 0 | 0.001 | 0.009 | 0.999 | 3.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaw disorder | 0 | 0.002 | 0.191 | 0.999 | 2.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine protein/creatinine ratio | 0 | 0.001 | 0.001 | 0.999 | 4.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta-2 glycoprotein antibody negative | 0 | 0.001 | 0.075 | 0.999 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gynaecological examination | 0 | 0 | 0.006 | 0.999 | 3.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterovirus test | 0 | 0.001 | 0.183 | 0.999 | 2.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain neoplasm | 0 | 0.001 | 0.018 | 0.999 | 3.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schizophrenia | 0 | 0 | 0 | 0.999 | 4.522 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site cellulitis | 0 | 0.001 | 0.008 | 0.999 | 3.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyanosis neonatal | 0 | 0.001 | 0.018 | 0.999 | 3.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small fibre neuropathy | 0 | 0.001 | 0.026 | 0.999 | 3.261 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanic membrane perforation | 0 | 0.003 | 0.237 | 0.999 | 2.189 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord oedema | 0 | 0 | 0.005 | 0.999 | 3.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colour blindness | 0 | 0 | 0.006 | 0.999 | 3.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholinesterase increased | 0 | 0.001 | 0.052 | 0.999 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival pruritus | 0 | 0 | 0.009 | 0.999 | 3.618 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.001 | 0.081 | 0.999 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchitis chronic | 0 | 0.001 | 0.012 | 0.999 | 3.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcal bacteraemia | 0 | 0 | 0 | 0.999 | 4.36 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antibody | 0 | 0 | 0 | 0.999 | 4.489 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic respiratory failure | 0 | 0.001 | 0.022 | 0.999 | 3.321 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear operation | 0 | 0 | 0.031 | 0.999 | 3.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteomyelitis | 0 | 0.003 | 0.181 | 0.999 | 2.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cranial nerve disorder | 0 | 0.001 | 0.181 | 0.999 | 2.36 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agranulocytosis | 0 | 0 | 0 | 0.999 | 4.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type V hyperlipidaemia | 0 | 0 | 0.008 | 0.999 | 3.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor feeding infant | 0 | 0.001 | 0.058 | 0.999 | 2.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytogenetic analysis | 0 | 0.006 | 0.409 | 0.999 | 1.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appetite disorder | 0 | 0.002 | 0.235 | 0.999 | 2.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan abnormal | 0 | 0.001 | 0.026 | 0.999 | 3.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood phosphorus | 0 | 0.005 | 0.347 | 0.999 | 1.924 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brucella test negative | 0 | 0.001 | 0.001 | 0.999 | 4.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrioventricular block complete | 0 | 0.001 | 0.088 | 0.999 | 2.746 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaesthesia | 0 | 0.001 | 0.081 | 0.999 | 2.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colostomy | 0 | 0.001 | 0.002 | 0.999 | 3.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint erythema | 0 | 0 | 0.028 | 0.999 | 3.234 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion missed | 0 | 0.001 | 0.095 | 0.999 | 2.711 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholangitis | 0 | 0.001 | 0.027 | 0.999 | 3.248 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menopausal symptoms | 0 | 0 | 0.014 | 0.999 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tic | 0 | 0.005 | 0.324 | 0.999 | 1.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin culture | 0 | 0.001 | 0.058 | 0.999 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung abscess | 0 | 0.001 | 0.013 | 0.999 | 3.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gluten free diet | 0 | 0 | 0 | 0.999 | 4.635 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental paraesthesia | 0 | 0 | 0.002 | 0.999 | 3.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimicrobial susceptibility test sensitive | 0 | 0 | 0 | 0.999 | 4.365 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea nitrogen/creatinine ratio increased | 0 | 0.001 | 0.013 | 0.999 | 3.501 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systolic dysfunction | 0 | 0 | 0.012 | 0.999 | 3.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scrotal oedema | 0 | 0 | 0.008 | 0.999 | 3.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida test | 0 | 0 | 0.004 | 0.999 | 3.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Testicular swelling | 0 | 0.001 | 0.106 | 0.999 | 2.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cortisol | 0 | 0.001 | 0.017 | 0.999 | 3.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical examination abnormal | 0 | 0.001 | 0.018 | 0.999 | 3.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin urine present | 0 | 0.001 | 0.017 | 0.999 | 3.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD8 lymphocytes increased | 0 | 0.001 | 0.064 | 0.999 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head deformity | 0 | 0 | 0 | 0.999 | 5.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Explorative laparotomy | 0 | 0.001 | 0.001 | 0.999 | 4.276 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asterixis | 0 | 0 | 0.02 | 0.999 | 3.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product contamination physical | 0 | 0.001 | 0.007 | 0.999 | 3.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram T wave abnormal | 0 | 0.003 | 0.251 | 0.999 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IIIrd nerve paralysis | 0 | 0.003 | 0.177 | 0.999 | 2.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue eruption | 0 | 0.003 | 0.347 | 0.999 | 1.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing aid user | 0 | 0.001 | 0.009 | 0.999 | 3.591 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left ventricular failure | 0 | 0.001 | 0.044 | 0.999 | 3.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal monitoring | 0 | 0 | 0.007 | 0.999 | 3.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhonchi | 0 | 0.001 | 0.158 | 0.999 | 2.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Campylobacter gastroenteritis | 0 | 0.001 | 0.054 | 0.999 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tensilon test abnormal | 0 | 0 | 0.007 | 0.999 | 3.686 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal flaring | 0 | 0.001 | 0.049 | 0.999 | 3.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulcer | 0 | 0.003 | 0.311 | 0.999 | 2.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue biting | 0 | 0.004 | 0.256 | 0.999 | 2.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacillus test positive | 0 | 0 | 0.002 | 0.999 | 4.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyanosis central | 0 | 0 | 0.017 | 0.999 | 3.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helplessness | 0 | 0 | 0.01 | 0.999 | 3.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Helicobacter test positive | 0 | 0.001 | 0.08 | 0.999 | 2.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous haemorrhage | 0 | 0 | 0.001 | 0.999 | 4.178 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida test positive | 0 | 0.001 | 0.034 | 0.999 | 3.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion related reaction | 0 | 0 | 0.004 | 0.999 | 3.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fundoscopy | 0 | 0.001 | 0.037 | 0.999 | 3.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angular cheilitis | 0 | 0.001 | 0.026 | 0.999 | 3.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral rash | 0 | 0.002 | 0.18 | 0.999 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deformity | 0 | 0.001 | 0.046 | 0.999 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pathogen resistance | 0 | 0 | 0.001 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte transformation test | 0 | 0 | 0.001 | 0.999 | 4.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal ulceration | 0 | 0.001 | 0.064 | 0.999 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinol binding protein | 0 | 0 | 0 | 0.999 | 4.46 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Astigmatism | 0 | 0 | 0.006 | 0.999 | 3.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thyroid stimulating hormone abnormal | 0 | 0 | 0.002 | 0.999 | 4.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total complement activity test | 0 | 0.001 | 0.014 | 0.999 | 3.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumocystis jirovecii infection | 0 | 0 | 0 | 0.999 | 4.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 increased | 0 | 0.002 | 0.094 | 0.999 | 2.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight fluctuation | 0 | 0 | 0 | 0.999 | 4.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loss of control of legs | 0 | 0.001 | 0.109 | 0.999 | 2.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood heavy metal increased | 0 | 0.001 | 0.023 | 0.999 | 3.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product effect decreased | 0 | 0.001 | 0.003 | 0.999 | 3.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV infection | 0 | 0.001 | 0.076 | 0.999 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular pressure decreased | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy upper gastrointestinal tract normal | 0 | 0.001 | 0.02 | 0.999 | 3.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amputation | 0 | 0 | 0 | 0.999 | 5.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin fissures | 0 | 0.001 | 0.083 | 0.999 | 2.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aldosterone normal | 0 | 0 | 0 | 0.999 | 4.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breech delivery | 0 | 0 | 0.001 | 0.999 | 4.139 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papillitis | 0 | 0.001 | 0.004 | 0.999 | 3.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyssomnia | 0 | 0 | 0.001 | 0.999 | 4.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurilemmoma benign | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Supraventricular extrasystoles | 0 | 0.002 | 0.261 | 0.999 | 2.127 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Slow speech | 0 | 0.001 | 0.063 | 0.999 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocytes normal | 0 | 0.001 | 0.009 | 0.999 | 3.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HLA-B*27 positive | 0 | 0.001 | 0.025 | 0.999 | 3.271 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic granulomatosis with polyangiitis | 0 | 0.001 | 0.063 | 0.999 | 2.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lordosis | 0 | 0.001 | 0.057 | 0.999 | 2.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine spasm | 0 | 0 | 0 | 0.999 | 4.417 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Right ventricular dysfunction | 0 | 0 | 0.015 | 0.999 | 3.451 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermal burn | 0 | 0.004 | 0.296 | 0.999 | 2.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aneurysm | 0 | 0.001 | 0.017 | 0.999 | 3.405 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH body fluid | 0 | 0.001 | 0.004 | 0.999 | 3.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracic operation | 0 | 0.001 | 0.076 | 0.999 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibody test normal | 0 | 0.001 | 0.003 | 0.999 | 3.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy liver | 0 | 0 | 0.021 | 0.999 | 3.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral mass effect | 0 | 0 | 0.001 | 0.999 | 4.082 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dairy intolerance | 0 | 0.002 | 0.166 | 0.999 | 2.407 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotavirus test | 0 | 0.001 | 0.003 | 0.999 | 3.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faeces hard | 0 | 0.001 | 0.029 | 0.999 | 3.215 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respirovirus test positive | 0 | 0.001 | 0.01 | 0.999 | 3.576 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestine polyp | 0 | 0.001 | 0.106 | 0.999 | 2.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory paralysis | 0 | 0 | 0.009 | 0.999 | 3.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound breast normal | 0 | 0 | 0.016 | 0.999 | 3.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-cyclic citrullinated peptide antibody | 0 | 0.002 | 0.255 | 0.999 | 2.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal spasm | 0 | 0.003 | 0.264 | 0.999 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basal ganglia haemorrhage | 0 | 0.001 | 0.015 | 0.999 | 3.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocytosis | 0 | 0 | 0.006 | 0.999 | 3.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Botulism | 0 | 0 | 0 | 0.999 | 4.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal haemorrhage | 0 | 0 | 0.001 | 0.999 | 4.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray dental normal | 0 | 0.001 | 0.097 | 0.999 | 2.701 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vocal cord disorder | 0 | 0.001 | 0.038 | 0.999 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytology abnormal | 0 | 0.001 | 0.02 | 0.999 | 3.353 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid irritation | 0 | 0.003 | 0.179 | 0.999 | 2.364 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholestasis | 0 | 0.001 | 0.022 | 0.999 | 3.312 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Death neonatal | 0 | 0 | 0 | 0.999 | 5.162 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal oedema | 0 | 0.001 | 0.013 | 0.999 | 3.496 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac imaging procedure normal | 0 | 0.001 | 0.022 | 0.999 | 3.319 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site cellulitis | 0 | 0 | 0 | 0.999 | 4.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metamyelocyte count | 0 | 0 | 0.031 | 0.999 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound testes | 0 | 0 | 0.002 | 0.999 | 3.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic infarction | 0 | 0 | 0.012 | 0.999 | 3.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laparoscopy | 0 | 0 | 0.009 | 0.999 | 3.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation time normal | 0 | 0 | 0.004 | 0.999 | 3.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cold-stimulus headache | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medication error | 0 | 0.003 | 0.23 | 0.999 | 2.208 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastoiditis | 0 | 0.001 | 0.005 | 0.999 | 3.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal X-ray | 0 | 0.006 | 0.403 | 0.999 | 1.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal pain | 0 | 0 | 0.007 | 0.999 | 3.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema infectiosum | 0 | 0.001 | 0.012 | 0.999 | 3.508 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocytosis | 0 | 0.001 | 0.064 | 0.999 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal dysplasia | 0 | 0 | 0.004 | 0.999 | 3.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personality disorder | 0 | 0.001 | 0.009 | 0.999 | 3.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Squamous cell carcinoma | 0 | 0.001 | 0.031 | 0.999 | 3.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site hyperaesthesia | 0 | 0.001 | 0.015 | 0.999 | 3.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint movement impairment | 0 | 0.001 | 0.015 | 0.999 | 3.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microcytosis | 0 | 0.001 | 0.048 | 0.999 | 3.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mixed connective tissue disease | 0 | 0 | 0 | 0.999 | 4.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal tenesmus | 0 | 0 | 0.003 | 0.999 | 3.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perfume sensitivity | 0 | 0.001 | 0.03 | 0.999 | 3.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acinetobacter test positive | 0 | 0 | 0.023 | 0.999 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxicologic test normal | 0 | 0.005 | 0.323 | 0.999 | 1.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood osmolarity decreased | 0 | 0.001 | 0.189 | 0.999 | 2.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar exudate | 0 | 0.001 | 0.046 | 0.999 | 3.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelodysplastic syndrome | 0 | 0.001 | 0.046 | 0.999 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood group O | 0 | 0.001 | 0.049 | 0.999 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose tolerance test abnormal | 0 | 0 | 0.01 | 0.999 | 3.581 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral venous thrombosis | 0 | 0 | 0.032 | 0.999 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperplasia | 0 | 0.001 | 0.002 | 0.999 | 4.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal motility disorder | 0 | 0.001 | 0.001 | 0.999 | 4.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral skin infection | 0 | 0 | 0.01 | 0.999 | 3.574 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus test | 0 | 0.005 | 0.279 | 0.999 | 2.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopnoea | 0 | 0.001 | 0.039 | 0.999 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctivitis bacterial | 0 | 0.001 | 0.069 | 0.999 | 2.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal vasculitis | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Critical illness | 0 | 0.001 | 0.039 | 0.999 | 3.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephropathy toxic | 0 | 0 | 0 | 0.999 | 4.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product label issue | 0 | 0.001 | 0.054 | 0.999 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononucleosis heterophile test negative | 0 | 0.004 | 0.292 | 0.999 | 2.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic cyst | 0 | 0.001 | 0.089 | 0.999 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-lymphocyte count decreased | 0 | 0.001 | 0.001 | 0.999 | 4.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C | 0 | 0.001 | 0.005 | 0.999 | 3.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual tracking test abnormal | 0 | 0.001 | 0.043 | 0.999 | 3.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | QRS axis abnormal | 0 | 0 | 0.002 | 0.999 | 3.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine abnormality | 0 | 0.004 | 0.244 | 0.999 | 2.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physiotherapy | 0 | 0 | 0.014 | 0.999 | 3.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue dry | 0 | 0.001 | 0.067 | 0.999 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site papule | 0 | 0.001 | 0.254 | 0.999 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoelectrophoresis | 0 | 0.001 | 0.031 | 0.999 | 3.193 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-platelet antibody negative | 0 | 0.001 | 0.006 | 0.999 | 3.705 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes virus test | 0 | 0.001 | 0.071 | 0.999 | 2.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic respiratory disease | 0 | 0 | 0.01 | 0.999 | 3.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast tenderness | 0 | 0.004 | 0.322 | 0.999 | 1.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phantom limb syndrome | 0 | 0.001 | 0.005 | 0.999 | 3.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug level increased | 0 | 0 | 0 | 0.999 | 4.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood iron normal | 0 | 0.002 | 0.228 | 0.999 | 2.214 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortisol decreased | 0 | 0.001 | 0.042 | 0.999 | 3.077 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Defaecation urgency | 0 | 0.002 | 0.226 | 0.999 | 2.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Growing pains | 0 | 0.001 | 0.001 | 0.999 | 4.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Manufacturing product shipping issue | 0 | 0.001 | 0.063 | 0.999 | 2.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal cord disorder | 0 | 0.001 | 0.088 | 0.999 | 2.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Klebsiella test positive | 0 | 0.001 | 0.038 | 0.999 | 3.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Restrictive pulmonary disease | 0 | 0 | 0.007 | 0.999 | 3.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy peripheral nerve abnormal | 0 | 0.001 | 0.021 | 0.999 | 3.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bloody discharge | 0 | 0.001 | 0.048 | 0.999 | 3.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gamma-glutamyltransferase normal | 0 | 0.001 | 0.095 | 0.999 | 2.71 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound biliary tract | 0 | 0.001 | 0.147 | 0.999 | 2.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atypical haemolytic uraemic syndrome | 0 | 0.001 | 0.072 | 0.999 | 2.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system infection | 0 | 0 | 0.008 | 0.999 | 3.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram coronary abnormal | 0 | 0.001 | 0.081 | 0.999 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial sepsis | 0 | 0.001 | 0.011 | 0.999 | 3.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute polyneuropathy | 0 | 0.001 | 0.008 | 0.999 | 3.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual evoked potentials | 0 | 0.001 | 0.061 | 0.999 | 2.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular drainage | 0 | 0.001 | 0.028 | 0.999 | 3.237 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angina unstable | 0 | 0.001 | 0.016 | 0.999 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pyruvic acid | 0 | 0.001 | 0.037 | 0.999 | 3.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb deformity | 0 | 0.001 | 0.009 | 0.999 | 3.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotavirus test negative | 0 | 0.001 | 0.008 | 0.999 | 3.647 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration joint | 0 | 0.003 | 0.262 | 0.999 | 2.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear haemorrhage | 0 | 0.003 | 0.197 | 0.999 | 2.305 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF oligoclonal band | 0 | 0.003 | 0.209 | 0.999 | 2.269 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram T wave peaked | 0 | 0.001 | 0.003 | 0.999 | 3.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyslalia | 0 | 0.001 | 0.014 | 0.999 | 3.469 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.002 | 0.2 | 0.999 | 2.298 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post inflammatory pigmentation change | 0 | 0 | 0.001 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sunburn | 0 | 0.001 | 0.173 | 0.999 | 2.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoscopy abnormal | 0 | 0.001 | 0.087 | 0.999 | 2.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Babinski reflex test | 0 | 0.001 | 0.028 | 0.999 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchial obstruction | 0 | 0.001 | 0.014 | 0.999 | 3.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterococcal infection | 0 | 0.001 | 0.004 | 0.999 | 3.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine disorder | 0 | 0.001 | 0.004 | 0.999 | 3.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complicated appendicitis | 0 | 0 | 0.003 | 0.999 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test urine positive | 0 | 0 | 0.001 | 0.999 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar ataxia | 0 | 0.002 | 0.098 | 0.999 | 2.691 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eschar | 0 | 0.001 | 0.039 | 0.999 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular septal defect | 0 | 0.001 | 0.035 | 0.999 | 3.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil count decreased | 0 | 0.001 | 0.059 | 0.999 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac electrophysiologic study normal | 0 | 0.001 | 0.003 | 0.999 | 3.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal erythema | 0 | 0 | 0.001 | 0.999 | 4.225 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary dilatation | 0 | 0 | 0.003 | 0.999 | 3.902 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiglottic oedema | 0 | 0.001 | 0.031 | 0.999 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammatory marker decreased | 0 | 0.001 | 0.041 | 0.999 | 3.082 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve disorder | 0 | 0.001 | 0.008 | 0.999 | 3.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein S normal | 0 | 0.001 | 0.058 | 0.999 | 2.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound foetal abnormal | 0 | 0 | 0.013 | 0.999 | 3.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oestradiol decreased | 0 | 0 | 0.002 | 0.999 | 3.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delusion | 0 | 0.007 | 0.439 | 0.999 | 1.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone marrow normal | 0 | 0.001 | 0.023 | 0.999 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine organic acid test | 0 | 0.001 | 0.009 | 0.999 | 3.602 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral discitis | 0 | 0.001 | 0.027 | 0.999 | 3.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH body fluid increased | 0 | 0.001 | 0.001 | 0.999 | 4.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation time prolonged | 0 | 0.001 | 0.048 | 0.999 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF pressure increased | 0 | 0.002 | 0.161 | 0.999 | 2.427 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spirometry | 0 | 0.001 | 0.01 | 0.999 | 3.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal exfoliation | 0 | 0.002 | 0.234 | 0.999 | 2.199 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normochromic normocytic anaemia | 0 | 0 | 0.012 | 0.999 | 3.516 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spondylolisthesis | 0 | 0.001 | 0.074 | 0.999 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichen sclerosus | 0 | 0.001 | 0.005 | 0.999 | 3.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory overload | 0 | 0.001 | 0.001 | 0.999 | 4.225 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle contusion | 0 | 0 | 0.032 | 0.999 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden infant death syndrome | 0 | 0.001 | 0.055 | 0.999 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal gastrointestinal tract imaging abnormal | 0 | 0 | 0 | 0.999 | 4.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovulation pain | 0 | 0 | 0 | 0.999 | 4.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurogenic bowel | 0 | 0 | 0 | 0.999 | 4.948 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depersonalisation/derealisation disorder | 0 | 0.001 | 0.084 | 0.999 | 2.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiolipin antibody | 0 | 0.001 | 0.067 | 0.999 | 2.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Posterior reversible encephalopathy syndrome | 0 | 0.001 | 0.037 | 0.999 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise electrocardiogram normal | 0 | 0.001 | 0.028 | 0.999 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | N-terminal prohormone brain natriuretic peptide | 0 | 0 | 0.01 | 0.999 | 3.581 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Connective tissue disorder | 0 | 0.001 | 0.016 | 0.999 | 3.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Behaviour disorder | 0 | 0 | 0.005 | 0.999 | 3.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delirium febrile | 0 | 0.001 | 0.015 | 0.999 | 3.456 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha haemolytic streptococcal infection | 0 | 0 | 0.008 | 0.999 | 3.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fear of falling | 0 | 0 | 0 | 0.999 | 4.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria chronic | 0 | 0.002 | 0.091 | 0.999 | 2.728 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagitis | 0 | 0.001 | 0.017 | 0.999 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypophosphataemia | 0 | 0.001 | 0.005 | 0.999 | 3.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Male sexual dysfunction | 0 | 0 | 0.001 | 0.999 | 4.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus viraemia | 0 | 0 | 0.013 | 0.999 | 3.505 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polymyositis | 0 | 0.001 | 0.003 | 0.999 | 3.881 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitrectomy | 0 | 0.001 | 0.089 | 0.999 | 2.746 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Umbilical cord abnormality | 0 | 0 | 0.004 | 0.999 | 3.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival blister | 0 | 0.001 | 0.032 | 0.999 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenoidal hypertrophy | 0 | 0.001 | 0.076 | 0.999 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjusted calcium | 0 | 0.001 | 0.015 | 0.999 | 3.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin level normal | 0 | 0.001 | 0.192 | 0.999 | 2.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth fracture | 0 | 0.002 | 0.253 | 0.999 | 2.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quarantine | 0 | 0.001 | 0.026 | 0.999 | 3.261 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear pruritus | 0 | 0.01 | 0.527 | 0.999 | 1.593 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stupor | 0 | 0.001 | 0.015 | 0.999 | 3.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis protein abnormal | 0 | 0.001 | 0.021 | 0.999 | 3.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST segment normal | 0 | 0 | 0.002 | 0.999 | 4.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gram stain positive | 0 | 0.003 | 0.21 | 0.999 | 2.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal calprotectin increased | 0 | 0 | 0.002 | 0.999 | 4.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-insulin antibody positive | 0 | 0 | 0 | 0.999 | 4.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram retina abnormal | 0 | 0.001 | 0.057 | 0.999 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratosis pilaris | 0 | 0.001 | 0.092 | 0.999 | 2.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral cyst | 0 | 0 | 0.001 | 0.999 | 4.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endodontic procedure | 0 | 0.001 | 0.018 | 0.999 | 3.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional product use issue | 0 | 0.001 | 0.017 | 0.999 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Underweight | 0 | 0.001 | 0.002 | 0.999 | 3.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retroperitoneal fibrosis (SMQ) [narrow] | 0 | 0.001 | 0.065 | 0.999 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer | 0 | 0.001 | 0.074 | 0.999 | 2.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasopressive therapy | 0 | 0 | 0.013 | 0.999 | 3.491 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electronystagmogram | 0 | 0 | 0.004 | 0.999 | 3.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin test negative | 0 | 0.001 | 0.15 | 0.999 | 2.469 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carboxyhaemoglobin decreased | 0 | 0 | 0.009 | 0.999 | 3.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postpartum haemorrhage | 0 | 0 | 0 | 0.999 | 4.61 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Absence of immediate treatment response | 0 | 0 | 0.007 | 0.999 | 3.68 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal operation | 0 | 0.001 | 0.004 | 0.999 | 3.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration bone marrow normal | 0 | 0.001 | 0.044 | 0.999 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haptoglobin normal | 0 | 0.001 | 0.027 | 0.999 | 3.252 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purulence | 0 | 0.001 | 0.2 | 0.999 | 2.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Torticollis | 0 | 0.003 | 0.255 | 0.999 | 2.139 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess limb | 0 | 0.001 | 0.194 | 0.999 | 2.315 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipoma | 0 | 0.001 | 0.142 | 0.999 | 2.501 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precancerous cells present | 0 | 0.001 | 0.001 | 0.999 | 4.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventilation/perfusion scan | 0 | 0.001 | 0.009 | 0.999 | 3.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast discharge | 0 | 0 | 0.001 | 0.999 | 4.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adhesiolysis | 0 | 0 | 0.004 | 0.999 | 3.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema induratum | 0 | 0.001 | 0.021 | 0.999 | 3.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy colon abnormal | 0 | 0.001 | 0.006 | 0.999 | 3.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exaggerated startle response | 0 | 0.001 | 0.026 | 0.999 | 3.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soliloquy | 0 | 0 | 0.009 | 0.999 | 3.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopaedic examination normal | 0 | 0.001 | 0.016 | 0.999 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve block | 0 | 0.001 | 0.023 | 0.999 | 3.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory papilloma | 0 | 0 | 0 | 0.999 | 4.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile spitting up | 0 | 0.001 | 0.04 | 0.999 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess sterile | 0 | 0.001 | 0.008 | 0.999 | 3.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrist fracture | 0 | 0.001 | 0.108 | 0.999 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microcytic anaemia | 0 | 0.003 | 0.214 | 0.999 | 2.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staphylococcal scalded skin syndrome | 0 | 0.001 | 0.023 | 0.999 | 3.298 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hand fracture | 0 | 0.001 | 0.074 | 0.999 | 2.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthma exercise induced | 0 | 0.001 | 0.021 | 0.999 | 3.341 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubber sensitivity | 0 | 0.001 | 0.161 | 0.999 | 2.427 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium tuberculosis complex test | 0 | 0.001 | 0.028 | 0.999 | 3.232 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell disorder | 0 | 0.004 | 0.304 | 0.999 | 2.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site oedema | 0 | 0 | 0.004 | 0.999 | 3.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stertor | 0 | 0 | 0 | 0.999 | 4.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Back injury | 0 | 0.003 | 0.297 | 0.999 | 2.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oculorespiratory syndrome | 0 | 0 | 0.001 | 0.999 | 4.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephritis | 0 | 0.001 | 0.013 | 0.999 | 3.49 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Altered visual depth perception | 0 | 0.001 | 0.045 | 0.999 | 3.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Energy increased | 0 | 0.001 | 0.043 | 0.999 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temporal lobe epilepsy | 0 | 0.001 | 0.059 | 0.999 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C RNA decreased | 0 | 0 | 0 | 0.999 | 4.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inner ear inflammation | 0 | 0 | 0.023 | 0.999 | 3.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Portal tract inflammation | 0 | 0 | 0.002 | 0.999 | 4.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Miliaria | 0 | 0.002 | 0.285 | 0.999 | 2.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post lumbar puncture syndrome | 0 | 0.001 | 0.006 | 0.999 | 3.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faecal calprotectin normal | 0 | 0.001 | 0.039 | 0.999 | 3.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schizoaffective disorder | 0 | 0 | 0 | 0.999 | 4.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteochondritis | 0 | 0 | 0.009 | 0.999 | 3.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis membranous | 0 | 0 | 0.003 | 0.999 | 3.92 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carpal tunnel syndrome | 0 | 0.001 | 0.093 | 0.999 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy artery abnormal | 0 | 0.001 | 0.028 | 0.999 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kinesitherapy | 0 | 0 | 0.011 | 0.999 | 3.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Internal hernia | 0 | 0 | 0 | 0.999 | 4.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased interest | 0 | 0.002 | 0.254 | 0.999 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pityriasis rosea | 0 | 0.002 | 0.266 | 0.999 | 2.113 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell count abnormal | 0 | 0.002 | 0.272 | 0.999 | 2.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extremity contracture | 0 | 0.003 | 0.169 | 0.999 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Puncture site induration | 0 | 0 | 0.005 | 0.999 | 3.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-Muellerian hormone level | 0 | 0 | 0.008 | 0.999 | 3.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otitis media bacterial | 0 | 0 | 0.001 | 0.999 | 4.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve conduction studies | 0 | 0.003 | 0.181 | 0.999 | 2.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon rupture | 0 | 0.002 | 0.187 | 0.999 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric dilatation | 0 | 0.001 | 0.109 | 0.999 | 2.639 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin odour abnormal | 0 | 0.001 | 0.009 | 0.999 | 3.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cochlea implant | 0 | 0 | 0.005 | 0.999 | 3.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital pain | 0 | 0.001 | 0.124 | 0.999 | 2.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular pressure test | 0 | 0.001 | 0.066 | 0.999 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostatic specific antigen normal | 0 | 0.001 | 0.034 | 0.999 | 3.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin increased | 0 | 0.001 | 0.014 | 0.999 | 3.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disseminated Bacillus Calmette-Guerin infection | 0 | 0.001 | 0.008 | 0.999 | 3.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Akinesia | 0 | 0.001 | 0.016 | 0.999 | 3.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chiropractic | 0 | 0.001 | 0.113 | 0.999 | 2.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroxine decreased | 0 | 0.001 | 0.013 | 0.999 | 3.488 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil percentage decreased | 0 | 0.001 | 0.025 | 0.999 | 3.279 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF protein abnormal | 0 | 0.001 | 0.024 | 0.999 | 3.289 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic colitis | 0 | 0 | 0.004 | 0.999 | 3.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycoplasma infection | 0 | 0.001 | 0.025 | 0.999 | 3.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enthesopathy | 0 | 0.001 | 0.035 | 0.999 | 3.146 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Saliva altered | 0 | 0.001 | 0.079 | 0.999 | 2.802 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis sapovirus | 0 | 0 | 0.001 | 0.999 | 4.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial nerve disorder | 0 | 0.001 | 0.183 | 0.999 | 2.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteochondrosis | 0 | 0.001 | 0.034 | 0.999 | 3.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical spinal stenosis | 0 | 0.001 | 0.175 | 0.999 | 2.378 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail discolouration | 0 | 0.001 | 0.018 | 0.999 | 3.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood phosphorus normal | 0 | 0.005 | 0.304 | 0.999 | 2.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil percentage increased | 0 | 0.001 | 0.126 | 0.999 | 2.563 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital pulmonary hypertension | 0 | 0 | 0 | 0.999 | 4.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycoplasma test positive | 0 | 0.001 | 0.005 | 0.999 | 3.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal dryness | 0 | 0.001 | 0.066 | 0.999 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine potassium | 0 | 0 | 0 | 0.999 | 5.71 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute vestibular syndrome | 0 | 0 | 0.004 | 0.999 | 3.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Learning disability | 0 | 0 | 0.013 | 0.999 | 3.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritonsillar abscess | 0 | 0.001 | 0.006 | 0.999 | 3.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Child abuse | 0 | 0 | 0 | 0.999 | 4.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mononeuritis | 0 | 0.001 | 0.015 | 0.999 | 3.459 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | End stage renal disease | 0 | 0.001 | 0.023 | 0.999 | 3.311 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle abscess | 0 | 0.001 | 0.01 | 0.999 | 3.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C4 decreased | 0 | 0 | 0.002 | 0.999 | 4.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised anxiety disorder | 0 | 0.001 | 0.042 | 0.999 | 3.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemangioma | 0 | 0.003 | 0.193 | 0.999 | 2.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound urinary system | 0 | 0.001 | 0.038 | 0.999 | 3.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic skin eruption | 0 | 0.001 | 0.014 | 0.999 | 3.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renovascular disorders (SMQ) [narrow] | 0 | 0.001 | 0.081 | 0.999 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal sphincter atony | 0 | 0.001 | 0.022 | 0.999 | 3.319 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site ulcer | 0 | 0.003 | 0.361 | 0.999 | 1.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic lupus erythematosus rash | 0 | 0 | 0.011 | 0.999 | 3.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dropped head syndrome | 0 | 0.001 | 0.034 | 0.999 | 3.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin D | 0 | 0.004 | 0.376 | 0.999 | 1.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palatal disorder | 0 | 0.002 | 0.145 | 0.999 | 2.485 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin wrinkling | 0 | 0.001 | 0.072 | 0.999 | 2.845 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Idiopathic urticaria | 0 | 0.001 | 0.04 | 0.999 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin atrophy | 0 | 0.001 | 0.036 | 0.999 | 3.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parotid gland enlargement | 0 | 0.001 | 0.004 | 0.999 | 3.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin globulin ratio increased | 0 | 0 | 0.007 | 0.999 | 3.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombotic microangiopathy | 0 | 0.001 | 0.086 | 0.999 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint contracture | 0 | 0.003 | 0.164 | 0.999 | 2.414 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disturbance in social behaviour | 0 | 0.001 | 0.016 | 0.999 | 3.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nail disorder | 0 | 0.001 | 0.022 | 0.999 | 3.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint irrigation | 0 | 0 | 0.034 | 0.999 | 3.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupillary light reflex tests normal | 0 | 0.001 | 0.027 | 0.999 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial neuralgia | 0 | 0.001 | 0.156 | 0.999 | 2.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site abscess sterile | 0 | 0 | 0.001 | 0.999 | 4.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Combined immunodeficiency | 0 | 0.001 | 0.001 | 0.999 | 4.185 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus test positive | 0 | 0.002 | 0.081 | 0.999 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Evans syndrome | 0 | 0.001 | 0.001 | 0.999 | 4.288 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face and mouth X-ray abnormal | 0 | 0.001 | 0.034 | 0.999 | 3.154 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lactate decreased | 0 | 0 | 0.002 | 0.999 | 3.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin normal | 0 | 0.001 | 0.001 | 0.998 | 4.146 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells urine negative | 0 | 0.003 | 0.131 | 0.998 | 2.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis enteroviral | 0 | 0 | 0 | 0.998 | 5.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatosensory evoked potentials | 0 | 0 | 0 | 0.998 | 4.534 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy kidney abnormal | 0 | 0.001 | 0.006 | 0.998 | 3.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Self esteem decreased | 0 | 0.001 | 0.001 | 0.998 | 4.115 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycotic allergy | 0 | 0.001 | 0.001 | 0.998 | 4.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site hypertrichosis | 0 | 0 | 0 | 0.998 | 5.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Social anxiety disorder | 0 | 0 | 0 | 0.998 | 4.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood testosterone decreased | 0 | 0.001 | 0.002 | 0.998 | 4.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Performance status decreased | 0 | 0.001 | 0.014 | 0.998 | 3.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face injury | 0 | 0.006 | 0.245 | 0.998 | 2.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin urine present | 0 | 0.003 | 0.147 | 0.998 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trichotillomania | 0 | 0.001 | 0.001 | 0.998 | 4.194 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site pain | 0 | 0.006 | 0.266 | 0.998 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product temperature excursion issue | 0 | 0 | 0 | 0.998 | 4.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Euphoric mood | 0 | 0.003 | 0.151 | 0.998 | 2.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin globulin ratio normal | 0 | 0.005 | 0.272 | 0.998 | 2.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan with contrast normal | 0 | 0.018 | 0.474 | 0.998 | 1.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF oligoclonal band present | 0 | 0.001 | 0.005 | 0.998 | 3.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site muscle weakness | 0 | 0.002 | 0.051 | 0.998 | 2.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cell death | 0 | 0.001 | 0 | 0.998 | 4.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb mass | 0 | 0.01 | 0.361 | 0.998 | 1.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypercholesterolaemia | 0 | 0.001 | 0 | 0.998 | 4.495 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleurisy | 0 | 0.005 | 0.251 | 0.998 | 2.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcium | 0 | 0.007 | 0.386 | 0.998 | 1.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antineutrophil cytoplasmic antibody positive | 0 | 0.001 | 0.018 | 0.998 | 3.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioallergosorbent test negative | 0 | 0.003 | 0.142 | 0.998 | 2.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scleroderma | 0 | 0.001 | 0.015 | 0.998 | 3.444 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolism venous | 0 | 0 | 0 | 0.998 | 4.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory symptom | 0 | 0.009 | 0.364 | 0.998 | 1.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amylase increased | 0 | 0.001 | 0.004 | 0.998 | 3.802 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tubulointerstitial diseases (SMQ) [narrow] | 0 | 0.002 | 0.045 | 0.998 | 3.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral myocarditis | 0 | 0.001 | 0.003 | 0.998 | 3.926 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukodystrophy | 0 | 0.001 | 0.001 | 0.998 | 4.22 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eclampsia | 0 | 0 | 0 | 0.998 | 4.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site abscess sterile | 0 | 0 | 0 | 0.998 | 5.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxicologic test | 0 | 0.005 | 0.307 | 0.998 | 2.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labyrinthitis | 0 | 0.004 | 0.122 | 0.998 | 2.575 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypometabolism | 0 | 0.001 | 0 | 0.998 | 4.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspergillus infection | 0 | 0 | 0 | 0.998 | 5.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procedural failure | 0 | 0.001 | 0 | 0.998 | 5.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adjustment disorder | 0 | 0.001 | 0.003 | 0.998 | 3.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clonus | 0 | 0.002 | 0.053 | 0.998 | 2.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumocystis jirovecii pneumonia | 0 | 0 | 0 | 0.998 | 4.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta-2 glycoprotein antibody positive | 0 | 0.001 | 0.001 | 0.998 | 4.224 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngitis | 0 | 0.004 | 0.148 | 0.998 | 2.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac stress test normal | 0 | 0.01 | 0.451 | 0.998 | 1.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising colitis | 0 | 0.001 | 0.001 | 0.998 | 4.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Organic brain syndrome | 0 | 0.001 | 0 | 0.998 | 4.549 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased appetite | 0 | 0.001 | 0.017 | 0.998 | 3.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraventricular haemorrhage neonatal | 0 | 0 | 0 | 0.998 | 5.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bundle branch block right | 0 | 0.003 | 0.144 | 0.998 | 2.488 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxiella test | 0 | 0.001 | 0 | 0.998 | 4.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetes insipidus | 0 | 0.001 | 0.004 | 0.998 | 3.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test urine | 0 | 0.002 | 0.096 | 0.998 | 2.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urobilinogen urine increased | 0 | 0.004 | 0.213 | 0.998 | 2.257 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid disorder | 0 | 0.008 | 0.364 | 0.998 | 1.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden visual loss | 0 | 0.004 | 0.167 | 0.998 | 2.401 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin test | 0 | 0.005 | 0.225 | 0.998 | 2.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic arteriosclerosis | 0 | 0.002 | 0.034 | 0.998 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurosis | 0 | 0 | 0 | 0.998 | 4.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral circulatory failure | 0 | 0.001 | 0.003 | 0.998 | 3.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide increased | 0 | 0.005 | 0.24 | 0.998 | 2.178 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychomotor retardation | 0 | 0.001 | 0 | 0.998 | 4.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yawning | 0 | 0.004 | 0.212 | 0.998 | 2.258 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.001 | 0 | 0.998 | 4.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immobilisation syndrome | 0 | 0 | 0 | 0.998 | 5.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palindromic rheumatism | 0 | 0.001 | 0.001 | 0.998 | 4.168 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyporeflexia | 0 | 0.003 | 0.128 | 0.998 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint erythema | 0 | 0.001 | 0.002 | 0.998 | 4.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF cell count | 0 | 0.001 | 0.01 | 0.998 | 3.565 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain death | 0 | 0.003 | 0.092 | 0.998 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ADAMTS13 activity decreased | 0 | 0 | 0 | 0.998 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Concussion | 0 | 0.005 | 0.211 | 0.998 | 2.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipase normal | 0 | 0.009 | 0.331 | 0.998 | 1.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phototherapy | 0 | 0.001 | 0 | 0.998 | 4.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Concomitant disease aggravated | 0 | 0.001 | 0.002 | 0.998 | 4.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test negative | 0 | 0.002 | 0.039 | 0.998 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reactogenicity event | 0 | 0.001 | 0 | 0.998 | 4.4 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoscopy | 0 | 0.002 | 0.042 | 0.998 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pyelitis | 0 | 0.001 | 0.001 | 0.998 | 4.234 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal inflammation | 0 | 0.005 | 0.162 | 0.998 | 2.418 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phlebitis | 0 | 0.002 | 0.053 | 0.998 | 2.975 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac tamponade | 0 | 0.001 | 0.014 | 0.998 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid mass | 0 | 0.004 | 0.227 | 0.998 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dehydroepiandrosterone decreased | 0 | 0 | 0 | 0.998 | 5.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Snoring | 0 | 0.003 | 0.156 | 0.998 | 2.442 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteolysis | 0 | 0.001 | 0.001 | 0.998 | 4.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug intolerance | 0 | 0.004 | 0.139 | 0.998 | 2.505 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour marker test | 0 | 0.001 | 0 | 0.998 | 4.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nitrite urine present | 0 | 0.003 | 0.128 | 0.998 | 2.553 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitritis | 0 | 0.001 | 0.004 | 0.998 | 3.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site joint pain | 0 | 0.012 | 0.442 | 0.998 | 1.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus hypersecretion | 0 | 0.007 | 0.295 | 0.998 | 2.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium double contrast | 0 | 0 | 0 | 0.998 | 4.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil percentage increased | 0 | 0.004 | 0.204 | 0.998 | 2.283 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis post immunisation | 0 | 0.001 | 0 | 0.998 | 4.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycosuria | 0 | 0.001 | 0.004 | 0.998 | 3.824 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site irritation | 0 | 0.009 | 0.354 | 0.998 | 1.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycosylated haemoglobin normal | 0 | 0.007 | 0.354 | 0.998 | 1.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipase | 0 | 0.011 | 0.445 | 0.998 | 1.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial spasm | 0 | 0.003 | 0.154 | 0.998 | 2.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal lymphadenopathy | 0 | 0.003 | 0.122 | 0.998 | 2.578 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | No reaction on previous exposure to drug | 0 | 0.004 | 0.185 | 0.998 | 2.342 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal exposure during pregnancy | 0 | 0.003 | 0.126 | 0.998 | 2.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Barium enema normal | 0 | 0 | 0 | 0.998 | 5.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture stool positive | 0 | 0 | 0 | 0.998 | 4.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint instability | 0 | 0.005 | 0.244 | 0.998 | 2.167 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor V level normal | 0 | 0.001 | 0 | 0.998 | 4.671 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mental fatigue | 0 | 0.003 | 0.149 | 0.998 | 2.469 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve injury | 0 | 0.001 | 0.009 | 0.998 | 3.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human papilloma virus test negative | 0 | 0 | 0 | 0.998 | 5.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Precancerous skin lesion | 0 | 0 | 0 | 0.998 | 5.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychomotor hyperactivity | 0 | 0.003 | 0.115 | 0.998 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Repetitive speech | 0 | 0.005 | 0.175 | 0.998 | 2.373 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arrhythmia related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.006 | 0.256 | 0.998 | 2.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Investigation abnormal | 0 | 0.003 | 0.135 | 0.998 | 2.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Penile erythema | 0 | 0 | 0 | 0.998 | 5.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aura | 0 | 0.004 | 0.208 | 0.998 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic atrophy | 0 | 0.001 | 0.001 | 0.998 | 4.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy skin normal | 0 | 0.001 | 0.004 | 0.998 | 3.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nucleated red cells | 0 | 0.005 | 0.243 | 0.998 | 2.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacunar infarction | 0 | 0.004 | 0.126 | 0.998 | 2.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colitis microscopic | 0 | 0.001 | 0.003 | 0.998 | 3.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose abnormal | 0 | 0.006 | 0.247 | 0.998 | 2.159 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestine perforation | 0 | 0.001 | 0 | 0.998 | 4.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotator cuff repair | 0 | 0.001 | 0.001 | 0.998 | 4.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound thyroid abnormal | 0 | 0.001 | 0.002 | 0.998 | 4.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunology test normal | 0 | 0.004 | 0.19 | 0.998 | 2.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colour vision tests normal | 0 | 0 | 0 | 0.998 | 5.036 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced vital capacity decreased | 0 | 0 | 0 | 0.998 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal sensation in eye | 0 | 0.007 | 0.337 | 0.998 | 1.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory integrative dysfunction | 0 | 0.001 | 0 | 0.998 | 4.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-GAD antibody positive | 0 | 0.003 | 0.056 | 0.998 | 2.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine sodium | 0 | 0.001 | 0 | 0.998 | 4.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of spontaneous speech | 0 | 0.001 | 0.008 | 0.998 | 3.622 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Globulins decreased | 0 | 0.006 | 0.211 | 0.998 | 2.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Localised infection | 0 | 0.003 | 0.105 | 0.998 | 2.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis | 0 | 0.01 | 0.392 | 0.998 | 1.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PCO2 normal | 0 | 0.002 | 0.04 | 0.998 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ammonia increased | 0 | 0.008 | 0.351 | 0.998 | 1.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood follicle stimulating hormone increased | 0 | 0.001 | 0 | 0.998 | 4.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunodeficiency common variable | 0 | 0.001 | 0 | 0.998 | 4.59 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microsomia | 0 | 0 | 0 | 0.998 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prenatal screening test abnormal | 0 | 0 | 0 | 0.998 | 5.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement deficiency disease | 0 | 0 | 0 | 0.998 | 5.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased activity | 0 | 0.004 | 0.247 | 0.998 | 2.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF virus no organisms observed | 0 | 0.001 | 0.004 | 0.998 | 3.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Presbyacusis | 0 | 0 | 0 | 0.998 | 5.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clostridium test positive | 0 | 0.004 | 0.189 | 0.998 | 2.327 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Venogram | 0 | 0.006 | 0.25 | 0.998 | 2.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder pain | 0 | 0.003 | 0.113 | 0.998 | 2.618 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal infection | 0 | 0.001 | 0 | 0.998 | 4.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex test positive | 0 | 0.002 | 0.046 | 0.998 | 3.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug screen | 0 | 0.006 | 0.259 | 0.998 | 2.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia infection | 0 | 0.002 | 0.074 | 0.998 | 2.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyst | 0 | 0.002 | 0.063 | 0.998 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extensor plantar response | 0 | 0.001 | 0.005 | 0.998 | 3.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunosuppressant drug therapy | 0 | 0.004 | 0.174 | 0.998 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reflex test abnormal | 0 | 0.001 | 0 | 0.998 | 4.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Percutaneous coronary intervention | 0 | 0.001 | 0.012 | 0.998 | 3.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bruxism | 0 | 0.005 | 0.266 | 0.998 | 2.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site haematoma | 0 | 0.008 | 0.352 | 0.998 | 1.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint injury | 0 | 0.008 | 0.391 | 0.998 | 1.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor quality product administered | 0 | 0.002 | 0.039 | 0.998 | 3.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alkaline phosphatase | 0 | 0.003 | 0.133 | 0.998 | 2.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung assist device therapy | 0 | 0.001 | 0.002 | 0.998 | 4.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 deficiency | 0 | 0.001 | 0 | 0.998 | 4.444 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colposcopy abnormal | 0 | 0 | 0 | 0.998 | 5.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C RNA increased | 0 | 0.001 | 0 | 0.998 | 4.85 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 | 0 | 0.006 | 0.254 | 0.998 | 2.139 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycobacterium tuberculosis complex test negative | 0 | 0.002 | 0.031 | 0.998 | 3.192 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prolonged labour | 0 | 0.001 | 0 | 0.998 | 4.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate increased | 0 | 0 | 0 | 0.998 | 5.647 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoclonic epilepsy | 0 | 0.001 | 0.009 | 0.998 | 3.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine leukocyte esterase positive | 0 | 0.008 | 0.33 | 0.998 | 1.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site swelling | 0 | 0.005 | 0.189 | 0.998 | 2.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coeliac disease | 0 | 0.002 | 0.03 | 0.998 | 3.201 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emergency care examination | 0 | 0 | 0 | 0.998 | 5.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased upper airway secretion | 0 | 0.005 | 0.256 | 0.998 | 2.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal neoplasms (SMQ) [broad] | 0 | 0.003 | 0.093 | 0.998 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phobia | 0 | 0.001 | 0.016 | 0.998 | 3.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical examination normal | 0 | 0.003 | 0.092 | 0.998 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound pelvis abnormal | 0 | 0.001 | 0.01 | 0.998 | 3.587 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catarrh | 0 | 0.001 | 0.004 | 0.998 | 3.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiglottitis | 0 | 0.001 | 0.001 | 0.998 | 4.239 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraventricular haemorrhage | 0 | 0.001 | 0.002 | 0.998 | 4.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subacute sclerosing panencephalitis | 0 | 0.001 | 0 | 0.998 | 5.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood heavy metal test | 0 | 0.002 | 0.024 | 0.998 | 3.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral disorder | 0 | 0.009 | 0.352 | 0.998 | 1.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papilloma excision | 0 | 0.001 | 0 | 0.998 | 4.485 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Slit-lamp tests normal | 0 | 0 | 0 | 0.998 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Audiogram abnormal | 0 | 0.008 | 0.379 | 0.998 | 1.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin oedema | 0 | 0.002 | 0.048 | 0.998 | 3.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incoherent | 0 | 0.021 | 0.505 | 0.998 | 1.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site scar | 0 | 0.004 | 0.206 | 0.998 | 2.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor peripheral circulation | 0 | 0.004 | 0.128 | 0.998 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malnutrition | 0 | 0.001 | 0.018 | 0.998 | 3.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal neoplasms (SMQ) [narrow] | 0 | 0.003 | 0.093 | 0.998 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time ratio | 0 | 0.001 | 0 | 0.998 | 4.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip oedema | 0 | 0.004 | 0.193 | 0.998 | 2.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac monitoring abnormal | 0 | 0.004 | 0.172 | 0.998 | 2.383 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus antibody negative | 0 | 0.004 | 0.192 | 0.998 | 2.32 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin positive | 0 | 0.001 | 0 | 0.998 | 4.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroiditis subacute | 0 | 0.001 | 0 | 0.998 | 4.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Slit-lamp tests abnormal | 0 | 0.001 | 0.001 | 0.998 | 4.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amaurosis fugax | 0 | 0.001 | 0.001 | 0.998 | 4.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular filtration rate normal | 0 | 0.008 | 0.33 | 0.998 | 1.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell nucleated morphology | 0 | 0.006 | 0.307 | 0.998 | 2.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premalignant disorders, general conditions and other site specific disorders (SMQ) [narrow] | 0 | 0 | 0 | 0.998 | 5.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle spasticity | 0 | 0.001 | 0.024 | 0.998 | 3.288 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Costochondritis | 0 | 0.003 | 0.115 | 0.998 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvovirus B19 test | 0 | 0.004 | 0.204 | 0.998 | 2.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic aneurysm | 0 | 0.002 | 0.045 | 0.998 | 3.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drowning | 0 | 0.001 | 0 | 0.998 | 4.521 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oophorectomy | 0 | 0.001 | 0 | 0.998 | 4.946 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy abnormal | 0 | 0.001 | 0.002 | 0.998 | 4.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single photon emission computerised tomogram normal | 0 | 0 | 0 | 0.998 | 5.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intracranial aneurysm | 0 | 0.006 | 0.258 | 0.998 | 2.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytogenetic abnormality | 0 | 0.001 | 0.004 | 0.998 | 3.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract infection bacterial | 0 | 0.001 | 0 | 0.998 | 4.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impulsive behaviour | 0 | 0.001 | 0.004 | 0.998 | 3.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone contusion | 0 | 0.001 | 0 | 0.998 | 4.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic inflammatory demyelinating polyradiculoneuropathy | 0 | 0.002 | 0.027 | 0.998 | 3.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bladder catheterisation | 0 | 0.005 | 0.258 | 0.998 | 2.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hallucination, visual | 0 | 0.009 | 0.344 | 0.998 | 1.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site necrosis | 0 | 0.002 | 0.024 | 0.998 | 3.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood phosphorus decreased | 0 | 0.004 | 0.226 | 0.998 | 2.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip haemorrhage | 0 | 0.006 | 0.285 | 0.998 | 2.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem auditory evoked response normal | 0 | 0.001 | 0.002 | 0.998 | 3.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric hypomotility | 0 | 0 | 0 | 0.998 | 5.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suture insertion | 0 | 0.009 | 0.398 | 0.998 | 1.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair colour changes | 0 | 0.001 | 0.002 | 0.998 | 4.028 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue blistering | 0 | 0.005 | 0.252 | 0.998 | 2.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheobronchitis | 0 | 0.001 | 0.001 | 0.998 | 4.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Q fever | 0 | 0.001 | 0 | 0.998 | 4.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin discomfort | 0 | 0.004 | 0.16 | 0.998 | 2.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin conjugated normal | 0 | 0.002 | 0.051 | 0.998 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site eczema | 0 | 0 | 0 | 0.998 | 5.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin candida | 0 | 0.001 | 0.001 | 0.998 | 4.162 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound liver abnormal | 0 | 0.001 | 0.001 | 0.998 | 4.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac function test normal | 0 | 0.008 | 0.381 | 0.998 | 1.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis acute | 0 | 0.001 | 0 | 0.998 | 4.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensation of blood flow | 0 | 0.001 | 0.011 | 0.998 | 3.543 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular insufficiency | 0 | 0.002 | 0.102 | 0.998 | 2.671 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mast cell activation syndrome | 0 | 0.001 | 0.001 | 0.998 | 4.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunology test abnormal | 0 | 0.002 | 0.018 | 0.998 | 3.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A virus test | 0 | 0.001 | 0.015 | 0.998 | 3.447 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemia | 0 | 0.003 | 0.084 | 0.998 | 2.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypernatraemia | 0 | 0.002 | 0.071 | 0.998 | 2.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post-tussive vomiting | 0 | 0.002 | 0.045 | 0.998 | 3.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peroneal nerve palsy | 0 | 0.007 | 0.298 | 0.998 | 2.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon injury | 0 | 0.002 | 0.038 | 0.998 | 3.114 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging thoracic abnormal | 0 | 0.003 | 0.151 | 0.998 | 2.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body temperature normal | 0 | 0.003 | 0.15 | 0.998 | 2.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy kidney | 0 | 0.003 | 0.145 | 0.998 | 2.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervicectomy | 0 | 0 | 0 | 0.998 | 4.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral disorder | 0 | 0.003 | 0.095 | 0.998 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hordeolum | 0 | 0.005 | 0.227 | 0.998 | 2.214 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myopathy | 0 | 0.002 | 0.043 | 0.998 | 3.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest tube insertion | 0 | 0.004 | 0.246 | 0.998 | 2.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteitis | 0 | 0.002 | 0.047 | 0.998 | 3.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue disorder | 0 | 0.018 | 0.476 | 0.998 | 1.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dissociative disorder | 0 | 0.004 | 0.148 | 0.998 | 2.471 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic cellulitis | 0 | 0.001 | 0.001 | 0.998 | 4.293 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram coronary normal | 0 | 0.004 | 0.23 | 0.998 | 2.206 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis protein | 0 | 0.004 | 0.207 | 0.998 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitiligo | 0 | 0.001 | 0.001 | 0.998 | 4.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product prescribing error | 0 | 0.003 | 0.176 | 0.998 | 2.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis viral | 0 | 0.008 | 0.387 | 0.998 | 1.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skull fracture | 0 | 0.001 | 0.017 | 0.998 | 3.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal inflammation | 0 | 0.004 | 0.199 | 0.998 | 2.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy test | 0 | 0.013 | 0.458 | 0.998 | 1.707 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile back arching | 0 | 0.001 | 0.001 | 0.998 | 4.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendon disorder | 0 | 0.002 | 0.072 | 0.998 | 2.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal mass | 0 | 0.001 | 0 | 0.998 | 4.691 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reaction to previous exposure to any vaccine | 0 | 0.003 | 0.177 | 0.998 | 2.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acoustic stimulation tests normal | 0 | 0.002 | 0.044 | 0.998 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystitis interstitial | 0 | 0.001 | 0 | 0.998 | 4.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low density lipoprotein normal | 0 | 0.006 | 0.299 | 0.998 | 2.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy salivary gland normal | 0 | 0.001 | 0 | 0.998 | 4.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine leukocyte esterase | 0 | 0.006 | 0.321 | 0.998 | 1.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acidosis | 0 | 0.004 | 0.161 | 0.998 | 2.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital pain | 0 | 0.001 | 0 | 0.998 | 4.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune hypothyroidism | 0 | 0 | 0 | 0.998 | 4.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postictal state | 0 | 0.009 | 0.422 | 0.998 | 1.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound chest | 0 | 0.004 | 0.25 | 0.998 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep paralysis | 0 | 0.001 | 0.001 | 0.998 | 4.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alanine aminotransferase decreased | 0 | 0.001 | 0.001 | 0.998 | 4.248 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microbiology test abnormal | 0 | 0.001 | 0.001 | 0.998 | 4.256 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gram stain | 0 | 0.004 | 0.157 | 0.998 | 2.439 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Listeria test | 0 | 0.001 | 0.002 | 0.998 | 3.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left ventricular hypertrophy | 0 | 0.004 | 0.155 | 0.998 | 2.444 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electromyogram | 0 | 0.006 | 0.285 | 0.998 | 2.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin degradation products increased | 0 | 0 | 0 | 0.998 | 4.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergic reaction to excipient | 0 | 0.003 | 0.097 | 0.998 | 2.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs indirect test positive | 0 | 0 | 0 | 0.998 | 4.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy upper gastrointestinal tract | 0 | 0.001 | 0.002 | 0.998 | 3.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal infection | 0 | 0.002 | 0.053 | 0.998 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Administration site reaction | 0 | 0.003 | 0.17 | 0.998 | 2.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood beryllium | 0 | 0.001 | 0 | 0.998 | 4.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD8 lymphocytes | 0 | 0.001 | 0 | 0.998 | 4.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram carotid | 0 | 0.007 | 0.308 | 0.998 | 2.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vein disorder | 0 | 0.004 | 0.164 | 0.998 | 2.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystatin C | 0 | 0.001 | 0 | 0.998 | 4.425 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Natural killer cell count increased | 0 | 0.001 | 0 | 0.998 | 4.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | West Nile virus test positive | 0 | 0 | 0 | 0.998 | 5.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obesity | 0 | 0.001 | 0.02 | 0.998 | 3.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hallucinations, mixed | 0 | 0.001 | 0.006 | 0.998 | 3.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Band neutrophil percentage | 0 | 0.005 | 0.213 | 0.998 | 2.255 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular purpura | 0 | 0.001 | 0.001 | 0.998 | 4.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-neutrophil cytoplasmic antibody positive vasculitis | 0 | 0.001 | 0 | 0.998 | 4.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum increased | 0 | 0.001 | 0.001 | 0.998 | 4.217 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromosome analysis normal | 0 | 0.001 | 0.008 | 0.998 | 3.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic alkalosis | 0 | 0 | 0 | 0.998 | 5.386 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial excision | 0 | 0.001 | 0.001 | 0.998 | 4.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight gain poor | 0 | 0.003 | 0.104 | 0.998 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcal infection | 0 | 0.003 | 0.09 | 0.998 | 2.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholesterol normal | 0 | 0.007 | 0.272 | 0.998 | 2.093 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Piloerection | 0 | 0.005 | 0.309 | 0.998 | 2.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy liver abnormal | 0 | 0.001 | 0.004 | 0.998 | 3.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adnexa uteri pain | 0 | 0 | 0 | 0.998 | 4.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperbilirubinaemia | 0 | 0.001 | 0.009 | 0.998 | 3.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Humoral immune defect | 0 | 0 | 0 | 0.998 | 5.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve compression | 0 | 0.006 | 0.222 | 0.998 | 2.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irregular breathing | 0 | 0.002 | 0.099 | 0.998 | 2.689 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematology test normal | 0 | 0.003 | 0.103 | 0.998 | 2.666 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal function test | 0 | 0.006 | 0.339 | 0.998 | 1.94 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General physical condition abnormal | 0 | 0.004 | 0.118 | 0.998 | 2.594 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic neuropathy | 0 | 0.001 | 0.013 | 0.998 | 3.487 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loss of employment | 0 | 0.001 | 0.002 | 0.998 | 4.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortisol increased | 0 | 0.001 | 0.005 | 0.998 | 3.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis chronic | 0 | 0 | 0 | 0.998 | 4.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin injury | 0 | 0.002 | 0.025 | 0.998 | 3.269 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Compartment syndrome | 0 | 0.001 | 0.004 | 0.998 | 3.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radioisotope scan normal | 0 | 0.001 | 0 | 0.998 | 4.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-1 test | 0 | 0.001 | 0.004 | 0.998 | 3.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Selective eating disorder | 0 | 0.003 | 0.077 | 0.998 | 2.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctival hyperaemia | 0 | 0.004 | 0.198 | 0.998 | 2.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hirsutism | 0 | 0.001 | 0 | 0.998 | 4.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chlamydia test negative | 0 | 0.003 | 0.2 | 0.998 | 2.295 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure systolic increased | 0 | 0.008 | 0.344 | 0.998 | 1.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Giant cell arteritis | 0 | 0.001 | 0.02 | 0.998 | 3.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal inflammation | 0 | 0.003 | 0.134 | 0.998 | 2.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear cervix normal | 0 | 0.001 | 0 | 0.998 | 4.702 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | May-Thurner syndrome | 0 | 0.001 | 0.004 | 0.998 | 3.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiacetylcholine receptor antibody positive | 0 | 0.001 | 0.006 | 0.998 | 3.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory rate decreased | 0 | 0.007 | 0.255 | 0.998 | 2.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immature granulocyte count increased | 0 | 0.003 | 0.182 | 0.998 | 2.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerulonephritis | 0 | 0.001 | 0 | 0.998 | 4.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood iron | 0 | 0.003 | 0.181 | 0.998 | 2.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral ischaemia | 0 | 0.005 | 0.217 | 0.998 | 2.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebellar stroke | 0 | 0.005 | 0.222 | 0.998 | 2.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urea urine normal | 0 | 0 | 0 | 0.998 | 5.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor | 0 | 0.005 | 0.227 | 0.998 | 2.215 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ankylosing spondylitis | 0 | 0.001 | 0 | 0.998 | 4.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluid overload | 0 | 0.004 | 0.156 | 0.998 | 2.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Concomitant disease progression | 0 | 0.001 | 0 | 0.998 | 4.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Slow response to stimuli | 0 | 0.003 | 0.13 | 0.998 | 2.543 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site hypersensitivity | 0 | 0.006 | 0.253 | 0.998 | 2.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vacuum extractor delivery | 0 | 0.001 | 0 | 0.998 | 4.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Localised oedema | 0 | 0.006 | 0.237 | 0.998 | 2.186 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep study abnormal | 0 | 0.001 | 0.004 | 0.998 | 3.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle ear effusion | 0 | 0.005 | 0.26 | 0.998 | 2.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tubulointerstitial nephritis | 0 | 0.001 | 0.027 | 0.998 | 3.239 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exophthalmos | 0 | 0.002 | 0.029 | 0.998 | 3.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile vomiting | 0 | 0.001 | 0 | 0.998 | 4.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C-reactive protein decreased | 0 | 0.001 | 0.012 | 0.998 | 3.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Induced labour | 0 | 0.002 | 0.073 | 0.998 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polymenorrhoea | 0 | 0.001 | 0 | 0.998 | 4.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychiatric evaluation abnormal | 0 | 0.001 | 0 | 0.998 | 4.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastication disorder | 0 | 0.01 | 0.42 | 0.998 | 1.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac failure chronic | 0 | 0.001 | 0.004 | 0.998 | 3.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary pain | 0 | 0.01 | 0.409 | 0.998 | 1.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C-reactive protein abnormal | 0 | 0.003 | 0.128 | 0.998 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileostomy | 0 | 0.001 | 0.001 | 0.998 | 4.228 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging thoracic normal | 0 | 0.003 | 0.11 | 0.998 | 2.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperaesthesia teeth | 0 | 0.001 | 0.018 | 0.998 | 3.384 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aluminium | 0 | 0.001 | 0.002 | 0.998 | 3.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthrogram | 0 | 0 | 0 | 0.998 | 4.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thinking abnormal | 0 | 0.012 | 0.462 | 0.998 | 1.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product packaging confusion | 0 | 0.001 | 0.009 | 0.998 | 3.61 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs test negative | 0 | 0.001 | 0.001 | 0.998 | 4.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound antenatal screen normal | 0 | 0.001 | 0.001 | 0.998 | 4.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukaemia | 0 | 0.004 | 0.156 | 0.998 | 2.442 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swallow study | 0 | 0.003 | 0.122 | 0.998 | 2.578 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panniculitis | 0 | 0.003 | 0.098 | 0.998 | 2.691 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral circulatory failure | 0 | 0 | 0 | 0.998 | 5.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival pain | 0 | 0.006 | 0.252 | 0.998 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan vagina | 0 | 0.002 | 0.068 | 0.998 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression suicidal | 0 | 0 | 0 | 0.998 | 5.011 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Excessive ocular convergence | 0 | 0 | 0 | 0.998 | 5.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular pain | 0 | 0.001 | 0.001 | 0.998 | 4.087 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinovirus infection | 0 | 0.003 | 0.084 | 0.998 | 2.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thalamic infarction | 0 | 0.001 | 0.009 | 0.998 | 3.59 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clinically isolated syndrome | 0 | 0 | 0 | 0.998 | 5.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renin normal | 0 | 0 | 0 | 0.998 | 5.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation factor V level decreased | 0 | 0 | 0 | 0.998 | 5.592 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphadenitis bacterial | 0 | 0.001 | 0 | 0.998 | 5.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood smear test normal | 0 | 0.004 | 0.133 | 0.998 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphangitis | 0 | 0.002 | 0.027 | 0.998 | 3.237 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha 1 foetoprotein normal | 0 | 0 | 0 | 0.998 | 5.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin lesion removal | 0 | 0.001 | 0.003 | 0.998 | 3.871 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitochondrial cytopathy | 0 | 0.001 | 0 | 0.998 | 4.385 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstruation delayed | 0 | 0.001 | 0.006 | 0.998 | 3.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swelling of eyelid | 0 | 0.024 | 0.597 | 0.998 | 1.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye irrigation | 0 | 0.002 | 0.038 | 0.998 | 3.113 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.002 | 0.062 | 0.998 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dissociation | 0 | 0.001 | 0.036 | 0.998 | 3.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal anastomosis | 0 | 0.001 | 0 | 0.998 | 4.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papilloedema | 0 | 0.004 | 0.227 | 0.998 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine pain | 0 | 0.001 | 0 | 0.998 | 4.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Umbilical hernia | 0 | 0.001 | 0 | 0.998 | 4.598 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF culture positive | 0 | 0.001 | 0 | 0.998 | 4.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site nerve damage | 0 | 0.003 | 0.157 | 0.998 | 2.439 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-lymphocyte count normal | 0 | 0.001 | 0.038 | 0.998 | 3.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic lymphocytic leukaemia | 0 | 0.001 | 0.001 | 0.998 | 4.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Insulin resistance | 0 | 0.001 | 0 | 0.998 | 4.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicocele | 0 | 0 | 0 | 0.998 | 5.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray gastrointestinal tract abnormal | 0 | 0.001 | 0 | 0.998 | 4.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion | 0 | 0 | 0 | 0.998 | 4.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine output decreased | 0 | 0.006 | 0.218 | 0.998 | 2.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryoglobulins absent | 0 | 0.001 | 0.018 | 0.998 | 3.387 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory rate | 0 | 0.008 | 0.313 | 0.998 | 1.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vesicoureteric reflux | 0 | 0.001 | 0 | 0.998 | 4.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carotid arteriosclerosis | 0 | 0.001 | 0.018 | 0.998 | 3.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagogastroduodenoscopy normal | 0 | 0.002 | 0.126 | 0.998 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin hypertrophy | 0 | 0.001 | 0.005 | 0.998 | 3.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site discharge | 0 | 0.001 | 0.005 | 0.998 | 3.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle contracture | 0 | 0.004 | 0.26 | 0.998 | 2.127 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric ulcer | 0 | 0.002 | 0.052 | 0.998 | 2.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-platelet antibody positive | 0 | 0.001 | 0 | 0.998 | 4.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin A increased | 0 | 0.002 | 0.06 | 0.998 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal reflex decreased | 0 | 0.007 | 0.257 | 0.998 | 2.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypocalcaemia | 0 | 0.004 | 0.202 | 0.998 | 2.289 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal weight gain | 0 | 0.001 | 0 | 0.998 | 4.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.001 | 0 | 0.998 | 4.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin turgor decreased | 0 | 0.001 | 0 | 0.998 | 4.42 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophagogastroduodenoscopy | 0 | 0.006 | 0.231 | 0.998 | 2.202 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipids normal | 0 | 0.004 | 0.176 | 0.998 | 2.37 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agonal rhythm | 0 | 0.001 | 0.005 | 0.998 | 3.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood folate | 0 | 0.004 | 0.186 | 0.998 | 2.338 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site haemorrhage | 0 | 0.001 | 0.003 | 0.998 | 3.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Distractibility | 0 | 0.001 | 0 | 0.998 | 4.305 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal oedema | 0 | 0.001 | 0.003 | 0.998 | 3.924 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood luteinising hormone increased | 0 | 0.001 | 0 | 0.998 | 4.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eating disorder | 0 | 0.009 | 0.421 | 0.998 | 1.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metal poisoning | 0 | 0.001 | 0.004 | 0.998 | 3.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time ratio | 0 | 0 | 0 | 0.998 | 4.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ammonia | 0 | 0.001 | 0 | 0.998 | 4.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amyotrophic lateral sclerosis | 0 | 0.001 | 0 | 0.998 | 4.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mass excision | 0 | 0.004 | 0.111 | 0.998 | 2.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine protein/creatinine ratio increased | 0 | 0.001 | 0 | 0.998 | 4.968 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound eye abnormal | 0 | 0.001 | 0 | 0.998 | 4.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc disorder | 0 | 0.004 | 0.208 | 0.998 | 2.27 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy site unspecified normal | 0 | 0 | 0 | 0.998 | 5.192 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella test negative | 0 | 0.001 | 0.007 | 0.998 | 3.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal operation | 0 | 0.002 | 0.013 | 0.998 | 3.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bed rest | 0 | 0.004 | 0.243 | 0.998 | 2.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug screen negative | 0 | 0.008 | 0.382 | 0.998 | 1.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Synovitis | 0 | 0.004 | 0.133 | 0.998 | 2.528 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound skull abnormal | 0 | 0.001 | 0 | 0.998 | 4.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suppressed lactation | 0 | 0.001 | 0.001 | 0.998 | 4.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rib fracture | 0 | 0.004 | 0.23 | 0.998 | 2.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic aneurysm rupture | 0 | 0.001 | 0.009 | 0.998 | 3.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urine absent | 0 | 0.005 | 0.29 | 0.998 | 2.05 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inguinal hernia | 0 | 0.003 | 0.15 | 0.998 | 2.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemiplegic migraine | 0 | 0.001 | 0.001 | 0.998 | 4.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulse abnormal | 0 | 0.017 | 0.471 | 0.998 | 1.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine leiomyoma | 0 | 0.001 | 0.001 | 0.998 | 4.275 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear site unspecified normal | 0 | 0.001 | 0.008 | 0.998 | 3.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingivitis | 0 | 0.003 | 0.119 | 0.998 | 2.592 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trichomoniasis | 0 | 0.001 | 0 | 0.998 | 4.331 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation test abnormal | 0 | 0.003 | 0.095 | 0.998 | 2.705 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Derealisation | 0 | 0.001 | 0.001 | 0.998 | 4.163 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal exudates | 0 | 0.003 | 0.109 | 0.998 | 2.638 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monoclonal gammopathy | 0 | 0.001 | 0 | 0.998 | 4.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram change | 0 | 0.004 | 0.227 | 0.998 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal disorder | 0 | 0 | 0 | 0.998 | 4.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glossodynia | 0 | 0.017 | 0.467 | 0.998 | 1.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Measles antibody | 0 | 0.001 | 0.002 | 0.998 | 3.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint range of motion measurement | 0 | 0.001 | 0.011 | 0.998 | 3.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microscopic polyangiitis | 0 | 0.001 | 0 | 0.998 | 4.511 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal resection | 0 | 0.001 | 0.004 | 0.998 | 3.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung neoplasm malignant | 0 | 0.004 | 0.218 | 0.998 | 2.241 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intellectual disability | 0 | 0.001 | 0.02 | 0.998 | 3.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coombs direct test positive | 0 | 0.001 | 0.002 | 0.998 | 3.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal perforation | 0 | 0.001 | 0.005 | 0.998 | 3.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal hypoxia | 0 | 0 | 0 | 0.998 | 4.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Romberg test positive | 0 | 0.002 | 0.039 | 0.998 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drooling | 0 | 0.019 | 0.548 | 0.998 | 1.558 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle contractions involuntary | 0 | 0.01 | 0.349 | 0.998 | 1.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal function test abnormal | 0 | 0.004 | 0.176 | 0.998 | 2.372 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic gastritis | 0 | 0.001 | 0 | 0.998 | 4.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apoptosis | 0 | 0 | 0 | 0.998 | 4.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocyte count | 0 | 0.006 | 0.253 | 0.998 | 2.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Croup infectious | 0 | 0.002 | 0.019 | 0.998 | 3.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza A virus test | 0 | 0.007 | 0.277 | 0.998 | 2.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colectomy | 0 | 0.001 | 0.001 | 0.998 | 4.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue mass | 0 | 0.001 | 0 | 0.998 | 4.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiphospholipid syndrome | 0 | 0.001 | 0 | 0.998 | 4.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immature granulocyte percentage increased | 0 | 0.005 | 0.24 | 0.998 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emotional disorder | 0 | 0.005 | 0.196 | 0.998 | 2.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Debridement | 0 | 0.002 | 0.05 | 0.998 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal haemorrhage | 0 | 0.002 | 0.081 | 0.998 | 2.782 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrophy | 0 | 0.004 | 0.142 | 0.998 | 2.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reticulocyte count increased | 0 | 0.003 | 0.106 | 0.998 | 2.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatosensory evoked potentials abnormal | 0 | 0.001 | 0.001 | 0.998 | 4.113 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation abnormal | 0 | 0.005 | 0.183 | 0.998 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoscopy normal | 0 | 0.003 | 0.127 | 0.998 | 2.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Globulins increased | 0 | 0.003 | 0.109 | 0.998 | 2.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time shortened | 0 | 0.003 | 0.089 | 0.998 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hiatus hernia | 0 | 0.004 | 0.138 | 0.998 | 2.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood uric acid normal | 0 | 0.005 | 0.18 | 0.998 | 2.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myosclerosis | 0 | 0.004 | 0.229 | 0.998 | 2.211 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral sensory neuropathy | 0 | 0.003 | 0.162 | 0.998 | 2.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperlipidaemia | 0 | 0.004 | 0.194 | 0.998 | 2.312 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic pain | 0 | 0.002 | 0.051 | 0.998 | 2.992 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal cyst | 0 | 0.005 | 0.205 | 0.998 | 2.278 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursa disorder | 0 | 0.002 | 0.065 | 0.998 | 2.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fine motor delay | 0 | 0.001 | 0 | 0.998 | 4.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polydipsia | 0 | 0.004 | 0.116 | 0.998 | 2.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vascular endothelial growth factor assay | 0 | 0 | 0 | 0.998 | 5.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis bacterial | 0 | 0.004 | 0.227 | 0.998 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryoglobulins present | 0 | 0.001 | 0 | 0.998 | 4.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest scan | 0 | 0.001 | 0.002 | 0.998 | 4.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amino acid level | 0 | 0.003 | 0.133 | 0.998 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borrelia test | 0 | 0.007 | 0.385 | 0.998 | 1.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cryotherapy | 0 | 0.001 | 0.002 | 0.998 | 4.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis acute | 0 | 0.002 | 0.028 | 0.998 | 3.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulvovaginal pruritus | 0 | 0.003 | 0.15 | 0.998 | 2.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital rash | 0 | 0.005 | 0.253 | 0.998 | 2.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired gastric emptying | 0 | 0.001 | 0.001 | 0.998 | 4.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood uric acid increased | 0 | 0.006 | 0.285 | 0.998 | 2.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal test negative | 0 | 0.006 | 0.268 | 0.998 | 2.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurogenic bladder | 0 | 0.001 | 0 | 0.998 | 4.528 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system vasculitis | 0 | 0.003 | 0.171 | 0.998 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fine motor skill dysfunction | 0 | 0.009 | 0.412 | 0.998 | 1.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hospice care | 0 | 0.005 | 0.216 | 0.998 | 2.244 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premalignant disorders, general conditions and other site specific disorders (SMQ) [broad] | 0 | 0 | 0 | 0.998 | 5.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smooth muscle antibody negative | 0 | 0.002 | 0.035 | 0.998 | 3.139 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb injury | 0 | 0.011 | 0.428 | 0.998 | 1.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholecystitis acute | 0 | 0.001 | 0.003 | 0.998 | 3.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin decreased | 0 | 0.004 | 0.17 | 0.998 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ectopic pregnancy | 0 | 0.001 | 0 | 0.998 | 4.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | FEV1/FVC ratio abnormal | 0 | 0 | 0 | 0.998 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus arrhythmia | 0 | 0.006 | 0.24 | 0.998 | 2.177 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QT interval | 0 | 0.001 | 0.002 | 0.998 | 4.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteoporosis/osteopenia (SMQ) [narrow] | 0 | 0.006 | 0.204 | 0.998 | 2.279 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital neurological disorder | 0 | 0 | 0 | 0.998 | 5.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatotoxicity | 0 | 0 | 0 | 0.998 | 4.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site joint swelling | 0 | 0.001 | 0 | 0.998 | 4.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningoencephalitis herpetic | 0 | 0.001 | 0.002 | 0.998 | 4.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal variceal ligation | 0 | 0 | 0 | 0.998 | 5.742 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reading disorder | 0 | 0.001 | 0.002 | 0.998 | 4.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatocellular carcinoma | 0 | 0 | 0 | 0.998 | 5.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occult blood negative | 0 | 0.002 | 0.052 | 0.998 | 2.979 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site discharge | 0 | 0.004 | 0.229 | 0.998 | 2.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Homeopathy | 0 | 0.001 | 0 | 0.998 | 4.58 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infusion | 0 | 0.001 | 0.008 | 0.998 | 3.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site nodule | 0 | 0.003 | 0.138 | 0.998 | 2.509 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory acidosis | 0 | 0.001 | 0.009 | 0.998 | 3.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Educational problem | 0 | 0 | 0 | 0.998 | 4.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malabsorption | 0 | 0.001 | 0.002 | 0.998 | 4.057 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enuresis | 0 | 0.001 | 0.022 | 0.998 | 3.318 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral discomfort | 0 | 0.016 | 0.477 | 0.998 | 1.673 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophilic dermatosis | 0 | 0 | 0 | 0.998 | 5.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortical dysplasia | 0 | 0 | 0 | 0.998 | 5.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood triglycerides increased | 0 | 0.003 | 0.186 | 0.998 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spirometry abnormal | 0 | 0 | 0 | 0.998 | 5.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cluster headache | 0 | 0.004 | 0.237 | 0.998 | 2.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysplasia | 0 | 0.001 | 0 | 0.998 | 4.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C antibody positive | 0 | 0.001 | 0 | 0.998 | 4.742 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal intussusception reduction | 0 | 0 | 0 | 0.998 | 4.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clumsiness | 0 | 0.003 | 0.12 | 0.998 | 2.587 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | N-terminal prohormone brain natriuretic peptide increased | 0 | 0.003 | 0.077 | 0.998 | 2.807 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Perfusion brain scan normal | 0 | 0.001 | 0.001 | 0.998 | 4.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Grunting | 0 | 0.008 | 0.302 | 0.998 | 2.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess decreased | 0 | 0.003 | 0.096 | 0.998 | 2.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faeces pale | 0 | 0.002 | 0.049 | 0.998 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antimicrobial susceptibility test | 0 | 0.001 | 0.004 | 0.998 | 3.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Social avoidant behaviour | 0 | 0.003 | 0.132 | 0.998 | 2.537 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-thyroid antibody positive | 0 | 0.001 | 0.004 | 0.998 | 3.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Walking disability | 0 | 0.002 | 0.015 | 0.998 | 3.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypovolaemic shock | 0 | 0.001 | 0 | 0.998 | 4.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral sepsis | 0 | 0 | 0 | 0.998 | 5.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prostate malignant tumours (SMQ) [broad] | 0 | 0.004 | 0.16 | 0.998 | 2.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | VIth nerve paralysis | 0 | 0.007 | 0.294 | 0.998 | 2.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antineutrophil cytoplasmic antibody | 0 | 0.005 | 0.209 | 0.998 | 2.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Schellong test | 0 | 0 | 0 | 0.998 | 5.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical examination | 0 | 0.005 | 0.227 | 0.998 | 2.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular neuronitis | 0 | 0.008 | 0.314 | 0.998 | 1.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelocyte present | 0 | 0 | 0 | 0.998 | 5.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasitic blood test negative | 0 | 0.001 | 0.004 | 0.998 | 3.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body temperature decreased | 0 | 0.012 | 0.467 | 0.998 | 1.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temporomandibular joint syndrome | 0 | 0.002 | 0.101 | 0.998 | 2.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute pulmonary oedema | 0 | 0.001 | 0.012 | 0.998 | 3.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystoscopy | 0 | 0.001 | 0.003 | 0.998 | 3.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute myeloid leukaemia | 0 | 0.008 | 0.296 | 0.998 | 2.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interleukin level increased | 0 | 0.001 | 0 | 0.998 | 4.464 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthmatic crisis | 0 | 0.001 | 0 | 0.998 | 4.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunophenotyping | 0 | 0.001 | 0.001 | 0.998 | 4.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin induration | 0 | 0.007 | 0.371 | 0.998 | 1.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pruritus | 1 | 1.038 | 0.469 | 0.997 | 1.685 | 0.355 | 0.864 | 1.832 | 0.964 | 0.944 | 0.191
COVID19_UNKNOWN MFR | Ear tube insertion | 0 | 0.006 | 0.204 | 0.997 | 2.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombectomy | 0 | 0.008 | 0.266 | 0.997 | 2.107 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal haematoma | 0 | 0 | 0 | 0.997 | 5.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery occlusion | 0 | 0.005 | 0.178 | 0.997 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheostomy | 0 | 0.001 | 0.001 | 0.997 | 4.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin D decreased | 0 | 0.003 | 0.061 | 0.997 | 2.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site infection | 0 | 0.007 | 0.239 | 0.997 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoaesthesia eye | 0 | 0.005 | 0.168 | 0.997 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammatory marker test | 0 | 0.007 | 0.221 | 0.997 | 2.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein urine absent | 0 | 0.007 | 0.175 | 0.997 | 2.37 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract infection viral | 0 | 0.001 | 0.002 | 0.997 | 3.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extraocular muscle paresis | 0 | 0.005 | 0.151 | 0.997 | 2.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver malignant tumours (SMQ) [broad] | 0 | 0.001 | 0 | 0.997 | 5.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-lymphocyte count decreased | 0 | 0.001 | 0 | 0.997 | 4.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tryptase | 0 | 0.012 | 0.32 | 0.997 | 1.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival swelling | 0 | 0.006 | 0.177 | 0.997 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriosclerosis coronary artery | 0 | 0.002 | 0.019 | 0.997 | 3.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombotic thrombocytopenic purpura | 0 | 0.002 | 0.027 | 0.997 | 3.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital anomaly | 0 | 0.001 | 0 | 0.997 | 4.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B core antigen | 0 | 0 | 0 | 0.997 | 5.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hunger | 0 | 0.003 | 0.066 | 0.997 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Azotaemia | 0 | 0.005 | 0.175 | 0.997 | 2.372 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery bypass | 0 | 0.004 | 0.078 | 0.997 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic inflammatory disease | 0 | 0 | 0 | 0.997 | 5.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenocarcinoma of the cervix | 0 | 0 | 0 | 0.997 | 5.297 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholecystitis | 0 | 0.004 | 0.128 | 0.997 | 2.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liquid product physical issue | 0 | 0.001 | 0 | 0.997 | 5.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Child maltreatment syndrome | 0 | 0 | 0 | 0.997 | 5.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemianaesthesia | 0 | 0.001 | 0 | 0.997 | 4.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-lymphocyte count | 0 | 0.001 | 0 | 0.997 | 4.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram carotid abnormal | 0 | 0.008 | 0.286 | 0.997 | 2.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombocytosis | 0 | 0.005 | 0.156 | 0.997 | 2.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pH increased | 0 | 0.006 | 0.182 | 0.997 | 2.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle swelling | 0 | 0.008 | 0.203 | 0.997 | 2.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral candidiasis | 0 | 0.007 | 0.163 | 0.997 | 2.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stevens-Johnson syndrome | 0 | 0.009 | 0.299 | 0.997 | 2.027 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematology test | 0 | 0.007 | 0.19 | 0.997 | 2.323 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac assistance device user | 0 | 0.002 | 0.012 | 0.997 | 3.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal disorder | 0 | 0.006 | 0.183 | 0.997 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic disorder | 0 | 0.002 | 0.003 | 0.997 | 3.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil count | 0 | 0.006 | 0.177 | 0.997 | 2.363 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Knee arthroplasty | 0 | 0.004 | 0.106 | 0.997 | 2.648 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site pustule | 0 | 0.004 | 0.09 | 0.997 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Imaging procedure abnormal | 0 | 0.005 | 0.119 | 0.997 | 2.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myasthenia gravis | 0 | 0.008 | 0.247 | 0.997 | 2.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiotherapy | 0 | 0.003 | 0.085 | 0.997 | 2.76 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture positive | 0 | 0.003 | 0.024 | 0.997 | 3.283 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iron deficiency anaemia | 0 | 0.003 | 0.044 | 0.997 | 3.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil count | 0 | 0.005 | 0.158 | 0.997 | 2.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asphyxia | 0 | 0.003 | 0.024 | 0.997 | 3.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital absence of bile ducts | 0 | 0 | 0 | 0.997 | 5.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Essential hypertension | 0 | 0.005 | 0.133 | 0.997 | 2.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure abnormal | 0 | 0.028 | 0.518 | 0.997 | 1.602 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy cervix | 0 | 0.001 | 0 | 0.997 | 5.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wound | 0 | 0.002 | 0.026 | 0.997 | 3.252 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculin test negative | 0 | 0.002 | 0.012 | 0.997 | 3.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein C | 0 | 0.003 | 0.069 | 0.997 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac telemetry | 0 | 0.004 | 0.091 | 0.997 | 2.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram pulmonary normal | 0 | 0.009 | 0.264 | 0.997 | 2.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasma cell myeloma | 0 | 0.001 | 0.003 | 0.997 | 3.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aggression | 0 | 0.009 | 0.283 | 0.997 | 2.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate abnormal | 0 | 0.01 | 0.275 | 0.997 | 2.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallstone related disorders (SMQ) [broad] | 0 | 0.009 | 0.309 | 0.997 | 2.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood count normal | 0 | 0.005 | 0.113 | 0.997 | 2.615 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Escherichia test positive | 0 | 0.005 | 0.118 | 0.997 | 2.594 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradycardia neonatal | 0 | 0 | 0 | 0.997 | 5.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microcephaly | 0 | 0.001 | 0 | 0.997 | 5.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess drainage | 0 | 0.003 | 0.077 | 0.997 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood magnesium decreased | 0 | 0.008 | 0.25 | 0.997 | 2.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF glucose increased | 0 | 0.003 | 0.065 | 0.997 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin urine | 0 | 0.008 | 0.236 | 0.997 | 2.186 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy | 0 | 0.002 | 0.017 | 0.997 | 3.405 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactic acidosis | 0 | 0.005 | 0.162 | 0.997 | 2.419 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory alkalosis | 0 | 0.001 | 0 | 0.997 | 5.192 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exfoliative rash | 0 | 0.009 | 0.31 | 0.997 | 2.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laser therapy | 0 | 0.001 | 0 | 0.997 | 4.733 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bicarbonate increased | 0 | 0.005 | 0.158 | 0.997 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone marrow | 0 | 0.004 | 0.148 | 0.997 | 2.471 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blepharospasm | 0 | 0.011 | 0.339 | 0.997 | 1.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipids | 0 | 0.018 | 0.418 | 0.997 | 1.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drainage | 0 | 0.002 | 0.007 | 0.997 | 3.667 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture urine positive | 0 | 0.007 | 0.203 | 0.997 | 2.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human rhinovirus test positive | 0 | 0.004 | 0.13 | 0.997 | 2.543 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site erythema | 0 | 0.001 | 0 | 0.997 | 5.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertonic bladder | 0 | 0.001 | 0 | 0.997 | 5.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aortic stenosis | 0 | 0.002 | 0.008 | 0.997 | 3.647 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis enteroviral | 0 | 0 | 0 | 0.997 | 5.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum ferritin normal | 0 | 0.008 | 0.233 | 0.997 | 2.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin decreased | 0 | 0.005 | 0.158 | 0.997 | 2.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroneurography | 0 | 0.001 | 0 | 0.997 | 4.853 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspiration pleural cavity | 0 | 0.005 | 0.127 | 0.997 | 2.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sarcoidosis | 0 | 0.003 | 0.051 | 0.997 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incontinence | 0 | 0.019 | 0.432 | 0.997 | 1.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin T | 0 | 0.002 | 0.035 | 0.997 | 3.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin increased | 0 | 0.008 | 0.222 | 0.997 | 2.223 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood phosphorus increased | 0 | 0.005 | 0.126 | 0.997 | 2.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basal cell carcinoma | 0 | 0.001 | 0 | 0.997 | 4.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersensitivity vasculitis | 0 | 0.004 | 0.062 | 0.997 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cortical visual impairment | 0 | 0 | 0 | 0.997 | 5.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatocellular injury | 0 | 0.001 | 0 | 0.997 | 4.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Left ventricular dysfunction | 0 | 0.006 | 0.165 | 0.997 | 2.407 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF culture | 0 | 0.004 | 0.078 | 0.997 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver malignant tumours (SMQ) [narrow] | 0 | 0.001 | 0 | 0.997 | 5.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time normal | 0 | 0.012 | 0.322 | 0.997 | 1.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Recalled product administered | 0 | 0 | 0 | 0.997 | 5.317 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram abdomen normal | 0 | 0.01 | 0.296 | 0.997 | 2.034 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiopathy | 0 | 0.002 | 0.008 | 0.997 | 3.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nonspecific reaction | 0 | 0.002 | 0.041 | 0.997 | 3.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tension | 0 | 0.008 | 0.223 | 0.997 | 2.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumothorax | 0 | 0.006 | 0.169 | 0.997 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heat oedema | 0 | 0.001 | 0 | 0.997 | 5.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocyte percentage | 0 | 0.008 | 0.263 | 0.997 | 2.115 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip pruritus | 0 | 0.011 | 0.29 | 0.997 | 2.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil count normal | 0 | 0.009 | 0.253 | 0.997 | 2.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apnoeic attack | 0 | 0.003 | 0.061 | 0.997 | 2.909 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-ganglioside antibody positive | 0 | 0.001 | 0 | 0.997 | 5.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell count increased | 0 | 0.008 | 0.197 | 0.997 | 2.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antinuclear antibody | 0 | 0.014 | 0.335 | 0.997 | 1.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphoedema | 0 | 0.01 | 0.325 | 0.997 | 1.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hormone level abnormal | 0 | 0.001 | 0 | 0.997 | 4.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunisation | 0 | 0.003 | 0.072 | 0.997 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cheilitis | 0 | 0.008 | 0.273 | 0.997 | 2.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin concentration increased | 0 | 0.001 | 0 | 0.997 | 5.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuse and dependence (SMQ) [narrow] | 0 | 0.001 | 0 | 0.997 | 4.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic function abnormal | 0 | 0.002 | 0.011 | 0.997 | 3.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal pain | 0 | 0.015 | 0.39 | 0.997 | 1.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site discolouration | 0 | 0.003 | 0.035 | 0.997 | 3.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary sediment present | 0 | 0.007 | 0.178 | 0.997 | 2.359 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stiff person syndrome | 0 | 0.001 | 0 | 0.997 | 4.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant lymphomas (SMQ) [narrow] | 0 | 0.006 | 0.145 | 0.997 | 2.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acoustic stimulation tests | 0 | 0.009 | 0.258 | 0.997 | 2.128 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myositis | 0 | 0.009 | 0.277 | 0.997 | 2.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose urine absent | 0 | 0.007 | 0.178 | 0.997 | 2.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired quality of life | 0 | 0.002 | 0.004 | 0.997 | 3.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-NMDA antibody positive | 0 | 0.001 | 0 | 0.997 | 4.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eructation | 0 | 0.012 | 0.317 | 0.997 | 1.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip pain | 0 | 0.005 | 0.134 | 0.997 | 2.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual evoked potentials normal | 0 | 0.001 | 0 | 0.997 | 4.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Macrophage count | 0 | 0 | 0 | 0.997 | 5.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobinuria | 0 | 0 | 0 | 0.997 | 5.294 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfective encephalitis | 0 | 0.007 | 0.239 | 0.997 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetic ketoacidosis | 0 | 0.012 | 0.351 | 0.997 | 1.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suspected COVID-19 | 0 | 0.003 | 0.054 | 0.997 | 2.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple sclerosis relapse | 0 | 0.003 | 0.06 | 0.997 | 2.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Increased bronchial secretion | 0 | 0.003 | 0.063 | 0.997 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertigo positional | 0 | 0.008 | 0.271 | 0.997 | 2.095 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Natural killer cell count | 0 | 0.001 | 0.001 | 0.997 | 4.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Creatinine urine | 0 | 0 | 0 | 0.997 | 5.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubella antibody positive | 0 | 0.001 | 0 | 0.997 | 4.9 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue swelling | 0 | 0.006 | 0.146 | 0.997 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obsessive-compulsive disorder | 0 | 0.005 | 0.163 | 0.997 | 2.414 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage subcutaneous | 0 | 0.002 | 0.005 | 0.997 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mouth haemorrhage | 0 | 0.011 | 0.328 | 0.997 | 1.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total lung capacity decreased | 0 | 0.001 | 0.002 | 0.997 | 4.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell count increased | 0 | 0.004 | 0.058 | 0.997 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Photopsia | 0 | 0.007 | 0.243 | 0.997 | 2.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyuria | 0 | 0.006 | 0.205 | 0.997 | 2.276 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract congestion | 0 | 0.004 | 0.078 | 0.997 | 2.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal tear | 0 | 0.003 | 0.061 | 0.997 | 2.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea nitrogen/creatinine ratio | 0 | 0.008 | 0.276 | 0.997 | 2.084 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brachial plexus injury | 0 | 0.001 | 0 | 0.997 | 4.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extraocular muscle disorder | 0 | 0.001 | 0 | 0.997 | 5.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Miller Fisher syndrome | 0 | 0.002 | 0.03 | 0.997 | 3.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dengue fever | 0 | 0 | 0 | 0.997 | 5.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug reaction with eosinophilia and systemic symptoms syndrome (SMQ) [narrow] | 0 | 0.003 | 0.094 | 0.997 | 2.71 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced expiratory volume | 0 | 0.001 | 0 | 0.997 | 4.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vogt-Koyanagi-Harada disease | 0 | 0 | 0 | 0.997 | 5.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glucose-6-phosphate dehydrogenase normal | 0 | 0 | 0 | 0.997 | 5.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epinephrine | 0 | 0.01 | 0.277 | 0.997 | 2.078 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin A | 0 | 0.005 | 0.117 | 0.997 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallstone related disorders (SMQ) [narrow] | 0 | 0.009 | 0.309 | 0.997 | 2.005 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oligohydramnios | 0 | 0 | 0 | 0.997 | 5.258 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Posturing | 0 | 0.005 | 0.113 | 0.997 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised oedema | 0 | 0.005 | 0.172 | 0.997 | 2.385 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactate dehydrogenase | 0 | 0.01 | 0.332 | 0.997 | 1.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site scar | 0 | 0.001 | 0 | 0.997 | 4.676 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infertility | 0 | 0.001 | 0 | 0.997 | 5.009 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tympanic membrane hyperaemia | 0 | 0.002 | 0.029 | 0.997 | 3.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal stenosis | 0 | 0.006 | 0.215 | 0.997 | 2.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | COVID-19 immunisation | 0 | 0.001 | 0.001 | 0.997 | 4.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microscopy | 0 | 0.007 | 0.23 | 0.997 | 2.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac flutter | 0 | 0.01 | 0.269 | 0.997 | 2.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma stage 0 | 0 | 0 | 0 | 0.997 | 5.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillitis bacterial | 0 | 0.001 | 0 | 0.997 | 4.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tandem gait test abnormal | 0 | 0.001 | 0 | 0.997 | 4.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ulcerative keratitis | 0 | 0.001 | 0 | 0.997 | 5.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac massage | 0 | 0.001 | 0 | 0.997 | 4.962 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Astrovirus test positive | 0 | 0 | 0 | 0.997 | 5.421 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia viral | 0 | 0.013 | 0.345 | 0.997 | 1.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Akathisia (SMQ) [narrow] | 0 | 0.001 | 0 | 0.997 | 5.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperkinesia | 0 | 0.001 | 0 | 0.997 | 5.245 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital herpes | 0 | 0.004 | 0.09 | 0.997 | 2.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute coronary syndrome | 0 | 0.006 | 0.131 | 0.997 | 2.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sedation | 0 | 0.019 | 0.412 | 0.997 | 1.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erectile dysfunction | 0 | 0.003 | 0.031 | 0.997 | 3.186 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular discomfort | 0 | 0.021 | 0.442 | 0.997 | 1.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hallucination, auditory | 0 | 0.004 | 0.073 | 0.997 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood count | 0 | 0.003 | 0.059 | 0.997 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal X-ray abnormal | 0 | 0.005 | 0.127 | 0.997 | 2.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Double stranded DNA antibody positive | 0 | 0.001 | 0 | 0.997 | 4.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin A decreased | 0 | 0.002 | 0.014 | 0.997 | 3.469 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor decreased | 0 | 0.001 | 0 | 0.997 | 5.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileus | 0 | 0.002 | 0.009 | 0.997 | 3.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temperature intolerance | 0 | 0.005 | 0.115 | 0.997 | 2.606 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product substitution | 0 | 0.001 | 0.001 | 0.997 | 4.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brudzinski's sign | 0 | 0.001 | 0 | 0.997 | 4.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bowel movement irregularity | 0 | 0.006 | 0.186 | 0.997 | 2.335 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast swelling | 0 | 0.006 | 0.161 | 0.997 | 2.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site necrosis | 0 | 0.002 | 0.033 | 0.997 | 3.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central pain syndrome | 0 | 0 | 0 | 0.997 | 5.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelids pruritus | 0 | 0.007 | 0.243 | 0.997 | 2.167 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperreflexia | 0 | 0.003 | 0.086 | 0.997 | 2.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coma | 0 | 0.009 | 0.25 | 0.997 | 2.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head titubation | 0 | 0.009 | 0.308 | 0.997 | 2.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulocytopenia | 0 | 0.003 | 0.058 | 0.997 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Phrenic nerve paralysis | 0 | 0 | 0 | 0.997 | 5.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cat scratch disease | 0 | 0 | 0 | 0.997 | 5.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine haemorrhage | 0 | 0.003 | 0.036 | 0.997 | 3.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purulent discharge | 0 | 0.006 | 0.137 | 0.997 | 2.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcium increased | 0 | 0.004 | 0.12 | 0.997 | 2.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness transitory | 0 | 0.004 | 0.107 | 0.997 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immobile | 0 | 0.006 | 0.225 | 0.997 | 2.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | ACTH stimulation test abnormal | 0 | 0 | 0 | 0.997 | 5.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chlamydial infection | 0 | 0.001 | 0 | 0.997 | 5.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oculogyric crisis | 0 | 0.002 | 0.007 | 0.997 | 3.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory depression | 0 | 0.012 | 0.356 | 0.997 | 1.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve conduction studies normal | 0 | 0.004 | 0.067 | 0.997 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage intracranial | 0 | 0.005 | 0.095 | 0.997 | 2.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cast application | 0 | 0.002 | 0.03 | 0.997 | 3.202 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelopathy | 0 | 0.003 | 0.071 | 0.997 | 2.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis exfoliative generalised | 0 | 0.005 | 0.139 | 0.997 | 2.505 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraesthesia ear | 0 | 0.001 | 0.002 | 0.997 | 4.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic stroke | 0 | 0.002 | 0.005 | 0.997 | 3.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray limb abnormal | 0 | 0.01 | 0.284 | 0.997 | 2.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depressive symptom | 0 | 0 | 0 | 0.997 | 5.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sapovirus test positive | 0 | 0 | 0 | 0.997 | 5.725 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human metapneumovirus test | 0 | 0.004 | 0.091 | 0.997 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin globulin ratio | 0 | 0.004 | 0.057 | 0.997 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychogenic seizure | 0 | 0.001 | 0 | 0.997 | 5.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flavivirus test negative | 0 | 0.001 | 0 | 0.997 | 4.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid disorder | 0 | 0.003 | 0.05 | 0.997 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney transplant rejection | 0 | 0.001 | 0 | 0.997 | 4.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shock symptom | 0 | 0.004 | 0.128 | 0.997 | 2.55 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue movement disturbance | 0 | 0.004 | 0.097 | 0.997 | 2.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single umbilical artery | 0 | 0.001 | 0 | 0.997 | 5.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenal insufficiency | 0 | 0.003 | 0.047 | 0.997 | 3.017 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal disorder | 0 | 0.002 | 0.022 | 0.997 | 3.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytopenia | 0 | 0.003 | 0.038 | 0.997 | 3.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis brain stem | 0 | 0 | 0 | 0.997 | 5.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF test | 0 | 0.004 | 0.072 | 0.997 | 2.837 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin reaction | 0 | 0.026 | 0.479 | 0.997 | 1.667 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST segment depression | 0 | 0.004 | 0.125 | 0.997 | 2.561 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver transplant | 0 | 0.001 | 0 | 0.997 | 4.591 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis E antibody negative | 0 | 0.001 | 0 | 0.997 | 4.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Differential white blood cell count abnormal | 0 | 0.005 | 0.147 | 0.997 | 2.471 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin plaque | 0 | 0.008 | 0.235 | 0.997 | 2.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus bradycardia | 0 | 0.002 | 0.016 | 0.997 | 3.416 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lyme disease | 0 | 0.002 | 0.018 | 0.997 | 3.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipase increased | 0 | 0.009 | 0.291 | 0.997 | 2.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray limb normal | 0 | 0.013 | 0.332 | 0.997 | 1.95 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine increased | 0 | 0.005 | 0.168 | 0.997 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via breast milk | 0 | 0.003 | 0.075 | 0.997 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningism | 0 | 0.003 | 0.034 | 0.997 | 3.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF oligoclonal band absent | 0 | 0.003 | 0.052 | 0.997 | 2.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panic disorder | 0 | 0.004 | 0.083 | 0.997 | 2.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occult blood | 0 | 0.005 | 0.124 | 0.997 | 2.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product reconstitution quality issue | 0 | 0.001 | 0 | 0.997 | 4.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basal ganglia stroke | 0 | 0.003 | 0.027 | 0.997 | 3.235 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone erosion | 0 | 0.001 | 0 | 0.997 | 4.622 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep study | 0 | 0.006 | 0.144 | 0.997 | 2.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arnold-Chiari malformation | 0 | 0.001 | 0 | 0.997 | 4.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle oedema | 0 | 0.002 | 0.013 | 0.997 | 3.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral venous sinus thrombosis | 0 | 0.002 | 0.015 | 0.997 | 3.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep talking | 0 | 0.003 | 0.08 | 0.997 | 2.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cataplexy | 0 | 0.001 | 0 | 0.997 | 5.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post vaccination syndrome | 0 | 0.001 | 0 | 0.997 | 4.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hernia | 0 | 0.003 | 0.063 | 0.997 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactic acid decreased | 0 | 0.002 | 0.021 | 0.997 | 3.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess increased | 0 | 0.004 | 0.082 | 0.997 | 2.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Double stranded DNA antibody | 0 | 0.002 | 0.012 | 0.997 | 3.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonic convulsion | 0 | 0.004 | 0.092 | 0.997 | 2.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial asymmetry | 0 | 0.008 | 0.241 | 0.997 | 2.173 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocytes | 0 | 0.001 | 0 | 0.997 | 4.606 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | International normalised ratio decreased | 0 | 0.004 | 0.099 | 0.997 | 2.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complex regional pain syndrome | 0 | 0.001 | 0.001 | 0.997 | 4.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paroxysmal nocturnal haemoglobinuria | 0 | 0.003 | 0.08 | 0.997 | 2.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Expanded disability status scale score increased | 0 | 0 | 0 | 0.997 | 5.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ileectomy | 0 | 0.001 | 0 | 0.997 | 5.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kernig's sign | 0 | 0.001 | 0 | 0.997 | 4.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stereotypy | 0 | 0.003 | 0.058 | 0.997 | 2.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granuloma | 0 | 0.001 | 0 | 0.997 | 4.565 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema mouth | 0 | 0.002 | 0.046 | 0.997 | 3.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stool analysis normal | 0 | 0.003 | 0.064 | 0.997 | 2.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram cerebral abnormal | 0 | 0.009 | 0.315 | 0.997 | 1.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thyroid stimulating hormone decreased | 0 | 0.007 | 0.203 | 0.997 | 2.283 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint injection | 0 | 0.003 | 0.049 | 0.997 | 3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle disorder | 0 | 0.007 | 0.181 | 0.997 | 2.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atonic seizures | 0 | 0.001 | 0 | 0.997 | 4.779 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil percentage decreased | 0 | 0.004 | 0.129 | 0.997 | 2.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bicarbonate decreased | 0 | 0.009 | 0.284 | 0.997 | 2.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otorrhoea | 0 | 0.005 | 0.108 | 0.997 | 2.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Internal haemorrhage | 0 | 0.004 | 0.063 | 0.997 | 2.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Akathisia | 0 | 0.001 | 0 | 0.997 | 5.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.001 | 0 | 0.997 | 5.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral upper respiratory tract infection | 0 | 0.003 | 0.077 | 0.997 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum ferritin | 0 | 0.007 | 0.194 | 0.997 | 2.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yellow skin | 0 | 0.008 | 0.263 | 0.997 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle tone disorder | 0 | 0.001 | 0 | 0.997 | 4.576 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epileptic encephalopathy | 0 | 0.001 | 0 | 0.997 | 5.166 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheterisation cardiac abnormal | 0 | 0.009 | 0.26 | 0.997 | 2.122 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin E increased | 0 | 0.003 | 0.036 | 0.997 | 3.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocytes increased | 0 | 0.001 | 0 | 0.997 | 4.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiphospholipid antibodies | 0 | 0.005 | 0.127 | 0.997 | 2.553 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal injury | 0 | 0.002 | 0.01 | 0.997 | 3.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [narrow] | 0 | 0.001 | 0 | 0.997 | 4.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral ischaemia | 0 | 0.001 | 0 | 0.997 | 4.537 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic encephalopathy | 0 | 0.006 | 0.214 | 0.997 | 2.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation test | 0 | 0.009 | 0.291 | 0.997 | 2.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperaemia | 0 | 0.003 | 0.066 | 0.997 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PO2 increased | 0 | 0.004 | 0.078 | 0.997 | 2.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous floaters | 0 | 0.01 | 0.329 | 0.997 | 1.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epidermal necrosis | 0 | 0.004 | 0.086 | 0.997 | 2.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Soft tissue inflammation | 0 | 0.003 | 0.047 | 0.997 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound joint | 0 | 0.004 | 0.103 | 0.997 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling of despair | 0 | 0.003 | 0.055 | 0.997 | 2.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug reaction with eosinophilia and systemic symptoms | 0 | 0.003 | 0.047 | 0.997 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycosylated haemoglobin | 0 | 0.017 | 0.413 | 0.997 | 1.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site streaking | 0 | 0.008 | 0.204 | 0.997 | 2.276 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrolyte imbalance | 0 | 0.001 | 0 | 0.997 | 4.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Empyema | 0 | 0 | 0 | 0.997 | 5.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intelligence test abnormal | 0 | 0.001 | 0 | 0.997 | 5.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mass | 0 | 0.019 | 0.479 | 0.997 | 1.668 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis viral | 0 | 0.005 | 0.144 | 0.997 | 2.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain injury | 0 | 0.011 | 0.297 | 0.997 | 2.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram normal | 0 | 0.007 | 0.267 | 0.997 | 2.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type IV hypersensitivity reaction | 0 | 0.009 | 0.232 | 0.997 | 2.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin T increased | 0 | 0.001 | 0.002 | 0.997 | 4.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary hypertension | 0 | 0.006 | 0.138 | 0.997 | 2.505 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram retina | 0 | 0.005 | 0.106 | 0.997 | 2.648 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain operation | 0 | 0.003 | 0.034 | 0.997 | 3.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Granulomatous dermatitis | 0 | 0 | 0 | 0.997 | 5.544 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholelithiasis | 0 | 0.01 | 0.329 | 0.997 | 1.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orchitis | 0 | 0 | 0 | 0.997 | 5.489 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corynebacterium test positive | 0 | 0.001 | 0 | 0.997 | 4.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hair growth abnormal | 0 | 0.001 | 0 | 0.997 | 4.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemianopia | 0 | 0.001 | 0 | 0.997 | 4.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood magnesium normal | 0 | 0.021 | 0.471 | 0.997 | 1.682 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery aneurysm | 0 | 0.001 | 0 | 0.997 | 4.705 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Norovirus test | 0 | 0.001 | 0 | 0.997 | 5.275 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin ulcer | 0 | 0.009 | 0.296 | 0.997 | 2.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral test positive | 0 | 0.006 | 0.224 | 0.997 | 2.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paresis | 0 | 0.002 | 0.003 | 0.997 | 3.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngitis streptococcal | 0 | 0.008 | 0.213 | 0.997 | 2.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Micturition urgency | 0 | 0.006 | 0.174 | 0.997 | 2.374 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug eruption | 0 | 0.003 | 0.068 | 0.997 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kidney infection | 0 | 0.003 | 0.044 | 0.997 | 3.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast mass | 0 | 0.002 | 0.015 | 0.997 | 3.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foaming at mouth | 0 | 0.014 | 0.354 | 0.997 | 1.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin haemorrhage | 0 | 0.008 | 0.221 | 0.997 | 2.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal hypermotility | 0 | 0.001 | 0 | 0.997 | 5.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubella antibody test | 0 | 0.001 | 0 | 0.997 | 4.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus test | 0 | 0.007 | 0.209 | 0.997 | 2.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin I | 0 | 0.007 | 0.249 | 0.997 | 2.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood fibrinogen increased | 0 | 0.002 | 0.006 | 0.997 | 3.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye haemorrhage | 0 | 0.015 | 0.372 | 0.997 | 1.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid function disorder | 0 | 0.02 | 0.433 | 0.997 | 1.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low density lipoprotein increased | 0 | 0.004 | 0.085 | 0.997 | 2.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis salmonella | 0 | 0.001 | 0 | 0.997 | 5.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cataract nuclear | 0 | 0.001 | 0 | 0.997 | 5.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Face oedema | 0 | 0.009 | 0.238 | 0.997 | 2.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | School refusal | 0 | 0 | 0 | 0.997 | 5.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulins normal | 0 | 0.003 | 0.064 | 0.997 | 2.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation normal | 0 | 0.008 | 0.216 | 0.997 | 2.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autonomic neuropathy | 0 | 0.001 | 0 | 0.997 | 5.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glaucoma | 0 | 0.003 | 0.081 | 0.997 | 2.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive emergency | 0 | 0.002 | 0.008 | 0.997 | 3.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parkinson's disease | 0 | 0.005 | 0.156 | 0.997 | 2.442 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthritis reactive | 0 | 0.005 | 0.123 | 0.997 | 2.569 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mumps antibody test | 0 | 0.001 | 0 | 0.997 | 5.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac pacemaker insertion | 0 | 0.008 | 0.27 | 0.997 | 2.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Partial seizures | 0 | 0.008 | 0.275 | 0.997 | 2.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Full blood count abnormal | 0 | 0.015 | 0.371 | 0.997 | 1.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis protein normal | 0 | 0.002 | 0.011 | 0.997 | 3.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal disorder | 0 | 0.001 | 0 | 0.996 | 4.513 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood potassium | 0 | 0.012 | 0.245 | 0.996 | 2.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Frequent bowel movements | 0 | 0.006 | 0.097 | 0.996 | 2.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertensive urgency | 0 | 0.002 | 0.002 | 0.996 | 4.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panic reaction | 0 | 0.012 | 0.269 | 0.996 | 2.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicidal ideation | 0 | 0.005 | 0.091 | 0.996 | 2.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mouth ulceration | 0 | 0.008 | 0.188 | 0.996 | 2.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thyroid stimulating hormone | 0 | 0.031 | 0.478 | 0.996 | 1.666 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flank pain | 0 | 0.037 | 0.519 | 0.996 | 1.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal tenderness | 0 | 0.01 | 0.213 | 0.996 | 2.248 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysmetria | 0 | 0.001 | 0 | 0.996 | 5.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paranasal sinus discomfort | 0 | 0.012 | 0.293 | 0.996 | 2.04 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal loss of weight | 0 | 0.002 | 0.01 | 0.996 | 3.573 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac telemetry normal | 0 | 0.002 | 0.006 | 0.996 | 3.712 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antibody positive | 0 | 0.001 | 0 | 0.996 | 5.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejection fraction | 0 | 0.002 | 0.004 | 0.996 | 3.8 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar puncture abnormal | 0 | 0.012 | 0.254 | 0.996 | 2.134 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendicitis perforated | 0 | 0.003 | 0.031 | 0.996 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet count | 0 | 0.017 | 0.378 | 0.996 | 1.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood cholesterol increased | 0 | 0.007 | 0.183 | 0.996 | 2.344 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea | 0 | 0.005 | 0.096 | 0.996 | 2.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin irritation | 0 | 0.012 | 0.249 | 0.996 | 2.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral load increased | 0 | 0.001 | 0 | 0.996 | 5.274 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngotonsillitis | 0 | 0.001 | 0 | 0.996 | 4.565 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD4 lymphocytes decreased | 0 | 0.002 | 0.008 | 0.996 | 3.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site irritation | 0 | 0.002 | 0.012 | 0.996 | 3.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psoriasis | 0 | 0.008 | 0.158 | 0.996 | 2.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypercalcaemia | 0 | 0.003 | 0.031 | 0.996 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anion gap increased | 0 | 0.003 | 0.047 | 0.996 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Failure to thrive | 0 | 0.004 | 0.075 | 0.996 | 2.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupillary reflex impaired | 0 | 0.007 | 0.145 | 0.996 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colonoscopy abnormal | 0 | 0.005 | 0.076 | 0.996 | 2.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secretion discharge | 0 | 0.015 | 0.32 | 0.996 | 1.976 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site scab | 0 | 0.006 | 0.103 | 0.996 | 2.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Severe myoclonic epilepsy of infancy | 0 | 0.001 | 0 | 0.996 | 5.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyhydramnios | 0 | 0.001 | 0 | 0.996 | 5.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Groin pain | 0 | 0.009 | 0.227 | 0.996 | 2.208 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil count increased | 0 | 0.004 | 0.042 | 0.996 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocytic infiltration | 0 | 0.004 | 0.037 | 0.996 | 3.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular disorder | 0 | 0.003 | 0.022 | 0.996 | 3.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy lung abnormal | 0 | 0.001 | 0 | 0.996 | 4.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF neutrophil count negative | 0 | 0.001 | 0 | 0.996 | 5.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte count decreased | 0 | 0.008 | 0.167 | 0.996 | 2.395 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatomegaly | 0 | 0.003 | 0.017 | 0.996 | 3.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus pain | 0 | 0.006 | 0.099 | 0.996 | 2.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyarthritis | 0 | 0.005 | 0.072 | 0.996 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to communicable disease | 0 | 0.005 | 0.084 | 0.996 | 2.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vocal cord paralysis | 0 | 0.008 | 0.183 | 0.996 | 2.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture | 0 | 0.011 | 0.255 | 0.996 | 2.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pH normal | 0 | 0.005 | 0.08 | 0.996 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood electrolytes | 0 | 0.012 | 0.253 | 0.996 | 2.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammatory bowel disease | 0 | 0.001 | 0 | 0.996 | 4.641 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF white blood cell count negative | 0 | 0.006 | 0.128 | 0.996 | 2.549 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary mass | 0 | 0.006 | 0.113 | 0.996 | 2.61 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver injury | 0 | 0.009 | 0.224 | 0.996 | 2.218 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell count | 0 | 0.003 | 0.017 | 0.996 | 3.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematocrit | 0 | 0.006 | 0.113 | 0.996 | 2.611 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anal incontinence | 0 | 0.013 | 0.264 | 0.996 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Application site pain | 0 | 0.002 | 0.005 | 0.996 | 3.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial ischaemia | 0 | 0.005 | 0.077 | 0.996 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medical induction of coma | 0 | 0.006 | 0.131 | 0.996 | 2.534 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food intolerance | 0 | 0.004 | 0.069 | 0.996 | 2.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiculopathy | 0 | 0.006 | 0.135 | 0.996 | 2.516 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint effusion | 0 | 0.009 | 0.223 | 0.996 | 2.221 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mumps antibody test positive | 0 | 0.001 | 0 | 0.996 | 5.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hospitalisation | 0 | 0.007 | 0.118 | 0.996 | 2.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic diathesis | 0 | 0.001 | 0 | 0.996 | 5.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden cardiac death | 0 | 0.003 | 0.019 | 0.996 | 3.354 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site hypertrichosis | 0 | 0 | 0 | 0.996 | 5.772 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendonitis | 0 | 0.005 | 0.087 | 0.996 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Imaging procedure | 0 | 0.013 | 0.314 | 0.996 | 1.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac murmur | 0 | 0.008 | 0.188 | 0.996 | 2.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transplant rejection | 0 | 0.001 | 0 | 0.996 | 5.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcus test | 0 | 0.012 | 0.285 | 0.996 | 2.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip erythema | 0 | 0.005 | 0.106 | 0.996 | 2.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin G decreased | 0 | 0.003 | 0.04 | 0.996 | 3.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gamma-glutamyltransferase increased | 0 | 0.003 | 0.023 | 0.996 | 3.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling jittery | 0 | 0.023 | 0.404 | 0.996 | 1.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mitral valve incompetence | 0 | 0.007 | 0.118 | 0.996 | 2.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monoparesis | 0 | 0.002 | 0.001 | 0.996 | 4.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle strain | 0 | 0.016 | 0.358 | 0.996 | 1.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF pressure normal | 0 | 0.001 | 0 | 0.996 | 5.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endocrine test | 0 | 0.001 | 0 | 0.996 | 5.507 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram QT prolonged | 0 | 0.007 | 0.168 | 0.996 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial septal defect | 0 | 0.004 | 0.054 | 0.996 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Genital haemorrhage | 0 | 0.001 | 0 | 0.996 | 5.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site abscess | 0 | 0.007 | 0.144 | 0.996 | 2.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy | 0 | 0.01 | 0.239 | 0.996 | 2.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral artery occlusion | 0 | 0.002 | 0.005 | 0.996 | 3.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular hypokinesia | 0 | 0.005 | 0.076 | 0.996 | 2.803 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tilt table test positive | 0 | 0.001 | 0 | 0.996 | 5.297 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood count abnormal | 0 | 0.01 | 0.238 | 0.996 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactoid reaction | 0 | 0.007 | 0.172 | 0.996 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid function test normal | 0 | 0.005 | 0.056 | 0.996 | 2.942 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood smear test | 0 | 0.007 | 0.135 | 0.996 | 2.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging neck | 0 | 0.017 | 0.333 | 0.996 | 1.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site paraesthesia | 0 | 0.032 | 0.467 | 0.996 | 1.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subglottic laryngitis | 0 | 0.001 | 0 | 0.996 | 5.414 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal impairment | 0 | 0.008 | 0.204 | 0.996 | 2.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactate dehydrogenase normal | 0 | 0.006 | 0.12 | 0.996 | 2.581 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site abscess | 0 | 0.003 | 0.015 | 0.996 | 3.446 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Differential white blood cell count normal | 0 | 0.019 | 0.396 | 0.996 | 1.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Continuous positive airway pressure | 0 | 0.005 | 0.077 | 0.996 | 2.8 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pathology test | 0 | 0.009 | 0.2 | 0.996 | 2.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatic disorder | 0 | 0.006 | 0.099 | 0.996 | 2.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumatosis intestinalis | 0 | 0.001 | 0 | 0.996 | 5.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain stem syndrome | 0 | 0.006 | 0.098 | 0.996 | 2.682 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicide attempt | 0 | 0.001 | 0 | 0.996 | 4.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood iron decreased | 0 | 0.005 | 0.067 | 0.996 | 2.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte percentage increased | 0 | 0.008 | 0.167 | 0.996 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic kidney disease | 0 | 0.005 | 0.07 | 0.996 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial drainage | 0 | 0.003 | 0.015 | 0.996 | 3.44 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central venous catheterisation | 0 | 0.01 | 0.267 | 0.996 | 2.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site bruising | 0 | 0.009 | 0.214 | 0.996 | 2.248 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary infarction | 0 | 0.002 | 0.003 | 0.996 | 3.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph node palpable | 0 | 0.005 | 0.089 | 0.996 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disseminated varicella zoster virus infection | 0 | 0.002 | 0.001 | 0.996 | 4.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mood swings | 0 | 0.003 | 0.016 | 0.996 | 3.409 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Odynophagia | 0 | 0.011 | 0.244 | 0.996 | 2.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis meningococcal | 0 | 0.001 | 0 | 0.996 | 5.257 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Keratitis | 0 | 0.003 | 0.013 | 0.996 | 3.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Craniocerebral injury | 0 | 0.003 | 0.031 | 0.996 | 3.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex encephalitis | 0 | 0.006 | 0.139 | 0.996 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aphthous ulcer | 0 | 0.006 | 0.121 | 0.996 | 2.579 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperthyroidism | 0 | 0.005 | 0.087 | 0.996 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Raynaud's phenomenon | 0 | 0.002 | 0.009 | 0.996 | 3.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte percentage | 0 | 0.011 | 0.254 | 0.996 | 2.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep attacks | 0 | 0.001 | 0 | 0.996 | 4.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body temperature fluctuation | 0 | 0.003 | 0.041 | 0.996 | 3.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Madarosis | 0 | 0.004 | 0.041 | 0.996 | 3.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear swelling | 0 | 0.018 | 0.384 | 0.996 | 1.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral pain | 0 | 0.023 | 0.433 | 0.996 | 1.747 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin | 0 | 0.006 | 0.118 | 0.996 | 2.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluid intake reduced | 0 | 0.021 | 0.409 | 0.996 | 1.792 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small intestinal obstruction | 0 | 0.012 | 0.291 | 0.996 | 2.044 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic procedure | 0 | 0.003 | 0.022 | 0.996 | 3.31 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flow cytometry | 0 | 0.01 | 0.211 | 0.996 | 2.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mastitis | 0 | 0.004 | 0.064 | 0.996 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emphysema | 0 | 0.004 | 0.063 | 0.996 | 2.894 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PO2 decreased | 0 | 0.005 | 0.082 | 0.996 | 2.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus test negative | 0 | 0.007 | 0.126 | 0.996 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuritis | 0 | 0.005 | 0.078 | 0.996 | 2.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray normal | 0 | 0.022 | 0.409 | 0.996 | 1.792 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin | 0 | 0.006 | 0.101 | 0.996 | 2.669 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature separation of placenta | 0 | 0.001 | 0 | 0.996 | 4.394 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised vaccinia | 0 | 0 | 0 | 0.996 | 5.552 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell volume increased | 0 | 0.008 | 0.189 | 0.996 | 2.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-aquaporin-4 antibody positive | 0 | 0 | 0 | 0.996 | 5.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus infection | 0 | 0.005 | 0.106 | 0.996 | 2.647 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin mass | 0 | 0.011 | 0.265 | 0.996 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan | 0 | 0.005 | 0.101 | 0.996 | 2.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antinuclear antibody positive | 0 | 0.006 | 0.114 | 0.996 | 2.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quadriplegia | 0 | 0.002 | 0.002 | 0.996 | 3.991 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrotising retinitis | 0 | 0.002 | 0 | 0.996 | 4.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aplastic anaemia | 0 | 0.008 | 0.2 | 0.996 | 2.29 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterobiasis | 0 | 0 | 0 | 0.996 | 5.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epstein-Barr virus antibody positive | 0 | 0.01 | 0.21 | 0.996 | 2.259 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital oedema | 0 | 0.007 | 0.126 | 0.996 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diverticulitis | 0 | 0.01 | 0.222 | 0.996 | 2.223 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Base excess | 0 | 0.005 | 0.078 | 0.996 | 2.797 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type III immune complex mediated reaction | 0 | 0.006 | 0.084 | 0.996 | 2.756 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling drunk | 0 | 0.009 | 0.198 | 0.996 | 2.293 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary arterial stent insertion | 0 | 0.008 | 0.154 | 0.996 | 2.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte stimulation test positive | 0 | 0.001 | 0 | 0.996 | 5.386 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to animal | 0 | 0.002 | 0.007 | 0.996 | 3.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extrasystoles | 0 | 0.012 | 0.262 | 0.996 | 2.115 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Documented hypersensitivity to administered product | 0 | 0.004 | 0.061 | 0.996 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus congestion | 0 | 0.022 | 0.391 | 0.996 | 1.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin M | 0 | 0.011 | 0.225 | 0.996 | 2.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Use of accessory respiratory muscles | 0 | 0.005 | 0.107 | 0.996 | 2.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholecystectomy | 0 | 0.012 | 0.238 | 0.996 | 2.175 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | IgA nephropathy | 0 | 0.004 | 0.033 | 0.996 | 3.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Expanded disability status scale score decreased | 0 | 0 | 0 | 0.996 | 5.71 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iritis | 0 | 0.003 | 0.013 | 0.996 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine chloride | 0 | 0 | 0 | 0.996 | 5.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray limb | 0 | 0.016 | 0.337 | 0.996 | 1.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy | 0 | 0.01 | 0.256 | 0.996 | 2.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound Doppler normal | 0 | 0.012 | 0.264 | 0.996 | 2.108 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Developmental delay | 0 | 0.005 | 0.07 | 0.996 | 2.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased eye contact | 0 | 0.006 | 0.13 | 0.996 | 2.536 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival bleeding | 0 | 0.01 | 0.255 | 0.996 | 2.134 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brachial plexopathy | 0 | 0.003 | 0.028 | 0.996 | 3.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis abnormal | 0 | 0.001 | 0 | 0.996 | 5.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hip fracture | 0 | 0.016 | 0.318 | 0.996 | 1.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irregular sleep wake rhythm disorder | 0 | 0.001 | 0 | 0.996 | 5.235 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle rigidity | 0 | 0.013 | 0.271 | 0.996 | 2.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tearfulness | 0 | 0.005 | 0.072 | 0.996 | 2.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood smear test abnormal | 0 | 0.005 | 0.062 | 0.996 | 2.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell sedimentation rate | 0 | 0.021 | 0.428 | 0.996 | 1.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound testes abnormal | 0 | 0 | 0 | 0.996 | 5.669 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute macular outer retinopathy | 0 | 0 | 0 | 0.996 | 5.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric disorder | 0 | 0.01 | 0.213 | 0.996 | 2.249 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fungal infection | 0 | 0.007 | 0.129 | 0.996 | 2.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase | 0 | 0.025 | 0.427 | 0.996 | 1.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ascites | 0 | 0.006 | 0.104 | 0.996 | 2.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis psoriasiform | 0 | 0.002 | 0.01 | 0.996 | 3.579 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmoplegia | 0 | 0.008 | 0.212 | 0.996 | 2.252 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiotensin converting enzyme decreased | 0 | 0.003 | 0.015 | 0.996 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Radiculitis brachial | 0 | 0.005 | 0.057 | 0.996 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonic clonic movements | 0 | 0.007 | 0.159 | 0.996 | 2.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Growth retardation | 0 | 0.004 | 0.033 | 0.996 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electromyogram normal | 0 | 0.004 | 0.051 | 0.996 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure fluctuation | 0 | 0.022 | 0.417 | 0.996 | 1.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypomenorrhoea | 0 | 0.001 | 0 | 0.996 | 5.289 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye infection | 0 | 0.005 | 0.071 | 0.996 | 2.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tuberculosis | 0 | 0.003 | 0.021 | 0.996 | 3.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hereditary neuropathy with liability to pressure palsies | 0 | 0 | 0 | 0.996 | 5.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aphonia | 0 | 0.014 | 0.314 | 0.996 | 1.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allodynia | 0 | 0.003 | 0.02 | 0.996 | 3.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy artery normal | 0 | 0.001 | 0 | 0.996 | 5.178 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysphemia | 0 | 0.004 | 0.049 | 0.996 | 3.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delivery | 0 | 0.001 | 0 | 0.996 | 5.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthropathy | 0 | 0.008 | 0.189 | 0.996 | 2.323 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal pain | 0 | 0.011 | 0.243 | 0.996 | 2.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia streptococcal | 0 | 0.001 | 0 | 0.996 | 5.335 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shift to the left | 0 | 0.005 | 0.062 | 0.996 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conversion disorder | 0 | 0.005 | 0.073 | 0.996 | 2.823 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasculitis | 0 | 0.013 | 0.279 | 0.996 | 2.071 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endoscopy normal | 0 | 0.004 | 0.063 | 0.996 | 2.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positron emission tomogram | 0 | 0.004 | 0.061 | 0.996 | 2.911 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adverse event following immunisation | 0 | 0.003 | 0.042 | 0.996 | 3.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature rupture of membranes | 0 | 0.002 | 0.002 | 0.996 | 4.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axillary mass | 0 | 0.016 | 0.34 | 0.996 | 1.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriosclerosis | 0 | 0.008 | 0.15 | 0.996 | 2.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary function test | 0 | 0.003 | 0.045 | 0.996 | 3.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sluggishness | 0 | 0.016 | 0.348 | 0.996 | 1.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coordination abnormal | 0 | 0.017 | 0.365 | 0.996 | 1.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cyst ruptured | 0 | 0.001 | 0 | 0.996 | 5.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Strabismus | 0 | 0.01 | 0.226 | 0.996 | 2.21 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoglobin blood increased | 0 | 0.002 | 0.002 | 0.996 | 3.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infantile spasms | 0 | 0.005 | 0.091 | 0.996 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast pain | 0 | 0.029 | 0.482 | 0.996 | 1.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seroconversion test negative | 0 | 0.001 | 0 | 0.996 | 5.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine ketone body absent | 0 | 0.01 | 0.205 | 0.996 | 2.271 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Refusal of treatment by patient | 0 | 0.009 | 0.179 | 0.996 | 2.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eyelid rash | 0 | 0.008 | 0.174 | 0.996 | 2.373 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Globulin | 0 | 0.007 | 0.114 | 0.996 | 2.606 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alcohol intolerance | 0 | 0.001 | 0 | 0.996 | 5.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myoclonus | 0 | 0.008 | 0.212 | 0.996 | 2.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular evaluation | 0 | 0.014 | 0.334 | 0.996 | 1.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Placenta praevia | 0 | 0.001 | 0 | 0.996 | 5.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperthermia | 0 | 0.002 | 0.008 | 0.996 | 3.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram spine | 0 | 0.015 | 0.329 | 0.996 | 1.955 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood aluminium increased | 0 | 0.002 | 0.004 | 0.996 | 3.846 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis | 0 | 0.015 | 0.306 | 0.996 | 2.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Moaning | 0 | 0.009 | 0.184 | 0.996 | 2.337 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tricuspid valve incompetence | 0 | 0.007 | 0.141 | 0.996 | 2.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypogeusia | 0 | 0.007 | 0.134 | 0.996 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product expiration date issue | 0 | 0.001 | 0 | 0.996 | 4.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute motor axonal neuropathy | 0 | 0.001 | 0 | 0.996 | 5.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contraindicated product administered | 0 | 0.004 | 0.055 | 0.996 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faeces soft | 0 | 0.002 | 0.006 | 0.996 | 3.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular filtration rate | 0 | 0.025 | 0.447 | 0.996 | 1.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site movement impairment | 0 | 0.007 | 0.139 | 0.996 | 2.502 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal sounds abnormal | 0 | 0.004 | 0.078 | 0.996 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue discomfort | 0 | 0.007 | 0.151 | 0.996 | 2.456 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ehlers-Danlos syndrome | 0 | 0.001 | 0 | 0.996 | 5.144 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxoplasma serology negative | 0 | 0.004 | 0.027 | 0.996 | 3.238 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage urinary tract | 0 | 0.002 | 0.001 | 0.996 | 4.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure systolic | 0 | 0.002 | 0.001 | 0.996 | 4.235 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood fibrinogen normal | 0 | 0.002 | 0.01 | 0.996 | 3.578 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophagocytic lymphohistiocytosis | 0 | 0.005 | 0.068 | 0.996 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupil fixed | 0 | 0.009 | 0.229 | 0.996 | 2.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-ganglioside antibody negative | 0 | 0.001 | 0 | 0.996 | 4.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Preterm premature rupture of membranes | 0 | 0.001 | 0 | 0.996 | 4.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin | 0 | 0.01 | 0.198 | 0.996 | 2.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peau d'orange | 0 | 0.003 | 0.033 | 0.996 | 3.16 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor quality sleep | 0 | 0.023 | 0.405 | 0.996 | 1.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nephrolithiasis | 0 | 0.008 | 0.188 | 0.996 | 2.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral pruritus | 0 | 0.02 | 0.348 | 0.995 | 1.912 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polycystic ovaries | 0 | 0.001 | 0 | 0.995 | 5.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coma scale abnormal | 0 | 0.005 | 0.046 | 0.995 | 3.028 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye irritation | 0 | 0.037 | 0.472 | 0.995 | 1.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High-pitched crying | 0 | 0.004 | 0.038 | 0.995 | 3.101 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chloride | 0 | 0.002 | 0.001 | 0.995 | 4.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle enzyme | 0 | 0.001 | 0 | 0.995 | 5.498 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis bullous | 0 | 0.009 | 0.16 | 0.995 | 2.42 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumococcal sepsis | 0 | 0.001 | 0 | 0.995 | 4.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basedow's disease | 0 | 0.004 | 0.029 | 0.995 | 3.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram pelvis | 0 | 0.012 | 0.221 | 0.995 | 2.223 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased vibratory sense | 0 | 0.003 | 0.005 | 0.995 | 3.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac stress test | 0 | 0.009 | 0.149 | 0.995 | 2.459 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quadriparesis | 0 | 0.003 | 0.007 | 0.995 | 3.681 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung adenocarcinoma | 0 | 0.001 | 0 | 0.995 | 5.573 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chloride increased | 0 | 0.019 | 0.309 | 0.995 | 1.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug effective for unapproved indication | 0 | 0.001 | 0 | 0.995 | 5.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injury | 0 | 0.008 | 0.147 | 0.995 | 2.468 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral atrophy | 0 | 0.008 | 0.135 | 0.995 | 2.517 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pupillary light reflex tests abnormal | 0 | 0.002 | 0.001 | 0.995 | 4.224 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticoagulant therapy | 0 | 0.004 | 0.033 | 0.995 | 3.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy cervix abnormal | 0 | 0 | 0 | 0.995 | 5.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disseminated varicella zoster vaccine virus infection | 0 | 0.001 | 0 | 0.995 | 5.184 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apparent life threatening event | 0 | 0.006 | 0.067 | 0.995 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gestational diabetes | 0 | 0.001 | 0 | 0.995 | 4.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight bearing difficulty | 0 | 0.015 | 0.293 | 0.995 | 2.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheterisation cardiac | 0 | 0.023 | 0.395 | 0.995 | 1.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash scarlatiniform | 0 | 0.001 | 0 | 0.995 | 5.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Milk allergy | 0 | 0.006 | 0.077 | 0.995 | 2.796 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic epidermal necrolysis | 0 | 0.004 | 0.015 | 0.995 | 3.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tetanus | 0 | 0.001 | 0 | 0.995 | 5.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysgraphia | 0 | 0.005 | 0.075 | 0.995 | 2.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial flutter | 0 | 0.005 | 0.063 | 0.995 | 2.888 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram pelvis abnormal | 0 | 0.012 | 0.214 | 0.995 | 2.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site lymphadenopathy | 0 | 0.004 | 0.017 | 0.995 | 3.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin I normal | 0 | 0.005 | 0.053 | 0.995 | 2.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyarrhythmia terms, nonspecific (SMQ) [narrow] | 0 | 0.025 | 0.38 | 0.995 | 1.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte count | 0 | 0.009 | 0.161 | 0.995 | 2.414 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal rigidity | 0 | 0.008 | 0.124 | 0.995 | 2.558 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A antibody positive | 0 | 0.001 | 0 | 0.995 | 5.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disseminated intravascular coagulation | 0 | 0.006 | 0.078 | 0.995 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemia | 0 | 0.012 | 0.192 | 0.995 | 2.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trismus | 0 | 0.007 | 0.124 | 0.995 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subchorionic haematoma | 0 | 0.001 | 0 | 0.995 | 5.484 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmological examination normal | 0 | 0.007 | 0.078 | 0.995 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A virus test positive | 0 | 0.001 | 0 | 0.995 | 5.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Legionella test | 0 | 0.005 | 0.067 | 0.995 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vulval cancer | 0 | 0 | 0 | 0.995 | 5.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary fibrosis | 0 | 0.003 | 0.02 | 0.995 | 3.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial necrosis marker normal | 0 | 0.008 | 0.144 | 0.995 | 2.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection transmission via personal contact | 0 | 0.001 | 0 | 0.995 | 5.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhagic stroke | 0 | 0.01 | 0.181 | 0.995 | 2.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic ischaemic neuropathy | 0 | 0.004 | 0.026 | 0.995 | 3.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy brain abnormal | 0 | 0.001 | 0 | 0.995 | 4.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epiglottitis haemophilus | 0 | 0.001 | 0 | 0.995 | 5.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interleukin level | 0 | 0.002 | 0 | 0.995 | 4.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF lymphocyte count increased | 0 | 0.005 | 0.043 | 0.995 | 3.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic function test abnormal | 0 | 0.006 | 0.095 | 0.995 | 2.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | pH urine normal | 0 | 0.016 | 0.27 | 0.995 | 2.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Patient isolation | 0 | 0.003 | 0.021 | 0.995 | 3.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum sickness-like reaction | 0 | 0.008 | 0.099 | 0.995 | 2.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitreous detachment | 0 | 0.004 | 0.029 | 0.995 | 3.211 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salivary hypersecretion | 0 | 0.008 | 0.106 | 0.995 | 2.639 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus headache | 0 | 0.008 | 0.136 | 0.995 | 2.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Borrelia test negative | 0 | 0.014 | 0.259 | 0.995 | 2.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune hepatitis | 0 | 0.002 | 0.002 | 0.995 | 3.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glycosylated haemoglobin increased | 0 | 0.008 | 0.128 | 0.995 | 2.542 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exercise tolerance decreased | 0 | 0.004 | 0.029 | 0.995 | 3.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dialysis | 0 | 0.014 | 0.245 | 0.995 | 2.156 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram cerebral | 0 | 0.016 | 0.288 | 0.995 | 2.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea decreased | 0 | 0.005 | 0.053 | 0.995 | 2.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancreatitis acute | 0 | 0.014 | 0.236 | 0.995 | 2.18 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein total increased | 0 | 0.008 | 0.133 | 0.995 | 2.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arthroscopy | 0 | 0.002 | 0.002 | 0.995 | 4.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin D deficiency | 0 | 0.003 | 0.01 | 0.995 | 3.556 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin depigmentation | 0 | 0.002 | 0.004 | 0.995 | 3.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intestinal obstruction | 0 | 0.004 | 0.023 | 0.995 | 3.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral infection | 0 | 0.024 | 0.365 | 0.995 | 1.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site vesicles | 0 | 0.004 | 0.017 | 0.995 | 3.4 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyneuropathy | 0 | 0.005 | 0.049 | 0.995 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus rhythm | 0 | 0.002 | 0 | 0.995 | 4.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choking | 0 | 0.008 | 0.142 | 0.995 | 2.488 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arrested labour | 0 | 0.001 | 0 | 0.995 | 5.628 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenitis | 0 | 0.001 | 0 | 0.995 | 5.792 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thirst | 0 | 0.025 | 0.409 | 0.995 | 1.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large intestinal obstruction reduction | 0 | 0.001 | 0 | 0.995 | 5.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle necrosis | 0 | 0.001 | 0 | 0.995 | 5.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Albumin CSF | 0 | 0.003 | 0.014 | 0.995 | 3.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood gases | 0 | 0.012 | 0.212 | 0.995 | 2.25 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterocolitis haemorrhagic | 0 | 0.001 | 0 | 0.995 | 5.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Robust take following exposure to vaccinia virus | 0 | 0.001 | 0 | 0.995 | 5.723 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gout | 0 | 0.007 | 0.102 | 0.995 | 2.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypomagnesaemia | 0 | 0.003 | 0.007 | 0.995 | 3.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ecchymosis | 0 | 0.01 | 0.193 | 0.995 | 2.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antineutrophil cytoplasmic antibody negative | 0 | 0.005 | 0.052 | 0.995 | 2.978 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver function test | 0 | 0.022 | 0.366 | 0.995 | 1.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | DNA antibody negative | 0 | 0.002 | 0.001 | 0.995 | 4.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchoalveolar lavage abnormal | 0 | 0.004 | 0.022 | 0.995 | 3.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tunnel vision | 0 | 0.016 | 0.294 | 0.995 | 2.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray abnormal | 0 | 0.009 | 0.143 | 0.995 | 2.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle fatigue | 0 | 0.016 | 0.257 | 0.995 | 2.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal non-stress test normal | 0 | 0.001 | 0 | 0.995 | 5.768 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viraemia | 0 | 0 | 0 | 0.995 | 5.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Endometriosis | 0 | 0.002 | 0 | 0.995 | 4.632 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell volume decreased | 0 | 0.005 | 0.057 | 0.995 | 2.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic acidosis | 0 | 0.005 | 0.052 | 0.995 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian cyst | 0 | 0.002 | 0.001 | 0.995 | 4.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nuchal rigidity | 0 | 0.004 | 0.019 | 0.995 | 3.351 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemolytic anaemia | 0 | 0.015 | 0.252 | 0.995 | 2.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system lesion | 0 | 0.007 | 0.134 | 0.995 | 2.52 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loss of proprioception | 0 | 0.002 | 0.003 | 0.995 | 3.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyarrhythmia terms, nonspecific (SMQ) [broad] | 0 | 0.025 | 0.38 | 0.995 | 1.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colonoscopy | 0 | 0.007 | 0.093 | 0.995 | 2.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food refusal | 0 | 0.005 | 0.048 | 0.995 | 3.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HLA marker study | 0 | 0.001 | 0 | 0.995 | 5.574 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular icterus | 0 | 0.005 | 0.041 | 0.995 | 3.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature menopause | 0 | 0.001 | 0 | 0.995 | 5.722 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial necrosis marker increased | 0 | 0.006 | 0.087 | 0.995 | 2.74 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza B virus test positive | 0 | 0.001 | 0 | 0.995 | 4.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy brain | 0 | 0 | 0 | 0.995 | 5.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Morose | 0 | 0.001 | 0 | 0.995 | 5.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adrenocortical insufficiency acute | 0 | 0.001 | 0 | 0.995 | 5.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis | 0 | 0.009 | 0.155 | 0.995 | 2.436 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nitrite urine absent | 0 | 0.016 | 0.281 | 0.995 | 2.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dry throat | 0 | 0.029 | 0.418 | 0.995 | 1.771 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site infection | 0 | 0.004 | 0.018 | 0.995 | 3.374 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cataract | 0 | 0.006 | 0.065 | 0.995 | 2.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial discomfort | 0 | 0.01 | 0.192 | 0.995 | 2.312 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ketoacidosis | 0 | 0.002 | 0 | 0.995 | 4.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shock | 0 | 0.008 | 0.139 | 0.995 | 2.498 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraparesis | 0 | 0.001 | 0 | 0.995 | 5.445 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yellow fever | 0 | 0 | 0 | 0.995 | 5.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mydriasis | 0 | 0.014 | 0.234 | 0.995 | 2.185 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gaze palsy | 0 | 0.011 | 0.173 | 0.995 | 2.373 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site movement impairment | 0 | 0.009 | 0.178 | 0.995 | 2.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin swelling | 0 | 0.017 | 0.323 | 0.995 | 1.967 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fear of death | 0 | 0.005 | 0.069 | 0.995 | 2.847 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubivirus test positive | 0 | 0.001 | 0 | 0.995 | 5.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombophlebitis (SMQ) [narrow] | 0 | 0.006 | 0.099 | 0.995 | 2.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opisthotonus | 0 | 0.008 | 0.123 | 0.995 | 2.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging spinal normal | 0 | 0.012 | 0.229 | 0.995 | 2.201 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis viral test negative | 0 | 0.005 | 0.064 | 0.995 | 2.886 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 antibody test negative | 0 | 0.025 | 0.381 | 0.995 | 1.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood magnesium | 0 | 0.025 | 0.366 | 0.995 | 1.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acne | 0 | 0.007 | 0.097 | 0.995 | 2.688 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site hypoaesthesia | 0 | 0.028 | 0.408 | 0.995 | 1.79 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal artery occlusion | 0 | 0.01 | 0.158 | 0.995 | 2.425 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal discomfort | 0 | 0.034 | 0.446 | 0.995 | 1.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Catheterisation cardiac normal | 0 | 0.021 | 0.364 | 0.995 | 1.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterocolitis | 0 | 0.002 | 0.004 | 0.995 | 3.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin concentration | 0 | 0.003 | 0.012 | 0.995 | 3.502 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip blister | 0 | 0.011 | 0.21 | 0.995 | 2.256 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antibody negative | 0 | 0.001 | 0 | 0.995 | 5.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcium decreased | 0 | 0.026 | 0.387 | 0.995 | 1.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal detachment | 0 | 0.004 | 0.014 | 0.995 | 3.453 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Positron emission tomogram abnormal | 0 | 0.005 | 0.033 | 0.995 | 3.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF protein | 0 | 0.002 | 0.001 | 0.995 | 4.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc protrusion | 0 | 0.007 | 0.094 | 0.995 | 2.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alanine aminotransferase | 0 | 0.007 | 0.11 | 0.995 | 2.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital signs measurement | 0 | 0.009 | 0.156 | 0.995 | 2.433 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean platelet volume increased | 0 | 0.005 | 0.05 | 0.995 | 2.987 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Goitre | 0 | 0.004 | 0.035 | 0.995 | 3.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bell's palsy | 0 | 0.002 | 0 | 0.995 | 4.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product odour abnormal | 0 | 0 | 0 | 0.995 | 5.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Investigation normal | 0 | 0.003 | 0.008 | 0.995 | 3.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anger | 0 | 0.015 | 0.258 | 0.995 | 2.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory syncytial virus test negative | 0 | 0.015 | 0.274 | 0.995 | 2.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemolytic uraemic syndrome | 0 | 0.001 | 0 | 0.995 | 5.694 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intermenstrual bleeding | 0 | 0.004 | 0.028 | 0.995 | 3.22 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal oedema | 0 | 0.005 | 0.033 | 0.995 | 3.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal pain | 0 | 0.01 | 0.184 | 0.995 | 2.337 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin necrosis | 0 | 0.006 | 0.088 | 0.995 | 2.735 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradyphrenia | 0 | 0.007 | 0.108 | 0.995 | 2.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poor sucking reflex | 0 | 0.002 | 0.002 | 0.995 | 3.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purpura fulminans | 0 | 0.001 | 0 | 0.995 | 5.302 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Choking sensation | 0 | 0.01 | 0.152 | 0.995 | 2.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Necrosis | 0 | 0.006 | 0.074 | 0.995 | 2.819 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subchorionic haemorrhage | 0 | 0.001 | 0 | 0.995 | 5.603 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 decreased | 0 | 0.003 | 0.005 | 0.995 | 3.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Secondary transmission | 0 | 0.002 | 0 | 0.995 | 4.408 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stool analysis | 0 | 0.005 | 0.046 | 0.995 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood sodium increased | 0 | 0.004 | 0.015 | 0.995 | 3.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laparotomy | 0 | 0.002 | 0.002 | 0.995 | 4.029 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine contractions during pregnancy | 0 | 0.001 | 0 | 0.995 | 4.751 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fluid retention | 0 | 0.008 | 0.136 | 0.995 | 2.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Communication disorder | 0 | 0.01 | 0.151 | 0.995 | 2.451 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuse, dependence and withdrawal (SMQ) [narrow] | 0 | 0.002 | 0.005 | 0.995 | 3.759 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peritonitis | 0 | 0.003 | 0.015 | 0.995 | 3.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonellosis | 0 | 0.002 | 0.001 | 0.995 | 4.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Candida infection | 0 | 0.007 | 0.1 | 0.995 | 2.668 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pseudomembranous colitis (SMQ) [narrow] | 0 | 0.018 | 0.338 | 0.995 | 1.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reaction to preservatives | 0 | 0.01 | 0.183 | 0.995 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticarial vasculitis | 0 | 0.002 | 0.002 | 0.995 | 3.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombocytopenic purpura | 0 | 0.003 | 0.003 | 0.994 | 3.901 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pancytopenia | 0 | 0.011 | 0.156 | 0.994 | 2.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.013 | 0.2 | 0.994 | 2.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired driving ability | 0 | 0.031 | 0.385 | 0.994 | 1.832 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anion gap | 0 | 0.025 | 0.342 | 0.994 | 1.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin M normal | 0 | 0.008 | 0.082 | 0.994 | 2.765 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Staring | 0 | 0.022 | 0.333 | 0.994 | 1.941 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time | 0 | 0.03 | 0.387 | 0.994 | 1.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspareunia | 0 | 0.001 | 0 | 0.994 | 5.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute left ventricular failure | 0 | 0.002 | 0 | 0.994 | 4.285 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone marrow failure | 0 | 0.004 | 0.021 | 0.994 | 3.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematoma | 0 | 0.014 | 0.224 | 0.994 | 2.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstruation irregular | 0 | 0.001 | 0 | 0.994 | 5.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type 2 diabetes mellitus | 0 | 0.008 | 0.086 | 0.994 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | B-lymphocyte count | 0 | 0.002 | 0 | 0.994 | 4.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.012 | 0.18 | 0.994 | 2.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Total complement activity decreased | 0 | 0.001 | 0 | 0.994 | 5.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Physical disability | 0 | 0.002 | 0 | 0.994 | 4.618 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transfusion | 0 | 0.032 | 0.393 | 0.994 | 1.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung disorder | 0 | 0.007 | 0.086 | 0.994 | 2.744 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parvovirus B19 test negative | 0 | 0.007 | 0.067 | 0.994 | 2.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcus test negative | 0 | 0.022 | 0.309 | 0.994 | 1.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil percentage | 0 | 0.02 | 0.306 | 0.994 | 2.002 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Trigeminal neuralgia | 0 | 0.006 | 0.042 | 0.994 | 3.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depressed mood | 0 | 0.01 | 0.128 | 0.994 | 2.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blindness unilateral | 0 | 0.019 | 0.283 | 0.994 | 2.057 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diet refusal | 0 | 0.014 | 0.213 | 0.994 | 2.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shoulder dystocia | 0 | 0.001 | 0 | 0.994 | 5.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mycoplasma test negative | 0 | 0.008 | 0.101 | 0.994 | 2.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Initial insomnia | 0 | 0.004 | 0.006 | 0.994 | 3.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF glucose normal | 0 | 0.011 | 0.142 | 0.994 | 2.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pH decreased | 0 | 0.012 | 0.18 | 0.994 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood fibrinogen | 0 | 0.006 | 0.056 | 0.994 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site vesicles | 0 | 0.015 | 0.22 | 0.994 | 2.222 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crepitations | 0 | 0.006 | 0.058 | 0.994 | 2.925 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sickle cell anaemia with crisis | 0 | 0.004 | 0.018 | 0.994 | 3.36 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Community acquired infection | 0 | 0 | 0 | 0.994 | 4.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-haematological tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.006 | 0.073 | 0.994 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniocentesis normal | 0 | 0.001 | 0 | 0.994 | 5.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diplegia | 0 | 0.006 | 0.058 | 0.994 | 2.924 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infective pulmonary exacerbation of cystic fibrosis | 0 | 0.001 | 0 | 0.994 | 5.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site extravasation | 0 | 0.009 | 0.124 | 0.994 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple use of single-use product | 0 | 0 | 0 | 0.994 | 4.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin G increased | 0 | 0.007 | 0.064 | 0.994 | 2.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart injury | 0 | 0.006 | 0.058 | 0.994 | 2.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Developmental regression | 0 | 0.007 | 0.07 | 0.994 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperglycaemia | 0 | 0.013 | 0.209 | 0.994 | 2.256 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Henoch-Schonlein purpura | 0 | 0.014 | 0.199 | 0.994 | 2.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic screen | 0 | 0.002 | 0 | 0.994 | 4.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast malignant tumours (SMQ) [narrow] | 0 | 0.012 | 0.18 | 0.994 | 2.349 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute febrile neutrophilic dermatosis | 0 | 0.002 | 0 | 0.994 | 4.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenovirus test | 0 | 0.005 | 0.029 | 0.994 | 3.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thoracic cavity drainage | 0 | 0.002 | 0 | 0.994 | 4.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune haemolytic anaemia | 0 | 0.009 | 0.11 | 0.994 | 2.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear cervix | 0 | 0.002 | 0 | 0.994 | 4.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmological examination | 0 | 0.016 | 0.24 | 0.994 | 2.167 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malaria | 0 | 0.001 | 0 | 0.994 | 5.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute disseminated encephalomyelitis | 0 | 0.007 | 0.078 | 0.994 | 2.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound skull normal | 0 | 0.001 | 0 | 0.994 | 4.947 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gestational hypertension | 0 | 0.001 | 0 | 0.994 | 5.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antiphospholipid antibodies negative | 0 | 0.004 | 0.013 | 0.994 | 3.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gluten sensitivity | 0 | 0.004 | 0.017 | 0.994 | 3.395 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Clostridium test negative | 0 | 0.006 | 0.061 | 0.994 | 2.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disorders of sinus node function (SMQ) [broad] | 0 | 0.007 | 0.067 | 0.994 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrostomy | 0 | 0.005 | 0.023 | 0.994 | 3.291 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin tightness | 0 | 0.021 | 0.314 | 0.994 | 1.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colitis ulcerative | 0 | 0.005 | 0.034 | 0.994 | 3.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Campylobacter test positive | 0 | 0.003 | 0.005 | 0.994 | 3.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte count normal | 0 | 0.013 | 0.189 | 0.994 | 2.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal erythema | 0 | 0.007 | 0.078 | 0.994 | 2.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychotic disorder | 0 | 0.005 | 0.033 | 0.994 | 3.158 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body temperature abnormal | 0 | 0.005 | 0.031 | 0.994 | 3.178 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiogenic shock | 0 | 0.007 | 0.066 | 0.994 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Personality change | 0 | 0.01 | 0.146 | 0.994 | 2.469 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein urine present | 0 | 0.014 | 0.205 | 0.994 | 2.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple allergies | 0 | 0.006 | 0.047 | 0.994 | 3.01 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood corticotrophin increased | 0 | 0 | 0 | 0.994 | 5.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis aseptic | 0 | 0.005 | 0.022 | 0.994 | 3.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal tube insertion | 0 | 0.01 | 0.13 | 0.994 | 2.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procalcitonin normal | 0 | 0.005 | 0.027 | 0.994 | 3.223 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occult blood positive | 0 | 0.005 | 0.025 | 0.994 | 3.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Spinal osteoarthritis | 0 | 0.006 | 0.049 | 0.994 | 2.989 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Supraventricular tachycardia | 0 | 0.026 | 0.346 | 0.994 | 1.913 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin increased | 0 | 0.005 | 0.027 | 0.994 | 3.229 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nightmare | 0 | 0.012 | 0.173 | 0.994 | 2.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial infection | 0 | 0.013 | 0.193 | 0.994 | 2.303 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast malignant tumours (SMQ) [broad] | 0 | 0.013 | 0.2 | 0.994 | 2.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product closure issue | 0 | 0 | 0 | 0.994 | 4.236 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diastolic dysfunction | 0 | 0.002 | 0 | 0.994 | 4.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactic acid normal | 0 | 0.019 | 0.281 | 0.994 | 2.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound antenatal screen | 0 | 0.002 | 0.001 | 0.994 | 4.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Placental disorder | 0 | 0.001 | 0 | 0.994 | 4.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil percentage decreased | 0 | 0.006 | 0.046 | 0.994 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin burning sensation | 0 | 0.026 | 0.367 | 0.994 | 1.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil count | 0 | 0.007 | 0.074 | 0.994 | 2.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-haematological tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.006 | 0.073 | 0.994 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Poliomyelitis | 0 | 0.001 | 0 | 0.994 | 5.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleocytosis | 0 | 0.003 | 0.003 | 0.994 | 3.904 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema nodosum | 0 | 0.006 | 0.051 | 0.994 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | High density lipoprotein decreased | 0 | 0.005 | 0.039 | 0.994 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST segment abnormal | 0 | 0.004 | 0.016 | 0.994 | 3.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronavirus infection | 0 | 0.006 | 0.052 | 0.994 | 2.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intervertebral disc degeneration | 0 | 0.004 | 0.015 | 0.994 | 3.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blindness transient | 0 | 0.008 | 0.1 | 0.994 | 2.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthostatic intolerance | 0 | 0.001 | 0 | 0.994 | 5.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella virus test negative | 0 | 0.009 | 0.125 | 0.994 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PCO2 decreased | 0 | 0.006 | 0.048 | 0.994 | 2.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time | 0 | 0.028 | 0.382 | 0.994 | 1.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal X-ray | 0 | 0.006 | 0.062 | 0.994 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adenovirus test positive | 0 | 0.005 | 0.034 | 0.994 | 3.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breast cancer female | 0 | 0.01 | 0.144 | 0.994 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancy related conditions (SMQ) [broad] | 0 | 0.005 | 0.026 | 0.994 | 3.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-glomerular basement membrane antibody negative | 0 | 0.001 | 0 | 0.994 | 5.516 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthenopia | 0 | 0.007 | 0.062 | 0.994 | 2.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastritis | 0 | 0.008 | 0.096 | 0.994 | 2.69 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sciatica | 0 | 0.016 | 0.234 | 0.994 | 2.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Demyelinating polyneuropathy | 0 | 0.005 | 0.026 | 0.994 | 3.244 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sopor | 0 | 0.001 | 0 | 0.994 | 5.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain natriuretic peptide | 0 | 0.026 | 0.371 | 0.994 | 1.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haptoglobin decreased | 0 | 0.005 | 0.031 | 0.994 | 3.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammatory marker increased | 0 | 0.016 | 0.239 | 0.994 | 2.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Collagen disorder | 0 | 0.001 | 0 | 0.994 | 5.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disorders of sinus node function (SMQ) [narrow] | 0 | 0.007 | 0.067 | 0.994 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradykinesia | 0 | 0.003 | 0.003 | 0.994 | 3.884 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Regurgitation | 0 | 0.004 | 0.018 | 0.994 | 3.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccine associated paralytic poliomyelitis | 0 | 0.001 | 0 | 0.994 | 5.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enema administration | 0 | 0.004 | 0.015 | 0.994 | 3.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Status epilepticus | 0 | 0.012 | 0.174 | 0.994 | 2.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polyarteritis nodosa | 0 | 0.001 | 0 | 0.994 | 5.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella post vaccine | 0 | 0.001 | 0 | 0.994 | 4.795 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin cancer | 0 | 0.004 | 0.022 | 0.994 | 3.3 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine potassium decreased | 0 | 0 | 0 | 0.994 | 5.691 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin T normal | 0 | 0.005 | 0.029 | 0.994 | 3.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 antibody test positive | 0 | 0.012 | 0.202 | 0.994 | 2.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stent placement | 0 | 0.023 | 0.315 | 0.994 | 1.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prenatal screening test | 0 | 0.001 | 0 | 0.994 | 5.42 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site injury | 0 | 0.007 | 0.075 | 0.994 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circadian rhythm sleep disorder | 0 | 0.002 | 0 | 0.994 | 4.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF test abnormal | 0 | 0.005 | 0.03 | 0.994 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness bilateral | 0 | 0.007 | 0.071 | 0.994 | 2.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis A antibody negative | 0 | 0.002 | 0 | 0.994 | 4.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint lock | 0 | 0.006 | 0.05 | 0.994 | 2.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hysterectomy | 0 | 0.001 | 0 | 0.994 | 4.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lumbar puncture normal | 0 | 0.022 | 0.315 | 0.994 | 1.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional lactation disorders (SMQ) [broad] | 0 | 0.006 | 0.068 | 0.994 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram abnormal | 0 | 0.007 | 0.057 | 0.994 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CD8 lymphocytes decreased | 0 | 0.002 | 0 | 0.994 | 4.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood triglycerides normal | 0 | 0.01 | 0.135 | 0.994 | 2.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin conjugated | 0 | 0.003 | 0.008 | 0.994 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tilt table test normal | 0 | 0.001 | 0 | 0.994 | 5.777 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle insomnia | 0 | 0.016 | 0.245 | 0.994 | 2.153 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin exfoliation | 0 | 0.033 | 0.41 | 0.994 | 1.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site dryness | 0 | 0.001 | 0 | 0.994 | 5.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lens disorders (SMQ) [narrow] | 0 | 0.007 | 0.075 | 0.994 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antithrombin III | 0 | 0.003 | 0.005 | 0.994 | 3.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site cellulitis | 0 | 0.006 | 0.052 | 0.994 | 2.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancy related conditions (SMQ) [narrow] | 0 | 0.005 | 0.026 | 0.994 | 3.242 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional lactation disorders (SMQ) [narrow] | 0 | 0.006 | 0.068 | 0.994 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte percentage increased | 0 | 0.007 | 0.075 | 0.994 | 2.806 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Iridocyclitis | 0 | 0.004 | 0.008 | 0.994 | 3.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin M increased | 0 | 0.004 | 0.013 | 0.994 | 3.486 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red cell distribution width | 0 | 0.011 | 0.146 | 0.994 | 2.468 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Overdose | 0 | 0.002 | 0.001 | 0.994 | 4.117 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coxsackie virus test positive | 0 | 0.004 | 0.014 | 0.994 | 3.451 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory rate increased | 0 | 0.028 | 0.361 | 0.994 | 1.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corynebacterium test negative | 0 | 0.001 | 0 | 0.994 | 5.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute haemorrhagic oedema of infancy | 0 | 0.003 | 0.002 | 0.993 | 4.026 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Type 1 diabetes mellitus | 0 | 0.006 | 0.033 | 0.993 | 3.148 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vital functions abnormal | 0 | 0.013 | 0.15 | 0.993 | 2.449 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.006 | 0.024 | 0.993 | 3.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Small for dates baby | 0 | 0.002 | 0 | 0.993 | 4.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B DNA assay | 0 | 0.001 | 0 | 0.993 | 5.761 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chromaturia | 0 | 0.024 | 0.314 | 0.993 | 1.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour markers (SMQ) [broad] | 0 | 0.006 | 0.029 | 0.993 | 3.199 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix disorder | 0 | 0.002 | 0 | 0.993 | 5.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal distress syndrome | 0 | 0.001 | 0 | 0.993 | 5.749 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prothrombin time normal | 0 | 0.024 | 0.302 | 0.993 | 2.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nystagmus | 0 | 0.01 | 0.111 | 0.993 | 2.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture urine | 0 | 0.02 | 0.276 | 0.993 | 2.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella test | 0 | 0.001 | 0 | 0.993 | 5.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour markers (SMQ) [narrow] | 0 | 0.006 | 0.029 | 0.993 | 3.199 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram neck | 0 | 0.02 | 0.28 | 0.993 | 2.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood folate normal | 0 | 0.007 | 0.056 | 0.993 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body height | 0 | 0.002 | 0 | 0.993 | 4.291 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vitamin B12 normal | 0 | 0.016 | 0.201 | 0.993 | 2.276 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Discoloured vomit | 0 | 0.01 | 0.092 | 0.993 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood thyroid stimulating hormone normal | 0 | 0.015 | 0.183 | 0.993 | 2.333 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular extrasystoles | 0 | 0.016 | 0.204 | 0.993 | 2.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound abdomen normal | 0 | 0.012 | 0.143 | 0.993 | 2.475 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonitis | 0 | 0.011 | 0.112 | 0.993 | 2.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver function test increased | 0 | 0.022 | 0.278 | 0.993 | 2.064 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysaesthesia | 0 | 0.004 | 0.004 | 0.993 | 3.827 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubulavirus test positive | 0 | 0.001 | 0 | 0.993 | 5.254 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal faeces | 0 | 0.012 | 0.157 | 0.993 | 2.426 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Beta haemolytic streptococcal infection | 0 | 0.003 | 0.002 | 0.993 | 4.031 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dementia | 0 | 0.01 | 0.106 | 0.993 | 2.636 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hostility/aggression (SMQ) [narrow] | 0 | 0.023 | 0.304 | 0.993 | 2.004 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infectious biliary disorders (SMQ) [narrow] | 0 | 0.008 | 0.075 | 0.993 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [narrow] | 0 | 0.024 | 0.302 | 0.993 | 2.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspartate aminotransferase | 0 | 0.015 | 0.192 | 0.993 | 2.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin M decreased | 0 | 0.005 | 0.018 | 0.993 | 3.358 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic colitis (SMQ) [narrow] | 0 | 0.007 | 0.05 | 0.993 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillectomy | 0 | 0.004 | 0.005 | 0.993 | 3.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccine breakthrough infection | 0 | 0.007 | 0.048 | 0.993 | 2.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiolipin antibody negative | 0 | 0.004 | 0.009 | 0.993 | 3.576 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fundoscopy abnormal | 0 | 0.005 | 0.015 | 0.993 | 3.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Single photon emission computerised tomogram abnormal | 0 | 0 | 0 | 0.993 | 5.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphopenia | 0 | 0.003 | 0.002 | 0.993 | 4.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pelvic pain | 0 | 0.005 | 0.027 | 0.993 | 3.226 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retching | 0 | 0.06 | 0.507 | 0.993 | 1.61 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Melaena | 0 | 0.007 | 0.061 | 0.993 | 2.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anuria | 0 | 0.004 | 0.011 | 0.993 | 3.526 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral mucosal blistering | 0 | 0.015 | 0.183 | 0.993 | 2.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chloride decreased | 0 | 0.016 | 0.211 | 0.993 | 2.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep apnoea syndrome | 0 | 0.006 | 0.033 | 0.993 | 3.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose decreased | 0 | 0.02 | 0.26 | 0.993 | 2.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillar hypertrophy | 0 | 0.007 | 0.054 | 0.993 | 2.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil percentage | 0 | 0.012 | 0.149 | 0.993 | 2.455 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labelled drug-food interaction medication error | 0 | 0 | 0 | 0.993 | 5.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site mass | 0 | 0.011 | 0.121 | 0.993 | 2.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal chest pain | 0 | 0.028 | 0.35 | 0.993 | 1.903 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex | 0 | 0.007 | 0.053 | 0.993 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus test positive | 0 | 0.007 | 0.047 | 0.993 | 3.008 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Motion sickness | 0 | 0.005 | 0.013 | 0.993 | 3.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infectious pleural effusion | 0 | 0.001 | 0 | 0.993 | 5.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thermometry abnormal | 0 | 0.001 | 0 | 0.993 | 5.715 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection parasitic | 0 | 0.001 | 0 | 0.993 | 5.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological decompensation | 0 | 0.003 | 0.005 | 0.993 | 3.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site discolouration | 0 | 0.027 | 0.324 | 0.993 | 1.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute pancreatitis (SMQ) [narrow] | 0 | 0.023 | 0.282 | 0.993 | 2.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised tonic-clonic seizure | 0 | 0.029 | 0.338 | 0.993 | 1.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus tachycardia | 0 | 0.015 | 0.183 | 0.993 | 2.333 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival disorders (SMQ) [narrow] | 0 | 0.022 | 0.271 | 0.993 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram carotid normal | 0 | 0.022 | 0.266 | 0.993 | 2.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antigen negative | 0 | 0.001 | 0 | 0.993 | 5.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin disorder | 0 | 0.013 | 0.155 | 0.993 | 2.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Temperature regulation disorder | 0 | 0.002 | 0 | 0.993 | 4.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gingival disorders (SMQ) [broad] | 0 | 0.022 | 0.271 | 0.993 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fear | 0 | 0.037 | 0.415 | 0.993 | 1.773 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraplegia | 0 | 0.006 | 0.035 | 0.993 | 3.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper-airway cough syndrome | 0 | 0.018 | 0.249 | 0.993 | 2.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte count | 0 | 0.006 | 0.021 | 0.993 | 3.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optical coherence tomography abnormal | 0 | 0.003 | 0.001 | 0.993 | 4.079 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal disorder | 0 | 0.028 | 0.341 | 0.993 | 1.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan with contrast | 0 | 0.041 | 0.427 | 0.993 | 1.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Attention deficit hyperactivity disorder | 0 | 0.006 | 0.028 | 0.993 | 3.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amylase decreased | 0 | 0.001 | 0 | 0.993 | 5.716 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve injury | 0 | 0.023 | 0.28 | 0.993 | 2.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renovascular disorders (SMQ) [broad] | 0 | 0.007 | 0.057 | 0.993 | 2.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Life support | 0 | 0.015 | 0.183 | 0.993 | 2.332 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infectious biliary disorders (SMQ) [broad] | 0 | 0.008 | 0.075 | 0.993 | 2.805 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Delirium | 0 | 0.029 | 0.33 | 0.993 | 1.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory disorder | 0 | 0.014 | 0.195 | 0.993 | 2.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuralgic amyotrophy | 0 | 0.011 | 0.13 | 0.993 | 2.53 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidental overdose | 0 | 0.006 | 0.03 | 0.993 | 3.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral small vessel ischaemic disease | 0 | 0.015 | 0.203 | 0.993 | 2.272 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF immunoglobulin increased | 0 | 0.004 | 0.01 | 0.993 | 3.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypopnoea | 0 | 0.023 | 0.278 | 0.993 | 2.065 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture stool | 0 | 0.009 | 0.098 | 0.993 | 2.673 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuromyelitis optica spectrum disorder | 0 | 0.002 | 0 | 0.993 | 4.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular examination | 0 | 0.005 | 0.014 | 0.993 | 3.455 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malaria antibody test negative | 0 | 0.001 | 0 | 0.993 | 5.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary incontinence | 0 | 0.038 | 0.407 | 0.993 | 1.787 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture throat positive | 0 | 0.005 | 0.018 | 0.993 | 3.374 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Quality of life decreased | 0 | 0.004 | 0.008 | 0.993 | 3.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agranulocytosis (SMQ) [narrow] | 0 | 0.019 | 0.253 | 0.993 | 2.131 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coronary artery disease | 0 | 0.005 | 0.027 | 0.993 | 3.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White matter lesion | 0 | 0.008 | 0.065 | 0.993 | 2.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenectomy | 0 | 0.004 | 0.01 | 0.993 | 3.538 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Differential white blood cell count | 0 | 0.045 | 0.458 | 0.993 | 1.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Needle issue | 0 | 0.01 | 0.112 | 0.993 | 2.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiomegaly | 0 | 0.009 | 0.094 | 0.993 | 2.694 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Measles antibody positive | 0 | 0.003 | 0 | 0.993 | 4.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arteriogram abnormal | 0 | 0 | 0 | 0.993 | 5.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin concentration decreased | 0 | 0.017 | 0.216 | 0.993 | 2.231 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alpha hydroxybutyrate dehydrogenase | 0 | 0.001 | 0 | 0.993 | 5.746 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyposmia | 0 | 0.003 | 0.002 | 0.993 | 3.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glare | 0 | 0.001 | 0 | 0.993 | 5.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune encephalopathy | 0 | 0 | 0 | 0.992 | 5.594 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human chorionic gonadotropin negative | 0 | 0.005 | 0.013 | 0.992 | 3.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Juvenile idiopathic arthritis | 0 | 0.004 | 0.007 | 0.992 | 3.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pre-eclampsia | 0 | 0.003 | 0 | 0.992 | 4.311 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Listless | 0 | 0.01 | 0.08 | 0.992 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extravasation events (injections, infusions and implants) (SMQ) [narrow] | 0 | 0.012 | 0.107 | 0.992 | 2.625 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoxic-ischaemic encephalopathy | 0 | 0.009 | 0.065 | 0.992 | 2.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial test negative | 0 | 0.015 | 0.172 | 0.992 | 2.37 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash maculo-papular | 0 | 0.027 | 0.298 | 0.992 | 2.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Obstructive airways disorder | 0 | 0.014 | 0.13 | 0.992 | 2.522 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sputum discoloured | 0 | 0.011 | 0.086 | 0.992 | 2.737 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acoustic stimulation tests abnormal | 0 | 0.014 | 0.146 | 0.992 | 2.462 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral infarction | 0 | 0.022 | 0.257 | 0.992 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling of body temperature change | 0 | 0.031 | 0.334 | 0.992 | 1.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ambulatory | 0 | 0.012 | 0.129 | 0.992 | 2.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | T-lymphocyte count increased | 0 | 0.004 | 0.007 | 0.992 | 3.638 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.009 | 0.068 | 0.992 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Subdural haematoma | 0 | 0.005 | 0.01 | 0.992 | 3.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypokinesia | 0 | 0.014 | 0.148 | 0.992 | 2.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Illusion | 0 | 0.002 | 0 | 0.992 | 4.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pemphigoid | 0 | 0.008 | 0.048 | 0.992 | 2.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bicarbonate normal | 0 | 0.008 | 0.062 | 0.992 | 2.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound Doppler abnormal | 0 | 0.012 | 0.127 | 0.992 | 2.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tonsillitis | 0 | 0.007 | 0.038 | 0.992 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Migraine with aura | 0 | 0.008 | 0.05 | 0.992 | 2.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Purpura | 0 | 0.023 | 0.247 | 0.992 | 2.141 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyporesponsive to stimuli | 0 | 0.016 | 0.18 | 0.992 | 2.339 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation | 0 | 0.036 | 0.358 | 0.992 | 1.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte count decreased | 0 | 0.015 | 0.166 | 0.992 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intraocular pressure test normal | 0 | 0.003 | 0.001 | 0.992 | 4.106 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Treponema test negative | 0 | 0.009 | 0.059 | 0.992 | 2.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C antibody negative | 0 | 0.003 | 0.001 | 0.992 | 4.262 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian disorder | 0 | 0.001 | 0 | 0.992 | 5.764 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulation test normal | 0 | 0.009 | 0.066 | 0.992 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic steatosis | 0 | 0.003 | 0 | 0.992 | 4.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vomiting projectile | 0 | 0.016 | 0.162 | 0.992 | 2.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic varices haemorrhage | 0 | 0 | 0 | 0.992 | 4.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stomatitis | 0 | 0.022 | 0.234 | 0.992 | 2.177 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial test positive | 0 | 0.015 | 0.156 | 0.992 | 2.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean platelet volume normal | 0 | 0.019 | 0.212 | 0.992 | 2.24 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejection fraction normal | 0 | 0.005 | 0.014 | 0.992 | 3.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram cerebral normal | 0 | 0.026 | 0.295 | 0.992 | 2.022 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laparoscopic surgery | 0 | 0.009 | 0.067 | 0.992 | 2.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary hypertension (SMQ) [narrow] | 0 | 0.011 | 0.109 | 0.992 | 2.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological examination normal | 0 | 0.017 | 0.196 | 0.992 | 2.291 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serology negative | 0 | 0.006 | 0.021 | 0.992 | 3.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperthyroidism (SMQ) [narrow] | 0 | 0.008 | 0.056 | 0.992 | 2.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site inflammation | 0 | 0.011 | 0.109 | 0.992 | 2.621 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood gases abnormal | 0 | 0.005 | 0.007 | 0.992 | 3.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutropenia | 0 | 0.014 | 0.155 | 0.992 | 2.428 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver function test abnormal | 0 | 0.016 | 0.185 | 0.992 | 2.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal discomfort | 0 | 0.008 | 0.051 | 0.992 | 2.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperkalaemia | 0 | 0.004 | 0.003 | 0.992 | 3.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilia | 0 | 0.008 | 0.054 | 0.992 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin | 0 | 0.007 | 0.036 | 0.992 | 3.114 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothyroidism | 0 | 0.007 | 0.04 | 0.992 | 3.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin papilloma | 0 | 0.004 | 0.002 | 0.992 | 3.928 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemolysis | 0 | 0.006 | 0.024 | 0.992 | 3.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tension headache | 0 | 0.01 | 0.071 | 0.992 | 2.821 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Packed red blood cell transfusion | 0 | 0.019 | 0.211 | 0.992 | 2.243 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amniotic cavity infection | 0 | 0.001 | 0 | 0.992 | 5.611 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain oedema | 0 | 0.012 | 0.102 | 0.992 | 2.65 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumours of unspecified malignancy (SMQ) [narrow] | 0 | 0.009 | 0.068 | 0.992 | 2.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyscalculia | 0 | 0.001 | 0 | 0.992 | 5.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prosopagnosia | 0 | 0 | 0 | 0.992 | 5.531 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil count normal | 0 | 0.014 | 0.151 | 0.992 | 2.443 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF protein normal | 0 | 0.009 | 0.072 | 0.992 | 2.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukopenia | 0 | 0.008 | 0.046 | 0.992 | 3.014 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Linear IgA disease | 0 | 0.001 | 0 | 0.992 | 5.77 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture negative | 0 | 0.015 | 0.153 | 0.992 | 2.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scar | 0 | 0.017 | 0.178 | 0.992 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enteritis | 0 | 0.007 | 0.041 | 0.992 | 3.067 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningococcal sepsis | 0 | 0.001 | 0 | 0.992 | 5.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy bone marrow abnormal | 0 | 0.011 | 0.087 | 0.992 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abscess | 0 | 0.009 | 0.066 | 0.992 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging spinal | 0 | 0.017 | 0.202 | 0.992 | 2.271 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide decreased | 0 | 0.021 | 0.224 | 0.992 | 2.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF glucose | 0 | 0.002 | 0 | 0.992 | 4.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteoarthritis | 0 | 0.011 | 0.11 | 0.992 | 2.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occupational exposure to SARS-CoV-2 | 0 | 0.004 | 0.001 | 0.992 | 4.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia bacterial | 0 | 0.006 | 0.026 | 0.992 | 3.236 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal exposure before pregnancy | 0 | 0.003 | 0 | 0.992 | 4.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site discomfort | 0 | 0.006 | 0.018 | 0.992 | 3.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet distribution width | 0 | 0.005 | 0.007 | 0.992 | 3.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye disorder | 0 | 0.014 | 0.15 | 0.992 | 2.446 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral titre decreased | 0 | 0.002 | 0 | 0.992 | 5.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ill-defined disorder | 0 | 0.012 | 0.114 | 0.992 | 2.596 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lupus nephritis | 0 | 0.002 | 0 | 0.992 | 4.868 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchiectasis | 0 | 0.004 | 0.004 | 0.992 | 3.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematemesis | 0 | 0.015 | 0.169 | 0.992 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan normal | 0 | 0.024 | 0.28 | 0.992 | 2.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastric variceal ligation | 0 | 0 | 0 | 0.992 | 5.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte count increased | 0 | 0.006 | 0.03 | 0.992 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Motor developmental delay | 0 | 0.005 | 0.009 | 0.992 | 3.573 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diabetes mellitus | 0 | 0.014 | 0.131 | 0.992 | 2.518 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anxiety disorder | 0 | 0.004 | 0.007 | 0.992 | 3.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [narrow] | 0 | 0.007 | 0.034 | 0.992 | 3.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological examination | 0 | 0.02 | 0.216 | 0.992 | 2.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal hypoaesthesia | 0 | 0.017 | 0.153 | 0.991 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardioversion | 0 | 0.044 | 0.376 | 0.991 | 1.843 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asymptomatic COVID-19 | 0 | 0.003 | 0 | 0.991 | 4.637 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proteinuria | 0 | 0.006 | 0.012 | 0.991 | 3.494 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus infection | 0 | 0.004 | 0.004 | 0.991 | 3.831 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet-large cell ratio | 0 | 0.003 | 0 | 0.991 | 4.306 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac failure acute | 0 | 0.015 | 0.139 | 0.991 | 2.486 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infectious mononucleosis | 0 | 0.007 | 0.023 | 0.991 | 3.277 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Coagulopathy | 0 | 0.011 | 0.083 | 0.991 | 2.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal heart rate abnormal | 0 | 0.006 | 0.01 | 0.991 | 3.538 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stool analysis abnormal | 0 | 0.002 | 0 | 0.991 | 4.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal pigment epitheliopathy | 0 | 0.003 | 0 | 0.991 | 4.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uveitis | 0 | 0.005 | 0.008 | 0.991 | 3.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis D antibody negative | 0 | 0.001 | 0 | 0.991 | 5.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood albumin normal | 0 | 0.019 | 0.191 | 0.991 | 2.303 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mental disorder | 0 | 0.01 | 0.062 | 0.991 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature labour | 0 | 0.004 | 0.003 | 0.991 | 3.895 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye discharge | 0 | 0.012 | 0.103 | 0.991 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | PCO2 increased | 0 | 0.007 | 0.03 | 0.991 | 3.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colitis | 0 | 0.01 | 0.073 | 0.991 | 2.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute hepatitis B | 0 | 0 | 0 | 0.991 | 4.611 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual acuity tests abnormal | 0 | 0.003 | 0.001 | 0.991 | 4.146 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear discomfort | 0 | 0.059 | 0.457 | 0.991 | 1.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterovirus test positive | 0 | 0.005 | 0.011 | 0.991 | 3.51 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scarlet fever | 0 | 0.004 | 0.002 | 0.991 | 4.03 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seasonal allergy | 0 | 0.009 | 0.045 | 0.991 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatinine | 0 | 0.013 | 0.106 | 0.991 | 2.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucous stools | 0 | 0.008 | 0.041 | 0.991 | 3.058 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte morphology abnormal | 0 | 0.003 | 0 | 0.991 | 4.314 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site haemorrhage | 0 | 0.023 | 0.223 | 0.991 | 2.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site induration | 0 | 0.024 | 0.244 | 0.991 | 2.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site inflammation | 0 | 0.035 | 0.341 | 0.991 | 1.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Specific gravity urine normal | 0 | 0.014 | 0.118 | 0.991 | 2.573 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periarthritis | 0 | 0.011 | 0.08 | 0.991 | 2.769 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine sodium normal | 0 | 0.001 | 0 | 0.991 | 5.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF cell count normal | 0 | 0.009 | 0.043 | 0.991 | 3.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scoliosis | 0 | 0.004 | 0.003 | 0.991 | 3.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypophagia | 0 | 0.045 | 0.389 | 0.991 | 1.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Altered state of consciousness | 0 | 0.018 | 0.185 | 0.991 | 2.322 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermo-hypodermitis | 0 | 0.003 | 0 | 0.991 | 4.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic enzyme increased | 0 | 0.026 | 0.252 | 0.991 | 2.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrooesophageal reflux disease | 0 | 0.02 | 0.19 | 0.991 | 2.303 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Decreased immune responsiveness | 0 | 0.005 | 0.004 | 0.991 | 3.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash morbilliform | 0 | 0.005 | 0.008 | 0.991 | 3.618 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibody test abnormal | 0 | 0.004 | 0.004 | 0.991 | 3.781 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthostatic hypotension | 0 | 0.006 | 0.019 | 0.991 | 3.341 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Indirect infection transmission | 0 | 0.001 | 0 | 0.991 | 5.557 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin decreased | 0 | 0.01 | 0.071 | 0.991 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal transplant failure | 0 | 0 | 0 | 0.991 | 5.37 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver disorder | 0 | 0.006 | 0.011 | 0.991 | 3.509 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin G | 0 | 0.011 | 0.083 | 0.991 | 2.748 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serology test | 0 | 0.008 | 0.034 | 0.991 | 3.128 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Grip strength decreased | 0 | 0.031 | 0.295 | 0.991 | 2.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacterial vaginosis | 0 | 0.001 | 0 | 0.991 | 5.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil percentage | 0 | 0.019 | 0.173 | 0.991 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin test positive | 0 | 0.005 | 0.008 | 0.991 | 3.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cells urine positive | 0 | 0.008 | 0.037 | 0.991 | 3.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injury associated with device | 0 | 0.007 | 0.023 | 0.991 | 3.269 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF cell count increased | 0 | 0.004 | 0.003 | 0.991 | 3.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lichen planus | 0 | 0.004 | 0.003 | 0.991 | 3.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post vaccination autoinoculation | 0 | 0 | 0 | 0.991 | 5.257 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tracheitis | 0 | 0.004 | 0.003 | 0.991 | 3.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging heart | 0 | 0.004 | 0.002 | 0.991 | 4.013 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red cell distribution width normal | 0 | 0.022 | 0.227 | 0.991 | 2.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serology positive | 0 | 0.001 | 0 | 0.991 | 5.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Serum ferritin increased | 0 | 0.01 | 0.066 | 0.991 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin A normal | 0 | 0.01 | 0.067 | 0.991 | 2.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal paraesthesia | 0 | 0.018 | 0.187 | 0.991 | 2.317 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema | 0 | 0.041 | 0.352 | 0.991 | 1.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoptysis | 0 | 0.014 | 0.125 | 0.991 | 2.545 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchospasm | 0 | 0.016 | 0.153 | 0.991 | 2.432 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose | 0 | 0.045 | 0.398 | 0.991 | 1.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiration abnormal | 0 | 0.018 | 0.19 | 0.991 | 2.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic pneumonia (SMQ) [narrow] | 0 | 0.014 | 0.122 | 0.991 | 2.558 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal disorders (SMQ) [narrow] | 0 | 0.015 | 0.112 | 0.99 | 2.598 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte percentage | 0 | 0.02 | 0.177 | 0.99 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Animal bite | 0 | 0.001 | 0 | 0.99 | 5.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disability | 0 | 0.008 | 0.034 | 0.99 | 3.123 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mouth swelling | 0 | 0.022 | 0.209 | 0.99 | 2.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papule | 0 | 0.015 | 0.114 | 0.99 | 2.59 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperaesthesia | 0 | 0.025 | 0.217 | 0.99 | 2.22 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes simplex test negative | 0 | 0.016 | 0.119 | 0.99 | 2.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin laceration | 0 | 0.029 | 0.26 | 0.99 | 2.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotavirus infection | 0 | 0.002 | 0 | 0.99 | 5.137 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood electrolytes normal | 0 | 0.014 | 0.11 | 0.99 | 2.606 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bone pain | 0 | 0.04 | 0.336 | 0.99 | 1.923 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis haemophilus | 0 | 0.001 | 0 | 0.99 | 5.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothyroidism (SMQ) [narrow] | 0 | 0.007 | 0.023 | 0.99 | 3.273 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilus sepsis | 0 | 0.001 | 0 | 0.99 | 5.693 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilirubin conjugated increased | 0 | 0.008 | 0.03 | 0.99 | 3.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dry skin | 0 | 0.027 | 0.231 | 0.99 | 2.179 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Livedo reticularis | 0 | 0.017 | 0.152 | 0.99 | 2.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B core antigen positive | 0 | 0.001 | 0 | 0.99 | 5.577 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimation increased | 0 | 0.034 | 0.293 | 0.99 | 2.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rectal haemorrhage | 0 | 0.01 | 0.055 | 0.99 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral vascular disorder | 0 | 0.006 | 0.009 | 0.99 | 3.565 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic herpes simplex | 0 | 0.003 | 0 | 0.99 | 4.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alkaline phosphatase normal | 0 | 0.018 | 0.161 | 0.99 | 2.401 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza virus test | 0 | 0.018 | 0.162 | 0.99 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial pain | 0 | 0.031 | 0.266 | 0.99 | 2.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site discomfort | 0 | 0.047 | 0.382 | 0.99 | 1.829 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dental caries | 0 | 0.002 | 0 | 0.99 | 5.234 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibody test positive | 0 | 0.009 | 0.04 | 0.99 | 3.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin malignant tumours (SMQ) [narrow] | 0 | 0.005 | 0.002 | 0.99 | 3.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint stiffness | 0 | 0.022 | 0.196 | 0.99 | 2.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transaminases increased | 0 | 0.009 | 0.037 | 0.99 | 3.094 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibody test | 0 | 0.009 | 0.037 | 0.99 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection | 0 | 0.024 | 0.224 | 0.99 | 2.201 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood calcium normal | 0 | 0.027 | 0.242 | 0.99 | 2.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glomerular filtration rate decreased | 0 | 0.041 | 0.339 | 0.99 | 1.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemia (SMQ) [narrow] | 0 | 0.029 | 0.265 | 0.99 | 2.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiotensin converting enzyme | 0 | 0.005 | 0.002 | 0.99 | 3.959 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain of skin | 0 | 0.047 | 0.37 | 0.99 | 1.851 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle atrophy | 0 | 0.011 | 0.063 | 0.99 | 2.87 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oesophageal varices haemorrhage | 0 | 0.001 | 0 | 0.99 | 5.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MB | 0 | 0.004 | 0.001 | 0.99 | 4.032 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal ulceration (SMQ) [broad] | 0 | 0.016 | 0.126 | 0.99 | 2.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body height decreased | 0 | 0.006 | 0.011 | 0.99 | 3.509 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C3 | 0 | 0.013 | 0.082 | 0.99 | 2.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via eye contact | 0 | 0.005 | 0.003 | 0.99 | 3.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor normal | 0 | 0.009 | 0.039 | 0.99 | 3.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin malignant tumours (SMQ) [broad] | 0 | 0.006 | 0.007 | 0.99 | 3.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral hypoperfusion | 0 | 0.001 | 0 | 0.99 | 5.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Otitis media | 0 | 0.013 | 0.092 | 0.99 | 2.695 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelitis transverse | 0 | 0.027 | 0.242 | 0.99 | 2.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid factor negative | 0 | 0.01 | 0.047 | 0.99 | 2.997 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gene mutation identification test negative | 0 | 0.003 | 0 | 0.99 | 4.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatomyositis | 0 | 0.004 | 0.001 | 0.99 | 4.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Petit mal epilepsy | 0 | 0.015 | 0.12 | 0.99 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laryngeal oedema | 0 | 0.005 | 0.004 | 0.99 | 3.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chemotherapy | 0 | 0.016 | 0.131 | 0.99 | 2.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nerve conduction studies abnormal | 0 | 0.007 | 0.021 | 0.99 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine analysis abnormal | 0 | 0.028 | 0.242 | 0.99 | 2.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conjunctivitis | 0 | 0.012 | 0.088 | 0.99 | 2.718 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF red blood cell count positive | 0 | 0.007 | 0.015 | 0.99 | 3.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular tachycardia | 0 | 0.008 | 0.025 | 0.99 | 3.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apnoea | 0 | 0.012 | 0.072 | 0.99 | 2.809 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Carbon dioxide normal | 0 | 0.024 | 0.201 | 0.99 | 2.266 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram thorax | 0 | 0.083 | 0.501 | 0.99 | 1.614 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaginal haemorrhage | 0 | 0.014 | 0.097 | 0.99 | 2.667 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antinuclear antibody negative | 0 | 0.015 | 0.13 | 0.99 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complement factor C4 | 0 | 0.011 | 0.067 | 0.99 | 2.848 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intentional product misuse | 0 | 0.001 | 0 | 0.99 | 5.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella zoster pneumonia | 0 | 0.002 | 0 | 0.99 | 5.382 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy skin | 0 | 0.008 | 0.03 | 0.99 | 3.171 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pollakiuria | 0 | 0.026 | 0.225 | 0.99 | 2.197 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tooth discolouration | 0 | 0.001 | 0 | 0.99 | 5.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphadenitis | 0 | 0.027 | 0.232 | 0.99 | 2.177 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dystonia (SMQ) [narrow] | 0 | 0.022 | 0.202 | 0.99 | 2.264 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bordetella test | 0 | 0.002 | 0 | 0.99 | 4.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Basophil count decreased | 0 | 0.007 | 0.014 | 0.99 | 3.437 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood test abnormal | 0 | 0.028 | 0.262 | 0.99 | 2.098 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngitis | 0 | 0.015 | 0.104 | 0.99 | 2.634 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal ulceration (SMQ) [narrow] | 0 | 0.016 | 0.126 | 0.99 | 2.535 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenomegaly | 0 | 0.011 | 0.057 | 0.99 | 2.914 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Speech disorder developmental | 0 | 0.01 | 0.048 | 0.99 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site rash | 0 | 0.02 | 0.181 | 0.99 | 2.334 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Emotional distress | 0 | 0.024 | 0.208 | 0.99 | 2.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yellow fever vaccine-associated viscerotropic disease | 0 | 0 | 0 | 0.99 | 4.866 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroencephalogram abnormal | 0 | 0.024 | 0.205 | 0.99 | 2.253 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV test negative | 0 | 0.014 | 0.102 | 0.99 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis allergic | 0 | 0.014 | 0.098 | 0.99 | 2.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelitis | 0 | 0.007 | 0.02 | 0.99 | 3.313 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster meningitis | 0 | 0.002 | 0 | 0.99 | 5.257 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate decreased | 0 | 0.06 | 0.432 | 0.99 | 1.734 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmological examination abnormal | 0 | 0.014 | 0.099 | 0.99 | 2.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle twitching | 0 | 0.048 | 0.354 | 0.989 | 1.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal hypokinesia | 0 | 0.003 | 0 | 0.989 | 4.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scan with contrast abnormal | 0 | 0.032 | 0.264 | 0.989 | 2.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mood altered | 0 | 0.014 | 0.093 | 0.989 | 2.688 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster oticus | 0 | 0.004 | 0.001 | 0.989 | 4.15 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood immunoglobulin G normal | 0 | 0.017 | 0.114 | 0.989 | 2.584 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder related disorders (SMQ) [broad] | 0 | 0.026 | 0.223 | 0.989 | 2.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis | 0 | 0.013 | 0.071 | 0.989 | 2.813 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital, familial, neonatal and genetic disorders of the liver (SMQ) [broad] | 0 | 0.002 | 0 | 0.989 | 5.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Activated partial thromboplastin time prolonged | 0 | 0.011 | 0.047 | 0.989 | 2.994 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological malignant tumours (SMQ) [narrow] | 0 | 0.028 | 0.239 | 0.989 | 2.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture stool negative | 0 | 0.015 | 0.094 | 0.989 | 2.683 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicide/self-injury (SMQ) [narrow] | 0 | 0.012 | 0.054 | 0.989 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amenorrhoea | 0 | 0.003 | 0 | 0.989 | 4.852 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasal pruritus | 0 | 0.002 | 0 | 0.989 | 4.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crohn's disease | 0 | 0.008 | 0.022 | 0.989 | 3.282 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atelectasis | 0 | 0.049 | 0.358 | 0.989 | 1.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal dreams | 0 | 0.007 | 0.012 | 0.989 | 3.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroencephalogram | 0 | 0.039 | 0.314 | 0.989 | 1.971 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cells urine positive | 0 | 0.013 | 0.086 | 0.989 | 2.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypokalaemia | 0 | 0.015 | 0.101 | 0.989 | 2.646 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Kawasaki's disease | 0 | 0.01 | 0.033 | 0.989 | 3.132 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irritable bowel syndrome | 0 | 0.007 | 0.011 | 0.989 | 3.522 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sjogren's syndrome | 0 | 0.006 | 0.008 | 0.989 | 3.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin D dimer normal | 0 | 0.012 | 0.062 | 0.989 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin discolouration | 0 | 0.078 | 0.472 | 0.989 | 1.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinus disorder | 0 | 0.01 | 0.038 | 0.989 | 3.086 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head injury | 0 | 0.044 | 0.333 | 0.989 | 1.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis viral | 0 | 0.01 | 0.041 | 0.989 | 3.049 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunodeficiency | 0 | 0.017 | 0.127 | 0.989 | 2.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stridor | 0 | 0.017 | 0.117 | 0.989 | 2.57 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gallbladder related disorders (SMQ) [narrow] | 0 | 0.026 | 0.223 | 0.989 | 2.2 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.021 | 0.158 | 0.989 | 2.408 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Head discomfort | 0 | 0.066 | 0.421 | 0.989 | 1.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil count decreased | 0 | 0.01 | 0.039 | 0.989 | 3.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red cell distribution width increased | 0 | 0.014 | 0.085 | 0.989 | 2.73 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine analysis normal | 0 | 0.075 | 0.449 | 0.989 | 1.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematological malignant tumours (SMQ) [broad] | 0 | 0.028 | 0.239 | 0.989 | 2.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye movement disorder | 0 | 0.041 | 0.322 | 0.989 | 1.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | International normalised ratio normal | 0 | 0.021 | 0.163 | 0.989 | 2.389 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein total decreased | 0 | 0.01 | 0.04 | 0.989 | 3.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periodic acid Schiff stain | 0 | 0.001 | 0 | 0.989 | 5.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual acuity reduced | 0 | 0.008 | 0.017 | 0.989 | 3.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urine present | 0 | 0.05 | 0.375 | 0.989 | 1.84 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Restless legs syndrome | 0 | 0.006 | 0.004 | 0.989 | 3.763 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological examination abnormal | 0 | 0.016 | 0.102 | 0.989 | 2.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase MB increased | 0 | 0.006 | 0.004 | 0.989 | 3.808 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Olfactory test abnormal | 0 | 0.001 | 0 | 0.989 | 5.567 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase normal | 0 | 0.021 | 0.161 | 0.989 | 2.398 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plasmapheresis | 0 | 0.011 | 0.052 | 0.989 | 2.953 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysentery | 0 | 0.007 | 0.008 | 0.989 | 3.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proteinuria (SMQ) [narrow] | 0 | 0.025 | 0.207 | 0.989 | 2.246 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital swelling | 0 | 0.035 | 0.282 | 0.989 | 2.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary congestion | 0 | 0.019 | 0.141 | 0.989 | 2.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B test negative | 0 | 0.01 | 0.039 | 0.989 | 3.069 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Suicide/self-injury (SMQ) [broad] | 0 | 0.012 | 0.054 | 0.989 | 2.935 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device connection issue | 0 | 0.009 | 0.019 | 0.988 | 3.328 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeding disorder | 0 | 0.048 | 0.334 | 0.988 | 1.922 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Plethysmography | 0 | 0.001 | 0 | 0.988 | 5.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram abdomen | 0 | 0.073 | 0.433 | 0.988 | 1.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF test normal | 0 | 0.017 | 0.104 | 0.988 | 2.627 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight | 0 | 0.002 | 0 | 0.988 | 5.187 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight increased | 0 | 0.014 | 0.072 | 0.988 | 2.81 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein total normal | 0 | 0.025 | 0.18 | 0.988 | 2.329 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Judgement impaired | 0 | 0.001 | 0 | 0.988 | 5.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glaucoma (SMQ) [narrow] | 0 | 0.017 | 0.101 | 0.988 | 2.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaundice neonatal | 0 | 0.001 | 0 | 0.988 | 5.745 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyponatraemia | 0 | 0.015 | 0.083 | 0.988 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic response unexpected | 0 | 0.007 | 0.007 | 0.988 | 3.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac monitoring | 0 | 0.028 | 0.2 | 0.988 | 2.264 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear infection | 0 | 0.027 | 0.202 | 0.988 | 2.259 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccine positive rechallenge | 0 | 0.009 | 0.018 | 0.988 | 3.344 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Occupational exposure to product | 0 | 0.009 | 0.017 | 0.988 | 3.362 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nodule | 0 | 0.028 | 0.212 | 0.988 | 2.228 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Faeces discoloured | 0 | 0.016 | 0.083 | 0.988 | 2.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lyssavirus test positive | 0 | 0 | 0 | 0.988 | 1.279 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monocyte count increased | 0 | 0.01 | 0.029 | 0.988 | 3.182 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleuritic pain | 0 | 0.014 | 0.074 | 0.988 | 2.794 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parotitis | 0 | 0.004 | 0 | 0.988 | 4.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrophoresis | 0 | 0.001 | 0 | 0.988 | 5.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual field defect | 0 | 0.014 | 0.075 | 0.988 | 2.789 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial paresis | 0 | 0.033 | 0.249 | 0.988 | 2.125 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuroleptic malignant syndrome (SMQ) [algorithm] | 0 | 0.019 | 0.132 | 0.988 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin wound | 0 | 0.003 | 0 | 0.988 | 4.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circumstance or information capable of leading to medication error | 0 | 0.019 | 0.129 | 0.988 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urine analysis | 0 | 0.134 | 0.562 | 0.988 | 1.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heavy menstrual bleeding | 0 | 0.006 | 0.002 | 0.988 | 3.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF protein increased | 0 | 0.019 | 0.122 | 0.988 | 2.548 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cytomegalovirus test negative | 0 | 0.013 | 0.06 | 0.988 | 2.885 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stem cell transplant | 0 | 0.008 | 0.014 | 0.988 | 3.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial disease | 0 | 0 | 0 | 0.988 | 4.046 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Motor dysfunction | 0 | 0.017 | 0.099 | 0.988 | 2.652 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes virus infection | 0 | 0.012 | 0.047 | 0.988 | 2.99 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis C test negative | 0 | 0.008 | 0.013 | 0.988 | 3.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy skin abnormal | 0 | 0.022 | 0.147 | 0.988 | 2.444 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram head | 0 | 0.156 | 0.583 | 0.988 | 1.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophil count increased | 0 | 0.014 | 0.064 | 0.988 | 2.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urea urine | 0 | 0.001 | 0 | 0.988 | 5.583 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound abdomen | 0 | 0.013 | 0.067 | 0.988 | 2.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Typhoid fever | 0 | 0.001 | 0 | 0.988 | 5.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Complication of pregnancy | 0 | 0.001 | 0 | 0.988 | 5.754 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 antibody test | 0 | 0.009 | 0.02 | 0.988 | 3.305 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Areflexia | 0 | 0.013 | 0.064 | 0.988 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood culture | 0 | 0.051 | 0.35 | 0.988 | 1.889 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan | 0 | 0.05 | 0.336 | 0.988 | 1.918 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil percentage increased | 0 | 0.018 | 0.104 | 0.987 | 2.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Demyelination | 0 | 0.01 | 0.023 | 0.987 | 3.262 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seizure like phenomena | 0 | 0.038 | 0.265 | 0.987 | 2.082 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram normal | 0 | 0.103 | 0.488 | 0.987 | 1.628 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Near death experience | 0 | 0.009 | 0.016 | 0.987 | 3.38 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hallucination | 0 | 0.047 | 0.318 | 0.987 | 1.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic stroke | 0 | 0.019 | 0.105 | 0.987 | 2.62 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidental exposure to product | 0 | 0.012 | 0.039 | 0.987 | 3.061 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug hypersensitivity | 0 | 0.021 | 0.13 | 0.987 | 2.509 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune system disorder | 0 | 0.019 | 0.098 | 0.987 | 2.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eosinophilic pneumonia (SMQ) [algorithm] | 0 | 0.02 | 0.115 | 0.987 | 2.574 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination complication | 0 | 0.085 | 0.446 | 0.987 | 1.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal pain lower | 0 | 0.023 | 0.156 | 0.987 | 2.41 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal function test normal | 0 | 0.011 | 0.029 | 0.987 | 3.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rales | 0 | 0.009 | 0.016 | 0.987 | 3.386 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema multiforme | 0 | 0.048 | 0.316 | 0.987 | 1.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood albumin decreased | 0 | 0.023 | 0.141 | 0.987 | 2.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irritability | 0 | 0.05 | 0.327 | 0.987 | 1.937 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyslipidaemia (SMQ) [broad] | 0 | 0.027 | 0.177 | 0.987 | 2.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abnormal behaviour | 0 | 0.046 | 0.311 | 0.987 | 1.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes ophthalmic | 0 | 0.005 | 0 | 0.987 | 4.308 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningococcal bacteraemia | 0 | 0.002 | 0 | 0.987 | 5.164 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Renal failure | 0 | 0.031 | 0.219 | 0.987 | 2.208 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung consolidation | 0 | 0.009 | 0.018 | 0.987 | 3.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interstitial lung disease | 0 | 0.009 | 0.015 | 0.987 | 3.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood albumin | 0 | 0.007 | 0.006 | 0.987 | 3.687 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to vaccinated person | 0 | 0.002 | 0 | 0.987 | 5.287 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Panic attack | 0 | 0.024 | 0.149 | 0.987 | 2.433 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Upper respiratory tract infection | 0 | 0.027 | 0.182 | 0.987 | 2.32 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram thorax normal | 0 | 0.022 | 0.133 | 0.987 | 2.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac disorder | 0 | 0.025 | 0.164 | 0.987 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tongue pruritus | 0 | 0.023 | 0.153 | 0.987 | 2.422 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymphocyte percentage decreased | 0 | 0.021 | 0.124 | 0.987 | 2.537 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Posture abnormal | 0 | 0.039 | 0.263 | 0.987 | 2.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinitis | 0 | 0.013 | 0.051 | 0.987 | 2.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil count decreased | 0 | 0.028 | 0.196 | 0.987 | 2.276 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tendinopathies and ligament disorders (SMQ) [narrow] | 0 | 0.028 | 0.188 | 0.987 | 2.301 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyslipidaemia (SMQ) [narrow] | 0 | 0.027 | 0.177 | 0.987 | 2.336 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autism spectrum disorder | 0 | 0.011 | 0.031 | 0.987 | 3.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood potassium decreased | 0 | 0.052 | 0.312 | 0.986 | 1.965 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Local reaction | 0 | 0.052 | 0.315 | 0.986 | 1.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemiplegia | 0 | 0.018 | 0.084 | 0.986 | 2.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal premalignant disorders (SMQ) [narrow] | 0 | 0.012 | 0.032 | 0.986 | 3.133 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchiolitis | 0 | 0.016 | 0.068 | 0.986 | 2.828 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depressed level of consciousness | 0 | 0.041 | 0.252 | 0.986 | 2.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dry eye | 0 | 0.011 | 0.024 | 0.986 | 3.236 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adverse drug reaction | 0 | 0.015 | 0.061 | 0.986 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Measles | 0 | 0.006 | 0.002 | 0.986 | 4.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Protein total | 0 | 0.008 | 0.006 | 0.986 | 3.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil count normal | 0 | 0.018 | 0.083 | 0.986 | 2.731 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Walking aid user | 0 | 0.027 | 0.167 | 0.986 | 2.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination error | 0 | 0.007 | 0.003 | 0.986 | 3.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Monoplegia | 0 | 0.013 | 0.043 | 0.986 | 3.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Food allergy | 0 | 0.028 | 0.172 | 0.986 | 2.35 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin concentration normal | 0 | 0.02 | 0.106 | 0.986 | 2.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug interaction | 0 | 0.005 | 0.001 | 0.986 | 4.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophil percentage decreased | 0 | 0.017 | 0.083 | 0.986 | 2.736 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematuria | 0 | 0.02 | 0.104 | 0.986 | 2.622 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver function test normal | 0 | 0.018 | 0.083 | 0.986 | 2.733 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound abdomen abnormal | 0 | 0.014 | 0.043 | 0.986 | 3.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contusion | 0 | 0.094 | 0.444 | 0.986 | 1.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital and eyelid disorders (SMQ) [narrow] | 0 | 0.15 | 0.549 | 0.986 | 1.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Septic shock | 0 | 0.02 | 0.102 | 0.986 | 2.63 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Periorbital and eyelid disorders (SMQ) [broad] | 0 | 0.15 | 0.549 | 0.986 | 1.527 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site oedema | 0 | 0.023 | 0.135 | 0.986 | 2.488 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product quality issue | 0 | 0.011 | 0.026 | 0.986 | 3.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint swelling | 0 | 0.085 | 0.435 | 0.986 | 1.719 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella virus test positive | 0 | 0.008 | 0.007 | 0.986 | 3.642 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensitive skin | 0 | 0.016 | 0.062 | 0.986 | 2.863 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiomyopathy | 0 | 0.012 | 0.028 | 0.986 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypokalaemia (SMQ) [narrow] | 0 | 0.05 | 0.299 | 0.986 | 1.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple organ dysfunction syndrome | 0 | 0.019 | 0.1 | 0.986 | 2.643 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell count normal | 0 | 0.022 | 0.126 | 0.986 | 2.523 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Proteinuria (SMQ) [broad] | 0 | 0.031 | 0.2 | 0.986 | 2.262 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site cellulitis | 0 | 0.04 | 0.247 | 0.986 | 2.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune demyelinating disease | 0 | 0.001 | 0 | 0.986 | 4.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laboratory test abnormal | 0 | 0.037 | 0.232 | 0.986 | 2.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoacusis | 0 | 0.051 | 0.317 | 0.986 | 1.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somatic symptom disorder | 0 | 0.002 | 0 | 0.986 | 5.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal premalignant disorders (SMQ) [broad] | 0 | 0.012 | 0.032 | 0.986 | 3.133 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site granuloma | 0 | 0.004 | 0 | 0.986 | 4.774 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Shoulder injury related to vaccine administration | 0 | 0.011 | 0.026 | 0.986 | 3.209 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scab | 0 | 0.019 | 0.097 | 0.986 | 2.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain in jaw | 0 | 0.066 | 0.37 | 0.986 | 1.842 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.024 | 0.137 | 0.986 | 2.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic product effect incomplete | 0 | 0.002 | 0 | 0.986 | 5.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye swelling | 0 | 0.101 | 0.471 | 0.986 | 1.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella zoster virus infection | 0 | 0.005 | 0.001 | 0.986 | 4.237 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | H3N2 influenza | 0 | 0.001 | 0 | 0.986 | 4.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet transfusion | 0 | 0.015 | 0.058 | 0.986 | 2.899 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conduction defects (SMQ) [narrow] | 0 | 0.024 | 0.13 | 0.985 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell haemoglobin normal | 0 | 0.022 | 0.106 | 0.985 | 2.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal seizure | 0 | 0.001 | 0 | 0.985 | 5.295 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bacteraemia | 0 | 0.004 | 0 | 0.985 | 4.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapeutic response decreased | 0 | 0.005 | 0 | 0.985 | 4.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Photosensitivity reaction | 0 | 0.01 | 0.014 | 0.985 | 3.412 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell count | 0 | 0.028 | 0.159 | 0.985 | 2.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-aquaporin-4 antibody negative | 0 | 0.003 | 0 | 0.985 | 5.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B DNA assay negative | 0 | 0.001 | 0 | 0.985 | 5.655 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis pneumococcal | 0 | 0.002 | 0 | 0.985 | 5.388 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemodialysis | 0 | 0.005 | 0 | 0.985 | 4.497 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Morbillivirus test positive | 0 | 0.003 | 0 | 0.985 | 4.936 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Productive cough | 0 | 0.044 | 0.251 | 0.985 | 2.11 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye pruritus | 0 | 0.046 | 0.261 | 0.985 | 2.085 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mite allergy | 0 | 0.006 | 0.001 | 0.985 | 4.048 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fever neonatal | 0 | 0.001 | 0 | 0.985 | 4.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactic acid increased | 0 | 0.036 | 0.211 | 0.985 | 2.222 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anticholinergic syndrome (SMQ) [algorithm] | 0 | 0.039 | 0.23 | 0.985 | 2.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunology test | 0 | 0.016 | 0.056 | 0.985 | 2.906 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic neuritis | 0 | 0.014 | 0.038 | 0.985 | 3.07 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood chloride normal | 0 | 0.031 | 0.185 | 0.985 | 2.305 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conduction defects (SMQ) [broad] | 0 | 0.024 | 0.13 | 0.985 | 2.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurone-specific enolase decreased | 0 | 0.001 | 0 | 0.985 | 5.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dementia (SMQ) [narrow] | 0 | 0.015 | 0.052 | 0.985 | 2.939 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Irritability postvaccinal | 0 | 0.005 | 0 | 0.985 | 4.545 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lower respiratory tract infection | 0 | 0.007 | 0.003 | 0.985 | 3.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mental status changes | 0 | 0.122 | 0.498 | 0.985 | 1.607 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ataxia | 0 | 0.028 | 0.158 | 0.985 | 2.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Microagglutination test | 0 | 0.001 | 0 | 0.985 | 5.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breech presentation | 0 | 0.004 | 0 | 0.985 | 4.685 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angina pectoris | 0 | 0.02 | 0.087 | 0.985 | 2.706 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumococcal bacteraemia | 0 | 0.001 | 0 | 0.985 | 4.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound skull | 0 | 0.007 | 0.001 | 0.985 | 4.023 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nervous system disorder | 0 | 0.015 | 0.05 | 0.985 | 2.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myelodysplastic syndrome (SMQ) [broad] | 0 | 0.042 | 0.252 | 0.985 | 2.109 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mucosal hyperaemia | 0 | 0.001 | 0 | 0.985 | 5.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post viral fatigue syndrome | 0 | 0.004 | 0 | 0.984 | 4.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysuria | 0 | 0.02 | 0.081 | 0.984 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toothache | 0 | 0.035 | 0.191 | 0.984 | 2.281 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemolytic disorders (SMQ) [narrow] | 0 | 0.025 | 0.123 | 0.984 | 2.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurological symptom | 0 | 0.046 | 0.252 | 0.984 | 2.105 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea normal | 0 | 0.031 | 0.171 | 0.984 | 2.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Salmonella test positive | 0 | 0.003 | 0 | 0.984 | 5.081 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging head | 0 | 0.077 | 0.368 | 0.984 | 1.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | International normalised ratio | 0 | 0.037 | 0.204 | 0.984 | 2.241 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sinusitis | 0 | 0.032 | 0.173 | 0.984 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemolytic disorders (SMQ) [broad] | 0 | 0.03 | 0.159 | 0.984 | 2.39 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anti-myelin-associated glycoprotein antibodies positive | 0 | 0.001 | 0 | 0.984 | 5.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Viral test negative | 0 | 0.028 | 0.142 | 0.984 | 2.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory loss | 0 | 0.043 | 0.234 | 0.984 | 2.155 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Device leakage | 0 | 0.002 | 0 | 0.984 | 5.672 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Splenic artery embolisation | 0 | 0.001 | 0 | 0.984 | 4.841 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electroencephalogram normal | 0 | 0.044 | 0.24 | 0.984 | 2.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cystitis | 0 | 0.01 | 0.009 | 0.984 | 3.56 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute respiratory failure | 0 | 0.022 | 0.095 | 0.984 | 2.659 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Surgery | 0 | 0.028 | 0.142 | 0.984 | 2.453 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute respiratory distress syndrome | 0 | 0.011 | 0.015 | 0.984 | 3.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial necrosis marker | 0 | 0.015 | 0.043 | 0.984 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to metals | 0 | 0.004 | 0 | 0.984 | 4.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procalcitonin | 0 | 0.009 | 0.006 | 0.984 | 3.656 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal haemorrhage | 0 | 0.013 | 0.033 | 0.984 | 3.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stillbirth | 0 | 0.004 | 0 | 0.984 | 4.811 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product container issue | 0 | 0.004 | 0 | 0.984 | 4.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sneezing | 0 | 0.031 | 0.156 | 0.984 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness unilateral | 0 | 0.058 | 0.307 | 0.984 | 1.972 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation (SMQ) [narrow] | 0 | 0.018 | 0.054 | 0.983 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diphtheria | 0 | 0.001 | 0 | 0.983 | 5.489 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product label confusion | 0 | 0.011 | 0.012 | 0.983 | 3.45 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [narrow] | 0 | 0.029 | 0.135 | 0.983 | 2.477 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agitation | 0 | 0.044 | 0.235 | 0.983 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site granuloma | 0 | 0.002 | 0 | 0.983 | 5.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensation of foreign body | 0 | 0.036 | 0.183 | 0.983 | 2.305 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradyarrhythmias (incl conduction defects and disorders of sinus node function) (SMQ) [broad] | 0 | 0.029 | 0.135 | 0.983 | 2.477 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apgar score abnormal | 0 | 0.003 | 0 | 0.983 | 5.231 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash rubelliform | 0 | 0.004 | 0 | 0.983 | 4.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutrophilia | 0 | 0.008 | 0.003 | 0.983 | 3.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation (SMQ) [broad] | 0 | 0.018 | 0.054 | 0.983 | 2.915 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound scan abnormal | 0 | 0.033 | 0.163 | 0.983 | 2.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inflammation | 0 | 0.09 | 0.395 | 0.983 | 1.784 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Narcolepsy | 0 | 0.004 | 0 | 0.983 | 5.001 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site reaction | 0 | 0.019 | 0.059 | 0.983 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site warmth | 0 | 0.036 | 0.188 | 0.983 | 2.29 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Screaming | 0 | 0.041 | 0.212 | 0.983 | 2.214 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen therapy | 0 | 0.034 | 0.17 | 0.983 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ejection fraction decreased | 0 | 0.016 | 0.04 | 0.983 | 3.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polymyalgia rheumatica | 0 | 0.017 | 0.045 | 0.983 | 2.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electromyogram abnormal | 0 | 0.014 | 0.027 | 0.983 | 3.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccinia virus infection | 0 | 0.001 | 0 | 0.983 | 4.619 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Jaundice | 0 | 0.017 | 0.052 | 0.983 | 2.931 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anogenital warts | 0 | 0.003 | 0 | 0.983 | 5.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest X-ray | 0 | 0.26 | 0.61 | 0.983 | 1.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C-reactive protein | 0 | 0.049 | 0.262 | 0.983 | 2.08 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loop electrosurgical excision procedure | 0 | 0.002 | 0 | 0.983 | 5.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis, non-infectious (SMQ) [broad] | 0 | 0.017 | 0.047 | 0.982 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy test positive | 0 | 0.01 | 0.006 | 0.982 | 3.645 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neoplasm malignant | 0 | 0.012 | 0.014 | 0.982 | 3.4 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Scratch | 0 | 0.012 | 0.012 | 0.982 | 3.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholestasis and jaundice of hepatic origin (SMQ) [broad] | 0 | 0.025 | 0.101 | 0.982 | 2.626 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertonia | 0 | 0.016 | 0.032 | 0.982 | 3.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital biliary disorders (SMQ) [narrow] | 0 | 0.002 | 0 | 0.982 | 5.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulse absent | 0 | 0.063 | 0.301 | 0.982 | 1.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis, non-infectious (SMQ) [narrow] | 0 | 0.017 | 0.047 | 0.982 | 2.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothermia | 0 | 0.016 | 0.035 | 0.982 | 3.09 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lipodystrophy (SMQ) [broad] | 0 | 0.058 | 0.275 | 0.982 | 2.042 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Severe cutaneous adverse reactions (SMQ) [narrow] | 0 | 0.081 | 0.355 | 0.982 | 1.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disease recurrence | 0 | 0.013 | 0.019 | 0.982 | 3.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular hyperaemia | 0 | 0.048 | 0.232 | 0.982 | 2.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital biliary disorders (SMQ) [broad] | 0 | 0.002 | 0 | 0.982 | 5.629 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotonic-hyporesponsive episode (SMQ) [algorithm] | 0 | 0.02 | 0.059 | 0.982 | 2.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram pulmonary abnormal | 0 | 0.028 | 0.116 | 0.982 | 2.555 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Enterovirus infection | 0 | 0.006 | 0 | 0.982 | 4.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant lymphomas (SMQ) [broad] | 0 | 0.03 | 0.135 | 0.982 | 2.472 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematocrit normal | 0 | 0.042 | 0.206 | 0.982 | 2.23 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary retention | 0 | 0.023 | 0.084 | 0.982 | 2.713 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhabdomyolysis | 0 | 0.017 | 0.042 | 0.982 | 3.015 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperacusis | 0 | 0.017 | 0.044 | 0.982 | 2.999 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bursitis | 0 | 0.016 | 0.033 | 0.982 | 3.108 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mean cell volume normal | 0 | 0.03 | 0.127 | 0.982 | 2.505 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Yellow fever vaccine-associated neurotropic disease | 0 | 0.001 | 0 | 0.982 | 5.157 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve disorders (SMQ) [narrow] | 0 | 0.02 | 0.06 | 0.982 | 2.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood sodium decreased | 0 | 0.038 | 0.174 | 0.982 | 2.33 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin D dimer | 0 | 0.047 | 0.224 | 0.981 | 2.175 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disorientation | 0 | 0.085 | 0.36 | 0.981 | 1.849 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic cytopenias affecting more than one type of blood cell (SMQ) [broad] | 0 | 0.039 | 0.172 | 0.981 | 2.334 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral herpes | 0 | 0.028 | 0.105 | 0.981 | 2.604 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet count increased | 0 | 0.024 | 0.077 | 0.981 | 2.753 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reaction to excipient | 0 | 0.004 | 0 | 0.981 | 4.879 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dermatitis atopic | 0 | 0.013 | 0.013 | 0.981 | 3.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalitis | 0 | 0.032 | 0.129 | 0.981 | 2.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging abnormal | 0 | 0.055 | 0.256 | 0.981 | 2.089 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | CSF culture negative | 0 | 0.017 | 0.033 | 0.981 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune disorder | 0 | 0.019 | 0.045 | 0.981 | 2.98 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal discomfort | 0 | 0.051 | 0.235 | 0.981 | 2.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure measurement | 0 | 0.025 | 0.081 | 0.981 | 2.729 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Middle ear inflammation | 0 | 0.005 | 0 | 0.981 | 4.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Throat clearing | 0 | 0.027 | 0.103 | 0.981 | 2.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site oedema | 0 | 0.017 | 0.033 | 0.981 | 3.111 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine and fallopian tube tumours of unspecified malignancy (SMQ) [broad] | 0 | 0.003 | 0 | 0.981 | 5.532 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericardial effusion | 0 | 0.022 | 0.072 | 0.981 | 2.786 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood potassium increased | 0 | 0.026 | 0.099 | 0.981 | 2.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell sedimentation rate normal | 0 | 0.036 | 0.163 | 0.981 | 2.366 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate irregular | 0 | 0.045 | 0.203 | 0.981 | 2.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendicectomy | 0 | 0.021 | 0.059 | 0.981 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect product formulation administered | 0 | 0.004 | 0 | 0.981 | 4.921 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HBV-DNA polymerase increased | 0 | 0.001 | 0 | 0.98 | 4.007 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site pruritus | 0 | 0.015 | 0.019 | 0.98 | 3.29 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biopsy muscle abnormal | 0 | 0.004 | 0 | 0.98 | 5.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactic acidosis (SMQ) [narrow] | 0 | 0.041 | 0.171 | 0.98 | 2.335 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Menstrual disorder | 0 | 0.002 | 0 | 0.98 | 5.688 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune thrombocytopenia | 0 | 0.035 | 0.145 | 0.98 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza virus test positive | 0 | 0.007 | 0 | 0.98 | 4.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid dysfunction (SMQ) [narrow] | 0 | 0.019 | 0.041 | 0.98 | 3.016 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteoporosis/osteopenia (SMQ) [broad] | 0 | 0.046 | 0.198 | 0.98 | 2.247 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ovarian failure | 0 | 0.002 | 0 | 0.98 | 5.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Torsade de pointes/QT prolongation (SMQ) [narrow] | 0 | 0.015 | 0.02 | 0.98 | 3.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunohistochemistry | 0 | 0.004 | 0 | 0.98 | 5.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blindness | 0 | 0.045 | 0.191 | 0.98 | 2.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alopecia | 0 | 0.022 | 0.064 | 0.98 | 2.83 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimal disorders (SMQ) [broad] | 0 | 0.059 | 0.257 | 0.98 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lacrimal disorders (SMQ) [narrow] | 0 | 0.059 | 0.257 | 0.98 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging spinal abnormal | 0 | 0.033 | 0.131 | 0.98 | 2.483 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden hearing loss | 0 | 0.02 | 0.05 | 0.98 | 2.943 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Transient ischaemic attack | 0 | 0.035 | 0.145 | 0.98 | 2.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute pancreatitis (SMQ) [algorithm] | 0 | 0.039 | 0.17 | 0.98 | 2.34 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Breath sounds abnormal | 0 | 0.027 | 0.093 | 0.98 | 2.661 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Maternal exposure during breast feeding | 0 | 0.01 | 0.005 | 0.98 | 3.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bradycardia | 0 | 0.035 | 0.145 | 0.98 | 2.43 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adverse reaction | 0 | 0.038 | 0.157 | 0.98 | 2.384 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidental underdose | 0 | 0.006 | 0 | 0.979 | 4.46 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotonic-hyporesponsive episode (SMQ) [narrow] | 0 | 0.017 | 0.024 | 0.979 | 3.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Prophylaxis | 0 | 0.006 | 0 | 0.979 | 4.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site bruising | 0 | 0.091 | 0.348 | 0.979 | 1.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Contraindication to vaccination | 0 | 0.014 | 0.013 | 0.979 | 3.409 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product complaint | 0 | 0.005 | 0 | 0.979 | 4.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle tightness | 0 | 0.061 | 0.249 | 0.979 | 2.1 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage laboratory terms (SMQ) [narrow] | 0 | 0.05 | 0.208 | 0.979 | 2.216 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotonia | 0 | 0.037 | 0.144 | 0.979 | 2.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site swelling | 0 | 0.06 | 0.246 | 0.979 | 2.106 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic lupus erythematosus | 0 | 0.014 | 0.011 | 0.979 | 3.475 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypotonic-hyporesponsive episode | 0 | 0.017 | 0.024 | 0.979 | 3.207 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product use in unapproved indication | 0 | 0.007 | 0 | 0.979 | 4.396 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract congestion | 0 | 0.088 | 0.345 | 0.979 | 1.877 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Encephalopathy | 0 | 0.026 | 0.08 | 0.979 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific inflammation (SMQ) [narrow] | 0 | 0.035 | 0.131 | 0.979 | 2.48 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diarrhoea haemorrhagic | 0 | 0.022 | 0.055 | 0.979 | 2.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness neurosensory | 0 | 0.023 | 0.058 | 0.979 | 2.873 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Labelled drug-drug interaction medication error | 0 | 0.005 | 0 | 0.979 | 4.835 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhabdomyolysis/myopathy (SMQ) [narrow] | 0 | 0.025 | 0.069 | 0.979 | 2.793 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal disorder | 0 | 0.031 | 0.106 | 0.979 | 2.588 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin lesion | 0 | 0.038 | 0.137 | 0.978 | 2.453 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swollen tongue | 0 | 0.177 | 0.487 | 0.978 | 1.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eczema | 0 | 0.033 | 0.114 | 0.978 | 2.554 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac failure | 0 | 0.026 | 0.065 | 0.978 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wheelchair user | 0 | 0.018 | 0.03 | 0.978 | 3.136 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Crying | 0 | 0.067 | 0.258 | 0.978 | 2.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular fibrillation | 0 | 0.039 | 0.143 | 0.978 | 2.429 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Taste disorder | 0 | 0.046 | 0.177 | 0.978 | 2.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell sedimentation rate increased | 0 | 0.059 | 0.232 | 0.978 | 2.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactate dehydrogenase increased | 0 | 0.022 | 0.048 | 0.978 | 2.951 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic fatigue syndrome | 0 | 0.006 | 0 | 0.978 | 4.679 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound antenatal screen abnormal | 0 | 0.01 | 0.002 | 0.978 | 3.954 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Discomfort | 0 | 0.151 | 0.454 | 0.978 | 1.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lip swelling | 0 | 0.175 | 0.485 | 0.978 | 1.612 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Intussusception | 0 | 0.01 | 0.002 | 0.978 | 3.916 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Febrile convulsion | 0 | 0.037 | 0.121 | 0.977 | 2.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autonomic nervous system imbalance | 0 | 0.009 | 0.001 | 0.977 | 4.076 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cholestasis and jaundice of hepatic origin (SMQ) [narrow] | 0 | 0.023 | 0.049 | 0.977 | 2.938 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site urticaria | 0 | 0.083 | 0.3 | 0.977 | 1.968 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaemia | 0 | 0.038 | 0.13 | 0.977 | 2.479 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram | 0 | 0.258 | 0.546 | 0.977 | 1.509 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood lactic acid | 0 | 0.07 | 0.262 | 0.977 | 2.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swelling face | 0 | 0.21 | 0.505 | 0.977 | 1.574 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyponatraemia/SIADH (SMQ) [narrow] | 0 | 0.051 | 0.19 | 0.977 | 2.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin normal | 0 | 0.031 | 0.086 | 0.977 | 2.686 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose normal | 0 | 0.089 | 0.322 | 0.977 | 1.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cyanosis | 0 | 0.066 | 0.25 | 0.977 | 2.092 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product physical issue | 0 | 0.003 | 0 | 0.977 | 5.473 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bronchitis | 0 | 0.04 | 0.144 | 0.977 | 2.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspepsia | 0 | 0.052 | 0.2 | 0.977 | 2.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood glucose increased | 0 | 0.136 | 0.419 | 0.977 | 1.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ear pain | 0 | 0.083 | 0.292 | 0.976 | 1.984 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoaesthesia oral | 0 | 0.106 | 0.348 | 0.976 | 1.86 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Measles post vaccine | 0 | 0.004 | 0 | 0.976 | 5.335 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | X-ray | 0 | 0.08 | 0.28 | 0.976 | 2.012 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood potassium normal | 0 | 0.053 | 0.192 | 0.976 | 2.255 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxoplasma serology | 0 | 0.002 | 0 | 0.976 | 5.542 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactic shock | 0 | 0.03 | 0.076 | 0.976 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperventilation | 0 | 0.02 | 0.028 | 0.976 | 3.154 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [narrow] | 0 | 0.017 | 0.018 | 0.976 | 3.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic inflammatory response syndrome | 0 | 0.013 | 0.006 | 0.976 | 3.634 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal death | 0 | 0.01 | 0.001 | 0.976 | 3.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyponatraemia/SIADH (SMQ) [broad] | 0 | 0.072 | 0.26 | 0.976 | 2.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angioedema | 0 | 0.059 | 0.213 | 0.976 | 2.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatinine normal | 0 | 0.049 | 0.171 | 0.976 | 2.324 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactation related topics (incl neonatal exposure through breast milk) (SMQ) [broad] | 0 | 0.017 | 0.018 | 0.976 | 3.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antibody positive | 0 | 0.001 | 0 | 0.976 | 3.499 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bilevel positive airway pressure | 0 | 0.016 | 0.012 | 0.976 | 3.424 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Limb discomfort | 0 | 0.202 | 0.493 | 0.976 | 1.592 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Induration | 0 | 0.077 | 0.275 | 0.976 | 2.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood sodium normal | 0 | 0.054 | 0.187 | 0.975 | 2.267 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin normal | 0 | 0.052 | 0.174 | 0.975 | 2.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumonia pneumococcal | 0 | 0.001 | 0 | 0.975 | 5.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal exposures via breast milk (SMQ) [narrow] | 0 | 0.013 | 0.004 | 0.975 | 3.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Petechiae | 0 | 0.067 | 0.231 | 0.975 | 2.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiomyopathy (SMQ) [narrow] | 0 | 0.038 | 0.113 | 0.975 | 2.546 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site nodule | 0 | 0.063 | 0.219 | 0.975 | 2.17 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immediate post-injection reaction | 0 | 0.243 | 0.515 | 0.975 | 1.553 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatine phosphokinase increased | 0 | 0.039 | 0.118 | 0.975 | 2.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging normal | 0 | 0.076 | 0.26 | 0.975 | 2.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal exposures via breast milk (SMQ) [broad] | 0 | 0.013 | 0.004 | 0.975 | 3.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HIV antibody | 0 | 0.001 | 0 | 0.975 | 4.791 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilus infection | 0 | 0.004 | 0 | 0.974 | 5.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mumps | 0 | 0.003 | 0 | 0.974 | 5.512 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tract disorders (SMQ) [broad] | 0 | 0.027 | 0.053 | 0.974 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital, familial and genetic disorders (SMQ) [narrow] | 0 | 0.038 | 0.104 | 0.974 | 2.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extensive swelling of vaccinated limb | 0 | 0.017 | 0.012 | 0.974 | 3.427 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Speech disorder | 0 | 0.107 | 0.335 | 0.974 | 1.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Culture urine negative | 0 | 0.032 | 0.078 | 0.974 | 2.727 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific dysfunction (SMQ) [narrow] | 0 | 0.068 | 0.225 | 0.974 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary tract disorders (SMQ) [narrow] | 0 | 0.027 | 0.053 | 0.974 | 2.896 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [broad] | 0 | 0.039 | 0.107 | 0.974 | 2.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Congenital, familial and genetic disorders (SMQ) [broad] | 0 | 0.038 | 0.104 | 0.974 | 2.586 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tenderness | 0 | 0.161 | 0.429 | 0.974 | 1.699 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression | 0 | 0.022 | 0.028 | 0.974 | 3.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic lupus erythematosus (SMQ) [algorithm] | 0 | 0.028 | 0.055 | 0.974 | 2.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product distribution issue | 0 | 0.002 | 0 | 0.974 | 5.674 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ) [narrow] | 0 | 0.038 | 0.108 | 0.974 | 2.566 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Weight decreased | 0 | 0.059 | 0.185 | 0.973 | 2.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression (excl suicide and self injury) (SMQ) [narrow] | 0 | 0.035 | 0.086 | 0.973 | 2.675 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysphonia | 0 | 0.075 | 0.245 | 0.973 | 2.096 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspartate aminotransferase normal | 0 | 0.038 | 0.1 | 0.973 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myofascitis | 0 | 0.005 | 0 | 0.973 | 5.274 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Musculoskeletal pain | 0 | 0.052 | 0.16 | 0.973 | 2.352 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate | 0 | 0.023 | 0.029 | 0.973 | 3.12 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Systemic lupus erythematosus (SMQ) [narrow] | 0 | 0.029 | 0.053 | 0.973 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Brain natriuretic peptide increased | 0 | 0.028 | 0.049 | 0.973 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Investigation | 0 | 0.015 | 0.005 | 0.973 | 3.671 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anosmia | 0 | 0.032 | 0.069 | 0.973 | 2.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombosis | 0 | 0.05 | 0.148 | 0.973 | 2.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Leukocytosis | 0 | 0.041 | 0.11 | 0.973 | 2.551 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Osteonecrosis (SMQ) [broad] | 0 | 0.147 | 0.397 | 0.973 | 1.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B surface antibody | 0 | 0.002 | 0 | 0.973 | 5.409 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laboratory test normal | 0 | 0.127 | 0.367 | 0.973 | 1.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pneumococcal infection | 0 | 0.002 | 0 | 0.973 | 5.67 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deafness | 0 | 0.057 | 0.172 | 0.972 | 2.307 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubella | 0 | 0.005 | 0 | 0.972 | 5.234 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood alkaline phosphatase increased | 0 | 0.044 | 0.117 | 0.972 | 2.516 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tumour lysis syndrome (SMQ) [algorithm] | 0 | 0.03 | 0.057 | 0.972 | 2.854 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypovolaemic shock conditions (SMQ) [narrow] | 0 | 0.037 | 0.087 | 0.972 | 2.664 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfectious encephalitis (SMQ) [narrow] | 0 | 0.042 | 0.112 | 0.972 | 2.54 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Campylobacter infection | 0 | 0.002 | 0 | 0.972 | 5.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram head normal | 0 | 0.113 | 0.328 | 0.972 | 1.893 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiovascular disorder | 0 | 0.015 | 0.005 | 0.972 | 3.662 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Amnesia | 0 | 0.034 | 0.074 | 0.972 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood bilirubin increased | 0 | 0.03 | 0.056 | 0.972 | 2.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | White blood cell count decreased | 0 | 0.06 | 0.179 | 0.972 | 2.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Full blood count normal | 0 | 0.126 | 0.351 | 0.972 | 1.844 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood test normal | 0 | 0.084 | 0.26 | 0.972 | 2.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Night sweats | 0 | 0.086 | 0.26 | 0.971 | 2.051 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hot flush | 0 | 0.097 | 0.278 | 0.971 | 2.003 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flavivirus test positive | 0 | 0.001 | 0 | 0.971 | 2.639 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningitis bacterial | 0 | 0.006 | 0 | 0.971 | 4.934 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parkinson-like events (SMQ) [narrow] | 0 | 0.047 | 0.122 | 0.971 | 2.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory arrest | 0 | 0.085 | 0.251 | 0.971 | 2.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling hot | 0 | 0.357 | 0.557 | 0.971 | 1.478 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Autoimmune thyroiditis | 0 | 0.017 | 0.007 | 0.971 | 3.568 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B virus test positive | 0 | 0.002 | 0 | 0.971 | 5.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apathy | 0 | 0.02 | 0.014 | 0.971 | 3.363 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Axillary pain | 0 | 0.121 | 0.334 | 0.971 | 1.878 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging | 0 | 0.173 | 0.415 | 0.971 | 1.717 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood pressure decreased | 0 | 0.072 | 0.215 | 0.971 | 2.171 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Burning sensation | 0 | 0.17 | 0.413 | 0.971 | 1.72 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis | 0 | 0.02 | 0.012 | 0.97 | 3.403 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Caesarean section | 0 | 0.004 | 0 | 0.97 | 5.411 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lung infiltration | 0 | 0.039 | 0.085 | 0.97 | 2.669 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Streptococcus test positive | 0 | 0.013 | 0.002 | 0.97 | 3.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Arrhythmia | 0 | 0.033 | 0.055 | 0.97 | 2.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Circulatory collapse | 0 | 0.025 | 0.024 | 0.97 | 3.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flatulence | 0 | 0.035 | 0.066 | 0.97 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibrin D dimer increased | 0 | 0.075 | 0.213 | 0.97 | 2.173 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nasopharyngitis | 0 | 0.079 | 0.223 | 0.969 | 2.143 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyskinesia | 0 | 0.069 | 0.19 | 0.969 | 2.241 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram abnormal | 0 | 0.086 | 0.24 | 0.969 | 2.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sudden death | 0 | 0.036 | 0.066 | 0.969 | 2.783 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antibody | 0 | 0.001 | 0 | 0.969 | 3.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular motility disorders (SMQ) [narrow] | 0 | 0.131 | 0.335 | 0.969 | 1.869 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyskinesia (SMQ) [narrow] | 0 | 0.076 | 0.212 | 0.969 | 2.174 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neurodermatitis | 0 | 0.011 | 0 | 0.969 | 4.286 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysmenorrhoea | 0 | 0.005 | 0 | 0.969 | 5.341 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemorrhage | 0 | 0.059 | 0.157 | 0.969 | 2.353 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [broad] | 0 | 0.01 | 0 | 0.968 | 4.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Constipation | 0 | 0.046 | 0.096 | 0.968 | 2.602 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood culture positive | 0 | 0.013 | 0.001 | 0.968 | 4.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fertility disorders (SMQ) [narrow] | 0 | 0.016 | 0.003 | 0.968 | 3.75 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendicitis (narrow) (Custom Term) | 0 | 0.03 | 0.037 | 0.968 | 3.021 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oedema peripheral | 0 | 0.1 | 0.263 | 0.968 | 2.033 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angiogram | 0 | 0.056 | 0.138 | 0.968 | 2.418 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Red blood cell count decreased | 0 | 0.032 | 0.047 | 0.968 | 2.927 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Colposcopy | 0 | 0.002 | 0 | 0.968 | 5.466 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebral haemorrhage | 0 | 0.02 | 0.01 | 0.968 | 3.458 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram abdomen abnormal | 0 | 0.036 | 0.061 | 0.968 | 2.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash papular | 0 | 0.094 | 0.253 | 0.968 | 2.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Postural orthostatic tachycardia syndrome | 0 | 0.011 | 0 | 0.968 | 4.299 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | HLA marker study positive | 0 | 0.006 | 0 | 0.968 | 5.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site erythema | 0 | 0.058 | 0.145 | 0.968 | 2.391 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Stress | 0 | 0.016 | 0.003 | 0.968 | 3.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemic and neurogenic shock conditions (SMQ) [narrow] | 0 | 0.039 | 0.074 | 0.968 | 2.726 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fibromyalgia | 0 | 0.017 | 0.004 | 0.968 | 3.696 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression and suicide/self-injury (SMQ) [narrow] | 0 | 0.044 | 0.094 | 0.968 | 2.615 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Unevaluable event | 0 | 0.107 | 0.273 | 0.967 | 2.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasculitis (SMQ) [narrow] | 0 | 0.074 | 0.19 | 0.967 | 2.233 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac failure congestive | 0 | 0.041 | 0.074 | 0.967 | 2.724 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dry mouth | 0 | 0.062 | 0.148 | 0.967 | 2.378 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pulmonary oedema | 0 | 0.056 | 0.128 | 0.967 | 2.454 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram ST segment elevation | 0 | 0.013 | 0.001 | 0.967 | 4.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysarthria | 0 | 0.129 | 0.315 | 0.967 | 1.907 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Nervousness | 0 | 0.042 | 0.081 | 0.967 | 2.684 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal disorders (SMQ) [narrow] | 0 | 0.079 | 0.203 | 0.967 | 2.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erysipelas | 0 | 0.012 | 0 | 0.967 | 4.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific dysfunction (SMQ) [broad] | 0 | 0.08 | 0.208 | 0.967 | 2.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epistaxis | 0 | 0.066 | 0.162 | 0.967 | 2.327 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hemiparesis | 0 | 0.091 | 0.236 | 0.967 | 2.102 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Diplopia | 0 | 0.044 | 0.087 | 0.967 | 2.647 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product preparation error | 0 | 0.015 | 0.002 | 0.966 | 3.889 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal distension | 0 | 0.053 | 0.113 | 0.966 | 2.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug related hepatic disorders - severe events only (SMQ) [narrow] | 0 | 0.049 | 0.101 | 0.966 | 2.572 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Multiple sclerosis | 0 | 0.014 | 0.001 | 0.966 | 3.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tubulointerstitial diseases (SMQ) [broad] | 0 | 0.08 | 0.196 | 0.966 | 2.211 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypothyroidism (SMQ) [broad] | 0 | 0.043 | 0.079 | 0.966 | 2.693 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug related hepatic disorders - severe events only (SMQ) [broad] | 0 | 0.05 | 0.102 | 0.966 | 2.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C-reactive protein normal | 0 | 0.053 | 0.116 | 0.966 | 2.506 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (SMQ) [narrow] | 0 | 0.007 | 0 | 0.966 | 4.93 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bedridden | 0 | 0.037 | 0.053 | 0.965 | 2.864 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parosmia | 0 | 0.018 | 0.004 | 0.965 | 3.708 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product administered at inappropriate site | 0 | 0.06 | 0.132 | 0.965 | 2.433 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product supply issue | 0 | 0.004 | 0 | 0.965 | 5.571 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Eye pain | 0 | 0.088 | 0.217 | 0.965 | 2.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Procalcitonin increased | 0 | 0.028 | 0.022 | 0.965 | 3.188 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic kidney disease (SMQ) [narrow] | 0 | 0.071 | 0.163 | 0.965 | 2.316 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Deep vein thrombosis | 0 | 0.064 | 0.145 | 0.965 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysstasia | 0 | 0.117 | 0.281 | 0.965 | 1.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral coldness | 0 | 0.069 | 0.154 | 0.964 | 2.346 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Balance disorder | 0 | 0.147 | 0.326 | 0.964 | 1.876 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lactic acidosis (SMQ) [broad] | 0 | 0.085 | 0.199 | 0.964 | 2.197 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersomnia | 0 | 0.07 | 0.154 | 0.964 | 2.344 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Throat irritation | 0 | 0.154 | 0.336 | 0.964 | 1.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemophilus test positive | 0 | 0.005 | 0 | 0.964 | 5.341 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfectious encephalopathy/delirium (SMQ) [narrow] | 0 | 0.058 | 0.122 | 0.964 | 2.475 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Restlessness | 0 | 0.059 | 0.117 | 0.963 | 2.492 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rubella antibody negative | 0 | 0.008 | 0 | 0.963 | 4.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Flushing | 0 | 0.254 | 0.44 | 0.963 | 1.65 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ageusia | 0 | 0.052 | 0.094 | 0.963 | 2.599 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic erythropenia (SMQ) [narrow] | 0 | 0.043 | 0.064 | 0.963 | 2.776 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echocardiogram abnormal | 0 | 0.043 | 0.068 | 0.963 | 2.752 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premalignant disorders (SMQ) [broad] | 0 | 0.023 | 0.009 | 0.963 | 3.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site reaction | 0 | 0.17 | 0.35 | 0.963 | 1.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis norovirus | 0 | 0.004 | 0 | 0.963 | 5.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premalignant disorders (SMQ) [narrow] | 0 | 0.023 | 0.009 | 0.963 | 3.465 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ultrasound Doppler | 0 | 0.042 | 0.062 | 0.963 | 2.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersensitivity (SMQ) [broad] | 5 | 6.019 | 0.641 | 0.962 | 1.337 | 0.452 | 0.834 | 1.436 | 0.831 | 0.708 | 0.458
COVID19_UNKNOWN MFR | Hyperthyroidism (SMQ) [broad] | 0 | 0.045 | 0.066 | 0.962 | 2.757 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vasculitis (SMQ) [broad] | 0 | 0.09 | 0.199 | 0.962 | 2.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal nonspecific inflammation (SMQ) [broad] | 0 | 0.067 | 0.139 | 0.962 | 2.399 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal infections (SMQ) [broad] | 0 | 0.091 | 0.202 | 0.962 | 2.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal infections (SMQ) [narrow] | 0 | 0.091 | 0.202 | 0.962 | 2.183 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Body temperature | 0 | 0.042 | 0.057 | 0.962 | 2.82 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thyroid dysfunction (SMQ) [broad] | 0 | 0.048 | 0.076 | 0.962 | 2.694 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mental impairment | 0 | 0.029 | 0.021 | 0.962 | 3.205 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal obstruction (SMQ) [broad] | 0 | 0.028 | 0.015 | 0.961 | 3.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal obstruction (SMQ) [narrow] | 0 | 0.028 | 0.015 | 0.961 | 3.296 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sensory disturbance | 0 | 0.041 | 0.05 | 0.961 | 2.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antigen positive | 0 | 0.002 | 0 | 0.961 | 5.355 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic-septic shock conditions (SMQ) [narrow] | 0 | 0.063 | 0.121 | 0.961 | 2.468 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mechanical ventilation | 0 | 0.062 | 0.118 | 0.961 | 2.481 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Orthopoxvirus test positive | 0 | 0.001 | 0 | 0.961 | 1.114 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardio-respiratory arrest | 0 | 0.052 | 0.082 | 0.961 | 2.657 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute myocardial infarction | 0 | 0.039 | 0.043 | 0.96 | 2.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infertility female | 0 | 0.004 | 0 | 0.96 | 5.589 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary system related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.046 | 0.062 | 0.96 | 2.78 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lethargy | 0 | 0.242 | 0.413 | 0.96 | 1.692 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dehydration | 0 | 0.11 | 0.236 | 0.96 | 2.083 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mumps antibody test negative | 0 | 0.006 | 0 | 0.96 | 5.367 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [narrow] | 1 | 1.699 | 0.48 | 0.959 | 1.572 | 0.307 | 0.753 | 1.6 | 0.589 | 0.98 | 0.234
COVID19_UNKNOWN MFR | Oropharyngeal conditions (excl neoplasms, infections and allergies) (SMQ) [broad] | 1 | 1.699 | 0.48 | 0.959 | 1.572 | 0.307 | 0.753 | 1.6 | 0.589 | 0.98 | 0.234
COVID19_UNKNOWN MFR | Dehydration (SMQ) [narrow] | 0 | 0.117 | 0.243 | 0.959 | 2.062 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Twin pregnancy | 0 | 0.005 | 0 | 0.959 | 5.493 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Joint range of motion decreased | 0 | 0.063 | 0.112 | 0.959 | 2.501 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lymph node pain | 0 | 0.104 | 0.211 | 0.959 | 2.146 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Measles antibody negative | 0 | 0.007 | 0 | 0.959 | 5.119 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature delivery | 0 | 0.011 | 0 | 0.959 | 4.66 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pharyngeal swelling | 0 | 0.133 | 0.272 | 0.959 | 1.988 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash pruritic | 0 | 0.179 | 0.339 | 0.959 | 1.834 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Computerised tomogram thorax abnormal | 0 | 0.055 | 0.082 | 0.958 | 2.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vision blurred | 0 | 0.174 | 0.325 | 0.958 | 1.861 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cognitive disorder | 0 | 0.026 | 0.008 | 0.958 | 3.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect route of product administration | 0 | 0.069 | 0.122 | 0.958 | 2.453 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alanine aminotransferase normal | 0 | 0.044 | 0.051 | 0.958 | 2.858 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Forced expiratory volume decreased | 0 | 0.003 | 0 | 0.958 | 5.504 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | H1N1 influenza | 0 | 0.005 | 0 | 0.958 | 5.459 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination failure | 0 | 0.023 | 0.005 | 0.958 | 3.613 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection susceptibility increased | 0 | 0.013 | 0 | 0.958 | 4.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Agranulocytosis (SMQ) [broad] | 0 | 0.102 | 0.2 | 0.957 | 2.175 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rheumatoid arthritis | 0 | 0.035 | 0.023 | 0.957 | 3.147 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood urea increased | 0 | 0.075 | 0.133 | 0.957 | 2.406 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Interchange of vaccine products | 0 | 0.013 | 0 | 0.957 | 4.369 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Social problem | 0 | 0.008 | 0 | 0.957 | 5.095 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immunoglobulin therapy | 0 | 0.069 | 0.118 | 0.957 | 2.467 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Throat tightness | 0 | 0.237 | 0.387 | 0.957 | 1.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product dose omission issue | 0 | 0.013 | 0 | 0.957 | 4.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Presyncope | 0 | 0.09 | 0.173 | 0.957 | 2.262 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Allergy to vaccine | 0 | 0.022 | 0.004 | 0.957 | 3.688 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthenia | 1 | 1.238 | 0.351 | 0.956 | 1.802 | 0.339 | 0.827 | 1.754 | 0.808 | 1.243 | 0.119
COVID19_UNKNOWN MFR | Hepatitis A | 0 | 0.003 | 0 | 0.956 | 5.418 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematochezia | 0 | 0.051 | 0.062 | 0.956 | 2.767 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dysphagia | 0 | 0.184 | 0.326 | 0.956 | 1.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antigen positive | 0 | 0.002 | 0 | 0.956 | 3.96 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthma | 0 | 0.058 | 0.082 | 0.956 | 2.64 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging head normal | 0 | 0.068 | 0.107 | 0.956 | 2.515 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aerophobia | 0 | 0.001 | 0 | 0.956 | 1.152 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccine virus shedding | 0 | 0.002 | 0 | 0.956 | 4.715 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dizziness postural | 0 | 0.027 | 0.008 | 0.956 | 3.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory failure | 0 | 0.083 | 0.15 | 0.956 | 2.338 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Asthma/bronchospasm (SMQ) [narrow] | 0 | 0.079 | 0.134 | 0.955 | 2.397 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Movement disorder | 0 | 0.045 | 0.044 | 0.955 | 2.905 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Adverse event | 0 | 0.049 | 0.054 | 0.955 | 2.822 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Appendicitis | 0 | 0.038 | 0.027 | 0.955 | 3.091 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aphasia | 0 | 0.111 | 0.207 | 0.955 | 2.149 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombophlebitis (SMQ) [broad] | 0 | 0.138 | 0.255 | 0.955 | 2.018 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory tract infection | 0 | 0.02 | 0.001 | 0.954 | 3.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [narrow] | 0 | 0.104 | 0.188 | 0.954 | 2.204 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet-derived growth factor receptor assay | 0 | 0.001 | 0 | 0.954 | 3.393 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Aspartate aminotransferase increased | 0 | 0.088 | 0.15 | 0.954 | 2.331 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echocardiogram normal | 0 | 0.06 | 0.082 | 0.954 | 2.636 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin | 0 | 0.062 | 0.086 | 0.954 | 2.616 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular infections (SMQ) [narrow] | 0 | 0.041 | 0.029 | 0.953 | 3.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tinnitus | 0 | 0.136 | 0.242 | 0.953 | 2.047 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuralgia | 0 | 0.065 | 0.089 | 0.953 | 2.591 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypersensitivity | 0 | 0.212 | 0.341 | 0.953 | 1.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Parasite stool test positive | 0 | 0.002 | 0 | 0.953 | 5.02 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paralysis | 0 | 0.045 | 0.039 | 0.953 | 2.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Immune-mediated/autoimmune disorders (SMQ) [broad] | 1 | 1.267 | 0.239 | 0.952 | 2.05 | 0.337 | 0.822 | 1.743 | 0.789 | 1.008 | 0.253
COVID19_UNKNOWN MFR | Off label use | 0 | 0.03 | 0.009 | 0.952 | 3.435 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Epilepsy | 0 | 0.034 | 0.014 | 0.952 | 3.288 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Alanine aminotransferase increased | 0 | 0.083 | 0.13 | 0.952 | 2.402 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza A virus test positive | 0 | 0.011 | 0 | 0.952 | 4.856 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure to SARS-CoV-2 | 0 | 0.011 | 0 | 0.952 | 4.825 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Laboratory test | 0 | 0.311 | 0.42 | 0.952 | 1.658 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional, inflammatory and gallstone related biliary disorders (SMQ) [narrow] | 0 | 0.065 | 0.086 | 0.952 | 2.608 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Torsade de pointes, shock-associated conditions (SMQ) [narrow] | 0 | 0.045 | 0.038 | 0.952 | 2.956 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urticaria | 0 | 0.688 | 0.572 | 0.952 | 1.411 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hostility/aggression (SMQ) [broad] | 0 | 0.251 | 0.367 | 0.951 | 1.756 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Thrombocytopenia | 0 | 0.087 | 0.135 | 0.951 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Norovirus test positive | 0 | 0.003 | 0 | 0.95 | 5.353 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oral administration complication | 0 | 0.01 | 0 | 0.949 | 4.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Skin warm | 0 | 0.257 | 0.366 | 0.949 | 1.755 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest X-ray normal | 0 | 0.163 | 0.263 | 0.949 | 1.981 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Photophobia | 0 | 0.062 | 0.068 | 0.949 | 2.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular motility disorders (SMQ) [broad] | 0 | 0.179 | 0.276 | 0.948 | 1.945 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical conisation | 0 | 0.003 | 0 | 0.948 | 5.333 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute kidney injury | 0 | 0.069 | 0.079 | 0.948 | 2.631 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperglycaemia/new onset diabetes mellitus (SMQ) [narrow] | 0 | 0.192 | 0.291 | 0.948 | 1.91 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuse and dependence (SMQ) [broad] | 0 | 0.161 | 0.256 | 0.948 | 1.998 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Muscle spasms | 0 | 0.148 | 0.234 | 0.948 | 2.052 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site induration | 0 | 0.165 | 0.261 | 0.948 | 1.983 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocarditis | 0 | 0.031 | 0.007 | 0.948 | 3.474 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Full blood count | 0 | 0.302 | 0.393 | 0.948 | 1.698 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematocrit decreased | 0 | 0.055 | 0.049 | 0.948 | 2.838 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular tachyarrhythmias (SMQ) [broad] | 0 | 0.049 | 0.034 | 0.947 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary system related investigations, signs and symptoms (SMQ) [broad] | 0 | 0.109 | 0.163 | 0.947 | 2.265 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pallor | 0 | 0.176 | 0.268 | 0.947 | 1.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normal pregnancy conditions and outcomes (SMQ) [narrow] | 0 | 0.032 | 0.007 | 0.947 | 3.459 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic leukopenia (SMQ) [narrow] | 0 | 0.101 | 0.146 | 0.947 | 2.323 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | C-reactive protein increased | 0 | 0.098 | 0.141 | 0.947 | 2.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ventricular tachyarrhythmias (SMQ) [narrow] | 0 | 0.049 | 0.034 | 0.947 | 2.973 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial infarction | 0 | 0.131 | 0.203 | 0.947 | 2.138 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Loss of personal independence in daily activities | 0 | 0.133 | 0.206 | 0.947 | 2.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sepsis | 0 | 0.089 | 0.117 | 0.946 | 2.438 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neutralising antibodies | 0 | 0.001 | 0 | 0.946 | 0.356 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extrapyramidal syndrome (SMQ) [narrow] | 0 | 0.136 | 0.206 | 0.946 | 2.126 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug abuse, dependence and withdrawal (SMQ) [broad] | 0 | 0.17 | 0.254 | 0.946 | 1.993 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure via skin contact | 0 | 0.031 | 0.006 | 0.946 | 3.529 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Extra dose administered | 0 | 0.106 | 0.154 | 0.946 | 2.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Disturbance in attention | 0 | 0.057 | 0.045 | 0.945 | 2.862 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pericarditis | 0 | 0.029 | 0.004 | 0.945 | 3.609 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fertility disorders (SMQ) [broad] | 0 | 0.031 | 0.005 | 0.945 | 3.547 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oxygen saturation decreased | 0 | 0.164 | 0.241 | 0.945 | 2.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychosis and psychotic disorders (SMQ) [narrow] | 0 | 0.098 | 0.132 | 0.945 | 2.371 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neisseria test positive | 0 | 0.008 | 0 | 0.944 | 5.339 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Metabolic function test | 0 | 0.245 | 0.329 | 0.944 | 1.816 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Normal pregnancy conditions and outcomes (SMQ) [broad] | 0 | 0.035 | 0.008 | 0.944 | 3.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neuropathy peripheral | 0 | 0.047 | 0.026 | 0.944 | 3.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyspnoea exertional | 0 | 0.042 | 0.017 | 0.944 | 3.195 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Antibody test negative | 0 | 0.036 | 0.009 | 0.944 | 3.392 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal discomfort | 0 | 0.156 | 0.229 | 0.944 | 2.057 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary disorders (SMQ) [narrow] | 0 | 0.072 | 0.071 | 0.943 | 2.663 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin I increased | 0 | 0.014 | 0 | 0.943 | 4.677 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal disorders (SMQ) [broad] | 1 | 1.866 | 0.462 | 0.942 | 1.558 | 0.297 | 0.729 | 1.551 | 0.536 | 0.839 | 0.083
COVID19_UNKNOWN MFR | Oropharyngeal disorders (SMQ) [narrow] | 1 | 1.866 | 0.462 | 0.942 | 1.558 | 0.297 | 0.729 | 1.551 | 0.536 | 0.839 | 0.083
COVID19_UNKNOWN MFR | Oropharyngeal allergic conditions (SMQ) [narrow] | 0 | 0.262 | 0.335 | 0.942 | 1.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Paraesthesia oral | 0 | 0.162 | 0.227 | 0.942 | 2.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Oropharyngeal allergic conditions (SMQ) [broad] | 0 | 0.262 | 0.335 | 0.942 | 1.798 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Magnetic resonance imaging head abnormal | 0 | 0.102 | 0.128 | 0.942 | 2.379 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | General physical health deterioration | 0 | 0.073 | 0.072 | 0.942 | 2.653 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Platelet count decreased | 0 | 0.159 | 0.225 | 0.942 | 2.063 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Urinary tract infection | 0 | 0.113 | 0.15 | 0.942 | 2.294 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [narrow] | 0 | 0.004 | 0 | 0.941 | 5.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Feeling cold | 0 | 0.186 | 0.253 | 0.941 | 1.982 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Somnolence | 0 | 0.175 | 0.239 | 0.941 | 2.019 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine and fallopian tube malignant tumours (SMQ) [narrow] | 0 | 0.004 | 0 | 0.941 | 5.413 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypertension | 0 | 0.235 | 0.308 | 0.941 | 1.855 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vaccination site pain | 0 | 0.198 | 0.265 | 0.94 | 1.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal growth restriction | 0 | 0.007 | 0 | 0.94 | 5.441 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Functional, inflammatory and gallstone related biliary disorders (SMQ) [broad] | 0 | 0.13 | 0.172 | 0.94 | 2.213 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Facial paralysis | 0 | 0.343 | 0.381 | 0.939 | 1.697 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Visual impairment | 0 | 0.117 | 0.143 | 0.939 | 2.309 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancy related therapeutic and diagnostic procedures (SMQ) [narrow] | 0 | 0.138 | 0.178 | 0.939 | 2.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Noninfectious meningitis (SMQ) [narrow] | 0 | 0.081 | 0.079 | 0.939 | 2.605 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervix carcinoma | 0 | 0.004 | 0 | 0.939 | 5.175 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antigen | 0 | 0.002 | 0 | 0.939 | 4.108 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancy related therapeutic and diagnostic procedures (SMQ) [broad] | 0 | 0.138 | 0.178 | 0.939 | 2.191 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic leukopenia (SMQ) [broad] | 0 | 0.147 | 0.186 | 0.937 | 2.161 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Other ischaemic heart disease (SMQ) [narrow] | 0 | 0.069 | 0.052 | 0.937 | 2.778 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Expired product administered | 0 | 0.061 | 0.034 | 0.936 | 2.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site rash | 0 | 0.197 | 0.242 | 0.935 | 1.995 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abortion spontaneous | 0 | 0.051 | 0.019 | 0.935 | 3.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood test | 0 | 0.355 | 0.372 | 0.935 | 1.704 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ocular infections (SMQ) [broad] | 0 | 0.115 | 0.125 | 0.934 | 2.365 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hyperpyrexia | 0 | 0.025 | 0 | 0.934 | 4.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Other ischaemic heart disease (SMQ) [broad] | 0 | 0.089 | 0.077 | 0.933 | 2.595 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sepsis (SMQ) [narrow] | 0 | 0.116 | 0.123 | 0.933 | 2.373 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pleural effusion | 0 | 0.053 | 0.019 | 0.932 | 3.124 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Memory impairment | 0 | 0.051 | 0.017 | 0.932 | 3.165 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular disorders (SMQ) [narrow] | 0 | 0.181 | 0.213 | 0.932 | 2.066 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injected limb mobility decreased | 0 | 0.152 | 0.172 | 0.932 | 2.187 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertigo | 0 | 0.193 | 0.221 | 0.931 | 2.039 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Supraventricular tachyarrhythmias (SMQ) [narrow] | 0 | 0.255 | 0.283 | 0.931 | 1.882 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Biliary disorders (SMQ) [broad] | 0 | 0.137 | 0.15 | 0.931 | 2.263 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B core antibody | 0 | 0.002 | 0 | 0.931 | 3.818 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory distress | 0 | 0.087 | 0.066 | 0.93 | 2.651 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Corneal disorders (SMQ) [broad] | 0 | 0.169 | 0.187 | 0.929 | 2.133 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apgar score low | 0 | 0.004 | 0 | 0.929 | 4.986 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Supraventricular tachyarrhythmias (SMQ) [broad] | 0 | 0.255 | 0.277 | 0.929 | 1.892 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant or unspecified tumours (SMQ) [broad] | 0 | 0.098 | 0.08 | 0.928 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic hepatitis B | 0 | 0.002 | 0 | 0.928 | 3.804 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fall | 0 | 0.368 | 0.355 | 0.928 | 1.721 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant or unspecified tumours (SMQ) [narrow] | 0 | 0.098 | 0.08 | 0.928 | 2.562 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Migraine | 0 | 0.172 | 0.182 | 0.927 | 2.142 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Syringe issue | 0 | 0.038 | 0.003 | 0.927 | 3.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Impaired work ability | 0 | 0.195 | 0.211 | 0.927 | 2.056 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal haemorrhage (SMQ) [broad] | 0 | 0.126 | 0.117 | 0.926 | 2.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal haemorrhage (SMQ) [narrow] | 0 | 0.126 | 0.117 | 0.926 | 2.375 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (SMQ) [broad] | 0 | 0.195 | 0.203 | 0.925 | 2.073 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Heart rate increased | 0 | 0.337 | 0.324 | 0.925 | 1.775 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Varicella | 0 | 0.03 | 0.001 | 0.925 | 3.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Guillain-Barre syndrome | 0 | 0.083 | 0.051 | 0.925 | 2.743 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong technique in product usage process | 0 | 0.035 | 0.001 | 0.924 | 3.766 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Polymerase chain reaction positive | 0 | 0.053 | 0.012 | 0.924 | 3.234 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Echocardiogram | 0 | 0.134 | 0.123 | 0.924 | 2.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dyskinesia (SMQ) [broad] | 0 | 0.216 | 0.217 | 0.922 | 2.025 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal disorders (SMQ) [broad] | 0 | 0.034 | 0.001 | 0.922 | 3.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Guillain-Barre syndrome (SMQ) [narrow] | 0 | 0.089 | 0.053 | 0.922 | 2.714 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver related investigations, signs and symptoms (SMQ) [narrow] | 0 | 0.187 | 0.18 | 0.921 | 2.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haemoglobin decreased | 0 | 0.139 | 0.12 | 0.92 | 2.347 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant tumours (SMQ) [narrow] | 0 | 0.1 | 0.065 | 0.92 | 2.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | SARS-CoV-2 test | 0 | 0.176 | 0.165 | 0.92 | 2.176 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignant tumours (SMQ) [broad] | 0 | 0.1 | 0.065 | 0.92 | 2.624 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic thrombocytopenia (SMQ) [narrow] | 0 | 0.219 | 0.21 | 0.919 | 2.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Swelling | 0 | 0.394 | 0.337 | 0.919 | 1.732 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic colitis (SMQ) [broad] | 0 | 0.137 | 0.116 | 0.919 | 2.361 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram abnormal | 0 | 0.1 | 0.061 | 0.918 | 2.644 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic thrombocytopenia (SMQ) [broad] | 0 | 0.221 | 0.207 | 0.918 | 2.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Drug ineffective | 0 | 0.049 | 0.006 | 0.918 | 3.404 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Termination of pregnancy and risk of abortion (SMQ) [broad] | 0 | 0.069 | 0.022 | 0.917 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Termination of pregnancy and risk of abortion (SMQ) [narrow] | 0 | 0.069 | 0.022 | 0.917 | 3.024 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Smear cervix abnormal | 0 | 0.006 | 0 | 0.917 | 5.167 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal disorders (SMQ) [narrow] | 0 | 0.035 | 0.001 | 0.916 | 3.875 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ophthalmic herpes zoster | 0 | 0.02 | 0 | 0.916 | 4.638 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Infection via vaccinee | 0 | 0.004 | 0 | 0.916 | 4.585 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Underdose | 0 | 0.052 | 0.007 | 0.916 | 3.357 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-haematological malignant tumours (SMQ) [broad] | 0 | 0.066 | 0.017 | 0.915 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Non-haematological malignant tumours (SMQ) [narrow] | 0 | 0.066 | 0.017 | 0.915 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Akathisia (SMQ) [broad] | 0 | 0.127 | 0.091 | 0.915 | 2.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute renal failure (SMQ) [narrow] | 0 | 0.163 | 0.135 | 0.914 | 2.268 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Seizure | 0 | 0.217 | 0.193 | 0.914 | 2.072 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Bordetella test positive | 0 | 0.01 | 0 | 0.914 | 5.292 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hydrophobia | 0 | 0.001 | 0 | 0.913 | 0.103 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Angioedema (SMQ) [narrow] | 0 | 1.357 | 0.553 | 0.912 | 1.345 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver related investigations, signs and symptoms (SMQ) [broad] | 0 | 0.212 | 0.182 | 0.912 | 2.099 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rash vesicular | 0 | 0.084 | 0.032 | 0.912 | 2.874 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactic reaction | 0 | 0.178 | 0.146 | 0.912 | 2.219 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute central respiratory depression (SMQ) [narrow] | 0 | 0.324 | 0.271 | 0.911 | 1.857 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gene sequencing | 0 | 0.016 | 0 | 0.91 | 4.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rotavirus test positive | 0 | 0.016 | 0 | 0.91 | 4.964 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachycardia | 0 | 0.231 | 0.192 | 0.909 | 2.06 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Electrocardiogram | 0 | 0.324 | 0.266 | 0.909 | 1.865 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Blood creatinine increased | 0 | 0.131 | 0.083 | 0.909 | 2.482 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Incorrect dose administered | 0 | 0.082 | 0.027 | 0.909 | 2.919 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product use issue | 0 | 0.028 | 0 | 0.909 | 4.26 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal disorders (SMQ) [broad] | 0 | 0.115 | 0.063 | 0.908 | 2.601 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dehydration (SMQ) [broad] | 1 | 1.612 | 0.375 | 0.907 | 1.626 | 0.313 | 0.765 | 1.627 | 0.62 | 1.221 | 0.128
COVID19_UNKNOWN MFR | Haematopoietic erythropenia (SMQ) [broad] | 0 | 0.2 | 0.155 | 0.906 | 2.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lens disorders (SMQ) [broad] | 0 | 0.283 | 0.217 | 0.903 | 1.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Troponin increased | 0 | 0.104 | 0.042 | 0.902 | 2.741 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gait disturbance | 0 | 0.255 | 0.192 | 0.902 | 2.037 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal pain upper | 0 | 0.221 | 0.161 | 0.901 | 2.135 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product administration error | 0 | 0.032 | 0 | 0.9 | 4.154 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Mobility decreased | 0 | 0.4 | 0.281 | 0.899 | 1.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancies (SMQ) [narrow] | 0 | 0.213 | 0.144 | 0.897 | 2.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Malignancies (SMQ) [broad] | 0 | 0.213 | 0.144 | 0.897 | 2.181 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rhinorrhoea | 0 | 0.177 | 0.107 | 0.896 | 2.325 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Accidents and injuries (SMQ) [narrow] | 0 | 0.647 | 0.375 | 0.896 | 1.597 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antigen negative | 0 | 0.008 | 0 | 0.894 | 5.14 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing impairment (SMQ) [narrow] | 0 | 0.304 | 0.202 | 0.891 | 1.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cerebrovascular accident | 0 | 0.238 | 0.154 | 0.891 | 2.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Acute renal failure (SMQ) [broad] | 0 | 0.338 | 0.224 | 0.89 | 1.917 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Psychosis and psychotic disorders (SMQ) [broad] | 0 | 0.317 | 0.206 | 0.889 | 1.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Demyelination (SMQ) [narrow] | 0 | 0.145 | 0.065 | 0.889 | 2.524 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B surface antigen negative | 0 | 0.023 | 0 | 0.888 | 4.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Large for dates baby | 0 | 0.006 | 0 | 0.887 | 4.665 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine and fallopian tube malignant tumours (SMQ) [broad] | 0 | 0.011 | 0 | 0.887 | 5.169 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Demyelination (SMQ) [broad] | 0 | 0.157 | 0.071 | 0.886 | 2.476 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised convulsive seizures following immunisation (SMQ) [narrow] | 0 | 0.27 | 0.168 | 0.886 | 2.068 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression (excl suicide and self injury) (SMQ) [broad] | 0 | 0.328 | 0.206 | 0.886 | 1.952 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [narrow] | 0 | 0.32 | 0.196 | 0.883 | 1.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Tachyarrhythmias (incl supraventricular and ventricular tachyarrhythmias) (SMQ) [broad] | 0 | 0.32 | 0.194 | 0.883 | 1.977 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cardiac failure (SMQ) [narrow] | 0 | 0.168 | 0.077 | 0.883 | 2.434 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic cytopenias (SMQ) [narrow] | 0 | 0.329 | 0.195 | 0.88 | 1.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Abdominal pain | 0 | 0.246 | 0.137 | 0.88 | 2.156 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Erythema | 0 | 0.859 | 0.392 | 0.88 | 1.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Neonatal disorders (SMQ) [narrow] | 0 | 0.123 | 0.034 | 0.879 | 2.739 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactic reaction (SMQ) [narrow] | 0 | 0.247 | 0.137 | 0.879 | 2.156 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opportunistic infections (SMQ) [narrow] | 0 | 0.108 | 0.022 | 0.878 | 2.883 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactic/anaphylactoid shock conditions (SMQ) [narrow] | 0 | 0.251 | 0.136 | 0.878 | 2.151 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sleep disorder | 0 | 0.186 | 0.083 | 0.877 | 2.382 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Depression and suicide/self-injury (SMQ) [broad] | 0 | 0.35 | 0.2 | 0.876 | 1.944 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [narrow] | 0 | 0.197 | 0.086 | 0.874 | 2.353 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Generalised convulsive seizures following immunisation (SMQ) [algorithm] | 0 | 0.297 | 0.161 | 0.874 | 2.055 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastroenteritis rotavirus | 0 | 0.022 | 0 | 0.874 | 4.788 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Uterine and fallopian tube neoplasms, malignant and unspecified (SMQ) [broad] | 0 | 0.013 | 0 | 0.873 | 5.088 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Papilloma viral infection | 0 | 0.01 | 0 | 0.872 | 5.006 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Palpitations | 0 | 0.268 | 0.137 | 0.872 | 2.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B surface antibody positive | 0 | 0.02 | 0 | 0.871 | 4.898 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pertussis | 0 | 0.022 | 0 | 0.87 | 4.814 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Respiratory failure (SMQ) [narrow] | 0 | 0.408 | 0.215 | 0.869 | 1.88 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Syncope | 0 | 0.372 | 0.195 | 0.869 | 1.933 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anxiety | 0 | 0.228 | 0.096 | 0.865 | 2.275 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site warmth | 0 | 0.383 | 0.192 | 0.864 | 1.929 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convulsions (SMQ) [narrow] | 0 | 0.367 | 0.179 | 0.862 | 1.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Human papilloma virus test positive | 0 | 0.017 | 0 | 0.862 | 4.985 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B core antibody negative | 0 | 0.021 | 0 | 0.86 | 4.859 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza like illness | 0 | 0.263 | 0.109 | 0.857 | 2.196 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic central nervous system vascular conditions (SMQ) [narrow] | 0 | 0.419 | 0.196 | 0.856 | 1.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic central nervous system vascular conditions (SMQ) [broad] | 0 | 0.419 | 0.196 | 0.856 | 1.897 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Haematopoietic cytopenias (SMQ) [broad] | 0 | 0.473 | 0.218 | 0.855 | 1.833 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Convulsions (SMQ) [broad] | 0 | 0.38 | 0.172 | 0.854 | 1.961 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Glaucoma (SMQ) [broad] | 0 | 0.544 | 0.245 | 0.854 | 1.762 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product administered to patient of inappropriate age | 0 | 0.101 | 0.007 | 0.852 | 3.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypovolaemic shock conditions (SMQ) [broad] | 0 | 0.308 | 0.127 | 0.85 | 2.104 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B surface antibody negative | 0 | 0.016 | 0 | 0.85 | 4.949 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Toxic-septic shock conditions (SMQ) [broad] | 0 | 0.333 | 0.14 | 0.85 | 2.054 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Optic nerve disorders (SMQ) [broad] | 0 | 0.262 | 0.096 | 0.849 | 2.227 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Gastrointestinal perforation, ulceration, haemorrhage or obstruction (SMQ) [broad] | 0 | 0.346 | 0.143 | 0.848 | 2.035 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site pruritus | 0 | 0.278 | 0.102 | 0.846 | 2.19 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing and vestibular disorders (SMQ) [narrow] | 0 | 0.506 | 0.215 | 0.846 | 1.815 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Retinal disorders (SMQ) [broad] | 0 | 0.458 | 0.193 | 0.845 | 1.872 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Wrong product administered | 0 | 0.187 | 0.045 | 0.845 | 2.514 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Sepsis (SMQ) [broad] | 0 | 0.201 | 0.054 | 0.845 | 2.452 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B core antibody positive | 0 | 0.013 | 0 | 0.844 | 4.839 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hypoglycaemic and neurogenic shock conditions (SMQ) [broad] | 0 | 0.312 | 0.117 | 0.842 | 2.118 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Therapy non-responder | 0 | 0.023 | 0 | 0.841 | 4.801 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Atrial fibrillation | 0 | 0.198 | 0.045 | 0.837 | 2.491 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Low birth weight baby | 0 | 0.013 | 0 | 0.836 | 4.799 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Torsade de pointes, shock-associated conditions (SMQ) [broad] | 0 | 0.316 | 0.108 | 0.835 | 2.129 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing impairment (SMQ) [broad] | 0 | 0.66 | 0.248 | 0.835 | 1.7 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product preparation issue | 0 | 0.06 | 0 | 0.831 | 3.817 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vestibular disorders (SMQ) [broad] | 1 | 2.222 | 0.353 | 0.83 | 1.471 | 0.276 | 0.682 | 1.455 | 0.45 | 0.641 | 0.002
COVID19_UNKNOWN MFR | Hepatitis B DNA increased | 0 | 0.007 | 0 | 0.828 | 3.461 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Influenza | 0 | 0.137 | 0.011 | 0.825 | 2.89 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Cervical dysplasia | 0 | 0.01 | 0 | 0.825 | 4.348 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Dizziness | 1 | 2 | 0.299 | 0.823 | 1.558 | 0.289 | 0.71 | 1.513 | 0.5 | 0.705 | 0.005
COVID19_UNKNOWN MFR | Incomplete course of vaccination | 0 | 0.081 | 0.001 | 0.821 | 3.498 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Opportunistic infections (SMQ) [broad] | 2 | 3.38 | 0.276 | 0.82 | 1.599 | 0.326 | 0.718 | 1.412 | 0.592 | 1.065 | 0.081
COVID19_UNKNOWN MFR | Hepatitis B surface antigen positive | 0 | 0.011 | 0 | 0.82 | 4.343 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver infections (SMQ) [broad] | 0 | 0.057 | 0 | 0.819 | 3.932 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pain in extremity | 1 | 2.055 | 0.312 | 0.818 | 1.516 | 0.286 | 0.703 | 1.498 | 0.487 | 0.449 | 0.256
COVID19_UNKNOWN MFR | Reproductive premalignant disorders (SMQ) [narrow] | 0 | 0.012 | 0 | 0.817 | 4.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Reproductive premalignant disorders (SMQ) [broad] | 0 | 0.012 | 0 | 0.817 | 4.431 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Peripheral neuropathy (SMQ) [narrow] | 0 | 0.335 | 0.095 | 0.817 | 2.13 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B surface antigen | 0 | 0.008 | 0 | 0.814 | 3.594 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Premature baby | 0 | 0.028 | 0 | 0.808 | 4.628 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B antibody negative | 0 | 0.021 | 0 | 0.806 | 4.697 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Apgar score normal | 0 | 0.041 | 0 | 0.806 | 4.323 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Liver infections (SMQ) [narrow] | 0 | 0.053 | 0 | 0.804 | 4.041 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Meningococcal infection | 0 | 0.011 | 0 | 0.801 | 3.963 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chest pain | 0 | 0.513 | 0.142 | 0.796 | 1.887 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (SMQ) [broad] | 0 | 0.405 | 0.097 | 0.792 | 2.045 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Exposure during pregnancy | 0 | 0.222 | 0.024 | 0.789 | 2.525 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Chronic kidney disease (SMQ) [broad] | 0 | 0.467 | 0.113 | 0.786 | 1.958 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hearing and vestibular disorders (SMQ) [broad] | 1 | 2.838 | 0.353 | 0.782 | 1.347 | 0.245 | 0.613 | 1.315 | 0.352 | 0.551 | 0.058
COVID19_UNKNOWN MFR | Malaise | 0 | 0.91 | 0.22 | 0.776 | 1.606 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Post herpetic neuralgia | 0 | 0.034 | 0 | 0.772 | 4.423 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy and neonatal topics (SMQ) [broad] | 0 | 0.481 | 0.103 | 0.772 | 1.957 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic and thrombotic events, arterial (SMQ) [broad] | 0 | 0.367 | 0.064 | 0.771 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Anaphylactic/anaphylactoid shock conditions (SMQ) [broad] | 0 | 0.557 | 0.126 | 0.771 | 1.867 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic and thrombotic events, arterial (SMQ) [narrow] | 0 | 0.367 | 0.064 | 0.771 | 2.145 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Fatigue | 1 | 2.819 | 0.318 | 0.77 | 1.382 | 0.246 | 0.615 | 1.319 | 0.355 | 0.55 | 0.059
COVID19_UNKNOWN MFR | Pregnancy and neonatal topics (SMQ) [narrow] | 0 | 0.474 | 0.098 | 0.769 | 1.97 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B e antibody negative | 0 | 0.011 | 0 | 0.765 | 3.519 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Foetal exposure during pregnancy | 0 | 0.077 | 0 | 0.763 | 3.709 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Injection site erythema | 0 | 0.87 | 0.196 | 0.763 | 1.633 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | COVID-19 pneumonia | 0 | 0.038 | 0 | 0.758 | 4.326 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Illness | 0 | 0.108 | 0 | 0.723 | 3.368 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [broad] | 0 | 0.504 | 0.067 | 0.722 | 1.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (SMQ) [narrow] | 0 | 0.504 | 0.067 | 0.722 | 1.969 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Inappropriate schedule of product administration | 0 | 0.297 | 0.015 | 0.715 | 2.381 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [narrow] | 0 | 0.335 | 0.021 | 0.709 | 2.284 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (SMQ) [broad] | 0 | 0.34 | 0.021 | 0.706 | 2.274 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial infarction (SMQ) [broad] | 0 | 0.387 | 0.029 | 0.705 | 2.172 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic heart disease (SMQ) [narrow] | 0 | 0.373 | 0.019 | 0.683 | 2.212 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Rabies | 0 | 0.007 | 0 | 0.679 | 0.891 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Ischaemic heart disease (SMQ) [broad] | 0 | 0.457 | 0.031 | 0.676 | 2.059 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Myocardial infarction (SMQ) [narrow] | 0 | 0.322 | 0.008 | 0.663 | 2.338 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Vertical infection transmission | 0 | 0.015 | 0 | 0.619 | 1.826 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of efficacy/effect (SMQ) [broad] | 0 | 0.421 | 0.006 | 0.589 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Lack of efficacy/effect (SMQ) [narrow] | 0 | 0.421 | 0.006 | 0.589 | 2.116 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B DNA assay positive | 0 | 0.024 | 0 | 0.589 | 2.538 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Hepatitis B | 0 | 0.04 | 0 | 0.57 | 3.097 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Herpes zoster | 0 | 0.754 | 0.002 | 0.404 | 1.539 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | No adverse event | 0 | 1.167 | 0.006 | 0.373 | 1.273 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Product storage error | 0 | 0.813 | 0.001 | 0.372 | 1.448 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medication errors (SMQ) [narrow] | 0 | 2.313 | 0.03 | 0.352 | 0.974 |  |  |  |  |  | 
COVID19_UNKNOWN MFR | Medication errors (SMQ) [broad] | 0 | 2.568 | 0.03 | 0.335 | 0.918 |  |  |  |  |  |